data_4ca9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 4ca9 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 54.6 mtt . . . . . 0 C--O 1.224 -0.263 0 CA-C-O 120.715 0.293 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 1.64 ' HD1' ' CD2' ' A' ' 8' ' ' PHE . 81.2 t80 -58.7 142.66 49.16 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -172.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.493 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 89.3 t90 -140.08 147.73 40.71 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.131 178.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.408 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -149.93 154.07 25.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.114 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.536 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 51.2 tp -146.61 109.05 4.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.818 0.342 . . . . 0.0 111.237 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -91.47 114.11 26.55 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.375 0.607 . . . . 0.0 111.093 176.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.458 ' HB2' HG21 ' A' ' 85' ' ' VAL . 3.5 mmt -93.15 137.32 32.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.016 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -100.64 153.34 37.79 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 171.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.421 ' HB3' ' HA ' ' A' ' 82' ' ' ASP . 84.1 Cg_exo -46.83 111.34 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.993 2.462 . . . . 0.0 113.096 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.684 ' HA ' ' O ' ' A' ' 79' ' ' THR . 39.6 mt-10 65.95 59.13 0.72 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.498 0.666 . . . . 0.0 111.356 177.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 70.5 mmt-85 -113.3 145.44 41.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.038 172.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.614 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 33.8 ttmt -128.02 111.27 13.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.308 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.403 ' OH ' ' HA ' ' A' ' 13' ' ' MET . 5.6 m-85 -108.69 104.12 13.34 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.686 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.4 ' HB3' ' SD ' ' A' ' 76' ' ' MET . 9.2 p -88.04 99.9 12.52 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 173.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -125.43 138.7 54.02 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.591 0.71 . . . . 0.0 112.378 -167.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 t -85.0 160.24 20.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.751 177.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 53.0 mt -114.14 116.74 53.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.005 0.431 . . . . 0.0 110.862 -176.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.553 HD12 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -104.0 -10.15 9.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.248 176.469 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -142.62 119.35 11.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.794 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.0 m -64.61 135.4 55.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.182 -177.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -147.25 160.78 42.09 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -174.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.472 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 5.3 t60 -114.87 128.07 56.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.405 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.52 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 56.5 mt -94.63 136.45 25.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 171.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.5 ' HB2' ' HB3' ' B' ' 66' ' ' ASP . 72.7 p -119.81 -16.74 8.69 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -170.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -163.78 144.85 9.84 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 119.365 -1.397 . . . . 0.0 113.5 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.404 HG21 ' HG ' ' A' ' 87' ' ' LEU . 12.4 p -129.02 125.71 63.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 170.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.66 152.18 41.02 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.606 -174.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.468 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 3.5 pp -114.26 137.9 51.18 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.871 0.843 . . . . 0.0 111.81 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -106.04 -55.35 2.34 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.436 175.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -101.98 126.87 49.01 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.745 170.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.433 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 147.96 162.51 10.16 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 119.612 -1.28 . . . . 0.0 113.561 176.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.438 ' O ' ' HG3' ' A' ' 58' ' ' LYS . 39.5 mt-30 -102.82 -48.13 4.18 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 178.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -151.77 134.49 15.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.382 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.411 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . . . -135.39 117.46 15.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.376 0.608 . . . . 0.0 111.112 172.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 79' ' ' THR . 48.3 mttm -97.65 116.02 29.06 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 173.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.8 tp -91.44 105.4 17.74 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.154 0.502 . . . . 0.0 110.037 -173.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 1.667 ' HD1' ' CD2' ' A' ' 43' ' ' TYR . 96.9 m-85 -103.43 150.91 23.39 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.256 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.618 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 1.1 tp -133.5 117.41 17.12 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.701 176.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -102.06 104.32 14.96 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.425 0.631 . . . . 0.0 109.615 175.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.402 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -134.28 152.18 51.68 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 57.79 24.14 10.41 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -174.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 58.45 42.24 21.47 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.286 -175.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.486 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 28.2 tp60 -137.62 131.85 32.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.562 178.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -79.58 107.1 12.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.916 0.389 . . . . 0.0 110.45 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 1.625 ' HE2' ' CE1' ' A' ' 51' ' ' TYR . 74.5 m-85 -100.16 129.32 46.17 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.051 176.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.421 HD11 ' CE1' ' A' ' 43' ' ' TYR . 4.6 tp -89.95 99.89 10.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 172.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.458 ' CG1' ' HB3' ' A' ' 44' ' ' LEU . 2.6 m -84.27 -33.79 9.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.131 -169.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -159.3 148.93 18.66 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.117 0.484 . . . . 0.0 111.885 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.2 m -117.39 102.96 9.66 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 170.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.7 p -110.6 116.26 51.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.439 0.638 . . . . 0.0 110.224 -176.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.8 p -122.7 -177.48 3.66 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.297 -175.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 38' ' ' GLN . 52.7 mtmt -59.8 -33.68 72.05 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.99 0.424 . . . . 0.0 110.288 169.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.93 -40.81 68.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.39 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.6 mt -116.6 80.14 10.17 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 174.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -72.38 0.23 7.73 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.804 2.336 . . . . 0.0 113.927 -167.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -162.43 119.21 2.0 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.126 0.489 . . . . 0.0 110.875 -176.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 92.8 t -110.2 101.67 12.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.216 175.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.14 111.36 17.51 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 173.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.05 150.78 52.09 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.079 -171.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.526 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 11.7 t0 -96.0 99.14 10.94 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.345 0.593 . . . . 0.0 110.006 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.52 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 4.2 mt -113.21 141.8 46.54 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.491 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.605 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 6.2 t30 -148.87 132.46 16.79 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.1 177.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.506 ' CZ ' HD23 ' A' ' 67' ' ' LEU . 63.4 m-85 -127.54 158.02 38.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.831 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.9 p -120.97 154.86 35.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.386 178.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.9 11.48 0.38 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -174.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.03 -29.48 9.69 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.678 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -101.53 163.11 12.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.942 0.371 . . . . 0.0 110.929 -175.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -123.14 111.42 16.49 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.9 pt -111.15 161.43 9.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.122 0.487 . . . . 0.0 111.71 -168.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.4 ' SD ' ' HB3' ' A' ' 20' ' ' SER . 4.9 mtm -121.84 124.86 45.13 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 173.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 1.639 ' HD2' ' CD1' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -105.05 128.16 53.2 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.162 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 1.609 ' HD1' ' CD2' ' A' ' 78' ' ' TYR . 30.1 p90 -151.06 138.93 19.88 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.137 -0.625 . . . . 0.0 112.055 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.684 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 11.3 p -109.72 137.54 47.38 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.878 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.68 157.22 18.73 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.588 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.73 -173.9 35.6 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -176.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.421 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 11.6 m-20 -114.05 103.17 10.87 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.843 177.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.433 ' CB ' ' HA3' ' A' ' 37' ' ' GLY . . . -172.31 155.14 3.46 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.153 171.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.5 t -110.41 114.46 27.92 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.468 ' CG1' ' HB3' ' A' ' 34' ' ' LEU . 6.8 m -112.98 143.49 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-O 121.357 0.599 . . . . 0.0 112.15 -174.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.8 t -108.86 118.65 37.34 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.72 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 5.2 mp -94.04 151.9 19.19 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tp -134.31 145.96 49.54 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.177 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.68 -167.52 29.44 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.455 -0.878 . . . . 0.0 112.084 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.593 ' CD2' ' HB3' ' B' ' 68' ' ' ASN . 8.7 p90 -151.54 130.23 12.33 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.732 0.777 . . . . 0.0 111.85 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.2 mt . . . . . 0 C--N 1.321 -0.671 0 CA-C-N 114.121 -1.399 . . . . 0.0 109.595 175.801 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 54.6 mtt . . . . . 0 C--O 1.225 -0.197 0 CA-C-O 120.876 0.369 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . 1.613 ' HE2' ' CE1' ' B' ' 8' ' ' PHE . 80.5 t80 -58.85 142.76 49.61 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -172.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . 0.491 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 89.2 t90 -140.11 147.67 40.56 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.141 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.432 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -149.9 154.03 25.46 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.097 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.546 ' HB3' ' HB2' ' B' ' 87' ' ' LEU . 51.7 tp -146.49 108.9 4.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.772 0.32 . . . . 0.0 111.296 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -91.34 114.06 26.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.332 0.587 . . . . 0.0 111.096 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' MET . . . . . 0.474 ' HB2' HG21 ' B' ' 85' ' ' VAL . 3.5 mmt -93.17 137.27 32.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.964 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -100.55 153.38 37.78 Favored Pre-proline 0 C--N 1.317 -0.828 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 171.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.429 ' HB3' ' HA ' ' B' ' 82' ' ' ASP . 84.2 Cg_exo -46.77 111.21 0.35 Allowed 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 123.058 2.505 . . . . 0.0 113.15 -178.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.684 ' HA ' ' O ' ' B' ' 79' ' ' THR . 39.5 mt-10 66.01 59.11 0.71 Allowed 'General case' 0 C--O 1.233 0.224 0 O-C-N 123.693 0.621 . . . . 0.0 111.316 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 70.5 mmt-85 -113.28 145.47 40.98 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.037 172.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . 0.613 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 33.9 ttmt -128.08 111.26 13.29 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.344 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' TYR . . . . . 0.41 ' OH ' ' HA ' ' B' ' 13' ' ' MET . 5.6 m-85 -108.68 104.05 13.27 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.687 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 9.6 p -88.0 100.03 12.6 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 173.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -125.53 138.74 53.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.59 0.71 . . . . 0.0 112.335 -167.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 14.8 t -85.07 160.36 20.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.691 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 53.0 mt -114.11 116.76 53.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 120.973 0.416 . . . . 0.0 110.877 -176.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.548 ' H ' HD12 ' B' ' 24' ' ' ILE . 0.2 OUTLIER -104.05 -10.24 9.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.257 176.413 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 ptpp? -142.64 119.38 11.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.736 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 23.8 m -64.57 135.46 56.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.21 -177.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -147.28 160.74 42.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.62 0.724 . . . . 0.0 112.908 -174.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' HIS . . . . . 0.478 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 5.3 t60 -114.85 128.06 56.08 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.418 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 56.5 mt -94.67 136.44 25.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 171.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.49 ' HB2' ' HB3' ' C' ' 66' ' ' ASP . 72.5 p -119.86 -16.64 8.67 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.961 -170.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -163.75 144.91 9.89 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 119.424 -1.369 . . . . 0.0 113.497 178.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.401 HG21 ' HG ' ' B' ' 87' ' ' LEU . 12.3 p -129.2 125.68 62.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 170.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.59 152.21 41.12 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 121.921 -0.487 . . . . 0.0 111.629 -174.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.47 ' HB3' ' CG1' ' B' ' 85' ' ' VAL . 3.5 pp -114.32 137.87 51.25 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.906 0.86 . . . . 0.0 111.781 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -105.94 -55.34 2.34 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.482 175.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -101.99 126.87 49.02 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.775 170.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.436 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 147.93 162.56 10.17 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 119.644 -1.265 . . . . 0.0 113.644 176.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . 0.438 ' O ' ' HG3' ' B' ' 58' ' ' LYS . 39.3 mt-30 -102.74 -48.14 4.19 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 178.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -151.86 134.47 15.45 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.433 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.42 ' HB3' ' HB1' ' B' ' 83' ' ' ALA . . . -135.37 117.39 15.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.39 0.614 . . . . 0.0 111.031 172.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' B' ' 79' ' ' THR . 48.3 mttm -97.58 116.01 28.98 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 173.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 53.7 tp -91.37 105.24 17.63 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.156 0.503 . . . . 0.0 110.111 -173.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . 1.667 ' HD1' ' CD2' ' B' ' 43' ' ' TYR . 96.9 m-85 -103.41 150.91 23.38 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.203 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.622 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 1.1 tp -133.55 117.36 17.02 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.619 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -102.03 104.25 14.9 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.382 0.611 . . . . 0.0 109.574 175.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.24 152.3 51.75 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.047 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 57.67 24.19 10.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.132 0.491 . . . . 0.0 109.729 -174.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 58.38 42.34 21.54 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.321 -175.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . 0.487 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 28.3 tp60 -137.67 131.8 31.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.55 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -79.55 107.16 12.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.815 0.341 . . . . 0.0 110.428 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 1.622 ' HE2' ' CE1' ' B' ' 51' ' ' TYR . 74.6 m-85 -100.26 129.27 46.24 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.004 176.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . 0.422 HD11 ' CE1' ' B' ' 43' ' ' TYR . 4.6 tp -89.84 99.93 10.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 172.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.455 ' CG1' ' HB3' ' B' ' 44' ' ' LEU . 2.6 m -84.25 -33.88 9.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.088 -169.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -159.3 148.94 18.66 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.026 0.441 . . . . 0.0 111.959 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 92.6 m -117.44 102.88 9.57 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 170.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 6.7 p -110.57 116.21 51.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.471 0.653 . . . . 0.0 110.225 -176.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 74.4 p -122.69 -177.42 3.64 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.305 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' B' ' 38' ' ' GLN . 52.6 mtmt -59.88 -33.72 72.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.963 0.411 . . . . 0.0 110.285 169.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.86 -40.75 68.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.472 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 74.9 mt -116.66 80.15 10.31 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 174.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -72.4 0.13 7.9 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.923 2.415 . . . . 0.0 113.881 -166.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -162.4 119.24 2.01 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.299 0.571 . . . . 0.0 110.866 -176.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 92.3 t -110.2 101.67 12.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.2 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.14 111.29 17.44 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 173.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.03 150.75 52.11 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.167 -171.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 11.7 t0 -96.0 99.14 10.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.399 0.619 . . . . 0.0 109.993 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.538 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 4.2 mt -113.19 141.8 46.52 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.424 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . 0.593 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 6.2 t30 -148.9 132.49 16.79 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.174 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . 0.509 ' CZ ' HD23 ' B' ' 67' ' ' LEU . 63.5 m-85 -127.6 158.08 38.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.825 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 4.8 p -121.05 154.92 35.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.304 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.92 11.47 0.39 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -174.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.06 -29.52 9.64 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.673 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -101.48 163.13 12.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.785 0.326 . . . . 0.0 110.918 -175.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -123.12 111.48 16.58 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 177.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 27.8 pt -111.2 161.41 9.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.092 0.472 . . . . 0.0 111.704 -168.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' MET . . . . . . . . . . . . . 4.9 mtm -121.82 124.77 44.95 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 173.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . 1.669 ' HE1' ' CE2' ' B' ' 77' ' ' PHE . 0.5 OUTLIER -104.96 128.16 53.11 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.113 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 1.635 ' HE1' ' CE2' ' B' ' 78' ' ' TYR . 30.2 p90 -151.04 138.89 19.86 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.023 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.684 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 11.2 p -109.73 137.5 47.45 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.953 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.48 157.12 18.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.632 176.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.74 -173.76 35.44 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -176.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' ASP . . . . . 0.429 ' HA ' ' HB3' ' B' ' 15' ' ' PRO . 11.7 m-20 -114.14 103.14 10.82 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.763 178.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.436 ' CB ' ' HA3' ' B' ' 37' ' ' GLY . . . -172.31 155.18 3.47 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.131 171.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 24.4 t -110.41 114.32 27.66 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.474 HG21 ' HB2' ' B' ' 13' ' ' MET . 6.8 m -112.86 143.62 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 CA-C-O 121.416 0.627 . . . . 0.0 112.198 -174.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 11.9 t -108.99 118.73 37.55 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.664 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.546 ' HB2' ' HB3' ' B' ' 11' ' ' LEU . 5.2 mp -94.17 151.87 19.15 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 174.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tp -134.25 145.97 49.63 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.124 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.73 -167.51 29.46 Favored Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.053 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' TYR . . . . . 0.582 ' CD2' ' HB3' ' C' ' 68' ' ' ASN . 8.7 p90 -151.62 130.29 12.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.798 0.808 . . . . 0.0 111.842 177.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 6.3 mt . . . . . 0 C--N 1.321 -0.631 0 CA-C-N 114.023 -1.444 . . . . 0.0 109.555 175.841 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 54.7 mtt . . . . . 0 C--O 1.225 -0.192 0 CA-C-O 120.736 0.303 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 8' ' ' PHE . . . . . 1.634 ' HD1' ' CD2' ' C' ' 8' ' ' PHE . 80.8 t80 -58.83 142.74 49.56 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -172.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . 0.491 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 89.1 t90 -140.11 147.67 40.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.169 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . 0.417 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -149.86 153.99 25.43 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.189 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.548 ' HB3' ' HB2' ' C' ' 87' ' ' LEU . 51.5 tp -146.52 109.0 4.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.77 0.319 . . . . 0.0 111.235 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -91.53 114.2 26.67 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.461 0.648 . . . . 0.0 111.005 176.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 13' ' ' MET . . . . . 0.462 ' HB2' HG21 ' C' ' 85' ' ' VAL . 3.5 mmt -93.21 137.29 32.68 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.006 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -100.56 153.29 37.83 Favored Pre-proline 0 C--N 1.318 -0.798 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 171.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . 0.424 ' HB3' ' HA ' ' C' ' 82' ' ' ASP . 85.4 Cg_exo -46.76 111.34 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.056 2.504 . . . . 0.0 113.183 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . 0.686 ' HA ' ' O ' ' C' ' 79' ' ' THR . 39.7 mt-10 65.83 59.2 0.74 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.471 0.653 . . . . 0.0 111.414 178.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 70.4 mmt-85 -113.35 145.46 41.06 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.932 172.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 18' ' ' LYS . . . . . 0.615 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 33.8 ttmt -128.08 111.28 13.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.304 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . 0.404 ' OH ' ' HA ' ' C' ' 13' ' ' MET . 5.6 m-85 -108.69 104.06 13.28 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.695 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 9.4 p -87.94 99.9 12.49 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 173.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -125.47 138.62 54.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.564 0.697 . . . . 0.0 112.368 -167.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 14.8 t -85.03 160.37 20.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.665 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 53.2 mt -114.15 116.81 53.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.915 0.388 . . . . 0.0 110.793 -176.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . 0.545 HD12 ' H ' ' C' ' 24' ' ' ILE . 0.2 OUTLIER -104.0 -10.17 9.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.257 176.362 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . 0.402 ' HD3' HD11 ' C' ' 91' ' ' LEU . 2.5 ptpp? -142.63 119.34 11.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.763 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 24.0 m -64.65 135.41 55.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.185 -177.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 27' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -147.19 160.73 42.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.62 0.724 . . . . 0.0 112.924 -174.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 28' ' ' HIS . . . . . 0.484 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 5.4 t60 -114.89 128.05 56.06 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.38 177.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . 0.522 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 56.7 mt -94.61 136.48 25.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 171.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 30' ' ' SER . . . . . 0.499 ' HB2' ' HB3' ' D' ' 66' ' ' ASP . 72.8 p -119.89 -16.66 8.65 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.97 -170.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 31' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -163.75 144.97 9.95 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 119.45 -1.357 . . . . 0.0 113.457 178.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 12.2 p -129.21 125.68 62.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 170.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.65 152.28 41.16 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.612 -174.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.469 ' HB3' ' CG1' ' C' ' 85' ' ' VAL . 3.5 pp -114.27 137.85 51.25 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.896 0.855 . . . . 0.0 111.794 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -106.03 -55.27 2.35 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.218 -1.356 . . . . 0.0 108.459 175.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -102.02 126.85 49.05 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.765 170.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 37' ' ' GLY . . . . . 0.43 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 147.95 162.56 10.18 Favored Glycine 0 N--CA 1.438 -1.189 0 C-N-CA 119.602 -1.285 . . . . 0.0 113.617 176.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 38' ' ' GLN . . . . . 0.442 ' O ' ' HG3' ' C' ' 58' ' ' LYS . 39.3 mt-30 -102.88 -48.1 4.18 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 178.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -151.84 134.54 15.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.405 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . 0.415 ' HB3' ' HB1' ' C' ' 83' ' ' ALA . . . -135.42 117.44 15.33 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.363 0.601 . . . . 0.0 111.093 172.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' C' ' 79' ' ' THR . 48.2 mttm -97.72 116.0 29.08 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 173.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 54.0 tp -91.44 105.4 17.74 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.12 0.486 . . . . 0.0 110.001 -173.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 43' ' ' TYR . . . . . 1.669 ' HE1' ' CE2' ' C' ' 43' ' ' TYR . 96.9 m-85 -103.49 150.83 23.51 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.218 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.618 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 1.1 tp -133.44 117.4 17.16 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.66 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -102.07 104.24 14.86 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.349 0.595 . . . . 0.0 109.582 175.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.21 152.21 51.71 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 57.74 24.11 10.3 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -174.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 58.43 42.33 21.42 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.255 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . 0.482 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 28.1 tp60 -137.65 131.91 32.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.628 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -79.72 107.17 12.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.804 0.335 . . . . 0.0 110.399 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 1.643 ' HE2' ' CE1' ' C' ' 51' ' ' TYR . 74.7 m-85 -100.3 129.24 46.27 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.976 176.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . 0.42 HD11 ' CE1' ' C' ' 43' ' ' TYR . 4.6 tp -89.83 99.88 10.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 172.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 53' ' ' VAL . . . . . 0.447 ' CG1' ' HB3' ' C' ' 44' ' ' LEU . 2.6 m -84.27 -33.77 9.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.129 -170.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 54' ' ' ALA . . . . . . . . . . . . . . . -159.37 148.96 18.55 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.093 0.473 . . . . 0.0 111.908 177.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 92.3 m -117.38 102.84 9.56 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 170.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 6.7 p -110.6 116.35 52.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.498 0.666 . . . . 0.0 110.193 -176.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 74.3 p -122.75 -177.43 3.65 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.202 -175.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 58' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' C' ' 38' ' ' GLN . 52.6 mtmt -59.76 -33.71 72.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.119 0.485 . . . . 0.0 110.345 169.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.95 -40.79 68.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.371 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 74.4 mt -116.64 80.18 10.29 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -72.5 0.32 7.67 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.835 2.357 . . . . 0.0 113.831 -166.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -162.5 119.1 1.97 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.165 0.507 . . . . 0.0 110.86 -176.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 91.9 t -110.19 101.7 12.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.198 175.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.06 111.22 17.32 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 173.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -132.99 150.8 52.13 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.206 -171.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 66' ' ' ASP . . . . . 0.49 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 11.6 t0 -96.02 99.18 10.97 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.415 0.626 . . . . 0.0 109.981 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . 0.522 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 4.1 mt -113.25 141.87 46.48 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.427 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . 0.582 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 6.2 t30 -148.91 132.5 16.78 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.175 177.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 69' ' ' PHE . . . . . 0.498 ' CZ ' HD23 ' C' ' 67' ' ' LEU . 63.7 m-85 -127.65 157.95 38.88 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.795 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 4.8 p -120.96 154.91 35.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.329 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.92 11.41 0.39 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -174.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.97 -29.61 9.62 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.688 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -101.36 163.11 12.43 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 122.575 -0.367 . . . . 0.0 111.039 -175.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -123.13 111.42 16.5 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 27.8 pt -111.09 161.38 9.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.142 0.496 . . . . 0.0 111.706 -168.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 76' ' ' MET . . . . . . . . . . . . . 4.9 mtm -121.84 124.84 45.09 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 173.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 77' ' ' PHE . . . . . 1.657 ' HE1' ' CE2' ' C' ' 77' ' ' PHE . 0.5 OUTLIER -105.05 128.16 53.2 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.158 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 78' ' ' TYR . . . . . 1.631 ' HD1' ' CD2' ' C' ' 78' ' ' TYR . 30.3 p90 -151.08 138.9 19.84 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.217 -0.593 . . . . 0.0 112.008 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 79' ' ' THR . . . . . 0.686 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 11.3 p -109.68 137.54 47.35 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.926 -179.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.53 157.23 18.65 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.619 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.65 -173.85 35.67 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -176.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 82' ' ' ASP . . . . . 0.424 ' HA ' ' HB3' ' C' ' 15' ' ' PRO . 11.5 m-20 -114.05 103.14 10.84 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 119.601 -0.839 . . . . 0.0 109.8 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . 0.43 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -172.35 155.14 3.44 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.159 171.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 25.0 t -110.3 114.49 27.99 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.469 ' CG1' ' HB3' ' C' ' 34' ' ' LEU . 6.8 m -113.03 143.57 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 CA-C-O 121.419 0.628 . . . . 0.0 112.118 -174.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 12.0 t -108.94 118.75 37.61 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.617 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . 0.548 ' HB2' ' HB3' ' C' ' 11' ' ' LEU . 5.2 mp -94.15 151.89 19.15 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 174.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tp -134.27 145.96 49.59 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.092 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.72 -167.51 29.46 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.228 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 90' ' ' TYR . . . . . 0.595 ' CD2' ' HB3' ' D' ' 68' ' ' ASN . 8.7 p90 -151.55 130.2 12.3 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.777 0.799 . . . . 0.0 111.901 177.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . 0.402 HD11 ' HD3' ' C' ' 25' ' ' LYS . 6.2 mt . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.643 175.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 54.6 mtt . . . . . 0 C--O 1.226 -0.134 0 CA-C-O 120.745 0.307 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 8' ' ' PHE . . . . . 1.661 ' HE1' ' CE2' ' D' ' 8' ' ' PHE . 81.0 t80 -58.7 142.66 49.15 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -172.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 9' ' ' TRP . . . . . 0.493 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 89.3 t90 -140.07 147.63 40.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.153 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . 0.434 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -149.84 154.0 25.45 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.215 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . 0.536 ' HB3' ' HB2' ' D' ' 87' ' ' LEU . 51.2 tp -146.55 109.0 4.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.777 0.322 . . . . 0.0 111.173 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -91.41 114.1 26.54 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.375 0.607 . . . . 0.0 111.134 176.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 13' ' ' MET . . . . . 0.464 ' HB2' HG21 ' D' ' 85' ' ' VAL . 3.5 mmt -93.12 137.33 32.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.017 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -100.6 153.37 37.78 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 171.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . 0.417 ' HB3' ' HA ' ' D' ' 82' ' ' ASP . 83.8 Cg_exo -46.82 111.4 0.38 Allowed 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.025 2.484 . . . . 0.0 113.103 -178.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . 0.674 ' HA ' ' O ' ' D' ' 79' ' ' THR . 39.6 mt-10 65.87 59.06 0.74 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.538 0.685 . . . . 0.0 111.446 177.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 70.7 mmt-85 -113.29 145.35 41.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.02 172.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . 0.589 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 33.8 ttmt -127.95 111.22 13.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.331 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 19' ' ' TYR . . . . . 0.407 ' OH ' ' HA ' ' D' ' 13' ' ' MET . 5.6 m-85 -108.56 104.17 13.43 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.662 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 20' ' ' SER . . . . . 0.4 ' HB3' ' SD ' ' D' ' 76' ' ' MET . 9.3 p -88.05 99.99 12.59 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 173.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -125.51 138.73 53.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.553 0.692 . . . . 0.0 112.324 -167.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 14.7 t -85.03 160.29 20.04 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.698 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 53.4 mt -114.14 116.7 53.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.053 0.454 . . . . 0.0 110.845 -176.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . 0.539 HD12 ' H ' ' D' ' 24' ' ' ILE . 0.2 OUTLIER -103.9 -10.21 9.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.287 176.36 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 ptpp? -142.65 119.35 11.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.751 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 23.9 m -64.65 135.44 55.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.246 -177.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 27' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -147.23 160.69 42.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.664 0.745 . . . . 0.0 112.837 -174.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 28' ' ' HIS . . . . . 0.481 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 5.4 t60 -114.8 128.01 56.06 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.5 177.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 29' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 56.6 mt -94.59 136.45 25.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 171.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 30' ' ' SER . . . . . 0.481 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 72.7 p -119.77 -16.73 8.71 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -170.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 31' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -163.82 144.84 9.82 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 119.331 -1.414 . . . . 0.0 113.447 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 12.3 p -129.05 125.72 63.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 170.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.66 152.21 41.06 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 121.882 -0.512 . . . . 0.0 111.615 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 34' ' ' LEU . . . . . 0.467 ' HB3' ' CG1' ' D' ' 85' ' ' VAL . 3.5 pp -114.28 137.76 51.37 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 121.905 0.859 . . . . 0.0 111.845 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -105.84 -55.39 2.33 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.218 -1.356 . . . . 0.0 108.524 175.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -101.92 126.91 48.93 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.822 170.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . 0.429 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 147.87 162.57 10.17 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 119.622 -1.275 . . . . 0.0 113.614 176.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 38' ' ' GLN . . . . . 0.438 ' O ' ' HG3' ' D' ' 58' ' ' LYS . 39.3 mt-30 -102.84 -48.17 4.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -151.82 134.5 15.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.447 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . 0.43 ' HB3' ' HB1' ' D' ' 83' ' ' ALA . . . -135.34 117.54 15.52 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.428 0.633 . . . . 0.0 111.152 172.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' D' ' 79' ' ' THR . 48.3 mttm -97.79 116.06 29.25 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 173.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 53.7 tp -91.45 105.35 17.7 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.163 0.506 . . . . 0.0 110.051 -173.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 43' ' ' TYR . . . . . 1.65 ' HD2' ' CD1' ' D' ' 43' ' ' TYR . 96.9 m-85 -103.46 150.92 23.41 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.17 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.613 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 1.1 tp -133.54 117.35 17.01 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.728 177.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 45' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -102.03 104.3 14.94 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.423 0.63 . . . . 0.0 109.543 175.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.27 152.14 51.65 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 57.85 24.17 10.54 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -174.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 58.32 42.26 21.88 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.298 -175.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . 0.486 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 28.1 tp60 -137.55 131.87 32.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.615 178.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -79.66 107.17 12.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.896 0.379 . . . . 0.0 110.401 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . 1.652 ' HE2' ' CE1' ' D' ' 51' ' ' TYR . 74.5 m-85 -100.3 129.28 46.27 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.047 176.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 52' ' ' ILE . . . . . 0.417 HD11 ' CE1' ' D' ' 43' ' ' TYR . 4.6 tp -89.89 99.84 10.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 172.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 53' ' ' VAL . . . . . 0.448 ' CG1' ' HB3' ' D' ' 44' ' ' LEU . 2.6 m -84.29 -33.69 9.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.147 -169.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 54' ' ' ALA . . . . . . . . . . . . . . . -159.33 148.93 18.6 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.072 0.463 . . . . 0.0 111.971 177.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 92.4 m -117.45 102.89 9.58 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 170.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 56' ' ' VAL . . . . . . . . . . . . . 6.8 p -110.57 116.34 52.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.582 0.706 . . . . 0.0 110.215 -176.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 74.0 p -122.81 -177.47 3.67 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.206 -175.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 58' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' D' ' 38' ' ' GLN . 52.7 mtmt -59.89 -33.58 72.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.021 0.439 . . . . 0.0 110.357 169.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.05 -40.67 68.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.313 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 74.8 mt -116.67 80.19 10.38 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 174.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.54 0.36 7.64 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.824 2.35 . . . . 0.0 113.84 -166.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -162.52 119.12 1.96 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.157 0.504 . . . . 0.0 110.844 -176.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 91.9 t -110.12 101.74 12.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.193 176.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.07 111.3 17.4 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.529 173.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 65' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.05 150.79 52.09 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.153 -171.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 66' ' ' ASP . . . . . 0.499 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 11.6 t0 -96.08 99.18 10.96 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.499 0.666 . . . . 0.0 110.006 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . 0.531 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 4.2 mt -113.15 141.88 46.42 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.447 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 68' ' ' ASN . . . . . 0.595 ' HB3' ' CD2' ' C' ' 90' ' ' TYR . 6.3 t30 -148.92 132.54 16.81 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.1 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 69' ' ' PHE . . . . . 0.516 ' CZ ' HD23 ' D' ' 67' ' ' LEU . 63.7 m-85 -127.74 157.97 38.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.764 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 4.7 p -120.97 154.89 35.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.281 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.87 11.48 0.38 Allowed 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -174.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.0 -29.66 9.55 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.592 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -101.35 163.1 12.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.906 0.353 . . . . 0.0 111.012 -175.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -123.14 111.43 16.51 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . . . . . . . . . 27.7 pt -111.1 161.38 9.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.039 0.447 . . . . 0.0 111.719 -168.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 76' ' ' MET . . . . . 0.4 ' SD ' ' HB3' ' D' ' 20' ' ' SER . 4.9 mtm -121.88 124.82 45.0 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 173.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 77' ' ' PHE . . . . . 1.645 ' HE1' ' CE2' ' D' ' 77' ' ' PHE . 0.5 OUTLIER -105.02 128.16 53.19 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.163 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 78' ' ' TYR . . . . . 1.612 ' HE2' ' CE1' ' D' ' 78' ' ' TYR . 30.4 p90 -151.07 138.87 19.82 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.245 -0.582 . . . . 0.0 112.108 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 79' ' ' THR . . . . . 0.674 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 11.4 p -109.71 137.57 47.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.923 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.57 157.17 18.72 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.612 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.8 -173.88 35.46 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 -176.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 82' ' ' ASP . . . . . 0.417 ' HA ' ' HB3' ' D' ' 15' ' ' PRO . 11.5 m-20 -114.03 103.27 10.97 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.803 177.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.43 ' HB1' ' HB3' ' D' ' 40' ' ' ALA . . . -172.4 155.19 3.41 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.083 171.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 24.4 t -110.44 114.42 27.84 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . 0.467 ' CG1' ' HB3' ' D' ' 34' ' ' LEU . 6.8 m -112.89 143.66 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-O 121.347 0.594 . . . . 0.0 112.159 -174.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 12.0 t -109.04 118.63 37.28 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.67 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 87' ' ' LEU . . . . . 0.536 ' HB2' ' HB3' ' D' ' 11' ' ' LEU . 5.2 mp -93.96 151.82 19.28 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 174.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tp -134.31 145.99 49.58 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.113 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.76 -167.49 29.46 Favored Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.087 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 90' ' ' TYR . . . . . 0.568 ' CD2' ' HB3' ' E' ' 68' ' ' ASN . 8.7 p90 -151.56 130.22 12.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.755 0.788 . . . . 0.0 111.876 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 6.2 mt . . . . . 0 C--N 1.321 -0.669 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.631 175.801 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 54.7 mtt . . . . . 0 C--O 1.225 -0.21 0 CA-C-O 120.834 0.35 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' E' E ' 8' ' ' PHE . . . . . 1.662 ' HE2' ' CE1' ' E' ' 8' ' ' PHE . 81.0 t80 -58.78 142.73 49.36 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -172.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 9' ' ' TRP . . . . . 0.493 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 89.2 t90 -140.11 147.71 40.64 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.104 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 10' ' ' GLY . . . . . 0.402 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -149.9 153.92 25.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.181 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 11' ' ' LEU . . . . . 0.525 ' HB3' ' HB2' ' E' ' 87' ' ' LEU . 51.6 tp -146.46 108.95 4.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.732 0.301 . . . . 0.0 111.251 -178.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -91.46 114.17 26.63 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.461 0.648 . . . . 0.0 110.994 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 13' ' ' MET . . . . . 0.469 ' HB2' HG21 ' E' ' 85' ' ' VAL . 3.5 mmt -93.15 137.32 32.6 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.043 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -100.67 153.31 37.81 Favored Pre-proline 0 C--N 1.318 -0.791 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 171.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . 0.428 ' HB3' ' HA ' ' E' ' 82' ' ' ASP . 84.9 Cg_exo -46.67 111.32 0.36 Allowed 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 123.08 2.52 . . . . 0.0 113.139 -178.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 16' ' ' GLU . . . . . 0.68 ' HA ' ' O ' ' E' ' 79' ' ' THR . 39.6 mt-10 65.94 59.02 0.73 Allowed 'General case' 0 C--O 1.232 0.181 0 O-C-N 123.77 0.669 . . . . 0.0 111.445 177.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 17' ' ' ARG . . . . . 0.402 ' HD3' ' HA ' ' E' ' 17' ' ' ARG . 70.4 mmt-85 -113.32 145.49 40.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.945 172.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . 0.614 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 33.8 ttmt -128.07 111.28 13.32 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.376 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . 0.404 ' OH ' ' HA ' ' E' ' 13' ' ' MET . 5.6 m-85 -108.61 104.03 13.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.681 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 9.4 p -88.06 99.96 12.57 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 173.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -125.45 138.71 54.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.543 0.687 . . . . 0.0 112.32 -167.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 14.8 t -85.1 160.29 20.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.701 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 53.4 mt -114.02 116.85 53.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 120.995 0.426 . . . . 0.0 110.856 -176.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . 0.547 HD12 ' H ' ' E' ' 24' ' ' ILE . 0.2 OUTLIER -104.08 -10.21 9.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.264 176.393 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 ptpp? -142.57 119.32 11.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.793 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 24.0 m -64.55 135.4 55.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.249 -177.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 27' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -147.22 160.76 42.09 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -174.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 28' ' ' HIS . . . . . 0.47 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 5.3 t60 -114.93 127.99 56.02 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.348 177.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 29' ' ' ILE . . . . . 0.529 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 56.6 mt -94.54 136.45 25.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 171.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 30' ' ' SER . . . . . 0.526 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 72.6 p -119.84 -16.67 8.68 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.712 -0.395 . . . . 0.0 112.018 -170.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 31' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -163.8 144.83 9.82 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 119.335 -1.412 . . . . 0.0 113.456 178.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 12.3 p -129.07 125.74 63.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 170.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.64 152.17 41.02 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.948 -0.47 . . . . 0.0 111.642 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 34' ' ' LEU . . . . . 0.468 ' HB3' ' CG1' ' E' ' 85' ' ' VAL . 3.5 pp -114.35 137.87 51.26 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 122.044 0.926 . . . . 0.0 111.719 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -106.09 -55.25 2.35 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.062 -1.427 . . . . 0.0 108.424 175.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -102.0 126.83 49.01 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.81 170.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . 0.429 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 147.94 162.52 10.16 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 119.576 -1.297 . . . . 0.0 113.596 176.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 38' ' ' GLN . . . . . 0.432 ' O ' ' HG3' ' E' ' 58' ' ' LYS . 39.2 mt-30 -102.77 -48.18 4.18 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 178.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -151.77 134.48 15.54 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.452 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . 0.411 ' HB3' ' HB1' ' E' ' 83' ' ' ALA . . . -135.27 117.34 15.38 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.278 0.561 . . . . 0.0 111.195 172.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 41' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' E' ' 79' ' ' THR . 48.2 mttm -97.62 116.08 29.15 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 173.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 53.6 tp -91.4 105.38 17.73 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.161 0.505 . . . . 0.0 110.053 -173.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 43' ' ' TYR . . . . . 1.665 ' HE1' ' CE2' ' E' ' 43' ' ' TYR . 97.1 m-85 -103.53 150.93 23.45 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.194 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 44' ' ' LEU . . . . . 0.611 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 1.1 tp -133.6 117.34 16.95 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.694 177.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 45' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -102.0 104.32 14.98 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.363 0.601 . . . . 0.0 109.554 175.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . 0.4 ' HB3' HD12 ' E' ' 44' ' ' LEU . . . -134.33 152.07 51.6 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 57.89 24.12 10.55 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -174.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 58.32 42.41 21.64 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.264 -175.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 49' ' ' GLN . . . . . 0.486 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 28.1 tp60 -137.61 131.84 32.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.545 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -79.66 107.22 12.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.909 0.385 . . . . 0.0 110.387 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . 1.644 ' HE2' ' CE1' ' E' ' 51' ' ' TYR . 74.5 m-85 -100.27 129.32 46.25 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.109 175.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 52' ' ' ILE . . . . . 0.414 HD11 ' CE1' ' E' ' 43' ' ' TYR . 4.6 tp -89.91 99.93 10.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 172.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . 0.452 ' CG1' ' HB3' ' E' ' 44' ' ' LEU . 2.6 m -84.32 -33.76 9.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.097 -169.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 54' ' ' ALA . . . . . . . . . . . . . . . -159.4 148.88 18.45 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.095 0.474 . . . . 0.0 111.887 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 92.4 m -117.36 102.9 9.62 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 170.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . . . . . . . . . 6.7 p -110.56 116.28 51.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.51 0.672 . . . . 0.0 110.214 -176.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 73.9 p -122.74 -177.44 3.65 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.248 -175.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 58' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' E' ' 38' ' ' GLN . 52.7 mtmt -59.86 -33.66 72.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.044 0.45 . . . . 0.0 110.309 169.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.92 -40.73 68.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.39 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 74.6 mt -116.64 80.09 10.22 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 174.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -72.46 0.27 7.73 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.87 2.38 . . . . 0.0 113.83 -166.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -162.44 119.11 1.99 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.196 0.522 . . . . 0.0 110.85 -176.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 92.0 t -110.09 101.72 12.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.232 175.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.21 111.26 17.47 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 173.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 65' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.0 150.87 52.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.109 -171.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 66' ' ' ASP . . . . . 0.473 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 11.6 t0 -96.06 99.11 10.89 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.414 0.626 . . . . 0.0 110.042 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 67' ' ' LEU . . . . . 0.529 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 4.1 mt -113.12 141.83 46.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.436 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 68' ' ' ASN . . . . . 0.568 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 6.2 t30 -148.92 132.48 16.76 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.068 177.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 69' ' ' PHE . . . . . 0.517 ' CZ ' HD23 ' E' ' 67' ' ' LEU . 63.4 m-85 -127.62 158.01 38.69 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.873 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 4.8 p -121.01 154.84 35.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.317 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.82 11.41 0.38 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -174.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.03 -29.57 9.62 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.626 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -101.45 163.13 12.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.95 0.405 . . . . 0.0 110.92 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -123.06 111.57 16.72 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 75' ' ' ILE . . . . . . . . . . . . . 27.9 pt -111.3 161.29 9.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.053 0.454 . . . . 0.0 111.697 -168.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 76' ' ' MET . . . . . . . . . . . . . 4.9 mtm -121.74 124.88 45.27 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 173.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 77' ' ' PHE . . . . . 1.637 ' HE2' ' CE1' ' E' ' 77' ' ' PHE . 0.5 OUTLIER -105.11 128.08 53.19 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.19 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 78' ' ' TYR . . . . . 1.651 ' HD1' ' CD2' ' E' ' 78' ' ' TYR . 30.2 p90 -151.01 138.86 19.86 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.059 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 79' ' ' THR . . . . . 0.68 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 11.1 p -109.74 137.55 47.38 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.898 -178.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.57 157.15 18.74 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.655 176.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.77 -173.84 35.46 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 82' ' ' ASP . . . . . 0.428 ' HA ' ' HB3' ' E' ' 15' ' ' PRO . 11.7 m-20 -114.05 103.18 10.88 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 119.609 -0.836 . . . . 0.0 109.873 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 83' ' ' ALA . . . . . 0.429 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -172.36 155.19 3.44 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.18 171.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 24.3 t -110.42 114.45 27.9 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 85' ' ' VAL . . . . . 0.469 HG21 ' HB2' ' E' ' 13' ' ' MET . 6.8 m -112.97 143.61 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 CA-C-O 121.514 0.673 . . . . 0.0 112.124 -174.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 11.9 t -108.97 118.73 37.56 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.641 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 87' ' ' LEU . . . . . 0.525 ' HB2' ' HB3' ' E' ' 11' ' ' LEU . 5.2 mp -94.17 151.89 19.13 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 174.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tp -134.32 145.95 49.52 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.089 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.73 -167.5 29.44 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.114 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 90' ' ' TYR . . . . . 0.605 ' CD2' ' HB3' ' A' ' 68' ' ' ASN . 8.8 p90 -151.58 130.24 12.31 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.742 0.782 . . . . 0.0 111.835 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 91' ' ' LEU . . . . . . . . . . . . . 6.3 mt . . . . . 0 C--N 1.321 -0.663 0 CA-C-N 114.051 -1.431 . . . . 0.0 109.595 175.799 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 51.2 mtt . . . . . 0 CA--C 1.52 -0.191 0 CA-C-O 121.18 0.514 . . . . 0.0 111.603 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.505 ' CE1' HD22 ' B' ' 44' ' ' LEU . 60.7 t80 -60.51 141.3 56.68 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.323 -174.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.491 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 91.9 t90 -130.41 144.8 51.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.915 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.1 140.81 9.11 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.395 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.491 ' HB2' ' CH2' ' A' ' 9' ' ' TRP . 56.6 tp -133.37 109.1 9.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.841 0.353 . . . . 0.0 110.348 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -97.78 104.11 16.11 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.636 ' SD ' HD12 ' A' ' 87' ' ' LEU . 35.9 mtp -98.4 137.86 36.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.588 -175.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -101.3 159.01 30.68 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.939 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.421 ' HB3' ' HA ' ' A' ' 82' ' ' ASP . 68.5 Cg_exo -42.89 118.45 1.22 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.752 2.968 . . . . 0.0 114.24 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.705 ' HA ' ' O ' ' A' ' 79' ' ' THR . 49.5 mt-10 57.16 55.99 5.54 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.068 174.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 78' ' ' TYR . 30.5 mmt180 -116.98 144.09 44.97 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.099 175.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.619 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 35.6 ttmt -126.23 112.78 16.16 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 123.491 0.494 . . . . 0.0 111.143 -176.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 1.609 ' HE1' ' CE2' ' A' ' 19' ' ' TYR . 2.3 m-85 -111.27 104.89 13.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.252 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.402 ' HB3' ' SD ' ' A' ' 76' ' ' MET . 3.7 p -88.2 104.8 17.05 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 173.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -124.13 148.11 47.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.432 0.634 . . . . 0.0 112.696 -168.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.2 t -90.96 161.06 15.32 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.513 175.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.409 HD11 ' HB2' ' A' ' 69' ' ' PHE . 67.6 mt -114.25 131.36 66.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.101 0.477 . . . . 0.0 111.62 -173.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.465 HD13 ' N ' ' A' ' 24' ' ' ILE . 4.2 mp -99.25 -48.92 11.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.085 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -114.46 140.55 48.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.657 177.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.2 m -63.54 109.4 1.64 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 1.632 ' HD2' ' CD1' ' A' ' 27' ' ' PHE . 14.7 p90 -125.02 159.54 31.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.626 0.727 . . . . 0.0 112.886 -170.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.566 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 9.4 t60 -116.45 125.85 52.57 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.077 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.522 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 61.2 mt -92.42 133.12 34.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 170.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.566 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 32.8 p -118.9 -14.35 9.43 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -169.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -167.33 147.98 12.49 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 119.153 -1.498 . . . . 0.0 113.416 178.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.4 p -134.63 129.06 51.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 172.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.08 155.5 42.24 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.896 -0.503 . . . . 0.0 111.653 -174.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.426 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 4.0 pp -120.98 142.27 49.93 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.442 0.639 . . . . 0.0 111.205 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.418 ' HB2' ' HH ' ' B' ' 43' ' ' TYR . 12.9 p-10 -110.03 -50.08 3.01 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.572 173.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -103.18 127.45 50.47 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 168.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.436 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 152.21 158.97 8.7 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 119.906 -1.14 . . . . 0.0 113.19 176.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.452 ' O ' ' HG3' ' A' ' 58' ' ' LYS . 94.5 mt-30 -102.59 -45.35 5.07 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 120.625 0.25 . . . . 0.0 111.379 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -153.68 130.48 10.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.238 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.426 ' HB1' HG11 ' A' ' 56' ' ' VAL . . . -131.35 113.86 14.29 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.367 0.603 . . . . 0.0 110.492 169.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -97.14 111.6 23.76 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.453 ' HG ' ' CG2' ' A' ' 53' ' ' VAL . 45.4 tp -83.6 112.57 20.14 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.624 -174.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -110.96 137.17 48.92 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.293 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.577 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 1.2 tp -120.56 119.36 32.71 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.383 175.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -106.19 114.15 28.1 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.227 0.537 . . . . 0.0 109.671 176.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.535 ' HB1' ' CE2' ' E' ' 8' ' ' PHE . . . -145.97 154.59 42.08 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.98 -178.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 57.98 27.83 15.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.938 0.399 . . . . 0.0 110.381 -176.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm 59.22 44.6 15.42 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.743 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -150.86 140.22 21.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.963 178.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -85.98 126.99 34.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.18 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 1.609 ' HD1' ' CD2' ' A' ' 51' ' ' TYR . 49.9 m-85 -123.14 123.92 41.9 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.704 176.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 tp -77.38 103.42 4.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 171.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.453 ' CG2' ' HG ' ' A' ' 42' ' ' LEU . 2.8 m -86.88 -35.17 8.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.875 -173.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.482 ' HB1' ' CD2' ' A' ' 65' ' ' LEU . . . -152.51 145.6 24.58 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.108 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.4 m -114.65 101.87 9.5 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 169.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.426 HG11 ' HB1' ' A' ' 40' ' ' ALA . 7.4 p -115.86 112.93 41.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.798 0.809 . . . . 0.0 110.164 -176.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 81.6 p -123.38 -176.82 3.54 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.217 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 38' ' ' GLN . 34.7 mtmm -58.56 -34.58 71.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.179 0.514 . . . . 0.0 110.084 170.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.27 -40.88 64.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.467 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 72.4 mt -115.37 80.78 7.92 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 174.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -71.08 -0.01 7.32 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.122 2.548 . . . . 0.0 113.541 -168.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -161.94 124.69 2.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.41 0.624 . . . . 0.0 111.11 -176.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.415 HG12 ' HB3' ' A' ' 54' ' ' ALA . 85.7 t -113.73 102.96 14.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.355 174.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.93 109.8 17.89 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.441 173.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.482 ' CD2' ' HB1' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -129.67 168.93 15.73 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.19 0.519 . . . . 0.0 111.539 -174.647 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.49 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 17.1 t0 -115.61 106.21 13.65 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.728 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.522 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 25.9 mt -123.55 142.96 50.51 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 175.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.645 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 4.9 t30 -150.79 130.79 13.4 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.073 177.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 1.621 ' HD1' ' CD2' ' A' ' 69' ' ' PHE . 3.1 m-85 -126.39 153.26 45.21 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.427 ' OG ' ' HG2' ' E' ' 7' ' ' MET . 89.1 p -98.36 164.68 12.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.036 0.446 . . . . 0.0 110.779 -178.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -5.47 7.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.821 177.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.25 -3.5 55.54 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 121.089 -0.577 . . . . 0.0 111.724 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -93.76 159.06 15.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.973 0.416 . . . . 0.0 110.873 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -144.14 125.48 14.74 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 174.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.1 pt -136.17 163.78 33.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.928 -166.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.402 ' SD ' ' HB3' ' A' ' 20' ' ' SER . 3.7 mtm -121.93 130.72 53.56 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.72 173.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.577 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -111.39 128.15 55.88 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.253 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.619 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 33.8 p90 -151.57 138.42 18.95 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.25 0.548 . . . . 0.0 111.788 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.705 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 6.0 p -107.44 134.87 49.85 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.144 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.69 154.18 19.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.112 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.2 -175.92 40.0 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -175.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.421 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 9.4 m-20 -113.62 103.29 11.1 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.209 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.436 ' CB ' ' HA3' ' A' ' 37' ' ' GLY . . . -170.09 155.08 5.31 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.819 172.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.2 t -112.05 123.29 49.93 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.426 ' CG1' ' HB3' ' A' ' 34' ' ' LEU . 6.1 m -121.46 145.86 27.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.415 0.626 . . . . 0.0 112.637 -172.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.3 m -109.91 120.86 43.79 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.591 175.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.636 HD12 ' SD ' ' A' ' 13' ' ' MET . 4.7 mp -98.0 144.89 27.05 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 171.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 87' ' ' LEU . 2.4 mm? -124.43 146.46 48.89 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.017 174.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.06 -168.33 23.81 Favored Glycine 0 N--CA 1.434 -1.434 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.189 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.613 ' CD2' ' HB3' ' B' ' 68' ' ' ASN . 9.9 p90 -151.41 128.52 11.13 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.828 0.823 . . . . 0.0 111.822 177.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.0 mt . . . . . 0 C--N 1.32 -0.689 0 CA-C-N 113.863 -1.517 . . . . 0.0 109.104 175.456 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 51.3 mtt . . . . . 0 CA--C 1.52 -0.197 0 CA-C-O 121.152 0.501 . . . . 0.0 111.657 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . 0.53 ' CE1' HD22 ' C' ' 44' ' ' LEU . 60.6 t80 -60.47 141.25 56.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.401 -174.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . 0.49 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 91.9 t90 -130.33 144.78 51.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.964 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.13 140.92 9.18 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.416 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.49 ' HB2' ' CH2' ' B' ' 9' ' ' TRP . 57.0 tp -133.54 109.13 9.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.828 0.347 . . . . 0.0 110.315 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -97.76 104.05 16.04 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' MET . . . . . 0.632 ' SD ' HD12 ' B' ' 87' ' ' LEU . 35.8 mtp -98.35 137.81 36.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.641 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.405 ' HB2' ' HZ3' ' B' ' 14' ' ' LYS . 10.1 mtmp? -101.11 159.1 30.45 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.009 176.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.438 ' HB3' ' HA ' ' B' ' 82' ' ' ASP . 69.6 Cg_exo -42.93 118.48 1.24 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.672 2.915 . . . . 0.0 114.323 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.704 ' HA ' ' O ' ' B' ' 79' ' ' THR . 49.7 mt-10 57.06 56.15 5.5 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.05 174.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.402 ' O ' ' HA ' ' B' ' 78' ' ' TYR . 30.4 mmt180 -117.11 144.07 45.1 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.079 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . 0.634 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 35.6 ttmt -126.18 112.79 16.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.091 -176.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' TYR . . . . . 1.585 ' HD1' ' CD2' ' B' ' 19' ' ' TYR . 2.4 m-85 -111.26 104.84 13.36 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.291 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 3.7 p -88.25 104.77 17.04 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 173.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -124.02 148.12 47.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.498 0.666 . . . . 0.0 112.711 -168.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 13.2 t -91.0 161.08 15.29 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.544 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.41 HD11 ' HB2' ' B' ' 69' ' ' PHE . 67.8 mt -114.25 131.26 66.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.116 0.484 . . . . 0.0 111.677 -173.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.466 HD13 ' N ' ' B' ' 24' ' ' ILE . 4.2 mp -99.23 -48.97 11.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.037 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -114.43 140.72 48.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.627 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 19.2 m -63.57 109.22 1.59 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 173.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . 1.627 ' HE2' ' CE1' ' B' ' 27' ' ' PHE . 14.6 p90 -124.93 159.56 30.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.627 0.727 . . . . 0.0 112.845 -170.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' HIS . . . . . 0.562 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 9.3 t60 -116.43 125.81 52.53 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.131 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 61.5 mt -92.44 133.11 34.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 170.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.562 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 33.2 p -118.88 -14.33 9.44 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -169.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -167.3 148.09 12.65 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 119.146 -1.502 . . . . 0.0 113.375 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 11.3 p -134.68 129.09 51.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 172.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.15 155.53 42.22 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.551 -174.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.436 ' HB3' HG13 ' B' ' 85' ' ' VAL . 4.0 pp -120.98 142.3 49.9 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.51 0.672 . . . . 0.0 111.206 178.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.44 ' HB2' ' HH ' ' C' ' 43' ' ' TYR . 13.0 p-10 -110.06 -50.04 3.01 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.578 173.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -103.14 127.53 50.39 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 168.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.44 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 152.17 158.88 8.65 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.217 176.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . 0.457 ' O ' ' HG3' ' B' ' 58' ' ' LYS . 94.5 mt-30 -102.46 -45.4 5.08 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.572 0.225 . . . . 0.0 111.441 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -153.77 130.54 10.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.189 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.43 ' HB3' ' HB1' ' B' ' 83' ' ' ALA . . . -131.36 113.88 14.3 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.411 0.624 . . . . 0.0 110.507 169.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -97.15 111.68 23.8 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 173.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.449 ' HG ' ' CG2' ' B' ' 53' ' ' VAL . 45.8 tp -83.76 112.57 20.21 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.614 -174.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . 0.418 ' HH ' ' HB2' ' A' ' 35' ' ' ASP . 83.8 m-85 -110.91 137.15 48.91 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.335 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.587 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 1.2 tp -120.57 119.33 32.59 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.344 175.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -106.23 114.1 28.02 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . 0.478 ' HB1' ' CE2' ' A' ' 8' ' ' PHE . . . -145.94 154.63 42.14 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.932 -178.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 57.95 27.82 15.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.947 0.403 . . . . 0.0 110.391 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm 59.18 44.61 15.53 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.722 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -150.82 140.17 21.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.901 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -85.82 127.07 34.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 1.611 ' HD1' ' CD2' ' B' ' 51' ' ' TYR . 49.8 m-85 -123.16 123.83 41.69 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.655 176.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 tp -77.25 103.3 4.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 171.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.449 ' CG2' ' HG ' ' B' ' 42' ' ' LEU . 2.8 m -86.8 -35.31 8.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.853 -173.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.479 ' HB1' ' CD2' ' B' ' 65' ' ' LEU . . . -152.49 145.62 24.61 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 120.239 -0.584 . . . . 0.0 112.155 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 27.3 m -114.64 101.94 9.57 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 169.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . 0.406 HG11 ' HB1' ' B' ' 40' ' ' ALA . 7.3 p -115.92 112.96 41.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.771 0.796 . . . . 0.0 110.079 -176.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 82.6 p -123.48 -176.93 3.57 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.185 -175.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' B' ' 38' ' ' GLN . 34.7 mtmm -58.39 -34.67 70.99 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.12 0.486 . . . . 0.0 110.062 170.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.4 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -73.31 -40.9 64.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.466 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 72.5 mt -115.32 80.81 7.81 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 10.2 Cg_exo -71.13 -0.0 7.34 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.107 2.538 . . . . 0.0 113.486 -168.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -161.93 124.86 3.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.375 0.607 . . . . 0.0 111.095 -176.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.408 HG12 ' HB3' ' B' ' 54' ' ' ALA . 85.7 t -113.78 102.93 14.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.311 174.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.95 109.81 17.91 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.46 173.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.479 ' CD2' ' HB1' ' B' ' 54' ' ' ALA . 0.4 OUTLIER -129.61 168.97 15.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.197 0.522 . . . . 0.0 111.608 -174.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . 0.511 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 16.9 t0 -115.65 106.3 13.74 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.719 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.525 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 26.2 mt -123.63 142.96 50.55 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . 0.613 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 4.9 t30 -150.83 130.76 13.33 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.062 177.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . 1.611 ' HE2' ' CE1' ' B' ' 69' ' ' PHE . 3.2 m-85 -126.43 153.2 45.34 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 88.9 p -98.3 164.72 12.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.003 0.43 . . . . 0.0 110.802 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -5.45 8.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.805 177.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.19 -3.58 55.57 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.765 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -93.72 159.09 15.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.96 0.409 . . . . 0.0 110.776 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -144.22 125.5 14.69 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 18.0 pt -136.21 163.84 33.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.04 0.448 . . . . 0.0 111.91 -166.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' MET . . . . . . . . . . . . . 3.7 mtm -121.99 130.78 53.59 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.698 173.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . 0.587 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.9 OUTLIER -111.36 128.18 55.89 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.269 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 0.634 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 33.5 p90 -151.61 138.47 18.96 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.199 0.523 . . . . 0.0 111.818 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.704 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 6.0 p -107.46 134.82 49.93 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.1 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.63 154.26 19.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.208 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.08 -175.88 40.15 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -175.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' ASP . . . . . 0.438 ' HA ' ' HB3' ' B' ' 15' ' ' PRO . 9.5 m-20 -113.65 103.34 11.14 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.136 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.44 ' CB ' ' HA3' ' B' ' 37' ' ' GLY . . . -170.16 154.99 5.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.838 172.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 16.1 t -111.99 123.31 49.98 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' B' ' 34' ' ' LEU . 6.1 m -121.54 145.81 27.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.494 0.664 . . . . 0.0 112.578 -172.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 20.3 m -109.88 120.87 43.81 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.575 175.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.632 HD12 ' SD ' ' B' ' 13' ' ' MET . 4.7 mp -97.92 144.9 26.99 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 171.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.456 HD12 ' O ' ' B' ' 87' ' ' LEU . 2.4 mm? -124.51 146.55 48.92 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.982 174.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.13 -168.36 23.91 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.25 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' TYR . . . . . 0.585 ' CD2' ' HB3' ' C' ' 68' ' ' ASN . 9.8 p90 -151.42 128.55 11.14 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.844 0.83 . . . . 0.0 111.777 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 7.0 mt . . . . . 0 C--N 1.32 -0.7 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.097 175.489 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 51.3 mtt . . . . . 0 CA--C 1.52 -0.182 0 CA-C-O 121.196 0.522 . . . . 0.0 111.601 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 8' ' ' PHE . . . . . 0.539 ' CE1' HD22 ' D' ' 44' ' ' LEU . 60.8 t80 -60.5 141.3 56.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.355 -174.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . 0.49 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 91.9 t90 -130.42 144.78 51.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.924 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.13 140.84 9.12 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.482 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.49 ' HB2' ' CH2' ' C' ' 9' ' ' TRP . 56.6 tp -133.39 108.99 9.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.802 0.334 . . . . 0.0 110.342 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -97.75 104.05 16.04 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 13' ' ' MET . . . . . 0.63 ' SD ' HD12 ' C' ' 87' ' ' LEU . 35.8 mtp -98.35 137.78 36.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.616 -175.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . 0.409 ' HZ3' ' HB2' ' C' ' 14' ' ' LYS . 10.1 mtmp? -101.2 159.14 30.32 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.034 176.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . 0.416 ' HB3' ' HA ' ' C' ' 82' ' ' ASP . 69.1 Cg_exo -43.01 118.52 1.28 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.727 2.952 . . . . 0.0 114.282 -177.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . 0.704 ' HA ' ' O ' ' C' ' 79' ' ' THR . 49.6 mt-10 57.02 56.19 5.5 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.085 174.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 17' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' C' ' 78' ' ' TYR . 30.5 mmt180 -117.15 144.05 45.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.114 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 18' ' ' LYS . . . . . 0.633 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 35.6 ttmt -126.18 112.85 16.27 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 123.455 0.472 . . . . 0.0 111.096 -176.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . 1.603 ' HE2' ' CE1' ' C' ' 19' ' ' TYR . 2.3 m-85 -111.34 104.77 13.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.302 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 20' ' ' SER . . . . . 0.404 ' HB3' ' SD ' ' C' ' 76' ' ' MET . 3.7 p -88.1 104.83 17.05 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 173.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -124.07 148.1 47.36 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.437 0.637 . . . . 0.0 112.715 -168.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 13.2 t -90.89 161.05 15.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.583 175.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . 0.41 HD11 ' HB2' ' C' ' 69' ' ' PHE . 67.7 mt -114.24 131.33 66.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.151 0.5 . . . . 0.0 111.667 -173.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . 0.463 HD13 ' N ' ' C' ' 24' ' ' ILE . 4.2 mp -99.27 -49.03 11.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.937 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -114.35 140.61 48.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.657 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 19.1 m -63.52 109.3 1.6 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 173.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 27' ' ' PHE . . . . . 1.63 ' HE2' ' CE1' ' C' ' 27' ' ' PHE . 14.7 p90 -124.92 159.53 30.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.703 0.764 . . . . 0.0 112.828 -170.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 28' ' ' HIS . . . . . 0.577 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 9.2 t60 -116.5 125.84 52.51 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.049 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . 0.516 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 61.2 mt -92.46 133.08 34.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 170.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 30' ' ' SER . . . . . 0.577 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 33.0 p -118.83 -14.32 9.47 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -169.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 31' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -167.36 148.01 12.52 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 119.092 -1.528 . . . . 0.0 113.356 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 11.4 p -134.57 129.06 51.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 172.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.14 155.42 42.13 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.686 -174.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.441 ' HB3' HG13 ' C' ' 85' ' ' VAL . 4.0 pp -120.9 142.37 49.76 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.462 0.648 . . . . 0.0 111.213 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . 0.413 ' HB2' ' HH ' ' D' ' 43' ' ' TYR . 12.9 p-10 -110.14 -50.02 3.01 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.516 173.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -103.24 127.52 50.52 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 168.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 37' ' ' GLY . . . . . 0.441 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 152.16 158.83 8.63 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 119.875 -1.155 . . . . 0.0 113.231 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 38' ' ' GLN . . . . . 0.45 ' O ' ' HG3' ' C' ' 58' ' ' LYS . 94.7 mt-30 -102.48 -45.39 5.08 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.519 0.2 . . . . 0.0 111.373 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -153.73 130.43 10.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.265 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . 0.425 ' HB3' ' HB1' ' C' ' 83' ' ' ALA . . . -131.35 113.8 14.21 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.388 0.613 . . . . 0.0 110.454 169.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -97.02 111.74 23.82 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.448 ' HG ' ' CG2' ' C' ' 53' ' ' VAL . 45.7 tp -83.84 112.57 20.24 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.593 -174.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 43' ' ' TYR . . . . . 0.44 ' HH ' ' HB2' ' B' ' 35' ' ' ASP . 83.9 m-85 -110.92 137.22 48.83 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.354 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.586 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 1.2 tp -120.61 119.36 32.65 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.381 175.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -106.26 114.13 28.07 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.168 0.509 . . . . 0.0 109.635 176.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . 0.496 ' HB1' ' CE2' ' B' ' 8' ' ' PHE . . . -145.95 154.67 42.17 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.929 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 58.02 27.76 15.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.971 0.415 . . . . 0.0 110.446 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm 59.27 44.44 15.48 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.788 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -150.73 140.1 21.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.983 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -85.69 127.04 34.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.235 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 1.636 ' HD1' ' CD2' ' C' ' 51' ' ' TYR . 50.0 m-85 -123.23 123.85 41.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.62 176.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 tp -77.33 103.39 4.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 171.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 53' ' ' VAL . . . . . 0.448 ' CG2' ' HG ' ' C' ' 42' ' ' LEU . 2.8 m -86.87 -35.26 8.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.819 -173.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 54' ' ' ALA . . . . . 0.489 ' HB1' ' CD2' ' C' ' 65' ' ' LEU . . . -152.54 145.54 24.51 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.145 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 27.7 m -114.69 101.96 9.58 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 169.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . 0.421 HG11 ' HB1' ' C' ' 40' ' ' ALA . 7.4 p -115.87 113.02 42.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.775 0.798 . . . . 0.0 110.126 -176.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 81.5 p -123.53 -176.79 3.54 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.208 -175.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 58' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' C' ' 38' ' ' GLN . 34.7 mtmm -58.51 -34.65 71.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.143 0.497 . . . . 0.0 110.065 170.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.3 -40.89 64.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.408 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 72.5 mt -115.35 80.74 7.84 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 174.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -70.97 -0.07 7.35 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.027 2.485 . . . . 0.0 113.552 -168.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -161.92 124.83 3.01 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.449 0.643 . . . . 0.0 111.062 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.4 HG12 ' HB3' ' C' ' 54' ' ' ALA . 85.9 t -113.75 102.96 14.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.252 174.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.05 109.78 17.94 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 173.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . 0.489 ' CD2' ' HB1' ' C' ' 54' ' ' ALA . 0.4 OUTLIER -129.53 168.96 15.6 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.171 0.51 . . . . 0.0 111.545 -174.68 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 66' ' ' ASP . . . . . 0.504 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 17.1 t0 -115.59 106.16 13.61 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.667 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . 0.516 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 26.1 mt -123.55 142.99 50.48 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . 0.585 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 4.9 t30 -150.87 130.72 13.26 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.1 177.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 69' ' ' PHE . . . . . 1.598 ' HD2' ' CD1' ' C' ' 69' ' ' PHE . 3.0 m-85 -126.32 153.24 45.12 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 88.9 p -98.4 164.67 12.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.073 0.463 . . . . 0.0 110.77 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -5.45 7.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.766 177.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.24 -3.54 55.53 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.738 176.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -93.77 159.17 15.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.991 0.424 . . . . 0.0 110.758 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -144.21 125.48 14.68 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 174.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 18.1 pt -136.13 163.83 33.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.999 0.428 . . . . 0.0 111.865 -166.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 76' ' ' MET . . . . . 0.404 ' SD ' ' HB3' ' C' ' 20' ' ' SER . 3.6 mtm -122.0 130.75 53.56 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.81 173.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 77' ' ' PHE . . . . . 0.586 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.9 OUTLIER -111.3 128.17 55.86 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.368 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 78' ' ' TYR . . . . . 0.633 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 34.0 p90 -151.68 138.37 18.81 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.177 0.513 . . . . 0.0 111.886 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 79' ' ' THR . . . . . 0.704 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 6.2 p -107.38 134.85 49.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.088 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.68 154.26 19.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.139 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.13 -175.85 40.04 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 82' ' ' ASP . . . . . 0.416 ' HA ' ' HB3' ' C' ' 15' ' ' PRO . 9.5 m-20 -113.68 103.33 11.12 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.159 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . 0.441 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -170.21 155.0 5.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.837 172.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 16.2 t -112.01 123.33 50.03 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.441 HG13 ' HB3' ' C' ' 34' ' ' LEU . 6.2 m -121.49 145.83 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 CA-C-O 121.505 0.669 . . . . 0.0 112.644 -172.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 20.3 m -109.92 120.9 43.92 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.591 175.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . 0.63 HD12 ' SD ' ' C' ' 13' ' ' MET . 4.7 mp -97.98 144.81 27.13 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 171.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . 0.469 HD12 ' O ' ' C' ' 87' ' ' LEU . 2.4 mm? -124.42 146.48 48.87 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.443 -0.798 . . . . 0.0 108.985 174.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.09 -168.34 23.84 Favored Glycine 0 N--CA 1.436 -1.366 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.204 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 90' ' ' TYR . . . . . 0.616 ' CD2' ' HB3' ' D' ' 68' ' ' ASN . 9.9 p90 -151.42 128.57 11.16 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.785 0.802 . . . . 0.0 111.783 177.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 7.0 mt . . . . . 0 C--N 1.319 -0.737 0 CA-C-N 113.858 -1.519 . . . . 0.0 108.993 175.54 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 51.4 mtt . . . . . 0 CA--C 1.521 -0.16 0 CA-C-O 121.135 0.493 . . . . 0.0 111.655 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 8' ' ' PHE . . . . . 0.531 ' CE1' HD22 ' E' ' 44' ' ' LEU . 60.4 t80 -60.52 141.3 56.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.41 -174.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 9' ' ' TRP . . . . . 0.491 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 92.1 t90 -130.41 144.79 51.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.913 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.12 140.95 9.21 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.374 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . 0.491 ' HB2' ' CH2' ' D' ' 9' ' ' TRP . 56.4 tp -133.45 109.08 9.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.768 0.318 . . . . 0.0 110.298 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -97.74 104.08 16.08 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 13' ' ' MET . . . . . 0.635 ' SD ' HD12 ' D' ' 87' ' ' LEU . 35.8 mtp -98.4 137.84 36.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.587 -175.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 14' ' ' LYS . . . . . 0.405 ' HB2' ' HZ3' ' D' ' 14' ' ' LYS . 10.1 mtmp? -101.14 159.13 30.36 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.052 176.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . 0.425 ' HB3' ' HA ' ' D' ' 82' ' ' ASP . 69.1 Cg_exo -42.94 118.44 1.23 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.696 2.931 . . . . 0.0 114.314 -177.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . 0.698 ' HA ' ' O ' ' D' ' 79' ' ' THR . 49.7 mt-10 57.19 56.07 5.46 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.024 174.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 17' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' D' ' 78' ' ' TYR . 30.5 mmt180 -117.08 144.04 45.1 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.033 175.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . 0.631 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 35.6 ttmt -126.18 112.86 16.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.07 -176.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 19' ' ' TYR . . . . . 1.643 ' HE2' ' CE1' ' D' ' 19' ' ' TYR . 2.4 m-85 -111.3 104.77 13.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.308 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 20' ' ' SER . . . . . 0.403 ' HB3' ' SD ' ' D' ' 76' ' ' MET . 3.7 p -88.14 104.75 16.99 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 173.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -124.0 148.17 47.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.442 0.639 . . . . 0.0 112.72 -168.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 13.2 t -91.0 161.1 15.28 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.533 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . 0.406 HD11 ' HB2' ' D' ' 69' ' ' PHE . 67.5 mt -114.31 131.24 66.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.191 0.519 . . . . 0.0 111.678 -173.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . 0.461 ' N ' HD13 ' D' ' 24' ' ' ILE . 4.2 mp -99.12 -49.06 11.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.095 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -114.35 140.64 48.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.648 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 19.3 m -63.55 109.4 1.64 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 173.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 27' ' ' PHE . . . . . 1.659 ' HD2' ' CD1' ' D' ' 27' ' ' PHE . 14.5 p90 -125.01 159.49 31.18 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.692 0.758 . . . . 0.0 112.824 -170.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 28' ' ' HIS . . . . . 0.58 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 9.4 t60 -116.37 125.82 52.61 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.222 -1.354 . . . . 0.0 110.156 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 29' ' ' ILE . . . . . 0.514 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 61.3 mt -92.41 133.04 35.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 170.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 30' ' ' SER . . . . . 0.58 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 33.2 p -118.79 -14.4 9.5 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -169.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 31' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -167.31 148.02 12.55 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 119.141 -1.504 . . . . 0.0 113.387 178.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 11.4 p -134.59 128.99 51.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 172.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.11 155.5 42.22 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.496 -0.481 . . . . 0.0 111.629 -174.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 34' ' ' LEU . . . . . 0.435 ' HB3' HG13 ' D' ' 85' ' ' VAL . 4.0 pp -120.98 142.24 49.96 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.455 0.645 . . . . 0.0 111.225 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . 0.463 ' HB2' ' HH ' ' E' ' 43' ' ' TYR . 12.9 p-10 -109.98 -50.16 3.0 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.554 173.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -103.09 127.54 50.32 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 168.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . 0.445 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 152.16 158.95 8.68 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 119.868 -1.158 . . . . 0.0 113.253 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 38' ' ' GLN . . . . . 0.447 ' O ' ' HG3' ' D' ' 58' ' ' LYS . 94.7 mt-30 -102.6 -45.35 5.07 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.625 0.25 . . . . 0.0 111.4 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -153.67 130.58 10.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.221 178.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . 0.438 ' HB3' ' HB1' ' D' ' 83' ' ' ALA . . . -131.43 113.82 14.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.417 0.627 . . . . 0.0 110.46 169.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -97.08 111.63 23.77 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 173.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.452 ' HG ' ' CG2' ' D' ' 53' ' ' VAL . 45.9 tp -83.73 112.61 20.22 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.522 -174.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 43' ' ' TYR . . . . . 0.413 ' HH ' ' HB2' ' C' ' 35' ' ' ASP . 84.3 m-85 -110.86 137.15 48.86 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.326 178.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.587 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 1.2 tp -120.61 119.44 32.87 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.37 175.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 45' ' ' ALA . . . . . . . . . . . . . . . -106.25 113.99 27.86 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . 0.508 ' HB1' ' CE2' ' C' ' 8' ' ' PHE . . . -145.92 154.61 42.13 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.961 -178.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 58.06 27.75 15.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.931 0.396 . . . . 0.0 110.421 -176.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm 59.24 44.54 15.45 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.809 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -150.83 140.36 21.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.896 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -85.99 127.01 34.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.18 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . 1.644 ' HD1' ' CD2' ' D' ' 51' ' ' TYR . 49.7 m-85 -123.15 123.79 41.61 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.722 176.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 tp -77.26 103.33 4.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 171.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 53' ' ' VAL . . . . . 0.452 ' CG2' ' HG ' ' D' ' 42' ' ' LEU . 2.8 m -86.79 -35.29 8.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.861 -173.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 54' ' ' ALA . . . . . 0.481 ' HB1' ' CD2' ' D' ' 65' ' ' LEU . . . -152.46 145.64 24.65 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.284 -0.566 . . . . 0.0 112.167 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 27.2 m -114.74 101.98 9.59 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 169.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 56' ' ' VAL . . . . . 0.421 HG11 ' HB1' ' D' ' 40' ' ' ALA . 7.4 p -115.94 112.98 41.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.791 0.805 . . . . 0.0 110.081 -176.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 82.5 p -123.48 -176.81 3.54 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.208 -175.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 58' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' D' ' 38' ' ' GLN . 34.7 mtmm -58.56 -34.59 71.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.128 0.49 . . . . 0.0 110.069 170.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.4 -40.73 64.07 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.452 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 72.4 mt -115.36 80.74 7.87 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 174.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -71.05 -0.1 7.44 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.109 2.539 . . . . 0.0 113.516 -168.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -161.84 124.73 3.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.327 0.584 . . . . 0.0 111.127 -176.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.421 HG12 ' HB3' ' D' ' 54' ' ' ALA . 85.1 t -113.72 102.91 14.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.32 174.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.01 109.8 17.93 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.404 173.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 65' ' ' LEU . . . . . 0.481 ' CD2' ' HB1' ' D' ' 54' ' ' ALA . 0.4 OUTLIER -129.66 168.9 15.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.107 0.479 . . . . 0.0 111.606 -174.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 66' ' ' ASP . . . . . 0.498 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 17.2 t0 -115.47 106.21 13.7 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.735 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . 0.514 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 25.9 mt -123.6 143.03 50.48 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 68' ' ' ASN . . . . . 0.616 ' HB3' ' CD2' ' C' ' 90' ' ' TYR . 4.9 t30 -150.83 130.73 13.31 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.026 177.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 69' ' ' PHE . . . . . 1.61 ' HE2' ' CE1' ' D' ' 69' ' ' PHE . 3.2 m-85 -126.33 153.23 45.16 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 89.0 p -98.36 164.63 12.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.029 0.442 . . . . 0.0 110.819 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.39 -5.49 7.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.824 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.19 -3.64 55.55 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.714 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -93.66 159.1 15.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.969 0.414 . . . . 0.0 110.836 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -144.25 125.53 14.69 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . . . . . . . . . 18.1 pt -136.13 163.79 33.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.925 -166.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 76' ' ' MET . . . . . 0.403 ' SD ' ' HB3' ' D' ' 20' ' ' SER . 3.6 mtm -121.95 130.67 53.51 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.752 173.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 77' ' ' PHE . . . . . 0.587 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.9 OUTLIER -111.34 128.21 55.89 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.277 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 78' ' ' TYR . . . . . 0.631 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 33.5 p90 -151.7 138.39 18.8 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.239 0.543 . . . . 0.0 111.822 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 79' ' ' THR . . . . . 0.698 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 6.0 p -107.4 134.89 49.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.101 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.74 154.16 19.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.189 175.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.24 -175.88 39.89 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -175.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 82' ' ' ASP . . . . . 0.425 ' HA ' ' HB3' ' D' ' 15' ' ' PRO . 9.5 m-20 -113.65 103.27 11.06 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.172 178.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.445 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -170.16 155.02 5.21 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.814 172.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 15.7 t -111.95 123.39 50.16 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . 0.435 HG13 ' HB3' ' D' ' 34' ' ' LEU . 6.2 m -121.52 145.85 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.454 0.645 . . . . 0.0 112.631 -172.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 20.2 m -109.88 120.83 43.71 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.582 175.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 87' ' ' LEU . . . . . 0.635 HD12 ' SD ' ' D' ' 13' ' ' MET . 4.7 mp -97.96 144.87 27.05 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 170.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . 0.473 HD12 ' O ' ' D' ' 87' ' ' LEU . 2.4 mm? -124.46 146.48 48.91 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.013 174.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.09 -168.26 23.74 Favored Glycine 0 N--CA 1.435 -1.421 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.189 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 90' ' ' TYR . . . . . 0.564 ' CD2' ' HB3' ' E' ' 68' ' ' ASN . 9.8 p90 -151.46 128.55 11.12 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.825 0.821 . . . . 0.0 111.757 177.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 6.9 mt . . . . . 0 C--N 1.32 -0.694 0 CA-C-N 113.852 -1.522 . . . . 0.0 109.047 175.507 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' E' E ' 7' ' ' MET . . . . . 0.427 ' HG2' ' OG ' ' A' ' 70' ' ' SER . 51.3 mtt . . . . . 0 CA--C 1.52 -0.201 0 CA-C-O 121.138 0.494 . . . . 0.0 111.634 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 8' ' ' PHE . . . . . 0.541 ' CE1' HD22 ' A' ' 44' ' ' LEU . 60.4 t80 -60.51 141.21 56.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.367 -174.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 9' ' ' TRP . . . . . 0.487 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 92.1 t90 -130.32 144.7 51.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.966 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.03 140.96 9.23 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.44 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 11' ' ' LEU . . . . . 0.487 ' HB2' ' CH2' ' E' ' 9' ' ' TRP . 56.7 tp -133.53 109.09 9.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.864 0.364 . . . . 0.0 110.335 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -97.78 104.05 16.04 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 13' ' ' MET . . . . . 0.64 ' SD ' HD12 ' E' ' 87' ' ' LEU . 35.8 mtp -98.3 137.74 36.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.615 -175.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -101.13 159.12 30.38 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.99 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . 0.425 ' HB3' ' HA ' ' E' ' 82' ' ' ASP . 68.6 Cg_exo -43.01 118.55 1.29 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.632 2.888 . . . . 0.0 114.298 -177.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 16' ' ' GLU . . . . . 0.698 ' HA ' ' O ' ' E' ' 79' ' ' THR . 49.6 mt-10 57.02 56.14 5.53 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.109 174.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 17' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' E' ' 78' ' ' TYR . 30.4 mmt180 -117.17 144.05 45.17 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.019 175.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . 0.637 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 35.6 ttmt -126.14 112.87 16.32 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 123.573 0.546 . . . . 0.0 111.096 -176.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . 1.648 ' HE1' ' CE2' ' E' ' 19' ' ' TYR . 2.3 m-85 -111.26 104.74 13.26 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.288 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 20' ' ' SER . . . . . 0.402 ' HB3' ' SD ' ' E' ' 76' ' ' MET . 3.8 p -88.03 104.79 16.99 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 173.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -124.07 148.04 47.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.482 0.658 . . . . 0.0 112.692 -168.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 13.1 t -90.88 161.11 15.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.536 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 23' ' ' ILE . . . . . 0.403 HD11 ' HB2' ' E' ' 69' ' ' PHE . 67.6 mt -114.34 131.31 66.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.125 0.488 . . . . 0.0 111.709 -173.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . 0.451 ' N ' HD13 ' E' ' 24' ' ' ILE . 4.2 mp -99.22 -48.92 11.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.0 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -114.49 140.62 48.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.61 177.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 19.1 m -63.58 109.35 1.63 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 173.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 27' ' ' PHE . . . . . 1.659 ' HD2' ' CD1' ' E' ' 27' ' ' PHE . 14.6 p90 -124.92 159.55 30.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.643 0.735 . . . . 0.0 112.88 -170.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 28' ' ' HIS . . . . . 0.571 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 9.3 t60 -116.45 125.83 52.53 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.047 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 29' ' ' ILE . . . . . 0.516 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 61.1 mt -92.38 133.12 34.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 170.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 30' ' ' SER . . . . . 0.571 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 32.9 p -118.96 -14.31 9.4 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -169.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 31' ' ' GLY . . . . . 0.556 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -167.32 148.01 12.53 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.143 -1.504 . . . . 0.0 113.352 178.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 11.5 p -134.69 128.99 51.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 172.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.07 155.49 42.24 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 121.942 -0.474 . . . . 0.0 111.655 -174.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 34' ' ' LEU . . . . . 0.441 ' HB3' HG13 ' E' ' 85' ' ' VAL . 4.0 pp -121.0 142.29 49.93 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.511 0.672 . . . . 0.0 111.181 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -110.11 -50.05 3.01 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.476 173.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -103.17 127.46 50.46 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 168.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . 0.443 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 152.17 158.85 8.64 Favored Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 119.875 -1.155 . . . . 0.0 113.293 176.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 38' ' ' GLN . . . . . 0.461 ' O ' ' HG3' ' E' ' 58' ' ' LYS . 94.4 mt-30 -102.47 -45.44 5.07 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 120.586 0.231 . . . . 0.0 111.39 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -153.68 130.59 10.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.229 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . 0.424 ' HB3' ' HB1' ' E' ' 83' ' ' ALA . . . -131.41 113.83 14.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.388 0.613 . . . . 0.0 110.467 169.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 41' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -97.06 111.63 23.77 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.445 ' HG ' ' CG2' ' E' ' 53' ' ' VAL . 45.7 tp -83.69 112.57 20.17 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.627 -174.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 43' ' ' TYR . . . . . 0.463 ' HH ' ' HB2' ' D' ' 35' ' ' ASP . 84.1 m-85 -110.95 137.14 48.95 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.32 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 44' ' ' LEU . . . . . 0.589 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 1.2 tp -120.54 119.43 32.92 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.377 175.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 45' ' ' ALA . . . . . . . . . . . . . . . -106.24 114.15 28.1 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . 0.506 ' HB1' ' CE2' ' D' ' 8' ' ' PHE . . . -146.04 154.58 42.02 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.957 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 58.02 27.77 15.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.027 0.441 . . . . 0.0 110.406 -176.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm 59.23 44.61 15.38 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.749 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 49' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -150.89 140.23 21.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.922 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -85.89 127.1 34.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.15 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . 1.634 ' HD1' ' CD2' ' E' ' 51' ' ' TYR . 49.8 m-85 -123.23 123.96 41.94 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.669 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 tp -77.39 103.36 4.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 171.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . 0.445 ' CG2' ' HG ' ' E' ' 42' ' ' LEU . 2.8 m -86.83 -35.32 8.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.786 -173.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 54' ' ' ALA . . . . . 0.486 ' HB1' ' CD2' ' E' ' 65' ' ' LEU . . . -152.49 145.53 24.55 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.312 -0.555 . . . . 0.0 112.191 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 27.4 m -114.63 101.95 9.58 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 169.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . 0.422 HG11 ' HB1' ' E' ' 40' ' ' ALA . 7.4 p -115.92 112.99 41.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.783 0.802 . . . . 0.0 110.114 -176.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 82.8 p -123.4 -176.81 3.53 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.234 -175.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 58' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' E' ' 38' ' ' GLN . 34.6 mtmm -58.45 -34.8 71.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.199 0.523 . . . . 0.0 110.043 170.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.24 -40.78 64.39 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.508 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 72.6 mt -115.38 80.67 7.87 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -71.06 0.02 7.27 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.047 2.498 . . . . 0.0 113.448 -168.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -162.01 124.75 2.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.504 0.669 . . . . 0.0 111.08 -176.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . 0.414 HG12 ' HB3' ' E' ' 54' ' ' ALA . 86.4 t -113.81 102.97 14.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.239 174.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.0 109.84 17.96 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.411 173.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 65' ' ' LEU . . . . . 0.486 ' CD2' ' HB1' ' E' ' 54' ' ' ALA . 0.4 OUTLIER -129.62 168.97 15.64 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.081 0.467 . . . . 0.0 111.583 -174.657 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 66' ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 17.1 t0 -115.68 106.26 13.68 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.708 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 67' ' ' LEU . . . . . 0.516 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 26.0 mt -123.55 143.0 50.47 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 175.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 68' ' ' ASN . . . . . 0.564 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 4.9 t30 -150.78 130.72 13.35 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.122 177.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 69' ' ' PHE . . . . . 1.603 ' HD2' ' CD1' ' E' ' 69' ' ' PHE . 3.1 m-85 -126.34 153.19 45.23 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 88.9 p -98.28 164.67 12.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.006 0.431 . . . . 0.0 110.786 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.42 -5.57 7.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.781 177.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.18 -3.44 55.64 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 121.043 -0.599 . . . . 0.0 111.791 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -93.74 159.08 15.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.99 0.424 . . . . 0.0 110.747 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -144.21 125.47 14.67 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 174.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 75' ' ' ILE . . . . . . . . . . . . . 18.0 pt -136.09 163.8 33.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.92 -166.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 76' ' ' MET . . . . . 0.402 ' SD ' ' HB3' ' E' ' 20' ' ' SER . 3.7 mtm -121.95 130.76 53.59 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 173.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 77' ' ' PHE . . . . . 0.589 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.9 OUTLIER -111.41 128.18 55.9 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.248 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 78' ' ' TYR . . . . . 0.637 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 33.9 p90 -151.64 138.45 18.91 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.242 0.544 . . . . 0.0 111.8 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 79' ' ' THR . . . . . 0.698 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 6.2 p -107.4 134.84 49.86 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.13 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.67 154.17 19.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.17 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.19 -175.91 39.99 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -175.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 82' ' ' ASP . . . . . 0.425 ' HA ' ' HB3' ' E' ' 15' ' ' PRO . 9.2 m-20 -113.64 103.37 11.17 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.132 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 83' ' ' ALA . . . . . 0.443 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -170.24 155.03 5.14 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.832 172.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 16.2 t -112.03 123.45 50.28 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 85' ' ' VAL . . . . . 0.441 HG13 ' HB3' ' E' ' 34' ' ' LEU . 6.1 m -121.62 145.76 27.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.424 0.631 . . . . 0.0 112.617 -172.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 20.4 m -109.87 120.82 43.67 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.619 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 87' ' ' LEU . . . . . 0.64 HD12 ' SD ' ' E' ' 13' ' ' MET . 4.7 mp -97.87 144.84 27.02 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 171.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . 0.467 HD12 ' O ' ' E' ' 87' ' ' LEU . 2.4 mm? -124.4 146.46 48.86 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.075 174.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.07 -168.34 23.83 Favored Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.272 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 90' ' ' TYR . . . . . 0.645 ' CD2' ' HB3' ' A' ' 68' ' ' ASN . 9.9 p90 -151.4 128.57 11.17 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.814 0.816 . . . . 0.0 111.794 177.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 91' ' ' LEU . . . . . . . . . . . . . 7.1 mt . . . . . 0 C--N 1.32 -0.71 0 CA-C-N 113.893 -1.503 . . . . 0.0 109.036 175.54 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 38.7 mtt . . . . . 0 C--O 1.225 -0.21 0 CA-C-O 120.864 0.364 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.419 ' CE1' HD22 ' B' ' 44' ' ' LEU . 61.0 t80 -64.7 146.39 54.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.54 -171.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.452 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 90.5 t90 -137.89 147.03 44.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.066 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.83 155.22 26.27 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.802 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.497 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 48.2 tp -143.86 108.72 4.93 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.768 0.318 . . . . 0.0 110.964 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -91.19 100.69 13.47 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.001 0.429 . . . . 0.0 110.057 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.597 ' SD ' HD12 ' A' ' 87' ' ' LEU . 57.0 mtp -90.56 138.03 31.88 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.21 -177.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.481 ' HB2' ' HD2' ' A' ' 17' ' ' ARG . 32.6 mmtp -101.24 150.94 37.57 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.911 -175.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.432 ' HD3' ' OG ' ' A' ' 84' ' ' SER . 81.9 Cg_exo -43.13 112.28 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 124.195 3.263 . . . . 0.0 114.745 -172.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.682 ' HA ' ' O ' ' A' ' 79' ' ' THR . 5.7 tt0 60.9 63.47 1.28 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.468 170.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.481 ' HD2' ' HB2' ' A' ' 14' ' ' LYS . 37.7 mtt85 -136.27 155.39 50.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.57 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.648 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 3.3 ttmp? -125.5 115.47 20.27 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.769 -175.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -112.6 119.49 38.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.866 176.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.3 p -79.54 133.39 36.47 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 172.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -108.69 115.95 31.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.08 0.467 . . . . 0.0 112.044 -167.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.6 m -93.18 123.12 36.23 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 169.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.9 mt -93.28 113.76 28.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.217 0.532 . . . . 0.0 111.548 -171.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.418 ' N ' HD13 ' A' ' 24' ' ' ILE . 4.5 mp -85.66 -48.32 16.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.491 178.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.401 ' HD2' HD12 ' A' ' 91' ' ' LEU . 47.0 mttt -119.33 132.47 55.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.267 178.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.6 p -59.62 123.14 15.95 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -136.56 161.84 34.76 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -170.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.554 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 21.6 t60 -115.86 128.1 55.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.885 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.547 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 44.1 mt -98.76 131.7 45.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 170.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.554 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 40.5 p -116.05 -15.15 11.17 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -171.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -164.05 155.04 26.22 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 119.391 -1.385 . . . . 0.0 113.503 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.5 p -137.33 124.43 29.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 171.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 62' ' ' GLN . . . -125.87 150.04 48.2 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -170.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.515 ' HB2' HG21 ' A' ' 56' ' ' VAL . 1.8 tm? -104.53 109.52 21.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.689 -174.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.53 -59.42 1.95 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.914 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.489 ' HB3' ' HZ3' ' A' ' 36' ' ' LYS . 3.1 mmmp? -104.09 129.4 51.77 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.605 175.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.565 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 134.84 177.59 15.06 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 119.275 -1.441 . . . . 0.0 113.506 174.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.407 ' HA ' ' HD2' ' A' ' 58' ' ' LYS . 74.4 mt-30 -103.41 -47.82 4.17 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.635 0.255 . . . . 0.0 111.295 176.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -151.2 133.27 15.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.42 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.88 114.86 17.02 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.322 0.582 . . . . 0.0 110.427 170.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -100.15 111.22 23.5 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.6 tp -84.2 115.78 22.6 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.044 -173.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.419 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 98.2 m-85 -117.47 145.34 44.24 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.47 ' HA ' ' O ' ' A' ' 76' ' ' MET . 0.2 OUTLIER -133.09 134.2 43.96 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 171.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.522 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -108.59 115.53 30.27 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.407 178.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.406 ' HB2' ' CE2' ' E' ' 8' ' ' PHE . . . -128.71 144.02 51.07 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 58.37 27.35 15.26 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -170.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.7 mttp 59.53 33.18 22.07 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.938 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.522 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 8.7 tp-100 -120.31 124.45 45.63 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -83.07 117.74 23.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.805 0.336 . . . . 0.0 110.878 -176.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -112.51 136.17 52.36 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.719 176.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.1 tp -78.38 109.89 13.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 168.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.462 HG11 ' CD2' ' E' ' 88' ' ' LEU . 2.7 t -82.97 -50.28 15.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.356 -173.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.425 ' HB2' HG12 ' A' ' 63' ' ' VAL . . . -155.4 144.16 20.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.187 -178.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.8 m -108.32 102.42 11.54 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 172.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.515 HG21 ' HB2' ' A' ' 34' ' ' LEU . 13.4 p -120.98 112.99 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-O 122.205 1.003 . . . . 0.0 110.781 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.7 p -123.31 -178.0 3.86 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.914 -174.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 38' ' ' GLN . 29.8 mtpp -59.66 -31.55 69.64 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.053 0.454 . . . . 0.0 110.222 169.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.06 -40.35 62.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.614 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.7 mt -112.46 84.47 6.27 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 173.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.2 0.74 6.23 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.111 2.54 . . . . 0.0 114.352 -166.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 18.9 pt20 -169.81 130.46 1.02 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.096 0.474 . . . . 0.0 111.127 -177.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.425 HG12 ' HB2' ' A' ' 54' ' ' ALA . 95.4 t -118.81 116.56 51.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.297 175.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.44 122.41 39.3 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.04 176.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -138.78 168.5 19.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.057 0.456 . . . . 0.0 111.527 -176.566 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.462 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 7.7 t0 -116.07 99.56 7.33 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.188 0.518 . . . . 0.0 110.232 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.547 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 21.0 mt -113.42 137.37 51.63 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.893 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.645 ' HB2' ' CD2' ' E' ' 90' ' ' TYR . 3.8 m-20 -138.0 118.18 13.56 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 176.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -117.37 151.46 36.98 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.358 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.6 t -113.02 152.99 28.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.068 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -69.68 -12.1 61.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.377 -176.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.2 -12.08 68.42 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.822 175.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -100.75 164.32 11.91 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -143.49 127.83 17.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.973 0.416 . . . . 0.0 109.961 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.9 pt -131.42 179.62 4.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.04 -170.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.47 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 12.0 mtm -136.05 135.56 39.51 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 171.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 1.652 ' HD1' ' CD2' ' A' ' 77' ' ' PHE . 1.1 m-85 -112.61 128.2 56.31 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.648 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 34.5 p90 -153.55 137.17 16.0 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.303 0.573 . . . . 0.0 112.105 -177.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.682 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 5.9 p -109.21 138.32 45.74 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.04 -177.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.79 162.3 13.91 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.194 176.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.87 -174.73 44.58 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -175.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -115.46 102.83 10.17 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.092 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.565 ' CB ' ' HA3' ' A' ' 37' ' ' GLY . . . -175.46 162.74 2.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.562 171.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.432 ' OG ' ' HD3' ' A' ' 15' ' ' PRO . 1.1 m -116.01 126.01 53.24 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.659 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 m -116.8 148.73 19.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -174.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.4 m -108.5 113.58 26.73 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.653 173.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.597 HD12 ' SD ' ' A' ' 13' ' ' MET . 5.2 mp -89.62 148.64 23.22 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 170.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.488 ' CD2' HG11 ' B' ' 53' ' ' VAL . 0.9 OUTLIER -132.06 138.93 48.36 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.079 -178.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.7 -167.12 24.75 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.878 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.668 ' CD2' ' HB2' ' B' ' 68' ' ' ASN . 13.0 p90 -150.71 128.86 11.9 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.995 0.902 . . . . 0.0 111.745 177.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.401 HD12 ' HD2' ' A' ' 25' ' ' LYS . 8.2 mt . . . . . 0 C--N 1.322 -0.63 0 CA-C-N 113.941 -1.481 . . . . 0.0 109.655 176.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 38.7 mtt . . . . . 0 C--O 1.226 -0.183 0 CA-C-O 120.91 0.386 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . 0.447 ' CE1' HD22 ' C' ' 44' ' ' LEU . 61.3 t80 -64.55 146.37 54.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.553 -171.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . 0.447 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 90.5 t90 -138.03 147.02 43.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.01 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.81 155.23 26.27 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.87 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.492 ' HB3' ' HB2' ' B' ' 87' ' ' LEU . 47.6 tp -143.88 108.78 4.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.743 0.306 . . . . 0.0 110.976 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -91.17 100.75 13.52 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.973 0.416 . . . . 0.0 110.039 173.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' MET . . . . . 0.61 ' SD ' HD12 ' B' ' 87' ' ' LEU . 57.4 mtp -90.61 137.96 31.94 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.196 -177.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.472 ' HB2' ' HD2' ' B' ' 17' ' ' ARG . 32.6 mmtp -101.17 150.99 37.58 Favored Pre-proline 0 C--N 1.317 -0.834 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.938 -175.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.432 ' HD3' ' OG ' ' B' ' 84' ' ' SER . 83.3 Cg_exo -43.19 112.23 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 124.187 3.258 . . . . 0.0 114.853 -172.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.675 ' HA ' ' O ' ' B' ' 79' ' ' THR . 5.7 tt0 61.0 63.33 1.28 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.502 170.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.472 ' HD2' ' HB2' ' B' ' 14' ' ' LYS . 37.7 mtt85 -136.19 155.56 49.96 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.601 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . 0.645 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 3.3 ttmp? -125.61 115.43 20.13 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.762 -175.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -112.64 119.38 37.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.842 176.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 10.1 p -79.55 133.33 36.46 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 172.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -108.67 116.03 31.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.063 0.459 . . . . 0.0 112.02 -167.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 28.3 m -93.12 123.16 36.19 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 169.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 52.9 mt -93.28 113.77 28.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.179 0.514 . . . . 0.0 111.536 -172.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.416 ' N ' HD13 ' B' ' 24' ' ' ILE . 4.5 mp -85.56 -48.46 16.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.543 178.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -119.32 132.46 55.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.267 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 12.7 p -59.58 123.09 15.74 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -136.56 161.76 34.98 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -169.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' HIS . . . . . 0.552 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 22.0 t60 -115.83 128.03 55.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.847 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 43.7 mt -98.68 131.7 45.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 170.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.552 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 41.0 p -116.06 -15.16 11.17 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -171.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -164.15 154.98 26.13 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 119.377 -1.392 . . . . 0.0 113.535 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 9.5 p -137.26 124.4 30.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' B' ' 62' ' ' GLN . . . -125.77 150.05 48.07 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -170.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.517 ' HB2' HG21 ' B' ' 56' ' ' VAL . 1.8 tm? -104.6 109.58 21.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.688 -174.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.52 -59.47 1.94 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.917 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.489 ' HZ3' ' HB3' ' B' ' 36' ' ' LYS . 3.1 mmmp? -104.02 129.38 51.64 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.712 175.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.57 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 134.73 177.53 15.01 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 119.222 -1.466 . . . . 0.0 113.485 174.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . 0.407 ' HA ' ' HD2' ' B' ' 58' ' ' LYS . 74.3 mt-30 -103.37 -47.85 4.17 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.633 0.254 . . . . 0.0 111.294 176.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -151.2 133.29 15.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.385 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.92 114.89 17.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.356 0.598 . . . . 0.0 110.453 170.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -100.15 111.14 23.42 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 48.2 tp -84.1 115.74 22.53 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.098 -173.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . 0.42 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 98.2 m-85 -117.43 145.37 44.18 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.2 OUTLIER -133.17 134.19 43.79 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.235 0.54 . . . . 0.0 109.549 171.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -108.51 115.54 30.29 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.357 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -128.8 144.06 51.07 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 58.42 27.29 15.25 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -170.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 59.7 mttp 59.46 33.24 22.19 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.923 -175.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . 0.527 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 8.7 tp-100 -120.31 124.48 45.7 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -82.98 117.61 22.92 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.767 0.318 . . . . 0.0 111.01 -176.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -112.47 136.2 52.26 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.672 176.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 6.2 tp -78.33 109.86 13.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 168.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.488 HG11 ' CD2' ' A' ' 88' ' ' LEU . 2.7 t -83.08 -50.14 15.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.3 -173.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.413 ' HB2' HG12 ' B' ' 63' ' ' VAL . . . -155.46 144.14 20.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.141 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 23.6 m -108.38 102.49 11.59 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 172.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . 0.517 HG21 ' HB2' ' B' ' 34' ' ' LEU . 13.3 p -121.01 112.95 37.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 122.224 1.012 . . . . 0.0 110.739 -175.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 68.2 p -123.29 -177.89 3.83 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.975 -174.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' B' ' 38' ' ' GLN . 29.8 mtpp -59.66 -31.6 69.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.18 0.514 . . . . 0.0 110.223 169.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.06 -40.3 62.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.629 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 83.9 mt -112.52 84.6 6.46 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 173.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.18 0.68 6.32 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.051 2.501 . . . . 0.0 114.427 -166.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' B' ' 33' ' ' ALA . 18.9 pt20 -169.77 130.49 1.03 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.167 0.508 . . . . 0.0 111.095 -177.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.413 HG12 ' HB2' ' B' ' 54' ' ' ALA . 95.6 t -118.8 116.53 51.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.308 175.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.45 122.3 39.2 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.067 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' B' ' 30' ' ' SER . 0.3 OUTLIER -138.67 168.57 19.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.02 0.438 . . . . 0.0 111.541 -176.617 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 7.6 t0 -116.07 99.56 7.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.145 0.498 . . . . 0.0 110.16 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.55 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 21.1 mt -113.48 137.21 51.88 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.978 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . 0.668 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 3.8 m-20 -137.88 118.16 13.66 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 176.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -117.42 151.51 36.9 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.271 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 14.8 t -113.12 153.01 28.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.067 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -69.65 -12.13 61.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.37 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.09 -12.19 68.48 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.849 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -100.72 164.25 11.95 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -143.44 127.9 17.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.936 0.398 . . . . 0.0 109.988 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 10.9 pt -131.56 179.63 4.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.958 -170.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' MET . . . . . 0.46 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 11.9 mtm -136.01 135.66 39.65 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 171.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . 1.667 ' HD1' ' CD2' ' B' ' 77' ' ' PHE . 1.1 m-85 -112.66 128.29 56.35 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 0.645 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 34.3 p90 -153.63 137.15 15.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.345 0.593 . . . . 0.0 112.093 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.675 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 5.9 p -109.15 138.21 45.86 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.068 -177.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.81 162.43 13.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.184 176.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.87 -174.78 44.64 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -175.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -115.45 102.83 10.17 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.614 -0.834 . . . . 0.0 110.026 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.57 ' CB ' ' HA3' ' B' ' 37' ' ' GLY . . . -175.54 162.69 2.84 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.528 171.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' SER . . . . . 0.432 ' OG ' ' HD3' ' B' ' 15' ' ' PRO . 1.1 m -115.98 126.01 53.27 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.553 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 2.7 m -116.87 148.81 19.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.147 0.499 . . . . 0.0 112.329 -174.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 43.1 m -108.52 113.63 26.8 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.63 173.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.61 HD12 ' SD ' ' B' ' 13' ' ' MET . 5.3 mp -89.74 148.62 23.15 Favored 'General case' 0 CA--C 1.5 -0.953 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.448 170.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.486 ' CD2' HG11 ' C' ' 53' ' ' VAL . 0.9 OUTLIER -132.04 138.98 48.41 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.078 -178.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.78 -167.17 24.93 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.872 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' TYR . . . . . 0.647 ' CD2' ' HB2' ' C' ' 68' ' ' ASN . 12.9 p90 -150.66 128.84 11.93 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.889 0.852 . . . . 0.0 111.786 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 8.3 mt . . . . . 0 C--N 1.321 -0.673 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.632 176.514 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 38.6 mtt . . . . . 0 C--O 1.225 -0.226 0 CA-C-O 120.884 0.373 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 8' ' ' PHE . . . . . 0.423 ' CE1' HD22 ' D' ' 44' ' ' LEU . 61.5 t80 -64.56 146.33 54.79 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.586 -171.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . 0.441 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 90.6 t90 -137.98 147.01 43.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.024 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.79 155.23 26.27 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.864 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.5 ' HB3' ' HB2' ' C' ' 87' ' ' LEU . 48.5 tp -143.93 108.71 4.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.805 0.336 . . . . 0.0 110.902 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -91.16 100.77 13.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.997 0.427 . . . . 0.0 109.992 173.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 13' ' ' MET . . . . . 0.597 ' SD ' HD12 ' C' ' 87' ' ' LEU . 57.3 mtp -90.65 137.96 31.95 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.216 -177.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . 0.461 ' HB2' ' HD2' ' C' ' 17' ' ' ARG . 32.6 mmtp -101.2 150.97 37.58 Favored Pre-proline 0 C--N 1.317 -0.81 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.898 -175.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . 0.434 ' HD3' ' OG ' ' C' ' 84' ' ' SER . 84.3 Cg_exo -43.15 112.33 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 124.146 3.231 . . . . 0.0 114.847 -172.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . 0.68 ' HA ' ' O ' ' C' ' 79' ' ' THR . 5.7 tt0 60.81 63.51 1.29 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.513 170.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 17' ' ' ARG . . . . . 0.461 ' HD2' ' HB2' ' C' ' 14' ' ' LYS . 37.8 mtt85 -136.28 155.53 49.96 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.613 178.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 18' ' ' LYS . . . . . 0.645 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 3.3 ttmp? -125.67 115.46 20.14 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.703 -175.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -112.73 119.42 38.01 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.893 176.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 10.0 p -79.53 133.46 36.47 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 172.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -108.68 116.03 31.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.089 0.471 . . . . 0.0 112.075 -167.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 28.3 m -93.19 123.2 36.3 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 169.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 52.8 mt -93.3 113.8 28.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.135 0.493 . . . . 0.0 111.448 -172.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . 0.417 ' N ' HD13 ' C' ' 24' ' ' ILE . 4.5 mp -85.62 -48.36 16.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.585 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . 0.41 ' HD2' HD11 ' C' ' 91' ' ' LEU . 47.1 mttt -119.39 132.4 55.83 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.242 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 12.4 p -59.54 123.13 15.87 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 177.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 27' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -136.6 161.79 34.91 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -170.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 28' ' ' HIS . . . . . 0.558 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 21.9 t60 -115.83 128.06 55.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.26 -1.337 . . . . 0.0 109.879 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 44.3 mt -98.69 131.71 45.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 170.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 30' ' ' SER . . . . . 0.558 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 39.7 p -116.06 -15.19 11.16 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.813 -171.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 31' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -164.04 155.04 26.22 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 119.355 -1.403 . . . . 0.0 113.533 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 9.5 p -137.36 124.36 29.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 171.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' C' ' 62' ' ' GLN . . . -125.78 150.17 47.99 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -170.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.508 ' HB2' HG21 ' C' ' 56' ' ' VAL . 1.8 tm? -104.68 109.58 21.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.63 -174.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.55 -59.45 1.95 Allowed 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.925 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 36' ' ' LYS . . . . . 0.492 ' HB3' ' HZ3' ' C' ' 36' ' ' LYS . 3.1 mmmp? -104.03 129.25 51.65 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.689 175.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 37' ' ' GLY . . . . . 0.576 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 134.87 177.7 15.14 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 119.339 -1.41 . . . . 0.0 113.451 174.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -103.43 -47.84 4.16 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.69 0.281 . . . . 0.0 111.303 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -151.12 133.22 15.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.441 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.89 114.83 16.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.336 0.589 . . . . 0.0 110.404 170.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -100.07 111.25 23.55 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 48.6 tp -84.2 115.88 22.65 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.004 -173.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 43' ' ' TYR . . . . . 0.418 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 98.2 m-85 -117.51 145.38 44.26 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 176.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' C' ' 76' ' ' MET . 0.2 OUTLIER -133.14 134.1 43.74 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 171.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -108.56 115.5 30.21 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.418 178.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -128.68 143.99 51.06 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 58.44 27.31 15.3 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -170.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 59.7 mttp 59.53 33.17 22.07 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.957 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . 0.531 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 8.7 tp-100 -120.2 124.39 45.59 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -83.05 117.75 23.05 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.917 0.389 . . . . 0.0 110.97 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -112.53 136.27 52.25 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.692 176.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 6.1 tp -78.4 109.92 13.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 168.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 53' ' ' VAL . . . . . 0.486 HG11 ' CD2' ' B' ' 88' ' ' LEU . 2.7 t -83.04 -50.21 15.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.377 -173.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 54' ' ' ALA . . . . . 0.412 ' HB2' HG12 ' C' ' 63' ' ' VAL . . . -155.49 144.09 20.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.187 -178.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 23.7 m -108.3 102.54 11.66 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 172.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . 0.508 HG21 ' HB2' ' C' ' 34' ' ' LEU . 13.3 p -121.02 113.02 38.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 122.225 1.012 . . . . 0.0 110.753 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 68.3 p -123.32 -177.95 3.85 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.969 -174.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -59.61 -31.62 69.66 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.106 0.479 . . . . 0.0 110.249 169.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.0 -40.38 62.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.598 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 84.0 mt -112.48 84.55 6.36 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 173.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.28 0.73 6.3 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.07 2.513 . . . . 0.0 114.367 -166.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . 0.425 ' HA ' ' HA ' ' C' ' 33' ' ' ALA . 18.8 pt20 -169.8 130.5 1.02 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.169 0.509 . . . . 0.0 111.133 -177.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.412 HG12 ' HB2' ' C' ' 54' ' ' ALA . 95.6 t -118.74 116.61 51.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.283 175.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.51 122.35 39.31 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.01 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' C' ' 30' ' ' SER . 0.3 OUTLIER -138.7 168.58 19.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.495 -176.576 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 66' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 7.6 t0 -116.1 99.51 7.29 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.232 0.539 . . . . 0.0 110.231 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . 0.541 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 21.1 mt -113.43 137.26 51.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.916 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . 0.647 ' HB2' ' CD2' ' B' ' 90' ' ' TYR . 3.8 m-20 -137.91 118.1 13.56 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 176.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -117.36 151.44 37.01 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.257 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 14.8 t -113.06 153.07 28.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.085 -177.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -69.65 -12.24 61.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.322 -176.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.07 -12.17 68.59 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.818 -0.705 . . . . 0.0 111.911 175.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -100.68 164.33 11.92 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -143.49 127.93 17.9 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 10.8 pt -131.49 179.64 4.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.995 -170.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 76' ' ' MET . . . . . 0.461 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 12.0 mtm -136.08 135.62 39.49 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 171.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 77' ' ' PHE . . . . . 1.658 ' HD1' ' CD2' ' C' ' 77' ' ' PHE . 1.1 m-85 -112.56 128.2 56.29 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 78' ' ' TYR . . . . . 0.645 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 34.3 p90 -153.6 137.24 16.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.314 0.578 . . . . 0.0 112.031 -177.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 79' ' ' THR . . . . . 0.68 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 5.9 p -109.21 138.1 46.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.103 -177.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.73 162.36 13.85 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.223 176.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.82 -174.79 44.72 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -175.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -115.48 102.8 10.14 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.078 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . 0.576 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -175.42 162.7 2.9 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.571 171.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 84' ' ' SER . . . . . 0.434 ' OG ' ' HD3' ' C' ' 15' ' ' PRO . 1.0 OUTLIER -115.95 125.86 53.11 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.654 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 m -116.76 148.91 19.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.213 0.53 . . . . 0.0 112.358 -174.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 42.8 m -108.54 113.59 26.73 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.645 173.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . 0.597 HD12 ' SD ' ' C' ' 13' ' ' MET . 5.3 mp -89.68 148.59 23.21 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 170.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . 0.474 ' CD2' HG11 ' D' ' 53' ' ' VAL . 0.9 OUTLIER -132.01 138.94 48.43 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.098 -178.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.71 -167.06 24.67 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.847 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 90' ' ' TYR . . . . . 0.657 ' CD2' ' HB2' ' D' ' 68' ' ' ASN . 12.8 p90 -150.74 128.77 11.81 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.91 0.862 . . . . 0.0 111.769 177.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . 0.41 HD11 ' HD2' ' C' ' 25' ' ' LYS . 8.3 mt . . . . . 0 C--N 1.321 -0.665 0 CA-C-N 113.964 -1.471 . . . . 0.0 109.6 176.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 38.6 mtt . . . . . 0 C--O 1.225 -0.221 0 CA-C-O 120.82 0.343 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 8' ' ' PHE . . . . . 0.419 ' CE1' HD22 ' E' ' 44' ' ' LEU . 61.1 t80 -64.59 146.44 54.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.481 -171.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 9' ' ' TRP . . . . . 0.448 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 90.5 t90 -138.09 147.06 43.65 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.034 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.85 155.17 26.24 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.792 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . 0.492 ' HB3' ' HB2' ' D' ' 87' ' ' LEU . 48.4 tp -143.87 108.75 4.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.766 0.317 . . . . 0.0 110.973 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -91.23 100.75 13.51 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.002 0.429 . . . . 0.0 110.021 173.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 13' ' ' MET . . . . . 0.611 ' SD ' HD12 ' D' ' 87' ' ' LEU . 57.3 mtp -90.56 137.93 31.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.196 -177.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 14' ' ' LYS . . . . . 0.46 ' HB2' ' HD2' ' D' ' 17' ' ' ARG . 32.6 mmtp -101.22 150.99 37.6 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.909 -175.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . 0.435 ' HD3' ' OG ' ' D' ' 84' ' ' SER . 81.9 Cg_exo -43.3 112.34 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 124.133 3.222 . . . . 0.0 114.796 -172.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . 0.685 ' HA ' ' O ' ' D' ' 79' ' ' THR . 5.7 tt0 60.92 63.38 1.29 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.572 170.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 17' ' ' ARG . . . . . 0.46 ' HD2' ' HB2' ' D' ' 14' ' ' LYS . 37.7 mtt85 -136.22 155.45 50.1 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.613 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . 0.632 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 3.3 ttmp? -125.55 115.46 20.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.755 -175.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -112.75 119.36 37.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.878 176.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 10.0 p -79.55 133.42 36.46 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 172.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -108.7 116.0 31.16 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.089 0.471 . . . . 0.0 112.1 -167.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 28.4 m -93.08 123.17 36.15 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 169.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 52.5 mt -93.29 113.73 28.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.214 0.531 . . . . 0.0 111.542 -172.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . 0.426 HD13 ' N ' ' D' ' 24' ' ' ILE . 4.5 mp -85.64 -48.35 16.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.58 178.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 47.1 mttt -119.35 132.45 55.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.283 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 12.5 p -59.54 123.14 15.91 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 27' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -136.59 161.74 35.07 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -170.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 28' ' ' HIS . . . . . 0.55 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 22.1 t60 -115.78 128.07 55.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.899 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 29' ' ' ILE . . . . . 0.552 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 44.0 mt -98.67 131.6 45.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 170.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 30' ' ' SER . . . . . 0.55 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 41.3 p -115.96 -15.24 11.22 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -171.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 31' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -164.06 155.06 26.24 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 119.41 -1.376 . . . . 0.0 113.53 178.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 p -137.38 124.37 29.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 171.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' D' ' 62' ' ' GLN . . . -125.81 150.0 48.17 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -170.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 34' ' ' LEU . . . . . 0.519 ' HB2' HG21 ' D' ' 56' ' ' VAL . 1.8 tm? -104.58 109.53 21.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.65 -174.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.49 -59.51 1.94 Allowed 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.851 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 36' ' ' LYS . . . . . 0.497 ' HB3' ' HZ3' ' D' ' 36' ' ' LYS . 3.1 mmmp? -104.0 129.41 51.6 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 175.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . 0.576 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 134.73 177.58 15.05 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 119.306 -1.426 . . . . 0.0 113.489 174.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -103.33 -47.79 4.19 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.691 0.282 . . . . 0.0 111.361 176.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -151.22 133.25 15.16 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.326 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.86 114.84 17.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.334 0.588 . . . . 0.0 110.447 170.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -100.15 111.16 23.44 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 48.5 tp -84.03 115.85 22.55 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.085 -173.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 43' ' ' TYR . . . . . 0.422 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 98.2 m-85 -117.52 145.38 44.26 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' D' ' 76' ' ' MET . 0.2 OUTLIER -133.15 134.21 43.87 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 171.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 45' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -108.65 115.65 30.5 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.298 178.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . 0.42 ' HB2' ' CE2' ' C' ' 8' ' ' PHE . . . -128.82 144.03 51.06 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 175.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 58.4 27.36 15.31 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -170.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 59.8 mttp 59.35 33.24 22.37 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.968 -175.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . 0.529 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 8.7 tp-100 -120.22 124.49 45.81 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -82.88 117.64 22.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.768 0.318 . . . . 0.0 111.011 -176.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -112.48 136.29 52.16 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.713 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 6.2 tp -78.43 109.83 13.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 168.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 53' ' ' VAL . . . . . 0.474 HG11 ' CD2' ' C' ' 88' ' ' LEU . 2.7 t -82.99 -50.22 15.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.311 -173.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 54' ' ' ALA . . . . . 0.428 ' HB2' HG12 ' D' ' 63' ' ' VAL . . . -155.47 144.1 20.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.175 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 23.7 m -108.26 102.54 11.65 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 172.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 56' ' ' VAL . . . . . 0.519 HG21 ' HB2' ' D' ' 34' ' ' LEU . 13.2 p -121.06 112.93 37.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 122.15 0.976 . . . . 0.0 110.743 -175.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 69.4 p -123.29 -177.87 3.82 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.937 -174.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -59.74 -31.53 69.72 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.184 169.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.09 -40.33 62.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.582 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 83.5 mt -112.43 84.56 6.3 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 173.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.18 0.73 6.24 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.017 2.478 . . . . 0.0 114.465 -166.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' D' ' 33' ' ' ALA . 18.9 pt20 -169.82 130.46 1.02 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.197 0.522 . . . . 0.0 111.088 -177.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.428 HG12 ' HB2' ' D' ' 54' ' ' ALA . 95.0 t -118.82 116.71 51.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.237 175.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.51 122.4 39.37 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.039 176.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 65' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' D' ' 30' ' ' SER . 0.3 OUTLIER -138.76 168.58 19.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.465 -176.574 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 66' ' ' ASP . . . . . 0.456 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 7.7 t0 -116.12 99.47 7.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.275 0.56 . . . . 0.0 110.26 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . 0.552 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 21.0 mt -113.32 137.31 51.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.01 178.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 68' ' ' ASN . . . . . 0.657 ' HB2' ' CD2' ' C' ' 90' ' ' TYR . 3.8 m-20 -137.95 118.21 13.63 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 176.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -117.48 151.36 37.26 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.236 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 14.7 t -112.97 153.06 28.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.094 -177.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -69.72 -12.12 61.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.377 -176.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.14 -12.14 68.46 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.832 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -100.8 164.28 11.92 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -143.48 127.92 17.91 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.021 0.438 . . . . 0.0 109.928 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . . . . . . . . . 10.9 pt -131.55 179.63 4.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.013 -170.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 76' ' ' MET . . . . . 0.463 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 12.0 mtm -136.08 135.58 39.45 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 171.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 77' ' ' PHE . . . . . 1.648 ' HE2' ' CE1' ' D' ' 77' ' ' PHE . 1.1 m-85 -112.61 128.26 56.32 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 78' ' ' TYR . . . . . 0.632 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 34.4 p90 -153.63 137.11 15.88 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.336 0.589 . . . . 0.0 112.064 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 79' ' ' THR . . . . . 0.685 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 5.9 p -109.09 138.22 45.79 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.07 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.83 162.47 13.77 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.14 176.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.82 -174.87 44.8 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 -175.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -115.41 102.8 10.16 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.037 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.576 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -175.4 162.71 2.92 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.563 171.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 84' ' ' SER . . . . . 0.435 ' OG ' ' HD3' ' D' ' 15' ' ' PRO . 1.1 m -115.98 126.08 53.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.614 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 2.7 m -116.84 148.76 19.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.119 0.485 . . . . 0.0 112.306 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 42.4 m -108.41 113.68 26.92 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.63 173.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 87' ' ' LEU . . . . . 0.611 HD12 ' SD ' ' D' ' 13' ' ' MET . 5.2 mp -89.76 148.63 23.13 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 170.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . 0.479 ' CD2' HG11 ' E' ' 53' ' ' VAL . 0.9 OUTLIER -132.1 138.99 48.32 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.002 -178.839 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.73 -167.15 24.84 Favored Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.897 -177.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 90' ' ' TYR . . . . . 0.639 ' CD2' ' HB2' ' E' ' 68' ' ' ASN . 13.0 p90 -150.66 128.86 11.95 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.873 0.844 . . . . 0.0 111.797 177.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 8.1 mt . . . . . 0 C--N 1.321 -0.671 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.669 176.485 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 38.7 mtt . . . . . 0 C--O 1.225 -0.212 0 CA-C-O 120.846 0.355 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' E' E ' 8' ' ' PHE . . . . . 0.411 ' CE1' HD22 ' A' ' 44' ' ' LEU . 61.0 t80 -64.68 146.44 54.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.525 -171.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 9' ' ' TRP . . . . . 0.439 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 90.4 t90 -137.99 146.98 43.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.056 178.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.76 155.21 26.27 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.875 177.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 11' ' ' LEU . . . . . 0.508 ' HB3' ' HB2' ' E' ' 87' ' ' LEU . 47.9 tp -143.93 108.78 4.93 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.803 0.335 . . . . 0.0 111.014 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -91.17 100.72 13.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.98 0.419 . . . . 0.0 110.066 173.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 13' ' ' MET . . . . . 0.597 ' SD ' HD12 ' E' ' 87' ' ' LEU . 57.3 mtp -90.56 137.97 31.93 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.141 -177.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 14' ' ' LYS . . . . . 0.471 ' HB2' ' HD2' ' E' ' 17' ' ' ARG . 32.6 mmtp -101.28 150.94 37.59 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.884 -175.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . 0.427 ' HD3' ' OG ' ' E' ' 84' ' ' SER . 84.4 Cg_exo -43.1 112.18 0.27 Allowed 'Trans proline' 0 N--CA 1.474 0.368 0 C-N-CA 124.157 3.238 . . . . 0.0 114.869 -172.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 16' ' ' GLU . . . . . 0.685 ' HA ' ' O ' ' E' ' 79' ' ' THR . 5.7 tt0 61.06 63.24 1.28 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.579 170.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 17' ' ' ARG . . . . . 0.471 ' HD2' ' HB2' ' E' ' 14' ' ' LYS . 38.0 mtt85 -136.19 155.47 50.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.611 178.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . 0.637 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 3.3 ttmp? -125.51 115.38 20.12 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.777 -175.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -112.58 119.4 38.0 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 176.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 10.1 p -79.58 133.29 36.44 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -108.57 116.04 31.22 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.076 0.465 . . . . 0.0 112.098 -167.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 28.4 m -93.05 123.14 36.1 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 169.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 52.7 mt -93.27 113.8 28.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.242 0.544 . . . . 0.0 111.513 -172.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . 0.427 ' N ' HD13 ' E' ' 24' ' ' ILE . 4.5 mp -85.64 -48.37 16.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.502 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . 0.411 ' HD2' HD11 ' E' ' 91' ' ' LEU . 47.2 mttt -119.32 132.45 55.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.214 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 12.6 p -59.5 123.15 15.9 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 27' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -136.55 161.73 35.06 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -170.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 28' ' ' HIS . . . . . 0.557 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 22.0 t60 -115.78 128.16 55.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.894 178.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 29' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 44.3 mt -98.8 131.72 45.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 170.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 30' ' ' SER . . . . . 0.557 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 41.0 p -116.08 -15.09 11.16 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.858 -171.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 31' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -164.11 155.05 26.24 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 119.307 -1.425 . . . . 0.0 113.494 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 p -137.29 124.27 29.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 171.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' E' ' 62' ' ' GLN . . . -125.76 150.11 48.01 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -170.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 34' ' ' LEU . . . . . 0.5 ' HB2' HG21 ' E' ' 56' ' ' VAL . 1.8 tm? -104.61 109.58 21.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.628 -174.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.58 -59.45 1.95 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.87 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 36' ' ' LYS . . . . . 0.497 ' HZ3' ' HB3' ' E' ' 36' ' ' LYS . 3.1 mmmp? -104.02 129.41 51.64 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.68 175.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . 0.572 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 134.7 177.61 15.07 Favored Glycine 0 N--CA 1.437 -1.244 0 C-N-CA 119.325 -1.417 . . . . 0.0 113.506 174.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 38' ' ' GLN . . . . . 0.403 ' HA ' ' HD2' ' E' ' 58' ' ' LYS . 74.4 mt-30 -103.33 -47.89 4.17 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.669 0.271 . . . . 0.0 111.306 176.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -151.16 133.23 15.2 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.404 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.89 114.89 17.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.394 0.616 . . . . 0.0 110.413 170.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 41' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -100.16 111.14 23.42 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 48.5 tp -84.08 115.75 22.53 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.061 -173.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 43' ' ' TYR . . . . . 0.413 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 98.2 m-85 -117.46 145.38 44.2 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 44' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' E' ' 76' ' ' MET . 0.2 OUTLIER -133.13 134.18 43.86 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 171.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 45' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -108.57 115.51 30.23 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.344 178.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -128.74 143.95 51.05 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 58.57 27.22 15.39 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -170.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 59.7 mttp 59.49 33.17 22.13 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.937 -175.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 49' ' ' GLN . . . . . 0.529 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 8.7 tp-100 -120.24 124.5 45.82 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -83.07 117.68 23.02 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.826 0.346 . . . . 0.0 110.92 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -112.48 136.36 52.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.663 176.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 6.2 tp -78.5 109.88 13.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 168.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . 0.479 HG11 ' CD2' ' D' ' 88' ' ' LEU . 2.7 t -83.02 -50.24 15.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.319 -173.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 54' ' ' ALA . . . . . 0.417 ' HB2' HG12 ' E' ' 63' ' ' VAL . . . -155.39 144.19 20.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.205 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 23.6 m -108.37 102.51 11.61 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 172.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . 0.5 HG21 ' HB2' ' E' ' 34' ' ' LEU . 13.2 p -121.0 112.98 38.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 122.143 0.973 . . . . 0.0 110.761 -175.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 70.6 p -123.25 -177.87 3.82 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.982 -174.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 58' ' ' LYS . . . . . 0.403 ' HD2' ' HA ' ' E' ' 38' ' ' GLN . 29.8 mtpp -59.81 -31.51 69.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.03 0.443 . . . . 0.0 110.228 169.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.99 -40.47 62.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.566 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 83.9 mt -112.46 84.58 6.36 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 173.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.25 0.71 6.31 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.043 2.495 . . . . 0.0 114.393 -166.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 62' ' ' GLN . . . . . 0.421 ' HA ' ' HA ' ' E' ' 33' ' ' ALA . 18.9 pt20 -169.68 130.56 1.05 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.106 0.479 . . . . 0.0 111.085 -177.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . 0.417 HG12 ' HB2' ' E' ' 54' ' ' ALA . 95.8 t -118.84 116.64 51.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.328 175.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.45 122.31 39.21 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.049 176.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 65' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' E' ' 30' ' ' SER . 0.3 OUTLIER -138.72 168.55 19.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.436 -176.543 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 66' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 7.6 t0 -116.05 99.54 7.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.207 0.527 . . . . 0.0 110.201 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 67' ' ' LEU . . . . . 0.54 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 21.0 mt -113.45 137.36 51.65 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.918 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 68' ' ' ASN . . . . . 0.639 ' HB2' ' CD2' ' D' ' 90' ' ' TYR . 3.8 m-20 -137.98 118.16 13.56 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 176.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -117.38 151.42 37.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.36 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 15.1 t -113.06 152.97 28.89 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -177.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -69.69 -12.19 61.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.305 -176.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.06 -12.15 68.63 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.903 175.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -100.67 164.3 11.94 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -143.51 127.91 17.87 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 75' ' ' ILE . . . . . . . . . . . . . 10.9 pt -131.52 179.66 4.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.004 -170.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 76' ' ' MET . . . . . 0.454 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 11.9 mtm -136.09 135.51 39.39 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 171.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 77' ' ' PHE . . . . . 1.662 ' HE2' ' CE1' ' E' ' 77' ' ' PHE . 1.1 m-85 -112.55 128.25 56.3 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 78' ' ' TYR . . . . . 0.637 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 34.5 p90 -153.57 137.2 16.01 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.295 0.569 . . . . 0.0 112.133 -177.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 79' ' ' THR . . . . . 0.685 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 5.8 p -109.25 138.23 45.92 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.028 -177.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.77 162.42 13.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.16 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.8 -174.73 44.71 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.511 -1.035 . . . . 0.0 110.511 -175.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -115.51 102.8 10.13 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.119 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 83' ' ' ALA . . . . . 0.572 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -175.47 162.63 2.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.574 171.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 84' ' ' SER . . . . . 0.427 ' OG ' ' HD3' ' E' ' 15' ' ' PRO . 1.0 OUTLIER -115.89 125.94 53.28 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.666 179.727 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 m -116.73 148.79 19.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -174.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 43.6 m -108.53 113.7 26.94 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.573 173.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 87' ' ' LEU . . . . . 0.597 HD12 ' SD ' ' E' ' 13' ' ' MET . 5.2 mp -89.76 148.61 23.14 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 170.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . 0.462 ' CD2' HG11 ' A' ' 53' ' ' VAL . 0.9 OUTLIER -132.0 138.92 48.45 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.06 -178.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.64 -167.0 24.51 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.932 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 90' ' ' TYR . . . . . 0.645 ' CD2' ' HB2' ' A' ' 68' ' ' ASN . 13.2 p90 -150.75 128.82 11.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.851 0.834 . . . . 0.0 111.816 177.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 91' ' ' LEU . . . . . 0.411 HD11 ' HD2' ' E' ' 25' ' ' LYS . 8.3 mt . . . . . 0 C--N 1.321 -0.651 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.634 176.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 47.5 mtt . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 120.584 0.23 . . . . 0.0 111.309 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 1.642 ' HD1' ' CD2' ' A' ' 8' ' ' PHE . 56.3 t80 -76.19 151.97 36.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.1 0.476 . . . . 0.0 112.194 -176.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.469 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 89.5 t90 -143.76 147.37 34.08 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.639 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.435 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -151.42 156.47 26.69 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.236 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.469 ' HB2' ' CH2' ' A' ' 9' ' ' TRP . 61.2 tp -149.01 109.66 4.25 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.854 0.359 . . . . 0.0 111.394 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -86.03 121.17 28.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.423 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.681 ' SD ' ' HE1' ' A' ' 19' ' ' TYR . 72.4 mmm -101.74 137.37 40.13 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.905 0.383 . . . . 0.0 111.056 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.478 ' HE3' ' HA ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -101.27 146.43 32.17 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.835 175.714 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -49.9 113.39 0.97 Allowed 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 123.174 2.583 . . . . 0.0 113.047 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 61.04 52.06 4.22 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.906 176.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -125.54 138.4 53.96 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.785 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.637 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 51.8 mttp -109.66 126.87 54.12 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.816 0.341 . . . . 0.0 111.767 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 1.665 ' HD1' ' CD2' ' A' ' 19' ' ' TYR . 2.4 m-85 -111.64 103.79 12.12 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 173.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.2 p -86.06 100.58 12.26 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 173.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -114.92 148.78 38.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.379 0.609 . . . . 0.0 112.241 -168.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.9 m -107.97 141.95 38.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.132 173.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 69.0 mt -102.2 138.38 26.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.149 0.5 . . . . 0.0 111.74 -173.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.44 HD13 ' N ' ' A' ' 24' ' ' ILE . 4.1 mp -110.62 -43.4 5.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.196 176.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.412 ' HD2' HD11 ' A' ' 91' ' ' LEU . 15.1 pttm -113.94 120.6 41.24 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.078 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.5 p -58.25 132.15 52.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.66 -178.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 1.654 ' HE2' ' CE1' ' A' ' 27' ' ' PHE . 54.5 p90 -139.2 157.6 45.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.577 0.703 . . . . 0.0 112.362 -176.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.612 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 7.1 t60 -114.69 124.76 52.63 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.458 177.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 42.7 mt -89.95 134.93 27.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 171.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.612 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 28.3 p -122.14 -12.32 8.32 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -171.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.12 155.81 27.31 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 119.617 -1.278 . . . . 0.0 113.195 177.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.43 ' CG2' ' HG ' ' A' ' 87' ' ' LEU . 12.3 p -143.3 125.53 12.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 172.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.22 161.01 39.99 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 122.036 -0.415 . . . . 0.0 111.66 -174.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.533 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 3.3 pp -123.44 142.32 51.11 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.828 0.823 . . . . 0.0 111.574 177.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.456 ' HB2' ' HH ' ' B' ' 43' ' ' TYR . 21.2 p-10 -104.11 -52.6 2.9 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.444 173.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -104.22 128.6 51.96 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.308 -0.626 . . . . 0.0 109.308 169.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.95 156.07 7.3 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 119.627 -1.273 . . . . 0.0 113.587 175.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.456 ' HA ' ' HB2' ' A' ' 58' ' ' LYS . 94.1 mt-30 -102.73 -44.25 5.35 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.699 0.285 . . . . 0.0 111.306 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -152.71 122.17 6.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.954 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.452 ' HB1' HG11 ' A' ' 56' ' ' VAL . . . -123.67 114.24 19.71 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.558 0.694 . . . . 0.0 110.212 170.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 80' ' ' ALA . 31.8 mmtp -96.86 105.85 18.05 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 176.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.9 tp -83.29 112.23 19.69 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -175.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.636 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 92.8 m-85 -118.68 147.2 44.05 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 175.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 76' ' ' MET . 0.3 OUTLIER -131.07 131.08 43.99 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 170.651 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -107.51 112.53 25.33 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.267 178.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.55 138.16 54.35 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.461 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 58.81 34.15 23.52 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.236 0.541 . . . . 0.0 110.026 -176.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.3 tttm 56.55 46.58 20.23 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.821 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.574 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 53.3 tp60 -137.84 127.78 25.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.469 176.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -87.18 121.37 29.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.954 0.407 . . . . 0.0 110.372 -176.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.432 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 81.5 m-85 -113.41 130.57 56.27 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.355 175.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.4 tp -79.57 105.83 9.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.705 0.764 . . . . 0.0 109.048 173.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.429 ' CG1' HD13 ' A' ' 67' ' ' LEU . 2.5 t -80.46 -49.16 19.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.633 -172.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.496 ' HB1' ' CD2' ' A' ' 65' ' ' LEU . . . -156.0 148.23 23.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.924 0.393 . . . . 0.0 111.709 -177.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.7 m -110.59 100.75 9.49 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 170.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.452 HG11 ' HB1' ' A' ' 40' ' ' ALA . 7.7 p -118.46 112.66 39.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.62 0.724 . . . . 0.0 109.699 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 63.8 p -122.86 -178.71 4.02 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.173 -172.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.456 ' HB2' ' HA ' ' A' ' 38' ' ' GLN . 56.0 tttt -59.52 -28.99 67.57 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.896 172.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.462 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -83.15 -40.41 19.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.622 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.0 mt -111.07 83.15 3.56 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 13.1 Cg_exo -69.82 0.18 6.06 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.084 2.523 . . . . 0.0 113.879 -168.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -163.2 131.34 3.75 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.335 0.588 . . . . 0.0 111.535 -176.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.438 HG12 ' HB3' ' A' ' 54' ' ' ALA . 96.1 t -118.87 112.66 38.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.382 173.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.95 116.12 27.76 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 174.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.496 ' CD2' ' HB1' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -137.19 169.6 17.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.055 0.455 . . . . 0.0 111.395 -175.263 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 9.6 t0 -118.66 119.01 33.18 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.114 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.538 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 8.0 mt -134.16 145.2 49.03 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 175.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -145.35 122.96 11.78 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 173.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -120.94 150.86 40.44 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.041 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.5 t -108.97 177.55 4.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.633 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.04 -19.27 65.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.192 0.52 . . . . 0.0 110.583 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.41 -9.81 81.03 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.272 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -92.72 120.02 32.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.132 0.491 . . . . 0.0 110.568 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -108.13 111.67 23.81 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 176.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.6 pt -128.71 156.08 40.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 120.949 0.404 . . . . 0.0 111.853 -168.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.485 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 4.5 mtm -115.61 119.39 35.97 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 173.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.46 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 1.1 m-85 -99.92 128.4 46.01 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.637 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 31.3 p90 -152.42 140.18 19.94 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.413 0.625 . . . . 0.0 112.194 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 2.3 p -113.16 125.77 54.71 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.854 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.413 ' HB2' ' HB2' ' A' ' 41' ' ' LYS . . . -96.53 164.82 12.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.607 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.16 -165.24 31.44 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -121.98 102.98 8.5 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.059 175.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -173.01 153.04 2.46 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.47 173.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.5 t -112.16 111.71 22.8 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.533 ' CG1' ' HB3' ' A' ' 34' ' ' LEU . 4.6 m -109.8 165.53 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.655 0 CA-C-O 121.408 0.623 . . . . 0.0 111.91 -174.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.8 t -131.61 123.16 27.31 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.914 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.456 HD22 HG22 ' A' ' 29' ' ' ILE . 4.9 mp -91.32 151.94 20.66 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 172.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 tp -134.77 142.49 46.73 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.746 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.0 -166.79 26.69 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.695 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -143.5 135.25 26.45 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.214 0.53 . . . . 0.0 110.931 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.412 HD11 ' HD2' ' A' ' 25' ' ' LYS . 64.5 mt . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.898 172.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 47.4 mtt . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 120.5 0.19 . . . . 0.0 111.327 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . 1.622 ' HE2' ' CE1' ' B' ' 8' ' ' PHE . 56.4 t80 -76.11 151.96 36.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.042 0.449 . . . . 0.0 112.194 -176.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . 0.466 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 89.7 t90 -143.86 147.44 34.05 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.583 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.427 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -151.5 156.44 26.68 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.19 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.472 ' HB3' ' HB2' ' B' ' 87' ' ' LEU . 61.3 tp -148.95 109.64 4.25 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 120.878 0.37 . . . . 0.0 111.422 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -85.98 121.12 28.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.461 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' MET . . . . . 0.672 ' SD ' ' HE1' ' B' ' 19' ' ' TYR . 72.5 mmm -101.75 137.33 40.19 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 120.931 0.396 . . . . 0.0 111.089 -178.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.487 ' HE3' ' HA ' ' B' ' 14' ' ' LYS . 0.0 OUTLIER -101.25 146.44 32.17 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.814 175.713 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -49.87 113.4 0.97 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.961 2.441 . . . . 0.0 113.098 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 61.16 52.01 4.14 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.912 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -125.61 138.32 53.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.736 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . 0.647 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 51.8 mttp -109.74 126.86 54.18 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 120.874 0.369 . . . . 0.0 111.72 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' TYR . . . . . 1.669 ' HD1' ' CD2' ' B' ' 19' ' ' TYR . 2.4 m-85 -111.64 103.89 12.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.739 173.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 9.2 p -86.11 100.51 12.25 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 173.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -114.82 148.8 38.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.35 0.595 . . . . 0.0 112.224 -168.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 38.3 m -107.96 141.95 38.82 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.192 173.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 69.4 mt -102.25 138.34 26.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.156 0.503 . . . . 0.0 111.743 -173.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.454 HD13 ' N ' ' B' ' 24' ' ' ILE . 4.1 mp -110.56 -43.34 5.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.312 176.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 15.2 pttm -113.89 120.54 41.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.149 178.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 14.9 p -58.26 132.09 52.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.715 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . 1.618 ' HD2' ' CD1' ' B' ' 27' ' ' PHE . 54.3 p90 -139.14 157.59 45.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.625 0.726 . . . . 0.0 112.365 -176.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' HIS . . . . . 0.608 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 7.1 t60 -114.7 124.78 52.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.455 177.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 42.6 mt -89.93 134.97 27.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 171.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.608 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 29.0 p -122.06 -12.3 8.36 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -171.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.12 155.84 27.36 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 119.579 -1.296 . . . . 0.0 113.157 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.432 ' CG2' ' HG ' ' B' ' 87' ' ' LEU . 12.3 p -143.31 125.39 12.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 172.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.14 161.06 39.81 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.08 -0.388 . . . . 0.0 111.651 -174.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.524 ' HB3' ' CG1' ' B' ' 85' ' ' VAL . 3.3 pp -123.41 142.27 51.14 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.749 0.785 . . . . 0.0 111.585 177.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.46 ' HB2' ' HH ' ' C' ' 43' ' ' TYR . 21.2 p-10 -103.99 -52.6 2.92 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.563 -1.199 . . . . 0.0 108.645 173.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -104.2 128.55 51.93 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 169.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 152.01 156.13 7.33 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 119.605 -1.284 . . . . 0.0 113.571 175.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . 0.447 ' HA ' ' HB2' ' B' ' 58' ' ' LYS . 94.0 mt-30 -102.82 -44.25 5.33 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.661 0.267 . . . . 0.0 111.273 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -152.73 122.13 6.75 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 121.229 -0.188 . . . . 0.0 110.974 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.446 ' HB1' HG11 ' B' ' 56' ' ' VAL . . . -123.62 114.23 19.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.51 0.672 . . . . 0.0 110.223 170.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' B' ' 79' ' ' THR . 31.8 mmtp -96.89 105.9 18.12 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 44.6 tp -83.31 112.17 19.66 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -175.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . 0.631 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 92.5 m-85 -118.62 147.12 44.08 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 175.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.498 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.3 OUTLIER -131.08 131.07 43.96 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 170.597 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -107.44 112.5 25.32 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.337 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.48 138.19 54.36 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.449 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 58.85 34.07 23.45 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 123.552 0.533 . . . . 0.0 110.012 -176.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 57.3 tttm 56.64 46.63 19.94 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.787 -177.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . 0.581 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 53.4 tp60 -137.99 127.74 25.29 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -87.13 121.4 29.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.066 0.46 . . . . 0.0 110.364 -176.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 0.435 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 81.7 m-85 -113.52 130.6 56.31 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.365 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -79.59 105.74 9.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.626 0.727 . . . . 0.0 109.07 173.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.435 ' CG1' HD13 ' B' ' 67' ' ' LEU . 2.5 t -80.4 -49.21 19.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.625 -172.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.494 ' HB1' ' CD2' ' B' ' 65' ' ' LEU . . . -155.98 148.28 23.57 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.012 0.434 . . . . 0.0 111.701 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 68.6 m -110.48 100.72 9.5 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 170.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . 0.446 HG11 ' HB1' ' B' ' 40' ' ' ALA . 7.7 p -118.42 112.72 39.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.718 0.77 . . . . 0.0 109.649 -177.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 60.9 p -122.9 -178.72 4.02 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.234 -172.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . 0.447 ' HB2' ' HA ' ' B' ' 38' ' ' GLN . 55.5 tttt -59.36 -29.04 67.4 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.944 171.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.456 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -83.21 -40.35 19.76 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.662 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 79.9 mt -111.13 83.11 3.61 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 13.0 Cg_exo -69.92 0.32 5.94 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.059 2.506 . . . . 0.0 113.789 -168.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -163.2 131.36 3.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.314 0.578 . . . . 0.0 111.554 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.423 HG12 ' HB3' ' B' ' 54' ' ' ALA . 96.3 t -118.91 112.72 39.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.336 173.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.98 116.17 27.83 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 174.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.494 ' CD2' ' HB1' ' B' ' 54' ' ' ALA . 0.3 OUTLIER -137.2 169.5 17.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.449 -175.295 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . 0.534 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 9.6 t0 -118.54 118.98 33.17 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.172 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.546 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 8.0 mt -134.19 145.25 49.04 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -145.38 123.0 11.79 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 173.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -120.93 150.86 40.44 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.062 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 14.4 t -108.93 177.43 4.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.774 -0.193 . . . . 0.0 110.637 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.9 -19.35 65.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.178 0.513 . . . . 0.0 110.674 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.31 -9.87 81.11 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.309 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -92.75 120.02 32.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.203 0.525 . . . . 0.0 110.588 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -108.13 111.58 23.67 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 176.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 7.6 pt -128.75 156.07 41.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.913 -168.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' MET . . . . . 0.498 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 4.5 mtm -115.44 119.44 36.24 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 173.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . 0.462 ' CD1' ' HB2' ' B' ' 44' ' ' LEU . 1.1 m-85 -99.91 128.42 46.01 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 0.647 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 31.2 p90 -152.49 140.15 19.84 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.415 0.626 . . . . 0.0 112.172 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' B' ' 41' ' ' LYS . 2.3 p -113.08 125.86 54.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.794 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . 0.404 ' HB2' ' HB2' ' B' ' 41' ' ' LYS . . . -96.66 164.86 12.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.672 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.15 -165.15 31.4 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -121.96 102.96 8.49 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.073 175.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -173.09 153.0 2.42 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.44 -1.255 . . . . 0.0 109.431 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 38.8 t -112.23 111.71 22.79 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.524 ' CG1' ' HB3' ' B' ' 34' ' ' LEU . 4.6 m -109.75 165.55 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.665 0 CA-C-O 121.411 0.624 . . . . 0.0 111.889 -174.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 24.3 t -131.6 123.21 27.42 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.846 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.472 ' HB2' ' HB3' ' B' ' 11' ' ' LEU . 4.9 mp -91.45 151.91 20.59 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 172.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 tp -134.75 142.44 46.75 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.77 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.96 -166.84 26.72 Favored Glycine 0 N--CA 1.438 -1.201 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.71 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -143.55 135.27 26.39 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.28 0.562 . . . . 0.0 110.907 177.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 64.6 mt . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.843 173.06 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 47.5 mtt . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 120.542 0.211 . . . . 0.0 111.369 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 8' ' ' PHE . . . . . 1.643 ' HD1' ' CD2' ' C' ' 8' ' ' PHE . 56.6 t80 -76.07 151.9 36.98 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -176.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . 0.46 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 89.8 t90 -143.81 147.52 34.24 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.514 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . 0.433 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -151.43 156.49 26.71 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.121 -0.562 . . . . 0.0 112.254 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.47 ' HB3' ' HB2' ' C' ' 87' ' ' LEU . 61.5 tp -149.0 109.57 4.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.894 0.378 . . . . 0.0 111.48 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -85.89 121.04 27.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.519 176.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 13' ' ' MET . . . . . 0.667 ' SD ' ' HE1' ' C' ' 19' ' ' TYR . 72.2 mmm -101.68 137.27 40.2 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 120.817 0.341 . . . . 0.0 111.126 -178.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . 0.46 ' HE3' ' HA ' ' C' ' 14' ' ' LYS . 0.0 OUTLIER -101.22 146.48 32.24 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.846 175.666 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -49.93 113.39 0.97 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.093 2.529 . . . . 0.0 113.043 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 60.99 52.05 4.26 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.961 176.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -125.49 138.42 53.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.8 175.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 18' ' ' LYS . . . . . 0.648 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 51.8 mttp -109.65 126.89 54.13 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.697 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . 1.667 ' HD2' ' CD1' ' C' ' 19' ' ' TYR . 2.4 m-85 -111.68 103.75 12.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.818 172.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 9.3 p -86.01 100.57 12.24 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 173.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -114.93 148.67 38.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.431 0.634 . . . . 0.0 112.203 -168.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 39.0 m -107.84 142.03 38.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.165 173.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 69.2 mt -102.29 138.36 26.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.169 0.509 . . . . 0.0 111.75 -173.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . 0.449 HD13 ' N ' ' C' ' 24' ' ' ILE . 4.1 mp -110.55 -43.4 5.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.266 176.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . 0.4 ' HD2' HD11 ' C' ' 91' ' ' LEU . 15.1 pttm -113.91 120.61 41.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.163 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 14.5 p -58.26 132.11 52.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.659 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 27' ' ' PHE . . . . . 1.659 ' HE2' ' CE1' ' C' ' 27' ' ' PHE . 54.2 p90 -139.12 157.56 45.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.597 0.713 . . . . 0.0 112.389 -176.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 28' ' ' HIS . . . . . 0.603 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 7.1 t60 -114.68 124.76 52.63 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.475 177.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 42.4 mt -89.93 134.96 27.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 171.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 30' ' ' SER . . . . . 0.603 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 29.1 p -122.1 -12.27 8.34 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -171.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.12 155.8 27.29 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 119.67 -1.252 . . . . 0.0 113.192 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.421 ' CG2' ' HG ' ' C' ' 87' ' ' LEU . 12.3 p -143.28 125.5 12.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 172.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.2 160.95 40.08 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.111 -0.368 . . . . 0.0 111.647 -174.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.536 ' HB3' ' CG1' ' C' ' 85' ' ' VAL . 3.4 pp -123.4 142.22 51.2 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.8 0.809 . . . . 0.0 111.619 177.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . 0.458 ' HB2' ' HH ' ' D' ' 43' ' ' TYR . 21.2 p-10 -104.02 -52.59 2.91 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.529 173.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -104.19 128.63 51.92 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 169.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.95 156.02 7.28 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 119.619 -1.277 . . . . 0.0 113.653 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 38' ' ' GLN . . . . . 0.447 ' HA ' ' HB2' ' C' ' 58' ' ' LYS . 94.1 mt-30 -102.76 -44.31 5.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.648 0.261 . . . . 0.0 111.232 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -152.67 122.09 6.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.766 -0.197 . . . . 0.0 110.98 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . 0.45 ' HB1' HG11 ' C' ' 56' ' ' VAL . . . -123.57 114.26 19.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.605 0.716 . . . . 0.0 110.27 170.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' C' ' 79' ' ' THR . 31.8 mmtp -96.87 105.8 18.0 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 44.9 tp -83.25 112.21 19.66 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -175.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 43' ' ' TYR . . . . . 0.637 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 92.8 m-85 -118.62 147.27 43.93 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.49 ' HA ' ' O ' ' C' ' 76' ' ' MET . 0.3 OUTLIER -131.08 131.13 44.0 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 170.648 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -107.57 112.49 25.26 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.275 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.49 138.08 54.37 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.487 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 58.95 34.08 23.41 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.238 0.542 . . . . 0.0 109.99 -176.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 57.5 tttm 56.65 46.58 20.0 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.707 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . 0.586 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 53.7 tp60 -137.92 127.77 25.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.465 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -87.2 121.39 29.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.077 0.465 . . . . 0.0 110.338 -176.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 0.427 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 81.3 m-85 -113.49 130.56 56.31 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.411 175.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -79.46 105.8 9.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.664 0.745 . . . . 0.0 109.019 173.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 53' ' ' VAL . . . . . 0.439 ' CG1' HD13 ' C' ' 67' ' ' LEU . 2.5 t -80.56 -49.07 19.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.65 -172.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 54' ' ' ALA . . . . . 0.489 ' HB1' ' CD2' ' C' ' 65' ' ' LEU . . . -155.99 148.22 23.5 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.812 -177.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 71.1 m -110.56 100.8 9.55 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 170.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . 0.45 HG11 ' HB1' ' C' ' 40' ' ' ALA . 7.7 p -118.49 112.74 39.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.658 0.742 . . . . 0.0 109.61 -177.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 64.4 p -122.87 -178.67 4.01 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.272 -172.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 58' ' ' LYS . . . . . 0.447 ' HB2' ' HA ' ' C' ' 38' ' ' GLN . 55.7 tttt -59.54 -28.97 67.57 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.855 172.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . 0.465 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -83.2 -40.39 19.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.648 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 80.1 mt -111.16 83.15 3.68 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 61' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 13.0 Cg_exo -69.84 0.18 6.08 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.074 2.516 . . . . 0.0 113.825 -168.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -163.13 131.34 3.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.297 0.57 . . . . 0.0 111.569 -176.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.426 HG12 ' HB3' ' C' ' 54' ' ' ALA . 96.0 t -118.91 112.67 38.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.392 173.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.91 116.14 27.75 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 174.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . 0.489 ' CD2' ' HB1' ' C' ' 54' ' ' ALA . 0.3 OUTLIER -137.24 169.5 17.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.95 0.405 . . . . 0.0 111.445 -175.26 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 66' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 9.6 t0 -118.59 119.08 33.44 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.106 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . 0.561 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 7.9 mt -134.18 145.26 49.05 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 175.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -145.43 123.03 11.78 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.721 -0.392 . . . . 0.0 109.947 173.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -120.91 150.89 40.38 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.965 -178.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 14.2 t -109.03 177.41 4.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.622 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.92 -19.29 65.7 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.258 0.552 . . . . 0.0 110.612 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.34 -9.9 81.01 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.261 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -92.63 119.93 32.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.059 0.457 . . . . 0.0 110.64 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -107.98 111.59 23.75 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 7.6 pt -128.73 156.1 41.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 120.962 0.41 . . . . 0.0 111.842 -168.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 76' ' ' MET . . . . . 0.49 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 4.5 mtm -115.48 119.42 36.13 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 173.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 77' ' ' PHE . . . . . 0.462 ' CD1' ' HB2' ' C' ' 44' ' ' LEU . 1.1 m-85 -99.9 128.37 45.99 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 78' ' ' TYR . . . . . 0.648 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 31.3 p90 -152.42 140.15 19.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.457 0.646 . . . . 0.0 112.252 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 79' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' C' ' 41' ' ' LYS . 2.3 p -113.04 125.79 54.78 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.837 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 80' ' ' ALA . . . . . 0.402 ' HB2' ' HB2' ' C' ' 41' ' ' LYS . . . -96.69 164.93 12.37 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.628 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.05 -165.21 31.57 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 -177.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -121.9 103.06 8.57 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 119.864 -0.735 . . . . 0.0 110.073 175.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -173.13 153.02 2.4 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.501 173.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 38.6 t -112.27 111.7 22.76 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.536 ' CG1' ' HB3' ' C' ' 34' ' ' LEU . 4.6 m -109.78 165.54 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 CA-C-O 121.308 0.575 . . . . 0.0 111.89 -174.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 23.9 t -131.58 123.09 27.2 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.953 176.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . 0.47 ' HB2' ' HB3' ' C' ' 11' ' ' LEU . 4.9 mp -91.31 151.94 20.67 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 172.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 tp -134.7 142.46 46.81 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.843 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.94 -166.85 26.71 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.804 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -143.56 135.17 26.28 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.256 0.55 . . . . 0.0 110.928 177.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . 0.4 HD11 ' HD2' ' C' ' 25' ' ' LYS . 64.7 mt . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.83 173.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 47.5 mtt . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 120.551 0.215 . . . . 0.0 111.376 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 8' ' ' PHE . . . . . 1.663 ' HE2' ' CE1' ' D' ' 8' ' ' PHE . 56.7 t80 -76.1 151.92 36.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.113 0.482 . . . . 0.0 112.261 -176.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 9' ' ' TRP . . . . . 0.466 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 89.6 t90 -143.77 147.38 34.08 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.66 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . 0.445 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -151.38 156.53 26.73 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.216 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . 0.466 ' HB2' ' CH2' ' D' ' 9' ' ' TRP . 61.3 tp -149.04 109.59 4.22 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.902 0.382 . . . . 0.0 111.403 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -85.96 121.1 28.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.387 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 13' ' ' MET . . . . . 0.676 ' SD ' ' HE1' ' D' ' 19' ' ' TYR . 72.3 mmm -101.76 137.3 40.24 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.884 0.373 . . . . 0.0 111.132 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 14' ' ' LYS . . . . . 0.471 ' HA ' ' HE3' ' D' ' 14' ' ' LYS . 0.0 OUTLIER -101.1 146.46 32.19 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.898 175.663 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -49.92 113.39 0.97 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.035 2.49 . . . . 0.0 113.066 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 61.11 51.98 4.2 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.928 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -125.5 138.35 53.98 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.737 175.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . 0.657 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 51.9 mttp -109.67 126.92 54.19 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 120.799 0.333 . . . . 0.0 111.732 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 19' ' ' TYR . . . . . 1.66 ' HD2' ' CD1' ' D' ' 19' ' ' TYR . 2.4 m-85 -111.74 103.7 12.0 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 173.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 9.3 p -86.0 100.62 12.27 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 173.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -114.88 148.73 38.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.283 -168.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 38.7 m -107.83 142.01 38.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.181 173.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 69.2 mt -102.32 138.37 26.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.226 0.536 . . . . 0.0 111.713 -173.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . 0.444 ' N ' HD13 ' D' ' 24' ' ' ILE . 4.1 mp -110.63 -43.26 5.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.269 176.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . 0.402 ' HD2' HD11 ' D' ' 91' ' ' LEU . 15.2 pttm -113.95 120.5 40.86 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.146 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 14.6 p -58.19 132.18 52.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.653 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 27' ' ' PHE . . . . . 1.661 ' HE2' ' CE1' ' D' ' 27' ' ' PHE . 54.4 p90 -139.24 157.55 45.72 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.632 0.73 . . . . 0.0 112.357 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 28' ' ' HIS . . . . . 0.611 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 7.0 t60 -114.67 124.67 52.42 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.505 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 29' ' ' ILE . . . . . 0.563 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 42.4 mt -89.85 134.98 27.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 171.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 30' ' ' SER . . . . . 0.611 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 28.7 p -122.13 -12.31 8.33 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -171.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.05 155.91 27.48 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.712 -1.232 . . . . 0.0 113.239 177.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . 0.425 ' CG2' ' HG ' ' D' ' 87' ' ' LEU . 12.4 p -143.41 125.46 11.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 172.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.11 161.06 39.8 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 122.023 -0.423 . . . . 0.0 111.682 -174.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 34' ' ' LEU . . . . . 0.536 ' HB3' ' CG1' ' D' ' 85' ' ' VAL . 3.3 pp -123.49 142.16 51.28 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.748 0.785 . . . . 0.0 111.621 177.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . 0.479 ' HB2' ' HH ' ' E' ' 43' ' ' TYR . 21.2 p-10 -104.04 -52.48 2.94 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.515 -1.221 . . . . 0.0 108.54 173.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -104.27 128.6 52.06 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 169.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 152.0 155.99 7.27 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 119.584 -1.293 . . . . 0.0 113.632 175.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 38' ' ' GLN . . . . . 0.459 ' HA ' ' HB2' ' D' ' 58' ' ' LYS . 94.1 mt-30 -102.7 -44.28 5.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.621 0.248 . . . . 0.0 111.29 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -152.74 122.08 6.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.025 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . 0.449 ' HB1' HG11 ' D' ' 56' ' ' VAL . . . -123.59 114.26 19.78 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.601 0.715 . . . . 0.0 110.203 170.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.416 ' HB2' ' HB2' ' D' ' 80' ' ' ALA . 31.8 mmtp -96.78 105.81 18.0 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 44.7 tp -83.25 112.19 19.64 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 43' ' ' TYR . . . . . 0.625 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 92.6 m-85 -118.66 147.17 44.07 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.489 ' HA ' ' O ' ' D' ' 76' ' ' MET . 0.3 OUTLIER -131.06 131.07 44.0 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 170.572 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 45' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -107.46 112.58 25.44 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.3 178.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.54 138.18 54.35 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.432 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 58.83 34.15 23.51 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.562 0.539 . . . . 0.0 109.975 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 57.3 tttm 56.64 46.42 20.31 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.807 -177.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . 0.578 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 53.6 tp60 -137.85 127.79 25.62 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 176.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -87.19 121.39 29.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.062 0.458 . . . . 0.0 110.369 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . 0.433 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 81.7 m-85 -113.48 130.54 56.31 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.4 175.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -79.55 105.79 9.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.646 0.736 . . . . 0.0 109.086 173.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 53' ' ' VAL . . . . . 0.435 ' CG1' HD13 ' D' ' 67' ' ' LEU . 2.5 t -80.46 -49.21 18.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.536 -172.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 54' ' ' ALA . . . . . 0.487 ' HB1' ' CD2' ' D' ' 65' ' ' LEU . . . -155.95 148.22 23.56 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 120.95 0.405 . . . . 0.0 111.731 -177.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 72.8 m -110.54 100.61 9.39 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 170.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 56' ' ' VAL . . . . . 0.449 HG11 ' HB1' ' D' ' 40' ' ' ALA . 7.7 p -118.36 112.65 39.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.658 0.742 . . . . 0.0 109.63 -177.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 61.9 p -122.79 -178.68 4.0 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.304 -172.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 58' ' ' LYS . . . . . 0.459 ' HB2' ' HA ' ' D' ' 38' ' ' GLN . 56.0 tttt -59.58 -28.88 67.54 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.899 172.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 59' ' ' ALA . . . . . 0.466 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -83.25 -40.44 19.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.592 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 79.6 mt -111.06 82.98 3.44 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 174.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 61' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 13.1 Cg_exo -69.72 0.22 5.92 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.047 2.498 . . . . 0.0 113.887 -168.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -163.13 131.26 3.76 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.273 0.559 . . . . 0.0 111.614 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.438 HG12 ' HB3' ' D' ' 54' ' ' ALA . 96.4 t -118.85 112.65 38.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.377 173.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.92 116.2 27.81 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 174.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 65' ' ' LEU . . . . . 0.487 ' CD2' ' HB1' ' D' ' 54' ' ' ALA . 0.3 OUTLIER -137.38 169.42 17.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.007 0.432 . . . . 0.0 111.426 -175.242 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 66' ' ' ASP . . . . . 0.523 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 9.7 t0 -118.45 118.97 33.18 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.114 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . 0.563 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 8.0 mt -134.14 145.3 49.15 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -145.37 123.0 11.8 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 173.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -120.96 150.93 40.34 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.008 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 14.2 t -109.05 177.44 4.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.748 -0.206 . . . . 0.0 110.592 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.92 -19.27 65.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.163 0.506 . . . . 0.0 110.659 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.33 -9.95 80.95 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.272 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -92.65 120.07 32.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.218 0.532 . . . . 0.0 110.584 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -108.12 111.55 23.63 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 176.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . . . . . . . . . 7.6 pt -128.63 156.15 40.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 120.963 0.411 . . . . 0.0 111.812 -168.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 76' ' ' MET . . . . . 0.489 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 4.5 mtm -115.53 119.37 35.94 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 173.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 77' ' ' PHE . . . . . 0.45 ' CD1' ' HB2' ' D' ' 44' ' ' LEU . 1.1 m-85 -99.85 128.36 45.95 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 78' ' ' TYR . . . . . 0.657 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 31.4 p90 -152.42 140.2 19.95 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.452 0.644 . . . . 0.0 112.227 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 79' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' D' ' 41' ' ' LYS . 2.3 p -113.15 125.74 54.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.802 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 80' ' ' ALA . . . . . 0.416 ' HB2' ' HB2' ' D' ' 41' ' ' LYS . . . -96.58 164.86 12.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.62 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.12 -165.15 31.43 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -177.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -121.98 103.0 8.51 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.047 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -173.07 153.09 2.45 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.528 173.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 38.6 t -112.27 111.62 22.62 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . 0.536 ' CG1' ' HB3' ' D' ' 34' ' ' LEU . 4.6 m -109.77 165.44 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.673 0 CA-C-O 121.459 0.647 . . . . 0.0 111.87 -174.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 24.0 t -131.55 123.12 27.3 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.896 176.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 87' ' ' LEU . . . . . 0.452 ' HB2' ' HB3' ' D' ' 11' ' ' LEU . 4.9 mp -91.37 151.97 20.62 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 172.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 tp -134.78 142.53 46.72 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.738 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.01 -166.82 26.75 Favored Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.743 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -143.47 135.21 26.47 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.151 0.5 . . . . 0.0 110.919 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . 0.402 HD11 ' HD2' ' D' ' 25' ' ' LYS . 64.9 mt . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.904 173.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 47.4 mtt . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 120.603 0.239 . . . . 0.0 111.333 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' E' E ' 8' ' ' PHE . . . . . 1.659 ' HE1' ' CE2' ' E' ' 8' ' ' PHE . 56.2 t80 -76.13 151.99 36.85 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -176.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 9' ' ' TRP . . . . . 0.456 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 89.7 t90 -143.85 147.43 34.06 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.631 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 10' ' ' GLY . . . . . 0.432 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -151.46 156.46 26.69 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.144 178.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 11' ' ' LEU . . . . . 0.468 ' HB3' ' HB2' ' E' ' 87' ' ' LEU . 61.2 tp -148.94 109.62 4.25 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.855 0.359 . . . . 0.0 111.445 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -85.98 121.13 28.17 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.435 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 13' ' ' MET . . . . . 0.684 ' SD ' ' HE1' ' E' ' 19' ' ' TYR . 72.3 mmm -101.74 137.29 40.25 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.0 111.069 -178.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 14' ' ' LYS . . . . . 0.476 ' HE3' ' HA ' ' E' ' 14' ' ' LYS . 0.0 OUTLIER -101.12 146.44 32.16 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.872 175.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -49.95 113.35 0.96 Allowed 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.995 2.463 . . . . 0.0 113.152 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 61.21 52.03 4.09 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.837 176.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -125.58 138.35 53.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.785 175.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . 0.658 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 51.8 mttp -109.66 126.85 54.1 Favored 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 123.264 0.352 . . . . 0.0 111.688 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . 1.65 ' HE2' ' CE1' ' E' ' 19' ' ' TYR . 2.4 m-85 -111.71 103.79 12.1 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.772 172.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 9.2 p -86.01 100.6 12.25 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 173.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -114.91 148.73 38.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.396 0.617 . . . . 0.0 112.235 -168.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 37.5 m -107.83 142.06 38.47 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.17 173.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 69.4 mt -102.39 138.37 26.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.233 0.54 . . . . 0.0 111.709 -173.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . 0.443 ' N ' HD13 ' E' ' 24' ' ' ILE . 4.1 mp -110.62 -43.42 5.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.203 176.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . 0.411 ' HD2' HD11 ' E' ' 91' ' ' LEU . 15.1 pttm -113.86 120.62 41.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.177 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 14.4 p -58.31 132.23 53.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.65 -178.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 27' ' ' PHE . . . . . 1.666 ' HE2' ' CE1' ' E' ' 27' ' ' PHE . 54.2 p90 -139.22 157.49 45.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.603 0.716 . . . . 0.0 112.377 -176.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 28' ' ' HIS . . . . . 0.601 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 7.2 t60 -114.6 124.72 52.56 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.552 177.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 29' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 42.5 mt -89.91 134.91 27.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 171.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 30' ' ' SER . . . . . 0.601 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 29.1 p -122.02 -12.34 8.36 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -171.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.16 155.86 27.38 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 119.626 -1.273 . . . . 0.0 113.188 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . 0.423 ' CG2' ' HG ' ' E' ' 87' ' ' LEU . 12.4 p -143.35 125.51 12.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 172.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.21 161.06 39.85 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.62 -174.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 34' ' ' LEU . . . . . 0.53 ' HB3' ' CG1' ' E' ' 85' ' ' VAL . 3.3 pp -123.48 142.21 51.23 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.717 0.77 . . . . 0.0 111.629 177.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . 0.463 ' HB2' ' HH ' ' A' ' 43' ' ' TYR . 21.2 p-10 -103.98 -52.58 2.92 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.584 173.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -104.17 128.63 51.88 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 169.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.96 156.05 7.3 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 119.568 -1.301 . . . . 0.0 113.644 175.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 38' ' ' GLN . . . . . 0.462 ' HA ' ' HB2' ' E' ' 58' ' ' LYS . 94.2 mt-30 -102.82 -44.22 5.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.692 0.282 . . . . 0.0 111.264 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -152.73 122.05 6.72 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 121.161 -0.216 . . . . 0.0 110.96 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . 0.434 ' HB1' HG11 ' E' ' 56' ' ' VAL . . . -123.56 114.31 19.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.536 0.684 . . . . 0.0 110.13 170.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 41' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' E' ' 79' ' ' THR . 31.8 mmtp -96.94 105.89 18.11 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 176.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 44.6 tp -83.21 112.17 19.61 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 -175.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 43' ' ' TYR . . . . . 0.629 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 92.9 m-85 -118.65 147.18 44.05 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 175.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 44' ' ' LEU . . . . . 0.491 ' HA ' ' O ' ' E' ' 76' ' ' MET . 0.3 OUTLIER -131.08 131.04 43.95 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 170.628 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 45' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -107.51 112.55 25.37 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.314 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.56 138.18 54.35 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.476 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 58.82 34.16 23.52 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.168 0.509 . . . . 0.0 109.983 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 57.3 tttm 56.62 46.53 20.14 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.811 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 49' ' ' GLN . . . . . 0.571 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 53.6 tp60 -137.89 127.74 25.48 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -87.13 121.39 29.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.056 0.455 . . . . 0.0 110.388 -176.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . 0.445 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 81.5 m-85 -113.51 130.5 56.33 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.375 175.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -79.47 105.8 9.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.622 0.725 . . . . 0.0 109.09 173.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . 0.43 ' CG1' HD13 ' E' ' 67' ' ' LEU . 2.5 t -80.45 -49.21 19.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.638 -172.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 54' ' ' ALA . . . . . 0.499 ' HB1' ' CD2' ' E' ' 65' ' ' LEU . . . -155.92 148.27 23.64 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.748 -177.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 67.4 m -110.52 100.7 9.47 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 170.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . 0.434 HG11 ' HB1' ' E' ' 40' ' ' ALA . 7.7 p -118.45 112.6 38.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.624 0.726 . . . . 0.0 109.73 -177.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 64.0 p -122.82 -178.71 4.01 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.178 -172.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 58' ' ' LYS . . . . . 0.462 ' HB2' ' HA ' ' E' ' 38' ' ' GLN . 55.8 tttt -59.49 -28.92 67.46 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.826 172.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 59' ' ' ALA . . . . . 0.465 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -83.36 -40.25 19.65 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.678 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 79.9 mt -111.07 83.03 3.49 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 61' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 13.1 Cg_exo -69.85 0.28 5.94 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.028 2.485 . . . . 0.0 113.861 -168.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -163.16 131.4 3.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.3 0.571 . . . . 0.0 111.548 -176.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . 0.427 HG12 ' HB3' ' E' ' 54' ' ' ALA . 95.6 t -118.98 112.76 39.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.334 173.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.05 116.14 27.85 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 174.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 65' ' ' LEU . . . . . 0.499 ' CD2' ' HB1' ' E' ' 54' ' ' ALA . 0.3 OUTLIER -137.19 169.54 17.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.492 -175.277 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 66' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 9.5 t0 -118.67 119.01 33.18 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.072 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 67' ' ' LEU . . . . . 0.549 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 8.0 mt -134.19 145.21 49.0 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 175.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -145.34 123.0 11.82 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 173.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -120.88 150.88 40.38 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.095 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 14.1 t -108.94 177.45 4.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.821 -0.172 . . . . 0.0 110.663 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.88 -19.31 65.71 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.255 0.55 . . . . 0.0 110.667 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.35 -9.93 80.94 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.256 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -92.61 120.0 32.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.166 0.508 . . . . 0.0 110.524 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -108.1 111.58 23.69 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 75' ' ' ILE . . . . . . . . . . . . . 7.6 pt -128.61 156.07 40.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 120.991 0.424 . . . . 0.0 111.878 -168.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 76' ' ' MET . . . . . 0.491 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 4.5 mtm -115.53 119.44 36.18 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 173.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 77' ' ' PHE . . . . . 0.462 ' CD1' ' HB2' ' E' ' 44' ' ' LEU . 1.1 m-85 -99.9 128.4 46.0 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 78' ' ' TYR . . . . . 0.658 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 31.3 p90 -152.42 140.3 20.05 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.43 0.633 . . . . 0.0 112.156 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 79' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' E' ' 41' ' ' LYS . 2.3 p -113.22 125.77 54.68 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.762 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 80' ' ' ALA . . . . . 0.409 ' HB2' ' HB2' ' E' ' 41' ' ' LYS . . . -96.58 164.87 12.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.697 178.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.08 -165.18 31.51 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -177.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -121.98 103.0 8.52 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.069 175.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 83' ' ' ALA . . . . . . . . . . . . . . . -173.07 153.08 2.45 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.504 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 39.2 t -112.27 111.58 22.55 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 85' ' ' VAL . . . . . 0.53 ' CG1' ' HB3' ' E' ' 34' ' ' LEU . 4.5 m -109.76 165.56 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-O 121.378 0.609 . . . . 0.0 111.842 -174.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 24.2 t -131.65 123.13 27.18 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.882 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 87' ' ' LEU . . . . . 0.468 ' HB2' ' HB3' ' E' ' 11' ' ' LEU . 4.9 mp -91.34 151.95 20.65 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 172.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 tp -134.76 142.46 46.73 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.789 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.91 -166.8 26.6 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.756 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 90' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -143.56 135.3 26.41 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.2 0.524 . . . . 0.0 110.936 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 91' ' ' LEU . . . . . 0.411 HD11 ' HD2' ' E' ' 25' ' ' LYS . 64.7 mt . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.885 173.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 46.9 mtt . . . . . 0 C--O 1.219 -0.522 0 CA-C-O 120.272 0.082 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 1.631 ' HE1' ' CE2' ' A' ' 8' ' ' PHE . 63.7 t80 -82.18 147.45 29.0 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -177.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.473 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 91.2 t90 -139.29 150.1 45.03 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.395 177.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.416 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -154.26 152.21 23.82 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.43 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.521 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 41.0 tp -143.19 108.33 4.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.741 0.305 . . . . 0.0 110.385 177.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -86.11 99.38 11.46 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.416 0.627 . . . . 0.0 109.99 175.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.502 ' HB3' HG22 ' A' ' 85' ' ' VAL . 23.8 tpp -88.02 135.12 33.56 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.881 -175.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -98.83 145.15 29.45 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.119 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.5 ' HB3' ' N ' ' A' ' 83' ' ' ALA . 10.3 Cg_endo -52.92 120.18 7.24 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 123.585 2.857 . . . . 0.0 113.276 -175.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.679 ' HA ' ' O ' ' A' ' 79' ' ' THR . 29.0 mt-10 58.26 63.07 1.83 Allowed 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 121.575 0.703 . . . . 0.0 111.596 177.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.59 148.95 46.28 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.592 174.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.625 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 35.0 ttmt -122.6 117.15 25.16 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 123.525 0.516 . . . . 0.0 111.314 -175.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 1.664 ' HE2' ' CE1' ' A' ' 19' ' ' TYR . 2.1 m-85 -110.98 104.36 12.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.974 177.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 76' ' ' MET . 10.0 p -88.25 99.95 12.62 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 173.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -121.4 149.9 42.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.501 0.667 . . . . 0.0 112.347 -169.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.2 t -99.21 160.8 14.01 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.405 176.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 53.2 mt -118.99 125.79 74.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.1 0.476 . . . . 0.0 111.531 -173.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.46 HD13 ' N ' ' A' ' 24' ' ' ILE . 4.2 mp -107.02 -33.56 2.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.336 177.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -118.94 122.18 41.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.572 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.5 t -60.82 133.06 55.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.879 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 1.654 ' HD2' ' CD1' ' A' ' 27' ' ' PHE . 53.9 p90 -137.42 143.13 41.71 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.939 0.876 . . . . 0.0 111.881 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.63 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 3.5 t60 -102.4 129.87 49.0 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.827 174.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 48.9 mt -97.53 130.28 46.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.63 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 46.6 p -114.0 -18.02 11.83 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.565 -171.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -162.2 149.03 16.87 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 119.611 -1.281 . . . . 0.0 113.031 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.2 p -135.19 121.99 34.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 172.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 85' ' ' VAL . . . -141.53 150.22 41.87 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.97 -171.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.463 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 4.3 pp -114.96 137.52 51.9 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 121.802 0.811 . . . . 0.0 111.167 178.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -107.01 -55.44 2.33 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.615 175.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -101.9 127.06 48.9 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.388 -0.823 . . . . 0.0 108.884 170.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.433 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 148.31 163.48 10.81 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.043 -1.075 . . . . 0.0 113.045 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -102.65 -47.19 4.51 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 121.099 -0.241 . . . . 0.0 111.404 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -151.92 136.39 16.86 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.632 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.49 113.59 12.65 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.478 0.656 . . . . 0.0 110.455 168.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 79' ' ' THR . 65.8 mttp -97.48 109.51 22.25 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.1 tp -85.75 114.78 22.97 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.993 -173.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 1.655 ' HD1' ' CD2' ' A' ' 43' ' ' TYR . 66.0 m-85 -116.41 145.75 43.02 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.492 ' HB2' ' CD1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -131.32 130.37 42.64 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 172.278 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -108.61 114.2 27.83 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.073 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.45 124.21 40.92 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.824 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.503 ' C ' ' HD2' ' A' ' 48' ' ' LYS . 4.2 mm-40 56.62 51.9 10.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.356 0.598 . . . . 0.0 111.066 -175.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.503 ' HD2' ' C ' ' A' ' 47' ' ' GLU . 6.7 mptt 59.0 39.58 23.35 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.459 174.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.576 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 24.0 tp60 -138.56 115.89 11.15 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -82.45 111.74 18.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.931 0.396 . . . . 0.0 110.714 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 1.648 ' HD1' ' CD2' ' A' ' 51' ' ' TYR . 80.3 m-85 -101.82 128.92 47.97 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.362 176.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -75.75 102.61 2.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 168.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.443 ' CG1' HD12 ' A' ' 67' ' ' LEU . 2.8 t -76.24 -51.52 19.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.579 -172.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.444 ' HB3' ' CD2' ' A' ' 65' ' ' LEU . . . -156.61 142.07 17.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.24 -177.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.8 m -105.1 101.35 10.91 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 172.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.71 112.55 40.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.783 0.802 . . . . 0.0 110.103 -177.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.8 p -123.47 -177.0 3.59 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.05 -176.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -59.13 -32.9 70.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.988 0.423 . . . . 0.0 110.44 169.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.64 -40.57 69.62 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.575 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.5 mt -117.69 81.77 15.34 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 174.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.64 -5.67 14.82 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.231 2.621 . . . . 0.0 113.988 -167.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -162.15 122.6 2.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.089 0.471 . . . . 0.0 110.974 -175.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.416 HG12 ' HB2' ' A' ' 54' ' ' ALA . 98.1 t -108.57 113.57 44.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.343 175.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.37 114.87 27.4 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.104 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -135.48 168.66 18.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.223 -176.19 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.515 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 6.0 t70 -114.56 99.82 7.82 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.44 0.638 . . . . 0.0 110.588 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.565 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 19.7 mt -111.41 140.98 45.55 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.12 116.57 9.62 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.415 174.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 1.656 ' HE1' ' CE2' ' A' ' 69' ' ' PHE . 21.6 m-85 -116.7 139.76 50.19 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.3 t -103.31 173.97 6.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.003 0.43 . . . . 0.0 110.613 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.57 1.29 12.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.539 -177.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.06 -5.84 54.41 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 173.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -100.36 151.43 21.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.865 0.364 . . . . 0.0 110.376 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -140.12 132.42 28.29 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 172.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.8 pt -139.79 164.64 23.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.011 0.434 . . . . 0.0 111.817 -167.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.48 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 4.5 mtm -118.65 121.74 40.87 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 173.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 1.66 ' HD1' ' CD2' ' A' ' 77' ' ' PHE . 1.0 OUTLIER -103.66 127.92 51.05 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.754 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.625 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 40.4 p90 -153.56 140.77 19.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.256 0.55 . . . . 0.0 111.886 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.679 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 15.2 p -111.9 144.97 40.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.297 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.09 148.66 28.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.31 173.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.85 176.83 41.1 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -176.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -108.53 102.55 11.62 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.046 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.5 ' N ' ' HB3' ' A' ' 15' ' ' PRO . . . -165.88 148.92 7.55 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.363 167.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 27.1 t -103.97 123.98 48.17 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.502 HG22 ' HB3' ' A' ' 13' ' ' MET . 8.0 m -121.01 135.25 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-O 121.349 0.595 . . . . 0.0 111.961 -173.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.1 m -97.47 118.39 33.86 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.908 175.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.521 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 5.0 mp -91.27 140.77 29.48 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 171.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.407 ' CD2' HG12 ' B' ' 53' ' ' VAL . 0.8 OUTLIER -127.62 143.64 51.14 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -178.254 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' A' ' 28' ' ' HIS . . . -166.28 -166.97 26.21 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.126 -1.035 . . . . 0.0 112.833 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 1.649 ' HD1' ' CD2' ' A' ' 90' ' ' TYR . 5.1 p90 -142.32 136.6 29.86 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 120.939 0.4 . . . . 0.0 110.676 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.416 HD22 ' HB3' ' A' ' 27' ' ' PHE . 84.5 mt . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.945 174.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 46.9 mtt . . . . . 0 C--O 1.219 -0.528 0 CA-C-O 120.272 0.082 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . 1.605 ' HD1' ' CD2' ' B' ' 8' ' ' PHE . 63.6 t80 -82.22 147.44 28.97 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.908 0.385 . . . . 0.0 112.024 -177.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . 0.475 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 91.1 t90 -139.24 150.02 45.01 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.458 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.425 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -154.11 152.27 23.87 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.489 178.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' B' ' 87' ' ' LEU . 41.1 tp -143.24 108.41 4.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.749 0.309 . . . . 0.0 110.364 177.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -86.04 99.32 11.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.257 0.551 . . . . 0.0 110.036 175.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' MET . . . . . 0.5 ' HB3' HG22 ' B' ' 85' ' ' VAL . 24.1 tpp -88.0 135.13 33.55 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.86 -175.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -98.86 145.24 29.62 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.075 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.5 ' HB3' ' N ' ' B' ' 83' ' ' ALA . 10.3 Cg_endo -53.01 120.15 7.23 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 123.591 2.861 . . . . 0.0 113.257 -175.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.679 ' HA ' ' O ' ' B' ' 79' ' ' THR . 29.1 mt-10 58.36 62.94 1.84 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.558 0.694 . . . . 0.0 111.628 177.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.54 148.98 46.39 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.586 174.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . 0.621 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 35.1 ttmt -122.62 117.11 25.06 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.596 0.56 . . . . 0.0 111.379 -175.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' TYR . . . . . 1.669 ' HD2' ' CD1' ' B' ' 19' ' ' TYR . 2.1 m-85 -110.97 104.23 12.79 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.05 177.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 9.8 p -88.19 99.98 12.62 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -121.44 149.9 42.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.369 0.604 . . . . 0.0 112.275 -169.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 12.1 t -99.34 160.88 13.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.369 176.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 53.1 mt -118.98 125.7 74.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.05 0.453 . . . . 0.0 111.606 -173.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.467 HD13 ' N ' ' B' ' 24' ' ' ILE . 4.2 mp -106.9 -33.63 2.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.357 177.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -118.94 122.2 41.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.563 177.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 20.3 t -60.81 133.14 55.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.917 -177.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . 1.669 ' HE2' ' CE1' ' B' ' 27' ' ' PHE . 53.8 p90 -137.48 143.17 41.6 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.932 0.872 . . . . 0.0 111.821 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' HIS . . . . . 0.617 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 3.6 t60 -102.4 129.88 49.01 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.1 -1.409 . . . . 0.0 108.823 174.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.57 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 49.2 mt -97.59 130.34 46.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 171.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.617 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 46.8 p -113.97 -17.99 11.85 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.531 -171.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -162.17 149.02 16.87 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 119.567 -1.302 . . . . 0.0 112.961 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 8.2 p -135.17 121.92 34.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 172.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.5 150.23 41.93 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.436 -0.506 . . . . 0.0 112.049 -171.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.454 ' O ' HD13 ' B' ' 34' ' ' LEU . 4.3 pp -114.91 137.58 51.8 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.816 0.817 . . . . 0.0 111.071 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -107.1 -55.46 2.33 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.585 175.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -101.89 127.07 48.88 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 170.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.435 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 148.37 163.57 10.88 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 119.988 -1.101 . . . . 0.0 112.904 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -102.66 -47.23 4.49 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.57 0.224 . . . . 0.0 111.402 177.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -151.89 136.37 16.88 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.62 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.41 113.61 12.73 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.398 0.618 . . . . 0.0 110.419 168.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' B' ' 79' ' ' THR . 65.8 mttp -97.48 109.66 22.37 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 173.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 34.6 tp -85.68 114.75 22.9 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.067 -173.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . 1.647 ' HD2' ' CD1' ' B' ' 43' ' ' TYR . 66.1 m-85 -116.39 145.82 42.95 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 175.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.501 ' HB2' ' CD1' ' B' ' 77' ' ' PHE . 0.2 OUTLIER -131.4 130.33 42.43 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 172.268 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -108.59 114.2 27.82 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.118 178.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.33 124.32 41.32 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.812 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . 0.503 ' C ' ' HD2' ' B' ' 48' ' ' LYS . 4.2 mm-40 56.36 52.02 10.66 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.688 0.618 . . . . 0.0 111.132 -175.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.503 ' HD2' ' C ' ' B' ' 47' ' ' GLU . 6.7 mptt 58.95 39.63 23.41 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.479 174.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . 0.581 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 24.1 tp60 -138.56 115.95 11.2 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -82.58 111.79 18.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.83 0.348 . . . . 0.0 110.596 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 1.647 ' HD1' ' CD2' ' B' ' 51' ' ' TYR . 80.3 m-85 -101.85 128.91 48.02 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.301 176.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -75.81 102.62 2.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 168.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.446 ' CG1' HD12 ' B' ' 67' ' ' LEU . 2.8 t -76.17 -51.64 19.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.542 -172.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.442 ' HB3' ' CD2' ' B' ' 65' ' ' LEU . . . -156.5 142.16 17.74 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.193 -177.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 42.6 m -105.17 101.45 11.0 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 171.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.73 112.51 40.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.788 0.804 . . . . 0.0 110.067 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 68.8 p -123.47 -177.09 3.61 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.054 -176.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -59.16 -32.73 70.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.976 0.417 . . . . 0.0 110.47 169.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.76 -40.59 69.2 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.523 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 76.4 mt -117.6 81.8 15.04 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 174.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.71 -5.64 14.82 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.312 2.675 . . . . 0.0 113.932 -167.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -162.18 122.64 2.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.208 0.528 . . . . 0.0 110.955 -175.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.413 HG12 ' HB2' ' B' ' 54' ' ' ALA . 97.9 t -108.57 113.51 44.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.374 175.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.36 114.85 27.38 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.102 175.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' B' ' 30' ' ' SER . 0.3 OUTLIER -135.46 168.7 18.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.191 -176.197 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 5.9 t70 -114.58 99.7 7.73 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.393 0.616 . . . . 0.0 110.598 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.57 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 19.7 mt -111.35 140.97 45.49 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.17 116.64 9.64 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.351 174.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . 1.643 ' HE1' ' CE2' ' B' ' 69' ' ' PHE . 22.1 m-85 -116.78 139.68 50.3 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 5.3 t -103.3 173.95 6.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.951 0.405 . . . . 0.0 110.633 -177.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.56 1.29 12.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.513 -177.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.0 -5.89 54.48 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 173.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -100.26 151.33 21.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.964 0.412 . . . . 0.0 110.35 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -140.1 132.48 28.43 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 172.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 6.9 pt -139.87 164.57 23.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.017 0.437 . . . . 0.0 111.837 -167.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 4.5 mtm -118.59 121.63 40.66 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 173.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . 1.67 ' HD1' ' CD2' ' B' ' 77' ' ' PHE . 1.1 m-85 -103.61 127.95 50.97 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 0.621 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 40.2 p90 -153.59 140.79 19.49 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.255 0.55 . . . . 0.0 111.845 -178.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.679 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 15.3 p -111.91 144.88 40.5 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.224 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.0 148.62 28.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.298 173.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.05 176.84 40.81 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -108.55 102.55 11.62 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.949 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.5 ' N ' ' HB3' ' B' ' 15' ' ' PRO . . . -165.92 148.85 7.47 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.382 167.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 27.2 t -103.94 124.02 48.22 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.5 HG22 ' HB3' ' B' ' 13' ' ' MET . 8.0 m -121.07 135.15 62.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-O 121.361 0.6 . . . . 0.0 111.895 -173.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 69.5 m -97.48 118.45 34.0 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.936 175.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.523 ' HB2' ' HB3' ' B' ' 11' ' ' LEU . 5.0 mp -91.27 140.79 29.46 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 171.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.412 HD21 HD22 ' C' ' 67' ' ' LEU . 0.8 OUTLIER -127.67 143.59 51.14 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.242 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' B' ' 28' ' ' HIS . . . -166.2 -166.92 26.04 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 120.112 -1.042 . . . . 0.0 112.801 -177.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' TYR . . . . . 1.644 ' HD2' ' CD1' ' B' ' 90' ' ' TYR . 5.1 p90 -142.4 136.54 29.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.002 0.43 . . . . 0.0 110.655 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . 0.42 HD22 ' HB3' ' B' ' 27' ' ' PHE . 84.8 mt . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.921 174.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 46.9 mtt . . . . . 0 C--O 1.219 -0.539 0 CA-C-O 120.273 0.082 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 8' ' ' PHE . . . . . 1.627 ' HD1' ' CD2' ' C' ' 8' ' ' PHE . 63.6 t80 -82.3 147.48 28.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.921 0.391 . . . . 0.0 111.955 -177.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . 0.471 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 91.1 t90 -139.32 149.98 44.85 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.421 177.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . 0.422 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -154.09 152.29 23.89 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.523 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.512 ' HB3' ' HB2' ' C' ' 87' ' ' LEU . 41.2 tp -143.27 108.34 4.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.74 0.305 . . . . 0.0 110.35 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -85.96 99.17 11.24 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.306 0.574 . . . . 0.0 110.099 175.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 13' ' ' MET . . . . . 0.51 ' HB3' HG22 ' C' ' 85' ' ' VAL . 24.1 tpp -87.97 135.1 33.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.888 -175.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -98.78 145.25 29.62 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.077 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . 0.507 ' HB3' ' N ' ' C' ' 83' ' ' ALA . 10.3 Cg_endo -53.04 120.14 7.22 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 123.624 2.883 . . . . 0.0 113.287 -175.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . 0.682 ' HA ' ' O ' ' C' ' 79' ' ' THR . 29.1 mt-10 58.35 63.0 1.83 Allowed 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.579 0.704 . . . . 0.0 111.658 177.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.63 148.93 46.2 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.518 174.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 18' ' ' LYS . . . . . 0.616 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 35.1 ttmt -122.6 117.09 25.02 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 123.482 0.489 . . . . 0.0 111.351 -175.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . 1.664 ' HD1' ' CD2' ' C' ' 19' ' ' TYR . 2.2 m-85 -111.01 104.28 12.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.007 177.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 20' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 9.4 p -88.24 100.03 12.67 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 173.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -121.32 150.04 42.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.339 0.59 . . . . 0.0 112.369 -169.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 12.2 t -99.42 160.85 13.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.327 176.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 53.3 mt -119.01 125.7 74.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.01 0.434 . . . . 0.0 111.532 -173.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . 0.451 HD13 ' N ' ' C' ' 24' ' ' ILE . 4.2 mp -106.99 -33.52 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.241 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -118.94 122.18 41.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.524 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 20.3 t -60.82 133.13 55.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.837 -177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 27' ' ' PHE . . . . . 1.669 ' HE1' ' CE2' ' C' ' 27' ' ' PHE . 53.9 p90 -137.47 143.11 41.6 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.962 0.887 . . . . 0.0 111.906 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 28' ' ' HIS . . . . . 0.631 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 3.5 t60 -102.33 129.84 48.89 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.114 -1.403 . . . . 0.0 108.905 174.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . 0.58 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 48.9 mt -97.56 130.27 46.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 171.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 30' ' ' SER . . . . . 0.631 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 46.4 p -113.95 -17.98 11.86 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.541 -171.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 31' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -162.2 149.05 16.91 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 119.611 -1.28 . . . . 0.0 112.873 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 8.3 p -135.12 121.9 34.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 172.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.37 150.3 42.23 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.501 -0.48 . . . . 0.0 112.06 -171.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.458 ' HB3' ' CG1' ' C' ' 85' ' ' VAL . 4.3 pp -115.04 137.44 52.0 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.757 0.789 . . . . 0.0 111.147 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -106.96 -55.51 2.32 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.548 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -101.89 127.06 48.88 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 171.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 37' ' ' GLY . . . . . 0.436 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 148.28 163.53 10.84 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.016 -1.088 . . . . 0.0 112.981 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -102.66 -47.26 4.48 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.555 0.217 . . . . 0.0 111.385 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -151.9 136.32 16.84 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.701 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.48 113.55 12.63 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.429 0.633 . . . . 0.0 110.42 168.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' C' ' 79' ' ' THR . 65.8 mttp -97.45 109.55 22.28 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 174.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 35.0 tp -85.66 114.69 22.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.047 -173.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 43' ' ' TYR . . . . . 1.668 ' HE1' ' CE2' ' C' ' 43' ' ' TYR . 66.4 m-85 -116.37 145.75 42.99 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.499 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 0.2 OUTLIER -131.31 130.35 42.63 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 172.228 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -108.56 114.1 27.65 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.113 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.34 124.39 41.45 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.759 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 47' ' ' GLU . . . . . 0.504 ' C ' ' HD2' ' C' ' 48' ' ' LYS . 4.3 mm-40 56.37 52.06 10.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.347 0.594 . . . . 0.0 111.071 -175.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . 0.504 ' HD2' ' C ' ' C' ' 47' ' ' GLU . 6.7 mptt 58.91 39.65 23.51 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.492 174.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . 0.576 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 24.1 tp60 -138.66 115.96 11.13 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -82.61 111.74 18.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.902 0.382 . . . . 0.0 110.635 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 1.649 ' HD1' ' CD2' ' C' ' 51' ' ' TYR . 80.0 m-85 -101.78 128.85 47.95 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.398 176.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -75.78 102.58 2.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 168.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 53' ' ' VAL . . . . . 0.444 ' CG1' HD12 ' C' ' 67' ' ' LEU . 2.8 t -76.17 -51.61 19.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.543 -172.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 54' ' ' ALA . . . . . 0.442 ' HB3' ' CD2' ' C' ' 65' ' ' LEU . . . -156.57 142.15 17.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.133 -177.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 42.4 m -105.21 101.44 10.98 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 171.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.7 112.56 40.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.815 0.817 . . . . 0.0 110.074 -177.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 68.0 p -123.47 -176.98 3.58 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.064 -176.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -59.33 -32.73 70.35 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.418 169.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.66 -40.72 69.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.486 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 76.0 mt -117.53 81.82 14.81 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 174.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.77 -5.73 15.09 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.256 2.637 . . . . 0.0 113.888 -167.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -162.04 122.67 2.59 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.075 0.464 . . . . 0.0 110.963 -175.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.402 HG12 ' HB2' ' C' ' 54' ' ' ALA . 97.8 t -108.6 113.59 44.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.346 175.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.35 114.82 27.35 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.123 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' C' ' 30' ' ' SER . 0.3 OUTLIER -135.38 168.68 18.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.259 -176.198 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 66' ' ' ASP . . . . . 0.51 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 5.9 t70 -114.64 99.78 7.78 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.542 0.687 . . . . 0.0 110.595 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . 0.58 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 19.8 mt -111.35 141.02 45.44 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -142.2 116.63 9.61 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.366 174.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 69' ' ' PHE . . . . . 1.604 ' HD2' ' CD1' ' C' ' 69' ' ' PHE . 21.9 m-85 -116.81 139.68 50.32 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 5.3 t -103.28 173.94 6.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.049 0.452 . . . . 0.0 110.635 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.53 1.3 12.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.487 -176.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.09 -5.75 54.45 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 173.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -100.36 151.32 21.64 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.793 0.33 . . . . 0.0 110.432 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -140.13 132.36 28.18 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 172.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 6.8 pt -139.74 164.5 23.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.966 0.412 . . . . 0.0 111.888 -167.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 76' ' ' MET . . . . . 0.483 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 4.5 mtm -118.57 121.68 40.79 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 173.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 77' ' ' PHE . . . . . 1.654 ' HD1' ' CD2' ' C' ' 77' ' ' PHE . 1.1 m-85 -103.65 128.02 51.01 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 78' ' ' TYR . . . . . 0.616 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 40.3 p90 -153.56 140.87 19.6 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.218 0.532 . . . . 0.0 111.879 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 79' ' ' THR . . . . . 0.682 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 15.2 p -112.0 144.98 40.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.22 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.1 148.83 28.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.248 173.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.71 176.89 41.31 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -176.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -108.55 102.45 11.52 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.019 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . 0.507 ' N ' ' HB3' ' C' ' 15' ' ' PRO . . . -165.83 148.93 7.61 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.356 167.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 27.1 t -104.0 123.89 48.01 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.51 HG22 ' HB3' ' C' ' 13' ' ' MET . 8.2 m -120.89 135.2 61.86 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 CA-C-O 121.323 0.582 . . . . 0.0 112.007 -173.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 68.7 m -97.39 118.32 33.6 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.439 -0.8 . . . . 0.0 108.957 175.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . 0.512 ' HB2' ' HB3' ' C' ' 11' ' ' LEU . 5.0 mp -91.16 140.83 29.44 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 171.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . 0.41 HD21 HD22 ' D' ' 67' ' ' LEU . 0.8 OUTLIER -127.66 143.58 51.14 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -178.253 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 89' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' C' ' 28' ' ' HIS . . . -166.26 -166.95 26.16 Favored Glycine 0 N--CA 1.439 -1.166 0 C-N-CA 120.051 -1.071 . . . . 0.0 112.738 -177.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 90' ' ' TYR . . . . . 1.632 ' HE1' ' CE2' ' C' ' 90' ' ' TYR . 5.1 p90 -142.31 136.59 29.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.984 0.421 . . . . 0.0 110.623 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . 0.415 HD22 ' HB3' ' C' ' 27' ' ' PHE . 84.7 mt . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.88 174.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 47.1 mtt . . . . . 0 C--O 1.219 -0.543 0 CA-C-O 120.307 0.099 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 8' ' ' PHE . . . . . 1.654 ' HE2' ' CE1' ' D' ' 8' ' ' PHE . 63.4 t80 -82.27 147.49 28.88 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.919 0.39 . . . . 0.0 111.93 -177.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 9' ' ' TRP . . . . . 0.472 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 91.2 t90 -139.3 149.94 44.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.45 177.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -154.12 152.3 23.9 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.511 178.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . 0.508 ' HB3' ' HB2' ' D' ' 87' ' ' LEU . 40.8 tp -143.23 108.37 4.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.751 0.31 . . . . 0.0 110.344 177.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -86.15 99.42 11.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.375 0.607 . . . . 0.0 110.053 175.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 13' ' ' MET . . . . . 0.51 ' HB3' HG22 ' D' ' 85' ' ' VAL . 24.0 tpp -88.07 135.09 33.58 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.868 -175.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -98.84 145.13 29.41 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.158 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . 0.506 ' HB3' ' N ' ' D' ' 83' ' ' ALA . 10.3 Cg_endo -52.93 120.08 7.08 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.642 2.895 . . . . 0.0 113.237 -175.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . 0.673 ' HA ' ' O ' ' D' ' 79' ' ' THR . 28.9 mt-10 58.44 62.92 1.84 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.634 177.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.5 148.86 46.35 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.613 174.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . 0.63 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 35.1 ttmt -122.54 117.13 25.17 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 123.556 0.535 . . . . 0.0 111.386 -175.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 19' ' ' TYR . . . . . 1.662 ' HD1' ' CD2' ' D' ' 19' ' ' TYR . 2.1 m-85 -111.03 104.23 12.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.022 177.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 9.5 p -88.23 99.86 12.54 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 173.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -121.31 149.93 42.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.443 0.64 . . . . 0.0 112.373 -169.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 12.1 t -99.32 160.87 13.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.349 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 53.0 mt -118.97 125.74 74.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.012 0.434 . . . . 0.0 111.562 -173.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . 0.458 ' N ' HD13 ' D' ' 24' ' ' ILE . 4.2 mp -106.95 -33.56 2.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.311 177.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -118.94 122.16 41.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.587 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 20.4 t -60.72 133.06 55.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.856 -177.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 27' ' ' PHE . . . . . 1.641 ' HD2' ' CD1' ' D' ' 27' ' ' PHE . 53.9 p90 -137.42 143.1 41.71 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.87 0.843 . . . . 0.0 111.981 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 28' ' ' HIS . . . . . 0.617 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 3.5 t60 -102.37 129.88 48.96 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.839 174.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 29' ' ' ILE . . . . . 0.579 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 48.8 mt -97.5 130.33 46.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 171.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 30' ' ' SER . . . . . 0.617 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 45.7 p -114.0 -18.06 11.82 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 120.973 0.416 . . . . 0.0 111.587 -171.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 31' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -162.15 149.01 16.87 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 119.573 -1.299 . . . . 0.0 113.022 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 8.2 p -135.15 121.95 34.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 172.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' D' ' 85' ' ' VAL . . . -141.46 150.33 42.12 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.47 -0.492 . . . . 0.0 112.038 -171.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 34' ' ' LEU . . . . . 0.459 ' HB3' ' CG1' ' D' ' 85' ' ' VAL . 4.3 pp -114.99 137.5 51.92 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.785 0.802 . . . . 0.0 111.116 178.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -107.0 -55.46 2.33 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.502 -1.227 . . . . 0.0 108.615 175.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -101.96 127.06 48.98 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.857 171.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . 0.428 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 148.32 163.57 10.87 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.01 -1.091 . . . . 0.0 112.991 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -102.69 -47.23 4.48 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.408 177.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -151.84 136.39 16.95 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.669 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.5 113.59 12.65 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.453 0.644 . . . . 0.0 110.402 168.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' D' ' 79' ' ' THR . 65.8 mttp -97.41 109.51 22.25 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 173.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 34.9 tp -85.63 114.77 22.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.087 -173.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 43' ' ' TYR . . . . . 1.666 ' HD2' ' CD1' ' D' ' 43' ' ' TYR . 66.1 m-85 -116.43 145.81 43.0 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 175.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.496 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.2 OUTLIER -131.45 130.33 42.34 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 172.342 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 45' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -108.58 114.02 27.5 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.102 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.28 124.37 41.48 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.832 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 47' ' ' GLU . . . . . 0.506 ' C ' ' HD2' ' D' ' 48' ' ' LYS . 4.3 mm-40 56.48 51.97 10.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.297 0.57 . . . . 0.0 111.042 -175.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 48' ' ' LYS . . . . . 0.506 ' HD2' ' C ' ' D' ' 47' ' ' GLU . 6.7 mptt 58.93 39.65 23.45 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.413 174.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . 0.57 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 24.7 tp60 -138.57 115.93 11.17 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -82.5 111.72 18.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.873 0.368 . . . . 0.0 110.713 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . 1.653 ' HE1' ' CE2' ' D' ' 51' ' ' TYR . 80.1 m-85 -101.82 128.85 47.99 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.278 176.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -75.73 102.61 2.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 168.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 53' ' ' VAL . . . . . 0.449 ' CG1' HD12 ' D' ' 67' ' ' LEU . 2.8 t -76.25 -51.54 19.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.542 -172.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 54' ' ' ALA . . . . . 0.442 ' HB3' ' CD2' ' D' ' 65' ' ' LEU . . . -156.59 142.0 17.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.207 -177.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 41.9 m -105.05 101.42 10.98 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 171.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.71 112.65 40.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.801 0.81 . . . . 0.0 110.039 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 70.0 p -123.54 -177.0 3.59 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.026 -176.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -59.19 -32.87 70.31 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.037 0.446 . . . . 0.0 110.434 169.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.6 -40.65 69.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.572 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 75.9 mt -117.53 81.79 14.77 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 174.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.72 -5.68 14.92 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.186 2.591 . . . . 0.0 114.007 -167.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -162.11 122.78 2.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.196 0.522 . . . . 0.0 110.916 -175.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.424 HG12 ' HB2' ' D' ' 54' ' ' ALA . 98.3 t -108.66 113.45 44.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.382 175.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.34 114.87 27.42 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.096 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 65' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' D' ' 30' ' ' SER . 0.3 OUTLIER -135.52 168.63 18.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.182 -176.185 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 66' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 5.9 t70 -114.52 99.82 7.83 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.407 0.622 . . . . 0.0 110.545 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . 0.579 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 19.8 mt -111.4 141.0 45.53 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 175.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.17 116.62 9.63 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.384 174.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 69' ' ' PHE . . . . . 1.623 ' HD2' ' CD1' ' D' ' 69' ' ' PHE . 22.4 m-85 -116.8 139.76 50.22 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 5.3 t -103.28 173.97 6.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.982 0.42 . . . . 0.0 110.643 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.62 1.38 12.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.53 -177.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.04 -5.95 54.35 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -100.3 151.4 21.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.825 0.345 . . . . 0.0 110.426 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -140.16 132.41 28.22 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 172.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . . . . . . . . . 6.8 pt -139.91 164.53 23.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.97 0.414 . . . . 0.0 111.803 -167.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 76' ' ' MET . . . . . 0.486 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 4.5 mtm -118.52 121.63 40.72 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 173.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 77' ' ' PHE . . . . . 1.654 ' HE2' ' CE1' ' D' ' 77' ' ' PHE . 1.1 m-85 -103.61 127.96 50.97 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 78' ' ' TYR . . . . . 0.63 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 40.2 p90 -153.61 140.88 19.56 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.229 0.538 . . . . 0.0 111.85 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 79' ' ' THR . . . . . 0.673 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 15.0 p -112.01 145.02 40.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.18 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.19 148.66 28.6 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.297 173.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.95 176.86 40.96 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -108.53 102.58 11.65 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.033 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.506 ' N ' ' HB3' ' D' ' 15' ' ' PRO . . . -165.87 148.89 7.54 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.329 167.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 26.9 t -103.95 124.02 48.23 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . 0.51 HG22 ' HB3' ' D' ' 13' ' ' MET . 8.2 m -120.95 135.1 62.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.338 0.589 . . . . 0.0 111.933 -173.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 68.5 m -97.38 118.5 34.0 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.964 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 87' ' ' LEU . . . . . 0.508 ' HB2' ' HB3' ' D' ' 11' ' ' LEU . 5.0 mp -91.33 140.87 29.37 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 171.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.75 143.58 51.13 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -178.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 89' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' D' ' 28' ' ' HIS . . . -166.21 -167.0 26.18 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 120.102 -1.047 . . . . 0.0 112.777 -177.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 90' ' ' TYR . . . . . 1.655 ' HE2' ' CE1' ' D' ' 90' ' ' TYR . 5.3 p90 -142.29 136.56 29.89 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 120.948 0.404 . . . . 0.0 110.609 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . 0.426 HD22 ' HB3' ' D' ' 27' ' ' PHE . 84.5 mt . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.999 174.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 47.0 mtt . . . . . 0 C--O 1.22 -0.464 0 N-CA-C 111.2 0.074 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' E' E ' 8' ' ' PHE . . . . . 1.657 ' HD1' ' CD2' ' E' ' 8' ' ' PHE . 63.5 t80 -82.2 147.55 28.93 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.888 0.375 . . . . 0.0 111.988 -177.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 9' ' ' TRP . . . . . 0.468 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 90.9 t90 -139.31 149.97 44.85 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 10' ' ' GLY . . . . . 0.43 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -154.14 152.28 23.88 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.446 178.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 11' ' ' LEU . . . . . 0.512 ' HB3' ' HB2' ' E' ' 87' ' ' LEU . 41.4 tp -143.17 108.3 4.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.735 0.302 . . . . 0.0 110.359 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -86.12 99.33 11.43 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.334 0.587 . . . . 0.0 110.042 175.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 13' ' ' MET . . . . . 0.505 ' HB3' HG22 ' E' ' 85' ' ' VAL . 23.9 tpp -88.0 135.12 33.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.853 -175.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -98.75 145.18 29.49 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.13 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . 0.502 ' HB3' ' N ' ' E' ' 83' ' ' ALA . 10.3 Cg_endo -52.97 120.07 7.09 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 123.653 2.902 . . . . 0.0 113.254 -175.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 16' ' ' GLU . . . . . 0.678 ' HA ' ' O ' ' E' ' 79' ' ' THR . 29.0 mt-10 58.44 62.88 1.85 Allowed 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 121.526 0.679 . . . . 0.0 111.653 177.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.49 148.92 46.42 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.578 174.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . 0.611 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 35.1 ttmt -122.61 117.17 25.19 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 123.569 0.543 . . . . 0.0 111.316 -175.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . 1.641 ' HE2' ' CE1' ' E' ' 19' ' ' TYR . 2.2 m-85 -111.02 104.39 12.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.993 177.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 9.9 p -88.34 99.99 12.68 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 173.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -121.3 150.0 42.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.386 0.613 . . . . 0.0 112.33 -169.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 12.2 t -99.3 160.81 14.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.331 176.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 52.9 mt -118.94 125.75 74.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.113 0.482 . . . . 0.0 111.663 -173.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . 0.453 ' N ' HD13 ' E' ' 24' ' ' ILE . 4.2 mp -106.98 -33.57 2.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.283 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -118.93 122.23 41.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.55 177.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 20.5 t -60.81 133.06 55.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.829 -177.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 27' ' ' PHE . . . . . 1.644 ' HD2' ' CD1' ' E' ' 27' ' ' PHE . 53.9 p90 -137.38 143.18 41.82 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.925 0.869 . . . . 0.0 111.954 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 28' ' ' HIS . . . . . 0.628 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 3.5 t60 -102.49 129.92 49.16 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.769 174.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 29' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 49.0 mt -97.44 130.3 46.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 171.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 30' ' ' SER . . . . . 0.628 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 46.5 p -114.0 -17.92 11.85 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.612 -171.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 31' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -162.23 148.97 16.72 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 119.656 -1.259 . . . . 0.0 112.984 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 8.3 p -135.11 121.92 34.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 172.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' E' ' 85' ' ' VAL . . . -141.47 150.24 41.99 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.52 -0.472 . . . . 0.0 112.01 -171.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 34' ' ' LEU . . . . . 0.455 ' HB3' ' CG1' ' E' ' 85' ' ' VAL . 4.3 pp -114.96 137.55 51.86 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.735 0.779 . . . . 0.0 111.111 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -107.07 -55.52 2.32 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.593 175.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -101.77 127.05 48.72 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . 0.433 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 148.28 163.55 10.84 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 119.995 -1.097 . . . . 0.0 112.998 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -102.7 -47.15 4.51 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.419 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -151.87 136.34 16.88 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.643 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.41 113.56 12.68 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.451 0.643 . . . . 0.0 110.404 168.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 41' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' E' ' 79' ' ' THR . 65.8 mttp -97.36 109.57 22.3 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 34.5 tp -85.62 114.67 22.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.067 -173.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 43' ' ' TYR . . . . . 1.671 ' HE1' ' CE2' ' E' ' 43' ' ' TYR . 66.2 m-85 -116.37 145.77 42.98 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 44' ' ' LEU . . . . . 0.497 ' HB2' ' CD1' ' E' ' 77' ' ' PHE . 0.2 OUTLIER -131.37 130.41 42.59 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 172.288 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 45' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -108.67 114.09 27.6 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.145 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.32 124.26 41.19 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.753 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 47' ' ' GLU . . . . . 0.502 ' C ' ' HD2' ' E' ' 48' ' ' LYS . 4.2 mm-40 56.57 52.03 10.37 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.663 0.602 . . . . 0.0 110.977 -175.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 48' ' ' LYS . . . . . 0.502 ' HD2' ' C ' ' E' ' 47' ' ' GLU . 6.7 mptt 59.0 39.5 23.43 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.493 174.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 49' ' ' GLN . . . . . 0.573 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 24.2 tp60 -138.61 116.03 11.22 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -82.55 111.73 18.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.897 0.379 . . . . 0.0 110.631 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . 1.645 ' HD1' ' CD2' ' E' ' 51' ' ' TYR . 80.6 m-85 -101.86 128.87 48.04 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.336 176.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -75.76 102.57 2.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 168.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . 0.44 ' CG1' HD12 ' E' ' 67' ' ' LEU . 2.8 t -76.22 -51.51 19.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.516 -172.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 54' ' ' ALA . . . . . 0.438 ' HB3' ' CD2' ' E' ' 65' ' ' LEU . . . -156.54 142.07 17.63 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.262 -177.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 43.3 m -105.14 101.45 11.0 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 171.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.75 112.67 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-O 121.759 0.79 . . . . 0.0 110.033 -177.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 69.4 p -123.59 -177.07 3.62 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.008 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -59.18 -32.87 70.3 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.914 0.388 . . . . 0.0 110.385 169.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.62 -40.62 69.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.526 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 76.2 mt -117.58 81.77 14.93 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.67 -5.73 15.0 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.257 2.638 . . . . 0.0 113.965 -167.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -162.07 122.66 2.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.202 0.525 . . . . 0.0 110.925 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . 0.421 HG12 ' HB2' ' E' ' 54' ' ' ALA . 97.4 t -108.62 113.56 44.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.307 175.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.32 114.83 27.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.122 175.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 65' ' ' LEU . . . . . 0.443 ' O ' ' HA ' ' E' ' 30' ' ' SER . 0.3 OUTLIER -135.42 168.6 18.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.263 -176.244 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 66' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 6.0 t70 -114.53 99.75 7.78 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.43 0.633 . . . . 0.0 110.66 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 67' ' ' LEU . . . . . 0.565 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 19.7 mt -111.35 140.99 45.47 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.13 116.57 9.62 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.417 174.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 69' ' ' PHE . . . . . 1.633 ' HE1' ' CE2' ' E' ' 69' ' ' PHE . 22.0 m-85 -116.72 139.74 50.21 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 5.3 t -103.31 173.92 6.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.977 0.418 . . . . 0.0 110.635 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.59 1.37 12.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.516 -177.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.05 -5.98 54.3 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 173.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -100.26 151.33 21.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.769 0.319 . . . . 0.0 110.465 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -140.02 132.42 28.46 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 172.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 75' ' ' ILE . . . . . . . . . . . . . 6.8 pt -139.83 164.58 23.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.973 0.416 . . . . 0.0 111.87 -167.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 76' ' ' MET . . . . . 0.483 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 4.5 mtm -118.58 121.68 40.79 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 77' ' ' PHE . . . . . 1.656 ' HE2' ' CE1' ' E' ' 77' ' ' PHE . 1.0 OUTLIER -103.73 127.98 51.15 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.738 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 78' ' ' TYR . . . . . 0.611 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 40.1 p90 -153.51 140.9 19.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.213 0.53 . . . . 0.0 111.905 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 79' ' ' THR . . . . . 0.678 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 14.7 p -111.98 144.99 40.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.17 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.24 148.66 28.66 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.214 173.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.87 176.83 41.08 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -176.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -108.56 102.56 11.63 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.949 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 83' ' ' ALA . . . . . 0.502 ' N ' ' HB3' ' E' ' 15' ' ' PRO . . . -165.9 148.86 7.5 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.39 167.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 27.2 t -103.95 123.93 48.06 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 85' ' ' VAL . . . . . 0.505 HG22 ' HB3' ' E' ' 13' ' ' MET . 8.1 m -120.87 135.2 61.81 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-O 121.377 0.608 . . . . 0.0 112.005 -173.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 69.1 m -97.48 118.38 33.84 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.455 -0.793 . . . . 0.0 108.866 175.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 87' ' ' LEU . . . . . 0.512 ' HB2' ' HB3' ' E' ' 11' ' ' LEU . 5.0 mp -91.27 140.81 29.44 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 171.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . 0.419 HD21 HD22 ' A' ' 67' ' ' LEU . 0.8 OUTLIER -127.67 143.64 51.14 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -178.247 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 89' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' E' ' 28' ' ' HIS . . . -166.22 -166.98 26.16 Favored Glycine 0 N--CA 1.438 -1.185 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.799 -177.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 90' ' ' TYR . . . . . 1.667 ' HD1' ' CD2' ' E' ' 90' ' ' TYR . 5.2 p90 -142.29 136.62 29.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.954 0.407 . . . . 0.0 110.632 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 91' ' ' LEU . . . . . 0.408 HD22 ' HB3' ' E' ' 27' ' ' PHE . 84.4 mt . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.953 174.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 CA--C 1.516 -0.345 0 CA-C-O 121.164 0.507 . . . . 0.0 111.674 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.555 ' CE1' HD23 ' B' ' 44' ' ' LEU . 31.1 t80 -72.26 145.87 47.63 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.409 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.406 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 92.1 t90 -134.31 147.97 50.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.391 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.496 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -152.25 154.92 25.83 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.855 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.472 HD22 ' SD ' ' A' ' 13' ' ' MET . 49.8 tp -147.38 108.26 4.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.857 0.36 . . . . 0.0 111.019 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -90.42 119.94 31.12 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.963 0.411 . . . . 0.0 110.545 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.702 ' SD ' ' HE1' ' A' ' 19' ' ' TYR . 52.9 mmm -99.96 139.67 35.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.226 -175.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -100.32 145.06 29.62 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.583 174.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.421 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 11.0 Cg_endo -55.14 116.29 3.04 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.147 2.565 . . . . 0.0 112.925 -177.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 62.92 64.85 0.84 Allowed 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.876 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -145.71 138.78 26.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.682 173.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.669 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 86.4 mttt -107.1 126.54 52.49 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -176.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 1.641 ' HE2' ' CE1' ' A' ' 19' ' ' TYR . 1.2 m-85 -112.6 103.84 11.9 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.192 174.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.0 p -88.37 100.33 12.94 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 174.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -113.24 144.37 42.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.434 0.635 . . . . 0.0 111.872 -170.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.5 m -101.95 140.91 35.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.556 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 74.1 mt -99.38 120.14 48.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.217 0.532 . . . . 0.0 111.723 -171.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.54 HD12 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -105.65 -9.84 10.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.276 176.044 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.5 pttt -141.55 119.16 11.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.872 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.9 p -67.05 133.67 50.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.809 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -147.56 166.49 27.19 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -173.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.533 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 9.4 t60 -118.88 126.21 51.27 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.908 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.504 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 42.6 mt -92.23 136.16 25.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 170.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.495 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 64.2 p -123.68 -5.66 8.09 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -170.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -177.46 160.79 27.76 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 119.086 -1.531 . . . . 0.0 113.823 176.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.5 p -144.5 129.96 14.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 174.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.45 157.7 43.97 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.012 -0.43 . . . . 0.0 111.482 -176.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.544 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 3.9 pp -122.05 145.3 48.28 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.795 0.807 . . . . 0.0 111.846 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -107.72 -56.02 2.28 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.64 173.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -103.14 127.26 50.49 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.368 173.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.586 ' O ' ' HG3' ' A' ' 58' ' ' LYS . . . 145.13 159.38 8.07 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 119.958 -1.115 . . . . 0.0 112.896 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -102.43 -45.61 5.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.477 0.18 . . . . 0.0 111.459 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -150.56 127.27 10.93 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 120.582 0.229 . . . . 0.0 111.056 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.42 114.94 18.17 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.295 0.569 . . . . 0.0 110.479 171.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 79' ' ' THR . 3.7 mppt? -95.1 112.05 23.8 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 174.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.6 tp -84.18 108.87 17.32 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -108.59 144.31 36.47 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.267 0.556 . . . . 0.0 110.073 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.642 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -129.23 116.64 19.47 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.413 174.454 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -103.45 110.52 22.58 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.251 0.548 . . . . 0.0 109.706 177.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.408 ' HB1' ' CE2' ' E' ' 8' ' ' PHE . . . -140.13 145.58 37.75 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.333 -177.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 58.11 33.14 22.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.474 0.654 . . . . 0.0 109.774 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 62.59 38.13 12.55 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.814 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.529 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 6.5 tp-100 -140.66 138.92 34.67 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 178.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.425 ' HG3' ' HH ' ' A' ' 78' ' ' TYR . 29.3 tt0 -90.92 110.04 21.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.88 0.371 . . . . 0.0 110.405 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 1.651 ' HD1' ' CD2' ' A' ' 51' ' ' TYR . 78.2 m-85 -101.82 130.65 48.32 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.473 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -85.24 101.86 10.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.74 0.781 . . . . 0.0 109.03 172.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.594 ' CG2' ' HB3' ' A' ' 44' ' ' LEU . 2.9 t -76.33 -49.81 23.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.72 -171.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.467 ' HB1' HD22 ' A' ' 65' ' ' LEU . . . -154.02 146.69 24.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.451 -177.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.5 m -111.06 100.94 9.53 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 170.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.8 114.65 46.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.665 0.745 . . . . 0.0 109.808 -176.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 78.0 p -122.86 -178.32 3.91 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.51 -173.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.586 ' HG3' ' O ' ' A' ' 37' ' ' GLY . 6.1 mttm -61.41 -29.9 70.23 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.012 0.434 . . . . 0.0 110.407 169.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.27 -40.2 52.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.431 178.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.2 mt -115.55 81.38 8.87 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -69.13 -0.47 6.44 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.152 2.568 . . . . 0.0 113.984 -167.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -163.06 130.24 3.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.361 0.601 . . . . 0.0 111.319 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.447 HG12 ' HB3' ' A' ' 54' ' ' ALA . 96.3 t -118.88 120.81 65.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.377 174.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.18 131.61 35.31 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 175.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.467 HD22 ' HB1' ' A' ' 54' ' ' ALA . 82.5 mt -124.0 167.14 14.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.449 0.642 . . . . 0.0 112.36 -173.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 14.4 t0 -143.15 99.18 3.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.514 170.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 2.4 mt -128.09 140.04 52.17 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.408 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -135.2 122.71 21.99 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.754 174.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -116.14 143.75 45.07 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.49 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.1 t -94.34 166.24 12.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.239 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.57 -7.05 51.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.164 0.506 . . . . 0.0 110.138 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.86 -8.16 62.16 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.494 174.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -93.71 144.62 25.23 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -136.12 127.74 28.88 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 171.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 8.5 pt -135.5 160.31 39.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.581 -163.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.413 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 3.0 mtm -114.05 120.39 40.41 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.499 172.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.642 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -103.67 127.85 51.07 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 176.235 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 1.595 ' HD2' ' CD1' ' A' ' 78' ' ' TYR . 53.0 p90 -156.4 143.15 18.66 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 119.735 -0.786 . . . . 0.0 112.238 -176.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 2.0 p -114.92 132.11 56.66 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.301 -176.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.42 160.65 14.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.797 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.02 -175.67 40.08 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -175.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -110.4 102.53 11.16 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.877 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.446 ' CB ' ' HA3' ' A' ' 37' ' ' GLY . . . -174.51 155.7 2.3 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.557 171.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.5 t -115.92 117.26 29.67 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.371 -0.604 . . . . 0.0 109.371 177.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.544 ' CG1' ' HB3' ' A' ' 34' ' ' LEU . 3.7 m -111.34 164.97 6.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.213 0.53 . . . . 0.0 112.126 -174.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 21.2 t -129.76 120.85 25.74 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.125 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 5.3 mp -92.86 154.43 18.23 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 121.004 0.43 . . . . 0.0 110.172 173.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.7 144.66 49.28 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.105 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.97 -167.45 28.64 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.01 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 1.659 ' HD1' ' CD2' ' A' ' 90' ' ' TYR . 43.3 p90 -145.99 136.48 24.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.513 0.673 . . . . 0.0 111.651 177.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.6 mt . . . . . 0 C--N 1.323 -0.564 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.495 175.782 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 CA--C 1.516 -0.334 0 CA-C-O 121.188 0.518 . . . . 0.0 111.631 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . 0.571 ' CE1' HD23 ' C' ' 44' ' ' LEU . 31.8 t80 -72.13 145.8 47.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.462 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . 0.407 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 92.1 t90 -134.26 147.95 50.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.474 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.523 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -152.27 154.92 25.83 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.85 178.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.48 ' HG ' ' SD ' ' B' ' 13' ' ' MET . 49.4 tp -147.37 108.34 4.21 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.856 0.36 . . . . 0.0 110.992 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -90.41 120.15 31.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.895 0.378 . . . . 0.0 110.479 176.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' MET . . . . . 0.709 ' SD ' ' HE1' ' B' ' 19' ' ' TYR . 53.4 mmm -100.1 139.62 35.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.145 -175.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -100.28 145.05 29.59 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.636 174.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.42 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 11.1 Cg_endo -55.15 116.26 3.02 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.136 2.558 . . . . 0.0 112.943 -177.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 62.96 64.85 0.84 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.89 176.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -145.74 138.89 26.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.622 173.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . 0.671 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 86.4 mttt -107.26 126.39 52.36 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -176.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' TYR . . . . . 1.66 ' HD2' ' CD1' ' B' ' 19' ' ' TYR . 1.2 m-85 -112.41 103.73 11.85 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.221 174.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 9.2 p -88.31 100.38 12.96 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -113.29 144.42 42.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.889 -170.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 27.6 m -101.94 140.96 35.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.521 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 73.6 mt -99.42 120.14 48.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.26 0.552 . . . . 0.0 111.754 -171.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.543 ' H ' HD12 ' B' ' 24' ' ' ILE . 0.2 OUTLIER -105.54 -9.88 10.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.323 175.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -141.52 119.11 11.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.872 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 5.9 p -67.02 133.75 50.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.818 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -147.59 166.42 27.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.668 0.747 . . . . 0.0 112.922 -173.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' HIS . . . . . 0.522 ' HA ' ' O ' ' B' ' 67' ' ' LEU . 9.3 t60 -118.82 126.23 51.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.964 178.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.503 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 43.3 mt -92.28 136.18 25.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 170.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.496 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 64.2 p -123.73 -5.67 8.06 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -170.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -177.41 160.77 27.77 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 119.032 -1.556 . . . . 0.0 113.823 176.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 11.4 p -144.52 130.02 14.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 173.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.41 157.7 43.97 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 122.0 -0.438 . . . . 0.0 111.598 -176.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.539 ' HB3' ' CG1' ' B' ' 85' ' ' VAL . 3.9 pp -122.11 145.32 48.28 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.856 0.836 . . . . 0.0 111.825 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -107.75 -56.09 2.27 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.614 173.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -103.07 127.23 50.41 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.344 173.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.576 ' O ' ' HG3' ' B' ' 58' ' ' LYS . . . 145.21 159.37 8.07 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 120.016 -1.088 . . . . 0.0 112.809 178.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -102.42 -45.56 5.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.474 0.178 . . . . 0.0 111.46 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -150.62 127.3 10.9 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 120.615 0.245 . . . . 0.0 110.958 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.41 114.95 18.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.235 0.541 . . . . 0.0 110.461 171.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' B' ' 79' ' ' THR . 3.7 mppt? -94.97 112.01 23.75 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 174.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 46.6 tp -84.26 108.84 17.36 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -176.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -108.56 144.31 36.42 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.338 0.589 . . . . 0.0 110.08 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.653 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 0.2 OUTLIER -129.25 116.74 19.61 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.378 174.397 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -103.44 110.5 22.54 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.18 0.514 . . . . 0.0 109.702 177.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.08 145.63 37.91 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.358 -177.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 58.1 33.0 22.72 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.521 0.677 . . . . 0.0 109.833 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 62.77 38.0 12.08 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.82 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . 0.525 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 6.5 tp-100 -140.64 139.0 34.77 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 178.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.425 ' HG3' ' HH ' ' B' ' 78' ' ' TYR . 29.3 tt0 -90.98 110.05 21.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.922 0.392 . . . . 0.0 110.352 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 1.648 ' HD1' ' CD2' ' B' ' 51' ' ' TYR . 78.3 m-85 -101.82 130.72 48.32 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.484 178.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -85.32 101.87 10.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.742 0.782 . . . . 0.0 108.971 172.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.596 ' CG2' ' HB3' ' B' ' 44' ' ' LEU . 2.9 t -76.4 -49.76 23.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.704 -171.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.464 ' HB1' HD22 ' B' ' 65' ' ' LEU . . . -154.1 146.71 24.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.434 -177.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 27.4 m -110.99 100.98 9.58 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.8 114.71 47.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.655 0.741 . . . . 0.0 109.855 -176.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 78.7 p -122.87 -178.24 3.89 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.45 -173.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . 0.576 ' HG3' ' O ' ' B' ' 37' ' ' GLY . 6.1 mttm -61.49 -30.04 70.36 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.07 0.462 . . . . 0.0 110.29 169.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.12 -40.33 53.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.41 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 79.3 mt -115.55 81.4 8.91 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.15 -0.35 6.29 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.043 2.495 . . . . 0.0 114.006 -167.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -163.13 130.15 3.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.226 0.536 . . . . 0.0 111.346 -176.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.442 HG12 ' HB3' ' B' ' 54' ' ' ALA . 96.1 t -118.82 120.81 65.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.373 174.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.24 131.51 35.3 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.464 HD22 ' HB1' ' B' ' 54' ' ' ALA . 82.4 mt -123.93 167.17 14.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.479 0.657 . . . . 0.0 112.348 -173.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . 0.44 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 14.4 t0 -143.13 99.11 3.39 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.563 170.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.522 ' O ' ' HA ' ' B' ' 28' ' ' HIS . 2.4 mt -128.02 140.16 52.13 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.395 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -135.35 122.7 21.8 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.714 174.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -116.08 143.72 45.1 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.508 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 34.0 t -94.37 166.26 12.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.216 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.59 -6.91 51.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.179 0.514 . . . . 0.0 110.175 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.95 -8.21 61.97 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.458 174.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -93.69 144.62 25.23 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -136.12 127.79 28.98 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 171.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.448 ' HB ' ' CD1' ' B' ' 44' ' ' LEU . 8.5 pt -135.46 160.41 40.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.606 -163.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' MET . . . . . 0.406 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 3.0 mtm -114.05 120.35 40.29 Favored 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.535 172.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . 0.653 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -103.75 127.78 51.19 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 176.288 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 1.604 ' HE2' ' CE1' ' B' ' 78' ' ' TYR . 52.7 p90 -156.31 143.18 18.79 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 119.802 -0.759 . . . . 0.0 112.238 -176.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' B' ' 41' ' ' LYS . 2.0 p -114.98 132.02 56.72 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.335 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.27 160.72 14.88 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.82 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.97 -175.67 40.16 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -175.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -110.37 102.58 11.21 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.878 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.449 ' CB ' ' HA3' ' B' ' 37' ' ' GLY . . . -174.55 155.62 2.27 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.567 171.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 32.2 t -115.91 117.25 29.66 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.539 ' CG1' ' HB3' ' B' ' 34' ' ' LEU . 3.7 m -111.3 164.88 6.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.245 0.545 . . . . 0.0 112.132 -174.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 21.3 t -129.7 120.83 25.79 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.156 176.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.471 ' HB2' ' HB3' ' B' ' 11' ' ' LEU . 5.3 mp -92.92 154.36 18.24 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.016 0.436 . . . . 0.0 110.163 173.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.65 144.66 49.35 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.083 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.94 -167.41 28.55 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.962 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' TYR . . . . . 1.64 ' HD1' ' CD2' ' B' ' 90' ' ' TYR . 43.6 p90 -146.07 136.49 23.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.582 0.706 . . . . 0.0 111.623 177.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 26.4 mt . . . . . 0 C--N 1.323 -0.572 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.474 175.819 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 C--O 1.223 -0.303 0 CA-C-O 121.094 0.473 . . . . 0.0 111.67 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 8' ' ' PHE . . . . . 0.58 ' CE1' HD23 ' D' ' 44' ' ' LEU . 31.2 t80 -72.26 145.88 47.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.376 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . 0.402 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 92.1 t90 -134.35 147.96 50.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.464 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . 0.516 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -152.23 154.91 25.83 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.828 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.479 ' HG ' ' SD ' ' C' ' 13' ' ' MET . 49.7 tp -147.37 108.37 4.22 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.923 0.392 . . . . 0.0 111.069 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -90.49 120.12 31.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.929 0.395 . . . . 0.0 110.536 176.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 13' ' ' MET . . . . . 0.71 ' SD ' ' HE1' ' C' ' 19' ' ' TYR . 53.2 mmm -100.01 139.66 35.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.254 -175.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -100.41 144.99 29.51 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.584 174.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . 0.422 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 11.0 Cg_endo -55.08 116.3 3.04 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 123.106 2.537 . . . . 0.0 112.932 -177.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 62.9 64.81 0.85 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.89 176.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -145.67 138.93 26.21 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.655 173.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 18' ' ' LYS . . . . . 0.668 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 86.7 mttt -107.13 126.48 52.43 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -176.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . 1.673 ' HD2' ' CD1' ' C' ' 19' ' ' TYR . 1.2 m-85 -112.52 103.84 11.93 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.145 174.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 9.0 p -88.38 100.24 12.88 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -113.23 144.45 42.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.434 0.635 . . . . 0.0 111.848 -170.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 27.3 m -101.98 140.9 35.65 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.452 176.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 73.9 mt -99.41 120.14 48.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.125 0.488 . . . . 0.0 111.772 -171.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . 0.555 HD12 ' H ' ' C' ' 24' ' ' ILE . 0.2 OUTLIER -105.57 -9.94 10.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.318 176.018 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 35.7 pttt -141.47 119.07 11.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.893 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 5.8 p -67.04 133.72 50.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.738 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 27' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -147.53 166.44 27.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.627 0.727 . . . . 0.0 112.956 -173.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 28' ' ' HIS . . . . . 0.525 ' HA ' ' O ' ' C' ' 67' ' ' LEU . 9.4 t60 -118.87 126.23 51.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.34 -1.3 . . . . 0.0 109.934 178.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . 0.512 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 42.7 mt -92.2 136.14 25.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 170.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 30' ' ' SER . . . . . 0.495 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 64.4 p -123.71 -5.62 8.07 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -170.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 31' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -177.45 160.71 27.64 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 119.038 -1.553 . . . . 0.0 113.816 176.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 11.5 p -144.49 129.99 14.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.42 157.72 43.97 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.889 -0.507 . . . . 0.0 111.517 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.543 ' HB3' ' CG1' ' C' ' 85' ' ' VAL . 3.8 pp -122.07 145.33 48.25 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.782 0.801 . . . . 0.0 111.803 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -107.79 -56.04 2.28 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.387 -1.278 . . . . 0.0 108.621 173.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -103.08 127.25 50.41 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.345 173.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 37' ' ' GLY . . . . . 0.585 ' O ' ' HG3' ' C' ' 58' ' ' LYS . . . 145.23 159.4 8.09 Favored Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 119.954 -1.117 . . . . 0.0 112.815 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -102.56 -45.58 5.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.465 0.174 . . . . 0.0 111.385 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -150.48 127.2 10.95 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.501 0.191 . . . . 0.0 111.094 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.38 115.0 18.28 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.328 0.585 . . . . 0.0 110.439 171.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' C' ' 79' ' ' THR . 3.7 mppt? -95.11 112.07 23.82 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 46.9 tp -84.31 108.93 17.44 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -176.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -108.62 144.33 36.49 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.327 0.584 . . . . 0.0 110.062 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.645 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 0.2 OUTLIER -129.28 116.79 19.65 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.364 174.395 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -103.51 110.4 22.42 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.206 0.527 . . . . 0.0 109.736 177.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.97 145.64 38.13 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.385 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 57.95 33.18 22.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.451 0.643 . . . . 0.0 109.844 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 60.0 mttp 62.69 38.03 12.3 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.822 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . 0.532 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 6.5 tp-100 -140.64 139.06 34.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.588 0.232 . . . . 0.0 110.379 178.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . 0.419 ' HG3' ' HH ' ' C' ' 78' ' ' TYR . 29.3 tt0 -91.07 110.02 21.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.32 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 1.654 ' HD1' ' CD2' ' C' ' 51' ' ' TYR . 78.1 m-85 -101.84 130.72 48.36 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.433 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -85.31 101.8 10.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.68 0.752 . . . . 0.0 108.995 173.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 53' ' ' VAL . . . . . 0.593 ' CG2' ' HB3' ' C' ' 44' ' ' LEU . 2.9 t -76.33 -49.88 23.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.696 -171.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 54' ' ' ALA . . . . . 0.466 ' HB1' HD22 ' C' ' 65' ' ' LEU . . . -153.98 146.71 24.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.511 -177.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 27.6 m -111.04 101.02 9.6 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 170.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.83 114.67 46.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.617 0.722 . . . . 0.0 109.807 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 78.1 p -122.89 -178.26 3.89 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.467 -173.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 58' ' ' LYS . . . . . 0.585 ' HG3' ' O ' ' C' ' 37' ' ' GLY . 6.2 mttm -61.51 -29.92 70.29 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.025 0.441 . . . . 0.0 110.35 169.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.18 -40.24 52.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.359 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 79.9 mt -115.65 81.48 9.23 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.18 -0.44 6.44 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.143 2.562 . . . . 0.0 113.972 -167.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -163.11 130.18 3.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.266 0.555 . . . . 0.0 111.333 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.432 HG12 ' HB3' ' C' ' 54' ' ' ALA . 96.9 t -118.72 120.84 65.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.458 174.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.29 131.58 35.3 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . 0.466 HD22 ' HB1' ' C' ' 54' ' ' ALA . 82.6 mt -123.99 167.19 14.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.473 0.654 . . . . 0.0 112.285 -173.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 66' ' ' ASP . . . . . 0.463 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 14.3 t0 -143.14 99.12 3.39 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.478 170.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' C' ' 28' ' ' HIS . 2.4 mt -128.1 140.15 52.1 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.419 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -135.32 122.73 21.88 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.75 174.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -116.12 143.75 45.07 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.429 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 33.8 t -94.31 166.23 12.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.231 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.57 -6.88 51.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.182 0.515 . . . . 0.0 110.185 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.97 -8.34 61.84 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.462 174.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -93.61 144.58 25.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.815 0.34 . . . . 0.0 110.097 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -136.06 127.72 28.96 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 171.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' C' ' 44' ' ' LEU . 8.5 pt -135.36 160.45 40.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.532 -163.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 76' ' ' MET . . . . . 0.41 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 3.0 mtm -114.14 120.37 40.28 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.51 172.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 77' ' ' PHE . . . . . 0.645 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.7 OUTLIER -103.8 127.81 51.26 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.315 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 78' ' ' TYR . . . . . 1.635 ' HE1' ' CE2' ' C' ' 78' ' ' TYR . 53.3 p90 -156.31 143.17 18.78 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.311 -176.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 79' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' C' ' 41' ' ' LYS . 2.0 p -114.98 131.99 56.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.362 -176.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.29 160.66 14.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.862 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.93 -175.69 40.24 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -175.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -110.39 102.61 11.23 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 119.391 -0.924 . . . . 0.0 109.867 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . 0.439 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -174.53 155.61 2.28 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.633 171.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 32.3 t -115.84 117.28 29.76 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.543 ' CG1' ' HB3' ' C' ' 34' ' ' LEU . 3.7 m -111.39 164.92 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-O 121.313 0.578 . . . . 0.0 112.106 -174.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 21.1 t -129.72 120.8 25.7 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.217 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . 0.475 ' HB2' ' HB3' ' C' ' 11' ' ' LEU . 5.3 mp -92.89 154.4 18.23 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 120.987 0.422 . . . . 0.0 110.157 173.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.68 144.67 49.32 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.135 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.0 -167.36 28.54 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.978 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 90' ' ' TYR . . . . . 1.63 ' HE1' ' CE2' ' C' ' 90' ' ' TYR . 43.6 p90 -146.06 136.45 23.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.564 0.697 . . . . 0.0 111.631 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 26.3 mt . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.486 175.788 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 C--O 1.224 -0.27 0 CA-C-O 121.148 0.499 . . . . 0.0 111.663 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 8' ' ' PHE . . . . . 0.565 ' CE1' HD23 ' E' ' 44' ' ' LEU . 31.0 t80 -72.27 145.78 47.66 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.37 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 9' ' ' TRP . . . . . 0.408 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 92.1 t90 -134.27 147.99 50.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.433 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . 0.506 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -152.21 154.91 25.83 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.872 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . 0.488 ' HG ' ' SD ' ' D' ' 13' ' ' MET . 50.1 tp -147.33 108.34 4.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.803 0.335 . . . . 0.0 111.02 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -90.52 120.09 31.32 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.974 0.416 . . . . 0.0 110.479 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 13' ' ' MET . . . . . 0.698 ' SD ' ' HE1' ' D' ' 19' ' ' TYR . 53.3 mmm -100.08 139.63 35.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.173 -175.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -100.3 145.07 29.63 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.59 174.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . 0.416 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 11.0 Cg_endo -55.23 116.3 3.04 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 123.099 2.533 . . . . 0.0 112.91 -177.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 63.04 64.79 0.83 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.843 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -145.65 138.86 26.19 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.598 173.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . 0.657 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 86.6 mttt -107.2 126.48 52.46 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -176.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 19' ' ' TYR . . . . . 1.654 ' HD2' ' CD1' ' D' ' 19' ' ' TYR . 1.2 m-85 -112.63 103.81 11.87 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.104 174.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 8.7 p -88.38 100.28 12.9 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 174.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -113.13 144.4 42.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.88 -170.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 27.2 m -101.95 140.9 35.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.609 176.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 74.2 mt -99.48 120.19 48.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.203 0.525 . . . . 0.0 111.651 -171.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . 0.55 HD12 ' H ' ' D' ' 24' ' ' ILE . 0.2 OUTLIER -105.61 -9.81 10.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.388 175.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -141.55 119.08 11.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.847 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 5.8 p -67.06 133.72 50.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.783 -176.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 27' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -147.56 166.39 27.48 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -173.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 28' ' ' HIS . . . . . 0.522 ' HA ' ' O ' ' D' ' 67' ' ' LEU . 9.3 t60 -118.73 126.23 51.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.973 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 29' ' ' ILE . . . . . 0.521 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 42.4 mt -92.24 136.14 25.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 170.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 30' ' ' SER . . . . . 0.505 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 64.3 p -123.77 -5.57 8.04 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -170.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 31' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -177.42 160.84 27.87 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 119.141 -1.504 . . . . 0.0 113.874 176.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 11.4 p -144.51 129.95 14.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 173.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.41 157.76 43.96 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.004 -0.435 . . . . 0.0 111.451 -176.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 34' ' ' LEU . . . . . 0.547 ' HB3' ' CG1' ' D' ' 85' ' ' VAL . 3.9 pp -122.11 145.26 48.34 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.8 0.809 . . . . 0.0 111.826 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -107.67 -55.98 2.28 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.663 173.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -103.2 127.25 50.56 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.336 173.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . 0.586 ' O ' ' HG3' ' D' ' 58' ' ' LYS . . . 145.15 159.33 8.04 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 119.997 -1.096 . . . . 0.0 112.83 178.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -102.47 -45.49 5.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -150.58 127.35 10.97 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.592 0.234 . . . . 0.0 110.955 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.51 114.97 18.15 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.223 0.535 . . . . 0.0 110.452 171.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' D' ' 79' ' ' THR . 3.7 mppt? -95.14 112.07 23.82 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 47.2 tp -84.26 108.88 17.38 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -176.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -108.51 144.32 36.32 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.129 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.65 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.2 OUTLIER -129.28 116.73 19.57 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.411 174.355 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 45' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -103.34 110.43 22.42 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.698 177.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . 0.412 ' HB1' ' CE2' ' C' ' 8' ' ' PHE . . . -140.05 145.53 37.84 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.339 -177.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 58.18 33.08 22.81 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.466 0.65 . . . . 0.0 109.819 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 62.65 37.95 12.48 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.904 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . 0.533 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 6.5 tp-100 -140.6 138.96 34.81 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 178.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.424 ' HG3' ' HH ' ' D' ' 78' ' ' TYR . 29.2 tt0 -90.95 110.14 21.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.315 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . 1.653 ' HD2' ' CD1' ' D' ' 51' ' ' TYR . 78.5 m-85 -101.87 130.7 48.41 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.444 178.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -85.27 101.91 10.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 172.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 53' ' ' VAL . . . . . 0.591 ' CG2' ' HB3' ' D' ' 44' ' ' LEU . 2.9 t -76.49 -49.69 23.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.716 -171.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 54' ' ' ALA . . . . . 0.464 ' HB1' HD22 ' D' ' 65' ' ' LEU . . . -154.05 146.73 24.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.414 -177.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 27.3 m -111.06 100.93 9.52 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 170.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.8 114.64 46.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.607 0.718 . . . . 0.0 109.85 -176.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 79.2 p -122.88 -178.24 3.89 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.487 -173.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 58' ' ' LYS . . . . . 0.586 ' HG3' ' O ' ' D' ' 37' ' ' GLY . 6.1 mttm -61.45 -29.95 70.28 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.037 0.446 . . . . 0.0 110.415 169.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.21 -40.21 52.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.438 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 79.5 mt -115.63 81.47 9.15 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 174.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -69.13 -0.42 6.37 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.15 2.567 . . . . 0.0 113.983 -167.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -163.15 130.1 3.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.222 0.534 . . . . 0.0 111.297 -176.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.452 HG12 ' HB3' ' D' ' 54' ' ' ALA . 96.4 t -118.76 120.87 65.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.39 174.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.2 131.49 35.3 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 65' ' ' LEU . . . . . 0.464 HD22 ' HB1' ' D' ' 54' ' ' ALA . 82.7 mt -123.96 167.17 14.5 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.474 0.654 . . . . 0.0 112.325 -173.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 66' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 14.4 t0 -143.09 99.03 3.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.592 170.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . 0.522 ' O ' ' HA ' ' D' ' 28' ' ' HIS . 2.4 mt -127.96 140.11 52.18 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.436 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -135.3 122.73 21.89 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.486 -0.485 . . . . 0.0 109.72 174.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -116.11 143.66 45.18 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.551 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 34.0 t -94.38 166.26 12.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.219 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.56 -7.02 51.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.271 0.557 . . . . 0.0 110.141 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.91 -8.19 62.05 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.496 174.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -93.63 144.52 25.31 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -136.08 127.75 28.97 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 171.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' D' ' 44' ' ' LEU . 8.6 pt -135.34 160.5 40.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.568 -163.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 76' ' ' MET . . . . . 0.412 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 3.0 mtm -114.16 120.43 40.47 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.454 172.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 77' ' ' PHE . . . . . 0.65 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.7 OUTLIER -103.79 127.73 51.25 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.263 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 78' ' ' TYR . . . . . 1.631 ' HE2' ' CE1' ' D' ' 78' ' ' TYR . 52.9 p90 -156.25 143.14 18.83 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.248 -176.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 79' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' D' ' 41' ' ' LYS . 2.0 p -114.9 132.01 56.68 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.305 -176.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.28 160.69 14.91 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.874 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.96 -175.7 40.2 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -175.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -110.34 102.53 11.17 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.97 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.444 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -174.54 155.54 2.26 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.591 171.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 32.4 t -115.81 117.14 29.39 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . 0.547 ' CG1' ' HB3' ' D' ' 34' ' ' LEU . 3.7 m -111.27 164.87 6.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.21 0.528 . . . . 0.0 112.151 -174.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 21.3 t -129.65 120.83 25.87 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.17 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 87' ' ' LEU . . . . . 0.466 ' HB2' ' HB3' ' D' ' 11' ' ' LEU . 5.3 mp -92.92 154.44 18.19 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 121.022 0.439 . . . . 0.0 110.1 173.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.7 144.65 49.27 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.111 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.88 -167.34 28.4 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.033 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 90' ' ' TYR . . . . . 1.658 ' HD1' ' CD2' ' D' ' 90' ' ' TYR . 43.3 p90 -146.1 136.49 23.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.556 0.693 . . . . 0.0 111.653 177.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 26.1 mt . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.536 175.774 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 C--O 1.223 -0.302 0 CA-C-O 121.093 0.473 . . . . 0.0 111.647 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' E' E ' 8' ' ' PHE . . . . . 0.6 ' CE1' HD23 ' A' ' 44' ' ' LEU . 31.2 t80 -72.13 145.9 47.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.46 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 9' ' ' TRP . . . . . . . . . . . . . 92.0 t90 -134.41 147.92 50.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.407 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 10' ' ' GLY . . . . . 0.528 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -152.18 154.93 25.84 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.908 178.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 11' ' ' LEU . . . . . 0.481 HD22 ' SD ' ' E' ' 13' ' ' MET . 49.5 tp -147.34 108.31 4.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.829 0.347 . . . . 0.0 111.018 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -90.47 120.18 31.36 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.002 0.43 . . . . 0.0 110.478 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 13' ' ' MET . . . . . 0.688 ' SD ' ' HE1' ' E' ' 19' ' ' TYR . 53.0 mmm -100.08 139.57 35.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.247 -175.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -100.28 145.08 29.64 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.665 174.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . 0.415 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 11.0 Cg_endo -55.15 116.34 3.07 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.088 2.525 . . . . 0.0 112.951 -177.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 62.89 64.81 0.85 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.892 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -145.73 138.86 26.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.653 173.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . 0.652 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 86.7 mttt -107.11 126.36 52.27 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -176.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . 1.61 ' HD2' ' CD1' ' E' ' 19' ' ' TYR . 1.2 m-85 -112.53 103.82 11.9 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.167 174.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 9.1 p -88.31 100.25 12.86 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -113.16 144.37 42.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.899 -170.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 27.5 m -101.98 140.99 35.52 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.508 176.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 73.9 mt -99.47 120.21 48.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.225 0.536 . . . . 0.0 111.668 -171.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . 0.554 HD12 ' H ' ' E' ' 24' ' ' ILE . 0.2 OUTLIER -105.63 -9.86 10.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.297 175.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 35.5 pttt -141.47 119.15 11.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.867 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 5.8 p -67.05 133.72 50.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.752 -176.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 27' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -147.54 166.4 27.41 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -173.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 28' ' ' HIS . . . . . 0.529 ' HA ' ' O ' ' E' ' 67' ' ' LEU . 9.4 t60 -118.77 126.28 51.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.968 178.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 29' ' ' ILE . . . . . 0.508 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 42.8 mt -92.25 136.15 25.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 170.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 30' ' ' SER . . . . . 0.495 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 64.2 p -123.69 -5.65 8.08 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -170.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 31' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -177.39 160.84 27.91 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.063 -1.541 . . . . 0.0 113.823 176.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 11.5 p -144.55 129.91 14.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.39 157.72 43.97 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 121.904 -0.497 . . . . 0.0 111.518 -176.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 34' ' ' LEU . . . . . 0.539 ' HB3' ' CG1' ' E' ' 85' ' ' VAL . 3.9 pp -122.06 145.27 48.31 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.858 0.837 . . . . 0.0 111.856 178.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -107.71 -56.06 2.27 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.222 -1.354 . . . . 0.0 108.612 173.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -103.12 127.23 50.48 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.411 173.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . 0.586 ' O ' ' HG3' ' E' ' 58' ' ' LYS . . . 145.19 159.34 8.06 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.016 -1.087 . . . . 0.0 112.897 178.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -102.53 -45.49 5.04 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.473 0.175 . . . . 0.0 111.473 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -150.53 127.36 11.02 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 120.526 0.203 . . . . 0.0 110.982 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.49 114.93 18.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.183 0.516 . . . . 0.0 110.473 171.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 41' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' E' ' 79' ' ' THR . 3.7 mppt? -95.08 112.1 23.84 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 174.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 46.7 tp -84.27 108.87 17.38 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -176.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -108.54 144.34 36.34 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.331 0.586 . . . . 0.0 110.112 177.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 44' ' ' LEU . . . . . 0.652 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 0.2 OUTLIER -129.26 116.76 19.63 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.42 174.384 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 45' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -103.51 110.47 22.52 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.236 0.541 . . . . 0.0 109.666 177.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.11 145.54 37.74 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.273 -177.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 58.15 33.04 22.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.476 0.655 . . . . 0.0 109.813 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 62.73 37.99 12.2 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.778 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 49' ' ' GLN . . . . . 0.535 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 6.5 tp-100 -140.56 138.98 34.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.59 0.233 . . . . 0.0 110.39 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 50' ' ' GLU . . . . . 0.429 ' HG3' ' HH ' ' E' ' 78' ' ' TYR . 29.3 tt0 -90.97 110.09 21.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.363 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . 1.672 ' HE1' ' CE2' ' E' ' 51' ' ' TYR . 78.2 m-85 -101.79 130.74 48.28 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.419 178.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -85.37 101.87 10.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.706 0.765 . . . . 0.0 109.023 172.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . 0.602 ' CG2' ' HB3' ' E' ' 44' ' ' LEU . 2.9 t -76.43 -49.76 23.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.714 -171.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 54' ' ' ALA . . . . . 0.453 ' HB1' HD22 ' E' ' 65' ' ' LEU . . . -154.02 146.67 24.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.498 -177.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 27.7 m -111.04 101.03 9.61 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 170.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.82 114.62 46.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.628 0.728 . . . . 0.0 109.754 -176.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 76.2 p -122.82 -178.23 3.88 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.465 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 58' ' ' LYS . . . . . 0.586 ' HG3' ' O ' ' E' ' 37' ' ' GLY . 6.1 mttm -61.53 -29.99 70.35 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.023 0.44 . . . . 0.0 110.287 169.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.06 -40.37 53.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.433 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 79.0 mt -115.51 81.49 8.9 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 174.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.2 -0.5 6.54 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.087 2.524 . . . . 0.0 114.029 -167.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -163.02 130.28 3.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.275 0.559 . . . . 0.0 111.305 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . 0.443 HG12 ' HB3' ' E' ' 54' ' ' ALA . 96.5 t -118.85 120.83 65.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.388 174.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.29 131.48 35.29 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 175.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 65' ' ' LEU . . . . . 0.453 HD22 ' HB1' ' E' ' 54' ' ' ALA . 82.6 mt -123.87 167.19 14.42 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.469 0.652 . . . . 0.0 112.336 -173.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 66' ' ' ASP . . . . . 0.462 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 14.3 t0 -143.15 99.17 3.4 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.504 170.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 67' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' E' ' 28' ' ' HIS . 2.5 mt -128.05 140.06 52.17 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.391 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -135.21 122.71 21.99 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.79 174.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -116.08 143.71 45.11 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.492 -178.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 34.2 t -94.4 166.27 12.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.194 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.55 -7.07 51.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.177 0.513 . . . . 0.0 110.151 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.8 -8.25 62.19 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.495 174.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -93.67 144.7 25.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.859 0.361 . . . . 0.0 110.074 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -136.2 127.72 28.69 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 171.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 75' ' ' ILE . . . . . 0.45 ' HB ' ' CD1' ' E' ' 44' ' ' LEU . 8.5 pt -135.4 160.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.634 -163.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 76' ' ' MET . . . . . 0.413 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 3.0 mtm -114.13 120.35 40.24 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 172.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 77' ' ' PHE . . . . . 0.652 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.7 OUTLIER -103.75 127.82 51.19 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.28 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 78' ' ' TYR . . . . . 1.63 ' HE2' ' CE1' ' E' ' 78' ' ' TYR . 53.2 p90 -156.37 143.11 18.67 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 119.79 -0.764 . . . . 0.0 112.269 -176.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 79' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' E' ' 41' ' ' LYS . 2.0 p -114.96 132.02 56.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.291 -176.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.37 160.7 14.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.817 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.0 -175.68 40.12 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -175.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -110.43 102.56 11.17 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.846 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 83' ' ' ALA . . . . . 0.445 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -174.5 155.62 2.29 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.624 171.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 32.2 t -115.84 117.33 29.9 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 85' ' ' VAL . . . . . 0.539 ' CG1' ' HB3' ' E' ' 34' ' ' LEU . 3.7 m -111.36 164.9 6.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.268 0.556 . . . . 0.0 112.137 -174.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 21.2 t -129.75 120.9 25.84 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.18 176.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 87' ' ' LEU . . . . . 0.454 ' HB2' ' HB3' ' E' ' 11' ' ' LEU . 5.3 mp -92.98 154.48 18.13 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 121.023 0.439 . . . . 0.0 110.132 173.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.7 144.7 49.3 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.086 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.99 -167.43 28.62 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.9 -0.666 . . . . 0.0 111.999 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 90' ' ' TYR . . . . . 1.645 ' HD2' ' CD1' ' E' ' 90' ' ' TYR . 43.5 p90 -146.05 136.49 23.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.573 0.701 . . . . 0.0 111.663 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 91' ' ' LEU . . . . . . . . . . . . . 26.2 mt . . . . . 0 C--N 1.323 -0.549 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.574 175.758 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 49.0 mtt . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 121.221 0.534 . . . . 0.0 111.524 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.494 ' CE1' HD22 ' B' ' 44' ' ' LEU . 60.5 t80 -56.85 142.02 42.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.487 -173.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.435 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 87.5 t90 -135.41 141.49 45.47 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.763 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.499 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -143.2 155.46 26.02 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.068 178.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.524 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 57.2 tp -145.21 108.53 4.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.709 0.29 . . . . 0.0 110.901 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -89.0 106.42 18.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.492 0.663 . . . . 0.0 110.91 177.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.461 ' HB2' HG22 ' A' ' 85' ' ' VAL . 4.1 mmt -86.96 134.42 33.5 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.931 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.47 ' HB2' ' HG3' ' A' ' 17' ' ' ARG . 54.5 mtmt -100.26 146.08 31.36 Favored Pre-proline 0 C--N 1.316 -0.851 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 172.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -48.12 110.37 0.32 Allowed 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 123.51 2.807 . . . . 0.0 113.432 -174.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.686 ' HA ' ' O ' ' A' ' 79' ' ' THR . 31.6 mt-10 69.5 54.07 0.41 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.531 178.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.47 ' HG3' ' HB2' ' A' ' 14' ' ' LYS . 19.5 mmt180 -110.75 152.7 26.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.868 172.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.655 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 36.0 ttmt -133.56 107.74 8.18 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.944 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 1.663 ' HD1' ' CD2' ' A' ' 19' ' ' TYR . 0.8 OUTLIER -111.05 121.09 44.45 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.752 179.516 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.4 p -75.29 126.79 31.74 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 170.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -103.95 116.56 32.48 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.125 0.488 . . . . 0.0 111.727 -164.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.5 p -97.22 123.12 40.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.879 173.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.3 mt -92.97 108.43 20.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.199 0.524 . . . . 0.0 111.575 -172.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.515 HD12 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -76.08 -39.65 36.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.007 177.805 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -139.58 141.47 37.17 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.6 m -60.86 120.82 10.89 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.66 0.6 . . . . 0.0 109.85 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 1.651 ' HD1' ' CD2' ' A' ' 27' ' ' PHE . 2.2 p90 -134.25 166.01 23.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.706 0.765 . . . . 0.0 112.721 -169.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.608 ' NE2' ' HB2' ' A' ' 30' ' ' SER . 9.3 t60 -118.72 125.13 48.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.302 -1.317 . . . . 0.0 109.958 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 39.8 mt -94.6 138.48 20.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 169.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.608 ' HB2' ' NE2' ' A' ' 28' ' ' HIS . 26.2 t -119.62 -23.51 6.54 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -169.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -161.92 156.89 28.57 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 119.408 -1.377 . . . . 0.0 113.253 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.2 p -137.36 125.38 32.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 172.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 85' ' ' VAL . . . -142.81 152.31 42.07 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -171.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.507 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 3.7 pp -119.18 142.73 47.71 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.583 0.706 . . . . 0.0 111.346 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.515 ' HB2' ' HH ' ' B' ' 43' ' ' TYR . 9.5 p-10 -110.12 -48.46 3.18 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.615 173.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -102.49 127.27 49.62 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 170.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.495 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 145.83 159.54 8.22 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 119.392 -1.385 . . . . 0.0 113.948 176.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.408 ' HA ' ' HB2' ' A' ' 58' ' ' LYS . 54.3 mt-30 -103.15 -44.5 5.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.653 -0.274 . . . . 0.0 111.127 177.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -150.63 132.63 15.21 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 120.5 0.19 . . . . 0.0 111.026 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.428 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . . . -133.02 114.32 13.84 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.286 0.565 . . . . 0.0 110.586 169.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 79' ' ' THR . 63.9 mttp -95.86 112.22 24.0 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 174.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 45.4 tp -83.99 115.93 22.57 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.439 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.524 ' HH ' ' HB2' ' E' ' 35' ' ' ASP . 97.1 m-85 -117.02 144.01 45.08 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 177.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 76' ' ' MET . 0.2 OUTLIER -131.34 132.54 44.55 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.2 0.524 . . . . 0.0 109.723 172.086 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -107.09 110.07 22.09 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.3 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.22 151.95 46.71 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 43.36 37.49 1.38 Allowed 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.939 0.774 . . . . 0.0 111.142 -171.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.7 tptp 54.65 46.66 24.26 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.157 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.571 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 6.5 tp-100 -135.17 130.71 35.78 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.669 175.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -85.68 110.86 19.59 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.343 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 1.625 ' HD2' ' CD1' ' A' ' 51' ' ' TYR . 82.5 m-85 -104.62 129.16 52.77 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.7 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 tp -77.25 103.79 4.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 169.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.507 HG11 ' CD2' ' E' ' 88' ' ' LEU . 2.6 t -76.39 -49.52 24.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.293 -173.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.471 ' HB3' ' CD2' ' A' ' 65' ' ' LEU . . . -159.03 144.86 16.47 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.19 -178.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.3 m -110.5 101.49 10.17 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 171.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -111.26 120.44 61.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.133 -178.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 54.8 p -122.61 -179.81 4.35 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -172.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.408 ' HB2' ' HA ' ' A' ' 38' ' ' GLN . 35.0 tttm -60.89 -27.04 67.86 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.272 0.558 . . . . 0.0 109.901 172.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.468 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -83.48 -40.57 19.07 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.734 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 90.9 mt -107.36 89.43 4.84 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 36.0 Cg_exo -61.32 -20.3 67.65 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.101 2.534 . . . . 0.0 113.941 -169.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -156.19 136.09 12.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.381 0.61 . . . . 0.0 111.974 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.401 HG12 ' HB2' ' A' ' 54' ' ' ALA . 98.4 t -111.38 113.8 45.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.729 171.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.03 122.15 34.27 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.08 177.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -142.6 143.5 32.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.248 0.547 . . . . 0.0 111.902 -177.084 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.479 ' HB3' ' OG ' ' E' ' 30' ' ' SER . 5.6 t70 -89.59 100.57 13.34 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.706 177.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.577 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 19.7 mt -110.81 138.39 47.27 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.686 176.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.638 ' HB2' ' CD2' ' E' ' 90' ' ' TYR . 10.5 m-80 -137.58 128.21 26.82 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 173.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 1.661 ' HD2' ' CD1' ' A' ' 69' ' ' PHE . 65.6 m-85 -124.43 146.81 48.69 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.977 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.0 t -99.93 148.97 23.9 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -67.14 -10.72 53.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.326 -178.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.42 -9.87 66.38 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.107 176.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -100.74 160.06 14.67 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -135.12 125.43 26.37 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.3 pt -131.21 178.13 5.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.93 0.395 . . . . 0.0 111.609 -171.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.496 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 24.5 mtp -130.9 136.31 48.49 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 174.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.458 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 1.2 m-85 -117.86 128.21 54.62 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.145 176.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 1.649 ' HE1' ' CE2' ' A' ' 78' ' ' TYR . 34.6 p90 -155.08 145.64 22.2 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.966 -178.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.686 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 13.2 p -117.33 144.95 44.36 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.507 -177.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -115.04 151.33 34.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.915 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.58 -177.16 29.29 Favored Glycine 0 CA--C 1.509 -0.334 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -109.74 102.93 11.69 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.684 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.495 ' CB ' ' HA3' ' A' ' 37' ' ' GLY . . . -175.27 155.94 1.97 Allowed 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.87 172.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.6 t -113.03 118.87 36.0 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.507 ' CG1' ' HB3' ' A' ' 34' ' ' LEU . 10.5 m -118.94 137.39 53.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -173.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 54.6 m -101.17 120.94 40.97 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.048 175.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.524 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 5.3 mp -89.41 145.71 25.15 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 170.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.5 ' CD2' HG11 ' B' ' 53' ' ' VAL . 1.2 tp -131.48 132.17 44.05 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.679 -177.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -159.66 -166.76 19.22 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.701 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.621 ' CD2' ' HB2' ' B' ' 68' ' ' ASN . 18.7 p90 -153.02 133.72 13.83 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.919 0.866 . . . . 0.0 111.547 177.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.1 mt . . . . . 0 C--N 1.319 -0.748 0 CA-C-N 113.981 -1.463 . . . . 0.0 108.926 174.714 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 48.7 mtt . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 121.25 0.548 . . . . 0.0 111.546 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . 0.459 ' CE1' HD22 ' C' ' 44' ' ' LEU . 60.7 t80 -56.82 141.91 42.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.515 -173.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . 0.437 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 87.5 t90 -135.34 141.42 45.59 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.817 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.472 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -143.13 155.53 26.04 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.105 178.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.514 ' HB3' ' HB2' ' B' ' 87' ' ' LEU . 56.9 tp -145.34 108.5 4.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.784 0.326 . . . . 0.0 110.819 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -88.98 106.44 18.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.495 0.664 . . . . 0.0 110.947 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' MET . . . . . 0.453 ' HB2' HG22 ' B' ' 85' ' ' VAL . 4.1 mmt -86.98 134.41 33.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.041 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.477 ' HB2' ' HG3' ' B' ' 17' ' ' ARG . 54.5 mtmt -100.18 146.14 31.45 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 172.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -48.19 110.35 0.32 Allowed 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 123.449 2.766 . . . . 0.0 113.444 -174.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.683 ' HA ' ' O ' ' B' ' 79' ' ' THR . 31.6 mt-10 69.52 54.1 0.4 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.48 178.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.477 ' HG3' ' HB2' ' B' ' 14' ' ' LYS . 19.5 mmt180 -110.73 152.72 26.24 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.879 172.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . 0.658 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 36.0 ttmt -133.59 107.79 8.2 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.825 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' TYR . . . . . 1.645 ' HD1' ' CD2' ' B' ' 19' ' ' TYR . 0.8 OUTLIER -110.99 121.07 44.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.803 179.423 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 5.2 p -75.3 126.74 31.63 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 170.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -103.83 116.45 32.3 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.713 -164.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 9.6 p -97.16 123.19 40.86 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.842 173.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 55.6 mt -93.02 108.51 20.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.032 0.444 . . . . 0.0 111.513 -172.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.515 ' H ' HD12 ' B' ' 24' ' ' ILE . 0.2 OUTLIER -76.1 -39.73 36.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.001 177.765 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -139.53 141.48 37.28 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 15.5 m -60.8 120.93 11.06 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.666 0.604 . . . . 0.0 109.814 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . 1.615 ' HE2' ' CE1' ' B' ' 27' ' ' PHE . 2.2 p90 -134.34 165.95 23.95 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.685 0.755 . . . . 0.0 112.73 -169.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' HIS . . . . . 0.608 ' NE2' ' HB2' ' B' ' 30' ' ' SER . 9.5 t60 -118.68 125.1 48.95 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.98 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.589 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 39.7 mt -94.53 138.54 20.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 169.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.608 ' HB2' ' NE2' ' B' ' 28' ' ' HIS . 26.1 t -119.65 -23.49 6.53 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -169.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -161.91 156.99 28.69 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.328 -1.415 . . . . 0.0 113.266 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 10.2 p -137.5 125.37 31.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 172.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' B' ' 85' ' ' VAL . . . -142.81 152.36 42.14 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -171.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.508 ' HB3' ' CG1' ' B' ' 85' ' ' VAL . 3.6 pp -119.21 142.75 47.73 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.542 0.687 . . . . 0.0 111.347 177.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.516 ' HB2' ' HH ' ' C' ' 43' ' ' TYR . 9.5 p-10 -110.22 -48.5 3.17 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.554 173.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -102.41 127.18 49.54 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 170.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.491 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 145.97 159.66 8.3 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 119.38 -1.39 . . . . 0.0 113.8 176.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . 0.404 ' HA ' ' HB2' ' B' ' 58' ' ' LYS . 54.3 mt-30 -103.17 -44.55 5.16 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.593 -0.304 . . . . 0.0 111.177 177.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -150.64 132.66 15.23 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 120.536 0.208 . . . . 0.0 111.014 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.427 ' HB3' ' HB1' ' B' ' 83' ' ' ALA . . . -133.0 114.31 13.83 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.266 0.555 . . . . 0.0 110.485 169.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' B' ' 79' ' ' THR . 64.0 mttp -95.88 112.17 23.97 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 174.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 45.2 tp -83.93 116.0 22.57 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.489 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . 0.515 ' HH ' ' HB2' ' A' ' 35' ' ' ASP . 97.2 m-85 -117.12 143.96 45.22 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.494 HD22 ' CE1' ' A' ' 8' ' ' PHE . 0.2 OUTLIER -131.32 132.52 44.56 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.705 172.1 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -107.05 110.12 22.16 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.373 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.25 151.96 46.75 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 43.37 37.45 1.36 Allowed 'General case' 0 N--CA 1.474 0.77 0 O-C-N 123.918 0.761 . . . . 0.0 111.155 -171.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 25.7 tptp 54.55 46.86 23.98 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.116 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . 0.573 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 6.5 tp-100 -135.28 130.72 35.57 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.603 175.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -85.74 110.9 19.66 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.315 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 1.618 ' HE2' ' CE1' ' B' ' 51' ' ' TYR . 82.3 m-85 -104.56 129.18 52.66 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.681 177.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 tp -77.39 103.83 4.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 169.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.5 HG11 ' CD2' ' A' ' 88' ' ' LEU . 2.6 t -76.35 -49.57 24.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.199 -173.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.462 ' HB3' ' CD2' ' B' ' 65' ' ' LEU . . . -159.1 144.84 16.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.178 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 43.7 m -110.51 101.55 10.23 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 171.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -111.3 120.48 61.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.147 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 52.8 p -122.67 -179.75 4.34 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.098 0.475 . . . . 0.0 112.215 -172.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . 0.404 ' HB2' ' HA ' ' B' ' 38' ' ' GLN . 34.9 tttm -60.9 -27.05 67.88 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.92 172.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.463 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -83.45 -40.57 19.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.791 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 90.9 mt -107.38 89.56 4.98 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 174.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 36.6 Cg_exo -61.46 -20.24 67.67 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.151 2.567 . . . . 0.0 113.949 -169.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -156.27 135.98 12.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.408 0.623 . . . . 0.0 111.886 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.404 HG12 ' HB2' ' B' ' 54' ' ' ALA . 98.6 t -111.3 113.79 45.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.726 171.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.03 122.19 34.31 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.109 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.462 ' CD2' ' HB3' ' B' ' 54' ' ' ALA . 0.2 OUTLIER -142.62 143.49 32.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.315 0.579 . . . . 0.0 111.916 -177.067 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . 0.443 ' HB3' ' OG ' ' A' ' 30' ' ' SER . 5.6 t70 -89.61 100.53 13.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.71 177.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.589 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 19.5 mt -110.87 138.38 47.35 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.64 176.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . 0.621 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 10.5 m-80 -137.5 128.18 26.92 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 173.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . 1.653 ' HE2' ' CE1' ' B' ' 69' ' ' PHE . 65.0 m-85 -124.4 146.77 48.68 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.03 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 28.8 t -100.03 148.93 24.0 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -67.17 -10.65 52.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.277 -177.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.46 -9.73 66.47 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.122 176.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -100.89 160.1 14.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -135.18 125.41 26.24 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 11.2 pt -131.19 178.06 6.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.901 0.381 . . . . 0.0 111.55 -171.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' MET . . . . . 0.489 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 24.7 mtp -130.87 136.4 48.6 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 174.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . 0.464 ' CD1' ' HB2' ' B' ' 44' ' ' LEU . 1.2 m-85 -117.91 128.16 54.55 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.146 176.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 1.665 ' HD2' ' CD1' ' B' ' 78' ' ' TYR . 34.3 p90 -155.07 145.7 22.27 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.922 -178.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.683 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 13.2 p -117.39 144.99 44.39 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.446 -177.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -115.12 151.27 34.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.903 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.7 -177.09 29.11 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -109.89 102.95 11.67 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 119.625 -0.83 . . . . 0.0 109.608 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.491 ' CB ' ' HA3' ' B' ' 37' ' ' GLY . . . -175.22 155.94 1.99 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.814 172.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 32.6 t -113.05 118.86 35.96 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.508 ' CG1' ' HB3' ' B' ' 34' ' ' LEU . 10.2 m -118.93 137.53 52.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 CA-C-O 121.403 0.621 . . . . 0.0 112.671 -173.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 54.5 m -101.27 120.92 40.97 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.093 175.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.514 ' HB2' ' HB3' ' B' ' 11' ' ' LEU . 5.3 mp -89.41 145.74 25.13 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 170.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.477 ' CD2' HG11 ' C' ' 53' ' ' VAL . 1.2 tp -131.54 132.16 43.94 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.645 -177.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -159.7 -166.78 19.28 Favored Glycine 0 N--CA 1.438 -1.233 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.638 -176.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' TYR . . . . . 0.62 ' CD2' ' HB2' ' C' ' 68' ' ' ASN . 18.7 p90 -152.97 133.68 13.85 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.909 0.861 . . . . 0.0 111.622 177.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 5.2 mt . . . . . 0 C--N 1.319 -0.745 0 CA-C-N 113.988 -1.46 . . . . 0.0 108.978 174.709 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 48.8 mtt . . . . . 0 CA--C 1.518 -0.272 0 CA-C-O 121.255 0.55 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 8' ' ' PHE . . . . . 0.479 ' CE1' HD22 ' D' ' 44' ' ' LEU . 60.1 t80 -56.88 141.94 43.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.448 -173.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . 0.441 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 87.5 t90 -135.33 141.41 45.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.802 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . 0.479 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -143.17 155.5 26.03 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.053 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' C' ' 87' ' ' LEU . 57.1 tp -145.26 108.58 4.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.821 0.343 . . . . 0.0 110.906 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -89.0 106.43 18.42 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.528 0.68 . . . . 0.0 110.852 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 13' ' ' MET . . . . . 0.457 ' HB2' HG22 ' C' ' 85' ' ' VAL . 4.1 mmt -86.96 134.38 33.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.014 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . 0.469 ' HB2' ' HG3' ' C' ' 17' ' ' ARG . 54.5 mtmt -100.16 146.16 31.46 Favored Pre-proline 0 C--N 1.316 -0.849 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -48.11 110.37 0.32 Allowed 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.52 2.814 . . . . 0.0 113.422 -174.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . 0.679 ' HA ' ' O ' ' C' ' 79' ' ' THR . 31.7 mt-10 69.47 54.08 0.41 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.541 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 17' ' ' ARG . . . . . 0.469 ' HG3' ' HB2' ' C' ' 14' ' ' LYS . 19.4 mmt180 -110.86 152.65 26.45 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.878 172.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 18' ' ' LYS . . . . . 0.652 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 36.0 ttmt -133.5 107.61 8.13 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.911 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . 1.653 ' HE2' ' CE1' ' C' ' 19' ' ' TYR . 0.8 OUTLIER -110.96 121.06 44.4 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.803 -0.444 . . . . 0.0 109.803 179.5 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 5.2 p -75.35 126.7 31.54 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 171.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -103.77 116.55 32.51 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.722 -164.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 9.6 p -97.21 123.16 40.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.872 173.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 55.2 mt -93.0 108.51 20.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.201 0.524 . . . . 0.0 111.54 -172.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . 0.507 HD12 ' H ' ' C' ' 24' ' ' ILE . 0.2 OUTLIER -76.13 -39.8 36.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.955 177.825 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -139.5 141.43 37.34 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 15.5 m -60.78 120.8 10.82 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 123.628 0.58 . . . . 0.0 109.858 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 27' ' ' PHE . . . . . 1.615 ' HE2' ' CE1' ' C' ' 27' ' ' PHE . 2.2 p90 -134.27 165.93 23.98 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.685 0.755 . . . . 0.0 112.715 -169.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 28' ' ' HIS . . . . . 0.596 ' NE2' ' HB2' ' C' ' 30' ' ' SER . 9.3 t60 -118.62 125.2 49.24 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.97 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . 0.566 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 39.9 mt -94.57 138.5 20.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 169.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 30' ' ' SER . . . . . 0.596 ' HB2' ' NE2' ' C' ' 28' ' ' HIS . 26.1 t -119.64 -23.47 6.54 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -169.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 31' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -161.9 157.0 28.7 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 119.374 -1.393 . . . . 0.0 113.29 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 10.2 p -137.45 125.41 31.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 172.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' C' ' 85' ' ' VAL . . . -142.85 152.34 42.05 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.636 -0.426 . . . . 0.0 112.143 -171.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.505 ' HB3' ' CG1' ' C' ' 85' ' ' VAL . 3.7 pp -119.2 142.74 47.72 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.49 0.662 . . . . 0.0 111.424 177.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . 0.512 ' HB2' ' HH ' ' D' ' 43' ' ' TYR . 9.5 p-10 -110.09 -48.58 3.17 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.581 173.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -102.38 127.24 49.48 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 170.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 37' ' ' GLY . . . . . 0.499 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 145.93 159.59 8.26 Favored Glycine 0 N--CA 1.437 -1.257 0 C-N-CA 119.318 -1.42 . . . . 0.0 113.834 176.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 38' ' ' GLN . . . . . 0.407 ' HA ' ' HB2' ' C' ' 58' ' ' LYS . 54.2 mt-30 -103.06 -44.55 5.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.658 -0.271 . . . . 0.0 111.214 177.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -150.67 132.61 15.15 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.483 0.182 . . . . 0.0 110.982 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . 0.42 ' HB3' ' HB1' ' C' ' 83' ' ' ALA . . . -133.02 114.35 13.86 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.286 0.565 . . . . 0.0 110.5 169.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' C' ' 79' ' ' THR . 64.0 mttp -95.91 112.16 23.96 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 174.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 45.4 tp -83.94 116.0 22.58 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 43' ' ' TYR . . . . . 0.516 ' HH ' ' HB2' ' B' ' 35' ' ' ASP . 97.1 m-85 -117.11 143.95 45.23 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' C' ' 76' ' ' MET . 0.2 OUTLIER -131.28 132.55 44.65 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.167 0.508 . . . . 0.0 109.665 172.07 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -107.06 110.14 22.18 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.341 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.28 151.91 46.85 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 43.38 37.47 1.38 Allowed 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.864 0.727 . . . . 0.0 111.193 -171.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 25.7 tptp 54.58 46.71 24.25 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.233 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . 0.578 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 6.5 tp-100 -135.22 130.72 35.69 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.567 175.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -85.78 110.84 19.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.906 0.384 . . . . 0.0 110.339 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 1.64 ' HE2' ' CE1' ' C' ' 51' ' ' TYR . 82.4 m-85 -104.5 129.19 52.54 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.702 177.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 tp -77.29 103.79 4.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 169.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 53' ' ' VAL . . . . . 0.477 HG11 ' CD2' ' B' ' 88' ' ' LEU . 2.6 t -76.36 -49.62 24.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.243 -173.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 54' ' ' ALA . . . . . 0.45 ' HB3' ' CD2' ' C' ' 65' ' ' LEU . . . -159.0 144.87 16.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.228 -178.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 43.5 m -110.53 101.52 10.19 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 171.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 7.6 p -111.26 120.53 62.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.204 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 52.7 p -122.76 -179.74 4.34 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.078 0.466 . . . . 0.0 112.17 -172.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 58' ' ' LYS . . . . . 0.407 ' HB2' ' HA ' ' C' ' 38' ' ' GLN . 34.9 tttm -60.92 -27.16 68.0 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.281 0.562 . . . . 0.0 109.849 172.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . 0.471 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -83.43 -40.51 19.22 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.817 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 90.5 mt -107.43 89.48 4.96 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 174.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 61' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 37.5 Cg_exo -61.32 -20.31 67.68 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.145 2.563 . . . . 0.0 113.892 -169.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -156.25 136.02 12.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.479 0.657 . . . . 0.0 111.869 -178.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.403 HG12 ' HB2' ' C' ' 54' ' ' ALA . 98.0 t -111.36 113.92 45.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.663 171.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.15 122.21 34.42 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.025 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . 0.45 ' CD2' ' HB3' ' C' ' 54' ' ' ALA . 0.2 OUTLIER -142.59 143.43 32.43 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.287 0.565 . . . . 0.0 111.955 -177.1 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 66' ' ' ASP . . . . . 0.452 ' HB3' ' OG ' ' B' ' 30' ' ' SER . 5.6 t70 -89.54 100.5 13.29 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.718 177.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . 0.566 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 19.7 mt -110.83 138.45 47.22 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.694 176.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . 0.62 ' HB2' ' CD2' ' B' ' 90' ' ' TYR . 10.5 m-80 -137.57 128.21 26.85 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 173.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 69' ' ' PHE . . . . . 1.638 ' HE1' ' CE2' ' C' ' 69' ' ' PHE . 65.9 m-85 -124.47 146.79 48.74 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.934 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 29.2 t -99.97 148.95 23.95 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -67.06 -10.81 53.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.271 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.42 -9.78 66.49 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.081 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -100.9 160.15 14.61 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -135.17 125.53 26.48 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 11.3 pt -131.33 178.04 6.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.836 0.35 . . . . 0.0 111.576 -171.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 76' ' ' MET . . . . . 0.482 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 24.6 mtp -130.79 136.25 48.53 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 77' ' ' PHE . . . . . 0.461 ' CD1' ' HB2' ' C' ' 44' ' ' LEU . 1.2 m-85 -117.79 128.23 54.66 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.17 176.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 78' ' ' TYR . . . . . 1.598 ' HD2' ' CD1' ' C' ' 78' ' ' TYR . 34.7 p90 -155.14 145.63 22.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.961 0.41 . . . . 0.0 111.987 -178.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 79' ' ' THR . . . . . 0.679 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 13.0 p -117.36 144.97 44.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.438 -177.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -115.09 151.28 34.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.972 177.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.67 -177.03 29.12 Favored Glycine 0 CA--C 1.508 -0.403 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -109.93 102.99 11.7 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.764 0.782 . . . . 0.0 109.637 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . 0.499 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -175.27 155.95 1.97 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.833 172.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 32.4 t -113.07 118.8 35.79 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.505 ' CG1' ' HB3' ' C' ' 34' ' ' LEU . 10.1 m -118.88 137.51 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -173.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 54.2 m -101.21 120.9 40.92 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.074 175.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . 0.518 ' HB2' ' HB3' ' C' ' 11' ' ' LEU . 5.3 mp -89.36 145.79 25.12 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 170.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . 0.497 ' CD2' HG11 ' D' ' 53' ' ' VAL . 1.2 tp -131.56 132.15 43.9 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.669 -177.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -159.71 -166.88 19.49 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.575 -176.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 90' ' ' TYR . . . . . 0.62 ' CD2' ' HB2' ' D' ' 68' ' ' ASN . 19.0 p90 -152.88 133.71 13.96 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.885 0.85 . . . . 0.0 111.658 177.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 5.1 mt . . . . . 0 C--N 1.319 -0.749 0 CA-C-N 114.011 -1.45 . . . . 0.0 108.97 174.675 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 49.0 mtt . . . . . 0 CA--C 1.519 -0.245 0 CA-C-O 121.312 0.577 . . . . 0.0 111.446 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 8' ' ' PHE . . . . . 0.49 ' CE1' HD22 ' E' ' 44' ' ' LEU . 60.6 t80 -56.78 141.92 42.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.685 -1.143 . . . . 0.0 112.49 -173.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 9' ' ' TRP . . . . . 0.438 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 87.5 t90 -135.38 141.4 45.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.75 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . 0.497 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -143.11 155.55 26.04 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.133 178.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' D' ' 87' ' ' LEU . 56.8 tp -145.35 108.51 4.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.832 0.348 . . . . 0.0 110.805 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -88.92 106.37 18.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.459 0.647 . . . . 0.0 110.932 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 13' ' ' MET . . . . . 0.468 ' HB2' HG22 ' D' ' 85' ' ' VAL . 4.1 mmt -86.9 134.44 33.52 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.046 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 14' ' ' LYS . . . . . 0.481 ' HB2' ' HG3' ' D' ' 17' ' ' ARG . 54.6 mtmt -100.32 146.15 31.48 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 172.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -48.11 110.39 0.32 Allowed 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 123.43 2.754 . . . . 0.0 113.441 -174.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . 0.681 ' HA ' ' O ' ' D' ' 79' ' ' THR . 31.6 mt-10 69.47 53.96 0.41 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.55 178.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 17' ' ' ARG . . . . . 0.481 ' HG3' ' HB2' ' D' ' 14' ' ' LYS . 19.5 mmt180 -110.57 152.72 26.08 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.948 172.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . 0.643 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 36.0 ttmt -133.62 107.75 8.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.903 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 19' ' ' TYR . . . . . 1.637 ' HE2' ' CE1' ' D' ' 19' ' ' TYR . 0.8 OUTLIER -111.11 121.06 44.35 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.579 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 5.2 p -75.26 126.8 31.76 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 170.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -103.97 116.5 32.36 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.054 0.454 . . . . 0.0 111.648 -164.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 9.1 p -97.28 123.14 40.99 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.826 173.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 55.2 mt -92.97 108.51 20.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.117 0.484 . . . . 0.0 111.521 -172.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . 0.522 HD12 ' H ' ' D' ' 24' ' ' ILE . 0.2 OUTLIER -76.23 -39.57 35.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.018 177.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -139.6 141.46 37.14 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 15.6 m -60.72 120.84 10.85 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 123.535 0.522 . . . . 0.0 109.747 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 27' ' ' PHE . . . . . 1.649 ' HE2' ' CE1' ' D' ' 27' ' ' PHE . 2.2 p90 -134.33 165.92 24.02 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.748 0.785 . . . . 0.0 112.725 -169.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 28' ' ' HIS . . . . . 0.606 ' NE2' ' HB2' ' D' ' 30' ' ' SER . 9.5 t60 -118.58 125.15 49.18 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.996 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 29' ' ' ILE . . . . . 0.579 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 39.5 mt -94.56 138.48 20.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 169.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 30' ' ' SER . . . . . 0.606 ' HB2' ' NE2' ' D' ' 28' ' ' HIS . 26.1 t -119.62 -23.46 6.55 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -169.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 31' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -161.97 156.94 28.65 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.385 -1.388 . . . . 0.0 113.257 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 10.4 p -137.4 125.42 32.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' D' ' 85' ' ' VAL . . . -142.84 152.36 42.08 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.641 -0.424 . . . . 0.0 112.039 -171.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 34' ' ' LEU . . . . . 0.512 ' HB3' ' CG1' ' D' ' 85' ' ' VAL . 3.7 pp -119.13 142.71 47.69 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.518 0.675 . . . . 0.0 111.415 177.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . 0.507 ' HB2' ' HH ' ' E' ' 43' ' ' TYR . 9.5 p-10 -110.08 -48.61 3.17 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.591 173.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -102.41 127.17 49.55 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 170.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . 0.502 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 145.86 159.63 8.27 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 119.379 -1.391 . . . . 0.0 113.916 176.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 38' ' ' GLN . . . . . 0.407 ' HA ' ' HB2' ' D' ' 58' ' ' LYS . 54.0 mt-30 -103.15 -44.53 5.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.702 -0.249 . . . . 0.0 111.157 177.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -150.68 132.61 15.14 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.566 0.222 . . . . 0.0 111.019 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . 0.434 ' HB3' ' HB1' ' D' ' 83' ' ' ALA . . . -132.98 114.33 13.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.234 0.54 . . . . 0.0 110.514 169.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' D' ' 79' ' ' THR . 64.0 mttp -95.86 112.05 23.88 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 45.3 tp -83.88 116.03 22.56 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -177.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 43' ' ' TYR . . . . . 0.512 ' HH ' ' HB2' ' C' ' 35' ' ' ASP . 97.1 m-85 -117.18 144.04 45.18 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.495 ' HA ' ' O ' ' D' ' 76' ' ' MET . 0.2 OUTLIER -131.4 132.5 44.42 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.697 172.095 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 45' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -107.04 110.12 22.17 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.396 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.31 151.9 46.92 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 43.4 37.49 1.4 Allowed 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.923 0.764 . . . . 0.0 111.09 -171.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 25.7 tptp 54.57 46.78 24.11 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.186 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . 0.579 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 6.5 tp-100 -135.18 130.71 35.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.623 175.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -85.69 110.81 19.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.342 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . 1.65 ' HE2' ' CE1' ' D' ' 51' ' ' TYR . 82.2 m-85 -104.45 129.2 52.46 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.707 177.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 tp -77.28 103.77 4.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 169.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 53' ' ' VAL . . . . . 0.497 HG11 ' CD2' ' C' ' 88' ' ' LEU . 2.6 t -76.38 -49.55 24.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.246 -173.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 54' ' ' ALA . . . . . 0.466 ' HB3' ' CD2' ' D' ' 65' ' ' LEU . . . -159.02 144.9 16.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.239 -178.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 43.9 m -110.54 101.55 10.22 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 171.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 56' ' ' VAL . . . . . . . . . . . . . 7.6 p -111.22 120.44 61.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.171 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 52.5 p -122.73 -179.79 4.36 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.084 0.469 . . . . 0.0 112.151 -172.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 58' ' ' LYS . . . . . 0.407 ' HB2' ' HA ' ' D' ' 38' ' ' GLN . 34.8 tttm -60.83 -27.18 67.87 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.289 0.566 . . . . 0.0 109.864 172.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 59' ' ' ALA . . . . . 0.468 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -83.39 -40.56 19.2 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.773 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 91.0 mt -107.33 89.48 4.86 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 61' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 37.6 Cg_exo -61.45 -20.29 67.87 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.193 2.595 . . . . 0.0 113.84 -169.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -156.24 136.03 12.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.409 0.623 . . . . 0.0 111.967 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.406 HG12 ' HB2' ' D' ' 54' ' ' ALA . 98.2 t -111.33 113.77 45.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.702 171.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.07 122.29 34.44 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.995 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 65' ' ' LEU . . . . . 0.466 ' CD2' ' HB3' ' D' ' 54' ' ' ALA . 0.2 OUTLIER -142.79 143.39 32.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.336 0.588 . . . . 0.0 111.856 -177.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 66' ' ' ASP . . . . . 0.461 ' HB3' ' OG ' ' C' ' 30' ' ' SER . 5.6 t70 -89.49 100.55 13.32 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.717 177.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . 0.579 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 19.8 mt -110.81 138.39 47.26 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.683 176.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 68' ' ' ASN . . . . . 0.62 ' HB2' ' CD2' ' C' ' 90' ' ' TYR . 10.6 m-80 -137.58 128.22 26.84 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 173.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 69' ' ' PHE . . . . . 1.632 ' HD2' ' CD1' ' D' ' 69' ' ' PHE . 65.4 m-85 -124.53 146.77 48.81 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.956 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 29.4 t -99.98 149.01 23.88 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -67.22 -10.66 52.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.265 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.52 -9.72 66.38 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.143 176.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -100.95 160.17 14.59 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -135.21 125.35 26.08 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . . . . . . . . . 11.3 pt -131.18 178.14 5.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.012 0.434 . . . . 0.0 111.491 -171.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 76' ' ' MET . . . . . 0.495 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 24.4 mtp -130.87 136.33 48.53 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 174.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 77' ' ' PHE . . . . . 0.459 ' CD1' ' HB2' ' D' ' 44' ' ' LEU . 1.2 m-85 -117.79 128.16 54.6 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.192 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 78' ' ' TYR . . . . . 1.645 ' HD2' ' CD1' ' D' ' 78' ' ' TYR . 34.5 p90 -155.1 145.63 22.17 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.953 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 79' ' ' THR . . . . . 0.681 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 13.4 p -117.29 144.94 44.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.522 -177.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -115.07 151.27 34.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.938 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.7 -177.04 29.09 Favored Glycine 0 CA--C 1.508 -0.348 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -109.82 102.89 11.63 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 119.661 -0.815 . . . . 0.0 109.686 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.502 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -175.25 155.89 1.97 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.782 172.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 32.8 t -112.98 118.84 35.97 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . 0.512 ' CG1' ' HB3' ' D' ' 34' ' ' LEU . 10.2 m -118.92 137.53 52.6 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -173.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 54.9 m -101.25 121.02 41.12 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.986 175.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 87' ' ' LEU . . . . . 0.523 ' HB2' ' HB3' ' D' ' 11' ' ' LEU . 5.3 mp -89.4 145.72 25.15 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 170.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . 0.496 ' CD2' HG11 ' E' ' 53' ' ' VAL . 1.2 tp -131.49 132.1 43.97 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.733 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -159.64 -166.78 19.23 Favored Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.641 -176.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 90' ' ' TYR . . . . . 0.635 ' CD2' ' HB2' ' E' ' 68' ' ' ASN . 19.0 p90 -152.91 133.66 13.89 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.882 0.849 . . . . 0.0 111.654 177.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 5.1 mt . . . . . 0 C--N 1.319 -0.73 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.003 174.645 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 48.8 mtt . . . . . 0 CA--C 1.518 -0.256 0 CA-C-O 121.218 0.532 . . . . 0.0 111.545 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' E' E ' 8' ' ' PHE . . . . . 0.485 ' CE1' HD22 ' A' ' 44' ' ' LEU . 60.6 t80 -56.75 141.94 42.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.601 -173.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 9' ' ' TRP . . . . . 0.438 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 87.3 t90 -135.34 141.34 45.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.056 -0.975 . . . . 0.0 108.812 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 10' ' ' GLY . . . . . 0.486 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -143.18 155.5 26.04 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.07 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 11' ' ' LEU . . . . . 0.506 ' HB3' ' HB2' ' E' ' 87' ' ' LEU . 57.2 tp -145.22 108.45 4.59 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.747 0.308 . . . . 0.0 110.89 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -88.96 106.42 18.41 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.413 0.625 . . . . 0.0 110.93 177.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 13' ' ' MET . . . . . 0.465 ' HB2' HG22 ' E' ' 85' ' ' VAL . 4.1 mmt -86.95 134.36 33.51 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.995 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 14' ' ' LYS . . . . . 0.458 ' HB2' ' HG3' ' E' ' 17' ' ' ARG . 54.6 mtmt -100.22 146.18 31.51 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 172.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -48.19 110.44 0.33 Allowed 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 123.418 2.745 . . . . 0.0 113.449 -174.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 16' ' ' GLU . . . . . 0.679 ' HA ' ' O ' ' E' ' 79' ' ' THR . 31.5 mt-10 69.46 53.99 0.41 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.533 178.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 17' ' ' ARG . . . . . 0.458 ' HG3' ' HB2' ' E' ' 14' ' ' LYS . 19.6 mmt180 -110.56 152.74 26.06 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.889 172.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . 0.65 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 36.0 ttmt -133.62 107.79 8.18 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.923 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . 1.651 ' HD1' ' CD2' ' E' ' 19' ' ' TYR . 0.8 OUTLIER -111.02 121.16 44.65 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 5.4 p -75.37 126.7 31.54 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 170.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -103.9 116.52 32.42 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.039 0.447 . . . . 0.0 111.66 -164.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 9.4 p -97.2 123.12 40.89 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.88 173.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 55.3 mt -92.99 108.5 20.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.18 0.514 . . . . 0.0 111.557 -172.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . 0.51 HD12 ' H ' ' E' ' 24' ' ' ILE . 0.2 OUTLIER -76.16 -39.7 36.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.97 177.814 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -139.58 141.43 37.19 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 15.5 m -60.69 120.87 10.9 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.671 0.607 . . . . 0.0 109.915 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 27' ' ' PHE . . . . . 1.668 ' HE2' ' CE1' ' E' ' 27' ' ' PHE . 2.2 p90 -134.39 165.92 24.04 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.741 0.782 . . . . 0.0 112.659 -169.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 28' ' ' HIS . . . . . 0.598 ' NE2' ' HB2' ' E' ' 30' ' ' SER . 9.4 t60 -118.6 125.13 49.11 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.933 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 29' ' ' ILE . . . . . 0.579 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 39.9 mt -94.57 138.49 20.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 169.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 30' ' ' SER . . . . . 0.598 ' HB2' ' NE2' ' E' ' 28' ' ' HIS . 26.1 t -119.66 -23.51 6.52 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -169.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 31' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -161.94 156.98 28.69 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 119.365 -1.398 . . . . 0.0 113.296 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 10.3 p -137.43 125.34 31.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 172.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' E' ' 85' ' ' VAL . . . -142.78 152.25 42.06 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -171.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 34' ' ' LEU . . . . . 0.509 ' HB3' ' CG1' ' E' ' 85' ' ' VAL . 3.6 pp -119.15 142.75 47.67 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.532 0.682 . . . . 0.0 111.38 177.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . 0.524 ' HB2' ' HH ' ' A' ' 43' ' ' TYR . 9.5 p-10 -110.13 -48.59 3.17 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.542 173.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -102.45 127.27 49.55 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 170.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . 0.5 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 145.85 159.49 8.2 Favored Glycine 0 N--CA 1.437 -1.242 0 C-N-CA 119.342 -1.409 . . . . 0.0 113.938 176.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 38' ' ' GLN . . . . . 0.403 ' HA ' ' HB2' ' E' ' 58' ' ' LYS . 54.3 mt-30 -103.11 -44.44 5.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.697 -0.252 . . . . 0.0 111.181 177.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -150.66 132.63 15.18 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 120.415 0.15 . . . . 0.0 110.974 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . 0.419 ' HB3' ' HB1' ' E' ' 83' ' ' ALA . . . -133.07 114.36 13.83 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.302 0.572 . . . . 0.0 110.498 169.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 41' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' E' ' 79' ' ' THR . 64.1 mttp -95.79 112.05 23.87 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 174.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 45.4 tp -83.87 115.97 22.53 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.484 -177.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 43' ' ' TYR . . . . . 0.507 ' HH ' ' HB2' ' D' ' 35' ' ' ASP . 97.2 m-85 -117.06 144.0 45.13 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 44' ' ' LEU . . . . . 0.49 HD22 ' CE1' ' D' ' 8' ' ' PHE . 0.2 OUTLIER -131.35 132.52 44.51 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.201 0.524 . . . . 0.0 109.684 172.061 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 45' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -107.05 110.11 22.16 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.371 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.26 151.98 46.73 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 43.39 37.44 1.38 Allowed 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.919 0.762 . . . . 0.0 111.146 -171.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 25.7 tptp 54.61 46.79 24.05 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.144 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 49' ' ' GLN . . . . . 0.576 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 6.5 tp-100 -135.31 130.76 35.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.639 175.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -85.78 110.83 19.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.264 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . 1.66 ' HE1' ' CE2' ' E' ' 51' ' ' TYR . 82.3 m-85 -104.49 129.15 52.54 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.764 177.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 tp -77.34 103.8 4.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 169.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . 0.496 HG11 ' CD2' ' D' ' 88' ' ' LEU . 2.6 t -76.32 -49.57 24.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.291 -173.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 54' ' ' ALA . . . . . 0.465 ' HB3' ' CD2' ' E' ' 65' ' ' LEU . . . -159.07 144.88 16.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.211 -178.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 44.4 m -110.52 101.46 10.14 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 171.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -111.22 120.54 62.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.176 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 52.3 p -122.73 -179.79 4.35 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.065 0.459 . . . . 0.0 112.153 -172.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 58' ' ' LYS . . . . . 0.403 ' HB2' ' HA ' ' E' ' 38' ' ' GLN . 34.9 tttm -60.84 -27.18 67.89 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.854 172.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 59' ' ' ALA . . . . . 0.468 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -83.38 -40.51 19.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.804 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 90.9 mt -107.45 89.51 5.01 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 174.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 61' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 36.2 Cg_exo -61.4 -20.31 67.86 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.193 2.595 . . . . 0.0 113.916 -169.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -156.32 136.07 12.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.452 0.644 . . . . 0.0 111.921 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . 0.415 HG12 ' HB2' ' E' ' 54' ' ' ALA . 98.9 t -111.33 113.73 45.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.763 171.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.06 122.22 34.36 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.057 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 65' ' ' LEU . . . . . 0.465 ' CD2' ' HB3' ' E' ' 54' ' ' ALA . 0.2 OUTLIER -142.74 143.49 32.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.335 0.588 . . . . 0.0 111.936 -177.128 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 66' ' ' ASP . . . . . 0.449 ' HB3' ' OG ' ' D' ' 30' ' ' SER . 5.6 t70 -89.49 100.53 13.31 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.679 177.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 67' ' ' LEU . . . . . 0.579 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 19.9 mt -110.91 138.41 47.34 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.646 176.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 68' ' ' ASN . . . . . 0.635 ' HB2' ' CD2' ' D' ' 90' ' ' TYR . 10.5 m-80 -137.63 128.26 26.8 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 173.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 69' ' ' PHE . . . . . 1.665 ' HD2' ' CD1' ' E' ' 69' ' ' PHE . 65.2 m-85 -124.47 146.79 48.73 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.974 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 29.5 t -100.12 149.01 23.95 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -67.14 -10.71 53.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.284 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.44 -9.77 66.48 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.064 176.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -100.83 160.17 14.59 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -135.22 125.48 26.33 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 75' ' ' ILE . . . . . . . . . . . . . 11.3 pt -131.31 178.08 6.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.835 0.35 . . . . 0.0 111.56 -171.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 76' ' ' MET . . . . . 0.478 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 24.6 mtp -130.89 136.28 48.47 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 77' ' ' PHE . . . . . 0.463 ' CD1' ' HB2' ' E' ' 44' ' ' LEU . 1.2 m-85 -117.82 128.2 54.63 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.199 176.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 78' ' ' TYR . . . . . 1.612 ' HD2' ' CD1' ' E' ' 78' ' ' TYR . 34.4 p90 -155.1 145.62 22.16 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.979 -178.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 79' ' ' THR . . . . . 0.679 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 13.3 p -117.3 144.91 44.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.496 -177.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -115.01 151.38 34.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.912 177.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.64 -177.2 29.25 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -109.81 102.88 11.63 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 117.79 0.795 . . . . 0.0 109.733 177.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 83' ' ' ALA . . . . . 0.5 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -175.22 155.94 1.99 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.823 172.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 32.6 t -113.06 118.83 35.86 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 85' ' ' VAL . . . . . 0.509 ' CG1' ' HB3' ' E' ' 34' ' ' LEU . 10.1 m -118.91 137.54 52.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -173.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 54.1 m -101.27 120.96 41.02 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.077 175.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 87' ' ' LEU . . . . . 0.506 ' HB2' ' HB3' ' E' ' 11' ' ' LEU . 5.3 mp -89.39 145.83 25.07 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 170.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . 0.507 ' CD2' HG11 ' A' ' 53' ' ' VAL . 1.2 tp -131.61 132.15 43.81 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.701 -177.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -159.67 -166.82 19.34 Favored Glycine 0 N--CA 1.439 -1.125 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.551 -176.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 90' ' ' TYR . . . . . 0.638 ' CD2' ' HB2' ' A' ' 68' ' ' ASN . 19.0 p90 -152.94 133.67 13.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.864 0.84 . . . . 0.0 111.687 177.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 91' ' ' LEU . . . . . . . . . . . . . 5.3 mt . . . . . 0 C--N 1.318 -0.775 0 CA-C-N 114.073 -1.421 . . . . 0.0 108.896 174.79 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.0 mtt . . . . . 0 C--O 1.226 -0.165 0 CA-C-O 120.886 0.374 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.432 ' CE1' HD23 ' B' ' 44' ' ' LEU . 74.6 t80 -54.83 143.94 24.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.847 -173.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.578 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 89.6 t90 -139.27 148.7 43.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.104 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.55 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -149.98 153.37 25.05 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.715 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.578 ' HB2' ' CH2' ' A' ' 9' ' ' TRP . 59.2 tp -139.06 108.8 6.24 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.916 0.389 . . . . 0.0 111.108 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -80.38 105.72 11.85 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.706 173.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.477 ' HB3' HG22 ' A' ' 85' ' ' VAL . 35.7 tpp -99.41 132.32 44.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.045 0.45 . . . . 0.0 110.956 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -98.63 146.6 31.88 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.89 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.471 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 10.4 Cg_endo -53.6 115.82 2.57 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 123.433 2.756 . . . . 0.0 113.141 -176.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.705 ' HA ' ' O ' ' A' ' 79' ' ' THR . 34.5 mt-10 63.49 38.12 10.06 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.591 177.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -109.36 149.95 28.74 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 173.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.644 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 34.4 ttmt -125.94 119.21 27.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.716 0.293 . . . . 0.0 111.592 -174.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.447 ' HH ' ' HA ' ' A' ' 13' ' ' MET . 3.6 m-85 -110.6 104.96 13.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.442 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.9 p -87.67 99.49 12.11 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 171.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -125.34 148.7 48.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.542 0.687 . . . . 0.0 112.466 -166.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.4 t -92.38 160.31 15.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.029 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 68.2 mt -106.24 117.79 52.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.05 0.452 . . . . 0.0 110.806 -175.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.443 HD13 ' N ' ' A' ' 24' ' ' ILE . 4.1 mp -79.31 -45.38 23.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.916 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -135.17 140.22 45.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.739 178.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.1 m -55.99 124.15 16.75 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.527 0.517 . . . . 0.0 109.647 177.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 1.67 ' HE2' ' CE1' ' A' ' 27' ' ' PHE . 3.9 p90 -140.09 158.53 43.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.685 0.755 . . . . 0.0 112.683 -171.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.563 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 14.3 t60 -112.8 125.94 54.89 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.102 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.564 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 44.6 mt -96.3 133.45 37.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 170.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.563 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 42.2 p -118.48 -15.07 9.66 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -170.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.83 151.97 22.53 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 119.329 -1.415 . . . . 0.0 113.48 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.1 p -140.76 123.88 16.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 171.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.49 154.68 43.89 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.394 -0.522 . . . . 0.0 112.044 -173.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.465 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 4.3 pp -118.28 138.86 52.08 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.726 0.774 . . . . 0.0 111.178 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -110.07 -47.6 3.3 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.495 172.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -103.15 127.42 50.44 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.171 170.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.436 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 147.28 163.05 10.33 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 119.729 -1.224 . . . . 0.0 113.443 177.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.453 ' O ' ' HG3' ' A' ' 58' ' ' LYS . 8.3 tt0 -102.23 -48.21 4.27 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.554 0.216 . . . . 0.0 111.207 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -153.07 137.85 17.03 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.729 -0.214 . . . . 0.0 110.657 176.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.435 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . . . -136.39 114.97 11.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.395 0.616 . . . . 0.0 111.12 171.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 79' ' ' THR . 68.1 mttm -95.07 115.03 26.91 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 171.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.1 tp -84.11 116.25 22.8 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -176.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 1.615 ' HE2' ' CE1' ' A' ' 43' ' ' TYR . 93.9 m-85 -117.09 143.82 45.35 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.525 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -131.7 131.71 43.3 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 172.68 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -111.87 118.15 34.75 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.132 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.48 133.66 46.46 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.485 178.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 56.05 38.9 30.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.135 0.493 . . . . 0.0 110.67 -175.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm 65.8 22.52 11.47 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.333 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.562 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 28.9 mm-40 -113.32 124.48 52.57 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -87.42 116.87 25.82 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.564 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 72.4 m-85 -111.61 131.07 55.52 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.782 177.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -81.34 103.42 8.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 171.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.481 HG11 ' CD2' ' E' ' 88' ' ' LEU . 2.3 t -76.87 -47.64 27.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.473 -172.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.432 ' HB2' HG12 ' A' ' 63' ' ' VAL . . . -156.7 151.53 25.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.327 -178.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 98.1 m -114.81 101.77 9.37 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 169.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -113.04 114.12 46.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.675 0.75 . . . . 0.0 109.759 -177.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 77.1 p -123.31 -177.75 3.79 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.411 -174.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 38' ' ' GLN . 28.8 mtpp -57.22 -36.13 70.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.101 0.477 . . . . 0.0 110.374 169.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.27 -41.23 66.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.551 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.9 mt -115.74 82.66 10.61 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 174.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.1 0.5 6.53 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.858 2.372 . . . . 0.0 113.598 -168.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -162.76 128.0 3.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.153 0.501 . . . . 0.0 111.029 -176.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.432 HG12 ' HB2' ' A' ' 54' ' ' ALA . 92.8 t -114.23 111.23 35.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.478 174.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.83 112.15 23.85 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.679 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -130.51 168.44 17.04 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.57 -175.522 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.463 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 6.5 t0 -115.25 99.92 7.76 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.344 0.592 . . . . 0.0 110.33 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.564 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 17.7 mt -114.59 141.23 48.03 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.667 177.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.408 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 6.2 t30 -146.62 115.32 6.81 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.975 0.417 . . . . 0.0 110.053 174.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -110.18 159.93 16.94 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.0 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.7 p -112.4 149.61 32.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.551 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.46 10.45 0.62 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -175.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.68 -21.39 14.48 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.087 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -101.23 171.39 7.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.777 0.322 . . . . 0.0 110.883 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 -137.72 129.3 28.23 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.5 pt -129.24 163.04 35.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.062 0.458 . . . . 0.0 111.691 -170.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.519 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 4.8 mtm -118.3 122.82 43.85 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 175.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 1.669 ' HD1' ' CD2' ' A' ' 77' ' ' PHE . 1.0 OUTLIER -105.05 127.69 52.99 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.171 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 1.634 ' HD1' ' CD2' ' A' ' 78' ' ' TYR . 49.5 p90 -155.9 150.6 26.12 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.508 -177.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.705 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 11.2 p -117.2 149.12 40.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.735 -178.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.04 144.6 42.33 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.247 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.19 176.99 34.69 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -175.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -106.47 102.8 12.17 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.932 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.471 ' H ' ' HB3' ' A' ' 15' ' ' PRO . . . -170.75 151.25 3.43 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.574 169.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.6 t -108.14 121.6 45.17 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.477 HG22 ' HB3' ' A' ' 13' ' ' MET . 11.4 m -118.54 146.19 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 CA-C-O 121.435 0.636 . . . . 0.0 111.666 -173.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.2 t -111.88 120.94 43.62 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.565 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 5.1 mp -93.0 151.63 19.78 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 174.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.451 ' CD2' HG11 ' B' ' 53' ' ' VAL . 1.6 tp -133.58 141.11 47.53 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.162 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.16 -166.67 26.63 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.825 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 1.624 ' HE2' ' CE1' ' A' ' 90' ' ' TYR . 8.1 p90 -150.96 130.16 12.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.754 0.788 . . . . 0.0 111.698 176.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.405 ' HA ' ' CB ' ' A' ' 27' ' ' PHE . 5.3 mt . . . . . 0 C--N 1.325 -0.485 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.886 176.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 59.9 mtt . . . . . 0 C--O 1.226 -0.179 0 CA-C-O 120.911 0.386 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . 0.471 ' CE1' HD23 ' C' ' 44' ' ' LEU . 73.9 t80 -54.97 144.03 24.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.853 -173.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . 0.575 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 89.5 t90 -139.38 148.6 43.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.971 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.584 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -149.85 153.44 25.11 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.828 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.575 ' HB2' ' CH2' ' B' ' 9' ' ' TRP . 59.5 tp -139.04 108.71 6.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.774 0.321 . . . . 0.0 111.197 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -80.35 105.84 11.92 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.706 173.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' MET . . . . . 0.497 ' HB3' HG22 ' B' ' 85' ' ' VAL . 35.6 tpp -99.53 132.44 44.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.156 0.503 . . . . 0.0 110.87 -176.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -98.61 146.61 31.9 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.915 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.466 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 10.3 Cg_endo -53.68 115.86 2.61 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 123.425 2.75 . . . . 0.0 113.134 -176.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.704 ' HA ' ' O ' ' B' ' 79' ' ' THR . 34.6 mt-10 63.5 38.02 10.1 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.666 177.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -109.31 149.84 28.86 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . 0.64 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 34.3 ttmt -125.95 119.23 27.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.774 0.321 . . . . 0.0 111.617 -174.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' TYR . . . . . 0.459 ' OH ' ' HA ' ' B' ' 13' ' ' MET . 3.6 m-85 -110.54 104.94 13.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.399 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 11.9 p -87.59 99.4 12.02 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 171.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -125.27 148.81 48.53 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.616 0.722 . . . . 0.0 112.5 -166.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 11.5 t -92.46 160.34 15.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.998 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 68.0 mt -106.28 117.69 52.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.085 0.469 . . . . 0.0 110.823 -175.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.436 HD13 ' N ' ' B' ' 24' ' ' ILE . 4.1 mp -79.27 -45.36 23.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.984 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -135.19 140.24 45.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.757 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 17.8 m -55.92 124.03 16.3 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 123.639 0.587 . . . . 0.0 109.646 177.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . 1.648 ' HE2' ' CE1' ' B' ' 27' ' ' PHE . 3.9 p90 -140.03 158.57 43.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.704 0.764 . . . . 0.0 112.739 -171.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' HIS . . . . . 0.562 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 14.2 t60 -112.86 126.05 55.03 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.07 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.571 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 44.0 mt -96.3 133.44 37.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 170.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.562 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 41.5 p -118.47 -15.04 9.67 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -170.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.87 151.97 22.52 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 119.276 -1.44 . . . . 0.0 113.456 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 9.1 p -140.74 123.88 16.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 171.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.5 154.63 43.84 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.486 -0.485 . . . . 0.0 112.085 -172.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.476 ' HB3' ' CG1' ' B' ' 85' ' ' VAL . 4.3 pp -118.28 138.88 52.07 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.627 0.727 . . . . 0.0 111.155 177.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -110.17 -47.56 3.29 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.404 172.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -103.2 127.44 50.49 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.167 170.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.435 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 147.26 162.99 10.3 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 119.696 -1.24 . . . . 0.0 113.405 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . 0.463 ' O ' ' HG3' ' B' ' 58' ' ' LYS . 8.3 tt0 -102.16 -48.3 4.26 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.474 0.178 . . . . 0.0 111.149 178.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -153.07 137.77 16.96 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.713 -0.222 . . . . 0.0 110.652 176.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.425 ' HB3' ' HB1' ' B' ' 83' ' ' ALA . . . -136.31 114.89 11.9 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.279 0.561 . . . . 0.0 111.196 171.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' B' ' 79' ' ' THR . 68.1 mttm -95.03 114.99 26.86 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 171.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 38.1 tp -84.06 116.25 22.77 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . 1.611 ' HE2' ' CE1' ' B' ' 43' ' ' TYR . 93.9 m-85 -117.09 143.79 45.39 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.539 177.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.534 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.1 OUTLIER -131.63 131.71 43.44 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 172.657 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -111.88 118.1 34.59 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.087 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.44 133.67 46.51 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.444 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 56.07 38.78 30.27 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.516 0.51 . . . . 0.0 110.675 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm 65.9 22.44 11.35 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.344 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . 0.558 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 28.9 mm-40 -113.32 124.5 52.61 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 177.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -87.52 116.92 25.97 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 0.55 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 72.3 m-85 -111.68 131.06 55.55 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.749 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -81.27 103.42 8.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 170.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.451 HG11 ' CD2' ' A' ' 88' ' ' LEU . 2.3 t -76.87 -47.65 27.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.476 -172.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.425 ' HB2' HG12 ' B' ' 63' ' ' VAL . . . -156.69 151.49 25.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.334 -178.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 99.9 m -114.78 101.77 9.38 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 169.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -113.0 114.07 45.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.578 0.704 . . . . 0.0 109.755 -177.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 76.3 p -123.27 -177.79 3.8 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.445 -174.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' B' ' 38' ' ' GLN . 28.8 mtpp -57.16 -36.18 70.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.073 0.463 . . . . 0.0 110.331 168.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.43 -41.19 66.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.503 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 76.3 mt -115.67 82.68 10.45 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 174.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.09 0.37 6.74 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.992 2.461 . . . . 0.0 113.606 -168.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -162.66 128.01 3.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.263 0.554 . . . . 0.0 111.005 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.425 HG12 ' HB2' ' B' ' 54' ' ' ALA . 94.9 t -114.13 111.24 35.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.54 174.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.81 112.0 23.62 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.728 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' B' ' 30' ' ' SER . 0.3 OUTLIER -130.43 168.46 16.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.558 -175.497 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . 0.466 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 6.5 t0 -115.26 99.96 7.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.298 0.57 . . . . 0.0 110.405 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.571 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 17.7 mt -114.58 141.3 47.94 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.66 177.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . 0.409 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 6.3 t30 -146.71 115.27 6.76 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.013 0.435 . . . . 0.0 110.074 174.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -110.22 159.92 16.96 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.929 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 10.3 p -112.45 149.56 32.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.544 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.4 10.52 0.6 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -175.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.71 -21.51 14.21 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.118 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -101.13 171.39 7.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.775 0.321 . . . . 0.0 110.901 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 -137.76 129.49 28.44 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 14.7 pt -129.36 162.95 35.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.027 0.441 . . . . 0.0 111.703 -170.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' MET . . . . . 0.534 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 4.8 mtm -118.28 122.87 44.0 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 175.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . 1.664 ' HD1' ' CD2' ' B' ' 77' ' ' PHE . 1.0 OUTLIER -105.12 127.72 53.03 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.183 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 1.649 ' HD1' ' CD2' ' B' ' 78' ' ' TYR . 49.3 p90 -155.93 150.63 26.09 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.471 -177.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.704 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 11.2 p -117.32 149.08 41.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.922 0.392 . . . . 0.0 111.679 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.06 144.54 42.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.269 174.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.25 176.96 34.6 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -106.5 102.8 12.17 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.932 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.466 ' H ' ' HB3' ' B' ' 15' ' ' PRO . . . -170.82 151.28 3.38 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.527 169.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 23.6 t -108.31 121.61 45.26 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.497 HG22 ' HB3' ' B' ' 13' ' ' MET . 11.6 m -118.41 146.19 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 CA-C-O 121.406 0.622 . . . . 0.0 111.665 -173.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 15.3 t -111.87 120.86 43.37 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.546 ' HB2' ' HB3' ' B' ' 11' ' ' LEU . 5.0 mp -92.91 151.57 19.88 Favored 'General case' 0 CA--C 1.502 -0.895 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.64 174.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.474 ' CD2' HG11 ' C' ' 53' ' ' VAL . 1.6 tp -133.49 141.12 47.63 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.129 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.2 -166.69 26.71 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.812 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' TYR . . . . . 1.627 ' HD1' ' CD2' ' B' ' 90' ' ' TYR . 8.2 p90 -150.89 130.13 12.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.679 0.752 . . . . 0.0 111.778 176.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . 0.406 ' HA ' ' CB ' ' B' ' 27' ' ' PHE . 5.4 mt . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 114.238 -1.346 . . . . 0.0 109.933 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 59.9 mtt . . . . . 0 C--O 1.227 -0.128 0 CA-C-O 120.874 0.369 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 8' ' ' PHE . . . . . 0.46 ' CE1' HD23 ' D' ' 44' ' ' LEU . 74.0 t80 -54.91 144.02 24.27 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.878 -173.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . 0.565 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 89.6 t90 -139.25 148.74 43.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.98 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . 0.538 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -149.97 153.44 25.09 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.764 177.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.565 ' HB2' ' CH2' ' C' ' 9' ' ' TRP . 59.5 tp -139.15 108.86 6.24 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.945 0.402 . . . . 0.0 111.093 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -80.35 105.7 11.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.751 173.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 13' ' ' MET . . . . . 0.498 ' HB3' HG22 ' C' ' 85' ' ' VAL . 35.8 tpp -99.48 132.27 44.93 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.116 0.484 . . . . 0.0 110.852 -176.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -98.47 146.53 31.74 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.013 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . 0.463 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 10.3 Cg_endo -53.62 115.95 2.67 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 123.362 2.708 . . . . 0.0 113.161 -176.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . 0.707 ' HA ' ' O ' ' C' ' 79' ' ' THR . 34.6 mt-10 63.4 38.07 10.33 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.699 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -109.3 149.85 28.85 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 173.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 18' ' ' LYS . . . . . 0.641 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 34.4 ttmt -126.05 119.26 27.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.748 0.309 . . . . 0.0 111.583 -174.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . 0.448 ' OH ' ' HA ' ' C' ' 13' ' ' MET . 3.6 m-85 -110.56 104.98 13.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.434 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 11.9 p -87.61 99.47 12.08 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 171.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -125.42 148.84 48.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.589 0.709 . . . . 0.0 112.462 -166.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 11.4 t -92.51 160.4 15.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.997 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -106.27 117.73 52.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.091 0.472 . . . . 0.0 110.824 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . 0.434 HD13 ' N ' ' C' ' 24' ' ' ILE . 4.1 mp -79.26 -45.44 23.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.965 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -135.16 140.3 45.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.707 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 18.0 m -56.03 124.15 16.78 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.582 0.551 . . . . 0.0 109.582 177.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 27' ' ' PHE . . . . . 1.61 ' HE2' ' CE1' ' C' ' 27' ' ' PHE . 3.9 p90 -140.08 158.5 43.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.739 0.781 . . . . 0.0 112.78 -171.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 28' ' ' HIS . . . . . 0.565 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 14.2 t60 -112.77 125.97 54.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.104 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . 0.566 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 44.2 mt -96.28 133.44 37.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 30' ' ' SER . . . . . 0.565 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 41.1 p -118.49 -14.98 9.66 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -170.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.91 151.84 22.35 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 119.314 -1.422 . . . . 0.0 113.508 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 9.0 p -140.74 123.89 16.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 171.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.56 154.59 43.75 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.397 -0.521 . . . . 0.0 112.077 -172.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.475 ' HB3' HG13 ' C' ' 85' ' ' VAL . 4.3 pp -118.14 138.86 52.0 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.685 0.755 . . . . 0.0 111.241 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -110.19 -47.52 3.29 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.772 -1.103 . . . . 0.0 108.464 172.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -103.17 127.51 50.44 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.227 170.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 37' ' ' GLY . . . . . 0.43 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 147.21 163.06 10.32 Favored Glycine 0 N--CA 1.439 -1.111 0 C-N-CA 119.718 -1.229 . . . . 0.0 113.442 177.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 38' ' ' GLN . . . . . 0.454 ' O ' ' HG3' ' C' ' 58' ' ' LYS . 8.4 tt0 -102.28 -48.27 4.25 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.483 0.183 . . . . 0.0 111.122 178.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -153.07 137.77 16.96 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 122.162 0.185 . . . . 0.0 110.714 176.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . 0.441 ' HB3' ' HB1' ' C' ' 83' ' ' ALA . . . -136.27 114.92 11.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.292 0.568 . . . . 0.0 111.171 171.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' C' ' 79' ' ' THR . 68.1 mttm -95.0 114.91 26.77 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 171.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 37.9 tp -84.04 116.26 22.76 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -176.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 43' ' ' TYR . . . . . 1.633 ' HE2' ' CE1' ' C' ' 43' ' ' TYR . 93.9 m-85 -117.09 143.77 45.42 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 177.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.522 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 0.1 OUTLIER -131.66 131.64 43.32 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 172.662 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . 0.568 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -111.89 118.16 34.76 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.164 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.43 133.58 46.45 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.45 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 56.12 38.79 30.24 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.524 0.515 . . . . 0.0 110.654 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm 65.9 22.35 11.35 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.362 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . 0.568 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 29.0 mm-40 -113.25 124.46 52.57 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -87.48 116.93 25.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.928 0.394 . . . . 0.0 110.046 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 0.584 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 72.5 m-85 -111.72 131.02 55.58 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.743 177.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -81.33 103.35 8.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 171.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 53' ' ' VAL . . . . . 0.474 HG11 ' CD2' ' B' ' 88' ' ' LEU . 2.3 t -76.87 -47.6 27.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.491 -172.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 54' ' ' ALA . . . . . 0.434 ' HB2' HG12 ' C' ' 63' ' ' VAL . . . -156.68 151.5 25.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.303 -178.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 99.6 m -114.74 101.69 9.31 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 169.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.92 114.04 45.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.596 0.712 . . . . 0.0 109.781 -177.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 77.4 p -123.26 -177.74 3.78 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.496 -174.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 58' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' C' ' 38' ' ' GLN . 28.8 mtpp -57.2 -36.18 70.53 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.032 0.444 . . . . 0.0 110.378 168.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.35 -41.16 66.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.521 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 76.5 mt -115.76 82.77 10.78 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 174.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.11 0.44 6.64 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.865 2.377 . . . . 0.0 113.662 -168.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -162.66 128.06 3.29 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.139 0.495 . . . . 0.0 111.087 -176.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.434 HG12 ' HB2' ' C' ' 54' ' ' ALA . 92.1 t -114.29 111.36 35.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.439 174.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.85 112.04 23.7 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.698 174.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' C' ' 30' ' ' SER . 0.3 OUTLIER -130.45 168.44 17.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.069 0.461 . . . . 0.0 111.599 -175.518 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 66' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 6.6 t0 -115.23 99.95 7.78 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.345 0.593 . . . . 0.0 110.386 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . 0.566 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 17.7 mt -114.58 141.22 48.03 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.695 177.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . 0.401 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 6.3 t30 -146.66 115.27 6.78 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.92 0.391 . . . . 0.0 110.043 174.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -110.07 159.93 16.89 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.061 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 10.7 p -112.49 149.49 32.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.557 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.38 10.41 0.62 Allowed 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -175.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.63 -21.51 14.35 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.111 176.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -101.15 171.31 7.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.787 0.327 . . . . 0.0 110.828 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 -137.72 129.46 28.47 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 14.8 pt -129.35 163.01 35.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.104 0.478 . . . . 0.0 111.696 -169.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 76' ' ' MET . . . . . 0.52 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 4.8 mtm -118.41 122.89 43.9 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 175.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 77' ' ' PHE . . . . . 1.642 ' HE2' ' CE1' ' C' ' 77' ' ' PHE . 1.0 OUTLIER -105.08 127.77 53.04 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 177.204 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 78' ' ' TYR . . . . . 1.659 ' HD2' ' CD1' ' C' ' 78' ' ' TYR . 49.3 p90 -155.95 150.65 26.1 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.494 -177.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 79' ' ' THR . . . . . 0.707 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 11.0 p -117.34 149.14 40.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.898 0.38 . . . . 0.0 111.622 -178.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.11 144.62 42.34 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.323 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.19 176.93 34.69 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -175.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -106.49 102.75 12.12 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.062 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . 0.463 ' H ' ' HB3' ' C' ' 15' ' ' PRO . . . -170.7 151.26 3.46 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.557 169.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 23.4 t -108.19 121.57 45.14 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.498 HG22 ' HB3' ' C' ' 13' ' ' MET . 11.6 m -118.49 146.24 23.35 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-O 121.403 0.62 . . . . 0.0 111.663 -173.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 15.2 t -111.94 120.88 43.41 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . 0.56 ' HB2' ' HB3' ' C' ' 11' ' ' LEU . 5.0 mp -92.92 151.68 19.81 Favored 'General case' 0 CA--C 1.502 -0.894 0 C-N-CA 120.364 -0.534 . . . . 0.0 109.646 174.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . 0.472 ' CD2' HG11 ' D' ' 53' ' ' VAL . 1.6 tp -133.58 141.11 47.53 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.156 -178.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.21 -166.72 26.77 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.825 -0.703 . . . . 0.0 111.86 -176.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 90' ' ' TYR . . . . . 1.617 ' HE1' ' CE2' ' C' ' 90' ' ' TYR . 8.3 p90 -150.86 130.1 12.77 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.632 0.729 . . . . 0.0 111.765 176.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 5.2 mt . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 114.253 -1.339 . . . . 0.0 109.93 176.511 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 59.9 mtt . . . . . 0 C--O 1.225 -0.21 0 CA-C-O 120.924 0.392 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 8' ' ' PHE . . . . . 0.473 ' CE1' HD23 ' E' ' 44' ' ' LEU . 74.2 t80 -55.01 144.06 24.55 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.849 -173.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 9' ' ' TRP . . . . . 0.575 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 89.7 t90 -139.29 148.7 43.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.987 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . 0.562 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -149.95 153.44 25.1 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.812 -0.708 . . . . 0.0 111.755 177.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . 0.575 ' HB2' ' CH2' ' D' ' 9' ' ' TRP . 58.9 tp -139.13 108.81 6.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.965 0.412 . . . . 0.0 111.094 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -80.35 105.75 11.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.685 173.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 13' ' ' MET . . . . . 0.49 ' HB3' HG22 ' D' ' 85' ' ' VAL . 35.7 tpp -99.52 132.31 44.94 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.067 0.46 . . . . 0.0 110.942 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -98.57 146.55 31.79 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.95 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . 0.463 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 10.5 Cg_endo -53.52 115.85 2.59 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 123.428 2.752 . . . . 0.0 113.154 -176.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . 0.721 ' HA ' ' O ' ' D' ' 79' ' ' THR . 34.3 mt-10 63.42 38.14 10.22 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.617 177.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -109.37 149.82 28.95 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 173.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . 0.637 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 34.4 ttmt -125.96 119.22 27.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.771 0.319 . . . . 0.0 111.59 -174.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 19' ' ' TYR . . . . . 0.452 ' OH ' ' HA ' ' D' ' 13' ' ' MET . 3.6 m-85 -110.51 104.9 13.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.402 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 11.7 p -87.69 99.43 12.07 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 171.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -125.25 148.7 48.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.492 0.663 . . . . 0.0 112.564 -166.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 11.4 t -92.32 160.35 15.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.049 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 68.0 mt -106.31 117.71 52.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.059 0.457 . . . . 0.0 110.771 -175.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . 0.441 ' N ' HD13 ' D' ' 24' ' ' ILE . 4.2 mp -79.26 -45.42 23.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.96 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -135.14 140.28 45.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.759 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 18.2 m -56.02 124.17 16.84 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 123.547 0.529 . . . . 0.0 109.595 177.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 27' ' ' PHE . . . . . 1.625 ' HD2' ' CD1' ' D' ' 27' ' ' PHE . 3.9 p90 -140.16 158.56 43.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.65 0.738 . . . . 0.0 112.731 -171.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 28' ' ' HIS . . . . . 0.565 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 14.1 t60 -112.87 125.99 54.97 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.048 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 29' ' ' ILE . . . . . 0.551 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 43.9 mt -96.3 133.46 37.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 30' ' ' SER . . . . . 0.565 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 42.4 p -118.53 -14.96 9.63 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -170.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.91 151.93 22.46 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 119.4 -1.381 . . . . 0.0 113.489 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 9.1 p -140.87 123.85 16.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 171.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.48 154.61 43.83 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.419 -0.512 . . . . 0.0 112.076 -172.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 34' ' ' LEU . . . . . 0.472 ' HB3' ' CG1' ' D' ' 85' ' ' VAL . 4.3 pp -118.2 138.86 52.04 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.669 0.747 . . . . 0.0 111.222 177.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -110.1 -47.55 3.3 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.475 172.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -103.2 127.52 50.47 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.176 170.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . 0.43 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 147.3 162.99 10.31 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 119.659 -1.258 . . . . 0.0 113.364 177.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 38' ' ' GLN . . . . . 0.462 ' O ' ' HG3' ' D' ' 58' ' ' LYS . 8.4 tt0 -102.21 -48.32 4.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.524 0.202 . . . . 0.0 111.155 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -153.0 137.84 17.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.784 -0.189 . . . . 0.0 110.667 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . 0.438 ' HB3' ' HB1' ' D' ' 83' ' ' ALA . . . -136.37 114.91 11.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.37 0.605 . . . . 0.0 111.126 171.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' D' ' 79' ' ' THR . 68.1 mttm -95.01 114.92 26.78 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 171.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 38.0 tp -83.99 116.13 22.67 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -176.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 43' ' ' TYR . . . . . 1.649 ' HE2' ' CE1' ' D' ' 43' ' ' TYR . 94.4 m-85 -117.03 143.74 45.4 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.524 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.1 OUTLIER -131.62 131.77 43.5 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 172.699 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 45' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -111.97 118.1 34.55 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.131 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.43 133.59 46.46 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.485 178.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 56.19 38.8 30.19 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 123.452 0.47 . . . . 0.0 110.591 -175.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm 65.94 22.43 11.31 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.214 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . 0.566 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 29.1 mm-40 -113.28 124.54 52.74 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -87.55 116.87 25.97 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . 0.538 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 72.3 m-85 -111.64 131.03 55.56 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.798 177.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -81.3 103.32 8.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 171.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 53' ' ' VAL . . . . . 0.472 HG11 ' CD2' ' C' ' 88' ' ' LEU . 2.3 t -76.76 -47.61 28.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.523 -172.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 54' ' ' ALA . . . . . 0.425 ' HB2' HG12 ' D' ' 63' ' ' VAL . . . -156.74 151.5 25.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.296 -178.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 99.9 m -114.74 101.64 9.26 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 169.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.97 114.14 46.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.584 0.707 . . . . 0.0 109.777 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 75.7 p -123.26 -177.82 3.81 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.495 -174.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 58' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' D' ' 38' ' ' GLN . 28.8 mtpp -57.2 -36.08 70.41 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.12 0.486 . . . . 0.0 110.43 168.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.4 -41.14 66.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.562 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 76.0 mt -115.72 82.69 10.59 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.03 0.42 6.63 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.839 2.359 . . . . 0.0 113.652 -168.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -162.64 128.22 3.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.154 0.502 . . . . 0.0 111.014 -176.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.425 HG12 ' HB2' ' D' ' 54' ' ' ALA . 92.7 t -114.39 111.36 35.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.433 174.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.93 112.01 23.7 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.678 174.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 65' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' D' ' 30' ' ' SER . 0.3 OUTLIER -130.41 168.56 16.77 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.065 0.46 . . . . 0.0 111.556 -175.518 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 66' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 6.5 t0 -115.32 99.99 7.79 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.33 0.586 . . . . 0.0 110.398 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . 0.551 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 17.7 mt -114.66 141.32 47.95 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.561 177.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 68' ' ' ASN . . . . . 0.419 ' HB3' ' CD2' ' C' ' 90' ' ' TYR . 6.2 t30 -146.71 115.28 6.76 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.006 0.431 . . . . 0.0 110.083 173.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -110.11 159.93 16.91 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.012 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 10.0 p -112.56 149.59 32.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.479 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.56 10.59 0.61 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -175.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.72 -21.38 14.44 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.131 176.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -101.21 171.41 7.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.839 0.352 . . . . 0.0 110.859 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 -137.72 129.33 28.28 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . . . . . . . . . 14.7 pt -129.3 162.94 35.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.088 0.47 . . . . 0.0 111.707 -169.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 76' ' ' MET . . . . . 0.52 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 4.8 mtm -118.22 122.79 43.87 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 175.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 77' ' ' PHE . . . . . 1.662 ' HE1' ' CE2' ' D' ' 77' ' ' PHE . 1.0 OUTLIER -105.03 127.77 53.02 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 177.209 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 78' ' ' TYR . . . . . 1.63 ' HE1' ' CE2' ' D' ' 78' ' ' TYR . 49.5 p90 -155.9 150.57 26.08 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.491 -177.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 79' ' ' THR . . . . . 0.721 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 11.1 p -117.23 149.19 40.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.935 0.397 . . . . 0.0 111.698 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.14 144.71 42.19 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.202 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.2 176.98 34.67 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -175.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -106.5 102.84 12.21 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.97 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.463 ' H ' ' HB3' ' D' ' 15' ' ' PRO . . . -170.82 151.27 3.38 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.486 169.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 23.5 t -108.21 121.49 44.98 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . 0.49 HG22 ' HB3' ' D' ' 13' ' ' MET . 11.7 m -118.41 146.18 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 CA-C-O 121.416 0.627 . . . . 0.0 111.69 -173.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 15.4 t -111.87 120.88 43.43 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 87' ' ' LEU . . . . . 0.561 ' HB2' ' HB3' ' D' ' 11' ' ' LEU . 5.0 mp -92.86 151.58 19.9 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 120.452 -0.499 . . . . 0.0 109.658 174.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . 0.489 ' CD2' HG11 ' E' ' 53' ' ' VAL . 1.6 tp -133.55 141.18 47.6 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.081 -178.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.24 -166.7 26.76 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.799 -176.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 90' ' ' TYR . . . . . 1.592 ' HE2' ' CE1' ' D' ' 90' ' ' TYR . 8.2 p90 -150.95 130.12 12.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.742 0.782 . . . . 0.0 111.781 176.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 5.3 mt . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.957 176.56 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 59.9 mtt . . . . . 0 C--O 1.225 -0.206 0 CA-C-O 120.943 0.401 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' E' E ' 8' ' ' PHE . . . . . 0.469 ' CE1' HD23 ' A' ' 44' ' ' LEU . 74.2 t80 -54.92 144.03 24.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.805 -173.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 9' ' ' TRP . . . . . 0.56 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 89.5 t90 -139.38 148.63 43.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.96 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 10' ' ' GLY . . . . . 0.564 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -149.88 153.43 25.1 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.79 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 11' ' ' LEU . . . . . 0.56 ' HB2' ' CH2' ' E' ' 9' ' ' TRP . 59.2 tp -139.06 108.79 6.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.898 0.38 . . . . 0.0 111.144 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -80.28 105.71 11.75 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.769 173.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 13' ' ' MET . . . . . 0.503 ' HB3' HG22 ' E' ' 85' ' ' VAL . 35.5 tpp -99.5 132.32 44.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.117 0.484 . . . . 0.0 110.935 -176.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -98.56 146.67 31.99 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.945 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . 0.458 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 10.4 Cg_endo -53.73 115.96 2.68 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 123.4 2.734 . . . . 0.0 113.104 -176.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 16' ' ' GLU . . . . . 0.721 ' HA ' ' O ' ' E' ' 79' ' ' THR . 34.6 mt-10 63.35 38.17 10.37 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.69 177.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -109.41 149.9 28.87 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 173.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . 0.636 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 34.4 ttmt -125.99 119.19 27.04 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.736 0.303 . . . . 0.0 111.613 -174.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . 0.451 ' OH ' ' HA ' ' E' ' 13' ' ' MET . 3.5 m-85 -110.44 104.86 13.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.546 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 12.0 p -87.54 99.47 12.06 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 171.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -125.41 148.77 48.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.537 0.684 . . . . 0.0 112.517 -166.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 11.5 t -92.45 160.27 15.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.989 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 68.1 mt -106.25 117.66 52.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.082 0.468 . . . . 0.0 110.894 -175.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . 0.433 ' N ' HD13 ' E' ' 24' ' ' ILE . 4.1 mp -79.19 -45.42 24.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.977 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -135.13 140.23 45.27 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.775 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 18.0 m -56.06 124.09 16.62 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 123.619 0.574 . . . . 0.0 109.648 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 27' ' ' PHE . . . . . 1.654 ' HE2' ' CE1' ' E' ' 27' ' ' PHE . 3.9 p90 -140.04 158.53 43.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.725 0.774 . . . . 0.0 112.765 -171.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 28' ' ' HIS . . . . . 0.564 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 14.3 t60 -112.72 125.99 54.92 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.159 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 29' ' ' ILE . . . . . 0.567 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 44.2 mt -96.29 133.41 37.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 170.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 30' ' ' SER . . . . . 0.564 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 43.3 p -118.49 -14.93 9.66 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -170.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.86 151.93 22.47 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 119.373 -1.394 . . . . 0.0 113.566 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 9.1 p -140.81 123.86 16.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 171.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.52 154.54 43.73 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.493 -0.483 . . . . 0.0 112.082 -172.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 34' ' ' LEU . . . . . 0.476 ' HB3' ' CG1' ' E' ' 85' ' ' VAL . 4.3 pp -118.2 138.89 52.01 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.714 0.769 . . . . 0.0 111.222 177.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -110.2 -47.44 3.3 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.485 172.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -103.28 127.47 50.6 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.201 170.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . 0.434 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 147.27 162.9 10.25 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 119.673 -1.251 . . . . 0.0 113.463 177.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 38' ' ' GLN . . . . . 0.46 ' O ' ' HG3' ' E' ' 58' ' ' LYS . 8.4 tt0 -102.22 -48.16 4.29 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.559 0.219 . . . . 0.0 111.143 178.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -153.11 137.76 16.91 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.781 -0.191 . . . . 0.0 110.639 176.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . 0.438 ' HB3' ' HB1' ' E' ' 83' ' ' ALA . . . -136.32 114.97 11.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.318 0.58 . . . . 0.0 111.147 171.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 41' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' E' ' 79' ' ' THR . 68.1 mttm -95.09 114.99 26.85 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 171.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 37.9 tp -84.05 116.17 22.72 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 43' ' ' TYR . . . . . 1.638 ' HE2' ' CE1' ' E' ' 43' ' ' TYR . 94.2 m-85 -117.05 143.72 45.43 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.501 177.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 44' ' ' LEU . . . . . 0.526 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 0.1 OUTLIER -131.59 131.66 43.45 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 172.653 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 45' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -111.88 118.07 34.51 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.158 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.42 133.62 46.5 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.485 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 56.11 38.85 30.31 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.457 0.473 . . . . 0.0 110.587 -175.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm 65.96 22.48 11.28 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.259 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 49' ' ' GLN . . . . . 0.563 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 29.2 mm-40 -113.36 124.54 52.71 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -87.57 116.84 25.96 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.847 0.356 . . . . 0.0 110.064 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . 0.562 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 72.1 m-85 -111.61 131.02 55.56 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.798 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -81.35 103.45 8.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 171.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . 0.489 HG11 ' CD2' ' D' ' 88' ' ' LEU . 2.3 t -76.89 -47.59 27.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.495 -172.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 54' ' ' ALA . . . . . 0.415 ' HB2' HG12 ' E' ' 63' ' ' VAL . . . -156.71 151.56 25.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.286 -178.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 99.9 m -114.82 101.64 9.25 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 169.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.92 114.07 45.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.626 0.727 . . . . 0.0 109.818 -177.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 75.4 p -123.23 -177.77 3.79 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.545 -174.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 58' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' E' ' 38' ' ' GLN . 28.8 mtpp -57.2 -36.25 70.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.074 0.464 . . . . 0.0 110.276 169.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.3 -41.13 66.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.508 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 76.4 mt -115.78 82.7 10.74 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.12 0.48 6.58 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.865 2.376 . . . . 0.0 113.707 -168.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -162.65 128.1 3.3 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.247 0.546 . . . . 0.0 111.048 -176.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . 0.415 HG12 ' HB2' ' E' ' 54' ' ' ALA . 92.7 t -114.32 111.35 35.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.412 174.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.96 112.13 23.88 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.602 174.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 65' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' E' ' 30' ' ' SER . 0.3 OUTLIER -130.51 168.44 17.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.095 0.474 . . . . 0.0 111.515 -175.541 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 66' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 6.5 t0 -115.22 99.97 7.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.322 0.582 . . . . 0.0 110.343 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 67' ' ' LEU . . . . . 0.567 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 17.7 mt -114.61 141.35 47.89 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.621 177.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 68' ' ' ASN . . . . . 0.442 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 6.3 t30 -146.69 115.2 6.74 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.99 0.424 . . . . 0.0 110.086 174.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -110.11 159.91 16.93 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.029 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 10.2 p -112.47 149.56 32.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.47 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.41 10.4 0.62 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -175.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.67 -21.39 14.51 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.116 176.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -101.23 171.34 7.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.75 0.309 . . . . 0.0 110.865 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 -137.76 129.4 28.3 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 75' ' ' ILE . . . . . . . . . . . . . 14.6 pt -129.21 162.96 35.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.012 0.434 . . . . 0.0 111.726 -169.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 76' ' ' MET . . . . . 0.515 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 4.8 mtm -118.38 122.91 43.98 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 175.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 77' ' ' PHE . . . . . 1.664 ' HE1' ' CE2' ' E' ' 77' ' ' PHE . 1.0 OUTLIER -105.12 127.59 52.97 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.295 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 78' ' ' TYR . . . . . 1.666 ' HD2' ' CD1' ' E' ' 78' ' ' TYR . 49.6 p90 -155.82 150.59 26.23 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.536 -177.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 79' ' ' THR . . . . . 0.721 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 11.3 p -117.2 149.14 40.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.828 0.347 . . . . 0.0 111.684 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.11 144.58 42.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.301 175.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.3 177.0 34.52 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -106.6 102.82 12.17 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.965 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 83' ' ' ALA . . . . . 0.458 ' H ' ' HB3' ' E' ' 15' ' ' PRO . . . -170.77 151.22 3.4 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.595 169.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 23.7 t -108.17 121.48 44.94 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 85' ' ' VAL . . . . . 0.503 HG22 ' HB3' ' E' ' 13' ' ' MET . 11.5 m -118.36 146.2 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 CA-C-O 121.382 0.61 . . . . 0.0 111.69 -173.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 15.3 t -111.94 120.92 43.55 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 87' ' ' LEU . . . . . 0.554 ' HB2' ' HB3' ' E' ' 11' ' ' LEU . 5.1 mp -92.95 151.68 19.78 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.652 174.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . 0.481 ' CD2' HG11 ' A' ' 53' ' ' VAL . 1.6 tp -133.6 141.1 47.51 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.203 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.16 -166.64 26.58 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.891 -176.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 90' ' ' TYR . . . . . 1.608 ' HE2' ' CE1' ' E' ' 90' ' ' TYR . 8.2 p90 -150.91 130.11 12.72 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.694 0.759 . . . . 0.0 111.804 176.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 91' ' ' LEU . . . . . 0.406 ' HA ' ' CB ' ' E' ' 27' ' ' PHE . 5.3 mt . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.903 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.503 ' HA ' ' HB2' ' B' ' 70' ' ' SER . 11.4 ttt . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 121.059 0.457 . . . . 0.0 111.898 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 1.662 ' HE1' ' CE2' ' A' ' 8' ' ' PHE . 62.3 t80 -55.91 143.93 30.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.458 -175.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.428 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 89.8 t90 -137.47 150.18 47.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.052 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.591 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -150.84 159.78 28.31 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.086 177.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 36.8 tp -148.4 108.21 4.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.835 0.35 . . . . 0.0 111.066 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -92.37 103.75 16.16 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.017 0.437 . . . . 0.0 110.076 174.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.653 ' SD ' HD12 ' A' ' 87' ' ' LEU . 53.4 mtp -94.99 144.94 25.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.132 -175.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -100.45 149.36 36.03 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.853 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 11.6 Cg_endo -55.69 121.9 10.77 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 123.265 2.643 . . . . 0.0 113.294 -176.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 79' ' ' THR . 49.9 mt-10 60.84 57.28 2.67 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.532 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.425 ' HB3' ' HH ' ' A' ' 19' ' ' TYR . 12.1 tpt180 -132.54 142.74 49.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.166 175.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.625 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 35.6 ttmt -118.45 116.33 26.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.869 0.366 . . . . 0.0 111.648 -174.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 1.659 ' HE2' ' CE1' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -112.25 110.3 20.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.992 178.298 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.7 p -77.35 122.17 24.76 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 173.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -99.63 128.51 45.74 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.884 -167.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.5 p -98.77 125.19 44.05 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 169.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.3 mt -96.41 118.72 43.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.326 0.584 . . . . 0.0 111.749 -172.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.415 HD13 ' N ' ' A' ' 24' ' ' ILE . 4.1 mp -93.94 -44.93 13.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.662 178.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -118.68 140.36 50.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.543 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.8 t -62.64 114.37 3.54 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 173.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 1.669 ' HE2' ' CE1' ' A' ' 27' ' ' PHE . 6.1 p90 -130.02 148.63 51.89 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.531 -0.868 . . . . 0.0 112.937 -170.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.565 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 17.6 t60 -106.08 125.68 51.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.242 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 46.9 mt -97.69 132.61 42.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 170.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.565 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 42.6 p -116.25 -14.71 11.07 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -170.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -164.56 152.49 22.21 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 119.232 -1.461 . . . . 0.0 113.411 178.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.01 122.82 23.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 172.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.61 156.14 46.35 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 122.148 -0.345 . . . . 0.0 111.394 -174.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.7 pp -115.15 141.28 48.23 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.838 0.827 . . . . 0.0 112.071 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -106.45 -57.3 2.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.055 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -102.6 127.46 49.68 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 169.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.468 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 153.4 160.61 9.82 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 119.338 -1.41 . . . . 0.0 113.749 176.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.59 ' O ' ' HG3' ' A' ' 58' ' ' LYS . 19.1 tt0 -102.22 -46.97 4.67 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.608 -0.296 . . . . 0.0 110.409 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.434 ' OE2' ' HG2' ' A' ' 38' ' ' GLN . 6.9 mp0 -152.25 129.52 11.25 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.383 176.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.476 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . . . -125.96 119.53 27.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.352 0.596 . . . . 0.0 110.237 171.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -104.47 108.95 20.62 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.5 tp -84.9 115.0 22.53 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.248 -173.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.51 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 91.9 m-85 -116.33 145.52 43.13 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' A' ' 76' ' ' MET . 0.2 OUTLIER -131.67 128.53 39.23 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 171.33 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.523 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -106.62 122.77 47.01 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.667 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.16 125.23 34.51 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 61.42 36.46 17.29 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -171.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.494 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 14.9 tmtt? 73.59 -7.5 1.56 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.383 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.523 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 24.1 tp60 -80.36 114.54 19.33 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 -177.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -81.32 110.14 16.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.937 0.399 . . . . 0.0 110.387 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 1.637 ' HD1' ' CD2' ' A' ' 51' ' ' TYR . 82.2 m-85 -99.34 129.95 45.59 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.259 177.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.27 99.46 4.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 171.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.449 HG11 ' CD2' ' E' ' 88' ' ' LEU . 2.4 t -74.67 -50.01 27.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.439 -171.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.423 ' HB3' ' CD2' ' A' ' 65' ' ' LEU . . . -158.27 138.94 12.85 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.404 -177.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.4 m -103.05 102.05 12.06 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 171.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.413 HG11 ' HB1' ' A' ' 40' ' ' ALA . 7.2 p -113.54 110.24 31.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.884 0.85 . . . . 0.0 109.814 -177.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 81.3 p -122.98 -176.97 3.54 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.137 -174.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.59 ' HG3' ' O ' ' A' ' 38' ' ' GLN . 9.7 mtmp? -56.72 -35.08 68.13 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.086 0.47 . . . . 0.0 110.288 169.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.3 -40.57 64.42 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.603 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 77.9 mt -117.11 80.49 11.78 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.16 -0.0 6.6 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.079 2.519 . . . . 0.0 113.264 -169.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -164.14 118.76 1.49 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.237 0.541 . . . . 0.0 110.948 -174.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.404 HG12 ' HB2' ' A' ' 54' ' ' ALA . 58.7 t -108.85 108.59 25.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.371 175.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.5 117.37 27.4 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.795 174.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.423 ' CD2' ' HB3' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -136.39 168.47 19.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.457 -176.013 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.48 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 8.9 t0 -113.96 99.47 7.69 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.204 0.526 . . . . 0.0 110.292 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.541 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 19.5 mt -112.66 142.01 45.76 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.486 177.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -150.63 115.75 5.35 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 174.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 1.65 ' HD1' ' CD2' ' A' ' 69' ' ' PHE . 32.9 m-85 -110.28 158.73 18.08 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.943 -177.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.49 ' HB2' ' HA ' ' E' ' 7' ' ' MET . 8.6 t -110.57 158.71 18.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.226 0.536 . . . . 0.0 110.646 -176.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -70.57 -4.69 24.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.637 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.43 -26.86 14.33 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.487 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -100.69 168.24 9.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.003 0.43 . . . . 0.0 110.955 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.7 mtm180 -136.84 143.7 43.22 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.2 pt -140.0 176.07 5.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.123 -172.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.544 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 9.2 mtm -134.03 131.8 39.3 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 171.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.441 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 1.2 m-85 -108.33 128.22 54.56 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.625 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 38.9 p90 -152.84 136.27 15.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.303 0.573 . . . . 0.0 111.714 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 2.1 p -111.13 133.16 53.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.22 -177.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.28 168.29 9.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.748 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.94 -170.33 43.42 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 -177.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -114.9 102.65 10.18 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 117.708 0.754 . . . . 0.0 109.702 174.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.514 ' H ' ' HB3' ' A' ' 15' ' ' PRO . . . -173.82 152.4 1.99 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.502 170.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.0 t -111.64 122.06 46.8 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.3 m -113.51 156.95 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 CA-C-O 121.546 0.688 . . . . 0.0 112.566 -172.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.9 t -123.63 113.84 19.2 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.595 177.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.653 HD12 ' SD ' ' A' ' 13' ' ' MET . 5.0 mp -90.15 153.57 20.42 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.106 0.479 . . . . 0.0 109.846 174.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.457 ' CD2' HG11 ' B' ' 53' ' ' VAL . 1.0 OUTLIER -133.49 139.34 46.6 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.093 -179.467 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.83 -166.85 24.45 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.886 -177.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -152.79 131.27 12.18 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.735 0.778 . . . . 0.0 111.856 176.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.7 mt . . . . . 0 C--N 1.322 -0.619 0 CA-C-N 114.056 -1.429 . . . . 0.0 109.306 175.094 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' MET . . . . . 0.49 ' HA ' ' HB2' ' C' ' 70' ' ' SER . 11.5 ttt . . . . . 0 N--CA 1.456 -0.167 0 CA-C-O 121.076 0.465 . . . . 0.0 111.774 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . 1.643 ' HE1' ' CE2' ' B' ' 8' ' ' PHE . 62.2 t80 -55.9 143.94 29.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.477 -175.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . 0.424 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 89.8 t90 -137.48 150.16 47.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.95 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.612 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -150.87 159.75 28.3 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.092 177.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.441 ' HB3' ' HB2' ' B' ' 87' ' ' LEU . 37.0 tp -148.32 108.24 4.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.864 0.364 . . . . 0.0 111.077 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -92.46 103.81 16.2 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.963 0.411 . . . . 0.0 110.011 174.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' MET . . . . . 0.648 ' SD ' HD12 ' B' ' 87' ' ' LEU . 53.7 mtp -95.11 144.95 25.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.06 -175.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -100.35 149.45 36.08 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.834 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.513 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 11.4 Cg_endo -55.85 121.81 10.63 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.283 2.655 . . . . 0.0 113.255 -176.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' B' ' 79' ' ' THR . 49.7 mt-10 60.9 57.38 2.61 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.49 178.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.415 ' HB3' ' HH ' ' B' ' 19' ' ' TYR . 12.2 tpt180 -132.6 142.63 49.22 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.207 175.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . 0.615 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 35.6 ttmt -118.38 116.25 26.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.804 0.335 . . . . 0.0 111.722 -174.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' TYR . . . . . 1.656 ' HE2' ' CE1' ' B' ' 19' ' ' TYR . 0.9 OUTLIER -112.2 110.35 20.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.023 178.309 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 4.7 p -77.27 122.29 24.88 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 173.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -99.74 128.6 45.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.815 -167.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 28.5 p -98.73 125.12 43.97 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 169.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 43.5 mt -96.46 118.65 43.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.256 0.551 . . . . 0.0 111.744 -172.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.409 HD13 ' N ' ' B' ' 24' ' ' ILE . 4.1 mp -93.84 -45.0 13.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.652 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -118.61 140.54 49.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.479 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 11.3 t -62.67 114.38 3.56 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 173.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . 1.631 ' HE2' ' CE1' ' B' ' 27' ' ' PHE . 6.0 p90 -130.02 148.73 51.91 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.502 -0.879 . . . . 0.0 112.923 -170.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' HIS . . . . . 0.562 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 17.9 t60 -106.15 125.65 51.25 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.194 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 47.5 mt -97.69 132.6 42.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 170.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.562 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 43.1 p -116.25 -14.75 11.07 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -170.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -164.55 152.45 22.15 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 119.322 -1.418 . . . . 0.0 113.464 178.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 8.7 p -137.91 122.78 23.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 172.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.63 156.15 46.34 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.335 -174.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 3.7 pp -115.18 141.37 48.11 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.853 0.835 . . . . 0.0 112.053 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -106.54 -57.32 2.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.044 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -102.64 127.42 49.76 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 169.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.474 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 153.52 160.67 9.87 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 119.311 -1.423 . . . . 0.0 113.729 176.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . 0.586 ' O ' ' HG3' ' B' ' 58' ' ' LYS . 19.0 tt0 -102.22 -47.0 4.66 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 120.784 0.326 . . . . 0.0 110.426 177.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.439 ' OE2' ' HG2' ' B' ' 38' ' ' GLN . 6.9 mp0 -152.27 129.52 11.24 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.352 177.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.481 ' HB3' ' HB1' ' B' ' 83' ' ' ALA . . . -126.02 119.48 27.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.355 0.598 . . . . 0.0 110.305 171.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -104.5 108.92 20.59 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 43.7 tp -84.82 115.02 22.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.33 -173.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . 0.512 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 91.6 m-85 -116.31 145.48 43.15 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 175.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.2 OUTLIER -131.63 128.46 39.16 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 171.337 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -106.64 122.95 47.36 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.6 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.19 125.26 34.52 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 175.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 61.37 36.44 17.47 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 123.532 0.52 . . . . 0.0 109.698 -171.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' B' ' 48' ' ' LYS . 14.9 tmtt? 73.6 -7.54 1.55 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.407 178.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . 0.527 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 24.3 tp60 -80.46 114.61 19.48 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -177.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -81.42 110.2 16.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.993 0.425 . . . . 0.0 110.307 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 1.633 ' HD1' ' CD2' ' B' ' 51' ' ' TYR . 82.2 m-85 -99.37 129.93 45.61 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.293 177.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.28 99.44 4.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 171.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.457 HG11 ' CD2' ' A' ' 88' ' ' LEU . 2.4 t -74.63 -50.06 27.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.412 -171.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.426 ' HB3' ' CD2' ' B' ' 65' ' ' LEU . . . -158.25 138.92 12.84 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.429 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 23.2 m -103.06 102.04 12.04 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 171.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . 0.428 HG11 ' HB1' ' B' ' 40' ' ' ALA . 7.3 p -113.46 110.19 31.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.796 0.808 . . . . 0.0 109.928 -177.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 81.5 p -122.96 -176.89 3.52 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.128 -174.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . 0.586 ' HG3' ' O ' ' B' ' 38' ' ' GLN . 9.7 mtmp? -56.77 -34.99 68.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.086 0.47 . . . . 0.0 110.372 169.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.5 -40.48 64.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.505 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 77.6 mt -117.16 80.57 12.04 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 173.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.15 -0.06 6.67 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.985 2.457 . . . . 0.0 113.251 -169.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -164.14 118.67 1.48 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.228 0.537 . . . . 0.0 111.111 -174.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.406 HG12 ' HB2' ' B' ' 54' ' ' ALA . 58.6 t -108.78 108.58 25.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.366 175.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.43 117.45 27.37 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.851 174.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.426 ' CD2' ' HB3' ' B' ' 54' ' ' ALA . 0.3 OUTLIER -136.53 168.43 19.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.459 -176.013 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . 0.518 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 8.9 t0 -113.88 99.46 7.69 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.175 0.512 . . . . 0.0 110.328 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.561 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 19.5 mt -112.77 142.06 45.85 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.409 177.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -150.6 115.87 5.39 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 174.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . 1.655 ' HD2' ' CD1' ' B' ' 69' ' ' PHE . 32.6 m-85 -110.32 158.78 18.06 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.906 -177.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' SER . . . . . 0.503 ' HB2' ' HA ' ' A' ' 7' ' ' MET . 8.6 t -110.63 158.65 18.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.239 0.543 . . . . 0.0 110.627 -176.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -70.53 -4.76 24.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.67 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.35 -26.97 14.13 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.404 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -100.61 168.31 9.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.12 0.486 . . . . 0.0 110.92 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 73.7 mtm180 -136.94 143.55 42.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.1 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 13.1 pt -139.85 175.98 6.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.59 0.233 . . . . 0.0 111.141 -172.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' MET . . . . . 0.54 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 9.2 mtm -133.97 131.81 39.43 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 171.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . 0.452 ' CD1' ' HB2' ' B' ' 44' ' ' LEU . 1.2 m-85 -108.35 128.2 54.55 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 0.615 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 38.8 p90 -152.84 136.27 15.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.341 0.591 . . . . 0.0 111.765 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 2.1 p -111.12 133.13 53.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.185 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.24 168.27 9.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.795 177.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.98 -170.31 43.32 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -115.04 102.72 10.2 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.659 174.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.513 ' H ' ' HB3' ' B' ' 15' ' ' PRO . . . -173.88 152.28 1.94 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.511 170.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 32.0 t -111.47 122.1 46.94 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 4.3 m -113.59 156.85 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-O 121.471 0.653 . . . . 0.0 112.567 -172.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 14.8 t -123.54 113.87 19.29 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.667 177.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.648 HD12 ' SD ' ' B' ' 13' ' ' MET . 5.0 mp -90.15 153.55 20.44 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 121.078 0.466 . . . . 0.0 109.887 174.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.45 ' CD2' HG11 ' C' ' 53' ' ' VAL . 1.0 OUTLIER -133.47 139.38 46.64 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.023 -179.43 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.87 -166.85 24.51 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.913 -177.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -152.73 131.31 12.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.751 0.786 . . . . 0.0 111.763 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 5.7 mt . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 114.078 -1.419 . . . . 0.0 109.301 174.995 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 7' ' ' MET . . . . . 0.477 ' HA ' ' HB2' ' D' ' 70' ' ' SER . 11.5 ttt . . . . . 0 N--CA 1.454 -0.248 0 CA-C-O 121.057 0.456 . . . . 0.0 111.854 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 8' ' ' PHE . . . . . 1.651 ' HD1' ' CD2' ' C' ' 8' ' ' PHE . 62.4 t80 -55.93 143.86 30.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.53 -175.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . 0.416 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 90.1 t90 -137.46 150.18 47.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.976 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . 0.574 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -150.88 159.63 28.24 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.098 177.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.451 ' HB3' ' HB2' ' C' ' 87' ' ' LEU . 37.3 tp -148.26 108.21 4.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.827 0.346 . . . . 0.0 111.178 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -92.4 103.78 16.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.076 0.465 . . . . 0.0 110.005 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 13' ' ' MET . . . . . 0.644 ' SD ' HD12 ' C' ' 87' ' ' LEU . 53.2 mtp -95.0 144.99 25.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.118 -175.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -100.43 149.42 36.08 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.86 177.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . 0.514 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 11.6 Cg_endo -55.83 121.85 10.71 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.254 2.636 . . . . 0.0 113.253 -176.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' C' ' 79' ' ' THR . 49.9 mt-10 60.9 57.28 2.64 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.564 178.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 17' ' ' ARG . . . . . 0.431 ' HB3' ' HH ' ' C' ' 19' ' ' TYR . 12.1 tpt180 -132.55 142.6 49.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.253 175.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 18' ' ' LYS . . . . . 0.62 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 35.5 ttmt -118.37 116.41 26.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.859 0.362 . . . . 0.0 111.721 -174.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . 1.66 ' HD1' ' CD2' ' C' ' 19' ' ' TYR . 0.9 OUTLIER -112.27 110.36 20.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.029 178.313 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -77.3 122.15 24.7 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 173.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -99.58 128.54 45.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.85 -167.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 28.0 p -98.7 125.01 43.89 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 169.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mt -96.43 118.72 43.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.2 0.524 . . . . 0.0 111.738 -172.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . 0.41 HD13 ' N ' ' C' ' 24' ' ' ILE . 4.1 mp -93.9 -44.97 13.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.649 178.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -118.64 140.39 49.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.539 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 11.6 t -62.58 114.3 3.48 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 173.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 27' ' ' PHE . . . . . 1.607 ' HD2' ' CD1' ' C' ' 27' ' ' PHE . 6.1 p90 -130.05 148.62 51.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.888 0.851 . . . . 0.0 112.947 -170.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 28' ' ' HIS . . . . . 0.565 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 17.7 t60 -106.08 125.6 51.19 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.158 -1.383 . . . . 0.0 110.201 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . 0.547 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 46.8 mt -97.7 132.63 42.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 170.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 30' ' ' SER . . . . . 0.565 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 42.4 p -116.31 -14.65 11.04 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -170.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 31' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -164.63 152.47 22.17 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 119.304 -1.427 . . . . 0.0 113.438 178.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 8.7 p -138.0 122.76 23.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 172.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.63 156.18 46.33 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.091 -0.38 . . . . 0.0 111.328 -174.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 3.7 pp -115.12 141.35 48.13 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.786 0.803 . . . . 0.0 112.129 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -106.58 -57.31 2.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.98 176.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -102.68 127.41 49.81 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 169.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 37' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 153.56 160.69 9.89 Favored Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 119.357 -1.402 . . . . 0.0 113.724 176.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 38' ' ' GLN . . . . . 0.6 ' O ' ' HG3' ' C' ' 58' ' ' LYS . 19.0 tt0 -102.22 -47.03 4.65 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 120.701 0.286 . . . . 0.0 110.467 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . 0.439 ' OE2' ' HG2' ' C' ' 38' ' ' GLN . 6.8 mp0 -152.26 129.52 11.25 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.412 176.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . 0.47 ' HB3' ' HB1' ' C' ' 83' ' ' ALA . . . -125.95 119.56 28.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.35 0.595 . . . . 0.0 110.296 171.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -104.54 108.88 20.55 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 43.5 tp -84.84 115.04 22.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.261 -173.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 43' ' ' TYR . . . . . 0.497 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 91.5 m-85 -116.33 145.5 43.15 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 175.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' C' ' 76' ' ' MET . 0.2 OUTLIER -131.69 128.48 39.07 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 171.434 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -106.55 122.9 47.25 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.633 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.3 125.16 34.05 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 61.46 36.42 17.19 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -171.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . 0.498 ' HD3' ' O ' ' C' ' 48' ' ' LYS . 14.9 tmtt? 73.72 -7.67 1.54 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.351 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . 0.53 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 24.8 tp60 -80.36 114.59 19.37 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.887 -0.508 . . . . 0.0 109.69 -177.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -81.28 110.1 16.42 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.343 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 1.643 ' HD1' ' CD2' ' C' ' 51' ' ' TYR . 82.2 m-85 -99.36 129.89 45.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.278 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.22 99.44 3.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 171.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 53' ' ' VAL . . . . . 0.45 HG11 ' CD2' ' B' ' 88' ' ' LEU . 2.4 t -74.64 -50.12 27.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.39 -171.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 54' ' ' ALA . . . . . 0.428 ' HB3' ' CD2' ' C' ' 65' ' ' LEU . . . -158.16 138.95 12.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.454 -177.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 23.5 m -103.05 102.09 12.09 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 171.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . 0.421 HG11 ' HB1' ' C' ' 40' ' ' ALA . 7.2 p -113.59 110.15 31.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.846 0.831 . . . . 0.0 109.889 -177.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 81.7 p -123.02 -177.01 3.55 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.124 -174.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 58' ' ' LYS . . . . . 0.6 ' HG3' ' O ' ' C' ' 38' ' ' GLN . 9.7 mtmp? -56.58 -35.11 67.82 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.058 0.456 . . . . 0.0 110.38 169.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.37 -40.55 64.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.514 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 77.9 mt -117.21 80.58 12.22 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 174.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.21 -0.07 6.74 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.053 2.502 . . . . 0.0 113.187 -169.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -164.12 118.68 1.49 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.139 0.495 . . . . 0.0 111.076 -174.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.408 HG12 ' HB2' ' C' ' 54' ' ' ALA . 58.9 t -108.79 108.65 25.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.281 175.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.53 117.41 27.46 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.772 174.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . 0.428 ' CD2' ' HB3' ' C' ' 54' ' ' ALA . 0.3 OUTLIER -136.39 168.49 19.35 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.497 -176.073 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 66' ' ' ASP . . . . . 0.48 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 8.9 t0 -114.02 99.58 7.76 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.306 0.574 . . . . 0.0 110.203 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . 0.547 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 19.6 mt -112.74 141.96 45.92 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.468 177.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -150.58 115.78 5.37 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 174.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 69' ' ' PHE . . . . . 1.669 ' HE2' ' CE1' ' C' ' 69' ' ' PHE . 32.7 m-85 -110.26 158.76 18.04 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.937 -177.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 70' ' ' SER . . . . . 0.49 ' HB2' ' HA ' ' B' ' 7' ' ' MET . 8.7 t -110.65 158.7 18.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.23 0.538 . . . . 0.0 110.654 -176.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -70.6 -4.67 24.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.596 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.51 -26.81 14.37 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.483 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -100.81 168.24 9.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.019 0.437 . . . . 0.0 110.846 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 73.7 mtm180 -136.86 143.59 43.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.136 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 13.2 pt -139.83 176.11 6.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.614 0.245 . . . . 0.0 111.128 -172.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 76' ' ' MET . . . . . 0.544 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 9.2 mtm -134.1 131.81 39.19 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 171.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 77' ' ' PHE . . . . . 0.441 ' CD1' ' HB2' ' C' ' 44' ' ' LEU . 1.2 m-85 -108.34 128.24 54.58 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 78' ' ' TYR . . . . . 0.62 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 38.9 p90 -152.8 136.32 15.97 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.37 0.605 . . . . 0.0 111.777 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 79' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 2.1 p -111.1 133.11 53.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.217 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.31 168.33 9.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.763 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.77 -170.26 43.68 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -114.97 102.7 10.21 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.651 174.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . 0.514 ' H ' ' HB3' ' C' ' 15' ' ' PRO . . . -173.83 152.34 1.97 Allowed 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.942 -1.027 . . . . 0.0 109.473 170.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 32.1 t -111.47 122.16 47.09 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 4.3 m -113.71 156.91 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-O 121.564 0.697 . . . . 0.0 112.537 -172.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 15.1 t -123.62 113.84 19.2 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.637 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . 0.644 HD12 ' SD ' ' C' ' 13' ' ' MET . 5.0 mp -90.08 153.55 20.46 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.07 0.462 . . . . 0.0 109.913 174.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . 0.445 ' CD2' HG11 ' D' ' 53' ' ' VAL . 1.0 OUTLIER -133.5 139.34 46.59 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.051 -179.422 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.86 -166.81 24.43 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.875 -177.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -152.79 131.27 12.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.809 0.814 . . . . 0.0 111.812 176.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 5.8 mt . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 114.007 -1.452 . . . . 0.0 109.253 175.097 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 7' ' ' MET . . . . . 0.474 ' HA ' ' HB2' ' E' ' 70' ' ' SER . 11.5 ttt . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 121.038 0.446 . . . . 0.0 111.783 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 8' ' ' PHE . . . . . 1.672 ' HE2' ' CE1' ' D' ' 8' ' ' PHE . 62.4 t80 -55.97 143.86 30.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.51 -175.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 9' ' ' TRP . . . . . 0.421 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 90.0 t90 -137.43 150.06 47.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.022 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . 0.578 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -150.83 159.71 28.28 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.098 177.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . 0.448 ' HB3' ' HB2' ' D' ' 87' ' ' LEU . 36.7 tp -148.35 108.18 4.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.834 0.349 . . . . 0.0 111.03 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -92.28 103.82 16.24 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.988 0.423 . . . . 0.0 109.975 174.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 13' ' ' MET . . . . . 0.649 ' SD ' HD12 ' D' ' 87' ' ' LEU . 53.8 mtp -95.12 145.01 25.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.12 -175.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -100.47 149.42 36.08 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.86 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . 0.506 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 11.5 Cg_endo -55.76 121.72 10.46 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 123.314 2.676 . . . . 0.0 113.319 -176.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' D' ' 79' ' ' THR . 49.8 mt-10 60.89 57.45 2.6 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.465 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 17' ' ' ARG . . . . . 0.431 ' HB3' ' HH ' ' D' ' 19' ' ' TYR . 12.1 tpt180 -132.64 142.66 49.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.202 175.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . 0.629 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 35.5 ttmt -118.41 116.26 26.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.86 0.362 . . . . 0.0 111.756 -175.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 19' ' ' TYR . . . . . 1.668 ' HE1' ' CE2' ' D' ' 19' ' ' TYR . 0.9 OUTLIER -112.09 110.25 20.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.095 178.272 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 4.7 p -77.17 122.22 24.72 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 173.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -99.67 128.45 45.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.886 -167.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 28.4 p -98.72 125.15 43.96 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 169.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 44.0 mt -96.41 118.58 43.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.205 0.526 . . . . 0.0 111.731 -172.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . 0.418 ' N ' HD13 ' D' ' 24' ' ' ILE . 4.1 mp -93.83 -44.98 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.673 178.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -118.65 140.44 49.91 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.491 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 11.6 t -62.65 114.37 3.54 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 173.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 27' ' ' PHE . . . . . 1.619 ' HE2' ' CE1' ' D' ' 27' ' ' PHE . 6.1 p90 -129.97 148.64 51.85 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.607 -0.837 . . . . 0.0 112.99 -170.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 28' ' ' HIS . . . . . 0.565 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 18.0 t60 -106.1 125.7 51.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.184 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 29' ' ' ILE . . . . . 0.544 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 46.8 mt -97.7 132.48 42.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 170.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 30' ' ' SER . . . . . 0.565 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 42.5 p -116.23 -14.65 11.09 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -170.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 31' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -164.58 152.48 22.2 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 119.278 -1.439 . . . . 0.0 113.453 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 8.6 p -137.97 122.86 23.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 172.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.63 156.07 46.36 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 122.153 -0.342 . . . . 0.0 111.414 -174.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 34' ' ' LEU . . . . . . . . . . . . . 3.7 pp -115.1 141.34 48.15 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.818 0.818 . . . . 0.0 112.126 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -106.51 -57.27 2.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.024 176.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -102.64 127.35 49.78 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 169.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . 0.471 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 153.5 160.61 9.83 Favored Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 119.278 -1.439 . . . . 0.0 113.711 176.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 38' ' ' GLN . . . . . 0.598 ' O ' ' HG3' ' D' ' 58' ' ' LYS . 19.1 tt0 -102.21 -46.98 4.66 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.579 -0.311 . . . . 0.0 110.391 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . 0.44 ' OE2' ' HG2' ' D' ' 38' ' ' GLN . 6.9 mp0 -152.27 129.45 11.18 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.417 176.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . 0.467 ' HB3' ' HB1' ' D' ' 83' ' ' ALA . . . -125.97 119.63 28.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.4 0.619 . . . . 0.0 110.218 171.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -104.51 109.01 20.73 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 43.8 tp -84.99 114.97 22.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.218 -173.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 43' ' ' TYR . . . . . 0.512 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 91.6 m-85 -116.26 145.51 43.1 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 175.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.546 ' HA ' ' O ' ' D' ' 76' ' ' MET . 0.2 OUTLIER -131.66 128.47 39.11 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 171.367 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 45' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -106.57 122.93 47.3 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.654 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.3 125.14 34.01 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 61.47 36.4 17.17 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -171.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 48' ' ' LYS . . . . . 0.503 ' HD3' ' O ' ' D' ' 48' ' ' LYS . 14.9 tmtt? 73.69 -7.54 1.56 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.307 178.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . 0.525 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 24.5 tp60 -80.37 114.56 19.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -177.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -81.32 110.11 16.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.424 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . 1.645 ' HD1' ' CD2' ' D' ' 51' ' ' TYR . 82.1 m-85 -99.32 129.95 45.57 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.225 177.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.24 99.42 3.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 171.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 53' ' ' VAL . . . . . 0.445 HG11 ' CD2' ' C' ' 88' ' ' LEU . 2.4 t -74.69 -50.08 27.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.376 -171.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 54' ' ' ALA . . . . . 0.422 ' HB3' ' CD2' ' D' ' 65' ' ' LEU . . . -158.21 139.02 12.97 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.453 -177.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 22.9 m -103.11 102.1 12.09 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 171.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 56' ' ' VAL . . . . . 0.426 HG11 ' HB1' ' D' ' 40' ' ' ALA . 7.2 p -113.55 110.21 31.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.889 0.852 . . . . 0.0 109.932 -177.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 81.6 p -122.97 -176.95 3.54 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.123 -174.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 58' ' ' LYS . . . . . 0.598 ' HG3' ' O ' ' D' ' 38' ' ' GLN . 9.7 mtmp? -56.64 -35.18 68.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.146 0.498 . . . . 0.0 110.329 169.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.24 -40.72 64.43 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.549 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 77.6 mt -116.93 80.55 11.29 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 173.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.28 0.06 6.6 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.018 2.479 . . . . 0.0 113.238 -169.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -164.19 118.7 1.47 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.267 0.556 . . . . 0.0 111.003 -174.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.414 HG12 ' HB2' ' D' ' 54' ' ' ALA . 58.6 t -108.83 108.58 25.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.299 175.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.55 117.39 27.47 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.83 174.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 65' ' ' LEU . . . . . 0.422 ' CD2' ' HB3' ' D' ' 54' ' ' ALA . 0.3 OUTLIER -136.35 168.51 19.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.465 -175.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 66' ' ' ASP . . . . . 0.494 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 8.8 t0 -114.0 99.61 7.79 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.206 0.527 . . . . 0.0 110.257 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . 0.544 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 19.5 mt -112.78 142.0 45.93 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.468 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -150.58 115.78 5.37 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 174.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 69' ' ' PHE . . . . . 1.67 ' HE1' ' CE2' ' D' ' 69' ' ' PHE . 32.7 m-85 -110.29 158.8 18.02 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.917 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 70' ' ' SER . . . . . 0.477 ' HB2' ' HA ' ' C' ' 7' ' ' MET . 8.6 t -110.68 158.68 18.35 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.212 0.529 . . . . 0.0 110.619 -176.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -70.5 -4.78 24.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.611 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.38 -26.96 14.14 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.49 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -100.66 168.24 9.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.033 0.444 . . . . 0.0 110.923 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -136.8 143.7 43.31 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . . . . . . . . . 13.3 pt -139.96 176.0 6.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.113 -172.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 76' ' ' MET . . . . . 0.546 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 9.2 mtm -134.03 131.82 39.32 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 171.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 77' ' ' PHE . . . . . 0.442 ' CD1' ' HB2' ' D' ' 44' ' ' LEU . 1.2 m-85 -108.28 128.28 54.6 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 78' ' ' TYR . . . . . 0.629 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 39.0 p90 -152.86 136.32 15.91 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.36 0.6 . . . . 0.0 111.734 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 79' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 2.1 p -111.2 133.13 53.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.187 -177.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.25 168.28 9.45 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.777 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.94 -170.24 43.32 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -115.09 102.72 10.19 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 117.723 0.761 . . . . 0.0 109.61 174.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.506 ' H ' ' HB3' ' D' ' 15' ' ' PRO . . . -173.86 152.4 1.97 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.487 170.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 32.0 t -111.55 122.09 46.91 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 4.3 m -113.62 156.85 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.635 0 CA-C-O 121.476 0.655 . . . . 0.0 112.58 -172.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 14.9 t -123.53 113.82 19.23 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.656 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 87' ' ' LEU . . . . . 0.649 HD12 ' SD ' ' D' ' 13' ' ' MET . 5.0 mp -90.09 153.5 20.5 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 121.139 0.495 . . . . 0.0 109.852 174.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . 0.46 ' CD2' HG11 ' E' ' 53' ' ' VAL . 1.0 OUTLIER -133.4 139.44 46.76 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.067 -179.526 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.87 -166.85 24.5 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.838 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -152.8 131.24 12.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.786 0.803 . . . . 0.0 111.843 176.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 5.7 mt . . . . . 0 C--N 1.323 -0.571 0 CA-C-N 113.984 -1.462 . . . . 0.0 109.299 175.078 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' E' E ' 7' ' ' MET . . . . . 0.49 ' HA ' ' HB2' ' A' ' 70' ' ' SER . 11.5 ttt . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 121.086 0.47 . . . . 0.0 111.825 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 8' ' ' PHE . . . . . 1.66 ' HD1' ' CD2' ' E' ' 8' ' ' PHE . 62.4 t80 -55.95 143.83 30.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.515 -175.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 9' ' ' TRP . . . . . 0.412 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 89.9 t90 -137.4 150.13 47.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.044 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 10' ' ' GLY . . . . . 0.577 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -150.87 159.68 28.27 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.082 177.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 11' ' ' LEU . . . . . 0.458 ' HB3' ' HB2' ' E' ' 87' ' ' LEU . 37.3 tp -148.29 108.2 4.04 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.808 0.337 . . . . 0.0 111.151 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -92.38 103.78 16.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.081 0.467 . . . . 0.0 110.007 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 13' ' ' MET . . . . . 0.656 ' SD ' HD12 ' E' ' 87' ' ' LEU . 53.1 mtp -95.06 144.99 25.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.099 -175.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -100.48 149.38 36.05 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.787 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . 0.507 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 11.5 Cg_endo -55.75 121.77 10.56 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.29 2.66 . . . . 0.0 113.292 -176.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 16' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' E' ' 79' ' ' THR . 49.8 mt-10 60.95 57.23 2.63 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.505 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 17' ' ' ARG . . . . . 0.428 ' HB3' ' HH ' ' E' ' 19' ' ' TYR . 12.1 tpt180 -132.43 142.67 49.36 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.29 174.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . 0.628 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 35.6 ttmt -118.42 116.3 26.43 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.881 0.372 . . . . 0.0 111.71 -175.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . 1.645 ' HD2' ' CD1' ' E' ' 19' ' ' TYR . 0.9 OUTLIER -112.21 110.33 20.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.013 178.327 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 4.8 p -77.3 122.04 24.56 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 173.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -99.57 128.59 45.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.872 -167.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 27.6 p -98.69 125.06 43.89 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 169.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 44.1 mt -96.43 118.67 43.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.303 0.573 . . . . 0.0 111.691 -172.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . 0.421 ' N ' HD13 ' E' ' 24' ' ' ILE . 4.1 mp -93.94 -44.93 13.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.581 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -118.72 140.32 50.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.471 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 11.3 t -62.53 114.39 3.52 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 173.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 27' ' ' PHE . . . . . 1.661 ' HE2' ' CE1' ' E' ' 27' ' ' PHE . 6.1 p90 -130.04 148.7 51.92 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 119.528 -0.869 . . . . 0.0 112.927 -170.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 28' ' ' HIS . . . . . 0.565 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 17.8 t60 -106.08 125.66 51.26 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.115 -1.402 . . . . 0.0 110.283 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 29' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 47.1 mt -97.7 132.55 42.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 30' ' ' SER . . . . . 0.565 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 44.1 p -116.28 -14.67 11.05 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -170.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 31' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -164.6 152.5 22.21 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 119.206 -1.473 . . . . 0.0 113.431 178.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 8.7 p -138.02 122.78 23.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 172.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.6 156.17 46.35 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.345 -174.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 34' ' ' LEU . . . . . . . . . . . . . 3.7 pp -115.21 141.39 48.08 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.836 0.827 . . . . 0.0 112.093 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -106.57 -57.31 2.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.003 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -102.64 127.4 49.76 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 169.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . 0.47 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 153.55 160.7 9.89 Favored Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 119.485 -1.341 . . . . 0.0 113.762 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 38' ' ' GLN . . . . . 0.584 ' O ' ' HG3' ' E' ' 58' ' ' LYS . 19.2 tt0 -102.29 -46.89 4.67 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.574 -0.313 . . . . 0.0 110.363 177.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 39' ' ' GLU . . . . . 0.44 ' OE2' ' HG2' ' E' ' 38' ' ' GLN . 6.9 mp0 -152.38 129.42 11.08 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.4 176.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . 0.467 ' HB3' ' HB1' ' E' ' 83' ' ' ALA . . . -125.92 119.56 28.1 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.398 0.618 . . . . 0.0 110.25 171.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 41' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -104.54 108.97 20.67 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 43.6 tp -84.89 115.05 22.56 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.291 -173.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 43' ' ' TYR . . . . . 0.511 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 91.4 m-85 -116.31 145.53 43.11 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 175.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 44' ' ' LEU . . . . . 0.536 ' HA ' ' O ' ' E' ' 76' ' ' MET . 0.2 OUTLIER -131.67 128.39 38.94 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 171.408 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 45' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -106.58 122.88 47.21 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.651 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.28 125.28 34.41 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 175.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 61.45 36.36 17.24 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.488 0.492 . . . . 0.0 109.719 -171.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 48' ' ' LYS . . . . . 0.502 ' HD3' ' O ' ' E' ' 48' ' ' LYS . 14.9 tmtt? 73.66 -7.52 1.56 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.413 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 49' ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 24.3 tp60 -80.39 114.58 19.39 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -177.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -81.39 110.21 16.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.999 0.428 . . . . 0.0 110.395 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . 1.656 ' HE1' ' CE2' ' E' ' 51' ' ' TYR . 82.2 m-85 -99.44 129.94 45.67 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.219 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.29 99.49 4.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 172.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . 0.46 HG11 ' CD2' ' D' ' 88' ' ' LEU . 2.4 t -74.67 -50.09 27.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.366 -171.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 54' ' ' ALA . . . . . 0.423 ' HB2' HG12 ' E' ' 63' ' ' VAL . . . -158.25 139.01 12.93 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.465 -177.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 23.2 m -102.98 102.12 12.15 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 171.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . 0.427 HG11 ' HB1' ' E' ' 40' ' ' ALA . 7.2 p -113.67 110.27 31.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.966 0.889 . . . . 0.0 109.844 -177.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 81.5 p -122.97 -176.89 3.52 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.181 -174.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 58' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' E' ' 38' ' ' GLN . 9.8 mtmp? -56.79 -35.01 68.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.016 0.436 . . . . 0.0 110.313 169.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.38 -40.62 64.21 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.506 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 77.8 mt -117.05 80.56 11.66 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.22 -0.04 6.7 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.038 2.492 . . . . 0.0 113.165 -169.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -164.11 118.69 1.49 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.159 0.504 . . . . 0.0 110.945 -174.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . 0.423 HG12 ' HB2' ' E' ' 54' ' ' ALA . 58.3 t -108.78 108.52 25.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.368 175.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.45 117.31 27.29 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.858 174.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 65' ' ' LEU . . . . . 0.42 ' CD2' ' HB3' ' E' ' 54' ' ' ALA . 0.3 OUTLIER -136.3 168.56 19.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.51 -176.043 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 66' ' ' ASP . . . . . 0.52 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 8.9 t0 -114.05 99.53 7.71 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.236 0.541 . . . . 0.0 110.258 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 67' ' ' LEU . . . . . 0.554 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 19.6 mt -112.74 142.11 45.75 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.458 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -150.63 115.81 5.36 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 174.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 69' ' ' PHE . . . . . 1.649 ' HE1' ' CE2' ' E' ' 69' ' ' PHE . 32.6 m-85 -110.37 158.68 18.19 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.884 -177.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 70' ' ' SER . . . . . 0.474 ' HB2' ' HA ' ' D' ' 7' ' ' MET . 8.6 t -110.58 158.68 18.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.35 0.595 . . . . 0.0 110.634 -176.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -70.53 -4.84 24.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.618 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.34 -26.87 14.46 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.49 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -100.63 168.27 9.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.104 0.478 . . . . 0.0 110.884 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -136.86 143.69 43.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.12 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 75' ' ' ILE . . . . . . . . . . . . . 13.2 pt -139.93 176.12 5.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.653 0.263 . . . . 0.0 111.071 -172.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 76' ' ' MET . . . . . 0.536 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 9.2 mtm -134.09 131.73 39.11 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 171.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 77' ' ' PHE . . . . . 0.449 ' CD1' ' HB2' ' E' ' 44' ' ' LEU . 1.2 m-85 -108.29 128.29 54.61 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 178.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 78' ' ' TYR . . . . . 0.628 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 38.8 p90 -152.84 136.32 15.93 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.325 0.583 . . . . 0.0 111.742 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 79' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 2.1 p -111.12 133.01 53.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.257 -177.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.1 168.22 9.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.9 177.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.0 -170.21 43.15 Favored Glycine 0 CA--C 1.508 -0.346 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -115.12 102.7 10.16 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 117.716 0.758 . . . . 0.0 109.626 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 83' ' ' ALA . . . . . 0.507 ' H ' ' HB3' ' E' ' 15' ' ' PRO . . . -173.82 152.28 1.96 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.509 170.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 31.9 t -111.46 122.19 47.18 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 85' ' ' VAL . . . . . . . . . . . . . 4.3 m -113.64 156.89 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 CA-C-O 121.538 0.685 . . . . 0.0 112.542 -172.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 14.9 t -123.62 113.8 19.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.794 -1.094 . . . . 0.0 108.63 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 87' ' ' LEU . . . . . 0.656 HD12 ' SD ' ' E' ' 13' ' ' MET . 5.0 mp -90.12 153.42 20.55 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.123 0.487 . . . . 0.0 109.867 174.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . 0.449 ' CD2' HG11 ' A' ' 53' ' ' VAL . 1.0 OUTLIER -133.28 139.44 46.91 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 114.803 -1.089 . . . . 0.0 109.077 -179.494 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.94 -166.83 24.55 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.849 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 90' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -152.8 131.33 12.22 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.769 0.795 . . . . 0.0 111.799 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 91' ' ' LEU . . . . . . . . . . . . . 5.8 mt . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.269 175.16 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 38.4 mtt . . . . . 0 CA--C 1.518 -0.256 0 CA-C-O 121.157 0.503 . . . . 0.0 112.089 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 1.658 ' HD1' ' CD2' ' A' ' 8' ' ' PHE . 28.9 t80 -62.34 145.7 53.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.547 -178.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -135.75 147.4 48.4 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.428 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -150.97 153.86 25.23 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.197 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 33.3 tp -147.77 106.54 3.82 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 86' ' ' SER . 2.3 p30 -97.85 110.54 23.09 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.543 0.687 . . . . 0.0 111.02 176.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.404 ' SD ' HG21 ' A' ' 79' ' ' THR . 7.3 mtt -85.19 142.22 29.61 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.285 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -89.82 144.26 31.38 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 170.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -46.31 109.77 0.22 Allowed 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 123.463 2.776 . . . . 0.0 113.594 -174.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.634 ' HA ' ' O ' ' A' ' 79' ' ' THR . 8.8 tt0 70.52 67.05 0.2 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.794 175.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.514 ' HA ' ' NE ' ' A' ' 17' ' ' ARG . 4.7 mmp_? -122.76 169.28 11.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.03 175.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.626 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 19.4 tttm -146.77 104.81 3.76 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.34 0.4 . . . . 0.0 111.274 -175.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 1.657 ' HD1' ' CD2' ' A' ' 19' ' ' TYR . 1.8 m-85 -111.74 111.5 22.51 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.053 -177.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 76' ' ' MET . 29.2 t -90.78 111.06 22.29 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 170.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -133.86 150.01 51.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.635 0.731 . . . . 0.0 112.687 -168.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.7 p -91.18 160.91 15.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.679 177.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 73.8 mt -111.2 126.29 68.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.219 -174.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.508 HD13 ' N ' ' A' ' 25' ' ' LYS . 1.8 pp -92.53 -24.44 5.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.641 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.508 ' N ' HD13 ' A' ' 24' ' ' ILE . 24.8 mtpp -147.44 132.93 18.66 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.6 m -55.05 119.4 5.39 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -137.34 156.72 47.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.737 0.78 . . . . 0.0 112.833 -170.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.573 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 15.1 t60 -109.88 124.65 51.73 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.118 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 39.3 mt -94.45 135.08 29.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 169.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.573 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 50.1 p -120.31 -15.85 8.55 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -169.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -160.39 145.21 10.84 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 119.288 -1.434 . . . . 0.0 113.324 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.2 p -129.85 121.55 52.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 168.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.07 154.38 43.9 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 121.928 -0.483 . . . . 0.0 112.018 -173.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.5 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 4.4 pp -125.15 144.0 50.65 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.499 0.666 . . . . 0.0 110.836 178.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -110.27 -45.98 3.49 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 173.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -103.63 128.66 50.89 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.593 171.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.472 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 146.63 163.01 10.18 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 119.627 -1.273 . . . . 0.0 113.501 176.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -102.24 -47.24 4.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.494 0.188 . . . . 0.0 110.97 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -152.16 133.71 14.63 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.093 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.29 113.46 11.97 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.391 0.615 . . . . 0.0 110.122 167.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -97.81 112.72 24.52 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 174.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.7 tp -83.81 113.29 20.82 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.557 -174.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.517 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 97.9 m-85 -115.78 141.45 48.07 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.526 ' HB2' ' CD1' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -129.85 131.82 46.25 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 173.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -110.71 114.96 28.74 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.028 177.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.91 142.54 50.64 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 58.65 29.24 18.28 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.949 0.404 . . . . 0.0 110.314 -174.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt 63.58 24.51 14.02 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.735 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.449 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 23.9 tp60 -115.65 126.69 54.47 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -83.44 125.01 31.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.891 0.377 . . . . 0.0 110.696 -177.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 1.649 ' HE2' ' CE1' ' A' ' 51' ' ' TYR . 66.3 m-85 -121.03 133.32 55.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.943 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -82.1 107.74 14.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 169.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.49 HG11 ' CD2' ' E' ' 88' ' ' LEU . 2.4 t -80.06 -49.56 18.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.64 -171.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.437 ' HB2' HG12 ' A' ' 63' ' ' VAL . . . -160.05 148.9 17.34 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.132 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.6 m -109.79 102.22 11.03 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 173.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.77 114.36 45.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.658 0.742 . . . . 0.0 110.016 -177.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 81.0 p -123.05 -178.3 3.92 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.55 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -63.47 -21.54 66.37 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.996 0.426 . . . . 0.0 110.444 170.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.47 -40.72 18.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.229 0.537 . . . . 0.0 110.244 177.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.1 mt -113.22 82.68 5.82 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 173.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.06 -0.11 6.69 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.156 2.57 . . . . 0.0 114.059 -167.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.28 127.12 2.44 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.175 0.512 . . . . 0.0 111.445 -176.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.437 HG12 ' HB2' ' A' ' 54' ' ' ALA . 85.2 t -117.44 106.22 19.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.311 174.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.47 121.68 27.07 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 173.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -140.69 168.16 20.46 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.766 -173.001 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.543 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 11.6 t0 -118.85 105.29 11.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.359 0.6 . . . . 0.0 110.497 -177.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 15.1 mt -118.8 144.43 46.32 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.655 177.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.425 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 57.5 t30 -148.44 114.79 5.89 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 173.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -110.13 164.51 12.57 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.091 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.0 t -107.85 149.15 28.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.859 0.361 . . . . 0.0 110.694 -177.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.14 -11.95 60.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.235 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.3 -5.76 61.83 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.537 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -100.25 167.9 10.13 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -145.23 128.21 16.5 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 15.4 pt -134.89 165.49 31.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.111 0.481 . . . . 0.0 111.79 -169.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.488 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 4.5 mtm -120.91 123.5 42.65 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.595 173.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 1.654 ' HD1' ' CD2' ' A' ' 77' ' ' PHE . 0.7 OUTLIER -105.96 127.61 53.26 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.587 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 1.658 ' HE2' ' CE1' ' A' ' 78' ' ' TYR . 40.5 p90 -154.95 144.13 21.05 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 120.031 -0.668 . . . . 0.0 112.006 -177.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.634 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 6.3 p -116.18 141.64 47.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.394 -177.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.72 153.37 23.04 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.221 176.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.93 -175.36 36.69 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -175.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -118.78 104.85 10.96 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 122.118 0.961 . . . . 0.0 110.499 176.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.472 ' CB ' ' HA3' ' A' ' 37' ' ' GLY . . . -166.1 154.83 11.16 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.22 170.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.3 t -106.3 111.19 23.67 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.5 ' CG1' ' HB3' ' A' ' 34' ' ' LEU . 3.4 m -111.33 138.08 41.25 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 CA-C-O 121.219 0.533 . . . . 0.0 112.191 -174.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 7.4 t -108.91 118.25 36.32 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.489 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 5.4 mp -89.73 149.26 22.82 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.532 174.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.501 ' CD2' HG11 ' B' ' 53' ' ' VAL . 1.3 tp -132.02 140.71 49.01 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.938 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.39 -167.14 25.52 Favored Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.695 -177.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 1.598 ' HE2' ' CE1' ' A' ' 90' ' ' TYR . 12.9 p90 -153.34 132.18 12.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.746 0.784 . . . . 0.0 111.643 177.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.3 mt . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.112 173.876 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 38.4 mtt . . . . . 0 CA--C 1.518 -0.269 0 CA-C-O 121.282 0.563 . . . . 0.0 112.041 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . 1.639 ' HE2' ' CE1' ' B' ' 8' ' ' PHE . 29.1 t80 -62.36 145.73 53.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.47 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -135.72 147.33 48.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.112 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.501 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -150.95 153.81 25.21 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.185 178.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.448 ' HB3' ' HB2' ' B' ' 87' ' ' LEU . 33.6 tp -147.7 106.59 3.83 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . 0.47 ' HA ' ' HA ' ' B' ' 86' ' ' SER . 2.3 p30 -97.88 110.58 23.12 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.597 0.713 . . . . 0.0 110.959 177.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' MET . . . . . 0.401 ' SD ' HG21 ' B' ' 79' ' ' THR . 7.3 mtt -85.14 142.17 29.68 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.366 -178.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.402 ' HB2' ' HG3' ' B' ' 17' ' ' ARG . 91.5 mttt -89.77 144.31 31.53 Favored Pre-proline 0 C--N 1.316 -0.874 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 170.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -46.3 109.69 0.22 Allowed 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 123.56 2.84 . . . . 0.0 113.496 -174.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.635 ' HA ' ' O ' ' B' ' 79' ' ' THR . 8.8 tt0 70.54 67.09 0.2 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.734 175.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.513 ' NE ' ' HA ' ' B' ' 17' ' ' ARG . 4.6 mmp_? -122.76 169.18 11.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.089 175.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . 0.607 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 19.5 tttm -146.68 104.77 3.77 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 123.325 0.391 . . . . 0.0 111.269 -175.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' TYR . . . . . 1.666 ' HD1' ' CD2' ' B' ' 19' ' ' TYR . 1.8 m-85 -111.76 111.53 22.57 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.079 -177.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 29.3 t -90.73 111.05 22.26 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -133.92 150.09 51.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.667 0.746 . . . . 0.0 112.66 -168.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 3.8 p -91.25 160.91 15.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.665 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 74.0 mt -111.24 126.31 68.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.144 -174.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.512 HD13 ' N ' ' B' ' 25' ' ' LYS . 1.8 pp -92.49 -24.44 5.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.692 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.512 ' N ' HD13 ' B' ' 24' ' ' ILE . 24.9 mtpp -147.36 132.86 18.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.87 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 15.5 m -54.96 119.32 5.25 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -137.31 156.62 48.03 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.669 0.747 . . . . 0.0 112.853 -170.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' HIS . . . . . 0.569 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 15.1 t60 -109.92 124.59 51.64 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.151 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.536 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 39.3 mt -94.39 135.1 29.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 169.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.569 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 48.7 p -120.34 -15.79 8.54 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -169.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -160.31 145.16 10.79 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 119.301 -1.428 . . . . 0.0 113.377 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 12.3 p -129.81 121.59 52.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 168.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.11 154.31 43.79 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.983 -173.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.514 ' HB3' ' CG1' ' B' ' 85' ' ' VAL . 4.4 pp -125.08 143.99 50.64 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.468 0.651 . . . . 0.0 110.791 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -110.15 -46.12 3.49 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 173.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -103.57 128.67 50.78 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.515 171.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.468 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 146.55 163.01 10.17 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 119.676 -1.25 . . . . 0.0 113.6 175.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -102.3 -47.04 4.63 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.19 -0.204 . . . . 0.0 111.043 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -152.22 133.68 14.55 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.999 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.38 113.46 11.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.474 0.654 . . . . 0.0 110.127 167.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -97.83 112.7 24.51 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 174.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 43.6 tp -83.71 113.37 20.83 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.56 -174.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . 0.517 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 98.0 m-85 -115.89 141.41 48.14 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 176.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.537 ' HB2' ' CD1' ' B' ' 77' ' ' PHE . 0.1 OUTLIER -129.85 131.9 46.27 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 173.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -110.7 114.94 28.7 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.01 177.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.91 142.54 50.64 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 58.6 29.31 18.31 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.994 0.426 . . . . 0.0 110.338 -174.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt 63.5 24.5 14.09 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.705 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . 0.455 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 24.0 tp60 -115.64 126.65 54.43 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -83.38 124.94 31.15 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.972 0.415 . . . . 0.0 110.702 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 1.646 ' HE2' ' CE1' ' B' ' 51' ' ' TYR . 66.4 m-85 -120.97 133.37 55.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.899 176.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -82.06 107.63 14.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 169.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.501 HG11 ' CD2' ' A' ' 88' ' ' LEU . 2.4 t -80.08 -49.54 18.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.61 -171.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.428 ' HB2' HG12 ' B' ' 63' ' ' VAL . . . -159.98 148.89 17.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.171 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 55.4 m -109.85 102.28 11.06 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 173.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.78 114.41 45.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.669 0.747 . . . . 0.0 110.001 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 81.3 p -123.12 -178.38 3.95 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.608 -174.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -63.45 -21.47 66.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.932 0.396 . . . . 0.0 110.484 170.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.48 -40.77 18.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.206 0.527 . . . . 0.0 110.216 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 80.4 mt -113.22 82.63 5.78 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.02 -0.2 6.78 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.17 2.58 . . . . 0.0 114.066 -167.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.21 127.17 2.47 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.159 0.504 . . . . 0.0 111.44 -176.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.428 HG12 ' HB2' ' B' ' 54' ' ' ALA . 85.5 t -117.35 106.21 19.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.35 174.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.49 121.7 27.1 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 173.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' B' ' 30' ' ' SER . 0.6 OUTLIER -140.76 168.12 20.55 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.741 -173.026 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . 0.566 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 11.8 t0 -118.73 105.26 11.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.264 0.554 . . . . 0.0 110.565 -177.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' B' ' 28' ' ' HIS . 15.1 mt -118.76 144.43 46.28 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.68 177.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . 0.415 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 57.4 t30 -148.52 114.8 5.86 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 173.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -110.14 164.56 12.52 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.12 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 33.1 t -107.93 149.18 28.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 0.0 110.677 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -11.95 60.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.271 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.28 -5.76 61.86 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.585 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -100.29 167.96 10.08 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -145.22 128.13 16.43 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 15.4 pt -134.84 165.44 31.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.082 0.467 . . . . 0.0 111.756 -169.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' MET . . . . . 0.487 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 4.5 mtm -120.91 123.61 42.93 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 173.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . 1.664 ' HD1' ' CD2' ' B' ' 77' ' ' PHE . 0.8 OUTLIER -106.02 127.62 53.29 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.441 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 1.619 ' HE2' ' CE1' ' B' ' 78' ' ' TYR . 40.4 p90 -154.9 144.19 21.16 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.993 -0.683 . . . . 0.0 112.034 -177.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.635 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 6.4 p -116.29 141.63 47.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.356 -177.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.72 153.41 22.99 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.241 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.79 -175.37 36.92 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -175.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -118.75 104.87 10.99 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.509 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.468 ' CB ' ' HA3' ' B' ' 37' ' ' GLY . . . -166.07 154.77 11.18 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.2 170.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 19.0 t -106.16 111.17 23.67 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.514 ' CG1' ' HB3' ' B' ' 34' ' ' LEU . 3.4 m -111.44 138.17 41.02 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 CA-C-O 121.3 0.571 . . . . 0.0 112.129 -174.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' B' ' 12' ' ' ASN . 7.4 t -108.94 118.25 36.32 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.793 178.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' B' ' 31' ' ' GLY . 5.4 mp -89.79 149.27 22.77 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.5 174.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.49 ' CD2' HG11 ' C' ' 53' ' ' VAL . 1.3 tp -131.99 140.69 49.04 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.971 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.41 -167.2 25.64 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.704 -177.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' TYR . . . . . 1.66 ' HE1' ' CE2' ' B' ' 90' ' ' TYR . 13.0 p90 -153.4 132.21 12.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.777 0.798 . . . . 0.0 111.603 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 22.2 mt . . . . . 0 C--N 1.322 -0.591 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.131 173.892 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 38.4 mtt . . . . . 0 CA--C 1.519 -0.233 0 CA-C-O 121.104 0.478 . . . . 0.0 112.106 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 8' ' ' PHE . . . . . 1.657 ' HD1' ' CD2' ' C' ' 8' ' ' PHE . 28.9 t80 -62.35 145.78 52.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.492 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -135.65 147.44 48.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.177 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . 0.443 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -151.04 153.8 25.19 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.203 178.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.44 ' HB3' ' HB2' ' C' ' 87' ' ' LEU . 33.4 tp -147.78 106.57 3.82 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . 0.464 ' HA ' ' HA ' ' C' ' 86' ' ' SER . 2.3 p30 -97.91 110.67 23.2 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.681 0.753 . . . . 0.0 110.937 177.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 13' ' ' MET . . . . . 0.405 ' SD ' HG21 ' C' ' 79' ' ' THR . 7.2 mtt -85.25 142.17 29.59 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.019 -0.992 . . . . 0.0 111.324 -178.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -89.67 144.17 31.45 Favored Pre-proline 0 C--N 1.315 -0.902 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 170.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -46.23 109.65 0.21 Allowed 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 123.503 2.802 . . . . 0.0 113.543 -174.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . 0.628 ' HA ' ' O ' ' C' ' 79' ' ' THR . 8.8 tt0 70.59 67.08 0.19 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.767 175.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 17' ' ' ARG . . . . . 0.506 ' NE ' ' HA ' ' C' ' 17' ' ' ARG . 4.7 mmp_? -122.76 169.22 11.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.133 175.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 18' ' ' LYS . . . . . 0.629 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 19.4 tttm -146.67 104.8 3.77 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.346 0.404 . . . . 0.0 111.305 -175.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . 1.671 ' HD2' ' CD1' ' C' ' 19' ' ' TYR . 1.8 m-85 -111.76 111.53 22.57 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.093 -177.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 20' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 29.5 t -90.84 111.05 22.29 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 170.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -133.89 150.11 51.34 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.693 0.758 . . . . 0.0 112.645 -168.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 3.8 p -91.2 160.83 15.34 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.657 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 74.1 mt -111.13 126.25 68.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.171 -174.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . 0.523 HD13 ' N ' ' C' ' 25' ' ' LYS . 1.8 pp -92.5 -24.38 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.69 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . 0.523 ' N ' HD13 ' C' ' 24' ' ' ILE . 24.8 mtpp -147.44 132.94 18.67 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.836 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 15.6 m -54.98 119.42 5.39 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 27' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -137.38 156.63 47.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.694 0.759 . . . . 0.0 112.788 -170.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 28' ' ' HIS . . . . . 0.573 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 15.1 t60 -109.9 124.61 51.66 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.244 -1.343 . . . . 0.0 110.101 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 39.4 mt -94.45 134.99 30.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 169.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 30' ' ' SER . . . . . 0.573 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 50.0 p -120.2 -15.88 8.6 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -169.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 31' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -160.34 145.17 10.8 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.382 -1.389 . . . . 0.0 113.38 178.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.407 HG11 ' O ' ' C' ' 32' ' ' VAL . 12.1 p -129.8 121.63 52.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 168.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.18 154.38 43.82 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.979 -173.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.506 ' HB3' ' CG1' ' C' ' 85' ' ' VAL . 4.4 pp -125.11 144.02 50.63 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.468 0.651 . . . . 0.0 110.787 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -110.16 -46.01 3.51 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -103.64 128.65 50.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.551 171.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 37' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 146.67 163.0 10.18 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 119.664 -1.255 . . . . 0.0 113.576 176.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -102.25 -47.22 4.58 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.463 0.173 . . . . 0.0 110.976 177.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -152.16 133.75 14.65 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.063 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.35 113.42 11.89 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.362 0.601 . . . . 0.0 110.097 168.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -97.77 112.57 24.42 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 174.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 43.7 tp -83.76 113.32 20.82 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.577 -174.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 43' ' ' TYR . . . . . 0.515 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 98.0 m-85 -115.8 141.53 47.98 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.539 ' HB2' ' CD1' ' C' ' 77' ' ' PHE . 0.1 OUTLIER -129.91 131.79 46.15 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 173.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -110.74 114.85 28.53 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.981 177.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.86 142.47 50.66 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 58.78 29.17 18.36 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.89 0.376 . . . . 0.0 110.284 -174.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt 63.55 24.57 14.07 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.681 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . 0.453 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 24.0 tp60 -115.67 126.67 54.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -83.42 124.85 31.09 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.869 0.366 . . . . 0.0 110.758 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 1.664 ' HE2' ' CE1' ' C' ' 51' ' ' TYR . 66.8 m-85 -120.91 133.35 55.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 176.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -82.14 107.7 14.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 169.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 53' ' ' VAL . . . . . 0.49 HG11 ' CD2' ' B' ' 88' ' ' LEU . 2.4 t -80.07 -49.58 18.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.643 -171.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 54' ' ' ALA . . . . . 0.428 ' HB2' HG12 ' C' ' 63' ' ' VAL . . . -159.99 148.98 17.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.232 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 54.1 m -109.81 102.19 10.99 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 173.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.69 114.39 45.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.653 0.739 . . . . 0.0 110.032 -177.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 81.2 p -123.05 -178.33 3.93 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.581 -174.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -63.57 -21.4 66.33 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.887 0.375 . . . . 0.0 110.491 170.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.52 -40.67 18.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.166 0.508 . . . . 0.0 110.228 177.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 80.6 mt -113.28 82.71 5.94 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 174.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.06 -0.13 6.71 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.15 2.567 . . . . 0.0 114.052 -167.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.3 127.18 2.44 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.146 0.498 . . . . 0.0 111.418 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.428 HG12 ' HB2' ' C' ' 54' ' ' ALA . 86.4 t -117.34 106.14 19.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.35 174.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.45 121.7 27.08 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 173.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' C' ' 30' ' ' SER . 0.6 OUTLIER -140.71 168.2 20.36 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.736 -172.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 66' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 11.6 t0 -118.88 105.18 11.24 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.322 0.582 . . . . 0.0 110.569 -177.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' C' ' 28' ' ' HIS . 15.2 mt -118.7 144.48 46.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.651 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . 0.409 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 57.4 t30 -148.55 114.74 5.83 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 173.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -110.09 164.5 12.57 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.122 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 33.1 t -107.85 149.2 28.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.371 . . . . 0.0 110.679 -177.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . 0.403 ' HE2' ' HB2' ' C' ' 71' ' ' LYS . 0.0 OUTLIER -68.19 -11.85 59.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.279 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.41 -5.8 61.63 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.565 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -100.13 167.9 10.16 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -145.2 128.14 16.45 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 15.3 pt -134.87 165.51 30.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.992 0.425 . . . . 0.0 111.75 -169.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 76' ' ' MET . . . . . 0.486 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 4.5 mtm -120.85 123.47 42.65 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.612 173.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 77' ' ' PHE . . . . . 1.658 ' HD1' ' CD2' ' C' ' 77' ' ' PHE . 0.8 OUTLIER -105.95 127.59 53.25 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.488 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 78' ' ' TYR . . . . . 1.666 ' HE2' ' CE1' ' C' ' 78' ' ' TYR . 40.5 p90 -154.92 144.16 21.12 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.086 -0.645 . . . . 0.0 111.994 -177.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 79' ' ' THR . . . . . 0.628 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 6.6 p -116.19 141.54 48.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.351 -177.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.69 153.44 22.93 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.248 175.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.83 -175.47 36.95 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -175.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -118.73 104.83 10.96 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 122.191 0.996 . . . . 0.0 110.58 176.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . 0.464 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -166.1 154.82 11.16 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.188 170.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 19.9 t -106.29 111.29 23.82 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.506 ' CG1' ' HB3' ' C' ' 34' ' ' LEU . 3.4 m -111.48 138.16 41.11 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 CA-C-O 121.304 0.573 . . . . 0.0 112.137 -174.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 86' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' C' ' 12' ' ' ASN . 7.4 t -108.99 118.37 36.63 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.76 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . 0.484 ' HA ' ' O ' ' C' ' 31' ' ' GLY . 5.4 mp -89.84 149.28 22.73 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.525 174.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . 0.473 ' CD2' HG11 ' D' ' 53' ' ' VAL . 1.3 tp -131.98 140.68 49.04 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.018 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.32 -167.12 25.42 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.683 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 90' ' ' TYR . . . . . 1.623 ' HE1' ' CE2' ' C' ' 90' ' ' TYR . 13.2 p90 -153.4 132.18 12.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.767 0.794 . . . . 0.0 111.656 177.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 21.9 mt . . . . . 0 C--N 1.322 -0.596 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.195 173.841 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 38.3 mtt . . . . . 0 CA--C 1.518 -0.256 0 CA-C-O 121.233 0.539 . . . . 0.0 112.041 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 8' ' ' PHE . . . . . 1.661 ' HE2' ' CE1' ' D' ' 8' ' ' PHE . 29.4 t80 -62.34 145.77 52.96 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.507 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 9' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -135.75 147.4 48.41 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.079 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . 0.455 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -151.03 153.87 25.23 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.179 178.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . 0.423 ' HB3' ' HB2' ' D' ' 87' ' ' LEU . 33.6 tp -147.69 106.54 3.83 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.34 -0.245 . . . . 0.0 110.34 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . 0.451 ' HA ' ' HA ' ' D' ' 86' ' ' SER . 2.3 p30 -97.9 110.56 23.11 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.63 0.729 . . . . 0.0 110.979 177.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 13' ' ' MET . . . . . . . . . . . . . 7.3 mtt -85.15 142.17 29.67 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.422 -178.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 14' ' ' LYS . . . . . 0.411 ' HB2' ' HG3' ' D' ' 17' ' ' ARG . 91.5 mttt -89.74 144.18 31.37 Favored Pre-proline 0 C--N 1.316 -0.891 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 170.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -46.27 109.73 0.22 Allowed 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 123.414 2.743 . . . . 0.0 113.605 -174.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . 0.61 ' HA ' ' O ' ' D' ' 79' ' ' THR . 8.9 tt0 70.61 67.07 0.19 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.762 175.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 17' ' ' ARG . . . . . 0.5 ' HA ' ' NE ' ' D' ' 17' ' ' ARG . 4.7 mmp_? -122.76 169.2 11.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.091 175.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . 0.629 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 19.4 tttm -146.69 104.79 3.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 123.292 0.37 . . . . 0.0 111.355 -175.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 19' ' ' TYR . . . . . 1.657 ' HD2' ' CD1' ' D' ' 19' ' ' TYR . 1.8 m-85 -111.69 111.55 22.62 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.115 -177.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 20' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 29.3 t -90.87 110.94 22.17 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -133.84 150.2 51.39 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.676 0.751 . . . . 0.0 112.743 -168.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 3.7 p -91.31 160.94 15.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.643 178.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 73.8 mt -111.19 126.29 68.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.241 -174.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . 0.521 HD13 ' N ' ' D' ' 25' ' ' LYS . 1.8 pp -92.5 -24.41 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.765 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . 0.521 ' N ' HD13 ' D' ' 24' ' ' ILE . 24.8 mtpp -147.43 132.86 18.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.8 178.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 15.5 m -54.96 119.4 5.35 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 175.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 27' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -137.38 156.74 47.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.789 0.804 . . . . 0.0 112.792 -170.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 28' ' ' HIS . . . . . 0.581 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 15.2 t60 -109.98 124.7 51.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.221 -1.354 . . . . 0.0 110.07 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 29' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 39.5 mt -94.55 135.05 29.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 169.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 30' ' ' SER . . . . . 0.581 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 50.1 p -120.25 -15.89 8.57 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -169.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 31' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -160.27 145.16 10.81 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 119.374 -1.393 . . . . 0.0 113.366 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . 0.402 HG11 ' O ' ' D' ' 32' ' ' VAL . 12.1 p -129.85 121.61 52.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 168.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.06 154.41 43.93 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.94 -173.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 34' ' ' LEU . . . . . 0.51 ' HB3' ' CG1' ' D' ' 85' ' ' VAL . 4.4 pp -125.15 144.05 50.63 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.475 0.655 . . . . 0.0 110.777 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -110.17 -46.08 3.49 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 173.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -103.63 128.64 50.9 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.562 171.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . 0.473 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 146.63 163.07 10.22 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 119.682 -1.247 . . . . 0.0 113.559 176.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -102.29 -47.22 4.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.59 0.233 . . . . 0.0 111.011 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -152.12 133.67 14.63 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.059 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.35 113.44 11.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.455 0.645 . . . . 0.0 110.177 167.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' D' ' 79' ' ' THR . 98.6 mttt -97.77 112.67 24.48 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 43.5 tp -83.74 113.34 20.82 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.607 -174.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 43' ' ' TYR . . . . . 0.509 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 98.0 m-85 -115.77 141.48 48.03 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.539 ' HB2' ' CD1' ' D' ' 77' ' ' PHE . 0.1 OUTLIER -129.96 131.83 46.09 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 173.874 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 45' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -110.65 115.0 28.83 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.888 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.91 142.57 50.64 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 58.7 29.19 18.27 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.315 0.384 . . . . 0.0 110.28 -174.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt 63.61 24.48 13.98 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.711 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . 0.446 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 24.1 tp60 -115.73 126.64 54.33 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -83.39 124.85 31.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.807 0.336 . . . . 0.0 110.755 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . 1.671 ' HE2' ' CE1' ' D' ' 51' ' ' TYR . 66.7 m-85 -120.89 133.35 55.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.904 176.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.0 tp -82.06 107.72 14.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 169.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 53' ' ' VAL . . . . . 0.473 HG11 ' CD2' ' C' ' 88' ' ' LEU . 2.4 t -80.09 -49.6 18.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.589 -171.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 54' ' ' ALA . . . . . 0.429 ' HB2' HG12 ' D' ' 63' ' ' VAL . . . -160.01 148.93 17.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.173 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 53.3 m -109.81 102.28 11.08 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.74 114.33 45.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.612 0.72 . . . . 0.0 109.981 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 81.2 p -123.05 -178.27 3.91 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.523 -174.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -63.57 -21.46 66.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.944 0.402 . . . . 0.0 110.461 170.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.51 -40.62 18.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.124 0.488 . . . . 0.0 110.222 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 80.3 mt -113.29 82.6 5.88 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 174.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -69.99 -0.18 6.73 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.186 2.591 . . . . 0.0 114.114 -167.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.25 127.1 2.45 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.112 0.482 . . . . 0.0 111.483 -176.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.429 HG12 ' HB2' ' D' ' 54' ' ' ALA . 87.2 t -117.3 106.09 19.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.426 174.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.48 121.73 27.13 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 173.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 65' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' D' ' 30' ' ' SER . 0.6 OUTLIER -140.72 168.2 20.35 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.728 -173.034 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 66' ' ' ASP . . . . . 0.549 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 11.9 t0 -118.82 105.23 11.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.251 0.548 . . . . 0.0 110.586 -177.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' D' ' 28' ' ' HIS . 15.1 mt -118.8 144.43 46.32 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.674 177.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 68' ' ' ASN . . . . . 0.441 ' HB3' ' CD2' ' C' ' 90' ' ' TYR . 57.3 t30 -148.47 114.83 5.89 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 173.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -110.15 164.58 12.5 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.106 -178.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 33.0 t -107.97 149.12 28.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.856 0.36 . . . . 0.0 110.723 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -12.03 59.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.344 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.35 -5.73 61.77 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.526 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -100.2 167.92 10.13 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -145.21 128.16 16.46 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . . . . . . . . . 15.4 pt -134.92 165.39 31.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.077 0.465 . . . . 0.0 111.771 -169.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 76' ' ' MET . . . . . 0.492 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 4.5 mtm -120.85 123.5 42.72 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 173.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 77' ' ' PHE . . . . . 1.663 ' HE2' ' CE1' ' D' ' 77' ' ' PHE . 0.8 OUTLIER -106.02 127.59 53.27 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.502 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 78' ' ' TYR . . . . . 1.625 ' HE1' ' CE2' ' D' ' 78' ' ' TYR . 40.8 p90 -154.93 144.16 21.11 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.967 -177.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 79' ' ' THR . . . . . 0.61 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 6.5 p -116.22 141.61 47.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.364 -177.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.69 153.31 23.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.289 176.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.92 -175.36 36.7 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -175.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -118.81 104.97 11.05 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 118.114 0.957 . . . . 0.0 110.46 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.473 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -166.15 154.77 11.02 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.204 170.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 19.9 t -106.25 111.23 23.74 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . 0.51 ' CG1' ' HB3' ' D' ' 34' ' ' LEU . 3.4 m -111.43 138.11 41.24 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.706 0 CA-C-O 121.289 0.566 . . . . 0.0 112.144 -174.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 86' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' D' ' 12' ' ' ASN . 7.4 t -108.9 118.31 36.47 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.353 -0.84 . . . . 0.0 108.791 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 87' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' D' ' 31' ' ' GLY . 5.4 mp -89.76 149.31 22.78 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.524 174.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . 0.469 ' CD2' HG11 ' E' ' 53' ' ' VAL . 1.3 tp -132.05 140.68 48.97 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.956 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.32 -167.08 25.36 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.683 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 90' ' ' TYR . . . . . 1.65 ' HE1' ' CE2' ' D' ' 90' ' ' TYR . 13.0 p90 -153.42 132.13 12.31 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.74 0.781 . . . . 0.0 111.636 177.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 22.4 mt . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.088 173.932 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 38.6 mtt . . . . . 0 CA--C 1.52 -0.205 0 CA-C-O 121.214 0.53 . . . . 0.0 112.096 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' E' E ' 8' ' ' PHE . . . . . 1.67 ' HE1' ' CE2' ' E' ' 8' ' ' PHE . 29.0 t80 -62.4 145.77 53.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.492 -178.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 9' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -135.72 147.38 48.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.096 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 10' ' ' GLY . . . . . 0.461 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -151.0 153.81 25.2 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.273 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 11' ' ' LEU . . . . . 0.429 ' HB3' ' HB2' ' E' ' 87' ' ' LEU . 33.2 tp -147.77 106.6 3.83 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 12' ' ' ASN . . . . . 0.457 ' HA ' ' HA ' ' E' ' 86' ' ' SER . 2.3 p30 -97.82 110.6 23.14 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.605 0.717 . . . . 0.0 110.987 176.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 13' ' ' MET . . . . . 0.4 ' SD ' HG21 ' E' ' 79' ' ' THR . 7.2 mtt -85.26 142.15 29.6 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.31 -178.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -89.71 144.21 31.47 Favored Pre-proline 0 C--N 1.315 -0.919 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 170.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -46.29 109.66 0.22 Allowed 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 123.519 2.813 . . . . 0.0 113.613 -174.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 16' ' ' GLU . . . . . 0.626 ' HA ' ' O ' ' E' ' 79' ' ' THR . 8.8 tt0 70.56 67.1 0.19 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.762 175.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 17' ' ' ARG . . . . . 0.507 ' HA ' ' NE ' ' E' ' 17' ' ' ARG . 4.7 mmp_? -122.79 169.2 11.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.013 175.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . 0.617 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 19.4 tttm -146.68 104.89 3.78 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.36 0.413 . . . . 0.0 111.303 -175.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . 1.653 ' HE2' ' CE1' ' E' ' 19' ' ' TYR . 1.8 m-85 -111.81 111.55 22.6 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.071 -177.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 20' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' E' ' 76' ' ' MET . 28.9 t -90.82 111.0 22.21 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -133.84 150.1 51.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.661 0.743 . . . . 0.0 112.721 -168.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 3.9 p -91.18 160.9 15.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.649 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 73.9 mt -111.14 126.26 68.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.176 -174.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . 0.506 HD13 ' N ' ' E' ' 25' ' ' LYS . 1.8 pp -92.55 -24.3 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.723 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . 0.506 ' N ' HD13 ' E' ' 24' ' ' ILE . 24.8 mtpp -147.56 132.96 18.57 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 15.5 m -54.9 119.4 5.33 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 27' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -137.4 156.67 47.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.725 0.774 . . . . 0.0 112.792 -170.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 28' ' ' HIS . . . . . 0.568 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 15.1 t60 -109.94 124.59 51.65 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.108 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 29' ' ' ILE . . . . . 0.529 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 39.3 mt -94.43 135.06 29.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 169.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 30' ' ' SER . . . . . 0.568 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 50.2 p -120.26 -15.87 8.57 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -169.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 31' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -160.32 145.21 10.86 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.314 -1.422 . . . . 0.0 113.361 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 12.0 p -129.92 121.65 52.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 168.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.1 154.37 43.86 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.955 -173.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 34' ' ' LEU . . . . . 0.514 ' HB3' ' CG1' ' E' ' 85' ' ' VAL . 4.4 pp -125.13 144.0 50.64 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.5 0.667 . . . . 0.0 110.836 177.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -110.24 -45.96 3.5 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 173.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -103.67 128.57 50.99 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.56 171.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . 0.474 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 146.7 163.0 10.19 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 119.641 -1.266 . . . . 0.0 113.57 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -102.25 -47.15 4.6 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.164 -0.214 . . . . 0.0 111.001 177.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -152.1 133.72 14.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.739 -0.21 . . . . 0.0 111.056 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.37 113.45 11.91 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.364 0.602 . . . . 0.0 110.167 167.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 41' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -97.86 112.66 24.49 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 174.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 43.1 tp -83.72 113.3 20.79 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.59 -174.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 43' ' ' TYR . . . . . 0.511 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 98.0 m-85 -115.77 141.47 48.05 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 44' ' ' LEU . . . . . 0.537 ' HB2' ' CD1' ' E' ' 77' ' ' PHE . 0.1 OUTLIER -129.95 131.89 46.13 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 173.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 45' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -110.78 114.95 28.7 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.994 177.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.86 142.49 50.66 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 58.79 29.19 18.4 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.372 0.42 . . . . 0.0 110.224 -174.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt 63.56 24.61 14.08 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.709 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 49' ' ' GLN . . . . . 0.449 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 24.1 tp60 -115.67 126.69 54.46 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -83.4 124.83 31.06 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.86 0.362 . . . . 0.0 110.724 -177.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . 1.666 ' HE2' ' CE1' ' E' ' 51' ' ' TYR . 66.2 m-85 -120.84 133.35 55.31 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.0 tp -82.12 107.65 14.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 169.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . 0.469 HG11 ' CD2' ' D' ' 88' ' ' LEU . 2.4 t -80.01 -49.58 18.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.663 -171.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 54' ' ' ALA . . . . . 0.436 ' HB2' HG12 ' E' ' 63' ' ' VAL . . . -160.01 148.96 17.44 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.099 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 54.4 m -109.86 102.24 11.03 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 173.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.76 114.27 44.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.625 0.726 . . . . 0.0 110.004 -177.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 81.1 p -123.06 -178.3 3.92 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.551 -174.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -63.58 -21.4 66.33 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.838 0.352 . . . . 0.0 110.414 170.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.55 -40.53 19.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.198 0.523 . . . . 0.0 110.245 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 80.6 mt -113.4 82.7 6.12 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 174.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.16 -0.17 6.85 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.106 2.537 . . . . 0.0 114.013 -167.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.15 127.15 2.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.163 0.506 . . . . 0.0 111.477 -176.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . 0.436 HG12 ' HB2' ' E' ' 54' ' ' ALA . 86.4 t -117.38 106.11 19.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.405 174.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.51 121.76 27.19 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 173.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 65' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' E' ' 30' ' ' SER . 0.6 OUTLIER -140.7 168.18 20.4 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.711 -173.044 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 66' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 11.7 t0 -118.83 105.18 11.26 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.267 0.556 . . . . 0.0 110.532 -177.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 67' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' E' ' 28' ' ' HIS . 15.2 mt -118.74 144.51 46.21 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.65 177.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 68' ' ' ASN . . . . . 0.42 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 57.3 t30 -148.53 114.73 5.84 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 173.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -110.06 164.53 12.53 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.187 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 33.0 t -107.91 149.17 28.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.836 0.351 . . . . 0.0 110.687 -177.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 71' ' ' LYS . . . . . 0.402 ' HE2' ' HB2' ' E' ' 71' ' ' LYS . 0.0 OUTLIER -68.06 -11.91 59.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.345 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.38 -5.81 61.68 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.583 175.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -100.02 167.91 10.18 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -145.19 128.11 16.44 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 75' ' ' ILE . . . . . . . . . . . . . 15.3 pt -134.93 165.51 30.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.094 0.473 . . . . 0.0 111.763 -169.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 76' ' ' MET . . . . . 0.484 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 4.5 mtm -120.92 123.5 42.63 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 173.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 77' ' ' PHE . . . . . 1.658 ' HE2' ' CE1' ' E' ' 77' ' ' PHE . 0.7 OUTLIER -106.03 127.6 53.28 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 78' ' ' TYR . . . . . 1.632 ' HE2' ' CE1' ' E' ' 78' ' ' TYR . 40.7 p90 -154.93 144.13 21.09 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.958 -177.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 79' ' ' THR . . . . . 0.626 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 6.5 p -116.18 141.54 48.01 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.396 -177.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.59 153.4 22.94 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.319 176.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.93 -175.41 36.73 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -175.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -118.76 104.84 10.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 118.12 0.96 . . . . 0.0 110.527 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 83' ' ' ALA . . . . . 0.474 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -166.1 154.83 11.17 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.182 170.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 19.5 t -106.21 111.23 23.74 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 85' ' ' VAL . . . . . 0.514 ' CG1' ' HB3' ' E' ' 34' ' ' LEU . 3.4 m -111.48 138.23 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 CA-C-O 121.348 0.594 . . . . 0.0 112.095 -174.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 86' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' E' ' 12' ' ' ASN . 7.4 t -108.95 118.19 36.16 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.8 178.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 87' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' E' ' 31' ' ' GLY . 5.4 mp -89.8 149.22 22.79 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.566 174.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . 0.49 ' CD2' HG11 ' A' ' 53' ' ' VAL . 1.3 tp -131.91 140.71 49.13 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.022 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.34 -167.14 25.47 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.776 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 90' ' ' TYR . . . . . 1.64 ' HE1' ' CE2' ' E' ' 90' ' ' TYR . 12.9 p90 -153.36 132.27 12.46 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.712 0.768 . . . . 0.0 111.604 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 91' ' ' LEU . . . . . . . . . . . . . 22.0 mt . . . . . 0 C--N 1.321 -0.644 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.177 173.856 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.555 ' HA ' ' OG ' ' B' ' 70' ' ' SER . 16.5 ttt . . . . . 0 CA--C 1.529 0.165 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 1.644 ' HE1' ' CE2' ' A' ' 8' ' ' PHE . 54.1 t80 -79.66 129.7 34.71 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.062 0.458 . . . . 0.0 112.102 -177.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.521 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 87.8 t90 -113.82 148.49 36.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.596 174.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.19 145.55 13.96 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.258 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.526 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 58.5 tp -139.09 110.25 6.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.027 0.441 . . . . 0.0 110.93 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -86.04 116.41 24.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.958 176.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.506 ' HB2' HG22 ' A' ' 85' ' ' VAL . 4.1 mmt -98.52 130.81 45.1 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.444 ' HD2' ' HD2' ' A' ' 15' ' ' PRO . 48.2 tptt -100.55 132.06 22.89 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 174.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.474 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 2.0 Cg_endo -46.25 117.68 2.07 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.539 2.826 . . . . 0.0 113.476 -175.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.659 ' HA ' ' O ' ' A' ' 79' ' ' THR . 37.8 mt-10 64.14 56.24 1.4 Allowed 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.411 178.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.86 135.31 52.78 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.63 172.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.672 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 82.8 mttt -103.73 115.71 30.98 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 123.313 0.383 . . . . 0.0 111.272 177.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.405 ' HH ' ' HA ' ' A' ' 13' ' ' MET . 4.6 m-85 -105.52 102.9 12.33 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 p -89.36 98.93 12.04 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 173.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -111.83 146.39 37.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.229 -167.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.8 m -100.45 143.06 31.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.282 174.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.455 ' CD1' ' HB2' ' A' ' 69' ' ' PHE . 54.0 mt -108.52 125.84 65.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.202 0.525 . . . . 0.0 111.772 -172.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.456 HD13 ' N ' ' A' ' 24' ' ' ILE . 4.2 mp -102.22 -50.6 9.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.395 -0.821 . . . . 0.0 108.852 176.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.7 pttp -103.21 122.41 44.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.552 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.6 t -60.94 142.71 56.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.964 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -147.8 148.27 30.74 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.517 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 2.1 t60 -102.65 125.18 49.29 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 114.147 -1.388 . . . . 0.0 109.601 176.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.484 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 47.0 mt -87.34 131.24 35.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 172.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.517 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 95.3 p -116.59 -12.25 10.97 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -169.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . 179.99 158.72 22.51 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 119.166 -1.492 . . . . 0.0 113.702 177.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.0 p -141.29 138.97 33.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 175.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -152.95 156.17 38.38 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 121.97 -0.457 . . . . 0.0 111.886 -177.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.566 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 4.1 pp -125.31 148.04 48.88 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.501 0.667 . . . . 0.0 111.911 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -110.64 -55.15 2.51 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.133 169.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -100.84 127.91 47.1 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.211 174.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.47 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 150.48 162.98 10.93 Favored Glycine 0 N--CA 1.434 -1.495 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.533 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -102.56 -47.04 4.57 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.713 0.292 . . . . 0.0 111.018 176.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -152.48 132.51 13.42 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.344 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.407 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . . . -127.28 113.28 16.08 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.436 0.636 . . . . 0.0 110.061 168.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 79' ' ' THR . 97.5 mttt -95.34 112.02 23.8 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.5 tp -86.12 107.48 17.87 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -174.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 1.599 ' HE2' ' CE1' ' A' ' 43' ' ' TYR . 75.4 m-85 -107.4 146.11 32.08 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.741 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.646 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 1.5 tp -129.98 116.32 18.42 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.665 176.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.55 109.28 21.12 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -143.14 150.05 38.91 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.423 -177.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 57.35 30.99 19.44 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.35 0.595 . . . . 0.0 109.98 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 61.2 40.49 14.6 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.204 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -144.16 136.59 26.73 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -87.35 117.72 26.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.936 0.398 . . . . 0.0 110.042 178.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 1.636 ' HD1' ' CD2' ' A' ' 51' ' ' TYR . 76.6 m-85 -112.76 122.97 49.23 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.673 178.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -80.82 100.9 5.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 170.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.445 HG13 ' CD2' ' E' ' 88' ' ' LEU . 21.6 m -86.45 -33.19 7.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.749 -172.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.469 ' HB1' HD22 ' A' ' 65' ' ' LEU . . . -153.19 144.59 23.23 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 120.28 -0.568 . . . . 0.0 112.214 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.2 m -115.51 102.47 9.83 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 169.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.405 HG11 ' HB1' ' A' ' 40' ' ' ALA . 8.9 p -116.18 114.21 45.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.744 0.783 . . . . 0.0 110.15 -177.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 69.1 p -123.18 -177.12 3.6 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.963 -175.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -59.37 -35.89 74.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.035 0.445 . . . . 0.0 109.971 169.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.407 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -71.23 -40.59 71.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.498 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.2 mt -114.31 82.33 7.34 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 17.3 Cg_exo -67.31 -6.65 16.83 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.208 2.605 . . . . 0.0 113.891 -168.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -161.49 132.09 5.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.262 0.554 . . . . 0.0 111.164 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.456 HG12 ' HB3' ' A' ' 54' ' ' ALA . 87.5 t -119.74 118.6 57.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.543 176.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.76 128.15 33.32 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.469 HD22 ' HB1' ' A' ' 54' ' ' ALA . 86.2 mt -120.21 163.82 17.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.457 0.646 . . . . 0.0 112.25 -172.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -140.86 97.4 3.18 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.548 169.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 2.8 mt -131.19 156.34 45.49 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.505 ' HB2' ' CZ ' ' E' ' 90' ' ' TYR . 42.7 t-20 -155.32 128.79 8.41 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 1.63 ' HE2' ' CE1' ' A' ' 69' ' ' PHE . 4.3 m-85 -124.03 145.05 49.47 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.522 ' OG ' ' HA ' ' E' ' 7' ' ' MET . 37.2 m -100.4 -178.53 3.84 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -175.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -62.34 -30.95 71.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.222 0.534 . . . . 0.0 110.345 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.82 4.44 85.03 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.661 -0.7 . . . . 0.0 113.074 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -99.94 119.59 38.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 117.171 0.485 . . . . 0.0 110.791 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -111.96 106.29 14.94 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 173.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.9 pt -120.91 168.07 13.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.163 -167.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.9 mtm -122.27 125.98 47.17 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 171.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 1.636 ' HD1' ' CD2' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -107.9 127.72 53.99 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 175.003 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 1.604 ' HD2' ' CD1' ' A' ' 78' ' ' TYR . 53.4 p90 -155.68 140.43 17.08 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 119.845 -0.742 . . . . 0.0 112.193 -175.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.659 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 12.0 p -106.09 138.85 41.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.958 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.09 153.23 22.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.413 174.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.45 -173.52 34.13 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -177.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -113.54 103.83 11.65 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.846 177.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.474 ' H ' ' HB3' ' A' ' 15' ' ' PRO . . . -170.87 153.65 4.0 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.89 169.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.7 p -110.23 123.23 49.4 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.15 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.566 ' CG1' ' HB3' ' A' ' 34' ' ' LEU . 10.9 m -124.74 153.35 31.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-O 121.459 0.647 . . . . 0.0 112.375 -173.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.5 m -113.26 126.78 55.78 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.854 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.526 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 4.6 mp -101.91 147.47 26.49 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 169.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.516 HD12 ' O ' ' A' ' 87' ' ' LEU . 2.3 mm? -125.22 154.3 41.81 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 173.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.67 -168.81 25.15 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 119.755 -1.212 . . . . 0.0 114.193 -178.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.514 ' CZ ' ' HB2' ' B' ' 68' ' ' ASN . 3.2 m-85 -117.56 118.92 33.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.344 -0.928 . . . . 0.0 110.392 -176.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.431 ' HB2' ' HB3' ' A' ' 7' ' ' MET . 16.5 mt . . . . . 0 C--N 1.317 -0.819 0 CA-C-O 121.12 0.486 . . . . 0.0 110.337 172.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' MET . . . . . 0.578 ' HA ' ' OG ' ' C' ' 70' ' ' SER . 16.6 ttt . . . . . 0 N--CA 1.456 -0.163 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . 1.622 ' HD1' ' CD2' ' B' ' 8' ' ' PHE . 54.4 t80 -79.51 129.72 34.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.034 0.445 . . . . 0.0 112.117 -177.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . 0.516 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 88.0 t90 -113.94 148.49 36.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.48 174.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.16 145.69 14.25 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.246 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.53 ' HB3' ' HB2' ' B' ' 87' ' ' LEU . 58.3 tp -139.16 110.12 6.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.941 0.4 . . . . 0.0 110.968 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -86.05 116.39 24.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.941 176.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' MET . . . . . 0.488 ' HB2' HG22 ' B' ' 85' ' ' VAL . 4.1 mmt -98.43 130.78 45.05 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -176.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.45 ' HD2' ' HD2' ' B' ' 15' ' ' PRO . 48.2 tptt -100.59 132.09 22.82 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 174.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.479 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 2.1 Cg_endo -46.24 117.82 2.14 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.441 2.761 . . . . 0.0 113.533 -175.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.66 ' HA ' ' O ' ' B' ' 79' ' ' THR . 37.9 mt-10 63.98 56.19 1.47 Allowed 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.492 178.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.75 135.29 52.86 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.644 172.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . 0.669 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 82.8 mttt -103.76 115.72 30.99 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 123.366 0.416 . . . . 0.0 111.236 177.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -105.49 102.82 12.26 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 14.7 p -89.3 98.84 11.99 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 173.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -111.78 146.39 37.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.389 0.614 . . . . 0.0 112.28 -167.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 28.9 m -100.43 143.1 31.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.249 174.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.446 ' CD1' ' HB2' ' B' ' 69' ' ' PHE . 54.2 mt -108.55 125.92 65.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.278 0.561 . . . . 0.0 111.748 -172.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.462 HD13 ' N ' ' B' ' 24' ' ' ILE . 4.2 mp -102.29 -50.56 9.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.825 176.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 12.8 pttp -103.13 122.31 44.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.63 174.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 35.6 t -60.97 142.73 56.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.95 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -147.83 148.24 30.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.963 0.887 . . . . 0.0 113.296 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' HIS . . . . . 0.519 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 2.1 t60 -102.55 125.15 49.17 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.692 176.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.482 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 46.8 mt -87.29 131.28 35.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 172.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.519 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 94.9 p -116.63 -12.33 10.92 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -169.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . 180.0 158.68 22.46 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 119.235 -1.46 . . . . 0.0 113.787 177.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 11.0 p -141.32 138.95 33.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 175.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -152.95 156.18 38.39 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.983 -0.448 . . . . 0.0 111.891 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.568 ' HB3' ' CG1' ' B' ' 85' ' ' VAL . 4.1 pp -125.31 148.03 48.88 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.52 0.676 . . . . 0.0 111.949 178.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -110.55 -55.3 2.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.129 169.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -100.79 128.06 46.98 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.26 174.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.466 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 150.42 163.02 10.95 Favored Glycine 0 N--CA 1.435 -1.423 0 C-N-CA 120.371 -0.918 . . . . 0.0 112.424 177.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -102.67 -46.94 4.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.647 0.26 . . . . 0.0 111.003 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -152.52 132.55 13.41 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.344 177.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.418 ' HB3' ' HB1' ' B' ' 83' ' ' ALA . . . -127.27 113.25 16.06 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.362 0.601 . . . . 0.0 110.166 167.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' B' ' 79' ' ' THR . 97.5 mttt -95.41 112.04 23.82 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 34.6 tp -86.15 107.47 17.88 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.711 -174.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . 1.594 ' HE2' ' CE1' ' B' ' 43' ' ' TYR . 74.8 m-85 -107.45 146.12 32.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.697 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.638 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 1.5 tp -129.94 116.39 18.55 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.69 176.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.57 109.24 21.07 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.203 0.525 . . . . 0.0 109.654 176.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -143.03 150.03 39.04 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.449 -177.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 57.41 30.88 19.31 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.44 0.638 . . . . 0.0 110.091 -179.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 61.18 40.55 14.59 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.213 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -144.19 136.74 26.83 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -87.43 117.67 26.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.867 0.365 . . . . 0.0 110.038 178.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 1.63 ' HD1' ' CD2' ' B' ' 51' ' ' TYR . 76.5 m-85 -112.73 122.98 49.25 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.698 178.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -80.82 100.91 5.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 170.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.453 HG13 ' CD2' ' A' ' 88' ' ' LEU . 21.5 m -86.52 -33.13 6.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.748 -172.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.465 ' HB1' HD22 ' B' ' 65' ' ' LEU . . . -153.12 144.54 23.27 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 120.284 -0.566 . . . . 0.0 112.208 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 27.2 m -115.55 102.4 9.75 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 169.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . 0.409 HG11 ' HB1' ' B' ' 40' ' ' ALA . 9.0 p -116.03 114.18 45.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.771 0.796 . . . . 0.0 110.149 -177.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 69.5 p -123.21 -177.19 3.62 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.905 -175.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -59.34 -35.87 74.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.06 0.457 . . . . 0.0 110.064 169.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.15 -40.6 71.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.538 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 79.0 mt -114.32 82.27 7.3 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.22 -6.77 17.02 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.329 2.686 . . . . 0.0 113.795 -168.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -161.44 132.12 5.15 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.409 0.623 . . . . 0.0 111.188 -175.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.46 HG12 ' HB3' ' B' ' 54' ' ' ALA . 87.8 t -119.77 118.75 58.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.532 176.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.86 128.15 33.34 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.465 HD22 ' HB1' ' B' ' 54' ' ' ALA . 86.0 mt -120.22 163.79 17.23 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.426 0.632 . . . . 0.0 112.297 -172.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -140.83 97.38 3.18 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.254 -0.884 . . . . 0.0 108.628 169.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' B' ' 28' ' ' HIS . 2.7 mt -131.19 156.3 45.57 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . 0.514 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 42.7 t-20 -155.32 128.68 8.36 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 174.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . 1.638 ' HD1' ' CD2' ' B' ' 69' ' ' PHE . 4.2 m-85 -123.88 145.05 49.38 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' SER . . . . . 0.555 ' OG ' ' HA ' ' A' ' 7' ' ' MET . 37.6 m -100.41 -178.54 3.84 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -175.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -62.31 -30.98 71.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.301 0.572 . . . . 0.0 110.31 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.91 4.53 85.08 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.696 -0.683 . . . . 0.0 113.022 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -100.06 119.56 38.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.058 0.456 . . . . 0.0 110.79 178.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -111.91 106.33 15.01 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 173.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 10.8 pt -121.02 168.0 13.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.193 -167.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' MET . . . . . . . . . . . . . 3.8 mtm -122.21 125.92 47.12 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 171.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . 1.65 ' HD1' ' CD2' ' B' ' 77' ' ' PHE . 0.3 OUTLIER -107.94 127.8 54.07 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 175.006 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 1.596 ' HE2' ' CE1' ' B' ' 78' ' ' TYR . 53.8 p90 -155.75 140.32 16.91 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 119.858 -0.737 . . . . 0.0 112.191 -175.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.66 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 12.1 p -105.98 138.8 41.54 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.975 -179.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.16 153.17 23.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.429 174.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.6 -173.5 33.89 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -113.53 103.88 11.71 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.832 177.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.479 ' H ' ' HB3' ' B' ' 15' ' ' PRO . . . -170.9 153.64 3.96 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.845 169.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 5.4 p -110.22 123.17 49.29 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.207 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.568 ' CG1' ' HB3' ' B' ' 34' ' ' LEU . 10.9 m -124.74 153.25 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-O 121.473 0.654 . . . . 0.0 112.364 -173.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 28.6 m -113.2 126.81 55.83 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.816 175.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.53 ' HB2' ' HB3' ' B' ' 11' ' ' LEU . 4.6 mp -101.98 147.46 26.54 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 169.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.514 HD12 ' O ' ' B' ' 87' ' ' LEU . 2.3 mm? -125.21 154.14 42.05 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 173.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.64 -168.73 24.99 Favored Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 119.776 -1.202 . . . . 0.0 114.21 -178.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 90' ' ' TYR . . . . . 0.517 ' CZ ' ' HB2' ' C' ' 68' ' ' ASN . 3.2 m-85 -117.55 118.91 33.45 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.348 -0.926 . . . . 0.0 110.396 -176.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . 0.445 ' HB2' ' HB3' ' B' ' 7' ' ' MET . 16.4 mt . . . . . 0 C--N 1.316 -0.852 0 CA-C-O 121.164 0.507 . . . . 0.0 110.336 172.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 7' ' ' MET . . . . . 0.504 ' HA ' ' OG ' ' D' ' 70' ' ' SER . 16.6 ttt . . . . . 0 N--CA 1.456 -0.151 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 8' ' ' PHE . . . . . 1.628 ' HE2' ' CE1' ' C' ' 8' ' ' PHE . 54.6 t80 -79.55 129.77 34.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.994 0.426 . . . . 0.0 112.093 -177.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . 0.518 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 87.9 t90 -114.01 148.52 36.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.456 174.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.23 145.58 14.0 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.286 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.529 ' HB3' ' HB2' ' C' ' 87' ' ' LEU . 58.3 tp -139.11 110.15 6.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.981 0.419 . . . . 0.0 110.937 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -86.01 116.37 24.18 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.98 176.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 13' ' ' MET . . . . . 0.506 ' HB2' HG22 ' C' ' 85' ' ' VAL . 4.1 mmt -98.48 130.74 45.08 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -176.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . 0.437 ' HD2' ' HD2' ' C' ' 15' ' ' PRO . 48.2 tptt -100.58 132.18 22.71 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 174.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . 0.479 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 2.0 Cg_endo -46.4 117.84 2.21 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.479 2.786 . . . . 0.0 113.52 -175.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . 0.663 ' HA ' ' O ' ' C' ' 79' ' ' THR . 38.0 mt-10 64.14 56.03 1.43 Allowed 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.481 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.75 135.31 52.88 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.64 173.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 18' ' ' LYS . . . . . 0.673 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 82.7 mttt -103.74 115.87 31.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.157 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . 0.41 ' HH ' ' HA ' ' C' ' 13' ' ' MET . 4.6 m-85 -105.56 102.81 12.25 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 175.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 15.3 p -89.43 98.92 12.04 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 173.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -111.82 146.46 37.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.178 -167.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 28.7 m -100.54 143.18 31.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.253 174.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . 0.452 ' CD1' ' HB2' ' C' ' 69' ' ' PHE . 53.8 mt -108.58 125.89 65.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.236 0.541 . . . . 0.0 111.722 -172.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . 0.458 HD13 ' N ' ' C' ' 24' ' ' ILE . 4.2 mp -102.28 -50.59 9.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.43 -0.804 . . . . 0.0 108.88 176.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 12.8 pttp -103.17 122.27 44.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.616 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 35.6 t -60.88 142.77 55.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.02 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 27' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -147.87 148.28 30.68 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 28' ' ' HIS . . . . . 0.52 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 2.1 t60 -102.62 125.25 49.28 Favored 'General case' 0 C--O 1.217 -0.658 0 CA-C-N 114.084 -1.416 . . . . 0.0 109.645 176.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . 0.479 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 46.7 mt -87.33 131.36 35.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 172.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 30' ' ' SER . . . . . 0.52 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 94.6 p -116.73 -12.24 10.87 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -169.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 31' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . 179.99 158.73 22.53 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 119.073 -1.536 . . . . 0.0 113.651 177.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 11.0 p -141.27 138.93 33.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 175.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -152.92 156.22 38.51 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.98 -0.45 . . . . 0.0 111.94 -177.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.565 ' HB3' ' CG1' ' C' ' 85' ' ' VAL . 4.1 pp -125.35 148.03 48.91 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.571 0.7 . . . . 0.0 111.892 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -110.62 -55.12 2.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.162 169.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -100.92 127.98 47.15 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.157 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 37' ' ' GLY . . . . . 0.456 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 150.49 163.04 10.97 Favored Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 120.333 -0.936 . . . . 0.0 112.461 177.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -102.67 -47.03 4.55 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.567 0.222 . . . . 0.0 111.001 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -152.42 132.54 13.5 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.364 177.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . 0.416 ' HB3' ' HB1' ' C' ' 83' ' ' ALA . . . -127.28 113.24 16.04 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.42 0.629 . . . . 0.0 110.113 168.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' C' ' 79' ' ' THR . 97.5 mttt -95.37 112.06 23.83 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 175.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 34.6 tp -86.17 107.48 17.9 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -174.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 43' ' ' TYR . . . . . 1.622 ' HE2' ' CE1' ' C' ' 43' ' ' TYR . 74.6 m-85 -107.47 146.14 32.15 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.7 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.649 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 1.5 tp -129.98 116.3 18.39 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.67 176.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.53 109.3 21.14 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.166 0.508 . . . . 0.0 109.668 176.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -143.12 150.1 39.01 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.495 -177.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 57.25 31.02 19.4 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.396 0.617 . . . . 0.0 110.033 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 97.0 mttt 61.13 40.5 14.8 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.261 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 15.0 tp60 -144.18 136.76 26.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.9 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -87.35 117.68 26.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.847 0.356 . . . . 0.0 110.066 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 1.649 ' HD1' ' CD2' ' C' ' 51' ' ' TYR . 76.6 m-85 -112.79 123.02 49.37 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.651 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -80.85 100.92 5.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 170.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 53' ' ' VAL . . . . . 0.461 HG13 ' CD2' ' B' ' 88' ' ' LEU . 21.5 m -86.46 -33.18 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.756 -172.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 54' ' ' ALA . . . . . 0.46 ' HB1' HD22 ' C' ' 65' ' ' LEU . . . -153.16 144.51 23.2 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 120.394 -0.522 . . . . 0.0 112.201 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 27.3 m -115.52 102.5 9.85 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 169.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . 0.409 HG11 ' HB1' ' C' ' 40' ' ' ALA . 9.0 p -116.13 114.12 45.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.763 0.792 . . . . 0.0 110.18 -177.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 69.7 p -123.15 -177.18 3.61 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.972 -175.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -59.32 -35.93 74.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.075 0.465 . . . . 0.0 110.015 169.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . 0.401 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -71.17 -40.56 71.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.527 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 79.0 mt -114.36 82.29 7.38 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 174.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 61' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 17.2 Cg_exo -67.27 -6.72 16.96 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.268 2.645 . . . . 0.0 113.851 -168.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -161.46 132.16 5.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.288 0.566 . . . . 0.0 111.2 -175.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.457 HG12 ' HB3' ' C' ' 54' ' ' ALA . 87.9 t -119.76 118.61 57.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.524 176.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.79 128.13 33.3 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . 0.46 HD22 ' HB1' ' C' ' 54' ' ' ALA . 85.9 mt -120.14 163.86 17.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.396 0.617 . . . . 0.0 112.277 -172.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -140.9 97.43 3.19 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.206 -0.907 . . . . 0.0 108.554 169.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' C' ' 28' ' ' HIS . 2.8 mt -131.22 156.31 45.58 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . 0.517 ' HB2' ' CZ ' ' B' ' 90' ' ' TYR . 42.7 t-20 -155.27 128.71 8.4 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 174.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 69' ' ' PHE . . . . . 1.66 ' HD1' ' CD2' ' C' ' 69' ' ' PHE . 4.2 m-85 -123.91 145.08 49.38 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 70' ' ' SER . . . . . 0.578 ' OG ' ' HA ' ' B' ' 7' ' ' MET . 37.7 m -100.51 -178.46 3.81 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -175.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -62.33 -30.91 71.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.244 0.545 . . . . 0.0 110.399 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.92 4.5 85.15 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.76 -0.654 . . . . 0.0 113.005 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -100.05 119.55 38.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.109 0.454 . . . . 0.0 110.81 178.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -111.96 106.34 15.0 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 173.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 10.8 pt -121.01 167.99 13.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.128 -167.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 76' ' ' MET . . . . . . . . . . . . . 3.9 mtm -122.15 126.06 47.52 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 171.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 77' ' ' PHE . . . . . 1.66 ' HD1' ' CD2' ' C' ' 77' ' ' PHE . 0.3 OUTLIER -107.99 127.7 53.99 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 174.864 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 78' ' ' TYR . . . . . 1.625 ' HE1' ' CE2' ' C' ' 78' ' ' TYR . 53.7 p90 -155.58 140.33 17.1 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 119.808 -0.757 . . . . 0.0 112.208 -175.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 79' ' ' THR . . . . . 0.663 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 12.3 p -105.9 138.82 41.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.052 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.13 153.21 22.98 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.364 174.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.46 -173.45 34.05 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -177.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -113.55 103.82 11.64 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.654 0.727 . . . . 0.0 109.842 177.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . 0.479 ' H ' ' HB3' ' C' ' 15' ' ' PRO . . . -170.92 153.6 3.93 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.813 169.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 5.7 p -110.22 123.27 49.47 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.192 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.565 ' CG1' ' HB3' ' C' ' 34' ' ' LEU . 10.8 m -124.82 153.36 31.76 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-O 121.447 0.642 . . . . 0.0 112.347 -173.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 29.0 m -113.3 126.66 55.63 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.772 175.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . 0.529 ' HB2' ' HB3' ' C' ' 11' ' ' LEU . 4.6 mp -101.83 147.42 26.52 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 169.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . 0.513 HD12 ' O ' ' C' ' 87' ' ' LEU . 2.3 mm? -125.21 154.19 41.98 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 173.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.65 -168.73 25.0 Favored Glycine 0 N--CA 1.438 -1.213 0 C-N-CA 119.753 -1.213 . . . . 0.0 114.222 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 90' ' ' TYR . . . . . 0.483 ' CZ ' ' HB2' ' D' ' 68' ' ' ASN . 3.2 m-85 -117.62 118.96 33.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.351 -0.925 . . . . 0.0 110.29 -176.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . 0.451 ' HB2' ' HB3' ' C' ' 7' ' ' MET . 16.4 mt . . . . . 0 C--N 1.317 -0.821 0 CA-C-O 121.199 0.523 . . . . 0.0 110.35 172.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 7' ' ' MET . . . . . 0.549 ' HA ' ' OG ' ' E' ' 70' ' ' SER . 16.6 ttt . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 8' ' ' PHE . . . . . 1.656 ' HE2' ' CE1' ' D' ' 8' ' ' PHE . 54.5 t80 -79.59 129.62 34.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.005 0.431 . . . . 0.0 112.135 -177.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 9' ' ' TRP . . . . . 0.52 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 87.9 t90 -113.81 148.51 36.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.496 174.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.18 145.66 14.18 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.225 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' D' ' 87' ' ' LEU . 58.7 tp -139.11 110.15 6.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.893 0.378 . . . . 0.0 111.005 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -86.09 116.47 24.32 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.916 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 13' ' ' MET . . . . . 0.502 ' HB2' HG22 ' D' ' 85' ' ' VAL . 4.1 mmt -98.49 130.66 45.09 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -176.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 14' ' ' LYS . . . . . 0.444 ' HD2' ' HD2' ' D' ' 15' ' ' PRO . 48.2 tptt -100.54 132.11 22.83 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . 0.48 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 1.9 Cg_endo -46.32 117.82 2.17 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.527 2.818 . . . . 0.0 113.464 -175.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . 0.648 ' HA ' ' O ' ' D' ' 79' ' ' THR . 37.9 mt-10 64.08 56.14 1.44 Allowed 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.452 178.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.79 135.38 52.91 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.609 172.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . 0.664 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 82.8 mttt -103.68 115.76 31.09 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 123.327 0.392 . . . . 0.0 111.168 177.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 19' ' ' TYR . . . . . 0.405 ' HH ' ' HA ' ' D' ' 13' ' ' MET . 4.5 m-85 -105.49 102.84 12.29 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 175.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 14.9 p -89.4 98.89 12.02 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -111.8 146.36 37.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.306 -167.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 29.0 m -100.47 143.17 30.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.234 174.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . 0.451 ' CD1' ' HB2' ' D' ' 69' ' ' PHE . 54.1 mt -108.46 125.87 65.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.193 0.52 . . . . 0.0 111.774 -172.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . 0.454 ' N ' HD13 ' D' ' 24' ' ' ILE . 4.2 mp -102.31 -50.57 9.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.382 -0.826 . . . . 0.0 108.884 176.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 12.8 pttp -103.17 122.38 44.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.604 174.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 35.6 t -60.86 142.7 55.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.923 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 27' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -147.83 148.33 30.77 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 28' ' ' HIS . . . . . 0.514 ' HA ' ' O ' ' D' ' 67' ' ' LEU . 2.1 t60 -102.66 125.2 49.31 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 114.106 -1.407 . . . . 0.0 109.649 176.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 29' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 46.9 mt -87.3 131.31 35.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 172.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 30' ' ' SER . . . . . 0.508 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 94.6 p -116.66 -12.24 10.92 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -169.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 31' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . 179.92 158.7 22.44 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 119.145 -1.502 . . . . 0.0 113.72 177.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 11.0 p -141.3 138.85 33.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 175.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -152.85 156.23 38.61 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.878 -0.514 . . . . 0.0 111.92 -177.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 34' ' ' LEU . . . . . 0.567 ' HB3' ' CG1' ' D' ' 85' ' ' VAL . 4.1 pp -125.33 148.01 48.9 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.475 0.655 . . . . 0.0 111.944 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -110.57 -55.28 2.49 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.14 169.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -100.76 128.0 46.97 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.154 174.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . 0.469 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 150.39 163.09 10.99 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.428 177.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -102.63 -47.01 4.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 120.58 0.228 . . . . 0.0 110.984 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -152.47 132.52 13.44 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.346 177.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . 0.41 ' HB3' ' HB1' ' D' ' 83' ' ' ALA . . . -127.26 113.26 16.08 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.414 0.626 . . . . 0.0 110.093 168.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' D' ' 79' ' ' THR . 97.5 mttt -95.34 112.01 23.79 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 34.6 tp -86.2 107.41 17.88 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -174.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 43' ' ' TYR . . . . . 1.644 ' HE2' ' CE1' ' D' ' 43' ' ' TYR . 75.1 m-85 -107.4 146.09 32.1 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.73 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.647 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 1.5 tp -129.95 116.34 18.47 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.65 176.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.62 109.3 21.16 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -143.04 150.18 39.24 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.423 -177.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 57.2 30.94 19.21 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.397 0.618 . . . . 0.0 110.043 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 61.2 40.59 14.47 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.154 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -144.16 136.66 26.8 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -87.3 117.71 26.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.912 0.387 . . . . 0.0 110.027 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . 1.659 ' HD1' ' CD2' ' D' ' 51' ' ' TYR . 76.6 m-85 -112.84 123.09 49.52 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.671 178.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -80.9 100.87 5.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 170.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 53' ' ' VAL . . . . . 0.454 HG13 ' CD2' ' C' ' 88' ' ' LEU . 21.4 m -86.42 -33.25 7.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.714 -172.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 54' ' ' ALA . . . . . 0.455 ' HB1' HD22 ' D' ' 65' ' ' LEU . . . -153.13 144.49 23.22 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 120.301 -0.56 . . . . 0.0 112.264 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 27.5 m -115.51 102.46 9.82 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 169.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 56' ' ' VAL . . . . . . . . . . . . . 8.9 p -116.12 114.19 45.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.75 0.786 . . . . 0.0 110.119 -177.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 67.7 p -123.19 -177.19 3.62 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.931 -175.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -59.27 -35.99 74.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.075 0.464 . . . . 0.0 110.008 169.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.16 -40.49 71.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.632 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 79.0 mt -114.33 82.28 7.33 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.26 -6.63 16.74 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.251 2.634 . . . . 0.0 113.904 -168.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -161.49 132.12 5.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.322 0.582 . . . . 0.0 111.169 -175.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.454 HG12 ' HB3' ' D' ' 54' ' ' ALA . 88.2 t -119.75 118.72 58.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.551 176.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.84 128.08 33.26 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 174.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 65' ' ' LEU . . . . . 0.455 HD22 ' HB1' ' D' ' 54' ' ' ALA . 86.1 mt -120.17 163.87 17.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.412 0.625 . . . . 0.0 112.287 -172.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -140.91 97.45 3.19 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 169.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' D' ' 28' ' ' HIS . 2.7 mt -131.21 156.29 45.6 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 68' ' ' ASN . . . . . 0.483 ' HB2' ' CZ ' ' C' ' 90' ' ' TYR . 42.8 t-20 -155.27 128.7 8.4 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 174.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 69' ' ' PHE . . . . . 1.657 ' HE1' ' CE2' ' D' ' 69' ' ' PHE . 4.3 m-85 -123.96 145.15 49.36 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 70' ' ' SER . . . . . 0.504 ' OG ' ' HA ' ' C' ' 7' ' ' MET . 37.7 m -100.43 -178.5 3.82 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -175.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -62.39 -30.9 71.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.291 0.567 . . . . 0.0 110.342 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.87 4.39 85.23 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.035 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -100.04 119.51 38.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.988 0.423 . . . . 0.0 110.775 178.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -111.81 106.37 15.1 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 173.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . . . . . . . . . 10.9 pt -121.05 168.04 13.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.087 -167.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 76' ' ' MET . . . . . . . . . . . . . 3.9 mtm -122.27 125.96 47.14 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 171.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 77' ' ' PHE . . . . . 1.663 ' HE2' ' CE1' ' D' ' 77' ' ' PHE . 0.3 OUTLIER -107.95 127.72 54.0 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 78' ' ' TYR . . . . . 1.626 ' HE2' ' CE1' ' D' ' 78' ' ' TYR . 53.4 p90 -155.65 140.32 17.02 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.849 -0.74 . . . . 0.0 112.198 -175.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 79' ' ' THR . . . . . 0.648 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 12.1 p -106.04 138.85 41.51 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.017 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.17 153.15 23.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.401 174.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.54 -173.58 34.06 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -176.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -113.52 103.8 11.62 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.879 177.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.48 ' H ' ' HB3' ' D' ' 15' ' ' PRO . . . -170.83 153.54 3.99 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.89 169.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 5.8 p -110.13 123.2 49.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.237 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . 0.567 ' CG1' ' HB3' ' D' ' 34' ' ' LEU . 11.0 m -124.7 153.39 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-O 121.381 0.61 . . . . 0.0 112.38 -173.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 27.8 m -113.31 126.75 55.73 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.843 175.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 87' ' ' LEU . . . . . 0.523 ' HB2' ' HB3' ' D' ' 11' ' ' LEU . 4.6 mp -101.89 147.47 26.49 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 169.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . 0.521 HD12 ' O ' ' D' ' 87' ' ' LEU . 2.3 mm? -125.2 154.19 41.96 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 173.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.75 -168.81 25.24 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 119.758 -1.21 . . . . 0.0 114.165 -178.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 90' ' ' TYR . . . . . 0.527 ' CZ ' ' HB2' ' E' ' 68' ' ' ASN . 3.2 m-85 -117.61 118.9 33.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.375 -0.912 . . . . 0.0 110.34 -176.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . 0.452 ' HB2' ' HB3' ' D' ' 7' ' ' MET . 16.5 mt . . . . . 0 C--N 1.317 -0.845 0 CA-C-O 121.09 0.472 . . . . 0.0 110.377 172.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 7' ' ' MET . . . . . 0.522 ' HA ' ' OG ' ' A' ' 70' ' ' SER . 16.6 ttt . . . . . 0 CA--C 1.53 0.176 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 8' ' ' PHE . . . . . 1.664 ' HD1' ' CD2' ' E' ' 8' ' ' PHE . 54.1 t80 -79.71 129.73 34.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.076 0.465 . . . . 0.0 112.048 -177.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 9' ' ' TRP . . . . . 0.525 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 87.8 t90 -113.87 148.54 36.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.537 174.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.24 145.63 14.11 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.236 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 11' ' ' LEU . . . . . 0.546 ' HB3' ' HB2' ' E' ' 87' ' ' LEU . 58.3 tp -139.16 110.19 6.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.909 0.385 . . . . 0.0 110.981 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -86.07 116.37 24.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.931 176.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 13' ' ' MET . . . . . 0.504 ' HB2' HG22 ' E' ' 85' ' ' VAL . 4.1 mmt -98.41 130.77 45.04 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -176.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 14' ' ' LYS . . . . . 0.445 ' HD2' ' HD2' ' E' ' 15' ' ' PRO . 48.3 tptt -100.65 132.13 22.71 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 174.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . 0.468 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 2.0 Cg_endo -46.22 117.75 2.1 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 123.513 2.808 . . . . 0.0 113.507 -175.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 16' ' ' GLU . . . . . 0.654 ' HA ' ' O ' ' E' ' 79' ' ' THR . 37.8 mt-10 64.05 56.18 1.44 Allowed 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.472 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.73 135.29 52.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.673 172.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . 0.668 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 82.9 mttt -103.65 115.76 31.1 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 123.302 0.376 . . . . 0.0 111.249 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . 0.408 ' HH ' ' HA ' ' E' ' 13' ' ' MET . 4.6 m-85 -105.48 102.84 12.28 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 175.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 15.4 p -89.35 98.85 12.0 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 173.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -111.92 146.41 37.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.449 0.642 . . . . 0.0 112.203 -167.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 29.2 m -100.49 143.1 31.07 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.218 174.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 23' ' ' ILE . . . . . 0.445 ' CD1' ' HB2' ' E' ' 69' ' ' PHE . 54.1 mt -108.52 125.92 65.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.143 0.497 . . . . 0.0 111.786 -172.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . 0.456 ' N ' HD13 ' E' ' 24' ' ' ILE . 4.3 mp -102.36 -50.56 9.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.823 176.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 12.7 pttp -103.24 122.37 44.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.56 174.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 35.6 t -60.94 142.71 56.2 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.936 -177.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 27' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -147.85 148.29 30.72 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -177.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 28' ' ' HIS . . . . . 0.513 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 2.1 t60 -102.52 125.18 49.16 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.714 176.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 29' ' ' ILE . . . . . 0.478 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 46.5 mt -87.32 131.28 35.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 172.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 30' ' ' SER . . . . . 0.513 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 94.9 p -116.61 -12.23 10.95 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -169.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 31' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . 179.95 158.65 22.37 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 119.144 -1.503 . . . . 0.0 113.724 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 11.0 p -141.28 138.94 33.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -152.91 156.17 38.41 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.967 -0.458 . . . . 0.0 111.945 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 34' ' ' LEU . . . . . 0.569 ' HB3' ' CG1' ' E' ' 85' ' ' VAL . 4.1 pp -125.29 148.06 48.86 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.593 0.711 . . . . 0.0 111.968 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -110.68 -55.13 2.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.068 169.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -100.87 127.96 47.11 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.226 174.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . 0.471 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 150.49 163.07 10.99 Favored Glycine 0 N--CA 1.434 -1.489 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.437 177.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 38' ' ' GLN . . . . . 0.401 ' HA ' ' HD2' ' E' ' 58' ' ' LYS . 25.7 mt-30 -102.6 -47.07 4.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.552 0.215 . . . . 0.0 111.037 176.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -152.45 132.45 13.41 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.356 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . 0.414 ' HB3' ' HB1' ' E' ' 83' ' ' ALA . . . -127.25 113.29 16.12 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.386 0.612 . . . . 0.0 110.109 168.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 41' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' E' ' 79' ' ' THR . 97.6 mttt -95.45 112.11 23.88 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 175.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 34.6 tp -86.21 107.53 17.95 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -174.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 43' ' ' TYR . . . . . 1.629 ' HE2' ' CE1' ' E' ' 43' ' ' TYR . 75.4 m-85 -107.41 146.01 32.23 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.765 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 44' ' ' LEU . . . . . 0.635 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 1.5 tp -129.93 116.42 18.61 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.662 176.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.55 109.31 21.15 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -143.13 150.12 39.02 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.407 -177.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 57.32 30.9 19.26 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.429 0.633 . . . . 0.0 110.047 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 61.29 40.46 14.37 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.201 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 49' ' ' GLN . . . . . . . . . . . . . 15.0 tp60 -144.12 136.7 26.89 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.932 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -87.34 117.7 26.28 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.901 0.382 . . . . 0.0 110.076 178.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . 1.656 ' HD1' ' CD2' ' E' ' 51' ' ' TYR . 76.7 m-85 -112.83 123.02 49.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.655 178.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -80.87 100.95 5.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 170.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . 0.44 HG13 ' CD2' ' D' ' 88' ' ' LEU . 21.5 m -86.42 -33.29 7.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.7 -172.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 54' ' ' ALA . . . . . 0.462 ' HB1' HD22 ' E' ' 65' ' ' LEU . . . -153.2 144.52 23.17 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 120.271 -0.571 . . . . 0.0 112.203 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 27.5 m -115.46 102.45 9.83 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 169.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . 0.409 HG11 ' HB1' ' E' ' 40' ' ' ALA . 9.0 p -116.13 114.2 45.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.819 0.818 . . . . 0.0 110.097 -177.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 70.4 p -123.26 -177.05 3.59 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.91 -175.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 58' ' ' LYS . . . . . 0.401 ' HD2' ' HA ' ' E' ' 38' ' ' GLN . 27.2 mtpp -59.32 -35.91 74.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.257 0.551 . . . . 0.0 110.048 169.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 59' ' ' ALA . . . . . 0.407 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -71.25 -40.56 70.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.487 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 79.5 mt -114.34 82.37 7.42 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 174.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 61' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 17.2 Cg_exo -67.37 -6.67 16.94 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.232 2.621 . . . . 0.0 113.893 -168.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -161.41 132.09 5.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.256 0.551 . . . . 0.0 111.252 -175.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . 0.447 HG12 ' HB3' ' E' ' 54' ' ' ALA . 87.3 t -119.76 118.72 58.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.511 176.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.85 128.19 33.38 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 174.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 65' ' ' LEU . . . . . 0.462 HD22 ' HB1' ' E' ' 54' ' ' ALA . 86.2 mt -120.2 163.75 17.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.339 0.59 . . . . 0.0 112.283 -172.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 66' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -140.79 97.39 3.18 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 169.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 67' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' E' ' 28' ' ' HIS . 2.7 mt -131.19 156.29 45.6 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 68' ' ' ASN . . . . . 0.527 ' HB2' ' CZ ' ' D' ' 90' ' ' TYR . 42.6 t-20 -155.31 128.67 8.35 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 69' ' ' PHE . . . . . 1.643 ' HE2' ' CE1' ' E' ' 69' ' ' PHE . 4.2 m-85 -123.88 145.07 49.36 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 70' ' ' SER . . . . . 0.549 ' OG ' ' HA ' ' D' ' 7' ' ' MET . 37.1 m -100.43 -178.56 3.84 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -175.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -62.37 -30.75 71.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.245 0.545 . . . . 0.0 110.422 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -85.08 4.52 85.36 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.949 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -100.11 119.53 38.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.11 0.455 . . . . 0.0 110.795 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -111.83 106.39 15.11 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 173.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 75' ' ' ILE . . . . . . . . . . . . . 10.8 pt -121.05 167.96 13.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.134 -167.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 76' ' ' MET . . . . . . . . . . . . . 3.9 mtm -122.21 126.04 47.38 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 171.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 77' ' ' PHE . . . . . 1.664 ' HE2' ' CE1' ' E' ' 77' ' ' PHE . 0.3 OUTLIER -107.89 127.73 53.99 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 174.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' E' E ' 78' ' ' TYR . . . . . 1.625 ' HE2' ' CE1' ' E' ' 78' ' ' TYR . 53.3 p90 -155.63 140.37 17.08 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 119.818 -0.753 . . . . 0.0 112.187 -175.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 79' ' ' THR . . . . . 0.654 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 12.1 p -106.07 138.93 41.4 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.948 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.19 153.15 23.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.418 174.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.53 -173.37 33.86 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -177.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -113.66 103.83 11.62 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.87 177.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 83' ' ' ALA . . . . . 0.471 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -170.98 153.56 3.86 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.856 169.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 5.6 p -110.24 123.15 49.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.246 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 85' ' ' VAL . . . . . 0.569 ' CG1' ' HB3' ' E' ' 34' ' ' LEU . 11.1 m -124.71 153.26 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-O 121.456 0.646 . . . . 0.0 112.388 -173.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 29.3 m -113.2 126.82 55.85 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.833 175.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 87' ' ' LEU . . . . . 0.546 ' HB2' ' HB3' ' E' ' 11' ' ' LEU . 4.6 mp -101.99 147.5 26.48 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 169.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . 0.518 HD12 ' O ' ' E' ' 87' ' ' LEU . 2.3 mm? -125.27 154.17 42.11 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 173.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.65 -168.76 25.05 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 119.728 -1.225 . . . . 0.0 114.161 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 90' ' ' TYR . . . . . 0.505 ' CZ ' ' HB2' ' A' ' 68' ' ' ASN . 3.2 m-85 -117.61 118.99 33.64 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.328 -0.936 . . . . 0.0 110.295 -176.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 91' ' ' LEU . . . . . 0.437 ' HB2' ' HB3' ' E' ' 7' ' ' MET . 16.4 mt . . . . . 0 C--N 1.317 -0.815 0 CA-C-O 121.189 0.519 . . . . 0.0 110.352 172.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.421 ' HA ' ' HB2' ' B' ' 70' ' ' SER . 46.1 ttm . . . . . 0 C--O 1.223 -0.334 0 CA-C-O 120.707 0.289 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 1.651 ' HD1' ' CD2' ' A' ' 8' ' ' PHE . 68.0 t80 -61.3 147.53 44.28 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -172.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.406 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 89.5 t90 -138.55 145.53 40.79 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.842 179.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.69 151.44 23.54 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.039 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.512 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 40.8 tp -146.28 109.66 4.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.63 0.252 . . . . 0.0 110.884 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 52.7 m-20 -88.46 125.31 34.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.475 0.655 . . . . 0.0 111.096 176.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.459 ' HB2' HG21 ' A' ' 85' ' ' VAL . 7.0 mmt -98.31 130.21 44.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.432 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.418 ' HB3' ' CG ' ' A' ' 17' ' ' ARG . 59.7 tttm -96.98 134.25 23.19 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 171.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.407 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 2.2 Cg_endo -43.95 112.95 0.36 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.398 2.732 . . . . 0.0 113.401 -174.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.667 ' HA ' ' O ' ' A' ' 79' ' ' THR . 48.8 mt-10 69.45 44.25 0.94 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.811 178.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.418 ' CG ' ' HB3' ' A' ' 14' ' ' LYS . 12.0 mmt180 -104.61 138.27 41.2 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.961 170.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.612 ' HG2' ' CB ' ' A' ' 78' ' ' TYR . 46.6 mttp -113.18 118.75 35.58 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 123.392 0.432 . . . . 0.0 110.501 175.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 1.613 ' HD1' ' CD2' ' A' ' 19' ' ' TYR . 6.2 m-85 -110.51 103.84 12.49 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 177.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 76' ' ' MET . 42.7 t -86.43 102.46 14.07 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 172.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -116.84 144.36 44.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.799 -170.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.1 t -97.84 157.0 16.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.01 174.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.4 mt -120.3 124.11 71.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.098 0.475 . . . . 0.0 111.365 -173.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.553 HD11 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -114.44 -18.32 7.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.894 176.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -132.47 121.79 23.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.657 176.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.0 t -65.73 133.44 51.07 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.056 -174.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.447 ' HB3' HD21 ' A' ' 91' ' ' LEU . 46.5 p90 -137.59 147.28 44.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.648 0.737 . . . . 0.0 112.219 -177.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.532 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 7.4 t60 -104.64 125.06 50.39 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.664 174.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 45.0 mt -90.87 133.19 33.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 170.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.532 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 67.8 p -119.82 -7.36 10.01 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -171.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -175.64 159.14 26.74 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 119.2 -1.476 . . . . 0.0 113.706 177.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 86' ' ' SER . 11.1 p -144.43 131.7 16.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.5 157.66 43.61 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.968 -0.458 . . . . 0.0 112.115 -175.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.56 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 4.2 pp -126.63 146.18 50.27 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.541 0.686 . . . . 0.0 111.996 178.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -110.76 -52.19 2.81 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.614 -1.175 . . . . 0.0 108.864 168.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -99.74 127.68 45.87 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.426 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 142.4 159.4 7.92 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.543 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -101.47 -45.41 5.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.723 0.297 . . . . 0.0 111.164 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -152.27 126.45 9.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.582 -179.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.416 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . . . -127.61 113.7 16.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.389 0.614 . . . . 0.0 110.221 169.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -99.35 112.16 24.39 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 174.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.1 tp -81.61 115.51 20.92 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.692 -175.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 1.63 ' HE2' ' CE1' ' A' ' 43' ' ' TYR . 74.8 m-85 -115.53 145.33 42.74 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.49 0.662 . . . . 0.0 110.245 178.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.611 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 0.9 OUTLIER -128.58 118.28 22.71 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.774 177.083 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -105.61 104.47 14.19 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.67 177.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.64 139.76 52.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.564 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 57.99 31.06 20.12 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 123.605 0.565 . . . . 0.0 110.06 -174.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 62.18 30.34 17.68 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.298 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 8.4 tp-100 -121.42 125.6 47.32 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 177.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -83.08 117.2 22.69 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.792 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -113.6 132.42 55.75 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.727 175.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -81.34 112.56 19.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 168.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.495 ' CG2' ' HB3' ' A' ' 44' ' ' LEU . 3.4 t -86.98 -51.62 12.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.737 -172.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.455 ' HB3' HG12 ' A' ' 63' ' ' VAL . . . -151.53 144.88 24.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.453 -176.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.5 m -109.29 101.7 10.69 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 171.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.18 110.84 32.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.907 0.86 . . . . 0.0 109.987 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 81.0 p -123.58 -177.47 3.73 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.356 -174.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -56.98 -34.98 68.64 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.862 0.363 . . . . 0.0 110.634 167.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.98 -40.68 65.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.526 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.9 mt -116.24 83.37 12.71 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.39 -3.76 11.58 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.129 2.553 . . . . 0.0 113.972 -168.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -162.84 130.86 3.81 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.26 0.553 . . . . 0.0 111.17 -176.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.455 HG12 ' HB3' ' A' ' 54' ' ' ALA . 87.0 t -118.53 117.44 54.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.636 175.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.48 126.93 31.83 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.726 174.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.442 HD22 ' HB1' ' A' ' 54' ' ' ALA . 74.7 mt -121.02 167.02 13.05 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.405 0.621 . . . . 0.0 112.295 -173.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.443 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 10.9 t0 -137.51 98.18 3.64 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.549 168.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.533 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 4.9 mt -124.75 146.38 49.22 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -148.25 120.85 8.57 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.072 175.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -116.62 141.62 47.96 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.897 -177.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.451 ' HB2' ' HA ' ' E' ' 7' ' ' MET . 9.0 t -96.98 169.26 9.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.902 0.382 . . . . 0.0 110.145 -177.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -75.23 0.34 16.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.755 -178.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.08 -4.16 56.64 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 173.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -95.51 147.09 23.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.01 0.433 . . . . 0.0 110.926 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -130.85 118.24 20.47 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 172.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.43 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 16.8 pt -130.55 157.3 42.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.087 0.47 . . . . 0.0 111.869 -169.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.425 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 67.1 ttp -119.51 114.78 22.8 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.03 175.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 1.621 ' HE2' ' CE1' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -100.82 129.8 46.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.961 -177.119 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 1.655 ' HD1' ' CD2' ' A' ' 78' ' ' TYR . 53.4 p90 -152.5 150.66 29.84 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 119.959 -0.696 . . . . 0.0 112.049 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.667 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 7.3 p -113.32 136.34 52.86 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.384 177.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.24 152.03 23.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.517 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.95 -171.96 30.5 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -114.78 102.9 10.44 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.916 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.426 ' CB ' ' HA3' ' A' ' 37' ' ' GLY . . . -171.13 155.27 4.33 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.909 170.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.5 p -111.99 120.77 43.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.113 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.56 ' CG1' ' HB3' ' A' ' 34' ' ' LEU . 10.1 m -122.06 150.63 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 121.173 0.511 . . . . 0.0 112.341 -174.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 38.8 m -107.35 124.77 50.29 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.668 174.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.512 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 5.3 mp -94.94 146.56 24.15 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 169.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.436 ' CD2' HG11 ' B' ' 53' ' ' VAL . 1.0 OUTLIER -131.34 142.09 50.02 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.082 -178.582 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.08 -166.94 25.96 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.233 -176.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -154.33 134.62 13.3 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.859 0.838 . . . . 0.0 112.518 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.447 HD21 ' HB3' ' A' ' 27' ' ' PHE . 14.4 mt . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.985 175.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' MET . . . . . 0.42 ' HA ' ' HB2' ' C' ' 70' ' ' SER . 45.9 ttm . . . . . 0 C--O 1.223 -0.341 0 CA-C-O 120.703 0.287 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . 1.638 ' HE2' ' CE1' ' B' ' 8' ' ' PHE . 67.9 t80 -61.22 147.49 44.13 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -172.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . 0.404 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 89.5 t90 -138.54 145.52 40.78 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.84 179.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.72 151.42 23.52 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.019 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' B' ' 87' ' ' LEU . 40.4 tp -146.3 109.64 4.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.638 0.256 . . . . 0.0 110.855 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 -88.44 125.34 34.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.38 0.61 . . . . 0.0 111.126 176.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' MET . . . . . 0.461 ' HB2' HG21 ' B' ' 85' ' ' VAL . 7.1 mmt -98.27 130.07 44.98 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.576 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.417 ' HB3' ' HG3' ' B' ' 17' ' ' ARG . 59.7 tttm -96.89 134.24 23.28 Favored Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 171.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.406 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 2.2 Cg_endo -43.92 112.84 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.454 2.769 . . . . 0.0 113.431 -174.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' B' ' 79' ' ' THR . 48.8 mt-10 69.55 44.1 0.94 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.896 178.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.417 ' HG3' ' HB3' ' B' ' 14' ' ' LYS . 11.9 mmt180 -104.51 138.37 40.98 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.989 170.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . 0.604 ' HG2' ' CB ' ' B' ' 78' ' ' TYR . 46.5 mttp -113.32 118.62 35.1 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.299 0.374 . . . . 0.0 110.513 175.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' TYR . . . . . 1.612 ' HD2' ' CD1' ' B' ' 19' ' ' TYR . 6.2 m-85 -110.35 103.84 12.54 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 42.2 t -86.39 102.68 14.25 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 172.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -117.07 144.38 44.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.747 -170.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 11.2 t -97.84 157.11 16.27 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.002 174.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 55.4 mt -120.36 124.03 71.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.051 0.453 . . . . 0.0 111.287 -173.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.56 HD11 ' H ' ' B' ' 24' ' ' ILE . 0.2 OUTLIER -114.39 -18.3 7.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.871 176.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -132.45 121.81 23.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.6 176.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 46.9 t -65.75 133.48 51.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.06 -174.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . 0.456 ' HB3' HD21 ' B' ' 91' ' ' LEU . 46.3 p90 -137.58 147.35 44.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.708 0.766 . . . . 0.0 112.255 -177.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' HIS . . . . . 0.535 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 7.5 t60 -104.74 125.0 50.39 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.506 -1.224 . . . . 0.0 109.578 174.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 44.7 mt -90.79 133.27 33.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 170.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.535 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 67.5 p -119.88 -7.3 9.99 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -171.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -175.71 159.06 26.55 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 119.213 -1.47 . . . . 0.0 113.706 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' B' ' 86' ' ' SER . 11.1 p -144.42 131.74 16.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 173.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.57 157.54 43.53 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 121.944 -0.472 . . . . 0.0 112.098 -174.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.554 ' HB3' ' CG1' ' B' ' 85' ' ' VAL . 4.2 pp -126.48 146.28 50.17 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.607 0.718 . . . . 0.0 111.947 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -110.87 -52.17 2.81 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.583 -1.189 . . . . 0.0 108.825 168.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -99.62 127.66 45.73 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 175.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.425 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 142.32 159.32 7.89 Favored Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 120.176 -1.011 . . . . 0.0 112.617 178.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -101.33 -45.54 5.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.837 0.351 . . . . 0.0 111.115 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -152.23 126.45 9.23 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.617 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.425 ' HB3' ' HB1' ' B' ' 83' ' ' ALA . . . -127.67 113.77 16.46 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.493 0.663 . . . . 0.0 110.267 169.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -99.42 112.19 24.42 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 47.2 tp -81.61 115.37 20.85 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.661 -174.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . 1.626 ' HE2' ' CE1' ' B' ' 43' ' ' TYR . 75.1 m-85 -115.49 145.36 42.68 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.457 0.646 . . . . 0.0 110.355 178.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.603 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 0.9 OUTLIER -128.56 118.34 22.83 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.862 177.101 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -105.7 104.39 14.1 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.724 177.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.47 139.75 52.99 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.511 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 58.09 30.97 20.08 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 123.528 0.518 . . . . 0.0 109.985 -174.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 62.17 30.37 17.69 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.311 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 8.4 tp-100 -121.41 125.71 47.58 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -83.18 117.19 22.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.764 -177.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -113.67 132.4 55.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.742 175.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -81.33 112.62 19.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 169.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.481 ' CG2' ' HB3' ' B' ' 44' ' ' LEU . 3.4 t -86.99 -51.66 12.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.648 -172.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.461 ' HB3' HG12 ' B' ' 63' ' ' VAL . . . -151.54 145.01 24.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.449 -176.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 28.3 m -109.32 101.71 10.69 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 171.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.25 111.08 33.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.877 0.846 . . . . 0.0 109.909 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 81.3 p -123.71 -177.55 3.77 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.368 -174.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -56.91 -34.92 68.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.889 0.376 . . . . 0.0 110.68 167.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.99 -40.64 65.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.551 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 75.7 mt -116.33 83.43 13.04 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 175.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.43 -3.74 11.58 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.169 2.579 . . . . 0.0 113.972 -168.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -162.89 130.86 3.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.216 0.531 . . . . 0.0 111.228 -176.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.461 HG12 ' HB3' ' B' ' 54' ' ' ALA . 85.8 t -118.59 117.41 54.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.613 175.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.5 126.96 31.87 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.735 174.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.443 HD22 ' HB1' ' B' ' 54' ' ' ALA . 75.1 mt -121.07 167.05 13.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.497 0.665 . . . . 0.0 112.265 -173.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . 0.442 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 10.9 t0 -137.45 98.2 3.64 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.533 168.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.541 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 4.9 mt -124.71 146.45 49.15 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.11 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -148.37 120.78 8.46 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.003 175.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -116.54 141.61 47.95 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.926 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' SER . . . . . 0.421 ' HB2' ' HA ' ' A' ' 7' ' ' MET . 9.0 t -97.03 169.14 10.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.898 0.38 . . . . 0.0 110.111 -177.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -75.08 0.39 16.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.802 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.23 -4.14 56.47 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 174.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -95.56 147.07 23.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.028 0.442 . . . . 0.0 110.946 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -130.79 118.29 20.6 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 172.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.424 ' HB ' ' CD1' ' B' ' 44' ' ' LEU . 16.7 pt -130.5 157.33 42.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.043 0.449 . . . . 0.0 111.827 -169.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' MET . . . . . 0.425 ' HA ' ' HA ' ' B' ' 20' ' ' SER . 67.1 ttp -119.61 114.87 22.88 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.949 175.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . 1.634 ' HD2' ' CD1' ' B' ' 77' ' ' PHE . 0.4 OUTLIER -100.86 129.8 46.78 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.017 -177.206 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 1.645 ' HE1' ' CE2' ' B' ' 78' ' ' TYR . 53.3 p90 -152.41 150.66 29.9 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.994 -0.683 . . . . 0.0 112.142 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.655 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 7.3 p -113.33 136.34 52.86 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.446 177.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.21 151.97 23.42 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.582 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.14 -172.02 30.29 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -114.71 102.86 10.42 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.011 177.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.425 ' HB1' ' HB3' ' B' ' 40' ' ' ALA . . . -171.11 155.22 4.32 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.947 170.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 10.1 p -111.89 120.7 42.82 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.204 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.554 ' CG1' ' HB3' ' B' ' 34' ' ' LEU . 10.3 m -121.91 150.78 25.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.206 0.527 . . . . 0.0 112.363 -174.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' B' ' 32' ' ' VAL . 38.7 m -107.43 124.76 50.34 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.579 174.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.51 ' HB2' ' HB3' ' B' ' 11' ' ' LEU . 5.3 mp -94.96 146.52 24.18 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 169.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.426 ' CD2' HG11 ' C' ' 53' ' ' VAL . 1.0 OUTLIER -131.22 142.13 50.13 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.142 -178.651 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.06 -166.91 25.87 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.259 -176.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -154.41 134.56 13.19 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.825 0.821 . . . . 0.0 112.582 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . 0.456 HD21 ' HB3' ' B' ' 27' ' ' PHE . 14.3 mt . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 113.872 -1.513 . . . . 0.0 110.006 175.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 7' ' ' MET . . . . . 0.456 ' HA ' ' HB2' ' D' ' 70' ' ' SER . 45.9 ttm . . . . . 0 C--O 1.223 -0.327 0 CA-C-O 120.638 0.256 . . . . 0.0 110.84 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 8' ' ' PHE . . . . . 1.655 ' HD1' ' CD2' ' C' ' 8' ' ' PHE . 67.8 t80 -61.32 147.36 44.94 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -172.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . 0.401 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 89.5 t90 -138.42 145.52 41.07 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.867 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.61 151.53 23.63 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.083 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.512 ' HB3' ' HB2' ' C' ' 87' ' ' LEU . 40.6 tp -146.33 109.63 4.74 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.706 0.253 . . . . 0.0 110.945 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -88.54 125.26 34.7 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.451 0.643 . . . . 0.0 111.037 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 13' ' ' MET . . . . . 0.459 ' HB2' HG21 ' C' ' 85' ' ' VAL . 7.1 mmt -98.26 130.17 44.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.568 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . 0.413 ' HB3' ' CG ' ' C' ' 17' ' ' ARG . 59.8 tttm -97.01 134.21 23.21 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 171.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . 0.408 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 2.2 Cg_endo -43.85 112.88 0.35 Allowed 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 123.451 2.767 . . . . 0.0 113.396 -174.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . 0.661 ' HA ' ' O ' ' C' ' 79' ' ' THR . 48.8 mt-10 69.45 44.32 0.94 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.813 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 17' ' ' ARG . . . . . 0.413 ' CG ' ' HB3' ' C' ' 14' ' ' LYS . 12.0 mmt180 -104.65 138.26 41.24 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.974 170.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 18' ' ' LYS . . . . . 0.614 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 46.5 mttp -113.27 118.61 35.1 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 123.375 0.422 . . . . 0.0 110.512 175.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . 1.633 ' HD2' ' CD1' ' C' ' 19' ' ' TYR . 6.2 m-85 -110.38 103.92 12.62 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 177.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 20' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 42.0 t -86.51 102.56 14.22 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 172.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -116.94 144.46 44.53 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.8 -170.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 11.1 t -97.9 157.06 16.31 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.99 174.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 55.6 mt -120.31 124.14 71.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.076 0.465 . . . . 0.0 111.309 -173.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . 0.554 HD11 ' H ' ' C' ' 24' ' ' ILE . 0.2 OUTLIER -114.48 -18.44 7.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.827 177.011 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -132.39 121.83 24.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.562 176.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 46.8 t -65.65 133.41 51.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.061 -174.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 27' ' ' PHE . . . . . 0.453 ' HB3' HD21 ' C' ' 91' ' ' LEU . 46.5 p90 -137.64 147.33 44.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.743 0.782 . . . . 0.0 112.184 -177.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 28' ' ' HIS . . . . . 0.539 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 7.3 t60 -104.84 125.12 50.55 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.521 174.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 44.5 mt -90.82 133.2 33.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 170.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 30' ' ' SER . . . . . 0.539 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 68.1 p -119.87 -7.27 10.01 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -171.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 31' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -175.73 159.1 26.59 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 119.204 -1.474 . . . . 0.0 113.708 177.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' C' ' 86' ' ' SER . 11.2 p -144.48 131.71 16.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 173.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.5 157.66 43.61 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.915 -0.491 . . . . 0.0 112.063 -175.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.557 ' HB3' ' CG1' ' C' ' 85' ' ' VAL . 4.2 pp -126.53 146.2 50.22 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.593 0.711 . . . . 0.0 111.966 178.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -110.7 -52.3 2.8 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.847 168.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -99.72 127.76 45.84 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 175.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 37' ' ' GLY . . . . . 0.424 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 142.29 159.31 7.88 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.53 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -101.45 -45.38 5.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.74 0.305 . . . . 0.0 111.166 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -152.3 126.54 9.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.532 -179.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . 0.42 ' HB3' ' HB1' ' C' ' 83' ' ' ALA . . . -127.74 113.74 16.39 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.475 0.655 . . . . 0.0 110.21 169.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -99.4 112.24 24.46 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 46.8 tp -81.64 115.51 20.94 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.635 -175.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 43' ' ' TYR . . . . . 1.651 ' HE2' ' CE1' ' C' ' 43' ' ' TYR . 75.0 m-85 -115.56 145.35 42.74 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.413 0.625 . . . . 0.0 110.356 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.621 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 0.9 OUTLIER -128.65 118.31 22.69 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.814 177.145 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -105.65 104.42 14.14 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.657 177.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.56 139.68 53.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.503 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 58.22 30.88 20.08 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 123.568 0.542 . . . . 0.0 110.029 -174.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 62.19 30.35 17.66 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.373 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . 0.415 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 8.4 tp-100 -121.38 125.68 47.55 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -83.14 117.18 22.71 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.851 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -113.62 132.43 55.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.696 176.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -81.4 112.49 19.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 169.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 53' ' ' VAL . . . . . 0.495 ' CG2' ' HB3' ' C' ' 44' ' ' LEU . 3.4 t -86.84 -51.74 12.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.736 -172.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 54' ' ' ALA . . . . . 0.463 ' HB3' HG12 ' C' ' 63' ' ' VAL . . . -151.43 144.97 24.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.504 -176.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 28.5 m -109.28 101.63 10.62 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 171.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.19 110.99 33.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.91 0.862 . . . . 0.0 109.944 -178.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 81.1 p -123.68 -177.48 3.75 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.274 -174.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -57.02 -34.98 68.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.985 0.421 . . . . 0.0 110.663 167.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.84 -40.79 65.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.529 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 75.6 mt -116.18 83.43 12.62 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 175.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.36 -3.78 11.59 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.228 2.618 . . . . 0.0 113.996 -168.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -162.9 130.86 3.77 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.256 0.551 . . . . 0.0 111.109 -175.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.463 HG12 ' HB3' ' C' ' 54' ' ' ALA . 86.5 t -118.6 117.45 54.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.636 175.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.53 126.97 31.89 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 174.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . 0.446 HD22 ' HB1' ' C' ' 54' ' ' ALA . 75.1 mt -121.14 166.99 13.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.41 0.624 . . . . 0.0 112.311 -173.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 66' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 10.9 t0 -137.43 98.11 3.63 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.585 168.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . 0.532 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 4.9 mt -124.71 146.42 49.17 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -148.28 120.87 8.57 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.005 175.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -116.62 141.7 47.85 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.86 -177.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 70' ' ' SER . . . . . 0.42 ' HB2' ' HA ' ' B' ' 7' ' ' MET . 9.0 t -97.11 169.2 9.97 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.901 0.382 . . . . 0.0 110.063 -177.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -75.28 0.51 16.38 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.793 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.18 -4.17 56.52 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 173.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -95.43 147.08 23.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.064 0.459 . . . . 0.0 110.943 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -130.82 118.39 20.72 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . 0.421 ' HB ' ' CD1' ' C' ' 44' ' ' LEU . 16.8 pt -130.55 157.31 42.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.04 0.448 . . . . 0.0 111.86 -169.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 76' ' ' MET . . . . . 0.413 ' HA ' ' HA ' ' C' ' 20' ' ' SER . 67.1 ttp -119.67 114.84 22.8 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.954 175.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 77' ' ' PHE . . . . . 1.655 ' HD1' ' CD2' ' C' ' 77' ' ' PHE . 0.4 OUTLIER -100.84 129.84 46.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.009 -177.143 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 78' ' ' TYR . . . . . 1.613 ' HE2' ' CE1' ' C' ' 78' ' ' TYR . 53.2 p90 -152.44 150.63 29.85 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.051 -0.66 . . . . 0.0 112.135 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 79' ' ' THR . . . . . 0.661 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 7.3 p -113.26 136.34 52.85 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.445 177.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.19 151.93 23.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.526 177.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.08 -172.08 30.44 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -176.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -114.7 102.96 10.51 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.03 177.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . 0.424 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -171.2 155.2 4.26 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.831 170.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 10.3 p -111.87 120.67 42.75 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.133 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.557 ' CG1' ' HB3' ' C' ' 34' ' ' LEU . 9.9 m -121.95 150.77 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 CA-C-O 121.268 0.556 . . . . 0.0 112.236 -174.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 86' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' C' ' 32' ' ' VAL . 38.0 m -107.37 124.76 50.29 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.691 174.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . 0.512 ' HB2' ' HB3' ' C' ' 11' ' ' LEU . 5.3 mp -94.9 146.53 24.16 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 169.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . 0.406 HD21 HD23 ' D' ' 67' ' ' LEU . 1.0 OUTLIER -131.3 142.1 50.06 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.086 -178.632 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.07 -166.87 25.83 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.198 -176.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -154.41 134.55 13.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.865 0.84 . . . . 0.0 112.563 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . 0.453 HD21 ' HB3' ' C' ' 27' ' ' PHE . 14.3 mt . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 113.809 -1.541 . . . . 0.0 110.046 175.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 7' ' ' MET . . . . . 0.446 ' HA ' ' HB2' ' E' ' 70' ' ' SER . 45.9 ttm . . . . . 0 C--O 1.223 -0.334 0 CA-C-O 120.753 0.311 . . . . 0.0 110.814 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 8' ' ' PHE . . . . . 1.67 ' HE2' ' CE1' ' D' ' 8' ' ' PHE . 67.9 t80 -61.27 147.45 44.46 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -172.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 9' ' ' TRP . . . . . 0.404 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 89.6 t90 -138.5 145.54 40.9 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.817 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.67 151.4 23.5 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.072 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . 0.514 ' HB3' ' HB2' ' D' ' 87' ' ' LEU . 40.1 tp -146.28 109.67 4.76 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.697 0.284 . . . . 0.0 110.909 -179.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -88.55 125.35 34.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.393 0.616 . . . . 0.0 111.046 176.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 13' ' ' MET . . . . . 0.467 ' HB2' HG21 ' D' ' 85' ' ' VAL . 7.1 mmt -98.3 130.14 44.99 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.526 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 14' ' ' LYS . . . . . 0.413 ' HB3' ' HG3' ' D' ' 17' ' ' ARG . 59.6 tttm -96.93 134.29 23.18 Favored Pre-proline 0 C--N 1.318 -0.799 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 171.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -44.03 112.91 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.482 2.788 . . . . 0.0 113.361 -174.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . 0.665 ' HA ' ' O ' ' D' ' 79' ' ' THR . 48.9 mt-10 69.47 44.2 0.94 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.869 178.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 17' ' ' ARG . . . . . 0.413 ' HG3' ' HB3' ' D' ' 14' ' ' LYS . 12.0 mmt180 -104.59 138.25 41.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.004 170.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . 0.61 ' HG2' ' CB ' ' D' ' 78' ' ' TYR . 46.6 mttp -113.26 118.64 35.22 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.367 0.417 . . . . 0.0 110.503 175.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 19' ' ' TYR . . . . . 1.664 ' HD2' ' CD1' ' D' ' 19' ' ' TYR . 6.2 m-85 -110.31 103.86 12.58 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 177.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 20' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 42.0 t -86.41 102.68 14.26 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 172.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -117.12 144.38 44.76 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.746 -170.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 11.3 t -97.8 157.08 16.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.068 174.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 55.7 mt -120.33 124.09 71.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.118 0.485 . . . . 0.0 111.287 -173.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . 0.557 ' H ' HD11 ' D' ' 24' ' ' ILE . 0.2 OUTLIER -114.43 -18.43 7.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.859 176.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -132.37 121.86 24.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.614 176.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 46.8 t -65.7 133.45 51.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.079 -174.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 27' ' ' PHE . . . . . 0.457 ' HB3' HD21 ' D' ' 91' ' ' LEU . 46.2 p90 -137.64 147.34 44.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.667 0.746 . . . . 0.0 112.171 -177.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 28' ' ' HIS . . . . . 0.542 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 7.4 t60 -104.77 125.04 50.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.616 174.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 29' ' ' ILE . . . . . 0.551 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 44.8 mt -90.78 133.18 33.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 170.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 30' ' ' SER . . . . . 0.542 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 67.4 p -119.82 -7.33 10.02 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -171.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 31' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -175.68 159.1 26.65 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 119.295 -1.431 . . . . 0.0 113.726 177.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 11.1 p -144.48 131.78 16.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 173.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.56 157.57 43.55 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.857 -0.527 . . . . 0.0 112.018 -174.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 34' ' ' LEU . . . . . 0.562 ' HB3' ' CG1' ' D' ' 85' ' ' VAL . 4.2 pp -126.53 146.17 50.23 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.645 0.736 . . . . 0.0 111.994 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -110.7 -52.3 2.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.865 168.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -99.7 127.73 45.82 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 175.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . 0.415 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 142.38 159.32 7.89 Favored Glycine 0 N--CA 1.435 -1.375 0 C-N-CA 120.191 -1.005 . . . . 0.0 112.562 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -101.42 -45.44 5.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.775 0.321 . . . . 0.0 111.167 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -152.28 126.49 9.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.634 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . 0.415 ' HB3' ' HB1' ' D' ' 83' ' ' ALA . . . -127.68 113.79 16.49 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.45 0.643 . . . . 0.0 110.227 169.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -99.44 112.15 24.39 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 46.9 tp -81.64 115.4 20.89 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.677 -174.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 43' ' ' TYR . . . . . 1.662 ' HE2' ' CE1' ' D' ' 43' ' ' TYR . 75.0 m-85 -115.49 145.3 42.74 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.394 0.616 . . . . 0.0 110.288 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.621 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.9 OUTLIER -128.46 118.34 22.93 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.845 177.032 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 45' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -105.7 104.47 14.19 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.641 177.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.62 139.76 52.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.575 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 58.13 30.93 20.06 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 123.509 0.506 . . . . 0.0 109.987 -174.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 62.24 30.46 17.59 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.232 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . 0.428 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 8.4 tp-100 -121.51 125.68 47.38 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -83.17 117.26 22.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.769 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -113.72 132.45 55.81 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.647 176.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -81.34 112.63 19.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 168.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 53' ' ' VAL . . . . . 0.492 ' CG2' ' HB3' ' D' ' 44' ' ' LEU . 3.4 t -87.01 -51.56 12.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.73 -172.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 54' ' ' ALA . . . . . 0.457 ' HB3' HG12 ' D' ' 63' ' ' VAL . . . -151.55 144.96 24.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.521 -176.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 28.5 m -109.33 101.73 10.7 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 171.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.25 110.98 32.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.956 0.884 . . . . 0.0 109.94 -178.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 81.0 p -123.58 -177.56 3.76 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.365 -174.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -57.03 -34.88 68.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.891 0.377 . . . . 0.0 110.642 167.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.01 -40.64 65.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.56 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 75.5 mt -116.27 83.45 12.9 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.48 -3.65 11.44 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.195 2.596 . . . . 0.0 113.933 -168.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -162.95 130.81 3.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.101 0.477 . . . . 0.0 111.162 -176.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.457 HG12 ' HB3' ' D' ' 54' ' ' ALA . 87.7 t -118.59 117.39 54.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.586 175.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.39 126.98 31.85 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 65' ' ' LEU . . . . . 0.448 HD22 ' HB1' ' D' ' 54' ' ' ALA . 75.6 mt -121.17 167.01 13.14 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.509 0.671 . . . . 0.0 112.209 -173.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 66' ' ' ASP . . . . . 0.419 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 10.8 t0 -137.46 98.14 3.63 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.538 168.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . 0.551 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 4.9 mt -124.69 146.38 49.17 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -148.32 120.77 8.48 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.061 175.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -116.54 141.67 47.88 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.9 -177.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 70' ' ' SER . . . . . 0.456 ' HB2' ' HA ' ' C' ' 7' ' ' MET . 9.0 t -97.0 169.15 10.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.875 0.369 . . . . 0.0 110.1 -177.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -75.26 0.46 16.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.74 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.19 -4.08 56.54 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 173.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -95.53 147.06 23.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.076 0.465 . . . . 0.0 110.936 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -130.82 118.32 20.62 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 172.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . 0.42 ' HB ' ' CD1' ' D' ' 44' ' ' LEU . 16.8 pt -130.58 157.42 42.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.102 0.477 . . . . 0.0 111.788 -169.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 76' ' ' MET . . . . . 0.417 ' HA ' ' HA ' ' D' ' 20' ' ' SER . 67.1 ttp -119.71 114.8 22.72 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.947 175.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 77' ' ' PHE . . . . . 1.655 ' HE2' ' CE1' ' D' ' 77' ' ' PHE . 0.4 OUTLIER -100.84 129.7 46.75 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.018 -177.132 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 78' ' ' TYR . . . . . 1.612 ' HD1' ' CD2' ' D' ' 78' ' ' TYR . 53.3 p90 -152.33 150.61 29.92 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.151 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 79' ' ' THR . . . . . 0.665 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 7.2 p -113.25 136.36 52.82 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.453 177.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.2 151.97 23.42 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.503 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.01 -171.97 30.43 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 -176.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -114.67 102.87 10.44 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.042 177.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.415 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -171.09 155.27 4.36 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.9 170.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 9.9 p -111.93 120.7 42.82 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.13 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . 0.562 ' CG1' ' HB3' ' D' ' 34' ' ' LEU . 10.1 m -122.0 150.74 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-O 121.298 0.57 . . . . 0.0 112.289 -174.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 38.7 m -107.41 124.83 50.43 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.588 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 87' ' ' LEU . . . . . 0.514 ' HB2' ' HB3' ' D' ' 11' ' ' LEU . 5.3 mp -94.93 146.58 24.13 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 169.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . 0.429 ' CD2' HG11 ' E' ' 53' ' ' VAL . 1.0 OUTLIER -131.31 142.09 50.05 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.125 -178.709 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.1 -166.99 26.05 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.229 -176.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -154.34 134.57 13.26 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.808 0.813 . . . . 0.0 112.583 178.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . 0.457 HD21 ' HB3' ' D' ' 27' ' ' PHE . 14.3 mt . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 113.89 -1.504 . . . . 0.0 109.987 175.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 7' ' ' MET . . . . . 0.451 ' HA ' ' HB2' ' A' ' 70' ' ' SER . 45.9 ttm . . . . . 0 C--O 1.223 -0.31 0 CA-C-O 120.734 0.302 . . . . 0.0 110.835 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 8' ' ' PHE . . . . . 1.663 ' HE1' ' CE2' ' E' ' 8' ' ' PHE . 68.1 t80 -61.26 147.45 44.44 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -172.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 9' ' ' TRP . . . . . 0.402 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 89.5 t90 -138.47 145.59 41.03 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.882 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.76 151.34 23.45 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.083 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 11' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' E' ' 87' ' ' LEU . 40.8 tp -146.2 109.62 4.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.67 0.272 . . . . 0.0 110.928 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 -88.43 125.28 34.65 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.356 0.598 . . . . 0.0 111.112 176.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 13' ' ' MET . . . . . 0.466 ' HB2' HG21 ' E' ' 85' ' ' VAL . 7.1 mmt -98.3 130.16 44.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.522 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 14' ' ' LYS . . . . . 0.416 ' HB3' ' CG ' ' E' ' 17' ' ' ARG . 59.7 tttm -97.05 134.24 23.14 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 171.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -44.05 112.93 0.37 Allowed 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 123.43 2.754 . . . . 0.0 113.373 -174.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 16' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' E' ' 79' ' ' THR . 48.8 mt-10 69.53 44.16 0.94 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.827 178.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 17' ' ' ARG . . . . . 0.416 ' CG ' ' HB3' ' E' ' 14' ' ' LYS . 11.9 mmt180 -104.46 138.27 41.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.978 170.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . 0.612 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 46.6 mttp -113.29 118.72 35.41 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.47 0.481 . . . . 0.0 110.521 175.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . 1.654 ' HE1' ' CE2' ' E' ' 19' ' ' TYR . 6.1 m-85 -110.35 103.96 12.67 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 177.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 20' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' E' ' 76' ' ' MET . 42.3 t -86.5 102.5 14.16 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 172.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -117.01 144.35 44.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.772 -170.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 11.3 t -97.81 157.03 16.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.005 174.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 55.5 mt -120.29 124.11 71.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.052 0.453 . . . . 0.0 111.323 -173.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . 0.565 ' H ' HD11 ' E' ' 24' ' ' ILE . 0.2 OUTLIER -114.43 -18.37 7.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.907 176.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -132.37 121.77 24.0 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.62 176.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 46.8 t -65.71 133.43 51.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.061 -174.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 27' ' ' PHE . . . . . 0.448 ' HB3' HD21 ' E' ' 91' ' ' LEU . 46.6 p90 -137.6 147.3 44.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.692 0.758 . . . . 0.0 112.241 -177.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 28' ' ' HIS . . . . . 0.527 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 7.4 t60 -104.73 124.99 50.36 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.64 174.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 29' ' ' ILE . . . . . 0.548 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 45.1 mt -90.75 133.15 33.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 170.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 30' ' ' SER . . . . . 0.527 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 67.5 p -119.87 -7.18 10.01 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -171.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 31' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -175.75 159.12 26.6 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 119.183 -1.484 . . . . 0.0 113.747 177.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 11.1 p -144.49 131.72 16.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 173.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.48 157.64 43.6 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.932 -0.48 . . . . 0.0 112.02 -174.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 34' ' ' LEU . . . . . 0.556 ' HB3' ' CG1' ' E' ' 85' ' ' VAL . 4.2 pp -126.6 146.26 50.23 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.635 0.731 . . . . 0.0 111.948 178.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -110.85 -52.21 2.8 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.818 168.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -99.72 127.71 45.84 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . 0.423 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 142.37 159.32 7.88 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.589 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -101.37 -45.41 5.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.708 0.289 . . . . 0.0 111.18 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -152.33 126.41 9.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.626 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . 0.418 ' HB3' ' HB1' ' E' ' 83' ' ' ALA . . . -127.61 113.81 16.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.438 0.637 . . . . 0.0 110.205 169.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 41' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -99.49 112.3 24.52 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 174.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 46.8 tp -81.66 115.41 20.91 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.651 -175.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 43' ' ' TYR . . . . . 1.652 ' HE2' ' CE1' ' E' ' 43' ' ' TYR . 75.3 m-85 -115.48 145.32 42.71 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.515 0.674 . . . . 0.0 110.297 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 44' ' ' LEU . . . . . 0.603 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 0.9 OUTLIER -128.6 118.34 22.79 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.801 177.066 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' E' E ' 45' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -105.64 104.42 14.13 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.697 177.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.54 139.77 52.96 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.587 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 57.98 31.04 20.09 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 123.611 0.569 . . . . 0.0 110.058 -174.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 62.24 30.27 17.56 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.284 -178.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 49' ' ' GLN . . . . . 0.429 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 8.4 tp-100 -121.35 125.67 47.55 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 178.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -83.16 117.2 22.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.815 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -113.64 132.44 55.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.714 175.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -81.27 112.51 19.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 168.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . 0.491 ' CG2' ' HB3' ' E' ' 44' ' ' LEU . 3.4 t -86.98 -51.51 12.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.732 -172.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 54' ' ' ALA . . . . . 0.453 ' HB1' HD22 ' E' ' 65' ' ' LEU . . . -151.57 144.97 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.468 -176.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 28.2 m -109.23 101.69 10.69 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 171.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.25 110.9 32.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.885 0.85 . . . . 0.0 109.9 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 81.1 p -123.59 -177.54 3.75 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.342 -174.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -56.92 -35.05 68.59 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.965 0.412 . . . . 0.0 110.555 167.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.9 -40.63 65.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.534 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 75.5 mt -116.35 83.38 13.0 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 175.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.38 -3.78 11.61 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.177 2.584 . . . . 0.0 113.933 -168.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -162.84 130.83 3.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.247 0.546 . . . . 0.0 111.135 -175.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . 0.445 HG12 ' HB3' ' E' ' 54' ' ' ALA . 87.9 t -118.66 117.51 54.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.556 175.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.5 126.94 31.85 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.672 174.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 65' ' ' LEU . . . . . 0.453 HD22 ' HB1' ' E' ' 54' ' ' ALA . 75.0 mt -121.04 167.02 13.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.439 0.637 . . . . 0.0 112.307 -173.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 66' ' ' ASP . . . . . 0.427 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 10.9 t0 -137.44 98.2 3.65 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.593 168.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 67' ' ' LEU . . . . . 0.548 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 4.9 mt -124.67 146.39 49.15 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.081 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -148.31 120.82 8.52 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.023 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -116.55 141.67 47.88 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.941 -177.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 70' ' ' SER . . . . . 0.446 ' HB2' ' HA ' ' D' ' 7' ' ' MET . 9.0 t -97.04 169.22 9.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.924 0.392 . . . . 0.0 110.034 -177.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -75.19 0.28 16.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.748 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.0 -4.23 56.72 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 173.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -95.46 147.13 23.86 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 120.992 0.425 . . . . 0.0 110.946 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -130.84 118.32 20.61 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 172.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 75' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' E' ' 44' ' ' LEU . 16.8 pt -130.61 157.32 42.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.131 0.491 . . . . 0.0 111.774 -169.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 76' ' ' MET . . . . . 0.417 ' HA ' ' HA ' ' E' ' 20' ' ' SER . 67.1 ttp -119.55 114.82 22.84 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.005 175.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 77' ' ' PHE . . . . . 1.66 ' HE2' ' CE1' ' E' ' 77' ' ' PHE . 0.4 OUTLIER -100.92 129.76 46.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.001 -177.133 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' E' E ' 78' ' ' TYR . . . . . 1.63 ' HE2' ' CE1' ' E' ' 78' ' ' TYR . 53.3 p90 -152.43 150.64 29.87 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.989 -0.685 . . . . 0.0 112.148 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 79' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 7.3 p -113.27 136.4 52.79 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.413 177.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.22 152.02 23.37 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.528 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.96 -171.9 30.43 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -176.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -114.73 102.84 10.39 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.054 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 83' ' ' ALA . . . . . 0.423 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -171.04 155.32 4.41 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.889 170.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 10.4 p -112.0 120.77 43.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.121 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 85' ' ' VAL . . . . . 0.556 ' CG1' ' HB3' ' E' ' 34' ' ' LEU . 9.8 m -122.12 150.71 25.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.237 0.542 . . . . 0.0 112.232 -174.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 38.9 m -107.43 124.75 50.32 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.606 174.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 87' ' ' LEU . . . . . 0.51 ' HB2' ' HB3' ' E' ' 11' ' ' LEU . 5.3 mp -94.87 146.54 24.14 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 169.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . 0.42 ' CD2' HG11 ' A' ' 53' ' ' VAL . 1.0 OUTLIER -131.28 142.05 50.06 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.164 -178.663 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.01 -166.87 25.77 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.259 -176.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 90' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -154.42 134.62 13.22 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.804 0.812 . . . . 0.0 112.561 178.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 91' ' ' LEU . . . . . 0.448 HD21 ' HB3' ' E' ' 27' ' ' PHE . 14.3 mt . . . . . 0 C--N 1.326 -0.438 0 CA-C-N 113.842 -1.527 . . . . 0.0 109.956 175.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.459 ' HA ' ' HB2' ' B' ' 70' ' ' SER . 55.9 mtp . . . . . 0 C--O 1.224 -0.281 0 CA-C-O 120.69 0.281 . . . . 0.0 111.333 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 1.658 ' HD1' ' CD2' ' A' ' 8' ' ' PHE . 33.8 t80 -88.34 152.2 22.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.244 -175.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 87.1 t90 -138.57 146.49 41.91 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.86 155.8 26.34 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.108 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 42.4 tp -149.98 108.27 3.77 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.695 0.283 . . . . 0.0 110.951 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -86.8 103.31 15.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.149 0.499 . . . . 0.0 110.855 175.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.456 ' HB2' HG22 ' A' ' 85' ' ' VAL . 2.9 mmt -80.69 136.61 36.22 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.345 -179.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.507 ' HB2' ' HG3' ' A' ' 17' ' ' ARG . 27.2 mtpp -99.85 142.58 24.88 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 173.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.513 ' HB3' ' N ' ' A' ' 83' ' ' ALA . 7.5 Cg_endo -50.19 115.26 1.79 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 123.443 2.762 . . . . 0.0 113.283 -175.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.666 ' HA ' ' O ' ' A' ' 79' ' ' THR . 26.1 mt-10 65.1 57.54 0.95 Allowed 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.597 0.713 . . . . 0.0 111.569 177.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.507 ' HG3' ' HB2' ' A' ' 14' ' ' LYS . 13.5 mmt180 -117.6 163.43 16.45 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.473 171.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.589 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 3.3 ttmp? -139.46 109.92 6.6 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 123.474 0.484 . . . . 0.0 110.843 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 1.651 ' HD1' ' CD2' ' A' ' 19' ' ' TYR . 1.5 m-85 -111.38 113.31 25.68 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.7 p -72.18 116.53 12.72 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 171.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -98.0 117.71 32.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.673 -163.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.5 t -91.99 143.44 26.47 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 171.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.9 mt -115.32 124.41 71.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.153 0.502 . . . . 0.0 111.768 -172.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.464 HD13 ' N ' ' A' ' 24' ' ' ILE . 4.1 mp -90.41 -43.8 14.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.816 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -140.09 149.45 43.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.12 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 23.1 t -59.9 115.22 3.25 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.102 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.421 ' HB3' HD21 ' A' ' 91' ' ' LEU . 12.5 p90 -122.86 148.97 44.8 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.471 0.653 . . . . 0.0 111.62 -177.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.653 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 10.3 t60 -106.66 120.43 41.94 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.552 178.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.558 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 31.4 mt -89.38 134.2 29.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 171.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.653 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 15.8 p -122.38 -15.52 7.61 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -171.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -155.66 152.87 24.31 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 119.533 -1.318 . . . . 0.0 113.227 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.437 ' CG2' ' HG ' ' A' ' 87' ' ' LEU . 11.7 p -150.15 122.28 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 171.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.29 154.61 42.54 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 122.008 -0.432 . . . . 0.0 111.572 -173.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.466 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 3.7 pp -113.94 139.28 49.35 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.638 0.733 . . . . 0.0 111.552 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -104.59 -56.06 2.24 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.83 173.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -102.27 127.82 49.08 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 170.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.475 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 150.93 162.26 10.55 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 119.683 -1.246 . . . . 0.0 113.472 176.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.515 ' O ' ' HG3' ' A' ' 58' ' ' LYS . 26.6 mt-30 -102.55 -47.99 4.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.573 0.225 . . . . 0.0 111.285 176.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -151.54 133.02 14.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.388 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.423 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . . . -132.54 116.22 16.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.411 0.625 . . . . 0.0 110.527 170.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 79' ' ' THR . 97.8 mttt -100.14 112.59 24.9 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.5 tp -84.55 114.41 21.94 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -176.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.457 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 98.5 m-85 -116.23 145.62 42.98 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 176.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.58 ' HA ' ' O ' ' A' ' 76' ' ' MET . 0.3 OUTLIER -131.9 130.85 42.13 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.667 171.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -104.36 113.74 27.51 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.764 177.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.07 139.22 53.57 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 174.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 57.3 30.34 18.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.27 0.557 . . . . 0.0 109.615 -171.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.506 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 0.3 OUTLIER 64.84 17.11 10.86 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.456 -179.109 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 7.7 tt0 -104.99 121.54 43.97 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -82.15 112.12 18.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.686 -177.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 1.65 ' HE2' ' CE1' ' A' ' 51' ' ' TYR . 58.4 m-85 -102.96 136.58 42.51 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.492 177.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -82.23 103.05 8.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 171.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.469 ' CG1' HD12 ' A' ' 67' ' ' LEU . 2.9 t -78.63 -52.8 14.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.763 -172.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.45 ' HB1' ' CD2' ' A' ' 65' ' ' LEU . . . -146.89 137.63 23.82 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.544 -177.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.1 m -104.49 101.62 11.29 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 170.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.2 p -121.7 109.81 25.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.979 0.895 . . . . 0.0 110.205 -177.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.6 p -122.85 -176.79 3.49 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.758 -175.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.563 ' HZ3' ' HB2' ' A' ' 58' ' ' LYS . 9.9 mtmp? -58.01 -31.54 67.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.028 0.442 . . . . 0.0 110.437 170.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.14 -40.82 51.76 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.551 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 69.9 mt -116.11 76.49 6.55 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 173.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -76.45 1.59 8.25 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.797 2.332 . . . . 0.0 113.329 -168.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -154.9 100.93 2.24 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.643 -170.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.439 HG12 ' HB3' ' A' ' 54' ' ' ALA . 66.0 t -102.59 121.02 53.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.113 0.482 . . . . 0.0 110.729 177.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.67 110.75 22.95 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.708 174.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -126.93 169.22 13.53 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.051 0.453 . . . . 0.0 111.708 -175.107 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.528 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 27.1 t0 -119.38 104.99 10.85 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.761 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.558 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 18.7 mt -120.65 150.68 40.55 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.992 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.522 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 5.9 t30 -152.41 127.14 9.5 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.943 0.401 . . . . 0.0 110.017 172.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.515 ' O ' ' HA ' ' A' ' 26' ' ' SER . 38.3 m-85 -121.31 161.47 21.97 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.764 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.484 ' HB2' ' HA ' ' E' ' 7' ' ' MET . 42.6 t -115.86 158.22 23.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.328 0.585 . . . . 0.0 111.87 -174.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -21.83 66.47 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.33 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.05 -1.06 61.48 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.894 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -100.56 166.11 11.08 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -145.14 129.63 17.92 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.7 pt -134.82 174.66 12.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.435 -173.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.58 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 23.1 mtp -130.46 123.81 30.61 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 1.647 ' HE2' ' CE1' ' A' ' 77' ' ' PHE . 1.0 OUTLIER -105.09 127.58 52.95 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.071 178.466 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 1.671 ' HE1' ' CE2' ' A' ' 78' ' ' TYR . 24.4 p90 -153.9 141.86 20.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.102 0.477 . . . . 0.0 111.811 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.666 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 11.6 p -113.32 141.88 46.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.08 -178.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -109.85 150.87 27.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.576 176.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.3 176.8 40.45 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -177.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -107.42 102.11 11.41 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.687 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.513 ' N ' ' HB3' ' A' ' 15' ' ' PRO . . . -170.22 150.43 3.65 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.874 169.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.3 t -104.41 119.28 38.6 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.466 ' CG1' ' HB3' ' A' ' 34' ' ' LEU . 5.7 m -119.21 135.18 60.44 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 CA-C-O 121.453 0.644 . . . . 0.0 112.135 -174.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.5 t -99.61 119.49 38.17 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.988 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.502 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 5.3 mp -92.96 147.11 23.11 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 173.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.434 ' CD2' HG11 ' B' ' 53' ' ' VAL . 1.5 tp -133.25 138.76 46.61 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.098 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.95 -167.6 23.62 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.985 -177.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.482 ' CD2' ' HB3' ' B' ' 68' ' ' ASN . 20.2 p90 -153.58 135.56 14.68 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.797 0.808 . . . . 0.0 112.567 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.421 HD21 ' HB3' ' A' ' 27' ' ' PHE . 5.3 mt . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.447 175.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' MET . . . . . 0.476 ' HA ' ' HB2' ' C' ' 70' ' ' SER . 56.0 mtp . . . . . 0 C--O 1.224 -0.262 0 CA-C-O 120.716 0.294 . . . . 0.0 111.308 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . 1.642 ' HE2' ' CE1' ' B' ' 8' ' ' PHE . 33.6 t80 -88.3 152.34 22.0 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.277 -175.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -138.7 146.46 41.58 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.9 155.83 26.35 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.13 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' B' ' 87' ' ' LEU . 42.2 tp -149.97 108.22 3.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.701 0.286 . . . . 0.0 110.822 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -86.71 103.31 15.05 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.056 0.455 . . . . 0.0 110.879 175.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' MET . . . . . 0.45 ' HB2' HG22 ' B' ' 85' ' ' VAL . 2.8 mmt -80.89 136.77 36.12 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.272 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.494 ' HB2' ' HG3' ' B' ' 17' ' ' ARG . 27.2 mtpp -99.89 142.61 24.94 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 173.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.518 ' HB3' ' N ' ' B' ' 83' ' ' ALA . 7.6 Cg_endo -50.15 115.23 1.77 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.413 2.742 . . . . 0.0 113.372 -175.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.659 ' HA ' ' O ' ' B' ' 79' ' ' THR . 25.9 mt-10 65.04 57.58 0.96 Allowed 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.623 0.725 . . . . 0.0 111.598 177.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.494 ' HG3' ' HB2' ' B' ' 14' ' ' LYS . 13.6 mmt180 -117.55 163.31 16.61 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.532 171.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . 0.601 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 3.3 ttmp? -139.42 110.02 6.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.746 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' TYR . . . . . 1.654 ' HD1' ' CD2' ' B' ' 19' ' ' TYR . 1.6 m-85 -111.42 113.34 25.72 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 2.7 p -72.07 116.48 12.53 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 171.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -97.84 117.55 32.41 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.764 -163.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 13.5 t -91.92 143.54 26.39 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 171.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 48.7 mt -115.44 124.46 71.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.227 0.537 . . . . 0.0 111.654 -172.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.456 HD13 ' N ' ' B' ' 24' ' ' ILE . 4.1 mp -90.44 -43.86 14.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.817 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -140.18 149.59 43.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.001 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' B' ' 69' ' ' PHE . 22.7 t -59.83 115.19 3.21 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.137 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' B' ' 68' ' ' ASN . 12.5 p90 -122.84 148.9 44.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.478 0.656 . . . . 0.0 111.682 -177.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' HIS . . . . . 0.655 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 10.4 t60 -106.62 120.43 41.94 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.605 178.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 31.6 mt -89.51 134.24 29.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 171.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.655 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 16.3 p -122.4 -15.4 7.63 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 112.179 0.436 . . . . 0.0 112.179 -170.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -155.75 152.9 24.32 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 119.513 -1.327 . . . . 0.0 113.137 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.433 ' CG2' ' HG ' ' B' ' 87' ' ' LEU . 11.5 p -150.14 122.35 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 171.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.28 154.63 42.56 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.554 -173.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.464 ' HB3' ' CG1' ' B' ' 85' ' ' VAL . 3.7 pp -113.96 139.28 49.36 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 121.624 0.726 . . . . 0.0 111.529 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -104.59 -56.01 2.25 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.796 173.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -102.28 127.78 49.11 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 170.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.474 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 150.89 162.17 10.48 Favored Glycine 0 N--CA 1.438 -1.211 0 C-N-CA 119.547 -1.311 . . . . 0.0 113.407 176.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . 0.517 ' O ' ' HG3' ' B' ' 58' ' ' LYS . 26.5 mt-30 -102.52 -47.98 4.29 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.601 0.238 . . . . 0.0 111.293 177.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -151.57 133.06 14.69 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.636 -0.257 . . . . 0.0 110.442 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.425 ' HB3' ' HB1' ' B' ' 83' ' ' ALA . . . -132.56 116.3 16.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.517 0.675 . . . . 0.0 110.516 170.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' B' ' 79' ' ' THR . 97.7 mttt -100.2 112.64 24.97 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 40.6 tp -84.63 114.48 22.03 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . 0.456 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 98.8 m-85 -116.36 145.65 43.06 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.578 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.3 OUTLIER -131.95 130.77 41.93 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 120.371 -0.531 . . . . 0.0 109.731 171.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -104.29 113.78 27.57 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.821 177.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.13 139.22 53.54 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 174.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 57.3 30.28 18.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.293 0.568 . . . . 0.0 109.645 -171.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.499 ' HA ' ' HE2' ' B' ' 48' ' ' LYS . 0.3 OUTLIER 64.9 17.05 10.87 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.383 -179.233 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . 0.496 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 7.7 tt0 -104.95 121.47 43.81 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -82.06 112.14 18.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.684 -177.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 1.647 ' HE2' ' CE1' ' B' ' 51' ' ' TYR . 57.9 m-85 -102.86 136.51 42.54 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.524 177.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -82.27 102.99 8.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.778 0.799 . . . . 0.0 108.897 171.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.471 ' CG1' HD12 ' B' ' 67' ' ' LEU . 2.9 t -78.58 -52.78 14.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.798 -171.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.454 ' HB1' ' CD2' ' B' ' 65' ' ' LEU . . . -146.9 137.72 23.86 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.492 -177.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 28.0 m -104.6 101.65 11.29 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 170.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 6.2 p -121.77 109.82 25.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 122.005 0.907 . . . . 0.0 110.202 -177.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 80.4 p -122.84 -176.77 3.48 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.76 -175.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . 0.568 ' HB2' ' HZ3' ' B' ' 58' ' ' LYS . 9.9 mtmp? -58.04 -31.52 67.1 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.453 170.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.05 -40.93 52.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.634 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 69.8 mt -116.02 76.49 6.38 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.44 1.6 8.23 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.731 2.287 . . . . 0.0 113.397 -168.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . 0.419 ' OE1' ' HA ' ' C' ' 54' ' ' ALA . 10.2 tt0 -154.82 101.03 2.26 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.705 -170.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.431 HG12 ' HB3' ' B' ' 54' ' ' ALA . 65.7 t -102.63 121.01 53.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.108 0.48 . . . . 0.0 110.695 177.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.7 110.78 22.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.651 174.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' B' ' 30' ' ' SER . 0.3 OUTLIER -126.97 169.14 13.62 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.042 0.449 . . . . 0.0 111.738 -175.117 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . 0.51 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 26.9 t0 -119.27 105.01 10.92 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.72 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.545 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 18.6 mt -120.76 150.76 40.49 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.999 178.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . 0.482 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 5.9 t30 -152.48 127.08 9.42 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.001 0.429 . . . . 0.0 110.022 172.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . 0.522 ' O ' ' HA ' ' B' ' 26' ' ' SER . 38.8 m-85 -121.31 161.49 21.94 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.695 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' SER . . . . . 0.459 ' HB2' ' HA ' ' A' ' 7' ' ' MET . 42.6 t -115.83 158.27 23.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.318 0.58 . . . . 0.0 111.874 -174.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -21.73 66.47 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.242 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.13 -0.84 61.45 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.897 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -100.69 166.01 11.1 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -145.12 129.5 17.81 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 9.7 pt -134.67 174.62 12.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.072 0.463 . . . . 0.0 111.404 -173.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' MET . . . . . 0.578 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 23.1 mtp -130.46 123.75 30.48 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . 1.645 ' HD1' ' CD2' ' B' ' 77' ' ' PHE . 0.9 OUTLIER -105.14 127.64 53.0 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.009 178.46 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 1.643 ' HD2' ' CD1' ' B' ' 78' ' ' TYR . 24.4 p90 -153.96 141.84 20.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.128 0.489 . . . . 0.0 111.772 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.659 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 11.6 p -113.3 141.83 46.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.053 -178.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -109.9 150.76 27.96 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.572 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.49 176.83 40.17 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -177.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -107.54 102.21 11.48 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.706 179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.518 ' N ' ' HB3' ' B' ' 15' ' ' PRO . . . -170.28 150.42 3.6 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.825 169.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 32.4 t -104.44 119.4 38.88 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.464 ' CG1' ' HB3' ' B' ' 34' ' ' LEU . 5.6 m -119.24 135.15 60.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 CA-C-O 121.488 0.661 . . . . 0.0 112.096 -174.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 7.5 t -99.6 119.56 38.27 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.98 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.502 ' HB2' ' HB3' ' B' ' 11' ' ' LEU . 5.3 mp -92.95 147.15 23.08 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 173.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.442 ' CD2' HG11 ' C' ' 53' ' ' VAL . 1.5 tp -133.19 138.73 46.67 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.117 -178.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.97 -167.61 23.64 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.972 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 90' ' ' TYR . . . . . 0.502 ' CD2' ' HB3' ' C' ' 68' ' ' ASN . 20.2 p90 -153.59 135.66 14.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.856 0.836 . . . . 0.0 112.451 178.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . 0.414 HD21 ' HB3' ' B' ' 27' ' ' PHE . 5.2 mt . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 114.098 -1.41 . . . . 0.0 109.42 175.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 7' ' ' MET . . . . . 0.469 ' HA ' ' HB2' ' D' ' 70' ' ' SER . 55.7 mtp . . . . . 0 C--O 1.225 -0.199 0 CA-C-O 120.761 0.315 . . . . 0.0 111.322 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 8' ' ' PHE . . . . . 1.66 ' HD1' ' CD2' ' C' ' 8' ' ' PHE . 33.3 t80 -88.4 152.28 22.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.242 -175.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -138.68 146.44 41.59 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.85 155.83 26.35 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.138 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.49 ' HB3' ' HB2' ' C' ' 87' ' ' LEU . 42.4 tp -150.02 108.3 3.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.719 0.295 . . . . 0.0 110.912 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -86.78 103.36 15.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.051 0.453 . . . . 0.0 110.814 175.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 13' ' ' MET . . . . . 0.446 ' HB2' HG22 ' C' ' 85' ' ' VAL . 2.8 mmt -80.91 136.75 36.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.191 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . 0.521 ' HB2' ' HG3' ' C' ' 17' ' ' ARG . 27.2 mtpp -99.81 142.6 24.92 Favored Pre-proline 0 C--N 1.316 -0.854 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 173.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . 0.515 ' HB3' ' N ' ' C' ' 83' ' ' ALA . 7.6 Cg_endo -50.13 115.22 1.76 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 123.454 2.769 . . . . 0.0 113.382 -175.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . 0.67 ' HA ' ' O ' ' C' ' 79' ' ' THR . 26.0 mt-10 64.97 57.56 0.97 Allowed 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.617 0.722 . . . . 0.0 111.648 177.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 17' ' ' ARG . . . . . 0.521 ' HG3' ' HB2' ' C' ' 14' ' ' LYS . 13.6 mmt180 -117.48 163.41 16.44 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.512 171.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 18' ' ' LYS . . . . . 0.598 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 3.3 ttmp? -139.5 109.93 6.6 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.811 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . 1.662 ' HD1' ' CD2' ' C' ' 19' ' ' TYR . 1.5 m-85 -111.34 113.29 25.66 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 2.7 p -72.05 116.39 12.4 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 171.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -97.81 117.69 32.7 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.777 -163.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 13.6 t -92.03 143.41 26.5 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 171.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 49.1 mt -115.36 124.48 71.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.168 0.509 . . . . 0.0 111.758 -172.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . 0.457 HD13 ' N ' ' C' ' 24' ' ' ILE . 4.1 mp -90.52 -43.72 14.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.794 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -140.23 149.47 42.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.039 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 26' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' C' ' 69' ' ' PHE . 23.0 t -59.89 115.28 3.29 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.064 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 27' ' ' PHE . . . . . 0.419 ' HB3' HD21 ' C' ' 91' ' ' LEU . 12.3 p90 -122.89 148.97 44.84 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.512 0.672 . . . . 0.0 111.608 -177.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 28' ' ' HIS . . . . . 0.643 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 10.3 t60 -106.61 120.43 41.94 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.438 -1.256 . . . . 0.0 109.593 178.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 31.7 mt -89.46 134.28 29.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 171.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 30' ' ' SER . . . . . 0.643 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 16.1 p -122.46 -15.41 7.59 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -171.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 31' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -155.68 152.92 24.36 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 119.54 -1.314 . . . . 0.0 113.179 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.436 ' CG2' ' HG ' ' C' ' 87' ' ' LEU . 11.5 p -150.18 122.35 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 171.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.32 154.53 42.43 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.091 -0.381 . . . . 0.0 111.581 -172.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.462 ' HB3' ' CG1' ' C' ' 85' ' ' VAL . 3.7 pp -113.86 139.3 49.29 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.703 0.763 . . . . 0.0 111.528 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -104.62 -55.99 2.25 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.929 173.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -102.31 127.9 49.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 37' ' ' GLY . . . . . 0.471 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 150.85 162.12 10.44 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 119.604 -1.284 . . . . 0.0 113.512 176.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 38' ' ' GLN . . . . . 0.522 ' O ' ' HG3' ' C' ' 58' ' ' LYS . 26.5 mt-30 -102.47 -47.97 4.3 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 120.644 0.259 . . . . 0.0 111.34 177.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -151.61 132.98 14.6 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.436 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . 0.408 ' HB3' ' HB1' ' C' ' 83' ' ' ALA . . . -132.53 116.25 16.49 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.47 0.653 . . . . 0.0 110.515 170.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' C' ' 79' ' ' THR . 97.8 mttt -100.12 112.66 24.97 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 40.7 tp -84.56 114.43 21.96 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -176.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 43' ' ' TYR . . . . . 0.452 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 98.6 m-85 -116.34 145.62 43.06 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.579 ' HA ' ' O ' ' C' ' 76' ' ' MET . 0.3 OUTLIER -131.92 130.82 42.06 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.769 171.864 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -104.27 113.75 27.51 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.8 177.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.09 139.24 53.55 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 174.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 57.19 30.42 18.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.392 0.615 . . . . 0.0 109.709 -171.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' C' ' 48' ' ' LYS . 0.3 OUTLIER 64.77 17.08 10.8 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.467 -179.125 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . 0.487 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 7.8 tt0 -104.89 121.5 43.83 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -82.05 112.14 18.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.773 -177.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 1.659 ' HE2' ' CE1' ' C' ' 51' ' ' TYR . 58.5 m-85 -102.96 136.61 42.46 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.505 177.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -82.29 103.03 8.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.803 0.811 . . . . 0.0 108.908 171.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 53' ' ' VAL . . . . . 0.465 ' CG1' HD12 ' C' ' 67' ' ' LEU . 3.0 t -78.62 -52.72 15.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.745 -171.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 54' ' ' ALA . . . . . 0.46 ' HB1' ' CD2' ' C' ' 65' ' ' LEU . . . -146.91 137.59 23.77 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.582 -177.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 27.9 m -104.46 101.62 11.29 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 170.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 6.1 p -121.75 109.77 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-O 121.958 0.885 . . . . 0.0 110.172 -177.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 80.7 p -122.85 -176.81 3.49 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.762 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 58' ' ' LYS . . . . . 0.566 ' HB2' ' HZ3' ' C' ' 58' ' ' LYS . 9.9 mtmp? -57.98 -31.62 67.08 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.396 170.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.01 -40.91 52.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.633 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 69.7 mt -115.96 76.46 6.24 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 173.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -76.41 1.59 8.22 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.766 2.311 . . . . 0.0 113.383 -168.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . 0.427 ' OE1' ' HA ' ' D' ' 54' ' ' ALA . 10.2 tt0 -154.9 101.03 2.25 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.649 -170.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.435 HG12 ' HB3' ' C' ' 54' ' ' ALA . 66.0 t -102.61 121.01 53.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.072 0.463 . . . . 0.0 110.728 177.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.72 110.85 23.09 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.64 174.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' C' ' 30' ' ' SER . 0.3 OUTLIER -126.97 169.15 13.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.109 0.48 . . . . 0.0 111.604 -175.068 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 66' ' ' ASP . . . . . 0.533 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 27.4 t0 -119.3 105.04 10.94 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.764 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' C' ' 28' ' ' HIS . 18.7 mt -120.71 150.64 40.65 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.024 178.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . 0.502 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 6.0 t30 -152.37 127.12 9.52 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.961 0.41 . . . . 0.0 110.077 172.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 69' ' ' PHE . . . . . 0.517 ' O ' ' HA ' ' C' ' 26' ' ' SER . 38.8 m-85 -121.36 161.54 21.92 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.699 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 70' ' ' SER . . . . . 0.476 ' HB2' ' HA ' ' B' ' 7' ' ' MET . 42.7 t -115.88 158.18 23.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.273 0.559 . . . . 0.0 111.856 -174.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -21.92 66.53 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.318 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.02 -0.83 61.64 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.91 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -100.72 166.04 11.08 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -145.09 129.65 17.98 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 9.7 pt -134.87 174.56 12.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.047 0.451 . . . . 0.0 111.375 -173.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 76' ' ' MET . . . . . 0.579 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 23.3 mtp -130.37 123.77 30.67 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.299 174.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 77' ' ' PHE . . . . . 1.669 ' HD1' ' CD2' ' C' ' 77' ' ' PHE . 1.0 OUTLIER -105.08 127.56 52.94 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.006 178.486 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 78' ' ' TYR . . . . . 1.633 ' HE2' ' CE1' ' C' ' 78' ' ' TYR . 24.4 p90 -153.94 141.83 20.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.067 0.46 . . . . 0.0 111.842 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 79' ' ' THR . . . . . 0.67 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 11.7 p -113.29 141.85 46.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.103 -178.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -109.9 150.74 28.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.629 176.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.41 176.77 40.28 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -177.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -107.48 102.22 11.5 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 119.436 -0.905 . . . . 0.0 109.715 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . 0.515 ' N ' ' HB3' ' C' ' 15' ' ' PRO . . . -170.2 150.41 3.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.942 169.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 32.5 t -104.42 119.38 38.84 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.462 ' CG1' ' HB3' ' C' ' 34' ' ' LEU . 5.6 m -119.28 135.08 60.82 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 CA-C-O 121.454 0.645 . . . . 0.0 112.126 -174.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 7.5 t -99.61 119.5 38.17 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.044 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . 0.49 ' HB2' ' HB3' ' C' ' 11' ' ' LEU . 5.3 mp -92.95 147.01 23.19 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 173.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . 0.445 ' CD2' HG11 ' D' ' 53' ' ' VAL . 1.5 tp -133.15 138.8 46.76 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.145 -178.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.89 -167.59 23.54 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.072 -177.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 90' ' ' TYR . . . . . 0.504 ' CD2' ' HB3' ' D' ' 68' ' ' ASN . 20.2 p90 -153.7 135.7 14.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.867 0.841 . . . . 0.0 112.455 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . 0.419 HD21 ' HB3' ' C' ' 27' ' ' PHE . 5.2 mt . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.487 176.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 7' ' ' MET . . . . . 0.464 ' HA ' ' HB2' ' E' ' 70' ' ' SER . 55.7 mtp . . . . . 0 C--O 1.225 -0.231 0 CA-C-O 120.756 0.312 . . . . 0.0 111.287 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 8' ' ' PHE . . . . . 1.67 ' HE2' ' CE1' ' D' ' 8' ' ' PHE . 33.5 t80 -88.29 152.23 22.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.287 -175.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 9' ' ' TRP . . . . . . . . . . . . . 87.1 t90 -138.64 146.44 41.68 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.83 155.89 26.38 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.038 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . 0.488 ' HB3' ' HB2' ' D' ' 87' ' ' LEU . 42.4 tp -150.04 108.23 3.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.665 0.269 . . . . 0.0 110.872 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 -86.79 103.31 15.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.072 0.463 . . . . 0.0 110.857 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 13' ' ' MET . . . . . 0.467 ' HB2' HG22 ' D' ' 85' ' ' VAL . 2.8 mmt -80.71 136.71 36.22 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.309 -178.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 14' ' ' LYS . . . . . 0.499 ' HB2' ' HG3' ' D' ' 17' ' ' ARG . 27.2 mtpp -99.88 142.61 24.92 Favored Pre-proline 0 C--N 1.317 -0.833 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . 0.516 ' HB3' ' N ' ' D' ' 83' ' ' ALA . 7.5 Cg_endo -50.11 115.28 1.79 Allowed 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 123.482 2.788 . . . . 0.0 113.293 -175.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . 0.679 ' HA ' ' O ' ' D' ' 79' ' ' THR . 26.1 mt-10 64.94 57.54 0.99 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.627 0.727 . . . . 0.0 111.631 177.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 17' ' ' ARG . . . . . 0.499 ' HG3' ' HB2' ' D' ' 14' ' ' LYS . 13.7 mmt180 -117.44 163.23 16.69 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.597 171.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . 0.607 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 3.3 ttmp? -139.38 109.96 6.65 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 123.446 0.466 . . . . 0.0 110.829 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 19' ' ' TYR . . . . . 1.669 ' HD2' ' CD1' ' D' ' 19' ' ' TYR . 1.6 m-85 -111.39 113.31 25.68 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 2.7 p -72.08 116.38 12.42 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 171.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -97.87 117.71 32.81 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.694 -163.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 13.7 t -92.06 143.41 26.49 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 171.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 49.0 mt -115.24 124.5 71.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.257 0.551 . . . . 0.0 111.761 -172.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . 0.465 ' N ' HD13 ' D' ' 24' ' ' ILE . 4.1 mp -90.59 -43.79 14.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.704 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -140.07 149.56 43.27 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.102 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 26' ' ' SER . . . . . 0.529 ' HA ' ' O ' ' D' ' 69' ' ' PHE . 22.7 t -59.9 115.2 3.24 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.151 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 27' ' ' PHE . . . . . 0.425 ' HB3' HD21 ' D' ' 91' ' ' LEU . 12.5 p90 -122.81 148.88 44.87 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.487 0.66 . . . . 0.0 111.697 -177.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 28' ' ' HIS . . . . . 0.655 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 10.3 t60 -106.55 120.43 41.92 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.662 178.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 29' ' ' ILE . . . . . 0.558 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 31.5 mt -89.43 134.3 29.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 171.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 30' ' ' SER . . . . . 0.655 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 16.1 p -122.46 -15.38 7.6 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -171.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 31' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -155.74 152.99 24.41 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 119.517 -1.325 . . . . 0.0 113.15 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . 0.424 ' CG2' ' HG ' ' D' ' 87' ' ' LEU . 11.6 p -150.23 122.28 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 171.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.3 154.58 42.5 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.13 -0.356 . . . . 0.0 111.599 -172.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 34' ' ' LEU . . . . . 0.459 ' HB3' ' CG1' ' D' ' 85' ' ' VAL . 3.7 pp -113.94 139.3 49.33 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.6 0.714 . . . . 0.0 111.502 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -104.61 -55.98 2.26 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.846 173.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -102.32 127.77 49.16 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 170.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . 0.466 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 150.89 162.2 10.5 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 119.623 -1.275 . . . . 0.0 113.507 176.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 38' ' ' GLN . . . . . 0.509 ' O ' ' HG3' ' D' ' 58' ' ' LYS . 26.6 mt-30 -102.55 -47.94 4.29 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 121.191 -0.203 . . . . 0.0 111.286 177.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -151.53 132.93 14.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.598 -0.273 . . . . 0.0 110.419 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . 0.425 ' HB3' ' HB1' ' D' ' 83' ' ' ALA . . . -132.46 116.33 16.65 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.422 0.629 . . . . 0.0 110.512 170.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' D' ' 79' ' ' THR . 97.7 mttt -100.18 112.67 24.99 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 174.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 40.5 tp -84.62 114.55 22.07 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -176.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 43' ' ' TYR . . . . . 0.459 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 98.7 m-85 -116.37 145.67 43.05 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.584 ' HA ' ' O ' ' D' ' 76' ' ' MET . 0.3 OUTLIER -132.0 130.74 41.82 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.71 171.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 45' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -104.28 113.74 27.51 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.848 177.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.02 139.13 53.66 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 174.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 57.38 30.27 18.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.355 0.598 . . . . 0.0 109.674 -171.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 48' ' ' LYS . . . . . 0.511 ' HE2' ' HA ' ' D' ' 48' ' ' LYS . 0.3 OUTLIER 64.87 17.09 10.86 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.47 -179.088 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 7.8 tt0 -104.92 121.5 43.84 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -82.11 112.07 18.82 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.76 -177.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . 1.656 ' HE2' ' CE1' ' D' ' 51' ' ' TYR . 58.0 m-85 -102.88 136.6 42.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.523 177.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -82.36 103.09 9.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 171.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 53' ' ' VAL . . . . . 0.471 ' CG1' HD12 ' D' ' 67' ' ' LEU . 3.0 t -78.72 -52.72 15.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.735 -171.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 54' ' ' ALA . . . . . 0.447 ' HB1' ' CD2' ' D' ' 65' ' ' LEU . . . -146.92 137.73 23.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.498 -177.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 28.4 m -104.61 101.64 11.28 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 170.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 56' ' ' VAL . . . . . . . . . . . . . 6.1 p -121.73 109.85 25.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 122.019 0.914 . . . . 0.0 110.199 -177.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 80.7 p -122.88 -176.75 3.48 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.811 -175.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 58' ' ' LYS . . . . . 0.562 ' HB2' ' HZ3' ' D' ' 58' ' ' LYS . 9.9 mtmp? -57.94 -31.63 67.03 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.418 170.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.06 -40.87 52.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.606 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 69.9 mt -116.09 76.51 6.53 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 173.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -76.39 1.47 8.34 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.769 2.313 . . . . 0.0 113.381 -168.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -154.79 100.95 2.26 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.736 -170.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.427 HG12 ' HB3' ' D' ' 54' ' ' ALA . 65.9 t -102.58 121.05 53.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.038 0.447 . . . . 0.0 110.688 177.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.72 110.77 22.99 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.666 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 65' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' D' ' 30' ' ' SER . 0.3 OUTLIER -126.98 169.16 13.61 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.124 0.488 . . . . 0.0 111.639 -175.055 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 66' ' ' ASP . . . . . 0.541 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 27.2 t0 -119.32 105.1 10.99 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.712 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . 0.558 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 18.6 mt -120.75 150.67 40.63 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.98 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 68' ' ' ASN . . . . . 0.504 ' HB3' ' CD2' ' C' ' 90' ' ' TYR . 6.0 t30 -152.41 127.11 9.49 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.91 0.386 . . . . 0.0 110.049 172.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 69' ' ' PHE . . . . . 0.529 ' O ' ' HA ' ' D' ' 26' ' ' SER . 38.4 m-85 -121.31 161.49 21.94 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.72 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 70' ' ' SER . . . . . 0.469 ' HB2' ' HA ' ' C' ' 7' ' ' MET . 42.3 t -115.82 158.25 23.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.263 0.554 . . . . 0.0 111.847 -174.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -21.97 66.58 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.272 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.86 -1.07 61.79 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.906 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -100.57 166.02 11.12 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -145.04 129.59 17.98 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . . . . . . . . . 9.8 pt -134.82 174.61 12.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.058 0.456 . . . . 0.0 111.322 -173.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 76' ' ' MET . . . . . 0.584 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 23.2 mtp -130.45 123.76 30.51 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.284 174.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 77' ' ' PHE . . . . . 1.645 ' HE2' ' CE1' ' D' ' 77' ' ' PHE . 1.0 OUTLIER -105.05 127.53 52.92 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.093 178.51 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 78' ' ' TYR . . . . . 1.652 ' HE2' ' CE1' ' D' ' 78' ' ' TYR . 24.2 p90 -153.89 141.91 20.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.096 0.474 . . . . 0.0 111.756 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 79' ' ' THR . . . . . 0.679 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 11.7 p -113.36 141.84 46.57 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.033 -178.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -109.88 150.72 28.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.622 176.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.42 176.79 40.28 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -177.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -107.4 102.21 11.51 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.716 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.516 ' N ' ' HB3' ' D' ' 15' ' ' PRO . . . -170.25 150.37 3.62 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.895 169.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 32.4 t -104.41 119.24 38.52 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . 0.467 HG22 ' HB2' ' D' ' 13' ' ' MET . 5.7 m -119.14 135.19 60.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-O 121.425 0.631 . . . . 0.0 112.107 -174.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 7.5 t -99.67 119.47 38.16 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.976 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 87' ' ' LEU . . . . . 0.488 ' HB2' ' HB3' ' D' ' 11' ' ' LEU . 5.3 mp -92.87 147.07 23.15 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 173.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . 0.429 ' CD2' HG11 ' E' ' 53' ' ' VAL . 1.5 tp -133.23 138.7 46.61 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.151 -178.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.82 -167.55 23.41 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.997 -177.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 90' ' ' TYR . . . . . 0.48 ' CD2' ' HB3' ' E' ' 68' ' ' ASN . 20.2 p90 -153.64 135.71 14.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.805 0.812 . . . . 0.0 112.497 178.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . 0.425 HD21 ' HB3' ' D' ' 27' ' ' PHE . 5.3 mt . . . . . 0 C--N 1.324 -0.504 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.396 176.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 7' ' ' MET . . . . . 0.484 ' HA ' ' HB2' ' A' ' 70' ' ' SER . 56.0 mtp . . . . . 0 C--O 1.224 -0.285 0 CA-C-O 120.681 0.277 . . . . 0.0 111.288 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 8' ' ' PHE . . . . . 1.671 ' HE1' ' CE2' ' E' ' 8' ' ' PHE . 33.4 t80 -88.33 152.17 22.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.316 -175.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 9' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -138.62 146.51 41.82 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -178.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.81 155.88 26.38 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.166 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 11' ' ' LEU . . . . . 0.492 ' HB3' ' HB2' ' E' ' 87' ' ' LEU . 42.2 tp -150.06 108.33 3.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.774 0.321 . . . . 0.0 110.912 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -86.81 103.37 15.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.161 0.505 . . . . 0.0 110.834 175.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 13' ' ' MET . . . . . 0.453 ' HB2' HG22 ' E' ' 85' ' ' VAL . 2.8 mmt -80.84 136.74 36.15 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.22 -178.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 14' ' ' LYS . . . . . 0.506 ' HB2' ' HG3' ' E' ' 17' ' ' ARG . 27.2 mtpp -99.87 142.6 24.91 Favored Pre-proline 0 C--N 1.318 -0.803 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . 0.508 ' HB3' ' N ' ' E' ' 83' ' ' ALA . 7.6 Cg_endo -50.02 115.22 1.74 Allowed 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 123.46 2.773 . . . . 0.0 113.399 -175.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 16' ' ' GLU . . . . . 0.675 ' HA ' ' O ' ' E' ' 79' ' ' THR . 25.9 mt-10 65.03 57.53 0.96 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.539 0.685 . . . . 0.0 111.637 177.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 17' ' ' ARG . . . . . 0.506 ' HG3' ' HB2' ' E' ' 14' ' ' LYS . 13.6 mmt180 -117.57 163.27 16.68 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.503 171.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . 0.601 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 3.3 ttmp? -139.47 109.96 6.62 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 123.457 0.473 . . . . 0.0 110.858 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . 1.665 ' HE2' ' CE1' ' E' ' 19' ' ' TYR . 1.5 m-85 -111.3 113.34 25.75 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 2.7 p -72.18 116.48 12.66 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -97.88 117.68 32.75 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.714 -163.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 13.5 t -91.98 143.44 26.48 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 171.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 48.7 mt -115.4 124.43 71.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.25 0.548 . . . . 0.0 111.781 -172.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . 0.47 ' N ' HD13 ' E' ' 24' ' ' ILE . 4.1 mp -90.41 -43.82 14.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.787 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -140.15 149.45 43.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.099 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 26' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' E' ' 69' ' ' PHE . 23.0 t -59.83 115.24 3.25 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.155 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 27' ' ' PHE . . . . . 0.42 ' HB3' HD21 ' E' ' 91' ' ' LEU . 12.4 p90 -122.88 148.86 44.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.463 0.649 . . . . 0.0 111.684 -177.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 28' ' ' HIS . . . . . 0.646 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 10.6 t60 -106.53 120.43 41.91 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.592 178.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 29' ' ' ILE . . . . . 0.539 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 31.5 mt -89.44 134.32 29.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 171.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 30' ' ' SER . . . . . 0.646 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 16.1 p -122.51 -15.41 7.57 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -171.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 31' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -155.77 152.89 24.32 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.562 -1.304 . . . . 0.0 113.195 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . 0.427 ' CG2' ' HG ' ' E' ' 87' ' ' LEU . 11.6 p -150.21 122.32 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 171.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.37 154.47 42.34 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 122.13 -0.356 . . . . 0.0 111.552 -172.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 34' ' ' LEU . . . . . 0.461 ' HB3' ' CG1' ' E' ' 85' ' ' VAL . 3.7 pp -113.84 139.32 49.25 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.677 0.751 . . . . 0.0 111.569 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -104.59 -56.08 2.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.829 173.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -102.31 127.86 49.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 170.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . 0.473 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 150.92 162.16 10.48 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 119.613 -1.28 . . . . 0.0 113.493 176.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 38' ' ' GLN . . . . . 0.506 ' O ' ' HG3' ' E' ' 58' ' ' LYS . 26.5 mt-30 -102.5 -47.98 4.29 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 121.155 -0.218 . . . . 0.0 111.3 177.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -151.55 132.97 14.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.439 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . 0.408 ' HB3' ' HB1' ' E' ' 83' ' ' ALA . . . -132.54 116.26 16.51 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.412 0.625 . . . . 0.0 110.557 170.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 41' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' E' ' 79' ' ' THR . 97.8 mttt -100.12 112.59 24.89 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 40.7 tp -84.58 114.54 22.05 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -176.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 43' ' ' TYR . . . . . 0.453 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 98.4 m-85 -116.39 145.62 43.1 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 44' ' ' LEU . . . . . 0.575 ' HA ' ' O ' ' E' ' 76' ' ' MET . 0.3 OUTLIER -132.0 130.83 41.92 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.673 171.9 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' E' E ' 45' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -104.3 113.82 27.64 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.787 177.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.12 139.18 53.58 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 174.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 57.3 30.3 18.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.315 0.578 . . . . 0.0 109.687 -171.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 48' ' ' LYS . . . . . 0.509 ' HE2' ' HA ' ' E' ' 48' ' ' LYS . 0.3 OUTLIER 64.88 17.17 10.9 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.41 -179.194 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' E' E ' 49' ' ' GLN . . . . . 0.49 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 7.7 tt0 -105.07 121.49 43.91 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -82.04 112.05 18.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.76 -177.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . 1.659 ' HE2' ' CE1' ' E' ' 51' ' ' TYR . 58.6 m-85 -102.91 136.57 42.48 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.491 177.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -82.27 103.11 9.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 171.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . 0.467 ' CG1' HD12 ' E' ' 67' ' ' LEU . 2.9 t -78.63 -52.75 15.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.79 -172.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 54' ' ' ALA . . . . . 0.452 ' HB1' ' CD2' ' E' ' 65' ' ' LEU . . . -146.93 137.66 23.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.5 -177.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 28.2 m -104.55 101.61 11.26 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 170.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . . . . . . . . . 6.3 p -121.67 109.78 25.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.974 0.893 . . . . 0.0 110.263 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 80.4 p -122.79 -176.76 3.47 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.816 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 58' ' ' LYS . . . . . 0.562 ' HZ3' ' HB2' ' E' ' 58' ' ' LYS . 9.9 mtmp? -57.95 -31.7 67.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.023 0.44 . . . . 0.0 110.417 170.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.97 -40.88 52.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.621 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 70.0 mt -116.05 76.41 6.4 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -76.33 1.58 8.2 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.836 2.357 . . . . 0.0 113.408 -168.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 62' ' ' GLN . . . . . 0.409 ' OE1' ' HA ' ' A' ' 54' ' ' ALA . 10.2 tt0 -154.89 100.99 2.25 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.613 -170.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . 0.448 HG12 ' HB3' ' E' ' 54' ' ' ALA . 66.3 t -102.66 120.99 53.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.112 0.482 . . . . 0.0 110.788 177.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.69 110.9 23.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.603 175.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 65' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' E' ' 30' ' ' SER . 0.3 OUTLIER -127.03 169.19 13.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.663 -175.096 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' E' E ' 66' ' ' ASP . . . . . 0.529 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 27.1 t0 -119.35 104.98 10.86 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.709 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 67' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' E' ' 28' ' ' HIS . 18.5 mt -120.74 150.64 40.67 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.979 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 68' ' ' ASN . . . . . 0.48 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 6.0 t30 -152.38 127.17 9.55 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.922 0.391 . . . . 0.0 110.013 172.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 69' ' ' PHE . . . . . 0.528 ' O ' ' HA ' ' E' ' 26' ' ' SER . 38.5 m-85 -121.3 161.52 21.87 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.745 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 70' ' ' SER . . . . . 0.464 ' HB2' ' HA ' ' D' ' 7' ' ' MET . 42.1 t -115.89 158.26 23.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.262 0.553 . . . . 0.0 111.841 -174.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -21.81 66.49 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.297 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.98 -1.03 61.61 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.949 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -100.59 166.0 11.13 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -145.03 129.71 18.09 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 75' ' ' ILE . . . . . . . . . . . . . 9.7 pt -134.84 174.6 12.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.002 0.43 . . . . 0.0 111.376 -173.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 76' ' ' MET . . . . . 0.575 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 22.9 mtp -130.41 123.76 30.56 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 77' ' ' PHE . . . . . 1.67 ' HE2' ' CE1' ' E' ' 77' ' ' PHE . 0.9 OUTLIER -105.08 127.58 52.95 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.038 178.493 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' E' E ' 78' ' ' TYR . . . . . 1.642 ' HD1' ' CD2' ' E' ' 78' ' ' TYR . 24.5 p90 -153.91 141.85 20.2 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.118 0.485 . . . . 0.0 111.822 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 79' ' ' THR . . . . . 0.675 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 11.5 p -113.3 141.94 46.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.046 -178.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -110.03 150.78 28.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.534 176.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.4 176.86 40.3 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -177.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -107.46 102.18 11.47 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 119.409 -0.916 . . . . 0.0 109.713 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 83' ' ' ALA . . . . . 0.508 ' N ' ' HB3' ' E' ' 15' ' ' PRO . . . -170.2 150.38 3.66 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.863 169.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 32.3 t -104.42 119.31 38.69 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 85' ' ' VAL . . . . . 0.461 ' CG1' ' HB3' ' E' ' 34' ' ' LEU . 5.7 m -119.2 135.1 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 CA-C-O 121.421 0.629 . . . . 0.0 112.17 -174.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 7.5 t -99.57 119.58 38.28 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.963 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 87' ' ' LEU . . . . . 0.492 ' HB2' ' HB3' ' E' ' 11' ' ' LEU . 5.3 mp -93.01 147.14 23.09 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . 0.448 ' CD2' HG11 ' A' ' 53' ' ' VAL . 1.5 tp -133.22 138.67 46.61 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.12 -178.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.86 -167.62 23.55 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.021 -177.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 90' ' ' TYR . . . . . 0.522 ' CD2' ' HB3' ' A' ' 68' ' ' ASN . 20.1 p90 -153.65 135.74 14.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.932 0.872 . . . . 0.0 112.403 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 91' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' E' ' 27' ' ' PHE . 5.2 mt . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 113.983 -1.462 . . . . 0.0 109.402 176.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 57.1 mtp . . . . . 0 CA--C 1.521 -0.145 0 CA-C-O 121.053 0.454 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 1.656 ' HD1' ' CD2' ' A' ' 8' ' ' PHE . 48.7 t80 -66.47 145.49 55.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.068 -176.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.542 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 90.2 t90 -132.71 146.08 51.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.007 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.1 146.69 16.36 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.095 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.542 ' HB2' ' CH2' ' A' ' 9' ' ' TRP . 63.5 tp -134.27 109.02 8.56 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.983 0.42 . . . . 0.0 110.454 178.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -91.52 107.71 19.4 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.516 177.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.62 ' SD ' HD12 ' A' ' 87' ' ' LEU . 54.2 mtp -102.27 143.82 31.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.38 0.61 . . . . 0.0 111.406 -174.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -100.92 151.39 37.6 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.193 -177.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.467 ' HB3' ' N ' ' A' ' 83' ' ' ALA . 11.2 Cg_endo -54.99 113.77 1.56 Allowed 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.19 2.593 . . . . 0.0 112.832 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 79' ' ' THR . 17.3 mt-10 59.96 70.96 0.6 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.508 0.67 . . . . 0.0 111.414 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.2 142.77 32.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.558 174.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.641 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 35.3 ttmt -116.44 117.46 29.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.389 -176.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.477 ' HH ' ' HA ' ' A' ' 13' ' ' MET . 1.9 m-85 -110.37 122.26 47.28 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.453 ' HB3' ' SD ' ' A' ' 76' ' ' MET . 6.0 p -102.51 99.78 9.83 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 169.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 19.9 pm0 -117.72 143.0 46.62 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.595 0.712 . . . . 0.0 112.274 -174.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.0 t -93.31 160.77 14.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.526 176.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 70.1 mt -112.47 119.35 60.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.066 0.46 . . . . 0.0 111.529 -173.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.7 pp -99.6 -11.53 8.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.025 177.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -148.0 119.53 7.96 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.3 p -61.7 140.53 58.18 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 123.379 0.425 . . . . 0.0 110.656 -175.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 1.624 ' HE1' ' CE2' ' A' ' 27' ' ' PHE . 42.6 p90 -152.13 162.79 40.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.718 0.77 . . . . 0.0 112.895 -174.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.518 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 7.7 t60 -114.74 124.52 52.0 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.009 176.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.501 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 41.6 mt -88.28 135.91 24.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 170.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.474 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 43.8 p -123.62 -5.26 8.15 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -170.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . 179.88 155.14 14.62 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 119.192 -1.48 . . . . 0.0 113.513 175.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.9 p -136.78 132.83 48.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.8 156.48 42.4 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.605 -176.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.468 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 4.1 pp -123.72 145.55 48.92 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.403 0.621 . . . . 0.0 111.01 177.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.408 ' HB2' ' HH ' ' B' ' 43' ' ' TYR . 18.8 p-10 -110.2 -52.06 2.81 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.653 174.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.516 ' HZ2' ' HB3' ' A' ' 36' ' ' LYS . 7.8 mtpm? -102.93 127.5 50.12 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 169.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.44 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 151.75 156.75 7.59 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 119.769 -1.205 . . . . 0.0 113.344 177.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.465 ' HA ' ' HB2' ' A' ' 58' ' ' LYS . 94.8 mt-30 -102.37 -44.48 5.37 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.616 0.246 . . . . 0.0 111.07 178.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -152.82 128.83 10.34 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.363 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.426 ' HB1' HG11 ' A' ' 56' ' ' VAL . . . -128.22 113.02 15.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.549 0.69 . . . . 0.0 109.981 168.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 79' ' ' THR . 28.6 mmmt -94.59 109.39 21.31 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.3 tp -82.08 109.52 16.47 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -174.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -112.24 136.33 51.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.108 177.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.69 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -123.88 121.76 36.21 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.525 175.441 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -109.92 111.1 22.29 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.02 178.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.402 ' HB1' ' CE2' ' E' ' 8' ' ' PHE . . . -128.72 139.32 52.28 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.539 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 56.61 35.65 26.41 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 123.751 0.657 . . . . 0.0 110.314 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.511 ' HZ2' ' HB3' ' A' ' 48' ' ' LYS . 9.1 mtpm? 63.6 32.26 14.1 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.102 -0.953 . . . . 0.0 112.284 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.545 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 59.4 tp60 -128.28 133.96 48.85 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 175.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -89.05 121.84 31.79 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 -177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -116.72 123.44 47.21 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.506 176.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -75.38 106.69 5.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 169.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.599 ' CG2' ' HB3' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -84.22 -46.37 17.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.532 -172.299 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.46 ' HB3' HG12 ' A' ' 63' ' ' VAL . . . -153.96 149.48 27.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.641 -177.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.2 m -113.02 101.6 9.62 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 169.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.426 HG11 ' HB1' ' A' ' 40' ' ' ALA . 7.8 p -115.7 114.36 46.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.544 0.688 . . . . 0.0 109.283 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 44.6 p -122.62 -179.12 4.11 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.214 -172.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.465 ' HB2' ' HA ' ' A' ' 38' ' ' GLN . 58.1 tttt -58.68 -32.29 68.98 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.704 171.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.4 -40.87 22.77 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.922 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 84.5 mt -108.38 86.63 3.55 Favored Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 175.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.08 0.17 8.76 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.665 2.243 . . . . 0.0 113.843 -166.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -164.49 131.07 3.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.24 0.543 . . . . 0.0 111.516 -175.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.46 HG12 ' HB3' ' A' ' 54' ' ' ALA . 93.4 t -122.0 112.22 33.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.311 174.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.59 131.49 41.76 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 174.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.451 HD22 ' HB1' ' A' ' 54' ' ' ALA . 86.3 mt -124.16 168.14 13.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.482 0.658 . . . . 0.0 112.303 -173.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.479 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 18.5 t0 -142.33 99.48 3.51 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.351 169.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.518 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 2.4 mt -129.46 144.21 51.16 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.415 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 5.9 t30 -141.79 114.91 8.74 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.539 -0.465 . . . . 0.0 109.771 176.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -111.14 146.93 35.96 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.541 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.9 t -97.88 166.72 11.32 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -75.57 2.21 12.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.241 0.543 . . . . 0.0 110.591 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.25 -7.77 51.47 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.294 172.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -93.18 138.75 31.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.044 0.449 . . . . 0.0 110.447 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -122.22 117.0 25.12 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.9 pt -128.58 162.73 34.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.188 0.518 . . . . 0.0 112.054 -168.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.453 ' SD ' ' HB3' ' A' ' 20' ' ' SER . 4.9 mtm -119.93 125.67 49.0 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 172.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 1.663 ' HD1' ' CD2' ' A' ' 77' ' ' PHE . 0.8 OUTLIER -109.6 127.09 54.27 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 176.548 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 1.632 ' HE1' ' CE2' ' A' ' 78' ' ' TYR . 53.2 p90 -155.42 139.22 16.18 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.009 -175.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.576 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 2.9 p -111.7 134.23 53.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.309 -176.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -100.74 157.09 16.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.536 175.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.81 179.08 46.16 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -176.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -108.18 102.96 12.06 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.003 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.467 ' N ' ' HB3' ' A' ' 15' ' ' PRO . . . -168.79 150.8 4.83 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.505 170.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.3 t -109.74 121.86 46.17 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.468 ' CG1' ' HB3' ' A' ' 34' ' ' LEU . 7.0 m -117.68 155.26 19.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.316 0.579 . . . . 0.0 112.38 -173.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.4 m -120.72 122.43 40.39 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.58 173.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.62 HD12 ' SD ' ' A' ' 13' ' ' MET . 4.7 mp -96.03 145.76 25.19 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 170.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.47 HD12 ' O ' ' A' ' 87' ' ' LEU . 1.2 mm? -121.02 150.3 41.35 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 173.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.31 -167.81 27.54 Favored Glycine 0 N--CA 1.438 -1.18 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.248 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.414 ' CD2' ' HB3' ' B' ' 68' ' ' ASN . 3.4 p90 -147.57 129.18 15.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.735 0.779 . . . . 0.0 112.07 177.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 15.7 mt . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 113.918 -1.492 . . . . 0.0 109.815 176.165 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 56.8 mtp . . . . . 0 CA--C 1.521 -0.162 0 CA-C-O 121.012 0.434 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . 1.647 ' HE2' ' CE1' ' B' ' 8' ' ' PHE . 48.2 t80 -66.5 145.55 55.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.057 -176.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . 0.546 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 90.1 t90 -132.75 146.06 51.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.003 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.19 146.74 16.44 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.118 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.546 ' HB2' ' CH2' ' B' ' 9' ' ' TRP . 63.5 tp -134.29 109.05 8.57 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.013 0.435 . . . . 0.0 110.557 178.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -91.43 107.68 19.37 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.556 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' MET . . . . . 0.615 ' SD ' HD12 ' B' ' 87' ' ' LEU . 53.8 mtp -102.29 143.67 31.76 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.396 0.617 . . . . 0.0 111.382 -174.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -100.88 151.48 37.62 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.095 -177.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.458 ' HB3' ' N ' ' B' ' 83' ' ' ALA . 11.1 Cg_endo -55.02 113.87 1.6 Allowed 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 123.142 2.561 . . . . 0.0 112.752 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.58 ' HA ' ' O ' ' B' ' 79' ' ' THR . 17.3 mt-10 59.91 71.02 0.59 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.501 0.667 . . . . 0.0 111.356 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.23 142.83 32.66 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.613 174.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . 0.639 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 35.3 ttmt -116.6 117.49 29.99 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.32 -176.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' TYR . . . . . 0.474 ' HH ' ' HA ' ' B' ' 13' ' ' MET . 1.9 m-85 -110.43 122.3 47.38 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.446 ' HB3' ' SD ' ' B' ' 76' ' ' MET . 5.9 p -102.58 99.83 9.86 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 169.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 19.8 pm0 -117.83 142.98 46.7 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.576 0.703 . . . . 0.0 112.165 -174.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 13.0 t -93.21 160.71 14.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.549 176.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 70.1 mt -112.52 119.4 60.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.138 0.494 . . . . 0.0 111.523 -173.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 1.7 pp -99.68 -11.52 8.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.906 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -147.95 119.58 8.01 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 31.4 p -61.67 140.53 58.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.654 -175.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . 1.595 ' HE2' ' CE1' ' B' ' 27' ' ' PHE . 42.8 p90 -152.16 162.73 40.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.774 0.797 . . . . 0.0 112.903 -174.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' HIS . . . . . 0.506 ' HA ' ' O ' ' B' ' 67' ' ' LEU . 7.6 t60 -114.66 124.49 51.95 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.053 177.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 41.8 mt -88.26 135.89 24.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 170.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.471 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 45.2 p -123.64 -5.2 8.14 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -170.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . 179.86 155.17 14.68 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 119.188 -1.482 . . . . 0.0 113.538 175.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 11.9 p -136.85 132.75 47.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 174.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.76 156.51 42.45 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 121.937 -0.477 . . . . 0.0 111.6 -176.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.474 ' HB3' ' CG1' ' B' ' 85' ' ' VAL . 4.1 pp -123.82 145.43 49.08 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.541 0.686 . . . . 0.0 111.038 177.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -110.02 -52.1 2.81 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.719 174.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.501 ' HB3' ' HZ2' ' B' ' 36' ' ' LYS . 7.8 mtpm? -102.93 127.38 50.16 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 169.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.436 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 151.9 156.79 7.62 Favored Glycine 0 N--CA 1.437 -1.253 0 C-N-CA 119.756 -1.211 . . . . 0.0 113.366 177.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . 0.457 ' HA ' ' HB2' ' B' ' 58' ' ' LYS . 94.9 mt-30 -102.36 -44.34 5.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.692 0.282 . . . . 0.0 111.091 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -152.95 128.77 10.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.561 0.22 . . . . 0.0 111.339 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.413 ' HB1' HG11 ' B' ' 56' ' ' VAL . . . -128.16 113.08 15.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.539 0.685 . . . . 0.0 109.916 167.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' B' ' 79' ' ' THR . 28.6 mmmt -94.57 109.31 21.22 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 48.6 tp -82.08 109.44 16.4 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -174.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . 0.408 ' HH ' ' HB2' ' A' ' 35' ' ' ASP . 89.1 m-85 -112.2 136.41 51.66 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.072 177.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.684 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 0.1 OUTLIER -123.94 121.67 35.9 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.478 175.465 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -109.82 111.24 22.55 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.968 178.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -128.75 139.28 52.28 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.602 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 56.63 35.61 26.37 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.746 0.654 . . . . 0.0 110.358 -177.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.503 ' HZ2' ' HB3' ' B' ' 48' ' ' LYS . 9.1 mtpm? 63.57 32.38 14.1 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.277 178.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . 0.539 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 59.3 tp60 -128.37 133.85 48.72 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 175.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -88.94 121.78 31.65 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -177.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -116.67 123.44 47.27 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.461 176.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -75.39 106.66 5.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 169.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.599 ' CG2' ' HB3' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -84.15 -46.42 17.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.535 -172.299 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.468 ' HB1' HD22 ' B' ' 65' ' ' LEU . . . -153.92 149.41 27.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.715 -177.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 53.2 m -113.0 101.67 9.69 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 169.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . 0.413 HG11 ' HB1' ' B' ' 40' ' ' ALA . 7.7 p -115.78 114.35 45.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.578 0.704 . . . . 0.0 109.249 -179.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 45.0 p -122.59 -179.18 4.13 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.195 -172.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . 0.457 ' HB2' ' HA ' ' B' ' 38' ' ' GLN . 58.0 tttt -58.66 -32.33 69.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.747 171.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.37 -40.87 22.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.928 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 84.0 mt -108.31 86.69 3.52 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.16 0.21 8.74 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.731 2.288 . . . . 0.0 113.807 -166.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -164.52 131.05 3.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.326 0.584 . . . . 0.0 111.528 -175.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.452 HG12 ' HB3' ' B' ' 54' ' ' ALA . 92.9 t -121.95 112.17 33.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.348 174.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.56 131.54 41.83 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 174.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.468 HD22 ' HB1' ' B' ' 54' ' ' ALA . 86.1 mt -124.2 168.12 13.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.46 0.648 . . . . 0.0 112.226 -173.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 18.6 t0 -142.4 99.44 3.5 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.396 169.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' B' ' 28' ' ' HIS . 2.3 mt -129.34 144.27 51.17 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . 0.414 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 5.9 t30 -141.98 114.89 8.65 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.836 176.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -111.03 146.89 35.92 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.552 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 21.9 t -97.83 166.7 11.34 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -75.53 2.11 12.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.208 0.528 . . . . 0.0 110.568 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.11 -7.78 51.82 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.336 172.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -93.24 138.68 31.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.183 0.516 . . . . 0.0 110.493 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -122.17 116.95 25.07 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 14.9 pt -128.41 162.86 34.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.243 0.545 . . . . 0.0 111.983 -168.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' MET . . . . . 0.464 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 4.9 mtm -120.08 125.8 49.18 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.389 172.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . 1.668 ' HD1' ' CD2' ' B' ' 77' ' ' PHE . 0.8 OUTLIER -109.64 127.08 54.3 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.64 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 1.642 ' HE2' ' CE1' ' B' ' 78' ' ' TYR . 53.2 p90 -155.43 139.23 16.19 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.983 -175.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.58 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 3.0 p -111.59 134.16 53.36 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.404 -176.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -100.64 157.03 16.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.518 175.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.91 178.96 46.04 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -176.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -108.08 102.91 12.03 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.971 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.458 ' N ' ' HB3' ' B' ' 15' ' ' PRO . . . -168.76 150.88 4.88 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.47 170.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 15.9 t -109.76 121.89 46.26 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.474 ' CG1' ' HB3' ' B' ' 34' ' ' LEU . 7.0 m -117.79 155.29 19.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.415 0.626 . . . . 0.0 112.331 -173.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 49.3 m -120.64 122.44 40.49 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.583 173.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.615 HD12 ' SD ' ' B' ' 13' ' ' MET . 4.7 mp -96.02 145.71 25.23 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 170.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.463 HD12 ' O ' ' B' ' 87' ' ' LEU . 1.2 mm? -120.96 150.2 41.48 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 173.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.21 -167.89 27.55 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.327 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 90' ' ' TYR . . . . . 0.412 ' CD2' ' HB3' ' C' ' 68' ' ' ASN . 3.4 p90 -147.53 129.22 15.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.755 0.788 . . . . 0.0 112.166 177.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 15.8 mt . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 113.949 -1.478 . . . . 0.0 109.766 176.264 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 56.4 mtp . . . . . 0 CA--C 1.521 -0.144 0 CA-C-O 120.973 0.416 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 8' ' ' PHE . . . . . 1.659 ' HD1' ' CD2' ' C' ' 8' ' ' PHE . 48.8 t80 -66.35 145.47 55.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.101 -176.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . 0.541 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 90.2 t90 -132.71 146.02 51.52 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.046 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.13 146.69 16.35 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.1 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.541 ' HB2' ' CH2' ' C' ' 9' ' ' TRP . 63.5 tp -134.29 109.0 8.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.032 0.444 . . . . 0.0 110.468 178.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -91.44 107.66 19.36 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.583 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 13' ' ' MET . . . . . 0.613 ' SD ' HD12 ' C' ' 87' ' ' LEU . 53.5 mtp -102.21 143.61 31.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.322 0.582 . . . . 0.0 111.496 -174.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -100.8 151.46 37.6 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.205 -177.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . 0.457 ' HB3' ' N ' ' C' ' 83' ' ' ALA . 11.2 Cg_endo -55.01 113.89 1.61 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 123.152 2.568 . . . . 0.0 112.796 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' C' ' 79' ' ' THR . 17.4 mt-10 59.96 70.97 0.6 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.46 0.648 . . . . 0.0 111.328 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.24 142.97 32.67 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.554 174.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 18' ' ' LYS . . . . . 0.635 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 35.2 ttmt -116.69 117.42 29.76 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.323 -176.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . 0.473 ' HH ' ' HA ' ' C' ' 13' ' ' MET . 1.9 m-85 -110.38 122.33 47.43 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 20' ' ' SER . . . . . 0.446 ' HB3' ' SD ' ' C' ' 76' ' ' MET . 6.1 p -102.59 99.84 9.87 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 169.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 19.8 pm0 -117.78 143.05 46.6 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.611 0.72 . . . . 0.0 112.163 -174.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 12.9 t -93.36 160.76 14.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.532 176.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 70.3 mt -112.54 119.35 60.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.141 0.495 . . . . 0.0 111.531 -173.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 1.7 pp -99.6 -11.51 8.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.022 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -148.02 119.46 7.91 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 31.7 p -61.57 140.46 58.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.688 -175.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 27' ' ' PHE . . . . . 1.612 ' HD2' ' CD1' ' C' ' 27' ' ' PHE . 42.6 p90 -152.04 162.86 40.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.652 0.739 . . . . 0.0 112.969 -175.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 28' ' ' HIS . . . . . 0.516 ' HA ' ' O ' ' C' ' 67' ' ' LEU . 7.5 t60 -114.81 124.58 52.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.01 177.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . 0.49 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 41.6 mt -88.32 135.92 24.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 170.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 30' ' ' SER . . . . . 0.483 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 44.9 p -123.59 -5.31 8.16 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -170.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 31' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . 179.89 155.09 14.49 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 119.181 -1.485 . . . . 0.0 113.547 176.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.402 HG21 ' HG ' ' C' ' 87' ' ' LEU . 12.0 p -136.8 132.84 48.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 174.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.82 156.52 42.45 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 121.952 -0.468 . . . . 0.0 111.589 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.475 ' HB3' HG13 ' C' ' 85' ' ' VAL . 4.1 pp -123.82 145.45 49.06 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.514 0.673 . . . . 0.0 111.044 177.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -110.03 -52.14 2.81 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.703 174.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 36' ' ' LYS . . . . . 0.512 ' HZ2' ' HB3' ' C' ' 36' ' ' LYS . 7.8 mtpm? -102.9 127.41 50.11 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 169.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 37' ' ' GLY . . . . . 0.444 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 151.86 156.76 7.6 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 119.848 -1.168 . . . . 0.0 113.46 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 38' ' ' GLN . . . . . 0.456 ' HA ' ' HB2' ' C' ' 58' ' ' LYS . 95.0 mt-30 -102.4 -44.34 5.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.642 0.258 . . . . 0.0 111.059 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -152.91 128.82 10.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.57 0.224 . . . . 0.0 111.361 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . 0.417 ' HB1' HG11 ' C' ' 56' ' ' VAL . . . -128.24 112.94 15.05 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.524 0.678 . . . . 0.0 109.972 168.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' C' ' 79' ' ' THR . 28.7 mmmt -94.57 109.32 21.23 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 176.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 48.5 tp -82.08 109.46 16.42 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -174.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -112.3 136.4 51.78 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.071 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.691 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 0.1 OUTLIER -123.88 121.79 36.29 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.478 175.463 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -109.85 111.14 22.38 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.968 178.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . 0.405 ' HB1' ' CE2' ' B' ' 8' ' ' PHE . . . -128.7 139.39 52.25 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.607 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 56.5 35.75 26.49 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 123.728 0.643 . . . . 0.0 110.304 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . 0.507 ' HZ2' ' HB3' ' C' ' 48' ' ' LYS . 9.1 mtpm? 63.64 32.2 14.05 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.253 178.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . 0.537 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 59.5 tp60 -128.23 133.88 48.9 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 175.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -88.99 121.69 31.61 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -116.66 123.43 47.26 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.453 176.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -75.4 106.72 5.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 53' ' ' VAL . . . . . 0.592 ' CG2' ' HB3' ' C' ' 44' ' ' LEU . 0.7 OUTLIER -84.2 -46.41 17.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.553 -172.351 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 54' ' ' ALA . . . . . 0.468 ' HB1' HD22 ' C' ' 65' ' ' LEU . . . -153.97 149.44 27.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.696 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 52.6 m -112.96 101.6 9.63 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 169.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . 0.417 HG11 ' HB1' ' C' ' 40' ' ' ALA . 7.8 p -115.69 114.33 45.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.517 0.675 . . . . 0.0 109.298 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 44.3 p -122.62 -179.17 4.13 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.205 -172.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 58' ' ' LYS . . . . . 0.456 ' HB2' ' HA ' ' C' ' 38' ' ' GLN . 57.9 tttt -58.52 -32.35 68.76 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.745 171.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.38 -41.03 22.57 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.851 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 83.9 mt -108.22 86.7 3.46 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 174.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.19 0.2 8.77 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.74 2.293 . . . . 0.0 113.786 -166.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -164.46 131.12 3.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.245 0.545 . . . . 0.0 111.576 -175.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.455 HG12 ' HB3' ' C' ' 54' ' ' ALA . 94.0 t -122.03 112.18 33.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.303 174.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.67 131.48 41.69 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . 0.468 HD22 ' HB1' ' C' ' 54' ' ' ALA . 86.2 mt -124.17 168.17 13.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.46 0.648 . . . . 0.0 112.265 -173.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 66' ' ' ASP . . . . . 0.454 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 18.5 t0 -142.46 99.46 3.5 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.964 -1.017 . . . . 0.0 108.332 169.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . 0.516 ' O ' ' HA ' ' C' ' 28' ' ' HIS . 2.3 mt -129.42 144.29 51.19 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . 0.412 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 5.9 t30 -141.86 114.95 8.74 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.762 176.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -111.17 146.88 36.1 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.529 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 21.9 t -97.81 166.62 11.38 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -75.46 2.08 12.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.215 0.531 . . . . 0.0 110.588 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.15 -7.7 51.87 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.253 172.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -93.27 138.7 31.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.123 0.487 . . . . 0.0 110.428 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -122.24 116.97 25.06 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 175.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 15.0 pt -128.51 162.73 34.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.259 0.552 . . . . 0.0 112.014 -168.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 76' ' ' MET . . . . . 0.458 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 4.8 mtm -119.92 125.69 49.08 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.475 172.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 77' ' ' PHE . . . . . 1.649 ' HD1' ' CD2' ' C' ' 77' ' ' PHE . 0.8 OUTLIER -109.66 127.11 54.33 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 176.635 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 78' ' ' TYR . . . . . 1.657 ' HE1' ' CE2' ' C' ' 78' ' ' TYR . 53.3 p90 -155.42 139.21 16.18 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.862 -0.735 . . . . 0.0 112.079 -176.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 79' ' ' THR . . . . . 0.577 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 3.0 p -111.56 134.22 53.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.42 -176.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -100.71 157.1 16.94 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.522 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.81 178.93 46.2 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -176.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -108.06 102.98 12.1 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.064 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . 0.457 ' N ' ' HB3' ' C' ' 15' ' ' PRO . . . -168.79 150.77 4.82 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.504 170.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 15.8 t -109.72 121.93 46.34 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.475 HG13 ' HB3' ' C' ' 34' ' ' LEU . 6.9 m -117.78 155.3 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 CA-C-O 121.344 0.592 . . . . 0.0 112.353 -173.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 49.9 m -120.62 122.41 40.45 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.573 173.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . 0.613 HD12 ' SD ' ' C' ' 13' ' ' MET . 4.7 mp -96.0 145.72 25.21 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 170.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . 0.472 HD12 ' O ' ' C' ' 87' ' ' LEU . 1.2 mm? -121.0 150.31 41.32 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 173.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.31 -167.96 27.77 Favored Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.249 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 90' ' ' TYR . . . . . 0.425 ' CD2' ' HB3' ' D' ' 68' ' ' ASN . 3.3 p90 -147.52 129.24 15.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.785 0.802 . . . . 0.0 112.086 177.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 15.9 mt . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 113.911 -1.495 . . . . 0.0 109.761 176.231 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 56.7 mtp . . . . . 0 CA--C 1.52 -0.183 0 CA-C-O 121.03 0.443 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 8' ' ' PHE . . . . . 1.666 ' HE2' ' CE1' ' D' ' 8' ' ' PHE . 48.6 t80 -66.5 145.55 55.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.1 -176.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 9' ' ' TRP . . . . . 0.538 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 90.2 t90 -132.75 146.02 51.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.013 179.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.11 146.71 16.41 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.125 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . 0.538 ' HB2' ' CH2' ' D' ' 9' ' ' TRP . 63.4 tp -134.31 108.95 8.5 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.031 0.443 . . . . 0.0 110.558 178.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -91.38 107.67 19.37 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.566 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 13' ' ' MET . . . . . 0.614 ' SD ' HD12 ' D' ' 87' ' ' LEU . 54.0 mtp -102.3 143.77 31.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.429 0.633 . . . . 0.0 111.408 -174.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -100.84 151.44 37.61 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.203 -177.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . 0.47 ' HB3' ' N ' ' D' ' 83' ' ' ALA . 11.1 Cg_endo -55.06 113.9 1.62 Allowed 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 123.119 2.546 . . . . 0.0 112.754 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . 0.569 ' HA ' ' O ' ' D' ' 79' ' ' THR . 17.3 mt-10 60.02 70.83 0.61 Allowed 'General case' 0 C--O 1.233 0.207 0 O-C-N 123.711 0.632 . . . . 0.0 111.36 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.13 142.97 32.81 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.516 174.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . 0.63 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 35.3 ttmt -116.69 117.44 29.81 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.373 -176.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 19' ' ' TYR . . . . . 0.474 ' HH ' ' HA ' ' D' ' 13' ' ' MET . 1.9 m-85 -110.29 122.38 47.52 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 20' ' ' SER . . . . . 0.448 ' HB3' ' SD ' ' D' ' 76' ' ' MET . 5.9 p -102.63 99.86 9.88 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 169.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 19.8 pm0 -117.76 142.98 46.66 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.516 0.674 . . . . 0.0 112.215 -174.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 13.0 t -93.24 160.77 14.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.609 176.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 70.1 mt -112.6 119.49 60.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.217 0.532 . . . . 0.0 111.449 -173.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 1.7 pp -99.7 -11.59 8.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.005 177.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -147.99 119.55 7.97 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 31.3 p -61.75 140.51 58.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.691 -175.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 27' ' ' PHE . . . . . 1.632 ' HE1' ' CE2' ' D' ' 27' ' ' PHE . 42.8 p90 -152.08 162.82 40.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.712 0.768 . . . . 0.0 112.898 -174.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 28' ' ' HIS . . . . . 0.505 ' HA ' ' O ' ' D' ' 67' ' ' LEU . 7.7 t60 -114.81 124.58 52.1 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.011 176.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 29' ' ' ILE . . . . . 0.484 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 42.1 mt -88.33 135.88 24.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 170.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 30' ' ' SER . . . . . 0.488 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 44.6 p -123.59 -5.28 8.16 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -170.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 31' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . 179.94 155.12 14.6 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 119.175 -1.488 . . . . 0.0 113.544 176.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . 0.401 HG21 ' HG ' ' D' ' 87' ' ' LEU . 12.0 p -136.84 132.84 48.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 174.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.83 156.46 42.36 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.918 -0.489 . . . . 0.0 111.598 -176.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 34' ' ' LEU . . . . . 0.474 ' HB3' ' CG1' ' D' ' 85' ' ' VAL . 4.1 pp -123.77 145.43 49.04 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.538 0.685 . . . . 0.0 111.069 177.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -110.13 -51.93 2.83 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.706 174.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 36' ' ' LYS . . . . . 0.511 ' HZ2' ' HB3' ' D' ' 36' ' ' LYS . 7.8 mtpm? -103.02 127.4 50.28 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 169.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . 0.447 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 151.81 156.81 7.62 Favored Glycine 0 N--CA 1.437 -1.253 0 C-N-CA 119.811 -1.185 . . . . 0.0 113.384 177.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 38' ' ' GLN . . . . . 0.468 ' HA ' ' HB2' ' D' ' 58' ' ' LYS . 95.0 mt-30 -102.43 -44.41 5.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.662 0.267 . . . . 0.0 111.053 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -152.87 128.84 10.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.327 178.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . 0.423 ' HB1' HG11 ' D' ' 56' ' ' VAL . . . -128.22 113.08 15.23 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.557 0.694 . . . . 0.0 109.884 168.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' D' ' 79' ' ' THR . 28.6 mmmt -94.6 109.35 21.27 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 176.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 48.5 tp -82.13 109.49 16.49 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -174.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -112.22 136.34 51.77 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.123 177.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.693 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.1 OUTLIER -123.91 121.78 36.24 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.498 175.427 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 45' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -109.91 111.16 22.39 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.915 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -128.72 139.39 52.24 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.567 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 56.57 35.72 26.5 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 123.654 0.596 . . . . 0.0 110.207 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 48' ' ' LYS . . . . . 0.51 ' HZ2' ' HB3' ' D' ' 48' ' ' LYS . 9.1 mtpm? 63.6 32.32 14.08 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.276 178.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . 0.543 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 59.5 tp60 -128.3 133.98 48.84 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -89.1 121.79 31.78 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -177.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -116.72 123.4 47.12 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.442 176.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -75.42 106.71 5.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 169.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 53' ' ' VAL . . . . . 0.596 ' CG2' ' HB3' ' D' ' 44' ' ' LEU . 0.7 OUTLIER -84.09 -46.44 18.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.599 -172.392 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 54' ' ' ALA . . . . . 0.456 ' HB3' HG12 ' D' ' 63' ' ' VAL . . . -153.89 149.38 27.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.728 -177.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 53.0 m -112.93 101.64 9.68 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 169.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 56' ' ' VAL . . . . . 0.423 HG11 ' HB1' ' D' ' 40' ' ' ALA . 7.8 p -115.71 114.37 46.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.605 0.716 . . . . 0.0 109.254 -179.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 44.7 p -122.65 -179.23 4.15 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.13 -172.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 58' ' ' LYS . . . . . 0.468 ' HB2' ' HA ' ' D' ' 38' ' ' GLN . 57.9 tttt -58.61 -32.3 68.87 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.721 171.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.38 -40.94 22.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.862 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 84.7 mt -108.33 86.68 3.53 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 175.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.11 0.23 8.7 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.79 2.327 . . . . 0.0 113.845 -166.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -164.52 131.07 3.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.342 0.591 . . . . 0.0 111.526 -175.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.456 HG12 ' HB3' ' D' ' 54' ' ' ALA . 93.5 t -122.09 112.24 33.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.308 174.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.64 131.56 41.8 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 174.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 65' ' ' LEU . . . . . 0.45 HD22 ' HB1' ' D' ' 54' ' ' ALA . 86.3 mt -124.2 168.16 13.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.559 0.695 . . . . 0.0 112.188 -173.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 66' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 18.6 t0 -142.44 99.46 3.5 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.319 169.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' D' ' 28' ' ' HIS . 2.3 mt -129.47 144.27 51.18 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 68' ' ' ASN . . . . . 0.425 ' HB3' ' CD2' ' C' ' 90' ' ' TYR . 5.9 t30 -141.88 114.9 8.7 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.538 -0.465 . . . . 0.0 109.805 176.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -111.06 146.86 36.0 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.569 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 21.8 t -97.78 166.7 11.35 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -75.54 2.15 12.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.195 0.522 . . . . 0.0 110.583 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.14 -7.76 51.77 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.271 172.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -93.28 138.76 31.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.159 0.504 . . . . 0.0 110.489 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -122.3 116.98 25.02 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 175.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . . . . . . . . . 14.9 pt -128.5 162.72 34.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.135 0.493 . . . . 0.0 112.051 -168.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 76' ' ' MET . . . . . 0.462 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 4.9 mtm -120.03 125.67 48.92 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.458 172.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 77' ' ' PHE . . . . . 1.656 ' HE2' ' CE1' ' D' ' 77' ' ' PHE . 0.8 OUTLIER -109.63 127.18 54.35 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.639 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 78' ' ' TYR . . . . . 1.655 ' HE2' ' CE1' ' D' ' 78' ' ' TYR . 53.3 p90 -155.52 139.2 16.07 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 119.814 -0.755 . . . . 0.0 112.006 -175.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 79' ' ' THR . . . . . 0.569 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 2.9 p -111.62 134.22 53.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.415 -176.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -100.66 157.19 16.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.499 175.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.69 178.99 46.35 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -108.1 103.0 12.11 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 117.784 0.792 . . . . 0.0 110.013 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.47 ' N ' ' HB3' ' D' ' 15' ' ' PRO . . . -168.92 150.73 4.68 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.46 170.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 15.3 t -109.64 121.85 46.14 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . 0.474 ' CG1' ' HB3' ' D' ' 34' ' ' LEU . 6.9 m -117.78 155.3 19.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.442 0.639 . . . . 0.0 112.288 -173.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 49.6 m -120.71 122.42 40.38 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.519 173.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 87' ' ' LEU . . . . . 0.614 HD12 ' SD ' ' D' ' 13' ' ' MET . 4.7 mp -96.0 145.72 25.21 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 170.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . 0.474 HD12 ' O ' ' D' ' 87' ' ' LEU . 1.1 mm? -121.0 150.28 41.38 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.25 -167.89 27.6 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.25 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 90' ' ' TYR . . . . . 0.401 ' CD2' ' HB3' ' E' ' 68' ' ' ASN . 3.4 p90 -147.46 129.25 15.24 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.769 0.795 . . . . 0.0 112.115 177.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 15.8 mt . . . . . 0 C--N 1.325 -0.461 0 CA-C-N 113.901 -1.5 . . . . 0.0 109.759 176.233 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 56.4 mtp . . . . . 0 CA--C 1.52 -0.195 0 CA-C-O 121.089 0.471 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' E' E ' 8' ' ' PHE . . . . . 1.672 ' HD2' ' CD1' ' E' ' 8' ' ' PHE . 48.6 t80 -66.5 145.51 55.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.074 -176.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 9' ' ' TRP . . . . . 0.538 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 90.4 t90 -132.71 146.03 51.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.006 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.1 146.65 16.28 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.195 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 11' ' ' LEU . . . . . 0.538 ' HB2' ' CH2' ' E' ' 9' ' ' TRP . 63.5 tp -134.15 109.05 8.65 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.945 0.402 . . . . 0.0 110.502 178.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -91.48 107.69 19.38 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 13' ' ' MET . . . . . 0.622 ' SD ' HD12 ' E' ' 87' ' ' LEU . 53.9 mtp -102.3 143.71 31.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.419 0.628 . . . . 0.0 111.445 -174.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -100.85 151.46 37.61 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.149 -177.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . 0.46 ' HB3' ' N ' ' E' ' 83' ' ' ALA . 11.1 Cg_endo -55.14 113.95 1.64 Allowed 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 123.188 2.592 . . . . 0.0 112.697 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 16' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' E' ' 79' ' ' THR . 17.4 mt-10 59.87 70.95 0.6 Allowed 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.426 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.14 142.92 32.79 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.56 174.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . 0.63 ' HA ' ' CB ' ' E' ' 78' ' ' TYR . 35.3 ttmt -116.6 117.46 29.92 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.322 -176.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . 0.474 ' HH ' ' HA ' ' E' ' 13' ' ' MET . 1.9 m-85 -110.35 122.24 47.21 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 20' ' ' SER . . . . . 0.446 ' HB3' ' SD ' ' E' ' 76' ' ' MET . 6.1 p -102.46 99.8 9.87 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 169.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 19.8 pm0 -117.79 143.07 46.59 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.628 0.728 . . . . 0.0 112.242 -174.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 13.0 t -93.36 160.77 14.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.551 176.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 69.9 mt -112.5 119.38 60.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.065 0.46 . . . . 0.0 111.579 -173.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 1.7 pp -99.6 -11.51 8.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.051 177.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -148.07 119.55 7.93 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 31.3 p -61.73 140.49 58.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.648 -175.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 27' ' ' PHE . . . . . 1.638 ' HE1' ' CE2' ' E' ' 27' ' ' PHE . 42.9 p90 -152.08 162.78 40.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.793 0.806 . . . . 0.0 112.907 -174.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 28' ' ' HIS . . . . . 0.515 ' HA ' ' O ' ' E' ' 67' ' ' LEU . 7.7 t60 -114.67 124.59 52.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.981 177.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 29' ' ' ILE . . . . . 0.479 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 42.2 mt -88.32 135.87 24.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 170.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 30' ' ' SER . . . . . 0.479 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 45.1 p -123.55 -5.31 8.18 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -170.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 31' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . 179.91 155.11 14.56 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 119.123 -1.513 . . . . 0.0 113.572 175.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 12.0 p -136.81 132.82 48.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 174.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.75 156.49 42.43 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 121.92 -0.487 . . . . 0.0 111.571 -176.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 34' ' ' LEU . . . . . 0.475 ' HB3' ' CG1' ' E' ' 85' ' ' VAL . 4.1 pp -123.81 145.52 49.0 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.607 0.718 . . . . 0.0 111.031 177.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -110.09 -52.07 2.81 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.977 -1.011 . . . . 0.0 108.683 174.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 36' ' ' LYS . . . . . 0.508 ' HZ2' ' HB3' ' E' ' 36' ' ' LYS . 7.8 mtpm? -102.98 127.31 50.27 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 169.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . 0.442 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 151.92 156.78 7.62 Favored Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 119.754 -1.212 . . . . 0.0 113.389 177.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 38' ' ' GLN . . . . . 0.469 ' HA ' ' HB2' ' E' ' 58' ' ' LYS . 94.9 mt-30 -102.39 -44.39 5.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.658 0.266 . . . . 0.0 111.094 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -152.88 128.81 10.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.411 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . 0.423 ' HB1' HG11 ' E' ' 56' ' ' VAL . . . -128.19 113.01 15.15 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.476 0.655 . . . . 0.0 109.89 168.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 41' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' E' ' 79' ' ' THR . 28.7 mmmt -94.59 109.34 21.26 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 48.1 tp -82.08 109.51 16.47 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -174.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -112.24 136.3 51.84 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.067 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 44' ' ' LEU . . . . . 0.68 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 0.1 OUTLIER -123.88 121.71 36.07 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.459 175.457 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' E' E ' 45' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -109.82 111.16 22.43 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.003 178.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -128.77 139.32 52.25 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.513 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 56.56 35.75 26.53 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 123.688 0.618 . . . . 0.0 110.225 -177.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 48' ' ' LYS . . . . . 0.506 ' HB3' ' HZ2' ' E' ' 48' ' ' LYS . 9.1 mtpm? 63.66 32.28 13.94 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.221 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 49' ' ' GLN . . . . . 0.547 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 59.2 tp60 -128.25 133.9 48.88 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 175.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -89.03 121.74 31.68 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -116.65 123.38 47.14 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.496 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -75.27 106.65 5.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 169.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . 0.592 ' CG2' ' HB3' ' E' ' 44' ' ' LEU . 0.7 OUTLIER -84.25 -46.36 17.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.508 -172.313 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' E' E ' 54' ' ' ALA . . . . . 0.465 ' HB1' HD22 ' E' ' 65' ' ' LEU . . . -153.91 149.4 27.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.664 -177.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 52.6 m -112.93 101.7 9.74 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 169.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . 0.423 HG11 ' HB1' ' E' ' 40' ' ' ALA . 7.7 p -115.8 114.32 45.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.579 0.704 . . . . 0.0 109.212 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 45.0 p -122.59 -179.17 4.13 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.194 -172.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 58' ' ' LYS . . . . . 0.469 ' HB2' ' HA ' ' E' ' 38' ' ' GLN . 58.2 tttt -58.62 -32.23 68.83 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.783 171.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.42 -40.95 22.61 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.885 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 84.1 mt -108.3 86.64 3.49 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 174.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.09 0.18 8.75 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.756 2.304 . . . . 0.0 113.848 -166.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -164.45 131.18 3.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.289 0.566 . . . . 0.0 111.551 -175.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . 0.454 HG12 ' HB3' ' E' ' 54' ' ' ALA . 94.2 t -122.08 112.21 33.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.281 174.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.57 131.5 41.79 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 65' ' ' LEU . . . . . 0.465 HD22 ' HB1' ' E' ' 54' ' ' ALA . 86.3 mt -124.23 168.08 13.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.496 0.665 . . . . 0.0 112.283 -173.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 66' ' ' ASP . . . . . 0.463 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 18.5 t0 -142.41 99.49 3.51 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.383 170.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 67' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' E' ' 28' ' ' HIS . 2.3 mt -129.46 144.3 51.2 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 68' ' ' ASN . . . . . 0.401 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 5.8 t30 -141.91 114.92 8.7 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.558 -0.457 . . . . 0.0 109.783 176.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -111.12 146.84 36.1 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.535 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 21.9 t -97.7 166.71 11.36 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -75.59 2.17 12.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.229 0.537 . . . . 0.0 110.531 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.14 -7.79 51.73 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.305 172.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -93.25 138.71 31.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.108 0.48 . . . . 0.0 110.463 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -122.22 116.9 24.96 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 75' ' ' ILE . . . . . . . . . . . . . 14.9 pt -128.38 162.73 34.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.219 0.533 . . . . 0.0 112.029 -168.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 76' ' ' MET . . . . . 0.46 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 4.9 mtm -119.97 125.72 49.09 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 172.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 77' ' ' PHE . . . . . 1.65 ' HE2' ' CE1' ' E' ' 77' ' ' PHE . 0.8 OUTLIER -109.64 127.22 54.39 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 176.576 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' E' E ' 78' ' ' TYR . . . . . 1.659 ' HE2' ' CE1' ' E' ' 78' ' ' TYR . 53.2 p90 -155.55 139.21 16.05 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 119.79 -0.764 . . . . 0.0 112.001 -175.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 79' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 3.0 p -111.58 134.23 53.3 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.389 -176.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -100.7 157.16 16.9 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.537 175.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.79 179.01 46.2 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -176.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -108.17 102.93 12.04 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 119.714 -0.794 . . . . 0.0 110.044 178.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 83' ' ' ALA . . . . . 0.46 ' N ' ' HB3' ' E' ' 15' ' ' PRO . . . -168.8 150.83 4.82 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.436 170.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 15.5 t -109.76 121.89 46.25 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 85' ' ' VAL . . . . . 0.475 ' CG1' ' HB3' ' E' ' 34' ' ' LEU . 6.9 m -117.77 155.32 19.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.398 0.618 . . . . 0.0 112.311 -173.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 49.3 m -120.67 122.43 40.45 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.542 173.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 87' ' ' LEU . . . . . 0.622 HD12 ' SD ' ' E' ' 13' ' ' MET . 4.7 mp -96.07 145.77 25.2 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 170.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . 0.469 HD12 ' O ' ' E' ' 87' ' ' LEU . 1.2 mm? -120.96 150.25 41.39 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 173.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.31 -167.91 27.69 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.363 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 90' ' ' TYR . . . . . 0.415 ' CD2' ' HB3' ' A' ' 68' ' ' ASN . 3.4 p90 -147.49 129.24 15.19 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.758 0.789 . . . . 0.0 112.126 177.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 91' ' ' LEU . . . . . . . . . . . . . 15.8 mt . . . . . 0 C--N 1.326 -0.454 0 CA-C-N 113.838 -1.528 . . . . 0.0 109.814 176.218 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.408 ' HG2' ' OG ' ' B' ' 70' ' ' SER . 58.8 mtt . . . . . 0 C--O 1.224 -0.273 0 CA-C-O 120.68 0.276 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.501 ' CE1' HD23 ' B' ' 44' ' ' LEU . 77.1 t80 -59.77 140.29 56.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -172.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.437 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 87.4 t90 -132.73 146.74 52.1 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.549 178.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.407 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -151.61 152.69 24.41 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.261 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.542 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 59.3 tp -140.45 106.7 5.24 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 178.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -86.31 100.92 12.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.502 0.667 . . . . 0.0 109.755 175.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.453 ' SD ' HD12 ' A' ' 87' ' ' LEU . 3.7 ttt -94.65 134.22 37.46 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.142 -168.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.432 ' HB2' ' HG3' ' A' ' 17' ' ' ARG . 2.5 mptp? -100.28 149.57 36.17 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.811 -178.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.433 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 12.2 Cg_endo -56.43 122.32 11.59 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.122 2.548 . . . . 0.0 112.987 -178.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 79' ' ' THR . 44.9 mt-10 61.53 51.79 3.93 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.564 177.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.432 ' HG3' ' HB2' ' A' ' 14' ' ' LYS . 29.0 mmt180 -117.57 145.52 44.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.131 173.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.648 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 40.5 tttt -123.28 109.82 14.43 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 123.505 0.503 . . . . 0.0 110.551 -176.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 1.641 ' HD1' ' CD2' ' A' ' 19' ' ' TYR . 3.4 m-85 -110.02 104.31 13.18 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.356 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.448 ' HB3' ' SD ' ' A' ' 76' ' ' MET . 13.8 p -84.99 99.45 11.0 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -113.41 143.99 43.55 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.568 0.699 . . . . 0.0 112.002 -168.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.3 p -96.43 157.35 15.94 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.612 174.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.425 ' CD1' ' HB3' ' A' ' 69' ' ' PHE . 54.1 mt -115.1 116.64 53.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.347 0.594 . . . . 0.0 111.18 -175.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.474 HD13 ' N ' ' A' ' 24' ' ' ILE . 3.9 mp -93.34 -40.97 12.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.101 178.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.8 pttt -123.88 128.22 49.16 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.586 176.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.8 p -64.65 141.83 58.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.259 -174.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 91' ' ' LEU . 39.8 p90 -142.08 152.52 43.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.745 0.783 . . . . 0.0 112.226 -177.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.614 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 6.1 t60 -108.24 120.52 42.6 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.354 173.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.503 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 35.1 mt -84.51 133.65 28.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 170.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.526 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 56.0 p -120.43 -6.87 9.78 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.683 0.278 . . . . 0.0 111.64 -173.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.15 158.32 25.84 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 119.455 -1.355 . . . . 0.0 113.622 176.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.2 p -140.43 127.24 22.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 172.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.16 152.87 41.48 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 121.972 -0.455 . . . . 0.0 111.389 -175.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.48 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 3.7 pp -117.82 145.88 44.25 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.787 0.803 . . . . 0.0 111.733 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -106.73 -55.99 2.25 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.894 175.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -102.59 128.03 49.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.049 170.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.437 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 153.23 158.53 8.6 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 119.437 -1.363 . . . . 0.0 113.892 175.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -101.76 -45.62 5.18 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.426 -0.387 . . . . 0.0 110.571 176.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -153.14 123.01 6.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.091 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.452 ' HB1' HG11 ' A' ' 56' ' ' VAL . . . -121.88 114.13 20.6 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.44 0.638 . . . . 0.0 110.033 170.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 79' ' ' THR . 13.7 mmmm -97.18 105.51 17.67 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.6 tp -83.71 111.47 19.19 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -174.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.531 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 79.9 m-85 -114.9 149.95 36.4 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 175.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.547 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -135.47 128.01 30.63 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.616 172.125 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.561 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -105.89 112.22 25.18 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.09 178.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -127.92 133.23 49.25 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.395 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 59.42 38.23 22.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.48 0.657 . . . . 0.0 109.629 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt 62.37 35.27 15.11 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.717 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.561 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 23.5 tp60 -130.18 118.23 21.1 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -81.63 108.29 15.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.878 0.371 . . . . 0.0 110.86 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.453 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 87.5 m-85 -99.87 133.41 44.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.519 177.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -80.14 104.65 8.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 168.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.453 HG22 ' HB3' ' A' ' 44' ' ' LEU . 3.2 t -79.68 -50.32 18.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.696 -172.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.461 ' HB1' HD22 ' A' ' 65' ' ' LEU . . . -153.46 147.22 25.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.656 -176.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.5 m -110.95 101.28 9.86 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 171.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.452 HG11 ' HB1' ' A' ' 40' ' ' ALA . 7.2 p -119.65 113.52 41.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.62 0.724 . . . . 0.0 109.741 -177.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.2 p -123.28 -178.42 3.98 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.684 -174.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -61.89 -23.01 66.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.908 0.385 . . . . 0.0 110.463 170.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.427 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -84.35 -40.87 17.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.245 0.545 . . . . 0.0 110.15 178.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.2 mt -112.75 82.62 5.14 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 11.5 Cg_exo -70.8 -0.38 7.68 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.06 2.506 . . . . 0.0 113.868 -167.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -162.99 127.0 2.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.339 0.59 . . . . 0.0 111.416 -176.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.458 HG12 ' HB3' ' A' ' 54' ' ' ALA . 87.0 t -116.38 121.92 68.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.399 174.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.43 127.63 32.99 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.973 176.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.461 HD22 ' HB1' ' A' ' 54' ' ' ALA . 91.0 mt -119.92 168.45 11.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.401 0.62 . . . . 0.0 112.226 -174.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 14.2 t0 -145.72 97.59 3.0 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 172.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.614 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 6.7 mt -133.54 110.0 9.63 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.797 -174.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.45 ' HB2' ' CG ' ' E' ' 90' ' ' TYR . 6.3 m-20 -103.82 113.92 27.8 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 1.598 ' HE2' ' CE1' ' A' ' 69' ' ' PHE . 86.0 m-85 -109.04 136.92 47.76 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.829 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.411 ' OG ' ' HG2' ' E' ' 7' ' ' MET . 87.8 p -97.35 166.69 11.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.744 0.307 . . . . 0.0 110.21 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -73.05 -4.89 35.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.919 0.39 . . . . 0.0 110.893 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.67 -9.16 58.96 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 174.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -88.49 140.3 29.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.929 0.395 . . . . 0.0 110.06 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -126.33 114.53 18.37 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 175.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.1 pt -131.03 158.7 43.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.053 0.454 . . . . 0.0 112.059 -166.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.465 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 3.6 mtm -119.19 123.92 45.51 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 174.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 1.662 ' HD1' ' CD2' ' A' ' 77' ' ' PHE . 1.1 m-85 -104.24 128.63 52.01 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.648 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 25.9 p90 -151.92 134.97 15.75 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.453 0.644 . . . . 0.0 112.488 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 2.6 p -108.94 130.58 55.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.748 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.9 164.72 11.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.439 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.57 -174.03 44.41 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -177.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -113.43 102.74 10.61 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.023 178.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.437 ' CB ' ' HA3' ' A' ' 37' ' ' GLY . . . -173.62 153.55 2.3 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.551 171.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.9 t -114.84 126.41 54.78 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.48 ' CG1' ' HB3' ' A' ' 34' ' ' LEU . 6.7 m -120.74 157.54 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-O 121.141 0.496 . . . . 0.0 112.144 -172.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.4 m -117.09 119.01 33.93 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.549 -0.75 . . . . 0.0 108.979 171.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.542 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 5.1 mp -89.78 145.33 25.27 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 170.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.432 ' CD2' HG11 ' B' ' 53' ' ' VAL . 0.8 OUTLIER -129.97 141.39 50.77 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.929 -177.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.82 -167.56 26.63 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.292 -177.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.484 ' CG ' ' HB2' ' B' ' 68' ' ' ASN . 13.7 p90 -150.29 129.6 12.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 122.093 0.949 . . . . 0.0 112.102 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 27' ' ' PHE . 7.9 mt . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.778 176.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 58.9 mtt . . . . . 0 C--O 1.222 -0.367 0 CA-C-O 120.737 0.303 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . 0.525 ' CE1' HD23 ' C' ' 44' ' ' LEU . 77.0 t80 -59.98 140.35 56.8 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -172.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . 0.433 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 87.3 t90 -132.74 146.74 52.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.547 178.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.433 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -151.65 152.69 24.41 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.262 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.532 ' HB3' ' HB2' ' B' ' 87' ' ' LEU . 59.7 tp -140.48 106.75 5.25 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -86.3 100.85 12.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.612 0.72 . . . . 0.0 109.785 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' MET . . . . . 0.453 ' SD ' HD12 ' B' ' 87' ' ' LEU . 3.7 ttt -94.61 134.24 37.39 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.68 -1.146 . . . . 0.0 111.059 -168.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.428 ' HB2' ' HG3' ' B' ' 17' ' ' ARG . 2.5 mptp? -100.43 149.45 36.1 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.788 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.434 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 12.2 Cg_endo -56.33 122.33 11.58 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.131 2.554 . . . . 0.0 112.965 -178.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' B' ' 79' ' ' THR . 44.8 mt-10 61.51 51.83 3.93 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.506 177.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.428 ' HG3' ' HB2' ' B' ' 14' ' ' LYS . 29.0 mmt180 -117.57 145.5 44.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.141 173.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . 0.661 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 40.6 tttt -123.22 109.87 14.52 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 123.465 0.478 . . . . 0.0 110.513 -176.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' TYR . . . . . 1.654 ' HE1' ' CE2' ' B' ' 19' ' ' TYR . 3.3 m-85 -110.09 104.36 13.22 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.289 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.442 ' HB3' ' SD ' ' B' ' 76' ' ' MET . 13.6 p -85.12 99.49 11.09 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 171.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -113.33 144.03 43.45 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.522 0.677 . . . . 0.0 112.019 -168.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 13.7 p -96.43 157.27 15.98 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.627 174.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.409 ' CD1' ' HB3' ' B' ' 69' ' ' PHE . 53.7 mt -115.06 116.56 52.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.335 0.588 . . . . 0.0 111.227 -175.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.478 HD13 ' N ' ' B' ' 24' ' ' ILE . 3.9 mp -93.27 -40.91 12.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.262 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 24.9 pttt -123.83 128.15 49.09 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.651 176.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 62.3 p -64.62 141.73 58.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.311 -174.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . 0.453 ' HA ' ' HA ' ' B' ' 91' ' ' LEU . 39.3 p90 -142.09 152.51 43.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.71 0.767 . . . . 0.0 112.231 -177.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' HIS . . . . . 0.624 ' HA ' ' O ' ' B' ' 67' ' ' LEU . 6.2 t60 -108.1 120.53 42.59 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.428 173.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.513 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 35.2 mt -84.6 133.55 29.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 170.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.532 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 56.4 p -120.29 -6.97 9.84 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.598 -173.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.13 158.31 25.82 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 119.462 -1.352 . . . . 0.0 113.555 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 13.2 p -140.36 127.33 22.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 172.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.2 152.85 41.42 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.958 -0.464 . . . . 0.0 111.342 -175.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.478 ' HB3' ' CG1' ' B' ' 85' ' ' VAL . 3.7 pp -117.89 145.79 44.38 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.791 0.805 . . . . 0.0 111.728 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -106.58 -56.21 2.22 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.859 175.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -102.43 127.98 49.23 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.096 170.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.434 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 153.2 158.53 8.59 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 119.393 -1.384 . . . . 0.0 113.893 175.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -101.77 -45.66 5.16 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.399 -0.4 . . . . 0.0 110.498 176.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -153.07 123.02 6.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.109 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.437 ' HB1' HG11 ' B' ' 56' ' ' VAL . . . -121.88 114.22 20.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.539 0.685 . . . . 0.0 110.007 170.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' B' ' 79' ' ' THR . 13.7 mmmm -97.2 105.44 17.59 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 49.3 tp -83.65 111.51 19.19 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -174.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . 0.54 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 79.9 m-85 -114.9 149.96 36.38 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 175.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.552 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 0.2 OUTLIER -135.49 128.13 30.83 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.612 172.03 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -105.99 111.99 24.86 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.187 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -127.76 133.35 49.48 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.409 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 59.31 38.2 23.24 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.564 0.697 . . . . 0.0 109.743 -176.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt 62.3 35.39 15.24 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.637 178.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . 0.563 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 23.1 tp60 -130.18 118.24 21.11 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 178.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -81.69 108.39 15.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.927 0.394 . . . . 0.0 110.799 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 0.407 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 86.9 m-85 -99.86 133.33 44.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.59 177.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -80.11 104.67 8.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 168.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.458 HG22 ' HB3' ' B' ' 44' ' ' LEU . 3.2 t -79.64 -50.32 18.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.779 -172.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.477 ' HB1' HD22 ' B' ' 65' ' ' LEU . . . -153.38 147.17 25.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.686 -176.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 31.1 m -110.96 101.26 9.84 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 171.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . 0.437 HG11 ' HB1' ' B' ' 40' ' ' ALA . 7.1 p -119.6 113.48 41.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.6 0.714 . . . . 0.0 109.844 -177.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 65.5 p -123.2 -178.38 3.96 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.73 -174.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -62.06 -22.86 66.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.045 0.45 . . . . 0.0 110.514 170.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.416 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -84.41 -40.82 17.34 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.19 0.519 . . . . 0.0 110.195 178.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 80.8 mt -112.69 82.59 5.05 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 11.4 Cg_exo -70.78 -0.36 7.64 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.022 2.482 . . . . 0.0 113.907 -168.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -163.04 127.03 2.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.383 0.611 . . . . 0.0 111.392 -176.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.465 HG12 ' HB3' ' B' ' 54' ' ' ALA . 87.6 t -116.34 121.91 68.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.418 174.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.53 127.67 33.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.01 176.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.477 HD22 ' HB1' ' B' ' 54' ' ' ALA . 90.8 mt -119.93 168.47 11.1 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.371 0.605 . . . . 0.0 112.114 -174.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 14.4 t0 -145.72 97.6 3.0 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 172.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.624 ' O ' ' HA ' ' B' ' 28' ' ' HIS . 6.7 mt -133.58 110.08 9.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.723 -174.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . 0.484 ' HB2' ' CG ' ' A' ' 90' ' ' TYR . 6.4 m-20 -103.86 113.82 27.62 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 176.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . 1.601 ' HD1' ' CD2' ' B' ' 69' ' ' PHE . 85.6 m-85 -108.92 136.9 47.7 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.861 178.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' SER . . . . . 0.408 ' OG ' ' HG2' ' A' ' 7' ' ' MET . 87.9 p -97.29 166.66 11.45 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.783 0.325 . . . . 0.0 110.191 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -72.96 -5.04 35.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.006 0.432 . . . . 0.0 110.868 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.52 -9.18 59.13 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.611 -0.595 . . . . 0.0 111.611 174.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -88.42 140.24 29.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.903 0.382 . . . . 0.0 110.108 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -126.3 114.54 18.4 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 13.2 pt -131.0 158.7 43.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.074 0.464 . . . . 0.0 111.995 -166.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' MET . . . . . 0.475 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 3.7 mtm -119.19 124.03 45.8 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 174.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . 1.668 ' HD1' ' CD2' ' B' ' 77' ' ' PHE . 1.1 m-85 -104.38 128.65 52.27 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 0.661 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 25.9 p90 -151.95 134.99 15.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.474 0.654 . . . . 0.0 112.494 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 2.6 p -108.9 130.62 55.44 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.707 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.97 164.79 11.53 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.524 176.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.37 -174.02 44.76 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -177.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -113.33 102.74 10.63 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 119.726 -0.789 . . . . 0.0 110.031 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.434 ' H ' ' HB3' ' B' ' 15' ' ' PRO . . . -173.67 153.55 2.28 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.548 171.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 18.8 t -114.77 126.42 54.82 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.478 ' CG1' ' HB3' ' B' ' 34' ' ' LEU . 6.7 m -120.81 157.58 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-O 121.116 0.484 . . . . 0.0 112.139 -172.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 67.1 m -117.12 119.02 33.96 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 171.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.532 ' HB2' ' HB3' ' B' ' 11' ' ' LEU . 5.2 mp -89.78 145.38 25.22 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 170.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.454 ' CD2' HG11 ' C' ' 53' ' ' VAL . 0.8 OUTLIER -130.04 141.35 50.74 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.465 -0.789 . . . . 0.0 108.888 -177.697 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.82 -167.53 26.59 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.275 -178.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 90' ' ' TYR . . . . . 0.442 ' CG ' ' HB2' ' C' ' 68' ' ' ASN . 13.8 p90 -150.24 129.52 12.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 122.02 0.914 . . . . 0.0 112.154 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . 0.453 ' HA ' ' HA ' ' B' ' 27' ' ' PHE . 8.0 mt . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 113.626 -1.624 . . . . 0.0 110.898 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 58.8 mtt . . . . . 0 C--O 1.224 -0.279 0 CA-C-O 120.677 0.275 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 8' ' ' PHE . . . . . 0.528 ' CE1' HD23 ' D' ' 44' ' ' LEU . 77.4 t80 -59.9 140.27 56.79 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -172.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . 0.427 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 87.3 t90 -132.63 146.79 52.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.555 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . 0.436 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -151.61 152.71 24.43 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.289 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.53 ' HB3' ' HB2' ' C' ' 87' ' ' LEU . 59.5 tp -140.5 106.79 5.25 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -86.3 100.82 12.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.599 0.714 . . . . 0.0 109.8 175.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 13' ' ' MET . . . . . 0.453 ' SD ' HD12 ' C' ' 87' ' ' LEU . 3.7 ttt -94.56 134.25 37.32 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.078 -168.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . 0.414 ' HB2' ' HG3' ' C' ' 17' ' ' ARG . 2.5 mptp? -100.38 149.5 36.13 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.8 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . 0.439 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 12.3 Cg_endo -56.29 122.25 11.45 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 123.191 2.594 . . . . 0.0 113.011 -178.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' C' ' 79' ' ' THR . 44.8 mt-10 61.49 51.84 3.95 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.543 177.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 17' ' ' ARG . . . . . 0.414 ' HG3' ' HB2' ' C' ' 14' ' ' LYS . 28.9 mmt180 -117.52 145.57 44.15 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.132 173.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 18' ' ' LYS . . . . . 0.653 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 40.7 tttt -123.41 109.89 14.44 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 123.479 0.487 . . . . 0.0 110.513 -176.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . 1.667 ' HE1' ' CE2' ' C' ' 19' ' ' TYR . 3.4 m-85 -110.09 104.29 13.14 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.342 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 20' ' ' SER . . . . . 0.458 ' HB3' ' SD ' ' C' ' 76' ' ' MET . 13.5 p -84.97 99.37 10.94 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 171.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -113.29 144.05 43.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.577 0.703 . . . . 0.0 112.064 -169.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 13.3 p -96.59 157.3 15.96 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.592 174.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . 0.424 ' CD1' ' HB3' ' C' ' 69' ' ' PHE . 53.8 mt -115.03 116.6 53.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.296 0.57 . . . . 0.0 111.16 -175.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . 0.48 HD13 ' N ' ' C' ' 24' ' ' ILE . 3.9 mp -93.26 -41.09 12.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.16 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 25.0 pttt -123.85 128.21 49.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.616 176.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 62.1 p -64.63 141.71 58.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.227 -174.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 27' ' ' PHE . . . . . 0.453 ' HA ' ' HA ' ' C' ' 91' ' ' LEU . 39.5 p90 -142.0 152.51 43.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.672 0.748 . . . . 0.0 112.23 -177.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 28' ' ' HIS . . . . . 0.621 ' HA ' ' O ' ' C' ' 67' ' ' LEU . 6.1 t60 -108.14 120.55 42.65 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.418 -1.264 . . . . 0.0 109.382 173.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 35.2 mt -84.59 133.59 28.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 170.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 30' ' ' SER . . . . . 0.532 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 56.1 p -120.41 -6.77 9.79 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.645 0.259 . . . . 0.0 111.639 -173.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.13 158.4 25.99 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 119.471 -1.347 . . . . 0.0 113.595 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 13.0 p -140.38 127.22 22.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.23 152.83 41.38 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.569 -0.453 . . . . 0.0 111.326 -175.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.482 ' HB3' ' CG1' ' C' ' 85' ' ' VAL . 3.7 pp -117.8 145.8 44.28 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 121.809 0.814 . . . . 0.0 111.792 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -106.58 -56.17 2.23 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.869 175.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -102.47 127.99 49.28 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.065 170.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 37' ' ' GLY . . . . . 0.443 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 153.25 158.44 8.56 Favored Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 119.39 -1.386 . . . . 0.0 113.902 175.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -101.76 -45.6 5.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.484 -0.358 . . . . 0.0 110.545 176.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -153.09 122.99 6.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.079 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . 0.448 ' HB1' HG11 ' C' ' 56' ' ' VAL . . . -121.88 114.23 20.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.518 0.675 . . . . 0.0 110.02 170.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' C' ' 79' ' ' THR . 13.7 mmmm -97.27 105.43 17.57 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 49.7 tp -83.66 111.48 19.17 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -174.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 43' ' ' TYR . . . . . 0.533 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 79.8 m-85 -114.86 149.93 36.35 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.555 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 0.2 OUTLIER -135.46 128.17 30.96 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.589 172.069 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -105.97 112.0 24.87 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.116 178.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -127.8 133.41 49.43 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.368 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 59.25 38.23 23.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.53 0.681 . . . . 0.0 109.763 -176.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt 62.3 35.21 15.36 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.751 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . 0.557 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 23.4 tp60 -130.04 118.28 21.32 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -81.74 108.36 15.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.969 0.414 . . . . 0.0 110.769 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 0.433 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 86.9 m-85 -99.79 133.39 44.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.627 177.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -80.12 104.57 8.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 168.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 53' ' ' VAL . . . . . 0.456 HG22 ' HB3' ' C' ' 44' ' ' LEU . 3.2 t -79.56 -50.44 18.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.652 -172.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 54' ' ' ALA . . . . . 0.477 ' HB1' HD22 ' C' ' 65' ' ' LEU . . . -153.37 147.17 25.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.723 -176.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 31.4 m -110.93 101.29 9.87 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 171.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . 0.448 HG11 ' HB1' ' C' ' 40' ' ' ALA . 7.2 p -119.6 113.47 41.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.513 0.673 . . . . 0.0 109.821 -177.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 66.0 p -123.24 -178.45 3.99 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.74 -174.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -61.99 -22.97 66.12 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.14 0.495 . . . . 0.0 110.43 171.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . 0.427 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -84.3 -40.76 17.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.19 0.519 . . . . 0.0 110.275 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 80.7 mt -112.8 82.5 5.11 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 174.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 61' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 11.4 Cg_exo -70.8 -0.2 7.41 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.997 2.465 . . . . 0.0 113.889 -167.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -163.12 127.04 2.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.325 0.583 . . . . 0.0 111.437 -176.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.467 HG12 ' HB3' ' C' ' 54' ' ' ALA . 86.2 t -116.38 122.02 68.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.345 174.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.49 127.54 32.93 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.131 175.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . 0.477 HD22 ' HB1' ' C' ' 54' ' ' ALA . 91.1 mt -119.76 168.45 11.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.471 0.653 . . . . 0.0 112.21 -174.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 66' ' ' ASP . . . . . 0.477 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 14.4 t0 -145.76 97.6 2.99 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 172.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . 0.621 ' O ' ' HA ' ' C' ' 28' ' ' HIS . 6.7 mt -133.54 110.0 9.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.772 -174.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . 0.442 ' HB2' ' CG ' ' B' ' 90' ' ' TYR . 6.4 m-20 -103.92 113.82 27.63 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 69' ' ' PHE . . . . . 1.624 ' HD2' ' CD1' ' C' ' 69' ' ' PHE . 86.0 m-85 -109.0 136.87 47.81 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.779 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 88.1 p -97.24 166.66 11.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.745 0.307 . . . . 0.0 110.235 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -73.12 -4.83 35.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.015 0.436 . . . . 0.0 110.901 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.55 -9.27 59.02 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 174.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -88.28 140.23 29.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.893 0.378 . . . . 0.0 110.115 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -126.33 114.49 18.31 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 175.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 13.3 pt -131.07 158.67 43.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.047 0.451 . . . . 0.0 112.034 -166.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 76' ' ' MET . . . . . 0.468 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 3.7 mtm -119.22 123.97 45.61 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 77' ' ' PHE . . . . . 1.639 ' HD1' ' CD2' ' C' ' 77' ' ' PHE . 1.1 m-85 -104.29 128.55 52.09 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 78' ' ' TYR . . . . . 0.653 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 25.9 p90 -151.87 134.96 15.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.419 0.628 . . . . 0.0 112.511 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 79' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 2.6 p -108.85 130.56 55.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.769 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.87 164.84 11.51 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.522 176.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.41 -173.98 44.64 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -177.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -113.38 102.77 10.65 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.031 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . 0.443 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -173.67 153.48 2.27 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.534 171.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 18.6 t -114.76 126.41 54.81 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.482 ' CG1' ' HB3' ' C' ' 34' ' ' LEU . 6.6 m -120.8 157.58 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 CA-C-O 121.213 0.53 . . . . 0.0 112.114 -172.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 66.6 m -117.04 119.02 33.99 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 171.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . 0.53 ' HB2' ' HB3' ' C' ' 11' ' ' LEU . 5.2 mp -89.75 145.29 25.3 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 170.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . 0.464 ' CD2' HG11 ' D' ' 53' ' ' VAL . 0.8 OUTLIER -130.01 141.46 50.74 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.438 -0.801 . . . . 0.0 108.913 -177.837 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.93 -167.59 26.79 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.331 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 90' ' ' TYR . . . . . 0.465 ' CG ' ' HB2' ' D' ' 68' ' ' ASN . 13.6 p90 -150.19 129.55 12.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 122.039 0.924 . . . . 0.0 112.109 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . 0.453 ' HA ' ' HA ' ' C' ' 27' ' ' PHE . 8.0 mt . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.826 176.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 7' ' ' MET . . . . . 0.435 ' HG2' ' OG ' ' E' ' 70' ' ' SER . 58.9 mtt . . . . . 0 C--O 1.224 -0.286 0 CA-C-O 120.748 0.309 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 8' ' ' PHE . . . . . 0.53 ' CE1' HD23 ' E' ' 44' ' ' LEU . 77.0 t80 -59.99 140.33 56.83 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -172.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 9' ' ' TRP . . . . . 0.433 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 87.3 t90 -132.76 146.68 52.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.552 178.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . 0.462 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -151.53 152.72 24.44 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.296 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . 0.542 ' HB3' ' HB2' ' D' ' 87' ' ' LEU . 59.8 tp -140.5 106.73 5.24 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -86.24 100.86 12.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.579 0.704 . . . . 0.0 109.743 175.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 13' ' ' MET . . . . . 0.453 ' SD ' HD12 ' D' ' 87' ' ' LEU . 3.7 ttt -94.67 134.21 37.5 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.085 -168.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 14' ' ' LYS . . . . . 0.423 ' HB2' ' HG3' ' D' ' 17' ' ' ARG . 2.5 mptp? -100.33 149.56 36.17 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.802 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . 0.441 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 12.3 Cg_endo -56.45 122.28 11.51 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.134 2.556 . . . . 0.0 113.013 -178.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' D' ' 79' ' ' THR . 44.9 mt-10 61.5 51.88 3.92 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.571 177.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 17' ' ' ARG . . . . . 0.423 ' HG3' ' HB2' ' D' ' 14' ' ' LYS . 28.9 mmt180 -117.58 145.56 44.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.133 173.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . 0.654 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 40.7 tttt -123.36 109.91 14.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 123.542 0.526 . . . . 0.0 110.524 -176.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 19' ' ' TYR . . . . . 1.663 ' HE1' ' CE2' ' D' ' 19' ' ' TYR . 3.3 m-85 -110.04 104.38 13.26 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.323 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 20' ' ' SER . . . . . 0.453 ' HB3' ' SD ' ' D' ' 76' ' ' MET . 13.4 p -85.08 99.45 11.05 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 171.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -113.37 144.01 43.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.483 0.659 . . . . 0.0 112.053 -168.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 14.0 p -96.49 157.31 15.96 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.627 174.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . 0.426 ' CD1' ' HB3' ' D' ' 69' ' ' PHE . 53.9 mt -115.02 116.61 53.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.15 0.5 . . . . 0.0 111.168 -175.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . 0.483 ' N ' HD13 ' D' ' 24' ' ' ILE . 3.9 mp -93.34 -40.95 12.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.125 178.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -123.88 128.24 49.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.663 176.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 61.9 p -64.65 141.72 58.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.258 -174.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 27' ' ' PHE . . . . . 0.455 ' HA ' ' HA ' ' D' ' 91' ' ' LEU . 39.4 p90 -141.97 152.59 43.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.713 0.768 . . . . 0.0 112.153 -177.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 28' ' ' HIS . . . . . 0.624 ' HA ' ' O ' ' D' ' 67' ' ' LEU . 6.2 t60 -108.21 120.5 42.54 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.407 -1.27 . . . . 0.0 109.399 173.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 29' ' ' ILE . . . . . 0.522 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 35.2 mt -84.57 133.55 29.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 170.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 30' ' ' SER . . . . . 0.534 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 56.8 p -120.3 -6.89 9.84 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.65 -173.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.08 158.41 26.05 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 119.481 -1.343 . . . . 0.0 113.566 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 13.3 p -140.48 127.27 22.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 172.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.17 152.94 41.58 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.332 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 34' ' ' LEU . . . . . 0.482 ' HB3' ' CG1' ' D' ' 85' ' ' VAL . 3.7 pp -117.93 145.88 44.36 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.798 0.808 . . . . 0.0 111.709 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -106.71 -56.03 2.25 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.226 -1.352 . . . . 0.0 108.819 175.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -102.53 127.95 49.37 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.099 170.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . 0.445 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 153.22 158.45 8.56 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 119.415 -1.374 . . . . 0.0 113.99 175.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -101.71 -45.65 5.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.786 0.327 . . . . 0.0 110.557 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -153.05 123.01 6.94 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.117 -178.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . 0.448 ' HB1' HG11 ' D' ' 56' ' ' VAL . . . -121.88 114.09 20.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.406 0.622 . . . . 0.0 110.06 170.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' D' ' 79' ' ' THR . 13.7 mmmm -97.11 105.42 17.56 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 49.5 tp -83.59 111.44 19.11 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -174.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 43' ' ' TYR . . . . . 0.538 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 80.4 m-85 -114.87 149.96 36.32 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 175.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.554 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.2 OUTLIER -135.41 128.09 30.92 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.672 172.004 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 45' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -105.92 112.17 25.12 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.156 178.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -127.84 133.34 49.37 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.344 178.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 59.3 38.14 23.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.558 0.694 . . . . 0.0 109.718 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt 62.41 35.24 15.0 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.683 178.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . 0.557 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 23.5 tp60 -130.06 118.26 21.26 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -81.62 108.3 15.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.909 0.385 . . . . 0.0 110.841 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . 0.436 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 87.3 m-85 -99.92 133.34 44.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.612 177.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 tp -80.13 104.73 8.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 169.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 53' ' ' VAL . . . . . 0.464 HG11 ' CD2' ' C' ' 88' ' ' LEU . 3.2 t -79.64 -50.3 18.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.698 -172.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 54' ' ' ALA . . . . . 0.46 ' HB1' HD22 ' D' ' 65' ' ' LEU . . . -153.44 147.16 25.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.711 -176.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 31.5 m -111.02 101.29 9.86 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 171.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 56' ' ' VAL . . . . . 0.448 HG11 ' HB1' ' D' ' 40' ' ' ALA . 7.2 p -119.67 113.5 41.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.545 0.688 . . . . 0.0 109.808 -177.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 67.5 p -123.24 -178.44 3.98 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.756 -174.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -61.97 -22.93 66.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.039 0.447 . . . . 0.0 110.522 170.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 59' ' ' ALA . . . . . 0.426 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -84.39 -40.82 17.36 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.253 0.549 . . . . 0.0 110.187 178.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 81.0 mt -112.76 82.63 5.16 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 174.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 61' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 11.5 Cg_exo -70.81 -0.29 7.56 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.063 2.508 . . . . 0.0 113.868 -168.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -163.11 127.0 2.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.315 0.579 . . . . 0.0 111.417 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.454 HG12 ' HB3' ' D' ' 54' ' ' ALA . 87.4 t -116.33 121.88 68.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.424 174.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.47 127.54 32.92 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.063 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 65' ' ' LEU . . . . . 0.46 HD22 ' HB1' ' D' ' 54' ' ' ALA . 90.8 mt -119.76 168.52 10.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.477 0.656 . . . . 0.0 112.2 -174.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 66' ' ' ASP . . . . . 0.494 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 14.2 t0 -145.79 97.59 2.99 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 172.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . 0.624 ' O ' ' HA ' ' D' ' 28' ' ' HIS . 6.7 mt -133.62 109.95 9.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.776 -174.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 68' ' ' ASN . . . . . 0.465 ' HB2' ' CG ' ' C' ' 90' ' ' TYR . 6.4 m-20 -103.76 113.87 27.71 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 176.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 69' ' ' PHE . . . . . 1.628 ' HE1' ' CE2' ' D' ' 69' ' ' PHE . 86.1 m-85 -109.08 136.97 47.72 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.771 178.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 88.1 p -97.28 166.61 11.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.741 0.305 . . . . 0.0 110.239 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -73.07 -4.87 35.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.023 0.439 . . . . 0.0 110.873 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.52 -9.32 59.02 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.584 -0.607 . . . . 0.0 111.584 174.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -88.37 140.16 29.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.861 0.362 . . . . 0.0 110.135 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -126.27 114.58 18.47 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . . . . . . . . . 13.2 pt -131.02 158.74 43.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.132 0.491 . . . . 0.0 112.0 -166.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 76' ' ' MET . . . . . 0.466 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 3.6 mtm -119.23 123.97 45.61 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 174.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 77' ' ' PHE . . . . . 1.634 ' HE2' ' CE1' ' D' ' 77' ' ' PHE . 1.1 m-85 -104.3 128.57 52.11 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 78' ' ' TYR . . . . . 0.654 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 25.7 p90 -151.86 134.94 15.78 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.47 0.652 . . . . 0.0 112.414 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 79' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 2.5 p -108.85 130.59 55.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.792 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.89 164.76 11.55 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.553 177.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.39 -174.11 44.8 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -113.27 102.64 10.54 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.06 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.445 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -173.65 153.51 2.28 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.531 171.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 18.9 t -114.84 126.5 54.89 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . 0.482 ' CG1' ' HB3' ' D' ' 34' ' ' LEU . 6.6 m -120.94 157.48 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-O 121.161 0.505 . . . . 0.0 112.11 -172.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 66.5 m -116.95 118.97 33.91 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 171.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 87' ' ' LEU . . . . . 0.542 ' HB2' ' HB3' ' D' ' 11' ' ' LEU . 5.1 mp -89.77 145.4 25.21 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 170.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . 0.438 ' CD2' HG11 ' E' ' 53' ' ' VAL . 0.8 OUTLIER -129.98 141.37 50.76 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.982 -177.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.81 -167.44 26.44 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.302 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 90' ' ' TYR . . . . . 0.458 ' CG ' ' HB2' ' E' ' 68' ' ' ASN . 13.6 p90 -150.33 129.55 12.79 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 122.102 0.954 . . . . 0.0 112.091 178.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . 0.455 ' HA ' ' HA ' ' D' ' 27' ' ' PHE . 8.1 mt . . . . . 0 C--N 1.322 -0.626 0 CA-C-N 113.621 -1.627 . . . . 0.0 110.839 176.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 7' ' ' MET . . . . . 0.411 ' HG2' ' OG ' ' A' ' 70' ' ' SER . 58.9 mtt . . . . . 0 C--O 1.223 -0.314 0 CA-C-O 120.787 0.327 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 8' ' ' PHE . . . . . 0.529 ' CE1' HD23 ' A' ' 44' ' ' LEU . 76.9 t80 -59.93 140.3 56.79 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -172.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 9' ' ' TRP . . . . . 0.422 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 87.4 t90 -132.74 146.76 52.11 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 10' ' ' GLY . . . . . 0.453 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -151.68 152.68 24.4 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.233 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 11' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' E' ' 87' ' ' LEU . 60.0 tp -140.44 106.71 5.25 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 178.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -86.31 100.87 12.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.571 0.7 . . . . 0.0 109.72 175.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 13' ' ' MET . . . . . 0.448 ' SD ' HD12 ' E' ' 87' ' ' LEU . 3.7 ttt -94.64 134.23 37.44 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.667 -1.152 . . . . 0.0 111.102 -168.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 14' ' ' LYS . . . . . 0.43 ' HB2' ' HG3' ' E' ' 17' ' ' ARG . 2.5 mptp? -100.29 149.53 36.14 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.791 -178.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . 0.43 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 12.2 Cg_endo -56.48 122.38 11.69 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.146 2.564 . . . . 0.0 112.95 -178.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 16' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' E' ' 79' ' ' THR . 44.7 mt-10 61.43 51.93 3.96 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.502 177.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 17' ' ' ARG . . . . . 0.43 ' HG3' ' HB2' ' E' ' 14' ' ' LYS . 29.0 mmt180 -117.61 145.52 44.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.161 173.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . 0.658 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 40.6 tttt -123.34 109.84 14.42 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 123.505 0.503 . . . . 0.0 110.465 -176.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . 1.666 ' HE2' ' CE1' ' E' ' 19' ' ' TYR . 3.4 m-85 -110.06 104.4 13.27 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.367 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 20' ' ' SER . . . . . 0.458 ' HB3' ' SD ' ' E' ' 76' ' ' MET . 13.5 p -85.08 99.43 11.04 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -113.39 144.13 43.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.596 0.712 . . . . 0.0 112.01 -168.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 13.9 p -96.51 157.3 15.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.623 174.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 23' ' ' ILE . . . . . 0.425 ' CD1' ' HB3' ' E' ' 69' ' ' PHE . 53.7 mt -115.02 116.47 52.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.218 0.532 . . . . 0.0 111.211 -175.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . 0.482 ' N ' HD13 ' E' ' 24' ' ' ILE . 3.9 mp -93.23 -40.93 12.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.205 178.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -123.87 128.16 49.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.582 176.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 62.2 p -64.6 141.72 58.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.247 -174.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 27' ' ' PHE . . . . . 0.466 ' HA ' ' HA ' ' E' ' 91' ' ' LEU . 40.0 p90 -142.09 152.53 43.38 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.727 0.775 . . . . 0.0 112.235 -177.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 28' ' ' HIS . . . . . 0.625 ' HA ' ' O ' ' E' ' 67' ' ' LEU . 6.3 t60 -108.15 120.5 42.52 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.397 173.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 29' ' ' ILE . . . . . 0.508 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 35.2 mt -84.56 133.56 28.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.129 -1.064 . . . . 0.0 108.129 170.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 30' ' ' SER . . . . . 0.52 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 56.8 p -120.35 -6.88 9.82 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -173.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.13 158.34 25.88 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 119.569 -1.3 . . . . 0.0 113.609 176.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 13.1 p -140.42 127.16 22.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 172.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.13 152.84 41.48 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 121.934 -0.478 . . . . 0.0 111.324 -175.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 34' ' ' LEU . . . . . 0.479 ' HB3' ' CG1' ' E' ' 85' ' ' VAL . 3.7 pp -117.78 145.87 44.2 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 121.739 0.781 . . . . 0.0 111.794 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -106.68 -56.09 2.24 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.855 175.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -102.47 127.94 49.3 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.113 170.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . 0.441 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 153.29 158.46 8.57 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 119.368 -1.396 . . . . 0.0 113.911 175.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -101.72 -45.67 5.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.497 -0.352 . . . . 0.0 110.559 176.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -153.1 123.0 6.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.052 -178.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . 0.442 ' HB1' HG11 ' E' ' 56' ' ' VAL . . . -121.87 114.17 20.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.515 0.674 . . . . 0.0 110.002 170.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 41' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' E' ' 79' ' ' THR . 13.7 mmmm -97.18 105.46 17.61 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 49.8 tp -83.71 111.49 19.2 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -174.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 43' ' ' TYR . . . . . 0.544 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 80.0 m-85 -114.86 149.98 36.26 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 175.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 44' ' ' LEU . . . . . 0.551 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 0.2 OUTLIER -135.58 128.13 30.66 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.532 172.082 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' E' E ' 45' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -105.92 112.1 25.01 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.151 178.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -127.87 133.29 49.33 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.344 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 59.29 38.24 23.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.607 0.718 . . . . 0.0 109.698 -176.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt 62.44 35.23 14.94 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.652 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 49' ' ' GLN . . . . . 0.554 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 23.2 tp60 -130.14 118.23 21.14 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -81.7 108.25 15.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.965 0.412 . . . . 0.0 110.859 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . 0.462 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 87.1 m-85 -99.81 133.33 44.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.615 177.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -80.06 104.71 8.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 169.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . 0.463 HG22 ' HB3' ' E' ' 44' ' ' LEU . 3.2 t -79.68 -50.4 18.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.667 -172.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 54' ' ' ALA . . . . . 0.477 ' HB1' HD22 ' E' ' 65' ' ' LEU . . . -153.33 147.18 25.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.723 -176.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 31.2 m -110.89 101.17 9.78 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 171.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . 0.442 HG11 ' HB1' ' E' ' 40' ' ' ALA . 7.1 p -119.54 113.45 41.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.64 0.733 . . . . 0.0 109.895 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 66.4 p -123.21 -178.43 3.98 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.746 -174.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -61.91 -22.98 66.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.961 0.41 . . . . 0.0 110.501 170.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 59' ' ' ALA . . . . . 0.429 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -84.34 -40.8 17.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.182 178.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 80.8 mt -112.78 82.56 5.13 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 174.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 61' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 11.5 Cg_exo -70.82 -0.29 7.56 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.066 2.511 . . . . 0.0 113.88 -167.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -163.12 127.1 2.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.399 0.618 . . . . 0.0 111.397 -176.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . 0.45 HG12 ' HB3' ' E' ' 54' ' ' ALA . 86.9 t -116.42 121.93 68.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.344 174.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.56 127.56 32.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.032 176.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 65' ' ' LEU . . . . . 0.477 HD22 ' HB1' ' E' ' 54' ' ' ALA . 90.8 mt -119.8 168.51 11.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.481 0.658 . . . . 0.0 112.184 -174.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 66' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 14.3 t0 -145.76 97.59 2.99 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 172.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 67' ' ' LEU . . . . . 0.625 ' O ' ' HA ' ' E' ' 28' ' ' HIS . 6.7 mt -133.57 109.99 9.61 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.809 -174.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 68' ' ' ASN . . . . . 0.458 ' HB2' ' CG ' ' D' ' 90' ' ' TYR . 6.4 m-20 -103.84 113.87 27.71 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 69' ' ' PHE . . . . . 1.604 ' HD1' ' CD2' ' E' ' 69' ' ' PHE . 86.1 m-85 -109.1 136.98 47.71 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.721 178.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 70' ' ' SER . . . . . 0.435 ' OG ' ' HG2' ' D' ' 7' ' ' MET . 88.0 p -97.35 166.7 11.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.802 0.334 . . . . 0.0 110.17 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -73.19 -4.83 35.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.002 0.43 . . . . 0.0 110.843 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.6 -9.14 59.07 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 174.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -88.5 140.25 29.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.863 0.363 . . . . 0.0 110.059 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -126.32 114.47 18.29 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 75' ' ' ILE . . . . . . . . . . . . . 13.3 pt -131.04 158.71 43.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.104 0.478 . . . . 0.0 111.945 -166.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 76' ' ' MET . . . . . 0.467 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 3.7 mtm -119.28 123.97 45.55 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 174.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 77' ' ' PHE . . . . . 1.644 ' HE1' ' CE2' ' E' ' 77' ' ' PHE . 1.1 m-85 -104.28 128.61 52.08 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 78' ' ' TYR . . . . . 0.658 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 26.0 p90 -151.95 135.0 15.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.504 0.669 . . . . 0.0 112.442 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 79' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 2.6 p -108.99 130.54 55.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.767 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.85 164.76 11.55 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.51 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.44 -174.04 44.65 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -113.32 102.69 10.58 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.977 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 83' ' ' ALA . . . . . 0.441 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -173.7 153.56 2.27 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.536 171.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 18.9 t -114.84 126.42 54.8 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 85' ' ' VAL . . . . . 0.479 ' CG1' ' HB3' ' E' ' 34' ' ' LEU . 6.7 m -120.78 157.68 23.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-O 121.222 0.534 . . . . 0.0 112.075 -172.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 66.6 m -117.21 118.93 33.65 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 171.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 87' ' ' LEU . . . . . 0.523 ' HB2' ' HB3' ' E' ' 11' ' ' LEU . 5.1 mp -89.77 145.43 25.19 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 170.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . 0.434 ' CD2' HG12 ' A' ' 53' ' ' VAL . 0.8 OUTLIER -130.1 141.4 50.7 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.873 -177.738 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.87 -167.51 26.61 Favored Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.253 -178.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 90' ' ' TYR . . . . . 0.45 ' CG ' ' HB2' ' A' ' 68' ' ' ASN . 13.6 p90 -150.24 129.58 12.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 122.04 0.924 . . . . 0.0 112.06 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 91' ' ' LEU . . . . . 0.466 ' HA ' ' HA ' ' E' ' 27' ' ' PHE . 8.0 mt . . . . . 0 C--N 1.321 -0.669 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.81 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 52.4 ttm . . . . . 0 N--CA 1.455 -0.181 0 CA-C-O 121.008 0.432 . . . . 0.0 111.622 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.438 ' CE1' HD23 ' B' ' 44' ' ' LEU . 61.4 t80 -52.77 142.1 19.64 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.619 -177.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.537 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 88.5 t90 -135.71 147.72 48.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.876 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.454 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -148.72 153.82 25.46 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.007 178.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.539 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 52.1 tp -140.44 108.18 5.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.022 0.439 . . . . 0.0 110.881 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -81.25 101.49 9.76 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.538 173.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.496 ' HB3' HG22 ' A' ' 85' ' ' VAL . 30.6 tpp -95.48 131.26 41.83 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.148 -174.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -100.82 145.31 30.15 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.915 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.518 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 12.3 Cg_endo -56.01 124.54 16.51 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 123.397 2.731 . . . . 0.0 113.493 -174.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' A' ' 79' ' ' THR . 25.3 mt-10 60.3 47.91 8.57 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.062 177.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -121.79 138.67 54.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.687 172.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.662 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 84.5 mttt -111.21 118.98 37.43 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.414 0.446 . . . . 0.0 111.519 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.61 103.91 12.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.827 176.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.8 p -88.47 98.84 11.85 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 174.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -117.36 144.84 44.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.472 0.653 . . . . 0.0 112.273 -169.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.5 m -94.06 143.15 26.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.542 177.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.437 ' CG2' ' HA ' ' A' ' 71' ' ' LYS . 59.4 mt -92.81 120.35 42.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.066 0.46 . . . . 0.0 111.119 -174.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.429 HD13 ' N ' ' A' ' 24' ' ' ILE . 4.1 mp -79.34 -52.9 14.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.351 178.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.456 ' HE2' ' HB3' ' A' ' 91' ' ' LEU . 13.5 ptmt -131.08 137.53 49.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.942 175.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.2 m -54.45 141.76 29.65 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.921 -176.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -149.06 158.26 44.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.655 0.741 . . . . 0.0 112.819 -175.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.593 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 9.2 t60 -111.41 127.41 55.67 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.392 -1.276 . . . . 0.0 109.745 178.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.535 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 35.0 mt -96.78 137.97 23.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 170.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.593 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 56.6 p -123.5 -20.42 5.57 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -171.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -153.88 156.34 26.74 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 119.273 -1.442 . . . . 0.0 113.578 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.8 p -146.51 124.39 4.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 172.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.19 155.68 44.0 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.75 -174.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.474 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 3.7 pp -120.39 140.55 51.17 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.914 0.864 . . . . 0.0 111.755 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -105.12 -53.6 2.63 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.334 -1.303 . . . . 0.0 108.788 174.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -102.91 127.44 50.12 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 169.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.46 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 151.22 156.03 7.21 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 119.784 -1.198 . . . . 0.0 113.608 177.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.418 ' HA ' ' HB2' ' A' ' 58' ' ' LYS . 91.0 mt-30 -102.66 -44.27 5.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.68 0.276 . . . . 0.0 111.053 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -153.12 126.41 8.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.095 176.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.51 113.16 17.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.563 0.697 . . . . 0.0 109.7 169.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 79' ' ' THR . 19.9 mtpp -96.06 107.05 19.31 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 41.2 tp -81.57 114.84 20.55 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -173.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.536 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 97.6 m-85 -120.49 139.46 52.86 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.271 177.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.497 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -125.15 133.27 52.87 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 172.67 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -112.04 113.07 25.14 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.156 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.47 137.8 54.4 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.416 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 59.7 30.72 20.33 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.473 0.483 . . . . 0.0 110.301 -174.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.477 ' NZ ' ' HB2' ' A' ' 48' ' ' LYS . 0.1 OUTLIER 62.57 33.6 15.74 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.14 -177.072 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.615 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 8.5 tp-100 -123.46 130.38 52.61 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.66 123.59 32.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.905 0.383 . . . . 0.0 110.769 -176.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 1.634 ' HD2' ' CD1' ' A' ' 51' ' ' TYR . 84.7 m-85 -118.02 130.08 55.96 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 175.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.09 103.77 7.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 171.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.531 ' CG1' HD12 ' A' ' 67' ' ' LEU . 2.6 t -78.7 -49.49 20.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.712 -171.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.454 ' HB2' HG12 ' A' ' 63' ' ' VAL . . . -158.38 146.58 18.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.852 -178.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.4 m -109.46 101.43 10.39 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 173.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.63 116.2 51.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.557 0.694 . . . . 0.0 109.565 -177.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 47.1 p -122.37 -179.13 4.09 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.335 -172.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.418 ' HB2' ' HA ' ' A' ' 38' ' ' GLN . 38.1 tttm -61.58 -27.38 68.59 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.892 172.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.481 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -84.24 -40.63 17.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.643 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.2 mt -109.45 83.99 2.82 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 174.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 9.7 Cg_exo -70.91 0.07 7.08 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.016 2.478 . . . . 0.0 113.762 -168.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -162.8 131.74 4.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.224 0.535 . . . . 0.0 111.254 -176.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.454 HG12 ' HB2' ' A' ' 54' ' ' ALA . 68.7 t -120.49 132.68 69.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.105 172.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.43 113.11 25.49 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.224 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.438 ' N ' HD11 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -121.46 170.01 10.07 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.34 -176.489 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 7.2 t0 -118.33 98.76 6.44 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.245 0.545 . . . . 0.0 109.619 175.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.535 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 19.8 mt -112.98 143.49 44.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.873 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.429 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 57.2 t30 -147.81 119.96 8.3 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 120.942 0.401 . . . . 0.0 110.008 174.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 1.67 ' HD2' ' CD1' ' A' ' 69' ' ' PHE . 55.3 m-85 -114.93 153.53 30.38 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.25 -178.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.7 t -103.67 148.88 25.51 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.983 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.499 ' HB2' ' HZ2' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -74.75 9.97 1.6 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -174.656 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.62 -15.21 30.04 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.865 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -101.28 170.82 7.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.77 0.319 . . . . 0.0 110.868 -175.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 61.9 ttt-85 -138.32 122.6 18.18 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.4 pt -125.69 160.86 31.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.431 -170.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.447 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 2.8 mtm -115.23 129.02 56.52 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 174.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.497 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -109.82 128.41 55.3 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.109 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 1.657 ' HE2' ' CE1' ' A' ' 78' ' ' TYR . 51.3 p90 -155.83 157.47 36.48 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 120.226 -0.59 . . . . 0.0 112.24 -177.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.552 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 14.8 p -124.81 144.0 50.51 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.264 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.42 156.63 18.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.981 174.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.01 -166.83 31.32 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -176.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -123.71 102.68 7.96 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 117.715 0.758 . . . . 0.0 110.42 176.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.518 ' H ' ' HB3' ' A' ' 15' ' ' PRO . . . -169.31 151.81 4.71 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.187 169.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.5 t -109.1 122.85 48.16 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.496 HG22 ' HB3' ' A' ' 13' ' ' MET . 6.7 m -119.78 147.12 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-O 121.266 0.555 . . . . 0.0 111.832 -173.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.0 t -111.01 119.34 38.72 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 5.2 mp -91.84 151.45 20.56 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 174.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 tp -133.0 140.3 47.69 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.301 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.23 -166.75 24.72 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.992 -177.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 1.612 ' HE2' ' CE1' ' A' ' 90' ' ' TYR . 11.5 p90 -152.93 132.86 13.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.697 0.76 . . . . 0.0 111.839 176.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.456 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 15.2 mt . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.095 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 52.5 ttm . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 121.002 0.429 . . . . 0.0 111.582 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . 0.487 ' CE1' HD23 ' C' ' 44' ' ' LEU . 61.8 t80 -52.72 142.05 19.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.627 -177.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . 0.535 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 88.5 t90 -135.7 147.71 48.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.856 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.501 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -148.71 153.86 25.48 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.984 178.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.535 ' HB2' ' CH2' ' B' ' 9' ' ' TRP . 52.3 tp -140.46 108.13 5.63 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.086 0.47 . . . . 0.0 110.915 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -81.23 101.59 9.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.529 173.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' MET . . . . . 0.506 ' HB3' HG22 ' B' ' 85' ' ' VAL . 30.8 tpp -95.58 131.23 42.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.114 0.483 . . . . 0.0 111.151 -174.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -100.74 145.26 30.05 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.969 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.509 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 12.4 Cg_endo -56.09 124.67 16.82 Favored 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 123.445 2.763 . . . . 0.0 113.487 -174.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.546 ' HA ' ' O ' ' B' ' 79' ' ' THR . 25.3 mt-10 60.24 47.91 8.72 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.031 177.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -121.76 138.78 54.23 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.696 172.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . 0.661 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 84.5 mttt -111.47 119.02 37.4 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 123.273 0.358 . . . . 0.0 111.491 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.67 103.86 12.47 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.766 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 7.3 p -88.48 98.87 11.87 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 174.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -117.39 144.81 44.57 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.538 0.685 . . . . 0.0 112.284 -169.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 17.7 m -94.06 143.11 26.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.523 177.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.446 ' CG2' ' HA ' ' B' ' 71' ' ' LYS . 59.3 mt -92.86 120.49 42.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.162 0.506 . . . . 0.0 111.117 -174.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.432 HD13 ' N ' ' B' ' 24' ' ' ILE . 4.0 mp -79.42 -52.89 14.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.286 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.464 ' HE2' ' HB3' ' B' ' 91' ' ' LEU . 13.5 ptmt -131.12 137.47 49.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.988 175.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 11.5 m -54.41 141.71 29.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.924 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -149.03 158.28 44.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.685 0.755 . . . . 0.0 112.774 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' HIS . . . . . 0.584 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 9.2 t60 -111.39 127.39 55.65 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.39 -1.277 . . . . 0.0 109.795 178.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 35.0 mt -96.79 137.98 23.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 170.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.584 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 56.4 p -123.52 -20.37 5.58 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -171.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -153.81 156.39 26.77 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 119.322 -1.418 . . . . 0.0 113.605 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 14.8 p -146.58 124.35 3.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 172.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.14 155.71 44.04 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.898 -0.501 . . . . 0.0 111.726 -174.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.465 ' HB3' ' CG1' ' B' ' 85' ' ' VAL . 3.7 pp -120.38 140.57 51.12 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.984 0.897 . . . . 0.0 111.728 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.471 ' CB ' ' HH ' ' C' ' 43' ' ' TYR . 23.7 p-10 -105.01 -53.8 2.6 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.37 -1.286 . . . . 0.0 108.855 174.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -102.82 127.44 49.99 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 169.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.469 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 151.3 156.09 7.25 Favored Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 119.829 -1.177 . . . . 0.0 113.547 176.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . 0.416 ' HA ' ' HB2' ' B' ' 58' ' ' LYS . 91.0 mt-30 -102.58 -44.3 5.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.737 0.303 . . . . 0.0 111.125 178.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -153.08 126.41 8.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.089 177.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.53 113.12 17.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.511 0.672 . . . . 0.0 109.776 169.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' B' ' 79' ' ' THR . 19.9 mtpp -96.15 107.04 19.32 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 41.2 tp -81.5 114.84 20.49 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 -173.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . 0.539 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 97.6 m-85 -120.51 139.42 52.93 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.494 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 0.2 OUTLIER -125.07 133.29 52.96 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 172.575 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.608 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -112.02 113.11 25.21 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.184 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.54 137.82 54.38 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.344 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 59.63 30.88 20.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.046 0.451 . . . . 0.0 110.293 -174.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.488 ' NZ ' ' HB2' ' B' ' 48' ' ' LYS . 0.1 OUTLIER 62.62 33.6 15.61 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.12 -177.153 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . 0.608 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 8.4 tp-100 -123.48 130.27 52.45 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.63 123.61 32.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.829 0.347 . . . . 0.0 110.7 -175.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 1.625 ' HD1' ' CD2' ' B' ' 51' ' ' TYR . 84.8 m-85 -117.99 130.15 56.02 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.888 175.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.1 tp -80.2 103.78 7.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.827 0.822 . . . . 0.0 108.807 171.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.536 ' CG1' HD12 ' B' ' 67' ' ' LEU . 2.6 t -78.7 -49.39 20.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.709 -171.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.46 ' HB2' HG12 ' B' ' 63' ' ' VAL . . . -158.38 146.65 18.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.889 -178.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 32.3 m -109.57 101.43 10.36 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.62 116.21 51.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.568 0.699 . . . . 0.0 109.557 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 46.8 p -122.37 -179.17 4.1 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.371 -172.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . 0.416 ' HB2' ' HA ' ' B' ' 38' ' ' GLN . 38.1 tttm -61.53 -27.33 68.53 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.878 172.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.471 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -84.34 -40.67 17.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.577 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 86.1 mt -109.41 84.11 2.85 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 174.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 9.8 Cg_exo -71.03 0.09 7.14 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.981 2.454 . . . . 0.0 113.707 -168.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -162.79 131.71 4.11 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.121 0.486 . . . . 0.0 111.221 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.46 HG12 ' HB2' ' B' ' 54' ' ' ALA . 71.7 t -120.57 132.8 69.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.964 172.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.52 113.22 25.69 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.09 177.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.436 ' N ' HD11 ' B' ' 65' ' ' LEU . 0.0 OUTLIER -121.58 170.05 10.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.325 -176.575 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 7.2 t0 -118.38 98.73 6.42 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.221 0.534 . . . . 0.0 109.602 175.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.554 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 19.7 mt -113.0 143.43 44.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.903 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -147.79 120.0 8.34 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.951 0.405 . . . . 0.0 109.965 174.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . 1.669 ' HD2' ' CD1' ' B' ' 69' ' ' PHE . 55.1 m-85 -114.98 153.5 30.5 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.273 -178.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 20.6 t -103.57 148.89 25.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.058 -178.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . 0.509 ' HZ2' ' HB2' ' B' ' 71' ' ' LYS . 0.0 OUTLIER -74.88 10.07 1.6 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -174.579 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.61 -15.22 30.04 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.86 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -101.13 170.83 7.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.846 0.355 . . . . 0.0 110.838 -175.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 62.0 ttt-85 -138.37 122.55 18.07 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 14.5 pt -125.73 160.86 31.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.389 -170.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' MET . . . . . 0.446 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 2.8 mtm -115.25 129.01 56.51 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 174.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . 0.494 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -109.81 128.39 55.28 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.187 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 1.635 ' HE2' ' CE1' ' B' ' 78' ' ' TYR . 51.4 p90 -155.79 157.4 36.43 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 120.241 -0.584 . . . . 0.0 112.215 -177.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.546 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 14.6 p -124.77 144.06 50.46 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.277 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.43 156.69 18.68 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.981 174.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.87 -166.91 31.55 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -123.75 102.76 7.99 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.36 176.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.509 ' H ' ' HB3' ' B' ' 15' ' ' PRO . . . -169.23 151.88 4.79 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.21 169.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 33.7 t -109.23 122.83 48.17 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.506 HG22 ' HB3' ' B' ' 13' ' ' MET . 6.8 m -119.78 147.18 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 CA-C-O 121.307 0.575 . . . . 0.0 111.838 -173.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 17.0 t -111.08 119.33 38.63 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.525 ' HB2' ' HB3' ' B' ' 11' ' ' LEU . 5.2 mp -91.72 151.49 20.61 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 174.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.404 ' CD2' HG11 ' C' ' 53' ' ' VAL . 1.2 tp -133.07 140.31 47.61 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.267 -178.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.28 -166.67 24.65 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.961 -177.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 90' ' ' TYR . . . . . 1.638 ' HE1' ' CE2' ' B' ' 90' ' ' TYR . 11.3 p90 -153.11 132.92 13.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.811 0.815 . . . . 0.0 111.742 176.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . 0.464 ' HB3' ' HE2' ' B' ' 25' ' ' LYS . 15.1 mt . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 114.13 -1.395 . . . . 0.0 110.127 177.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 52.4 ttm . . . . . 0 C--O 1.226 -0.161 0 CA-C-O 121.005 0.431 . . . . 0.0 111.567 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 8' ' ' PHE . . . . . 0.476 ' CE1' HD23 ' D' ' 44' ' ' LEU . 61.4 t80 -52.73 142.1 19.48 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.937 -1.028 . . . . 0.0 112.62 -177.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . 0.521 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 88.3 t90 -135.71 147.57 48.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.867 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . 0.515 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -148.69 153.8 25.44 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.094 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.538 ' HB3' ' HB2' ' C' ' 87' ' ' LEU . 52.6 tp -140.36 108.15 5.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.989 0.423 . . . . 0.0 110.914 178.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -81.29 101.48 9.78 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.507 173.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 13' ' ' MET . . . . . 0.513 ' HB3' HG22 ' C' ' 85' ' ' VAL . 30.7 tpp -95.48 131.23 41.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.132 0.492 . . . . 0.0 111.128 -174.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -100.82 145.32 30.17 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.899 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . 0.503 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 12.4 Cg_endo -56.06 124.61 16.69 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 123.404 2.736 . . . . 0.0 113.459 -174.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . 0.55 ' HA ' ' O ' ' C' ' 79' ' ' THR . 25.1 mt-10 60.28 47.91 8.63 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.024 177.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -121.72 138.72 54.24 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.653 172.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 18' ' ' LYS . . . . . 0.667 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 84.5 mttt -111.37 119.06 37.58 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.454 0.471 . . . . 0.0 111.484 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -110.7 103.86 12.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.735 176.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 7.8 p -88.43 98.84 11.85 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 174.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -117.38 144.77 44.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.553 0.692 . . . . 0.0 112.271 -169.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 17.4 m -94.01 143.19 26.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.577 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . 0.435 ' CG2' ' HA ' ' C' ' 71' ' ' LYS . 59.4 mt -92.89 120.48 42.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.054 0.454 . . . . 0.0 111.09 -174.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . 0.436 HD13 ' N ' ' C' ' 24' ' ' ILE . 4.0 mp -79.43 -52.88 14.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.315 178.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . 0.456 ' HE2' ' HB3' ' C' ' 91' ' ' LEU . 13.6 ptmt -131.12 137.46 49.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.95 175.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 11.5 m -54.43 141.69 29.77 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.921 -176.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 27' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -149.0 158.24 44.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.71 0.767 . . . . 0.0 112.834 -176.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 28' ' ' HIS . . . . . 0.586 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 9.2 t60 -111.41 127.41 55.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.405 -1.271 . . . . 0.0 109.864 178.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 35.6 mt -96.82 138.02 23.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 170.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 30' ' ' SER . . . . . 0.586 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 56.4 p -123.46 -20.45 5.58 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -171.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -153.78 156.36 26.74 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 119.352 -1.404 . . . . 0.0 113.634 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 14.8 p -146.57 124.31 3.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.12 155.74 44.06 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.947 -0.471 . . . . 0.0 111.752 -174.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.47 ' HB3' ' CG1' ' C' ' 85' ' ' VAL . 3.7 pp -120.44 140.58 51.17 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.938 0.875 . . . . 0.0 111.752 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . 0.456 ' CB ' ' HH ' ' D' ' 43' ' ' TYR . 23.7 p-10 -105.13 -53.7 2.62 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.757 174.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -102.9 127.47 50.09 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 169.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 37' ' ' GLY . . . . . 0.46 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 151.24 156.09 7.24 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 119.901 -1.142 . . . . 0.0 113.685 177.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 38' ' ' GLN . . . . . 0.413 ' HA ' ' HB2' ' C' ' 58' ' ' LYS . 90.9 mt-30 -102.68 -44.23 5.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.766 0.317 . . . . 0.0 111.156 178.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -153.1 126.46 8.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.071 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.46 113.08 17.66 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.441 0.638 . . . . 0.0 109.793 169.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' C' ' 79' ' ' THR . 19.9 mtpp -96.07 107.02 19.27 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 176.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 41.3 tp -81.48 114.81 20.46 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -173.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 43' ' ' TYR . . . . . 0.539 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 97.6 m-85 -120.53 139.41 52.95 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.488 ' HB2' ' CD1' ' C' ' 77' ' ' PHE . 0.2 OUTLIER -125.12 133.25 52.92 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.656 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . 0.613 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -112.07 113.11 25.2 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.096 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.46 137.82 54.4 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.333 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 59.72 30.73 20.32 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 123.503 0.502 . . . . 0.0 110.258 -174.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . 0.489 ' NZ ' ' HB2' ' C' ' 48' ' ' LYS . 0.1 OUTLIER 62.53 33.62 15.83 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.201 -177.033 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . 0.613 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 8.4 tp-100 -123.53 130.27 52.43 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.53 123.64 31.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.792 0.33 . . . . 0.0 110.806 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 1.643 ' HD1' ' CD2' ' C' ' 51' ' ' TYR . 84.6 m-85 -118.03 130.12 55.98 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.84 175.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.1 tp -80.23 103.82 7.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 171.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 53' ' ' VAL . . . . . 0.537 ' CG1' HD12 ' C' ' 67' ' ' LEU . 2.6 t -78.7 -49.5 20.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.648 -171.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 54' ' ' ALA . . . . . 0.461 ' HB2' HG12 ' C' ' 63' ' ' VAL . . . -158.35 146.56 18.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.827 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 32.5 m -109.42 101.37 10.35 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 173.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.54 116.27 51.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.587 0.708 . . . . 0.0 109.569 -177.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 47.0 p -122.44 -179.13 4.1 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.346 -172.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 58' ' ' LYS . . . . . 0.413 ' HB2' ' HA ' ' C' ' 38' ' ' GLN . 38.1 tttm -61.45 -27.53 68.63 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.871 172.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . 0.489 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -84.14 -40.66 17.95 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.647 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 86.1 mt -109.43 84.05 2.83 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 174.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 61' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 9.8 Cg_exo -71.03 0.12 7.09 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.099 2.533 . . . . 0.0 113.729 -168.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -162.77 131.69 4.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.166 0.508 . . . . 0.0 111.274 -176.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.461 HG12 ' HB2' ' C' ' 54' ' ' ALA . 69.0 t -120.47 132.86 68.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.0 172.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.61 113.12 25.5 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.115 177.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . 0.441 ' N ' HD11 ' C' ' 65' ' ' LEU . 0.0 OUTLIER -121.51 170.03 10.08 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.064 0.459 . . . . 0.0 111.294 -176.508 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 66' ' ' ASP . . . . . 0.497 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 7.4 t0 -118.3 98.76 6.44 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.199 0.524 . . . . 0.0 109.678 175.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . 0.537 HD12 ' CG1' ' C' ' 53' ' ' VAL . 19.7 mt -112.98 143.4 44.33 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.902 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -147.75 119.96 8.34 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 174.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 69' ' ' PHE . . . . . 1.651 ' HE2' ' CE1' ' C' ' 69' ' ' PHE . 55.7 m-85 -115.01 153.53 30.48 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.186 -178.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 20.5 t -103.61 148.88 25.47 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.991 -178.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . 0.501 ' HB2' ' HZ2' ' C' ' 71' ' ' LYS . 0.0 OUTLIER -74.76 9.91 1.63 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -174.66 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.57 -15.14 30.37 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.594 -0.813 . . . . 0.0 111.994 175.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -101.16 170.87 7.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.792 0.329 . . . . 0.0 110.91 -175.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 61.8 ttt-85 -138.36 122.64 18.19 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 14.4 pt -125.76 160.84 31.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.4 -170.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 76' ' ' MET . . . . . 0.445 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 2.8 mtm -115.24 129.02 56.52 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 174.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 77' ' ' PHE . . . . . 0.488 ' CD1' ' HB2' ' C' ' 44' ' ' LEU . 0.6 OUTLIER -109.91 128.38 55.32 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.179 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 78' ' ' TYR . . . . . 1.659 ' HE2' ' CE1' ' C' ' 78' ' ' TYR . 51.2 p90 -155.78 157.45 36.51 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 120.235 -0.586 . . . . 0.0 112.254 -177.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 79' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 14.7 p -124.74 143.98 50.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.234 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.34 156.62 18.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.017 174.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.04 -166.74 31.23 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -176.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -123.79 102.72 7.96 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 117.693 0.746 . . . . 0.0 110.462 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . 0.503 ' H ' ' HB3' ' C' ' 15' ' ' PRO . . . -169.26 151.81 4.74 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.366 -1.288 . . . . 0.0 109.258 169.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 33.5 t -109.18 122.78 48.03 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.513 HG22 ' HB3' ' C' ' 13' ' ' MET . 6.7 m -119.68 147.17 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 CA-C-O 121.264 0.554 . . . . 0.0 111.818 -173.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 17.2 t -111.11 119.36 38.74 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . 0.538 ' HB2' ' HB3' ' C' ' 11' ' ' LEU . 5.2 mp -91.67 151.46 20.66 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 174.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 tp -133.07 140.33 47.62 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.3 -178.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.29 -166.73 24.77 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.955 -0.64 . . . . 0.0 111.991 -177.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 90' ' ' TYR . . . . . 1.621 ' HE1' ' CE2' ' C' ' 90' ' ' TYR . 11.5 p90 -153.0 132.81 13.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.714 0.769 . . . . 0.0 111.817 176.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . 0.456 ' HB3' ' HE2' ' C' ' 25' ' ' LYS . 15.2 mt . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.094 177.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 52.4 ttm . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 120.997 0.427 . . . . 0.0 111.594 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' D' D ' 8' ' ' PHE . . . . . 0.484 ' CE1' HD23 ' E' ' 44' ' ' LEU . 61.4 t80 -52.76 142.16 19.48 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.603 -177.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 9' ' ' TRP . . . . . 0.534 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 88.2 t90 -135.81 147.67 48.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.113 -0.948 . . . . 0.0 108.899 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . 0.512 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -148.74 153.76 25.41 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.083 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . 0.534 ' HB2' ' CH2' ' D' ' 9' ' ' TRP . 52.1 tp -140.32 108.25 5.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.065 0.46 . . . . 0.0 110.85 178.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -81.32 101.68 9.93 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.473 173.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 13' ' ' MET . . . . . 0.503 ' HB3' HG22 ' D' ' 85' ' ' VAL . 30.5 tpp -95.57 131.31 41.91 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.181 -174.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -100.87 145.32 30.19 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.885 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . 0.506 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 12.3 Cg_endo -56.12 124.61 16.69 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 123.421 2.747 . . . . 0.0 113.413 -174.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . 0.551 ' HA ' ' O ' ' D' ' 79' ' ' THR . 25.2 mt-10 60.33 47.91 8.52 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.547 -0.752 . . . . 0.0 112.017 177.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -121.78 138.69 54.27 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.654 172.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . 0.656 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 84.6 mttt -111.39 119.1 37.71 Favored 'General case' 0 CA--C 1.517 -0.316 0 O-C-N 123.384 0.428 . . . . 0.0 111.472 178.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.61 103.84 12.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.794 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 7.5 p -88.38 98.84 11.83 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 174.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -117.44 144.79 44.65 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.537 0.684 . . . . 0.0 112.271 -169.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 17.4 m -94.08 143.1 26.67 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.56 177.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . 0.445 ' CG2' ' HA ' ' D' ' 71' ' ' LYS . 59.5 mt -92.86 120.55 42.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.167 0.508 . . . . 0.0 111.077 -174.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . 0.438 ' N ' HD13 ' D' ' 24' ' ' ILE . 4.0 mp -79.47 -52.9 14.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.294 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . 0.46 ' HE2' ' HB3' ' D' ' 91' ' ' LEU . 13.6 ptmt -131.03 137.56 49.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.053 175.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 11.7 m -54.49 141.71 30.06 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 124.01 0.818 . . . . 0.0 110.894 -176.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 27' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -149.04 158.28 44.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.717 0.77 . . . . 0.0 112.767 -175.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 28' ' ' HIS . . . . . 0.586 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 9.2 t60 -111.44 127.35 55.66 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.739 178.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 29' ' ' ILE . . . . . 0.536 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 35.4 mt -96.7 138.11 22.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 170.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 30' ' ' SER . . . . . 0.586 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 55.7 p -123.65 -20.35 5.53 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -171.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -153.79 156.38 26.76 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 119.305 -1.426 . . . . 0.0 113.635 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 14.8 p -146.63 124.23 3.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.11 155.74 44.07 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.91 -0.494 . . . . 0.0 111.791 -174.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 34' ' ' LEU . . . . . 0.474 ' HB3' ' CG1' ' D' ' 85' ' ' VAL . 3.7 pp -120.37 140.47 51.26 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.894 0.854 . . . . 0.0 111.781 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . 0.435 ' CB ' ' HH ' ' E' ' 43' ' ' TYR . 23.6 p-10 -105.07 -53.59 2.64 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.416 -1.266 . . . . 0.0 108.84 174.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -102.92 127.47 50.12 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 168.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . 0.468 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 151.18 155.92 7.16 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 119.859 -1.162 . . . . 0.0 113.688 177.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 38' ' ' GLN . . . . . 0.423 ' HA ' ' HB2' ' D' ' 58' ' ' LYS . 91.2 mt-30 -102.59 -44.2 5.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.662 0.268 . . . . 0.0 111.119 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -153.13 126.36 8.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.147 176.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.48 113.15 17.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.535 0.683 . . . . 0.0 109.741 169.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' D' ' 79' ' ' THR . 19.9 mtpp -96.24 107.11 19.41 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 176.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 41.3 tp -81.52 114.83 20.5 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -173.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 43' ' ' TYR . . . . . 0.538 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 97.6 m-85 -120.55 139.4 52.99 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.492 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.2 OUTLIER -125.04 133.21 53.04 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 172.67 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 45' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -112.03 113.16 25.28 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.131 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.49 137.69 54.4 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.419 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 59.74 30.89 20.48 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.504 0.503 . . . . 0.0 110.22 -174.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 48' ' ' LYS . . . . . 0.483 ' NZ ' ' HB2' ' D' ' 48' ' ' LYS . 0.1 OUTLIER 62.41 33.73 16.06 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.132 -177.104 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . 0.615 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 8.5 tp-100 -123.58 130.27 52.42 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.53 123.56 31.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.764 0.316 . . . . 0.0 110.784 -176.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . 1.653 ' HD2' ' CD1' ' D' ' 51' ' ' TYR . 84.6 m-85 -118.01 130.11 55.98 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 175.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.15 103.78 7.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 171.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 53' ' ' VAL . . . . . 0.533 ' CG1' HD12 ' D' ' 67' ' ' LEU . 2.6 t -78.74 -49.52 20.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.662 -171.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 54' ' ' ALA . . . . . 0.448 ' HB2' HG12 ' D' ' 63' ' ' VAL . . . -158.3 146.61 18.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.9 -178.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 32.5 m -109.55 101.43 10.37 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 173.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.6 116.2 51.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.564 0.697 . . . . 0.0 109.599 -177.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 46.2 p -122.38 -179.07 4.07 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.31 -172.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 58' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' D' ' 38' ' ' GLN . 38.2 tttm -61.64 -27.39 68.63 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.82 172.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 59' ' ' ALA . . . . . 0.482 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -84.24 -40.69 17.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.652 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 86.1 mt -109.34 84.08 2.78 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 61' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 9.7 Cg_exo -71.04 0.09 7.14 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.038 2.492 . . . . 0.0 113.725 -168.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -162.76 131.64 4.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.132 0.492 . . . . 0.0 111.298 -176.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.448 HG12 ' HB2' ' D' ' 54' ' ' ALA . 69.2 t -120.43 132.71 69.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.107 172.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.49 113.13 25.52 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.197 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 65' ' ' LEU . . . . . 0.437 ' N ' HD11 ' D' ' 65' ' ' LEU . 0.0 OUTLIER -121.44 170.05 10.03 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.344 -176.508 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 66' ' ' ASP . . . . . 0.478 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 7.3 t0 -118.42 98.84 6.47 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.284 0.564 . . . . 0.0 109.584 175.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . 0.536 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 19.8 mt -113.0 143.46 44.27 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.929 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -147.77 119.95 8.32 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.96 0.409 . . . . 0.0 109.961 174.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 69' ' ' PHE . . . . . 1.652 ' HE1' ' CE2' ' D' ' 69' ' ' PHE . 55.3 m-85 -114.98 153.55 30.41 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.24 -178.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 20.7 t -103.62 148.93 25.42 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.969 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 71' ' ' LYS . . . . . 0.496 ' HB2' ' HZ2' ' D' ' 71' ' ' LYS . 0.0 OUTLIER -74.91 10.02 1.63 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -174.614 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.51 -15.3 30.06 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.949 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -101.21 170.9 7.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.745 0.307 . . . . 0.0 110.876 -175.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 62.0 ttt-85 -138.43 122.65 18.12 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . . . . . . . . . 14.3 pt -125.75 160.86 31.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.403 -170.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 76' ' ' MET . . . . . 0.454 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 2.9 mtm -115.24 128.98 56.5 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 174.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 77' ' ' PHE . . . . . 0.492 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.6 OUTLIER -109.84 128.4 55.3 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.204 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 78' ' ' TYR . . . . . 1.64 ' HE1' ' CE2' ' D' ' 78' ' ' TYR . 51.6 p90 -155.79 157.46 36.51 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 120.231 -0.588 . . . . 0.0 112.232 -177.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 79' ' ' THR . . . . . 0.551 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 14.0 p -124.87 144.03 50.53 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.171 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.34 156.55 18.79 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.98 174.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.04 -166.83 31.29 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -176.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -123.67 102.74 8.0 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 117.797 0.799 . . . . 0.0 110.365 176.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.506 ' H ' ' HB3' ' D' ' 15' ' ' PRO . . . -169.23 151.87 4.79 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.157 169.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 33.4 t -109.21 122.82 48.14 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . 0.503 HG22 ' HB3' ' D' ' 13' ' ' MET . 6.8 m -119.75 147.11 23.6 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 CA-C-O 121.298 0.571 . . . . 0.0 111.814 -173.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 16.9 t -111.05 119.32 38.64 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 177.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 87' ' ' LEU . . . . . 0.534 ' HB2' ' HB3' ' D' ' 11' ' ' LEU . 5.2 mp -91.68 151.45 20.66 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 174.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 tp -133.07 140.26 47.6 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.287 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.24 -166.71 24.67 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.978 -177.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 90' ' ' TYR . . . . . 1.622 ' HE1' ' CE2' ' D' ' 90' ' ' TYR . 11.5 p90 -153.01 132.82 13.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.739 0.78 . . . . 0.0 111.814 176.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . 0.46 ' HB3' ' HE2' ' D' ' 25' ' ' LYS . 15.2 mt . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.096 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 52.4 ttm . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 121.021 0.439 . . . . 0.0 111.567 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' E' E ' 8' ' ' PHE . . . . . 0.497 ' CE1' HD23 ' A' ' 44' ' ' LEU . 61.2 t80 -52.8 142.17 19.59 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.548 -177.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 9' ' ' TRP . . . . . 0.517 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 88.3 t90 -135.73 147.68 48.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.838 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 10' ' ' GLY . . . . . 0.49 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -148.72 153.87 25.49 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.04 177.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 11' ' ' LEU . . . . . 0.542 ' HB3' ' HB2' ' E' ' 87' ' ' LEU . 52.7 tp -140.38 108.13 5.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.061 0.458 . . . . 0.0 110.919 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -81.15 101.56 9.73 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.553 173.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 13' ' ' MET . . . . . 0.499 ' HB3' HG22 ' E' ' 85' ' ' VAL . 30.6 tpp -95.49 131.19 41.92 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.109 0.48 . . . . 0.0 111.184 -174.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -100.78 145.38 30.27 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.97 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . 0.519 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 12.3 Cg_endo -56.2 124.65 16.78 Favored 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 123.365 2.71 . . . . 0.0 113.424 -174.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 16' ' ' GLU . . . . . 0.55 ' HA ' ' O ' ' E' ' 79' ' ' THR . 25.3 mt-10 60.37 47.82 8.5 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.016 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -121.66 138.71 54.22 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.652 172.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . 0.658 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 84.6 mttt -111.4 119.2 38.01 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.35 0.406 . . . . 0.0 111.414 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.72 103.84 12.43 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.853 176.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 7.9 p -88.43 98.94 11.9 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 174.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -117.44 144.92 44.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.56 0.695 . . . . 0.0 112.266 -169.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 17.8 m -94.19 143.1 26.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.487 177.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 23' ' ' ILE . . . . . 0.447 ' CG2' ' HA ' ' E' ' 71' ' ' LYS . 59.4 mt -92.79 120.45 42.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.007 0.432 . . . . 0.0 111.17 -174.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . 0.427 ' N ' HD13 ' E' ' 24' ' ' ILE . 4.0 mp -79.42 -52.99 14.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.24 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . 0.455 ' HE2' ' HB3' ' E' ' 91' ' ' LEU . 13.5 ptmt -131.05 137.46 49.16 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.027 175.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 11.4 m -54.37 141.7 29.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.931 -176.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 27' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -149.01 158.21 44.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.728 0.775 . . . . 0.0 112.762 -175.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 28' ' ' HIS . . . . . 0.585 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 9.3 t60 -111.39 127.37 55.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.842 178.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 29' ' ' ILE . . . . . 0.543 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 35.6 mt -96.8 138.05 22.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 170.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 30' ' ' SER . . . . . 0.585 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 55.7 p -123.58 -20.33 5.57 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -171.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -153.76 156.42 26.78 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 119.27 -1.443 . . . . 0.0 113.578 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 14.8 p -146.61 124.35 3.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 172.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.15 155.64 44.01 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.931 -0.481 . . . . 0.0 111.764 -174.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 34' ' ' LEU . . . . . 0.467 ' HB3' ' CG1' ' E' ' 85' ' ' VAL . 3.7 pp -120.33 140.47 51.23 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.914 0.864 . . . . 0.0 111.771 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . 0.431 ' CB ' ' HH ' ' A' ' 43' ' ' TYR . 23.7 p-10 -104.98 -53.74 2.61 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.378 -1.283 . . . . 0.0 108.826 174.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -102.82 127.38 50.01 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 169.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . 0.467 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 151.3 156.04 7.22 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 119.794 -1.193 . . . . 0.0 113.631 176.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 38' ' ' GLN . . . . . 0.421 ' HA ' ' HB2' ' E' ' 58' ' ' LYS . 91.1 mt-30 -102.61 -44.19 5.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.681 0.277 . . . . 0.0 111.127 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -153.16 126.39 8.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.095 176.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.51 113.14 17.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.534 0.683 . . . . 0.0 109.771 169.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 41' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' E' ' 79' ' ' THR . 19.9 mtpp -96.11 107.02 19.29 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 41.2 tp -81.45 114.85 20.47 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -173.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 43' ' ' TYR . . . . . 0.53 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 97.5 m-85 -120.59 139.39 53.04 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 177.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 44' ' ' LEU . . . . . 0.499 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 0.2 OUTLIER -125.09 133.26 52.96 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 172.574 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' E' E ' 45' ' ' ALA . . . . . 0.618 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -111.98 113.15 25.29 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.118 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.53 137.77 54.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.371 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 59.81 30.8 20.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.001 0.429 . . . . 0.0 110.204 -174.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 48' ' ' LYS . . . . . 0.481 ' HB2' ' NZ ' ' E' ' 48' ' ' LYS . 0.1 OUTLIER 62.54 33.63 15.8 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.171 -177.045 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' E' E ' 49' ' ' GLN . . . . . 0.618 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 8.4 tp-100 -123.6 130.39 52.59 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -86.63 123.65 32.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.817 0.341 . . . . 0.0 110.726 -176.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . 1.668 ' HE1' ' CE2' ' E' ' 51' ' ' TYR . 84.6 m-85 -118.09 130.08 55.93 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.866 175.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.11 103.82 7.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 171.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . 0.532 ' CG1' HD12 ' E' ' 67' ' ' LEU . 2.6 t -78.76 -49.41 20.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.664 -171.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 54' ' ' ALA . . . . . 0.447 ' HB2' HG12 ' E' ' 63' ' ' VAL . . . -158.41 146.59 18.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.834 -178.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 32.5 m -109.52 101.45 10.39 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 173.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.56 116.15 51.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.501 0.667 . . . . 0.0 109.635 -177.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 46.7 p -122.29 -179.08 4.06 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.43 -172.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 58' ' ' LYS . . . . . 0.421 ' HB2' ' HA ' ' E' ' 38' ' ' GLN . 38.2 tttm -61.67 -27.3 68.58 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.872 172.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 59' ' ' ALA . . . . . 0.487 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -84.26 -40.68 17.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.673 178.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 85.9 mt -109.35 83.98 2.74 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 174.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 61' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 9.6 Cg_exo -70.96 0.16 6.98 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.033 2.489 . . . . 0.0 113.746 -168.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -162.88 131.59 4.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.088 0.471 . . . . 0.0 111.3 -176.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . 0.447 HG12 ' HB2' ' E' ' 54' ' ' ALA . 70.0 t -120.43 132.73 69.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.049 172.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.45 113.07 25.43 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.193 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 65' ' ' LEU . . . . . 0.43 ' N ' HD11 ' E' ' 65' ' ' LEU . 0.0 OUTLIER -121.48 170.07 10.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.346 -176.51 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' E' E ' 66' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 7.3 t0 -118.31 98.73 6.43 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.193 0.521 . . . . 0.0 109.641 175.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 67' ' ' LEU . . . . . 0.543 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 19.8 mt -112.99 143.42 44.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.879 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -147.77 119.92 8.3 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.945 0.402 . . . . 0.0 109.99 174.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 69' ' ' PHE . . . . . 1.664 ' HD1' ' CD2' ' E' ' 69' ' ' PHE . 54.9 m-85 -114.91 153.53 30.34 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.262 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 21.0 t -103.63 148.95 25.4 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.979 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 71' ' ' LYS . . . . . 0.508 ' HB2' ' HZ2' ' E' ' 71' ' ' LYS . 0.0 OUTLIER -74.92 10.12 1.6 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -174.596 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.71 -15.19 29.87 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.823 175.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -101.24 170.87 7.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.825 0.345 . . . . 0.0 110.902 -175.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 62.0 ttt-85 -138.33 122.56 18.13 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 75' ' ' ILE . . . . . . . . . . . . . 14.5 pt -125.72 160.9 31.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 120.897 0.38 . . . . 0.0 111.399 -170.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 76' ' ' MET . . . . . 0.446 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 2.9 mtm -115.3 129.0 56.49 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 77' ' ' PHE . . . . . 0.499 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.6 OUTLIER -109.82 128.44 55.32 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 177.207 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' E' E ' 78' ' ' TYR . . . . . 1.649 ' HD2' ' CD1' ' E' ' 78' ' ' TYR . 51.3 p90 -155.88 157.43 36.35 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.146 -0.622 . . . . 0.0 112.185 -177.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 79' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 14.6 p -124.77 143.94 50.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.238 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.31 156.57 18.75 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.985 174.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.99 -166.86 31.36 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -176.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -123.67 102.68 7.96 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 117.734 0.767 . . . . 0.0 110.5 176.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 83' ' ' ALA . . . . . 0.519 ' H ' ' HB3' ' E' ' 15' ' ' PRO . . . -169.25 151.8 4.75 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.16 169.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 33.4 t -109.15 122.8 48.07 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 85' ' ' VAL . . . . . 0.499 HG22 ' HB3' ' E' ' 13' ' ' MET . 6.8 m -119.68 147.16 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-O 121.274 0.559 . . . . 0.0 111.888 -173.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 17.1 t -111.12 119.28 38.44 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 87' ' ' LEU . . . . . 0.542 ' HB2' ' HB3' ' E' ' 11' ' ' LEU . 5.2 mp -91.64 151.52 20.65 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 174.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . 0.401 ' CD2' HG11 ' A' ' 53' ' ' VAL . 1.2 tp -133.13 140.26 47.53 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.304 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.23 -166.74 24.7 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.936 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 90' ' ' TYR . . . . . 1.613 ' HE1' ' CE2' ' E' ' 90' ' ' TYR . 11.4 p90 -153.04 132.8 13.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.787 0.804 . . . . 0.0 111.796 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 91' ' ' LEU . . . . . 0.455 ' HB3' ' HE2' ' E' ' 25' ' ' LYS . 15.1 mt . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.109 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.223 -0.324 0 CA-C-O 120.502 0.191 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 1.661 ' HE2' ' CE1' ' A' ' 8' ' ' PHE . 70.1 t80 -67.95 142.93 55.85 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.079 0.466 . . . . 0.0 112.124 -177.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.553 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 88.2 t90 -134.93 148.1 49.96 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.19 177.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.75 153.08 24.71 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.482 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.553 ' HB2' ' CH2' ' A' ' 9' ' ' TRP . 41.7 tp -144.18 109.94 5.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.81 0.338 . . . . 0.0 110.35 177.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -96.55 96.78 8.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.847 0.356 . . . . 0.0 110.078 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.679 ' SD ' HD12 ' A' ' 87' ' ' LEU . 62.6 mtp -92.98 144.1 25.59 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.941 -173.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -101.17 166.97 11.43 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.163 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.43 ' HB3' ' HA ' ' A' ' 82' ' ' ASP . 87.2 Cg_exo -49.84 115.69 1.98 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.737 2.292 . . . . 0.0 112.799 176.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 79' ' ' THR . 29.1 mt-10 63.31 39.5 9.44 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.29 0.566 . . . . 0.0 111.328 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 78' ' ' TYR . 0.5 OUTLIER -88.12 133.47 33.99 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.038 175.42 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.564 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 33.9 ttmt -123.31 116.09 22.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.122 0.487 . . . . 0.0 111.074 -178.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.474 ' CE2' HD12 ' A' ' 11' ' ' LEU . 18.3 m-85 -107.11 102.59 11.92 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.591 178.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.0 p -90.11 97.2 11.05 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 169.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -117.09 145.46 43.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.508 0.67 . . . . 0.0 112.48 -165.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.7 m -97.62 132.93 42.82 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.011 174.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.409 ' CD1' ' HB3' ' A' ' 69' ' ' PHE . 70.3 mt -87.77 118.08 32.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-O 121.127 0.489 . . . . 0.0 110.987 -173.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.489 HD12 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -90.09 -18.05 7.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.057 -179.476 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -155.12 129.2 8.82 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.101 -175.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.7 p -58.63 127.41 32.05 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.411 0.445 . . . . 0.0 110.652 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 1.615 ' HE1' ' CE2' ' A' ' 27' ' ' PHE . 10.4 p90 -143.68 166.34 25.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.693 0.758 . . . . 0.0 112.748 -174.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.529 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 4.8 t60 -121.8 127.4 50.55 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.421 178.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.576 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 47.3 mt -94.55 135.22 29.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.529 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 56.0 p -119.85 -13.51 9.06 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -169.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -164.09 141.54 7.17 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 119.452 -1.356 . . . . 0.0 113.403 177.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.412 ' O ' HG11 ' A' ' 32' ' ' VAL . 11.9 p -126.93 120.65 56.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 169.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.14 157.25 45.54 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 121.947 -0.471 . . . . 0.0 111.65 -174.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.477 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 4.6 pp -127.14 145.51 50.72 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.769 0.795 . . . . 0.0 111.237 178.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -110.21 -47.06 3.35 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.29 173.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -102.68 128.16 49.5 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.312 173.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.507 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 141.54 161.37 8.69 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 119.451 -1.357 . . . . 0.0 113.857 176.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -102.72 -43.98 5.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.681 0.276 . . . . 0.0 110.971 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -151.78 125.68 9.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.17 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.429 ' HB1' HG11 ' A' ' 56' ' ' VAL . . . -127.79 113.04 15.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.46 0.647 . . . . 0.0 109.699 168.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 79' ' ' THR . 56.0 mtpt -99.54 106.13 18.1 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 178.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.2 tp -79.11 108.77 12.84 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.819 -173.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -107.86 141.02 40.09 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.295 176.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.547 ' CD1' ' HB ' ' A' ' 75' ' ' ILE . 4.4 tp -124.48 116.38 22.42 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.082 176.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -101.78 104.21 14.98 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 174.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.425 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -127.08 136.44 52.17 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.4 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 56.38 35.99 26.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.371 0.605 . . . . 0.0 110.247 -175.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 61.36 39.7 15.01 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.123 178.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.542 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 8.5 tp-100 -134.63 128.09 32.45 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 175.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -85.28 105.72 16.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.937 0.398 . . . . 0.0 110.399 -178.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 1.617 ' HE2' ' CE1' ' A' ' 51' ' ' TYR . 74.0 m-85 -100.13 131.29 46.16 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.461 177.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 tp -79.8 108.74 13.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 168.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.521 HG11 ' CD2' ' E' ' 88' ' ' LEU . 2.3 t -82.52 -51.32 14.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.578 -172.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.439 ' HB2' HG12 ' A' ' 63' ' ' VAL . . . -156.3 145.61 20.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.067 -178.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.6 m -109.21 101.77 10.77 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 173.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.429 HG11 ' HB1' ' A' ' 40' ' ' ALA . 7.4 p -115.5 114.93 47.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.534 0.683 . . . . 0.0 109.765 -177.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.5 p -122.93 -178.26 3.9 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.415 -174.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -63.92 -22.43 66.92 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.028 0.442 . . . . 0.0 110.271 171.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.432 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -83.95 -40.5 18.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.278 177.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.9 mt -112.38 81.63 4.13 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 173.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 12.2 Cg_exo -70.19 0.15 6.4 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.219 2.613 . . . . 0.0 113.972 -166.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -163.83 129.59 3.04 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.161 0.505 . . . . 0.0 111.464 -175.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.439 HG12 ' HB2' ' A' ' 54' ' ' ALA . 66.0 t -119.01 99.94 8.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.24 173.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.21 117.12 21.47 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 173.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.17 168.1 20.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.933 0.397 . . . . 0.0 110.994 -171.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 11.9 t0 -112.45 104.58 12.71 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.341 0.591 . . . . 0.0 110.077 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.576 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 11.1 mt -117.31 141.11 48.71 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.039 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -142.04 132.38 25.02 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.804 0.335 . . . . 0.0 110.7 174.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.469 ' CZ ' HD21 ' A' ' 67' ' ' LEU . 58.7 m-85 -129.92 160.56 33.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.009 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.4 t -120.08 158.78 26.14 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -79.44 9.09 5.16 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.865 0.364 . . . . 0.0 111.104 -175.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.21 -29.38 9.0 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 174.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -100.38 165.88 11.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.016 0.436 . . . . 0.0 110.737 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -135.76 143.46 45.29 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.547 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 25.0 pt -135.71 159.22 39.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.145 0.497 . . . . 0.0 112.27 -168.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.438 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 10.9 mtp -115.0 117.5 30.76 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.703 173.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.503 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -104.23 126.95 51.76 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.127 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.564 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 23.2 p90 -152.2 134.67 15.28 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.935 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 2.4 p -107.83 120.05 41.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.332 -177.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.27 160.95 15.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.672 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.47 -170.51 31.24 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -177.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.43 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 18.9 t70 -116.9 103.47 10.33 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 117.868 0.834 . . . . 0.0 109.983 176.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.507 ' CB ' ' HA3' ' A' ' 37' ' ' GLY . . . -173.31 158.69 3.62 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.736 172.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.4 t -117.74 122.44 43.47 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.477 ' CG1' ' HB3' ' A' ' 34' ' ' LEU . 4.9 m -115.84 156.07 17.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.529 0.68 . . . . 0.0 112.408 -172.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -119.07 117.19 28.07 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.038 173.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.679 HD12 ' SD ' ' A' ' 13' ' ' MET . 5.1 mp -91.68 147.05 23.28 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 171.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.52 ' CD2' HG11 ' B' ' 53' ' ' VAL . 0.7 OUTLIER -130.75 142.53 50.41 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.756 179.585 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.89 -167.97 27.34 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.106 -178.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -145.44 130.29 18.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.742 0.782 . . . . 0.0 112.132 178.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.2 mt . . . . . 0 C--N 1.325 -0.499 0 CA-C-N 114.328 -1.305 . . . . 0.0 109.46 173.94 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.222 -0.394 0 CA-C-O 120.481 0.182 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . 1.655 ' HD1' ' CD2' ' B' ' 8' ' ' PHE . 69.8 t80 -68.08 143.0 55.65 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.036 0.446 . . . . 0.0 112.043 -177.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . 0.545 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 88.1 t90 -134.97 148.01 49.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.112 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.67 153.09 24.73 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.461 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.545 ' HB2' ' CH2' ' B' ' 9' ' ' TRP . 41.6 tp -144.13 109.9 5.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.764 0.316 . . . . 0.0 110.457 177.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -96.56 96.83 8.93 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' MET . . . . . 0.679 ' SD ' HD12 ' B' ' 87' ' ' LEU . 62.4 mtp -93.0 144.14 25.55 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.015 -173.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -101.28 167.01 11.32 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.162 177.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.414 ' HB3' ' HA ' ' B' ' 82' ' ' ASP . 86.5 Cg_exo -49.84 115.68 1.97 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.785 2.324 . . . . 0.0 112.723 176.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' B' ' 79' ' ' THR . 29.0 mt-10 63.27 39.65 9.39 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.285 0.564 . . . . 0.0 111.254 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' B' ' 78' ' ' TYR . 0.5 OUTLIER -88.16 133.5 34.0 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.342 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . 0.556 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 33.8 ttmt -123.34 116.12 22.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.167 0.508 . . . . 0.0 111.086 -178.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' TYR . . . . . 0.469 ' CE2' HD12 ' B' ' 11' ' ' LEU . 18.6 m-85 -107.09 102.54 11.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.565 178.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 10.9 p -90.03 97.21 11.06 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 169.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.13 145.54 43.75 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.489 0.661 . . . . 0.0 112.457 -165.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 21.4 m -97.77 132.86 43.01 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.949 174.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.411 ' CD1' ' HB3' ' B' ' 69' ' ' PHE . 70.0 mt -87.73 117.99 32.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.12 0.486 . . . . 0.0 111.074 -173.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.487 ' H ' HD12 ' B' ' 24' ' ' ILE . 0.2 OUTLIER -90.04 -18.02 7.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.069 -179.426 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -155.18 129.14 8.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.097 -175.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 6.9 p -58.55 127.38 31.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.683 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . 1.636 ' HE2' ' CE1' ' B' ' 27' ' ' PHE . 10.2 p90 -143.66 166.37 25.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.691 0.758 . . . . 0.0 112.687 -174.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' HIS . . . . . 0.533 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 4.8 t60 -121.87 127.44 50.49 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.256 -1.338 . . . . 0.0 109.353 178.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.567 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 47.2 mt -94.59 135.3 29.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 171.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.533 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 55.9 p -119.82 -13.65 9.06 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -169.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -164.07 141.5 7.15 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 119.373 -1.394 . . . . 0.0 113.385 177.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.409 HG11 ' O ' ' B' ' 32' ' ' VAL . 11.8 p -126.91 120.72 56.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 169.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.19 157.19 45.6 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.605 -173.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.484 ' HB3' HG13 ' B' ' 85' ' ' VAL . 4.6 pp -127.1 145.62 50.67 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.696 0.76 . . . . 0.0 111.279 178.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -110.27 -46.94 3.36 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.27 173.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -102.68 128.15 49.5 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.257 173.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.502 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 141.51 161.3 8.66 Favored Glycine 0 N--CA 1.438 -1.189 0 C-N-CA 119.488 -1.339 . . . . 0.0 113.886 176.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -102.64 -44.09 5.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.62 -0.29 . . . . 0.0 110.929 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -151.73 125.71 9.16 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.201 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.434 ' HB1' HG11 ' B' ' 56' ' ' VAL . . . -127.79 113.14 15.58 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.44 0.638 . . . . 0.0 109.632 168.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' B' ' 79' ' ' THR . 56.0 mtpt -99.66 106.11 18.02 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 46.6 tp -79.22 108.83 13.02 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.753 -173.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -107.85 140.93 40.21 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.293 176.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.544 ' CD1' ' HB ' ' B' ' 75' ' ' ILE . 4.4 tp -124.4 116.44 22.57 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.115 176.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -101.83 104.25 15.0 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 174.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . 0.421 ' HB3' HD12 ' B' ' 44' ' ' LEU . . . -127.12 136.45 52.14 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.351 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 56.37 35.99 26.78 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 123.592 0.557 . . . . 0.0 110.175 -175.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 61.47 39.53 14.88 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 114.816 -1.083 . . . . 0.0 112.165 178.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . 0.541 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 8.6 tp-100 -134.58 128.03 32.41 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 175.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -85.2 105.65 16.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.902 0.382 . . . . 0.0 110.429 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 1.624 ' HE1' ' CE2' ' B' ' 51' ' ' TYR . 73.9 m-85 -100.07 131.23 46.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.46 177.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 tp -79.67 108.72 13.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 168.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.52 HG11 ' CD2' ' A' ' 88' ' ' LEU . 2.3 t -82.59 -51.22 15.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.576 -172.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.419 ' HB2' HG12 ' B' ' 63' ' ' VAL . . . -156.33 145.57 20.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.079 -178.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 32.2 m -109.18 101.78 10.79 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 173.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . 0.434 HG11 ' HB1' ' B' ' 40' ' ' ALA . 7.4 p -115.53 114.88 47.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.495 0.664 . . . . 0.0 109.744 -177.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 64.1 p -122.87 -178.31 3.91 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.428 -174.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -63.83 -22.52 66.95 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.047 0.451 . . . . 0.0 110.244 171.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.425 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -83.89 -40.51 18.51 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.194 0.521 . . . . 0.0 110.235 177.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.4 81.56 4.11 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 173.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 12.1 Cg_exo -70.16 0.15 6.38 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.126 2.55 . . . . 0.0 113.954 -166.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -163.78 129.6 3.06 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.163 0.506 . . . . 0.0 111.378 -175.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.419 HG12 ' HB2' ' B' ' 54' ' ' ALA . 66.6 t -119.06 99.93 8.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.24 173.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.15 117.15 21.46 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 173.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' B' ' 30' ' ' SER . 0.9 OUTLIER -139.05 168.15 20.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.95 0.405 . . . . 0.0 111.065 -171.186 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . 0.504 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 12.1 t0 -112.4 104.52 12.66 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.262 0.553 . . . . 0.0 110.122 -178.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.567 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 11.0 mt -117.28 141.14 48.67 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.019 178.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.04 132.49 25.18 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.66 174.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . 0.465 ' CZ ' HD21 ' B' ' 67' ' ' LEU . 58.7 m-85 -130.02 160.55 33.33 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.985 178.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 18.5 t -120.18 158.78 26.23 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -79.4 9.11 5.11 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.966 0.412 . . . . 0.0 111.094 -175.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.32 -29.25 9.04 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 174.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -100.51 165.75 11.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.108 0.48 . . . . 0.0 110.698 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -135.68 143.36 45.39 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.233 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.544 ' HB ' ' CD1' ' B' ' 44' ' ' LEU . 25.0 pt -135.58 159.24 40.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.171 0.51 . . . . 0.0 112.216 -168.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' MET . . . . . 0.433 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 10.9 mtp -114.94 117.5 30.82 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.632 173.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . 0.499 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -104.25 126.97 51.8 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 175.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 0.556 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 23.2 p90 -152.21 134.65 15.25 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.311 -0.555 . . . . 0.0 111.999 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 2.5 p -107.79 120.04 41.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.345 -177.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.27 161.03 15.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.636 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.46 -170.68 31.41 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -177.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 82' ' ' ASP . . . . . 0.414 ' HA ' ' HB3' ' B' ' 15' ' ' PRO . 19.0 t70 -116.87 103.56 10.43 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.917 176.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.502 ' CB ' ' HA3' ' B' ' 37' ' ' GLY . . . -173.37 158.73 3.59 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.815 172.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 25.8 t -117.82 122.33 43.11 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.484 HG13 ' HB3' ' B' ' 34' ' ' LEU . 4.9 m -115.83 156.06 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-O 121.529 0.681 . . . . 0.0 112.445 -172.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 50.1 m -119.07 117.32 28.42 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.008 173.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.679 HD12 ' SD ' ' B' ' 13' ' ' MET . 5.1 mp -91.73 147.0 23.31 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 171.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.524 ' CD2' HG11 ' C' ' 53' ' ' VAL . 0.7 OUTLIER -130.84 142.51 50.39 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.959 -1.018 . . . . 0.0 108.748 179.582 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.9 -167.96 27.34 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.036 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -145.45 130.23 18.13 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.775 0.797 . . . . 0.0 112.056 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 18.1 mt . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 114.255 -1.339 . . . . 0.0 109.396 173.907 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.302 0 CA-C-O 120.467 0.175 . . . . 0.0 110.967 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 8' ' ' PHE . . . . . 1.664 ' HE1' ' CE2' ' C' ' 8' ' ' PHE . 70.0 t80 -67.88 142.95 55.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.039 0.447 . . . . 0.0 112.068 -177.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . 0.55 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 88.2 t90 -135.07 148.09 49.77 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.71 153.05 24.7 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.415 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.55 ' HB2' ' CH2' ' C' ' 9' ' ' TRP . 41.6 tp -144.13 109.95 5.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.773 0.32 . . . . 0.0 110.429 177.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -96.55 96.84 8.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.92 0.391 . . . . 0.0 110.11 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 13' ' ' MET . . . . . 0.689 ' SD ' HD12 ' C' ' 87' ' ' LEU . 62.7 mtp -93.05 144.11 25.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.001 -173.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -101.2 167.01 11.35 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.154 177.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . 0.429 ' HB3' ' HA ' ' C' ' 82' ' ' ASP . 88.0 Cg_exo -49.8 115.68 1.96 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.731 2.288 . . . . 0.0 112.818 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' C' ' 79' ' ' THR . 29.1 mt-10 63.19 39.66 9.55 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.432 0.634 . . . . 0.0 111.36 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 17' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' C' ' 78' ' ' TYR . 0.5 OUTLIER -88.15 133.41 34.02 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.431 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 18' ' ' LYS . . . . . 0.561 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 33.9 ttmt -123.21 116.13 22.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.047 0.451 . . . . 0.0 111.109 -178.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . 0.472 ' CE2' HD12 ' C' ' 11' ' ' LEU . 18.8 m-85 -107.2 102.61 11.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.536 178.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 10.9 p -90.04 97.14 11.02 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 169.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.08 145.51 43.71 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.535 0.683 . . . . 0.0 112.55 -165.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 21.7 m -97.65 132.95 42.83 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.691 -1.141 . . . . 0.0 108.964 174.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . 0.412 ' CD1' ' HB3' ' C' ' 69' ' ' PHE . 70.4 mt -87.85 118.15 33.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.206 0.527 . . . . 0.0 110.995 -173.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . 0.489 HD12 ' H ' ' C' ' 24' ' ' ILE . 0.2 OUTLIER -90.14 -17.99 7.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.092 -179.456 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -155.15 129.22 8.81 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.103 -175.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 6.6 p -58.62 127.47 32.32 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.696 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 27' ' ' PHE . . . . . 1.642 ' HE2' ' CE1' ' C' ' 27' ' ' PHE . 10.2 p90 -143.64 166.42 24.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.633 0.73 . . . . 0.0 112.774 -174.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 28' ' ' HIS . . . . . 0.541 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 4.8 t60 -121.94 127.47 50.42 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.291 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . 0.584 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 47.6 mt -94.57 135.3 29.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 171.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 30' ' ' SER . . . . . 0.541 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 55.8 p -119.87 -13.53 9.05 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -169.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 31' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -164.09 141.46 7.12 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 119.372 -1.394 . . . . 0.0 113.329 177.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.421 ' O ' HG11 ' C' ' 32' ' ' VAL . 11.8 p -126.95 120.69 56.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 169.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.16 157.23 45.56 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.886 -0.509 . . . . 0.0 111.647 -173.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.485 ' HB3' HG13 ' C' ' 85' ' ' VAL . 4.6 pp -127.14 145.52 50.72 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.656 0.741 . . . . 0.0 111.284 178.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -110.32 -46.89 3.36 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.251 173.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -102.62 128.12 49.44 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.259 173.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 37' ' ' GLY . . . . . 0.51 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 141.64 161.36 8.7 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 119.446 -1.359 . . . . 0.0 113.888 176.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -102.71 -44.1 5.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.753 0.311 . . . . 0.0 110.973 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -151.73 125.71 9.16 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.119 -177.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . 0.423 ' HB1' HG11 ' C' ' 56' ' ' VAL . . . -127.77 113.02 15.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.376 0.608 . . . . 0.0 109.655 168.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' C' ' 79' ' ' THR . 56.0 mtpt -99.56 106.11 18.06 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 46.5 tp -79.18 108.8 12.95 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.803 -173.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -107.83 141.0 40.08 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.339 176.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.538 ' CD1' ' HB ' ' C' ' 75' ' ' ILE . 4.4 tp -124.46 116.4 22.45 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.098 176.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -101.77 104.22 15.0 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 174.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . 0.41 ' HB3' HD12 ' C' ' 44' ' ' LEU . . . -127.08 136.42 52.14 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.367 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 56.31 36.01 26.78 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.642 0.589 . . . . 0.0 110.215 -175.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 61.5 39.59 14.71 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.087 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . 0.535 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 8.5 tp-100 -134.67 127.94 32.06 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 175.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -85.15 105.74 16.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.854 0.359 . . . . 0.0 110.444 -178.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 1.642 ' HE2' ' CE1' ' C' ' 51' ' ' TYR . 74.2 m-85 -100.18 131.26 46.23 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.436 177.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 tp -79.78 108.74 13.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 168.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 53' ' ' VAL . . . . . 0.524 HG11 ' CD2' ' B' ' 88' ' ' LEU . 2.3 t -82.5 -51.25 15.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.642 -172.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 54' ' ' ALA . . . . . 0.434 ' HB2' HG12 ' C' ' 63' ' ' VAL . . . -156.29 145.58 20.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.006 -178.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 31.9 m -109.28 101.82 10.79 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 173.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . 0.423 HG11 ' HB1' ' C' ' 40' ' ' ALA . 7.4 p -115.57 114.91 47.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.533 0.682 . . . . 0.0 109.695 -177.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 64.2 p -123.03 -178.33 3.93 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.337 -174.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -63.83 -22.51 66.95 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.112 0.482 . . . . 0.0 110.227 171.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . 0.432 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -83.87 -40.56 18.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.237 177.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 78.0 mt -112.34 81.57 4.05 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 173.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 61' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 12.1 Cg_exo -70.07 -0.0 6.53 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.142 2.562 . . . . 0.0 114.025 -166.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -163.73 129.62 3.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.185 0.517 . . . . 0.0 111.52 -175.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.434 HG12 ' HB2' ' C' ' 54' ' ' ALA . 66.1 t -119.07 100.01 8.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.219 173.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.22 117.01 21.39 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 173.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.01 168.09 20.6 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.952 0.406 . . . . 0.0 111.087 -171.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 66' ' ' ASP . . . . . 0.509 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 12.1 t0 -112.39 104.6 12.75 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.315 0.579 . . . . 0.0 110.132 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . 0.584 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 11.1 mt -117.3 141.22 48.57 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.048 178.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -142.11 132.47 25.04 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.641 174.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 69' ' ' PHE . . . . . 0.463 ' CZ ' HD21 ' C' ' 67' ' ' LEU . 59.1 m-85 -130.03 160.61 33.16 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.932 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 18.3 t -120.12 158.8 26.13 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -79.45 9.08 5.19 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.979 0.419 . . . . 0.0 111.083 -175.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.26 -29.23 9.08 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 174.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -100.5 165.8 11.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.966 0.413 . . . . 0.0 110.784 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -135.71 143.49 45.41 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . 0.538 ' HB ' ' CD1' ' C' ' 44' ' ' LEU . 24.9 pt -135.67 159.14 39.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.12 0.486 . . . . 0.0 112.305 -168.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 76' ' ' MET . . . . . 0.441 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 10.8 mtp -114.88 117.51 30.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.764 173.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 77' ' ' PHE . . . . . 0.496 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.6 OUTLIER -104.16 126.89 51.64 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 176.104 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 78' ' ' TYR . . . . . 0.561 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 23.4 p90 -152.19 134.63 15.25 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.969 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 79' ' ' THR . . . . . 0.52 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 2.4 p -107.8 120.01 41.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.352 -177.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.24 160.92 15.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.613 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.6 -170.54 31.08 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 82' ' ' ASP . . . . . 0.429 ' HA ' ' HB3' ' C' ' 15' ' ' PRO . 19.0 t70 -116.91 103.49 10.34 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.955 176.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . 0.51 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -173.31 158.79 3.64 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.794 172.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 25.6 t -117.88 122.38 43.18 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.485 HG13 ' HB3' ' C' ' 34' ' ' LEU . 5.0 m -115.74 156.1 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-O 121.453 0.644 . . . . 0.0 112.464 -172.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 50.3 m -119.08 117.31 28.38 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.045 173.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . 0.689 HD12 ' SD ' ' C' ' 13' ' ' MET . 5.1 mp -91.76 146.97 23.34 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 171.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . 0.539 ' CD2' HG11 ' D' ' 53' ' ' VAL . 0.7 OUTLIER -130.74 142.47 50.41 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.796 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.89 -168.0 27.39 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.082 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -145.4 130.24 18.18 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.741 0.781 . . . . 0.0 112.158 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 18.1 mt . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 114.321 -1.308 . . . . 0.0 109.415 173.988 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.222 -0.377 0 CA-C-O 120.557 0.218 . . . . 0.0 110.837 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 8' ' ' PHE . . . . . 1.669 ' HD1' ' CD2' ' D' ' 8' ' ' PHE . 70.4 t80 -67.93 142.96 55.86 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.17 0.509 . . . . 0.0 112.063 -177.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 9' ' ' TRP . . . . . 0.549 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 88.2 t90 -135.03 147.97 49.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.133 177.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.6 153.2 24.8 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.455 179.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . 0.549 ' HB2' ' CH2' ' D' ' 9' ' ' TRP . 41.7 tp -144.19 109.95 5.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.751 0.31 . . . . 0.0 110.392 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -96.55 96.74 8.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.921 0.391 . . . . 0.0 110.102 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 13' ' ' MET . . . . . 0.668 ' SD ' HD12 ' D' ' 87' ' ' LEU . 62.7 mtp -93.05 144.24 25.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.961 -173.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -101.24 167.0 11.35 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.174 177.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . 0.418 ' HB3' ' HA ' ' D' ' 82' ' ' ASP . 86.9 Cg_exo -49.86 115.61 1.93 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.8 2.334 . . . . 0.0 112.74 176.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' D' ' 79' ' ' THR . 29.1 mt-10 63.37 39.53 9.26 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.326 0.584 . . . . 0.0 111.299 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 17' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' D' ' 78' ' ' TYR . 0.5 OUTLIER -88.04 133.44 33.97 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.383 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . 0.577 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 33.9 ttmt -123.26 116.13 22.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.199 0.524 . . . . 0.0 111.077 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 19' ' ' TYR . . . . . 0.474 ' CE2' HD12 ' D' ' 11' ' ' LEU . 18.8 m-85 -107.11 102.46 11.79 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.595 178.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 11.0 p -89.97 97.18 11.04 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 169.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.07 145.5 43.7 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.556 0.693 . . . . 0.0 112.483 -165.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 21.5 m -97.71 132.83 42.98 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.99 174.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . 0.411 ' CD1' ' HB3' ' D' ' 69' ' ' PHE . 70.3 mt -87.68 118.08 32.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.11 0.481 . . . . 0.0 111.093 -173.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . 0.495 HD12 ' H ' ' D' ' 24' ' ' ILE . 0.2 OUTLIER -90.09 -18.02 7.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.097 -179.422 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -155.16 129.12 8.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.085 -175.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 6.8 p -58.49 127.46 32.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.689 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 27' ' ' PHE . . . . . 1.671 ' HE1' ' CE2' ' D' ' 27' ' ' PHE . 10.3 p90 -143.73 166.36 25.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.721 0.772 . . . . 0.0 112.727 -174.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 28' ' ' HIS . . . . . 0.539 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 4.7 t60 -121.93 127.42 50.39 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.285 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 29' ' ' ILE . . . . . 0.581 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 47.4 mt -94.5 135.33 29.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 171.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 30' ' ' SER . . . . . 0.539 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 55.9 p -119.96 -13.43 9.03 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -169.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 31' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -164.14 141.5 7.14 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 119.431 -1.366 . . . . 0.0 113.354 177.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . 0.415 HG11 ' O ' ' D' ' 32' ' ' VAL . 11.8 p -126.97 120.69 56.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 169.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.17 157.21 45.58 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 121.95 -0.469 . . . . 0.0 111.589 -173.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 34' ' ' LEU . . . . . 0.488 ' HB3' HG13 ' D' ' 85' ' ' VAL . 4.6 pp -127.11 145.56 50.7 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.682 0.753 . . . . 0.0 111.254 178.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -110.34 -46.91 3.35 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.761 -1.108 . . . . 0.0 108.24 173.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -102.61 128.14 49.42 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.279 173.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . 0.513 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 141.6 161.4 8.72 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 119.459 -1.353 . . . . 0.0 113.814 176.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -102.77 -44.06 5.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.616 -0.292 . . . . 0.0 110.975 177.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -151.71 125.71 9.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.204 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . 0.434 ' HB1' HG11 ' D' ' 56' ' ' VAL . . . -127.82 113.08 15.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.443 0.639 . . . . 0.0 109.724 168.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' D' ' 79' ' ' THR . 56.0 mtpt -99.58 106.06 18.0 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 46.4 tp -79.12 108.72 12.82 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.814 -173.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -107.77 140.98 40.03 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.363 176.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.54 ' CD1' ' HB ' ' D' ' 75' ' ' ILE . 4.4 tp -124.41 116.47 22.6 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.14 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 45' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -101.84 104.18 14.92 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 174.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . 0.422 ' HB3' HD12 ' D' ' 44' ' ' LEU . . . -127.08 136.4 52.1 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.403 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 56.41 35.91 26.68 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.383 0.611 . . . . 0.0 110.25 -175.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 61.61 39.44 14.53 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.117 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . 0.544 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 8.5 tp-100 -134.57 127.95 32.29 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 175.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -85.15 105.71 16.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.88 0.371 . . . . 0.0 110.456 -178.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . 1.657 ' HE2' ' CE1' ' D' ' 51' ' ' TYR . 74.0 m-85 -100.1 131.28 46.14 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.44 177.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 tp -79.73 108.82 13.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 168.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 53' ' ' VAL . . . . . 0.539 HG11 ' CD2' ' C' ' 88' ' ' LEU . 2.3 t -82.69 -51.2 14.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.575 -172.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 54' ' ' ALA . . . . . 0.432 ' HB2' HG12 ' D' ' 63' ' ' VAL . . . -156.34 145.56 20.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.076 -178.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 31.9 m -109.2 101.8 10.8 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 173.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 56' ' ' VAL . . . . . 0.434 HG11 ' HB1' ' D' ' 40' ' ' ALA . 7.4 p -115.57 114.93 47.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.483 0.659 . . . . 0.0 109.701 -177.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 63.1 p -122.95 -178.31 3.91 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.433 -174.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -63.78 -22.48 66.93 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.992 0.425 . . . . 0.0 110.321 171.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 59' ' ' ALA . . . . . 0.431 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -83.91 -40.71 18.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.143 177.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 78.2 mt -112.24 81.54 3.94 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 173.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 61' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 12.1 Cg_exo -70.14 0.14 6.37 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.163 2.575 . . . . 0.0 114.007 -166.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -163.85 129.58 3.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.085 0.469 . . . . 0.0 111.432 -175.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.432 HG12 ' HB2' ' D' ' 54' ' ' ALA . 66.8 t -119.03 99.93 8.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.176 173.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.14 117.06 21.37 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 173.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 65' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' D' ' 30' ' ' SER . 0.9 OUTLIER -139.05 168.13 20.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.865 0.364 . . . . 0.0 111.098 -171.129 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 66' ' ' ASP . . . . . 0.487 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 12.2 t0 -112.44 104.48 12.61 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.354 0.597 . . . . 0.0 110.181 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . 0.581 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 11.1 mt -117.31 141.18 48.62 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.985 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.04 132.48 25.17 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.583 174.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 69' ' ' PHE . . . . . 0.469 ' CZ ' HD21 ' D' ' 67' ' ' LEU . 59.0 m-85 -130.01 160.63 33.07 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.97 178.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 18.3 t -120.21 158.73 26.38 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -79.34 9.11 5.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.846 0.355 . . . . 0.0 111.103 -175.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.34 -29.21 9.05 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 174.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -100.42 165.82 11.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.044 0.449 . . . . 0.0 110.746 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -135.74 143.49 45.35 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . 0.54 ' HB ' ' CD1' ' D' ' 44' ' ' LEU . 24.7 pt -135.72 159.2 39.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.211 0.529 . . . . 0.0 112.25 -168.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 76' ' ' MET . . . . . 0.439 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 10.9 mtp -114.95 117.41 30.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.801 173.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 77' ' ' PHE . . . . . 0.493 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.6 OUTLIER -104.19 126.95 51.71 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.134 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 78' ' ' TYR . . . . . 0.577 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 23.1 p90 -152.22 134.66 15.25 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.886 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 79' ' ' THR . . . . . 0.524 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 2.4 p -107.85 119.96 40.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.297 -177.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.23 160.88 15.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.619 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.61 -170.51 31.05 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 110.656 -0.977 . . . . 0.0 110.656 -177.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 82' ' ' ASP . . . . . 0.418 ' HA ' ' HB3' ' D' ' 15' ' ' PRO . 19.0 t70 -116.92 103.45 10.3 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 117.861 0.831 . . . . 0.0 109.951 176.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.513 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -173.38 158.69 3.57 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.744 172.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 26.2 t -117.78 122.37 43.27 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' D' ' 34' ' ' LEU . 5.0 m -115.9 156.11 17.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.491 0.662 . . . . 0.0 112.429 -172.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -119.08 117.16 28.0 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.04 173.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 87' ' ' LEU . . . . . 0.668 HD12 ' SD ' ' D' ' 13' ' ' MET . 5.1 mp -91.69 146.99 23.33 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 171.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . 0.517 ' CD2' HG11 ' E' ' 53' ' ' VAL . 0.7 OUTLIER -130.78 142.52 50.41 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.747 179.617 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.9 -167.98 27.36 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.981 -178.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -145.39 130.26 18.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.734 0.778 . . . . 0.0 112.156 178.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 18.1 mt . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.469 173.954 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.222 -0.346 0 CA-C-O 120.524 0.202 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 8' ' ' PHE . . . . . 1.646 ' HE2' ' CE1' ' E' ' 8' ' ' PHE . 70.2 t80 -67.8 142.99 56.02 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.036 0.446 . . . . 0.0 112.071 -177.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 9' ' ' TRP . . . . . 0.542 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 88.2 t90 -135.12 148.04 49.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.118 177.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.69 153.14 24.75 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.448 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 11' ' ' LEU . . . . . 0.542 ' HB2' ' CH2' ' E' ' 9' ' ' TRP . 41.2 tp -144.1 109.98 5.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.779 0.323 . . . . 0.0 110.455 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -96.59 96.73 8.85 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.908 0.385 . . . . 0.0 110.04 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 13' ' ' MET . . . . . 0.676 ' SD ' HD12 ' E' ' 87' ' ' LEU . 62.7 mtp -92.98 144.14 25.54 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.963 -173.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -101.19 166.91 11.52 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.139 177.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . 0.424 ' HB3' ' HA ' ' E' ' 82' ' ' ASP . 87.9 Cg_exo -49.77 115.61 1.92 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.78 2.32 . . . . 0.0 112.797 176.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 16' ' ' GLU . . . . . 0.519 ' HA ' ' O ' ' E' ' 79' ' ' THR . 29.0 mt-10 63.29 39.65 9.34 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.295 0.569 . . . . 0.0 111.259 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 17' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' E' ' 78' ' ' TYR . 0.5 OUTLIER -88.15 133.43 34.01 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.353 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . 0.557 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 33.9 ttmt -123.21 116.14 22.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.153 0.502 . . . . 0.0 111.036 -178.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . 0.472 ' CE2' HD12 ' E' ' 11' ' ' LEU . 18.7 m-85 -107.1 102.7 12.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.568 177.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 10.9 p -90.22 97.26 11.08 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 169.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.18 145.5 43.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.474 0.654 . . . . 0.0 112.454 -165.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 21.8 m -97.68 132.82 42.97 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.949 174.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 23' ' ' ILE . . . . . 0.418 ' CD1' ' HB3' ' E' ' 69' ' ' PHE . 70.0 mt -87.72 118.06 32.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.085 0.469 . . . . 0.0 111.083 -173.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . 0.483 HD12 ' H ' ' E' ' 24' ' ' ILE . 0.2 OUTLIER -90.11 -17.98 7.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.092 -179.421 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -155.15 129.21 8.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.075 -175.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 7.0 p -58.54 127.4 31.95 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.458 0.474 . . . . 0.0 110.679 -178.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 27' ' ' PHE . . . . . 1.647 ' HE2' ' CE1' ' E' ' 27' ' ' PHE . 10.2 p90 -143.68 166.44 24.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.645 0.736 . . . . 0.0 112.726 -174.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 28' ' ' HIS . . . . . 0.524 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 4.8 t60 -121.9 127.45 50.46 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.36 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 29' ' ' ILE . . . . . 0.581 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 47.6 mt -94.63 135.33 29.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 30' ' ' SER . . . . . 0.524 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 55.0 p -119.94 -13.48 9.03 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -169.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 31' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -164.14 141.48 7.13 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 119.36 -1.4 . . . . 0.0 113.339 177.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . 0.41 HG11 ' O ' ' E' ' 32' ' ' VAL . 11.9 p -126.89 120.71 56.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 169.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.17 157.15 45.66 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.601 -173.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 34' ' ' LEU . . . . . 0.483 ' HB3' HG13 ' E' ' 85' ' ' VAL . 4.6 pp -127.11 145.55 50.7 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.686 0.755 . . . . 0.0 111.179 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -110.22 -47.01 3.35 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.256 173.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -102.64 128.11 49.47 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.294 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . 0.513 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 141.62 161.45 8.74 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 119.566 -1.302 . . . . 0.0 113.886 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -102.76 -44.08 5.39 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.734 0.302 . . . . 0.0 110.952 177.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -151.72 125.74 9.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.168 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . 0.422 ' HB1' HG11 ' E' ' 56' ' ' VAL . . . -127.84 113.1 15.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.422 0.629 . . . . 0.0 109.671 168.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 41' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' E' ' 79' ' ' THR . 56.0 mtpt -99.64 106.07 17.98 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 46.3 tp -79.16 108.77 12.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.792 -173.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -107.83 141.01 40.07 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.303 176.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 44' ' ' LEU . . . . . 0.54 ' CD1' ' HB ' ' E' ' 75' ' ' ILE . 4.4 tp -124.46 116.4 22.47 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.096 176.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 45' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -101.76 104.2 14.97 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 174.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . 0.426 ' HB3' HD12 ' E' ' 44' ' ' LEU . . . -127.12 136.36 52.0 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.387 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 56.53 35.87 26.7 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.657 0.598 . . . . 0.0 110.216 -175.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 61.52 39.49 14.77 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.154 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 49' ' ' GLN . . . . . 0.54 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 8.5 tp-100 -134.56 128.08 32.55 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 175.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -85.22 105.7 16.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.875 0.369 . . . . 0.0 110.381 -178.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . 1.647 ' HE2' ' CE1' ' E' ' 51' ' ' TYR . 74.1 m-85 -100.15 131.21 46.23 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.427 177.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 6.0 tp -79.6 108.74 13.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 168.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . 0.517 HG11 ' CD2' ' D' ' 88' ' ' LEU . 2.3 t -82.64 -51.27 14.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.526 -172.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 54' ' ' ALA . . . . . 0.432 ' HB2' HG12 ' E' ' 63' ' ' VAL . . . -156.32 145.64 20.65 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.012 -178.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 31.9 m -109.19 101.7 10.71 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 173.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . 0.422 HG11 ' HB1' ' E' ' 40' ' ' ALA . 7.4 p -115.51 114.92 47.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.621 0.724 . . . . 0.0 109.724 -177.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 63.2 p -122.87 -178.29 3.9 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.434 -174.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -63.87 -22.46 66.93 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.07 0.462 . . . . 0.0 110.298 171.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 59' ' ' ALA . . . . . 0.435 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -83.96 -40.59 18.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.187 177.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.38 81.53 4.07 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 173.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 61' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 12.0 Cg_exo -70.09 0.13 6.35 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.133 2.556 . . . . 0.0 114.024 -166.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -163.81 129.53 3.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.195 0.521 . . . . 0.0 111.469 -175.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . 0.432 HG12 ' HB2' ' E' ' 54' ' ' ALA . 66.5 t -119.03 100.03 9.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.207 173.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.2 117.09 21.44 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 173.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 65' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' E' ' 30' ' ' SER . 0.9 OUTLIER -139.1 168.16 20.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.893 0.378 . . . . 0.0 111.097 -171.168 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' E' E ' 66' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 12.1 t0 -112.39 104.49 12.63 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.3 0.571 . . . . 0.0 110.121 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 67' ' ' LEU . . . . . 0.581 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 11.1 mt -117.31 141.25 48.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.988 178.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.11 132.46 25.03 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.849 0.357 . . . . 0.0 110.682 174.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 69' ' ' PHE . . . . . 0.461 ' CZ ' HD21 ' E' ' 67' ' ' LEU . 58.5 m-85 -130.04 160.54 33.36 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.91 178.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 18.1 t -120.11 158.75 26.23 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -79.46 9.1 5.19 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.06 0.457 . . . . 0.0 111.102 -175.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.3 -29.28 9.03 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.453 174.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -100.38 165.85 11.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.033 0.444 . . . . 0.0 110.706 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -135.77 143.41 45.24 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 75' ' ' ILE . . . . . 0.54 ' HB ' ' CD1' ' E' ' 44' ' ' LEU . 24.9 pt -135.65 159.2 40.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.179 0.514 . . . . 0.0 112.278 -168.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 76' ' ' MET . . . . . 0.436 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 10.8 mtp -115.0 117.48 30.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.752 173.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 77' ' ' PHE . . . . . 0.494 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.6 OUTLIER -104.14 126.92 51.65 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 176.147 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' E' E ' 78' ' ' TYR . . . . . 0.557 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 23.0 p90 -152.22 134.61 15.21 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.985 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 79' ' ' THR . . . . . 0.519 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 2.4 p -107.8 120.0 41.02 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.375 -177.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.23 160.89 15.96 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.65 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.6 -170.48 31.04 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -177.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 82' ' ' ASP . . . . . 0.424 ' HA ' ' HB3' ' E' ' 15' ' ' PRO . 19.1 t70 -116.88 103.46 10.32 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 119.676 -0.809 . . . . 0.0 109.941 176.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 83' ' ' ALA . . . . . 0.513 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -173.33 158.7 3.61 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.776 172.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 25.9 t -117.86 122.47 43.42 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 85' ' ' VAL . . . . . 0.483 HG13 ' HB3' ' E' ' 34' ' ' LEU . 4.9 m -115.85 156.13 17.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.487 0.66 . . . . 0.0 112.328 -172.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 50.4 m -119.09 117.17 28.02 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.042 173.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 87' ' ' LEU . . . . . 0.676 HD12 ' SD ' ' E' ' 13' ' ' MET . 5.1 mp -91.72 147.03 23.29 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 171.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . 0.521 ' CD2' HG11 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -130.81 142.51 50.4 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.744 179.643 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.95 -168.0 27.45 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.016 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 90' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -145.42 130.19 18.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.643 0.735 . . . . 0.0 112.191 178.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 91' ' ' LEU . . . . . . . . . . . . . 18.2 mt . . . . . 0 C--N 1.324 -0.518 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.498 173.968 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 21.7 ttt . . . . . 0 C--O 1.226 -0.137 0 CA-C-O 121.188 0.518 . . . . 0.0 112.317 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 1.639 ' HD1' ' CD2' ' A' ' 8' ' ' PHE . 77.7 t80 -54.49 141.45 30.96 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.967 -176.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.514 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 89.5 t90 -133.46 147.23 51.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.704 -1.134 . . . . 0.0 108.503 177.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.89 145.54 14.45 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.658 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.514 ' HB2' ' CH2' ' A' ' 9' ' ' TRP . 50.1 tp -135.89 108.74 7.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.894 0.378 . . . . 0.0 110.317 177.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -96.64 100.96 12.49 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 176.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.624 ' SD ' HD12 ' A' ' 87' ' ' LEU . 61.0 mtp -92.5 143.47 26.32 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.291 0.567 . . . . 0.0 111.383 -172.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -100.49 145.02 29.57 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.425 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.456 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 9.5 Cg_endo -51.84 123.22 11.89 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 123.64 2.893 . . . . 0.0 113.597 -174.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 79' ' ' THR . 35.8 mt-10 57.71 73.6 0.46 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.689 178.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.85 138.34 19.59 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.224 176.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.671 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 50.2 mttp -107.34 121.9 45.51 Favored 'General case' 0 CA--C 1.512 -0.497 0 O-C-N 123.451 0.47 . . . . 0.0 111.368 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 1.663 ' HE2' ' CE1' ' A' ' 19' ' ' TYR . 3.1 m-85 -110.57 102.79 11.34 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 76' ' ' MET . 44.4 t -90.08 99.22 12.28 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 173.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -115.55 139.76 49.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.594 0.712 . . . . 0.0 112.2 -168.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.1 m -84.72 132.17 34.48 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.348 174.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 59.3 mt -86.35 115.45 27.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.07 0.462 . . . . 0.0 110.934 -175.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.423 HD13 ' N ' ' A' ' 25' ' ' LYS . 1.9 pp -88.7 -12.44 10.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.399 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.423 ' N ' HD13 ' A' ' 24' ' ' ILE . 83.3 tttt -160.03 120.12 2.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.486 178.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.7 m -51.54 137.16 24.99 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.683 0.614 . . . . 0.0 110.403 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -147.35 165.32 30.52 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -174.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.484 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 8.3 t60 -116.17 120.28 38.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.699 177.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.502 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 42.6 mt -84.51 134.68 26.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 169.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.496 ' HB2' ' HB3' ' B' ' 66' ' ' ASP . 76.7 p -119.68 -10.05 9.65 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -171.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -178.11 158.57 23.53 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 119.263 -1.446 . . . . 0.0 113.628 177.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.406 HG21 ' HG ' ' A' ' 87' ' ' LEU . 11.9 p -139.67 137.24 39.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 175.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -150.18 154.83 38.69 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.903 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.439 ' HB3' HG13 ' A' ' 85' ' ' VAL . 4.3 pp -118.19 140.02 50.42 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.964 0.888 . . . . 0.0 111.615 178.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -110.28 -53.41 2.68 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.981 -1.463 . . . . 0.0 108.549 174.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -101.47 126.79 48.32 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.589 175.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.453 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 140.54 165.64 10.38 Favored Glycine 0 N--CA 1.439 -1.119 0 C-N-CA 119.588 -1.292 . . . . 0.0 113.542 178.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -102.72 -46.58 4.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.58 0.228 . . . . 0.0 111.395 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -151.46 134.23 15.65 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.018 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.77 113.71 13.27 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.46 0.648 . . . . 0.0 110.42 170.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 79' ' ' THR . 65.4 mttp -98.21 113.36 25.26 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 174.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.409 ' HG ' ' CG2' ' A' ' 53' ' ' VAL . 58.7 tp -89.93 109.03 20.08 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.424 -170.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 1.644 ' HE2' ' CE1' ' A' ' 43' ' ' TYR . 71.5 m-85 -109.02 148.6 30.52 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.852 178.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.652 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -128.41 117.07 20.75 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.606 176.046 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.555 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -102.9 104.45 14.68 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.429 0.633 . . . . 0.0 109.927 176.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -128.79 143.72 50.99 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.316 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 61.16 26.59 16.47 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.716 0.769 . . . . 0.0 109.074 -174.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 59.2 38.36 23.55 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.874 -177.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.555 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 6.6 tp-100 -129.5 127.91 41.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.823 178.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -81.38 106.01 13.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.096 0.474 . . . . 0.0 110.599 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 1.621 ' HE2' ' CE1' ' A' ' 51' ' ' TYR . 73.8 m-85 -102.3 116.98 33.78 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.339 176.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.403 HD11 ' CE1' ' A' ' 43' ' ' TYR . 4.8 tp -74.71 99.84 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 171.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.479 HG13 ' CD2' ' E' ' 88' ' ' LEU . 29.3 m -87.43 -32.45 6.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.611 -172.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.478 ' HB1' HD22 ' A' ' 65' ' ' LEU . . . -152.93 142.42 21.75 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.371 -0.532 . . . . 0.0 112.211 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.1 m -112.97 101.93 9.94 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 169.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.0 p -118.36 112.43 38.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.932 0.873 . . . . 0.0 110.443 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 78.5 p -123.34 -177.34 3.67 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.194 -176.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -60.93 -29.37 69.57 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.445 168.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.22 -40.66 62.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.252 0.549 . . . . 0.0 110.292 178.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 77.4 mt -117.8 81.69 15.65 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.35 -4.17 12.34 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.191 2.594 . . . . 0.0 113.963 -168.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -160.67 129.71 4.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.281 0.562 . . . . 0.0 111.206 -175.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.457 HG12 ' HB3' ' A' ' 54' ' ' ALA . 96.7 t -120.17 125.59 74.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.525 176.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.36 130.68 34.54 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 175.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.478 HD22 ' HB1' ' A' ' 54' ' ' ALA . 88.5 mt -122.82 166.64 14.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.394 0.616 . . . . 0.0 112.288 -173.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 26.9 t0 -144.51 97.95 3.12 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 170.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.502 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 7.0 mt -133.0 109.38 9.51 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.347 -175.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.461 ' HB2' ' CD2' ' E' ' 90' ' ' TYR . 7.5 m-20 -104.73 114.7 29.08 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.839 0.352 . . . . 0.0 110.149 178.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 1.668 ' HD1' ' CD2' ' A' ' 69' ' ' PHE . 57.9 m-85 -108.09 160.35 15.87 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.338 179.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.5 t -116.14 149.64 38.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.955 0.407 . . . . 0.0 110.625 -177.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -69.15 0.13 5.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.198 -176.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.46 -18.56 35.35 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.345 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -101.51 164.06 11.95 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.708 -0.289 . . . . 0.0 110.836 -175.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -130.9 108.76 10.06 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.4 pt -109.52 158.46 9.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.259 -170.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.411 ' HA ' ' O ' ' A' ' 19' ' ' TYR . 2.6 mtm -116.69 122.88 45.82 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.873 175.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.652 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -104.49 128.57 52.45 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.688 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 1.648 ' HE2' ' CE1' ' A' ' 78' ' ' TYR . 36.4 p90 -149.98 135.34 18.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.529 0.68 . . . . 0.0 112.492 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 3.9 p -106.36 132.56 52.25 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.763 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.54 154.42 18.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.799 177.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.413 ' O ' ' HG3' ' A' ' 16' ' ' GLU . . . 91.33 -172.14 35.98 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -176.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -113.13 102.86 10.79 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.825 176.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.456 ' H ' ' HB3' ' A' ' 15' ' ' PRO . . . -169.28 153.74 5.51 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.85 167.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.4 t -111.05 120.66 43.08 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.439 HG13 ' HB3' ' A' ' 34' ' ' LEU . 3.8 m -114.9 149.31 17.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -172.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.8 m -110.93 115.4 29.43 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.598 175.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.624 HD12 ' SD ' ' A' ' 13' ' ' MET . 4.8 mp -94.85 145.17 25.08 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 170.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.473 ' CD2' HG13 ' B' ' 53' ' ' VAL . 2.4 mm? -124.28 149.53 46.4 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 175.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.82 -167.35 26.32 Favored Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.48 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 1.649 ' HE1' ' CE2' ' A' ' 90' ' ' TYR . 5.1 p90 -149.31 131.38 15.35 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.763 0.792 . . . . 0.0 111.795 176.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 27.3 mt . . . . . 0 C--N 1.323 -0.582 0 CA-C-N 113.927 -1.488 . . . . 0.0 110.279 177.039 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 21.8 ttt . . . . . 0 C--O 1.225 -0.208 0 CA-C-O 121.189 0.519 . . . . 0.0 112.251 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . 1.615 ' HE2' ' CE1' ' B' ' 8' ' ' PHE . 78.1 t80 -54.51 141.53 30.8 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 114.76 -1.109 . . . . 0.0 113.001 -176.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . 0.512 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 89.3 t90 -133.53 147.28 51.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.531 177.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.91 145.54 14.44 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.607 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.512 ' HB2' ' CH2' ' B' ' 9' ' ' TRP . 50.2 tp -135.9 108.8 7.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.91 0.386 . . . . 0.0 110.344 176.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -96.76 101.1 12.64 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' MET . . . . . 0.618 ' SD ' HD12 ' B' ' 87' ' ' LEU . 60.8 mtp -92.58 143.46 26.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.304 0.573 . . . . 0.0 111.372 -172.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -100.49 145.02 29.59 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 114.926 -1.033 . . . . 0.0 109.371 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.473 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 9.5 Cg_endo -51.91 123.13 11.74 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.708 2.938 . . . . 0.0 113.597 -174.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' B' ' 79' ' ' THR . 35.8 mt-10 57.86 73.44 0.47 Allowed 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.668 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.76 138.5 19.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.214 176.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . 0.657 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 50.2 mttp -107.39 121.95 45.63 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 123.397 0.436 . . . . 0.0 111.322 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' TYR . . . . . 1.644 ' HE1' ' CE2' ' B' ' 19' ' ' TYR . 3.1 m-85 -110.6 102.65 11.21 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 174.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 45.2 t -89.84 99.2 12.25 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 173.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -115.55 139.74 49.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.3 -168.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 54.4 m -84.66 132.16 34.51 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.399 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 59.3 mt -86.33 115.48 27.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.041 0.448 . . . . 0.0 110.924 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.424 HD13 ' N ' ' B' ' 25' ' ' LYS . 1.9 pp -88.7 -12.57 10.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.369 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.424 ' N ' HD13 ' B' ' 24' ' ' ILE . 83.3 tttt -159.99 120.17 2.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.479 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 13.6 m -51.47 137.09 24.7 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 123.768 0.667 . . . . 0.0 110.515 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -147.34 165.34 30.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.386 0.612 . . . . 0.0 112.51 -174.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' HIS . . . . . 0.475 ' HA ' ' O ' ' B' ' 67' ' ' LEU . 8.3 t60 -116.15 120.24 38.39 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.749 176.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.507 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 42.5 mt -84.56 134.69 26.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 169.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.518 ' HB2' ' HB3' ' C' ' 66' ' ' ASP . 77.2 p -119.61 -10.1 9.67 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -171.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -178.16 158.5 23.38 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.314 -1.422 . . . . 0.0 113.678 177.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.4 HG21 ' HG ' ' B' ' 87' ' ' LEU . 11.9 p -139.71 137.27 39.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -150.16 154.78 38.61 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.972 -0.455 . . . . 0.0 110.961 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.447 ' HB3' HG13 ' B' ' 85' ' ' VAL . 4.3 pp -118.14 140.06 50.35 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.963 0.887 . . . . 0.0 111.651 178.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -110.41 -53.25 2.7 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.067 -1.424 . . . . 0.0 108.508 174.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -101.55 126.74 48.42 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.672 175.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.462 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 140.67 165.72 10.41 Favored Glycine 0 N--CA 1.439 -1.132 0 C-N-CA 119.602 -1.285 . . . . 0.0 113.484 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -102.76 -46.48 4.7 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.589 0.233 . . . . 0.0 111.481 176.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -151.5 134.24 15.62 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.95 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.402 ' HB3' ' HB1' ' B' ' 83' ' ' ALA . . . -132.83 113.71 13.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.494 0.664 . . . . 0.0 110.423 170.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' B' ' 79' ' ' THR . 65.4 mttp -98.19 113.22 25.06 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 174.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.417 ' HG ' ' CG2' ' B' ' 53' ' ' VAL . 58.9 tp -89.85 109.14 20.17 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.367 -170.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . 1.631 ' HE2' ' CE1' ' B' ' 43' ' ' TYR . 71.1 m-85 -109.04 148.53 30.66 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.919 177.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.663 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 0.4 OUTLIER -128.37 117.12 20.86 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.589 176.058 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -102.89 104.4 14.64 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.358 0.599 . . . . 0.0 109.925 176.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -128.85 143.67 50.97 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 61.06 26.64 16.56 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.769 0.795 . . . . 0.0 109.168 -174.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 59.19 38.28 23.61 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.009 -177.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . 0.554 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 6.6 tp-100 -129.46 127.97 41.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.727 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -81.43 106.04 13.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.966 0.413 . . . . 0.0 110.591 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 1.617 ' HE2' ' CE1' ' B' ' 51' ' ' TYR . 74.1 m-85 -102.3 116.95 33.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.348 176.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . 0.408 HD11 ' CE1' ' B' ' 43' ' ' TYR . 4.9 tp -74.7 99.88 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 171.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.473 HG13 ' CD2' ' A' ' 88' ' ' LEU . 28.8 m -87.39 -32.51 6.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.576 -172.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.483 ' HB1' HD22 ' B' ' 65' ' ' LEU . . . -152.89 142.31 21.68 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 26.8 m -112.96 101.96 9.98 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 169.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 p -118.33 112.36 37.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.857 0.837 . . . . 0.0 110.468 -176.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 77.1 p -123.39 -177.39 3.69 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.107 -176.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -60.86 -29.41 69.51 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.507 168.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.15 -40.69 62.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.338 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 77.8 mt -117.73 81.64 15.31 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 173.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.34 -4.15 12.28 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.164 2.576 . . . . 0.0 113.922 -168.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -160.69 129.76 4.82 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.307 0.575 . . . . 0.0 111.164 -175.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.461 HG12 ' HB3' ' B' ' 54' ' ' ALA . 96.8 t -120.19 125.58 74.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.522 176.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.41 130.76 34.52 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.483 HD22 ' HB1' ' B' ' 54' ' ' ALA . 88.4 mt -122.91 166.59 14.79 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.408 0.623 . . . . 0.0 112.369 -173.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 26.1 t0 -144.45 97.94 3.12 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 170.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.507 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 7.0 mt -132.88 109.32 9.53 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.406 -175.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . 0.446 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 7.5 m-20 -104.69 114.65 29.0 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.899 0.38 . . . . 0.0 110.175 178.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . 1.67 ' HD2' ' CD1' ' B' ' 69' ' ' PHE . 57.9 m-85 -108.05 160.31 15.89 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.349 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 36.0 t -116.16 149.6 38.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.959 0.409 . . . . 0.0 110.563 -177.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -69.1 0.23 4.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.272 -176.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.54 -18.46 35.49 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.356 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -101.47 164.24 11.86 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.681 -0.305 . . . . 0.0 110.891 -176.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -131.11 108.81 10.02 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 22.4 pt -109.5 158.35 9.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.256 -170.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 76' ' ' MET . . . . . 0.415 ' HA ' ' O ' ' B' ' 19' ' ' TYR . 2.6 mtm -116.64 122.79 45.61 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 120.296 -0.562 . . . . 0.0 109.924 175.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . 0.663 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -104.49 128.61 52.46 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.665 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 1.667 ' HE1' ' CE2' ' B' ' 78' ' ' TYR . 36.0 p90 -150.08 135.37 18.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.589 0.709 . . . . 0.0 112.498 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 3.8 p -106.35 132.56 52.24 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.835 178.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.46 154.39 18.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.806 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' B' ' 16' ' ' GLU . . . 91.38 -172.18 35.94 Favored Glycine 0 CA--C 1.506 -0.492 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -176.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -113.09 102.9 10.83 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.854 176.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.473 ' H ' ' HB3' ' B' ' 15' ' ' PRO . . . -169.32 153.71 5.45 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.818 167.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 24.3 t -111.0 120.65 43.07 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.447 HG13 ' HB3' ' B' ' 34' ' ' LEU . 3.8 m -114.97 149.27 17.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.544 0.688 . . . . 0.0 112.816 -172.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 25.0 m -110.87 115.38 29.42 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.61 175.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.618 HD12 ' SD ' ' B' ' 13' ' ' MET . 4.8 mp -94.81 145.25 25.01 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 170.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.455 HD12 ' O ' ' B' ' 87' ' ' LEU . 2.4 mm? -124.48 149.51 46.77 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.81 -167.29 26.22 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.512 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 90' ' ' TYR . . . . . 1.634 ' HE2' ' CE1' ' B' ' 90' ' ' TYR . 5.1 p90 -149.35 131.34 15.27 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.787 0.803 . . . . 0.0 111.682 176.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 27.3 mt . . . . . 0 C--N 1.324 -0.543 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.256 176.92 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 21.8 ttt . . . . . 0 C--O 1.226 -0.183 0 CA-C-O 121.166 0.508 . . . . 0.0 112.325 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' C' C ' 8' ' ' PHE . . . . . 1.637 ' HD1' ' CD2' ' C' ' 8' ' ' PHE . 77.8 t80 -54.56 141.55 31.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.788 -1.097 . . . . 0.0 112.917 -176.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . 0.507 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 89.4 t90 -133.48 147.23 51.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.582 177.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.85 145.65 14.7 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.554 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.507 ' HB2' ' CH2' ' C' ' 9' ' ' TRP . 50.0 tp -135.97 108.74 7.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.923 0.392 . . . . 0.0 110.254 177.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -96.7 101.1 12.64 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 13' ' ' MET . . . . . 0.616 ' SD ' HD12 ' C' ' 87' ' ' LEU . 60.9 mtp -92.57 143.44 26.34 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.282 0.563 . . . . 0.0 111.401 -172.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -100.48 144.98 29.51 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.424 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . 0.463 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 9.5 Cg_endo -51.87 123.23 11.94 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 123.647 2.898 . . . . 0.0 113.559 -174.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' C' ' 79' ' ' THR . 36.1 mt-10 57.8 73.45 0.47 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.686 178.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.82 138.43 19.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.173 176.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 18' ' ' LYS . . . . . 0.666 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 50.2 mttp -107.37 121.98 45.67 Favored 'General case' 0 CA--C 1.511 -0.531 0 O-C-N 123.368 0.418 . . . . 0.0 111.325 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . 1.657 ' HD1' ' CD2' ' C' ' 19' ' ' TYR . 3.1 m-85 -110.63 102.74 11.28 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 174.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 20' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 44.7 t -89.97 99.22 12.27 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 173.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -115.52 139.69 49.83 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.272 -168.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 54.2 m -84.63 132.13 34.52 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.426 174.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 59.1 mt -86.21 115.32 27.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.048 0.452 . . . . 0.0 111.001 -175.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . 0.418 HD13 ' N ' ' C' ' 25' ' ' LYS . 1.9 pp -88.64 -12.57 10.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.39 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . 0.418 ' N ' HD13 ' C' ' 24' ' ' ILE . 83.3 tttt -159.95 120.24 2.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.431 178.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 13.4 m -51.47 137.13 24.66 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 123.736 0.647 . . . . 0.0 110.532 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 27' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -147.39 165.32 30.57 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.448 0.642 . . . . 0.0 112.579 -174.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 28' ' ' HIS . . . . . 0.483 ' HA ' ' O ' ' C' ' 67' ' ' LEU . 8.3 t60 -116.1 120.29 38.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.728 177.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . 0.49 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 42.3 mt -84.61 134.68 26.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 169.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 30' ' ' SER . . . . . 0.487 ' HB2' ' HB3' ' D' ' 66' ' ' ASP . 75.9 p -119.59 -10.05 9.68 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -171.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 31' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -178.11 158.45 23.32 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 119.194 -1.479 . . . . 0.0 113.617 177.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.401 HG21 ' HG ' ' C' ' 87' ' ' LEU . 12.0 p -139.67 137.28 39.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -150.17 154.79 38.63 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 121.946 -0.471 . . . . 0.0 110.922 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.441 ' O ' HD13 ' C' ' 34' ' ' LEU . 4.3 pp -118.24 140.09 50.33 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 122.01 0.909 . . . . 0.0 111.585 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -110.33 -53.32 2.7 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.934 -1.485 . . . . 0.0 108.514 174.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -101.59 126.72 48.46 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.603 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 37' ' ' GLY . . . . . 0.462 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 140.72 165.68 10.4 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 119.55 -1.309 . . . . 0.0 113.56 178.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -102.78 -46.46 4.7 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 120.575 0.226 . . . . 0.0 111.452 176.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -151.49 134.31 15.68 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.979 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.83 113.66 13.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.401 0.62 . . . . 0.0 110.451 170.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' C' ' 79' ' ' THR . 65.4 mttp -98.17 113.27 25.13 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 174.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.426 ' HG ' ' CG2' ' C' ' 53' ' ' VAL . 59.0 tp -89.92 109.08 20.12 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.416 -170.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 43' ' ' TYR . . . . . 1.652 ' HE1' ' CE2' ' C' ' 43' ' ' TYR . 71.3 m-85 -108.99 148.58 30.53 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.92 177.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.663 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 0.4 OUTLIER -128.39 117.09 20.78 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.579 176.045 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -102.87 104.5 14.76 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.33 0.586 . . . . 0.0 109.851 176.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -128.76 143.74 50.99 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.34 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 61.11 26.52 16.42 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.768 0.794 . . . . 0.0 109.138 -174.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 59.28 38.27 23.32 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.969 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . 0.549 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 6.6 tp-100 -129.49 127.96 41.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.715 178.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -81.51 106.08 13.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.074 0.464 . . . . 0.0 110.565 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 1.641 ' HE2' ' CE1' ' C' ' 51' ' ' TYR . 73.9 m-85 -102.29 116.97 33.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.304 176.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . 0.406 HD11 ' CE1' ' C' ' 43' ' ' TYR . 4.8 tp -74.74 99.88 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 171.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 53' ' ' VAL . . . . . 0.453 HG13 ' CD2' ' B' ' 88' ' ' LEU . 28.4 m -87.43 -32.43 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.618 -172.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 54' ' ' ALA . . . . . 0.479 ' HB1' HD22 ' C' ' 65' ' ' LEU . . . -152.89 142.41 21.77 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 120.308 -0.557 . . . . 0.0 112.261 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 27.0 m -113.05 101.97 9.96 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 169.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 p -118.26 112.39 38.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.817 0.818 . . . . 0.0 110.414 -176.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 77.0 p -123.45 -177.35 3.69 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.205 -176.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -60.81 -29.47 69.48 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.484 168.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.13 -40.68 62.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.289 0.566 . . . . 0.0 110.329 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 77.5 mt -117.75 81.65 15.4 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 173.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.33 -4.12 12.22 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.148 2.565 . . . . 0.0 113.969 -168.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -160.69 129.7 4.8 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.348 0.594 . . . . 0.0 111.194 -175.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.458 HG12 ' HB3' ' C' ' 54' ' ' ALA . 97.2 t -120.1 125.55 74.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.552 176.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.39 130.76 34.52 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 175.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . 0.479 HD22 ' HB1' ' C' ' 54' ' ' ALA . 88.2 mt -122.84 166.59 14.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.506 0.669 . . . . 0.0 112.376 -173.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 66' ' ' ASP . . . . . 0.518 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 26.4 t0 -144.52 98.07 3.14 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . 0.49 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 7.0 mt -132.95 109.37 9.53 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.443 -175.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . 0.434 ' HB2' ' CD2' ' B' ' 90' ' ' TYR . 7.4 m-20 -104.7 114.63 28.97 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 120.802 0.334 . . . . 0.0 110.158 178.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 69' ' ' PHE . . . . . 1.648 ' HD2' ' CD1' ' C' ' 69' ' ' PHE . 58.2 m-85 -108.11 160.38 15.85 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.254 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 36.6 t -116.16 149.64 38.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.565 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -69.15 0.01 5.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.203 -176.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.32 -18.54 35.85 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.406 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -101.51 164.09 11.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.706 0.289 . . . . 0.0 110.841 -176.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -131.0 108.81 10.06 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 22.5 pt -109.52 158.41 9.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.216 -170.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 76' ' ' MET . . . . . 0.41 ' HA ' ' O ' ' C' ' 19' ' ' TYR . 2.5 mtm -116.69 122.81 45.61 Favored 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.887 175.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 77' ' ' PHE . . . . . 0.663 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.7 OUTLIER -104.55 128.63 52.56 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.721 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 78' ' ' TYR . . . . . 1.624 ' HE2' ' CE1' ' C' ' 78' ' ' TYR . 36.4 p90 -150.04 135.33 18.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.581 0.705 . . . . 0.0 112.531 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 79' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 3.9 p -106.35 132.51 52.3 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.777 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.48 154.5 18.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.778 177.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.3 -172.16 36.03 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -176.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -113.07 102.95 10.88 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.879 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . 0.463 ' H ' ' HB3' ' C' ' 15' ' ' PRO . . . -169.38 153.6 5.34 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.845 167.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 25.3 t -110.94 120.71 43.3 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.439 HG13 ' HB3' ' C' ' 34' ' ' LEU . 3.8 m -114.96 149.38 17.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 24.1 m -110.97 115.31 29.28 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.641 175.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . 0.616 HD12 ' SD ' ' C' ' 13' ' ' MET . 4.8 mp -94.83 145.19 25.06 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 170.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . 0.462 HD12 ' O ' ' C' ' 87' ' ' LEU . 2.4 mm? -124.38 149.49 46.61 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.77 -167.29 26.16 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.471 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 90' ' ' TYR . . . . . 1.642 ' HD2' ' CD1' ' C' ' 90' ' ' TYR . 5.1 p90 -149.33 131.41 15.36 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.744 0.783 . . . . 0.0 111.741 176.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 27.7 mt . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.247 177.024 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 21.7 ttt . . . . . 0 C--O 1.225 -0.223 0 CA-C-O 121.142 0.496 . . . . 0.0 112.28 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' D' D ' 8' ' ' PHE . . . . . 1.651 ' HE2' ' CE1' ' D' ' 8' ' ' PHE . 78.0 t80 -54.55 141.59 30.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.971 -176.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 9' ' ' TRP . . . . . 0.511 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 89.3 t90 -133.53 147.21 51.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.536 177.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.79 145.64 14.68 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.591 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . 0.511 ' HB2' ' CH2' ' D' ' 9' ' ' TRP . 49.9 tp -136.0 108.85 7.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.923 0.392 . . . . 0.0 110.246 176.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -96.76 101.01 12.53 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 13' ' ' MET . . . . . 0.62 ' SD ' HD12 ' D' ' 87' ' ' LEU . 60.8 mtp -92.42 143.45 26.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.241 0.543 . . . . 0.0 111.434 -173.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -100.47 144.94 29.43 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.416 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . 0.463 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 9.5 Cg_endo -51.73 123.16 11.7 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.645 2.896 . . . . 0.0 113.626 -174.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' D' ' 79' ' ' THR . 35.9 mt-10 57.81 73.46 0.47 Allowed 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.707 178.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.85 138.44 19.66 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.197 176.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . 0.662 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 50.2 mttp -107.39 121.98 45.67 Favored 'General case' 0 CA--C 1.511 -0.533 0 O-C-N 123.387 0.429 . . . . 0.0 111.399 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 19' ' ' TYR . . . . . 1.669 ' HD1' ' CD2' ' D' ' 19' ' ' TYR . 3.1 m-85 -110.61 102.64 11.2 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 174.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 20' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 44.9 t -89.97 99.17 12.24 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -115.51 139.8 49.73 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.219 -168.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 55.2 m -84.74 132.25 34.47 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.292 174.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 59.4 mt -86.38 115.35 27.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.057 0.456 . . . . 0.0 110.914 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . 0.406 HD13 ' N ' ' D' ' 25' ' ' LYS . 1.9 pp -88.67 -12.51 10.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.417 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . 0.406 ' N ' HD13 ' D' ' 24' ' ' ILE . 83.3 tttt -159.93 120.28 2.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.493 178.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 13.6 m -51.6 137.13 25.4 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 123.761 0.663 . . . . 0.0 110.415 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 27' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -147.39 165.27 30.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.399 0.619 . . . . 0.0 112.569 -174.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 28' ' ' HIS . . . . . 0.482 ' HA ' ' O ' ' D' ' 67' ' ' LEU . 8.3 t60 -116.15 120.3 38.59 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.676 177.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 29' ' ' ILE . . . . . 0.501 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 42.4 mt -84.5 134.66 26.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 169.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 30' ' ' SER . . . . . 0.496 ' HB2' ' HB3' ' E' ' 66' ' ' ASP . 77.2 p -119.6 -10.12 9.67 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -171.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 31' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -178.15 158.5 23.38 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 119.309 -1.425 . . . . 0.0 113.686 177.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 12.0 p -139.67 137.26 39.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 175.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -150.16 154.85 38.74 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.025 -0.422 . . . . 0.0 110.916 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 34' ' ' LEU . . . . . 0.437 HD13 ' O ' ' D' ' 34' ' ' LEU . 4.3 pp -118.24 140.01 50.45 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.957 0.884 . . . . 0.0 111.607 178.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -110.32 -53.31 2.7 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.556 174.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -101.54 126.79 48.41 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.631 175.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . 0.461 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 140.65 165.67 10.39 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 119.554 -1.308 . . . . 0.0 113.447 178.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -102.8 -46.46 4.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.485 0.183 . . . . 0.0 111.409 176.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -151.44 134.21 15.66 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.012 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . 0.414 ' HB3' ' HB1' ' D' ' 83' ' ' ALA . . . -132.76 113.7 13.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.433 0.635 . . . . 0.0 110.53 170.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' D' ' 79' ' ' THR . 65.4 mttp -98.16 113.28 25.13 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 174.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.424 ' HG ' ' CG2' ' D' ' 53' ' ' VAL . 58.8 tp -89.95 109.05 20.1 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.409 -170.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 43' ' ' TYR . . . . . 1.664 ' HD2' ' CD1' ' D' ' 43' ' ' TYR . 70.6 m-85 -108.97 148.55 30.54 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.989 177.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.66 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.4 OUTLIER -128.37 117.08 20.8 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.568 176.092 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 45' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -102.89 104.46 14.7 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.376 0.608 . . . . 0.0 109.871 176.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -128.85 143.62 50.95 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.034 -0.984 . . . . 0.0 108.377 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 61.2 26.55 16.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.711 0.767 . . . . 0.0 109.104 -174.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 59.29 38.23 23.29 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.992 -177.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . 0.55 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 6.6 tp-100 -129.53 127.91 41.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.685 178.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -81.47 106.08 13.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.069 0.461 . . . . 0.0 110.607 -178.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . 1.653 ' HE2' ' CE1' ' D' ' 51' ' ' TYR . 73.7 m-85 -102.3 116.97 33.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.355 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 52' ' ' ILE . . . . . 0.404 HD11 ' CE1' ' D' ' 43' ' ' TYR . 4.9 tp -74.67 99.88 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 53' ' ' VAL . . . . . 0.438 HG13 ' CD2' ' C' ' 88' ' ' LEU . 28.6 m -87.43 -32.43 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.586 -172.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 54' ' ' ALA . . . . . 0.467 ' HB1' HD22 ' D' ' 65' ' ' LEU . . . -152.93 142.27 21.61 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.246 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 27.2 m -112.97 102.05 10.05 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 169.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 p -118.4 112.33 37.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.904 0.859 . . . . 0.0 110.421 -176.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 78.4 p -123.33 -177.34 3.68 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.155 -176.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -60.86 -29.47 69.55 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.486 168.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.12 -40.68 62.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.326 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 77.6 mt -117.77 81.7 15.54 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 173.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.38 -4.1 12.22 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.137 2.558 . . . . 0.0 113.938 -168.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -160.69 129.69 4.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.299 0.571 . . . . 0.0 111.164 -175.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.459 HG12 ' HB3' ' D' ' 54' ' ' ALA . 97.1 t -120.12 125.67 74.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.555 176.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.43 130.83 34.5 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 65' ' ' LEU . . . . . 0.467 HD22 ' HB1' ' D' ' 54' ' ' ALA . 88.3 mt -122.97 166.53 14.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.353 0.597 . . . . 0.0 112.302 -173.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 66' ' ' ASP . . . . . 0.487 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 26.1 t0 -144.44 98.0 3.13 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 170.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . 0.501 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 6.9 mt -132.94 109.33 9.51 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.415 -175.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 68' ' ' ASN . . . . . 0.429 ' HB2' ' CD2' ' C' ' 90' ' ' TYR . 7.5 m-20 -104.72 114.67 29.03 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.857 0.36 . . . . 0.0 110.119 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 69' ' ' PHE . . . . . 1.655 ' HE1' ' CE2' ' D' ' 69' ' ' PHE . 57.7 m-85 -108.1 160.33 15.89 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.333 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 35.6 t -116.17 149.54 38.92 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.696 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -69.07 0.12 5.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.241 -176.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.45 -18.41 35.93 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.437 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -101.49 164.16 11.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.735 0.302 . . . . 0.0 110.848 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -131.08 108.92 10.1 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . . . . . . . . . 22.4 pt -109.57 158.47 9.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.22 -170.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 76' ' ' MET . . . . . 0.411 ' HA ' ' O ' ' D' ' 19' ' ' TYR . 2.5 mtm -116.67 122.78 45.53 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 120.281 -0.567 . . . . 0.0 109.904 175.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 77' ' ' PHE . . . . . 0.66 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.7 OUTLIER -104.53 128.57 52.51 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.727 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 78' ' ' TYR . . . . . 1.674 ' HE1' ' CE2' ' D' ' 78' ' ' TYR . 36.5 p90 -149.97 135.38 18.19 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.622 0.725 . . . . 0.0 112.608 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 79' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 3.9 p -106.41 132.43 52.44 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.788 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.35 154.47 18.17 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.806 177.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.41 ' O ' ' HG3' ' D' ' 16' ' ' GLU . . . 91.41 -172.21 35.93 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -176.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -113.09 102.79 10.73 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 119.584 -0.846 . . . . 0.0 109.894 176.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.463 ' H ' ' HB3' ' D' ' 15' ' ' PRO . . . -169.2 153.7 5.56 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.846 167.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 24.3 t -110.98 120.73 43.36 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . 0.437 HG13 ' HB3' ' D' ' 34' ' ' LEU . 3.8 m -115.0 149.37 17.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.538 0.685 . . . . 0.0 112.764 -172.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 24.6 m -110.97 115.39 29.4 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.569 175.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 87' ' ' LEU . . . . . 0.62 HD12 ' SD ' ' D' ' 13' ' ' MET . 4.7 mp -94.8 145.14 25.09 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 170.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . 0.471 ' CD2' HG13 ' E' ' 53' ' ' VAL . 2.4 mm? -124.35 149.56 46.5 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.81 -167.28 26.2 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.441 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 90' ' ' TYR . . . . . 1.624 ' HD2' ' CD1' ' D' ' 90' ' ' TYR . 5.2 p90 -149.33 131.26 15.21 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.744 0.783 . . . . 0.0 111.811 176.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 27.5 mt . . . . . 0 C--N 1.323 -0.569 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.289 176.957 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 21.7 ttt . . . . . 0 C--O 1.225 -0.192 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' E' E ' 8' ' ' PHE . . . . . 1.658 ' HE1' ' CE2' ' E' ' 8' ' ' PHE . 77.7 t80 -54.65 141.54 31.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.899 -176.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 9' ' ' TRP . . . . . 0.499 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 89.5 t90 -133.43 147.27 51.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.55 177.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.86 145.62 14.63 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.625 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 11' ' ' LEU . . . . . 0.499 ' HB2' ' CH2' ' E' ' 9' ' ' TRP . 49.8 tp -136.07 108.85 7.54 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.007 0.432 . . . . 0.0 110.261 176.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -96.68 100.98 12.51 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 13' ' ' MET . . . . . 0.626 ' SD ' HD12 ' E' ' 87' ' ' LEU . 60.3 mtp -92.41 143.47 26.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.227 0.537 . . . . 0.0 111.451 -172.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -100.51 144.95 29.45 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.386 178.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . 0.465 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 9.5 Cg_endo -51.8 123.21 11.85 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.651 2.901 . . . . 0.0 113.623 -174.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 16' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' E' ' 79' ' ' THR . 35.9 mt-10 57.77 73.45 0.47 Allowed 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.722 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.85 138.44 19.67 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.203 176.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . 0.667 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 50.2 mttp -107.32 121.99 45.67 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 123.387 0.43 . . . . 0.0 111.306 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . 1.654 ' HE2' ' CE1' ' E' ' 19' ' ' TYR . 3.1 m-85 -110.62 102.67 11.22 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 174.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 20' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' E' ' 76' ' ' MET . 44.6 t -89.99 99.18 12.24 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 173.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -115.5 139.85 49.68 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.279 -168.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 56.0 m -84.81 132.15 34.45 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.382 174.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 59.3 mt -86.32 115.37 27.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.086 0.469 . . . . 0.0 110.932 -175.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . 0.419 HD13 ' N ' ' E' ' 25' ' ' LYS . 1.9 pp -88.69 -12.49 10.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.414 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . 0.419 ' N ' HD13 ' E' ' 24' ' ' ILE . 83.3 tttt -159.95 120.19 2.97 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.501 178.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 13.6 m -51.53 137.07 25.1 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.801 0.688 . . . . 0.0 110.498 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 27' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -147.31 165.19 30.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.422 0.629 . . . . 0.0 112.597 -174.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 28' ' ' HIS . . . . . 0.49 ' HA ' ' O ' ' E' ' 67' ' ' LEU . 8.3 t60 -115.97 120.32 38.78 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.682 -1.144 . . . . 0.0 109.786 176.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 29' ' ' ILE . . . . . 0.5 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 42.1 mt -84.61 134.66 26.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 169.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 30' ' ' SER . . . . . 0.525 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 76.6 p -119.59 -10.03 9.69 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -171.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 31' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -178.11 158.55 23.49 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.252 -1.451 . . . . 0.0 113.595 177.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . 0.403 HG21 ' HG ' ' E' ' 87' ' ' LEU . 12.0 p -139.77 137.25 39.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 174.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -150.17 154.83 38.68 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.916 -178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 34' ' ' LEU . . . . . 0.443 HD13 ' O ' ' E' ' 34' ' ' LEU . 4.3 pp -118.24 140.04 50.4 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.953 0.882 . . . . 0.0 111.665 178.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -110.4 -53.3 2.7 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 113.98 -1.464 . . . . 0.0 108.494 174.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -101.54 126.77 48.4 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.676 175.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . 0.454 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 140.55 165.73 10.41 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 119.6 -1.286 . . . . 0.0 113.552 178.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -102.79 -46.55 4.67 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 123.501 0.177 . . . . 0.0 111.417 177.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -151.39 134.28 15.75 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.693 -0.23 . . . . 0.0 110.992 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.84 113.68 13.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.416 0.627 . . . . 0.0 110.442 170.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 41' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' E' ' 79' ' ' THR . 65.4 mttp -98.16 113.24 25.08 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 174.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.42 ' HG ' ' CG2' ' E' ' 53' ' ' VAL . 58.9 tp -89.91 109.08 20.12 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.396 -170.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 43' ' ' TYR . . . . . 1.659 ' HE1' ' CE2' ' E' ' 43' ' ' TYR . 71.2 m-85 -109.0 148.62 30.47 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.931 177.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 44' ' ' LEU . . . . . 0.664 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 0.4 OUTLIER -128.46 117.16 20.87 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.52 176.105 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' E' E ' 45' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -102.95 104.41 14.62 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.412 0.625 . . . . 0.0 109.877 176.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -128.85 143.67 50.97 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.302 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 61.16 26.57 16.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.802 0.81 . . . . 0.0 109.131 -174.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 59.31 38.23 23.2 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.952 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 49' ' ' GLN . . . . . 0.547 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 6.6 tp-100 -129.49 127.92 41.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.696 178.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -81.53 106.13 13.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.081 0.467 . . . . 0.0 110.567 -178.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . 1.644 ' HE2' ' CE1' ' E' ' 51' ' ' TYR . 73.9 m-85 -102.35 116.97 33.73 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.33 176.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -74.71 99.85 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . 0.471 HG13 ' CD2' ' D' ' 88' ' ' LEU . 29.3 m -87.35 -32.54 6.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.606 -172.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 54' ' ' ALA . . . . . 0.465 ' HB1' HD22 ' E' ' 65' ' ' LEU . . . -152.9 142.35 21.71 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 120.334 -0.547 . . . . 0.0 112.191 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 27.0 m -112.92 102.05 10.07 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 169.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 p -118.37 112.37 37.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.881 0.848 . . . . 0.0 110.416 -176.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 76.1 p -123.44 -177.38 3.69 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.172 -176.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -60.89 -29.33 69.51 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.516 168.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.2 -40.71 62.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.266 0.555 . . . . 0.0 110.345 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 77.3 mt -117.64 81.57 14.89 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 173.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.31 -4.11 12.17 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.16 2.573 . . . . 0.0 113.97 -168.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -160.65 129.7 4.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.273 0.559 . . . . 0.0 111.148 -175.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . 0.458 HG12 ' HB3' ' E' ' 54' ' ' ALA . 96.9 t -120.12 125.63 74.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.524 176.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.4 130.73 34.52 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 175.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 65' ' ' LEU . . . . . 0.465 HD22 ' HB1' ' E' ' 54' ' ' ALA . 88.1 mt -122.82 166.51 14.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.444 0.64 . . . . 0.0 112.342 -173.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 66' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 26.6 t0 -144.44 98.04 3.14 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 170.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 67' ' ' LEU . . . . . 0.5 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 7.0 mt -132.97 109.33 9.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.456 -175.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 68' ' ' ASN . . . . . 0.471 ' HB2' ' CD2' ' D' ' 90' ' ' TYR . 7.5 m-20 -104.66 114.67 29.03 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.831 0.348 . . . . 0.0 110.149 178.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 69' ' ' PHE . . . . . 1.657 ' HE1' ' CE2' ' E' ' 69' ' ' PHE . 58.1 m-85 -108.17 160.31 15.92 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.269 179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 36.6 t -116.15 149.68 38.64 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.635 -177.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -69.15 0.11 5.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.136 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.51 -18.45 35.62 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.346 177.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -101.48 164.15 11.91 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.697 -0.296 . . . . 0.0 110.851 -176.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -131.09 108.77 9.99 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 75' ' ' ILE . . . . . . . . . . . . . 22.3 pt -109.43 158.39 9.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.29 -170.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 76' ' ' MET . . . . . 0.416 ' HA ' ' O ' ' E' ' 19' ' ' TYR . 2.5 mtm -116.66 122.79 45.59 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.906 175.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 77' ' ' PHE . . . . . 0.664 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.7 OUTLIER -104.46 128.62 52.4 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.653 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' E' E ' 78' ' ' TYR . . . . . 1.614 ' HD2' ' CD1' ' E' ' 78' ' ' TYR . 36.6 p90 -150.05 135.24 17.99 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.57 0.7 . . . . 0.0 112.569 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 79' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 3.9 p -106.29 132.57 52.18 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.806 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.55 154.38 18.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.778 177.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 81' ' ' GLY . . . . . 0.41 ' O ' ' HG3' ' E' ' 16' ' ' GLU . . . 91.46 -172.22 35.85 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -176.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -113.04 102.83 10.78 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.881 176.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 83' ' ' ALA . . . . . 0.465 ' H ' ' HB3' ' E' ' 15' ' ' PRO . . . -169.28 153.68 5.48 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.84 167.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 24.3 t -110.98 120.72 43.33 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 85' ' ' VAL . . . . . 0.438 HG13 ' HB3' ' E' ' 34' ' ' LEU . 3.8 m -114.98 149.39 17.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -172.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 24.6 m -110.97 115.24 29.15 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.619 175.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 87' ' ' LEU . . . . . 0.626 HD12 ' SD ' ' E' ' 13' ' ' MET . 4.8 mp -94.79 145.15 25.08 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 170.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . 0.479 ' CD2' HG13 ' A' ' 53' ' ' VAL . 2.4 mm? -124.34 149.58 46.45 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.92 -167.35 26.41 Favored Glycine 0 N--CA 1.437 -1.275 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.376 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 90' ' ' TYR . . . . . 1.67 ' HD2' ' CD1' ' E' ' 90' ' ' TYR . 5.1 p90 -149.31 131.34 15.31 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.744 0.783 . . . . 0.0 111.766 176.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 91' ' ' LEU . . . . . . . . . . . . . 27.2 mt . . . . . 0 C--N 1.323 -0.555 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.29 176.998 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 48.5 mtt . . . . . 0 C--O 1.224 -0.276 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 1.654 ' HD1' ' CD2' ' A' ' 8' ' ' PHE . 70.4 t80 -69.46 146.36 52.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.21 0.529 . . . . 0.0 112.191 -175.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.456 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 92.2 t90 -136.7 145.58 44.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.025 176.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.53 146.6 16.3 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.531 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.456 ' HB2' ' CH2' ' A' ' 9' ' ' TRP . 43.6 tp -138.48 109.9 6.98 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.885 0.374 . . . . 0.0 110.507 177.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -97.33 105.12 17.22 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.6 ' SD ' HD12 ' A' ' 87' ' ' LEU . 44.3 mtp -98.39 143.95 28.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.917 0.389 . . . . 0.0 111.038 -174.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.479 ' HB2' ' HG3' ' A' ' 17' ' ' ARG . 37.8 mtmm -100.98 157.7 33.16 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.367 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.491 ' HB3' ' HA ' ' A' ' 82' ' ' ASP . 91.1 Cg_exo -47.76 115.42 1.44 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.581 2.854 . . . . 0.0 113.66 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' A' ' 79' ' ' THR . 44.6 mt-10 59.8 58.36 2.84 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.368 0.604 . . . . 0.0 111.848 175.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.479 ' HG3' ' HB2' ' A' ' 14' ' ' LYS . 29.1 mmt180 -118.68 153.17 34.79 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.946 174.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.635 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 3.5 ttmp? -130.95 110.82 11.53 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 123.456 0.473 . . . . 0.0 110.958 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.43 ' HH ' ' HA ' ' A' ' 13' ' ' MET . 2.1 m-85 -111.38 112.6 24.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.885 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -75.14 114.56 13.77 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 171.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -92.81 114.09 26.54 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.426 -165.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.7 m -93.62 119.56 32.8 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.108 172.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.3 mt -96.79 113.01 30.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.99 0.424 . . . . 0.0 111.342 -173.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.449 HD13 ' N ' ' A' ' 24' ' ' ILE . 4.2 mp -88.91 -34.75 7.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.444 0.64 . . . . 0.0 109.342 177.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.406 ' HD2' HD11 ' A' ' 91' ' ' LEU . 19.4 pttt -132.73 128.74 37.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.183 178.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.2 m -56.2 148.36 18.46 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.746 -176.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -157.97 162.87 38.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.717 0.77 . . . . 0.0 112.924 -178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.521 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 2.0 t60 -119.18 123.83 45.3 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.392 -1.277 . . . . 0.0 109.444 176.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 51.7 mt -85.27 134.68 26.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 170.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.528 ' HB2' ' HB3' ' B' ' 66' ' ' ASP . 61.7 p -117.55 -15.01 10.26 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -171.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -171.41 152.1 17.08 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 119.43 -1.367 . . . . 0.0 113.242 177.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.423 ' CG2' ' HG ' ' A' ' 87' ' ' LEU . 11.3 p -136.68 131.51 47.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 174.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.88 155.99 42.21 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.014 -0.429 . . . . 0.0 111.161 -176.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.4 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 4.1 pp -118.05 141.28 48.64 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.887 0.851 . . . . 0.0 111.925 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -110.07 -54.18 2.6 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.807 176.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.427 ' HZ2' ' HB3' ' A' ' 36' ' ' LYS . 6.9 ttpm? -100.85 128.12 47.02 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 171.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.523 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 139.25 161.57 8.78 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 119.705 -1.236 . . . . 0.0 113.373 176.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -103.4 -43.81 5.32 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -149.42 132.32 16.11 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 120.512 0.196 . . . . 0.0 111.043 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.74 113.8 13.98 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.409 0.624 . . . . 0.0 110.128 169.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 79' ' ' THR . 97.4 mttt -96.25 110.57 22.85 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 175.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.401 ' HG ' ' CG2' ' A' ' 53' ' ' VAL . 51.0 tp -87.02 109.76 19.61 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.025 -172.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.424 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 96.8 m-85 -108.25 141.85 39.42 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.252 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.552 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 1.5 tp -123.57 112.79 17.86 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.488 176.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -99.18 108.84 21.53 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.19 0.519 . . . . 0.0 109.855 176.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.66 140.9 37.03 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.529 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 53.33 41.93 32.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.526 0.679 . . . . 0.0 110.248 -178.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.2 mttp 69.87 21.46 6.32 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.414 172.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.573 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 79.2 mm-40 -128.36 137.44 51.9 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 122.211 -0.306 . . . . 0.0 111.097 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -87.31 104.94 16.88 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 174.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 1.593 ' HE2' ' CE1' ' A' ' 51' ' ' TYR . 75.8 m-85 -99.83 120.22 39.41 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.775 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -77.36 99.96 2.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 170.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.493 HG13 ' CD2' ' E' ' 88' ' ' LEU . 18.5 m -86.97 -34.58 7.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.817 -172.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.524 ' HB1' ' CD2' ' A' ' 65' ' ' LEU . . . -151.13 140.83 21.75 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.107 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.7 m -111.52 101.25 9.68 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 169.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.15 113.71 43.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.724 0.773 . . . . 0.0 110.052 -176.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 78.2 p -123.27 -177.89 3.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.204 -175.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -64.0 -24.22 67.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.025 0.441 . . . . 0.0 110.53 169.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.39 -40.52 43.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.169 176.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.6 mt -116.84 81.92 12.53 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 173.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.94 -5.15 12.77 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.206 2.604 . . . . 0.0 114.133 -167.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -160.48 128.62 4.61 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.129 0.49 . . . . 0.0 111.189 -175.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.2 t -118.45 108.19 23.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.408 175.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.71 121.46 30.17 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 174.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.524 ' CD2' ' HB1' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -143.66 168.79 19.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.147 0.499 . . . . 0.0 111.978 -174.42 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.54 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 9.5 t0 -116.36 107.13 14.43 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.739 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.541 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 32.9 mt -126.37 107.74 10.58 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 177.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -111.08 127.87 55.69 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.913 -178.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 1.65 ' HE1' ' CE2' ' A' ' 69' ' ' PHE . 10.9 m-85 -127.19 150.32 49.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.908 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.0 m -102.59 161.78 13.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.057 0.456 . . . . 0.0 110.748 176.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -69.34 -5.1 21.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.159 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.78 -7.72 62.66 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.446 -0.661 . . . . 0.0 111.446 173.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -100.28 143.55 30.33 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -122.97 125.59 45.57 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 174.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.487 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 15.0 pt -132.06 172.18 16.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.744 -171.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 7.9 mtm -130.04 131.68 45.92 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 170.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 1.625 ' HE1' ' CE2' ' A' ' 77' ' ' PHE . 0.9 OUTLIER -110.25 128.33 55.45 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 177.348 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 1.625 ' HE2' ' CE1' ' A' ' 78' ' ' TYR . 40.9 p90 -153.69 140.43 19.01 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.292 -0.563 . . . . 0.0 112.12 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 8.0 p -111.92 136.43 51.24 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.25 -177.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.61 161.07 14.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.232 174.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.485 ' O ' ' HG3' ' A' ' 16' ' ' GLU . . . 81.97 177.27 51.73 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -173.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.491 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 7.0 p-10 -112.97 104.11 12.07 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 118.284 -1.367 . . . . 0.0 110.848 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.523 ' CB ' ' HA3' ' A' ' 37' ' ' GLY . . . -164.76 153.26 12.37 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 113.734 -1.575 . . . . 0.0 109.882 169.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.6 p -104.97 123.39 47.7 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 177.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.4 ' CG1' ' HB3' ' A' ' 34' ' ' LEU . 3.6 m -118.23 144.43 26.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.556 0.693 . . . . 0.0 112.776 -173.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.8 m -108.02 116.25 31.61 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.739 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.6 HD12 ' SD ' ' A' ' 13' ' ' MET . 4.5 mp -96.02 143.02 27.55 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 170.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.518 ' CD2' HG13 ' B' ' 53' ' ' VAL . 2.6 mm? -124.97 152.04 44.71 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 174.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.6 -167.86 30.73 Favored Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.429 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -139.15 131.42 28.3 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.498 0.666 . . . . 0.0 110.805 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.406 HD11 ' HD2' ' A' ' 25' ' ' LYS . 24.1 mt . . . . . 0 C--N 1.319 -0.744 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.892 173.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 48.5 mtt . . . . . 0 C--O 1.224 -0.283 0 CA-C-O 120.731 0.3 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . 1.627 ' HE2' ' CE1' ' B' ' 8' ' ' PHE . 70.5 t80 -69.42 146.35 52.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.231 0.539 . . . . 0.0 112.19 -175.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . 0.457 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 92.1 t90 -136.73 145.58 44.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.981 176.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.4 146.66 16.45 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.589 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.457 ' HB2' ' CH2' ' B' ' 9' ' ' TRP . 43.9 tp -138.44 109.84 6.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.792 0.329 . . . . 0.0 110.531 177.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -97.41 105.07 17.16 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' MET . . . . . 0.611 ' SD ' HD12 ' B' ' 87' ' ' LEU . 44.3 mtp -98.33 143.88 28.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.111 -174.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.48 ' HB2' ' HG3' ' B' ' 17' ' ' ARG . 37.9 mtmm -101.02 157.77 33.03 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.256 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.502 ' HB3' ' HA ' ' B' ' 82' ' ' ASP . 93.4 Cg_exo -47.86 115.4 1.45 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.619 2.879 . . . . 0.0 113.629 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.651 ' HA ' ' O ' ' B' ' 79' ' ' THR . 44.5 mt-10 59.87 58.39 2.8 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 121.256 0.55 . . . . 0.0 111.841 175.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.48 ' HG3' ' HB2' ' B' ' 14' ' ' LYS . 29.0 mmt180 -118.8 153.19 34.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.891 174.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . 0.634 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 3.5 ttmp? -130.91 110.68 11.45 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.04 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' TYR . . . . . 0.426 ' HH ' ' HA ' ' B' ' 13' ' ' MET . 2.1 m-85 -111.33 112.59 24.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.909 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 4.5 p -75.1 114.61 13.8 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 171.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -92.82 114.04 26.48 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.425 -165.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 22.9 m -93.51 119.46 32.61 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.175 172.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 42.1 mt -96.78 112.9 29.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.05 0.452 . . . . 0.0 111.407 -173.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.451 HD13 ' N ' ' B' ' 24' ' ' ILE . 4.2 mp -88.86 -34.78 7.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.302 177.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 19.5 pttt -132.75 128.74 37.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.088 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -56.21 148.35 18.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.84 -177.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -157.96 162.91 38.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.702 0.763 . . . . 0.0 112.881 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' HIS . . . . . 0.519 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 2.0 t60 -119.24 123.83 45.24 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.345 176.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.543 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 51.6 mt -85.27 134.6 26.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 170.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.553 ' HB2' ' HB3' ' C' ' 66' ' ' ASP . 61.5 p -117.48 -15.01 10.31 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -171.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -171.38 152.15 17.24 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.443 -1.361 . . . . 0.0 113.245 177.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.415 ' CG2' ' HG ' ' B' ' 87' ' ' LEU . 11.2 p -136.67 131.53 47.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 174.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.91 156.01 42.22 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.066 -0.396 . . . . 0.0 111.134 -176.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.407 ' HB3' ' CG1' ' B' ' 85' ' ' VAL . 4.1 pp -118.08 141.42 48.5 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.848 0.833 . . . . 0.0 111.96 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -110.17 -54.17 2.6 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.768 176.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.432 ' HB3' ' HZ2' ' B' ' 36' ' ' LYS . 6.9 ttpm? -100.92 128.1 47.1 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.862 171.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.532 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 139.32 161.55 8.77 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 119.583 -1.294 . . . . 0.0 113.35 176.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -103.32 -43.83 5.33 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 178.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -149.44 132.41 16.18 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.543 0.211 . . . . 0.0 110.983 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.84 113.71 13.82 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.388 0.613 . . . . 0.0 110.12 169.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' B' ' 79' ' ' THR . 97.3 mttt -96.22 110.59 22.86 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.407 ' HG ' ' CG2' ' B' ' 53' ' ' VAL . 51.1 tp -87.05 109.73 19.6 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.062 -172.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . 0.42 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 96.7 m-85 -108.2 141.85 39.32 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.293 178.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.558 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 1.5 tp -123.58 112.84 17.92 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.451 176.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -99.21 108.86 21.55 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.178 0.513 . . . . 0.0 109.82 176.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.69 140.97 36.97 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.535 -177.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 53.25 41.95 32.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.557 0.694 . . . . 0.0 110.238 -177.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 39.2 mttp 69.93 21.41 6.26 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.404 172.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . 0.564 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 79.1 mm-40 -128.33 137.49 51.95 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.055 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -87.27 104.88 16.82 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 1.649 ' HD2' ' CD1' ' B' ' 51' ' ' TYR . 76.0 m-85 -99.92 120.27 39.53 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.71 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -77.33 99.98 2.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 170.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.518 HG13 ' CD2' ' A' ' 88' ' ' LEU . 18.9 m -86.92 -34.68 7.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.878 -172.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.519 ' HB1' ' CD2' ' B' ' 65' ' ' LEU . . . -151.08 140.79 21.77 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 120.383 -0.527 . . . . 0.0 112.139 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 21.8 m -111.47 101.29 9.74 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 169.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.23 113.73 43.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.707 0.765 . . . . 0.0 110.052 -176.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 74.6 p -123.3 -177.82 3.81 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.201 -175.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -63.98 -24.27 67.65 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.508 169.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.33 -40.58 43.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.291 0.567 . . . . 0.0 110.187 176.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 79.8 mt -116.82 81.99 12.56 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 173.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.07 -5.16 12.93 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.232 2.621 . . . . 0.0 114.053 -167.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -160.42 128.63 4.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.273 0.558 . . . . 0.0 111.242 -175.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.404 HG12 ' HB3' ' B' ' 54' ' ' ALA . 88.9 t -118.58 108.23 23.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.462 175.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.72 121.47 30.19 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 174.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.519 ' CD2' ' HB1' ' B' ' 54' ' ' ALA . 0.4 OUTLIER -143.65 168.78 19.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.074 0.464 . . . . 0.0 112.009 -174.459 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . 0.528 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 9.4 t0 -116.32 107.13 14.44 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.772 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.543 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 32.7 mt -126.38 107.69 10.53 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 177.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -111.16 127.9 55.73 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.915 -178.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . 1.661 ' HD1' ' CD2' ' B' ' 69' ' ' PHE . 11.0 m-85 -127.13 150.34 49.54 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.883 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 58.1 m -102.62 161.78 13.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.071 0.462 . . . . 0.0 110.748 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -69.19 -5.22 21.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.231 177.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.79 -7.62 62.73 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 173.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -100.32 143.53 30.4 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -123.0 125.63 45.61 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 174.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.492 ' HB ' ' CD1' ' B' ' 44' ' ' LEU . 15.1 pt -132.07 172.15 16.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.718 -171.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 76' ' ' MET . . . . . . . . . . . . . 7.9 mtm -129.97 131.7 46.03 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 170.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . 1.651 ' HE1' ' CE2' ' B' ' 77' ' ' PHE . 0.9 OUTLIER -110.22 128.32 55.43 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.29 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 1.66 ' HE2' ' CE1' ' B' ' 78' ' ' TYR . 41.1 p90 -153.6 140.42 19.1 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.299 -0.56 . . . . 0.0 112.098 -178.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.651 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 8.1 p -111.91 136.48 51.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.216 -177.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.65 161.06 14.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.207 174.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.483 ' O ' ' HG3' ' B' ' 16' ' ' GLU . . . 81.93 177.38 51.78 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -173.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 82' ' ' ASP . . . . . 0.502 ' HA ' ' HB3' ' B' ' 15' ' ' PRO . 6.9 p-10 -113.14 104.18 12.1 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 118.267 -1.373 . . . . 0.0 110.82 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.532 ' CB ' ' HA3' ' B' ' 37' ' ' GLY . . . -164.83 153.25 12.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 113.638 -1.619 . . . . 0.0 109.861 169.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 6.7 p -104.96 123.4 47.71 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.407 ' CG1' ' HB3' ' B' ' 34' ' ' LEU . 3.5 m -118.21 144.44 26.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.571 0.7 . . . . 0.0 112.744 -173.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 50.9 m -108.11 116.25 31.62 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.704 175.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.611 HD12 ' SD ' ' B' ' 13' ' ' MET . 4.5 mp -96.04 143.14 27.45 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 170.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.5 ' CD2' HG13 ' C' ' 53' ' ' VAL . 2.6 mm? -125.09 151.96 44.99 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 174.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.55 -167.89 30.73 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.328 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -139.11 131.46 28.44 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.515 0.674 . . . . 0.0 110.851 176.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 23.4 mt . . . . . 0 C--N 1.319 -0.745 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.923 173.155 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 48.6 mtt . . . . . 0 C--O 1.222 -0.345 0 CA-C-O 120.75 0.309 . . . . 0.0 111.666 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 8' ' ' PHE . . . . . 1.651 ' HD1' ' CD2' ' C' ' 8' ' ' PHE . 70.6 t80 -69.41 146.36 52.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.284 0.564 . . . . 0.0 112.174 -175.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . 0.453 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 92.2 t90 -136.7 145.5 44.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.008 176.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.47 146.6 16.31 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.575 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.453 ' HB2' ' CH2' ' C' ' 9' ' ' TRP . 44.0 tp -138.37 109.87 7.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.834 0.35 . . . . 0.0 110.56 177.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -97.33 105.01 17.08 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 13' ' ' MET . . . . . 0.606 ' SD ' HD12 ' C' ' 87' ' ' LEU . 44.2 mtp -98.34 144.0 28.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.994 0.426 . . . . 0.0 111.041 -174.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . 0.477 ' HB2' ' HG3' ' C' ' 17' ' ' ARG . 37.8 mtmm -101.13 157.7 33.17 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.25 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . 0.506 ' HB3' ' HA ' ' C' ' 82' ' ' ASP . 92.2 Cg_exo -47.78 115.43 1.45 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.609 2.873 . . . . 0.0 113.585 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' C' ' 79' ' ' THR . 44.5 mt-10 59.81 58.36 2.83 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.306 0.574 . . . . 0.0 111.874 175.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 17' ' ' ARG . . . . . 0.477 ' HG3' ' HB2' ' C' ' 14' ' ' LYS . 29.0 mmt180 -118.72 153.24 34.71 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.939 174.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 18' ' ' LYS . . . . . 0.639 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 3.5 ttmp? -130.98 110.81 11.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.0 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . 0.422 ' HH ' ' HA ' ' C' ' 13' ' ' MET . 2.1 m-85 -111.41 112.63 24.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.848 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 4.4 p -75.2 114.7 14.02 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 172.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -92.97 114.11 26.57 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.43 -165.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 24.0 m -93.53 119.52 32.69 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.124 172.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 42.4 mt -96.84 112.97 30.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.158 0.504 . . . . 0.0 111.324 -173.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . 0.445 HD13 ' N ' ' C' ' 24' ' ' ILE . 4.2 mp -88.88 -34.76 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.294 177.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 19.4 pttt -132.76 128.76 37.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.097 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 16.2 m -56.25 148.4 18.54 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.806 -177.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 27' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -158.02 162.88 38.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.722 0.772 . . . . 0.0 112.867 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 28' ' ' HIS . . . . . 0.526 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 2.0 t60 -119.19 123.84 45.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.392 176.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . 0.539 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 51.5 mt -85.21 134.64 26.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 170.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 30' ' ' SER . . . . . 0.526 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 61.8 p -117.5 -15.03 10.29 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -171.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 31' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -171.36 152.1 17.14 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 119.517 -1.325 . . . . 0.0 113.27 177.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.42 ' CG2' ' HG ' ' C' ' 87' ' ' LEU . 11.2 p -136.68 131.54 47.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 174.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.91 155.98 42.18 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 122.017 -0.427 . . . . 0.0 111.187 -176.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.406 ' HB3' HG13 ' C' ' 85' ' ' VAL . 4.1 pp -118.09 141.39 48.53 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.889 0.852 . . . . 0.0 111.918 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -110.16 -54.16 2.6 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.216 -1.356 . . . . 0.0 108.776 176.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 36' ' ' LYS . . . . . 0.426 ' HZ2' ' HB3' ' C' ' 36' ' ' LYS . 6.9 ttpm? -100.89 128.19 47.03 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 171.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 37' ' ' GLY . . . . . 0.535 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 139.25 161.51 8.75 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 119.532 -1.318 . . . . 0.0 113.319 176.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -103.32 -43.77 5.34 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 178.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -149.49 132.31 16.04 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 120.504 0.192 . . . . 0.0 111.039 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.72 113.72 13.89 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.41 0.624 . . . . 0.0 110.141 169.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' C' ' 79' ' ' THR . 97.4 mttt -96.28 110.67 22.95 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 175.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.403 ' HG ' ' CG2' ' C' ' 53' ' ' VAL . 51.1 tp -87.14 109.77 19.67 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.982 -172.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 43' ' ' TYR . . . . . 0.423 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 96.7 m-85 -108.24 141.81 39.45 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.284 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.558 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 1.5 tp -123.56 112.75 17.82 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.532 176.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -99.16 108.78 21.48 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.143 0.497 . . . . 0.0 109.795 176.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.69 140.97 36.99 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.551 -177.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 53.19 41.97 32.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.575 0.703 . . . . 0.0 110.33 -177.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 39.2 mttp 69.95 21.38 6.25 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 114.843 -1.072 . . . . 0.0 112.39 172.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . 0.574 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 79.2 mm-40 -128.3 137.48 51.97 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.07 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -87.26 104.98 16.91 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 174.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 1.603 ' HE2' ' CE1' ' C' ' 51' ' ' TYR . 76.0 m-85 -99.98 120.26 39.54 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.698 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -77.31 99.92 2.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 170.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 53' ' ' VAL . . . . . 0.5 HG13 ' CD2' ' B' ' 88' ' ' LEU . 18.7 m -86.92 -34.66 7.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.85 -172.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 54' ' ' ALA . . . . . 0.522 ' HB1' ' CD2' ' C' ' 65' ' ' LEU . . . -151.06 140.92 21.91 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 120.343 -0.543 . . . . 0.0 112.092 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 21.4 m -111.5 101.34 9.77 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 169.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.26 113.69 43.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.757 0.789 . . . . 0.0 110.038 -176.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 77.2 p -123.22 -177.83 3.81 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.194 -175.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -64.05 -24.16 67.6 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.007 0.432 . . . . 0.0 110.52 169.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.4 -40.55 43.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.198 0.523 . . . . 0.0 110.125 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 79.5 mt -116.81 81.96 12.52 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 173.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.02 -5.09 12.69 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.218 2.612 . . . . 0.0 114.119 -167.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -160.49 128.61 4.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.185 0.517 . . . . 0.0 111.266 -175.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.4 HG12 ' HB3' ' C' ' 54' ' ' ALA . 88.0 t -118.54 108.21 23.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.43 175.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.7 121.4 30.08 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . 0.522 ' CD2' ' HB1' ' C' ' 54' ' ' ALA . 0.4 OUTLIER -143.65 168.88 18.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.17 0.51 . . . . 0.0 111.954 -174.554 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 66' ' ' ASP . . . . . 0.553 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 9.4 t0 -116.35 107.16 14.47 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.79 178.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . 0.539 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 32.8 mt -126.5 107.76 10.54 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -111.08 127.79 55.67 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.958 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 69' ' ' PHE . . . . . 1.669 ' HD2' ' CD1' ' C' ' 69' ' ' PHE . 11.0 m-85 -127.07 150.26 49.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.919 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 58.1 m -102.56 161.77 13.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.978 0.418 . . . . 0.0 110.733 176.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -69.23 -5.22 21.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.194 177.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.76 -7.66 62.75 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 173.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -100.3 143.51 30.4 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -122.99 125.65 45.66 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . 0.489 ' HB ' ' CD1' ' C' ' 44' ' ' LEU . 15.1 pt -132.05 172.18 16.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.663 -171.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 76' ' ' MET . . . . . . . . . . . . . 7.8 mtm -129.99 131.64 45.97 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 170.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 77' ' ' PHE . . . . . 1.648 ' HD1' ' CD2' ' C' ' 77' ' ' PHE . 0.9 OUTLIER -110.17 128.28 55.39 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.274 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 78' ' ' TYR . . . . . 1.661 ' HD2' ' CD1' ' C' ' 78' ' ' TYR . 41.0 p90 -153.61 140.42 19.09 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.291 -0.564 . . . . 0.0 112.116 -178.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 79' ' ' THR . . . . . 0.649 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 8.2 p -111.91 136.4 51.28 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.25 -177.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.59 161.05 14.45 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.29 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . 0.483 ' O ' ' HG3' ' C' ' 16' ' ' GLU . . . 81.96 177.24 51.71 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -173.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 82' ' ' ASP . . . . . 0.506 ' HA ' ' HB3' ' C' ' 15' ' ' PRO . 6.9 p-10 -112.94 104.21 12.18 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 118.304 -1.358 . . . . 0.0 110.873 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . 0.535 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -164.82 153.25 12.24 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.66 -1.609 . . . . 0.0 109.869 169.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 6.4 p -104.96 123.4 47.7 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.406 HG13 ' HB3' ' C' ' 34' ' ' LEU . 3.6 m -118.24 144.48 26.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.582 0.706 . . . . 0.0 112.765 -173.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 50.6 m -108.14 116.22 31.57 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.67 175.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . 0.606 HD12 ' SD ' ' C' ' 13' ' ' MET . 4.5 mp -96.04 143.15 27.44 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 170.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . 0.492 ' CD2' HG13 ' D' ' 53' ' ' VAL . 2.6 mm? -125.06 151.97 44.94 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 174.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.55 -167.9 30.75 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.443 177.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -139.06 131.47 28.54 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.432 0.634 . . . . 0.0 110.852 176.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 23.7 mt . . . . . 0 C--N 1.318 -0.764 0 CA-C-N 114.537 -1.21 . . . . 0.0 108.943 173.194 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 48.6 mtt . . . . . 0 C--O 1.223 -0.312 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' D' D ' 8' ' ' PHE . . . . . 1.665 ' HE1' ' CE2' ' D' ' 8' ' ' PHE . 70.7 t80 -69.35 146.37 52.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.217 0.532 . . . . 0.0 112.176 -175.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 9' ' ' TRP . . . . . 0.457 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 92.2 t90 -136.76 145.62 44.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.397 -0.819 . . . . 0.0 108.965 176.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.57 146.54 16.17 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.507 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . 0.457 ' HB2' ' CH2' ' D' ' 9' ' ' TRP . 44.0 tp -138.38 109.84 6.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.837 0.351 . . . . 0.0 110.595 177.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -97.29 105.04 17.12 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 13' ' ' MET . . . . . 0.604 ' SD ' HD12 ' D' ' 87' ' ' LEU . 44.5 mtp -98.42 143.94 28.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.965 0.412 . . . . 0.0 111.011 -174.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 14' ' ' LYS . . . . . 0.471 ' HB2' ' HG3' ' D' ' 17' ' ' ARG . 37.8 mtmm -101.04 157.74 33.09 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.257 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . 0.5 ' HB3' ' HA ' ' D' ' 82' ' ' ASP . 92.5 Cg_exo -47.81 115.36 1.42 Allowed 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.597 2.865 . . . . 0.0 113.686 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . 0.66 ' HA ' ' O ' ' D' ' 79' ' ' THR . 44.5 mt-10 59.88 58.38 2.79 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.333 0.587 . . . . 0.0 111.81 175.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 17' ' ' ARG . . . . . 0.471 ' HG3' ' HB2' ' D' ' 14' ' ' LYS . 29.0 mmt180 -118.72 153.12 34.91 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.899 174.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . 0.645 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 3.5 ttmp? -130.94 110.81 11.53 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.021 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 19' ' ' TYR . . . . . 0.417 ' HH ' ' HA ' ' D' ' 13' ' ' MET . 2.1 m-85 -111.32 112.55 24.4 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.942 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -75.08 114.66 13.83 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 171.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -92.96 114.12 26.59 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.386 -165.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 23.8 m -93.68 119.53 32.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.126 172.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 42.6 mt -96.82 112.96 29.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.112 0.482 . . . . 0.0 111.36 -173.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . 0.446 ' N ' HD13 ' D' ' 24' ' ' ILE . 4.2 mp -88.81 -34.8 7.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.354 177.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 19.4 pttt -132.67 128.81 37.83 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.077 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -56.21 148.36 18.49 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.757 -177.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 27' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -158.06 162.93 38.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.782 0.801 . . . . 0.0 112.842 -178.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 28' ' ' HIS . . . . . 0.535 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 2.0 t60 -119.2 123.83 45.29 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.401 176.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 29' ' ' ILE . . . . . 0.535 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 51.3 mt -85.29 134.65 26.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 170.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 30' ' ' SER . . . . . 0.549 ' HB2' ' HB3' ' E' ' 66' ' ' ASP . 61.2 p -117.53 -15.0 10.28 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -171.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 31' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -171.35 152.07 17.09 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 119.488 -1.339 . . . . 0.0 113.246 177.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . 0.422 ' CG2' ' HG ' ' D' ' 87' ' ' LEU . 11.4 p -136.62 131.49 47.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 174.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.86 156.01 42.24 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 122.057 -0.402 . . . . 0.0 111.185 -176.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 34' ' ' LEU . . . . . 0.409 ' HB3' ' CG1' ' D' ' 85' ' ' VAL . 4.1 pp -118.07 141.41 48.5 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.869 0.842 . . . . 0.0 111.905 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -110.18 -54.21 2.6 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.232 -1.349 . . . . 0.0 108.806 176.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 36' ' ' LYS . . . . . 0.431 ' HZ2' ' HB3' ' D' ' 36' ' ' LYS . 6.9 ttpm? -100.83 128.1 47.01 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.827 171.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . 0.533 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 139.27 161.54 8.77 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 119.64 -1.267 . . . . 0.0 113.378 176.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -103.34 -43.79 5.33 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 178.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -149.43 132.28 16.07 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 120.529 0.204 . . . . 0.0 111.048 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.76 113.74 13.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.405 0.621 . . . . 0.0 110.146 169.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' D' ' 79' ' ' THR . 97.3 mttt -96.21 110.54 22.82 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 175.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.402 ' HG ' ' CG2' ' D' ' 53' ' ' VAL . 50.9 tp -87.0 109.71 19.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.005 -172.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 43' ' ' TYR . . . . . 0.428 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 96.6 m-85 -108.23 141.88 39.32 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.303 178.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.559 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 1.5 tp -123.61 112.81 17.87 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.489 176.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 45' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -99.19 108.84 21.53 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.14 0.495 . . . . 0.0 109.806 176.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.67 140.96 37.02 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.51 -177.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 53.26 41.9 32.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.506 0.669 . . . . 0.0 110.273 -178.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 39.2 mttp 69.94 21.5 6.22 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.389 172.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . 0.576 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 79.2 mm-40 -128.41 137.48 51.88 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.055 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -87.35 105.02 16.97 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 174.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . 1.621 ' HE2' ' CE1' ' D' ' 51' ' ' TYR . 75.9 m-85 -99.93 120.29 39.56 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.657 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -77.31 99.92 2.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 170.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 53' ' ' VAL . . . . . 0.492 HG13 ' CD2' ' C' ' 88' ' ' LEU . 18.5 m -86.99 -34.62 7.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.818 -172.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 54' ' ' ALA . . . . . 0.516 ' HB1' ' CD2' ' D' ' 65' ' ' LEU . . . -151.11 140.86 21.81 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 120.361 -0.535 . . . . 0.0 112.085 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 21.9 m -111.57 101.3 9.71 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 169.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.18 113.65 43.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.724 0.774 . . . . 0.0 110.036 -176.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 76.9 p -123.2 -177.86 3.81 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.25 -175.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -64.03 -24.19 67.61 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.01 0.433 . . . . 0.0 110.535 169.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.33 -40.58 43.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.192 176.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 79.5 mt -116.81 81.9 12.44 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 173.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.95 -5.19 12.87 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.264 2.643 . . . . 0.0 114.052 -167.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -160.44 128.57 4.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.351 0.596 . . . . 0.0 111.268 -175.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 89.8 t -118.43 108.16 23.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.455 175.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.78 121.54 30.32 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 174.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 65' ' ' LEU . . . . . 0.516 ' CD2' ' HB1' ' D' ' 54' ' ' ALA . 0.4 OUTLIER -143.65 168.88 18.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.113 0.482 . . . . 0.0 111.93 -174.541 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 66' ' ' ASP . . . . . 0.513 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 9.2 t0 -116.35 107.13 14.43 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.806 178.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . 0.535 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 32.8 mt -126.43 107.69 10.51 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 177.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -111.08 127.78 55.67 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.939 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 69' ' ' PHE . . . . . 1.661 ' HD2' ' CD1' ' D' ' 69' ' ' PHE . 11.0 m-85 -127.12 150.28 49.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.902 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 58.1 m -102.57 161.83 13.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.025 0.441 . . . . 0.0 110.739 176.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -69.32 -5.26 22.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.16 177.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.71 -7.65 62.83 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 173.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -100.29 143.53 30.38 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -122.98 125.67 45.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . 0.482 ' HB ' ' CD1' ' D' ' 44' ' ' LEU . 14.9 pt -132.08 172.22 16.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.625 -171.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 76' ' ' MET . . . . . . . . . . . . . 7.9 mtm -130.09 131.67 45.83 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 170.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 77' ' ' PHE . . . . . 1.655 ' HE2' ' CE1' ' D' ' 77' ' ' PHE . 0.9 OUTLIER -110.18 128.23 55.37 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.37 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 78' ' ' TYR . . . . . 1.624 ' HE1' ' CE2' ' D' ' 78' ' ' TYR . 41.1 p90 -153.6 140.33 19.0 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.312 -0.555 . . . . 0.0 112.172 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 79' ' ' THR . . . . . 0.66 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 8.3 p -111.83 136.51 51.02 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.295 -177.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.66 161.06 14.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.244 174.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' D' ' 16' ' ' GLU . . . 81.97 177.23 51.71 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -173.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 82' ' ' ASP . . . . . 0.5 ' HA ' ' HB3' ' D' ' 15' ' ' PRO . 6.9 p-10 -112.9 104.15 12.14 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 118.263 -1.375 . . . . 0.0 110.928 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.533 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -164.8 153.32 12.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.75 -1.568 . . . . 0.0 109.858 169.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 6.6 p -104.94 123.41 47.7 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.686 -0.486 . . . . 0.0 109.686 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . 0.409 ' CG1' ' HB3' ' D' ' 34' ' ' LEU . 3.6 m -118.23 144.5 26.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.603 0.716 . . . . 0.0 112.729 -173.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 50.6 m -108.11 116.32 31.75 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.704 175.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 87' ' ' LEU . . . . . 0.604 HD12 ' SD ' ' D' ' 13' ' ' MET . 4.5 mp -96.05 143.05 27.54 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 170.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . 0.503 ' CD2' HG13 ' E' ' 53' ' ' VAL . 2.6 mm? -125.08 152.09 44.8 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 174.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.6 -167.91 30.8 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.365 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -139.13 131.49 28.45 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.496 0.665 . . . . 0.0 110.836 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 23.7 mt . . . . . 0 C--N 1.318 -0.766 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.904 173.179 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 48.5 mtt . . . . . 0 C--O 1.224 -0.257 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' E' E ' 8' ' ' PHE . . . . . 1.66 ' HE1' ' CE2' ' E' ' 8' ' ' PHE . 70.7 t80 -69.36 146.35 52.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.163 0.506 . . . . 0.0 112.169 -175.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 9' ' ' TRP . . . . . 0.449 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 92.2 t90 -136.79 145.53 44.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.997 176.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.41 146.63 16.39 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.61 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 11' ' ' LEU . . . . . 0.465 ' HB3' ' HB2' ' E' ' 87' ' ' LEU . 43.8 tp -138.54 109.94 6.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.943 0.402 . . . . 0.0 110.55 177.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -97.37 105.05 17.13 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 176.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 13' ' ' MET . . . . . 0.6 ' SD ' HD12 ' E' ' 87' ' ' LEU . 44.6 mtp -98.4 143.95 28.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.993 0.425 . . . . 0.0 110.98 -174.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 14' ' ' LYS . . . . . 0.471 ' HB2' ' HG3' ' E' ' 17' ' ' ARG . 37.8 mtmm -101.07 157.8 32.97 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.334 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . 0.494 ' HB3' ' HA ' ' E' ' 82' ' ' ASP . 91.5 Cg_exo -47.88 115.35 1.43 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.588 2.859 . . . . 0.0 113.703 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 16' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' E' ' 79' ' ' THR . 44.4 mt-10 59.99 58.35 2.76 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.712 0.633 . . . . 0.0 111.728 175.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 17' ' ' ARG . . . . . 0.471 ' HG3' ' HB2' ' E' ' 14' ' ' LYS . 29.1 mmt180 -118.73 153.1 34.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.942 174.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . 0.643 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 3.5 ttmp? -130.88 110.83 11.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.032 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . 0.428 ' HH ' ' HA ' ' E' ' 13' ' ' MET . 2.1 m-85 -111.38 112.55 24.38 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.895 179.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 4.5 p -75.13 114.67 13.9 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -92.93 114.06 26.52 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.353 -165.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 23.8 m -93.62 119.58 32.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.079 172.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 42.4 mt -96.85 112.96 30.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.131 0.491 . . . . 0.0 111.275 -173.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . 0.45 ' N ' HD13 ' E' ' 24' ' ' ILE . 4.2 mp -88.84 -34.79 7.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.329 177.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . 0.406 ' HD2' HD11 ' E' ' 91' ' ' LEU . 19.3 pttt -132.77 128.73 37.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.116 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -56.18 148.38 18.32 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.775 -177.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 27' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -157.99 162.94 38.21 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.691 0.757 . . . . 0.0 112.916 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 28' ' ' HIS . . . . . 0.532 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 2.0 t60 -119.16 123.9 45.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.341 -1.299 . . . . 0.0 109.427 176.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 29' ' ' ILE . . . . . 0.543 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 51.2 mt -85.32 134.65 26.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 170.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 30' ' ' SER . . . . . 0.54 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 61.9 p -117.44 -15.14 10.32 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -171.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 31' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -171.34 152.08 17.11 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 119.498 -1.335 . . . . 0.0 113.33 177.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . 0.423 ' CG2' ' HG ' ' E' ' 87' ' ' LEU . 11.3 p -136.63 131.54 47.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 174.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.93 155.96 42.16 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.068 -0.395 . . . . 0.0 111.174 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 34' ' ' LEU . . . . . 0.408 ' HB3' ' CG1' ' E' ' 85' ' ' VAL . 4.1 pp -117.98 141.37 48.52 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.886 0.85 . . . . 0.0 111.93 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -110.22 -54.16 2.6 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.177 -1.374 . . . . 0.0 108.801 176.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 36' ' ' LYS . . . . . 0.425 ' HZ2' ' HB3' ' E' ' 36' ' ' LYS . 6.9 ttpm? -100.85 128.12 47.02 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 171.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . 0.524 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 139.19 161.5 8.75 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 119.586 -1.293 . . . . 0.0 113.333 176.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -103.24 -43.82 5.35 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 178.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -149.52 132.36 16.05 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.572 0.225 . . . . 0.0 111.023 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.79 113.71 13.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.345 0.593 . . . . 0.0 110.152 169.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 41' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' E' ' 79' ' ' THR . 97.4 mttt -96.32 110.62 22.91 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.402 ' HG ' ' CG2' ' E' ' 53' ' ' VAL . 51.1 tp -87.02 109.76 19.61 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.018 -172.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 43' ' ' TYR . . . . . 0.427 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 96.8 m-85 -108.31 141.85 39.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.268 178.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 44' ' ' LEU . . . . . 0.557 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 1.5 tp -123.62 112.84 17.9 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.388 176.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 45' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -99.19 108.9 21.6 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.209 0.528 . . . . 0.0 109.78 176.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.69 140.98 36.98 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.504 -177.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 53.25 41.95 32.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.604 0.716 . . . . 0.0 110.271 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 39.1 mttp 69.84 21.54 6.33 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.399 172.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 49' ' ' GLN . . . . . 0.576 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 79.2 mm-40 -128.45 137.44 51.82 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 122.245 -0.285 . . . . 0.0 111.066 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -87.27 105.02 16.95 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 174.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . 1.606 ' HE2' ' CE1' ' E' ' 51' ' ' TYR . 75.9 m-85 -99.99 120.26 39.54 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.681 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -77.42 99.97 2.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 171.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . 0.503 HG13 ' CD2' ' D' ' 88' ' ' LEU . 18.3 m -87.06 -34.53 7.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.789 -172.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 54' ' ' ALA . . . . . 0.512 ' HB1' ' CD2' ' E' ' 65' ' ' LEU . . . -151.07 140.86 21.84 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 120.352 -0.539 . . . . 0.0 112.104 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 21.7 m -111.51 101.22 9.66 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 169.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.19 113.67 43.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.757 0.789 . . . . 0.0 110.062 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 77.8 p -123.15 -177.74 3.77 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.236 -175.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -64.17 -24.18 67.58 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.478 169.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.38 -40.58 43.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.25 0.548 . . . . 0.0 110.114 176.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 79.6 mt -116.88 81.95 12.67 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 173.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.99 -5.13 12.76 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.174 2.583 . . . . 0.0 114.088 -167.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -160.48 128.69 4.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.231 0.539 . . . . 0.0 111.238 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 89.2 t -118.5 108.19 23.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.456 175.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.69 121.44 30.13 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 174.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 65' ' ' LEU . . . . . 0.512 ' CD2' ' HB1' ' E' ' 54' ' ' ALA . 0.4 OUTLIER -143.66 168.84 18.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.207 0.527 . . . . 0.0 111.951 -174.47 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' E' E ' 66' ' ' ASP . . . . . 0.549 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 9.3 t0 -116.32 107.16 14.48 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.772 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 67' ' ' LEU . . . . . 0.543 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 33.1 mt -126.49 107.71 10.5 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 177.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -111.07 127.91 55.7 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.907 -178.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 69' ' ' PHE . . . . . 1.666 ' HE2' ' CE1' ' E' ' 69' ' ' PHE . 11.1 m-85 -127.15 150.39 49.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.87 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 58.0 m -102.63 161.75 13.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.043 0.449 . . . . 0.0 110.795 176.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -69.29 -5.09 20.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.219 177.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.86 -7.55 62.67 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 173.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -100.32 143.45 30.5 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 178.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -122.95 125.72 45.84 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 174.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 75' ' ' ILE . . . . . 0.481 ' HB ' ' CD1' ' E' ' 44' ' ' LEU . 15.1 pt -132.03 172.2 16.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.666 -171.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 76' ' ' MET . . . . . . . . . . . . . 7.9 mtm -130.12 131.66 45.8 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 170.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 77' ' ' PHE . . . . . 1.652 ' HE2' ' CE1' ' E' ' 77' ' ' PHE . 0.9 OUTLIER -110.21 128.36 55.45 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 177.292 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' E' E ' 78' ' ' TYR . . . . . 1.67 ' HE1' ' CE2' ' E' ' 78' ' ' TYR . 40.9 p90 -153.64 140.41 19.05 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.287 -0.565 . . . . 0.0 112.112 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 79' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 8.3 p -111.88 136.36 51.28 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.28 -177.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.55 161.03 14.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.258 174.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 81' ' ' GLY . . . . . 0.473 ' O ' ' HG3' ' E' ' 16' ' ' GLU . . . 81.99 177.2 51.7 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -173.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 82' ' ' ASP . . . . . 0.494 ' HA ' ' HB3' ' E' ' 15' ' ' PRO . 6.9 p-10 -112.88 104.21 12.2 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 118.276 -1.37 . . . . 0.0 110.903 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 83' ' ' ALA . . . . . 0.524 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -164.84 153.22 12.17 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 113.708 -1.587 . . . . 0.0 109.836 169.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 6.6 p -104.93 123.48 47.83 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 85' ' ' VAL . . . . . 0.408 ' CG1' ' HB3' ' E' ' 34' ' ' LEU . 3.6 m -118.2 144.43 26.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -173.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 50.8 m -108.05 116.25 31.61 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.701 175.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 87' ' ' LEU . . . . . 0.6 HD12 ' SD ' ' E' ' 13' ' ' MET . 4.5 mp -96.1 143.12 27.51 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 170.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . 0.493 ' CD2' HG13 ' A' ' 53' ' ' VAL . 2.6 mm? -125.03 152.07 44.74 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 174.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.6 -167.86 30.73 Favored Glycine 0 N--CA 1.435 -1.377 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.409 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 90' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -139.19 131.46 28.32 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.565 0.698 . . . . 0.0 110.803 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 91' ' ' LEU . . . . . 0.406 HD11 ' HD2' ' E' ' 25' ' ' LYS . 23.7 mt . . . . . 0 C--N 1.32 -0.717 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.903 173.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.55 ' HA ' ' OG ' ' B' ' 70' ' ' SER . 45.5 mtt . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 121.559 0.695 . . . . 0.0 112.621 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.42 ' CE1' HD23 ' B' ' 44' ' ' LEU . 55.8 t80 -59.71 142.71 52.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.262 -176.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.529 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 88.5 t90 -134.14 142.05 47.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.735 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.91 140.05 8.38 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.143 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.538 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 56.6 tp -128.36 108.29 10.45 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.974 0.416 . . . . 0.0 110.048 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -86.46 101.38 13.1 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 175.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.484 ' HB3' HG22 ' A' ' 85' ' ' VAL . 27.3 tpp -91.95 129.27 37.95 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.39 -171.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.481 ' HD2' ' N ' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -95.54 140.74 22.48 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.799 179.405 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.526 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 9.5 Cg_endo -53.63 121.73 10.04 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.624 2.882 . . . . 0.0 113.474 -175.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.654 ' HA ' ' O ' ' A' ' 79' ' ' THR . 31.3 mt-10 61.53 47.0 6.9 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.911 177.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.494 ' HA ' ' NE ' ' A' ' 17' ' ' ARG . 1.2 tpm_? -122.33 137.39 54.87 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 173.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.614 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 88.4 mttt -108.81 121.47 45.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.685 0.279 . . . . 0.0 111.684 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 1.654 ' HE2' ' CE1' ' A' ' 19' ' ' TYR . 3.8 m-85 -111.06 103.57 12.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.303 176.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 76' ' ' MET . 45.7 t -90.47 99.42 12.45 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 172.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -120.12 148.12 44.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.146 -168.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.5 m -93.44 141.27 28.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.49 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -89.89 117.01 32.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 120.92 0.39 . . . . 0.0 111.243 -173.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.498 HD13 ' N ' ' A' ' 25' ' ' LYS . 1.4 pp -79.63 -27.57 12.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.735 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.498 ' N ' HD13 ' A' ' 24' ' ' ILE . 31.7 ttpt -155.28 136.17 13.66 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -178.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 39.2 m -58.32 130.03 44.82 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.659 0.599 . . . . 0.0 110.091 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.442 ' CB ' ' HA ' ' A' ' 91' ' ' LEU . 10.1 p90 -144.26 161.92 37.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.611 0.719 . . . . 0.0 112.886 -172.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.579 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 15.7 t60 -114.82 123.87 50.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.187 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 37.6 mt -92.6 136.28 25.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 170.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.571 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 64.8 p -123.08 -20.19 5.82 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -170.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -154.85 146.3 14.17 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 119.324 -1.417 . . . . 0.0 113.336 178.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.445 ' CG2' ' HG ' ' A' ' 87' ' ' LEU . 14.3 p -140.01 126.81 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 170.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.81 158.11 43.92 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.903 -0.498 . . . . 0.0 111.576 -174.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.454 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 4.0 pp -118.9 139.21 52.01 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.587 0.708 . . . . 0.0 111.456 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -108.13 -51.33 2.91 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.298 173.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -102.52 128.12 49.3 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 170.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.484 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 145.08 162.39 9.55 Favored Glycine 0 N--CA 1.437 -1.263 0 C-N-CA 119.949 -1.12 . . . . 0.0 113.098 176.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -102.7 -46.81 4.61 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 111.487 0.18 . . . . 0.0 111.487 177.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -150.68 130.88 13.57 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.73 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.83 113.0 13.53 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.585 0.707 . . . . 0.0 110.186 169.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 79' ' ' THR . 4.5 mptp? -95.34 106.38 18.43 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 174.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.416 ' O ' HG22 ' A' ' 53' ' ' VAL . 41.6 tp -78.8 114.01 17.37 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -176.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 1.61 ' HD1' ' CD2' ' A' ' 43' ' ' TYR . 77.4 m-85 -114.82 135.88 53.7 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.283 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.499 ' HB3' HG21 ' A' ' 53' ' ' VAL . 5.0 tp -115.77 116.15 27.54 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.498 176.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -103.38 103.73 13.76 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 176.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.53 140.85 50.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.105 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 58.0 32.44 21.97 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.71 0.767 . . . . 0.0 109.445 -175.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 57.44 37.11 27.72 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.466 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 6.6 tp-100 -127.75 131.77 49.63 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 176.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.406 ' HG3' ' HH ' ' A' ' 78' ' ' TYR . 32.7 tt0 -87.35 112.27 21.93 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.427 -177.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 1.639 ' HD2' ' CD1' ' A' ' 51' ' ' TYR . 78.1 m-85 -108.4 131.37 54.84 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.793 177.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -78.78 100.42 3.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 169.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.499 HG21 ' HB3' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -72.4 -51.49 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.877 -174.151 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.507 ' HA ' ' OE1' ' E' ' 62' ' ' GLN . . . -154.57 132.47 11.57 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.516 -177.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.3 t -101.95 102.46 13.01 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 174.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.67 109.7 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-O 122.128 0.966 . . . . 0.0 110.047 -176.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 66.9 p -122.55 -176.95 3.5 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.378 -176.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -65.07 -20.61 66.57 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 119.976 -0.689 . . . . 0.0 110.574 169.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.95 -40.68 27.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.246 0.546 . . . . 0.0 110.047 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.4 mt -118.68 77.65 14.7 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 172.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.446 ' HA ' ' O ' ' A' ' 57' ' ' THR . 9.8 Cg_exo -71.73 0.84 6.43 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.11 2.54 . . . . 0.0 113.636 -168.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.49 ' OE1' ' HA ' ' B' ' 54' ' ' ALA . 10.3 tt0 -160.06 114.7 2.28 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.237 -170.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' A' ' 54' ' ' ALA . 86.5 t -112.8 115.16 49.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.061 0.458 . . . . 0.0 111.247 177.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.04 116.0 28.38 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 171.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.64 168.3 19.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.817 0.341 . . . . 0.0 111.036 -171.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.534 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 7.4 t0 -122.91 109.43 14.14 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.139 0.495 . . . . 0.0 110.36 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.579 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 12.8 mt -124.05 138.84 54.39 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.683 177.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -138.43 114.61 10.22 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 173.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 1.668 ' HD2' ' CD1' ' A' ' 69' ' ' PHE . 66.2 m-85 -109.17 163.07 13.68 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.385 -178.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.533 ' OG ' ' HA ' ' E' ' 7' ' ' MET . 4.5 m -117.22 149.03 41.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.154 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.482 ' HZ3' ' HB2' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -70.04 -5.9 29.86 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.736 -177.103 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.87 -28.54 45.84 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.319 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -101.3 171.25 7.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.702 0.287 . . . . 0.0 110.43 -176.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -137.3 136.5 38.06 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.454 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 22.6 pt -133.07 158.4 43.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.081 0.467 . . . . 0.0 111.571 -169.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.411 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 65.3 ttp -117.52 118.09 31.21 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.342 176.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 1.62 ' HE1' ' CE2' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -105.53 129.37 53.82 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.806 -177.773 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 1.65 ' HD2' ' CD1' ' A' ' 78' ' ' TYR . 39.0 p90 -155.74 162.79 40.47 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.847 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.654 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 12.6 p -125.21 143.86 50.74 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.108 178.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.3 149.48 26.87 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.231 173.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.0 -176.92 36.47 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -176.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -114.48 102.64 10.27 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.238 178.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.526 ' H ' ' HB3' ' A' ' 15' ' ' PRO . . . -166.74 150.05 6.85 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.479 168.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.2 p -106.04 122.11 45.5 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.484 HG22 ' HB3' ' A' ' 13' ' ' MET . 13.5 m -121.54 144.23 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-O 121.241 0.543 . . . . 0.0 111.801 -172.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 43.3 m -105.21 122.85 46.77 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.276 175.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.538 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 5.1 mp -95.22 143.93 26.23 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 170.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.465 ' CD2' HG12 ' B' ' 53' ' ' VAL . 0.9 OUTLIER -130.39 141.23 50.56 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.152 -178.718 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.66 -166.89 27.5 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.953 -0.642 . . . . 0.0 111.795 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -147.06 133.49 19.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.474 0.654 . . . . 0.0 111.161 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.485 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 15.1 mt . . . . . 0 C--N 1.322 -0.623 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.106 175.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' MET . . . . . 0.567 ' HA ' ' OG ' ' C' ' 70' ' ' SER . 45.5 mtt . . . . . 0 CA--C 1.518 -0.282 0 CA-C-O 121.533 0.682 . . . . 0.0 112.727 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . 0.428 ' CE1' HD23 ' C' ' 44' ' ' LEU . 55.5 t80 -59.76 142.74 52.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.247 -176.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . 0.525 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 88.6 t90 -134.14 142.01 47.32 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.75 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.87 140.06 8.39 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.253 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.525 ' HB2' ' CH2' ' B' ' 9' ' ' TRP . 56.8 tp -128.36 108.35 10.5 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.972 0.415 . . . . 0.0 110.079 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -86.46 101.29 13.03 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 175.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' MET . . . . . 0.479 ' HB3' HG22 ' B' ' 85' ' ' VAL . 27.4 tpp -91.95 129.37 37.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.349 -171.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.482 ' N ' ' HD2' ' B' ' 14' ' ' LYS . 0.3 OUTLIER -95.69 140.83 22.5 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.757 179.362 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.532 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 9.4 Cg_endo -53.62 121.71 10.0 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 123.656 2.904 . . . . 0.0 113.425 -175.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.653 ' HA ' ' O ' ' B' ' 79' ' ' THR . 31.2 mt-10 61.58 47.04 6.8 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.835 177.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.491 ' NE ' ' HA ' ' B' ' 17' ' ' ARG . 1.1 tpm_? -122.36 137.3 54.9 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 173.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . 0.61 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 88.5 mttt -108.84 121.57 45.37 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' TYR . . . . . 1.662 ' HD2' ' CD1' ' B' ' 19' ' ' TYR . 3.8 m-85 -111.2 103.56 11.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.233 176.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 45.0 t -90.4 99.47 12.48 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -120.2 148.17 44.01 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.55 0.69 . . . . 0.0 112.152 -168.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 19.7 m -93.49 141.27 28.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.436 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -89.93 117.07 32.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.085 0.469 . . . . 0.0 111.214 -173.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.494 HD13 ' N ' ' B' ' 25' ' ' LYS . 1.4 pp -79.63 -27.58 12.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.709 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.494 ' N ' HD13 ' B' ' 24' ' ' ILE . 31.7 ttpt -155.3 136.1 13.59 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 38.9 m -58.23 130.03 44.75 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.725 0.641 . . . . 0.0 110.096 -178.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . 0.44 ' CB ' ' HA ' ' B' ' 91' ' ' LEU . 10.0 p90 -144.25 161.86 37.83 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -172.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' HIS . . . . . 0.573 ' HA ' ' O ' ' B' ' 67' ' ' LEU . 16.1 t60 -114.74 123.9 50.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.194 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.527 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 37.8 mt -92.66 136.17 25.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 170.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.572 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 65.1 p -122.91 -20.28 5.87 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -170.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.509 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -154.82 146.19 13.97 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 119.508 -1.329 . . . . 0.0 113.416 179.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.44 ' CG2' ' HG ' ' B' ' 87' ' ' LEU . 14.4 p -139.99 126.71 23.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 170.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.79 158.15 43.95 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.925 -0.484 . . . . 0.0 111.669 -174.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.464 ' HB3' HG13 ' B' ' 85' ' ' VAL . 4.0 pp -118.91 139.26 51.93 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.719 0.771 . . . . 0.0 111.356 178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -108.21 -51.29 2.92 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.355 173.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -102.46 128.15 49.19 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 170.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.483 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 145.01 162.43 9.56 Favored Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 119.906 -1.14 . . . . 0.0 113.01 176.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -102.73 -46.67 4.65 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 177.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -150.77 130.81 13.43 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.754 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.78 113.06 13.64 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.55 0.691 . . . . 0.0 110.165 169.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' B' ' 79' ' ' THR . 4.5 mptp? -95.42 106.33 18.38 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 174.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.414 ' O ' HG22 ' B' ' 53' ' ' VAL . 41.4 tp -78.67 113.92 17.14 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -176.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' TYR . . . . . 1.602 ' HD1' ' CD2' ' B' ' 43' ' ' TYR . 77.7 m-85 -114.78 135.89 53.68 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.247 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.485 ' HB3' HG21 ' B' ' 53' ' ' VAL . 4.9 tp -115.85 116.18 27.55 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.509 176.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -103.31 103.71 13.75 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 176.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . 0.405 ' HB3' HD12 ' B' ' 44' ' ' LEU . . . -130.61 140.79 50.43 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.125 -178.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 58.19 32.29 21.85 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.543 0.687 . . . . 0.0 109.34 -175.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 62.4 mttp 57.54 37.0 27.49 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.508 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . 0.497 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 6.6 tp-100 -127.67 131.8 49.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.588 176.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -87.47 112.32 22.07 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.828 0.346 . . . . 0.0 110.389 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 1.627 ' HE2' ' CE1' ' B' ' 51' ' ' TYR . 78.3 m-85 -108.48 131.37 54.87 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.763 177.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -78.82 100.41 3.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 169.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.485 HG21 ' HB3' ' B' ' 44' ' ' LEU . 0.9 OUTLIER -72.3 -51.53 29.11 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.011 -174.205 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.49 ' HA ' ' OE1' ' A' ' 62' ' ' GLN . . . -154.48 132.53 11.69 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.547 -177.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 7.5 t -101.97 102.43 12.96 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 174.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.63 109.79 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-O 122.062 0.934 . . . . 0.0 109.964 -176.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' B' ' 61' ' ' PRO . 67.1 p -122.63 -176.94 3.51 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.352 -176.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -65.06 -20.63 66.57 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.551 169.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.86 -40.82 27.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.267 0.556 . . . . 0.0 110.02 176.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 74.2 mt -118.7 77.6 14.73 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 172.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' B' ' 57' ' ' THR . 9.7 Cg_exo -71.71 0.88 6.35 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.083 2.522 . . . . 0.0 113.721 -168.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . 0.502 ' OE1' ' HA ' ' C' ' 54' ' ' ALA . 10.3 tt0 -160.12 114.72 2.27 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.256 -170.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.437 HG12 ' HB2' ' B' ' 54' ' ' ALA . 86.0 t -112.75 115.17 49.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.108 0.48 . . . . 0.0 111.259 177.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.05 115.92 28.29 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 171.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.56 168.26 19.29 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.06 -171.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . 0.528 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 7.4 t0 -122.89 109.46 14.18 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.111 0.481 . . . . 0.0 110.365 -179.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.573 ' O ' ' HA ' ' B' ' 28' ' ' HIS . 12.7 mt -124.02 138.91 54.39 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.67 177.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -138.64 114.65 10.12 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 173.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . 1.663 ' HD2' ' CD1' ' B' ' 69' ' ' PHE . 66.2 m-85 -109.23 162.99 13.77 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.395 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 70' ' ' SER . . . . . 0.55 ' OG ' ' HA ' ' A' ' 7' ' ' MET . 4.4 m -117.12 149.01 41.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.22 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . 0.481 ' HB2' ' HZ3' ' B' ' 71' ' ' LYS . 0.0 OUTLIER -69.95 -6.15 31.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.71 -177.13 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.81 -28.38 46.7 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.365 177.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -101.24 171.32 7.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.764 0.316 . . . . 0.0 110.44 -176.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -137.37 136.47 37.93 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.444 ' HB ' ' CD1' ' B' ' 44' ' ' LEU . 22.3 pt -133.03 158.39 43.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.912 0.387 . . . . 0.0 111.668 -169.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 76' ' ' MET . . . . . 0.415 ' HA ' ' HA ' ' B' ' 20' ' ' SER . 65.3 ttp -117.47 118.21 31.56 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.056 0.455 . . . . 0.0 110.319 176.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . 1.661 ' HD2' ' CD1' ' B' ' 77' ' ' PHE . 0.4 OUTLIER -105.63 129.39 53.88 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.788 -177.807 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 1.667 ' HD1' ' CD2' ' B' ' 78' ' ' TYR . 39.0 p90 -155.79 162.72 40.44 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.871 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.653 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 12.5 p -125.26 143.89 50.73 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.094 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.45 149.61 26.88 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.088 173.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.87 -176.95 36.69 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -176.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -114.38 102.67 10.31 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 117.988 0.894 . . . . 0.0 110.289 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.532 ' H ' ' HB3' ' B' ' 15' ' ' PRO . . . -166.72 150.04 6.88 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.465 168.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 6.1 p -106.05 122.17 45.62 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.479 HG22 ' HB3' ' B' ' 13' ' ' MET . 13.4 m -121.59 144.26 31.33 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 121.241 0.544 . . . . 0.0 111.771 -172.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 44.0 m -105.25 122.88 46.86 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.24 175.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.522 ' HB2' ' HB3' ' B' ' 11' ' ' LEU . 5.1 mp -95.16 143.95 26.17 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.467 ' CD2' HG12 ' C' ' 53' ' ' VAL . 0.9 OUTLIER -130.44 141.23 50.53 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.17 -178.712 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.68 -166.93 27.59 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.752 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -147.0 133.54 19.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.428 0.633 . . . . 0.0 111.029 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . 0.476 ' HB3' ' HE3' ' B' ' 25' ' ' LYS . 15.1 mt . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.083 175.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 7' ' ' MET . . . . . 0.572 ' HA ' ' OG ' ' D' ' 70' ' ' SER . 45.3 mtt . . . . . 0 N--CA 1.454 -0.239 0 CA-C-O 121.522 0.677 . . . . 0.0 112.657 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 8' ' ' PHE . . . . . 0.411 ' CE1' HD23 ' D' ' 44' ' ' LEU . 55.5 t80 -59.78 142.66 52.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.401 -1.272 . . . . 0.0 112.203 -176.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . 0.519 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 88.4 t90 -134.08 142.08 47.41 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.766 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.84 140.07 8.41 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.148 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.536 ' HB3' ' HB2' ' C' ' 87' ' ' LEU . 56.3 tp -128.33 108.24 10.42 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.893 0.378 . . . . 0.0 110.153 178.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -86.27 101.25 12.89 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 175.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 13' ' ' MET . . . . . 0.489 ' HB3' HG22 ' C' ' 85' ' ' VAL . 27.2 tpp -91.99 129.42 37.95 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.362 -171.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . 0.476 ' HD2' ' N ' ' C' ' 14' ' ' LYS . 0.3 OUTLIER -95.68 140.74 22.46 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.833 179.385 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . 0.536 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 9.5 Cg_endo -53.59 121.73 10.03 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.606 2.871 . . . . 0.0 113.51 -175.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' C' ' 79' ' ' THR . 31.5 mt-10 61.56 47.04 6.84 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.838 177.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 17' ' ' ARG . . . . . 0.493 ' NE ' ' HA ' ' C' ' 17' ' ' ARG . 1.2 tpm_? -122.33 137.33 54.89 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 173.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 18' ' ' LYS . . . . . 0.613 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 88.4 mttt -108.85 121.51 45.24 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . 1.669 ' HD1' ' CD2' ' C' ' 19' ' ' TYR . 3.7 m-85 -111.07 103.71 12.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.252 176.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 20' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 45.2 t -90.59 99.52 12.53 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 172.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -120.23 148.14 44.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.125 -168.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 19.5 m -93.42 141.2 28.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.538 176.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 67.7 mt -89.84 117.06 32.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.974 0.416 . . . . 0.0 111.295 -173.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . 0.49 HD13 ' N ' ' C' ' 25' ' ' LYS . 1.4 pp -79.68 -27.5 12.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.703 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . 0.49 ' N ' HD13 ' C' ' 24' ' ' ILE . 31.7 ttpt -155.41 136.18 13.54 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 39.4 m -58.33 130.08 45.05 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.715 0.634 . . . . 0.0 110.085 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 27' ' ' PHE . . . . . 0.434 ' CB ' ' HA ' ' C' ' 91' ' ' LEU . 9.9 p90 -144.27 161.89 37.79 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.654 0.74 . . . . 0.0 112.905 -172.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 28' ' ' HIS . . . . . 0.586 ' HA ' ' O ' ' C' ' 67' ' ' LEU . 15.9 t60 -114.75 123.9 50.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.203 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 38.0 mt -92.66 136.21 25.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 170.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 30' ' ' SER . . . . . 0.563 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 65.2 p -122.98 -20.25 5.84 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -170.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 31' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -154.74 146.21 14.04 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.403 -1.379 . . . . 0.0 113.395 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.445 ' CG2' ' HG ' ' C' ' 87' ' ' LEU . 14.4 p -140.08 126.73 22.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 170.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.73 158.21 43.99 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.617 -174.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.459 ' HB3' HG13 ' C' ' 85' ' ' VAL . 4.0 pp -118.99 139.21 52.07 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.739 0.781 . . . . 0.0 111.339 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -108.14 -51.28 2.92 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.572 -1.194 . . . . 0.0 108.382 173.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -102.42 128.03 49.2 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 170.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 37' ' ' GLY . . . . . 0.48 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 145.09 162.42 9.56 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.056 176.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -102.7 -46.73 4.63 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 177.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -150.73 130.81 13.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.809 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.81 113.02 13.56 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.53 0.681 . . . . 0.0 110.172 169.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' C' ' 79' ' ' THR . 4.5 mptp? -95.36 106.33 18.37 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 174.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.419 ' O ' HG22 ' C' ' 53' ' ' VAL . 41.7 tp -78.69 113.97 17.21 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -176.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 43' ' ' TYR . . . . . 1.628 ' HD1' ' CD2' ' C' ' 43' ' ' TYR . 77.4 m-85 -114.86 135.88 53.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.244 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.504 ' HB3' HG21 ' C' ' 53' ' ' VAL . 4.9 tp -115.73 116.05 27.4 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.56 176.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -103.27 103.76 13.82 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 176.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . 0.405 ' HB3' HD12 ' C' ' 44' ' ' LEU . . . -130.58 140.85 50.45 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.108 -178.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 58.05 32.4 21.93 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.611 0.719 . . . . 0.0 109.416 -175.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 62.4 mttp 57.38 37.11 27.84 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.523 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . 0.491 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 6.6 tp-100 -127.73 131.72 49.67 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.558 176.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . 0.406 ' HG3' ' HH ' ' C' ' 78' ' ' TYR . 32.7 tt0 -87.39 112.31 22.0 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.791 0.329 . . . . 0.0 110.401 -177.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 1.639 ' HD1' ' CD2' ' C' ' 51' ' ' TYR . 78.1 m-85 -108.39 131.3 54.9 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.775 177.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -78.76 100.47 3.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 169.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 53' ' ' VAL . . . . . 0.504 HG21 ' HB3' ' C' ' 44' ' ' LEU . 0.9 OUTLIER -72.45 -51.46 28.85 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.955 -174.211 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 54' ' ' ALA . . . . . 0.502 ' HA ' ' OE1' ' B' ' 62' ' ' GLN . . . -154.5 132.5 11.65 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.597 -177.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 7.4 t -102.0 102.46 12.98 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 174.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.61 109.74 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-O 122.005 0.907 . . . . 0.0 110.057 -176.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 57' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' C' ' 61' ' ' PRO . 66.9 p -122.62 -177.09 3.54 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.379 -176.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -64.95 -20.73 66.62 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.578 169.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.76 -40.82 27.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.247 0.546 . . . . 0.0 110.084 176.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 74.0 mt -118.7 77.64 14.77 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 172.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 61' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' C' ' 57' ' ' THR . 9.7 Cg_exo -71.74 0.86 6.39 Favored 'Trans proline' 0 N--CA 1.473 0.308 0 C-N-CA 123.099 2.532 . . . . 0.0 113.618 -168.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . 0.578 ' OE1' ' HA ' ' D' ' 54' ' ' ALA . 10.3 tt0 -160.13 114.73 2.27 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.733 0.301 . . . . 0.0 111.307 -170.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.444 HG12 ' HB2' ' C' ' 54' ' ' ALA . 85.9 t -112.79 115.16 49.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.13 0.49 . . . . 0.0 111.264 177.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.0 115.97 28.36 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 171.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.53 168.35 19.12 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.138 -171.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 66' ' ' ASP . . . . . 0.478 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 7.4 t0 -122.95 109.37 14.05 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.077 0.465 . . . . 0.0 110.278 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . 0.586 ' O ' ' HA ' ' C' ' 28' ' ' HIS . 12.8 mt -124.03 138.79 54.4 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.696 176.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -138.45 114.57 10.17 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 172.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 69' ' ' PHE . . . . . 1.635 ' HE2' ' CE1' ' C' ' 69' ' ' PHE . 66.4 m-85 -109.12 163.0 13.72 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.348 -178.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 70' ' ' SER . . . . . 0.567 ' OG ' ' HA ' ' B' ' 7' ' ' MET . 4.5 m -117.16 149.03 41.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.161 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . 0.486 ' HB2' ' HZ3' ' C' ' 71' ' ' LYS . 0.0 OUTLIER -69.97 -6.04 30.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.737 -177.186 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.88 -28.44 46.16 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.269 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -101.2 171.32 7.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.603 0.239 . . . . 0.0 110.491 -176.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -137.35 136.54 38.02 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . 0.447 ' HB ' ' CD1' ' C' ' 44' ' ' LEU . 22.6 pt -133.06 158.39 43.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.022 0.439 . . . . 0.0 111.647 -169.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 76' ' ' MET . . . . . 0.408 ' HA ' ' HA ' ' C' ' 20' ' ' SER . 65.4 ttp -117.46 118.08 31.22 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.279 176.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 77' ' ' PHE . . . . . 1.668 ' HD2' ' CD1' ' C' ' 77' ' ' PHE . 0.4 OUTLIER -105.62 129.34 53.88 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.791 -177.833 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 78' ' ' TYR . . . . . 1.664 ' HE2' ' CE1' ' C' ' 78' ' ' TYR . 38.9 p90 -155.73 162.72 40.48 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.839 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 79' ' ' THR . . . . . 0.655 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 12.6 p -125.12 143.88 50.71 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.143 178.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.43 149.63 26.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.072 173.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.88 -176.87 36.6 Favored Glycine 0 CA--C 1.508 -0.346 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -176.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -114.5 102.63 10.25 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.24 178.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . 0.536 ' H ' ' HB3' ' C' ' 15' ' ' PRO . . . -166.69 150.06 6.93 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.508 167.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 6.3 p -106.01 122.2 45.67 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.489 HG22 ' HB3' ' C' ' 13' ' ' MET . 13.5 m -121.62 144.2 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-O 121.223 0.535 . . . . 0.0 111.769 -172.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 43.6 m -105.23 122.87 46.82 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.28 175.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . 0.536 ' HB2' ' HB3' ' C' ' 11' ' ' LEU . 5.1 mp -95.15 144.03 26.11 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 170.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . 0.471 HD21 HD23 ' D' ' 67' ' ' LEU . 0.9 OUTLIER -130.5 141.21 50.5 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.161 -178.685 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.67 -166.93 27.57 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.744 -177.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -146.95 133.57 19.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.384 0.612 . . . . 0.0 111.095 177.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . 0.477 ' HB3' ' HE3' ' C' ' 25' ' ' LYS . 15.1 mt . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.07 175.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 7' ' ' MET . . . . . 0.558 ' HA ' ' OG ' ' E' ' 70' ' ' SER . 45.2 mtt . . . . . 0 CA--C 1.518 -0.26 0 CA-C-O 121.566 0.698 . . . . 0.0 112.674 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 8' ' ' PHE . . . . . 0.437 ' CE1' HD23 ' E' ' 44' ' ' LEU . 55.8 t80 -59.64 142.74 52.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.341 -1.299 . . . . 0.0 112.24 -176.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 9' ' ' TRP . . . . . 0.523 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 88.4 t90 -134.27 142.08 47.19 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.9 140.08 8.4 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.188 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . 0.534 ' HB3' ' HB2' ' D' ' 87' ' ' LEU . 56.8 tp -128.3 108.23 10.42 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.899 0.381 . . . . 0.0 110.077 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -86.49 101.41 13.15 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 13' ' ' MET . . . . . 0.483 ' HB3' HG22 ' D' ' 85' ' ' VAL . 27.4 tpp -92.0 129.36 37.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.377 -171.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 14' ' ' LYS . . . . . 0.473 ' HD2' ' N ' ' D' ' 14' ' ' LYS . 0.3 OUTLIER -95.69 140.69 22.44 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.806 179.418 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . 0.54 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 9.5 Cg_endo -53.57 121.81 10.17 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 123.609 2.873 . . . . 0.0 113.411 -175.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' D' ' 79' ' ' THR . 31.4 mt-10 61.44 47.01 7.06 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.956 177.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 17' ' ' ARG . . . . . 0.493 ' HA ' ' NE ' ' D' ' 17' ' ' ARG . 1.1 tpm_? -122.29 137.28 54.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.056 173.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . 0.618 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 88.4 mttt -108.77 121.48 45.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.723 0.297 . . . . 0.0 111.695 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 19' ' ' TYR . . . . . 1.654 ' HD2' ' CD1' ' D' ' 19' ' ' TYR . 3.7 m-85 -111.14 103.65 12.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.283 176.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 20' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 44.9 t -90.48 99.49 12.51 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 172.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -120.25 148.21 43.99 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.105 -168.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 19.3 m -93.48 141.24 28.69 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.478 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -89.93 117.04 32.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.082 0.468 . . . . 0.0 111.227 -173.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . 0.493 HD13 ' N ' ' D' ' 25' ' ' LYS . 1.4 pp -79.55 -27.61 12.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.782 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . 0.494 ' HE3' ' HB3' ' D' ' 91' ' ' LEU . 31.7 ttpt -155.31 136.18 13.64 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 39.3 m -58.31 130.06 44.93 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.68 0.613 . . . . 0.0 110.134 -178.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 27' ' ' PHE . . . . . 0.433 ' CB ' ' HA ' ' D' ' 91' ' ' LEU . 9.9 p90 -144.28 161.86 37.86 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -172.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 28' ' ' HIS . . . . . 0.577 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 16.0 t60 -114.74 123.92 50.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.173 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 29' ' ' ILE . . . . . 0.535 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 37.7 mt -92.7 136.18 25.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 170.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 30' ' ' SER . . . . . 0.577 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 65.9 p -122.96 -20.23 5.86 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -170.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 31' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -154.78 146.22 14.04 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 119.425 -1.369 . . . . 0.0 113.409 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . 0.435 ' CG2' ' HG ' ' D' ' 87' ' ' LEU . 14.2 p -139.95 126.8 23.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 170.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.87 158.14 43.94 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.8 -0.562 . . . . 0.0 111.654 -174.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 34' ' ' LEU . . . . . 0.449 ' HB3' ' CG1' ' D' ' 85' ' ' VAL . 4.0 pp -118.89 139.24 51.96 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.682 0.753 . . . . 0.0 111.431 178.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -108.21 -51.25 2.92 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.333 173.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -102.36 128.02 49.12 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 170.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . 0.478 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 145.1 162.41 9.56 Favored Glycine 0 N--CA 1.438 -1.167 0 C-N-CA 119.867 -1.159 . . . . 0.0 113.065 176.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -102.73 -46.66 4.65 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.609 0.242 . . . . 0.0 111.581 177.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -150.72 130.82 13.49 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.769 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . 0.404 ' HB1' HG11 ' D' ' 56' ' ' VAL . . . -130.79 113.0 13.56 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.492 0.663 . . . . 0.0 110.2 169.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' D' ' 79' ' ' THR . 4.5 mptp? -95.37 106.38 18.43 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 174.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.413 ' O ' HG22 ' D' ' 53' ' ' VAL . 41.9 tp -78.88 113.96 17.41 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -176.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 43' ' ' TYR . . . . . 1.644 ' HD1' ' CD2' ' D' ' 43' ' ' TYR . 77.4 m-85 -114.79 135.95 53.62 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.336 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.503 ' HB3' HG21 ' D' ' 53' ' ' VAL . 4.9 tp -115.82 116.07 27.37 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.444 176.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 45' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -103.28 103.68 13.73 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . 0.402 ' HB3' HD12 ' D' ' 44' ' ' LEU . . . -130.55 140.83 50.47 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.052 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 58.1 32.4 21.95 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.652 0.739 . . . . 0.0 109.365 -175.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 62.4 mttp 57.44 37.04 27.7 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 114.854 -1.067 . . . . 0.0 111.547 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . 0.492 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 6.6 tp-100 -127.69 131.78 49.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.573 176.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.406 ' HG3' ' HH ' ' D' ' 78' ' ' TYR . 32.8 tt0 -87.42 112.35 22.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.383 -177.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . 1.644 ' HE2' ' CE1' ' D' ' 51' ' ' TYR . 78.5 m-85 -108.46 131.44 54.8 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.743 177.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -78.84 100.36 3.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 169.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 53' ' ' VAL . . . . . 0.503 HG21 ' HB3' ' D' ' 44' ' ' LEU . 0.9 OUTLIER -72.34 -51.49 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.988 -174.174 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 54' ' ' ALA . . . . . 0.578 ' HA ' ' OE1' ' C' ' 62' ' ' GLN . . . -154.46 132.38 11.6 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.538 -177.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 7.6 t -101.89 102.47 13.04 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 174.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 56' ' ' VAL . . . . . 0.404 HG11 ' HB1' ' D' ' 40' ' ' ALA . 7.1 p -116.69 109.76 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-O 122.039 0.923 . . . . 0.0 110.052 -176.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 57' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' D' ' 61' ' ' PRO . 67.3 p -122.64 -176.99 3.52 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.347 -176.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -65.03 -20.68 66.61 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.541 169.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.76 -40.84 27.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.265 0.555 . . . . 0.0 110.07 176.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 74.6 mt -118.73 77.64 14.87 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 172.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 61' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' D' ' 57' ' ' THR . 9.7 Cg_exo -71.7 0.88 6.35 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.159 2.573 . . . . 0.0 113.651 -168.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . 0.486 ' OE1' ' HA ' ' E' ' 54' ' ' ALA . 10.3 tt0 -160.09 114.77 2.28 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.274 -170.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.443 HG12 ' HB2' ' D' ' 54' ' ' ALA . 86.1 t -112.84 115.06 48.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.104 0.478 . . . . 0.0 111.236 177.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.87 115.92 28.34 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 171.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.55 168.32 19.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.777 0.322 . . . . 0.0 111.092 -171.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 66' ' ' ASP . . . . . 0.529 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 7.5 t0 -122.91 109.39 14.09 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.127 0.489 . . . . 0.0 110.365 -178.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' D' ' 28' ' ' HIS . 12.8 mt -124.0 138.9 54.39 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.712 176.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -138.57 114.61 10.13 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 173.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 69' ' ' PHE . . . . . 1.635 ' HE1' ' CE2' ' D' ' 69' ' ' PHE . 66.6 m-85 -109.16 163.07 13.68 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.315 -178.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 70' ' ' SER . . . . . 0.572 ' OG ' ' HA ' ' C' ' 7' ' ' MET . 4.4 m -117.21 149.06 41.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.186 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 71' ' ' LYS . . . . . 0.471 ' HB2' ' HZ3' ' D' ' 71' ' ' LYS . 0.0 OUTLIER -70.05 -6.14 31.63 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.72 -177.104 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.68 -28.62 46.37 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.319 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -101.12 171.31 7.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.757 0.313 . . . . 0.0 110.449 -176.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -137.31 136.49 38.03 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 75' ' ' ILE . . . . . 0.45 ' HB ' ' CD1' ' D' ' 44' ' ' LEU . 22.6 pt -133.03 158.36 43.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.014 0.435 . . . . 0.0 111.642 -169.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 76' ' ' MET . . . . . 0.408 ' HA ' ' HA ' ' D' ' 20' ' ' SER . 65.4 ttp -117.43 118.08 31.24 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.372 176.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 77' ' ' PHE . . . . . 1.664 ' HD2' ' CD1' ' D' ' 77' ' ' PHE . 0.4 OUTLIER -105.57 129.42 53.83 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.789 -177.812 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 78' ' ' TYR . . . . . 1.664 ' HD1' ' CD2' ' D' ' 78' ' ' TYR . 39.0 p90 -155.76 162.78 40.45 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.881 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 79' ' ' THR . . . . . 0.641 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 12.6 p -125.22 143.87 50.74 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.116 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.35 149.61 26.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.097 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.87 -177.05 36.77 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -176.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -114.4 102.58 10.22 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.242 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.54 ' H ' ' HB3' ' D' ' 15' ' ' PRO . . . -166.69 150.13 6.94 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.385 168.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 6.2 p -106.1 122.25 45.81 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . 0.483 HG22 ' HB3' ' D' ' 13' ' ' MET . 13.4 m -121.65 144.19 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-O 121.203 0.525 . . . . 0.0 111.792 -172.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 43.6 m -105.1 122.79 46.63 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.322 175.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 87' ' ' LEU . . . . . 0.534 ' HB2' ' HB3' ' D' ' 11' ' ' LEU . 5.1 mp -95.22 143.97 26.2 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 170.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . 0.496 ' CD2' HG12 ' E' ' 53' ' ' VAL . 0.9 OUTLIER -130.4 141.18 50.55 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.175 -178.686 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.58 -166.84 27.33 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.756 -177.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -147.05 133.51 19.69 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.437 0.637 . . . . 0.0 111.113 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . 0.494 ' HB3' ' HE3' ' D' ' 25' ' ' LYS . 15.1 mt . . . . . 0 C--N 1.322 -0.6 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.065 175.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 7' ' ' MET . . . . . 0.533 ' HA ' ' OG ' ' A' ' 70' ' ' SER . 45.2 mtt . . . . . 0 CA--C 1.519 -0.231 0 CA-C-O 121.653 0.739 . . . . 0.0 112.626 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 8' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -59.64 142.7 52.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.291 -1.322 . . . . 0.0 112.293 -176.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 9' ' ' TRP . . . . . 0.512 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 88.6 t90 -134.21 142.04 47.25 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.84 140.06 8.4 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.162 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 11' ' ' LEU . . . . . 0.543 ' HB3' ' HB2' ' E' ' 87' ' ' LEU . 56.8 tp -128.36 108.32 10.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.966 0.412 . . . . 0.0 110.101 178.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -86.45 101.34 13.06 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 175.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 13' ' ' MET . . . . . 0.479 ' HB3' HG22 ' E' ' 85' ' ' VAL . 27.3 tpp -91.99 129.41 37.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.419 -171.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 14' ' ' LYS . . . . . 0.471 ' N ' ' HD2' ' E' ' 14' ' ' LYS . 0.3 OUTLIER -95.68 140.69 22.44 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.843 179.394 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . 0.53 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 9.5 Cg_endo -53.63 121.79 10.14 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 123.508 2.805 . . . . 0.0 113.514 -175.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 16' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' E' ' 79' ' ' THR . 31.3 mt-10 61.54 47.06 6.84 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.887 177.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 17' ' ' ARG . . . . . 0.495 ' HA ' ' NE ' ' E' ' 17' ' ' ARG . 1.2 tpm_? -122.41 137.34 54.9 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 173.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . 0.616 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 88.6 mttt -108.83 121.51 45.24 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . 1.662 ' HE2' ' CE1' ' E' ' 19' ' ' TYR . 3.7 m-85 -111.11 103.64 12.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.213 176.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 20' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' E' ' 76' ' ' MET . 44.5 t -90.46 99.39 12.43 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 172.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -120.22 148.11 44.09 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.523 0.678 . . . . 0.0 112.093 -168.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 19.8 m -93.46 141.22 28.7 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.469 176.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 67.8 mt -89.84 117.08 32.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.044 0.449 . . . . 0.0 111.284 -173.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . 0.494 HD13 ' N ' ' E' ' 25' ' ' LYS . 1.4 pp -79.67 -27.54 12.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.721 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . 0.494 ' N ' HD13 ' E' ' 24' ' ' ILE . 31.7 ttpt -155.37 136.14 13.55 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 39.6 m -58.3 130.09 45.07 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.654 0.596 . . . . 0.0 110.08 -178.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 27' ' ' PHE . . . . . 0.442 ' CB ' ' HA ' ' E' ' 91' ' ' LEU . 10.0 p90 -144.24 161.92 37.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -172.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 28' ' ' HIS . . . . . 0.582 ' HA ' ' O ' ' E' ' 67' ' ' LEU . 16.0 t60 -114.85 123.87 50.27 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.172 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 29' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 38.1 mt -92.67 136.25 25.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 170.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 30' ' ' SER . . . . . 0.565 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 65.5 p -122.94 -20.26 5.86 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -170.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 31' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -154.81 146.23 14.06 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 119.36 -1.4 . . . . 0.0 113.365 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . 0.43 ' CG2' ' HG ' ' E' ' 87' ' ' LEU . 14.4 p -140.02 126.84 23.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 170.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.84 158.17 43.97 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 121.861 -0.524 . . . . 0.0 111.649 -174.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 34' ' ' LEU . . . . . 0.462 ' HB3' ' CG1' ' E' ' 85' ' ' VAL . 4.0 pp -119.0 139.21 52.07 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.713 0.768 . . . . 0.0 111.445 178.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -108.06 -51.29 2.92 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.392 173.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -102.38 127.94 49.17 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 170.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . 0.485 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 145.17 162.49 9.62 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 119.916 -1.135 . . . . 0.0 113.04 176.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -102.8 -46.65 4.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.536 0.208 . . . . 0.0 111.539 177.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -150.75 130.84 13.48 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.712 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . 0.401 ' HB1' HG11 ' E' ' 56' ' ' VAL . . . -130.8 113.06 13.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.555 0.693 . . . . 0.0 110.175 168.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 41' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' E' ' 79' ' ' THR . 4.5 mptp? -95.42 106.43 18.49 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 174.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.417 ' O ' HG22 ' E' ' 53' ' ' VAL . 41.7 tp -78.82 114.04 17.41 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -176.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 43' ' ' TYR . . . . . 1.636 ' HD1' ' CD2' ' E' ' 43' ' ' TYR . 76.9 m-85 -114.93 135.93 53.67 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.24 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 44' ' ' LEU . . . . . 0.482 ' HB3' HG21 ' E' ' 53' ' ' VAL . 5.0 tp -115.75 116.01 27.32 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.575 176.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 45' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -103.27 103.68 13.73 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 176.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.54 140.74 50.48 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.168 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 58.2 32.33 21.89 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.61 0.719 . . . . 0.0 109.368 -175.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 62.4 mttp 57.43 37.1 27.73 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.479 -178.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 49' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 6.6 tp-100 -127.65 131.74 49.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.612 176.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 50' ' ' GLU . . . . . 0.405 ' HG3' ' HH ' ' E' ' 78' ' ' TYR . 32.8 tt0 -87.37 112.24 21.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.43 -177.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . 1.665 ' HE1' ' CE2' ' E' ' 51' ' ' TYR . 78.0 m-85 -108.36 131.35 54.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.776 177.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -78.8 100.42 3.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 169.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . 0.496 HG12 ' CD2' ' D' ' 88' ' ' LEU . 0.9 OUTLIER -72.35 -51.49 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.998 -174.243 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' E' E ' 54' ' ' ALA . . . . . 0.486 ' HA ' ' OE1' ' D' ' 62' ' ' GLN . . . -154.51 132.53 11.67 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.513 -177.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 7.6 t -101.97 102.43 12.96 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . 0.401 HG11 ' HB1' ' E' ' 40' ' ' ALA . 7.1 p -116.62 109.72 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-O 122.048 0.928 . . . . 0.0 110.025 -176.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 57' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' E' ' 61' ' ' PRO . 68.3 p -122.62 -177.06 3.53 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.342 -176.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -64.98 -20.69 66.62 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.469 169.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.85 -40.82 27.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.313 0.577 . . . . 0.0 110.008 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 74.4 mt -118.66 77.6 14.61 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 172.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 61' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' E' ' 57' ' ' THR . 9.6 Cg_exo -71.69 0.89 6.33 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.095 2.53 . . . . 0.0 113.727 -168.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 62' ' ' GLN . . . . . 0.507 ' OE1' ' HA ' ' A' ' 54' ' ' ALA . 10.3 tt0 -160.11 114.66 2.26 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.792 0.329 . . . . 0.0 111.312 -170.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . 0.432 HG12 ' HB2' ' E' ' 54' ' ' ALA . 86.1 t -112.74 115.18 49.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.065 0.459 . . . . 0.0 111.199 177.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.11 115.99 28.36 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 171.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.55 168.22 19.36 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.058 -171.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 66' ' ' ASP . . . . . 0.524 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 7.5 t0 -122.84 109.43 14.17 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.144 0.497 . . . . 0.0 110.417 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 67' ' ' LEU . . . . . 0.582 ' O ' ' HA ' ' E' ' 28' ' ' HIS . 12.8 mt -123.99 138.91 54.39 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.7 176.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -138.57 114.55 10.08 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 173.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 69' ' ' PHE . . . . . 1.645 ' HD1' ' CD2' ' E' ' 69' ' ' PHE . 65.9 m-85 -109.1 163.0 13.73 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.519 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 70' ' ' SER . . . . . 0.558 ' OG ' ' HA ' ' D' ' 7' ' ' MET . 4.5 m -117.09 149.0 41.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.185 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 71' ' ' LYS . . . . . 0.481 ' HB2' ' HZ3' ' E' ' 71' ' ' LYS . 0.0 OUTLIER -69.99 -6.05 30.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.698 -177.153 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.87 -28.4 46.38 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.344 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -101.24 171.28 7.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.704 0.288 . . . . 0.0 110.364 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -137.32 136.53 38.06 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 75' ' ' ILE . . . . . 0.44 ' HB ' ' CD1' ' E' ' 44' ' ' LEU . 22.4 pt -133.04 158.37 43.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.947 0.403 . . . . 0.0 111.66 -169.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 76' ' ' MET . . . . . 0.421 ' HA ' ' HA ' ' E' ' 20' ' ' SER . 65.3 ttp -117.49 118.11 31.29 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.055 0.455 . . . . 0.0 110.339 176.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 77' ' ' PHE . . . . . 1.635 ' HE2' ' CE1' ' E' ' 77' ' ' PHE . 0.4 OUTLIER -105.59 129.47 53.84 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.693 -177.747 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' E' E ' 78' ' ' TYR . . . . . 1.665 ' HE2' ' CE1' ' E' ' 78' ' ' TYR . 38.8 p90 -155.76 162.68 40.47 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.838 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 79' ' ' THR . . . . . 0.641 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 12.7 p -125.14 143.82 50.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.209 178.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.37 149.68 26.75 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.095 173.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.82 -176.91 36.73 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -176.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -114.45 102.76 10.38 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.14 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 83' ' ' ALA . . . . . 0.53 ' H ' ' HB3' ' E' ' 15' ' ' PRO . . . -166.78 150.05 6.79 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.477 168.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 6.2 p -106.14 122.24 45.8 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 85' ' ' VAL . . . . . 0.479 HG22 ' HB3' ' E' ' 13' ' ' MET . 13.7 m -121.57 144.19 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 CA-C-O 121.161 0.505 . . . . 0.0 111.831 -172.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 44.3 m -105.23 122.84 46.77 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.274 175.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 87' ' ' LEU . . . . . 0.543 ' HB2' ' HB3' ' E' ' 11' ' ' LEU . 5.1 mp -95.16 143.9 26.21 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 170.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . 0.458 ' CD2' HG12 ' A' ' 53' ' ' VAL . 0.9 OUTLIER -130.42 141.25 50.55 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.134 -178.664 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.67 -166.88 27.49 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.678 -177.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 90' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -147.05 133.59 19.78 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.469 0.652 . . . . 0.0 111.066 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 91' ' ' LEU . . . . . 0.483 ' HB3' ' HE3' ' E' ' 25' ' ' LYS . 15.1 mt . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.117 175.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 1.657 ' HD1' ' CD2' ' A' ' 1' ' ' PHE . 97.9 m-85 . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.433 0.159 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 65.46 178.87 0.2 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.187 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.59 105.32 3.24 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.703 -176.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.16 -49.11 7.99 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 172.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.507 ' SD ' ' HA ' ' A' ' 94' ' ' ILE . 22.4 mmt 66.71 -65.73 0.2 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 114.671 -1.149 . . . . 0.0 112.098 174.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 91' ' ' LEU . . . -103.55 112.89 26.02 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.843 0.354 . . . . 0.0 110.674 -178.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 54.6 mtt -108.18 147.05 31.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.83 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 1.64 ' HD1' ' CD2' ' A' ' 8' ' ' PHE . 81.2 t80 -58.7 142.66 49.16 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -172.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.493 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 89.3 t90 -140.08 147.73 40.71 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.131 178.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.408 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -149.93 154.07 25.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.114 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.536 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 51.2 tp -146.61 109.05 4.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.818 0.342 . . . . 0.0 111.237 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -91.47 114.11 26.55 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.375 0.607 . . . . 0.0 111.093 176.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.458 ' HB2' HG21 ' A' ' 85' ' ' VAL . 3.5 mmt -93.15 137.32 32.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.016 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -100.64 153.34 37.79 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 171.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.421 ' HB3' ' HA ' ' A' ' 82' ' ' ASP . 84.1 Cg_exo -46.83 111.34 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.993 2.462 . . . . 0.0 113.096 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.684 ' HA ' ' O ' ' A' ' 79' ' ' THR . 39.6 mt-10 65.95 59.13 0.72 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.498 0.666 . . . . 0.0 111.356 177.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 70.5 mmt-85 -113.3 145.44 41.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.038 172.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.614 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 33.8 ttmt -128.02 111.27 13.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.308 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.403 ' OH ' ' HA ' ' A' ' 13' ' ' MET . 5.6 m-85 -108.69 104.12 13.34 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.686 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.4 ' HB3' ' SD ' ' A' ' 76' ' ' MET . 9.2 p -88.04 99.9 12.52 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 173.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -125.43 138.7 54.02 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.591 0.71 . . . . 0.0 112.378 -167.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 t -85.0 160.24 20.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.751 177.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 53.0 mt -114.14 116.74 53.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.005 0.431 . . . . 0.0 110.862 -176.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.553 HD12 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -104.0 -10.15 9.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.248 176.469 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -142.62 119.35 11.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.794 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.0 m -64.61 135.4 55.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.182 -177.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -147.25 160.78 42.09 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -174.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.472 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 5.3 t60 -114.87 128.07 56.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.405 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.52 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 56.5 mt -94.63 136.45 25.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 171.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.5 ' HB2' ' HB3' ' B' ' 66' ' ' ASP . 72.7 p -119.81 -16.74 8.69 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -170.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -163.78 144.85 9.84 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 119.365 -1.397 . . . . 0.0 113.5 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.404 HG21 ' HG ' ' A' ' 87' ' ' LEU . 12.4 p -129.02 125.71 63.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 170.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.66 152.18 41.02 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.606 -174.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.468 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 3.5 pp -114.26 137.9 51.18 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.871 0.843 . . . . 0.0 111.81 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -106.04 -55.35 2.34 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.436 175.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -101.98 126.87 49.01 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.745 170.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.433 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 147.96 162.51 10.16 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 119.612 -1.28 . . . . 0.0 113.561 176.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.438 ' O ' ' HG3' ' A' ' 58' ' ' LYS . 39.5 mt-30 -102.82 -48.13 4.18 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 178.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -151.77 134.49 15.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.382 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.411 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . . . -135.39 117.46 15.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.376 0.608 . . . . 0.0 111.112 172.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 79' ' ' THR . 48.3 mttm -97.65 116.02 29.06 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 173.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.8 tp -91.44 105.4 17.74 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.154 0.502 . . . . 0.0 110.037 -173.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 1.667 ' HD1' ' CD2' ' A' ' 43' ' ' TYR . 96.9 m-85 -103.43 150.91 23.39 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.256 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.618 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 1.1 tp -133.5 117.41 17.12 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.701 176.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -102.06 104.32 14.96 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.425 0.631 . . . . 0.0 109.615 175.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.402 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -134.28 152.18 51.68 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 57.79 24.14 10.41 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -174.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 58.45 42.24 21.47 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.286 -175.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.486 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 28.2 tp60 -137.62 131.85 32.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.562 178.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -79.58 107.1 12.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.916 0.389 . . . . 0.0 110.45 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 1.625 ' HE2' ' CE1' ' A' ' 51' ' ' TYR . 74.5 m-85 -100.16 129.32 46.17 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.051 176.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.421 HD11 ' CE1' ' A' ' 43' ' ' TYR . 4.6 tp -89.95 99.89 10.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 172.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.458 ' CG1' ' HB3' ' A' ' 44' ' ' LEU . 2.6 m -84.27 -33.79 9.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.131 -169.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -159.3 148.93 18.66 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.117 0.484 . . . . 0.0 111.885 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.2 m -117.39 102.96 9.66 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 170.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.7 p -110.6 116.26 51.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.439 0.638 . . . . 0.0 110.224 -176.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.8 p -122.7 -177.48 3.66 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.297 -175.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 38' ' ' GLN . 52.7 mtmt -59.8 -33.68 72.05 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.99 0.424 . . . . 0.0 110.288 169.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.93 -40.81 68.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.39 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.6 mt -116.6 80.14 10.17 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 174.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -72.38 0.23 7.73 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.804 2.336 . . . . 0.0 113.927 -167.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -162.43 119.21 2.0 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.126 0.489 . . . . 0.0 110.875 -176.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 92.8 t -110.2 101.67 12.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.216 175.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.14 111.36 17.51 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 173.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.05 150.78 52.09 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.079 -171.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.526 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 11.7 t0 -96.0 99.14 10.94 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.345 0.593 . . . . 0.0 110.006 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.52 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 4.2 mt -113.21 141.8 46.54 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.491 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.605 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 6.2 t30 -148.87 132.46 16.79 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.1 177.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.506 ' CZ ' HD23 ' A' ' 67' ' ' LEU . 63.4 m-85 -127.54 158.02 38.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.831 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.9 p -120.97 154.86 35.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.386 178.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.9 11.48 0.38 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -174.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.03 -29.48 9.69 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.678 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -101.53 163.11 12.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.942 0.371 . . . . 0.0 110.929 -175.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -123.14 111.42 16.49 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.9 pt -111.15 161.43 9.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.122 0.487 . . . . 0.0 111.71 -168.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.4 ' SD ' ' HB3' ' A' ' 20' ' ' SER . 4.9 mtm -121.84 124.86 45.13 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 173.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 1.639 ' HD2' ' CD1' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -105.05 128.16 53.2 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.162 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 1.609 ' HD1' ' CD2' ' A' ' 78' ' ' TYR . 30.1 p90 -151.06 138.93 19.88 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.137 -0.625 . . . . 0.0 112.055 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.684 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 11.3 p -109.72 137.54 47.38 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.878 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.68 157.22 18.73 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.588 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.73 -173.9 35.6 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -176.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.421 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 11.6 m-20 -114.05 103.17 10.87 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.843 177.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.433 ' CB ' ' HA3' ' A' ' 37' ' ' GLY . . . -172.31 155.14 3.46 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.153 171.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.5 t -110.41 114.46 27.92 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.468 ' CG1' ' HB3' ' A' ' 34' ' ' LEU . 6.8 m -112.98 143.49 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-O 121.357 0.599 . . . . 0.0 112.15 -174.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.8 t -108.86 118.65 37.34 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.72 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 5.2 mp -94.04 151.9 19.19 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tp -134.31 145.96 49.54 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.177 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.68 -167.52 29.44 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.455 -0.878 . . . . 0.0 112.084 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.593 ' CD2' ' HB3' ' B' ' 68' ' ' ASN . 8.7 p90 -151.54 130.23 12.33 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.732 0.777 . . . . 0.0 111.85 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 6' ' ' ALA . 6.2 mt -66.97 122.68 18.27 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.121 -1.399 . . . . 0.0 109.595 175.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -101.62 108.55 20.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.368 0.604 . . . . 0.0 110.591 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -118.13 76.93 1.11 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.536 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.507 ' HA ' ' SD ' ' A' ' 5' ' ' MET . 5.0 tp -78.65 120.99 30.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.38 0.609 . . . . 0.0 110.503 -177.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -119.32 139.46 51.9 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.977 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 38.2 m -137.51 31.38 2.57 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.199 0.523 . . . . 0.0 110.005 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 64.86 -131.98 37.0 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.024 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.7 p . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.944 -0.551 . . . . 0.0 110.085 177.929 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 1.657 ' HD1' ' CD2' ' B' ' 1' ' ' PHE . 97.7 m-85 . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 120.363 0.125 . . . . 0.0 111.018 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 65.2 178.88 0.19 Allowed 'General case' 0 C--O 1.232 0.181 0 O-C-N 123.51 0.507 . . . . 0.0 111.278 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.64 105.28 3.24 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.65 -176.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.24 -49.14 7.93 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 172.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' MET . . . . . 0.498 ' SD ' ' HA ' ' B' ' 94' ' ' ILE . 22.4 mmt 66.78 -65.78 0.2 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.0 174.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' B' ' 91' ' ' LEU . . . -103.48 112.78 25.84 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.736 -177.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 54.6 mtt -108.23 147.15 31.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.806 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 1.613 ' HE2' ' CE1' ' B' ' 8' ' ' PHE . 80.5 t80 -58.85 142.76 49.61 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -172.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . 0.491 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 89.2 t90 -140.11 147.67 40.56 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.141 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.432 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -149.9 154.03 25.46 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.097 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.546 ' HB3' ' HB2' ' B' ' 87' ' ' LEU . 51.7 tp -146.49 108.9 4.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.772 0.32 . . . . 0.0 111.296 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -91.34 114.06 26.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.332 0.587 . . . . 0.0 111.096 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' MET . . . . . 0.474 ' HB2' HG21 ' B' ' 85' ' ' VAL . 3.5 mmt -93.17 137.27 32.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.964 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -100.55 153.38 37.78 Favored Pre-proline 0 C--N 1.317 -0.828 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 171.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.429 ' HB3' ' HA ' ' B' ' 82' ' ' ASP . 84.2 Cg_exo -46.77 111.21 0.35 Allowed 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 123.058 2.505 . . . . 0.0 113.15 -178.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.684 ' HA ' ' O ' ' B' ' 79' ' ' THR . 39.5 mt-10 66.01 59.11 0.71 Allowed 'General case' 0 C--O 1.233 0.224 0 O-C-N 123.693 0.621 . . . . 0.0 111.316 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 70.5 mmt-85 -113.28 145.47 40.98 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.037 172.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . 0.613 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 33.9 ttmt -128.08 111.26 13.29 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.344 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' TYR . . . . . 0.41 ' OH ' ' HA ' ' B' ' 13' ' ' MET . 5.6 m-85 -108.68 104.05 13.27 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.687 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 9.6 p -88.0 100.03 12.6 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 173.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -125.53 138.74 53.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.59 0.71 . . . . 0.0 112.335 -167.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 14.8 t -85.07 160.36 20.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.691 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 53.0 mt -114.11 116.76 53.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 120.973 0.416 . . . . 0.0 110.877 -176.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.548 ' H ' HD12 ' B' ' 24' ' ' ILE . 0.2 OUTLIER -104.05 -10.24 9.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.257 176.413 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 ptpp? -142.64 119.38 11.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.736 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 23.8 m -64.57 135.46 56.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.21 -177.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -147.28 160.74 42.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.62 0.724 . . . . 0.0 112.908 -174.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' HIS . . . . . 0.478 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 5.3 t60 -114.85 128.06 56.08 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.418 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 56.5 mt -94.67 136.44 25.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 171.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.49 ' HB2' ' HB3' ' C' ' 66' ' ' ASP . 72.5 p -119.86 -16.64 8.67 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.961 -170.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -163.75 144.91 9.89 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 119.424 -1.369 . . . . 0.0 113.497 178.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.401 HG21 ' HG ' ' B' ' 87' ' ' LEU . 12.3 p -129.2 125.68 62.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 170.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.59 152.21 41.12 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 121.921 -0.487 . . . . 0.0 111.629 -174.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.47 ' HB3' ' CG1' ' B' ' 85' ' ' VAL . 3.5 pp -114.32 137.87 51.25 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.906 0.86 . . . . 0.0 111.781 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -105.94 -55.34 2.34 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.482 175.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -101.99 126.87 49.02 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.775 170.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.436 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 147.93 162.56 10.17 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 119.644 -1.265 . . . . 0.0 113.644 176.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . 0.438 ' O ' ' HG3' ' B' ' 58' ' ' LYS . 39.3 mt-30 -102.74 -48.14 4.19 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 178.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -151.86 134.47 15.45 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.433 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.42 ' HB3' ' HB1' ' B' ' 83' ' ' ALA . . . -135.37 117.39 15.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.39 0.614 . . . . 0.0 111.031 172.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' B' ' 79' ' ' THR . 48.3 mttm -97.58 116.01 28.98 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 173.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 53.7 tp -91.37 105.24 17.63 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.156 0.503 . . . . 0.0 110.111 -173.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . 1.667 ' HD1' ' CD2' ' B' ' 43' ' ' TYR . 96.9 m-85 -103.41 150.91 23.38 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.203 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.622 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 1.1 tp -133.55 117.36 17.02 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.619 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -102.03 104.25 14.9 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.382 0.611 . . . . 0.0 109.574 175.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.24 152.3 51.75 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.047 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 57.67 24.19 10.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.132 0.491 . . . . 0.0 109.729 -174.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 58.38 42.34 21.54 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.321 -175.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.487 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 28.3 tp60 -137.67 131.8 31.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.55 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -79.55 107.16 12.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.815 0.341 . . . . 0.0 110.428 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 1.622 ' HE2' ' CE1' ' B' ' 51' ' ' TYR . 74.6 m-85 -100.26 129.27 46.24 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.004 176.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . 0.422 HD11 ' CE1' ' B' ' 43' ' ' TYR . 4.6 tp -89.84 99.93 10.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 172.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.455 ' CG1' ' HB3' ' B' ' 44' ' ' LEU . 2.6 m -84.25 -33.88 9.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.088 -169.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -159.3 148.94 18.66 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.026 0.441 . . . . 0.0 111.959 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 92.6 m -117.44 102.88 9.57 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 170.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 6.7 p -110.57 116.21 51.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.471 0.653 . . . . 0.0 110.225 -176.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 74.4 p -122.69 -177.42 3.64 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.305 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' B' ' 38' ' ' GLN . 52.6 mtmt -59.88 -33.72 72.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.963 0.411 . . . . 0.0 110.285 169.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.86 -40.75 68.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.472 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 74.9 mt -116.66 80.15 10.31 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 174.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -72.4 0.13 7.9 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.923 2.415 . . . . 0.0 113.881 -166.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -162.4 119.24 2.01 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.299 0.571 . . . . 0.0 110.866 -176.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 92.3 t -110.2 101.67 12.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.2 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.14 111.29 17.44 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 173.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.03 150.75 52.11 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.167 -171.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 11.7 t0 -96.0 99.14 10.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.399 0.619 . . . . 0.0 109.993 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.538 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 4.2 mt -113.19 141.8 46.52 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.424 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . 0.593 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 6.2 t30 -148.9 132.49 16.79 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.174 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . 0.509 ' CZ ' HD23 ' B' ' 67' ' ' LEU . 63.5 m-85 -127.6 158.08 38.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.825 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 4.8 p -121.05 154.92 35.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.304 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.92 11.47 0.39 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -174.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.06 -29.52 9.64 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.673 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -101.48 163.13 12.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.785 0.326 . . . . 0.0 110.918 -175.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -123.12 111.48 16.58 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 177.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 27.8 pt -111.2 161.41 9.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.092 0.472 . . . . 0.0 111.704 -168.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' MET . . . . . . . . . . . . . 4.9 mtm -121.82 124.77 44.95 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 173.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . 1.669 ' HE1' ' CE2' ' B' ' 77' ' ' PHE . 0.5 OUTLIER -104.96 128.16 53.11 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.113 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 1.635 ' HE1' ' CE2' ' B' ' 78' ' ' TYR . 30.2 p90 -151.04 138.89 19.86 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.023 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.684 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 11.2 p -109.73 137.5 47.45 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.953 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.48 157.12 18.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.632 176.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.74 -173.76 35.44 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -176.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' ASP . . . . . 0.429 ' HA ' ' HB3' ' B' ' 15' ' ' PRO . 11.7 m-20 -114.14 103.14 10.82 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.763 178.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.436 ' CB ' ' HA3' ' B' ' 37' ' ' GLY . . . -172.31 155.18 3.47 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.131 171.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 24.4 t -110.41 114.32 27.66 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.474 HG21 ' HB2' ' B' ' 13' ' ' MET . 6.8 m -112.86 143.62 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 CA-C-O 121.416 0.627 . . . . 0.0 112.198 -174.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 11.9 t -108.99 118.73 37.55 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.664 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.546 ' HB2' ' HB3' ' B' ' 11' ' ' LEU . 5.2 mp -94.17 151.87 19.15 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 174.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tp -134.25 145.97 49.63 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.124 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.73 -167.51 29.46 Favored Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.053 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' TYR . . . . . 0.582 ' CD2' ' HB3' ' C' ' 68' ' ' ASN . 8.7 p90 -151.62 130.29 12.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.798 0.808 . . . . 0.0 111.842 177.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' B' ' 6' ' ' ALA . 6.3 mt -66.98 122.59 18.08 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.023 -1.444 . . . . 0.0 109.555 175.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -101.48 108.49 20.09 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.363 0.602 . . . . 0.0 110.612 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -118.13 77.02 1.12 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.467 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . 0.498 ' HA ' ' SD ' ' B' ' 5' ' ' MET . 5.1 tp -78.58 120.94 30.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.542 -177.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -119.43 139.45 52.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.97 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 37.8 m -137.4 31.24 2.61 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.241 0.544 . . . . 0.0 110.055 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . 64.87 -131.93 36.93 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.172 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 11.7 p . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.826 -0.607 . . . . 0.0 110.147 177.888 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' PHE . . . . . 1.625 ' HD2' ' CD1' ' C' ' 1' ' ' PHE . 98.1 m-85 . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.422 0.153 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 65.32 178.86 0.19 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.181 0.515 . . . . 0.0 111.169 -177.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.62 105.33 3.25 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.615 -176.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.15 -49.12 7.99 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 171.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' MET . . . . . 0.505 ' SD ' ' HA ' ' C' ' 94' ' ' ILE . 22.4 mmt 66.67 -65.71 0.2 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 114.663 -1.153 . . . . 0.0 112.077 174.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' C' ' 91' ' ' LEU . . . -103.5 112.7 25.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.767 -178.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 54.7 mtt -108.17 147.13 31.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.756 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' PHE . . . . . 1.634 ' HD1' ' CD2' ' C' ' 8' ' ' PHE . 80.8 t80 -58.83 142.74 49.56 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -172.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . 0.491 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 89.1 t90 -140.11 147.67 40.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.169 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . 0.417 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -149.86 153.99 25.43 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.189 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.548 ' HB3' ' HB2' ' C' ' 87' ' ' LEU . 51.5 tp -146.52 109.0 4.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.77 0.319 . . . . 0.0 111.235 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -91.53 114.2 26.67 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.461 0.648 . . . . 0.0 111.005 176.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' MET . . . . . 0.462 ' HB2' HG21 ' C' ' 85' ' ' VAL . 3.5 mmt -93.21 137.29 32.68 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.006 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -100.56 153.29 37.83 Favored Pre-proline 0 C--N 1.318 -0.798 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 171.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . 0.424 ' HB3' ' HA ' ' C' ' 82' ' ' ASP . 85.4 Cg_exo -46.76 111.34 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.056 2.504 . . . . 0.0 113.183 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . 0.686 ' HA ' ' O ' ' C' ' 79' ' ' THR . 39.7 mt-10 65.83 59.2 0.74 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.471 0.653 . . . . 0.0 111.414 178.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 70.4 mmt-85 -113.35 145.46 41.06 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.932 172.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' LYS . . . . . 0.615 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 33.8 ttmt -128.08 111.28 13.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.304 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . 0.404 ' OH ' ' HA ' ' C' ' 13' ' ' MET . 5.6 m-85 -108.69 104.06 13.28 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.695 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 9.4 p -87.94 99.9 12.49 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 173.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -125.47 138.62 54.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.564 0.697 . . . . 0.0 112.368 -167.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 14.8 t -85.03 160.37 20.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.665 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 53.2 mt -114.15 116.81 53.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.915 0.388 . . . . 0.0 110.793 -176.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . 0.545 HD12 ' H ' ' C' ' 24' ' ' ILE . 0.2 OUTLIER -104.0 -10.17 9.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.257 176.362 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . 0.402 ' HD3' HD11 ' C' ' 91' ' ' LEU . 2.5 ptpp? -142.63 119.34 11.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.763 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 24.0 m -64.65 135.41 55.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.185 -177.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -147.19 160.73 42.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.62 0.724 . . . . 0.0 112.924 -174.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' HIS . . . . . 0.484 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 5.4 t60 -114.89 128.05 56.06 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.38 177.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . 0.522 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 56.7 mt -94.61 136.48 25.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 171.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' SER . . . . . 0.499 ' HB2' ' HB3' ' D' ' 66' ' ' ASP . 72.8 p -119.89 -16.66 8.65 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.97 -170.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -163.75 144.97 9.95 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 119.45 -1.357 . . . . 0.0 113.457 178.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 12.2 p -129.21 125.68 62.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 170.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.65 152.28 41.16 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.612 -174.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.469 ' HB3' ' CG1' ' C' ' 85' ' ' VAL . 3.5 pp -114.27 137.85 51.25 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.896 0.855 . . . . 0.0 111.794 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -106.03 -55.27 2.35 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.218 -1.356 . . . . 0.0 108.459 175.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -102.02 126.85 49.05 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.765 170.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' GLY . . . . . 0.43 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 147.95 162.56 10.18 Favored Glycine 0 N--CA 1.438 -1.189 0 C-N-CA 119.602 -1.285 . . . . 0.0 113.617 176.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' GLN . . . . . 0.442 ' O ' ' HG3' ' C' ' 58' ' ' LYS . 39.3 mt-30 -102.88 -48.1 4.18 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 178.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -151.84 134.54 15.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.405 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . 0.415 ' HB3' ' HB1' ' C' ' 83' ' ' ALA . . . -135.42 117.44 15.33 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.363 0.601 . . . . 0.0 111.093 172.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' C' ' 79' ' ' THR . 48.2 mttm -97.72 116.0 29.08 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 173.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 54.0 tp -91.44 105.4 17.74 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.12 0.486 . . . . 0.0 110.001 -173.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' TYR . . . . . 1.669 ' HE1' ' CE2' ' C' ' 43' ' ' TYR . 96.9 m-85 -103.49 150.83 23.51 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.218 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.618 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 1.1 tp -133.44 117.4 17.16 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.66 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -102.07 104.24 14.86 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.349 0.595 . . . . 0.0 109.582 175.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.21 152.21 51.71 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 57.74 24.11 10.3 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -174.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 58.43 42.33 21.42 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.255 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . 0.482 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 28.1 tp60 -137.65 131.91 32.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.628 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -79.72 107.17 12.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.804 0.335 . . . . 0.0 110.399 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 1.643 ' HE2' ' CE1' ' C' ' 51' ' ' TYR . 74.7 m-85 -100.3 129.24 46.27 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.976 176.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . 0.42 HD11 ' CE1' ' C' ' 43' ' ' TYR . 4.6 tp -89.83 99.88 10.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 172.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' VAL . . . . . 0.447 ' CG1' ' HB3' ' C' ' 44' ' ' LEU . 2.6 m -84.27 -33.77 9.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.129 -170.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' ALA . . . . . . . . . . . . . . . -159.37 148.96 18.55 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.093 0.473 . . . . 0.0 111.908 177.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 92.3 m -117.38 102.84 9.56 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 170.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 6.7 p -110.6 116.35 52.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.498 0.666 . . . . 0.0 110.193 -176.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 74.3 p -122.75 -177.43 3.65 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.202 -175.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' C' ' 38' ' ' GLN . 52.6 mtmt -59.76 -33.71 72.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.119 0.485 . . . . 0.0 110.345 169.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.95 -40.79 68.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.371 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 74.4 mt -116.64 80.18 10.29 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -72.5 0.32 7.67 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.835 2.357 . . . . 0.0 113.831 -166.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -162.5 119.1 1.97 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.165 0.507 . . . . 0.0 110.86 -176.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 91.9 t -110.19 101.7 12.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.198 175.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.06 111.22 17.32 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 173.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -132.99 150.8 52.13 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.206 -171.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 66' ' ' ASP . . . . . 0.49 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 11.6 t0 -96.02 99.18 10.97 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.415 0.626 . . . . 0.0 109.981 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . 0.522 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 4.1 mt -113.25 141.87 46.48 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.427 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . 0.582 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 6.2 t30 -148.91 132.5 16.78 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.175 177.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 69' ' ' PHE . . . . . 0.498 ' CZ ' HD23 ' C' ' 67' ' ' LEU . 63.7 m-85 -127.65 157.95 38.88 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.795 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 4.8 p -120.96 154.91 35.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.329 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.92 11.41 0.39 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -174.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.97 -29.61 9.62 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.688 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -101.36 163.11 12.43 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 122.575 -0.367 . . . . 0.0 111.039 -175.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -123.13 111.42 16.5 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 27.8 pt -111.09 161.38 9.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.142 0.496 . . . . 0.0 111.706 -168.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 76' ' ' MET . . . . . . . . . . . . . 4.9 mtm -121.84 124.84 45.09 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 173.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 77' ' ' PHE . . . . . 1.657 ' HE1' ' CE2' ' C' ' 77' ' ' PHE . 0.5 OUTLIER -105.05 128.16 53.2 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.158 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 78' ' ' TYR . . . . . 1.631 ' HD1' ' CD2' ' C' ' 78' ' ' TYR . 30.3 p90 -151.08 138.9 19.84 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.217 -0.593 . . . . 0.0 112.008 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 79' ' ' THR . . . . . 0.686 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 11.3 p -109.68 137.54 47.35 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.926 -179.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.53 157.23 18.65 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.619 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.65 -173.85 35.67 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -176.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 82' ' ' ASP . . . . . 0.424 ' HA ' ' HB3' ' C' ' 15' ' ' PRO . 11.5 m-20 -114.05 103.14 10.84 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 119.601 -0.839 . . . . 0.0 109.8 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . 0.43 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -172.35 155.14 3.44 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.159 171.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 25.0 t -110.3 114.49 27.99 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.469 ' CG1' ' HB3' ' C' ' 34' ' ' LEU . 6.8 m -113.03 143.57 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 CA-C-O 121.419 0.628 . . . . 0.0 112.118 -174.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 12.0 t -108.94 118.75 37.61 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.617 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . 0.548 ' HB2' ' HB3' ' C' ' 11' ' ' LEU . 5.2 mp -94.15 151.89 19.15 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 174.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tp -134.27 145.96 49.59 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.092 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.72 -167.51 29.46 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.228 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 90' ' ' TYR . . . . . 0.595 ' CD2' ' HB3' ' D' ' 68' ' ' ASN . 8.7 p90 -151.55 130.2 12.3 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.777 0.799 . . . . 0.0 111.901 177.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . 0.554 ' O ' ' HA ' ' C' ' 6' ' ' ALA . 6.2 mt -66.94 122.66 18.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.643 175.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -101.57 108.57 20.16 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.408 0.623 . . . . 0.0 110.612 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -118.22 77.0 1.12 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.472 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . 0.505 ' HA ' ' SD ' ' C' ' 5' ' ' MET . 5.1 tp -78.52 120.97 30.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.596 -177.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -119.43 139.48 51.96 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.003 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 38.4 m -137.46 31.28 2.59 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.144 0.497 . . . . 0.0 109.988 177.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 64.91 -131.93 36.81 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.179 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 11.7 p . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.958 -0.544 . . . . 0.0 110.076 177.874 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . 1.641 ' HE1' ' CE2' ' D' ' 1' ' ' PHE . 98.4 m-85 . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 120.394 0.14 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 65.21 178.83 0.19 Allowed 'General case' 0 C--O 1.232 0.161 0 O-C-N 123.544 0.528 . . . . 0.0 111.24 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.56 105.24 3.23 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.718 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.13 -49.03 8.06 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 172.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 5' ' ' MET . . . . . 0.506 ' SD ' ' HA ' ' D' ' 94' ' ' ILE . 22.4 mmt 66.7 -65.83 0.2 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.605 -1.18 . . . . 0.0 112.066 174.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 6' ' ' ALA . . . . . 0.555 ' HA ' ' O ' ' D' ' 91' ' ' LEU . . . -103.49 112.68 25.69 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.846 0.355 . . . . 0.0 110.801 -178.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 54.6 mtt -108.15 147.09 31.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.855 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 8' ' ' PHE . . . . . 1.661 ' HE1' ' CE2' ' D' ' 8' ' ' PHE . 81.0 t80 -58.7 142.66 49.15 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -172.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 9' ' ' TRP . . . . . 0.493 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 89.3 t90 -140.07 147.63 40.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.153 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . 0.434 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -149.84 154.0 25.45 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.215 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . 0.536 ' HB3' ' HB2' ' D' ' 87' ' ' LEU . 51.2 tp -146.55 109.0 4.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.777 0.322 . . . . 0.0 111.173 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -91.41 114.1 26.54 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.375 0.607 . . . . 0.0 111.134 176.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 13' ' ' MET . . . . . 0.464 ' HB2' HG21 ' D' ' 85' ' ' VAL . 3.5 mmt -93.12 137.33 32.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.017 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -100.6 153.37 37.78 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 171.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . 0.417 ' HB3' ' HA ' ' D' ' 82' ' ' ASP . 83.8 Cg_exo -46.82 111.4 0.38 Allowed 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.025 2.484 . . . . 0.0 113.103 -178.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . 0.674 ' HA ' ' O ' ' D' ' 79' ' ' THR . 39.6 mt-10 65.87 59.06 0.74 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.538 0.685 . . . . 0.0 111.446 177.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 70.7 mmt-85 -113.29 145.35 41.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.02 172.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . 0.589 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 33.8 ttmt -127.95 111.22 13.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.331 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 19' ' ' TYR . . . . . 0.407 ' OH ' ' HA ' ' D' ' 13' ' ' MET . 5.6 m-85 -108.56 104.17 13.43 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.662 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 20' ' ' SER . . . . . 0.4 ' HB3' ' SD ' ' D' ' 76' ' ' MET . 9.3 p -88.05 99.99 12.59 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 173.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -125.51 138.73 53.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.553 0.692 . . . . 0.0 112.324 -167.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 14.7 t -85.03 160.29 20.04 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.698 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 53.4 mt -114.14 116.7 53.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.053 0.454 . . . . 0.0 110.845 -176.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . 0.539 HD12 ' H ' ' D' ' 24' ' ' ILE . 0.2 OUTLIER -103.9 -10.21 9.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.287 176.36 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 ptpp? -142.65 119.35 11.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.751 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 23.9 m -64.65 135.44 55.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.246 -177.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 27' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -147.23 160.69 42.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.664 0.745 . . . . 0.0 112.837 -174.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 28' ' ' HIS . . . . . 0.481 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 5.4 t60 -114.8 128.01 56.06 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.5 177.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 29' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 56.6 mt -94.59 136.45 25.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 171.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 30' ' ' SER . . . . . 0.481 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 72.7 p -119.77 -16.73 8.71 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -170.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 31' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -163.82 144.84 9.82 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 119.331 -1.414 . . . . 0.0 113.447 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 12.3 p -129.05 125.72 63.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 170.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.66 152.21 41.06 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 121.882 -0.512 . . . . 0.0 111.615 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 34' ' ' LEU . . . . . 0.467 ' HB3' ' CG1' ' D' ' 85' ' ' VAL . 3.5 pp -114.28 137.76 51.37 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 121.905 0.859 . . . . 0.0 111.845 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -105.84 -55.39 2.33 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.218 -1.356 . . . . 0.0 108.524 175.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -101.92 126.91 48.93 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.822 170.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . 0.429 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 147.87 162.57 10.17 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 119.622 -1.275 . . . . 0.0 113.614 176.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 38' ' ' GLN . . . . . 0.438 ' O ' ' HG3' ' D' ' 58' ' ' LYS . 39.3 mt-30 -102.84 -48.17 4.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -151.82 134.5 15.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.447 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . 0.43 ' HB3' ' HB1' ' D' ' 83' ' ' ALA . . . -135.34 117.54 15.52 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.428 0.633 . . . . 0.0 111.152 172.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' D' ' 79' ' ' THR . 48.3 mttm -97.79 116.06 29.25 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 173.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 53.7 tp -91.45 105.35 17.7 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.163 0.506 . . . . 0.0 110.051 -173.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 43' ' ' TYR . . . . . 1.65 ' HD2' ' CD1' ' D' ' 43' ' ' TYR . 96.9 m-85 -103.46 150.92 23.41 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.17 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.613 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 1.1 tp -133.54 117.35 17.01 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.728 177.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 45' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -102.03 104.3 14.94 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.423 0.63 . . . . 0.0 109.543 175.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.27 152.14 51.65 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 57.85 24.17 10.54 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -174.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 58.32 42.26 21.88 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.298 -175.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . 0.486 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 28.1 tp60 -137.55 131.87 32.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.615 178.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -79.66 107.17 12.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.896 0.379 . . . . 0.0 110.401 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . 1.652 ' HE2' ' CE1' ' D' ' 51' ' ' TYR . 74.5 m-85 -100.3 129.28 46.27 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.047 176.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 52' ' ' ILE . . . . . 0.417 HD11 ' CE1' ' D' ' 43' ' ' TYR . 4.6 tp -89.89 99.84 10.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 172.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 53' ' ' VAL . . . . . 0.448 ' CG1' ' HB3' ' D' ' 44' ' ' LEU . 2.6 m -84.29 -33.69 9.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.147 -169.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 54' ' ' ALA . . . . . . . . . . . . . . . -159.33 148.93 18.6 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.072 0.463 . . . . 0.0 111.971 177.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 92.4 m -117.45 102.89 9.58 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 170.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 56' ' ' VAL . . . . . . . . . . . . . 6.8 p -110.57 116.34 52.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.582 0.706 . . . . 0.0 110.215 -176.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 74.0 p -122.81 -177.47 3.67 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.206 -175.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 58' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' D' ' 38' ' ' GLN . 52.7 mtmt -59.89 -33.58 72.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.021 0.439 . . . . 0.0 110.357 169.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.05 -40.67 68.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.313 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 74.8 mt -116.67 80.19 10.38 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 174.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.54 0.36 7.64 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.824 2.35 . . . . 0.0 113.84 -166.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -162.52 119.12 1.96 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.157 0.504 . . . . 0.0 110.844 -176.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 91.9 t -110.12 101.74 12.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.193 176.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.07 111.3 17.4 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.529 173.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 65' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.05 150.79 52.09 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.153 -171.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 66' ' ' ASP . . . . . 0.499 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 11.6 t0 -96.08 99.18 10.96 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.499 0.666 . . . . 0.0 110.006 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . 0.531 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 4.2 mt -113.15 141.88 46.42 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.447 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 68' ' ' ASN . . . . . 0.595 ' HB3' ' CD2' ' C' ' 90' ' ' TYR . 6.3 t30 -148.92 132.54 16.81 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.1 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 69' ' ' PHE . . . . . 0.516 ' CZ ' HD23 ' D' ' 67' ' ' LEU . 63.7 m-85 -127.74 157.97 38.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.764 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 4.7 p -120.97 154.89 35.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.281 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.87 11.48 0.38 Allowed 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -174.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.0 -29.66 9.55 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.592 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -101.35 163.1 12.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.906 0.353 . . . . 0.0 111.012 -175.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -123.14 111.43 16.51 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . . . . . . . . . 27.7 pt -111.1 161.38 9.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.039 0.447 . . . . 0.0 111.719 -168.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 76' ' ' MET . . . . . 0.4 ' SD ' ' HB3' ' D' ' 20' ' ' SER . 4.9 mtm -121.88 124.82 45.0 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 173.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 77' ' ' PHE . . . . . 1.645 ' HE1' ' CE2' ' D' ' 77' ' ' PHE . 0.5 OUTLIER -105.02 128.16 53.19 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.163 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 78' ' ' TYR . . . . . 1.612 ' HE2' ' CE1' ' D' ' 78' ' ' TYR . 30.4 p90 -151.07 138.87 19.82 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.245 -0.582 . . . . 0.0 112.108 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 79' ' ' THR . . . . . 0.674 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 11.4 p -109.71 137.57 47.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.923 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.57 157.17 18.72 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.612 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.8 -173.88 35.46 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 -176.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 82' ' ' ASP . . . . . 0.417 ' HA ' ' HB3' ' D' ' 15' ' ' PRO . 11.5 m-20 -114.03 103.27 10.97 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.803 177.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.43 ' HB1' ' HB3' ' D' ' 40' ' ' ALA . . . -172.4 155.19 3.41 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.083 171.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 24.4 t -110.44 114.42 27.84 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . 0.467 ' CG1' ' HB3' ' D' ' 34' ' ' LEU . 6.8 m -112.89 143.66 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-O 121.347 0.594 . . . . 0.0 112.159 -174.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 12.0 t -109.04 118.63 37.28 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.67 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 87' ' ' LEU . . . . . 0.536 ' HB2' ' HB3' ' D' ' 11' ' ' LEU . 5.2 mp -93.96 151.82 19.28 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 174.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tp -134.31 145.99 49.58 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.113 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.76 -167.49 29.46 Favored Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.087 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 90' ' ' TYR . . . . . 0.568 ' CD2' ' HB3' ' E' ' 68' ' ' ASN . 8.7 p90 -151.56 130.22 12.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.755 0.788 . . . . 0.0 111.876 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' D' ' 6' ' ' ALA . 6.2 mt -66.92 122.6 18.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.631 175.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -101.58 108.5 20.07 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.405 0.621 . . . . 0.0 110.63 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -118.05 76.98 1.11 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.533 176.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . 0.506 ' HA ' ' SD ' ' D' ' 5' ' ' MET . 5.1 tp -78.52 120.92 30.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.584 -177.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -119.42 139.45 52.01 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.953 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 38.4 m -137.45 31.29 2.6 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.185 0.517 . . . . 0.0 110.141 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . 64.87 -131.94 36.95 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.187 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 11.8 p . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.107 177.811 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 1' ' ' PHE . . . . . 1.662 ' HD2' ' CD1' ' E' ' 1' ' ' PHE . 98.1 m-85 . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 120.313 0.102 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 65.25 178.87 0.19 Allowed 'General case' 0 C--O 1.233 0.228 0 O-C-N 123.588 0.555 . . . . 0.0 111.223 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.58 105.29 3.24 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.627 -176.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.22 -49.02 8.03 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 171.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 5' ' ' MET . . . . . 0.506 ' SD ' ' HA ' ' E' ' 94' ' ' ILE . 22.4 mmt 66.7 -65.75 0.2 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 114.601 -1.182 . . . . 0.0 112.065 174.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 6' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' E' ' 91' ' ' LEU . . . -103.52 112.73 25.77 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.78 0.324 . . . . 0.0 110.773 -178.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 54.7 mtt -108.21 147.12 31.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.778 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 8' ' ' PHE . . . . . 1.662 ' HE2' ' CE1' ' E' ' 8' ' ' PHE . 81.0 t80 -58.78 142.73 49.36 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -172.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 9' ' ' TRP . . . . . 0.493 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 89.2 t90 -140.11 147.71 40.64 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.104 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 10' ' ' GLY . . . . . 0.402 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -149.9 153.92 25.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.181 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . 0.525 ' HB3' ' HB2' ' E' ' 87' ' ' LEU . 51.6 tp -146.46 108.95 4.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.732 0.301 . . . . 0.0 111.251 -178.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -91.46 114.17 26.63 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.461 0.648 . . . . 0.0 110.994 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 13' ' ' MET . . . . . 0.469 ' HB2' HG21 ' E' ' 85' ' ' VAL . 3.5 mmt -93.15 137.32 32.6 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.043 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -100.67 153.31 37.81 Favored Pre-proline 0 C--N 1.318 -0.791 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 171.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . 0.428 ' HB3' ' HA ' ' E' ' 82' ' ' ASP . 84.9 Cg_exo -46.67 111.32 0.36 Allowed 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 123.08 2.52 . . . . 0.0 113.139 -178.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 16' ' ' GLU . . . . . 0.68 ' HA ' ' O ' ' E' ' 79' ' ' THR . 39.6 mt-10 65.94 59.02 0.73 Allowed 'General case' 0 C--O 1.232 0.181 0 O-C-N 123.77 0.669 . . . . 0.0 111.445 177.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 17' ' ' ARG . . . . . 0.402 ' HD3' ' HA ' ' E' ' 17' ' ' ARG . 70.4 mmt-85 -113.32 145.49 40.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.945 172.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . 0.614 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 33.8 ttmt -128.07 111.28 13.32 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.376 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . 0.404 ' OH ' ' HA ' ' E' ' 13' ' ' MET . 5.6 m-85 -108.61 104.03 13.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.681 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 9.4 p -88.06 99.96 12.57 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 173.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -125.45 138.71 54.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.543 0.687 . . . . 0.0 112.32 -167.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 14.8 t -85.1 160.29 20.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.701 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 53.4 mt -114.02 116.85 53.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 120.995 0.426 . . . . 0.0 110.856 -176.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . 0.547 HD12 ' H ' ' E' ' 24' ' ' ILE . 0.2 OUTLIER -104.08 -10.21 9.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.264 176.393 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 ptpp? -142.57 119.32 11.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.793 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 24.0 m -64.55 135.4 55.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.249 -177.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 27' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -147.22 160.76 42.09 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -174.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 28' ' ' HIS . . . . . 0.47 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 5.3 t60 -114.93 127.99 56.02 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.348 177.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 29' ' ' ILE . . . . . 0.529 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 56.6 mt -94.54 136.45 25.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 171.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 30' ' ' SER . . . . . 0.526 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 72.6 p -119.84 -16.67 8.68 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.712 -0.395 . . . . 0.0 112.018 -170.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 31' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -163.8 144.83 9.82 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 119.335 -1.412 . . . . 0.0 113.456 178.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 12.3 p -129.07 125.74 63.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 170.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.64 152.17 41.02 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.948 -0.47 . . . . 0.0 111.642 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 34' ' ' LEU . . . . . 0.468 ' HB3' ' CG1' ' E' ' 85' ' ' VAL . 3.5 pp -114.35 137.87 51.26 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 122.044 0.926 . . . . 0.0 111.719 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -106.09 -55.25 2.35 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.062 -1.427 . . . . 0.0 108.424 175.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -102.0 126.83 49.01 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.81 170.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . 0.429 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 147.94 162.52 10.16 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 119.576 -1.297 . . . . 0.0 113.596 176.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 38' ' ' GLN . . . . . 0.432 ' O ' ' HG3' ' E' ' 58' ' ' LYS . 39.2 mt-30 -102.77 -48.18 4.18 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 178.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -151.77 134.48 15.54 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.452 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . 0.411 ' HB3' ' HB1' ' E' ' 83' ' ' ALA . . . -135.27 117.34 15.38 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.278 0.561 . . . . 0.0 111.195 172.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 41' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' E' ' 79' ' ' THR . 48.2 mttm -97.62 116.08 29.15 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 173.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 53.6 tp -91.4 105.38 17.73 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.161 0.505 . . . . 0.0 110.053 -173.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 43' ' ' TYR . . . . . 1.665 ' HE1' ' CE2' ' E' ' 43' ' ' TYR . 97.1 m-85 -103.53 150.93 23.45 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.194 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 44' ' ' LEU . . . . . 0.611 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 1.1 tp -133.6 117.34 16.95 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.694 177.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 45' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -102.0 104.32 14.98 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.363 0.601 . . . . 0.0 109.554 175.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . 0.4 ' HB3' HD12 ' E' ' 44' ' ' LEU . . . -134.33 152.07 51.6 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 57.89 24.12 10.55 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -174.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 58.32 42.41 21.64 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.264 -175.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 49' ' ' GLN . . . . . 0.486 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 28.1 tp60 -137.61 131.84 32.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.545 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -79.66 107.22 12.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.909 0.385 . . . . 0.0 110.387 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . 1.644 ' HE2' ' CE1' ' E' ' 51' ' ' TYR . 74.5 m-85 -100.27 129.32 46.25 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.109 175.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 52' ' ' ILE . . . . . 0.414 HD11 ' CE1' ' E' ' 43' ' ' TYR . 4.6 tp -89.91 99.93 10.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 172.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . 0.452 ' CG1' ' HB3' ' E' ' 44' ' ' LEU . 2.6 m -84.32 -33.76 9.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.097 -169.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 54' ' ' ALA . . . . . . . . . . . . . . . -159.4 148.88 18.45 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.095 0.474 . . . . 0.0 111.887 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 92.4 m -117.36 102.9 9.62 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 170.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . . . . . . . . . 6.7 p -110.56 116.28 51.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.51 0.672 . . . . 0.0 110.214 -176.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 73.9 p -122.74 -177.44 3.65 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.248 -175.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 58' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' E' ' 38' ' ' GLN . 52.7 mtmt -59.86 -33.66 72.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.044 0.45 . . . . 0.0 110.309 169.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.92 -40.73 68.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.39 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 74.6 mt -116.64 80.09 10.22 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 174.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -72.46 0.27 7.73 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.87 2.38 . . . . 0.0 113.83 -166.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -162.44 119.11 1.99 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.196 0.522 . . . . 0.0 110.85 -176.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 92.0 t -110.09 101.72 12.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.232 175.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.21 111.26 17.47 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 173.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.0 150.87 52.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.109 -171.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 66' ' ' ASP . . . . . 0.473 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 11.6 t0 -96.06 99.11 10.89 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.414 0.626 . . . . 0.0 110.042 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 67' ' ' LEU . . . . . 0.529 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 4.1 mt -113.12 141.83 46.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.436 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 68' ' ' ASN . . . . . 0.568 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 6.2 t30 -148.92 132.48 16.76 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.068 177.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 69' ' ' PHE . . . . . 0.517 ' CZ ' HD23 ' E' ' 67' ' ' LEU . 63.4 m-85 -127.62 158.01 38.69 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.873 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 4.8 p -121.01 154.84 35.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.317 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.82 11.41 0.38 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -174.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.03 -29.57 9.62 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.626 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -101.45 163.13 12.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.95 0.405 . . . . 0.0 110.92 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -123.06 111.57 16.72 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 75' ' ' ILE . . . . . . . . . . . . . 27.9 pt -111.3 161.29 9.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.053 0.454 . . . . 0.0 111.697 -168.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 76' ' ' MET . . . . . . . . . . . . . 4.9 mtm -121.74 124.88 45.27 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 173.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 77' ' ' PHE . . . . . 1.637 ' HE2' ' CE1' ' E' ' 77' ' ' PHE . 0.5 OUTLIER -105.11 128.08 53.19 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.19 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 78' ' ' TYR . . . . . 1.651 ' HD1' ' CD2' ' E' ' 78' ' ' TYR . 30.2 p90 -151.01 138.86 19.86 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.059 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 79' ' ' THR . . . . . 0.68 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 11.1 p -109.74 137.55 47.38 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.898 -178.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.57 157.15 18.74 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.655 176.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.77 -173.84 35.46 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 82' ' ' ASP . . . . . 0.428 ' HA ' ' HB3' ' E' ' 15' ' ' PRO . 11.7 m-20 -114.05 103.18 10.88 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 119.609 -0.836 . . . . 0.0 109.873 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 83' ' ' ALA . . . . . 0.429 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -172.36 155.19 3.44 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.18 171.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 24.3 t -110.42 114.45 27.9 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 85' ' ' VAL . . . . . 0.469 HG21 ' HB2' ' E' ' 13' ' ' MET . 6.8 m -112.97 143.61 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 CA-C-O 121.514 0.673 . . . . 0.0 112.124 -174.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 11.9 t -108.97 118.73 37.56 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.641 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 87' ' ' LEU . . . . . 0.525 ' HB2' ' HB3' ' E' ' 11' ' ' LEU . 5.2 mp -94.17 151.89 19.13 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 174.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tp -134.32 145.95 49.52 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.089 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.73 -167.5 29.44 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.114 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 90' ' ' TYR . . . . . 0.605 ' CD2' ' HB3' ' A' ' 68' ' ' ASN . 8.8 p90 -151.58 130.24 12.31 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.742 0.782 . . . . 0.0 111.835 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 91' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' E' ' 6' ' ' ALA . 6.3 mt -67.0 122.57 18.04 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.051 -1.431 . . . . 0.0 109.595 175.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -101.48 108.55 20.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.376 0.607 . . . . 0.0 110.611 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -118.14 77.0 1.11 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.465 176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 94' ' ' ILE . . . . . 0.506 ' HA ' ' SD ' ' E' ' 5' ' ' MET . 5.0 tp -78.52 121.02 30.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.538 -177.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -119.47 139.48 52.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.961 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 37.7 m -137.44 31.21 2.6 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.056 0.455 . . . . 0.0 110.053 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . 64.93 -131.98 36.76 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.089 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 11.8 p . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.846 -0.597 . . . . 0.0 110.023 177.87 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 1.661 ' HD2' ' CD1' ' A' ' 1' ' ' PHE . 79.3 m-85 . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 121.036 0.446 . . . . 0.0 110.469 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -100.48 98.58 9.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.27 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.86 53.06 3.68 Favored Glycine 0 CA--C 1.517 0.165 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.64 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.61 -104.04 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 122.833 0.453 . . . . 0.0 109.805 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 42.5 ttp 53.59 28.8 8.28 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.089 0.556 . . . . 0.0 111.582 176.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.442 ' HB1' ' ND2' ' B' ' 68' ' ' ASN . . . -67.34 123.47 20.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.254 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 51.2 mtt -90.32 137.87 32.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.18 0.514 . . . . 0.0 111.603 -173.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.505 ' CE1' HD22 ' B' ' 44' ' ' LEU . 60.7 t80 -60.51 141.3 56.68 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.323 -174.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.491 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 91.9 t90 -130.41 144.8 51.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.915 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.1 140.81 9.11 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.395 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.491 ' HB2' ' CH2' ' A' ' 9' ' ' TRP . 56.6 tp -133.37 109.1 9.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.841 0.353 . . . . 0.0 110.348 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -97.78 104.11 16.11 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.636 ' SD ' HD12 ' A' ' 87' ' ' LEU . 35.9 mtp -98.4 137.86 36.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.588 -175.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -101.3 159.01 30.68 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.939 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.421 ' HB3' ' HA ' ' A' ' 82' ' ' ASP . 68.5 Cg_exo -42.89 118.45 1.22 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.752 2.968 . . . . 0.0 114.24 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.705 ' HA ' ' O ' ' A' ' 79' ' ' THR . 49.5 mt-10 57.16 55.99 5.54 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.068 174.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 78' ' ' TYR . 30.5 mmt180 -116.98 144.09 44.97 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.099 175.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.619 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 35.6 ttmt -126.23 112.78 16.16 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 123.491 0.494 . . . . 0.0 111.143 -176.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 1.609 ' HE1' ' CE2' ' A' ' 19' ' ' TYR . 2.3 m-85 -111.27 104.89 13.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.252 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.402 ' HB3' ' SD ' ' A' ' 76' ' ' MET . 3.7 p -88.2 104.8 17.05 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 173.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -124.13 148.11 47.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.432 0.634 . . . . 0.0 112.696 -168.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.2 t -90.96 161.06 15.32 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.513 175.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.409 HD11 ' HB2' ' A' ' 69' ' ' PHE . 67.6 mt -114.25 131.36 66.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.101 0.477 . . . . 0.0 111.62 -173.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.465 HD13 ' N ' ' A' ' 24' ' ' ILE . 4.2 mp -99.25 -48.92 11.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.085 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.407 ' HZ1' ' CG ' ' A' ' 93' ' ' ASP . 85.2 mttt -114.46 140.55 48.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.657 177.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.2 m -63.54 109.4 1.64 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 1.632 ' HD2' ' CD1' ' A' ' 27' ' ' PHE . 14.7 p90 -125.02 159.54 31.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.626 0.727 . . . . 0.0 112.886 -170.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.566 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 9.4 t60 -116.45 125.85 52.57 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.077 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.522 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 61.2 mt -92.42 133.12 34.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 170.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.566 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 32.8 p -118.9 -14.35 9.43 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -169.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -167.33 147.98 12.49 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 119.153 -1.498 . . . . 0.0 113.416 178.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.4 p -134.63 129.06 51.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 172.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.08 155.5 42.24 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.896 -0.503 . . . . 0.0 111.653 -174.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.426 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 4.0 pp -120.98 142.27 49.93 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.442 0.639 . . . . 0.0 111.205 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.418 ' HB2' ' HH ' ' B' ' 43' ' ' TYR . 12.9 p-10 -110.03 -50.08 3.01 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.572 173.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -103.18 127.45 50.47 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 168.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.436 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 152.21 158.97 8.7 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 119.906 -1.14 . . . . 0.0 113.19 176.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.452 ' O ' ' HG3' ' A' ' 58' ' ' LYS . 94.5 mt-30 -102.59 -45.35 5.07 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 120.625 0.25 . . . . 0.0 111.379 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -153.68 130.48 10.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.238 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.426 ' HB1' HG11 ' A' ' 56' ' ' VAL . . . -131.35 113.86 14.29 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.367 0.603 . . . . 0.0 110.492 169.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -97.14 111.6 23.76 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.453 ' HG ' ' CG2' ' A' ' 53' ' ' VAL . 45.4 tp -83.6 112.57 20.14 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.624 -174.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -110.96 137.17 48.92 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.293 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.577 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 1.2 tp -120.56 119.36 32.71 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.383 175.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -106.19 114.15 28.1 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.227 0.537 . . . . 0.0 109.671 176.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.535 ' HB1' ' CE2' ' E' ' 8' ' ' PHE . . . -145.97 154.59 42.08 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.98 -178.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 57.98 27.83 15.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.938 0.399 . . . . 0.0 110.381 -176.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm 59.22 44.6 15.42 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.743 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -150.86 140.22 21.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.963 178.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -85.98 126.99 34.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.18 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 1.609 ' HD1' ' CD2' ' A' ' 51' ' ' TYR . 49.9 m-85 -123.14 123.92 41.9 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.704 176.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 tp -77.38 103.42 4.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 171.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.453 ' CG2' ' HG ' ' A' ' 42' ' ' LEU . 2.8 m -86.88 -35.17 8.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.875 -173.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.482 ' HB1' ' CD2' ' A' ' 65' ' ' LEU . . . -152.51 145.6 24.58 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.108 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.4 m -114.65 101.87 9.5 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 169.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.426 HG11 ' HB1' ' A' ' 40' ' ' ALA . 7.4 p -115.86 112.93 41.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.798 0.809 . . . . 0.0 110.164 -176.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 81.6 p -123.38 -176.82 3.54 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.217 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 38' ' ' GLN . 34.7 mtmm -58.56 -34.58 71.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.179 0.514 . . . . 0.0 110.084 170.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.27 -40.88 64.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.467 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 72.4 mt -115.37 80.78 7.92 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 174.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -71.08 -0.01 7.32 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.122 2.548 . . . . 0.0 113.541 -168.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -161.94 124.69 2.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.41 0.624 . . . . 0.0 111.11 -176.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.415 HG12 ' HB3' ' A' ' 54' ' ' ALA . 85.7 t -113.73 102.96 14.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.355 174.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.93 109.8 17.89 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.441 173.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.482 ' CD2' ' HB1' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -129.67 168.93 15.73 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.19 0.519 . . . . 0.0 111.539 -174.647 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.49 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 17.1 t0 -115.61 106.21 13.65 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.728 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.522 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 25.9 mt -123.55 142.96 50.51 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 175.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.645 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 4.9 t30 -150.79 130.79 13.4 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.073 177.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 1.621 ' HD1' ' CD2' ' A' ' 69' ' ' PHE . 3.1 m-85 -126.39 153.26 45.21 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.427 ' OG ' ' HG2' ' E' ' 7' ' ' MET . 89.1 p -98.36 164.68 12.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.036 0.446 . . . . 0.0 110.779 -178.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -5.47 7.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.821 177.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.25 -3.5 55.54 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 121.089 -0.577 . . . . 0.0 111.724 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -93.76 159.06 15.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.973 0.416 . . . . 0.0 110.873 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -144.14 125.48 14.74 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 174.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.1 pt -136.17 163.78 33.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.928 -166.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.402 ' SD ' ' HB3' ' A' ' 20' ' ' SER . 3.7 mtm -121.93 130.72 53.56 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.72 173.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.577 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -111.39 128.15 55.88 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.253 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.619 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 33.8 p90 -151.57 138.42 18.95 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.25 0.548 . . . . 0.0 111.788 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.705 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 6.0 p -107.44 134.87 49.85 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.144 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.69 154.18 19.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.112 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.2 -175.92 40.0 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -175.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.421 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 9.4 m-20 -113.62 103.29 11.1 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.209 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.436 ' CB ' ' HA3' ' A' ' 37' ' ' GLY . . . -170.09 155.08 5.31 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.819 172.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.2 t -112.05 123.29 49.93 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.426 ' CG1' ' HB3' ' A' ' 34' ' ' LEU . 6.1 m -121.46 145.86 27.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.415 0.626 . . . . 0.0 112.637 -172.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.3 m -109.91 120.86 43.79 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.591 175.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.636 HD12 ' SD ' ' A' ' 13' ' ' MET . 4.7 mp -98.0 144.89 27.05 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 171.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 87' ' ' LEU . 2.4 mm? -124.43 146.46 48.89 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.017 174.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.06 -168.33 23.81 Favored Glycine 0 N--CA 1.434 -1.434 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.189 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.613 ' CD2' ' HB3' ' B' ' 68' ' ' ASN . 9.9 p90 -151.41 128.52 11.13 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.828 0.823 . . . . 0.0 111.822 177.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.0 mt -68.5 130.87 44.14 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 113.863 -1.517 . . . . 0.0 109.104 175.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -79.58 108.0 12.78 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.161 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.407 ' CG ' ' HZ1' ' A' ' 25' ' ' LYS . 3.0 m-20 -106.58 171.27 7.45 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.987 177.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 7.9 tp -172.98 143.45 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.407 ' CG ' ' H3 ' ' A' ' 1' ' ' PHE . 0.5 OUTLIER -111.1 162.97 14.36 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.262 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 30.7 t -126.15 31.59 5.4 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.087 0.47 . . . . 0.0 110.369 -178.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.14 -140.12 3.17 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.281 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.517 179.165 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 1.661 ' HE2' ' CE1' ' B' ' 1' ' ' PHE . 79.4 m-85 . . . . . 0 N--CA 1.481 1.125 0 CA-C-O 120.99 0.424 . . . . 0.0 110.434 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -100.59 98.64 9.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.189 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.8 53.02 3.65 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.613 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.58 -103.92 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 122.935 0.494 . . . . 0.0 109.897 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 42.4 ttp 53.41 28.83 7.96 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.054 0.542 . . . . 0.0 111.671 176.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.449 ' HB1' ' ND2' ' C' ' 68' ' ' ASN . . . -67.39 123.52 20.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.271 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 51.3 mtt -90.29 137.84 32.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.152 0.501 . . . . 0.0 111.657 -173.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 0.53 ' CE1' HD22 ' C' ' 44' ' ' LEU . 60.6 t80 -60.47 141.25 56.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.401 -174.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . 0.49 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 91.9 t90 -130.33 144.78 51.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.964 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.13 140.92 9.18 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.416 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.49 ' HB2' ' CH2' ' B' ' 9' ' ' TRP . 57.0 tp -133.54 109.13 9.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.828 0.347 . . . . 0.0 110.315 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -97.76 104.05 16.04 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' MET . . . . . 0.632 ' SD ' HD12 ' B' ' 87' ' ' LEU . 35.8 mtp -98.35 137.81 36.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.641 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.405 ' HB2' ' HZ3' ' B' ' 14' ' ' LYS . 10.1 mtmp? -101.11 159.1 30.45 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.009 176.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.438 ' HB3' ' HA ' ' B' ' 82' ' ' ASP . 69.6 Cg_exo -42.93 118.48 1.24 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.672 2.915 . . . . 0.0 114.323 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.704 ' HA ' ' O ' ' B' ' 79' ' ' THR . 49.7 mt-10 57.06 56.15 5.5 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.05 174.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.402 ' O ' ' HA ' ' B' ' 78' ' ' TYR . 30.4 mmt180 -117.11 144.07 45.1 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.079 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . 0.634 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 35.6 ttmt -126.18 112.79 16.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.091 -176.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' TYR . . . . . 1.585 ' HD1' ' CD2' ' B' ' 19' ' ' TYR . 2.4 m-85 -111.26 104.84 13.36 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.291 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 3.7 p -88.25 104.77 17.04 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 173.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -124.02 148.12 47.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.498 0.666 . . . . 0.0 112.711 -168.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 13.2 t -91.0 161.08 15.29 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.544 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.41 HD11 ' HB2' ' B' ' 69' ' ' PHE . 67.8 mt -114.25 131.26 66.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.116 0.484 . . . . 0.0 111.677 -173.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.466 HD13 ' N ' ' B' ' 24' ' ' ILE . 4.2 mp -99.23 -48.97 11.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.037 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.411 ' HZ1' ' CG ' ' B' ' 93' ' ' ASP . 85.3 mttt -114.43 140.72 48.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.627 177.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 19.2 m -63.57 109.22 1.59 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 173.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . 1.627 ' HE2' ' CE1' ' B' ' 27' ' ' PHE . 14.6 p90 -124.93 159.56 30.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.627 0.727 . . . . 0.0 112.845 -170.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' HIS . . . . . 0.562 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 9.3 t60 -116.43 125.81 52.53 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.131 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 61.5 mt -92.44 133.11 34.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 170.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.562 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 33.2 p -118.88 -14.33 9.44 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -169.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -167.3 148.09 12.65 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 119.146 -1.502 . . . . 0.0 113.375 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 11.3 p -134.68 129.09 51.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 172.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.15 155.53 42.22 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.551 -174.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.436 ' HB3' HG13 ' B' ' 85' ' ' VAL . 4.0 pp -120.98 142.3 49.9 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.51 0.672 . . . . 0.0 111.206 178.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.44 ' HB2' ' HH ' ' C' ' 43' ' ' TYR . 13.0 p-10 -110.06 -50.04 3.01 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.578 173.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -103.14 127.53 50.39 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 168.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.44 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 152.17 158.88 8.65 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.217 176.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . 0.457 ' O ' ' HG3' ' B' ' 58' ' ' LYS . 94.5 mt-30 -102.46 -45.4 5.08 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.572 0.225 . . . . 0.0 111.441 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -153.77 130.54 10.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.189 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.43 ' HB3' ' HB1' ' B' ' 83' ' ' ALA . . . -131.36 113.88 14.3 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.411 0.624 . . . . 0.0 110.507 169.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -97.15 111.68 23.8 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 173.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.449 ' HG ' ' CG2' ' B' ' 53' ' ' VAL . 45.8 tp -83.76 112.57 20.21 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.614 -174.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . 0.418 ' HH ' ' HB2' ' A' ' 35' ' ' ASP . 83.8 m-85 -110.91 137.15 48.91 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.335 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.587 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 1.2 tp -120.57 119.33 32.59 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.344 175.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -106.23 114.1 28.02 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . 0.478 ' HB1' ' CE2' ' A' ' 8' ' ' PHE . . . -145.94 154.63 42.14 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.932 -178.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 57.95 27.82 15.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.947 0.403 . . . . 0.0 110.391 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm 59.18 44.61 15.53 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.722 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -150.82 140.17 21.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.901 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -85.82 127.07 34.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 1.611 ' HD1' ' CD2' ' B' ' 51' ' ' TYR . 49.8 m-85 -123.16 123.83 41.69 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.655 176.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 tp -77.25 103.3 4.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 171.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.449 ' CG2' ' HG ' ' B' ' 42' ' ' LEU . 2.8 m -86.8 -35.31 8.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.853 -173.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.479 ' HB1' ' CD2' ' B' ' 65' ' ' LEU . . . -152.49 145.62 24.61 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 120.239 -0.584 . . . . 0.0 112.155 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 27.3 m -114.64 101.94 9.57 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 169.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . 0.406 HG11 ' HB1' ' B' ' 40' ' ' ALA . 7.3 p -115.92 112.96 41.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.771 0.796 . . . . 0.0 110.079 -176.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 82.6 p -123.48 -176.93 3.57 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.185 -175.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' B' ' 38' ' ' GLN . 34.7 mtmm -58.39 -34.67 70.99 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.12 0.486 . . . . 0.0 110.062 170.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.4 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -73.31 -40.9 64.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.466 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 72.5 mt -115.32 80.81 7.81 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 10.2 Cg_exo -71.13 -0.0 7.34 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.107 2.538 . . . . 0.0 113.486 -168.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -161.93 124.86 3.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.375 0.607 . . . . 0.0 111.095 -176.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.408 HG12 ' HB3' ' B' ' 54' ' ' ALA . 85.7 t -113.78 102.93 14.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.311 174.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.95 109.81 17.91 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.46 173.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.479 ' CD2' ' HB1' ' B' ' 54' ' ' ALA . 0.4 OUTLIER -129.61 168.97 15.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.197 0.522 . . . . 0.0 111.608 -174.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . 0.511 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 16.9 t0 -115.65 106.3 13.74 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.719 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.525 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 26.2 mt -123.63 142.96 50.55 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . 0.613 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 4.9 t30 -150.83 130.76 13.33 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.062 177.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . 1.611 ' HE2' ' CE1' ' B' ' 69' ' ' PHE . 3.2 m-85 -126.43 153.2 45.34 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 88.9 p -98.3 164.72 12.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.003 0.43 . . . . 0.0 110.802 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -5.45 8.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.805 177.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.19 -3.58 55.57 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.765 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -93.72 159.09 15.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.96 0.409 . . . . 0.0 110.776 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -144.22 125.5 14.69 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 18.0 pt -136.21 163.84 33.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.04 0.448 . . . . 0.0 111.91 -166.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' MET . . . . . . . . . . . . . 3.7 mtm -121.99 130.78 53.59 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.698 173.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . 0.587 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.9 OUTLIER -111.36 128.18 55.89 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.269 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 0.634 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 33.5 p90 -151.61 138.47 18.96 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.199 0.523 . . . . 0.0 111.818 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.704 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 6.0 p -107.46 134.82 49.93 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.1 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.63 154.26 19.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.208 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.08 -175.88 40.15 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -175.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' ASP . . . . . 0.438 ' HA ' ' HB3' ' B' ' 15' ' ' PRO . 9.5 m-20 -113.65 103.34 11.14 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.136 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.44 ' CB ' ' HA3' ' B' ' 37' ' ' GLY . . . -170.16 154.99 5.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.838 172.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 16.1 t -111.99 123.31 49.98 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' B' ' 34' ' ' LEU . 6.1 m -121.54 145.81 27.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.494 0.664 . . . . 0.0 112.578 -172.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 20.3 m -109.88 120.87 43.81 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.575 175.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.632 HD12 ' SD ' ' B' ' 13' ' ' MET . 4.7 mp -97.92 144.9 26.99 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 171.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.456 HD12 ' O ' ' B' ' 87' ' ' LEU . 2.4 mm? -124.51 146.55 48.92 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.982 174.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.13 -168.36 23.91 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.25 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' TYR . . . . . 0.585 ' CD2' ' HB3' ' C' ' 68' ' ' ASN . 9.8 p90 -151.42 128.55 11.14 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.844 0.83 . . . . 0.0 111.777 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 7.0 mt -68.56 130.94 44.34 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.097 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -79.67 108.01 12.89 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.105 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . 0.411 ' CG ' ' HZ1' ' B' ' 25' ' ' LYS . 2.9 m-20 -106.62 171.2 7.49 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.831 177.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 7.9 tp -172.88 143.49 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . 0.412 ' CG ' ' H3 ' ' B' ' 1' ' ' PHE . 0.6 OUTLIER -111.21 162.91 14.47 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.223 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 30.4 t -126.17 31.82 5.35 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.093 0.473 . . . . 0.0 110.388 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.29 -140.04 3.15 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.281 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.553 -0.736 . . . . 0.0 109.454 179.195 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 1' ' ' PHE . . . . . 1.648 ' HE2' ' CE1' ' C' ' 1' ' ' PHE . 79.3 m-85 . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 121.082 0.468 . . . . 0.0 110.529 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -100.59 98.59 9.15 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.202 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.74 52.92 3.62 Favored Glycine 0 CA--C 1.517 0.184 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.609 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.57 -104.03 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 122.889 0.476 . . . . 0.0 109.79 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 42.5 ttp 53.55 28.92 8.35 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.078 0.551 . . . . 0.0 111.589 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 6' ' ' ALA . . . . . 0.458 ' HB1' ' ND2' ' D' ' 68' ' ' ASN . . . -67.52 123.53 20.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.193 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 51.3 mtt -90.33 137.88 31.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.196 0.522 . . . . 0.0 111.601 -173.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 8' ' ' PHE . . . . . 0.539 ' CE1' HD22 ' D' ' 44' ' ' LEU . 60.8 t80 -60.5 141.3 56.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.355 -174.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . 0.49 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 91.9 t90 -130.42 144.78 51.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.924 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.13 140.84 9.12 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.482 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.49 ' HB2' ' CH2' ' C' ' 9' ' ' TRP . 56.6 tp -133.39 108.99 9.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.802 0.334 . . . . 0.0 110.342 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -97.75 104.05 16.04 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 13' ' ' MET . . . . . 0.63 ' SD ' HD12 ' C' ' 87' ' ' LEU . 35.8 mtp -98.35 137.78 36.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.616 -175.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . 0.409 ' HZ3' ' HB2' ' C' ' 14' ' ' LYS . 10.1 mtmp? -101.2 159.14 30.32 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.034 176.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . 0.416 ' HB3' ' HA ' ' C' ' 82' ' ' ASP . 69.1 Cg_exo -43.01 118.52 1.28 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.727 2.952 . . . . 0.0 114.282 -177.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . 0.704 ' HA ' ' O ' ' C' ' 79' ' ' THR . 49.6 mt-10 57.02 56.19 5.5 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.085 174.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 17' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' C' ' 78' ' ' TYR . 30.5 mmt180 -117.15 144.05 45.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.114 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 18' ' ' LYS . . . . . 0.633 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 35.6 ttmt -126.18 112.85 16.27 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 123.455 0.472 . . . . 0.0 111.096 -176.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . 1.603 ' HE2' ' CE1' ' C' ' 19' ' ' TYR . 2.3 m-85 -111.34 104.77 13.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.302 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 20' ' ' SER . . . . . 0.404 ' HB3' ' SD ' ' C' ' 76' ' ' MET . 3.7 p -88.1 104.83 17.05 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 173.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -124.07 148.1 47.36 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.437 0.637 . . . . 0.0 112.715 -168.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 13.2 t -90.89 161.05 15.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.583 175.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . 0.41 HD11 ' HB2' ' C' ' 69' ' ' PHE . 67.7 mt -114.24 131.33 66.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.151 0.5 . . . . 0.0 111.667 -173.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . 0.463 HD13 ' N ' ' C' ' 24' ' ' ILE . 4.2 mp -99.27 -49.03 11.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.937 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . 0.41 ' HZ1' ' CG ' ' C' ' 93' ' ' ASP . 85.2 mttt -114.35 140.61 48.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.657 177.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 19.1 m -63.52 109.3 1.6 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 173.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 27' ' ' PHE . . . . . 1.63 ' HE2' ' CE1' ' C' ' 27' ' ' PHE . 14.7 p90 -124.92 159.53 30.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.703 0.764 . . . . 0.0 112.828 -170.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 28' ' ' HIS . . . . . 0.577 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 9.2 t60 -116.5 125.84 52.51 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.049 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . 0.516 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 61.2 mt -92.46 133.08 34.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 170.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 30' ' ' SER . . . . . 0.577 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 33.0 p -118.83 -14.32 9.47 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -169.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -167.36 148.01 12.52 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 119.092 -1.528 . . . . 0.0 113.356 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 11.4 p -134.57 129.06 51.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 172.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.14 155.42 42.13 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.686 -174.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.441 ' HB3' HG13 ' C' ' 85' ' ' VAL . 4.0 pp -120.9 142.37 49.76 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.462 0.648 . . . . 0.0 111.213 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . 0.413 ' HB2' ' HH ' ' D' ' 43' ' ' TYR . 12.9 p-10 -110.14 -50.02 3.01 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.516 173.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -103.24 127.52 50.52 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 168.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 37' ' ' GLY . . . . . 0.441 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 152.16 158.83 8.63 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 119.875 -1.155 . . . . 0.0 113.231 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 38' ' ' GLN . . . . . 0.45 ' O ' ' HG3' ' C' ' 58' ' ' LYS . 94.7 mt-30 -102.48 -45.39 5.08 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.519 0.2 . . . . 0.0 111.373 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -153.73 130.43 10.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.265 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . 0.425 ' HB3' ' HB1' ' C' ' 83' ' ' ALA . . . -131.35 113.8 14.21 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.388 0.613 . . . . 0.0 110.454 169.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -97.02 111.74 23.82 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.448 ' HG ' ' CG2' ' C' ' 53' ' ' VAL . 45.7 tp -83.84 112.57 20.24 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.593 -174.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 43' ' ' TYR . . . . . 0.44 ' HH ' ' HB2' ' B' ' 35' ' ' ASP . 83.9 m-85 -110.92 137.22 48.83 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.354 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.586 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 1.2 tp -120.61 119.36 32.65 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.381 175.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -106.26 114.13 28.07 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.168 0.509 . . . . 0.0 109.635 176.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . 0.496 ' HB1' ' CE2' ' B' ' 8' ' ' PHE . . . -145.95 154.67 42.17 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.929 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 58.02 27.76 15.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.971 0.415 . . . . 0.0 110.446 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm 59.27 44.44 15.48 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.788 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -150.73 140.1 21.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.983 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -85.69 127.04 34.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.235 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 1.636 ' HD1' ' CD2' ' C' ' 51' ' ' TYR . 50.0 m-85 -123.23 123.85 41.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.62 176.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 tp -77.33 103.39 4.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 171.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 53' ' ' VAL . . . . . 0.448 ' CG2' ' HG ' ' C' ' 42' ' ' LEU . 2.8 m -86.87 -35.26 8.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.819 -173.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 54' ' ' ALA . . . . . 0.489 ' HB1' ' CD2' ' C' ' 65' ' ' LEU . . . -152.54 145.54 24.51 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.145 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 27.7 m -114.69 101.96 9.58 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 169.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . 0.421 HG11 ' HB1' ' C' ' 40' ' ' ALA . 7.4 p -115.87 113.02 42.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.775 0.798 . . . . 0.0 110.126 -176.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 81.5 p -123.53 -176.79 3.54 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.208 -175.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 58' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' C' ' 38' ' ' GLN . 34.7 mtmm -58.51 -34.65 71.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.143 0.497 . . . . 0.0 110.065 170.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.3 -40.89 64.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.408 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 72.5 mt -115.35 80.74 7.84 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 174.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -70.97 -0.07 7.35 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.027 2.485 . . . . 0.0 113.552 -168.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -161.92 124.83 3.01 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.449 0.643 . . . . 0.0 111.062 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.4 HG12 ' HB3' ' C' ' 54' ' ' ALA . 85.9 t -113.75 102.96 14.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.252 174.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.05 109.78 17.94 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 173.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . 0.489 ' CD2' ' HB1' ' C' ' 54' ' ' ALA . 0.4 OUTLIER -129.53 168.96 15.6 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.171 0.51 . . . . 0.0 111.545 -174.68 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 66' ' ' ASP . . . . . 0.504 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 17.1 t0 -115.59 106.16 13.61 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.667 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . 0.516 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 26.1 mt -123.55 142.99 50.48 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . 0.585 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 4.9 t30 -150.87 130.72 13.26 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.1 177.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 69' ' ' PHE . . . . . 1.598 ' HD2' ' CD1' ' C' ' 69' ' ' PHE . 3.0 m-85 -126.32 153.24 45.12 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 88.9 p -98.4 164.67 12.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.073 0.463 . . . . 0.0 110.77 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -5.45 7.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.766 177.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.24 -3.54 55.53 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.738 176.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -93.77 159.17 15.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.991 0.424 . . . . 0.0 110.758 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -144.21 125.48 14.68 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 174.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 18.1 pt -136.13 163.83 33.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.999 0.428 . . . . 0.0 111.865 -166.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 76' ' ' MET . . . . . 0.404 ' SD ' ' HB3' ' C' ' 20' ' ' SER . 3.6 mtm -122.0 130.75 53.56 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.81 173.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 77' ' ' PHE . . . . . 0.586 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.9 OUTLIER -111.3 128.17 55.86 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.368 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 78' ' ' TYR . . . . . 0.633 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 34.0 p90 -151.68 138.37 18.81 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.177 0.513 . . . . 0.0 111.886 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 79' ' ' THR . . . . . 0.704 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 6.2 p -107.38 134.85 49.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.088 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.68 154.26 19.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.139 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.13 -175.85 40.04 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 82' ' ' ASP . . . . . 0.416 ' HA ' ' HB3' ' C' ' 15' ' ' PRO . 9.5 m-20 -113.68 103.33 11.12 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.159 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . 0.441 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -170.21 155.0 5.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.837 172.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 16.2 t -112.01 123.33 50.03 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.441 HG13 ' HB3' ' C' ' 34' ' ' LEU . 6.2 m -121.49 145.83 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 CA-C-O 121.505 0.669 . . . . 0.0 112.644 -172.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 20.3 m -109.92 120.9 43.92 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.591 175.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . 0.63 HD12 ' SD ' ' C' ' 13' ' ' MET . 4.7 mp -97.98 144.81 27.13 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 171.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . 0.469 HD12 ' O ' ' C' ' 87' ' ' LEU . 2.4 mm? -124.42 146.48 48.87 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.443 -0.798 . . . . 0.0 108.985 174.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.09 -168.34 23.84 Favored Glycine 0 N--CA 1.436 -1.366 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.204 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 90' ' ' TYR . . . . . 0.616 ' CD2' ' HB3' ' D' ' 68' ' ' ASN . 9.9 p90 -151.42 128.57 11.16 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.785 0.802 . . . . 0.0 111.783 177.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 7.0 mt -68.62 130.99 44.45 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 113.858 -1.519 . . . . 0.0 108.993 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -79.75 108.05 13.0 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.125 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 93' ' ' ASP . . . . . 0.41 ' CG ' ' HZ1' ' C' ' 25' ' ' LYS . 3.0 m-20 -106.61 171.18 7.5 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.892 177.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 7.9 tp -172.87 143.45 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.684 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 95' ' ' ASP . . . . . 0.416 ' CG ' ' H3 ' ' C' ' 1' ' ' PHE . 0.5 OUTLIER -111.18 162.95 14.41 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.187 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 31.1 t -126.15 31.82 5.35 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.108 0.48 . . . . 0.0 110.419 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.28 -140.04 3.15 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.249 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.425 -0.798 . . . . 0.0 109.363 179.281 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . 1.628 ' HE2' ' CE1' ' D' ' 1' ' ' PHE . 79.4 m-85 . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 121.114 0.483 . . . . 0.0 110.53 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -100.53 98.59 9.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.234 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.81 53.09 3.66 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.557 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.7 -103.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 122.858 0.463 . . . . 0.0 109.821 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 42.4 ttp 53.41 28.92 8.06 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.041 0.537 . . . . 0.0 111.642 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 6' ' ' ALA . . . . . 0.435 ' HB1' ' ND2' ' E' ' 68' ' ' ASN . . . -67.51 123.46 20.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.243 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 51.4 mtt -90.28 137.88 31.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.655 -173.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 8' ' ' PHE . . . . . 0.531 ' CE1' HD22 ' E' ' 44' ' ' LEU . 60.4 t80 -60.52 141.3 56.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.41 -174.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 9' ' ' TRP . . . . . 0.491 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 92.1 t90 -130.41 144.79 51.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.913 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.12 140.95 9.21 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.374 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . 0.491 ' HB2' ' CH2' ' D' ' 9' ' ' TRP . 56.4 tp -133.45 109.08 9.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.768 0.318 . . . . 0.0 110.298 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -97.74 104.08 16.08 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 13' ' ' MET . . . . . 0.635 ' SD ' HD12 ' D' ' 87' ' ' LEU . 35.8 mtp -98.4 137.84 36.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.587 -175.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 14' ' ' LYS . . . . . 0.405 ' HB2' ' HZ3' ' D' ' 14' ' ' LYS . 10.1 mtmp? -101.14 159.13 30.36 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.052 176.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . 0.425 ' HB3' ' HA ' ' D' ' 82' ' ' ASP . 69.1 Cg_exo -42.94 118.44 1.23 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.696 2.931 . . . . 0.0 114.314 -177.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . 0.698 ' HA ' ' O ' ' D' ' 79' ' ' THR . 49.7 mt-10 57.19 56.07 5.46 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.024 174.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 17' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' D' ' 78' ' ' TYR . 30.5 mmt180 -117.08 144.04 45.1 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.033 175.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . 0.631 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 35.6 ttmt -126.18 112.86 16.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.07 -176.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 19' ' ' TYR . . . . . 1.643 ' HE2' ' CE1' ' D' ' 19' ' ' TYR . 2.4 m-85 -111.3 104.77 13.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.308 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 20' ' ' SER . . . . . 0.403 ' HB3' ' SD ' ' D' ' 76' ' ' MET . 3.7 p -88.14 104.75 16.99 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 173.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -124.0 148.17 47.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.442 0.639 . . . . 0.0 112.72 -168.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 13.2 t -91.0 161.1 15.28 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.533 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . 0.406 HD11 ' HB2' ' D' ' 69' ' ' PHE . 67.5 mt -114.31 131.24 66.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.191 0.519 . . . . 0.0 111.678 -173.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . 0.461 ' N ' HD13 ' D' ' 24' ' ' ILE . 4.2 mp -99.12 -49.06 11.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.095 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . 0.404 ' HZ1' ' CG ' ' D' ' 93' ' ' ASP . 85.2 mttt -114.35 140.64 48.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.648 177.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 19.3 m -63.55 109.4 1.64 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 173.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 27' ' ' PHE . . . . . 1.659 ' HD2' ' CD1' ' D' ' 27' ' ' PHE . 14.5 p90 -125.01 159.49 31.18 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.692 0.758 . . . . 0.0 112.824 -170.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 28' ' ' HIS . . . . . 0.58 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 9.4 t60 -116.37 125.82 52.61 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.222 -1.354 . . . . 0.0 110.156 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 29' ' ' ILE . . . . . 0.514 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 61.3 mt -92.41 133.04 35.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 170.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 30' ' ' SER . . . . . 0.58 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 33.2 p -118.79 -14.4 9.5 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -169.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 31' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -167.31 148.02 12.55 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 119.141 -1.504 . . . . 0.0 113.387 178.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 11.4 p -134.59 128.99 51.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 172.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.11 155.5 42.22 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.496 -0.481 . . . . 0.0 111.629 -174.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 34' ' ' LEU . . . . . 0.435 ' HB3' HG13 ' D' ' 85' ' ' VAL . 4.0 pp -120.98 142.24 49.96 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.455 0.645 . . . . 0.0 111.225 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . 0.463 ' HB2' ' HH ' ' E' ' 43' ' ' TYR . 12.9 p-10 -109.98 -50.16 3.0 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.554 173.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -103.09 127.54 50.32 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 168.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . 0.445 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 152.16 158.95 8.68 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 119.868 -1.158 . . . . 0.0 113.253 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 38' ' ' GLN . . . . . 0.447 ' O ' ' HG3' ' D' ' 58' ' ' LYS . 94.7 mt-30 -102.6 -45.35 5.07 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.625 0.25 . . . . 0.0 111.4 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -153.67 130.58 10.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.221 178.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . 0.438 ' HB3' ' HB1' ' D' ' 83' ' ' ALA . . . -131.43 113.82 14.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.417 0.627 . . . . 0.0 110.46 169.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -97.08 111.63 23.77 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 173.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.452 ' HG ' ' CG2' ' D' ' 53' ' ' VAL . 45.9 tp -83.73 112.61 20.22 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.522 -174.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 43' ' ' TYR . . . . . 0.413 ' HH ' ' HB2' ' C' ' 35' ' ' ASP . 84.3 m-85 -110.86 137.15 48.86 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.326 178.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.587 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 1.2 tp -120.61 119.44 32.87 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.37 175.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 45' ' ' ALA . . . . . . . . . . . . . . . -106.25 113.99 27.86 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . 0.508 ' HB1' ' CE2' ' C' ' 8' ' ' PHE . . . -145.92 154.61 42.13 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.961 -178.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 58.06 27.75 15.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.931 0.396 . . . . 0.0 110.421 -176.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm 59.24 44.54 15.45 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.809 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -150.83 140.36 21.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.896 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -85.99 127.01 34.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.18 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . 1.644 ' HD1' ' CD2' ' D' ' 51' ' ' TYR . 49.7 m-85 -123.15 123.79 41.61 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.722 176.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 tp -77.26 103.33 4.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 171.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 53' ' ' VAL . . . . . 0.452 ' CG2' ' HG ' ' D' ' 42' ' ' LEU . 2.8 m -86.79 -35.29 8.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.861 -173.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 54' ' ' ALA . . . . . 0.481 ' HB1' ' CD2' ' D' ' 65' ' ' LEU . . . -152.46 145.64 24.65 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.284 -0.566 . . . . 0.0 112.167 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 27.2 m -114.74 101.98 9.59 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 169.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 56' ' ' VAL . . . . . 0.421 HG11 ' HB1' ' D' ' 40' ' ' ALA . 7.4 p -115.94 112.98 41.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.791 0.805 . . . . 0.0 110.081 -176.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 82.5 p -123.48 -176.81 3.54 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.208 -175.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 58' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' D' ' 38' ' ' GLN . 34.7 mtmm -58.56 -34.59 71.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.128 0.49 . . . . 0.0 110.069 170.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.4 -40.73 64.07 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.452 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 72.4 mt -115.36 80.74 7.87 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 174.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -71.05 -0.1 7.44 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.109 2.539 . . . . 0.0 113.516 -168.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -161.84 124.73 3.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.327 0.584 . . . . 0.0 111.127 -176.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.421 HG12 ' HB3' ' D' ' 54' ' ' ALA . 85.1 t -113.72 102.91 14.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.32 174.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.01 109.8 17.93 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.404 173.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 65' ' ' LEU . . . . . 0.481 ' CD2' ' HB1' ' D' ' 54' ' ' ALA . 0.4 OUTLIER -129.66 168.9 15.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.107 0.479 . . . . 0.0 111.606 -174.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 66' ' ' ASP . . . . . 0.498 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 17.2 t0 -115.47 106.21 13.7 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.735 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . 0.514 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 25.9 mt -123.6 143.03 50.48 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 68' ' ' ASN . . . . . 0.616 ' HB3' ' CD2' ' C' ' 90' ' ' TYR . 4.9 t30 -150.83 130.73 13.31 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.026 177.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 69' ' ' PHE . . . . . 1.61 ' HE2' ' CE1' ' D' ' 69' ' ' PHE . 3.2 m-85 -126.33 153.23 45.16 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 89.0 p -98.36 164.63 12.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.029 0.442 . . . . 0.0 110.819 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.39 -5.49 7.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.824 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.19 -3.64 55.55 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.714 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -93.66 159.1 15.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.969 0.414 . . . . 0.0 110.836 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -144.25 125.53 14.69 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . . . . . . . . . 18.1 pt -136.13 163.79 33.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.925 -166.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 76' ' ' MET . . . . . 0.403 ' SD ' ' HB3' ' D' ' 20' ' ' SER . 3.6 mtm -121.95 130.67 53.51 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.752 173.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 77' ' ' PHE . . . . . 0.587 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.9 OUTLIER -111.34 128.21 55.89 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.277 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 78' ' ' TYR . . . . . 0.631 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 33.5 p90 -151.7 138.39 18.8 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.239 0.543 . . . . 0.0 111.822 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 79' ' ' THR . . . . . 0.698 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 6.0 p -107.4 134.89 49.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.101 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.74 154.16 19.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.189 175.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.24 -175.88 39.89 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -175.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 82' ' ' ASP . . . . . 0.425 ' HA ' ' HB3' ' D' ' 15' ' ' PRO . 9.5 m-20 -113.65 103.27 11.06 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.172 178.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.445 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -170.16 155.02 5.21 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.814 172.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 15.7 t -111.95 123.39 50.16 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . 0.435 HG13 ' HB3' ' D' ' 34' ' ' LEU . 6.2 m -121.52 145.85 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.454 0.645 . . . . 0.0 112.631 -172.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 20.2 m -109.88 120.83 43.71 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.582 175.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 87' ' ' LEU . . . . . 0.635 HD12 ' SD ' ' D' ' 13' ' ' MET . 4.7 mp -97.96 144.87 27.05 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 170.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . 0.473 HD12 ' O ' ' D' ' 87' ' ' LEU . 2.4 mm? -124.46 146.48 48.91 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.013 174.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.09 -168.26 23.74 Favored Glycine 0 N--CA 1.435 -1.421 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.189 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 90' ' ' TYR . . . . . 0.564 ' CD2' ' HB3' ' E' ' 68' ' ' ASN . 9.8 p90 -151.46 128.55 11.12 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.825 0.821 . . . . 0.0 111.757 177.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 6.9 mt -68.62 131.04 44.54 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.852 -1.522 . . . . 0.0 109.047 175.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -79.76 108.03 13.01 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.099 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 93' ' ' ASP . . . . . 0.404 ' CG ' ' HZ1' ' D' ' 25' ' ' LYS . 2.9 m-20 -106.61 171.18 7.5 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.929 177.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 7.9 tp -172.88 143.48 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 95' ' ' ASP . . . . . 0.416 ' CG ' ' H3 ' ' D' ' 1' ' ' PHE . 0.6 OUTLIER -111.17 162.92 14.44 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.284 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 31.5 t -126.15 31.69 5.38 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.066 0.46 . . . . 0.0 110.364 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.21 -139.98 3.14 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.263 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.63 -0.7 . . . . 0.0 109.43 179.205 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' E' E ' 1' ' ' PHE . . . . . 1.639 ' HE1' ' CE2' ' E' ' 1' ' ' PHE . 79.3 m-85 . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 121.065 0.46 . . . . 0.0 110.536 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -100.58 98.6 9.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.236 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.87 53.04 3.68 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 121.159 -0.544 . . . . 0.0 112.636 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.55 -104.02 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 122.87 0.468 . . . . 0.0 109.824 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 42.3 ttp 53.57 28.73 8.18 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.646 176.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 6' ' ' ALA . . . . . 0.478 ' HB1' ' ND2' ' A' ' 68' ' ' ASN . . . -67.31 123.48 20.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.236 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 7' ' ' MET . . . . . 0.427 ' HG2' ' OG ' ' A' ' 70' ' ' SER . 51.3 mtt -90.3 137.82 32.04 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.138 0.494 . . . . 0.0 111.634 -173.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 8' ' ' PHE . . . . . 0.541 ' CE1' HD22 ' A' ' 44' ' ' LEU . 60.4 t80 -60.51 141.21 56.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.367 -174.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 9' ' ' TRP . . . . . 0.487 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 92.1 t90 -130.32 144.7 51.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.966 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.03 140.96 9.23 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.44 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . 0.487 ' HB2' ' CH2' ' E' ' 9' ' ' TRP . 56.7 tp -133.53 109.09 9.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.864 0.364 . . . . 0.0 110.335 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -97.78 104.05 16.04 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 13' ' ' MET . . . . . 0.64 ' SD ' HD12 ' E' ' 87' ' ' LEU . 35.8 mtp -98.3 137.74 36.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.615 -175.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -101.13 159.12 30.38 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.99 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . 0.425 ' HB3' ' HA ' ' E' ' 82' ' ' ASP . 68.6 Cg_exo -43.01 118.55 1.29 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.632 2.888 . . . . 0.0 114.298 -177.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 16' ' ' GLU . . . . . 0.698 ' HA ' ' O ' ' E' ' 79' ' ' THR . 49.6 mt-10 57.02 56.14 5.53 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.109 174.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 17' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' E' ' 78' ' ' TYR . 30.4 mmt180 -117.17 144.05 45.17 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.019 175.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . 0.637 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 35.6 ttmt -126.14 112.87 16.32 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 123.573 0.546 . . . . 0.0 111.096 -176.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . 1.648 ' HE1' ' CE2' ' E' ' 19' ' ' TYR . 2.3 m-85 -111.26 104.74 13.26 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.288 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 20' ' ' SER . . . . . 0.402 ' HB3' ' SD ' ' E' ' 76' ' ' MET . 3.8 p -88.03 104.79 16.99 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 173.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -124.07 148.04 47.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.482 0.658 . . . . 0.0 112.692 -168.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 13.1 t -90.88 161.11 15.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.536 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 23' ' ' ILE . . . . . 0.403 HD11 ' HB2' ' E' ' 69' ' ' PHE . 67.6 mt -114.34 131.31 66.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.125 0.488 . . . . 0.0 111.709 -173.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . 0.451 ' N ' HD13 ' E' ' 24' ' ' ILE . 4.2 mp -99.22 -48.92 11.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.0 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . 0.4 ' HZ1' ' CG ' ' E' ' 93' ' ' ASP . 85.3 mttt -114.49 140.62 48.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.61 177.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 19.1 m -63.58 109.35 1.63 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 173.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 27' ' ' PHE . . . . . 1.659 ' HD2' ' CD1' ' E' ' 27' ' ' PHE . 14.6 p90 -124.92 159.55 30.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.643 0.735 . . . . 0.0 112.88 -170.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 28' ' ' HIS . . . . . 0.571 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 9.3 t60 -116.45 125.83 52.53 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.047 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 29' ' ' ILE . . . . . 0.516 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 61.1 mt -92.38 133.12 34.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 170.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 30' ' ' SER . . . . . 0.571 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 32.9 p -118.96 -14.31 9.4 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -169.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 31' ' ' GLY . . . . . 0.556 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -167.32 148.01 12.53 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.143 -1.504 . . . . 0.0 113.352 178.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 11.5 p -134.69 128.99 51.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 172.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.07 155.49 42.24 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 121.942 -0.474 . . . . 0.0 111.655 -174.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 34' ' ' LEU . . . . . 0.441 ' HB3' HG13 ' E' ' 85' ' ' VAL . 4.0 pp -121.0 142.29 49.93 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.511 0.672 . . . . 0.0 111.181 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -110.11 -50.05 3.01 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.476 173.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -103.17 127.46 50.46 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 168.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . 0.443 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 152.17 158.85 8.64 Favored Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 119.875 -1.155 . . . . 0.0 113.293 176.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 38' ' ' GLN . . . . . 0.461 ' O ' ' HG3' ' E' ' 58' ' ' LYS . 94.4 mt-30 -102.47 -45.44 5.07 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 120.586 0.231 . . . . 0.0 111.39 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -153.68 130.59 10.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.229 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . 0.424 ' HB3' ' HB1' ' E' ' 83' ' ' ALA . . . -131.41 113.83 14.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.388 0.613 . . . . 0.0 110.467 169.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 41' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -97.06 111.63 23.77 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.445 ' HG ' ' CG2' ' E' ' 53' ' ' VAL . 45.7 tp -83.69 112.57 20.17 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.627 -174.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 43' ' ' TYR . . . . . 0.463 ' HH ' ' HB2' ' D' ' 35' ' ' ASP . 84.1 m-85 -110.95 137.14 48.95 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.32 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 44' ' ' LEU . . . . . 0.589 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 1.2 tp -120.54 119.43 32.92 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.377 175.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 45' ' ' ALA . . . . . . . . . . . . . . . -106.24 114.15 28.1 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . 0.506 ' HB1' ' CE2' ' D' ' 8' ' ' PHE . . . -146.04 154.58 42.02 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.957 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 58.02 27.77 15.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.027 0.441 . . . . 0.0 110.406 -176.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm 59.23 44.61 15.38 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.749 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 49' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -150.89 140.23 21.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.922 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -85.89 127.1 34.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.15 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . 1.634 ' HD1' ' CD2' ' E' ' 51' ' ' TYR . 49.8 m-85 -123.23 123.96 41.94 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.669 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 tp -77.39 103.36 4.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 171.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . 0.445 ' CG2' ' HG ' ' E' ' 42' ' ' LEU . 2.8 m -86.83 -35.32 8.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.786 -173.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 54' ' ' ALA . . . . . 0.486 ' HB1' ' CD2' ' E' ' 65' ' ' LEU . . . -152.49 145.53 24.55 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.312 -0.555 . . . . 0.0 112.191 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 27.4 m -114.63 101.95 9.58 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 169.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . 0.422 HG11 ' HB1' ' E' ' 40' ' ' ALA . 7.4 p -115.92 112.99 41.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.783 0.802 . . . . 0.0 110.114 -176.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 82.8 p -123.4 -176.81 3.53 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.234 -175.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 58' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' E' ' 38' ' ' GLN . 34.6 mtmm -58.45 -34.8 71.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.199 0.523 . . . . 0.0 110.043 170.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.24 -40.78 64.39 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.508 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 72.6 mt -115.38 80.67 7.87 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -71.06 0.02 7.27 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.047 2.498 . . . . 0.0 113.448 -168.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -162.01 124.75 2.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.504 0.669 . . . . 0.0 111.08 -176.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . 0.414 HG12 ' HB3' ' E' ' 54' ' ' ALA . 86.4 t -113.81 102.97 14.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.239 174.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.0 109.84 17.96 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.411 173.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . 0.486 ' CD2' ' HB1' ' E' ' 54' ' ' ALA . 0.4 OUTLIER -129.62 168.97 15.64 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.081 0.467 . . . . 0.0 111.583 -174.657 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 66' ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 17.1 t0 -115.68 106.26 13.68 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.708 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 67' ' ' LEU . . . . . 0.516 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 26.0 mt -123.55 143.0 50.47 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 175.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 68' ' ' ASN . . . . . 0.564 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 4.9 t30 -150.78 130.72 13.35 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.122 177.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 69' ' ' PHE . . . . . 1.603 ' HD2' ' CD1' ' E' ' 69' ' ' PHE . 3.1 m-85 -126.34 153.19 45.23 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 88.9 p -98.28 164.67 12.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.006 0.431 . . . . 0.0 110.786 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.42 -5.57 7.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.781 177.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.18 -3.44 55.64 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 121.043 -0.599 . . . . 0.0 111.791 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -93.74 159.08 15.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.99 0.424 . . . . 0.0 110.747 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -144.21 125.47 14.67 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 174.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 75' ' ' ILE . . . . . . . . . . . . . 18.0 pt -136.09 163.8 33.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.92 -166.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 76' ' ' MET . . . . . 0.402 ' SD ' ' HB3' ' E' ' 20' ' ' SER . 3.7 mtm -121.95 130.76 53.59 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 173.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 77' ' ' PHE . . . . . 0.589 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.9 OUTLIER -111.41 128.18 55.9 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.248 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 78' ' ' TYR . . . . . 0.637 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 33.9 p90 -151.64 138.45 18.91 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.242 0.544 . . . . 0.0 111.8 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 79' ' ' THR . . . . . 0.698 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 6.2 p -107.4 134.84 49.86 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.13 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.67 154.17 19.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.17 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.19 -175.91 39.99 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -175.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 82' ' ' ASP . . . . . 0.425 ' HA ' ' HB3' ' E' ' 15' ' ' PRO . 9.2 m-20 -113.64 103.37 11.17 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.132 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 83' ' ' ALA . . . . . 0.443 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -170.24 155.03 5.14 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.832 172.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 16.2 t -112.03 123.45 50.28 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 85' ' ' VAL . . . . . 0.441 HG13 ' HB3' ' E' ' 34' ' ' LEU . 6.1 m -121.62 145.76 27.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.424 0.631 . . . . 0.0 112.617 -172.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 20.4 m -109.87 120.82 43.67 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.619 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 87' ' ' LEU . . . . . 0.64 HD12 ' SD ' ' E' ' 13' ' ' MET . 4.7 mp -97.87 144.84 27.02 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 171.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . 0.467 HD12 ' O ' ' E' ' 87' ' ' LEU . 2.4 mm? -124.4 146.46 48.86 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.075 174.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.07 -168.34 23.83 Favored Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.272 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 90' ' ' TYR . . . . . 0.645 ' CD2' ' HB3' ' A' ' 68' ' ' ASN . 9.9 p90 -151.4 128.57 11.17 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.814 0.816 . . . . 0.0 111.794 177.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 91' ' ' LEU . . . . . . . . . . . . . 7.1 mt -68.61 131.0 44.49 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 113.893 -1.503 . . . . 0.0 109.036 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -79.79 108.04 13.04 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.104 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 93' ' ' ASP . . . . . 0.4 ' CG ' ' HZ1' ' E' ' 25' ' ' LYS . 3.0 m-20 -106.51 171.17 7.5 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.956 177.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 7.9 tp -172.93 143.38 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 95' ' ' ASP . . . . . 0.411 ' CG ' ' H3 ' ' E' ' 1' ' ' PHE . 0.5 OUTLIER -111.08 162.97 14.34 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.203 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 31.0 t -126.07 31.65 5.4 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.208 0.527 . . . . 0.0 110.513 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.18 -139.96 3.14 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.524 -0.845 . . . . 0.0 112.243 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.509 -0.758 . . . . 0.0 109.392 179.315 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 69.16 -60.46 0.46 Allowed 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.82 0.7 . . . . 0.0 110.969 -176.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -91.01 -71.27 1.21 Allowed Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.93 176.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.21 133.16 43.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.019 0.438 . . . . 0.0 111.672 -177.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 67.4 mtp -144.18 -170.64 3.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.913 173.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' B' ' 70' ' ' SER . . . -50.14 137.56 17.51 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.677 0.611 . . . . 0.0 112.1 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 38.7 mtt -111.8 146.46 37.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.963 -176.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.419 ' CE1' HD22 ' B' ' 44' ' ' LEU . 61.0 t80 -64.7 146.39 54.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.54 -171.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.452 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 90.5 t90 -137.89 147.03 44.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.066 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.83 155.22 26.27 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.802 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.497 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 48.2 tp -143.86 108.72 4.93 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.768 0.318 . . . . 0.0 110.964 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -91.19 100.69 13.47 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.001 0.429 . . . . 0.0 110.057 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.597 ' SD ' HD12 ' A' ' 87' ' ' LEU . 57.0 mtp -90.56 138.03 31.88 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.21 -177.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.481 ' HB2' ' HD2' ' A' ' 17' ' ' ARG . 32.6 mmtp -101.24 150.94 37.57 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.911 -175.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.432 ' HD3' ' OG ' ' A' ' 84' ' ' SER . 81.9 Cg_exo -43.13 112.28 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 124.195 3.263 . . . . 0.0 114.745 -172.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.682 ' HA ' ' O ' ' A' ' 79' ' ' THR . 5.7 tt0 60.9 63.47 1.28 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.468 170.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.481 ' HD2' ' HB2' ' A' ' 14' ' ' LYS . 37.7 mtt85 -136.27 155.39 50.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.57 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.648 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 3.3 ttmp? -125.5 115.47 20.27 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.769 -175.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -112.6 119.49 38.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.866 176.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.3 p -79.54 133.39 36.47 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 172.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -108.69 115.95 31.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.08 0.467 . . . . 0.0 112.044 -167.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.6 m -93.18 123.12 36.23 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 169.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.9 mt -93.28 113.76 28.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.217 0.532 . . . . 0.0 111.548 -171.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.418 HD13 ' N ' ' A' ' 24' ' ' ILE . 4.5 mp -85.66 -48.32 16.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.491 178.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.401 ' HD2' HD12 ' A' ' 91' ' ' LEU . 47.0 mttt -119.33 132.47 55.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.267 178.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.6 p -59.62 123.14 15.95 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -136.56 161.84 34.76 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -170.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.554 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 21.6 t60 -115.86 128.1 55.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.885 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.547 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 44.1 mt -98.76 131.7 45.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 170.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.554 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 40.5 p -116.05 -15.15 11.17 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -171.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -164.05 155.04 26.22 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 119.391 -1.385 . . . . 0.0 113.503 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.5 p -137.33 124.43 29.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 171.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 62' ' ' GLN . . . -125.87 150.04 48.2 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -170.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.515 ' HB2' HG21 ' A' ' 56' ' ' VAL . 1.8 tm? -104.53 109.52 21.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.689 -174.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.53 -59.42 1.95 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.914 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.489 ' HB3' ' HZ3' ' A' ' 36' ' ' LYS . 3.1 mmmp? -104.09 129.4 51.77 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.605 175.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.565 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 134.84 177.59 15.06 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 119.275 -1.441 . . . . 0.0 113.506 174.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.407 ' HA ' ' HD2' ' A' ' 58' ' ' LYS . 74.4 mt-30 -103.41 -47.82 4.17 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.635 0.255 . . . . 0.0 111.295 176.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -151.2 133.27 15.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.42 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.88 114.86 17.02 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.322 0.582 . . . . 0.0 110.427 170.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -100.15 111.22 23.5 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.6 tp -84.2 115.78 22.6 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.044 -173.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.419 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 98.2 m-85 -117.47 145.34 44.24 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.47 ' HA ' ' O ' ' A' ' 76' ' ' MET . 0.2 OUTLIER -133.09 134.2 43.96 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 171.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.522 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -108.59 115.53 30.27 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.407 178.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.406 ' HB2' ' CE2' ' E' ' 8' ' ' PHE . . . -128.71 144.02 51.07 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 58.37 27.35 15.26 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -170.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.7 mttp 59.53 33.18 22.07 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.938 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.522 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 8.7 tp-100 -120.31 124.45 45.63 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -83.07 117.74 23.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.805 0.336 . . . . 0.0 110.878 -176.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -112.51 136.17 52.36 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.719 176.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.1 tp -78.38 109.89 13.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 168.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.462 HG11 ' CD2' ' E' ' 88' ' ' LEU . 2.7 t -82.97 -50.28 15.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.356 -173.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.425 ' HB2' HG12 ' A' ' 63' ' ' VAL . . . -155.4 144.16 20.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.187 -178.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.8 m -108.32 102.42 11.54 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 172.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.515 HG21 ' HB2' ' A' ' 34' ' ' LEU . 13.4 p -120.98 112.99 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-O 122.205 1.003 . . . . 0.0 110.781 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.7 p -123.31 -178.0 3.86 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.914 -174.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 38' ' ' GLN . 29.8 mtpp -59.66 -31.55 69.64 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.053 0.454 . . . . 0.0 110.222 169.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.06 -40.35 62.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.614 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.7 mt -112.46 84.47 6.27 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 173.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.2 0.74 6.23 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.111 2.54 . . . . 0.0 114.352 -166.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 18.9 pt20 -169.81 130.46 1.02 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.096 0.474 . . . . 0.0 111.127 -177.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.425 HG12 ' HB2' ' A' ' 54' ' ' ALA . 95.4 t -118.81 116.56 51.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.297 175.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.44 122.41 39.3 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.04 176.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -138.78 168.5 19.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.057 0.456 . . . . 0.0 111.527 -176.566 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.462 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 7.7 t0 -116.07 99.56 7.33 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.188 0.518 . . . . 0.0 110.232 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.547 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 21.0 mt -113.42 137.37 51.63 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.893 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.645 ' HB2' ' CD2' ' E' ' 90' ' ' TYR . 3.8 m-20 -138.0 118.18 13.56 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 176.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -117.37 151.46 36.98 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.358 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' E' ' 6' ' ' ALA . 14.6 t -113.02 152.99 28.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.068 -177.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -69.68 -12.1 61.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.377 -176.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.2 -12.08 68.42 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.822 175.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -100.75 164.32 11.91 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -143.49 127.83 17.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.973 0.416 . . . . 0.0 109.961 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.9 pt -131.42 179.62 4.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.04 -170.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.47 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 12.0 mtm -136.05 135.56 39.51 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 171.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 1.652 ' HD1' ' CD2' ' A' ' 77' ' ' PHE . 1.1 m-85 -112.61 128.2 56.31 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.648 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 34.5 p90 -153.55 137.17 16.0 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.303 0.573 . . . . 0.0 112.105 -177.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.682 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 5.9 p -109.21 138.32 45.74 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.04 -177.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.79 162.3 13.91 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.194 176.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.87 -174.73 44.58 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -175.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -115.46 102.83 10.17 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.092 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.565 ' CB ' ' HA3' ' A' ' 37' ' ' GLY . . . -175.46 162.74 2.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.562 171.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.432 ' OG ' ' HD3' ' A' ' 15' ' ' PRO . 1.1 m -116.01 126.01 53.24 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.659 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 m -116.8 148.73 19.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -174.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.4 m -108.5 113.58 26.73 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.653 173.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.597 HD12 ' SD ' ' A' ' 13' ' ' MET . 5.2 mp -89.62 148.64 23.22 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 170.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.488 ' CD2' HG11 ' B' ' 53' ' ' VAL . 0.9 OUTLIER -132.06 138.93 48.36 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.079 -178.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.7 -167.12 24.75 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.878 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.668 ' CD2' ' HB2' ' B' ' 68' ' ' ASN . 13.0 p90 -150.71 128.86 11.9 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.995 0.902 . . . . 0.0 111.745 177.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.401 HD12 ' HD2' ' A' ' 25' ' ' LYS . 8.2 mt -69.7 135.01 49.31 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 113.941 -1.481 . . . . 0.0 109.655 176.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -86.96 107.67 18.49 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -157.52 136.55 11.68 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -176.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.02 117.86 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.103 0.478 . . . . 0.0 110.77 -175.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -95.67 168.89 10.4 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.792 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 28.5 t 62.7 44.53 6.54 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.384 0.611 . . . . 0.0 109.986 -177.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.99 69.19 3.42 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.142 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.5 t . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.669 -0.681 . . . . 0.0 109.544 179.527 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 69.37 -60.59 0.46 Allowed 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.842 0.714 . . . . 0.0 110.925 -176.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.99 -71.16 1.21 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.958 176.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.21 133.17 43.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.02 0.438 . . . . 0.0 111.668 -177.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 67.1 mtp -144.16 -170.64 3.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.887 173.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' C' ' 70' ' ' SER . . . -50.14 137.64 17.36 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 123.706 0.629 . . . . 0.0 112.018 -176.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 38.7 mtt -111.9 146.41 37.81 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.904 -176.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 0.447 ' CE1' HD22 ' C' ' 44' ' ' LEU . 61.3 t80 -64.55 146.37 54.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.553 -171.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . 0.447 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 90.5 t90 -138.03 147.02 43.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.01 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.81 155.23 26.27 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.87 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.492 ' HB3' ' HB2' ' B' ' 87' ' ' LEU . 47.6 tp -143.88 108.78 4.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.743 0.306 . . . . 0.0 110.976 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -91.17 100.75 13.52 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.973 0.416 . . . . 0.0 110.039 173.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' MET . . . . . 0.61 ' SD ' HD12 ' B' ' 87' ' ' LEU . 57.4 mtp -90.61 137.96 31.94 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.196 -177.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.472 ' HB2' ' HD2' ' B' ' 17' ' ' ARG . 32.6 mmtp -101.17 150.99 37.58 Favored Pre-proline 0 C--N 1.317 -0.834 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.938 -175.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.432 ' HD3' ' OG ' ' B' ' 84' ' ' SER . 83.3 Cg_exo -43.19 112.23 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 124.187 3.258 . . . . 0.0 114.853 -172.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.675 ' HA ' ' O ' ' B' ' 79' ' ' THR . 5.7 tt0 61.0 63.33 1.28 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.502 170.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.472 ' HD2' ' HB2' ' B' ' 14' ' ' LYS . 37.7 mtt85 -136.19 155.56 49.96 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.601 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . 0.645 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 3.3 ttmp? -125.61 115.43 20.13 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.762 -175.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -112.64 119.38 37.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.842 176.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 10.1 p -79.55 133.33 36.46 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 172.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -108.67 116.03 31.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.063 0.459 . . . . 0.0 112.02 -167.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 28.3 m -93.12 123.16 36.19 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 169.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 52.9 mt -93.28 113.77 28.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.179 0.514 . . . . 0.0 111.536 -172.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.416 HD13 ' N ' ' B' ' 24' ' ' ILE . 4.5 mp -85.56 -48.46 16.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.543 178.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -119.32 132.46 55.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.267 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 12.7 p -59.58 123.09 15.74 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -136.56 161.76 34.98 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -169.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' HIS . . . . . 0.552 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 22.0 t60 -115.83 128.03 55.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.847 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 43.7 mt -98.68 131.7 45.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 170.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.552 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 41.0 p -116.06 -15.16 11.17 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -171.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -164.15 154.98 26.13 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 119.377 -1.392 . . . . 0.0 113.535 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 9.5 p -137.26 124.4 30.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' B' ' 62' ' ' GLN . . . -125.77 150.05 48.07 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -170.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.517 ' HB2' HG21 ' B' ' 56' ' ' VAL . 1.8 tm? -104.6 109.58 21.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.688 -174.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.52 -59.47 1.94 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.917 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.489 ' HB3' ' HZ3' ' B' ' 36' ' ' LYS . 3.1 mmmp? -104.02 129.38 51.64 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.712 175.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.57 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 134.73 177.53 15.01 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 119.222 -1.466 . . . . 0.0 113.485 174.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . 0.407 ' HA ' ' HD2' ' B' ' 58' ' ' LYS . 74.3 mt-30 -103.37 -47.85 4.17 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.633 0.254 . . . . 0.0 111.294 176.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -151.2 133.29 15.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.385 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.92 114.89 17.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.356 0.598 . . . . 0.0 110.453 170.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -100.15 111.14 23.42 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 48.2 tp -84.1 115.74 22.53 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.098 -173.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . 0.42 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 98.2 m-85 -117.43 145.37 44.18 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.2 OUTLIER -133.17 134.19 43.79 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.235 0.54 . . . . 0.0 109.549 171.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -108.51 115.54 30.29 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.357 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -128.8 144.06 51.07 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 58.42 27.29 15.25 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -170.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 59.7 mttp 59.46 33.24 22.19 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.923 -175.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.527 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 8.7 tp-100 -120.31 124.48 45.7 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -82.98 117.61 22.92 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.767 0.318 . . . . 0.0 111.01 -176.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -112.47 136.2 52.26 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.672 176.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 6.2 tp -78.33 109.86 13.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 168.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.488 HG11 ' CD2' ' A' ' 88' ' ' LEU . 2.7 t -83.08 -50.14 15.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.3 -173.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.413 ' HB2' HG12 ' B' ' 63' ' ' VAL . . . -155.46 144.14 20.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.141 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 23.6 m -108.38 102.49 11.59 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 172.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . 0.517 HG21 ' HB2' ' B' ' 34' ' ' LEU . 13.3 p -121.01 112.95 37.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 122.224 1.012 . . . . 0.0 110.739 -175.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 68.2 p -123.29 -177.89 3.83 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.975 -174.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' B' ' 38' ' ' GLN . 29.8 mtpp -59.66 -31.6 69.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.18 0.514 . . . . 0.0 110.223 169.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.06 -40.3 62.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.629 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 83.9 mt -112.52 84.6 6.46 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 173.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.18 0.68 6.32 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.051 2.501 . . . . 0.0 114.427 -166.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' B' ' 33' ' ' ALA . 18.9 pt20 -169.77 130.49 1.03 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.167 0.508 . . . . 0.0 111.095 -177.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.413 HG12 ' HB2' ' B' ' 54' ' ' ALA . 95.6 t -118.8 116.53 51.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.308 175.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.45 122.3 39.2 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.067 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' B' ' 30' ' ' SER . 0.3 OUTLIER -138.67 168.57 19.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.02 0.438 . . . . 0.0 111.541 -176.617 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 7.6 t0 -116.07 99.56 7.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.145 0.498 . . . . 0.0 110.16 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.55 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 21.1 mt -113.48 137.21 51.88 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.978 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . 0.668 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 3.8 m-20 -137.88 118.16 13.66 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 176.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -117.42 151.51 36.9 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.271 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 6' ' ' ALA . 14.8 t -113.12 153.01 28.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.067 -177.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -69.65 -12.13 61.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.37 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.09 -12.19 68.48 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.849 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -100.72 164.25 11.95 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -143.44 127.9 17.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.936 0.398 . . . . 0.0 109.988 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 10.9 pt -131.56 179.63 4.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.958 -170.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' MET . . . . . 0.46 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 11.9 mtm -136.01 135.66 39.65 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 171.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . 1.667 ' HD1' ' CD2' ' B' ' 77' ' ' PHE . 1.1 m-85 -112.66 128.29 56.35 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 0.645 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 34.3 p90 -153.63 137.15 15.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.345 0.593 . . . . 0.0 112.093 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.675 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 5.9 p -109.15 138.21 45.86 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.068 -177.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.81 162.43 13.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.184 176.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.87 -174.78 44.64 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -175.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -115.45 102.83 10.17 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.614 -0.834 . . . . 0.0 110.026 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.57 ' CB ' ' HA3' ' B' ' 37' ' ' GLY . . . -175.54 162.69 2.84 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.528 171.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' SER . . . . . 0.432 ' OG ' ' HD3' ' B' ' 15' ' ' PRO . 1.1 m -115.98 126.01 53.27 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.553 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 2.7 m -116.87 148.81 19.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.147 0.499 . . . . 0.0 112.329 -174.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 43.1 m -108.52 113.63 26.8 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.63 173.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.61 HD12 ' SD ' ' B' ' 13' ' ' MET . 5.3 mp -89.74 148.62 23.15 Favored 'General case' 0 CA--C 1.5 -0.953 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.448 170.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.486 ' CD2' HG11 ' C' ' 53' ' ' VAL . 0.9 OUTLIER -132.04 138.98 48.41 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.078 -178.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.78 -167.17 24.93 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.872 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' TYR . . . . . 0.647 ' CD2' ' HB2' ' C' ' 68' ' ' ASN . 12.9 p90 -150.66 128.84 11.93 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.889 0.852 . . . . 0.0 111.786 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 8.3 mt -69.69 135.06 49.38 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.632 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -87.05 107.76 18.57 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 174.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -157.51 136.46 11.62 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.93 117.94 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.116 0.484 . . . . 0.0 110.759 -175.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -95.74 168.98 10.33 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.815 175.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 27.4 t 62.65 44.6 6.6 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.347 0.594 . . . . 0.0 109.881 -177.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . -83.09 69.43 3.38 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.036 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 12.2 t . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.75 -0.643 . . . . 0.0 109.643 179.346 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 69.4 -60.54 0.46 Allowed 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.822 0.701 . . . . 0.0 110.922 -176.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . -91.03 -71.23 1.21 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.943 176.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.22 133.2 43.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.981 0.42 . . . . 0.0 111.723 -177.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 67.0 mtp -144.18 -170.57 3.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.874 173.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 6' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' D' ' 70' ' ' SER . . . -50.18 137.63 17.56 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 123.692 0.62 . . . . 0.0 112.086 -176.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 38.6 mtt -111.88 146.36 37.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.921 -176.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 8' ' ' PHE . . . . . 0.423 ' CE1' HD22 ' D' ' 44' ' ' LEU . 61.5 t80 -64.56 146.33 54.79 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.586 -171.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . 0.441 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 90.6 t90 -137.98 147.01 43.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.024 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.79 155.23 26.27 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.864 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.5 ' HB3' ' HB2' ' C' ' 87' ' ' LEU . 48.5 tp -143.93 108.71 4.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.805 0.336 . . . . 0.0 110.902 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -91.16 100.77 13.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.997 0.427 . . . . 0.0 109.992 173.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 13' ' ' MET . . . . . 0.597 ' SD ' HD12 ' C' ' 87' ' ' LEU . 57.3 mtp -90.65 137.96 31.95 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.216 -177.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . 0.461 ' HB2' ' HD2' ' C' ' 17' ' ' ARG . 32.6 mmtp -101.2 150.97 37.58 Favored Pre-proline 0 C--N 1.317 -0.81 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.898 -175.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . 0.434 ' HD3' ' OG ' ' C' ' 84' ' ' SER . 84.3 Cg_exo -43.15 112.33 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 124.146 3.231 . . . . 0.0 114.847 -172.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . 0.68 ' HA ' ' O ' ' C' ' 79' ' ' THR . 5.7 tt0 60.81 63.51 1.29 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.513 170.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 17' ' ' ARG . . . . . 0.461 ' HD2' ' HB2' ' C' ' 14' ' ' LYS . 37.8 mtt85 -136.28 155.53 49.96 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.613 178.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 18' ' ' LYS . . . . . 0.645 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 3.3 ttmp? -125.67 115.46 20.14 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.703 -175.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -112.73 119.42 38.01 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.893 176.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 10.0 p -79.53 133.46 36.47 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 172.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -108.68 116.03 31.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.089 0.471 . . . . 0.0 112.075 -167.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 28.3 m -93.19 123.2 36.3 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 169.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 52.8 mt -93.3 113.8 28.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.135 0.493 . . . . 0.0 111.448 -172.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . 0.417 HD13 ' N ' ' C' ' 24' ' ' ILE . 4.5 mp -85.62 -48.36 16.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.585 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . 0.41 ' HD2' HD11 ' C' ' 91' ' ' LEU . 47.1 mttt -119.39 132.4 55.83 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.242 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 12.4 p -59.54 123.13 15.87 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 177.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 27' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -136.6 161.79 34.91 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -170.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 28' ' ' HIS . . . . . 0.558 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 21.9 t60 -115.83 128.06 55.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.26 -1.337 . . . . 0.0 109.879 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 44.3 mt -98.69 131.71 45.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 170.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 30' ' ' SER . . . . . 0.558 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 39.7 p -116.06 -15.19 11.16 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.813 -171.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -164.04 155.04 26.22 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 119.355 -1.403 . . . . 0.0 113.533 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 9.5 p -137.36 124.36 29.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 171.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' C' ' 62' ' ' GLN . . . -125.78 150.17 47.99 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -170.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.508 ' HB2' HG21 ' C' ' 56' ' ' VAL . 1.8 tm? -104.68 109.58 21.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.63 -174.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.55 -59.45 1.95 Allowed 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.925 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 36' ' ' LYS . . . . . 0.492 ' HB3' ' HZ3' ' C' ' 36' ' ' LYS . 3.1 mmmp? -104.03 129.25 51.65 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.689 175.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 37' ' ' GLY . . . . . 0.576 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 134.87 177.7 15.14 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 119.339 -1.41 . . . . 0.0 113.451 174.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -103.43 -47.84 4.16 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.69 0.281 . . . . 0.0 111.303 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -151.12 133.22 15.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.441 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.89 114.83 16.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.336 0.589 . . . . 0.0 110.404 170.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -100.07 111.25 23.55 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 48.6 tp -84.2 115.88 22.65 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.004 -173.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 43' ' ' TYR . . . . . 0.418 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 98.2 m-85 -117.51 145.38 44.26 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 176.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' C' ' 76' ' ' MET . 0.2 OUTLIER -133.14 134.1 43.74 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 171.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -108.56 115.5 30.21 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.418 178.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -128.68 143.99 51.06 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 58.44 27.31 15.3 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -170.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 59.7 mttp 59.53 33.17 22.07 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.957 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . 0.531 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 8.7 tp-100 -120.2 124.39 45.59 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -83.05 117.75 23.05 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.917 0.389 . . . . 0.0 110.97 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -112.53 136.27 52.25 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.692 176.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 6.1 tp -78.4 109.92 13.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 168.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 53' ' ' VAL . . . . . 0.486 HG11 ' CD2' ' B' ' 88' ' ' LEU . 2.7 t -83.04 -50.21 15.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.377 -173.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 54' ' ' ALA . . . . . 0.412 ' HB2' HG12 ' C' ' 63' ' ' VAL . . . -155.49 144.09 20.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.187 -178.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 23.7 m -108.3 102.54 11.66 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 172.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . 0.508 HG21 ' HB2' ' C' ' 34' ' ' LEU . 13.3 p -121.02 113.02 38.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 122.225 1.012 . . . . 0.0 110.753 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 68.3 p -123.32 -177.95 3.85 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.969 -174.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -59.61 -31.62 69.66 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.106 0.479 . . . . 0.0 110.249 169.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.0 -40.38 62.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.598 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 84.0 mt -112.48 84.55 6.36 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 173.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.28 0.73 6.3 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.07 2.513 . . . . 0.0 114.367 -166.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . 0.425 ' HA ' ' HA ' ' C' ' 33' ' ' ALA . 18.8 pt20 -169.8 130.5 1.02 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.169 0.509 . . . . 0.0 111.133 -177.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.412 HG12 ' HB2' ' C' ' 54' ' ' ALA . 95.6 t -118.74 116.61 51.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.283 175.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.51 122.35 39.31 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.01 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' C' ' 30' ' ' SER . 0.3 OUTLIER -138.7 168.58 19.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.495 -176.576 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 66' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 7.6 t0 -116.1 99.51 7.29 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.232 0.539 . . . . 0.0 110.231 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . 0.541 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 21.1 mt -113.43 137.26 51.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.916 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . 0.647 ' HB2' ' CD2' ' B' ' 90' ' ' TYR . 3.8 m-20 -137.91 118.1 13.56 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 176.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -117.36 151.44 37.01 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.257 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 70' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' B' ' 6' ' ' ALA . 14.8 t -113.06 153.07 28.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.085 -177.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -69.65 -12.24 61.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.322 -176.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.07 -12.17 68.59 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.818 -0.705 . . . . 0.0 111.911 175.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -100.68 164.33 11.92 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -143.49 127.93 17.9 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 10.8 pt -131.49 179.64 4.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.995 -170.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 76' ' ' MET . . . . . 0.461 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 12.0 mtm -136.08 135.62 39.49 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 171.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 77' ' ' PHE . . . . . 1.658 ' HD1' ' CD2' ' C' ' 77' ' ' PHE . 1.1 m-85 -112.56 128.2 56.29 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 78' ' ' TYR . . . . . 0.645 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 34.3 p90 -153.6 137.24 16.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.314 0.578 . . . . 0.0 112.031 -177.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 79' ' ' THR . . . . . 0.68 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 5.9 p -109.21 138.1 46.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.103 -177.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.73 162.36 13.85 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.223 176.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.82 -174.79 44.72 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -175.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -115.48 102.8 10.14 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.078 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . 0.576 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -175.42 162.7 2.9 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.571 171.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 84' ' ' SER . . . . . 0.434 ' OG ' ' HD3' ' C' ' 15' ' ' PRO . 1.0 OUTLIER -115.95 125.86 53.11 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.654 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 m -116.76 148.91 19.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.213 0.53 . . . . 0.0 112.358 -174.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 42.8 m -108.54 113.59 26.73 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.645 173.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . 0.597 HD12 ' SD ' ' C' ' 13' ' ' MET . 5.3 mp -89.68 148.59 23.21 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 170.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . 0.474 ' CD2' HG11 ' D' ' 53' ' ' VAL . 0.9 OUTLIER -132.01 138.94 48.43 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.098 -178.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.71 -167.06 24.67 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.847 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 90' ' ' TYR . . . . . 0.657 ' CD2' ' HB2' ' D' ' 68' ' ' ASN . 12.8 p90 -150.74 128.77 11.81 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.91 0.862 . . . . 0.0 111.769 177.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . 0.41 HD11 ' HD2' ' C' ' 25' ' ' LYS . 8.3 mt -69.72 135.04 49.32 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.964 -1.471 . . . . 0.0 109.6 176.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -87.05 107.8 18.59 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -157.55 136.45 11.57 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -176.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.95 117.77 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.113 0.483 . . . . 0.0 110.762 -175.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -95.68 168.92 10.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.82 175.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 29.0 t 62.61 44.69 6.61 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.382 0.61 . . . . 0.0 109.887 -177.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -83.09 69.26 3.41 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.045 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 12.5 t . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.628 -0.701 . . . . 0.0 109.569 179.477 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 69.43 -60.51 0.46 Allowed 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.79 0.681 . . . . 0.0 110.879 -176.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . -91.15 -71.05 1.21 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.922 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.28 133.08 44.09 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.993 0.425 . . . . 0.0 111.674 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 67.1 mtp -144.11 -170.6 3.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.836 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 6' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' E' ' 70' ' ' SER . . . -50.2 137.67 17.55 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 123.677 0.611 . . . . 0.0 112.037 -176.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 38.6 mtt -111.89 146.46 37.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.986 -176.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 8' ' ' PHE . . . . . 0.419 ' CE1' HD22 ' E' ' 44' ' ' LEU . 61.1 t80 -64.59 146.44 54.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.481 -171.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 9' ' ' TRP . . . . . 0.448 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 90.5 t90 -138.09 147.06 43.65 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.034 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.85 155.17 26.24 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.792 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . 0.492 ' HB3' ' HB2' ' D' ' 87' ' ' LEU . 48.4 tp -143.87 108.75 4.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.766 0.317 . . . . 0.0 110.973 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -91.23 100.75 13.51 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.002 0.429 . . . . 0.0 110.021 173.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 13' ' ' MET . . . . . 0.611 ' SD ' HD12 ' D' ' 87' ' ' LEU . 57.3 mtp -90.56 137.93 31.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.196 -177.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 14' ' ' LYS . . . . . 0.46 ' HB2' ' HD2' ' D' ' 17' ' ' ARG . 32.6 mmtp -101.22 150.99 37.6 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.909 -175.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . 0.435 ' HD3' ' OG ' ' D' ' 84' ' ' SER . 81.9 Cg_exo -43.3 112.34 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 124.133 3.222 . . . . 0.0 114.796 -172.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . 0.685 ' HA ' ' O ' ' D' ' 79' ' ' THR . 5.7 tt0 60.92 63.38 1.29 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.572 170.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 17' ' ' ARG . . . . . 0.46 ' HD2' ' HB2' ' D' ' 14' ' ' LYS . 37.7 mtt85 -136.22 155.45 50.1 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.613 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . 0.632 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 3.3 ttmp? -125.55 115.46 20.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.755 -175.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -112.75 119.36 37.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.878 176.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 10.0 p -79.55 133.42 36.46 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 172.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -108.7 116.0 31.16 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.089 0.471 . . . . 0.0 112.1 -167.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 28.4 m -93.08 123.17 36.15 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 169.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 52.5 mt -93.29 113.73 28.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.214 0.531 . . . . 0.0 111.542 -172.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . 0.426 ' N ' HD13 ' D' ' 24' ' ' ILE . 4.5 mp -85.64 -48.35 16.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.58 178.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 47.1 mttt -119.35 132.45 55.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.283 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 12.5 p -59.54 123.14 15.91 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 27' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -136.59 161.74 35.07 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -170.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 28' ' ' HIS . . . . . 0.55 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 22.1 t60 -115.78 128.07 55.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.899 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 29' ' ' ILE . . . . . 0.552 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 44.0 mt -98.67 131.6 45.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 170.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 30' ' ' SER . . . . . 0.55 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 41.3 p -115.96 -15.24 11.22 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -171.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 31' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -164.06 155.06 26.24 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 119.41 -1.376 . . . . 0.0 113.53 178.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 p -137.38 124.37 29.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 171.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' D' ' 62' ' ' GLN . . . -125.81 150.0 48.17 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -170.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 34' ' ' LEU . . . . . 0.519 ' HB2' HG21 ' D' ' 56' ' ' VAL . 1.8 tm? -104.58 109.53 21.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.65 -174.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.49 -59.51 1.94 Allowed 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.851 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 36' ' ' LYS . . . . . 0.497 ' HB3' ' HZ3' ' D' ' 36' ' ' LYS . 3.1 mmmp? -104.0 129.41 51.6 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 175.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . 0.576 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 134.73 177.58 15.05 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 119.306 -1.426 . . . . 0.0 113.489 174.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -103.33 -47.79 4.19 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.691 0.282 . . . . 0.0 111.361 176.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -151.22 133.25 15.16 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.326 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.86 114.84 17.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.334 0.588 . . . . 0.0 110.447 170.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -100.15 111.16 23.44 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 48.5 tp -84.03 115.85 22.55 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.085 -173.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 43' ' ' TYR . . . . . 0.422 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 98.2 m-85 -117.52 145.38 44.26 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' D' ' 76' ' ' MET . 0.2 OUTLIER -133.15 134.21 43.87 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 171.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 45' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -108.65 115.65 30.5 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.298 178.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . 0.42 ' HB2' ' CE2' ' C' ' 8' ' ' PHE . . . -128.82 144.03 51.06 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 175.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 58.4 27.36 15.31 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -170.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 59.8 mttp 59.35 33.24 22.37 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.968 -175.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . 0.529 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 8.7 tp-100 -120.22 124.49 45.81 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -82.88 117.64 22.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.768 0.318 . . . . 0.0 111.011 -176.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -112.48 136.29 52.16 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.713 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 6.2 tp -78.43 109.83 13.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 168.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 53' ' ' VAL . . . . . 0.474 HG11 ' CD2' ' C' ' 88' ' ' LEU . 2.7 t -82.99 -50.22 15.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.311 -173.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 54' ' ' ALA . . . . . 0.428 ' HB2' HG12 ' D' ' 63' ' ' VAL . . . -155.47 144.1 20.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.175 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 23.7 m -108.26 102.54 11.65 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 172.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 56' ' ' VAL . . . . . 0.519 HG21 ' HB2' ' D' ' 34' ' ' LEU . 13.2 p -121.06 112.93 37.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 122.15 0.976 . . . . 0.0 110.743 -175.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 69.4 p -123.29 -177.87 3.82 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.937 -174.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -59.74 -31.53 69.72 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.184 169.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.09 -40.33 62.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.582 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 83.5 mt -112.43 84.56 6.3 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 173.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.18 0.73 6.24 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.017 2.478 . . . . 0.0 114.465 -166.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' D' ' 33' ' ' ALA . 18.9 pt20 -169.82 130.46 1.02 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.197 0.522 . . . . 0.0 111.088 -177.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.428 HG12 ' HB2' ' D' ' 54' ' ' ALA . 95.0 t -118.82 116.71 51.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.237 175.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.51 122.4 39.37 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.039 176.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 65' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' D' ' 30' ' ' SER . 0.3 OUTLIER -138.76 168.58 19.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.465 -176.574 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 66' ' ' ASP . . . . . 0.456 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 7.7 t0 -116.12 99.47 7.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.275 0.56 . . . . 0.0 110.26 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . 0.552 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 21.0 mt -113.32 137.31 51.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.01 178.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 68' ' ' ASN . . . . . 0.657 ' HB2' ' CD2' ' C' ' 90' ' ' TYR . 3.8 m-20 -137.95 118.21 13.63 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 176.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -117.48 151.36 37.26 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.236 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 70' ' ' SER . . . . . 0.498 ' HB2' ' O ' ' C' ' 6' ' ' ALA . 14.7 t -112.97 153.06 28.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.094 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -69.72 -12.12 61.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.377 -176.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.14 -12.14 68.46 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.832 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -100.8 164.28 11.92 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -143.48 127.92 17.91 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.021 0.438 . . . . 0.0 109.928 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . . . . . . . . . 10.9 pt -131.55 179.63 4.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.013 -170.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 76' ' ' MET . . . . . 0.463 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 12.0 mtm -136.08 135.58 39.45 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 171.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 77' ' ' PHE . . . . . 1.648 ' HE2' ' CE1' ' D' ' 77' ' ' PHE . 1.1 m-85 -112.61 128.26 56.32 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 78' ' ' TYR . . . . . 0.632 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 34.4 p90 -153.63 137.11 15.88 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.336 0.589 . . . . 0.0 112.064 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 79' ' ' THR . . . . . 0.685 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 5.9 p -109.09 138.22 45.79 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.07 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.83 162.47 13.77 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.14 176.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.82 -174.87 44.8 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 -175.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -115.41 102.8 10.16 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.037 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.576 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -175.4 162.71 2.92 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.563 171.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 84' ' ' SER . . . . . 0.435 ' OG ' ' HD3' ' D' ' 15' ' ' PRO . 1.1 m -115.98 126.08 53.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.614 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 2.7 m -116.84 148.76 19.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.119 0.485 . . . . 0.0 112.306 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 42.4 m -108.41 113.68 26.92 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.63 173.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 87' ' ' LEU . . . . . 0.611 HD12 ' SD ' ' D' ' 13' ' ' MET . 5.2 mp -89.76 148.63 23.13 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 170.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . 0.479 ' CD2' HG11 ' E' ' 53' ' ' VAL . 0.9 OUTLIER -132.1 138.99 48.32 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.002 -178.839 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.73 -167.15 24.84 Favored Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.897 -177.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 90' ' ' TYR . . . . . 0.639 ' CD2' ' HB2' ' E' ' 68' ' ' ASN . 13.0 p90 -150.66 128.86 11.95 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.873 0.844 . . . . 0.0 111.797 177.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 8.1 mt -69.78 135.03 49.23 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.669 176.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -87.0 107.74 18.54 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -157.5 136.42 11.61 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -176.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.96 117.93 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.214 0.531 . . . . 0.0 110.74 -175.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -95.78 168.93 10.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.749 175.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 27.8 t 62.64 44.56 6.66 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.32 0.581 . . . . 0.0 109.942 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . -83.05 69.27 3.41 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.037 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 12.3 t . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.626 -0.702 . . . . 0.0 109.608 179.336 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 69.4 -60.51 0.46 Allowed 'General case' 0 N--CA 1.469 0.489 0 O-C-N 123.934 0.771 . . . . 0.0 110.933 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . -91.02 -71.26 1.21 Allowed Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.929 176.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.09 133.12 43.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.939 0.399 . . . . 0.0 111.675 -177.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 67.2 mtp -144.19 -170.57 3.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.887 173.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 6' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 70' ' ' SER . . . -50.12 137.59 17.36 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 123.626 0.579 . . . . 0.0 112.069 -176.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 38.7 mtt -111.84 146.44 37.69 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.003 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 8' ' ' PHE . . . . . 0.411 ' CE1' HD22 ' A' ' 44' ' ' LEU . 61.0 t80 -64.68 146.44 54.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.525 -171.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 9' ' ' TRP . . . . . 0.439 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 90.4 t90 -137.99 146.98 43.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.056 178.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.76 155.21 26.27 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.875 177.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . 0.508 ' HB3' ' HB2' ' E' ' 87' ' ' LEU . 47.9 tp -143.93 108.78 4.93 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.803 0.335 . . . . 0.0 111.014 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -91.17 100.72 13.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.98 0.419 . . . . 0.0 110.066 173.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 13' ' ' MET . . . . . 0.597 ' SD ' HD12 ' E' ' 87' ' ' LEU . 57.3 mtp -90.56 137.97 31.93 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.141 -177.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 14' ' ' LYS . . . . . 0.471 ' HB2' ' HD2' ' E' ' 17' ' ' ARG . 32.6 mmtp -101.28 150.94 37.59 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.884 -175.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . 0.427 ' HD3' ' OG ' ' E' ' 84' ' ' SER . 84.4 Cg_exo -43.1 112.18 0.27 Allowed 'Trans proline' 0 N--CA 1.474 0.368 0 C-N-CA 124.157 3.238 . . . . 0.0 114.869 -172.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 16' ' ' GLU . . . . . 0.685 ' HA ' ' O ' ' E' ' 79' ' ' THR . 5.7 tt0 61.06 63.24 1.28 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.579 170.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 17' ' ' ARG . . . . . 0.471 ' HD2' ' HB2' ' E' ' 14' ' ' LYS . 38.0 mtt85 -136.19 155.47 50.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.611 178.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . 0.637 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 3.3 ttmp? -125.51 115.38 20.12 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.777 -175.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -112.58 119.4 38.0 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 176.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 10.1 p -79.58 133.29 36.44 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -108.57 116.04 31.22 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.076 0.465 . . . . 0.0 112.098 -167.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 28.4 m -93.05 123.14 36.1 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 169.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 52.7 mt -93.27 113.8 28.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.242 0.544 . . . . 0.0 111.513 -172.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . 0.427 ' N ' HD13 ' E' ' 24' ' ' ILE . 4.5 mp -85.64 -48.37 16.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.502 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . 0.411 ' HD2' HD11 ' E' ' 91' ' ' LEU . 47.2 mttt -119.32 132.45 55.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.214 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 12.6 p -59.5 123.15 15.9 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 27' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -136.55 161.73 35.06 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -170.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 28' ' ' HIS . . . . . 0.557 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 22.0 t60 -115.78 128.16 55.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.894 178.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 29' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 44.3 mt -98.8 131.72 45.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 170.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 30' ' ' SER . . . . . 0.557 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 41.0 p -116.08 -15.09 11.16 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.858 -171.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 31' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -164.11 155.05 26.24 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 119.307 -1.425 . . . . 0.0 113.494 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 p -137.29 124.27 29.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 171.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' E' ' 62' ' ' GLN . . . -125.76 150.11 48.01 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -170.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 34' ' ' LEU . . . . . 0.5 ' HB2' HG21 ' E' ' 56' ' ' VAL . 1.8 tm? -104.61 109.58 21.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.628 -174.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.58 -59.45 1.95 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.87 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 36' ' ' LYS . . . . . 0.497 ' HB3' ' HZ3' ' E' ' 36' ' ' LYS . 3.1 mmmp? -104.02 129.41 51.64 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.68 175.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . 0.572 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 134.7 177.61 15.07 Favored Glycine 0 N--CA 1.437 -1.244 0 C-N-CA 119.325 -1.417 . . . . 0.0 113.506 174.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 38' ' ' GLN . . . . . 0.403 ' HA ' ' HD2' ' E' ' 58' ' ' LYS . 74.4 mt-30 -103.33 -47.89 4.17 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.669 0.271 . . . . 0.0 111.306 176.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -151.16 133.23 15.2 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.404 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.89 114.89 17.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.394 0.616 . . . . 0.0 110.413 170.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 41' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -100.16 111.14 23.42 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 48.5 tp -84.08 115.75 22.53 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.061 -173.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 43' ' ' TYR . . . . . 0.413 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 98.2 m-85 -117.46 145.38 44.2 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 44' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' E' ' 76' ' ' MET . 0.2 OUTLIER -133.13 134.18 43.86 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 171.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 45' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -108.57 115.51 30.23 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.344 178.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -128.74 143.95 51.05 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 58.57 27.22 15.39 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -170.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 59.7 mttp 59.49 33.17 22.13 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.937 -175.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 49' ' ' GLN . . . . . 0.529 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 8.7 tp-100 -120.24 124.5 45.82 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -83.07 117.68 23.02 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.826 0.346 . . . . 0.0 110.92 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -112.48 136.36 52.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.663 176.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 6.2 tp -78.5 109.88 13.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 168.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . 0.479 HG11 ' CD2' ' D' ' 88' ' ' LEU . 2.7 t -83.02 -50.24 15.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.319 -173.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 54' ' ' ALA . . . . . 0.417 ' HB2' HG12 ' E' ' 63' ' ' VAL . . . -155.39 144.19 20.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.205 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 23.6 m -108.37 102.51 11.61 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 172.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . 0.5 HG21 ' HB2' ' E' ' 34' ' ' LEU . 13.2 p -121.0 112.98 38.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 122.143 0.973 . . . . 0.0 110.761 -175.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 70.6 p -123.25 -177.87 3.82 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.982 -174.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 58' ' ' LYS . . . . . 0.403 ' HD2' ' HA ' ' E' ' 38' ' ' GLN . 29.8 mtpp -59.81 -31.51 69.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.03 0.443 . . . . 0.0 110.228 169.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.99 -40.47 62.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.566 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 83.9 mt -112.46 84.58 6.36 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 173.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.25 0.71 6.31 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.043 2.495 . . . . 0.0 114.393 -166.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 62' ' ' GLN . . . . . 0.421 ' HA ' ' HA ' ' E' ' 33' ' ' ALA . 18.9 pt20 -169.68 130.56 1.05 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.106 0.479 . . . . 0.0 111.085 -177.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . 0.417 HG12 ' HB2' ' E' ' 54' ' ' ALA . 95.8 t -118.84 116.64 51.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.328 175.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.45 122.31 39.21 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.049 176.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' E' ' 30' ' ' SER . 0.3 OUTLIER -138.72 168.55 19.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.436 -176.543 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 66' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 7.6 t0 -116.05 99.54 7.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.207 0.527 . . . . 0.0 110.201 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 67' ' ' LEU . . . . . 0.54 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 21.0 mt -113.45 137.36 51.65 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.918 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 68' ' ' ASN . . . . . 0.639 ' HB2' ' CD2' ' D' ' 90' ' ' TYR . 3.8 m-20 -137.98 118.16 13.56 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 176.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -117.38 151.42 37.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.36 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 70' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' D' ' 6' ' ' ALA . 15.1 t -113.06 152.97 28.89 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -177.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -69.69 -12.19 61.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.305 -176.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.06 -12.15 68.63 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.903 175.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -100.67 164.3 11.94 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -143.51 127.91 17.87 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 75' ' ' ILE . . . . . . . . . . . . . 10.9 pt -131.52 179.66 4.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.004 -170.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 76' ' ' MET . . . . . 0.454 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 11.9 mtm -136.09 135.51 39.39 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 171.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 77' ' ' PHE . . . . . 1.662 ' HE2' ' CE1' ' E' ' 77' ' ' PHE . 1.1 m-85 -112.55 128.25 56.3 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 78' ' ' TYR . . . . . 0.637 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 34.5 p90 -153.57 137.2 16.01 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.295 0.569 . . . . 0.0 112.133 -177.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 79' ' ' THR . . . . . 0.685 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 5.8 p -109.25 138.23 45.92 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.028 -177.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.77 162.42 13.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.16 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.8 -174.73 44.71 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.511 -1.035 . . . . 0.0 110.511 -175.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -115.51 102.8 10.13 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.119 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 83' ' ' ALA . . . . . 0.572 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -175.47 162.63 2.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.574 171.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 84' ' ' SER . . . . . 0.427 ' OG ' ' HD3' ' E' ' 15' ' ' PRO . 1.0 OUTLIER -115.89 125.94 53.28 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.666 179.727 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 m -116.73 148.79 19.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -174.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 43.6 m -108.53 113.7 26.94 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.573 173.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 87' ' ' LEU . . . . . 0.597 HD12 ' SD ' ' E' ' 13' ' ' MET . 5.2 mp -89.76 148.61 23.14 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 170.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . 0.462 ' CD2' HG11 ' A' ' 53' ' ' VAL . 0.9 OUTLIER -132.0 138.92 48.45 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.06 -178.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.64 -167.0 24.51 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.932 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 90' ' ' TYR . . . . . 0.645 ' CD2' ' HB2' ' A' ' 68' ' ' ASN . 13.2 p90 -150.75 128.82 11.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.851 0.834 . . . . 0.0 111.816 177.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 91' ' ' LEU . . . . . 0.411 HD11 ' HD2' ' E' ' 25' ' ' LYS . 8.3 mt -69.77 134.98 49.18 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.634 176.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -86.98 107.76 18.54 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -157.56 136.38 11.51 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -176.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.87 117.94 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.19 0.519 . . . . 0.0 110.76 -175.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -95.84 168.84 10.4 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.772 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 28.6 t 62.76 44.64 6.33 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.43 0.634 . . . . 0.0 109.891 -177.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . -83.06 69.2 3.42 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.077 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 12.4 t . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.703 -0.665 . . . . 0.0 109.485 179.554 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 1.657 ' HD2' ' CD1' ' A' ' 1' ' ' PHE . 53.4 p90 . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -99.73 146.29 26.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 176.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -125.19 113.4 1.92 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.782 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -102.12 58.01 0.81 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.214 0.53 . . . . 0.0 110.241 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 24.8 mmt -101.97 -160.49 0.79 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.272 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.75 148.37 4.08 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.139 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 47.5 mtt -108.53 165.61 11.4 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.309 -175.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 1.642 ' HD1' ' CD2' ' A' ' 8' ' ' PHE . 56.3 t80 -76.19 151.97 36.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.1 0.476 . . . . 0.0 112.194 -176.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.469 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 89.5 t90 -143.76 147.37 34.08 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.639 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.435 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -151.42 156.47 26.69 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.236 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.469 ' HB2' ' CH2' ' A' ' 9' ' ' TRP . 61.2 tp -149.01 109.66 4.25 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.854 0.359 . . . . 0.0 111.394 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -86.03 121.17 28.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.423 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.681 ' SD ' ' HE1' ' A' ' 19' ' ' TYR . 72.4 mmm -101.74 137.37 40.13 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.905 0.383 . . . . 0.0 111.056 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.478 ' HE3' ' HA ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -101.27 146.43 32.17 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.835 175.714 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -49.9 113.39 0.97 Allowed 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 123.174 2.583 . . . . 0.0 113.047 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 61.04 52.06 4.22 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.906 176.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -125.54 138.4 53.96 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.785 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.637 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 51.8 mttp -109.66 126.87 54.12 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.816 0.341 . . . . 0.0 111.767 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 1.665 ' HD1' ' CD2' ' A' ' 19' ' ' TYR . 2.4 m-85 -111.64 103.79 12.12 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 173.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.2 p -86.06 100.58 12.26 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 173.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -114.92 148.78 38.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.379 0.609 . . . . 0.0 112.241 -168.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.9 m -107.97 141.95 38.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.132 173.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 69.0 mt -102.2 138.38 26.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.149 0.5 . . . . 0.0 111.74 -173.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.44 HD13 ' N ' ' A' ' 24' ' ' ILE . 4.1 mp -110.62 -43.4 5.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.196 176.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.5 ' HB3' ' O ' ' E' ' 1' ' ' PHE . 15.1 pttm -113.94 120.6 41.24 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.078 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.5 p -58.25 132.15 52.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.66 -178.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 1.654 ' HE2' ' CE1' ' A' ' 27' ' ' PHE . 54.5 p90 -139.2 157.6 45.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.577 0.703 . . . . 0.0 112.362 -176.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.612 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 7.1 t60 -114.69 124.76 52.63 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.458 177.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 42.7 mt -89.95 134.93 27.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 171.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.612 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 28.3 p -122.14 -12.32 8.32 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -171.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.12 155.81 27.31 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 119.617 -1.278 . . . . 0.0 113.195 177.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.43 ' CG2' ' HG ' ' A' ' 87' ' ' LEU . 12.3 p -143.3 125.53 12.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 172.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.22 161.01 39.99 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 122.036 -0.415 . . . . 0.0 111.66 -174.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.533 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 3.3 pp -123.44 142.32 51.11 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.828 0.823 . . . . 0.0 111.574 177.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.456 ' HB2' ' HH ' ' B' ' 43' ' ' TYR . 21.2 p-10 -104.11 -52.6 2.9 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.444 173.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -104.22 128.6 51.96 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.308 -0.626 . . . . 0.0 109.308 169.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.95 156.07 7.3 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 119.627 -1.273 . . . . 0.0 113.587 175.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.456 ' HA ' ' HB2' ' A' ' 58' ' ' LYS . 94.1 mt-30 -102.73 -44.25 5.35 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.699 0.285 . . . . 0.0 111.306 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -152.71 122.17 6.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.954 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.452 ' HB1' HG11 ' A' ' 56' ' ' VAL . . . -123.67 114.24 19.71 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.558 0.694 . . . . 0.0 110.212 170.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 80' ' ' ALA . 31.8 mmtp -96.86 105.85 18.05 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 176.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.9 tp -83.29 112.23 19.69 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -175.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.636 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 92.8 m-85 -118.68 147.2 44.05 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 175.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 76' ' ' MET . 0.3 OUTLIER -131.07 131.08 43.99 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 170.651 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -107.51 112.53 25.33 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.267 178.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.55 138.16 54.35 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.461 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 58.81 34.15 23.52 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.236 0.541 . . . . 0.0 110.026 -176.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.3 tttm 56.55 46.58 20.23 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.821 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.574 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 53.3 tp60 -137.84 127.78 25.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.469 176.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -87.18 121.37 29.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.954 0.407 . . . . 0.0 110.372 -176.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.432 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 81.5 m-85 -113.41 130.57 56.27 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.355 175.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.4 tp -79.57 105.83 9.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.705 0.764 . . . . 0.0 109.048 173.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.429 ' CG1' HD13 ' A' ' 67' ' ' LEU . 2.5 t -80.46 -49.16 19.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.633 -172.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.496 ' HB1' ' CD2' ' A' ' 65' ' ' LEU . . . -156.0 148.23 23.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.924 0.393 . . . . 0.0 111.709 -177.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.7 m -110.59 100.75 9.49 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 170.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.452 HG11 ' HB1' ' A' ' 40' ' ' ALA . 7.7 p -118.46 112.66 39.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.62 0.724 . . . . 0.0 109.699 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 63.8 p -122.86 -178.71 4.02 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.173 -172.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.456 ' HB2' ' HA ' ' A' ' 38' ' ' GLN . 56.0 tttt -59.52 -28.99 67.57 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.896 172.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.462 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -83.15 -40.41 19.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.622 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.0 mt -111.07 83.15 3.56 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 13.1 Cg_exo -69.82 0.18 6.06 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.084 2.523 . . . . 0.0 113.879 -168.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -163.2 131.34 3.75 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.335 0.588 . . . . 0.0 111.535 -176.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.438 HG12 ' HB3' ' A' ' 54' ' ' ALA . 96.1 t -118.87 112.66 38.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.382 173.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.95 116.12 27.76 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 174.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.496 ' CD2' ' HB1' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -137.19 169.6 17.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.055 0.455 . . . . 0.0 111.395 -175.263 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 9.6 t0 -118.66 119.01 33.18 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.114 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.538 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 8.0 mt -134.16 145.2 49.03 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 175.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -145.35 122.96 11.78 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 173.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -120.94 150.86 40.44 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.041 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' E' ' 6' ' ' ALA . 14.5 t -108.97 177.55 4.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.633 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.04 -19.27 65.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.192 0.52 . . . . 0.0 110.583 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.41 -9.81 81.03 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.272 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -92.72 120.02 32.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.132 0.491 . . . . 0.0 110.568 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -108.13 111.67 23.81 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 176.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.6 pt -128.71 156.08 40.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 120.949 0.404 . . . . 0.0 111.853 -168.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.485 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 4.5 mtm -115.61 119.39 35.97 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 173.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.46 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 1.1 m-85 -99.92 128.4 46.01 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.637 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 31.3 p90 -152.42 140.18 19.94 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.413 0.625 . . . . 0.0 112.194 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 2.3 p -113.16 125.77 54.71 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.854 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.413 ' HB2' ' HB2' ' A' ' 41' ' ' LYS . . . -96.53 164.82 12.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.607 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.16 -165.24 31.44 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -121.98 102.98 8.5 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.059 175.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -173.01 153.04 2.46 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.47 173.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.5 t -112.16 111.71 22.8 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.533 ' CG1' ' HB3' ' A' ' 34' ' ' LEU . 4.6 m -109.8 165.53 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.655 0 CA-C-O 121.408 0.623 . . . . 0.0 111.91 -174.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.8 t -131.61 123.16 27.31 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.914 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.456 HD22 HG22 ' A' ' 29' ' ' ILE . 4.9 mp -91.32 151.94 20.66 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 172.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 tp -134.77 142.49 46.73 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.746 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.0 -166.79 26.69 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.695 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -143.5 135.25 26.45 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.214 0.53 . . . . 0.0 110.931 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.412 HD11 ' HD2' ' A' ' 25' ' ' LYS . 64.5 mt -59.29 116.77 4.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.898 172.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.417 ' H ' ' HA ' ' A' ' 27' ' ' PHE . 72.5 t60 -87.53 108.34 19.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.895 -167.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -153.28 155.42 36.52 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.081 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 35.6 pt -122.9 143.1 37.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.959 0.409 . . . . 0.0 111.154 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -117.25 112.09 20.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.902 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.2 p -83.44 110.05 17.85 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.123 0.487 . . . . 0.0 110.785 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -70.25 -30.05 69.79 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.172 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 33.9 m . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.777 -0.63 . . . . 0.0 109.735 178.303 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 1.669 ' HD2' ' CD1' ' B' ' 1' ' ' PHE . 53.4 p90 . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -99.67 146.31 26.63 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 176.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -125.18 113.27 1.89 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.323 -0.942 . . . . 0.0 112.874 -176.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -101.99 58.02 0.82 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.135 0.493 . . . . 0.0 110.293 177.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 24.7 mmt -102.0 -160.38 0.78 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.224 -176.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.87 148.49 4.11 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.075 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 47.4 mtt -108.56 165.55 11.45 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.327 -175.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 1.622 ' HE2' ' CE1' ' B' ' 8' ' ' PHE . 56.4 t80 -76.11 151.96 36.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.042 0.449 . . . . 0.0 112.194 -176.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . 0.466 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 89.7 t90 -143.86 147.44 34.05 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.583 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.427 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -151.5 156.44 26.68 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.19 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.472 ' HB3' ' HB2' ' B' ' 87' ' ' LEU . 61.3 tp -148.95 109.64 4.25 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 120.878 0.37 . . . . 0.0 111.422 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -85.98 121.12 28.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.461 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' MET . . . . . 0.672 ' SD ' ' HE1' ' B' ' 19' ' ' TYR . 72.5 mmm -101.75 137.33 40.19 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 120.931 0.396 . . . . 0.0 111.089 -178.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.487 ' HE3' ' HA ' ' B' ' 14' ' ' LYS . 0.0 OUTLIER -101.25 146.44 32.17 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.814 175.713 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -49.87 113.4 0.97 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.961 2.441 . . . . 0.0 113.098 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 61.16 52.01 4.14 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.912 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -125.61 138.32 53.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.736 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . 0.647 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 51.8 mttp -109.74 126.86 54.18 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 120.874 0.369 . . . . 0.0 111.72 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' TYR . . . . . 1.669 ' HD1' ' CD2' ' B' ' 19' ' ' TYR . 2.4 m-85 -111.64 103.89 12.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.739 173.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 9.2 p -86.11 100.51 12.25 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 173.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -114.82 148.8 38.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.35 0.595 . . . . 0.0 112.224 -168.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 38.3 m -107.96 141.95 38.82 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.192 173.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 69.4 mt -102.25 138.34 26.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.156 0.503 . . . . 0.0 111.743 -173.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.454 HD13 ' N ' ' B' ' 24' ' ' ILE . 4.1 mp -110.56 -43.34 5.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.312 176.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 1' ' ' PHE . 15.2 pttm -113.89 120.54 41.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.149 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 14.9 p -58.26 132.09 52.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.715 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . 1.618 ' HD2' ' CD1' ' B' ' 27' ' ' PHE . 54.3 p90 -139.14 157.59 45.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.625 0.726 . . . . 0.0 112.365 -176.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' HIS . . . . . 0.608 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 7.1 t60 -114.7 124.78 52.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.455 177.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 42.6 mt -89.93 134.97 27.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 171.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.608 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 29.0 p -122.06 -12.3 8.36 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -171.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.12 155.84 27.36 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 119.579 -1.296 . . . . 0.0 113.157 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.432 ' CG2' ' HG ' ' B' ' 87' ' ' LEU . 12.3 p -143.31 125.39 12.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 172.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.14 161.06 39.81 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.08 -0.388 . . . . 0.0 111.651 -174.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.524 ' HB3' ' CG1' ' B' ' 85' ' ' VAL . 3.3 pp -123.41 142.27 51.14 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.749 0.785 . . . . 0.0 111.585 177.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.46 ' HB2' ' HH ' ' C' ' 43' ' ' TYR . 21.2 p-10 -103.99 -52.6 2.92 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.563 -1.199 . . . . 0.0 108.645 173.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -104.2 128.55 51.93 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 169.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 152.01 156.13 7.33 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 119.605 -1.284 . . . . 0.0 113.571 175.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . 0.447 ' HA ' ' HB2' ' B' ' 58' ' ' LYS . 94.0 mt-30 -102.82 -44.25 5.33 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.661 0.267 . . . . 0.0 111.273 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -152.73 122.13 6.75 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 121.229 -0.188 . . . . 0.0 110.974 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.446 ' HB1' HG11 ' B' ' 56' ' ' VAL . . . -123.62 114.23 19.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.51 0.672 . . . . 0.0 110.223 170.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' B' ' 79' ' ' THR . 31.8 mmtp -96.89 105.9 18.12 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 44.6 tp -83.31 112.17 19.66 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -175.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . 0.631 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 92.5 m-85 -118.62 147.12 44.08 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 175.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.498 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.3 OUTLIER -131.08 131.07 43.96 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 170.597 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -107.44 112.5 25.32 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.337 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.48 138.19 54.36 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.449 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 58.85 34.07 23.45 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 123.552 0.533 . . . . 0.0 110.012 -176.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 57.3 tttm 56.64 46.63 19.94 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.787 -177.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.581 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 53.4 tp60 -137.99 127.74 25.29 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -87.13 121.4 29.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.066 0.46 . . . . 0.0 110.364 -176.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 0.435 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 81.7 m-85 -113.52 130.6 56.31 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.365 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -79.59 105.74 9.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.626 0.727 . . . . 0.0 109.07 173.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.435 ' CG1' HD13 ' B' ' 67' ' ' LEU . 2.5 t -80.4 -49.21 19.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.625 -172.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.494 ' HB1' ' CD2' ' B' ' 65' ' ' LEU . . . -155.98 148.28 23.57 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.012 0.434 . . . . 0.0 111.701 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 68.6 m -110.48 100.72 9.5 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 170.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . 0.446 HG11 ' HB1' ' B' ' 40' ' ' ALA . 7.7 p -118.42 112.72 39.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.718 0.77 . . . . 0.0 109.649 -177.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 60.9 p -122.9 -178.72 4.02 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.234 -172.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . 0.447 ' HB2' ' HA ' ' B' ' 38' ' ' GLN . 55.5 tttt -59.36 -29.04 67.4 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.944 171.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.456 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -83.21 -40.35 19.76 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.662 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 79.9 mt -111.13 83.11 3.61 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 13.0 Cg_exo -69.92 0.32 5.94 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.059 2.506 . . . . 0.0 113.789 -168.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -163.2 131.36 3.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.314 0.578 . . . . 0.0 111.554 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.423 HG12 ' HB3' ' B' ' 54' ' ' ALA . 96.3 t -118.91 112.72 39.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.336 173.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.98 116.17 27.83 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 174.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.494 ' CD2' ' HB1' ' B' ' 54' ' ' ALA . 0.3 OUTLIER -137.2 169.5 17.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.449 -175.295 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . 0.534 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 9.6 t0 -118.54 118.98 33.17 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.172 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.546 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 8.0 mt -134.19 145.25 49.04 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -145.38 123.0 11.79 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 173.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -120.93 150.86 40.44 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.062 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 14.4 t -108.93 177.43 4.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.774 -0.193 . . . . 0.0 110.637 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.9 -19.35 65.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.178 0.513 . . . . 0.0 110.674 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.31 -9.87 81.11 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.309 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -92.75 120.02 32.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.203 0.525 . . . . 0.0 110.588 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -108.13 111.58 23.67 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 176.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 7.6 pt -128.75 156.07 41.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.913 -168.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' MET . . . . . 0.498 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 4.5 mtm -115.44 119.44 36.24 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 173.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . 0.462 ' CD1' ' HB2' ' B' ' 44' ' ' LEU . 1.1 m-85 -99.91 128.42 46.01 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 0.647 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 31.2 p90 -152.49 140.15 19.84 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.415 0.626 . . . . 0.0 112.172 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' B' ' 41' ' ' LYS . 2.3 p -113.08 125.86 54.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.794 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . 0.404 ' HB2' ' HB2' ' B' ' 41' ' ' LYS . . . -96.66 164.86 12.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.672 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.15 -165.15 31.4 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -121.96 102.96 8.49 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.073 175.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -173.09 153.0 2.42 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.44 -1.255 . . . . 0.0 109.431 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 38.8 t -112.23 111.71 22.79 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.524 ' CG1' ' HB3' ' B' ' 34' ' ' LEU . 4.6 m -109.75 165.55 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.665 0 CA-C-O 121.411 0.624 . . . . 0.0 111.889 -174.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 24.3 t -131.6 123.21 27.42 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.846 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.472 ' HB2' ' HB3' ' B' ' 11' ' ' LEU . 4.9 mp -91.45 151.91 20.59 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 172.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 tp -134.75 142.44 46.75 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.77 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.96 -166.84 26.72 Favored Glycine 0 N--CA 1.438 -1.201 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.71 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -143.55 135.27 26.39 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.28 0.562 . . . . 0.0 110.907 177.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 64.6 mt -59.27 116.81 4.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.843 173.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . 0.404 ' H ' ' HA ' ' B' ' 27' ' ' PHE . 72.5 t60 -87.57 108.32 19.0 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.889 -168.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -153.23 155.51 36.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.072 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 35.8 pt -122.9 143.09 37.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.854 0.359 . . . . 0.0 111.103 -176.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -117.3 112.19 20.42 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.898 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 3.2 p -83.46 110.05 17.86 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.042 0.448 . . . . 0.0 110.701 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . -70.33 -29.96 69.71 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.081 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 33.4 m . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.663 -0.684 . . . . 0.0 109.767 178.317 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 1' ' ' PHE . . . . . 1.64 ' HD2' ' CD1' ' C' ' 1' ' ' PHE . 53.5 p90 . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -99.71 146.31 26.66 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 176.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . -125.23 113.27 1.89 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.83 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -102.03 58.06 0.82 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.128 0.49 . . . . 0.0 110.315 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 5' ' ' MET . . . . . 0.401 ' HB3' ' H ' ' C' ' 6' ' ' ALA . 24.8 mmt -101.97 -160.45 0.79 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.289 -176.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 6' ' ' ALA . . . . . 0.401 ' H ' ' HB3' ' C' ' 5' ' ' MET . . . -50.78 148.36 4.12 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.14 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 47.5 mtt -108.47 165.52 11.46 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.369 -175.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 8' ' ' PHE . . . . . 1.643 ' HD1' ' CD2' ' C' ' 8' ' ' PHE . 56.6 t80 -76.07 151.9 36.98 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -176.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . 0.46 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 89.8 t90 -143.81 147.52 34.24 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.514 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . 0.433 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -151.43 156.49 26.71 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.121 -0.562 . . . . 0.0 112.254 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.47 ' HB3' ' HB2' ' C' ' 87' ' ' LEU . 61.5 tp -149.0 109.57 4.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.894 0.378 . . . . 0.0 111.48 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -85.89 121.04 27.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.519 176.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 13' ' ' MET . . . . . 0.667 ' SD ' ' HE1' ' C' ' 19' ' ' TYR . 72.2 mmm -101.68 137.27 40.2 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 120.817 0.341 . . . . 0.0 111.126 -178.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . 0.46 ' HE3' ' HA ' ' C' ' 14' ' ' LYS . 0.0 OUTLIER -101.22 146.48 32.24 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.846 175.666 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -49.93 113.39 0.97 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.093 2.529 . . . . 0.0 113.043 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 60.99 52.05 4.26 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.961 176.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -125.49 138.42 53.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.8 175.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 18' ' ' LYS . . . . . 0.648 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 51.8 mttp -109.65 126.89 54.13 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.697 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . 1.667 ' HD2' ' CD1' ' C' ' 19' ' ' TYR . 2.4 m-85 -111.68 103.75 12.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.818 172.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 9.3 p -86.01 100.57 12.24 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 173.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -114.93 148.67 38.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.431 0.634 . . . . 0.0 112.203 -168.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 39.0 m -107.84 142.03 38.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.165 173.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 69.2 mt -102.29 138.36 26.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.169 0.509 . . . . 0.0 111.75 -173.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . 0.449 HD13 ' N ' ' C' ' 24' ' ' ILE . 4.1 mp -110.55 -43.4 5.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.266 176.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . 0.527 ' HB3' ' O ' ' B' ' 1' ' ' PHE . 15.1 pttm -113.91 120.61 41.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.163 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 14.5 p -58.26 132.11 52.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.659 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 27' ' ' PHE . . . . . 1.659 ' HE2' ' CE1' ' C' ' 27' ' ' PHE . 54.2 p90 -139.12 157.56 45.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.597 0.713 . . . . 0.0 112.389 -176.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 28' ' ' HIS . . . . . 0.603 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 7.1 t60 -114.68 124.76 52.63 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.475 177.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 42.4 mt -89.93 134.96 27.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 171.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 30' ' ' SER . . . . . 0.603 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 29.1 p -122.1 -12.27 8.34 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -171.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.12 155.8 27.29 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 119.67 -1.252 . . . . 0.0 113.192 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.421 ' CG2' ' HG ' ' C' ' 87' ' ' LEU . 12.3 p -143.28 125.5 12.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 172.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.2 160.95 40.08 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.111 -0.368 . . . . 0.0 111.647 -174.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.536 ' HB3' ' CG1' ' C' ' 85' ' ' VAL . 3.4 pp -123.4 142.22 51.2 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.8 0.809 . . . . 0.0 111.619 177.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . 0.458 ' HB2' ' HH ' ' D' ' 43' ' ' TYR . 21.2 p-10 -104.02 -52.59 2.91 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.529 173.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -104.19 128.63 51.92 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 169.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.95 156.02 7.28 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 119.619 -1.277 . . . . 0.0 113.653 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 38' ' ' GLN . . . . . 0.447 ' HA ' ' HB2' ' C' ' 58' ' ' LYS . 94.1 mt-30 -102.76 -44.31 5.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.648 0.261 . . . . 0.0 111.232 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -152.67 122.09 6.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.766 -0.197 . . . . 0.0 110.98 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . 0.45 ' HB1' HG11 ' C' ' 56' ' ' VAL . . . -123.57 114.26 19.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.605 0.716 . . . . 0.0 110.27 170.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' C' ' 79' ' ' THR . 31.8 mmtp -96.87 105.8 18.0 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 44.9 tp -83.25 112.21 19.66 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -175.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 43' ' ' TYR . . . . . 0.637 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 92.8 m-85 -118.62 147.27 43.93 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.49 ' HA ' ' O ' ' C' ' 76' ' ' MET . 0.3 OUTLIER -131.08 131.13 44.0 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 170.648 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -107.57 112.49 25.26 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.275 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.49 138.08 54.37 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.487 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 58.95 34.08 23.41 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.238 0.542 . . . . 0.0 109.99 -176.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 57.5 tttm 56.65 46.58 20.0 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.707 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . 0.586 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 53.7 tp60 -137.92 127.77 25.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.465 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -87.2 121.39 29.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.077 0.465 . . . . 0.0 110.338 -176.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 0.427 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 81.3 m-85 -113.49 130.56 56.31 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.411 175.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -79.46 105.8 9.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.664 0.745 . . . . 0.0 109.019 173.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 53' ' ' VAL . . . . . 0.439 ' CG1' HD13 ' C' ' 67' ' ' LEU . 2.5 t -80.56 -49.07 19.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.65 -172.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 54' ' ' ALA . . . . . 0.489 ' HB1' ' CD2' ' C' ' 65' ' ' LEU . . . -155.99 148.22 23.5 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.812 -177.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 71.1 m -110.56 100.8 9.55 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 170.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . 0.45 HG11 ' HB1' ' C' ' 40' ' ' ALA . 7.7 p -118.49 112.74 39.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.658 0.742 . . . . 0.0 109.61 -177.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 64.4 p -122.87 -178.67 4.01 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.272 -172.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 58' ' ' LYS . . . . . 0.447 ' HB2' ' HA ' ' C' ' 38' ' ' GLN . 55.7 tttt -59.54 -28.97 67.57 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.855 172.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . 0.465 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -83.2 -40.39 19.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.648 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 80.1 mt -111.16 83.15 3.68 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 61' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 13.0 Cg_exo -69.84 0.18 6.08 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.074 2.516 . . . . 0.0 113.825 -168.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -163.13 131.34 3.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.297 0.57 . . . . 0.0 111.569 -176.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.426 HG12 ' HB3' ' C' ' 54' ' ' ALA . 96.0 t -118.91 112.67 38.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.392 173.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.91 116.14 27.75 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 174.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . 0.489 ' CD2' ' HB1' ' C' ' 54' ' ' ALA . 0.3 OUTLIER -137.24 169.5 17.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.95 0.405 . . . . 0.0 111.445 -175.26 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 66' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 9.6 t0 -118.59 119.08 33.44 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.106 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . 0.561 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 7.9 mt -134.18 145.26 49.05 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 175.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -145.43 123.03 11.78 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.721 -0.392 . . . . 0.0 109.947 173.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -120.91 150.89 40.38 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.965 -178.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 14.2 t -109.03 177.41 4.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.622 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.92 -19.29 65.7 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.258 0.552 . . . . 0.0 110.612 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.34 -9.9 81.01 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.261 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -92.63 119.93 32.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.059 0.457 . . . . 0.0 110.64 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -107.98 111.59 23.75 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 7.6 pt -128.73 156.1 41.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 120.962 0.41 . . . . 0.0 111.842 -168.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 76' ' ' MET . . . . . 0.49 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 4.5 mtm -115.48 119.42 36.13 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 173.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 77' ' ' PHE . . . . . 0.462 ' CD1' ' HB2' ' C' ' 44' ' ' LEU . 1.1 m-85 -99.9 128.37 45.99 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 78' ' ' TYR . . . . . 0.648 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 31.3 p90 -152.42 140.15 19.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.457 0.646 . . . . 0.0 112.252 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 79' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' C' ' 41' ' ' LYS . 2.3 p -113.04 125.79 54.78 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.837 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 80' ' ' ALA . . . . . 0.402 ' HB2' ' HB2' ' C' ' 41' ' ' LYS . . . -96.69 164.93 12.37 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.628 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.05 -165.21 31.57 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 -177.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -121.9 103.06 8.57 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 119.864 -0.735 . . . . 0.0 110.073 175.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -173.13 153.02 2.4 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.501 173.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 38.6 t -112.27 111.7 22.76 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.536 ' CG1' ' HB3' ' C' ' 34' ' ' LEU . 4.6 m -109.78 165.54 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 CA-C-O 121.308 0.575 . . . . 0.0 111.89 -174.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 23.9 t -131.58 123.09 27.2 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.953 176.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . 0.47 ' HB2' ' HB3' ' C' ' 11' ' ' LEU . 4.9 mp -91.31 151.94 20.67 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 172.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 tp -134.7 142.46 46.81 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.843 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.94 -166.85 26.71 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.804 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -143.56 135.17 26.28 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.256 0.55 . . . . 0.0 110.928 177.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . 0.4 HD11 ' HD2' ' C' ' 25' ' ' LYS . 64.7 mt -59.2 116.83 4.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.83 173.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 92' ' ' HIS . . . . . 0.408 ' H ' ' HA ' ' C' ' 27' ' ' PHE . 72.8 t60 -87.63 108.32 19.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.867 -167.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -153.29 155.52 36.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.058 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 35.5 pt -122.91 143.06 37.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.919 0.39 . . . . 0.0 111.141 -176.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -117.22 112.24 20.54 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.941 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 3.2 p -83.49 110.03 17.86 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.015 0.436 . . . . 0.0 110.757 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -70.37 -29.87 69.7 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.138 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 33.2 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.727 -0.654 . . . . 0.0 109.847 178.254 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . 1.621 ' HE2' ' CE1' ' D' ' 1' ' ' PHE . 53.4 p90 . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -99.69 146.34 26.62 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 176.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . -125.29 113.32 1.89 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.815 -176.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -102.01 57.96 0.82 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.087 0.47 . . . . 0.0 110.305 177.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 24.8 mmt -101.99 -160.42 0.79 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.315 -176.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.71 148.34 4.06 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 123.556 0.535 . . . . 0.0 112.164 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 47.5 mtt -108.47 165.5 11.47 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.376 -175.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 8' ' ' PHE . . . . . 1.663 ' HE2' ' CE1' ' D' ' 8' ' ' PHE . 56.7 t80 -76.1 151.92 36.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.113 0.482 . . . . 0.0 112.261 -176.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 9' ' ' TRP . . . . . 0.466 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 89.6 t90 -143.77 147.38 34.08 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.66 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . 0.445 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -151.38 156.53 26.73 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.216 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . 0.466 ' HB2' ' CH2' ' D' ' 9' ' ' TRP . 61.3 tp -149.04 109.59 4.22 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.902 0.382 . . . . 0.0 111.403 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -85.96 121.1 28.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.387 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 13' ' ' MET . . . . . 0.676 ' SD ' ' HE1' ' D' ' 19' ' ' TYR . 72.3 mmm -101.76 137.3 40.24 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.884 0.373 . . . . 0.0 111.132 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 14' ' ' LYS . . . . . 0.471 ' HA ' ' HE3' ' D' ' 14' ' ' LYS . 0.0 OUTLIER -101.1 146.46 32.19 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.898 175.663 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -49.92 113.39 0.97 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.035 2.49 . . . . 0.0 113.066 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 61.11 51.98 4.2 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.928 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -125.5 138.35 53.98 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.737 175.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . 0.657 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 51.9 mttp -109.67 126.92 54.19 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 120.799 0.333 . . . . 0.0 111.732 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 19' ' ' TYR . . . . . 1.66 ' HD2' ' CD1' ' D' ' 19' ' ' TYR . 2.4 m-85 -111.74 103.7 12.0 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 173.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 9.3 p -86.0 100.62 12.27 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 173.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -114.88 148.73 38.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.283 -168.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 38.7 m -107.83 142.01 38.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.181 173.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 69.2 mt -102.32 138.37 26.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.226 0.536 . . . . 0.0 111.713 -173.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . 0.444 ' N ' HD13 ' D' ' 24' ' ' ILE . 4.1 mp -110.63 -43.26 5.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.269 176.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . 0.524 ' HB3' ' O ' ' C' ' 1' ' ' PHE . 15.2 pttm -113.95 120.5 40.86 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.146 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 14.6 p -58.19 132.18 52.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.653 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 27' ' ' PHE . . . . . 1.661 ' HE2' ' CE1' ' D' ' 27' ' ' PHE . 54.4 p90 -139.24 157.55 45.72 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.632 0.73 . . . . 0.0 112.357 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 28' ' ' HIS . . . . . 0.611 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 7.0 t60 -114.67 124.67 52.42 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.505 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 29' ' ' ILE . . . . . 0.563 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 42.4 mt -89.85 134.98 27.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 171.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 30' ' ' SER . . . . . 0.611 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 28.7 p -122.13 -12.31 8.33 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -171.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.05 155.91 27.48 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.712 -1.232 . . . . 0.0 113.239 177.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . 0.425 ' CG2' ' HG ' ' D' ' 87' ' ' LEU . 12.4 p -143.41 125.46 11.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 172.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.11 161.06 39.8 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 122.023 -0.423 . . . . 0.0 111.682 -174.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 34' ' ' LEU . . . . . 0.536 ' HB3' ' CG1' ' D' ' 85' ' ' VAL . 3.3 pp -123.49 142.16 51.28 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.748 0.785 . . . . 0.0 111.621 177.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . 0.479 ' HB2' ' HH ' ' E' ' 43' ' ' TYR . 21.2 p-10 -104.04 -52.48 2.94 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.515 -1.221 . . . . 0.0 108.54 173.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -104.27 128.6 52.06 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 169.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 152.0 155.99 7.27 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 119.584 -1.293 . . . . 0.0 113.632 175.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 38' ' ' GLN . . . . . 0.459 ' HA ' ' HB2' ' D' ' 58' ' ' LYS . 94.1 mt-30 -102.7 -44.28 5.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.621 0.248 . . . . 0.0 111.29 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -152.74 122.08 6.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.025 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . 0.449 ' HB1' HG11 ' D' ' 56' ' ' VAL . . . -123.59 114.26 19.78 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.601 0.715 . . . . 0.0 110.203 170.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.416 ' HB2' ' HB2' ' D' ' 80' ' ' ALA . 31.8 mmtp -96.78 105.81 18.0 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 44.7 tp -83.25 112.19 19.64 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 43' ' ' TYR . . . . . 0.625 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 92.6 m-85 -118.66 147.17 44.07 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.489 ' HA ' ' O ' ' D' ' 76' ' ' MET . 0.3 OUTLIER -131.06 131.07 44.0 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 170.572 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 45' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -107.46 112.58 25.44 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.3 178.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.54 138.18 54.35 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.432 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 58.83 34.15 23.51 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.562 0.539 . . . . 0.0 109.975 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 57.3 tttm 56.64 46.42 20.31 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.807 -177.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . 0.578 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 53.6 tp60 -137.85 127.79 25.62 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 176.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -87.19 121.39 29.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.062 0.458 . . . . 0.0 110.369 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . 0.433 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 81.7 m-85 -113.48 130.54 56.31 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.4 175.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -79.55 105.79 9.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.646 0.736 . . . . 0.0 109.086 173.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 53' ' ' VAL . . . . . 0.435 ' CG1' HD13 ' D' ' 67' ' ' LEU . 2.5 t -80.46 -49.21 18.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.536 -172.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 54' ' ' ALA . . . . . 0.487 ' HB1' ' CD2' ' D' ' 65' ' ' LEU . . . -155.95 148.22 23.56 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 120.95 0.405 . . . . 0.0 111.731 -177.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 72.8 m -110.54 100.61 9.39 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 170.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 56' ' ' VAL . . . . . 0.449 HG11 ' HB1' ' D' ' 40' ' ' ALA . 7.7 p -118.36 112.65 39.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.658 0.742 . . . . 0.0 109.63 -177.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 61.9 p -122.79 -178.68 4.0 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.304 -172.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 58' ' ' LYS . . . . . 0.459 ' HB2' ' HA ' ' D' ' 38' ' ' GLN . 56.0 tttt -59.58 -28.88 67.54 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.899 172.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 59' ' ' ALA . . . . . 0.466 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -83.25 -40.44 19.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.592 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 79.6 mt -111.06 82.98 3.44 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 174.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 61' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 13.1 Cg_exo -69.72 0.22 5.92 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.047 2.498 . . . . 0.0 113.887 -168.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -163.13 131.26 3.76 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.273 0.559 . . . . 0.0 111.614 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.438 HG12 ' HB3' ' D' ' 54' ' ' ALA . 96.4 t -118.85 112.65 38.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.377 173.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.92 116.2 27.81 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 174.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 65' ' ' LEU . . . . . 0.487 ' CD2' ' HB1' ' D' ' 54' ' ' ALA . 0.3 OUTLIER -137.38 169.42 17.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.007 0.432 . . . . 0.0 111.426 -175.242 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 66' ' ' ASP . . . . . 0.523 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 9.7 t0 -118.45 118.97 33.18 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.114 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . 0.563 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 8.0 mt -134.14 145.3 49.15 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -145.37 123.0 11.8 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 173.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -120.96 150.93 40.34 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.008 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 14.2 t -109.05 177.44 4.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.748 -0.206 . . . . 0.0 110.592 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.92 -19.27 65.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.163 0.506 . . . . 0.0 110.659 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.33 -9.95 80.95 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.272 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -92.65 120.07 32.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.218 0.532 . . . . 0.0 110.584 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -108.12 111.55 23.63 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 176.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . . . . . . . . . 7.6 pt -128.63 156.15 40.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 120.963 0.411 . . . . 0.0 111.812 -168.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 76' ' ' MET . . . . . 0.489 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 4.5 mtm -115.53 119.37 35.94 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 173.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 77' ' ' PHE . . . . . 0.45 ' CD1' ' HB2' ' D' ' 44' ' ' LEU . 1.1 m-85 -99.85 128.36 45.95 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 78' ' ' TYR . . . . . 0.657 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 31.4 p90 -152.42 140.2 19.95 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.452 0.644 . . . . 0.0 112.227 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 79' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' D' ' 41' ' ' LYS . 2.3 p -113.15 125.74 54.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.802 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 80' ' ' ALA . . . . . 0.416 ' HB2' ' HB2' ' D' ' 41' ' ' LYS . . . -96.58 164.86 12.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.62 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.12 -165.15 31.43 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -177.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -121.98 103.0 8.51 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.047 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -173.07 153.09 2.45 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.528 173.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 38.6 t -112.27 111.62 22.62 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . 0.536 ' CG1' ' HB3' ' D' ' 34' ' ' LEU . 4.6 m -109.77 165.44 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.673 0 CA-C-O 121.459 0.647 . . . . 0.0 111.87 -174.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 24.0 t -131.55 123.12 27.3 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.896 176.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 87' ' ' LEU . . . . . 0.452 ' HB2' ' HB3' ' D' ' 11' ' ' LEU . 4.9 mp -91.37 151.97 20.62 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 172.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 tp -134.78 142.53 46.72 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.738 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.01 -166.82 26.75 Favored Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.743 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -143.47 135.21 26.47 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.151 0.5 . . . . 0.0 110.919 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . 0.402 HD11 ' HD2' ' D' ' 25' ' ' LYS . 64.9 mt -59.36 116.81 4.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.904 173.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . 0.415 ' H ' ' HA ' ' D' ' 27' ' ' PHE . 72.6 t60 -87.5 108.23 18.94 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.921 -167.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -153.19 155.46 36.72 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.102 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 35.5 pt -122.9 143.07 37.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.845 0.355 . . . . 0.0 111.088 -176.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -117.27 112.22 20.47 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.868 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 3.2 p -83.52 110.03 17.87 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.033 0.444 . . . . 0.0 110.752 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . -70.35 -29.95 69.68 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.06 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 33.8 m . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.522 -0.751 . . . . 0.0 109.794 178.281 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' E' E ' 1' ' ' PHE . . . . . 1.641 ' HE2' ' CE1' ' E' ' 1' ' ' PHE . 53.3 p90 . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -99.74 146.31 26.69 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 176.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . -125.16 113.32 1.9 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.812 -176.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -102.1 58.07 0.82 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.2 0.524 . . . . 0.0 110.3 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 24.8 mmt -102.06 -160.61 0.8 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.196 -176.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 6' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 70' ' ' SER . . . -50.65 148.26 4.06 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.129 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 47.4 mtt -108.38 165.52 11.45 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.333 -175.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 8' ' ' PHE . . . . . 1.659 ' HE1' ' CE2' ' E' ' 8' ' ' PHE . 56.2 t80 -76.13 151.99 36.85 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -176.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 9' ' ' TRP . . . . . 0.456 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 89.7 t90 -143.85 147.43 34.06 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.631 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 10' ' ' GLY . . . . . 0.432 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -151.46 156.46 26.69 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.144 178.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . 0.468 ' HB3' ' HB2' ' E' ' 87' ' ' LEU . 61.2 tp -148.94 109.62 4.25 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.855 0.359 . . . . 0.0 111.445 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -85.98 121.13 28.17 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.435 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 13' ' ' MET . . . . . 0.684 ' SD ' ' HE1' ' E' ' 19' ' ' TYR . 72.3 mmm -101.74 137.29 40.25 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.0 111.069 -178.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 14' ' ' LYS . . . . . 0.476 ' HE3' ' HA ' ' E' ' 14' ' ' LYS . 0.0 OUTLIER -101.12 146.44 32.16 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.872 175.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -49.95 113.35 0.96 Allowed 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.995 2.463 . . . . 0.0 113.152 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 61.21 52.03 4.09 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.837 176.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -125.58 138.35 53.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.785 175.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . 0.658 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 51.8 mttp -109.66 126.85 54.1 Favored 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 123.264 0.352 . . . . 0.0 111.688 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . 1.65 ' HE2' ' CE1' ' E' ' 19' ' ' TYR . 2.4 m-85 -111.71 103.79 12.1 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.772 172.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 9.2 p -86.01 100.6 12.25 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 173.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -114.91 148.73 38.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.396 0.617 . . . . 0.0 112.235 -168.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 37.5 m -107.83 142.06 38.47 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.17 173.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 69.4 mt -102.39 138.37 26.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.233 0.54 . . . . 0.0 111.709 -173.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . 0.443 ' N ' HD13 ' E' ' 24' ' ' ILE . 4.1 mp -110.62 -43.42 5.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.203 176.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . 0.519 ' HB3' ' O ' ' D' ' 1' ' ' PHE . 15.1 pttm -113.86 120.62 41.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.177 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 14.4 p -58.31 132.23 53.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.65 -178.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 27' ' ' PHE . . . . . 1.666 ' HE2' ' CE1' ' E' ' 27' ' ' PHE . 54.2 p90 -139.22 157.49 45.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.603 0.716 . . . . 0.0 112.377 -176.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 28' ' ' HIS . . . . . 0.601 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 7.2 t60 -114.6 124.72 52.56 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.552 177.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 29' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 42.5 mt -89.91 134.91 27.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 171.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 30' ' ' SER . . . . . 0.601 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 29.1 p -122.02 -12.34 8.36 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -171.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.16 155.86 27.38 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 119.626 -1.273 . . . . 0.0 113.188 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . 0.423 ' CG2' ' HG ' ' E' ' 87' ' ' LEU . 12.4 p -143.35 125.51 12.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 172.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.21 161.06 39.85 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.62 -174.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 34' ' ' LEU . . . . . 0.53 ' HB3' ' CG1' ' E' ' 85' ' ' VAL . 3.3 pp -123.48 142.21 51.23 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.717 0.77 . . . . 0.0 111.629 177.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . 0.463 ' HB2' ' HH ' ' A' ' 43' ' ' TYR . 21.2 p-10 -103.98 -52.58 2.92 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.584 173.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -104.17 128.63 51.88 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 169.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.96 156.05 7.3 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 119.568 -1.301 . . . . 0.0 113.644 175.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 38' ' ' GLN . . . . . 0.462 ' HA ' ' HB2' ' E' ' 58' ' ' LYS . 94.2 mt-30 -102.82 -44.22 5.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.692 0.282 . . . . 0.0 111.264 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -152.73 122.05 6.72 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 121.161 -0.216 . . . . 0.0 110.96 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . 0.434 ' HB1' HG11 ' E' ' 56' ' ' VAL . . . -123.56 114.31 19.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.536 0.684 . . . . 0.0 110.13 170.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 41' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' E' ' 79' ' ' THR . 31.8 mmtp -96.94 105.89 18.11 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 176.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 44.6 tp -83.21 112.17 19.61 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 -175.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 43' ' ' TYR . . . . . 0.629 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 92.9 m-85 -118.65 147.18 44.05 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 175.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 44' ' ' LEU . . . . . 0.491 ' HA ' ' O ' ' E' ' 76' ' ' MET . 0.3 OUTLIER -131.08 131.04 43.95 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 170.628 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 45' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -107.51 112.55 25.37 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.314 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.56 138.18 54.35 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.476 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 58.82 34.16 23.52 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.168 0.509 . . . . 0.0 109.983 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 57.3 tttm 56.62 46.53 20.14 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.811 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 49' ' ' GLN . . . . . 0.571 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 53.6 tp60 -137.89 127.74 25.48 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -87.13 121.39 29.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.056 0.455 . . . . 0.0 110.388 -176.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . 0.445 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 81.5 m-85 -113.51 130.5 56.33 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.375 175.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -79.47 105.8 9.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.622 0.725 . . . . 0.0 109.09 173.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . 0.43 ' CG1' HD13 ' E' ' 67' ' ' LEU . 2.5 t -80.45 -49.21 19.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.638 -172.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 54' ' ' ALA . . . . . 0.499 ' HB1' ' CD2' ' E' ' 65' ' ' LEU . . . -155.92 148.27 23.64 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.748 -177.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 67.4 m -110.52 100.7 9.47 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 170.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . 0.434 HG11 ' HB1' ' E' ' 40' ' ' ALA . 7.7 p -118.45 112.6 38.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.624 0.726 . . . . 0.0 109.73 -177.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 64.0 p -122.82 -178.71 4.01 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.178 -172.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 58' ' ' LYS . . . . . 0.462 ' HB2' ' HA ' ' E' ' 38' ' ' GLN . 55.8 tttt -59.49 -28.92 67.46 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.826 172.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 59' ' ' ALA . . . . . 0.465 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -83.36 -40.25 19.65 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.678 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 79.9 mt -111.07 83.03 3.49 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 61' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 13.1 Cg_exo -69.85 0.28 5.94 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.028 2.485 . . . . 0.0 113.861 -168.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -163.16 131.4 3.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.3 0.571 . . . . 0.0 111.548 -176.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . 0.427 HG12 ' HB3' ' E' ' 54' ' ' ALA . 95.6 t -118.98 112.76 39.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.334 173.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.05 116.14 27.85 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 174.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . 0.499 ' CD2' ' HB1' ' E' ' 54' ' ' ALA . 0.3 OUTLIER -137.19 169.54 17.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.492 -175.277 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 66' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 9.5 t0 -118.67 119.01 33.18 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.072 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 67' ' ' LEU . . . . . 0.549 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 8.0 mt -134.19 145.21 49.0 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 175.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -145.34 123.0 11.82 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 173.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -120.88 150.88 40.38 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.095 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 14.1 t -108.94 177.45 4.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.821 -0.172 . . . . 0.0 110.663 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.88 -19.31 65.71 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.255 0.55 . . . . 0.0 110.667 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.35 -9.93 80.94 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.256 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -92.61 120.0 32.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.166 0.508 . . . . 0.0 110.524 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -108.1 111.58 23.69 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 75' ' ' ILE . . . . . . . . . . . . . 7.6 pt -128.61 156.07 40.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 120.991 0.424 . . . . 0.0 111.878 -168.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 76' ' ' MET . . . . . 0.491 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 4.5 mtm -115.53 119.44 36.18 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 173.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 77' ' ' PHE . . . . . 0.462 ' CD1' ' HB2' ' E' ' 44' ' ' LEU . 1.1 m-85 -99.9 128.4 46.0 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 78' ' ' TYR . . . . . 0.658 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 31.3 p90 -152.42 140.3 20.05 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.43 0.633 . . . . 0.0 112.156 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 79' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' E' ' 41' ' ' LYS . 2.3 p -113.22 125.77 54.68 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.762 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 80' ' ' ALA . . . . . 0.409 ' HB2' ' HB2' ' E' ' 41' ' ' LYS . . . -96.58 164.87 12.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.697 178.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.08 -165.18 31.51 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -177.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -121.98 103.0 8.52 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.069 175.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 83' ' ' ALA . . . . . . . . . . . . . . . -173.07 153.08 2.45 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.504 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 39.2 t -112.27 111.58 22.55 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 85' ' ' VAL . . . . . 0.53 ' CG1' ' HB3' ' E' ' 34' ' ' LEU . 4.5 m -109.76 165.56 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-O 121.378 0.609 . . . . 0.0 111.842 -174.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 24.2 t -131.65 123.13 27.18 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.882 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 87' ' ' LEU . . . . . 0.468 ' HB2' ' HB3' ' E' ' 11' ' ' LEU . 4.9 mp -91.34 151.95 20.65 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 172.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 tp -134.76 142.46 46.73 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.789 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.91 -166.8 26.6 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.756 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 90' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -143.56 135.3 26.41 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.2 0.524 . . . . 0.0 110.936 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 91' ' ' LEU . . . . . 0.411 HD11 ' HD2' ' E' ' 25' ' ' LYS . 64.7 mt -59.35 116.84 4.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.885 173.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 92' ' ' HIS . . . . . 0.405 ' H ' ' HA ' ' E' ' 27' ' ' PHE . 72.8 t60 -87.64 108.33 19.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.901 -167.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -153.29 155.45 36.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.035 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 35.6 pt -122.91 143.09 37.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.965 0.412 . . . . 0.0 111.095 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -117.2 112.22 20.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.839 177.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 3.3 p -83.61 110.05 17.94 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.058 0.456 . . . . 0.0 110.696 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . -70.32 -29.94 69.74 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.172 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 32.8 m . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.621 -0.704 . . . . 0.0 109.773 178.195 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.41 ' H3 ' ' CG ' ' B' ' 93' ' ' ASP . 91.5 m-85 . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 120.769 0.319 . . . . 0.0 110.651 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -89.67 -41.25 12.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.219 0.533 . . . . 0.0 110.954 -173.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.465 ' HA2' ' CB ' ' B' ' 26' ' ' SER . . . 78.55 -139.75 22.7 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.541 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 65.95 -173.83 0.18 Allowed 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.095 0.558 . . . . 0.0 111.469 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 68.6 mtm 70.94 -74.22 0.09 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.993 176.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' B' ' 70' ' ' SER . . . -106.11 125.83 51.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.814 -174.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 46.9 mtt -119.28 173.74 6.77 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.113 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 1.631 ' HE1' ' CE2' ' A' ' 8' ' ' PHE . 63.7 t80 -82.18 147.45 29.0 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -177.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.473 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 91.2 t90 -139.29 150.1 45.03 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.395 177.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.416 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -154.26 152.21 23.82 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.43 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.521 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 41.0 tp -143.19 108.33 4.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.741 0.305 . . . . 0.0 110.385 177.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -86.11 99.38 11.46 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.416 0.627 . . . . 0.0 109.99 175.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.502 ' HB3' HG22 ' A' ' 85' ' ' VAL . 23.8 tpp -88.02 135.12 33.56 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.881 -175.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -98.83 145.15 29.45 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.119 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.5 ' HB3' ' N ' ' A' ' 83' ' ' ALA . 10.3 Cg_endo -52.92 120.18 7.24 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 123.585 2.857 . . . . 0.0 113.276 -175.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.679 ' HA ' ' O ' ' A' ' 79' ' ' THR . 29.0 mt-10 58.26 63.07 1.83 Allowed 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 121.575 0.703 . . . . 0.0 111.596 177.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.59 148.95 46.28 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.592 174.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.625 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 35.0 ttmt -122.6 117.15 25.16 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 123.525 0.516 . . . . 0.0 111.314 -175.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 1.664 ' HE2' ' CE1' ' A' ' 19' ' ' TYR . 2.1 m-85 -110.98 104.36 12.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.974 177.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 76' ' ' MET . 10.0 p -88.25 99.95 12.62 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 173.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -121.4 149.9 42.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.501 0.667 . . . . 0.0 112.347 -169.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.2 t -99.21 160.8 14.01 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.405 176.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 53.2 mt -118.99 125.79 74.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.1 0.476 . . . . 0.0 111.531 -173.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.46 HD13 ' N ' ' A' ' 24' ' ' ILE . 4.2 mp -107.02 -33.56 2.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.336 177.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -118.94 122.18 41.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.572 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.464 ' CB ' ' HA2' ' E' ' 3' ' ' GLY . 20.5 t -60.82 133.06 55.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.879 -177.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 1.654 ' HD2' ' CD1' ' A' ' 27' ' ' PHE . 53.9 p90 -137.42 143.13 41.71 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.939 0.876 . . . . 0.0 111.881 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.63 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 3.5 t60 -102.4 129.87 49.0 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.827 174.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 48.9 mt -97.53 130.28 46.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.63 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 46.6 p -114.0 -18.02 11.83 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.565 -171.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -162.2 149.03 16.87 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 119.611 -1.281 . . . . 0.0 113.031 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.2 p -135.19 121.99 34.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 172.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 85' ' ' VAL . . . -141.53 150.22 41.87 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.97 -171.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.463 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 4.3 pp -114.96 137.52 51.9 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 121.802 0.811 . . . . 0.0 111.167 178.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -107.01 -55.44 2.33 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.615 175.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -101.9 127.06 48.9 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.388 -0.823 . . . . 0.0 108.884 170.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.433 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 148.31 163.48 10.81 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.043 -1.075 . . . . 0.0 113.045 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -102.65 -47.19 4.51 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 121.099 -0.241 . . . . 0.0 111.404 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -151.92 136.39 16.86 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.632 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.49 113.59 12.65 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.478 0.656 . . . . 0.0 110.455 168.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 79' ' ' THR . 65.8 mttp -97.48 109.51 22.25 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.1 tp -85.75 114.78 22.97 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.993 -173.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 1.655 ' HD1' ' CD2' ' A' ' 43' ' ' TYR . 66.0 m-85 -116.41 145.75 43.02 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.492 ' HB2' ' CD1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -131.32 130.37 42.64 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 172.278 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -108.61 114.2 27.83 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.073 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.45 124.21 40.92 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.824 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.503 ' C ' ' HD2' ' A' ' 48' ' ' LYS . 4.2 mm-40 56.62 51.9 10.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.356 0.598 . . . . 0.0 111.066 -175.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.503 ' HD2' ' C ' ' A' ' 47' ' ' GLU . 6.7 mptt 59.0 39.58 23.35 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.459 174.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.576 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 24.0 tp60 -138.56 115.89 11.15 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -82.45 111.74 18.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.931 0.396 . . . . 0.0 110.714 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 1.648 ' HD1' ' CD2' ' A' ' 51' ' ' TYR . 80.3 m-85 -101.82 128.92 47.97 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.362 176.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -75.75 102.61 2.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 168.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.443 ' CG1' HD12 ' A' ' 67' ' ' LEU . 2.8 t -76.24 -51.52 19.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.579 -172.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.444 ' HB3' ' CD2' ' A' ' 65' ' ' LEU . . . -156.61 142.07 17.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.24 -177.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.8 m -105.1 101.35 10.91 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 172.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.71 112.55 40.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.783 0.802 . . . . 0.0 110.103 -177.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.8 p -123.47 -177.0 3.59 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.05 -176.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -59.13 -32.9 70.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.988 0.423 . . . . 0.0 110.44 169.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.64 -40.57 69.62 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.575 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.5 mt -117.69 81.77 15.34 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 174.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.64 -5.67 14.82 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.231 2.621 . . . . 0.0 113.988 -167.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -162.15 122.6 2.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.089 0.471 . . . . 0.0 110.974 -175.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.416 HG12 ' HB2' ' A' ' 54' ' ' ALA . 98.1 t -108.57 113.57 44.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.343 175.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.37 114.87 27.4 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.104 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -135.48 168.66 18.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.223 -176.19 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.515 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 6.0 t70 -114.56 99.82 7.82 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.44 0.638 . . . . 0.0 110.588 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.565 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 19.7 mt -111.41 140.98 45.55 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.12 116.57 9.62 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.415 174.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 1.656 ' HE1' ' CE2' ' A' ' 69' ' ' PHE . 21.6 m-85 -116.7 139.76 50.19 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.523 ' HB2' ' O ' ' E' ' 6' ' ' ALA . 5.3 t -103.31 173.97 6.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.003 0.43 . . . . 0.0 110.613 -177.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.57 1.29 12.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.539 -177.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.06 -5.84 54.41 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 173.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -100.36 151.43 21.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.865 0.364 . . . . 0.0 110.376 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -140.12 132.42 28.29 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 172.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.8 pt -139.79 164.64 23.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.011 0.434 . . . . 0.0 111.817 -167.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.48 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 4.5 mtm -118.65 121.74 40.87 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 173.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 1.66 ' HD1' ' CD2' ' A' ' 77' ' ' PHE . 1.0 OUTLIER -103.66 127.92 51.05 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.754 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.625 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 40.4 p90 -153.56 140.77 19.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.256 0.55 . . . . 0.0 111.886 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.679 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 15.2 p -111.9 144.97 40.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.297 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.09 148.66 28.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.31 173.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.85 176.83 41.1 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -176.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -108.53 102.55 11.62 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.046 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.5 ' N ' ' HB3' ' A' ' 15' ' ' PRO . . . -165.88 148.92 7.55 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.363 167.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 27.1 t -103.97 123.98 48.17 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.502 HG22 ' HB3' ' A' ' 13' ' ' MET . 8.0 m -121.01 135.25 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-O 121.349 0.595 . . . . 0.0 111.961 -173.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.1 m -97.47 118.39 33.86 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.908 175.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.521 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 5.0 mp -91.27 140.77 29.48 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 171.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.407 ' CD2' HG12 ' B' ' 53' ' ' VAL . 0.8 OUTLIER -127.62 143.64 51.14 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -178.254 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' A' ' 28' ' ' HIS . . . -166.28 -166.97 26.21 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.126 -1.035 . . . . 0.0 112.833 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 1.649 ' HD1' ' CD2' ' A' ' 90' ' ' TYR . 5.1 p90 -142.32 136.6 29.86 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 120.939 0.4 . . . . 0.0 110.676 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 6' ' ' ALA . 84.5 mt -64.23 119.83 11.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.945 174.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 38.5 t60 -102.22 108.44 19.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.71 -172.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -172.85 -174.32 1.09 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.687 170.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 20.4 pt -129.78 134.22 63.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.775 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -81.3 139.72 35.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.547 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.0 p -74.15 131.49 41.33 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.716 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 157.54 -34.95 0.54 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.094 -0.574 . . . . 0.0 111.745 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.4 p . . . . . 0 C--O 1.251 1.18 0 CA-C-O 118.704 -0.665 . . . . 0.0 110.248 178.149 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.434 ' H3 ' ' CG ' ' C' ' 93' ' ' ASP . 91.4 m-85 . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.666 0.269 . . . . 0.0 110.649 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -89.71 -41.25 12.01 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.132 0.491 . . . . 0.0 110.888 -173.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . 0.447 ' HA2' ' CB ' ' C' ' 26' ' ' SER . . . 78.48 -139.79 22.79 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.551 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . 65.96 -173.82 0.18 Allowed 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.105 0.562 . . . . 0.0 111.455 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 68.6 mtm 70.91 -74.25 0.09 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.981 176.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' C' ' 70' ' ' SER . . . -106.05 125.85 51.49 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.876 -174.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 46.9 mtt -119.37 173.81 6.74 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.122 -178.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 1.605 ' HD1' ' CD2' ' B' ' 8' ' ' PHE . 63.6 t80 -82.22 147.44 28.97 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.908 0.385 . . . . 0.0 112.024 -177.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . 0.475 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 91.1 t90 -139.24 150.02 45.01 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.458 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.425 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -154.11 152.27 23.87 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.489 178.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' B' ' 87' ' ' LEU . 41.1 tp -143.24 108.41 4.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.749 0.309 . . . . 0.0 110.364 177.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -86.04 99.32 11.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.257 0.551 . . . . 0.0 110.036 175.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' MET . . . . . 0.5 ' HB3' HG22 ' B' ' 85' ' ' VAL . 24.1 tpp -88.0 135.13 33.55 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.86 -175.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -98.86 145.24 29.62 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.075 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.5 ' HB3' ' N ' ' B' ' 83' ' ' ALA . 10.3 Cg_endo -53.01 120.15 7.23 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 123.591 2.861 . . . . 0.0 113.257 -175.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.679 ' HA ' ' O ' ' B' ' 79' ' ' THR . 29.1 mt-10 58.36 62.94 1.84 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.558 0.694 . . . . 0.0 111.628 177.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.54 148.98 46.39 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.586 174.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . 0.621 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 35.1 ttmt -122.62 117.11 25.06 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.596 0.56 . . . . 0.0 111.379 -175.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' TYR . . . . . 1.669 ' HD2' ' CD1' ' B' ' 19' ' ' TYR . 2.1 m-85 -110.97 104.23 12.79 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.05 177.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 9.8 p -88.19 99.98 12.62 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -121.44 149.9 42.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.369 0.604 . . . . 0.0 112.275 -169.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 12.1 t -99.34 160.88 13.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.369 176.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 53.1 mt -118.98 125.7 74.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.05 0.453 . . . . 0.0 111.606 -173.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.467 HD13 ' N ' ' B' ' 24' ' ' ILE . 4.2 mp -106.9 -33.63 2.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.357 177.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -118.94 122.2 41.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.563 177.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' SER . . . . . 0.465 ' CB ' ' HA2' ' A' ' 3' ' ' GLY . 20.3 t -60.81 133.14 55.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.917 -177.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . 1.669 ' HE2' ' CE1' ' B' ' 27' ' ' PHE . 53.8 p90 -137.48 143.17 41.6 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.932 0.872 . . . . 0.0 111.821 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' HIS . . . . . 0.617 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 3.6 t60 -102.4 129.88 49.01 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.1 -1.409 . . . . 0.0 108.823 174.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.57 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 49.2 mt -97.59 130.34 46.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 171.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.617 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 46.8 p -113.97 -17.99 11.85 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.531 -171.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -162.17 149.02 16.87 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 119.567 -1.302 . . . . 0.0 112.961 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 8.2 p -135.17 121.92 34.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 172.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.5 150.23 41.93 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.436 -0.506 . . . . 0.0 112.049 -171.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.454 ' O ' HD13 ' B' ' 34' ' ' LEU . 4.3 pp -114.91 137.58 51.8 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.816 0.817 . . . . 0.0 111.071 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -107.1 -55.46 2.33 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.585 175.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -101.89 127.07 48.88 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 170.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.435 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 148.37 163.57 10.88 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 119.988 -1.101 . . . . 0.0 112.904 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -102.66 -47.23 4.49 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.57 0.224 . . . . 0.0 111.402 177.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -151.89 136.37 16.88 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.62 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.41 113.61 12.73 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.398 0.618 . . . . 0.0 110.419 168.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' B' ' 79' ' ' THR . 65.8 mttp -97.48 109.66 22.37 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 173.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 34.6 tp -85.68 114.75 22.9 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.067 -173.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . 1.647 ' HD2' ' CD1' ' B' ' 43' ' ' TYR . 66.1 m-85 -116.39 145.82 42.95 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 175.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.501 ' HB2' ' CD1' ' B' ' 77' ' ' PHE . 0.2 OUTLIER -131.4 130.33 42.43 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 172.268 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -108.59 114.2 27.82 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.118 178.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.33 124.32 41.32 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.812 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . 0.503 ' C ' ' HD2' ' B' ' 48' ' ' LYS . 4.2 mm-40 56.36 52.02 10.66 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.688 0.618 . . . . 0.0 111.132 -175.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.503 ' HD2' ' C ' ' B' ' 47' ' ' GLU . 6.7 mptt 58.95 39.63 23.41 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.479 174.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.581 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 24.1 tp60 -138.56 115.95 11.2 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -82.58 111.79 18.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.83 0.348 . . . . 0.0 110.596 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 1.647 ' HD1' ' CD2' ' B' ' 51' ' ' TYR . 80.3 m-85 -101.85 128.91 48.02 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.301 176.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -75.81 102.62 2.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 168.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.446 ' CG1' HD12 ' B' ' 67' ' ' LEU . 2.8 t -76.17 -51.64 19.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.542 -172.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.442 ' HB3' ' CD2' ' B' ' 65' ' ' LEU . . . -156.5 142.16 17.74 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.193 -177.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 42.6 m -105.17 101.45 11.0 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 171.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.73 112.51 40.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.788 0.804 . . . . 0.0 110.067 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 68.8 p -123.47 -177.09 3.61 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.054 -176.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -59.16 -32.73 70.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.976 0.417 . . . . 0.0 110.47 169.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.76 -40.59 69.2 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.523 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 76.4 mt -117.6 81.8 15.04 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 174.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.71 -5.64 14.82 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.312 2.675 . . . . 0.0 113.932 -167.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -162.18 122.64 2.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.208 0.528 . . . . 0.0 110.955 -175.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.413 HG12 ' HB2' ' B' ' 54' ' ' ALA . 97.9 t -108.57 113.51 44.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.374 175.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.36 114.85 27.38 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.102 175.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' B' ' 30' ' ' SER . 0.3 OUTLIER -135.46 168.7 18.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.191 -176.197 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 5.9 t70 -114.58 99.7 7.73 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.393 0.616 . . . . 0.0 110.598 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.57 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 19.7 mt -111.35 140.97 45.49 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.17 116.64 9.64 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.351 174.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . 1.643 ' HE1' ' CE2' ' B' ' 69' ' ' PHE . 22.1 m-85 -116.78 139.68 50.3 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 6' ' ' ALA . 5.3 t -103.3 173.95 6.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.951 0.405 . . . . 0.0 110.633 -177.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.56 1.29 12.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.513 -177.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.0 -5.89 54.48 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 173.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -100.26 151.33 21.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.964 0.412 . . . . 0.0 110.35 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -140.1 132.48 28.43 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 172.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 6.9 pt -139.87 164.57 23.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.017 0.437 . . . . 0.0 111.837 -167.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 4.5 mtm -118.59 121.63 40.66 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 173.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . 1.67 ' HD1' ' CD2' ' B' ' 77' ' ' PHE . 1.1 m-85 -103.61 127.95 50.97 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 0.621 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 40.2 p90 -153.59 140.79 19.49 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.255 0.55 . . . . 0.0 111.845 -178.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.679 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 15.3 p -111.91 144.88 40.5 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.224 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.0 148.62 28.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.298 173.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.05 176.84 40.81 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -108.55 102.55 11.62 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.949 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.5 ' N ' ' HB3' ' B' ' 15' ' ' PRO . . . -165.92 148.85 7.47 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.382 167.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 27.2 t -103.94 124.02 48.22 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.5 HG22 ' HB3' ' B' ' 13' ' ' MET . 8.0 m -121.07 135.15 62.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-O 121.361 0.6 . . . . 0.0 111.895 -173.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 69.5 m -97.48 118.45 34.0 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.936 175.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.523 ' HB2' ' HB3' ' B' ' 11' ' ' LEU . 5.0 mp -91.27 140.79 29.46 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 171.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.412 HD21 HD22 ' C' ' 67' ' ' LEU . 0.8 OUTLIER -127.67 143.59 51.14 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.242 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' B' ' 28' ' ' HIS . . . -166.2 -166.92 26.04 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 120.112 -1.042 . . . . 0.0 112.801 -177.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' TYR . . . . . 1.644 ' HD2' ' CD1' ' B' ' 90' ' ' TYR . 5.1 p90 -142.4 136.54 29.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.002 0.43 . . . . 0.0 110.655 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' B' ' 6' ' ' ALA . 84.8 mt -64.22 119.77 10.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.921 174.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 38.1 t60 -102.11 108.5 19.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.681 -172.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . 0.421 ' HB3' ' H ' ' A' ' 3' ' ' GLY . 2.7 p30 -172.86 -174.28 1.08 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.794 170.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 20.2 pt -129.8 134.3 63.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.937 0.398 . . . . 0.0 110.713 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -81.36 139.71 35.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.64 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 4.1 p -74.11 131.48 41.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.743 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . 157.61 -34.91 0.54 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.817 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 12.3 p . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.589 -0.719 . . . . 0.0 110.327 178.153 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 . . . . . 0 N--CA 1.482 1.129 0 CA-C-O 120.794 0.331 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -89.68 -41.4 11.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.196 0.522 . . . . 0.0 110.853 -173.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 3' ' ' GLY . . . . . 0.433 ' HA2' ' CB ' ' D' ' 26' ' ' SER . . . 78.66 -139.79 22.66 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.46 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . 65.94 -173.85 0.18 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.105 0.562 . . . . 0.0 111.404 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 68.6 mtm 70.85 -74.18 0.09 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.03 176.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 6' ' ' ALA . . . . . 0.529 ' O ' ' HB2' ' D' ' 70' ' ' SER . . . -106.09 125.84 51.48 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.847 -174.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 46.9 mtt -119.29 173.85 6.7 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.122 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 8' ' ' PHE . . . . . 1.627 ' HD1' ' CD2' ' C' ' 8' ' ' PHE . 63.6 t80 -82.3 147.48 28.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.921 0.391 . . . . 0.0 111.955 -177.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . 0.471 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 91.1 t90 -139.32 149.98 44.85 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.421 177.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . 0.422 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -154.09 152.29 23.89 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.523 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.512 ' HB3' ' HB2' ' C' ' 87' ' ' LEU . 41.2 tp -143.27 108.34 4.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.74 0.305 . . . . 0.0 110.35 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -85.96 99.17 11.24 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.306 0.574 . . . . 0.0 110.099 175.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 13' ' ' MET . . . . . 0.51 ' HB3' HG22 ' C' ' 85' ' ' VAL . 24.1 tpp -87.97 135.1 33.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.888 -175.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -98.78 145.25 29.62 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.077 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . 0.507 ' HB3' ' N ' ' C' ' 83' ' ' ALA . 10.3 Cg_endo -53.04 120.14 7.22 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 123.624 2.883 . . . . 0.0 113.287 -175.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . 0.682 ' HA ' ' O ' ' C' ' 79' ' ' THR . 29.1 mt-10 58.35 63.0 1.83 Allowed 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.579 0.704 . . . . 0.0 111.658 177.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.63 148.93 46.2 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.518 174.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 18' ' ' LYS . . . . . 0.616 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 35.1 ttmt -122.6 117.09 25.02 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 123.482 0.489 . . . . 0.0 111.351 -175.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . 1.664 ' HD1' ' CD2' ' C' ' 19' ' ' TYR . 2.2 m-85 -111.01 104.28 12.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.007 177.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 20' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 9.4 p -88.24 100.03 12.67 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 173.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -121.32 150.04 42.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.339 0.59 . . . . 0.0 112.369 -169.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 12.2 t -99.42 160.85 13.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.327 176.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 53.3 mt -119.01 125.7 74.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.01 0.434 . . . . 0.0 111.532 -173.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . 0.451 HD13 ' N ' ' C' ' 24' ' ' ILE . 4.2 mp -106.99 -33.52 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.241 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -118.94 122.18 41.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.524 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 26' ' ' SER . . . . . 0.447 ' CB ' ' HA2' ' B' ' 3' ' ' GLY . 20.3 t -60.82 133.13 55.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.837 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 27' ' ' PHE . . . . . 1.669 ' HE1' ' CE2' ' C' ' 27' ' ' PHE . 53.9 p90 -137.47 143.11 41.6 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.962 0.887 . . . . 0.0 111.906 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 28' ' ' HIS . . . . . 0.631 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 3.5 t60 -102.33 129.84 48.89 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.114 -1.403 . . . . 0.0 108.905 174.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . 0.58 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 48.9 mt -97.56 130.27 46.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 171.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 30' ' ' SER . . . . . 0.631 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 46.4 p -113.95 -17.98 11.86 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.541 -171.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -162.2 149.05 16.91 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 119.611 -1.28 . . . . 0.0 112.873 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 8.3 p -135.12 121.9 34.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 172.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.37 150.3 42.23 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.501 -0.48 . . . . 0.0 112.06 -171.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.458 ' HB3' ' CG1' ' C' ' 85' ' ' VAL . 4.3 pp -115.04 137.44 52.0 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.757 0.789 . . . . 0.0 111.147 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -106.96 -55.51 2.32 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.548 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -101.89 127.06 48.88 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 171.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 37' ' ' GLY . . . . . 0.436 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 148.28 163.53 10.84 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.016 -1.088 . . . . 0.0 112.981 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -102.66 -47.26 4.48 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.555 0.217 . . . . 0.0 111.385 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -151.9 136.32 16.84 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.701 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.48 113.55 12.63 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.429 0.633 . . . . 0.0 110.42 168.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' C' ' 79' ' ' THR . 65.8 mttp -97.45 109.55 22.28 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 174.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 35.0 tp -85.66 114.69 22.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.047 -173.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 43' ' ' TYR . . . . . 1.668 ' HE1' ' CE2' ' C' ' 43' ' ' TYR . 66.4 m-85 -116.37 145.75 42.99 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.499 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 0.2 OUTLIER -131.31 130.35 42.63 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 172.228 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -108.56 114.1 27.65 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.113 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.34 124.39 41.45 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.759 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 47' ' ' GLU . . . . . 0.504 ' C ' ' HD2' ' C' ' 48' ' ' LYS . 4.3 mm-40 56.37 52.06 10.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.347 0.594 . . . . 0.0 111.071 -175.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . 0.504 ' HD2' ' C ' ' C' ' 47' ' ' GLU . 6.7 mptt 58.91 39.65 23.51 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.492 174.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . 0.576 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 24.1 tp60 -138.66 115.96 11.13 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -82.61 111.74 18.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.902 0.382 . . . . 0.0 110.635 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 1.649 ' HD1' ' CD2' ' C' ' 51' ' ' TYR . 80.0 m-85 -101.78 128.85 47.95 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.398 176.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -75.78 102.58 2.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 168.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 53' ' ' VAL . . . . . 0.444 ' CG1' HD12 ' C' ' 67' ' ' LEU . 2.8 t -76.17 -51.61 19.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.543 -172.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 54' ' ' ALA . . . . . 0.442 ' HB3' ' CD2' ' C' ' 65' ' ' LEU . . . -156.57 142.15 17.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.133 -177.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 42.4 m -105.21 101.44 10.98 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 171.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.7 112.56 40.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.815 0.817 . . . . 0.0 110.074 -177.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 68.0 p -123.47 -176.98 3.58 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.064 -176.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -59.33 -32.73 70.35 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.418 169.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.66 -40.72 69.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.486 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 76.0 mt -117.53 81.82 14.81 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 174.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.77 -5.73 15.09 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.256 2.637 . . . . 0.0 113.888 -167.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -162.04 122.67 2.59 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.075 0.464 . . . . 0.0 110.963 -175.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.402 HG12 ' HB2' ' C' ' 54' ' ' ALA . 97.8 t -108.6 113.59 44.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.346 175.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.35 114.82 27.35 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.123 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' C' ' 30' ' ' SER . 0.3 OUTLIER -135.38 168.68 18.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.259 -176.198 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 66' ' ' ASP . . . . . 0.51 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 5.9 t70 -114.64 99.78 7.78 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.542 0.687 . . . . 0.0 110.595 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . 0.58 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 19.8 mt -111.35 141.02 45.44 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -142.2 116.63 9.61 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.366 174.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 69' ' ' PHE . . . . . 1.604 ' HD2' ' CD1' ' C' ' 69' ' ' PHE . 21.9 m-85 -116.81 139.68 50.32 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 70' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' B' ' 6' ' ' ALA . 5.3 t -103.28 173.94 6.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.049 0.452 . . . . 0.0 110.635 -177.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.53 1.3 12.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.487 -176.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.09 -5.75 54.45 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 173.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -100.36 151.32 21.64 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.793 0.33 . . . . 0.0 110.432 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -140.13 132.36 28.18 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 172.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 6.8 pt -139.74 164.5 23.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.966 0.412 . . . . 0.0 111.888 -167.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 76' ' ' MET . . . . . 0.483 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 4.5 mtm -118.57 121.68 40.79 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 173.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 77' ' ' PHE . . . . . 1.654 ' HD1' ' CD2' ' C' ' 77' ' ' PHE . 1.1 m-85 -103.65 128.02 51.01 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 78' ' ' TYR . . . . . 0.616 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 40.3 p90 -153.56 140.87 19.6 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.218 0.532 . . . . 0.0 111.879 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 79' ' ' THR . . . . . 0.682 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 15.2 p -112.0 144.98 40.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.22 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.1 148.83 28.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.248 173.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.71 176.89 41.31 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -176.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -108.55 102.45 11.52 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.019 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . 0.507 ' N ' ' HB3' ' C' ' 15' ' ' PRO . . . -165.83 148.93 7.61 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.356 167.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 27.1 t -104.0 123.89 48.01 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.51 HG22 ' HB3' ' C' ' 13' ' ' MET . 8.2 m -120.89 135.2 61.86 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 CA-C-O 121.323 0.582 . . . . 0.0 112.007 -173.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 68.7 m -97.39 118.32 33.6 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.439 -0.8 . . . . 0.0 108.957 175.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . 0.512 ' HB2' ' HB3' ' C' ' 11' ' ' LEU . 5.0 mp -91.16 140.83 29.44 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 171.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . 0.41 HD21 HD22 ' D' ' 67' ' ' LEU . 0.8 OUTLIER -127.66 143.58 51.14 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -178.253 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 89' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' C' ' 28' ' ' HIS . . . -166.26 -166.95 26.16 Favored Glycine 0 N--CA 1.439 -1.166 0 C-N-CA 120.051 -1.071 . . . . 0.0 112.738 -177.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 90' ' ' TYR . . . . . 1.632 ' HE1' ' CE2' ' C' ' 90' ' ' TYR . 5.1 p90 -142.31 136.59 29.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.984 0.421 . . . . 0.0 110.623 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' C' ' 6' ' ' ALA . 84.7 mt -64.24 119.82 10.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.88 174.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -102.11 108.43 19.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.735 -172.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 93' ' ' ASP . . . . . 0.434 ' CG ' ' H3 ' ' B' ' 1' ' ' PHE . 2.7 p30 -172.87 -174.28 1.08 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.826 170.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 20.4 pt -129.82 134.25 63.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.022 0.439 . . . . 0.0 110.74 -178.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.24 139.7 35.33 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.671 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 4.0 p -74.18 131.56 41.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.713 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 157.58 -34.96 0.54 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.744 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 12.7 p . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.646 -0.693 . . . . 0.0 110.241 178.164 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . 0.444 ' H3 ' ' CG ' ' E' ' 93' ' ' ASP . 91.4 m-85 . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.69 0.281 . . . . 0.0 110.663 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -89.62 -41.34 12.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.248 0.547 . . . . 0.0 110.9 -173.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 3' ' ' GLY . . . . . 0.422 ' HA2' ' CB ' ' E' ' 26' ' ' SER . . . 78.64 -139.79 22.67 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.543 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . 65.87 -173.86 0.18 Allowed 'General case' 0 C--O 1.236 0.349 0 O-C-N 124.099 0.529 . . . . 0.0 111.51 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 68.5 mtm 71.04 -74.31 0.09 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.344 0.657 . . . . 0.0 111.945 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 6' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' E' ' 70' ' ' SER . . . -105.99 125.79 51.42 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.848 -174.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 47.1 mtt -119.31 173.86 6.7 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.053 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 8' ' ' PHE . . . . . 1.654 ' HE2' ' CE1' ' D' ' 8' ' ' PHE . 63.4 t80 -82.27 147.49 28.88 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.919 0.39 . . . . 0.0 111.93 -177.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 9' ' ' TRP . . . . . 0.472 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 91.2 t90 -139.3 149.94 44.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.45 177.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -154.12 152.3 23.9 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.511 178.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . 0.508 ' HB3' ' HB2' ' D' ' 87' ' ' LEU . 40.8 tp -143.23 108.37 4.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.751 0.31 . . . . 0.0 110.344 177.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -86.15 99.42 11.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.375 0.607 . . . . 0.0 110.053 175.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 13' ' ' MET . . . . . 0.51 ' HB3' HG22 ' D' ' 85' ' ' VAL . 24.0 tpp -88.07 135.09 33.58 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.868 -175.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -98.84 145.13 29.41 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.158 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . 0.506 ' HB3' ' N ' ' D' ' 83' ' ' ALA . 10.3 Cg_endo -52.93 120.08 7.08 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.642 2.895 . . . . 0.0 113.237 -175.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . 0.673 ' HA ' ' O ' ' D' ' 79' ' ' THR . 28.9 mt-10 58.44 62.92 1.84 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.634 177.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.5 148.86 46.35 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.613 174.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . 0.63 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 35.1 ttmt -122.54 117.13 25.17 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 123.556 0.535 . . . . 0.0 111.386 -175.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 19' ' ' TYR . . . . . 1.662 ' HD1' ' CD2' ' D' ' 19' ' ' TYR . 2.1 m-85 -111.03 104.23 12.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.022 177.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 9.5 p -88.23 99.86 12.54 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 173.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -121.31 149.93 42.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.443 0.64 . . . . 0.0 112.373 -169.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 12.1 t -99.32 160.87 13.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.349 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 53.0 mt -118.97 125.74 74.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.012 0.434 . . . . 0.0 111.562 -173.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . 0.458 ' N ' HD13 ' D' ' 24' ' ' ILE . 4.2 mp -106.95 -33.56 2.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.311 177.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -118.94 122.16 41.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.587 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 26' ' ' SER . . . . . 0.433 ' CB ' ' HA2' ' C' ' 3' ' ' GLY . 20.4 t -60.72 133.06 55.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.856 -177.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 27' ' ' PHE . . . . . 1.641 ' HD2' ' CD1' ' D' ' 27' ' ' PHE . 53.9 p90 -137.42 143.1 41.71 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.87 0.843 . . . . 0.0 111.981 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 28' ' ' HIS . . . . . 0.617 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 3.5 t60 -102.37 129.88 48.96 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.839 174.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 29' ' ' ILE . . . . . 0.579 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 48.8 mt -97.5 130.33 46.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 171.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 30' ' ' SER . . . . . 0.617 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 45.7 p -114.0 -18.06 11.82 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 120.973 0.416 . . . . 0.0 111.587 -171.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 31' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -162.15 149.01 16.87 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 119.573 -1.299 . . . . 0.0 113.022 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 8.2 p -135.15 121.95 34.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 172.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' D' ' 85' ' ' VAL . . . -141.46 150.33 42.12 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.47 -0.492 . . . . 0.0 112.038 -171.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 34' ' ' LEU . . . . . 0.459 ' HB3' ' CG1' ' D' ' 85' ' ' VAL . 4.3 pp -114.99 137.5 51.92 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.785 0.802 . . . . 0.0 111.116 178.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -107.0 -55.46 2.33 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.502 -1.227 . . . . 0.0 108.615 175.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -101.96 127.06 48.98 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.857 171.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . 0.428 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 148.32 163.57 10.87 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.01 -1.091 . . . . 0.0 112.991 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -102.69 -47.23 4.48 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.408 177.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -151.84 136.39 16.95 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.669 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.5 113.59 12.65 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.453 0.644 . . . . 0.0 110.402 168.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' D' ' 79' ' ' THR . 65.8 mttp -97.41 109.51 22.25 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 173.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 34.9 tp -85.63 114.77 22.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.087 -173.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 43' ' ' TYR . . . . . 1.666 ' HD2' ' CD1' ' D' ' 43' ' ' TYR . 66.1 m-85 -116.43 145.81 43.0 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 175.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.496 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.2 OUTLIER -131.45 130.33 42.34 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 172.342 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 45' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -108.58 114.02 27.5 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.102 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.28 124.37 41.48 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.832 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 47' ' ' GLU . . . . . 0.506 ' C ' ' HD2' ' D' ' 48' ' ' LYS . 4.3 mm-40 56.48 51.97 10.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.297 0.57 . . . . 0.0 111.042 -175.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 48' ' ' LYS . . . . . 0.506 ' HD2' ' C ' ' D' ' 47' ' ' GLU . 6.7 mptt 58.93 39.65 23.45 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.413 174.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . 0.57 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 24.7 tp60 -138.57 115.93 11.17 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -82.5 111.72 18.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.873 0.368 . . . . 0.0 110.713 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . 1.653 ' HE1' ' CE2' ' D' ' 51' ' ' TYR . 80.1 m-85 -101.82 128.85 47.99 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.278 176.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -75.73 102.61 2.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 168.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 53' ' ' VAL . . . . . 0.449 ' CG1' HD12 ' D' ' 67' ' ' LEU . 2.8 t -76.25 -51.54 19.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.542 -172.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 54' ' ' ALA . . . . . 0.442 ' HB3' ' CD2' ' D' ' 65' ' ' LEU . . . -156.59 142.0 17.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.207 -177.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 41.9 m -105.05 101.42 10.98 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 171.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.71 112.65 40.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.801 0.81 . . . . 0.0 110.039 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 70.0 p -123.54 -177.0 3.59 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.026 -176.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -59.19 -32.87 70.31 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.037 0.446 . . . . 0.0 110.434 169.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.6 -40.65 69.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.572 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 75.9 mt -117.53 81.79 14.77 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 174.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.72 -5.68 14.92 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.186 2.591 . . . . 0.0 114.007 -167.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -162.11 122.78 2.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.196 0.522 . . . . 0.0 110.916 -175.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.424 HG12 ' HB2' ' D' ' 54' ' ' ALA . 98.3 t -108.66 113.45 44.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.382 175.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.34 114.87 27.42 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.096 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 65' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' D' ' 30' ' ' SER . 0.3 OUTLIER -135.52 168.63 18.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.182 -176.185 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 66' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 5.9 t70 -114.52 99.82 7.83 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.407 0.622 . . . . 0.0 110.545 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . 0.579 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 19.8 mt -111.4 141.0 45.53 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 175.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.17 116.62 9.63 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.384 174.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 69' ' ' PHE . . . . . 1.623 ' HD2' ' CD1' ' D' ' 69' ' ' PHE . 22.4 m-85 -116.8 139.76 50.22 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 70' ' ' SER . . . . . 0.529 ' HB2' ' O ' ' C' ' 6' ' ' ALA . 5.3 t -103.28 173.97 6.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.982 0.42 . . . . 0.0 110.643 -177.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.62 1.38 12.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.53 -177.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.04 -5.95 54.35 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -100.3 151.4 21.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.825 0.345 . . . . 0.0 110.426 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -140.16 132.41 28.22 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 172.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . . . . . . . . . 6.8 pt -139.91 164.53 23.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.97 0.414 . . . . 0.0 111.803 -167.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 76' ' ' MET . . . . . 0.486 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 4.5 mtm -118.52 121.63 40.72 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 173.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 77' ' ' PHE . . . . . 1.654 ' HE2' ' CE1' ' D' ' 77' ' ' PHE . 1.1 m-85 -103.61 127.96 50.97 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 78' ' ' TYR . . . . . 0.63 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 40.2 p90 -153.61 140.88 19.56 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.229 0.538 . . . . 0.0 111.85 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 79' ' ' THR . . . . . 0.673 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 15.0 p -112.01 145.02 40.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.18 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.19 148.66 28.6 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.297 173.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.95 176.86 40.96 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -108.53 102.58 11.65 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.033 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.506 ' N ' ' HB3' ' D' ' 15' ' ' PRO . . . -165.87 148.89 7.54 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.329 167.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 26.9 t -103.95 124.02 48.23 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . 0.51 HG22 ' HB3' ' D' ' 13' ' ' MET . 8.2 m -120.95 135.1 62.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.338 0.589 . . . . 0.0 111.933 -173.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 68.5 m -97.38 118.5 34.0 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.964 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 87' ' ' LEU . . . . . 0.508 ' HB2' ' HB3' ' D' ' 11' ' ' LEU . 5.0 mp -91.33 140.87 29.37 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 171.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.75 143.58 51.13 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -178.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 89' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' D' ' 28' ' ' HIS . . . -166.21 -167.0 26.18 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 120.102 -1.047 . . . . 0.0 112.777 -177.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 90' ' ' TYR . . . . . 1.655 ' HE2' ' CE1' ' D' ' 90' ' ' TYR . 5.3 p90 -142.29 136.56 29.89 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 120.948 0.404 . . . . 0.0 110.609 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . 0.426 HD22 ' HB3' ' D' ' 27' ' ' PHE . 84.5 mt -64.25 119.65 10.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.999 174.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 38.2 t60 -101.95 108.42 19.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.784 -172.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -172.81 -174.32 1.1 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.683 170.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 20.6 pt -129.73 134.24 63.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.962 0.41 . . . . 0.0 110.777 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -81.41 139.79 35.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.517 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 4.1 p -74.25 131.55 41.3 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.695 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . 157.58 -35.0 0.54 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.788 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 12.6 p . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.552 -0.737 . . . . 0.0 110.263 178.158 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 120.813 0.34 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -89.68 -41.31 12.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.156 0.503 . . . . 0.0 110.924 -173.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 3' ' ' GLY . . . . . 0.464 ' HA2' ' CB ' ' A' ' 26' ' ' SER . . . 78.61 -139.82 22.73 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.528 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . 66.03 -173.82 0.18 Allowed 'General case' 0 C--O 1.236 0.358 0 O-C-N 124.089 0.523 . . . . 0.0 111.493 178.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 68.6 mtm 70.89 -74.29 0.09 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.904 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 6' ' ' ALA . . . . . 0.523 ' O ' ' HB2' ' A' ' 70' ' ' SER . . . -106.05 125.72 51.33 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.832 -174.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 47.0 mtt -119.25 173.8 6.73 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.2 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 8' ' ' PHE . . . . . 1.657 ' HD1' ' CD2' ' E' ' 8' ' ' PHE . 63.5 t80 -82.2 147.55 28.93 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.888 0.375 . . . . 0.0 111.988 -177.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 9' ' ' TRP . . . . . 0.468 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 90.9 t90 -139.31 149.97 44.85 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 10' ' ' GLY . . . . . 0.43 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -154.14 152.28 23.88 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.446 178.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . 0.512 ' HB3' ' HB2' ' E' ' 87' ' ' LEU . 41.4 tp -143.17 108.3 4.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.735 0.302 . . . . 0.0 110.359 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -86.12 99.33 11.43 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.334 0.587 . . . . 0.0 110.042 175.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 13' ' ' MET . . . . . 0.505 ' HB3' HG22 ' E' ' 85' ' ' VAL . 23.9 tpp -88.0 135.12 33.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.853 -175.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -98.75 145.18 29.49 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.13 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . 0.502 ' HB3' ' N ' ' E' ' 83' ' ' ALA . 10.3 Cg_endo -52.97 120.07 7.09 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 123.653 2.902 . . . . 0.0 113.254 -175.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 16' ' ' GLU . . . . . 0.678 ' HA ' ' O ' ' E' ' 79' ' ' THR . 29.0 mt-10 58.44 62.88 1.85 Allowed 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 121.526 0.679 . . . . 0.0 111.653 177.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.49 148.92 46.42 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.578 174.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . 0.611 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 35.1 ttmt -122.61 117.17 25.19 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 123.569 0.543 . . . . 0.0 111.316 -175.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . 1.641 ' HE2' ' CE1' ' E' ' 19' ' ' TYR . 2.2 m-85 -111.02 104.39 12.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.993 177.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 9.9 p -88.34 99.99 12.68 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 173.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -121.3 150.0 42.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.386 0.613 . . . . 0.0 112.33 -169.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 12.2 t -99.3 160.81 14.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.331 176.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 52.9 mt -118.94 125.75 74.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.113 0.482 . . . . 0.0 111.663 -173.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . 0.453 ' N ' HD13 ' E' ' 24' ' ' ILE . 4.2 mp -106.98 -33.57 2.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.283 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -118.93 122.23 41.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.55 177.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 26' ' ' SER . . . . . 0.422 ' CB ' ' HA2' ' D' ' 3' ' ' GLY . 20.5 t -60.81 133.06 55.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.829 -177.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 27' ' ' PHE . . . . . 1.644 ' HD2' ' CD1' ' E' ' 27' ' ' PHE . 53.9 p90 -137.38 143.18 41.82 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.925 0.869 . . . . 0.0 111.954 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 28' ' ' HIS . . . . . 0.628 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 3.5 t60 -102.49 129.92 49.16 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.769 174.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 29' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 49.0 mt -97.44 130.3 46.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 171.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 30' ' ' SER . . . . . 0.628 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 46.5 p -114.0 -17.92 11.85 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.612 -171.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 31' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -162.23 148.97 16.72 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 119.656 -1.259 . . . . 0.0 112.984 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 8.3 p -135.11 121.92 34.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 172.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' E' ' 85' ' ' VAL . . . -141.47 150.24 41.99 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.52 -0.472 . . . . 0.0 112.01 -171.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 34' ' ' LEU . . . . . 0.455 ' HB3' ' CG1' ' E' ' 85' ' ' VAL . 4.3 pp -114.96 137.55 51.86 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.735 0.779 . . . . 0.0 111.111 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -107.07 -55.52 2.32 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.593 175.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -101.77 127.05 48.72 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . 0.433 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 148.28 163.55 10.84 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 119.995 -1.097 . . . . 0.0 112.998 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -102.7 -47.15 4.51 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.419 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -151.87 136.34 16.88 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.643 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.41 113.56 12.68 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.451 0.643 . . . . 0.0 110.404 168.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 41' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' E' ' 79' ' ' THR . 65.8 mttp -97.36 109.57 22.3 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 34.5 tp -85.62 114.67 22.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.067 -173.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 43' ' ' TYR . . . . . 1.671 ' HE1' ' CE2' ' E' ' 43' ' ' TYR . 66.2 m-85 -116.37 145.77 42.98 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 44' ' ' LEU . . . . . 0.497 ' HB2' ' CD1' ' E' ' 77' ' ' PHE . 0.2 OUTLIER -131.37 130.41 42.59 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 172.288 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 45' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -108.67 114.09 27.6 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.145 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.32 124.26 41.19 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.753 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 47' ' ' GLU . . . . . 0.502 ' C ' ' HD2' ' E' ' 48' ' ' LYS . 4.2 mm-40 56.57 52.03 10.37 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.663 0.602 . . . . 0.0 110.977 -175.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 48' ' ' LYS . . . . . 0.502 ' HD2' ' C ' ' E' ' 47' ' ' GLU . 6.7 mptt 59.0 39.5 23.43 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.493 174.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 49' ' ' GLN . . . . . 0.573 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 24.2 tp60 -138.61 116.03 11.22 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -82.55 111.73 18.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.897 0.379 . . . . 0.0 110.631 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . 1.645 ' HD1' ' CD2' ' E' ' 51' ' ' TYR . 80.6 m-85 -101.86 128.87 48.04 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.336 176.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -75.76 102.57 2.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 168.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . 0.44 ' CG1' HD12 ' E' ' 67' ' ' LEU . 2.8 t -76.22 -51.51 19.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.516 -172.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 54' ' ' ALA . . . . . 0.438 ' HB3' ' CD2' ' E' ' 65' ' ' LEU . . . -156.54 142.07 17.63 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.262 -177.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 43.3 m -105.14 101.45 11.0 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 171.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.75 112.67 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-O 121.759 0.79 . . . . 0.0 110.033 -177.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 69.4 p -123.59 -177.07 3.62 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.008 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -59.18 -32.87 70.3 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.914 0.388 . . . . 0.0 110.385 169.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.62 -40.62 69.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.526 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 76.2 mt -117.58 81.77 14.93 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.67 -5.73 15.0 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.257 2.638 . . . . 0.0 113.965 -167.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -162.07 122.66 2.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.202 0.525 . . . . 0.0 110.925 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . 0.421 HG12 ' HB2' ' E' ' 54' ' ' ALA . 97.4 t -108.62 113.56 44.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.307 175.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.32 114.83 27.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.122 175.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . 0.443 ' O ' ' HA ' ' E' ' 30' ' ' SER . 0.3 OUTLIER -135.42 168.6 18.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.263 -176.244 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 66' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 6.0 t70 -114.53 99.75 7.78 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.43 0.633 . . . . 0.0 110.66 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 67' ' ' LEU . . . . . 0.565 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 19.7 mt -111.35 140.99 45.47 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.13 116.57 9.62 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.417 174.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 69' ' ' PHE . . . . . 1.633 ' HE1' ' CE2' ' E' ' 69' ' ' PHE . 22.0 m-85 -116.72 139.74 50.21 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 70' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' D' ' 6' ' ' ALA . 5.3 t -103.31 173.92 6.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.977 0.418 . . . . 0.0 110.635 -177.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.59 1.37 12.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.516 -177.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.05 -5.98 54.3 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 173.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -100.26 151.33 21.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.769 0.319 . . . . 0.0 110.465 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -140.02 132.42 28.46 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 172.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 75' ' ' ILE . . . . . . . . . . . . . 6.8 pt -139.83 164.58 23.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.973 0.416 . . . . 0.0 111.87 -167.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 76' ' ' MET . . . . . 0.483 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 4.5 mtm -118.58 121.68 40.79 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 77' ' ' PHE . . . . . 1.656 ' HE2' ' CE1' ' E' ' 77' ' ' PHE . 1.0 OUTLIER -103.73 127.98 51.15 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.738 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 78' ' ' TYR . . . . . 0.611 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 40.1 p90 -153.51 140.9 19.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.213 0.53 . . . . 0.0 111.905 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 79' ' ' THR . . . . . 0.678 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 14.7 p -111.98 144.99 40.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.17 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.24 148.66 28.66 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.214 173.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.87 176.83 41.08 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -176.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -108.56 102.56 11.63 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.949 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 83' ' ' ALA . . . . . 0.502 ' N ' ' HB3' ' E' ' 15' ' ' PRO . . . -165.9 148.86 7.5 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.39 167.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 27.2 t -103.95 123.93 48.06 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 85' ' ' VAL . . . . . 0.505 HG22 ' HB3' ' E' ' 13' ' ' MET . 8.1 m -120.87 135.2 61.81 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-O 121.377 0.608 . . . . 0.0 112.005 -173.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 69.1 m -97.48 118.38 33.84 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.455 -0.793 . . . . 0.0 108.866 175.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 87' ' ' LEU . . . . . 0.512 ' HB2' ' HB3' ' E' ' 11' ' ' LEU . 5.0 mp -91.27 140.81 29.44 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 171.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . 0.419 HD21 HD22 ' A' ' 67' ' ' LEU . 0.8 OUTLIER -127.67 143.64 51.14 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -178.247 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 89' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' E' ' 28' ' ' HIS . . . -166.22 -166.98 26.16 Favored Glycine 0 N--CA 1.438 -1.185 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.799 -177.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 90' ' ' TYR . . . . . 1.667 ' HD1' ' CD2' ' E' ' 90' ' ' TYR . 5.2 p90 -142.29 136.62 29.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.954 0.407 . . . . 0.0 110.632 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 91' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' E' ' 6' ' ' ALA . 84.4 mt -64.21 119.74 10.81 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.953 174.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 38.2 t60 -102.14 108.45 19.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.694 -172.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 93' ' ' ASP . . . . . 0.444 ' CG ' ' H3 ' ' D' ' 1' ' ' PHE . 2.7 p30 -172.86 -174.27 1.08 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.73 170.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 20.5 pt -129.83 134.24 63.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.745 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -81.32 139.76 35.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.584 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 4.0 p -74.24 131.48 41.25 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.734 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . 157.56 -34.92 0.54 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.795 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 12.4 p . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.646 -0.692 . . . . 0.0 110.266 178.119 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 1.637 ' HD2' ' CD1' ' A' ' 1' ' ' PHE . 94.1 m-85 . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 120.976 0.417 . . . . 0.0 110.296 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -136.16 163.62 29.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.17 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 122.3 25.57 1.99 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.209 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -167.31 53.43 0.07 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.037 0.446 . . . . 0.0 110.071 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.405 ' HB3' ' OG ' ' B' ' 70' ' ' SER . 3.6 mpp? -111.15 67.63 0.65 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.02 -174.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.476 ' HB1' ' ND2' ' B' ' 68' ' ' ASN . . . -60.81 131.37 50.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.77 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -81.33 150.88 28.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.164 0.507 . . . . 0.0 111.674 -174.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.555 ' CE1' HD23 ' B' ' 44' ' ' LEU . 31.1 t80 -72.26 145.87 47.63 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.409 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.406 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 92.1 t90 -134.31 147.97 50.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.391 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.496 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -152.25 154.92 25.83 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.855 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.472 HD22 ' SD ' ' A' ' 13' ' ' MET . 49.8 tp -147.38 108.26 4.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.857 0.36 . . . . 0.0 111.019 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -90.42 119.94 31.12 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.963 0.411 . . . . 0.0 110.545 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.702 ' SD ' ' HE1' ' A' ' 19' ' ' TYR . 52.9 mmm -99.96 139.67 35.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.226 -175.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -100.32 145.06 29.62 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.583 174.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.421 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 11.0 Cg_endo -55.14 116.29 3.04 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.147 2.565 . . . . 0.0 112.925 -177.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 62.92 64.85 0.84 Allowed 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.876 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -145.71 138.78 26.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.682 173.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.669 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 86.4 mttt -107.1 126.54 52.49 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -176.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 1.641 ' HE2' ' CE1' ' A' ' 19' ' ' TYR . 1.2 m-85 -112.6 103.84 11.9 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.192 174.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.0 p -88.37 100.33 12.94 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 174.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -113.24 144.37 42.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.434 0.635 . . . . 0.0 111.872 -170.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.5 m -101.95 140.91 35.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.556 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 74.1 mt -99.38 120.14 48.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.217 0.532 . . . . 0.0 111.723 -171.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.54 HD12 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -105.65 -9.84 10.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.276 176.044 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.5 pttt -141.55 119.16 11.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.872 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.9 p -67.05 133.67 50.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.809 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -147.56 166.49 27.19 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -173.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.533 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 9.4 t60 -118.88 126.21 51.27 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.908 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.504 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 42.6 mt -92.23 136.16 25.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 170.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.495 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 64.2 p -123.68 -5.66 8.09 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -170.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -177.46 160.79 27.76 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 119.086 -1.531 . . . . 0.0 113.823 176.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.5 p -144.5 129.96 14.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 174.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.45 157.7 43.97 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.012 -0.43 . . . . 0.0 111.482 -176.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.544 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 3.9 pp -122.05 145.3 48.28 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.795 0.807 . . . . 0.0 111.846 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -107.72 -56.02 2.28 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.64 173.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -103.14 127.26 50.49 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.368 173.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.586 ' O ' ' HG3' ' A' ' 58' ' ' LYS . . . 145.13 159.38 8.07 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 119.958 -1.115 . . . . 0.0 112.896 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -102.43 -45.61 5.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.477 0.18 . . . . 0.0 111.459 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -150.56 127.27 10.93 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 120.582 0.229 . . . . 0.0 111.056 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.42 114.94 18.17 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.295 0.569 . . . . 0.0 110.479 171.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 79' ' ' THR . 3.7 mppt? -95.1 112.05 23.8 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 174.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.6 tp -84.18 108.87 17.32 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -108.59 144.31 36.47 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.267 0.556 . . . . 0.0 110.073 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.642 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -129.23 116.64 19.47 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.413 174.454 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -103.45 110.52 22.58 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.251 0.548 . . . . 0.0 109.706 177.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.408 ' HB1' ' CE2' ' E' ' 8' ' ' PHE . . . -140.13 145.58 37.75 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.333 -177.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 58.11 33.14 22.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.474 0.654 . . . . 0.0 109.774 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 62.59 38.13 12.55 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.814 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.529 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 6.5 tp-100 -140.66 138.92 34.67 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 178.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.425 ' HG3' ' HH ' ' A' ' 78' ' ' TYR . 29.3 tt0 -90.92 110.04 21.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.88 0.371 . . . . 0.0 110.405 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 1.651 ' HD1' ' CD2' ' A' ' 51' ' ' TYR . 78.2 m-85 -101.82 130.65 48.32 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.473 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -85.24 101.86 10.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.74 0.781 . . . . 0.0 109.03 172.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.594 ' CG2' ' HB3' ' A' ' 44' ' ' LEU . 2.9 t -76.33 -49.81 23.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.72 -171.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.467 ' HB1' HD22 ' A' ' 65' ' ' LEU . . . -154.02 146.69 24.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.451 -177.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.5 m -111.06 100.94 9.53 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 170.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.8 114.65 46.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.665 0.745 . . . . 0.0 109.808 -176.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 78.0 p -122.86 -178.32 3.91 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.51 -173.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.586 ' HG3' ' O ' ' A' ' 37' ' ' GLY . 6.1 mttm -61.41 -29.9 70.23 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.012 0.434 . . . . 0.0 110.407 169.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.27 -40.2 52.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.431 178.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.2 mt -115.55 81.38 8.87 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -69.13 -0.47 6.44 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.152 2.568 . . . . 0.0 113.984 -167.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -163.06 130.24 3.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.361 0.601 . . . . 0.0 111.319 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.447 HG12 ' HB3' ' A' ' 54' ' ' ALA . 96.3 t -118.88 120.81 65.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.377 174.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.18 131.61 35.31 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 175.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.467 HD22 ' HB1' ' A' ' 54' ' ' ALA . 82.5 mt -124.0 167.14 14.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.449 0.642 . . . . 0.0 112.36 -173.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 14.4 t0 -143.15 99.18 3.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.514 170.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 2.4 mt -128.09 140.04 52.17 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.408 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.491 ' ND2' ' HB1' ' E' ' 6' ' ' ALA . 5.3 t30 -135.2 122.71 21.99 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.754 174.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -116.14 143.75 45.07 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.49 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.407 ' OG ' ' HB3' ' E' ' 5' ' ' MET . 34.1 t -94.34 166.24 12.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.239 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.57 -7.05 51.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.164 0.506 . . . . 0.0 110.138 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.86 -8.16 62.16 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.494 174.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -93.71 144.62 25.23 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -136.12 127.74 28.88 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 171.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 8.5 pt -135.5 160.31 39.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.581 -163.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.413 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 3.0 mtm -114.05 120.39 40.41 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.499 172.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.642 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -103.67 127.85 51.07 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 176.235 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 1.595 ' HD2' ' CD1' ' A' ' 78' ' ' TYR . 53.0 p90 -156.4 143.15 18.66 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 119.735 -0.786 . . . . 0.0 112.238 -176.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 2.0 p -114.92 132.11 56.66 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.301 -176.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.42 160.65 14.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.797 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.02 -175.67 40.08 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -175.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -110.4 102.53 11.16 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.877 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.446 ' CB ' ' HA3' ' A' ' 37' ' ' GLY . . . -174.51 155.7 2.3 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.557 171.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.5 t -115.92 117.26 29.67 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.371 -0.604 . . . . 0.0 109.371 177.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.544 ' CG1' ' HB3' ' A' ' 34' ' ' LEU . 3.7 m -111.34 164.97 6.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.213 0.53 . . . . 0.0 112.126 -174.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 21.2 t -129.76 120.85 25.74 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.125 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 5.3 mp -92.86 154.43 18.23 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 121.004 0.43 . . . . 0.0 110.172 173.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.7 144.66 49.28 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.105 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.97 -167.45 28.64 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.01 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 1.659 ' HD1' ' CD2' ' A' ' 90' ' ' TYR . 43.3 p90 -145.99 136.48 24.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.513 0.673 . . . . 0.0 111.651 177.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.6 mt -77.66 137.28 38.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.495 175.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -73.15 119.17 17.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.012 0.434 . . . . 0.0 110.652 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -89.01 -6.64 57.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.863 0.839 . . . . 0.0 109.296 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.9 mp 69.93 86.77 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.303 -176.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.85 110.88 5.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.382 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.467 ' HA ' ' C ' ' E' ' 97' ' ' GLY . 20.2 m -79.17 -36.12 40.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.737 -177.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.494 ' C ' ' HA ' ' B' ' 96' ' ' SER . . . 72.91 -67.99 1.34 Allowed Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.736 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 C--O 1.251 1.145 0 CA-C-O 118.261 -0.876 . . . . 0.0 109.794 -178.052 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 1.639 ' HD1' ' CD2' ' B' ' 1' ' ' PHE . 94.1 m-85 . . . . . 0 N--CA 1.477 0.922 0 CA-C-O 120.949 0.404 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -136.18 163.58 30.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.22 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 122.3 25.53 2.0 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.266 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -167.36 53.44 0.07 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.115 0.483 . . . . 0.0 110.119 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' MET . . . . . 0.449 ' HB3' ' OG ' ' C' ' 70' ' ' SER . 3.6 mpp? -111.1 67.56 0.64 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.043 -174.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.458 ' HB1' ' ND2' ' C' ' 68' ' ' ASN . . . -60.75 131.4 50.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.901 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -81.36 150.77 28.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.188 0.518 . . . . 0.0 111.631 -174.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 0.571 ' CE1' HD23 ' C' ' 44' ' ' LEU . 31.8 t80 -72.13 145.8 47.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.462 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . 0.407 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 92.1 t90 -134.26 147.95 50.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.474 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.523 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -152.27 154.92 25.83 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.85 178.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.48 ' HG ' ' SD ' ' B' ' 13' ' ' MET . 49.4 tp -147.37 108.34 4.21 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.856 0.36 . . . . 0.0 110.992 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -90.41 120.15 31.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.895 0.378 . . . . 0.0 110.479 176.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' MET . . . . . 0.709 ' SD ' ' HE1' ' B' ' 19' ' ' TYR . 53.4 mmm -100.1 139.62 35.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.145 -175.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -100.28 145.05 29.59 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.636 174.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.42 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 11.1 Cg_endo -55.15 116.26 3.02 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.136 2.558 . . . . 0.0 112.943 -177.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 62.96 64.85 0.84 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.89 176.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -145.74 138.89 26.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.622 173.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . 0.671 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 86.4 mttt -107.26 126.39 52.36 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -176.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' TYR . . . . . 1.66 ' HD2' ' CD1' ' B' ' 19' ' ' TYR . 1.2 m-85 -112.41 103.73 11.85 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.221 174.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 9.2 p -88.31 100.38 12.96 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -113.29 144.42 42.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.889 -170.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 27.6 m -101.94 140.96 35.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.521 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 73.6 mt -99.42 120.14 48.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.26 0.552 . . . . 0.0 111.754 -171.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.543 ' H ' HD12 ' B' ' 24' ' ' ILE . 0.2 OUTLIER -105.54 -9.88 10.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.323 175.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -141.52 119.11 11.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.872 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 5.9 p -67.02 133.75 50.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.818 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -147.59 166.42 27.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.668 0.747 . . . . 0.0 112.922 -173.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' HIS . . . . . 0.522 ' HA ' ' O ' ' B' ' 67' ' ' LEU . 9.3 t60 -118.82 126.23 51.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.964 178.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.503 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 43.3 mt -92.28 136.18 25.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 170.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.496 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 64.2 p -123.73 -5.67 8.06 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -170.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -177.41 160.77 27.77 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 119.032 -1.556 . . . . 0.0 113.823 176.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 11.4 p -144.52 130.02 14.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 173.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.41 157.7 43.97 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 122.0 -0.438 . . . . 0.0 111.598 -176.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.539 ' HB3' ' CG1' ' B' ' 85' ' ' VAL . 3.9 pp -122.11 145.32 48.28 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.856 0.836 . . . . 0.0 111.825 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -107.75 -56.09 2.27 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.614 173.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -103.07 127.23 50.41 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.344 173.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.576 ' O ' ' HG3' ' B' ' 58' ' ' LYS . . . 145.21 159.37 8.07 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 120.016 -1.088 . . . . 0.0 112.809 178.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -102.42 -45.56 5.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.474 0.178 . . . . 0.0 111.46 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -150.62 127.3 10.9 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 120.615 0.245 . . . . 0.0 110.958 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.41 114.95 18.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.235 0.541 . . . . 0.0 110.461 171.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' B' ' 79' ' ' THR . 3.7 mppt? -94.97 112.01 23.75 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 174.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 46.6 tp -84.26 108.84 17.36 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -176.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -108.56 144.31 36.42 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.338 0.589 . . . . 0.0 110.08 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.653 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 0.2 OUTLIER -129.25 116.74 19.61 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.378 174.397 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -103.44 110.5 22.54 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.18 0.514 . . . . 0.0 109.702 177.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.08 145.63 37.91 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.358 -177.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 58.1 33.0 22.72 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.521 0.677 . . . . 0.0 109.833 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 62.77 38.0 12.08 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.82 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.525 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 6.5 tp-100 -140.64 139.0 34.77 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 178.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.425 ' HG3' ' HH ' ' B' ' 78' ' ' TYR . 29.3 tt0 -90.98 110.05 21.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.922 0.392 . . . . 0.0 110.352 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 1.648 ' HD1' ' CD2' ' B' ' 51' ' ' TYR . 78.3 m-85 -101.82 130.72 48.32 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.484 178.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -85.32 101.87 10.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.742 0.782 . . . . 0.0 108.971 172.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.596 ' CG2' ' HB3' ' B' ' 44' ' ' LEU . 2.9 t -76.4 -49.76 23.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.704 -171.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.464 ' HB1' HD22 ' B' ' 65' ' ' LEU . . . -154.1 146.71 24.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.434 -177.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 27.4 m -110.99 100.98 9.58 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.8 114.71 47.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.655 0.741 . . . . 0.0 109.855 -176.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 78.7 p -122.87 -178.24 3.89 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.45 -173.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . 0.576 ' HG3' ' O ' ' B' ' 37' ' ' GLY . 6.1 mttm -61.49 -30.04 70.36 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.07 0.462 . . . . 0.0 110.29 169.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.12 -40.33 53.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.41 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 79.3 mt -115.55 81.4 8.91 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.15 -0.35 6.29 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.043 2.495 . . . . 0.0 114.006 -167.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -163.13 130.15 3.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.226 0.536 . . . . 0.0 111.346 -176.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.442 HG12 ' HB3' ' B' ' 54' ' ' ALA . 96.1 t -118.82 120.81 65.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.373 174.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.24 131.51 35.3 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.464 HD22 ' HB1' ' B' ' 54' ' ' ALA . 82.4 mt -123.93 167.17 14.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.479 0.657 . . . . 0.0 112.348 -173.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . 0.44 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 14.4 t0 -143.13 99.11 3.39 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.563 170.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.522 ' O ' ' HA ' ' B' ' 28' ' ' HIS . 2.4 mt -128.02 140.16 52.13 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.395 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . 0.476 ' ND2' ' HB1' ' A' ' 6' ' ' ALA . 5.3 t30 -135.35 122.7 21.8 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.714 174.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -116.08 143.72 45.1 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.508 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.405 ' OG ' ' HB3' ' A' ' 5' ' ' MET . 34.0 t -94.37 166.26 12.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.216 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.59 -6.91 51.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.179 0.514 . . . . 0.0 110.175 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.95 -8.21 61.97 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.458 174.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -93.69 144.62 25.23 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -136.12 127.79 28.98 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 171.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.448 ' HB ' ' CD1' ' B' ' 44' ' ' LEU . 8.5 pt -135.46 160.41 40.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.606 -163.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' MET . . . . . 0.406 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 3.0 mtm -114.05 120.35 40.29 Favored 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.535 172.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . 0.653 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -103.75 127.78 51.19 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 176.288 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 1.604 ' HE2' ' CE1' ' B' ' 78' ' ' TYR . 52.7 p90 -156.31 143.18 18.79 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 119.802 -0.759 . . . . 0.0 112.238 -176.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' B' ' 41' ' ' LYS . 2.0 p -114.98 132.02 56.72 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.335 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.27 160.72 14.88 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.82 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.97 -175.67 40.16 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -175.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -110.37 102.58 11.21 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.878 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.449 ' CB ' ' HA3' ' B' ' 37' ' ' GLY . . . -174.55 155.62 2.27 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.567 171.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 32.2 t -115.91 117.25 29.66 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.539 ' CG1' ' HB3' ' B' ' 34' ' ' LEU . 3.7 m -111.3 164.88 6.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.245 0.545 . . . . 0.0 112.132 -174.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 21.3 t -129.7 120.83 25.79 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.156 176.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.471 ' HB2' ' HB3' ' B' ' 11' ' ' LEU . 5.3 mp -92.92 154.36 18.24 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.016 0.436 . . . . 0.0 110.163 173.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.65 144.66 49.35 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.083 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.94 -167.41 28.55 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.962 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' TYR . . . . . 1.64 ' HD1' ' CD2' ' B' ' 90' ' ' TYR . 43.6 p90 -146.07 136.49 23.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.582 0.706 . . . . 0.0 111.623 177.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 26.4 mt -77.65 137.22 38.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.474 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -73.09 119.02 16.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.029 0.442 . . . . 0.0 110.657 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -88.89 -6.63 57.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.907 0.861 . . . . 0.0 109.404 176.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 1.9 mp 69.88 86.8 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 114.176 -1.375 . . . . 0.0 109.347 -176.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.86 110.98 5.93 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.367 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' SER . . . . . 0.494 ' HA ' ' C ' ' A' ' 97' ' ' GLY . 20.3 m -79.29 -36.13 40.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.685 -177.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' GLY . . . . . 0.401 ' C ' ' HA ' ' C' ' 96' ' ' SER . . . 72.9 -67.96 1.34 Allowed Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.739 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.493 -0.765 . . . . 0.0 109.8 -178.029 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 1' ' ' PHE . . . . . 1.648 ' HE2' ' CE1' ' C' ' 1' ' ' PHE . 94.1 m-85 . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 120.985 0.421 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -136.15 163.61 29.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.161 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . 122.32 25.52 1.99 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.243 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -167.39 53.47 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.136 0.494 . . . . 0.0 110.048 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 5' ' ' MET . . . . . 0.418 ' HB3' ' OG ' ' D' ' 70' ' ' SER . 3.6 mpp? -111.1 67.66 0.65 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.001 -174.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 6' ' ' ALA . . . . . 0.503 ' HB1' ' ND2' ' D' ' 68' ' ' ASN . . . -60.81 131.39 50.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.85 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -81.39 150.88 28.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.094 0.473 . . . . 0.0 111.67 -174.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 8' ' ' PHE . . . . . 0.58 ' CE1' HD23 ' D' ' 44' ' ' LEU . 31.2 t80 -72.26 145.88 47.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.376 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . 0.402 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 92.1 t90 -134.35 147.96 50.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.464 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . 0.516 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -152.23 154.91 25.83 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.828 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.479 ' HG ' ' SD ' ' C' ' 13' ' ' MET . 49.7 tp -147.37 108.37 4.22 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.923 0.392 . . . . 0.0 111.069 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -90.49 120.12 31.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.929 0.395 . . . . 0.0 110.536 176.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 13' ' ' MET . . . . . 0.71 ' SD ' ' HE1' ' C' ' 19' ' ' TYR . 53.2 mmm -100.01 139.66 35.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.254 -175.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -100.41 144.99 29.51 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.584 174.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . 0.422 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 11.0 Cg_endo -55.08 116.3 3.04 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 123.106 2.537 . . . . 0.0 112.932 -177.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 62.9 64.81 0.85 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.89 176.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -145.67 138.93 26.21 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.655 173.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 18' ' ' LYS . . . . . 0.668 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 86.7 mttt -107.13 126.48 52.43 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -176.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . 1.673 ' HD2' ' CD1' ' C' ' 19' ' ' TYR . 1.2 m-85 -112.52 103.84 11.93 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.145 174.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 9.0 p -88.38 100.24 12.88 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -113.23 144.45 42.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.434 0.635 . . . . 0.0 111.848 -170.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 27.3 m -101.98 140.9 35.65 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.452 176.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 73.9 mt -99.41 120.14 48.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.125 0.488 . . . . 0.0 111.772 -171.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . 0.555 HD12 ' H ' ' C' ' 24' ' ' ILE . 0.2 OUTLIER -105.57 -9.94 10.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.318 176.018 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 35.7 pttt -141.47 119.07 11.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.893 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 5.8 p -67.04 133.72 50.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.738 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 27' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -147.53 166.44 27.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.627 0.727 . . . . 0.0 112.956 -173.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 28' ' ' HIS . . . . . 0.525 ' HA ' ' O ' ' C' ' 67' ' ' LEU . 9.4 t60 -118.87 126.23 51.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.34 -1.3 . . . . 0.0 109.934 178.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . 0.512 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 42.7 mt -92.2 136.14 25.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 170.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 30' ' ' SER . . . . . 0.495 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 64.4 p -123.71 -5.62 8.07 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -170.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -177.45 160.71 27.64 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 119.038 -1.553 . . . . 0.0 113.816 176.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 11.5 p -144.49 129.99 14.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.42 157.72 43.97 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.889 -0.507 . . . . 0.0 111.517 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.543 ' HB3' ' CG1' ' C' ' 85' ' ' VAL . 3.8 pp -122.07 145.33 48.25 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.782 0.801 . . . . 0.0 111.803 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -107.79 -56.04 2.28 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.387 -1.278 . . . . 0.0 108.621 173.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -103.08 127.25 50.41 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.345 173.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 37' ' ' GLY . . . . . 0.585 ' O ' ' HG3' ' C' ' 58' ' ' LYS . . . 145.23 159.4 8.09 Favored Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 119.954 -1.117 . . . . 0.0 112.815 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -102.56 -45.58 5.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.465 0.174 . . . . 0.0 111.385 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -150.48 127.2 10.95 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.501 0.191 . . . . 0.0 111.094 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.38 115.0 18.28 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.328 0.585 . . . . 0.0 110.439 171.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' C' ' 79' ' ' THR . 3.7 mppt? -95.11 112.07 23.82 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 46.9 tp -84.31 108.93 17.44 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -176.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -108.62 144.33 36.49 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.327 0.584 . . . . 0.0 110.062 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.645 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 0.2 OUTLIER -129.28 116.79 19.65 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.364 174.395 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -103.51 110.4 22.42 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.206 0.527 . . . . 0.0 109.736 177.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.97 145.64 38.13 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.385 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 57.95 33.18 22.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.451 0.643 . . . . 0.0 109.844 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 60.0 mttp 62.69 38.03 12.3 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.822 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . 0.532 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 6.5 tp-100 -140.64 139.06 34.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.588 0.232 . . . . 0.0 110.379 178.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . 0.419 ' HG3' ' HH ' ' C' ' 78' ' ' TYR . 29.3 tt0 -91.07 110.02 21.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.32 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 1.654 ' HD1' ' CD2' ' C' ' 51' ' ' TYR . 78.1 m-85 -101.84 130.72 48.36 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.433 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -85.31 101.8 10.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.68 0.752 . . . . 0.0 108.995 173.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 53' ' ' VAL . . . . . 0.593 ' CG2' ' HB3' ' C' ' 44' ' ' LEU . 2.9 t -76.33 -49.88 23.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.696 -171.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 54' ' ' ALA . . . . . 0.466 ' HB1' HD22 ' C' ' 65' ' ' LEU . . . -153.98 146.71 24.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.511 -177.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 27.6 m -111.04 101.02 9.6 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 170.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.83 114.67 46.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.617 0.722 . . . . 0.0 109.807 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 78.1 p -122.89 -178.26 3.89 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.467 -173.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 58' ' ' LYS . . . . . 0.585 ' HG3' ' O ' ' C' ' 37' ' ' GLY . 6.2 mttm -61.51 -29.92 70.29 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.025 0.441 . . . . 0.0 110.35 169.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.18 -40.24 52.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.359 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 79.9 mt -115.65 81.48 9.23 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.18 -0.44 6.44 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.143 2.562 . . . . 0.0 113.972 -167.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -163.11 130.18 3.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.266 0.555 . . . . 0.0 111.333 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.432 HG12 ' HB3' ' C' ' 54' ' ' ALA . 96.9 t -118.72 120.84 65.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.458 174.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.29 131.58 35.3 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . 0.466 HD22 ' HB1' ' C' ' 54' ' ' ALA . 82.6 mt -123.99 167.19 14.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.473 0.654 . . . . 0.0 112.285 -173.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 66' ' ' ASP . . . . . 0.463 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 14.3 t0 -143.14 99.12 3.39 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.478 170.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' C' ' 28' ' ' HIS . 2.4 mt -128.1 140.15 52.1 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.419 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . 0.458 ' ND2' ' HB1' ' B' ' 6' ' ' ALA . 5.2 t30 -135.32 122.73 21.88 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.75 174.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -116.12 143.75 45.07 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.429 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 70' ' ' SER . . . . . 0.449 ' OG ' ' HB3' ' B' ' 5' ' ' MET . 33.8 t -94.31 166.23 12.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.231 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.57 -6.88 51.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.182 0.515 . . . . 0.0 110.185 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.97 -8.34 61.84 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.462 174.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -93.61 144.58 25.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.815 0.34 . . . . 0.0 110.097 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -136.06 127.72 28.96 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 171.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' C' ' 44' ' ' LEU . 8.5 pt -135.36 160.45 40.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.532 -163.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 76' ' ' MET . . . . . 0.41 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 3.0 mtm -114.14 120.37 40.28 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.51 172.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 77' ' ' PHE . . . . . 0.645 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.7 OUTLIER -103.8 127.81 51.26 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.315 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 78' ' ' TYR . . . . . 1.635 ' HE1' ' CE2' ' C' ' 78' ' ' TYR . 53.3 p90 -156.31 143.17 18.78 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.311 -176.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 79' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' C' ' 41' ' ' LYS . 2.0 p -114.98 131.99 56.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.362 -176.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.29 160.66 14.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.862 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.93 -175.69 40.24 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -175.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -110.39 102.61 11.23 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 119.391 -0.924 . . . . 0.0 109.867 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . 0.439 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -174.53 155.61 2.28 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.633 171.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 32.3 t -115.84 117.28 29.76 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.543 ' CG1' ' HB3' ' C' ' 34' ' ' LEU . 3.7 m -111.39 164.92 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-O 121.313 0.578 . . . . 0.0 112.106 -174.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 21.1 t -129.72 120.8 25.7 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.217 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . 0.475 ' HB2' ' HB3' ' C' ' 11' ' ' LEU . 5.3 mp -92.89 154.4 18.23 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 120.987 0.422 . . . . 0.0 110.157 173.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.68 144.67 49.32 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.135 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.0 -167.36 28.54 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.978 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 90' ' ' TYR . . . . . 1.63 ' HE1' ' CE2' ' C' ' 90' ' ' TYR . 43.6 p90 -146.06 136.45 23.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.564 0.697 . . . . 0.0 111.631 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 26.3 mt -77.63 137.16 38.39 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.486 175.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -73.05 119.16 16.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.073 0.463 . . . . 0.0 110.64 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -88.93 -6.8 57.02 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.863 0.839 . . . . 0.0 109.348 176.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 1.9 mp 70.1 86.66 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 114.229 -1.35 . . . . 0.0 109.314 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.79 110.94 5.86 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.311 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 96' ' ' SER . . . . . 0.401 ' HA ' ' C ' ' B' ' 97' ' ' GLY . 20.1 m -79.25 -36.05 40.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.739 -177.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . 0.498 ' C ' ' HA ' ' D' ' 96' ' ' SER . . . 72.8 -67.85 1.32 Allowed Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.804 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.336 -0.84 . . . . 0.0 109.785 -178.079 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . 1.628 ' HE2' ' CE1' ' D' ' 1' ' ' PHE . 94.1 m-85 . . . . . 0 N--CA 1.479 0.981 0 CA-C-O 120.914 0.388 . . . . 0.0 110.263 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -136.2 163.58 30.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.164 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . 122.31 25.53 1.99 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.213 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -167.42 53.58 0.07 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.925 0.393 . . . . 0.0 110.003 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 5' ' ' MET . . . . . 0.414 ' HB3' ' OG ' ' E' ' 70' ' ' SER . 3.6 mpp? -111.2 67.65 0.65 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.011 -174.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 6' ' ' ALA . . . . . 0.489 ' HB1' ' ND2' ' E' ' 68' ' ' ASN . . . -60.77 131.35 50.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.773 178.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -81.33 150.88 28.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.148 0.499 . . . . 0.0 111.663 -174.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 8' ' ' PHE . . . . . 0.565 ' CE1' HD23 ' E' ' 44' ' ' LEU . 31.0 t80 -72.27 145.78 47.66 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.37 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 9' ' ' TRP . . . . . 0.408 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 92.1 t90 -134.27 147.99 50.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.433 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . 0.506 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -152.21 154.91 25.83 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.872 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . 0.488 ' HG ' ' SD ' ' D' ' 13' ' ' MET . 50.1 tp -147.33 108.34 4.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.803 0.335 . . . . 0.0 111.02 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -90.52 120.09 31.32 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.974 0.416 . . . . 0.0 110.479 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 13' ' ' MET . . . . . 0.698 ' SD ' ' HE1' ' D' ' 19' ' ' TYR . 53.3 mmm -100.08 139.63 35.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.173 -175.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -100.3 145.07 29.63 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.59 174.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . 0.416 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 11.0 Cg_endo -55.23 116.3 3.04 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 123.099 2.533 . . . . 0.0 112.91 -177.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 63.04 64.79 0.83 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.843 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -145.65 138.86 26.19 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.598 173.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . 0.657 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 86.6 mttt -107.2 126.48 52.46 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -176.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 19' ' ' TYR . . . . . 1.654 ' HD2' ' CD1' ' D' ' 19' ' ' TYR . 1.2 m-85 -112.63 103.81 11.87 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.104 174.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 8.7 p -88.38 100.28 12.9 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 174.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -113.13 144.4 42.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.88 -170.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 27.2 m -101.95 140.9 35.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.609 176.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 74.2 mt -99.48 120.19 48.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.203 0.525 . . . . 0.0 111.651 -171.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . 0.55 HD12 ' H ' ' D' ' 24' ' ' ILE . 0.2 OUTLIER -105.61 -9.81 10.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.388 175.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -141.55 119.08 11.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.847 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 5.8 p -67.06 133.72 50.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.783 -176.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 27' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -147.56 166.39 27.48 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -173.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 28' ' ' HIS . . . . . 0.522 ' HA ' ' O ' ' D' ' 67' ' ' LEU . 9.3 t60 -118.73 126.23 51.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.973 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 29' ' ' ILE . . . . . 0.521 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 42.4 mt -92.24 136.14 25.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 170.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 30' ' ' SER . . . . . 0.505 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 64.3 p -123.77 -5.57 8.04 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -170.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 31' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -177.42 160.84 27.87 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 119.141 -1.504 . . . . 0.0 113.874 176.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 11.4 p -144.51 129.95 14.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 173.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.41 157.76 43.96 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.004 -0.435 . . . . 0.0 111.451 -176.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 34' ' ' LEU . . . . . 0.547 ' HB3' ' CG1' ' D' ' 85' ' ' VAL . 3.9 pp -122.11 145.26 48.34 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.8 0.809 . . . . 0.0 111.826 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -107.67 -55.98 2.28 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.663 173.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -103.2 127.25 50.56 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.336 173.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . 0.586 ' O ' ' HG3' ' D' ' 58' ' ' LYS . . . 145.15 159.33 8.04 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 119.997 -1.096 . . . . 0.0 112.83 178.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -102.47 -45.49 5.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -150.58 127.35 10.97 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.592 0.234 . . . . 0.0 110.955 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.51 114.97 18.15 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.223 0.535 . . . . 0.0 110.452 171.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' D' ' 79' ' ' THR . 3.7 mppt? -95.14 112.07 23.82 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 47.2 tp -84.26 108.88 17.38 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -176.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -108.51 144.32 36.32 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.129 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.65 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.2 OUTLIER -129.28 116.73 19.57 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.411 174.355 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 45' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -103.34 110.43 22.42 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.698 177.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . 0.412 ' HB1' ' CE2' ' C' ' 8' ' ' PHE . . . -140.05 145.53 37.84 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.339 -177.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 58.18 33.08 22.81 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.466 0.65 . . . . 0.0 109.819 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 62.65 37.95 12.48 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.904 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . 0.533 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 6.5 tp-100 -140.6 138.96 34.81 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 178.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.424 ' HG3' ' HH ' ' D' ' 78' ' ' TYR . 29.2 tt0 -90.95 110.14 21.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.315 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . 1.653 ' HD2' ' CD1' ' D' ' 51' ' ' TYR . 78.5 m-85 -101.87 130.7 48.41 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.444 178.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -85.27 101.91 10.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 172.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 53' ' ' VAL . . . . . 0.591 ' CG2' ' HB3' ' D' ' 44' ' ' LEU . 2.9 t -76.49 -49.69 23.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.716 -171.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 54' ' ' ALA . . . . . 0.464 ' HB1' HD22 ' D' ' 65' ' ' LEU . . . -154.05 146.73 24.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.414 -177.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 27.3 m -111.06 100.93 9.52 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 170.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.8 114.64 46.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.607 0.718 . . . . 0.0 109.85 -176.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 79.2 p -122.88 -178.24 3.89 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.487 -173.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 58' ' ' LYS . . . . . 0.586 ' HG3' ' O ' ' D' ' 37' ' ' GLY . 6.1 mttm -61.45 -29.95 70.28 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.037 0.446 . . . . 0.0 110.415 169.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.21 -40.21 52.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.438 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 79.5 mt -115.63 81.47 9.15 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 174.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -69.13 -0.42 6.37 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.15 2.567 . . . . 0.0 113.983 -167.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -163.15 130.1 3.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.222 0.534 . . . . 0.0 111.297 -176.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.452 HG12 ' HB3' ' D' ' 54' ' ' ALA . 96.4 t -118.76 120.87 65.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.39 174.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.2 131.49 35.3 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 65' ' ' LEU . . . . . 0.464 HD22 ' HB1' ' D' ' 54' ' ' ALA . 82.7 mt -123.96 167.17 14.5 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.474 0.654 . . . . 0.0 112.325 -173.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 66' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 14.4 t0 -143.09 99.03 3.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.592 170.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . 0.522 ' O ' ' HA ' ' D' ' 28' ' ' HIS . 2.4 mt -127.96 140.11 52.18 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.436 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 68' ' ' ASN . . . . . 0.503 ' ND2' ' HB1' ' C' ' 6' ' ' ALA . 5.2 t30 -135.3 122.73 21.89 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.486 -0.485 . . . . 0.0 109.72 174.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -116.11 143.66 45.18 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.551 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 70' ' ' SER . . . . . 0.418 ' OG ' ' HB3' ' C' ' 5' ' ' MET . 34.0 t -94.38 166.26 12.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.219 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.56 -7.02 51.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.271 0.557 . . . . 0.0 110.141 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.91 -8.19 62.05 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.496 174.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -93.63 144.52 25.31 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -136.08 127.75 28.97 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 171.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' D' ' 44' ' ' LEU . 8.6 pt -135.34 160.5 40.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.568 -163.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 76' ' ' MET . . . . . 0.412 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 3.0 mtm -114.16 120.43 40.47 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.454 172.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 77' ' ' PHE . . . . . 0.65 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.7 OUTLIER -103.79 127.73 51.25 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.263 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 78' ' ' TYR . . . . . 1.631 ' HE2' ' CE1' ' D' ' 78' ' ' TYR . 52.9 p90 -156.25 143.14 18.83 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.248 -176.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 79' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' D' ' 41' ' ' LYS . 2.0 p -114.9 132.01 56.68 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.305 -176.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.28 160.69 14.91 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.874 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.96 -175.7 40.2 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -175.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -110.34 102.53 11.17 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.97 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.444 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -174.54 155.54 2.26 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.591 171.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 32.4 t -115.81 117.14 29.39 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . 0.547 ' CG1' ' HB3' ' D' ' 34' ' ' LEU . 3.7 m -111.27 164.87 6.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.21 0.528 . . . . 0.0 112.151 -174.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 21.3 t -129.65 120.83 25.87 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.17 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 87' ' ' LEU . . . . . 0.466 ' HB2' ' HB3' ' D' ' 11' ' ' LEU . 5.3 mp -92.92 154.44 18.19 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 121.022 0.439 . . . . 0.0 110.1 173.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.7 144.65 49.27 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.111 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.88 -167.34 28.4 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.033 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 90' ' ' TYR . . . . . 1.658 ' HD1' ' CD2' ' D' ' 90' ' ' TYR . 43.3 p90 -146.1 136.49 23.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.556 0.693 . . . . 0.0 111.653 177.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 26.1 mt -77.59 137.22 38.45 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.536 175.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -73.08 119.09 16.85 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.965 0.412 . . . . 0.0 110.738 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -88.95 -6.67 57.09 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.95 0.881 . . . . 0.0 109.34 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 1.9 mp 69.97 86.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.361 -176.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.78 110.97 5.87 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.414 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 96' ' ' SER . . . . . 0.498 ' HA ' ' C ' ' C' ' 97' ' ' GLY . 20.1 m -79.24 -36.17 40.39 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.69 -177.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 97' ' ' GLY . . . . . 0.491 ' C ' ' HA ' ' E' ' 96' ' ' SER . . . 72.94 -67.87 1.35 Allowed Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.707 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.49 -0.766 . . . . 0.0 109.844 -178.053 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' E' E ' 1' ' ' PHE . . . . . 1.608 ' HD2' ' CD1' ' E' ' 1' ' ' PHE . 94.0 m-85 . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 120.894 0.378 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -136.16 163.56 30.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.227 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . 122.38 25.54 1.98 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.162 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -167.35 53.48 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.102 0.477 . . . . 0.0 110.058 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 5' ' ' MET . . . . . 0.407 ' HB3' ' OG ' ' A' ' 70' ' ' SER . 3.6 mpp? -111.17 67.69 0.65 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.977 -174.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 6' ' ' ALA . . . . . 0.491 ' HB1' ' ND2' ' A' ' 68' ' ' ASN . . . -60.79 131.39 50.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.846 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -81.37 150.76 28.27 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.093 0.473 . . . . 0.0 111.647 -174.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 8' ' ' PHE . . . . . 0.6 ' CE1' HD23 ' A' ' 44' ' ' LEU . 31.2 t80 -72.13 145.9 47.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.46 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 9' ' ' TRP . . . . . . . . . . . . . 92.0 t90 -134.41 147.92 50.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.407 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 10' ' ' GLY . . . . . 0.528 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -152.18 154.93 25.84 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.908 178.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . 0.481 HD22 ' SD ' ' E' ' 13' ' ' MET . 49.5 tp -147.34 108.31 4.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.829 0.347 . . . . 0.0 111.018 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -90.47 120.18 31.36 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.002 0.43 . . . . 0.0 110.478 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 13' ' ' MET . . . . . 0.688 ' SD ' ' HE1' ' E' ' 19' ' ' TYR . 53.0 mmm -100.08 139.57 35.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.247 -175.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -100.28 145.08 29.64 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.665 174.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . 0.415 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 11.0 Cg_endo -55.15 116.34 3.07 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.088 2.525 . . . . 0.0 112.951 -177.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 62.89 64.81 0.85 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.892 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -145.73 138.86 26.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.653 173.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . 0.652 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 86.7 mttt -107.11 126.36 52.27 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -176.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . 1.61 ' HD2' ' CD1' ' E' ' 19' ' ' TYR . 1.2 m-85 -112.53 103.82 11.9 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.167 174.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 9.1 p -88.31 100.25 12.86 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -113.16 144.37 42.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.899 -170.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 27.5 m -101.98 140.99 35.52 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.508 176.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 73.9 mt -99.47 120.21 48.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.225 0.536 . . . . 0.0 111.668 -171.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . 0.554 HD12 ' H ' ' E' ' 24' ' ' ILE . 0.2 OUTLIER -105.63 -9.86 10.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.297 175.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 35.5 pttt -141.47 119.15 11.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.867 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 5.8 p -67.05 133.72 50.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.752 -176.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 27' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -147.54 166.4 27.41 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -173.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 28' ' ' HIS . . . . . 0.529 ' HA ' ' O ' ' E' ' 67' ' ' LEU . 9.4 t60 -118.77 126.28 51.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.968 178.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 29' ' ' ILE . . . . . 0.508 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 42.8 mt -92.25 136.15 25.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 170.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 30' ' ' SER . . . . . 0.495 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 64.2 p -123.69 -5.65 8.08 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -170.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 31' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -177.39 160.84 27.91 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.063 -1.541 . . . . 0.0 113.823 176.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 11.5 p -144.55 129.91 14.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.39 157.72 43.97 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 121.904 -0.497 . . . . 0.0 111.518 -176.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 34' ' ' LEU . . . . . 0.539 ' HB3' ' CG1' ' E' ' 85' ' ' VAL . 3.9 pp -122.06 145.27 48.31 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.858 0.837 . . . . 0.0 111.856 178.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -107.71 -56.06 2.27 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.222 -1.354 . . . . 0.0 108.612 173.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -103.12 127.23 50.48 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.411 173.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . 0.586 ' O ' ' HG3' ' E' ' 58' ' ' LYS . . . 145.19 159.34 8.06 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.016 -1.087 . . . . 0.0 112.897 178.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -102.53 -45.49 5.04 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.473 0.175 . . . . 0.0 111.473 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -150.53 127.36 11.02 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 120.526 0.203 . . . . 0.0 110.982 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.49 114.93 18.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.183 0.516 . . . . 0.0 110.473 171.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 41' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' E' ' 79' ' ' THR . 3.7 mppt? -95.08 112.1 23.84 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 174.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 46.7 tp -84.27 108.87 17.38 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -176.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -108.54 144.34 36.34 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.331 0.586 . . . . 0.0 110.112 177.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 44' ' ' LEU . . . . . 0.652 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 0.2 OUTLIER -129.26 116.76 19.63 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.42 174.384 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 45' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -103.51 110.47 22.52 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.236 0.541 . . . . 0.0 109.666 177.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.11 145.54 37.74 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.273 -177.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 58.15 33.04 22.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.476 0.655 . . . . 0.0 109.813 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 62.73 37.99 12.2 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.778 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 49' ' ' GLN . . . . . 0.535 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 6.5 tp-100 -140.56 138.98 34.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.59 0.233 . . . . 0.0 110.39 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 50' ' ' GLU . . . . . 0.429 ' HG3' ' HH ' ' E' ' 78' ' ' TYR . 29.3 tt0 -90.97 110.09 21.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.363 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . 1.672 ' HE1' ' CE2' ' E' ' 51' ' ' TYR . 78.2 m-85 -101.79 130.74 48.28 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.419 178.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -85.37 101.87 10.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.706 0.765 . . . . 0.0 109.023 172.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . 0.602 ' CG2' ' HB3' ' E' ' 44' ' ' LEU . 2.9 t -76.43 -49.76 23.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.714 -171.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 54' ' ' ALA . . . . . 0.453 ' HB1' HD22 ' E' ' 65' ' ' LEU . . . -154.02 146.67 24.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.498 -177.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 27.7 m -111.04 101.03 9.61 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 170.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.82 114.62 46.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.628 0.728 . . . . 0.0 109.754 -176.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 76.2 p -122.82 -178.23 3.88 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.465 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 58' ' ' LYS . . . . . 0.586 ' HG3' ' O ' ' E' ' 37' ' ' GLY . 6.1 mttm -61.53 -29.99 70.35 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.023 0.44 . . . . 0.0 110.287 169.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.06 -40.37 53.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.433 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 79.0 mt -115.51 81.49 8.9 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 174.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.2 -0.5 6.54 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.087 2.524 . . . . 0.0 114.029 -167.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -163.02 130.28 3.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.275 0.559 . . . . 0.0 111.305 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . 0.443 HG12 ' HB3' ' E' ' 54' ' ' ALA . 96.5 t -118.85 120.83 65.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.388 174.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.29 131.48 35.29 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 175.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . 0.453 HD22 ' HB1' ' E' ' 54' ' ' ALA . 82.6 mt -123.87 167.19 14.42 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.469 0.652 . . . . 0.0 112.336 -173.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 66' ' ' ASP . . . . . 0.462 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 14.3 t0 -143.15 99.17 3.4 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.504 170.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 67' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' E' ' 28' ' ' HIS . 2.5 mt -128.05 140.06 52.17 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.391 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 68' ' ' ASN . . . . . 0.489 ' ND2' ' HB1' ' D' ' 6' ' ' ALA . 5.3 t30 -135.21 122.71 21.99 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.79 174.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -116.08 143.71 45.11 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.492 -178.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 70' ' ' SER . . . . . 0.414 ' OG ' ' HB3' ' D' ' 5' ' ' MET . 34.2 t -94.4 166.27 12.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.194 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.55 -7.07 51.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.177 0.513 . . . . 0.0 110.151 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.8 -8.25 62.19 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.495 174.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -93.67 144.7 25.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.859 0.361 . . . . 0.0 110.074 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -136.2 127.72 28.69 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 171.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 75' ' ' ILE . . . . . 0.45 ' HB ' ' CD1' ' E' ' 44' ' ' LEU . 8.5 pt -135.4 160.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.634 -163.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 76' ' ' MET . . . . . 0.413 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 3.0 mtm -114.13 120.35 40.24 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 172.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 77' ' ' PHE . . . . . 0.652 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.7 OUTLIER -103.75 127.82 51.19 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.28 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 78' ' ' TYR . . . . . 1.63 ' HE2' ' CE1' ' E' ' 78' ' ' TYR . 53.2 p90 -156.37 143.11 18.67 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 119.79 -0.764 . . . . 0.0 112.269 -176.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 79' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' E' ' 41' ' ' LYS . 2.0 p -114.96 132.02 56.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.291 -176.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.37 160.7 14.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.817 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.0 -175.68 40.12 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -175.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -110.43 102.56 11.17 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.846 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 83' ' ' ALA . . . . . 0.445 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -174.5 155.62 2.29 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.624 171.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 32.2 t -115.84 117.33 29.9 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 85' ' ' VAL . . . . . 0.539 ' CG1' ' HB3' ' E' ' 34' ' ' LEU . 3.7 m -111.36 164.9 6.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.268 0.556 . . . . 0.0 112.137 -174.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 21.2 t -129.75 120.9 25.84 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.18 176.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 87' ' ' LEU . . . . . 0.454 ' HB2' ' HB3' ' E' ' 11' ' ' LEU . 5.3 mp -92.98 154.48 18.13 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 121.023 0.439 . . . . 0.0 110.132 173.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.7 144.7 49.3 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.086 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.99 -167.43 28.62 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.9 -0.666 . . . . 0.0 111.999 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 90' ' ' TYR . . . . . 1.645 ' HD2' ' CD1' ' E' ' 90' ' ' TYR . 43.5 p90 -146.05 136.49 23.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.573 0.701 . . . . 0.0 111.663 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 91' ' ' LEU . . . . . . . . . . . . . 26.2 mt -77.54 137.15 38.45 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.574 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -73.08 119.06 16.8 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.959 0.409 . . . . 0.0 110.728 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -88.92 -6.64 57.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.893 0.854 . . . . 0.0 109.293 176.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 1.9 mp 69.88 86.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.323 -176.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.93 111.0 5.99 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.382 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 96' ' ' SER . . . . . 0.491 ' HA ' ' C ' ' D' ' 97' ' ' GLY . 20.1 m -79.24 -36.19 40.36 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.689 -177.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 97' ' ' GLY . . . . . 0.467 ' C ' ' HA ' ' A' ' 96' ' ' SER . . . 72.91 -67.85 1.35 Allowed Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.689 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.383 -0.817 . . . . 0.0 109.822 -178.021 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -127.48 66.54 1.31 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.653 0.739 . . . . 0.0 109.569 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.48 136.53 20.29 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.996 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.92 146.9 22.25 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 59.4 mtt -125.94 39.84 3.86 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.343 0.402 . . . . 0.0 109.957 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -51.02 129.26 23.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.892 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 49.0 mtt -96.36 129.77 43.63 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.221 0.534 . . . . 0.0 111.524 -173.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.494 ' CE1' HD22 ' B' ' 44' ' ' LEU . 60.5 t80 -56.85 142.02 42.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.487 -173.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.435 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 87.5 t90 -135.41 141.49 45.47 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.763 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.499 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -143.2 155.46 26.02 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.068 178.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.524 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 57.2 tp -145.21 108.53 4.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.709 0.29 . . . . 0.0 110.901 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -89.0 106.42 18.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.492 0.663 . . . . 0.0 110.91 177.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.461 ' HB2' HG22 ' A' ' 85' ' ' VAL . 4.1 mmt -86.96 134.42 33.5 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.931 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.47 ' HB2' ' HG3' ' A' ' 17' ' ' ARG . 54.5 mtmt -100.26 146.08 31.36 Favored Pre-proline 0 C--N 1.316 -0.851 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 172.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -48.12 110.37 0.32 Allowed 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 123.51 2.807 . . . . 0.0 113.432 -174.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.686 ' HA ' ' O ' ' A' ' 79' ' ' THR . 31.6 mt-10 69.5 54.07 0.41 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.531 178.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.47 ' HG3' ' HB2' ' A' ' 14' ' ' LYS . 19.5 mmt180 -110.75 152.7 26.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.868 172.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.655 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 36.0 ttmt -133.56 107.74 8.18 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.944 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 1.663 ' HD1' ' CD2' ' A' ' 19' ' ' TYR . 0.8 OUTLIER -111.05 121.09 44.45 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.752 179.516 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.4 p -75.29 126.79 31.74 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 170.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -103.95 116.56 32.48 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.125 0.488 . . . . 0.0 111.727 -164.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.5 p -97.22 123.12 40.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.879 173.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.3 mt -92.97 108.43 20.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.199 0.524 . . . . 0.0 111.575 -172.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.515 HD12 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -76.08 -39.65 36.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.007 177.805 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -139.58 141.47 37.17 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.6 m -60.86 120.82 10.89 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.66 0.6 . . . . 0.0 109.85 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 1.651 ' HD1' ' CD2' ' A' ' 27' ' ' PHE . 2.2 p90 -134.25 166.01 23.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.706 0.765 . . . . 0.0 112.721 -169.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.608 ' NE2' ' HB2' ' A' ' 30' ' ' SER . 9.3 t60 -118.72 125.13 48.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.302 -1.317 . . . . 0.0 109.958 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 39.8 mt -94.6 138.48 20.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 169.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.608 ' HB2' ' NE2' ' A' ' 28' ' ' HIS . 26.2 t -119.62 -23.51 6.54 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -169.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -161.92 156.89 28.57 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 119.408 -1.377 . . . . 0.0 113.253 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.2 p -137.36 125.38 32.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 172.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 85' ' ' VAL . . . -142.81 152.31 42.07 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -171.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.507 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 3.7 pp -119.18 142.73 47.71 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.583 0.706 . . . . 0.0 111.346 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.515 ' HB2' ' HH ' ' B' ' 43' ' ' TYR . 9.5 p-10 -110.12 -48.46 3.18 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.615 173.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -102.49 127.27 49.62 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 170.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.495 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 145.83 159.54 8.22 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 119.392 -1.385 . . . . 0.0 113.948 176.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.408 ' HA ' ' HB2' ' A' ' 58' ' ' LYS . 54.3 mt-30 -103.15 -44.5 5.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.653 -0.274 . . . . 0.0 111.127 177.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -150.63 132.63 15.21 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 120.5 0.19 . . . . 0.0 111.026 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.428 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . . . -133.02 114.32 13.84 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.286 0.565 . . . . 0.0 110.586 169.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 79' ' ' THR . 63.9 mttp -95.86 112.22 24.0 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 174.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 45.4 tp -83.99 115.93 22.57 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.439 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.524 ' HH ' ' HB2' ' E' ' 35' ' ' ASP . 97.1 m-85 -117.02 144.01 45.08 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 177.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 76' ' ' MET . 0.2 OUTLIER -131.34 132.54 44.55 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.2 0.524 . . . . 0.0 109.723 172.086 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -107.09 110.07 22.09 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.3 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.22 151.95 46.71 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 43.36 37.49 1.38 Allowed 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.939 0.774 . . . . 0.0 111.142 -171.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.7 tptp 54.65 46.66 24.26 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.157 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.571 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 6.5 tp-100 -135.17 130.71 35.78 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.669 175.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -85.68 110.86 19.59 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.343 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 1.625 ' HD2' ' CD1' ' A' ' 51' ' ' TYR . 82.5 m-85 -104.62 129.16 52.77 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.7 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 tp -77.25 103.79 4.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 169.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.507 HG11 ' CD2' ' E' ' 88' ' ' LEU . 2.6 t -76.39 -49.52 24.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.293 -173.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.471 ' HB3' ' CD2' ' A' ' 65' ' ' LEU . . . -159.03 144.86 16.47 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.19 -178.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.3 m -110.5 101.49 10.17 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 171.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -111.26 120.44 61.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.133 -178.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 54.8 p -122.61 -179.81 4.35 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -172.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.408 ' HB2' ' HA ' ' A' ' 38' ' ' GLN . 35.0 tttm -60.89 -27.04 67.86 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.272 0.558 . . . . 0.0 109.901 172.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.468 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -83.48 -40.57 19.07 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.734 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 90.9 mt -107.36 89.43 4.84 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 36.0 Cg_exo -61.32 -20.3 67.65 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.101 2.534 . . . . 0.0 113.941 -169.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -156.19 136.09 12.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.381 0.61 . . . . 0.0 111.974 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.401 HG12 ' HB2' ' A' ' 54' ' ' ALA . 98.4 t -111.38 113.8 45.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.729 171.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.03 122.15 34.27 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.08 177.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -142.6 143.5 32.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.248 0.547 . . . . 0.0 111.902 -177.084 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.479 ' HB3' ' OG ' ' E' ' 30' ' ' SER . 5.6 t70 -89.59 100.57 13.34 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.706 177.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.577 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 19.7 mt -110.81 138.39 47.27 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.686 176.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.638 ' HB2' ' CD2' ' E' ' 90' ' ' TYR . 10.5 m-80 -137.58 128.21 26.82 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 173.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 1.661 ' HD2' ' CD1' ' A' ' 69' ' ' PHE . 65.6 m-85 -124.43 146.81 48.69 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.977 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.0 t -99.93 148.97 23.9 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -67.14 -10.72 53.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.326 -178.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.42 -9.87 66.38 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.107 176.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -100.74 160.06 14.67 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -135.12 125.43 26.37 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.3 pt -131.21 178.13 5.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.93 0.395 . . . . 0.0 111.609 -171.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.496 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 24.5 mtp -130.9 136.31 48.49 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 174.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.458 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 1.2 m-85 -117.86 128.21 54.62 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.145 176.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 1.649 ' HE1' ' CE2' ' A' ' 78' ' ' TYR . 34.6 p90 -155.08 145.64 22.2 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.966 -178.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.686 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 13.2 p -117.33 144.95 44.36 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.507 -177.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -115.04 151.33 34.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.915 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.58 -177.16 29.29 Favored Glycine 0 CA--C 1.509 -0.334 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -109.74 102.93 11.69 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.684 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.495 ' CB ' ' HA3' ' A' ' 37' ' ' GLY . . . -175.27 155.94 1.97 Allowed 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.87 172.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.6 t -113.03 118.87 36.0 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.507 ' CG1' ' HB3' ' A' ' 34' ' ' LEU . 10.5 m -118.94 137.39 53.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -173.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 54.6 m -101.17 120.94 40.97 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.048 175.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.524 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 5.3 mp -89.41 145.71 25.15 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 170.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.5 ' CD2' HG11 ' B' ' 53' ' ' VAL . 1.2 tp -131.48 132.17 44.05 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.679 -177.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -159.66 -166.76 19.22 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.701 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.621 ' CD2' ' HB2' ' B' ' 68' ' ' ASN . 18.7 p90 -153.02 133.72 13.83 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.919 0.866 . . . . 0.0 111.547 177.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.1 mt -71.32 138.21 49.1 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 113.981 -1.463 . . . . 0.0 108.926 174.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -68.01 123.77 21.55 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.78 -77.73 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 O-C-N 124.129 0.893 . . . . 0.0 113.352 -169.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 69.9 mt -137.18 115.94 14.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.942 0.401 . . . . 0.0 110.647 -177.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -93.01 84.88 4.96 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.0 t -167.38 130.43 1.72 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.818 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.38 150.06 36.3 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.803 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.488 -0.768 . . . . 0.0 110.206 -179.562 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -127.38 66.55 1.31 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.56 0.695 . . . . 0.0 109.572 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.55 136.52 20.22 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.978 178.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.92 146.85 22.21 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 59.4 mtt -125.97 39.85 3.86 Favored 'General case' 0 C--N 1.321 -0.65 0 O-C-N 123.32 0.388 . . . . 0.0 109.954 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -51.04 129.24 23.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.85 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 48.7 mtt -96.34 129.84 43.59 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.25 0.548 . . . . 0.0 111.546 -173.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 0.459 ' CE1' HD22 ' C' ' 44' ' ' LEU . 60.7 t80 -56.82 141.91 42.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.515 -173.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . 0.437 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 87.5 t90 -135.34 141.42 45.59 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.817 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.472 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -143.13 155.53 26.04 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.105 178.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.514 ' HB3' ' HB2' ' B' ' 87' ' ' LEU . 56.9 tp -145.34 108.5 4.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.784 0.326 . . . . 0.0 110.819 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -88.98 106.44 18.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.495 0.664 . . . . 0.0 110.947 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' MET . . . . . 0.453 ' HB2' HG22 ' B' ' 85' ' ' VAL . 4.1 mmt -86.98 134.41 33.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.041 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.477 ' HB2' ' HG3' ' B' ' 17' ' ' ARG . 54.5 mtmt -100.18 146.14 31.45 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 172.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -48.19 110.35 0.32 Allowed 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 123.449 2.766 . . . . 0.0 113.444 -174.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.683 ' HA ' ' O ' ' B' ' 79' ' ' THR . 31.6 mt-10 69.52 54.1 0.4 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.48 178.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.477 ' HG3' ' HB2' ' B' ' 14' ' ' LYS . 19.5 mmt180 -110.73 152.72 26.24 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.879 172.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . 0.658 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 36.0 ttmt -133.59 107.79 8.2 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.825 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' TYR . . . . . 1.645 ' HD1' ' CD2' ' B' ' 19' ' ' TYR . 0.8 OUTLIER -110.99 121.07 44.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.803 179.423 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 5.2 p -75.3 126.74 31.63 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 170.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -103.83 116.45 32.3 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.713 -164.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 9.6 p -97.16 123.19 40.86 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.842 173.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 55.6 mt -93.02 108.51 20.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.032 0.444 . . . . 0.0 111.513 -172.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.515 ' H ' HD12 ' B' ' 24' ' ' ILE . 0.2 OUTLIER -76.1 -39.73 36.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.001 177.765 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -139.53 141.48 37.28 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 15.5 m -60.8 120.93 11.06 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.666 0.604 . . . . 0.0 109.814 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . 1.615 ' HE2' ' CE1' ' B' ' 27' ' ' PHE . 2.2 p90 -134.34 165.95 23.95 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.685 0.755 . . . . 0.0 112.73 -169.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' HIS . . . . . 0.608 ' NE2' ' HB2' ' B' ' 30' ' ' SER . 9.5 t60 -118.68 125.1 48.95 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.98 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.589 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 39.7 mt -94.53 138.54 20.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 169.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.608 ' HB2' ' NE2' ' B' ' 28' ' ' HIS . 26.1 t -119.65 -23.49 6.53 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -169.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -161.91 156.99 28.69 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.328 -1.415 . . . . 0.0 113.266 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 10.2 p -137.5 125.37 31.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 172.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' B' ' 85' ' ' VAL . . . -142.81 152.36 42.14 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -171.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.508 ' HB3' ' CG1' ' B' ' 85' ' ' VAL . 3.6 pp -119.21 142.75 47.73 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.542 0.687 . . . . 0.0 111.347 177.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.516 ' HB2' ' HH ' ' C' ' 43' ' ' TYR . 9.5 p-10 -110.22 -48.5 3.17 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.554 173.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -102.41 127.18 49.54 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 170.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.491 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 145.97 159.66 8.3 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 119.38 -1.39 . . . . 0.0 113.8 176.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . 0.404 ' HA ' ' HB2' ' B' ' 58' ' ' LYS . 54.3 mt-30 -103.17 -44.55 5.16 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.593 -0.304 . . . . 0.0 111.177 177.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -150.64 132.66 15.23 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 120.536 0.208 . . . . 0.0 111.014 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.427 ' HB3' ' HB1' ' B' ' 83' ' ' ALA . . . -133.0 114.31 13.83 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.266 0.555 . . . . 0.0 110.485 169.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' B' ' 79' ' ' THR . 64.0 mttp -95.88 112.17 23.97 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 174.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 45.2 tp -83.93 116.0 22.57 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.489 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . 0.515 ' HH ' ' HB2' ' A' ' 35' ' ' ASP . 97.2 m-85 -117.12 143.96 45.22 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.494 HD22 ' CE1' ' A' ' 8' ' ' PHE . 0.2 OUTLIER -131.32 132.52 44.56 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.705 172.1 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -107.05 110.12 22.16 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.373 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.25 151.96 46.75 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 43.37 37.45 1.36 Allowed 'General case' 0 N--CA 1.474 0.77 0 O-C-N 123.918 0.761 . . . . 0.0 111.155 -171.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 25.7 tptp 54.55 46.86 23.98 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.116 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.573 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 6.5 tp-100 -135.28 130.72 35.57 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.603 175.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -85.74 110.9 19.66 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.315 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 1.618 ' HE2' ' CE1' ' B' ' 51' ' ' TYR . 82.3 m-85 -104.56 129.18 52.66 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.681 177.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 tp -77.39 103.83 4.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 169.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.5 HG11 ' CD2' ' A' ' 88' ' ' LEU . 2.6 t -76.35 -49.57 24.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.199 -173.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.462 ' HB3' ' CD2' ' B' ' 65' ' ' LEU . . . -159.1 144.84 16.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.178 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 43.7 m -110.51 101.55 10.23 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 171.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -111.3 120.48 61.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.147 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 52.8 p -122.67 -179.75 4.34 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.098 0.475 . . . . 0.0 112.215 -172.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . 0.404 ' HB2' ' HA ' ' B' ' 38' ' ' GLN . 34.9 tttm -60.9 -27.05 67.88 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.92 172.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.463 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -83.45 -40.57 19.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.791 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 90.9 mt -107.38 89.56 4.98 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 174.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 36.6 Cg_exo -61.46 -20.24 67.67 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.151 2.567 . . . . 0.0 113.949 -169.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -156.27 135.98 12.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.408 0.623 . . . . 0.0 111.886 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.404 HG12 ' HB2' ' B' ' 54' ' ' ALA . 98.6 t -111.3 113.79 45.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.726 171.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.03 122.19 34.31 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.109 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.462 ' CD2' ' HB3' ' B' ' 54' ' ' ALA . 0.2 OUTLIER -142.62 143.49 32.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.315 0.579 . . . . 0.0 111.916 -177.067 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . 0.443 ' HB3' ' OG ' ' A' ' 30' ' ' SER . 5.6 t70 -89.61 100.53 13.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.71 177.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.589 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 19.5 mt -110.87 138.38 47.35 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.64 176.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . 0.621 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 10.5 m-80 -137.5 128.18 26.92 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 173.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . 1.653 ' HE2' ' CE1' ' B' ' 69' ' ' PHE . 65.0 m-85 -124.4 146.77 48.68 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.03 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 28.8 t -100.03 148.93 24.0 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -67.17 -10.65 52.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.277 -177.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.46 -9.73 66.47 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.122 176.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -100.89 160.1 14.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -135.18 125.41 26.24 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 11.2 pt -131.19 178.06 6.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.901 0.381 . . . . 0.0 111.55 -171.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' MET . . . . . 0.489 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 24.7 mtp -130.87 136.4 48.6 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 174.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . 0.464 ' CD1' ' HB2' ' B' ' 44' ' ' LEU . 1.2 m-85 -117.91 128.16 54.55 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.146 176.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 1.665 ' HD2' ' CD1' ' B' ' 78' ' ' TYR . 34.3 p90 -155.07 145.7 22.27 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.922 -178.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.683 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 13.2 p -117.39 144.99 44.39 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.446 -177.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -115.12 151.27 34.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.903 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.7 -177.09 29.11 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -109.89 102.95 11.67 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 119.625 -0.83 . . . . 0.0 109.608 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.491 ' CB ' ' HA3' ' B' ' 37' ' ' GLY . . . -175.22 155.94 1.99 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.814 172.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 32.6 t -113.05 118.86 35.96 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.508 ' CG1' ' HB3' ' B' ' 34' ' ' LEU . 10.2 m -118.93 137.53 52.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 CA-C-O 121.403 0.621 . . . . 0.0 112.671 -173.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 54.5 m -101.27 120.92 40.97 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.093 175.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.514 ' HB2' ' HB3' ' B' ' 11' ' ' LEU . 5.3 mp -89.41 145.74 25.13 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 170.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.477 ' CD2' HG11 ' C' ' 53' ' ' VAL . 1.2 tp -131.54 132.16 43.94 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.645 -177.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -159.7 -166.78 19.28 Favored Glycine 0 N--CA 1.438 -1.233 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.638 -176.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' TYR . . . . . 0.62 ' CD2' ' HB2' ' C' ' 68' ' ' ASN . 18.7 p90 -152.97 133.68 13.85 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.909 0.861 . . . . 0.0 111.622 177.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 5.2 mt -71.29 138.11 49.08 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 113.988 -1.46 . . . . 0.0 108.978 174.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -67.94 123.74 21.42 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.73 -77.73 0.02 OUTLIER 'General case' 0 C--O 1.235 0.319 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -169.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 70.1 mt -137.19 115.99 14.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.853 0.358 . . . . 0.0 110.67 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -92.99 84.81 4.95 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 29.4 t -167.36 130.42 1.73 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.832 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.42 150.09 36.28 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.883 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.672 -0.68 . . . . 0.0 110.233 -179.443 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -127.44 66.5 1.31 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.702 0.763 . . . . 0.0 109.636 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.46 136.51 20.28 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.988 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.91 146.89 22.25 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 59.3 mtt -125.92 39.68 3.9 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.323 0.389 . . . . 0.0 109.964 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.95 129.17 23.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.918 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 48.8 mtt -96.33 129.86 43.57 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.255 0.55 . . . . 0.0 111.578 -173.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 8' ' ' PHE . . . . . 0.479 ' CE1' HD22 ' D' ' 44' ' ' LEU . 60.1 t80 -56.88 141.94 43.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.448 -173.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . 0.441 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 87.5 t90 -135.33 141.41 45.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.802 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . 0.479 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -143.17 155.5 26.03 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.053 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' C' ' 87' ' ' LEU . 57.1 tp -145.26 108.58 4.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.821 0.343 . . . . 0.0 110.906 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -89.0 106.43 18.42 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.528 0.68 . . . . 0.0 110.852 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 13' ' ' MET . . . . . 0.457 ' HB2' HG22 ' C' ' 85' ' ' VAL . 4.1 mmt -86.96 134.38 33.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.014 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . 0.469 ' HB2' ' HG3' ' C' ' 17' ' ' ARG . 54.5 mtmt -100.16 146.16 31.46 Favored Pre-proline 0 C--N 1.316 -0.849 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -48.11 110.37 0.32 Allowed 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.52 2.814 . . . . 0.0 113.422 -174.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . 0.679 ' HA ' ' O ' ' C' ' 79' ' ' THR . 31.7 mt-10 69.47 54.08 0.41 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.541 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 17' ' ' ARG . . . . . 0.469 ' HG3' ' HB2' ' C' ' 14' ' ' LYS . 19.4 mmt180 -110.86 152.65 26.45 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.878 172.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 18' ' ' LYS . . . . . 0.652 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 36.0 ttmt -133.5 107.61 8.13 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.911 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . 1.653 ' HE2' ' CE1' ' C' ' 19' ' ' TYR . 0.8 OUTLIER -110.96 121.06 44.4 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.803 -0.444 . . . . 0.0 109.803 179.5 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 5.2 p -75.35 126.7 31.54 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 171.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -103.77 116.55 32.51 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.722 -164.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 9.6 p -97.21 123.16 40.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.872 173.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 55.2 mt -93.0 108.51 20.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.201 0.524 . . . . 0.0 111.54 -172.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . 0.507 HD12 ' H ' ' C' ' 24' ' ' ILE . 0.2 OUTLIER -76.13 -39.8 36.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.955 177.825 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -139.5 141.43 37.34 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 15.5 m -60.78 120.8 10.82 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 123.628 0.58 . . . . 0.0 109.858 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 27' ' ' PHE . . . . . 1.615 ' HE2' ' CE1' ' C' ' 27' ' ' PHE . 2.2 p90 -134.27 165.93 23.98 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.685 0.755 . . . . 0.0 112.715 -169.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 28' ' ' HIS . . . . . 0.596 ' NE2' ' HB2' ' C' ' 30' ' ' SER . 9.3 t60 -118.62 125.2 49.24 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.97 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . 0.566 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 39.9 mt -94.57 138.5 20.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 169.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 30' ' ' SER . . . . . 0.596 ' HB2' ' NE2' ' C' ' 28' ' ' HIS . 26.1 t -119.64 -23.47 6.54 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -169.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -161.9 157.0 28.7 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 119.374 -1.393 . . . . 0.0 113.29 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 10.2 p -137.45 125.41 31.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 172.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' C' ' 85' ' ' VAL . . . -142.85 152.34 42.05 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.636 -0.426 . . . . 0.0 112.143 -171.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.505 ' HB3' ' CG1' ' C' ' 85' ' ' VAL . 3.7 pp -119.2 142.74 47.72 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.49 0.662 . . . . 0.0 111.424 177.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . 0.512 ' HB2' ' HH ' ' D' ' 43' ' ' TYR . 9.5 p-10 -110.09 -48.58 3.17 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.581 173.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -102.38 127.24 49.48 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 170.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 37' ' ' GLY . . . . . 0.499 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 145.93 159.59 8.26 Favored Glycine 0 N--CA 1.437 -1.257 0 C-N-CA 119.318 -1.42 . . . . 0.0 113.834 176.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 38' ' ' GLN . . . . . 0.407 ' HA ' ' HB2' ' C' ' 58' ' ' LYS . 54.2 mt-30 -103.06 -44.55 5.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.658 -0.271 . . . . 0.0 111.214 177.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -150.67 132.61 15.15 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.483 0.182 . . . . 0.0 110.982 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . 0.42 ' HB3' ' HB1' ' C' ' 83' ' ' ALA . . . -133.02 114.35 13.86 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.286 0.565 . . . . 0.0 110.5 169.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' C' ' 79' ' ' THR . 64.0 mttp -95.91 112.16 23.96 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 174.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 45.4 tp -83.94 116.0 22.58 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 43' ' ' TYR . . . . . 0.516 ' HH ' ' HB2' ' B' ' 35' ' ' ASP . 97.1 m-85 -117.11 143.95 45.23 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' C' ' 76' ' ' MET . 0.2 OUTLIER -131.28 132.55 44.65 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.167 0.508 . . . . 0.0 109.665 172.07 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -107.06 110.14 22.18 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.341 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.28 151.91 46.85 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 43.38 37.47 1.38 Allowed 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.864 0.727 . . . . 0.0 111.193 -171.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 25.7 tptp 54.58 46.71 24.25 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.233 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . 0.578 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 6.5 tp-100 -135.22 130.72 35.69 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.567 175.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -85.78 110.84 19.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.906 0.384 . . . . 0.0 110.339 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 1.64 ' HE2' ' CE1' ' C' ' 51' ' ' TYR . 82.4 m-85 -104.5 129.19 52.54 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.702 177.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 tp -77.29 103.79 4.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 169.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 53' ' ' VAL . . . . . 0.477 HG11 ' CD2' ' B' ' 88' ' ' LEU . 2.6 t -76.36 -49.62 24.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.243 -173.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 54' ' ' ALA . . . . . 0.45 ' HB3' ' CD2' ' C' ' 65' ' ' LEU . . . -159.0 144.87 16.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.228 -178.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 43.5 m -110.53 101.52 10.19 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 171.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 7.6 p -111.26 120.53 62.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.204 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 52.7 p -122.76 -179.74 4.34 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.078 0.466 . . . . 0.0 112.17 -172.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 58' ' ' LYS . . . . . 0.407 ' HB2' ' HA ' ' C' ' 38' ' ' GLN . 34.9 tttm -60.92 -27.16 68.0 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.281 0.562 . . . . 0.0 109.849 172.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . 0.471 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -83.43 -40.51 19.22 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.817 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 90.5 mt -107.43 89.48 4.96 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 174.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 61' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 37.5 Cg_exo -61.32 -20.31 67.68 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.145 2.563 . . . . 0.0 113.892 -169.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -156.25 136.02 12.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.479 0.657 . . . . 0.0 111.869 -178.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.403 HG12 ' HB2' ' C' ' 54' ' ' ALA . 98.0 t -111.36 113.92 45.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.663 171.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.15 122.21 34.42 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.025 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . 0.45 ' CD2' ' HB3' ' C' ' 54' ' ' ALA . 0.2 OUTLIER -142.59 143.43 32.43 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.287 0.565 . . . . 0.0 111.955 -177.1 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 66' ' ' ASP . . . . . 0.452 ' HB3' ' OG ' ' B' ' 30' ' ' SER . 5.6 t70 -89.54 100.5 13.29 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.718 177.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . 0.566 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 19.7 mt -110.83 138.45 47.22 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.694 176.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . 0.62 ' HB2' ' CD2' ' B' ' 90' ' ' TYR . 10.5 m-80 -137.57 128.21 26.85 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 173.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 69' ' ' PHE . . . . . 1.638 ' HE1' ' CE2' ' C' ' 69' ' ' PHE . 65.9 m-85 -124.47 146.79 48.74 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.934 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 29.2 t -99.97 148.95 23.95 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -67.06 -10.81 53.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.271 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.42 -9.78 66.49 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.081 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -100.9 160.15 14.61 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -135.17 125.53 26.48 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 11.3 pt -131.33 178.04 6.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.836 0.35 . . . . 0.0 111.576 -171.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 76' ' ' MET . . . . . 0.482 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 24.6 mtp -130.79 136.25 48.53 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 77' ' ' PHE . . . . . 0.461 ' CD1' ' HB2' ' C' ' 44' ' ' LEU . 1.2 m-85 -117.79 128.23 54.66 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.17 176.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 78' ' ' TYR . . . . . 1.598 ' HD2' ' CD1' ' C' ' 78' ' ' TYR . 34.7 p90 -155.14 145.63 22.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.961 0.41 . . . . 0.0 111.987 -178.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 79' ' ' THR . . . . . 0.679 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 13.0 p -117.36 144.97 44.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.438 -177.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -115.09 151.28 34.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.972 177.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.67 -177.03 29.12 Favored Glycine 0 CA--C 1.508 -0.403 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -109.93 102.99 11.7 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.764 0.782 . . . . 0.0 109.637 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . 0.499 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -175.27 155.95 1.97 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.833 172.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 32.4 t -113.07 118.8 35.79 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.505 ' CG1' ' HB3' ' C' ' 34' ' ' LEU . 10.1 m -118.88 137.51 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -173.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 54.2 m -101.21 120.9 40.92 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.074 175.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . 0.518 ' HB2' ' HB3' ' C' ' 11' ' ' LEU . 5.3 mp -89.36 145.79 25.12 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 170.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . 0.497 ' CD2' HG11 ' D' ' 53' ' ' VAL . 1.2 tp -131.56 132.15 43.9 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.669 -177.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -159.71 -166.88 19.49 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.575 -176.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 90' ' ' TYR . . . . . 0.62 ' CD2' ' HB2' ' D' ' 68' ' ' ASN . 19.0 p90 -152.88 133.71 13.96 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.885 0.85 . . . . 0.0 111.658 177.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 5.1 mt -71.33 138.11 49.01 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.011 -1.45 . . . . 0.0 108.97 174.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -67.95 123.73 21.4 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.61 -77.73 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -169.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 69.8 mt -137.17 115.91 14.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.819 0.342 . . . . 0.0 110.698 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -92.97 84.78 4.96 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 30.0 t -167.26 130.45 1.76 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.839 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.35 150.12 36.44 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.84 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.472 -0.775 . . . . 0.0 110.303 -179.552 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 . . . . . 0 N--CA 1.476 0.827 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -127.42 66.6 1.31 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.685 0.755 . . . . 0.0 109.606 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.57 136.5 20.16 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.919 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.87 146.98 22.38 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 59.2 mtt -126.06 39.81 3.87 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.92 129.18 22.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.951 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 49.0 mtt -96.42 129.85 43.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.312 0.577 . . . . 0.0 111.446 -173.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 8' ' ' PHE . . . . . 0.49 ' CE1' HD22 ' E' ' 44' ' ' LEU . 60.6 t80 -56.78 141.92 42.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.685 -1.143 . . . . 0.0 112.49 -173.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 9' ' ' TRP . . . . . 0.438 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 87.5 t90 -135.38 141.4 45.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.75 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . 0.497 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -143.11 155.55 26.04 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.133 178.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' D' ' 87' ' ' LEU . 56.8 tp -145.35 108.51 4.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.832 0.348 . . . . 0.0 110.805 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -88.92 106.37 18.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.459 0.647 . . . . 0.0 110.932 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 13' ' ' MET . . . . . 0.468 ' HB2' HG22 ' D' ' 85' ' ' VAL . 4.1 mmt -86.9 134.44 33.52 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.046 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 14' ' ' LYS . . . . . 0.481 ' HB2' ' HG3' ' D' ' 17' ' ' ARG . 54.6 mtmt -100.32 146.15 31.48 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 172.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -48.11 110.39 0.32 Allowed 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 123.43 2.754 . . . . 0.0 113.441 -174.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . 0.681 ' HA ' ' O ' ' D' ' 79' ' ' THR . 31.6 mt-10 69.47 53.96 0.41 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.55 178.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 17' ' ' ARG . . . . . 0.481 ' HG3' ' HB2' ' D' ' 14' ' ' LYS . 19.5 mmt180 -110.57 152.72 26.08 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.948 172.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . 0.643 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 36.0 ttmt -133.62 107.75 8.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.903 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 19' ' ' TYR . . . . . 1.637 ' HE2' ' CE1' ' D' ' 19' ' ' TYR . 0.8 OUTLIER -111.11 121.06 44.35 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.579 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 5.2 p -75.26 126.8 31.76 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 170.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -103.97 116.5 32.36 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.054 0.454 . . . . 0.0 111.648 -164.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 9.1 p -97.28 123.14 40.99 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.826 173.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 55.2 mt -92.97 108.51 20.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.117 0.484 . . . . 0.0 111.521 -172.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . 0.522 HD12 ' H ' ' D' ' 24' ' ' ILE . 0.2 OUTLIER -76.23 -39.57 35.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.018 177.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -139.6 141.46 37.14 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 15.6 m -60.72 120.84 10.85 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 123.535 0.522 . . . . 0.0 109.747 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 27' ' ' PHE . . . . . 1.649 ' HE2' ' CE1' ' D' ' 27' ' ' PHE . 2.2 p90 -134.33 165.92 24.02 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.748 0.785 . . . . 0.0 112.725 -169.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 28' ' ' HIS . . . . . 0.606 ' NE2' ' HB2' ' D' ' 30' ' ' SER . 9.5 t60 -118.58 125.15 49.18 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.996 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 29' ' ' ILE . . . . . 0.579 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 39.5 mt -94.56 138.48 20.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 169.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 30' ' ' SER . . . . . 0.606 ' HB2' ' NE2' ' D' ' 28' ' ' HIS . 26.1 t -119.62 -23.46 6.55 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -169.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 31' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -161.97 156.94 28.65 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.385 -1.388 . . . . 0.0 113.257 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 10.4 p -137.4 125.42 32.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' D' ' 85' ' ' VAL . . . -142.84 152.36 42.08 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.641 -0.424 . . . . 0.0 112.039 -171.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 34' ' ' LEU . . . . . 0.512 ' HB3' ' CG1' ' D' ' 85' ' ' VAL . 3.7 pp -119.13 142.71 47.69 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.518 0.675 . . . . 0.0 111.415 177.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . 0.507 ' HB2' ' HH ' ' E' ' 43' ' ' TYR . 9.5 p-10 -110.08 -48.61 3.17 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.591 173.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -102.41 127.17 49.55 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 170.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . 0.502 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 145.86 159.63 8.27 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 119.379 -1.391 . . . . 0.0 113.916 176.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 38' ' ' GLN . . . . . 0.407 ' HA ' ' HB2' ' D' ' 58' ' ' LYS . 54.0 mt-30 -103.15 -44.53 5.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.702 -0.249 . . . . 0.0 111.157 177.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -150.68 132.61 15.14 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.566 0.222 . . . . 0.0 111.019 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . 0.434 ' HB3' ' HB1' ' D' ' 83' ' ' ALA . . . -132.98 114.33 13.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.234 0.54 . . . . 0.0 110.514 169.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' D' ' 79' ' ' THR . 64.0 mttp -95.86 112.05 23.88 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 45.3 tp -83.88 116.03 22.56 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -177.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 43' ' ' TYR . . . . . 0.512 ' HH ' ' HB2' ' C' ' 35' ' ' ASP . 97.1 m-85 -117.18 144.04 45.18 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.495 ' HA ' ' O ' ' D' ' 76' ' ' MET . 0.2 OUTLIER -131.4 132.5 44.42 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.697 172.095 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 45' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -107.04 110.12 22.17 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.396 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.31 151.9 46.92 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 43.4 37.49 1.4 Allowed 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.923 0.764 . . . . 0.0 111.09 -171.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 25.7 tptp 54.57 46.78 24.11 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.186 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . 0.579 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 6.5 tp-100 -135.18 130.71 35.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.623 175.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -85.69 110.81 19.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.342 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . 1.65 ' HE2' ' CE1' ' D' ' 51' ' ' TYR . 82.2 m-85 -104.45 129.2 52.46 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.707 177.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 tp -77.28 103.77 4.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 169.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 53' ' ' VAL . . . . . 0.497 HG11 ' CD2' ' C' ' 88' ' ' LEU . 2.6 t -76.38 -49.55 24.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.246 -173.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 54' ' ' ALA . . . . . 0.466 ' HB3' ' CD2' ' D' ' 65' ' ' LEU . . . -159.02 144.9 16.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.239 -178.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 43.9 m -110.54 101.55 10.22 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 171.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 56' ' ' VAL . . . . . . . . . . . . . 7.6 p -111.22 120.44 61.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.171 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 52.5 p -122.73 -179.79 4.36 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.084 0.469 . . . . 0.0 112.151 -172.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 58' ' ' LYS . . . . . 0.407 ' HB2' ' HA ' ' D' ' 38' ' ' GLN . 34.8 tttm -60.83 -27.18 67.87 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.289 0.566 . . . . 0.0 109.864 172.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 59' ' ' ALA . . . . . 0.468 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -83.39 -40.56 19.2 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.773 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 91.0 mt -107.33 89.48 4.86 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 61' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 37.6 Cg_exo -61.45 -20.29 67.87 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.193 2.595 . . . . 0.0 113.84 -169.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -156.24 136.03 12.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.409 0.623 . . . . 0.0 111.967 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.406 HG12 ' HB2' ' D' ' 54' ' ' ALA . 98.2 t -111.33 113.77 45.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.702 171.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.07 122.29 34.44 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.995 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 65' ' ' LEU . . . . . 0.466 ' CD2' ' HB3' ' D' ' 54' ' ' ALA . 0.2 OUTLIER -142.79 143.39 32.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.336 0.588 . . . . 0.0 111.856 -177.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 66' ' ' ASP . . . . . 0.461 ' HB3' ' OG ' ' C' ' 30' ' ' SER . 5.6 t70 -89.49 100.55 13.32 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.717 177.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . 0.579 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 19.8 mt -110.81 138.39 47.26 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.683 176.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 68' ' ' ASN . . . . . 0.62 ' HB2' ' CD2' ' C' ' 90' ' ' TYR . 10.6 m-80 -137.58 128.22 26.84 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 173.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 69' ' ' PHE . . . . . 1.632 ' HD2' ' CD1' ' D' ' 69' ' ' PHE . 65.4 m-85 -124.53 146.77 48.81 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.956 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 29.4 t -99.98 149.01 23.88 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -67.22 -10.66 52.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.265 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.52 -9.72 66.38 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.143 176.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -100.95 160.17 14.59 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -135.21 125.35 26.08 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . . . . . . . . . 11.3 pt -131.18 178.14 5.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.012 0.434 . . . . 0.0 111.491 -171.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 76' ' ' MET . . . . . 0.495 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 24.4 mtp -130.87 136.33 48.53 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 174.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 77' ' ' PHE . . . . . 0.459 ' CD1' ' HB2' ' D' ' 44' ' ' LEU . 1.2 m-85 -117.79 128.16 54.6 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.192 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 78' ' ' TYR . . . . . 1.645 ' HD2' ' CD1' ' D' ' 78' ' ' TYR . 34.5 p90 -155.1 145.63 22.17 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.953 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 79' ' ' THR . . . . . 0.681 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 13.4 p -117.29 144.94 44.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.522 -177.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -115.07 151.27 34.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.938 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.7 -177.04 29.09 Favored Glycine 0 CA--C 1.508 -0.348 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -109.82 102.89 11.63 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 119.661 -0.815 . . . . 0.0 109.686 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.502 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -175.25 155.89 1.97 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.782 172.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 32.8 t -112.98 118.84 35.97 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . 0.512 ' CG1' ' HB3' ' D' ' 34' ' ' LEU . 10.2 m -118.92 137.53 52.6 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -173.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 54.9 m -101.25 121.02 41.12 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.986 175.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 87' ' ' LEU . . . . . 0.523 ' HB2' ' HB3' ' D' ' 11' ' ' LEU . 5.3 mp -89.4 145.72 25.15 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 170.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . 0.496 ' CD2' HG11 ' E' ' 53' ' ' VAL . 1.2 tp -131.49 132.1 43.97 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.733 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -159.64 -166.78 19.23 Favored Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.641 -176.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 90' ' ' TYR . . . . . 0.635 ' CD2' ' HB2' ' E' ' 68' ' ' ASN . 19.0 p90 -152.91 133.66 13.89 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.882 0.849 . . . . 0.0 111.654 177.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 5.1 mt -71.16 138.04 49.28 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.003 174.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -67.98 123.75 21.47 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.64 -77.77 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 O-C-N 124.18 0.925 . . . . 0.0 113.354 -169.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 70.3 mt -137.17 115.91 14.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.865 0.364 . . . . 0.0 110.704 -177.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -93.06 84.81 4.93 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 176.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 29.2 t -167.34 130.44 1.73 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.803 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.32 150.07 36.44 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.866 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.335 -0.84 . . . . 0.0 110.266 -179.503 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -127.37 66.56 1.31 Allowed 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.654 0.74 . . . . 0.0 109.627 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.55 136.49 20.16 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.987 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.89 146.86 22.26 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 59.5 mtt -125.93 39.78 3.88 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 6' ' ' ALA . . . . . . . . . . . . . . . -51.02 129.22 23.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.921 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 48.8 mtt -96.27 129.73 43.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.218 0.532 . . . . 0.0 111.545 -173.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 8' ' ' PHE . . . . . 0.485 ' CE1' HD22 ' A' ' 44' ' ' LEU . 60.6 t80 -56.75 141.94 42.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.601 -173.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 9' ' ' TRP . . . . . 0.438 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 87.3 t90 -135.34 141.34 45.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.056 -0.975 . . . . 0.0 108.812 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 10' ' ' GLY . . . . . 0.486 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -143.18 155.5 26.04 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.07 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . 0.506 ' HB3' ' HB2' ' E' ' 87' ' ' LEU . 57.2 tp -145.22 108.45 4.59 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.747 0.308 . . . . 0.0 110.89 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -88.96 106.42 18.41 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.413 0.625 . . . . 0.0 110.93 177.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 13' ' ' MET . . . . . 0.465 ' HB2' HG22 ' E' ' 85' ' ' VAL . 4.1 mmt -86.95 134.36 33.51 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.995 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 14' ' ' LYS . . . . . 0.458 ' HB2' ' HG3' ' E' ' 17' ' ' ARG . 54.6 mtmt -100.22 146.18 31.51 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 172.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -48.19 110.44 0.33 Allowed 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 123.418 2.745 . . . . 0.0 113.449 -174.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 16' ' ' GLU . . . . . 0.679 ' HA ' ' O ' ' E' ' 79' ' ' THR . 31.5 mt-10 69.46 53.99 0.41 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.533 178.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 17' ' ' ARG . . . . . 0.458 ' HG3' ' HB2' ' E' ' 14' ' ' LYS . 19.6 mmt180 -110.56 152.74 26.06 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.889 172.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . 0.65 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 36.0 ttmt -133.62 107.79 8.18 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.923 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . 1.651 ' HD1' ' CD2' ' E' ' 19' ' ' TYR . 0.8 OUTLIER -111.02 121.16 44.65 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 5.4 p -75.37 126.7 31.54 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 170.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -103.9 116.52 32.42 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.039 0.447 . . . . 0.0 111.66 -164.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 9.4 p -97.2 123.12 40.89 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.88 173.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 55.3 mt -92.99 108.5 20.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.18 0.514 . . . . 0.0 111.557 -172.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . 0.51 HD12 ' H ' ' E' ' 24' ' ' ILE . 0.2 OUTLIER -76.16 -39.7 36.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.97 177.814 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -139.58 141.43 37.19 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 15.5 m -60.69 120.87 10.9 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.671 0.607 . . . . 0.0 109.915 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 27' ' ' PHE . . . . . 1.668 ' HE2' ' CE1' ' E' ' 27' ' ' PHE . 2.2 p90 -134.39 165.92 24.04 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.741 0.782 . . . . 0.0 112.659 -169.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 28' ' ' HIS . . . . . 0.598 ' NE2' ' HB2' ' E' ' 30' ' ' SER . 9.4 t60 -118.6 125.13 49.11 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.933 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 29' ' ' ILE . . . . . 0.579 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 39.9 mt -94.57 138.49 20.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 169.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 30' ' ' SER . . . . . 0.598 ' HB2' ' NE2' ' E' ' 28' ' ' HIS . 26.1 t -119.66 -23.51 6.52 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -169.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 31' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -161.94 156.98 28.69 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 119.365 -1.398 . . . . 0.0 113.296 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 10.3 p -137.43 125.34 31.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 172.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' E' ' 85' ' ' VAL . . . -142.78 152.25 42.06 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -171.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 34' ' ' LEU . . . . . 0.509 ' HB3' ' CG1' ' E' ' 85' ' ' VAL . 3.6 pp -119.15 142.75 47.67 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.532 0.682 . . . . 0.0 111.38 177.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . 0.524 ' HB2' ' HH ' ' A' ' 43' ' ' TYR . 9.5 p-10 -110.13 -48.59 3.17 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.542 173.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -102.45 127.27 49.55 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 170.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . 0.5 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 145.85 159.49 8.2 Favored Glycine 0 N--CA 1.437 -1.242 0 C-N-CA 119.342 -1.409 . . . . 0.0 113.938 176.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 38' ' ' GLN . . . . . 0.403 ' HA ' ' HB2' ' E' ' 58' ' ' LYS . 54.3 mt-30 -103.11 -44.44 5.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.697 -0.252 . . . . 0.0 111.181 177.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -150.66 132.63 15.18 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 120.415 0.15 . . . . 0.0 110.974 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . 0.419 ' HB3' ' HB1' ' E' ' 83' ' ' ALA . . . -133.07 114.36 13.83 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.302 0.572 . . . . 0.0 110.498 169.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 41' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' E' ' 79' ' ' THR . 64.1 mttp -95.79 112.05 23.87 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 174.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 45.4 tp -83.87 115.97 22.53 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.484 -177.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 43' ' ' TYR . . . . . 0.507 ' HH ' ' HB2' ' D' ' 35' ' ' ASP . 97.2 m-85 -117.06 144.0 45.13 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 44' ' ' LEU . . . . . 0.49 HD22 ' CE1' ' D' ' 8' ' ' PHE . 0.2 OUTLIER -131.35 132.52 44.51 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.201 0.524 . . . . 0.0 109.684 172.061 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 45' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -107.05 110.11 22.16 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.371 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.26 151.98 46.73 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 43.39 37.44 1.38 Allowed 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.919 0.762 . . . . 0.0 111.146 -171.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 25.7 tptp 54.61 46.79 24.05 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.144 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 49' ' ' GLN . . . . . 0.576 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 6.5 tp-100 -135.31 130.76 35.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.639 175.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -85.78 110.83 19.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.264 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . 1.66 ' HE1' ' CE2' ' E' ' 51' ' ' TYR . 82.3 m-85 -104.49 129.15 52.54 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.764 177.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 tp -77.34 103.8 4.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 169.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . 0.496 HG11 ' CD2' ' D' ' 88' ' ' LEU . 2.6 t -76.32 -49.57 24.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.291 -173.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 54' ' ' ALA . . . . . 0.465 ' HB3' ' CD2' ' E' ' 65' ' ' LEU . . . -159.07 144.88 16.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.211 -178.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 44.4 m -110.52 101.46 10.14 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 171.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -111.22 120.54 62.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.176 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 52.3 p -122.73 -179.79 4.35 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.065 0.459 . . . . 0.0 112.153 -172.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 58' ' ' LYS . . . . . 0.403 ' HB2' ' HA ' ' E' ' 38' ' ' GLN . 34.9 tttm -60.84 -27.18 67.89 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.854 172.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 59' ' ' ALA . . . . . 0.468 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -83.38 -40.51 19.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.804 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 90.9 mt -107.45 89.51 5.01 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 174.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 61' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 36.2 Cg_exo -61.4 -20.31 67.86 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.193 2.595 . . . . 0.0 113.916 -169.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -156.32 136.07 12.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.452 0.644 . . . . 0.0 111.921 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . 0.415 HG12 ' HB2' ' E' ' 54' ' ' ALA . 98.9 t -111.33 113.73 45.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.763 171.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.06 122.22 34.36 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.057 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . 0.465 ' CD2' ' HB3' ' E' ' 54' ' ' ALA . 0.2 OUTLIER -142.74 143.49 32.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.335 0.588 . . . . 0.0 111.936 -177.128 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 66' ' ' ASP . . . . . 0.449 ' HB3' ' OG ' ' D' ' 30' ' ' SER . 5.6 t70 -89.49 100.53 13.31 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.679 177.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 67' ' ' LEU . . . . . 0.579 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 19.9 mt -110.91 138.41 47.34 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.646 176.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 68' ' ' ASN . . . . . 0.635 ' HB2' ' CD2' ' D' ' 90' ' ' TYR . 10.5 m-80 -137.63 128.26 26.8 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 173.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 69' ' ' PHE . . . . . 1.665 ' HD2' ' CD1' ' E' ' 69' ' ' PHE . 65.2 m-85 -124.47 146.79 48.73 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.974 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 29.5 t -100.12 149.01 23.95 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -67.14 -10.71 53.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.284 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.44 -9.77 66.48 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.064 176.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -100.83 160.17 14.59 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -135.22 125.48 26.33 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 75' ' ' ILE . . . . . . . . . . . . . 11.3 pt -131.31 178.08 6.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.835 0.35 . . . . 0.0 111.56 -171.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 76' ' ' MET . . . . . 0.478 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 24.6 mtp -130.89 136.28 48.47 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 77' ' ' PHE . . . . . 0.463 ' CD1' ' HB2' ' E' ' 44' ' ' LEU . 1.2 m-85 -117.82 128.2 54.63 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.199 176.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 78' ' ' TYR . . . . . 1.612 ' HD2' ' CD1' ' E' ' 78' ' ' TYR . 34.4 p90 -155.1 145.62 22.16 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.979 -178.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 79' ' ' THR . . . . . 0.679 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 13.3 p -117.3 144.91 44.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.496 -177.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -115.01 151.38 34.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.912 177.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.64 -177.2 29.25 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -109.81 102.88 11.63 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 117.79 0.795 . . . . 0.0 109.733 177.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 83' ' ' ALA . . . . . 0.5 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -175.22 155.94 1.99 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.823 172.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 32.6 t -113.06 118.83 35.86 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 85' ' ' VAL . . . . . 0.509 ' CG1' ' HB3' ' E' ' 34' ' ' LEU . 10.1 m -118.91 137.54 52.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -173.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 54.1 m -101.27 120.96 41.02 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.077 175.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 87' ' ' LEU . . . . . 0.506 ' HB2' ' HB3' ' E' ' 11' ' ' LEU . 5.3 mp -89.39 145.83 25.07 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 170.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . 0.507 ' CD2' HG11 ' A' ' 53' ' ' VAL . 1.2 tp -131.61 132.15 43.81 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.701 -177.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -159.67 -166.82 19.34 Favored Glycine 0 N--CA 1.439 -1.125 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.551 -176.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 90' ' ' TYR . . . . . 0.638 ' CD2' ' HB2' ' A' ' 68' ' ' ASN . 19.0 p90 -152.94 133.67 13.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.864 0.84 . . . . 0.0 111.687 177.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 91' ' ' LEU . . . . . . . . . . . . . 5.3 mt -71.35 138.11 48.97 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.073 -1.421 . . . . 0.0 108.896 174.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -67.9 123.71 21.33 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.71 -77.76 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 O-C-N 124.121 0.888 . . . . 0.0 113.346 -169.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 70.1 mt -137.15 116.04 14.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.806 0.336 . . . . 0.0 110.659 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -93.04 84.79 4.93 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 176.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 29.4 t -167.28 130.4 1.75 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.854 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.34 150.13 36.47 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.913 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.563 -0.732 . . . . 0.0 110.137 -179.452 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 64.06 -164.98 0.24 Allowed 'General case' 0 C--O 1.235 0.308 0 O-C-N 123.842 0.714 . . . . 0.0 111.501 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 101.89 102.3 2.61 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.868 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.47 133.41 52.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.948 0.404 . . . . 0.0 111.144 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 76.1 mtm -99.11 141.35 31.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.565 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -110.2 154.98 22.61 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.32 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.0 mtt -111.67 139.9 46.74 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.96 -178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.432 ' CE1' HD23 ' B' ' 44' ' ' LEU . 74.6 t80 -54.83 143.94 24.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.847 -173.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.578 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 89.6 t90 -139.27 148.7 43.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.104 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.55 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -149.98 153.37 25.05 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.715 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.578 ' HB2' ' CH2' ' A' ' 9' ' ' TRP . 59.2 tp -139.06 108.8 6.24 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.916 0.389 . . . . 0.0 111.108 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -80.38 105.72 11.85 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.706 173.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.477 ' HB3' HG22 ' A' ' 85' ' ' VAL . 35.7 tpp -99.41 132.32 44.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.045 0.45 . . . . 0.0 110.956 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -98.63 146.6 31.88 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.89 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.471 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 10.4 Cg_endo -53.6 115.82 2.57 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 123.433 2.756 . . . . 0.0 113.141 -176.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.705 ' HA ' ' O ' ' A' ' 79' ' ' THR . 34.5 mt-10 63.49 38.12 10.06 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.591 177.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -109.36 149.95 28.74 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 173.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.644 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 34.4 ttmt -125.94 119.21 27.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.716 0.293 . . . . 0.0 111.592 -174.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.447 ' HH ' ' HA ' ' A' ' 13' ' ' MET . 3.6 m-85 -110.6 104.96 13.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.442 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.9 p -87.67 99.49 12.11 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 171.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -125.34 148.7 48.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.542 0.687 . . . . 0.0 112.466 -166.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.4 t -92.38 160.31 15.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.029 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 68.2 mt -106.24 117.79 52.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.05 0.452 . . . . 0.0 110.806 -175.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.443 HD13 ' N ' ' A' ' 24' ' ' ILE . 4.1 mp -79.31 -45.38 23.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.916 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -135.17 140.22 45.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.739 178.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.1 m -55.99 124.15 16.75 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.527 0.517 . . . . 0.0 109.647 177.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 1.67 ' HE2' ' CE1' ' A' ' 27' ' ' PHE . 3.9 p90 -140.09 158.53 43.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.685 0.755 . . . . 0.0 112.683 -171.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.563 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 14.3 t60 -112.8 125.94 54.89 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.102 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.564 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 44.6 mt -96.3 133.45 37.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 170.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.563 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 42.2 p -118.48 -15.07 9.66 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -170.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.83 151.97 22.53 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 119.329 -1.415 . . . . 0.0 113.48 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.1 p -140.76 123.88 16.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 171.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.49 154.68 43.89 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.394 -0.522 . . . . 0.0 112.044 -173.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.465 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 4.3 pp -118.28 138.86 52.08 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.726 0.774 . . . . 0.0 111.178 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -110.07 -47.6 3.3 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.495 172.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -103.15 127.42 50.44 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.171 170.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.436 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 147.28 163.05 10.33 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 119.729 -1.224 . . . . 0.0 113.443 177.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.453 ' O ' ' HG3' ' A' ' 58' ' ' LYS . 8.3 tt0 -102.23 -48.21 4.27 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.554 0.216 . . . . 0.0 111.207 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -153.07 137.85 17.03 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.729 -0.214 . . . . 0.0 110.657 176.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.435 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . . . -136.39 114.97 11.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.395 0.616 . . . . 0.0 111.12 171.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 79' ' ' THR . 68.1 mttm -95.07 115.03 26.91 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 171.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.1 tp -84.11 116.25 22.8 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -176.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 1.615 ' HE2' ' CE1' ' A' ' 43' ' ' TYR . 93.9 m-85 -117.09 143.82 45.35 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.525 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -131.7 131.71 43.3 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 172.68 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -111.87 118.15 34.75 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.132 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.48 133.66 46.46 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.485 178.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 56.05 38.9 30.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.135 0.493 . . . . 0.0 110.67 -175.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm 65.8 22.52 11.47 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.333 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.562 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 28.9 mm-40 -113.32 124.48 52.57 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -87.42 116.87 25.82 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.564 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 72.4 m-85 -111.61 131.07 55.52 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.782 177.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -81.34 103.42 8.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 171.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.481 HG11 ' CD2' ' E' ' 88' ' ' LEU . 2.3 t -76.87 -47.64 27.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.473 -172.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.432 ' HB2' HG12 ' A' ' 63' ' ' VAL . . . -156.7 151.53 25.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.327 -178.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 98.1 m -114.81 101.77 9.37 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 169.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -113.04 114.12 46.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.675 0.75 . . . . 0.0 109.759 -177.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 77.1 p -123.31 -177.75 3.79 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.411 -174.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 38' ' ' GLN . 28.8 mtpp -57.22 -36.13 70.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.101 0.477 . . . . 0.0 110.374 169.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.27 -41.23 66.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.551 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.9 mt -115.74 82.66 10.61 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 174.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.1 0.5 6.53 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.858 2.372 . . . . 0.0 113.598 -168.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -162.76 128.0 3.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.153 0.501 . . . . 0.0 111.029 -176.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.432 HG12 ' HB2' ' A' ' 54' ' ' ALA . 92.8 t -114.23 111.23 35.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.478 174.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.83 112.15 23.85 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.679 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -130.51 168.44 17.04 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.57 -175.522 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.463 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 6.5 t0 -115.25 99.92 7.76 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.344 0.592 . . . . 0.0 110.33 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.564 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 17.7 mt -114.59 141.23 48.03 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.667 177.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.408 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 6.2 t30 -146.62 115.32 6.81 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.975 0.417 . . . . 0.0 110.053 174.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -110.18 159.93 16.94 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.0 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.7 p -112.4 149.61 32.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.551 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.46 10.45 0.62 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -175.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.68 -21.39 14.48 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.087 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -101.23 171.39 7.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.777 0.322 . . . . 0.0 110.883 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 -137.72 129.3 28.23 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.5 pt -129.24 163.04 35.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.062 0.458 . . . . 0.0 111.691 -170.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.519 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 4.8 mtm -118.3 122.82 43.85 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 175.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 1.669 ' HD1' ' CD2' ' A' ' 77' ' ' PHE . 1.0 OUTLIER -105.05 127.69 52.99 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.171 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 1.634 ' HD1' ' CD2' ' A' ' 78' ' ' TYR . 49.5 p90 -155.9 150.6 26.12 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.508 -177.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.705 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 11.2 p -117.2 149.12 40.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.735 -178.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.04 144.6 42.33 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.247 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.19 176.99 34.69 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -175.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -106.47 102.8 12.17 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.932 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.471 ' H ' ' HB3' ' A' ' 15' ' ' PRO . . . -170.75 151.25 3.43 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.574 169.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.6 t -108.14 121.6 45.17 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.477 HG22 ' HB3' ' A' ' 13' ' ' MET . 11.4 m -118.54 146.19 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 CA-C-O 121.435 0.636 . . . . 0.0 111.666 -173.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.2 t -111.88 120.94 43.62 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.565 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 5.1 mp -93.0 151.63 19.78 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 174.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.451 ' CD2' HG11 ' B' ' 53' ' ' VAL . 1.6 tp -133.58 141.11 47.53 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.162 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.16 -166.67 26.63 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.825 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 1.624 ' HE2' ' CE1' ' A' ' 90' ' ' TYR . 8.1 p90 -150.96 130.16 12.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.754 0.788 . . . . 0.0 111.698 176.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.405 ' HA ' ' CB ' ' A' ' 27' ' ' PHE . 5.3 mt -72.97 136.24 45.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.886 176.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -79.21 108.94 13.09 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 174.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -114.8 -177.16 3.06 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -176.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.427 ' N ' HD13 ' A' ' 94' ' ' ILE . 4.2 mp -105.2 -35.96 3.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 25.2 t70 65.87 135.51 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.366 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.2 p -88.6 6.41 38.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.929 -176.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.73 -65.07 3.77 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.678 -0.773 . . . . 0.0 111.399 -177.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.8 p . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.793 -0.622 . . . . 0.0 109.712 176.988 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 64.11 -165.08 0.24 Allowed 'General case' 0 C--O 1.235 0.334 0 O-C-N 123.771 0.669 . . . . 0.0 111.386 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 101.99 102.34 2.62 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.771 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.47 133.38 52.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.909 0.385 . . . . 0.0 111.201 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 75.9 mtm -99.08 141.27 32.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.606 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -110.15 155.01 22.52 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.345 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 59.9 mtt -111.63 139.98 46.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.965 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 0.471 ' CE1' HD23 ' C' ' 44' ' ' LEU . 73.9 t80 -54.97 144.03 24.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.853 -173.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . 0.575 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 89.5 t90 -139.38 148.6 43.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.971 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.584 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -149.85 153.44 25.11 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.828 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.575 ' HB2' ' CH2' ' B' ' 9' ' ' TRP . 59.5 tp -139.04 108.71 6.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.774 0.321 . . . . 0.0 111.197 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -80.35 105.84 11.92 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.706 173.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' MET . . . . . 0.497 ' HB3' HG22 ' B' ' 85' ' ' VAL . 35.6 tpp -99.53 132.44 44.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.156 0.503 . . . . 0.0 110.87 -176.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -98.61 146.61 31.9 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.915 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.466 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 10.3 Cg_endo -53.68 115.86 2.61 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 123.425 2.75 . . . . 0.0 113.134 -176.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.704 ' HA ' ' O ' ' B' ' 79' ' ' THR . 34.6 mt-10 63.5 38.02 10.1 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.666 177.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -109.31 149.84 28.86 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . 0.64 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 34.3 ttmt -125.95 119.23 27.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.774 0.321 . . . . 0.0 111.617 -174.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' TYR . . . . . 0.459 ' OH ' ' HA ' ' B' ' 13' ' ' MET . 3.6 m-85 -110.54 104.94 13.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.399 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 11.9 p -87.59 99.4 12.02 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 171.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -125.27 148.81 48.53 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.616 0.722 . . . . 0.0 112.5 -166.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 11.5 t -92.46 160.34 15.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.998 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 68.0 mt -106.28 117.69 52.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.085 0.469 . . . . 0.0 110.823 -175.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.436 HD13 ' N ' ' B' ' 24' ' ' ILE . 4.1 mp -79.27 -45.36 23.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.984 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.405 ' HE3' ' OD2' ' B' ' 93' ' ' ASP . 35.0 mtmm -135.19 140.24 45.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.757 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 17.8 m -55.92 124.03 16.3 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 123.639 0.587 . . . . 0.0 109.646 177.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . 1.648 ' HE2' ' CE1' ' B' ' 27' ' ' PHE . 3.9 p90 -140.03 158.57 43.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.704 0.764 . . . . 0.0 112.739 -171.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' HIS . . . . . 0.562 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 14.2 t60 -112.86 126.05 55.03 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.07 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.571 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 44.0 mt -96.3 133.44 37.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 170.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.562 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 41.5 p -118.47 -15.04 9.67 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -170.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.87 151.97 22.52 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 119.276 -1.44 . . . . 0.0 113.456 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 9.1 p -140.74 123.88 16.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 171.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.5 154.63 43.84 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.486 -0.485 . . . . 0.0 112.085 -172.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.476 ' HB3' ' CG1' ' B' ' 85' ' ' VAL . 4.3 pp -118.28 138.88 52.07 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.627 0.727 . . . . 0.0 111.155 177.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -110.17 -47.56 3.29 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.404 172.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -103.2 127.44 50.49 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.167 170.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.435 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 147.26 162.99 10.3 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 119.696 -1.24 . . . . 0.0 113.405 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . 0.463 ' O ' ' HG3' ' B' ' 58' ' ' LYS . 8.3 tt0 -102.16 -48.3 4.26 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.474 0.178 . . . . 0.0 111.149 178.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -153.07 137.77 16.96 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.713 -0.222 . . . . 0.0 110.652 176.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.425 ' HB3' ' HB1' ' B' ' 83' ' ' ALA . . . -136.31 114.89 11.9 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.279 0.561 . . . . 0.0 111.196 171.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' B' ' 79' ' ' THR . 68.1 mttm -95.03 114.99 26.86 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 171.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 38.1 tp -84.06 116.25 22.77 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . 1.611 ' HE2' ' CE1' ' B' ' 43' ' ' TYR . 93.9 m-85 -117.09 143.79 45.39 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.539 177.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.534 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.1 OUTLIER -131.63 131.71 43.44 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 172.657 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -111.88 118.1 34.59 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.087 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.44 133.67 46.51 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.444 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 56.07 38.78 30.27 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.516 0.51 . . . . 0.0 110.675 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm 65.9 22.44 11.35 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.344 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.558 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 28.9 mm-40 -113.32 124.5 52.61 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 177.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -87.52 116.92 25.97 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 0.55 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 72.3 m-85 -111.68 131.06 55.55 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.749 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -81.27 103.42 8.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 170.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.451 HG11 ' CD2' ' A' ' 88' ' ' LEU . 2.3 t -76.87 -47.65 27.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.476 -172.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.425 ' HB2' HG12 ' B' ' 63' ' ' VAL . . . -156.69 151.49 25.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.334 -178.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 99.9 m -114.78 101.77 9.38 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 169.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -113.0 114.07 45.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.578 0.704 . . . . 0.0 109.755 -177.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 76.3 p -123.27 -177.79 3.8 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.445 -174.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' B' ' 38' ' ' GLN . 28.8 mtpp -57.16 -36.18 70.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.073 0.463 . . . . 0.0 110.331 168.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.43 -41.19 66.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.503 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 76.3 mt -115.67 82.68 10.45 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 174.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.09 0.37 6.74 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.992 2.461 . . . . 0.0 113.606 -168.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -162.66 128.01 3.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.263 0.554 . . . . 0.0 111.005 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.425 HG12 ' HB2' ' B' ' 54' ' ' ALA . 94.9 t -114.13 111.24 35.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.54 174.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.81 112.0 23.62 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.728 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' B' ' 30' ' ' SER . 0.3 OUTLIER -130.43 168.46 16.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.558 -175.497 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . 0.466 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 6.5 t0 -115.26 99.96 7.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.298 0.57 . . . . 0.0 110.405 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.571 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 17.7 mt -114.58 141.3 47.94 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.66 177.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . 0.409 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 6.3 t30 -146.71 115.27 6.76 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.013 0.435 . . . . 0.0 110.074 174.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -110.22 159.92 16.96 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.929 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 10.3 p -112.45 149.56 32.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.544 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.4 10.52 0.6 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -175.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.71 -21.51 14.21 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.118 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -101.13 171.39 7.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.775 0.321 . . . . 0.0 110.901 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 -137.76 129.49 28.44 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 14.7 pt -129.36 162.95 35.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.027 0.441 . . . . 0.0 111.703 -170.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' MET . . . . . 0.534 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 4.8 mtm -118.28 122.87 44.0 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 175.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . 1.664 ' HD1' ' CD2' ' B' ' 77' ' ' PHE . 1.0 OUTLIER -105.12 127.72 53.03 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.183 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 1.649 ' HD1' ' CD2' ' B' ' 78' ' ' TYR . 49.3 p90 -155.93 150.63 26.09 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.471 -177.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.704 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 11.2 p -117.32 149.08 41.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.922 0.392 . . . . 0.0 111.679 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.06 144.54 42.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.269 174.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.25 176.96 34.6 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -106.5 102.8 12.17 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.932 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.466 ' H ' ' HB3' ' B' ' 15' ' ' PRO . . . -170.82 151.28 3.38 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.527 169.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 23.6 t -108.31 121.61 45.26 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.497 HG22 ' HB3' ' B' ' 13' ' ' MET . 11.6 m -118.41 146.19 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 CA-C-O 121.406 0.622 . . . . 0.0 111.665 -173.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 15.3 t -111.87 120.86 43.37 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.546 ' HB2' ' HB3' ' B' ' 11' ' ' LEU . 5.0 mp -92.91 151.57 19.88 Favored 'General case' 0 CA--C 1.502 -0.895 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.64 174.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.474 ' CD2' HG11 ' C' ' 53' ' ' VAL . 1.6 tp -133.49 141.12 47.63 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.129 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.2 -166.69 26.71 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.812 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' TYR . . . . . 1.627 ' HD1' ' CD2' ' B' ' 90' ' ' TYR . 8.2 p90 -150.89 130.13 12.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.679 0.752 . . . . 0.0 111.778 176.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . 0.406 ' HA ' ' CB ' ' B' ' 27' ' ' PHE . 5.4 mt -72.92 136.26 45.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.238 -1.346 . . . . 0.0 109.933 176.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -79.17 108.82 12.95 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . 0.405 ' OD2' ' HE3' ' B' ' 25' ' ' LYS . 7.7 t70 -114.73 -177.05 3.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.752 -177.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . 0.434 HD13 ' N ' ' B' ' 94' ' ' ILE . 4.2 mp -105.26 -35.96 3.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 25.3 t70 65.82 135.57 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.366 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 11.3 p -88.64 6.63 37.4 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.931 -176.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.64 -65.1 3.74 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.471 -177.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 15.2 p . . . . . 0 C--O 1.252 1.191 0 CA-C-O 118.856 -0.592 . . . . 0.0 109.75 177.083 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 64.3 -165.13 0.24 Allowed 'General case' 0 C--O 1.235 0.3 0 O-C-N 123.68 0.613 . . . . 0.0 111.375 176.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . 102.03 102.33 2.62 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.793 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.53 133.42 52.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.995 0.426 . . . . 0.0 111.151 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 76.1 mtm -99.08 141.21 32.13 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.569 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 6' ' ' ALA . . . . . . . . . . . . . . . -110.11 155.06 22.41 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.347 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 59.9 mtt -111.7 139.87 46.8 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.906 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 8' ' ' PHE . . . . . 0.46 ' CE1' HD23 ' D' ' 44' ' ' LEU . 74.0 t80 -54.91 144.02 24.27 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.878 -173.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . 0.565 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 89.6 t90 -139.25 148.74 43.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.98 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . 0.538 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -149.97 153.44 25.09 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.764 177.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.565 ' HB2' ' CH2' ' C' ' 9' ' ' TRP . 59.5 tp -139.15 108.86 6.24 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.945 0.402 . . . . 0.0 111.093 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -80.35 105.7 11.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.751 173.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 13' ' ' MET . . . . . 0.498 ' HB3' HG22 ' C' ' 85' ' ' VAL . 35.8 tpp -99.48 132.27 44.93 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.116 0.484 . . . . 0.0 110.852 -176.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -98.47 146.53 31.74 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.013 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . 0.463 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 10.3 Cg_endo -53.62 115.95 2.67 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 123.362 2.708 . . . . 0.0 113.161 -176.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . 0.707 ' HA ' ' O ' ' C' ' 79' ' ' THR . 34.6 mt-10 63.4 38.07 10.33 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.699 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -109.3 149.85 28.85 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 173.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 18' ' ' LYS . . . . . 0.641 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 34.4 ttmt -126.05 119.26 27.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.748 0.309 . . . . 0.0 111.583 -174.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . 0.448 ' OH ' ' HA ' ' C' ' 13' ' ' MET . 3.6 m-85 -110.56 104.98 13.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.434 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 11.9 p -87.61 99.47 12.08 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 171.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -125.42 148.84 48.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.589 0.709 . . . . 0.0 112.462 -166.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 11.4 t -92.51 160.4 15.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.997 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -106.27 117.73 52.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.091 0.472 . . . . 0.0 110.824 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . 0.434 HD13 ' N ' ' C' ' 24' ' ' ILE . 4.1 mp -79.26 -45.44 23.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.965 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . 0.404 ' HE3' ' OD2' ' C' ' 93' ' ' ASP . 35.0 mtmm -135.16 140.3 45.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.707 178.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 18.0 m -56.03 124.15 16.78 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.582 0.551 . . . . 0.0 109.582 177.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 27' ' ' PHE . . . . . 1.61 ' HE2' ' CE1' ' C' ' 27' ' ' PHE . 3.9 p90 -140.08 158.5 43.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.739 0.781 . . . . 0.0 112.78 -171.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 28' ' ' HIS . . . . . 0.565 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 14.2 t60 -112.77 125.97 54.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.104 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . 0.566 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 44.2 mt -96.28 133.44 37.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 30' ' ' SER . . . . . 0.565 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 41.1 p -118.49 -14.98 9.66 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -170.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.91 151.84 22.35 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 119.314 -1.422 . . . . 0.0 113.508 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 9.0 p -140.74 123.89 16.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 171.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.56 154.59 43.75 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.397 -0.521 . . . . 0.0 112.077 -172.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.475 ' HB3' HG13 ' C' ' 85' ' ' VAL . 4.3 pp -118.14 138.86 52.0 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.685 0.755 . . . . 0.0 111.241 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -110.19 -47.52 3.29 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.772 -1.103 . . . . 0.0 108.464 172.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -103.17 127.51 50.44 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.227 170.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 37' ' ' GLY . . . . . 0.43 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 147.21 163.06 10.32 Favored Glycine 0 N--CA 1.439 -1.111 0 C-N-CA 119.718 -1.229 . . . . 0.0 113.442 177.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 38' ' ' GLN . . . . . 0.454 ' O ' ' HG3' ' C' ' 58' ' ' LYS . 8.4 tt0 -102.28 -48.27 4.25 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.483 0.183 . . . . 0.0 111.122 178.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -153.07 137.77 16.96 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 122.162 0.185 . . . . 0.0 110.714 176.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . 0.441 ' HB3' ' HB1' ' C' ' 83' ' ' ALA . . . -136.27 114.92 11.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.292 0.568 . . . . 0.0 111.171 171.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' C' ' 79' ' ' THR . 68.1 mttm -95.0 114.91 26.77 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 171.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 37.9 tp -84.04 116.26 22.76 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -176.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 43' ' ' TYR . . . . . 1.633 ' HE2' ' CE1' ' C' ' 43' ' ' TYR . 93.9 m-85 -117.09 143.77 45.42 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 177.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.522 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 0.1 OUTLIER -131.66 131.64 43.32 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 172.662 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . 0.568 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -111.89 118.16 34.76 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.164 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.43 133.58 46.45 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.45 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 56.12 38.79 30.24 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.524 0.515 . . . . 0.0 110.654 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm 65.9 22.35 11.35 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.362 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . 0.568 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 29.0 mm-40 -113.25 124.46 52.57 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -87.48 116.93 25.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.928 0.394 . . . . 0.0 110.046 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 0.584 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 72.5 m-85 -111.72 131.02 55.58 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.743 177.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -81.33 103.35 8.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 171.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 53' ' ' VAL . . . . . 0.474 HG11 ' CD2' ' B' ' 88' ' ' LEU . 2.3 t -76.87 -47.6 27.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.491 -172.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 54' ' ' ALA . . . . . 0.434 ' HB2' HG12 ' C' ' 63' ' ' VAL . . . -156.68 151.5 25.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.303 -178.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 99.6 m -114.74 101.69 9.31 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 169.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.92 114.04 45.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.596 0.712 . . . . 0.0 109.781 -177.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 77.4 p -123.26 -177.74 3.78 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.496 -174.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 58' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' C' ' 38' ' ' GLN . 28.8 mtpp -57.2 -36.18 70.53 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.032 0.444 . . . . 0.0 110.378 168.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.35 -41.16 66.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.521 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 76.5 mt -115.76 82.77 10.78 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 174.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.11 0.44 6.64 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.865 2.377 . . . . 0.0 113.662 -168.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -162.66 128.06 3.29 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.139 0.495 . . . . 0.0 111.087 -176.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.434 HG12 ' HB2' ' C' ' 54' ' ' ALA . 92.1 t -114.29 111.36 35.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.439 174.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.85 112.04 23.7 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.698 174.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' C' ' 30' ' ' SER . 0.3 OUTLIER -130.45 168.44 17.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.069 0.461 . . . . 0.0 111.599 -175.518 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 66' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 6.6 t0 -115.23 99.95 7.78 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.345 0.593 . . . . 0.0 110.386 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . 0.566 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 17.7 mt -114.58 141.22 48.03 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.695 177.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . 0.401 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 6.3 t30 -146.66 115.27 6.78 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.92 0.391 . . . . 0.0 110.043 174.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -110.07 159.93 16.89 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.061 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 10.7 p -112.49 149.49 32.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.557 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.38 10.41 0.62 Allowed 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -175.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.63 -21.51 14.35 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.111 176.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -101.15 171.31 7.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.787 0.327 . . . . 0.0 110.828 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 -137.72 129.46 28.47 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 14.8 pt -129.35 163.01 35.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.104 0.478 . . . . 0.0 111.696 -169.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 76' ' ' MET . . . . . 0.52 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 4.8 mtm -118.41 122.89 43.9 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 175.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 77' ' ' PHE . . . . . 1.642 ' HE2' ' CE1' ' C' ' 77' ' ' PHE . 1.0 OUTLIER -105.08 127.77 53.04 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 177.204 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 78' ' ' TYR . . . . . 1.659 ' HD2' ' CD1' ' C' ' 78' ' ' TYR . 49.3 p90 -155.95 150.65 26.1 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.494 -177.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 79' ' ' THR . . . . . 0.707 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 11.0 p -117.34 149.14 40.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.898 0.38 . . . . 0.0 111.622 -178.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.11 144.62 42.34 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.323 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.19 176.93 34.69 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -175.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -106.49 102.75 12.12 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.062 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . 0.463 ' H ' ' HB3' ' C' ' 15' ' ' PRO . . . -170.7 151.26 3.46 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.557 169.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 23.4 t -108.19 121.57 45.14 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.498 HG22 ' HB3' ' C' ' 13' ' ' MET . 11.6 m -118.49 146.24 23.35 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-O 121.403 0.62 . . . . 0.0 111.663 -173.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 15.2 t -111.94 120.88 43.41 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . 0.56 ' HB2' ' HB3' ' C' ' 11' ' ' LEU . 5.0 mp -92.92 151.68 19.81 Favored 'General case' 0 CA--C 1.502 -0.894 0 C-N-CA 120.364 -0.534 . . . . 0.0 109.646 174.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . 0.472 ' CD2' HG11 ' D' ' 53' ' ' VAL . 1.6 tp -133.58 141.11 47.53 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.156 -178.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.21 -166.72 26.77 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.825 -0.703 . . . . 0.0 111.86 -176.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 90' ' ' TYR . . . . . 1.617 ' HE1' ' CE2' ' C' ' 90' ' ' TYR . 8.3 p90 -150.86 130.1 12.77 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.632 0.729 . . . . 0.0 111.765 176.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 5.2 mt -72.93 136.2 45.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.253 -1.339 . . . . 0.0 109.93 176.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -79.16 108.87 12.98 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 93' ' ' ASP . . . . . 0.404 ' OD2' ' HE3' ' C' ' 25' ' ' LYS . 7.8 t70 -114.73 -177.07 3.04 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.727 -176.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . 0.428 HD13 ' N ' ' C' ' 94' ' ' ILE . 4.2 mp -105.31 -35.91 3.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 25.2 t70 65.77 135.71 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.302 -176.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 11.3 p -88.71 6.51 38.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.84 -176.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.6 -64.97 3.75 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.395 -177.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 15.3 p . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.913 -0.565 . . . . 0.0 109.698 177.071 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 64.12 -165.09 0.24 Allowed 'General case' 0 C--O 1.235 0.312 0 O-C-N 123.715 0.635 . . . . 0.0 111.439 176.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . 101.93 102.4 2.62 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.893 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.53 133.45 52.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.893 0.378 . . . . 0.0 111.107 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 76.0 mtm -99.1 141.34 31.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.612 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 6' ' ' ALA . . . . . . . . . . . . . . . -110.22 154.99 22.6 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.351 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 59.9 mtt -111.68 139.95 46.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.924 0.392 . . . . 0.0 110.872 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 8' ' ' PHE . . . . . 0.473 ' CE1' HD23 ' E' ' 44' ' ' LEU . 74.2 t80 -55.01 144.06 24.55 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.849 -173.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 9' ' ' TRP . . . . . 0.575 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 89.7 t90 -139.29 148.7 43.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.987 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . 0.562 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -149.95 153.44 25.1 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.812 -0.708 . . . . 0.0 111.755 177.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . 0.575 ' HB2' ' CH2' ' D' ' 9' ' ' TRP . 58.9 tp -139.13 108.81 6.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.965 0.412 . . . . 0.0 111.094 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -80.35 105.75 11.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.685 173.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 13' ' ' MET . . . . . 0.49 ' HB3' HG22 ' D' ' 85' ' ' VAL . 35.7 tpp -99.52 132.31 44.94 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.067 0.46 . . . . 0.0 110.942 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -98.57 146.55 31.79 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.95 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . 0.463 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 10.5 Cg_endo -53.52 115.85 2.59 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 123.428 2.752 . . . . 0.0 113.154 -176.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . 0.721 ' HA ' ' O ' ' D' ' 79' ' ' THR . 34.3 mt-10 63.42 38.14 10.22 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.617 177.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -109.37 149.82 28.95 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 173.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . 0.637 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 34.4 ttmt -125.96 119.22 27.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.771 0.319 . . . . 0.0 111.59 -174.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 19' ' ' TYR . . . . . 0.452 ' OH ' ' HA ' ' D' ' 13' ' ' MET . 3.6 m-85 -110.51 104.9 13.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.402 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 11.7 p -87.69 99.43 12.07 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 171.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -125.25 148.7 48.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.492 0.663 . . . . 0.0 112.564 -166.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 11.4 t -92.32 160.35 15.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.049 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 68.0 mt -106.31 117.71 52.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.059 0.457 . . . . 0.0 110.771 -175.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . 0.441 ' N ' HD13 ' D' ' 24' ' ' ILE . 4.2 mp -79.26 -45.42 23.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.96 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . 0.404 ' HE3' ' OD2' ' D' ' 93' ' ' ASP . 35.0 mtmm -135.14 140.28 45.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.759 178.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 18.2 m -56.02 124.17 16.84 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 123.547 0.529 . . . . 0.0 109.595 177.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 27' ' ' PHE . . . . . 1.625 ' HD2' ' CD1' ' D' ' 27' ' ' PHE . 3.9 p90 -140.16 158.56 43.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.65 0.738 . . . . 0.0 112.731 -171.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 28' ' ' HIS . . . . . 0.565 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 14.1 t60 -112.87 125.99 54.97 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.048 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 29' ' ' ILE . . . . . 0.551 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 43.9 mt -96.3 133.46 37.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 30' ' ' SER . . . . . 0.565 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 42.4 p -118.53 -14.96 9.63 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -170.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.91 151.93 22.46 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 119.4 -1.381 . . . . 0.0 113.489 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 9.1 p -140.87 123.85 16.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 171.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.48 154.61 43.83 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.419 -0.512 . . . . 0.0 112.076 -172.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 34' ' ' LEU . . . . . 0.472 ' HB3' ' CG1' ' D' ' 85' ' ' VAL . 4.3 pp -118.2 138.86 52.04 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.669 0.747 . . . . 0.0 111.222 177.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -110.1 -47.55 3.3 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.475 172.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -103.2 127.52 50.47 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.176 170.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . 0.43 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 147.3 162.99 10.31 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 119.659 -1.258 . . . . 0.0 113.364 177.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 38' ' ' GLN . . . . . 0.462 ' O ' ' HG3' ' D' ' 58' ' ' LYS . 8.4 tt0 -102.21 -48.32 4.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.524 0.202 . . . . 0.0 111.155 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -153.0 137.84 17.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.784 -0.189 . . . . 0.0 110.667 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . 0.438 ' HB3' ' HB1' ' D' ' 83' ' ' ALA . . . -136.37 114.91 11.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.37 0.605 . . . . 0.0 111.126 171.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' D' ' 79' ' ' THR . 68.1 mttm -95.01 114.92 26.78 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 171.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 38.0 tp -83.99 116.13 22.67 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -176.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 43' ' ' TYR . . . . . 1.649 ' HE2' ' CE1' ' D' ' 43' ' ' TYR . 94.4 m-85 -117.03 143.74 45.4 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.524 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.1 OUTLIER -131.62 131.77 43.5 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 172.699 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 45' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -111.97 118.1 34.55 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.131 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.43 133.59 46.46 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.485 178.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 56.19 38.8 30.19 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 123.452 0.47 . . . . 0.0 110.591 -175.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm 65.94 22.43 11.31 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.214 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . 0.566 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 29.1 mm-40 -113.28 124.54 52.74 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -87.55 116.87 25.97 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . 0.538 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 72.3 m-85 -111.64 131.03 55.56 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.798 177.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -81.3 103.32 8.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 171.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 53' ' ' VAL . . . . . 0.472 HG11 ' CD2' ' C' ' 88' ' ' LEU . 2.3 t -76.76 -47.61 28.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.523 -172.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 54' ' ' ALA . . . . . 0.425 ' HB2' HG12 ' D' ' 63' ' ' VAL . . . -156.74 151.5 25.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.296 -178.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 99.9 m -114.74 101.64 9.26 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 169.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.97 114.14 46.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.584 0.707 . . . . 0.0 109.777 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 75.7 p -123.26 -177.82 3.81 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.495 -174.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 58' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' D' ' 38' ' ' GLN . 28.8 mtpp -57.2 -36.08 70.41 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.12 0.486 . . . . 0.0 110.43 168.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.4 -41.14 66.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.562 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 76.0 mt -115.72 82.69 10.59 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.03 0.42 6.63 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.839 2.359 . . . . 0.0 113.652 -168.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -162.64 128.22 3.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.154 0.502 . . . . 0.0 111.014 -176.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.425 HG12 ' HB2' ' D' ' 54' ' ' ALA . 92.7 t -114.39 111.36 35.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.433 174.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.93 112.01 23.7 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.678 174.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 65' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' D' ' 30' ' ' SER . 0.3 OUTLIER -130.41 168.56 16.77 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.065 0.46 . . . . 0.0 111.556 -175.518 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 66' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 6.5 t0 -115.32 99.99 7.79 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.33 0.586 . . . . 0.0 110.398 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . 0.551 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 17.7 mt -114.66 141.32 47.95 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.561 177.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 68' ' ' ASN . . . . . 0.419 ' HB3' ' CD2' ' C' ' 90' ' ' TYR . 6.2 t30 -146.71 115.28 6.76 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.006 0.431 . . . . 0.0 110.083 173.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -110.11 159.93 16.91 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.012 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 10.0 p -112.56 149.59 32.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.479 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.56 10.59 0.61 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -175.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.72 -21.38 14.44 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.131 176.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -101.21 171.41 7.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.839 0.352 . . . . 0.0 110.859 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 -137.72 129.33 28.28 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . . . . . . . . . 14.7 pt -129.3 162.94 35.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.088 0.47 . . . . 0.0 111.707 -169.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 76' ' ' MET . . . . . 0.52 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 4.8 mtm -118.22 122.79 43.87 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 175.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 77' ' ' PHE . . . . . 1.662 ' HE1' ' CE2' ' D' ' 77' ' ' PHE . 1.0 OUTLIER -105.03 127.77 53.02 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 177.209 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 78' ' ' TYR . . . . . 1.63 ' HE1' ' CE2' ' D' ' 78' ' ' TYR . 49.5 p90 -155.9 150.57 26.08 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.491 -177.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 79' ' ' THR . . . . . 0.721 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 11.1 p -117.23 149.19 40.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.935 0.397 . . . . 0.0 111.698 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.14 144.71 42.19 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.202 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.2 176.98 34.67 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -175.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -106.5 102.84 12.21 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.97 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.463 ' H ' ' HB3' ' D' ' 15' ' ' PRO . . . -170.82 151.27 3.38 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.486 169.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 23.5 t -108.21 121.49 44.98 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . 0.49 HG22 ' HB3' ' D' ' 13' ' ' MET . 11.7 m -118.41 146.18 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 CA-C-O 121.416 0.627 . . . . 0.0 111.69 -173.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 15.4 t -111.87 120.88 43.43 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 87' ' ' LEU . . . . . 0.561 ' HB2' ' HB3' ' D' ' 11' ' ' LEU . 5.0 mp -92.86 151.58 19.9 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 120.452 -0.499 . . . . 0.0 109.658 174.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . 0.489 ' CD2' HG11 ' E' ' 53' ' ' VAL . 1.6 tp -133.55 141.18 47.6 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.081 -178.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.24 -166.7 26.76 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.799 -176.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 90' ' ' TYR . . . . . 1.592 ' HE2' ' CE1' ' D' ' 90' ' ' TYR . 8.2 p90 -150.95 130.12 12.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.742 0.782 . . . . 0.0 111.781 176.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 5.3 mt -72.91 136.17 45.19 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.957 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -79.13 108.79 12.88 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 93' ' ' ASP . . . . . 0.404 ' OD2' ' HE3' ' D' ' 25' ' ' LYS . 7.7 t70 -114.7 -177.14 3.06 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -176.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . 0.428 HD13 ' N ' ' D' ' 94' ' ' ILE . 4.2 mp -105.26 -35.9 3.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 25.2 t70 65.78 135.52 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.352 -176.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 11.2 p -88.65 6.54 37.91 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.906 -176.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.6 -64.94 3.76 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.481 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 15.1 p . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.913 -0.565 . . . . 0.0 109.728 177.02 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 64.16 -165.08 0.24 Allowed 'General case' 0 C--O 1.236 0.361 0 O-C-N 123.686 0.616 . . . . 0.0 111.385 176.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . 102.04 102.25 2.62 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.804 -0.713 . . . . 0.0 111.851 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.47 133.49 52.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.922 0.391 . . . . 0.0 111.168 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 76.0 mtm -99.2 141.33 32.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.56 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 6' ' ' ALA . . . . . . . . . . . . . . . -110.09 154.94 22.55 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.399 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 59.9 mtt -111.67 139.97 46.68 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.943 0.401 . . . . 0.0 110.859 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 8' ' ' PHE . . . . . 0.469 ' CE1' HD23 ' A' ' 44' ' ' LEU . 74.2 t80 -54.92 144.03 24.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.805 -173.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 9' ' ' TRP . . . . . 0.56 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 89.5 t90 -139.38 148.63 43.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.96 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 10' ' ' GLY . . . . . 0.564 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -149.88 153.43 25.1 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.79 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . 0.56 ' HB2' ' CH2' ' E' ' 9' ' ' TRP . 59.2 tp -139.06 108.79 6.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.898 0.38 . . . . 0.0 111.144 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -80.28 105.71 11.75 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.769 173.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 13' ' ' MET . . . . . 0.503 ' HB3' HG22 ' E' ' 85' ' ' VAL . 35.5 tpp -99.5 132.32 44.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.117 0.484 . . . . 0.0 110.935 -176.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -98.56 146.67 31.99 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.945 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . 0.458 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 10.4 Cg_endo -53.73 115.96 2.68 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 123.4 2.734 . . . . 0.0 113.104 -176.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 16' ' ' GLU . . . . . 0.721 ' HA ' ' O ' ' E' ' 79' ' ' THR . 34.6 mt-10 63.35 38.17 10.37 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.69 177.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -109.41 149.9 28.87 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 173.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . 0.636 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 34.4 ttmt -125.99 119.19 27.04 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.736 0.303 . . . . 0.0 111.613 -174.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . 0.451 ' OH ' ' HA ' ' E' ' 13' ' ' MET . 3.5 m-85 -110.44 104.86 13.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.546 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 12.0 p -87.54 99.47 12.06 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 171.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -125.41 148.77 48.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.537 0.684 . . . . 0.0 112.517 -166.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 11.5 t -92.45 160.27 15.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.989 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 68.1 mt -106.25 117.66 52.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.082 0.468 . . . . 0.0 110.894 -175.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . 0.433 ' N ' HD13 ' E' ' 24' ' ' ILE . 4.1 mp -79.19 -45.42 24.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.977 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . 0.402 ' HE3' ' OD2' ' E' ' 93' ' ' ASP . 35.0 mtmm -135.13 140.23 45.27 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.775 178.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 18.0 m -56.06 124.09 16.62 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 123.619 0.574 . . . . 0.0 109.648 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 27' ' ' PHE . . . . . 1.654 ' HE2' ' CE1' ' E' ' 27' ' ' PHE . 3.9 p90 -140.04 158.53 43.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.725 0.774 . . . . 0.0 112.765 -171.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 28' ' ' HIS . . . . . 0.564 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 14.3 t60 -112.72 125.99 54.92 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.159 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 29' ' ' ILE . . . . . 0.567 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 44.2 mt -96.29 133.41 37.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 170.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 30' ' ' SER . . . . . 0.564 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 43.3 p -118.49 -14.93 9.66 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -170.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.86 151.93 22.47 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 119.373 -1.394 . . . . 0.0 113.566 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 9.1 p -140.81 123.86 16.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 171.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.52 154.54 43.73 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.493 -0.483 . . . . 0.0 112.082 -172.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 34' ' ' LEU . . . . . 0.476 ' HB3' ' CG1' ' E' ' 85' ' ' VAL . 4.3 pp -118.2 138.89 52.01 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.714 0.769 . . . . 0.0 111.222 177.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -110.2 -47.44 3.3 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.485 172.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -103.28 127.47 50.6 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.201 170.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . 0.434 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 147.27 162.9 10.25 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 119.673 -1.251 . . . . 0.0 113.463 177.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 38' ' ' GLN . . . . . 0.46 ' O ' ' HG3' ' E' ' 58' ' ' LYS . 8.4 tt0 -102.22 -48.16 4.29 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.559 0.219 . . . . 0.0 111.143 178.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -153.11 137.76 16.91 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.781 -0.191 . . . . 0.0 110.639 176.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . 0.438 ' HB3' ' HB1' ' E' ' 83' ' ' ALA . . . -136.32 114.97 11.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.318 0.58 . . . . 0.0 111.147 171.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 41' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' E' ' 79' ' ' THR . 68.1 mttm -95.09 114.99 26.85 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 171.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 37.9 tp -84.05 116.17 22.72 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 43' ' ' TYR . . . . . 1.638 ' HE2' ' CE1' ' E' ' 43' ' ' TYR . 94.2 m-85 -117.05 143.72 45.43 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.501 177.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 44' ' ' LEU . . . . . 0.526 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 0.1 OUTLIER -131.59 131.66 43.45 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 172.653 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 45' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -111.88 118.07 34.51 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.158 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.42 133.62 46.5 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.485 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 56.11 38.85 30.31 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.457 0.473 . . . . 0.0 110.587 -175.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm 65.96 22.48 11.28 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.259 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 49' ' ' GLN . . . . . 0.563 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 29.2 mm-40 -113.36 124.54 52.71 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -87.57 116.84 25.96 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.847 0.356 . . . . 0.0 110.064 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . 0.562 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 72.1 m-85 -111.61 131.02 55.56 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.798 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -81.35 103.45 8.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 171.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . 0.489 HG11 ' CD2' ' D' ' 88' ' ' LEU . 2.3 t -76.89 -47.59 27.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.495 -172.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 54' ' ' ALA . . . . . 0.415 ' HB2' HG12 ' E' ' 63' ' ' VAL . . . -156.71 151.56 25.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.286 -178.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 99.9 m -114.82 101.64 9.25 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 169.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.92 114.07 45.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.626 0.727 . . . . 0.0 109.818 -177.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 75.4 p -123.23 -177.77 3.79 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.545 -174.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 58' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' E' ' 38' ' ' GLN . 28.8 mtpp -57.2 -36.25 70.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.074 0.464 . . . . 0.0 110.276 169.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.3 -41.13 66.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.508 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 76.4 mt -115.78 82.7 10.74 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.12 0.48 6.58 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.865 2.376 . . . . 0.0 113.707 -168.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -162.65 128.1 3.3 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.247 0.546 . . . . 0.0 111.048 -176.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . 0.415 HG12 ' HB2' ' E' ' 54' ' ' ALA . 92.7 t -114.32 111.35 35.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.412 174.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.96 112.13 23.88 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.602 174.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' E' ' 30' ' ' SER . 0.3 OUTLIER -130.51 168.44 17.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.095 0.474 . . . . 0.0 111.515 -175.541 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 66' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 6.5 t0 -115.22 99.97 7.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.322 0.582 . . . . 0.0 110.343 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 67' ' ' LEU . . . . . 0.567 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 17.7 mt -114.61 141.35 47.89 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.621 177.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 68' ' ' ASN . . . . . 0.442 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 6.3 t30 -146.69 115.2 6.74 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.99 0.424 . . . . 0.0 110.086 174.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -110.11 159.91 16.93 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.029 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 10.2 p -112.47 149.56 32.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.47 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.41 10.4 0.62 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -175.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.67 -21.39 14.51 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.116 176.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -101.23 171.34 7.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.75 0.309 . . . . 0.0 110.865 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 -137.76 129.4 28.3 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 75' ' ' ILE . . . . . . . . . . . . . 14.6 pt -129.21 162.96 35.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.012 0.434 . . . . 0.0 111.726 -169.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 76' ' ' MET . . . . . 0.515 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 4.8 mtm -118.38 122.91 43.98 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 175.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 77' ' ' PHE . . . . . 1.664 ' HE1' ' CE2' ' E' ' 77' ' ' PHE . 1.0 OUTLIER -105.12 127.59 52.97 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.295 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 78' ' ' TYR . . . . . 1.666 ' HD2' ' CD1' ' E' ' 78' ' ' TYR . 49.6 p90 -155.82 150.59 26.23 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.536 -177.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 79' ' ' THR . . . . . 0.721 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 11.3 p -117.2 149.14 40.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.828 0.347 . . . . 0.0 111.684 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.11 144.58 42.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.301 175.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.3 177.0 34.52 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -106.6 102.82 12.17 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.965 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 83' ' ' ALA . . . . . 0.458 ' H ' ' HB3' ' E' ' 15' ' ' PRO . . . -170.77 151.22 3.4 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.595 169.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 23.7 t -108.17 121.48 44.94 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 85' ' ' VAL . . . . . 0.503 HG22 ' HB3' ' E' ' 13' ' ' MET . 11.5 m -118.36 146.2 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 CA-C-O 121.382 0.61 . . . . 0.0 111.69 -173.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 15.3 t -111.94 120.92 43.55 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 87' ' ' LEU . . . . . 0.554 ' HB2' ' HB3' ' E' ' 11' ' ' LEU . 5.1 mp -92.95 151.68 19.78 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.652 174.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . 0.481 ' CD2' HG11 ' A' ' 53' ' ' VAL . 1.6 tp -133.6 141.1 47.51 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.203 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.16 -166.64 26.58 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.891 -176.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 90' ' ' TYR . . . . . 1.608 ' HE2' ' CE1' ' E' ' 90' ' ' TYR . 8.2 p90 -150.91 130.11 12.72 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.694 0.759 . . . . 0.0 111.804 176.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 91' ' ' LEU . . . . . 0.406 ' HA ' ' CB ' ' E' ' 27' ' ' PHE . 5.3 mt -72.89 136.24 45.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.903 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -79.25 108.94 13.12 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 93' ' ' ASP . . . . . 0.402 ' OD2' ' HE3' ' E' ' 25' ' ' LYS . 7.8 t70 -114.78 -177.11 3.05 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.687 -176.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 94' ' ' ILE . . . . . 0.434 HD13 ' N ' ' E' ' 94' ' ' ILE . 4.2 mp -105.27 -35.94 3.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 25.3 t70 65.92 135.57 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.355 -176.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 11.2 p -88.7 6.55 38.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.884 -176.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.59 -64.95 3.76 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.562 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 15.4 p . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.864 -0.588 . . . . 0.0 109.768 176.927 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 96' ' ' SER . 95.7 m-85 . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -157.72 64.21 0.47 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.38 0.61 . . . . 0.0 110.021 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.48 -21.59 37.1 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.964 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 55.67 73.9 0.4 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.473 0.654 . . . . 0.0 111.047 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 20.3 ptm -105.35 59.95 0.67 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.08 -176.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.476 ' HB1' ' ND2' ' B' ' 68' ' ' ASN . . . -54.55 140.28 35.3 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.715 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.503 ' HA ' ' HB2' ' B' ' 70' ' ' SER . 11.4 ttt -104.39 134.3 47.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.059 0.457 . . . . 0.0 111.898 -170.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 1.662 ' HE1' ' CE2' ' A' ' 8' ' ' PHE . 62.3 t80 -55.91 143.93 30.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.458 -175.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.428 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 89.8 t90 -137.47 150.18 47.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.052 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.591 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -150.84 159.78 28.31 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.086 177.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 36.8 tp -148.4 108.21 4.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.835 0.35 . . . . 0.0 111.066 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -92.37 103.75 16.16 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.017 0.437 . . . . 0.0 110.076 174.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.653 ' SD ' HD12 ' A' ' 87' ' ' LEU . 53.4 mtp -94.99 144.94 25.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.132 -175.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -100.45 149.36 36.03 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.853 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 11.6 Cg_endo -55.69 121.9 10.77 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 123.265 2.643 . . . . 0.0 113.294 -176.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 79' ' ' THR . 49.9 mt-10 60.84 57.28 2.67 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.532 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.425 ' HB3' ' HH ' ' A' ' 19' ' ' TYR . 12.1 tpt180 -132.54 142.74 49.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.166 175.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.625 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 35.6 ttmt -118.45 116.33 26.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.869 0.366 . . . . 0.0 111.648 -174.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 1.659 ' HE2' ' CE1' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -112.25 110.3 20.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.992 178.298 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.7 p -77.35 122.17 24.76 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 173.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -99.63 128.51 45.74 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.884 -167.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.5 p -98.77 125.19 44.05 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 169.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.3 mt -96.41 118.72 43.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.326 0.584 . . . . 0.0 111.749 -172.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.415 HD13 ' N ' ' A' ' 24' ' ' ILE . 4.1 mp -93.94 -44.93 13.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.662 178.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -118.68 140.36 50.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.543 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.8 t -62.64 114.37 3.54 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 173.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 1.669 ' HE2' ' CE1' ' A' ' 27' ' ' PHE . 6.1 p90 -130.02 148.63 51.89 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.531 -0.868 . . . . 0.0 112.937 -170.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.565 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 17.6 t60 -106.08 125.68 51.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.242 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 46.9 mt -97.69 132.61 42.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 170.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.565 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 42.6 p -116.25 -14.71 11.07 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -170.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -164.56 152.49 22.21 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 119.232 -1.461 . . . . 0.0 113.411 178.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.01 122.82 23.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 172.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.61 156.14 46.35 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 122.148 -0.345 . . . . 0.0 111.394 -174.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.7 pp -115.15 141.28 48.23 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.838 0.827 . . . . 0.0 112.071 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -106.45 -57.3 2.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.055 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -102.6 127.46 49.68 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 169.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.468 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 153.4 160.61 9.82 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 119.338 -1.41 . . . . 0.0 113.749 176.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.59 ' O ' ' HG3' ' A' ' 58' ' ' LYS . 19.1 tt0 -102.22 -46.97 4.67 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.608 -0.296 . . . . 0.0 110.409 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.434 ' OE2' ' HG2' ' A' ' 38' ' ' GLN . 6.9 mp0 -152.25 129.52 11.25 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.383 176.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.476 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . . . -125.96 119.53 27.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.352 0.596 . . . . 0.0 110.237 171.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -104.47 108.95 20.62 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.5 tp -84.9 115.0 22.53 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.248 -173.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.51 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 91.9 m-85 -116.33 145.52 43.13 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' A' ' 76' ' ' MET . 0.2 OUTLIER -131.67 128.53 39.23 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 171.33 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.523 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -106.62 122.77 47.01 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.667 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.16 125.23 34.51 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 61.42 36.46 17.29 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -171.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.494 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 14.9 tmtt? 73.59 -7.5 1.56 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.383 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.523 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 24.1 tp60 -80.36 114.54 19.33 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 -177.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -81.32 110.14 16.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.937 0.399 . . . . 0.0 110.387 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 1.637 ' HD1' ' CD2' ' A' ' 51' ' ' TYR . 82.2 m-85 -99.34 129.95 45.59 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.259 177.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.27 99.46 4.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 171.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.449 HG11 ' CD2' ' E' ' 88' ' ' LEU . 2.4 t -74.67 -50.01 27.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.439 -171.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.423 ' HB3' ' CD2' ' A' ' 65' ' ' LEU . . . -158.27 138.94 12.85 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.404 -177.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.4 m -103.05 102.05 12.06 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 171.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.413 HG11 ' HB1' ' A' ' 40' ' ' ALA . 7.2 p -113.54 110.24 31.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.884 0.85 . . . . 0.0 109.814 -177.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 81.3 p -122.98 -176.97 3.54 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.137 -174.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.59 ' HG3' ' O ' ' A' ' 38' ' ' GLN . 9.7 mtmp? -56.72 -35.08 68.13 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.086 0.47 . . . . 0.0 110.288 169.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.3 -40.57 64.42 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.603 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 77.9 mt -117.11 80.49 11.78 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.16 -0.0 6.6 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.079 2.519 . . . . 0.0 113.264 -169.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -164.14 118.76 1.49 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.237 0.541 . . . . 0.0 110.948 -174.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.404 HG12 ' HB2' ' A' ' 54' ' ' ALA . 58.7 t -108.85 108.59 25.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.371 175.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.5 117.37 27.4 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.795 174.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.423 ' CD2' ' HB3' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -136.39 168.47 19.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.457 -176.013 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.48 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 8.9 t0 -113.96 99.47 7.69 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.204 0.526 . . . . 0.0 110.292 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.541 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 19.5 mt -112.66 142.01 45.76 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.486 177.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.449 ' ND2' ' HB1' ' E' ' 6' ' ' ALA . 63.0 t30 -150.63 115.75 5.35 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 174.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 1.65 ' HD1' ' CD2' ' A' ' 69' ' ' PHE . 32.9 m-85 -110.28 158.73 18.08 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.943 -177.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.49 ' HB2' ' HA ' ' E' ' 7' ' ' MET . 8.6 t -110.57 158.71 18.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.226 0.536 . . . . 0.0 110.646 -176.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -70.57 -4.69 24.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.637 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.43 -26.86 14.33 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.487 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -100.69 168.24 9.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.003 0.43 . . . . 0.0 110.955 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.7 mtm180 -136.84 143.7 43.22 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.2 pt -140.0 176.07 5.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.123 -172.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.544 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 9.2 mtm -134.03 131.8 39.3 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 171.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.441 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 1.2 m-85 -108.33 128.22 54.56 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.625 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 38.9 p90 -152.84 136.27 15.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.303 0.573 . . . . 0.0 111.714 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 2.1 p -111.13 133.16 53.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.22 -177.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.28 168.29 9.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.748 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.94 -170.33 43.42 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 -177.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -114.9 102.65 10.18 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 117.708 0.754 . . . . 0.0 109.702 174.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.514 ' H ' ' HB3' ' A' ' 15' ' ' PRO . . . -173.82 152.4 1.99 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.502 170.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.0 t -111.64 122.06 46.8 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.3 m -113.51 156.95 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 CA-C-O 121.546 0.688 . . . . 0.0 112.566 -172.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.9 t -123.63 113.84 19.2 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.595 177.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.653 HD12 ' SD ' ' A' ' 13' ' ' MET . 5.0 mp -90.15 153.57 20.42 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.106 0.479 . . . . 0.0 109.846 174.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.457 ' CD2' HG11 ' B' ' 53' ' ' VAL . 1.0 OUTLIER -133.49 139.34 46.6 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.093 -179.467 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.83 -166.85 24.45 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.886 -177.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -152.79 131.27 12.18 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.735 0.778 . . . . 0.0 111.856 176.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.7 mt -69.99 133.34 47.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.056 -1.429 . . . . 0.0 109.306 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -70.51 129.52 39.45 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -83.05 164.88 20.04 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.805 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 18.1 mt -127.5 49.85 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.473 0.654 . . . . 0.0 109.268 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -63.66 -32.04 73.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.042 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 1' ' ' PHE . 40.6 m -82.56 51.0 1.76 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.666 176.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -178.59 -52.02 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.136 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.396 178.793 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.467 ' O ' ' HA ' ' B' ' 96' ' ' SER . 95.6 m-85 . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -157.75 64.27 0.47 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.404 0.621 . . . . 0.0 110.052 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.48 -21.56 37.19 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.957 177.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . 55.59 73.95 0.4 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.395 0.617 . . . . 0.0 111.075 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 20.3 ptm -105.36 59.81 0.67 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.013 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.473 ' HB1' ' ND2' ' C' ' 68' ' ' ASN . . . -54.43 140.27 34.55 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.73 178.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' MET . . . . . 0.49 ' HA ' ' HB2' ' C' ' 70' ' ' SER . 11.5 ttt -104.47 134.27 47.95 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.076 0.465 . . . . 0.0 111.774 -170.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 1.643 ' HE1' ' CE2' ' B' ' 8' ' ' PHE . 62.2 t80 -55.9 143.94 29.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.477 -175.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . 0.424 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 89.8 t90 -137.48 150.16 47.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.95 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.612 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -150.87 159.75 28.3 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.092 177.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.441 ' HB3' ' HB2' ' B' ' 87' ' ' LEU . 37.0 tp -148.32 108.24 4.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.864 0.364 . . . . 0.0 111.077 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -92.46 103.81 16.2 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.963 0.411 . . . . 0.0 110.011 174.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' MET . . . . . 0.648 ' SD ' HD12 ' B' ' 87' ' ' LEU . 53.7 mtp -95.11 144.95 25.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.06 -175.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -100.35 149.45 36.08 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.834 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.513 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 11.4 Cg_endo -55.85 121.81 10.63 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.283 2.655 . . . . 0.0 113.255 -176.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' B' ' 79' ' ' THR . 49.7 mt-10 60.9 57.38 2.61 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.49 178.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.415 ' HB3' ' HH ' ' B' ' 19' ' ' TYR . 12.2 tpt180 -132.6 142.63 49.22 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.207 175.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . 0.615 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 35.6 ttmt -118.38 116.25 26.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.804 0.335 . . . . 0.0 111.722 -174.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' TYR . . . . . 1.656 ' HE2' ' CE1' ' B' ' 19' ' ' TYR . 0.9 OUTLIER -112.2 110.35 20.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.023 178.309 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 4.7 p -77.27 122.29 24.88 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 173.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -99.74 128.6 45.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.815 -167.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 28.5 p -98.73 125.12 43.97 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 169.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 43.5 mt -96.46 118.65 43.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.256 0.551 . . . . 0.0 111.744 -172.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.409 HD13 ' N ' ' B' ' 24' ' ' ILE . 4.1 mp -93.84 -45.0 13.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.652 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -118.61 140.54 49.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.479 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 11.3 t -62.67 114.38 3.56 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 173.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . 1.631 ' HE2' ' CE1' ' B' ' 27' ' ' PHE . 6.0 p90 -130.02 148.73 51.91 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.502 -0.879 . . . . 0.0 112.923 -170.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' HIS . . . . . 0.562 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 17.9 t60 -106.15 125.65 51.25 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.194 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 47.5 mt -97.69 132.6 42.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 170.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.562 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 43.1 p -116.25 -14.75 11.07 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -170.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -164.55 152.45 22.15 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 119.322 -1.418 . . . . 0.0 113.464 178.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 8.7 p -137.91 122.78 23.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 172.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.63 156.15 46.34 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.335 -174.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 3.7 pp -115.18 141.37 48.11 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.853 0.835 . . . . 0.0 112.053 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -106.54 -57.32 2.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.044 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -102.64 127.42 49.76 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 169.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.474 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 153.52 160.67 9.87 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 119.311 -1.423 . . . . 0.0 113.729 176.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . 0.586 ' O ' ' HG3' ' B' ' 58' ' ' LYS . 19.0 tt0 -102.22 -47.0 4.66 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 120.784 0.326 . . . . 0.0 110.426 177.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.439 ' OE2' ' HG2' ' B' ' 38' ' ' GLN . 6.9 mp0 -152.27 129.52 11.24 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.352 177.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.481 ' HB3' ' HB1' ' B' ' 83' ' ' ALA . . . -126.02 119.48 27.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.355 0.598 . . . . 0.0 110.305 171.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -104.5 108.92 20.59 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 43.7 tp -84.82 115.02 22.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.33 -173.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . 0.512 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 91.6 m-85 -116.31 145.48 43.15 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 175.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.2 OUTLIER -131.63 128.46 39.16 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 171.337 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -106.64 122.95 47.36 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.6 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.19 125.26 34.52 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 175.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 61.37 36.44 17.47 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 123.532 0.52 . . . . 0.0 109.698 -171.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' B' ' 48' ' ' LYS . 14.9 tmtt? 73.6 -7.54 1.55 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.407 178.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.527 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 24.3 tp60 -80.46 114.61 19.48 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -177.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -81.42 110.2 16.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.993 0.425 . . . . 0.0 110.307 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 1.633 ' HD1' ' CD2' ' B' ' 51' ' ' TYR . 82.2 m-85 -99.37 129.93 45.61 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.293 177.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.28 99.44 4.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 171.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.457 HG11 ' CD2' ' A' ' 88' ' ' LEU . 2.4 t -74.63 -50.06 27.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.412 -171.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.426 ' HB3' ' CD2' ' B' ' 65' ' ' LEU . . . -158.25 138.92 12.84 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.429 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 23.2 m -103.06 102.04 12.04 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 171.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . 0.428 HG11 ' HB1' ' B' ' 40' ' ' ALA . 7.3 p -113.46 110.19 31.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.796 0.808 . . . . 0.0 109.928 -177.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 81.5 p -122.96 -176.89 3.52 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.128 -174.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . 0.586 ' HG3' ' O ' ' B' ' 38' ' ' GLN . 9.7 mtmp? -56.77 -34.99 68.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.086 0.47 . . . . 0.0 110.372 169.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.5 -40.48 64.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.505 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 77.6 mt -117.16 80.57 12.04 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 173.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.15 -0.06 6.67 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.985 2.457 . . . . 0.0 113.251 -169.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -164.14 118.67 1.48 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.228 0.537 . . . . 0.0 111.111 -174.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.406 HG12 ' HB2' ' B' ' 54' ' ' ALA . 58.6 t -108.78 108.58 25.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.366 175.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.43 117.45 27.37 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.851 174.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.426 ' CD2' ' HB3' ' B' ' 54' ' ' ALA . 0.3 OUTLIER -136.53 168.43 19.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.459 -176.013 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . 0.518 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 8.9 t0 -113.88 99.46 7.69 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.175 0.512 . . . . 0.0 110.328 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.561 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 19.5 mt -112.77 142.06 45.85 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.409 177.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . 0.476 ' ND2' ' HB1' ' A' ' 6' ' ' ALA . 63.1 t30 -150.6 115.87 5.39 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 174.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . 1.655 ' HD2' ' CD1' ' B' ' 69' ' ' PHE . 32.6 m-85 -110.32 158.78 18.06 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.906 -177.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.503 ' HB2' ' HA ' ' A' ' 7' ' ' MET . 8.6 t -110.63 158.65 18.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.239 0.543 . . . . 0.0 110.627 -176.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -70.53 -4.76 24.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.67 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.35 -26.97 14.13 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.404 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -100.61 168.31 9.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.12 0.486 . . . . 0.0 110.92 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 73.7 mtm180 -136.94 143.55 42.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.1 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 13.1 pt -139.85 175.98 6.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.59 0.233 . . . . 0.0 111.141 -172.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' MET . . . . . 0.54 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 9.2 mtm -133.97 131.81 39.43 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 171.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . 0.452 ' CD1' ' HB2' ' B' ' 44' ' ' LEU . 1.2 m-85 -108.35 128.2 54.55 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 0.615 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 38.8 p90 -152.84 136.27 15.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.341 0.591 . . . . 0.0 111.765 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 2.1 p -111.12 133.13 53.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.185 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.24 168.27 9.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.795 177.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.98 -170.31 43.32 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -115.04 102.72 10.2 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.659 174.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.513 ' H ' ' HB3' ' B' ' 15' ' ' PRO . . . -173.88 152.28 1.94 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.511 170.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 32.0 t -111.47 122.1 46.94 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 4.3 m -113.59 156.85 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-O 121.471 0.653 . . . . 0.0 112.567 -172.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 14.8 t -123.54 113.87 19.29 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.667 177.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.648 HD12 ' SD ' ' B' ' 13' ' ' MET . 5.0 mp -90.15 153.55 20.44 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 121.078 0.466 . . . . 0.0 109.887 174.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.45 ' CD2' HG11 ' C' ' 53' ' ' VAL . 1.0 OUTLIER -133.47 139.38 46.64 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.023 -179.43 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.87 -166.85 24.51 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.913 -177.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -152.73 131.31 12.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.751 0.786 . . . . 0.0 111.763 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 5.7 mt -70.05 133.32 47.08 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.078 -1.419 . . . . 0.0 109.301 174.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -70.44 129.43 39.25 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.961 0.41 . . . . 0.0 110.012 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -82.99 164.79 20.16 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.811 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 17.9 mt -127.44 49.87 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.533 0.683 . . . . 0.0 109.276 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -63.58 -32.06 73.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.08 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' B' ' 1' ' ' PHE . 40.3 m -82.61 50.99 1.77 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.527 0.679 . . . . 0.0 110.675 176.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . -178.61 -52.1 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.123 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 11.4 t . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.311 178.789 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 1' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' C' ' 96' ' ' SER . 95.4 m-85 . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -157.82 64.32 0.47 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.418 0.628 . . . . 0.0 110.046 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.55 -21.65 36.69 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.905 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . 55.69 73.9 0.4 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.38 0.609 . . . . 0.0 111.075 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 20.3 ptm -105.38 59.88 0.67 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.049 -176.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 6' ' ' ALA . . . . . 0.491 ' HB1' ' ND2' ' D' ' 68' ' ' ASN . . . -54.4 140.21 34.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.761 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 7' ' ' MET . . . . . 0.477 ' HA ' ' HB2' ' D' ' 70' ' ' SER . 11.5 ttt -104.45 134.38 47.75 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.057 0.456 . . . . 0.0 111.854 -170.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 8' ' ' PHE . . . . . 1.651 ' HD1' ' CD2' ' C' ' 8' ' ' PHE . 62.4 t80 -55.93 143.86 30.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.53 -175.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . 0.416 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 90.1 t90 -137.46 150.18 47.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.976 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . 0.574 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -150.88 159.63 28.24 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.098 177.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.451 ' HB3' ' HB2' ' C' ' 87' ' ' LEU . 37.3 tp -148.26 108.21 4.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.827 0.346 . . . . 0.0 111.178 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -92.4 103.78 16.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.076 0.465 . . . . 0.0 110.005 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 13' ' ' MET . . . . . 0.644 ' SD ' HD12 ' C' ' 87' ' ' LEU . 53.2 mtp -95.0 144.99 25.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.118 -175.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -100.43 149.42 36.08 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.86 177.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . 0.514 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 11.6 Cg_endo -55.83 121.85 10.71 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.254 2.636 . . . . 0.0 113.253 -176.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' C' ' 79' ' ' THR . 49.9 mt-10 60.9 57.28 2.64 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.564 178.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 17' ' ' ARG . . . . . 0.431 ' HB3' ' HH ' ' C' ' 19' ' ' TYR . 12.1 tpt180 -132.55 142.6 49.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.253 175.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 18' ' ' LYS . . . . . 0.62 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 35.5 ttmt -118.37 116.41 26.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.859 0.362 . . . . 0.0 111.721 -174.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . 1.66 ' HD1' ' CD2' ' C' ' 19' ' ' TYR . 0.9 OUTLIER -112.27 110.36 20.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.029 178.313 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -77.3 122.15 24.7 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 173.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -99.58 128.54 45.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.85 -167.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 28.0 p -98.7 125.01 43.89 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 169.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mt -96.43 118.72 43.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.2 0.524 . . . . 0.0 111.738 -172.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . 0.41 HD13 ' N ' ' C' ' 24' ' ' ILE . 4.1 mp -93.9 -44.97 13.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.649 178.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -118.64 140.39 49.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.539 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 11.6 t -62.58 114.3 3.48 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 173.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 27' ' ' PHE . . . . . 1.607 ' HD2' ' CD1' ' C' ' 27' ' ' PHE . 6.1 p90 -130.05 148.62 51.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.888 0.851 . . . . 0.0 112.947 -170.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 28' ' ' HIS . . . . . 0.565 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 17.7 t60 -106.08 125.6 51.19 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.158 -1.383 . . . . 0.0 110.201 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . 0.547 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 46.8 mt -97.7 132.63 42.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 170.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 30' ' ' SER . . . . . 0.565 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 42.4 p -116.31 -14.65 11.04 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -170.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -164.63 152.47 22.17 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 119.304 -1.427 . . . . 0.0 113.438 178.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 8.7 p -138.0 122.76 23.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 172.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.63 156.18 46.33 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.091 -0.38 . . . . 0.0 111.328 -174.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 3.7 pp -115.12 141.35 48.13 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.786 0.803 . . . . 0.0 112.129 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -106.58 -57.31 2.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.98 176.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -102.68 127.41 49.81 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 169.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 37' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 153.56 160.69 9.89 Favored Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 119.357 -1.402 . . . . 0.0 113.724 176.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 38' ' ' GLN . . . . . 0.6 ' O ' ' HG3' ' C' ' 58' ' ' LYS . 19.0 tt0 -102.22 -47.03 4.65 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 120.701 0.286 . . . . 0.0 110.467 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . 0.439 ' OE2' ' HG2' ' C' ' 38' ' ' GLN . 6.8 mp0 -152.26 129.52 11.25 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.412 176.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . 0.47 ' HB3' ' HB1' ' C' ' 83' ' ' ALA . . . -125.95 119.56 28.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.35 0.595 . . . . 0.0 110.296 171.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -104.54 108.88 20.55 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 43.5 tp -84.84 115.04 22.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.261 -173.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 43' ' ' TYR . . . . . 0.497 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 91.5 m-85 -116.33 145.5 43.15 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 175.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' C' ' 76' ' ' MET . 0.2 OUTLIER -131.69 128.48 39.07 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 171.434 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -106.55 122.9 47.25 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.633 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.3 125.16 34.05 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 61.46 36.42 17.19 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -171.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . 0.498 ' HD3' ' O ' ' C' ' 48' ' ' LYS . 14.9 tmtt? 73.72 -7.67 1.54 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.351 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . 0.53 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 24.8 tp60 -80.36 114.59 19.37 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.887 -0.508 . . . . 0.0 109.69 -177.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -81.28 110.1 16.42 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.343 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 1.643 ' HD1' ' CD2' ' C' ' 51' ' ' TYR . 82.2 m-85 -99.36 129.89 45.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.278 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.22 99.44 3.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 171.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 53' ' ' VAL . . . . . 0.45 HG11 ' CD2' ' B' ' 88' ' ' LEU . 2.4 t -74.64 -50.12 27.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.39 -171.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 54' ' ' ALA . . . . . 0.428 ' HB3' ' CD2' ' C' ' 65' ' ' LEU . . . -158.16 138.95 12.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.454 -177.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 23.5 m -103.05 102.09 12.09 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 171.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . 0.421 HG11 ' HB1' ' C' ' 40' ' ' ALA . 7.2 p -113.59 110.15 31.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.846 0.831 . . . . 0.0 109.889 -177.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 81.7 p -123.02 -177.01 3.55 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.124 -174.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 58' ' ' LYS . . . . . 0.6 ' HG3' ' O ' ' C' ' 38' ' ' GLN . 9.7 mtmp? -56.58 -35.11 67.82 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.058 0.456 . . . . 0.0 110.38 169.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.37 -40.55 64.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.514 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 77.9 mt -117.21 80.58 12.22 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 174.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.21 -0.07 6.74 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.053 2.502 . . . . 0.0 113.187 -169.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -164.12 118.68 1.49 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.139 0.495 . . . . 0.0 111.076 -174.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.408 HG12 ' HB2' ' C' ' 54' ' ' ALA . 58.9 t -108.79 108.65 25.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.281 175.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.53 117.41 27.46 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.772 174.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . 0.428 ' CD2' ' HB3' ' C' ' 54' ' ' ALA . 0.3 OUTLIER -136.39 168.49 19.35 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.497 -176.073 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 66' ' ' ASP . . . . . 0.48 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 8.9 t0 -114.02 99.58 7.76 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.306 0.574 . . . . 0.0 110.203 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . 0.547 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 19.6 mt -112.74 141.96 45.92 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.468 177.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . 0.473 ' ND2' ' HB1' ' B' ' 6' ' ' ALA . 63.2 t30 -150.58 115.78 5.37 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 174.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 69' ' ' PHE . . . . . 1.669 ' HE2' ' CE1' ' C' ' 69' ' ' PHE . 32.7 m-85 -110.26 158.76 18.04 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.937 -177.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 70' ' ' SER . . . . . 0.49 ' HB2' ' HA ' ' B' ' 7' ' ' MET . 8.7 t -110.65 158.7 18.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.23 0.538 . . . . 0.0 110.654 -176.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -70.6 -4.67 24.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.596 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.51 -26.81 14.37 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.483 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -100.81 168.24 9.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.019 0.437 . . . . 0.0 110.846 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 73.7 mtm180 -136.86 143.59 43.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.136 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 13.2 pt -139.83 176.11 6.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.614 0.245 . . . . 0.0 111.128 -172.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 76' ' ' MET . . . . . 0.544 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 9.2 mtm -134.1 131.81 39.19 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 171.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 77' ' ' PHE . . . . . 0.441 ' CD1' ' HB2' ' C' ' 44' ' ' LEU . 1.2 m-85 -108.34 128.24 54.58 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 78' ' ' TYR . . . . . 0.62 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 38.9 p90 -152.8 136.32 15.97 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.37 0.605 . . . . 0.0 111.777 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 79' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 2.1 p -111.1 133.11 53.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.217 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.31 168.33 9.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.763 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.77 -170.26 43.68 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -114.97 102.7 10.21 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.651 174.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . 0.514 ' H ' ' HB3' ' C' ' 15' ' ' PRO . . . -173.83 152.34 1.97 Allowed 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.942 -1.027 . . . . 0.0 109.473 170.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 32.1 t -111.47 122.16 47.09 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 4.3 m -113.71 156.91 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-O 121.564 0.697 . . . . 0.0 112.537 -172.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 15.1 t -123.62 113.84 19.2 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.637 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . 0.644 HD12 ' SD ' ' C' ' 13' ' ' MET . 5.0 mp -90.08 153.55 20.46 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.07 0.462 . . . . 0.0 109.913 174.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . 0.445 ' CD2' HG11 ' D' ' 53' ' ' VAL . 1.0 OUTLIER -133.5 139.34 46.59 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.051 -179.422 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.86 -166.81 24.43 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.875 -177.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -152.79 131.27 12.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.809 0.814 . . . . 0.0 111.812 176.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 5.8 mt -70.14 133.37 47.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.007 -1.452 . . . . 0.0 109.253 175.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -70.37 129.52 39.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.913 0.387 . . . . 0.0 109.974 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -83.06 164.87 20.03 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.838 177.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 18.2 mt -127.54 49.84 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.523 0.678 . . . . 0.0 109.238 176.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -63.47 -32.22 73.6 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.072 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 96' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' C' ' 1' ' ' PHE . 40.5 m -82.51 51.01 1.75 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.668 176.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -178.65 -51.95 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.116 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 11.5 t . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.405 178.795 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' D' ' 96' ' ' SER . 95.5 m-85 . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -157.69 64.33 0.47 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.381 0.61 . . . . 0.0 110.003 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.51 -21.63 36.89 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.901 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . 55.64 73.84 0.41 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.385 0.612 . . . . 0.0 111.1 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 20.3 ptm -105.2 59.85 0.68 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.084 -176.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 6' ' ' ALA . . . . . 0.505 ' HB1' ' ND2' ' E' ' 68' ' ' ASN . . . -54.47 140.31 34.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.788 178.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 7' ' ' MET . . . . . 0.474 ' HA ' ' HB2' ' E' ' 70' ' ' SER . 11.5 ttt -104.53 134.28 47.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.038 0.446 . . . . 0.0 111.783 -170.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 8' ' ' PHE . . . . . 1.672 ' HE2' ' CE1' ' D' ' 8' ' ' PHE . 62.4 t80 -55.97 143.86 30.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.51 -175.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 9' ' ' TRP . . . . . 0.421 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 90.0 t90 -137.43 150.06 47.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.022 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . 0.578 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -150.83 159.71 28.28 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.098 177.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . 0.448 ' HB3' ' HB2' ' D' ' 87' ' ' LEU . 36.7 tp -148.35 108.18 4.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.834 0.349 . . . . 0.0 111.03 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -92.28 103.82 16.24 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.988 0.423 . . . . 0.0 109.975 174.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 13' ' ' MET . . . . . 0.649 ' SD ' HD12 ' D' ' 87' ' ' LEU . 53.8 mtp -95.12 145.01 25.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.12 -175.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -100.47 149.42 36.08 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.86 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . 0.506 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 11.5 Cg_endo -55.76 121.72 10.46 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 123.314 2.676 . . . . 0.0 113.319 -176.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' D' ' 79' ' ' THR . 49.8 mt-10 60.89 57.45 2.6 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.465 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 17' ' ' ARG . . . . . 0.431 ' HB3' ' HH ' ' D' ' 19' ' ' TYR . 12.1 tpt180 -132.64 142.66 49.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.202 175.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . 0.629 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 35.5 ttmt -118.41 116.26 26.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.86 0.362 . . . . 0.0 111.756 -175.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 19' ' ' TYR . . . . . 1.668 ' HE1' ' CE2' ' D' ' 19' ' ' TYR . 0.9 OUTLIER -112.09 110.25 20.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.095 178.272 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 4.7 p -77.17 122.22 24.72 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 173.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -99.67 128.45 45.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.886 -167.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 28.4 p -98.72 125.15 43.96 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 169.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 44.0 mt -96.41 118.58 43.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.205 0.526 . . . . 0.0 111.731 -172.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . 0.418 ' N ' HD13 ' D' ' 24' ' ' ILE . 4.1 mp -93.83 -44.98 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.673 178.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -118.65 140.44 49.91 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.491 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 11.6 t -62.65 114.37 3.54 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 173.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 27' ' ' PHE . . . . . 1.619 ' HE2' ' CE1' ' D' ' 27' ' ' PHE . 6.1 p90 -129.97 148.64 51.85 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.607 -0.837 . . . . 0.0 112.99 -170.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 28' ' ' HIS . . . . . 0.565 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 18.0 t60 -106.1 125.7 51.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.184 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 29' ' ' ILE . . . . . 0.544 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 46.8 mt -97.7 132.48 42.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 170.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 30' ' ' SER . . . . . 0.565 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 42.5 p -116.23 -14.65 11.09 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -170.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 31' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -164.58 152.48 22.2 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 119.278 -1.439 . . . . 0.0 113.453 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 8.6 p -137.97 122.86 23.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 172.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.63 156.07 46.36 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 122.153 -0.342 . . . . 0.0 111.414 -174.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 34' ' ' LEU . . . . . . . . . . . . . 3.7 pp -115.1 141.34 48.15 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.818 0.818 . . . . 0.0 112.126 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -106.51 -57.27 2.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.024 176.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -102.64 127.35 49.78 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 169.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . 0.471 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 153.5 160.61 9.83 Favored Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 119.278 -1.439 . . . . 0.0 113.711 176.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 38' ' ' GLN . . . . . 0.598 ' O ' ' HG3' ' D' ' 58' ' ' LYS . 19.1 tt0 -102.21 -46.98 4.66 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.579 -0.311 . . . . 0.0 110.391 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . 0.44 ' OE2' ' HG2' ' D' ' 38' ' ' GLN . 6.9 mp0 -152.27 129.45 11.18 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.417 176.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . 0.467 ' HB3' ' HB1' ' D' ' 83' ' ' ALA . . . -125.97 119.63 28.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.4 0.619 . . . . 0.0 110.218 171.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -104.51 109.01 20.73 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 43.8 tp -84.99 114.97 22.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.218 -173.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 43' ' ' TYR . . . . . 0.512 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 91.6 m-85 -116.26 145.51 43.1 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 175.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.546 ' HA ' ' O ' ' D' ' 76' ' ' MET . 0.2 OUTLIER -131.66 128.47 39.11 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 171.367 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 45' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -106.57 122.93 47.3 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.654 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.3 125.14 34.01 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 61.47 36.4 17.17 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -171.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 48' ' ' LYS . . . . . 0.503 ' HD3' ' O ' ' D' ' 48' ' ' LYS . 14.9 tmtt? 73.69 -7.54 1.56 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.307 178.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . 0.525 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 24.5 tp60 -80.37 114.56 19.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -177.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -81.32 110.11 16.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.424 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . 1.645 ' HD1' ' CD2' ' D' ' 51' ' ' TYR . 82.1 m-85 -99.32 129.95 45.57 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.225 177.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.24 99.42 3.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 171.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 53' ' ' VAL . . . . . 0.445 HG11 ' CD2' ' C' ' 88' ' ' LEU . 2.4 t -74.69 -50.08 27.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.376 -171.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 54' ' ' ALA . . . . . 0.422 ' HB3' ' CD2' ' D' ' 65' ' ' LEU . . . -158.21 139.02 12.97 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.453 -177.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 22.9 m -103.11 102.1 12.09 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 171.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 56' ' ' VAL . . . . . 0.426 HG11 ' HB1' ' D' ' 40' ' ' ALA . 7.2 p -113.55 110.21 31.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.889 0.852 . . . . 0.0 109.932 -177.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 81.6 p -122.97 -176.95 3.54 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.123 -174.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 58' ' ' LYS . . . . . 0.598 ' HG3' ' O ' ' D' ' 38' ' ' GLN . 9.7 mtmp? -56.64 -35.18 68.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.146 0.498 . . . . 0.0 110.329 169.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.24 -40.72 64.43 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.549 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 77.6 mt -116.93 80.55 11.29 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 173.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.28 0.06 6.6 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.018 2.479 . . . . 0.0 113.238 -169.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -164.19 118.7 1.47 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.267 0.556 . . . . 0.0 111.003 -174.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.414 HG12 ' HB2' ' D' ' 54' ' ' ALA . 58.6 t -108.83 108.58 25.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.299 175.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.55 117.39 27.47 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.83 174.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 65' ' ' LEU . . . . . 0.422 ' CD2' ' HB3' ' D' ' 54' ' ' ALA . 0.3 OUTLIER -136.35 168.51 19.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.465 -175.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 66' ' ' ASP . . . . . 0.494 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 8.8 t0 -114.0 99.61 7.79 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.206 0.527 . . . . 0.0 110.257 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . 0.544 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 19.5 mt -112.78 142.0 45.93 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.468 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 68' ' ' ASN . . . . . 0.491 ' ND2' ' HB1' ' C' ' 6' ' ' ALA . 63.2 t30 -150.58 115.78 5.37 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 174.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 69' ' ' PHE . . . . . 1.67 ' HE1' ' CE2' ' D' ' 69' ' ' PHE . 32.7 m-85 -110.29 158.8 18.02 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.917 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 70' ' ' SER . . . . . 0.477 ' HB2' ' HA ' ' C' ' 7' ' ' MET . 8.6 t -110.68 158.68 18.35 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.212 0.529 . . . . 0.0 110.619 -176.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -70.5 -4.78 24.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.611 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.38 -26.96 14.14 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.49 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -100.66 168.24 9.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.033 0.444 . . . . 0.0 110.923 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -136.8 143.7 43.31 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . . . . . . . . . 13.3 pt -139.96 176.0 6.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.113 -172.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 76' ' ' MET . . . . . 0.546 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 9.2 mtm -134.03 131.82 39.32 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 171.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 77' ' ' PHE . . . . . 0.442 ' CD1' ' HB2' ' D' ' 44' ' ' LEU . 1.2 m-85 -108.28 128.28 54.6 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 78' ' ' TYR . . . . . 0.629 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 39.0 p90 -152.86 136.32 15.91 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.36 0.6 . . . . 0.0 111.734 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 79' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 2.1 p -111.2 133.13 53.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.187 -177.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.25 168.28 9.45 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.777 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.94 -170.24 43.32 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -115.09 102.72 10.19 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 117.723 0.761 . . . . 0.0 109.61 174.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.506 ' H ' ' HB3' ' D' ' 15' ' ' PRO . . . -173.86 152.4 1.97 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.487 170.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 32.0 t -111.55 122.09 46.91 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 4.3 m -113.62 156.85 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.635 0 CA-C-O 121.476 0.655 . . . . 0.0 112.58 -172.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 14.9 t -123.53 113.82 19.23 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.656 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 87' ' ' LEU . . . . . 0.649 HD12 ' SD ' ' D' ' 13' ' ' MET . 5.0 mp -90.09 153.5 20.5 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 121.139 0.495 . . . . 0.0 109.852 174.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . 0.46 ' CD2' HG11 ' E' ' 53' ' ' VAL . 1.0 OUTLIER -133.4 139.44 46.76 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.067 -179.526 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.87 -166.85 24.5 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.838 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -152.8 131.24 12.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.786 0.803 . . . . 0.0 111.843 176.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 5.7 mt -70.08 133.38 47.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.984 -1.462 . . . . 0.0 109.299 175.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -70.45 129.43 39.23 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -82.98 164.76 20.19 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.864 177.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 18.2 mt -127.42 49.89 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.499 0.666 . . . . 0.0 109.222 176.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -63.61 -32.16 73.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.036 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 96' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' D' ' 1' ' ' PHE . 40.8 m -82.52 51.08 1.77 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.69 176.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . -178.7 -51.95 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.126 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 11.3 t . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.34 178.73 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' E' E ' 1' ' ' PHE . . . . . 0.455 ' O ' ' HA ' ' E' ' 96' ' ' SER . 95.6 m-85 . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -157.73 64.47 0.47 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.467 0.651 . . . . 0.0 109.997 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.59 -21.57 36.81 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.96 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . 55.66 73.84 0.41 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.424 0.631 . . . . 0.0 111.078 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 20.2 ptm -105.33 59.87 0.67 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.035 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 6' ' ' ALA . . . . . 0.449 ' HB1' ' ND2' ' A' ' 68' ' ' ASN . . . -54.47 140.26 34.85 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.766 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 7' ' ' MET . . . . . 0.49 ' HA ' ' HB2' ' A' ' 70' ' ' SER . 11.5 ttt -104.43 134.34 47.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.086 0.47 . . . . 0.0 111.825 -170.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 8' ' ' PHE . . . . . 1.66 ' HD1' ' CD2' ' E' ' 8' ' ' PHE . 62.4 t80 -55.95 143.83 30.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.515 -175.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 9' ' ' TRP . . . . . 0.412 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 89.9 t90 -137.4 150.13 47.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.044 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 10' ' ' GLY . . . . . 0.577 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -150.87 159.68 28.27 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.082 177.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . 0.458 ' HB3' ' HB2' ' E' ' 87' ' ' LEU . 37.3 tp -148.29 108.2 4.04 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.808 0.337 . . . . 0.0 111.151 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -92.38 103.78 16.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.081 0.467 . . . . 0.0 110.007 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 13' ' ' MET . . . . . 0.656 ' SD ' HD12 ' E' ' 87' ' ' LEU . 53.1 mtp -95.06 144.99 25.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.099 -175.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -100.48 149.38 36.05 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.787 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . 0.507 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 11.5 Cg_endo -55.75 121.77 10.56 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.29 2.66 . . . . 0.0 113.292 -176.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 16' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' E' ' 79' ' ' THR . 49.8 mt-10 60.95 57.23 2.63 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.505 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 17' ' ' ARG . . . . . 0.428 ' HB3' ' HH ' ' E' ' 19' ' ' TYR . 12.1 tpt180 -132.43 142.67 49.36 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.29 174.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . 0.628 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 35.6 ttmt -118.42 116.3 26.43 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.881 0.372 . . . . 0.0 111.71 -175.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . 1.645 ' HD2' ' CD1' ' E' ' 19' ' ' TYR . 0.9 OUTLIER -112.21 110.33 20.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.013 178.327 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 4.8 p -77.3 122.04 24.56 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 173.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -99.57 128.59 45.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.872 -167.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 27.6 p -98.69 125.06 43.89 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 169.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 44.1 mt -96.43 118.67 43.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.303 0.573 . . . . 0.0 111.691 -172.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . 0.421 ' N ' HD13 ' E' ' 24' ' ' ILE . 4.1 mp -93.94 -44.93 13.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.581 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -118.72 140.32 50.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.471 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 11.3 t -62.53 114.39 3.52 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 173.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 27' ' ' PHE . . . . . 1.661 ' HE2' ' CE1' ' E' ' 27' ' ' PHE . 6.1 p90 -130.04 148.7 51.92 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 119.528 -0.869 . . . . 0.0 112.927 -170.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 28' ' ' HIS . . . . . 0.565 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 17.8 t60 -106.08 125.66 51.26 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.115 -1.402 . . . . 0.0 110.283 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 29' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 47.1 mt -97.7 132.55 42.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 30' ' ' SER . . . . . 0.565 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 44.1 p -116.28 -14.67 11.05 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -170.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 31' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -164.6 152.5 22.21 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 119.206 -1.473 . . . . 0.0 113.431 178.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 8.7 p -138.02 122.78 23.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 172.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.6 156.17 46.35 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.345 -174.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 34' ' ' LEU . . . . . . . . . . . . . 3.7 pp -115.21 141.39 48.08 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.836 0.827 . . . . 0.0 112.093 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -106.57 -57.31 2.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.003 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -102.64 127.4 49.76 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 169.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . 0.47 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 153.55 160.7 9.89 Favored Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 119.485 -1.341 . . . . 0.0 113.762 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 38' ' ' GLN . . . . . 0.584 ' O ' ' HG3' ' E' ' 58' ' ' LYS . 19.2 tt0 -102.29 -46.89 4.67 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.574 -0.313 . . . . 0.0 110.363 177.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 39' ' ' GLU . . . . . 0.44 ' OE2' ' HG2' ' E' ' 38' ' ' GLN . 6.9 mp0 -152.38 129.42 11.08 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.4 176.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . 0.467 ' HB3' ' HB1' ' E' ' 83' ' ' ALA . . . -125.92 119.56 28.1 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.398 0.618 . . . . 0.0 110.25 171.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 41' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -104.54 108.97 20.67 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 43.6 tp -84.89 115.05 22.56 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.291 -173.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 43' ' ' TYR . . . . . 0.511 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 91.4 m-85 -116.31 145.53 43.11 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 175.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 44' ' ' LEU . . . . . 0.536 ' HA ' ' O ' ' E' ' 76' ' ' MET . 0.2 OUTLIER -131.67 128.39 38.94 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 171.408 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 45' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -106.58 122.88 47.21 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.651 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.28 125.28 34.41 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 175.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 61.45 36.36 17.24 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.488 0.492 . . . . 0.0 109.719 -171.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 48' ' ' LYS . . . . . 0.502 ' HD3' ' O ' ' E' ' 48' ' ' LYS . 14.9 tmtt? 73.66 -7.52 1.56 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.413 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 49' ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 24.3 tp60 -80.39 114.58 19.39 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -177.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -81.39 110.21 16.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.999 0.428 . . . . 0.0 110.395 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . 1.656 ' HE1' ' CE2' ' E' ' 51' ' ' TYR . 82.2 m-85 -99.44 129.94 45.67 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.219 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.29 99.49 4.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 172.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . 0.46 HG11 ' CD2' ' D' ' 88' ' ' LEU . 2.4 t -74.67 -50.09 27.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.366 -171.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 54' ' ' ALA . . . . . 0.423 ' HB2' HG12 ' E' ' 63' ' ' VAL . . . -158.25 139.01 12.93 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.465 -177.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 23.2 m -102.98 102.12 12.15 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 171.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . 0.427 HG11 ' HB1' ' E' ' 40' ' ' ALA . 7.2 p -113.67 110.27 31.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.966 0.889 . . . . 0.0 109.844 -177.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 81.5 p -122.97 -176.89 3.52 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.181 -174.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 58' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' E' ' 38' ' ' GLN . 9.8 mtmp? -56.79 -35.01 68.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.016 0.436 . . . . 0.0 110.313 169.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.38 -40.62 64.21 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.506 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 77.8 mt -117.05 80.56 11.66 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.22 -0.04 6.7 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.038 2.492 . . . . 0.0 113.165 -169.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -164.11 118.69 1.49 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.159 0.504 . . . . 0.0 110.945 -174.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . 0.423 HG12 ' HB2' ' E' ' 54' ' ' ALA . 58.3 t -108.78 108.52 25.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.368 175.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.45 117.31 27.29 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.858 174.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . 0.42 ' CD2' ' HB3' ' E' ' 54' ' ' ALA . 0.3 OUTLIER -136.3 168.56 19.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.51 -176.043 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 66' ' ' ASP . . . . . 0.52 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 8.9 t0 -114.05 99.53 7.71 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.236 0.541 . . . . 0.0 110.258 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 67' ' ' LEU . . . . . 0.554 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 19.6 mt -112.74 142.11 45.75 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.458 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 68' ' ' ASN . . . . . 0.505 ' ND2' ' HB1' ' D' ' 6' ' ' ALA . 63.2 t30 -150.63 115.81 5.36 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 174.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 69' ' ' PHE . . . . . 1.649 ' HE1' ' CE2' ' E' ' 69' ' ' PHE . 32.6 m-85 -110.37 158.68 18.19 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.884 -177.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 70' ' ' SER . . . . . 0.474 ' HB2' ' HA ' ' D' ' 7' ' ' MET . 8.6 t -110.58 158.68 18.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.35 0.595 . . . . 0.0 110.634 -176.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -70.53 -4.84 24.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.618 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.34 -26.87 14.46 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.49 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -100.63 168.27 9.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.104 0.478 . . . . 0.0 110.884 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -136.86 143.69 43.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.12 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 75' ' ' ILE . . . . . . . . . . . . . 13.2 pt -139.93 176.12 5.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.653 0.263 . . . . 0.0 111.071 -172.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 76' ' ' MET . . . . . 0.536 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 9.2 mtm -134.09 131.73 39.11 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 171.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 77' ' ' PHE . . . . . 0.449 ' CD1' ' HB2' ' E' ' 44' ' ' LEU . 1.2 m-85 -108.29 128.29 54.61 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 178.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 78' ' ' TYR . . . . . 0.628 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 38.8 p90 -152.84 136.32 15.93 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.325 0.583 . . . . 0.0 111.742 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 79' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 2.1 p -111.12 133.01 53.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.257 -177.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.1 168.22 9.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.9 177.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.0 -170.21 43.15 Favored Glycine 0 CA--C 1.508 -0.346 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -115.12 102.7 10.16 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 117.716 0.758 . . . . 0.0 109.626 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 83' ' ' ALA . . . . . 0.507 ' H ' ' HB3' ' E' ' 15' ' ' PRO . . . -173.82 152.28 1.96 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.509 170.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 31.9 t -111.46 122.19 47.18 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 85' ' ' VAL . . . . . . . . . . . . . 4.3 m -113.64 156.89 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 CA-C-O 121.538 0.685 . . . . 0.0 112.542 -172.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 14.9 t -123.62 113.8 19.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.794 -1.094 . . . . 0.0 108.63 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 87' ' ' LEU . . . . . 0.656 HD12 ' SD ' ' E' ' 13' ' ' MET . 5.0 mp -90.12 153.42 20.55 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.123 0.487 . . . . 0.0 109.867 174.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . 0.449 ' CD2' HG11 ' A' ' 53' ' ' VAL . 1.0 OUTLIER -133.28 139.44 46.91 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 114.803 -1.089 . . . . 0.0 109.077 -179.494 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.94 -166.83 24.55 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.849 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 90' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -152.8 131.33 12.22 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.769 0.795 . . . . 0.0 111.799 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 91' ' ' LEU . . . . . . . . . . . . . 5.8 mt -70.19 133.37 47.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.269 175.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -70.39 129.49 39.42 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -83.02 164.86 20.08 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.852 177.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 18.1 mt -127.46 49.87 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.498 0.666 . . . . 0.0 109.216 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -63.51 -32.13 73.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.096 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 96' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' E' ' 1' ' ' PHE . 40.7 m -82.57 51.03 1.77 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.643 176.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . -178.61 -52.1 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.136 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.378 178.847 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.716 0.293 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -80.12 -47.93 14.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.079 0.466 . . . . 0.0 109.941 176.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 135.17 -175.84 20.41 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.601 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.4 -48.13 10.69 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.477 ' HG3' ' CB ' ' B' ' 95' ' ' ASP . 22.7 mmt 58.59 -100.14 0.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.854 -1.066 . . . . 0.0 112.942 172.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.538 ' O ' ' HB2' ' B' ' 70' ' ' SER . . . -86.21 131.07 34.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.66 0.267 . . . . 0.0 110.402 -177.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 38.4 mtt -124.18 144.11 50.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.157 0.503 . . . . 0.0 112.089 -175.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 1.658 ' HD1' ' CD2' ' A' ' 8' ' ' PHE . 28.9 t80 -62.34 145.7 53.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.547 -178.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -135.75 147.4 48.4 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.428 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -150.97 153.86 25.23 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.197 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 33.3 tp -147.77 106.54 3.82 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 86' ' ' SER . 2.3 p30 -97.85 110.54 23.09 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.543 0.687 . . . . 0.0 111.02 176.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.404 ' SD ' HG21 ' A' ' 79' ' ' THR . 7.3 mtt -85.19 142.22 29.61 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.285 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -89.82 144.26 31.38 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 170.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -46.31 109.77 0.22 Allowed 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 123.463 2.776 . . . . 0.0 113.594 -174.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.634 ' HA ' ' O ' ' A' ' 79' ' ' THR . 8.8 tt0 70.52 67.05 0.2 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.794 175.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.514 ' HA ' ' NE ' ' A' ' 17' ' ' ARG . 4.7 mmp_? -122.76 169.28 11.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.03 175.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.626 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 19.4 tttm -146.77 104.81 3.76 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.34 0.4 . . . . 0.0 111.274 -175.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 1.657 ' HD1' ' CD2' ' A' ' 19' ' ' TYR . 1.8 m-85 -111.74 111.5 22.51 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.053 -177.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 76' ' ' MET . 29.2 t -90.78 111.06 22.29 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 170.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -133.86 150.01 51.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.635 0.731 . . . . 0.0 112.687 -168.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.7 p -91.18 160.91 15.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.679 177.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 73.8 mt -111.2 126.29 68.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.219 -174.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.508 HD13 ' N ' ' A' ' 25' ' ' LYS . 1.8 pp -92.53 -24.44 5.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.641 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.508 ' N ' HD13 ' A' ' 24' ' ' ILE . 24.8 mtpp -147.44 132.93 18.66 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' ' 92' ' ' HIS . 15.6 m -55.05 119.4 5.39 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -137.34 156.72 47.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.737 0.78 . . . . 0.0 112.833 -170.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.573 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 15.1 t60 -109.88 124.65 51.73 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.118 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 39.3 mt -94.45 135.08 29.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 169.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.573 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 50.1 p -120.31 -15.85 8.55 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -169.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -160.39 145.21 10.84 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 119.288 -1.434 . . . . 0.0 113.324 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.2 p -129.85 121.55 52.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 168.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.07 154.38 43.9 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 121.928 -0.483 . . . . 0.0 112.018 -173.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.5 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 4.4 pp -125.15 144.0 50.65 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.499 0.666 . . . . 0.0 110.836 178.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -110.27 -45.98 3.49 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 173.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -103.63 128.66 50.89 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.593 171.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.472 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 146.63 163.01 10.18 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 119.627 -1.273 . . . . 0.0 113.501 176.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -102.24 -47.24 4.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.494 0.188 . . . . 0.0 110.97 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -152.16 133.71 14.63 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.093 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.29 113.46 11.97 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.391 0.615 . . . . 0.0 110.122 167.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -97.81 112.72 24.52 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 174.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.7 tp -83.81 113.29 20.82 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.557 -174.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.517 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 97.9 m-85 -115.78 141.45 48.07 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.526 ' HB2' ' CD1' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -129.85 131.82 46.25 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 173.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -110.71 114.96 28.74 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.028 177.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.91 142.54 50.64 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 58.65 29.24 18.28 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.949 0.404 . . . . 0.0 110.314 -174.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt 63.58 24.51 14.02 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.735 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.449 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 23.9 tp60 -115.65 126.69 54.47 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -83.44 125.01 31.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.891 0.377 . . . . 0.0 110.696 -177.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 1.649 ' HE2' ' CE1' ' A' ' 51' ' ' TYR . 66.3 m-85 -121.03 133.32 55.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.943 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -82.1 107.74 14.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 169.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.49 HG11 ' CD2' ' E' ' 88' ' ' LEU . 2.4 t -80.06 -49.56 18.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.64 -171.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.437 ' HB2' HG12 ' A' ' 63' ' ' VAL . . . -160.05 148.9 17.34 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.132 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.6 m -109.79 102.22 11.03 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 173.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.77 114.36 45.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.658 0.742 . . . . 0.0 110.016 -177.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 81.0 p -123.05 -178.3 3.92 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.55 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -63.47 -21.54 66.37 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.996 0.426 . . . . 0.0 110.444 170.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.47 -40.72 18.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.229 0.537 . . . . 0.0 110.244 177.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.1 mt -113.22 82.68 5.82 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 173.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.06 -0.11 6.69 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.156 2.57 . . . . 0.0 114.059 -167.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.28 127.12 2.44 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.175 0.512 . . . . 0.0 111.445 -176.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.437 HG12 ' HB2' ' A' ' 54' ' ' ALA . 85.2 t -117.44 106.22 19.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.311 174.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.47 121.68 27.07 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 173.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -140.69 168.16 20.46 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.766 -173.001 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.543 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 11.6 t0 -118.85 105.29 11.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.359 0.6 . . . . 0.0 110.497 -177.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 15.1 mt -118.8 144.43 46.32 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.655 177.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.425 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 57.5 t30 -148.44 114.79 5.89 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 173.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -110.13 164.51 12.57 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.091 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.538 ' HB2' ' O ' ' E' ' 6' ' ' ALA . 33.0 t -107.85 149.15 28.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.859 0.361 . . . . 0.0 110.694 -177.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.14 -11.95 60.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.235 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.3 -5.76 61.83 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.537 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -100.25 167.9 10.13 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -145.23 128.21 16.5 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 15.4 pt -134.89 165.49 31.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.111 0.481 . . . . 0.0 111.79 -169.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.488 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 4.5 mtm -120.91 123.5 42.65 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.595 173.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 1.654 ' HD1' ' CD2' ' A' ' 77' ' ' PHE . 0.7 OUTLIER -105.96 127.61 53.26 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.587 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 1.658 ' HE2' ' CE1' ' A' ' 78' ' ' TYR . 40.5 p90 -154.95 144.13 21.05 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 120.031 -0.668 . . . . 0.0 112.006 -177.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.634 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 6.3 p -116.18 141.64 47.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.394 -177.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.72 153.37 23.04 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.221 176.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.93 -175.36 36.69 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -175.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -118.78 104.85 10.96 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 122.118 0.961 . . . . 0.0 110.499 176.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.472 ' CB ' ' HA3' ' A' ' 37' ' ' GLY . . . -166.1 154.83 11.16 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.22 170.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.3 t -106.3 111.19 23.67 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.5 ' CG1' ' HB3' ' A' ' 34' ' ' LEU . 3.4 m -111.33 138.08 41.25 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 CA-C-O 121.219 0.533 . . . . 0.0 112.191 -174.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 7.4 t -108.91 118.25 36.32 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.489 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 5.4 mp -89.73 149.26 22.82 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.532 174.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.501 ' CD2' HG11 ' B' ' 53' ' ' VAL . 1.3 tp -132.02 140.71 49.01 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.938 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.39 -167.14 25.52 Favored Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.695 -177.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 1.598 ' HE2' ' CE1' ' A' ' 90' ' ' TYR . 12.9 p90 -153.34 132.18 12.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.746 0.784 . . . . 0.0 111.643 177.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.3 mt -64.62 126.97 29.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.112 173.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.403 ' HB3' ' O ' ' A' ' 26' ' ' SER . 28.4 t60 -66.84 144.43 56.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.472 0.653 . . . . 0.0 111.275 -175.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.411 ' HB2' ' H ' ' A' ' 94' ' ' ILE . 7.7 p-10 -73.39 -154.24 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.012 177.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.411 ' H ' ' HB2' ' A' ' 93' ' ' ASP . 30.8 pt -72.19 133.13 32.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.418 0.628 . . . . 0.0 111.45 -177.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.433 ' CB ' ' HG3' ' E' ' 5' ' ' MET . 8.6 m-20 -81.12 64.19 5.76 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.007 176.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 26.6 m 63.25 -165.15 0.24 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.025 -175.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 70.62 45.68 51.73 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.344 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.7 p . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.571 -0.728 . . . . 0.0 110.437 178.994 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 120.734 0.302 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -80.05 -47.97 14.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.105 0.479 . . . . 0.0 109.933 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 135.23 -175.87 20.41 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.652 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.39 -48.01 10.81 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' MET . . . . . 0.407 ' HG3' ' CB ' ' C' ' 95' ' ' ASP . 22.7 mmt 58.57 -100.14 0.11 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 114.834 -1.076 . . . . 0.0 112.933 172.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.582 ' O ' ' HB2' ' C' ' 70' ' ' SER . . . -86.18 131.06 34.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.427 -177.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 38.4 mtt -124.21 144.09 50.14 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.282 0.563 . . . . 0.0 112.041 -175.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 1.639 ' HE2' ' CE1' ' B' ' 8' ' ' PHE . 29.1 t80 -62.36 145.73 53.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.47 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -135.72 147.33 48.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.112 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.501 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -150.95 153.81 25.21 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.185 178.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.448 ' HB3' ' HB2' ' B' ' 87' ' ' LEU . 33.6 tp -147.7 106.59 3.83 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . 0.47 ' HA ' ' HA ' ' B' ' 86' ' ' SER . 2.3 p30 -97.88 110.58 23.12 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.597 0.713 . . . . 0.0 110.959 177.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' MET . . . . . 0.401 ' SD ' HG21 ' B' ' 79' ' ' THR . 7.3 mtt -85.14 142.17 29.68 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.366 -178.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.402 ' HB2' ' HG3' ' B' ' 17' ' ' ARG . 91.5 mttt -89.77 144.31 31.53 Favored Pre-proline 0 C--N 1.316 -0.874 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 170.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -46.3 109.69 0.22 Allowed 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 123.56 2.84 . . . . 0.0 113.496 -174.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.635 ' HA ' ' O ' ' B' ' 79' ' ' THR . 8.8 tt0 70.54 67.09 0.2 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.734 175.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.513 ' NE ' ' HA ' ' B' ' 17' ' ' ARG . 4.6 mmp_? -122.76 169.18 11.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.089 175.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . 0.607 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 19.5 tttm -146.68 104.77 3.77 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 123.325 0.391 . . . . 0.0 111.269 -175.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' TYR . . . . . 1.666 ' HD1' ' CD2' ' B' ' 19' ' ' TYR . 1.8 m-85 -111.76 111.53 22.57 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.079 -177.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 29.3 t -90.73 111.05 22.26 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -133.92 150.09 51.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.667 0.746 . . . . 0.0 112.66 -168.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 3.8 p -91.25 160.91 15.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.665 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 74.0 mt -111.24 126.31 68.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.144 -174.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.512 HD13 ' N ' ' B' ' 25' ' ' LYS . 1.8 pp -92.49 -24.44 5.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.692 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.512 ' N ' HD13 ' B' ' 24' ' ' ILE . 24.9 mtpp -147.36 132.86 18.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.87 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' SER . . . . . 0.409 ' O ' ' HB3' ' B' ' 92' ' ' HIS . 15.5 m -54.96 119.32 5.25 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 175.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -137.31 156.62 48.03 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.669 0.747 . . . . 0.0 112.853 -170.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' HIS . . . . . 0.569 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 15.1 t60 -109.92 124.59 51.64 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.151 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.536 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 39.3 mt -94.39 135.1 29.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 169.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.569 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 48.7 p -120.34 -15.79 8.54 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -169.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -160.31 145.16 10.79 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 119.301 -1.428 . . . . 0.0 113.377 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 12.3 p -129.81 121.59 52.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 168.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.11 154.31 43.79 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.983 -173.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.514 ' HB3' ' CG1' ' B' ' 85' ' ' VAL . 4.4 pp -125.08 143.99 50.64 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.468 0.651 . . . . 0.0 110.791 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -110.15 -46.12 3.49 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 173.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -103.57 128.67 50.78 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.515 171.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.468 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 146.55 163.01 10.17 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 119.676 -1.25 . . . . 0.0 113.6 175.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -102.3 -47.04 4.63 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.19 -0.204 . . . . 0.0 111.043 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -152.22 133.68 14.55 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.999 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.38 113.46 11.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.474 0.654 . . . . 0.0 110.127 167.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -97.83 112.7 24.51 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 174.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 43.6 tp -83.71 113.37 20.83 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.56 -174.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . 0.517 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 98.0 m-85 -115.89 141.41 48.14 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 176.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.537 ' HB2' ' CD1' ' B' ' 77' ' ' PHE . 0.1 OUTLIER -129.85 131.9 46.27 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 173.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -110.7 114.94 28.7 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.01 177.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.91 142.54 50.64 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 58.6 29.31 18.31 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.994 0.426 . . . . 0.0 110.338 -174.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt 63.5 24.5 14.09 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.705 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.455 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 24.0 tp60 -115.64 126.65 54.43 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -83.38 124.94 31.15 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.972 0.415 . . . . 0.0 110.702 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 1.646 ' HE2' ' CE1' ' B' ' 51' ' ' TYR . 66.4 m-85 -120.97 133.37 55.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.899 176.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -82.06 107.63 14.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 169.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.501 HG11 ' CD2' ' A' ' 88' ' ' LEU . 2.4 t -80.08 -49.54 18.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.61 -171.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.428 ' HB2' HG12 ' B' ' 63' ' ' VAL . . . -159.98 148.89 17.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.171 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 55.4 m -109.85 102.28 11.06 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 173.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.78 114.41 45.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.669 0.747 . . . . 0.0 110.001 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 81.3 p -123.12 -178.38 3.95 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.608 -174.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -63.45 -21.47 66.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.932 0.396 . . . . 0.0 110.484 170.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.48 -40.77 18.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.206 0.527 . . . . 0.0 110.216 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 80.4 mt -113.22 82.63 5.78 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.02 -0.2 6.78 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.17 2.58 . . . . 0.0 114.066 -167.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.21 127.17 2.47 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.159 0.504 . . . . 0.0 111.44 -176.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.428 HG12 ' HB2' ' B' ' 54' ' ' ALA . 85.5 t -117.35 106.21 19.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.35 174.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.49 121.7 27.1 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 173.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' B' ' 30' ' ' SER . 0.6 OUTLIER -140.76 168.12 20.55 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.741 -173.026 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . 0.566 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 11.8 t0 -118.73 105.26 11.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.264 0.554 . . . . 0.0 110.565 -177.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' B' ' 28' ' ' HIS . 15.1 mt -118.76 144.43 46.28 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.68 177.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . 0.415 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 57.4 t30 -148.52 114.8 5.86 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 173.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -110.14 164.56 12.52 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.12 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.538 ' HB2' ' O ' ' A' ' 6' ' ' ALA . 33.1 t -107.93 149.18 28.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 0.0 110.677 -177.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -11.95 60.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.271 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.28 -5.76 61.86 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.585 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -100.29 167.96 10.08 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -145.22 128.13 16.43 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 15.4 pt -134.84 165.44 31.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.082 0.467 . . . . 0.0 111.756 -169.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' MET . . . . . 0.487 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 4.5 mtm -120.91 123.61 42.93 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 173.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . 1.664 ' HD1' ' CD2' ' B' ' 77' ' ' PHE . 0.8 OUTLIER -106.02 127.62 53.29 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.441 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 1.619 ' HE2' ' CE1' ' B' ' 78' ' ' TYR . 40.4 p90 -154.9 144.19 21.16 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.993 -0.683 . . . . 0.0 112.034 -177.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.635 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 6.4 p -116.29 141.63 47.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.356 -177.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.72 153.41 22.99 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.241 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.79 -175.37 36.92 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -175.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -118.75 104.87 10.99 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.509 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.468 ' CB ' ' HA3' ' B' ' 37' ' ' GLY . . . -166.07 154.77 11.18 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.2 170.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 19.0 t -106.16 111.17 23.67 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.514 ' CG1' ' HB3' ' B' ' 34' ' ' LEU . 3.4 m -111.44 138.17 41.02 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 CA-C-O 121.3 0.571 . . . . 0.0 112.129 -174.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' B' ' 12' ' ' ASN . 7.4 t -108.94 118.25 36.32 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.793 178.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' B' ' 31' ' ' GLY . 5.4 mp -89.79 149.27 22.77 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.5 174.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.49 ' CD2' HG11 ' C' ' 53' ' ' VAL . 1.3 tp -131.99 140.69 49.04 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.971 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.41 -167.2 25.64 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.704 -177.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' TYR . . . . . 1.66 ' HE1' ' CE2' ' B' ' 90' ' ' TYR . 13.0 p90 -153.4 132.21 12.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.777 0.798 . . . . 0.0 111.603 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 22.2 mt -64.49 126.98 29.58 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.131 173.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . 0.409 ' HB3' ' O ' ' B' ' 26' ' ' SER . 28.3 t60 -66.85 144.36 56.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.478 0.656 . . . . 0.0 111.23 -175.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . 0.402 ' CB ' ' HB3' ' B' ' 5' ' ' MET . 7.8 p-10 -73.34 -154.27 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.504 -1.225 . . . . 0.0 111.056 177.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 31.2 pt -72.15 133.19 32.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.418 0.628 . . . . 0.0 111.424 -177.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . 0.477 ' CB ' ' HG3' ' A' ' 5' ' ' MET . 8.5 m-20 -81.13 64.13 5.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.966 176.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 27.9 m 63.28 -165.22 0.24 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.003 -175.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . 70.73 45.75 50.6 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.305 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 10.6 p . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.768 -0.634 . . . . 0.0 110.445 179.034 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 120.788 0.328 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -80.12 -48.02 13.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.033 0.444 . . . . 0.0 109.833 176.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . 135.25 -175.91 20.38 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.625 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.36 -48.09 10.76 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 5' ' ' MET . . . . . 0.461 ' HG3' ' CB ' ' D' ' 95' ' ' ASP . 22.8 mmt 58.56 -100.14 0.11 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.982 172.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 6' ' ' ALA . . . . . 0.572 ' O ' ' HB2' ' D' ' 70' ' ' SER . . . -86.15 131.06 34.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.621 0.248 . . . . 0.0 110.434 -177.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 38.4 mtt -124.19 143.95 50.21 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.104 0.478 . . . . 0.0 112.106 -175.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 8' ' ' PHE . . . . . 1.657 ' HD1' ' CD2' ' C' ' 8' ' ' PHE . 28.9 t80 -62.35 145.78 52.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.492 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -135.65 147.44 48.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.177 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . 0.443 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -151.04 153.8 25.19 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.203 178.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.44 ' HB3' ' HB2' ' C' ' 87' ' ' LEU . 33.4 tp -147.78 106.57 3.82 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . 0.464 ' HA ' ' HA ' ' C' ' 86' ' ' SER . 2.3 p30 -97.91 110.67 23.2 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.681 0.753 . . . . 0.0 110.937 177.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 13' ' ' MET . . . . . 0.405 ' SD ' HG21 ' C' ' 79' ' ' THR . 7.2 mtt -85.25 142.17 29.59 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.019 -0.992 . . . . 0.0 111.324 -178.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -89.67 144.17 31.45 Favored Pre-proline 0 C--N 1.315 -0.902 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 170.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -46.23 109.65 0.21 Allowed 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 123.503 2.802 . . . . 0.0 113.543 -174.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . 0.628 ' HA ' ' O ' ' C' ' 79' ' ' THR . 8.8 tt0 70.59 67.08 0.19 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.767 175.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 17' ' ' ARG . . . . . 0.506 ' NE ' ' HA ' ' C' ' 17' ' ' ARG . 4.7 mmp_? -122.76 169.22 11.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.133 175.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 18' ' ' LYS . . . . . 0.629 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 19.4 tttm -146.67 104.8 3.77 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.346 0.404 . . . . 0.0 111.305 -175.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . 1.671 ' HD2' ' CD1' ' C' ' 19' ' ' TYR . 1.8 m-85 -111.76 111.53 22.57 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.093 -177.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 20' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 29.5 t -90.84 111.05 22.29 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 170.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -133.89 150.11 51.34 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.693 0.758 . . . . 0.0 112.645 -168.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 3.8 p -91.2 160.83 15.34 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.657 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 74.1 mt -111.13 126.25 68.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.171 -174.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . 0.523 HD13 ' N ' ' C' ' 25' ' ' LYS . 1.8 pp -92.5 -24.38 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.69 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . 0.523 ' N ' HD13 ' C' ' 24' ' ' ILE . 24.8 mtpp -147.44 132.94 18.67 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.836 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 26' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' C' ' 92' ' ' HIS . 15.6 m -54.98 119.42 5.39 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 27' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -137.38 156.63 47.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.694 0.759 . . . . 0.0 112.788 -170.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 28' ' ' HIS . . . . . 0.573 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 15.1 t60 -109.9 124.61 51.66 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.244 -1.343 . . . . 0.0 110.101 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 39.4 mt -94.45 134.99 30.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 169.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 30' ' ' SER . . . . . 0.573 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 50.0 p -120.2 -15.88 8.6 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -169.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -160.34 145.17 10.8 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.382 -1.389 . . . . 0.0 113.38 178.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.407 HG11 ' O ' ' C' ' 32' ' ' VAL . 12.1 p -129.8 121.63 52.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 168.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.18 154.38 43.82 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.979 -173.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.506 ' HB3' ' CG1' ' C' ' 85' ' ' VAL . 4.4 pp -125.11 144.02 50.63 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.468 0.651 . . . . 0.0 110.787 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -110.16 -46.01 3.51 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -103.64 128.65 50.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.551 171.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 37' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 146.67 163.0 10.18 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 119.664 -1.255 . . . . 0.0 113.576 176.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -102.25 -47.22 4.58 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.463 0.173 . . . . 0.0 110.976 177.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -152.16 133.75 14.65 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.063 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.35 113.42 11.89 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.362 0.601 . . . . 0.0 110.097 168.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -97.77 112.57 24.42 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 174.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 43.7 tp -83.76 113.32 20.82 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.577 -174.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 43' ' ' TYR . . . . . 0.515 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 98.0 m-85 -115.8 141.53 47.98 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.539 ' HB2' ' CD1' ' C' ' 77' ' ' PHE . 0.1 OUTLIER -129.91 131.79 46.15 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 173.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -110.74 114.85 28.53 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.981 177.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.86 142.47 50.66 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 58.78 29.17 18.36 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.89 0.376 . . . . 0.0 110.284 -174.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt 63.55 24.57 14.07 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.681 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . 0.453 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 24.0 tp60 -115.67 126.67 54.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -83.42 124.85 31.09 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.869 0.366 . . . . 0.0 110.758 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 1.664 ' HE2' ' CE1' ' C' ' 51' ' ' TYR . 66.8 m-85 -120.91 133.35 55.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 176.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -82.14 107.7 14.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 169.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 53' ' ' VAL . . . . . 0.49 HG11 ' CD2' ' B' ' 88' ' ' LEU . 2.4 t -80.07 -49.58 18.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.643 -171.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 54' ' ' ALA . . . . . 0.428 ' HB2' HG12 ' C' ' 63' ' ' VAL . . . -159.99 148.98 17.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.232 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 54.1 m -109.81 102.19 10.99 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 173.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.69 114.39 45.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.653 0.739 . . . . 0.0 110.032 -177.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 81.2 p -123.05 -178.33 3.93 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.581 -174.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -63.57 -21.4 66.33 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.887 0.375 . . . . 0.0 110.491 170.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.52 -40.67 18.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.166 0.508 . . . . 0.0 110.228 177.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 80.6 mt -113.28 82.71 5.94 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 174.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.06 -0.13 6.71 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.15 2.567 . . . . 0.0 114.052 -167.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.3 127.18 2.44 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.146 0.498 . . . . 0.0 111.418 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.428 HG12 ' HB2' ' C' ' 54' ' ' ALA . 86.4 t -117.34 106.14 19.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.35 174.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.45 121.7 27.08 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 173.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' C' ' 30' ' ' SER . 0.6 OUTLIER -140.71 168.2 20.36 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.736 -172.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 66' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 11.6 t0 -118.88 105.18 11.24 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.322 0.582 . . . . 0.0 110.569 -177.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' C' ' 28' ' ' HIS . 15.2 mt -118.7 144.48 46.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.651 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . 0.409 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 57.4 t30 -148.55 114.74 5.83 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 173.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -110.09 164.5 12.57 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.122 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 70' ' ' SER . . . . . 0.582 ' HB2' ' O ' ' B' ' 6' ' ' ALA . 33.1 t -107.85 149.2 28.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.371 . . . . 0.0 110.679 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . 0.403 ' HE2' ' HB2' ' C' ' 71' ' ' LYS . 0.0 OUTLIER -68.19 -11.85 59.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.279 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.41 -5.8 61.63 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.565 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -100.13 167.9 10.16 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -145.2 128.14 16.45 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 15.3 pt -134.87 165.51 30.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.992 0.425 . . . . 0.0 111.75 -169.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 76' ' ' MET . . . . . 0.486 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 4.5 mtm -120.85 123.47 42.65 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.612 173.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 77' ' ' PHE . . . . . 1.658 ' HD1' ' CD2' ' C' ' 77' ' ' PHE . 0.8 OUTLIER -105.95 127.59 53.25 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.488 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 78' ' ' TYR . . . . . 1.666 ' HE2' ' CE1' ' C' ' 78' ' ' TYR . 40.5 p90 -154.92 144.16 21.12 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.086 -0.645 . . . . 0.0 111.994 -177.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 79' ' ' THR . . . . . 0.628 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 6.6 p -116.19 141.54 48.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.351 -177.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.69 153.44 22.93 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.248 175.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.83 -175.47 36.95 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -175.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -118.73 104.83 10.96 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 122.191 0.996 . . . . 0.0 110.58 176.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . 0.464 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -166.1 154.82 11.16 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.188 170.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 19.9 t -106.29 111.29 23.82 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.506 ' CG1' ' HB3' ' C' ' 34' ' ' LEU . 3.4 m -111.48 138.16 41.11 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 CA-C-O 121.304 0.573 . . . . 0.0 112.137 -174.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 86' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' C' ' 12' ' ' ASN . 7.4 t -108.99 118.37 36.63 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.76 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . 0.484 ' HA ' ' O ' ' C' ' 31' ' ' GLY . 5.4 mp -89.84 149.28 22.73 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.525 174.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . 0.473 ' CD2' HG11 ' D' ' 53' ' ' VAL . 1.3 tp -131.98 140.68 49.04 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.018 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.32 -167.12 25.42 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.683 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 90' ' ' TYR . . . . . 1.623 ' HE1' ' CE2' ' C' ' 90' ' ' TYR . 13.2 p90 -153.4 132.18 12.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.767 0.794 . . . . 0.0 111.656 177.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 21.9 mt -64.52 127.02 29.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.195 173.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 92' ' ' HIS . . . . . 0.407 ' HB3' ' O ' ' C' ' 26' ' ' SER . 28.4 t60 -66.86 144.37 56.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.489 0.661 . . . . 0.0 111.231 -175.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -73.37 -154.2 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.007 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 31.0 pt -72.28 133.15 32.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.431 0.634 . . . . 0.0 111.419 -177.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 95' ' ' ASP . . . . . 0.407 ' CB ' ' HG3' ' B' ' 5' ' ' MET . 8.7 m-20 -81.14 64.23 5.8 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.958 176.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 27.8 m 63.14 -165.25 0.24 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.943 -175.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 70.78 45.58 51.35 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.432 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 10.7 p . . . . . 0 C--O 1.252 1.222 0 CA-C-O 118.626 -0.702 . . . . 0.0 110.433 179.139 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 120.76 0.314 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -80.1 -48.06 13.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.13 0.491 . . . . 0.0 109.88 176.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . 135.28 -175.9 20.4 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.566 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.3 -48.09 10.8 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 5' ' ' MET . . . . . 0.478 ' HG3' ' CB ' ' E' ' 95' ' ' ASP . 22.6 mmt 58.5 -100.07 0.1 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.918 172.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 6' ' ' ALA . . . . . 0.537 ' O ' ' HB2' ' E' ' 70' ' ' SER . . . -86.21 131.06 34.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.652 0.263 . . . . 0.0 110.453 -177.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 38.3 mtt -124.2 144.11 50.13 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.233 0.539 . . . . 0.0 112.041 -175.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 8' ' ' PHE . . . . . 1.661 ' HE2' ' CE1' ' D' ' 8' ' ' PHE . 29.4 t80 -62.34 145.77 52.96 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.507 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 9' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -135.75 147.4 48.41 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.079 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . 0.455 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -151.03 153.87 25.23 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.179 178.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . 0.423 ' HB3' ' HB2' ' D' ' 87' ' ' LEU . 33.6 tp -147.69 106.54 3.83 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.34 -0.245 . . . . 0.0 110.34 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . 0.451 ' HA ' ' HA ' ' D' ' 86' ' ' SER . 2.3 p30 -97.9 110.56 23.11 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.63 0.729 . . . . 0.0 110.979 177.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 13' ' ' MET . . . . . . . . . . . . . 7.3 mtt -85.15 142.17 29.67 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.422 -178.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 14' ' ' LYS . . . . . 0.411 ' HB2' ' HG3' ' D' ' 17' ' ' ARG . 91.5 mttt -89.74 144.18 31.37 Favored Pre-proline 0 C--N 1.316 -0.891 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 170.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -46.27 109.73 0.22 Allowed 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 123.414 2.743 . . . . 0.0 113.605 -174.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . 0.61 ' HA ' ' O ' ' D' ' 79' ' ' THR . 8.9 tt0 70.61 67.07 0.19 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.762 175.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 17' ' ' ARG . . . . . 0.5 ' HA ' ' NE ' ' D' ' 17' ' ' ARG . 4.7 mmp_? -122.76 169.2 11.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.091 175.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . 0.629 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 19.4 tttm -146.69 104.79 3.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 123.292 0.37 . . . . 0.0 111.355 -175.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 19' ' ' TYR . . . . . 1.657 ' HD2' ' CD1' ' D' ' 19' ' ' TYR . 1.8 m-85 -111.69 111.55 22.62 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.115 -177.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 20' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 29.3 t -90.87 110.94 22.17 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -133.84 150.2 51.39 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.676 0.751 . . . . 0.0 112.743 -168.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 3.7 p -91.31 160.94 15.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.643 178.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 73.8 mt -111.19 126.29 68.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.241 -174.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . 0.521 HD13 ' N ' ' D' ' 25' ' ' LYS . 1.8 pp -92.5 -24.41 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.765 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . 0.521 ' N ' HD13 ' D' ' 24' ' ' ILE . 24.8 mtpp -147.43 132.86 18.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.8 178.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 26' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' D' ' 92' ' ' HIS . 15.5 m -54.96 119.4 5.35 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 175.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 27' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -137.38 156.74 47.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.789 0.804 . . . . 0.0 112.792 -170.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 28' ' ' HIS . . . . . 0.581 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 15.2 t60 -109.98 124.7 51.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.221 -1.354 . . . . 0.0 110.07 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 29' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 39.5 mt -94.55 135.05 29.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 169.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 30' ' ' SER . . . . . 0.581 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 50.1 p -120.25 -15.89 8.57 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -169.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 31' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -160.27 145.16 10.81 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 119.374 -1.393 . . . . 0.0 113.366 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . 0.402 HG11 ' O ' ' D' ' 32' ' ' VAL . 12.1 p -129.85 121.61 52.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 168.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.06 154.41 43.93 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.94 -173.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 34' ' ' LEU . . . . . 0.51 ' HB3' ' CG1' ' D' ' 85' ' ' VAL . 4.4 pp -125.15 144.05 50.63 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.475 0.655 . . . . 0.0 110.777 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -110.17 -46.08 3.49 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 173.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -103.63 128.64 50.9 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.562 171.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . 0.473 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 146.63 163.07 10.22 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 119.682 -1.247 . . . . 0.0 113.559 176.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -102.29 -47.22 4.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.59 0.233 . . . . 0.0 111.011 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -152.12 133.67 14.63 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.059 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.35 113.44 11.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.455 0.645 . . . . 0.0 110.177 167.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' D' ' 79' ' ' THR . 98.6 mttt -97.77 112.67 24.48 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 43.5 tp -83.74 113.34 20.82 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.607 -174.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 43' ' ' TYR . . . . . 0.509 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 98.0 m-85 -115.77 141.48 48.03 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.539 ' HB2' ' CD1' ' D' ' 77' ' ' PHE . 0.1 OUTLIER -129.96 131.83 46.09 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 173.874 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 45' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -110.65 115.0 28.83 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.888 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.91 142.57 50.64 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 58.7 29.19 18.27 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.315 0.384 . . . . 0.0 110.28 -174.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt 63.61 24.48 13.98 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.711 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . 0.446 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 24.1 tp60 -115.73 126.64 54.33 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -83.39 124.85 31.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.807 0.336 . . . . 0.0 110.755 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . 1.671 ' HE2' ' CE1' ' D' ' 51' ' ' TYR . 66.7 m-85 -120.89 133.35 55.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.904 176.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.0 tp -82.06 107.72 14.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 169.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 53' ' ' VAL . . . . . 0.473 HG11 ' CD2' ' C' ' 88' ' ' LEU . 2.4 t -80.09 -49.6 18.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.589 -171.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 54' ' ' ALA . . . . . 0.429 ' HB2' HG12 ' D' ' 63' ' ' VAL . . . -160.01 148.93 17.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.173 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 53.3 m -109.81 102.28 11.08 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.74 114.33 45.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.612 0.72 . . . . 0.0 109.981 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 81.2 p -123.05 -178.27 3.91 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.523 -174.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -63.57 -21.46 66.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.944 0.402 . . . . 0.0 110.461 170.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.51 -40.62 18.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.124 0.488 . . . . 0.0 110.222 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 80.3 mt -113.29 82.6 5.88 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 174.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -69.99 -0.18 6.73 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.186 2.591 . . . . 0.0 114.114 -167.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.25 127.1 2.45 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.112 0.482 . . . . 0.0 111.483 -176.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.429 HG12 ' HB2' ' D' ' 54' ' ' ALA . 87.2 t -117.3 106.09 19.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.426 174.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.48 121.73 27.13 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 173.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 65' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' D' ' 30' ' ' SER . 0.6 OUTLIER -140.72 168.2 20.35 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.728 -173.034 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 66' ' ' ASP . . . . . 0.549 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 11.9 t0 -118.82 105.23 11.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.251 0.548 . . . . 0.0 110.586 -177.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' D' ' 28' ' ' HIS . 15.1 mt -118.8 144.43 46.32 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.674 177.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 68' ' ' ASN . . . . . 0.441 ' HB3' ' CD2' ' C' ' 90' ' ' TYR . 57.3 t30 -148.47 114.83 5.89 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 173.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -110.15 164.58 12.5 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.106 -178.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 70' ' ' SER . . . . . 0.572 ' HB2' ' O ' ' C' ' 6' ' ' ALA . 33.0 t -107.97 149.12 28.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.856 0.36 . . . . 0.0 110.723 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -12.03 59.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.344 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.35 -5.73 61.77 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.526 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -100.2 167.92 10.13 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -145.21 128.16 16.46 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . . . . . . . . . 15.4 pt -134.92 165.39 31.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.077 0.465 . . . . 0.0 111.771 -169.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 76' ' ' MET . . . . . 0.492 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 4.5 mtm -120.85 123.5 42.72 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 173.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 77' ' ' PHE . . . . . 1.663 ' HE2' ' CE1' ' D' ' 77' ' ' PHE . 0.8 OUTLIER -106.02 127.59 53.27 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.502 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 78' ' ' TYR . . . . . 1.625 ' HE1' ' CE2' ' D' ' 78' ' ' TYR . 40.8 p90 -154.93 144.16 21.11 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.967 -177.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 79' ' ' THR . . . . . 0.61 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 6.5 p -116.22 141.61 47.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.364 -177.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.69 153.31 23.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.289 176.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.92 -175.36 36.7 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -175.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -118.81 104.97 11.05 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 118.114 0.957 . . . . 0.0 110.46 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.473 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -166.15 154.77 11.02 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.204 170.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 19.9 t -106.25 111.23 23.74 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . 0.51 ' CG1' ' HB3' ' D' ' 34' ' ' LEU . 3.4 m -111.43 138.11 41.24 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.706 0 CA-C-O 121.289 0.566 . . . . 0.0 112.144 -174.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 86' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' D' ' 12' ' ' ASN . 7.4 t -108.9 118.31 36.47 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.353 -0.84 . . . . 0.0 108.791 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 87' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' D' ' 31' ' ' GLY . 5.4 mp -89.76 149.31 22.78 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.524 174.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . 0.469 ' CD2' HG11 ' E' ' 53' ' ' VAL . 1.3 tp -132.05 140.68 48.97 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.956 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.32 -167.08 25.36 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.683 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 90' ' ' TYR . . . . . 1.65 ' HE1' ' CE2' ' D' ' 90' ' ' TYR . 13.0 p90 -153.42 132.13 12.31 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.74 0.781 . . . . 0.0 111.636 177.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 22.4 mt -64.58 127.03 29.78 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.088 173.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . 0.401 ' HB3' ' O ' ' D' ' 26' ' ' SER . 28.3 t60 -66.88 144.38 56.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.366 0.603 . . . . 0.0 111.289 -175.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 93' ' ' ASP . . . . . 0.402 ' CB ' ' HB3' ' D' ' 5' ' ' MET . 7.7 p-10 -73.35 -154.27 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.966 177.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 31.1 pt -72.21 133.15 32.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.441 0.639 . . . . 0.0 111.5 -177.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 95' ' ' ASP . . . . . 0.461 ' CB ' ' HG3' ' C' ' 5' ' ' MET . 8.6 m-20 -81.11 64.2 5.76 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.947 176.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 28.1 m 63.24 -165.36 0.24 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.955 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . 70.87 45.67 50.25 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.311 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 10.4 p . . . . . 0 C--O 1.251 1.181 0 CA-C-O 118.556 -0.735 . . . . 0.0 110.333 179.144 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 . . . . . 0 N--CA 1.48 1.072 0 CA-C-O 120.7 0.286 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -80.13 -48.04 13.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.131 0.491 . . . . 0.0 109.875 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . 135.26 -176.01 20.32 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.589 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.23 -48.08 10.87 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 5' ' ' MET . . . . . 0.433 ' HG3' ' CB ' ' A' ' 95' ' ' ASP . 22.7 mmt 58.47 -99.98 0.1 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.956 172.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 6' ' ' ALA . . . . . 0.538 ' O ' ' HB2' ' A' ' 70' ' ' SER . . . -86.31 131.07 34.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.796 0.331 . . . . 0.0 110.373 -177.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 38.6 mtt -124.14 144.14 50.08 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.214 0.53 . . . . 0.0 112.096 -176.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 8' ' ' PHE . . . . . 1.67 ' HE1' ' CE2' ' E' ' 8' ' ' PHE . 29.0 t80 -62.4 145.77 53.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.492 -178.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 9' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -135.72 147.38 48.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.096 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 10' ' ' GLY . . . . . 0.461 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -151.0 153.81 25.2 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.273 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . 0.429 ' HB3' ' HB2' ' E' ' 87' ' ' LEU . 33.2 tp -147.77 106.6 3.83 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 12' ' ' ASN . . . . . 0.457 ' HA ' ' HA ' ' E' ' 86' ' ' SER . 2.3 p30 -97.82 110.6 23.14 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.605 0.717 . . . . 0.0 110.987 176.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 13' ' ' MET . . . . . 0.4 ' SD ' HG21 ' E' ' 79' ' ' THR . 7.2 mtt -85.26 142.15 29.6 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.31 -178.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -89.71 144.21 31.47 Favored Pre-proline 0 C--N 1.315 -0.919 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 170.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -46.29 109.66 0.22 Allowed 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 123.519 2.813 . . . . 0.0 113.613 -174.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 16' ' ' GLU . . . . . 0.626 ' HA ' ' O ' ' E' ' 79' ' ' THR . 8.8 tt0 70.56 67.1 0.19 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.762 175.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 17' ' ' ARG . . . . . 0.507 ' HA ' ' NE ' ' E' ' 17' ' ' ARG . 4.7 mmp_? -122.79 169.2 11.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.013 175.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . 0.617 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 19.4 tttm -146.68 104.89 3.78 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.36 0.413 . . . . 0.0 111.303 -175.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . 1.653 ' HE2' ' CE1' ' E' ' 19' ' ' TYR . 1.8 m-85 -111.81 111.55 22.6 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.071 -177.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 20' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' E' ' 76' ' ' MET . 28.9 t -90.82 111.0 22.21 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -133.84 150.1 51.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.661 0.743 . . . . 0.0 112.721 -168.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 3.9 p -91.18 160.9 15.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.649 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 73.9 mt -111.14 126.26 68.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.176 -174.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . 0.506 HD13 ' N ' ' E' ' 25' ' ' LYS . 1.8 pp -92.55 -24.3 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.723 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . 0.506 ' N ' HD13 ' E' ' 24' ' ' ILE . 24.8 mtpp -147.56 132.96 18.57 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 15.5 m -54.9 119.4 5.33 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 27' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -137.4 156.67 47.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.725 0.774 . . . . 0.0 112.792 -170.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 28' ' ' HIS . . . . . 0.568 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 15.1 t60 -109.94 124.59 51.65 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.108 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 29' ' ' ILE . . . . . 0.529 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 39.3 mt -94.43 135.06 29.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 169.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 30' ' ' SER . . . . . 0.568 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 50.2 p -120.26 -15.87 8.57 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -169.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 31' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -160.32 145.21 10.86 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.314 -1.422 . . . . 0.0 113.361 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 12.0 p -129.92 121.65 52.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 168.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.1 154.37 43.86 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.955 -173.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 34' ' ' LEU . . . . . 0.514 ' HB3' ' CG1' ' E' ' 85' ' ' VAL . 4.4 pp -125.13 144.0 50.64 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.5 0.667 . . . . 0.0 110.836 177.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -110.24 -45.96 3.5 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 173.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -103.67 128.57 50.99 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.56 171.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . 0.474 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 146.7 163.0 10.19 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 119.641 -1.266 . . . . 0.0 113.57 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -102.25 -47.15 4.6 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.164 -0.214 . . . . 0.0 111.001 177.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -152.1 133.72 14.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.739 -0.21 . . . . 0.0 111.056 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.37 113.45 11.91 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.364 0.602 . . . . 0.0 110.167 167.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 41' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -97.86 112.66 24.49 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 174.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 43.1 tp -83.72 113.3 20.79 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.59 -174.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 43' ' ' TYR . . . . . 0.511 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 98.0 m-85 -115.77 141.47 48.05 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 44' ' ' LEU . . . . . 0.537 ' HB2' ' CD1' ' E' ' 77' ' ' PHE . 0.1 OUTLIER -129.95 131.89 46.13 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 173.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 45' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -110.78 114.95 28.7 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.994 177.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.86 142.49 50.66 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 58.79 29.19 18.4 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.372 0.42 . . . . 0.0 110.224 -174.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt 63.56 24.61 14.08 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.709 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 49' ' ' GLN . . . . . 0.449 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 24.1 tp60 -115.67 126.69 54.46 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -83.4 124.83 31.06 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.86 0.362 . . . . 0.0 110.724 -177.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . 1.666 ' HE2' ' CE1' ' E' ' 51' ' ' TYR . 66.2 m-85 -120.84 133.35 55.31 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.0 tp -82.12 107.65 14.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 169.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . 0.469 HG11 ' CD2' ' D' ' 88' ' ' LEU . 2.4 t -80.01 -49.58 18.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.663 -171.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 54' ' ' ALA . . . . . 0.436 ' HB2' HG12 ' E' ' 63' ' ' VAL . . . -160.01 148.96 17.44 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.099 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 54.4 m -109.86 102.24 11.03 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 173.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.76 114.27 44.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.625 0.726 . . . . 0.0 110.004 -177.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 81.1 p -123.06 -178.3 3.92 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.551 -174.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -63.58 -21.4 66.33 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.838 0.352 . . . . 0.0 110.414 170.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.55 -40.53 19.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.198 0.523 . . . . 0.0 110.245 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 80.6 mt -113.4 82.7 6.12 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 174.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.16 -0.17 6.85 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.106 2.537 . . . . 0.0 114.013 -167.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.15 127.15 2.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.163 0.506 . . . . 0.0 111.477 -176.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . 0.436 HG12 ' HB2' ' E' ' 54' ' ' ALA . 86.4 t -117.38 106.11 19.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.405 174.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.51 121.76 27.19 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 173.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' E' ' 30' ' ' SER . 0.6 OUTLIER -140.7 168.18 20.4 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.711 -173.044 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 66' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 11.7 t0 -118.83 105.18 11.26 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.267 0.556 . . . . 0.0 110.532 -177.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 67' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' E' ' 28' ' ' HIS . 15.2 mt -118.74 144.51 46.21 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.65 177.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 68' ' ' ASN . . . . . 0.42 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 57.3 t30 -148.53 114.73 5.84 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 173.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -110.06 164.53 12.53 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.187 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 70' ' ' SER . . . . . 0.537 ' HB2' ' O ' ' D' ' 6' ' ' ALA . 33.0 t -107.91 149.17 28.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.836 0.351 . . . . 0.0 110.687 -177.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 71' ' ' LYS . . . . . 0.402 ' HE2' ' HB2' ' E' ' 71' ' ' LYS . 0.0 OUTLIER -68.06 -11.91 59.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.345 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.38 -5.81 61.68 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.583 175.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -100.02 167.91 10.18 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -145.19 128.11 16.44 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 75' ' ' ILE . . . . . . . . . . . . . 15.3 pt -134.93 165.51 30.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.094 0.473 . . . . 0.0 111.763 -169.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 76' ' ' MET . . . . . 0.484 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 4.5 mtm -120.92 123.5 42.63 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 173.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 77' ' ' PHE . . . . . 1.658 ' HE2' ' CE1' ' E' ' 77' ' ' PHE . 0.7 OUTLIER -106.03 127.6 53.28 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 78' ' ' TYR . . . . . 1.632 ' HE2' ' CE1' ' E' ' 78' ' ' TYR . 40.7 p90 -154.93 144.13 21.09 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.958 -177.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 79' ' ' THR . . . . . 0.626 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 6.5 p -116.18 141.54 48.01 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.396 -177.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.59 153.4 22.94 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.319 176.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.93 -175.41 36.73 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -175.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -118.76 104.84 10.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 118.12 0.96 . . . . 0.0 110.527 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 83' ' ' ALA . . . . . 0.474 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -166.1 154.83 11.17 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.182 170.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 19.5 t -106.21 111.23 23.74 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 85' ' ' VAL . . . . . 0.514 ' CG1' ' HB3' ' E' ' 34' ' ' LEU . 3.4 m -111.48 138.23 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 CA-C-O 121.348 0.594 . . . . 0.0 112.095 -174.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 86' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' E' ' 12' ' ' ASN . 7.4 t -108.95 118.19 36.16 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.8 178.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 87' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' E' ' 31' ' ' GLY . 5.4 mp -89.8 149.22 22.79 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.566 174.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . 0.49 ' CD2' HG11 ' A' ' 53' ' ' VAL . 1.3 tp -131.91 140.71 49.13 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.022 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.34 -167.14 25.47 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.776 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 90' ' ' TYR . . . . . 1.64 ' HE1' ' CE2' ' E' ' 90' ' ' TYR . 12.9 p90 -153.36 132.27 12.46 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.712 0.768 . . . . 0.0 111.604 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 91' ' ' LEU . . . . . . . . . . . . . 22.0 mt -64.6 126.97 29.57 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.177 173.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -66.83 144.43 56.29 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.479 0.656 . . . . 0.0 111.242 -175.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 93' ' ' ASP . . . . . 0.405 ' CB ' ' HB3' ' E' ' 5' ' ' MET . 7.6 p-10 -73.46 -154.22 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.997 177.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 94' ' ' ILE . . . . . 0.402 ' H ' ' HB2' ' E' ' 93' ' ' ASP . 30.9 pt -72.2 133.06 32.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.377 0.608 . . . . 0.0 111.484 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 95' ' ' ASP . . . . . 0.478 ' CB ' ' HG3' ' D' ' 5' ' ' MET . 8.4 m-20 -81.03 64.27 5.72 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.028 176.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 28.4 m 63.17 -165.24 0.24 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.964 -175.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . 70.85 45.62 50.67 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.318 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 10.6 p . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.703 -0.665 . . . . 0.0 110.383 179.092 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 120.905 0.383 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -145.39 175.57 10.22 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.609 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.13 155.9 53.25 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.489 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.58 156.13 24.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.993 0.425 . . . . 0.0 111.332 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 22.1 ptm -136.75 148.58 47.34 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.51 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -111.43 147.69 34.7 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.159 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.555 ' HA ' ' OG ' ' B' ' 70' ' ' SER . 16.5 ttt -93.44 168.87 10.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.275 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 1.644 ' HE1' ' CE2' ' A' ' 8' ' ' PHE . 54.1 t80 -79.66 129.7 34.71 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.062 0.458 . . . . 0.0 112.102 -177.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.521 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 87.8 t90 -113.82 148.49 36.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.596 174.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.19 145.55 13.96 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.258 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.526 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 58.5 tp -139.09 110.25 6.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.027 0.441 . . . . 0.0 110.93 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -86.04 116.41 24.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.958 176.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.506 ' HB2' HG22 ' A' ' 85' ' ' VAL . 4.1 mmt -98.52 130.81 45.1 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.444 ' HD2' ' HD2' ' A' ' 15' ' ' PRO . 48.2 tptt -100.55 132.06 22.89 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 174.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.474 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 2.0 Cg_endo -46.25 117.68 2.07 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.539 2.826 . . . . 0.0 113.476 -175.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.659 ' HA ' ' O ' ' A' ' 79' ' ' THR . 37.8 mt-10 64.14 56.24 1.4 Allowed 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.411 178.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.86 135.31 52.78 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.63 172.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.672 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 82.8 mttt -103.73 115.71 30.98 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 123.313 0.383 . . . . 0.0 111.272 177.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.405 ' HH ' ' HA ' ' A' ' 13' ' ' MET . 4.6 m-85 -105.52 102.9 12.33 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 p -89.36 98.93 12.04 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 173.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -111.83 146.39 37.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.229 -167.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.8 m -100.45 143.06 31.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.282 174.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.455 ' CD1' ' HB2' ' A' ' 69' ' ' PHE . 54.0 mt -108.52 125.84 65.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.202 0.525 . . . . 0.0 111.772 -172.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.456 HD13 ' N ' ' A' ' 24' ' ' ILE . 4.2 mp -102.22 -50.6 9.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.395 -0.821 . . . . 0.0 108.852 176.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.7 pttp -103.21 122.41 44.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.552 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.6 t -60.94 142.71 56.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.964 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -147.8 148.27 30.74 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.517 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 2.1 t60 -102.65 125.18 49.29 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 114.147 -1.388 . . . . 0.0 109.601 176.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.484 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 47.0 mt -87.34 131.24 35.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 172.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.517 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 95.3 p -116.59 -12.25 10.97 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -169.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . 179.99 158.72 22.51 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 119.166 -1.492 . . . . 0.0 113.702 177.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.0 p -141.29 138.97 33.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 175.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -152.95 156.17 38.38 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 121.97 -0.457 . . . . 0.0 111.886 -177.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.566 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 4.1 pp -125.31 148.04 48.88 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.501 0.667 . . . . 0.0 111.911 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -110.64 -55.15 2.51 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.133 169.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -100.84 127.91 47.1 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.211 174.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.47 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 150.48 162.98 10.93 Favored Glycine 0 N--CA 1.434 -1.495 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.533 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -102.56 -47.04 4.57 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.713 0.292 . . . . 0.0 111.018 176.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -152.48 132.51 13.42 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.344 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.407 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . . . -127.28 113.28 16.08 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.436 0.636 . . . . 0.0 110.061 168.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 79' ' ' THR . 97.5 mttt -95.34 112.02 23.8 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.5 tp -86.12 107.48 17.87 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -174.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 1.599 ' HE2' ' CE1' ' A' ' 43' ' ' TYR . 75.4 m-85 -107.4 146.11 32.08 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.741 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.646 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 1.5 tp -129.98 116.32 18.42 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.665 176.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.55 109.28 21.12 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -143.14 150.05 38.91 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.423 -177.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 57.35 30.99 19.44 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.35 0.595 . . . . 0.0 109.98 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 61.2 40.49 14.6 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.204 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -144.16 136.59 26.73 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -87.35 117.72 26.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.936 0.398 . . . . 0.0 110.042 178.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 1.636 ' HD1' ' CD2' ' A' ' 51' ' ' TYR . 76.6 m-85 -112.76 122.97 49.23 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.673 178.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -80.82 100.9 5.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 170.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.445 HG13 ' CD2' ' E' ' 88' ' ' LEU . 21.6 m -86.45 -33.19 7.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.749 -172.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.469 ' HB1' HD22 ' A' ' 65' ' ' LEU . . . -153.19 144.59 23.23 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 120.28 -0.568 . . . . 0.0 112.214 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.2 m -115.51 102.47 9.83 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 169.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.405 HG11 ' HB1' ' A' ' 40' ' ' ALA . 8.9 p -116.18 114.21 45.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.744 0.783 . . . . 0.0 110.15 -177.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 69.1 p -123.18 -177.12 3.6 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.963 -175.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -59.37 -35.89 74.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.035 0.445 . . . . 0.0 109.971 169.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.407 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -71.23 -40.59 71.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.498 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.2 mt -114.31 82.33 7.34 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 17.3 Cg_exo -67.31 -6.65 16.83 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.208 2.605 . . . . 0.0 113.891 -168.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -161.49 132.09 5.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.262 0.554 . . . . 0.0 111.164 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.456 HG12 ' HB3' ' A' ' 54' ' ' ALA . 87.5 t -119.74 118.6 57.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.543 176.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.76 128.15 33.32 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.469 HD22 ' HB1' ' A' ' 54' ' ' ALA . 86.2 mt -120.21 163.82 17.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.457 0.646 . . . . 0.0 112.25 -172.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -140.86 97.4 3.18 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.548 169.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 2.8 mt -131.19 156.34 45.49 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.505 ' HB2' ' CZ ' ' E' ' 90' ' ' TYR . 42.7 t-20 -155.32 128.79 8.41 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 1.63 ' HE2' ' CE1' ' A' ' 69' ' ' PHE . 4.3 m-85 -124.03 145.05 49.47 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.522 ' OG ' ' HA ' ' E' ' 7' ' ' MET . 37.2 m -100.4 -178.53 3.84 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -175.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -62.34 -30.95 71.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.222 0.534 . . . . 0.0 110.345 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.82 4.44 85.03 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.661 -0.7 . . . . 0.0 113.074 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -99.94 119.59 38.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 117.171 0.485 . . . . 0.0 110.791 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -111.96 106.29 14.94 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 173.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.9 pt -120.91 168.07 13.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.163 -167.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.9 mtm -122.27 125.98 47.17 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 171.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 1.636 ' HD1' ' CD2' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -107.9 127.72 53.99 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 175.003 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 1.604 ' HD2' ' CD1' ' A' ' 78' ' ' TYR . 53.4 p90 -155.68 140.43 17.08 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 119.845 -0.742 . . . . 0.0 112.193 -175.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.659 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 12.0 p -106.09 138.85 41.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.958 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.09 153.23 22.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.413 174.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.45 -173.52 34.13 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -177.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -113.54 103.83 11.65 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.846 177.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.474 ' H ' ' HB3' ' A' ' 15' ' ' PRO . . . -170.87 153.65 4.0 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.89 169.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.7 p -110.23 123.23 49.4 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.15 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.566 ' CG1' ' HB3' ' A' ' 34' ' ' LEU . 10.9 m -124.74 153.35 31.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-O 121.459 0.647 . . . . 0.0 112.375 -173.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.5 m -113.26 126.78 55.78 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.854 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.526 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 4.6 mp -101.91 147.47 26.49 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 169.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.516 HD12 ' O ' ' A' ' 87' ' ' LEU . 2.3 mm? -125.22 154.3 41.81 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 173.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.67 -168.81 25.15 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 119.755 -1.212 . . . . 0.0 114.193 -178.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.514 ' CZ ' ' HB2' ' B' ' 68' ' ' ASN . 3.2 m-85 -117.56 118.92 33.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.344 -0.928 . . . . 0.0 110.392 -176.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.431 ' HB2' ' HB3' ' A' ' 7' ' ' MET . 16.5 mt -82.79 117.67 22.85 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.12 0.486 . . . . 0.0 110.337 172.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -93.72 173.72 7.54 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 175.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 74.25 4.81 4.59 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 122.911 0.484 . . . . 0.0 110.85 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 5.4 tp -69.91 126.19 29.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.568 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -77.12 79.97 3.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.308 0.575 . . . . 0.0 109.886 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.1 t -154.24 135.67 14.19 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.0 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -173.58 36.74 0.13 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.68 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.692 -0.67 . . . . 0.0 109.317 -178.779 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 120.954 0.407 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -145.38 175.6 10.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.594 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.22 155.82 53.2 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.444 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.47 156.11 23.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.154 0.502 . . . . 0.0 111.278 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 22.0 ptm -136.79 148.61 47.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.468 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -111.44 147.69 34.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.232 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' MET . . . . . 0.578 ' HA ' ' OG ' ' C' ' 70' ' ' SER . 16.6 ttt -93.43 168.79 10.83 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.295 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 1.622 ' HD1' ' CD2' ' B' ' 8' ' ' PHE . 54.4 t80 -79.51 129.72 34.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.034 0.445 . . . . 0.0 112.117 -177.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . 0.516 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 88.0 t90 -113.94 148.49 36.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.48 174.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.16 145.69 14.25 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.246 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.53 ' HB3' ' HB2' ' B' ' 87' ' ' LEU . 58.3 tp -139.16 110.12 6.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.941 0.4 . . . . 0.0 110.968 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -86.05 116.39 24.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.941 176.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' MET . . . . . 0.488 ' HB2' HG22 ' B' ' 85' ' ' VAL . 4.1 mmt -98.43 130.78 45.05 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -176.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.45 ' HD2' ' HD2' ' B' ' 15' ' ' PRO . 48.2 tptt -100.59 132.09 22.82 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 174.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.479 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 2.1 Cg_endo -46.24 117.82 2.14 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.441 2.761 . . . . 0.0 113.533 -175.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.66 ' HA ' ' O ' ' B' ' 79' ' ' THR . 37.9 mt-10 63.98 56.19 1.47 Allowed 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.492 178.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.75 135.29 52.86 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.644 172.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . 0.669 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 82.8 mttt -103.76 115.72 30.99 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 123.366 0.416 . . . . 0.0 111.236 177.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -105.49 102.82 12.26 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 14.7 p -89.3 98.84 11.99 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 173.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -111.78 146.39 37.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.389 0.614 . . . . 0.0 112.28 -167.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 28.9 m -100.43 143.1 31.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.249 174.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.446 ' CD1' ' HB2' ' B' ' 69' ' ' PHE . 54.2 mt -108.55 125.92 65.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.278 0.561 . . . . 0.0 111.748 -172.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.462 HD13 ' N ' ' B' ' 24' ' ' ILE . 4.2 mp -102.29 -50.56 9.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.825 176.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 12.8 pttp -103.13 122.31 44.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.63 174.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 35.6 t -60.97 142.73 56.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.95 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -147.83 148.24 30.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.963 0.887 . . . . 0.0 113.296 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' HIS . . . . . 0.519 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 2.1 t60 -102.55 125.15 49.17 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.692 176.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.482 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 46.8 mt -87.29 131.28 35.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 172.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.519 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 94.9 p -116.63 -12.33 10.92 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -169.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . 180.0 158.68 22.46 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 119.235 -1.46 . . . . 0.0 113.787 177.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 11.0 p -141.32 138.95 33.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 175.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -152.95 156.18 38.39 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.983 -0.448 . . . . 0.0 111.891 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.568 ' HB3' ' CG1' ' B' ' 85' ' ' VAL . 4.1 pp -125.31 148.03 48.88 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.52 0.676 . . . . 0.0 111.949 178.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -110.55 -55.3 2.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.129 169.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -100.79 128.06 46.98 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.26 174.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.466 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 150.42 163.02 10.95 Favored Glycine 0 N--CA 1.435 -1.423 0 C-N-CA 120.371 -0.918 . . . . 0.0 112.424 177.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -102.67 -46.94 4.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.647 0.26 . . . . 0.0 111.003 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -152.52 132.55 13.41 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.344 177.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.418 ' HB3' ' HB1' ' B' ' 83' ' ' ALA . . . -127.27 113.25 16.06 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.362 0.601 . . . . 0.0 110.166 167.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' B' ' 79' ' ' THR . 97.5 mttt -95.41 112.04 23.82 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 34.6 tp -86.15 107.47 17.88 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.711 -174.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . 1.594 ' HE2' ' CE1' ' B' ' 43' ' ' TYR . 74.8 m-85 -107.45 146.12 32.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.697 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.638 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 1.5 tp -129.94 116.39 18.55 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.69 176.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.57 109.24 21.07 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.203 0.525 . . . . 0.0 109.654 176.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -143.03 150.03 39.04 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.449 -177.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 57.41 30.88 19.31 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.44 0.638 . . . . 0.0 110.091 -179.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 61.18 40.55 14.59 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.213 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -144.19 136.74 26.83 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -87.43 117.67 26.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.867 0.365 . . . . 0.0 110.038 178.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 1.63 ' HD1' ' CD2' ' B' ' 51' ' ' TYR . 76.5 m-85 -112.73 122.98 49.25 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.698 178.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -80.82 100.91 5.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 170.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.453 HG13 ' CD2' ' A' ' 88' ' ' LEU . 21.5 m -86.52 -33.13 6.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.748 -172.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.465 ' HB1' HD22 ' B' ' 65' ' ' LEU . . . -153.12 144.54 23.27 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 120.284 -0.566 . . . . 0.0 112.208 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 27.2 m -115.55 102.4 9.75 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 169.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . 0.409 HG11 ' HB1' ' B' ' 40' ' ' ALA . 9.0 p -116.03 114.18 45.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.771 0.796 . . . . 0.0 110.149 -177.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 69.5 p -123.21 -177.19 3.62 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.905 -175.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -59.34 -35.87 74.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.06 0.457 . . . . 0.0 110.064 169.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.15 -40.6 71.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.538 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 79.0 mt -114.32 82.27 7.3 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.22 -6.77 17.02 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.329 2.686 . . . . 0.0 113.795 -168.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -161.44 132.12 5.15 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.409 0.623 . . . . 0.0 111.188 -175.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.46 HG12 ' HB3' ' B' ' 54' ' ' ALA . 87.8 t -119.77 118.75 58.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.532 176.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.86 128.15 33.34 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.465 HD22 ' HB1' ' B' ' 54' ' ' ALA . 86.0 mt -120.22 163.79 17.23 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.426 0.632 . . . . 0.0 112.297 -172.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -140.83 97.38 3.18 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.254 -0.884 . . . . 0.0 108.628 169.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' B' ' 28' ' ' HIS . 2.7 mt -131.19 156.3 45.57 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . 0.514 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 42.7 t-20 -155.32 128.68 8.36 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 174.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . 1.638 ' HD1' ' CD2' ' B' ' 69' ' ' PHE . 4.2 m-85 -123.88 145.05 49.38 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.555 ' OG ' ' HA ' ' A' ' 7' ' ' MET . 37.6 m -100.41 -178.54 3.84 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -175.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -62.31 -30.98 71.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.301 0.572 . . . . 0.0 110.31 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.91 4.53 85.08 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.696 -0.683 . . . . 0.0 113.022 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -100.06 119.56 38.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.058 0.456 . . . . 0.0 110.79 178.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -111.91 106.33 15.01 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 173.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 10.8 pt -121.02 168.0 13.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.193 -167.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' MET . . . . . . . . . . . . . 3.8 mtm -122.21 125.92 47.12 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 171.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . 1.65 ' HD1' ' CD2' ' B' ' 77' ' ' PHE . 0.3 OUTLIER -107.94 127.8 54.07 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 175.006 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 1.596 ' HE2' ' CE1' ' B' ' 78' ' ' TYR . 53.8 p90 -155.75 140.32 16.91 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 119.858 -0.737 . . . . 0.0 112.191 -175.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.66 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 12.1 p -105.98 138.8 41.54 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.975 -179.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.16 153.17 23.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.429 174.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.6 -173.5 33.89 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -113.53 103.88 11.71 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.832 177.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.479 ' H ' ' HB3' ' B' ' 15' ' ' PRO . . . -170.9 153.64 3.96 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.845 169.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 5.4 p -110.22 123.17 49.29 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.207 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.568 ' CG1' ' HB3' ' B' ' 34' ' ' LEU . 10.9 m -124.74 153.25 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-O 121.473 0.654 . . . . 0.0 112.364 -173.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 28.6 m -113.2 126.81 55.83 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.816 175.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.53 ' HB2' ' HB3' ' B' ' 11' ' ' LEU . 4.6 mp -101.98 147.46 26.54 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 169.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.514 HD12 ' O ' ' B' ' 87' ' ' LEU . 2.3 mm? -125.21 154.14 42.05 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 173.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.64 -168.73 24.99 Favored Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 119.776 -1.202 . . . . 0.0 114.21 -178.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' TYR . . . . . 0.517 ' CZ ' ' HB2' ' C' ' 68' ' ' ASN . 3.2 m-85 -117.55 118.91 33.45 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.348 -0.926 . . . . 0.0 110.396 -176.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . 0.445 ' HB2' ' HB3' ' B' ' 7' ' ' MET . 16.4 mt -82.83 117.65 22.86 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.164 0.507 . . . . 0.0 110.336 172.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 61.1 t60 -93.73 173.73 7.54 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 175.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 74.28 4.81 4.57 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.799 0.44 . . . . 0.0 110.853 176.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 5.3 tp -70.01 126.19 29.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.103 0.478 . . . . 0.0 110.453 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -77.16 79.98 3.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.567 0.699 . . . . 0.0 109.895 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 14.3 t -154.28 135.63 14.12 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.374 -0.83 . . . . 0.0 108.96 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . -173.5 36.96 0.13 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.743 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.689 -0.672 . . . . 0.0 109.348 -178.773 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 . . . . . 0 N--CA 1.481 1.102 0 CA-C-O 120.952 0.406 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -145.43 175.58 10.21 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.596 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.25 155.91 53.22 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.455 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.43 156.18 23.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.058 0.456 . . . . 0.0 111.219 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 22.1 ptm -136.89 148.57 47.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.523 -178.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 6' ' ' ALA . . . . . . . . . . . . . . . -111.47 147.66 34.82 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.217 178.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 7' ' ' MET . . . . . 0.504 ' HA ' ' OG ' ' D' ' 70' ' ' SER . 16.6 ttt -93.36 168.87 10.79 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.276 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 8' ' ' PHE . . . . . 1.628 ' HE2' ' CE1' ' C' ' 8' ' ' PHE . 54.6 t80 -79.55 129.77 34.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.994 0.426 . . . . 0.0 112.093 -177.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . 0.518 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 87.9 t90 -114.01 148.52 36.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.456 174.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.23 145.58 14.0 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.286 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.529 ' HB3' ' HB2' ' C' ' 87' ' ' LEU . 58.3 tp -139.11 110.15 6.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.981 0.419 . . . . 0.0 110.937 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -86.01 116.37 24.18 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.98 176.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 13' ' ' MET . . . . . 0.506 ' HB2' HG22 ' C' ' 85' ' ' VAL . 4.1 mmt -98.48 130.74 45.08 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -176.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . 0.437 ' HD2' ' HD2' ' C' ' 15' ' ' PRO . 48.2 tptt -100.58 132.18 22.71 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 174.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . 0.479 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 2.0 Cg_endo -46.4 117.84 2.21 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.479 2.786 . . . . 0.0 113.52 -175.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . 0.663 ' HA ' ' O ' ' C' ' 79' ' ' THR . 38.0 mt-10 64.14 56.03 1.43 Allowed 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.481 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.75 135.31 52.88 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.64 173.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 18' ' ' LYS . . . . . 0.673 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 82.7 mttt -103.74 115.87 31.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.157 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . 0.41 ' HH ' ' HA ' ' C' ' 13' ' ' MET . 4.6 m-85 -105.56 102.81 12.25 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 175.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 15.3 p -89.43 98.92 12.04 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 173.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -111.82 146.46 37.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.178 -167.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 28.7 m -100.54 143.18 31.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.253 174.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . 0.452 ' CD1' ' HB2' ' C' ' 69' ' ' PHE . 53.8 mt -108.58 125.89 65.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.236 0.541 . . . . 0.0 111.722 -172.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . 0.458 HD13 ' N ' ' C' ' 24' ' ' ILE . 4.2 mp -102.28 -50.59 9.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.43 -0.804 . . . . 0.0 108.88 176.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 12.8 pttp -103.17 122.27 44.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.616 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 35.6 t -60.88 142.77 55.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.02 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 27' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -147.87 148.28 30.68 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 28' ' ' HIS . . . . . 0.52 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 2.1 t60 -102.62 125.25 49.28 Favored 'General case' 0 C--O 1.217 -0.658 0 CA-C-N 114.084 -1.416 . . . . 0.0 109.645 176.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . 0.479 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 46.7 mt -87.33 131.36 35.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 172.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 30' ' ' SER . . . . . 0.52 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 94.6 p -116.73 -12.24 10.87 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -169.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . 179.99 158.73 22.53 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 119.073 -1.536 . . . . 0.0 113.651 177.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 11.0 p -141.27 138.93 33.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 175.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -152.92 156.22 38.51 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.98 -0.45 . . . . 0.0 111.94 -177.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.565 ' HB3' ' CG1' ' C' ' 85' ' ' VAL . 4.1 pp -125.35 148.03 48.91 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.571 0.7 . . . . 0.0 111.892 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -110.62 -55.12 2.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.162 169.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -100.92 127.98 47.15 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.157 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 37' ' ' GLY . . . . . 0.456 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 150.49 163.04 10.97 Favored Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 120.333 -0.936 . . . . 0.0 112.461 177.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -102.67 -47.03 4.55 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.567 0.222 . . . . 0.0 111.001 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -152.42 132.54 13.5 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.364 177.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . 0.416 ' HB3' ' HB1' ' C' ' 83' ' ' ALA . . . -127.28 113.24 16.04 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.42 0.629 . . . . 0.0 110.113 168.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' C' ' 79' ' ' THR . 97.5 mttt -95.37 112.06 23.83 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 175.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 34.6 tp -86.17 107.48 17.9 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -174.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 43' ' ' TYR . . . . . 1.622 ' HE2' ' CE1' ' C' ' 43' ' ' TYR . 74.6 m-85 -107.47 146.14 32.15 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.7 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.649 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 1.5 tp -129.98 116.3 18.39 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.67 176.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.53 109.3 21.14 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.166 0.508 . . . . 0.0 109.668 176.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -143.12 150.1 39.01 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.495 -177.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 57.25 31.02 19.4 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.396 0.617 . . . . 0.0 110.033 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 97.0 mttt 61.13 40.5 14.8 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.261 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 15.0 tp60 -144.18 136.76 26.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.9 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -87.35 117.68 26.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.847 0.356 . . . . 0.0 110.066 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 1.649 ' HD1' ' CD2' ' C' ' 51' ' ' TYR . 76.6 m-85 -112.79 123.02 49.37 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.651 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -80.85 100.92 5.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 170.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 53' ' ' VAL . . . . . 0.461 HG13 ' CD2' ' B' ' 88' ' ' LEU . 21.5 m -86.46 -33.18 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.756 -172.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 54' ' ' ALA . . . . . 0.46 ' HB1' HD22 ' C' ' 65' ' ' LEU . . . -153.16 144.51 23.2 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 120.394 -0.522 . . . . 0.0 112.201 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 27.3 m -115.52 102.5 9.85 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 169.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . 0.409 HG11 ' HB1' ' C' ' 40' ' ' ALA . 9.0 p -116.13 114.12 45.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.763 0.792 . . . . 0.0 110.18 -177.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 69.7 p -123.15 -177.18 3.61 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.972 -175.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -59.32 -35.93 74.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.075 0.465 . . . . 0.0 110.015 169.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . 0.401 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -71.17 -40.56 71.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.527 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 79.0 mt -114.36 82.29 7.38 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 174.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 61' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 17.2 Cg_exo -67.27 -6.72 16.96 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.268 2.645 . . . . 0.0 113.851 -168.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -161.46 132.16 5.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.288 0.566 . . . . 0.0 111.2 -175.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.457 HG12 ' HB3' ' C' ' 54' ' ' ALA . 87.9 t -119.76 118.61 57.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.524 176.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.79 128.13 33.3 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . 0.46 HD22 ' HB1' ' C' ' 54' ' ' ALA . 85.9 mt -120.14 163.86 17.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.396 0.617 . . . . 0.0 112.277 -172.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -140.9 97.43 3.19 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.206 -0.907 . . . . 0.0 108.554 169.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' C' ' 28' ' ' HIS . 2.8 mt -131.22 156.31 45.58 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . 0.517 ' HB2' ' CZ ' ' B' ' 90' ' ' TYR . 42.7 t-20 -155.27 128.71 8.4 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 174.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 69' ' ' PHE . . . . . 1.66 ' HD1' ' CD2' ' C' ' 69' ' ' PHE . 4.2 m-85 -123.91 145.08 49.38 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 70' ' ' SER . . . . . 0.578 ' OG ' ' HA ' ' B' ' 7' ' ' MET . 37.7 m -100.51 -178.46 3.81 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -175.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -62.33 -30.91 71.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.244 0.545 . . . . 0.0 110.399 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.92 4.5 85.15 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.76 -0.654 . . . . 0.0 113.005 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -100.05 119.55 38.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.109 0.454 . . . . 0.0 110.81 178.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -111.96 106.34 15.0 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 173.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 10.8 pt -121.01 167.99 13.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.128 -167.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 76' ' ' MET . . . . . . . . . . . . . 3.9 mtm -122.15 126.06 47.52 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 171.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 77' ' ' PHE . . . . . 1.66 ' HD1' ' CD2' ' C' ' 77' ' ' PHE . 0.3 OUTLIER -107.99 127.7 53.99 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 174.864 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 78' ' ' TYR . . . . . 1.625 ' HE1' ' CE2' ' C' ' 78' ' ' TYR . 53.7 p90 -155.58 140.33 17.1 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 119.808 -0.757 . . . . 0.0 112.208 -175.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 79' ' ' THR . . . . . 0.663 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 12.3 p -105.9 138.82 41.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.052 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.13 153.21 22.98 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.364 174.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.46 -173.45 34.05 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -177.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -113.55 103.82 11.64 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.654 0.727 . . . . 0.0 109.842 177.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . 0.479 ' H ' ' HB3' ' C' ' 15' ' ' PRO . . . -170.92 153.6 3.93 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.813 169.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 5.7 p -110.22 123.27 49.47 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.192 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.565 ' CG1' ' HB3' ' C' ' 34' ' ' LEU . 10.8 m -124.82 153.36 31.76 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-O 121.447 0.642 . . . . 0.0 112.347 -173.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 29.0 m -113.3 126.66 55.63 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.772 175.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . 0.529 ' HB2' ' HB3' ' C' ' 11' ' ' LEU . 4.6 mp -101.83 147.42 26.52 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 169.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . 0.513 HD12 ' O ' ' C' ' 87' ' ' LEU . 2.3 mm? -125.21 154.19 41.98 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 173.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.65 -168.73 25.0 Favored Glycine 0 N--CA 1.438 -1.213 0 C-N-CA 119.753 -1.213 . . . . 0.0 114.222 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 90' ' ' TYR . . . . . 0.483 ' CZ ' ' HB2' ' D' ' 68' ' ' ASN . 3.2 m-85 -117.62 118.96 33.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.351 -0.925 . . . . 0.0 110.29 -176.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . 0.451 ' HB2' ' HB3' ' C' ' 7' ' ' MET . 16.4 mt -82.8 117.62 22.82 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.199 0.523 . . . . 0.0 110.35 172.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 61.1 t60 -93.66 173.73 7.54 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 175.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 74.27 4.73 4.56 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.401 0.438 . . . . 0.0 110.901 176.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 5.4 tp -69.91 126.23 29.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.54 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -77.15 79.88 3.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.398 0.618 . . . . 0.0 109.899 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 14.1 t -154.18 135.74 14.3 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.96 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -173.59 36.89 0.13 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.74 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.628 -0.701 . . . . 0.0 109.332 -178.768 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 120.983 0.42 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -145.37 175.58 10.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.67 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.21 155.91 53.23 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.47 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.49 156.13 23.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.158 0.504 . . . . 0.0 111.264 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 22.0 ptm -136.93 148.55 47.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.499 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 6' ' ' ALA . . . . . . . . . . . . . . . -111.45 147.69 34.74 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.187 178.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 7' ' ' MET . . . . . 0.549 ' HA ' ' OG ' ' E' ' 70' ' ' SER . 16.6 ttt -93.45 168.87 10.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.274 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 8' ' ' PHE . . . . . 1.656 ' HE2' ' CE1' ' D' ' 8' ' ' PHE . 54.5 t80 -79.59 129.62 34.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.005 0.431 . . . . 0.0 112.135 -177.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 9' ' ' TRP . . . . . 0.52 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 87.9 t90 -113.81 148.51 36.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.496 174.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.18 145.66 14.18 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.225 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' D' ' 87' ' ' LEU . 58.7 tp -139.11 110.15 6.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.893 0.378 . . . . 0.0 111.005 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -86.09 116.47 24.32 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.916 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 13' ' ' MET . . . . . 0.502 ' HB2' HG22 ' D' ' 85' ' ' VAL . 4.1 mmt -98.49 130.66 45.09 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -176.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 14' ' ' LYS . . . . . 0.444 ' HD2' ' HD2' ' D' ' 15' ' ' PRO . 48.2 tptt -100.54 132.11 22.83 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . 0.48 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 1.9 Cg_endo -46.32 117.82 2.17 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.527 2.818 . . . . 0.0 113.464 -175.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . 0.648 ' HA ' ' O ' ' D' ' 79' ' ' THR . 37.9 mt-10 64.08 56.14 1.44 Allowed 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.452 178.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.79 135.38 52.91 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.609 172.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . 0.664 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 82.8 mttt -103.68 115.76 31.09 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 123.327 0.392 . . . . 0.0 111.168 177.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 19' ' ' TYR . . . . . 0.405 ' HH ' ' HA ' ' D' ' 13' ' ' MET . 4.5 m-85 -105.49 102.84 12.29 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 175.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 14.9 p -89.4 98.89 12.02 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -111.8 146.36 37.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.306 -167.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 29.0 m -100.47 143.17 30.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.234 174.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . 0.451 ' CD1' ' HB2' ' D' ' 69' ' ' PHE . 54.1 mt -108.46 125.87 65.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.193 0.52 . . . . 0.0 111.774 -172.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . 0.454 ' N ' HD13 ' D' ' 24' ' ' ILE . 4.2 mp -102.31 -50.57 9.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.382 -0.826 . . . . 0.0 108.884 176.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 12.8 pttp -103.17 122.38 44.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.604 174.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 35.6 t -60.86 142.7 55.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.923 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 27' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -147.83 148.33 30.77 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 28' ' ' HIS . . . . . 0.514 ' HA ' ' O ' ' D' ' 67' ' ' LEU . 2.1 t60 -102.66 125.2 49.31 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 114.106 -1.407 . . . . 0.0 109.649 176.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 29' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 46.9 mt -87.3 131.31 35.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 172.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 30' ' ' SER . . . . . 0.508 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 94.6 p -116.66 -12.24 10.92 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -169.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 31' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . 179.92 158.7 22.44 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 119.145 -1.502 . . . . 0.0 113.72 177.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 11.0 p -141.3 138.85 33.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 175.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -152.85 156.23 38.61 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.878 -0.514 . . . . 0.0 111.92 -177.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 34' ' ' LEU . . . . . 0.567 ' HB3' ' CG1' ' D' ' 85' ' ' VAL . 4.1 pp -125.33 148.01 48.9 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.475 0.655 . . . . 0.0 111.944 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -110.57 -55.28 2.49 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.14 169.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -100.76 128.0 46.97 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.154 174.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . 0.469 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 150.39 163.09 10.99 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.428 177.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -102.63 -47.01 4.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 120.58 0.228 . . . . 0.0 110.984 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -152.47 132.52 13.44 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.346 177.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . 0.41 ' HB3' ' HB1' ' D' ' 83' ' ' ALA . . . -127.26 113.26 16.08 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.414 0.626 . . . . 0.0 110.093 168.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' D' ' 79' ' ' THR . 97.5 mttt -95.34 112.01 23.79 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 34.6 tp -86.2 107.41 17.88 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -174.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 43' ' ' TYR . . . . . 1.644 ' HE2' ' CE1' ' D' ' 43' ' ' TYR . 75.1 m-85 -107.4 146.09 32.1 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.73 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.647 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 1.5 tp -129.95 116.34 18.47 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.65 176.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.62 109.3 21.16 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -143.04 150.18 39.24 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.423 -177.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 57.2 30.94 19.21 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.397 0.618 . . . . 0.0 110.043 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 61.2 40.59 14.47 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.154 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -144.16 136.66 26.8 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -87.3 117.71 26.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.912 0.387 . . . . 0.0 110.027 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . 1.659 ' HD1' ' CD2' ' D' ' 51' ' ' TYR . 76.6 m-85 -112.84 123.09 49.52 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.671 178.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -80.9 100.87 5.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 170.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 53' ' ' VAL . . . . . 0.454 HG13 ' CD2' ' C' ' 88' ' ' LEU . 21.4 m -86.42 -33.25 7.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.714 -172.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 54' ' ' ALA . . . . . 0.455 ' HB1' HD22 ' D' ' 65' ' ' LEU . . . -153.13 144.49 23.22 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 120.301 -0.56 . . . . 0.0 112.264 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 27.5 m -115.51 102.46 9.82 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 169.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 56' ' ' VAL . . . . . . . . . . . . . 8.9 p -116.12 114.19 45.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.75 0.786 . . . . 0.0 110.119 -177.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 67.7 p -123.19 -177.19 3.62 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.931 -175.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -59.27 -35.99 74.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.075 0.464 . . . . 0.0 110.008 169.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.16 -40.49 71.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.632 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 79.0 mt -114.33 82.28 7.33 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.26 -6.63 16.74 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.251 2.634 . . . . 0.0 113.904 -168.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -161.49 132.12 5.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.322 0.582 . . . . 0.0 111.169 -175.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.454 HG12 ' HB3' ' D' ' 54' ' ' ALA . 88.2 t -119.75 118.72 58.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.551 176.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.84 128.08 33.26 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 174.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 65' ' ' LEU . . . . . 0.455 HD22 ' HB1' ' D' ' 54' ' ' ALA . 86.1 mt -120.17 163.87 17.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.412 0.625 . . . . 0.0 112.287 -172.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -140.91 97.45 3.19 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 169.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' D' ' 28' ' ' HIS . 2.7 mt -131.21 156.29 45.6 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 68' ' ' ASN . . . . . 0.483 ' HB2' ' CZ ' ' C' ' 90' ' ' TYR . 42.8 t-20 -155.27 128.7 8.4 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 174.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 69' ' ' PHE . . . . . 1.657 ' HE1' ' CE2' ' D' ' 69' ' ' PHE . 4.3 m-85 -123.96 145.15 49.36 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 70' ' ' SER . . . . . 0.504 ' OG ' ' HA ' ' C' ' 7' ' ' MET . 37.7 m -100.43 -178.5 3.82 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -175.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -62.39 -30.9 71.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.291 0.567 . . . . 0.0 110.342 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.87 4.39 85.23 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.035 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -100.04 119.51 38.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.988 0.423 . . . . 0.0 110.775 178.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -111.81 106.37 15.1 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 173.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . . . . . . . . . 10.9 pt -121.05 168.04 13.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.087 -167.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 76' ' ' MET . . . . . . . . . . . . . 3.9 mtm -122.27 125.96 47.14 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 171.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 77' ' ' PHE . . . . . 1.663 ' HE2' ' CE1' ' D' ' 77' ' ' PHE . 0.3 OUTLIER -107.95 127.72 54.0 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 78' ' ' TYR . . . . . 1.626 ' HE2' ' CE1' ' D' ' 78' ' ' TYR . 53.4 p90 -155.65 140.32 17.02 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.849 -0.74 . . . . 0.0 112.198 -175.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 79' ' ' THR . . . . . 0.648 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 12.1 p -106.04 138.85 41.51 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.017 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.17 153.15 23.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.401 174.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.54 -173.58 34.06 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -176.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -113.52 103.8 11.62 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.879 177.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.48 ' H ' ' HB3' ' D' ' 15' ' ' PRO . . . -170.83 153.54 3.99 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.89 169.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 5.8 p -110.13 123.2 49.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.237 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . 0.567 ' CG1' ' HB3' ' D' ' 34' ' ' LEU . 11.0 m -124.7 153.39 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-O 121.381 0.61 . . . . 0.0 112.38 -173.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 27.8 m -113.31 126.75 55.73 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.843 175.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 87' ' ' LEU . . . . . 0.523 ' HB2' ' HB3' ' D' ' 11' ' ' LEU . 4.6 mp -101.89 147.47 26.49 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 169.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . 0.521 HD12 ' O ' ' D' ' 87' ' ' LEU . 2.3 mm? -125.2 154.19 41.96 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 173.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.75 -168.81 25.24 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 119.758 -1.21 . . . . 0.0 114.165 -178.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 90' ' ' TYR . . . . . 0.527 ' CZ ' ' HB2' ' E' ' 68' ' ' ASN . 3.2 m-85 -117.61 118.9 33.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.375 -0.912 . . . . 0.0 110.34 -176.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . 0.452 ' HB2' ' HB3' ' D' ' 7' ' ' MET . 16.5 mt -82.7 117.68 22.8 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.09 0.472 . . . . 0.0 110.377 172.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -93.81 173.69 7.55 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 74.37 4.77 4.53 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 122.887 0.475 . . . . 0.0 110.795 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 5.4 tp -69.91 126.23 29.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.519 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -77.25 80.04 3.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.538 0.685 . . . . 0.0 109.865 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 14.1 t -154.23 135.71 14.23 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.043 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . -173.65 36.83 0.13 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.679 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.675 -0.679 . . . . 0.0 109.333 -178.846 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 . . . . . 0 N--CA 1.479 1.024 0 CA-C-O 120.981 0.42 . . . . 0.0 110.4 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -145.33 175.64 10.15 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.617 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.29 155.82 53.18 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.424 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.35 156.17 23.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.074 0.464 . . . . 0.0 111.302 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 22.1 ptm -136.94 148.44 46.97 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.46 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 6' ' ' ALA . . . . . . . . . . . . . . . -111.38 147.71 34.61 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.198 178.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 7' ' ' MET . . . . . 0.522 ' HA ' ' OG ' ' A' ' 70' ' ' SER . 16.6 ttt -93.45 168.92 10.74 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.26 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 8' ' ' PHE . . . . . 1.664 ' HD1' ' CD2' ' E' ' 8' ' ' PHE . 54.1 t80 -79.71 129.73 34.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.076 0.465 . . . . 0.0 112.048 -177.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 9' ' ' TRP . . . . . 0.525 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 87.8 t90 -113.87 148.54 36.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.537 174.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.24 145.63 14.11 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.236 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . 0.546 ' HB3' ' HB2' ' E' ' 87' ' ' LEU . 58.3 tp -139.16 110.19 6.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.909 0.385 . . . . 0.0 110.981 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -86.07 116.37 24.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.931 176.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 13' ' ' MET . . . . . 0.504 ' HB2' HG22 ' E' ' 85' ' ' VAL . 4.1 mmt -98.41 130.77 45.04 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -176.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 14' ' ' LYS . . . . . 0.445 ' HD2' ' HD2' ' E' ' 15' ' ' PRO . 48.3 tptt -100.65 132.13 22.71 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 174.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . 0.468 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 2.0 Cg_endo -46.22 117.75 2.1 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 123.513 2.808 . . . . 0.0 113.507 -175.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 16' ' ' GLU . . . . . 0.654 ' HA ' ' O ' ' E' ' 79' ' ' THR . 37.8 mt-10 64.05 56.18 1.44 Allowed 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.472 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.73 135.29 52.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.673 172.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . 0.668 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 82.9 mttt -103.65 115.76 31.1 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 123.302 0.376 . . . . 0.0 111.249 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . 0.408 ' HH ' ' HA ' ' E' ' 13' ' ' MET . 4.6 m-85 -105.48 102.84 12.28 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 175.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 15.4 p -89.35 98.85 12.0 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 173.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -111.92 146.41 37.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.449 0.642 . . . . 0.0 112.203 -167.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 29.2 m -100.49 143.1 31.07 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.218 174.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 23' ' ' ILE . . . . . 0.445 ' CD1' ' HB2' ' E' ' 69' ' ' PHE . 54.1 mt -108.52 125.92 65.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.143 0.497 . . . . 0.0 111.786 -172.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . 0.456 ' N ' HD13 ' E' ' 24' ' ' ILE . 4.3 mp -102.36 -50.56 9.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.823 176.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 12.7 pttp -103.24 122.37 44.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.56 174.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 35.6 t -60.94 142.71 56.2 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.936 -177.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 27' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -147.85 148.29 30.72 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -177.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 28' ' ' HIS . . . . . 0.513 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 2.1 t60 -102.52 125.18 49.16 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.714 176.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 29' ' ' ILE . . . . . 0.478 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 46.5 mt -87.32 131.28 35.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 172.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 30' ' ' SER . . . . . 0.513 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 94.9 p -116.61 -12.23 10.95 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -169.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 31' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . 179.95 158.65 22.37 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 119.144 -1.503 . . . . 0.0 113.724 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 11.0 p -141.28 138.94 33.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -152.91 156.17 38.41 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.967 -0.458 . . . . 0.0 111.945 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 34' ' ' LEU . . . . . 0.569 ' HB3' ' CG1' ' E' ' 85' ' ' VAL . 4.1 pp -125.29 148.06 48.86 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.593 0.711 . . . . 0.0 111.968 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -110.68 -55.13 2.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.068 169.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -100.87 127.96 47.11 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.226 174.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . 0.471 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 150.49 163.07 10.99 Favored Glycine 0 N--CA 1.434 -1.489 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.437 177.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 38' ' ' GLN . . . . . 0.401 ' HA ' ' HD2' ' E' ' 58' ' ' LYS . 25.7 mt-30 -102.6 -47.07 4.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.552 0.215 . . . . 0.0 111.037 176.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -152.45 132.45 13.41 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.356 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . 0.414 ' HB3' ' HB1' ' E' ' 83' ' ' ALA . . . -127.25 113.29 16.12 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.386 0.612 . . . . 0.0 110.109 168.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 41' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' E' ' 79' ' ' THR . 97.6 mttt -95.45 112.11 23.88 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 175.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 34.6 tp -86.21 107.53 17.95 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -174.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 43' ' ' TYR . . . . . 1.629 ' HE2' ' CE1' ' E' ' 43' ' ' TYR . 75.4 m-85 -107.41 146.01 32.23 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.765 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 44' ' ' LEU . . . . . 0.635 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 1.5 tp -129.93 116.42 18.61 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.662 176.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.55 109.31 21.15 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -143.13 150.12 39.02 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.407 -177.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 57.32 30.9 19.26 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.429 0.633 . . . . 0.0 110.047 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 61.29 40.46 14.37 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.201 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 49' ' ' GLN . . . . . . . . . . . . . 15.0 tp60 -144.12 136.7 26.89 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.932 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -87.34 117.7 26.28 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.901 0.382 . . . . 0.0 110.076 178.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . 1.656 ' HD1' ' CD2' ' E' ' 51' ' ' TYR . 76.7 m-85 -112.83 123.02 49.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.655 178.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -80.87 100.95 5.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 170.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . 0.44 HG13 ' CD2' ' D' ' 88' ' ' LEU . 21.5 m -86.42 -33.29 7.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.7 -172.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 54' ' ' ALA . . . . . 0.462 ' HB1' HD22 ' E' ' 65' ' ' LEU . . . -153.2 144.52 23.17 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 120.271 -0.571 . . . . 0.0 112.203 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 27.5 m -115.46 102.45 9.83 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 169.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . 0.409 HG11 ' HB1' ' E' ' 40' ' ' ALA . 9.0 p -116.13 114.2 45.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.819 0.818 . . . . 0.0 110.097 -177.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 70.4 p -123.26 -177.05 3.59 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.91 -175.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 58' ' ' LYS . . . . . 0.401 ' HD2' ' HA ' ' E' ' 38' ' ' GLN . 27.2 mtpp -59.32 -35.91 74.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.257 0.551 . . . . 0.0 110.048 169.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 59' ' ' ALA . . . . . 0.407 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -71.25 -40.56 70.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.487 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 79.5 mt -114.34 82.37 7.42 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 174.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 61' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 17.2 Cg_exo -67.37 -6.67 16.94 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.232 2.621 . . . . 0.0 113.893 -168.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -161.41 132.09 5.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.256 0.551 . . . . 0.0 111.252 -175.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . 0.447 HG12 ' HB3' ' E' ' 54' ' ' ALA . 87.3 t -119.76 118.72 58.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.511 176.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.85 128.19 33.38 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 174.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . 0.462 HD22 ' HB1' ' E' ' 54' ' ' ALA . 86.2 mt -120.2 163.75 17.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.339 0.59 . . . . 0.0 112.283 -172.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 66' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -140.79 97.39 3.18 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 169.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 67' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' E' ' 28' ' ' HIS . 2.7 mt -131.19 156.29 45.6 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 68' ' ' ASN . . . . . 0.527 ' HB2' ' CZ ' ' D' ' 90' ' ' TYR . 42.6 t-20 -155.31 128.67 8.35 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 69' ' ' PHE . . . . . 1.643 ' HE2' ' CE1' ' E' ' 69' ' ' PHE . 4.2 m-85 -123.88 145.07 49.36 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 70' ' ' SER . . . . . 0.549 ' OG ' ' HA ' ' D' ' 7' ' ' MET . 37.1 m -100.43 -178.56 3.84 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -175.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -62.37 -30.75 71.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.245 0.545 . . . . 0.0 110.422 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -85.08 4.52 85.36 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.949 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -100.11 119.53 38.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.11 0.455 . . . . 0.0 110.795 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -111.83 106.39 15.11 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 173.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 75' ' ' ILE . . . . . . . . . . . . . 10.8 pt -121.05 167.96 13.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.134 -167.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 76' ' ' MET . . . . . . . . . . . . . 3.9 mtm -122.21 126.04 47.38 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 171.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 77' ' ' PHE . . . . . 1.664 ' HE2' ' CE1' ' E' ' 77' ' ' PHE . 0.3 OUTLIER -107.89 127.73 53.99 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 174.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' E' E ' 78' ' ' TYR . . . . . 1.625 ' HE2' ' CE1' ' E' ' 78' ' ' TYR . 53.3 p90 -155.63 140.37 17.08 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 119.818 -0.753 . . . . 0.0 112.187 -175.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 79' ' ' THR . . . . . 0.654 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 12.1 p -106.07 138.93 41.4 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.948 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.19 153.15 23.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.418 174.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.53 -173.37 33.86 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -177.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -113.66 103.83 11.62 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.87 177.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 83' ' ' ALA . . . . . 0.471 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -170.98 153.56 3.86 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.856 169.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 5.6 p -110.24 123.15 49.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.246 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 85' ' ' VAL . . . . . 0.569 ' CG1' ' HB3' ' E' ' 34' ' ' LEU . 11.1 m -124.71 153.26 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-O 121.456 0.646 . . . . 0.0 112.388 -173.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 29.3 m -113.2 126.82 55.85 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.833 175.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 87' ' ' LEU . . . . . 0.546 ' HB2' ' HB3' ' E' ' 11' ' ' LEU . 4.6 mp -101.99 147.5 26.48 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 169.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . 0.518 HD12 ' O ' ' E' ' 87' ' ' LEU . 2.3 mm? -125.27 154.17 42.11 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 173.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.65 -168.76 25.05 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 119.728 -1.225 . . . . 0.0 114.161 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 90' ' ' TYR . . . . . 0.505 ' CZ ' ' HB2' ' A' ' 68' ' ' ASN . 3.2 m-85 -117.61 118.99 33.64 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.328 -0.936 . . . . 0.0 110.295 -176.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 91' ' ' LEU . . . . . 0.437 ' HB2' ' HB3' ' E' ' 7' ' ' MET . 16.4 mt -82.86 117.71 22.92 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.189 0.519 . . . . 0.0 110.352 172.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 61.3 t60 -93.7 173.8 7.5 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 74.26 4.72 4.57 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.404 0.44 . . . . 0.0 110.864 176.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 5.4 tp -69.86 126.19 29.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.515 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -77.16 79.96 3.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.421 0.629 . . . . 0.0 109.861 177.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 14.3 t -154.21 135.68 14.22 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.009 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . -173.59 36.84 0.13 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.72 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.68 -0.676 . . . . 0.0 109.289 -178.779 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 1.656 ' HE1' ' CE2' ' A' ' 1' ' ' PHE . 90.2 t80 . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 120.539 0.209 . . . . 0.0 110.511 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.669 ' O ' ' HB ' ' B' ' 94' ' ' ILE . 42.5 mt-30 54.52 -101.43 0.12 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.315 -177.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.597 ' HA2' ' O ' ' A' ' 94' ' ' ILE . . . 103.36 174.33 26.17 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.027 -1.083 . . . . 0.0 113.894 173.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 67.08 26.75 8.84 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.813 0.845 . . . . 0.0 111.314 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 44.3 ttm -88.15 47.53 1.51 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.529 0.681 . . . . 0.0 109.845 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.539 ' HB2' ' ND2' ' B' ' 68' ' ' ASN . . . -65.92 151.96 45.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.337 -176.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.421 ' HA ' ' HB2' ' B' ' 70' ' ' SER . 46.1 ttm -104.29 142.5 34.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.823 -174.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 1.651 ' HD1' ' CD2' ' A' ' 8' ' ' PHE . 68.0 t80 -61.3 147.53 44.28 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -172.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.406 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 89.5 t90 -138.55 145.53 40.79 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.842 179.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.69 151.44 23.54 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.039 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.512 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 40.8 tp -146.28 109.66 4.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.63 0.252 . . . . 0.0 110.884 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 52.7 m-20 -88.46 125.31 34.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.475 0.655 . . . . 0.0 111.096 176.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.459 ' HB2' HG21 ' A' ' 85' ' ' VAL . 7.0 mmt -98.31 130.21 44.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.432 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.418 ' HB3' ' CG ' ' A' ' 17' ' ' ARG . 59.7 tttm -96.98 134.25 23.19 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 171.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.407 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 2.2 Cg_endo -43.95 112.95 0.36 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.398 2.732 . . . . 0.0 113.401 -174.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.667 ' HA ' ' O ' ' A' ' 79' ' ' THR . 48.8 mt-10 69.45 44.25 0.94 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.811 178.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.418 ' CG ' ' HB3' ' A' ' 14' ' ' LYS . 12.0 mmt180 -104.61 138.27 41.2 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.961 170.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.612 ' HG2' ' CB ' ' A' ' 78' ' ' TYR . 46.6 mttp -113.18 118.75 35.58 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 123.392 0.432 . . . . 0.0 110.501 175.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 1.613 ' HD1' ' CD2' ' A' ' 19' ' ' TYR . 6.2 m-85 -110.51 103.84 12.49 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 177.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 76' ' ' MET . 42.7 t -86.43 102.46 14.07 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 172.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -116.84 144.36 44.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.799 -170.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.1 t -97.84 157.0 16.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.01 174.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.4 mt -120.3 124.11 71.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.098 0.475 . . . . 0.0 111.365 -173.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.553 HD11 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -114.44 -18.32 7.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.894 176.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -132.47 121.79 23.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.657 176.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.0 t -65.73 133.44 51.07 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.056 -174.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.447 ' HB3' HD21 ' A' ' 91' ' ' LEU . 46.5 p90 -137.59 147.28 44.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.648 0.737 . . . . 0.0 112.219 -177.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.532 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 7.4 t60 -104.64 125.06 50.39 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.664 174.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 45.0 mt -90.87 133.19 33.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 170.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.532 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 67.8 p -119.82 -7.36 10.01 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -171.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -175.64 159.14 26.74 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 119.2 -1.476 . . . . 0.0 113.706 177.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 86' ' ' SER . 11.1 p -144.43 131.7 16.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.5 157.66 43.61 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.968 -0.458 . . . . 0.0 112.115 -175.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.56 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 4.2 pp -126.63 146.18 50.27 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.541 0.686 . . . . 0.0 111.996 178.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -110.76 -52.19 2.81 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.614 -1.175 . . . . 0.0 108.864 168.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -99.74 127.68 45.87 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.426 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 142.4 159.4 7.92 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.543 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -101.47 -45.41 5.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.723 0.297 . . . . 0.0 111.164 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -152.27 126.45 9.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.582 -179.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.416 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . . . -127.61 113.7 16.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.389 0.614 . . . . 0.0 110.221 169.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -99.35 112.16 24.39 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 174.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.1 tp -81.61 115.51 20.92 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.692 -175.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 1.63 ' HE2' ' CE1' ' A' ' 43' ' ' TYR . 74.8 m-85 -115.53 145.33 42.74 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.49 0.662 . . . . 0.0 110.245 178.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.611 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 0.9 OUTLIER -128.58 118.28 22.71 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.774 177.083 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -105.61 104.47 14.19 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.67 177.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.64 139.76 52.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.564 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 57.99 31.06 20.12 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 123.605 0.565 . . . . 0.0 110.06 -174.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 62.18 30.34 17.68 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.298 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 8.4 tp-100 -121.42 125.6 47.32 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 177.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -83.08 117.2 22.69 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.792 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -113.6 132.42 55.75 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.727 175.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -81.34 112.56 19.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 168.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.495 ' CG2' ' HB3' ' A' ' 44' ' ' LEU . 3.4 t -86.98 -51.62 12.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.737 -172.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.455 ' HB3' HG12 ' A' ' 63' ' ' VAL . . . -151.53 144.88 24.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.453 -176.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.5 m -109.29 101.7 10.69 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 171.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.18 110.84 32.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.907 0.86 . . . . 0.0 109.987 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 81.0 p -123.58 -177.47 3.73 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.356 -174.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -56.98 -34.98 68.64 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.862 0.363 . . . . 0.0 110.634 167.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.98 -40.68 65.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.526 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.9 mt -116.24 83.37 12.71 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.39 -3.76 11.58 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.129 2.553 . . . . 0.0 113.972 -168.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -162.84 130.86 3.81 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.26 0.553 . . . . 0.0 111.17 -176.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.455 HG12 ' HB3' ' A' ' 54' ' ' ALA . 87.0 t -118.53 117.44 54.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.636 175.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.48 126.93 31.83 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.726 174.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.442 HD22 ' HB1' ' A' ' 54' ' ' ALA . 74.7 mt -121.02 167.02 13.05 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.405 0.621 . . . . 0.0 112.295 -173.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.443 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 10.9 t0 -137.51 98.18 3.64 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.549 168.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.533 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 4.9 mt -124.75 146.38 49.22 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.534 ' ND2' ' HB1' ' E' ' 6' ' ' ALA . 56.6 t30 -148.25 120.85 8.57 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.072 175.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -116.62 141.62 47.96 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.897 -177.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.451 ' HB2' ' HA ' ' E' ' 7' ' ' MET . 9.0 t -96.98 169.26 9.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.902 0.382 . . . . 0.0 110.145 -177.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -75.23 0.34 16.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.755 -178.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.08 -4.16 56.64 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 173.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -95.51 147.09 23.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.01 0.433 . . . . 0.0 110.926 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -130.85 118.24 20.47 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 172.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.43 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 16.8 pt -130.55 157.3 42.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.087 0.47 . . . . 0.0 111.869 -169.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.425 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 67.1 ttp -119.51 114.78 22.8 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.03 175.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 1.621 ' HE2' ' CE1' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -100.82 129.8 46.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.961 -177.119 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 1.655 ' HD1' ' CD2' ' A' ' 78' ' ' TYR . 53.4 p90 -152.5 150.66 29.84 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 119.959 -0.696 . . . . 0.0 112.049 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.667 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 7.3 p -113.32 136.34 52.86 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.384 177.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.24 152.03 23.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.517 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.95 -171.96 30.5 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -114.78 102.9 10.44 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.916 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.426 ' CB ' ' HA3' ' A' ' 37' ' ' GLY . . . -171.13 155.27 4.33 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.909 170.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.5 p -111.99 120.77 43.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.113 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.56 ' CG1' ' HB3' ' A' ' 34' ' ' LEU . 10.1 m -122.06 150.63 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 121.173 0.511 . . . . 0.0 112.341 -174.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 38.8 m -107.35 124.77 50.29 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.668 174.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.512 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 5.3 mp -94.94 146.56 24.15 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 169.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.436 ' CD2' HG11 ' B' ' 53' ' ' VAL . 1.0 OUTLIER -131.34 142.09 50.02 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.082 -178.582 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.08 -166.94 25.96 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.233 -176.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -154.33 134.62 13.3 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.859 0.838 . . . . 0.0 112.518 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.447 HD21 ' HB3' ' A' ' 27' ' ' PHE . 14.4 mt -70.6 139.35 51.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.985 175.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -86.13 109.27 18.75 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -172.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -134.96 74.95 1.54 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 167.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.624 ' HB ' ' O ' ' E' ' 2' ' ' GLN . 43.8 mm -74.45 -82.02 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.227 -172.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -82.26 84.09 7.21 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.238 0.542 . . . . 0.0 110.169 -178.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.7 m -68.58 -26.21 65.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.075 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -115.41 101.69 1.06 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.184 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.421 ' OG ' ' HA ' ' E' ' 1' ' ' PHE . 16.0 m . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.701 -0.666 . . . . 0.0 110.208 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 1.661 ' HE1' ' CE2' ' B' ' 1' ' ' PHE . 90.2 t80 . . . . . 0 N--CA 1.484 1.228 0 N-CA-C 110.558 -0.164 . . . . 0.0 110.558 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . 0.672 ' O ' ' HB ' ' C' ' 94' ' ' ILE . 42.9 mt-30 54.82 -101.63 0.13 Allowed 'General case' 0 N--CA 1.464 0.25 0 O-C-N 123.724 0.64 . . . . 0.0 110.26 -177.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . 0.602 ' HA2' ' O ' ' B' ' 94' ' ' ILE . . . 103.46 174.44 26.07 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.088 -1.054 . . . . 0.0 113.799 173.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . 66.97 26.82 9.01 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.818 0.847 . . . . 0.0 111.326 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 44.5 ttm -88.24 47.6 1.52 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.613 0.72 . . . . 0.0 109.85 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.513 ' HB1' ' ND2' ' C' ' 68' ' ' ASN . . . -65.87 151.97 45.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.32 -176.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' MET . . . . . 0.42 ' HA ' ' HB2' ' C' ' 70' ' ' SER . 45.9 ttm -104.33 142.5 34.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.898 -174.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 1.638 ' HE2' ' CE1' ' B' ' 8' ' ' PHE . 67.9 t80 -61.22 147.49 44.13 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -172.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . 0.404 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 89.5 t90 -138.54 145.52 40.78 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.84 179.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.72 151.42 23.52 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.019 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' B' ' 87' ' ' LEU . 40.4 tp -146.3 109.64 4.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.638 0.256 . . . . 0.0 110.855 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 -88.44 125.34 34.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.38 0.61 . . . . 0.0 111.126 176.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' MET . . . . . 0.461 ' HB2' HG21 ' B' ' 85' ' ' VAL . 7.1 mmt -98.27 130.07 44.98 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.576 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.417 ' HB3' ' HG3' ' B' ' 17' ' ' ARG . 59.7 tttm -96.89 134.24 23.28 Favored Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 171.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.406 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 2.2 Cg_endo -43.92 112.84 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.454 2.769 . . . . 0.0 113.431 -174.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' B' ' 79' ' ' THR . 48.8 mt-10 69.55 44.1 0.94 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.896 178.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.417 ' HG3' ' HB3' ' B' ' 14' ' ' LYS . 11.9 mmt180 -104.51 138.37 40.98 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.989 170.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . 0.604 ' HG2' ' CB ' ' B' ' 78' ' ' TYR . 46.5 mttp -113.32 118.62 35.1 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.299 0.374 . . . . 0.0 110.513 175.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' TYR . . . . . 1.612 ' HD2' ' CD1' ' B' ' 19' ' ' TYR . 6.2 m-85 -110.35 103.84 12.54 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 42.2 t -86.39 102.68 14.25 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 172.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -117.07 144.38 44.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.747 -170.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 11.2 t -97.84 157.11 16.27 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.002 174.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 55.4 mt -120.36 124.03 71.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.051 0.453 . . . . 0.0 111.287 -173.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.56 HD11 ' H ' ' B' ' 24' ' ' ILE . 0.2 OUTLIER -114.39 -18.3 7.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.871 176.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -132.45 121.81 23.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.6 176.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 46.9 t -65.75 133.48 51.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.06 -174.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . 0.456 ' HB3' HD21 ' B' ' 91' ' ' LEU . 46.3 p90 -137.58 147.35 44.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.708 0.766 . . . . 0.0 112.255 -177.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' HIS . . . . . 0.535 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 7.5 t60 -104.74 125.0 50.39 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.506 -1.224 . . . . 0.0 109.578 174.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 44.7 mt -90.79 133.27 33.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 170.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.535 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 67.5 p -119.88 -7.3 9.99 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -171.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -175.71 159.06 26.55 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 119.213 -1.47 . . . . 0.0 113.706 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' B' ' 86' ' ' SER . 11.1 p -144.42 131.74 16.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 173.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.57 157.54 43.53 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 121.944 -0.472 . . . . 0.0 112.098 -174.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.554 ' HB3' ' CG1' ' B' ' 85' ' ' VAL . 4.2 pp -126.48 146.28 50.17 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.607 0.718 . . . . 0.0 111.947 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -110.87 -52.17 2.81 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.583 -1.189 . . . . 0.0 108.825 168.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -99.62 127.66 45.73 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 175.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.425 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 142.32 159.32 7.89 Favored Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 120.176 -1.011 . . . . 0.0 112.617 178.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -101.33 -45.54 5.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.837 0.351 . . . . 0.0 111.115 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -152.23 126.45 9.23 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.617 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.425 ' HB3' ' HB1' ' B' ' 83' ' ' ALA . . . -127.67 113.77 16.46 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.493 0.663 . . . . 0.0 110.267 169.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -99.42 112.19 24.42 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 47.2 tp -81.61 115.37 20.85 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.661 -174.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . 1.626 ' HE2' ' CE1' ' B' ' 43' ' ' TYR . 75.1 m-85 -115.49 145.36 42.68 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.457 0.646 . . . . 0.0 110.355 178.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.603 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 0.9 OUTLIER -128.56 118.34 22.83 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.862 177.101 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -105.7 104.39 14.1 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.724 177.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.47 139.75 52.99 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.511 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 58.09 30.97 20.08 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 123.528 0.518 . . . . 0.0 109.985 -174.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 62.17 30.37 17.69 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.311 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 8.4 tp-100 -121.41 125.71 47.58 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -83.18 117.19 22.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.764 -177.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -113.67 132.4 55.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.742 175.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -81.33 112.62 19.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 169.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.481 ' CG2' ' HB3' ' B' ' 44' ' ' LEU . 3.4 t -86.99 -51.66 12.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.648 -172.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.461 ' HB3' HG12 ' B' ' 63' ' ' VAL . . . -151.54 145.01 24.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.449 -176.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 28.3 m -109.32 101.71 10.69 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 171.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.25 111.08 33.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.877 0.846 . . . . 0.0 109.909 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 81.3 p -123.71 -177.55 3.77 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.368 -174.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -56.91 -34.92 68.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.889 0.376 . . . . 0.0 110.68 167.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.99 -40.64 65.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.551 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 75.7 mt -116.33 83.43 13.04 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 175.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.43 -3.74 11.58 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.169 2.579 . . . . 0.0 113.972 -168.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -162.89 130.86 3.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.216 0.531 . . . . 0.0 111.228 -176.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.461 HG12 ' HB3' ' B' ' 54' ' ' ALA . 85.8 t -118.59 117.41 54.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.613 175.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.5 126.96 31.87 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.735 174.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.443 HD22 ' HB1' ' B' ' 54' ' ' ALA . 75.1 mt -121.07 167.05 13.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.497 0.665 . . . . 0.0 112.265 -173.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . 0.442 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 10.9 t0 -137.45 98.2 3.64 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.533 168.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.541 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 4.9 mt -124.71 146.45 49.15 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.11 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . 0.539 ' ND2' ' HB2' ' A' ' 6' ' ' ALA . 56.4 t30 -148.37 120.78 8.46 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.003 175.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -116.54 141.61 47.95 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.926 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.421 ' HB2' ' HA ' ' A' ' 7' ' ' MET . 9.0 t -97.03 169.14 10.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.898 0.38 . . . . 0.0 110.111 -177.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -75.08 0.39 16.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.802 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.23 -4.14 56.47 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 174.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -95.56 147.07 23.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.028 0.442 . . . . 0.0 110.946 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -130.79 118.29 20.6 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 172.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.424 ' HB ' ' CD1' ' B' ' 44' ' ' LEU . 16.7 pt -130.5 157.33 42.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.043 0.449 . . . . 0.0 111.827 -169.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' MET . . . . . 0.425 ' HA ' ' HA ' ' B' ' 20' ' ' SER . 67.1 ttp -119.61 114.87 22.88 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.949 175.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . 1.634 ' HD2' ' CD1' ' B' ' 77' ' ' PHE . 0.4 OUTLIER -100.86 129.8 46.78 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.017 -177.206 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 1.645 ' HE1' ' CE2' ' B' ' 78' ' ' TYR . 53.3 p90 -152.41 150.66 29.9 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.994 -0.683 . . . . 0.0 112.142 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.655 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 7.3 p -113.33 136.34 52.86 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.446 177.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.21 151.97 23.42 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.582 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.14 -172.02 30.29 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -114.71 102.86 10.42 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.011 177.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.425 ' HB1' ' HB3' ' B' ' 40' ' ' ALA . . . -171.11 155.22 4.32 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.947 170.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 10.1 p -111.89 120.7 42.82 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.204 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.554 ' CG1' ' HB3' ' B' ' 34' ' ' LEU . 10.3 m -121.91 150.78 25.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.206 0.527 . . . . 0.0 112.363 -174.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' B' ' 32' ' ' VAL . 38.7 m -107.43 124.76 50.34 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.579 174.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.51 ' HB2' ' HB3' ' B' ' 11' ' ' LEU . 5.3 mp -94.96 146.52 24.18 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 169.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.426 ' CD2' HG11 ' C' ' 53' ' ' VAL . 1.0 OUTLIER -131.22 142.13 50.13 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.142 -178.651 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.06 -166.91 25.87 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.259 -176.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -154.41 134.56 13.19 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.825 0.821 . . . . 0.0 112.582 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . 0.456 HD21 ' HB3' ' B' ' 27' ' ' PHE . 14.3 mt -70.5 139.32 51.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.872 -1.513 . . . . 0.0 110.006 175.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -86.14 109.2 18.71 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -172.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -134.93 75.06 1.55 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 167.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . 0.669 ' HB ' ' O ' ' A' ' 2' ' ' GLN . 44.0 mm -74.56 -82.06 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.217 -172.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -82.2 84.14 7.16 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.21 0.529 . . . . 0.0 110.217 -178.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 5.8 m -68.59 -26.18 65.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.103 -179.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . -115.46 101.75 1.06 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.122 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 98' ' ' SER . . . . . 0.419 ' OG ' ' HA ' ' A' ' 1' ' ' PHE . 15.9 m . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.763 -0.637 . . . . 0.0 110.25 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 1' ' ' PHE . . . . . 1.663 ' HE1' ' CE2' ' C' ' 1' ' ' PHE . 90.2 t80 . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 110.514 -0.18 . . . . 0.0 110.514 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . 0.599 ' O ' ' HB ' ' D' ' 94' ' ' ILE . 42.8 mt-30 54.58 -101.44 0.12 Allowed 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.646 0.591 . . . . 0.0 110.326 -177.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 3' ' ' GLY . . . . . 0.613 ' HA2' ' O ' ' C' ' 94' ' ' ILE . . . 103.33 174.42 26.2 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.114 -1.041 . . . . 0.0 113.804 173.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . 66.99 26.82 8.97 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.793 0.837 . . . . 0.0 111.365 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 44.5 ttm -88.19 47.55 1.52 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.488 0.661 . . . . 0.0 109.8 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 6' ' ' ALA . . . . . 0.512 ' HB2' ' ND2' ' D' ' 68' ' ' ASN . . . -65.93 152.02 45.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.336 -176.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 7' ' ' MET . . . . . 0.456 ' HA ' ' HB2' ' D' ' 70' ' ' SER . 45.9 ttm -104.29 142.45 34.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.84 -174.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 8' ' ' PHE . . . . . 1.655 ' HD1' ' CD2' ' C' ' 8' ' ' PHE . 67.8 t80 -61.32 147.36 44.94 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -172.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . 0.401 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 89.5 t90 -138.42 145.52 41.07 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.867 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.61 151.53 23.63 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.083 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.512 ' HB3' ' HB2' ' C' ' 87' ' ' LEU . 40.6 tp -146.33 109.63 4.74 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.706 0.253 . . . . 0.0 110.945 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -88.54 125.26 34.7 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.451 0.643 . . . . 0.0 111.037 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 13' ' ' MET . . . . . 0.459 ' HB2' HG21 ' C' ' 85' ' ' VAL . 7.1 mmt -98.26 130.17 44.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.568 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . 0.413 ' HB3' ' CG ' ' C' ' 17' ' ' ARG . 59.8 tttm -97.01 134.21 23.21 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 171.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . 0.408 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 2.2 Cg_endo -43.85 112.88 0.35 Allowed 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 123.451 2.767 . . . . 0.0 113.396 -174.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . 0.661 ' HA ' ' O ' ' C' ' 79' ' ' THR . 48.8 mt-10 69.45 44.32 0.94 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.813 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 17' ' ' ARG . . . . . 0.413 ' CG ' ' HB3' ' C' ' 14' ' ' LYS . 12.0 mmt180 -104.65 138.26 41.24 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.974 170.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 18' ' ' LYS . . . . . 0.614 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 46.5 mttp -113.27 118.61 35.1 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 123.375 0.422 . . . . 0.0 110.512 175.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . 1.633 ' HD2' ' CD1' ' C' ' 19' ' ' TYR . 6.2 m-85 -110.38 103.92 12.62 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 177.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 20' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 42.0 t -86.51 102.56 14.22 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 172.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -116.94 144.46 44.53 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.8 -170.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 11.1 t -97.9 157.06 16.31 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.99 174.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 55.6 mt -120.31 124.14 71.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.076 0.465 . . . . 0.0 111.309 -173.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . 0.554 HD11 ' H ' ' C' ' 24' ' ' ILE . 0.2 OUTLIER -114.48 -18.44 7.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.827 177.011 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -132.39 121.83 24.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.562 176.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 46.8 t -65.65 133.41 51.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.061 -174.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 27' ' ' PHE . . . . . 0.453 ' HB3' HD21 ' C' ' 91' ' ' LEU . 46.5 p90 -137.64 147.33 44.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.743 0.782 . . . . 0.0 112.184 -177.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 28' ' ' HIS . . . . . 0.539 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 7.3 t60 -104.84 125.12 50.55 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.521 174.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 44.5 mt -90.82 133.2 33.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 170.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 30' ' ' SER . . . . . 0.539 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 68.1 p -119.87 -7.27 10.01 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -171.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -175.73 159.1 26.59 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 119.204 -1.474 . . . . 0.0 113.708 177.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' C' ' 86' ' ' SER . 11.2 p -144.48 131.71 16.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 173.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.5 157.66 43.61 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.915 -0.491 . . . . 0.0 112.063 -175.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.557 ' HB3' ' CG1' ' C' ' 85' ' ' VAL . 4.2 pp -126.53 146.2 50.22 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.593 0.711 . . . . 0.0 111.966 178.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -110.7 -52.3 2.8 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.847 168.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -99.72 127.76 45.84 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 175.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 37' ' ' GLY . . . . . 0.424 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 142.29 159.31 7.88 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.53 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -101.45 -45.38 5.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.74 0.305 . . . . 0.0 111.166 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -152.3 126.54 9.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.532 -179.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . 0.42 ' HB3' ' HB1' ' C' ' 83' ' ' ALA . . . -127.74 113.74 16.39 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.475 0.655 . . . . 0.0 110.21 169.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -99.4 112.24 24.46 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 46.8 tp -81.64 115.51 20.94 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.635 -175.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 43' ' ' TYR . . . . . 1.651 ' HE2' ' CE1' ' C' ' 43' ' ' TYR . 75.0 m-85 -115.56 145.35 42.74 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.413 0.625 . . . . 0.0 110.356 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.621 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 0.9 OUTLIER -128.65 118.31 22.69 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.814 177.145 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -105.65 104.42 14.14 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.657 177.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.56 139.68 53.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.503 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 58.22 30.88 20.08 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 123.568 0.542 . . . . 0.0 110.029 -174.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 62.19 30.35 17.66 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.373 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . 0.415 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 8.4 tp-100 -121.38 125.68 47.55 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -83.14 117.18 22.71 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.851 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -113.62 132.43 55.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.696 176.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -81.4 112.49 19.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 169.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 53' ' ' VAL . . . . . 0.495 ' CG2' ' HB3' ' C' ' 44' ' ' LEU . 3.4 t -86.84 -51.74 12.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.736 -172.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 54' ' ' ALA . . . . . 0.463 ' HB3' HG12 ' C' ' 63' ' ' VAL . . . -151.43 144.97 24.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.504 -176.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 28.5 m -109.28 101.63 10.62 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 171.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.19 110.99 33.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.91 0.862 . . . . 0.0 109.944 -178.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 81.1 p -123.68 -177.48 3.75 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.274 -174.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -57.02 -34.98 68.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.985 0.421 . . . . 0.0 110.663 167.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.84 -40.79 65.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.529 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 75.6 mt -116.18 83.43 12.62 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 175.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.36 -3.78 11.59 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.228 2.618 . . . . 0.0 113.996 -168.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -162.9 130.86 3.77 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.256 0.551 . . . . 0.0 111.109 -175.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.463 HG12 ' HB3' ' C' ' 54' ' ' ALA . 86.5 t -118.6 117.45 54.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.636 175.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.53 126.97 31.89 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 174.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . 0.446 HD22 ' HB1' ' C' ' 54' ' ' ALA . 75.1 mt -121.14 166.99 13.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.41 0.624 . . . . 0.0 112.311 -173.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 66' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 10.9 t0 -137.43 98.11 3.63 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.585 168.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . 0.532 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 4.9 mt -124.71 146.42 49.17 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . 0.513 ' ND2' ' HB1' ' B' ' 6' ' ' ALA . 56.4 t30 -148.28 120.87 8.57 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.005 175.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -116.62 141.7 47.85 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.86 -177.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 70' ' ' SER . . . . . 0.42 ' HB2' ' HA ' ' B' ' 7' ' ' MET . 9.0 t -97.11 169.2 9.97 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.901 0.382 . . . . 0.0 110.063 -177.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -75.28 0.51 16.38 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.793 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.18 -4.17 56.52 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 173.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -95.43 147.08 23.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.064 0.459 . . . . 0.0 110.943 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -130.82 118.39 20.72 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . 0.421 ' HB ' ' CD1' ' C' ' 44' ' ' LEU . 16.8 pt -130.55 157.31 42.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.04 0.448 . . . . 0.0 111.86 -169.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 76' ' ' MET . . . . . 0.413 ' HA ' ' HA ' ' C' ' 20' ' ' SER . 67.1 ttp -119.67 114.84 22.8 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.954 175.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 77' ' ' PHE . . . . . 1.655 ' HD1' ' CD2' ' C' ' 77' ' ' PHE . 0.4 OUTLIER -100.84 129.84 46.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.009 -177.143 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 78' ' ' TYR . . . . . 1.613 ' HE2' ' CE1' ' C' ' 78' ' ' TYR . 53.2 p90 -152.44 150.63 29.85 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.051 -0.66 . . . . 0.0 112.135 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 79' ' ' THR . . . . . 0.661 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 7.3 p -113.26 136.34 52.85 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.445 177.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.19 151.93 23.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.526 177.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.08 -172.08 30.44 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -176.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -114.7 102.96 10.51 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.03 177.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . 0.424 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -171.2 155.2 4.26 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.831 170.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 10.3 p -111.87 120.67 42.75 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.133 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.557 ' CG1' ' HB3' ' C' ' 34' ' ' LEU . 9.9 m -121.95 150.77 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 CA-C-O 121.268 0.556 . . . . 0.0 112.236 -174.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 86' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' C' ' 32' ' ' VAL . 38.0 m -107.37 124.76 50.29 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.691 174.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . 0.512 ' HB2' ' HB3' ' C' ' 11' ' ' LEU . 5.3 mp -94.9 146.53 24.16 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 169.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . 0.406 HD21 HD23 ' D' ' 67' ' ' LEU . 1.0 OUTLIER -131.3 142.1 50.06 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.086 -178.632 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.07 -166.87 25.83 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.198 -176.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -154.41 134.55 13.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.865 0.84 . . . . 0.0 112.563 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . 0.453 HD21 ' HB3' ' C' ' 27' ' ' PHE . 14.3 mt -70.43 139.36 51.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 113.809 -1.541 . . . . 0.0 110.046 175.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -86.11 109.22 18.7 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -172.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -134.9 75.0 1.55 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 167.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . 0.672 ' HB ' ' O ' ' B' ' 2' ' ' GLN . 43.8 mm -74.55 -81.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.279 -172.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -82.27 84.17 7.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.19 0.519 . . . . 0.0 110.173 -178.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 5.7 m -68.6 -26.22 65.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.126 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -115.41 101.83 1.07 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.051 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 98' ' ' SER . . . . . 0.44 ' OG ' ' HA ' ' B' ' 1' ' ' PHE . 16.0 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.566 -0.73 . . . . 0.0 110.183 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . 1.661 ' HD2' ' CD1' ' D' ' 1' ' ' PHE . 90.2 t80 . . . . . 0 N--CA 1.483 1.179 0 N-CA-C 110.5 -0.185 . . . . 0.0 110.5 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . 0.642 ' O ' ' HB ' ' E' ' 94' ' ' ILE . 42.8 mt-30 54.73 -101.47 0.13 Allowed 'General case' 0 N--CA 1.464 0.273 0 O-C-N 123.716 0.635 . . . . 0.0 110.319 -177.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 3' ' ' GLY . . . . . 0.606 ' HA2' ' O ' ' D' ' 94' ' ' ILE . . . 103.45 174.31 26.08 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.851 173.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . 67.07 26.8 8.85 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.797 0.839 . . . . 0.0 111.335 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 44.5 ttm -88.25 47.58 1.52 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.554 0.692 . . . . 0.0 109.838 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 6' ' ' ALA . . . . . 0.515 ' HB2' ' ND2' ' E' ' 68' ' ' ASN . . . -65.91 152.03 45.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.363 -176.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 7' ' ' MET . . . . . 0.446 ' HA ' ' HB2' ' E' ' 70' ' ' SER . 45.9 ttm -104.3 142.47 34.49 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.814 -174.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 8' ' ' PHE . . . . . 1.67 ' HE2' ' CE1' ' D' ' 8' ' ' PHE . 67.9 t80 -61.27 147.45 44.46 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -172.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 9' ' ' TRP . . . . . 0.404 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 89.6 t90 -138.5 145.54 40.9 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.817 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.67 151.4 23.5 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.072 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . 0.514 ' HB3' ' HB2' ' D' ' 87' ' ' LEU . 40.1 tp -146.28 109.67 4.76 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.697 0.284 . . . . 0.0 110.909 -179.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -88.55 125.35 34.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.393 0.616 . . . . 0.0 111.046 176.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 13' ' ' MET . . . . . 0.467 ' HB2' HG21 ' D' ' 85' ' ' VAL . 7.1 mmt -98.3 130.14 44.99 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.526 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 14' ' ' LYS . . . . . 0.413 ' HB3' ' HG3' ' D' ' 17' ' ' ARG . 59.6 tttm -96.93 134.29 23.18 Favored Pre-proline 0 C--N 1.318 -0.799 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 171.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -44.03 112.91 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.482 2.788 . . . . 0.0 113.361 -174.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . 0.665 ' HA ' ' O ' ' D' ' 79' ' ' THR . 48.9 mt-10 69.47 44.2 0.94 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.869 178.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 17' ' ' ARG . . . . . 0.413 ' HG3' ' HB3' ' D' ' 14' ' ' LYS . 12.0 mmt180 -104.59 138.25 41.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.004 170.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . 0.61 ' HG2' ' CB ' ' D' ' 78' ' ' TYR . 46.6 mttp -113.26 118.64 35.22 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.367 0.417 . . . . 0.0 110.503 175.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 19' ' ' TYR . . . . . 1.664 ' HD2' ' CD1' ' D' ' 19' ' ' TYR . 6.2 m-85 -110.31 103.86 12.58 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 177.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 20' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 42.0 t -86.41 102.68 14.26 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 172.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -117.12 144.38 44.76 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.746 -170.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 11.3 t -97.8 157.08 16.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.068 174.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 55.7 mt -120.33 124.09 71.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.118 0.485 . . . . 0.0 111.287 -173.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . 0.557 ' H ' HD11 ' D' ' 24' ' ' ILE . 0.2 OUTLIER -114.43 -18.43 7.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.859 176.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -132.37 121.86 24.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.614 176.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 46.8 t -65.7 133.45 51.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.079 -174.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 27' ' ' PHE . . . . . 0.457 ' HB3' HD21 ' D' ' 91' ' ' LEU . 46.2 p90 -137.64 147.34 44.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.667 0.746 . . . . 0.0 112.171 -177.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 28' ' ' HIS . . . . . 0.542 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 7.4 t60 -104.77 125.04 50.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.616 174.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 29' ' ' ILE . . . . . 0.551 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 44.8 mt -90.78 133.18 33.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 170.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 30' ' ' SER . . . . . 0.542 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 67.4 p -119.82 -7.33 10.02 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -171.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 31' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -175.68 159.1 26.65 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 119.295 -1.431 . . . . 0.0 113.726 177.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 11.1 p -144.48 131.78 16.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 173.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.56 157.57 43.55 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.857 -0.527 . . . . 0.0 112.018 -174.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 34' ' ' LEU . . . . . 0.562 ' HB3' ' CG1' ' D' ' 85' ' ' VAL . 4.2 pp -126.53 146.17 50.23 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.645 0.736 . . . . 0.0 111.994 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -110.7 -52.3 2.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.865 168.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -99.7 127.73 45.82 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 175.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . 0.415 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 142.38 159.32 7.89 Favored Glycine 0 N--CA 1.435 -1.375 0 C-N-CA 120.191 -1.005 . . . . 0.0 112.562 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -101.42 -45.44 5.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.775 0.321 . . . . 0.0 111.167 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -152.28 126.49 9.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.634 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . 0.415 ' HB3' ' HB1' ' D' ' 83' ' ' ALA . . . -127.68 113.79 16.49 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.45 0.643 . . . . 0.0 110.227 169.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -99.44 112.15 24.39 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 46.9 tp -81.64 115.4 20.89 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.677 -174.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 43' ' ' TYR . . . . . 1.662 ' HE2' ' CE1' ' D' ' 43' ' ' TYR . 75.0 m-85 -115.49 145.3 42.74 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.394 0.616 . . . . 0.0 110.288 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.621 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.9 OUTLIER -128.46 118.34 22.93 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.845 177.032 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 45' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -105.7 104.47 14.19 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.641 177.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.62 139.76 52.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.575 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 58.13 30.93 20.06 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 123.509 0.506 . . . . 0.0 109.987 -174.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 62.24 30.46 17.59 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.232 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . 0.428 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 8.4 tp-100 -121.51 125.68 47.38 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -83.17 117.26 22.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.769 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -113.72 132.45 55.81 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.647 176.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -81.34 112.63 19.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 168.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 53' ' ' VAL . . . . . 0.492 ' CG2' ' HB3' ' D' ' 44' ' ' LEU . 3.4 t -87.01 -51.56 12.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.73 -172.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 54' ' ' ALA . . . . . 0.457 ' HB3' HG12 ' D' ' 63' ' ' VAL . . . -151.55 144.96 24.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.521 -176.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 28.5 m -109.33 101.73 10.7 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 171.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.25 110.98 32.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.956 0.884 . . . . 0.0 109.94 -178.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 81.0 p -123.58 -177.56 3.76 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.365 -174.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -57.03 -34.88 68.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.891 0.377 . . . . 0.0 110.642 167.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.01 -40.64 65.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.56 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 75.5 mt -116.27 83.45 12.9 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.48 -3.65 11.44 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.195 2.596 . . . . 0.0 113.933 -168.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -162.95 130.81 3.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.101 0.477 . . . . 0.0 111.162 -176.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.457 HG12 ' HB3' ' D' ' 54' ' ' ALA . 87.7 t -118.59 117.39 54.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.586 175.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.39 126.98 31.85 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 65' ' ' LEU . . . . . 0.448 HD22 ' HB1' ' D' ' 54' ' ' ALA . 75.6 mt -121.17 167.01 13.14 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.509 0.671 . . . . 0.0 112.209 -173.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 66' ' ' ASP . . . . . 0.419 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 10.8 t0 -137.46 98.14 3.63 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.538 168.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . 0.551 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 4.9 mt -124.69 146.38 49.17 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 68' ' ' ASN . . . . . 0.512 ' ND2' ' HB2' ' C' ' 6' ' ' ALA . 56.5 t30 -148.32 120.77 8.48 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.061 175.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -116.54 141.67 47.88 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.9 -177.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 70' ' ' SER . . . . . 0.456 ' HB2' ' HA ' ' C' ' 7' ' ' MET . 9.0 t -97.0 169.15 10.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.875 0.369 . . . . 0.0 110.1 -177.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -75.26 0.46 16.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.74 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.19 -4.08 56.54 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 173.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -95.53 147.06 23.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.076 0.465 . . . . 0.0 110.936 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -130.82 118.32 20.62 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 172.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . 0.42 ' HB ' ' CD1' ' D' ' 44' ' ' LEU . 16.8 pt -130.58 157.42 42.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.102 0.477 . . . . 0.0 111.788 -169.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 76' ' ' MET . . . . . 0.417 ' HA ' ' HA ' ' D' ' 20' ' ' SER . 67.1 ttp -119.71 114.8 22.72 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.947 175.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 77' ' ' PHE . . . . . 1.655 ' HE2' ' CE1' ' D' ' 77' ' ' PHE . 0.4 OUTLIER -100.84 129.7 46.75 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.018 -177.132 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 78' ' ' TYR . . . . . 1.612 ' HD1' ' CD2' ' D' ' 78' ' ' TYR . 53.3 p90 -152.33 150.61 29.92 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.151 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 79' ' ' THR . . . . . 0.665 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 7.2 p -113.25 136.36 52.82 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.453 177.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.2 151.97 23.42 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.503 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.01 -171.97 30.43 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 -176.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -114.67 102.87 10.44 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.042 177.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.415 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -171.09 155.27 4.36 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.9 170.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 9.9 p -111.93 120.7 42.82 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.13 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . 0.562 ' CG1' ' HB3' ' D' ' 34' ' ' LEU . 10.1 m -122.0 150.74 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-O 121.298 0.57 . . . . 0.0 112.289 -174.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 38.7 m -107.41 124.83 50.43 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.588 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 87' ' ' LEU . . . . . 0.514 ' HB2' ' HB3' ' D' ' 11' ' ' LEU . 5.3 mp -94.93 146.58 24.13 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 169.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . 0.429 ' CD2' HG11 ' E' ' 53' ' ' VAL . 1.0 OUTLIER -131.31 142.09 50.05 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.125 -178.709 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.1 -166.99 26.05 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.229 -176.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -154.34 134.57 13.26 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.808 0.813 . . . . 0.0 112.583 178.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . 0.457 HD21 ' HB3' ' D' ' 27' ' ' PHE . 14.3 mt -70.52 139.32 51.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 113.89 -1.504 . . . . 0.0 109.987 175.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -86.06 109.13 18.61 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -172.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -134.9 75.05 1.55 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 167.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . 0.606 ' O ' ' HA2' ' D' ' 3' ' ' GLY . 43.9 mm -74.44 -82.02 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.258 -172.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -82.32 84.21 7.2 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.29 0.566 . . . . 0.0 110.163 -178.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 5.8 m -68.66 -26.18 65.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.129 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . -115.38 101.69 1.06 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.211 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 98' ' ' SER . . . . . 0.4 ' OG ' ' HA ' ' C' ' 1' ' ' PHE . 16.0 m . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.82 -0.61 . . . . 0.0 110.189 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 1' ' ' PHE . . . . . 1.67 ' HE2' ' CE1' ' E' ' 1' ' ' PHE . 90.1 t80 . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 110.539 -0.171 . . . . 0.0 110.539 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 2' ' ' GLN . . . . . 0.624 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 42.6 mt-30 54.7 -101.56 0.13 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.319 -177.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 3' ' ' GLY . . . . . 0.604 ' HA2' ' O ' ' E' ' 94' ' ' ILE . . . 103.48 174.38 26.05 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 119.975 -1.107 . . . . 0.0 113.795 173.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . 67.04 26.76 8.9 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.806 0.842 . . . . 0.0 111.339 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 44.5 ttm -88.22 47.61 1.53 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.597 0.713 . . . . 0.0 109.836 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 6' ' ' ALA . . . . . 0.534 ' HB1' ' ND2' ' A' ' 68' ' ' ASN . . . -65.98 151.98 45.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.338 -176.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 7' ' ' MET . . . . . 0.451 ' HA ' ' HB2' ' A' ' 70' ' ' SER . 45.9 ttm -104.25 142.47 34.47 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.835 -174.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 8' ' ' PHE . . . . . 1.663 ' HE1' ' CE2' ' E' ' 8' ' ' PHE . 68.1 t80 -61.26 147.45 44.44 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -172.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 9' ' ' TRP . . . . . 0.402 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 89.5 t90 -138.47 145.59 41.03 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.882 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.76 151.34 23.45 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.083 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' E' ' 87' ' ' LEU . 40.8 tp -146.2 109.62 4.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.67 0.272 . . . . 0.0 110.928 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 -88.43 125.28 34.65 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.356 0.598 . . . . 0.0 111.112 176.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 13' ' ' MET . . . . . 0.466 ' HB2' HG21 ' E' ' 85' ' ' VAL . 7.1 mmt -98.3 130.16 44.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.522 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 14' ' ' LYS . . . . . 0.416 ' HB3' ' CG ' ' E' ' 17' ' ' ARG . 59.7 tttm -97.05 134.24 23.14 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 171.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -44.05 112.93 0.37 Allowed 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 123.43 2.754 . . . . 0.0 113.373 -174.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 16' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' E' ' 79' ' ' THR . 48.8 mt-10 69.53 44.16 0.94 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.827 178.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 17' ' ' ARG . . . . . 0.416 ' CG ' ' HB3' ' E' ' 14' ' ' LYS . 11.9 mmt180 -104.46 138.27 41.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.978 170.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . 0.612 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 46.6 mttp -113.29 118.72 35.41 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.47 0.481 . . . . 0.0 110.521 175.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . 1.654 ' HE1' ' CE2' ' E' ' 19' ' ' TYR . 6.1 m-85 -110.35 103.96 12.67 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 177.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 20' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' E' ' 76' ' ' MET . 42.3 t -86.5 102.5 14.16 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 172.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -117.01 144.35 44.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.772 -170.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 11.3 t -97.81 157.03 16.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.005 174.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 55.5 mt -120.29 124.11 71.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.052 0.453 . . . . 0.0 111.323 -173.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . 0.565 ' H ' HD11 ' E' ' 24' ' ' ILE . 0.2 OUTLIER -114.43 -18.37 7.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.907 176.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -132.37 121.77 24.0 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.62 176.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 46.8 t -65.71 133.43 51.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.061 -174.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 27' ' ' PHE . . . . . 0.448 ' HB3' HD21 ' E' ' 91' ' ' LEU . 46.6 p90 -137.6 147.3 44.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.692 0.758 . . . . 0.0 112.241 -177.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 28' ' ' HIS . . . . . 0.527 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 7.4 t60 -104.73 124.99 50.36 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.64 174.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 29' ' ' ILE . . . . . 0.548 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 45.1 mt -90.75 133.15 33.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 170.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 30' ' ' SER . . . . . 0.527 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 67.5 p -119.87 -7.18 10.01 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -171.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 31' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -175.75 159.12 26.6 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 119.183 -1.484 . . . . 0.0 113.747 177.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 11.1 p -144.49 131.72 16.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 173.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.48 157.64 43.6 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.932 -0.48 . . . . 0.0 112.02 -174.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 34' ' ' LEU . . . . . 0.556 ' HB3' ' CG1' ' E' ' 85' ' ' VAL . 4.2 pp -126.6 146.26 50.23 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.635 0.731 . . . . 0.0 111.948 178.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -110.85 -52.21 2.8 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.818 168.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -99.72 127.71 45.84 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . 0.423 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 142.37 159.32 7.88 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.589 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -101.37 -45.41 5.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.708 0.289 . . . . 0.0 111.18 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -152.33 126.41 9.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.626 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . 0.418 ' HB3' ' HB1' ' E' ' 83' ' ' ALA . . . -127.61 113.81 16.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.438 0.637 . . . . 0.0 110.205 169.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 41' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -99.49 112.3 24.52 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 174.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 46.8 tp -81.66 115.41 20.91 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.651 -175.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 43' ' ' TYR . . . . . 1.652 ' HE2' ' CE1' ' E' ' 43' ' ' TYR . 75.3 m-85 -115.48 145.32 42.71 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.515 0.674 . . . . 0.0 110.297 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 44' ' ' LEU . . . . . 0.603 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 0.9 OUTLIER -128.6 118.34 22.79 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.801 177.066 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' E' E ' 45' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -105.64 104.42 14.13 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.697 177.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.54 139.77 52.96 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.587 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 57.98 31.04 20.09 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 123.611 0.569 . . . . 0.0 110.058 -174.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 62.24 30.27 17.56 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.284 -178.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 49' ' ' GLN . . . . . 0.429 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 8.4 tp-100 -121.35 125.67 47.55 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 178.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -83.16 117.2 22.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.815 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -113.64 132.44 55.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.714 175.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -81.27 112.51 19.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 168.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . 0.491 ' CG2' ' HB3' ' E' ' 44' ' ' LEU . 3.4 t -86.98 -51.51 12.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.732 -172.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 54' ' ' ALA . . . . . 0.453 ' HB1' HD22 ' E' ' 65' ' ' LEU . . . -151.57 144.97 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.468 -176.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 28.2 m -109.23 101.69 10.69 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 171.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.25 110.9 32.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.885 0.85 . . . . 0.0 109.9 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 81.1 p -123.59 -177.54 3.75 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.342 -174.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -56.92 -35.05 68.59 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.965 0.412 . . . . 0.0 110.555 167.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.9 -40.63 65.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.534 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 75.5 mt -116.35 83.38 13.0 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 175.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.38 -3.78 11.61 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.177 2.584 . . . . 0.0 113.933 -168.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -162.84 130.83 3.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.247 0.546 . . . . 0.0 111.135 -175.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . 0.445 HG12 ' HB3' ' E' ' 54' ' ' ALA . 87.9 t -118.66 117.51 54.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.556 175.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.5 126.94 31.85 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.672 174.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . 0.453 HD22 ' HB1' ' E' ' 54' ' ' ALA . 75.0 mt -121.04 167.02 13.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.439 0.637 . . . . 0.0 112.307 -173.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 66' ' ' ASP . . . . . 0.427 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 10.9 t0 -137.44 98.2 3.65 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.593 168.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 67' ' ' LEU . . . . . 0.548 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 4.9 mt -124.67 146.39 49.15 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.081 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 68' ' ' ASN . . . . . 0.515 ' ND2' ' HB2' ' D' ' 6' ' ' ALA . 56.4 t30 -148.31 120.82 8.52 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.023 175.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -116.55 141.67 47.88 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.941 -177.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 70' ' ' SER . . . . . 0.446 ' HB2' ' HA ' ' D' ' 7' ' ' MET . 9.0 t -97.04 169.22 9.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.924 0.392 . . . . 0.0 110.034 -177.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -75.19 0.28 16.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.748 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.0 -4.23 56.72 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 173.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -95.46 147.13 23.86 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 120.992 0.425 . . . . 0.0 110.946 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -130.84 118.32 20.61 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 172.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 75' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' E' ' 44' ' ' LEU . 16.8 pt -130.61 157.32 42.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.131 0.491 . . . . 0.0 111.774 -169.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 76' ' ' MET . . . . . 0.417 ' HA ' ' HA ' ' E' ' 20' ' ' SER . 67.1 ttp -119.55 114.82 22.84 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.005 175.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 77' ' ' PHE . . . . . 1.66 ' HE2' ' CE1' ' E' ' 77' ' ' PHE . 0.4 OUTLIER -100.92 129.76 46.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.001 -177.133 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' E' E ' 78' ' ' TYR . . . . . 1.63 ' HE2' ' CE1' ' E' ' 78' ' ' TYR . 53.3 p90 -152.43 150.64 29.87 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.989 -0.685 . . . . 0.0 112.148 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 79' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 7.3 p -113.27 136.4 52.79 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.413 177.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.22 152.02 23.37 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.528 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.96 -171.9 30.43 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -176.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -114.73 102.84 10.39 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.054 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 83' ' ' ALA . . . . . 0.423 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -171.04 155.32 4.41 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.889 170.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 10.4 p -112.0 120.77 43.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.121 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 85' ' ' VAL . . . . . 0.556 ' CG1' ' HB3' ' E' ' 34' ' ' LEU . 9.8 m -122.12 150.71 25.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.237 0.542 . . . . 0.0 112.232 -174.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 38.9 m -107.43 124.75 50.32 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.606 174.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 87' ' ' LEU . . . . . 0.51 ' HB2' ' HB3' ' E' ' 11' ' ' LEU . 5.3 mp -94.87 146.54 24.14 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 169.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . 0.42 ' CD2' HG11 ' A' ' 53' ' ' VAL . 1.0 OUTLIER -131.28 142.05 50.06 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.164 -178.663 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.01 -166.87 25.77 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.259 -176.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 90' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -154.42 134.62 13.22 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.804 0.812 . . . . 0.0 112.561 178.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 91' ' ' LEU . . . . . 0.448 HD21 ' HB3' ' E' ' 27' ' ' PHE . 14.3 mt -70.56 139.34 51.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.842 -1.527 . . . . 0.0 109.956 175.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -86.14 109.19 18.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.359 0.6 . . . . 0.0 112.517 -172.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -134.91 74.95 1.55 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 167.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 94' ' ' ILE . . . . . 0.642 ' HB ' ' O ' ' D' ' 2' ' ' GLN . 44.1 mm -74.48 -81.98 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.298 -172.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -82.28 84.12 7.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.219 0.533 . . . . 0.0 110.159 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 5.8 m -68.63 -26.21 65.23 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.055 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . -115.43 101.78 1.06 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.119 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 98' ' ' SER . . . . . 0.447 ' OG ' ' HA ' ' D' ' 1' ' ' PHE . 16.1 m . . . . . 0 C--O 1.247 0.974 0 CA-C-O 118.822 -0.609 . . . . 0.0 110.21 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 1.662 ' HD2' ' CD1' ' A' ' 1' ' ' PHE . 97.4 m-85 . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.83 0.348 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.493 ' NE2' ' HD3' ' B' ' 25' ' ' LYS . 4.4 pt20 -156.28 179.35 9.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.238 -175.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.423 ' HA3' ' N ' ' B' ' 94' ' ' ILE . . . -78.64 65.92 3.38 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.35 -0.453 . . . . 0.0 113.294 -174.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -130.2 68.22 1.46 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.899 0.38 . . . . 0.0 110.345 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.419 ' HE1' ' HB3' ' A' ' 95' ' ' ASP . 2.2 mpt? -105.15 -42.09 5.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.543 -177.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' B' ' 70' ' ' SER . . . -57.87 120.2 8.05 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.951 -174.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.459 ' HA ' ' HB2' ' B' ' 70' ' ' SER . 55.9 mtp -101.97 169.45 8.76 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.333 -176.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 1.658 ' HD1' ' CD2' ' A' ' 8' ' ' PHE . 33.8 t80 -88.34 152.2 22.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.244 -175.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 87.1 t90 -138.57 146.49 41.91 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.86 155.8 26.34 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.108 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 42.4 tp -149.98 108.27 3.77 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.695 0.283 . . . . 0.0 110.951 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -86.8 103.31 15.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.149 0.499 . . . . 0.0 110.855 175.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.456 ' HB2' HG22 ' A' ' 85' ' ' VAL . 2.9 mmt -80.69 136.61 36.22 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.345 -179.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.507 ' HB2' ' HG3' ' A' ' 17' ' ' ARG . 27.2 mtpp -99.85 142.58 24.88 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 173.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.513 ' HB3' ' N ' ' A' ' 83' ' ' ALA . 7.5 Cg_endo -50.19 115.26 1.79 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 123.443 2.762 . . . . 0.0 113.283 -175.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.666 ' HA ' ' O ' ' A' ' 79' ' ' THR . 26.1 mt-10 65.1 57.54 0.95 Allowed 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.597 0.713 . . . . 0.0 111.569 177.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.507 ' HG3' ' HB2' ' A' ' 14' ' ' LYS . 13.5 mmt180 -117.6 163.43 16.45 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.473 171.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.589 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 3.3 ttmp? -139.46 109.92 6.6 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 123.474 0.484 . . . . 0.0 110.843 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 1.651 ' HD1' ' CD2' ' A' ' 19' ' ' TYR . 1.5 m-85 -111.38 113.31 25.68 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.7 p -72.18 116.53 12.72 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 171.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -98.0 117.71 32.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.673 -163.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.5 t -91.99 143.44 26.47 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 171.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.9 mt -115.32 124.41 71.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.153 0.502 . . . . 0.0 111.768 -172.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.464 HD13 ' N ' ' A' ' 24' ' ' ILE . 4.1 mp -90.41 -43.8 14.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.816 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.447 ' HD3' ' NE2' ' E' ' 2' ' ' GLN . 27.3 ttpt -140.09 149.45 43.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.12 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 23.1 t -59.9 115.22 3.25 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.102 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.421 ' HB3' HD21 ' A' ' 91' ' ' LEU . 12.5 p90 -122.86 148.97 44.8 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.471 0.653 . . . . 0.0 111.62 -177.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.653 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 10.3 t60 -106.66 120.43 41.94 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.552 178.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.558 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 31.4 mt -89.38 134.2 29.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 171.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.653 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 15.8 p -122.38 -15.52 7.61 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -171.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -155.66 152.87 24.31 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 119.533 -1.318 . . . . 0.0 113.227 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.437 ' CG2' ' HG ' ' A' ' 87' ' ' LEU . 11.7 p -150.15 122.28 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 171.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.29 154.61 42.54 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 122.008 -0.432 . . . . 0.0 111.572 -173.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.466 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 3.7 pp -113.94 139.28 49.35 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.638 0.733 . . . . 0.0 111.552 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -104.59 -56.06 2.24 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.83 173.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -102.27 127.82 49.08 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 170.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.475 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 150.93 162.26 10.55 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 119.683 -1.246 . . . . 0.0 113.472 176.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.515 ' O ' ' HG3' ' A' ' 58' ' ' LYS . 26.6 mt-30 -102.55 -47.99 4.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.573 0.225 . . . . 0.0 111.285 176.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -151.54 133.02 14.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.388 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.423 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . . . -132.54 116.22 16.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.411 0.625 . . . . 0.0 110.527 170.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 79' ' ' THR . 97.8 mttt -100.14 112.59 24.9 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.5 tp -84.55 114.41 21.94 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -176.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.457 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 98.5 m-85 -116.23 145.62 42.98 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 176.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.58 ' HA ' ' O ' ' A' ' 76' ' ' MET . 0.3 OUTLIER -131.9 130.85 42.13 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.667 171.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -104.36 113.74 27.51 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.764 177.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.07 139.22 53.57 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 174.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 57.3 30.34 18.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.27 0.557 . . . . 0.0 109.615 -171.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.506 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 0.3 OUTLIER 64.84 17.11 10.86 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.456 -179.109 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 7.7 tt0 -104.99 121.54 43.97 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -82.15 112.12 18.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.686 -177.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 1.65 ' HE2' ' CE1' ' A' ' 51' ' ' TYR . 58.4 m-85 -102.96 136.58 42.51 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.492 177.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -82.23 103.05 8.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 171.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.469 ' CG1' HD12 ' A' ' 67' ' ' LEU . 2.9 t -78.63 -52.8 14.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.763 -172.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.45 ' HB1' ' CD2' ' A' ' 65' ' ' LEU . . . -146.89 137.63 23.82 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.544 -177.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.1 m -104.49 101.62 11.29 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 170.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.2 p -121.7 109.81 25.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.979 0.895 . . . . 0.0 110.205 -177.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.6 p -122.85 -176.79 3.49 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.758 -175.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.563 ' HZ3' ' HB2' ' A' ' 58' ' ' LYS . 9.9 mtmp? -58.01 -31.54 67.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.028 0.442 . . . . 0.0 110.437 170.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.14 -40.82 51.76 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.551 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 69.9 mt -116.11 76.49 6.55 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 173.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -76.45 1.59 8.25 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.797 2.332 . . . . 0.0 113.329 -168.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -154.9 100.93 2.24 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.643 -170.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.439 HG12 ' HB3' ' A' ' 54' ' ' ALA . 66.0 t -102.59 121.02 53.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.113 0.482 . . . . 0.0 110.729 177.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.67 110.75 22.95 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.708 174.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -126.93 169.22 13.53 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.051 0.453 . . . . 0.0 111.708 -175.107 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.528 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 27.1 t0 -119.38 104.99 10.85 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.761 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.558 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 18.7 mt -120.65 150.68 40.55 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.992 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.522 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 5.9 t30 -152.41 127.14 9.5 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.943 0.401 . . . . 0.0 110.017 172.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.515 ' O ' ' HA ' ' A' ' 26' ' ' SER . 38.3 m-85 -121.31 161.47 21.97 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.764 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.584 ' HB2' ' O ' ' E' ' 6' ' ' ALA . 42.6 t -115.86 158.22 23.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.328 0.585 . . . . 0.0 111.87 -174.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -21.83 66.47 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.33 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.05 -1.06 61.48 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.894 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -100.56 166.11 11.08 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -145.14 129.63 17.92 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.7 pt -134.82 174.66 12.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.435 -173.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.58 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 23.1 mtp -130.46 123.81 30.61 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 1.647 ' HE2' ' CE1' ' A' ' 77' ' ' PHE . 1.0 OUTLIER -105.09 127.58 52.95 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.071 178.466 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 1.671 ' HE1' ' CE2' ' A' ' 78' ' ' TYR . 24.4 p90 -153.9 141.86 20.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.102 0.477 . . . . 0.0 111.811 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.666 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 11.6 p -113.32 141.88 46.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.08 -178.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -109.85 150.87 27.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.576 176.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.3 176.8 40.45 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -177.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -107.42 102.11 11.41 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.687 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.513 ' N ' ' HB3' ' A' ' 15' ' ' PRO . . . -170.22 150.43 3.65 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.874 169.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.3 t -104.41 119.28 38.6 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.466 ' CG1' ' HB3' ' A' ' 34' ' ' LEU . 5.7 m -119.21 135.18 60.44 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 CA-C-O 121.453 0.644 . . . . 0.0 112.135 -174.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.5 t -99.61 119.49 38.17 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.988 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.502 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 5.3 mp -92.96 147.11 23.11 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 173.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.434 ' CD2' HG11 ' B' ' 53' ' ' VAL . 1.5 tp -133.25 138.76 46.61 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.098 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.95 -167.6 23.62 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.985 -177.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.482 ' CD2' ' HB3' ' B' ' 68' ' ' ASN . 20.2 p90 -153.58 135.56 14.68 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.797 0.808 . . . . 0.0 112.567 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.421 HD21 ' HB3' ' A' ' 27' ' ' PHE . 5.3 mt -77.08 110.0 11.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.447 175.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -90.37 151.25 21.53 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.02 -177.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -139.36 167.61 21.68 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.406 ' N ' ' HA3' ' E' ' 3' ' ' GLY . 77.5 mt -129.06 123.24 58.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.001 0.429 . . . . 0.0 110.586 -177.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.419 ' HB3' ' HE1' ' A' ' 5' ' ' MET . 19.3 t70 -148.87 154.82 40.02 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.0 p -70.76 -12.04 61.31 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -175.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.59 -6.97 81.24 Favored Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.6 t . . . . . 0 C--O 1.249 1.034 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.467 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 1.618 ' HD2' ' CD1' ' B' ' 1' ' ' PHE . 97.3 m-85 . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 120.792 0.329 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . 0.44 ' NE2' ' HD3' ' C' ' 25' ' ' LYS . 4.4 pt20 -156.32 179.29 9.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.292 -175.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . 0.428 ' HA3' ' N ' ' C' ' 94' ' ' ILE . . . -78.59 65.86 3.37 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.348 -0.454 . . . . 0.0 113.309 -174.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -130.17 68.17 1.46 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.817 0.341 . . . . 0.0 110.338 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' MET . . . . . 0.417 ' HE1' ' HB3' ' B' ' 95' ' ' ASP . 2.2 mpt? -105.12 -42.12 5.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.544 -177.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.546 ' O ' ' HB2' ' C' ' 70' ' ' SER . . . -57.91 120.22 8.1 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.898 -174.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' MET . . . . . 0.476 ' HA ' ' HB2' ' C' ' 70' ' ' SER . 56.0 mtp -102.02 169.42 8.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.308 -176.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 1.642 ' HE2' ' CE1' ' B' ' 8' ' ' PHE . 33.6 t80 -88.3 152.34 22.0 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.277 -175.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -138.7 146.46 41.58 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.9 155.83 26.35 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.13 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' B' ' 87' ' ' LEU . 42.2 tp -149.97 108.22 3.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.701 0.286 . . . . 0.0 110.822 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -86.71 103.31 15.05 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.056 0.455 . . . . 0.0 110.879 175.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' MET . . . . . 0.45 ' HB2' HG22 ' B' ' 85' ' ' VAL . 2.8 mmt -80.89 136.77 36.12 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.272 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.494 ' HB2' ' HG3' ' B' ' 17' ' ' ARG . 27.2 mtpp -99.89 142.61 24.94 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 173.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.518 ' HB3' ' N ' ' B' ' 83' ' ' ALA . 7.6 Cg_endo -50.15 115.23 1.77 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.413 2.742 . . . . 0.0 113.372 -175.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.659 ' HA ' ' O ' ' B' ' 79' ' ' THR . 25.9 mt-10 65.04 57.58 0.96 Allowed 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.623 0.725 . . . . 0.0 111.598 177.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.494 ' HG3' ' HB2' ' B' ' 14' ' ' LYS . 13.6 mmt180 -117.55 163.31 16.61 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.532 171.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . 0.601 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 3.3 ttmp? -139.42 110.02 6.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.746 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' TYR . . . . . 1.654 ' HD1' ' CD2' ' B' ' 19' ' ' TYR . 1.6 m-85 -111.42 113.34 25.72 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 2.7 p -72.07 116.48 12.53 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 171.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -97.84 117.55 32.41 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.764 -163.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 13.5 t -91.92 143.54 26.39 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 171.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 48.7 mt -115.44 124.46 71.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.227 0.537 . . . . 0.0 111.654 -172.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.456 HD13 ' N ' ' B' ' 24' ' ' ILE . 4.1 mp -90.44 -43.86 14.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.817 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.493 ' HD3' ' NE2' ' A' ' 2' ' ' GLN . 27.2 ttpt -140.18 149.59 43.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.001 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' B' ' 69' ' ' PHE . 22.7 t -59.83 115.19 3.21 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.137 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' B' ' 68' ' ' ASN . 12.5 p90 -122.84 148.9 44.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.478 0.656 . . . . 0.0 111.682 -177.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' HIS . . . . . 0.655 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 10.4 t60 -106.62 120.43 41.94 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.605 178.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 31.6 mt -89.51 134.24 29.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 171.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.655 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 16.3 p -122.4 -15.4 7.63 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 112.179 0.436 . . . . 0.0 112.179 -170.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -155.75 152.9 24.32 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 119.513 -1.327 . . . . 0.0 113.137 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.433 ' CG2' ' HG ' ' B' ' 87' ' ' LEU . 11.5 p -150.14 122.35 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 171.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.28 154.63 42.56 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.554 -173.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.464 ' HB3' ' CG1' ' B' ' 85' ' ' VAL . 3.7 pp -113.96 139.28 49.36 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 121.624 0.726 . . . . 0.0 111.529 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -104.59 -56.01 2.25 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.796 173.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -102.28 127.78 49.11 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 170.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.474 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 150.89 162.17 10.48 Favored Glycine 0 N--CA 1.438 -1.211 0 C-N-CA 119.547 -1.311 . . . . 0.0 113.407 176.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . 0.517 ' O ' ' HG3' ' B' ' 58' ' ' LYS . 26.5 mt-30 -102.52 -47.98 4.29 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.601 0.238 . . . . 0.0 111.293 177.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -151.57 133.06 14.69 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.636 -0.257 . . . . 0.0 110.442 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.425 ' HB3' ' HB1' ' B' ' 83' ' ' ALA . . . -132.56 116.3 16.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.517 0.675 . . . . 0.0 110.516 170.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' B' ' 79' ' ' THR . 97.7 mttt -100.2 112.64 24.97 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 40.6 tp -84.63 114.48 22.03 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . 0.456 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 98.8 m-85 -116.36 145.65 43.06 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.578 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.3 OUTLIER -131.95 130.77 41.93 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 120.371 -0.531 . . . . 0.0 109.731 171.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -104.29 113.78 27.57 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.821 177.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.13 139.22 53.54 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 174.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 57.3 30.28 18.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.293 0.568 . . . . 0.0 109.645 -171.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.499 ' HA ' ' HE2' ' B' ' 48' ' ' LYS . 0.3 OUTLIER 64.9 17.05 10.87 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.383 -179.233 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.496 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 7.7 tt0 -104.95 121.47 43.81 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -82.06 112.14 18.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.684 -177.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 1.647 ' HE2' ' CE1' ' B' ' 51' ' ' TYR . 57.9 m-85 -102.86 136.51 42.54 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.524 177.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -82.27 102.99 8.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.778 0.799 . . . . 0.0 108.897 171.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.471 ' CG1' HD12 ' B' ' 67' ' ' LEU . 2.9 t -78.58 -52.78 14.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.798 -171.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.454 ' HB1' ' CD2' ' B' ' 65' ' ' LEU . . . -146.9 137.72 23.86 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.492 -177.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 28.0 m -104.6 101.65 11.29 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 170.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 6.2 p -121.77 109.82 25.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 122.005 0.907 . . . . 0.0 110.202 -177.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 80.4 p -122.84 -176.77 3.48 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.76 -175.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . 0.568 ' HB2' ' HZ3' ' B' ' 58' ' ' LYS . 9.9 mtmp? -58.04 -31.52 67.1 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.453 170.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.05 -40.93 52.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.634 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 69.8 mt -116.02 76.49 6.38 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.44 1.6 8.23 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.731 2.287 . . . . 0.0 113.397 -168.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . 0.419 ' OE1' ' HA ' ' C' ' 54' ' ' ALA . 10.2 tt0 -154.82 101.03 2.26 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.705 -170.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.431 HG12 ' HB3' ' B' ' 54' ' ' ALA . 65.7 t -102.63 121.01 53.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.108 0.48 . . . . 0.0 110.695 177.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.7 110.78 22.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.651 174.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' B' ' 30' ' ' SER . 0.3 OUTLIER -126.97 169.14 13.62 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.042 0.449 . . . . 0.0 111.738 -175.117 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . 0.51 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 26.9 t0 -119.27 105.01 10.92 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.72 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.545 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 18.6 mt -120.76 150.76 40.49 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.999 178.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . 0.482 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 5.9 t30 -152.48 127.08 9.42 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.001 0.429 . . . . 0.0 110.022 172.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . 0.522 ' O ' ' HA ' ' B' ' 26' ' ' SER . 38.8 m-85 -121.31 161.49 21.94 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.695 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.551 ' HB2' ' O ' ' A' ' 6' ' ' ALA . 42.6 t -115.83 158.27 23.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.318 0.58 . . . . 0.0 111.874 -174.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -21.73 66.47 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.242 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.13 -0.84 61.45 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.897 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -100.69 166.01 11.1 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -145.12 129.5 17.81 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 9.7 pt -134.67 174.62 12.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.072 0.463 . . . . 0.0 111.404 -173.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' MET . . . . . 0.578 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 23.1 mtp -130.46 123.75 30.48 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . 1.645 ' HD1' ' CD2' ' B' ' 77' ' ' PHE . 0.9 OUTLIER -105.14 127.64 53.0 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.009 178.46 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 1.643 ' HD2' ' CD1' ' B' ' 78' ' ' TYR . 24.4 p90 -153.96 141.84 20.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.128 0.489 . . . . 0.0 111.772 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.659 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 11.6 p -113.3 141.83 46.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.053 -178.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -109.9 150.76 27.96 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.572 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.49 176.83 40.17 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -177.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -107.54 102.21 11.48 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.706 179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.518 ' N ' ' HB3' ' B' ' 15' ' ' PRO . . . -170.28 150.42 3.6 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.825 169.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 32.4 t -104.44 119.4 38.88 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.464 ' CG1' ' HB3' ' B' ' 34' ' ' LEU . 5.6 m -119.24 135.15 60.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 CA-C-O 121.488 0.661 . . . . 0.0 112.096 -174.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 7.5 t -99.6 119.56 38.27 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.98 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.502 ' HB2' ' HB3' ' B' ' 11' ' ' LEU . 5.3 mp -92.95 147.15 23.08 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 173.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.442 ' CD2' HG11 ' C' ' 53' ' ' VAL . 1.5 tp -133.19 138.73 46.67 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.117 -178.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.97 -167.61 23.64 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.972 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' TYR . . . . . 0.502 ' CD2' ' HB3' ' C' ' 68' ' ' ASN . 20.2 p90 -153.59 135.66 14.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.856 0.836 . . . . 0.0 112.451 178.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . 0.414 HD21 ' HB3' ' B' ' 27' ' ' PHE . 5.2 mt -77.22 110.02 11.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.098 -1.41 . . . . 0.0 109.42 175.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -90.33 151.22 21.57 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.082 -177.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -139.36 167.69 21.51 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . 0.423 ' N ' ' HA3' ' A' ' 3' ' ' GLY . 77.7 mt -129.13 123.23 58.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.001 0.429 . . . . 0.0 110.623 -177.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . 0.417 ' HB3' ' HE1' ' B' ' 5' ' ' MET . 19.6 t70 -148.91 154.84 40.01 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.532 -0.758 . . . . 0.0 108.961 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 10.9 p -70.74 -12.01 61.29 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.56 -6.99 81.11 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -177.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 20.1 t . . . . . 0 C--O 1.247 0.955 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.536 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 1' ' ' PHE . . . . . 1.616 ' HD1' ' CD2' ' C' ' 1' ' ' PHE . 97.3 m-85 . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 120.857 0.36 . . . . 0.0 110.783 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . 0.451 ' NE2' ' HD3' ' D' ' 25' ' ' LYS . 4.4 pt20 -156.27 179.31 9.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.314 -175.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.62 65.88 3.38 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.434 -0.412 . . . . 0.0 113.267 -174.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -130.2 68.1 1.46 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.832 0.349 . . . . 0.0 110.342 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 5' ' ' MET . . . . . 0.415 ' HE1' ' HB3' ' C' ' 95' ' ' ASP . 2.2 mpt? -105.08 -42.05 5.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.574 -177.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 6' ' ' ALA . . . . . 0.576 ' O ' ' HB2' ' D' ' 70' ' ' SER . . . -57.91 120.18 8.03 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.973 -174.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 7' ' ' MET . . . . . 0.469 ' HA ' ' HB2' ' D' ' 70' ' ' SER . 55.7 mtp -101.92 169.48 8.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.322 -176.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 8' ' ' PHE . . . . . 1.66 ' HD1' ' CD2' ' C' ' 8' ' ' PHE . 33.3 t80 -88.4 152.28 22.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.242 -175.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -138.68 146.44 41.59 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.85 155.83 26.35 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.138 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.49 ' HB3' ' HB2' ' C' ' 87' ' ' LEU . 42.4 tp -150.02 108.3 3.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.719 0.295 . . . . 0.0 110.912 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -86.78 103.36 15.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.051 0.453 . . . . 0.0 110.814 175.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 13' ' ' MET . . . . . 0.446 ' HB2' HG22 ' C' ' 85' ' ' VAL . 2.8 mmt -80.91 136.75 36.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.191 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . 0.521 ' HB2' ' HG3' ' C' ' 17' ' ' ARG . 27.2 mtpp -99.81 142.6 24.92 Favored Pre-proline 0 C--N 1.316 -0.854 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 173.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . 0.515 ' HB3' ' N ' ' C' ' 83' ' ' ALA . 7.6 Cg_endo -50.13 115.22 1.76 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 123.454 2.769 . . . . 0.0 113.382 -175.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . 0.67 ' HA ' ' O ' ' C' ' 79' ' ' THR . 26.0 mt-10 64.97 57.56 0.97 Allowed 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.617 0.722 . . . . 0.0 111.648 177.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 17' ' ' ARG . . . . . 0.521 ' HG3' ' HB2' ' C' ' 14' ' ' LYS . 13.6 mmt180 -117.48 163.41 16.44 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.512 171.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 18' ' ' LYS . . . . . 0.598 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 3.3 ttmp? -139.5 109.93 6.6 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.811 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . 1.662 ' HD1' ' CD2' ' C' ' 19' ' ' TYR . 1.5 m-85 -111.34 113.29 25.66 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 2.7 p -72.05 116.39 12.4 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 171.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -97.81 117.69 32.7 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.777 -163.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 13.6 t -92.03 143.41 26.5 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 171.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 49.1 mt -115.36 124.48 71.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.168 0.509 . . . . 0.0 111.758 -172.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . 0.457 HD13 ' N ' ' C' ' 24' ' ' ILE . 4.1 mp -90.52 -43.72 14.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.794 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . 0.44 ' HD3' ' NE2' ' B' ' 2' ' ' GLN . 27.3 ttpt -140.23 149.47 42.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.039 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 26' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' C' ' 69' ' ' PHE . 23.0 t -59.89 115.28 3.29 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.064 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 27' ' ' PHE . . . . . 0.419 ' HB3' HD21 ' C' ' 91' ' ' LEU . 12.3 p90 -122.89 148.97 44.84 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.512 0.672 . . . . 0.0 111.608 -177.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 28' ' ' HIS . . . . . 0.643 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 10.3 t60 -106.61 120.43 41.94 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.438 -1.256 . . . . 0.0 109.593 178.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 31.7 mt -89.46 134.28 29.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 171.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 30' ' ' SER . . . . . 0.643 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 16.1 p -122.46 -15.41 7.59 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -171.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -155.68 152.92 24.36 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 119.54 -1.314 . . . . 0.0 113.179 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.436 ' CG2' ' HG ' ' C' ' 87' ' ' LEU . 11.5 p -150.18 122.35 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 171.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.32 154.53 42.43 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.091 -0.381 . . . . 0.0 111.581 -172.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.462 ' HB3' ' CG1' ' C' ' 85' ' ' VAL . 3.7 pp -113.86 139.3 49.29 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.703 0.763 . . . . 0.0 111.528 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -104.62 -55.99 2.25 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.929 173.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -102.31 127.9 49.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 37' ' ' GLY . . . . . 0.471 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 150.85 162.12 10.44 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 119.604 -1.284 . . . . 0.0 113.512 176.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 38' ' ' GLN . . . . . 0.522 ' O ' ' HG3' ' C' ' 58' ' ' LYS . 26.5 mt-30 -102.47 -47.97 4.3 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 120.644 0.259 . . . . 0.0 111.34 177.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -151.61 132.98 14.6 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.436 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . 0.408 ' HB3' ' HB1' ' C' ' 83' ' ' ALA . . . -132.53 116.25 16.49 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.47 0.653 . . . . 0.0 110.515 170.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' C' ' 79' ' ' THR . 97.8 mttt -100.12 112.66 24.97 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 40.7 tp -84.56 114.43 21.96 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -176.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 43' ' ' TYR . . . . . 0.452 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 98.6 m-85 -116.34 145.62 43.06 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.579 ' HA ' ' O ' ' C' ' 76' ' ' MET . 0.3 OUTLIER -131.92 130.82 42.06 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.769 171.864 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -104.27 113.75 27.51 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.8 177.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.09 139.24 53.55 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 174.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 57.19 30.42 18.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.392 0.615 . . . . 0.0 109.709 -171.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' C' ' 48' ' ' LYS . 0.3 OUTLIER 64.77 17.08 10.8 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.467 -179.125 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . 0.487 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 7.8 tt0 -104.89 121.5 43.83 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -82.05 112.14 18.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.773 -177.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 1.659 ' HE2' ' CE1' ' C' ' 51' ' ' TYR . 58.5 m-85 -102.96 136.61 42.46 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.505 177.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -82.29 103.03 8.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.803 0.811 . . . . 0.0 108.908 171.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 53' ' ' VAL . . . . . 0.465 ' CG1' HD12 ' C' ' 67' ' ' LEU . 3.0 t -78.62 -52.72 15.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.745 -171.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 54' ' ' ALA . . . . . 0.46 ' HB1' ' CD2' ' C' ' 65' ' ' LEU . . . -146.91 137.59 23.77 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.582 -177.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 27.9 m -104.46 101.62 11.29 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 170.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 6.1 p -121.75 109.77 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-O 121.958 0.885 . . . . 0.0 110.172 -177.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 80.7 p -122.85 -176.81 3.49 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.762 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 58' ' ' LYS . . . . . 0.566 ' HB2' ' HZ3' ' C' ' 58' ' ' LYS . 9.9 mtmp? -57.98 -31.62 67.08 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.396 170.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.01 -40.91 52.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.633 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 69.7 mt -115.96 76.46 6.24 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 173.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -76.41 1.59 8.22 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.766 2.311 . . . . 0.0 113.383 -168.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . 0.427 ' OE1' ' HA ' ' D' ' 54' ' ' ALA . 10.2 tt0 -154.9 101.03 2.25 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.649 -170.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.435 HG12 ' HB3' ' C' ' 54' ' ' ALA . 66.0 t -102.61 121.01 53.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.072 0.463 . . . . 0.0 110.728 177.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.72 110.85 23.09 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.64 174.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' C' ' 30' ' ' SER . 0.3 OUTLIER -126.97 169.15 13.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.109 0.48 . . . . 0.0 111.604 -175.068 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 66' ' ' ASP . . . . . 0.533 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 27.4 t0 -119.3 105.04 10.94 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.764 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' C' ' 28' ' ' HIS . 18.7 mt -120.71 150.64 40.65 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.024 178.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . 0.502 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 6.0 t30 -152.37 127.12 9.52 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.961 0.41 . . . . 0.0 110.077 172.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 69' ' ' PHE . . . . . 0.517 ' O ' ' HA ' ' C' ' 26' ' ' SER . 38.8 m-85 -121.36 161.54 21.92 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.699 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 70' ' ' SER . . . . . 0.546 ' HB2' ' O ' ' B' ' 6' ' ' ALA . 42.7 t -115.88 158.18 23.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.273 0.559 . . . . 0.0 111.856 -174.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -21.92 66.53 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.318 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.02 -0.83 61.64 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.91 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -100.72 166.04 11.08 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -145.09 129.65 17.98 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 9.7 pt -134.87 174.56 12.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.047 0.451 . . . . 0.0 111.375 -173.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 76' ' ' MET . . . . . 0.579 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 23.3 mtp -130.37 123.77 30.67 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.299 174.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 77' ' ' PHE . . . . . 1.669 ' HD1' ' CD2' ' C' ' 77' ' ' PHE . 1.0 OUTLIER -105.08 127.56 52.94 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.006 178.486 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 78' ' ' TYR . . . . . 1.633 ' HE2' ' CE1' ' C' ' 78' ' ' TYR . 24.4 p90 -153.94 141.83 20.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.067 0.46 . . . . 0.0 111.842 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 79' ' ' THR . . . . . 0.67 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 11.7 p -113.29 141.85 46.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.103 -178.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -109.9 150.74 28.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.629 176.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.41 176.77 40.28 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -177.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -107.48 102.22 11.5 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 119.436 -0.905 . . . . 0.0 109.715 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . 0.515 ' N ' ' HB3' ' C' ' 15' ' ' PRO . . . -170.2 150.41 3.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.942 169.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 32.5 t -104.42 119.38 38.84 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.462 ' CG1' ' HB3' ' C' ' 34' ' ' LEU . 5.6 m -119.28 135.08 60.82 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 CA-C-O 121.454 0.645 . . . . 0.0 112.126 -174.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 7.5 t -99.61 119.5 38.17 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.044 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . 0.49 ' HB2' ' HB3' ' C' ' 11' ' ' LEU . 5.3 mp -92.95 147.01 23.19 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 173.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . 0.445 ' CD2' HG11 ' D' ' 53' ' ' VAL . 1.5 tp -133.15 138.8 46.76 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.145 -178.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.89 -167.59 23.54 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.072 -177.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 90' ' ' TYR . . . . . 0.504 ' CD2' ' HB3' ' D' ' 68' ' ' ASN . 20.2 p90 -153.7 135.7 14.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.867 0.841 . . . . 0.0 112.455 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . 0.419 HD21 ' HB3' ' C' ' 27' ' ' PHE . 5.2 mt -77.2 109.95 11.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.487 176.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -90.33 151.28 21.54 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.039 -177.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -139.34 167.71 21.46 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . 0.428 ' N ' ' HA3' ' B' ' 3' ' ' GLY . 77.6 mt -129.24 123.17 57.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.028 0.442 . . . . 0.0 110.614 -177.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 95' ' ' ASP . . . . . 0.415 ' HB3' ' HE1' ' C' ' 5' ' ' MET . 19.5 t70 -148.79 154.85 40.13 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.533 -0.758 . . . . 0.0 108.981 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 11.1 p -70.72 -12.02 61.3 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.5 -7.01 80.9 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -177.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 19.7 t . . . . . 0 C--O 1.249 1.078 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.576 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . 1.649 ' HE1' ' CE2' ' D' ' 1' ' ' PHE . 97.3 m-85 . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 120.823 0.345 . . . . 0.0 110.784 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . 0.438 ' NE2' ' HD3' ' E' ' 25' ' ' LYS . 4.4 pt20 -156.31 179.33 9.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.301 -175.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 3' ' ' GLY . . . . . 0.406 ' HA3' ' N ' ' E' ' 94' ' ' ILE . . . -78.61 65.89 3.37 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.382 -0.437 . . . . 0.0 113.297 -174.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -130.15 68.09 1.46 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.866 0.365 . . . . 0.0 110.325 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 5' ' ' MET . . . . . 0.41 ' HE1' ' HB3' ' D' ' 95' ' ' ASP . 2.2 mpt? -105.15 -41.9 5.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.625 -177.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 6' ' ' ALA . . . . . 0.534 ' O ' ' HB2' ' E' ' 70' ' ' SER . . . -58.03 120.18 8.1 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.913 -174.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 7' ' ' MET . . . . . 0.464 ' HA ' ' HB2' ' E' ' 70' ' ' SER . 55.7 mtp -102.07 169.44 8.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.287 -176.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 8' ' ' PHE . . . . . 1.67 ' HE2' ' CE1' ' D' ' 8' ' ' PHE . 33.5 t80 -88.29 152.23 22.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.287 -175.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 9' ' ' TRP . . . . . . . . . . . . . 87.1 t90 -138.64 146.44 41.68 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.83 155.89 26.38 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.038 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . 0.488 ' HB3' ' HB2' ' D' ' 87' ' ' LEU . 42.4 tp -150.04 108.23 3.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.665 0.269 . . . . 0.0 110.872 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 -86.79 103.31 15.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.072 0.463 . . . . 0.0 110.857 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 13' ' ' MET . . . . . 0.467 ' HB2' HG22 ' D' ' 85' ' ' VAL . 2.8 mmt -80.71 136.71 36.22 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.309 -178.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 14' ' ' LYS . . . . . 0.499 ' HB2' ' HG3' ' D' ' 17' ' ' ARG . 27.2 mtpp -99.88 142.61 24.92 Favored Pre-proline 0 C--N 1.317 -0.833 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . 0.516 ' HB3' ' N ' ' D' ' 83' ' ' ALA . 7.5 Cg_endo -50.11 115.28 1.79 Allowed 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 123.482 2.788 . . . . 0.0 113.293 -175.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . 0.679 ' HA ' ' O ' ' D' ' 79' ' ' THR . 26.1 mt-10 64.94 57.54 0.99 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.627 0.727 . . . . 0.0 111.631 177.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 17' ' ' ARG . . . . . 0.499 ' HG3' ' HB2' ' D' ' 14' ' ' LYS . 13.7 mmt180 -117.44 163.23 16.69 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.597 171.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . 0.607 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 3.3 ttmp? -139.38 109.96 6.65 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 123.446 0.466 . . . . 0.0 110.829 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 19' ' ' TYR . . . . . 1.669 ' HD2' ' CD1' ' D' ' 19' ' ' TYR . 1.6 m-85 -111.39 113.31 25.68 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 2.7 p -72.08 116.38 12.42 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 171.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -97.87 117.71 32.81 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.694 -163.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 13.7 t -92.06 143.41 26.49 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 171.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 49.0 mt -115.24 124.5 71.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.257 0.551 . . . . 0.0 111.761 -172.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . 0.465 ' N ' HD13 ' D' ' 24' ' ' ILE . 4.1 mp -90.59 -43.79 14.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.704 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . 0.451 ' HD3' ' NE2' ' C' ' 2' ' ' GLN . 27.3 ttpt -140.07 149.56 43.27 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.102 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 26' ' ' SER . . . . . 0.529 ' HA ' ' O ' ' D' ' 69' ' ' PHE . 22.7 t -59.9 115.2 3.24 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.151 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 27' ' ' PHE . . . . . 0.425 ' HB3' HD21 ' D' ' 91' ' ' LEU . 12.5 p90 -122.81 148.88 44.87 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.487 0.66 . . . . 0.0 111.697 -177.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 28' ' ' HIS . . . . . 0.655 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 10.3 t60 -106.55 120.43 41.92 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.662 178.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 29' ' ' ILE . . . . . 0.558 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 31.5 mt -89.43 134.3 29.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 171.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 30' ' ' SER . . . . . 0.655 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 16.1 p -122.46 -15.38 7.6 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -171.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 31' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -155.74 152.99 24.41 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 119.517 -1.325 . . . . 0.0 113.15 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . 0.424 ' CG2' ' HG ' ' D' ' 87' ' ' LEU . 11.6 p -150.23 122.28 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 171.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.3 154.58 42.5 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.13 -0.356 . . . . 0.0 111.599 -172.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 34' ' ' LEU . . . . . 0.459 ' HB3' ' CG1' ' D' ' 85' ' ' VAL . 3.7 pp -113.94 139.3 49.33 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.6 0.714 . . . . 0.0 111.502 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -104.61 -55.98 2.26 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.846 173.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -102.32 127.77 49.16 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 170.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . 0.466 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 150.89 162.2 10.5 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 119.623 -1.275 . . . . 0.0 113.507 176.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 38' ' ' GLN . . . . . 0.509 ' O ' ' HG3' ' D' ' 58' ' ' LYS . 26.6 mt-30 -102.55 -47.94 4.29 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 121.191 -0.203 . . . . 0.0 111.286 177.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -151.53 132.93 14.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.598 -0.273 . . . . 0.0 110.419 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . 0.425 ' HB3' ' HB1' ' D' ' 83' ' ' ALA . . . -132.46 116.33 16.65 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.422 0.629 . . . . 0.0 110.512 170.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' D' ' 79' ' ' THR . 97.7 mttt -100.18 112.67 24.99 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 174.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 40.5 tp -84.62 114.55 22.07 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -176.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 43' ' ' TYR . . . . . 0.459 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 98.7 m-85 -116.37 145.67 43.05 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.584 ' HA ' ' O ' ' D' ' 76' ' ' MET . 0.3 OUTLIER -132.0 130.74 41.82 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.71 171.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 45' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -104.28 113.74 27.51 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.848 177.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.02 139.13 53.66 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 174.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 57.38 30.27 18.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.355 0.598 . . . . 0.0 109.674 -171.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 48' ' ' LYS . . . . . 0.511 ' HE2' ' HA ' ' D' ' 48' ' ' LYS . 0.3 OUTLIER 64.87 17.09 10.86 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.47 -179.088 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 7.8 tt0 -104.92 121.5 43.84 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -82.11 112.07 18.82 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.76 -177.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . 1.656 ' HE2' ' CE1' ' D' ' 51' ' ' TYR . 58.0 m-85 -102.88 136.6 42.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.523 177.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -82.36 103.09 9.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 171.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 53' ' ' VAL . . . . . 0.471 ' CG1' HD12 ' D' ' 67' ' ' LEU . 3.0 t -78.72 -52.72 15.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.735 -171.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 54' ' ' ALA . . . . . 0.447 ' HB1' ' CD2' ' D' ' 65' ' ' LEU . . . -146.92 137.73 23.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.498 -177.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 28.4 m -104.61 101.64 11.28 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 170.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 56' ' ' VAL . . . . . . . . . . . . . 6.1 p -121.73 109.85 25.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 122.019 0.914 . . . . 0.0 110.199 -177.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 80.7 p -122.88 -176.75 3.48 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.811 -175.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 58' ' ' LYS . . . . . 0.562 ' HB2' ' HZ3' ' D' ' 58' ' ' LYS . 9.9 mtmp? -57.94 -31.63 67.03 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.418 170.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.06 -40.87 52.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.606 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 69.9 mt -116.09 76.51 6.53 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 173.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -76.39 1.47 8.34 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.769 2.313 . . . . 0.0 113.381 -168.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -154.79 100.95 2.26 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.736 -170.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.427 HG12 ' HB3' ' D' ' 54' ' ' ALA . 65.9 t -102.58 121.05 53.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.038 0.447 . . . . 0.0 110.688 177.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.72 110.77 22.99 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.666 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 65' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' D' ' 30' ' ' SER . 0.3 OUTLIER -126.98 169.16 13.61 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.124 0.488 . . . . 0.0 111.639 -175.055 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 66' ' ' ASP . . . . . 0.541 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 27.2 t0 -119.32 105.1 10.99 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.712 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . 0.558 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 18.6 mt -120.75 150.67 40.63 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.98 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 68' ' ' ASN . . . . . 0.504 ' HB3' ' CD2' ' C' ' 90' ' ' TYR . 6.0 t30 -152.41 127.11 9.49 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.91 0.386 . . . . 0.0 110.049 172.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 69' ' ' PHE . . . . . 0.529 ' O ' ' HA ' ' D' ' 26' ' ' SER . 38.4 m-85 -121.31 161.49 21.94 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.72 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 70' ' ' SER . . . . . 0.576 ' HB2' ' O ' ' C' ' 6' ' ' ALA . 42.3 t -115.82 158.25 23.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.263 0.554 . . . . 0.0 111.847 -174.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -21.97 66.58 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.272 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.86 -1.07 61.79 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.906 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -100.57 166.02 11.12 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -145.04 129.59 17.98 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . . . . . . . . . 9.8 pt -134.82 174.61 12.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.058 0.456 . . . . 0.0 111.322 -173.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 76' ' ' MET . . . . . 0.584 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 23.2 mtp -130.45 123.76 30.51 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.284 174.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 77' ' ' PHE . . . . . 1.645 ' HE2' ' CE1' ' D' ' 77' ' ' PHE . 1.0 OUTLIER -105.05 127.53 52.92 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.093 178.51 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 78' ' ' TYR . . . . . 1.652 ' HE2' ' CE1' ' D' ' 78' ' ' TYR . 24.2 p90 -153.89 141.91 20.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.096 0.474 . . . . 0.0 111.756 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 79' ' ' THR . . . . . 0.679 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 11.7 p -113.36 141.84 46.57 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.033 -178.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -109.88 150.72 28.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.622 176.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.42 176.79 40.28 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -177.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -107.4 102.21 11.51 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.716 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.516 ' N ' ' HB3' ' D' ' 15' ' ' PRO . . . -170.25 150.37 3.62 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.895 169.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 32.4 t -104.41 119.24 38.52 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . 0.467 HG22 ' HB2' ' D' ' 13' ' ' MET . 5.7 m -119.14 135.19 60.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-O 121.425 0.631 . . . . 0.0 112.107 -174.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 7.5 t -99.67 119.47 38.16 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.976 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 87' ' ' LEU . . . . . 0.488 ' HB2' ' HB3' ' D' ' 11' ' ' LEU . 5.3 mp -92.87 147.07 23.15 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 173.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . 0.429 ' CD2' HG11 ' E' ' 53' ' ' VAL . 1.5 tp -133.23 138.7 46.61 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.151 -178.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.82 -167.55 23.41 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.997 -177.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 90' ' ' TYR . . . . . 0.48 ' CD2' ' HB3' ' E' ' 68' ' ' ASN . 20.2 p90 -153.64 135.71 14.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.805 0.812 . . . . 0.0 112.497 178.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . 0.425 HD21 ' HB3' ' D' ' 27' ' ' PHE . 5.3 mt -77.33 110.02 11.71 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.396 176.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -90.35 151.22 21.55 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.011 -177.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -139.32 167.68 21.53 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 77.9 mt -129.15 123.34 58.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.064 0.459 . . . . 0.0 110.6 -177.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 95' ' ' ASP . . . . . 0.41 ' HB3' ' HE1' ' D' ' 5' ' ' MET . 19.5 t70 -148.91 154.8 39.94 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.008 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 11.0 p -70.62 -12.04 61.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -175.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.61 -7.07 80.95 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -177.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 19.5 t . . . . . 0 C--O 1.25 1.114 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.54 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' E' E ' 1' ' ' PHE . . . . . 1.67 ' HD2' ' CD1' ' E' ' 1' ' ' PHE . 97.4 m-85 . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 120.852 0.358 . . . . 0.0 110.806 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 2' ' ' GLN . . . . . 0.447 ' NE2' ' HD3' ' A' ' 25' ' ' LYS . 4.5 pt20 -156.29 179.31 9.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.264 -175.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 3' ' ' GLY . . . . . 0.406 ' HA3' ' N ' ' A' ' 94' ' ' ILE . . . -78.6 65.79 3.39 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 116.246 -0.434 . . . . 0.0 113.289 -174.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -130.15 68.24 1.46 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.739 0.304 . . . . 0.0 110.272 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 5' ' ' MET . . . . . 0.419 ' HE1' ' HB3' ' E' ' 95' ' ' ASP . 2.2 mpt? -105.1 -42.16 5.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.59 -177.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 6' ' ' ALA . . . . . 0.584 ' O ' ' HB2' ' A' ' 70' ' ' SER . . . -57.84 120.11 7.87 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.987 -174.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 7' ' ' MET . . . . . 0.484 ' HA ' ' HB2' ' A' ' 70' ' ' SER . 56.0 mtp -101.95 169.43 8.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.288 -176.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 8' ' ' PHE . . . . . 1.671 ' HE1' ' CE2' ' E' ' 8' ' ' PHE . 33.4 t80 -88.33 152.17 22.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.316 -175.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 9' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -138.62 146.51 41.82 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -178.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.81 155.88 26.38 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.166 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . 0.492 ' HB3' ' HB2' ' E' ' 87' ' ' LEU . 42.2 tp -150.06 108.33 3.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.774 0.321 . . . . 0.0 110.912 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -86.81 103.37 15.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.161 0.505 . . . . 0.0 110.834 175.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 13' ' ' MET . . . . . 0.453 ' HB2' HG22 ' E' ' 85' ' ' VAL . 2.8 mmt -80.84 136.74 36.15 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.22 -178.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 14' ' ' LYS . . . . . 0.506 ' HB2' ' HG3' ' E' ' 17' ' ' ARG . 27.2 mtpp -99.87 142.6 24.91 Favored Pre-proline 0 C--N 1.318 -0.803 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . 0.508 ' HB3' ' N ' ' E' ' 83' ' ' ALA . 7.6 Cg_endo -50.02 115.22 1.74 Allowed 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 123.46 2.773 . . . . 0.0 113.399 -175.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 16' ' ' GLU . . . . . 0.675 ' HA ' ' O ' ' E' ' 79' ' ' THR . 25.9 mt-10 65.03 57.53 0.96 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.539 0.685 . . . . 0.0 111.637 177.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 17' ' ' ARG . . . . . 0.506 ' HG3' ' HB2' ' E' ' 14' ' ' LYS . 13.6 mmt180 -117.57 163.27 16.68 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.503 171.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . 0.601 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 3.3 ttmp? -139.47 109.96 6.62 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 123.457 0.473 . . . . 0.0 110.858 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . 1.665 ' HE2' ' CE1' ' E' ' 19' ' ' TYR . 1.5 m-85 -111.3 113.34 25.75 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 2.7 p -72.18 116.48 12.66 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -97.88 117.68 32.75 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.714 -163.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 13.5 t -91.98 143.44 26.48 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 171.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 48.7 mt -115.4 124.43 71.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.25 0.548 . . . . 0.0 111.781 -172.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . 0.47 ' N ' HD13 ' E' ' 24' ' ' ILE . 4.1 mp -90.41 -43.82 14.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.787 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . 0.438 ' HD3' ' NE2' ' D' ' 2' ' ' GLN . 27.3 ttpt -140.15 149.45 43.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.099 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 26' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' E' ' 69' ' ' PHE . 23.0 t -59.83 115.24 3.25 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.155 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 27' ' ' PHE . . . . . 0.42 ' HB3' HD21 ' E' ' 91' ' ' LEU . 12.4 p90 -122.88 148.86 44.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.463 0.649 . . . . 0.0 111.684 -177.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 28' ' ' HIS . . . . . 0.646 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 10.6 t60 -106.53 120.43 41.91 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.592 178.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 29' ' ' ILE . . . . . 0.539 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 31.5 mt -89.44 134.32 29.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 171.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 30' ' ' SER . . . . . 0.646 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 16.1 p -122.51 -15.41 7.57 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -171.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 31' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -155.77 152.89 24.32 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.562 -1.304 . . . . 0.0 113.195 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . 0.427 ' CG2' ' HG ' ' E' ' 87' ' ' LEU . 11.6 p -150.21 122.32 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 171.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.37 154.47 42.34 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 122.13 -0.356 . . . . 0.0 111.552 -172.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 34' ' ' LEU . . . . . 0.461 ' HB3' ' CG1' ' E' ' 85' ' ' VAL . 3.7 pp -113.84 139.32 49.25 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.677 0.751 . . . . 0.0 111.569 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -104.59 -56.08 2.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.829 173.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -102.31 127.86 49.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 170.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . 0.473 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 150.92 162.16 10.48 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 119.613 -1.28 . . . . 0.0 113.493 176.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 38' ' ' GLN . . . . . 0.506 ' O ' ' HG3' ' E' ' 58' ' ' LYS . 26.5 mt-30 -102.5 -47.98 4.29 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 121.155 -0.218 . . . . 0.0 111.3 177.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -151.55 132.97 14.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.439 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . 0.408 ' HB3' ' HB1' ' E' ' 83' ' ' ALA . . . -132.54 116.26 16.51 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.412 0.625 . . . . 0.0 110.557 170.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 41' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' E' ' 79' ' ' THR . 97.8 mttt -100.12 112.59 24.89 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 40.7 tp -84.58 114.54 22.05 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -176.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 43' ' ' TYR . . . . . 0.453 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 98.4 m-85 -116.39 145.62 43.1 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 44' ' ' LEU . . . . . 0.575 ' HA ' ' O ' ' E' ' 76' ' ' MET . 0.3 OUTLIER -132.0 130.83 41.92 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.673 171.9 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' E' E ' 45' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -104.3 113.82 27.64 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.787 177.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.12 139.18 53.58 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 174.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 57.3 30.3 18.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.315 0.578 . . . . 0.0 109.687 -171.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 48' ' ' LYS . . . . . 0.509 ' HE2' ' HA ' ' E' ' 48' ' ' LYS . 0.3 OUTLIER 64.88 17.17 10.9 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.41 -179.194 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' E' E ' 49' ' ' GLN . . . . . 0.49 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 7.7 tt0 -105.07 121.49 43.91 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -82.04 112.05 18.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.76 -177.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . 1.659 ' HE2' ' CE1' ' E' ' 51' ' ' TYR . 58.6 m-85 -102.91 136.57 42.48 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.491 177.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -82.27 103.11 9.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 171.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . 0.467 ' CG1' HD12 ' E' ' 67' ' ' LEU . 2.9 t -78.63 -52.75 15.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.79 -172.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 54' ' ' ALA . . . . . 0.452 ' HB1' ' CD2' ' E' ' 65' ' ' LEU . . . -146.93 137.66 23.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.5 -177.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 28.2 m -104.55 101.61 11.26 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 170.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . . . . . . . . . 6.3 p -121.67 109.78 25.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.974 0.893 . . . . 0.0 110.263 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 80.4 p -122.79 -176.76 3.47 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.816 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 58' ' ' LYS . . . . . 0.562 ' HZ3' ' HB2' ' E' ' 58' ' ' LYS . 9.9 mtmp? -57.95 -31.7 67.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.023 0.44 . . . . 0.0 110.417 170.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.97 -40.88 52.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.621 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 70.0 mt -116.05 76.41 6.4 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -76.33 1.58 8.2 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.836 2.357 . . . . 0.0 113.408 -168.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 62' ' ' GLN . . . . . 0.409 ' OE1' ' HA ' ' A' ' 54' ' ' ALA . 10.2 tt0 -154.89 100.99 2.25 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.613 -170.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . 0.448 HG12 ' HB3' ' E' ' 54' ' ' ALA . 66.3 t -102.66 120.99 53.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.112 0.482 . . . . 0.0 110.788 177.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.69 110.9 23.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.603 175.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' E' ' 30' ' ' SER . 0.3 OUTLIER -127.03 169.19 13.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.663 -175.096 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' E' E ' 66' ' ' ASP . . . . . 0.529 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 27.1 t0 -119.35 104.98 10.86 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.709 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 67' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' E' ' 28' ' ' HIS . 18.5 mt -120.74 150.64 40.67 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.979 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 68' ' ' ASN . . . . . 0.48 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 6.0 t30 -152.38 127.17 9.55 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.922 0.391 . . . . 0.0 110.013 172.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 69' ' ' PHE . . . . . 0.528 ' O ' ' HA ' ' E' ' 26' ' ' SER . 38.5 m-85 -121.3 161.52 21.87 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.745 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 70' ' ' SER . . . . . 0.534 ' HB2' ' O ' ' D' ' 6' ' ' ALA . 42.1 t -115.89 158.26 23.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.262 0.553 . . . . 0.0 111.841 -174.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -21.81 66.49 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.297 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.98 -1.03 61.61 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.949 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -100.59 166.0 11.13 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -145.03 129.71 18.09 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 75' ' ' ILE . . . . . . . . . . . . . 9.7 pt -134.84 174.6 12.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.002 0.43 . . . . 0.0 111.376 -173.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 76' ' ' MET . . . . . 0.575 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 22.9 mtp -130.41 123.76 30.56 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 77' ' ' PHE . . . . . 1.67 ' HE2' ' CE1' ' E' ' 77' ' ' PHE . 0.9 OUTLIER -105.08 127.58 52.95 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.038 178.493 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' E' E ' 78' ' ' TYR . . . . . 1.642 ' HD1' ' CD2' ' E' ' 78' ' ' TYR . 24.5 p90 -153.91 141.85 20.2 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.118 0.485 . . . . 0.0 111.822 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 79' ' ' THR . . . . . 0.675 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 11.5 p -113.3 141.94 46.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.046 -178.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -110.03 150.78 28.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.534 176.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.4 176.86 40.3 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -177.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -107.46 102.18 11.47 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 119.409 -0.916 . . . . 0.0 109.713 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 83' ' ' ALA . . . . . 0.508 ' N ' ' HB3' ' E' ' 15' ' ' PRO . . . -170.2 150.38 3.66 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.863 169.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 32.3 t -104.42 119.31 38.69 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 85' ' ' VAL . . . . . 0.461 ' CG1' ' HB3' ' E' ' 34' ' ' LEU . 5.7 m -119.2 135.1 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 CA-C-O 121.421 0.629 . . . . 0.0 112.17 -174.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 7.5 t -99.57 119.58 38.28 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.963 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 87' ' ' LEU . . . . . 0.492 ' HB2' ' HB3' ' E' ' 11' ' ' LEU . 5.3 mp -93.01 147.14 23.09 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . 0.448 ' CD2' HG11 ' A' ' 53' ' ' VAL . 1.5 tp -133.22 138.67 46.61 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.12 -178.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.86 -167.62 23.55 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.021 -177.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 90' ' ' TYR . . . . . 0.522 ' CD2' ' HB3' ' A' ' 68' ' ' ASN . 20.1 p90 -153.65 135.74 14.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.932 0.872 . . . . 0.0 112.403 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 91' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' E' ' 27' ' ' PHE . 5.2 mt -77.25 110.05 11.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 113.983 -1.462 . . . . 0.0 109.402 176.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -90.41 151.29 21.49 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.044 -177.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -139.39 167.68 21.53 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 94' ' ' ILE . . . . . 0.406 ' N ' ' HA3' ' D' ' 3' ' ' GLY . 77.9 mt -129.17 123.3 58.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.008 0.433 . . . . 0.0 110.565 -177.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 95' ' ' ASP . . . . . 0.419 ' HB3' ' HE1' ' E' ' 5' ' ' MET . 19.6 t70 -148.89 154.86 40.05 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.444 -0.798 . . . . 0.0 108.958 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 10.9 p -70.73 -12.01 61.29 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -175.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.61 -6.99 81.24 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -177.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 20.2 t . . . . . 0 C--O 1.25 1.099 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.58 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 1.671 ' HE1' ' CE2' ' A' ' 1' ' ' PHE . 83.4 t80 . . . . . 0 N--CA 1.478 0.925 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.405 ' HG3' ' H ' ' A' ' 3' ' ' GLY . 3.9 pt20 53.44 -68.2 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.668 1.587 . . . . 0.0 114.14 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.405 ' H ' ' HG3' ' A' ' 2' ' ' GLN . . . -155.67 33.11 0.63 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.398 -177.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.06 -64.82 0.97 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.87 0.366 . . . . 0.0 110.646 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 26.3 mmt -105.53 43.89 1.08 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.35 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.12 134.97 53.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.971 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 57.1 mtp -98.15 151.12 20.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.053 0.454 . . . . 0.0 111.23 -174.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 1.656 ' HD1' ' CD2' ' A' ' 8' ' ' PHE . 48.7 t80 -66.47 145.49 55.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.068 -176.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.542 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 90.2 t90 -132.71 146.08 51.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.007 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.1 146.69 16.36 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.095 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.542 ' HB2' ' CH2' ' A' ' 9' ' ' TRP . 63.5 tp -134.27 109.02 8.56 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.983 0.42 . . . . 0.0 110.454 178.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -91.52 107.71 19.4 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.516 177.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.62 ' SD ' HD12 ' A' ' 87' ' ' LEU . 54.2 mtp -102.27 143.82 31.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.38 0.61 . . . . 0.0 111.406 -174.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -100.92 151.39 37.6 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.193 -177.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.467 ' HB3' ' N ' ' A' ' 83' ' ' ALA . 11.2 Cg_endo -54.99 113.77 1.56 Allowed 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.19 2.593 . . . . 0.0 112.832 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 79' ' ' THR . 17.3 mt-10 59.96 70.96 0.6 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.508 0.67 . . . . 0.0 111.414 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.2 142.77 32.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.558 174.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.641 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 35.3 ttmt -116.44 117.46 29.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.389 -176.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.477 ' HH ' ' HA ' ' A' ' 13' ' ' MET . 1.9 m-85 -110.37 122.26 47.28 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.453 ' HB3' ' SD ' ' A' ' 76' ' ' MET . 6.0 p -102.51 99.78 9.83 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 169.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 19.9 pm0 -117.72 143.0 46.62 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.595 0.712 . . . . 0.0 112.274 -174.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.0 t -93.31 160.77 14.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.526 176.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 70.1 mt -112.47 119.35 60.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.066 0.46 . . . . 0.0 111.529 -173.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.7 pp -99.6 -11.53 8.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.025 177.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -148.0 119.53 7.96 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.3 p -61.7 140.53 58.18 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 123.379 0.425 . . . . 0.0 110.656 -175.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 1.624 ' HE1' ' CE2' ' A' ' 27' ' ' PHE . 42.6 p90 -152.13 162.79 40.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.718 0.77 . . . . 0.0 112.895 -174.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.518 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 7.7 t60 -114.74 124.52 52.0 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.009 176.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.501 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 41.6 mt -88.28 135.91 24.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 170.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.474 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 43.8 p -123.62 -5.26 8.15 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -170.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . 179.88 155.14 14.62 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 119.192 -1.48 . . . . 0.0 113.513 175.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.9 p -136.78 132.83 48.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.8 156.48 42.4 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.605 -176.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.468 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 4.1 pp -123.72 145.55 48.92 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.403 0.621 . . . . 0.0 111.01 177.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.408 ' HB2' ' HH ' ' B' ' 43' ' ' TYR . 18.8 p-10 -110.2 -52.06 2.81 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.653 174.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.516 ' HZ2' ' HB3' ' A' ' 36' ' ' LYS . 7.8 mtpm? -102.93 127.5 50.12 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 169.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.44 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 151.75 156.75 7.59 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 119.769 -1.205 . . . . 0.0 113.344 177.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.465 ' HA ' ' HB2' ' A' ' 58' ' ' LYS . 94.8 mt-30 -102.37 -44.48 5.37 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.616 0.246 . . . . 0.0 111.07 178.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -152.82 128.83 10.34 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.363 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.426 ' HB1' HG11 ' A' ' 56' ' ' VAL . . . -128.22 113.02 15.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.549 0.69 . . . . 0.0 109.981 168.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 79' ' ' THR . 28.6 mmmt -94.59 109.39 21.31 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.3 tp -82.08 109.52 16.47 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -174.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -112.24 136.33 51.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.108 177.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.69 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -123.88 121.76 36.21 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.525 175.441 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -109.92 111.1 22.29 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.02 178.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.402 ' HB1' ' CE2' ' E' ' 8' ' ' PHE . . . -128.72 139.32 52.28 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.539 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 56.61 35.65 26.41 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 123.751 0.657 . . . . 0.0 110.314 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.511 ' HZ2' ' HB3' ' A' ' 48' ' ' LYS . 9.1 mtpm? 63.6 32.26 14.1 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.102 -0.953 . . . . 0.0 112.284 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.545 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 59.4 tp60 -128.28 133.96 48.85 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 175.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -89.05 121.84 31.79 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 -177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -116.72 123.44 47.21 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.506 176.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -75.38 106.69 5.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 169.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.599 ' CG2' ' HB3' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -84.22 -46.37 17.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.532 -172.299 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.46 ' HB3' HG12 ' A' ' 63' ' ' VAL . . . -153.96 149.48 27.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.641 -177.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.2 m -113.02 101.6 9.62 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 169.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.426 HG11 ' HB1' ' A' ' 40' ' ' ALA . 7.8 p -115.7 114.36 46.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.544 0.688 . . . . 0.0 109.283 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 44.6 p -122.62 -179.12 4.11 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.214 -172.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.465 ' HB2' ' HA ' ' A' ' 38' ' ' GLN . 58.1 tttt -58.68 -32.29 68.98 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.704 171.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.4 -40.87 22.77 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.922 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 84.5 mt -108.38 86.63 3.55 Favored Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 175.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.08 0.17 8.76 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.665 2.243 . . . . 0.0 113.843 -166.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -164.49 131.07 3.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.24 0.543 . . . . 0.0 111.516 -175.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.46 HG12 ' HB3' ' A' ' 54' ' ' ALA . 93.4 t -122.0 112.22 33.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.311 174.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.59 131.49 41.76 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 174.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.451 HD22 ' HB1' ' A' ' 54' ' ' ALA . 86.3 mt -124.16 168.14 13.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.482 0.658 . . . . 0.0 112.303 -173.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.479 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 18.5 t0 -142.33 99.48 3.51 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.351 169.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.518 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 2.4 mt -129.46 144.21 51.16 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.415 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 5.9 t30 -141.79 114.91 8.74 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.539 -0.465 . . . . 0.0 109.771 176.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -111.14 146.93 35.96 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.541 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.9 t -97.88 166.72 11.32 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -75.57 2.21 12.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.241 0.543 . . . . 0.0 110.591 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.25 -7.77 51.47 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.294 172.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -93.18 138.75 31.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.044 0.449 . . . . 0.0 110.447 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -122.22 117.0 25.12 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.9 pt -128.58 162.73 34.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.188 0.518 . . . . 0.0 112.054 -168.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.453 ' SD ' ' HB3' ' A' ' 20' ' ' SER . 4.9 mtm -119.93 125.67 49.0 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 172.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 1.663 ' HD1' ' CD2' ' A' ' 77' ' ' PHE . 0.8 OUTLIER -109.6 127.09 54.27 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 176.548 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 1.632 ' HE1' ' CE2' ' A' ' 78' ' ' TYR . 53.2 p90 -155.42 139.22 16.18 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.009 -175.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.576 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 2.9 p -111.7 134.23 53.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.309 -176.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -100.74 157.09 16.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.536 175.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.81 179.08 46.16 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -176.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -108.18 102.96 12.06 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.003 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.467 ' N ' ' HB3' ' A' ' 15' ' ' PRO . . . -168.79 150.8 4.83 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.505 170.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.3 t -109.74 121.86 46.17 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.468 ' CG1' ' HB3' ' A' ' 34' ' ' LEU . 7.0 m -117.68 155.26 19.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.316 0.579 . . . . 0.0 112.38 -173.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.4 m -120.72 122.43 40.39 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.58 173.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.62 HD12 ' SD ' ' A' ' 13' ' ' MET . 4.7 mp -96.03 145.76 25.19 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 170.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.47 HD12 ' O ' ' A' ' 87' ' ' LEU . 1.2 mm? -121.02 150.3 41.35 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 173.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.31 -167.81 27.54 Favored Glycine 0 N--CA 1.438 -1.18 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.248 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.414 ' CD2' ' HB3' ' B' ' 68' ' ' ASN . 3.4 p90 -147.57 129.18 15.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.735 0.779 . . . . 0.0 112.07 177.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 15.7 mt -71.43 140.94 50.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 113.918 -1.492 . . . . 0.0 109.815 176.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 55.9 m-70 -66.61 141.85 57.67 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.266 0.555 . . . . 0.0 111.504 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -90.48 124.58 35.1 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.306 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 16.3 pt -82.73 -48.46 17.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.368 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -175.23 42.46 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.939 0.4 . . . . 0.0 110.988 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.4 m -78.41 61.09 2.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.057 0.456 . . . . 0.0 110.692 -178.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.41 80.78 1.48 Allowed Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.871 -0.681 . . . . 0.0 111.618 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.9 m . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.459 -179.895 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 1.66 ' HD2' ' CD1' ' B' ' 1' ' ' PHE . 83.6 t80 . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 53.36 -68.28 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.714 1.605 . . . . 0.0 114.129 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -155.53 33.14 0.64 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.404 -177.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.14 -64.7 1.0 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.812 0.339 . . . . 0.0 110.613 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 26.3 mmt -105.55 43.8 1.09 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.366 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' C' ' 70' ' ' SER . . . -56.07 134.95 52.96 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.951 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 56.8 mtp -98.18 151.09 20.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.267 -174.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 1.647 ' HE2' ' CE1' ' B' ' 8' ' ' PHE . 48.2 t80 -66.5 145.55 55.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.057 -176.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . 0.546 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 90.1 t90 -132.75 146.06 51.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.003 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.19 146.74 16.44 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.118 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.546 ' HB2' ' CH2' ' B' ' 9' ' ' TRP . 63.5 tp -134.29 109.05 8.57 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.013 0.435 . . . . 0.0 110.557 178.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -91.43 107.68 19.37 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.556 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' MET . . . . . 0.615 ' SD ' HD12 ' B' ' 87' ' ' LEU . 53.8 mtp -102.29 143.67 31.76 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.396 0.617 . . . . 0.0 111.382 -174.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -100.88 151.48 37.62 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.095 -177.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.458 ' HB3' ' N ' ' B' ' 83' ' ' ALA . 11.1 Cg_endo -55.02 113.87 1.6 Allowed 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 123.142 2.561 . . . . 0.0 112.752 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.58 ' HA ' ' O ' ' B' ' 79' ' ' THR . 17.3 mt-10 59.91 71.02 0.59 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.501 0.667 . . . . 0.0 111.356 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.23 142.83 32.66 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.613 174.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . 0.639 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 35.3 ttmt -116.6 117.49 29.99 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.32 -176.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' TYR . . . . . 0.474 ' HH ' ' HA ' ' B' ' 13' ' ' MET . 1.9 m-85 -110.43 122.3 47.38 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.446 ' HB3' ' SD ' ' B' ' 76' ' ' MET . 5.9 p -102.58 99.83 9.86 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 169.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 19.8 pm0 -117.83 142.98 46.7 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.576 0.703 . . . . 0.0 112.165 -174.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 13.0 t -93.21 160.71 14.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.549 176.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 70.1 mt -112.52 119.4 60.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.138 0.494 . . . . 0.0 111.523 -173.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 1.7 pp -99.68 -11.52 8.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.906 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -147.95 119.58 8.01 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 31.4 p -61.67 140.53 58.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.654 -175.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . 1.595 ' HE2' ' CE1' ' B' ' 27' ' ' PHE . 42.8 p90 -152.16 162.73 40.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.774 0.797 . . . . 0.0 112.903 -174.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' HIS . . . . . 0.506 ' HA ' ' O ' ' B' ' 67' ' ' LEU . 7.6 t60 -114.66 124.49 51.95 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.053 177.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 41.8 mt -88.26 135.89 24.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 170.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.471 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 45.2 p -123.64 -5.2 8.14 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -170.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . 179.86 155.17 14.68 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 119.188 -1.482 . . . . 0.0 113.538 175.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 11.9 p -136.85 132.75 47.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 174.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.76 156.51 42.45 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 121.937 -0.477 . . . . 0.0 111.6 -176.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.474 ' HB3' ' CG1' ' B' ' 85' ' ' VAL . 4.1 pp -123.82 145.43 49.08 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.541 0.686 . . . . 0.0 111.038 177.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -110.02 -52.1 2.81 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.719 174.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.501 ' HB3' ' HZ2' ' B' ' 36' ' ' LYS . 7.8 mtpm? -102.93 127.38 50.16 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 169.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.436 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 151.9 156.79 7.62 Favored Glycine 0 N--CA 1.437 -1.253 0 C-N-CA 119.756 -1.211 . . . . 0.0 113.366 177.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . 0.457 ' HA ' ' HB2' ' B' ' 58' ' ' LYS . 94.9 mt-30 -102.36 -44.34 5.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.692 0.282 . . . . 0.0 111.091 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -152.95 128.77 10.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.561 0.22 . . . . 0.0 111.339 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.413 ' HB1' HG11 ' B' ' 56' ' ' VAL . . . -128.16 113.08 15.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.539 0.685 . . . . 0.0 109.916 167.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' B' ' 79' ' ' THR . 28.6 mmmt -94.57 109.31 21.22 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 48.6 tp -82.08 109.44 16.4 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -174.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . 0.408 ' HH ' ' HB2' ' A' ' 35' ' ' ASP . 89.1 m-85 -112.2 136.41 51.66 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.072 177.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.684 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 0.1 OUTLIER -123.94 121.67 35.9 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.478 175.465 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -109.82 111.24 22.55 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.968 178.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -128.75 139.28 52.28 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.602 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 56.63 35.61 26.37 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.746 0.654 . . . . 0.0 110.358 -177.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.503 ' HZ2' ' HB3' ' B' ' 48' ' ' LYS . 9.1 mtpm? 63.57 32.38 14.1 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.277 178.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.539 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 59.3 tp60 -128.37 133.85 48.72 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 175.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -88.94 121.78 31.65 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -177.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -116.67 123.44 47.27 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.461 176.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -75.39 106.66 5.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 169.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.599 ' CG2' ' HB3' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -84.15 -46.42 17.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.535 -172.299 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.468 ' HB1' HD22 ' B' ' 65' ' ' LEU . . . -153.92 149.41 27.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.715 -177.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 53.2 m -113.0 101.67 9.69 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 169.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . 0.413 HG11 ' HB1' ' B' ' 40' ' ' ALA . 7.7 p -115.78 114.35 45.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.578 0.704 . . . . 0.0 109.249 -179.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 45.0 p -122.59 -179.18 4.13 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.195 -172.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . 0.457 ' HB2' ' HA ' ' B' ' 38' ' ' GLN . 58.0 tttt -58.66 -32.33 69.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.747 171.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.37 -40.87 22.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.928 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 84.0 mt -108.31 86.69 3.52 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.16 0.21 8.74 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.731 2.288 . . . . 0.0 113.807 -166.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -164.52 131.05 3.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.326 0.584 . . . . 0.0 111.528 -175.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.452 HG12 ' HB3' ' B' ' 54' ' ' ALA . 92.9 t -121.95 112.17 33.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.348 174.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.56 131.54 41.83 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 174.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.468 HD22 ' HB1' ' B' ' 54' ' ' ALA . 86.1 mt -124.2 168.12 13.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.46 0.648 . . . . 0.0 112.226 -173.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 18.6 t0 -142.4 99.44 3.5 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.396 169.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' B' ' 28' ' ' HIS . 2.3 mt -129.34 144.27 51.17 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . 0.414 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 5.9 t30 -141.98 114.89 8.65 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.836 176.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -111.03 146.89 35.92 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.552 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 21.9 t -97.83 166.7 11.34 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -75.53 2.11 12.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.208 0.528 . . . . 0.0 110.568 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.11 -7.78 51.82 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.336 172.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -93.24 138.68 31.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.183 0.516 . . . . 0.0 110.493 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -122.17 116.95 25.07 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 14.9 pt -128.41 162.86 34.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.243 0.545 . . . . 0.0 111.983 -168.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' MET . . . . . 0.464 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 4.9 mtm -120.08 125.8 49.18 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.389 172.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . 1.668 ' HD1' ' CD2' ' B' ' 77' ' ' PHE . 0.8 OUTLIER -109.64 127.08 54.3 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.64 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 1.642 ' HE2' ' CE1' ' B' ' 78' ' ' TYR . 53.2 p90 -155.43 139.23 16.19 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.983 -175.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.58 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 3.0 p -111.59 134.16 53.36 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.404 -176.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -100.64 157.03 16.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.518 175.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.91 178.96 46.04 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -176.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -108.08 102.91 12.03 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.971 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.458 ' N ' ' HB3' ' B' ' 15' ' ' PRO . . . -168.76 150.88 4.88 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.47 170.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 15.9 t -109.76 121.89 46.26 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.474 ' CG1' ' HB3' ' B' ' 34' ' ' LEU . 7.0 m -117.79 155.29 19.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.415 0.626 . . . . 0.0 112.331 -173.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 49.3 m -120.64 122.44 40.49 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.583 173.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.615 HD12 ' SD ' ' B' ' 13' ' ' MET . 4.7 mp -96.02 145.71 25.23 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 170.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.463 HD12 ' O ' ' B' ' 87' ' ' LEU . 1.2 mm? -120.96 150.2 41.48 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 173.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.21 -167.89 27.55 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.327 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' TYR . . . . . 0.412 ' CD2' ' HB3' ' C' ' 68' ' ' ASN . 3.4 p90 -147.53 129.22 15.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.755 0.788 . . . . 0.0 112.166 177.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 15.8 mt -71.52 140.98 50.13 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 113.949 -1.478 . . . . 0.0 109.766 176.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 -66.63 141.93 57.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.134 0.493 . . . . 0.0 111.515 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -90.57 124.7 35.24 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.232 177.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 16.5 pt -82.76 -48.41 17.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.459 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -175.24 42.47 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.879 0.371 . . . . 0.0 110.976 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 1.5 m -78.55 61.14 2.83 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.987 0.423 . . . . 0.0 110.665 -178.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.41 80.83 1.48 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.507 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 48.3 m . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.358 -179.999 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 1' ' ' PHE . . . . . 1.634 ' HD2' ' CD1' ' C' ' 1' ' ' PHE . 83.4 t80 . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . 0.407 ' HG3' ' H ' ' C' ' 3' ' ' GLY . 3.9 pt20 53.26 -68.13 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.762 1.625 . . . . 0.0 114.134 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 3' ' ' GLY . . . . . 0.407 ' H ' ' HG3' ' C' ' 2' ' ' GLN . . . -155.59 33.08 0.63 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.361 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.09 -64.75 0.99 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.887 0.375 . . . . 0.0 110.614 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 26.3 mmt -105.55 43.89 1.08 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.29 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.18 135.03 53.39 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.953 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 56.4 mtp -98.25 151.04 20.89 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.289 -174.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 8' ' ' PHE . . . . . 1.659 ' HD1' ' CD2' ' C' ' 8' ' ' PHE . 48.8 t80 -66.35 145.47 55.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.101 -176.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . 0.541 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 90.2 t90 -132.71 146.02 51.52 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.046 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.13 146.69 16.35 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.1 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.541 ' HB2' ' CH2' ' C' ' 9' ' ' TRP . 63.5 tp -134.29 109.0 8.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.032 0.444 . . . . 0.0 110.468 178.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -91.44 107.66 19.36 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.583 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 13' ' ' MET . . . . . 0.613 ' SD ' HD12 ' C' ' 87' ' ' LEU . 53.5 mtp -102.21 143.61 31.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.322 0.582 . . . . 0.0 111.496 -174.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -100.8 151.46 37.6 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.205 -177.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . 0.457 ' HB3' ' N ' ' C' ' 83' ' ' ALA . 11.2 Cg_endo -55.01 113.89 1.61 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 123.152 2.568 . . . . 0.0 112.796 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' C' ' 79' ' ' THR . 17.4 mt-10 59.96 70.97 0.6 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.46 0.648 . . . . 0.0 111.328 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.24 142.97 32.67 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.554 174.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 18' ' ' LYS . . . . . 0.635 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 35.2 ttmt -116.69 117.42 29.76 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.323 -176.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . 0.473 ' HH ' ' HA ' ' C' ' 13' ' ' MET . 1.9 m-85 -110.38 122.33 47.43 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 20' ' ' SER . . . . . 0.446 ' HB3' ' SD ' ' C' ' 76' ' ' MET . 6.1 p -102.59 99.84 9.87 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 169.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 19.8 pm0 -117.78 143.05 46.6 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.611 0.72 . . . . 0.0 112.163 -174.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 12.9 t -93.36 160.76 14.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.532 176.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 70.3 mt -112.54 119.35 60.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.141 0.495 . . . . 0.0 111.531 -173.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 1.7 pp -99.6 -11.51 8.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.022 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -148.02 119.46 7.91 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 31.7 p -61.57 140.46 58.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.688 -175.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 27' ' ' PHE . . . . . 1.612 ' HD2' ' CD1' ' C' ' 27' ' ' PHE . 42.6 p90 -152.04 162.86 40.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.652 0.739 . . . . 0.0 112.969 -175.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 28' ' ' HIS . . . . . 0.516 ' HA ' ' O ' ' C' ' 67' ' ' LEU . 7.5 t60 -114.81 124.58 52.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.01 177.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . 0.49 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 41.6 mt -88.32 135.92 24.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 170.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 30' ' ' SER . . . . . 0.483 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 44.9 p -123.59 -5.31 8.16 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -170.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . 179.89 155.09 14.49 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 119.181 -1.485 . . . . 0.0 113.547 176.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.402 HG21 ' HG ' ' C' ' 87' ' ' LEU . 12.0 p -136.8 132.84 48.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 174.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.82 156.52 42.45 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 121.952 -0.468 . . . . 0.0 111.589 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.475 ' HB3' HG13 ' C' ' 85' ' ' VAL . 4.1 pp -123.82 145.45 49.06 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.514 0.673 . . . . 0.0 111.044 177.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -110.03 -52.14 2.81 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.703 174.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 36' ' ' LYS . . . . . 0.512 ' HZ2' ' HB3' ' C' ' 36' ' ' LYS . 7.8 mtpm? -102.9 127.41 50.11 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 169.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 37' ' ' GLY . . . . . 0.444 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 151.86 156.76 7.6 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 119.848 -1.168 . . . . 0.0 113.46 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 38' ' ' GLN . . . . . 0.456 ' HA ' ' HB2' ' C' ' 58' ' ' LYS . 95.0 mt-30 -102.4 -44.34 5.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.642 0.258 . . . . 0.0 111.059 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -152.91 128.82 10.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.57 0.224 . . . . 0.0 111.361 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . 0.417 ' HB1' HG11 ' C' ' 56' ' ' VAL . . . -128.24 112.94 15.05 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.524 0.678 . . . . 0.0 109.972 168.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' C' ' 79' ' ' THR . 28.7 mmmt -94.57 109.32 21.23 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 176.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 48.5 tp -82.08 109.46 16.42 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -174.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -112.3 136.4 51.78 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.071 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.691 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 0.1 OUTLIER -123.88 121.79 36.29 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.478 175.463 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -109.85 111.14 22.38 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.968 178.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . 0.405 ' HB1' ' CE2' ' B' ' 8' ' ' PHE . . . -128.7 139.39 52.25 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.607 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 56.5 35.75 26.49 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 123.728 0.643 . . . . 0.0 110.304 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . 0.507 ' HZ2' ' HB3' ' C' ' 48' ' ' LYS . 9.1 mtpm? 63.64 32.2 14.05 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.253 178.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . 0.537 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 59.5 tp60 -128.23 133.88 48.9 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 175.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -88.99 121.69 31.61 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -116.66 123.43 47.26 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.453 176.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -75.4 106.72 5.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 53' ' ' VAL . . . . . 0.592 ' CG2' ' HB3' ' C' ' 44' ' ' LEU . 0.7 OUTLIER -84.2 -46.41 17.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.553 -172.351 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 54' ' ' ALA . . . . . 0.468 ' HB1' HD22 ' C' ' 65' ' ' LEU . . . -153.97 149.44 27.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.696 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 52.6 m -112.96 101.6 9.63 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 169.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . 0.417 HG11 ' HB1' ' C' ' 40' ' ' ALA . 7.8 p -115.69 114.33 45.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.517 0.675 . . . . 0.0 109.298 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 44.3 p -122.62 -179.17 4.13 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.205 -172.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 58' ' ' LYS . . . . . 0.456 ' HB2' ' HA ' ' C' ' 38' ' ' GLN . 57.9 tttt -58.52 -32.35 68.76 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.745 171.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.38 -41.03 22.57 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.851 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 83.9 mt -108.22 86.7 3.46 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 174.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.19 0.2 8.77 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.74 2.293 . . . . 0.0 113.786 -166.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -164.46 131.12 3.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.245 0.545 . . . . 0.0 111.576 -175.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.455 HG12 ' HB3' ' C' ' 54' ' ' ALA . 94.0 t -122.03 112.18 33.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.303 174.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.67 131.48 41.69 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . 0.468 HD22 ' HB1' ' C' ' 54' ' ' ALA . 86.2 mt -124.17 168.17 13.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.46 0.648 . . . . 0.0 112.265 -173.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 66' ' ' ASP . . . . . 0.454 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 18.5 t0 -142.46 99.46 3.5 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.964 -1.017 . . . . 0.0 108.332 169.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . 0.516 ' O ' ' HA ' ' C' ' 28' ' ' HIS . 2.3 mt -129.42 144.29 51.19 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . 0.412 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 5.9 t30 -141.86 114.95 8.74 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.762 176.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -111.17 146.88 36.1 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.529 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 70' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' B' ' 6' ' ' ALA . 21.9 t -97.81 166.62 11.38 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -75.46 2.08 12.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.215 0.531 . . . . 0.0 110.588 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.15 -7.7 51.87 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.253 172.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -93.27 138.7 31.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.123 0.487 . . . . 0.0 110.428 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -122.24 116.97 25.06 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 175.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 15.0 pt -128.51 162.73 34.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.259 0.552 . . . . 0.0 112.014 -168.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 76' ' ' MET . . . . . 0.458 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 4.8 mtm -119.92 125.69 49.08 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.475 172.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 77' ' ' PHE . . . . . 1.649 ' HD1' ' CD2' ' C' ' 77' ' ' PHE . 0.8 OUTLIER -109.66 127.11 54.33 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 176.635 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 78' ' ' TYR . . . . . 1.657 ' HE1' ' CE2' ' C' ' 78' ' ' TYR . 53.3 p90 -155.42 139.21 16.18 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.862 -0.735 . . . . 0.0 112.079 -176.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 79' ' ' THR . . . . . 0.577 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 3.0 p -111.56 134.22 53.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.42 -176.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -100.71 157.1 16.94 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.522 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.81 178.93 46.2 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -176.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -108.06 102.98 12.1 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.064 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . 0.457 ' N ' ' HB3' ' C' ' 15' ' ' PRO . . . -168.79 150.77 4.82 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.504 170.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 15.8 t -109.72 121.93 46.34 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.475 HG13 ' HB3' ' C' ' 34' ' ' LEU . 6.9 m -117.78 155.3 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 CA-C-O 121.344 0.592 . . . . 0.0 112.353 -173.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 49.9 m -120.62 122.41 40.45 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.573 173.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . 0.613 HD12 ' SD ' ' C' ' 13' ' ' MET . 4.7 mp -96.0 145.72 25.21 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 170.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . 0.472 HD12 ' O ' ' C' ' 87' ' ' LEU . 1.2 mm? -121.0 150.31 41.32 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 173.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.31 -167.96 27.77 Favored Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.249 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 90' ' ' TYR . . . . . 0.425 ' CD2' ' HB3' ' D' ' 68' ' ' ASN . 3.3 p90 -147.52 129.24 15.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.785 0.802 . . . . 0.0 112.086 177.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 15.9 mt -71.53 141.03 50.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 113.911 -1.495 . . . . 0.0 109.761 176.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 55.8 m-70 -66.6 141.86 57.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.184 0.516 . . . . 0.0 111.499 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -90.57 124.64 35.19 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.202 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 16.6 pt -82.77 -48.48 17.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.384 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -175.2 42.54 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.874 0.369 . . . . 0.0 110.963 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 1.4 m -78.44 60.98 2.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.951 0.405 . . . . 0.0 110.645 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.46 80.91 1.48 Allowed Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 -177.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.394 -179.978 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . 1.629 ' HD1' ' CD2' ' D' ' 1' ' ' PHE . 83.5 t80 . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . 0.411 ' HG3' ' H ' ' D' ' 3' ' ' GLY . 3.9 pt20 53.43 -68.22 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.704 1.602 . . . . 0.0 114.131 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 3' ' ' GLY . . . . . 0.411 ' H ' ' HG3' ' D' ' 2' ' ' GLN . . . -155.64 33.03 0.63 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.35 -177.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.03 -64.83 0.97 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.873 0.368 . . . . 0.0 110.634 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 26.3 mmt -105.45 43.84 1.09 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.348 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.1 134.91 53.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.939 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 56.7 mtp -98.17 151.07 20.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.03 0.443 . . . . 0.0 111.326 -174.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 8' ' ' PHE . . . . . 1.666 ' HE2' ' CE1' ' D' ' 8' ' ' PHE . 48.6 t80 -66.5 145.55 55.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.1 -176.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 9' ' ' TRP . . . . . 0.538 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 90.2 t90 -132.75 146.02 51.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.013 179.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.11 146.71 16.41 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.125 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . 0.538 ' HB2' ' CH2' ' D' ' 9' ' ' TRP . 63.4 tp -134.31 108.95 8.5 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.031 0.443 . . . . 0.0 110.558 178.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -91.38 107.67 19.37 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.566 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 13' ' ' MET . . . . . 0.614 ' SD ' HD12 ' D' ' 87' ' ' LEU . 54.0 mtp -102.3 143.77 31.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.429 0.633 . . . . 0.0 111.408 -174.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -100.84 151.44 37.61 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.203 -177.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . 0.47 ' HB3' ' N ' ' D' ' 83' ' ' ALA . 11.1 Cg_endo -55.06 113.9 1.62 Allowed 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 123.119 2.546 . . . . 0.0 112.754 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . 0.569 ' HA ' ' O ' ' D' ' 79' ' ' THR . 17.3 mt-10 60.02 70.83 0.61 Allowed 'General case' 0 C--O 1.233 0.207 0 O-C-N 123.711 0.632 . . . . 0.0 111.36 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.13 142.97 32.81 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.516 174.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . 0.63 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 35.3 ttmt -116.69 117.44 29.81 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.373 -176.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 19' ' ' TYR . . . . . 0.474 ' HH ' ' HA ' ' D' ' 13' ' ' MET . 1.9 m-85 -110.29 122.38 47.52 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 20' ' ' SER . . . . . 0.448 ' HB3' ' SD ' ' D' ' 76' ' ' MET . 5.9 p -102.63 99.86 9.88 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 169.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 19.8 pm0 -117.76 142.98 46.66 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.516 0.674 . . . . 0.0 112.215 -174.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 13.0 t -93.24 160.77 14.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.609 176.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 70.1 mt -112.6 119.49 60.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.217 0.532 . . . . 0.0 111.449 -173.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 1.7 pp -99.7 -11.59 8.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.005 177.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -147.99 119.55 7.97 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 31.3 p -61.75 140.51 58.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.691 -175.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 27' ' ' PHE . . . . . 1.632 ' HE1' ' CE2' ' D' ' 27' ' ' PHE . 42.8 p90 -152.08 162.82 40.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.712 0.768 . . . . 0.0 112.898 -174.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 28' ' ' HIS . . . . . 0.505 ' HA ' ' O ' ' D' ' 67' ' ' LEU . 7.7 t60 -114.81 124.58 52.1 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.011 176.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 29' ' ' ILE . . . . . 0.484 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 42.1 mt -88.33 135.88 24.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 170.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 30' ' ' SER . . . . . 0.488 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 44.6 p -123.59 -5.28 8.16 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -170.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 31' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . 179.94 155.12 14.6 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 119.175 -1.488 . . . . 0.0 113.544 176.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . 0.401 HG21 ' HG ' ' D' ' 87' ' ' LEU . 12.0 p -136.84 132.84 48.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 174.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.83 156.46 42.36 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.918 -0.489 . . . . 0.0 111.598 -176.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 34' ' ' LEU . . . . . 0.474 ' HB3' ' CG1' ' D' ' 85' ' ' VAL . 4.1 pp -123.77 145.43 49.04 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.538 0.685 . . . . 0.0 111.069 177.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -110.13 -51.93 2.83 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.706 174.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 36' ' ' LYS . . . . . 0.511 ' HZ2' ' HB3' ' D' ' 36' ' ' LYS . 7.8 mtpm? -103.02 127.4 50.28 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 169.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . 0.447 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 151.81 156.81 7.62 Favored Glycine 0 N--CA 1.437 -1.253 0 C-N-CA 119.811 -1.185 . . . . 0.0 113.384 177.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 38' ' ' GLN . . . . . 0.468 ' HA ' ' HB2' ' D' ' 58' ' ' LYS . 95.0 mt-30 -102.43 -44.41 5.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.662 0.267 . . . . 0.0 111.053 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -152.87 128.84 10.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.327 178.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . 0.423 ' HB1' HG11 ' D' ' 56' ' ' VAL . . . -128.22 113.08 15.23 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.557 0.694 . . . . 0.0 109.884 168.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' D' ' 79' ' ' THR . 28.6 mmmt -94.6 109.35 21.27 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 176.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 48.5 tp -82.13 109.49 16.49 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -174.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -112.22 136.34 51.77 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.123 177.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.693 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.1 OUTLIER -123.91 121.78 36.24 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.498 175.427 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 45' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -109.91 111.16 22.39 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.915 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -128.72 139.39 52.24 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.567 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 56.57 35.72 26.5 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 123.654 0.596 . . . . 0.0 110.207 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 48' ' ' LYS . . . . . 0.51 ' HZ2' ' HB3' ' D' ' 48' ' ' LYS . 9.1 mtpm? 63.6 32.32 14.08 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.276 178.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . 0.543 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 59.5 tp60 -128.3 133.98 48.84 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -89.1 121.79 31.78 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -177.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -116.72 123.4 47.12 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.442 176.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -75.42 106.71 5.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 169.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 53' ' ' VAL . . . . . 0.596 ' CG2' ' HB3' ' D' ' 44' ' ' LEU . 0.7 OUTLIER -84.09 -46.44 18.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.599 -172.392 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 54' ' ' ALA . . . . . 0.456 ' HB3' HG12 ' D' ' 63' ' ' VAL . . . -153.89 149.38 27.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.728 -177.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 53.0 m -112.93 101.64 9.68 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 169.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 56' ' ' VAL . . . . . 0.423 HG11 ' HB1' ' D' ' 40' ' ' ALA . 7.8 p -115.71 114.37 46.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.605 0.716 . . . . 0.0 109.254 -179.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 44.7 p -122.65 -179.23 4.15 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.13 -172.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 58' ' ' LYS . . . . . 0.468 ' HB2' ' HA ' ' D' ' 38' ' ' GLN . 57.9 tttt -58.61 -32.3 68.87 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.721 171.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.38 -40.94 22.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.862 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 84.7 mt -108.33 86.68 3.53 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 175.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.11 0.23 8.7 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.79 2.327 . . . . 0.0 113.845 -166.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -164.52 131.07 3.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.342 0.591 . . . . 0.0 111.526 -175.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.456 HG12 ' HB3' ' D' ' 54' ' ' ALA . 93.5 t -122.09 112.24 33.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.308 174.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.64 131.56 41.8 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 174.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 65' ' ' LEU . . . . . 0.45 HD22 ' HB1' ' D' ' 54' ' ' ALA . 86.3 mt -124.2 168.16 13.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.559 0.695 . . . . 0.0 112.188 -173.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 66' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 18.6 t0 -142.44 99.46 3.5 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.319 169.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' D' ' 28' ' ' HIS . 2.3 mt -129.47 144.27 51.18 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 68' ' ' ASN . . . . . 0.425 ' HB3' ' CD2' ' C' ' 90' ' ' TYR . 5.9 t30 -141.88 114.9 8.7 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.538 -0.465 . . . . 0.0 109.805 176.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -111.06 146.86 36.0 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.569 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 21.8 t -97.78 166.7 11.35 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -75.54 2.15 12.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.195 0.522 . . . . 0.0 110.583 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.14 -7.76 51.77 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.271 172.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -93.28 138.76 31.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.159 0.504 . . . . 0.0 110.489 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -122.3 116.98 25.02 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 175.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . . . . . . . . . 14.9 pt -128.5 162.72 34.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.135 0.493 . . . . 0.0 112.051 -168.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 76' ' ' MET . . . . . 0.462 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 4.9 mtm -120.03 125.67 48.92 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.458 172.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 77' ' ' PHE . . . . . 1.656 ' HE2' ' CE1' ' D' ' 77' ' ' PHE . 0.8 OUTLIER -109.63 127.18 54.35 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.639 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 78' ' ' TYR . . . . . 1.655 ' HE2' ' CE1' ' D' ' 78' ' ' TYR . 53.3 p90 -155.52 139.2 16.07 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 119.814 -0.755 . . . . 0.0 112.006 -175.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 79' ' ' THR . . . . . 0.569 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 2.9 p -111.62 134.22 53.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.415 -176.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -100.66 157.19 16.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.499 175.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.69 178.99 46.35 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -108.1 103.0 12.11 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 117.784 0.792 . . . . 0.0 110.013 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.47 ' N ' ' HB3' ' D' ' 15' ' ' PRO . . . -168.92 150.73 4.68 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.46 170.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 15.3 t -109.64 121.85 46.14 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . 0.474 ' CG1' ' HB3' ' D' ' 34' ' ' LEU . 6.9 m -117.78 155.3 19.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.442 0.639 . . . . 0.0 112.288 -173.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 49.6 m -120.71 122.42 40.38 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.519 173.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 87' ' ' LEU . . . . . 0.614 HD12 ' SD ' ' D' ' 13' ' ' MET . 4.7 mp -96.0 145.72 25.21 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 170.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . 0.474 HD12 ' O ' ' D' ' 87' ' ' LEU . 1.1 mm? -121.0 150.28 41.38 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.25 -167.89 27.6 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.25 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 90' ' ' TYR . . . . . 0.401 ' CD2' ' HB3' ' E' ' 68' ' ' ASN . 3.4 p90 -147.46 129.25 15.24 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.769 0.795 . . . . 0.0 112.115 177.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 15.8 mt -71.52 141.0 50.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 113.901 -1.5 . . . . 0.0 109.759 176.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -66.7 141.89 57.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.237 0.541 . . . . 0.0 111.514 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -90.52 124.65 35.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.215 177.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 16.3 pt -82.77 -48.49 17.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.32 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -175.24 42.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.895 0.379 . . . . 0.0 110.9 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 1.5 m -78.58 61.1 2.85 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.112 0.482 . . . . 0.0 110.674 -178.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.37 80.89 1.48 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.599 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 C--O 1.247 0.931 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.338 -179.94 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' E' E ' 1' ' ' PHE . . . . . 1.667 ' HD1' ' CD2' ' E' ' 1' ' ' PHE . 83.2 t80 . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 2' ' ' GLN . . . . . 0.41 ' HG3' ' H ' ' E' ' 3' ' ' GLY . 3.9 pt20 53.38 -68.18 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.743 1.617 . . . . 0.0 114.155 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 3' ' ' GLY . . . . . 0.41 ' H ' ' HG3' ' E' ' 2' ' ' GLN . . . -155.65 33.12 0.63 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.388 -177.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.08 -64.8 0.98 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.902 0.382 . . . . 0.0 110.59 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 26.3 mmt -105.58 43.92 1.08 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.325 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.11 135.04 53.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.966 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 56.4 mtp -98.33 151.05 20.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.089 0.471 . . . . 0.0 111.268 -174.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 8' ' ' PHE . . . . . 1.672 ' HD2' ' CD1' ' E' ' 8' ' ' PHE . 48.6 t80 -66.5 145.51 55.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.074 -176.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 9' ' ' TRP . . . . . 0.538 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 90.4 t90 -132.71 146.03 51.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.006 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.1 146.65 16.28 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.195 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . 0.538 ' HB2' ' CH2' ' E' ' 9' ' ' TRP . 63.5 tp -134.15 109.05 8.65 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.945 0.402 . . . . 0.0 110.502 178.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -91.48 107.69 19.38 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 13' ' ' MET . . . . . 0.622 ' SD ' HD12 ' E' ' 87' ' ' LEU . 53.9 mtp -102.3 143.71 31.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.419 0.628 . . . . 0.0 111.445 -174.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -100.85 151.46 37.61 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.149 -177.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . 0.46 ' HB3' ' N ' ' E' ' 83' ' ' ALA . 11.1 Cg_endo -55.14 113.95 1.64 Allowed 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 123.188 2.592 . . . . 0.0 112.697 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 16' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' E' ' 79' ' ' THR . 17.4 mt-10 59.87 70.95 0.6 Allowed 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.426 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.14 142.92 32.79 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.56 174.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . 0.63 ' HA ' ' CB ' ' E' ' 78' ' ' TYR . 35.3 ttmt -116.6 117.46 29.92 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.322 -176.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . 0.474 ' HH ' ' HA ' ' E' ' 13' ' ' MET . 1.9 m-85 -110.35 122.24 47.21 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 20' ' ' SER . . . . . 0.446 ' HB3' ' SD ' ' E' ' 76' ' ' MET . 6.1 p -102.46 99.8 9.87 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 169.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 19.8 pm0 -117.79 143.07 46.59 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.628 0.728 . . . . 0.0 112.242 -174.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 13.0 t -93.36 160.77 14.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.551 176.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 69.9 mt -112.5 119.38 60.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.065 0.46 . . . . 0.0 111.579 -173.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 1.7 pp -99.6 -11.51 8.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.051 177.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -148.07 119.55 7.93 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 31.3 p -61.73 140.49 58.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.648 -175.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 27' ' ' PHE . . . . . 1.638 ' HE1' ' CE2' ' E' ' 27' ' ' PHE . 42.9 p90 -152.08 162.78 40.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.793 0.806 . . . . 0.0 112.907 -174.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 28' ' ' HIS . . . . . 0.515 ' HA ' ' O ' ' E' ' 67' ' ' LEU . 7.7 t60 -114.67 124.59 52.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.981 177.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 29' ' ' ILE . . . . . 0.479 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 42.2 mt -88.32 135.87 24.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 170.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 30' ' ' SER . . . . . 0.479 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 45.1 p -123.55 -5.31 8.18 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -170.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 31' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . 179.91 155.11 14.56 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 119.123 -1.513 . . . . 0.0 113.572 175.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 12.0 p -136.81 132.82 48.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 174.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.75 156.49 42.43 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 121.92 -0.487 . . . . 0.0 111.571 -176.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 34' ' ' LEU . . . . . 0.475 ' HB3' ' CG1' ' E' ' 85' ' ' VAL . 4.1 pp -123.81 145.52 49.0 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.607 0.718 . . . . 0.0 111.031 177.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -110.09 -52.07 2.81 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.977 -1.011 . . . . 0.0 108.683 174.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 36' ' ' LYS . . . . . 0.508 ' HZ2' ' HB3' ' E' ' 36' ' ' LYS . 7.8 mtpm? -102.98 127.31 50.27 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 169.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . 0.442 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 151.92 156.78 7.62 Favored Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 119.754 -1.212 . . . . 0.0 113.389 177.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 38' ' ' GLN . . . . . 0.469 ' HA ' ' HB2' ' E' ' 58' ' ' LYS . 94.9 mt-30 -102.39 -44.39 5.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.658 0.266 . . . . 0.0 111.094 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -152.88 128.81 10.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.411 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . 0.423 ' HB1' HG11 ' E' ' 56' ' ' VAL . . . -128.19 113.01 15.15 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.476 0.655 . . . . 0.0 109.89 168.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 41' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' E' ' 79' ' ' THR . 28.7 mmmt -94.59 109.34 21.26 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 48.1 tp -82.08 109.51 16.47 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -174.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -112.24 136.3 51.84 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.067 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 44' ' ' LEU . . . . . 0.68 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 0.1 OUTLIER -123.88 121.71 36.07 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.459 175.457 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' E' E ' 45' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -109.82 111.16 22.43 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.003 178.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -128.77 139.32 52.25 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.513 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 56.56 35.75 26.53 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 123.688 0.618 . . . . 0.0 110.225 -177.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 48' ' ' LYS . . . . . 0.506 ' HB3' ' HZ2' ' E' ' 48' ' ' LYS . 9.1 mtpm? 63.66 32.28 13.94 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.221 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 49' ' ' GLN . . . . . 0.547 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 59.2 tp60 -128.25 133.9 48.88 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 175.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -89.03 121.74 31.68 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -116.65 123.38 47.14 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.496 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -75.27 106.65 5.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 169.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . 0.592 ' CG2' ' HB3' ' E' ' 44' ' ' LEU . 0.7 OUTLIER -84.25 -46.36 17.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.508 -172.313 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' E' E ' 54' ' ' ALA . . . . . 0.465 ' HB1' HD22 ' E' ' 65' ' ' LEU . . . -153.91 149.4 27.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.664 -177.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 52.6 m -112.93 101.7 9.74 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 169.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . 0.423 HG11 ' HB1' ' E' ' 40' ' ' ALA . 7.7 p -115.8 114.32 45.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.579 0.704 . . . . 0.0 109.212 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 45.0 p -122.59 -179.17 4.13 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.194 -172.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 58' ' ' LYS . . . . . 0.469 ' HB2' ' HA ' ' E' ' 38' ' ' GLN . 58.2 tttt -58.62 -32.23 68.83 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.783 171.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.42 -40.95 22.61 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.885 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 84.1 mt -108.3 86.64 3.49 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 174.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.09 0.18 8.75 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.756 2.304 . . . . 0.0 113.848 -166.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -164.45 131.18 3.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.289 0.566 . . . . 0.0 111.551 -175.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . 0.454 HG12 ' HB3' ' E' ' 54' ' ' ALA . 94.2 t -122.08 112.21 33.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.281 174.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.57 131.5 41.79 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . 0.465 HD22 ' HB1' ' E' ' 54' ' ' ALA . 86.3 mt -124.23 168.08 13.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.496 0.665 . . . . 0.0 112.283 -173.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 66' ' ' ASP . . . . . 0.463 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 18.5 t0 -142.41 99.49 3.51 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.383 170.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 67' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' E' ' 28' ' ' HIS . 2.3 mt -129.46 144.3 51.2 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 68' ' ' ASN . . . . . 0.401 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 5.8 t30 -141.91 114.92 8.7 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.558 -0.457 . . . . 0.0 109.783 176.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -111.12 146.84 36.1 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.535 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 21.9 t -97.7 166.71 11.36 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -75.59 2.17 12.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.229 0.537 . . . . 0.0 110.531 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.14 -7.79 51.73 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.305 172.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -93.25 138.71 31.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.108 0.48 . . . . 0.0 110.463 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -122.22 116.9 24.96 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 75' ' ' ILE . . . . . . . . . . . . . 14.9 pt -128.38 162.73 34.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.219 0.533 . . . . 0.0 112.029 -168.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 76' ' ' MET . . . . . 0.46 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 4.9 mtm -119.97 125.72 49.09 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 172.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 77' ' ' PHE . . . . . 1.65 ' HE2' ' CE1' ' E' ' 77' ' ' PHE . 0.8 OUTLIER -109.64 127.22 54.39 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 176.576 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' E' E ' 78' ' ' TYR . . . . . 1.659 ' HE2' ' CE1' ' E' ' 78' ' ' TYR . 53.2 p90 -155.55 139.21 16.05 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 119.79 -0.764 . . . . 0.0 112.001 -175.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 79' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 3.0 p -111.58 134.23 53.3 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.389 -176.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -100.7 157.16 16.9 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.537 175.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.79 179.01 46.2 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -176.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -108.17 102.93 12.04 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 119.714 -0.794 . . . . 0.0 110.044 178.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 83' ' ' ALA . . . . . 0.46 ' N ' ' HB3' ' E' ' 15' ' ' PRO . . . -168.8 150.83 4.82 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.436 170.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 15.5 t -109.76 121.89 46.25 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 85' ' ' VAL . . . . . 0.475 ' CG1' ' HB3' ' E' ' 34' ' ' LEU . 6.9 m -117.77 155.32 19.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.398 0.618 . . . . 0.0 112.311 -173.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 49.3 m -120.67 122.43 40.45 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.542 173.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 87' ' ' LEU . . . . . 0.622 HD12 ' SD ' ' E' ' 13' ' ' MET . 4.7 mp -96.07 145.77 25.2 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 170.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . 0.469 HD12 ' O ' ' E' ' 87' ' ' LEU . 1.2 mm? -120.96 150.25 41.39 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 173.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.31 -167.91 27.69 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.363 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 90' ' ' TYR . . . . . 0.415 ' CD2' ' HB3' ' A' ' 68' ' ' ASN . 3.4 p90 -147.49 129.24 15.19 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.758 0.789 . . . . 0.0 112.126 177.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 91' ' ' LEU . . . . . . . . . . . . . 15.8 mt -71.48 140.97 50.2 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 113.838 -1.528 . . . . 0.0 109.814 176.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -66.63 141.88 57.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.163 0.506 . . . . 0.0 111.526 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -90.55 124.72 35.24 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.246 177.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 16.5 pt -82.78 -48.55 17.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.379 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -175.17 42.59 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.864 0.364 . . . . 0.0 110.889 -178.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 1.4 m -78.58 61.08 2.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.992 0.425 . . . . 0.0 110.606 -178.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.41 80.91 1.48 Allowed Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.953 -0.642 . . . . 0.0 111.597 -177.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 48.4 m . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.279 -179.868 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 77.3 t80 . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.413 ' H ' HG22 ' B' ' 94' ' ' ILE . 3.7 pt20 -154.41 -47.26 0.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.711 0.291 . . . . 0.0 111.318 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.503 ' H ' HG22 ' B' ' 94' ' ' ILE . . . 83.22 -58.77 5.03 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.877 175.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 58.86 43.24 18.48 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.409 0.623 . . . . 0.0 110.299 -176.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.6 ttm -80.21 94.48 6.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.499 -177.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.97 152.38 24.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.577 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.408 ' HG2' ' OG ' ' B' ' 70' ' ' SER . 58.8 mtt -110.09 139.33 45.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.903 -176.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.501 ' CE1' HD23 ' B' ' 44' ' ' LEU . 77.1 t80 -59.77 140.29 56.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -172.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.437 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 87.4 t90 -132.73 146.74 52.1 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.549 178.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.407 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -151.61 152.69 24.41 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.261 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.542 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 59.3 tp -140.45 106.7 5.24 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 178.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -86.31 100.92 12.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.502 0.667 . . . . 0.0 109.755 175.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.453 ' SD ' HD12 ' A' ' 87' ' ' LEU . 3.7 ttt -94.65 134.22 37.46 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.142 -168.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.432 ' HB2' ' HG3' ' A' ' 17' ' ' ARG . 2.5 mptp? -100.28 149.57 36.17 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.811 -178.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.433 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 12.2 Cg_endo -56.43 122.32 11.59 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.122 2.548 . . . . 0.0 112.987 -178.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 79' ' ' THR . 44.9 mt-10 61.53 51.79 3.93 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.564 177.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.432 ' HG3' ' HB2' ' A' ' 14' ' ' LYS . 29.0 mmt180 -117.57 145.52 44.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.131 173.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.648 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 40.5 tttt -123.28 109.82 14.43 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 123.505 0.503 . . . . 0.0 110.551 -176.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 1.641 ' HD1' ' CD2' ' A' ' 19' ' ' TYR . 3.4 m-85 -110.02 104.31 13.18 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.356 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.448 ' HB3' ' SD ' ' A' ' 76' ' ' MET . 13.8 p -84.99 99.45 11.0 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -113.41 143.99 43.55 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.568 0.699 . . . . 0.0 112.002 -168.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.3 p -96.43 157.35 15.94 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.612 174.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.425 ' CD1' ' HB3' ' A' ' 69' ' ' PHE . 54.1 mt -115.1 116.64 53.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.347 0.594 . . . . 0.0 111.18 -175.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.474 HD13 ' N ' ' A' ' 24' ' ' ILE . 3.9 mp -93.34 -40.97 12.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.101 178.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.8 pttt -123.88 128.22 49.16 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.586 176.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.8 p -64.65 141.83 58.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.259 -174.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 91' ' ' LEU . 39.8 p90 -142.08 152.52 43.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.745 0.783 . . . . 0.0 112.226 -177.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.614 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 6.1 t60 -108.24 120.52 42.6 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.354 173.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.503 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 35.1 mt -84.51 133.65 28.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 170.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.526 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 56.0 p -120.43 -6.87 9.78 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.683 0.278 . . . . 0.0 111.64 -173.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.15 158.32 25.84 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 119.455 -1.355 . . . . 0.0 113.622 176.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.2 p -140.43 127.24 22.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 172.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.16 152.87 41.48 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 121.972 -0.455 . . . . 0.0 111.389 -175.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.48 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 3.7 pp -117.82 145.88 44.25 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.787 0.803 . . . . 0.0 111.733 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -106.73 -55.99 2.25 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.894 175.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -102.59 128.03 49.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.049 170.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.437 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 153.23 158.53 8.6 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 119.437 -1.363 . . . . 0.0 113.892 175.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -101.76 -45.62 5.18 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.426 -0.387 . . . . 0.0 110.571 176.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -153.14 123.01 6.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.091 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.452 ' HB1' HG11 ' A' ' 56' ' ' VAL . . . -121.88 114.13 20.6 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.44 0.638 . . . . 0.0 110.033 170.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 79' ' ' THR . 13.7 mmmm -97.18 105.51 17.67 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.6 tp -83.71 111.47 19.19 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -174.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.531 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 79.9 m-85 -114.9 149.95 36.4 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 175.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.547 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -135.47 128.01 30.63 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.616 172.125 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.561 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -105.89 112.22 25.18 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.09 178.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -127.92 133.23 49.25 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.395 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 59.42 38.23 22.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.48 0.657 . . . . 0.0 109.629 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt 62.37 35.27 15.11 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.717 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.561 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 23.5 tp60 -130.18 118.23 21.1 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -81.63 108.29 15.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.878 0.371 . . . . 0.0 110.86 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.453 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 87.5 m-85 -99.87 133.41 44.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.519 177.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -80.14 104.65 8.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 168.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.453 HG22 ' HB3' ' A' ' 44' ' ' LEU . 3.2 t -79.68 -50.32 18.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.696 -172.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.461 ' HB1' HD22 ' A' ' 65' ' ' LEU . . . -153.46 147.22 25.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.656 -176.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.5 m -110.95 101.28 9.86 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 171.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.452 HG11 ' HB1' ' A' ' 40' ' ' ALA . 7.2 p -119.65 113.52 41.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.62 0.724 . . . . 0.0 109.741 -177.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.2 p -123.28 -178.42 3.98 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.684 -174.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -61.89 -23.01 66.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.908 0.385 . . . . 0.0 110.463 170.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.427 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -84.35 -40.87 17.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.245 0.545 . . . . 0.0 110.15 178.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.2 mt -112.75 82.62 5.14 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 11.5 Cg_exo -70.8 -0.38 7.68 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.06 2.506 . . . . 0.0 113.868 -167.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -162.99 127.0 2.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.339 0.59 . . . . 0.0 111.416 -176.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.458 HG12 ' HB3' ' A' ' 54' ' ' ALA . 87.0 t -116.38 121.92 68.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.399 174.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.43 127.63 32.99 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.973 176.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.461 HD22 ' HB1' ' A' ' 54' ' ' ALA . 91.0 mt -119.92 168.45 11.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.401 0.62 . . . . 0.0 112.226 -174.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 14.2 t0 -145.72 97.59 3.0 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 172.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.614 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 6.7 mt -133.54 110.0 9.63 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.797 -174.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.45 ' HB2' ' CG ' ' E' ' 90' ' ' TYR . 6.3 m-20 -103.82 113.92 27.8 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 1.598 ' HE2' ' CE1' ' A' ' 69' ' ' PHE . 86.0 m-85 -109.04 136.92 47.76 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.829 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.411 ' OG ' ' HG2' ' E' ' 7' ' ' MET . 87.8 p -97.35 166.69 11.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.744 0.307 . . . . 0.0 110.21 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.431 ' HE3' ' OG ' ' E' ' 98' ' ' SER . 14.9 ptmm? -73.05 -4.89 35.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.919 0.39 . . . . 0.0 110.893 -178.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.67 -9.16 58.96 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 174.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -88.49 140.3 29.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.929 0.395 . . . . 0.0 110.06 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -126.33 114.53 18.37 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 175.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.1 pt -131.03 158.7 43.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.053 0.454 . . . . 0.0 112.059 -166.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.465 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 3.6 mtm -119.19 123.92 45.51 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 174.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 1.662 ' HD1' ' CD2' ' A' ' 77' ' ' PHE . 1.1 m-85 -104.24 128.63 52.01 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.648 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 25.9 p90 -151.92 134.97 15.75 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.453 0.644 . . . . 0.0 112.488 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 2.6 p -108.94 130.58 55.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.748 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.9 164.72 11.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.439 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.57 -174.03 44.41 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -177.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -113.43 102.74 10.61 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.023 178.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.437 ' CB ' ' HA3' ' A' ' 37' ' ' GLY . . . -173.62 153.55 2.3 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.551 171.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.9 t -114.84 126.41 54.78 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.48 ' CG1' ' HB3' ' A' ' 34' ' ' LEU . 6.7 m -120.74 157.54 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-O 121.141 0.496 . . . . 0.0 112.144 -172.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.4 m -117.09 119.01 33.93 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.549 -0.75 . . . . 0.0 108.979 171.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.542 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 5.1 mp -89.78 145.33 25.27 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 170.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.432 ' CD2' HG11 ' B' ' 53' ' ' VAL . 0.8 OUTLIER -129.97 141.39 50.77 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.929 -177.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.82 -167.56 26.63 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.292 -177.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.484 ' CG ' ' HB2' ' B' ' 68' ' ' ASN . 13.7 p90 -150.29 129.6 12.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 122.093 0.949 . . . . 0.0 112.102 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 27' ' ' PHE . 7.9 mt -66.77 141.12 57.84 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.778 176.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -80.92 109.32 15.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.672 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -132.76 173.8 10.98 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.438 HG22 ' H ' ' E' ' 3' ' ' GLY . 1.5 pp -142.42 14.01 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -174.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.85 87.53 3.43 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.231 0.539 . . . . 0.0 110.09 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.2 t -88.56 73.05 8.71 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.552 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.1 162.37 48.22 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.681 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 25.6 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 119.079 -0.486 . . . . 0.0 110.948 179.887 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 77.6 t80 . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . 0.402 ' H ' HG22 ' C' ' 94' ' ' ILE . 3.7 pt20 -154.36 -47.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.704 0.287 . . . . 0.0 111.303 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . 0.45 ' H ' HG22 ' C' ' 94' ' ' ILE . . . 83.32 -58.83 5.02 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.865 175.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . 58.93 43.22 18.27 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.332 0.586 . . . . 0.0 110.246 -176.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 48.6 ttm -80.14 94.37 5.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.514 -177.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.88 152.36 24.59 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.601 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 58.9 mtt -110.01 139.45 45.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.88 -177.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 0.525 ' CE1' HD23 ' C' ' 44' ' ' LEU . 77.0 t80 -59.98 140.35 56.8 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -172.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . 0.433 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 87.3 t90 -132.74 146.74 52.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.547 178.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.433 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -151.65 152.69 24.41 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.262 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.532 ' HB3' ' HB2' ' B' ' 87' ' ' LEU . 59.7 tp -140.48 106.75 5.25 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -86.3 100.85 12.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.612 0.72 . . . . 0.0 109.785 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' MET . . . . . 0.453 ' SD ' HD12 ' B' ' 87' ' ' LEU . 3.7 ttt -94.61 134.24 37.39 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.68 -1.146 . . . . 0.0 111.059 -168.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.428 ' HB2' ' HG3' ' B' ' 17' ' ' ARG . 2.5 mptp? -100.43 149.45 36.1 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.788 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.434 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 12.2 Cg_endo -56.33 122.33 11.58 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.131 2.554 . . . . 0.0 112.965 -178.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' B' ' 79' ' ' THR . 44.8 mt-10 61.51 51.83 3.93 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.506 177.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.428 ' HG3' ' HB2' ' B' ' 14' ' ' LYS . 29.0 mmt180 -117.57 145.5 44.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.141 173.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . 0.661 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 40.6 tttt -123.22 109.87 14.52 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 123.465 0.478 . . . . 0.0 110.513 -176.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' TYR . . . . . 1.654 ' HE1' ' CE2' ' B' ' 19' ' ' TYR . 3.3 m-85 -110.09 104.36 13.22 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.289 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.442 ' HB3' ' SD ' ' B' ' 76' ' ' MET . 13.6 p -85.12 99.49 11.09 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 171.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -113.33 144.03 43.45 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.522 0.677 . . . . 0.0 112.019 -168.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 13.7 p -96.43 157.27 15.98 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.627 174.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.409 ' CD1' ' HB3' ' B' ' 69' ' ' PHE . 53.7 mt -115.06 116.56 52.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.335 0.588 . . . . 0.0 111.227 -175.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.478 HD13 ' N ' ' B' ' 24' ' ' ILE . 3.9 mp -93.27 -40.91 12.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.262 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 24.9 pttt -123.83 128.15 49.09 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.651 176.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 62.3 p -64.62 141.73 58.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.311 -174.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . 0.453 ' HA ' ' HA ' ' B' ' 91' ' ' LEU . 39.3 p90 -142.09 152.51 43.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.71 0.767 . . . . 0.0 112.231 -177.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' HIS . . . . . 0.624 ' HA ' ' O ' ' B' ' 67' ' ' LEU . 6.2 t60 -108.1 120.53 42.59 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.428 173.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.513 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 35.2 mt -84.6 133.55 29.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 170.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.532 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 56.4 p -120.29 -6.97 9.84 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.598 -173.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.13 158.31 25.82 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 119.462 -1.352 . . . . 0.0 113.555 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 13.2 p -140.36 127.33 22.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 172.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.2 152.85 41.42 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.958 -0.464 . . . . 0.0 111.342 -175.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.478 ' HB3' ' CG1' ' B' ' 85' ' ' VAL . 3.7 pp -117.89 145.79 44.38 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.791 0.805 . . . . 0.0 111.728 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -106.58 -56.21 2.22 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.859 175.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -102.43 127.98 49.23 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.096 170.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.434 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 153.2 158.53 8.59 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 119.393 -1.384 . . . . 0.0 113.893 175.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -101.77 -45.66 5.16 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.399 -0.4 . . . . 0.0 110.498 176.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -153.07 123.02 6.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.109 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.437 ' HB1' HG11 ' B' ' 56' ' ' VAL . . . -121.88 114.22 20.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.539 0.685 . . . . 0.0 110.007 170.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' B' ' 79' ' ' THR . 13.7 mmmm -97.2 105.44 17.59 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 49.3 tp -83.65 111.51 19.19 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -174.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . 0.54 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 79.9 m-85 -114.9 149.96 36.38 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 175.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.552 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 0.2 OUTLIER -135.49 128.13 30.83 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.612 172.03 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -105.99 111.99 24.86 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.187 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -127.76 133.35 49.48 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.409 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 59.31 38.2 23.24 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.564 0.697 . . . . 0.0 109.743 -176.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt 62.3 35.39 15.24 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.637 178.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.563 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 23.1 tp60 -130.18 118.24 21.11 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 178.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -81.69 108.39 15.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.927 0.394 . . . . 0.0 110.799 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 0.407 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 86.9 m-85 -99.86 133.33 44.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.59 177.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -80.11 104.67 8.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 168.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.458 HG22 ' HB3' ' B' ' 44' ' ' LEU . 3.2 t -79.64 -50.32 18.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.779 -172.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.477 ' HB1' HD22 ' B' ' 65' ' ' LEU . . . -153.38 147.17 25.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.686 -176.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 31.1 m -110.96 101.26 9.84 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 171.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . 0.437 HG11 ' HB1' ' B' ' 40' ' ' ALA . 7.1 p -119.6 113.48 41.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.6 0.714 . . . . 0.0 109.844 -177.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 65.5 p -123.2 -178.38 3.96 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.73 -174.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -62.06 -22.86 66.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.045 0.45 . . . . 0.0 110.514 170.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.416 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -84.41 -40.82 17.34 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.19 0.519 . . . . 0.0 110.195 178.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 80.8 mt -112.69 82.59 5.05 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 11.4 Cg_exo -70.78 -0.36 7.64 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.022 2.482 . . . . 0.0 113.907 -168.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -163.04 127.03 2.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.383 0.611 . . . . 0.0 111.392 -176.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.465 HG12 ' HB3' ' B' ' 54' ' ' ALA . 87.6 t -116.34 121.91 68.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.418 174.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.53 127.67 33.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.01 176.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.477 HD22 ' HB1' ' B' ' 54' ' ' ALA . 90.8 mt -119.93 168.47 11.1 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.371 0.605 . . . . 0.0 112.114 -174.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 14.4 t0 -145.72 97.6 3.0 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 172.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.624 ' O ' ' HA ' ' B' ' 28' ' ' HIS . 6.7 mt -133.58 110.08 9.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.723 -174.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . 0.484 ' HB2' ' CG ' ' A' ' 90' ' ' TYR . 6.4 m-20 -103.86 113.82 27.62 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 176.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . 1.601 ' HD1' ' CD2' ' B' ' 69' ' ' PHE . 85.6 m-85 -108.92 136.9 47.7 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.861 178.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.408 ' OG ' ' HG2' ' A' ' 7' ' ' MET . 87.9 p -97.29 166.66 11.45 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.783 0.325 . . . . 0.0 110.191 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -72.96 -5.04 35.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.006 0.432 . . . . 0.0 110.868 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.52 -9.18 59.13 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.611 -0.595 . . . . 0.0 111.611 174.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -88.42 140.24 29.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.903 0.382 . . . . 0.0 110.108 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -126.3 114.54 18.4 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 13.2 pt -131.0 158.7 43.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.074 0.464 . . . . 0.0 111.995 -166.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' MET . . . . . 0.475 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 3.7 mtm -119.19 124.03 45.8 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 174.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . 1.668 ' HD1' ' CD2' ' B' ' 77' ' ' PHE . 1.1 m-85 -104.38 128.65 52.27 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 0.661 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 25.9 p90 -151.95 134.99 15.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.474 0.654 . . . . 0.0 112.494 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 2.6 p -108.9 130.62 55.44 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.707 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.97 164.79 11.53 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.524 176.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.37 -174.02 44.76 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -177.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -113.33 102.74 10.63 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 119.726 -0.789 . . . . 0.0 110.031 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.434 ' H ' ' HB3' ' B' ' 15' ' ' PRO . . . -173.67 153.55 2.28 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.548 171.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 18.8 t -114.77 126.42 54.82 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.478 ' CG1' ' HB3' ' B' ' 34' ' ' LEU . 6.7 m -120.81 157.58 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-O 121.116 0.484 . . . . 0.0 112.139 -172.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 67.1 m -117.12 119.02 33.96 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 171.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.532 ' HB2' ' HB3' ' B' ' 11' ' ' LEU . 5.2 mp -89.78 145.38 25.22 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 170.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.454 ' CD2' HG11 ' C' ' 53' ' ' VAL . 0.8 OUTLIER -130.04 141.35 50.74 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.465 -0.789 . . . . 0.0 108.888 -177.697 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.82 -167.53 26.59 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.275 -178.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' TYR . . . . . 0.442 ' CG ' ' HB2' ' C' ' 68' ' ' ASN . 13.8 p90 -150.24 129.52 12.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 122.02 0.914 . . . . 0.0 112.154 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . 0.453 ' HA ' ' HA ' ' B' ' 27' ' ' PHE . 8.0 mt -66.74 141.05 57.87 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 113.626 -1.624 . . . . 0.0 110.898 176.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -80.84 109.25 15.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.655 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -132.83 173.74 11.06 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 177.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . 0.503 HG22 ' H ' ' A' ' 3' ' ' GLY . 1.5 pp -142.31 13.98 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -174.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -76.84 87.57 3.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.283 0.563 . . . . 0.0 110.119 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 17.7 t -88.58 73.21 8.66 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.488 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.18 162.34 48.04 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.752 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 98' ' ' SER . . . . . 0.413 ' OG ' ' HE3' ' C' ' 71' ' ' LYS . 26.7 m . . . . . 0 C--O 1.247 0.949 0 CA-C-O 119.054 -0.498 . . . . 0.0 111.006 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 77.1 t80 . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -154.38 -47.35 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.736 0.303 . . . . 0.0 111.256 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 3' ' ' GLY . . . . . 0.441 ' H ' HG22 ' D' ' 94' ' ' ILE . . . 83.37 -58.8 5.02 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.824 175.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . 58.88 43.25 18.41 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.372 0.606 . . . . 0.0 110.249 -176.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 48.6 ttm -80.2 94.49 6.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.524 -177.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.0 152.25 24.55 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.584 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 58.8 mtt -109.99 139.41 45.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.985 -177.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 8' ' ' PHE . . . . . 0.528 ' CE1' HD23 ' D' ' 44' ' ' LEU . 77.4 t80 -59.9 140.27 56.79 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -172.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . 0.427 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 87.3 t90 -132.63 146.79 52.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.555 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . 0.436 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -151.61 152.71 24.43 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.289 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.53 ' HB3' ' HB2' ' C' ' 87' ' ' LEU . 59.5 tp -140.5 106.79 5.25 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -86.3 100.82 12.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.599 0.714 . . . . 0.0 109.8 175.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 13' ' ' MET . . . . . 0.453 ' SD ' HD12 ' C' ' 87' ' ' LEU . 3.7 ttt -94.56 134.25 37.32 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.078 -168.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . 0.414 ' HB2' ' HG3' ' C' ' 17' ' ' ARG . 2.5 mptp? -100.38 149.5 36.13 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.8 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . 0.439 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 12.3 Cg_endo -56.29 122.25 11.45 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 123.191 2.594 . . . . 0.0 113.011 -178.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' C' ' 79' ' ' THR . 44.8 mt-10 61.49 51.84 3.95 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.543 177.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 17' ' ' ARG . . . . . 0.414 ' HG3' ' HB2' ' C' ' 14' ' ' LYS . 28.9 mmt180 -117.52 145.57 44.15 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.132 173.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 18' ' ' LYS . . . . . 0.653 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 40.7 tttt -123.41 109.89 14.44 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 123.479 0.487 . . . . 0.0 110.513 -176.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . 1.667 ' HE1' ' CE2' ' C' ' 19' ' ' TYR . 3.4 m-85 -110.09 104.29 13.14 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.342 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 20' ' ' SER . . . . . 0.458 ' HB3' ' SD ' ' C' ' 76' ' ' MET . 13.5 p -84.97 99.37 10.94 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 171.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -113.29 144.05 43.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.577 0.703 . . . . 0.0 112.064 -169.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 13.3 p -96.59 157.3 15.96 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.592 174.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . 0.424 ' CD1' ' HB3' ' C' ' 69' ' ' PHE . 53.8 mt -115.03 116.6 53.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.296 0.57 . . . . 0.0 111.16 -175.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . 0.48 HD13 ' N ' ' C' ' 24' ' ' ILE . 3.9 mp -93.26 -41.09 12.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.16 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 25.0 pttt -123.85 128.21 49.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.616 176.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 62.1 p -64.63 141.71 58.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.227 -174.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 27' ' ' PHE . . . . . 0.453 ' HA ' ' HA ' ' C' ' 91' ' ' LEU . 39.5 p90 -142.0 152.51 43.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.672 0.748 . . . . 0.0 112.23 -177.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 28' ' ' HIS . . . . . 0.621 ' HA ' ' O ' ' C' ' 67' ' ' LEU . 6.1 t60 -108.14 120.55 42.65 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.418 -1.264 . . . . 0.0 109.382 173.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 35.2 mt -84.59 133.59 28.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 170.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 30' ' ' SER . . . . . 0.532 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 56.1 p -120.41 -6.77 9.79 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.645 0.259 . . . . 0.0 111.639 -173.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.13 158.4 25.99 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 119.471 -1.347 . . . . 0.0 113.595 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 13.0 p -140.38 127.22 22.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.23 152.83 41.38 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.569 -0.453 . . . . 0.0 111.326 -175.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.482 ' HB3' ' CG1' ' C' ' 85' ' ' VAL . 3.7 pp -117.8 145.8 44.28 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 121.809 0.814 . . . . 0.0 111.792 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -106.58 -56.17 2.23 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.869 175.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -102.47 127.99 49.28 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.065 170.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 37' ' ' GLY . . . . . 0.443 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 153.25 158.44 8.56 Favored Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 119.39 -1.386 . . . . 0.0 113.902 175.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -101.76 -45.6 5.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.484 -0.358 . . . . 0.0 110.545 176.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -153.09 122.99 6.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.079 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . 0.448 ' HB1' HG11 ' C' ' 56' ' ' VAL . . . -121.88 114.23 20.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.518 0.675 . . . . 0.0 110.02 170.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' C' ' 79' ' ' THR . 13.7 mmmm -97.27 105.43 17.57 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 49.7 tp -83.66 111.48 19.17 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -174.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 43' ' ' TYR . . . . . 0.533 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 79.8 m-85 -114.86 149.93 36.35 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.555 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 0.2 OUTLIER -135.46 128.17 30.96 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.589 172.069 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -105.97 112.0 24.87 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.116 178.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -127.8 133.41 49.43 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.368 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 59.25 38.23 23.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.53 0.681 . . . . 0.0 109.763 -176.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt 62.3 35.21 15.36 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.751 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . 0.557 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 23.4 tp60 -130.04 118.28 21.32 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -81.74 108.36 15.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.969 0.414 . . . . 0.0 110.769 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 0.433 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 86.9 m-85 -99.79 133.39 44.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.627 177.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -80.12 104.57 8.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 168.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 53' ' ' VAL . . . . . 0.456 HG22 ' HB3' ' C' ' 44' ' ' LEU . 3.2 t -79.56 -50.44 18.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.652 -172.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 54' ' ' ALA . . . . . 0.477 ' HB1' HD22 ' C' ' 65' ' ' LEU . . . -153.37 147.17 25.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.723 -176.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 31.4 m -110.93 101.29 9.87 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 171.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . 0.448 HG11 ' HB1' ' C' ' 40' ' ' ALA . 7.2 p -119.6 113.47 41.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.513 0.673 . . . . 0.0 109.821 -177.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 66.0 p -123.24 -178.45 3.99 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.74 -174.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -61.99 -22.97 66.12 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.14 0.495 . . . . 0.0 110.43 171.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . 0.427 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -84.3 -40.76 17.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.19 0.519 . . . . 0.0 110.275 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 80.7 mt -112.8 82.5 5.11 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 174.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 61' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 11.4 Cg_exo -70.8 -0.2 7.41 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.997 2.465 . . . . 0.0 113.889 -167.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -163.12 127.04 2.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.325 0.583 . . . . 0.0 111.437 -176.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.467 HG12 ' HB3' ' C' ' 54' ' ' ALA . 86.2 t -116.38 122.02 68.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.345 174.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.49 127.54 32.93 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.131 175.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . 0.477 HD22 ' HB1' ' C' ' 54' ' ' ALA . 91.1 mt -119.76 168.45 11.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.471 0.653 . . . . 0.0 112.21 -174.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 66' ' ' ASP . . . . . 0.477 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 14.4 t0 -145.76 97.6 2.99 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 172.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . 0.621 ' O ' ' HA ' ' C' ' 28' ' ' HIS . 6.7 mt -133.54 110.0 9.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.772 -174.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . 0.442 ' HB2' ' CG ' ' B' ' 90' ' ' TYR . 6.4 m-20 -103.92 113.82 27.63 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 69' ' ' PHE . . . . . 1.624 ' HD2' ' CD1' ' C' ' 69' ' ' PHE . 86.0 m-85 -109.0 136.87 47.81 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.779 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 88.1 p -97.24 166.66 11.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.745 0.307 . . . . 0.0 110.235 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . 0.413 ' HE3' ' OG ' ' B' ' 98' ' ' SER . 14.9 ptmm? -73.12 -4.83 35.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.015 0.436 . . . . 0.0 110.901 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.55 -9.27 59.02 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 174.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -88.28 140.23 29.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.893 0.378 . . . . 0.0 110.115 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -126.33 114.49 18.31 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 175.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 13.3 pt -131.07 158.67 43.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.047 0.451 . . . . 0.0 112.034 -166.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 76' ' ' MET . . . . . 0.468 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 3.7 mtm -119.22 123.97 45.61 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 77' ' ' PHE . . . . . 1.639 ' HD1' ' CD2' ' C' ' 77' ' ' PHE . 1.1 m-85 -104.29 128.55 52.09 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 78' ' ' TYR . . . . . 0.653 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 25.9 p90 -151.87 134.96 15.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.419 0.628 . . . . 0.0 112.511 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 79' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 2.6 p -108.85 130.56 55.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.769 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.87 164.84 11.51 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.522 176.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.41 -173.98 44.64 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -177.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -113.38 102.77 10.65 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.031 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . 0.443 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -173.67 153.48 2.27 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.534 171.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 18.6 t -114.76 126.41 54.81 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.482 ' CG1' ' HB3' ' C' ' 34' ' ' LEU . 6.6 m -120.8 157.58 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 CA-C-O 121.213 0.53 . . . . 0.0 112.114 -172.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 66.6 m -117.04 119.02 33.99 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 171.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . 0.53 ' HB2' ' HB3' ' C' ' 11' ' ' LEU . 5.2 mp -89.75 145.29 25.3 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 170.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . 0.464 ' CD2' HG11 ' D' ' 53' ' ' VAL . 0.8 OUTLIER -130.01 141.46 50.74 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.438 -0.801 . . . . 0.0 108.913 -177.837 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.93 -167.59 26.79 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.331 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 90' ' ' TYR . . . . . 0.465 ' CG ' ' HB2' ' D' ' 68' ' ' ASN . 13.6 p90 -150.19 129.55 12.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 122.039 0.924 . . . . 0.0 112.109 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . 0.453 ' HA ' ' HA ' ' C' ' 27' ' ' PHE . 8.0 mt -66.84 141.15 57.78 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.826 176.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -80.85 109.34 15.32 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.686 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -132.96 173.77 11.06 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . 0.45 HG22 ' H ' ' B' ' 3' ' ' GLY . 1.5 pp -142.34 13.94 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -174.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.82 87.59 3.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.292 0.568 . . . . 0.0 110.131 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 17.9 t -88.56 73.14 8.69 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.409 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.04 162.31 48.27 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.706 -178.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 98' ' ' SER . . . . . 0.417 ' OG ' ' HE3' ' D' ' 71' ' ' LYS . 27.0 m . . . . . 0 C--O 1.249 1.034 0 C-N-CA 122.822 0.449 . . . . 0.0 111.063 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 77.1 t80 . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . 0.416 ' H ' HG22 ' E' ' 94' ' ' ILE . 3.7 pt20 -154.38 -47.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.697 0.284 . . . . 0.0 111.235 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 3' ' ' GLY . . . . . 0.455 ' H ' HG22 ' E' ' 94' ' ' ILE . . . 83.23 -58.84 5.03 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.849 175.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . 58.88 43.2 18.46 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.377 0.608 . . . . 0.0 110.306 -176.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 48.5 ttm -80.19 94.41 6.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.527 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.93 152.28 24.59 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.557 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 7' ' ' MET . . . . . 0.435 ' HG2' ' OG ' ' E' ' 70' ' ' SER . 58.9 mtt -109.99 139.46 45.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 -177.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 8' ' ' PHE . . . . . 0.53 ' CE1' HD23 ' E' ' 44' ' ' LEU . 77.0 t80 -59.99 140.33 56.83 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -172.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 9' ' ' TRP . . . . . 0.433 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 87.3 t90 -132.76 146.68 52.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.552 178.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . 0.462 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -151.53 152.72 24.44 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.296 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . 0.542 ' HB3' ' HB2' ' D' ' 87' ' ' LEU . 59.8 tp -140.5 106.73 5.24 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -86.24 100.86 12.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.579 0.704 . . . . 0.0 109.743 175.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 13' ' ' MET . . . . . 0.453 ' SD ' HD12 ' D' ' 87' ' ' LEU . 3.7 ttt -94.67 134.21 37.5 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.085 -168.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 14' ' ' LYS . . . . . 0.423 ' HB2' ' HG3' ' D' ' 17' ' ' ARG . 2.5 mptp? -100.33 149.56 36.17 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.802 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . 0.441 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 12.3 Cg_endo -56.45 122.28 11.51 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.134 2.556 . . . . 0.0 113.013 -178.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' D' ' 79' ' ' THR . 44.9 mt-10 61.5 51.88 3.92 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.571 177.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 17' ' ' ARG . . . . . 0.423 ' HG3' ' HB2' ' D' ' 14' ' ' LYS . 28.9 mmt180 -117.58 145.56 44.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.133 173.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . 0.654 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 40.7 tttt -123.36 109.91 14.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 123.542 0.526 . . . . 0.0 110.524 -176.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 19' ' ' TYR . . . . . 1.663 ' HE1' ' CE2' ' D' ' 19' ' ' TYR . 3.3 m-85 -110.04 104.38 13.26 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.323 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 20' ' ' SER . . . . . 0.453 ' HB3' ' SD ' ' D' ' 76' ' ' MET . 13.4 p -85.08 99.45 11.05 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 171.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -113.37 144.01 43.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.483 0.659 . . . . 0.0 112.053 -168.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 14.0 p -96.49 157.31 15.96 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.627 174.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . 0.426 ' CD1' ' HB3' ' D' ' 69' ' ' PHE . 53.9 mt -115.02 116.61 53.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.15 0.5 . . . . 0.0 111.168 -175.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . 0.483 ' N ' HD13 ' D' ' 24' ' ' ILE . 3.9 mp -93.34 -40.95 12.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.125 178.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -123.88 128.24 49.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.663 176.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 61.9 p -64.65 141.72 58.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.258 -174.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 27' ' ' PHE . . . . . 0.455 ' HA ' ' HA ' ' D' ' 91' ' ' LEU . 39.4 p90 -141.97 152.59 43.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.713 0.768 . . . . 0.0 112.153 -177.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 28' ' ' HIS . . . . . 0.624 ' HA ' ' O ' ' D' ' 67' ' ' LEU . 6.2 t60 -108.21 120.5 42.54 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.407 -1.27 . . . . 0.0 109.399 173.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 29' ' ' ILE . . . . . 0.522 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 35.2 mt -84.57 133.55 29.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 170.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 30' ' ' SER . . . . . 0.534 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 56.8 p -120.3 -6.89 9.84 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.65 -173.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.08 158.41 26.05 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 119.481 -1.343 . . . . 0.0 113.566 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 13.3 p -140.48 127.27 22.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 172.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.17 152.94 41.58 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.332 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 34' ' ' LEU . . . . . 0.482 ' HB3' ' CG1' ' D' ' 85' ' ' VAL . 3.7 pp -117.93 145.88 44.36 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.798 0.808 . . . . 0.0 111.709 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -106.71 -56.03 2.25 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.226 -1.352 . . . . 0.0 108.819 175.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -102.53 127.95 49.37 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.099 170.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . 0.445 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 153.22 158.45 8.56 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 119.415 -1.374 . . . . 0.0 113.99 175.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -101.71 -45.65 5.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.786 0.327 . . . . 0.0 110.557 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -153.05 123.01 6.94 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.117 -178.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . 0.448 ' HB1' HG11 ' D' ' 56' ' ' VAL . . . -121.88 114.09 20.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.406 0.622 . . . . 0.0 110.06 170.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' D' ' 79' ' ' THR . 13.7 mmmm -97.11 105.42 17.56 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 49.5 tp -83.59 111.44 19.11 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -174.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 43' ' ' TYR . . . . . 0.538 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 80.4 m-85 -114.87 149.96 36.32 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 175.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.554 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.2 OUTLIER -135.41 128.09 30.92 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.672 172.004 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 45' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -105.92 112.17 25.12 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.156 178.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -127.84 133.34 49.37 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.344 178.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 59.3 38.14 23.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.558 0.694 . . . . 0.0 109.718 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt 62.41 35.24 15.0 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.683 178.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . 0.557 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 23.5 tp60 -130.06 118.26 21.26 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -81.62 108.3 15.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.909 0.385 . . . . 0.0 110.841 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . 0.436 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 87.3 m-85 -99.92 133.34 44.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.612 177.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 tp -80.13 104.73 8.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 169.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 53' ' ' VAL . . . . . 0.464 HG11 ' CD2' ' C' ' 88' ' ' LEU . 3.2 t -79.64 -50.3 18.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.698 -172.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 54' ' ' ALA . . . . . 0.46 ' HB1' HD22 ' D' ' 65' ' ' LEU . . . -153.44 147.16 25.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.711 -176.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 31.5 m -111.02 101.29 9.86 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 171.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 56' ' ' VAL . . . . . 0.448 HG11 ' HB1' ' D' ' 40' ' ' ALA . 7.2 p -119.67 113.5 41.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.545 0.688 . . . . 0.0 109.808 -177.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 67.5 p -123.24 -178.44 3.98 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.756 -174.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -61.97 -22.93 66.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.039 0.447 . . . . 0.0 110.522 170.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 59' ' ' ALA . . . . . 0.426 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -84.39 -40.82 17.36 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.253 0.549 . . . . 0.0 110.187 178.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 81.0 mt -112.76 82.63 5.16 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 174.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 61' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 11.5 Cg_exo -70.81 -0.29 7.56 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.063 2.508 . . . . 0.0 113.868 -168.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -163.11 127.0 2.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.315 0.579 . . . . 0.0 111.417 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.454 HG12 ' HB3' ' D' ' 54' ' ' ALA . 87.4 t -116.33 121.88 68.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.424 174.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.47 127.54 32.92 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.063 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 65' ' ' LEU . . . . . 0.46 HD22 ' HB1' ' D' ' 54' ' ' ALA . 90.8 mt -119.76 168.52 10.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.477 0.656 . . . . 0.0 112.2 -174.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 66' ' ' ASP . . . . . 0.494 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 14.2 t0 -145.79 97.59 2.99 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 172.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . 0.624 ' O ' ' HA ' ' D' ' 28' ' ' HIS . 6.7 mt -133.62 109.95 9.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.776 -174.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 68' ' ' ASN . . . . . 0.465 ' HB2' ' CG ' ' C' ' 90' ' ' TYR . 6.4 m-20 -103.76 113.87 27.71 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 176.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 69' ' ' PHE . . . . . 1.628 ' HE1' ' CE2' ' D' ' 69' ' ' PHE . 86.1 m-85 -109.08 136.97 47.72 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.771 178.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 88.1 p -97.28 166.61 11.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.741 0.305 . . . . 0.0 110.239 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 71' ' ' LYS . . . . . 0.417 ' HE3' ' OG ' ' C' ' 98' ' ' SER . 14.9 ptmm? -73.07 -4.87 35.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.023 0.439 . . . . 0.0 110.873 -178.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.52 -9.32 59.02 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.584 -0.607 . . . . 0.0 111.584 174.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -88.37 140.16 29.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.861 0.362 . . . . 0.0 110.135 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -126.27 114.58 18.47 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . . . . . . . . . 13.2 pt -131.02 158.74 43.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.132 0.491 . . . . 0.0 112.0 -166.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 76' ' ' MET . . . . . 0.466 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 3.6 mtm -119.23 123.97 45.61 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 174.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 77' ' ' PHE . . . . . 1.634 ' HE2' ' CE1' ' D' ' 77' ' ' PHE . 1.1 m-85 -104.3 128.57 52.11 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 78' ' ' TYR . . . . . 0.654 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 25.7 p90 -151.86 134.94 15.78 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.47 0.652 . . . . 0.0 112.414 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 79' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 2.5 p -108.85 130.59 55.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.792 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.89 164.76 11.55 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.553 177.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.39 -174.11 44.8 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -113.27 102.64 10.54 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.06 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.445 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -173.65 153.51 2.28 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.531 171.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 18.9 t -114.84 126.5 54.89 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . 0.482 ' CG1' ' HB3' ' D' ' 34' ' ' LEU . 6.6 m -120.94 157.48 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-O 121.161 0.505 . . . . 0.0 112.11 -172.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 66.5 m -116.95 118.97 33.91 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 171.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 87' ' ' LEU . . . . . 0.542 ' HB2' ' HB3' ' D' ' 11' ' ' LEU . 5.1 mp -89.77 145.4 25.21 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 170.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . 0.438 ' CD2' HG11 ' E' ' 53' ' ' VAL . 0.8 OUTLIER -129.98 141.37 50.76 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.982 -177.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.81 -167.44 26.44 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.302 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 90' ' ' TYR . . . . . 0.458 ' CG ' ' HB2' ' E' ' 68' ' ' ASN . 13.6 p90 -150.33 129.55 12.79 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 122.102 0.954 . . . . 0.0 112.091 178.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . 0.455 ' HA ' ' HA ' ' D' ' 27' ' ' PHE . 8.1 mt -66.78 141.09 57.84 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.621 -1.627 . . . . 0.0 110.839 176.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -80.85 109.36 15.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.654 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -132.94 173.73 11.09 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . 0.441 HG22 ' H ' ' C' ' 3' ' ' GLY . 1.5 pp -142.34 13.88 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -174.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.77 87.56 3.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.256 0.55 . . . . 0.0 110.144 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 18.1 t -88.54 73.01 8.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.515 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.96 162.22 48.34 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.778 -178.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 98' ' ' SER . . . . . 0.403 ' OG ' ' HE3' ' E' ' 71' ' ' LYS . 28.7 m . . . . . 0 C--O 1.249 1.061 0 C-N-CA 122.896 0.478 . . . . 0.0 111.017 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 77.3 t80 . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -154.43 -47.25 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.771 0.319 . . . . 0.0 111.245 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 3' ' ' GLY . . . . . 0.438 ' H ' HG22 ' A' ' 94' ' ' ILE . . . 83.29 -58.87 5.02 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.853 175.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . 58.91 43.21 18.35 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.319 0.581 . . . . 0.0 110.271 -176.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 48.5 ttm -80.12 94.48 6.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.482 -177.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.08 152.28 24.44 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.55 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 7' ' ' MET . . . . . 0.411 ' HG2' ' OG ' ' A' ' 70' ' ' SER . 58.9 mtt -109.98 139.46 45.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.841 -176.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 8' ' ' PHE . . . . . 0.529 ' CE1' HD23 ' A' ' 44' ' ' LEU . 76.9 t80 -59.93 140.3 56.79 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -172.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 9' ' ' TRP . . . . . 0.422 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 87.4 t90 -132.74 146.76 52.11 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 10' ' ' GLY . . . . . 0.453 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -151.68 152.68 24.4 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.233 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' E' ' 87' ' ' LEU . 60.0 tp -140.44 106.71 5.25 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 178.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -86.31 100.87 12.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.571 0.7 . . . . 0.0 109.72 175.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 13' ' ' MET . . . . . 0.448 ' SD ' HD12 ' E' ' 87' ' ' LEU . 3.7 ttt -94.64 134.23 37.44 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.667 -1.152 . . . . 0.0 111.102 -168.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 14' ' ' LYS . . . . . 0.43 ' HB2' ' HG3' ' E' ' 17' ' ' ARG . 2.5 mptp? -100.29 149.53 36.14 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.791 -178.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . 0.43 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 12.2 Cg_endo -56.48 122.38 11.69 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.146 2.564 . . . . 0.0 112.95 -178.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 16' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' E' ' 79' ' ' THR . 44.7 mt-10 61.43 51.93 3.96 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.502 177.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 17' ' ' ARG . . . . . 0.43 ' HG3' ' HB2' ' E' ' 14' ' ' LYS . 29.0 mmt180 -117.61 145.52 44.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.161 173.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . 0.658 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 40.6 tttt -123.34 109.84 14.42 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 123.505 0.503 . . . . 0.0 110.465 -176.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . 1.666 ' HE2' ' CE1' ' E' ' 19' ' ' TYR . 3.4 m-85 -110.06 104.4 13.27 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.367 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 20' ' ' SER . . . . . 0.458 ' HB3' ' SD ' ' E' ' 76' ' ' MET . 13.5 p -85.08 99.43 11.04 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -113.39 144.13 43.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.596 0.712 . . . . 0.0 112.01 -168.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 13.9 p -96.51 157.3 15.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.623 174.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 23' ' ' ILE . . . . . 0.425 ' CD1' ' HB3' ' E' ' 69' ' ' PHE . 53.7 mt -115.02 116.47 52.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.218 0.532 . . . . 0.0 111.211 -175.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . 0.482 ' N ' HD13 ' E' ' 24' ' ' ILE . 3.9 mp -93.23 -40.93 12.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.205 178.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -123.87 128.16 49.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.582 176.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 62.2 p -64.6 141.72 58.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.247 -174.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 27' ' ' PHE . . . . . 0.466 ' HA ' ' HA ' ' E' ' 91' ' ' LEU . 40.0 p90 -142.09 152.53 43.38 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.727 0.775 . . . . 0.0 112.235 -177.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 28' ' ' HIS . . . . . 0.625 ' HA ' ' O ' ' E' ' 67' ' ' LEU . 6.3 t60 -108.15 120.5 42.52 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.397 173.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 29' ' ' ILE . . . . . 0.508 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 35.2 mt -84.56 133.56 28.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.129 -1.064 . . . . 0.0 108.129 170.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 30' ' ' SER . . . . . 0.52 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 56.8 p -120.35 -6.88 9.82 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -173.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.13 158.34 25.88 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 119.569 -1.3 . . . . 0.0 113.609 176.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 13.1 p -140.42 127.16 22.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 172.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.13 152.84 41.48 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 121.934 -0.478 . . . . 0.0 111.324 -175.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 34' ' ' LEU . . . . . 0.479 ' HB3' ' CG1' ' E' ' 85' ' ' VAL . 3.7 pp -117.78 145.87 44.2 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 121.739 0.781 . . . . 0.0 111.794 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -106.68 -56.09 2.24 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.855 175.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -102.47 127.94 49.3 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.113 170.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . 0.441 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 153.29 158.46 8.57 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 119.368 -1.396 . . . . 0.0 113.911 175.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -101.72 -45.67 5.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.497 -0.352 . . . . 0.0 110.559 176.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -153.1 123.0 6.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.052 -178.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . 0.442 ' HB1' HG11 ' E' ' 56' ' ' VAL . . . -121.87 114.17 20.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.515 0.674 . . . . 0.0 110.002 170.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 41' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' E' ' 79' ' ' THR . 13.7 mmmm -97.18 105.46 17.61 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 49.8 tp -83.71 111.49 19.2 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -174.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 43' ' ' TYR . . . . . 0.544 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 80.0 m-85 -114.86 149.98 36.26 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 175.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 44' ' ' LEU . . . . . 0.551 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 0.2 OUTLIER -135.58 128.13 30.66 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.532 172.082 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' E' E ' 45' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -105.92 112.1 25.01 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.151 178.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -127.87 133.29 49.33 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.344 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 59.29 38.24 23.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.607 0.718 . . . . 0.0 109.698 -176.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt 62.44 35.23 14.94 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.652 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 49' ' ' GLN . . . . . 0.554 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 23.2 tp60 -130.14 118.23 21.14 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -81.7 108.25 15.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.965 0.412 . . . . 0.0 110.859 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . 0.462 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 87.1 m-85 -99.81 133.33 44.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.615 177.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -80.06 104.71 8.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 169.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . 0.463 HG22 ' HB3' ' E' ' 44' ' ' LEU . 3.2 t -79.68 -50.4 18.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.667 -172.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 54' ' ' ALA . . . . . 0.477 ' HB1' HD22 ' E' ' 65' ' ' LEU . . . -153.33 147.18 25.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.723 -176.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 31.2 m -110.89 101.17 9.78 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 171.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . 0.442 HG11 ' HB1' ' E' ' 40' ' ' ALA . 7.1 p -119.54 113.45 41.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.64 0.733 . . . . 0.0 109.895 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 66.4 p -123.21 -178.43 3.98 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.746 -174.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -61.91 -22.98 66.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.961 0.41 . . . . 0.0 110.501 170.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 59' ' ' ALA . . . . . 0.429 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -84.34 -40.8 17.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.182 178.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 80.8 mt -112.78 82.56 5.13 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 174.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 61' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 11.5 Cg_exo -70.82 -0.29 7.56 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.066 2.511 . . . . 0.0 113.88 -167.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -163.12 127.1 2.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.399 0.618 . . . . 0.0 111.397 -176.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . 0.45 HG12 ' HB3' ' E' ' 54' ' ' ALA . 86.9 t -116.42 121.93 68.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.344 174.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.56 127.56 32.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.032 176.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . 0.477 HD22 ' HB1' ' E' ' 54' ' ' ALA . 90.8 mt -119.8 168.51 11.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.481 0.658 . . . . 0.0 112.184 -174.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 66' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 14.3 t0 -145.76 97.59 2.99 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 172.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 67' ' ' LEU . . . . . 0.625 ' O ' ' HA ' ' E' ' 28' ' ' HIS . 6.7 mt -133.57 109.99 9.61 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.809 -174.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 68' ' ' ASN . . . . . 0.458 ' HB2' ' CG ' ' D' ' 90' ' ' TYR . 6.4 m-20 -103.84 113.87 27.71 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 69' ' ' PHE . . . . . 1.604 ' HD1' ' CD2' ' E' ' 69' ' ' PHE . 86.1 m-85 -109.1 136.98 47.71 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.721 178.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 70' ' ' SER . . . . . 0.435 ' OG ' ' HG2' ' D' ' 7' ' ' MET . 88.0 p -97.35 166.7 11.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.802 0.334 . . . . 0.0 110.17 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 71' ' ' LYS . . . . . 0.403 ' HE3' ' OG ' ' D' ' 98' ' ' SER . 14.9 ptmm? -73.19 -4.83 35.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.002 0.43 . . . . 0.0 110.843 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.6 -9.14 59.07 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 174.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -88.5 140.25 29.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.863 0.363 . . . . 0.0 110.059 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -126.32 114.47 18.29 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 75' ' ' ILE . . . . . . . . . . . . . 13.3 pt -131.04 158.71 43.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.104 0.478 . . . . 0.0 111.945 -166.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 76' ' ' MET . . . . . 0.467 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 3.7 mtm -119.28 123.97 45.55 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 174.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 77' ' ' PHE . . . . . 1.644 ' HE1' ' CE2' ' E' ' 77' ' ' PHE . 1.1 m-85 -104.28 128.61 52.08 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 78' ' ' TYR . . . . . 0.658 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 26.0 p90 -151.95 135.0 15.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.504 0.669 . . . . 0.0 112.442 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 79' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 2.6 p -108.99 130.54 55.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.767 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.85 164.76 11.55 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.51 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.44 -174.04 44.65 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -113.32 102.69 10.58 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.977 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 83' ' ' ALA . . . . . 0.441 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -173.7 153.56 2.27 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.536 171.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 18.9 t -114.84 126.42 54.8 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 85' ' ' VAL . . . . . 0.479 ' CG1' ' HB3' ' E' ' 34' ' ' LEU . 6.7 m -120.78 157.68 23.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-O 121.222 0.534 . . . . 0.0 112.075 -172.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 66.6 m -117.21 118.93 33.65 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 171.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 87' ' ' LEU . . . . . 0.523 ' HB2' ' HB3' ' E' ' 11' ' ' LEU . 5.1 mp -89.77 145.43 25.19 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 170.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . 0.434 ' CD2' HG12 ' A' ' 53' ' ' VAL . 0.8 OUTLIER -130.1 141.4 50.7 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.873 -177.738 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.87 -167.51 26.61 Favored Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.253 -178.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 90' ' ' TYR . . . . . 0.45 ' CG ' ' HB2' ' A' ' 68' ' ' ASN . 13.6 p90 -150.24 129.58 12.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 122.04 0.924 . . . . 0.0 112.06 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 91' ' ' LEU . . . . . 0.466 ' HA ' ' HA ' ' E' ' 27' ' ' PHE . 8.0 mt -66.8 141.13 57.81 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.81 176.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -80.92 109.36 15.42 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.684 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -132.9 173.74 11.07 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 177.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 94' ' ' ILE . . . . . 0.455 HG22 ' H ' ' D' ' 3' ' ' GLY . 1.5 pp -142.36 13.88 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -174.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -76.81 87.65 3.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.28 0.562 . . . . 0.0 110.125 178.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 18.4 t -88.64 73.1 8.63 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.13 162.3 48.1 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.708 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 98' ' ' SER . . . . . 0.431 ' OG ' ' HE3' ' A' ' 71' ' ' LYS . 27.1 m . . . . . 0 C--O 1.248 1.001 0 C-N-CA 122.938 0.495 . . . . 0.0 110.943 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -102.09 145.51 29.24 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 149.93 -171.71 29.91 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.795 -177.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.546 ' O ' ' HB3' ' A' ' 93' ' ' ASP . . . 57.02 44.26 23.1 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 123.882 0.401 . . . . 0.0 110.921 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -70.33 172.64 7.93 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.895 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.587 ' HB1' ' ND2' ' B' ' 68' ' ' ASN . . . -54.25 131.5 41.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.761 177.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 52.4 ttm -100.36 139.01 36.65 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.622 -173.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.438 ' CE1' HD23 ' B' ' 44' ' ' LEU . 61.4 t80 -52.77 142.1 19.64 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.619 -177.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.537 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 88.5 t90 -135.71 147.72 48.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.876 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.454 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -148.72 153.82 25.46 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.007 178.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.539 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 52.1 tp -140.44 108.18 5.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.022 0.439 . . . . 0.0 110.881 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -81.25 101.49 9.76 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.538 173.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.496 ' HB3' HG22 ' A' ' 85' ' ' VAL . 30.6 tpp -95.48 131.26 41.83 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.148 -174.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -100.82 145.31 30.15 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.915 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.518 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 12.3 Cg_endo -56.01 124.54 16.51 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 123.397 2.731 . . . . 0.0 113.493 -174.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' A' ' 79' ' ' THR . 25.3 mt-10 60.3 47.91 8.57 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.062 177.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -121.79 138.67 54.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.687 172.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.662 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 84.5 mttt -111.21 118.98 37.43 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.414 0.446 . . . . 0.0 111.519 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.61 103.91 12.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.827 176.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.8 p -88.47 98.84 11.85 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 174.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -117.36 144.84 44.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.472 0.653 . . . . 0.0 112.273 -169.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.5 m -94.06 143.15 26.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.542 177.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.437 ' CG2' ' HA ' ' A' ' 71' ' ' LYS . 59.4 mt -92.81 120.35 42.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.066 0.46 . . . . 0.0 111.119 -174.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.429 HD13 ' N ' ' A' ' 24' ' ' ILE . 4.1 mp -79.34 -52.9 14.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.351 178.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.456 ' HE2' ' HB3' ' A' ' 91' ' ' LEU . 13.5 ptmt -131.08 137.53 49.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.942 175.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.2 m -54.45 141.76 29.65 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.921 -176.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -149.06 158.26 44.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.655 0.741 . . . . 0.0 112.819 -175.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.593 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 9.2 t60 -111.41 127.41 55.67 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.392 -1.276 . . . . 0.0 109.745 178.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.535 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 35.0 mt -96.78 137.97 23.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 170.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.593 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 56.6 p -123.5 -20.42 5.57 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -171.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -153.88 156.34 26.74 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 119.273 -1.442 . . . . 0.0 113.578 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.8 p -146.51 124.39 4.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 172.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.19 155.68 44.0 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.75 -174.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.474 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 3.7 pp -120.39 140.55 51.17 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.914 0.864 . . . . 0.0 111.755 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -105.12 -53.6 2.63 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.334 -1.303 . . . . 0.0 108.788 174.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -102.91 127.44 50.12 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 169.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.46 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 151.22 156.03 7.21 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 119.784 -1.198 . . . . 0.0 113.608 177.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.418 ' HA ' ' HB2' ' A' ' 58' ' ' LYS . 91.0 mt-30 -102.66 -44.27 5.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.68 0.276 . . . . 0.0 111.053 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -153.12 126.41 8.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.095 176.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.51 113.16 17.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.563 0.697 . . . . 0.0 109.7 169.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 79' ' ' THR . 19.9 mtpp -96.06 107.05 19.31 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 41.2 tp -81.57 114.84 20.55 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -173.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.536 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 97.6 m-85 -120.49 139.46 52.86 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.271 177.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.497 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -125.15 133.27 52.87 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 172.67 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -112.04 113.07 25.14 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.156 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.47 137.8 54.4 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.416 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 59.7 30.72 20.33 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.473 0.483 . . . . 0.0 110.301 -174.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.477 ' NZ ' ' HB2' ' A' ' 48' ' ' LYS . 0.1 OUTLIER 62.57 33.6 15.74 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.14 -177.072 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.615 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 8.5 tp-100 -123.46 130.38 52.61 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.66 123.59 32.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.905 0.383 . . . . 0.0 110.769 -176.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 1.634 ' HD2' ' CD1' ' A' ' 51' ' ' TYR . 84.7 m-85 -118.02 130.08 55.96 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 175.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.09 103.77 7.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 171.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.531 ' CG1' HD12 ' A' ' 67' ' ' LEU . 2.6 t -78.7 -49.49 20.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.712 -171.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.454 ' HB2' HG12 ' A' ' 63' ' ' VAL . . . -158.38 146.58 18.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.852 -178.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.4 m -109.46 101.43 10.39 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 173.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.63 116.2 51.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.557 0.694 . . . . 0.0 109.565 -177.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 47.1 p -122.37 -179.13 4.09 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.335 -172.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.418 ' HB2' ' HA ' ' A' ' 38' ' ' GLN . 38.1 tttm -61.58 -27.38 68.59 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.892 172.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.481 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -84.24 -40.63 17.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.643 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.2 mt -109.45 83.99 2.82 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 174.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 9.7 Cg_exo -70.91 0.07 7.08 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.016 2.478 . . . . 0.0 113.762 -168.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -162.8 131.74 4.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.224 0.535 . . . . 0.0 111.254 -176.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.454 HG12 ' HB2' ' A' ' 54' ' ' ALA . 68.7 t -120.49 132.68 69.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.105 172.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.43 113.11 25.49 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.224 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.438 ' N ' HD11 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -121.46 170.01 10.07 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.34 -176.489 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 7.2 t0 -118.33 98.76 6.44 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.245 0.545 . . . . 0.0 109.619 175.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.535 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 19.8 mt -112.98 143.49 44.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.873 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.623 ' ND2' ' HB1' ' E' ' 6' ' ' ALA . 57.2 t30 -147.81 119.96 8.3 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 120.942 0.401 . . . . 0.0 110.008 174.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 1.67 ' HD2' ' CD1' ' A' ' 69' ' ' PHE . 55.3 m-85 -114.93 153.53 30.38 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.25 -178.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.7 t -103.67 148.88 25.51 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.983 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.499 ' HB2' ' HZ2' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -74.75 9.97 1.6 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -174.656 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.62 -15.21 30.04 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.865 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -101.28 170.82 7.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.77 0.319 . . . . 0.0 110.868 -175.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 61.9 ttt-85 -138.32 122.6 18.18 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.4 pt -125.69 160.86 31.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.431 -170.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.447 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 2.8 mtm -115.23 129.02 56.52 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 174.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.497 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -109.82 128.41 55.3 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.109 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 1.657 ' HE2' ' CE1' ' A' ' 78' ' ' TYR . 51.3 p90 -155.83 157.47 36.48 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 120.226 -0.59 . . . . 0.0 112.24 -177.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.552 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 14.8 p -124.81 144.0 50.51 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.264 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.42 156.63 18.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.981 174.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.01 -166.83 31.32 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -176.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -123.71 102.68 7.96 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 117.715 0.758 . . . . 0.0 110.42 176.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.518 ' H ' ' HB3' ' A' ' 15' ' ' PRO . . . -169.31 151.81 4.71 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.187 169.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.5 t -109.1 122.85 48.16 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.496 HG22 ' HB3' ' A' ' 13' ' ' MET . 6.7 m -119.78 147.12 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-O 121.266 0.555 . . . . 0.0 111.832 -173.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.0 t -111.01 119.34 38.72 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 5.2 mp -91.84 151.45 20.56 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 174.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 tp -133.0 140.3 47.69 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.301 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.23 -166.75 24.72 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.992 -177.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 1.612 ' HE2' ' CE1' ' A' ' 90' ' ' TYR . 11.5 p90 -152.93 132.86 13.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.697 0.76 . . . . 0.0 111.839 176.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.456 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 15.2 mt -67.56 139.84 56.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.095 177.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -72.97 113.46 10.03 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -174.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.546 ' HB3' ' O ' ' A' ' 4' ' ' ALA . 3.2 m-20 -142.21 136.24 29.71 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.113 -0.948 . . . . 0.0 108.937 171.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 39.5 pt -77.78 145.0 10.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.096 0.474 . . . . 0.0 111.358 -175.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -66.48 -9.31 33.16 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.053 -177.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.9 m 65.05 -159.52 0.29 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.569 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.16 -61.34 3.99 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.749 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 68.9 m . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.261 176.397 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -102.12 145.5 29.27 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . 0.404 ' HA2' ' SD ' ' B' ' 5' ' ' MET . . . 149.92 -171.71 29.9 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.782 -177.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' B' ' 93' ' ' ASP . . . 57.03 44.35 22.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 0.0 110.868 -178.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' MET . . . . . 0.404 ' SD ' ' HA2' ' B' ' 3' ' ' GLY . 2.5 mpt? -70.43 172.66 8.01 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.862 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.624 ' HB1' ' ND2' ' C' ' 68' ' ' ASN . . . -54.26 131.46 41.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.677 177.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 52.5 ttm -100.34 139.06 36.55 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.582 -173.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 0.487 ' CE1' HD23 ' C' ' 44' ' ' LEU . 61.8 t80 -52.72 142.05 19.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.627 -177.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . 0.535 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 88.5 t90 -135.7 147.71 48.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.856 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.501 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -148.71 153.86 25.48 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.984 178.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.535 ' HB2' ' CH2' ' B' ' 9' ' ' TRP . 52.3 tp -140.46 108.13 5.63 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.086 0.47 . . . . 0.0 110.915 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -81.23 101.59 9.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.529 173.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' MET . . . . . 0.506 ' HB3' HG22 ' B' ' 85' ' ' VAL . 30.8 tpp -95.58 131.23 42.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.114 0.483 . . . . 0.0 111.151 -174.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -100.74 145.26 30.05 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.969 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.509 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 12.4 Cg_endo -56.09 124.67 16.82 Favored 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 123.445 2.763 . . . . 0.0 113.487 -174.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.546 ' HA ' ' O ' ' B' ' 79' ' ' THR . 25.3 mt-10 60.24 47.91 8.72 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.031 177.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -121.76 138.78 54.23 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.696 172.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . 0.661 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 84.5 mttt -111.47 119.02 37.4 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 123.273 0.358 . . . . 0.0 111.491 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.67 103.86 12.47 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.766 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 7.3 p -88.48 98.87 11.87 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 174.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -117.39 144.81 44.57 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.538 0.685 . . . . 0.0 112.284 -169.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 17.7 m -94.06 143.11 26.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.523 177.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.446 ' CG2' ' HA ' ' B' ' 71' ' ' LYS . 59.3 mt -92.86 120.49 42.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.162 0.506 . . . . 0.0 111.117 -174.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.432 HD13 ' N ' ' B' ' 24' ' ' ILE . 4.0 mp -79.42 -52.89 14.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.286 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.464 ' HE2' ' HB3' ' B' ' 91' ' ' LEU . 13.5 ptmt -131.12 137.47 49.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.988 175.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 11.5 m -54.41 141.71 29.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.924 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -149.03 158.28 44.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.685 0.755 . . . . 0.0 112.774 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' HIS . . . . . 0.584 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 9.2 t60 -111.39 127.39 55.65 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.39 -1.277 . . . . 0.0 109.795 178.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 35.0 mt -96.79 137.98 23.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 170.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.584 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 56.4 p -123.52 -20.37 5.58 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -171.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -153.81 156.39 26.77 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 119.322 -1.418 . . . . 0.0 113.605 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 14.8 p -146.58 124.35 3.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 172.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.14 155.71 44.04 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.898 -0.501 . . . . 0.0 111.726 -174.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.465 ' HB3' ' CG1' ' B' ' 85' ' ' VAL . 3.7 pp -120.38 140.57 51.12 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.984 0.897 . . . . 0.0 111.728 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.471 ' CB ' ' HH ' ' C' ' 43' ' ' TYR . 23.7 p-10 -105.01 -53.8 2.6 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.37 -1.286 . . . . 0.0 108.855 174.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -102.82 127.44 49.99 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 169.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.469 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 151.3 156.09 7.25 Favored Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 119.829 -1.177 . . . . 0.0 113.547 176.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . 0.416 ' HA ' ' HB2' ' B' ' 58' ' ' LYS . 91.0 mt-30 -102.58 -44.3 5.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.737 0.303 . . . . 0.0 111.125 178.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -153.08 126.41 8.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.089 177.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.53 113.12 17.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.511 0.672 . . . . 0.0 109.776 169.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' B' ' 79' ' ' THR . 19.9 mtpp -96.15 107.04 19.32 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 41.2 tp -81.5 114.84 20.49 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 -173.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . 0.539 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 97.6 m-85 -120.51 139.42 52.93 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.494 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 0.2 OUTLIER -125.07 133.29 52.96 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 172.575 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.608 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -112.02 113.11 25.21 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.184 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.54 137.82 54.38 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.344 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 59.63 30.88 20.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.046 0.451 . . . . 0.0 110.293 -174.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.488 ' NZ ' ' HB2' ' B' ' 48' ' ' LYS . 0.1 OUTLIER 62.62 33.6 15.61 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.12 -177.153 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.608 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 8.4 tp-100 -123.48 130.27 52.45 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.63 123.61 32.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.829 0.347 . . . . 0.0 110.7 -175.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 1.625 ' HD1' ' CD2' ' B' ' 51' ' ' TYR . 84.8 m-85 -117.99 130.15 56.02 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.888 175.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.1 tp -80.2 103.78 7.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.827 0.822 . . . . 0.0 108.807 171.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.536 ' CG1' HD12 ' B' ' 67' ' ' LEU . 2.6 t -78.7 -49.39 20.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.709 -171.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.46 ' HB2' HG12 ' B' ' 63' ' ' VAL . . . -158.38 146.65 18.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.889 -178.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 32.3 m -109.57 101.43 10.36 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.62 116.21 51.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.568 0.699 . . . . 0.0 109.557 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 46.8 p -122.37 -179.17 4.1 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.371 -172.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . 0.416 ' HB2' ' HA ' ' B' ' 38' ' ' GLN . 38.1 tttm -61.53 -27.33 68.53 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.878 172.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.471 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -84.34 -40.67 17.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.577 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 86.1 mt -109.41 84.11 2.85 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 174.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 9.8 Cg_exo -71.03 0.09 7.14 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.981 2.454 . . . . 0.0 113.707 -168.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -162.79 131.71 4.11 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.121 0.486 . . . . 0.0 111.221 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.46 HG12 ' HB2' ' B' ' 54' ' ' ALA . 71.7 t -120.57 132.8 69.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.964 172.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.52 113.22 25.69 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.09 177.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.436 ' N ' HD11 ' B' ' 65' ' ' LEU . 0.0 OUTLIER -121.58 170.05 10.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.325 -176.575 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 7.2 t0 -118.38 98.73 6.42 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.221 0.534 . . . . 0.0 109.602 175.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.554 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 19.7 mt -113.0 143.43 44.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.903 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . 0.587 ' ND2' ' HB1' ' A' ' 6' ' ' ALA . 57.0 t30 -147.79 120.0 8.34 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.951 0.405 . . . . 0.0 109.965 174.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . 1.669 ' HD2' ' CD1' ' B' ' 69' ' ' PHE . 55.1 m-85 -114.98 153.5 30.5 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.273 -178.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 20.6 t -103.57 148.89 25.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.058 -178.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . 0.509 ' HZ2' ' HB2' ' B' ' 71' ' ' LYS . 0.0 OUTLIER -74.88 10.07 1.6 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -174.579 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.61 -15.22 30.04 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.86 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -101.13 170.83 7.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.846 0.355 . . . . 0.0 110.838 -175.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 62.0 ttt-85 -138.37 122.55 18.07 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 14.5 pt -125.73 160.86 31.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.389 -170.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' MET . . . . . 0.446 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 2.8 mtm -115.25 129.01 56.51 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 174.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . 0.494 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -109.81 128.39 55.28 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.187 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 1.635 ' HE2' ' CE1' ' B' ' 78' ' ' TYR . 51.4 p90 -155.79 157.4 36.43 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 120.241 -0.584 . . . . 0.0 112.215 -177.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.546 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 14.6 p -124.77 144.06 50.46 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.277 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.43 156.69 18.68 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.981 174.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.87 -166.91 31.55 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -123.75 102.76 7.99 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.36 176.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.509 ' H ' ' HB3' ' B' ' 15' ' ' PRO . . . -169.23 151.88 4.79 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.21 169.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 33.7 t -109.23 122.83 48.17 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.506 HG22 ' HB3' ' B' ' 13' ' ' MET . 6.8 m -119.78 147.18 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 CA-C-O 121.307 0.575 . . . . 0.0 111.838 -173.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 17.0 t -111.08 119.33 38.63 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.525 ' HB2' ' HB3' ' B' ' 11' ' ' LEU . 5.2 mp -91.72 151.49 20.61 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 174.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.404 ' CD2' HG11 ' C' ' 53' ' ' VAL . 1.2 tp -133.07 140.31 47.61 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.267 -178.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.28 -166.67 24.65 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.961 -177.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' TYR . . . . . 1.638 ' HE1' ' CE2' ' B' ' 90' ' ' TYR . 11.3 p90 -153.11 132.92 13.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.811 0.815 . . . . 0.0 111.742 176.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . 0.464 ' HB3' ' HE2' ' B' ' 25' ' ' LYS . 15.1 mt -67.57 139.79 56.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.13 -1.395 . . . . 0.0 110.127 177.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -72.9 113.39 9.88 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -174.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . 0.531 ' HB3' ' O ' ' B' ' 4' ' ' ALA . 3.3 m-20 -142.21 136.11 29.58 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.909 171.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 39.5 pt -77.68 145.05 10.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.037 0.446 . . . . 0.0 111.497 -175.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -66.52 -9.33 33.66 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.085 -177.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 19.8 m 65.04 -159.65 0.29 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.594 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.29 -61.14 3.97 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.757 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 68.6 m . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.696 -0.669 . . . . 0.0 110.263 176.247 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -102.04 145.39 29.38 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 3' ' ' GLY . . . . . 0.404 ' HA2' ' SD ' ' C' ' 5' ' ' MET . . . 149.94 -171.83 29.91 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.808 -177.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . 0.536 ' O ' ' HB3' ' C' ' 93' ' ' ASP . . . 57.21 44.13 22.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.853 0.359 . . . . 0.0 110.907 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 5' ' ' MET . . . . . 0.404 ' SD ' ' HA2' ' C' ' 3' ' ' GLY . 2.5 mpt? -70.2 172.56 7.91 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.903 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 6' ' ' ALA . . . . . 0.577 ' HB1' ' ND2' ' D' ' 68' ' ' ASN . . . -54.2 131.39 41.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.68 177.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 52.4 ttm -100.33 138.99 36.64 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.567 -173.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 8' ' ' PHE . . . . . 0.476 ' CE1' HD23 ' D' ' 44' ' ' LEU . 61.4 t80 -52.73 142.1 19.48 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.937 -1.028 . . . . 0.0 112.62 -177.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . 0.521 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 88.3 t90 -135.71 147.57 48.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.867 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . 0.515 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -148.69 153.8 25.44 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.094 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.538 ' HB3' ' HB2' ' C' ' 87' ' ' LEU . 52.6 tp -140.36 108.15 5.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.989 0.423 . . . . 0.0 110.914 178.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -81.29 101.48 9.78 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.507 173.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 13' ' ' MET . . . . . 0.513 ' HB3' HG22 ' C' ' 85' ' ' VAL . 30.7 tpp -95.48 131.23 41.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.132 0.492 . . . . 0.0 111.128 -174.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -100.82 145.32 30.17 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.899 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . 0.503 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 12.4 Cg_endo -56.06 124.61 16.69 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 123.404 2.736 . . . . 0.0 113.459 -174.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . 0.55 ' HA ' ' O ' ' C' ' 79' ' ' THR . 25.1 mt-10 60.28 47.91 8.63 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.024 177.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -121.72 138.72 54.24 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.653 172.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 18' ' ' LYS . . . . . 0.667 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 84.5 mttt -111.37 119.06 37.58 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.454 0.471 . . . . 0.0 111.484 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -110.7 103.86 12.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.735 176.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 7.8 p -88.43 98.84 11.85 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 174.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -117.38 144.77 44.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.553 0.692 . . . . 0.0 112.271 -169.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 17.4 m -94.01 143.19 26.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.577 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . 0.435 ' CG2' ' HA ' ' C' ' 71' ' ' LYS . 59.4 mt -92.89 120.48 42.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.054 0.454 . . . . 0.0 111.09 -174.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . 0.436 HD13 ' N ' ' C' ' 24' ' ' ILE . 4.0 mp -79.43 -52.88 14.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.315 178.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . 0.456 ' HE2' ' HB3' ' C' ' 91' ' ' LEU . 13.6 ptmt -131.12 137.46 49.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.95 175.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 11.5 m -54.43 141.69 29.77 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.921 -176.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 27' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -149.0 158.24 44.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.71 0.767 . . . . 0.0 112.834 -176.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 28' ' ' HIS . . . . . 0.586 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 9.2 t60 -111.41 127.41 55.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.405 -1.271 . . . . 0.0 109.864 178.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 35.6 mt -96.82 138.02 23.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 170.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 30' ' ' SER . . . . . 0.586 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 56.4 p -123.46 -20.45 5.58 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -171.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -153.78 156.36 26.74 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 119.352 -1.404 . . . . 0.0 113.634 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 14.8 p -146.57 124.31 3.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.12 155.74 44.06 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.947 -0.471 . . . . 0.0 111.752 -174.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.47 ' HB3' ' CG1' ' C' ' 85' ' ' VAL . 3.7 pp -120.44 140.58 51.17 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.938 0.875 . . . . 0.0 111.752 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . 0.456 ' CB ' ' HH ' ' D' ' 43' ' ' TYR . 23.7 p-10 -105.13 -53.7 2.62 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.757 174.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -102.9 127.47 50.09 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 169.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 37' ' ' GLY . . . . . 0.46 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 151.24 156.09 7.24 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 119.901 -1.142 . . . . 0.0 113.685 177.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 38' ' ' GLN . . . . . 0.413 ' HA ' ' HB2' ' C' ' 58' ' ' LYS . 90.9 mt-30 -102.68 -44.23 5.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.766 0.317 . . . . 0.0 111.156 178.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -153.1 126.46 8.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.071 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.46 113.08 17.66 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.441 0.638 . . . . 0.0 109.793 169.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' C' ' 79' ' ' THR . 19.9 mtpp -96.07 107.02 19.27 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 176.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 41.3 tp -81.48 114.81 20.46 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -173.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 43' ' ' TYR . . . . . 0.539 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 97.6 m-85 -120.53 139.41 52.95 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.488 ' HB2' ' CD1' ' C' ' 77' ' ' PHE . 0.2 OUTLIER -125.12 133.25 52.92 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.656 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . 0.613 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -112.07 113.11 25.2 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.096 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.46 137.82 54.4 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.333 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 59.72 30.73 20.32 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 123.503 0.502 . . . . 0.0 110.258 -174.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . 0.489 ' NZ ' ' HB2' ' C' ' 48' ' ' LYS . 0.1 OUTLIER 62.53 33.62 15.83 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.201 -177.033 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . 0.613 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 8.4 tp-100 -123.53 130.27 52.43 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.53 123.64 31.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.792 0.33 . . . . 0.0 110.806 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 1.643 ' HD1' ' CD2' ' C' ' 51' ' ' TYR . 84.6 m-85 -118.03 130.12 55.98 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.84 175.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.1 tp -80.23 103.82 7.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 171.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 53' ' ' VAL . . . . . 0.537 ' CG1' HD12 ' C' ' 67' ' ' LEU . 2.6 t -78.7 -49.5 20.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.648 -171.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 54' ' ' ALA . . . . . 0.461 ' HB2' HG12 ' C' ' 63' ' ' VAL . . . -158.35 146.56 18.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.827 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 32.5 m -109.42 101.37 10.35 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 173.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.54 116.27 51.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.587 0.708 . . . . 0.0 109.569 -177.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 47.0 p -122.44 -179.13 4.1 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.346 -172.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 58' ' ' LYS . . . . . 0.413 ' HB2' ' HA ' ' C' ' 38' ' ' GLN . 38.1 tttm -61.45 -27.53 68.63 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.871 172.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . 0.489 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -84.14 -40.66 17.95 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.647 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 86.1 mt -109.43 84.05 2.83 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 174.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 61' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 9.8 Cg_exo -71.03 0.12 7.09 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.099 2.533 . . . . 0.0 113.729 -168.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -162.77 131.69 4.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.166 0.508 . . . . 0.0 111.274 -176.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.461 HG12 ' HB2' ' C' ' 54' ' ' ALA . 69.0 t -120.47 132.86 68.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.0 172.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.61 113.12 25.5 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.115 177.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . 0.441 ' N ' HD11 ' C' ' 65' ' ' LEU . 0.0 OUTLIER -121.51 170.03 10.08 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.064 0.459 . . . . 0.0 111.294 -176.508 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 66' ' ' ASP . . . . . 0.497 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 7.4 t0 -118.3 98.76 6.44 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.199 0.524 . . . . 0.0 109.678 175.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . 0.537 HD12 ' CG1' ' C' ' 53' ' ' VAL . 19.7 mt -112.98 143.4 44.33 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.902 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . 0.624 ' ND2' ' HB1' ' B' ' 6' ' ' ALA . 57.1 t30 -147.75 119.96 8.34 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 174.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 69' ' ' PHE . . . . . 1.651 ' HE2' ' CE1' ' C' ' 69' ' ' PHE . 55.7 m-85 -115.01 153.53 30.48 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.186 -178.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 20.5 t -103.61 148.88 25.47 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.991 -178.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . 0.501 ' HB2' ' HZ2' ' C' ' 71' ' ' LYS . 0.0 OUTLIER -74.76 9.91 1.63 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -174.66 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.57 -15.14 30.37 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.594 -0.813 . . . . 0.0 111.994 175.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -101.16 170.87 7.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.792 0.329 . . . . 0.0 110.91 -175.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 61.8 ttt-85 -138.36 122.64 18.19 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 14.4 pt -125.76 160.84 31.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.4 -170.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 76' ' ' MET . . . . . 0.445 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 2.8 mtm -115.24 129.02 56.52 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 174.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 77' ' ' PHE . . . . . 0.488 ' CD1' ' HB2' ' C' ' 44' ' ' LEU . 0.6 OUTLIER -109.91 128.38 55.32 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.179 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 78' ' ' TYR . . . . . 1.659 ' HE2' ' CE1' ' C' ' 78' ' ' TYR . 51.2 p90 -155.78 157.45 36.51 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 120.235 -0.586 . . . . 0.0 112.254 -177.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 79' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 14.7 p -124.74 143.98 50.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.234 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.34 156.62 18.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.017 174.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.04 -166.74 31.23 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -176.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -123.79 102.72 7.96 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 117.693 0.746 . . . . 0.0 110.462 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . 0.503 ' H ' ' HB3' ' C' ' 15' ' ' PRO . . . -169.26 151.81 4.74 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.366 -1.288 . . . . 0.0 109.258 169.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 33.5 t -109.18 122.78 48.03 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.513 HG22 ' HB3' ' C' ' 13' ' ' MET . 6.7 m -119.68 147.17 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 CA-C-O 121.264 0.554 . . . . 0.0 111.818 -173.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 17.2 t -111.11 119.36 38.74 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . 0.538 ' HB2' ' HB3' ' C' ' 11' ' ' LEU . 5.2 mp -91.67 151.46 20.66 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 174.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 tp -133.07 140.33 47.62 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.3 -178.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.29 -166.73 24.77 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.955 -0.64 . . . . 0.0 111.991 -177.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 90' ' ' TYR . . . . . 1.621 ' HE1' ' CE2' ' C' ' 90' ' ' TYR . 11.5 p90 -153.0 132.81 13.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.714 0.769 . . . . 0.0 111.817 176.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . 0.456 ' HB3' ' HE2' ' C' ' 25' ' ' LYS . 15.2 mt -67.6 139.76 56.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.094 177.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -72.83 113.39 9.8 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -174.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 93' ' ' ASP . . . . . 0.536 ' HB3' ' O ' ' C' ' 4' ' ' ALA . 3.2 m-20 -142.19 136.3 29.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.896 171.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 39.5 pt -77.86 144.99 10.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.016 0.436 . . . . 0.0 111.393 -175.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.42 -9.34 32.93 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.028 -177.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 20.1 m 64.93 -159.57 0.29 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.621 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.31 -61.36 3.94 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.831 -0.7 . . . . 0.0 111.68 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.716 -0.659 . . . . 0.0 110.209 176.435 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -102.01 145.38 29.38 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 3' ' ' GLY . . . . . 0.412 ' HA2' ' SD ' ' D' ' 5' ' ' MET . . . 150.0 -171.88 29.94 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.799 -177.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 4' ' ' ALA . . . . . 0.533 ' O ' ' HB3' ' D' ' 93' ' ' ASP . . . 57.25 44.2 22.43 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 123.834 0.373 . . . . 0.0 110.854 -178.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 5' ' ' MET . . . . . 0.412 ' SD ' ' HA2' ' D' ' 3' ' ' GLY . 2.5 mpt? -70.33 172.64 7.92 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.837 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 6' ' ' ALA . . . . . 0.582 ' HB1' ' ND2' ' E' ' 68' ' ' ASN . . . -54.27 131.48 41.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.69 177.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 52.4 ttm -100.36 139.06 36.58 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.594 -173.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 8' ' ' PHE . . . . . 0.484 ' CE1' HD23 ' E' ' 44' ' ' LEU . 61.4 t80 -52.76 142.16 19.48 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.603 -177.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 9' ' ' TRP . . . . . 0.534 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 88.2 t90 -135.81 147.67 48.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.113 -0.948 . . . . 0.0 108.899 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . 0.512 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -148.74 153.76 25.41 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.083 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . 0.534 ' HB2' ' CH2' ' D' ' 9' ' ' TRP . 52.1 tp -140.32 108.25 5.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.065 0.46 . . . . 0.0 110.85 178.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -81.32 101.68 9.93 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.473 173.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 13' ' ' MET . . . . . 0.503 ' HB3' HG22 ' D' ' 85' ' ' VAL . 30.5 tpp -95.57 131.31 41.91 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.181 -174.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -100.87 145.32 30.19 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.885 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . 0.506 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 12.3 Cg_endo -56.12 124.61 16.69 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 123.421 2.747 . . . . 0.0 113.413 -174.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . 0.551 ' HA ' ' O ' ' D' ' 79' ' ' THR . 25.2 mt-10 60.33 47.91 8.52 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.547 -0.752 . . . . 0.0 112.017 177.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -121.78 138.69 54.27 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.654 172.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . 0.656 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 84.6 mttt -111.39 119.1 37.71 Favored 'General case' 0 CA--C 1.517 -0.316 0 O-C-N 123.384 0.428 . . . . 0.0 111.472 178.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.61 103.84 12.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.794 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 7.5 p -88.38 98.84 11.83 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 174.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -117.44 144.79 44.65 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.537 0.684 . . . . 0.0 112.271 -169.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 17.4 m -94.08 143.1 26.67 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.56 177.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . 0.445 ' CG2' ' HA ' ' D' ' 71' ' ' LYS . 59.5 mt -92.86 120.55 42.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.167 0.508 . . . . 0.0 111.077 -174.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . 0.438 ' N ' HD13 ' D' ' 24' ' ' ILE . 4.0 mp -79.47 -52.9 14.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.294 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . 0.46 ' HE2' ' HB3' ' D' ' 91' ' ' LEU . 13.6 ptmt -131.03 137.56 49.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.053 175.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 11.7 m -54.49 141.71 30.06 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 124.01 0.818 . . . . 0.0 110.894 -176.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 27' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -149.04 158.28 44.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.717 0.77 . . . . 0.0 112.767 -175.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 28' ' ' HIS . . . . . 0.586 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 9.2 t60 -111.44 127.35 55.66 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.739 178.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 29' ' ' ILE . . . . . 0.536 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 35.4 mt -96.7 138.11 22.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 170.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 30' ' ' SER . . . . . 0.586 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 55.7 p -123.65 -20.35 5.53 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -171.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -153.79 156.38 26.76 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 119.305 -1.426 . . . . 0.0 113.635 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 14.8 p -146.63 124.23 3.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.11 155.74 44.07 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.91 -0.494 . . . . 0.0 111.791 -174.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 34' ' ' LEU . . . . . 0.474 ' HB3' ' CG1' ' D' ' 85' ' ' VAL . 3.7 pp -120.37 140.47 51.26 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.894 0.854 . . . . 0.0 111.781 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . 0.435 ' CB ' ' HH ' ' E' ' 43' ' ' TYR . 23.6 p-10 -105.07 -53.59 2.64 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.416 -1.266 . . . . 0.0 108.84 174.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -102.92 127.47 50.12 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 168.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . 0.468 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 151.18 155.92 7.16 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 119.859 -1.162 . . . . 0.0 113.688 177.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 38' ' ' GLN . . . . . 0.423 ' HA ' ' HB2' ' D' ' 58' ' ' LYS . 91.2 mt-30 -102.59 -44.2 5.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.662 0.268 . . . . 0.0 111.119 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -153.13 126.36 8.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.147 176.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.48 113.15 17.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.535 0.683 . . . . 0.0 109.741 169.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' D' ' 79' ' ' THR . 19.9 mtpp -96.24 107.11 19.41 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 176.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 41.3 tp -81.52 114.83 20.5 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -173.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 43' ' ' TYR . . . . . 0.538 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 97.6 m-85 -120.55 139.4 52.99 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.492 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.2 OUTLIER -125.04 133.21 53.04 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 172.67 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 45' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -112.03 113.16 25.28 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.131 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.49 137.69 54.4 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.419 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 59.74 30.89 20.48 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.504 0.503 . . . . 0.0 110.22 -174.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 48' ' ' LYS . . . . . 0.483 ' NZ ' ' HB2' ' D' ' 48' ' ' LYS . 0.1 OUTLIER 62.41 33.73 16.06 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.132 -177.104 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . 0.615 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 8.5 tp-100 -123.58 130.27 52.42 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.53 123.56 31.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.764 0.316 . . . . 0.0 110.784 -176.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . 1.653 ' HD2' ' CD1' ' D' ' 51' ' ' TYR . 84.6 m-85 -118.01 130.11 55.98 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 175.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.15 103.78 7.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 171.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 53' ' ' VAL . . . . . 0.533 ' CG1' HD12 ' D' ' 67' ' ' LEU . 2.6 t -78.74 -49.52 20.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.662 -171.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 54' ' ' ALA . . . . . 0.448 ' HB2' HG12 ' D' ' 63' ' ' VAL . . . -158.3 146.61 18.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.9 -178.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 32.5 m -109.55 101.43 10.37 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 173.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.6 116.2 51.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.564 0.697 . . . . 0.0 109.599 -177.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 46.2 p -122.38 -179.07 4.07 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.31 -172.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 58' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' D' ' 38' ' ' GLN . 38.2 tttm -61.64 -27.39 68.63 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.82 172.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 59' ' ' ALA . . . . . 0.482 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -84.24 -40.69 17.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.652 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 86.1 mt -109.34 84.08 2.78 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 61' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 9.7 Cg_exo -71.04 0.09 7.14 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.038 2.492 . . . . 0.0 113.725 -168.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -162.76 131.64 4.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.132 0.492 . . . . 0.0 111.298 -176.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.448 HG12 ' HB2' ' D' ' 54' ' ' ALA . 69.2 t -120.43 132.71 69.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.107 172.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.49 113.13 25.52 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.197 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 65' ' ' LEU . . . . . 0.437 ' N ' HD11 ' D' ' 65' ' ' LEU . 0.0 OUTLIER -121.44 170.05 10.03 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.344 -176.508 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 66' ' ' ASP . . . . . 0.478 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 7.3 t0 -118.42 98.84 6.47 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.284 0.564 . . . . 0.0 109.584 175.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . 0.536 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 19.8 mt -113.0 143.46 44.27 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.929 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 68' ' ' ASN . . . . . 0.577 ' ND2' ' HB1' ' C' ' 6' ' ' ALA . 57.1 t30 -147.77 119.95 8.32 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.96 0.409 . . . . 0.0 109.961 174.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 69' ' ' PHE . . . . . 1.652 ' HE1' ' CE2' ' D' ' 69' ' ' PHE . 55.3 m-85 -114.98 153.55 30.41 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.24 -178.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 20.7 t -103.62 148.93 25.42 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.969 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 71' ' ' LYS . . . . . 0.496 ' HB2' ' HZ2' ' D' ' 71' ' ' LYS . 0.0 OUTLIER -74.91 10.02 1.63 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -174.614 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.51 -15.3 30.06 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.949 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -101.21 170.9 7.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.745 0.307 . . . . 0.0 110.876 -175.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 62.0 ttt-85 -138.43 122.65 18.12 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . . . . . . . . . 14.3 pt -125.75 160.86 31.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.403 -170.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 76' ' ' MET . . . . . 0.454 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 2.9 mtm -115.24 128.98 56.5 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 174.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 77' ' ' PHE . . . . . 0.492 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.6 OUTLIER -109.84 128.4 55.3 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.204 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 78' ' ' TYR . . . . . 1.64 ' HE1' ' CE2' ' D' ' 78' ' ' TYR . 51.6 p90 -155.79 157.46 36.51 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 120.231 -0.588 . . . . 0.0 112.232 -177.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 79' ' ' THR . . . . . 0.551 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 14.0 p -124.87 144.03 50.53 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.171 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.34 156.55 18.79 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.98 174.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.04 -166.83 31.29 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -176.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -123.67 102.74 8.0 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 117.797 0.799 . . . . 0.0 110.365 176.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.506 ' H ' ' HB3' ' D' ' 15' ' ' PRO . . . -169.23 151.87 4.79 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.157 169.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 33.4 t -109.21 122.82 48.14 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . 0.503 HG22 ' HB3' ' D' ' 13' ' ' MET . 6.8 m -119.75 147.11 23.6 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 CA-C-O 121.298 0.571 . . . . 0.0 111.814 -173.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 16.9 t -111.05 119.32 38.64 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 177.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 87' ' ' LEU . . . . . 0.534 ' HB2' ' HB3' ' D' ' 11' ' ' LEU . 5.2 mp -91.68 151.45 20.66 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 174.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 tp -133.07 140.26 47.6 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.287 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.24 -166.71 24.67 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.978 -177.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 90' ' ' TYR . . . . . 1.622 ' HE1' ' CE2' ' D' ' 90' ' ' TYR . 11.5 p90 -153.01 132.82 13.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.739 0.78 . . . . 0.0 111.814 176.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . 0.46 ' HB3' ' HE2' ' D' ' 25' ' ' LYS . 15.2 mt -67.61 139.78 56.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.096 177.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -72.91 113.46 9.96 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -174.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 93' ' ' ASP . . . . . 0.533 ' HB3' ' O ' ' D' ' 4' ' ' ALA . 3.2 m-20 -142.18 136.28 29.79 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.03 -0.987 . . . . 0.0 108.876 171.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 39.4 pt -77.87 144.93 10.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.156 0.503 . . . . 0.0 111.319 -175.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.43 -9.29 32.51 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.08 -177.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 19.9 m 65.02 -159.53 0.29 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.621 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.18 -61.28 3.99 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.757 -178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 68.9 m . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.699 -0.667 . . . . 0.0 110.311 176.323 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -102.16 145.5 29.3 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 3' ' ' GLY . . . . . 0.41 ' HA2' ' SD ' ' E' ' 5' ' ' MET . . . 149.85 -171.85 29.83 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.815 -177.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 4' ' ' ALA . . . . . 0.546 ' O ' ' HB3' ' E' ' 93' ' ' ASP . . . 57.31 44.08 22.43 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 123.796 0.351 . . . . 0.0 110.816 -178.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 5' ' ' MET . . . . . 0.41 ' SD ' ' HA2' ' E' ' 3' ' ' GLY . 2.5 mpt? -70.15 172.61 7.77 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.982 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 6' ' ' ALA . . . . . 0.623 ' HB1' ' ND2' ' A' ' 68' ' ' ASN . . . -54.27 131.43 41.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.727 177.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 52.4 ttm -100.24 139.06 36.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.567 -173.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 8' ' ' PHE . . . . . 0.497 ' CE1' HD23 ' A' ' 44' ' ' LEU . 61.2 t80 -52.8 142.17 19.59 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.548 -177.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 9' ' ' TRP . . . . . 0.517 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 88.3 t90 -135.73 147.68 48.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.838 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 10' ' ' GLY . . . . . 0.49 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -148.72 153.87 25.49 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.04 177.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . 0.542 ' HB3' ' HB2' ' E' ' 87' ' ' LEU . 52.7 tp -140.38 108.13 5.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.061 0.458 . . . . 0.0 110.919 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -81.15 101.56 9.73 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.553 173.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 13' ' ' MET . . . . . 0.499 ' HB3' HG22 ' E' ' 85' ' ' VAL . 30.6 tpp -95.49 131.19 41.92 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.109 0.48 . . . . 0.0 111.184 -174.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -100.78 145.38 30.27 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.97 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . 0.519 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 12.3 Cg_endo -56.2 124.65 16.78 Favored 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 123.365 2.71 . . . . 0.0 113.424 -174.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 16' ' ' GLU . . . . . 0.55 ' HA ' ' O ' ' E' ' 79' ' ' THR . 25.3 mt-10 60.37 47.82 8.5 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.016 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -121.66 138.71 54.22 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.652 172.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . 0.658 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 84.6 mttt -111.4 119.2 38.01 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.35 0.406 . . . . 0.0 111.414 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.72 103.84 12.43 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.853 176.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 7.9 p -88.43 98.94 11.9 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 174.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -117.44 144.92 44.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.56 0.695 . . . . 0.0 112.266 -169.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 17.8 m -94.19 143.1 26.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.487 177.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 23' ' ' ILE . . . . . 0.447 ' CG2' ' HA ' ' E' ' 71' ' ' LYS . 59.4 mt -92.79 120.45 42.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.007 0.432 . . . . 0.0 111.17 -174.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . 0.427 ' N ' HD13 ' E' ' 24' ' ' ILE . 4.0 mp -79.42 -52.99 14.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.24 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . 0.455 ' HE2' ' HB3' ' E' ' 91' ' ' LEU . 13.5 ptmt -131.05 137.46 49.16 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.027 175.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 11.4 m -54.37 141.7 29.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.931 -176.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 27' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -149.01 158.21 44.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.728 0.775 . . . . 0.0 112.762 -175.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 28' ' ' HIS . . . . . 0.585 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 9.3 t60 -111.39 127.37 55.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.842 178.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 29' ' ' ILE . . . . . 0.543 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 35.6 mt -96.8 138.05 22.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 170.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 30' ' ' SER . . . . . 0.585 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 55.7 p -123.58 -20.33 5.57 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -171.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -153.76 156.42 26.78 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 119.27 -1.443 . . . . 0.0 113.578 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 14.8 p -146.61 124.35 3.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 172.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.15 155.64 44.01 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.931 -0.481 . . . . 0.0 111.764 -174.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 34' ' ' LEU . . . . . 0.467 ' HB3' ' CG1' ' E' ' 85' ' ' VAL . 3.7 pp -120.33 140.47 51.23 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.914 0.864 . . . . 0.0 111.771 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . 0.431 ' CB ' ' HH ' ' A' ' 43' ' ' TYR . 23.7 p-10 -104.98 -53.74 2.61 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.378 -1.283 . . . . 0.0 108.826 174.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -102.82 127.38 50.01 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 169.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . 0.467 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 151.3 156.04 7.22 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 119.794 -1.193 . . . . 0.0 113.631 176.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 38' ' ' GLN . . . . . 0.421 ' HA ' ' HB2' ' E' ' 58' ' ' LYS . 91.1 mt-30 -102.61 -44.19 5.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.681 0.277 . . . . 0.0 111.127 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -153.16 126.39 8.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.095 176.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.51 113.14 17.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.534 0.683 . . . . 0.0 109.771 169.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 41' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' E' ' 79' ' ' THR . 19.9 mtpp -96.11 107.02 19.29 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 41.2 tp -81.45 114.85 20.47 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -173.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 43' ' ' TYR . . . . . 0.53 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 97.5 m-85 -120.59 139.39 53.04 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 177.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 44' ' ' LEU . . . . . 0.499 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 0.2 OUTLIER -125.09 133.26 52.96 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 172.574 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' E' E ' 45' ' ' ALA . . . . . 0.618 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -111.98 113.15 25.29 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.118 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.53 137.77 54.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.371 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 59.81 30.8 20.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.001 0.429 . . . . 0.0 110.204 -174.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 48' ' ' LYS . . . . . 0.481 ' HB2' ' NZ ' ' E' ' 48' ' ' LYS . 0.1 OUTLIER 62.54 33.63 15.8 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.171 -177.045 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' E' E ' 49' ' ' GLN . . . . . 0.618 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 8.4 tp-100 -123.6 130.39 52.59 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -86.63 123.65 32.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.817 0.341 . . . . 0.0 110.726 -176.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . 1.668 ' HE1' ' CE2' ' E' ' 51' ' ' TYR . 84.6 m-85 -118.09 130.08 55.93 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.866 175.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.11 103.82 7.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 171.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . 0.532 ' CG1' HD12 ' E' ' 67' ' ' LEU . 2.6 t -78.76 -49.41 20.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.664 -171.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 54' ' ' ALA . . . . . 0.447 ' HB2' HG12 ' E' ' 63' ' ' VAL . . . -158.41 146.59 18.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.834 -178.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 32.5 m -109.52 101.45 10.39 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 173.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.56 116.15 51.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.501 0.667 . . . . 0.0 109.635 -177.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 46.7 p -122.29 -179.08 4.06 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.43 -172.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 58' ' ' LYS . . . . . 0.421 ' HB2' ' HA ' ' E' ' 38' ' ' GLN . 38.2 tttm -61.67 -27.3 68.58 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.872 172.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 59' ' ' ALA . . . . . 0.487 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -84.26 -40.68 17.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.673 178.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 85.9 mt -109.35 83.98 2.74 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 174.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 61' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 9.6 Cg_exo -70.96 0.16 6.98 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.033 2.489 . . . . 0.0 113.746 -168.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -162.88 131.59 4.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.088 0.471 . . . . 0.0 111.3 -176.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . 0.447 HG12 ' HB2' ' E' ' 54' ' ' ALA . 70.0 t -120.43 132.73 69.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.049 172.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.45 113.07 25.43 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.193 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . 0.43 ' N ' HD11 ' E' ' 65' ' ' LEU . 0.0 OUTLIER -121.48 170.07 10.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.346 -176.51 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' E' E ' 66' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 7.3 t0 -118.31 98.73 6.43 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.193 0.521 . . . . 0.0 109.641 175.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 67' ' ' LEU . . . . . 0.543 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 19.8 mt -112.99 143.42 44.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.879 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 68' ' ' ASN . . . . . 0.582 ' ND2' ' HB1' ' D' ' 6' ' ' ALA . 57.1 t30 -147.77 119.92 8.3 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.945 0.402 . . . . 0.0 109.99 174.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 69' ' ' PHE . . . . . 1.664 ' HD1' ' CD2' ' E' ' 69' ' ' PHE . 54.9 m-85 -114.91 153.53 30.34 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.262 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 21.0 t -103.63 148.95 25.4 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.979 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 71' ' ' LYS . . . . . 0.508 ' HB2' ' HZ2' ' E' ' 71' ' ' LYS . 0.0 OUTLIER -74.92 10.12 1.6 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -174.596 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.71 -15.19 29.87 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.823 175.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -101.24 170.87 7.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.825 0.345 . . . . 0.0 110.902 -175.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 62.0 ttt-85 -138.33 122.56 18.13 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 75' ' ' ILE . . . . . . . . . . . . . 14.5 pt -125.72 160.9 31.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 120.897 0.38 . . . . 0.0 111.399 -170.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 76' ' ' MET . . . . . 0.446 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 2.9 mtm -115.3 129.0 56.49 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 77' ' ' PHE . . . . . 0.499 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.6 OUTLIER -109.82 128.44 55.32 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 177.207 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' E' E ' 78' ' ' TYR . . . . . 1.649 ' HD2' ' CD1' ' E' ' 78' ' ' TYR . 51.3 p90 -155.88 157.43 36.35 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.146 -0.622 . . . . 0.0 112.185 -177.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 79' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 14.6 p -124.77 143.94 50.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.238 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.31 156.57 18.75 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.985 174.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.99 -166.86 31.36 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -176.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -123.67 102.68 7.96 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 117.734 0.767 . . . . 0.0 110.5 176.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 83' ' ' ALA . . . . . 0.519 ' H ' ' HB3' ' E' ' 15' ' ' PRO . . . -169.25 151.8 4.75 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.16 169.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 33.4 t -109.15 122.8 48.07 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 85' ' ' VAL . . . . . 0.499 HG22 ' HB3' ' E' ' 13' ' ' MET . 6.8 m -119.68 147.16 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-O 121.274 0.559 . . . . 0.0 111.888 -173.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 17.1 t -111.12 119.28 38.44 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 87' ' ' LEU . . . . . 0.542 ' HB2' ' HB3' ' E' ' 11' ' ' LEU . 5.2 mp -91.64 151.52 20.65 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 174.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . 0.401 ' CD2' HG11 ' A' ' 53' ' ' VAL . 1.2 tp -133.13 140.26 47.53 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.304 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.23 -166.74 24.7 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.936 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 90' ' ' TYR . . . . . 1.613 ' HE1' ' CE2' ' E' ' 90' ' ' TYR . 11.4 p90 -153.04 132.8 13.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.787 0.804 . . . . 0.0 111.796 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 91' ' ' LEU . . . . . 0.455 ' HB3' ' HE2' ' E' ' 25' ' ' LYS . 15.1 mt -67.51 139.77 57.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.109 177.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -72.9 113.52 10.03 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -174.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 93' ' ' ASP . . . . . 0.546 ' HB3' ' O ' ' E' ' 4' ' ' ALA . 3.3 m-20 -142.25 136.29 29.67 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.785 171.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 39.4 pt -77.87 145.05 10.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.158 0.504 . . . . 0.0 111.374 -175.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -66.5 -9.32 33.44 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.069 -177.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 19.9 m 65.04 -159.59 0.29 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.629 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.17 -61.13 4.01 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.706 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 68.9 m . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.762 -0.637 . . . . 0.0 110.229 176.299 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 1.631 ' HD2' ' CD1' ' A' ' 1' ' ' PHE . 96.5 m-85 . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.513 ' OE1' ' HB3' ' A' ' 95' ' ' ASP . 8.2 tt0 65.8 105.28 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.918 0.761 . . . . 0.0 112.019 177.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.3 -1.05 61.04 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.506 175.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.411 ' HA ' ' HE2' ' A' ' 7' ' ' MET . . . -79.58 56.74 2.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.272 0.558 . . . . 0.0 111.276 -179.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 66.4 mtt -97.78 -69.44 0.76 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.844 177.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.73 111.1 21.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.714 177.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.411 ' HE2' ' HA ' ' A' ' 4' ' ' ALA . 0.0 OUTLIER -99.89 154.68 18.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.962 178.045 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 1.661 ' HE2' ' CE1' ' A' ' 8' ' ' PHE . 70.1 t80 -67.95 142.93 55.85 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.079 0.466 . . . . 0.0 112.124 -177.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.553 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 88.2 t90 -134.93 148.1 49.96 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.19 177.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.75 153.08 24.71 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.482 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.553 ' HB2' ' CH2' ' A' ' 9' ' ' TRP . 41.7 tp -144.18 109.94 5.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.81 0.338 . . . . 0.0 110.35 177.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -96.55 96.78 8.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.847 0.356 . . . . 0.0 110.078 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.679 ' SD ' HD12 ' A' ' 87' ' ' LEU . 62.6 mtp -92.98 144.1 25.59 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.941 -173.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -101.17 166.97 11.43 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.163 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.43 ' HB3' ' HA ' ' A' ' 82' ' ' ASP . 87.2 Cg_exo -49.84 115.69 1.98 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.737 2.292 . . . . 0.0 112.799 176.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 79' ' ' THR . 29.1 mt-10 63.31 39.5 9.44 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.29 0.566 . . . . 0.0 111.328 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 78' ' ' TYR . 0.5 OUTLIER -88.12 133.47 33.99 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.038 175.42 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.564 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 33.9 ttmt -123.31 116.09 22.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.122 0.487 . . . . 0.0 111.074 -178.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.474 ' CE2' HD12 ' A' ' 11' ' ' LEU . 18.3 m-85 -107.11 102.59 11.92 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.591 178.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.0 p -90.11 97.2 11.05 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 169.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -117.09 145.46 43.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.508 0.67 . . . . 0.0 112.48 -165.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.7 m -97.62 132.93 42.82 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.011 174.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.409 ' CD1' ' HB3' ' A' ' 69' ' ' PHE . 70.3 mt -87.77 118.08 32.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-O 121.127 0.489 . . . . 0.0 110.987 -173.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.489 HD12 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -90.09 -18.05 7.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.057 -179.476 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -155.12 129.2 8.82 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.101 -175.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.7 p -58.63 127.41 32.05 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.411 0.445 . . . . 0.0 110.652 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 1.615 ' HE1' ' CE2' ' A' ' 27' ' ' PHE . 10.4 p90 -143.68 166.34 25.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.693 0.758 . . . . 0.0 112.748 -174.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.529 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 4.8 t60 -121.8 127.4 50.55 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.421 178.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.576 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 47.3 mt -94.55 135.22 29.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.529 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 56.0 p -119.85 -13.51 9.06 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -169.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -164.09 141.54 7.17 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 119.452 -1.356 . . . . 0.0 113.403 177.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.412 ' O ' HG11 ' A' ' 32' ' ' VAL . 11.9 p -126.93 120.65 56.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 169.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.14 157.25 45.54 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 121.947 -0.471 . . . . 0.0 111.65 -174.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.477 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 4.6 pp -127.14 145.51 50.72 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.769 0.795 . . . . 0.0 111.237 178.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -110.21 -47.06 3.35 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.29 173.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -102.68 128.16 49.5 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.312 173.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.507 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 141.54 161.37 8.69 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 119.451 -1.357 . . . . 0.0 113.857 176.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -102.72 -43.98 5.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.681 0.276 . . . . 0.0 110.971 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -151.78 125.68 9.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.17 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.429 ' HB1' HG11 ' A' ' 56' ' ' VAL . . . -127.79 113.04 15.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.46 0.647 . . . . 0.0 109.699 168.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 79' ' ' THR . 56.0 mtpt -99.54 106.13 18.1 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 178.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.2 tp -79.11 108.77 12.84 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.819 -173.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -107.86 141.02 40.09 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.295 176.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.547 ' CD1' ' HB ' ' A' ' 75' ' ' ILE . 4.4 tp -124.48 116.38 22.42 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.082 176.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -101.78 104.21 14.98 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 174.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.425 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -127.08 136.44 52.17 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.4 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 56.38 35.99 26.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.371 0.605 . . . . 0.0 110.247 -175.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 61.36 39.7 15.01 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.123 178.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.542 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 8.5 tp-100 -134.63 128.09 32.45 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 175.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -85.28 105.72 16.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.937 0.398 . . . . 0.0 110.399 -178.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 1.617 ' HE2' ' CE1' ' A' ' 51' ' ' TYR . 74.0 m-85 -100.13 131.29 46.16 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.461 177.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 tp -79.8 108.74 13.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 168.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.521 HG11 ' CD2' ' E' ' 88' ' ' LEU . 2.3 t -82.52 -51.32 14.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.578 -172.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.439 ' HB2' HG12 ' A' ' 63' ' ' VAL . . . -156.3 145.61 20.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.067 -178.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.6 m -109.21 101.77 10.77 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 173.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.429 HG11 ' HB1' ' A' ' 40' ' ' ALA . 7.4 p -115.5 114.93 47.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.534 0.683 . . . . 0.0 109.765 -177.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.5 p -122.93 -178.26 3.9 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.415 -174.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -63.92 -22.43 66.92 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.028 0.442 . . . . 0.0 110.271 171.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.432 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -83.95 -40.5 18.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.278 177.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.9 mt -112.38 81.63 4.13 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 173.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 12.2 Cg_exo -70.19 0.15 6.4 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.219 2.613 . . . . 0.0 113.972 -166.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -163.83 129.59 3.04 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.161 0.505 . . . . 0.0 111.464 -175.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.439 HG12 ' HB2' ' A' ' 54' ' ' ALA . 66.0 t -119.01 99.94 8.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.24 173.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.21 117.12 21.47 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 173.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.17 168.1 20.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.933 0.397 . . . . 0.0 110.994 -171.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 11.9 t0 -112.45 104.58 12.71 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.341 0.591 . . . . 0.0 110.077 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.576 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 11.1 mt -117.31 141.11 48.71 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.039 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -142.04 132.38 25.02 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.804 0.335 . . . . 0.0 110.7 174.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.469 ' CZ ' HD21 ' A' ' 67' ' ' LEU . 58.7 m-85 -129.92 160.56 33.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.009 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.4 t -120.08 158.78 26.14 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -79.44 9.09 5.16 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.865 0.364 . . . . 0.0 111.104 -175.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.21 -29.38 9.0 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 174.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -100.38 165.88 11.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.016 0.436 . . . . 0.0 110.737 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -135.76 143.46 45.29 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.547 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 25.0 pt -135.71 159.22 39.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.145 0.497 . . . . 0.0 112.27 -168.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.438 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 10.9 mtp -115.0 117.5 30.76 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.703 173.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.503 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -104.23 126.95 51.76 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.127 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.564 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 23.2 p90 -152.2 134.67 15.28 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.935 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 2.4 p -107.83 120.05 41.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.332 -177.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.27 160.95 15.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.672 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.47 -170.51 31.24 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -177.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.43 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 18.9 t70 -116.9 103.47 10.33 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 117.868 0.834 . . . . 0.0 109.983 176.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.507 ' CB ' ' HA3' ' A' ' 37' ' ' GLY . . . -173.31 158.69 3.62 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.736 172.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.4 t -117.74 122.44 43.47 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.477 ' CG1' ' HB3' ' A' ' 34' ' ' LEU . 4.9 m -115.84 156.07 17.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.529 0.68 . . . . 0.0 112.408 -172.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -119.07 117.19 28.07 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.038 173.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.679 HD12 ' SD ' ' A' ' 13' ' ' MET . 5.1 mp -91.68 147.05 23.28 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 171.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.52 ' CD2' HG11 ' B' ' 53' ' ' VAL . 0.7 OUTLIER -130.75 142.53 50.41 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.756 179.585 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.89 -167.97 27.34 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.106 -178.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -145.44 130.29 18.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.742 0.782 . . . . 0.0 112.132 178.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.2 mt -71.68 113.55 8.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.328 -1.305 . . . . 0.0 109.46 173.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -100.97 117.52 35.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.095 0.474 . . . . 0.0 110.74 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -98.44 -53.99 3.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.692 176.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 60.2 mt 64.65 88.5 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.264 177.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.513 ' HB3' ' OE1' ' A' ' 2' ' ' GLN . 30.0 t70 -127.02 134.47 50.32 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.829 178.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.2 m -96.6 27.45 3.86 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.944 0.402 . . . . 0.0 111.01 -177.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -80.05 78.86 1.76 Allowed Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.984 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.8 p . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.582 -0.723 . . . . 0.0 110.354 178.913 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 1.651 ' HD2' ' CD1' ' B' ' 1' ' ' PHE . 96.2 m-85 . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . 0.513 ' OE1' ' HB3' ' B' ' 95' ' ' ASP . 8.2 tt0 65.9 105.22 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 O-C-N 123.947 0.779 . . . . 0.0 112.063 177.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.32 -1.09 60.99 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.418 175.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.42 ' HA ' ' HE2' ' B' ' 7' ' ' MET . . . -79.47 56.77 2.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.288 0.566 . . . . 0.0 111.311 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 66.4 mtt -97.81 -69.42 0.76 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.852 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.74 111.15 21.73 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.733 177.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' MET . . . . . 0.42 ' HE2' ' HA ' ' B' ' 4' ' ' ALA . 0.0 OUTLIER -99.93 154.75 18.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.941 178.073 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 1.655 ' HD1' ' CD2' ' B' ' 8' ' ' PHE . 69.8 t80 -68.08 143.0 55.65 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.036 0.446 . . . . 0.0 112.043 -177.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . 0.545 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 88.1 t90 -134.97 148.01 49.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.112 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.67 153.09 24.73 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.461 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.545 ' HB2' ' CH2' ' B' ' 9' ' ' TRP . 41.6 tp -144.13 109.9 5.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.764 0.316 . . . . 0.0 110.457 177.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -96.56 96.83 8.93 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' MET . . . . . 0.679 ' SD ' HD12 ' B' ' 87' ' ' LEU . 62.4 mtp -93.0 144.14 25.55 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.015 -173.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -101.28 167.01 11.32 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.162 177.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.414 ' HB3' ' HA ' ' B' ' 82' ' ' ASP . 86.5 Cg_exo -49.84 115.68 1.97 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.785 2.324 . . . . 0.0 112.723 176.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' B' ' 79' ' ' THR . 29.0 mt-10 63.27 39.65 9.39 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.285 0.564 . . . . 0.0 111.254 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' B' ' 78' ' ' TYR . 0.5 OUTLIER -88.16 133.5 34.0 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.342 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . 0.556 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 33.8 ttmt -123.34 116.12 22.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.167 0.508 . . . . 0.0 111.086 -178.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' TYR . . . . . 0.469 ' CE2' HD12 ' B' ' 11' ' ' LEU . 18.6 m-85 -107.09 102.54 11.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.565 178.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 10.9 p -90.03 97.21 11.06 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 169.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.13 145.54 43.75 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.489 0.661 . . . . 0.0 112.457 -165.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 21.4 m -97.77 132.86 43.01 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.949 174.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.411 ' CD1' ' HB3' ' B' ' 69' ' ' PHE . 70.0 mt -87.73 117.99 32.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.12 0.486 . . . . 0.0 111.074 -173.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.487 ' H ' HD12 ' B' ' 24' ' ' ILE . 0.2 OUTLIER -90.04 -18.02 7.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.069 -179.426 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -155.18 129.14 8.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.097 -175.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 6.9 p -58.55 127.38 31.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.683 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . 1.636 ' HE2' ' CE1' ' B' ' 27' ' ' PHE . 10.2 p90 -143.66 166.37 25.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.691 0.758 . . . . 0.0 112.687 -174.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' HIS . . . . . 0.533 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 4.8 t60 -121.87 127.44 50.49 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.256 -1.338 . . . . 0.0 109.353 178.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.567 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 47.2 mt -94.59 135.3 29.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 171.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.533 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 55.9 p -119.82 -13.65 9.06 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -169.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -164.07 141.5 7.15 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 119.373 -1.394 . . . . 0.0 113.385 177.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.409 HG11 ' O ' ' B' ' 32' ' ' VAL . 11.8 p -126.91 120.72 56.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 169.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.19 157.19 45.6 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.605 -173.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.484 ' HB3' HG13 ' B' ' 85' ' ' VAL . 4.6 pp -127.1 145.62 50.67 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.696 0.76 . . . . 0.0 111.279 178.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -110.27 -46.94 3.36 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.27 173.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -102.68 128.15 49.5 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.257 173.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.502 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 141.51 161.3 8.66 Favored Glycine 0 N--CA 1.438 -1.189 0 C-N-CA 119.488 -1.339 . . . . 0.0 113.886 176.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -102.64 -44.09 5.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.62 -0.29 . . . . 0.0 110.929 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -151.73 125.71 9.16 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.201 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.434 ' HB1' HG11 ' B' ' 56' ' ' VAL . . . -127.79 113.14 15.58 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.44 0.638 . . . . 0.0 109.632 168.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' B' ' 79' ' ' THR . 56.0 mtpt -99.66 106.11 18.02 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 46.6 tp -79.22 108.83 13.02 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.753 -173.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -107.85 140.93 40.21 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.293 176.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.544 ' CD1' ' HB ' ' B' ' 75' ' ' ILE . 4.4 tp -124.4 116.44 22.57 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.115 176.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -101.83 104.25 15.0 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 174.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . 0.421 ' HB3' HD12 ' B' ' 44' ' ' LEU . . . -127.12 136.45 52.14 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.351 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 56.37 35.99 26.78 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 123.592 0.557 . . . . 0.0 110.175 -175.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 61.47 39.53 14.88 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 114.816 -1.083 . . . . 0.0 112.165 178.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.541 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 8.6 tp-100 -134.58 128.03 32.41 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 175.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -85.2 105.65 16.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.902 0.382 . . . . 0.0 110.429 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 1.624 ' HE1' ' CE2' ' B' ' 51' ' ' TYR . 73.9 m-85 -100.07 131.23 46.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.46 177.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 tp -79.67 108.72 13.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 168.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.52 HG11 ' CD2' ' A' ' 88' ' ' LEU . 2.3 t -82.59 -51.22 15.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.576 -172.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.419 ' HB2' HG12 ' B' ' 63' ' ' VAL . . . -156.33 145.57 20.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.079 -178.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 32.2 m -109.18 101.78 10.79 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 173.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . 0.434 HG11 ' HB1' ' B' ' 40' ' ' ALA . 7.4 p -115.53 114.88 47.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.495 0.664 . . . . 0.0 109.744 -177.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 64.1 p -122.87 -178.31 3.91 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.428 -174.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -63.83 -22.52 66.95 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.047 0.451 . . . . 0.0 110.244 171.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.425 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -83.89 -40.51 18.51 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.194 0.521 . . . . 0.0 110.235 177.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.4 81.56 4.11 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 173.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 12.1 Cg_exo -70.16 0.15 6.38 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.126 2.55 . . . . 0.0 113.954 -166.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -163.78 129.6 3.06 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.163 0.506 . . . . 0.0 111.378 -175.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.419 HG12 ' HB2' ' B' ' 54' ' ' ALA . 66.6 t -119.06 99.93 8.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.24 173.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.15 117.15 21.46 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 173.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' B' ' 30' ' ' SER . 0.9 OUTLIER -139.05 168.15 20.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.95 0.405 . . . . 0.0 111.065 -171.186 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . 0.504 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 12.1 t0 -112.4 104.52 12.66 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.262 0.553 . . . . 0.0 110.122 -178.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.567 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 11.0 mt -117.28 141.14 48.67 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.019 178.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.04 132.49 25.18 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.66 174.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . 0.465 ' CZ ' HD21 ' B' ' 67' ' ' LEU . 58.7 m-85 -130.02 160.55 33.33 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.985 178.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 18.5 t -120.18 158.78 26.23 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -79.4 9.11 5.11 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.966 0.412 . . . . 0.0 111.094 -175.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.32 -29.25 9.04 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 174.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -100.51 165.75 11.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.108 0.48 . . . . 0.0 110.698 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -135.68 143.36 45.39 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.233 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.544 ' HB ' ' CD1' ' B' ' 44' ' ' LEU . 25.0 pt -135.58 159.24 40.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.171 0.51 . . . . 0.0 112.216 -168.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' MET . . . . . 0.433 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 10.9 mtp -114.94 117.5 30.82 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.632 173.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . 0.499 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -104.25 126.97 51.8 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 175.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 0.556 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 23.2 p90 -152.21 134.65 15.25 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.311 -0.555 . . . . 0.0 111.999 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 2.5 p -107.79 120.04 41.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.345 -177.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.27 161.03 15.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.636 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.46 -170.68 31.41 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -177.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' ASP . . . . . 0.414 ' HA ' ' HB3' ' B' ' 15' ' ' PRO . 19.0 t70 -116.87 103.56 10.43 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.917 176.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.502 ' CB ' ' HA3' ' B' ' 37' ' ' GLY . . . -173.37 158.73 3.59 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.815 172.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 25.8 t -117.82 122.33 43.11 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.484 HG13 ' HB3' ' B' ' 34' ' ' LEU . 4.9 m -115.83 156.06 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-O 121.529 0.681 . . . . 0.0 112.445 -172.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 50.1 m -119.07 117.32 28.42 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.008 173.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.679 HD12 ' SD ' ' B' ' 13' ' ' MET . 5.1 mp -91.73 147.0 23.31 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 171.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.524 ' CD2' HG11 ' C' ' 53' ' ' VAL . 0.7 OUTLIER -130.84 142.51 50.39 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.959 -1.018 . . . . 0.0 108.748 179.582 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.9 -167.96 27.34 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.036 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -145.45 130.23 18.13 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.775 0.797 . . . . 0.0 112.056 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 18.1 mt -71.6 113.48 8.68 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.255 -1.339 . . . . 0.0 109.396 173.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -100.96 117.48 35.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.122 0.487 . . . . 0.0 110.794 -178.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -98.36 -53.95 3.19 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.753 176.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 59.7 mt 64.58 88.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.314 177.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . 0.513 ' HB3' ' OE1' ' B' ' 2' ' ' GLN . 29.9 t70 -126.89 134.63 50.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.777 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 18.9 m -96.68 27.49 3.88 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.073 0.463 . . . . 0.0 111.041 -177.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . -80.22 78.97 1.77 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.04 178.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 10.7 p . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.444 -0.789 . . . . 0.0 110.357 178.976 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' 1' ' ' PHE . . . . . 1.645 ' HD2' ' CD1' ' C' ' 1' ' ' PHE . 96.3 m-85 . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . 0.511 ' OE1' ' HB3' ' C' ' 95' ' ' ASP . 8.2 tt0 65.57 105.38 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.985 0.803 . . . . 0.0 112.086 177.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.36 -1.12 60.9 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.431 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . 0.418 ' HA ' ' HE2' ' C' ' 7' ' ' MET . . . -79.45 56.78 2.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.273 0.559 . . . . 0.0 111.287 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 66.5 mtt -97.92 -69.36 0.76 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.804 177.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.76 111.05 21.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.772 177.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 7' ' ' MET . . . . . 0.418 ' HE2' ' HA ' ' C' ' 4' ' ' ALA . 0.0 OUTLIER -99.9 154.64 18.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.967 178.103 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 8' ' ' PHE . . . . . 1.664 ' HE1' ' CE2' ' C' ' 8' ' ' PHE . 70.0 t80 -67.88 142.95 55.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.039 0.447 . . . . 0.0 112.068 -177.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . 0.55 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 88.2 t90 -135.07 148.09 49.77 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.71 153.05 24.7 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.415 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.55 ' HB2' ' CH2' ' C' ' 9' ' ' TRP . 41.6 tp -144.13 109.95 5.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.773 0.32 . . . . 0.0 110.429 177.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -96.55 96.84 8.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.92 0.391 . . . . 0.0 110.11 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 13' ' ' MET . . . . . 0.689 ' SD ' HD12 ' C' ' 87' ' ' LEU . 62.7 mtp -93.05 144.11 25.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.001 -173.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -101.2 167.01 11.35 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.154 177.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . 0.429 ' HB3' ' HA ' ' C' ' 82' ' ' ASP . 88.0 Cg_exo -49.8 115.68 1.96 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.731 2.288 . . . . 0.0 112.818 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' C' ' 79' ' ' THR . 29.1 mt-10 63.19 39.66 9.55 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.432 0.634 . . . . 0.0 111.36 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 17' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' C' ' 78' ' ' TYR . 0.5 OUTLIER -88.15 133.41 34.02 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.431 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 18' ' ' LYS . . . . . 0.561 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 33.9 ttmt -123.21 116.13 22.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.047 0.451 . . . . 0.0 111.109 -178.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . 0.472 ' CE2' HD12 ' C' ' 11' ' ' LEU . 18.8 m-85 -107.2 102.61 11.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.536 178.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 10.9 p -90.04 97.14 11.02 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 169.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.08 145.51 43.71 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.535 0.683 . . . . 0.0 112.55 -165.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 21.7 m -97.65 132.95 42.83 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.691 -1.141 . . . . 0.0 108.964 174.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . 0.412 ' CD1' ' HB3' ' C' ' 69' ' ' PHE . 70.4 mt -87.85 118.15 33.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.206 0.527 . . . . 0.0 110.995 -173.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . 0.489 HD12 ' H ' ' C' ' 24' ' ' ILE . 0.2 OUTLIER -90.14 -17.99 7.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.092 -179.456 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -155.15 129.22 8.81 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.103 -175.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 6.6 p -58.62 127.47 32.32 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.696 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 27' ' ' PHE . . . . . 1.642 ' HE2' ' CE1' ' C' ' 27' ' ' PHE . 10.2 p90 -143.64 166.42 24.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.633 0.73 . . . . 0.0 112.774 -174.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 28' ' ' HIS . . . . . 0.541 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 4.8 t60 -121.94 127.47 50.42 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.291 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . 0.584 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 47.6 mt -94.57 135.3 29.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 171.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 30' ' ' SER . . . . . 0.541 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 55.8 p -119.87 -13.53 9.05 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -169.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -164.09 141.46 7.12 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 119.372 -1.394 . . . . 0.0 113.329 177.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.421 ' O ' HG11 ' C' ' 32' ' ' VAL . 11.8 p -126.95 120.69 56.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 169.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.16 157.23 45.56 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.886 -0.509 . . . . 0.0 111.647 -173.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.485 ' HB3' HG13 ' C' ' 85' ' ' VAL . 4.6 pp -127.14 145.52 50.72 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.656 0.741 . . . . 0.0 111.284 178.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -110.32 -46.89 3.36 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.251 173.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -102.62 128.12 49.44 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.259 173.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 37' ' ' GLY . . . . . 0.51 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 141.64 161.36 8.7 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 119.446 -1.359 . . . . 0.0 113.888 176.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -102.71 -44.1 5.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.753 0.311 . . . . 0.0 110.973 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -151.73 125.71 9.16 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.119 -177.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . 0.423 ' HB1' HG11 ' C' ' 56' ' ' VAL . . . -127.77 113.02 15.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.376 0.608 . . . . 0.0 109.655 168.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' C' ' 79' ' ' THR . 56.0 mtpt -99.56 106.11 18.06 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 46.5 tp -79.18 108.8 12.95 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.803 -173.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -107.83 141.0 40.08 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.339 176.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.538 ' CD1' ' HB ' ' C' ' 75' ' ' ILE . 4.4 tp -124.46 116.4 22.45 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.098 176.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -101.77 104.22 15.0 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 174.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . 0.41 ' HB3' HD12 ' C' ' 44' ' ' LEU . . . -127.08 136.42 52.14 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.367 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 56.31 36.01 26.78 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.642 0.589 . . . . 0.0 110.215 -175.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 61.5 39.59 14.71 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.087 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . 0.535 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 8.5 tp-100 -134.67 127.94 32.06 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 175.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -85.15 105.74 16.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.854 0.359 . . . . 0.0 110.444 -178.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 1.642 ' HE2' ' CE1' ' C' ' 51' ' ' TYR . 74.2 m-85 -100.18 131.26 46.23 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.436 177.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 tp -79.78 108.74 13.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 168.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 53' ' ' VAL . . . . . 0.524 HG11 ' CD2' ' B' ' 88' ' ' LEU . 2.3 t -82.5 -51.25 15.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.642 -172.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 54' ' ' ALA . . . . . 0.434 ' HB2' HG12 ' C' ' 63' ' ' VAL . . . -156.29 145.58 20.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.006 -178.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 31.9 m -109.28 101.82 10.79 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 173.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . 0.423 HG11 ' HB1' ' C' ' 40' ' ' ALA . 7.4 p -115.57 114.91 47.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.533 0.682 . . . . 0.0 109.695 -177.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 64.2 p -123.03 -178.33 3.93 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.337 -174.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -63.83 -22.51 66.95 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.112 0.482 . . . . 0.0 110.227 171.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . 0.432 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -83.87 -40.56 18.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.237 177.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 78.0 mt -112.34 81.57 4.05 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 173.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 61' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 12.1 Cg_exo -70.07 -0.0 6.53 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.142 2.562 . . . . 0.0 114.025 -166.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -163.73 129.62 3.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.185 0.517 . . . . 0.0 111.52 -175.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.434 HG12 ' HB2' ' C' ' 54' ' ' ALA . 66.1 t -119.07 100.01 8.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.219 173.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.22 117.01 21.39 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 173.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.01 168.09 20.6 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.952 0.406 . . . . 0.0 111.087 -171.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 66' ' ' ASP . . . . . 0.509 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 12.1 t0 -112.39 104.6 12.75 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.315 0.579 . . . . 0.0 110.132 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . 0.584 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 11.1 mt -117.3 141.22 48.57 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.048 178.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -142.11 132.47 25.04 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.641 174.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 69' ' ' PHE . . . . . 0.463 ' CZ ' HD21 ' C' ' 67' ' ' LEU . 59.1 m-85 -130.03 160.61 33.16 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.932 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 18.3 t -120.12 158.8 26.13 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -79.45 9.08 5.19 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.979 0.419 . . . . 0.0 111.083 -175.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.26 -29.23 9.08 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 174.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -100.5 165.8 11.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.966 0.413 . . . . 0.0 110.784 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -135.71 143.49 45.41 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . 0.538 ' HB ' ' CD1' ' C' ' 44' ' ' LEU . 24.9 pt -135.67 159.14 39.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.12 0.486 . . . . 0.0 112.305 -168.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 76' ' ' MET . . . . . 0.441 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 10.8 mtp -114.88 117.51 30.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.764 173.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 77' ' ' PHE . . . . . 0.496 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.6 OUTLIER -104.16 126.89 51.64 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 176.104 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 78' ' ' TYR . . . . . 0.561 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 23.4 p90 -152.19 134.63 15.25 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.969 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 79' ' ' THR . . . . . 0.52 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 2.4 p -107.8 120.01 41.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.352 -177.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.24 160.92 15.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.613 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.6 -170.54 31.08 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 82' ' ' ASP . . . . . 0.429 ' HA ' ' HB3' ' C' ' 15' ' ' PRO . 19.0 t70 -116.91 103.49 10.34 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.955 176.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . 0.51 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -173.31 158.79 3.64 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.794 172.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 25.6 t -117.88 122.38 43.18 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.485 HG13 ' HB3' ' C' ' 34' ' ' LEU . 5.0 m -115.74 156.1 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-O 121.453 0.644 . . . . 0.0 112.464 -172.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 50.3 m -119.08 117.31 28.38 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.045 173.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . 0.689 HD12 ' SD ' ' C' ' 13' ' ' MET . 5.1 mp -91.76 146.97 23.34 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 171.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . 0.539 ' CD2' HG11 ' D' ' 53' ' ' VAL . 0.7 OUTLIER -130.74 142.47 50.41 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.796 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.89 -168.0 27.39 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.082 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -145.4 130.24 18.18 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.741 0.781 . . . . 0.0 112.158 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 18.1 mt -71.63 113.61 8.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.321 -1.308 . . . . 0.0 109.415 173.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -101.05 117.48 35.11 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.203 0.525 . . . . 0.0 110.731 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -98.38 -54.01 3.17 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.691 176.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 59.7 mt 64.62 88.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.297 177.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 95' ' ' ASP . . . . . 0.511 ' HB3' ' OE1' ' C' ' 2' ' ' GLN . 30.0 t70 -126.95 134.58 50.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.739 178.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 18.7 m -96.73 27.45 3.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.037 0.446 . . . . 0.0 110.996 -177.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -80.14 78.97 1.76 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.962 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 10.9 p . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.524 -0.75 . . . . 0.0 110.313 178.902 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . 1.615 ' HD2' ' CD1' ' D' ' 1' ' ' PHE . 96.6 m-85 . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . 0.495 ' OE1' ' HB3' ' D' ' 95' ' ' ASP . 8.2 tt0 65.65 105.39 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 O-C-N 123.886 0.741 . . . . 0.0 111.996 177.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.43 -0.95 60.86 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.492 175.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 4' ' ' ALA . . . . . 0.411 ' HA ' ' HE2' ' D' ' 7' ' ' MET . . . -79.62 56.74 2.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.314 0.578 . . . . 0.0 111.3 -179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 66.4 mtt -97.69 -69.42 0.76 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.864 177.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.77 111.19 21.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.671 177.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 7' ' ' MET . . . . . 0.411 ' HE2' ' HA ' ' D' ' 4' ' ' ALA . 0.0 OUTLIER -100.09 154.65 18.25 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.837 178.118 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 8' ' ' PHE . . . . . 1.669 ' HD1' ' CD2' ' D' ' 8' ' ' PHE . 70.4 t80 -67.93 142.96 55.86 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.17 0.509 . . . . 0.0 112.063 -177.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 9' ' ' TRP . . . . . 0.549 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 88.2 t90 -135.03 147.97 49.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.133 177.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.6 153.2 24.8 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.455 179.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . 0.549 ' HB2' ' CH2' ' D' ' 9' ' ' TRP . 41.7 tp -144.19 109.95 5.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.751 0.31 . . . . 0.0 110.392 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -96.55 96.74 8.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.921 0.391 . . . . 0.0 110.102 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 13' ' ' MET . . . . . 0.668 ' SD ' HD12 ' D' ' 87' ' ' LEU . 62.7 mtp -93.05 144.24 25.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.961 -173.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -101.24 167.0 11.35 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.174 177.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . 0.418 ' HB3' ' HA ' ' D' ' 82' ' ' ASP . 86.9 Cg_exo -49.86 115.61 1.93 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.8 2.334 . . . . 0.0 112.74 176.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' D' ' 79' ' ' THR . 29.1 mt-10 63.37 39.53 9.26 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.326 0.584 . . . . 0.0 111.299 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 17' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' D' ' 78' ' ' TYR . 0.5 OUTLIER -88.04 133.44 33.97 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.383 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . 0.577 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 33.9 ttmt -123.26 116.13 22.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.199 0.524 . . . . 0.0 111.077 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 19' ' ' TYR . . . . . 0.474 ' CE2' HD12 ' D' ' 11' ' ' LEU . 18.8 m-85 -107.11 102.46 11.79 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.595 178.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 11.0 p -89.97 97.18 11.04 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 169.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.07 145.5 43.7 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.556 0.693 . . . . 0.0 112.483 -165.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 21.5 m -97.71 132.83 42.98 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.99 174.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . 0.411 ' CD1' ' HB3' ' D' ' 69' ' ' PHE . 70.3 mt -87.68 118.08 32.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.11 0.481 . . . . 0.0 111.093 -173.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . 0.495 HD12 ' H ' ' D' ' 24' ' ' ILE . 0.2 OUTLIER -90.09 -18.02 7.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.097 -179.422 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -155.16 129.12 8.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.085 -175.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 6.8 p -58.49 127.46 32.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.689 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 27' ' ' PHE . . . . . 1.671 ' HE1' ' CE2' ' D' ' 27' ' ' PHE . 10.3 p90 -143.73 166.36 25.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.721 0.772 . . . . 0.0 112.727 -174.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 28' ' ' HIS . . . . . 0.539 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 4.7 t60 -121.93 127.42 50.39 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.285 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 29' ' ' ILE . . . . . 0.581 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 47.4 mt -94.5 135.33 29.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 171.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 30' ' ' SER . . . . . 0.539 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 55.9 p -119.96 -13.43 9.03 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -169.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 31' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -164.14 141.5 7.14 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 119.431 -1.366 . . . . 0.0 113.354 177.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . 0.415 HG11 ' O ' ' D' ' 32' ' ' VAL . 11.8 p -126.97 120.69 56.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 169.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.17 157.21 45.58 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 121.95 -0.469 . . . . 0.0 111.589 -173.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 34' ' ' LEU . . . . . 0.488 ' HB3' HG13 ' D' ' 85' ' ' VAL . 4.6 pp -127.11 145.56 50.7 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.682 0.753 . . . . 0.0 111.254 178.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -110.34 -46.91 3.35 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.761 -1.108 . . . . 0.0 108.24 173.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -102.61 128.14 49.42 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.279 173.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . 0.513 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 141.6 161.4 8.72 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 119.459 -1.353 . . . . 0.0 113.814 176.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -102.77 -44.06 5.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.616 -0.292 . . . . 0.0 110.975 177.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -151.71 125.71 9.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.204 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . 0.434 ' HB1' HG11 ' D' ' 56' ' ' VAL . . . -127.82 113.08 15.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.443 0.639 . . . . 0.0 109.724 168.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' D' ' 79' ' ' THR . 56.0 mtpt -99.58 106.06 18.0 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 46.4 tp -79.12 108.72 12.82 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.814 -173.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -107.77 140.98 40.03 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.363 176.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.54 ' CD1' ' HB ' ' D' ' 75' ' ' ILE . 4.4 tp -124.41 116.47 22.6 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.14 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 45' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -101.84 104.18 14.92 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 174.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . 0.422 ' HB3' HD12 ' D' ' 44' ' ' LEU . . . -127.08 136.4 52.1 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.403 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 56.41 35.91 26.68 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.383 0.611 . . . . 0.0 110.25 -175.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 61.61 39.44 14.53 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.117 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . 0.544 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 8.5 tp-100 -134.57 127.95 32.29 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 175.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -85.15 105.71 16.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.88 0.371 . . . . 0.0 110.456 -178.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . 1.657 ' HE2' ' CE1' ' D' ' 51' ' ' TYR . 74.0 m-85 -100.1 131.28 46.14 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.44 177.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 tp -79.73 108.82 13.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 168.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 53' ' ' VAL . . . . . 0.539 HG11 ' CD2' ' C' ' 88' ' ' LEU . 2.3 t -82.69 -51.2 14.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.575 -172.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 54' ' ' ALA . . . . . 0.432 ' HB2' HG12 ' D' ' 63' ' ' VAL . . . -156.34 145.56 20.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.076 -178.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 31.9 m -109.2 101.8 10.8 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 173.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 56' ' ' VAL . . . . . 0.434 HG11 ' HB1' ' D' ' 40' ' ' ALA . 7.4 p -115.57 114.93 47.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.483 0.659 . . . . 0.0 109.701 -177.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 63.1 p -122.95 -178.31 3.91 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.433 -174.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -63.78 -22.48 66.93 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.992 0.425 . . . . 0.0 110.321 171.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 59' ' ' ALA . . . . . 0.431 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -83.91 -40.71 18.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.143 177.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 78.2 mt -112.24 81.54 3.94 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 173.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 61' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 12.1 Cg_exo -70.14 0.14 6.37 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.163 2.575 . . . . 0.0 114.007 -166.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -163.85 129.58 3.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.085 0.469 . . . . 0.0 111.432 -175.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.432 HG12 ' HB2' ' D' ' 54' ' ' ALA . 66.8 t -119.03 99.93 8.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.176 173.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.14 117.06 21.37 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 173.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 65' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' D' ' 30' ' ' SER . 0.9 OUTLIER -139.05 168.13 20.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.865 0.364 . . . . 0.0 111.098 -171.129 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 66' ' ' ASP . . . . . 0.487 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 12.2 t0 -112.44 104.48 12.61 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.354 0.597 . . . . 0.0 110.181 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . 0.581 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 11.1 mt -117.31 141.18 48.62 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.985 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.04 132.48 25.17 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.583 174.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 69' ' ' PHE . . . . . 0.469 ' CZ ' HD21 ' D' ' 67' ' ' LEU . 59.0 m-85 -130.01 160.63 33.07 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.97 178.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 18.3 t -120.21 158.73 26.38 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -79.34 9.11 5.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.846 0.355 . . . . 0.0 111.103 -175.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.34 -29.21 9.05 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 174.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -100.42 165.82 11.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.044 0.449 . . . . 0.0 110.746 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -135.74 143.49 45.35 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . 0.54 ' HB ' ' CD1' ' D' ' 44' ' ' LEU . 24.7 pt -135.72 159.2 39.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.211 0.529 . . . . 0.0 112.25 -168.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 76' ' ' MET . . . . . 0.439 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 10.9 mtp -114.95 117.41 30.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.801 173.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 77' ' ' PHE . . . . . 0.493 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.6 OUTLIER -104.19 126.95 51.71 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.134 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 78' ' ' TYR . . . . . 0.577 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 23.1 p90 -152.22 134.66 15.25 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.886 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 79' ' ' THR . . . . . 0.524 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 2.4 p -107.85 119.96 40.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.297 -177.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.23 160.88 15.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.619 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.61 -170.51 31.05 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 110.656 -0.977 . . . . 0.0 110.656 -177.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 82' ' ' ASP . . . . . 0.418 ' HA ' ' HB3' ' D' ' 15' ' ' PRO . 19.0 t70 -116.92 103.45 10.3 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 117.861 0.831 . . . . 0.0 109.951 176.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.513 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -173.38 158.69 3.57 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.744 172.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 26.2 t -117.78 122.37 43.27 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' D' ' 34' ' ' LEU . 5.0 m -115.9 156.11 17.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.491 0.662 . . . . 0.0 112.429 -172.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -119.08 117.16 28.0 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.04 173.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 87' ' ' LEU . . . . . 0.668 HD12 ' SD ' ' D' ' 13' ' ' MET . 5.1 mp -91.69 146.99 23.33 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 171.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . 0.517 ' CD2' HG11 ' E' ' 53' ' ' VAL . 0.7 OUTLIER -130.78 142.52 50.41 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.747 179.617 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.9 -167.98 27.36 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.981 -178.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -145.39 130.26 18.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.734 0.778 . . . . 0.0 112.156 178.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 18.1 mt -71.61 113.51 8.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.469 173.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -100.99 117.53 35.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.143 0.497 . . . . 0.0 110.718 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -98.47 -53.81 3.22 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.713 176.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 59.7 mt 64.54 88.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.259 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 95' ' ' ASP . . . . . 0.495 ' HB3' ' OE1' ' D' ' 2' ' ' GLN . 29.9 t70 -127.03 134.59 50.29 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.722 178.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 18.8 m -96.59 27.34 3.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.973 0.416 . . . . 0.0 110.932 -177.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . -80.16 79.09 1.75 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.972 -0.632 . . . . 0.0 111.963 178.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 10.5 p . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.448 -0.786 . . . . 0.0 110.362 178.942 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' E' E ' 1' ' ' PHE . . . . . 1.606 ' HD2' ' CD1' ' E' ' 1' ' ' PHE . 96.3 m-85 . . . . . 0 N--CA 1.477 0.915 0 N-CA-C 110.348 -0.242 . . . . 0.0 110.348 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 2' ' ' GLN . . . . . 0.513 ' OE1' ' HB3' ' E' ' 95' ' ' ASP . 8.2 tt0 65.77 105.33 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.944 0.778 . . . . 0.0 112.025 176.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.37 -1.09 60.9 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.602 -0.809 . . . . 0.0 111.519 175.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 4' ' ' ALA . . . . . 0.419 ' HA ' ' HE2' ' E' ' 7' ' ' MET . . . -79.51 56.71 2.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.261 0.553 . . . . 0.0 111.339 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 66.5 mtt -97.76 -69.45 0.76 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.776 177.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.71 111.18 21.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.751 177.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 7' ' ' MET . . . . . 0.419 ' HE2' ' HA ' ' E' ' 4' ' ' ALA . 0.0 OUTLIER -99.99 154.6 18.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.913 178.151 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' E' E ' 8' ' ' PHE . . . . . 1.646 ' HE2' ' CE1' ' E' ' 8' ' ' PHE . 70.2 t80 -67.8 142.99 56.02 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.036 0.446 . . . . 0.0 112.071 -177.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 9' ' ' TRP . . . . . 0.542 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 88.2 t90 -135.12 148.04 49.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.118 177.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.69 153.14 24.75 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.448 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . 0.542 ' HB2' ' CH2' ' E' ' 9' ' ' TRP . 41.2 tp -144.1 109.98 5.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.779 0.323 . . . . 0.0 110.455 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -96.59 96.73 8.85 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.908 0.385 . . . . 0.0 110.04 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 13' ' ' MET . . . . . 0.676 ' SD ' HD12 ' E' ' 87' ' ' LEU . 62.7 mtp -92.98 144.14 25.54 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.963 -173.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -101.19 166.91 11.52 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.139 177.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . 0.424 ' HB3' ' HA ' ' E' ' 82' ' ' ASP . 87.9 Cg_exo -49.77 115.61 1.92 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.78 2.32 . . . . 0.0 112.797 176.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 16' ' ' GLU . . . . . 0.519 ' HA ' ' O ' ' E' ' 79' ' ' THR . 29.0 mt-10 63.29 39.65 9.34 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.295 0.569 . . . . 0.0 111.259 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 17' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' E' ' 78' ' ' TYR . 0.5 OUTLIER -88.15 133.43 34.01 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.353 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . 0.557 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 33.9 ttmt -123.21 116.14 22.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.153 0.502 . . . . 0.0 111.036 -178.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . 0.472 ' CE2' HD12 ' E' ' 11' ' ' LEU . 18.7 m-85 -107.1 102.7 12.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.568 177.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 10.9 p -90.22 97.26 11.08 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 169.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.18 145.5 43.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.474 0.654 . . . . 0.0 112.454 -165.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 21.8 m -97.68 132.82 42.97 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.949 174.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 23' ' ' ILE . . . . . 0.418 ' CD1' ' HB3' ' E' ' 69' ' ' PHE . 70.0 mt -87.72 118.06 32.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.085 0.469 . . . . 0.0 111.083 -173.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . 0.483 HD12 ' H ' ' E' ' 24' ' ' ILE . 0.2 OUTLIER -90.11 -17.98 7.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.092 -179.421 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -155.15 129.21 8.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.075 -175.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 7.0 p -58.54 127.4 31.95 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.458 0.474 . . . . 0.0 110.679 -178.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 27' ' ' PHE . . . . . 1.647 ' HE2' ' CE1' ' E' ' 27' ' ' PHE . 10.2 p90 -143.68 166.44 24.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.645 0.736 . . . . 0.0 112.726 -174.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 28' ' ' HIS . . . . . 0.524 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 4.8 t60 -121.9 127.45 50.46 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.36 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 29' ' ' ILE . . . . . 0.581 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 47.6 mt -94.63 135.33 29.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 30' ' ' SER . . . . . 0.524 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 55.0 p -119.94 -13.48 9.03 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -169.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 31' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -164.14 141.48 7.13 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 119.36 -1.4 . . . . 0.0 113.339 177.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . 0.41 HG11 ' O ' ' E' ' 32' ' ' VAL . 11.9 p -126.89 120.71 56.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 169.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.17 157.15 45.66 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.601 -173.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 34' ' ' LEU . . . . . 0.483 ' HB3' HG13 ' E' ' 85' ' ' VAL . 4.6 pp -127.11 145.55 50.7 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.686 0.755 . . . . 0.0 111.179 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -110.22 -47.01 3.35 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.256 173.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -102.64 128.11 49.47 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.294 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . 0.513 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 141.62 161.45 8.74 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 119.566 -1.302 . . . . 0.0 113.886 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -102.76 -44.08 5.39 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.734 0.302 . . . . 0.0 110.952 177.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -151.72 125.74 9.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.168 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . 0.422 ' HB1' HG11 ' E' ' 56' ' ' VAL . . . -127.84 113.1 15.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.422 0.629 . . . . 0.0 109.671 168.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 41' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' E' ' 79' ' ' THR . 56.0 mtpt -99.64 106.07 17.98 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 46.3 tp -79.16 108.77 12.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.792 -173.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -107.83 141.01 40.07 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.303 176.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 44' ' ' LEU . . . . . 0.54 ' CD1' ' HB ' ' E' ' 75' ' ' ILE . 4.4 tp -124.46 116.4 22.47 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.096 176.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 45' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -101.76 104.2 14.97 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 174.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . 0.426 ' HB3' HD12 ' E' ' 44' ' ' LEU . . . -127.12 136.36 52.0 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.387 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 56.53 35.87 26.7 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.657 0.598 . . . . 0.0 110.216 -175.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 61.52 39.49 14.77 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.154 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 49' ' ' GLN . . . . . 0.54 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 8.5 tp-100 -134.56 128.08 32.55 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 175.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -85.22 105.7 16.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.875 0.369 . . . . 0.0 110.381 -178.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . 1.647 ' HE2' ' CE1' ' E' ' 51' ' ' TYR . 74.1 m-85 -100.15 131.21 46.23 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.427 177.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 6.0 tp -79.6 108.74 13.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 168.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . 0.517 HG11 ' CD2' ' D' ' 88' ' ' LEU . 2.3 t -82.64 -51.27 14.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.526 -172.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 54' ' ' ALA . . . . . 0.432 ' HB2' HG12 ' E' ' 63' ' ' VAL . . . -156.32 145.64 20.65 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.012 -178.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 31.9 m -109.19 101.7 10.71 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 173.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . 0.422 HG11 ' HB1' ' E' ' 40' ' ' ALA . 7.4 p -115.51 114.92 47.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.621 0.724 . . . . 0.0 109.724 -177.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 63.2 p -122.87 -178.29 3.9 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.434 -174.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -63.87 -22.46 66.93 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.07 0.462 . . . . 0.0 110.298 171.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 59' ' ' ALA . . . . . 0.435 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -83.96 -40.59 18.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.187 177.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.38 81.53 4.07 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 173.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 61' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 12.0 Cg_exo -70.09 0.13 6.35 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.133 2.556 . . . . 0.0 114.024 -166.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -163.81 129.53 3.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.195 0.521 . . . . 0.0 111.469 -175.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . 0.432 HG12 ' HB2' ' E' ' 54' ' ' ALA . 66.5 t -119.03 100.03 9.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.207 173.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.2 117.09 21.44 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 173.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' E' ' 30' ' ' SER . 0.9 OUTLIER -139.1 168.16 20.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.893 0.378 . . . . 0.0 111.097 -171.168 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' E' E ' 66' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 12.1 t0 -112.39 104.49 12.63 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.3 0.571 . . . . 0.0 110.121 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 67' ' ' LEU . . . . . 0.581 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 11.1 mt -117.31 141.25 48.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.988 178.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.11 132.46 25.03 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.849 0.357 . . . . 0.0 110.682 174.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 69' ' ' PHE . . . . . 0.461 ' CZ ' HD21 ' E' ' 67' ' ' LEU . 58.5 m-85 -130.04 160.54 33.36 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.91 178.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 18.1 t -120.11 158.75 26.23 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -79.46 9.1 5.19 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.06 0.457 . . . . 0.0 111.102 -175.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.3 -29.28 9.03 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.453 174.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -100.38 165.85 11.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.033 0.444 . . . . 0.0 110.706 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -135.77 143.41 45.24 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 75' ' ' ILE . . . . . 0.54 ' HB ' ' CD1' ' E' ' 44' ' ' LEU . 24.9 pt -135.65 159.2 40.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.179 0.514 . . . . 0.0 112.278 -168.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 76' ' ' MET . . . . . 0.436 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 10.8 mtp -115.0 117.48 30.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.752 173.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 77' ' ' PHE . . . . . 0.494 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.6 OUTLIER -104.14 126.92 51.65 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 176.147 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' E' E ' 78' ' ' TYR . . . . . 0.557 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 23.0 p90 -152.22 134.61 15.21 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.985 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 79' ' ' THR . . . . . 0.519 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 2.4 p -107.8 120.0 41.02 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.375 -177.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.23 160.89 15.96 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.65 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.6 -170.48 31.04 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -177.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 82' ' ' ASP . . . . . 0.424 ' HA ' ' HB3' ' E' ' 15' ' ' PRO . 19.1 t70 -116.88 103.46 10.32 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 119.676 -0.809 . . . . 0.0 109.941 176.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 83' ' ' ALA . . . . . 0.513 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -173.33 158.7 3.61 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.776 172.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 25.9 t -117.86 122.47 43.42 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 85' ' ' VAL . . . . . 0.483 HG13 ' HB3' ' E' ' 34' ' ' LEU . 4.9 m -115.85 156.13 17.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.487 0.66 . . . . 0.0 112.328 -172.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 50.4 m -119.09 117.17 28.02 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.042 173.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 87' ' ' LEU . . . . . 0.676 HD12 ' SD ' ' E' ' 13' ' ' MET . 5.1 mp -91.72 147.03 23.29 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 171.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . 0.521 ' CD2' HG11 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -130.81 142.51 50.4 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.744 179.643 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.95 -168.0 27.45 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.016 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 90' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -145.42 130.19 18.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.643 0.735 . . . . 0.0 112.191 178.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 91' ' ' LEU . . . . . . . . . . . . . 18.2 mt -71.62 113.48 8.7 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.498 173.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -101.03 117.54 35.24 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.161 0.505 . . . . 0.0 110.706 -178.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -98.45 -53.94 3.18 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.638 176.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 59.9 mt 64.66 88.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.248 177.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 95' ' ' ASP . . . . . 0.513 ' HB3' ' OE1' ' E' ' 2' ' ' GLN . 29.9 t70 -126.99 134.6 50.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.765 178.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 18.9 m -96.73 27.59 3.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.0 0.429 . . . . 0.0 110.971 -177.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . -80.19 78.88 1.78 Allowed Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.047 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 10.9 p . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.45 -0.786 . . . . 0.0 110.397 179.007 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 . . . . . 0 N--CA 1.481 1.102 0 CA-C-O 120.516 0.198 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -71.42 90.51 0.97 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.976 0.417 . . . . 0.0 110.571 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 142.52 -137.7 7.96 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 -177.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -141.87 -175.01 4.24 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.537 0.208 . . . . 0.0 110.581 -179.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.451 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 2.7 mpt? -142.7 -173.68 3.95 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 175.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.55 120.0 5.14 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 174.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 21.7 ttt -103.37 140.78 36.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.188 0.518 . . . . 0.0 112.317 -170.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 1.639 ' HD1' ' CD2' ' A' ' 8' ' ' PHE . 77.7 t80 -54.49 141.45 30.96 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.967 -176.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.514 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 89.5 t90 -133.46 147.23 51.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.704 -1.134 . . . . 0.0 108.503 177.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.89 145.54 14.45 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.658 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.514 ' HB2' ' CH2' ' A' ' 9' ' ' TRP . 50.1 tp -135.89 108.74 7.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.894 0.378 . . . . 0.0 110.317 177.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -96.64 100.96 12.49 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 176.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.624 ' SD ' HD12 ' A' ' 87' ' ' LEU . 61.0 mtp -92.5 143.47 26.32 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.291 0.567 . . . . 0.0 111.383 -172.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -100.49 145.02 29.57 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.425 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.456 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 9.5 Cg_endo -51.84 123.22 11.89 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 123.64 2.893 . . . . 0.0 113.597 -174.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 79' ' ' THR . 35.8 mt-10 57.71 73.6 0.46 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.689 178.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.85 138.34 19.59 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.224 176.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.671 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 50.2 mttp -107.34 121.9 45.51 Favored 'General case' 0 CA--C 1.512 -0.497 0 O-C-N 123.451 0.47 . . . . 0.0 111.368 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 1.663 ' HE2' ' CE1' ' A' ' 19' ' ' TYR . 3.1 m-85 -110.57 102.79 11.34 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 76' ' ' MET . 44.4 t -90.08 99.22 12.28 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 173.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -115.55 139.76 49.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.594 0.712 . . . . 0.0 112.2 -168.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.1 m -84.72 132.17 34.48 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.348 174.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 59.3 mt -86.35 115.45 27.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.07 0.462 . . . . 0.0 110.934 -175.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.423 HD13 ' N ' ' A' ' 25' ' ' LYS . 1.9 pp -88.7 -12.44 10.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.399 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.423 ' N ' HD13 ' A' ' 24' ' ' ILE . 83.3 tttt -160.03 120.12 2.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.486 178.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.7 m -51.54 137.16 24.99 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.683 0.614 . . . . 0.0 110.403 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -147.35 165.32 30.52 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -174.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.484 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 8.3 t60 -116.17 120.28 38.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.699 177.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.502 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 42.6 mt -84.51 134.68 26.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 169.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.496 ' HB2' ' HB3' ' B' ' 66' ' ' ASP . 76.7 p -119.68 -10.05 9.65 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -171.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -178.11 158.57 23.53 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 119.263 -1.446 . . . . 0.0 113.628 177.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.406 HG21 ' HG ' ' A' ' 87' ' ' LEU . 11.9 p -139.67 137.24 39.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 175.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -150.18 154.83 38.69 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.903 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.439 ' HB3' HG13 ' A' ' 85' ' ' VAL . 4.3 pp -118.19 140.02 50.42 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.964 0.888 . . . . 0.0 111.615 178.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -110.28 -53.41 2.68 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.981 -1.463 . . . . 0.0 108.549 174.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -101.47 126.79 48.32 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.589 175.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.453 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 140.54 165.64 10.38 Favored Glycine 0 N--CA 1.439 -1.119 0 C-N-CA 119.588 -1.292 . . . . 0.0 113.542 178.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -102.72 -46.58 4.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.58 0.228 . . . . 0.0 111.395 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -151.46 134.23 15.65 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.018 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.77 113.71 13.27 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.46 0.648 . . . . 0.0 110.42 170.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 79' ' ' THR . 65.4 mttp -98.21 113.36 25.26 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 174.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.409 ' HG ' ' CG2' ' A' ' 53' ' ' VAL . 58.7 tp -89.93 109.03 20.08 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.424 -170.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 1.644 ' HE2' ' CE1' ' A' ' 43' ' ' TYR . 71.5 m-85 -109.02 148.6 30.52 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.852 178.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.652 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -128.41 117.07 20.75 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.606 176.046 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.555 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -102.9 104.45 14.68 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.429 0.633 . . . . 0.0 109.927 176.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -128.79 143.72 50.99 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.316 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 61.16 26.59 16.47 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.716 0.769 . . . . 0.0 109.074 -174.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 59.2 38.36 23.55 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.874 -177.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.555 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 6.6 tp-100 -129.5 127.91 41.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.823 178.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -81.38 106.01 13.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.096 0.474 . . . . 0.0 110.599 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 1.621 ' HE2' ' CE1' ' A' ' 51' ' ' TYR . 73.8 m-85 -102.3 116.98 33.78 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.339 176.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.403 HD11 ' CE1' ' A' ' 43' ' ' TYR . 4.8 tp -74.71 99.84 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 171.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.479 HG13 ' CD2' ' E' ' 88' ' ' LEU . 29.3 m -87.43 -32.45 6.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.611 -172.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.478 ' HB1' HD22 ' A' ' 65' ' ' LEU . . . -152.93 142.42 21.75 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.371 -0.532 . . . . 0.0 112.211 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.1 m -112.97 101.93 9.94 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 169.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.0 p -118.36 112.43 38.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.932 0.873 . . . . 0.0 110.443 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 78.5 p -123.34 -177.34 3.67 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.194 -176.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -60.93 -29.37 69.57 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.445 168.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.22 -40.66 62.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.252 0.549 . . . . 0.0 110.292 178.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 77.4 mt -117.8 81.69 15.65 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.35 -4.17 12.34 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.191 2.594 . . . . 0.0 113.963 -168.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -160.67 129.71 4.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.281 0.562 . . . . 0.0 111.206 -175.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.457 HG12 ' HB3' ' A' ' 54' ' ' ALA . 96.7 t -120.17 125.59 74.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.525 176.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.36 130.68 34.54 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 175.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.478 HD22 ' HB1' ' A' ' 54' ' ' ALA . 88.5 mt -122.82 166.64 14.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.394 0.616 . . . . 0.0 112.288 -173.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 26.9 t0 -144.51 97.95 3.12 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 170.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.502 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 7.0 mt -133.0 109.38 9.51 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.347 -175.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.461 ' HB2' ' CD2' ' E' ' 90' ' ' TYR . 7.5 m-20 -104.73 114.7 29.08 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.839 0.352 . . . . 0.0 110.149 178.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 1.668 ' HD1' ' CD2' ' A' ' 69' ' ' PHE . 57.9 m-85 -108.09 160.35 15.87 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.338 179.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.5 t -116.14 149.64 38.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.955 0.407 . . . . 0.0 110.625 -177.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -69.15 0.13 5.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.198 -176.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.46 -18.56 35.35 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.345 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -101.51 164.06 11.95 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.708 -0.289 . . . . 0.0 110.836 -175.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -130.9 108.76 10.06 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.4 pt -109.52 158.46 9.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.259 -170.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.411 ' HA ' ' O ' ' A' ' 19' ' ' TYR . 2.6 mtm -116.69 122.88 45.82 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.873 175.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.652 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -104.49 128.57 52.45 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.688 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 1.648 ' HE2' ' CE1' ' A' ' 78' ' ' TYR . 36.4 p90 -149.98 135.34 18.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.529 0.68 . . . . 0.0 112.492 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 3.9 p -106.36 132.56 52.25 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.763 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.54 154.42 18.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.799 177.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.413 ' O ' ' HG3' ' A' ' 16' ' ' GLU . . . 91.33 -172.14 35.98 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -176.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -113.13 102.86 10.79 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.825 176.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.456 ' H ' ' HB3' ' A' ' 15' ' ' PRO . . . -169.28 153.74 5.51 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.85 167.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.4 t -111.05 120.66 43.08 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.439 HG13 ' HB3' ' A' ' 34' ' ' LEU . 3.8 m -114.9 149.31 17.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -172.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.8 m -110.93 115.4 29.43 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.598 175.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.624 HD12 ' SD ' ' A' ' 13' ' ' MET . 4.8 mp -94.85 145.17 25.08 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 170.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.473 ' CD2' HG13 ' B' ' 53' ' ' VAL . 2.4 mm? -124.28 149.53 46.4 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 175.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.82 -167.35 26.32 Favored Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.48 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 1.649 ' HE1' ' CE2' ' A' ' 90' ' ' TYR . 5.1 p90 -149.31 131.38 15.35 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.763 0.792 . . . . 0.0 111.795 176.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 27.3 mt -63.91 138.9 58.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.927 -1.488 . . . . 0.0 110.279 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.405 ' HD1' ' CG ' ' E' ' 95' ' ' ASP . 23.2 m-70 -65.64 120.3 12.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.786 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -150.82 169.65 21.17 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 5' ' ' MET . 2.2 pp -91.76 149.03 4.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 120.791 0.329 . . . . 0.0 110.796 -178.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.42 98.6 11.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.822 -178.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 28.4 t -67.04 105.64 1.72 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.076 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.38 -48.93 4.11 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.0 178.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.1 m . . . . . 0 C--O 1.249 1.053 0 CA-C-O 119.033 -0.508 . . . . 0.0 110.413 -176.873 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 120.483 0.182 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -71.43 90.42 0.97 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.015 0.436 . . . . 0.0 110.581 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 142.63 -137.67 7.91 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -177.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -141.92 -175.04 4.25 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.533 0.206 . . . . 0.0 110.615 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' MET . . . . . 0.437 ' HA ' ' O ' ' B' ' 94' ' ' ILE . 2.7 mpt? -142.58 -173.6 3.91 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 175.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.59 119.99 5.14 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 174.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 21.8 ttt -103.3 140.79 36.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.189 0.519 . . . . 0.0 112.251 -170.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 1.615 ' HE2' ' CE1' ' B' ' 8' ' ' PHE . 78.1 t80 -54.51 141.53 30.8 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 114.76 -1.109 . . . . 0.0 113.001 -176.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . 0.512 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 89.3 t90 -133.53 147.28 51.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.531 177.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.91 145.54 14.44 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.607 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.512 ' HB2' ' CH2' ' B' ' 9' ' ' TRP . 50.2 tp -135.9 108.8 7.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.91 0.386 . . . . 0.0 110.344 176.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -96.76 101.1 12.64 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' MET . . . . . 0.618 ' SD ' HD12 ' B' ' 87' ' ' LEU . 60.8 mtp -92.58 143.46 26.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.304 0.573 . . . . 0.0 111.372 -172.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -100.49 145.02 29.59 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 114.926 -1.033 . . . . 0.0 109.371 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.473 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 9.5 Cg_endo -51.91 123.13 11.74 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.708 2.938 . . . . 0.0 113.597 -174.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' B' ' 79' ' ' THR . 35.8 mt-10 57.86 73.44 0.47 Allowed 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.668 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.76 138.5 19.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.214 176.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . 0.657 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 50.2 mttp -107.39 121.95 45.63 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 123.397 0.436 . . . . 0.0 111.322 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' TYR . . . . . 1.644 ' HE1' ' CE2' ' B' ' 19' ' ' TYR . 3.1 m-85 -110.6 102.65 11.21 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 174.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 45.2 t -89.84 99.2 12.25 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 173.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -115.55 139.74 49.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.3 -168.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 54.4 m -84.66 132.16 34.51 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.399 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 59.3 mt -86.33 115.48 27.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.041 0.448 . . . . 0.0 110.924 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.424 HD13 ' N ' ' B' ' 25' ' ' LYS . 1.9 pp -88.7 -12.57 10.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.369 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.424 ' N ' HD13 ' B' ' 24' ' ' ILE . 83.3 tttt -159.99 120.17 2.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.479 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 13.6 m -51.47 137.09 24.7 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 123.768 0.667 . . . . 0.0 110.515 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -147.34 165.34 30.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.386 0.612 . . . . 0.0 112.51 -174.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' HIS . . . . . 0.475 ' HA ' ' O ' ' B' ' 67' ' ' LEU . 8.3 t60 -116.15 120.24 38.39 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.749 176.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.507 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 42.5 mt -84.56 134.69 26.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 169.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.518 ' HB2' ' HB3' ' C' ' 66' ' ' ASP . 77.2 p -119.61 -10.1 9.67 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -171.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -178.16 158.5 23.38 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.314 -1.422 . . . . 0.0 113.678 177.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.4 HG21 ' HG ' ' B' ' 87' ' ' LEU . 11.9 p -139.71 137.27 39.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -150.16 154.78 38.61 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.972 -0.455 . . . . 0.0 110.961 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.447 ' HB3' HG13 ' B' ' 85' ' ' VAL . 4.3 pp -118.14 140.06 50.35 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.963 0.887 . . . . 0.0 111.651 178.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -110.41 -53.25 2.7 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.067 -1.424 . . . . 0.0 108.508 174.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -101.55 126.74 48.42 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.672 175.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.462 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 140.67 165.72 10.41 Favored Glycine 0 N--CA 1.439 -1.132 0 C-N-CA 119.602 -1.285 . . . . 0.0 113.484 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -102.76 -46.48 4.7 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.589 0.233 . . . . 0.0 111.481 176.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -151.5 134.24 15.62 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.95 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.402 ' HB3' ' HB1' ' B' ' 83' ' ' ALA . . . -132.83 113.71 13.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.494 0.664 . . . . 0.0 110.423 170.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' B' ' 79' ' ' THR . 65.4 mttp -98.19 113.22 25.06 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 174.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.417 ' HG ' ' CG2' ' B' ' 53' ' ' VAL . 58.9 tp -89.85 109.14 20.17 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.367 -170.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . 1.631 ' HE2' ' CE1' ' B' ' 43' ' ' TYR . 71.1 m-85 -109.04 148.53 30.66 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.919 177.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.663 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 0.4 OUTLIER -128.37 117.12 20.86 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.589 176.058 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -102.89 104.4 14.64 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.358 0.599 . . . . 0.0 109.925 176.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -128.85 143.67 50.97 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 61.06 26.64 16.56 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.769 0.795 . . . . 0.0 109.168 -174.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 59.19 38.28 23.61 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.009 -177.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.554 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 6.6 tp-100 -129.46 127.97 41.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.727 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -81.43 106.04 13.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.966 0.413 . . . . 0.0 110.591 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 1.617 ' HE2' ' CE1' ' B' ' 51' ' ' TYR . 74.1 m-85 -102.3 116.95 33.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.348 176.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . 0.408 HD11 ' CE1' ' B' ' 43' ' ' TYR . 4.9 tp -74.7 99.88 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 171.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.473 HG13 ' CD2' ' A' ' 88' ' ' LEU . 28.8 m -87.39 -32.51 6.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.576 -172.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.483 ' HB1' HD22 ' B' ' 65' ' ' LEU . . . -152.89 142.31 21.68 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 26.8 m -112.96 101.96 9.98 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 169.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 p -118.33 112.36 37.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.857 0.837 . . . . 0.0 110.468 -176.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 77.1 p -123.39 -177.39 3.69 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.107 -176.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -60.86 -29.41 69.51 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.507 168.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.15 -40.69 62.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.338 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 77.8 mt -117.73 81.64 15.31 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 173.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.34 -4.15 12.28 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.164 2.576 . . . . 0.0 113.922 -168.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -160.69 129.76 4.82 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.307 0.575 . . . . 0.0 111.164 -175.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.461 HG12 ' HB3' ' B' ' 54' ' ' ALA . 96.8 t -120.19 125.58 74.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.522 176.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.41 130.76 34.52 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.483 HD22 ' HB1' ' B' ' 54' ' ' ALA . 88.4 mt -122.91 166.59 14.79 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.408 0.623 . . . . 0.0 112.369 -173.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 26.1 t0 -144.45 97.94 3.12 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 170.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.507 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 7.0 mt -132.88 109.32 9.53 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.406 -175.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . 0.446 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 7.5 m-20 -104.69 114.65 29.0 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.899 0.38 . . . . 0.0 110.175 178.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . 1.67 ' HD2' ' CD1' ' B' ' 69' ' ' PHE . 57.9 m-85 -108.05 160.31 15.89 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.349 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 36.0 t -116.16 149.6 38.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.959 0.409 . . . . 0.0 110.563 -177.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -69.1 0.23 4.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.272 -176.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.54 -18.46 35.49 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.356 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -101.47 164.24 11.86 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.681 -0.305 . . . . 0.0 110.891 -176.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -131.11 108.81 10.02 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 22.4 pt -109.5 158.35 9.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.256 -170.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' MET . . . . . 0.415 ' HA ' ' O ' ' B' ' 19' ' ' TYR . 2.6 mtm -116.64 122.79 45.61 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 120.296 -0.562 . . . . 0.0 109.924 175.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . 0.663 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -104.49 128.61 52.46 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.665 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 1.667 ' HE1' ' CE2' ' B' ' 78' ' ' TYR . 36.0 p90 -150.08 135.37 18.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.589 0.709 . . . . 0.0 112.498 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 3.8 p -106.35 132.56 52.24 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.835 178.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.46 154.39 18.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.806 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' B' ' 16' ' ' GLU . . . 91.38 -172.18 35.94 Favored Glycine 0 CA--C 1.506 -0.492 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -176.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -113.09 102.9 10.83 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.854 176.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.473 ' H ' ' HB3' ' B' ' 15' ' ' PRO . . . -169.32 153.71 5.45 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.818 167.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 24.3 t -111.0 120.65 43.07 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.447 HG13 ' HB3' ' B' ' 34' ' ' LEU . 3.8 m -114.97 149.27 17.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.544 0.688 . . . . 0.0 112.816 -172.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 25.0 m -110.87 115.38 29.42 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.61 175.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.618 HD12 ' SD ' ' B' ' 13' ' ' MET . 4.8 mp -94.81 145.25 25.01 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 170.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.455 HD12 ' O ' ' B' ' 87' ' ' LEU . 2.4 mm? -124.48 149.51 46.77 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.81 -167.29 26.22 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.512 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' TYR . . . . . 1.634 ' HE2' ' CE1' ' B' ' 90' ' ' TYR . 5.1 p90 -149.35 131.34 15.27 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.787 0.803 . . . . 0.0 111.682 176.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 27.3 mt -63.89 139.01 58.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.256 176.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -65.89 120.42 13.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.679 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -150.87 169.57 21.39 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' B' ' 5' ' ' MET . 2.2 pp -91.7 149.26 4.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.77 -178.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.62 98.68 11.92 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.785 -178.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 28.4 t -67.1 105.67 1.75 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.126 177.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.42 -48.75 4.16 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.111 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 16.6 m . . . . . 0 C--O 1.249 1.073 0 CA-C-O 119.143 -0.456 . . . . 0.0 110.547 -176.929 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 120.491 0.186 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -71.44 90.47 0.98 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.954 0.407 . . . . 0.0 110.583 -178.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . 142.52 -137.62 7.91 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 -177.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -141.93 -174.98 4.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.56 0.219 . . . . 0.0 110.528 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 5' ' ' MET . . . . . 0.445 ' HA ' ' O ' ' C' ' 94' ' ' ILE . 2.7 mpt? -142.69 -173.63 3.93 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.6 119.89 5.04 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 174.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 21.8 ttt -103.21 140.79 36.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.166 0.508 . . . . 0.0 112.325 -170.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 8' ' ' PHE . . . . . 1.637 ' HD1' ' CD2' ' C' ' 8' ' ' PHE . 77.8 t80 -54.56 141.55 31.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.788 -1.097 . . . . 0.0 112.917 -176.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . 0.507 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 89.4 t90 -133.48 147.23 51.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.582 177.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.85 145.65 14.7 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.554 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.507 ' HB2' ' CH2' ' C' ' 9' ' ' TRP . 50.0 tp -135.97 108.74 7.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.923 0.392 . . . . 0.0 110.254 177.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -96.7 101.1 12.64 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 13' ' ' MET . . . . . 0.616 ' SD ' HD12 ' C' ' 87' ' ' LEU . 60.9 mtp -92.57 143.44 26.34 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.282 0.563 . . . . 0.0 111.401 -172.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -100.48 144.98 29.51 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.424 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . 0.463 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 9.5 Cg_endo -51.87 123.23 11.94 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 123.647 2.898 . . . . 0.0 113.559 -174.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' C' ' 79' ' ' THR . 36.1 mt-10 57.8 73.45 0.47 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.686 178.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.82 138.43 19.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.173 176.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 18' ' ' LYS . . . . . 0.666 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 50.2 mttp -107.37 121.98 45.67 Favored 'General case' 0 CA--C 1.511 -0.531 0 O-C-N 123.368 0.418 . . . . 0.0 111.325 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . 1.657 ' HD1' ' CD2' ' C' ' 19' ' ' TYR . 3.1 m-85 -110.63 102.74 11.28 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 174.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 20' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 44.7 t -89.97 99.22 12.27 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 173.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -115.52 139.69 49.83 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.272 -168.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 54.2 m -84.63 132.13 34.52 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.426 174.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 59.1 mt -86.21 115.32 27.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.048 0.452 . . . . 0.0 111.001 -175.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . 0.418 HD13 ' N ' ' C' ' 25' ' ' LYS . 1.9 pp -88.64 -12.57 10.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.39 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . 0.418 ' N ' HD13 ' C' ' 24' ' ' ILE . 83.3 tttt -159.95 120.24 2.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.431 178.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 13.4 m -51.47 137.13 24.66 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 123.736 0.647 . . . . 0.0 110.532 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 27' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -147.39 165.32 30.57 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.448 0.642 . . . . 0.0 112.579 -174.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 28' ' ' HIS . . . . . 0.483 ' HA ' ' O ' ' C' ' 67' ' ' LEU . 8.3 t60 -116.1 120.29 38.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.728 177.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . 0.49 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 42.3 mt -84.61 134.68 26.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 169.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 30' ' ' SER . . . . . 0.487 ' HB2' ' HB3' ' D' ' 66' ' ' ASP . 75.9 p -119.59 -10.05 9.68 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -171.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -178.11 158.45 23.32 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 119.194 -1.479 . . . . 0.0 113.617 177.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.401 HG21 ' HG ' ' C' ' 87' ' ' LEU . 12.0 p -139.67 137.28 39.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -150.17 154.79 38.63 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 121.946 -0.471 . . . . 0.0 110.922 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.441 ' O ' HD13 ' C' ' 34' ' ' LEU . 4.3 pp -118.24 140.09 50.33 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 122.01 0.909 . . . . 0.0 111.585 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -110.33 -53.32 2.7 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.934 -1.485 . . . . 0.0 108.514 174.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -101.59 126.72 48.46 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.603 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 37' ' ' GLY . . . . . 0.462 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 140.72 165.68 10.4 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 119.55 -1.309 . . . . 0.0 113.56 178.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -102.78 -46.46 4.7 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 120.575 0.226 . . . . 0.0 111.452 176.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -151.49 134.31 15.68 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.979 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.83 113.66 13.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.401 0.62 . . . . 0.0 110.451 170.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' C' ' 79' ' ' THR . 65.4 mttp -98.17 113.27 25.13 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 174.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.426 ' HG ' ' CG2' ' C' ' 53' ' ' VAL . 59.0 tp -89.92 109.08 20.12 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.416 -170.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 43' ' ' TYR . . . . . 1.652 ' HE1' ' CE2' ' C' ' 43' ' ' TYR . 71.3 m-85 -108.99 148.58 30.53 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.92 177.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.663 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 0.4 OUTLIER -128.39 117.09 20.78 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.579 176.045 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -102.87 104.5 14.76 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.33 0.586 . . . . 0.0 109.851 176.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -128.76 143.74 50.99 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.34 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 61.11 26.52 16.42 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.768 0.794 . . . . 0.0 109.138 -174.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 59.28 38.27 23.32 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.969 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . 0.549 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 6.6 tp-100 -129.49 127.96 41.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.715 178.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -81.51 106.08 13.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.074 0.464 . . . . 0.0 110.565 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 1.641 ' HE2' ' CE1' ' C' ' 51' ' ' TYR . 73.9 m-85 -102.29 116.97 33.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.304 176.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . 0.406 HD11 ' CE1' ' C' ' 43' ' ' TYR . 4.8 tp -74.74 99.88 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 171.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 53' ' ' VAL . . . . . 0.453 HG13 ' CD2' ' B' ' 88' ' ' LEU . 28.4 m -87.43 -32.43 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.618 -172.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 54' ' ' ALA . . . . . 0.479 ' HB1' HD22 ' C' ' 65' ' ' LEU . . . -152.89 142.41 21.77 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 120.308 -0.557 . . . . 0.0 112.261 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 27.0 m -113.05 101.97 9.96 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 169.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 p -118.26 112.39 38.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.817 0.818 . . . . 0.0 110.414 -176.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 77.0 p -123.45 -177.35 3.69 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.205 -176.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -60.81 -29.47 69.48 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.484 168.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.13 -40.68 62.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.289 0.566 . . . . 0.0 110.329 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 77.5 mt -117.75 81.65 15.4 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 173.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.33 -4.12 12.22 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.148 2.565 . . . . 0.0 113.969 -168.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -160.69 129.7 4.8 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.348 0.594 . . . . 0.0 111.194 -175.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.458 HG12 ' HB3' ' C' ' 54' ' ' ALA . 97.2 t -120.1 125.55 74.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.552 176.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.39 130.76 34.52 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 175.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . 0.479 HD22 ' HB1' ' C' ' 54' ' ' ALA . 88.2 mt -122.84 166.59 14.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.506 0.669 . . . . 0.0 112.376 -173.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 66' ' ' ASP . . . . . 0.518 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 26.4 t0 -144.52 98.07 3.14 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . 0.49 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 7.0 mt -132.95 109.37 9.53 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.443 -175.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . 0.434 ' HB2' ' CD2' ' B' ' 90' ' ' TYR . 7.4 m-20 -104.7 114.63 28.97 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 120.802 0.334 . . . . 0.0 110.158 178.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 69' ' ' PHE . . . . . 1.648 ' HD2' ' CD1' ' C' ' 69' ' ' PHE . 58.2 m-85 -108.11 160.38 15.85 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.254 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 36.6 t -116.16 149.64 38.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.565 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -69.15 0.01 5.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.203 -176.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.32 -18.54 35.85 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.406 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -101.51 164.09 11.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.706 0.289 . . . . 0.0 110.841 -176.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -131.0 108.81 10.06 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 22.5 pt -109.52 158.41 9.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.216 -170.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 76' ' ' MET . . . . . 0.41 ' HA ' ' O ' ' C' ' 19' ' ' TYR . 2.5 mtm -116.69 122.81 45.61 Favored 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.887 175.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 77' ' ' PHE . . . . . 0.663 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.7 OUTLIER -104.55 128.63 52.56 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.721 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 78' ' ' TYR . . . . . 1.624 ' HE2' ' CE1' ' C' ' 78' ' ' TYR . 36.4 p90 -150.04 135.33 18.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.581 0.705 . . . . 0.0 112.531 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 79' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 3.9 p -106.35 132.51 52.3 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.777 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.48 154.5 18.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.778 177.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.3 -172.16 36.03 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -176.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -113.07 102.95 10.88 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.879 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . 0.463 ' H ' ' HB3' ' C' ' 15' ' ' PRO . . . -169.38 153.6 5.34 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.845 167.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 25.3 t -110.94 120.71 43.3 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.439 HG13 ' HB3' ' C' ' 34' ' ' LEU . 3.8 m -114.96 149.38 17.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 24.1 m -110.97 115.31 29.28 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.641 175.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . 0.616 HD12 ' SD ' ' C' ' 13' ' ' MET . 4.8 mp -94.83 145.19 25.06 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 170.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . 0.462 HD12 ' O ' ' C' ' 87' ' ' LEU . 2.4 mm? -124.38 149.49 46.61 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.77 -167.29 26.16 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.471 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 90' ' ' TYR . . . . . 1.642 ' HD2' ' CD1' ' C' ' 90' ' ' TYR . 5.1 p90 -149.33 131.41 15.36 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.744 0.783 . . . . 0.0 111.741 176.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.97 139.1 58.73 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.247 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -65.93 120.32 12.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.659 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -150.83 169.63 21.23 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' C' ' 5' ' ' MET . 2.2 pp -91.73 149.16 4.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 120.799 0.333 . . . . 0.0 110.799 -178.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 95' ' ' ASP . . . . . 0.406 ' CG ' ' HD1' ' D' ' 92' ' ' HIS . 0.1 OUTLIER -90.53 98.67 11.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.786 -178.408 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 28.5 t -67.12 105.66 1.76 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.048 177.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.34 -48.93 4.12 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.079 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 C--O 1.247 0.964 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.522 -176.831 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 120.486 0.184 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -71.42 90.45 0.97 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.913 0.387 . . . . 0.0 110.547 -178.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . 142.51 -137.66 7.94 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -177.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -141.82 -174.95 4.22 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.627 0.214 . . . . 0.0 110.576 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 5' ' ' MET . . . . . 0.444 ' HA ' ' O ' ' D' ' 94' ' ' ILE . 2.7 mpt? -142.74 -173.61 3.93 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 175.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.62 119.94 5.11 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.741 0.305 . . . . 0.0 110.185 174.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 21.7 ttt -103.2 140.8 36.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.142 0.496 . . . . 0.0 112.28 -170.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 8' ' ' PHE . . . . . 1.651 ' HE2' ' CE1' ' D' ' 8' ' ' PHE . 78.0 t80 -54.55 141.59 30.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.971 -176.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 9' ' ' TRP . . . . . 0.511 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 89.3 t90 -133.53 147.21 51.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.536 177.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.79 145.64 14.68 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.591 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . 0.511 ' HB2' ' CH2' ' D' ' 9' ' ' TRP . 49.9 tp -136.0 108.85 7.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.923 0.392 . . . . 0.0 110.246 176.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -96.76 101.01 12.53 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 13' ' ' MET . . . . . 0.62 ' SD ' HD12 ' D' ' 87' ' ' LEU . 60.8 mtp -92.42 143.45 26.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.241 0.543 . . . . 0.0 111.434 -173.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -100.47 144.94 29.43 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.416 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . 0.463 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 9.5 Cg_endo -51.73 123.16 11.7 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.645 2.896 . . . . 0.0 113.626 -174.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' D' ' 79' ' ' THR . 35.9 mt-10 57.81 73.46 0.47 Allowed 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.707 178.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.85 138.44 19.66 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.197 176.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . 0.662 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 50.2 mttp -107.39 121.98 45.67 Favored 'General case' 0 CA--C 1.511 -0.533 0 O-C-N 123.387 0.429 . . . . 0.0 111.399 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 19' ' ' TYR . . . . . 1.669 ' HD1' ' CD2' ' D' ' 19' ' ' TYR . 3.1 m-85 -110.61 102.64 11.2 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 174.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 20' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 44.9 t -89.97 99.17 12.24 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -115.51 139.8 49.73 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.219 -168.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 55.2 m -84.74 132.25 34.47 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.292 174.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 59.4 mt -86.38 115.35 27.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.057 0.456 . . . . 0.0 110.914 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . 0.406 HD13 ' N ' ' D' ' 25' ' ' LYS . 1.9 pp -88.67 -12.51 10.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.417 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . 0.406 ' N ' HD13 ' D' ' 24' ' ' ILE . 83.3 tttt -159.93 120.28 2.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.493 178.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 13.6 m -51.6 137.13 25.4 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 123.761 0.663 . . . . 0.0 110.415 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 27' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -147.39 165.27 30.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.399 0.619 . . . . 0.0 112.569 -174.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 28' ' ' HIS . . . . . 0.482 ' HA ' ' O ' ' D' ' 67' ' ' LEU . 8.3 t60 -116.15 120.3 38.59 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.676 177.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 29' ' ' ILE . . . . . 0.501 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 42.4 mt -84.5 134.66 26.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 169.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 30' ' ' SER . . . . . 0.496 ' HB2' ' HB3' ' E' ' 66' ' ' ASP . 77.2 p -119.6 -10.12 9.67 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -171.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 31' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -178.15 158.5 23.38 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 119.309 -1.425 . . . . 0.0 113.686 177.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 12.0 p -139.67 137.26 39.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 175.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -150.16 154.85 38.74 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.025 -0.422 . . . . 0.0 110.916 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 34' ' ' LEU . . . . . 0.437 HD13 ' O ' ' D' ' 34' ' ' LEU . 4.3 pp -118.24 140.01 50.45 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.957 0.884 . . . . 0.0 111.607 178.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -110.32 -53.31 2.7 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.556 174.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -101.54 126.79 48.41 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.631 175.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . 0.461 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 140.65 165.67 10.39 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 119.554 -1.308 . . . . 0.0 113.447 178.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -102.8 -46.46 4.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.485 0.183 . . . . 0.0 111.409 176.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -151.44 134.21 15.66 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.012 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . 0.414 ' HB3' ' HB1' ' D' ' 83' ' ' ALA . . . -132.76 113.7 13.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.433 0.635 . . . . 0.0 110.53 170.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' D' ' 79' ' ' THR . 65.4 mttp -98.16 113.28 25.13 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 174.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.424 ' HG ' ' CG2' ' D' ' 53' ' ' VAL . 58.8 tp -89.95 109.05 20.1 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.409 -170.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 43' ' ' TYR . . . . . 1.664 ' HD2' ' CD1' ' D' ' 43' ' ' TYR . 70.6 m-85 -108.97 148.55 30.54 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.989 177.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.66 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.4 OUTLIER -128.37 117.08 20.8 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.568 176.092 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 45' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -102.89 104.46 14.7 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.376 0.608 . . . . 0.0 109.871 176.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -128.85 143.62 50.95 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.034 -0.984 . . . . 0.0 108.377 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 61.2 26.55 16.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.711 0.767 . . . . 0.0 109.104 -174.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 59.29 38.23 23.29 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.992 -177.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . 0.55 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 6.6 tp-100 -129.53 127.91 41.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.685 178.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -81.47 106.08 13.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.069 0.461 . . . . 0.0 110.607 -178.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . 1.653 ' HE2' ' CE1' ' D' ' 51' ' ' TYR . 73.7 m-85 -102.3 116.97 33.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.355 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 52' ' ' ILE . . . . . 0.404 HD11 ' CE1' ' D' ' 43' ' ' TYR . 4.9 tp -74.67 99.88 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 53' ' ' VAL . . . . . 0.438 HG13 ' CD2' ' C' ' 88' ' ' LEU . 28.6 m -87.43 -32.43 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.586 -172.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 54' ' ' ALA . . . . . 0.467 ' HB1' HD22 ' D' ' 65' ' ' LEU . . . -152.93 142.27 21.61 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.246 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 27.2 m -112.97 102.05 10.05 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 169.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 p -118.4 112.33 37.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.904 0.859 . . . . 0.0 110.421 -176.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 78.4 p -123.33 -177.34 3.68 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.155 -176.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -60.86 -29.47 69.55 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.486 168.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.12 -40.68 62.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.326 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 77.6 mt -117.77 81.7 15.54 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 173.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.38 -4.1 12.22 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.137 2.558 . . . . 0.0 113.938 -168.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -160.69 129.69 4.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.299 0.571 . . . . 0.0 111.164 -175.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.459 HG12 ' HB3' ' D' ' 54' ' ' ALA . 97.1 t -120.12 125.67 74.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.555 176.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.43 130.83 34.5 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 65' ' ' LEU . . . . . 0.467 HD22 ' HB1' ' D' ' 54' ' ' ALA . 88.3 mt -122.97 166.53 14.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.353 0.597 . . . . 0.0 112.302 -173.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 66' ' ' ASP . . . . . 0.487 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 26.1 t0 -144.44 98.0 3.13 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 170.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . 0.501 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 6.9 mt -132.94 109.33 9.51 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.415 -175.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 68' ' ' ASN . . . . . 0.429 ' HB2' ' CD2' ' C' ' 90' ' ' TYR . 7.5 m-20 -104.72 114.67 29.03 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.857 0.36 . . . . 0.0 110.119 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 69' ' ' PHE . . . . . 1.655 ' HE1' ' CE2' ' D' ' 69' ' ' PHE . 57.7 m-85 -108.1 160.33 15.89 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.333 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 35.6 t -116.17 149.54 38.92 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.696 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -69.07 0.12 5.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.241 -176.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.45 -18.41 35.93 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.437 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -101.49 164.16 11.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.735 0.302 . . . . 0.0 110.848 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -131.08 108.92 10.1 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . . . . . . . . . 22.4 pt -109.57 158.47 9.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.22 -170.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 76' ' ' MET . . . . . 0.411 ' HA ' ' O ' ' D' ' 19' ' ' TYR . 2.5 mtm -116.67 122.78 45.53 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 120.281 -0.567 . . . . 0.0 109.904 175.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 77' ' ' PHE . . . . . 0.66 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.7 OUTLIER -104.53 128.57 52.51 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.727 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 78' ' ' TYR . . . . . 1.674 ' HE1' ' CE2' ' D' ' 78' ' ' TYR . 36.5 p90 -149.97 135.38 18.19 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.622 0.725 . . . . 0.0 112.608 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 79' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 3.9 p -106.41 132.43 52.44 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.788 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.35 154.47 18.17 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.806 177.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.41 ' O ' ' HG3' ' D' ' 16' ' ' GLU . . . 91.41 -172.21 35.93 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -176.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -113.09 102.79 10.73 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 119.584 -0.846 . . . . 0.0 109.894 176.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.463 ' H ' ' HB3' ' D' ' 15' ' ' PRO . . . -169.2 153.7 5.56 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.846 167.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 24.3 t -110.98 120.73 43.36 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . 0.437 HG13 ' HB3' ' D' ' 34' ' ' LEU . 3.8 m -115.0 149.37 17.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.538 0.685 . . . . 0.0 112.764 -172.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 24.6 m -110.97 115.39 29.4 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.569 175.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 87' ' ' LEU . . . . . 0.62 HD12 ' SD ' ' D' ' 13' ' ' MET . 4.7 mp -94.8 145.14 25.09 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 170.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . 0.471 ' CD2' HG13 ' E' ' 53' ' ' VAL . 2.4 mm? -124.35 149.56 46.5 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.81 -167.28 26.2 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.441 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 90' ' ' TYR . . . . . 1.624 ' HD2' ' CD1' ' D' ' 90' ' ' TYR . 5.2 p90 -149.33 131.26 15.21 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.744 0.783 . . . . 0.0 111.811 176.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 27.5 mt -63.81 138.95 58.7 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.289 176.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . 0.406 ' HD1' ' CG ' ' C' ' 95' ' ' ASP . 23.0 m-70 -65.8 120.33 12.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.761 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -150.79 169.67 21.11 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' D' ' 5' ' ' MET . 2.2 pp -91.75 149.13 4.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.808 -178.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.44 98.61 11.88 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.761 -178.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 28.5 t -67.09 105.72 1.76 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.079 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.39 -48.92 4.11 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.042 178.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.995 -0.526 . . . . 0.0 110.498 -176.827 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.513 0.197 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -71.4 90.39 0.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.039 0.447 . . . . 0.0 110.6 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . 142.56 -137.71 7.95 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 111.439 -0.665 . . . . 0.0 111.439 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -141.82 -175.03 4.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.671 0.235 . . . . 0.0 110.692 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 5' ' ' MET . . . . . 0.438 ' HA ' ' O ' ' E' ' 94' ' ' ILE . 2.7 mpt? -142.64 -173.65 3.93 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 175.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.58 119.98 5.13 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 174.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 21.7 ttt -103.29 140.82 36.91 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -170.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 8' ' ' PHE . . . . . 1.658 ' HE1' ' CE2' ' E' ' 8' ' ' PHE . 77.7 t80 -54.65 141.54 31.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.899 -176.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 9' ' ' TRP . . . . . 0.499 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 89.5 t90 -133.43 147.27 51.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.55 177.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.86 145.62 14.63 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.625 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . 0.499 ' HB2' ' CH2' ' E' ' 9' ' ' TRP . 49.8 tp -136.07 108.85 7.54 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.007 0.432 . . . . 0.0 110.261 176.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -96.68 100.98 12.51 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 13' ' ' MET . . . . . 0.626 ' SD ' HD12 ' E' ' 87' ' ' LEU . 60.3 mtp -92.41 143.47 26.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.227 0.537 . . . . 0.0 111.451 -172.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -100.51 144.95 29.45 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.386 178.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . 0.465 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 9.5 Cg_endo -51.8 123.21 11.85 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.651 2.901 . . . . 0.0 113.623 -174.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 16' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' E' ' 79' ' ' THR . 35.9 mt-10 57.77 73.45 0.47 Allowed 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.722 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.85 138.44 19.67 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.203 176.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . 0.667 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 50.2 mttp -107.32 121.99 45.67 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 123.387 0.43 . . . . 0.0 111.306 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . 1.654 ' HE2' ' CE1' ' E' ' 19' ' ' TYR . 3.1 m-85 -110.62 102.67 11.22 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 174.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 20' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' E' ' 76' ' ' MET . 44.6 t -89.99 99.18 12.24 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 173.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -115.5 139.85 49.68 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.279 -168.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 56.0 m -84.81 132.15 34.45 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.382 174.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 59.3 mt -86.32 115.37 27.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.086 0.469 . . . . 0.0 110.932 -175.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . 0.419 HD13 ' N ' ' E' ' 25' ' ' LYS . 1.9 pp -88.69 -12.49 10.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.414 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . 0.419 ' N ' HD13 ' E' ' 24' ' ' ILE . 83.3 tttt -159.95 120.19 2.97 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.501 178.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 13.6 m -51.53 137.07 25.1 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.801 0.688 . . . . 0.0 110.498 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 27' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -147.31 165.19 30.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.422 0.629 . . . . 0.0 112.597 -174.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 28' ' ' HIS . . . . . 0.49 ' HA ' ' O ' ' E' ' 67' ' ' LEU . 8.3 t60 -115.97 120.32 38.78 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.682 -1.144 . . . . 0.0 109.786 176.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 29' ' ' ILE . . . . . 0.5 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 42.1 mt -84.61 134.66 26.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 169.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 30' ' ' SER . . . . . 0.525 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 76.6 p -119.59 -10.03 9.69 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -171.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 31' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -178.11 158.55 23.49 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.252 -1.451 . . . . 0.0 113.595 177.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . 0.403 HG21 ' HG ' ' E' ' 87' ' ' LEU . 12.0 p -139.77 137.25 39.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 174.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -150.17 154.83 38.68 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.916 -178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 34' ' ' LEU . . . . . 0.443 HD13 ' O ' ' E' ' 34' ' ' LEU . 4.3 pp -118.24 140.04 50.4 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.953 0.882 . . . . 0.0 111.665 178.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -110.4 -53.3 2.7 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 113.98 -1.464 . . . . 0.0 108.494 174.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -101.54 126.77 48.4 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.676 175.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . 0.454 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 140.55 165.73 10.41 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 119.6 -1.286 . . . . 0.0 113.552 178.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -102.79 -46.55 4.67 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 123.501 0.177 . . . . 0.0 111.417 177.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -151.39 134.28 15.75 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.693 -0.23 . . . . 0.0 110.992 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.84 113.68 13.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.416 0.627 . . . . 0.0 110.442 170.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 41' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' E' ' 79' ' ' THR . 65.4 mttp -98.16 113.24 25.08 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 174.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.42 ' HG ' ' CG2' ' E' ' 53' ' ' VAL . 58.9 tp -89.91 109.08 20.12 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.396 -170.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 43' ' ' TYR . . . . . 1.659 ' HE1' ' CE2' ' E' ' 43' ' ' TYR . 71.2 m-85 -109.0 148.62 30.47 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.931 177.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 44' ' ' LEU . . . . . 0.664 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 0.4 OUTLIER -128.46 117.16 20.87 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.52 176.105 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' E' E ' 45' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -102.95 104.41 14.62 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.412 0.625 . . . . 0.0 109.877 176.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -128.85 143.67 50.97 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.302 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 61.16 26.57 16.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.802 0.81 . . . . 0.0 109.131 -174.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 59.31 38.23 23.2 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.952 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 49' ' ' GLN . . . . . 0.547 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 6.6 tp-100 -129.49 127.92 41.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.696 178.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -81.53 106.13 13.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.081 0.467 . . . . 0.0 110.567 -178.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . 1.644 ' HE2' ' CE1' ' E' ' 51' ' ' TYR . 73.9 m-85 -102.35 116.97 33.73 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.33 176.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -74.71 99.85 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . 0.471 HG13 ' CD2' ' D' ' 88' ' ' LEU . 29.3 m -87.35 -32.54 6.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.606 -172.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 54' ' ' ALA . . . . . 0.465 ' HB1' HD22 ' E' ' 65' ' ' LEU . . . -152.9 142.35 21.71 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 120.334 -0.547 . . . . 0.0 112.191 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 27.0 m -112.92 102.05 10.07 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 169.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 p -118.37 112.37 37.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.881 0.848 . . . . 0.0 110.416 -176.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 76.1 p -123.44 -177.38 3.69 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.172 -176.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -60.89 -29.33 69.51 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.516 168.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.2 -40.71 62.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.266 0.555 . . . . 0.0 110.345 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 77.3 mt -117.64 81.57 14.89 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 173.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.31 -4.11 12.17 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.16 2.573 . . . . 0.0 113.97 -168.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -160.65 129.7 4.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.273 0.559 . . . . 0.0 111.148 -175.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . 0.458 HG12 ' HB3' ' E' ' 54' ' ' ALA . 96.9 t -120.12 125.63 74.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.524 176.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.4 130.73 34.52 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 175.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . 0.465 HD22 ' HB1' ' E' ' 54' ' ' ALA . 88.1 mt -122.82 166.51 14.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.444 0.64 . . . . 0.0 112.342 -173.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 66' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 26.6 t0 -144.44 98.04 3.14 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 170.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 67' ' ' LEU . . . . . 0.5 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 7.0 mt -132.97 109.33 9.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.456 -175.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 68' ' ' ASN . . . . . 0.471 ' HB2' ' CD2' ' D' ' 90' ' ' TYR . 7.5 m-20 -104.66 114.67 29.03 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.831 0.348 . . . . 0.0 110.149 178.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 69' ' ' PHE . . . . . 1.657 ' HE1' ' CE2' ' E' ' 69' ' ' PHE . 58.1 m-85 -108.17 160.31 15.92 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.269 179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 36.6 t -116.15 149.68 38.64 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.635 -177.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -69.15 0.11 5.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.136 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.51 -18.45 35.62 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.346 177.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -101.48 164.15 11.91 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.697 -0.296 . . . . 0.0 110.851 -176.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -131.09 108.77 9.99 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 75' ' ' ILE . . . . . . . . . . . . . 22.3 pt -109.43 158.39 9.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.29 -170.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 76' ' ' MET . . . . . 0.416 ' HA ' ' O ' ' E' ' 19' ' ' TYR . 2.5 mtm -116.66 122.79 45.59 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.906 175.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 77' ' ' PHE . . . . . 0.664 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.7 OUTLIER -104.46 128.62 52.4 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.653 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' E' E ' 78' ' ' TYR . . . . . 1.614 ' HD2' ' CD1' ' E' ' 78' ' ' TYR . 36.6 p90 -150.05 135.24 17.99 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.57 0.7 . . . . 0.0 112.569 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 79' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 3.9 p -106.29 132.57 52.18 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.806 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.55 154.38 18.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.778 177.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 81' ' ' GLY . . . . . 0.41 ' O ' ' HG3' ' E' ' 16' ' ' GLU . . . 91.46 -172.22 35.85 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -176.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -113.04 102.83 10.78 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.881 176.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 83' ' ' ALA . . . . . 0.465 ' H ' ' HB3' ' E' ' 15' ' ' PRO . . . -169.28 153.68 5.48 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.84 167.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 24.3 t -110.98 120.72 43.33 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 85' ' ' VAL . . . . . 0.438 HG13 ' HB3' ' E' ' 34' ' ' LEU . 3.8 m -114.98 149.39 17.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -172.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 24.6 m -110.97 115.24 29.15 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.619 175.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 87' ' ' LEU . . . . . 0.626 HD12 ' SD ' ' E' ' 13' ' ' MET . 4.8 mp -94.79 145.15 25.08 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 170.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . 0.479 ' CD2' HG13 ' A' ' 53' ' ' VAL . 2.4 mm? -124.34 149.58 46.45 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.92 -167.35 26.41 Favored Glycine 0 N--CA 1.437 -1.275 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.376 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 90' ' ' TYR . . . . . 1.67 ' HD2' ' CD1' ' E' ' 90' ' ' TYR . 5.1 p90 -149.31 131.34 15.31 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.744 0.783 . . . . 0.0 111.766 176.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 91' ' ' LEU . . . . . . . . . . . . . 27.2 mt -63.81 138.97 58.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.29 176.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -65.84 120.38 12.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.671 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -150.81 169.68 21.09 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 94' ' ' ILE . . . . . 0.439 ' O ' HD13 ' E' ' 94' ' ' ILE . 2.2 pp -91.75 149.16 4.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.798 -178.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 95' ' ' ASP . . . . . 0.405 ' CG ' ' HD1' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -90.48 98.68 11.92 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.805 -178.497 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 28.5 t -67.1 105.74 1.77 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.061 177.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.48 -48.86 4.11 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.048 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 17.0 m . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.899 -0.572 . . . . 0.0 110.454 -176.93 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 1.647 ' HE1' ' CE2' ' A' ' 1' ' ' PHE . 29.2 p90 . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 110.713 -0.106 . . . . 0.0 110.713 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 63.66 84.06 0.15 Allowed 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.719 0.637 . . . . 0.0 111.41 -176.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.53 55.7 4.68 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.237 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.15 34.77 0.52 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.112 0.482 . . . . 0.0 110.428 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 72.4 mtm -89.96 -13.82 35.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.53 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 91' ' ' LEU . . . -109.92 99.54 8.64 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.765 177.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 48.5 mtt -105.11 167.68 9.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.754 -172.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 1.654 ' HD1' ' CD2' ' A' ' 8' ' ' PHE . 70.4 t80 -69.46 146.36 52.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.21 0.529 . . . . 0.0 112.191 -175.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.456 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 92.2 t90 -136.7 145.58 44.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.025 176.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.53 146.6 16.3 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.531 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.456 ' HB2' ' CH2' ' A' ' 9' ' ' TRP . 43.6 tp -138.48 109.9 6.98 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.885 0.374 . . . . 0.0 110.507 177.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -97.33 105.12 17.22 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.6 ' SD ' HD12 ' A' ' 87' ' ' LEU . 44.3 mtp -98.39 143.95 28.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.917 0.389 . . . . 0.0 111.038 -174.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.479 ' HB2' ' HG3' ' A' ' 17' ' ' ARG . 37.8 mtmm -100.98 157.7 33.16 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.367 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.491 ' HB3' ' HA ' ' A' ' 82' ' ' ASP . 91.1 Cg_exo -47.76 115.42 1.44 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.581 2.854 . . . . 0.0 113.66 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' A' ' 79' ' ' THR . 44.6 mt-10 59.8 58.36 2.84 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.368 0.604 . . . . 0.0 111.848 175.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.479 ' HG3' ' HB2' ' A' ' 14' ' ' LYS . 29.1 mmt180 -118.68 153.17 34.79 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.946 174.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.635 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 3.5 ttmp? -130.95 110.82 11.53 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 123.456 0.473 . . . . 0.0 110.958 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.43 ' HH ' ' HA ' ' A' ' 13' ' ' MET . 2.1 m-85 -111.38 112.6 24.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.885 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -75.14 114.56 13.77 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 171.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -92.81 114.09 26.54 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.426 -165.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.7 m -93.62 119.56 32.8 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.108 172.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.3 mt -96.79 113.01 30.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.99 0.424 . . . . 0.0 111.342 -173.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.449 HD13 ' N ' ' A' ' 24' ' ' ILE . 4.2 mp -88.91 -34.75 7.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.444 0.64 . . . . 0.0 109.342 177.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.406 ' HD2' HD11 ' A' ' 91' ' ' LEU . 19.4 pttt -132.73 128.74 37.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.183 178.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.2 m -56.2 148.36 18.46 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.746 -176.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -157.97 162.87 38.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.717 0.77 . . . . 0.0 112.924 -178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.521 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 2.0 t60 -119.18 123.83 45.3 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.392 -1.277 . . . . 0.0 109.444 176.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 51.7 mt -85.27 134.68 26.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 170.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.528 ' HB2' ' HB3' ' B' ' 66' ' ' ASP . 61.7 p -117.55 -15.01 10.26 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -171.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -171.41 152.1 17.08 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 119.43 -1.367 . . . . 0.0 113.242 177.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.423 ' CG2' ' HG ' ' A' ' 87' ' ' LEU . 11.3 p -136.68 131.51 47.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 174.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.88 155.99 42.21 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.014 -0.429 . . . . 0.0 111.161 -176.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.4 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 4.1 pp -118.05 141.28 48.64 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.887 0.851 . . . . 0.0 111.925 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -110.07 -54.18 2.6 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.807 176.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.427 ' HZ2' ' HB3' ' A' ' 36' ' ' LYS . 6.9 ttpm? -100.85 128.12 47.02 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 171.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.523 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 139.25 161.57 8.78 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 119.705 -1.236 . . . . 0.0 113.373 176.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -103.4 -43.81 5.32 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -149.42 132.32 16.11 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 120.512 0.196 . . . . 0.0 111.043 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.74 113.8 13.98 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.409 0.624 . . . . 0.0 110.128 169.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 79' ' ' THR . 97.4 mttt -96.25 110.57 22.85 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 175.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.401 ' HG ' ' CG2' ' A' ' 53' ' ' VAL . 51.0 tp -87.02 109.76 19.61 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.025 -172.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.424 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 96.8 m-85 -108.25 141.85 39.42 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.252 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.552 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 1.5 tp -123.57 112.79 17.86 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.488 176.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -99.18 108.84 21.53 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.19 0.519 . . . . 0.0 109.855 176.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.66 140.9 37.03 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.529 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 53.33 41.93 32.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.526 0.679 . . . . 0.0 110.248 -178.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.2 mttp 69.87 21.46 6.32 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.414 172.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.573 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 79.2 mm-40 -128.36 137.44 51.9 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 122.211 -0.306 . . . . 0.0 111.097 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -87.31 104.94 16.88 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 174.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 1.593 ' HE2' ' CE1' ' A' ' 51' ' ' TYR . 75.8 m-85 -99.83 120.22 39.41 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.775 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -77.36 99.96 2.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 170.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.493 HG13 ' CD2' ' E' ' 88' ' ' LEU . 18.5 m -86.97 -34.58 7.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.817 -172.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.524 ' HB1' ' CD2' ' A' ' 65' ' ' LEU . . . -151.13 140.83 21.75 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.107 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.7 m -111.52 101.25 9.68 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 169.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.15 113.71 43.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.724 0.773 . . . . 0.0 110.052 -176.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 78.2 p -123.27 -177.89 3.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.204 -175.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -64.0 -24.22 67.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.025 0.441 . . . . 0.0 110.53 169.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.39 -40.52 43.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.169 176.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.6 mt -116.84 81.92 12.53 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 173.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.94 -5.15 12.77 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.206 2.604 . . . . 0.0 114.133 -167.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -160.48 128.62 4.61 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.129 0.49 . . . . 0.0 111.189 -175.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.2 t -118.45 108.19 23.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.408 175.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.71 121.46 30.17 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 174.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.524 ' CD2' ' HB1' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -143.66 168.79 19.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.147 0.499 . . . . 0.0 111.978 -174.42 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.54 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 9.5 t0 -116.36 107.13 14.43 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.739 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.541 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 32.9 mt -126.37 107.74 10.58 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 177.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -111.08 127.87 55.69 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.913 -178.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 1.65 ' HE1' ' CE2' ' A' ' 69' ' ' PHE . 10.9 m-85 -127.19 150.32 49.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.908 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.0 m -102.59 161.78 13.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.057 0.456 . . . . 0.0 110.748 176.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -69.34 -5.1 21.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.159 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.78 -7.72 62.66 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.446 -0.661 . . . . 0.0 111.446 173.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -100.28 143.55 30.33 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -122.97 125.59 45.57 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 174.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.487 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 15.0 pt -132.06 172.18 16.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.744 -171.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 7.9 mtm -130.04 131.68 45.92 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 170.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 1.625 ' HE1' ' CE2' ' A' ' 77' ' ' PHE . 0.9 OUTLIER -110.25 128.33 55.45 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 177.348 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 1.625 ' HE2' ' CE1' ' A' ' 78' ' ' TYR . 40.9 p90 -153.69 140.43 19.01 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.292 -0.563 . . . . 0.0 112.12 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 8.0 p -111.92 136.43 51.24 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.25 -177.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.61 161.07 14.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.232 174.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.485 ' O ' ' HG3' ' A' ' 16' ' ' GLU . . . 81.97 177.27 51.73 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -173.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.491 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 7.0 p-10 -112.97 104.11 12.07 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 118.284 -1.367 . . . . 0.0 110.848 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.523 ' CB ' ' HA3' ' A' ' 37' ' ' GLY . . . -164.76 153.26 12.37 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 113.734 -1.575 . . . . 0.0 109.882 169.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.6 p -104.97 123.39 47.7 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 177.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.4 ' CG1' ' HB3' ' A' ' 34' ' ' LEU . 3.6 m -118.23 144.43 26.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.556 0.693 . . . . 0.0 112.776 -173.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.8 m -108.02 116.25 31.61 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.739 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.6 HD12 ' SD ' ' A' ' 13' ' ' MET . 4.5 mp -96.02 143.02 27.55 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 170.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.518 ' CD2' HG13 ' B' ' 53' ' ' VAL . 2.6 mm? -124.97 152.04 44.71 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 174.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.6 -167.86 30.73 Favored Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.429 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -139.15 131.42 28.3 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.498 0.666 . . . . 0.0 110.805 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.559 ' O ' ' HA ' ' A' ' 6' ' ' ALA . 24.1 mt -62.68 131.73 49.93 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.892 173.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.65 -179.46 4.13 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.747 -176.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -41.82 107.96 0.09 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.392 1.058 . . . . 0.0 112.192 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 47.1 mt -68.74 -13.51 17.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.715 174.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.58 ' OD1' ' HA ' ' E' ' 1' ' ' PHE . 40.5 t0 70.78 59.65 0.2 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.148 175.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.9 p -105.67 -33.74 7.95 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.206 175.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.408 ' HA2' ' CZ ' ' A' ' 1' ' ' PHE . . . -133.76 34.35 2.42 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.407 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 31.6 t . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.831 -179.57 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 1.626 ' HE1' ' CE2' ' B' ' 1' ' ' PHE . 29.5 p90 . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 110.735 -0.098 . . . . 0.0 110.735 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 63.73 83.99 0.15 Allowed 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.717 0.636 . . . . 0.0 111.455 -176.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.5 55.66 4.67 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.233 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.07 34.73 0.53 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.104 0.478 . . . . 0.0 110.365 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 72.4 mtm -89.84 -13.81 35.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.594 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' B' ' 91' ' ' LEU . . . -109.98 99.57 8.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.747 177.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 48.5 mtt -105.07 167.72 9.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.788 -172.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 1.627 ' HE2' ' CE1' ' B' ' 8' ' ' PHE . 70.5 t80 -69.42 146.35 52.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.231 0.539 . . . . 0.0 112.19 -175.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . 0.457 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 92.1 t90 -136.73 145.58 44.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.981 176.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.4 146.66 16.45 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.589 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.457 ' HB2' ' CH2' ' B' ' 9' ' ' TRP . 43.9 tp -138.44 109.84 6.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.792 0.329 . . . . 0.0 110.531 177.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -97.41 105.07 17.16 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' MET . . . . . 0.611 ' SD ' HD12 ' B' ' 87' ' ' LEU . 44.3 mtp -98.33 143.88 28.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.111 -174.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.48 ' HB2' ' HG3' ' B' ' 17' ' ' ARG . 37.9 mtmm -101.02 157.77 33.03 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.256 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.502 ' HB3' ' HA ' ' B' ' 82' ' ' ASP . 93.4 Cg_exo -47.86 115.4 1.45 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.619 2.879 . . . . 0.0 113.629 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.651 ' HA ' ' O ' ' B' ' 79' ' ' THR . 44.5 mt-10 59.87 58.39 2.8 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 121.256 0.55 . . . . 0.0 111.841 175.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.48 ' HG3' ' HB2' ' B' ' 14' ' ' LYS . 29.0 mmt180 -118.8 153.19 34.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.891 174.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . 0.634 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 3.5 ttmp? -130.91 110.68 11.45 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.04 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' TYR . . . . . 0.426 ' HH ' ' HA ' ' B' ' 13' ' ' MET . 2.1 m-85 -111.33 112.59 24.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.909 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 4.5 p -75.1 114.61 13.8 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 171.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -92.82 114.04 26.48 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.425 -165.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 22.9 m -93.51 119.46 32.61 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.175 172.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 42.1 mt -96.78 112.9 29.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.05 0.452 . . . . 0.0 111.407 -173.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.451 HD13 ' N ' ' B' ' 24' ' ' ILE . 4.2 mp -88.86 -34.78 7.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.302 177.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 19.5 pttt -132.75 128.74 37.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.088 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -56.21 148.35 18.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.84 -177.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -157.96 162.91 38.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.702 0.763 . . . . 0.0 112.881 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' HIS . . . . . 0.519 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 2.0 t60 -119.24 123.83 45.24 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.345 176.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.543 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 51.6 mt -85.27 134.6 26.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 170.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.553 ' HB2' ' HB3' ' C' ' 66' ' ' ASP . 61.5 p -117.48 -15.01 10.31 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -171.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -171.38 152.15 17.24 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.443 -1.361 . . . . 0.0 113.245 177.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.415 ' CG2' ' HG ' ' B' ' 87' ' ' LEU . 11.2 p -136.67 131.53 47.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 174.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.91 156.01 42.22 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.066 -0.396 . . . . 0.0 111.134 -176.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.407 ' HB3' ' CG1' ' B' ' 85' ' ' VAL . 4.1 pp -118.08 141.42 48.5 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.848 0.833 . . . . 0.0 111.96 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -110.17 -54.17 2.6 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.768 176.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.432 ' HB3' ' HZ2' ' B' ' 36' ' ' LYS . 6.9 ttpm? -100.92 128.1 47.1 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.862 171.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.532 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 139.32 161.55 8.77 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 119.583 -1.294 . . . . 0.0 113.35 176.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -103.32 -43.83 5.33 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 178.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -149.44 132.41 16.18 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.543 0.211 . . . . 0.0 110.983 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.84 113.71 13.82 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.388 0.613 . . . . 0.0 110.12 169.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' B' ' 79' ' ' THR . 97.3 mttt -96.22 110.59 22.86 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.407 ' HG ' ' CG2' ' B' ' 53' ' ' VAL . 51.1 tp -87.05 109.73 19.6 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.062 -172.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . 0.42 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 96.7 m-85 -108.2 141.85 39.32 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.293 178.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.558 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 1.5 tp -123.58 112.84 17.92 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.451 176.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -99.21 108.86 21.55 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.178 0.513 . . . . 0.0 109.82 176.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.69 140.97 36.97 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.535 -177.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 53.25 41.95 32.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.557 0.694 . . . . 0.0 110.238 -177.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 39.2 mttp 69.93 21.41 6.26 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.404 172.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.564 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 79.1 mm-40 -128.33 137.49 51.95 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.055 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -87.27 104.88 16.82 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 1.649 ' HD2' ' CD1' ' B' ' 51' ' ' TYR . 76.0 m-85 -99.92 120.27 39.53 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.71 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -77.33 99.98 2.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 170.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.518 HG13 ' CD2' ' A' ' 88' ' ' LEU . 18.9 m -86.92 -34.68 7.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.878 -172.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.519 ' HB1' ' CD2' ' B' ' 65' ' ' LEU . . . -151.08 140.79 21.77 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 120.383 -0.527 . . . . 0.0 112.139 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 21.8 m -111.47 101.29 9.74 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 169.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.23 113.73 43.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.707 0.765 . . . . 0.0 110.052 -176.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 74.6 p -123.3 -177.82 3.81 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.201 -175.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -63.98 -24.27 67.65 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.508 169.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.33 -40.58 43.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.291 0.567 . . . . 0.0 110.187 176.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 79.8 mt -116.82 81.99 12.56 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 173.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.07 -5.16 12.93 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.232 2.621 . . . . 0.0 114.053 -167.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -160.42 128.63 4.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.273 0.558 . . . . 0.0 111.242 -175.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.404 HG12 ' HB3' ' B' ' 54' ' ' ALA . 88.9 t -118.58 108.23 23.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.462 175.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.72 121.47 30.19 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 174.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.519 ' CD2' ' HB1' ' B' ' 54' ' ' ALA . 0.4 OUTLIER -143.65 168.78 19.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.074 0.464 . . . . 0.0 112.009 -174.459 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . 0.528 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 9.4 t0 -116.32 107.13 14.44 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.772 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.543 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 32.7 mt -126.38 107.69 10.53 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 177.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -111.16 127.9 55.73 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.915 -178.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . 1.661 ' HD1' ' CD2' ' B' ' 69' ' ' PHE . 11.0 m-85 -127.13 150.34 49.54 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.883 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 58.1 m -102.62 161.78 13.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.071 0.462 . . . . 0.0 110.748 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -69.19 -5.22 21.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.231 177.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.79 -7.62 62.73 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 173.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -100.32 143.53 30.4 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -123.0 125.63 45.61 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 174.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.492 ' HB ' ' CD1' ' B' ' 44' ' ' LEU . 15.1 pt -132.07 172.15 16.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.718 -171.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' MET . . . . . . . . . . . . . 7.9 mtm -129.97 131.7 46.03 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 170.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . 1.651 ' HE1' ' CE2' ' B' ' 77' ' ' PHE . 0.9 OUTLIER -110.22 128.32 55.43 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.29 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 1.66 ' HE2' ' CE1' ' B' ' 78' ' ' TYR . 41.1 p90 -153.6 140.42 19.1 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.299 -0.56 . . . . 0.0 112.098 -178.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.651 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 8.1 p -111.91 136.48 51.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.216 -177.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.65 161.06 14.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.207 174.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.483 ' O ' ' HG3' ' B' ' 16' ' ' GLU . . . 81.93 177.38 51.78 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -173.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' ASP . . . . . 0.502 ' HA ' ' HB3' ' B' ' 15' ' ' PRO . 6.9 p-10 -113.14 104.18 12.1 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 118.267 -1.373 . . . . 0.0 110.82 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.532 ' CB ' ' HA3' ' B' ' 37' ' ' GLY . . . -164.83 153.25 12.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 113.638 -1.619 . . . . 0.0 109.861 169.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 6.7 p -104.96 123.4 47.71 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.407 ' CG1' ' HB3' ' B' ' 34' ' ' LEU . 3.5 m -118.21 144.44 26.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.571 0.7 . . . . 0.0 112.744 -173.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 50.9 m -108.11 116.25 31.62 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.704 175.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.611 HD12 ' SD ' ' B' ' 13' ' ' MET . 4.5 mp -96.04 143.14 27.45 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 170.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.5 ' CD2' HG13 ' C' ' 53' ' ' VAL . 2.6 mm? -125.09 151.96 44.99 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 174.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.55 -167.89 30.73 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.328 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -139.11 131.46 28.44 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.515 0.674 . . . . 0.0 110.851 176.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' B' ' 6' ' ' ALA . 23.4 mt -62.65 131.62 49.61 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.923 173.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.61 -179.48 4.11 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 123.36 0.413 . . . . 0.0 110.699 -176.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -41.79 108.03 0.09 Allowed 'General case' 0 C--N 1.326 -0.424 0 O-C-N 124.4 1.062 . . . . 0.0 112.242 -175.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 47.2 mt -68.85 -13.45 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.673 0.749 . . . . 0.0 109.729 174.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . 0.66 ' OD1' ' HA ' ' A' ' 1' ' ' PHE . 40.4 t0 70.82 59.53 0.2 Allowed 'General case' 0 CA--C 1.523 -0.08 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.212 175.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 7.7 p -105.61 -33.63 8.01 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.166 175.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 97' ' ' GLY . . . . . 0.414 ' HA2' ' CZ ' ' B' ' 1' ' ' PHE . . . -133.79 34.29 2.42 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.367 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 31.9 t . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.461 -0.78 . . . . 0.0 109.805 -179.598 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 1' ' ' PHE . . . . . 1.642 ' HE2' ' CE1' ' C' ' 1' ' ' PHE . 29.4 p90 . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 110.709 -0.108 . . . . 0.0 110.709 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 63.81 83.95 0.16 Allowed 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.646 0.592 . . . . 0.0 111.475 -176.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.48 55.65 4.67 Favored Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.258 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.13 34.63 0.53 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.172 0.51 . . . . 0.0 110.364 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 72.4 mtm -89.8 -13.79 35.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.594 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 6' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' C' ' 91' ' ' LEU . . . -110.03 99.65 8.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.728 177.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 48.6 mtt -105.27 167.75 9.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.666 -172.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 8' ' ' PHE . . . . . 1.651 ' HD1' ' CD2' ' C' ' 8' ' ' PHE . 70.6 t80 -69.41 146.36 52.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.284 0.564 . . . . 0.0 112.174 -175.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . 0.453 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 92.2 t90 -136.7 145.5 44.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.008 176.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.47 146.6 16.31 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.575 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.453 ' HB2' ' CH2' ' C' ' 9' ' ' TRP . 44.0 tp -138.37 109.87 7.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.834 0.35 . . . . 0.0 110.56 177.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -97.33 105.01 17.08 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 13' ' ' MET . . . . . 0.606 ' SD ' HD12 ' C' ' 87' ' ' LEU . 44.2 mtp -98.34 144.0 28.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.994 0.426 . . . . 0.0 111.041 -174.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . 0.477 ' HB2' ' HG3' ' C' ' 17' ' ' ARG . 37.8 mtmm -101.13 157.7 33.17 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.25 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . 0.506 ' HB3' ' HA ' ' C' ' 82' ' ' ASP . 92.2 Cg_exo -47.78 115.43 1.45 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.609 2.873 . . . . 0.0 113.585 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' C' ' 79' ' ' THR . 44.5 mt-10 59.81 58.36 2.83 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.306 0.574 . . . . 0.0 111.874 175.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 17' ' ' ARG . . . . . 0.477 ' HG3' ' HB2' ' C' ' 14' ' ' LYS . 29.0 mmt180 -118.72 153.24 34.71 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.939 174.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 18' ' ' LYS . . . . . 0.639 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 3.5 ttmp? -130.98 110.81 11.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.0 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . 0.422 ' HH ' ' HA ' ' C' ' 13' ' ' MET . 2.1 m-85 -111.41 112.63 24.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.848 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 4.4 p -75.2 114.7 14.02 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 172.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -92.97 114.11 26.57 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.43 -165.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 24.0 m -93.53 119.52 32.69 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.124 172.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 42.4 mt -96.84 112.97 30.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.158 0.504 . . . . 0.0 111.324 -173.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . 0.445 HD13 ' N ' ' C' ' 24' ' ' ILE . 4.2 mp -88.88 -34.76 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.294 177.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 19.4 pttt -132.76 128.76 37.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.097 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 16.2 m -56.25 148.4 18.54 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.806 -177.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 27' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -158.02 162.88 38.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.722 0.772 . . . . 0.0 112.867 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 28' ' ' HIS . . . . . 0.526 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 2.0 t60 -119.19 123.84 45.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.392 176.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . 0.539 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 51.5 mt -85.21 134.64 26.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 170.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 30' ' ' SER . . . . . 0.526 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 61.8 p -117.5 -15.03 10.29 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -171.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -171.36 152.1 17.14 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 119.517 -1.325 . . . . 0.0 113.27 177.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.42 ' CG2' ' HG ' ' C' ' 87' ' ' LEU . 11.2 p -136.68 131.54 47.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 174.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.91 155.98 42.18 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 122.017 -0.427 . . . . 0.0 111.187 -176.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.406 ' HB3' HG13 ' C' ' 85' ' ' VAL . 4.1 pp -118.09 141.39 48.53 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.889 0.852 . . . . 0.0 111.918 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -110.16 -54.16 2.6 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.216 -1.356 . . . . 0.0 108.776 176.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 36' ' ' LYS . . . . . 0.426 ' HZ2' ' HB3' ' C' ' 36' ' ' LYS . 6.9 ttpm? -100.89 128.19 47.03 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 171.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 37' ' ' GLY . . . . . 0.535 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 139.25 161.51 8.75 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 119.532 -1.318 . . . . 0.0 113.319 176.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -103.32 -43.77 5.34 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 178.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -149.49 132.31 16.04 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 120.504 0.192 . . . . 0.0 111.039 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.72 113.72 13.89 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.41 0.624 . . . . 0.0 110.141 169.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' C' ' 79' ' ' THR . 97.4 mttt -96.28 110.67 22.95 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 175.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.403 ' HG ' ' CG2' ' C' ' 53' ' ' VAL . 51.1 tp -87.14 109.77 19.67 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.982 -172.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 43' ' ' TYR . . . . . 0.423 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 96.7 m-85 -108.24 141.81 39.45 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.284 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.558 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 1.5 tp -123.56 112.75 17.82 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.532 176.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -99.16 108.78 21.48 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.143 0.497 . . . . 0.0 109.795 176.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.69 140.97 36.99 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.551 -177.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 53.19 41.97 32.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.575 0.703 . . . . 0.0 110.33 -177.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 39.2 mttp 69.95 21.38 6.25 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 114.843 -1.072 . . . . 0.0 112.39 172.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . 0.574 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 79.2 mm-40 -128.3 137.48 51.97 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.07 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -87.26 104.98 16.91 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 174.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 1.603 ' HE2' ' CE1' ' C' ' 51' ' ' TYR . 76.0 m-85 -99.98 120.26 39.54 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.698 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -77.31 99.92 2.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 170.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 53' ' ' VAL . . . . . 0.5 HG13 ' CD2' ' B' ' 88' ' ' LEU . 18.7 m -86.92 -34.66 7.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.85 -172.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 54' ' ' ALA . . . . . 0.522 ' HB1' ' CD2' ' C' ' 65' ' ' LEU . . . -151.06 140.92 21.91 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 120.343 -0.543 . . . . 0.0 112.092 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 21.4 m -111.5 101.34 9.77 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 169.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.26 113.69 43.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.757 0.789 . . . . 0.0 110.038 -176.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 77.2 p -123.22 -177.83 3.81 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.194 -175.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -64.05 -24.16 67.6 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.007 0.432 . . . . 0.0 110.52 169.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.4 -40.55 43.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.198 0.523 . . . . 0.0 110.125 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 79.5 mt -116.81 81.96 12.52 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 173.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.02 -5.09 12.69 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.218 2.612 . . . . 0.0 114.119 -167.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -160.49 128.61 4.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.185 0.517 . . . . 0.0 111.266 -175.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.4 HG12 ' HB3' ' C' ' 54' ' ' ALA . 88.0 t -118.54 108.21 23.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.43 175.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.7 121.4 30.08 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . 0.522 ' CD2' ' HB1' ' C' ' 54' ' ' ALA . 0.4 OUTLIER -143.65 168.88 18.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.17 0.51 . . . . 0.0 111.954 -174.554 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 66' ' ' ASP . . . . . 0.553 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 9.4 t0 -116.35 107.16 14.47 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.79 178.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . 0.539 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 32.8 mt -126.5 107.76 10.54 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -111.08 127.79 55.67 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.958 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 69' ' ' PHE . . . . . 1.669 ' HD2' ' CD1' ' C' ' 69' ' ' PHE . 11.0 m-85 -127.07 150.26 49.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.919 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 58.1 m -102.56 161.77 13.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.978 0.418 . . . . 0.0 110.733 176.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -69.23 -5.22 21.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.194 177.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.76 -7.66 62.75 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 173.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -100.3 143.51 30.4 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -122.99 125.65 45.66 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . 0.489 ' HB ' ' CD1' ' C' ' 44' ' ' LEU . 15.1 pt -132.05 172.18 16.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.663 -171.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 76' ' ' MET . . . . . . . . . . . . . 7.8 mtm -129.99 131.64 45.97 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 170.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 77' ' ' PHE . . . . . 1.648 ' HD1' ' CD2' ' C' ' 77' ' ' PHE . 0.9 OUTLIER -110.17 128.28 55.39 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.274 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 78' ' ' TYR . . . . . 1.661 ' HD2' ' CD1' ' C' ' 78' ' ' TYR . 41.0 p90 -153.61 140.42 19.09 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.291 -0.564 . . . . 0.0 112.116 -178.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 79' ' ' THR . . . . . 0.649 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 8.2 p -111.91 136.4 51.28 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.25 -177.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.59 161.05 14.45 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.29 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . 0.483 ' O ' ' HG3' ' C' ' 16' ' ' GLU . . . 81.96 177.24 51.71 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -173.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 82' ' ' ASP . . . . . 0.506 ' HA ' ' HB3' ' C' ' 15' ' ' PRO . 6.9 p-10 -112.94 104.21 12.18 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 118.304 -1.358 . . . . 0.0 110.873 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . 0.535 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -164.82 153.25 12.24 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.66 -1.609 . . . . 0.0 109.869 169.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 6.4 p -104.96 123.4 47.7 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.406 HG13 ' HB3' ' C' ' 34' ' ' LEU . 3.6 m -118.24 144.48 26.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.582 0.706 . . . . 0.0 112.765 -173.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 50.6 m -108.14 116.22 31.57 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.67 175.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . 0.606 HD12 ' SD ' ' C' ' 13' ' ' MET . 4.5 mp -96.04 143.15 27.44 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 170.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . 0.492 ' CD2' HG13 ' D' ' 53' ' ' VAL . 2.6 mm? -125.06 151.97 44.94 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 174.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.55 -167.9 30.75 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.443 177.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -139.06 131.47 28.54 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.432 0.634 . . . . 0.0 110.852 176.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . 0.548 ' O ' ' HA ' ' C' ' 6' ' ' ALA . 23.7 mt -62.78 131.7 49.73 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.537 -1.21 . . . . 0.0 108.943 173.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.59 -179.54 4.14 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 123.36 0.412 . . . . 0.0 110.654 -176.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -41.73 107.98 0.09 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.455 1.097 . . . . 0.0 112.239 -175.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 47.2 mt -68.83 -13.54 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.714 0.768 . . . . 0.0 109.72 174.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 95' ' ' ASP . . . . . 0.681 ' OD1' ' HA ' ' B' ' 1' ' ' PHE . 40.4 t0 70.78 59.75 0.2 Allowed 'General case' 0 N--CA 1.46 0.059 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.169 175.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 7.7 p -105.77 -33.66 7.93 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.159 175.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . 0.402 ' HA2' ' CZ ' ' C' ' 1' ' ' PHE . . . -133.79 34.27 2.43 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.377 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 C--O 1.245 0.857 0 CA-C-O 118.557 -0.735 . . . . 0.0 109.911 -179.515 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . 1.663 ' HE1' ' CE2' ' D' ' 1' ' ' PHE . 29.5 p90 . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 110.708 -0.108 . . . . 0.0 110.708 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 63.65 83.97 0.15 Allowed 'General case' 0 N--CA 1.464 0.263 0 O-C-N 123.653 0.595 . . . . 0.0 111.46 -176.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.41 55.65 4.65 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.287 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.19 34.75 0.52 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.156 0.503 . . . . 0.0 110.337 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 72.3 mtm -89.9 -13.81 35.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.635 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 6' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' D' ' 91' ' ' LEU . . . -110.07 99.56 8.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.756 177.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 48.6 mtt -105.15 167.71 9.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.757 -172.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 8' ' ' PHE . . . . . 1.665 ' HE1' ' CE2' ' D' ' 8' ' ' PHE . 70.7 t80 -69.35 146.37 52.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.217 0.532 . . . . 0.0 112.176 -175.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 9' ' ' TRP . . . . . 0.457 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 92.2 t90 -136.76 145.62 44.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.397 -0.819 . . . . 0.0 108.965 176.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.57 146.54 16.17 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.507 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . 0.457 ' HB2' ' CH2' ' D' ' 9' ' ' TRP . 44.0 tp -138.38 109.84 6.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.837 0.351 . . . . 0.0 110.595 177.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -97.29 105.04 17.12 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 13' ' ' MET . . . . . 0.604 ' SD ' HD12 ' D' ' 87' ' ' LEU . 44.5 mtp -98.42 143.94 28.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.965 0.412 . . . . 0.0 111.011 -174.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 14' ' ' LYS . . . . . 0.471 ' HB2' ' HG3' ' D' ' 17' ' ' ARG . 37.8 mtmm -101.04 157.74 33.09 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.257 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . 0.5 ' HB3' ' HA ' ' D' ' 82' ' ' ASP . 92.5 Cg_exo -47.81 115.36 1.42 Allowed 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.597 2.865 . . . . 0.0 113.686 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . 0.66 ' HA ' ' O ' ' D' ' 79' ' ' THR . 44.5 mt-10 59.88 58.38 2.79 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.333 0.587 . . . . 0.0 111.81 175.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 17' ' ' ARG . . . . . 0.471 ' HG3' ' HB2' ' D' ' 14' ' ' LYS . 29.0 mmt180 -118.72 153.12 34.91 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.899 174.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . 0.645 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 3.5 ttmp? -130.94 110.81 11.53 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.021 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 19' ' ' TYR . . . . . 0.417 ' HH ' ' HA ' ' D' ' 13' ' ' MET . 2.1 m-85 -111.32 112.55 24.4 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.942 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -75.08 114.66 13.83 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 171.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -92.96 114.12 26.59 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.386 -165.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 23.8 m -93.68 119.53 32.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.126 172.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 42.6 mt -96.82 112.96 29.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.112 0.482 . . . . 0.0 111.36 -173.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . 0.446 ' N ' HD13 ' D' ' 24' ' ' ILE . 4.2 mp -88.81 -34.8 7.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.354 177.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 19.4 pttt -132.67 128.81 37.83 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.077 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -56.21 148.36 18.49 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.757 -177.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 27' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -158.06 162.93 38.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.782 0.801 . . . . 0.0 112.842 -178.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 28' ' ' HIS . . . . . 0.535 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 2.0 t60 -119.2 123.83 45.29 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.401 176.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 29' ' ' ILE . . . . . 0.535 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 51.3 mt -85.29 134.65 26.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 170.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 30' ' ' SER . . . . . 0.549 ' HB2' ' HB3' ' E' ' 66' ' ' ASP . 61.2 p -117.53 -15.0 10.28 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -171.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 31' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -171.35 152.07 17.09 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 119.488 -1.339 . . . . 0.0 113.246 177.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . 0.422 ' CG2' ' HG ' ' D' ' 87' ' ' LEU . 11.4 p -136.62 131.49 47.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 174.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.86 156.01 42.24 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 122.057 -0.402 . . . . 0.0 111.185 -176.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 34' ' ' LEU . . . . . 0.409 ' HB3' ' CG1' ' D' ' 85' ' ' VAL . 4.1 pp -118.07 141.41 48.5 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.869 0.842 . . . . 0.0 111.905 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -110.18 -54.21 2.6 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.232 -1.349 . . . . 0.0 108.806 176.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 36' ' ' LYS . . . . . 0.431 ' HZ2' ' HB3' ' D' ' 36' ' ' LYS . 6.9 ttpm? -100.83 128.1 47.01 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.827 171.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . 0.533 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 139.27 161.54 8.77 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 119.64 -1.267 . . . . 0.0 113.378 176.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -103.34 -43.79 5.33 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 178.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -149.43 132.28 16.07 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 120.529 0.204 . . . . 0.0 111.048 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.76 113.74 13.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.405 0.621 . . . . 0.0 110.146 169.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' D' ' 79' ' ' THR . 97.3 mttt -96.21 110.54 22.82 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 175.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.402 ' HG ' ' CG2' ' D' ' 53' ' ' VAL . 50.9 tp -87.0 109.71 19.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.005 -172.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 43' ' ' TYR . . . . . 0.428 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 96.6 m-85 -108.23 141.88 39.32 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.303 178.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.559 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 1.5 tp -123.61 112.81 17.87 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.489 176.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 45' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -99.19 108.84 21.53 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.14 0.495 . . . . 0.0 109.806 176.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.67 140.96 37.02 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.51 -177.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 53.26 41.9 32.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.506 0.669 . . . . 0.0 110.273 -178.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 39.2 mttp 69.94 21.5 6.22 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.389 172.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . 0.576 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 79.2 mm-40 -128.41 137.48 51.88 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.055 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -87.35 105.02 16.97 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 174.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . 1.621 ' HE2' ' CE1' ' D' ' 51' ' ' TYR . 75.9 m-85 -99.93 120.29 39.56 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.657 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -77.31 99.92 2.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 170.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 53' ' ' VAL . . . . . 0.492 HG13 ' CD2' ' C' ' 88' ' ' LEU . 18.5 m -86.99 -34.62 7.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.818 -172.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 54' ' ' ALA . . . . . 0.516 ' HB1' ' CD2' ' D' ' 65' ' ' LEU . . . -151.11 140.86 21.81 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 120.361 -0.535 . . . . 0.0 112.085 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 21.9 m -111.57 101.3 9.71 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 169.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.18 113.65 43.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.724 0.774 . . . . 0.0 110.036 -176.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 76.9 p -123.2 -177.86 3.81 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.25 -175.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -64.03 -24.19 67.61 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.01 0.433 . . . . 0.0 110.535 169.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.33 -40.58 43.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.192 176.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 79.5 mt -116.81 81.9 12.44 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 173.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.95 -5.19 12.87 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.264 2.643 . . . . 0.0 114.052 -167.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -160.44 128.57 4.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.351 0.596 . . . . 0.0 111.268 -175.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 89.8 t -118.43 108.16 23.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.455 175.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.78 121.54 30.32 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 174.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 65' ' ' LEU . . . . . 0.516 ' CD2' ' HB1' ' D' ' 54' ' ' ALA . 0.4 OUTLIER -143.65 168.88 18.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.113 0.482 . . . . 0.0 111.93 -174.541 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 66' ' ' ASP . . . . . 0.513 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 9.2 t0 -116.35 107.13 14.43 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.806 178.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . 0.535 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 32.8 mt -126.43 107.69 10.51 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 177.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -111.08 127.78 55.67 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.939 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 69' ' ' PHE . . . . . 1.661 ' HD2' ' CD1' ' D' ' 69' ' ' PHE . 11.0 m-85 -127.12 150.28 49.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.902 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 58.1 m -102.57 161.83 13.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.025 0.441 . . . . 0.0 110.739 176.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -69.32 -5.26 22.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.16 177.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.71 -7.65 62.83 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 173.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -100.29 143.53 30.38 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -122.98 125.67 45.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . 0.482 ' HB ' ' CD1' ' D' ' 44' ' ' LEU . 14.9 pt -132.08 172.22 16.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.625 -171.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 76' ' ' MET . . . . . . . . . . . . . 7.9 mtm -130.09 131.67 45.83 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 170.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 77' ' ' PHE . . . . . 1.655 ' HE2' ' CE1' ' D' ' 77' ' ' PHE . 0.9 OUTLIER -110.18 128.23 55.37 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.37 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 78' ' ' TYR . . . . . 1.624 ' HE1' ' CE2' ' D' ' 78' ' ' TYR . 41.1 p90 -153.6 140.33 19.0 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.312 -0.555 . . . . 0.0 112.172 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 79' ' ' THR . . . . . 0.66 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 8.3 p -111.83 136.51 51.02 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.295 -177.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.66 161.06 14.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.244 174.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' D' ' 16' ' ' GLU . . . 81.97 177.23 51.71 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -173.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 82' ' ' ASP . . . . . 0.5 ' HA ' ' HB3' ' D' ' 15' ' ' PRO . 6.9 p-10 -112.9 104.15 12.14 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 118.263 -1.375 . . . . 0.0 110.928 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.533 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -164.8 153.32 12.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.75 -1.568 . . . . 0.0 109.858 169.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 6.6 p -104.94 123.41 47.7 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.686 -0.486 . . . . 0.0 109.686 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . 0.409 ' CG1' ' HB3' ' D' ' 34' ' ' LEU . 3.6 m -118.23 144.5 26.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.603 0.716 . . . . 0.0 112.729 -173.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 50.6 m -108.11 116.32 31.75 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.704 175.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 87' ' ' LEU . . . . . 0.604 HD12 ' SD ' ' D' ' 13' ' ' MET . 4.5 mp -96.05 143.05 27.54 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 170.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . 0.503 ' CD2' HG13 ' E' ' 53' ' ' VAL . 2.6 mm? -125.08 152.09 44.8 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 174.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.6 -167.91 30.8 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.365 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -139.13 131.49 28.45 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.496 0.665 . . . . 0.0 110.836 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' D' ' 6' ' ' ALA . 23.7 mt -62.72 131.76 49.99 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.904 173.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.72 -179.38 4.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.707 -176.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -41.88 107.95 0.09 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.31 1.006 . . . . 0.0 112.213 -175.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 46.7 mt -68.73 -13.58 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.736 0.779 . . . . 0.0 109.7 174.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 95' ' ' ASP . . . . . 0.619 ' OD1' ' HA ' ' C' ' 1' ' ' PHE . 40.3 t0 70.9 59.59 0.19 Allowed 'General case' 0 CA--C 1.524 -0.043 0 CA-C-N 114.463 -1.244 . . . . 0.0 111.163 175.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 7.9 p -105.74 -33.57 7.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.189 175.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 97' ' ' GLY . . . . . 0.412 ' HA2' ' CZ ' ' D' ' 1' ' ' PHE . . . -133.87 34.37 2.41 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.365 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 31.7 t . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.454 -0.784 . . . . 0.0 109.844 -179.621 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' E' E ' 1' ' ' PHE . . . . . 1.664 ' HE1' ' CE2' ' E' ' 1' ' ' PHE . 29.6 p90 . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 110.699 -0.112 . . . . 0.0 110.699 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 63.67 83.97 0.15 Allowed 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.761 0.663 . . . . 0.0 111.463 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.54 55.69 4.68 Favored Glycine 0 N--CA 1.453 -0.204 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.265 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.15 34.7 0.52 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.108 0.48 . . . . 0.0 110.385 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 72.3 mtm -89.95 -13.73 35.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.517 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 6' ' ' ALA . . . . . 0.546 ' HA ' ' O ' ' E' ' 91' ' ' LEU . . . -110.1 99.59 8.65 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 177.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 48.5 mtt -105.09 167.68 9.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.834 -172.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 8' ' ' PHE . . . . . 1.66 ' HE1' ' CE2' ' E' ' 8' ' ' PHE . 70.7 t80 -69.36 146.35 52.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.163 0.506 . . . . 0.0 112.169 -175.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 9' ' ' TRP . . . . . 0.449 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 92.2 t90 -136.79 145.53 44.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.997 176.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.41 146.63 16.39 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.61 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . 0.465 ' HB3' ' HB2' ' E' ' 87' ' ' LEU . 43.8 tp -138.54 109.94 6.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.943 0.402 . . . . 0.0 110.55 177.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -97.37 105.05 17.13 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 176.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 13' ' ' MET . . . . . 0.6 ' SD ' HD12 ' E' ' 87' ' ' LEU . 44.6 mtp -98.4 143.95 28.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.993 0.425 . . . . 0.0 110.98 -174.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 14' ' ' LYS . . . . . 0.471 ' HB2' ' HG3' ' E' ' 17' ' ' ARG . 37.8 mtmm -101.07 157.8 32.97 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.334 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . 0.494 ' HB3' ' HA ' ' E' ' 82' ' ' ASP . 91.5 Cg_exo -47.88 115.35 1.43 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.588 2.859 . . . . 0.0 113.703 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 16' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' E' ' 79' ' ' THR . 44.4 mt-10 59.99 58.35 2.76 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.712 0.633 . . . . 0.0 111.728 175.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 17' ' ' ARG . . . . . 0.471 ' HG3' ' HB2' ' E' ' 14' ' ' LYS . 29.1 mmt180 -118.73 153.1 34.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.942 174.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . 0.643 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 3.5 ttmp? -130.88 110.83 11.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.032 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . 0.428 ' HH ' ' HA ' ' E' ' 13' ' ' MET . 2.1 m-85 -111.38 112.55 24.38 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.895 179.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 4.5 p -75.13 114.67 13.9 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -92.93 114.06 26.52 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.353 -165.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 23.8 m -93.62 119.58 32.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.079 172.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 42.4 mt -96.85 112.96 30.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.131 0.491 . . . . 0.0 111.275 -173.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . 0.45 ' N ' HD13 ' E' ' 24' ' ' ILE . 4.2 mp -88.84 -34.79 7.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.329 177.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . 0.406 ' HD2' HD11 ' E' ' 91' ' ' LEU . 19.3 pttt -132.77 128.73 37.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.116 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -56.18 148.38 18.32 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.775 -177.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 27' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -157.99 162.94 38.21 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.691 0.757 . . . . 0.0 112.916 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 28' ' ' HIS . . . . . 0.532 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 2.0 t60 -119.16 123.9 45.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.341 -1.299 . . . . 0.0 109.427 176.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 29' ' ' ILE . . . . . 0.543 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 51.2 mt -85.32 134.65 26.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 170.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 30' ' ' SER . . . . . 0.54 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 61.9 p -117.44 -15.14 10.32 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -171.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 31' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -171.34 152.08 17.11 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 119.498 -1.335 . . . . 0.0 113.33 177.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . 0.423 ' CG2' ' HG ' ' E' ' 87' ' ' LEU . 11.3 p -136.63 131.54 47.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 174.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.93 155.96 42.16 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.068 -0.395 . . . . 0.0 111.174 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 34' ' ' LEU . . . . . 0.408 ' HB3' ' CG1' ' E' ' 85' ' ' VAL . 4.1 pp -117.98 141.37 48.52 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.886 0.85 . . . . 0.0 111.93 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -110.22 -54.16 2.6 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.177 -1.374 . . . . 0.0 108.801 176.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 36' ' ' LYS . . . . . 0.425 ' HZ2' ' HB3' ' E' ' 36' ' ' LYS . 6.9 ttpm? -100.85 128.12 47.02 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 171.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . 0.524 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 139.19 161.5 8.75 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 119.586 -1.293 . . . . 0.0 113.333 176.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -103.24 -43.82 5.35 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 178.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -149.52 132.36 16.05 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.572 0.225 . . . . 0.0 111.023 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.79 113.71 13.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.345 0.593 . . . . 0.0 110.152 169.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 41' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' E' ' 79' ' ' THR . 97.4 mttt -96.32 110.62 22.91 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.402 ' HG ' ' CG2' ' E' ' 53' ' ' VAL . 51.1 tp -87.02 109.76 19.61 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.018 -172.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 43' ' ' TYR . . . . . 0.427 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 96.8 m-85 -108.31 141.85 39.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.268 178.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 44' ' ' LEU . . . . . 0.557 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 1.5 tp -123.62 112.84 17.9 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.388 176.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 45' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -99.19 108.9 21.6 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.209 0.528 . . . . 0.0 109.78 176.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.69 140.98 36.98 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.504 -177.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 53.25 41.95 32.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.604 0.716 . . . . 0.0 110.271 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 39.1 mttp 69.84 21.54 6.33 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.399 172.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 49' ' ' GLN . . . . . 0.576 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 79.2 mm-40 -128.45 137.44 51.82 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 122.245 -0.285 . . . . 0.0 111.066 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -87.27 105.02 16.95 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 174.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . 1.606 ' HE2' ' CE1' ' E' ' 51' ' ' TYR . 75.9 m-85 -99.99 120.26 39.54 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.681 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -77.42 99.97 2.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 171.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . 0.503 HG13 ' CD2' ' D' ' 88' ' ' LEU . 18.3 m -87.06 -34.53 7.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.789 -172.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 54' ' ' ALA . . . . . 0.512 ' HB1' ' CD2' ' E' ' 65' ' ' LEU . . . -151.07 140.86 21.84 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 120.352 -0.539 . . . . 0.0 112.104 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 21.7 m -111.51 101.22 9.66 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 169.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.19 113.67 43.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.757 0.789 . . . . 0.0 110.062 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 77.8 p -123.15 -177.74 3.77 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.236 -175.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -64.17 -24.18 67.58 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.478 169.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.38 -40.58 43.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.25 0.548 . . . . 0.0 110.114 176.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 79.6 mt -116.88 81.95 12.67 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 173.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.99 -5.13 12.76 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.174 2.583 . . . . 0.0 114.088 -167.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -160.48 128.69 4.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.231 0.539 . . . . 0.0 111.238 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 89.2 t -118.5 108.19 23.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.456 175.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.69 121.44 30.13 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 174.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . 0.512 ' CD2' ' HB1' ' E' ' 54' ' ' ALA . 0.4 OUTLIER -143.66 168.84 18.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.207 0.527 . . . . 0.0 111.951 -174.47 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' E' E ' 66' ' ' ASP . . . . . 0.549 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 9.3 t0 -116.32 107.16 14.48 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.772 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 67' ' ' LEU . . . . . 0.543 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 33.1 mt -126.49 107.71 10.5 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 177.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -111.07 127.91 55.7 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.907 -178.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 69' ' ' PHE . . . . . 1.666 ' HE2' ' CE1' ' E' ' 69' ' ' PHE . 11.1 m-85 -127.15 150.39 49.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.87 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 58.0 m -102.63 161.75 13.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.043 0.449 . . . . 0.0 110.795 176.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -69.29 -5.09 20.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.219 177.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.86 -7.55 62.67 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 173.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -100.32 143.45 30.5 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 178.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -122.95 125.72 45.84 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 174.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 75' ' ' ILE . . . . . 0.481 ' HB ' ' CD1' ' E' ' 44' ' ' LEU . 15.1 pt -132.03 172.2 16.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.666 -171.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 76' ' ' MET . . . . . . . . . . . . . 7.9 mtm -130.12 131.66 45.8 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 170.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 77' ' ' PHE . . . . . 1.652 ' HE2' ' CE1' ' E' ' 77' ' ' PHE . 0.9 OUTLIER -110.21 128.36 55.45 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 177.292 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' E' E ' 78' ' ' TYR . . . . . 1.67 ' HE1' ' CE2' ' E' ' 78' ' ' TYR . 40.9 p90 -153.64 140.41 19.05 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.287 -0.565 . . . . 0.0 112.112 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 79' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 8.3 p -111.88 136.36 51.28 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.28 -177.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.55 161.03 14.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.258 174.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 81' ' ' GLY . . . . . 0.473 ' O ' ' HG3' ' E' ' 16' ' ' GLU . . . 81.99 177.2 51.7 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -173.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 82' ' ' ASP . . . . . 0.494 ' HA ' ' HB3' ' E' ' 15' ' ' PRO . 6.9 p-10 -112.88 104.21 12.2 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 118.276 -1.37 . . . . 0.0 110.903 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 83' ' ' ALA . . . . . 0.524 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -164.84 153.22 12.17 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 113.708 -1.587 . . . . 0.0 109.836 169.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 6.6 p -104.93 123.48 47.83 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 85' ' ' VAL . . . . . 0.408 ' CG1' ' HB3' ' E' ' 34' ' ' LEU . 3.6 m -118.2 144.43 26.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -173.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 50.8 m -108.05 116.25 31.61 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.701 175.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 87' ' ' LEU . . . . . 0.6 HD12 ' SD ' ' E' ' 13' ' ' MET . 4.5 mp -96.1 143.12 27.51 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 170.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . 0.493 ' CD2' HG13 ' A' ' 53' ' ' VAL . 2.6 mm? -125.03 152.07 44.74 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 174.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.6 -167.86 30.73 Favored Glycine 0 N--CA 1.435 -1.377 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.409 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 90' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -139.19 131.46 28.32 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.565 0.698 . . . . 0.0 110.803 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 91' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' E' ' 6' ' ' ALA . 23.7 mt -62.65 131.61 49.57 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.903 173.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.64 -179.47 4.12 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.686 -176.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -41.68 107.86 0.08 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.311 1.007 . . . . 0.0 112.228 -175.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 46.8 mt -68.7 -13.6 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.59 0.709 . . . . 0.0 109.656 174.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 95' ' ' ASP . . . . . 0.645 ' OD1' ' HA ' ' D' ' 1' ' ' PHE . 40.3 t0 70.82 59.6 0.2 Allowed 'General case' 0 CA--C 1.524 -0.037 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.185 175.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 8.1 p -105.55 -33.78 7.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.244 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 97' ' ' GLY . . . . . 0.414 ' HA2' ' CZ ' ' E' ' 1' ' ' PHE . . . -133.73 34.29 2.43 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.388 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 31.5 t . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.4 -0.81 . . . . 0.0 109.815 -179.586 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 51.4 p90 . . . . . 0 N--CA 1.479 0.998 0 CA-C-O 120.823 0.344 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -90.7 -29.38 17.73 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.817 176.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 94' ' ' ILE . . . 77.47 -60.78 3.62 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.44 177.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.425 ' HB3' ' CG ' ' B' ' 92' ' ' HIS . . . -82.38 71.85 9.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.17 0.509 . . . . 0.0 110.93 -178.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.412 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 13.0 tpt -82.04 -3.99 55.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.268 173.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.46 107.29 0.9 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.974 177.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.55 ' HA ' ' OG ' ' B' ' 70' ' ' SER . 45.5 mtt -94.29 155.12 17.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.559 0.695 . . . . 0.0 112.621 -170.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.42 ' CE1' HD23 ' B' ' 44' ' ' LEU . 55.8 t80 -59.71 142.71 52.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.262 -176.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.529 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 88.5 t90 -134.14 142.05 47.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.735 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.91 140.05 8.38 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.143 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.538 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 56.6 tp -128.36 108.29 10.45 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.974 0.416 . . . . 0.0 110.048 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -86.46 101.38 13.1 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 175.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.484 ' HB3' HG22 ' A' ' 85' ' ' VAL . 27.3 tpp -91.95 129.27 37.95 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.39 -171.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.481 ' HD2' ' N ' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -95.54 140.74 22.48 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.799 179.405 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.526 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 9.5 Cg_endo -53.63 121.73 10.04 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.624 2.882 . . . . 0.0 113.474 -175.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.654 ' HA ' ' O ' ' A' ' 79' ' ' THR . 31.3 mt-10 61.53 47.0 6.9 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.911 177.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.494 ' HA ' ' NE ' ' A' ' 17' ' ' ARG . 1.2 tpm_? -122.33 137.39 54.87 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 173.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.614 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 88.4 mttt -108.81 121.47 45.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.685 0.279 . . . . 0.0 111.684 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 1.654 ' HE2' ' CE1' ' A' ' 19' ' ' TYR . 3.8 m-85 -111.06 103.57 12.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.303 176.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 76' ' ' MET . 45.7 t -90.47 99.42 12.45 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 172.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -120.12 148.12 44.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.146 -168.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.5 m -93.44 141.27 28.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.49 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -89.89 117.01 32.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 120.92 0.39 . . . . 0.0 111.243 -173.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.498 HD13 ' N ' ' A' ' 25' ' ' LYS . 1.4 pp -79.63 -27.57 12.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.735 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.498 ' N ' HD13 ' A' ' 24' ' ' ILE . 31.7 ttpt -155.28 136.17 13.66 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -178.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 39.2 m -58.32 130.03 44.82 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.659 0.599 . . . . 0.0 110.091 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.442 ' CB ' ' HA ' ' A' ' 91' ' ' LEU . 10.1 p90 -144.26 161.92 37.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.611 0.719 . . . . 0.0 112.886 -172.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.579 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 15.7 t60 -114.82 123.87 50.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.187 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 37.6 mt -92.6 136.28 25.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 170.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.571 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 64.8 p -123.08 -20.19 5.82 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -170.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -154.85 146.3 14.17 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 119.324 -1.417 . . . . 0.0 113.336 178.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.445 ' CG2' ' HG ' ' A' ' 87' ' ' LEU . 14.3 p -140.01 126.81 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 170.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.81 158.11 43.92 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.903 -0.498 . . . . 0.0 111.576 -174.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.454 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 4.0 pp -118.9 139.21 52.01 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.587 0.708 . . . . 0.0 111.456 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -108.13 -51.33 2.91 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.298 173.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -102.52 128.12 49.3 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 170.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.484 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 145.08 162.39 9.55 Favored Glycine 0 N--CA 1.437 -1.263 0 C-N-CA 119.949 -1.12 . . . . 0.0 113.098 176.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -102.7 -46.81 4.61 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 111.487 0.18 . . . . 0.0 111.487 177.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -150.68 130.88 13.57 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.73 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.83 113.0 13.53 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.585 0.707 . . . . 0.0 110.186 169.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 79' ' ' THR . 4.5 mptp? -95.34 106.38 18.43 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 174.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.416 ' O ' HG22 ' A' ' 53' ' ' VAL . 41.6 tp -78.8 114.01 17.37 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -176.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 1.61 ' HD1' ' CD2' ' A' ' 43' ' ' TYR . 77.4 m-85 -114.82 135.88 53.7 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.283 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.499 ' HB3' HG21 ' A' ' 53' ' ' VAL . 5.0 tp -115.77 116.15 27.54 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.498 176.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -103.38 103.73 13.76 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 176.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.53 140.85 50.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.105 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 58.0 32.44 21.97 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.71 0.767 . . . . 0.0 109.445 -175.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 57.44 37.11 27.72 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.466 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 6.6 tp-100 -127.75 131.77 49.63 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 176.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.406 ' HG3' ' HH ' ' A' ' 78' ' ' TYR . 32.7 tt0 -87.35 112.27 21.93 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.427 -177.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 1.639 ' HD2' ' CD1' ' A' ' 51' ' ' TYR . 78.1 m-85 -108.4 131.37 54.84 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.793 177.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -78.78 100.42 3.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 169.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.499 HG21 ' HB3' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -72.4 -51.49 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.877 -174.151 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.507 ' HA ' ' OE1' ' E' ' 62' ' ' GLN . . . -154.57 132.47 11.57 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.516 -177.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.3 t -101.95 102.46 13.01 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 174.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.67 109.7 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-O 122.128 0.966 . . . . 0.0 110.047 -176.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 66.9 p -122.55 -176.95 3.5 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.378 -176.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -65.07 -20.61 66.57 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 119.976 -0.689 . . . . 0.0 110.574 169.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.95 -40.68 27.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.246 0.546 . . . . 0.0 110.047 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.4 mt -118.68 77.65 14.7 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 172.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.446 ' HA ' ' O ' ' A' ' 57' ' ' THR . 9.8 Cg_exo -71.73 0.84 6.43 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.11 2.54 . . . . 0.0 113.636 -168.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.49 ' OE1' ' HA ' ' B' ' 54' ' ' ALA . 10.3 tt0 -160.06 114.7 2.28 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.237 -170.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' A' ' 54' ' ' ALA . 86.5 t -112.8 115.16 49.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.061 0.458 . . . . 0.0 111.247 177.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.04 116.0 28.38 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 171.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.64 168.3 19.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.817 0.341 . . . . 0.0 111.036 -171.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.534 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 7.4 t0 -122.91 109.43 14.14 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.139 0.495 . . . . 0.0 110.36 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.579 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 12.8 mt -124.05 138.84 54.39 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.683 177.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -138.43 114.61 10.22 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 173.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 1.668 ' HD2' ' CD1' ' A' ' 69' ' ' PHE . 66.2 m-85 -109.17 163.07 13.68 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.385 -178.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.533 ' OG ' ' HA ' ' E' ' 7' ' ' MET . 4.5 m -117.22 149.03 41.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.154 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.482 ' HZ3' ' HB2' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -70.04 -5.9 29.86 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.736 -177.103 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.87 -28.54 45.84 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.319 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -101.3 171.25 7.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.702 0.287 . . . . 0.0 110.43 -176.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -137.3 136.5 38.06 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.454 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 22.6 pt -133.07 158.4 43.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.081 0.467 . . . . 0.0 111.571 -169.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.411 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 65.3 ttp -117.52 118.09 31.21 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.342 176.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 1.62 ' HE1' ' CE2' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -105.53 129.37 53.82 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.806 -177.773 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 1.65 ' HD2' ' CD1' ' A' ' 78' ' ' TYR . 39.0 p90 -155.74 162.79 40.47 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.847 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.654 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 12.6 p -125.21 143.86 50.74 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.108 178.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.3 149.48 26.87 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.231 173.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.0 -176.92 36.47 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -176.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -114.48 102.64 10.27 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.238 178.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.526 ' H ' ' HB3' ' A' ' 15' ' ' PRO . . . -166.74 150.05 6.85 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.479 168.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.2 p -106.04 122.11 45.5 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.484 HG22 ' HB3' ' A' ' 13' ' ' MET . 13.5 m -121.54 144.23 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-O 121.241 0.543 . . . . 0.0 111.801 -172.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 43.3 m -105.21 122.85 46.77 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.276 175.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.538 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 5.1 mp -95.22 143.93 26.23 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 170.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.465 ' CD2' HG12 ' B' ' 53' ' ' VAL . 0.9 OUTLIER -130.39 141.23 50.56 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.152 -178.718 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.66 -166.89 27.5 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.953 -0.642 . . . . 0.0 111.795 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -147.06 133.49 19.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.474 0.654 . . . . 0.0 111.161 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.485 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 15.1 mt -69.68 128.8 37.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.106 175.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.422 ' CG ' ' HB3' ' E' ' 4' ' ' ALA . 12.3 t60 -81.84 108.35 15.3 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.049 0.452 . . . . 0.0 111.158 -173.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -108.21 -79.44 0.58 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 168.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.498 ' HA ' ' O ' ' A' ' 3' ' ' GLY . 50.4 mm 62.1 99.98 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.447 176.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.412 ' OD2' ' HB2' ' A' ' 5' ' ' MET . 28.4 m-20 -76.3 133.72 39.95 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.664 -178.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 23.3 t -91.13 86.99 6.37 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.35 -50.69 64.83 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.965 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.8 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.946 177.564 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 51.6 p90 . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.741 0.305 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -90.86 -29.42 17.54 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.756 177.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' B' ' 94' ' ' ILE . . . 77.6 -60.95 3.65 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.423 177.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.28 71.96 9.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.178 0.514 . . . . 0.0 110.944 -178.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' MET . . . . . 0.41 ' HB2' ' OD2' ' B' ' 95' ' ' ASP . 12.9 tpt -82.15 -3.96 55.96 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.235 173.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.42 107.32 0.9 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.0 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' MET . . . . . 0.567 ' HA ' ' OG ' ' C' ' 70' ' ' SER . 45.5 mtt -94.25 155.1 17.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.533 0.682 . . . . 0.0 112.727 -170.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 0.428 ' CE1' HD23 ' C' ' 44' ' ' LEU . 55.5 t80 -59.76 142.74 52.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.247 -176.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . 0.525 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 88.6 t90 -134.14 142.01 47.32 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.75 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.87 140.06 8.39 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.253 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.525 ' HB2' ' CH2' ' B' ' 9' ' ' TRP . 56.8 tp -128.36 108.35 10.5 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.972 0.415 . . . . 0.0 110.079 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -86.46 101.29 13.03 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 175.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' MET . . . . . 0.479 ' HB3' HG22 ' B' ' 85' ' ' VAL . 27.4 tpp -91.95 129.37 37.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.349 -171.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.482 ' N ' ' HD2' ' B' ' 14' ' ' LYS . 0.3 OUTLIER -95.69 140.83 22.5 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.757 179.362 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.532 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 9.4 Cg_endo -53.62 121.71 10.0 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 123.656 2.904 . . . . 0.0 113.425 -175.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.653 ' HA ' ' O ' ' B' ' 79' ' ' THR . 31.2 mt-10 61.58 47.04 6.8 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.835 177.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.491 ' NE ' ' HA ' ' B' ' 17' ' ' ARG . 1.1 tpm_? -122.36 137.3 54.9 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 173.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . 0.61 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 88.5 mttt -108.84 121.57 45.37 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' TYR . . . . . 1.662 ' HD2' ' CD1' ' B' ' 19' ' ' TYR . 3.8 m-85 -111.2 103.56 11.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.233 176.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 45.0 t -90.4 99.47 12.48 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -120.2 148.17 44.01 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.55 0.69 . . . . 0.0 112.152 -168.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 19.7 m -93.49 141.27 28.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.436 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -89.93 117.07 32.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.085 0.469 . . . . 0.0 111.214 -173.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.494 HD13 ' N ' ' B' ' 25' ' ' LYS . 1.4 pp -79.63 -27.58 12.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.709 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.494 ' N ' HD13 ' B' ' 24' ' ' ILE . 31.7 ttpt -155.3 136.1 13.59 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 38.9 m -58.23 130.03 44.75 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.725 0.641 . . . . 0.0 110.096 -178.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . 0.44 ' CB ' ' HA ' ' B' ' 91' ' ' LEU . 10.0 p90 -144.25 161.86 37.83 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -172.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' HIS . . . . . 0.573 ' HA ' ' O ' ' B' ' 67' ' ' LEU . 16.1 t60 -114.74 123.9 50.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.194 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.527 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 37.8 mt -92.66 136.17 25.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 170.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.572 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 65.1 p -122.91 -20.28 5.87 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -170.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.509 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -154.82 146.19 13.97 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 119.508 -1.329 . . . . 0.0 113.416 179.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.44 ' CG2' ' HG ' ' B' ' 87' ' ' LEU . 14.4 p -139.99 126.71 23.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 170.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.79 158.15 43.95 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.925 -0.484 . . . . 0.0 111.669 -174.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.464 ' HB3' HG13 ' B' ' 85' ' ' VAL . 4.0 pp -118.91 139.26 51.93 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.719 0.771 . . . . 0.0 111.356 178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -108.21 -51.29 2.92 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.355 173.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -102.46 128.15 49.19 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 170.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.483 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 145.01 162.43 9.56 Favored Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 119.906 -1.14 . . . . 0.0 113.01 176.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -102.73 -46.67 4.65 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 177.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -150.77 130.81 13.43 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.754 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.78 113.06 13.64 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.55 0.691 . . . . 0.0 110.165 169.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' B' ' 79' ' ' THR . 4.5 mptp? -95.42 106.33 18.38 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 174.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.414 ' O ' HG22 ' B' ' 53' ' ' VAL . 41.4 tp -78.67 113.92 17.14 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -176.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . 1.602 ' HD1' ' CD2' ' B' ' 43' ' ' TYR . 77.7 m-85 -114.78 135.89 53.68 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.247 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.485 ' HB3' HG21 ' B' ' 53' ' ' VAL . 4.9 tp -115.85 116.18 27.55 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.509 176.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -103.31 103.71 13.75 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 176.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . 0.405 ' HB3' HD12 ' B' ' 44' ' ' LEU . . . -130.61 140.79 50.43 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.125 -178.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 58.19 32.29 21.85 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.543 0.687 . . . . 0.0 109.34 -175.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 62.4 mttp 57.54 37.0 27.49 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.508 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.497 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 6.6 tp-100 -127.67 131.8 49.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.588 176.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -87.47 112.32 22.07 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.828 0.346 . . . . 0.0 110.389 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 1.627 ' HE2' ' CE1' ' B' ' 51' ' ' TYR . 78.3 m-85 -108.48 131.37 54.87 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.763 177.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -78.82 100.41 3.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 169.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.485 HG21 ' HB3' ' B' ' 44' ' ' LEU . 0.9 OUTLIER -72.3 -51.53 29.11 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.011 -174.205 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.49 ' HA ' ' OE1' ' A' ' 62' ' ' GLN . . . -154.48 132.53 11.69 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.547 -177.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 7.5 t -101.97 102.43 12.96 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 174.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.63 109.79 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-O 122.062 0.934 . . . . 0.0 109.964 -176.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' B' ' 61' ' ' PRO . 67.1 p -122.63 -176.94 3.51 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.352 -176.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -65.06 -20.63 66.57 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.551 169.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.86 -40.82 27.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.267 0.556 . . . . 0.0 110.02 176.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 74.2 mt -118.7 77.6 14.73 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 172.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' B' ' 57' ' ' THR . 9.7 Cg_exo -71.71 0.88 6.35 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.083 2.522 . . . . 0.0 113.721 -168.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . 0.502 ' OE1' ' HA ' ' C' ' 54' ' ' ALA . 10.3 tt0 -160.12 114.72 2.27 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.256 -170.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.437 HG12 ' HB2' ' B' ' 54' ' ' ALA . 86.0 t -112.75 115.17 49.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.108 0.48 . . . . 0.0 111.259 177.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.05 115.92 28.29 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 171.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.56 168.26 19.29 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.06 -171.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . 0.528 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 7.4 t0 -122.89 109.46 14.18 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.111 0.481 . . . . 0.0 110.365 -179.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.573 ' O ' ' HA ' ' B' ' 28' ' ' HIS . 12.7 mt -124.02 138.91 54.39 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.67 177.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -138.64 114.65 10.12 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 173.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . 1.663 ' HD2' ' CD1' ' B' ' 69' ' ' PHE . 66.2 m-85 -109.23 162.99 13.77 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.395 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.55 ' OG ' ' HA ' ' A' ' 7' ' ' MET . 4.4 m -117.12 149.01 41.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.22 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . 0.481 ' HB2' ' HZ3' ' B' ' 71' ' ' LYS . 0.0 OUTLIER -69.95 -6.15 31.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.71 -177.13 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.81 -28.38 46.7 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.365 177.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -101.24 171.32 7.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.764 0.316 . . . . 0.0 110.44 -176.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -137.37 136.47 37.93 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.444 ' HB ' ' CD1' ' B' ' 44' ' ' LEU . 22.3 pt -133.03 158.39 43.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.912 0.387 . . . . 0.0 111.668 -169.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' MET . . . . . 0.415 ' HA ' ' HA ' ' B' ' 20' ' ' SER . 65.3 ttp -117.47 118.21 31.56 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.056 0.455 . . . . 0.0 110.319 176.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . 1.661 ' HD2' ' CD1' ' B' ' 77' ' ' PHE . 0.4 OUTLIER -105.63 129.39 53.88 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.788 -177.807 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 1.667 ' HD1' ' CD2' ' B' ' 78' ' ' TYR . 39.0 p90 -155.79 162.72 40.44 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.871 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.653 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 12.5 p -125.26 143.89 50.73 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.094 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.45 149.61 26.88 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.088 173.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.87 -176.95 36.69 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -176.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -114.38 102.67 10.31 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 117.988 0.894 . . . . 0.0 110.289 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.532 ' H ' ' HB3' ' B' ' 15' ' ' PRO . . . -166.72 150.04 6.88 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.465 168.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 6.1 p -106.05 122.17 45.62 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.479 HG22 ' HB3' ' B' ' 13' ' ' MET . 13.4 m -121.59 144.26 31.33 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 121.241 0.544 . . . . 0.0 111.771 -172.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 44.0 m -105.25 122.88 46.86 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.24 175.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.522 ' HB2' ' HB3' ' B' ' 11' ' ' LEU . 5.1 mp -95.16 143.95 26.17 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.467 ' CD2' HG12 ' C' ' 53' ' ' VAL . 0.9 OUTLIER -130.44 141.23 50.53 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.17 -178.712 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.68 -166.93 27.59 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.752 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -147.0 133.54 19.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.428 0.633 . . . . 0.0 111.029 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . 0.476 ' HB3' ' HE3' ' B' ' 25' ' ' LYS . 15.1 mt -69.8 128.9 38.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.083 175.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . 0.425 ' CG ' ' HB3' ' A' ' 4' ' ' ALA . 12.3 t60 -81.85 108.26 15.23 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.068 0.461 . . . . 0.0 111.091 -173.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -108.24 -79.51 0.58 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 168.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' B' ' 3' ' ' GLY . 50.7 mm 62.19 100.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.336 176.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . 0.41 ' OD2' ' HB2' ' B' ' 5' ' ' MET . 28.2 m-20 -76.25 133.66 40.03 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.671 -178.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 23.3 t -91.05 87.02 6.41 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 176.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.4 -50.64 65.42 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.998 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 10.9 m . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.087 -0.958 . . . . 0.0 110.952 177.551 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 51.6 p90 . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.801 0.334 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -90.81 -29.41 17.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.793 176.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 3' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' C' ' 94' ' ' ILE . . . 77.67 -60.93 3.68 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.395 177.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 4' ' ' ALA . . . . . 0.411 ' HB3' ' CG ' ' D' ' 92' ' ' HIS . . . -82.24 71.84 9.29 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.213 0.53 . . . . 0.0 110.993 -178.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 5' ' ' MET . . . . . 0.405 ' HB2' ' OD2' ' C' ' 95' ' ' ASP . 13.0 tpt -82.09 -4.01 55.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.273 173.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.39 107.29 0.89 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.029 177.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 7' ' ' MET . . . . . 0.572 ' HA ' ' OG ' ' D' ' 70' ' ' SER . 45.3 mtt -94.31 155.16 17.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.522 0.677 . . . . 0.0 112.657 -170.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 8' ' ' PHE . . . . . 0.411 ' CE1' HD23 ' D' ' 44' ' ' LEU . 55.5 t80 -59.78 142.66 52.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.401 -1.272 . . . . 0.0 112.203 -176.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . 0.519 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 88.4 t90 -134.08 142.08 47.41 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.766 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.84 140.07 8.41 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.148 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.536 ' HB3' ' HB2' ' C' ' 87' ' ' LEU . 56.3 tp -128.33 108.24 10.42 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.893 0.378 . . . . 0.0 110.153 178.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -86.27 101.25 12.89 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 175.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 13' ' ' MET . . . . . 0.489 ' HB3' HG22 ' C' ' 85' ' ' VAL . 27.2 tpp -91.99 129.42 37.95 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.362 -171.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . 0.476 ' HD2' ' N ' ' C' ' 14' ' ' LYS . 0.3 OUTLIER -95.68 140.74 22.46 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.833 179.385 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . 0.536 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 9.5 Cg_endo -53.59 121.73 10.03 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.606 2.871 . . . . 0.0 113.51 -175.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' C' ' 79' ' ' THR . 31.5 mt-10 61.56 47.04 6.84 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.838 177.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 17' ' ' ARG . . . . . 0.493 ' NE ' ' HA ' ' C' ' 17' ' ' ARG . 1.2 tpm_? -122.33 137.33 54.89 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 173.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 18' ' ' LYS . . . . . 0.613 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 88.4 mttt -108.85 121.51 45.24 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . 1.669 ' HD1' ' CD2' ' C' ' 19' ' ' TYR . 3.7 m-85 -111.07 103.71 12.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.252 176.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 20' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 45.2 t -90.59 99.52 12.53 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 172.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -120.23 148.14 44.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.125 -168.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 19.5 m -93.42 141.2 28.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.538 176.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 67.7 mt -89.84 117.06 32.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.974 0.416 . . . . 0.0 111.295 -173.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . 0.49 HD13 ' N ' ' C' ' 25' ' ' LYS . 1.4 pp -79.68 -27.5 12.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.703 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . 0.49 ' N ' HD13 ' C' ' 24' ' ' ILE . 31.7 ttpt -155.41 136.18 13.54 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 39.4 m -58.33 130.08 45.05 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.715 0.634 . . . . 0.0 110.085 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 27' ' ' PHE . . . . . 0.434 ' CB ' ' HA ' ' C' ' 91' ' ' LEU . 9.9 p90 -144.27 161.89 37.79 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.654 0.74 . . . . 0.0 112.905 -172.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 28' ' ' HIS . . . . . 0.586 ' HA ' ' O ' ' C' ' 67' ' ' LEU . 15.9 t60 -114.75 123.9 50.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.203 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 38.0 mt -92.66 136.21 25.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 170.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 30' ' ' SER . . . . . 0.563 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 65.2 p -122.98 -20.25 5.84 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -170.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -154.74 146.21 14.04 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.403 -1.379 . . . . 0.0 113.395 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.445 ' CG2' ' HG ' ' C' ' 87' ' ' LEU . 14.4 p -140.08 126.73 22.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 170.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.73 158.21 43.99 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.617 -174.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.459 ' HB3' HG13 ' C' ' 85' ' ' VAL . 4.0 pp -118.99 139.21 52.07 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.739 0.781 . . . . 0.0 111.339 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -108.14 -51.28 2.92 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.572 -1.194 . . . . 0.0 108.382 173.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -102.42 128.03 49.2 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 170.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 37' ' ' GLY . . . . . 0.48 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 145.09 162.42 9.56 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.056 176.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -102.7 -46.73 4.63 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 177.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -150.73 130.81 13.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.809 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.81 113.02 13.56 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.53 0.681 . . . . 0.0 110.172 169.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' C' ' 79' ' ' THR . 4.5 mptp? -95.36 106.33 18.37 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 174.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.419 ' O ' HG22 ' C' ' 53' ' ' VAL . 41.7 tp -78.69 113.97 17.21 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -176.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 43' ' ' TYR . . . . . 1.628 ' HD1' ' CD2' ' C' ' 43' ' ' TYR . 77.4 m-85 -114.86 135.88 53.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.244 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.504 ' HB3' HG21 ' C' ' 53' ' ' VAL . 4.9 tp -115.73 116.05 27.4 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.56 176.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -103.27 103.76 13.82 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 176.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . 0.405 ' HB3' HD12 ' C' ' 44' ' ' LEU . . . -130.58 140.85 50.45 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.108 -178.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 58.05 32.4 21.93 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.611 0.719 . . . . 0.0 109.416 -175.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 62.4 mttp 57.38 37.11 27.84 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.523 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . 0.491 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 6.6 tp-100 -127.73 131.72 49.67 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.558 176.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . 0.406 ' HG3' ' HH ' ' C' ' 78' ' ' TYR . 32.7 tt0 -87.39 112.31 22.0 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.791 0.329 . . . . 0.0 110.401 -177.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 1.639 ' HD1' ' CD2' ' C' ' 51' ' ' TYR . 78.1 m-85 -108.39 131.3 54.9 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.775 177.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -78.76 100.47 3.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 169.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 53' ' ' VAL . . . . . 0.504 HG21 ' HB3' ' C' ' 44' ' ' LEU . 0.9 OUTLIER -72.45 -51.46 28.85 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.955 -174.211 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 54' ' ' ALA . . . . . 0.502 ' HA ' ' OE1' ' B' ' 62' ' ' GLN . . . -154.5 132.5 11.65 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.597 -177.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 7.4 t -102.0 102.46 12.98 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 174.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.61 109.74 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-O 122.005 0.907 . . . . 0.0 110.057 -176.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 57' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' C' ' 61' ' ' PRO . 66.9 p -122.62 -177.09 3.54 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.379 -176.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -64.95 -20.73 66.62 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.578 169.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.76 -40.82 27.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.247 0.546 . . . . 0.0 110.084 176.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 74.0 mt -118.7 77.64 14.77 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 172.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 61' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' C' ' 57' ' ' THR . 9.7 Cg_exo -71.74 0.86 6.39 Favored 'Trans proline' 0 N--CA 1.473 0.308 0 C-N-CA 123.099 2.532 . . . . 0.0 113.618 -168.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . 0.578 ' OE1' ' HA ' ' D' ' 54' ' ' ALA . 10.3 tt0 -160.13 114.73 2.27 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.733 0.301 . . . . 0.0 111.307 -170.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.444 HG12 ' HB2' ' C' ' 54' ' ' ALA . 85.9 t -112.79 115.16 49.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.13 0.49 . . . . 0.0 111.264 177.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.0 115.97 28.36 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 171.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.53 168.35 19.12 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.138 -171.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 66' ' ' ASP . . . . . 0.478 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 7.4 t0 -122.95 109.37 14.05 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.077 0.465 . . . . 0.0 110.278 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . 0.586 ' O ' ' HA ' ' C' ' 28' ' ' HIS . 12.8 mt -124.03 138.79 54.4 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.696 176.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -138.45 114.57 10.17 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 172.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 69' ' ' PHE . . . . . 1.635 ' HE2' ' CE1' ' C' ' 69' ' ' PHE . 66.4 m-85 -109.12 163.0 13.72 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.348 -178.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 70' ' ' SER . . . . . 0.567 ' OG ' ' HA ' ' B' ' 7' ' ' MET . 4.5 m -117.16 149.03 41.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.161 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . 0.486 ' HB2' ' HZ3' ' C' ' 71' ' ' LYS . 0.0 OUTLIER -69.97 -6.04 30.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.737 -177.186 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.88 -28.44 46.16 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.269 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -101.2 171.32 7.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.603 0.239 . . . . 0.0 110.491 -176.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -137.35 136.54 38.02 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . 0.447 ' HB ' ' CD1' ' C' ' 44' ' ' LEU . 22.6 pt -133.06 158.39 43.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.022 0.439 . . . . 0.0 111.647 -169.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 76' ' ' MET . . . . . 0.408 ' HA ' ' HA ' ' C' ' 20' ' ' SER . 65.4 ttp -117.46 118.08 31.22 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.279 176.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 77' ' ' PHE . . . . . 1.668 ' HD2' ' CD1' ' C' ' 77' ' ' PHE . 0.4 OUTLIER -105.62 129.34 53.88 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.791 -177.833 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 78' ' ' TYR . . . . . 1.664 ' HE2' ' CE1' ' C' ' 78' ' ' TYR . 38.9 p90 -155.73 162.72 40.48 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.839 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 79' ' ' THR . . . . . 0.655 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 12.6 p -125.12 143.88 50.71 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.143 178.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.43 149.63 26.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.072 173.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.88 -176.87 36.6 Favored Glycine 0 CA--C 1.508 -0.346 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -176.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -114.5 102.63 10.25 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.24 178.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . 0.536 ' H ' ' HB3' ' C' ' 15' ' ' PRO . . . -166.69 150.06 6.93 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.508 167.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 6.3 p -106.01 122.2 45.67 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.489 HG22 ' HB3' ' C' ' 13' ' ' MET . 13.5 m -121.62 144.2 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-O 121.223 0.535 . . . . 0.0 111.769 -172.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 43.6 m -105.23 122.87 46.82 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.28 175.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . 0.536 ' HB2' ' HB3' ' C' ' 11' ' ' LEU . 5.1 mp -95.15 144.03 26.11 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 170.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . 0.471 HD21 HD23 ' D' ' 67' ' ' LEU . 0.9 OUTLIER -130.5 141.21 50.5 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.161 -178.685 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.67 -166.93 27.57 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.744 -177.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -146.95 133.57 19.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.384 0.612 . . . . 0.0 111.095 177.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . 0.477 ' HB3' ' HE3' ' C' ' 25' ' ' LYS . 15.1 mt -69.79 128.89 38.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.07 175.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -81.89 108.32 15.31 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.052 0.453 . . . . 0.0 111.1 -173.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -108.17 -79.53 0.58 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 168.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' C' ' 3' ' ' GLY . 50.6 mm 62.14 100.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.373 176.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 95' ' ' ASP . . . . . 0.405 ' OD2' ' HB2' ' C' ' 5' ' ' MET . 28.2 m-20 -76.37 133.75 39.85 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.622 -178.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 23.3 t -91.05 86.98 6.4 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.33 -50.65 65.35 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.037 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 10.8 m . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.956 177.513 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 51.7 p90 . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 120.731 0.301 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -90.77 -29.52 17.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.771 177.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 3' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' D' ' 94' ' ' ILE . . . 77.64 -60.95 3.67 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.423 177.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 4' ' ' ALA . . . . . 0.428 ' HB3' ' CG ' ' E' ' 92' ' ' HIS . . . -82.22 71.82 9.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.176 0.513 . . . . 0.0 111.006 -178.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 5' ' ' MET . . . . . 0.418 ' HB2' ' OD2' ' D' ' 95' ' ' ASP . 12.9 tpt -82.08 -3.97 55.84 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.215 173.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.4 107.21 0.87 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.032 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 7' ' ' MET . . . . . 0.558 ' HA ' ' OG ' ' E' ' 70' ' ' SER . 45.2 mtt -94.27 155.12 17.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.566 0.698 . . . . 0.0 112.674 -170.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 8' ' ' PHE . . . . . 0.437 ' CE1' HD23 ' E' ' 44' ' ' LEU . 55.8 t80 -59.64 142.74 52.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.341 -1.299 . . . . 0.0 112.24 -176.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 9' ' ' TRP . . . . . 0.523 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 88.4 t90 -134.27 142.08 47.19 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.9 140.08 8.4 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.188 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . 0.534 ' HB3' ' HB2' ' D' ' 87' ' ' LEU . 56.8 tp -128.3 108.23 10.42 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.899 0.381 . . . . 0.0 110.077 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -86.49 101.41 13.15 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 13' ' ' MET . . . . . 0.483 ' HB3' HG22 ' D' ' 85' ' ' VAL . 27.4 tpp -92.0 129.36 37.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.377 -171.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 14' ' ' LYS . . . . . 0.473 ' HD2' ' N ' ' D' ' 14' ' ' LYS . 0.3 OUTLIER -95.69 140.69 22.44 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.806 179.418 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . 0.54 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 9.5 Cg_endo -53.57 121.81 10.17 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 123.609 2.873 . . . . 0.0 113.411 -175.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' D' ' 79' ' ' THR . 31.4 mt-10 61.44 47.01 7.06 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.956 177.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 17' ' ' ARG . . . . . 0.493 ' HA ' ' NE ' ' D' ' 17' ' ' ARG . 1.1 tpm_? -122.29 137.28 54.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.056 173.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . 0.618 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 88.4 mttt -108.77 121.48 45.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.723 0.297 . . . . 0.0 111.695 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 19' ' ' TYR . . . . . 1.654 ' HD2' ' CD1' ' D' ' 19' ' ' TYR . 3.7 m-85 -111.14 103.65 12.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.283 176.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 20' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 44.9 t -90.48 99.49 12.51 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 172.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -120.25 148.21 43.99 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.105 -168.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 19.3 m -93.48 141.24 28.69 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.478 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -89.93 117.04 32.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.082 0.468 . . . . 0.0 111.227 -173.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . 0.493 HD13 ' N ' ' D' ' 25' ' ' LYS . 1.4 pp -79.55 -27.61 12.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.782 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . 0.494 ' HE3' ' HB3' ' D' ' 91' ' ' LEU . 31.7 ttpt -155.31 136.18 13.64 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 39.3 m -58.31 130.06 44.93 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.68 0.613 . . . . 0.0 110.134 -178.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 27' ' ' PHE . . . . . 0.433 ' CB ' ' HA ' ' D' ' 91' ' ' LEU . 9.9 p90 -144.28 161.86 37.86 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -172.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 28' ' ' HIS . . . . . 0.577 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 16.0 t60 -114.74 123.92 50.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.173 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 29' ' ' ILE . . . . . 0.535 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 37.7 mt -92.7 136.18 25.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 170.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 30' ' ' SER . . . . . 0.577 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 65.9 p -122.96 -20.23 5.86 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -170.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 31' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -154.78 146.22 14.04 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 119.425 -1.369 . . . . 0.0 113.409 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . 0.435 ' CG2' ' HG ' ' D' ' 87' ' ' LEU . 14.2 p -139.95 126.8 23.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 170.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.87 158.14 43.94 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.8 -0.562 . . . . 0.0 111.654 -174.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 34' ' ' LEU . . . . . 0.449 ' HB3' ' CG1' ' D' ' 85' ' ' VAL . 4.0 pp -118.89 139.24 51.96 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.682 0.753 . . . . 0.0 111.431 178.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -108.21 -51.25 2.92 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.333 173.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -102.36 128.02 49.12 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 170.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . 0.478 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 145.1 162.41 9.56 Favored Glycine 0 N--CA 1.438 -1.167 0 C-N-CA 119.867 -1.159 . . . . 0.0 113.065 176.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -102.73 -46.66 4.65 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.609 0.242 . . . . 0.0 111.581 177.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -150.72 130.82 13.49 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.769 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . 0.404 ' HB1' HG11 ' D' ' 56' ' ' VAL . . . -130.79 113.0 13.56 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.492 0.663 . . . . 0.0 110.2 169.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' D' ' 79' ' ' THR . 4.5 mptp? -95.37 106.38 18.43 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 174.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.413 ' O ' HG22 ' D' ' 53' ' ' VAL . 41.9 tp -78.88 113.96 17.41 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -176.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 43' ' ' TYR . . . . . 1.644 ' HD1' ' CD2' ' D' ' 43' ' ' TYR . 77.4 m-85 -114.79 135.95 53.62 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.336 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.503 ' HB3' HG21 ' D' ' 53' ' ' VAL . 4.9 tp -115.82 116.07 27.37 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.444 176.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 45' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -103.28 103.68 13.73 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . 0.402 ' HB3' HD12 ' D' ' 44' ' ' LEU . . . -130.55 140.83 50.47 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.052 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 58.1 32.4 21.95 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.652 0.739 . . . . 0.0 109.365 -175.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 62.4 mttp 57.44 37.04 27.7 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 114.854 -1.067 . . . . 0.0 111.547 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . 0.492 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 6.6 tp-100 -127.69 131.78 49.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.573 176.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.406 ' HG3' ' HH ' ' D' ' 78' ' ' TYR . 32.8 tt0 -87.42 112.35 22.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.383 -177.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . 1.644 ' HE2' ' CE1' ' D' ' 51' ' ' TYR . 78.5 m-85 -108.46 131.44 54.8 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.743 177.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -78.84 100.36 3.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 169.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 53' ' ' VAL . . . . . 0.503 HG21 ' HB3' ' D' ' 44' ' ' LEU . 0.9 OUTLIER -72.34 -51.49 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.988 -174.174 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 54' ' ' ALA . . . . . 0.578 ' HA ' ' OE1' ' C' ' 62' ' ' GLN . . . -154.46 132.38 11.6 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.538 -177.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 7.6 t -101.89 102.47 13.04 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 174.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 56' ' ' VAL . . . . . 0.404 HG11 ' HB1' ' D' ' 40' ' ' ALA . 7.1 p -116.69 109.76 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-O 122.039 0.923 . . . . 0.0 110.052 -176.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 57' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' D' ' 61' ' ' PRO . 67.3 p -122.64 -176.99 3.52 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.347 -176.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -65.03 -20.68 66.61 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.541 169.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.76 -40.84 27.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.265 0.555 . . . . 0.0 110.07 176.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 74.6 mt -118.73 77.64 14.87 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 172.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 61' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' D' ' 57' ' ' THR . 9.7 Cg_exo -71.7 0.88 6.35 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.159 2.573 . . . . 0.0 113.651 -168.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . 0.486 ' OE1' ' HA ' ' E' ' 54' ' ' ALA . 10.3 tt0 -160.09 114.77 2.28 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.274 -170.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.443 HG12 ' HB2' ' D' ' 54' ' ' ALA . 86.1 t -112.84 115.06 48.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.104 0.478 . . . . 0.0 111.236 177.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.87 115.92 28.34 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 171.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.55 168.32 19.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.777 0.322 . . . . 0.0 111.092 -171.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 66' ' ' ASP . . . . . 0.529 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 7.5 t0 -122.91 109.39 14.09 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.127 0.489 . . . . 0.0 110.365 -178.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' D' ' 28' ' ' HIS . 12.8 mt -124.0 138.9 54.39 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.712 176.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -138.57 114.61 10.13 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 173.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 69' ' ' PHE . . . . . 1.635 ' HE1' ' CE2' ' D' ' 69' ' ' PHE . 66.6 m-85 -109.16 163.07 13.68 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.315 -178.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 70' ' ' SER . . . . . 0.572 ' OG ' ' HA ' ' C' ' 7' ' ' MET . 4.4 m -117.21 149.06 41.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.186 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 71' ' ' LYS . . . . . 0.471 ' HB2' ' HZ3' ' D' ' 71' ' ' LYS . 0.0 OUTLIER -70.05 -6.14 31.63 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.72 -177.104 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.68 -28.62 46.37 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.319 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -101.12 171.31 7.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.757 0.313 . . . . 0.0 110.449 -176.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -137.31 136.49 38.03 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 75' ' ' ILE . . . . . 0.45 ' HB ' ' CD1' ' D' ' 44' ' ' LEU . 22.6 pt -133.03 158.36 43.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.014 0.435 . . . . 0.0 111.642 -169.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 76' ' ' MET . . . . . 0.408 ' HA ' ' HA ' ' D' ' 20' ' ' SER . 65.4 ttp -117.43 118.08 31.24 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.372 176.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 77' ' ' PHE . . . . . 1.664 ' HD2' ' CD1' ' D' ' 77' ' ' PHE . 0.4 OUTLIER -105.57 129.42 53.83 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.789 -177.812 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 78' ' ' TYR . . . . . 1.664 ' HD1' ' CD2' ' D' ' 78' ' ' TYR . 39.0 p90 -155.76 162.78 40.45 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.881 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 79' ' ' THR . . . . . 0.641 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 12.6 p -125.22 143.87 50.74 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.116 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.35 149.61 26.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.097 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.87 -177.05 36.77 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -176.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -114.4 102.58 10.22 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.242 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.54 ' H ' ' HB3' ' D' ' 15' ' ' PRO . . . -166.69 150.13 6.94 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.385 168.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 6.2 p -106.1 122.25 45.81 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . 0.483 HG22 ' HB3' ' D' ' 13' ' ' MET . 13.4 m -121.65 144.19 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-O 121.203 0.525 . . . . 0.0 111.792 -172.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 43.6 m -105.1 122.79 46.63 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.322 175.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 87' ' ' LEU . . . . . 0.534 ' HB2' ' HB3' ' D' ' 11' ' ' LEU . 5.1 mp -95.22 143.97 26.2 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 170.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . 0.496 ' CD2' HG12 ' E' ' 53' ' ' VAL . 0.9 OUTLIER -130.4 141.18 50.55 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.175 -178.686 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.58 -166.84 27.33 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.756 -177.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -147.05 133.51 19.69 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.437 0.637 . . . . 0.0 111.113 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . 0.494 ' HB3' ' HE3' ' D' ' 25' ' ' LYS . 15.1 mt -69.77 128.86 37.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.065 175.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . 0.411 ' CG ' ' HB3' ' C' ' 4' ' ' ALA . 12.4 t60 -81.84 108.2 15.18 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.07 0.462 . . . . 0.0 111.094 -173.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -108.12 -79.36 0.58 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 168.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' D' ' 3' ' ' GLY . 50.6 mm 62.09 100.14 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.318 176.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 95' ' ' ASP . . . . . 0.418 ' OD2' ' HB2' ' D' ' 5' ' ' MET . 27.8 m-20 -76.44 133.73 39.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.588 -178.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 23.3 t -91.09 86.97 6.38 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.25 -50.72 64.55 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.035 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 10.5 m . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.996 177.541 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 51.6 p90 . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 120.89 0.376 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -90.64 -29.38 17.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.828 176.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 3' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' E' ' 94' ' ' ILE . . . 77.45 -60.84 3.61 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.461 177.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 4' ' ' ALA . . . . . 0.422 ' HB3' ' CG ' ' A' ' 92' ' ' HIS . . . -82.19 71.82 9.25 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.153 0.501 . . . . 0.0 111.014 -178.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 5' ' ' MET . . . . . 0.404 ' HB2' ' OD2' ' E' ' 95' ' ' ASP . 13.0 tpt -82.16 -4.02 56.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.221 173.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.3 107.28 0.87 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.058 177.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 7' ' ' MET . . . . . 0.533 ' HA ' ' OG ' ' A' ' 70' ' ' SER . 45.2 mtt -94.36 155.07 17.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.653 0.739 . . . . 0.0 112.626 -170.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 8' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -59.64 142.7 52.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.291 -1.322 . . . . 0.0 112.293 -176.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 9' ' ' TRP . . . . . 0.512 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 88.6 t90 -134.21 142.04 47.25 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.84 140.06 8.4 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.162 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . 0.543 ' HB3' ' HB2' ' E' ' 87' ' ' LEU . 56.8 tp -128.36 108.32 10.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.966 0.412 . . . . 0.0 110.101 178.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -86.45 101.34 13.06 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 175.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 13' ' ' MET . . . . . 0.479 ' HB3' HG22 ' E' ' 85' ' ' VAL . 27.3 tpp -91.99 129.41 37.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.419 -171.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 14' ' ' LYS . . . . . 0.471 ' N ' ' HD2' ' E' ' 14' ' ' LYS . 0.3 OUTLIER -95.68 140.69 22.44 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.843 179.394 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . 0.53 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 9.5 Cg_endo -53.63 121.79 10.14 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 123.508 2.805 . . . . 0.0 113.514 -175.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 16' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' E' ' 79' ' ' THR . 31.3 mt-10 61.54 47.06 6.84 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.887 177.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 17' ' ' ARG . . . . . 0.495 ' HA ' ' NE ' ' E' ' 17' ' ' ARG . 1.2 tpm_? -122.41 137.34 54.9 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 173.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . 0.616 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 88.6 mttt -108.83 121.51 45.24 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . 1.662 ' HE2' ' CE1' ' E' ' 19' ' ' TYR . 3.7 m-85 -111.11 103.64 12.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.213 176.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 20' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' E' ' 76' ' ' MET . 44.5 t -90.46 99.39 12.43 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 172.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -120.22 148.11 44.09 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.523 0.678 . . . . 0.0 112.093 -168.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 19.8 m -93.46 141.22 28.7 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.469 176.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 67.8 mt -89.84 117.08 32.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.044 0.449 . . . . 0.0 111.284 -173.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . 0.494 HD13 ' N ' ' E' ' 25' ' ' LYS . 1.4 pp -79.67 -27.54 12.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.721 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . 0.494 ' N ' HD13 ' E' ' 24' ' ' ILE . 31.7 ttpt -155.37 136.14 13.55 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 39.6 m -58.3 130.09 45.07 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.654 0.596 . . . . 0.0 110.08 -178.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 27' ' ' PHE . . . . . 0.442 ' CB ' ' HA ' ' E' ' 91' ' ' LEU . 10.0 p90 -144.24 161.92 37.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -172.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 28' ' ' HIS . . . . . 0.582 ' HA ' ' O ' ' E' ' 67' ' ' LEU . 16.0 t60 -114.85 123.87 50.27 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.172 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 29' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 38.1 mt -92.67 136.25 25.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 170.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 30' ' ' SER . . . . . 0.565 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 65.5 p -122.94 -20.26 5.86 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -170.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 31' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -154.81 146.23 14.06 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 119.36 -1.4 . . . . 0.0 113.365 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . 0.43 ' CG2' ' HG ' ' E' ' 87' ' ' LEU . 14.4 p -140.02 126.84 23.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 170.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.84 158.17 43.97 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 121.861 -0.524 . . . . 0.0 111.649 -174.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 34' ' ' LEU . . . . . 0.462 ' HB3' ' CG1' ' E' ' 85' ' ' VAL . 4.0 pp -119.0 139.21 52.07 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.713 0.768 . . . . 0.0 111.445 178.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -108.06 -51.29 2.92 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.392 173.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -102.38 127.94 49.17 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 170.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . 0.485 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 145.17 162.49 9.62 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 119.916 -1.135 . . . . 0.0 113.04 176.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -102.8 -46.65 4.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.536 0.208 . . . . 0.0 111.539 177.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -150.75 130.84 13.48 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.712 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . 0.401 ' HB1' HG11 ' E' ' 56' ' ' VAL . . . -130.8 113.06 13.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.555 0.693 . . . . 0.0 110.175 168.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 41' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' E' ' 79' ' ' THR . 4.5 mptp? -95.42 106.43 18.49 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 174.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.417 ' O ' HG22 ' E' ' 53' ' ' VAL . 41.7 tp -78.82 114.04 17.41 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -176.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 43' ' ' TYR . . . . . 1.636 ' HD1' ' CD2' ' E' ' 43' ' ' TYR . 76.9 m-85 -114.93 135.93 53.67 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.24 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 44' ' ' LEU . . . . . 0.482 ' HB3' HG21 ' E' ' 53' ' ' VAL . 5.0 tp -115.75 116.01 27.32 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.575 176.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 45' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -103.27 103.68 13.73 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 176.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.54 140.74 50.48 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.168 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 58.2 32.33 21.89 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.61 0.719 . . . . 0.0 109.368 -175.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 62.4 mttp 57.43 37.1 27.73 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.479 -178.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 49' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 6.6 tp-100 -127.65 131.74 49.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.612 176.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 50' ' ' GLU . . . . . 0.405 ' HG3' ' HH ' ' E' ' 78' ' ' TYR . 32.8 tt0 -87.37 112.24 21.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.43 -177.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . 1.665 ' HE1' ' CE2' ' E' ' 51' ' ' TYR . 78.0 m-85 -108.36 131.35 54.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.776 177.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -78.8 100.42 3.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 169.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . 0.496 HG12 ' CD2' ' D' ' 88' ' ' LEU . 0.9 OUTLIER -72.35 -51.49 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.998 -174.243 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' E' E ' 54' ' ' ALA . . . . . 0.486 ' HA ' ' OE1' ' D' ' 62' ' ' GLN . . . -154.51 132.53 11.67 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.513 -177.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 7.6 t -101.97 102.43 12.96 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . 0.401 HG11 ' HB1' ' E' ' 40' ' ' ALA . 7.1 p -116.62 109.72 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-O 122.048 0.928 . . . . 0.0 110.025 -176.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 57' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' E' ' 61' ' ' PRO . 68.3 p -122.62 -177.06 3.53 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.342 -176.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -64.98 -20.69 66.62 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.469 169.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.85 -40.82 27.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.313 0.577 . . . . 0.0 110.008 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 74.4 mt -118.66 77.6 14.61 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 172.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 61' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' E' ' 57' ' ' THR . 9.6 Cg_exo -71.69 0.89 6.33 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.095 2.53 . . . . 0.0 113.727 -168.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 62' ' ' GLN . . . . . 0.507 ' OE1' ' HA ' ' A' ' 54' ' ' ALA . 10.3 tt0 -160.11 114.66 2.26 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.792 0.329 . . . . 0.0 111.312 -170.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . 0.432 HG12 ' HB2' ' E' ' 54' ' ' ALA . 86.1 t -112.74 115.18 49.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.065 0.459 . . . . 0.0 111.199 177.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.11 115.99 28.36 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 171.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.55 168.22 19.36 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.058 -171.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 66' ' ' ASP . . . . . 0.524 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 7.5 t0 -122.84 109.43 14.17 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.144 0.497 . . . . 0.0 110.417 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 67' ' ' LEU . . . . . 0.582 ' O ' ' HA ' ' E' ' 28' ' ' HIS . 12.8 mt -123.99 138.91 54.39 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.7 176.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -138.57 114.55 10.08 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 173.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 69' ' ' PHE . . . . . 1.645 ' HD1' ' CD2' ' E' ' 69' ' ' PHE . 65.9 m-85 -109.1 163.0 13.73 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.519 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 70' ' ' SER . . . . . 0.558 ' OG ' ' HA ' ' D' ' 7' ' ' MET . 4.5 m -117.09 149.0 41.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.185 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 71' ' ' LYS . . . . . 0.481 ' HB2' ' HZ3' ' E' ' 71' ' ' LYS . 0.0 OUTLIER -69.99 -6.05 30.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.698 -177.153 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.87 -28.4 46.38 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.344 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -101.24 171.28 7.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.704 0.288 . . . . 0.0 110.364 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -137.32 136.53 38.06 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 75' ' ' ILE . . . . . 0.44 ' HB ' ' CD1' ' E' ' 44' ' ' LEU . 22.4 pt -133.04 158.37 43.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.947 0.403 . . . . 0.0 111.66 -169.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 76' ' ' MET . . . . . 0.421 ' HA ' ' HA ' ' E' ' 20' ' ' SER . 65.3 ttp -117.49 118.11 31.29 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.055 0.455 . . . . 0.0 110.339 176.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 77' ' ' PHE . . . . . 1.635 ' HE2' ' CE1' ' E' ' 77' ' ' PHE . 0.4 OUTLIER -105.59 129.47 53.84 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.693 -177.747 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' E' E ' 78' ' ' TYR . . . . . 1.665 ' HE2' ' CE1' ' E' ' 78' ' ' TYR . 38.8 p90 -155.76 162.68 40.47 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.838 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 79' ' ' THR . . . . . 0.641 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 12.7 p -125.14 143.82 50.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.209 178.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.37 149.68 26.75 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.095 173.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.82 -176.91 36.73 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -176.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -114.45 102.76 10.38 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.14 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 83' ' ' ALA . . . . . 0.53 ' H ' ' HB3' ' E' ' 15' ' ' PRO . . . -166.78 150.05 6.79 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.477 168.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 6.2 p -106.14 122.24 45.8 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 85' ' ' VAL . . . . . 0.479 HG22 ' HB3' ' E' ' 13' ' ' MET . 13.7 m -121.57 144.19 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 CA-C-O 121.161 0.505 . . . . 0.0 111.831 -172.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 44.3 m -105.23 122.84 46.77 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.274 175.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 87' ' ' LEU . . . . . 0.543 ' HB2' ' HB3' ' E' ' 11' ' ' LEU . 5.1 mp -95.16 143.9 26.21 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 170.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . 0.458 ' CD2' HG12 ' A' ' 53' ' ' VAL . 0.9 OUTLIER -130.42 141.25 50.55 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.134 -178.664 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.67 -166.88 27.49 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.678 -177.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 90' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -147.05 133.59 19.78 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.469 0.652 . . . . 0.0 111.066 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 91' ' ' LEU . . . . . 0.483 ' HB3' ' HE3' ' E' ' 25' ' ' LYS . 15.1 mt -69.74 128.77 37.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.117 175.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 92' ' ' HIS . . . . . 0.428 ' CG ' ' HB3' ' D' ' 4' ' ' ALA . 12.3 t60 -81.83 108.28 15.23 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.075 0.465 . . . . 0.0 111.105 -173.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -108.2 -79.45 0.58 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 168.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 94' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' E' ' 3' ' ' GLY . 50.5 mm 62.18 99.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 O-C-N 123.793 0.683 . . . . 0.0 111.385 176.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 95' ' ' ASP . . . . . 0.404 ' OD2' ' HB2' ' E' ' 5' ' ' MET . 28.7 m-20 -76.33 133.67 39.93 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.681 -178.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 23.3 t -91.11 87.05 6.4 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 176.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.34 -50.61 65.75 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.038 -179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 10.8 m . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.085 -0.959 . . . . 0.0 110.976 177.497 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 54.6 mtt . . . . . 0 C--O 1.224 -0.263 0 CA-C-O 120.715 0.293 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.519 ' CE1' HD21 ' B' ' 44' ' ' LEU . 81.2 t80 -58.7 142.66 49.16 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -172.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.509 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 89.3 t90 -140.08 147.73 40.71 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.131 178.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.413 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -149.93 154.07 25.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.114 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.631 HD23 HD13 ' A' ' 87' ' ' LEU . 51.2 tp -146.61 109.05 4.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.818 0.342 . . . . 0.0 111.237 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -91.47 114.11 26.55 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.375 0.607 . . . . 0.0 111.093 176.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.539 ' HB2' HG23 ' A' ' 85' ' ' VAL . 3.5 mmt -93.15 137.32 32.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.016 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -100.64 153.34 37.79 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 171.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.441 ' HB3' ' HA ' ' A' ' 82' ' ' ASP . 84.1 Cg_exo -46.83 111.34 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.993 2.462 . . . . 0.0 113.096 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.686 ' HA ' ' O ' ' A' ' 79' ' ' THR . 39.6 mt-10 65.95 59.13 0.72 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.498 0.666 . . . . 0.0 111.356 177.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.43 ' HD3' ' HA ' ' A' ' 17' ' ' ARG . 70.5 mmt-85 -113.3 145.44 41.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.038 172.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.669 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 33.8 ttmt -128.02 111.27 13.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.308 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.414 ' OH ' ' HA ' ' A' ' 13' ' ' MET . 5.6 m-85 -108.69 104.12 13.34 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.686 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.417 ' HB3' ' SD ' ' A' ' 76' ' ' MET . 9.2 p -88.04 99.9 12.52 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 173.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -125.43 138.7 54.02 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.591 0.71 . . . . 0.0 112.378 -167.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 t -85.0 160.24 20.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.751 177.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.403 ' CD1' ' HB3' ' A' ' 69' ' ' PHE . 53.0 mt -114.14 116.74 53.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.005 0.431 . . . . 0.0 110.862 -176.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.754 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -104.0 -10.15 9.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.248 176.469 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.612 ' HD3' HD22 ' A' ' 91' ' ' LEU . 2.6 ptpp? -142.62 119.35 11.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.794 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.0 m -64.61 135.4 55.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.182 -177.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.78 ' HB3' HD23 ' A' ' 91' ' ' LEU . 19.2 p90 -147.25 160.78 42.09 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -174.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.49 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 5.3 t60 -114.87 128.07 56.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.405 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 56.5 mt -94.63 136.45 25.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 171.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.519 ' HB2' ' HB3' ' B' ' 66' ' ' ASP . 72.7 p -119.81 -16.74 8.69 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -170.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -163.78 144.85 9.84 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 119.365 -1.397 . . . . 0.0 113.5 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.448 HG23 ' HG ' ' A' ' 87' ' ' LEU . 12.4 p -129.02 125.71 63.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 170.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.66 152.18 41.02 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.606 -174.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.573 ' HB3' HG12 ' A' ' 85' ' ' VAL . 3.5 pp -114.26 137.9 51.18 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.871 0.843 . . . . 0.0 111.81 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -106.04 -55.35 2.34 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.436 175.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -101.98 126.87 49.01 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.745 170.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.458 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 147.96 162.51 10.16 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 119.612 -1.28 . . . . 0.0 113.561 176.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.442 ' O ' ' HG3' ' A' ' 58' ' ' LYS . 39.5 mt-30 -102.82 -48.13 4.18 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 178.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -151.77 134.49 15.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.382 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.561 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -135.39 117.46 15.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.376 0.608 . . . . 0.0 111.112 172.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 79' ' ' THR . 48.3 mttm -97.65 116.02 29.06 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 173.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.429 HD21 HD21 ' A' ' 87' ' ' LEU . 53.8 tp -91.44 105.4 17.74 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.154 0.502 . . . . 0.0 110.037 -173.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.408 ' HB2' ' CE2' ' A' ' 78' ' ' TYR . 96.9 m-85 -103.43 150.91 23.39 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.256 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.627 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 1.1 tp -133.5 117.41 17.12 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.701 176.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -102.06 104.32 14.96 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.425 0.631 . . . . 0.0 109.615 175.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.513 ' HB2' HD11 ' A' ' 44' ' ' LEU . . . -134.28 152.18 51.68 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 57.79 24.14 10.41 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -174.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 58.45 42.24 21.47 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.286 -175.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 28.2 tp60 -137.62 131.85 32.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.562 178.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -79.58 107.1 12.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.916 0.389 . . . . 0.0 110.45 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.405 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 74.5 m-85 -100.16 129.32 46.17 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.051 176.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 tp -89.95 99.89 10.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 172.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.475 ' CG1' ' HB3' ' A' ' 44' ' ' LEU . 2.6 m -84.27 -33.79 9.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.131 -169.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.524 ' HB2' HD13 ' A' ' 65' ' ' LEU . . . -159.3 148.93 18.66 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.117 0.484 . . . . 0.0 111.885 177.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.2 m -117.39 102.96 9.66 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 170.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.42 ' CG1' HG11 ' A' ' 85' ' ' VAL . 6.7 p -110.6 116.26 51.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.439 0.638 . . . . 0.0 110.224 -176.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.8 p -122.7 -177.48 3.66 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.297 -175.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 38' ' ' GLN . 52.7 mtmt -59.8 -33.68 72.05 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.99 0.424 . . . . 0.0 110.288 169.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.93 -40.81 68.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.39 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.6 mt -116.6 80.14 10.17 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 174.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -72.38 0.23 7.73 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.804 2.336 . . . . 0.0 113.927 -167.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -162.43 119.21 2.0 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.126 0.489 . . . . 0.0 110.875 -176.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.457 HG11 ' HB1' ' A' ' 54' ' ' ALA . 92.8 t -110.2 101.67 12.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.216 175.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.14 111.36 17.51 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 173.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.524 HD13 ' HB2' ' A' ' 54' ' ' ALA . 1.0 OUTLIER -133.05 150.78 52.09 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.079 -171.254 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.544 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 11.7 t0 -96.0 99.14 10.94 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.345 0.593 . . . . 0.0 110.006 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.557 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 4.2 mt -113.21 141.8 46.54 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.491 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.624 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 6.2 t30 -148.87 132.46 16.79 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.1 177.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.513 ' CZ ' HD22 ' A' ' 67' ' ' LEU . 63.4 m-85 -127.54 158.02 38.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.831 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.9 p -120.97 154.86 35.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.386 178.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.465 ' HD3' ' H ' ' A' ' 71' ' ' LYS . 0.2 OUTLIER -70.9 11.48 0.38 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -174.837 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.03 -29.48 9.69 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.678 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -101.53 163.11 12.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.942 0.371 . . . . 0.0 110.929 -175.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -123.14 111.42 16.49 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.444 HG22 ' CB ' ' A' ' 46' ' ' ALA . 27.9 pt -111.15 161.43 9.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.122 0.487 . . . . 0.0 111.71 -168.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.417 ' SD ' ' HB3' ' A' ' 20' ' ' SER . 4.9 mtm -121.84 124.86 45.13 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 173.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.627 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -105.05 128.16 53.2 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.162 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.669 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 30.1 p90 -151.06 138.93 19.88 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.137 -0.625 . . . . 0.0 112.055 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.686 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 11.3 p -109.72 137.54 47.38 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.878 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.68 157.22 18.73 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.588 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.73 -173.9 35.6 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -176.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.441 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 11.6 m-20 -114.05 103.17 10.87 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.843 177.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -172.31 155.14 3.46 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.153 171.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.5 t -110.41 114.46 27.92 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.573 HG12 ' HB3' ' A' ' 34' ' ' LEU . 6.8 m -112.98 143.49 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-O 121.357 0.599 . . . . 0.0 112.15 -174.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.8 t -108.86 118.65 37.34 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.72 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.631 HD13 HD23 ' A' ' 11' ' ' LEU . 5.2 mp -94.04 151.9 19.19 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.41 ' CD2' HD21 ' B' ' 67' ' ' LEU . 2.2 tp -134.31 145.96 49.54 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.177 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.68 -167.52 29.44 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.455 -0.878 . . . . 0.0 112.084 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.611 ' CD2' ' HB3' ' B' ' 68' ' ' ASN . 8.7 p90 -151.54 130.23 12.33 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.732 0.777 . . . . 0.0 111.85 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.78 HD23 ' HB3' ' A' ' 27' ' ' PHE . 6.2 mt . . . . . 0 C--N 1.321 -0.671 0 CA-C-N 114.121 -1.399 . . . . 0.0 109.595 175.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 54.6 mtt . . . . . 0 C--O 1.225 -0.197 0 CA-C-O 120.876 0.369 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 8' ' ' PHE . . . . . 0.53 ' CE1' HD21 ' C' ' 44' ' ' LEU . 80.5 t80 -58.85 142.76 49.61 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -172.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' TRP . . . . . 0.509 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 89.2 t90 -140.11 147.67 40.56 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.141 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.439 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -149.9 154.03 25.46 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.097 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.621 HD23 HD13 ' B' ' 87' ' ' LEU . 51.7 tp -146.49 108.9 4.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.772 0.32 . . . . 0.0 111.296 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -91.34 114.06 26.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.332 0.587 . . . . 0.0 111.096 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' MET . . . . . 0.558 ' HB2' HG23 ' B' ' 85' ' ' VAL . 3.5 mmt -93.17 137.27 32.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.964 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -100.55 153.38 37.78 Favored Pre-proline 0 C--N 1.317 -0.828 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 171.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.449 ' HB3' ' HA ' ' B' ' 82' ' ' ASP . 84.2 Cg_exo -46.77 111.21 0.35 Allowed 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 123.058 2.505 . . . . 0.0 113.15 -178.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.686 ' HA ' ' O ' ' B' ' 79' ' ' THR . 39.5 mt-10 66.01 59.11 0.71 Allowed 'General case' 0 C--O 1.233 0.224 0 O-C-N 123.693 0.621 . . . . 0.0 111.316 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.431 ' HD3' ' HA ' ' B' ' 17' ' ' ARG . 70.5 mmt-85 -113.28 145.47 40.98 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.037 172.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.664 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 33.9 ttmt -128.08 111.26 13.29 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.344 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' TYR . . . . . 0.423 ' OH ' ' HA ' ' B' ' 13' ' ' MET . 5.6 m-85 -108.68 104.05 13.27 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.687 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.415 ' HB3' ' SD ' ' B' ' 76' ' ' MET . 9.6 p -88.0 100.03 12.6 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 173.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -125.53 138.74 53.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.59 0.71 . . . . 0.0 112.335 -167.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 14.8 t -85.07 160.36 20.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.691 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.401 ' CD1' ' HB3' ' B' ' 69' ' ' PHE . 53.0 mt -114.11 116.76 53.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 120.973 0.416 . . . . 0.0 110.877 -176.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.758 ' H ' HD13 ' B' ' 24' ' ' ILE . 0.2 OUTLIER -104.05 -10.24 9.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.257 176.413 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.597 ' HD3' HD22 ' B' ' 91' ' ' LEU . 2.5 ptpp? -142.64 119.38 11.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.736 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 23.8 m -64.57 135.46 56.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.21 -177.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' PHE . . . . . 0.777 ' HB3' HD23 ' B' ' 91' ' ' LEU . 19.3 p90 -147.28 160.74 42.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.62 0.724 . . . . 0.0 112.908 -174.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' HIS . . . . . 0.495 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 5.3 t60 -114.85 128.06 56.08 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.418 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 56.5 mt -94.67 136.44 25.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 171.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.506 ' HB2' ' HB3' ' C' ' 66' ' ' ASP . 72.5 p -119.86 -16.64 8.67 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.961 -170.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -163.75 144.91 9.89 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 119.424 -1.369 . . . . 0.0 113.497 178.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.442 HG23 ' HG ' ' B' ' 87' ' ' LEU . 12.3 p -129.2 125.68 62.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 170.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.59 152.21 41.12 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 121.921 -0.487 . . . . 0.0 111.629 -174.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.591 ' HB3' HG12 ' B' ' 85' ' ' VAL . 3.5 pp -114.32 137.87 51.25 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.906 0.86 . . . . 0.0 111.781 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -105.94 -55.34 2.34 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.482 175.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -101.99 126.87 49.02 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.775 170.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.456 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 147.93 162.56 10.17 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 119.644 -1.265 . . . . 0.0 113.644 176.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' GLN . . . . . 0.44 ' O ' ' HG3' ' B' ' 58' ' ' LYS . 39.3 mt-30 -102.74 -48.14 4.19 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 178.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -151.86 134.47 15.45 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.433 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.559 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -135.37 117.39 15.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.39 0.614 . . . . 0.0 111.031 172.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' B' ' 79' ' ' THR . 48.3 mttm -97.58 116.01 28.98 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 173.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.427 HD21 HD21 ' B' ' 87' ' ' LEU . 53.7 tp -91.37 105.24 17.63 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.156 0.503 . . . . 0.0 110.111 -173.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' TYR . . . . . 0.415 ' HB2' ' CE2' ' B' ' 78' ' ' TYR . 96.9 m-85 -103.41 150.91 23.38 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.203 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.631 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 1.1 tp -133.55 117.36 17.02 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.619 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -102.03 104.25 14.9 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.382 0.611 . . . . 0.0 109.574 175.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.504 ' HB2' HD11 ' B' ' 44' ' ' LEU . . . -134.24 152.3 51.75 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.047 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 57.67 24.19 10.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.132 0.491 . . . . 0.0 109.729 -174.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 58.38 42.34 21.54 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.321 -175.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.497 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 28.3 tp60 -137.67 131.8 31.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.55 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -79.55 107.16 12.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.815 0.341 . . . . 0.0 110.428 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.413 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 74.6 m-85 -100.26 129.27 46.24 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.004 176.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 tp -89.84 99.93 10.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 172.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.47 ' CG1' ' HB3' ' B' ' 44' ' ' LEU . 2.6 m -84.25 -33.88 9.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.088 -169.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.498 ' HB2' HD13 ' B' ' 65' ' ' LEU . . . -159.3 148.94 18.66 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.026 0.441 . . . . 0.0 111.959 177.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 92.6 m -117.44 102.88 9.57 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 170.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 56' ' ' VAL . . . . . 0.419 ' CG1' HG11 ' B' ' 85' ' ' VAL . 6.7 p -110.57 116.21 51.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.471 0.653 . . . . 0.0 110.225 -176.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 74.4 p -122.69 -177.42 3.64 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.305 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' B' ' 38' ' ' GLN . 52.6 mtmt -59.88 -33.72 72.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.963 0.411 . . . . 0.0 110.285 169.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.86 -40.75 68.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.472 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 74.9 mt -116.66 80.15 10.31 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 174.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -72.4 0.13 7.9 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.923 2.415 . . . . 0.0 113.881 -166.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -162.4 119.24 2.01 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.299 0.571 . . . . 0.0 110.866 -176.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.442 HG11 ' HB1' ' B' ' 54' ' ' ALA . 92.3 t -110.2 101.67 12.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.2 176.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.14 111.29 17.44 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 173.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.498 HD13 ' HB2' ' B' ' 54' ' ' ALA . 1.0 OUTLIER -133.03 150.75 52.11 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.167 -171.295 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 66' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 11.7 t0 -96.0 99.14 10.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.399 0.619 . . . . 0.0 109.993 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.572 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 4.2 mt -113.19 141.8 46.52 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.424 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 68' ' ' ASN . . . . . 0.611 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 6.2 t30 -148.9 132.49 16.79 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.174 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 69' ' ' PHE . . . . . 0.527 ' CZ ' HD22 ' B' ' 67' ' ' LEU . 63.5 m-85 -127.6 158.08 38.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.825 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 4.8 p -121.05 154.92 35.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.304 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 71' ' ' LYS . . . . . 0.469 ' HD3' ' H ' ' B' ' 71' ' ' LYS . 0.2 OUTLIER -70.92 11.47 0.39 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -174.785 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.06 -29.52 9.64 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.673 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -101.48 163.13 12.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.785 0.326 . . . . 0.0 110.918 -175.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -123.12 111.48 16.58 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 177.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.443 HG22 ' CB ' ' B' ' 46' ' ' ALA . 27.8 pt -111.2 161.41 9.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.092 0.472 . . . . 0.0 111.704 -168.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.415 ' SD ' ' HB3' ' B' ' 20' ' ' SER . 4.9 mtm -121.82 124.77 44.95 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 173.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 77' ' ' PHE . . . . . 0.631 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.5 OUTLIER -104.96 128.16 53.11 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.113 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.664 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 30.2 p90 -151.04 138.89 19.86 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.023 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.686 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 11.2 p -109.73 137.5 47.45 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.953 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.48 157.12 18.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.632 176.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.74 -173.76 35.44 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -176.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 82' ' ' ASP . . . . . 0.449 ' HA ' ' HB3' ' B' ' 15' ' ' PRO . 11.7 m-20 -114.14 103.14 10.82 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.763 178.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.559 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -172.31 155.18 3.47 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.131 171.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 24.4 t -110.41 114.32 27.66 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.591 HG12 ' HB3' ' B' ' 34' ' ' LEU . 6.8 m -112.86 143.62 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 CA-C-O 121.416 0.627 . . . . 0.0 112.198 -174.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 11.9 t -108.99 118.73 37.55 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.664 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.621 HD13 HD23 ' B' ' 11' ' ' LEU . 5.2 mp -94.17 151.87 19.15 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 174.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.4 ' CD2' HD21 ' C' ' 67' ' ' LEU . 2.2 tp -134.25 145.97 49.63 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.124 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.73 -167.51 29.46 Favored Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.053 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 90' ' ' TYR . . . . . 0.599 ' CD2' ' HB3' ' C' ' 68' ' ' ASN . 8.7 p90 -151.62 130.29 12.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.798 0.808 . . . . 0.0 111.842 177.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 91' ' ' LEU . . . . . 0.777 HD23 ' HB3' ' B' ' 27' ' ' PHE . 6.3 mt . . . . . 0 C--N 1.321 -0.631 0 CA-C-N 114.023 -1.444 . . . . 0.0 109.555 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 54.7 mtt . . . . . 0 C--O 1.225 -0.192 0 CA-C-O 120.736 0.303 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 8' ' ' PHE . . . . . 0.511 ' CE1' HD21 ' D' ' 44' ' ' LEU . 80.8 t80 -58.83 142.74 49.56 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -172.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 9' ' ' TRP . . . . . 0.51 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 89.1 t90 -140.11 147.67 40.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.169 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 10' ' ' GLY . . . . . 0.421 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -149.86 153.99 25.43 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.189 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.648 HD23 HD13 ' C' ' 87' ' ' LEU . 51.5 tp -146.52 109.0 4.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.77 0.319 . . . . 0.0 111.235 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -91.53 114.2 26.67 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.461 0.648 . . . . 0.0 111.005 176.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 13' ' ' MET . . . . . 0.543 ' HB2' HG23 ' C' ' 85' ' ' VAL . 3.5 mmt -93.21 137.29 32.68 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.006 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -100.56 153.29 37.83 Favored Pre-proline 0 C--N 1.318 -0.798 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 171.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 15' ' ' PRO . . . . . 0.44 ' HB3' ' HA ' ' C' ' 82' ' ' ASP . 85.4 Cg_exo -46.76 111.34 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.056 2.504 . . . . 0.0 113.183 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 16' ' ' GLU . . . . . 0.69 ' HA ' ' O ' ' C' ' 79' ' ' THR . 39.7 mt-10 65.83 59.2 0.74 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.471 0.653 . . . . 0.0 111.414 178.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 17' ' ' ARG . . . . . 0.441 ' HD3' ' HA ' ' C' ' 17' ' ' ARG . 70.4 mmt-85 -113.35 145.46 41.06 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.932 172.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 18' ' ' LYS . . . . . 0.671 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 33.8 ttmt -128.08 111.28 13.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.304 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 19' ' ' TYR . . . . . 0.416 ' OH ' ' HA ' ' C' ' 13' ' ' MET . 5.6 m-85 -108.69 104.06 13.28 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.695 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 20' ' ' SER . . . . . 0.418 ' HB3' ' SD ' ' C' ' 76' ' ' MET . 9.4 p -87.94 99.9 12.49 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 173.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -125.47 138.62 54.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.564 0.697 . . . . 0.0 112.368 -167.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 14.8 t -85.03 160.37 20.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.665 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 23' ' ' ILE . . . . . 0.4 ' CD1' ' HB3' ' C' ' 69' ' ' PHE . 53.2 mt -114.15 116.81 53.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.915 0.388 . . . . 0.0 110.793 -176.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 24' ' ' ILE . . . . . 0.764 ' H ' HD13 ' C' ' 24' ' ' ILE . 0.2 OUTLIER -104.0 -10.17 9.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.257 176.362 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 25' ' ' LYS . . . . . 0.607 ' HD3' HD22 ' C' ' 91' ' ' LEU . 2.5 ptpp? -142.63 119.34 11.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.763 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 24.0 m -64.65 135.41 55.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.185 -177.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 27' ' ' PHE . . . . . 0.777 ' HB3' HD23 ' C' ' 91' ' ' LEU . 19.2 p90 -147.19 160.73 42.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.62 0.724 . . . . 0.0 112.924 -174.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 28' ' ' HIS . . . . . 0.5 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 5.4 t60 -114.89 128.05 56.06 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.38 177.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 29' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 56.7 mt -94.61 136.48 25.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 171.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.521 ' HB2' ' HB3' ' D' ' 66' ' ' ASP . 72.8 p -119.89 -16.66 8.65 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.97 -170.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 31' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -163.75 144.97 9.95 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 119.45 -1.357 . . . . 0.0 113.457 178.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.441 HG23 ' HG ' ' C' ' 87' ' ' LEU . 12.2 p -129.21 125.68 62.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 170.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.65 152.28 41.16 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.612 -174.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.593 ' HB3' HG12 ' C' ' 85' ' ' VAL . 3.5 pp -114.27 137.85 51.25 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.896 0.855 . . . . 0.0 111.794 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -106.03 -55.27 2.35 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.218 -1.356 . . . . 0.0 108.459 175.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -102.02 126.85 49.05 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.765 170.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 37' ' ' GLY . . . . . 0.448 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 147.95 162.56 10.18 Favored Glycine 0 N--CA 1.438 -1.189 0 C-N-CA 119.602 -1.285 . . . . 0.0 113.617 176.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 38' ' ' GLN . . . . . 0.443 ' O ' ' HG3' ' C' ' 58' ' ' LYS . 39.3 mt-30 -102.88 -48.1 4.18 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 178.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -151.84 134.54 15.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.405 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.554 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -135.42 117.44 15.33 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.363 0.601 . . . . 0.0 111.093 172.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' C' ' 79' ' ' THR . 48.2 mttm -97.72 116.0 29.08 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 173.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.411 HD21 HD21 ' C' ' 87' ' ' LEU . 54.0 tp -91.44 105.4 17.74 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.12 0.486 . . . . 0.0 110.001 -173.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 43' ' ' TYR . . . . . 0.418 ' HB2' ' CE2' ' C' ' 78' ' ' TYR . 96.9 m-85 -103.49 150.83 23.51 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.218 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.63 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 1.1 tp -133.44 117.4 17.16 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.66 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 45' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -102.07 104.24 14.86 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.349 0.595 . . . . 0.0 109.582 175.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.503 ' HB2' HD11 ' C' ' 44' ' ' LEU . . . -134.21 152.21 51.71 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 57.74 24.11 10.3 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -174.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 58.43 42.33 21.42 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.255 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 49' ' ' GLN . . . . . 0.491 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 28.1 tp60 -137.65 131.91 32.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.628 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -79.72 107.17 12.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.804 0.335 . . . . 0.0 110.399 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 51' ' ' TYR . . . . . 0.439 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 74.7 m-85 -100.3 129.24 46.27 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.976 176.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 tp -89.83 99.88 10.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 172.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 53' ' ' VAL . . . . . 0.464 ' CG1' ' HB3' ' C' ' 44' ' ' LEU . 2.6 m -84.27 -33.77 9.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.129 -170.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 54' ' ' ALA . . . . . 0.508 ' HB2' HD13 ' C' ' 65' ' ' LEU . . . -159.37 148.96 18.55 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.093 0.473 . . . . 0.0 111.908 177.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 92.3 m -117.38 102.84 9.56 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 170.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 56' ' ' VAL . . . . . 0.42 ' CG1' HG11 ' C' ' 85' ' ' VAL . 6.7 p -110.6 116.35 52.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.498 0.666 . . . . 0.0 110.193 -176.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 74.3 p -122.75 -177.43 3.65 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.202 -175.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 58' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' C' ' 38' ' ' GLN . 52.6 mtmt -59.76 -33.71 72.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.119 0.485 . . . . 0.0 110.345 169.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.95 -40.79 68.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.371 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 74.4 mt -116.64 80.18 10.29 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -72.5 0.32 7.67 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.835 2.357 . . . . 0.0 113.831 -166.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -162.5 119.1 1.97 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.165 0.507 . . . . 0.0 110.86 -176.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.455 HG11 ' HB1' ' C' ' 54' ' ' ALA . 91.9 t -110.19 101.7 12.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.198 175.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.06 111.22 17.32 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 173.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 65' ' ' LEU . . . . . 0.508 HD13 ' HB2' ' C' ' 54' ' ' ALA . 1.0 OUTLIER -132.99 150.8 52.13 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.206 -171.396 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 66' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 11.6 t0 -96.02 99.18 10.97 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.415 0.626 . . . . 0.0 109.981 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.557 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 4.1 mt -113.25 141.87 46.48 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.427 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 68' ' ' ASN . . . . . 0.599 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 6.2 t30 -148.91 132.5 16.78 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.175 177.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 69' ' ' PHE . . . . . 0.515 ' CZ ' HD22 ' C' ' 67' ' ' LEU . 63.7 m-85 -127.65 157.95 38.88 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.795 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 4.8 p -120.96 154.91 35.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.329 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 71' ' ' LYS . . . . . 0.472 ' HD3' ' H ' ' C' ' 71' ' ' LYS . 0.2 OUTLIER -70.92 11.41 0.39 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -174.705 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.97 -29.61 9.62 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.688 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -101.36 163.11 12.43 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 122.575 -0.367 . . . . 0.0 111.039 -175.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -123.13 111.42 16.5 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.433 HG22 ' CB ' ' C' ' 46' ' ' ALA . 27.8 pt -111.09 161.38 9.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.142 0.496 . . . . 0.0 111.706 -168.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.418 ' SD ' ' HB3' ' C' ' 20' ' ' SER . 4.9 mtm -121.84 124.84 45.09 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 173.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 77' ' ' PHE . . . . . 0.63 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.5 OUTLIER -105.05 128.16 53.2 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.158 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 78' ' ' TYR . . . . . 0.671 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 30.3 p90 -151.08 138.9 19.84 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.217 -0.593 . . . . 0.0 112.008 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 79' ' ' THR . . . . . 0.69 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 11.3 p -109.68 137.54 47.35 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.926 -179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.53 157.23 18.65 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.619 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.65 -173.85 35.67 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -176.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 82' ' ' ASP . . . . . 0.44 ' HA ' ' HB3' ' C' ' 15' ' ' PRO . 11.5 m-20 -114.05 103.14 10.84 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 119.601 -0.839 . . . . 0.0 109.8 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 83' ' ' ALA . . . . . 0.554 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -172.35 155.14 3.44 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.159 171.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 25.0 t -110.3 114.49 27.99 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.593 HG12 ' HB3' ' C' ' 34' ' ' LEU . 6.8 m -113.03 143.57 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 CA-C-O 121.419 0.628 . . . . 0.0 112.118 -174.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 12.0 t -108.94 118.75 37.61 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.617 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 87' ' ' LEU . . . . . 0.648 HD13 HD23 ' C' ' 11' ' ' LEU . 5.2 mp -94.15 151.89 19.15 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 174.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 88' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' C' ' 88' ' ' LEU . 2.2 tp -134.27 145.96 49.59 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.092 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.72 -167.51 29.46 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.228 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 90' ' ' TYR . . . . . 0.613 ' CD2' ' HB3' ' D' ' 68' ' ' ASN . 8.7 p90 -151.55 130.2 12.3 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.777 0.799 . . . . 0.0 111.901 177.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 91' ' ' LEU . . . . . 0.777 HD23 ' HB3' ' C' ' 27' ' ' PHE . 6.2 mt . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.643 175.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 54.6 mtt . . . . . 0 C--O 1.226 -0.134 0 CA-C-O 120.745 0.307 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 8' ' ' PHE . . . . . 0.519 ' CE1' HD21 ' E' ' 44' ' ' LEU . 81.0 t80 -58.7 142.66 49.15 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -172.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 9' ' ' TRP . . . . . 0.511 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 89.3 t90 -140.07 147.63 40.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.153 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 10' ' ' GLY . . . . . 0.438 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -149.84 154.0 25.45 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.215 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 11' ' ' LEU . . . . . 0.645 HD23 HD13 ' D' ' 87' ' ' LEU . 51.2 tp -146.55 109.0 4.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.777 0.322 . . . . 0.0 111.173 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -91.41 114.1 26.54 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.375 0.607 . . . . 0.0 111.134 176.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 13' ' ' MET . . . . . 0.544 ' HB2' HG23 ' D' ' 85' ' ' VAL . 3.5 mmt -93.12 137.33 32.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.017 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -100.6 153.37 37.78 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 171.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 15' ' ' PRO . . . . . 0.434 ' HB3' ' HA ' ' D' ' 82' ' ' ASP . 83.8 Cg_exo -46.82 111.4 0.38 Allowed 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.025 2.484 . . . . 0.0 113.103 -178.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 16' ' ' GLU . . . . . 0.68 ' HA ' ' O ' ' D' ' 79' ' ' THR . 39.6 mt-10 65.87 59.06 0.74 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.538 0.685 . . . . 0.0 111.446 177.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 17' ' ' ARG . . . . . 0.426 ' HA ' ' HD3' ' D' ' 17' ' ' ARG . 70.7 mmt-85 -113.29 145.35 41.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.02 172.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 18' ' ' LYS . . . . . 0.644 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 33.8 ttmt -127.95 111.22 13.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.331 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 19' ' ' TYR . . . . . 0.418 ' OH ' ' HA ' ' D' ' 13' ' ' MET . 5.6 m-85 -108.56 104.17 13.43 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.662 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 20' ' ' SER . . . . . 0.419 ' HB3' ' SD ' ' D' ' 76' ' ' MET . 9.3 p -88.05 99.99 12.59 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 173.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -125.51 138.73 53.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.553 0.692 . . . . 0.0 112.324 -167.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 14.7 t -85.03 160.29 20.04 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.698 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 23' ' ' ILE . . . . . 0.402 ' CD1' ' HB3' ' D' ' 69' ' ' PHE . 53.4 mt -114.14 116.7 53.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.053 0.454 . . . . 0.0 110.845 -176.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 24' ' ' ILE . . . . . 0.772 ' H ' HD13 ' D' ' 24' ' ' ILE . 0.2 OUTLIER -103.9 -10.21 9.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.287 176.36 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 25' ' ' LYS . . . . . 0.591 ' HD3' HD22 ' D' ' 91' ' ' LEU . 2.5 ptpp? -142.65 119.35 11.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.751 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 23.9 m -64.65 135.44 55.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.246 -177.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 27' ' ' PHE . . . . . 0.774 ' HB3' HD23 ' D' ' 91' ' ' LEU . 19.2 p90 -147.23 160.69 42.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.664 0.745 . . . . 0.0 112.837 -174.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 28' ' ' HIS . . . . . 0.492 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 5.4 t60 -114.8 128.01 56.06 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.5 177.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 29' ' ' ILE . . . . . 0.567 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 56.6 mt -94.59 136.45 25.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 171.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 30' ' ' SER . . . . . 0.492 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 72.7 p -119.77 -16.73 8.71 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -170.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 31' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -163.82 144.84 9.82 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 119.331 -1.414 . . . . 0.0 113.447 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.442 HG23 ' HG ' ' D' ' 87' ' ' LEU . 12.3 p -129.05 125.72 63.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 170.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.66 152.21 41.06 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 121.882 -0.512 . . . . 0.0 111.615 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 34' ' ' LEU . . . . . 0.582 ' HB3' HG12 ' D' ' 85' ' ' VAL . 3.5 pp -114.28 137.76 51.37 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 121.905 0.859 . . . . 0.0 111.845 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -105.84 -55.39 2.33 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.218 -1.356 . . . . 0.0 108.524 175.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -101.92 126.91 48.93 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.822 170.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 37' ' ' GLY . . . . . 0.451 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 147.87 162.57 10.17 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 119.622 -1.275 . . . . 0.0 113.614 176.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 38' ' ' GLN . . . . . 0.443 ' O ' ' HG3' ' D' ' 58' ' ' LYS . 39.3 mt-30 -102.84 -48.17 4.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -151.82 134.5 15.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.447 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 40' ' ' ALA . . . . . 0.539 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -135.34 117.54 15.52 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.428 0.633 . . . . 0.0 111.152 172.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' D' ' 79' ' ' THR . 48.3 mttm -97.79 116.06 29.25 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 173.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.43 HD21 HD21 ' D' ' 87' ' ' LEU . 53.7 tp -91.45 105.35 17.7 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.163 0.506 . . . . 0.0 110.051 -173.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 43' ' ' TYR . . . . . 0.418 ' HB2' ' CE2' ' D' ' 78' ' ' TYR . 96.9 m-85 -103.46 150.92 23.41 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.17 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.623 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 1.1 tp -133.54 117.35 17.01 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.728 177.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 45' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -102.03 104.3 14.94 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.423 0.63 . . . . 0.0 109.543 175.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.509 ' HB2' HD11 ' D' ' 44' ' ' LEU . . . -134.27 152.14 51.65 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 57.85 24.17 10.54 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -174.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 58.32 42.26 21.88 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.298 -175.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 49' ' ' GLN . . . . . 0.498 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 28.1 tp60 -137.55 131.87 32.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.615 178.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -79.66 107.17 12.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.896 0.379 . . . . 0.0 110.401 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 51' ' ' TYR . . . . . 0.421 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 74.5 m-85 -100.3 129.28 46.27 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.047 176.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 tp -89.89 99.84 10.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 172.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 53' ' ' VAL . . . . . 0.466 ' CG1' ' HB3' ' D' ' 44' ' ' LEU . 2.6 m -84.29 -33.69 9.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.147 -169.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 54' ' ' ALA . . . . . 0.508 ' HB2' HD13 ' D' ' 65' ' ' LEU . . . -159.33 148.93 18.6 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.072 0.463 . . . . 0.0 111.971 177.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 92.4 m -117.45 102.89 9.58 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 170.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 56' ' ' VAL . . . . . 0.42 ' CG1' HG11 ' D' ' 85' ' ' VAL . 6.8 p -110.57 116.34 52.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.582 0.706 . . . . 0.0 110.215 -176.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 74.0 p -122.81 -177.47 3.67 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.206 -175.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 58' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' D' ' 38' ' ' GLN . 52.7 mtmt -59.89 -33.58 72.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.021 0.439 . . . . 0.0 110.357 169.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.05 -40.67 68.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.313 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 74.8 mt -116.67 80.19 10.38 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 174.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.54 0.36 7.64 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.824 2.35 . . . . 0.0 113.84 -166.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -162.52 119.12 1.96 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.157 0.504 . . . . 0.0 110.844 -176.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.445 HG11 ' HB1' ' D' ' 54' ' ' ALA . 91.9 t -110.12 101.74 12.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.193 176.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.07 111.3 17.4 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.529 173.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 65' ' ' LEU . . . . . 0.508 HD13 ' HB2' ' D' ' 54' ' ' ALA . 1.0 OUTLIER -133.05 150.79 52.09 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.153 -171.323 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 66' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 11.6 t0 -96.08 99.18 10.96 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.499 0.666 . . . . 0.0 110.006 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.567 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 4.2 mt -113.15 141.88 46.42 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.447 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 68' ' ' ASN . . . . . 0.613 ' HB3' ' CD2' ' C' ' 90' ' ' TYR . 6.3 t30 -148.92 132.54 16.81 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.1 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 69' ' ' PHE . . . . . 0.526 ' CZ ' HD22 ' D' ' 67' ' ' LEU . 63.7 m-85 -127.74 157.97 38.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.764 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 4.7 p -120.97 154.89 35.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.281 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 71' ' ' LYS . . . . . 0.459 ' HD3' ' H ' ' D' ' 71' ' ' LYS . 0.2 OUTLIER -70.87 11.48 0.38 Allowed 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -174.822 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.0 -29.66 9.55 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.592 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -101.35 163.1 12.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.906 0.353 . . . . 0.0 111.012 -175.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -123.14 111.43 16.51 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.438 HG22 ' CB ' ' D' ' 46' ' ' ALA . 27.7 pt -111.1 161.38 9.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.039 0.447 . . . . 0.0 111.719 -168.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 76' ' ' MET . . . . . 0.419 ' SD ' ' HB3' ' D' ' 20' ' ' SER . 4.9 mtm -121.88 124.82 45.0 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 173.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 77' ' ' PHE . . . . . 0.623 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.5 OUTLIER -105.02 128.16 53.19 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.163 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 78' ' ' TYR . . . . . 0.644 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 30.4 p90 -151.07 138.87 19.82 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.245 -0.582 . . . . 0.0 112.108 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 79' ' ' THR . . . . . 0.68 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 11.4 p -109.71 137.57 47.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.923 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.57 157.17 18.72 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.612 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.8 -173.88 35.46 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 -176.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 82' ' ' ASP . . . . . 0.434 ' HA ' ' HB3' ' D' ' 15' ' ' PRO . 11.5 m-20 -114.03 103.27 10.97 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.803 177.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 83' ' ' ALA . . . . . 0.539 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -172.4 155.19 3.41 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.083 171.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 24.4 t -110.44 114.42 27.84 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.582 HG12 ' HB3' ' D' ' 34' ' ' LEU . 6.8 m -112.89 143.66 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-O 121.347 0.594 . . . . 0.0 112.159 -174.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 12.0 t -109.04 118.63 37.28 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.67 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 87' ' ' LEU . . . . . 0.645 HD13 HD23 ' D' ' 11' ' ' LEU . 5.2 mp -93.96 151.82 19.28 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 174.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tp -134.31 145.99 49.58 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.113 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.76 -167.49 29.46 Favored Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.087 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 90' ' ' TYR . . . . . 0.586 ' CD2' ' HB3' ' E' ' 68' ' ' ASN . 8.7 p90 -151.56 130.22 12.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.755 0.788 . . . . 0.0 111.876 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 91' ' ' LEU . . . . . 0.774 HD23 ' HB3' ' D' ' 27' ' ' PHE . 6.2 mt . . . . . 0 C--N 1.321 -0.669 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.631 175.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 54.7 mtt . . . . . 0 C--O 1.225 -0.21 0 CA-C-O 120.834 0.35 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' E' E ' 8' ' ' PHE . . . . . 0.509 ' CE1' HD21 ' A' ' 44' ' ' LEU . 81.0 t80 -58.78 142.73 49.36 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -172.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 9' ' ' TRP . . . . . 0.512 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 89.2 t90 -140.11 147.71 40.64 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.104 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 10' ' ' GLY . . . . . 0.405 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -149.9 153.92 25.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.181 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 11' ' ' LEU . . . . . 0.625 HD23 HD13 ' E' ' 87' ' ' LEU . 51.6 tp -146.46 108.95 4.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.732 0.301 . . . . 0.0 111.251 -178.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -91.46 114.17 26.63 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.461 0.648 . . . . 0.0 110.994 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 13' ' ' MET . . . . . 0.551 ' HB2' HG23 ' E' ' 85' ' ' VAL . 3.5 mmt -93.15 137.32 32.6 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.043 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -100.67 153.31 37.81 Favored Pre-proline 0 C--N 1.318 -0.791 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 171.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 15' ' ' PRO . . . . . 0.446 ' HB3' ' HA ' ' E' ' 82' ' ' ASP . 84.9 Cg_exo -46.67 111.32 0.36 Allowed 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 123.08 2.52 . . . . 0.0 113.139 -178.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 16' ' ' GLU . . . . . 0.686 ' HA ' ' O ' ' E' ' 79' ' ' THR . 39.6 mt-10 65.94 59.02 0.73 Allowed 'General case' 0 C--O 1.232 0.181 0 O-C-N 123.77 0.669 . . . . 0.0 111.445 177.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 17' ' ' ARG . . . . . 0.44 ' HD3' ' HA ' ' E' ' 17' ' ' ARG . 70.4 mmt-85 -113.32 145.49 40.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.945 172.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 18' ' ' LYS . . . . . 0.668 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 33.8 ttmt -128.07 111.28 13.32 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.376 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 19' ' ' TYR . . . . . 0.416 ' OH ' ' HA ' ' E' ' 13' ' ' MET . 5.6 m-85 -108.61 104.03 13.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.681 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 20' ' ' SER . . . . . 0.418 ' HB3' ' SD ' ' E' ' 76' ' ' MET . 9.4 p -88.06 99.96 12.57 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 173.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -125.45 138.71 54.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.543 0.687 . . . . 0.0 112.32 -167.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 14.8 t -85.1 160.29 20.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.701 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 23' ' ' ILE . . . . . 0.402 ' CD1' ' HB3' ' E' ' 69' ' ' PHE . 53.4 mt -114.02 116.85 53.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 120.995 0.426 . . . . 0.0 110.856 -176.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 24' ' ' ILE . . . . . 0.773 ' H ' HD13 ' E' ' 24' ' ' ILE . 0.2 OUTLIER -104.08 -10.21 9.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.264 176.393 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 25' ' ' LYS . . . . . 0.593 ' HD3' HD22 ' E' ' 91' ' ' LEU . 2.5 ptpp? -142.57 119.32 11.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.793 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 24.0 m -64.55 135.4 55.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.249 -177.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 27' ' ' PHE . . . . . 0.773 ' HB3' HD23 ' E' ' 91' ' ' LEU . 19.1 p90 -147.22 160.76 42.09 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -174.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 28' ' ' HIS . . . . . 0.53 ' HE2' ' HB3' ' E' ' 30' ' ' SER . 5.3 t60 -114.93 127.99 56.02 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.348 177.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 29' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 56.6 mt -94.54 136.45 25.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 171.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 30' ' ' SER . . . . . 0.544 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 72.6 p -119.84 -16.67 8.68 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.712 -0.395 . . . . 0.0 112.018 -170.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 31' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -163.8 144.83 9.82 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 119.335 -1.412 . . . . 0.0 113.456 178.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.437 HG23 ' HG ' ' E' ' 87' ' ' LEU . 12.3 p -129.07 125.74 63.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 170.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.64 152.17 41.02 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.948 -0.47 . . . . 0.0 111.642 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 34' ' ' LEU . . . . . 0.591 ' HB3' HG12 ' E' ' 85' ' ' VAL . 3.5 pp -114.35 137.87 51.26 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 122.044 0.926 . . . . 0.0 111.719 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -106.09 -55.25 2.35 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.062 -1.427 . . . . 0.0 108.424 175.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -102.0 126.83 49.01 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.81 170.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 37' ' ' GLY . . . . . 0.454 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 147.94 162.52 10.16 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 119.576 -1.297 . . . . 0.0 113.596 176.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 38' ' ' GLN . . . . . 0.433 ' O ' ' HG3' ' E' ' 58' ' ' LYS . 39.2 mt-30 -102.77 -48.18 4.18 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 178.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -151.77 134.48 15.54 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.452 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 40' ' ' ALA . . . . . 0.553 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -135.27 117.34 15.38 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.278 0.561 . . . . 0.0 111.195 172.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 41' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' E' ' 79' ' ' THR . 48.2 mttm -97.62 116.08 29.15 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 173.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.412 HD21 HD21 ' E' ' 87' ' ' LEU . 53.6 tp -91.4 105.38 17.73 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.161 0.505 . . . . 0.0 110.053 -173.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 43' ' ' TYR . . . . . 0.413 ' HB2' ' CE2' ' E' ' 78' ' ' TYR . 97.1 m-85 -103.53 150.93 23.45 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.194 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 44' ' ' LEU . . . . . 0.619 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 1.1 tp -133.6 117.34 16.95 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.694 177.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 45' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -102.0 104.32 14.98 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.363 0.601 . . . . 0.0 109.554 175.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 46' ' ' ALA . . . . . 0.507 ' HB2' HD11 ' E' ' 44' ' ' LEU . . . -134.33 152.07 51.6 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 57.89 24.12 10.55 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -174.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 58.32 42.41 21.64 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.264 -175.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 49' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 28.1 tp60 -137.61 131.84 32.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.545 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -79.66 107.22 12.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.909 0.385 . . . . 0.0 110.387 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 51' ' ' TYR . . . . . 0.438 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 74.5 m-85 -100.27 129.32 46.25 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.109 175.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 tp -89.91 99.93 10.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 172.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 53' ' ' VAL . . . . . 0.467 ' CG1' ' HB3' ' E' ' 44' ' ' LEU . 2.6 m -84.32 -33.76 9.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.097 -169.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 54' ' ' ALA . . . . . 0.499 ' HB2' HD13 ' E' ' 65' ' ' LEU . . . -159.4 148.88 18.45 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.095 0.474 . . . . 0.0 111.887 177.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 92.4 m -117.36 102.9 9.62 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 170.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 56' ' ' VAL . . . . . 0.422 ' CG1' HG11 ' E' ' 85' ' ' VAL . 6.7 p -110.56 116.28 51.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.51 0.672 . . . . 0.0 110.214 -176.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 73.9 p -122.74 -177.44 3.65 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.248 -175.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 58' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' E' ' 38' ' ' GLN . 52.7 mtmt -59.86 -33.66 72.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.044 0.45 . . . . 0.0 110.309 169.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.92 -40.73 68.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.39 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 74.6 mt -116.64 80.09 10.22 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 174.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -72.46 0.27 7.73 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.87 2.38 . . . . 0.0 113.83 -166.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -162.44 119.11 1.99 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.196 0.522 . . . . 0.0 110.85 -176.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 63' ' ' VAL . . . . . 0.459 HG11 ' HB1' ' E' ' 54' ' ' ALA . 92.0 t -110.09 101.72 12.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.232 175.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.21 111.26 17.47 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 173.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 65' ' ' LEU . . . . . 0.499 HD13 ' HB2' ' E' ' 54' ' ' ALA . 1.0 OUTLIER -133.0 150.87 52.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.109 -171.351 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 66' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 11.6 t0 -96.06 99.11 10.89 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.414 0.626 . . . . 0.0 110.042 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 67' ' ' LEU . . . . . 0.565 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 4.1 mt -113.12 141.83 46.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.436 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 68' ' ' ASN . . . . . 0.586 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 6.2 t30 -148.92 132.48 16.76 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.068 177.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 69' ' ' PHE . . . . . 0.53 ' CZ ' HD22 ' E' ' 67' ' ' LEU . 63.4 m-85 -127.62 158.01 38.69 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.873 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 4.8 p -121.01 154.84 35.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.317 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 71' ' ' LYS . . . . . 0.46 ' HD3' ' H ' ' E' ' 71' ' ' LYS . 0.2 OUTLIER -70.82 11.41 0.38 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -174.802 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.03 -29.57 9.62 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.626 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -101.45 163.13 12.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.95 0.405 . . . . 0.0 110.92 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -123.06 111.57 16.72 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 75' ' ' ILE . . . . . 0.44 HG22 ' CB ' ' E' ' 46' ' ' ALA . 27.9 pt -111.3 161.29 9.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.053 0.454 . . . . 0.0 111.697 -168.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 76' ' ' MET . . . . . 0.418 ' SD ' ' HB3' ' E' ' 20' ' ' SER . 4.9 mtm -121.74 124.88 45.27 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 173.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 77' ' ' PHE . . . . . 0.619 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.5 OUTLIER -105.11 128.08 53.19 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.19 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 78' ' ' TYR . . . . . 0.668 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 30.2 p90 -151.01 138.86 19.86 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.059 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 79' ' ' THR . . . . . 0.686 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 11.1 p -109.74 137.55 47.38 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.898 -178.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.57 157.15 18.74 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.655 176.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.77 -173.84 35.46 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 82' ' ' ASP . . . . . 0.446 ' HA ' ' HB3' ' E' ' 15' ' ' PRO . 11.7 m-20 -114.05 103.18 10.88 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 119.609 -0.836 . . . . 0.0 109.873 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 83' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -172.36 155.19 3.44 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.18 171.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 24.3 t -110.42 114.45 27.9 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 85' ' ' VAL . . . . . 0.591 HG12 ' HB3' ' E' ' 34' ' ' LEU . 6.8 m -112.97 143.61 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 CA-C-O 121.514 0.673 . . . . 0.0 112.124 -174.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 11.9 t -108.97 118.73 37.56 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.641 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 87' ' ' LEU . . . . . 0.625 HD13 HD23 ' E' ' 11' ' ' LEU . 5.2 mp -94.17 151.89 19.13 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 174.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 88' ' ' LEU . . . . . 0.406 ' CD2' HD21 ' A' ' 67' ' ' LEU . 2.2 tp -134.32 145.95 49.52 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.089 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.73 -167.5 29.44 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.114 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 90' ' ' TYR . . . . . 0.624 ' CD2' ' HB3' ' A' ' 68' ' ' ASN . 8.8 p90 -151.58 130.24 12.31 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.742 0.782 . . . . 0.0 111.835 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 91' ' ' LEU . . . . . 0.773 HD23 ' HB3' ' E' ' 27' ' ' PHE . 6.3 mt . . . . . 0 C--N 1.321 -0.663 0 CA-C-N 114.051 -1.431 . . . . 0.0 109.595 175.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 51.2 mtt . . . . . 0 CA--C 1.52 -0.191 0 CA-C-O 121.18 0.514 . . . . 0.0 111.603 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.554 ' CE1' HD12 ' A' ' 88' ' ' LEU . 60.7 t80 -60.51 141.3 56.68 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.323 -174.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.508 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 91.9 t90 -130.41 144.8 51.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.915 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.1 140.81 9.11 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.395 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.626 HD23 HD13 ' A' ' 87' ' ' LEU . 56.6 tp -133.37 109.1 9.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.841 0.353 . . . . 0.0 110.348 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -97.78 104.11 16.11 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.571 ' SD ' HD11 ' A' ' 87' ' ' LEU . 35.9 mtp -98.4 137.86 36.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.588 -175.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -101.3 159.01 30.68 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.939 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.432 ' HB3' ' HA ' ' A' ' 82' ' ' ASP . 68.5 Cg_exo -42.89 118.45 1.22 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.752 2.968 . . . . 0.0 114.24 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.711 ' HA ' ' O ' ' A' ' 79' ' ' THR . 49.5 mt-10 57.16 55.99 5.54 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.068 174.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 78' ' ' TYR . 30.5 mmt180 -116.98 144.09 44.97 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.099 175.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.652 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 35.6 ttmt -126.23 112.78 16.16 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 123.491 0.494 . . . . 0.0 111.143 -176.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.415 ' OH ' ' HA ' ' A' ' 13' ' ' MET . 2.3 m-85 -111.27 104.89 13.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.252 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.42 ' HB3' ' SD ' ' A' ' 76' ' ' MET . 3.7 p -88.2 104.8 17.05 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 173.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -124.13 148.11 47.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.432 0.634 . . . . 0.0 112.696 -168.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.2 t -90.96 161.06 15.32 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.513 175.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.52 HD13 ' HB2' ' A' ' 69' ' ' PHE . 67.6 mt -114.25 131.36 66.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.101 0.477 . . . . 0.0 111.62 -173.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.468 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.2 mp -99.25 -48.92 11.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.085 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -114.46 140.55 48.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.657 177.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.2 m -63.54 109.4 1.64 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.482 ' HB3' HD23 ' A' ' 91' ' ' LEU . 14.7 p90 -125.02 159.54 31.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.626 0.727 . . . . 0.0 112.886 -170.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.578 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 9.4 t60 -116.45 125.85 52.57 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.077 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 61.2 mt -92.42 133.12 34.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 170.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.578 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 32.8 p -118.9 -14.35 9.43 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -169.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.541 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -167.33 147.98 12.49 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 119.153 -1.498 . . . . 0.0 113.416 178.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.442 HG23 ' HG ' ' A' ' 87' ' ' LEU . 11.4 p -134.63 129.06 51.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 172.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.08 155.5 42.24 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.896 -0.503 . . . . 0.0 111.653 -174.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.548 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.0 pp -120.98 142.27 49.93 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.442 0.639 . . . . 0.0 111.205 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -110.03 -50.08 3.01 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.572 173.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -103.18 127.45 50.47 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 168.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.455 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 152.21 158.97 8.7 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 119.906 -1.14 . . . . 0.0 113.19 176.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.464 ' O ' ' HG3' ' A' ' 58' ' ' LYS . 94.5 mt-30 -102.59 -45.35 5.07 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 120.625 0.25 . . . . 0.0 111.379 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.447 ' HG3' HG22 ' A' ' 57' ' ' THR . 13.5 tt0 -153.68 130.48 10.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.238 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.585 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -131.35 113.86 14.29 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.367 0.603 . . . . 0.0 110.492 169.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -97.14 111.6 23.76 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.456 ' HG ' ' CG2' ' A' ' 53' ' ' VAL . 45.4 tp -83.6 112.57 20.14 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.624 -174.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -110.96 137.17 48.92 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.293 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.582 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 1.2 tp -120.56 119.36 32.71 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.383 175.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -106.19 114.15 28.1 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.227 0.537 . . . . 0.0 109.671 176.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.544 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -145.97 154.59 42.08 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.98 -178.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 57.98 27.83 15.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.938 0.399 . . . . 0.0 110.381 -176.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm 59.22 44.6 15.42 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.743 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -150.86 140.22 21.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.963 178.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -85.98 126.99 34.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.18 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -123.14 123.92 41.9 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.704 176.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 tp -77.38 103.42 4.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 171.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.456 ' CG2' ' HG ' ' A' ' 42' ' ' LEU . 2.8 m -86.88 -35.17 8.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.875 -173.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.542 ' HB2' HD23 ' A' ' 65' ' ' LEU . . . -152.51 145.6 24.58 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.108 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.4 m -114.65 101.87 9.5 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 169.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.457 HG13 ' HB3' ' A' ' 40' ' ' ALA . 7.4 p -115.86 112.93 41.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.798 0.809 . . . . 0.0 110.164 -176.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.447 HG22 ' HG3' ' A' ' 39' ' ' GLU . 81.6 p -123.38 -176.82 3.54 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.217 -175.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 38' ' ' GLN . 34.7 mtmm -58.56 -34.58 71.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.179 0.514 . . . . 0.0 110.084 170.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.27 -40.88 64.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.467 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 72.4 mt -115.37 80.78 7.92 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 174.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -71.08 -0.01 7.32 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.122 2.548 . . . . 0.0 113.541 -168.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -161.94 124.69 2.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.41 0.624 . . . . 0.0 111.11 -176.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 85.7 t -113.73 102.96 14.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.355 174.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.93 109.8 17.89 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.441 173.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.542 HD23 ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -129.67 168.93 15.73 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.19 0.519 . . . . 0.0 111.539 -174.647 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 17.1 t0 -115.61 106.21 13.65 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.728 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.554 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 25.9 mt -123.55 142.96 50.51 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 175.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.664 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 4.9 t30 -150.79 130.79 13.4 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.073 177.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.52 ' HB2' HD13 ' A' ' 23' ' ' ILE . 3.1 m-85 -126.39 153.26 45.21 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.425 ' OG ' ' HG2' ' E' ' 7' ' ' MET . 89.1 p -98.36 164.68 12.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.036 0.446 . . . . 0.0 110.779 -178.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.403 ' H ' ' HG3' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -65.44 -5.47 7.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.821 177.876 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.25 -3.5 55.54 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 121.089 -0.577 . . . . 0.0 111.724 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -93.76 159.06 15.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.973 0.416 . . . . 0.0 110.873 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -144.14 125.48 14.74 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 174.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.544 HG22 ' HB2' ' A' ' 46' ' ' ALA . 18.1 pt -136.17 163.78 33.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.928 -166.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.42 ' SD ' ' HB3' ' A' ' 20' ' ' SER . 3.7 mtm -121.93 130.72 53.56 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.72 173.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.582 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -111.39 128.15 55.88 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.253 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.652 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 33.8 p90 -151.57 138.42 18.95 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.25 0.548 . . . . 0.0 111.788 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.711 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 6.0 p -107.44 134.87 49.85 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.144 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.69 154.18 19.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.112 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.2 -175.92 40.0 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -175.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.432 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 9.4 m-20 -113.62 103.29 11.1 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.209 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.585 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -170.09 155.08 5.31 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.819 172.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.2 t -112.05 123.29 49.93 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.548 HG12 ' HB3' ' A' ' 34' ' ' LEU . 6.1 m -121.46 145.86 27.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.415 0.626 . . . . 0.0 112.637 -172.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.3 m -109.91 120.86 43.79 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.591 175.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.626 HD13 HD23 ' A' ' 11' ' ' LEU . 4.7 mp -98.0 144.89 27.05 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 171.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.554 HD12 ' CE1' ' A' ' 8' ' ' PHE . 2.4 mm? -124.43 146.46 48.89 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.017 174.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.06 -168.33 23.81 Favored Glycine 0 N--CA 1.434 -1.434 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.189 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.632 ' CD2' ' HB3' ' B' ' 68' ' ' ASN . 9.9 p90 -151.41 128.52 11.13 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.828 0.823 . . . . 0.0 111.822 177.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.482 HD23 ' HB3' ' A' ' 27' ' ' PHE . 7.0 mt . . . . . 0 C--N 1.32 -0.689 0 CA-C-N 113.863 -1.517 . . . . 0.0 109.104 175.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 51.3 mtt . . . . . 0 CA--C 1.52 -0.197 0 CA-C-O 121.152 0.501 . . . . 0.0 111.657 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 8' ' ' PHE . . . . . 0.558 ' CE1' HD21 ' C' ' 44' ' ' LEU . 60.6 t80 -60.47 141.25 56.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.401 -174.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' TRP . . . . . 0.508 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 91.9 t90 -130.33 144.78 51.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.964 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.13 140.92 9.18 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.416 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.615 HD23 HD13 ' B' ' 87' ' ' LEU . 57.0 tp -133.54 109.13 9.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.828 0.347 . . . . 0.0 110.315 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -97.76 104.05 16.04 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' MET . . . . . 0.583 ' SD ' HD11 ' B' ' 87' ' ' LEU . 35.8 mtp -98.35 137.81 36.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.641 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -101.11 159.1 30.45 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.009 176.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.453 ' HB3' ' HA ' ' B' ' 82' ' ' ASP . 69.6 Cg_exo -42.93 118.48 1.24 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.672 2.915 . . . . 0.0 114.323 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.713 ' HA ' ' O ' ' B' ' 79' ' ' THR . 49.7 mt-10 57.06 56.15 5.5 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.05 174.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' B' ' 78' ' ' TYR . 30.4 mmt180 -117.11 144.07 45.1 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.079 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.671 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 35.6 ttmt -126.18 112.79 16.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.091 -176.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' TYR . . . . . 0.403 ' OH ' ' HA ' ' B' ' 13' ' ' MET . 2.4 m-85 -111.26 104.84 13.36 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.291 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.416 ' HB3' ' SD ' ' B' ' 76' ' ' MET . 3.7 p -88.25 104.77 17.04 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 173.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -124.02 148.12 47.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.498 0.666 . . . . 0.0 112.711 -168.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 13.2 t -91.0 161.08 15.29 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.544 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.52 HD13 ' HB2' ' B' ' 69' ' ' PHE . 67.8 mt -114.25 131.26 66.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.116 0.484 . . . . 0.0 111.677 -173.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.47 ' N ' HD12 ' B' ' 24' ' ' ILE . 4.2 mp -99.23 -48.97 11.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.037 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -114.43 140.72 48.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.627 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 19.2 m -63.57 109.22 1.59 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 173.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' PHE . . . . . 0.47 ' HB3' HD23 ' B' ' 91' ' ' LEU . 14.6 p90 -124.93 159.56 30.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.627 0.727 . . . . 0.0 112.845 -170.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' HIS . . . . . 0.59 ' HE2' ' HB3' ' B' ' 30' ' ' SER . 9.3 t60 -116.43 125.81 52.53 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.131 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 61.5 mt -92.44 133.11 34.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 170.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.59 ' HB3' ' HE2' ' B' ' 28' ' ' HIS . 33.2 p -118.88 -14.33 9.44 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -169.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -167.3 148.09 12.65 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 119.146 -1.502 . . . . 0.0 113.375 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.447 HG23 ' HG ' ' B' ' 87' ' ' LEU . 11.3 p -134.68 129.09 51.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 172.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.15 155.53 42.22 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.551 -174.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.561 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.0 pp -120.98 142.3 49.9 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.51 0.672 . . . . 0.0 111.206 178.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -110.06 -50.04 3.01 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.578 173.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -103.14 127.53 50.39 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 168.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 152.17 158.88 8.65 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.217 176.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' GLN . . . . . 0.472 ' O ' ' HG3' ' B' ' 58' ' ' LYS . 94.5 mt-30 -102.46 -45.4 5.08 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.572 0.225 . . . . 0.0 111.441 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.456 ' HG3' HG22 ' B' ' 57' ' ' THR . 13.4 tt0 -153.77 130.54 10.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.189 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.589 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -131.36 113.88 14.3 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.411 0.624 . . . . 0.0 110.507 169.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -97.15 111.68 23.8 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 173.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.454 ' HG ' ' CG2' ' B' ' 53' ' ' VAL . 45.8 tp -83.76 112.57 20.21 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.614 -174.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -110.91 137.15 48.91 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.335 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.592 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 1.2 tp -120.57 119.33 32.59 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.344 175.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -106.23 114.1 28.02 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.523 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -145.94 154.63 42.14 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.932 -178.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 57.95 27.82 15.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.947 0.403 . . . . 0.0 110.391 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm 59.18 44.61 15.53 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.722 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -150.82 140.17 21.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.901 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -85.82 127.07 34.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -123.16 123.83 41.69 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.655 176.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 tp -77.25 103.3 4.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 171.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.454 ' CG2' ' HG ' ' B' ' 42' ' ' LEU . 2.8 m -86.8 -35.31 8.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.853 -173.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.537 ' HB2' HD23 ' B' ' 65' ' ' LEU . . . -152.49 145.62 24.61 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 120.239 -0.584 . . . . 0.0 112.155 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 27.3 m -114.64 101.94 9.57 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 169.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 56' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' B' ' 40' ' ' ALA . 7.3 p -115.92 112.96 41.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.771 0.796 . . . . 0.0 110.079 -176.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.456 HG22 ' HG3' ' B' ' 39' ' ' GLU . 82.6 p -123.48 -176.93 3.57 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.185 -175.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 58' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' B' ' 38' ' ' GLN . 34.7 mtmm -58.39 -34.67 70.99 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.12 0.486 . . . . 0.0 110.062 170.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.408 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -73.31 -40.9 64.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.466 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 72.5 mt -115.32 80.81 7.81 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 61' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 10.2 Cg_exo -71.13 -0.0 7.34 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.107 2.538 . . . . 0.0 113.486 -168.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -161.93 124.86 3.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.375 0.607 . . . . 0.0 111.095 -176.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 85.7 t -113.78 102.93 14.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.311 174.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.95 109.81 17.91 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.46 173.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.537 HD23 ' HB2' ' B' ' 54' ' ' ALA . 0.4 OUTLIER -129.61 168.97 15.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.197 0.522 . . . . 0.0 111.608 -174.721 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 66' ' ' ASP . . . . . 0.526 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 16.9 t0 -115.65 106.3 13.74 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.719 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.557 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 26.2 mt -123.63 142.96 50.55 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 68' ' ' ASN . . . . . 0.632 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 4.9 t30 -150.83 130.76 13.33 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.062 177.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 69' ' ' PHE . . . . . 0.52 ' HB2' HD13 ' B' ' 23' ' ' ILE . 3.2 m-85 -126.43 153.2 45.34 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 88.9 p -98.3 164.72 12.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.003 0.43 . . . . 0.0 110.802 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 71' ' ' LYS . . . . . 0.427 ' HG3' ' H ' ' B' ' 71' ' ' LYS . 0.0 OUTLIER -65.52 -5.45 8.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.805 177.921 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.19 -3.58 55.57 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.765 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -93.72 159.09 15.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.96 0.409 . . . . 0.0 110.776 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -144.22 125.5 14.69 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.523 HG22 ' HB2' ' B' ' 46' ' ' ALA . 18.0 pt -136.21 163.84 33.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.04 0.448 . . . . 0.0 111.91 -166.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.416 ' SD ' ' HB3' ' B' ' 20' ' ' SER . 3.7 mtm -121.99 130.78 53.59 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.698 173.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 77' ' ' PHE . . . . . 0.592 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.9 OUTLIER -111.36 128.18 55.89 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.269 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.671 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 33.5 p90 -151.61 138.47 18.96 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.199 0.523 . . . . 0.0 111.818 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.713 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 6.0 p -107.46 134.82 49.93 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.1 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.63 154.26 19.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.208 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.08 -175.88 40.15 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -175.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 82' ' ' ASP . . . . . 0.453 ' HA ' ' HB3' ' B' ' 15' ' ' PRO . 9.5 m-20 -113.65 103.34 11.14 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.136 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.589 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -170.16 154.99 5.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.838 172.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 16.1 t -111.99 123.31 49.98 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.561 HG12 ' HB3' ' B' ' 34' ' ' LEU . 6.1 m -121.54 145.81 27.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.494 0.664 . . . . 0.0 112.578 -172.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 20.3 m -109.88 120.87 43.81 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.575 175.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.615 HD13 HD23 ' B' ' 11' ' ' LEU . 4.7 mp -97.92 144.9 26.99 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 171.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.55 HD12 ' CE1' ' B' ' 8' ' ' PHE . 2.4 mm? -124.51 146.55 48.92 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.982 174.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.13 -168.36 23.91 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.25 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 90' ' ' TYR . . . . . 0.604 ' CD2' ' HB3' ' C' ' 68' ' ' ASN . 9.8 p90 -151.42 128.55 11.14 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.844 0.83 . . . . 0.0 111.777 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 91' ' ' LEU . . . . . 0.47 HD23 ' HB3' ' B' ' 27' ' ' PHE . 7.0 mt . . . . . 0 C--N 1.32 -0.7 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.097 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 51.3 mtt . . . . . 0 CA--C 1.52 -0.182 0 CA-C-O 121.196 0.522 . . . . 0.0 111.601 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 8' ' ' PHE . . . . . 0.579 ' CE1' HD21 ' D' ' 44' ' ' LEU . 60.8 t80 -60.5 141.3 56.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.355 -174.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 9' ' ' TRP . . . . . 0.507 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 91.9 t90 -130.42 144.78 51.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.924 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.13 140.84 9.12 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.482 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.633 HD23 HD13 ' C' ' 87' ' ' LEU . 56.6 tp -133.39 108.99 9.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.802 0.334 . . . . 0.0 110.342 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -97.75 104.05 16.04 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 13' ' ' MET . . . . . 0.575 ' SD ' HD11 ' C' ' 87' ' ' LEU . 35.8 mtp -98.35 137.78 36.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.616 -175.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -101.2 159.14 30.32 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.034 176.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 15' ' ' PRO . . . . . 0.428 ' HB3' ' HA ' ' C' ' 82' ' ' ASP . 69.1 Cg_exo -43.01 118.52 1.28 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.727 2.952 . . . . 0.0 114.282 -177.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 16' ' ' GLU . . . . . 0.71 ' HA ' ' O ' ' C' ' 79' ' ' THR . 49.6 mt-10 57.02 56.19 5.5 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.085 174.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 17' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' C' ' 78' ' ' TYR . 30.5 mmt180 -117.15 144.05 45.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.114 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 18' ' ' LYS . . . . . 0.674 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 35.6 ttmt -126.18 112.85 16.27 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 123.455 0.472 . . . . 0.0 111.096 -176.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 19' ' ' TYR . . . . . 0.413 ' OH ' ' HA ' ' C' ' 13' ' ' MET . 2.3 m-85 -111.34 104.77 13.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.302 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 20' ' ' SER . . . . . 0.419 ' HB3' ' SD ' ' C' ' 76' ' ' MET . 3.7 p -88.1 104.83 17.05 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 173.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -124.07 148.1 47.36 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.437 0.637 . . . . 0.0 112.715 -168.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 13.2 t -90.89 161.05 15.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.583 175.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 23' ' ' ILE . . . . . 0.504 HD13 ' HB2' ' C' ' 69' ' ' PHE . 67.7 mt -114.24 131.33 66.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.151 0.5 . . . . 0.0 111.667 -173.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 24' ' ' ILE . . . . . 0.468 ' N ' HD12 ' C' ' 24' ' ' ILE . 4.2 mp -99.27 -49.03 11.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.937 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -114.35 140.61 48.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.657 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 19.1 m -63.52 109.3 1.6 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 173.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 27' ' ' PHE . . . . . 0.483 ' HB3' HD23 ' C' ' 91' ' ' LEU . 14.7 p90 -124.92 159.53 30.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.703 0.764 . . . . 0.0 112.828 -170.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 28' ' ' HIS . . . . . 0.593 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 9.2 t60 -116.5 125.84 52.51 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.049 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 29' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 61.2 mt -92.46 133.08 34.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 170.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.593 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 33.0 p -118.83 -14.32 9.47 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -169.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 31' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -167.36 148.01 12.52 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 119.092 -1.528 . . . . 0.0 113.356 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.449 HG23 ' HG ' ' C' ' 87' ' ' LEU . 11.4 p -134.57 129.06 51.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 172.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.14 155.42 42.13 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.686 -174.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.554 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.0 pp -120.9 142.37 49.76 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.462 0.648 . . . . 0.0 111.213 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -110.14 -50.02 3.01 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.516 173.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -103.24 127.52 50.52 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 168.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 37' ' ' GLY . . . . . 0.461 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 152.16 158.83 8.63 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 119.875 -1.155 . . . . 0.0 113.231 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 38' ' ' GLN . . . . . 0.463 ' O ' ' HG3' ' C' ' 58' ' ' LYS . 94.7 mt-30 -102.48 -45.39 5.08 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.519 0.2 . . . . 0.0 111.373 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 39' ' ' GLU . . . . . 0.451 ' HG3' HG22 ' C' ' 57' ' ' THR . 13.4 tt0 -153.73 130.43 10.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.265 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.577 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -131.35 113.8 14.21 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.388 0.613 . . . . 0.0 110.454 169.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -97.02 111.74 23.82 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.453 ' HG ' ' CG2' ' C' ' 53' ' ' VAL . 45.7 tp -83.84 112.57 20.24 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.593 -174.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -110.92 137.22 48.83 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.354 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.594 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 1.2 tp -120.61 119.36 32.65 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.381 175.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -106.26 114.13 28.07 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.168 0.509 . . . . 0.0 109.635 176.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.528 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -145.95 154.67 42.17 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.929 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 58.02 27.76 15.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.971 0.415 . . . . 0.0 110.446 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm 59.27 44.44 15.48 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.788 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -150.73 140.1 21.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.983 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -85.69 127.04 34.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.235 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -123.23 123.85 41.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.62 176.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 tp -77.33 103.39 4.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 171.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 53' ' ' VAL . . . . . 0.453 ' CG2' ' HG ' ' C' ' 42' ' ' LEU . 2.8 m -86.87 -35.26 8.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.819 -173.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 54' ' ' ALA . . . . . 0.535 ' HB2' HD23 ' C' ' 65' ' ' LEU . . . -152.54 145.54 24.51 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.145 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 27.7 m -114.69 101.96 9.58 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 169.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 56' ' ' VAL . . . . . 0.449 HG13 ' HB3' ' C' ' 40' ' ' ALA . 7.4 p -115.87 113.02 42.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.775 0.798 . . . . 0.0 110.126 -176.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 57' ' ' THR . . . . . 0.451 HG22 ' HG3' ' C' ' 39' ' ' GLU . 81.5 p -123.53 -176.79 3.54 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.208 -175.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 58' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' C' ' 38' ' ' GLN . 34.7 mtmm -58.51 -34.65 71.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.143 0.497 . . . . 0.0 110.065 170.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 59' ' ' ALA . . . . . 0.405 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -73.3 -40.89 64.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.408 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 72.5 mt -115.35 80.74 7.84 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 174.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 61' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 10.3 Cg_exo -70.97 -0.07 7.35 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.027 2.485 . . . . 0.0 113.552 -168.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -161.92 124.83 3.01 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.449 0.643 . . . . 0.0 111.062 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 85.9 t -113.75 102.96 14.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.252 174.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.05 109.78 17.94 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 173.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 65' ' ' LEU . . . . . 0.535 HD23 ' HB2' ' C' ' 54' ' ' ALA . 0.4 OUTLIER -129.53 168.96 15.6 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.171 0.51 . . . . 0.0 111.545 -174.68 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 66' ' ' ASP . . . . . 0.518 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 17.1 t0 -115.59 106.16 13.61 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.667 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.549 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 26.1 mt -123.55 142.99 50.48 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 68' ' ' ASN . . . . . 0.604 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 4.9 t30 -150.87 130.72 13.26 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.1 177.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 69' ' ' PHE . . . . . 0.504 ' HB2' HD13 ' C' ' 23' ' ' ILE . 3.0 m-85 -126.32 153.24 45.12 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 88.9 p -98.4 164.67 12.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.073 0.463 . . . . 0.0 110.77 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 71' ' ' LYS . . . . . 0.424 ' H ' ' HG3' ' C' ' 71' ' ' LYS . 0.0 OUTLIER -65.44 -5.45 7.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.766 177.919 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.24 -3.54 55.53 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.738 176.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -93.77 159.17 15.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.991 0.424 . . . . 0.0 110.758 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -144.21 125.48 14.68 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 174.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.528 HG22 ' HB2' ' C' ' 46' ' ' ALA . 18.1 pt -136.13 163.83 33.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.999 0.428 . . . . 0.0 111.865 -166.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.419 ' SD ' ' HB3' ' C' ' 20' ' ' SER . 3.6 mtm -122.0 130.75 53.56 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.81 173.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 77' ' ' PHE . . . . . 0.594 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.9 OUTLIER -111.3 128.17 55.86 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.368 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 78' ' ' TYR . . . . . 0.674 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 34.0 p90 -151.68 138.37 18.81 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.177 0.513 . . . . 0.0 111.886 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 79' ' ' THR . . . . . 0.71 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 6.2 p -107.38 134.85 49.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.088 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.68 154.26 19.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.139 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.13 -175.85 40.04 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 82' ' ' ASP . . . . . 0.428 ' HA ' ' HB3' ' C' ' 15' ' ' PRO . 9.5 m-20 -113.68 103.33 11.12 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.159 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 83' ' ' ALA . . . . . 0.577 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -170.21 155.0 5.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.837 172.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 16.2 t -112.01 123.33 50.03 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.554 HG12 ' HB3' ' C' ' 34' ' ' LEU . 6.2 m -121.49 145.83 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 CA-C-O 121.505 0.669 . . . . 0.0 112.644 -172.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 20.3 m -109.92 120.9 43.92 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.591 175.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 87' ' ' LEU . . . . . 0.633 HD13 HD23 ' C' ' 11' ' ' LEU . 4.7 mp -97.98 144.81 27.13 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 171.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 88' ' ' LEU . . . . . 0.555 HD12 ' CE1' ' C' ' 8' ' ' PHE . 2.4 mm? -124.42 146.48 48.87 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.443 -0.798 . . . . 0.0 108.985 174.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.09 -168.34 23.84 Favored Glycine 0 N--CA 1.436 -1.366 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.204 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 90' ' ' TYR . . . . . 0.635 ' CD2' ' HB3' ' D' ' 68' ' ' ASN . 9.9 p90 -151.42 128.57 11.16 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.785 0.802 . . . . 0.0 111.783 177.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 91' ' ' LEU . . . . . 0.483 HD23 ' HB3' ' C' ' 27' ' ' PHE . 7.0 mt . . . . . 0 C--N 1.319 -0.737 0 CA-C-N 113.858 -1.519 . . . . 0.0 108.993 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 51.4 mtt . . . . . 0 CA--C 1.521 -0.16 0 CA-C-O 121.135 0.493 . . . . 0.0 111.655 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 8' ' ' PHE . . . . . 0.56 ' CE1' HD21 ' E' ' 44' ' ' LEU . 60.4 t80 -60.52 141.3 56.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.41 -174.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 9' ' ' TRP . . . . . 0.508 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 92.1 t90 -130.41 144.79 51.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.913 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.12 140.95 9.21 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.374 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 11' ' ' LEU . . . . . 0.615 HD23 HD13 ' D' ' 87' ' ' LEU . 56.4 tp -133.45 109.08 9.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.768 0.318 . . . . 0.0 110.298 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -97.74 104.08 16.08 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 13' ' ' MET . . . . . 0.582 ' SD ' HD11 ' D' ' 87' ' ' LEU . 35.8 mtp -98.4 137.84 36.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.587 -175.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -101.14 159.13 30.36 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.052 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 15' ' ' PRO . . . . . 0.437 ' HB3' ' HA ' ' D' ' 82' ' ' ASP . 69.1 Cg_exo -42.94 118.44 1.23 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.696 2.931 . . . . 0.0 114.314 -177.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 16' ' ' GLU . . . . . 0.703 ' HA ' ' O ' ' D' ' 79' ' ' THR . 49.7 mt-10 57.19 56.07 5.46 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.024 174.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 17' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' D' ' 78' ' ' TYR . 30.5 mmt180 -117.08 144.04 45.1 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.033 175.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 18' ' ' LYS . . . . . 0.673 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 35.6 ttmt -126.18 112.86 16.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.07 -176.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 19' ' ' TYR . . . . . 0.406 ' OH ' ' HA ' ' D' ' 13' ' ' MET . 2.4 m-85 -111.3 104.77 13.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.308 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 20' ' ' SER . . . . . 0.418 ' HB3' ' SD ' ' D' ' 76' ' ' MET . 3.7 p -88.14 104.75 16.99 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 173.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -124.0 148.17 47.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.442 0.639 . . . . 0.0 112.72 -168.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 13.2 t -91.0 161.1 15.28 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.533 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 23' ' ' ILE . . . . . 0.506 HD13 ' HB2' ' D' ' 69' ' ' PHE . 67.5 mt -114.31 131.24 66.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.191 0.519 . . . . 0.0 111.678 -173.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 24' ' ' ILE . . . . . 0.463 HD12 ' N ' ' D' ' 24' ' ' ILE . 4.2 mp -99.12 -49.06 11.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.095 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -114.35 140.64 48.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.648 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 19.3 m -63.55 109.4 1.64 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 173.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 27' ' ' PHE . . . . . 0.482 ' HB3' HD23 ' D' ' 91' ' ' LEU . 14.5 p90 -125.01 159.49 31.18 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.692 0.758 . . . . 0.0 112.824 -170.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 28' ' ' HIS . . . . . 0.594 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 9.4 t60 -116.37 125.82 52.61 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.222 -1.354 . . . . 0.0 110.156 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 29' ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 61.3 mt -92.41 133.04 35.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 170.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 30' ' ' SER . . . . . 0.594 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 33.2 p -118.79 -14.4 9.5 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -169.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 31' ' ' GLY . . . . . 0.545 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -167.31 148.02 12.55 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 119.141 -1.504 . . . . 0.0 113.387 178.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.451 HG23 ' HG ' ' D' ' 87' ' ' LEU . 11.4 p -134.59 128.99 51.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 172.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.11 155.5 42.22 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.496 -0.481 . . . . 0.0 111.629 -174.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 34' ' ' LEU . . . . . 0.552 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.0 pp -120.98 142.24 49.96 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.455 0.645 . . . . 0.0 111.225 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -109.98 -50.16 3.0 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.554 173.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -103.09 127.54 50.32 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 168.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 37' ' ' GLY . . . . . 0.467 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 152.16 158.95 8.68 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 119.868 -1.158 . . . . 0.0 113.253 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 38' ' ' GLN . . . . . 0.46 ' O ' ' HG3' ' D' ' 58' ' ' LYS . 94.7 mt-30 -102.6 -45.35 5.07 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.625 0.25 . . . . 0.0 111.4 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 39' ' ' GLU . . . . . 0.459 ' HG3' HG22 ' D' ' 57' ' ' THR . 13.5 tt0 -153.67 130.58 10.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.221 178.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 40' ' ' ALA . . . . . 0.573 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -131.43 113.82 14.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.417 0.627 . . . . 0.0 110.46 169.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -97.08 111.63 23.77 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 173.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.458 ' HG ' ' CG2' ' D' ' 53' ' ' VAL . 45.9 tp -83.73 112.61 20.22 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.522 -174.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -110.86 137.15 48.86 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.326 178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.593 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 1.2 tp -120.61 119.44 32.87 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.37 175.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 45' ' ' ALA . . . . . . . . . . . . . . . -106.25 113.99 27.86 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.529 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -145.92 154.61 42.13 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.961 -178.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 58.06 27.75 15.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.931 0.396 . . . . 0.0 110.421 -176.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm 59.24 44.54 15.45 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.809 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -150.83 140.36 21.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.896 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -85.99 127.01 34.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.18 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -123.15 123.79 41.61 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.722 176.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 tp -77.26 103.33 4.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 171.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 53' ' ' VAL . . . . . 0.458 ' CG2' ' HG ' ' D' ' 42' ' ' LEU . 2.8 m -86.79 -35.29 8.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.861 -173.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 54' ' ' ALA . . . . . 0.54 ' HB2' HD23 ' D' ' 65' ' ' LEU . . . -152.46 145.64 24.65 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.284 -0.566 . . . . 0.0 112.167 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 27.2 m -114.74 101.98 9.59 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 169.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 56' ' ' VAL . . . . . 0.449 HG13 ' HB3' ' D' ' 40' ' ' ALA . 7.4 p -115.94 112.98 41.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.791 0.805 . . . . 0.0 110.081 -176.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 57' ' ' THR . . . . . 0.459 HG22 ' HG3' ' D' ' 39' ' ' GLU . 82.5 p -123.48 -176.81 3.54 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.208 -175.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 58' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' D' ' 38' ' ' GLN . 34.7 mtmm -58.56 -34.59 71.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.128 0.49 . . . . 0.0 110.069 170.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 59' ' ' ALA . . . . . 0.4 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -73.4 -40.73 64.07 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.452 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 72.4 mt -115.36 80.74 7.87 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 174.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 61' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 10.4 Cg_exo -71.05 -0.1 7.44 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.109 2.539 . . . . 0.0 113.516 -168.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -161.84 124.73 3.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.327 0.584 . . . . 0.0 111.127 -176.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 85.1 t -113.72 102.91 14.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.32 174.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.01 109.8 17.93 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.404 173.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 65' ' ' LEU . . . . . 0.54 HD23 ' HB2' ' D' ' 54' ' ' ALA . 0.4 OUTLIER -129.66 168.9 15.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.107 0.479 . . . . 0.0 111.606 -174.721 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 66' ' ' ASP . . . . . 0.518 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 17.2 t0 -115.47 106.21 13.7 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.735 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.546 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 25.9 mt -123.6 143.03 50.48 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 68' ' ' ASN . . . . . 0.635 ' HB3' ' CD2' ' C' ' 90' ' ' TYR . 4.9 t30 -150.83 130.73 13.31 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.026 177.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 69' ' ' PHE . . . . . 0.506 ' HB2' HD13 ' D' ' 23' ' ' ILE . 3.2 m-85 -126.33 153.23 45.16 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 89.0 p -98.36 164.63 12.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.029 0.442 . . . . 0.0 110.819 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 71' ' ' LYS . . . . . 0.42 ' H ' ' HG3' ' D' ' 71' ' ' LYS . 0.0 OUTLIER -65.39 -5.49 7.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.824 177.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.19 -3.64 55.55 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.714 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -93.66 159.1 15.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.969 0.414 . . . . 0.0 110.836 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -144.25 125.53 14.69 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.529 HG22 ' HB2' ' D' ' 46' ' ' ALA . 18.1 pt -136.13 163.79 33.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.925 -166.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 76' ' ' MET . . . . . 0.418 ' SD ' ' HB3' ' D' ' 20' ' ' SER . 3.6 mtm -121.95 130.67 53.51 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.752 173.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 77' ' ' PHE . . . . . 0.593 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.9 OUTLIER -111.34 128.21 55.89 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.277 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 78' ' ' TYR . . . . . 0.673 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 33.5 p90 -151.7 138.39 18.8 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.239 0.543 . . . . 0.0 111.822 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 79' ' ' THR . . . . . 0.703 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 6.0 p -107.4 134.89 49.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.101 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.74 154.16 19.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.189 175.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.24 -175.88 39.89 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -175.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 82' ' ' ASP . . . . . 0.437 ' HA ' ' HB3' ' D' ' 15' ' ' PRO . 9.5 m-20 -113.65 103.27 11.06 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.172 178.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 83' ' ' ALA . . . . . 0.573 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -170.16 155.02 5.21 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.814 172.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 15.7 t -111.95 123.39 50.16 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.552 HG12 ' HB3' ' D' ' 34' ' ' LEU . 6.2 m -121.52 145.85 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.454 0.645 . . . . 0.0 112.631 -172.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 20.2 m -109.88 120.83 43.71 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.582 175.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 87' ' ' LEU . . . . . 0.615 HD13 HD23 ' D' ' 11' ' ' LEU . 4.7 mp -97.96 144.87 27.05 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 170.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.549 HD12 ' CZ ' ' D' ' 8' ' ' PHE . 2.4 mm? -124.46 146.48 48.91 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.013 174.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.09 -168.26 23.74 Favored Glycine 0 N--CA 1.435 -1.421 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.189 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 90' ' ' TYR . . . . . 0.584 ' CD2' ' HB3' ' E' ' 68' ' ' ASN . 9.8 p90 -151.46 128.55 11.12 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.825 0.821 . . . . 0.0 111.757 177.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 91' ' ' LEU . . . . . 0.482 HD23 ' HB3' ' D' ' 27' ' ' PHE . 6.9 mt . . . . . 0 C--N 1.32 -0.694 0 CA-C-N 113.852 -1.522 . . . . 0.0 109.047 175.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 7' ' ' MET . . . . . 0.425 ' HG2' ' OG ' ' A' ' 70' ' ' SER . 51.3 mtt . . . . . 0 CA--C 1.52 -0.201 0 CA-C-O 121.138 0.494 . . . . 0.0 111.634 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 8' ' ' PHE . . . . . 0.576 ' CE1' HD21 ' A' ' 44' ' ' LEU . 60.4 t80 -60.51 141.21 56.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.367 -174.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 9' ' ' TRP . . . . . 0.505 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 92.1 t90 -130.32 144.7 51.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.966 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.03 140.96 9.23 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.44 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 11' ' ' LEU . . . . . 0.629 HD23 HD13 ' E' ' 87' ' ' LEU . 56.7 tp -133.53 109.09 9.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.864 0.364 . . . . 0.0 110.335 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -97.78 104.05 16.04 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 13' ' ' MET . . . . . 0.58 ' SD ' HD11 ' E' ' 87' ' ' LEU . 35.8 mtp -98.3 137.74 36.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.615 -175.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -101.13 159.12 30.38 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.99 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 15' ' ' PRO . . . . . 0.436 ' HB3' ' HA ' ' E' ' 82' ' ' ASP . 68.6 Cg_exo -43.01 118.55 1.29 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.632 2.888 . . . . 0.0 114.298 -177.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 16' ' ' GLU . . . . . 0.707 ' HA ' ' O ' ' E' ' 79' ' ' THR . 49.6 mt-10 57.02 56.14 5.53 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.109 174.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 17' ' ' ARG . . . . . 0.429 ' O ' ' HA ' ' E' ' 78' ' ' TYR . 30.4 mmt180 -117.17 144.05 45.17 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.019 175.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 18' ' ' LYS . . . . . 0.68 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 35.6 ttmt -126.14 112.87 16.32 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 123.573 0.546 . . . . 0.0 111.096 -176.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 19' ' ' TYR . . . . . 0.413 ' OH ' ' HA ' ' E' ' 13' ' ' MET . 2.3 m-85 -111.26 104.74 13.26 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.288 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 20' ' ' SER . . . . . 0.417 ' HB3' ' SD ' ' E' ' 76' ' ' MET . 3.8 p -88.03 104.79 16.99 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 173.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -124.07 148.04 47.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.482 0.658 . . . . 0.0 112.692 -168.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 13.1 t -90.88 161.11 15.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.536 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 23' ' ' ILE . . . . . 0.511 HD13 ' HB2' ' E' ' 69' ' ' PHE . 67.6 mt -114.34 131.31 66.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.125 0.488 . . . . 0.0 111.709 -173.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 24' ' ' ILE . . . . . 0.457 HD12 ' N ' ' E' ' 24' ' ' ILE . 4.2 mp -99.22 -48.92 11.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.0 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -114.49 140.62 48.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.61 177.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 19.1 m -63.58 109.35 1.63 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 173.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 27' ' ' PHE . . . . . 0.473 ' HB3' HD23 ' E' ' 91' ' ' LEU . 14.6 p90 -124.92 159.55 30.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.643 0.735 . . . . 0.0 112.88 -170.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 28' ' ' HIS . . . . . 0.582 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 9.3 t60 -116.45 125.83 52.53 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.047 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 29' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 61.1 mt -92.38 133.12 34.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 170.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 30' ' ' SER . . . . . 0.582 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 32.9 p -118.96 -14.31 9.4 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -169.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 31' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -167.32 148.01 12.53 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.143 -1.504 . . . . 0.0 113.352 178.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.437 HG23 ' HG ' ' E' ' 87' ' ' LEU . 11.5 p -134.69 128.99 51.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 172.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.07 155.49 42.24 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 121.942 -0.474 . . . . 0.0 111.655 -174.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 34' ' ' LEU . . . . . 0.551 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.0 pp -121.0 142.29 49.93 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.511 0.672 . . . . 0.0 111.181 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -110.11 -50.05 3.01 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.476 173.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -103.17 127.46 50.46 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 168.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 37' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 152.17 158.85 8.64 Favored Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 119.875 -1.155 . . . . 0.0 113.293 176.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 38' ' ' GLN . . . . . 0.474 ' O ' ' HG3' ' E' ' 58' ' ' LYS . 94.4 mt-30 -102.47 -45.44 5.07 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 120.586 0.231 . . . . 0.0 111.39 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 39' ' ' GLU . . . . . 0.433 ' HG3' HG22 ' E' ' 57' ' ' THR . 13.4 tt0 -153.68 130.59 10.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.229 178.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 40' ' ' ALA . . . . . 0.583 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -131.41 113.83 14.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.388 0.613 . . . . 0.0 110.467 169.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 41' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -97.06 111.63 23.77 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.45 ' HG ' ' CG2' ' E' ' 53' ' ' VAL . 45.7 tp -83.69 112.57 20.17 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.627 -174.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -110.95 137.14 48.95 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.32 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 44' ' ' LEU . . . . . 0.594 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 1.2 tp -120.54 119.43 32.92 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.377 175.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 45' ' ' ALA . . . . . . . . . . . . . . . -106.24 114.15 28.1 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 46' ' ' ALA . . . . . 0.523 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -146.04 154.58 42.02 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.957 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 58.02 27.77 15.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.027 0.441 . . . . 0.0 110.406 -176.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm 59.23 44.61 15.38 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.749 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 49' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -150.89 140.23 21.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.922 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -85.89 127.1 34.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.15 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 51' ' ' TYR . . . . . 0.414 ' CB ' HD11 ' D' ' 88' ' ' LEU . 49.8 m-85 -123.23 123.96 41.94 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.669 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 tp -77.39 103.36 4.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 171.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 53' ' ' VAL . . . . . 0.45 ' CG2' ' HG ' ' E' ' 42' ' ' LEU . 2.8 m -86.83 -35.32 8.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.786 -173.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 54' ' ' ALA . . . . . 0.519 ' HB2' ' CD2' ' E' ' 65' ' ' LEU . . . -152.49 145.53 24.55 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.312 -0.555 . . . . 0.0 112.191 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 27.4 m -114.63 101.95 9.58 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 169.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 56' ' ' VAL . . . . . 0.454 HG13 ' HB3' ' E' ' 40' ' ' ALA . 7.4 p -115.92 112.99 41.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.783 0.802 . . . . 0.0 110.114 -176.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 57' ' ' THR . . . . . 0.433 HG22 ' HG3' ' E' ' 39' ' ' GLU . 82.8 p -123.4 -176.81 3.53 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.234 -175.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 58' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' E' ' 38' ' ' GLN . 34.6 mtmm -58.45 -34.8 71.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.199 0.523 . . . . 0.0 110.043 170.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 59' ' ' ALA . . . . . 0.404 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -73.24 -40.78 64.39 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.508 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 72.6 mt -115.38 80.67 7.87 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 61' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 10.3 Cg_exo -71.06 0.02 7.27 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.047 2.498 . . . . 0.0 113.448 -168.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -162.01 124.75 2.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.504 0.669 . . . . 0.0 111.08 -176.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 86.4 t -113.81 102.97 14.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.239 174.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.0 109.84 17.96 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.411 173.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 65' ' ' LEU . . . . . 0.519 ' CD2' ' HB2' ' E' ' 54' ' ' ALA . 0.4 OUTLIER -129.62 168.97 15.64 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.081 0.467 . . . . 0.0 111.583 -174.657 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 66' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 17.1 t0 -115.68 106.26 13.68 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.708 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 67' ' ' LEU . . . . . 0.55 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 26.0 mt -123.55 143.0 50.47 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 175.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 68' ' ' ASN . . . . . 0.584 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 4.9 t30 -150.78 130.72 13.35 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.122 177.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 69' ' ' PHE . . . . . 0.511 ' HB2' HD13 ' E' ' 23' ' ' ILE . 3.1 m-85 -126.34 153.19 45.23 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 88.9 p -98.28 164.67 12.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.006 0.431 . . . . 0.0 110.786 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 71' ' ' LYS . . . . . 0.427 ' H ' ' HG3' ' E' ' 71' ' ' LYS . 0.0 OUTLIER -65.42 -5.57 7.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.781 177.884 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.18 -3.44 55.64 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 121.043 -0.599 . . . . 0.0 111.791 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -93.74 159.08 15.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.99 0.424 . . . . 0.0 110.747 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -144.21 125.47 14.67 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 174.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 75' ' ' ILE . . . . . 0.523 HG22 ' HB2' ' E' ' 46' ' ' ALA . 18.0 pt -136.09 163.8 33.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.92 -166.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 76' ' ' MET . . . . . 0.417 ' SD ' ' HB3' ' E' ' 20' ' ' SER . 3.7 mtm -121.95 130.76 53.59 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 173.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 77' ' ' PHE . . . . . 0.594 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.9 OUTLIER -111.41 128.18 55.9 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.248 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 78' ' ' TYR . . . . . 0.68 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 33.9 p90 -151.64 138.45 18.91 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.242 0.544 . . . . 0.0 111.8 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 79' ' ' THR . . . . . 0.707 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 6.2 p -107.4 134.84 49.86 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.13 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.67 154.17 19.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.17 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.19 -175.91 39.99 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -175.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 82' ' ' ASP . . . . . 0.436 ' HA ' ' HB3' ' E' ' 15' ' ' PRO . 9.2 m-20 -113.64 103.37 11.17 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.132 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 83' ' ' ALA . . . . . 0.583 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -170.24 155.03 5.14 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.832 172.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 16.2 t -112.03 123.45 50.28 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 85' ' ' VAL . . . . . 0.551 HG12 ' HB3' ' E' ' 34' ' ' LEU . 6.1 m -121.62 145.76 27.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.424 0.631 . . . . 0.0 112.617 -172.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 20.4 m -109.87 120.82 43.67 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.619 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 87' ' ' LEU . . . . . 0.629 HD13 HD23 ' E' ' 11' ' ' LEU . 4.7 mp -97.87 144.84 27.02 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 171.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 88' ' ' LEU . . . . . 0.552 HD12 ' CE1' ' E' ' 8' ' ' PHE . 2.4 mm? -124.4 146.46 48.86 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.075 174.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.07 -168.34 23.83 Favored Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.272 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 90' ' ' TYR . . . . . 0.664 ' CD2' ' HB3' ' A' ' 68' ' ' ASN . 9.9 p90 -151.4 128.57 11.17 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.814 0.816 . . . . 0.0 111.794 177.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 91' ' ' LEU . . . . . 0.473 HD23 ' HB3' ' E' ' 27' ' ' PHE . 7.1 mt . . . . . 0 C--N 1.32 -0.71 0 CA-C-N 113.893 -1.503 . . . . 0.0 109.036 175.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 38.7 mtt . . . . . 0 C--O 1.225 -0.21 0 CA-C-O 120.864 0.364 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.438 ' CE1' HD21 ' B' ' 44' ' ' LEU . 61.0 t80 -64.7 146.39 54.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.54 -171.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.469 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 90.5 t90 -137.89 147.03 44.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.066 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.83 155.22 26.27 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.802 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.575 HD23 HD13 ' A' ' 87' ' ' LEU . 48.2 tp -143.86 108.72 4.93 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.768 0.318 . . . . 0.0 110.964 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -91.19 100.69 13.47 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.001 0.429 . . . . 0.0 110.057 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.519 ' SD ' HD11 ' A' ' 87' ' ' LEU . 57.0 mtp -90.56 138.03 31.88 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.21 -177.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.532 ' HB2' ' HD2' ' A' ' 17' ' ' ARG . 32.6 mmtp -101.24 150.94 37.57 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.911 -175.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.434 ' HD3' ' OG ' ' A' ' 84' ' ' SER . 81.9 Cg_exo -43.13 112.28 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 124.195 3.263 . . . . 0.0 114.745 -172.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.689 ' HA ' ' O ' ' A' ' 79' ' ' THR . 5.7 tt0 60.9 63.47 1.28 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.468 170.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.532 ' HD2' ' HB2' ' A' ' 14' ' ' LYS . 37.7 mtt85 -136.27 155.39 50.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.57 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.698 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 3.3 ttmp? -125.5 115.47 20.27 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.769 -175.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -112.6 119.49 38.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.866 176.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.3 p -79.54 133.39 36.47 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 172.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -108.69 115.95 31.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.08 0.467 . . . . 0.0 112.044 -167.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.6 m -93.18 123.12 36.23 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 169.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.9 mt -93.28 113.76 28.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.217 0.532 . . . . 0.0 111.548 -171.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.427 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.5 mp -85.66 -48.32 16.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.491 178.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.432 ' HD2' HD13 ' A' ' 91' ' ' LEU . 47.0 mttt -119.33 132.47 55.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.267 178.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.6 p -59.62 123.14 15.95 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.545 ' HB3' HD23 ' A' ' 91' ' ' LEU . 3.3 p90 -136.56 161.84 34.76 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -170.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.567 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 21.6 t60 -115.86 128.1 55.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.885 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.578 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 44.1 mt -98.76 131.7 45.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 170.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.567 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 40.5 p -116.05 -15.15 11.17 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -171.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.05 155.04 26.22 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 119.391 -1.385 . . . . 0.0 113.503 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.443 HG23 ' HG ' ' A' ' 87' ' ' LEU . 9.5 p -137.33 124.43 29.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 171.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 62' ' ' GLN . . . -125.87 150.04 48.2 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -170.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.865 ' HB2' HG22 ' A' ' 56' ' ' VAL . 1.8 tm? -104.53 109.52 21.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.689 -174.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.53 -59.42 1.95 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.914 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -104.09 129.4 51.77 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.605 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.588 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 134.84 177.59 15.06 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 119.275 -1.441 . . . . 0.0 113.506 174.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.429 ' HA ' ' HD2' ' A' ' 58' ' ' LYS . 74.4 mt-30 -103.41 -47.82 4.17 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.635 0.255 . . . . 0.0 111.295 176.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -151.2 133.27 15.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.42 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.88 114.86 17.02 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.322 0.582 . . . . 0.0 110.427 170.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -100.15 111.22 23.5 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.6 tp -84.2 115.78 22.6 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.044 -173.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.435 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 98.2 m-85 -117.47 145.34 44.24 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.497 ' HA ' ' O ' ' A' ' 76' ' ' MET . 0.2 OUTLIER -133.09 134.2 43.96 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 171.872 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -108.59 115.53 30.27 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.407 178.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.638 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -128.71 144.02 51.07 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 58.37 27.35 15.26 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -170.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.7 mttp 59.53 33.18 22.07 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.938 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.533 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 8.7 tp-100 -120.31 124.45 45.63 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -83.07 117.74 23.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.805 0.336 . . . . 0.0 110.878 -176.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -112.51 136.17 52.36 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.719 176.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.1 tp -78.38 109.89 13.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 168.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.481 HG13 ' CD2' ' E' ' 88' ' ' LEU . 2.7 t -82.97 -50.28 15.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.356 -173.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.433 ' HB1' HG11 ' A' ' 63' ' ' VAL . . . -155.4 144.16 20.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.187 -178.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.8 m -108.32 102.42 11.54 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 172.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.865 HG22 ' HB2' ' A' ' 34' ' ' LEU . 13.4 p -120.98 112.99 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-O 122.205 1.003 . . . . 0.0 110.781 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.7 p -123.31 -178.0 3.86 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.914 -174.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.429 ' HD2' ' HA ' ' A' ' 38' ' ' GLN . 29.8 mtpp -59.66 -31.55 69.64 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.053 0.454 . . . . 0.0 110.222 169.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.06 -40.35 62.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.614 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.7 mt -112.46 84.47 6.27 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 173.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.2 0.74 6.23 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.111 2.54 . . . . 0.0 114.352 -166.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 18.9 pt20 -169.81 130.46 1.02 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.096 0.474 . . . . 0.0 111.127 -177.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.433 HG11 ' HB1' ' A' ' 54' ' ' ALA . 95.4 t -118.81 116.56 51.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.297 175.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.44 122.41 39.3 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.04 176.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -138.78 168.5 19.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.057 0.456 . . . . 0.0 111.527 -176.566 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 7.7 t0 -116.07 99.56 7.33 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.188 0.518 . . . . 0.0 110.232 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.682 HD21 HD23 ' E' ' 88' ' ' LEU . 21.0 mt -113.42 137.37 51.63 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.893 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.66 ' HB2' ' CD2' ' E' ' 90' ' ' TYR . 3.8 m-20 -138.0 118.18 13.56 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 176.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -117.37 151.46 36.98 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.358 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.6 t -113.02 152.99 28.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.068 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -69.68 -12.1 61.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.377 -176.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.2 -12.08 68.42 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.822 175.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -100.75 164.32 11.91 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -143.49 127.83 17.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.973 0.416 . . . . 0.0 109.961 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.638 HG22 ' HB2' ' A' ' 46' ' ' ALA . 10.9 pt -131.42 179.62 4.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.04 -170.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 12.0 mtm -136.05 135.56 39.51 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 171.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.447 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 1.1 m-85 -112.61 128.2 56.31 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.698 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 34.5 p90 -153.55 137.17 16.0 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.303 0.573 . . . . 0.0 112.105 -177.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.689 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 5.9 p -109.21 138.32 45.74 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.04 -177.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.79 162.3 13.91 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.194 176.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.87 -174.73 44.58 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -175.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -115.46 102.83 10.17 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.092 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.588 ' CB ' ' HA3' ' A' ' 37' ' ' GLY . . . -175.46 162.74 2.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.562 171.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.434 ' OG ' ' HD3' ' A' ' 15' ' ' PRO . 1.1 m -116.01 126.01 53.24 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.659 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.407 HG11 ' CG1' ' A' ' 56' ' ' VAL . 2.8 m -116.8 148.73 19.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -174.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.4 m -108.5 113.58 26.73 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.653 173.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.575 HD13 HD23 ' A' ' 11' ' ' LEU . 5.2 mp -89.62 148.64 23.22 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 170.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.702 HD23 HD21 ' B' ' 67' ' ' LEU . 0.9 OUTLIER -132.06 138.93 48.36 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.079 -178.906 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.7 -167.12 24.75 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.878 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.682 ' CD2' ' HB2' ' B' ' 68' ' ' ASN . 13.0 p90 -150.71 128.86 11.9 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.995 0.902 . . . . 0.0 111.745 177.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.545 HD23 ' HB3' ' A' ' 27' ' ' PHE . 8.2 mt . . . . . 0 C--N 1.322 -0.63 0 CA-C-N 113.941 -1.481 . . . . 0.0 109.655 176.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 38.7 mtt . . . . . 0 C--O 1.226 -0.183 0 CA-C-O 120.91 0.386 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 8' ' ' PHE . . . . . 0.465 ' CE1' HD21 ' C' ' 44' ' ' LEU . 61.3 t80 -64.55 146.37 54.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.553 -171.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' TRP . . . . . 0.464 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 90.5 t90 -138.03 147.02 43.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.01 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.81 155.23 26.27 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.87 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.583 HD23 HD13 ' B' ' 87' ' ' LEU . 47.6 tp -143.88 108.78 4.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.743 0.306 . . . . 0.0 110.976 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -91.17 100.75 13.52 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.973 0.416 . . . . 0.0 110.039 173.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' MET . . . . . 0.523 ' SD ' HD11 ' B' ' 87' ' ' LEU . 57.4 mtp -90.61 137.96 31.94 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.196 -177.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.524 ' HB2' ' HD2' ' B' ' 17' ' ' ARG . 32.6 mmtp -101.17 150.99 37.58 Favored Pre-proline 0 C--N 1.317 -0.834 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.938 -175.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.436 ' HD3' ' OG ' ' B' ' 84' ' ' SER . 83.3 Cg_exo -43.19 112.23 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 124.187 3.258 . . . . 0.0 114.853 -172.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.683 ' HA ' ' O ' ' B' ' 79' ' ' THR . 5.7 tt0 61.0 63.33 1.28 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.502 170.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.524 ' HD2' ' HB2' ' B' ' 14' ' ' LYS . 37.7 mtt85 -136.19 155.56 49.96 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.601 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.694 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 3.3 ttmp? -125.61 115.43 20.13 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.762 -175.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -112.64 119.38 37.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.842 176.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 10.1 p -79.55 133.33 36.46 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 172.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -108.67 116.03 31.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.063 0.459 . . . . 0.0 112.02 -167.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 28.3 m -93.12 123.16 36.19 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 169.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 52.9 mt -93.28 113.77 28.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.179 0.514 . . . . 0.0 111.536 -172.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.425 ' N ' HD12 ' B' ' 24' ' ' ILE . 4.5 mp -85.56 -48.46 16.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.543 178.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.444 ' HD2' HD13 ' B' ' 91' ' ' LEU . 47.2 mttt -119.32 132.46 55.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.267 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 12.7 p -59.58 123.09 15.74 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' PHE . . . . . 0.538 ' HB3' HD23 ' B' ' 91' ' ' LEU . 3.3 p90 -136.56 161.76 34.98 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -169.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' HIS . . . . . 0.565 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 22.0 t60 -115.83 128.03 55.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.847 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.583 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 43.7 mt -98.68 131.7 45.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 170.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.565 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 41.0 p -116.06 -15.16 11.17 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -171.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.15 154.98 26.13 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 119.377 -1.392 . . . . 0.0 113.535 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.443 HG23 ' HG ' ' B' ' 87' ' ' LEU . 9.5 p -137.26 124.4 30.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 171.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 33' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' B' ' 62' ' ' GLN . . . -125.77 150.05 48.07 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -170.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.885 ' HB2' HG22 ' B' ' 56' ' ' VAL . 1.8 tm? -104.6 109.58 21.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.688 -174.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.52 -59.47 1.94 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.917 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -104.02 129.38 51.64 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.712 175.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.585 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 134.73 177.53 15.01 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 119.222 -1.466 . . . . 0.0 113.485 174.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' GLN . . . . . 0.427 ' HA ' ' HD2' ' B' ' 58' ' ' LYS . 74.3 mt-30 -103.37 -47.85 4.17 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.633 0.254 . . . . 0.0 111.294 176.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -151.2 133.29 15.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.385 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.92 114.89 17.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.356 0.598 . . . . 0.0 110.453 170.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -100.15 111.14 23.42 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 48.2 tp -84.1 115.74 22.53 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.098 -173.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' TYR . . . . . 0.435 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 98.2 m-85 -117.43 145.37 44.18 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.487 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.2 OUTLIER -133.17 134.19 43.79 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.235 0.54 . . . . 0.0 109.549 171.899 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -108.51 115.54 30.29 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.357 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.635 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -128.8 144.06 51.07 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 58.42 27.29 15.25 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -170.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 59.7 mttp 59.46 33.24 22.19 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.923 -175.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.54 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 8.7 tp-100 -120.31 124.48 45.7 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -82.98 117.61 22.92 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.767 0.318 . . . . 0.0 111.01 -176.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -112.47 136.2 52.26 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.672 176.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 6.2 tp -78.33 109.86 13.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 168.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.506 HG13 ' CD2' ' A' ' 88' ' ' LEU . 2.7 t -83.08 -50.14 15.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.3 -173.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.424 ' HB1' HG11 ' B' ' 63' ' ' VAL . . . -155.46 144.14 20.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.141 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 23.6 m -108.38 102.49 11.59 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 172.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' VAL . . . . . 0.885 HG22 ' HB2' ' B' ' 34' ' ' LEU . 13.3 p -121.01 112.95 37.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 122.224 1.012 . . . . 0.0 110.739 -175.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 68.2 p -123.29 -177.89 3.83 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.975 -174.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' LYS . . . . . 0.427 ' HD2' ' HA ' ' B' ' 38' ' ' GLN . 29.8 mtpp -59.66 -31.6 69.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.18 0.514 . . . . 0.0 110.223 169.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.06 -40.3 62.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.629 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 83.9 mt -112.52 84.6 6.46 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 173.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.18 0.68 6.32 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.051 2.501 . . . . 0.0 114.427 -166.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 62' ' ' GLN . . . . . 0.432 ' HA ' ' HA ' ' B' ' 33' ' ' ALA . 18.9 pt20 -169.77 130.49 1.03 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.167 0.508 . . . . 0.0 111.095 -177.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.424 HG11 ' HB1' ' B' ' 54' ' ' ALA . 95.6 t -118.8 116.53 51.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.308 175.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.45 122.3 39.2 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.067 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' B' ' 30' ' ' SER . 0.3 OUTLIER -138.67 168.57 19.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.02 0.438 . . . . 0.0 111.541 -176.617 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 66' ' ' ASP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 7.6 t0 -116.07 99.56 7.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.145 0.498 . . . . 0.0 110.16 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.702 HD21 HD23 ' A' ' 88' ' ' LEU . 21.1 mt -113.48 137.21 51.88 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.978 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 68' ' ' ASN . . . . . 0.682 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 3.8 m-20 -137.88 118.16 13.66 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 176.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -117.42 151.51 36.9 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.271 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 14.8 t -113.12 153.01 28.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.067 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -69.65 -12.13 61.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.37 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.09 -12.19 68.48 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.849 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -100.72 164.25 11.95 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -143.44 127.9 17.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.936 0.398 . . . . 0.0 109.988 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.635 HG22 ' HB2' ' B' ' 46' ' ' ALA . 10.9 pt -131.56 179.63 4.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.958 -170.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.487 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 11.9 mtm -136.01 135.66 39.65 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 171.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 77' ' ' PHE . . . . . 0.46 ' CD1' ' HB2' ' B' ' 44' ' ' LEU . 1.1 m-85 -112.66 128.29 56.35 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.694 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 34.3 p90 -153.63 137.15 15.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.345 0.593 . . . . 0.0 112.093 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.683 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 5.9 p -109.15 138.21 45.86 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.068 -177.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.81 162.43 13.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.184 176.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.87 -174.78 44.64 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -175.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -115.45 102.83 10.17 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.614 -0.834 . . . . 0.0 110.026 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.585 ' CB ' ' HA3' ' B' ' 37' ' ' GLY . . . -175.54 162.69 2.84 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.528 171.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 84' ' ' SER . . . . . 0.436 ' OG ' ' HD3' ' B' ' 15' ' ' PRO . 1.1 m -115.98 126.01 53.27 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.553 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.413 HG11 ' CG1' ' B' ' 56' ' ' VAL . 2.7 m -116.87 148.81 19.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.147 0.499 . . . . 0.0 112.329 -174.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 86' ' ' SER . . . . . 0.419 ' OG ' HG22 ' C' ' 52' ' ' ILE . 43.1 m -108.52 113.63 26.8 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.63 173.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.583 HD13 HD23 ' B' ' 11' ' ' LEU . 5.3 mp -89.74 148.62 23.15 Favored 'General case' 0 CA--C 1.5 -0.953 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.448 170.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.675 HD23 HD21 ' C' ' 67' ' ' LEU . 0.9 OUTLIER -132.04 138.98 48.41 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.078 -178.888 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.78 -167.17 24.93 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.872 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 90' ' ' TYR . . . . . 0.66 ' CD2' ' HB2' ' C' ' 68' ' ' ASN . 12.9 p90 -150.66 128.84 11.93 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.889 0.852 . . . . 0.0 111.786 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 91' ' ' LEU . . . . . 0.538 HD23 ' HB3' ' B' ' 27' ' ' PHE . 8.3 mt . . . . . 0 C--N 1.321 -0.673 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.632 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 38.6 mtt . . . . . 0 C--O 1.225 -0.226 0 CA-C-O 120.884 0.373 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 8' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' D' ' 46' ' ' ALA . 61.5 t80 -64.56 146.33 54.79 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.586 -171.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 9' ' ' TRP . . . . . 0.461 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 90.6 t90 -137.98 147.01 43.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.024 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.79 155.23 26.27 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.864 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.561 HD23 HD13 ' C' ' 87' ' ' LEU . 48.5 tp -143.93 108.71 4.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.805 0.336 . . . . 0.0 110.902 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -91.16 100.77 13.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.997 0.427 . . . . 0.0 109.992 173.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 13' ' ' MET . . . . . 0.515 ' SD ' HD11 ' C' ' 87' ' ' LEU . 57.3 mtp -90.65 137.96 31.95 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.216 -177.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 14' ' ' LYS . . . . . 0.513 ' HB2' ' HD2' ' C' ' 17' ' ' ARG . 32.6 mmtp -101.2 150.97 37.58 Favored Pre-proline 0 C--N 1.317 -0.81 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.898 -175.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 15' ' ' PRO . . . . . 0.438 ' HD3' ' OG ' ' C' ' 84' ' ' SER . 84.3 Cg_exo -43.15 112.33 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 124.146 3.231 . . . . 0.0 114.847 -172.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 16' ' ' GLU . . . . . 0.69 ' HA ' ' O ' ' C' ' 79' ' ' THR . 5.7 tt0 60.81 63.51 1.29 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.513 170.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 17' ' ' ARG . . . . . 0.513 ' HD2' ' HB2' ' C' ' 14' ' ' LYS . 37.8 mtt85 -136.28 155.53 49.96 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.613 178.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 18' ' ' LYS . . . . . 0.694 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 3.3 ttmp? -125.67 115.46 20.14 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.703 -175.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -112.73 119.42 38.01 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.893 176.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 10.0 p -79.53 133.46 36.47 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 172.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -108.68 116.03 31.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.089 0.471 . . . . 0.0 112.075 -167.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 28.3 m -93.19 123.2 36.3 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 169.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 52.8 mt -93.3 113.8 28.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.135 0.493 . . . . 0.0 111.448 -172.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 24' ' ' ILE . . . . . 0.425 ' N ' HD12 ' C' ' 24' ' ' ILE . 4.5 mp -85.62 -48.36 16.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.585 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 25' ' ' LYS . . . . . 0.451 ' HD2' HD13 ' C' ' 91' ' ' LEU . 47.1 mttt -119.39 132.4 55.83 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.242 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 12.4 p -59.54 123.13 15.87 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 177.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 27' ' ' PHE . . . . . 0.545 ' HB3' HD23 ' C' ' 91' ' ' LEU . 3.2 p90 -136.6 161.79 34.91 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -170.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 28' ' ' HIS . . . . . 0.572 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 21.9 t60 -115.83 128.06 55.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.26 -1.337 . . . . 0.0 109.879 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 29' ' ' ILE . . . . . 0.578 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 44.3 mt -98.69 131.71 45.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 170.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.572 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 39.7 p -116.06 -15.19 11.16 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.813 -171.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.04 155.04 26.22 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 119.355 -1.403 . . . . 0.0 113.533 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.438 HG23 ' HG ' ' C' ' 87' ' ' LEU . 9.5 p -137.36 124.36 29.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 171.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' C' ' 62' ' ' GLN . . . -125.78 150.17 47.99 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -170.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.868 ' HB2' HG22 ' C' ' 56' ' ' VAL . 1.8 tm? -104.68 109.58 21.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.63 -174.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.55 -59.45 1.95 Allowed 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.925 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -104.03 129.25 51.65 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.689 175.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 37' ' ' GLY . . . . . 0.593 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 134.87 177.7 15.14 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 119.339 -1.41 . . . . 0.0 113.451 174.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 38' ' ' GLN . . . . . 0.422 ' HA ' ' HD2' ' C' ' 58' ' ' LYS . 74.5 mt-30 -103.43 -47.84 4.16 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.69 0.281 . . . . 0.0 111.303 176.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -151.12 133.22 15.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.441 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.401 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -128.89 114.83 16.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.336 0.589 . . . . 0.0 110.404 170.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -100.07 111.25 23.55 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 48.6 tp -84.2 115.88 22.65 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.004 -173.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 43' ' ' TYR . . . . . 0.435 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 98.2 m-85 -117.51 145.38 44.26 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 176.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.492 ' HA ' ' O ' ' C' ' 76' ' ' MET . 0.2 OUTLIER -133.14 134.1 43.74 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 171.887 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 45' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -108.56 115.5 30.21 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.418 178.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.616 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -128.68 143.99 51.06 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 58.44 27.31 15.3 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -170.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 59.7 mttp 59.53 33.17 22.07 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.957 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 49' ' ' GLN . . . . . 0.545 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 8.7 tp-100 -120.2 124.39 45.59 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -83.05 117.75 23.05 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.917 0.389 . . . . 0.0 110.97 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -112.53 136.27 52.25 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.692 176.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 52' ' ' ILE . . . . . 0.419 HG22 ' OG ' ' B' ' 86' ' ' SER . 6.1 tp -78.4 109.92 13.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 168.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 53' ' ' VAL . . . . . 0.509 HG13 ' CD2' ' B' ' 88' ' ' LEU . 2.7 t -83.04 -50.21 15.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.377 -173.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 54' ' ' ALA . . . . . 0.421 ' HB1' HG11 ' C' ' 63' ' ' VAL . . . -155.49 144.09 20.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.187 -178.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 23.7 m -108.3 102.54 11.66 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 172.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 56' ' ' VAL . . . . . 0.868 HG22 ' HB2' ' C' ' 34' ' ' LEU . 13.3 p -121.02 113.02 38.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 122.225 1.012 . . . . 0.0 110.753 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 68.3 p -123.32 -177.95 3.85 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.969 -174.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 58' ' ' LYS . . . . . 0.422 ' HD2' ' HA ' ' C' ' 38' ' ' GLN . 29.8 mtpp -59.61 -31.62 69.66 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.106 0.479 . . . . 0.0 110.249 169.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.0 -40.38 62.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.598 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 84.0 mt -112.48 84.55 6.36 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 173.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.28 0.73 6.3 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.07 2.513 . . . . 0.0 114.367 -166.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 62' ' ' GLN . . . . . 0.44 ' HA ' ' HA ' ' C' ' 33' ' ' ALA . 18.8 pt20 -169.8 130.5 1.02 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.169 0.509 . . . . 0.0 111.133 -177.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.421 HG11 ' HB1' ' C' ' 54' ' ' ALA . 95.6 t -118.74 116.61 51.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.283 175.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.51 122.35 39.31 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.01 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 65' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' C' ' 30' ' ' SER . 0.3 OUTLIER -138.7 168.58 19.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.495 -176.576 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 66' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 7.6 t0 -116.1 99.51 7.29 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.232 0.539 . . . . 0.0 110.231 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.675 HD21 HD23 ' B' ' 88' ' ' LEU . 21.1 mt -113.43 137.26 51.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.916 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 68' ' ' ASN . . . . . 0.66 ' HB2' ' CD2' ' B' ' 90' ' ' TYR . 3.8 m-20 -137.91 118.1 13.56 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 176.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -117.36 151.44 37.01 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.257 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 14.8 t -113.06 153.07 28.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.085 -177.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -69.65 -12.24 61.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.322 -176.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.07 -12.17 68.59 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.818 -0.705 . . . . 0.0 111.911 175.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -100.68 164.33 11.92 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -143.49 127.93 17.9 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.616 HG22 ' HB2' ' C' ' 46' ' ' ALA . 10.8 pt -131.49 179.64 4.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.995 -170.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.492 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 12.0 mtm -136.08 135.62 39.49 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 171.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 77' ' ' PHE . . . . . 0.455 ' CD1' ' HB2' ' C' ' 44' ' ' LEU . 1.1 m-85 -112.56 128.2 56.29 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 78' ' ' TYR . . . . . 0.694 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 34.3 p90 -153.6 137.24 16.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.314 0.578 . . . . 0.0 112.031 -177.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 79' ' ' THR . . . . . 0.69 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 5.9 p -109.21 138.1 46.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.103 -177.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.73 162.36 13.85 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.223 176.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.82 -174.79 44.72 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -175.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -115.48 102.8 10.14 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.078 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 83' ' ' ALA . . . . . 0.593 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -175.42 162.7 2.9 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.571 171.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 84' ' ' SER . . . . . 0.438 ' OG ' ' HD3' ' C' ' 15' ' ' PRO . 1.0 OUTLIER -115.95 125.86 53.11 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.654 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.408 HG11 ' CG1' ' C' ' 56' ' ' VAL . 2.8 m -116.76 148.91 19.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.213 0.53 . . . . 0.0 112.358 -174.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 42.8 m -108.54 113.59 26.73 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.645 173.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 87' ' ' LEU . . . . . 0.561 HD13 HD23 ' C' ' 11' ' ' LEU . 5.3 mp -89.68 148.59 23.21 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 170.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 88' ' ' LEU . . . . . 0.707 HD23 HD21 ' D' ' 67' ' ' LEU . 0.9 OUTLIER -132.01 138.94 48.43 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.098 -178.91 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.71 -167.06 24.67 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.847 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 90' ' ' TYR . . . . . 0.674 ' CD2' ' HB2' ' D' ' 68' ' ' ASN . 12.8 p90 -150.74 128.77 11.81 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.91 0.862 . . . . 0.0 111.769 177.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 91' ' ' LEU . . . . . 0.545 HD23 ' HB3' ' C' ' 27' ' ' PHE . 8.3 mt . . . . . 0 C--N 1.321 -0.665 0 CA-C-N 113.964 -1.471 . . . . 0.0 109.6 176.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 38.6 mtt . . . . . 0 C--O 1.225 -0.221 0 CA-C-O 120.82 0.343 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 8' ' ' PHE . . . . . 0.439 ' CE1' HD21 ' E' ' 44' ' ' LEU . 61.1 t80 -64.59 146.44 54.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.481 -171.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 9' ' ' TRP . . . . . 0.465 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 90.5 t90 -138.09 147.06 43.65 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.034 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.85 155.17 26.24 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.792 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 11' ' ' LEU . . . . . 0.582 HD23 HD13 ' D' ' 87' ' ' LEU . 48.4 tp -143.87 108.75 4.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.766 0.317 . . . . 0.0 110.973 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -91.23 100.75 13.51 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.002 0.429 . . . . 0.0 110.021 173.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 13' ' ' MET . . . . . 0.519 ' SD ' HD11 ' D' ' 87' ' ' LEU . 57.3 mtp -90.56 137.93 31.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.196 -177.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 14' ' ' LYS . . . . . 0.519 ' HB2' ' HD2' ' D' ' 17' ' ' ARG . 32.6 mmtp -101.22 150.99 37.6 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.909 -175.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 15' ' ' PRO . . . . . 0.436 ' HD3' ' OG ' ' D' ' 84' ' ' SER . 81.9 Cg_exo -43.3 112.34 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 124.133 3.222 . . . . 0.0 114.796 -172.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 16' ' ' GLU . . . . . 0.694 ' HA ' ' O ' ' D' ' 79' ' ' THR . 5.7 tt0 60.92 63.38 1.29 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.572 170.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 17' ' ' ARG . . . . . 0.519 ' HD2' ' HB2' ' D' ' 14' ' ' LYS . 37.7 mtt85 -136.22 155.45 50.1 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.613 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 18' ' ' LYS . . . . . 0.685 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 3.3 ttmp? -125.55 115.46 20.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.755 -175.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -112.75 119.36 37.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.878 176.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 10.0 p -79.55 133.42 36.46 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 172.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -108.7 116.0 31.16 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.089 0.471 . . . . 0.0 112.1 -167.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 28.4 m -93.08 123.17 36.15 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 169.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 52.5 mt -93.29 113.73 28.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.214 0.531 . . . . 0.0 111.542 -172.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 24' ' ' ILE . . . . . 0.436 HD12 ' N ' ' D' ' 24' ' ' ILE . 4.5 mp -85.64 -48.35 16.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.58 178.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 25' ' ' LYS . . . . . 0.443 ' HD2' HD13 ' D' ' 91' ' ' LEU . 47.1 mttt -119.35 132.45 55.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.283 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 12.5 p -59.54 123.14 15.91 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 27' ' ' PHE . . . . . 0.551 ' HB3' HD23 ' D' ' 91' ' ' LEU . 3.2 p90 -136.59 161.74 35.07 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -170.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 28' ' ' HIS . . . . . 0.561 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 22.1 t60 -115.78 128.07 55.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.899 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 29' ' ' ILE . . . . . 0.59 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 44.0 mt -98.67 131.6 45.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 170.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 30' ' ' SER . . . . . 0.561 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 41.3 p -115.96 -15.24 11.22 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -171.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.06 155.06 26.24 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 119.41 -1.376 . . . . 0.0 113.53 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.424 HG23 ' HG ' ' D' ' 87' ' ' LEU . 9.6 p -137.38 124.37 29.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 171.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 33' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' D' ' 62' ' ' GLN . . . -125.81 150.0 48.17 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -170.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 34' ' ' LEU . . . . . 0.851 ' HB2' HG22 ' D' ' 56' ' ' VAL . 1.8 tm? -104.58 109.53 21.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.65 -174.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.49 -59.51 1.94 Allowed 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.851 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -104.0 129.41 51.6 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 175.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 37' ' ' GLY . . . . . 0.595 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 134.73 177.58 15.05 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 119.306 -1.426 . . . . 0.0 113.489 174.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 38' ' ' GLN . . . . . 0.412 ' HA ' ' HD2' ' D' ' 58' ' ' LYS . 74.3 mt-30 -103.33 -47.79 4.19 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.691 0.282 . . . . 0.0 111.361 176.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -151.22 133.25 15.16 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.326 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.86 114.84 17.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.334 0.588 . . . . 0.0 110.447 170.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -100.15 111.16 23.44 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 48.5 tp -84.03 115.85 22.55 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.085 -173.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 43' ' ' TYR . . . . . 0.437 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 98.2 m-85 -117.52 145.38 44.26 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.49 ' HA ' ' O ' ' D' ' 76' ' ' MET . 0.2 OUTLIER -133.15 134.21 43.87 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 171.914 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 45' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -108.65 115.65 30.5 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.298 178.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.631 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -128.82 144.03 51.06 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 175.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 58.4 27.36 15.31 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -170.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 59.8 mttp 59.35 33.24 22.37 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.968 -175.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 49' ' ' GLN . . . . . 0.544 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 8.7 tp-100 -120.22 124.49 45.81 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -82.88 117.64 22.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.768 0.318 . . . . 0.0 111.011 -176.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -112.48 136.29 52.16 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.713 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 6.2 tp -78.43 109.83 13.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 168.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 53' ' ' VAL . . . . . 0.496 HG13 ' CD2' ' C' ' 88' ' ' LEU . 2.7 t -82.99 -50.22 15.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.311 -173.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 54' ' ' ALA . . . . . 0.437 ' HB1' HG11 ' D' ' 63' ' ' VAL . . . -155.47 144.1 20.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.175 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 23.7 m -108.26 102.54 11.65 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 172.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 56' ' ' VAL . . . . . 0.851 HG22 ' HB2' ' D' ' 34' ' ' LEU . 13.2 p -121.06 112.93 37.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 122.15 0.976 . . . . 0.0 110.743 -175.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 69.4 p -123.29 -177.87 3.82 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.937 -174.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 58' ' ' LYS . . . . . 0.412 ' HD2' ' HA ' ' D' ' 38' ' ' GLN . 29.8 mtpp -59.74 -31.53 69.72 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.184 169.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.09 -40.33 62.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.582 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 83.5 mt -112.43 84.56 6.3 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 173.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.18 0.73 6.24 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.017 2.478 . . . . 0.0 114.465 -166.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 62' ' ' GLN . . . . . 0.437 ' HA ' ' HA ' ' D' ' 33' ' ' ALA . 18.9 pt20 -169.82 130.46 1.02 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.197 0.522 . . . . 0.0 111.088 -177.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.437 HG11 ' HB1' ' D' ' 54' ' ' ALA . 95.0 t -118.82 116.71 51.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.237 175.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.51 122.4 39.37 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.039 176.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 65' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' D' ' 30' ' ' SER . 0.3 OUTLIER -138.76 168.58 19.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.465 -176.574 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 66' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 7.7 t0 -116.12 99.47 7.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.275 0.56 . . . . 0.0 110.26 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.707 HD21 HD23 ' C' ' 88' ' ' LEU . 21.0 mt -113.32 137.31 51.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.01 178.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 68' ' ' ASN . . . . . 0.674 ' HB2' ' CD2' ' C' ' 90' ' ' TYR . 3.8 m-20 -137.95 118.21 13.63 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 176.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -117.48 151.36 37.26 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.236 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 14.7 t -112.97 153.06 28.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.094 -177.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -69.72 -12.12 61.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.377 -176.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.14 -12.14 68.46 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.832 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -100.8 164.28 11.92 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -143.48 127.92 17.91 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.021 0.438 . . . . 0.0 109.928 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.631 HG22 ' HB2' ' D' ' 46' ' ' ALA . 10.9 pt -131.55 179.63 4.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.013 -170.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 76' ' ' MET . . . . . 0.49 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 12.0 mtm -136.08 135.58 39.45 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 171.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 77' ' ' PHE . . . . . 0.453 ' CD1' ' HB2' ' D' ' 44' ' ' LEU . 1.1 m-85 -112.61 128.26 56.32 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 78' ' ' TYR . . . . . 0.685 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 34.4 p90 -153.63 137.11 15.88 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.336 0.589 . . . . 0.0 112.064 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 79' ' ' THR . . . . . 0.694 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 5.9 p -109.09 138.22 45.79 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.07 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.83 162.47 13.77 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.14 176.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.82 -174.87 44.8 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 -175.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -115.41 102.8 10.16 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.037 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 83' ' ' ALA . . . . . 0.595 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -175.4 162.71 2.92 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.563 171.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 84' ' ' SER . . . . . 0.436 ' OG ' ' HD3' ' D' ' 15' ' ' PRO . 1.1 m -115.98 126.08 53.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.614 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.413 HG11 ' CG1' ' D' ' 56' ' ' VAL . 2.7 m -116.84 148.76 19.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.119 0.485 . . . . 0.0 112.306 -174.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 42.4 m -108.41 113.68 26.92 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.63 173.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 87' ' ' LEU . . . . . 0.582 HD13 HD23 ' D' ' 11' ' ' LEU . 5.2 mp -89.76 148.63 23.13 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 170.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.685 HD23 HD21 ' E' ' 67' ' ' LEU . 0.9 OUTLIER -132.1 138.99 48.32 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.002 -178.839 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.73 -167.15 24.84 Favored Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.897 -177.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 90' ' ' TYR . . . . . 0.656 ' CD2' ' HB2' ' E' ' 68' ' ' ASN . 13.0 p90 -150.66 128.86 11.95 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.873 0.844 . . . . 0.0 111.797 177.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 91' ' ' LEU . . . . . 0.551 HD23 ' HB3' ' D' ' 27' ' ' PHE . 8.1 mt . . . . . 0 C--N 1.321 -0.671 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.669 176.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 38.7 mtt . . . . . 0 C--O 1.225 -0.212 0 CA-C-O 120.846 0.355 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' E' E ' 8' ' ' PHE . . . . . 0.428 ' CE1' HD21 ' A' ' 44' ' ' LEU . 61.0 t80 -64.68 146.44 54.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.525 -171.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 9' ' ' TRP . . . . . 0.455 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 90.4 t90 -137.99 146.98 43.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.056 178.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.76 155.21 26.27 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.875 177.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 11' ' ' LEU . . . . . 0.578 HD23 HD13 ' E' ' 87' ' ' LEU . 47.9 tp -143.93 108.78 4.93 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.803 0.335 . . . . 0.0 111.014 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -91.17 100.72 13.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.98 0.419 . . . . 0.0 110.066 173.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 13' ' ' MET . . . . . 0.515 ' SD ' HD11 ' E' ' 87' ' ' LEU . 57.3 mtp -90.56 137.97 31.93 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.141 -177.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 14' ' ' LYS . . . . . 0.521 ' HB2' ' HD2' ' E' ' 17' ' ' ARG . 32.6 mmtp -101.28 150.94 37.59 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.884 -175.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 15' ' ' PRO . . . . . 0.431 ' HD3' ' OG ' ' E' ' 84' ' ' SER . 84.4 Cg_exo -43.1 112.18 0.27 Allowed 'Trans proline' 0 N--CA 1.474 0.368 0 C-N-CA 124.157 3.238 . . . . 0.0 114.869 -172.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 16' ' ' GLU . . . . . 0.693 ' HA ' ' O ' ' E' ' 79' ' ' THR . 5.7 tt0 61.06 63.24 1.28 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.579 170.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 17' ' ' ARG . . . . . 0.521 ' HD2' ' HB2' ' E' ' 14' ' ' LYS . 38.0 mtt85 -136.19 155.47 50.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.611 178.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 18' ' ' LYS . . . . . 0.687 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 3.3 ttmp? -125.51 115.38 20.12 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.777 -175.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -112.58 119.4 38.0 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 176.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 10.1 p -79.58 133.29 36.44 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -108.57 116.04 31.22 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.076 0.465 . . . . 0.0 112.098 -167.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 28.4 m -93.05 123.14 36.1 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 169.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 52.7 mt -93.27 113.8 28.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.242 0.544 . . . . 0.0 111.513 -172.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 24' ' ' ILE . . . . . 0.435 HD12 ' N ' ' E' ' 24' ' ' ILE . 4.5 mp -85.64 -48.37 16.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.502 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 25' ' ' LYS . . . . . 0.449 ' HD2' HD13 ' E' ' 91' ' ' LEU . 47.2 mttt -119.32 132.45 55.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.214 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 12.6 p -59.5 123.15 15.9 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 27' ' ' PHE . . . . . 0.533 ' HB3' HD23 ' E' ' 91' ' ' LEU . 3.3 p90 -136.55 161.73 35.06 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -170.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 28' ' ' HIS . . . . . 0.571 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 22.0 t60 -115.78 128.16 55.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.894 178.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 29' ' ' ILE . . . . . 0.578 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 44.3 mt -98.8 131.72 45.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 170.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 30' ' ' SER . . . . . 0.571 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 41.0 p -116.08 -15.09 11.16 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.858 -171.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.11 155.05 26.24 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 119.307 -1.425 . . . . 0.0 113.494 178.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.438 HG23 ' HG ' ' E' ' 87' ' ' LEU . 9.6 p -137.29 124.27 29.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 171.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 33' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' E' ' 62' ' ' GLN . . . -125.76 150.11 48.01 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -170.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 34' ' ' LEU . . . . . 0.872 ' HB2' HG22 ' E' ' 56' ' ' VAL . 1.8 tm? -104.61 109.58 21.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.628 -174.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.58 -59.45 1.95 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.87 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -104.02 129.41 51.64 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.68 175.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 37' ' ' GLY . . . . . 0.594 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 134.7 177.61 15.07 Favored Glycine 0 N--CA 1.437 -1.244 0 C-N-CA 119.325 -1.417 . . . . 0.0 113.506 174.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 38' ' ' GLN . . . . . 0.421 ' HA ' ' HD2' ' E' ' 58' ' ' LYS . 74.4 mt-30 -103.33 -47.89 4.17 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.669 0.271 . . . . 0.0 111.306 176.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -151.16 133.23 15.2 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.404 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 40' ' ' ALA . . . . . 0.402 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -128.89 114.89 17.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.394 0.616 . . . . 0.0 110.413 170.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 41' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -100.16 111.14 23.42 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 48.5 tp -84.08 115.75 22.53 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.061 -173.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 43' ' ' TYR . . . . . 0.427 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 98.2 m-85 -117.46 145.38 44.2 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 44' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' E' ' 76' ' ' MET . 0.2 OUTLIER -133.13 134.18 43.86 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 171.879 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 45' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -108.57 115.51 30.23 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.344 178.041 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 46' ' ' ALA . . . . . 0.615 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -128.74 143.95 51.05 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 58.57 27.22 15.39 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -170.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 59.7 mttp 59.49 33.17 22.13 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.937 -175.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 49' ' ' GLN . . . . . 0.543 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 8.7 tp-100 -120.24 124.5 45.82 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -83.07 117.68 23.02 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.826 0.346 . . . . 0.0 110.92 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -112.48 136.36 52.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.663 176.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 6.2 tp -78.5 109.88 13.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 168.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 53' ' ' VAL . . . . . 0.503 HG13 ' CD2' ' D' ' 88' ' ' LEU . 2.7 t -83.02 -50.24 15.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.319 -173.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 54' ' ' ALA . . . . . 0.425 ' HB1' HG11 ' E' ' 63' ' ' VAL . . . -155.39 144.19 20.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.205 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 23.6 m -108.37 102.51 11.61 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 172.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 56' ' ' VAL . . . . . 0.872 HG22 ' HB2' ' E' ' 34' ' ' LEU . 13.2 p -121.0 112.98 38.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 122.143 0.973 . . . . 0.0 110.761 -175.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 70.6 p -123.25 -177.87 3.82 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.982 -174.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 58' ' ' LYS . . . . . 0.421 ' HD2' ' HA ' ' E' ' 38' ' ' GLN . 29.8 mtpp -59.81 -31.51 69.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.03 0.443 . . . . 0.0 110.228 169.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.99 -40.47 62.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.566 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 83.9 mt -112.46 84.58 6.36 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 173.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.25 0.71 6.31 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.043 2.495 . . . . 0.0 114.393 -166.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 62' ' ' GLN . . . . . 0.435 ' HA ' ' HA ' ' E' ' 33' ' ' ALA . 18.9 pt20 -169.68 130.56 1.05 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.106 0.479 . . . . 0.0 111.085 -177.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 63' ' ' VAL . . . . . 0.425 HG11 ' HB1' ' E' ' 54' ' ' ALA . 95.8 t -118.84 116.64 51.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.328 175.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.45 122.31 39.21 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.049 176.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 65' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' E' ' 30' ' ' SER . 0.3 OUTLIER -138.72 168.55 19.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.436 -176.543 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 66' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 7.6 t0 -116.05 99.54 7.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.207 0.527 . . . . 0.0 110.201 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 67' ' ' LEU . . . . . 0.685 HD21 HD23 ' D' ' 88' ' ' LEU . 21.0 mt -113.45 137.36 51.65 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.918 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 68' ' ' ASN . . . . . 0.656 ' HB2' ' CD2' ' D' ' 90' ' ' TYR . 3.8 m-20 -137.98 118.16 13.56 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 176.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -117.38 151.42 37.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.36 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 15.1 t -113.06 152.97 28.89 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -177.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -69.69 -12.19 61.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.305 -176.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.06 -12.15 68.63 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.903 175.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -100.67 164.3 11.94 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -143.51 127.91 17.87 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 75' ' ' ILE . . . . . 0.615 HG22 ' HB2' ' E' ' 46' ' ' ALA . 10.9 pt -131.52 179.66 4.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.004 -170.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 76' ' ' MET . . . . . 0.483 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 11.9 mtm -136.09 135.51 39.39 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 171.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 77' ' ' PHE . . . . . 0.458 ' CD1' ' HB2' ' E' ' 44' ' ' LEU . 1.1 m-85 -112.55 128.25 56.3 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 78' ' ' TYR . . . . . 0.687 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 34.5 p90 -153.57 137.2 16.01 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.295 0.569 . . . . 0.0 112.133 -177.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 79' ' ' THR . . . . . 0.693 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 5.8 p -109.25 138.23 45.92 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.028 -177.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.77 162.42 13.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.16 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.8 -174.73 44.71 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.511 -1.035 . . . . 0.0 110.511 -175.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -115.51 102.8 10.13 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.119 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 83' ' ' ALA . . . . . 0.594 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -175.47 162.63 2.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.574 171.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 84' ' ' SER . . . . . 0.431 ' OG ' ' HD3' ' E' ' 15' ' ' PRO . 1.0 OUTLIER -115.89 125.94 53.28 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.666 179.727 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 85' ' ' VAL . . . . . 0.412 HG11 ' CG1' ' E' ' 56' ' ' VAL . 2.8 m -116.73 148.79 19.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -174.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 43.6 m -108.53 113.7 26.94 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.573 173.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 87' ' ' LEU . . . . . 0.578 HD13 HD23 ' E' ' 11' ' ' LEU . 5.2 mp -89.76 148.61 23.14 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 170.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 88' ' ' LEU . . . . . 0.682 HD23 HD21 ' A' ' 67' ' ' LEU . 0.9 OUTLIER -132.0 138.92 48.45 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.06 -178.875 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.64 -167.0 24.51 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.932 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 90' ' ' TYR . . . . . 0.66 ' CD2' ' HB2' ' A' ' 68' ' ' ASN . 13.2 p90 -150.75 128.82 11.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.851 0.834 . . . . 0.0 111.816 177.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 91' ' ' LEU . . . . . 0.533 HD23 ' HB3' ' E' ' 27' ' ' PHE . 8.3 mt . . . . . 0 C--N 1.321 -0.651 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.634 176.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.441 ' HB2' HD12 ' A' ' 91' ' ' LEU . 47.5 mtt . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 120.584 0.23 . . . . 0.0 111.309 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.456 ' CE1' HD21 ' B' ' 44' ' ' LEU . 56.3 t80 -76.19 151.97 36.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.1 0.476 . . . . 0.0 112.194 -176.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.485 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 89.5 t90 -143.76 147.37 34.08 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.639 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.439 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -151.42 156.47 26.69 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.236 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.564 HD23 HD13 ' A' ' 87' ' ' LEU . 61.2 tp -149.01 109.66 4.25 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.854 0.359 . . . . 0.0 111.394 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -86.03 121.17 28.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.423 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.678 ' SD ' ' HE2' ' A' ' 19' ' ' TYR . 72.4 mmm -101.74 137.37 40.13 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.905 0.383 . . . . 0.0 111.056 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.495 ' HE3' ' HA ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -101.27 146.43 32.17 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.835 175.714 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -49.9 113.39 0.97 Allowed 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 123.174 2.583 . . . . 0.0 113.047 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 61.04 52.06 4.22 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.906 176.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -125.54 138.4 53.96 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.785 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.677 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 51.8 mttp -109.66 126.87 54.12 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.816 0.341 . . . . 0.0 111.767 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.678 ' HE2' ' SD ' ' A' ' 13' ' ' MET . 2.4 m-85 -111.64 103.79 12.12 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 173.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.2 p -86.06 100.58 12.26 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 173.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -114.92 148.78 38.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.379 0.609 . . . . 0.0 112.241 -168.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.9 m -107.97 141.95 38.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.132 173.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 69.0 mt -102.2 138.38 26.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.149 0.5 . . . . 0.0 111.74 -173.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.434 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.1 mp -110.62 -43.4 5.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.196 176.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.509 ' HD2' HD13 ' A' ' 91' ' ' LEU . 15.1 pttm -113.94 120.6 41.24 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.078 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.5 p -58.25 132.15 52.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.66 -178.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.59 ' HB3' HD23 ' A' ' 91' ' ' LEU . 54.5 p90 -139.2 157.6 45.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.577 0.703 . . . . 0.0 112.362 -176.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.626 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 7.1 t60 -114.69 124.76 52.63 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.458 177.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 42.7 mt -89.95 134.93 27.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 171.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.626 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 28.3 p -122.14 -12.32 8.32 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -171.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.12 155.81 27.31 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 119.617 -1.278 . . . . 0.0 113.195 177.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.438 ' CG2' ' HG ' ' A' ' 87' ' ' LEU . 12.3 p -143.3 125.53 12.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 172.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.436 ' HA ' HG21 ' A' ' 56' ' ' VAL . . . -144.22 161.01 39.99 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 122.036 -0.415 . . . . 0.0 111.66 -174.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.641 ' HB3' HG12 ' A' ' 85' ' ' VAL . 3.3 pp -123.44 142.32 51.11 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.828 0.823 . . . . 0.0 111.574 177.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -104.11 -52.6 2.9 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.444 173.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -104.22 128.6 51.96 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.308 -0.626 . . . . 0.0 109.308 169.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.417 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 151.95 156.07 7.3 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 119.627 -1.273 . . . . 0.0 113.587 175.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.474 ' HA ' ' HB2' ' A' ' 58' ' ' LYS . 94.1 mt-30 -102.73 -44.25 5.35 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.699 0.285 . . . . 0.0 111.306 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.52 ' HG3' HG22 ' A' ' 57' ' ' THR . 34.8 tt0 -152.71 122.17 6.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.954 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.559 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -123.67 114.24 19.71 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.558 0.694 . . . . 0.0 110.212 170.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.439 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 31.8 mmtp -96.86 105.85 18.05 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 176.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.9 tp -83.29 112.23 19.69 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -175.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.651 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 92.8 m-85 -118.68 147.2 44.05 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 175.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 76' ' ' MET . 0.3 OUTLIER -131.07 131.08 43.99 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 170.651 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -107.51 112.53 25.33 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.267 178.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.641 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -124.55 138.16 54.35 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.461 178.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 58.81 34.15 23.52 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.236 0.541 . . . . 0.0 110.026 -176.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.3 tttm 56.55 46.58 20.23 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.821 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.591 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 8.6 tp-100 -137.84 127.78 25.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.469 176.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -87.18 121.37 29.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.954 0.407 . . . . 0.0 110.372 -176.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.437 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 81.5 m-85 -113.41 130.57 56.27 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.355 175.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.452 HG22 ' HB3' ' E' ' 86' ' ' SER . 4.4 tp -79.57 105.83 9.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.705 0.764 . . . . 0.0 109.048 173.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.541 HG13 HD23 ' E' ' 88' ' ' LEU . 2.5 t -80.46 -49.16 19.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.633 -172.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.514 ' HB2' HD23 ' A' ' 65' ' ' LEU . . . -156.0 148.23 23.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.924 0.393 . . . . 0.0 111.709 -177.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.7 m -110.59 100.75 9.49 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 170.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.49 HG13 ' HB3' ' A' ' 40' ' ' ALA . 7.7 p -118.46 112.66 39.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.62 0.724 . . . . 0.0 109.699 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.52 HG22 ' HG3' ' A' ' 39' ' ' GLU . 63.8 p -122.86 -178.71 4.02 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.173 -172.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.474 ' HB2' ' HA ' ' A' ' 38' ' ' GLN . 56.0 tttt -59.52 -28.99 67.57 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.896 172.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.471 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -83.15 -40.41 19.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.622 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.0 mt -111.07 83.15 3.56 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 13.1 Cg_exo -69.82 0.18 6.06 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.084 2.523 . . . . 0.0 113.879 -168.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -163.2 131.34 3.75 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.335 0.588 . . . . 0.0 111.535 -176.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.403 HG23 ' HB ' ' A' ' 56' ' ' VAL . 96.1 t -118.87 112.66 38.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.382 173.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.95 116.12 27.76 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 174.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.514 HD23 ' HB2' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -137.19 169.6 17.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.055 0.455 . . . . 0.0 111.395 -175.263 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.524 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 9.6 t0 -118.66 119.01 33.18 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.114 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.592 HD21 HD23 ' E' ' 88' ' ' LEU . 8.0 mt -134.16 145.2 49.03 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 175.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -145.35 122.96 11.78 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 173.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -120.94 150.86 40.44 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.041 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.5 t -108.97 177.55 4.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.633 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.04 -19.27 65.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.192 0.52 . . . . 0.0 110.583 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.41 -9.81 81.03 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.272 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -92.72 120.02 32.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.132 0.491 . . . . 0.0 110.568 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -108.13 111.67 23.81 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 176.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.641 HG22 ' HB2' ' A' ' 46' ' ' ALA . 7.6 pt -128.71 156.08 40.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 120.949 0.404 . . . . 0.0 111.853 -168.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.511 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 4.5 mtm -115.61 119.39 35.97 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 173.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.475 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 1.1 m-85 -99.92 128.4 46.01 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.677 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 31.3 p90 -152.42 140.18 19.94 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.413 0.625 . . . . 0.0 112.194 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 2.3 p -113.16 125.77 54.71 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.854 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.439 ' HB3' ' HB2' ' A' ' 41' ' ' LYS . . . -96.53 164.82 12.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.607 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.16 -165.24 31.44 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -121.98 102.98 8.5 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.059 175.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.559 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -173.01 153.04 2.46 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.47 173.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.5 t -112.16 111.71 22.8 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.641 HG12 ' HB3' ' A' ' 34' ' ' LEU . 4.6 m -109.8 165.53 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.655 0 CA-C-O 121.408 0.623 . . . . 0.0 111.91 -174.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.48 ' HB3' HG22 ' B' ' 52' ' ' ILE . 23.8 t -131.61 123.16 27.31 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.914 176.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.565 HD23 HG21 ' A' ' 29' ' ' ILE . 4.9 mp -91.32 151.94 20.66 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 172.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.59 HD23 HD21 ' B' ' 67' ' ' LEU . 1.4 tp -134.77 142.49 46.73 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.746 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.0 -166.79 26.69 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.695 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -143.5 135.25 26.45 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.214 0.53 . . . . 0.0 110.931 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.59 HD23 ' HB3' ' A' ' 27' ' ' PHE . 64.5 mt . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.898 172.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 7' ' ' MET . . . . . 0.44 ' HB2' HD12 ' B' ' 91' ' ' LEU . 47.4 mtt . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 120.5 0.19 . . . . 0.0 111.327 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 8' ' ' PHE . . . . . 0.443 ' CE1' HD21 ' C' ' 44' ' ' LEU . 56.4 t80 -76.11 151.96 36.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.042 0.449 . . . . 0.0 112.194 -176.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' TRP . . . . . 0.482 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 89.7 t90 -143.86 147.44 34.05 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.583 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.43 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -151.5 156.44 26.68 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.19 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.553 HD23 HD13 ' B' ' 87' ' ' LEU . 61.3 tp -148.95 109.64 4.25 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 120.878 0.37 . . . . 0.0 111.422 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -85.98 121.12 28.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.461 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' MET . . . . . 0.669 ' SD ' ' HE2' ' B' ' 19' ' ' TYR . 72.5 mmm -101.75 137.33 40.19 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 120.931 0.396 . . . . 0.0 111.089 -178.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.506 ' HE3' ' HA ' ' B' ' 14' ' ' LYS . 0.0 OUTLIER -101.25 146.44 32.17 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.814 175.713 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -49.87 113.4 0.97 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.961 2.441 . . . . 0.0 113.098 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 61.16 52.01 4.14 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.912 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -125.61 138.32 53.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.736 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.692 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 51.8 mttp -109.74 126.86 54.18 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 120.874 0.369 . . . . 0.0 111.72 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' TYR . . . . . 0.669 ' HE2' ' SD ' ' B' ' 13' ' ' MET . 2.4 m-85 -111.64 103.89 12.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.739 173.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 9.2 p -86.11 100.51 12.25 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 173.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -114.82 148.8 38.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.35 0.595 . . . . 0.0 112.224 -168.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 38.3 m -107.96 141.95 38.82 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.192 173.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 69.4 mt -102.25 138.34 26.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.156 0.503 . . . . 0.0 111.743 -173.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.449 ' N ' HD12 ' B' ' 24' ' ' ILE . 4.1 mp -110.56 -43.34 5.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.312 176.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.515 ' HD2' HD13 ' B' ' 91' ' ' LEU . 15.2 pttm -113.89 120.54 41.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.149 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 14.9 p -58.26 132.09 52.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.715 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' PHE . . . . . 0.596 ' HB3' HD23 ' B' ' 91' ' ' LEU . 54.3 p90 -139.14 157.59 45.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.625 0.726 . . . . 0.0 112.365 -176.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' HIS . . . . . 0.621 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 7.1 t60 -114.7 124.78 52.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.455 177.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.584 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 42.6 mt -89.93 134.97 27.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 171.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.621 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 29.0 p -122.06 -12.3 8.36 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -171.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.12 155.84 27.36 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 119.579 -1.296 . . . . 0.0 113.157 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.442 HG23 ' HG ' ' B' ' 87' ' ' LEU . 12.3 p -143.31 125.39 12.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 172.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' ALA . . . . . 0.423 ' HA ' HG21 ' B' ' 56' ' ' VAL . . . -144.14 161.06 39.81 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.08 -0.388 . . . . 0.0 111.651 -174.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.638 ' HB3' HG12 ' B' ' 85' ' ' VAL . 3.3 pp -123.41 142.27 51.14 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.749 0.785 . . . . 0.0 111.585 177.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -103.99 -52.6 2.92 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.563 -1.199 . . . . 0.0 108.645 173.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -104.2 128.55 51.93 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 169.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.412 ' HA3' ' HB1' ' B' ' 83' ' ' ALA . . . 152.01 156.13 7.33 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 119.605 -1.284 . . . . 0.0 113.571 175.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' GLN . . . . . 0.463 ' HA ' ' HB2' ' B' ' 58' ' ' LYS . 94.0 mt-30 -102.82 -44.25 5.33 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.661 0.267 . . . . 0.0 111.273 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.54 ' HG3' HG22 ' B' ' 57' ' ' THR . 34.9 tt0 -152.73 122.13 6.75 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 121.229 -0.188 . . . . 0.0 110.974 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.569 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -123.62 114.23 19.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.51 0.672 . . . . 0.0 110.223 170.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.447 ' HB2' ' HB3' ' B' ' 80' ' ' ALA . 31.8 mmtp -96.89 105.9 18.12 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 44.6 tp -83.31 112.17 19.66 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -175.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' TYR . . . . . 0.647 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 92.5 m-85 -118.62 147.12 44.08 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 175.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.521 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.3 OUTLIER -131.08 131.07 43.96 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 170.597 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.597 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -107.44 112.5 25.32 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.337 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.629 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -124.48 138.19 54.36 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.449 178.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 58.85 34.07 23.45 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 123.552 0.533 . . . . 0.0 110.012 -176.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 57.3 tttm 56.64 46.63 19.94 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.787 -177.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.597 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 8.6 tp-100 -137.99 127.74 25.29 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -87.13 121.4 29.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.066 0.46 . . . . 0.0 110.364 -176.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.439 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 81.7 m-85 -113.52 130.6 56.31 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.365 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 52' ' ' ILE . . . . . 0.48 HG22 ' HB3' ' A' ' 86' ' ' SER . 4.5 tp -79.59 105.74 9.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.626 0.727 . . . . 0.0 109.07 173.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.555 HG13 HD23 ' A' ' 88' ' ' LEU . 2.5 t -80.4 -49.21 19.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.625 -172.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.513 ' HB2' ' CD2' ' B' ' 65' ' ' LEU . . . -155.98 148.28 23.57 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.012 0.434 . . . . 0.0 111.701 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 68.6 m -110.48 100.72 9.5 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 170.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' VAL . . . . . 0.481 HG13 ' HB3' ' B' ' 40' ' ' ALA . 7.7 p -118.42 112.72 39.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.718 0.77 . . . . 0.0 109.649 -177.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.54 HG22 ' HG3' ' B' ' 39' ' ' GLU . 60.9 p -122.9 -178.72 4.02 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.234 -172.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 58' ' ' LYS . . . . . 0.463 ' HB2' ' HA ' ' B' ' 38' ' ' GLN . 55.5 tttt -59.36 -29.04 67.4 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.944 171.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.464 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -83.21 -40.35 19.76 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.662 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 79.9 mt -111.13 83.11 3.61 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 61' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 13.0 Cg_exo -69.92 0.32 5.94 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.059 2.506 . . . . 0.0 113.789 -168.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -163.2 131.36 3.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.314 0.578 . . . . 0.0 111.554 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 96.3 t -118.91 112.72 39.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.336 173.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.98 116.17 27.83 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 174.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.513 ' CD2' ' HB2' ' B' ' 54' ' ' ALA . 0.3 OUTLIER -137.2 169.5 17.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.449 -175.295 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 66' ' ' ASP . . . . . 0.558 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 9.6 t0 -118.54 118.98 33.17 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.172 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.59 HD21 HD23 ' A' ' 88' ' ' LEU . 8.0 mt -134.19 145.25 49.04 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -145.38 123.0 11.79 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 173.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -120.93 150.86 40.44 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.062 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 14.4 t -108.93 177.43 4.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.774 -0.193 . . . . 0.0 110.637 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.9 -19.35 65.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.178 0.513 . . . . 0.0 110.674 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.31 -9.87 81.11 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.309 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -92.75 120.02 32.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.203 0.525 . . . . 0.0 110.588 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -108.13 111.58 23.67 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 176.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.629 HG22 ' HB2' ' B' ' 46' ' ' ALA . 7.6 pt -128.75 156.07 41.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.913 -168.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.521 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 4.5 mtm -115.44 119.44 36.24 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 173.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 77' ' ' PHE . . . . . 0.475 ' CD1' ' HB2' ' B' ' 44' ' ' LEU . 1.1 m-85 -99.91 128.42 46.01 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.692 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 31.2 p90 -152.49 140.15 19.84 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.415 0.626 . . . . 0.0 112.172 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' B' ' 41' ' ' LYS . 2.3 p -113.08 125.86 54.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.794 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 80' ' ' ALA . . . . . 0.447 ' HB3' ' HB2' ' B' ' 41' ' ' LYS . . . -96.66 164.86 12.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.672 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.15 -165.15 31.4 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -121.96 102.96 8.49 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.073 175.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.569 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -173.09 153.0 2.42 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.44 -1.255 . . . . 0.0 109.431 173.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 38.8 t -112.23 111.71 22.79 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.638 HG12 ' HB3' ' B' ' 34' ' ' LEU . 4.6 m -109.75 165.55 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.665 0 CA-C-O 121.411 0.624 . . . . 0.0 111.889 -174.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 86' ' ' SER . . . . . 0.47 ' HB3' HG22 ' C' ' 52' ' ' ILE . 24.3 t -131.6 123.21 27.42 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.846 176.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.556 HD23 HG21 ' B' ' 29' ' ' ILE . 4.9 mp -91.45 151.91 20.59 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 172.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.605 HD23 HD21 ' C' ' 67' ' ' LEU . 1.4 tp -134.75 142.44 46.75 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.77 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.96 -166.84 26.72 Favored Glycine 0 N--CA 1.438 -1.201 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.71 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -143.55 135.27 26.39 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.28 0.562 . . . . 0.0 110.907 177.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 91' ' ' LEU . . . . . 0.596 HD23 ' HB3' ' B' ' 27' ' ' PHE . 64.6 mt . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.843 173.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 7' ' ' MET . . . . . 0.423 ' HB2' HD12 ' C' ' 91' ' ' LEU . 47.5 mtt . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 120.542 0.211 . . . . 0.0 111.369 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 8' ' ' PHE . . . . . 0.449 ' CE1' HD21 ' D' ' 44' ' ' LEU . 56.6 t80 -76.07 151.9 36.98 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -176.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 9' ' ' TRP . . . . . 0.477 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 89.8 t90 -143.81 147.52 34.24 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.514 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 10' ' ' GLY . . . . . 0.439 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -151.43 156.49 26.71 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.121 -0.562 . . . . 0.0 112.254 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.563 HD23 HD13 ' C' ' 87' ' ' LEU . 61.5 tp -149.0 109.57 4.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.894 0.378 . . . . 0.0 111.48 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -85.89 121.04 27.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.519 176.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 13' ' ' MET . . . . . 0.666 ' SD ' ' HE2' ' C' ' 19' ' ' TYR . 72.2 mmm -101.68 137.27 40.2 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 120.817 0.341 . . . . 0.0 111.126 -178.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 14' ' ' LYS . . . . . 0.481 ' HE3' ' HA ' ' C' ' 14' ' ' LYS . 0.0 OUTLIER -101.22 146.48 32.24 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.846 175.666 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -49.93 113.39 0.97 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.093 2.529 . . . . 0.0 113.043 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 60.99 52.05 4.26 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.961 176.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -125.49 138.42 53.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.8 175.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 18' ' ' LYS . . . . . 0.697 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 51.8 mttp -109.65 126.89 54.13 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.697 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 19' ' ' TYR . . . . . 0.666 ' HE2' ' SD ' ' C' ' 13' ' ' MET . 2.4 m-85 -111.68 103.75 12.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.818 172.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 20' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 9.3 p -86.01 100.57 12.24 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 173.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -114.93 148.67 38.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.431 0.634 . . . . 0.0 112.203 -168.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 39.0 m -107.84 142.03 38.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.165 173.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 69.2 mt -102.29 138.36 26.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.169 0.509 . . . . 0.0 111.75 -173.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 24' ' ' ILE . . . . . 0.44 ' N ' HD12 ' C' ' 24' ' ' ILE . 4.1 mp -110.55 -43.4 5.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.266 176.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 25' ' ' LYS . . . . . 0.506 ' HD2' HD13 ' C' ' 91' ' ' LEU . 15.1 pttm -113.91 120.61 41.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.163 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 14.5 p -58.26 132.11 52.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.659 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 27' ' ' PHE . . . . . 0.603 ' HB3' HD23 ' C' ' 91' ' ' LEU . 54.2 p90 -139.12 157.56 45.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.597 0.713 . . . . 0.0 112.389 -176.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 28' ' ' HIS . . . . . 0.631 ' HE2' ' HB3' ' C' ' 30' ' ' SER . 7.1 t60 -114.68 124.76 52.63 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.475 177.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 29' ' ' ILE . . . . . 0.598 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 42.4 mt -89.93 134.96 27.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 171.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.631 ' HB3' ' HE2' ' C' ' 28' ' ' HIS . 29.1 p -122.1 -12.27 8.34 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -171.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.12 155.8 27.29 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 119.67 -1.252 . . . . 0.0 113.192 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.438 HG23 ' HG ' ' C' ' 87' ' ' LEU . 12.3 p -143.28 125.5 12.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 172.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.422 ' HA ' HG21 ' C' ' 56' ' ' VAL . . . -144.2 160.95 40.08 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.111 -0.368 . . . . 0.0 111.647 -174.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.658 ' HB3' HG12 ' C' ' 85' ' ' VAL . 3.4 pp -123.4 142.22 51.2 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.8 0.809 . . . . 0.0 111.619 177.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -104.02 -52.59 2.91 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.529 173.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -104.19 128.63 51.92 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 169.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 37' ' ' GLY . . . . . 0.416 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 151.95 156.02 7.28 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 119.619 -1.277 . . . . 0.0 113.653 175.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 38' ' ' GLN . . . . . 0.467 ' HA ' ' HB2' ' C' ' 58' ' ' LYS . 94.1 mt-30 -102.76 -44.31 5.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.648 0.261 . . . . 0.0 111.232 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 39' ' ' GLU . . . . . 0.525 ' HG3' HG22 ' C' ' 57' ' ' THR . 34.8 tt0 -152.67 122.09 6.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.766 -0.197 . . . . 0.0 110.98 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.586 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -123.57 114.26 19.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.605 0.716 . . . . 0.0 110.27 170.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.448 ' HB2' ' HB3' ' C' ' 80' ' ' ALA . 31.8 mmtp -96.87 105.8 18.0 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 44.9 tp -83.25 112.21 19.66 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -175.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 43' ' ' TYR . . . . . 0.653 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 92.8 m-85 -118.62 147.27 43.93 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.515 ' HA ' ' O ' ' C' ' 76' ' ' MET . 0.3 OUTLIER -131.08 131.13 44.0 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 170.648 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 45' ' ' ALA . . . . . 0.601 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -107.57 112.49 25.26 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.275 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.635 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -124.49 138.08 54.37 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.487 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 58.95 34.08 23.41 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.238 0.542 . . . . 0.0 109.99 -176.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 57.5 tttm 56.65 46.58 20.0 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.707 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 49' ' ' GLN . . . . . 0.601 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 8.6 tp-100 -137.92 127.77 25.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.465 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -87.2 121.39 29.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.077 0.465 . . . . 0.0 110.338 -176.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 51' ' ' TYR . . . . . 0.43 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 81.3 m-85 -113.49 130.56 56.31 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.411 175.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 52' ' ' ILE . . . . . 0.47 HG22 ' HB3' ' B' ' 86' ' ' SER . 4.5 tp -79.46 105.8 9.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.664 0.745 . . . . 0.0 109.019 173.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 53' ' ' VAL . . . . . 0.556 HG13 HD23 ' B' ' 88' ' ' LEU . 2.5 t -80.56 -49.07 19.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.65 -172.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 54' ' ' ALA . . . . . 0.513 ' HB2' HD23 ' C' ' 65' ' ' LEU . . . -155.99 148.22 23.5 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.812 -177.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 71.1 m -110.56 100.8 9.55 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 170.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 56' ' ' VAL . . . . . 0.487 HG13 ' HB3' ' C' ' 40' ' ' ALA . 7.7 p -118.49 112.74 39.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.658 0.742 . . . . 0.0 109.61 -177.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 57' ' ' THR . . . . . 0.525 HG22 ' HG3' ' C' ' 39' ' ' GLU . 64.4 p -122.87 -178.67 4.01 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.272 -172.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 58' ' ' LYS . . . . . 0.467 ' HB2' ' HA ' ' C' ' 38' ' ' GLN . 55.7 tttt -59.54 -28.97 67.57 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.855 172.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 59' ' ' ALA . . . . . 0.472 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -83.2 -40.39 19.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.648 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 80.1 mt -111.16 83.15 3.68 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 61' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 13.0 Cg_exo -69.84 0.18 6.08 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.074 2.516 . . . . 0.0 113.825 -168.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -163.13 131.34 3.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.297 0.57 . . . . 0.0 111.569 -176.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 96.0 t -118.91 112.67 38.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.392 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.91 116.14 27.75 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 174.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 65' ' ' LEU . . . . . 0.513 HD23 ' HB2' ' C' ' 54' ' ' ALA . 0.3 OUTLIER -137.24 169.5 17.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.95 0.405 . . . . 0.0 111.445 -175.26 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 66' ' ' ASP . . . . . 0.544 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 9.6 t0 -118.59 119.08 33.44 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.106 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.605 HD21 HD23 ' B' ' 88' ' ' LEU . 7.9 mt -134.18 145.26 49.05 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 175.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -145.43 123.03 11.78 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.721 -0.392 . . . . 0.0 109.947 173.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -120.91 150.89 40.38 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.965 -178.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 14.2 t -109.03 177.41 4.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.622 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.92 -19.29 65.7 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.258 0.552 . . . . 0.0 110.612 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.34 -9.9 81.01 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.261 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -92.63 119.93 32.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.059 0.457 . . . . 0.0 110.64 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -107.98 111.59 23.75 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.635 HG22 ' HB2' ' C' ' 46' ' ' ALA . 7.6 pt -128.73 156.1 41.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 120.962 0.41 . . . . 0.0 111.842 -168.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.515 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 4.5 mtm -115.48 119.42 36.13 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 173.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 77' ' ' PHE . . . . . 0.478 ' CD1' ' HB2' ' C' ' 44' ' ' LEU . 1.1 m-85 -99.9 128.37 45.99 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 78' ' ' TYR . . . . . 0.697 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 31.3 p90 -152.42 140.15 19.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.457 0.646 . . . . 0.0 112.252 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 79' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' C' ' 41' ' ' LYS . 2.3 p -113.04 125.79 54.78 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.837 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 80' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' C' ' 41' ' ' LYS . . . -96.69 164.93 12.37 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.628 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.05 -165.21 31.57 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 -177.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -121.9 103.06 8.57 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 119.864 -0.735 . . . . 0.0 110.073 175.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 83' ' ' ALA . . . . . 0.586 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -173.13 153.02 2.4 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.501 173.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 38.6 t -112.27 111.7 22.76 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.658 HG12 ' HB3' ' C' ' 34' ' ' LEU . 4.6 m -109.78 165.54 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 CA-C-O 121.308 0.575 . . . . 0.0 111.89 -174.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 86' ' ' SER . . . . . 0.466 ' HB3' HG22 ' D' ' 52' ' ' ILE . 23.9 t -131.58 123.09 27.2 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.953 176.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 87' ' ' LEU . . . . . 0.565 HD23 HG21 ' C' ' 29' ' ' ILE . 4.9 mp -91.31 151.94 20.67 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 172.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 88' ' ' LEU . . . . . 0.584 HD23 HD21 ' D' ' 67' ' ' LEU . 1.4 tp -134.7 142.46 46.81 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.843 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.94 -166.85 26.71 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.804 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -143.56 135.17 26.28 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.256 0.55 . . . . 0.0 110.928 177.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 91' ' ' LEU . . . . . 0.603 HD23 ' HB3' ' C' ' 27' ' ' PHE . 64.7 mt . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.83 173.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 7' ' ' MET . . . . . 0.445 ' HB2' HD12 ' D' ' 91' ' ' LEU . 47.5 mtt . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 120.551 0.215 . . . . 0.0 111.376 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 8' ' ' PHE . . . . . 0.438 ' CE1' HD21 ' E' ' 44' ' ' LEU . 56.7 t80 -76.1 151.92 36.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.113 0.482 . . . . 0.0 112.261 -176.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 9' ' ' TRP . . . . . 0.482 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 89.6 t90 -143.77 147.38 34.08 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.66 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 10' ' ' GLY . . . . . 0.449 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -151.38 156.53 26.73 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.216 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 11' ' ' LEU . . . . . 0.566 HD23 HD13 ' D' ' 87' ' ' LEU . 61.3 tp -149.04 109.59 4.22 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.902 0.382 . . . . 0.0 111.403 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -85.96 121.1 28.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.387 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 13' ' ' MET . . . . . 0.672 ' SD ' ' HE2' ' D' ' 19' ' ' TYR . 72.3 mmm -101.76 137.3 40.24 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.884 0.373 . . . . 0.0 111.132 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 14' ' ' LYS . . . . . 0.486 ' HE3' ' HA ' ' D' ' 14' ' ' LYS . 0.0 OUTLIER -101.1 146.46 32.19 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.898 175.663 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -49.92 113.39 0.97 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.035 2.49 . . . . 0.0 113.066 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 61.11 51.98 4.2 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.928 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -125.5 138.35 53.98 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.737 175.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 18' ' ' LYS . . . . . 0.699 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 51.9 mttp -109.67 126.92 54.19 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 120.799 0.333 . . . . 0.0 111.732 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 19' ' ' TYR . . . . . 0.672 ' HE2' ' SD ' ' D' ' 13' ' ' MET . 2.4 m-85 -111.74 103.7 12.0 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 173.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 20' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 9.3 p -86.0 100.62 12.27 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 173.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -114.88 148.73 38.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.283 -168.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 38.7 m -107.83 142.01 38.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.181 173.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 69.2 mt -102.32 138.37 26.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.226 0.536 . . . . 0.0 111.713 -173.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 24' ' ' ILE . . . . . 0.437 HD12 ' N ' ' D' ' 24' ' ' ILE . 4.1 mp -110.63 -43.26 5.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.269 176.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 25' ' ' LYS . . . . . 0.508 ' HD2' HD13 ' D' ' 91' ' ' LEU . 15.2 pttm -113.95 120.5 40.86 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.146 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 14.6 p -58.19 132.18 52.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.653 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 27' ' ' PHE . . . . . 0.61 ' HB3' HD23 ' D' ' 91' ' ' LEU . 54.4 p90 -139.24 157.55 45.72 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.632 0.73 . . . . 0.0 112.357 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 28' ' ' HIS . . . . . 0.637 ' HE2' ' HB3' ' D' ' 30' ' ' SER . 7.0 t60 -114.67 124.67 52.42 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.505 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 29' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 42.4 mt -89.85 134.98 27.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 171.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 30' ' ' SER . . . . . 0.637 ' HB3' ' HE2' ' D' ' 28' ' ' HIS . 28.7 p -122.13 -12.31 8.33 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -171.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.05 155.91 27.48 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.712 -1.232 . . . . 0.0 113.239 177.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.443 HG23 ' HG ' ' D' ' 87' ' ' LEU . 12.4 p -143.41 125.46 11.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 172.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 33' ' ' ALA . . . . . 0.426 ' HA ' HG21 ' D' ' 56' ' ' VAL . . . -144.11 161.06 39.8 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 122.023 -0.423 . . . . 0.0 111.682 -174.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 34' ' ' LEU . . . . . 0.636 ' HB3' HG12 ' D' ' 85' ' ' VAL . 3.3 pp -123.49 142.16 51.28 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.748 0.785 . . . . 0.0 111.621 177.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -104.04 -52.48 2.94 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.515 -1.221 . . . . 0.0 108.54 173.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -104.27 128.6 52.06 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 169.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 37' ' ' GLY . . . . . 0.414 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 152.0 155.99 7.27 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 119.584 -1.293 . . . . 0.0 113.632 175.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 38' ' ' GLN . . . . . 0.48 ' HA ' ' HB2' ' D' ' 58' ' ' LYS . 94.1 mt-30 -102.7 -44.28 5.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.621 0.248 . . . . 0.0 111.29 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 39' ' ' GLU . . . . . 0.535 ' HG3' HG22 ' D' ' 57' ' ' THR . 35.0 tt0 -152.74 122.08 6.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.025 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 40' ' ' ALA . . . . . 0.573 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -123.59 114.26 19.78 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.601 0.715 . . . . 0.0 110.203 170.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.442 ' HB2' ' HB3' ' D' ' 80' ' ' ALA . 31.8 mmtp -96.78 105.81 18.0 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 44.7 tp -83.25 112.19 19.64 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 43' ' ' TYR . . . . . 0.639 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 92.6 m-85 -118.66 147.17 44.07 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' D' ' 76' ' ' MET . 0.3 OUTLIER -131.06 131.07 44.0 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 170.572 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 45' ' ' ALA . . . . . 0.593 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -107.46 112.58 25.44 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.3 178.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.632 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -124.54 138.18 54.35 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.432 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 58.83 34.15 23.51 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.562 0.539 . . . . 0.0 109.975 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 57.3 tttm 56.64 46.42 20.31 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.807 -177.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 49' ' ' GLN . . . . . 0.593 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 8.6 tp-100 -137.85 127.79 25.62 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 176.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -87.19 121.39 29.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.062 0.458 . . . . 0.0 110.369 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 51' ' ' TYR . . . . . 0.439 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 81.7 m-85 -113.48 130.54 56.31 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.4 175.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 52' ' ' ILE . . . . . 0.466 HG22 ' HB3' ' C' ' 86' ' ' SER . 4.5 tp -79.55 105.79 9.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.646 0.736 . . . . 0.0 109.086 173.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 53' ' ' VAL . . . . . 0.57 HG13 HD23 ' C' ' 88' ' ' LEU . 2.5 t -80.46 -49.21 18.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.536 -172.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 54' ' ' ALA . . . . . 0.517 ' HB2' HD23 ' D' ' 65' ' ' LEU . . . -155.95 148.22 23.56 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 120.95 0.405 . . . . 0.0 111.731 -177.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 72.8 m -110.54 100.61 9.39 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 170.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 56' ' ' VAL . . . . . 0.486 HG13 ' HB3' ' D' ' 40' ' ' ALA . 7.7 p -118.36 112.65 39.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.658 0.742 . . . . 0.0 109.63 -177.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 57' ' ' THR . . . . . 0.535 HG22 ' HG3' ' D' ' 39' ' ' GLU . 61.9 p -122.79 -178.68 4.0 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.304 -172.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 58' ' ' LYS . . . . . 0.48 ' HB2' ' HA ' ' D' ' 38' ' ' GLN . 56.0 tttt -59.58 -28.88 67.54 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.899 172.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 59' ' ' ALA . . . . . 0.473 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -83.25 -40.44 19.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.592 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 79.6 mt -111.06 82.98 3.44 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 174.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 61' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 13.1 Cg_exo -69.72 0.22 5.92 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.047 2.498 . . . . 0.0 113.887 -168.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -163.13 131.26 3.76 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.273 0.559 . . . . 0.0 111.614 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.408 HG23 ' HB ' ' D' ' 56' ' ' VAL . 96.4 t -118.85 112.65 38.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.377 173.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.92 116.2 27.81 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 174.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 65' ' ' LEU . . . . . 0.517 HD23 ' HB2' ' D' ' 54' ' ' ALA . 0.3 OUTLIER -137.38 169.42 17.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.007 0.432 . . . . 0.0 111.426 -175.242 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 66' ' ' ASP . . . . . 0.545 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 9.7 t0 -118.45 118.97 33.18 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.114 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.601 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 8.0 mt -134.14 145.3 49.15 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -145.37 123.0 11.8 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 173.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -120.96 150.93 40.34 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.008 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 14.2 t -109.05 177.44 4.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.748 -0.206 . . . . 0.0 110.592 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.92 -19.27 65.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.163 0.506 . . . . 0.0 110.659 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.33 -9.95 80.95 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.272 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -92.65 120.07 32.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.218 0.532 . . . . 0.0 110.584 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -108.12 111.55 23.63 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 176.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.632 HG22 ' HB2' ' D' ' 46' ' ' ALA . 7.6 pt -128.63 156.15 40.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 120.963 0.411 . . . . 0.0 111.812 -168.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 76' ' ' MET . . . . . 0.519 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 4.5 mtm -115.53 119.37 35.94 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 173.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 77' ' ' PHE . . . . . 0.466 ' CD1' ' HB2' ' D' ' 44' ' ' LEU . 1.1 m-85 -99.85 128.36 45.95 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 78' ' ' TYR . . . . . 0.699 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 31.4 p90 -152.42 140.2 19.95 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.452 0.644 . . . . 0.0 112.227 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 79' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' D' ' 41' ' ' LYS . 2.3 p -113.15 125.74 54.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.802 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 80' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' D' ' 41' ' ' LYS . . . -96.58 164.86 12.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.62 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.12 -165.15 31.43 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -177.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -121.98 103.0 8.51 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.047 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 83' ' ' ALA . . . . . 0.573 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -173.07 153.09 2.45 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.528 173.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 38.6 t -112.27 111.62 22.62 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.636 HG12 ' HB3' ' D' ' 34' ' ' LEU . 4.6 m -109.77 165.44 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.673 0 CA-C-O 121.459 0.647 . . . . 0.0 111.87 -174.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 86' ' ' SER . . . . . 0.478 ' HB3' HG22 ' E' ' 52' ' ' ILE . 24.0 t -131.55 123.12 27.3 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.896 176.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 87' ' ' LEU . . . . . 0.566 HD13 HD23 ' D' ' 11' ' ' LEU . 4.9 mp -91.37 151.97 20.62 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 172.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.588 HD23 HD21 ' E' ' 67' ' ' LEU . 1.4 tp -134.78 142.53 46.72 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.738 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.01 -166.82 26.75 Favored Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.743 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -143.47 135.21 26.47 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.151 0.5 . . . . 0.0 110.919 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 91' ' ' LEU . . . . . 0.61 HD23 ' HB3' ' D' ' 27' ' ' PHE . 64.9 mt . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.904 173.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 7' ' ' MET . . . . . 0.443 ' HB2' HD12 ' E' ' 91' ' ' LEU . 47.4 mtt . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 120.603 0.239 . . . . 0.0 111.333 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 8' ' ' PHE . . . . . 0.416 ' CE1' HD21 ' A' ' 44' ' ' LEU . 56.2 t80 -76.13 151.99 36.85 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -176.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 9' ' ' TRP . . . . . 0.473 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 89.7 t90 -143.85 147.43 34.06 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.631 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 10' ' ' GLY . . . . . 0.437 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -151.46 156.46 26.69 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.144 178.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 11' ' ' LEU . . . . . 0.566 HD23 HD13 ' E' ' 87' ' ' LEU . 61.2 tp -148.94 109.62 4.25 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.855 0.359 . . . . 0.0 111.445 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -85.98 121.13 28.17 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.435 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 13' ' ' MET . . . . . 0.679 ' SD ' ' HE2' ' E' ' 19' ' ' TYR . 72.3 mmm -101.74 137.29 40.25 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.0 111.069 -178.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 14' ' ' LYS . . . . . 0.497 ' HE3' ' HA ' ' E' ' 14' ' ' LYS . 0.0 OUTLIER -101.12 146.44 32.16 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.872 175.657 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -49.95 113.35 0.96 Allowed 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.995 2.463 . . . . 0.0 113.152 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 61.21 52.03 4.09 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.837 176.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -125.58 138.35 53.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.785 175.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 18' ' ' LYS . . . . . 0.707 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 51.8 mttp -109.66 126.85 54.1 Favored 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 123.264 0.352 . . . . 0.0 111.688 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 19' ' ' TYR . . . . . 0.679 ' HE2' ' SD ' ' E' ' 13' ' ' MET . 2.4 m-85 -111.71 103.79 12.1 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.772 172.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 9.2 p -86.01 100.6 12.25 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 173.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -114.91 148.73 38.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.396 0.617 . . . . 0.0 112.235 -168.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 37.5 m -107.83 142.06 38.47 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.17 173.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 69.4 mt -102.39 138.37 26.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.233 0.54 . . . . 0.0 111.709 -173.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 24' ' ' ILE . . . . . 0.437 HD12 ' N ' ' E' ' 24' ' ' ILE . 4.1 mp -110.62 -43.42 5.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.203 176.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 25' ' ' LYS . . . . . 0.505 ' HD2' HD13 ' E' ' 91' ' ' LEU . 15.1 pttm -113.86 120.62 41.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.177 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 14.4 p -58.31 132.23 53.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.65 -178.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 27' ' ' PHE . . . . . 0.601 ' HB3' HD23 ' E' ' 91' ' ' LEU . 54.2 p90 -139.22 157.49 45.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.603 0.716 . . . . 0.0 112.377 -176.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 28' ' ' HIS . . . . . 0.633 ' HE2' ' HB3' ' E' ' 30' ' ' SER . 7.2 t60 -114.6 124.72 52.56 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.552 177.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 29' ' ' ILE . . . . . 0.587 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 42.5 mt -89.91 134.91 27.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 171.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 30' ' ' SER . . . . . 0.633 ' HB3' ' HE2' ' E' ' 28' ' ' HIS . 29.1 p -122.02 -12.34 8.36 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -171.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.16 155.86 27.38 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 119.626 -1.273 . . . . 0.0 113.188 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.445 HG23 ' HG ' ' E' ' 87' ' ' LEU . 12.4 p -143.35 125.51 12.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 172.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 33' ' ' ALA . . . . . 0.429 ' HA ' HG21 ' E' ' 56' ' ' VAL . . . -144.21 161.06 39.85 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.62 -174.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 34' ' ' LEU . . . . . 0.66 ' HB3' HG12 ' E' ' 85' ' ' VAL . 3.3 pp -123.48 142.21 51.23 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.717 0.77 . . . . 0.0 111.629 177.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -103.98 -52.58 2.92 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.584 173.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -104.17 128.63 51.88 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 169.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 37' ' ' GLY . . . . . 0.416 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 151.96 156.05 7.3 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 119.568 -1.301 . . . . 0.0 113.644 175.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 38' ' ' GLN . . . . . 0.484 ' HA ' ' HB2' ' E' ' 58' ' ' LYS . 94.2 mt-30 -102.82 -44.22 5.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.692 0.282 . . . . 0.0 111.264 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 39' ' ' GLU . . . . . 0.527 ' HG3' HG22 ' E' ' 57' ' ' THR . 34.9 tt0 -152.73 122.05 6.72 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 121.161 -0.216 . . . . 0.0 110.96 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 40' ' ' ALA . . . . . 0.588 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -123.56 114.31 19.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.536 0.684 . . . . 0.0 110.13 170.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 41' ' ' LYS . . . . . 0.435 ' HB2' ' HB3' ' E' ' 80' ' ' ALA . 31.8 mmtp -96.94 105.89 18.11 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 176.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 44.6 tp -83.21 112.17 19.61 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 -175.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 43' ' ' TYR . . . . . 0.645 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 92.9 m-85 -118.65 147.18 44.05 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 175.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 44' ' ' LEU . . . . . 0.524 ' HA ' ' O ' ' E' ' 76' ' ' MET . 0.3 OUTLIER -131.08 131.04 43.95 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 170.628 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 45' ' ' ALA . . . . . 0.587 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -107.51 112.55 25.37 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.314 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 46' ' ' ALA . . . . . 0.635 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -124.56 138.18 54.35 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.476 178.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 58.82 34.16 23.52 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.168 0.509 . . . . 0.0 109.983 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 57.3 tttm 56.62 46.53 20.14 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.811 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 49' ' ' GLN . . . . . 0.587 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 8.5 tp-100 -137.89 127.74 25.48 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -87.13 121.39 29.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.056 0.455 . . . . 0.0 110.388 -176.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 51' ' ' TYR . . . . . 0.449 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 81.5 m-85 -113.51 130.5 56.33 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.375 175.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 52' ' ' ILE . . . . . 0.478 HG22 ' HB3' ' D' ' 86' ' ' SER . 4.5 tp -79.47 105.8 9.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.622 0.725 . . . . 0.0 109.09 173.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 53' ' ' VAL . . . . . 0.571 HG13 HD23 ' D' ' 88' ' ' LEU . 2.5 t -80.45 -49.21 19.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.638 -172.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 54' ' ' ALA . . . . . 0.514 ' HB2' ' CD2' ' E' ' 65' ' ' LEU . . . -155.92 148.27 23.64 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.748 -177.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 67.4 m -110.52 100.7 9.47 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 170.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 56' ' ' VAL . . . . . 0.476 HG13 ' HB3' ' E' ' 40' ' ' ALA . 7.7 p -118.45 112.6 38.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.624 0.726 . . . . 0.0 109.73 -177.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 57' ' ' THR . . . . . 0.527 HG22 ' HG3' ' E' ' 39' ' ' GLU . 64.0 p -122.82 -178.71 4.01 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.178 -172.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 58' ' ' LYS . . . . . 0.484 ' HB2' ' HA ' ' E' ' 38' ' ' GLN . 55.8 tttt -59.49 -28.92 67.46 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.826 172.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 59' ' ' ALA . . . . . 0.472 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -83.36 -40.25 19.65 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.678 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 79.9 mt -111.07 83.03 3.49 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 61' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 13.1 Cg_exo -69.85 0.28 5.94 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.028 2.485 . . . . 0.0 113.861 -168.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -163.16 131.4 3.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.3 0.571 . . . . 0.0 111.548 -176.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 63' ' ' VAL . . . . . 0.408 HG23 ' HB ' ' E' ' 56' ' ' VAL . 95.6 t -118.98 112.76 39.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.334 173.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.05 116.14 27.85 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 174.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 65' ' ' LEU . . . . . 0.514 ' CD2' ' HB2' ' E' ' 54' ' ' ALA . 0.3 OUTLIER -137.19 169.54 17.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.492 -175.277 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 66' ' ' ASP . . . . . 0.529 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 9.5 t0 -118.67 119.01 33.18 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.072 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 67' ' ' LEU . . . . . 0.588 HD21 HD23 ' D' ' 88' ' ' LEU . 8.0 mt -134.19 145.21 49.0 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 175.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -145.34 123.0 11.82 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 173.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -120.88 150.88 40.38 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.095 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 14.1 t -108.94 177.45 4.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.821 -0.172 . . . . 0.0 110.663 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.88 -19.31 65.71 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.255 0.55 . . . . 0.0 110.667 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.35 -9.93 80.94 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.256 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -92.61 120.0 32.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.166 0.508 . . . . 0.0 110.524 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -108.1 111.58 23.69 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 75' ' ' ILE . . . . . 0.635 HG22 ' HB2' ' E' ' 46' ' ' ALA . 7.6 pt -128.61 156.07 40.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 120.991 0.424 . . . . 0.0 111.878 -168.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 76' ' ' MET . . . . . 0.524 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 4.5 mtm -115.53 119.44 36.18 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 173.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 77' ' ' PHE . . . . . 0.478 ' CD1' ' HB2' ' E' ' 44' ' ' LEU . 1.1 m-85 -99.9 128.4 46.0 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 78' ' ' TYR . . . . . 0.707 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 31.3 p90 -152.42 140.3 20.05 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.43 0.633 . . . . 0.0 112.156 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 79' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' E' ' 41' ' ' LYS . 2.3 p -113.22 125.77 54.68 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.762 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 80' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' E' ' 41' ' ' LYS . . . -96.58 164.87 12.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.697 178.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.08 -165.18 31.51 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -177.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -121.98 103.0 8.52 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.069 175.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 83' ' ' ALA . . . . . 0.588 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -173.07 153.08 2.45 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.504 173.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 39.2 t -112.27 111.58 22.55 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 85' ' ' VAL . . . . . 0.66 HG12 ' HB3' ' E' ' 34' ' ' LEU . 4.5 m -109.76 165.56 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-O 121.378 0.609 . . . . 0.0 111.842 -174.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 86' ' ' SER . . . . . 0.452 ' HB3' HG22 ' A' ' 52' ' ' ILE . 24.2 t -131.65 123.13 27.18 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.882 176.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 87' ' ' LEU . . . . . 0.566 HD13 HD23 ' E' ' 11' ' ' LEU . 4.9 mp -91.34 151.95 20.65 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 172.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 88' ' ' LEU . . . . . 0.592 HD23 HD21 ' A' ' 67' ' ' LEU . 1.4 tp -134.76 142.46 46.73 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.789 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.91 -166.8 26.6 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.756 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 90' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -143.56 135.3 26.41 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.2 0.524 . . . . 0.0 110.936 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 91' ' ' LEU . . . . . 0.601 HD23 ' HB3' ' E' ' 27' ' ' PHE . 64.7 mt . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.885 173.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 46.9 mtt . . . . . 0 C--O 1.219 -0.522 0 CA-C-O 120.272 0.082 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -82.18 147.45 29.0 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.491 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 91.2 t90 -139.29 150.1 45.03 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.395 177.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.421 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -154.26 152.21 23.82 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.43 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.61 HD23 HD13 ' A' ' 87' ' ' LEU . 41.0 tp -143.19 108.33 4.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.741 0.305 . . . . 0.0 110.385 177.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -86.11 99.38 11.46 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.416 0.627 . . . . 0.0 109.99 175.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.605 ' HB3' HG23 ' A' ' 85' ' ' VAL . 23.8 tpp -88.02 135.12 33.56 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.881 -175.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -98.83 145.15 29.45 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.119 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HB3' ' N ' ' A' ' 83' ' ' ALA . 10.3 Cg_endo -52.92 120.18 7.24 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 123.585 2.857 . . . . 0.0 113.276 -175.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.682 ' HA ' ' O ' ' A' ' 79' ' ' THR . 29.0 mt-10 58.26 63.07 1.83 Allowed 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 121.575 0.703 . . . . 0.0 111.596 177.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.59 148.95 46.28 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.592 174.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.656 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 35.0 ttmt -122.6 117.15 25.16 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 123.525 0.516 . . . . 0.0 111.314 -175.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -110.98 104.36 12.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.974 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 76' ' ' MET . 10.0 p -88.25 99.95 12.62 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 173.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -121.4 149.9 42.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.501 0.667 . . . . 0.0 112.347 -169.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.2 t -99.21 160.8 14.01 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.405 176.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 53.2 mt -118.99 125.79 74.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.1 0.476 . . . . 0.0 111.531 -173.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.462 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.2 mp -107.02 -33.56 2.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.336 177.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -118.94 122.18 41.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.572 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.404 ' OG ' ' HA ' ' A' ' 70' ' ' SER . 20.5 t -60.82 133.06 55.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.879 -177.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.511 ' HB3' HD23 ' A' ' 91' ' ' LEU . 53.9 p90 -137.42 143.13 41.71 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.939 0.876 . . . . 0.0 111.881 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.642 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 3.5 t60 -102.4 129.87 49.0 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.827 174.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.6 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 48.9 mt -97.53 130.28 46.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.642 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 46.6 p -114.0 -18.02 11.83 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.565 -171.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -162.2 149.03 16.87 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 119.611 -1.281 . . . . 0.0 113.031 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.476 HG23 ' HG ' ' A' ' 87' ' ' LEU . 8.2 p -135.19 121.99 34.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 172.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.53 150.22 41.87 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.97 -171.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.536 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.3 pp -114.96 137.52 51.9 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 121.802 0.811 . . . . 0.0 111.167 178.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -107.01 -55.44 2.33 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.615 175.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -101.9 127.06 48.9 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.388 -0.823 . . . . 0.0 108.884 170.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.451 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 148.31 163.48 10.81 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.043 -1.075 . . . . 0.0 113.045 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -102.65 -47.19 4.51 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 121.099 -0.241 . . . . 0.0 111.404 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -151.92 136.39 16.86 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.632 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.446 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -133.49 113.59 12.65 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.478 0.656 . . . . 0.0 110.455 168.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 79' ' ' THR . 65.8 mttp -97.48 109.51 22.25 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.1 tp -85.75 114.78 22.97 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.993 -173.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.554 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 66.0 m-85 -116.41 145.75 43.02 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.509 ' HB2' ' CD1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -131.32 130.37 42.64 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 172.278 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -108.61 114.2 27.83 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.073 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.67 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -125.45 124.21 40.92 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.824 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.519 ' C ' ' HD2' ' A' ' 48' ' ' LYS . 4.2 mm-40 56.62 51.9 10.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.356 0.598 . . . . 0.0 111.066 -175.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.519 ' HD2' ' C ' ' A' ' 47' ' ' GLU . 6.7 mptt 59.0 39.58 23.35 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.459 174.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.591 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 24.0 tp60 -138.56 115.89 11.15 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -82.45 111.74 18.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.931 0.396 . . . . 0.0 110.714 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.438 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 80.3 m-85 -101.82 128.92 47.97 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.362 176.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -75.75 102.61 2.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 168.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.474 ' CG1' HD11 ' A' ' 67' ' ' LEU . 2.8 t -76.24 -51.52 19.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.579 -172.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.454 ' HB2' ' CD2' ' A' ' 65' ' ' LEU . . . -156.61 142.07 17.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.24 -177.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.8 m -105.1 101.35 10.91 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 172.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.71 112.55 40.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.783 0.802 . . . . 0.0 110.103 -177.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.8 p -123.47 -177.0 3.59 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.05 -176.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -59.13 -32.9 70.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.988 0.423 . . . . 0.0 110.44 169.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.64 -40.57 69.62 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.575 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.5 mt -117.69 81.77 15.34 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 174.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.64 -5.67 14.82 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.231 2.621 . . . . 0.0 113.988 -167.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -162.15 122.6 2.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.089 0.471 . . . . 0.0 110.974 -175.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.413 HG11 ' HB1' ' A' ' 54' ' ' ALA . 98.1 t -108.57 113.57 44.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.343 175.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.37 114.87 27.4 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.104 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -135.48 168.66 18.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.223 -176.19 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 6.0 t70 -114.56 99.82 7.82 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.44 0.638 . . . . 0.0 110.588 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.644 HD21 HD23 ' E' ' 88' ' ' LEU . 19.7 mt -111.41 140.98 45.55 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.12 116.57 9.62 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.415 174.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -116.7 139.76 50.19 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.404 ' HA ' ' OG ' ' A' ' 26' ' ' SER . 5.3 t -103.31 173.97 6.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.003 0.43 . . . . 0.0 110.613 -177.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.57 1.29 12.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.539 -177.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.06 -5.84 54.41 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 173.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -100.36 151.43 21.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.865 0.364 . . . . 0.0 110.376 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -140.12 132.42 28.29 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 172.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.67 HG22 ' HB2' ' A' ' 46' ' ' ALA . 6.8 pt -139.79 164.64 23.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.011 0.434 . . . . 0.0 111.817 -167.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.502 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 4.5 mtm -118.65 121.74 40.87 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 173.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.509 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 1.0 OUTLIER -103.66 127.92 51.05 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.754 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.656 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 40.4 p90 -153.56 140.77 19.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.256 0.55 . . . . 0.0 111.886 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.682 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 15.2 p -111.9 144.97 40.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.297 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.09 148.66 28.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.31 173.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.85 176.83 41.1 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -176.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -108.53 102.55 11.62 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.046 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.514 ' N ' ' HB3' ' A' ' 15' ' ' PRO . . . -165.88 148.92 7.55 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.363 167.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 27.1 t -103.97 123.98 48.17 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.605 HG23 ' HB3' ' A' ' 13' ' ' MET . 8.0 m -121.01 135.25 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-O 121.349 0.595 . . . . 0.0 111.961 -173.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.1 m -97.47 118.39 33.86 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.908 175.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.61 HD13 HD23 ' A' ' 11' ' ' LEU . 5.0 mp -91.27 140.77 29.48 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 171.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.637 HD23 HD21 ' B' ' 67' ' ' LEU . 0.8 OUTLIER -127.62 143.64 51.14 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -178.254 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 28' ' ' HIS . . . -166.28 -166.97 26.21 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.126 -1.035 . . . . 0.0 112.833 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -142.32 136.6 29.86 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 120.939 0.4 . . . . 0.0 110.676 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.511 HD23 ' HB3' ' A' ' 27' ' ' PHE . 84.5 mt . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.945 174.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 46.9 mtt . . . . . 0 C--O 1.219 -0.528 0 CA-C-O 120.272 0.082 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -82.22 147.44 28.97 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.908 0.385 . . . . 0.0 112.024 -177.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 9' ' ' TRP . . . . . 0.492 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 91.1 t90 -139.24 150.02 45.01 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.458 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.432 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -154.11 152.27 23.87 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.489 178.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.6 HD23 HD13 ' B' ' 87' ' ' LEU . 41.1 tp -143.24 108.41 4.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.749 0.309 . . . . 0.0 110.364 177.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -86.04 99.32 11.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.257 0.551 . . . . 0.0 110.036 175.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' MET . . . . . 0.587 ' HB3' HG23 ' B' ' 85' ' ' VAL . 24.1 tpp -88.0 135.13 33.55 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.86 -175.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -98.86 145.24 29.62 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.075 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.512 ' HB3' ' N ' ' B' ' 83' ' ' ALA . 10.3 Cg_endo -53.01 120.15 7.23 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 123.591 2.861 . . . . 0.0 113.257 -175.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.683 ' HA ' ' O ' ' B' ' 79' ' ' THR . 29.1 mt-10 58.36 62.94 1.84 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.558 0.694 . . . . 0.0 111.628 177.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.54 148.98 46.39 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.586 174.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.653 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 35.1 ttmt -122.62 117.11 25.06 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.596 0.56 . . . . 0.0 111.379 -175.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -110.97 104.23 12.79 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.05 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 9.8 p -88.19 99.98 12.62 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -121.44 149.9 42.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.369 0.604 . . . . 0.0 112.275 -169.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 12.1 t -99.34 160.88 13.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.369 176.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 53.1 mt -118.98 125.7 74.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.05 0.453 . . . . 0.0 111.606 -173.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.464 ' N ' HD12 ' B' ' 24' ' ' ILE . 4.2 mp -106.9 -33.63 2.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.357 177.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -118.94 122.2 41.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.563 177.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 20.3 t -60.81 133.14 55.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.917 -177.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' PHE . . . . . 0.501 ' HB3' HD23 ' B' ' 91' ' ' LEU . 53.8 p90 -137.48 143.17 41.6 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.932 0.872 . . . . 0.0 111.821 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' HIS . . . . . 0.63 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 3.6 t60 -102.4 129.88 49.01 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.1 -1.409 . . . . 0.0 108.823 174.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.607 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 49.2 mt -97.59 130.34 46.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 171.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.63 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 46.8 p -113.97 -17.99 11.85 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.531 -171.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -162.17 149.02 16.87 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 119.567 -1.302 . . . . 0.0 112.961 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.473 HG23 ' HG ' ' B' ' 87' ' ' LEU . 8.2 p -135.17 121.92 34.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 172.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.5 150.23 41.93 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.436 -0.506 . . . . 0.0 112.049 -171.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.523 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.3 pp -114.91 137.58 51.8 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.816 0.817 . . . . 0.0 111.071 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -107.1 -55.46 2.33 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.585 175.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -101.89 127.07 48.88 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 170.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.457 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 148.37 163.57 10.88 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 119.988 -1.101 . . . . 0.0 112.904 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -102.66 -47.23 4.49 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.57 0.224 . . . . 0.0 111.402 177.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -151.89 136.37 16.88 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.62 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.427 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -133.41 113.61 12.73 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.398 0.618 . . . . 0.0 110.419 168.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' B' ' 79' ' ' THR . 65.8 mttp -97.48 109.66 22.37 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 173.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 34.6 tp -85.68 114.75 22.9 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.067 -173.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' TYR . . . . . 0.55 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 66.1 m-85 -116.39 145.82 42.95 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 175.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.521 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.2 OUTLIER -131.4 130.33 42.43 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 172.268 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -108.59 114.2 27.82 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.118 178.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.662 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -125.33 124.32 41.32 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.812 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.516 ' C ' ' HD2' ' B' ' 48' ' ' LYS . 4.2 mm-40 56.36 52.02 10.66 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.688 0.618 . . . . 0.0 111.132 -175.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.516 ' HD2' ' C ' ' B' ' 47' ' ' GLU . 6.7 mptt 58.95 39.63 23.41 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.479 174.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.596 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 24.1 tp60 -138.56 115.95 11.2 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -82.58 111.79 18.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.83 0.348 . . . . 0.0 110.596 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.421 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 80.3 m-85 -101.85 128.91 48.02 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.301 176.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -75.81 102.62 2.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 168.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.476 ' CG1' HD11 ' B' ' 67' ' ' LEU . 2.8 t -76.17 -51.64 19.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.542 -172.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.453 ' HB2' ' CD2' ' B' ' 65' ' ' LEU . . . -156.5 142.16 17.74 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.193 -177.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 42.6 m -105.17 101.45 11.0 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 171.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 56' ' ' VAL . . . . . 0.403 HG13 ' HB3' ' B' ' 40' ' ' ALA . 7.5 p -115.73 112.51 40.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.788 0.804 . . . . 0.0 110.067 -177.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 68.8 p -123.47 -177.09 3.61 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.054 -176.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -59.16 -32.73 70.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.976 0.417 . . . . 0.0 110.47 169.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.76 -40.59 69.2 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.523 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 76.4 mt -117.6 81.8 15.04 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 174.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.71 -5.64 14.82 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.312 2.675 . . . . 0.0 113.932 -167.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -162.18 122.64 2.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.208 0.528 . . . . 0.0 110.955 -175.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.413 HG11 ' HB1' ' B' ' 54' ' ' ALA . 97.9 t -108.57 113.51 44.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.374 175.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.36 114.85 27.38 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.102 175.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' B' ' 30' ' ' SER . 0.3 OUTLIER -135.46 168.7 18.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.191 -176.197 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 66' ' ' ASP . . . . . 0.527 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 5.9 t70 -114.58 99.7 7.73 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.393 0.616 . . . . 0.0 110.598 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.637 HD21 HD23 ' A' ' 88' ' ' LEU . 19.7 mt -111.35 140.97 45.49 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.17 116.64 9.64 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.351 174.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -116.78 139.68 50.3 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 5.3 t -103.3 173.95 6.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.951 0.405 . . . . 0.0 110.633 -177.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 71' ' ' LYS . . . . . 0.416 ' H ' ' HG3' ' B' ' 71' ' ' LYS . 0.0 OUTLIER -74.56 1.29 12.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.513 -177.009 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.0 -5.89 54.48 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 173.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -100.26 151.33 21.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.964 0.412 . . . . 0.0 110.35 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -140.1 132.48 28.43 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 172.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.662 HG22 ' HB2' ' B' ' 46' ' ' ALA . 6.9 pt -139.87 164.57 23.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.017 0.437 . . . . 0.0 111.837 -167.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.521 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 4.5 mtm -118.59 121.63 40.66 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 173.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 77' ' ' PHE . . . . . 0.518 ' CD1' ' HB2' ' B' ' 44' ' ' LEU . 1.1 m-85 -103.61 127.95 50.97 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.653 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 40.2 p90 -153.59 140.79 19.49 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.255 0.55 . . . . 0.0 111.845 -178.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.683 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 15.3 p -111.91 144.88 40.5 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.224 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.0 148.62 28.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.298 173.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.05 176.84 40.81 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -108.55 102.55 11.62 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.949 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.512 ' N ' ' HB3' ' B' ' 15' ' ' PRO . . . -165.92 148.85 7.47 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.382 167.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 27.2 t -103.94 124.02 48.22 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.587 HG23 ' HB3' ' B' ' 13' ' ' MET . 8.0 m -121.07 135.15 62.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-O 121.361 0.6 . . . . 0.0 111.895 -173.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 69.5 m -97.48 118.45 34.0 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.936 175.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.6 HD13 HD23 ' B' ' 11' ' ' LEU . 5.0 mp -91.27 140.79 29.46 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 171.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.636 HD23 HD21 ' C' ' 67' ' ' LEU . 0.8 OUTLIER -127.67 143.59 51.14 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.242 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 89' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' B' ' 28' ' ' HIS . . . -166.2 -166.92 26.04 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 120.112 -1.042 . . . . 0.0 112.801 -177.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -142.4 136.54 29.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.002 0.43 . . . . 0.0 110.655 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 91' ' ' LEU . . . . . 0.501 HD23 ' HB3' ' B' ' 27' ' ' PHE . 84.8 mt . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.921 174.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 7' ' ' MET . . . . . 0.408 ' O ' ' HA ' ' C' ' 90' ' ' TYR . 46.9 mtt . . . . . 0 C--O 1.219 -0.539 0 CA-C-O 120.273 0.082 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 8' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -82.3 147.48 28.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.921 0.391 . . . . 0.0 111.955 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 9' ' ' TRP . . . . . 0.488 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 91.1 t90 -139.32 149.98 44.85 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.421 177.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 10' ' ' GLY . . . . . 0.43 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -154.09 152.29 23.89 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.523 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.626 HD23 HD13 ' C' ' 87' ' ' LEU . 41.2 tp -143.27 108.34 4.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.74 0.305 . . . . 0.0 110.35 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -85.96 99.17 11.24 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.306 0.574 . . . . 0.0 110.099 175.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 13' ' ' MET . . . . . 0.606 ' HB3' HG23 ' C' ' 85' ' ' VAL . 24.1 tpp -87.97 135.1 33.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.888 -175.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -98.78 145.25 29.62 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.077 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 15' ' ' PRO . . . . . 0.518 ' HB3' ' N ' ' C' ' 83' ' ' ALA . 10.3 Cg_endo -53.04 120.14 7.22 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 123.624 2.883 . . . . 0.0 113.287 -175.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 16' ' ' GLU . . . . . 0.686 ' HA ' ' O ' ' C' ' 79' ' ' THR . 29.1 mt-10 58.35 63.0 1.83 Allowed 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.579 0.704 . . . . 0.0 111.658 177.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.63 148.93 46.2 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.518 174.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 18' ' ' LYS . . . . . 0.647 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 35.1 ttmt -122.6 117.09 25.02 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 123.482 0.489 . . . . 0.0 111.351 -175.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -111.01 104.28 12.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.007 177.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 20' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 9.4 p -88.24 100.03 12.67 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 173.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -121.32 150.04 42.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.339 0.59 . . . . 0.0 112.369 -169.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 12.2 t -99.42 160.85 13.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.327 176.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 53.3 mt -119.01 125.7 74.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.01 0.434 . . . . 0.0 111.532 -173.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 24' ' ' ILE . . . . . 0.451 ' N ' HD12 ' C' ' 24' ' ' ILE . 4.2 mp -106.99 -33.52 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.241 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -118.94 122.18 41.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.524 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 26' ' ' SER . . . . . 0.401 ' OG ' ' HA ' ' C' ' 70' ' ' SER . 20.3 t -60.82 133.13 55.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.837 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 27' ' ' PHE . . . . . 0.491 ' HB3' HD23 ' C' ' 91' ' ' LEU . 53.9 p90 -137.47 143.11 41.6 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.962 0.887 . . . . 0.0 111.906 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 28' ' ' HIS . . . . . 0.645 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 3.5 t60 -102.33 129.84 48.89 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.114 -1.403 . . . . 0.0 108.905 174.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 29' ' ' ILE . . . . . 0.619 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 48.9 mt -97.56 130.27 46.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 171.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.645 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 46.4 p -113.95 -17.98 11.86 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.541 -171.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 31' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -162.2 149.05 16.91 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 119.611 -1.28 . . . . 0.0 112.873 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.464 HG23 ' HG ' ' C' ' 87' ' ' LEU . 8.3 p -135.12 121.9 34.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 172.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.37 150.3 42.23 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.501 -0.48 . . . . 0.0 112.06 -171.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.529 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.3 pp -115.04 137.44 52.0 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.757 0.789 . . . . 0.0 111.147 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -106.96 -55.51 2.32 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.548 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -101.89 127.06 48.88 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 171.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 37' ' ' GLY . . . . . 0.459 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 148.28 163.53 10.84 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.016 -1.088 . . . . 0.0 112.981 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -102.66 -47.26 4.48 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.555 0.217 . . . . 0.0 111.385 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -151.9 136.32 16.84 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.701 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -133.48 113.55 12.63 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.429 0.633 . . . . 0.0 110.42 168.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' C' ' 79' ' ' THR . 65.8 mttp -97.45 109.55 22.28 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 174.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 35.0 tp -85.66 114.69 22.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.047 -173.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 43' ' ' TYR . . . . . 0.553 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 66.4 m-85 -116.37 145.75 42.99 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.513 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 0.2 OUTLIER -131.31 130.35 42.63 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 172.228 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 45' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -108.56 114.1 27.65 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.113 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.68 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -125.34 124.39 41.45 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.759 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 47' ' ' GLU . . . . . 0.519 ' C ' ' HD2' ' C' ' 48' ' ' LYS . 4.3 mm-40 56.37 52.06 10.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.347 0.594 . . . . 0.0 111.071 -175.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 48' ' ' LYS . . . . . 0.519 ' HD2' ' C ' ' C' ' 47' ' ' GLU . 6.7 mptt 58.91 39.65 23.51 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.492 174.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 49' ' ' GLN . . . . . 0.591 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 24.1 tp60 -138.66 115.96 11.13 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -82.61 111.74 18.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.902 0.382 . . . . 0.0 110.635 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 51' ' ' TYR . . . . . 0.432 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 80.0 m-85 -101.78 128.85 47.95 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.398 176.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -75.78 102.58 2.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 168.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 53' ' ' VAL . . . . . 0.478 ' CG1' HD11 ' C' ' 67' ' ' LEU . 2.8 t -76.17 -51.61 19.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.543 -172.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 54' ' ' ALA . . . . . 0.453 ' HB2' ' CD2' ' C' ' 65' ' ' LEU . . . -156.57 142.15 17.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.133 -177.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 42.4 m -105.21 101.44 10.98 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 171.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.7 112.56 40.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.815 0.817 . . . . 0.0 110.074 -177.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 68.0 p -123.47 -176.98 3.58 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.064 -176.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -59.33 -32.73 70.35 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.418 169.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.66 -40.72 69.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.486 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 76.0 mt -117.53 81.82 14.81 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 174.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.77 -5.73 15.09 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.256 2.637 . . . . 0.0 113.888 -167.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -162.04 122.67 2.59 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.075 0.464 . . . . 0.0 110.963 -175.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 97.8 t -108.6 113.59 44.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.346 175.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.35 114.82 27.35 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.123 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 65' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' C' ' 30' ' ' SER . 0.3 OUTLIER -135.38 168.68 18.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.259 -176.198 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 66' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 5.9 t70 -114.64 99.78 7.78 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.542 0.687 . . . . 0.0 110.595 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.636 HD21 HD23 ' B' ' 88' ' ' LEU . 19.8 mt -111.35 141.02 45.44 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -142.2 116.63 9.61 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.366 174.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -116.81 139.68 50.32 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 70' ' ' SER . . . . . 0.401 ' HA ' ' OG ' ' C' ' 26' ' ' SER . 5.3 t -103.28 173.94 6.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.049 0.452 . . . . 0.0 110.635 -177.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 71' ' ' LYS . . . . . 0.434 ' H ' ' HG3' ' C' ' 71' ' ' LYS . 0.0 OUTLIER -74.53 1.3 12.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.487 -176.991 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.09 -5.75 54.45 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 173.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -100.36 151.32 21.64 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.793 0.33 . . . . 0.0 110.432 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -140.13 132.36 28.18 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 172.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.68 HG22 ' HB2' ' C' ' 46' ' ' ALA . 6.8 pt -139.74 164.5 23.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.966 0.412 . . . . 0.0 111.888 -167.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.506 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 4.5 mtm -118.57 121.68 40.79 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 173.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 77' ' ' PHE . . . . . 0.513 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 1.1 m-85 -103.65 128.02 51.01 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 78' ' ' TYR . . . . . 0.647 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 40.3 p90 -153.56 140.87 19.6 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.218 0.532 . . . . 0.0 111.879 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 79' ' ' THR . . . . . 0.686 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 15.2 p -112.0 144.98 40.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.22 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.1 148.83 28.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.248 173.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.71 176.89 41.31 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -176.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -108.55 102.45 11.52 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.019 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 83' ' ' ALA . . . . . 0.518 ' N ' ' HB3' ' C' ' 15' ' ' PRO . . . -165.83 148.93 7.61 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.356 167.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 27.1 t -104.0 123.89 48.01 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.606 HG23 ' HB3' ' C' ' 13' ' ' MET . 8.2 m -120.89 135.2 61.86 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 CA-C-O 121.323 0.582 . . . . 0.0 112.007 -173.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 68.7 m -97.39 118.32 33.6 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.439 -0.8 . . . . 0.0 108.957 175.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 87' ' ' LEU . . . . . 0.626 HD13 HD23 ' C' ' 11' ' ' LEU . 5.0 mp -91.16 140.83 29.44 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 171.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 88' ' ' LEU . . . . . 0.623 HD23 HD21 ' D' ' 67' ' ' LEU . 0.8 OUTLIER -127.66 143.58 51.14 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -178.253 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 89' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' C' ' 28' ' ' HIS . . . -166.26 -166.95 26.16 Favored Glycine 0 N--CA 1.439 -1.166 0 C-N-CA 120.051 -1.071 . . . . 0.0 112.738 -177.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 90' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' C' ' 7' ' ' MET . 5.1 p90 -142.31 136.59 29.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.984 0.421 . . . . 0.0 110.623 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 91' ' ' LEU . . . . . 0.491 HD23 ' HB3' ' C' ' 27' ' ' PHE . 84.7 mt . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.88 174.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 47.1 mtt . . . . . 0 C--O 1.219 -0.543 0 CA-C-O 120.307 0.099 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 8' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -82.27 147.49 28.88 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.919 0.39 . . . . 0.0 111.93 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 9' ' ' TRP . . . . . 0.49 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 91.2 t90 -139.3 149.94 44.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.45 177.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -154.12 152.3 23.9 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.511 178.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 11' ' ' LEU . . . . . 0.624 HD23 HD13 ' D' ' 87' ' ' LEU . 40.8 tp -143.23 108.37 4.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.751 0.31 . . . . 0.0 110.344 177.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -86.15 99.42 11.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.375 0.607 . . . . 0.0 110.053 175.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 13' ' ' MET . . . . . 0.615 ' HB3' HG23 ' D' ' 85' ' ' VAL . 24.0 tpp -88.07 135.09 33.58 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.868 -175.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -98.84 145.13 29.41 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.158 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 15' ' ' PRO . . . . . 0.516 ' HB3' ' N ' ' D' ' 83' ' ' ALA . 10.3 Cg_endo -52.93 120.08 7.08 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.642 2.895 . . . . 0.0 113.237 -175.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 16' ' ' GLU . . . . . 0.677 ' HA ' ' O ' ' D' ' 79' ' ' THR . 28.9 mt-10 58.44 62.92 1.84 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.634 177.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.5 148.86 46.35 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.613 174.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 18' ' ' LYS . . . . . 0.665 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 35.1 ttmt -122.54 117.13 25.17 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 123.556 0.535 . . . . 0.0 111.386 -175.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -111.03 104.23 12.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.022 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 20' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 9.5 p -88.23 99.86 12.54 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 173.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -121.31 149.93 42.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.443 0.64 . . . . 0.0 112.373 -169.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 12.1 t -99.32 160.87 13.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.349 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 53.0 mt -118.97 125.74 74.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.012 0.434 . . . . 0.0 111.562 -173.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 24' ' ' ILE . . . . . 0.457 HD12 ' N ' ' D' ' 24' ' ' ILE . 4.2 mp -106.95 -33.56 2.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.311 177.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -118.94 122.16 41.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.587 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 26' ' ' SER . . . . . 0.407 ' OG ' ' HA ' ' D' ' 70' ' ' SER . 20.4 t -60.72 133.06 55.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.856 -177.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 27' ' ' PHE . . . . . 0.499 ' HB3' HD23 ' D' ' 91' ' ' LEU . 53.9 p90 -137.42 143.1 41.71 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.87 0.843 . . . . 0.0 111.981 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 28' ' ' HIS . . . . . 0.631 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 3.5 t60 -102.37 129.88 48.96 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.839 174.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 29' ' ' ILE . . . . . 0.617 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 48.8 mt -97.5 130.33 46.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 171.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 30' ' ' SER . . . . . 0.631 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 45.7 p -114.0 -18.06 11.82 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 120.973 0.416 . . . . 0.0 111.587 -171.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 31' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -162.15 149.01 16.87 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 119.573 -1.299 . . . . 0.0 113.022 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.466 HG23 ' HG ' ' D' ' 87' ' ' LEU . 8.2 p -135.15 121.95 34.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 172.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.46 150.33 42.12 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.47 -0.492 . . . . 0.0 112.038 -171.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 34' ' ' LEU . . . . . 0.523 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.3 pp -114.99 137.5 51.92 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.785 0.802 . . . . 0.0 111.116 178.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -107.0 -55.46 2.33 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.502 -1.227 . . . . 0.0 108.615 175.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -101.96 127.06 48.98 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.857 171.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 37' ' ' GLY . . . . . 0.453 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 148.32 163.57 10.87 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.01 -1.091 . . . . 0.0 112.991 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -102.69 -47.23 4.48 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.408 177.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -151.84 136.39 16.95 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.669 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 40' ' ' ALA . . . . . 0.43 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -133.5 113.59 12.65 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.453 0.644 . . . . 0.0 110.402 168.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' D' ' 79' ' ' THR . 65.8 mttp -97.41 109.51 22.25 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 173.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 34.9 tp -85.63 114.77 22.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.087 -173.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 43' ' ' TYR . . . . . 0.544 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 66.1 m-85 -116.43 145.81 43.0 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 175.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.51 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.2 OUTLIER -131.45 130.33 42.34 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 172.342 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 45' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -108.58 114.02 27.5 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.102 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.672 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -125.28 124.37 41.48 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.832 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 47' ' ' GLU . . . . . 0.519 ' C ' ' HD2' ' D' ' 48' ' ' LYS . 4.3 mm-40 56.48 51.97 10.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.297 0.57 . . . . 0.0 111.042 -175.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 48' ' ' LYS . . . . . 0.519 ' HD2' ' C ' ' D' ' 47' ' ' GLU . 6.7 mptt 58.93 39.65 23.45 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.413 174.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 49' ' ' GLN . . . . . 0.585 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 24.7 tp60 -138.57 115.93 11.17 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -82.5 111.72 18.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.873 0.368 . . . . 0.0 110.713 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 51' ' ' TYR . . . . . 0.43 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 80.1 m-85 -101.82 128.85 47.99 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.278 176.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -75.73 102.61 2.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 168.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 53' ' ' VAL . . . . . 0.479 ' CG1' HD11 ' D' ' 67' ' ' LEU . 2.8 t -76.25 -51.54 19.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.542 -172.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 54' ' ' ALA . . . . . 0.451 ' HB2' ' CD2' ' D' ' 65' ' ' LEU . . . -156.59 142.0 17.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.207 -177.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 41.9 m -105.05 101.42 10.98 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 171.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 56' ' ' VAL . . . . . 0.402 HG13 ' HB3' ' D' ' 40' ' ' ALA . 7.5 p -115.71 112.65 40.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.801 0.81 . . . . 0.0 110.039 -177.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 70.0 p -123.54 -177.0 3.59 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.026 -176.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -59.19 -32.87 70.31 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.037 0.446 . . . . 0.0 110.434 169.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.6 -40.65 69.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.572 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 75.9 mt -117.53 81.79 14.77 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 174.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.72 -5.68 14.92 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.186 2.591 . . . . 0.0 114.007 -167.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -162.11 122.78 2.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.196 0.522 . . . . 0.0 110.916 -175.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.42 HG11 ' HB1' ' D' ' 54' ' ' ALA . 98.3 t -108.66 113.45 44.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.382 175.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.34 114.87 27.42 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.096 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 65' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' D' ' 30' ' ' SER . 0.3 OUTLIER -135.52 168.63 18.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.182 -176.185 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 66' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 5.9 t70 -114.52 99.82 7.83 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.407 0.622 . . . . 0.0 110.545 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.623 HD21 HD23 ' C' ' 88' ' ' LEU . 19.8 mt -111.4 141.0 45.53 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 175.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.17 116.62 9.63 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.384 174.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -116.8 139.76 50.22 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 70' ' ' SER . . . . . 0.407 ' HA ' ' OG ' ' D' ' 26' ' ' SER . 5.3 t -103.28 173.97 6.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.982 0.42 . . . . 0.0 110.643 -177.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 71' ' ' LYS . . . . . 0.404 ' HG3' ' H ' ' D' ' 71' ' ' LYS . 0.0 OUTLIER -74.62 1.38 12.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.53 -177.034 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.04 -5.95 54.35 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -100.3 151.4 21.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.825 0.345 . . . . 0.0 110.426 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -140.16 132.41 28.22 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 172.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.672 HG22 ' HB2' ' D' ' 46' ' ' ALA . 6.8 pt -139.91 164.53 23.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.97 0.414 . . . . 0.0 111.803 -167.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 76' ' ' MET . . . . . 0.507 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 4.5 mtm -118.52 121.63 40.72 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 173.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 77' ' ' PHE . . . . . 0.51 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 1.1 m-85 -103.61 127.96 50.97 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 78' ' ' TYR . . . . . 0.665 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 40.2 p90 -153.61 140.88 19.56 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.229 0.538 . . . . 0.0 111.85 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 79' ' ' THR . . . . . 0.677 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 15.0 p -112.01 145.02 40.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.18 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.19 148.66 28.6 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.297 173.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.95 176.86 40.96 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -108.53 102.58 11.65 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.033 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 83' ' ' ALA . . . . . 0.516 ' N ' ' HB3' ' D' ' 15' ' ' PRO . . . -165.87 148.89 7.54 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.329 167.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 26.9 t -103.95 124.02 48.23 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.615 HG23 ' HB3' ' D' ' 13' ' ' MET . 8.2 m -120.95 135.1 62.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.338 0.589 . . . . 0.0 111.933 -173.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 68.5 m -97.38 118.5 34.0 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.964 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 87' ' ' LEU . . . . . 0.624 HD13 HD23 ' D' ' 11' ' ' LEU . 5.0 mp -91.33 140.87 29.37 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 171.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.636 HD23 HD21 ' E' ' 67' ' ' LEU . 0.8 OUTLIER -127.75 143.58 51.13 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -178.207 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 89' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' D' ' 28' ' ' HIS . . . -166.21 -167.0 26.18 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 120.102 -1.047 . . . . 0.0 112.777 -177.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -142.29 136.56 29.89 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 120.948 0.404 . . . . 0.0 110.609 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 91' ' ' LEU . . . . . 0.499 HD23 ' HB3' ' D' ' 27' ' ' PHE . 84.5 mt . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.999 174.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 7' ' ' MET . . . . . 0.402 ' O ' ' HA ' ' E' ' 90' ' ' TYR . 47.0 mtt . . . . . 0 C--O 1.22 -0.464 0 N-CA-C 111.2 0.074 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 8' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -82.2 147.55 28.93 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.888 0.375 . . . . 0.0 111.988 -177.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 9' ' ' TRP . . . . . 0.485 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 90.9 t90 -139.31 149.97 44.85 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 10' ' ' GLY . . . . . 0.438 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -154.14 152.28 23.88 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.446 178.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 11' ' ' LEU . . . . . 0.609 HD23 HD13 ' E' ' 87' ' ' LEU . 41.4 tp -143.17 108.3 4.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.735 0.302 . . . . 0.0 110.359 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -86.12 99.33 11.43 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.334 0.587 . . . . 0.0 110.042 175.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 13' ' ' MET . . . . . 0.614 ' HB3' HG23 ' E' ' 85' ' ' VAL . 23.9 tpp -88.0 135.12 33.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.853 -175.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -98.75 145.18 29.49 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.13 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 15' ' ' PRO . . . . . 0.511 ' HB3' ' N ' ' E' ' 83' ' ' ALA . 10.3 Cg_endo -52.97 120.07 7.09 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 123.653 2.902 . . . . 0.0 113.254 -175.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 16' ' ' GLU . . . . . 0.682 ' HA ' ' O ' ' E' ' 79' ' ' THR . 29.0 mt-10 58.44 62.88 1.85 Allowed 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 121.526 0.679 . . . . 0.0 111.653 177.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.49 148.92 46.42 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.578 174.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 18' ' ' LYS . . . . . 0.648 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 35.1 ttmt -122.61 117.17 25.19 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 123.569 0.543 . . . . 0.0 111.316 -175.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -111.02 104.39 12.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.993 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 20' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' E' ' 76' ' ' MET . 9.9 p -88.34 99.99 12.68 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 173.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -121.3 150.0 42.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.386 0.613 . . . . 0.0 112.33 -169.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 12.2 t -99.3 160.81 14.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.331 176.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 52.9 mt -118.94 125.75 74.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.113 0.482 . . . . 0.0 111.663 -173.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 24' ' ' ILE . . . . . 0.451 HD12 ' N ' ' E' ' 24' ' ' ILE . 4.2 mp -106.98 -33.57 2.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.283 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -118.93 122.23 41.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.55 177.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 26' ' ' SER . . . . . 0.407 ' OG ' ' HA ' ' E' ' 70' ' ' SER . 20.5 t -60.81 133.06 55.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.829 -177.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 27' ' ' PHE . . . . . 0.499 ' HB3' HD23 ' E' ' 91' ' ' LEU . 53.9 p90 -137.38 143.18 41.82 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.925 0.869 . . . . 0.0 111.954 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 28' ' ' HIS . . . . . 0.64 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 3.5 t60 -102.49 129.92 49.16 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.769 174.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 29' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 49.0 mt -97.44 130.3 46.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 171.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 30' ' ' SER . . . . . 0.64 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 46.5 p -114.0 -17.92 11.85 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.612 -171.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 31' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -162.23 148.97 16.72 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 119.656 -1.259 . . . . 0.0 112.984 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.469 HG23 ' HG ' ' E' ' 87' ' ' LEU . 8.3 p -135.11 121.92 34.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 172.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.47 150.24 41.99 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.52 -0.472 . . . . 0.0 112.01 -171.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 34' ' ' LEU . . . . . 0.528 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.3 pp -114.96 137.55 51.86 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.735 0.779 . . . . 0.0 111.111 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -107.07 -55.52 2.32 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.593 175.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -101.77 127.05 48.72 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 37' ' ' GLY . . . . . 0.455 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 148.28 163.55 10.84 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 119.995 -1.097 . . . . 0.0 112.998 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -102.7 -47.15 4.51 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.419 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -151.87 136.34 16.88 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.643 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 40' ' ' ALA . . . . . 0.428 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -133.41 113.56 12.68 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.451 0.643 . . . . 0.0 110.404 168.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 41' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' E' ' 79' ' ' THR . 65.8 mttp -97.36 109.57 22.3 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 34.5 tp -85.62 114.67 22.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.067 -173.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 43' ' ' TYR . . . . . 0.55 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 66.2 m-85 -116.37 145.77 42.98 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 44' ' ' LEU . . . . . 0.513 ' HB2' ' CD1' ' E' ' 77' ' ' PHE . 0.2 OUTLIER -131.37 130.41 42.59 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 172.288 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 45' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -108.67 114.09 27.6 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.145 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 46' ' ' ALA . . . . . 0.668 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -125.32 124.26 41.19 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.753 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 47' ' ' GLU . . . . . 0.518 ' C ' ' HD2' ' E' ' 48' ' ' LYS . 4.2 mm-40 56.57 52.03 10.37 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.663 0.602 . . . . 0.0 110.977 -175.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 48' ' ' LYS . . . . . 0.518 ' HD2' ' C ' ' E' ' 47' ' ' GLU . 6.7 mptt 59.0 39.5 23.43 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.493 174.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 49' ' ' GLN . . . . . 0.586 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 24.2 tp60 -138.61 116.03 11.22 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -82.55 111.73 18.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.897 0.379 . . . . 0.0 110.631 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -101.86 128.87 48.04 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.336 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -75.76 102.57 2.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 168.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 53' ' ' VAL . . . . . 0.472 ' CG1' HD11 ' E' ' 67' ' ' LEU . 2.8 t -76.22 -51.51 19.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.516 -172.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 54' ' ' ALA . . . . . 0.449 ' HB2' ' CD2' ' E' ' 65' ' ' LEU . . . -156.54 142.07 17.63 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.262 -177.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 43.3 m -105.14 101.45 11.0 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 171.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 56' ' ' VAL . . . . . 0.4 HG13 ' HB3' ' E' ' 40' ' ' ALA . 7.5 p -115.75 112.67 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-O 121.759 0.79 . . . . 0.0 110.033 -177.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 69.4 p -123.59 -177.07 3.62 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.008 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -59.18 -32.87 70.3 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.914 0.388 . . . . 0.0 110.385 169.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.62 -40.62 69.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.526 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 76.2 mt -117.58 81.77 14.93 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.67 -5.73 15.0 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.257 2.638 . . . . 0.0 113.965 -167.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -162.07 122.66 2.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.202 0.525 . . . . 0.0 110.925 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 63' ' ' VAL . . . . . 0.42 HG11 ' HB1' ' E' ' 54' ' ' ALA . 97.4 t -108.62 113.56 44.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.307 175.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.32 114.83 27.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.122 175.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 65' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' E' ' 30' ' ' SER . 0.3 OUTLIER -135.42 168.6 18.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.263 -176.244 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 66' ' ' ASP . . . . . 0.546 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 6.0 t70 -114.53 99.75 7.78 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.43 0.633 . . . . 0.0 110.66 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 67' ' ' LEU . . . . . 0.636 HD21 HD23 ' D' ' 88' ' ' LEU . 19.7 mt -111.35 140.99 45.47 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.13 116.57 9.62 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.417 174.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -116.72 139.74 50.21 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 70' ' ' SER . . . . . 0.407 ' HA ' ' OG ' ' E' ' 26' ' ' SER . 5.3 t -103.31 173.92 6.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.977 0.418 . . . . 0.0 110.635 -177.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.59 1.37 12.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.516 -177.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.05 -5.98 54.3 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 173.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -100.26 151.33 21.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.769 0.319 . . . . 0.0 110.465 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -140.02 132.42 28.46 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 172.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 75' ' ' ILE . . . . . 0.668 HG22 ' HB2' ' E' ' 46' ' ' ALA . 6.8 pt -139.83 164.58 23.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.973 0.416 . . . . 0.0 111.87 -167.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 76' ' ' MET . . . . . 0.505 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 4.5 mtm -118.58 121.68 40.79 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 77' ' ' PHE . . . . . 0.513 ' CD1' ' HB2' ' E' ' 44' ' ' LEU . 1.0 OUTLIER -103.73 127.98 51.15 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.738 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 78' ' ' TYR . . . . . 0.648 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 40.1 p90 -153.51 140.9 19.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.213 0.53 . . . . 0.0 111.905 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 79' ' ' THR . . . . . 0.682 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 14.7 p -111.98 144.99 40.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.17 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.24 148.66 28.66 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.214 173.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.87 176.83 41.08 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -176.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -108.56 102.56 11.63 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.949 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 83' ' ' ALA . . . . . 0.511 ' N ' ' HB3' ' E' ' 15' ' ' PRO . . . -165.9 148.86 7.5 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.39 167.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 27.2 t -103.95 123.93 48.06 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 85' ' ' VAL . . . . . 0.614 HG23 ' HB3' ' E' ' 13' ' ' MET . 8.1 m -120.87 135.2 61.81 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-O 121.377 0.608 . . . . 0.0 112.005 -173.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 69.1 m -97.48 118.38 33.84 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.455 -0.793 . . . . 0.0 108.866 175.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 87' ' ' LEU . . . . . 0.609 HD13 HD23 ' E' ' 11' ' ' LEU . 5.0 mp -91.27 140.81 29.44 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 171.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 88' ' ' LEU . . . . . 0.644 HD23 HD21 ' A' ' 67' ' ' LEU . 0.8 OUTLIER -127.67 143.64 51.14 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -178.247 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 89' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' E' ' 28' ' ' HIS . . . -166.22 -166.98 26.16 Favored Glycine 0 N--CA 1.438 -1.185 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.799 -177.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 90' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' E' ' 7' ' ' MET . 5.2 p90 -142.29 136.62 29.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.954 0.407 . . . . 0.0 110.632 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 91' ' ' LEU . . . . . 0.499 HD23 ' HB3' ' E' ' 27' ' ' PHE . 84.4 mt . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.953 174.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 CA--C 1.516 -0.345 0 CA-C-O 121.164 0.507 . . . . 0.0 111.674 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.64 ' CE1' HD21 ' B' ' 44' ' ' LEU . 31.1 t80 -72.26 145.87 47.63 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.409 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.422 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 92.1 t90 -134.31 147.97 50.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.391 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.502 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -152.25 154.92 25.83 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.855 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.526 HD23 HD13 ' A' ' 87' ' ' LEU . 49.8 tp -147.38 108.26 4.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.857 0.36 . . . . 0.0 111.019 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -90.42 119.94 31.12 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.963 0.411 . . . . 0.0 110.545 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.694 ' SD ' ' HE2' ' A' ' 19' ' ' TYR . 52.9 mmm -99.96 139.67 35.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.226 -175.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -100.32 145.06 29.62 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.583 174.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.468 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 11.0 Cg_endo -55.14 116.29 3.04 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.147 2.565 . . . . 0.0 112.925 -177.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 62.92 64.85 0.84 Allowed 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.876 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -145.71 138.78 26.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.682 173.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.728 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 86.4 mttt -107.1 126.54 52.49 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -176.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.694 ' HE2' ' SD ' ' A' ' 13' ' ' MET . 1.2 m-85 -112.6 103.84 11.9 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.192 174.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.0 p -88.37 100.33 12.94 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 174.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -113.24 144.37 42.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.434 0.635 . . . . 0.0 111.872 -170.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.5 m -101.95 140.91 35.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.556 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.403 HG22 ' HA ' ' A' ' 71' ' ' LYS . 74.1 mt -99.38 120.14 48.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.217 0.532 . . . . 0.0 111.723 -171.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.753 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -105.65 -9.84 10.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.276 176.044 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.516 ' HD2' HD13 ' A' ' 91' ' ' LEU . 35.5 pttt -141.55 119.16 11.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.872 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.9 p -67.05 133.67 50.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.809 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.671 ' HB3' HD23 ' A' ' 91' ' ' LEU . 32.6 p90 -147.56 166.49 27.19 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -173.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.554 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 9.4 t60 -118.88 126.21 51.27 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.908 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 42.6 mt -92.23 136.16 25.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 170.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.513 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 64.2 p -123.68 -5.66 8.09 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -170.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.46 160.79 27.76 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 119.086 -1.531 . . . . 0.0 113.823 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.466 HG23 ' HG ' ' A' ' 87' ' ' LEU . 11.5 p -144.5 129.96 14.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 174.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.45 157.7 43.97 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.012 -0.43 . . . . 0.0 111.482 -176.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.649 ' HB3' HG12 ' A' ' 85' ' ' VAL . 3.9 pp -122.05 145.3 48.28 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.795 0.807 . . . . 0.0 111.846 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -107.72 -56.02 2.28 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.64 173.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -103.14 127.26 50.49 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.368 173.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.59 ' O ' ' HG3' ' A' ' 58' ' ' LYS . . . 145.13 159.38 8.07 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 119.958 -1.115 . . . . 0.0 112.896 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -102.43 -45.61 5.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.477 0.18 . . . . 0.0 111.459 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -150.56 127.27 10.93 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 120.582 0.229 . . . . 0.0 111.056 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.519 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -127.42 114.94 18.17 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.295 0.569 . . . . 0.0 110.479 171.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 79' ' ' THR . 3.7 mppt? -95.1 112.05 23.8 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 174.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.6 tp -84.18 108.87 17.32 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -108.59 144.31 36.47 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.267 0.556 . . . . 0.0 110.073 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.674 HD21 ' CE1' ' E' ' 8' ' ' PHE . 0.2 OUTLIER -129.23 116.64 19.47 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.413 174.454 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -103.45 110.52 22.58 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.251 0.548 . . . . 0.0 109.706 177.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.52 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -140.13 145.58 37.75 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.333 -177.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 58.11 33.14 22.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.474 0.654 . . . . 0.0 109.774 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 62.59 38.13 12.55 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.814 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.545 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 6.5 tp-100 -140.66 138.92 34.67 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 178.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -90.92 110.04 21.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.88 0.371 . . . . 0.0 110.405 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.536 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 78.2 m-85 -101.82 130.65 48.32 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.473 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -85.24 101.86 10.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.74 0.781 . . . . 0.0 109.03 172.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.609 ' CG2' ' HB3' ' A' ' 44' ' ' LEU . 2.9 t -76.33 -49.81 23.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.72 -171.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.545 ' HB2' HD21 ' A' ' 65' ' ' LEU . . . -154.02 146.69 24.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.451 -177.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.5 m -111.06 100.94 9.53 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 170.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.464 HG11 HG11 ' A' ' 85' ' ' VAL . 7.5 p -115.8 114.65 46.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.665 0.745 . . . . 0.0 109.808 -176.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 78.0 p -122.86 -178.32 3.91 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.51 -173.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.59 ' HG3' ' O ' ' A' ' 37' ' ' GLY . 6.1 mttm -61.41 -29.9 70.23 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.012 0.434 . . . . 0.0 110.407 169.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.27 -40.2 52.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.431 178.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.2 mt -115.55 81.38 8.87 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -69.13 -0.47 6.44 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.152 2.568 . . . . 0.0 113.984 -167.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -163.06 130.24 3.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.361 0.601 . . . . 0.0 111.319 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 96.3 t -118.88 120.81 65.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.377 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.18 131.61 35.31 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 175.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.545 HD21 ' HB2' ' A' ' 54' ' ' ALA . 82.5 mt -124.0 167.14 14.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.449 0.642 . . . . 0.0 112.36 -173.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.451 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 14.4 t0 -143.15 99.18 3.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.514 170.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.596 HD21 HD23 ' E' ' 88' ' ' LEU . 2.4 mt -128.09 140.04 52.17 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.408 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -135.2 122.71 21.99 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.754 174.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -116.14 143.75 45.07 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.49 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.1 t -94.34 166.24 12.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.239 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.403 ' HA ' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -74.57 -7.05 51.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.164 0.506 . . . . 0.0 110.138 178.985 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.86 -8.16 62.16 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.494 174.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -93.71 144.62 25.23 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -136.12 127.74 28.88 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 171.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.52 HG22 ' HB2' ' A' ' 46' ' ' ALA . 8.5 pt -135.5 160.31 39.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.581 -163.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.436 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 3.0 mtm -114.05 120.39 40.41 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.499 172.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.651 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -103.67 127.85 51.07 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 176.235 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.728 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 53.0 p90 -156.4 143.15 18.66 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 119.735 -0.786 . . . . 0.0 112.238 -176.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 2.0 p -114.92 132.11 56.66 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.301 -176.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.42 160.65 14.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.797 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.02 -175.67 40.08 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -175.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -110.4 102.53 11.16 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.877 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -174.51 155.7 2.3 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.557 171.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.5 t -115.92 117.26 29.67 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.371 -0.604 . . . . 0.0 109.371 177.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.649 HG12 ' HB3' ' A' ' 34' ' ' LEU . 3.7 m -111.34 164.97 6.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.213 0.53 . . . . 0.0 112.126 -174.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 21.2 t -129.76 120.85 25.74 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.125 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.526 HD13 HD23 ' A' ' 11' ' ' LEU . 5.3 mp -92.86 154.43 18.23 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 121.004 0.43 . . . . 0.0 110.172 173.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.599 HD23 HD21 ' B' ' 67' ' ' LEU . 0.2 OUTLIER -133.7 144.66 49.28 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.105 179.827 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.97 -167.45 28.64 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.01 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -145.99 136.48 24.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.513 0.673 . . . . 0.0 111.651 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.671 HD23 ' HB3' ' A' ' 27' ' ' PHE . 26.6 mt . . . . . 0 C--N 1.323 -0.564 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.495 175.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 CA--C 1.516 -0.334 0 CA-C-O 121.188 0.518 . . . . 0.0 111.631 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 8' ' ' PHE . . . . . 0.655 ' CE1' HD21 ' C' ' 44' ' ' LEU . 31.8 t80 -72.13 145.8 47.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.462 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 9' ' ' TRP . . . . . 0.423 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 92.1 t90 -134.26 147.95 50.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.474 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.528 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -152.27 154.92 25.83 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.85 178.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.541 HD23 HD13 ' B' ' 87' ' ' LEU . 49.4 tp -147.37 108.34 4.21 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.856 0.36 . . . . 0.0 110.992 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -90.41 120.15 31.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.895 0.378 . . . . 0.0 110.479 176.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' MET . . . . . 0.705 ' SD ' ' HE2' ' B' ' 19' ' ' TYR . 53.4 mmm -100.1 139.62 35.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.145 -175.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -100.28 145.05 29.59 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.636 174.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.476 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 11.1 Cg_endo -55.15 116.26 3.02 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.136 2.558 . . . . 0.0 112.943 -177.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 62.96 64.85 0.84 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.89 176.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -145.74 138.89 26.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.622 173.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.734 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 86.4 mttt -107.26 126.39 52.36 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -176.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' TYR . . . . . 0.705 ' HE2' ' SD ' ' B' ' 13' ' ' MET . 1.2 m-85 -112.41 103.73 11.85 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.221 174.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 9.2 p -88.31 100.38 12.96 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -113.29 144.42 42.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.889 -170.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 27.6 m -101.94 140.96 35.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.521 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.405 HG22 ' HA ' ' B' ' 71' ' ' LYS . 73.6 mt -99.42 120.14 48.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.26 0.552 . . . . 0.0 111.754 -171.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.749 ' H ' HD13 ' B' ' 24' ' ' ILE . 0.2 OUTLIER -105.54 -9.88 10.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.323 175.99 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.5 ' HD2' HD13 ' B' ' 91' ' ' LEU . 35.4 pttt -141.52 119.11 11.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.872 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 5.9 p -67.02 133.75 50.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.818 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' PHE . . . . . 0.666 ' HB3' HD23 ' B' ' 91' ' ' LEU . 32.9 p90 -147.59 166.42 27.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.668 0.747 . . . . 0.0 112.922 -173.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' HIS . . . . . 0.543 ' HA ' ' O ' ' B' ' 67' ' ' LEU . 9.3 t60 -118.82 126.23 51.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.964 178.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.534 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 43.3 mt -92.28 136.18 25.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 170.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.512 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 64.2 p -123.73 -5.67 8.06 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -170.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.41 160.77 27.77 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 119.032 -1.556 . . . . 0.0 113.823 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.473 HG23 ' HG ' ' B' ' 87' ' ' LEU . 11.4 p -144.52 130.02 14.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 173.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.41 157.7 43.97 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 122.0 -0.438 . . . . 0.0 111.598 -176.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.654 ' HB3' HG12 ' B' ' 85' ' ' VAL . 3.9 pp -122.11 145.32 48.28 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.856 0.836 . . . . 0.0 111.825 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -107.75 -56.09 2.27 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.614 173.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -103.07 127.23 50.41 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.344 173.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.579 ' O ' ' HG3' ' B' ' 58' ' ' LYS . . . 145.21 159.37 8.07 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 120.016 -1.088 . . . . 0.0 112.809 178.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -102.42 -45.56 5.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.474 0.178 . . . . 0.0 111.46 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -150.62 127.3 10.9 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 120.615 0.245 . . . . 0.0 110.958 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.531 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -127.41 114.95 18.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.235 0.541 . . . . 0.0 110.461 171.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' B' ' 79' ' ' THR . 3.7 mppt? -94.97 112.01 23.75 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 174.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 46.6 tp -84.26 108.84 17.36 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -176.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -108.56 144.31 36.42 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.338 0.589 . . . . 0.0 110.08 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.662 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 0.2 OUTLIER -129.25 116.74 19.61 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.378 174.397 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.546 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -103.44 110.5 22.54 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.18 0.514 . . . . 0.0 109.702 177.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.513 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -140.08 145.63 37.91 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.358 -177.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 58.1 33.0 22.72 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.521 0.677 . . . . 0.0 109.833 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 62.77 38.0 12.08 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.82 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.546 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 6.5 tp-100 -140.64 139.0 34.77 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 178.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -90.98 110.05 21.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.922 0.392 . . . . 0.0 110.352 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.502 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 78.3 m-85 -101.82 130.72 48.32 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.484 178.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -85.32 101.87 10.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.742 0.782 . . . . 0.0 108.971 172.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.613 ' CG2' ' HB3' ' B' ' 44' ' ' LEU . 2.9 t -76.4 -49.76 23.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.704 -171.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.547 ' HB2' HD21 ' B' ' 65' ' ' LEU . . . -154.1 146.71 24.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.434 -177.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 27.4 m -110.99 100.98 9.58 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 56' ' ' VAL . . . . . 0.468 HG11 HG11 ' B' ' 85' ' ' VAL . 7.5 p -115.8 114.71 47.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.655 0.741 . . . . 0.0 109.855 -176.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 78.7 p -122.87 -178.24 3.89 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.45 -173.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' LYS . . . . . 0.579 ' HG3' ' O ' ' B' ' 37' ' ' GLY . 6.1 mttm -61.49 -30.04 70.36 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.07 0.462 . . . . 0.0 110.29 169.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.12 -40.33 53.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.41 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 79.3 mt -115.55 81.4 8.91 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.15 -0.35 6.29 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.043 2.495 . . . . 0.0 114.006 -167.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -163.13 130.15 3.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.226 0.536 . . . . 0.0 111.346 -176.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 96.1 t -118.82 120.81 65.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.373 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.24 131.51 35.3 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.547 HD21 ' HB2' ' B' ' 54' ' ' ALA . 82.4 mt -123.93 167.17 14.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.479 0.657 . . . . 0.0 112.348 -173.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 66' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 14.4 t0 -143.13 99.11 3.39 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.563 170.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.599 HD21 HD23 ' A' ' 88' ' ' LEU . 2.4 mt -128.02 140.16 52.13 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.395 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -135.35 122.7 21.8 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.714 174.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -116.08 143.72 45.1 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.508 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 34.0 t -94.37 166.26 12.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.216 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 71' ' ' LYS . . . . . 0.405 ' HA ' HG22 ' B' ' 23' ' ' ILE . 0.0 OUTLIER -74.59 -6.91 51.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.179 0.514 . . . . 0.0 110.175 178.969 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.95 -8.21 61.97 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.458 174.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -93.69 144.62 25.23 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -136.12 127.79 28.98 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 171.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.513 HG22 ' HB2' ' B' ' 46' ' ' ALA . 8.5 pt -135.46 160.41 40.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.606 -163.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.432 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 3.0 mtm -114.05 120.35 40.29 Favored 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.535 172.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 77' ' ' PHE . . . . . 0.662 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -103.75 127.78 51.19 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 176.288 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.734 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 52.7 p90 -156.31 143.18 18.79 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 119.802 -0.759 . . . . 0.0 112.238 -176.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' B' ' 41' ' ' LYS . 2.0 p -114.98 132.02 56.72 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.335 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.27 160.72 14.88 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.82 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.97 -175.67 40.16 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -175.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -110.37 102.58 11.21 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.878 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -174.55 155.62 2.27 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.567 171.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 32.2 t -115.91 117.25 29.66 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.654 HG12 ' HB3' ' B' ' 34' ' ' LEU . 3.7 m -111.3 164.88 6.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.245 0.545 . . . . 0.0 112.132 -174.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 21.3 t -129.7 120.83 25.79 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.156 176.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.541 HD13 HD23 ' B' ' 11' ' ' LEU . 5.3 mp -92.92 154.36 18.24 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.016 0.436 . . . . 0.0 110.163 173.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.58 HD23 HD21 ' C' ' 67' ' ' LEU . 0.2 OUTLIER -133.65 144.66 49.35 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.083 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.94 -167.41 28.55 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.962 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -146.07 136.49 23.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.582 0.706 . . . . 0.0 111.623 177.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 91' ' ' LEU . . . . . 0.666 HD23 ' HB3' ' B' ' 27' ' ' PHE . 26.4 mt . . . . . 0 C--N 1.323 -0.572 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.474 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 C--O 1.223 -0.303 0 CA-C-O 121.094 0.473 . . . . 0.0 111.67 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 8' ' ' PHE . . . . . 0.654 ' CE1' HD21 ' D' ' 44' ' ' LEU . 31.2 t80 -72.26 145.88 47.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.376 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 9' ' ' TRP . . . . . 0.419 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 92.1 t90 -134.35 147.96 50.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.464 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 10' ' ' GLY . . . . . 0.524 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -152.23 154.91 25.83 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.828 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.532 HD23 HD13 ' C' ' 87' ' ' LEU . 49.7 tp -147.37 108.37 4.22 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.923 0.392 . . . . 0.0 111.069 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -90.49 120.12 31.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.929 0.395 . . . . 0.0 110.536 176.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 13' ' ' MET . . . . . 0.706 ' SD ' ' HE2' ' C' ' 19' ' ' TYR . 53.2 mmm -100.01 139.66 35.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.254 -175.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -100.41 144.99 29.51 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.584 174.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 15' ' ' PRO . . . . . 0.481 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 11.0 Cg_endo -55.08 116.3 3.04 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 123.106 2.537 . . . . 0.0 112.932 -177.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 62.9 64.81 0.85 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.89 176.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -145.67 138.93 26.21 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.655 173.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 18' ' ' LYS . . . . . 0.727 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 86.7 mttt -107.13 126.48 52.43 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -176.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 19' ' ' TYR . . . . . 0.706 ' HE2' ' SD ' ' C' ' 13' ' ' MET . 1.2 m-85 -112.52 103.84 11.93 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.145 174.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 20' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 9.0 p -88.38 100.24 12.88 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -113.23 144.45 42.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.434 0.635 . . . . 0.0 111.848 -170.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 27.3 m -101.98 140.9 35.65 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.452 176.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 23' ' ' ILE . . . . . 0.403 HG22 ' HA ' ' C' ' 71' ' ' LYS . 73.9 mt -99.41 120.14 48.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.125 0.488 . . . . 0.0 111.772 -171.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 24' ' ' ILE . . . . . 0.767 ' H ' HD13 ' C' ' 24' ' ' ILE . 0.2 OUTLIER -105.57 -9.94 10.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.318 176.018 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 25' ' ' LYS . . . . . 0.516 ' HD2' HD13 ' C' ' 91' ' ' LEU . 35.7 pttt -141.47 119.07 11.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.893 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 5.8 p -67.04 133.72 50.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.738 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 27' ' ' PHE . . . . . 0.662 ' HB3' HD23 ' C' ' 91' ' ' LEU . 32.4 p90 -147.53 166.44 27.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.627 0.727 . . . . 0.0 112.956 -173.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 28' ' ' HIS . . . . . 0.545 ' HA ' ' O ' ' C' ' 67' ' ' LEU . 9.4 t60 -118.87 126.23 51.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.34 -1.3 . . . . 0.0 109.934 178.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 29' ' ' ILE . . . . . 0.542 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 42.7 mt -92.2 136.14 25.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 170.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.514 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 64.4 p -123.71 -5.62 8.07 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -170.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.45 160.71 27.64 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 119.038 -1.553 . . . . 0.0 113.816 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.477 HG23 ' HG ' ' C' ' 87' ' ' LEU . 11.5 p -144.49 129.99 14.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 173.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.42 157.72 43.97 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.889 -0.507 . . . . 0.0 111.517 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.669 ' HB3' HG12 ' C' ' 85' ' ' VAL . 3.8 pp -122.07 145.33 48.25 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.782 0.801 . . . . 0.0 111.803 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -107.79 -56.04 2.28 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.387 -1.278 . . . . 0.0 108.621 173.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -103.08 127.25 50.41 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.345 173.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 37' ' ' GLY . . . . . 0.588 ' O ' ' HG3' ' C' ' 58' ' ' LYS . . . 145.23 159.4 8.09 Favored Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 119.954 -1.117 . . . . 0.0 112.815 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -102.56 -45.58 5.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.465 0.174 . . . . 0.0 111.385 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -150.48 127.2 10.95 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.501 0.191 . . . . 0.0 111.094 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.53 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -127.38 115.0 18.28 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.328 0.585 . . . . 0.0 110.439 171.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' C' ' 79' ' ' THR . 3.7 mppt? -95.11 112.07 23.82 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 46.9 tp -84.31 108.93 17.44 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -176.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -108.62 144.33 36.49 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.327 0.584 . . . . 0.0 110.062 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.655 HD21 ' CE1' ' B' ' 8' ' ' PHE . 0.2 OUTLIER -129.28 116.79 19.65 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.364 174.395 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 45' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -103.51 110.4 22.42 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.206 0.527 . . . . 0.0 109.736 177.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.512 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -139.97 145.64 38.13 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.385 -177.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 57.95 33.18 22.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.451 0.643 . . . . 0.0 109.844 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 60.0 mttp 62.69 38.03 12.3 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.822 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 49' ' ' GLN . . . . . 0.552 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 6.5 tp-100 -140.64 139.06 34.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.588 0.232 . . . . 0.0 110.379 178.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -91.07 110.02 21.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.32 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 51' ' ' TYR . . . . . 0.528 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 78.1 m-85 -101.84 130.72 48.36 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.433 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -85.31 101.8 10.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.68 0.752 . . . . 0.0 108.995 173.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 53' ' ' VAL . . . . . 0.609 ' CG2' ' HB3' ' C' ' 44' ' ' LEU . 2.9 t -76.33 -49.88 23.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.696 -171.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 54' ' ' ALA . . . . . 0.542 ' HB2' HD21 ' C' ' 65' ' ' LEU . . . -153.98 146.71 24.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.511 -177.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 27.6 m -111.04 101.02 9.6 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 170.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 56' ' ' VAL . . . . . 0.463 HG11 HG11 ' C' ' 85' ' ' VAL . 7.5 p -115.83 114.67 46.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.617 0.722 . . . . 0.0 109.807 -176.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 78.1 p -122.89 -178.26 3.89 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.467 -173.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 58' ' ' LYS . . . . . 0.588 ' HG3' ' O ' ' C' ' 37' ' ' GLY . 6.2 mttm -61.51 -29.92 70.29 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.025 0.441 . . . . 0.0 110.35 169.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.18 -40.24 52.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.359 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 79.9 mt -115.65 81.48 9.23 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.18 -0.44 6.44 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.143 2.562 . . . . 0.0 113.972 -167.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -163.11 130.18 3.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.266 0.555 . . . . 0.0 111.333 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 96.9 t -118.72 120.84 65.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.458 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.29 131.58 35.3 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 65' ' ' LEU . . . . . 0.542 HD21 ' HB2' ' C' ' 54' ' ' ALA . 82.6 mt -123.99 167.19 14.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.473 0.654 . . . . 0.0 112.285 -173.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 66' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 14.3 t0 -143.14 99.12 3.39 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.478 170.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.58 HD21 HD23 ' B' ' 88' ' ' LEU . 2.4 mt -128.1 140.15 52.1 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.419 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -135.32 122.73 21.88 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.75 174.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -116.12 143.75 45.07 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.429 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 33.8 t -94.31 166.23 12.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.231 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 71' ' ' LYS . . . . . 0.403 ' HA ' HG22 ' C' ' 23' ' ' ILE . 0.0 OUTLIER -74.57 -6.88 51.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.182 0.515 . . . . 0.0 110.185 178.913 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.97 -8.34 61.84 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.462 174.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -93.61 144.58 25.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.815 0.34 . . . . 0.0 110.097 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -136.06 127.72 28.96 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 171.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.512 HG22 ' HB2' ' C' ' 46' ' ' ALA . 8.5 pt -135.36 160.45 40.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.532 -163.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.436 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 3.0 mtm -114.14 120.37 40.28 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.51 172.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 77' ' ' PHE . . . . . 0.653 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.7 OUTLIER -103.8 127.81 51.26 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.315 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 78' ' ' TYR . . . . . 0.727 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 53.3 p90 -156.31 143.17 18.78 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.311 -176.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 79' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' C' ' 41' ' ' LYS . 2.0 p -114.98 131.99 56.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.362 -176.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.29 160.66 14.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.862 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.93 -175.69 40.24 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -175.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -110.39 102.61 11.23 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 119.391 -0.924 . . . . 0.0 109.867 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 83' ' ' ALA . . . . . 0.53 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -174.53 155.61 2.28 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.633 171.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 32.3 t -115.84 117.28 29.76 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.669 HG12 ' HB3' ' C' ' 34' ' ' LEU . 3.7 m -111.39 164.92 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-O 121.313 0.578 . . . . 0.0 112.106 -174.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 21.1 t -129.72 120.8 25.7 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.217 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 87' ' ' LEU . . . . . 0.532 HD13 HD23 ' C' ' 11' ' ' LEU . 5.3 mp -92.89 154.4 18.23 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 120.987 0.422 . . . . 0.0 110.157 173.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 88' ' ' LEU . . . . . 0.581 HD23 HD21 ' D' ' 67' ' ' LEU . 0.2 OUTLIER -133.68 144.67 49.32 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.135 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.0 -167.36 28.54 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.978 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -146.06 136.45 23.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.564 0.697 . . . . 0.0 111.631 177.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 91' ' ' LEU . . . . . 0.662 HD23 ' HB3' ' C' ' 27' ' ' PHE . 26.3 mt . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.486 175.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 C--O 1.224 -0.27 0 CA-C-O 121.148 0.499 . . . . 0.0 111.663 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 8' ' ' PHE . . . . . 0.639 ' CE1' HD21 ' E' ' 44' ' ' LEU . 31.0 t80 -72.27 145.78 47.66 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.37 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 9' ' ' TRP . . . . . 0.426 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 92.1 t90 -134.27 147.99 50.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.433 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 10' ' ' GLY . . . . . 0.513 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -152.21 154.91 25.83 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.872 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 11' ' ' LEU . . . . . 0.54 HD23 HD13 ' D' ' 87' ' ' LEU . 50.1 tp -147.33 108.34 4.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.803 0.335 . . . . 0.0 111.02 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -90.52 120.09 31.32 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.974 0.416 . . . . 0.0 110.479 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 13' ' ' MET . . . . . 0.689 ' SD ' ' HE2' ' D' ' 19' ' ' TYR . 53.3 mmm -100.08 139.63 35.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.173 -175.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -100.3 145.07 29.63 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.59 174.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 15' ' ' PRO . . . . . 0.461 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 11.0 Cg_endo -55.23 116.3 3.04 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 123.099 2.533 . . . . 0.0 112.91 -177.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 63.04 64.79 0.83 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.843 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -145.65 138.86 26.19 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.598 173.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 18' ' ' LYS . . . . . 0.718 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 86.6 mttt -107.2 126.48 52.46 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -176.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 19' ' ' TYR . . . . . 0.689 ' HE2' ' SD ' ' D' ' 13' ' ' MET . 1.2 m-85 -112.63 103.81 11.87 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.104 174.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 20' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 8.7 p -88.38 100.28 12.9 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 174.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -113.13 144.4 42.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.88 -170.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 27.2 m -101.95 140.9 35.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.609 176.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 23' ' ' ILE . . . . . 0.418 HG22 ' HA ' ' D' ' 71' ' ' LYS . 74.2 mt -99.48 120.19 48.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.203 0.525 . . . . 0.0 111.651 -171.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 24' ' ' ILE . . . . . 0.775 ' H ' HD13 ' D' ' 24' ' ' ILE . 0.2 OUTLIER -105.61 -9.81 10.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.388 175.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 25' ' ' LYS . . . . . 0.507 ' HD2' HD13 ' D' ' 91' ' ' LEU . 35.4 pttt -141.55 119.08 11.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.847 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 5.8 p -67.06 133.72 50.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.783 -176.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 27' ' ' PHE . . . . . 0.68 ' HB3' HD23 ' D' ' 91' ' ' LEU . 32.7 p90 -147.56 166.39 27.48 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -173.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 28' ' ' HIS . . . . . 0.546 ' HA ' ' O ' ' D' ' 67' ' ' LEU . 9.3 t60 -118.73 126.23 51.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.973 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 29' ' ' ILE . . . . . 0.551 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 42.4 mt -92.24 136.14 25.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 170.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 30' ' ' SER . . . . . 0.522 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 64.3 p -123.77 -5.57 8.04 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -170.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.42 160.84 27.87 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 119.141 -1.504 . . . . 0.0 113.874 176.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.462 HG23 ' HG ' ' D' ' 87' ' ' LEU . 11.4 p -144.51 129.95 14.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 173.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.41 157.76 43.96 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.004 -0.435 . . . . 0.0 111.451 -176.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 34' ' ' LEU . . . . . 0.646 ' HB3' HG12 ' D' ' 85' ' ' VAL . 3.9 pp -122.11 145.26 48.34 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.8 0.809 . . . . 0.0 111.826 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -107.67 -55.98 2.28 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.663 173.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -103.2 127.25 50.56 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.336 173.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 37' ' ' GLY . . . . . 0.59 ' O ' ' HG3' ' D' ' 58' ' ' LYS . . . 145.15 159.33 8.04 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 119.997 -1.096 . . . . 0.0 112.83 178.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -102.47 -45.49 5.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -150.58 127.35 10.97 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.592 0.234 . . . . 0.0 110.955 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 40' ' ' ALA . . . . . 0.538 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -127.51 114.97 18.15 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.223 0.535 . . . . 0.0 110.452 171.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' D' ' 79' ' ' THR . 3.7 mppt? -95.14 112.07 23.82 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 47.2 tp -84.26 108.88 17.38 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -176.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -108.51 144.32 36.32 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.129 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.656 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.2 OUTLIER -129.28 116.73 19.57 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.411 174.355 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 45' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -103.34 110.43 22.42 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.698 177.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.508 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -140.05 145.53 37.84 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.339 -177.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 58.18 33.08 22.81 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.466 0.65 . . . . 0.0 109.819 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 62.65 37.95 12.48 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.904 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 49' ' ' GLN . . . . . 0.553 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 6.5 tp-100 -140.6 138.96 34.81 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 178.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -90.95 110.14 21.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.315 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 51' ' ' TYR . . . . . 0.524 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 78.5 m-85 -101.87 130.7 48.41 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.444 178.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -85.27 101.91 10.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 172.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 53' ' ' VAL . . . . . 0.607 ' CG2' ' HB3' ' D' ' 44' ' ' LEU . 2.9 t -76.49 -49.69 23.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.716 -171.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 54' ' ' ALA . . . . . 0.554 ' HB2' HD21 ' D' ' 65' ' ' LEU . . . -154.05 146.73 24.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.414 -177.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 27.3 m -111.06 100.93 9.52 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 170.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 56' ' ' VAL . . . . . 0.463 HG11 HG11 ' D' ' 85' ' ' VAL . 7.4 p -115.8 114.64 46.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.607 0.718 . . . . 0.0 109.85 -176.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 79.2 p -122.88 -178.24 3.89 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.487 -173.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 58' ' ' LYS . . . . . 0.59 ' HG3' ' O ' ' D' ' 37' ' ' GLY . 6.1 mttm -61.45 -29.95 70.28 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.037 0.446 . . . . 0.0 110.415 169.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.21 -40.21 52.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.438 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 79.5 mt -115.63 81.47 9.15 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 174.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -69.13 -0.42 6.37 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.15 2.567 . . . . 0.0 113.983 -167.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -163.15 130.1 3.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.222 0.534 . . . . 0.0 111.297 -176.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 96.4 t -118.76 120.87 65.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.39 174.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.2 131.49 35.3 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 65' ' ' LEU . . . . . 0.554 HD21 ' HB2' ' D' ' 54' ' ' ALA . 82.7 mt -123.96 167.17 14.5 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.474 0.654 . . . . 0.0 112.325 -173.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 66' ' ' ASP . . . . . 0.427 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 14.4 t0 -143.09 99.03 3.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.592 170.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.581 HD21 HD23 ' C' ' 88' ' ' LEU . 2.4 mt -127.96 140.11 52.18 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.436 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -135.3 122.73 21.89 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.486 -0.485 . . . . 0.0 109.72 174.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -116.11 143.66 45.18 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.551 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 34.0 t -94.38 166.26 12.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.219 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 71' ' ' LYS . . . . . 0.418 ' HA ' HG22 ' D' ' 23' ' ' ILE . 0.0 OUTLIER -74.56 -7.02 51.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.271 0.557 . . . . 0.0 110.141 179.065 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.91 -8.19 62.05 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.496 174.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -93.63 144.52 25.31 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -136.08 127.75 28.97 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 171.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.508 HG22 ' HB2' ' D' ' 46' ' ' ALA . 8.6 pt -135.34 160.5 40.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.568 -163.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 76' ' ' MET . . . . . 0.437 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 3.0 mtm -114.16 120.43 40.47 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.454 172.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 77' ' ' PHE . . . . . 0.656 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.7 OUTLIER -103.79 127.73 51.25 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.263 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 78' ' ' TYR . . . . . 0.718 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 52.9 p90 -156.25 143.14 18.83 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.248 -176.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 79' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' D' ' 41' ' ' LYS . 2.0 p -114.9 132.01 56.68 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.305 -176.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.28 160.69 14.91 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.874 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.96 -175.7 40.2 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -175.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -110.34 102.53 11.17 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.97 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 83' ' ' ALA . . . . . 0.538 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -174.54 155.54 2.26 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.591 171.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 32.4 t -115.81 117.14 29.39 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.646 HG12 ' HB3' ' D' ' 34' ' ' LEU . 3.7 m -111.27 164.87 6.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.21 0.528 . . . . 0.0 112.151 -174.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 21.3 t -129.65 120.83 25.87 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.17 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 87' ' ' LEU . . . . . 0.54 HD13 HD23 ' D' ' 11' ' ' LEU . 5.3 mp -92.92 154.44 18.19 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 121.022 0.439 . . . . 0.0 110.1 173.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.594 HD23 HD21 ' E' ' 67' ' ' LEU . 0.2 OUTLIER -133.7 144.65 49.27 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.111 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.88 -167.34 28.4 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.033 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -146.1 136.49 23.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.556 0.693 . . . . 0.0 111.653 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 91' ' ' LEU . . . . . 0.68 HD23 ' HB3' ' D' ' 27' ' ' PHE . 26.1 mt . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.536 175.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 C--O 1.223 -0.302 0 CA-C-O 121.093 0.473 . . . . 0.0 111.647 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' E' E ' 8' ' ' PHE . . . . . 0.674 ' CE1' HD21 ' A' ' 44' ' ' LEU . 31.2 t80 -72.13 145.9 47.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.46 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 9' ' ' TRP . . . . . 0.414 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 92.0 t90 -134.41 147.92 50.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.407 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 10' ' ' GLY . . . . . 0.536 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -152.18 154.93 25.84 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.908 178.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 11' ' ' LEU . . . . . 0.539 HD23 HD13 ' E' ' 87' ' ' LEU . 49.5 tp -147.34 108.31 4.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.829 0.347 . . . . 0.0 111.018 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -90.47 120.18 31.36 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.002 0.43 . . . . 0.0 110.478 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 13' ' ' MET . . . . . 0.685 ' SD ' ' HE2' ' E' ' 19' ' ' TYR . 53.0 mmm -100.08 139.57 35.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.247 -175.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -100.28 145.08 29.64 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.665 174.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 15' ' ' PRO . . . . . 0.465 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 11.0 Cg_endo -55.15 116.34 3.07 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.088 2.525 . . . . 0.0 112.951 -177.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 62.89 64.81 0.85 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.892 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -145.73 138.86 26.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.653 173.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 18' ' ' LYS . . . . . 0.713 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 86.7 mttt -107.11 126.36 52.27 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -176.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 19' ' ' TYR . . . . . 0.685 ' HE2' ' SD ' ' E' ' 13' ' ' MET . 1.2 m-85 -112.53 103.82 11.9 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.167 174.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 20' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' E' ' 76' ' ' MET . 9.1 p -88.31 100.25 12.86 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 174.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -113.16 144.37 42.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.899 -170.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 27.5 m -101.98 140.99 35.52 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.508 176.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 73.9 mt -99.47 120.21 48.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.225 0.536 . . . . 0.0 111.668 -171.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 24' ' ' ILE . . . . . 0.759 ' H ' HD13 ' E' ' 24' ' ' ILE . 0.2 OUTLIER -105.63 -9.86 10.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.297 175.969 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 25' ' ' LYS . . . . . 0.506 ' HD2' HD13 ' E' ' 91' ' ' LEU . 35.5 pttt -141.47 119.15 11.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.867 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 5.8 p -67.05 133.72 50.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.752 -176.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 27' ' ' PHE . . . . . 0.675 ' HB3' HD23 ' E' ' 91' ' ' LEU . 32.6 p90 -147.54 166.4 27.41 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -173.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 28' ' ' HIS . . . . . 0.55 ' HA ' ' O ' ' E' ' 67' ' ' LEU . 9.4 t60 -118.77 126.28 51.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.968 178.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 29' ' ' ILE . . . . . 0.542 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 42.8 mt -92.25 136.15 25.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 170.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 30' ' ' SER . . . . . 0.507 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 64.2 p -123.69 -5.65 8.08 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -170.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.39 160.84 27.91 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.063 -1.541 . . . . 0.0 113.823 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.47 HG23 ' HG ' ' E' ' 87' ' ' LEU . 11.5 p -144.55 129.91 14.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.39 157.72 43.97 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 121.904 -0.497 . . . . 0.0 111.518 -176.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 34' ' ' LEU . . . . . 0.667 ' HB3' HG12 ' E' ' 85' ' ' VAL . 3.9 pp -122.06 145.27 48.31 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.858 0.837 . . . . 0.0 111.856 178.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -107.71 -56.06 2.27 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.222 -1.354 . . . . 0.0 108.612 173.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -103.12 127.23 50.48 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.411 173.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 37' ' ' GLY . . . . . 0.587 ' O ' ' HG3' ' E' ' 58' ' ' LYS . . . 145.19 159.34 8.06 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.016 -1.087 . . . . 0.0 112.897 178.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -102.53 -45.49 5.04 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.473 0.175 . . . . 0.0 111.473 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -150.53 127.36 11.02 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 120.526 0.203 . . . . 0.0 110.982 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 40' ' ' ALA . . . . . 0.529 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -127.49 114.93 18.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.183 0.516 . . . . 0.0 110.473 171.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 41' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' E' ' 79' ' ' THR . 3.7 mppt? -95.08 112.1 23.84 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 174.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 46.7 tp -84.27 108.87 17.38 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -176.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -108.54 144.34 36.34 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.331 0.586 . . . . 0.0 110.112 177.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 44' ' ' LEU . . . . . 0.661 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 0.2 OUTLIER -129.26 116.76 19.63 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.42 174.384 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 45' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -103.51 110.47 22.52 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.236 0.541 . . . . 0.0 109.666 177.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 46' ' ' ALA . . . . . 0.507 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -140.11 145.54 37.74 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.273 -177.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 58.15 33.04 22.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.476 0.655 . . . . 0.0 109.813 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 62.73 37.99 12.2 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.778 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 49' ' ' GLN . . . . . 0.551 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 6.5 tp-100 -140.56 138.98 34.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.59 0.233 . . . . 0.0 110.39 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -90.97 110.09 21.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.363 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 51' ' ' TYR . . . . . 0.513 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 78.2 m-85 -101.79 130.74 48.28 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.419 178.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -85.37 101.87 10.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.706 0.765 . . . . 0.0 109.023 172.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 53' ' ' VAL . . . . . 0.617 ' CG2' ' HB3' ' E' ' 44' ' ' LEU . 2.9 t -76.43 -49.76 23.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.714 -171.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 54' ' ' ALA . . . . . 0.545 ' HB2' HD21 ' E' ' 65' ' ' LEU . . . -154.02 146.67 24.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.498 -177.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 27.7 m -111.04 101.03 9.61 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 170.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 56' ' ' VAL . . . . . 0.46 HG11 HG11 ' E' ' 85' ' ' VAL . 7.5 p -115.82 114.62 46.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.628 0.728 . . . . 0.0 109.754 -176.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 76.2 p -122.82 -178.23 3.88 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.465 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 58' ' ' LYS . . . . . 0.587 ' HG3' ' O ' ' E' ' 37' ' ' GLY . 6.1 mttm -61.53 -29.99 70.35 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.023 0.44 . . . . 0.0 110.287 169.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.06 -40.37 53.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.433 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 79.0 mt -115.51 81.49 8.9 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 174.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.2 -0.5 6.54 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.087 2.524 . . . . 0.0 114.029 -167.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -163.02 130.28 3.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.275 0.559 . . . . 0.0 111.305 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 96.5 t -118.85 120.83 65.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.388 174.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.29 131.48 35.29 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 175.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 65' ' ' LEU . . . . . 0.545 HD21 ' HB2' ' E' ' 54' ' ' ALA . 82.6 mt -123.87 167.19 14.42 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.469 0.652 . . . . 0.0 112.336 -173.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 66' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 14.3 t0 -143.15 99.17 3.4 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.504 170.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 67' ' ' LEU . . . . . 0.594 HD21 HD23 ' D' ' 88' ' ' LEU . 2.5 mt -128.05 140.06 52.17 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.391 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -135.21 122.71 21.99 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.79 174.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -116.08 143.71 45.11 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.492 -178.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 34.2 t -94.4 166.27 12.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.194 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.55 -7.07 51.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.177 0.513 . . . . 0.0 110.151 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.8 -8.25 62.19 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.495 174.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -93.67 144.7 25.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.859 0.361 . . . . 0.0 110.074 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -136.2 127.72 28.69 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 171.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 75' ' ' ILE . . . . . 0.507 HG22 ' HB2' ' E' ' 46' ' ' ALA . 8.5 pt -135.4 160.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.634 -163.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 76' ' ' MET . . . . . 0.437 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 3.0 mtm -114.13 120.35 40.24 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 172.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 77' ' ' PHE . . . . . 0.661 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.7 OUTLIER -103.75 127.82 51.19 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.28 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 78' ' ' TYR . . . . . 0.713 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 53.2 p90 -156.37 143.11 18.67 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 119.79 -0.764 . . . . 0.0 112.269 -176.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 79' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' E' ' 41' ' ' LYS . 2.0 p -114.96 132.02 56.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.291 -176.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.37 160.7 14.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.817 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.0 -175.68 40.12 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -175.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -110.43 102.56 11.17 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.846 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 83' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -174.5 155.62 2.29 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.624 171.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 32.2 t -115.84 117.33 29.9 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 85' ' ' VAL . . . . . 0.667 HG12 ' HB3' ' E' ' 34' ' ' LEU . 3.7 m -111.36 164.9 6.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.268 0.556 . . . . 0.0 112.137 -174.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 21.2 t -129.75 120.9 25.84 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.18 176.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 87' ' ' LEU . . . . . 0.539 HD13 HD23 ' E' ' 11' ' ' LEU . 5.3 mp -92.98 154.48 18.13 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 121.023 0.439 . . . . 0.0 110.132 173.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 88' ' ' LEU . . . . . 0.596 HD23 HD21 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -133.7 144.7 49.3 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.086 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.99 -167.43 28.62 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.9 -0.666 . . . . 0.0 111.999 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 90' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -146.05 136.49 23.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.573 0.701 . . . . 0.0 111.663 177.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 91' ' ' LEU . . . . . 0.675 HD23 ' HB3' ' E' ' 27' ' ' PHE . 26.2 mt . . . . . 0 C--N 1.323 -0.549 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.574 175.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 49.0 mtt . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 121.221 0.534 . . . . 0.0 111.524 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.505 ' CE1' HD21 ' B' ' 44' ' ' LEU . 60.5 t80 -56.85 142.02 42.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.487 -173.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.45 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 87.5 t90 -135.41 141.49 45.47 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.763 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.503 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -143.2 155.46 26.02 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.068 178.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.643 HD23 HD13 ' A' ' 87' ' ' LEU . 57.2 tp -145.21 108.53 4.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.709 0.29 . . . . 0.0 110.901 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -89.0 106.42 18.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.492 0.663 . . . . 0.0 110.91 177.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.558 ' HB2' HG23 ' A' ' 85' ' ' VAL . 4.1 mmt -86.96 134.42 33.5 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.931 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.517 ' HB2' ' HG3' ' A' ' 17' ' ' ARG . 54.5 mtmt -100.26 146.08 31.36 Favored Pre-proline 0 C--N 1.316 -0.851 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 172.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.435 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 5.8 Cg_endo -48.12 110.37 0.32 Allowed 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 123.51 2.807 . . . . 0.0 113.432 -174.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.69 ' HA ' ' O ' ' A' ' 79' ' ' THR . 31.6 mt-10 69.5 54.07 0.41 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.531 178.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.517 ' HG3' ' HB2' ' A' ' 14' ' ' LYS . 19.5 mmt180 -110.75 152.7 26.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.868 172.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.719 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 36.0 ttmt -133.56 107.74 8.18 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.944 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.42 ' OH ' ' HA ' ' A' ' 13' ' ' MET . 0.8 OUTLIER -111.05 121.09 44.45 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.752 179.516 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.4 p -75.29 126.79 31.74 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 170.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -103.95 116.56 32.48 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.125 0.488 . . . . 0.0 111.727 -164.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.5 p -97.22 123.12 40.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.879 173.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.404 ' CG2' ' HA ' ' A' ' 71' ' ' LYS . 55.3 mt -92.97 108.43 20.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.199 0.524 . . . . 0.0 111.575 -172.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.713 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -76.08 -39.65 36.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.007 177.805 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -139.58 141.47 37.17 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.6 m -60.86 120.82 10.89 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.66 0.6 . . . . 0.0 109.85 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.548 ' HB3' HD23 ' A' ' 91' ' ' LEU . 2.2 p90 -134.25 166.01 23.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.706 0.765 . . . . 0.0 112.721 -169.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.621 ' HE2' ' HB2' ' A' ' 30' ' ' SER . 9.3 t60 -118.72 125.13 48.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.302 -1.317 . . . . 0.0 109.958 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.617 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 39.8 mt -94.6 138.48 20.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 169.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.621 ' HB2' ' HE2' ' A' ' 28' ' ' HIS . 26.2 t -119.62 -23.51 6.54 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -169.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -161.92 156.89 28.57 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 119.408 -1.377 . . . . 0.0 113.253 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.405 HG23 ' HG ' ' A' ' 87' ' ' LEU . 10.2 p -137.36 125.38 32.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 172.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.81 152.31 42.07 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -171.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.572 ' HB3' HG12 ' A' ' 85' ' ' VAL . 3.7 pp -119.18 142.73 47.71 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.583 0.706 . . . . 0.0 111.346 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -110.12 -48.46 3.18 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.615 173.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -102.49 127.27 49.62 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 170.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.522 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 145.83 159.54 8.22 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 119.392 -1.385 . . . . 0.0 113.948 176.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.428 ' HA ' ' HB2' ' A' ' 58' ' ' LYS . 54.3 mt-30 -103.15 -44.5 5.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.653 -0.274 . . . . 0.0 111.127 177.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -150.63 132.63 15.21 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 120.5 0.19 . . . . 0.0 111.026 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.527 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -133.02 114.32 13.84 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.286 0.565 . . . . 0.0 110.586 169.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 79' ' ' THR . 63.9 mttp -95.86 112.22 24.0 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 174.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 45.4 tp -83.99 115.93 22.57 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.439 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -117.02 144.01 45.08 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.533 ' HA ' ' O ' ' A' ' 76' ' ' MET . 0.2 OUTLIER -131.34 132.54 44.55 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.2 0.524 . . . . 0.0 109.723 172.086 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -107.09 110.07 22.09 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.3 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.587 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -126.22 151.95 46.71 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 43.36 37.49 1.38 Allowed 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.939 0.774 . . . . 0.0 111.142 -171.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.7 tptp 54.65 46.66 24.26 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.157 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.585 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 6.5 tp-100 -135.17 130.71 35.78 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.669 175.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -85.68 110.86 19.59 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.343 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.49 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 82.5 m-85 -104.62 129.16 52.77 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.7 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 tp -77.25 103.79 4.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 169.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.534 HG13 ' CD2' ' E' ' 88' ' ' LEU . 2.6 t -76.39 -49.52 24.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.293 -173.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.489 ' HB2' ' CD2' ' A' ' 65' ' ' LEU . . . -159.03 144.86 16.47 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.19 -178.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.3 m -110.5 101.49 10.17 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 171.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.431 ' CG1' HG11 ' A' ' 85' ' ' VAL . 7.5 p -111.26 120.44 61.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.133 -178.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 54.8 p -122.61 -179.81 4.35 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -172.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 38' ' ' GLN . 35.0 tttm -60.89 -27.04 67.86 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.272 0.558 . . . . 0.0 109.901 172.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.479 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -83.48 -40.57 19.07 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.734 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 90.9 mt -107.36 89.43 4.84 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 36.0 Cg_exo -61.32 -20.3 67.65 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.101 2.534 . . . . 0.0 113.941 -169.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -156.19 136.09 12.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.381 0.61 . . . . 0.0 111.974 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.453 HG11 ' HB1' ' A' ' 54' ' ' ALA . 98.4 t -111.38 113.8 45.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.729 171.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.03 122.15 34.27 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.08 177.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.489 ' CD2' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -142.6 143.5 32.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.248 0.547 . . . . 0.0 111.902 -177.084 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.471 ' HB3' ' OG ' ' E' ' 30' ' ' SER . 5.6 t70 -89.59 100.57 13.34 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.706 177.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.726 HD21 HD23 ' E' ' 88' ' ' LEU . 19.7 mt -110.81 138.39 47.27 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.686 176.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.649 ' HB2' ' CD2' ' E' ' 90' ' ' TYR . 10.5 m-80 -137.58 128.21 26.82 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 173.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -124.43 146.81 48.69 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.977 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.0 t -99.93 148.97 23.9 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.404 ' HA ' ' CG2' ' A' ' 23' ' ' ILE . 15.1 ptmm? -67.14 -10.72 53.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.326 -178.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.42 -9.87 66.38 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.107 176.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -100.74 160.06 14.67 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -135.12 125.43 26.37 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.587 HG22 ' HB2' ' A' ' 46' ' ' ALA . 11.3 pt -131.21 178.13 5.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.93 0.395 . . . . 0.0 111.609 -171.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.533 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 24.5 mtp -130.9 136.31 48.49 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 174.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.472 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 1.2 m-85 -117.86 128.21 54.62 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.145 176.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.719 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 34.6 p90 -155.08 145.64 22.2 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.966 -178.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.69 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 13.2 p -117.33 144.95 44.36 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.507 -177.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -115.04 151.33 34.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.915 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.58 -177.16 29.29 Favored Glycine 0 CA--C 1.509 -0.334 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -109.74 102.93 11.69 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.684 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -175.27 155.94 1.97 Allowed 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.87 172.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.6 t -113.03 118.87 36.0 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.572 HG12 ' HB3' ' A' ' 34' ' ' LEU . 10.5 m -118.94 137.39 53.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -173.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 54.6 m -101.17 120.94 40.97 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.048 175.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.643 HD13 HD23 ' A' ' 11' ' ' LEU . 5.3 mp -89.41 145.71 25.15 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 170.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.698 HD23 HD21 ' B' ' 67' ' ' LEU . 1.2 tp -131.48 132.17 44.05 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.679 -177.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -159.66 -166.76 19.22 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.701 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.634 ' CD2' ' HB2' ' B' ' 68' ' ' ASN . 18.7 p90 -153.02 133.72 13.83 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.919 0.866 . . . . 0.0 111.547 177.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.548 HD23 ' HB3' ' A' ' 27' ' ' PHE . 5.1 mt . . . . . 0 C--N 1.319 -0.748 0 CA-C-N 113.981 -1.463 . . . . 0.0 108.926 174.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 48.7 mtt . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 121.25 0.548 . . . . 0.0 111.546 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 8' ' ' PHE . . . . . 0.467 ' CE1' HD21 ' C' ' 44' ' ' LEU . 60.7 t80 -56.82 141.91 42.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.515 -173.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' TRP . . . . . 0.454 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 87.5 t90 -135.34 141.42 45.59 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.817 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.479 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -143.13 155.53 26.04 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.105 178.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.637 HD23 HD13 ' B' ' 87' ' ' LEU . 56.9 tp -145.34 108.5 4.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.784 0.326 . . . . 0.0 110.819 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -88.98 106.44 18.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.495 0.664 . . . . 0.0 110.947 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' MET . . . . . 0.553 ' HB2' HG23 ' B' ' 85' ' ' VAL . 4.1 mmt -86.98 134.41 33.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.041 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.526 ' HB2' ' HG3' ' B' ' 17' ' ' ARG . 54.5 mtmt -100.18 146.14 31.45 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 172.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.44 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 5.8 Cg_endo -48.19 110.35 0.32 Allowed 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 123.449 2.766 . . . . 0.0 113.444 -174.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.69 ' HA ' ' O ' ' B' ' 79' ' ' THR . 31.6 mt-10 69.52 54.1 0.4 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.48 178.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.526 ' HG3' ' HB2' ' B' ' 14' ' ' LYS . 19.5 mmt180 -110.73 152.72 26.24 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.879 172.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.724 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 36.0 ttmt -133.59 107.79 8.2 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.825 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' TYR . . . . . 0.42 ' OH ' ' HA ' ' B' ' 13' ' ' MET . 0.8 OUTLIER -110.99 121.07 44.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.803 179.423 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 5.2 p -75.3 126.74 31.63 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 170.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -103.83 116.45 32.3 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.713 -164.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 9.6 p -97.16 123.19 40.86 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.842 173.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 55.6 mt -93.02 108.51 20.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.032 0.444 . . . . 0.0 111.513 -172.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.711 ' H ' HD13 ' B' ' 24' ' ' ILE . 0.2 OUTLIER -76.1 -39.73 36.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.001 177.765 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -139.53 141.48 37.28 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 15.5 m -60.8 120.93 11.06 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.666 0.604 . . . . 0.0 109.814 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' PHE . . . . . 0.545 ' HB3' HD23 ' B' ' 91' ' ' LEU . 2.2 p90 -134.34 165.95 23.95 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.685 0.755 . . . . 0.0 112.73 -169.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' HIS . . . . . 0.62 ' HE2' ' HB2' ' B' ' 30' ' ' SER . 9.5 t60 -118.68 125.1 48.95 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.98 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.627 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 39.7 mt -94.53 138.54 20.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 169.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.62 ' HB2' ' HE2' ' B' ' 28' ' ' HIS . 26.1 t -119.65 -23.49 6.53 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -169.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -161.91 156.99 28.69 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.328 -1.415 . . . . 0.0 113.266 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.405 HG23 ' HG ' ' B' ' 87' ' ' LEU . 10.2 p -137.5 125.37 31.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 172.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.81 152.36 42.14 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -171.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.585 ' HB3' HG12 ' B' ' 85' ' ' VAL . 3.6 pp -119.21 142.75 47.73 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.542 0.687 . . . . 0.0 111.347 177.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -110.22 -48.5 3.17 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.554 173.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -102.41 127.18 49.54 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 170.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.518 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 145.97 159.66 8.3 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 119.38 -1.39 . . . . 0.0 113.8 176.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' GLN . . . . . 0.423 ' HA ' ' HB2' ' B' ' 58' ' ' LYS . 54.3 mt-30 -103.17 -44.55 5.16 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.593 -0.304 . . . . 0.0 111.177 177.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -150.64 132.66 15.23 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 120.536 0.208 . . . . 0.0 111.014 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.507 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -133.0 114.31 13.83 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.266 0.555 . . . . 0.0 110.485 169.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' B' ' 79' ' ' THR . 64.0 mttp -95.88 112.17 23.97 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 174.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 45.2 tp -83.93 116.0 22.57 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.489 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -117.12 143.96 45.22 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.526 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.2 OUTLIER -131.32 132.52 44.56 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.705 172.1 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -107.05 110.12 22.16 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.373 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.584 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -126.25 151.96 46.75 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 43.37 37.45 1.36 Allowed 'General case' 0 N--CA 1.474 0.77 0 O-C-N 123.918 0.761 . . . . 0.0 111.155 -171.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 25.7 tptp 54.55 46.86 23.98 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.116 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.585 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 6.5 tp-100 -135.28 130.72 35.57 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.603 175.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -85.74 110.9 19.66 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.315 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.503 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 82.3 m-85 -104.56 129.18 52.66 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.681 177.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 tp -77.39 103.83 4.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 169.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.53 HG13 ' CD2' ' A' ' 88' ' ' LEU . 2.6 t -76.35 -49.57 24.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.199 -173.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.478 ' HB2' ' CD2' ' B' ' 65' ' ' LEU . . . -159.1 144.84 16.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.178 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 43.7 m -110.51 101.55 10.23 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 171.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 56' ' ' VAL . . . . . 0.431 ' CG1' HG11 ' B' ' 85' ' ' VAL . 7.5 p -111.3 120.48 61.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.147 -178.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 52.8 p -122.67 -179.75 4.34 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.098 0.475 . . . . 0.0 112.215 -172.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' B' ' 38' ' ' GLN . 34.9 tttm -60.9 -27.05 67.88 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.92 172.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.473 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -83.45 -40.57 19.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.791 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 90.9 mt -107.38 89.56 4.98 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 174.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 36.6 Cg_exo -61.46 -20.24 67.67 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.151 2.567 . . . . 0.0 113.949 -169.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -156.27 135.98 12.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.408 0.623 . . . . 0.0 111.886 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.457 HG11 ' HB1' ' B' ' 54' ' ' ALA . 98.6 t -111.3 113.79 45.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.726 171.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.03 122.19 34.31 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.109 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.478 ' CD2' ' HB2' ' B' ' 54' ' ' ALA . 0.2 OUTLIER -142.62 143.49 32.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.315 0.579 . . . . 0.0 111.916 -177.067 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 66' ' ' ASP . . . . . 0.432 ' HB3' ' OG ' ' A' ' 30' ' ' SER . 5.6 t70 -89.61 100.53 13.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.71 177.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.698 HD21 HD23 ' A' ' 88' ' ' LEU . 19.5 mt -110.87 138.38 47.35 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.64 176.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 68' ' ' ASN . . . . . 0.634 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 10.5 m-80 -137.5 128.18 26.92 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 173.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -124.4 146.77 48.68 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.03 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 28.8 t -100.03 148.93 24.0 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -67.17 -10.65 52.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.277 -177.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.46 -9.73 66.47 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.122 176.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -100.89 160.1 14.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -135.18 125.41 26.24 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.584 HG22 ' HB2' ' B' ' 46' ' ' ALA . 11.2 pt -131.19 178.06 6.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.901 0.381 . . . . 0.0 111.55 -171.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.526 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 24.7 mtp -130.87 136.4 48.6 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 174.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 77' ' ' PHE . . . . . 0.48 ' CD1' ' HB2' ' B' ' 44' ' ' LEU . 1.2 m-85 -117.91 128.16 54.55 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.146 176.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.724 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 34.3 p90 -155.07 145.7 22.27 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.922 -178.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.69 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 13.2 p -117.39 144.99 44.39 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.446 -177.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -115.12 151.27 34.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.903 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.7 -177.09 29.11 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -109.89 102.95 11.67 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 119.625 -0.83 . . . . 0.0 109.608 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.518 ' CB ' ' HA3' ' B' ' 37' ' ' GLY . . . -175.22 155.94 1.99 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.814 172.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 32.6 t -113.05 118.86 35.96 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.585 HG12 ' HB3' ' B' ' 34' ' ' LEU . 10.2 m -118.93 137.53 52.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 CA-C-O 121.403 0.621 . . . . 0.0 112.671 -173.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 54.5 m -101.27 120.92 40.97 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.093 175.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.637 HD13 HD23 ' B' ' 11' ' ' LEU . 5.3 mp -89.41 145.74 25.13 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 170.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.696 HD23 HD21 ' C' ' 67' ' ' LEU . 1.2 tp -131.54 132.16 43.94 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.645 -177.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -159.7 -166.78 19.28 Favored Glycine 0 N--CA 1.438 -1.233 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.638 -176.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 90' ' ' TYR . . . . . 0.629 ' CD2' ' HB2' ' C' ' 68' ' ' ASN . 18.7 p90 -152.97 133.68 13.85 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.909 0.861 . . . . 0.0 111.622 177.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 91' ' ' LEU . . . . . 0.545 HD23 ' HB3' ' B' ' 27' ' ' PHE . 5.2 mt . . . . . 0 C--N 1.319 -0.745 0 CA-C-N 113.988 -1.46 . . . . 0.0 108.978 174.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 48.8 mtt . . . . . 0 CA--C 1.518 -0.272 0 CA-C-O 121.255 0.55 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 8' ' ' PHE . . . . . 0.487 ' CE1' HD21 ' D' ' 44' ' ' LEU . 60.1 t80 -56.88 141.94 43.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.448 -173.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 9' ' ' TRP . . . . . 0.457 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 87.5 t90 -135.33 141.41 45.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.802 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 10' ' ' GLY . . . . . 0.484 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -143.17 155.5 26.03 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.053 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.637 HD23 HD13 ' C' ' 87' ' ' LEU . 57.1 tp -145.26 108.58 4.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.821 0.343 . . . . 0.0 110.906 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -89.0 106.43 18.42 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.528 0.68 . . . . 0.0 110.852 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 13' ' ' MET . . . . . 0.555 ' HB2' HG23 ' C' ' 85' ' ' VAL . 4.1 mmt -86.96 134.38 33.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.014 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 14' ' ' LYS . . . . . 0.513 ' HB2' ' HG3' ' C' ' 17' ' ' ARG . 54.5 mtmt -100.16 146.16 31.46 Favored Pre-proline 0 C--N 1.316 -0.849 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 15' ' ' PRO . . . . . 0.436 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 5.8 Cg_endo -48.11 110.37 0.32 Allowed 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.52 2.814 . . . . 0.0 113.422 -174.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 16' ' ' GLU . . . . . 0.685 ' HA ' ' O ' ' C' ' 79' ' ' THR . 31.7 mt-10 69.47 54.08 0.41 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.541 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 17' ' ' ARG . . . . . 0.513 ' HG3' ' HB2' ' C' ' 14' ' ' LYS . 19.4 mmt180 -110.86 152.65 26.45 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.878 172.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 18' ' ' LYS . . . . . 0.718 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 36.0 ttmt -133.5 107.61 8.13 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.911 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 19' ' ' TYR . . . . . 0.422 ' OH ' ' HA ' ' C' ' 13' ' ' MET . 0.8 OUTLIER -110.96 121.06 44.4 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.803 -0.444 . . . . 0.0 109.803 179.5 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 5.2 p -75.35 126.7 31.54 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 171.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -103.77 116.55 32.51 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.722 -164.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 9.6 p -97.21 123.16 40.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.872 173.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 23' ' ' ILE . . . . . 0.402 ' CG2' ' HA ' ' C' ' 71' ' ' LYS . 55.2 mt -93.0 108.51 20.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.201 0.524 . . . . 0.0 111.54 -172.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 24' ' ' ILE . . . . . 0.697 ' H ' HD13 ' C' ' 24' ' ' ILE . 0.2 OUTLIER -76.13 -39.8 36.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.955 177.825 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -139.5 141.43 37.34 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 15.5 m -60.78 120.8 10.82 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 123.628 0.58 . . . . 0.0 109.858 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 27' ' ' PHE . . . . . 0.553 ' HB3' HD23 ' C' ' 91' ' ' LEU . 2.2 p90 -134.27 165.93 23.98 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.685 0.755 . . . . 0.0 112.715 -169.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 28' ' ' HIS . . . . . 0.626 ' HE2' ' HB2' ' C' ' 30' ' ' SER . 9.3 t60 -118.62 125.2 49.24 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.97 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 29' ' ' ILE . . . . . 0.605 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 39.9 mt -94.57 138.5 20.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 169.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.626 ' HB2' ' HE2' ' C' ' 28' ' ' HIS . 26.1 t -119.64 -23.47 6.54 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -169.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 31' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -161.9 157.0 28.7 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 119.374 -1.393 . . . . 0.0 113.29 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 10.2 p -137.45 125.41 31.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 172.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.85 152.34 42.05 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.636 -0.426 . . . . 0.0 112.143 -171.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.592 ' HB3' HG12 ' C' ' 85' ' ' VAL . 3.7 pp -119.2 142.74 47.72 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.49 0.662 . . . . 0.0 111.424 177.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -110.09 -48.58 3.17 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.581 173.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -102.38 127.24 49.48 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 170.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 37' ' ' GLY . . . . . 0.52 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 145.93 159.59 8.26 Favored Glycine 0 N--CA 1.437 -1.257 0 C-N-CA 119.318 -1.42 . . . . 0.0 113.834 176.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 38' ' ' GLN . . . . . 0.425 ' HA ' ' HB2' ' C' ' 58' ' ' LYS . 54.2 mt-30 -103.06 -44.55 5.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.658 -0.271 . . . . 0.0 111.214 177.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -150.67 132.61 15.15 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.483 0.182 . . . . 0.0 110.982 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.519 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -133.02 114.35 13.86 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.286 0.565 . . . . 0.0 110.5 169.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' C' ' 79' ' ' THR . 64.0 mttp -95.91 112.16 23.96 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 174.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 45.4 tp -83.94 116.0 22.58 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -117.11 143.95 45.23 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.52 ' HA ' ' O ' ' C' ' 76' ' ' MET . 0.2 OUTLIER -131.28 132.55 44.65 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.167 0.508 . . . . 0.0 109.665 172.07 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 45' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -107.06 110.14 22.18 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.341 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.573 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -126.28 151.91 46.85 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 43.38 37.47 1.38 Allowed 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.864 0.727 . . . . 0.0 111.193 -171.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 25.7 tptp 54.58 46.71 24.25 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.233 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 49' ' ' GLN . . . . . 0.591 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 6.5 tp-100 -135.22 130.72 35.69 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.567 175.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -85.78 110.84 19.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.906 0.384 . . . . 0.0 110.339 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 51' ' ' TYR . . . . . 0.479 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 82.4 m-85 -104.5 129.19 52.54 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.702 177.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 tp -77.29 103.79 4.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 169.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 53' ' ' VAL . . . . . 0.507 HG13 ' CD2' ' B' ' 88' ' ' LEU . 2.6 t -76.36 -49.62 24.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.243 -173.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 54' ' ' ALA . . . . . 0.466 ' HB2' ' CD2' ' C' ' 65' ' ' LEU . . . -159.0 144.87 16.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.228 -178.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 43.5 m -110.53 101.52 10.19 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 171.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 56' ' ' VAL . . . . . 0.429 ' CG1' HG11 ' C' ' 85' ' ' VAL . 7.6 p -111.26 120.53 62.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.204 -178.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 52.7 p -122.76 -179.74 4.34 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.078 0.466 . . . . 0.0 112.17 -172.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 58' ' ' LYS . . . . . 0.425 ' HB2' ' HA ' ' C' ' 38' ' ' GLN . 34.9 tttm -60.92 -27.16 68.0 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.281 0.562 . . . . 0.0 109.849 172.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 59' ' ' ALA . . . . . 0.476 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -83.43 -40.51 19.22 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.817 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 90.5 mt -107.43 89.48 4.96 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 174.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 61' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 37.5 Cg_exo -61.32 -20.31 67.68 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.145 2.563 . . . . 0.0 113.892 -169.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -156.25 136.02 12.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.479 0.657 . . . . 0.0 111.869 -178.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.456 HG11 ' HB1' ' C' ' 54' ' ' ALA . 98.0 t -111.36 113.92 45.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.663 171.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.15 122.21 34.42 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.025 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 65' ' ' LEU . . . . . 0.466 ' CD2' ' HB2' ' C' ' 54' ' ' ALA . 0.2 OUTLIER -142.59 143.43 32.43 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.287 0.565 . . . . 0.0 111.955 -177.1 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 66' ' ' ASP . . . . . 0.445 ' HB3' ' OG ' ' B' ' 30' ' ' SER . 5.6 t70 -89.54 100.5 13.29 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.718 177.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.696 HD21 HD23 ' B' ' 88' ' ' LEU . 19.7 mt -110.83 138.45 47.22 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.694 176.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 68' ' ' ASN . . . . . 0.629 ' HB2' ' CD2' ' B' ' 90' ' ' TYR . 10.5 m-80 -137.57 128.21 26.85 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 173.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -124.47 146.79 48.74 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.934 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 29.2 t -99.97 148.95 23.95 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 71' ' ' LYS . . . . . 0.402 ' HA ' ' CG2' ' C' ' 23' ' ' ILE . 15.1 ptmm? -67.06 -10.81 53.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.271 -178.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.42 -9.78 66.49 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.081 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -100.9 160.15 14.61 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -135.17 125.53 26.48 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.573 HG22 ' HB2' ' C' ' 46' ' ' ALA . 11.3 pt -131.33 178.04 6.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.836 0.35 . . . . 0.0 111.576 -171.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.52 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 24.6 mtp -130.79 136.25 48.53 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 77' ' ' PHE . . . . . 0.477 ' CD1' ' HB2' ' C' ' 44' ' ' LEU . 1.2 m-85 -117.79 128.23 54.66 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.17 176.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 78' ' ' TYR . . . . . 0.718 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 34.7 p90 -155.14 145.63 22.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.961 0.41 . . . . 0.0 111.987 -178.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 79' ' ' THR . . . . . 0.685 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 13.0 p -117.36 144.97 44.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.438 -177.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -115.09 151.28 34.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.972 177.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.67 -177.03 29.12 Favored Glycine 0 CA--C 1.508 -0.403 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -109.93 102.99 11.7 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.764 0.782 . . . . 0.0 109.637 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 83' ' ' ALA . . . . . 0.52 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -175.27 155.95 1.97 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.833 172.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 32.4 t -113.07 118.8 35.79 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.592 HG12 ' HB3' ' C' ' 34' ' ' LEU . 10.1 m -118.88 137.51 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -173.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 54.2 m -101.21 120.9 40.92 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.074 175.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 87' ' ' LEU . . . . . 0.637 HD13 HD23 ' C' ' 11' ' ' LEU . 5.3 mp -89.36 145.79 25.12 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 170.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 88' ' ' LEU . . . . . 0.687 HD23 HD21 ' D' ' 67' ' ' LEU . 1.2 tp -131.56 132.15 43.9 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.669 -177.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -159.71 -166.88 19.49 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.575 -176.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 90' ' ' TYR . . . . . 0.631 ' CD2' ' HB2' ' D' ' 68' ' ' ASN . 19.0 p90 -152.88 133.71 13.96 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.885 0.85 . . . . 0.0 111.658 177.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 91' ' ' LEU . . . . . 0.553 HD23 ' HB3' ' C' ' 27' ' ' PHE . 5.1 mt . . . . . 0 C--N 1.319 -0.749 0 CA-C-N 114.011 -1.45 . . . . 0.0 108.97 174.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 49.0 mtt . . . . . 0 CA--C 1.519 -0.245 0 CA-C-O 121.312 0.577 . . . . 0.0 111.446 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 8' ' ' PHE . . . . . 0.496 ' CE1' HD21 ' E' ' 44' ' ' LEU . 60.6 t80 -56.78 141.92 42.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.685 -1.143 . . . . 0.0 112.49 -173.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 9' ' ' TRP . . . . . 0.454 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 87.5 t90 -135.38 141.4 45.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.75 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 10' ' ' GLY . . . . . 0.501 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -143.11 155.55 26.04 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.133 178.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 11' ' ' LEU . . . . . 0.635 HD23 HD13 ' D' ' 87' ' ' LEU . 56.8 tp -145.35 108.51 4.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.832 0.348 . . . . 0.0 110.805 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -88.92 106.37 18.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.459 0.647 . . . . 0.0 110.932 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 13' ' ' MET . . . . . 0.566 ' HB2' HG23 ' D' ' 85' ' ' VAL . 4.1 mmt -86.9 134.44 33.52 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.046 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 14' ' ' LYS . . . . . 0.529 ' HB2' ' HG3' ' D' ' 17' ' ' ARG . 54.6 mtmt -100.32 146.15 31.48 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 172.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 15' ' ' PRO . . . . . 0.428 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 5.7 Cg_endo -48.11 110.39 0.32 Allowed 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 123.43 2.754 . . . . 0.0 113.441 -174.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 16' ' ' GLU . . . . . 0.684 ' HA ' ' O ' ' D' ' 79' ' ' THR . 31.6 mt-10 69.47 53.96 0.41 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.55 178.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 17' ' ' ARG . . . . . 0.529 ' HG3' ' HB2' ' D' ' 14' ' ' LYS . 19.5 mmt180 -110.57 152.72 26.08 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.948 172.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 18' ' ' LYS . . . . . 0.707 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 36.0 ttmt -133.62 107.75 8.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.903 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 19' ' ' TYR . . . . . 0.42 ' OH ' ' HA ' ' D' ' 13' ' ' MET . 0.8 OUTLIER -111.11 121.06 44.35 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.579 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 5.2 p -75.26 126.8 31.76 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 170.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -103.97 116.5 32.36 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.054 0.454 . . . . 0.0 111.648 -164.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 9.1 p -97.28 123.14 40.99 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.826 173.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 23' ' ' ILE . . . . . 0.405 ' CG2' ' HA ' ' D' ' 71' ' ' LYS . 55.2 mt -92.97 108.51 20.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.117 0.484 . . . . 0.0 111.521 -172.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 24' ' ' ILE . . . . . 0.709 ' H ' HD13 ' D' ' 24' ' ' ILE . 0.2 OUTLIER -76.23 -39.57 35.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.018 177.827 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -139.6 141.46 37.14 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 15.6 m -60.72 120.84 10.85 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 123.535 0.522 . . . . 0.0 109.747 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 27' ' ' PHE . . . . . 0.565 ' HB3' HD23 ' D' ' 91' ' ' LEU . 2.2 p90 -134.33 165.92 24.02 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.748 0.785 . . . . 0.0 112.725 -169.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 28' ' ' HIS . . . . . 0.631 ' HE2' ' HB2' ' D' ' 30' ' ' SER . 9.5 t60 -118.58 125.15 49.18 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.996 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 29' ' ' ILE . . . . . 0.616 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 39.5 mt -94.56 138.48 20.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 169.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 30' ' ' SER . . . . . 0.631 ' HB2' ' HE2' ' D' ' 28' ' ' HIS . 26.1 t -119.62 -23.46 6.55 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -169.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 31' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -161.97 156.94 28.65 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.385 -1.388 . . . . 0.0 113.257 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.403 HG23 ' HG ' ' D' ' 87' ' ' LEU . 10.4 p -137.4 125.42 32.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.84 152.36 42.08 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.641 -0.424 . . . . 0.0 112.039 -171.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 34' ' ' LEU . . . . . 0.578 ' HB3' HG12 ' D' ' 85' ' ' VAL . 3.7 pp -119.13 142.71 47.69 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.518 0.675 . . . . 0.0 111.415 177.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -110.08 -48.61 3.17 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.591 173.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -102.41 127.17 49.55 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 170.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 37' ' ' GLY . . . . . 0.525 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 145.86 159.63 8.27 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 119.379 -1.391 . . . . 0.0 113.916 176.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 38' ' ' GLN . . . . . 0.428 ' HA ' ' HB2' ' D' ' 58' ' ' LYS . 54.0 mt-30 -103.15 -44.53 5.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.702 -0.249 . . . . 0.0 111.157 177.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -150.68 132.61 15.14 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.566 0.222 . . . . 0.0 111.019 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 40' ' ' ALA . . . . . 0.522 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -132.98 114.33 13.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.234 0.54 . . . . 0.0 110.514 169.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' D' ' 79' ' ' THR . 64.0 mttp -95.86 112.05 23.88 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 45.3 tp -83.88 116.03 22.56 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -177.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -117.18 144.04 45.18 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.531 ' HA ' ' O ' ' D' ' 76' ' ' MET . 0.2 OUTLIER -131.4 132.5 44.42 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.697 172.095 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 45' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -107.04 110.12 22.17 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.396 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.593 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -126.31 151.9 46.92 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 43.4 37.49 1.4 Allowed 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.923 0.764 . . . . 0.0 111.09 -171.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 25.7 tptp 54.57 46.78 24.11 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.186 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 49' ' ' GLN . . . . . 0.589 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 6.5 tp-100 -135.18 130.71 35.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.623 175.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -85.69 110.81 19.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.342 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 51' ' ' TYR . . . . . 0.484 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 82.2 m-85 -104.45 129.2 52.46 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.707 177.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 tp -77.28 103.77 4.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 169.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 53' ' ' VAL . . . . . 0.53 HG13 ' CD2' ' C' ' 88' ' ' LEU . 2.6 t -76.38 -49.55 24.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.246 -173.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 54' ' ' ALA . . . . . 0.485 ' HB2' ' CD2' ' D' ' 65' ' ' LEU . . . -159.02 144.9 16.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.239 -178.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 43.9 m -110.54 101.55 10.22 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 171.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 56' ' ' VAL . . . . . 0.427 ' CG1' HG11 ' D' ' 85' ' ' VAL . 7.6 p -111.22 120.44 61.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.171 -178.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 52.5 p -122.73 -179.79 4.36 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.084 0.469 . . . . 0.0 112.151 -172.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 58' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' D' ' 38' ' ' GLN . 34.8 tttm -60.83 -27.18 67.87 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.289 0.566 . . . . 0.0 109.864 172.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 59' ' ' ALA . . . . . 0.477 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -83.39 -40.56 19.2 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.773 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 91.0 mt -107.33 89.48 4.86 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 61' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 37.6 Cg_exo -61.45 -20.29 67.87 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.193 2.595 . . . . 0.0 113.84 -169.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -156.24 136.03 12.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.409 0.623 . . . . 0.0 111.967 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.46 HG11 ' HB1' ' D' ' 54' ' ' ALA . 98.2 t -111.33 113.77 45.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.702 171.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.07 122.29 34.44 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.995 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 65' ' ' LEU . . . . . 0.485 ' CD2' ' HB2' ' D' ' 54' ' ' ALA . 0.2 OUTLIER -142.79 143.39 32.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.336 0.588 . . . . 0.0 111.856 -177.075 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 66' ' ' ASP . . . . . 0.457 ' HB3' ' OG ' ' C' ' 30' ' ' SER . 5.6 t70 -89.49 100.55 13.32 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.717 177.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.687 HD21 HD23 ' C' ' 88' ' ' LEU . 19.8 mt -110.81 138.39 47.26 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.683 176.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 68' ' ' ASN . . . . . 0.631 ' HB2' ' CD2' ' C' ' 90' ' ' TYR . 10.6 m-80 -137.58 128.22 26.84 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 173.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -124.53 146.77 48.81 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.956 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 29.4 t -99.98 149.01 23.88 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 71' ' ' LYS . . . . . 0.405 ' HA ' ' CG2' ' D' ' 23' ' ' ILE . 15.1 ptmm? -67.22 -10.66 52.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.265 -178.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.52 -9.72 66.38 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.143 176.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -100.95 160.17 14.59 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -135.21 125.35 26.08 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.593 HG22 ' HB2' ' D' ' 46' ' ' ALA . 11.3 pt -131.18 178.14 5.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.012 0.434 . . . . 0.0 111.491 -171.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 76' ' ' MET . . . . . 0.531 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 24.4 mtp -130.87 136.33 48.53 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 174.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 77' ' ' PHE . . . . . 0.476 ' CD1' ' HB2' ' D' ' 44' ' ' LEU . 1.2 m-85 -117.79 128.16 54.6 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.192 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 78' ' ' TYR . . . . . 0.707 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 34.5 p90 -155.1 145.63 22.17 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.953 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 79' ' ' THR . . . . . 0.684 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 13.4 p -117.29 144.94 44.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.522 -177.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -115.07 151.27 34.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.938 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.7 -177.04 29.09 Favored Glycine 0 CA--C 1.508 -0.348 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -109.82 102.89 11.63 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 119.661 -0.815 . . . . 0.0 109.686 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 83' ' ' ALA . . . . . 0.525 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -175.25 155.89 1.97 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.782 172.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 32.8 t -112.98 118.84 35.97 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.578 HG12 ' HB3' ' D' ' 34' ' ' LEU . 10.2 m -118.92 137.53 52.6 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -173.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 54.9 m -101.25 121.02 41.12 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.986 175.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 87' ' ' LEU . . . . . 0.635 HD13 HD23 ' D' ' 11' ' ' LEU . 5.3 mp -89.4 145.72 25.15 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 170.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.699 HD23 HD21 ' E' ' 67' ' ' LEU . 1.2 tp -131.49 132.1 43.97 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.733 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -159.64 -166.78 19.23 Favored Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.641 -176.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 90' ' ' TYR . . . . . 0.645 ' CD2' ' HB2' ' E' ' 68' ' ' ASN . 19.0 p90 -152.91 133.66 13.89 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.882 0.849 . . . . 0.0 111.654 177.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 91' ' ' LEU . . . . . 0.565 HD23 ' HB3' ' D' ' 27' ' ' PHE . 5.1 mt . . . . . 0 C--N 1.319 -0.73 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.003 174.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 48.8 mtt . . . . . 0 CA--C 1.518 -0.256 0 CA-C-O 121.218 0.532 . . . . 0.0 111.545 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' E' E ' 8' ' ' PHE . . . . . 0.494 ' CE1' HD21 ' A' ' 44' ' ' LEU . 60.6 t80 -56.75 141.94 42.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.601 -173.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 9' ' ' TRP . . . . . 0.455 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 87.3 t90 -135.34 141.34 45.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.056 -0.975 . . . . 0.0 108.812 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 10' ' ' GLY . . . . . 0.49 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -143.18 155.5 26.04 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.07 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 11' ' ' LEU . . . . . 0.628 HD23 HD13 ' E' ' 87' ' ' LEU . 57.2 tp -145.22 108.45 4.59 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.747 0.308 . . . . 0.0 110.89 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -88.96 106.42 18.41 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.413 0.625 . . . . 0.0 110.93 177.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 13' ' ' MET . . . . . 0.566 ' HB2' HG23 ' E' ' 85' ' ' VAL . 4.1 mmt -86.95 134.36 33.51 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.995 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 14' ' ' LYS . . . . . 0.506 ' HB2' ' HG3' ' E' ' 17' ' ' ARG . 54.6 mtmt -100.22 146.18 31.51 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 172.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 15' ' ' PRO . . . . . 0.428 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 5.7 Cg_endo -48.19 110.44 0.33 Allowed 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 123.418 2.745 . . . . 0.0 113.449 -174.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 16' ' ' GLU . . . . . 0.683 ' HA ' ' O ' ' E' ' 79' ' ' THR . 31.5 mt-10 69.46 53.99 0.41 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.533 178.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 17' ' ' ARG . . . . . 0.506 ' HG3' ' HB2' ' E' ' 14' ' ' LYS . 19.6 mmt180 -110.56 152.74 26.06 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.889 172.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 18' ' ' LYS . . . . . 0.716 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 36.0 ttmt -133.62 107.79 8.18 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.923 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 19' ' ' TYR . . . . . 0.42 ' OH ' ' HA ' ' E' ' 13' ' ' MET . 0.8 OUTLIER -111.02 121.16 44.65 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 5.4 p -75.37 126.7 31.54 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 170.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -103.9 116.52 32.42 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.039 0.447 . . . . 0.0 111.66 -164.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 9.4 p -97.2 123.12 40.89 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.88 173.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 55.3 mt -92.99 108.5 20.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.18 0.514 . . . . 0.0 111.557 -172.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 24' ' ' ILE . . . . . 0.715 ' H ' HD13 ' E' ' 24' ' ' ILE . 0.2 OUTLIER -76.16 -39.7 36.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.97 177.814 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -139.58 141.43 37.19 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 15.5 m -60.69 120.87 10.9 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.671 0.607 . . . . 0.0 109.915 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 27' ' ' PHE . . . . . 0.543 ' HB3' HD23 ' E' ' 91' ' ' LEU . 2.2 p90 -134.39 165.92 24.04 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.741 0.782 . . . . 0.0 112.659 -169.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 28' ' ' HIS . . . . . 0.624 ' HE2' ' HB2' ' E' ' 30' ' ' SER . 9.4 t60 -118.6 125.13 49.11 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.933 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 29' ' ' ILE . . . . . 0.618 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 39.9 mt -94.57 138.49 20.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 169.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 30' ' ' SER . . . . . 0.624 ' HB2' ' HE2' ' E' ' 28' ' ' HIS . 26.1 t -119.66 -23.51 6.52 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -169.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 31' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -161.94 156.98 28.69 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 119.365 -1.398 . . . . 0.0 113.296 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.41 HG23 ' HG ' ' E' ' 87' ' ' LEU . 10.3 p -137.43 125.34 31.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 172.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.78 152.25 42.06 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -171.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 34' ' ' LEU . . . . . 0.59 ' HB3' HG12 ' E' ' 85' ' ' VAL . 3.6 pp -119.15 142.75 47.67 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.532 0.682 . . . . 0.0 111.38 177.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -110.13 -48.59 3.17 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.542 173.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -102.45 127.27 49.55 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 170.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 37' ' ' GLY . . . . . 0.526 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 145.85 159.49 8.2 Favored Glycine 0 N--CA 1.437 -1.242 0 C-N-CA 119.342 -1.409 . . . . 0.0 113.938 176.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 38' ' ' GLN . . . . . 0.423 ' HA ' ' HB2' ' E' ' 58' ' ' LYS . 54.3 mt-30 -103.11 -44.44 5.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.697 -0.252 . . . . 0.0 111.181 177.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -150.66 132.63 15.18 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 120.415 0.15 . . . . 0.0 110.974 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 40' ' ' ALA . . . . . 0.511 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -133.07 114.36 13.83 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.302 0.572 . . . . 0.0 110.498 169.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 41' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' E' ' 79' ' ' THR . 64.1 mttp -95.79 112.05 23.87 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 174.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 45.4 tp -83.87 115.97 22.53 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.484 -177.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -117.06 144.0 45.13 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 44' ' ' LEU . . . . . 0.514 ' HA ' ' O ' ' E' ' 76' ' ' MET . 0.2 OUTLIER -131.35 132.52 44.51 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.201 0.524 . . . . 0.0 109.684 172.061 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 45' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -107.05 110.11 22.16 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.371 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 46' ' ' ALA . . . . . 0.576 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -126.26 151.98 46.73 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 176.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 43.39 37.44 1.38 Allowed 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.919 0.762 . . . . 0.0 111.146 -171.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 25.7 tptp 54.61 46.79 24.05 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.144 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 49' ' ' GLN . . . . . 0.586 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 6.5 tp-100 -135.31 130.76 35.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.639 175.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -85.78 110.83 19.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.264 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 51' ' ' TYR . . . . . 0.501 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 82.3 m-85 -104.49 129.15 52.54 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.764 177.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 tp -77.34 103.8 4.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 169.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 53' ' ' VAL . . . . . 0.529 HG13 ' CD2' ' D' ' 88' ' ' LEU . 2.6 t -76.32 -49.57 24.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.291 -173.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 54' ' ' ALA . . . . . 0.483 ' HB2' ' CD2' ' E' ' 65' ' ' LEU . . . -159.07 144.88 16.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.211 -178.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 44.4 m -110.52 101.46 10.14 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 171.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 56' ' ' VAL . . . . . 0.425 ' CG1' HG11 ' E' ' 85' ' ' VAL . 7.5 p -111.22 120.54 62.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.176 -178.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 52.3 p -122.73 -179.79 4.35 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.065 0.459 . . . . 0.0 112.153 -172.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 58' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' E' ' 38' ' ' GLN . 34.9 tttm -60.84 -27.18 67.89 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.854 172.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 59' ' ' ALA . . . . . 0.474 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -83.38 -40.51 19.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.804 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 90.9 mt -107.45 89.51 5.01 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 174.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 61' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 36.2 Cg_exo -61.4 -20.31 67.86 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.193 2.595 . . . . 0.0 113.916 -169.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -156.32 136.07 12.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.452 0.644 . . . . 0.0 111.921 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 63' ' ' VAL . . . . . 0.471 HG11 ' HB1' ' E' ' 54' ' ' ALA . 98.9 t -111.33 113.73 45.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.763 171.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.06 122.22 34.36 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.057 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 65' ' ' LEU . . . . . 0.483 ' CD2' ' HB2' ' E' ' 54' ' ' ALA . 0.2 OUTLIER -142.74 143.49 32.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.335 0.588 . . . . 0.0 111.936 -177.128 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 66' ' ' ASP . . . . . 0.442 ' HB3' ' OG ' ' D' ' 30' ' ' SER . 5.6 t70 -89.49 100.53 13.31 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.679 177.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 67' ' ' LEU . . . . . 0.699 HD21 HD23 ' D' ' 88' ' ' LEU . 19.9 mt -110.91 138.41 47.34 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.646 176.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 68' ' ' ASN . . . . . 0.645 ' HB2' ' CD2' ' D' ' 90' ' ' TYR . 10.5 m-80 -137.63 128.26 26.8 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 173.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -124.47 146.79 48.73 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.974 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 29.5 t -100.12 149.01 23.95 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -67.14 -10.71 53.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.284 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.44 -9.77 66.48 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.064 176.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -100.83 160.17 14.59 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -135.22 125.48 26.33 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 75' ' ' ILE . . . . . 0.576 HG22 ' HB2' ' E' ' 46' ' ' ALA . 11.3 pt -131.31 178.08 6.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.835 0.35 . . . . 0.0 111.56 -171.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 76' ' ' MET . . . . . 0.514 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 24.6 mtp -130.89 136.28 48.47 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 77' ' ' PHE . . . . . 0.478 ' CD1' ' HB2' ' E' ' 44' ' ' LEU . 1.2 m-85 -117.82 128.2 54.63 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.199 176.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 78' ' ' TYR . . . . . 0.716 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 34.4 p90 -155.1 145.62 22.16 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.979 -178.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 79' ' ' THR . . . . . 0.683 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 13.3 p -117.3 144.91 44.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.496 -177.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -115.01 151.38 34.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.912 177.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.64 -177.2 29.25 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -109.81 102.88 11.63 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 117.79 0.795 . . . . 0.0 109.733 177.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 83' ' ' ALA . . . . . 0.526 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -175.22 155.94 1.99 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.823 172.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 32.6 t -113.06 118.83 35.86 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 85' ' ' VAL . . . . . 0.59 HG12 ' HB3' ' E' ' 34' ' ' LEU . 10.1 m -118.91 137.54 52.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -173.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 54.1 m -101.27 120.96 41.02 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.077 175.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 87' ' ' LEU . . . . . 0.628 HD13 HD23 ' E' ' 11' ' ' LEU . 5.3 mp -89.39 145.83 25.07 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 170.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 88' ' ' LEU . . . . . 0.726 HD23 HD21 ' A' ' 67' ' ' LEU . 1.2 tp -131.61 132.15 43.81 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.701 -177.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -159.67 -166.82 19.34 Favored Glycine 0 N--CA 1.439 -1.125 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.551 -176.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 90' ' ' TYR . . . . . 0.649 ' CD2' ' HB2' ' A' ' 68' ' ' ASN . 19.0 p90 -152.94 133.67 13.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.864 0.84 . . . . 0.0 111.687 177.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 91' ' ' LEU . . . . . 0.543 HD23 ' HB3' ' E' ' 27' ' ' PHE . 5.3 mt . . . . . 0 C--N 1.318 -0.775 0 CA-C-N 114.073 -1.421 . . . . 0.0 108.896 174.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.0 mtt . . . . . 0 C--O 1.226 -0.165 0 CA-C-O 120.886 0.374 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.436 ' CE1' HD21 ' B' ' 44' ' ' LEU . 74.6 t80 -54.83 143.94 24.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.847 -173.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.594 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 89.6 t90 -139.27 148.7 43.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.104 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.554 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -149.98 153.37 25.05 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.715 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.727 HD23 HD13 ' A' ' 87' ' ' LEU . 59.2 tp -139.06 108.8 6.24 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.916 0.389 . . . . 0.0 111.108 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -80.38 105.72 11.85 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.706 173.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.595 ' HB3' HG23 ' A' ' 85' ' ' VAL . 35.7 tpp -99.41 132.32 44.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.045 0.45 . . . . 0.0 110.956 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -98.63 146.6 31.88 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.89 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.527 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 10.4 Cg_endo -53.6 115.82 2.57 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 123.433 2.756 . . . . 0.0 113.141 -176.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.711 ' HA ' ' O ' ' A' ' 79' ' ' THR . 34.5 mt-10 63.49 38.12 10.06 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.591 177.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -109.36 149.95 28.74 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 173.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.694 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 34.4 ttmt -125.94 119.21 27.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.716 0.293 . . . . 0.0 111.592 -174.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.467 ' OH ' ' HA ' ' A' ' 13' ' ' MET . 3.6 m-85 -110.6 104.96 13.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.442 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.9 p -87.67 99.49 12.11 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 171.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -125.34 148.7 48.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.542 0.687 . . . . 0.0 112.466 -166.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.4 t -92.38 160.31 15.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.029 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 68.2 mt -106.24 117.79 52.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.05 0.452 . . . . 0.0 110.806 -175.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.466 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.1 mp -79.31 -45.38 23.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.916 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -135.17 140.22 45.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.739 178.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.1 m -55.99 124.15 16.75 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.527 0.517 . . . . 0.0 109.647 177.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.549 ' HB3' HD23 ' A' ' 91' ' ' LEU . 3.9 p90 -140.09 158.53 43.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.685 0.755 . . . . 0.0 112.683 -171.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.577 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 14.3 t60 -112.8 125.94 54.89 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.102 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 44.6 mt -96.3 133.45 37.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 170.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.577 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 42.2 p -118.48 -15.07 9.66 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -170.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.83 151.97 22.53 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 119.329 -1.415 . . . . 0.0 113.48 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.465 HG23 ' HG ' ' A' ' 87' ' ' LEU . 9.1 p -140.76 123.88 16.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 171.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.422 ' HA ' HG21 ' A' ' 56' ' ' VAL . . . -143.49 154.68 43.89 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.394 -0.522 . . . . 0.0 112.044 -173.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.631 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.3 pp -118.28 138.86 52.08 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.726 0.774 . . . . 0.0 111.178 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -110.07 -47.6 3.3 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.495 172.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -103.15 127.42 50.44 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.171 170.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.459 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 147.28 163.05 10.33 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 119.729 -1.224 . . . . 0.0 113.443 177.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.455 ' O ' ' HG3' ' A' ' 58' ' ' LYS . 48.8 tt0 -102.23 -48.21 4.27 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.554 0.216 . . . . 0.0 111.207 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -153.07 137.85 17.03 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.729 -0.214 . . . . 0.0 110.657 176.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.549 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -136.39 114.97 11.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.395 0.616 . . . . 0.0 111.12 171.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 79' ' ' THR . 68.1 mttm -95.07 115.03 26.91 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 171.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.403 HD23 ' HB ' ' A' ' 53' ' ' VAL . 38.1 tp -84.11 116.25 22.8 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -176.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.409 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 93.9 m-85 -117.09 143.82 45.35 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' A' ' 76' ' ' MET . 0.1 OUTLIER -131.7 131.71 43.3 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 172.68 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.577 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -111.87 118.15 34.75 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.132 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.638 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -130.48 133.66 46.46 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.485 178.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 56.05 38.9 30.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.135 0.493 . . . . 0.0 110.67 -175.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm 65.8 22.52 11.47 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.333 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.577 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 28.9 mm-40 -113.32 124.48 52.57 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -87.42 116.87 25.82 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.569 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 72.4 m-85 -111.61 131.07 55.52 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.782 177.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -81.34 103.42 8.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 171.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.506 HG13 ' CD2' ' E' ' 88' ' ' LEU . 2.3 t -76.87 -47.64 27.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.473 -172.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.476 ' HB2' HD23 ' A' ' 65' ' ' LEU . . . -156.7 151.53 25.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.327 -178.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 98.1 m -114.81 101.77 9.37 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 169.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.469 HG11 HG11 ' A' ' 85' ' ' VAL . 7.4 p -113.04 114.12 46.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.675 0.75 . . . . 0.0 109.759 -177.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 77.1 p -123.31 -177.75 3.79 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.411 -174.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 38' ' ' GLN . 28.8 mtpp -57.22 -36.13 70.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.101 0.477 . . . . 0.0 110.374 169.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.27 -41.23 66.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.551 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.9 mt -115.74 82.66 10.61 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 174.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.1 0.5 6.53 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.858 2.372 . . . . 0.0 113.598 -168.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -162.76 128.0 3.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.153 0.501 . . . . 0.0 111.029 -176.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.426 HG23 ' HB ' ' A' ' 56' ' ' VAL . 92.8 t -114.23 111.23 35.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.478 174.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.83 112.15 23.85 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.679 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.476 HD23 ' HB2' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -130.51 168.44 17.04 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.57 -175.522 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 6.5 t0 -115.25 99.92 7.76 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.344 0.592 . . . . 0.0 110.33 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.656 HD21 HD23 ' E' ' 88' ' ' LEU . 17.7 mt -114.59 141.23 48.03 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.667 177.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.429 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 6.2 t30 -146.62 115.32 6.81 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.975 0.417 . . . . 0.0 110.053 174.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -110.18 159.93 16.94 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.0 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.7 p -112.4 149.61 32.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.551 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.426 ' HG3' ' H ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -71.46 10.45 0.62 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -175.645 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.68 -21.39 14.48 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.087 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -101.23 171.39 7.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.777 0.322 . . . . 0.0 110.883 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 -137.72 129.3 28.23 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.638 HG22 ' HB2' ' A' ' 46' ' ' ALA . 14.5 pt -129.24 163.04 35.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.062 0.458 . . . . 0.0 111.691 -170.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.544 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 4.8 mtm -118.3 122.82 43.85 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 175.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.537 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 1.0 OUTLIER -105.05 127.69 52.99 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.171 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.694 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 49.5 p90 -155.9 150.6 26.12 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.508 -177.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.711 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 11.2 p -117.2 149.12 40.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.735 -178.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.04 144.6 42.33 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.247 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.19 176.99 34.69 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -175.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -106.47 102.8 12.17 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.932 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.549 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -170.75 151.25 3.43 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.574 169.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.6 t -108.14 121.6 45.17 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.631 HG12 ' HB3' ' A' ' 34' ' ' LEU . 11.4 m -118.54 146.19 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 CA-C-O 121.435 0.636 . . . . 0.0 111.666 -173.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.2 t -111.88 120.94 43.62 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.727 HD13 HD23 ' A' ' 11' ' ' LEU . 5.1 mp -93.0 151.63 19.78 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 174.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.635 HD23 HD21 ' B' ' 67' ' ' LEU . 1.6 tp -133.58 141.11 47.53 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.162 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.16 -166.67 26.63 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.825 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.43 ' CD2' ' HB3' ' B' ' 68' ' ' ASN . 8.1 p90 -150.96 130.16 12.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.754 0.788 . . . . 0.0 111.698 176.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.549 HD23 ' HB3' ' A' ' 27' ' ' PHE . 5.3 mt . . . . . 0 C--N 1.325 -0.485 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.886 176.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 59.9 mtt . . . . . 0 C--O 1.226 -0.179 0 CA-C-O 120.911 0.386 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 8' ' ' PHE . . . . . 0.483 ' CE1' HD21 ' C' ' 44' ' ' LEU . 73.9 t80 -54.97 144.03 24.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.853 -173.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' TRP . . . . . 0.589 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 89.5 t90 -139.38 148.6 43.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.971 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.587 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -149.85 153.44 25.11 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.828 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.735 HD23 HD13 ' B' ' 87' ' ' LEU . 59.5 tp -139.04 108.71 6.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.774 0.321 . . . . 0.0 111.197 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -80.35 105.84 11.92 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.706 173.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' MET . . . . . 0.611 ' HB3' HG23 ' B' ' 85' ' ' VAL . 35.6 tpp -99.53 132.44 44.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.156 0.503 . . . . 0.0 110.87 -176.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -98.61 146.61 31.9 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.915 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.525 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 10.3 Cg_endo -53.68 115.86 2.61 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 123.425 2.75 . . . . 0.0 113.134 -176.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.709 ' HA ' ' O ' ' B' ' 79' ' ' THR . 34.6 mt-10 63.5 38.02 10.1 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.666 177.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -109.31 149.84 28.86 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.69 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 34.3 ttmt -125.95 119.23 27.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.774 0.321 . . . . 0.0 111.617 -174.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' TYR . . . . . 0.48 ' OH ' ' HA ' ' B' ' 13' ' ' MET . 3.6 m-85 -110.54 104.94 13.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.399 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 11.9 p -87.59 99.4 12.02 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 171.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -125.27 148.81 48.53 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.616 0.722 . . . . 0.0 112.5 -166.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 11.5 t -92.46 160.34 15.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.998 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 68.0 mt -106.28 117.69 52.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.085 0.469 . . . . 0.0 110.823 -175.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.463 ' H ' HD12 ' B' ' 24' ' ' ILE . 4.1 mp -79.27 -45.36 23.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.984 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -135.19 140.24 45.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.757 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 17.8 m -55.92 124.03 16.3 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 123.639 0.587 . . . . 0.0 109.646 177.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' PHE . . . . . 0.559 ' HB3' HD23 ' B' ' 91' ' ' LEU . 3.9 p90 -140.03 158.57 43.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.704 0.764 . . . . 0.0 112.739 -171.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' HIS . . . . . 0.576 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 14.2 t60 -112.86 126.05 55.03 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.07 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.608 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 44.0 mt -96.3 133.44 37.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 170.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.576 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 41.5 p -118.47 -15.04 9.67 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -170.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.87 151.97 22.52 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 119.276 -1.44 . . . . 0.0 113.456 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.463 HG23 ' HG ' ' B' ' 87' ' ' LEU . 9.1 p -140.74 123.88 16.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 171.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' ALA . . . . . 0.405 ' HA ' HG21 ' B' ' 56' ' ' VAL . . . -143.5 154.63 43.84 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.486 -0.485 . . . . 0.0 112.085 -172.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.636 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.3 pp -118.28 138.88 52.07 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.627 0.727 . . . . 0.0 111.155 177.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -110.17 -47.56 3.29 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.404 172.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -103.2 127.44 50.49 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.167 170.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.455 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 147.26 162.99 10.3 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 119.696 -1.24 . . . . 0.0 113.405 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' GLN . . . . . 0.464 ' O ' ' HG3' ' B' ' 58' ' ' LYS . 48.7 tt0 -102.16 -48.3 4.26 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.474 0.178 . . . . 0.0 111.149 178.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -153.07 137.77 16.96 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.713 -0.222 . . . . 0.0 110.652 176.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.542 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -136.31 114.89 11.9 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.279 0.561 . . . . 0.0 111.196 171.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' B' ' 79' ' ' THR . 68.1 mttm -95.03 114.99 26.86 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 171.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.406 HD23 ' HB ' ' B' ' 53' ' ' VAL . 38.1 tp -84.06 116.25 22.77 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -176.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' TYR . . . . . 0.409 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 93.9 m-85 -117.09 143.79 45.39 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.539 177.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.561 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.1 OUTLIER -131.63 131.71 43.44 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 172.657 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -111.88 118.1 34.59 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.087 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.631 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -130.44 133.67 46.51 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.444 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 56.07 38.78 30.27 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.516 0.51 . . . . 0.0 110.675 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm 65.9 22.44 11.35 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.344 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.574 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 28.9 mm-40 -113.32 124.5 52.61 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 177.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -87.52 116.92 25.97 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.554 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 72.3 m-85 -111.68 131.06 55.55 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.749 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -81.27 103.42 8.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 170.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.47 HG13 ' CD2' ' A' ' 88' ' ' LEU . 2.3 t -76.87 -47.65 27.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.476 -172.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.471 ' HB2' HD23 ' B' ' 65' ' ' LEU . . . -156.69 151.49 25.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.334 -178.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 99.9 m -114.78 101.77 9.38 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 169.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 56' ' ' VAL . . . . . 0.474 HG11 HG11 ' B' ' 85' ' ' VAL . 7.4 p -113.0 114.07 45.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.578 0.704 . . . . 0.0 109.755 -177.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 76.3 p -123.27 -177.79 3.8 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.445 -174.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' B' ' 38' ' ' GLN . 28.8 mtpp -57.16 -36.18 70.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.073 0.463 . . . . 0.0 110.331 168.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.43 -41.19 66.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.503 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 76.3 mt -115.67 82.68 10.45 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 174.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.09 0.37 6.74 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.992 2.461 . . . . 0.0 113.606 -168.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -162.66 128.01 3.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.263 0.554 . . . . 0.0 111.005 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.432 HG23 ' HB ' ' B' ' 56' ' ' VAL . 94.9 t -114.13 111.24 35.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.54 174.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.81 112.0 23.62 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.728 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.471 HD23 ' HB2' ' B' ' 54' ' ' ALA . 0.3 OUTLIER -130.43 168.46 16.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.558 -175.497 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 66' ' ' ASP . . . . . 0.49 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 6.5 t0 -115.26 99.96 7.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.298 0.57 . . . . 0.0 110.405 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.635 HD21 HD23 ' A' ' 88' ' ' LEU . 17.7 mt -114.58 141.3 47.94 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.66 177.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 68' ' ' ASN . . . . . 0.43 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 6.3 t30 -146.71 115.27 6.76 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.013 0.435 . . . . 0.0 110.074 174.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -110.22 159.92 16.96 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.929 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 10.3 p -112.45 149.56 32.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.544 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 71' ' ' LYS . . . . . 0.422 ' H ' ' HG3' ' B' ' 71' ' ' LYS . 0.0 OUTLIER -71.4 10.52 0.6 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -175.592 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.71 -21.51 14.21 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.118 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -101.13 171.39 7.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.775 0.321 . . . . 0.0 110.901 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 -137.76 129.49 28.44 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.631 HG22 ' HB2' ' B' ' 46' ' ' ALA . 14.7 pt -129.36 162.95 35.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.027 0.441 . . . . 0.0 111.703 -170.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.561 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 4.8 mtm -118.28 122.87 44.0 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 175.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 77' ' ' PHE . . . . . 0.54 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 1.0 OUTLIER -105.12 127.72 53.03 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.183 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.69 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 49.3 p90 -155.93 150.63 26.09 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.471 -177.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.709 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 11.2 p -117.32 149.08 41.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.922 0.392 . . . . 0.0 111.679 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.06 144.54 42.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.269 174.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.25 176.96 34.6 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -106.5 102.8 12.17 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.932 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.542 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -170.82 151.28 3.38 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.527 169.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 23.6 t -108.31 121.61 45.26 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.636 HG12 ' HB3' ' B' ' 34' ' ' LEU . 11.6 m -118.41 146.19 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 CA-C-O 121.406 0.622 . . . . 0.0 111.665 -173.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 15.3 t -111.87 120.86 43.37 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.735 HD13 HD23 ' B' ' 11' ' ' LEU . 5.0 mp -92.91 151.57 19.88 Favored 'General case' 0 CA--C 1.502 -0.895 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.64 174.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.618 HD23 HD21 ' C' ' 67' ' ' LEU . 1.6 tp -133.49 141.12 47.63 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.129 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.2 -166.69 26.71 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.812 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 90' ' ' TYR . . . . . 0.421 ' CD2' ' HB3' ' C' ' 68' ' ' ASN . 8.2 p90 -150.89 130.13 12.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.679 0.752 . . . . 0.0 111.778 176.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 91' ' ' LEU . . . . . 0.559 HD23 ' HB3' ' B' ' 27' ' ' PHE . 5.4 mt . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 114.238 -1.346 . . . . 0.0 109.933 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 59.9 mtt . . . . . 0 C--O 1.227 -0.128 0 CA-C-O 120.874 0.369 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 8' ' ' PHE . . . . . 0.466 ' CE1' HD21 ' D' ' 44' ' ' LEU . 74.0 t80 -54.91 144.02 24.27 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.878 -173.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 9' ' ' TRP . . . . . 0.581 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 89.6 t90 -139.25 148.74 43.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.98 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 10' ' ' GLY . . . . . 0.543 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -149.97 153.44 25.09 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.764 177.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.716 HD23 HD13 ' C' ' 87' ' ' LEU . 59.5 tp -139.15 108.86 6.24 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.945 0.402 . . . . 0.0 111.093 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -80.35 105.7 11.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.751 173.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 13' ' ' MET . . . . . 0.615 ' HB3' HG23 ' C' ' 85' ' ' VAL . 35.8 tpp -99.48 132.27 44.93 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.116 0.484 . . . . 0.0 110.852 -176.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -98.47 146.53 31.74 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.013 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 15' ' ' PRO . . . . . 0.53 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 10.3 Cg_endo -53.62 115.95 2.67 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 123.362 2.708 . . . . 0.0 113.161 -176.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 16' ' ' GLU . . . . . 0.712 ' HA ' ' O ' ' C' ' 79' ' ' THR . 34.6 mt-10 63.4 38.07 10.33 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.699 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -109.3 149.85 28.85 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 173.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 18' ' ' LYS . . . . . 0.691 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 34.4 ttmt -126.05 119.26 27.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.748 0.309 . . . . 0.0 111.583 -174.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 19' ' ' TYR . . . . . 0.467 ' OH ' ' HA ' ' C' ' 13' ' ' MET . 3.6 m-85 -110.56 104.98 13.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.434 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 11.9 p -87.61 99.47 12.08 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 171.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -125.42 148.84 48.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.589 0.709 . . . . 0.0 112.462 -166.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 11.4 t -92.51 160.4 15.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.997 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -106.27 117.73 52.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.091 0.472 . . . . 0.0 110.824 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 24' ' ' ILE . . . . . 0.471 ' H ' HD12 ' C' ' 24' ' ' ILE . 4.1 mp -79.26 -45.44 23.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.965 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -135.16 140.3 45.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.707 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 18.0 m -56.03 124.15 16.78 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.582 0.551 . . . . 0.0 109.582 177.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 27' ' ' PHE . . . . . 0.562 ' HB3' HD23 ' C' ' 91' ' ' LEU . 3.9 p90 -140.08 158.5 43.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.739 0.781 . . . . 0.0 112.78 -171.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 28' ' ' HIS . . . . . 0.582 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 14.2 t60 -112.77 125.97 54.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.104 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 29' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 44.2 mt -96.28 133.44 37.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.582 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 41.1 p -118.49 -14.98 9.66 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -170.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.91 151.84 22.35 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 119.314 -1.422 . . . . 0.0 113.508 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.456 HG23 ' HG ' ' C' ' 87' ' ' LEU . 9.0 p -140.74 123.89 16.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 171.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.42 ' HA ' HG21 ' C' ' 56' ' ' VAL . . . -143.56 154.59 43.75 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.397 -0.521 . . . . 0.0 112.077 -172.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.617 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.3 pp -118.14 138.86 52.0 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.685 0.755 . . . . 0.0 111.241 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -110.19 -47.52 3.29 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.772 -1.103 . . . . 0.0 108.464 172.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -103.17 127.51 50.44 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.227 170.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 37' ' ' GLY . . . . . 0.454 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 147.21 163.06 10.32 Favored Glycine 0 N--CA 1.439 -1.111 0 C-N-CA 119.718 -1.229 . . . . 0.0 113.442 177.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 38' ' ' GLN . . . . . 0.456 ' O ' ' HG3' ' C' ' 58' ' ' LYS . 48.9 tt0 -102.28 -48.27 4.25 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.483 0.183 . . . . 0.0 111.122 178.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -153.07 137.77 16.96 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 122.162 0.185 . . . . 0.0 110.714 176.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.534 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -136.27 114.92 11.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.292 0.568 . . . . 0.0 111.171 171.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' C' ' 79' ' ' THR . 68.1 mttm -95.0 114.91 26.77 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 171.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.411 HD23 ' HB ' ' C' ' 53' ' ' VAL . 37.9 tp -84.04 116.26 22.76 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -176.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 43' ' ' TYR . . . . . 0.401 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 93.9 m-85 -117.09 143.77 45.42 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 177.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' C' ' 76' ' ' MET . 0.1 OUTLIER -131.66 131.64 43.32 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 172.662 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 45' ' ' ALA . . . . . 0.582 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -111.89 118.16 34.76 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.164 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.649 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -130.43 133.58 46.45 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.45 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 56.12 38.79 30.24 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.524 0.515 . . . . 0.0 110.654 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm 65.9 22.35 11.35 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.362 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 49' ' ' GLN . . . . . 0.582 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 29.0 mm-40 -113.25 124.46 52.57 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -87.48 116.93 25.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.928 0.394 . . . . 0.0 110.046 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 51' ' ' TYR . . . . . 0.587 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 72.5 m-85 -111.72 131.02 55.58 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.743 177.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -81.33 103.35 8.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 171.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 53' ' ' VAL . . . . . 0.499 HG13 ' CD2' ' B' ' 88' ' ' LEU . 2.3 t -76.87 -47.6 27.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.491 -172.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 54' ' ' ALA . . . . . 0.474 ' HB2' HD23 ' C' ' 65' ' ' LEU . . . -156.68 151.5 25.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.303 -178.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 99.6 m -114.74 101.69 9.31 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 169.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 56' ' ' VAL . . . . . 0.471 HG11 HG11 ' C' ' 85' ' ' VAL . 7.4 p -112.92 114.04 45.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.596 0.712 . . . . 0.0 109.781 -177.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 77.4 p -123.26 -177.74 3.78 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.496 -174.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 58' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' C' ' 38' ' ' GLN . 28.8 mtpp -57.2 -36.18 70.53 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.032 0.444 . . . . 0.0 110.378 168.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.35 -41.16 66.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.521 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 76.5 mt -115.76 82.77 10.78 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 174.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.11 0.44 6.64 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.865 2.377 . . . . 0.0 113.662 -168.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -162.66 128.06 3.29 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.139 0.495 . . . . 0.0 111.087 -176.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.431 HG23 ' HB ' ' C' ' 56' ' ' VAL . 92.1 t -114.29 111.36 35.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.439 174.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.85 112.04 23.7 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.698 174.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 65' ' ' LEU . . . . . 0.474 HD23 ' HB2' ' C' ' 54' ' ' ALA . 0.3 OUTLIER -130.45 168.44 17.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.069 0.461 . . . . 0.0 111.599 -175.518 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 66' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 6.6 t0 -115.23 99.95 7.78 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.345 0.593 . . . . 0.0 110.386 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.618 HD21 HD23 ' B' ' 88' ' ' LEU . 17.7 mt -114.58 141.22 48.03 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.695 177.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 68' ' ' ASN . . . . . 0.421 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 6.3 t30 -146.66 115.27 6.78 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.92 0.391 . . . . 0.0 110.043 174.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -110.07 159.93 16.89 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.061 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 10.7 p -112.49 149.49 32.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.557 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 71' ' ' LYS . . . . . 0.416 ' H ' ' HG3' ' C' ' 71' ' ' LYS . 0.0 OUTLIER -71.38 10.41 0.62 Allowed 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -175.58 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.63 -21.51 14.35 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.111 176.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -101.15 171.31 7.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.787 0.327 . . . . 0.0 110.828 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 -137.72 129.46 28.47 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.649 HG22 ' HB2' ' C' ' 46' ' ' ALA . 14.8 pt -129.35 163.01 35.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.104 0.478 . . . . 0.0 111.696 -169.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.544 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 4.8 mtm -118.41 122.89 43.9 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 175.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 77' ' ' PHE . . . . . 0.535 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 1.0 OUTLIER -105.08 127.77 53.04 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 177.204 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 78' ' ' TYR . . . . . 0.691 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 49.3 p90 -155.95 150.65 26.1 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.494 -177.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 79' ' ' THR . . . . . 0.712 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 11.0 p -117.34 149.14 40.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.898 0.38 . . . . 0.0 111.622 -178.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.11 144.62 42.34 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.323 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.19 176.93 34.69 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -175.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -106.49 102.75 12.12 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.062 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 83' ' ' ALA . . . . . 0.534 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -170.7 151.26 3.46 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.557 169.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 23.4 t -108.19 121.57 45.14 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.617 HG12 ' HB3' ' C' ' 34' ' ' LEU . 11.6 m -118.49 146.24 23.35 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-O 121.403 0.62 . . . . 0.0 111.663 -173.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 15.2 t -111.94 120.88 43.41 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 87' ' ' LEU . . . . . 0.716 HD13 HD23 ' C' ' 11' ' ' LEU . 5.0 mp -92.92 151.68 19.81 Favored 'General case' 0 CA--C 1.502 -0.894 0 C-N-CA 120.364 -0.534 . . . . 0.0 109.646 174.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 88' ' ' LEU . . . . . 0.65 HD23 HD21 ' D' ' 67' ' ' LEU . 1.6 tp -133.58 141.11 47.53 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.156 -178.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.21 -166.72 26.77 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.825 -0.703 . . . . 0.0 111.86 -176.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 90' ' ' TYR . . . . . 0.438 ' CD2' ' HB3' ' D' ' 68' ' ' ASN . 8.3 p90 -150.86 130.1 12.77 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.632 0.729 . . . . 0.0 111.765 176.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 91' ' ' LEU . . . . . 0.562 HD23 ' HB3' ' C' ' 27' ' ' PHE . 5.2 mt . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 114.253 -1.339 . . . . 0.0 109.93 176.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 59.9 mtt . . . . . 0 C--O 1.225 -0.21 0 CA-C-O 120.924 0.392 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 8' ' ' PHE . . . . . 0.48 ' CE1' HD21 ' E' ' 44' ' ' LEU . 74.2 t80 -55.01 144.06 24.55 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.849 -173.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 9' ' ' TRP . . . . . 0.589 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 89.7 t90 -139.29 148.7 43.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.987 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 10' ' ' GLY . . . . . 0.566 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -149.95 153.44 25.1 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.812 -0.708 . . . . 0.0 111.755 177.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 11' ' ' LEU . . . . . 0.73 HD23 HD13 ' D' ' 87' ' ' LEU . 58.9 tp -139.13 108.81 6.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.965 0.412 . . . . 0.0 111.094 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -80.35 105.75 11.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.685 173.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 13' ' ' MET . . . . . 0.6 ' HB3' HG23 ' D' ' 85' ' ' VAL . 35.7 tpp -99.52 132.31 44.94 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.067 0.46 . . . . 0.0 110.942 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -98.57 146.55 31.79 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.95 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 15' ' ' PRO . . . . . 0.518 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 10.5 Cg_endo -53.52 115.85 2.59 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 123.428 2.752 . . . . 0.0 113.154 -176.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 16' ' ' GLU . . . . . 0.723 ' HA ' ' O ' ' D' ' 79' ' ' THR . 34.3 mt-10 63.42 38.14 10.22 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.617 177.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -109.37 149.82 28.95 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 173.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 18' ' ' LYS . . . . . 0.691 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 34.4 ttmt -125.96 119.22 27.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.771 0.319 . . . . 0.0 111.59 -174.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 19' ' ' TYR . . . . . 0.473 ' OH ' ' HA ' ' D' ' 13' ' ' MET . 3.6 m-85 -110.51 104.9 13.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.402 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 20' ' ' SER . . . . . 0.401 ' HB3' ' SD ' ' D' ' 76' ' ' MET . 11.7 p -87.69 99.43 12.07 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 171.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -125.25 148.7 48.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.492 0.663 . . . . 0.0 112.564 -166.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 11.4 t -92.32 160.35 15.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.049 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 68.0 mt -106.31 117.71 52.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.059 0.457 . . . . 0.0 110.771 -175.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 24' ' ' ILE . . . . . 0.476 HD12 ' H ' ' D' ' 24' ' ' ILE . 4.2 mp -79.26 -45.42 23.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.96 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -135.14 140.28 45.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.759 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 18.2 m -56.02 124.17 16.84 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 123.547 0.529 . . . . 0.0 109.595 177.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 27' ' ' PHE . . . . . 0.556 ' HB3' HD23 ' D' ' 91' ' ' LEU . 3.9 p90 -140.16 158.56 43.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.65 0.738 . . . . 0.0 112.731 -171.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 28' ' ' HIS . . . . . 0.577 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 14.1 t60 -112.87 125.99 54.97 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.048 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 29' ' ' ILE . . . . . 0.59 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 43.9 mt -96.3 133.46 37.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 30' ' ' SER . . . . . 0.577 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 42.4 p -118.53 -14.96 9.63 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -170.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.91 151.93 22.46 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 119.4 -1.381 . . . . 0.0 113.489 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.45 HG23 ' HG ' ' D' ' 87' ' ' LEU . 9.1 p -140.87 123.85 16.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 171.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 33' ' ' ALA . . . . . 0.417 ' HA ' HG21 ' D' ' 56' ' ' VAL . . . -143.48 154.61 43.83 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.419 -0.512 . . . . 0.0 112.076 -172.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 34' ' ' LEU . . . . . 0.619 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.3 pp -118.2 138.86 52.04 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.669 0.747 . . . . 0.0 111.222 177.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -110.1 -47.55 3.3 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.475 172.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -103.2 127.52 50.47 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.176 170.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 37' ' ' GLY . . . . . 0.451 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 147.3 162.99 10.31 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 119.659 -1.258 . . . . 0.0 113.364 177.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 38' ' ' GLN . . . . . 0.461 ' O ' ' HG3' ' D' ' 58' ' ' LYS . 48.6 tt0 -102.21 -48.32 4.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.524 0.202 . . . . 0.0 111.155 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -153.0 137.84 17.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.784 -0.189 . . . . 0.0 110.667 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 40' ' ' ALA . . . . . 0.535 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -136.37 114.91 11.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.37 0.605 . . . . 0.0 111.126 171.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' D' ' 79' ' ' THR . 68.1 mttm -95.01 114.92 26.78 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 171.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.411 HD23 ' HB ' ' D' ' 53' ' ' VAL . 38.0 tp -83.99 116.13 22.67 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -176.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 43' ' ' TYR . . . . . 0.41 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 94.4 m-85 -117.03 143.74 45.4 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.548 ' HA ' ' O ' ' D' ' 76' ' ' MET . 0.1 OUTLIER -131.62 131.77 43.5 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 172.699 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 45' ' ' ALA . . . . . 0.582 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -111.97 118.1 34.55 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.131 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.657 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -130.43 133.59 46.46 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.485 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 56.19 38.8 30.19 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 123.452 0.47 . . . . 0.0 110.591 -175.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm 65.94 22.43 11.31 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.214 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 49' ' ' GLN . . . . . 0.582 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 29.1 mm-40 -113.28 124.54 52.74 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -87.55 116.87 25.97 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 51' ' ' TYR . . . . . 0.543 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 72.3 m-85 -111.64 131.03 55.56 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.798 177.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -81.3 103.32 8.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 171.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 53' ' ' VAL . . . . . 0.499 HG13 ' CD2' ' C' ' 88' ' ' LEU . 2.3 t -76.76 -47.61 28.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.523 -172.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 54' ' ' ALA . . . . . 0.476 ' HB2' HD23 ' D' ' 65' ' ' LEU . . . -156.74 151.5 25.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.296 -178.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 99.9 m -114.74 101.64 9.26 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 169.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 56' ' ' VAL . . . . . 0.475 HG11 HG11 ' D' ' 85' ' ' VAL . 7.4 p -112.97 114.14 46.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.584 0.707 . . . . 0.0 109.777 -177.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 75.7 p -123.26 -177.82 3.81 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.495 -174.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 58' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' D' ' 38' ' ' GLN . 28.8 mtpp -57.2 -36.08 70.41 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.12 0.486 . . . . 0.0 110.43 168.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.4 -41.14 66.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.562 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 76.0 mt -115.72 82.69 10.59 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.03 0.42 6.63 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.839 2.359 . . . . 0.0 113.652 -168.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -162.64 128.22 3.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.154 0.502 . . . . 0.0 111.014 -176.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.425 HG23 ' HB ' ' D' ' 56' ' ' VAL . 92.7 t -114.39 111.36 35.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.433 174.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.93 112.01 23.7 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.678 174.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 65' ' ' LEU . . . . . 0.476 HD23 ' HB2' ' D' ' 54' ' ' ALA . 0.3 OUTLIER -130.41 168.56 16.77 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.065 0.46 . . . . 0.0 111.556 -175.518 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 66' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 6.5 t0 -115.32 99.99 7.79 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.33 0.586 . . . . 0.0 110.398 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.65 HD21 HD23 ' C' ' 88' ' ' LEU . 17.7 mt -114.66 141.32 47.95 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.561 177.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 68' ' ' ASN . . . . . 0.438 ' HB3' ' CD2' ' C' ' 90' ' ' TYR . 6.2 t30 -146.71 115.28 6.76 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.006 0.431 . . . . 0.0 110.083 173.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -110.11 159.93 16.91 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.012 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 10.0 p -112.56 149.59 32.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.479 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.56 10.59 0.61 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -175.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.72 -21.38 14.44 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.131 176.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -101.21 171.41 7.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.839 0.352 . . . . 0.0 110.859 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 -137.72 129.33 28.28 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.657 HG22 ' HB2' ' D' ' 46' ' ' ALA . 14.7 pt -129.3 162.94 35.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.088 0.47 . . . . 0.0 111.707 -169.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 76' ' ' MET . . . . . 0.548 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 4.8 mtm -118.22 122.79 43.87 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 175.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 77' ' ' PHE . . . . . 0.536 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 1.0 OUTLIER -105.03 127.77 53.02 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 177.209 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 78' ' ' TYR . . . . . 0.691 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 49.5 p90 -155.9 150.57 26.08 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.491 -177.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 79' ' ' THR . . . . . 0.723 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 11.1 p -117.23 149.19 40.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.935 0.397 . . . . 0.0 111.698 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.14 144.71 42.19 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.202 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.2 176.98 34.67 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -175.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -106.5 102.84 12.21 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.97 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 83' ' ' ALA . . . . . 0.535 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -170.82 151.27 3.38 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.486 169.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 23.5 t -108.21 121.49 44.98 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.619 HG12 ' HB3' ' D' ' 34' ' ' LEU . 11.7 m -118.41 146.18 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 CA-C-O 121.416 0.627 . . . . 0.0 111.69 -173.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 15.4 t -111.87 120.88 43.43 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 87' ' ' LEU . . . . . 0.73 HD13 HD23 ' D' ' 11' ' ' LEU . 5.0 mp -92.86 151.58 19.9 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 120.452 -0.499 . . . . 0.0 109.658 174.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.675 HD23 HD21 ' E' ' 67' ' ' LEU . 1.6 tp -133.55 141.18 47.6 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.081 -178.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.24 -166.7 26.76 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.799 -176.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 90' ' ' TYR . . . . . 0.463 ' CD2' ' HB3' ' E' ' 68' ' ' ASN . 8.2 p90 -150.95 130.12 12.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.742 0.782 . . . . 0.0 111.781 176.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 91' ' ' LEU . . . . . 0.556 HD23 ' HB3' ' D' ' 27' ' ' PHE . 5.3 mt . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.957 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 59.9 mtt . . . . . 0 C--O 1.225 -0.206 0 CA-C-O 120.943 0.401 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' E' E ' 8' ' ' PHE . . . . . 0.475 ' CE1' HD21 ' A' ' 44' ' ' LEU . 74.2 t80 -54.92 144.03 24.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.805 -173.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 9' ' ' TRP . . . . . 0.574 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 89.5 t90 -139.38 148.63 43.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.96 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 10' ' ' GLY . . . . . 0.569 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -149.88 153.43 25.1 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.79 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 11' ' ' LEU . . . . . 0.744 HD23 HD13 ' E' ' 87' ' ' LEU . 59.2 tp -139.06 108.79 6.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.898 0.38 . . . . 0.0 111.144 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -80.28 105.71 11.75 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.769 173.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 13' ' ' MET . . . . . 0.594 ' HB3' HG23 ' E' ' 85' ' ' VAL . 35.5 tpp -99.5 132.32 44.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.117 0.484 . . . . 0.0 110.935 -176.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -98.56 146.67 31.99 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.945 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 15' ' ' PRO . . . . . 0.52 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 10.4 Cg_endo -53.73 115.96 2.68 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 123.4 2.734 . . . . 0.0 113.104 -176.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 16' ' ' GLU . . . . . 0.727 ' HA ' ' O ' ' E' ' 79' ' ' THR . 34.6 mt-10 63.35 38.17 10.37 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.69 177.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -109.41 149.9 28.87 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 173.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 18' ' ' LYS . . . . . 0.686 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 34.4 ttmt -125.99 119.19 27.04 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.736 0.303 . . . . 0.0 111.613 -174.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 19' ' ' TYR . . . . . 0.471 ' OH ' ' HA ' ' E' ' 13' ' ' MET . 3.5 m-85 -110.44 104.86 13.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.546 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 12.0 p -87.54 99.47 12.06 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 171.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -125.41 148.77 48.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.537 0.684 . . . . 0.0 112.517 -166.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 11.5 t -92.45 160.27 15.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.989 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 68.1 mt -106.25 117.66 52.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.082 0.468 . . . . 0.0 110.894 -175.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 24' ' ' ILE . . . . . 0.465 HD12 ' H ' ' E' ' 24' ' ' ILE . 4.1 mp -79.19 -45.42 24.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.977 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -135.13 140.23 45.27 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.775 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 18.0 m -56.06 124.09 16.62 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 123.619 0.574 . . . . 0.0 109.648 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 27' ' ' PHE . . . . . 0.566 ' HB3' HD23 ' E' ' 91' ' ' LEU . 3.9 p90 -140.04 158.53 43.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.725 0.774 . . . . 0.0 112.765 -171.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 28' ' ' HIS . . . . . 0.58 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 14.3 t60 -112.72 125.99 54.92 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.159 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 29' ' ' ILE . . . . . 0.604 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 44.2 mt -96.29 133.41 37.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 170.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 30' ' ' SER . . . . . 0.58 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 43.3 p -118.49 -14.93 9.66 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -170.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.86 151.93 22.47 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 119.373 -1.394 . . . . 0.0 113.566 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.46 HG23 ' HG ' ' E' ' 87' ' ' LEU . 9.1 p -140.81 123.86 16.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 171.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 33' ' ' ALA . . . . . 0.407 ' HA ' HG21 ' E' ' 56' ' ' VAL . . . -143.52 154.54 43.73 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.493 -0.483 . . . . 0.0 112.082 -172.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 34' ' ' LEU . . . . . 0.615 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.3 pp -118.2 138.89 52.01 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.714 0.769 . . . . 0.0 111.222 177.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -110.2 -47.44 3.3 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.485 172.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -103.28 127.47 50.6 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.201 170.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 37' ' ' GLY . . . . . 0.458 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 147.27 162.9 10.25 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 119.673 -1.251 . . . . 0.0 113.463 177.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 38' ' ' GLN . . . . . 0.457 ' O ' ' HG3' ' E' ' 58' ' ' LYS . 48.8 tt0 -102.22 -48.16 4.29 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.559 0.219 . . . . 0.0 111.143 178.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -153.11 137.76 16.91 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.781 -0.191 . . . . 0.0 110.639 176.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 40' ' ' ALA . . . . . 0.541 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -136.32 114.97 11.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.318 0.58 . . . . 0.0 111.147 171.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 41' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' E' ' 79' ' ' THR . 68.1 mttm -95.09 114.99 26.85 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 171.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.401 HD23 ' HB ' ' E' ' 53' ' ' VAL . 37.9 tp -84.05 116.17 22.72 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -176.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 43' ' ' TYR . . . . . 0.411 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 94.2 m-85 -117.05 143.72 45.43 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.501 177.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 44' ' ' LEU . . . . . 0.545 ' HA ' ' O ' ' E' ' 76' ' ' MET . 0.1 OUTLIER -131.59 131.66 43.45 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 172.653 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 45' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -111.88 118.07 34.51 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.158 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 46' ' ' ALA . . . . . 0.636 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -130.42 133.62 46.5 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.485 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 56.11 38.85 30.31 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.457 0.473 . . . . 0.0 110.587 -175.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm 65.96 22.48 11.28 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.259 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 49' ' ' GLN . . . . . 0.576 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 29.2 mm-40 -113.36 124.54 52.71 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -87.57 116.84 25.96 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.847 0.356 . . . . 0.0 110.064 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 51' ' ' TYR . . . . . 0.566 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 72.1 m-85 -111.61 131.02 55.56 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.798 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -81.35 103.45 8.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 171.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 53' ' ' VAL . . . . . 0.512 HG13 ' CD2' ' D' ' 88' ' ' LEU . 2.3 t -76.89 -47.59 27.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.495 -172.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 54' ' ' ALA . . . . . 0.463 ' HB2' HD23 ' E' ' 65' ' ' LEU . . . -156.71 151.56 25.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.286 -178.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 99.9 m -114.82 101.64 9.25 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 169.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 56' ' ' VAL . . . . . 0.482 HG11 HG11 ' E' ' 85' ' ' VAL . 7.4 p -112.92 114.07 45.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.626 0.727 . . . . 0.0 109.818 -177.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 75.4 p -123.23 -177.77 3.79 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.545 -174.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 58' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' E' ' 38' ' ' GLN . 28.8 mtpp -57.2 -36.25 70.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.074 0.464 . . . . 0.0 110.276 169.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.3 -41.13 66.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.508 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 76.4 mt -115.78 82.7 10.74 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.12 0.48 6.58 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.865 2.376 . . . . 0.0 113.707 -168.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -162.65 128.1 3.3 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.247 0.546 . . . . 0.0 111.048 -176.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 63' ' ' VAL . . . . . 0.421 HG23 ' HB ' ' E' ' 56' ' ' VAL . 92.7 t -114.32 111.35 35.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.412 174.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.96 112.13 23.88 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.602 174.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 65' ' ' LEU . . . . . 0.463 HD23 ' HB2' ' E' ' 54' ' ' ALA . 0.3 OUTLIER -130.51 168.44 17.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.095 0.474 . . . . 0.0 111.515 -175.541 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 66' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 6.5 t0 -115.22 99.97 7.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.322 0.582 . . . . 0.0 110.343 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 67' ' ' LEU . . . . . 0.675 HD21 HD23 ' D' ' 88' ' ' LEU . 17.7 mt -114.61 141.35 47.89 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.621 177.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 68' ' ' ASN . . . . . 0.463 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 6.3 t30 -146.69 115.2 6.74 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.99 0.424 . . . . 0.0 110.086 174.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -110.11 159.91 16.93 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.029 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 10.2 p -112.47 149.56 32.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.47 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 71' ' ' LYS . . . . . 0.425 ' H ' ' HG3' ' E' ' 71' ' ' LYS . 0.0 OUTLIER -71.41 10.4 0.62 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -175.596 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.67 -21.39 14.51 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.116 176.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -101.23 171.34 7.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.75 0.309 . . . . 0.0 110.865 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 -137.76 129.4 28.3 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 75' ' ' ILE . . . . . 0.636 HG22 ' HB2' ' E' ' 46' ' ' ALA . 14.6 pt -129.21 162.96 35.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.012 0.434 . . . . 0.0 111.726 -169.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 76' ' ' MET . . . . . 0.545 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 4.8 mtm -118.38 122.91 43.98 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 175.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 77' ' ' PHE . . . . . 0.539 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 1.0 OUTLIER -105.12 127.59 52.97 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.295 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 78' ' ' TYR . . . . . 0.686 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 49.6 p90 -155.82 150.59 26.23 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.536 -177.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 79' ' ' THR . . . . . 0.727 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 11.3 p -117.2 149.14 40.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.828 0.347 . . . . 0.0 111.684 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.11 144.58 42.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.301 175.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.3 177.0 34.52 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -106.6 102.82 12.17 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.965 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 83' ' ' ALA . . . . . 0.541 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -170.77 151.22 3.4 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.595 169.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 23.7 t -108.17 121.48 44.94 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 85' ' ' VAL . . . . . 0.615 HG12 ' HB3' ' E' ' 34' ' ' LEU . 11.5 m -118.36 146.2 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 CA-C-O 121.382 0.61 . . . . 0.0 111.69 -173.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 15.3 t -111.94 120.92 43.55 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 87' ' ' LEU . . . . . 0.744 HD13 HD23 ' E' ' 11' ' ' LEU . 5.1 mp -92.95 151.68 19.78 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.652 174.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 88' ' ' LEU . . . . . 0.656 HD23 HD21 ' A' ' 67' ' ' LEU . 1.6 tp -133.6 141.1 47.51 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.203 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.16 -166.64 26.58 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.891 -176.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 90' ' ' TYR . . . . . 0.429 ' CD2' ' HB3' ' A' ' 68' ' ' ASN . 8.2 p90 -150.91 130.11 12.72 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.694 0.759 . . . . 0.0 111.804 176.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 91' ' ' LEU . . . . . 0.566 HD23 ' HB3' ' E' ' 27' ' ' PHE . 5.3 mt . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.903 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.524 ' HA ' ' HB2' ' B' ' 70' ' ' SER . 11.4 ttt . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 121.059 0.457 . . . . 0.0 111.898 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.407 ' CE1' HD21 ' B' ' 44' ' ' LEU . 62.3 t80 -55.91 143.93 30.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.458 -175.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.445 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 89.8 t90 -137.47 150.18 47.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.052 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.595 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -150.84 159.78 28.31 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.086 177.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.58 HD23 HD13 ' A' ' 87' ' ' LEU . 36.8 tp -148.4 108.21 4.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.835 0.35 . . . . 0.0 111.066 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -92.37 103.75 16.16 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.017 0.437 . . . . 0.0 110.076 174.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.589 ' SD ' HD11 ' A' ' 87' ' ' LEU . 53.4 mtp -94.99 144.94 25.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.132 -175.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -100.45 149.36 36.03 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.853 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.566 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 11.6 Cg_endo -55.69 121.9 10.77 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 123.265 2.643 . . . . 0.0 113.294 -176.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 79' ' ' THR . 49.9 mt-10 60.84 57.28 2.67 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.532 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -132.54 142.74 49.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.166 175.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.675 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 35.6 ttmt -118.45 116.33 26.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.869 0.366 . . . . 0.0 111.648 -174.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -112.25 110.3 20.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.992 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.7 p -77.35 122.17 24.76 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 173.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -99.63 128.51 45.74 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.884 -167.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.5 p -98.77 125.19 44.05 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 169.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.3 mt -96.41 118.72 43.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.326 0.584 . . . . 0.0 111.749 -172.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.1 mp -93.94 -44.93 13.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.662 178.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -118.68 140.36 50.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.543 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.8 t -62.64 114.37 3.54 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 173.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -130.02 148.63 51.89 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.531 -0.868 . . . . 0.0 112.937 -170.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.579 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 17.6 t60 -106.08 125.68 51.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.242 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.575 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 46.9 mt -97.69 132.61 42.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 170.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.579 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 42.6 p -116.25 -14.71 11.07 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -170.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.56 152.49 22.21 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 119.232 -1.461 . . . . 0.0 113.411 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.423 HG23 ' HG ' ' A' ' 87' ' ' LEU . 8.5 p -138.01 122.82 23.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 172.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.408 ' HA ' HG21 ' A' ' 56' ' ' VAL . . . -140.61 156.14 46.35 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 122.148 -0.345 . . . . 0.0 111.394 -174.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.469 ' HB3' HG12 ' A' ' 85' ' ' VAL . 3.7 pp -115.15 141.28 48.23 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.838 0.827 . . . . 0.0 112.071 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -106.45 -57.3 2.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.055 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -102.6 127.46 49.68 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 169.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.493 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 153.4 160.61 9.82 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 119.338 -1.41 . . . . 0.0 113.749 176.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.602 ' O ' ' HG3' ' A' ' 58' ' ' LYS . 19.1 tt0 -102.22 -46.97 4.67 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.608 -0.296 . . . . 0.0 110.409 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.448 ' OE2' ' HG2' ' A' ' 38' ' ' GLN . 6.9 mp0 -152.25 129.52 11.25 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.383 176.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.663 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -125.96 119.53 27.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.352 0.596 . . . . 0.0 110.237 171.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -104.47 108.95 20.62 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.5 tp -84.9 115.0 22.53 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.248 -173.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.525 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 91.9 m-85 -116.33 145.52 43.13 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.579 ' HA ' ' O ' ' A' ' 76' ' ' MET . 0.2 OUTLIER -131.67 128.53 39.23 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 171.33 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -106.62 122.77 47.01 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.667 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.71 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -130.16 125.23 34.51 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 175.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 61.42 36.46 17.29 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -171.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.486 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 14.9 tmtt? 73.59 -7.5 1.56 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.383 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.535 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 24.1 tp60 -80.36 114.54 19.33 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 -177.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -81.32 110.14 16.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.937 0.399 . . . . 0.0 110.387 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.582 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 82.2 m-85 -99.34 129.95 45.59 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.259 177.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.27 99.46 4.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 171.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.467 HG13 ' CD2' ' E' ' 88' ' ' LEU . 2.4 t -74.67 -50.01 27.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.439 -171.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.425 ' HB2' ' CD2' ' A' ' 65' ' ' LEU . . . -158.27 138.94 12.85 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.404 -177.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.4 m -103.05 102.05 12.06 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 171.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.458 HG13 ' HB3' ' A' ' 40' ' ' ALA . 7.2 p -113.54 110.24 31.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.884 0.85 . . . . 0.0 109.814 -177.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 81.3 p -122.98 -176.97 3.54 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.137 -174.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.602 ' HG3' ' O ' ' A' ' 38' ' ' GLN . 9.7 mtmp? -56.72 -35.08 68.13 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.086 0.47 . . . . 0.0 110.288 169.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.3 -40.57 64.42 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.603 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 77.9 mt -117.11 80.49 11.78 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.16 -0.0 6.6 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.079 2.519 . . . . 0.0 113.264 -169.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -164.14 118.76 1.49 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.237 0.541 . . . . 0.0 110.948 -174.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.7 t -108.85 108.59 25.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.371 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.5 117.37 27.4 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.795 174.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -136.39 168.47 19.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.457 -176.013 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 8.9 t0 -113.96 99.47 7.69 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.204 0.526 . . . . 0.0 110.292 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.6 HD21 HD23 ' E' ' 88' ' ' LEU . 19.5 mt -112.66 142.01 45.76 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.486 177.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -150.63 115.75 5.35 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 174.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -110.28 158.73 18.08 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.943 -177.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.513 ' HB2' ' HA ' ' E' ' 7' ' ' MET . 8.6 t -110.57 158.71 18.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.226 0.536 . . . . 0.0 110.646 -176.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -70.57 -4.69 24.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.637 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.43 -26.86 14.33 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.487 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -100.69 168.24 9.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.003 0.43 . . . . 0.0 110.955 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.7 mtm180 -136.84 143.7 43.22 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.71 HG22 ' HB2' ' A' ' 46' ' ' ALA . 13.2 pt -140.0 176.07 5.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.123 -172.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.579 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 9.2 mtm -134.03 131.8 39.3 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 171.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.458 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 1.2 m-85 -108.33 128.22 54.56 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.675 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 38.9 p90 -152.84 136.27 15.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.303 0.573 . . . . 0.0 111.714 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 2.1 p -111.13 133.16 53.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.22 -177.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.28 168.29 9.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.748 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.94 -170.33 43.42 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 -177.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -114.9 102.65 10.18 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 117.708 0.754 . . . . 0.0 109.702 174.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.663 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -173.82 152.4 1.99 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.502 170.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.0 t -111.64 122.06 46.8 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.469 HG12 ' HB3' ' A' ' 34' ' ' LEU . 4.3 m -113.51 156.95 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 CA-C-O 121.546 0.688 . . . . 0.0 112.566 -172.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.9 t -123.63 113.84 19.2 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.595 177.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.589 HD11 ' SD ' ' A' ' 13' ' ' MET . 5.0 mp -90.15 153.57 20.42 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.106 0.479 . . . . 0.0 109.846 174.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.594 HD23 HD21 ' B' ' 67' ' ' LEU . 1.0 OUTLIER -133.49 139.34 46.6 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.093 -179.467 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.83 -166.85 24.45 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.886 -177.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -152.79 131.27 12.18 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.735 0.778 . . . . 0.0 111.856 176.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.7 mt . . . . . 0 C--N 1.322 -0.619 0 CA-C-N 114.056 -1.429 . . . . 0.0 109.306 175.094 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 7' ' ' MET . . . . . 0.516 ' HA ' ' HB2' ' C' ' 70' ' ' SER . 11.5 ttt . . . . . 0 N--CA 1.456 -0.167 0 CA-C-O 121.076 0.465 . . . . 0.0 111.774 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' PHE . . . . . 0.418 ' CE1' HD21 ' C' ' 44' ' ' LEU . 62.2 t80 -55.9 143.94 29.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.477 -175.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' TRP . . . . . 0.44 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 89.8 t90 -137.48 150.16 47.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.95 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.618 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -150.87 159.75 28.3 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.092 177.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.594 HD23 HD13 ' B' ' 87' ' ' LEU . 37.0 tp -148.32 108.24 4.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.864 0.364 . . . . 0.0 111.077 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -92.46 103.81 16.2 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.963 0.411 . . . . 0.0 110.011 174.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' MET . . . . . 0.602 ' SD ' HD11 ' B' ' 87' ' ' LEU . 53.7 mtp -95.11 144.95 25.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.06 -175.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -100.35 149.45 36.08 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.834 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.572 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 11.4 Cg_endo -55.85 121.81 10.63 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.283 2.655 . . . . 0.0 113.255 -176.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' B' ' 79' ' ' THR . 49.7 mt-10 60.9 57.38 2.61 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.49 178.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -132.6 142.63 49.22 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.207 175.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.657 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 35.6 ttmt -118.38 116.25 26.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.804 0.335 . . . . 0.0 111.722 -174.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -112.2 110.35 20.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.023 178.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 4.7 p -77.27 122.29 24.88 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 173.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -99.74 128.6 45.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.815 -167.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 28.5 p -98.73 125.12 43.97 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 169.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 43.5 mt -96.46 118.65 43.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.256 0.551 . . . . 0.0 111.744 -172.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.417 ' N ' HD12 ' B' ' 24' ' ' ILE . 4.1 mp -93.84 -45.0 13.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.652 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -118.61 140.54 49.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.479 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 11.3 t -62.67 114.38 3.56 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 173.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -130.02 148.73 51.91 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.502 -0.879 . . . . 0.0 112.923 -170.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' HIS . . . . . 0.576 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 17.9 t60 -106.15 125.65 51.25 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.194 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.597 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 47.5 mt -97.69 132.6 42.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 170.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.576 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 43.1 p -116.25 -14.75 11.07 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -170.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.55 152.45 22.15 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 119.322 -1.418 . . . . 0.0 113.464 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.426 HG23 ' HG ' ' B' ' 87' ' ' LEU . 8.7 p -137.91 122.78 23.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 172.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' ALA . . . . . 0.412 ' HA ' HG21 ' B' ' 56' ' ' VAL . . . -140.63 156.15 46.34 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.335 -174.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.469 ' HB3' HG12 ' B' ' 85' ' ' VAL . 3.7 pp -115.18 141.37 48.11 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.853 0.835 . . . . 0.0 112.053 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -106.54 -57.32 2.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.044 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -102.64 127.42 49.76 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 169.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.498 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 153.52 160.67 9.87 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 119.311 -1.423 . . . . 0.0 113.729 176.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' GLN . . . . . 0.592 ' O ' ' HG3' ' B' ' 58' ' ' LYS . 19.0 tt0 -102.22 -47.0 4.66 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 120.784 0.326 . . . . 0.0 110.426 177.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.448 ' OE2' ' HG2' ' B' ' 38' ' ' GLN . 6.9 mp0 -152.27 129.52 11.24 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.352 177.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.669 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -126.02 119.48 27.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.355 0.598 . . . . 0.0 110.305 171.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -104.5 108.92 20.59 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 43.7 tp -84.82 115.02 22.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.33 -173.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' TYR . . . . . 0.525 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 91.6 m-85 -116.31 145.48 43.15 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 175.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.577 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.2 OUTLIER -131.63 128.46 39.16 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 171.337 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -106.64 122.95 47.36 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.6 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.704 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -130.19 125.26 34.52 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 175.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 61.37 36.44 17.47 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 123.532 0.52 . . . . 0.0 109.698 -171.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.482 ' O ' ' HD3' ' B' ' 48' ' ' LYS . 14.9 tmtt? 73.6 -7.54 1.55 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.407 178.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.537 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 24.3 tp60 -80.46 114.61 19.48 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -177.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -81.42 110.2 16.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.993 0.425 . . . . 0.0 110.307 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.595 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 82.2 m-85 -99.37 129.93 45.61 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.293 177.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.28 99.44 4.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 171.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.482 HG13 ' CD2' ' A' ' 88' ' ' LEU . 2.4 t -74.63 -50.06 27.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.412 -171.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.433 ' HB2' ' CD2' ' B' ' 65' ' ' LEU . . . -158.25 138.92 12.84 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.429 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 23.2 m -103.06 102.04 12.04 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 171.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 56' ' ' VAL . . . . . 0.468 HG13 ' HB3' ' B' ' 40' ' ' ALA . 7.3 p -113.46 110.19 31.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.796 0.808 . . . . 0.0 109.928 -177.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 81.5 p -122.96 -176.89 3.52 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.128 -174.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' LYS . . . . . 0.592 ' HG3' ' O ' ' B' ' 38' ' ' GLN . 9.7 mtmp? -56.77 -34.99 68.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.086 0.47 . . . . 0.0 110.372 169.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.5 -40.48 64.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.505 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 77.6 mt -117.16 80.57 12.04 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 173.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.15 -0.06 6.67 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.985 2.457 . . . . 0.0 113.251 -169.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -164.14 118.67 1.48 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.228 0.537 . . . . 0.0 111.111 -174.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 58.6 t -108.78 108.58 25.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.366 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.43 117.45 27.37 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.851 174.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' B' ' 30' ' ' SER . 0.3 OUTLIER -136.53 168.43 19.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.459 -176.013 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 66' ' ' ASP . . . . . 0.54 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 8.9 t0 -113.88 99.46 7.69 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.175 0.512 . . . . 0.0 110.328 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.597 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 19.5 mt -112.77 142.06 45.85 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.409 177.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -150.6 115.87 5.39 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 174.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -110.32 158.78 18.06 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.906 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.524 ' HB2' ' HA ' ' A' ' 7' ' ' MET . 8.6 t -110.63 158.65 18.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.239 0.543 . . . . 0.0 110.627 -176.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -70.53 -4.76 24.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.67 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.35 -26.97 14.13 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.404 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -100.61 168.31 9.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.12 0.486 . . . . 0.0 110.92 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 73.7 mtm180 -136.94 143.55 42.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.1 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.704 HG22 ' HB2' ' B' ' 46' ' ' ALA . 13.1 pt -139.85 175.98 6.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.59 0.233 . . . . 0.0 111.141 -172.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.577 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 9.2 mtm -133.97 131.81 39.43 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 171.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 77' ' ' PHE . . . . . 0.468 ' CD1' ' HB2' ' B' ' 44' ' ' LEU . 1.2 m-85 -108.35 128.2 54.55 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.657 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 38.8 p90 -152.84 136.27 15.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.341 0.591 . . . . 0.0 111.765 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 2.1 p -111.12 133.13 53.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.185 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.24 168.27 9.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.795 177.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.98 -170.31 43.32 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -115.04 102.72 10.2 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.659 174.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.669 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -173.88 152.28 1.94 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.511 170.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 32.0 t -111.47 122.1 46.94 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.469 HG12 ' HB3' ' B' ' 34' ' ' LEU . 4.3 m -113.59 156.85 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-O 121.471 0.653 . . . . 0.0 112.567 -172.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 14.8 t -123.54 113.87 19.29 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.667 177.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.602 HD11 ' SD ' ' B' ' 13' ' ' MET . 5.0 mp -90.15 153.55 20.44 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 121.078 0.466 . . . . 0.0 109.887 174.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.578 HD23 HD21 ' C' ' 67' ' ' LEU . 1.0 OUTLIER -133.47 139.38 46.64 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.023 -179.43 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.87 -166.85 24.51 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.913 -177.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -152.73 131.31 12.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.751 0.786 . . . . 0.0 111.763 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 5.7 mt . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 114.078 -1.419 . . . . 0.0 109.301 174.995 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 7' ' ' MET . . . . . 0.506 ' HA ' ' HB2' ' D' ' 70' ' ' SER . 11.5 ttt . . . . . 0 N--CA 1.454 -0.248 0 CA-C-O 121.057 0.456 . . . . 0.0 111.854 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 8' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -55.93 143.86 30.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.53 -175.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 9' ' ' TRP . . . . . 0.432 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 90.1 t90 -137.46 150.18 47.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.976 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 10' ' ' GLY . . . . . 0.578 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -150.88 159.63 28.24 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.098 177.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.58 HD23 HD13 ' C' ' 87' ' ' LEU . 37.3 tp -148.26 108.21 4.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.827 0.346 . . . . 0.0 111.178 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -92.4 103.78 16.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.076 0.465 . . . . 0.0 110.005 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 13' ' ' MET . . . . . 0.591 ' SD ' HD11 ' C' ' 87' ' ' LEU . 53.2 mtp -95.0 144.99 25.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.118 -175.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -100.43 149.42 36.08 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.86 177.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 15' ' ' PRO . . . . . 0.579 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 11.6 Cg_endo -55.83 121.85 10.71 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.254 2.636 . . . . 0.0 113.253 -176.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 16' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' C' ' 79' ' ' THR . 49.9 mt-10 60.9 57.28 2.64 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.564 178.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -132.55 142.6 49.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.253 175.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 18' ' ' LYS . . . . . 0.666 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 35.5 ttmt -118.37 116.41 26.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.859 0.362 . . . . 0.0 111.721 -174.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -112.27 110.36 20.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.029 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -77.3 122.15 24.7 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 173.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -99.58 128.54 45.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.85 -167.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 28.0 p -98.7 125.01 43.89 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 169.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mt -96.43 118.72 43.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.2 0.524 . . . . 0.0 111.738 -172.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 24' ' ' ILE . . . . . 0.42 ' N ' HD12 ' C' ' 24' ' ' ILE . 4.1 mp -93.9 -44.97 13.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.649 178.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -118.64 140.39 49.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.539 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 11.6 t -62.58 114.3 3.48 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 173.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 27' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -130.05 148.62 51.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.888 0.851 . . . . 0.0 112.947 -170.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 28' ' ' HIS . . . . . 0.581 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 17.7 t60 -106.08 125.6 51.19 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.158 -1.383 . . . . 0.0 110.201 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 29' ' ' ILE . . . . . 0.579 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 46.8 mt -97.7 132.63 42.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 170.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.581 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 42.4 p -116.31 -14.65 11.04 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -170.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.63 152.47 22.17 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 119.304 -1.427 . . . . 0.0 113.438 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.424 HG23 ' HG ' ' C' ' 87' ' ' LEU . 8.7 p -138.0 122.76 23.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 172.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.408 ' HA ' HG21 ' C' ' 56' ' ' VAL . . . -140.63 156.18 46.33 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.091 -0.38 . . . . 0.0 111.328 -174.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.452 ' HB3' HG12 ' C' ' 85' ' ' VAL . 3.7 pp -115.12 141.35 48.13 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.786 0.803 . . . . 0.0 112.129 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -106.58 -57.31 2.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.98 176.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -102.68 127.41 49.81 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 169.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 37' ' ' GLY . . . . . 0.486 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 153.56 160.69 9.89 Favored Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 119.357 -1.402 . . . . 0.0 113.724 176.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 38' ' ' GLN . . . . . 0.607 ' O ' ' HG3' ' C' ' 58' ' ' LYS . 19.0 tt0 -102.22 -47.03 4.65 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 120.701 0.286 . . . . 0.0 110.467 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 39' ' ' GLU . . . . . 0.449 ' OE2' ' HG2' ' C' ' 38' ' ' GLN . 6.8 mp0 -152.26 129.52 11.25 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.412 176.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.663 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -125.95 119.56 28.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.35 0.595 . . . . 0.0 110.296 171.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -104.54 108.88 20.55 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 43.5 tp -84.84 115.04 22.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.261 -173.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 43' ' ' TYR . . . . . 0.51 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 91.5 m-85 -116.33 145.5 43.15 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 175.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.575 ' HA ' ' O ' ' C' ' 76' ' ' MET . 0.2 OUTLIER -131.69 128.48 39.07 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 171.434 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 45' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -106.55 122.9 47.25 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.633 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.712 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -130.3 125.16 34.05 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 61.46 36.42 17.19 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -171.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 48' ' ' LYS . . . . . 0.493 ' O ' ' HD3' ' C' ' 48' ' ' LYS . 14.9 tmtt? 73.72 -7.67 1.54 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.351 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 49' ' ' GLN . . . . . 0.54 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 24.8 tp60 -80.36 114.59 19.37 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.887 -0.508 . . . . 0.0 109.69 -177.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -81.28 110.1 16.42 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.343 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 51' ' ' TYR . . . . . 0.618 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 82.2 m-85 -99.36 129.89 45.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.278 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.22 99.44 3.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 171.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 53' ' ' VAL . . . . . 0.474 HG13 ' CD2' ' B' ' 88' ' ' LEU . 2.4 t -74.64 -50.12 27.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.39 -171.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 54' ' ' ALA . . . . . 0.433 ' HB2' ' CD2' ' C' ' 65' ' ' LEU . . . -158.16 138.95 12.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.454 -177.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 23.5 m -103.05 102.09 12.09 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 171.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 56' ' ' VAL . . . . . 0.457 HG13 ' HB3' ' C' ' 40' ' ' ALA . 7.2 p -113.59 110.15 31.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.846 0.831 . . . . 0.0 109.889 -177.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 81.7 p -123.02 -177.01 3.55 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.124 -174.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 58' ' ' LYS . . . . . 0.607 ' HG3' ' O ' ' C' ' 38' ' ' GLN . 9.7 mtmp? -56.58 -35.11 67.82 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.058 0.456 . . . . 0.0 110.38 169.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.37 -40.55 64.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.514 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 77.9 mt -117.21 80.58 12.22 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 174.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.21 -0.07 6.74 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.053 2.502 . . . . 0.0 113.187 -169.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -164.12 118.68 1.49 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.139 0.495 . . . . 0.0 111.076 -174.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 58.9 t -108.79 108.65 25.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.281 175.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.53 117.41 27.46 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.772 174.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 65' ' ' LEU . . . . . 0.433 ' CD2' ' HB2' ' C' ' 54' ' ' ALA . 0.3 OUTLIER -136.39 168.49 19.35 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.497 -176.073 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 66' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 8.9 t0 -114.02 99.58 7.76 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.306 0.574 . . . . 0.0 110.203 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.579 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 19.6 mt -112.74 141.96 45.92 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.468 177.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -150.58 115.78 5.37 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 174.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -110.26 158.76 18.04 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.937 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 70' ' ' SER . . . . . 0.516 ' HB2' ' HA ' ' B' ' 7' ' ' MET . 8.7 t -110.65 158.7 18.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.23 0.538 . . . . 0.0 110.654 -176.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -70.6 -4.67 24.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.596 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.51 -26.81 14.37 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.483 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -100.81 168.24 9.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.019 0.437 . . . . 0.0 110.846 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 73.7 mtm180 -136.86 143.59 43.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.136 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.712 HG22 ' HB2' ' C' ' 46' ' ' ALA . 13.2 pt -139.83 176.11 6.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.614 0.245 . . . . 0.0 111.128 -172.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.575 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 9.2 mtm -134.1 131.81 39.19 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 171.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 77' ' ' PHE . . . . . 0.456 ' CD1' ' HB2' ' C' ' 44' ' ' LEU . 1.2 m-85 -108.34 128.24 54.58 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 78' ' ' TYR . . . . . 0.666 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 38.9 p90 -152.8 136.32 15.97 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.37 0.605 . . . . 0.0 111.777 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 79' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 2.1 p -111.1 133.11 53.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.217 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.31 168.33 9.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.763 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.77 -170.26 43.68 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -114.97 102.7 10.21 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.651 174.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 83' ' ' ALA . . . . . 0.663 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -173.83 152.34 1.97 Allowed 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.942 -1.027 . . . . 0.0 109.473 170.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 32.1 t -111.47 122.16 47.09 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.454 HG11 HG11 ' C' ' 56' ' ' VAL . 4.3 m -113.71 156.91 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-O 121.564 0.697 . . . . 0.0 112.537 -172.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 15.1 t -123.62 113.84 19.2 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.637 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 87' ' ' LEU . . . . . 0.591 HD11 ' SD ' ' C' ' 13' ' ' MET . 5.0 mp -90.08 153.55 20.46 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.07 0.462 . . . . 0.0 109.913 174.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 88' ' ' LEU . . . . . 0.59 HD23 HD21 ' D' ' 67' ' ' LEU . 1.0 OUTLIER -133.5 139.34 46.59 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.051 -179.422 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.86 -166.81 24.43 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.875 -177.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -152.79 131.27 12.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.809 0.814 . . . . 0.0 111.812 176.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 5.8 mt . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 114.007 -1.452 . . . . 0.0 109.253 175.097 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 7' ' ' MET . . . . . 0.496 ' HA ' ' HB2' ' E' ' 70' ' ' SER . 11.5 ttt . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 121.038 0.446 . . . . 0.0 111.783 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 8' ' ' PHE . . . . . 0.405 ' CE1' HD21 ' E' ' 44' ' ' LEU . 62.4 t80 -55.97 143.86 30.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.51 -175.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 9' ' ' TRP . . . . . 0.439 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 90.0 t90 -137.43 150.06 47.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.022 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 10' ' ' GLY . . . . . 0.585 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -150.83 159.71 28.28 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.098 177.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 11' ' ' LEU . . . . . 0.594 HD23 HD13 ' D' ' 87' ' ' LEU . 36.7 tp -148.35 108.18 4.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.834 0.349 . . . . 0.0 111.03 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -92.28 103.82 16.24 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.988 0.423 . . . . 0.0 109.975 174.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 13' ' ' MET . . . . . 0.6 ' SD ' HD11 ' D' ' 87' ' ' LEU . 53.8 mtp -95.12 145.01 25.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.12 -175.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -100.47 149.42 36.08 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.86 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 15' ' ' PRO . . . . . 0.557 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 11.5 Cg_endo -55.76 121.72 10.46 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 123.314 2.676 . . . . 0.0 113.319 -176.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 16' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' D' ' 79' ' ' THR . 49.8 mt-10 60.89 57.45 2.6 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.465 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -132.64 142.66 49.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.202 175.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 18' ' ' LYS . . . . . 0.665 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 35.5 ttmt -118.41 116.26 26.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.86 0.362 . . . . 0.0 111.756 -175.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -112.09 110.25 20.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.095 178.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 4.7 p -77.17 122.22 24.72 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 173.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -99.67 128.45 45.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.886 -167.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 28.4 p -98.72 125.15 43.96 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 169.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 44.0 mt -96.41 118.58 43.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.205 0.526 . . . . 0.0 111.731 -172.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 24' ' ' ILE . . . . . 0.426 HD12 ' N ' ' D' ' 24' ' ' ILE . 4.1 mp -93.83 -44.98 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.673 178.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -118.65 140.44 49.91 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.491 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 11.6 t -62.65 114.37 3.54 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 173.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 27' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -129.97 148.64 51.85 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.607 -0.837 . . . . 0.0 112.99 -170.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 28' ' ' HIS . . . . . 0.578 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 18.0 t60 -106.1 125.7 51.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.184 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 29' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 46.8 mt -97.7 132.48 42.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 170.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 30' ' ' SER . . . . . 0.578 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 42.5 p -116.23 -14.65 11.09 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -170.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.58 152.48 22.2 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 119.278 -1.439 . . . . 0.0 113.453 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.424 HG23 ' HG ' ' D' ' 87' ' ' LEU . 8.6 p -137.97 122.86 23.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 172.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 33' ' ' ALA . . . . . 0.408 ' HA ' HG21 ' D' ' 56' ' ' VAL . . . -140.63 156.07 46.36 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 122.153 -0.342 . . . . 0.0 111.414 -174.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 34' ' ' LEU . . . . . 0.453 ' HB3' HG12 ' D' ' 85' ' ' VAL . 3.7 pp -115.1 141.34 48.15 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.818 0.818 . . . . 0.0 112.126 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -106.51 -57.27 2.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.024 176.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -102.64 127.35 49.78 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 169.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 37' ' ' GLY . . . . . 0.493 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 153.5 160.61 9.83 Favored Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 119.278 -1.439 . . . . 0.0 113.711 176.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 38' ' ' GLN . . . . . 0.607 ' O ' ' HG3' ' D' ' 58' ' ' LYS . 19.1 tt0 -102.21 -46.98 4.66 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.579 -0.311 . . . . 0.0 110.391 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 39' ' ' GLU . . . . . 0.45 ' OE2' ' HG2' ' D' ' 38' ' ' GLN . 6.9 mp0 -152.27 129.45 11.18 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.417 176.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 40' ' ' ALA . . . . . 0.673 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -125.97 119.63 28.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.4 0.619 . . . . 0.0 110.218 171.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -104.51 109.01 20.73 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 43.8 tp -84.99 114.97 22.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.218 -173.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 43' ' ' TYR . . . . . 0.523 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 91.6 m-85 -116.26 145.51 43.1 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 175.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.58 ' HA ' ' O ' ' D' ' 76' ' ' MET . 0.2 OUTLIER -131.66 128.47 39.11 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 171.367 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 45' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -106.57 122.93 47.3 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.654 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.718 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -130.3 125.14 34.01 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 61.47 36.4 17.17 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -171.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 48' ' ' LYS . . . . . 0.498 ' O ' ' HD3' ' D' ' 48' ' ' LYS . 14.9 tmtt? 73.69 -7.54 1.56 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.307 178.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 49' ' ' GLN . . . . . 0.537 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 24.5 tp60 -80.37 114.56 19.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -177.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -81.32 110.11 16.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.424 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 51' ' ' TYR . . . . . 0.578 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 82.1 m-85 -99.32 129.95 45.57 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.225 177.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.24 99.42 3.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 171.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 53' ' ' VAL . . . . . 0.468 HG13 ' CD2' ' C' ' 88' ' ' LEU . 2.4 t -74.69 -50.08 27.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.376 -171.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 54' ' ' ALA . . . . . 0.425 ' HB2' ' CD2' ' D' ' 65' ' ' LEU . . . -158.21 139.02 12.97 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.453 -177.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 22.9 m -103.11 102.1 12.09 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 171.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 56' ' ' VAL . . . . . 0.472 HG13 ' HB3' ' D' ' 40' ' ' ALA . 7.2 p -113.55 110.21 31.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.889 0.852 . . . . 0.0 109.932 -177.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 81.6 p -122.97 -176.95 3.54 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.123 -174.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 58' ' ' LYS . . . . . 0.607 ' HG3' ' O ' ' D' ' 38' ' ' GLN . 9.7 mtmp? -56.64 -35.18 68.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.146 0.498 . . . . 0.0 110.329 169.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.24 -40.72 64.43 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.549 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 77.6 mt -116.93 80.55 11.29 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 173.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.28 0.06 6.6 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.018 2.479 . . . . 0.0 113.238 -169.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -164.19 118.7 1.47 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.267 0.556 . . . . 0.0 111.003 -174.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 58.6 t -108.83 108.58 25.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.299 175.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.55 117.39 27.47 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.83 174.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 65' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' D' ' 30' ' ' SER . 0.3 OUTLIER -136.35 168.51 19.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.465 -175.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 66' ' ' ASP . . . . . 0.512 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 8.8 t0 -114.0 99.61 7.79 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.206 0.527 . . . . 0.0 110.257 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.59 HD21 HD23 ' C' ' 88' ' ' LEU . 19.5 mt -112.78 142.0 45.93 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.468 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -150.58 115.78 5.37 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 174.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -110.29 158.8 18.02 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.917 -177.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 70' ' ' SER . . . . . 0.506 ' HB2' ' HA ' ' C' ' 7' ' ' MET . 8.6 t -110.68 158.68 18.35 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.212 0.529 . . . . 0.0 110.619 -176.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -70.5 -4.78 24.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.611 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.38 -26.96 14.14 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.49 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -100.66 168.24 9.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.033 0.444 . . . . 0.0 110.923 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -136.8 143.7 43.31 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.718 HG22 ' HB2' ' D' ' 46' ' ' ALA . 13.3 pt -139.96 176.0 6.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.113 -172.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 76' ' ' MET . . . . . 0.58 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 9.2 mtm -134.03 131.82 39.32 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 171.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 77' ' ' PHE . . . . . 0.457 ' CD1' ' HB2' ' D' ' 44' ' ' LEU . 1.2 m-85 -108.28 128.28 54.6 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 78' ' ' TYR . . . . . 0.665 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 39.0 p90 -152.86 136.32 15.91 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.36 0.6 . . . . 0.0 111.734 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 79' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 2.1 p -111.2 133.13 53.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.187 -177.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.25 168.28 9.45 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.777 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.94 -170.24 43.32 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -115.09 102.72 10.19 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 117.723 0.761 . . . . 0.0 109.61 174.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 83' ' ' ALA . . . . . 0.673 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -173.86 152.4 1.97 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.487 170.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 32.0 t -111.55 122.09 46.91 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.453 HG12 ' HB3' ' D' ' 34' ' ' LEU . 4.3 m -113.62 156.85 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.635 0 CA-C-O 121.476 0.655 . . . . 0.0 112.58 -172.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 14.9 t -123.53 113.82 19.23 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.656 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 87' ' ' LEU . . . . . 0.6 HD11 ' SD ' ' D' ' 13' ' ' MET . 5.0 mp -90.09 153.5 20.5 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 121.139 0.495 . . . . 0.0 109.852 174.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.561 HD23 HD21 ' E' ' 67' ' ' LEU . 1.0 OUTLIER -133.4 139.44 46.76 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.067 -179.526 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.87 -166.85 24.5 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.838 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -152.8 131.24 12.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.786 0.803 . . . . 0.0 111.843 176.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 5.7 mt . . . . . 0 C--N 1.323 -0.571 0 CA-C-N 113.984 -1.462 . . . . 0.0 109.299 175.078 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' E' E ' 7' ' ' MET . . . . . 0.513 ' HA ' ' HB2' ' A' ' 70' ' ' SER . 11.5 ttt . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 121.086 0.47 . . . . 0.0 111.825 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 8' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -55.95 143.83 30.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.515 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 9' ' ' TRP . . . . . 0.429 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 89.9 t90 -137.4 150.13 47.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.044 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 10' ' ' GLY . . . . . 0.582 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -150.87 159.68 28.27 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.082 177.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 11' ' ' LEU . . . . . 0.599 HD23 HD13 ' E' ' 87' ' ' LEU . 37.3 tp -148.29 108.2 4.04 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.808 0.337 . . . . 0.0 111.151 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -92.38 103.78 16.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.081 0.467 . . . . 0.0 110.007 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 13' ' ' MET . . . . . 0.597 ' SD ' HD11 ' E' ' 87' ' ' LEU . 53.1 mtp -95.06 144.99 25.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.099 -175.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -100.48 149.38 36.05 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.787 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 15' ' ' PRO . . . . . 0.56 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 11.5 Cg_endo -55.75 121.77 10.56 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.29 2.66 . . . . 0.0 113.292 -176.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 16' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' E' ' 79' ' ' THR . 49.8 mt-10 60.95 57.23 2.63 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.505 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -132.43 142.67 49.36 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.29 174.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 18' ' ' LYS . . . . . 0.661 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 35.6 ttmt -118.42 116.3 26.43 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.881 0.372 . . . . 0.0 111.71 -175.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -112.21 110.33 20.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.013 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 4.8 p -77.3 122.04 24.56 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 173.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -99.57 128.59 45.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.872 -167.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 27.6 p -98.69 125.06 43.89 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 169.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 44.1 mt -96.43 118.67 43.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.303 0.573 . . . . 0.0 111.691 -172.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 24' ' ' ILE . . . . . 0.429 HD12 ' N ' ' E' ' 24' ' ' ILE . 4.1 mp -93.94 -44.93 13.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.581 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -118.72 140.32 50.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.471 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 11.3 t -62.53 114.39 3.52 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 173.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 27' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -130.04 148.7 51.92 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 119.528 -0.869 . . . . 0.0 112.927 -170.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 28' ' ' HIS . . . . . 0.58 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 17.8 t60 -106.08 125.66 51.26 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.115 -1.402 . . . . 0.0 110.283 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 29' ' ' ILE . . . . . 0.59 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 47.1 mt -97.7 132.55 42.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 30' ' ' SER . . . . . 0.58 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 44.1 p -116.28 -14.67 11.05 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -170.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.6 152.5 22.21 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 119.206 -1.473 . . . . 0.0 113.431 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.422 HG23 ' HG ' ' E' ' 87' ' ' LEU . 8.7 p -138.02 122.78 23.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 172.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 33' ' ' ALA . . . . . 0.416 ' HA ' HG21 ' E' ' 56' ' ' VAL . . . -140.6 156.17 46.35 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.345 -174.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 34' ' ' LEU . . . . . 0.449 ' HB3' HG12 ' E' ' 85' ' ' VAL . 3.7 pp -115.21 141.39 48.08 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.836 0.827 . . . . 0.0 112.093 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -106.57 -57.31 2.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.003 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -102.64 127.4 49.76 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 169.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 37' ' ' GLY . . . . . 0.494 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 153.55 160.7 9.89 Favored Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 119.485 -1.341 . . . . 0.0 113.762 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 38' ' ' GLN . . . . . 0.592 ' O ' ' HG3' ' E' ' 58' ' ' LYS . 19.2 tt0 -102.29 -46.89 4.67 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.574 -0.313 . . . . 0.0 110.363 177.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 39' ' ' GLU . . . . . 0.452 ' OE2' ' HG2' ' E' ' 38' ' ' GLN . 6.9 mp0 -152.38 129.42 11.08 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.4 176.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 40' ' ' ALA . . . . . 0.66 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -125.92 119.56 28.1 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.398 0.618 . . . . 0.0 110.25 171.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 41' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -104.54 108.97 20.67 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 43.6 tp -84.89 115.05 22.56 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.291 -173.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 43' ' ' TYR . . . . . 0.528 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 91.4 m-85 -116.31 145.53 43.11 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 175.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 44' ' ' LEU . . . . . 0.573 ' HA ' ' O ' ' E' ' 76' ' ' MET . 0.2 OUTLIER -131.67 128.39 38.94 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 171.408 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 45' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -106.58 122.88 47.21 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.651 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 46' ' ' ALA . . . . . 0.699 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -130.28 125.28 34.41 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 175.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 61.45 36.36 17.24 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.488 0.492 . . . . 0.0 109.719 -171.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 48' ' ' LYS . . . . . 0.494 ' O ' ' HD3' ' E' ' 48' ' ' LYS . 14.9 tmtt? 73.66 -7.52 1.56 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.413 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 49' ' ' GLN . . . . . 0.529 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 24.3 tp60 -80.39 114.58 19.39 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -177.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -81.39 110.21 16.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.999 0.428 . . . . 0.0 110.395 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 51' ' ' TYR . . . . . 0.585 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 82.2 m-85 -99.44 129.94 45.67 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.219 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.29 99.49 4.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 172.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 53' ' ' VAL . . . . . 0.479 HG13 ' CD2' ' D' ' 88' ' ' LEU . 2.4 t -74.67 -50.09 27.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.366 -171.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 54' ' ' ALA . . . . . 0.424 ' HB2' ' CD2' ' E' ' 65' ' ' LEU . . . -158.25 139.01 12.93 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.465 -177.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 23.2 m -102.98 102.12 12.15 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 171.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 56' ' ' VAL . . . . . 0.473 HG13 ' HB3' ' E' ' 40' ' ' ALA . 7.2 p -113.67 110.27 31.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.966 0.889 . . . . 0.0 109.844 -177.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 81.5 p -122.97 -176.89 3.52 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.181 -174.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 58' ' ' LYS . . . . . 0.592 ' HG3' ' O ' ' E' ' 38' ' ' GLN . 9.8 mtmp? -56.79 -35.01 68.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.016 0.436 . . . . 0.0 110.313 169.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.38 -40.62 64.21 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.506 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 77.8 mt -117.05 80.56 11.66 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.22 -0.04 6.7 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.038 2.492 . . . . 0.0 113.165 -169.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -164.11 118.69 1.49 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.159 0.504 . . . . 0.0 110.945 -174.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 63' ' ' VAL . . . . . 0.402 HG11 ' HB1' ' E' ' 54' ' ' ALA . 58.3 t -108.78 108.52 25.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.368 175.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.45 117.31 27.29 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.858 174.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 65' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' E' ' 30' ' ' SER . 0.3 OUTLIER -136.3 168.56 19.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.51 -176.043 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 66' ' ' ASP . . . . . 0.545 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 8.9 t0 -114.05 99.53 7.71 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.236 0.541 . . . . 0.0 110.258 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 67' ' ' LEU . . . . . 0.59 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 19.6 mt -112.74 142.11 45.75 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.458 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -150.63 115.81 5.36 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 174.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -110.37 158.68 18.19 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.884 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 70' ' ' SER . . . . . 0.496 ' HB2' ' HA ' ' D' ' 7' ' ' MET . 8.6 t -110.58 158.68 18.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.35 0.595 . . . . 0.0 110.634 -176.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -70.53 -4.84 24.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.618 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.34 -26.87 14.46 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.49 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -100.63 168.27 9.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.104 0.478 . . . . 0.0 110.884 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -136.86 143.69 43.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.12 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 75' ' ' ILE . . . . . 0.699 HG22 ' HB2' ' E' ' 46' ' ' ALA . 13.2 pt -139.93 176.12 5.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.653 0.263 . . . . 0.0 111.071 -172.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 76' ' ' MET . . . . . 0.573 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 9.2 mtm -134.09 131.73 39.11 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 171.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 77' ' ' PHE . . . . . 0.465 ' CD1' ' HB2' ' E' ' 44' ' ' LEU . 1.2 m-85 -108.29 128.29 54.61 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 178.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 78' ' ' TYR . . . . . 0.661 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 38.8 p90 -152.84 136.32 15.93 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.325 0.583 . . . . 0.0 111.742 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 79' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 2.1 p -111.12 133.01 53.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.257 -177.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.1 168.22 9.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.9 177.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.0 -170.21 43.15 Favored Glycine 0 CA--C 1.508 -0.346 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -115.12 102.7 10.16 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 117.716 0.758 . . . . 0.0 109.626 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 83' ' ' ALA . . . . . 0.66 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -173.82 152.28 1.96 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.509 170.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 31.9 t -111.46 122.19 47.18 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 85' ' ' VAL . . . . . 0.449 HG12 ' HB3' ' E' ' 34' ' ' LEU . 4.3 m -113.64 156.89 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 CA-C-O 121.538 0.685 . . . . 0.0 112.542 -172.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 14.9 t -123.62 113.8 19.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.794 -1.094 . . . . 0.0 108.63 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 87' ' ' LEU . . . . . 0.599 HD13 HD23 ' E' ' 11' ' ' LEU . 5.0 mp -90.12 153.42 20.55 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.123 0.487 . . . . 0.0 109.867 174.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 88' ' ' LEU . . . . . 0.6 HD23 HD21 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -133.28 139.44 46.91 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 114.803 -1.089 . . . . 0.0 109.077 -179.494 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.94 -166.83 24.55 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.849 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 90' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -152.8 131.33 12.22 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.769 0.795 . . . . 0.0 111.799 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 91' ' ' LEU . . . . . . . . . . . . . 5.8 mt . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.269 175.16 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 38.4 mtt . . . . . 0 CA--C 1.518 -0.256 0 CA-C-O 121.157 0.503 . . . . 0.0 112.089 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.513 ' CE1' HD21 ' B' ' 44' ' ' LEU . 28.9 t80 -62.34 145.7 53.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.547 -178.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -135.75 147.4 48.4 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.431 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -150.97 153.86 25.23 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.197 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.598 HD23 HD13 ' A' ' 87' ' ' LEU . 33.3 tp -147.77 106.54 3.82 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 86' ' ' SER . 0.2 OUTLIER -97.85 110.54 23.09 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.543 0.687 . . . . 0.0 111.02 176.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.443 ' SD ' HG23 ' A' ' 79' ' ' THR . 7.3 mtt -85.19 142.22 29.61 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.285 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.431 ' HB2' ' HG3' ' A' ' 17' ' ' ARG . 91.6 mttt -89.82 144.26 31.38 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 170.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -46.31 109.77 0.22 Allowed 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 123.463 2.776 . . . . 0.0 113.594 -174.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.64 ' HA ' ' O ' ' A' ' 79' ' ' THR . 8.8 tt0 70.52 67.05 0.2 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.794 175.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.536 ' NE ' ' HA ' ' A' ' 17' ' ' ARG . 4.7 mmp_? -122.76 169.28 11.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.03 175.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.68 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 19.4 tttm -146.77 104.81 3.76 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.34 0.4 . . . . 0.0 111.274 -175.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -111.74 111.5 22.51 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.053 -177.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 76' ' ' MET . 29.2 t -90.78 111.06 22.29 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 170.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -133.86 150.01 51.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.635 0.731 . . . . 0.0 112.687 -168.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.7 p -91.18 160.91 15.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.679 177.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.436 HG22 ' HA ' ' A' ' 71' ' ' LYS . 73.8 mt -111.2 126.29 68.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.219 -174.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.521 HD12 ' N ' ' A' ' 25' ' ' LYS . 1.8 pp -92.53 -24.44 5.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.641 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.521 ' N ' HD12 ' A' ' 24' ' ' ILE . 24.8 mtpp -147.44 132.93 18.66 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.6 m -55.05 119.4 5.39 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.407 ' HB3' HD23 ' A' ' 91' ' ' LEU . 5.7 p90 -137.34 156.72 47.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.737 0.78 . . . . 0.0 112.833 -170.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.588 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 15.1 t60 -109.88 124.65 51.73 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.118 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.574 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 39.3 mt -94.45 135.08 29.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 169.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.593 ' HB2' ' HB3' ' B' ' 66' ' ' ASP . 50.1 p -120.31 -15.85 8.55 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -169.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -160.39 145.21 10.84 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 119.288 -1.434 . . . . 0.0 113.324 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.443 HG23 ' HG ' ' A' ' 87' ' ' LEU . 12.2 p -129.85 121.55 52.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 168.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.07 154.38 43.9 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 121.928 -0.483 . . . . 0.0 112.018 -173.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.558 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.4 pp -125.15 144.0 50.65 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.499 0.666 . . . . 0.0 110.836 178.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -110.27 -45.98 3.49 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 173.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -103.63 128.66 50.89 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.593 171.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.496 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 146.63 163.01 10.18 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 119.627 -1.273 . . . . 0.0 113.501 176.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -102.24 -47.24 4.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.494 0.188 . . . . 0.0 110.97 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -152.16 133.71 14.63 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.093 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.478 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -134.29 113.46 11.97 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.391 0.615 . . . . 0.0 110.122 167.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -97.81 112.72 24.52 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 174.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.7 tp -83.81 113.29 20.82 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.557 -174.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.532 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 97.9 m-85 -115.78 141.45 48.07 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.541 ' HB2' ' CD1' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -129.85 131.82 46.25 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 173.885 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -110.71 114.96 28.74 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.028 177.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.619 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -129.91 142.54 50.64 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 58.65 29.24 18.28 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.949 0.404 . . . . 0.0 110.314 -174.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt 63.58 24.51 14.02 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.735 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 23.9 tp60 -115.65 126.69 54.47 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -83.44 125.01 31.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.891 0.377 . . . . 0.0 110.696 -177.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.465 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 66.3 m-85 -121.03 133.32 55.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.943 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -82.1 107.74 14.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 169.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.51 HG13 ' CD2' ' E' ' 88' ' ' LEU . 2.4 t -80.06 -49.56 18.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.64 -171.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.534 ' HB1' HG11 ' A' ' 63' ' ' VAL . . . -160.05 148.9 17.34 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.132 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.6 m -109.79 102.22 11.03 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 173.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.415 ' CG1' HG11 ' A' ' 85' ' ' VAL . 7.3 p -117.77 114.36 45.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.658 0.742 . . . . 0.0 110.016 -177.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 81.0 p -123.05 -178.3 3.92 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.55 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -63.47 -21.54 66.37 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.996 0.426 . . . . 0.0 110.444 170.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.406 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -83.47 -40.72 18.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.229 0.537 . . . . 0.0 110.244 177.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.1 mt -113.22 82.68 5.82 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 173.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 12.5 Cg_exo -70.06 -0.11 6.69 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.156 2.57 . . . . 0.0 114.059 -167.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.28 127.12 2.44 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.175 0.512 . . . . 0.0 111.445 -176.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.534 HG11 ' HB1' ' A' ' 54' ' ' ALA . 85.2 t -117.44 106.22 19.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.311 174.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.47 121.68 27.07 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 173.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -140.69 168.16 20.46 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.766 -173.001 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.569 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 11.6 t0 -118.85 105.29 11.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.359 0.6 . . . . 0.0 110.497 -177.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.591 HD21 HD23 ' E' ' 88' ' ' LEU . 15.1 mt -118.8 144.43 46.32 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.655 177.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.447 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 57.5 t30 -148.44 114.79 5.89 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 173.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.403 ' CZ ' HD22 ' A' ' 67' ' ' LEU . 51.7 m-85 -110.13 164.51 12.57 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.091 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.0 t -107.85 149.15 28.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.859 0.361 . . . . 0.0 110.694 -177.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.436 ' HA ' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -68.14 -11.95 60.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.235 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.3 -5.76 61.83 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.537 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -100.25 167.9 10.13 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -145.23 128.21 16.5 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.619 HG22 ' HB2' ' A' ' 46' ' ' ALA . 15.4 pt -134.89 165.49 31.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.111 0.481 . . . . 0.0 111.79 -169.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.517 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 4.5 mtm -120.91 123.5 42.65 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.595 173.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.541 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -105.96 127.61 53.26 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.587 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.68 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 40.5 p90 -154.95 144.13 21.05 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 120.031 -0.668 . . . . 0.0 112.006 -177.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.64 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 6.3 p -116.18 141.64 47.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.394 -177.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.72 153.37 23.04 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.221 176.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.93 -175.36 36.69 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -175.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -118.78 104.85 10.96 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 122.118 0.961 . . . . 0.0 110.499 176.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.496 ' CB ' ' HA3' ' A' ' 37' ' ' GLY . . . -166.1 154.83 11.16 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.22 170.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.3 t -106.3 111.19 23.67 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.558 HG12 ' HB3' ' A' ' 34' ' ' LEU . 3.4 m -111.33 138.08 41.25 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 CA-C-O 121.219 0.533 . . . . 0.0 112.191 -174.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 7.4 t -108.91 118.25 36.32 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.598 HD13 HD23 ' A' ' 11' ' ' LEU . 5.4 mp -89.73 149.26 22.82 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.532 174.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.592 HD23 HD21 ' B' ' 67' ' ' LEU . 1.3 tp -132.02 140.71 49.01 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.938 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.39 -167.14 25.52 Favored Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.695 -177.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.436 ' CD2' ' HB3' ' B' ' 68' ' ' ASN . 12.9 p90 -153.34 132.18 12.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.746 0.784 . . . . 0.0 111.643 177.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.416 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 22.3 mt . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.112 173.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 38.4 mtt . . . . . 0 CA--C 1.518 -0.269 0 CA-C-O 121.282 0.563 . . . . 0.0 112.041 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 8' ' ' PHE . . . . . 0.528 ' CE1' HD21 ' C' ' 44' ' ' LEU . 29.1 t80 -62.36 145.73 53.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.47 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -135.72 147.33 48.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.112 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.504 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -150.95 153.81 25.21 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.185 178.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.626 HD23 HD13 ' B' ' 87' ' ' LEU . 33.6 tp -147.7 106.59 3.83 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 12' ' ' ASN . . . . . 0.491 ' HA ' ' HA ' ' B' ' 86' ' ' SER . 0.2 OUTLIER -97.88 110.58 23.12 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.597 0.713 . . . . 0.0 110.959 177.01 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 13' ' ' MET . . . . . 0.439 ' SD ' HG23 ' B' ' 79' ' ' THR . 7.3 mtt -85.14 142.17 29.68 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.366 -178.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.439 ' HB2' ' HG3' ' B' ' 17' ' ' ARG . 91.5 mttt -89.77 144.31 31.53 Favored Pre-proline 0 C--N 1.316 -0.874 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 170.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -46.3 109.69 0.22 Allowed 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 123.56 2.84 . . . . 0.0 113.496 -174.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.642 ' HA ' ' O ' ' B' ' 79' ' ' THR . 8.8 tt0 70.54 67.09 0.2 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.734 175.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.534 ' NE ' ' HA ' ' B' ' 17' ' ' ARG . 4.6 mmp_? -122.76 169.18 11.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.089 175.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.67 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 19.5 tttm -146.68 104.77 3.77 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 123.325 0.391 . . . . 0.0 111.269 -175.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -111.76 111.53 22.57 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.079 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 29.3 t -90.73 111.05 22.26 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -133.92 150.09 51.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.667 0.746 . . . . 0.0 112.66 -168.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 3.8 p -91.25 160.91 15.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.665 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.436 HG22 ' HA ' ' B' ' 71' ' ' LYS . 74.0 mt -111.24 126.31 68.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.144 -174.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.527 HD12 ' N ' ' B' ' 25' ' ' LYS . 1.8 pp -92.49 -24.44 5.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.692 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.527 ' N ' HD12 ' B' ' 24' ' ' ILE . 24.9 mtpp -147.36 132.86 18.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.87 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 15.5 m -54.96 119.32 5.25 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' PHE . . . . . 0.42 ' HB3' HD23 ' B' ' 91' ' ' LEU . 5.8 p90 -137.31 156.62 48.03 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.669 0.747 . . . . 0.0 112.853 -170.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 28' ' ' HIS . . . . . 0.587 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 15.1 t60 -109.92 124.59 51.64 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.151 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.571 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 39.3 mt -94.39 135.1 29.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 169.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.587 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 48.7 p -120.34 -15.79 8.54 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -169.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -160.31 145.16 10.79 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 119.301 -1.428 . . . . 0.0 113.377 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.439 HG23 ' HG ' ' B' ' 87' ' ' LEU . 12.3 p -129.81 121.59 52.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 168.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.11 154.31 43.79 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.983 -173.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.556 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.4 pp -125.08 143.99 50.64 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.468 0.651 . . . . 0.0 110.791 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -110.15 -46.12 3.49 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 173.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -103.57 128.67 50.78 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.515 171.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.493 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 146.55 163.01 10.17 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 119.676 -1.25 . . . . 0.0 113.6 175.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -102.3 -47.04 4.63 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.19 -0.204 . . . . 0.0 111.043 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -152.22 133.68 14.55 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.999 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.48 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -134.38 113.46 11.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.474 0.654 . . . . 0.0 110.127 167.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -97.83 112.7 24.51 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 174.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 43.6 tp -83.71 113.37 20.83 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.56 -174.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' TYR . . . . . 0.532 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 98.0 m-85 -115.89 141.41 48.14 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 176.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.551 ' HB2' ' CD1' ' B' ' 77' ' ' PHE . 0.1 OUTLIER -129.85 131.9 46.27 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 173.906 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -110.7 114.94 28.7 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.01 177.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.622 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -129.91 142.54 50.64 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 58.6 29.31 18.31 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.994 0.426 . . . . 0.0 110.338 -174.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt 63.5 24.5 14.09 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.705 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.473 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 24.0 tp60 -115.64 126.65 54.43 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -83.38 124.94 31.15 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.972 0.415 . . . . 0.0 110.702 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.431 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 66.4 m-85 -120.97 133.37 55.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.899 176.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -82.06 107.63 14.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 169.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.528 HG13 ' CD2' ' A' ' 88' ' ' LEU . 2.4 t -80.08 -49.54 18.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.61 -171.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.528 ' HB1' HG11 ' B' ' 63' ' ' VAL . . . -159.98 148.89 17.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.171 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 55.4 m -109.85 102.28 11.06 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 173.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 56' ' ' VAL . . . . . 0.414 ' CG1' HG11 ' B' ' 85' ' ' VAL . 7.3 p -117.78 114.41 45.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.669 0.747 . . . . 0.0 110.001 -177.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 81.3 p -123.12 -178.38 3.95 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.608 -174.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -63.45 -21.47 66.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.932 0.396 . . . . 0.0 110.484 170.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.402 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -83.48 -40.77 18.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.206 0.527 . . . . 0.0 110.216 177.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 80.4 mt -113.22 82.63 5.78 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 12.5 Cg_exo -70.02 -0.2 6.78 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.17 2.58 . . . . 0.0 114.066 -167.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.21 127.17 2.47 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.159 0.504 . . . . 0.0 111.44 -176.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.528 HG11 ' HB1' ' B' ' 54' ' ' ALA . 85.5 t -117.35 106.21 19.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.35 174.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.49 121.7 27.1 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 173.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' B' ' 30' ' ' SER . 0.6 OUTLIER -140.76 168.12 20.55 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.741 -173.026 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 66' ' ' ASP . . . . . 0.593 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 11.8 t0 -118.73 105.26 11.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.264 0.554 . . . . 0.0 110.565 -177.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.592 HD21 HD23 ' A' ' 88' ' ' LEU . 15.1 mt -118.76 144.43 46.28 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.68 177.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 68' ' ' ASN . . . . . 0.436 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 57.4 t30 -148.52 114.8 5.86 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 173.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 69' ' ' PHE . . . . . 0.401 ' CZ ' HD22 ' B' ' 67' ' ' LEU . 51.7 m-85 -110.14 164.56 12.52 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.12 -178.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 33.1 t -107.93 149.18 28.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 0.0 110.677 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 71' ' ' LYS . . . . . 0.436 ' HA ' HG22 ' B' ' 23' ' ' ILE . 0.0 OUTLIER -68.11 -11.95 60.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.271 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.28 -5.76 61.86 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.585 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -100.29 167.96 10.08 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -145.22 128.13 16.43 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.622 HG22 ' HB2' ' B' ' 46' ' ' ALA . 15.4 pt -134.84 165.44 31.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.082 0.467 . . . . 0.0 111.756 -169.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.52 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 4.5 mtm -120.91 123.61 42.93 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 173.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 77' ' ' PHE . . . . . 0.551 ' CD1' ' HB2' ' B' ' 44' ' ' LEU . 0.8 OUTLIER -106.02 127.62 53.29 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.441 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.67 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 40.4 p90 -154.9 144.19 21.16 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.993 -0.683 . . . . 0.0 112.034 -177.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.642 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 6.4 p -116.29 141.63 47.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.356 -177.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.72 153.41 22.99 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.241 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.79 -175.37 36.92 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -175.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -118.75 104.87 10.99 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.509 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.493 ' CB ' ' HA3' ' B' ' 37' ' ' GLY . . . -166.07 154.77 11.18 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.2 170.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 19.0 t -106.16 111.17 23.67 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.556 HG12 ' HB3' ' B' ' 34' ' ' LEU . 3.4 m -111.44 138.17 41.02 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 CA-C-O 121.3 0.571 . . . . 0.0 112.129 -174.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 86' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' B' ' 12' ' ' ASN . 7.4 t -108.94 118.25 36.32 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.793 178.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.626 HD13 HD23 ' B' ' 11' ' ' LEU . 5.4 mp -89.79 149.27 22.77 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.5 174.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.585 HD23 HD21 ' C' ' 67' ' ' LEU . 1.3 tp -131.99 140.69 49.04 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.971 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.41 -167.2 25.64 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.704 -177.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 90' ' ' TYR . . . . . 0.43 ' CD2' ' HB3' ' C' ' 68' ' ' ASN . 13.0 p90 -153.4 132.21 12.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.777 0.798 . . . . 0.0 111.603 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 91' ' ' LEU . . . . . 0.42 HD23 ' HB3' ' B' ' 27' ' ' PHE . 22.2 mt . . . . . 0 C--N 1.322 -0.591 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.131 173.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 38.4 mtt . . . . . 0 CA--C 1.519 -0.233 0 CA-C-O 121.104 0.478 . . . . 0.0 112.106 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 8' ' ' PHE . . . . . 0.502 ' CE1' HD21 ' D' ' 44' ' ' LEU . 28.9 t80 -62.35 145.78 52.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.492 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -135.65 147.44 48.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.177 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 10' ' ' GLY . . . . . 0.447 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -151.04 153.8 25.19 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.203 178.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.624 HD23 HD13 ' C' ' 87' ' ' LEU . 33.4 tp -147.78 106.57 3.82 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 12' ' ' ASN . . . . . 0.483 ' HA ' ' HA ' ' C' ' 86' ' ' SER . 0.2 OUTLIER -97.91 110.67 23.2 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.681 0.753 . . . . 0.0 110.937 177.034 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 13' ' ' MET . . . . . 0.445 ' SD ' HG23 ' C' ' 79' ' ' THR . 7.2 mtt -85.25 142.17 29.59 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.019 -0.992 . . . . 0.0 111.324 -178.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 14' ' ' LYS . . . . . 0.431 ' HB2' ' HG3' ' C' ' 17' ' ' ARG . 91.4 mttt -89.67 144.17 31.45 Favored Pre-proline 0 C--N 1.315 -0.902 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 170.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -46.23 109.65 0.21 Allowed 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 123.503 2.802 . . . . 0.0 113.543 -174.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 16' ' ' GLU . . . . . 0.634 ' HA ' ' O ' ' C' ' 79' ' ' THR . 8.8 tt0 70.59 67.08 0.19 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.767 175.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 17' ' ' ARG . . . . . 0.527 ' NE ' ' HA ' ' C' ' 17' ' ' ARG . 4.7 mmp_? -122.76 169.22 11.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.133 175.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 18' ' ' LYS . . . . . 0.682 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 19.4 tttm -146.67 104.8 3.77 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.346 0.404 . . . . 0.0 111.305 -175.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -111.76 111.53 22.57 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.093 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 20' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 29.5 t -90.84 111.05 22.29 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 170.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -133.89 150.11 51.34 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.693 0.758 . . . . 0.0 112.645 -168.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 3.8 p -91.2 160.83 15.34 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.657 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 23' ' ' ILE . . . . . 0.445 HG22 ' HA ' ' C' ' 71' ' ' LYS . 74.1 mt -111.13 126.25 68.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.171 -174.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 24' ' ' ILE . . . . . 0.537 HD12 ' N ' ' C' ' 25' ' ' LYS . 1.8 pp -92.5 -24.38 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.69 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 25' ' ' LYS . . . . . 0.537 ' N ' HD12 ' C' ' 24' ' ' ILE . 24.8 mtpp -147.44 132.94 18.67 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.836 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 15.6 m -54.98 119.42 5.39 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 27' ' ' PHE . . . . . 0.421 ' HB3' HD23 ' C' ' 91' ' ' LEU . 5.8 p90 -137.38 156.63 47.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.694 0.759 . . . . 0.0 112.788 -170.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 28' ' ' HIS . . . . . 0.591 ' HA ' ' O ' ' C' ' 67' ' ' LEU . 15.1 t60 -109.9 124.61 51.66 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.244 -1.343 . . . . 0.0 110.101 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 29' ' ' ILE . . . . . 0.573 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 39.4 mt -94.45 134.99 30.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 169.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.589 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 50.0 p -120.2 -15.88 8.6 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -169.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 31' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -160.34 145.17 10.8 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.382 -1.389 . . . . 0.0 113.38 178.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.449 HG23 ' HG ' ' C' ' 87' ' ' LEU . 12.1 p -129.8 121.63 52.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 168.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.18 154.38 43.82 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.979 -173.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.555 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.4 pp -125.11 144.02 50.63 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.468 0.651 . . . . 0.0 110.787 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -110.16 -46.01 3.51 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -103.64 128.65 50.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.551 171.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 37' ' ' GLY . . . . . 0.483 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 146.67 163.0 10.18 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 119.664 -1.255 . . . . 0.0 113.576 176.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -102.25 -47.22 4.58 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.463 0.173 . . . . 0.0 110.976 177.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -152.16 133.75 14.65 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.063 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.469 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -134.35 113.42 11.89 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.362 0.601 . . . . 0.0 110.097 168.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -97.77 112.57 24.42 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 174.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 43.7 tp -83.76 113.32 20.82 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.577 -174.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 43' ' ' TYR . . . . . 0.529 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 98.0 m-85 -115.8 141.53 47.98 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.553 ' HB2' ' CD1' ' C' ' 77' ' ' PHE . 0.1 OUTLIER -129.91 131.79 46.15 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 173.898 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 45' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -110.74 114.85 28.53 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.981 177.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.597 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -129.86 142.47 50.66 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 58.78 29.17 18.36 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.89 0.376 . . . . 0.0 110.284 -174.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt 63.55 24.57 14.07 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.681 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 49' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 24.0 tp60 -115.67 126.67 54.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -83.42 124.85 31.09 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.869 0.366 . . . . 0.0 110.758 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 51' ' ' TYR . . . . . 0.504 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 66.8 m-85 -120.91 133.35 55.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 176.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -82.14 107.7 14.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 169.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 53' ' ' VAL . . . . . 0.509 HG13 ' CD2' ' B' ' 88' ' ' LEU . 2.4 t -80.07 -49.58 18.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.643 -171.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 54' ' ' ALA . . . . . 0.525 ' HB1' HG11 ' C' ' 63' ' ' VAL . . . -159.99 148.98 17.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.232 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 54.1 m -109.81 102.19 10.99 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 173.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 56' ' ' VAL . . . . . 0.412 ' CG1' HG11 ' C' ' 85' ' ' VAL . 7.4 p -117.69 114.39 45.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.653 0.739 . . . . 0.0 110.032 -177.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 81.2 p -123.05 -178.33 3.93 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.581 -174.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -63.57 -21.4 66.33 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.887 0.375 . . . . 0.0 110.491 170.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 59' ' ' ALA . . . . . 0.402 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -83.52 -40.67 18.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.166 0.508 . . . . 0.0 110.228 177.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 80.6 mt -113.28 82.71 5.94 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 174.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 61' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 12.5 Cg_exo -70.06 -0.13 6.71 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.15 2.567 . . . . 0.0 114.052 -167.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.3 127.18 2.44 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.146 0.498 . . . . 0.0 111.418 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.525 HG11 ' HB1' ' C' ' 54' ' ' ALA . 86.4 t -117.34 106.14 19.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.35 174.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.45 121.7 27.08 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 173.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 65' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' C' ' 30' ' ' SER . 0.6 OUTLIER -140.71 168.2 20.36 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.736 -172.974 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 66' ' ' ASP . . . . . 0.538 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 11.6 t0 -118.88 105.18 11.24 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.322 0.582 . . . . 0.0 110.569 -177.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.591 ' O ' ' HA ' ' C' ' 28' ' ' HIS . 15.2 mt -118.7 144.48 46.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.651 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 68' ' ' ASN . . . . . 0.43 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 57.4 t30 -148.55 114.74 5.83 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 173.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -110.09 164.5 12.57 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.122 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 33.1 t -107.85 149.2 28.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.371 . . . . 0.0 110.679 -177.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 71' ' ' LYS . . . . . 0.445 ' HA ' HG22 ' C' ' 23' ' ' ILE . 0.0 OUTLIER -68.19 -11.85 59.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.279 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.41 -5.8 61.63 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.565 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -100.13 167.9 10.16 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -145.2 128.14 16.45 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.597 HG22 ' HB2' ' C' ' 46' ' ' ALA . 15.3 pt -134.87 165.51 30.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.992 0.425 . . . . 0.0 111.75 -169.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.515 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 4.5 mtm -120.85 123.47 42.65 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.612 173.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 77' ' ' PHE . . . . . 0.553 ' CD1' ' HB2' ' C' ' 44' ' ' LEU . 0.8 OUTLIER -105.95 127.59 53.25 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.488 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 78' ' ' TYR . . . . . 0.682 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 40.5 p90 -154.92 144.16 21.12 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.086 -0.645 . . . . 0.0 111.994 -177.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 79' ' ' THR . . . . . 0.634 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 6.6 p -116.19 141.54 48.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.351 -177.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.69 153.44 22.93 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.248 175.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.83 -175.47 36.95 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -175.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -118.73 104.83 10.96 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 122.191 0.996 . . . . 0.0 110.58 176.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 83' ' ' ALA . . . . . 0.483 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -166.1 154.82 11.16 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.188 170.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 19.9 t -106.29 111.29 23.82 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.555 HG12 ' HB3' ' C' ' 34' ' ' LEU . 3.4 m -111.48 138.16 41.11 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 CA-C-O 121.304 0.573 . . . . 0.0 112.137 -174.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 86' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' C' ' 12' ' ' ASN . 7.4 t -108.99 118.37 36.63 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.76 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 87' ' ' LEU . . . . . 0.624 HD13 HD23 ' C' ' 11' ' ' LEU . 5.4 mp -89.84 149.28 22.73 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.525 174.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 88' ' ' LEU . . . . . 0.592 HD23 HD21 ' D' ' 67' ' ' LEU . 1.3 tp -131.98 140.68 49.04 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.018 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.32 -167.12 25.42 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.683 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 90' ' ' TYR . . . . . 0.464 ' CD2' ' HB3' ' D' ' 68' ' ' ASN . 13.2 p90 -153.4 132.18 12.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.767 0.794 . . . . 0.0 111.656 177.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 91' ' ' LEU . . . . . 0.421 HD23 ' HB3' ' C' ' 27' ' ' PHE . 21.9 mt . . . . . 0 C--N 1.322 -0.596 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.195 173.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 38.3 mtt . . . . . 0 CA--C 1.518 -0.256 0 CA-C-O 121.233 0.539 . . . . 0.0 112.041 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 8' ' ' PHE . . . . . 0.494 ' CE1' HD21 ' E' ' 44' ' ' LEU . 29.4 t80 -62.34 145.77 52.96 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.507 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 9' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -135.75 147.4 48.41 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.079 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 10' ' ' GLY . . . . . 0.46 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -151.03 153.87 25.23 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.179 178.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 11' ' ' LEU . . . . . 0.614 HD23 HD13 ' D' ' 87' ' ' LEU . 33.6 tp -147.69 106.54 3.83 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.34 -0.245 . . . . 0.0 110.34 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 12' ' ' ASN . . . . . 0.482 ' HA ' ' HA ' ' D' ' 86' ' ' SER . 0.2 OUTLIER -97.9 110.56 23.11 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.63 0.729 . . . . 0.0 110.979 177.035 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 13' ' ' MET . . . . . 0.435 ' SD ' HG23 ' D' ' 79' ' ' THR . 7.3 mtt -85.15 142.17 29.67 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.422 -178.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 14' ' ' LYS . . . . . 0.447 ' HB2' ' HG3' ' D' ' 17' ' ' ARG . 91.5 mttt -89.74 144.18 31.37 Favored Pre-proline 0 C--N 1.316 -0.891 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 170.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -46.27 109.73 0.22 Allowed 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 123.414 2.743 . . . . 0.0 113.605 -174.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 16' ' ' GLU . . . . . 0.619 ' HA ' ' O ' ' D' ' 79' ' ' THR . 8.9 tt0 70.61 67.07 0.19 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.762 175.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 17' ' ' ARG . . . . . 0.52 ' NE ' ' HA ' ' D' ' 17' ' ' ARG . 4.7 mmp_? -122.76 169.2 11.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.091 175.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 18' ' ' LYS . . . . . 0.689 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 19.4 tttm -146.69 104.79 3.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 123.292 0.37 . . . . 0.0 111.355 -175.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -111.69 111.55 22.62 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.115 -177.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 20' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 29.3 t -90.87 110.94 22.17 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -133.84 150.2 51.39 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.676 0.751 . . . . 0.0 112.743 -168.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 3.7 p -91.31 160.94 15.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.643 178.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 23' ' ' ILE . . . . . 0.43 HG22 ' HA ' ' D' ' 71' ' ' LYS . 73.8 mt -111.19 126.29 68.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.241 -174.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 24' ' ' ILE . . . . . 0.536 HD12 ' N ' ' D' ' 25' ' ' LYS . 1.8 pp -92.5 -24.41 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.765 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 25' ' ' LYS . . . . . 0.536 ' N ' HD12 ' D' ' 24' ' ' ILE . 24.8 mtpp -147.43 132.86 18.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.8 178.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 15.5 m -54.96 119.4 5.35 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 175.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 27' ' ' PHE . . . . . 0.42 ' HB3' HD23 ' D' ' 91' ' ' LEU . 5.9 p90 -137.38 156.74 47.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.789 0.804 . . . . 0.0 112.792 -170.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 28' ' ' HIS . . . . . 0.597 ' HE2' ' HB3' ' D' ' 30' ' ' SER . 15.2 t60 -109.98 124.7 51.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.221 -1.354 . . . . 0.0 110.07 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 29' ' ' ILE . . . . . 0.581 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 39.5 mt -94.55 135.05 29.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 169.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 30' ' ' SER . . . . . 0.597 ' HB3' ' HE2' ' D' ' 28' ' ' HIS . 50.1 p -120.25 -15.89 8.57 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -169.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 31' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -160.27 145.16 10.81 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 119.374 -1.393 . . . . 0.0 113.366 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.458 HG23 ' HG ' ' D' ' 87' ' ' LEU . 12.1 p -129.85 121.61 52.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 168.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.06 154.41 43.93 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.94 -173.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 34' ' ' LEU . . . . . 0.553 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.4 pp -125.15 144.05 50.63 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.475 0.655 . . . . 0.0 110.777 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -110.17 -46.08 3.49 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 173.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -103.63 128.64 50.9 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.562 171.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 37' ' ' GLY . . . . . 0.493 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 146.63 163.07 10.22 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 119.682 -1.247 . . . . 0.0 113.559 176.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -102.29 -47.22 4.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.59 0.233 . . . . 0.0 111.011 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -152.12 133.67 14.63 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.059 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 40' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -134.35 113.44 11.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.455 0.645 . . . . 0.0 110.177 167.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' D' ' 79' ' ' THR . 98.6 mttt -97.77 112.67 24.48 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 43.5 tp -83.74 113.34 20.82 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.607 -174.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 43' ' ' TYR . . . . . 0.523 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 98.0 m-85 -115.77 141.48 48.03 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.554 ' HB2' ' CD1' ' D' ' 77' ' ' PHE . 0.1 OUTLIER -129.96 131.83 46.09 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 173.874 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 45' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -110.65 115.0 28.83 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.888 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.61 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -129.91 142.57 50.64 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 58.7 29.19 18.27 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.315 0.384 . . . . 0.0 110.28 -174.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt 63.61 24.48 13.98 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.711 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 49' ' ' GLN . . . . . 0.463 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 24.1 tp60 -115.73 126.64 54.33 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -83.39 124.85 31.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.807 0.336 . . . . 0.0 110.755 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 51' ' ' TYR . . . . . 0.447 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 66.7 m-85 -120.89 133.35 55.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.904 176.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.0 tp -82.06 107.72 14.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 169.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 53' ' ' VAL . . . . . 0.499 HG13 ' CD2' ' C' ' 88' ' ' LEU . 2.4 t -80.09 -49.6 18.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.589 -171.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 54' ' ' ALA . . . . . 0.521 ' HB1' HG11 ' D' ' 63' ' ' VAL . . . -160.01 148.93 17.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.173 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 53.3 m -109.81 102.28 11.08 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 56' ' ' VAL . . . . . 0.406 ' CG1' HG11 ' D' ' 85' ' ' VAL . 7.4 p -117.74 114.33 45.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.612 0.72 . . . . 0.0 109.981 -177.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 81.2 p -123.05 -178.27 3.91 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.523 -174.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -63.57 -21.46 66.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.944 0.402 . . . . 0.0 110.461 170.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 59' ' ' ALA . . . . . 0.405 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -83.51 -40.62 18.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.124 0.488 . . . . 0.0 110.222 177.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 80.3 mt -113.29 82.6 5.88 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 174.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 61' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 12.4 Cg_exo -69.99 -0.18 6.73 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.186 2.591 . . . . 0.0 114.114 -167.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.25 127.1 2.45 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.112 0.482 . . . . 0.0 111.483 -176.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.521 HG11 ' HB1' ' D' ' 54' ' ' ALA . 87.2 t -117.3 106.09 19.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.426 174.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.48 121.73 27.13 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 173.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 65' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' D' ' 30' ' ' SER . 0.6 OUTLIER -140.72 168.2 20.35 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.728 -173.034 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 66' ' ' ASP . . . . . 0.576 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 11.9 t0 -118.82 105.23 11.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.251 0.548 . . . . 0.0 110.586 -177.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.592 HD21 HD23 ' C' ' 88' ' ' LEU . 15.1 mt -118.8 144.43 46.32 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.674 177.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 68' ' ' ASN . . . . . 0.464 ' HB3' ' CD2' ' C' ' 90' ' ' TYR . 57.3 t30 -148.47 114.83 5.89 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 173.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 69' ' ' PHE . . . . . 0.4 ' CZ ' HD22 ' D' ' 67' ' ' LEU . 51.8 m-85 -110.15 164.58 12.5 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.106 -178.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 33.0 t -107.97 149.12 28.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.856 0.36 . . . . 0.0 110.723 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 71' ' ' LYS . . . . . 0.43 ' HA ' HG22 ' D' ' 23' ' ' ILE . 0.0 OUTLIER -67.94 -12.03 59.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.344 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.35 -5.73 61.77 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.526 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -100.2 167.92 10.13 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -145.21 128.16 16.46 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.61 HG22 ' HB2' ' D' ' 46' ' ' ALA . 15.4 pt -134.92 165.39 31.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.077 0.465 . . . . 0.0 111.771 -169.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 76' ' ' MET . . . . . 0.521 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 4.5 mtm -120.85 123.5 42.72 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 173.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 77' ' ' PHE . . . . . 0.554 ' CD1' ' HB2' ' D' ' 44' ' ' LEU . 0.8 OUTLIER -106.02 127.59 53.27 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.502 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 78' ' ' TYR . . . . . 0.689 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 40.8 p90 -154.93 144.16 21.11 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.967 -177.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 79' ' ' THR . . . . . 0.619 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 6.5 p -116.22 141.61 47.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.364 -177.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.69 153.31 23.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.289 176.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.92 -175.36 36.7 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -175.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -118.81 104.97 11.05 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 118.114 0.957 . . . . 0.0 110.46 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 83' ' ' ALA . . . . . 0.493 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -166.15 154.77 11.02 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.204 170.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 19.9 t -106.25 111.23 23.74 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.553 HG12 ' HB3' ' D' ' 34' ' ' LEU . 3.4 m -111.43 138.11 41.24 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.706 0 CA-C-O 121.289 0.566 . . . . 0.0 112.144 -174.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 86' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' D' ' 12' ' ' ASN . 7.4 t -108.9 118.31 36.47 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.353 -0.84 . . . . 0.0 108.791 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 87' ' ' LEU . . . . . 0.614 HD13 HD23 ' D' ' 11' ' ' LEU . 5.4 mp -89.76 149.31 22.78 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.524 174.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.572 HD23 HD21 ' E' ' 67' ' ' LEU . 1.3 tp -132.05 140.68 48.97 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.956 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.32 -167.08 25.36 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.683 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 90' ' ' TYR . . . . . 0.442 ' CD2' ' HB3' ' E' ' 68' ' ' ASN . 13.0 p90 -153.42 132.13 12.31 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.74 0.781 . . . . 0.0 111.636 177.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 91' ' ' LEU . . . . . 0.42 HD23 ' HB3' ' D' ' 27' ' ' PHE . 22.4 mt . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.088 173.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 38.6 mtt . . . . . 0 CA--C 1.52 -0.205 0 CA-C-O 121.214 0.53 . . . . 0.0 112.096 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' E' E ' 8' ' ' PHE . . . . . 0.493 ' CE1' HD21 ' A' ' 44' ' ' LEU . 29.0 t80 -62.4 145.77 53.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.492 -178.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 9' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -135.72 147.38 48.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.096 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 10' ' ' GLY . . . . . 0.465 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -151.0 153.81 25.2 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.273 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 11' ' ' LEU . . . . . 0.617 HD23 HD13 ' E' ' 87' ' ' LEU . 33.2 tp -147.77 106.6 3.83 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 12' ' ' ASN . . . . . 0.487 ' HA ' ' HA ' ' E' ' 86' ' ' SER . 0.2 OUTLIER -97.82 110.6 23.14 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.605 0.717 . . . . 0.0 110.987 176.98 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 13' ' ' MET . . . . . 0.438 ' SD ' HG23 ' E' ' 79' ' ' THR . 7.2 mtt -85.26 142.15 29.6 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.31 -178.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 14' ' ' LYS . . . . . 0.424 ' HB2' ' HG3' ' E' ' 17' ' ' ARG . 91.5 mttt -89.71 144.21 31.47 Favored Pre-proline 0 C--N 1.315 -0.919 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 170.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -46.29 109.66 0.22 Allowed 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 123.519 2.813 . . . . 0.0 113.613 -174.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 16' ' ' GLU . . . . . 0.632 ' HA ' ' O ' ' E' ' 79' ' ' THR . 8.8 tt0 70.56 67.1 0.19 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.762 175.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 17' ' ' ARG . . . . . 0.529 ' NE ' ' HA ' ' E' ' 17' ' ' ARG . 4.7 mmp_? -122.79 169.2 11.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.013 175.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 18' ' ' LYS . . . . . 0.673 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 19.4 tttm -146.68 104.89 3.78 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.36 0.413 . . . . 0.0 111.303 -175.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -111.81 111.55 22.6 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.071 -177.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 20' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' E' ' 76' ' ' MET . 28.9 t -90.82 111.0 22.21 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -133.84 150.1 51.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.661 0.743 . . . . 0.0 112.721 -168.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 3.9 p -91.18 160.9 15.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.649 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 23' ' ' ILE . . . . . 0.443 HG22 ' HA ' ' E' ' 71' ' ' LYS . 73.9 mt -111.14 126.26 68.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.176 -174.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 24' ' ' ILE . . . . . 0.523 HD12 ' N ' ' E' ' 25' ' ' LYS . 1.8 pp -92.55 -24.3 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.723 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 25' ' ' LYS . . . . . 0.523 ' N ' HD12 ' E' ' 24' ' ' ILE . 24.8 mtpp -147.56 132.96 18.57 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 15.5 m -54.9 119.4 5.33 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 27' ' ' PHE . . . . . 0.428 ' HB3' HD23 ' E' ' 91' ' ' LEU . 5.8 p90 -137.4 156.67 47.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.725 0.774 . . . . 0.0 112.792 -170.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 28' ' ' HIS . . . . . 0.585 ' HE2' ' HB3' ' E' ' 30' ' ' SER . 15.1 t60 -109.94 124.59 51.65 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.108 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 29' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 39.3 mt -94.43 135.06 29.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 169.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 30' ' ' SER . . . . . 0.585 ' HB3' ' HE2' ' E' ' 28' ' ' HIS . 50.2 p -120.26 -15.87 8.57 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -169.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 31' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -160.32 145.21 10.86 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.314 -1.422 . . . . 0.0 113.361 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.454 HG23 ' HG ' ' E' ' 87' ' ' LEU . 12.0 p -129.92 121.65 52.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 168.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.1 154.37 43.86 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.955 -173.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 34' ' ' LEU . . . . . 0.554 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.4 pp -125.13 144.0 50.64 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.5 0.667 . . . . 0.0 110.836 177.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -110.24 -45.96 3.5 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 173.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -103.67 128.57 50.99 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.56 171.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 37' ' ' GLY . . . . . 0.496 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 146.7 163.0 10.19 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 119.641 -1.266 . . . . 0.0 113.57 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -102.25 -47.15 4.6 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.164 -0.214 . . . . 0.0 111.001 177.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -152.1 133.72 14.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.739 -0.21 . . . . 0.0 111.056 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 40' ' ' ALA . . . . . 0.48 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -134.37 113.45 11.91 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.364 0.602 . . . . 0.0 110.167 167.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 41' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' E' ' 79' ' ' THR . 98.6 mttt -97.86 112.66 24.49 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 174.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 43.1 tp -83.72 113.3 20.79 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.59 -174.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 43' ' ' TYR . . . . . 0.525 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 98.0 m-85 -115.77 141.47 48.05 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 44' ' ' LEU . . . . . 0.552 ' HB2' ' CD1' ' E' ' 77' ' ' PHE . 0.1 OUTLIER -129.95 131.89 46.13 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 173.938 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 45' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -110.78 114.95 28.7 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.994 177.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 46' ' ' ALA . . . . . 0.601 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -129.86 142.49 50.66 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 58.79 29.19 18.4 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.372 0.42 . . . . 0.0 110.224 -174.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt 63.56 24.61 14.08 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.709 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 49' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 24.1 tp60 -115.67 126.69 54.46 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -83.4 124.83 31.06 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.86 0.362 . . . . 0.0 110.724 -177.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 51' ' ' TYR . . . . . 0.46 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 66.2 m-85 -120.84 133.35 55.31 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.0 tp -82.12 107.65 14.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 169.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 53' ' ' VAL . . . . . 0.493 HG13 ' CD2' ' D' ' 88' ' ' LEU . 2.4 t -80.01 -49.58 18.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.663 -171.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 54' ' ' ALA . . . . . 0.538 ' HB1' HG11 ' E' ' 63' ' ' VAL . . . -160.01 148.96 17.44 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.099 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 54.4 m -109.86 102.24 11.03 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 173.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 56' ' ' VAL . . . . . 0.411 ' CG1' HG11 ' E' ' 85' ' ' VAL . 7.4 p -117.76 114.27 44.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.625 0.726 . . . . 0.0 110.004 -177.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 81.1 p -123.06 -178.3 3.92 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.551 -174.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -63.58 -21.4 66.33 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.838 0.352 . . . . 0.0 110.414 170.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 59' ' ' ALA . . . . . 0.403 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -83.55 -40.53 19.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.198 0.523 . . . . 0.0 110.245 177.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 80.6 mt -113.4 82.7 6.12 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 174.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 61' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 12.6 Cg_exo -70.16 -0.17 6.85 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.106 2.537 . . . . 0.0 114.013 -167.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.15 127.15 2.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.163 0.506 . . . . 0.0 111.477 -176.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 63' ' ' VAL . . . . . 0.538 HG11 ' HB1' ' E' ' 54' ' ' ALA . 86.4 t -117.38 106.11 19.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.405 174.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.51 121.76 27.19 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 173.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 65' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' E' ' 30' ' ' SER . 0.6 OUTLIER -140.7 168.18 20.4 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.711 -173.044 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 66' ' ' ASP . . . . . 0.543 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 11.7 t0 -118.83 105.18 11.26 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.267 0.556 . . . . 0.0 110.532 -177.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 67' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' E' ' 28' ' ' HIS . 15.2 mt -118.74 144.51 46.21 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.65 177.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 68' ' ' ASN . . . . . 0.442 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 57.3 t30 -148.53 114.73 5.84 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 173.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 69' ' ' PHE . . . . . 0.401 ' CZ ' HD22 ' E' ' 67' ' ' LEU . 51.4 m-85 -110.06 164.53 12.53 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.187 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 33.0 t -107.91 149.17 28.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.836 0.351 . . . . 0.0 110.687 -177.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 71' ' ' LYS . . . . . 0.443 ' HA ' HG22 ' E' ' 23' ' ' ILE . 0.0 OUTLIER -68.06 -11.91 59.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.345 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.38 -5.81 61.68 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.583 175.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -100.02 167.91 10.18 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -145.19 128.11 16.44 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 75' ' ' ILE . . . . . 0.601 HG22 ' HB2' ' E' ' 46' ' ' ALA . 15.3 pt -134.93 165.51 30.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.094 0.473 . . . . 0.0 111.763 -169.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 76' ' ' MET . . . . . 0.514 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 4.5 mtm -120.92 123.5 42.63 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 173.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 77' ' ' PHE . . . . . 0.552 ' CD1' ' HB2' ' E' ' 44' ' ' LEU . 0.7 OUTLIER -106.03 127.6 53.28 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.51 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 78' ' ' TYR . . . . . 0.673 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 40.7 p90 -154.93 144.13 21.09 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.958 -177.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 79' ' ' THR . . . . . 0.632 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 6.5 p -116.18 141.54 48.01 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.396 -177.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.59 153.4 22.94 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.319 176.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.93 -175.41 36.73 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -175.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -118.76 104.84 10.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 118.12 0.96 . . . . 0.0 110.527 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 83' ' ' ALA . . . . . 0.496 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -166.1 154.83 11.17 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.182 170.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 19.5 t -106.21 111.23 23.74 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 85' ' ' VAL . . . . . 0.554 HG12 ' HB3' ' E' ' 34' ' ' LEU . 3.4 m -111.48 138.23 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 CA-C-O 121.348 0.594 . . . . 0.0 112.095 -174.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 86' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' E' ' 12' ' ' ASN . 7.4 t -108.95 118.19 36.16 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.8 178.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 87' ' ' LEU . . . . . 0.617 HD13 HD23 ' E' ' 11' ' ' LEU . 5.4 mp -89.8 149.22 22.79 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.566 174.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 88' ' ' LEU . . . . . 0.591 HD23 HD21 ' A' ' 67' ' ' LEU . 1.3 tp -131.91 140.71 49.13 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.022 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.34 -167.14 25.47 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.776 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 90' ' ' TYR . . . . . 0.447 ' CD2' ' HB3' ' A' ' 68' ' ' ASN . 12.9 p90 -153.36 132.27 12.46 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.712 0.768 . . . . 0.0 111.604 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 91' ' ' LEU . . . . . 0.428 HD23 ' HB3' ' E' ' 27' ' ' PHE . 22.0 mt . . . . . 0 C--N 1.321 -0.644 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.177 173.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.559 ' HA ' ' OG ' ' B' ' 70' ' ' SER . 16.5 ttt . . . . . 0 CA--C 1.529 0.165 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.568 ' CE1' HD12 ' A' ' 88' ' ' LEU . 54.1 t80 -79.66 129.7 34.71 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.062 0.458 . . . . 0.0 112.102 -177.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.537 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 87.8 t90 -113.82 148.49 36.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.596 174.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.19 145.55 13.96 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.258 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.644 HD23 HD13 ' A' ' 87' ' ' LEU . 58.5 tp -139.09 110.25 6.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.027 0.441 . . . . 0.0 110.93 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -86.04 116.41 24.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.958 176.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.634 ' HB2' HG23 ' A' ' 85' ' ' VAL . 4.1 mmt -98.52 130.81 45.1 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.455 ' HD2' ' HD2' ' A' ' 15' ' ' PRO . 48.2 tptt -100.55 132.06 22.89 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 174.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.543 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 2.0 Cg_endo -46.25 117.68 2.07 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.539 2.826 . . . . 0.0 113.476 -175.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.662 ' HA ' ' O ' ' A' ' 79' ' ' THR . 37.8 mt-10 64.14 56.24 1.4 Allowed 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.411 178.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.86 135.31 52.78 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.63 172.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.738 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 82.8 mttt -103.73 115.71 30.98 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 123.313 0.383 . . . . 0.0 111.272 177.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -105.52 102.9 12.33 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 p -89.36 98.93 12.04 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 173.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -111.83 146.39 37.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.229 -167.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.8 m -100.45 143.06 31.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.282 174.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.476 ' CD1' ' HB2' ' A' ' 69' ' ' PHE . 54.0 mt -108.52 125.84 65.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.202 0.525 . . . . 0.0 111.772 -172.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.454 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.2 mp -102.22 -50.6 9.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.395 -0.821 . . . . 0.0 108.852 176.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.528 ' HD2' HD22 ' A' ' 91' ' ' LEU . 12.7 pttp -103.21 122.41 44.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.552 174.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.6 t -60.94 142.71 56.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.964 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.488 ' HB3' HD23 ' A' ' 91' ' ' LEU . 54.6 p90 -147.8 148.27 30.74 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -177.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.538 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 2.1 t60 -102.65 125.18 49.29 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 114.147 -1.388 . . . . 0.0 109.601 176.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 47.0 mt -87.34 131.24 35.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 172.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.538 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 95.3 p -116.59 -12.25 10.97 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -169.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . 179.99 158.72 22.51 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 119.166 -1.492 . . . . 0.0 113.702 177.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.462 HG23 ' HG ' ' A' ' 87' ' ' LEU . 11.0 p -141.29 138.97 33.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 175.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -152.95 156.17 38.38 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 121.97 -0.457 . . . . 0.0 111.886 -177.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.702 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.1 pp -125.31 148.04 48.88 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.501 0.667 . . . . 0.0 111.911 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -110.64 -55.15 2.51 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.133 169.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -100.84 127.91 47.1 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.211 174.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.495 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 150.48 162.98 10.93 Favored Glycine 0 N--CA 1.434 -1.495 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.533 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.407 ' HA ' ' HD2' ' A' ' 58' ' ' LYS . 69.7 mt-30 -102.56 -47.04 4.57 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.713 0.292 . . . . 0.0 111.018 176.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -152.48 132.51 13.42 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.344 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.527 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -127.28 113.28 16.08 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.436 0.636 . . . . 0.0 110.061 168.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 79' ' ' THR . 97.5 mttt -95.34 112.02 23.8 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.443 HD21 HD21 ' A' ' 87' ' ' LEU . 34.5 tp -86.12 107.48 17.87 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -174.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -107.4 146.11 32.08 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.741 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.652 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 1.5 tp -129.98 116.32 18.42 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.665 176.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.55 109.28 21.12 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.436 ' HB2' HD11 ' A' ' 44' ' ' LEU . . . -143.14 150.05 38.91 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.423 -177.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 57.35 30.99 19.44 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.35 0.595 . . . . 0.0 109.98 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 61.2 40.49 14.6 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.204 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -144.16 136.59 26.73 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -87.35 117.72 26.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.936 0.398 . . . . 0.0 110.042 178.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -112.76 122.97 49.23 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.673 178.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -80.82 100.9 5.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 170.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.48 HG12 ' CD2' ' E' ' 88' ' ' LEU . 21.6 m -86.45 -33.19 7.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.749 -172.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.729 ' HB2' HD21 ' A' ' 65' ' ' LEU . . . -153.19 144.59 23.23 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 120.28 -0.568 . . . . 0.0 112.214 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.2 m -115.51 102.47 9.83 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 169.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.428 HG13 ' HB3' ' A' ' 40' ' ' ALA . 8.9 p -116.18 114.21 45.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.744 0.783 . . . . 0.0 110.15 -177.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 69.1 p -123.18 -177.12 3.6 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.963 -175.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 38' ' ' GLN . 27.3 mtpp -59.37 -35.89 74.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.035 0.445 . . . . 0.0 109.971 169.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.419 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -71.23 -40.59 71.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.498 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.2 mt -114.31 82.33 7.34 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 17.3 Cg_exo -67.31 -6.65 16.83 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.208 2.605 . . . . 0.0 113.891 -168.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -161.49 132.09 5.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.262 0.554 . . . . 0.0 111.164 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 87.5 t -119.74 118.6 57.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.543 176.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.76 128.15 33.32 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.729 HD21 ' HB2' ' A' ' 54' ' ' ALA . 86.2 mt -120.21 163.82 17.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.457 0.646 . . . . 0.0 112.25 -172.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -140.86 97.4 3.18 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.548 169.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 2.8 mt -131.19 156.34 45.49 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.528 ' HB2' ' CZ ' ' E' ' 90' ' ' TYR . 42.7 t-20 -155.32 128.79 8.41 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.476 ' HB2' ' CD1' ' A' ' 23' ' ' ILE . 4.3 m-85 -124.03 145.05 49.47 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.522 ' OG ' ' HA ' ' E' ' 7' ' ' MET . 37.2 m -100.4 -178.53 3.84 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -175.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -62.34 -30.95 71.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.222 0.534 . . . . 0.0 110.345 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.82 4.44 85.03 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.661 -0.7 . . . . 0.0 113.074 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -99.94 119.59 38.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 117.171 0.485 . . . . 0.0 110.791 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -111.96 106.29 14.94 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 173.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.409 HG22 ' CB ' ' A' ' 46' ' ' ALA . 10.9 pt -120.91 168.07 13.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.163 -167.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.9 mtm -122.27 125.98 47.17 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 171.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.652 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -107.9 127.72 53.99 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 175.003 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.738 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 53.4 p90 -155.68 140.43 17.08 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 119.845 -0.742 . . . . 0.0 112.193 -175.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.662 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 12.0 p -106.09 138.85 41.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.958 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.4 ' HB3' ' HB2' ' A' ' 41' ' ' LYS . . . -107.09 153.23 22.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.413 174.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.4 ' O ' ' HG3' ' A' ' 16' ' ' GLU . . . 93.45 -173.52 34.13 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -177.058 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -113.54 103.83 11.65 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.846 177.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.543 ' H ' ' HB3' ' A' ' 15' ' ' PRO . . . -170.87 153.65 4.0 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.89 169.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.7 p -110.23 123.23 49.4 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.15 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.702 HG12 ' HB3' ' A' ' 34' ' ' LEU . 10.9 m -124.74 153.35 31.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-O 121.459 0.647 . . . . 0.0 112.375 -173.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.5 m -113.26 126.78 55.78 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.854 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.644 HD13 HD23 ' A' ' 11' ' ' LEU . 4.6 mp -101.91 147.47 26.49 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 169.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.568 HD12 ' CE1' ' A' ' 8' ' ' PHE . 2.3 mm? -125.22 154.3 41.81 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 173.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.67 -168.81 25.15 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 119.755 -1.212 . . . . 0.0 114.193 -178.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.536 ' CZ ' ' HB2' ' B' ' 68' ' ' ASN . 3.2 m-85 -117.56 118.92 33.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.344 -0.928 . . . . 0.0 110.392 -176.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.528 HD22 ' HD2' ' A' ' 25' ' ' LYS . 16.5 mt . . . . . 0 C--N 1.317 -0.819 0 CA-C-O 121.12 0.486 . . . . 0.0 110.337 172.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 7' ' ' MET . . . . . 0.578 ' HA ' ' OG ' ' C' ' 70' ' ' SER . 16.6 ttt . . . . . 0 N--CA 1.456 -0.163 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 8' ' ' PHE . . . . . 0.572 ' CZ ' HD21 ' C' ' 44' ' ' LEU . 54.4 t80 -79.51 129.72 34.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.034 0.445 . . . . 0.0 112.117 -177.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 9' ' ' TRP . . . . . 0.531 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 88.0 t90 -113.94 148.49 36.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.48 174.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.16 145.69 14.25 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.246 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.629 HD23 HD13 ' B' ' 87' ' ' LEU . 58.3 tp -139.16 110.12 6.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.941 0.4 . . . . 0.0 110.968 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -86.05 116.39 24.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.941 176.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 13' ' ' MET . . . . . 0.62 ' HB2' HG23 ' B' ' 85' ' ' VAL . 4.1 mmt -98.43 130.78 45.05 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -176.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.465 ' HD2' ' HD2' ' B' ' 15' ' ' PRO . 48.2 tptt -100.59 132.09 22.82 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 174.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.546 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 2.1 Cg_endo -46.24 117.82 2.14 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.441 2.761 . . . . 0.0 113.533 -175.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.666 ' HA ' ' O ' ' B' ' 79' ' ' THR . 37.9 mt-10 63.98 56.19 1.47 Allowed 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.492 178.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.75 135.29 52.86 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.644 172.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.734 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 82.8 mttt -103.76 115.72 30.99 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 123.366 0.416 . . . . 0.0 111.236 177.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -105.49 102.82 12.26 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 14.7 p -89.3 98.84 11.99 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 173.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -111.78 146.39 37.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.389 0.614 . . . . 0.0 112.28 -167.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 28.9 m -100.43 143.1 31.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.249 174.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.468 ' CD1' ' HB2' ' B' ' 69' ' ' PHE . 54.2 mt -108.55 125.92 65.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.278 0.561 . . . . 0.0 111.748 -172.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.461 ' N ' HD12 ' B' ' 24' ' ' ILE . 4.2 mp -102.29 -50.56 9.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.825 176.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.531 ' HD2' HD22 ' B' ' 91' ' ' LEU . 12.8 pttp -103.13 122.31 44.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.63 174.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 35.6 t -60.97 142.73 56.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.95 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' PHE . . . . . 0.481 ' HB3' HD23 ' B' ' 91' ' ' LEU . 54.6 p90 -147.83 148.24 30.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.963 0.887 . . . . 0.0 113.296 -177.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 28' ' ' HIS . . . . . 0.537 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 2.1 t60 -102.55 125.15 49.17 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.692 176.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.5 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 46.8 mt -87.29 131.28 35.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 172.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.537 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 94.9 p -116.63 -12.33 10.92 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -169.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . 180.0 158.68 22.46 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 119.235 -1.46 . . . . 0.0 113.787 177.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.466 HG23 ' HG ' ' B' ' 87' ' ' LEU . 11.0 p -141.32 138.95 33.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 175.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -152.95 156.18 38.39 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.983 -0.448 . . . . 0.0 111.891 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.718 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.1 pp -125.31 148.03 48.88 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.52 0.676 . . . . 0.0 111.949 178.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -110.55 -55.3 2.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.129 169.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -100.79 128.06 46.98 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.26 174.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.492 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 150.42 163.02 10.95 Favored Glycine 0 N--CA 1.435 -1.423 0 C-N-CA 120.371 -0.918 . . . . 0.0 112.424 177.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -102.67 -46.94 4.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.647 0.26 . . . . 0.0 111.003 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -152.52 132.55 13.41 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.344 177.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.534 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -127.27 113.25 16.06 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.362 0.601 . . . . 0.0 110.166 167.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' B' ' 79' ' ' THR . 97.5 mttt -95.41 112.04 23.82 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.45 HD21 HD21 ' B' ' 87' ' ' LEU . 34.6 tp -86.15 107.47 17.88 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.711 -174.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -107.45 146.12 32.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.697 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.645 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 1.5 tp -129.94 116.39 18.55 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.69 176.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.57 109.24 21.07 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.203 0.525 . . . . 0.0 109.654 176.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.436 ' HB2' HD11 ' B' ' 44' ' ' LEU . . . -143.03 150.03 39.04 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.449 -177.096 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 57.41 30.88 19.31 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.44 0.638 . . . . 0.0 110.091 -179.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 61.18 40.55 14.59 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.213 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -144.19 136.74 26.83 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -87.43 117.67 26.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.867 0.365 . . . . 0.0 110.038 178.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -112.73 122.98 49.25 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.698 178.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -80.82 100.91 5.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 170.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.485 HG12 ' CD2' ' A' ' 88' ' ' LEU . 21.5 m -86.52 -33.13 6.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.748 -172.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.745 ' HB2' HD21 ' B' ' 65' ' ' LEU . . . -153.12 144.54 23.27 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 120.284 -0.566 . . . . 0.0 112.208 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 27.2 m -115.55 102.4 9.75 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 169.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 56' ' ' VAL . . . . . 0.435 HG13 ' HB3' ' B' ' 40' ' ' ALA . 9.0 p -116.03 114.18 45.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.771 0.796 . . . . 0.0 110.149 -177.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 69.5 p -123.21 -177.19 3.62 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.905 -175.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -59.34 -35.87 74.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.06 0.457 . . . . 0.0 110.064 169.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.414 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -71.15 -40.6 71.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.538 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 79.0 mt -114.32 82.27 7.3 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 61' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 17.2 Cg_exo -67.22 -6.77 17.02 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.329 2.686 . . . . 0.0 113.795 -168.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -161.44 132.12 5.15 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.409 0.623 . . . . 0.0 111.188 -175.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 87.8 t -119.77 118.75 58.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.532 176.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.86 128.15 33.34 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.745 HD21 ' HB2' ' B' ' 54' ' ' ALA . 86.0 mt -120.22 163.79 17.23 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.426 0.632 . . . . 0.0 112.297 -172.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -140.83 97.38 3.18 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.254 -0.884 . . . . 0.0 108.628 169.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' B' ' 28' ' ' HIS . 2.7 mt -131.19 156.3 45.57 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 68' ' ' ASN . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 42.7 t-20 -155.32 128.68 8.36 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 174.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 69' ' ' PHE . . . . . 0.468 ' HB2' ' CD1' ' B' ' 23' ' ' ILE . 4.2 m-85 -123.88 145.05 49.38 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.559 ' OG ' ' HA ' ' A' ' 7' ' ' MET . 37.6 m -100.41 -178.54 3.84 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -175.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -62.31 -30.98 71.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.301 0.572 . . . . 0.0 110.31 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.91 4.53 85.08 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.696 -0.683 . . . . 0.0 113.022 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -100.06 119.56 38.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.058 0.456 . . . . 0.0 110.79 178.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -111.91 106.33 15.01 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 173.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.404 HG22 ' CB ' ' B' ' 46' ' ' ALA . 10.8 pt -121.02 168.0 13.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.193 -167.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 76' ' ' MET . . . . . . . . . . . . . 3.8 mtm -122.21 125.92 47.12 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 171.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 77' ' ' PHE . . . . . 0.645 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.3 OUTLIER -107.94 127.8 54.07 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 175.006 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.734 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 53.8 p90 -155.75 140.32 16.91 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 119.858 -0.737 . . . . 0.0 112.191 -175.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.666 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 12.1 p -105.98 138.8 41.54 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.975 -179.061 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.16 153.17 23.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.429 174.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.6 -173.5 33.89 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -113.53 103.88 11.71 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.832 177.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.546 ' H ' ' HB3' ' B' ' 15' ' ' PRO . . . -170.9 153.64 3.96 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.845 169.259 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 5.4 p -110.22 123.17 49.29 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.207 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.718 HG12 ' HB3' ' B' ' 34' ' ' LEU . 10.9 m -124.74 153.25 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-O 121.473 0.654 . . . . 0.0 112.364 -173.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 28.6 m -113.2 126.81 55.83 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.816 175.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.629 HD13 HD23 ' B' ' 11' ' ' LEU . 4.6 mp -101.98 147.46 26.54 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 169.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.565 HD13 ' O ' ' B' ' 87' ' ' LEU . 2.3 mm? -125.21 154.14 42.05 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 173.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.64 -168.73 24.99 Favored Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 119.776 -1.202 . . . . 0.0 114.21 -178.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 90' ' ' TYR . . . . . 0.538 ' CZ ' ' HB2' ' C' ' 68' ' ' ASN . 3.2 m-85 -117.55 118.91 33.45 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.348 -0.926 . . . . 0.0 110.396 -176.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 91' ' ' LEU . . . . . 0.531 HD22 ' HD2' ' B' ' 25' ' ' LYS . 16.4 mt . . . . . 0 C--N 1.316 -0.852 0 CA-C-O 121.164 0.507 . . . . 0.0 110.336 172.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 7' ' ' MET . . . . . 0.507 ' HA ' ' OG ' ' D' ' 70' ' ' SER . 16.6 ttt . . . . . 0 N--CA 1.456 -0.151 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 8' ' ' PHE . . . . . 0.564 ' CE1' HD12 ' C' ' 88' ' ' LEU . 54.6 t80 -79.55 129.77 34.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.994 0.426 . . . . 0.0 112.093 -177.259 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 9' ' ' TRP . . . . . 0.534 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 87.9 t90 -114.01 148.52 36.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.456 174.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.23 145.58 14.0 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.286 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.632 HD23 HD13 ' C' ' 87' ' ' LEU . 58.3 tp -139.11 110.15 6.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.981 0.419 . . . . 0.0 110.937 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -86.01 116.37 24.18 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.98 176.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 13' ' ' MET . . . . . 0.634 ' HB2' HG23 ' C' ' 85' ' ' VAL . 4.1 mmt -98.48 130.74 45.08 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -176.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 14' ' ' LYS . . . . . 0.444 ' HD2' ' HD2' ' C' ' 15' ' ' PRO . 48.2 tptt -100.58 132.18 22.71 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 174.053 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 15' ' ' PRO . . . . . 0.543 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 2.0 Cg_endo -46.4 117.84 2.21 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.479 2.786 . . . . 0.0 113.52 -175.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 16' ' ' GLU . . . . . 0.667 ' HA ' ' O ' ' C' ' 79' ' ' THR . 38.0 mt-10 64.14 56.03 1.43 Allowed 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.481 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.75 135.31 52.88 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.64 173.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 18' ' ' LYS . . . . . 0.742 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 82.7 mttt -103.74 115.87 31.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.157 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -105.56 102.81 12.25 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 175.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 15.3 p -89.43 98.92 12.04 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 173.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -111.82 146.46 37.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.178 -167.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 28.7 m -100.54 143.18 31.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.253 174.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 23' ' ' ILE . . . . . 0.475 ' CD1' ' HB2' ' C' ' 69' ' ' PHE . 53.8 mt -108.58 125.89 65.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.236 0.541 . . . . 0.0 111.722 -172.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 24' ' ' ILE . . . . . 0.455 ' N ' HD12 ' C' ' 24' ' ' ILE . 4.2 mp -102.28 -50.59 9.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.43 -0.804 . . . . 0.0 108.88 176.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 25' ' ' LYS . . . . . 0.535 ' HD2' HD22 ' C' ' 91' ' ' LEU . 12.8 pttp -103.17 122.27 44.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.616 174.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 35.6 t -60.88 142.77 55.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.02 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 27' ' ' PHE . . . . . 0.487 ' HB3' HD23 ' C' ' 91' ' ' LEU . 54.7 p90 -147.87 148.28 30.68 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -177.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 28' ' ' HIS . . . . . 0.539 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 2.1 t60 -102.62 125.25 49.28 Favored 'General case' 0 C--O 1.217 -0.658 0 CA-C-N 114.084 -1.416 . . . . 0.0 109.645 176.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 29' ' ' ILE . . . . . 0.495 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 46.7 mt -87.33 131.36 35.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 172.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.539 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 94.6 p -116.73 -12.24 10.87 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -169.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 31' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . 179.99 158.73 22.53 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 119.073 -1.536 . . . . 0.0 113.651 177.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.467 HG23 ' HG ' ' C' ' 87' ' ' LEU . 11.0 p -141.27 138.93 33.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 175.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -152.92 156.22 38.51 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.98 -0.45 . . . . 0.0 111.94 -177.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.718 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.1 pp -125.35 148.03 48.91 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.571 0.7 . . . . 0.0 111.892 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -110.62 -55.12 2.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.162 169.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -100.92 127.98 47.15 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.157 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 37' ' ' GLY . . . . . 0.484 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 150.49 163.04 10.97 Favored Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 120.333 -0.936 . . . . 0.0 112.461 177.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -102.67 -47.03 4.55 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.567 0.222 . . . . 0.0 111.001 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -152.42 132.54 13.5 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.364 177.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.527 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -127.28 113.24 16.04 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.42 0.629 . . . . 0.0 110.113 168.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' C' ' 79' ' ' THR . 97.5 mttt -95.37 112.06 23.83 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 175.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.446 HD21 HD21 ' C' ' 87' ' ' LEU . 34.6 tp -86.17 107.48 17.9 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -174.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -107.47 146.14 32.15 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.7 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.657 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 1.5 tp -129.98 116.3 18.39 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.67 176.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.53 109.3 21.14 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.166 0.508 . . . . 0.0 109.668 176.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.431 ' HB2' HD11 ' C' ' 44' ' ' LEU . . . -143.12 150.1 39.01 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.495 -177.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 57.25 31.02 19.4 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.396 0.617 . . . . 0.0 110.033 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 97.0 mttt 61.13 40.5 14.8 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.261 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 15.0 tp60 -144.18 136.76 26.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.9 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -87.35 117.68 26.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.847 0.356 . . . . 0.0 110.066 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -112.79 123.02 49.37 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.651 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -80.85 100.92 5.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 170.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 53' ' ' VAL . . . . . 0.496 HG12 ' CD2' ' B' ' 88' ' ' LEU . 21.5 m -86.46 -33.18 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.756 -172.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 54' ' ' ALA . . . . . 0.734 ' HB2' HD21 ' C' ' 65' ' ' LEU . . . -153.16 144.51 23.2 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 120.394 -0.522 . . . . 0.0 112.201 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 27.3 m -115.52 102.5 9.85 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 169.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 56' ' ' VAL . . . . . 0.434 HG13 ' HB3' ' C' ' 40' ' ' ALA . 9.0 p -116.13 114.12 45.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.763 0.792 . . . . 0.0 110.18 -177.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 69.7 p -123.15 -177.18 3.61 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.972 -175.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -59.32 -35.93 74.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.075 0.465 . . . . 0.0 110.015 169.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 59' ' ' ALA . . . . . 0.412 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -71.17 -40.56 71.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.527 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 79.0 mt -114.36 82.29 7.38 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 174.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 61' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 17.2 Cg_exo -67.27 -6.72 16.96 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.268 2.645 . . . . 0.0 113.851 -168.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -161.46 132.16 5.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.288 0.566 . . . . 0.0 111.2 -175.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 87.9 t -119.76 118.61 57.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.524 176.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.79 128.13 33.3 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 65' ' ' LEU . . . . . 0.734 HD21 ' HB2' ' C' ' 54' ' ' ALA . 85.9 mt -120.14 163.86 17.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.396 0.617 . . . . 0.0 112.277 -172.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -140.9 97.43 3.19 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.206 -0.907 . . . . 0.0 108.554 169.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.526 ' O ' ' HA ' ' C' ' 28' ' ' HIS . 2.8 mt -131.22 156.31 45.58 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 68' ' ' ASN . . . . . 0.538 ' HB2' ' CZ ' ' B' ' 90' ' ' TYR . 42.7 t-20 -155.27 128.71 8.4 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 174.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 69' ' ' PHE . . . . . 0.475 ' HB2' ' CD1' ' C' ' 23' ' ' ILE . 4.2 m-85 -123.91 145.08 49.38 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 70' ' ' SER . . . . . 0.578 ' OG ' ' HA ' ' B' ' 7' ' ' MET . 37.7 m -100.51 -178.46 3.81 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -175.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -62.33 -30.91 71.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.244 0.545 . . . . 0.0 110.399 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.92 4.5 85.15 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.76 -0.654 . . . . 0.0 113.005 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -100.05 119.55 38.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.109 0.454 . . . . 0.0 110.81 178.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -111.96 106.34 15.0 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 173.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.412 HG22 ' CB ' ' C' ' 46' ' ' ALA . 10.8 pt -121.01 167.99 13.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.128 -167.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 76' ' ' MET . . . . . . . . . . . . . 3.9 mtm -122.15 126.06 47.52 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 171.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 77' ' ' PHE . . . . . 0.657 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.3 OUTLIER -107.99 127.7 53.99 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 174.864 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 78' ' ' TYR . . . . . 0.742 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 53.7 p90 -155.58 140.33 17.1 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 119.808 -0.757 . . . . 0.0 112.208 -175.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 79' ' ' THR . . . . . 0.667 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 12.3 p -105.9 138.82 41.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.052 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.13 153.21 22.98 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.364 174.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.46 -173.45 34.05 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -177.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -113.55 103.82 11.64 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.654 0.727 . . . . 0.0 109.842 177.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 83' ' ' ALA . . . . . 0.543 ' H ' ' HB3' ' C' ' 15' ' ' PRO . . . -170.92 153.6 3.93 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.813 169.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 5.7 p -110.22 123.27 49.47 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.192 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.718 HG12 ' HB3' ' C' ' 34' ' ' LEU . 10.8 m -124.82 153.36 31.76 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-O 121.447 0.642 . . . . 0.0 112.347 -173.358 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 29.0 m -113.3 126.66 55.63 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.772 175.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 87' ' ' LEU . . . . . 0.632 HD13 HD23 ' C' ' 11' ' ' LEU . 4.6 mp -101.83 147.42 26.52 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 169.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 88' ' ' LEU . . . . . 0.564 HD12 ' CE1' ' C' ' 8' ' ' PHE . 2.3 mm? -125.21 154.19 41.98 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 173.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.65 -168.73 25.0 Favored Glycine 0 N--CA 1.438 -1.213 0 C-N-CA 119.753 -1.213 . . . . 0.0 114.222 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 90' ' ' TYR . . . . . 0.506 ' CZ ' ' HB2' ' D' ' 68' ' ' ASN . 3.2 m-85 -117.62 118.96 33.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.351 -0.925 . . . . 0.0 110.29 -176.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 91' ' ' LEU . . . . . 0.535 HD22 ' HD2' ' C' ' 25' ' ' LYS . 16.4 mt . . . . . 0 C--N 1.317 -0.821 0 CA-C-O 121.199 0.523 . . . . 0.0 110.35 172.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 7' ' ' MET . . . . . 0.552 ' HA ' ' OG ' ' E' ' 70' ' ' SER . 16.6 ttt . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 8' ' ' PHE . . . . . 0.563 ' CE1' HD12 ' D' ' 88' ' ' LEU . 54.5 t80 -79.59 129.62 34.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.005 0.431 . . . . 0.0 112.135 -177.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 9' ' ' TRP . . . . . 0.536 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 87.9 t90 -113.81 148.51 36.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.496 174.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.18 145.66 14.18 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.225 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 11' ' ' LEU . . . . . 0.625 HD23 HD13 ' D' ' 87' ' ' LEU . 58.7 tp -139.11 110.15 6.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.893 0.378 . . . . 0.0 111.005 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -86.09 116.47 24.32 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.916 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 13' ' ' MET . . . . . 0.63 ' HB2' HG23 ' D' ' 85' ' ' VAL . 4.1 mmt -98.49 130.66 45.09 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -176.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 14' ' ' LYS . . . . . 0.455 ' HD2' ' HD2' ' D' ' 15' ' ' PRO . 48.2 tptt -100.54 132.11 22.83 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 15' ' ' PRO . . . . . 0.538 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 1.9 Cg_endo -46.32 117.82 2.17 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.527 2.818 . . . . 0.0 113.464 -175.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 16' ' ' GLU . . . . . 0.652 ' HA ' ' O ' ' D' ' 79' ' ' THR . 37.9 mt-10 64.08 56.14 1.44 Allowed 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.452 178.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.79 135.38 52.91 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.609 172.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 18' ' ' LYS . . . . . 0.729 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 82.8 mttt -103.68 115.76 31.09 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 123.327 0.392 . . . . 0.0 111.168 177.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -105.49 102.84 12.29 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 175.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 14.9 p -89.4 98.89 12.02 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -111.8 146.36 37.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.306 -167.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 29.0 m -100.47 143.17 30.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.234 174.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 23' ' ' ILE . . . . . 0.472 ' CD1' ' HB2' ' D' ' 69' ' ' PHE . 54.1 mt -108.46 125.87 65.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.193 0.52 . . . . 0.0 111.774 -172.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 24' ' ' ILE . . . . . 0.454 HD12 ' N ' ' D' ' 24' ' ' ILE . 4.2 mp -102.31 -50.57 9.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.382 -0.826 . . . . 0.0 108.884 176.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 25' ' ' LYS . . . . . 0.534 ' HD2' HD22 ' D' ' 91' ' ' LEU . 12.8 pttp -103.17 122.38 44.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.604 174.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 35.6 t -60.86 142.7 55.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.923 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 27' ' ' PHE . . . . . 0.49 ' HB3' HD23 ' D' ' 91' ' ' LEU . 54.7 p90 -147.83 148.33 30.77 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -177.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 28' ' ' HIS . . . . . 0.54 ' HA ' ' O ' ' D' ' 67' ' ' LEU . 2.1 t60 -102.66 125.2 49.31 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 114.106 -1.407 . . . . 0.0 109.649 176.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 29' ' ' ILE . . . . . 0.506 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 46.9 mt -87.3 131.31 35.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 172.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 30' ' ' SER . . . . . 0.525 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 94.6 p -116.66 -12.24 10.92 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -169.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 31' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . 179.92 158.7 22.44 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 119.145 -1.502 . . . . 0.0 113.72 177.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.462 HG23 ' HG ' ' D' ' 87' ' ' LEU . 11.0 p -141.3 138.85 33.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 175.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -152.85 156.23 38.61 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.878 -0.514 . . . . 0.0 111.92 -177.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 34' ' ' LEU . . . . . 0.702 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.1 pp -125.33 148.01 48.9 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.475 0.655 . . . . 0.0 111.944 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -110.57 -55.28 2.49 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.14 169.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -100.76 128.0 46.97 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.154 174.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 37' ' ' GLY . . . . . 0.49 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 150.39 163.09 10.99 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.428 177.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 38' ' ' GLN . . . . . 0.4 ' HA ' ' HD2' ' D' ' 58' ' ' LYS . 69.9 mt-30 -102.63 -47.01 4.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 120.58 0.228 . . . . 0.0 110.984 176.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -152.47 132.52 13.44 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.346 177.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 40' ' ' ALA . . . . . 0.543 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -127.26 113.26 16.08 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.414 0.626 . . . . 0.0 110.093 168.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' D' ' 79' ' ' THR . 97.5 mttt -95.34 112.01 23.79 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.438 ' HB3' ' HB3' ' D' ' 54' ' ' ALA . 34.6 tp -86.2 107.41 17.88 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -174.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -107.4 146.09 32.1 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.73 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.656 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 1.5 tp -129.95 116.34 18.47 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.65 176.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.62 109.3 21.16 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.427 ' HB2' HD11 ' D' ' 44' ' ' LEU . . . -143.04 150.18 39.24 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.423 -177.072 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 57.2 30.94 19.21 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.397 0.618 . . . . 0.0 110.043 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 61.2 40.59 14.47 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.154 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -144.16 136.66 26.8 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -87.3 117.71 26.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.912 0.387 . . . . 0.0 110.027 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -112.84 123.09 49.52 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.671 178.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -80.9 100.87 5.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 170.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 53' ' ' VAL . . . . . 0.492 HG12 ' CD2' ' C' ' 88' ' ' LEU . 21.4 m -86.42 -33.25 7.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.714 -172.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 54' ' ' ALA . . . . . 0.731 ' HB2' HD21 ' D' ' 65' ' ' LEU . . . -153.13 144.49 23.22 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 120.301 -0.56 . . . . 0.0 112.264 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 27.5 m -115.51 102.46 9.82 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 169.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 56' ' ' VAL . . . . . 0.424 HG11 HG11 ' D' ' 85' ' ' VAL . 8.9 p -116.12 114.19 45.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.75 0.786 . . . . 0.0 110.119 -177.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 67.7 p -123.19 -177.19 3.62 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.931 -175.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 58' ' ' LYS . . . . . 0.4 ' HD2' ' HA ' ' D' ' 38' ' ' GLN . 27.2 mtpp -59.27 -35.99 74.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.075 0.464 . . . . 0.0 110.008 169.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 59' ' ' ALA . . . . . 0.408 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -71.16 -40.49 71.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.632 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 79.0 mt -114.33 82.28 7.33 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 61' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 17.2 Cg_exo -67.26 -6.63 16.74 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.251 2.634 . . . . 0.0 113.904 -168.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -161.49 132.12 5.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.322 0.582 . . . . 0.0 111.169 -175.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 88.2 t -119.75 118.72 58.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.551 176.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.84 128.08 33.26 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 174.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 65' ' ' LEU . . . . . 0.731 HD21 ' HB2' ' D' ' 54' ' ' ALA . 86.1 mt -120.17 163.87 17.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.412 0.625 . . . . 0.0 112.287 -172.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -140.91 97.45 3.19 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 169.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' D' ' 28' ' ' HIS . 2.7 mt -131.21 156.29 45.6 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 68' ' ' ASN . . . . . 0.506 ' HB2' ' CZ ' ' C' ' 90' ' ' TYR . 42.8 t-20 -155.27 128.7 8.4 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 174.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 69' ' ' PHE . . . . . 0.472 ' HB2' ' CD1' ' D' ' 23' ' ' ILE . 4.3 m-85 -123.96 145.15 49.36 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 70' ' ' SER . . . . . 0.507 ' OG ' ' HA ' ' C' ' 7' ' ' MET . 37.7 m -100.43 -178.5 3.82 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -175.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -62.39 -30.9 71.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.291 0.567 . . . . 0.0 110.342 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.87 4.39 85.23 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.035 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -100.04 119.51 38.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.988 0.423 . . . . 0.0 110.775 178.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -111.81 106.37 15.1 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 173.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.413 HG22 ' CB ' ' D' ' 46' ' ' ALA . 10.9 pt -121.05 168.04 13.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.087 -167.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 76' ' ' MET . . . . . . . . . . . . . 3.9 mtm -122.27 125.96 47.14 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 171.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 77' ' ' PHE . . . . . 0.656 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.3 OUTLIER -107.95 127.72 54.0 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.981 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 78' ' ' TYR . . . . . 0.729 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 53.4 p90 -155.65 140.32 17.02 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.849 -0.74 . . . . 0.0 112.198 -175.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 79' ' ' THR . . . . . 0.652 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 12.1 p -106.04 138.85 41.51 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.017 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 80' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' D' ' 41' ' ' LYS . . . -107.17 153.15 23.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.401 174.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.4 ' O ' ' HG3' ' D' ' 16' ' ' GLU . . . 93.54 -173.58 34.06 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -176.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -113.52 103.8 11.62 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.879 177.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 83' ' ' ALA . . . . . 0.543 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -170.83 153.54 3.99 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.89 169.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 5.8 p -110.13 123.2 49.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.237 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.702 HG12 ' HB3' ' D' ' 34' ' ' LEU . 11.0 m -124.7 153.39 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-O 121.381 0.61 . . . . 0.0 112.38 -173.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 27.8 m -113.31 126.75 55.73 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.843 175.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 87' ' ' LEU . . . . . 0.625 HD13 HD23 ' D' ' 11' ' ' LEU . 4.6 mp -101.89 147.47 26.49 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 169.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.563 HD12 ' CE1' ' D' ' 8' ' ' PHE . 2.3 mm? -125.2 154.19 41.96 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 173.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.75 -168.81 25.24 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 119.758 -1.21 . . . . 0.0 114.165 -178.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 90' ' ' TYR . . . . . 0.549 ' CZ ' ' HB2' ' E' ' 68' ' ' ASN . 3.2 m-85 -117.61 118.9 33.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.375 -0.912 . . . . 0.0 110.34 -176.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 91' ' ' LEU . . . . . 0.534 HD22 ' HD2' ' D' ' 25' ' ' LYS . 16.5 mt . . . . . 0 C--N 1.317 -0.845 0 CA-C-O 121.09 0.472 . . . . 0.0 110.377 172.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 7' ' ' MET . . . . . 0.522 ' HA ' ' OG ' ' A' ' 70' ' ' SER . 16.6 ttt . . . . . 0 CA--C 1.53 0.176 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 8' ' ' PHE . . . . . 0.566 ' CE1' HD12 ' E' ' 88' ' ' LEU . 54.1 t80 -79.71 129.73 34.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.076 0.465 . . . . 0.0 112.048 -177.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 9' ' ' TRP . . . . . 0.54 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 87.8 t90 -113.87 148.54 36.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.537 174.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.24 145.63 14.11 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.236 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 11' ' ' LEU . . . . . 0.636 HD23 HD13 ' E' ' 87' ' ' LEU . 58.3 tp -139.16 110.19 6.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.909 0.385 . . . . 0.0 110.981 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -86.07 116.37 24.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.931 176.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 13' ' ' MET . . . . . 0.64 ' HB2' HG23 ' E' ' 85' ' ' VAL . 4.1 mmt -98.41 130.77 45.04 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -176.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 14' ' ' LYS . . . . . 0.461 ' HD2' ' HD2' ' E' ' 15' ' ' PRO . 48.3 tptt -100.65 132.13 22.71 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 174.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 15' ' ' PRO . . . . . 0.522 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 2.0 Cg_endo -46.22 117.75 2.1 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 123.513 2.808 . . . . 0.0 113.507 -175.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 16' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' E' ' 79' ' ' THR . 37.8 mt-10 64.05 56.18 1.44 Allowed 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.472 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.73 135.29 52.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.673 172.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 18' ' ' LYS . . . . . 0.733 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 82.9 mttt -103.65 115.76 31.1 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 123.302 0.376 . . . . 0.0 111.249 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -105.48 102.84 12.28 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 175.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 15.4 p -89.35 98.85 12.0 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 173.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -111.92 146.41 37.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.449 0.642 . . . . 0.0 112.203 -167.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 29.2 m -100.49 143.1 31.07 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.218 174.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 23' ' ' ILE . . . . . 0.465 ' CD1' ' HB2' ' E' ' 69' ' ' PHE . 54.1 mt -108.52 125.92 65.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.143 0.497 . . . . 0.0 111.786 -172.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 24' ' ' ILE . . . . . 0.457 HD12 ' N ' ' E' ' 24' ' ' ILE . 4.3 mp -102.36 -50.56 9.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.823 176.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 25' ' ' LYS . . . . . 0.526 ' HD2' HD22 ' E' ' 91' ' ' LEU . 12.7 pttp -103.24 122.37 44.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.56 174.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 35.6 t -60.94 142.71 56.2 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.936 -177.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 27' ' ' PHE . . . . . 0.481 ' HB3' HD23 ' E' ' 91' ' ' LEU . 54.7 p90 -147.85 148.29 30.72 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -177.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 28' ' ' HIS . . . . . 0.536 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 2.1 t60 -102.52 125.18 49.16 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.714 176.217 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 29' ' ' ILE . . . . . 0.498 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 46.5 mt -87.32 131.28 35.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 172.024 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 30' ' ' SER . . . . . 0.536 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 94.9 p -116.61 -12.23 10.95 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -169.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 31' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . 179.95 158.65 22.37 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 119.144 -1.503 . . . . 0.0 113.724 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.468 HG23 ' HG ' ' E' ' 87' ' ' LEU . 11.0 p -141.28 138.94 33.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 175.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -152.91 156.17 38.41 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.967 -0.458 . . . . 0.0 111.945 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 34' ' ' LEU . . . . . 0.716 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.1 pp -125.29 148.06 48.86 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.593 0.711 . . . . 0.0 111.968 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -110.68 -55.13 2.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.068 169.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -100.87 127.96 47.11 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.226 174.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 37' ' ' GLY . . . . . 0.494 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 150.49 163.07 10.99 Favored Glycine 0 N--CA 1.434 -1.489 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.437 177.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 38' ' ' GLN . . . . . 0.409 ' HA ' ' HD2' ' E' ' 58' ' ' LYS . 25.7 mt-30 -102.6 -47.07 4.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.552 0.215 . . . . 0.0 111.037 176.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -152.45 132.45 13.41 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.356 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 40' ' ' ALA . . . . . 0.525 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -127.25 113.29 16.12 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.386 0.612 . . . . 0.0 110.109 168.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 41' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' E' ' 79' ' ' THR . 97.6 mttt -95.45 112.11 23.88 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 175.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.439 ' HB3' ' HB3' ' E' ' 54' ' ' ALA . 34.6 tp -86.21 107.53 17.95 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -174.134 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -107.41 146.01 32.23 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.765 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 44' ' ' LEU . . . . . 0.641 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 1.5 tp -129.93 116.42 18.61 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.662 176.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.55 109.31 21.15 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 46' ' ' ALA . . . . . 0.428 ' HB2' HD11 ' E' ' 44' ' ' LEU . . . -143.13 150.12 39.02 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.407 -177.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 57.32 30.9 19.26 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.429 0.633 . . . . 0.0 110.047 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 61.29 40.46 14.37 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.201 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 49' ' ' GLN . . . . . . . . . . . . . 15.0 tp60 -144.12 136.7 26.89 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.932 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -87.34 117.7 26.28 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.901 0.382 . . . . 0.0 110.076 178.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 51' ' ' TYR . . . . . 0.401 ' CG ' HD11 ' D' ' 88' ' ' LEU . 76.7 m-85 -112.83 123.02 49.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.655 178.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -80.87 100.95 5.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 170.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 53' ' ' VAL . . . . . 0.48 HG12 ' CD2' ' D' ' 88' ' ' LEU . 21.5 m -86.42 -33.29 7.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.7 -172.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 54' ' ' ALA . . . . . 0.737 ' HB2' HD21 ' E' ' 65' ' ' LEU . . . -153.2 144.52 23.17 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 120.271 -0.571 . . . . 0.0 112.203 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 27.5 m -115.46 102.45 9.83 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 169.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 56' ' ' VAL . . . . . 0.432 HG13 ' HB3' ' E' ' 40' ' ' ALA . 9.0 p -116.13 114.2 45.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.819 0.818 . . . . 0.0 110.097 -177.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 70.4 p -123.26 -177.05 3.59 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.91 -175.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 58' ' ' LYS . . . . . 0.409 ' HD2' ' HA ' ' E' ' 38' ' ' GLN . 27.2 mtpp -59.32 -35.91 74.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.257 0.551 . . . . 0.0 110.048 169.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 59' ' ' ALA . . . . . 0.418 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -71.25 -40.56 70.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.487 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 79.5 mt -114.34 82.37 7.42 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 174.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 61' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 17.2 Cg_exo -67.37 -6.67 16.94 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.232 2.621 . . . . 0.0 113.893 -168.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -161.41 132.09 5.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.256 0.551 . . . . 0.0 111.252 -175.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 87.3 t -119.76 118.72 58.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.511 176.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.85 128.19 33.38 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 174.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 65' ' ' LEU . . . . . 0.737 HD21 ' HB2' ' E' ' 54' ' ' ALA . 86.2 mt -120.2 163.75 17.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.339 0.59 . . . . 0.0 112.283 -172.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 66' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -140.79 97.39 3.18 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 169.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 67' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' E' ' 28' ' ' HIS . 2.7 mt -131.19 156.29 45.6 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 68' ' ' ASN . . . . . 0.549 ' HB2' ' CZ ' ' D' ' 90' ' ' TYR . 42.6 t-20 -155.31 128.67 8.35 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 69' ' ' PHE . . . . . 0.465 ' HB2' ' CD1' ' E' ' 23' ' ' ILE . 4.2 m-85 -123.88 145.07 49.36 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 70' ' ' SER . . . . . 0.552 ' OG ' ' HA ' ' D' ' 7' ' ' MET . 37.1 m -100.43 -178.56 3.84 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -175.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -62.37 -30.75 71.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.245 0.545 . . . . 0.0 110.422 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -85.08 4.52 85.36 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.949 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -100.11 119.53 38.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.11 0.455 . . . . 0.0 110.795 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -111.83 106.39 15.11 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 173.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 75' ' ' ILE . . . . . 0.406 HG22 ' CB ' ' E' ' 46' ' ' ALA . 10.8 pt -121.05 167.96 13.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.134 -167.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 76' ' ' MET . . . . . . . . . . . . . 3.9 mtm -122.21 126.04 47.38 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 171.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 77' ' ' PHE . . . . . 0.641 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.3 OUTLIER -107.89 127.73 53.99 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 174.962 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' E' E ' 78' ' ' TYR . . . . . 0.733 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 53.3 p90 -155.63 140.37 17.08 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 119.818 -0.753 . . . . 0.0 112.187 -175.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 79' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 12.1 p -106.07 138.93 41.4 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.948 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.19 153.15 23.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.418 174.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.53 -173.37 33.86 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -177.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -113.66 103.83 11.62 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.87 177.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 83' ' ' ALA . . . . . 0.525 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -170.98 153.56 3.86 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.856 169.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 5.6 p -110.24 123.15 49.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.246 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 85' ' ' VAL . . . . . 0.716 HG12 ' HB3' ' E' ' 34' ' ' LEU . 11.1 m -124.71 153.26 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-O 121.456 0.646 . . . . 0.0 112.388 -173.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 29.3 m -113.2 126.82 55.85 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.833 175.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 87' ' ' LEU . . . . . 0.636 HD13 HD23 ' E' ' 11' ' ' LEU . 4.6 mp -101.99 147.5 26.48 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 169.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 88' ' ' LEU . . . . . 0.566 HD12 ' CE1' ' E' ' 8' ' ' PHE . 2.3 mm? -125.27 154.17 42.11 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 173.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.65 -168.76 25.05 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 119.728 -1.225 . . . . 0.0 114.161 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 90' ' ' TYR . . . . . 0.528 ' CZ ' ' HB2' ' A' ' 68' ' ' ASN . 3.2 m-85 -117.61 118.99 33.64 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.328 -0.936 . . . . 0.0 110.295 -176.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 91' ' ' LEU . . . . . 0.526 HD22 ' HD2' ' E' ' 25' ' ' LYS . 16.4 mt . . . . . 0 C--N 1.317 -0.815 0 CA-C-O 121.189 0.519 . . . . 0.0 110.352 172.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.438 ' HA ' ' HB2' ' B' ' 70' ' ' SER . 46.1 ttm . . . . . 0 C--O 1.223 -0.334 0 CA-C-O 120.707 0.289 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.627 ' CE1' HD21 ' B' ' 44' ' ' LEU . 68.0 t80 -61.3 147.53 44.28 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -172.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.424 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 89.5 t90 -138.55 145.53 40.79 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.842 179.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.69 151.44 23.54 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.039 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.617 HD23 HD13 ' A' ' 87' ' ' LEU . 40.8 tp -146.28 109.66 4.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.63 0.252 . . . . 0.0 110.884 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 52.7 m-20 -88.46 125.31 34.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.475 0.655 . . . . 0.0 111.096 176.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.545 ' HB2' HG23 ' A' ' 85' ' ' VAL . 7.0 mmt -98.31 130.21 44.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.432 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.457 ' HB3' ' HG3' ' A' ' 17' ' ' ARG . 59.7 tttm -96.98 134.25 23.19 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 171.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.438 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 2.2 Cg_endo -43.95 112.95 0.36 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.398 2.732 . . . . 0.0 113.401 -174.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.666 ' HA ' ' O ' ' A' ' 79' ' ' THR . 48.8 mt-10 69.45 44.25 0.94 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.811 178.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.457 ' HG3' ' HB3' ' A' ' 14' ' ' LYS . 12.0 mmt180 -104.61 138.27 41.2 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.961 170.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.662 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 46.6 mttp -113.18 118.75 35.58 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 123.392 0.432 . . . . 0.0 110.501 175.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -110.51 103.84 12.49 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 177.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 76' ' ' MET . 42.7 t -86.43 102.46 14.07 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 172.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -116.84 144.36 44.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.799 -170.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.1 t -97.84 157.0 16.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.01 174.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.4 mt -120.3 124.11 71.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.098 0.475 . . . . 0.0 111.365 -173.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.625 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -114.44 -18.32 7.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.894 176.977 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -132.47 121.79 23.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.657 176.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.0 t -65.73 133.44 51.07 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.056 -174.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.854 ' HB3' HD23 ' A' ' 91' ' ' LEU . 46.5 p90 -137.59 147.28 44.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.648 0.737 . . . . 0.0 112.219 -177.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.551 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 7.4 t60 -104.64 125.06 50.39 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.664 174.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.57 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 45.0 mt -90.87 133.19 33.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 170.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.551 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 67.8 p -119.82 -7.36 10.01 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -171.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.64 159.14 26.74 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 119.2 -1.476 . . . . 0.0 113.706 177.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.458 HG23 ' HG ' ' A' ' 87' ' ' LEU . 11.1 p -144.43 131.7 16.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.429 ' HA ' HG21 ' A' ' 56' ' ' VAL . . . -148.5 157.66 43.61 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.968 -0.458 . . . . 0.0 112.115 -175.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.697 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.2 pp -126.63 146.18 50.27 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.541 0.686 . . . . 0.0 111.996 178.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -110.76 -52.19 2.81 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.614 -1.175 . . . . 0.0 108.864 168.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -99.74 127.68 45.87 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.447 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 142.4 159.4 7.92 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.543 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -101.47 -45.41 5.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.723 0.297 . . . . 0.0 111.164 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.414 ' HG3' HG22 ' A' ' 57' ' ' THR . 11.5 tt0 -152.27 126.45 9.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.582 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.564 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -127.61 113.7 16.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.389 0.614 . . . . 0.0 110.221 169.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -99.35 112.16 24.39 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 174.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.1 tp -81.61 115.51 20.92 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.692 -175.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -115.53 145.33 42.74 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.49 0.662 . . . . 0.0 110.245 178.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.621 HD21 ' CE1' ' E' ' 8' ' ' PHE . 0.9 OUTLIER -128.58 118.28 22.71 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.774 177.083 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -105.61 104.47 14.19 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.67 177.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.467 ' HB2' HD11 ' A' ' 44' ' ' LEU . . . -126.64 139.76 52.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.564 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 57.99 31.06 20.12 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 123.605 0.565 . . . . 0.0 110.06 -174.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 62.18 30.34 17.68 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.298 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 8.4 tp-100 -121.42 125.6 47.32 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 177.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -83.08 117.2 22.69 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.792 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -113.6 132.42 55.75 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.727 175.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -81.34 112.56 19.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 168.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.51 ' CG2' ' HB3' ' A' ' 44' ' ' LEU . 3.4 t -86.98 -51.62 12.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.737 -172.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.622 ' HB2' HD21 ' A' ' 65' ' ' LEU . . . -151.53 144.88 24.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.453 -176.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.5 m -109.29 101.7 10.69 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 171.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.429 HG21 ' HA ' ' A' ' 33' ' ' ALA . 7.2 p -117.18 110.84 32.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.907 0.86 . . . . 0.0 109.987 -177.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.414 HG22 ' HG3' ' A' ' 39' ' ' GLU . 81.0 p -123.58 -177.47 3.73 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.356 -174.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -56.98 -34.98 68.64 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.862 0.363 . . . . 0.0 110.634 167.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.98 -40.68 65.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.526 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.9 mt -116.24 83.37 12.71 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.39 -3.76 11.58 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.129 2.553 . . . . 0.0 113.972 -168.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -162.84 130.86 3.81 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.26 0.553 . . . . 0.0 111.17 -176.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 87.0 t -118.53 117.44 54.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.636 175.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.48 126.93 31.83 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.726 174.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.622 HD21 ' HB2' ' A' ' 54' ' ' ALA . 74.7 mt -121.02 167.02 13.05 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.405 0.621 . . . . 0.0 112.295 -173.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 10.9 t0 -137.51 98.18 3.64 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.549 168.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.717 HD21 HD23 ' E' ' 88' ' ' LEU . 4.9 mt -124.75 146.38 49.22 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -148.25 120.85 8.57 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.072 175.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -116.62 141.62 47.96 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.897 -177.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.462 ' HB2' ' HA ' ' E' ' 7' ' ' MET . 9.0 t -96.98 169.26 9.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.902 0.382 . . . . 0.0 110.145 -177.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -75.23 0.34 16.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.755 -178.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.08 -4.16 56.64 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 173.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -95.51 147.09 23.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.01 0.433 . . . . 0.0 110.926 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -130.85 118.24 20.47 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 172.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.44 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 16.8 pt -130.55 157.3 42.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.087 0.47 . . . . 0.0 111.869 -169.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.446 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 67.1 ttp -119.51 114.78 22.8 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.03 175.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.62 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -100.82 129.8 46.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.961 -177.119 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.662 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 53.4 p90 -152.5 150.66 29.84 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 119.959 -0.696 . . . . 0.0 112.049 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.666 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 7.3 p -113.32 136.34 52.86 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.384 177.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.24 152.03 23.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.517 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.95 -171.96 30.5 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -114.78 102.9 10.44 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.916 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.564 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -171.13 155.27 4.33 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.909 170.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.5 p -111.99 120.77 43.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.113 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.697 HG12 ' HB3' ' A' ' 34' ' ' LEU . 10.1 m -122.06 150.63 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 121.173 0.511 . . . . 0.0 112.341 -174.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 38.8 m -107.35 124.77 50.29 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.668 174.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.617 HD13 HD23 ' A' ' 11' ' ' LEU . 5.3 mp -94.94 146.56 24.15 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 169.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.685 HD23 HD21 ' B' ' 67' ' ' LEU . 1.0 OUTLIER -131.34 142.09 50.02 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.082 -178.582 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.08 -166.94 25.96 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.233 -176.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -154.33 134.62 13.3 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.859 0.838 . . . . 0.0 112.518 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.854 HD23 ' HB3' ' A' ' 27' ' ' PHE . 14.4 mt . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.985 175.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 7' ' ' MET . . . . . 0.437 ' HA ' ' HB2' ' C' ' 70' ' ' SER . 45.9 ttm . . . . . 0 C--O 1.223 -0.341 0 CA-C-O 120.703 0.287 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 8' ' ' PHE . . . . . 0.61 ' CE1' HD21 ' C' ' 44' ' ' LEU . 67.9 t80 -61.22 147.49 44.13 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -172.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 9' ' ' TRP . . . . . 0.424 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 89.5 t90 -138.54 145.52 40.78 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.84 179.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.72 151.42 23.52 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.019 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.6 HD23 HD13 ' B' ' 87' ' ' LEU . 40.4 tp -146.3 109.64 4.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.638 0.256 . . . . 0.0 110.855 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 -88.44 125.34 34.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.38 0.61 . . . . 0.0 111.126 176.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 13' ' ' MET . . . . . 0.543 ' HB2' HG23 ' B' ' 85' ' ' VAL . 7.1 mmt -98.27 130.07 44.98 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.576 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.463 ' HB3' ' HG3' ' B' ' 17' ' ' ARG . 59.7 tttm -96.89 134.24 23.28 Favored Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 171.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.44 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 2.2 Cg_endo -43.92 112.84 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.454 2.769 . . . . 0.0 113.431 -174.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.653 ' HA ' ' O ' ' B' ' 79' ' ' THR . 48.8 mt-10 69.55 44.1 0.94 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.896 178.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.463 ' HG3' ' HB3' ' B' ' 14' ' ' LYS . 11.9 mmt180 -104.51 138.37 40.98 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.989 170.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.653 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 46.5 mttp -113.32 118.62 35.1 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.299 0.374 . . . . 0.0 110.513 175.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -110.35 103.84 12.54 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 42.2 t -86.39 102.68 14.25 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 172.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -117.07 144.38 44.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.747 -170.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 11.2 t -97.84 157.11 16.27 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.002 174.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 55.4 mt -120.36 124.03 71.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.051 0.453 . . . . 0.0 111.287 -173.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.628 ' H ' HD13 ' B' ' 24' ' ' ILE . 0.2 OUTLIER -114.39 -18.3 7.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.871 176.915 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -132.45 121.81 23.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.6 176.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 46.9 t -65.75 133.48 51.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.06 -174.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 27' ' ' PHE . . . . . 0.862 ' HB3' HD23 ' B' ' 91' ' ' LEU . 46.3 p90 -137.58 147.35 44.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.708 0.766 . . . . 0.0 112.255 -177.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 28' ' ' HIS . . . . . 0.554 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 7.5 t60 -104.74 125.0 50.39 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.506 -1.224 . . . . 0.0 109.578 174.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.575 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 44.7 mt -90.79 133.27 33.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 170.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.554 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 67.5 p -119.88 -7.3 9.99 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -171.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.71 159.06 26.55 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 119.213 -1.47 . . . . 0.0 113.706 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.461 HG23 ' HG ' ' B' ' 87' ' ' LEU . 11.1 p -144.42 131.74 16.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 173.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 33' ' ' ALA . . . . . 0.414 ' HA ' HG21 ' B' ' 56' ' ' VAL . . . -148.57 157.54 43.53 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 121.944 -0.472 . . . . 0.0 112.098 -174.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.708 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.2 pp -126.48 146.28 50.17 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.607 0.718 . . . . 0.0 111.947 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -110.87 -52.17 2.81 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.583 -1.189 . . . . 0.0 108.825 168.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -99.62 127.66 45.73 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 175.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.447 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 142.32 159.32 7.89 Favored Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 120.176 -1.011 . . . . 0.0 112.617 178.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -101.33 -45.54 5.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.837 0.351 . . . . 0.0 111.115 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.407 ' HG3' HG22 ' B' ' 57' ' ' THR . 11.4 tt0 -152.23 126.45 9.23 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.617 -178.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.571 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -127.67 113.77 16.46 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.493 0.663 . . . . 0.0 110.267 169.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -99.42 112.19 24.42 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 47.2 tp -81.61 115.37 20.85 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.661 -174.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -115.49 145.36 42.68 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.457 0.646 . . . . 0.0 110.355 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.627 HD21 ' CE1' ' A' ' 8' ' ' PHE . 0.9 OUTLIER -128.56 118.34 22.83 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.862 177.101 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -105.7 104.39 14.1 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.724 177.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.459 ' HB2' HD11 ' B' ' 44' ' ' LEU . . . -126.47 139.75 52.99 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.511 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 58.09 30.97 20.08 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 123.528 0.518 . . . . 0.0 109.985 -174.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 62.17 30.37 17.69 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.311 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 8.4 tp-100 -121.41 125.71 47.58 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -83.18 117.19 22.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.764 -177.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -113.67 132.4 55.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.742 175.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -81.33 112.62 19.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 169.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.495 ' CG2' ' HB3' ' B' ' 44' ' ' LEU . 3.4 t -86.99 -51.66 12.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.648 -172.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.62 ' HB2' HD21 ' B' ' 65' ' ' LEU . . . -151.54 145.01 24.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.449 -176.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 28.3 m -109.32 101.71 10.69 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 171.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 56' ' ' VAL . . . . . 0.418 ' CG1' HG11 ' B' ' 85' ' ' VAL . 7.2 p -117.25 111.08 33.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.877 0.846 . . . . 0.0 109.909 -178.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.407 HG22 ' HG3' ' B' ' 39' ' ' GLU . 81.3 p -123.71 -177.55 3.77 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.368 -174.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -56.91 -34.92 68.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.889 0.376 . . . . 0.0 110.68 167.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.99 -40.64 65.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.551 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 75.7 mt -116.33 83.43 13.04 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 175.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.43 -3.74 11.58 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.169 2.579 . . . . 0.0 113.972 -168.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -162.89 130.86 3.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.216 0.531 . . . . 0.0 111.228 -176.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 85.8 t -118.59 117.41 54.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.613 175.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.5 126.96 31.87 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.735 174.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.62 HD21 ' HB2' ' B' ' 54' ' ' ALA . 75.1 mt -121.07 167.05 13.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.497 0.665 . . . . 0.0 112.265 -173.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 66' ' ' ASP . . . . . 0.45 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 10.9 t0 -137.45 98.2 3.64 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.533 168.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.685 HD21 HD23 ' A' ' 88' ' ' LEU . 4.9 mt -124.71 146.45 49.15 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.11 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -148.37 120.78 8.46 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.003 175.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -116.54 141.61 47.95 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.926 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.438 ' HB2' ' HA ' ' A' ' 7' ' ' MET . 9.0 t -97.03 169.14 10.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.898 0.38 . . . . 0.0 110.111 -177.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -75.08 0.39 16.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.802 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.23 -4.14 56.47 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 174.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -95.56 147.07 23.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.028 0.442 . . . . 0.0 110.946 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -130.79 118.29 20.6 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 172.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.445 HG22 ' HB2' ' B' ' 46' ' ' ALA . 16.7 pt -130.5 157.33 42.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.043 0.449 . . . . 0.0 111.827 -169.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.448 ' HA ' ' HA ' ' B' ' 20' ' ' SER . 67.1 ttp -119.61 114.87 22.88 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.949 175.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 77' ' ' PHE . . . . . 0.611 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.4 OUTLIER -100.86 129.8 46.78 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.017 -177.206 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.653 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 53.3 p90 -152.41 150.66 29.9 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.994 -0.683 . . . . 0.0 112.142 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.653 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 7.3 p -113.33 136.34 52.86 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.446 177.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.21 151.97 23.42 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.582 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.14 -172.02 30.29 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -114.71 102.86 10.42 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.011 177.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.571 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -171.11 155.22 4.32 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.947 170.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 10.1 p -111.89 120.7 42.82 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.204 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.708 HG12 ' HB3' ' B' ' 34' ' ' LEU . 10.3 m -121.91 150.78 25.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.206 0.527 . . . . 0.0 112.363 -174.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 86' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' B' ' 32' ' ' VAL . 38.7 m -107.43 124.76 50.34 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.579 174.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.6 HD13 HD23 ' B' ' 11' ' ' LEU . 5.3 mp -94.96 146.52 24.18 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 169.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.672 HD23 HD21 ' C' ' 67' ' ' LEU . 1.0 OUTLIER -131.22 142.13 50.13 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.142 -178.651 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.06 -166.91 25.87 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.259 -176.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -154.41 134.56 13.19 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.825 0.821 . . . . 0.0 112.582 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 91' ' ' LEU . . . . . 0.862 HD23 ' HB3' ' B' ' 27' ' ' PHE . 14.3 mt . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 113.872 -1.513 . . . . 0.0 110.006 175.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 7' ' ' MET . . . . . 0.47 ' HA ' ' HB2' ' D' ' 70' ' ' SER . 45.9 ttm . . . . . 0 C--O 1.223 -0.327 0 CA-C-O 120.638 0.256 . . . . 0.0 110.84 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 8' ' ' PHE . . . . . 0.625 ' CE1' HD21 ' D' ' 44' ' ' LEU . 67.8 t80 -61.32 147.36 44.94 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -172.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 9' ' ' TRP . . . . . 0.419 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 89.5 t90 -138.42 145.52 41.07 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.867 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.61 151.53 23.63 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.083 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.606 HD23 HD13 ' C' ' 87' ' ' LEU . 40.6 tp -146.33 109.63 4.74 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.706 0.253 . . . . 0.0 110.945 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -88.54 125.26 34.7 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.451 0.643 . . . . 0.0 111.037 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 13' ' ' MET . . . . . 0.549 ' HB2' HG23 ' C' ' 85' ' ' VAL . 7.1 mmt -98.26 130.17 44.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.568 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 14' ' ' LYS . . . . . 0.459 ' HB3' ' HG3' ' C' ' 17' ' ' ARG . 59.8 tttm -97.01 134.21 23.21 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 171.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 15' ' ' PRO . . . . . 0.447 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 2.2 Cg_endo -43.85 112.88 0.35 Allowed 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 123.451 2.767 . . . . 0.0 113.396 -174.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 16' ' ' GLU . . . . . 0.662 ' HA ' ' O ' ' C' ' 79' ' ' THR . 48.8 mt-10 69.45 44.32 0.94 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.813 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 17' ' ' ARG . . . . . 0.459 ' HG3' ' HB3' ' C' ' 14' ' ' LYS . 12.0 mmt180 -104.65 138.26 41.24 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.974 170.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 18' ' ' LYS . . . . . 0.667 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 46.5 mttp -113.27 118.61 35.1 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 123.375 0.422 . . . . 0.0 110.512 175.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -110.38 103.92 12.62 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 177.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 20' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 42.0 t -86.51 102.56 14.22 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 172.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -116.94 144.46 44.53 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.8 -170.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 11.1 t -97.9 157.06 16.31 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.99 174.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 23' ' ' ILE . . . . . 0.405 HG22 ' HA ' ' C' ' 71' ' ' LYS . 55.6 mt -120.31 124.14 71.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.076 0.465 . . . . 0.0 111.309 -173.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 24' ' ' ILE . . . . . 0.622 ' H ' HD13 ' C' ' 24' ' ' ILE . 0.2 OUTLIER -114.48 -18.44 7.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.827 177.011 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -132.39 121.83 24.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.562 176.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 46.8 t -65.65 133.41 51.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.061 -174.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 27' ' ' PHE . . . . . 0.825 ' HB3' HD23 ' C' ' 91' ' ' LEU . 46.5 p90 -137.64 147.33 44.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.743 0.782 . . . . 0.0 112.184 -177.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 28' ' ' HIS . . . . . 0.555 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 7.3 t60 -104.84 125.12 50.55 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.521 174.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 29' ' ' ILE . . . . . 0.566 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 44.5 mt -90.82 133.2 33.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 170.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.555 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 68.1 p -119.87 -7.27 10.01 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -171.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.73 159.1 26.59 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 119.204 -1.474 . . . . 0.0 113.708 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.454 HG23 ' HG ' ' C' ' 87' ' ' LEU . 11.2 p -144.48 131.71 16.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 173.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.414 ' HA ' HG21 ' C' ' 56' ' ' VAL . . . -148.5 157.66 43.61 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.915 -0.491 . . . . 0.0 112.063 -175.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.719 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.2 pp -126.53 146.2 50.22 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.593 0.711 . . . . 0.0 111.966 178.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -110.7 -52.3 2.8 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.847 168.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -99.72 127.76 45.84 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 175.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 37' ' ' GLY . . . . . 0.447 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 142.29 159.31 7.88 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.53 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -101.45 -45.38 5.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.74 0.305 . . . . 0.0 111.166 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 39' ' ' GLU . . . . . 0.426 ' HG3' HG22 ' C' ' 57' ' ' THR . 11.5 tt0 -152.3 126.54 9.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.532 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.564 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -127.74 113.74 16.39 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.475 0.655 . . . . 0.0 110.21 169.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -99.4 112.24 24.46 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 46.8 tp -81.64 115.51 20.94 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.635 -175.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -115.56 145.35 42.74 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.413 0.625 . . . . 0.0 110.356 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.627 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 0.9 OUTLIER -128.65 118.31 22.69 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.814 177.145 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 45' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -105.65 104.42 14.14 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.657 177.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.455 ' HB2' HD11 ' C' ' 44' ' ' LEU . . . -126.56 139.68 53.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.503 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 58.22 30.88 20.08 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 123.568 0.542 . . . . 0.0 110.029 -174.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 62.19 30.35 17.66 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.373 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 49' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 8.4 tp-100 -121.38 125.68 47.55 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -83.14 117.18 22.71 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.851 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -113.62 132.43 55.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.696 176.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -81.4 112.49 19.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 169.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 53' ' ' VAL . . . . . 0.511 ' CG2' ' HB3' ' C' ' 44' ' ' LEU . 3.4 t -86.84 -51.74 12.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.736 -172.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 54' ' ' ALA . . . . . 0.604 ' HB2' HD21 ' C' ' 65' ' ' LEU . . . -151.43 144.97 24.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.504 -176.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 28.5 m -109.28 101.63 10.62 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 171.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 56' ' ' VAL . . . . . 0.426 ' CG1' HG11 ' C' ' 85' ' ' VAL . 7.2 p -117.19 110.99 33.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.91 0.862 . . . . 0.0 109.944 -178.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 57' ' ' THR . . . . . 0.426 HG22 ' HG3' ' C' ' 39' ' ' GLU . 81.1 p -123.68 -177.48 3.75 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.274 -174.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -57.02 -34.98 68.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.985 0.421 . . . . 0.0 110.663 167.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.84 -40.79 65.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.529 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 75.6 mt -116.18 83.43 12.62 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 175.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.36 -3.78 11.59 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.228 2.618 . . . . 0.0 113.996 -168.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -162.9 130.86 3.77 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.256 0.551 . . . . 0.0 111.109 -175.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 86.5 t -118.6 117.45 54.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.636 175.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.53 126.97 31.89 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 174.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 65' ' ' LEU . . . . . 0.604 HD21 ' HB2' ' C' ' 54' ' ' ALA . 75.1 mt -121.14 166.99 13.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.41 0.624 . . . . 0.0 112.311 -173.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 66' ' ' ASP . . . . . 0.439 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 10.9 t0 -137.43 98.11 3.63 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.585 168.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.672 HD21 HD23 ' B' ' 88' ' ' LEU . 4.9 mt -124.71 146.42 49.17 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -148.28 120.87 8.57 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.005 175.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -116.62 141.7 47.85 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.86 -177.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 70' ' ' SER . . . . . 0.437 ' HB2' ' HA ' ' B' ' 7' ' ' MET . 9.0 t -97.11 169.2 9.97 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.901 0.382 . . . . 0.0 110.063 -177.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 71' ' ' LYS . . . . . 0.405 ' HA ' HG22 ' C' ' 23' ' ' ILE . 15.0 ptmm? -75.28 0.51 16.38 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.793 -178.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.18 -4.17 56.52 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 173.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -95.43 147.08 23.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.064 0.459 . . . . 0.0 110.943 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -130.82 118.39 20.72 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.452 HG22 ' HB2' ' C' ' 46' ' ' ALA . 16.8 pt -130.55 157.31 42.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.04 0.448 . . . . 0.0 111.86 -169.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.438 ' HA ' ' HA ' ' C' ' 20' ' ' SER . 67.1 ttp -119.67 114.84 22.8 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.954 175.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 77' ' ' PHE . . . . . 0.627 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.4 OUTLIER -100.84 129.84 46.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.009 -177.143 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 78' ' ' TYR . . . . . 0.667 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 53.2 p90 -152.44 150.63 29.85 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.051 -0.66 . . . . 0.0 112.135 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 79' ' ' THR . . . . . 0.662 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 7.3 p -113.26 136.34 52.85 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.445 177.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.19 151.93 23.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.526 177.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.08 -172.08 30.44 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -176.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -114.7 102.96 10.51 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.03 177.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 83' ' ' ALA . . . . . 0.564 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -171.2 155.2 4.26 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.831 170.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 10.3 p -111.87 120.67 42.75 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.133 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.719 HG12 ' HB3' ' C' ' 34' ' ' LEU . 9.9 m -121.95 150.77 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 CA-C-O 121.268 0.556 . . . . 0.0 112.236 -174.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 86' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' C' ' 32' ' ' VAL . 38.0 m -107.37 124.76 50.29 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.691 174.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 87' ' ' LEU . . . . . 0.606 HD13 HD23 ' C' ' 11' ' ' LEU . 5.3 mp -94.9 146.53 24.16 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 169.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 88' ' ' LEU . . . . . 0.707 HD23 HD21 ' D' ' 67' ' ' LEU . 1.0 OUTLIER -131.3 142.1 50.06 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.086 -178.632 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.07 -166.87 25.83 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.198 -176.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -154.41 134.55 13.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.865 0.84 . . . . 0.0 112.563 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 91' ' ' LEU . . . . . 0.825 HD23 ' HB3' ' C' ' 27' ' ' PHE . 14.3 mt . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 113.809 -1.541 . . . . 0.0 110.046 175.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 7' ' ' MET . . . . . 0.457 ' HA ' ' HB2' ' E' ' 70' ' ' SER . 45.9 ttm . . . . . 0 C--O 1.223 -0.334 0 CA-C-O 120.753 0.311 . . . . 0.0 110.814 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 8' ' ' PHE . . . . . 0.62 ' CE1' HD21 ' E' ' 44' ' ' LEU . 67.9 t80 -61.27 147.45 44.46 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -172.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 9' ' ' TRP . . . . . 0.421 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 89.6 t90 -138.5 145.54 40.9 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.817 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.67 151.4 23.5 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.072 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 11' ' ' LEU . . . . . 0.608 HD23 HD13 ' D' ' 87' ' ' LEU . 40.1 tp -146.28 109.67 4.76 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.697 0.284 . . . . 0.0 110.909 -179.137 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -88.55 125.35 34.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.393 0.616 . . . . 0.0 111.046 176.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 13' ' ' MET . . . . . 0.55 ' HB2' HG23 ' D' ' 85' ' ' VAL . 7.1 mmt -98.3 130.14 44.99 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.526 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 14' ' ' LYS . . . . . 0.458 ' HB3' ' HG3' ' D' ' 17' ' ' ARG . 59.6 tttm -96.93 134.29 23.18 Favored Pre-proline 0 C--N 1.318 -0.799 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 171.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 15' ' ' PRO . . . . . 0.444 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 2.2 Cg_endo -44.03 112.91 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.482 2.788 . . . . 0.0 113.361 -174.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 16' ' ' GLU . . . . . 0.663 ' HA ' ' O ' ' D' ' 79' ' ' THR . 48.9 mt-10 69.47 44.2 0.94 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.869 178.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 17' ' ' ARG . . . . . 0.458 ' HG3' ' HB3' ' D' ' 14' ' ' LYS . 12.0 mmt180 -104.59 138.25 41.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.004 170.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 18' ' ' LYS . . . . . 0.649 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 46.6 mttp -113.26 118.64 35.22 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.367 0.417 . . . . 0.0 110.503 175.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -110.31 103.86 12.58 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 177.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 20' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 42.0 t -86.41 102.68 14.26 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 172.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -117.12 144.38 44.76 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.746 -170.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 11.3 t -97.8 157.08 16.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.068 174.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 55.7 mt -120.33 124.09 71.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.118 0.485 . . . . 0.0 111.287 -173.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 24' ' ' ILE . . . . . 0.638 ' H ' HD13 ' D' ' 24' ' ' ILE . 0.2 OUTLIER -114.43 -18.43 7.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.859 176.967 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -132.37 121.86 24.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.614 176.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 46.8 t -65.7 133.45 51.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.079 -174.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 27' ' ' PHE . . . . . 0.837 ' HB3' HD23 ' D' ' 91' ' ' LEU . 46.2 p90 -137.64 147.34 44.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.667 0.746 . . . . 0.0 112.171 -177.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 28' ' ' HIS . . . . . 0.559 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 7.4 t60 -104.77 125.04 50.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.616 174.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 29' ' ' ILE . . . . . 0.585 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 44.8 mt -90.78 133.18 33.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 170.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 30' ' ' SER . . . . . 0.559 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 67.4 p -119.82 -7.33 10.02 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -171.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.68 159.1 26.65 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 119.295 -1.431 . . . . 0.0 113.726 177.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.474 HG23 ' HG ' ' D' ' 87' ' ' LEU . 11.1 p -144.48 131.78 16.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 173.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 33' ' ' ALA . . . . . 0.414 ' HA ' HG21 ' D' ' 56' ' ' VAL . . . -148.56 157.57 43.55 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.857 -0.527 . . . . 0.0 112.018 -174.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 34' ' ' LEU . . . . . 0.698 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.2 pp -126.53 146.17 50.23 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.645 0.736 . . . . 0.0 111.994 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -110.7 -52.3 2.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.865 168.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -99.7 127.73 45.82 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 175.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 37' ' ' GLY . . . . . 0.439 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 142.38 159.32 7.89 Favored Glycine 0 N--CA 1.435 -1.375 0 C-N-CA 120.191 -1.005 . . . . 0.0 112.562 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -101.42 -45.44 5.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.775 0.321 . . . . 0.0 111.167 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 39' ' ' GLU . . . . . 0.415 ' HG3' HG22 ' D' ' 57' ' ' THR . 11.6 tt0 -152.28 126.49 9.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.634 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 40' ' ' ALA . . . . . 0.579 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -127.68 113.79 16.49 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.45 0.643 . . . . 0.0 110.227 169.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -99.44 112.15 24.39 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 46.9 tp -81.64 115.4 20.89 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.677 -174.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -115.49 145.3 42.74 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.394 0.616 . . . . 0.0 110.288 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.628 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.9 OUTLIER -128.46 118.34 22.93 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.845 177.032 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 45' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -105.7 104.47 14.19 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.641 177.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.455 ' HB2' HD11 ' D' ' 44' ' ' LEU . . . -126.62 139.76 52.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.575 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 58.13 30.93 20.06 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 123.509 0.506 . . . . 0.0 109.987 -174.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 62.24 30.46 17.59 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.232 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 49' ' ' GLN . . . . . 0.443 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 8.4 tp-100 -121.51 125.68 47.38 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.022 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -83.17 117.26 22.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.769 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -113.72 132.45 55.81 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.647 176.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -81.34 112.63 19.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 168.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 53' ' ' VAL . . . . . 0.508 ' CG2' ' HB3' ' D' ' 44' ' ' LEU . 3.4 t -87.01 -51.56 12.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.73 -172.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 54' ' ' ALA . . . . . 0.621 ' HB2' HD21 ' D' ' 65' ' ' LEU . . . -151.55 144.96 24.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.521 -176.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 28.5 m -109.33 101.73 10.7 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 171.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 56' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' D' ' 40' ' ' ALA . 7.2 p -117.25 110.98 32.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.956 0.884 . . . . 0.0 109.94 -178.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 57' ' ' THR . . . . . 0.415 HG22 ' HG3' ' D' ' 39' ' ' GLU . 81.0 p -123.58 -177.56 3.76 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.365 -174.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -57.03 -34.88 68.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.891 0.377 . . . . 0.0 110.642 167.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.01 -40.64 65.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.56 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 75.5 mt -116.27 83.45 12.9 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.48 -3.65 11.44 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.195 2.596 . . . . 0.0 113.933 -168.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -162.95 130.81 3.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.101 0.477 . . . . 0.0 111.162 -176.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 87.7 t -118.59 117.39 54.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.586 175.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.39 126.98 31.85 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 65' ' ' LEU . . . . . 0.621 HD21 ' HB2' ' D' ' 54' ' ' ALA . 75.6 mt -121.17 167.01 13.14 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.509 0.671 . . . . 0.0 112.209 -173.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 66' ' ' ASP . . . . . 0.434 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 10.8 t0 -137.46 98.14 3.63 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.538 168.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.707 HD21 HD23 ' C' ' 88' ' ' LEU . 4.9 mt -124.69 146.38 49.17 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -148.32 120.77 8.48 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.061 175.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -116.54 141.67 47.88 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.9 -177.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 70' ' ' SER . . . . . 0.47 ' HB2' ' HA ' ' C' ' 7' ' ' MET . 9.0 t -97.0 169.15 10.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.875 0.369 . . . . 0.0 110.1 -177.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -75.26 0.46 16.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.74 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.19 -4.08 56.54 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 173.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -95.53 147.06 23.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.076 0.465 . . . . 0.0 110.936 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -130.82 118.32 20.62 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 172.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.453 HG22 ' HB2' ' D' ' 46' ' ' ALA . 16.8 pt -130.58 157.42 42.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.102 0.477 . . . . 0.0 111.788 -169.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 76' ' ' MET . . . . . 0.436 ' HA ' ' HA ' ' D' ' 20' ' ' SER . 67.1 ttp -119.71 114.8 22.72 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.947 175.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 77' ' ' PHE . . . . . 0.628 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.4 OUTLIER -100.84 129.7 46.75 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.018 -177.132 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 78' ' ' TYR . . . . . 0.649 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 53.3 p90 -152.33 150.61 29.92 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.151 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 79' ' ' THR . . . . . 0.663 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 7.2 p -113.25 136.36 52.82 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.453 177.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.2 151.97 23.42 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.503 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.01 -171.97 30.43 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 -176.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -114.67 102.87 10.44 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.042 177.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 83' ' ' ALA . . . . . 0.579 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -171.09 155.27 4.36 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.9 170.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 9.9 p -111.93 120.7 42.82 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.13 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.698 HG12 ' HB3' ' D' ' 34' ' ' LEU . 10.1 m -122.0 150.74 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-O 121.298 0.57 . . . . 0.0 112.289 -174.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 86' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' D' ' 32' ' ' VAL . 38.7 m -107.41 124.83 50.43 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.588 174.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 87' ' ' LEU . . . . . 0.608 HD13 HD23 ' D' ' 11' ' ' LEU . 5.3 mp -94.93 146.58 24.13 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 169.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.703 HD23 HD21 ' E' ' 67' ' ' LEU . 1.0 OUTLIER -131.31 142.09 50.05 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.125 -178.709 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.1 -166.99 26.05 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.229 -176.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -154.34 134.57 13.26 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.808 0.813 . . . . 0.0 112.583 178.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 91' ' ' LEU . . . . . 0.837 HD23 ' HB3' ' D' ' 27' ' ' PHE . 14.3 mt . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 113.89 -1.504 . . . . 0.0 109.987 175.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 7' ' ' MET . . . . . 0.462 ' HA ' ' HB2' ' A' ' 70' ' ' SER . 45.9 ttm . . . . . 0 C--O 1.223 -0.31 0 CA-C-O 120.734 0.302 . . . . 0.0 110.835 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 8' ' ' PHE . . . . . 0.621 ' CE1' HD21 ' A' ' 44' ' ' LEU . 68.1 t80 -61.26 147.45 44.44 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -172.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 9' ' ' TRP . . . . . 0.422 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 89.5 t90 -138.47 145.59 41.03 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.882 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.76 151.34 23.45 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.083 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 11' ' ' LEU . . . . . 0.602 HD23 HD13 ' E' ' 87' ' ' LEU . 40.8 tp -146.2 109.62 4.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.67 0.272 . . . . 0.0 110.928 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 -88.43 125.28 34.65 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.356 0.598 . . . . 0.0 111.112 176.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 13' ' ' MET . . . . . 0.554 ' HB2' HG23 ' E' ' 85' ' ' VAL . 7.1 mmt -98.3 130.16 44.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.522 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 14' ' ' LYS . . . . . 0.46 ' HB3' ' HG3' ' E' ' 17' ' ' ARG . 59.7 tttm -97.05 134.24 23.14 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 171.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 15' ' ' PRO . . . . . 0.451 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 2.3 Cg_endo -44.05 112.93 0.37 Allowed 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 123.43 2.754 . . . . 0.0 113.373 -174.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 16' ' ' GLU . . . . . 0.657 ' HA ' ' O ' ' E' ' 79' ' ' THR . 48.8 mt-10 69.53 44.16 0.94 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.827 178.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 17' ' ' ARG . . . . . 0.46 ' HG3' ' HB3' ' E' ' 14' ' ' LYS . 11.9 mmt180 -104.46 138.27 41.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.978 170.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 18' ' ' LYS . . . . . 0.663 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 46.6 mttp -113.29 118.72 35.41 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.47 0.481 . . . . 0.0 110.521 175.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -110.35 103.96 12.67 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 20' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' E' ' 76' ' ' MET . 42.3 t -86.5 102.5 14.16 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 172.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -117.01 144.35 44.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.772 -170.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 11.3 t -97.81 157.03 16.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.005 174.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 23' ' ' ILE . . . . . 0.402 HG22 ' HA ' ' E' ' 71' ' ' LYS . 55.5 mt -120.29 124.11 71.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.052 0.453 . . . . 0.0 111.323 -173.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 24' ' ' ILE . . . . . 0.633 ' H ' HD13 ' E' ' 24' ' ' ILE . 0.2 OUTLIER -114.43 -18.37 7.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.907 176.918 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -132.37 121.77 24.0 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.62 176.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 46.8 t -65.71 133.43 51.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.061 -174.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 27' ' ' PHE . . . . . 0.831 ' HB3' HD23 ' E' ' 91' ' ' LEU . 46.6 p90 -137.6 147.3 44.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.692 0.758 . . . . 0.0 112.241 -177.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 28' ' ' HIS . . . . . 0.545 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 7.4 t60 -104.73 124.99 50.36 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.64 174.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 29' ' ' ILE . . . . . 0.585 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 45.1 mt -90.75 133.15 33.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 170.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 30' ' ' SER . . . . . 0.545 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 67.5 p -119.87 -7.18 10.01 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -171.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.75 159.12 26.6 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 119.183 -1.484 . . . . 0.0 113.747 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.465 HG23 ' HG ' ' E' ' 87' ' ' LEU . 11.1 p -144.49 131.72 16.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 173.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 33' ' ' ALA . . . . . 0.419 ' HA ' HG21 ' E' ' 56' ' ' VAL . . . -148.48 157.64 43.6 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.932 -0.48 . . . . 0.0 112.02 -174.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 34' ' ' LEU . . . . . 0.719 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.2 pp -126.6 146.26 50.23 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.635 0.731 . . . . 0.0 111.948 178.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -110.85 -52.21 2.8 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.818 168.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -99.72 127.71 45.84 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 37' ' ' GLY . . . . . 0.445 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 142.37 159.32 7.88 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.589 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -101.37 -45.41 5.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.708 0.289 . . . . 0.0 111.18 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 39' ' ' GLU . . . . . 0.41 ' HG3' HG22 ' E' ' 57' ' ' THR . 11.5 tt0 -152.33 126.41 9.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.626 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 40' ' ' ALA . . . . . 0.561 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -127.61 113.81 16.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.438 0.637 . . . . 0.0 110.205 169.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 41' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -99.49 112.3 24.52 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 174.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 46.8 tp -81.66 115.41 20.91 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.651 -175.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -115.48 145.32 42.71 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.515 0.674 . . . . 0.0 110.297 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 44' ' ' LEU . . . . . 0.62 HD21 ' CE1' ' D' ' 8' ' ' PHE . 0.9 OUTLIER -128.6 118.34 22.79 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.801 177.066 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' E' E ' 45' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -105.64 104.42 14.13 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.697 177.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 46' ' ' ALA . . . . . 0.461 ' HB2' HD11 ' E' ' 44' ' ' LEU . . . -126.54 139.77 52.96 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.587 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 57.98 31.04 20.09 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 123.611 0.569 . . . . 0.0 110.058 -174.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 62.24 30.27 17.56 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.284 -178.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 49' ' ' GLN . . . . . 0.449 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 8.4 tp-100 -121.35 125.67 47.55 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 178.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -83.16 117.2 22.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.815 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -113.64 132.44 55.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.714 175.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -81.27 112.51 19.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 168.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 53' ' ' VAL . . . . . 0.506 ' CG2' ' HB3' ' E' ' 44' ' ' LEU . 3.4 t -86.98 -51.51 12.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.732 -172.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 54' ' ' ALA . . . . . 0.606 ' HB2' HD21 ' E' ' 65' ' ' LEU . . . -151.57 144.97 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.468 -176.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 28.2 m -109.23 101.69 10.69 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 171.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 56' ' ' VAL . . . . . 0.421 ' CG1' HG11 ' E' ' 85' ' ' VAL . 7.2 p -117.25 110.9 32.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.885 0.85 . . . . 0.0 109.9 -177.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 57' ' ' THR . . . . . 0.41 HG22 ' HG3' ' E' ' 39' ' ' GLU . 81.1 p -123.59 -177.54 3.75 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.342 -174.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -56.92 -35.05 68.59 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.965 0.412 . . . . 0.0 110.555 167.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.9 -40.63 65.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.534 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 75.5 mt -116.35 83.38 13.0 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 175.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.38 -3.78 11.61 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.177 2.584 . . . . 0.0 113.933 -168.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -162.84 130.83 3.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.247 0.546 . . . . 0.0 111.135 -175.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 87.9 t -118.66 117.51 54.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.556 175.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.5 126.94 31.85 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.672 174.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 65' ' ' LEU . . . . . 0.606 HD21 ' HB2' ' E' ' 54' ' ' ALA . 75.0 mt -121.04 167.02 13.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.439 0.637 . . . . 0.0 112.307 -173.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 66' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 10.9 t0 -137.44 98.2 3.65 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.593 168.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 67' ' ' LEU . . . . . 0.703 HD21 HD23 ' D' ' 88' ' ' LEU . 4.9 mt -124.67 146.39 49.15 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.081 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -148.31 120.82 8.52 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.023 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -116.55 141.67 47.88 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.941 -177.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 70' ' ' SER . . . . . 0.457 ' HB2' ' HA ' ' D' ' 7' ' ' MET . 9.0 t -97.04 169.22 9.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.924 0.392 . . . . 0.0 110.034 -177.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 71' ' ' LYS . . . . . 0.402 ' HA ' HG22 ' E' ' 23' ' ' ILE . 15.1 ptmm? -75.19 0.28 16.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.748 -178.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.0 -4.23 56.72 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 173.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -95.46 147.13 23.86 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 120.992 0.425 . . . . 0.0 110.946 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -130.84 118.32 20.61 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 172.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 75' ' ' ILE . . . . . 0.449 HG22 ' HB2' ' E' ' 46' ' ' ALA . 16.8 pt -130.61 157.32 42.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.131 0.491 . . . . 0.0 111.774 -169.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 76' ' ' MET . . . . . 0.437 ' HA ' ' HA ' ' E' ' 20' ' ' SER . 67.1 ttp -119.55 114.82 22.84 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.005 175.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 77' ' ' PHE . . . . . 0.611 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.4 OUTLIER -100.92 129.76 46.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.001 -177.133 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' E' E ' 78' ' ' TYR . . . . . 0.663 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 53.3 p90 -152.43 150.64 29.87 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.989 -0.685 . . . . 0.0 112.148 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 79' ' ' THR . . . . . 0.657 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 7.3 p -113.27 136.4 52.79 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.413 177.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.22 152.02 23.37 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.528 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.96 -171.9 30.43 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -176.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -114.73 102.84 10.39 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.054 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 83' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -171.04 155.32 4.41 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.889 170.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 10.4 p -112.0 120.77 43.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.121 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 85' ' ' VAL . . . . . 0.719 HG12 ' HB3' ' E' ' 34' ' ' LEU . 9.8 m -122.12 150.71 25.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.237 0.542 . . . . 0.0 112.232 -174.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 38.9 m -107.43 124.75 50.32 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.606 174.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 87' ' ' LEU . . . . . 0.602 HD13 HD23 ' E' ' 11' ' ' LEU . 5.3 mp -94.87 146.54 24.14 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 169.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 88' ' ' LEU . . . . . 0.717 HD23 HD21 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -131.28 142.05 50.06 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.164 -178.663 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.01 -166.87 25.77 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.259 -176.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 90' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -154.42 134.62 13.22 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.804 0.812 . . . . 0.0 112.561 178.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 91' ' ' LEU . . . . . 0.831 HD23 ' HB3' ' E' ' 27' ' ' PHE . 14.3 mt . . . . . 0 C--N 1.326 -0.438 0 CA-C-N 113.842 -1.527 . . . . 0.0 109.956 175.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.502 ' HA ' ' HB2' ' B' ' 70' ' ' SER . 55.9 mtp . . . . . 0 C--O 1.224 -0.281 0 CA-C-O 120.69 0.281 . . . . 0.0 111.333 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -88.34 152.2 22.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.244 -175.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 87.1 t90 -138.57 146.49 41.91 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.86 155.8 26.34 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.108 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.627 HD23 HD13 ' A' ' 87' ' ' LEU . 42.4 tp -149.98 108.27 3.77 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.695 0.283 . . . . 0.0 110.951 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -86.8 103.31 15.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.149 0.499 . . . . 0.0 110.855 175.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.563 ' HB2' HG23 ' A' ' 85' ' ' VAL . 2.9 mmt -80.69 136.61 36.22 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.345 -179.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.552 ' HB2' ' HG3' ' A' ' 17' ' ' ARG . 27.2 mtpp -99.85 142.58 24.88 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 173.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.526 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 7.5 Cg_endo -50.19 115.26 1.79 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 123.443 2.762 . . . . 0.0 113.283 -175.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.67 ' HA ' ' O ' ' A' ' 79' ' ' THR . 26.1 mt-10 65.1 57.54 0.95 Allowed 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.597 0.713 . . . . 0.0 111.569 177.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.552 ' HG3' ' HB2' ' A' ' 14' ' ' LYS . 13.5 mmt180 -117.6 163.43 16.45 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.473 171.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.627 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 3.3 ttmp? -139.46 109.92 6.6 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 123.474 0.484 . . . . 0.0 110.843 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -111.38 113.31 25.68 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.7 p -72.18 116.53 12.72 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 171.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -98.0 117.71 32.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.673 -163.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.5 t -91.99 143.44 26.47 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 171.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.9 mt -115.32 124.41 71.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.153 0.502 . . . . 0.0 111.768 -172.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.1 mp -90.41 -43.8 14.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.816 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -140.09 149.45 43.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.12 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.532 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 23.1 t -59.9 115.22 3.25 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.102 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.907 ' HB3' HD23 ' A' ' 91' ' ' LEU . 12.5 p90 -122.86 148.97 44.8 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.471 0.653 . . . . 0.0 111.62 -177.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.668 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 10.3 t60 -106.66 120.43 41.94 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.552 178.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.597 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 31.4 mt -89.38 134.2 29.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 171.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.668 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 15.8 p -122.38 -15.52 7.61 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -171.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -155.66 152.87 24.31 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 119.533 -1.318 . . . . 0.0 113.227 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.463 HG23 ' HG ' ' A' ' 87' ' ' LEU . 11.7 p -150.15 122.28 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 171.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.29 154.61 42.54 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 122.008 -0.432 . . . . 0.0 111.572 -173.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.515 ' HB3' HG12 ' A' ' 85' ' ' VAL . 3.7 pp -113.94 139.28 49.35 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.638 0.733 . . . . 0.0 111.552 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -104.59 -56.06 2.24 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.83 173.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -102.27 127.82 49.08 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 170.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.497 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 150.93 162.26 10.55 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 119.683 -1.246 . . . . 0.0 113.472 176.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.524 ' O ' ' HG3' ' A' ' 58' ' ' LYS . 70.0 mt-30 -102.55 -47.99 4.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.573 0.225 . . . . 0.0 111.285 176.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -151.54 133.02 14.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.388 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.533 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -132.54 116.22 16.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.411 0.625 . . . . 0.0 110.527 170.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 79' ' ' THR . 97.8 mttt -100.14 112.59 24.9 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.5 tp -84.55 114.41 21.94 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -176.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.475 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 98.5 m-85 -116.23 145.62 42.98 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 176.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.607 ' HA ' ' O ' ' A' ' 76' ' ' MET . 0.3 OUTLIER -131.9 130.85 42.13 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.667 171.919 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -104.36 113.74 27.51 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.764 177.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.753 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -126.07 139.22 53.57 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 174.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 57.3 30.34 18.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.27 0.557 . . . . 0.0 109.615 -171.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.535 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 0.3 OUTLIER 64.84 17.11 10.86 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.456 -179.109 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 47.9 tt0 -104.99 121.54 43.97 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -82.15 112.12 18.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.686 -177.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -102.96 136.58 42.51 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.492 177.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -82.23 103.05 8.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 171.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.51 ' CG1' HD11 ' A' ' 67' ' ' LEU . 2.9 t -78.63 -52.8 14.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.763 -172.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.487 ' HB2' ' CD2' ' A' ' 65' ' ' LEU . . . -146.89 137.63 23.82 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.544 -177.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.1 m -104.49 101.62 11.29 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 170.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.428 ' CG1' HG11 ' A' ' 85' ' ' VAL . 6.2 p -121.7 109.81 25.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.979 0.895 . . . . 0.0 110.205 -177.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.6 p -122.85 -176.79 3.49 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.758 -175.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 38' ' ' GLN . 9.9 mtmp? -58.01 -31.54 67.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.028 0.442 . . . . 0.0 110.437 170.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.14 -40.82 51.76 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.551 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 69.9 mt -116.11 76.49 6.55 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 173.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -76.45 1.59 8.25 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.797 2.332 . . . . 0.0 113.329 -168.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -154.9 100.93 2.24 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.643 -170.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 66.0 t -102.59 121.02 53.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.113 0.482 . . . . 0.0 110.729 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.67 110.75 22.95 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.708 174.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -126.93 169.22 13.53 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.051 0.453 . . . . 0.0 111.708 -175.107 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.556 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 27.1 t0 -119.38 104.99 10.85 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.761 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.643 HD21 HD23 ' E' ' 88' ' ' LEU . 18.7 mt -120.65 150.68 40.55 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.992 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.542 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 5.9 t30 -152.41 127.14 9.5 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.943 0.401 . . . . 0.0 110.017 172.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' A' ' 26' ' ' SER . 38.3 m-85 -121.31 161.47 21.97 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.764 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.527 ' HB2' ' HA ' ' E' ' 7' ' ' MET . 42.6 t -115.86 158.22 23.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.328 0.585 . . . . 0.0 111.87 -174.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -21.83 66.47 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.33 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.05 -1.06 61.48 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.894 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -100.56 166.11 11.08 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -145.14 129.63 17.92 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.753 HG22 ' HB2' ' A' ' 46' ' ' ALA . 9.7 pt -134.82 174.66 12.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.435 -173.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.607 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 23.1 mtp -130.46 123.81 30.61 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -105.09 127.58 52.95 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.071 178.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.627 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 24.4 p90 -153.9 141.86 20.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.102 0.477 . . . . 0.0 111.811 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.67 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 11.6 p -113.32 141.88 46.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.08 -178.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -109.85 150.87 27.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.576 176.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.3 176.8 40.45 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -177.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -107.42 102.11 11.41 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.687 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.533 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -170.22 150.43 3.65 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.874 169.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.3 t -104.41 119.28 38.6 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.563 HG23 ' HB2' ' A' ' 13' ' ' MET . 5.7 m -119.21 135.18 60.44 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 CA-C-O 121.453 0.644 . . . . 0.0 112.135 -174.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.5 t -99.61 119.49 38.17 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.988 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.627 HD13 HD23 ' A' ' 11' ' ' LEU . 5.3 mp -92.96 147.11 23.11 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 173.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.589 HD23 HD21 ' B' ' 67' ' ' LEU . 1.5 tp -133.25 138.76 46.61 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.098 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.95 -167.6 23.62 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.985 -177.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.503 ' CD2' ' HB3' ' B' ' 68' ' ' ASN . 20.2 p90 -153.58 135.56 14.68 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.797 0.808 . . . . 0.0 112.567 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.907 HD23 ' HB3' ' A' ' 27' ' ' PHE . 5.3 mt . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.447 175.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 7' ' ' MET . . . . . 0.522 ' HA ' ' HB2' ' C' ' 70' ' ' SER . 56.0 mtp . . . . . 0 C--O 1.224 -0.262 0 CA-C-O 120.716 0.294 . . . . 0.0 111.308 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -88.3 152.34 22.0 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.277 -175.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -138.7 146.46 41.58 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.9 155.83 26.35 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.13 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.64 HD23 HD13 ' B' ' 87' ' ' LEU . 42.2 tp -149.97 108.22 3.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.701 0.286 . . . . 0.0 110.822 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -86.71 103.31 15.05 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.056 0.455 . . . . 0.0 110.879 175.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 13' ' ' MET . . . . . 0.564 ' HB2' HG23 ' B' ' 85' ' ' VAL . 2.8 mmt -80.89 136.77 36.12 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.272 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.544 ' HB2' ' HG3' ' B' ' 17' ' ' ARG . 27.2 mtpp -99.89 142.61 24.94 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 173.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.525 ' HB3' ' N ' ' B' ' 83' ' ' ALA . 7.6 Cg_endo -50.15 115.23 1.77 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.413 2.742 . . . . 0.0 113.372 -175.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.663 ' HA ' ' O ' ' B' ' 79' ' ' THR . 25.9 mt-10 65.04 57.58 0.96 Allowed 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.623 0.725 . . . . 0.0 111.598 177.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.544 ' HG3' ' HB2' ' B' ' 14' ' ' LYS . 13.6 mmt180 -117.55 163.31 16.61 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.532 171.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.649 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 3.3 ttmp? -139.42 110.02 6.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.746 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -111.42 113.34 25.72 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 2.7 p -72.07 116.48 12.53 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 171.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -97.84 117.55 32.41 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.764 -163.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 13.5 t -91.92 143.54 26.39 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 171.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 48.7 mt -115.44 124.46 71.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.227 0.537 . . . . 0.0 111.654 -172.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.463 ' N ' HD12 ' B' ' 24' ' ' ILE . 4.1 mp -90.44 -43.86 14.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.817 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -140.18 149.59 43.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.001 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' B' ' 69' ' ' PHE . 22.7 t -59.83 115.19 3.21 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.137 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 27' ' ' PHE . . . . . 0.91 ' HB3' HD23 ' B' ' 91' ' ' LEU . 12.5 p90 -122.84 148.9 44.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.478 0.656 . . . . 0.0 111.682 -177.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 28' ' ' HIS . . . . . 0.668 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 10.4 t60 -106.62 120.43 41.94 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.605 178.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.584 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 31.6 mt -89.51 134.24 29.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 171.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.668 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 16.3 p -122.4 -15.4 7.63 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 112.179 0.436 . . . . 0.0 112.179 -170.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -155.75 152.9 24.32 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 119.513 -1.327 . . . . 0.0 113.137 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.462 HG23 ' HG ' ' B' ' 87' ' ' LEU . 11.5 p -150.14 122.35 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 171.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.28 154.63 42.56 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.554 -173.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.499 ' HB3' HG12 ' B' ' 85' ' ' VAL . 3.7 pp -113.96 139.28 49.36 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 121.624 0.726 . . . . 0.0 111.529 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -104.59 -56.01 2.25 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.796 173.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -102.28 127.78 49.11 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 170.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.498 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 150.89 162.17 10.48 Favored Glycine 0 N--CA 1.438 -1.211 0 C-N-CA 119.547 -1.311 . . . . 0.0 113.407 176.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 38' ' ' GLN . . . . . 0.521 ' O ' ' HG3' ' B' ' 58' ' ' LYS . 26.5 mt-30 -102.52 -47.98 4.29 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.601 0.238 . . . . 0.0 111.293 177.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -151.57 133.06 14.69 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.636 -0.257 . . . . 0.0 110.442 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.529 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -132.56 116.3 16.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.517 0.675 . . . . 0.0 110.516 170.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' B' ' 79' ' ' THR . 97.7 mttt -100.2 112.64 24.97 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 40.6 tp -84.63 114.48 22.03 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 43' ' ' TYR . . . . . 0.473 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 98.8 m-85 -116.36 145.65 43.06 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.608 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.3 OUTLIER -131.95 130.77 41.93 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 120.371 -0.531 . . . . 0.0 109.731 171.944 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -104.29 113.78 27.57 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.821 177.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.773 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -126.13 139.22 53.54 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 174.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 57.3 30.28 18.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.293 0.568 . . . . 0.0 109.645 -171.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.526 ' HA ' ' HE2' ' B' ' 48' ' ' LYS . 0.3 OUTLIER 64.9 17.05 10.87 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.383 -179.233 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.505 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 47.9 tt0 -104.95 121.47 43.81 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -82.06 112.14 18.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.684 -177.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -102.86 136.51 42.54 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.524 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -82.27 102.99 8.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.778 0.799 . . . . 0.0 108.897 171.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.512 ' CG1' HD11 ' B' ' 67' ' ' LEU . 2.9 t -78.58 -52.78 14.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.798 -171.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.485 ' HB2' ' CD2' ' B' ' 65' ' ' LEU . . . -146.9 137.72 23.86 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.492 -177.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 28.0 m -104.6 101.65 11.29 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 170.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 56' ' ' VAL . . . . . 0.425 ' CG1' HG11 ' B' ' 85' ' ' VAL . 6.2 p -121.77 109.82 25.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 122.005 0.907 . . . . 0.0 110.202 -177.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 80.4 p -122.84 -176.77 3.48 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.76 -175.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 58' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' B' ' 38' ' ' GLN . 9.9 mtmp? -58.04 -31.52 67.1 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.453 170.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.05 -40.93 52.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.634 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 69.8 mt -116.02 76.49 6.38 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.44 1.6 8.23 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.731 2.287 . . . . 0.0 113.397 -168.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 62' ' ' GLN . . . . . 0.415 ' OE1' ' HA ' ' C' ' 54' ' ' ALA . 10.2 tt0 -154.82 101.03 2.26 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.705 -170.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 65.7 t -102.63 121.01 53.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.108 0.48 . . . . 0.0 110.695 177.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.7 110.78 22.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.651 174.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' B' ' 30' ' ' SER . 0.3 OUTLIER -126.97 169.14 13.62 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.042 0.449 . . . . 0.0 111.738 -175.117 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 66' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 26.9 t0 -119.27 105.01 10.92 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.72 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.589 HD21 HD23 ' A' ' 88' ' ' LEU . 18.6 mt -120.76 150.76 40.49 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.999 178.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 68' ' ' ASN . . . . . 0.503 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 5.9 t30 -152.48 127.08 9.42 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.001 0.429 . . . . 0.0 110.022 172.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 69' ' ' PHE . . . . . 0.54 ' O ' ' HA ' ' B' ' 26' ' ' SER . 38.8 m-85 -121.31 161.49 21.94 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.695 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.502 ' HB2' ' HA ' ' A' ' 7' ' ' MET . 42.6 t -115.83 158.27 23.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.318 0.58 . . . . 0.0 111.874 -174.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -21.73 66.47 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.242 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.13 -0.84 61.45 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.897 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -100.69 166.01 11.1 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -145.12 129.5 17.81 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.773 HG22 ' HB2' ' B' ' 46' ' ' ALA . 9.7 pt -134.67 174.62 12.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.072 0.463 . . . . 0.0 111.404 -173.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.608 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 23.1 mtp -130.46 123.75 30.48 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 77' ' ' PHE . . . . . 0.403 ' CD1' ' HB2' ' B' ' 44' ' ' LEU . 0.9 OUTLIER -105.14 127.64 53.0 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.009 178.46 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.649 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 24.4 p90 -153.96 141.84 20.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.128 0.489 . . . . 0.0 111.772 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.663 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 11.6 p -113.3 141.83 46.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.053 -178.002 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -109.9 150.76 27.96 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.572 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.49 176.83 40.17 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -177.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -107.54 102.21 11.48 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.706 179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -170.28 150.42 3.6 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.825 169.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 32.4 t -104.44 119.4 38.88 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.564 HG23 ' HB2' ' B' ' 13' ' ' MET . 5.6 m -119.24 135.15 60.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 CA-C-O 121.488 0.661 . . . . 0.0 112.096 -174.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 7.5 t -99.6 119.56 38.27 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.98 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.64 HD13 HD23 ' B' ' 11' ' ' LEU . 5.3 mp -92.95 147.15 23.08 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 173.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.641 HD23 HD21 ' C' ' 67' ' ' LEU . 1.5 tp -133.19 138.73 46.67 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.117 -178.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.97 -167.61 23.64 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.972 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 90' ' ' TYR . . . . . 0.523 ' CD2' ' HB3' ' C' ' 68' ' ' ASN . 20.2 p90 -153.59 135.66 14.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.856 0.836 . . . . 0.0 112.451 178.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 91' ' ' LEU . . . . . 0.91 HD23 ' HB3' ' B' ' 27' ' ' PHE . 5.2 mt . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 114.098 -1.41 . . . . 0.0 109.42 175.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 7' ' ' MET . . . . . 0.512 ' HA ' ' HB2' ' D' ' 70' ' ' SER . 55.7 mtp . . . . . 0 C--O 1.225 -0.199 0 CA-C-O 120.761 0.315 . . . . 0.0 111.322 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 8' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -88.4 152.28 22.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.242 -175.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -138.68 146.44 41.59 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.85 155.83 26.35 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.138 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.627 HD23 HD13 ' C' ' 87' ' ' LEU . 42.4 tp -150.02 108.3 3.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.719 0.295 . . . . 0.0 110.912 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -86.78 103.36 15.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.051 0.453 . . . . 0.0 110.814 175.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 13' ' ' MET . . . . . 0.546 ' HB2' HG23 ' C' ' 85' ' ' VAL . 2.8 mmt -80.91 136.75 36.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.191 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 14' ' ' LYS . . . . . 0.571 ' HB2' ' HG3' ' C' ' 17' ' ' ARG . 27.2 mtpp -99.81 142.6 24.92 Favored Pre-proline 0 C--N 1.316 -0.854 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 173.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 15' ' ' PRO . . . . . 0.522 ' HB3' ' N ' ' C' ' 83' ' ' ALA . 7.6 Cg_endo -50.13 115.22 1.76 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 123.454 2.769 . . . . 0.0 113.382 -175.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 16' ' ' GLU . . . . . 0.673 ' HA ' ' O ' ' C' ' 79' ' ' THR . 26.0 mt-10 64.97 57.56 0.97 Allowed 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.617 0.722 . . . . 0.0 111.648 177.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 17' ' ' ARG . . . . . 0.571 ' HG3' ' HB2' ' C' ' 14' ' ' LYS . 13.6 mmt180 -117.48 163.41 16.44 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.512 171.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 18' ' ' LYS . . . . . 0.639 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 3.3 ttmp? -139.5 109.93 6.6 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.811 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -111.34 113.29 25.66 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 2.7 p -72.05 116.39 12.4 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 171.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -97.81 117.69 32.7 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.777 -163.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 13.6 t -92.03 143.41 26.5 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 171.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 49.1 mt -115.36 124.48 71.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.168 0.509 . . . . 0.0 111.758 -172.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 24' ' ' ILE . . . . . 0.463 ' N ' HD12 ' C' ' 24' ' ' ILE . 4.1 mp -90.52 -43.72 14.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.794 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -140.23 149.47 42.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.039 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 26' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' C' ' 69' ' ' PHE . 23.0 t -59.89 115.28 3.29 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.064 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 27' ' ' PHE . . . . . 0.918 ' HB3' HD23 ' C' ' 91' ' ' LEU . 12.3 p90 -122.89 148.97 44.84 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.512 0.672 . . . . 0.0 111.608 -177.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 28' ' ' HIS . . . . . 0.659 ' HE2' ' HB3' ' C' ' 30' ' ' SER . 10.3 t60 -106.61 120.43 41.94 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.438 -1.256 . . . . 0.0 109.593 178.164 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 29' ' ' ILE . . . . . 0.595 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 31.7 mt -89.46 134.28 29.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 171.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.659 ' HB3' ' HE2' ' C' ' 28' ' ' HIS . 16.1 p -122.46 -15.41 7.59 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -171.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 31' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -155.68 152.92 24.36 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 119.54 -1.314 . . . . 0.0 113.179 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.454 HG23 ' HG ' ' C' ' 87' ' ' LEU . 11.5 p -150.18 122.35 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 171.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.32 154.53 42.43 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.091 -0.381 . . . . 0.0 111.581 -172.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.512 ' HB3' HG12 ' C' ' 85' ' ' VAL . 3.7 pp -113.86 139.3 49.29 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.703 0.763 . . . . 0.0 111.528 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -104.62 -55.99 2.25 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.929 173.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -102.31 127.9 49.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 37' ' ' GLY . . . . . 0.494 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 150.85 162.12 10.44 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 119.604 -1.284 . . . . 0.0 113.512 176.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 38' ' ' GLN . . . . . 0.529 ' O ' ' HG3' ' C' ' 58' ' ' LYS . 26.5 mt-30 -102.47 -47.97 4.3 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 120.644 0.259 . . . . 0.0 111.34 177.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -151.61 132.98 14.6 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.436 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.535 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -132.53 116.25 16.49 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.47 0.653 . . . . 0.0 110.515 170.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' C' ' 79' ' ' THR . 97.8 mttt -100.12 112.66 24.97 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.124 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 40.7 tp -84.56 114.43 21.96 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -176.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 43' ' ' TYR . . . . . 0.472 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 98.6 m-85 -116.34 145.62 43.06 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.606 ' HA ' ' O ' ' C' ' 76' ' ' MET . 0.3 OUTLIER -131.92 130.82 42.06 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.769 171.864 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 45' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -104.27 113.75 27.51 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.8 177.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.748 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -126.09 139.24 53.55 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 174.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 57.19 30.42 18.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.392 0.615 . . . . 0.0 109.709 -171.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 48' ' ' LYS . . . . . 0.515 ' HA ' ' HE2' ' C' ' 48' ' ' LYS . 0.3 OUTLIER 64.77 17.08 10.8 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.467 -179.125 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 49' ' ' GLN . . . . . 0.498 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 47.9 tt0 -104.89 121.5 43.83 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -82.05 112.14 18.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.773 -177.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -102.96 136.61 42.46 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.505 177.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -82.29 103.03 8.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.803 0.811 . . . . 0.0 108.908 171.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 53' ' ' VAL . . . . . 0.513 ' CG1' HD11 ' C' ' 67' ' ' LEU . 3.0 t -78.62 -52.72 15.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.745 -171.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 54' ' ' ALA . . . . . 0.484 ' HB2' HD23 ' C' ' 65' ' ' LEU . . . -146.91 137.59 23.77 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.582 -177.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 27.9 m -104.46 101.62 11.29 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 170.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 56' ' ' VAL . . . . . 0.43 ' CG1' HG11 ' C' ' 85' ' ' VAL . 6.1 p -121.75 109.77 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-O 121.958 0.885 . . . . 0.0 110.172 -177.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 80.7 p -122.85 -176.81 3.49 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.762 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 58' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' C' ' 38' ' ' GLN . 9.9 mtmp? -57.98 -31.62 67.08 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.396 170.105 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.01 -40.91 52.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.633 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 69.7 mt -115.96 76.46 6.24 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 173.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -76.41 1.59 8.22 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.766 2.311 . . . . 0.0 113.383 -168.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 62' ' ' GLN . . . . . 0.424 ' OE1' ' HA ' ' D' ' 54' ' ' ALA . 10.2 tt0 -154.9 101.03 2.25 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.649 -170.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 66.0 t -102.61 121.01 53.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.072 0.463 . . . . 0.0 110.728 177.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.72 110.85 23.09 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.64 174.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 65' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' C' ' 30' ' ' SER . 0.3 OUTLIER -126.97 169.15 13.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.109 0.48 . . . . 0.0 111.604 -175.068 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 66' ' ' ASP . . . . . 0.561 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 27.4 t0 -119.3 105.04 10.94 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.764 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.641 HD21 HD23 ' B' ' 88' ' ' LEU . 18.7 mt -120.71 150.64 40.65 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.024 178.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 68' ' ' ASN . . . . . 0.523 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 6.0 t30 -152.37 127.12 9.52 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.961 0.41 . . . . 0.0 110.077 172.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 69' ' ' PHE . . . . . 0.536 ' O ' ' HA ' ' C' ' 26' ' ' SER . 38.8 m-85 -121.36 161.54 21.92 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.699 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 70' ' ' SER . . . . . 0.522 ' HB2' ' HA ' ' B' ' 7' ' ' MET . 42.7 t -115.88 158.18 23.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.273 0.559 . . . . 0.0 111.856 -174.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -21.92 66.53 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.318 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.02 -0.83 61.64 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.91 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -100.72 166.04 11.08 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -145.09 129.65 17.98 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.748 HG22 ' HB2' ' C' ' 46' ' ' ALA . 9.7 pt -134.87 174.56 12.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.047 0.451 . . . . 0.0 111.375 -173.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.606 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 23.3 mtp -130.37 123.77 30.67 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.299 174.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 77' ' ' PHE . . . . . 0.405 ' CD1' ' HB2' ' C' ' 44' ' ' LEU . 1.0 OUTLIER -105.08 127.56 52.94 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.006 178.486 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 78' ' ' TYR . . . . . 0.639 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 24.4 p90 -153.94 141.83 20.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.067 0.46 . . . . 0.0 111.842 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 79' ' ' THR . . . . . 0.673 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 11.7 p -113.29 141.85 46.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.103 -178.037 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -109.9 150.74 28.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.629 176.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.41 176.77 40.28 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -177.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -107.48 102.22 11.5 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 119.436 -0.905 . . . . 0.0 109.715 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 83' ' ' ALA . . . . . 0.535 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -170.2 150.41 3.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.942 169.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 32.5 t -104.42 119.38 38.84 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.546 HG23 ' HB2' ' C' ' 13' ' ' MET . 5.6 m -119.28 135.08 60.82 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 CA-C-O 121.454 0.645 . . . . 0.0 112.126 -174.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 7.5 t -99.61 119.5 38.17 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.044 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 87' ' ' LEU . . . . . 0.627 HD13 HD23 ' C' ' 11' ' ' LEU . 5.3 mp -92.95 147.01 23.19 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 173.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 88' ' ' LEU . . . . . 0.619 HD23 HD21 ' D' ' 67' ' ' LEU . 1.5 tp -133.15 138.8 46.76 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.145 -178.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.89 -167.59 23.54 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.072 -177.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 90' ' ' TYR . . . . . 0.524 ' CD2' ' HB3' ' D' ' 68' ' ' ASN . 20.2 p90 -153.7 135.7 14.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.867 0.841 . . . . 0.0 112.455 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 91' ' ' LEU . . . . . 0.918 HD23 ' HB3' ' C' ' 27' ' ' PHE . 5.2 mt . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.487 176.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 7' ' ' MET . . . . . 0.51 ' HA ' ' HB2' ' E' ' 70' ' ' SER . 55.7 mtp . . . . . 0 C--O 1.225 -0.231 0 CA-C-O 120.756 0.312 . . . . 0.0 111.287 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 8' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -88.29 152.23 22.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.287 -175.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 9' ' ' TRP . . . . . . . . . . . . . 87.1 t90 -138.64 146.44 41.68 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.83 155.89 26.38 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.038 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 11' ' ' LEU . . . . . 0.639 HD23 HD13 ' D' ' 87' ' ' LEU . 42.4 tp -150.04 108.23 3.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.665 0.269 . . . . 0.0 110.872 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 -86.79 103.31 15.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.072 0.463 . . . . 0.0 110.857 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 13' ' ' MET . . . . . 0.57 ' HB2' HG23 ' D' ' 85' ' ' VAL . 2.8 mmt -80.71 136.71 36.22 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.309 -178.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 14' ' ' LYS . . . . . 0.549 ' HB2' ' HG3' ' D' ' 17' ' ' ARG . 27.2 mtpp -99.88 142.61 24.92 Favored Pre-proline 0 C--N 1.317 -0.833 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 15' ' ' PRO . . . . . 0.521 ' HB3' ' N ' ' D' ' 83' ' ' ALA . 7.5 Cg_endo -50.11 115.28 1.79 Allowed 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 123.482 2.788 . . . . 0.0 113.293 -175.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 16' ' ' GLU . . . . . 0.681 ' HA ' ' O ' ' D' ' 79' ' ' THR . 26.1 mt-10 64.94 57.54 0.99 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.627 0.727 . . . . 0.0 111.631 177.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 17' ' ' ARG . . . . . 0.549 ' HG3' ' HB2' ' D' ' 14' ' ' LYS . 13.7 mmt180 -117.44 163.23 16.69 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.597 171.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 18' ' ' LYS . . . . . 0.648 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 3.3 ttmp? -139.38 109.96 6.65 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 123.446 0.466 . . . . 0.0 110.829 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -111.39 113.31 25.68 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 2.7 p -72.08 116.38 12.42 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 171.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -97.87 117.71 32.81 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.694 -163.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 13.7 t -92.06 143.41 26.49 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 171.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 49.0 mt -115.24 124.5 71.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.257 0.551 . . . . 0.0 111.761 -172.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 24' ' ' ILE . . . . . 0.47 HD12 ' N ' ' D' ' 24' ' ' ILE . 4.1 mp -90.59 -43.79 14.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.704 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -140.07 149.56 43.27 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.102 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 26' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' D' ' 69' ' ' PHE . 22.7 t -59.9 115.2 3.24 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.151 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 27' ' ' PHE . . . . . 0.889 ' HB3' HD23 ' D' ' 91' ' ' LEU . 12.5 p90 -122.81 148.88 44.87 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.487 0.66 . . . . 0.0 111.697 -177.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 28' ' ' HIS . . . . . 0.676 ' HE2' ' HB3' ' D' ' 30' ' ' SER . 10.3 t60 -106.55 120.43 41.92 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.662 178.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 29' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 31.5 mt -89.43 134.3 29.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 171.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 30' ' ' SER . . . . . 0.676 ' HB3' ' HE2' ' D' ' 28' ' ' HIS . 16.1 p -122.46 -15.38 7.6 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -171.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 31' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -155.74 152.99 24.41 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 119.517 -1.325 . . . . 0.0 113.15 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.471 HG23 ' HG ' ' D' ' 87' ' ' LEU . 11.6 p -150.23 122.28 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 171.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.3 154.58 42.5 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.13 -0.356 . . . . 0.0 111.599 -172.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 34' ' ' LEU . . . . . 0.508 ' HB3' HG12 ' D' ' 85' ' ' VAL . 3.7 pp -113.94 139.3 49.33 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.6 0.714 . . . . 0.0 111.502 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -104.61 -55.98 2.26 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.846 173.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -102.32 127.77 49.16 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 170.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 37' ' ' GLY . . . . . 0.486 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 150.89 162.2 10.5 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 119.623 -1.275 . . . . 0.0 113.507 176.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 38' ' ' GLN . . . . . 0.516 ' O ' ' HG3' ' D' ' 58' ' ' LYS . 70.0 mt-30 -102.55 -47.94 4.29 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 121.191 -0.203 . . . . 0.0 111.286 177.048 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -151.53 132.93 14.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.598 -0.273 . . . . 0.0 110.419 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 40' ' ' ALA . . . . . 0.546 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -132.46 116.33 16.65 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.422 0.629 . . . . 0.0 110.512 170.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' D' ' 79' ' ' THR . 97.7 mttt -100.18 112.67 24.99 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 174.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 40.5 tp -84.62 114.55 22.07 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -176.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 43' ' ' TYR . . . . . 0.476 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 98.7 m-85 -116.37 145.67 43.05 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.612 ' HA ' ' O ' ' D' ' 76' ' ' MET . 0.3 OUTLIER -132.0 130.74 41.82 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.71 171.961 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 45' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -104.28 113.74 27.51 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.848 177.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.763 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -126.02 139.13 53.66 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 174.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 57.38 30.27 18.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.355 0.598 . . . . 0.0 109.674 -171.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 48' ' ' LYS . . . . . 0.54 ' HA ' ' HE2' ' D' ' 48' ' ' LYS . 0.3 OUTLIER 64.87 17.09 10.86 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.47 -179.088 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 49' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 48.0 tt0 -104.92 121.5 43.84 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -82.11 112.07 18.82 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.76 -177.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -102.88 136.6 42.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.523 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -82.36 103.09 9.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 171.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 53' ' ' VAL . . . . . 0.518 ' CG1' HD11 ' D' ' 67' ' ' LEU . 3.0 t -78.72 -52.72 15.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.735 -171.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 54' ' ' ALA . . . . . 0.485 ' HB2' ' CD2' ' D' ' 65' ' ' LEU . . . -146.92 137.73 23.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.498 -177.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 28.4 m -104.61 101.64 11.28 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 170.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 56' ' ' VAL . . . . . 0.416 ' CG1' HG11 ' D' ' 85' ' ' VAL . 6.1 p -121.73 109.85 25.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 122.019 0.914 . . . . 0.0 110.199 -177.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 80.7 p -122.88 -176.75 3.48 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.811 -175.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 58' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' D' ' 38' ' ' GLN . 9.9 mtmp? -57.94 -31.63 67.03 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.418 170.105 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.06 -40.87 52.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.606 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 69.9 mt -116.09 76.51 6.53 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 173.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -76.39 1.47 8.34 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.769 2.313 . . . . 0.0 113.381 -168.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -154.79 100.95 2.26 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.736 -170.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 65.9 t -102.58 121.05 53.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.038 0.447 . . . . 0.0 110.688 177.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.72 110.77 22.99 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.666 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 65' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' D' ' 30' ' ' SER . 0.3 OUTLIER -126.98 169.16 13.61 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.124 0.488 . . . . 0.0 111.639 -175.055 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 66' ' ' ASP . . . . . 0.57 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 27.2 t0 -119.32 105.1 10.99 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.712 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.619 HD21 HD23 ' C' ' 88' ' ' LEU . 18.6 mt -120.75 150.67 40.63 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.98 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 68' ' ' ASN . . . . . 0.524 ' HB3' ' CD2' ' C' ' 90' ' ' TYR . 6.0 t30 -152.41 127.11 9.49 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.91 0.386 . . . . 0.0 110.049 172.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 69' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' D' ' 26' ' ' SER . 38.4 m-85 -121.31 161.49 21.94 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.72 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 70' ' ' SER . . . . . 0.512 ' HB2' ' HA ' ' C' ' 7' ' ' MET . 42.3 t -115.82 158.25 23.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.263 0.554 . . . . 0.0 111.847 -174.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -21.97 66.58 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.272 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.86 -1.07 61.79 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.906 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -100.57 166.02 11.12 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -145.04 129.59 17.98 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.763 HG22 ' HB2' ' D' ' 46' ' ' ALA . 9.8 pt -134.82 174.61 12.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.058 0.456 . . . . 0.0 111.322 -173.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 76' ' ' MET . . . . . 0.612 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 23.2 mtp -130.45 123.76 30.51 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.284 174.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 77' ' ' PHE . . . . . 0.411 ' CD1' ' HB2' ' D' ' 44' ' ' LEU . 1.0 OUTLIER -105.05 127.53 52.92 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.093 178.51 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 78' ' ' TYR . . . . . 0.648 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 24.2 p90 -153.89 141.91 20.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.096 0.474 . . . . 0.0 111.756 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 79' ' ' THR . . . . . 0.681 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 11.7 p -113.36 141.84 46.57 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.033 -178.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -109.88 150.72 28.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.622 176.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.42 176.79 40.28 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -177.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -107.4 102.21 11.51 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.716 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 83' ' ' ALA . . . . . 0.546 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -170.25 150.37 3.62 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.895 169.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 32.4 t -104.41 119.24 38.52 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.57 HG23 ' HB2' ' D' ' 13' ' ' MET . 5.7 m -119.14 135.19 60.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-O 121.425 0.631 . . . . 0.0 112.107 -174.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 7.5 t -99.67 119.47 38.16 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.976 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 87' ' ' LEU . . . . . 0.639 HD13 HD23 ' D' ' 11' ' ' LEU . 5.3 mp -92.87 147.07 23.15 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 173.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.613 HD23 HD21 ' E' ' 67' ' ' LEU . 1.5 tp -133.23 138.7 46.61 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.151 -178.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.82 -167.55 23.41 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.997 -177.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 90' ' ' TYR . . . . . 0.502 ' CD2' ' HB3' ' E' ' 68' ' ' ASN . 20.2 p90 -153.64 135.71 14.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.805 0.812 . . . . 0.0 112.497 178.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 91' ' ' LEU . . . . . 0.889 HD23 ' HB3' ' D' ' 27' ' ' PHE . 5.3 mt . . . . . 0 C--N 1.324 -0.504 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.396 176.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 7' ' ' MET . . . . . 0.527 ' HA ' ' HB2' ' A' ' 70' ' ' SER . 56.0 mtp . . . . . 0 C--O 1.224 -0.285 0 CA-C-O 120.681 0.277 . . . . 0.0 111.288 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 8' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -88.33 152.17 22.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.316 -175.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 9' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -138.62 146.51 41.82 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -178.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.81 155.88 26.38 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.166 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 11' ' ' LEU . . . . . 0.633 HD23 HD13 ' E' ' 87' ' ' LEU . 42.2 tp -150.06 108.33 3.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.774 0.321 . . . . 0.0 110.912 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -86.81 103.37 15.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.161 0.505 . . . . 0.0 110.834 175.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 13' ' ' MET . . . . . 0.552 ' HB2' HG23 ' E' ' 85' ' ' VAL . 2.8 mmt -80.84 136.74 36.15 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.22 -178.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 14' ' ' LYS . . . . . 0.553 ' HB2' ' HG3' ' E' ' 17' ' ' ARG . 27.2 mtpp -99.87 142.6 24.91 Favored Pre-proline 0 C--N 1.318 -0.803 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 15' ' ' PRO . . . . . 0.527 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 7.6 Cg_endo -50.02 115.22 1.74 Allowed 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 123.46 2.773 . . . . 0.0 113.399 -175.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 16' ' ' GLU . . . . . 0.678 ' HA ' ' O ' ' E' ' 79' ' ' THR . 25.9 mt-10 65.03 57.53 0.96 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.539 0.685 . . . . 0.0 111.637 177.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 17' ' ' ARG . . . . . 0.553 ' HG3' ' HB2' ' E' ' 14' ' ' LYS . 13.6 mmt180 -117.57 163.27 16.68 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.503 171.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 18' ' ' LYS . . . . . 0.639 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 3.3 ttmp? -139.47 109.96 6.62 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 123.457 0.473 . . . . 0.0 110.858 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -111.3 113.34 25.75 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 2.7 p -72.18 116.48 12.66 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -97.88 117.68 32.75 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.714 -163.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 13.5 t -91.98 143.44 26.48 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 171.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 48.7 mt -115.4 124.43 71.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.25 0.548 . . . . 0.0 111.781 -172.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 24' ' ' ILE . . . . . 0.475 HD12 ' N ' ' E' ' 24' ' ' ILE . 4.1 mp -90.41 -43.82 14.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.787 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -140.15 149.45 43.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.099 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 26' ' ' SER . . . . . 0.545 ' HA ' ' O ' ' E' ' 69' ' ' PHE . 23.0 t -59.83 115.24 3.25 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.155 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 27' ' ' PHE . . . . . 0.922 ' HB3' HD23 ' E' ' 91' ' ' LEU . 12.4 p90 -122.88 148.86 44.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.463 0.649 . . . . 0.0 111.684 -177.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 28' ' ' HIS . . . . . 0.678 ' HE2' ' HB3' ' E' ' 30' ' ' SER . 10.6 t60 -106.53 120.43 41.91 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.592 178.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 29' ' ' ILE . . . . . 0.58 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 31.5 mt -89.44 134.32 29.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 171.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 30' ' ' SER . . . . . 0.678 ' HB3' ' HE2' ' E' ' 28' ' ' HIS . 16.1 p -122.51 -15.41 7.57 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -171.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 31' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -155.77 152.89 24.32 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.562 -1.304 . . . . 0.0 113.195 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.469 HG23 ' HG ' ' E' ' 87' ' ' LEU . 11.6 p -150.21 122.32 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 171.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.37 154.47 42.34 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 122.13 -0.356 . . . . 0.0 111.552 -172.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 34' ' ' LEU . . . . . 0.511 ' HB3' HG12 ' E' ' 85' ' ' VAL . 3.7 pp -113.84 139.32 49.25 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.677 0.751 . . . . 0.0 111.569 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -104.59 -56.08 2.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.829 173.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -102.31 127.86 49.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 170.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 37' ' ' GLY . . . . . 0.494 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 150.92 162.16 10.48 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 119.613 -1.28 . . . . 0.0 113.493 176.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 38' ' ' GLN . . . . . 0.508 ' O ' ' HG3' ' E' ' 58' ' ' LYS . 69.8 mt-30 -102.5 -47.98 4.29 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 121.155 -0.218 . . . . 0.0 111.3 177.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -151.55 132.97 14.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.439 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 40' ' ' ALA . . . . . 0.531 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -132.54 116.26 16.51 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.412 0.625 . . . . 0.0 110.557 170.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 41' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' E' ' 79' ' ' THR . 97.8 mttt -100.12 112.59 24.89 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 40.7 tp -84.58 114.54 22.05 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -176.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 43' ' ' TYR . . . . . 0.471 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 98.4 m-85 -116.39 145.62 43.1 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 44' ' ' LEU . . . . . 0.605 ' HA ' ' O ' ' E' ' 76' ' ' MET . 0.3 OUTLIER -132.0 130.83 41.92 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.673 171.9 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' E' E ' 45' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -104.3 113.82 27.64 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.787 177.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 46' ' ' ALA . . . . . 0.771 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -126.12 139.18 53.58 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 174.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 57.3 30.3 18.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.315 0.578 . . . . 0.0 109.687 -171.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 48' ' ' LYS . . . . . 0.532 ' HA ' ' HE2' ' E' ' 48' ' ' LYS . 0.3 OUTLIER 64.88 17.17 10.9 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.41 -179.194 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' E' E ' 49' ' ' GLN . . . . . 0.504 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 47.9 tt0 -105.07 121.49 43.91 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -82.04 112.05 18.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.76 -177.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -102.91 136.57 42.48 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.491 177.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -82.27 103.11 9.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 171.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 53' ' ' VAL . . . . . 0.508 ' CG1' HD11 ' E' ' 67' ' ' LEU . 2.9 t -78.63 -52.75 15.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.79 -172.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 54' ' ' ALA . . . . . 0.489 ' HB2' ' CD2' ' E' ' 65' ' ' LEU . . . -146.93 137.66 23.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.5 -177.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 28.2 m -104.55 101.61 11.26 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 170.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 56' ' ' VAL . . . . . 0.427 ' CG1' HG11 ' E' ' 85' ' ' VAL . 6.3 p -121.67 109.78 25.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.974 0.893 . . . . 0.0 110.263 -177.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 80.4 p -122.79 -176.76 3.47 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.816 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 58' ' ' LYS . . . . . 0.508 ' HG3' ' O ' ' E' ' 38' ' ' GLN . 9.9 mtmp? -57.95 -31.7 67.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.023 0.44 . . . . 0.0 110.417 170.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.97 -40.88 52.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.621 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 70.0 mt -116.05 76.41 6.4 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -76.33 1.58 8.2 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.836 2.357 . . . . 0.0 113.408 -168.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 62' ' ' GLN . . . . . 0.408 ' OE1' ' HA ' ' A' ' 54' ' ' ALA . 10.2 tt0 -154.89 100.99 2.25 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.613 -170.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 66.3 t -102.66 120.99 53.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.112 0.482 . . . . 0.0 110.788 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.69 110.9 23.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.603 175.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 65' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' E' ' 30' ' ' SER . 0.3 OUTLIER -127.03 169.19 13.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.663 -175.096 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' E' E ' 66' ' ' ASP . . . . . 0.557 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 27.1 t0 -119.35 104.98 10.86 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.709 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 67' ' ' LEU . . . . . 0.613 HD21 HD23 ' D' ' 88' ' ' LEU . 18.5 mt -120.74 150.64 40.67 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.979 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 68' ' ' ASN . . . . . 0.502 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 6.0 t30 -152.38 127.17 9.55 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.922 0.391 . . . . 0.0 110.013 172.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 69' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' E' ' 26' ' ' SER . 38.5 m-85 -121.3 161.52 21.87 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.745 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 70' ' ' SER . . . . . 0.51 ' HB2' ' HA ' ' D' ' 7' ' ' MET . 42.1 t -115.89 158.26 23.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.262 0.553 . . . . 0.0 111.841 -174.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -21.81 66.49 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.297 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.98 -1.03 61.61 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.949 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -100.59 166.0 11.13 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -145.03 129.71 18.09 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 75' ' ' ILE . . . . . 0.771 HG22 ' HB2' ' E' ' 46' ' ' ALA . 9.7 pt -134.84 174.6 12.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.002 0.43 . . . . 0.0 111.376 -173.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 76' ' ' MET . . . . . 0.605 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 22.9 mtp -130.41 123.76 30.56 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 77' ' ' PHE . . . . . 0.404 ' CD1' ' HB2' ' E' ' 44' ' ' LEU . 0.9 OUTLIER -105.08 127.58 52.95 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.038 178.493 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' E' E ' 78' ' ' TYR . . . . . 0.639 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 24.5 p90 -153.91 141.85 20.2 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.118 0.485 . . . . 0.0 111.822 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 79' ' ' THR . . . . . 0.678 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 11.5 p -113.3 141.94 46.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.046 -178.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -110.03 150.78 28.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.534 176.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.4 176.86 40.3 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -177.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -107.46 102.18 11.47 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 119.409 -0.916 . . . . 0.0 109.713 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 83' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -170.2 150.38 3.66 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.863 169.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 32.3 t -104.42 119.31 38.69 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 85' ' ' VAL . . . . . 0.552 HG23 ' HB2' ' E' ' 13' ' ' MET . 5.7 m -119.2 135.1 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 CA-C-O 121.421 0.629 . . . . 0.0 112.17 -174.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 7.5 t -99.57 119.58 38.28 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.963 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 87' ' ' LEU . . . . . 0.633 HD13 HD23 ' E' ' 11' ' ' LEU . 5.3 mp -93.01 147.14 23.09 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 88' ' ' LEU . . . . . 0.643 HD23 HD21 ' A' ' 67' ' ' LEU . 1.5 tp -133.22 138.67 46.61 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.12 -178.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.86 -167.62 23.55 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.021 -177.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 90' ' ' TYR . . . . . 0.542 ' CD2' ' HB3' ' A' ' 68' ' ' ASN . 20.1 p90 -153.65 135.74 14.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.932 0.872 . . . . 0.0 112.403 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 91' ' ' LEU . . . . . 0.922 HD23 ' HB3' ' E' ' 27' ' ' PHE . 5.2 mt . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 113.983 -1.462 . . . . 0.0 109.402 176.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.416 ' HA ' ' HB2' ' B' ' 70' ' ' SER . 57.1 mtp . . . . . 0 CA--C 1.521 -0.145 0 CA-C-O 121.053 0.454 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.557 ' CE1' HD21 ' B' ' 44' ' ' LEU . 48.7 t80 -66.47 145.49 55.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.068 -176.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.56 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 90.2 t90 -132.71 146.08 51.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.007 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.1 146.69 16.36 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.095 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.56 ' HB2' ' CH2' ' A' ' 9' ' ' TRP . 63.5 tp -134.27 109.02 8.56 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.983 0.42 . . . . 0.0 110.454 178.071 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -91.52 107.71 19.4 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.516 177.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.565 ' SD ' HD11 ' A' ' 87' ' ' LEU . 54.2 mtp -102.27 143.82 31.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.38 0.61 . . . . 0.0 111.406 -174.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -100.92 151.39 37.6 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.193 -177.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.472 ' HB3' ' N ' ' A' ' 83' ' ' ALA . 11.2 Cg_endo -54.99 113.77 1.56 Allowed 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.19 2.593 . . . . 0.0 112.832 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 79' ' ' THR . 17.3 mt-10 59.96 70.96 0.6 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.508 0.67 . . . . 0.0 111.414 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.2 142.77 32.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.558 174.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.712 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 35.3 ttmt -116.44 117.46 29.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.389 -176.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.418 ' OH ' ' HA ' ' A' ' 13' ' ' MET . 1.9 m-85 -110.37 122.26 47.28 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.47 ' HB3' ' SD ' ' A' ' 76' ' ' MET . 6.0 p -102.51 99.78 9.83 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 169.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 19.9 pm0 -117.72 143.0 46.62 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.595 0.712 . . . . 0.0 112.274 -174.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.0 t -93.31 160.77 14.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.526 176.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.412 HG22 ' HA ' ' A' ' 71' ' ' LYS . 70.1 mt -112.47 119.35 60.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.066 0.46 . . . . 0.0 111.529 -173.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.407 HD12 ' N ' ' A' ' 25' ' ' LYS . 1.7 pp -99.6 -11.53 8.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.025 177.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.407 ' N ' HD12 ' A' ' 24' ' ' ILE . 84.7 tttt -148.0 119.53 7.96 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.3 p -61.7 140.53 58.18 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 123.379 0.425 . . . . 0.0 110.656 -175.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.798 ' HB3' HD23 ' A' ' 91' ' ' LEU . 42.6 p90 -152.13 162.79 40.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.718 0.77 . . . . 0.0 112.895 -174.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.544 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 7.7 t60 -114.74 124.52 52.0 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.009 176.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 41.6 mt -88.28 135.91 24.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 170.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.487 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 43.8 p -123.62 -5.26 8.15 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -170.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . 179.88 155.14 14.62 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 119.192 -1.48 . . . . 0.0 113.513 175.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.447 HG23 ' HG ' ' A' ' 87' ' ' LEU . 11.9 p -136.78 132.83 48.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.8 156.48 42.4 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.605 -176.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.613 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.1 pp -123.72 145.55 48.92 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.403 0.621 . . . . 0.0 111.01 177.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -110.2 -52.06 2.81 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.653 174.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -102.93 127.5 50.12 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 169.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.46 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 151.75 156.75 7.59 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 119.769 -1.205 . . . . 0.0 113.344 177.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.487 ' HA ' ' HB2' ' A' ' 58' ' ' LYS . 94.8 mt-30 -102.37 -44.48 5.37 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.616 0.246 . . . . 0.0 111.07 178.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -152.82 128.83 10.34 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.363 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.477 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -128.22 113.02 15.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.549 0.69 . . . . 0.0 109.981 168.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 79' ' ' THR . 28.6 mmmt -94.59 109.39 21.31 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.51 HD23 ' HB ' ' A' ' 53' ' ' VAL . 48.3 tp -82.08 109.52 16.47 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -174.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -112.24 136.33 51.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.108 177.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.698 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -123.88 121.76 36.21 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.525 175.441 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -109.92 111.1 22.29 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.02 178.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.522 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -128.72 139.32 52.28 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.539 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 56.61 35.65 26.41 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 123.751 0.657 . . . . 0.0 110.314 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.429 ' HB3' ' NZ ' ' A' ' 48' ' ' LYS . 9.1 mtpm? 63.6 32.26 14.1 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.102 -0.953 . . . . 0.0 112.284 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.559 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 59.4 tp60 -128.28 133.96 48.85 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 175.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -89.05 121.84 31.79 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 -177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -116.72 123.44 47.21 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.506 176.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -75.38 106.69 5.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 169.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.613 ' CG2' ' HB3' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -84.22 -46.37 17.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.532 -172.299 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.56 ' HB2' HD21 ' A' ' 65' ' ' LEU . . . -153.96 149.48 27.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.641 -177.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.2 m -113.02 101.6 9.62 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 169.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.45 HG13 ' HB3' ' A' ' 40' ' ' ALA . 7.8 p -115.7 114.36 46.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.544 0.688 . . . . 0.0 109.283 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 44.6 p -122.62 -179.12 4.11 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.214 -172.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HB2' ' HA ' ' A' ' 38' ' ' GLN . 58.1 tttt -58.68 -32.29 68.98 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.704 171.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.4 -40.87 22.77 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.922 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 84.5 mt -108.38 86.63 3.55 Favored Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 175.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.08 0.17 8.76 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.665 2.243 . . . . 0.0 113.843 -166.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -164.49 131.07 3.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.24 0.543 . . . . 0.0 111.516 -175.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 93.4 t -122.0 112.22 33.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.311 174.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.59 131.49 41.76 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 174.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.56 HD21 ' HB2' ' A' ' 54' ' ' ALA . 86.3 mt -124.16 168.14 13.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.482 0.658 . . . . 0.0 112.303 -173.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.491 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 18.5 t0 -142.33 99.48 3.51 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.351 169.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 2.4 mt -129.46 144.21 51.16 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.034 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.437 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 5.9 t30 -141.79 114.91 8.74 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.539 -0.465 . . . . 0.0 109.771 176.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -111.14 146.93 35.96 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.541 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.9 t -97.88 166.72 11.32 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.412 ' HA ' HG22 ' A' ' 23' ' ' ILE . 21.6 ptmt -75.57 2.21 12.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.241 0.543 . . . . 0.0 110.591 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.25 -7.77 51.47 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.294 172.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -93.18 138.75 31.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.044 0.449 . . . . 0.0 110.447 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -122.22 117.0 25.12 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.522 HG22 ' HB2' ' A' ' 46' ' ' ALA . 14.9 pt -128.58 162.73 34.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.188 0.518 . . . . 0.0 112.054 -168.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.482 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 4.9 mtm -119.93 125.67 49.0 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 172.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.698 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -109.6 127.09 54.27 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 176.548 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.712 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 53.2 p90 -155.42 139.22 16.18 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.009 -175.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.576 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 2.9 p -111.7 134.23 53.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.309 -176.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.423 ' HB3' ' HB2' ' A' ' 41' ' ' LYS . . . -100.74 157.09 16.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.536 175.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.81 179.08 46.16 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -176.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -108.18 102.96 12.06 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.003 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.477 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -168.79 150.8 4.83 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.505 170.125 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.3 t -109.74 121.86 46.17 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.613 HG12 ' HB3' ' A' ' 34' ' ' LEU . 7.0 m -117.68 155.26 19.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.316 0.579 . . . . 0.0 112.38 -173.181 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.4 m -120.72 122.43 40.39 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.58 173.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.565 HD11 ' SD ' ' A' ' 13' ' ' MET . 4.7 mp -96.03 145.76 25.19 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 170.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.526 HD13 ' O ' ' A' ' 87' ' ' LEU . 1.2 mm? -121.02 150.3 41.35 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 173.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.31 -167.81 27.54 Favored Glycine 0 N--CA 1.438 -1.18 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.248 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.436 ' CD2' ' HB3' ' B' ' 68' ' ' ASN . 3.4 p90 -147.57 129.18 15.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.735 0.779 . . . . 0.0 112.07 177.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.798 HD23 ' HB3' ' A' ' 27' ' ' PHE . 15.7 mt . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 113.918 -1.492 . . . . 0.0 109.815 176.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 56.8 mtp . . . . . 0 CA--C 1.521 -0.162 0 CA-C-O 121.012 0.434 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 8' ' ' PHE . . . . . 0.614 ' CE1' HD21 ' C' ' 44' ' ' LEU . 48.2 t80 -66.5 145.55 55.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.057 -176.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 9' ' ' TRP . . . . . 0.565 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 90.1 t90 -132.75 146.06 51.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.003 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.19 146.74 16.44 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.118 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.565 ' HB2' ' CH2' ' B' ' 9' ' ' TRP . 63.5 tp -134.29 109.05 8.57 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.013 0.435 . . . . 0.0 110.557 178.062 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -91.43 107.68 19.37 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.556 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 13' ' ' MET . . . . . 0.579 ' SD ' HD11 ' B' ' 87' ' ' LEU . 53.8 mtp -102.29 143.67 31.76 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.396 0.617 . . . . 0.0 111.382 -174.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -100.88 151.48 37.62 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.095 -177.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.464 ' HB3' ' N ' ' B' ' 83' ' ' ALA . 11.1 Cg_endo -55.02 113.87 1.6 Allowed 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 123.142 2.561 . . . . 0.0 112.752 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.581 ' HA ' ' O ' ' B' ' 79' ' ' THR . 17.3 mt-10 59.91 71.02 0.59 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.501 0.667 . . . . 0.0 111.356 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.23 142.83 32.66 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.613 174.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.709 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 35.3 ttmt -116.6 117.49 29.99 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.32 -176.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 19' ' ' TYR . . . . . 0.42 ' OH ' ' HA ' ' B' ' 13' ' ' MET . 1.9 m-85 -110.43 122.3 47.38 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.464 ' HB3' ' SD ' ' B' ' 76' ' ' MET . 5.9 p -102.58 99.83 9.86 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 169.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 19.8 pm0 -117.83 142.98 46.7 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.576 0.703 . . . . 0.0 112.165 -174.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 13.0 t -93.21 160.71 14.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.549 176.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.415 HG22 ' HA ' ' B' ' 71' ' ' LYS . 70.1 mt -112.52 119.4 60.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.138 0.494 . . . . 0.0 111.523 -173.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.405 HD12 ' N ' ' B' ' 25' ' ' LYS . 1.7 pp -99.68 -11.52 8.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.906 177.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.405 ' N ' HD12 ' B' ' 24' ' ' ILE . 84.8 tttt -147.95 119.58 8.01 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 31.4 p -61.67 140.53 58.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.654 -175.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 27' ' ' PHE . . . . . 0.792 ' HB3' HD23 ' B' ' 91' ' ' LEU . 42.8 p90 -152.16 162.73 40.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.774 0.797 . . . . 0.0 112.903 -174.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 28' ' ' HIS . . . . . 0.53 ' HA ' ' O ' ' B' ' 67' ' ' LEU . 7.6 t60 -114.66 124.49 51.95 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.053 177.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 41.8 mt -88.26 135.89 24.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 170.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.491 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 45.2 p -123.64 -5.2 8.14 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -170.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . 179.86 155.17 14.68 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 119.188 -1.482 . . . . 0.0 113.538 175.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.452 HG23 ' HG ' ' B' ' 87' ' ' LEU . 11.9 p -136.85 132.75 47.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 174.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.76 156.51 42.45 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 121.937 -0.477 . . . . 0.0 111.6 -176.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.629 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.1 pp -123.82 145.43 49.08 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.541 0.686 . . . . 0.0 111.038 177.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -110.02 -52.1 2.81 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.719 174.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -102.93 127.38 50.16 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 169.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.456 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 151.9 156.79 7.62 Favored Glycine 0 N--CA 1.437 -1.253 0 C-N-CA 119.756 -1.211 . . . . 0.0 113.366 177.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 38' ' ' GLN . . . . . 0.479 ' HA ' ' HB2' ' B' ' 58' ' ' LYS . 94.9 mt-30 -102.36 -44.34 5.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.692 0.282 . . . . 0.0 111.091 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -152.95 128.77 10.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.561 0.22 . . . . 0.0 111.339 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.472 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -128.16 113.08 15.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.539 0.685 . . . . 0.0 109.916 167.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' B' ' 79' ' ' THR . 28.6 mmmt -94.57 109.31 21.22 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.509 HD23 ' HB ' ' B' ' 53' ' ' VAL . 48.6 tp -82.08 109.44 16.4 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -174.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -112.2 136.41 51.66 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.072 177.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.694 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 0.1 OUTLIER -123.94 121.67 35.9 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.478 175.465 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -109.82 111.24 22.55 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.968 178.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.536 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -128.75 139.28 52.28 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.602 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 56.63 35.61 26.37 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.746 0.654 . . . . 0.0 110.358 -177.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.435 ' HB3' ' NZ ' ' B' ' 48' ' ' LYS . 9.1 mtpm? 63.57 32.38 14.1 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.277 178.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.553 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 59.3 tp60 -128.37 133.85 48.72 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 175.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -88.94 121.78 31.65 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -177.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -116.67 123.44 47.27 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.461 176.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -75.39 106.66 5.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 169.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.613 ' CG2' ' HB3' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -84.15 -46.42 17.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.535 -172.299 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.553 ' HB2' HD21 ' B' ' 65' ' ' LEU . . . -153.92 149.41 27.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.715 -177.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 53.2 m -113.0 101.67 9.69 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 169.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 56' ' ' VAL . . . . . 0.437 HG13 ' HB3' ' B' ' 40' ' ' ALA . 7.7 p -115.78 114.35 45.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.578 0.704 . . . . 0.0 109.249 -179.028 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 45.0 p -122.59 -179.18 4.13 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.195 -172.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 58' ' ' LYS . . . . . 0.479 ' HB2' ' HA ' ' B' ' 38' ' ' GLN . 58.0 tttt -58.66 -32.33 69.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.747 171.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.37 -40.87 22.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.928 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 84.0 mt -108.31 86.69 3.52 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.16 0.21 8.74 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.731 2.288 . . . . 0.0 113.807 -166.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -164.52 131.05 3.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.326 0.584 . . . . 0.0 111.528 -175.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 92.9 t -121.95 112.17 33.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.348 174.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.56 131.54 41.83 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 174.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.553 HD21 ' HB2' ' B' ' 54' ' ' ALA . 86.1 mt -124.2 168.12 13.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.46 0.648 . . . . 0.0 112.226 -173.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 66' ' ' ASP . . . . . 0.484 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 18.6 t0 -142.4 99.44 3.5 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.396 169.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' B' ' 28' ' ' HIS . 2.3 mt -129.34 144.27 51.17 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 68' ' ' ASN . . . . . 0.436 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 5.9 t30 -141.98 114.89 8.65 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.836 176.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -111.03 146.89 35.92 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.552 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.416 ' HB2' ' HA ' ' A' ' 7' ' ' MET . 21.9 t -97.83 166.7 11.34 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 71' ' ' LYS . . . . . 0.415 ' HA ' HG22 ' B' ' 23' ' ' ILE . 21.6 ptmt -75.53 2.11 12.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.208 0.528 . . . . 0.0 110.568 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.11 -7.78 51.82 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.336 172.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -93.24 138.68 31.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.183 0.516 . . . . 0.0 110.493 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -122.17 116.95 25.07 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.536 HG22 ' HB2' ' B' ' 46' ' ' ALA . 14.9 pt -128.41 162.86 34.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.243 0.545 . . . . 0.0 111.983 -168.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.491 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 4.9 mtm -120.08 125.8 49.18 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.389 172.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 77' ' ' PHE . . . . . 0.694 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.8 OUTLIER -109.64 127.08 54.3 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.64 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.709 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 53.2 p90 -155.43 139.23 16.19 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.983 -175.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.581 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 3.0 p -111.59 134.16 53.36 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.404 -176.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 80' ' ' ALA . . . . . 0.427 ' HB3' ' HB2' ' B' ' 41' ' ' LYS . . . -100.64 157.03 16.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.518 175.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.91 178.96 46.04 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -176.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -108.08 102.91 12.03 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.971 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.472 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -168.76 150.88 4.88 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.47 170.069 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 15.9 t -109.76 121.89 46.26 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.629 HG12 ' HB3' ' B' ' 34' ' ' LEU . 7.0 m -117.79 155.29 19.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.415 0.626 . . . . 0.0 112.331 -173.221 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 49.3 m -120.64 122.44 40.49 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.583 173.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.579 HD11 ' SD ' ' B' ' 13' ' ' MET . 4.7 mp -96.02 145.71 25.23 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 170.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.528 HD13 ' O ' ' B' ' 87' ' ' LEU . 1.2 mm? -120.96 150.2 41.48 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 173.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.21 -167.89 27.55 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.327 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 90' ' ' TYR . . . . . 0.435 ' CD2' ' HB3' ' C' ' 68' ' ' ASN . 3.4 p90 -147.53 129.22 15.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.755 0.788 . . . . 0.0 112.166 177.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 91' ' ' LEU . . . . . 0.792 HD23 ' HB3' ' B' ' 27' ' ' PHE . 15.8 mt . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 113.949 -1.478 . . . . 0.0 109.766 176.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 7' ' ' MET . . . . . 0.422 ' HA ' ' HB2' ' D' ' 70' ' ' SER . 56.4 mtp . . . . . 0 CA--C 1.521 -0.144 0 CA-C-O 120.973 0.416 . . . . 0.0 111.289 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 8' ' ' PHE . . . . . 0.594 ' CE1' HD21 ' D' ' 44' ' ' LEU . 48.8 t80 -66.35 145.47 55.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.101 -176.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 9' ' ' TRP . . . . . 0.559 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 90.2 t90 -132.71 146.02 51.52 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.046 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.13 146.69 16.35 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.1 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.559 ' HB2' ' CH2' ' C' ' 9' ' ' TRP . 63.5 tp -134.29 109.0 8.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.032 0.444 . . . . 0.0 110.468 178.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -91.44 107.66 19.36 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.583 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 13' ' ' MET . . . . . 0.572 ' SD ' HD11 ' C' ' 87' ' ' LEU . 53.5 mtp -102.21 143.61 31.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.322 0.582 . . . . 0.0 111.496 -174.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -100.8 151.46 37.6 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.205 -177.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 15' ' ' PRO . . . . . 0.463 ' HB3' ' N ' ' C' ' 83' ' ' ALA . 11.2 Cg_endo -55.01 113.89 1.61 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 123.152 2.568 . . . . 0.0 112.796 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 16' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' C' ' 79' ' ' THR . 17.4 mt-10 59.96 70.97 0.6 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.46 0.648 . . . . 0.0 111.328 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.24 142.97 32.67 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.554 174.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 18' ' ' LYS . . . . . 0.703 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 35.2 ttmt -116.69 117.42 29.76 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.323 -176.078 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 19' ' ' TYR . . . . . 0.426 ' OH ' ' HA ' ' C' ' 13' ' ' MET . 1.9 m-85 -110.38 122.33 47.43 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 20' ' ' SER . . . . . 0.458 ' HB3' ' SD ' ' C' ' 76' ' ' MET . 6.1 p -102.59 99.84 9.87 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 169.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 19.8 pm0 -117.78 143.05 46.6 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.611 0.72 . . . . 0.0 112.163 -174.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 12.9 t -93.36 160.76 14.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.532 176.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 23' ' ' ILE . . . . . 0.404 HG22 ' HA ' ' C' ' 71' ' ' LYS . 70.3 mt -112.54 119.35 60.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.141 0.495 . . . . 0.0 111.531 -173.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 24' ' ' ILE . . . . . 0.414 HD12 ' N ' ' C' ' 25' ' ' LYS . 1.7 pp -99.6 -11.51 8.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.022 177.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 25' ' ' LYS . . . . . 0.414 ' N ' HD12 ' C' ' 24' ' ' ILE . 84.7 tttt -148.02 119.46 7.91 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 31.7 p -61.57 140.46 58.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.688 -175.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 27' ' ' PHE . . . . . 0.806 ' HB3' HD23 ' C' ' 91' ' ' LEU . 42.6 p90 -152.04 162.86 40.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.652 0.739 . . . . 0.0 112.969 -175.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 28' ' ' HIS . . . . . 0.538 ' HA ' ' O ' ' C' ' 67' ' ' LEU . 7.5 t60 -114.81 124.58 52.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.01 177.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 29' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 41.6 mt -88.32 135.92 24.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 170.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.502 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 44.9 p -123.59 -5.31 8.16 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -170.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 31' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . 179.89 155.09 14.49 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 119.181 -1.485 . . . . 0.0 113.547 176.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.463 HG23 ' HG ' ' C' ' 87' ' ' LEU . 12.0 p -136.8 132.84 48.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 174.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.82 156.52 42.45 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 121.952 -0.468 . . . . 0.0 111.589 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.625 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.1 pp -123.82 145.45 49.06 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.514 0.673 . . . . 0.0 111.044 177.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -110.03 -52.14 2.81 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.703 174.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -102.9 127.41 50.11 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 169.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 37' ' ' GLY . . . . . 0.465 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 151.86 156.76 7.6 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 119.848 -1.168 . . . . 0.0 113.46 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 38' ' ' GLN . . . . . 0.478 ' HA ' ' HB2' ' C' ' 58' ' ' LYS . 95.0 mt-30 -102.4 -44.34 5.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.642 0.258 . . . . 0.0 111.059 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -152.91 128.82 10.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.57 0.224 . . . . 0.0 111.361 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.471 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -128.24 112.94 15.05 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.524 0.678 . . . . 0.0 109.972 168.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' C' ' 79' ' ' THR . 28.7 mmmt -94.57 109.32 21.23 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 176.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.508 HD23 ' HB ' ' C' ' 53' ' ' VAL . 48.5 tp -82.08 109.46 16.42 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -174.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -112.3 136.4 51.78 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.071 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.7 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 0.1 OUTLIER -123.88 121.79 36.29 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.478 175.463 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 45' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -109.85 111.14 22.38 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.968 178.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.532 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -128.7 139.39 52.25 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.607 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 56.5 35.75 26.49 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 123.728 0.643 . . . . 0.0 110.304 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 48' ' ' LYS . . . . . 0.426 ' HB3' ' NZ ' ' C' ' 48' ' ' LYS . 9.1 mtpm? 63.64 32.2 14.05 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.253 178.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 49' ' ' GLN . . . . . 0.554 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 59.5 tp60 -128.23 133.88 48.9 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 175.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -88.99 121.69 31.61 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -116.66 123.43 47.26 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.453 176.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -75.4 106.72 5.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 53' ' ' VAL . . . . . 0.608 ' CG2' ' HB3' ' C' ' 44' ' ' LEU . 0.7 OUTLIER -84.2 -46.41 17.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.553 -172.351 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 54' ' ' ALA . . . . . 0.552 ' HB2' HD21 ' C' ' 65' ' ' LEU . . . -153.97 149.44 27.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.696 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 52.6 m -112.96 101.6 9.63 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 169.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 56' ' ' VAL . . . . . 0.44 HG13 ' HB3' ' C' ' 40' ' ' ALA . 7.8 p -115.69 114.33 45.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.517 0.675 . . . . 0.0 109.298 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 44.3 p -122.62 -179.17 4.13 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.205 -172.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 58' ' ' LYS . . . . . 0.478 ' HB2' ' HA ' ' C' ' 38' ' ' GLN . 57.9 tttt -58.52 -32.35 68.76 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.745 171.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.38 -41.03 22.57 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.851 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 83.9 mt -108.22 86.7 3.46 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 174.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.19 0.2 8.77 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.74 2.293 . . . . 0.0 113.786 -166.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -164.46 131.12 3.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.245 0.545 . . . . 0.0 111.576 -175.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 94.0 t -122.03 112.18 33.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.303 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.67 131.48 41.69 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 65' ' ' LEU . . . . . 0.552 HD21 ' HB2' ' C' ' 54' ' ' ALA . 86.2 mt -124.17 168.17 13.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.46 0.648 . . . . 0.0 112.265 -173.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 66' ' ' ASP . . . . . 0.461 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 18.5 t0 -142.46 99.46 3.5 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.964 -1.017 . . . . 0.0 108.332 169.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' C' ' 28' ' ' HIS . 2.3 mt -129.42 144.29 51.19 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 68' ' ' ASN . . . . . 0.435 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 5.9 t30 -141.86 114.95 8.74 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.762 176.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -111.17 146.88 36.1 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.529 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 21.9 t -97.81 166.62 11.38 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 71' ' ' LYS . . . . . 0.404 ' HA ' HG22 ' C' ' 23' ' ' ILE . 21.6 ptmt -75.46 2.08 12.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.215 0.531 . . . . 0.0 110.588 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.15 -7.7 51.87 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.253 172.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -93.27 138.7 31.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.123 0.487 . . . . 0.0 110.428 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -122.24 116.97 25.06 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 175.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.532 HG22 ' HB2' ' C' ' 46' ' ' ALA . 15.0 pt -128.51 162.73 34.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.259 0.552 . . . . 0.0 112.014 -168.262 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.486 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 4.8 mtm -119.92 125.69 49.08 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.475 172.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 77' ' ' PHE . . . . . 0.7 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.8 OUTLIER -109.66 127.11 54.33 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 176.635 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 78' ' ' TYR . . . . . 0.703 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 53.3 p90 -155.42 139.21 16.18 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.862 -0.735 . . . . 0.0 112.079 -176.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 79' ' ' THR . . . . . 0.577 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 3.0 p -111.56 134.22 53.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.42 -176.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 80' ' ' ALA . . . . . 0.436 ' HB3' ' HB2' ' C' ' 41' ' ' LYS . . . -100.71 157.1 16.94 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.522 175.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.81 178.93 46.2 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -176.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -108.06 102.98 12.1 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.064 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 83' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -168.79 150.77 4.82 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.504 170.11 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 15.8 t -109.72 121.93 46.34 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.625 HG12 ' HB3' ' C' ' 34' ' ' LEU . 6.9 m -117.78 155.3 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 CA-C-O 121.344 0.592 . . . . 0.0 112.353 -173.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 49.9 m -120.62 122.41 40.45 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.573 173.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 87' ' ' LEU . . . . . 0.572 HD11 ' SD ' ' C' ' 13' ' ' MET . 4.7 mp -96.0 145.72 25.21 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 170.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 88' ' ' LEU . . . . . 0.521 HD13 ' O ' ' C' ' 87' ' ' LEU . 1.2 mm? -121.0 150.31 41.32 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 173.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.31 -167.96 27.77 Favored Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.249 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 90' ' ' TYR . . . . . 0.447 ' CD2' ' HB3' ' D' ' 68' ' ' ASN . 3.3 p90 -147.52 129.24 15.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.785 0.802 . . . . 0.0 112.086 177.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 91' ' ' LEU . . . . . 0.806 HD23 ' HB3' ' C' ' 27' ' ' PHE . 15.9 mt . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 113.911 -1.495 . . . . 0.0 109.761 176.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 56.7 mtp . . . . . 0 CA--C 1.52 -0.183 0 CA-C-O 121.03 0.443 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 8' ' ' PHE . . . . . 0.592 ' CE1' HD21 ' E' ' 44' ' ' LEU . 48.6 t80 -66.5 145.55 55.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.1 -176.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 9' ' ' TRP . . . . . 0.556 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 90.2 t90 -132.75 146.02 51.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.013 179.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.11 146.71 16.41 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.125 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 11' ' ' LEU . . . . . 0.556 ' HB2' ' CH2' ' D' ' 9' ' ' TRP . 63.4 tp -134.31 108.95 8.5 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.031 0.443 . . . . 0.0 110.558 178.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -91.38 107.67 19.37 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.566 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 13' ' ' MET . . . . . 0.575 ' SD ' HD11 ' D' ' 87' ' ' LEU . 54.0 mtp -102.3 143.77 31.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.429 0.633 . . . . 0.0 111.408 -174.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -100.84 151.44 37.61 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.203 -177.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 15' ' ' PRO . . . . . 0.473 ' HB3' ' N ' ' D' ' 83' ' ' ALA . 11.1 Cg_endo -55.06 113.9 1.62 Allowed 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 123.119 2.546 . . . . 0.0 112.754 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 16' ' ' GLU . . . . . 0.57 ' HA ' ' O ' ' D' ' 79' ' ' THR . 17.3 mt-10 60.02 70.83 0.61 Allowed 'General case' 0 C--O 1.233 0.207 0 O-C-N 123.711 0.632 . . . . 0.0 111.36 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.13 142.97 32.81 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.516 174.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 18' ' ' LYS . . . . . 0.702 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 35.3 ttmt -116.69 117.44 29.81 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.373 -176.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 19' ' ' TYR . . . . . 0.426 ' OH ' ' HA ' ' D' ' 13' ' ' MET . 1.9 m-85 -110.29 122.38 47.52 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 20' ' ' SER . . . . . 0.462 ' HB3' ' SD ' ' D' ' 76' ' ' MET . 5.9 p -102.63 99.86 9.88 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 169.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 19.8 pm0 -117.76 142.98 46.66 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.516 0.674 . . . . 0.0 112.215 -174.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 13.0 t -93.24 160.77 14.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.609 176.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 70.1 mt -112.6 119.49 60.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.217 0.532 . . . . 0.0 111.449 -173.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 24' ' ' ILE . . . . . 0.409 HD12 ' N ' ' D' ' 25' ' ' LYS . 1.7 pp -99.7 -11.59 8.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.005 177.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 25' ' ' LYS . . . . . 0.409 ' N ' HD12 ' D' ' 24' ' ' ILE . 84.7 tttt -147.99 119.55 7.97 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 31.3 p -61.75 140.51 58.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.691 -175.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 27' ' ' PHE . . . . . 0.806 ' HB3' HD23 ' D' ' 91' ' ' LEU . 42.8 p90 -152.08 162.82 40.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.712 0.768 . . . . 0.0 112.898 -174.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 28' ' ' HIS . . . . . 0.53 ' HA ' ' O ' ' D' ' 67' ' ' LEU . 7.7 t60 -114.81 124.58 52.1 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.011 176.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 29' ' ' ILE . . . . . 0.513 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 42.1 mt -88.33 135.88 24.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 170.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 30' ' ' SER . . . . . 0.504 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 44.6 p -123.59 -5.28 8.16 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -170.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 31' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . 179.94 155.12 14.6 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 119.175 -1.488 . . . . 0.0 113.544 176.003 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.473 HG23 ' HG ' ' D' ' 87' ' ' LEU . 12.0 p -136.84 132.84 48.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 174.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.83 156.46 42.36 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.918 -0.489 . . . . 0.0 111.598 -176.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 34' ' ' LEU . . . . . 0.624 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.1 pp -123.77 145.43 49.04 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.538 0.685 . . . . 0.0 111.069 177.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -110.13 -51.93 2.83 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.706 174.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -103.02 127.4 50.28 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 169.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 37' ' ' GLY . . . . . 0.47 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 151.81 156.81 7.62 Favored Glycine 0 N--CA 1.437 -1.253 0 C-N-CA 119.811 -1.185 . . . . 0.0 113.384 177.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 38' ' ' GLN . . . . . 0.49 ' HA ' ' HB2' ' D' ' 58' ' ' LYS . 95.0 mt-30 -102.43 -44.41 5.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.662 0.267 . . . . 0.0 111.053 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -152.87 128.84 10.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.327 178.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 40' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -128.22 113.08 15.23 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.557 0.694 . . . . 0.0 109.884 168.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' D' ' 79' ' ' THR . 28.6 mmmt -94.6 109.35 21.27 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 176.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.51 HD23 ' HB ' ' D' ' 53' ' ' VAL . 48.5 tp -82.13 109.49 16.49 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -174.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -112.22 136.34 51.77 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.123 177.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.704 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.1 OUTLIER -123.91 121.78 36.24 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.498 175.427 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 45' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -109.91 111.16 22.39 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.915 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.532 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -128.72 139.39 52.24 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.567 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 56.57 35.72 26.5 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 123.654 0.596 . . . . 0.0 110.207 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 48' ' ' LYS . . . . . 0.431 ' HB3' ' NZ ' ' D' ' 48' ' ' LYS . 9.1 mtpm? 63.6 32.32 14.08 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.276 178.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 49' ' ' GLN . . . . . 0.558 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 59.5 tp60 -128.3 133.98 48.84 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -89.1 121.79 31.78 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -177.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -116.72 123.4 47.12 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.442 176.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -75.42 106.71 5.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 169.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 53' ' ' VAL . . . . . 0.61 ' CG2' ' HB3' ' D' ' 44' ' ' LEU . 0.7 OUTLIER -84.09 -46.44 18.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.599 -172.392 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 54' ' ' ALA . . . . . 0.55 ' HB2' HD21 ' D' ' 65' ' ' LEU . . . -153.89 149.38 27.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.728 -177.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 53.0 m -112.93 101.64 9.68 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 169.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 56' ' ' VAL . . . . . 0.444 HG13 ' HB3' ' D' ' 40' ' ' ALA . 7.8 p -115.71 114.37 46.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.605 0.716 . . . . 0.0 109.254 -179.094 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 44.7 p -122.65 -179.23 4.15 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.13 -172.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 58' ' ' LYS . . . . . 0.49 ' HB2' ' HA ' ' D' ' 38' ' ' GLN . 57.9 tttt -58.61 -32.3 68.87 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.721 171.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.38 -40.94 22.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.862 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 84.7 mt -108.33 86.68 3.53 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 175.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.11 0.23 8.7 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.79 2.327 . . . . 0.0 113.845 -166.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -164.52 131.07 3.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.342 0.591 . . . . 0.0 111.526 -175.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 93.5 t -122.09 112.24 33.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.308 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.64 131.56 41.8 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 174.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 65' ' ' LEU . . . . . 0.55 HD21 ' HB2' ' D' ' 54' ' ' ALA . 86.3 mt -124.2 168.16 13.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.559 0.695 . . . . 0.0 112.188 -173.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 66' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 18.6 t0 -142.44 99.46 3.5 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.319 169.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' D' ' 28' ' ' HIS . 2.3 mt -129.47 144.27 51.18 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 68' ' ' ASN . . . . . 0.447 ' HB3' ' CD2' ' C' ' 90' ' ' TYR . 5.9 t30 -141.88 114.9 8.7 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.538 -0.465 . . . . 0.0 109.805 176.143 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -111.06 146.86 36.0 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.569 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 70' ' ' SER . . . . . 0.422 ' HB2' ' HA ' ' C' ' 7' ' ' MET . 21.8 t -97.78 166.7 11.35 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -75.54 2.15 12.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.195 0.522 . . . . 0.0 110.583 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.14 -7.76 51.77 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.271 172.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -93.28 138.76 31.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.159 0.504 . . . . 0.0 110.489 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -122.3 116.98 25.02 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 175.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.532 HG22 ' HB2' ' D' ' 46' ' ' ALA . 14.9 pt -128.5 162.72 34.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.135 0.493 . . . . 0.0 112.051 -168.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 76' ' ' MET . . . . . 0.496 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 4.9 mtm -120.03 125.67 48.92 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.458 172.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 77' ' ' PHE . . . . . 0.704 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.8 OUTLIER -109.63 127.18 54.35 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.639 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 78' ' ' TYR . . . . . 0.702 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 53.3 p90 -155.52 139.2 16.07 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 119.814 -0.755 . . . . 0.0 112.006 -175.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 79' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 2.9 p -111.62 134.22 53.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.415 -176.14 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 80' ' ' ALA . . . . . 0.412 ' HB3' ' HB2' ' D' ' 41' ' ' LYS . . . -100.66 157.19 16.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.499 175.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.69 178.99 46.35 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -108.1 103.0 12.11 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 117.784 0.792 . . . . 0.0 110.013 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 83' ' ' ALA . . . . . 0.49 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -168.92 150.73 4.68 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.46 170.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 15.3 t -109.64 121.85 46.14 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.624 HG12 ' HB3' ' D' ' 34' ' ' LEU . 6.9 m -117.78 155.3 19.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.442 0.639 . . . . 0.0 112.288 -173.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 49.6 m -120.71 122.42 40.38 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.519 173.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 87' ' ' LEU . . . . . 0.575 HD11 ' SD ' ' D' ' 13' ' ' MET . 4.7 mp -96.0 145.72 25.21 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 170.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.521 HD13 ' O ' ' D' ' 87' ' ' LEU . 1.1 mm? -121.0 150.28 41.38 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.25 -167.89 27.6 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.25 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 90' ' ' TYR . . . . . 0.422 ' CD2' ' HB3' ' E' ' 68' ' ' ASN . 3.4 p90 -147.46 129.25 15.24 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.769 0.795 . . . . 0.0 112.115 177.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 91' ' ' LEU . . . . . 0.806 HD23 ' HB3' ' D' ' 27' ' ' PHE . 15.8 mt . . . . . 0 C--N 1.325 -0.461 0 CA-C-N 113.901 -1.5 . . . . 0.0 109.759 176.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 56.4 mtp . . . . . 0 CA--C 1.52 -0.195 0 CA-C-O 121.089 0.471 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' E' E ' 8' ' ' PHE . . . . . 0.641 ' CE1' HD21 ' A' ' 44' ' ' LEU . 48.6 t80 -66.5 145.51 55.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.074 -176.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 9' ' ' TRP . . . . . 0.555 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 90.4 t90 -132.71 146.03 51.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.006 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.1 146.65 16.28 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.195 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 11' ' ' LEU . . . . . 0.555 ' HB2' ' CH2' ' E' ' 9' ' ' TRP . 63.5 tp -134.15 109.05 8.65 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.945 0.402 . . . . 0.0 110.502 178.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -91.48 107.69 19.38 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 13' ' ' MET . . . . . 0.576 ' SD ' HD11 ' E' ' 87' ' ' LEU . 53.9 mtp -102.3 143.71 31.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.419 0.628 . . . . 0.0 111.445 -174.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -100.85 151.46 37.61 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.149 -177.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 15' ' ' PRO . . . . . 0.462 ' HB3' ' N ' ' E' ' 83' ' ' ALA . 11.1 Cg_endo -55.14 113.95 1.64 Allowed 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 123.188 2.592 . . . . 0.0 112.697 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 16' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' E' ' 79' ' ' THR . 17.4 mt-10 59.87 70.95 0.6 Allowed 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.426 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.14 142.92 32.79 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.56 174.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 18' ' ' LYS . . . . . 0.688 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 35.3 ttmt -116.6 117.46 29.92 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.322 -176.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 19' ' ' TYR . . . . . 0.424 ' OH ' ' HA ' ' E' ' 13' ' ' MET . 1.9 m-85 -110.35 122.24 47.21 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 20' ' ' SER . . . . . 0.459 ' HB3' ' SD ' ' E' ' 76' ' ' MET . 6.1 p -102.46 99.8 9.87 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 169.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 19.8 pm0 -117.79 143.07 46.59 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.628 0.728 . . . . 0.0 112.242 -174.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 13.0 t -93.36 160.77 14.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.551 176.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 23' ' ' ILE . . . . . 0.406 HG22 ' HA ' ' E' ' 71' ' ' LYS . 69.9 mt -112.5 119.38 60.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.065 0.46 . . . . 0.0 111.579 -173.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 24' ' ' ILE . . . . . 0.407 HD12 ' N ' ' E' ' 25' ' ' LYS . 1.7 pp -99.6 -11.51 8.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.051 177.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 25' ' ' LYS . . . . . 0.407 ' N ' HD12 ' E' ' 24' ' ' ILE . 84.7 tttt -148.07 119.55 7.93 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 31.3 p -61.73 140.49 58.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.648 -175.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 27' ' ' PHE . . . . . 0.805 ' HB3' HD23 ' E' ' 91' ' ' LEU . 42.9 p90 -152.08 162.78 40.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.793 0.806 . . . . 0.0 112.907 -174.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 28' ' ' HIS . . . . . 0.539 ' HA ' ' O ' ' E' ' 67' ' ' LEU . 7.7 t60 -114.67 124.59 52.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.981 177.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 29' ' ' ILE . . . . . 0.508 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 42.2 mt -88.32 135.87 24.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 170.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 30' ' ' SER . . . . . 0.492 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 45.1 p -123.55 -5.31 8.18 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -170.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 31' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . 179.91 155.11 14.56 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 119.123 -1.513 . . . . 0.0 113.572 175.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.463 HG23 ' HG ' ' E' ' 87' ' ' LEU . 12.0 p -136.81 132.82 48.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 174.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.75 156.49 42.43 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 121.92 -0.487 . . . . 0.0 111.571 -176.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 34' ' ' LEU . . . . . 0.622 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.1 pp -123.81 145.52 49.0 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.607 0.718 . . . . 0.0 111.031 177.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -110.09 -52.07 2.81 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.977 -1.011 . . . . 0.0 108.683 174.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -102.98 127.31 50.27 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 169.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 37' ' ' GLY . . . . . 0.463 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 151.92 156.78 7.62 Favored Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 119.754 -1.212 . . . . 0.0 113.389 177.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 38' ' ' GLN . . . . . 0.495 ' HA ' ' HB2' ' E' ' 58' ' ' LYS . 94.9 mt-30 -102.39 -44.39 5.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.658 0.266 . . . . 0.0 111.094 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -152.88 128.81 10.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.411 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 40' ' ' ALA . . . . . 0.466 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -128.19 113.01 15.15 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.476 0.655 . . . . 0.0 109.89 168.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 41' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' E' ' 79' ' ' THR . 28.7 mmmt -94.59 109.34 21.26 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.503 HD23 ' HB ' ' E' ' 53' ' ' VAL . 48.1 tp -82.08 109.51 16.47 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -174.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -112.24 136.3 51.84 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.067 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 44' ' ' LEU . . . . . 0.689 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 0.1 OUTLIER -123.88 121.71 36.07 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.459 175.457 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' E' E ' 45' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -109.82 111.16 22.43 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.003 178.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 46' ' ' ALA . . . . . 0.532 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -128.77 139.32 52.25 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.513 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 56.56 35.75 26.53 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 123.688 0.618 . . . . 0.0 110.225 -177.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 48' ' ' LYS . . . . . 0.424 ' HB3' ' NZ ' ' E' ' 48' ' ' LYS . 9.1 mtpm? 63.66 32.28 13.94 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.221 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 49' ' ' GLN . . . . . 0.562 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 59.2 tp60 -128.25 133.9 48.88 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 175.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -89.03 121.74 31.68 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -116.65 123.38 47.14 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.496 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -75.27 106.65 5.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 169.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 53' ' ' VAL . . . . . 0.607 ' CG2' ' HB3' ' E' ' 44' ' ' LEU . 0.7 OUTLIER -84.25 -46.36 17.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.508 -172.313 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' E' E ' 54' ' ' ALA . . . . . 0.569 ' HB2' HD21 ' E' ' 65' ' ' LEU . . . -153.91 149.4 27.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.664 -177.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 52.6 m -112.93 101.7 9.74 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 169.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 56' ' ' VAL . . . . . 0.446 HG13 ' HB3' ' E' ' 40' ' ' ALA . 7.7 p -115.8 114.32 45.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.579 0.704 . . . . 0.0 109.212 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 45.0 p -122.59 -179.17 4.13 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.194 -172.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 58' ' ' LYS . . . . . 0.495 ' HB2' ' HA ' ' E' ' 38' ' ' GLN . 58.2 tttt -58.62 -32.23 68.83 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.783 171.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.42 -40.95 22.61 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.885 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 84.1 mt -108.3 86.64 3.49 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 174.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.09 0.18 8.75 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.756 2.304 . . . . 0.0 113.848 -166.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -164.45 131.18 3.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.289 0.566 . . . . 0.0 111.551 -175.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 94.2 t -122.08 112.21 33.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.281 174.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.57 131.5 41.79 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 65' ' ' LEU . . . . . 0.569 HD21 ' HB2' ' E' ' 54' ' ' ALA . 86.3 mt -124.23 168.08 13.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.496 0.665 . . . . 0.0 112.283 -173.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 66' ' ' ASP . . . . . 0.475 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 18.5 t0 -142.41 99.49 3.51 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.383 170.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 67' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' E' ' 28' ' ' HIS . 2.3 mt -129.46 144.3 51.2 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 68' ' ' ASN . . . . . 0.422 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 5.8 t30 -141.91 114.92 8.7 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.558 -0.457 . . . . 0.0 109.783 176.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -111.12 146.84 36.1 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.535 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 21.9 t -97.7 166.71 11.36 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 71' ' ' LYS . . . . . 0.406 ' HA ' HG22 ' E' ' 23' ' ' ILE . 21.6 ptmt -75.59 2.17 12.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.229 0.537 . . . . 0.0 110.531 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.14 -7.79 51.73 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.305 172.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -93.25 138.71 31.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.108 0.48 . . . . 0.0 110.463 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -122.22 116.9 24.96 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 75' ' ' ILE . . . . . 0.532 HG22 ' HB2' ' E' ' 46' ' ' ALA . 14.9 pt -128.38 162.73 34.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.219 0.533 . . . . 0.0 112.029 -168.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 76' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 4.9 mtm -119.97 125.72 49.09 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 172.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 77' ' ' PHE . . . . . 0.689 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.8 OUTLIER -109.64 127.22 54.39 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 176.576 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' E' E ' 78' ' ' TYR . . . . . 0.688 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 53.2 p90 -155.55 139.21 16.05 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 119.79 -0.764 . . . . 0.0 112.001 -175.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 79' ' ' THR . . . . . 0.568 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 3.0 p -111.58 134.23 53.3 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.389 -176.143 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 80' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' E' ' 41' ' ' LYS . . . -100.7 157.16 16.9 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.537 175.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.79 179.01 46.2 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -176.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -108.17 102.93 12.04 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 119.714 -0.794 . . . . 0.0 110.044 178.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 83' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -168.8 150.83 4.82 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.436 170.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 15.5 t -109.76 121.89 46.25 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 85' ' ' VAL . . . . . 0.622 HG12 ' HB3' ' E' ' 34' ' ' LEU . 6.9 m -117.77 155.32 19.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.398 0.618 . . . . 0.0 112.311 -173.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 49.3 m -120.67 122.43 40.45 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.542 173.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 87' ' ' LEU . . . . . 0.576 HD11 ' SD ' ' E' ' 13' ' ' MET . 4.7 mp -96.07 145.77 25.2 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 170.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 88' ' ' LEU . . . . . 0.526 HD13 ' O ' ' E' ' 87' ' ' LEU . 1.2 mm? -120.96 150.25 41.39 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 173.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.31 -167.91 27.69 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.363 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 90' ' ' TYR . . . . . 0.437 ' CD2' ' HB3' ' A' ' 68' ' ' ASN . 3.4 p90 -147.49 129.24 15.19 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.758 0.789 . . . . 0.0 112.126 177.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 91' ' ' LEU . . . . . 0.805 HD23 ' HB3' ' E' ' 27' ' ' PHE . 15.8 mt . . . . . 0 C--N 1.326 -0.454 0 CA-C-N 113.838 -1.528 . . . . 0.0 109.814 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.409 ' HG2' ' OG ' ' B' ' 70' ' ' SER . 58.8 mtt . . . . . 0 C--O 1.224 -0.273 0 CA-C-O 120.68 0.276 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.521 ' CE1' HD21 ' B' ' 44' ' ' LEU . 77.1 t80 -59.77 140.29 56.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -172.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.449 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 87.4 t90 -132.73 146.74 52.1 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.549 178.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.414 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -151.61 152.69 24.41 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.261 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.731 HD23 HD13 ' A' ' 87' ' ' LEU . 59.3 tp -140.45 106.7 5.24 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 178.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -86.31 100.92 12.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.502 0.667 . . . . 0.0 109.755 175.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.471 ' HB3' HG23 ' A' ' 85' ' ' VAL . 3.7 ttt -94.65 134.22 37.46 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.142 -168.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.476 ' HB2' ' HG3' ' A' ' 17' ' ' ARG . 2.5 mptp? -100.28 149.57 36.17 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.811 -178.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.515 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 12.2 Cg_endo -56.43 122.32 11.59 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.122 2.548 . . . . 0.0 112.987 -178.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 79' ' ' THR . 44.9 mt-10 61.53 51.79 3.93 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.564 177.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.476 ' HG3' ' HB2' ' A' ' 14' ' ' LYS . 29.0 mmt180 -117.57 145.52 44.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.131 173.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.695 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 40.5 tttt -123.28 109.82 14.43 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 123.505 0.503 . . . . 0.0 110.551 -176.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.447 ' HE2' ' HG3' ' A' ' 13' ' ' MET . 3.4 m-85 -110.02 104.31 13.18 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.356 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.467 ' HB3' ' SD ' ' A' ' 76' ' ' MET . 13.8 p -84.99 99.45 11.0 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -113.41 143.99 43.55 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.568 0.699 . . . . 0.0 112.002 -168.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.3 p -96.43 157.35 15.94 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.612 174.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.442 ' CD1' ' HB3' ' A' ' 69' ' ' PHE . 54.1 mt -115.1 116.64 53.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.347 0.594 . . . . 0.0 111.18 -175.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.478 ' N ' HD12 ' A' ' 24' ' ' ILE . 3.9 mp -93.34 -40.97 12.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.101 178.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.8 pttt -123.88 128.22 49.16 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.586 176.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.8 p -64.65 141.83 58.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.259 -174.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.828 ' HB3' HD23 ' A' ' 91' ' ' LEU . 39.8 p90 -142.08 152.52 43.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.745 0.783 . . . . 0.0 112.226 -177.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.627 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 6.1 t60 -108.24 120.52 42.6 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.354 173.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 35.1 mt -84.51 133.65 28.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 170.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.545 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 56.0 p -120.43 -6.87 9.78 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.683 0.278 . . . . 0.0 111.64 -173.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.15 158.32 25.84 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 119.455 -1.355 . . . . 0.0 113.622 176.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.497 HG23 ' HG ' ' A' ' 87' ' ' LEU . 13.2 p -140.43 127.24 22.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 172.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.16 152.87 41.48 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 121.972 -0.455 . . . . 0.0 111.389 -175.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.606 ' HB3' HG12 ' A' ' 85' ' ' VAL . 3.7 pp -117.82 145.88 44.25 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.787 0.803 . . . . 0.0 111.733 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -106.73 -55.99 2.25 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.894 175.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -102.59 128.03 49.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.049 170.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.458 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 153.23 158.53 8.6 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 119.437 -1.363 . . . . 0.0 113.892 175.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -101.76 -45.62 5.18 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.426 -0.387 . . . . 0.0 110.571 176.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.46 ' HG3' HG22 ' A' ' 57' ' ' THR . 32.7 tt0 -153.14 123.01 6.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.091 -178.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.554 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -121.88 114.13 20.6 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.44 0.638 . . . . 0.0 110.033 170.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 79' ' ' THR . 13.7 mmmm -97.18 105.51 17.67 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.6 tp -83.71 111.47 19.19 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -174.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.546 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 79.9 m-85 -114.9 149.95 36.4 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 175.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.557 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -135.47 128.01 30.63 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.616 172.125 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -105.89 112.22 25.18 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.09 178.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.567 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -127.92 133.23 49.25 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.395 178.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 59.42 38.23 22.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.48 0.657 . . . . 0.0 109.629 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt 62.37 35.27 15.11 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.717 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.574 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 23.5 tp60 -130.18 118.23 21.1 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -81.63 108.29 15.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.878 0.371 . . . . 0.0 110.86 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.456 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 87.5 m-85 -99.87 133.41 44.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.519 177.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -80.14 104.65 8.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 168.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.481 HG21 ' HB3' ' A' ' 44' ' ' LEU . 3.2 t -79.68 -50.32 18.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.696 -172.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.6 ' HB2' HD21 ' A' ' 65' ' ' LEU . . . -153.46 147.22 25.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.656 -176.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.5 m -110.95 101.28 9.86 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 171.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.48 HG13 ' HB3' ' A' ' 40' ' ' ALA . 7.2 p -119.65 113.52 41.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.62 0.724 . . . . 0.0 109.741 -177.153 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.46 HG22 ' HG3' ' A' ' 39' ' ' GLU . 65.2 p -123.28 -178.42 3.98 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.684 -174.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -61.89 -23.01 66.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.908 0.385 . . . . 0.0 110.463 170.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.435 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -84.35 -40.87 17.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.245 0.545 . . . . 0.0 110.15 178.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.2 mt -112.75 82.62 5.14 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 11.5 Cg_exo -70.8 -0.38 7.68 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.06 2.506 . . . . 0.0 113.868 -167.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -162.99 127.0 2.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.339 0.59 . . . . 0.0 111.416 -176.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 87.0 t -116.38 121.92 68.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.399 174.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.43 127.63 32.99 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.973 176.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.6 HD21 ' HB2' ' A' ' 54' ' ' ALA . 91.0 mt -119.92 168.45 11.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.401 0.62 . . . . 0.0 112.226 -174.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 14.2 t0 -145.72 97.59 3.0 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 172.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.668 HD21 HD23 ' E' ' 88' ' ' LEU . 6.7 mt -133.54 110.0 9.63 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.797 -174.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.452 ' HB2' ' CG ' ' E' ' 90' ' ' TYR . 6.3 m-20 -103.82 113.92 27.8 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.442 ' HB3' ' CD1' ' A' ' 23' ' ' ILE . 86.0 m-85 -109.04 136.92 47.76 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.829 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.413 ' OG ' ' HG2' ' E' ' 7' ' ' MET . 87.8 p -97.35 166.69 11.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.744 0.307 . . . . 0.0 110.21 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -73.05 -4.89 35.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.919 0.39 . . . . 0.0 110.893 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.67 -9.16 58.96 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 174.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -88.49 140.3 29.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.929 0.395 . . . . 0.0 110.06 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -126.33 114.53 18.37 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 175.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.567 HG22 ' HB2' ' A' ' 46' ' ' ALA . 13.1 pt -131.03 158.7 43.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.053 0.454 . . . . 0.0 112.059 -166.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.494 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 3.6 mtm -119.19 123.92 45.51 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 174.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.557 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 1.1 m-85 -104.24 128.63 52.01 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.695 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 25.9 p90 -151.92 134.97 15.75 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.453 0.644 . . . . 0.0 112.488 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 2.6 p -108.94 130.58 55.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.748 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.9 164.72 11.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.439 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.57 -174.03 44.41 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -177.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -113.43 102.74 10.61 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.023 178.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.554 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -173.62 153.55 2.3 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.551 171.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.9 t -114.84 126.41 54.78 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.606 HG12 ' HB3' ' A' ' 34' ' ' LEU . 6.7 m -120.74 157.54 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-O 121.141 0.496 . . . . 0.0 112.144 -172.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.4 m -117.09 119.01 33.93 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.549 -0.75 . . . . 0.0 108.979 171.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.731 HD13 HD23 ' A' ' 11' ' ' LEU . 5.1 mp -89.78 145.33 25.27 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 170.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.708 HD23 HD21 ' B' ' 67' ' ' LEU . 0.8 OUTLIER -129.97 141.39 50.77 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.929 -177.756 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.82 -167.56 26.63 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.292 -177.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.486 ' CG ' ' HB2' ' B' ' 68' ' ' ASN . 13.7 p90 -150.29 129.6 12.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 122.093 0.949 . . . . 0.0 112.102 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.828 HD23 ' HB3' ' A' ' 27' ' ' PHE . 7.9 mt . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.778 176.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 7' ' ' MET . . . . . 0.401 ' HG2' ' OG ' ' C' ' 70' ' ' SER . 58.9 mtt . . . . . 0 C--O 1.222 -0.367 0 CA-C-O 120.737 0.303 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 8' ' ' PHE . . . . . 0.532 ' CE1' HD21 ' C' ' 44' ' ' LEU . 77.0 t80 -59.98 140.35 56.8 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -172.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 9' ' ' TRP . . . . . 0.449 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 87.3 t90 -132.74 146.74 52.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.547 178.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.439 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -151.65 152.69 24.41 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.262 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.739 HD23 HD13 ' B' ' 87' ' ' LEU . 59.7 tp -140.48 106.75 5.25 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -86.3 100.85 12.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.612 0.72 . . . . 0.0 109.785 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 13' ' ' MET . . . . . 0.465 ' HB3' HG23 ' B' ' 85' ' ' VAL . 3.7 ttt -94.61 134.24 37.39 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.68 -1.146 . . . . 0.0 111.059 -168.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.471 ' HB2' ' HG3' ' B' ' 17' ' ' ARG . 2.5 mptp? -100.43 149.45 36.1 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.788 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.517 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 12.2 Cg_endo -56.33 122.33 11.58 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.131 2.554 . . . . 0.0 112.965 -178.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' B' ' 79' ' ' THR . 44.8 mt-10 61.51 51.83 3.93 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.506 177.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.471 ' HG3' ' HB2' ' B' ' 14' ' ' LYS . 29.0 mmt180 -117.57 145.5 44.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.141 173.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.713 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 40.6 tttt -123.22 109.87 14.52 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 123.465 0.478 . . . . 0.0 110.513 -176.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 19' ' ' TYR . . . . . 0.434 ' HE2' ' HG3' ' B' ' 13' ' ' MET . 3.3 m-85 -110.09 104.36 13.22 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.289 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.462 ' HB3' ' SD ' ' B' ' 76' ' ' MET . 13.6 p -85.12 99.49 11.09 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 171.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -113.33 144.03 43.45 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.522 0.677 . . . . 0.0 112.019 -168.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 13.7 p -96.43 157.27 15.98 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.627 174.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.428 ' CD1' ' HB3' ' B' ' 69' ' ' PHE . 53.7 mt -115.06 116.56 52.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.335 0.588 . . . . 0.0 111.227 -175.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.479 ' N ' HD12 ' B' ' 24' ' ' ILE . 3.9 mp -93.27 -40.91 12.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.262 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 24.9 pttt -123.83 128.15 49.09 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.651 176.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 62.3 p -64.62 141.73 58.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.311 -174.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' PHE . . . . . 0.834 ' HB3' HD23 ' B' ' 91' ' ' LEU . 39.3 p90 -142.09 152.51 43.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.71 0.767 . . . . 0.0 112.231 -177.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 28' ' ' HIS . . . . . 0.639 ' HA ' ' O ' ' B' ' 67' ' ' LEU . 6.2 t60 -108.1 120.53 42.59 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.428 173.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.548 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 35.2 mt -84.6 133.55 29.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 170.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.548 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 56.4 p -120.29 -6.97 9.84 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.598 -173.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.13 158.31 25.82 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 119.462 -1.352 . . . . 0.0 113.555 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.496 HG23 ' HG ' ' B' ' 87' ' ' LEU . 13.2 p -140.36 127.33 22.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 172.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.2 152.85 41.42 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.958 -0.464 . . . . 0.0 111.342 -175.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.617 ' HB3' HG12 ' B' ' 85' ' ' VAL . 3.7 pp -117.89 145.79 44.38 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.791 0.805 . . . . 0.0 111.728 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -106.58 -56.21 2.22 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.859 175.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -102.43 127.98 49.23 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.096 170.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.455 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 153.2 158.53 8.59 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 119.393 -1.384 . . . . 0.0 113.893 175.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -101.77 -45.66 5.16 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.399 -0.4 . . . . 0.0 110.498 176.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.444 ' HG3' HG22 ' B' ' 57' ' ' THR . 32.9 tt0 -153.07 123.02 6.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.109 -178.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -121.88 114.22 20.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.539 0.685 . . . . 0.0 110.007 170.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' B' ' 79' ' ' THR . 13.7 mmmm -97.2 105.44 17.59 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 49.3 tp -83.65 111.51 19.19 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -174.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 43' ' ' TYR . . . . . 0.552 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 79.9 m-85 -114.9 149.96 36.38 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 175.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.564 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 0.2 OUTLIER -135.49 128.13 30.83 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.612 172.03 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.575 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -105.99 111.99 24.86 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.187 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.581 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -127.76 133.35 49.48 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.409 178.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 59.31 38.2 23.24 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.564 0.697 . . . . 0.0 109.743 -176.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt 62.3 35.39 15.24 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.637 178.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.575 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 23.1 tp60 -130.18 118.24 21.11 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 178.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -81.69 108.39 15.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.927 0.394 . . . . 0.0 110.799 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.414 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 86.9 m-85 -99.86 133.33 44.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.59 177.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -80.11 104.67 8.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 168.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.488 HG21 ' HB3' ' B' ' 44' ' ' LEU . 3.2 t -79.64 -50.32 18.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.779 -172.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.591 ' HB2' HD21 ' B' ' 65' ' ' LEU . . . -153.38 147.17 25.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.686 -176.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 31.1 m -110.96 101.26 9.84 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 171.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 56' ' ' VAL . . . . . 0.465 HG13 ' HB3' ' B' ' 40' ' ' ALA . 7.1 p -119.6 113.48 41.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.6 0.714 . . . . 0.0 109.844 -177.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.444 HG22 ' HG3' ' B' ' 39' ' ' GLU . 65.5 p -123.2 -178.38 3.96 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.73 -174.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -62.06 -22.86 66.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.045 0.45 . . . . 0.0 110.514 170.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.424 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -84.41 -40.82 17.34 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.19 0.519 . . . . 0.0 110.195 178.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 80.8 mt -112.69 82.59 5.05 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 61' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 11.4 Cg_exo -70.78 -0.36 7.64 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.022 2.482 . . . . 0.0 113.907 -168.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -163.04 127.03 2.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.383 0.611 . . . . 0.0 111.392 -176.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 87.6 t -116.34 121.91 68.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.418 174.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.53 127.67 33.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.01 176.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.591 HD21 ' HB2' ' B' ' 54' ' ' ALA . 90.8 mt -119.93 168.47 11.1 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.371 0.605 . . . . 0.0 112.114 -174.151 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 66' ' ' ASP . . . . . 0.531 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 14.4 t0 -145.72 97.6 3.0 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 172.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.708 HD21 HD23 ' A' ' 88' ' ' LEU . 6.7 mt -133.58 110.08 9.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.723 -174.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 68' ' ' ASN . . . . . 0.486 ' HB2' ' CG ' ' A' ' 90' ' ' TYR . 6.4 m-20 -103.86 113.82 27.62 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 176.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 69' ' ' PHE . . . . . 0.428 ' HB3' ' CD1' ' B' ' 23' ' ' ILE . 85.6 m-85 -108.92 136.9 47.7 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.861 178.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.409 ' OG ' ' HG2' ' A' ' 7' ' ' MET . 87.9 p -97.29 166.66 11.45 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.783 0.325 . . . . 0.0 110.191 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -72.96 -5.04 35.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.006 0.432 . . . . 0.0 110.868 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.52 -9.18 59.13 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.611 -0.595 . . . . 0.0 111.611 174.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -88.42 140.24 29.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.903 0.382 . . . . 0.0 110.108 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -126.3 114.54 18.4 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.581 HG22 ' HB2' ' B' ' 46' ' ' ALA . 13.2 pt -131.0 158.7 43.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.074 0.464 . . . . 0.0 111.995 -166.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.505 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 3.7 mtm -119.19 124.03 45.8 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 174.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 77' ' ' PHE . . . . . 0.564 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 1.1 m-85 -104.38 128.65 52.27 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.713 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 25.9 p90 -151.95 134.99 15.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.474 0.654 . . . . 0.0 112.494 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 2.6 p -108.9 130.62 55.44 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.707 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.97 164.79 11.53 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.524 176.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.37 -174.02 44.76 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -177.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -113.33 102.74 10.63 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 119.726 -0.789 . . . . 0.0 110.031 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -173.67 153.55 2.28 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.548 171.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 18.8 t -114.77 126.42 54.82 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.617 HG12 ' HB3' ' B' ' 34' ' ' LEU . 6.7 m -120.81 157.58 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-O 121.116 0.484 . . . . 0.0 112.139 -172.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 67.1 m -117.12 119.02 33.96 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 171.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.739 HD13 HD23 ' B' ' 11' ' ' LEU . 5.2 mp -89.78 145.38 25.22 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 170.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.687 HD23 HD21 ' C' ' 67' ' ' LEU . 0.8 OUTLIER -130.04 141.35 50.74 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.465 -0.789 . . . . 0.0 108.888 -177.697 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.82 -167.53 26.59 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.275 -178.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 90' ' ' TYR . . . . . 0.443 ' CG ' ' HB2' ' C' ' 68' ' ' ASN . 13.8 p90 -150.24 129.52 12.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 122.02 0.914 . . . . 0.0 112.154 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 91' ' ' LEU . . . . . 0.834 HD23 ' HB3' ' B' ' 27' ' ' PHE . 8.0 mt . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 113.626 -1.624 . . . . 0.0 110.898 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 7' ' ' MET . . . . . 0.401 ' HG2' ' OG ' ' D' ' 70' ' ' SER . 58.8 mtt . . . . . 0 C--O 1.224 -0.279 0 CA-C-O 120.677 0.275 . . . . 0.0 110.985 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 8' ' ' PHE . . . . . 0.546 ' CE1' HD21 ' D' ' 44' ' ' LEU . 77.4 t80 -59.9 140.27 56.79 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -172.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 9' ' ' TRP . . . . . 0.441 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 87.3 t90 -132.63 146.79 52.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.555 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 10' ' ' GLY . . . . . 0.44 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -151.61 152.71 24.43 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.289 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.714 HD23 HD13 ' C' ' 87' ' ' LEU . 59.5 tp -140.5 106.79 5.25 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -86.3 100.82 12.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.599 0.714 . . . . 0.0 109.8 175.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 13' ' ' MET . . . . . 0.464 ' HB3' HG23 ' C' ' 85' ' ' VAL . 3.7 ttt -94.56 134.25 37.32 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.078 -168.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 14' ' ' LYS . . . . . 0.457 ' HB2' ' HG3' ' C' ' 17' ' ' ARG . 2.5 mptp? -100.38 149.5 36.13 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.8 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 15' ' ' PRO . . . . . 0.517 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 12.3 Cg_endo -56.29 122.25 11.45 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 123.191 2.594 . . . . 0.0 113.011 -178.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 16' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' C' ' 79' ' ' THR . 44.8 mt-10 61.49 51.84 3.95 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.543 177.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 17' ' ' ARG . . . . . 0.457 ' HG3' ' HB2' ' C' ' 14' ' ' LYS . 28.9 mmt180 -117.52 145.57 44.15 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.132 173.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 18' ' ' LYS . . . . . 0.706 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 40.7 tttt -123.41 109.89 14.44 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 123.479 0.487 . . . . 0.0 110.513 -176.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 19' ' ' TYR . . . . . 0.448 ' HE2' ' HG3' ' C' ' 13' ' ' MET . 3.4 m-85 -110.09 104.29 13.14 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.342 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 20' ' ' SER . . . . . 0.474 ' HB3' ' SD ' ' C' ' 76' ' ' MET . 13.5 p -84.97 99.37 10.94 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 171.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -113.29 144.05 43.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.577 0.703 . . . . 0.0 112.064 -169.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 13.3 p -96.59 157.3 15.96 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.592 174.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 23' ' ' ILE . . . . . 0.442 ' CD1' ' HB3' ' C' ' 69' ' ' PHE . 53.8 mt -115.03 116.6 53.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.296 0.57 . . . . 0.0 111.16 -175.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 24' ' ' ILE . . . . . 0.481 ' N ' HD12 ' C' ' 24' ' ' ILE . 3.9 mp -93.26 -41.09 12.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.16 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 25.0 pttt -123.85 128.21 49.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.616 176.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 62.1 p -64.63 141.71 58.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.227 -174.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 27' ' ' PHE . . . . . 0.844 ' HB3' HD23 ' C' ' 91' ' ' LEU . 39.5 p90 -142.0 152.51 43.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.672 0.748 . . . . 0.0 112.23 -177.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 28' ' ' HIS . . . . . 0.634 ' HA ' ' O ' ' C' ' 67' ' ' LEU . 6.1 t60 -108.14 120.55 42.65 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.418 -1.264 . . . . 0.0 109.382 173.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 29' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 35.2 mt -84.59 133.59 28.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 170.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.548 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 56.1 p -120.41 -6.77 9.79 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.645 0.259 . . . . 0.0 111.639 -173.091 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.13 158.4 25.99 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 119.471 -1.347 . . . . 0.0 113.595 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.493 HG23 ' HG ' ' C' ' 87' ' ' LEU . 13.0 p -140.38 127.22 22.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.23 152.83 41.38 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.569 -0.453 . . . . 0.0 111.326 -175.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.621 ' HB3' HG12 ' C' ' 85' ' ' VAL . 3.7 pp -117.8 145.8 44.28 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 121.809 0.814 . . . . 0.0 111.792 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -106.58 -56.17 2.23 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.869 175.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -102.47 127.99 49.28 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.065 170.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 37' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 153.25 158.44 8.56 Favored Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 119.39 -1.386 . . . . 0.0 113.902 175.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -101.76 -45.6 5.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.484 -0.358 . . . . 0.0 110.545 176.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 39' ' ' GLU . . . . . 0.447 ' HG3' HG22 ' C' ' 57' ' ' THR . 32.8 tt0 -153.09 122.99 6.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.079 -178.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.569 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -121.88 114.23 20.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.518 0.675 . . . . 0.0 110.02 170.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' C' ' 79' ' ' THR . 13.7 mmmm -97.27 105.43 17.57 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.062 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 49.7 tp -83.66 111.48 19.17 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -174.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 43' ' ' TYR . . . . . 0.546 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 79.8 m-85 -114.86 149.93 36.35 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.566 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 0.2 OUTLIER -135.46 128.17 30.96 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.589 172.069 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 45' ' ' ALA . . . . . 0.569 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -105.97 112.0 24.87 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.116 178.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.579 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -127.8 133.41 49.43 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.368 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 59.25 38.23 23.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.53 0.681 . . . . 0.0 109.763 -176.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt 62.3 35.21 15.36 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.751 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 49' ' ' GLN . . . . . 0.569 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 23.4 tp60 -130.04 118.28 21.32 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -81.74 108.36 15.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.969 0.414 . . . . 0.0 110.769 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 51' ' ' TYR . . . . . 0.439 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 86.9 m-85 -99.79 133.39 44.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.627 177.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -80.12 104.57 8.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 168.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 53' ' ' VAL . . . . . 0.486 HG21 ' HB3' ' C' ' 44' ' ' LEU . 3.2 t -79.56 -50.44 18.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.652 -172.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 54' ' ' ALA . . . . . 0.592 ' HB2' HD21 ' C' ' 65' ' ' LEU . . . -153.37 147.17 25.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.723 -176.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 31.4 m -110.93 101.29 9.87 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 171.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 56' ' ' VAL . . . . . 0.474 HG13 ' HB3' ' C' ' 40' ' ' ALA . 7.2 p -119.6 113.47 41.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.513 0.673 . . . . 0.0 109.821 -177.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 57' ' ' THR . . . . . 0.447 HG22 ' HG3' ' C' ' 39' ' ' GLU . 66.0 p -123.24 -178.45 3.99 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.74 -174.12 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -61.99 -22.97 66.12 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.14 0.495 . . . . 0.0 110.43 171.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 59' ' ' ALA . . . . . 0.433 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -84.3 -40.76 17.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.19 0.519 . . . . 0.0 110.275 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 80.7 mt -112.8 82.5 5.11 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 174.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 61' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 11.4 Cg_exo -70.8 -0.2 7.41 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.997 2.465 . . . . 0.0 113.889 -167.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -163.12 127.04 2.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.325 0.583 . . . . 0.0 111.437 -176.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 86.2 t -116.38 122.02 68.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.345 174.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.49 127.54 32.93 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.131 175.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 65' ' ' LEU . . . . . 0.592 HD21 ' HB2' ' C' ' 54' ' ' ALA . 91.1 mt -119.76 168.45 11.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.471 0.653 . . . . 0.0 112.21 -174.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 66' ' ' ASP . . . . . 0.489 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 14.4 t0 -145.76 97.6 2.99 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 172.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.687 HD21 HD23 ' B' ' 88' ' ' LEU . 6.7 mt -133.54 110.0 9.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.772 -174.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 68' ' ' ASN . . . . . 0.443 ' HB2' ' CG ' ' B' ' 90' ' ' TYR . 6.4 m-20 -103.92 113.82 27.63 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 69' ' ' PHE . . . . . 0.442 ' HB3' ' CD1' ' C' ' 23' ' ' ILE . 86.0 m-85 -109.0 136.87 47.81 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.779 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 70' ' ' SER . . . . . 0.401 ' OG ' ' HG2' ' B' ' 7' ' ' MET . 88.1 p -97.24 166.66 11.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.745 0.307 . . . . 0.0 110.235 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -73.12 -4.83 35.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.015 0.436 . . . . 0.0 110.901 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.55 -9.27 59.02 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 174.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -88.28 140.23 29.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.893 0.378 . . . . 0.0 110.115 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -126.33 114.49 18.31 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 175.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.579 HG22 ' HB2' ' C' ' 46' ' ' ALA . 13.3 pt -131.07 158.67 43.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.047 0.451 . . . . 0.0 112.034 -166.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.498 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 3.7 mtm -119.22 123.97 45.61 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 77' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 1.1 m-85 -104.29 128.55 52.09 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 78' ' ' TYR . . . . . 0.706 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 25.9 p90 -151.87 134.96 15.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.419 0.628 . . . . 0.0 112.511 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 79' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 2.6 p -108.85 130.56 55.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.769 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.87 164.84 11.51 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.522 176.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.41 -173.98 44.64 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -177.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -113.38 102.77 10.65 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.031 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 83' ' ' ALA . . . . . 0.569 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -173.67 153.48 2.27 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.534 171.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 18.6 t -114.76 126.41 54.81 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.621 HG12 ' HB3' ' C' ' 34' ' ' LEU . 6.6 m -120.8 157.58 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 CA-C-O 121.213 0.53 . . . . 0.0 112.114 -172.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 66.6 m -117.04 119.02 33.99 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 171.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 87' ' ' LEU . . . . . 0.714 HD13 HD23 ' C' ' 11' ' ' LEU . 5.2 mp -89.75 145.29 25.3 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 170.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 88' ' ' LEU . . . . . 0.681 HD23 HD21 ' D' ' 67' ' ' LEU . 0.8 OUTLIER -130.01 141.46 50.74 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.438 -0.801 . . . . 0.0 108.913 -177.837 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.93 -167.59 26.79 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.331 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 90' ' ' TYR . . . . . 0.467 ' CG ' ' HB2' ' D' ' 68' ' ' ASN . 13.6 p90 -150.19 129.55 12.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 122.039 0.924 . . . . 0.0 112.109 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 91' ' ' LEU . . . . . 0.844 HD23 ' HB3' ' C' ' 27' ' ' PHE . 8.0 mt . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.826 176.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 7' ' ' MET . . . . . 0.435 ' HG2' ' OG ' ' E' ' 70' ' ' SER . 58.9 mtt . . . . . 0 C--O 1.224 -0.286 0 CA-C-O 120.748 0.309 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 8' ' ' PHE . . . . . 0.552 ' CE1' HD21 ' E' ' 44' ' ' LEU . 77.0 t80 -59.99 140.33 56.83 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -172.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 9' ' ' TRP . . . . . 0.447 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 87.3 t90 -132.76 146.68 52.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.552 178.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 10' ' ' GLY . . . . . 0.467 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -151.53 152.72 24.44 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.296 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 11' ' ' LEU . . . . . 0.736 HD23 HD13 ' D' ' 87' ' ' LEU . 59.8 tp -140.5 106.73 5.24 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -86.24 100.86 12.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.579 0.704 . . . . 0.0 109.743 175.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 13' ' ' MET . . . . . 0.471 ' HB3' HG23 ' D' ' 85' ' ' VAL . 3.7 ttt -94.67 134.21 37.5 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.085 -168.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 14' ' ' LYS . . . . . 0.469 ' HB2' ' HG3' ' D' ' 17' ' ' ARG . 2.5 mptp? -100.33 149.56 36.17 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.802 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 15' ' ' PRO . . . . . 0.518 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 12.3 Cg_endo -56.45 122.28 11.51 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.134 2.556 . . . . 0.0 113.013 -178.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 16' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' D' ' 79' ' ' THR . 44.9 mt-10 61.5 51.88 3.92 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.571 177.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 17' ' ' ARG . . . . . 0.469 ' HG3' ' HB2' ' D' ' 14' ' ' LYS . 28.9 mmt180 -117.58 145.56 44.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.133 173.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 18' ' ' LYS . . . . . 0.705 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 40.7 tttt -123.36 109.91 14.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 123.542 0.526 . . . . 0.0 110.524 -176.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 19' ' ' TYR . . . . . 0.431 ' HE2' ' HG3' ' D' ' 13' ' ' MET . 3.3 m-85 -110.04 104.38 13.26 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.323 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 20' ' ' SER . . . . . 0.469 ' HB3' ' SD ' ' D' ' 76' ' ' MET . 13.4 p -85.08 99.45 11.05 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 171.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -113.37 144.01 43.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.483 0.659 . . . . 0.0 112.053 -168.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 14.0 p -96.49 157.31 15.96 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.627 174.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 23' ' ' ILE . . . . . 0.444 ' CD1' ' HB3' ' D' ' 69' ' ' PHE . 53.9 mt -115.02 116.61 53.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.15 0.5 . . . . 0.0 111.168 -175.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 24' ' ' ILE . . . . . 0.483 HD12 ' N ' ' D' ' 24' ' ' ILE . 3.9 mp -93.34 -40.95 12.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.125 178.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -123.88 128.24 49.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.663 176.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 61.9 p -64.65 141.72 58.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.258 -174.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 27' ' ' PHE . . . . . 0.807 ' HB3' HD23 ' D' ' 91' ' ' LEU . 39.4 p90 -141.97 152.59 43.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.713 0.768 . . . . 0.0 112.153 -177.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 28' ' ' HIS . . . . . 0.635 ' HA ' ' O ' ' D' ' 67' ' ' LEU . 6.2 t60 -108.21 120.5 42.54 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.407 -1.27 . . . . 0.0 109.399 173.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 29' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 35.2 mt -84.57 133.55 29.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 170.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 30' ' ' SER . . . . . 0.548 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 56.8 p -120.3 -6.89 9.84 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.65 -173.093 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.08 158.41 26.05 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 119.481 -1.343 . . . . 0.0 113.566 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.498 HG23 ' HG ' ' D' ' 87' ' ' LEU . 13.3 p -140.48 127.27 22.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 172.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.17 152.94 41.58 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.332 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 34' ' ' LEU . . . . . 0.603 ' HB3' HG12 ' D' ' 85' ' ' VAL . 3.7 pp -117.93 145.88 44.36 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.798 0.808 . . . . 0.0 111.709 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -106.71 -56.03 2.25 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.226 -1.352 . . . . 0.0 108.819 175.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -102.53 127.95 49.37 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.099 170.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 37' ' ' GLY . . . . . 0.468 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 153.22 158.45 8.56 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 119.415 -1.374 . . . . 0.0 113.99 175.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -101.71 -45.65 5.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.786 0.327 . . . . 0.0 110.557 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 39' ' ' GLU . . . . . 0.45 ' HG3' HG22 ' D' ' 57' ' ' THR . 32.8 tt0 -153.05 123.01 6.94 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.117 -178.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 40' ' ' ALA . . . . . 0.561 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -121.88 114.09 20.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.406 0.622 . . . . 0.0 110.06 170.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' D' ' 79' ' ' THR . 13.7 mmmm -97.11 105.42 17.56 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 49.5 tp -83.59 111.44 19.11 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -174.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 43' ' ' TYR . . . . . 0.554 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 80.4 m-85 -114.87 149.96 36.32 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 175.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.566 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.2 OUTLIER -135.41 128.09 30.92 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.672 172.004 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 45' ' ' ALA . . . . . 0.569 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -105.92 112.17 25.12 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.156 178.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.569 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -127.84 133.34 49.37 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.344 178.12 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 59.3 38.14 23.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.558 0.694 . . . . 0.0 109.718 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt 62.41 35.24 15.0 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.683 178.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 49' ' ' GLN . . . . . 0.569 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 23.5 tp60 -130.06 118.26 21.26 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -81.62 108.3 15.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.909 0.385 . . . . 0.0 110.841 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 51' ' ' TYR . . . . . 0.44 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 87.3 m-85 -99.92 133.34 44.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.612 177.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 tp -80.13 104.73 8.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 169.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 53' ' ' VAL . . . . . 0.488 HG21 ' HB3' ' D' ' 44' ' ' LEU . 3.2 t -79.64 -50.3 18.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.698 -172.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 54' ' ' ALA . . . . . 0.589 ' HB2' HD21 ' D' ' 65' ' ' LEU . . . -153.44 147.16 25.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.711 -176.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 31.5 m -111.02 101.29 9.86 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 171.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 56' ' ' VAL . . . . . 0.477 HG13 ' HB3' ' D' ' 40' ' ' ALA . 7.2 p -119.67 113.5 41.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.545 0.688 . . . . 0.0 109.808 -177.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 57' ' ' THR . . . . . 0.45 HG22 ' HG3' ' D' ' 39' ' ' GLU . 67.5 p -123.24 -178.44 3.98 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.756 -174.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -61.97 -22.93 66.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.039 0.447 . . . . 0.0 110.522 170.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 59' ' ' ALA . . . . . 0.436 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -84.39 -40.82 17.36 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.253 0.549 . . . . 0.0 110.187 178.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 81.0 mt -112.76 82.63 5.16 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 174.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 61' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 11.5 Cg_exo -70.81 -0.29 7.56 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.063 2.508 . . . . 0.0 113.868 -168.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -163.11 127.0 2.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.315 0.579 . . . . 0.0 111.417 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 87.4 t -116.33 121.88 68.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.424 174.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.47 127.54 32.92 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.063 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 65' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' D' ' 54' ' ' ALA . 90.8 mt -119.76 168.52 10.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.477 0.656 . . . . 0.0 112.2 -174.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 66' ' ' ASP . . . . . 0.517 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 14.2 t0 -145.79 97.59 2.99 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 172.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.681 HD21 HD23 ' C' ' 88' ' ' LEU . 6.7 mt -133.62 109.95 9.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.776 -174.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 68' ' ' ASN . . . . . 0.467 ' HB2' ' CG ' ' C' ' 90' ' ' TYR . 6.4 m-20 -103.76 113.87 27.71 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 176.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 69' ' ' PHE . . . . . 0.444 ' HB3' ' CD1' ' D' ' 23' ' ' ILE . 86.1 m-85 -109.08 136.97 47.72 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.771 178.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 70' ' ' SER . . . . . 0.401 ' OG ' ' HG2' ' C' ' 7' ' ' MET . 88.1 p -97.28 166.61 11.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.741 0.305 . . . . 0.0 110.239 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -73.07 -4.87 35.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.023 0.439 . . . . 0.0 110.873 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.52 -9.32 59.02 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.584 -0.607 . . . . 0.0 111.584 174.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -88.37 140.16 29.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.861 0.362 . . . . 0.0 110.135 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -126.27 114.58 18.47 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.569 HG22 ' HB2' ' D' ' 46' ' ' ALA . 13.2 pt -131.02 158.74 43.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.132 0.491 . . . . 0.0 112.0 -166.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 76' ' ' MET . . . . . 0.493 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 3.6 mtm -119.23 123.97 45.61 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 174.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 77' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 1.1 m-85 -104.3 128.57 52.11 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 78' ' ' TYR . . . . . 0.705 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 25.7 p90 -151.86 134.94 15.78 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.47 0.652 . . . . 0.0 112.414 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 79' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 2.5 p -108.85 130.59 55.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.792 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.89 164.76 11.55 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.553 177.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.39 -174.11 44.8 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -113.27 102.64 10.54 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.06 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 83' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -173.65 153.51 2.28 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.531 171.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 18.9 t -114.84 126.5 54.89 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.603 HG12 ' HB3' ' D' ' 34' ' ' LEU . 6.6 m -120.94 157.48 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-O 121.161 0.505 . . . . 0.0 112.11 -172.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 66.5 m -116.95 118.97 33.91 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 171.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 87' ' ' LEU . . . . . 0.736 HD13 HD23 ' D' ' 11' ' ' LEU . 5.1 mp -89.77 145.4 25.21 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 170.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.678 HD23 HD21 ' E' ' 67' ' ' LEU . 0.8 OUTLIER -129.98 141.37 50.76 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.982 -177.797 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.81 -167.44 26.44 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.302 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 90' ' ' TYR . . . . . 0.462 ' CG ' ' HB2' ' E' ' 68' ' ' ASN . 13.6 p90 -150.33 129.55 12.79 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 122.102 0.954 . . . . 0.0 112.091 178.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 91' ' ' LEU . . . . . 0.807 HD23 ' HB3' ' D' ' 27' ' ' PHE . 8.1 mt . . . . . 0 C--N 1.322 -0.626 0 CA-C-N 113.621 -1.627 . . . . 0.0 110.839 176.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 7' ' ' MET . . . . . 0.413 ' HG2' ' OG ' ' A' ' 70' ' ' SER . 58.9 mtt . . . . . 0 C--O 1.223 -0.314 0 CA-C-O 120.787 0.327 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 8' ' ' PHE . . . . . 0.545 ' CE1' HD21 ' A' ' 44' ' ' LEU . 76.9 t80 -59.93 140.3 56.79 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -172.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 9' ' ' TRP . . . . . 0.439 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 87.4 t90 -132.74 146.76 52.11 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 10' ' ' GLY . . . . . 0.456 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -151.68 152.68 24.4 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.233 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 11' ' ' LEU . . . . . 0.74 HD23 HD13 ' E' ' 87' ' ' LEU . 60.0 tp -140.44 106.71 5.25 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 178.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -86.31 100.87 12.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.571 0.7 . . . . 0.0 109.72 175.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 13' ' ' MET . . . . . 0.471 ' HB3' HG23 ' E' ' 85' ' ' VAL . 3.7 ttt -94.64 134.23 37.44 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.667 -1.152 . . . . 0.0 111.102 -168.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 14' ' ' LYS . . . . . 0.473 ' HB2' ' HG3' ' E' ' 17' ' ' ARG . 2.5 mptp? -100.29 149.53 36.14 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.791 -178.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 15' ' ' PRO . . . . . 0.502 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 12.2 Cg_endo -56.48 122.38 11.69 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.146 2.564 . . . . 0.0 112.95 -178.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 16' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' E' ' 79' ' ' THR . 44.7 mt-10 61.43 51.93 3.96 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.502 177.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 17' ' ' ARG . . . . . 0.473 ' HG3' ' HB2' ' E' ' 14' ' ' LYS . 29.0 mmt180 -117.61 145.52 44.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.161 173.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 18' ' ' LYS . . . . . 0.713 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 40.6 tttt -123.34 109.84 14.42 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 123.505 0.503 . . . . 0.0 110.465 -176.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 19' ' ' TYR . . . . . 0.447 ' HE2' ' HG3' ' E' ' 13' ' ' MET . 3.4 m-85 -110.06 104.4 13.27 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.367 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 20' ' ' SER . . . . . 0.474 ' HB3' ' SD ' ' E' ' 76' ' ' MET . 13.5 p -85.08 99.43 11.04 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -113.39 144.13 43.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.596 0.712 . . . . 0.0 112.01 -168.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 13.9 p -96.51 157.3 15.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.623 174.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 23' ' ' ILE . . . . . 0.442 ' CD1' ' HB3' ' E' ' 69' ' ' PHE . 53.7 mt -115.02 116.47 52.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.218 0.532 . . . . 0.0 111.211 -175.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 24' ' ' ILE . . . . . 0.483 HD12 ' N ' ' E' ' 24' ' ' ILE . 3.9 mp -93.23 -40.93 12.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.205 178.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -123.87 128.16 49.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.582 176.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 62.2 p -64.6 141.72 58.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.247 -174.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 27' ' ' PHE . . . . . 0.845 ' HB3' HD23 ' E' ' 91' ' ' LEU . 40.0 p90 -142.09 152.53 43.38 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.727 0.775 . . . . 0.0 112.235 -177.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 28' ' ' HIS . . . . . 0.639 ' HA ' ' O ' ' E' ' 67' ' ' LEU . 6.3 t60 -108.15 120.5 42.52 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.397 173.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 29' ' ' ILE . . . . . 0.543 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 35.2 mt -84.56 133.56 28.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.129 -1.064 . . . . 0.0 108.129 170.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 30' ' ' SER . . . . . 0.541 ' HB3' ' HE2' ' E' ' 28' ' ' HIS . 56.8 p -120.35 -6.88 9.82 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -173.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.13 158.34 25.88 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 119.569 -1.3 . . . . 0.0 113.609 176.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.5 HG23 ' HG ' ' E' ' 87' ' ' LEU . 13.1 p -140.42 127.16 22.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 172.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.13 152.84 41.48 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 121.934 -0.478 . . . . 0.0 111.324 -175.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 34' ' ' LEU . . . . . 0.623 ' HB3' HG12 ' E' ' 85' ' ' VAL . 3.7 pp -117.78 145.87 44.2 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 121.739 0.781 . . . . 0.0 111.794 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -106.68 -56.09 2.24 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.855 175.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -102.47 127.94 49.3 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.113 170.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 37' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 153.29 158.46 8.57 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 119.368 -1.396 . . . . 0.0 113.911 175.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -101.72 -45.67 5.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.497 -0.352 . . . . 0.0 110.559 176.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 39' ' ' GLU . . . . . 0.45 ' HG3' HG22 ' E' ' 57' ' ' THR . 32.7 tt0 -153.1 123.0 6.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.052 -178.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 40' ' ' ALA . . . . . 0.567 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -121.87 114.17 20.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.515 0.674 . . . . 0.0 110.002 170.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 41' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' E' ' 79' ' ' THR . 13.7 mmmm -97.18 105.46 17.61 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 49.8 tp -83.71 111.49 19.2 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -174.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 43' ' ' TYR . . . . . 0.559 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 80.0 m-85 -114.86 149.98 36.26 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 175.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 44' ' ' LEU . . . . . 0.562 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 0.2 OUTLIER -135.58 128.13 30.66 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.532 172.082 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' E' E ' 45' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -105.92 112.1 25.01 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.151 178.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 46' ' ' ALA . . . . . 0.581 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -127.87 133.29 49.33 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.344 178.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 59.29 38.24 23.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.607 0.718 . . . . 0.0 109.698 -176.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt 62.44 35.23 14.94 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.652 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 49' ' ' GLN . . . . . 0.566 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 23.2 tp60 -130.14 118.23 21.14 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -81.7 108.25 15.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.965 0.412 . . . . 0.0 110.859 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 51' ' ' TYR . . . . . 0.467 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 87.1 m-85 -99.81 133.33 44.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.615 177.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -80.06 104.71 8.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 169.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 53' ' ' VAL . . . . . 0.492 HG21 ' HB3' ' E' ' 44' ' ' LEU . 3.2 t -79.68 -50.4 18.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.667 -172.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 54' ' ' ALA . . . . . 0.61 ' HB2' HD21 ' E' ' 65' ' ' LEU . . . -153.33 147.18 25.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.723 -176.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 31.2 m -110.89 101.17 9.78 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 171.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 56' ' ' VAL . . . . . 0.47 HG13 ' HB3' ' E' ' 40' ' ' ALA . 7.1 p -119.54 113.45 41.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.64 0.733 . . . . 0.0 109.895 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 57' ' ' THR . . . . . 0.45 HG22 ' HG3' ' E' ' 39' ' ' GLU . 66.4 p -123.21 -178.43 3.98 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.746 -174.073 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -61.91 -22.98 66.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.961 0.41 . . . . 0.0 110.501 170.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 59' ' ' ALA . . . . . 0.437 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -84.34 -40.8 17.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.182 178.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 80.8 mt -112.78 82.56 5.13 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 174.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 61' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 11.5 Cg_exo -70.82 -0.29 7.56 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.066 2.511 . . . . 0.0 113.88 -167.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -163.12 127.1 2.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.399 0.618 . . . . 0.0 111.397 -176.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 86.9 t -116.42 121.93 68.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.344 174.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.56 127.56 32.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.032 176.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 65' ' ' LEU . . . . . 0.61 HD21 ' HB2' ' E' ' 54' ' ' ALA . 90.8 mt -119.8 168.51 11.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.481 0.658 . . . . 0.0 112.184 -174.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 66' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 14.3 t0 -145.76 97.59 2.99 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 172.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 67' ' ' LEU . . . . . 0.678 HD21 HD23 ' D' ' 88' ' ' LEU . 6.7 mt -133.57 109.99 9.61 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.809 -174.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 68' ' ' ASN . . . . . 0.462 ' HB2' ' CG ' ' D' ' 90' ' ' TYR . 6.4 m-20 -103.84 113.87 27.71 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 69' ' ' PHE . . . . . 0.442 ' HB3' ' CD1' ' E' ' 23' ' ' ILE . 86.1 m-85 -109.1 136.98 47.71 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.721 178.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 70' ' ' SER . . . . . 0.435 ' OG ' ' HG2' ' D' ' 7' ' ' MET . 88.0 p -97.35 166.7 11.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.802 0.334 . . . . 0.0 110.17 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -73.19 -4.83 35.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.002 0.43 . . . . 0.0 110.843 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.6 -9.14 59.07 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 174.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -88.5 140.25 29.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.863 0.363 . . . . 0.0 110.059 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -126.32 114.47 18.29 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 75' ' ' ILE . . . . . 0.581 HG22 ' HB2' ' E' ' 46' ' ' ALA . 13.3 pt -131.04 158.71 43.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.104 0.478 . . . . 0.0 111.945 -166.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 76' ' ' MET . . . . . 0.495 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 3.7 mtm -119.28 123.97 45.55 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 174.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 77' ' ' PHE . . . . . 0.562 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 1.1 m-85 -104.28 128.61 52.08 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 78' ' ' TYR . . . . . 0.713 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 26.0 p90 -151.95 135.0 15.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.504 0.669 . . . . 0.0 112.442 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 79' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 2.6 p -108.99 130.54 55.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.767 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.85 164.76 11.55 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.51 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.44 -174.04 44.65 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -113.32 102.69 10.58 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.977 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 83' ' ' ALA . . . . . 0.567 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -173.7 153.56 2.27 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.536 171.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 18.9 t -114.84 126.42 54.8 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 85' ' ' VAL . . . . . 0.623 HG12 ' HB3' ' E' ' 34' ' ' LEU . 6.7 m -120.78 157.68 23.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-O 121.222 0.534 . . . . 0.0 112.075 -172.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 66.6 m -117.21 118.93 33.65 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 171.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 87' ' ' LEU . . . . . 0.74 HD13 HD23 ' E' ' 11' ' ' LEU . 5.1 mp -89.77 145.43 25.19 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 170.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 88' ' ' LEU . . . . . 0.668 HD23 HD21 ' A' ' 67' ' ' LEU . 0.8 OUTLIER -130.1 141.4 50.7 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.873 -177.738 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.87 -167.51 26.61 Favored Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.253 -178.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 90' ' ' TYR . . . . . 0.452 ' CG ' ' HB2' ' A' ' 68' ' ' ASN . 13.6 p90 -150.24 129.58 12.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 122.04 0.924 . . . . 0.0 112.06 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 91' ' ' LEU . . . . . 0.845 HD23 ' HB3' ' E' ' 27' ' ' PHE . 8.0 mt . . . . . 0 C--N 1.321 -0.669 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.81 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 52.4 ttm . . . . . 0 N--CA 1.455 -0.181 0 CA-C-O 121.008 0.432 . . . . 0.0 111.622 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.439 ' CE1' HD21 ' B' ' 44' ' ' LEU . 61.4 t80 -52.77 142.1 19.64 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.619 -177.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.555 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 88.5 t90 -135.71 147.72 48.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.876 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.46 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -148.72 153.82 25.46 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.007 178.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.652 HD23 HD13 ' A' ' 87' ' ' LEU . 52.1 tp -140.44 108.18 5.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.022 0.439 . . . . 0.0 110.881 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -81.25 101.49 9.76 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.538 173.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.592 ' HB3' HG23 ' A' ' 85' ' ' VAL . 30.6 tpp -95.48 131.26 41.83 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.148 -174.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -100.82 145.31 30.15 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.915 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.598 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 12.3 Cg_endo -56.01 124.54 16.51 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 123.397 2.731 . . . . 0.0 113.493 -174.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.556 ' HA ' ' O ' ' A' ' 79' ' ' THR . 25.3 mt-10 60.3 47.91 8.57 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.062 177.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -121.79 138.67 54.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.687 172.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.726 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 84.5 mttt -111.21 118.98 37.43 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.414 0.446 . . . . 0.0 111.519 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.61 103.91 12.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.827 176.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.41 ' HB3' ' SD ' ' A' ' 76' ' ' MET . 7.8 p -88.47 98.84 11.85 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 174.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -117.36 144.84 44.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.472 0.653 . . . . 0.0 112.273 -169.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.5 m -94.06 143.15 26.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.542 177.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.435 ' CG2' ' HA ' ' A' ' 71' ' ' LYS . 59.4 mt -92.81 120.35 42.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.066 0.46 . . . . 0.0 111.119 -174.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.1 mp -79.34 -52.9 14.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.351 178.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.493 ' HE2' ' HB3' ' A' ' 91' ' ' LEU . 13.5 ptmt -131.08 137.53 49.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.942 175.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.2 m -54.45 141.76 29.65 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.921 -176.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.666 ' HB3' HD23 ' A' ' 91' ' ' LEU . 11.9 p90 -149.06 158.26 44.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.655 0.741 . . . . 0.0 112.819 -175.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.608 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 9.2 t60 -111.41 127.41 55.67 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.392 -1.276 . . . . 0.0 109.745 178.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.573 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 35.0 mt -96.78 137.97 23.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 170.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.608 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 56.6 p -123.5 -20.42 5.57 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -171.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -153.88 156.34 26.74 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 119.273 -1.442 . . . . 0.0 113.578 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.5 HG23 ' HG ' ' A' ' 87' ' ' LEU . 14.8 p -146.51 124.39 4.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 172.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.19 155.68 44.0 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.75 -174.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.581 ' HB3' HG12 ' A' ' 85' ' ' VAL . 3.7 pp -120.39 140.55 51.17 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.914 0.864 . . . . 0.0 111.755 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -105.12 -53.6 2.63 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.334 -1.303 . . . . 0.0 108.788 174.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -102.91 127.44 50.12 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 169.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.485 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 151.22 156.03 7.21 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 119.784 -1.198 . . . . 0.0 113.608 177.03 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.44 ' HA ' ' HB2' ' A' ' 58' ' ' LYS . 91.0 mt-30 -102.66 -44.27 5.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.68 0.276 . . . . 0.0 111.053 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -153.12 126.41 8.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.095 176.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.564 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -124.51 113.16 17.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.563 0.697 . . . . 0.0 109.7 169.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 79' ' ' THR . 19.9 mtpp -96.06 107.05 19.31 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 41.2 tp -81.57 114.84 20.55 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -173.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.55 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 97.6 m-85 -120.49 139.46 52.86 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.271 177.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.51 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -125.15 133.27 52.87 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 172.67 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.631 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -112.04 113.07 25.14 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.156 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.53 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -124.47 137.8 54.4 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.416 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 59.7 30.72 20.33 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.473 0.483 . . . . 0.0 110.301 -174.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.479 ' HB2' ' NZ ' ' A' ' 48' ' ' LYS . 0.1 OUTLIER 62.57 33.6 15.74 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.14 -177.072 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.631 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 8.5 tp-100 -123.46 130.38 52.61 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.66 123.59 32.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.905 0.383 . . . . 0.0 110.769 -176.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.499 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 84.7 m-85 -118.02 130.08 55.96 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 175.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.09 103.77 7.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 171.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.546 ' CG1' HD11 ' A' ' 67' ' ' LEU . 2.6 t -78.7 -49.49 20.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.712 -171.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.462 ' HB1' HG11 ' A' ' 63' ' ' VAL . . . -158.38 146.58 18.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.852 -178.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.4 m -109.46 101.43 10.39 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 173.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.456 HG11 HG11 ' A' ' 85' ' ' VAL . 7.4 p -115.63 116.2 51.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.557 0.694 . . . . 0.0 109.565 -177.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 47.1 p -122.37 -179.13 4.09 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.335 -172.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.44 ' HB2' ' HA ' ' A' ' 38' ' ' GLN . 38.1 tttm -61.58 -27.38 68.59 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.892 172.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.487 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -84.24 -40.63 17.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.643 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.2 mt -109.45 83.99 2.82 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 174.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 9.7 Cg_exo -70.91 0.07 7.08 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.016 2.478 . . . . 0.0 113.762 -168.087 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -162.8 131.74 4.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.224 0.535 . . . . 0.0 111.254 -176.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.462 HG11 ' HB1' ' A' ' 54' ' ' ALA . 68.7 t -120.49 132.68 69.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.105 172.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.43 113.11 25.49 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.224 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -121.46 170.01 10.07 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.34 -176.489 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.549 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 7.2 t0 -118.33 98.76 6.44 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.245 0.545 . . . . 0.0 109.619 175.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.613 HD21 HD23 ' E' ' 88' ' ' LEU . 19.8 mt -112.98 143.49 44.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.873 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.451 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 57.2 t30 -147.81 119.96 8.3 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 120.942 0.401 . . . . 0.0 110.008 174.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -114.93 153.53 30.38 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.25 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.7 t -103.67 148.88 25.51 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.983 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.493 ' HB2' ' NZ ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -74.75 9.97 1.6 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -174.656 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.62 -15.21 30.04 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.865 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -101.28 170.82 7.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.77 0.319 . . . . 0.0 110.868 -175.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 61.9 ttt-85 -138.32 122.6 18.18 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.53 HG22 ' HB2' ' A' ' 46' ' ' ALA . 14.4 pt -125.69 160.86 31.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.431 -170.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.48 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 2.8 mtm -115.23 129.02 56.52 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 174.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.51 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -109.82 128.41 55.3 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.109 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.726 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 51.3 p90 -155.83 157.47 36.48 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 120.226 -0.59 . . . . 0.0 112.24 -177.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 14.8 p -124.81 144.0 50.51 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.264 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.42 156.63 18.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.981 174.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.01 -166.83 31.32 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -176.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -123.71 102.68 7.96 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 117.715 0.758 . . . . 0.0 110.42 176.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.598 ' H ' ' HB3' ' A' ' 15' ' ' PRO . . . -169.31 151.81 4.71 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.187 169.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.5 t -109.1 122.85 48.16 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.592 HG23 ' HB3' ' A' ' 13' ' ' MET . 6.7 m -119.78 147.12 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-O 121.266 0.555 . . . . 0.0 111.832 -173.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.0 t -111.01 119.34 38.72 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.652 HD13 HD23 ' A' ' 11' ' ' LEU . 5.2 mp -91.84 151.45 20.56 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 174.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.568 HD23 HD21 ' B' ' 67' ' ' LEU . 1.2 tp -133.0 140.3 47.69 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.301 -178.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.23 -166.75 24.72 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.992 -177.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.408 ' CD2' ' HB3' ' B' ' 68' ' ' ASN . 11.5 p90 -152.93 132.86 13.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.697 0.76 . . . . 0.0 111.839 176.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.666 HD23 ' HB3' ' A' ' 27' ' ' PHE . 15.2 mt . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.095 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 52.5 ttm . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 121.002 0.429 . . . . 0.0 111.582 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 8' ' ' PHE . . . . . 0.49 ' CE1' HD21 ' C' ' 44' ' ' LEU . 61.8 t80 -52.72 142.05 19.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.627 -177.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 9' ' ' TRP . . . . . 0.551 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 88.5 t90 -135.7 147.71 48.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.856 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.507 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -148.71 153.86 25.48 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.984 178.109 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.662 HD23 HD13 ' B' ' 87' ' ' LEU . 52.3 tp -140.46 108.13 5.63 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.086 0.47 . . . . 0.0 110.915 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -81.23 101.59 9.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.529 173.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 13' ' ' MET . . . . . 0.591 ' HB3' HG23 ' B' ' 85' ' ' VAL . 30.8 tpp -95.58 131.23 42.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.114 0.483 . . . . 0.0 111.151 -174.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -100.74 145.26 30.05 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.969 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.587 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 12.4 Cg_endo -56.09 124.67 16.82 Favored 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 123.445 2.763 . . . . 0.0 113.487 -174.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.549 ' HA ' ' O ' ' B' ' 79' ' ' THR . 25.3 mt-10 60.24 47.91 8.72 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.031 177.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -121.76 138.78 54.23 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.696 172.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.721 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 84.5 mttt -111.47 119.02 37.4 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 123.273 0.358 . . . . 0.0 111.491 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.67 103.86 12.47 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.766 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 7.3 p -88.48 98.87 11.87 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 174.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -117.39 144.81 44.57 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.538 0.685 . . . . 0.0 112.284 -169.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 17.7 m -94.06 143.11 26.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.523 177.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.445 ' CG2' ' HA ' ' B' ' 71' ' ' LYS . 59.3 mt -92.86 120.49 42.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.162 0.506 . . . . 0.0 111.117 -174.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.444 ' N ' HD12 ' B' ' 24' ' ' ILE . 4.0 mp -79.42 -52.89 14.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.286 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.502 ' HE2' ' HB3' ' B' ' 91' ' ' LEU . 13.5 ptmt -131.12 137.47 49.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.988 175.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 11.5 m -54.41 141.71 29.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.924 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 27' ' ' PHE . . . . . 0.66 ' HB3' HD23 ' B' ' 91' ' ' LEU . 12.1 p90 -149.03 158.28 44.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.685 0.755 . . . . 0.0 112.774 -175.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 28' ' ' HIS . . . . . 0.598 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 9.2 t60 -111.39 127.39 55.65 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.39 -1.277 . . . . 0.0 109.795 178.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.589 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 35.0 mt -96.79 137.98 23.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 170.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.598 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 56.4 p -123.52 -20.37 5.58 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -171.273 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -153.81 156.39 26.77 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 119.322 -1.418 . . . . 0.0 113.605 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.498 HG23 ' HG ' ' B' ' 87' ' ' LEU . 14.8 p -146.58 124.35 3.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 172.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.14 155.71 44.04 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.898 -0.501 . . . . 0.0 111.726 -174.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.586 ' HB3' HG12 ' B' ' 85' ' ' VAL . 3.7 pp -120.38 140.57 51.12 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.984 0.897 . . . . 0.0 111.728 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -105.01 -53.8 2.6 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.37 -1.286 . . . . 0.0 108.855 174.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -102.82 127.44 49.99 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 169.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.492 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 151.3 156.09 7.25 Favored Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 119.829 -1.177 . . . . 0.0 113.547 176.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 38' ' ' GLN . . . . . 0.438 ' HA ' ' HB2' ' B' ' 58' ' ' LYS . 91.0 mt-30 -102.58 -44.3 5.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.737 0.303 . . . . 0.0 111.125 178.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -153.08 126.41 8.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.089 177.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.555 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -124.53 113.12 17.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.511 0.672 . . . . 0.0 109.776 169.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' B' ' 79' ' ' THR . 19.9 mtpp -96.15 107.04 19.32 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 41.2 tp -81.5 114.84 20.49 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 -173.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 43' ' ' TYR . . . . . 0.553 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 97.6 m-85 -120.51 139.42 52.93 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.507 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 0.2 OUTLIER -125.07 133.29 52.96 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 172.575 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.625 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -112.02 113.11 25.21 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.184 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.515 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -124.54 137.82 54.38 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.344 178.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 59.63 30.88 20.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.046 0.451 . . . . 0.0 110.293 -174.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.488 ' HB2' ' NZ ' ' B' ' 48' ' ' LYS . 0.1 OUTLIER 62.62 33.6 15.61 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.12 -177.153 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.625 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 8.4 tp-100 -123.48 130.27 52.45 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.63 123.61 32.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.829 0.347 . . . . 0.0 110.7 -175.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.46 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 84.8 m-85 -117.99 130.15 56.02 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.888 175.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.1 tp -80.2 103.78 7.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.827 0.822 . . . . 0.0 108.807 171.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.552 ' CG1' HD11 ' B' ' 67' ' ' LEU . 2.6 t -78.7 -49.39 20.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.709 -171.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.468 ' HB1' HG11 ' B' ' 63' ' ' VAL . . . -158.38 146.65 18.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.889 -178.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 32.3 m -109.57 101.43 10.36 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 56' ' ' VAL . . . . . 0.449 HG11 HG11 ' B' ' 85' ' ' VAL . 7.4 p -115.62 116.21 51.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.568 0.699 . . . . 0.0 109.557 -177.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 46.8 p -122.37 -179.17 4.1 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.371 -172.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 58' ' ' LYS . . . . . 0.438 ' HB2' ' HA ' ' B' ' 38' ' ' GLN . 38.1 tttm -61.53 -27.33 68.53 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.878 172.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.479 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -84.34 -40.67 17.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.577 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 86.1 mt -109.41 84.11 2.85 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 174.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 61' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 9.8 Cg_exo -71.03 0.09 7.14 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.981 2.454 . . . . 0.0 113.707 -168.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -162.79 131.71 4.11 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.121 0.486 . . . . 0.0 111.221 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.468 HG11 ' HB1' ' B' ' 54' ' ' ALA . 71.7 t -120.57 132.8 69.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.964 172.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.52 113.22 25.69 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.09 177.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.435 HD13 ' N ' ' B' ' 65' ' ' LEU . 0.0 OUTLIER -121.58 170.05 10.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.325 -176.575 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 66' ' ' ASP . . . . . 0.511 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 7.2 t0 -118.38 98.73 6.42 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.221 0.534 . . . . 0.0 109.602 175.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.589 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 19.7 mt -113.0 143.43 44.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.903 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 68' ' ' ASN . . . . . 0.408 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 57.0 t30 -147.79 120.0 8.34 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.951 0.405 . . . . 0.0 109.965 174.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -114.98 153.5 30.5 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.273 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 20.6 t -103.57 148.89 25.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.058 -178.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 71' ' ' LYS . . . . . 0.486 ' HB2' ' NZ ' ' B' ' 71' ' ' LYS . 0.0 OUTLIER -74.88 10.07 1.6 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -174.579 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.61 -15.22 30.04 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.86 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -101.13 170.83 7.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.846 0.355 . . . . 0.0 110.838 -175.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 62.0 ttt-85 -138.37 122.55 18.07 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.515 HG22 ' HB2' ' B' ' 46' ' ' ALA . 14.5 pt -125.73 160.86 31.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.389 -170.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.483 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 2.8 mtm -115.25 129.01 56.51 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 174.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 77' ' ' PHE . . . . . 0.507 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -109.81 128.39 55.28 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.187 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.721 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 51.4 p90 -155.79 157.4 36.43 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 120.241 -0.584 . . . . 0.0 112.215 -177.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 14.6 p -124.77 144.06 50.46 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.277 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.43 156.69 18.68 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.981 174.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.87 -166.91 31.55 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -123.75 102.76 7.99 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.36 176.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.587 ' H ' ' HB3' ' B' ' 15' ' ' PRO . . . -169.23 151.88 4.79 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.21 169.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 33.7 t -109.23 122.83 48.17 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.591 HG23 ' HB3' ' B' ' 13' ' ' MET . 6.8 m -119.78 147.18 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 CA-C-O 121.307 0.575 . . . . 0.0 111.838 -173.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 17.0 t -111.08 119.33 38.63 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.662 HD13 HD23 ' B' ' 11' ' ' LEU . 5.2 mp -91.72 151.49 20.61 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 174.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.602 HD23 HD21 ' C' ' 67' ' ' LEU . 1.2 tp -133.07 140.31 47.61 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.267 -178.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.28 -166.67 24.65 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.961 -177.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 90' ' ' TYR . . . . . 0.42 ' CD2' ' HB3' ' C' ' 68' ' ' ASN . 11.3 p90 -153.11 132.92 13.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.811 0.815 . . . . 0.0 111.742 176.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 91' ' ' LEU . . . . . 0.66 HD23 ' HB3' ' B' ' 27' ' ' PHE . 15.1 mt . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 114.13 -1.395 . . . . 0.0 110.127 177.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 52.4 ttm . . . . . 0 C--O 1.226 -0.161 0 CA-C-O 121.005 0.431 . . . . 0.0 111.567 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' C' C ' 8' ' ' PHE . . . . . 0.491 ' CE1' HD21 ' D' ' 44' ' ' LEU . 61.4 t80 -52.73 142.1 19.48 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.937 -1.028 . . . . 0.0 112.62 -177.423 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 9' ' ' TRP . . . . . 0.537 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 88.3 t90 -135.71 147.57 48.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.867 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 10' ' ' GLY . . . . . 0.521 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -148.69 153.8 25.44 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.094 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.652 HD23 HD13 ' C' ' 87' ' ' LEU . 52.6 tp -140.36 108.15 5.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.989 0.423 . . . . 0.0 110.914 178.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -81.29 101.48 9.78 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.507 173.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 13' ' ' MET . . . . . 0.604 ' HB3' HG23 ' C' ' 85' ' ' VAL . 30.7 tpp -95.48 131.23 41.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.132 0.492 . . . . 0.0 111.128 -174.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -100.82 145.32 30.17 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.899 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 15' ' ' PRO . . . . . 0.591 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 12.4 Cg_endo -56.06 124.61 16.69 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 123.404 2.736 . . . . 0.0 113.459 -174.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 16' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' C' ' 79' ' ' THR . 25.1 mt-10 60.28 47.91 8.63 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.024 177.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -121.72 138.72 54.24 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.653 172.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 18' ' ' LYS . . . . . 0.729 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 84.5 mttt -111.37 119.06 37.58 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.454 0.471 . . . . 0.0 111.484 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -110.7 103.86 12.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.735 176.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 20' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 7.8 p -88.43 98.84 11.85 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 174.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -117.38 144.77 44.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.553 0.692 . . . . 0.0 112.271 -169.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 17.4 m -94.01 143.19 26.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.577 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 23' ' ' ILE . . . . . 0.435 ' CG2' ' HA ' ' C' ' 71' ' ' LYS . 59.4 mt -92.89 120.48 42.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.054 0.454 . . . . 0.0 111.09 -174.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 24' ' ' ILE . . . . . 0.449 ' N ' HD12 ' C' ' 24' ' ' ILE . 4.0 mp -79.43 -52.88 14.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.315 178.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 25' ' ' LYS . . . . . 0.492 ' HE2' ' HB3' ' C' ' 91' ' ' LEU . 13.6 ptmt -131.12 137.46 49.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.95 175.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 11.5 m -54.43 141.69 29.77 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.921 -176.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 27' ' ' PHE . . . . . 0.651 ' HB3' HD23 ' C' ' 91' ' ' LEU . 12.1 p90 -149.0 158.24 44.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.71 0.767 . . . . 0.0 112.834 -176.005 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 28' ' ' HIS . . . . . 0.603 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 9.2 t60 -111.41 127.41 55.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.405 -1.271 . . . . 0.0 109.864 178.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 29' ' ' ILE . . . . . 0.566 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 35.6 mt -96.82 138.02 23.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 170.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.603 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 56.4 p -123.46 -20.45 5.58 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -171.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -153.78 156.36 26.74 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 119.352 -1.404 . . . . 0.0 113.634 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.489 HG23 ' HG ' ' C' ' 87' ' ' LEU . 14.8 p -146.57 124.31 3.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.12 155.74 44.06 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.947 -0.471 . . . . 0.0 111.752 -174.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.597 ' HB3' HG12 ' C' ' 85' ' ' VAL . 3.7 pp -120.44 140.58 51.17 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.938 0.875 . . . . 0.0 111.752 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -105.13 -53.7 2.62 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.757 174.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -102.9 127.47 50.09 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 169.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 37' ' ' GLY . . . . . 0.48 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 151.24 156.09 7.24 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 119.901 -1.142 . . . . 0.0 113.685 177.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 38' ' ' GLN . . . . . 0.438 ' HA ' ' HB2' ' C' ' 58' ' ' LYS . 90.9 mt-30 -102.68 -44.23 5.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.766 0.317 . . . . 0.0 111.156 178.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -153.1 126.46 8.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.071 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.56 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -124.46 113.08 17.66 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.441 0.638 . . . . 0.0 109.793 169.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' C' ' 79' ' ' THR . 19.9 mtpp -96.07 107.02 19.27 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 176.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 41.3 tp -81.48 114.81 20.46 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -173.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 43' ' ' TYR . . . . . 0.553 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 97.6 m-85 -120.53 139.41 52.95 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.503 ' HB2' ' CD1' ' C' ' 77' ' ' PHE . 0.2 OUTLIER -125.12 133.25 52.92 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.656 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 45' ' ' ALA . . . . . 0.631 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -112.07 113.11 25.2 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.096 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.519 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -124.46 137.82 54.4 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.333 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 59.72 30.73 20.32 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 123.503 0.502 . . . . 0.0 110.258 -174.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 48' ' ' LYS . . . . . 0.488 ' HB2' ' NZ ' ' C' ' 48' ' ' LYS . 0.1 OUTLIER 62.53 33.62 15.83 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.201 -177.033 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 49' ' ' GLN . . . . . 0.631 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 8.4 tp-100 -123.53 130.27 52.43 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.53 123.64 31.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.792 0.33 . . . . 0.0 110.806 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 51' ' ' TYR . . . . . 0.507 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 84.6 m-85 -118.03 130.12 55.98 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.84 175.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.1 tp -80.23 103.82 7.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 171.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 53' ' ' VAL . . . . . 0.555 ' CG1' HD11 ' C' ' 67' ' ' LEU . 2.6 t -78.7 -49.5 20.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.648 -171.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 54' ' ' ALA . . . . . 0.471 ' HB1' HG11 ' C' ' 63' ' ' VAL . . . -158.35 146.56 18.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.827 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 32.5 m -109.42 101.37 10.35 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 173.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 56' ' ' VAL . . . . . 0.462 HG11 HG11 ' C' ' 85' ' ' VAL . 7.4 p -115.54 116.27 51.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.587 0.708 . . . . 0.0 109.569 -177.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 47.0 p -122.44 -179.13 4.1 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.346 -172.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 58' ' ' LYS . . . . . 0.438 ' HB2' ' HA ' ' C' ' 38' ' ' GLN . 38.1 tttm -61.45 -27.53 68.63 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.871 172.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 59' ' ' ALA . . . . . 0.493 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -84.14 -40.66 17.95 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.647 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 86.1 mt -109.43 84.05 2.83 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 174.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 61' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 9.8 Cg_exo -71.03 0.12 7.09 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.099 2.533 . . . . 0.0 113.729 -168.069 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -162.77 131.69 4.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.166 0.508 . . . . 0.0 111.274 -176.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.471 HG11 ' HB1' ' C' ' 54' ' ' ALA . 69.0 t -120.47 132.86 68.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.0 172.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.61 113.12 25.5 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.115 177.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 65' ' ' LEU . . . . . 0.439 HD13 ' N ' ' C' ' 65' ' ' LEU . 0.0 OUTLIER -121.51 170.03 10.08 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.064 0.459 . . . . 0.0 111.294 -176.508 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 66' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 7.4 t0 -118.3 98.76 6.44 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.199 0.524 . . . . 0.0 109.678 175.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.602 HD21 HD23 ' B' ' 88' ' ' LEU . 19.7 mt -112.98 143.4 44.33 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.902 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 68' ' ' ASN . . . . . 0.42 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 57.1 t30 -147.75 119.96 8.34 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 174.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -115.01 153.53 30.48 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.186 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 20.5 t -103.61 148.88 25.47 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.991 -178.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 71' ' ' LYS . . . . . 0.48 ' HB2' ' NZ ' ' C' ' 71' ' ' LYS . 0.0 OUTLIER -74.76 9.91 1.63 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -174.66 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.57 -15.14 30.37 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.594 -0.813 . . . . 0.0 111.994 175.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -101.16 170.87 7.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.792 0.329 . . . . 0.0 110.91 -175.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 61.8 ttt-85 -138.36 122.64 18.19 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.519 HG22 ' HB2' ' C' ' 46' ' ' ALA . 14.4 pt -125.76 160.84 31.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.4 -170.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.476 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 2.8 mtm -115.24 129.02 56.52 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 174.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 77' ' ' PHE . . . . . 0.503 ' CD1' ' HB2' ' C' ' 44' ' ' LEU . 0.6 OUTLIER -109.91 128.38 55.32 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.179 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 78' ' ' TYR . . . . . 0.729 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 51.2 p90 -155.78 157.45 36.51 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 120.235 -0.586 . . . . 0.0 112.254 -177.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 79' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 14.7 p -124.74 143.98 50.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.234 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.34 156.62 18.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.017 174.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.04 -166.74 31.23 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -176.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -123.79 102.72 7.96 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 117.693 0.746 . . . . 0.0 110.462 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 83' ' ' ALA . . . . . 0.591 ' H ' ' HB3' ' C' ' 15' ' ' PRO . . . -169.26 151.81 4.74 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.366 -1.288 . . . . 0.0 109.258 169.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 33.5 t -109.18 122.78 48.03 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.604 HG23 ' HB3' ' C' ' 13' ' ' MET . 6.7 m -119.68 147.17 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 CA-C-O 121.264 0.554 . . . . 0.0 111.818 -173.228 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 86' ' ' SER . . . . . 0.4 ' HB3' HG22 ' D' ' 52' ' ' ILE . 17.2 t -111.11 119.36 38.74 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.096 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 87' ' ' LEU . . . . . 0.652 HD13 HD23 ' C' ' 11' ' ' LEU . 5.2 mp -91.67 151.46 20.66 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 174.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 88' ' ' LEU . . . . . 0.564 HD23 HD21 ' D' ' 67' ' ' LEU . 1.2 tp -133.07 140.33 47.62 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.3 -178.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.29 -166.73 24.77 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.955 -0.64 . . . . 0.0 111.991 -177.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -153.0 132.81 13.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.714 0.769 . . . . 0.0 111.817 176.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 91' ' ' LEU . . . . . 0.651 HD23 ' HB3' ' C' ' 27' ' ' PHE . 15.2 mt . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.094 177.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 52.4 ttm . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 120.997 0.427 . . . . 0.0 111.594 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' D' D ' 8' ' ' PHE . . . . . 0.496 ' CE1' HD21 ' E' ' 44' ' ' LEU . 61.4 t80 -52.76 142.16 19.48 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.603 -177.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 9' ' ' TRP . . . . . 0.55 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 88.2 t90 -135.81 147.67 48.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.113 -0.948 . . . . 0.0 108.899 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 10' ' ' GLY . . . . . 0.518 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -148.74 153.76 25.41 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.083 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 11' ' ' LEU . . . . . 0.663 HD23 HD13 ' D' ' 87' ' ' LEU . 52.1 tp -140.32 108.25 5.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.065 0.46 . . . . 0.0 110.85 178.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -81.32 101.68 9.93 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.473 173.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 13' ' ' MET . . . . . 0.601 ' HB3' HG23 ' D' ' 85' ' ' VAL . 30.5 tpp -95.57 131.31 41.91 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.181 -174.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -100.87 145.32 30.19 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.885 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 15' ' ' PRO . . . . . 0.595 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 12.3 Cg_endo -56.12 124.61 16.69 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 123.421 2.747 . . . . 0.0 113.413 -174.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 16' ' ' GLU . . . . . 0.556 ' HA ' ' O ' ' D' ' 79' ' ' THR . 25.2 mt-10 60.33 47.91 8.52 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.547 -0.752 . . . . 0.0 112.017 177.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -121.78 138.69 54.27 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.654 172.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 18' ' ' LYS . . . . . 0.714 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 84.6 mttt -111.39 119.1 37.71 Favored 'General case' 0 CA--C 1.517 -0.316 0 O-C-N 123.384 0.428 . . . . 0.0 111.472 178.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.61 103.84 12.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.794 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 20' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 7.5 p -88.38 98.84 11.83 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 174.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -117.44 144.79 44.65 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.537 0.684 . . . . 0.0 112.271 -169.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 17.4 m -94.08 143.1 26.67 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.56 177.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 23' ' ' ILE . . . . . 0.443 ' CG2' ' HA ' ' D' ' 71' ' ' LYS . 59.5 mt -92.86 120.55 42.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.167 0.508 . . . . 0.0 111.077 -174.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 24' ' ' ILE . . . . . 0.452 HD12 ' N ' ' D' ' 24' ' ' ILE . 4.0 mp -79.47 -52.9 14.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.294 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 25' ' ' LYS . . . . . 0.498 ' HE2' ' HB3' ' D' ' 91' ' ' LEU . 13.6 ptmt -131.03 137.56 49.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.053 175.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 11.7 m -54.49 141.71 30.06 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 124.01 0.818 . . . . 0.0 110.894 -176.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 27' ' ' PHE . . . . . 0.657 ' HB3' HD23 ' D' ' 91' ' ' LEU . 11.9 p90 -149.04 158.28 44.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.717 0.77 . . . . 0.0 112.767 -175.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 28' ' ' HIS . . . . . 0.598 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 9.2 t60 -111.44 127.35 55.66 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.739 178.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 29' ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 35.4 mt -96.7 138.11 22.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 170.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 30' ' ' SER . . . . . 0.598 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 55.7 p -123.65 -20.35 5.53 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -171.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -153.79 156.38 26.76 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 119.305 -1.426 . . . . 0.0 113.635 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.489 HG23 ' HG ' ' D' ' 87' ' ' LEU . 14.8 p -146.63 124.23 3.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.11 155.74 44.07 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.91 -0.494 . . . . 0.0 111.791 -174.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 34' ' ' LEU . . . . . 0.576 ' HB3' HG12 ' D' ' 85' ' ' VAL . 3.7 pp -120.37 140.47 51.26 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.894 0.854 . . . . 0.0 111.781 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -105.07 -53.59 2.64 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.416 -1.266 . . . . 0.0 108.84 174.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -102.92 127.47 50.12 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 168.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 37' ' ' GLY . . . . . 0.488 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 151.18 155.92 7.16 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 119.859 -1.162 . . . . 0.0 113.688 177.006 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 38' ' ' GLN . . . . . 0.447 ' HA ' ' HB2' ' D' ' 58' ' ' LYS . 91.2 mt-30 -102.59 -44.2 5.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.662 0.268 . . . . 0.0 111.119 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -153.13 126.36 8.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.147 176.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 40' ' ' ALA . . . . . 0.559 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -124.48 113.15 17.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.535 0.683 . . . . 0.0 109.741 169.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' D' ' 79' ' ' THR . 19.9 mtpp -96.24 107.11 19.41 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 176.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 41.3 tp -81.52 114.83 20.5 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -173.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 43' ' ' TYR . . . . . 0.553 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 97.6 m-85 -120.55 139.4 52.99 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.505 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.2 OUTLIER -125.04 133.21 53.04 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 172.67 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 45' ' ' ALA . . . . . 0.635 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -112.03 113.16 25.28 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.131 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.512 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -124.49 137.69 54.4 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.419 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 59.74 30.89 20.48 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.504 0.503 . . . . 0.0 110.22 -174.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 48' ' ' LYS . . . . . 0.482 ' HB2' ' NZ ' ' D' ' 48' ' ' LYS . 0.1 OUTLIER 62.41 33.73 16.06 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.132 -177.104 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 49' ' ' GLN . . . . . 0.635 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 8.5 tp-100 -123.58 130.27 52.42 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.53 123.56 31.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.764 0.316 . . . . 0.0 110.784 -176.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 51' ' ' TYR . . . . . 0.521 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 84.6 m-85 -118.01 130.11 55.98 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 175.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 52' ' ' ILE . . . . . 0.4 HG22 ' HB3' ' C' ' 86' ' ' SER . 5.2 tp -80.15 103.78 7.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 171.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 53' ' ' VAL . . . . . 0.548 ' CG1' HD11 ' D' ' 67' ' ' LEU . 2.6 t -78.74 -49.52 20.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.662 -171.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 54' ' ' ALA . . . . . 0.459 ' HB1' HG11 ' D' ' 63' ' ' VAL . . . -158.3 146.61 18.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.9 -178.417 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 32.5 m -109.55 101.43 10.37 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 173.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 56' ' ' VAL . . . . . 0.451 HG11 HG11 ' D' ' 85' ' ' VAL . 7.4 p -115.6 116.2 51.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.564 0.697 . . . . 0.0 109.599 -177.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 46.2 p -122.38 -179.07 4.07 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.31 -172.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 58' ' ' LYS . . . . . 0.447 ' HB2' ' HA ' ' D' ' 38' ' ' GLN . 38.2 tttm -61.64 -27.39 68.63 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.82 172.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 59' ' ' ALA . . . . . 0.487 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -84.24 -40.69 17.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.652 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 86.1 mt -109.34 84.08 2.78 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 61' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 9.7 Cg_exo -71.04 0.09 7.14 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.038 2.492 . . . . 0.0 113.725 -168.135 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -162.76 131.64 4.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.132 0.492 . . . . 0.0 111.298 -176.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.459 HG11 ' HB1' ' D' ' 54' ' ' ALA . 69.2 t -120.43 132.71 69.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.107 172.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.49 113.13 25.52 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.197 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 65' ' ' LEU . . . . . 0.436 ' H ' HD13 ' D' ' 65' ' ' LEU . 0.0 OUTLIER -121.44 170.05 10.03 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.344 -176.508 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 66' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 7.3 t0 -118.42 98.84 6.47 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.284 0.564 . . . . 0.0 109.584 175.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.572 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 19.8 mt -113.0 143.46 44.27 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.929 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -147.77 119.95 8.32 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.96 0.409 . . . . 0.0 109.961 174.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -114.98 153.55 30.41 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.24 -178.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 20.7 t -103.62 148.93 25.42 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.969 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 71' ' ' LYS . . . . . 0.492 ' HB2' ' NZ ' ' D' ' 71' ' ' LYS . 0.0 OUTLIER -74.91 10.02 1.63 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -174.614 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.51 -15.3 30.06 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.949 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -101.21 170.9 7.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.745 0.307 . . . . 0.0 110.876 -175.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 62.0 ttt-85 -138.43 122.65 18.12 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.512 HG22 ' HB2' ' D' ' 46' ' ' ALA . 14.3 pt -125.75 160.86 31.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.403 -170.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 76' ' ' MET . . . . . 0.486 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 2.9 mtm -115.24 128.98 56.5 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 174.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 77' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.6 OUTLIER -109.84 128.4 55.3 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.204 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 78' ' ' TYR . . . . . 0.714 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 51.6 p90 -155.79 157.46 36.51 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 120.231 -0.588 . . . . 0.0 112.232 -177.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 79' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 14.0 p -124.87 144.03 50.53 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.171 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.34 156.55 18.79 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.98 174.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.04 -166.83 31.29 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -176.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -123.67 102.74 8.0 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 117.797 0.799 . . . . 0.0 110.365 176.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 83' ' ' ALA . . . . . 0.595 ' H ' ' HB3' ' D' ' 15' ' ' PRO . . . -169.23 151.87 4.79 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.157 169.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 33.4 t -109.21 122.82 48.14 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.601 HG23 ' HB3' ' D' ' 13' ' ' MET . 6.8 m -119.75 147.11 23.6 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 CA-C-O 121.298 0.571 . . . . 0.0 111.814 -173.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 16.9 t -111.05 119.32 38.64 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 177.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 87' ' ' LEU . . . . . 0.663 HD13 HD23 ' D' ' 11' ' ' LEU . 5.2 mp -91.68 151.45 20.66 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 174.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.571 HD23 HD21 ' E' ' 67' ' ' LEU . 1.2 tp -133.07 140.26 47.6 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.287 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.24 -166.71 24.67 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.978 -177.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 90' ' ' TYR . . . . . 0.415 ' CD2' ' HB3' ' E' ' 68' ' ' ASN . 11.5 p90 -153.01 132.82 13.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.739 0.78 . . . . 0.0 111.814 176.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 91' ' ' LEU . . . . . 0.657 HD23 ' HB3' ' D' ' 27' ' ' PHE . 15.2 mt . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.096 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 52.4 ttm . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 121.021 0.439 . . . . 0.0 111.567 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' E' E ' 8' ' ' PHE . . . . . 0.495 ' CE1' HD21 ' A' ' 44' ' ' LEU . 61.2 t80 -52.8 142.17 19.59 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.548 -177.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 9' ' ' TRP . . . . . 0.535 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 88.3 t90 -135.73 147.68 48.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.838 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 10' ' ' GLY . . . . . 0.499 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -148.72 153.87 25.49 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.04 177.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 11' ' ' LEU . . . . . 0.671 HD23 HD13 ' E' ' 87' ' ' LEU . 52.7 tp -140.38 108.13 5.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.061 0.458 . . . . 0.0 110.919 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -81.15 101.56 9.73 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.553 173.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 13' ' ' MET . . . . . 0.597 ' HB3' HG23 ' E' ' 85' ' ' VAL . 30.6 tpp -95.49 131.19 41.92 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.109 0.48 . . . . 0.0 111.184 -174.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -100.78 145.38 30.27 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.97 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 15' ' ' PRO . . . . . 0.601 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 12.3 Cg_endo -56.2 124.65 16.78 Favored 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 123.365 2.71 . . . . 0.0 113.424 -174.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 16' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' E' ' 79' ' ' THR . 25.3 mt-10 60.37 47.82 8.5 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.016 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -121.66 138.71 54.22 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.652 172.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 18' ' ' LYS . . . . . 0.714 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 84.6 mttt -111.4 119.2 38.01 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.35 0.406 . . . . 0.0 111.414 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.72 103.84 12.43 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.853 176.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 20' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' E' ' 76' ' ' MET . 7.9 p -88.43 98.94 11.9 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 174.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -117.44 144.92 44.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.56 0.695 . . . . 0.0 112.266 -169.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 17.8 m -94.19 143.1 26.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.487 177.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 23' ' ' ILE . . . . . 0.447 ' CG2' ' HA ' ' E' ' 71' ' ' LYS . 59.4 mt -92.79 120.45 42.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.007 0.432 . . . . 0.0 111.17 -174.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 24' ' ' ILE . . . . . 0.438 HD12 ' N ' ' E' ' 24' ' ' ILE . 4.0 mp -79.42 -52.99 14.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.24 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 25' ' ' LYS . . . . . 0.495 ' HE2' ' HB3' ' E' ' 91' ' ' LEU . 13.5 ptmt -131.05 137.46 49.16 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.027 175.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 11.4 m -54.37 141.7 29.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.931 -176.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 27' ' ' PHE . . . . . 0.649 ' HB3' HD23 ' E' ' 91' ' ' LEU . 12.1 p90 -149.01 158.21 44.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.728 0.775 . . . . 0.0 112.762 -175.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 28' ' ' HIS . . . . . 0.601 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 9.3 t60 -111.39 127.37 55.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.842 178.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 29' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 35.6 mt -96.8 138.05 22.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 170.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 30' ' ' SER . . . . . 0.601 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 55.7 p -123.58 -20.33 5.57 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -171.273 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -153.76 156.42 26.78 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 119.27 -1.443 . . . . 0.0 113.578 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.5 HG23 ' HG ' ' E' ' 87' ' ' LEU . 14.8 p -146.61 124.35 3.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 172.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.15 155.64 44.01 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.931 -0.481 . . . . 0.0 111.764 -174.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 34' ' ' LEU . . . . . 0.597 ' HB3' HG12 ' E' ' 85' ' ' VAL . 3.7 pp -120.33 140.47 51.23 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.914 0.864 . . . . 0.0 111.771 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -104.98 -53.74 2.61 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.378 -1.283 . . . . 0.0 108.826 174.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -102.82 127.38 50.01 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 169.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 37' ' ' GLY . . . . . 0.489 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 151.3 156.04 7.22 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 119.794 -1.193 . . . . 0.0 113.631 176.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 38' ' ' GLN . . . . . 0.444 ' HA ' ' HB2' ' E' ' 58' ' ' LYS . 91.1 mt-30 -102.61 -44.19 5.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.681 0.277 . . . . 0.0 111.127 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -153.16 126.39 8.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.095 176.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 40' ' ' ALA . . . . . 0.563 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -124.51 113.14 17.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.534 0.683 . . . . 0.0 109.771 169.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 41' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' E' ' 79' ' ' THR . 19.9 mtpp -96.11 107.02 19.29 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 41.2 tp -81.45 114.85 20.47 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -173.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 43' ' ' TYR . . . . . 0.546 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 97.5 m-85 -120.59 139.39 53.04 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 177.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 44' ' ' LEU . . . . . 0.512 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 0.2 OUTLIER -125.09 133.26 52.96 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 172.574 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' E' E ' 45' ' ' ALA . . . . . 0.634 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -111.98 113.15 25.29 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.118 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 46' ' ' ALA . . . . . 0.519 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -124.53 137.77 54.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.371 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 59.81 30.8 20.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.001 0.429 . . . . 0.0 110.204 -174.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 48' ' ' LYS . . . . . 0.479 ' HB2' ' NZ ' ' E' ' 48' ' ' LYS . 0.1 OUTLIER 62.54 33.63 15.8 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.171 -177.045 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' E' E ' 49' ' ' GLN . . . . . 0.634 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 8.4 tp-100 -123.6 130.39 52.59 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -86.63 123.65 32.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.817 0.341 . . . . 0.0 110.726 -176.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 51' ' ' TYR . . . . . 0.518 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 84.6 m-85 -118.09 130.08 55.93 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.866 175.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.11 103.82 7.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 171.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 53' ' ' VAL . . . . . 0.544 ' CG1' HD11 ' E' ' 67' ' ' LEU . 2.6 t -78.76 -49.41 20.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.664 -171.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 54' ' ' ALA . . . . . 0.455 ' HB1' HG11 ' E' ' 63' ' ' VAL . . . -158.41 146.59 18.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.834 -178.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 32.5 m -109.52 101.45 10.39 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 173.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 56' ' ' VAL . . . . . 0.466 HG11 HG11 ' E' ' 85' ' ' VAL . 7.4 p -115.56 116.15 51.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.501 0.667 . . . . 0.0 109.635 -177.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 46.7 p -122.29 -179.08 4.06 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.43 -172.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 58' ' ' LYS . . . . . 0.444 ' HB2' ' HA ' ' E' ' 38' ' ' GLN . 38.2 tttm -61.67 -27.3 68.58 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.872 172.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 59' ' ' ALA . . . . . 0.493 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -84.26 -40.68 17.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.673 178.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 85.9 mt -109.35 83.98 2.74 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 174.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 61' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 9.6 Cg_exo -70.96 0.16 6.98 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.033 2.489 . . . . 0.0 113.746 -168.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -162.88 131.59 4.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.088 0.471 . . . . 0.0 111.3 -176.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 63' ' ' VAL . . . . . 0.455 HG11 ' HB1' ' E' ' 54' ' ' ALA . 70.0 t -120.43 132.73 69.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.049 172.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.45 113.07 25.43 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.193 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 65' ' ' LEU . . . . . 0.428 HD13 ' N ' ' E' ' 65' ' ' LEU . 0.0 OUTLIER -121.48 170.07 10.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.346 -176.51 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' E' E ' 66' ' ' ASP . . . . . 0.511 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 7.3 t0 -118.31 98.73 6.43 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.193 0.521 . . . . 0.0 109.641 175.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 67' ' ' LEU . . . . . 0.577 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 19.8 mt -112.99 143.42 44.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.879 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 68' ' ' ASN . . . . . 0.415 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 57.1 t30 -147.77 119.92 8.3 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.945 0.402 . . . . 0.0 109.99 174.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -114.91 153.53 30.34 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.262 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 21.0 t -103.63 148.95 25.4 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.979 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 71' ' ' LYS . . . . . 0.493 ' HB2' ' NZ ' ' E' ' 71' ' ' LYS . 0.0 OUTLIER -74.92 10.12 1.6 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -174.596 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.71 -15.19 29.87 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.823 175.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -101.24 170.87 7.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.825 0.345 . . . . 0.0 110.902 -175.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 62.0 ttt-85 -138.33 122.56 18.13 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 75' ' ' ILE . . . . . 0.519 HG22 ' HB2' ' E' ' 46' ' ' ALA . 14.5 pt -125.72 160.9 31.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 120.897 0.38 . . . . 0.0 111.399 -170.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 76' ' ' MET . . . . . 0.481 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 2.9 mtm -115.3 129.0 56.49 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 77' ' ' PHE . . . . . 0.512 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.6 OUTLIER -109.82 128.44 55.32 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 177.207 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' E' E ' 78' ' ' TYR . . . . . 0.714 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 51.3 p90 -155.88 157.43 36.35 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.146 -0.622 . . . . 0.0 112.185 -177.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 79' ' ' THR . . . . . 0.552 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 14.6 p -124.77 143.94 50.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.238 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.31 156.57 18.75 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.985 174.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.99 -166.86 31.36 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -176.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -123.67 102.68 7.96 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 117.734 0.767 . . . . 0.0 110.5 176.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 83' ' ' ALA . . . . . 0.601 ' H ' ' HB3' ' E' ' 15' ' ' PRO . . . -169.25 151.8 4.75 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.16 169.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 33.4 t -109.15 122.8 48.07 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 85' ' ' VAL . . . . . 0.597 HG23 ' HB3' ' E' ' 13' ' ' MET . 6.8 m -119.68 147.16 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-O 121.274 0.559 . . . . 0.0 111.888 -173.29 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 17.1 t -111.12 119.28 38.44 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 87' ' ' LEU . . . . . 0.671 HD13 HD23 ' E' ' 11' ' ' LEU . 5.2 mp -91.64 151.52 20.65 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 174.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 88' ' ' LEU . . . . . 0.613 HD23 HD21 ' A' ' 67' ' ' LEU . 1.2 tp -133.13 140.26 47.53 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.304 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.23 -166.74 24.7 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.936 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 90' ' ' TYR . . . . . 0.451 ' CD2' ' HB3' ' A' ' 68' ' ' ASN . 11.4 p90 -153.04 132.8 13.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.787 0.804 . . . . 0.0 111.796 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 91' ' ' LEU . . . . . 0.649 HD23 ' HB3' ' E' ' 27' ' ' PHE . 15.1 mt . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.109 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.223 -0.324 0 CA-C-O 120.502 0.191 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.512 ' CE1' HD21 ' B' ' 44' ' ' LEU . 70.1 t80 -67.95 142.93 55.85 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.079 0.466 . . . . 0.0 112.124 -177.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.57 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 88.2 t90 -134.93 148.1 49.96 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.19 177.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.75 153.08 24.71 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.482 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.57 ' HB2' ' CH2' ' A' ' 9' ' ' TRP . 41.7 tp -144.18 109.94 5.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.81 0.338 . . . . 0.0 110.35 177.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -96.55 96.78 8.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.847 0.356 . . . . 0.0 110.078 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.621 ' SD ' HD11 ' A' ' 87' ' ' LEU . 62.6 mtp -92.98 144.1 25.59 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.941 -173.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -101.17 166.97 11.43 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.163 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.448 ' HB3' ' HA ' ' A' ' 82' ' ' ASP . 87.2 Cg_exo -49.84 115.69 1.98 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.737 2.292 . . . . 0.0 112.799 176.201 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 79' ' ' THR . 29.1 mt-10 63.31 39.5 9.44 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.29 0.566 . . . . 0.0 111.328 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 78' ' ' TYR . 0.5 OUTLIER -88.12 133.47 33.99 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.038 175.42 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.592 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 33.9 ttmt -123.31 116.09 22.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.122 0.487 . . . . 0.0 111.074 -178.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.471 ' CZ ' ' HG2' ' A' ' 17' ' ' ARG . 18.3 m-85 -107.11 102.59 11.92 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.591 178.016 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.0 p -90.11 97.2 11.05 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 169.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -117.09 145.46 43.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.508 0.67 . . . . 0.0 112.48 -165.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.7 m -97.62 132.93 42.82 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.011 174.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.43 ' CD1' ' HB3' ' A' ' 69' ' ' PHE . 70.3 mt -87.77 118.08 32.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-O 121.127 0.489 . . . . 0.0 110.987 -173.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.679 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -90.09 -18.05 7.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.057 -179.476 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -155.12 129.2 8.82 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.101 -175.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.7 p -58.63 127.41 32.05 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.411 0.445 . . . . 0.0 110.652 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.746 ' HB3' HD23 ' A' ' 91' ' ' LEU . 10.4 p90 -143.68 166.34 25.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.693 0.758 . . . . 0.0 112.748 -174.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.564 ' HE2' ' HB3' ' A' ' 30' ' ' SER . 4.8 t60 -121.8 127.4 50.55 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.421 178.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.618 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 47.3 mt -94.55 135.22 29.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.564 ' HB3' ' HE2' ' A' ' 28' ' ' HIS . 56.0 p -119.85 -13.51 9.06 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -169.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -164.09 141.54 7.17 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 119.452 -1.356 . . . . 0.0 113.403 177.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.439 HG23 ' HG ' ' A' ' 87' ' ' LEU . 11.9 p -126.93 120.65 56.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 169.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.409 ' HA ' HG21 ' A' ' 56' ' ' VAL . . . -141.14 157.25 45.54 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 121.947 -0.471 . . . . 0.0 111.65 -174.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.629 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.6 pp -127.14 145.51 50.72 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.769 0.795 . . . . 0.0 111.237 178.233 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -110.21 -47.06 3.35 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.29 173.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -102.68 128.16 49.5 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.312 173.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.533 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 141.54 161.37 8.69 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 119.451 -1.357 . . . . 0.0 113.857 176.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -102.72 -43.98 5.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.681 0.276 . . . . 0.0 110.971 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -151.78 125.68 9.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.17 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -127.79 113.04 15.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.46 0.647 . . . . 0.0 109.699 168.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 79' ' ' THR . 56.0 mtpt -99.54 106.13 18.1 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 178.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.2 tp -79.11 108.77 12.84 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.819 -173.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -107.86 141.02 40.09 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.295 176.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.558 ' CD1' ' HB ' ' A' ' 75' ' ' ILE . 4.4 tp -124.48 116.38 22.42 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.082 176.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -101.78 104.21 14.98 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 174.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.488 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -127.08 136.44 52.17 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.4 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 56.38 35.99 26.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.371 0.605 . . . . 0.0 110.247 -175.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 61.36 39.7 15.01 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.123 178.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.553 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 8.5 tp-100 -134.63 128.09 32.45 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 175.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -85.28 105.72 16.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.937 0.398 . . . . 0.0 110.399 -178.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -100.13 131.29 46.16 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.461 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 tp -79.8 108.74 13.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 168.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.529 HG13 ' CD2' ' E' ' 88' ' ' LEU . 2.3 t -82.52 -51.32 14.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.578 -172.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.496 ' HB1' HG11 ' A' ' 63' ' ' VAL . . . -156.3 145.61 20.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.067 -178.174 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.6 m -109.21 101.77 10.77 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 173.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.476 HG13 ' HB3' ' A' ' 40' ' ' ALA . 7.4 p -115.5 114.93 47.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.534 0.683 . . . . 0.0 109.765 -177.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.5 p -122.93 -178.26 3.9 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.415 -174.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -63.92 -22.43 66.92 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.028 0.442 . . . . 0.0 110.271 171.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.439 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -83.95 -40.5 18.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.278 177.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.9 mt -112.38 81.63 4.13 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 173.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 12.2 Cg_exo -70.19 0.15 6.4 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.219 2.613 . . . . 0.0 113.972 -166.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -163.83 129.59 3.04 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.161 0.505 . . . . 0.0 111.464 -175.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.496 HG11 ' HB1' ' A' ' 54' ' ' ALA . 66.0 t -119.01 99.94 8.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.24 173.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.21 117.12 21.47 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 173.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.448 HD23 ' H ' ' A' ' 65' ' ' LEU . 0.9 OUTLIER -139.17 168.1 20.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.933 0.397 . . . . 0.0 110.994 -171.055 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.524 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 11.9 t0 -112.45 104.58 12.71 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.341 0.591 . . . . 0.0 110.077 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.667 HD21 HD23 ' E' ' 88' ' ' LEU . 11.1 mt -117.31 141.11 48.71 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.039 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -142.04 132.38 25.02 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.804 0.335 . . . . 0.0 110.7 174.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.477 ' CZ ' HD22 ' A' ' 67' ' ' LEU . 58.7 m-85 -129.92 160.56 33.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.009 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.4 t -120.08 158.78 26.14 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -79.44 9.09 5.16 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.865 0.364 . . . . 0.0 111.104 -175.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.21 -29.38 9.0 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 174.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -100.38 165.88 11.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.016 0.436 . . . . 0.0 110.737 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -135.76 143.46 45.29 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.558 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 25.0 pt -135.71 159.22 39.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.145 0.497 . . . . 0.0 112.27 -168.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.458 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 10.9 mtp -115.0 117.5 30.76 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.703 173.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.51 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -104.23 126.95 51.76 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.127 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.592 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 23.2 p90 -152.2 134.67 15.28 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.935 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 2.4 p -107.83 120.05 41.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.332 -177.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.27 160.95 15.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.672 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.47 -170.51 31.24 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -177.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.448 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 18.9 t70 -116.9 103.47 10.33 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 117.868 0.834 . . . . 0.0 109.983 176.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.533 ' CB ' ' HA3' ' A' ' 37' ' ' GLY . . . -173.31 158.69 3.62 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.736 172.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.4 t -117.74 122.44 43.47 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.629 HG12 ' HB3' ' A' ' 34' ' ' LEU . 4.9 m -115.84 156.07 17.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.529 0.68 . . . . 0.0 112.408 -172.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -119.07 117.19 28.07 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.038 173.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.621 HD11 ' SD ' ' A' ' 13' ' ' MET . 5.1 mp -91.68 147.05 23.28 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 171.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.692 HD23 HD21 ' B' ' 67' ' ' LEU . 0.7 OUTLIER -130.75 142.53 50.41 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.756 179.585 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.89 -167.97 27.34 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.106 -178.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -145.44 130.29 18.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.742 0.782 . . . . 0.0 112.132 178.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.746 HD23 ' HB3' ' A' ' 27' ' ' PHE . 18.2 mt . . . . . 0 C--N 1.325 -0.499 0 CA-C-N 114.328 -1.305 . . . . 0.0 109.46 173.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.222 -0.394 0 CA-C-O 120.481 0.182 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 8' ' ' PHE . . . . . 0.517 ' CE1' HD21 ' C' ' 44' ' ' LEU . 69.8 t80 -68.08 143.0 55.65 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.036 0.446 . . . . 0.0 112.043 -177.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 9' ' ' TRP . . . . . 0.563 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 88.1 t90 -134.97 148.01 49.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.112 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.67 153.09 24.73 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.461 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.563 ' HB2' ' CH2' ' B' ' 9' ' ' TRP . 41.6 tp -144.13 109.9 5.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.764 0.316 . . . . 0.0 110.457 177.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -96.56 96.83 8.93 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 13' ' ' MET . . . . . 0.631 ' SD ' HD11 ' B' ' 87' ' ' LEU . 62.4 mtp -93.0 144.14 25.55 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.015 -173.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -101.28 167.01 11.32 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.162 177.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.432 ' HB3' ' HA ' ' B' ' 82' ' ' ASP . 86.5 Cg_exo -49.84 115.68 1.97 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.785 2.324 . . . . 0.0 112.723 176.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' B' ' 79' ' ' THR . 29.0 mt-10 63.27 39.65 9.39 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.285 0.564 . . . . 0.0 111.254 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' B' ' 78' ' ' TYR . 0.5 OUTLIER -88.16 133.5 34.0 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.342 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.589 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 33.8 ttmt -123.34 116.12 22.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.167 0.508 . . . . 0.0 111.086 -178.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 19' ' ' TYR . . . . . 0.458 ' CZ ' ' HG2' ' B' ' 17' ' ' ARG . 18.6 m-85 -107.09 102.54 11.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.565 178.041 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 10.9 p -90.03 97.21 11.06 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 169.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.13 145.54 43.75 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.489 0.661 . . . . 0.0 112.457 -165.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 21.4 m -97.77 132.86 43.01 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.949 174.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.431 ' CD1' ' HB3' ' B' ' 69' ' ' PHE . 70.0 mt -87.73 117.99 32.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.12 0.486 . . . . 0.0 111.074 -173.24 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.683 ' H ' HD13 ' B' ' 24' ' ' ILE . 0.2 OUTLIER -90.04 -18.02 7.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.069 -179.426 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -155.18 129.14 8.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.097 -175.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 6.9 p -58.55 127.38 31.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.683 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 27' ' ' PHE . . . . . 0.748 ' HB3' HD23 ' B' ' 91' ' ' LEU . 10.2 p90 -143.66 166.37 25.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.691 0.758 . . . . 0.0 112.687 -174.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 28' ' ' HIS . . . . . 0.573 ' HE2' ' HB3' ' B' ' 30' ' ' SER . 4.8 t60 -121.87 127.44 50.49 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.256 -1.338 . . . . 0.0 109.353 178.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.611 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 47.2 mt -94.59 135.3 29.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 171.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.573 ' HB3' ' HE2' ' B' ' 28' ' ' HIS . 55.9 p -119.82 -13.65 9.06 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -169.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -164.07 141.5 7.15 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 119.373 -1.394 . . . . 0.0 113.385 177.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.437 HG23 ' HG ' ' B' ' 87' ' ' LEU . 11.8 p -126.91 120.72 56.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 169.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 33' ' ' ALA . . . . . 0.406 ' HA ' HG21 ' B' ' 56' ' ' VAL . . . -141.19 157.19 45.6 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.605 -173.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.634 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.6 pp -127.1 145.62 50.67 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.696 0.76 . . . . 0.0 111.279 178.123 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -110.27 -46.94 3.36 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.27 173.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -102.68 128.15 49.5 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.257 173.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.527 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 141.51 161.3 8.66 Favored Glycine 0 N--CA 1.438 -1.189 0 C-N-CA 119.488 -1.339 . . . . 0.0 113.886 176.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -102.64 -44.09 5.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.62 -0.29 . . . . 0.0 110.929 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -151.73 125.71 9.16 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.201 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.499 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -127.79 113.14 15.58 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.44 0.638 . . . . 0.0 109.632 168.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' B' ' 79' ' ' THR . 56.0 mtpt -99.66 106.11 18.02 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 46.6 tp -79.22 108.83 13.02 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.753 -173.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -107.85 140.93 40.21 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.293 176.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.558 ' CD1' ' HB ' ' B' ' 75' ' ' ILE . 4.4 tp -124.4 116.44 22.57 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.115 176.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -101.83 104.25 15.0 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 174.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.49 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -127.12 136.45 52.14 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.351 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 56.37 35.99 26.78 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 123.592 0.557 . . . . 0.0 110.175 -175.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 61.47 39.53 14.88 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 114.816 -1.083 . . . . 0.0 112.165 178.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.549 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 8.6 tp-100 -134.58 128.03 32.41 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 175.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -85.2 105.65 16.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.902 0.382 . . . . 0.0 110.429 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -100.07 131.23 46.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.46 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 tp -79.67 108.72 13.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 168.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.528 HG13 ' CD2' ' A' ' 88' ' ' LEU . 2.3 t -82.59 -51.22 15.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.576 -172.188 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.474 ' HB1' HG11 ' B' ' 63' ' ' VAL . . . -156.33 145.57 20.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.079 -178.216 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 32.2 m -109.18 101.78 10.79 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 173.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 56' ' ' VAL . . . . . 0.47 HG13 ' HB3' ' B' ' 40' ' ' ALA . 7.4 p -115.53 114.88 47.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.495 0.664 . . . . 0.0 109.744 -177.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 64.1 p -122.87 -178.31 3.91 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.428 -174.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -63.83 -22.52 66.95 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.047 0.451 . . . . 0.0 110.244 171.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.43 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -83.89 -40.51 18.51 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.194 0.521 . . . . 0.0 110.235 177.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.4 81.56 4.11 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 173.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 61' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 12.1 Cg_exo -70.16 0.15 6.38 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.126 2.55 . . . . 0.0 113.954 -166.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -163.78 129.6 3.06 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.163 0.506 . . . . 0.0 111.378 -175.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.474 HG11 ' HB1' ' B' ' 54' ' ' ALA . 66.6 t -119.06 99.93 8.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.24 173.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.15 117.15 21.46 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 173.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.444 HD23 ' H ' ' B' ' 65' ' ' LEU . 0.9 OUTLIER -139.05 168.15 20.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.95 0.405 . . . . 0.0 111.065 -171.186 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 66' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 12.1 t0 -112.4 104.52 12.66 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.262 0.553 . . . . 0.0 110.122 -178.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.692 HD21 HD23 ' A' ' 88' ' ' LEU . 11.0 mt -117.28 141.14 48.67 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.019 178.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.04 132.49 25.18 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.66 174.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 69' ' ' PHE . . . . . 0.484 ' CZ ' HD22 ' B' ' 67' ' ' LEU . 58.7 m-85 -130.02 160.55 33.33 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.985 178.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 18.5 t -120.18 158.78 26.23 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -79.4 9.11 5.11 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.966 0.412 . . . . 0.0 111.094 -175.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.32 -29.25 9.04 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 174.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -100.51 165.75 11.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.108 0.48 . . . . 0.0 110.698 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -135.68 143.36 45.39 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.233 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.558 ' HB ' ' CD1' ' B' ' 44' ' ' LEU . 25.0 pt -135.58 159.24 40.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.171 0.51 . . . . 0.0 112.216 -168.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.451 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 10.9 mtp -114.94 117.5 30.82 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.632 173.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 77' ' ' PHE . . . . . 0.507 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -104.25 126.97 51.8 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 175.987 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.589 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 23.2 p90 -152.21 134.65 15.25 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.311 -0.555 . . . . 0.0 111.999 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 2.5 p -107.79 120.04 41.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.345 -177.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.27 161.03 15.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.636 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.46 -170.68 31.41 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -177.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 82' ' ' ASP . . . . . 0.432 ' HA ' ' HB3' ' B' ' 15' ' ' PRO . 19.0 t70 -116.87 103.56 10.43 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.917 176.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.527 ' CB ' ' HA3' ' B' ' 37' ' ' GLY . . . -173.37 158.73 3.59 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.815 172.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 25.8 t -117.82 122.33 43.11 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.634 HG12 ' HB3' ' B' ' 34' ' ' LEU . 4.9 m -115.83 156.06 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-O 121.529 0.681 . . . . 0.0 112.445 -172.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 50.1 m -119.07 117.32 28.42 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.008 173.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.631 HD11 ' SD ' ' B' ' 13' ' ' MET . 5.1 mp -91.73 147.0 23.31 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 171.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.663 HD23 HD21 ' C' ' 67' ' ' LEU . 0.7 OUTLIER -130.84 142.51 50.39 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.959 -1.018 . . . . 0.0 108.748 179.582 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.9 -167.96 27.34 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.036 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -145.45 130.23 18.13 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.775 0.797 . . . . 0.0 112.056 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 91' ' ' LEU . . . . . 0.748 HD23 ' HB3' ' B' ' 27' ' ' PHE . 18.1 mt . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 114.255 -1.339 . . . . 0.0 109.396 173.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.302 0 CA-C-O 120.467 0.175 . . . . 0.0 110.967 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 8' ' ' PHE . . . . . 0.516 ' CE1' HD21 ' D' ' 44' ' ' LEU . 70.0 t80 -67.88 142.95 55.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.039 0.447 . . . . 0.0 112.068 -177.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 9' ' ' TRP . . . . . 0.568 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 88.2 t90 -135.07 148.09 49.77 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.71 153.05 24.7 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.415 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.568 ' HB2' ' CH2' ' C' ' 9' ' ' TRP . 41.6 tp -144.13 109.95 5.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.773 0.32 . . . . 0.0 110.429 177.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -96.55 96.84 8.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.92 0.391 . . . . 0.0 110.11 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 13' ' ' MET . . . . . 0.628 ' SD ' HD11 ' C' ' 87' ' ' LEU . 62.7 mtp -93.05 144.11 25.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.001 -173.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -101.2 167.01 11.35 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.154 177.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 15' ' ' PRO . . . . . 0.449 ' HB3' ' HA ' ' C' ' 82' ' ' ASP . 88.0 Cg_exo -49.8 115.68 1.96 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.731 2.288 . . . . 0.0 112.818 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 16' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' C' ' 79' ' ' THR . 29.1 mt-10 63.19 39.66 9.55 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.432 0.634 . . . . 0.0 111.36 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 17' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' C' ' 78' ' ' TYR . 0.5 OUTLIER -88.15 133.41 34.02 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.431 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 18' ' ' LYS . . . . . 0.592 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 33.9 ttmt -123.21 116.13 22.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.047 0.451 . . . . 0.0 111.109 -178.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 19' ' ' TYR . . . . . 0.461 ' CZ ' ' HG2' ' C' ' 17' ' ' ARG . 18.8 m-85 -107.2 102.61 11.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.536 178.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 10.9 p -90.04 97.14 11.02 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 169.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.08 145.51 43.71 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.535 0.683 . . . . 0.0 112.55 -165.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 21.7 m -97.65 132.95 42.83 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.691 -1.141 . . . . 0.0 108.964 174.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 23' ' ' ILE . . . . . 0.432 ' CD1' ' HB3' ' C' ' 69' ' ' PHE . 70.4 mt -87.85 118.15 33.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.206 0.527 . . . . 0.0 110.995 -173.24 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 24' ' ' ILE . . . . . 0.684 ' H ' HD13 ' C' ' 24' ' ' ILE . 0.2 OUTLIER -90.14 -17.99 7.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.092 -179.456 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -155.15 129.22 8.81 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.103 -175.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 6.6 p -58.62 127.47 32.32 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.696 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 27' ' ' PHE . . . . . 0.741 ' HB3' HD23 ' C' ' 91' ' ' LEU . 10.2 p90 -143.64 166.42 24.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.633 0.73 . . . . 0.0 112.774 -174.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 28' ' ' HIS . . . . . 0.577 ' HE2' ' HB3' ' C' ' 30' ' ' SER . 4.8 t60 -121.94 127.47 50.42 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.291 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 29' ' ' ILE . . . . . 0.627 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 47.6 mt -94.57 135.3 29.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 171.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.577 ' HB3' ' HE2' ' C' ' 28' ' ' HIS . 55.8 p -119.87 -13.53 9.05 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -169.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 31' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -164.09 141.46 7.12 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 119.372 -1.394 . . . . 0.0 113.329 177.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.439 HG23 ' HG ' ' C' ' 87' ' ' LEU . 11.8 p -126.95 120.69 56.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 169.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.41 ' HA ' HG21 ' C' ' 56' ' ' VAL . . . -141.16 157.23 45.56 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.886 -0.509 . . . . 0.0 111.647 -173.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.627 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.6 pp -127.14 145.52 50.72 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.656 0.741 . . . . 0.0 111.284 178.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -110.32 -46.89 3.36 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.251 173.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -102.62 128.12 49.44 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.259 173.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 37' ' ' GLY . . . . . 0.529 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 141.64 161.36 8.7 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 119.446 -1.359 . . . . 0.0 113.888 176.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -102.71 -44.1 5.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.753 0.311 . . . . 0.0 110.973 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -151.73 125.71 9.16 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.119 -177.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.492 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -127.77 113.02 15.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.376 0.608 . . . . 0.0 109.655 168.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' C' ' 79' ' ' THR . 56.0 mtpt -99.56 106.11 18.06 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.4 HD23 ' HB ' ' C' ' 53' ' ' VAL . 46.5 tp -79.18 108.8 12.95 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.803 -173.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -107.83 141.0 40.08 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.339 176.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.551 ' CD1' ' HB ' ' C' ' 75' ' ' ILE . 4.4 tp -124.46 116.4 22.45 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.098 176.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 45' ' ' ALA . . . . . 0.546 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -101.77 104.22 15.0 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 174.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.478 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -127.08 136.42 52.14 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.367 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 56.31 36.01 26.78 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.642 0.589 . . . . 0.0 110.215 -175.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 61.5 39.59 14.71 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.087 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 49' ' ' GLN . . . . . 0.546 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 8.5 tp-100 -134.67 127.94 32.06 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 175.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -85.15 105.74 16.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.854 0.359 . . . . 0.0 110.444 -178.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -100.18 131.26 46.23 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.436 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 tp -79.78 108.74 13.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 168.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 53' ' ' VAL . . . . . 0.533 HG13 ' CD2' ' B' ' 88' ' ' LEU . 2.3 t -82.5 -51.25 15.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.642 -172.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 54' ' ' ALA . . . . . 0.49 ' HB1' HG11 ' C' ' 63' ' ' VAL . . . -156.29 145.58 20.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.006 -178.134 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 31.9 m -109.28 101.82 10.79 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 173.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 56' ' ' VAL . . . . . 0.471 HG13 ' HB3' ' C' ' 40' ' ' ALA . 7.4 p -115.57 114.91 47.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.533 0.682 . . . . 0.0 109.695 -177.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 64.2 p -123.03 -178.33 3.93 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.337 -174.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -63.83 -22.51 66.95 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.112 0.482 . . . . 0.0 110.227 171.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 59' ' ' ALA . . . . . 0.44 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -83.87 -40.56 18.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.237 177.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 78.0 mt -112.34 81.57 4.05 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 173.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 61' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 12.1 Cg_exo -70.07 -0.0 6.53 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.142 2.562 . . . . 0.0 114.025 -166.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -163.73 129.62 3.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.185 0.517 . . . . 0.0 111.52 -175.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.49 HG11 ' HB1' ' C' ' 54' ' ' ALA . 66.1 t -119.07 100.01 8.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.219 173.153 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.22 117.01 21.39 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 173.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 65' ' ' LEU . . . . . 0.442 HD23 ' H ' ' C' ' 65' ' ' LEU . 0.9 OUTLIER -139.01 168.09 20.6 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.952 0.406 . . . . 0.0 111.087 -171.137 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 66' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 12.1 t0 -112.39 104.6 12.75 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.315 0.579 . . . . 0.0 110.132 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.663 HD21 HD23 ' B' ' 88' ' ' LEU . 11.1 mt -117.3 141.22 48.57 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.048 178.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -142.11 132.47 25.04 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.641 174.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 69' ' ' PHE . . . . . 0.476 ' CZ ' HD22 ' C' ' 67' ' ' LEU . 59.1 m-85 -130.03 160.61 33.16 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.932 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 18.3 t -120.12 158.8 26.13 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -79.45 9.08 5.19 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.979 0.419 . . . . 0.0 111.083 -175.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.26 -29.23 9.08 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 174.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -100.5 165.8 11.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.966 0.413 . . . . 0.0 110.784 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -135.71 143.49 45.41 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.551 ' HB ' ' CD1' ' C' ' 44' ' ' LEU . 24.9 pt -135.67 159.14 39.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.12 0.486 . . . . 0.0 112.305 -168.134 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.462 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 10.8 mtp -114.88 117.51 30.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.764 173.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 77' ' ' PHE . . . . . 0.504 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.6 OUTLIER -104.16 126.89 51.64 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 176.104 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 78' ' ' TYR . . . . . 0.592 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 23.4 p90 -152.19 134.63 15.25 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.969 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 79' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 2.4 p -107.8 120.01 41.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.352 -177.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.24 160.92 15.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.613 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.6 -170.54 31.08 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 82' ' ' ASP . . . . . 0.449 ' HA ' ' HB3' ' C' ' 15' ' ' PRO . 19.0 t70 -116.91 103.49 10.34 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.955 176.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 83' ' ' ALA . . . . . 0.529 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -173.31 158.79 3.64 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.794 172.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 25.6 t -117.88 122.38 43.18 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.627 HG12 ' HB3' ' C' ' 34' ' ' LEU . 5.0 m -115.74 156.1 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-O 121.453 0.644 . . . . 0.0 112.464 -172.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 50.3 m -119.08 117.31 28.38 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.045 173.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 87' ' ' LEU . . . . . 0.628 HD11 ' SD ' ' C' ' 13' ' ' MET . 5.1 mp -91.76 146.97 23.34 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 171.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 88' ' ' LEU . . . . . 0.675 HD23 HD21 ' D' ' 67' ' ' LEU . 0.7 OUTLIER -130.74 142.47 50.41 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.796 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.89 -168.0 27.39 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.082 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -145.4 130.24 18.18 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.741 0.781 . . . . 0.0 112.158 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 91' ' ' LEU . . . . . 0.741 HD23 ' HB3' ' C' ' 27' ' ' PHE . 18.1 mt . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 114.321 -1.308 . . . . 0.0 109.415 173.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.222 -0.377 0 CA-C-O 120.557 0.218 . . . . 0.0 110.837 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 8' ' ' PHE . . . . . 0.522 ' CE1' HD21 ' E' ' 44' ' ' LEU . 70.4 t80 -67.93 142.96 55.86 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.17 0.509 . . . . 0.0 112.063 -177.255 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 9' ' ' TRP . . . . . 0.567 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 88.2 t90 -135.03 147.97 49.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.133 177.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.6 153.2 24.8 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.455 179.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 11' ' ' LEU . . . . . 0.567 ' HB2' ' CH2' ' D' ' 9' ' ' TRP . 41.7 tp -144.19 109.95 5.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.751 0.31 . . . . 0.0 110.392 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -96.55 96.74 8.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.921 0.391 . . . . 0.0 110.102 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 13' ' ' MET . . . . . 0.627 ' SD ' HD11 ' D' ' 87' ' ' LEU . 62.7 mtp -93.05 144.24 25.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.961 -173.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -101.24 167.0 11.35 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.174 177.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 15' ' ' PRO . . . . . 0.434 ' HB3' ' HA ' ' D' ' 82' ' ' ASP . 86.9 Cg_exo -49.86 115.61 1.93 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.8 2.334 . . . . 0.0 112.74 176.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 16' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' D' ' 79' ' ' THR . 29.1 mt-10 63.37 39.53 9.26 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.326 0.584 . . . . 0.0 111.299 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 17' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' D' ' 78' ' ' TYR . 0.5 OUTLIER -88.04 133.44 33.97 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.383 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 18' ' ' LYS . . . . . 0.606 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 33.9 ttmt -123.26 116.13 22.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.199 0.524 . . . . 0.0 111.077 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 19' ' ' TYR . . . . . 0.47 ' CZ ' ' HG2' ' D' ' 17' ' ' ARG . 18.8 m-85 -107.11 102.46 11.79 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.595 178.033 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 11.0 p -89.97 97.18 11.04 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 169.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.07 145.5 43.7 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.556 0.693 . . . . 0.0 112.483 -165.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 21.5 m -97.71 132.83 42.98 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.99 174.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 23' ' ' ILE . . . . . 0.431 ' CD1' ' HB3' ' D' ' 69' ' ' PHE . 70.3 mt -87.68 118.08 32.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.11 0.481 . . . . 0.0 111.093 -173.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 24' ' ' ILE . . . . . 0.694 ' H ' HD13 ' D' ' 24' ' ' ILE . 0.2 OUTLIER -90.09 -18.02 7.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.097 -179.422 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -155.16 129.12 8.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.085 -175.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 6.8 p -58.49 127.46 32.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.689 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 27' ' ' PHE . . . . . 0.721 ' HB3' HD23 ' D' ' 91' ' ' LEU . 10.3 p90 -143.73 166.36 25.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.721 0.772 . . . . 0.0 112.727 -174.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 28' ' ' HIS . . . . . 0.569 ' HE2' ' HB3' ' D' ' 30' ' ' SER . 4.7 t60 -121.93 127.42 50.39 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.285 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 29' ' ' ILE . . . . . 0.621 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 47.4 mt -94.5 135.33 29.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 171.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 30' ' ' SER . . . . . 0.569 ' HB3' ' HE2' ' D' ' 28' ' ' HIS . 55.9 p -119.96 -13.43 9.03 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -169.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 31' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -164.14 141.5 7.14 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 119.431 -1.366 . . . . 0.0 113.354 177.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.45 HG23 ' HG ' ' D' ' 87' ' ' LEU . 11.8 p -126.97 120.69 56.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 169.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 33' ' ' ALA . . . . . 0.4 ' HA ' HG21 ' D' ' 56' ' ' VAL . . . -141.17 157.21 45.58 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 121.95 -0.469 . . . . 0.0 111.589 -173.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 34' ' ' LEU . . . . . 0.635 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.6 pp -127.11 145.56 50.7 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.682 0.753 . . . . 0.0 111.254 178.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -110.34 -46.91 3.35 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.761 -1.108 . . . . 0.0 108.24 173.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -102.61 128.14 49.42 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.279 173.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 37' ' ' GLY . . . . . 0.538 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 141.6 161.4 8.72 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 119.459 -1.353 . . . . 0.0 113.814 176.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -102.77 -44.06 5.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.616 -0.292 . . . . 0.0 110.975 177.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -151.71 125.71 9.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.204 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 40' ' ' ALA . . . . . 0.513 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -127.82 113.08 15.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.443 0.639 . . . . 0.0 109.724 168.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' D' ' 79' ' ' THR . 56.0 mtpt -99.58 106.06 18.0 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.401 HD23 ' HB ' ' D' ' 53' ' ' VAL . 46.4 tp -79.12 108.72 12.82 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.814 -173.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -107.77 140.98 40.03 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.363 176.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.55 ' CD1' ' HB ' ' D' ' 75' ' ' ILE . 4.4 tp -124.41 116.47 22.6 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.14 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 45' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -101.84 104.18 14.92 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 174.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.49 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -127.08 136.4 52.1 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.403 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 56.41 35.91 26.68 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.383 0.611 . . . . 0.0 110.25 -175.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 61.61 39.44 14.53 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.117 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 49' ' ' GLN . . . . . 0.553 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 8.5 tp-100 -134.57 127.95 32.29 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 175.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -85.15 105.71 16.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.88 0.371 . . . . 0.0 110.456 -178.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -100.1 131.28 46.14 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.44 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 tp -79.73 108.82 13.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 168.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 53' ' ' VAL . . . . . 0.548 HG13 ' CD2' ' C' ' 88' ' ' LEU . 2.3 t -82.69 -51.2 14.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.575 -172.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 54' ' ' ALA . . . . . 0.487 ' HB1' HG11 ' D' ' 63' ' ' VAL . . . -156.34 145.56 20.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.076 -178.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 31.9 m -109.2 101.8 10.8 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 173.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 56' ' ' VAL . . . . . 0.477 HG13 ' HB3' ' D' ' 40' ' ' ALA . 7.4 p -115.57 114.93 47.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.483 0.659 . . . . 0.0 109.701 -177.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 63.1 p -122.95 -178.31 3.91 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.433 -174.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -63.78 -22.48 66.93 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.992 0.425 . . . . 0.0 110.321 171.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 59' ' ' ALA . . . . . 0.439 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -83.91 -40.71 18.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.143 177.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 78.2 mt -112.24 81.54 3.94 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 173.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 61' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 12.1 Cg_exo -70.14 0.14 6.37 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.163 2.575 . . . . 0.0 114.007 -166.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -163.85 129.58 3.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.085 0.469 . . . . 0.0 111.432 -175.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.487 HG11 ' HB1' ' D' ' 54' ' ' ALA . 66.8 t -119.03 99.93 8.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.176 173.201 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.14 117.06 21.37 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 173.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 65' ' ' LEU . . . . . 0.443 HD23 ' H ' ' D' ' 65' ' ' LEU . 0.9 OUTLIER -139.05 168.13 20.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.865 0.364 . . . . 0.0 111.098 -171.129 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 66' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 12.2 t0 -112.44 104.48 12.61 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.354 0.597 . . . . 0.0 110.181 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.675 HD21 HD23 ' C' ' 88' ' ' LEU . 11.1 mt -117.31 141.18 48.62 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.985 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.04 132.48 25.17 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.583 174.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 69' ' ' PHE . . . . . 0.479 ' CZ ' HD22 ' D' ' 67' ' ' LEU . 59.0 m-85 -130.01 160.63 33.07 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.97 178.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 18.3 t -120.21 158.73 26.38 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -79.34 9.11 5.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.846 0.355 . . . . 0.0 111.103 -175.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.34 -29.21 9.05 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 174.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -100.42 165.82 11.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.044 0.449 . . . . 0.0 110.746 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -135.74 143.49 45.35 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.55 ' HB ' ' CD1' ' D' ' 44' ' ' LEU . 24.7 pt -135.72 159.2 39.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.211 0.529 . . . . 0.0 112.25 -168.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 76' ' ' MET . . . . . 0.459 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 10.9 mtp -114.95 117.41 30.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.801 173.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 77' ' ' PHE . . . . . 0.503 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.6 OUTLIER -104.19 126.95 51.71 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.134 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 78' ' ' TYR . . . . . 0.606 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 23.1 p90 -152.22 134.66 15.25 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.886 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 79' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 2.4 p -107.85 119.96 40.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.297 -177.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.23 160.88 15.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.619 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.61 -170.51 31.05 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 110.656 -0.977 . . . . 0.0 110.656 -177.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 82' ' ' ASP . . . . . 0.434 ' HA ' ' HB3' ' D' ' 15' ' ' PRO . 19.0 t70 -116.92 103.45 10.3 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 117.861 0.831 . . . . 0.0 109.951 176.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 83' ' ' ALA . . . . . 0.538 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -173.38 158.69 3.57 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.744 172.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 26.2 t -117.78 122.37 43.27 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.635 HG12 ' HB3' ' D' ' 34' ' ' LEU . 5.0 m -115.9 156.11 17.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.491 0.662 . . . . 0.0 112.429 -172.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -119.08 117.16 28.0 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.04 173.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 87' ' ' LEU . . . . . 0.627 HD11 ' SD ' ' D' ' 13' ' ' MET . 5.1 mp -91.69 146.99 23.33 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 171.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.658 HD23 HD21 ' E' ' 67' ' ' LEU . 0.7 OUTLIER -130.78 142.52 50.41 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.747 179.617 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.9 -167.98 27.36 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.981 -178.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -145.39 130.26 18.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.734 0.778 . . . . 0.0 112.156 178.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 91' ' ' LEU . . . . . 0.721 HD23 ' HB3' ' D' ' 27' ' ' PHE . 18.1 mt . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.469 173.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 7' ' ' MET . . . . . 0.4 ' O ' ' HA ' ' E' ' 90' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.222 -0.346 0 CA-C-O 120.524 0.202 . . . . 0.0 110.913 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 8' ' ' PHE . . . . . 0.524 ' CE1' HD21 ' A' ' 44' ' ' LEU . 70.2 t80 -67.8 142.99 56.02 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.036 0.446 . . . . 0.0 112.071 -177.264 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 9' ' ' TRP . . . . . 0.558 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 88.2 t90 -135.12 148.04 49.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.118 177.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.69 153.14 24.75 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.448 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 11' ' ' LEU . . . . . 0.558 ' HB2' ' CH2' ' E' ' 9' ' ' TRP . 41.2 tp -144.1 109.98 5.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.779 0.323 . . . . 0.0 110.455 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -96.59 96.73 8.85 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.908 0.385 . . . . 0.0 110.04 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 13' ' ' MET . . . . . 0.632 ' SD ' HD11 ' E' ' 87' ' ' LEU . 62.7 mtp -92.98 144.14 25.54 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.963 -173.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -101.19 166.91 11.52 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.139 177.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 15' ' ' PRO . . . . . 0.441 ' HB3' ' HA ' ' E' ' 82' ' ' ASP . 87.9 Cg_exo -49.77 115.61 1.92 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.78 2.32 . . . . 0.0 112.797 176.099 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 16' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' E' ' 79' ' ' THR . 29.0 mt-10 63.29 39.65 9.34 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.295 0.569 . . . . 0.0 111.259 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 17' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' E' ' 78' ' ' TYR . 0.5 OUTLIER -88.15 133.43 34.01 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.353 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' E' E ' 18' ' ' LYS . . . . . 0.586 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 33.9 ttmt -123.21 116.14 22.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.153 0.502 . . . . 0.0 111.036 -178.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 19' ' ' TYR . . . . . 0.462 ' CZ ' ' HG2' ' E' ' 17' ' ' ARG . 18.7 m-85 -107.1 102.7 12.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.568 177.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 10.9 p -90.22 97.26 11.08 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 169.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.18 145.5 43.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.474 0.654 . . . . 0.0 112.454 -165.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 21.8 m -97.68 132.82 42.97 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.949 174.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 23' ' ' ILE . . . . . 0.436 ' CD1' ' HB3' ' E' ' 69' ' ' PHE . 70.0 mt -87.72 118.06 32.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.085 0.469 . . . . 0.0 111.083 -173.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 24' ' ' ILE . . . . . 0.673 ' H ' HD13 ' E' ' 24' ' ' ILE . 0.2 OUTLIER -90.11 -17.98 7.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.092 -179.421 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -155.15 129.21 8.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.075 -175.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 7.0 p -58.54 127.4 31.95 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.458 0.474 . . . . 0.0 110.679 -178.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 27' ' ' PHE . . . . . 0.736 ' HB3' HD23 ' E' ' 91' ' ' LEU . 10.2 p90 -143.68 166.44 24.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.645 0.736 . . . . 0.0 112.726 -174.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 28' ' ' HIS . . . . . 0.568 ' HE2' ' HB3' ' E' ' 30' ' ' SER . 4.8 t60 -121.9 127.45 50.46 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.36 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 29' ' ' ILE . . . . . 0.625 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 47.6 mt -94.63 135.33 29.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 30' ' ' SER . . . . . 0.568 ' HB3' ' HE2' ' E' ' 28' ' ' HIS . 55.0 p -119.94 -13.48 9.03 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -169.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 31' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -164.14 141.48 7.13 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 119.36 -1.4 . . . . 0.0 113.339 177.136 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.449 HG23 ' HG ' ' E' ' 87' ' ' LEU . 11.9 p -126.89 120.71 56.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 169.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 33' ' ' ALA . . . . . 0.407 ' HA ' HG21 ' E' ' 56' ' ' VAL . . . -141.17 157.15 45.66 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.601 -173.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 34' ' ' LEU . . . . . 0.622 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.6 pp -127.11 145.55 50.7 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.686 0.755 . . . . 0.0 111.179 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -110.22 -47.01 3.35 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.256 173.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -102.64 128.11 49.47 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.294 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 37' ' ' GLY . . . . . 0.538 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 141.62 161.45 8.74 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 119.566 -1.302 . . . . 0.0 113.886 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -102.76 -44.08 5.39 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.734 0.302 . . . . 0.0 110.952 177.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -151.72 125.74 9.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.168 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 40' ' ' ALA . . . . . 0.491 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -127.84 113.1 15.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.422 0.629 . . . . 0.0 109.671 168.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 41' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' E' ' 79' ' ' THR . 56.0 mtpt -99.64 106.07 17.98 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 46.3 tp -79.16 108.77 12.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.792 -173.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -107.83 141.01 40.07 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.303 176.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 44' ' ' LEU . . . . . 0.554 ' CD1' ' HB ' ' E' ' 75' ' ' ILE . 4.4 tp -124.46 116.4 22.47 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.096 176.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 45' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -101.76 104.2 14.97 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 174.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 46' ' ' ALA . . . . . 0.479 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -127.12 136.36 52.0 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.387 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 56.53 35.87 26.7 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.657 0.598 . . . . 0.0 110.216 -175.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 61.52 39.49 14.77 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.154 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 49' ' ' GLN . . . . . 0.547 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 8.5 tp-100 -134.56 128.08 32.55 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 175.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -85.22 105.7 16.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.875 0.369 . . . . 0.0 110.381 -178.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -100.15 131.21 46.23 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.427 177.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 6.0 tp -79.6 108.74 13.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 168.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 53' ' ' VAL . . . . . 0.526 HG13 ' CD2' ' D' ' 88' ' ' LEU . 2.3 t -82.64 -51.27 14.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.526 -172.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 54' ' ' ALA . . . . . 0.49 ' HB1' HG11 ' E' ' 63' ' ' VAL . . . -156.32 145.64 20.65 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.012 -178.197 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 31.9 m -109.19 101.7 10.71 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 173.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 56' ' ' VAL . . . . . 0.462 HG13 ' HB3' ' E' ' 40' ' ' ALA . 7.4 p -115.51 114.92 47.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.621 0.724 . . . . 0.0 109.724 -177.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 63.2 p -122.87 -178.29 3.9 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.434 -174.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -63.87 -22.46 66.93 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.07 0.462 . . . . 0.0 110.298 171.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 59' ' ' ALA . . . . . 0.441 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -83.96 -40.59 18.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.187 177.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.38 81.53 4.07 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 173.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 61' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 12.0 Cg_exo -70.09 0.13 6.35 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.133 2.556 . . . . 0.0 114.024 -166.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -163.81 129.53 3.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.195 0.521 . . . . 0.0 111.469 -175.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 63' ' ' VAL . . . . . 0.49 HG11 ' HB1' ' E' ' 54' ' ' ALA . 66.5 t -119.03 100.03 9.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.207 173.066 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.2 117.09 21.44 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 173.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 65' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' E' ' 30' ' ' SER . 0.9 OUTLIER -139.1 168.16 20.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.893 0.378 . . . . 0.0 111.097 -171.168 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' E' E ' 66' ' ' ASP . . . . . 0.512 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 12.1 t0 -112.39 104.49 12.63 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.3 0.571 . . . . 0.0 110.121 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 67' ' ' LEU . . . . . 0.658 HD21 HD23 ' D' ' 88' ' ' LEU . 11.1 mt -117.31 141.25 48.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.988 178.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.11 132.46 25.03 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.849 0.357 . . . . 0.0 110.682 174.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 69' ' ' PHE . . . . . 0.468 ' CZ ' HD22 ' E' ' 67' ' ' LEU . 58.5 m-85 -130.04 160.54 33.36 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.91 178.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 18.1 t -120.11 158.75 26.23 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -79.46 9.1 5.19 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.06 0.457 . . . . 0.0 111.102 -175.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.3 -29.28 9.03 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.453 174.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -100.38 165.85 11.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.033 0.444 . . . . 0.0 110.706 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -135.77 143.41 45.24 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 75' ' ' ILE . . . . . 0.554 ' HB ' ' CD1' ' E' ' 44' ' ' LEU . 24.9 pt -135.65 159.2 40.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.179 0.514 . . . . 0.0 112.278 -168.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 76' ' ' MET . . . . . 0.456 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 10.8 mtp -115.0 117.48 30.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.752 173.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 77' ' ' PHE . . . . . 0.5 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.6 OUTLIER -104.14 126.92 51.65 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 176.147 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' E' E ' 78' ' ' TYR . . . . . 0.586 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 23.0 p90 -152.22 134.61 15.21 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.985 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 79' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 2.4 p -107.8 120.0 41.02 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.375 -177.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.23 160.89 15.96 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.65 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.6 -170.48 31.04 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -177.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 82' ' ' ASP . . . . . 0.441 ' HA ' ' HB3' ' E' ' 15' ' ' PRO . 19.1 t70 -116.88 103.46 10.32 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 119.676 -0.809 . . . . 0.0 109.941 176.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 83' ' ' ALA . . . . . 0.538 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -173.33 158.7 3.61 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.776 172.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 25.9 t -117.86 122.47 43.42 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 85' ' ' VAL . . . . . 0.622 HG12 ' HB3' ' E' ' 34' ' ' LEU . 4.9 m -115.85 156.13 17.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.487 0.66 . . . . 0.0 112.328 -172.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 50.4 m -119.09 117.17 28.02 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.042 173.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 87' ' ' LEU . . . . . 0.632 HD11 ' SD ' ' E' ' 13' ' ' MET . 5.1 mp -91.72 147.03 23.29 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 171.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 88' ' ' LEU . . . . . 0.667 HD23 HD21 ' A' ' 67' ' ' LEU . 0.7 OUTLIER -130.81 142.51 50.4 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.744 179.643 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.95 -168.0 27.45 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.016 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 90' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' E' ' 7' ' ' MET . 37.0 p90 -145.42 130.19 18.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.643 0.735 . . . . 0.0 112.191 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 91' ' ' LEU . . . . . 0.736 HD23 ' HB3' ' E' ' 27' ' ' PHE . 18.2 mt . . . . . 0 C--N 1.324 -0.518 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.498 173.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 21.7 ttt . . . . . 0 C--O 1.226 -0.137 0 CA-C-O 121.188 0.518 . . . . 0.0 112.317 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.569 ' CE1' HD12 ' A' ' 88' ' ' LEU . 77.7 t80 -54.49 141.45 30.96 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.967 -176.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.531 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 89.5 t90 -133.46 147.23 51.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.704 -1.134 . . . . 0.0 108.503 177.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.89 145.54 14.45 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.658 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.558 HD23 HD13 ' A' ' 87' ' ' LEU . 50.1 tp -135.89 108.74 7.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.894 0.378 . . . . 0.0 110.317 177.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -96.64 100.96 12.49 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 176.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.562 ' SD ' HD11 ' A' ' 87' ' ' LEU . 61.0 mtp -92.5 143.47 26.32 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.291 0.567 . . . . 0.0 111.383 -172.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -100.49 145.02 29.57 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.425 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.526 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 9.5 Cg_endo -51.84 123.22 11.89 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 123.64 2.893 . . . . 0.0 113.597 -174.446 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' A' ' 79' ' ' THR . 35.8 mt-10 57.71 73.6 0.46 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.689 178.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.85 138.34 19.59 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.224 176.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.723 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 50.2 mttp -107.34 121.9 45.51 Favored 'General case' 0 CA--C 1.512 -0.497 0 O-C-N 123.451 0.47 . . . . 0.0 111.368 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.57 102.79 11.34 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 76' ' ' MET . 44.4 t -90.08 99.22 12.28 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 173.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -115.55 139.76 49.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.594 0.712 . . . . 0.0 112.2 -168.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.1 m -84.72 132.17 34.48 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.348 174.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 59.3 mt -86.35 115.45 27.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.07 0.462 . . . . 0.0 110.934 -175.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.431 HD12 ' N ' ' A' ' 25' ' ' LYS . 1.9 pp -88.7 -12.44 10.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.399 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.431 ' N ' HD12 ' A' ' 24' ' ' ILE . 83.3 tttt -160.03 120.12 2.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.486 178.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.7 m -51.54 137.16 24.99 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.683 0.614 . . . . 0.0 110.403 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.715 ' HB3' HD23 ' A' ' 91' ' ' LEU . 33.1 p90 -147.35 165.32 30.52 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -174.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.498 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 8.3 t60 -116.17 120.28 38.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.699 177.024 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 42.6 mt -84.51 134.68 26.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 169.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.508 ' HB2' ' HB3' ' B' ' 66' ' ' ASP . 76.7 p -119.68 -10.05 9.65 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -171.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -178.11 158.57 23.53 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 119.263 -1.446 . . . . 0.0 113.628 177.039 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.483 HG23 ' HG ' ' A' ' 87' ' ' LEU . 11.9 p -139.67 137.24 39.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 175.032 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -150.18 154.83 38.69 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.903 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.562 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.3 pp -118.19 140.02 50.42 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.964 0.888 . . . . 0.0 111.615 178.265 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -110.28 -53.41 2.68 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.981 -1.463 . . . . 0.0 108.549 174.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -101.47 126.79 48.32 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.589 175.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.508 ' HA3' ' HA ' ' A' ' 83' ' ' ALA . . . 140.54 165.64 10.38 Favored Glycine 0 N--CA 1.439 -1.119 0 C-N-CA 119.588 -1.292 . . . . 0.0 113.542 178.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -102.72 -46.58 4.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.58 0.228 . . . . 0.0 111.395 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -151.46 134.23 15.65 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.018 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.509 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -132.77 113.71 13.27 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.46 0.648 . . . . 0.0 110.42 170.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 79' ' ' THR . 65.4 mttp -98.21 113.36 25.26 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 174.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.414 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 58.7 tp -89.93 109.03 20.08 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.424 -170.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.537 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 71.5 m-85 -109.02 148.6 30.52 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.852 178.016 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.658 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -128.41 117.07 20.75 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.606 176.046 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -102.9 104.45 14.68 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.429 0.633 . . . . 0.0 109.927 176.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.491 ' HB2' HD11 ' A' ' 44' ' ' LEU . . . -128.79 143.72 50.99 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.316 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 61.16 26.59 16.47 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.716 0.769 . . . . 0.0 109.074 -174.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.4 ' N ' ' HD2' ' A' ' 48' ' ' LYS . 4.2 mptp? 59.2 38.36 23.55 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.874 -177.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.567 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 6.6 tp-100 -129.5 127.91 41.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.823 178.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -81.38 106.01 13.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.096 0.474 . . . . 0.0 110.599 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -102.3 116.98 33.78 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.339 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 tp -74.71 99.84 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 171.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.502 HG12 ' CD2' ' E' ' 88' ' ' LEU . 29.3 m -87.43 -32.45 6.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.611 -172.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.746 ' HB2' HD21 ' A' ' 65' ' ' LEU . . . -152.93 142.42 21.75 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.371 -0.532 . . . . 0.0 112.211 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.1 m -112.97 101.93 9.94 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 169.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.0 p -118.36 112.43 38.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.932 0.873 . . . . 0.0 110.443 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 78.5 p -123.34 -177.34 3.67 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.194 -176.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -60.93 -29.37 69.57 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.445 168.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.22 -40.66 62.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.252 0.549 . . . . 0.0 110.292 178.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 77.4 mt -117.8 81.69 15.65 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.35 -4.17 12.34 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.191 2.594 . . . . 0.0 113.963 -168.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -160.67 129.71 4.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.281 0.562 . . . . 0.0 111.206 -175.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 96.7 t -120.17 125.59 74.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.525 176.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.36 130.68 34.54 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 175.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.746 HD21 ' HB2' ' A' ' 54' ' ' ALA . 88.5 mt -122.82 166.64 14.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.394 0.616 . . . . 0.0 112.288 -173.061 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.539 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 26.9 t0 -144.51 97.95 3.12 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 170.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.531 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 7.0 mt -133.0 109.38 9.51 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.347 -175.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.451 ' HB2' ' CD2' ' E' ' 90' ' ' TYR . 7.5 m-20 -104.73 114.7 29.08 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.839 0.352 . . . . 0.0 110.149 178.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -108.09 160.35 15.87 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.338 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.5 t -116.14 149.64 38.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.955 0.407 . . . . 0.0 110.625 -177.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -69.15 0.13 5.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.198 -176.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.46 -18.56 35.35 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.345 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -101.51 164.06 11.95 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.708 -0.289 . . . . 0.0 110.836 -175.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -130.9 108.76 10.06 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.4 pt -109.52 158.46 9.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.259 -170.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.436 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 2.6 mtm -116.69 122.88 45.82 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.873 175.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.658 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -104.49 128.57 52.45 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.688 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.723 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 36.4 p90 -149.98 135.34 18.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.529 0.68 . . . . 0.0 112.492 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 3.9 p -106.36 132.56 52.25 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.763 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.54 154.42 18.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.799 177.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.422 ' O ' ' HG3' ' A' ' 16' ' ' GLU . . . 91.33 -172.14 35.98 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -176.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.403 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 21.3 t70 -113.13 102.86 10.79 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.825 176.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.526 ' H ' ' HB3' ' A' ' 15' ' ' PRO . . . -169.28 153.74 5.51 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.85 167.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.4 t -111.05 120.66 43.08 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.562 HG12 ' HB3' ' A' ' 34' ' ' LEU . 3.8 m -114.9 149.31 17.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -172.047 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.8 m -110.93 115.4 29.43 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.598 175.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.562 HD11 ' SD ' ' A' ' 13' ' ' MET . 4.8 mp -94.85 145.17 25.08 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 170.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.569 HD12 ' CE1' ' A' ' 8' ' ' PHE . 2.4 mm? -124.28 149.53 46.4 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 175.064 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.82 -167.35 26.32 Favored Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.48 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.44 ' CD2' ' HB2' ' B' ' 68' ' ' ASN . 5.1 p90 -149.31 131.38 15.35 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.763 0.792 . . . . 0.0 111.795 176.058 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.715 HD23 ' HB3' ' A' ' 27' ' ' PHE . 27.3 mt . . . . . 0 C--N 1.323 -0.582 0 CA-C-N 113.927 -1.488 . . . . 0.0 110.279 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 21.8 ttt . . . . . 0 C--O 1.225 -0.208 0 CA-C-O 121.189 0.519 . . . . 0.0 112.251 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 8' ' ' PHE . . . . . 0.559 ' CE1' HD12 ' B' ' 88' ' ' LEU . 78.1 t80 -54.51 141.53 30.8 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 114.76 -1.109 . . . . 0.0 113.001 -176.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 9' ' ' TRP . . . . . 0.531 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 89.3 t90 -133.53 147.28 51.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.531 177.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.91 145.54 14.44 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.607 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.546 HD23 HD13 ' B' ' 87' ' ' LEU . 50.2 tp -135.9 108.8 7.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.91 0.386 . . . . 0.0 110.344 176.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -96.76 101.1 12.64 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 13' ' ' MET . . . . . 0.568 ' SD ' HD11 ' B' ' 87' ' ' LEU . 60.8 mtp -92.58 143.46 26.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.304 0.573 . . . . 0.0 111.372 -172.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -100.49 145.02 29.59 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 114.926 -1.033 . . . . 0.0 109.371 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.521 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 9.5 Cg_endo -51.91 123.13 11.74 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.708 2.938 . . . . 0.0 113.597 -174.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' B' ' 79' ' ' THR . 35.8 mt-10 57.86 73.44 0.47 Allowed 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.668 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.76 138.5 19.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.214 176.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.711 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 50.2 mttp -107.39 121.95 45.63 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 123.397 0.436 . . . . 0.0 111.322 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 19' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' B' ' 76' ' ' MET . 3.1 m-85 -110.6 102.65 11.21 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 174.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 45.2 t -89.84 99.2 12.25 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 173.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -115.55 139.74 49.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.3 -168.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 54.4 m -84.66 132.16 34.51 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.399 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 59.3 mt -86.33 115.48 27.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.041 0.448 . . . . 0.0 110.924 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.431 HD12 ' N ' ' B' ' 25' ' ' LYS . 1.9 pp -88.7 -12.57 10.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.369 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.431 ' N ' HD12 ' B' ' 24' ' ' ILE . 83.3 tttt -159.99 120.17 2.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.479 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 13.6 m -51.47 137.09 24.7 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 123.768 0.667 . . . . 0.0 110.515 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 27' ' ' PHE . . . . . 0.719 ' HB3' HD23 ' B' ' 91' ' ' LEU . 33.0 p90 -147.34 165.34 30.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.386 0.612 . . . . 0.0 112.51 -174.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 28' ' ' HIS . . . . . 0.484 ' HA ' ' O ' ' B' ' 67' ' ' LEU . 8.3 t60 -116.15 120.24 38.39 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.749 176.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.536 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 42.5 mt -84.56 134.69 26.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 169.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.53 ' HB2' ' HB3' ' C' ' 66' ' ' ASP . 77.2 p -119.61 -10.1 9.67 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -171.121 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -178.16 158.5 23.38 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.314 -1.422 . . . . 0.0 113.678 177.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.485 HG23 ' HG ' ' B' ' 87' ' ' LEU . 11.9 p -139.71 137.27 39.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -150.16 154.78 38.61 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.972 -0.455 . . . . 0.0 110.961 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.565 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.3 pp -118.14 140.06 50.35 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.963 0.887 . . . . 0.0 111.651 178.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -110.41 -53.25 2.7 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.067 -1.424 . . . . 0.0 108.508 174.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -101.55 126.74 48.42 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.672 175.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' B' ' 83' ' ' ALA . . . 140.67 165.72 10.41 Favored Glycine 0 N--CA 1.439 -1.132 0 C-N-CA 119.602 -1.285 . . . . 0.0 113.484 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -102.76 -46.48 4.7 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.589 0.233 . . . . 0.0 111.481 176.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -151.5 134.24 15.62 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.95 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.518 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -132.83 113.71 13.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.494 0.664 . . . . 0.0 110.423 170.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' B' ' 79' ' ' THR . 65.4 mttp -98.19 113.22 25.06 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 174.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.422 ' HB3' ' HB3' ' B' ' 54' ' ' ALA . 58.9 tp -89.85 109.14 20.17 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.367 -170.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 43' ' ' TYR . . . . . 0.554 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 71.1 m-85 -109.04 148.53 30.66 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.919 177.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.672 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 0.4 OUTLIER -128.37 117.12 20.86 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.589 176.058 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -102.89 104.4 14.64 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.358 0.599 . . . . 0.0 109.925 176.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.485 ' HB2' HD11 ' B' ' 44' ' ' LEU . . . -128.85 143.67 50.97 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 61.06 26.64 16.56 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.769 0.795 . . . . 0.0 109.168 -174.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 59.19 38.28 23.61 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.009 -177.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.564 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 6.6 tp-100 -129.46 127.97 41.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.727 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -81.43 106.04 13.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.966 0.413 . . . . 0.0 110.591 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -102.3 116.95 33.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.348 176.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -74.7 99.88 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 171.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.495 HG12 ' CD2' ' A' ' 88' ' ' LEU . 28.8 m -87.39 -32.51 6.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.576 -172.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.775 ' HB2' HD21 ' B' ' 65' ' ' LEU . . . -152.89 142.31 21.68 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 26.8 m -112.96 101.96 9.98 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 169.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 p -118.33 112.36 37.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.857 0.837 . . . . 0.0 110.468 -176.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 77.1 p -123.39 -177.39 3.69 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.107 -176.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -60.86 -29.41 69.51 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.507 168.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.15 -40.69 62.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.338 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 77.8 mt -117.73 81.64 15.31 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 173.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.34 -4.15 12.28 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.164 2.576 . . . . 0.0 113.922 -168.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -160.69 129.76 4.82 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.307 0.575 . . . . 0.0 111.164 -175.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 96.8 t -120.19 125.58 74.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.522 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.41 130.76 34.52 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.775 HD21 ' HB2' ' B' ' 54' ' ' ALA . 88.4 mt -122.91 166.59 14.79 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.408 0.623 . . . . 0.0 112.369 -173.111 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 66' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 26.1 t0 -144.45 97.94 3.12 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 170.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.536 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 7.0 mt -132.88 109.32 9.53 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.406 -175.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 68' ' ' ASN . . . . . 0.44 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 7.5 m-20 -104.69 114.65 29.0 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.899 0.38 . . . . 0.0 110.175 178.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -108.05 160.31 15.89 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.349 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 36.0 t -116.16 149.6 38.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.959 0.409 . . . . 0.0 110.563 -177.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -69.1 0.23 4.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.272 -176.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.54 -18.46 35.49 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.356 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -101.47 164.24 11.86 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.681 -0.305 . . . . 0.0 110.891 -176.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -131.11 108.81 10.02 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 22.4 pt -109.5 158.35 9.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.256 -170.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.438 ' HA ' ' HA ' ' B' ' 20' ' ' SER . 2.6 mtm -116.64 122.79 45.61 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 120.296 -0.562 . . . . 0.0 109.924 175.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 77' ' ' PHE . . . . . 0.672 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -104.49 128.61 52.46 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.665 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.711 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 36.0 p90 -150.08 135.37 18.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.589 0.709 . . . . 0.0 112.498 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 3.8 p -106.35 132.56 52.24 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.835 178.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.46 154.39 18.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.806 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.415 ' O ' ' HG3' ' B' ' 16' ' ' GLU . . . 91.38 -172.18 35.94 Favored Glycine 0 CA--C 1.506 -0.492 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -176.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 82' ' ' ASP . . . . . 0.407 ' HA ' ' HB3' ' B' ' 15' ' ' PRO . 21.5 t70 -113.09 102.9 10.83 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.854 176.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.521 ' H ' ' HB3' ' B' ' 15' ' ' PRO . . . -169.32 153.71 5.45 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.818 167.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 24.3 t -111.0 120.65 43.07 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.565 HG12 ' HB3' ' B' ' 34' ' ' LEU . 3.8 m -114.97 149.27 17.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.544 0.688 . . . . 0.0 112.816 -172.091 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 25.0 m -110.87 115.38 29.42 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.61 175.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.568 HD11 ' SD ' ' B' ' 13' ' ' MET . 4.8 mp -94.81 145.25 25.01 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 170.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.559 HD12 ' CE1' ' B' ' 8' ' ' PHE . 2.4 mm? -124.48 149.51 46.77 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.81 -167.29 26.22 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.512 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 90' ' ' TYR . . . . . 0.428 ' CD2' ' HB2' ' C' ' 68' ' ' ASN . 5.1 p90 -149.35 131.34 15.27 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.787 0.803 . . . . 0.0 111.682 176.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 91' ' ' LEU . . . . . 0.719 HD23 ' HB3' ' B' ' 27' ' ' PHE . 27.3 mt . . . . . 0 C--N 1.324 -0.543 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.256 176.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 21.8 ttt . . . . . 0 C--O 1.226 -0.183 0 CA-C-O 121.166 0.508 . . . . 0.0 112.325 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' C' C ' 8' ' ' PHE . . . . . 0.571 ' CE1' HD12 ' C' ' 88' ' ' LEU . 77.8 t80 -54.56 141.55 31.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.788 -1.097 . . . . 0.0 112.917 -176.154 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 9' ' ' TRP . . . . . 0.524 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 89.4 t90 -133.48 147.23 51.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.582 177.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.85 145.65 14.7 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.554 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.563 HD23 HD13 ' C' ' 87' ' ' LEU . 50.0 tp -135.97 108.74 7.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.923 0.392 . . . . 0.0 110.254 177.039 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -96.7 101.1 12.64 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 13' ' ' MET . . . . . 0.557 ' SD ' HD11 ' C' ' 87' ' ' LEU . 60.9 mtp -92.57 143.44 26.34 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.282 0.563 . . . . 0.0 111.401 -172.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -100.48 144.98 29.51 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.424 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 15' ' ' PRO . . . . . 0.526 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 9.5 Cg_endo -51.87 123.23 11.94 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 123.647 2.898 . . . . 0.0 113.559 -174.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 16' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' C' ' 79' ' ' THR . 36.1 mt-10 57.8 73.45 0.47 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.686 178.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.82 138.43 19.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.173 176.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 18' ' ' LYS . . . . . 0.723 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 50.2 mttp -107.37 121.98 45.67 Favored 'General case' 0 CA--C 1.511 -0.531 0 O-C-N 123.368 0.418 . . . . 0.0 111.325 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 19' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' C' ' 76' ' ' MET . 3.1 m-85 -110.63 102.74 11.28 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 174.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 20' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 44.7 t -89.97 99.22 12.27 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 173.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -115.52 139.69 49.83 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.272 -168.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 54.2 m -84.63 132.13 34.52 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.426 174.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 59.1 mt -86.21 115.32 27.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.048 0.452 . . . . 0.0 111.001 -175.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 24' ' ' ILE . . . . . 0.426 HD12 ' N ' ' C' ' 25' ' ' LYS . 1.9 pp -88.64 -12.57 10.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.39 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 25' ' ' LYS . . . . . 0.426 ' N ' HD12 ' C' ' 24' ' ' ILE . 83.3 tttt -159.95 120.24 2.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.431 178.265 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 13.4 m -51.47 137.13 24.66 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 123.736 0.647 . . . . 0.0 110.532 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 27' ' ' PHE . . . . . 0.73 ' HB3' HD23 ' C' ' 91' ' ' LEU . 32.9 p90 -147.39 165.32 30.57 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.448 0.642 . . . . 0.0 112.579 -174.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 28' ' ' HIS . . . . . 0.497 ' HA ' ' O ' ' C' ' 67' ' ' LEU . 8.3 t60 -116.1 120.29 38.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.728 177.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 29' ' ' ILE . . . . . 0.518 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 42.3 mt -84.61 134.68 26.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 169.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.5 ' HB2' ' HB3' ' D' ' 66' ' ' ASP . 75.9 p -119.59 -10.05 9.68 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -171.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 31' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -178.11 158.45 23.32 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 119.194 -1.479 . . . . 0.0 113.617 177.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.492 HG23 ' HG ' ' C' ' 87' ' ' LEU . 12.0 p -139.67 137.28 39.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -150.17 154.79 38.63 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 121.946 -0.471 . . . . 0.0 110.922 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.546 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.3 pp -118.24 140.09 50.33 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 122.01 0.909 . . . . 0.0 111.585 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -110.33 -53.32 2.7 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.934 -1.485 . . . . 0.0 108.514 174.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -101.59 126.72 48.46 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.603 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 37' ' ' GLY . . . . . 0.491 ' HA3' ' HA ' ' C' ' 83' ' ' ALA . . . 140.72 165.68 10.4 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 119.55 -1.309 . . . . 0.0 113.56 178.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -102.78 -46.46 4.7 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 120.575 0.226 . . . . 0.0 111.452 176.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -151.49 134.31 15.68 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.979 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.5 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -132.83 113.66 13.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.401 0.62 . . . . 0.0 110.451 170.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' C' ' 79' ' ' THR . 65.4 mttp -98.17 113.27 25.13 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 174.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.428 ' HG ' ' CG2' ' C' ' 53' ' ' VAL . 59.0 tp -89.92 109.08 20.12 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.416 -170.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 43' ' ' TYR . . . . . 0.543 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 71.3 m-85 -108.99 148.58 30.53 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.92 177.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.671 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 0.4 OUTLIER -128.39 117.09 20.78 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.579 176.045 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 45' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -102.87 104.5 14.76 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.33 0.586 . . . . 0.0 109.851 176.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.498 ' HB2' HD11 ' C' ' 44' ' ' LEU . . . -128.76 143.74 50.99 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.34 178.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 61.11 26.52 16.42 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.768 0.794 . . . . 0.0 109.138 -174.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 59.28 38.27 23.32 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.969 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 49' ' ' GLN . . . . . 0.558 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 6.6 tp-100 -129.49 127.96 41.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.715 178.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -81.51 106.08 13.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.074 0.464 . . . . 0.0 110.565 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -102.29 116.97 33.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.304 176.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 tp -74.74 99.88 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 171.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 53' ' ' VAL . . . . . 0.48 HG12 ' CD2' ' B' ' 88' ' ' LEU . 28.4 m -87.43 -32.43 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.618 -172.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 54' ' ' ALA . . . . . 0.776 ' HB2' HD21 ' C' ' 65' ' ' LEU . . . -152.89 142.41 21.77 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 120.308 -0.557 . . . . 0.0 112.261 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 27.0 m -113.05 101.97 9.96 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 169.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 p -118.26 112.39 38.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.817 0.818 . . . . 0.0 110.414 -176.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 77.0 p -123.45 -177.35 3.69 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.205 -176.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -60.81 -29.47 69.48 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.484 168.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.13 -40.68 62.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.289 0.566 . . . . 0.0 110.329 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 77.5 mt -117.75 81.65 15.4 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 173.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.33 -4.12 12.22 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.148 2.565 . . . . 0.0 113.969 -168.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -160.69 129.7 4.8 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.348 0.594 . . . . 0.0 111.194 -175.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 97.2 t -120.1 125.55 74.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.552 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.39 130.76 34.52 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 175.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 65' ' ' LEU . . . . . 0.776 HD21 ' HB2' ' C' ' 54' ' ' ALA . 88.2 mt -122.84 166.59 14.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.506 0.669 . . . . 0.0 112.376 -173.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 66' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 26.4 t0 -144.52 98.07 3.14 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.518 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 7.0 mt -132.95 109.37 9.53 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.443 -175.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 68' ' ' ASN . . . . . 0.428 ' HB2' ' CD2' ' B' ' 90' ' ' TYR . 7.4 m-20 -104.7 114.63 28.97 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 120.802 0.334 . . . . 0.0 110.158 178.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -108.11 160.38 15.85 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.254 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 36.6 t -116.16 149.64 38.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.565 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -69.15 0.01 5.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.203 -176.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.32 -18.54 35.85 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.406 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -101.51 164.09 11.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.706 0.289 . . . . 0.0 110.841 -176.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -131.0 108.81 10.06 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 22.5 pt -109.52 158.41 9.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.216 -170.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.443 ' HA ' ' HA ' ' C' ' 20' ' ' SER . 2.5 mtm -116.69 122.81 45.61 Favored 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.887 175.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 77' ' ' PHE . . . . . 0.671 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.7 OUTLIER -104.55 128.63 52.56 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.721 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 78' ' ' TYR . . . . . 0.723 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 36.4 p90 -150.04 135.33 18.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.581 0.705 . . . . 0.0 112.531 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 79' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 3.9 p -106.35 132.51 52.3 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.777 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.48 154.5 18.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.778 177.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.408 ' O ' ' HG3' ' C' ' 16' ' ' GLU . . . 91.3 -172.16 36.03 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -176.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 82' ' ' ASP . . . . . 0.402 ' HA ' ' HB3' ' C' ' 15' ' ' PRO . 21.3 t70 -113.07 102.95 10.88 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.879 176.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 83' ' ' ALA . . . . . 0.526 ' H ' ' HB3' ' C' ' 15' ' ' PRO . . . -169.38 153.6 5.34 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.845 167.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 25.3 t -110.94 120.71 43.3 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.546 HG12 ' HB3' ' C' ' 34' ' ' LEU . 3.8 m -114.96 149.38 17.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.122 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 24.1 m -110.97 115.31 29.28 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.641 175.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 87' ' ' LEU . . . . . 0.563 HD13 HD23 ' C' ' 11' ' ' LEU . 4.8 mp -94.83 145.19 25.06 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 170.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 88' ' ' LEU . . . . . 0.571 HD12 ' CE1' ' C' ' 8' ' ' PHE . 2.4 mm? -124.38 149.49 46.61 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.77 -167.29 26.16 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.471 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 90' ' ' TYR . . . . . 0.424 ' CD2' ' HB2' ' D' ' 68' ' ' ASN . 5.1 p90 -149.33 131.41 15.36 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.744 0.783 . . . . 0.0 111.741 176.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 91' ' ' LEU . . . . . 0.73 HD23 ' HB3' ' C' ' 27' ' ' PHE . 27.7 mt . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.247 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 21.7 ttt . . . . . 0 C--O 1.225 -0.223 0 CA-C-O 121.142 0.496 . . . . 0.0 112.28 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' D' D ' 8' ' ' PHE . . . . . 0.561 ' CE1' HD12 ' D' ' 88' ' ' LEU . 78.0 t80 -54.55 141.59 30.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.971 -176.247 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 9' ' ' TRP . . . . . 0.529 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 89.3 t90 -133.53 147.21 51.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.536 177.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.79 145.64 14.68 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.591 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 11' ' ' LEU . . . . . 0.55 HD23 HD13 ' D' ' 87' ' ' LEU . 49.9 tp -136.0 108.85 7.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.923 0.392 . . . . 0.0 110.246 176.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -96.76 101.01 12.53 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 13' ' ' MET . . . . . 0.569 ' SD ' HD11 ' D' ' 87' ' ' LEU . 60.8 mtp -92.42 143.45 26.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.241 0.543 . . . . 0.0 111.434 -173.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -100.47 144.94 29.43 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.416 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 15' ' ' PRO . . . . . 0.529 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 9.5 Cg_endo -51.73 123.16 11.7 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.645 2.896 . . . . 0.0 113.626 -174.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 16' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' D' ' 79' ' ' THR . 35.9 mt-10 57.81 73.46 0.47 Allowed 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.707 178.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.85 138.44 19.66 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.197 176.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 18' ' ' LYS . . . . . 0.714 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 50.2 mttp -107.39 121.98 45.67 Favored 'General case' 0 CA--C 1.511 -0.533 0 O-C-N 123.387 0.429 . . . . 0.0 111.399 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.61 102.64 11.2 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 174.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 20' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 44.9 t -89.97 99.17 12.24 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.127 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -115.51 139.8 49.73 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.219 -168.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 55.2 m -84.74 132.25 34.47 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.292 174.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 59.4 mt -86.38 115.35 27.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.057 0.456 . . . . 0.0 110.914 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 24' ' ' ILE . . . . . 0.416 HD12 ' N ' ' D' ' 25' ' ' LYS . 1.9 pp -88.67 -12.51 10.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.417 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 25' ' ' LYS . . . . . 0.416 ' N ' HD12 ' D' ' 24' ' ' ILE . 83.3 tttt -159.93 120.28 2.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.493 178.214 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 13.6 m -51.6 137.13 25.4 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 123.761 0.663 . . . . 0.0 110.415 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 27' ' ' PHE . . . . . 0.735 ' HB3' HD23 ' D' ' 91' ' ' LEU . 32.9 p90 -147.39 165.27 30.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.399 0.619 . . . . 0.0 112.569 -174.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 28' ' ' HIS . . . . . 0.495 ' HA ' ' O ' ' D' ' 67' ' ' LEU . 8.3 t60 -116.15 120.3 38.59 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.676 177.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 29' ' ' ILE . . . . . 0.53 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 42.4 mt -84.5 134.66 26.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 169.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 30' ' ' SER . . . . . 0.51 ' HB2' ' HB3' ' E' ' 66' ' ' ASP . 77.2 p -119.6 -10.12 9.67 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -171.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 31' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -178.15 158.5 23.38 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 119.309 -1.425 . . . . 0.0 113.686 177.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.476 HG23 ' HG ' ' D' ' 87' ' ' LEU . 12.0 p -139.67 137.26 39.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 175.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -150.16 154.85 38.74 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.025 -0.422 . . . . 0.0 110.916 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 34' ' ' LEU . . . . . 0.543 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.3 pp -118.24 140.01 50.45 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.957 0.884 . . . . 0.0 111.607 178.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -110.32 -53.31 2.7 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.556 174.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -101.54 126.79 48.41 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.631 175.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 37' ' ' GLY . . . . . 0.496 ' HA3' ' HA ' ' D' ' 83' ' ' ALA . . . 140.65 165.67 10.39 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 119.554 -1.308 . . . . 0.0 113.447 178.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -102.8 -46.46 4.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.485 0.183 . . . . 0.0 111.409 176.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -151.44 134.21 15.66 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.012 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 40' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -132.76 113.7 13.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.433 0.635 . . . . 0.0 110.53 170.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' D' ' 79' ' ' THR . 65.4 mttp -98.16 113.28 25.13 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 174.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.425 ' HG ' ' CG2' ' D' ' 53' ' ' VAL . 58.8 tp -89.95 109.05 20.1 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.409 -170.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 43' ' ' TYR . . . . . 0.548 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 70.6 m-85 -108.97 148.55 30.54 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.989 177.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.668 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.4 OUTLIER -128.37 117.08 20.8 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.568 176.092 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 45' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -102.89 104.46 14.7 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.376 0.608 . . . . 0.0 109.871 176.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.492 ' HB2' HD11 ' D' ' 44' ' ' LEU . . . -128.85 143.62 50.95 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.034 -0.984 . . . . 0.0 108.377 178.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 61.2 26.55 16.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.711 0.767 . . . . 0.0 109.104 -174.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 59.29 38.23 23.29 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.992 -177.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 49' ' ' GLN . . . . . 0.562 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 6.6 tp-100 -129.53 127.91 41.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.685 178.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -81.47 106.08 13.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.069 0.461 . . . . 0.0 110.607 -178.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -102.3 116.97 33.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.355 176.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -74.67 99.88 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 53' ' ' VAL . . . . . 0.463 HG12 ' CD2' ' C' ' 88' ' ' LEU . 28.6 m -87.43 -32.43 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.586 -172.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 54' ' ' ALA . . . . . 0.748 ' HB2' HD21 ' D' ' 65' ' ' LEU . . . -152.93 142.27 21.61 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.246 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 27.2 m -112.97 102.05 10.05 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 169.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 p -118.4 112.33 37.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.904 0.859 . . . . 0.0 110.421 -176.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 78.4 p -123.33 -177.34 3.68 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.155 -176.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -60.86 -29.47 69.55 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.486 168.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.12 -40.68 62.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.326 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 77.6 mt -117.77 81.7 15.54 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 173.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.38 -4.1 12.22 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.137 2.558 . . . . 0.0 113.938 -168.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -160.69 129.69 4.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.299 0.571 . . . . 0.0 111.164 -175.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 97.1 t -120.12 125.67 74.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.555 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.43 130.83 34.5 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 65' ' ' LEU . . . . . 0.748 HD21 ' HB2' ' D' ' 54' ' ' ALA . 88.3 mt -122.97 166.53 14.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.353 0.597 . . . . 0.0 112.302 -173.059 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 66' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 26.1 t0 -144.44 98.0 3.13 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 170.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.53 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 6.9 mt -132.94 109.33 9.51 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.415 -175.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 68' ' ' ASN . . . . . 0.424 ' HB2' ' CD2' ' C' ' 90' ' ' TYR . 7.5 m-20 -104.72 114.67 29.03 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.857 0.36 . . . . 0.0 110.119 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -108.1 160.33 15.89 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.333 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 35.6 t -116.17 149.54 38.92 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.696 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -69.07 0.12 5.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.241 -176.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.45 -18.41 35.93 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.437 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -101.49 164.16 11.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.735 0.302 . . . . 0.0 110.848 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -131.08 108.92 10.1 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 75' ' ' ILE . . . . . . . . . . . . . 22.4 pt -109.57 158.47 9.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.22 -170.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 76' ' ' MET . . . . . 0.444 ' HA ' ' HA ' ' D' ' 20' ' ' SER . 2.5 mtm -116.67 122.78 45.53 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 120.281 -0.567 . . . . 0.0 109.904 175.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 77' ' ' PHE . . . . . 0.668 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.7 OUTLIER -104.53 128.57 52.51 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.727 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 78' ' ' TYR . . . . . 0.714 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 36.5 p90 -149.97 135.38 18.19 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.622 0.725 . . . . 0.0 112.608 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 79' ' ' THR . . . . . 0.524 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 3.9 p -106.41 132.43 52.44 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.788 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.35 154.47 18.17 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.806 177.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.417 ' O ' ' HG3' ' D' ' 16' ' ' GLU . . . 91.41 -172.21 35.93 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -176.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 82' ' ' ASP . . . . . 0.413 ' HA ' ' HB3' ' D' ' 15' ' ' PRO . 21.2 t70 -113.09 102.79 10.73 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 119.584 -0.846 . . . . 0.0 109.894 176.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 83' ' ' ALA . . . . . 0.529 ' H ' ' HB3' ' D' ' 15' ' ' PRO . . . -169.2 153.7 5.56 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.846 167.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 24.3 t -110.98 120.73 43.36 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.543 HG12 ' HB3' ' D' ' 34' ' ' LEU . 3.8 m -115.0 149.37 17.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.538 0.685 . . . . 0.0 112.764 -172.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 24.6 m -110.97 115.39 29.4 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.569 175.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 87' ' ' LEU . . . . . 0.569 HD11 ' SD ' ' D' ' 13' ' ' MET . 4.7 mp -94.8 145.14 25.09 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 170.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.561 HD12 ' CE1' ' D' ' 8' ' ' PHE . 2.4 mm? -124.35 149.56 46.5 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.81 -167.28 26.2 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.441 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 90' ' ' TYR . . . . . 0.464 ' CD2' ' HB2' ' E' ' 68' ' ' ASN . 5.2 p90 -149.33 131.26 15.21 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.744 0.783 . . . . 0.0 111.811 176.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 91' ' ' LEU . . . . . 0.735 HD23 ' HB3' ' D' ' 27' ' ' PHE . 27.5 mt . . . . . 0 C--N 1.323 -0.569 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.289 176.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 21.7 ttt . . . . . 0 C--O 1.225 -0.192 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' E' E ' 8' ' ' PHE . . . . . 0.572 ' CE1' HD12 ' E' ' 88' ' ' LEU . 77.7 t80 -54.65 141.54 31.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.899 -176.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 9' ' ' TRP . . . . . 0.518 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 89.5 t90 -133.43 147.27 51.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.55 177.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.86 145.62 14.63 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.625 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 11' ' ' LEU . . . . . 0.557 HD23 HD13 ' E' ' 87' ' ' LEU . 49.8 tp -136.07 108.85 7.54 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.007 0.432 . . . . 0.0 110.261 176.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -96.68 100.98 12.51 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 13' ' ' MET . . . . . 0.563 ' SD ' HD11 ' E' ' 87' ' ' LEU . 60.3 mtp -92.41 143.47 26.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.227 0.537 . . . . 0.0 111.451 -172.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -100.51 144.95 29.45 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.386 178.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 15' ' ' PRO . . . . . 0.528 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 9.5 Cg_endo -51.8 123.21 11.85 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.651 2.901 . . . . 0.0 113.623 -174.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 16' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' E' ' 79' ' ' THR . 35.9 mt-10 57.77 73.45 0.47 Allowed 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.722 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.85 138.44 19.67 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.203 176.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 18' ' ' LYS . . . . . 0.718 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 50.2 mttp -107.32 121.99 45.67 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 123.387 0.43 . . . . 0.0 111.306 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 19' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' E' ' 76' ' ' MET . 3.1 m-85 -110.62 102.67 11.22 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 174.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 20' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' E' ' 76' ' ' MET . 44.6 t -89.99 99.18 12.24 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 173.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -115.5 139.85 49.68 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.279 -168.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 56.0 m -84.81 132.15 34.45 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.382 174.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 59.3 mt -86.32 115.37 27.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.086 0.469 . . . . 0.0 110.932 -175.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 24' ' ' ILE . . . . . 0.426 HD12 ' N ' ' E' ' 25' ' ' LYS . 1.9 pp -88.69 -12.49 10.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.414 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 25' ' ' LYS . . . . . 0.426 ' N ' HD12 ' E' ' 24' ' ' ILE . 83.3 tttt -159.95 120.19 2.97 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.501 178.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 13.6 m -51.53 137.07 25.1 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.801 0.688 . . . . 0.0 110.498 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 27' ' ' PHE . . . . . 0.729 ' HB3' HD23 ' E' ' 91' ' ' LEU . 33.1 p90 -147.31 165.19 30.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.422 0.629 . . . . 0.0 112.597 -174.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 28' ' ' HIS . . . . . 0.502 ' HA ' ' O ' ' E' ' 67' ' ' LEU . 8.3 t60 -115.97 120.32 38.78 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.682 -1.144 . . . . 0.0 109.786 176.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 29' ' ' ILE . . . . . 0.529 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 42.1 mt -84.61 134.66 26.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 169.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 30' ' ' SER . . . . . 0.539 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 76.6 p -119.59 -10.03 9.69 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -171.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 31' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -178.11 158.55 23.49 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.252 -1.451 . . . . 0.0 113.595 177.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.485 HG23 ' HG ' ' E' ' 87' ' ' LEU . 12.0 p -139.77 137.25 39.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 174.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -150.17 154.83 38.68 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.916 -178.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 34' ' ' LEU . . . . . 0.541 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.3 pp -118.24 140.04 50.4 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.953 0.882 . . . . 0.0 111.665 178.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -110.4 -53.3 2.7 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 113.98 -1.464 . . . . 0.0 108.494 174.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -101.54 126.77 48.4 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.676 175.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 37' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' E' ' 83' ' ' ALA . . . 140.55 165.73 10.41 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 119.6 -1.286 . . . . 0.0 113.552 178.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -102.79 -46.55 4.67 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 123.501 0.177 . . . . 0.0 111.417 177.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -151.39 134.28 15.75 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.693 -0.23 . . . . 0.0 110.992 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 40' ' ' ALA . . . . . 0.511 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -132.84 113.68 13.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.416 0.627 . . . . 0.0 110.442 170.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 41' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' E' ' 79' ' ' THR . 65.4 mttp -98.16 113.24 25.08 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 174.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.425 ' HG ' ' CG2' ' E' ' 53' ' ' VAL . 58.9 tp -89.91 109.08 20.12 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.396 -170.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 43' ' ' TYR . . . . . 0.542 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 71.2 m-85 -109.0 148.62 30.47 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.931 177.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 44' ' ' LEU . . . . . 0.672 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 0.4 OUTLIER -128.46 117.16 20.87 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.52 176.105 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' E' E ' 45' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -102.95 104.41 14.62 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.412 0.625 . . . . 0.0 109.877 176.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 46' ' ' ALA . . . . . 0.486 ' HB2' HD11 ' E' ' 44' ' ' LEU . . . -128.85 143.67 50.97 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.302 178.404 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 61.16 26.57 16.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.802 0.81 . . . . 0.0 109.131 -174.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 59.31 38.23 23.2 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.952 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 49' ' ' GLN . . . . . 0.56 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 6.6 tp-100 -129.49 127.92 41.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.696 178.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -81.53 106.13 13.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.081 0.467 . . . . 0.0 110.567 -178.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -102.35 116.97 33.73 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.33 176.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -74.71 99.85 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 53' ' ' VAL . . . . . 0.497 HG12 ' CD2' ' D' ' 88' ' ' LEU . 29.3 m -87.35 -32.54 6.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.606 -172.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 54' ' ' ALA . . . . . 0.762 ' HB2' HD21 ' E' ' 65' ' ' LEU . . . -152.9 142.35 21.71 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 120.334 -0.547 . . . . 0.0 112.191 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 27.0 m -112.92 102.05 10.07 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 169.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 p -118.37 112.37 37.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.881 0.848 . . . . 0.0 110.416 -176.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 76.1 p -123.44 -177.38 3.69 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.172 -176.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -60.89 -29.33 69.51 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.516 168.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.2 -40.71 62.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.266 0.555 . . . . 0.0 110.345 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 77.3 mt -117.64 81.57 14.89 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 173.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.31 -4.11 12.17 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.16 2.573 . . . . 0.0 113.97 -168.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -160.65 129.7 4.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.273 0.559 . . . . 0.0 111.148 -175.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 96.9 t -120.12 125.63 74.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.524 176.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.4 130.73 34.52 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 175.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 65' ' ' LEU . . . . . 0.762 HD21 ' HB2' ' E' ' 54' ' ' ALA . 88.1 mt -122.82 166.51 14.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.444 0.64 . . . . 0.0 112.342 -173.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 66' ' ' ASP . . . . . 0.51 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 26.6 t0 -144.44 98.04 3.14 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 170.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 67' ' ' LEU . . . . . 0.529 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 7.0 mt -132.97 109.33 9.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.456 -175.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 68' ' ' ASN . . . . . 0.464 ' HB2' ' CD2' ' D' ' 90' ' ' TYR . 7.5 m-20 -104.66 114.67 29.03 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.831 0.348 . . . . 0.0 110.149 178.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -108.17 160.31 15.92 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.269 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 36.6 t -116.15 149.68 38.64 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.635 -177.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -69.15 0.11 5.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.136 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.51 -18.45 35.62 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.346 177.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -101.48 164.15 11.91 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.697 -0.296 . . . . 0.0 110.851 -176.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -131.09 108.77 9.99 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 75' ' ' ILE . . . . . . . . . . . . . 22.3 pt -109.43 158.39 9.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.29 -170.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 76' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' E' ' 20' ' ' SER . 2.5 mtm -116.66 122.79 45.59 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.906 175.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 77' ' ' PHE . . . . . 0.672 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.7 OUTLIER -104.46 128.62 52.4 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.653 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' E' E ' 78' ' ' TYR . . . . . 0.718 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 36.6 p90 -150.05 135.24 17.99 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.57 0.7 . . . . 0.0 112.569 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 79' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 3.9 p -106.29 132.57 52.18 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.806 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.55 154.38 18.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.778 177.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 81' ' ' GLY . . . . . 0.417 ' O ' ' HG3' ' E' ' 16' ' ' GLU . . . 91.46 -172.22 35.85 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -176.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -113.04 102.83 10.78 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.881 176.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 83' ' ' ALA . . . . . 0.528 ' H ' ' HB3' ' E' ' 15' ' ' PRO . . . -169.28 153.68 5.48 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.84 167.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 24.3 t -110.98 120.72 43.33 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 85' ' ' VAL . . . . . 0.541 HG12 ' HB3' ' E' ' 34' ' ' LEU . 3.8 m -114.98 149.39 17.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -172.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 24.6 m -110.97 115.24 29.15 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.619 175.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 87' ' ' LEU . . . . . 0.563 HD11 ' SD ' ' E' ' 13' ' ' MET . 4.8 mp -94.79 145.15 25.08 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 170.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 88' ' ' LEU . . . . . 0.572 HD12 ' CE1' ' E' ' 8' ' ' PHE . 2.4 mm? -124.34 149.58 46.45 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.92 -167.35 26.41 Favored Glycine 0 N--CA 1.437 -1.275 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.376 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 90' ' ' TYR . . . . . 0.451 ' CD2' ' HB2' ' A' ' 68' ' ' ASN . 5.1 p90 -149.31 131.34 15.31 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.744 0.783 . . . . 0.0 111.766 176.141 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 91' ' ' LEU . . . . . 0.729 HD23 ' HB3' ' E' ' 27' ' ' PHE . 27.2 mt . . . . . 0 C--N 1.323 -0.555 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.29 176.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 48.5 mtt . . . . . 0 C--O 1.224 -0.276 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.565 ' CE1' HD21 ' B' ' 44' ' ' LEU . 70.4 t80 -69.46 146.36 52.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.21 0.529 . . . . 0.0 112.191 -175.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.475 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 92.2 t90 -136.7 145.58 44.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.025 176.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.53 146.6 16.3 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.531 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.517 HD23 HD13 ' A' ' 87' ' ' LEU . 43.6 tp -138.48 109.9 6.98 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.885 0.374 . . . . 0.0 110.507 177.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -97.33 105.12 17.22 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.55 ' SD ' HD11 ' A' ' 87' ' ' LEU . 44.3 mtp -98.39 143.95 28.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.917 0.389 . . . . 0.0 111.038 -174.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.524 ' HB2' ' HG3' ' A' ' 17' ' ' ARG . 37.8 mtmm -100.98 157.7 33.16 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.367 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.518 ' HB3' ' HA ' ' A' ' 82' ' ' ASP . 91.1 Cg_exo -47.76 115.42 1.44 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.581 2.854 . . . . 0.0 113.66 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.667 ' HA ' ' O ' ' A' ' 79' ' ' THR . 44.6 mt-10 59.8 58.36 2.84 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.368 0.604 . . . . 0.0 111.848 175.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.524 ' HG3' ' HB2' ' A' ' 14' ' ' LYS . 29.1 mmt180 -118.68 153.17 34.79 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.946 174.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.683 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 3.5 ttmp? -130.95 110.82 11.53 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 123.456 0.473 . . . . 0.0 110.958 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -111.38 112.6 24.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.885 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -75.14 114.56 13.77 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 171.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -92.81 114.09 26.54 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.426 -165.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.7 m -93.62 119.56 32.8 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.108 172.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.3 mt -96.79 113.01 30.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.99 0.424 . . . . 0.0 111.342 -173.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.2 mp -88.91 -34.75 7.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.444 0.64 . . . . 0.0 109.342 177.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.427 ' HD2' HD13 ' A' ' 91' ' ' LEU . 19.4 pttt -132.73 128.74 37.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.183 178.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.2 m -56.2 148.36 18.46 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.746 -176.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.736 ' HB3' HD23 ' A' ' 91' ' ' LEU . 38.5 p90 -157.97 162.87 38.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.717 0.77 . . . . 0.0 112.924 -178.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.535 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 2.0 t60 -119.18 123.83 45.3 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.392 -1.277 . . . . 0.0 109.444 176.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.574 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 51.7 mt -85.27 134.68 26.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 170.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.541 ' HB2' ' HB3' ' B' ' 66' ' ' ASP . 61.7 p -117.55 -15.01 10.26 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -171.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -171.41 152.1 17.08 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 119.43 -1.367 . . . . 0.0 113.242 177.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.485 HG23 ' HG ' ' A' ' 87' ' ' LEU . 11.3 p -136.68 131.51 47.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 174.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.88 155.99 42.21 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.014 -0.429 . . . . 0.0 111.161 -176.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.489 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.1 pp -118.05 141.28 48.64 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.887 0.851 . . . . 0.0 111.925 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -110.07 -54.18 2.6 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.807 176.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -100.85 128.12 47.02 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 171.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.551 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 139.25 161.57 8.78 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 119.705 -1.236 . . . . 0.0 113.373 176.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -103.4 -43.81 5.32 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -149.42 132.32 16.11 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 120.512 0.196 . . . . 0.0 111.043 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.474 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -131.74 113.8 13.98 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.409 0.624 . . . . 0.0 110.128 169.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 79' ' ' THR . 97.4 mttt -96.25 110.57 22.85 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 175.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.403 ' HG ' ' CG2' ' A' ' 53' ' ' VAL . 51.0 tp -87.02 109.76 19.61 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.025 -172.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.434 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 96.8 m-85 -108.25 141.85 39.42 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.252 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.559 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 1.5 tp -123.57 112.79 17.86 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.488 176.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.582 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -99.18 108.84 21.53 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.19 0.519 . . . . 0.0 109.855 176.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.479 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -139.66 140.9 37.03 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.529 -177.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 53.33 41.93 32.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.526 0.679 . . . . 0.0 110.248 -178.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.2 mttp 69.87 21.46 6.32 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.414 172.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.582 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 79.2 mm-40 -128.36 137.44 51.9 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 122.211 -0.306 . . . . 0.0 111.097 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -87.31 104.94 16.88 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 174.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 49' ' ' GLN . 75.8 m-85 -99.83 120.22 39.41 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.775 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -77.36 99.96 2.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 170.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.52 HG12 ' CD2' ' E' ' 88' ' ' LEU . 18.5 m -86.97 -34.58 7.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.817 -172.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.563 ' HB2' ' CD2' ' A' ' 65' ' ' LEU . . . -151.13 140.83 21.75 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.107 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.7 m -111.52 101.25 9.68 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 169.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.15 113.71 43.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.724 0.773 . . . . 0.0 110.052 -176.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 78.2 p -123.27 -177.89 3.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.204 -175.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -64.0 -24.22 67.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.025 0.441 . . . . 0.0 110.53 169.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.39 -40.52 43.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.169 176.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.6 mt -116.84 81.92 12.53 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 173.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.94 -5.15 12.77 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.206 2.604 . . . . 0.0 114.133 -167.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -160.48 128.62 4.61 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.129 0.49 . . . . 0.0 111.189 -175.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.2 t -118.45 108.19 23.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.408 175.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.71 121.46 30.17 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 174.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.563 ' CD2' ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -143.66 168.79 19.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.147 0.499 . . . . 0.0 111.978 -174.42 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.558 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 9.5 t0 -116.36 107.13 14.43 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.739 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.574 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 32.9 mt -126.37 107.74 10.58 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 177.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -111.08 127.87 55.69 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.913 -178.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -127.19 150.32 49.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.908 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.0 m -102.59 161.78 13.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.057 0.456 . . . . 0.0 110.748 176.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -69.34 -5.1 21.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.159 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.78 -7.72 62.66 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.446 -0.661 . . . . 0.0 111.446 173.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -100.28 143.55 30.33 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -122.97 125.59 45.57 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 174.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.496 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 15.0 pt -132.06 172.18 16.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.744 -171.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 7.9 mtm -130.04 131.68 45.92 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 170.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.559 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -110.25 128.33 55.45 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 177.348 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.683 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 40.9 p90 -153.69 140.43 19.01 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.292 -0.563 . . . . 0.0 112.12 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.667 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 8.0 p -111.92 136.43 51.24 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.25 -177.133 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.61 161.07 14.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.232 174.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.5 ' O ' ' HG3' ' A' ' 16' ' ' GLU . . . 81.97 177.27 51.73 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -173.111 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.518 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 7.0 p-10 -112.97 104.11 12.07 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 118.284 -1.367 . . . . 0.0 110.848 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.551 ' CB ' ' HA3' ' A' ' 37' ' ' GLY . . . -164.76 153.26 12.37 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 113.734 -1.575 . . . . 0.0 109.882 169.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.6 p -104.97 123.39 47.7 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 177.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.489 HG12 ' HB3' ' A' ' 34' ' ' LEU . 3.6 m -118.23 144.43 26.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.556 0.693 . . . . 0.0 112.776 -173.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.8 m -108.02 116.25 31.61 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.739 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.55 HD11 ' SD ' ' A' ' 13' ' ' MET . 4.5 mp -96.02 143.02 27.55 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 170.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.543 ' CD2' HG12 ' B' ' 53' ' ' VAL . 2.6 mm? -124.97 152.04 44.71 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 174.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.6 -167.86 30.73 Favored Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.429 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -139.15 131.42 28.3 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.498 0.666 . . . . 0.0 110.805 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.736 HD23 ' HB3' ' A' ' 27' ' ' PHE . 24.1 mt . . . . . 0 C--N 1.319 -0.744 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.892 173.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 48.5 mtt . . . . . 0 C--O 1.224 -0.283 0 CA-C-O 120.731 0.3 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 8' ' ' PHE . . . . . 0.561 ' CE1' HD21 ' C' ' 44' ' ' LEU . 70.5 t80 -69.42 146.35 52.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.231 0.539 . . . . 0.0 112.19 -175.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 9' ' ' TRP . . . . . 0.474 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 92.1 t90 -136.73 145.58 44.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.981 176.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.4 146.66 16.45 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.589 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.505 HD23 HD13 ' B' ' 87' ' ' LEU . 43.9 tp -138.44 109.84 6.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.792 0.329 . . . . 0.0 110.531 177.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -97.41 105.07 17.16 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 13' ' ' MET . . . . . 0.554 ' SD ' HD11 ' B' ' 87' ' ' LEU . 44.3 mtp -98.33 143.88 28.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.111 -174.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.525 ' HB2' ' HG3' ' B' ' 17' ' ' ARG . 37.9 mtmm -101.02 157.77 33.03 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.256 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.53 ' HB3' ' HA ' ' B' ' 82' ' ' ASP . 93.4 Cg_exo -47.86 115.4 1.45 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.619 2.879 . . . . 0.0 113.629 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.661 ' HA ' ' O ' ' B' ' 79' ' ' THR . 44.5 mt-10 59.87 58.39 2.8 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 121.256 0.55 . . . . 0.0 111.841 175.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.525 ' HG3' ' HB2' ' B' ' 14' ' ' LYS . 29.0 mmt180 -118.8 153.19 34.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.891 174.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.683 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 3.5 ttmp? -130.91 110.68 11.45 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.04 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -111.33 112.59 24.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.909 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 4.5 p -75.1 114.61 13.8 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 171.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -92.82 114.04 26.48 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.425 -165.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 22.9 m -93.51 119.46 32.61 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.175 172.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 42.1 mt -96.78 112.9 29.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.05 0.452 . . . . 0.0 111.407 -173.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.454 ' N ' HD12 ' B' ' 24' ' ' ILE . 4.2 mp -88.86 -34.78 7.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.302 177.346 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.406 ' HD2' HD13 ' B' ' 91' ' ' LEU . 19.5 pttt -132.75 128.74 37.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.088 178.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -56.21 148.35 18.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.84 -177.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 27' ' ' PHE . . . . . 0.73 ' HB3' HD23 ' B' ' 91' ' ' LEU . 38.7 p90 -157.96 162.91 38.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.702 0.763 . . . . 0.0 112.881 -178.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 28' ' ' HIS . . . . . 0.534 ' HE2' ' HB3' ' B' ' 30' ' ' SER . 2.0 t60 -119.24 123.83 45.24 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.345 176.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.578 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 51.6 mt -85.27 134.6 26.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 170.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.567 ' HB2' ' HB3' ' C' ' 66' ' ' ASP . 61.5 p -117.48 -15.01 10.31 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -171.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -171.38 152.15 17.24 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.443 -1.361 . . . . 0.0 113.245 177.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.488 HG23 ' HG ' ' B' ' 87' ' ' LEU . 11.2 p -136.67 131.53 47.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 174.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.91 156.01 42.22 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.066 -0.396 . . . . 0.0 111.134 -176.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.5 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.1 pp -118.08 141.42 48.5 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.848 0.833 . . . . 0.0 111.96 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -110.17 -54.17 2.6 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.768 176.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -100.92 128.1 47.1 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.862 171.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.555 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 139.32 161.55 8.77 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 119.583 -1.294 . . . . 0.0 113.35 176.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -103.32 -43.83 5.33 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 178.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -149.44 132.41 16.18 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.543 0.211 . . . . 0.0 110.983 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.459 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -131.84 113.71 13.82 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.388 0.613 . . . . 0.0 110.12 169.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' B' ' 79' ' ' THR . 97.3 mttt -96.22 110.59 22.86 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.409 ' HG ' ' CG2' ' B' ' 53' ' ' VAL . 51.1 tp -87.05 109.73 19.6 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.062 -172.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 43' ' ' TYR . . . . . 0.428 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 96.7 m-85 -108.2 141.85 39.32 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.293 178.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.565 HD21 ' CE1' ' A' ' 8' ' ' PHE . 1.5 tp -123.58 112.84 17.92 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.451 176.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -99.21 108.86 21.55 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.178 0.513 . . . . 0.0 109.82 176.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.481 ' CB ' HG22 ' B' ' 75' ' ' ILE . . . -139.69 140.97 36.97 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.535 -177.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 53.25 41.95 32.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.557 0.694 . . . . 0.0 110.238 -177.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 39.2 mttp 69.93 21.41 6.26 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.404 172.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.573 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 79.1 mm-40 -128.33 137.49 51.95 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.055 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -87.27 104.88 16.82 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.432 ' CZ ' ' HB2' ' B' ' 49' ' ' GLN . 76.0 m-85 -99.92 120.27 39.53 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.71 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -77.33 99.98 2.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 170.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.543 HG12 ' CD2' ' A' ' 88' ' ' LEU . 18.9 m -86.92 -34.68 7.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.878 -172.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.556 ' HB2' ' CD2' ' B' ' 65' ' ' LEU . . . -151.08 140.79 21.77 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 120.383 -0.527 . . . . 0.0 112.139 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 21.8 m -111.47 101.29 9.74 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 169.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.23 113.73 43.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.707 0.765 . . . . 0.0 110.052 -176.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 74.6 p -123.3 -177.82 3.81 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.201 -175.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -63.98 -24.27 67.65 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.508 169.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.33 -40.58 43.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.291 0.567 . . . . 0.0 110.187 176.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 79.8 mt -116.82 81.99 12.56 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 173.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.07 -5.16 12.93 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.232 2.621 . . . . 0.0 114.053 -167.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -160.42 128.63 4.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.273 0.558 . . . . 0.0 111.242 -175.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 88.9 t -118.58 108.23 23.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.462 175.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.72 121.47 30.19 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 174.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.556 ' CD2' ' HB2' ' B' ' 54' ' ' ALA . 0.4 OUTLIER -143.65 168.78 19.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.074 0.464 . . . . 0.0 112.009 -174.459 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 66' ' ' ASP . . . . . 0.541 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 9.4 t0 -116.32 107.13 14.44 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.772 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.578 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 32.7 mt -126.38 107.69 10.53 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 177.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -111.16 127.9 55.73 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.915 -178.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -127.13 150.34 49.54 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.883 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 58.1 m -102.62 161.78 13.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.071 0.462 . . . . 0.0 110.748 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -69.19 -5.22 21.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.231 177.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.79 -7.62 62.73 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 173.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -100.32 143.53 30.4 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -123.0 125.63 45.61 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 174.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.501 ' HB ' ' CD1' ' B' ' 44' ' ' LEU . 15.1 pt -132.07 172.15 16.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.718 -171.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 76' ' ' MET . . . . . . . . . . . . . 7.9 mtm -129.97 131.7 46.03 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 170.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 77' ' ' PHE . . . . . 0.564 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.9 OUTLIER -110.22 128.32 55.43 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.29 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.683 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 41.1 p90 -153.6 140.42 19.1 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.299 -0.56 . . . . 0.0 112.098 -178.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.661 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 8.1 p -111.91 136.48 51.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.216 -177.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.65 161.06 14.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.207 174.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.494 ' O ' ' HG3' ' B' ' 16' ' ' GLU . . . 81.93 177.38 51.78 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -173.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 82' ' ' ASP . . . . . 0.53 ' HA ' ' HB3' ' B' ' 15' ' ' PRO . 6.9 p-10 -113.14 104.18 12.1 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 118.267 -1.373 . . . . 0.0 110.82 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.555 ' CB ' ' HA3' ' B' ' 37' ' ' GLY . . . -164.83 153.25 12.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 113.638 -1.619 . . . . 0.0 109.861 169.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 6.7 p -104.96 123.4 47.71 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.5 HG12 ' HB3' ' B' ' 34' ' ' LEU . 3.5 m -118.21 144.44 26.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.571 0.7 . . . . 0.0 112.744 -173.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 50.9 m -108.11 116.25 31.62 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.704 175.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.554 HD11 ' SD ' ' B' ' 13' ' ' MET . 4.5 mp -96.04 143.14 27.45 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 170.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.524 ' CD2' HG12 ' C' ' 53' ' ' VAL . 2.6 mm? -125.09 151.96 44.99 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 174.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.55 -167.89 30.73 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.328 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -139.11 131.46 28.44 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.515 0.674 . . . . 0.0 110.851 176.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 91' ' ' LEU . . . . . 0.73 HD23 ' HB3' ' B' ' 27' ' ' PHE . 23.4 mt . . . . . 0 C--N 1.319 -0.745 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.923 173.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 48.6 mtt . . . . . 0 C--O 1.222 -0.345 0 CA-C-O 120.75 0.309 . . . . 0.0 111.666 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' C' C ' 8' ' ' PHE . . . . . 0.581 ' CE1' HD21 ' D' ' 44' ' ' LEU . 70.6 t80 -69.41 146.36 52.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.284 0.564 . . . . 0.0 112.174 -175.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 9' ' ' TRP . . . . . 0.471 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 92.2 t90 -136.7 145.5 44.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.008 176.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.47 146.6 16.31 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.575 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.523 HD23 HD13 ' C' ' 87' ' ' LEU . 44.0 tp -138.37 109.87 7.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.834 0.35 . . . . 0.0 110.56 177.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -97.33 105.01 17.08 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 13' ' ' MET . . . . . 0.543 ' SD ' HD11 ' C' ' 87' ' ' LEU . 44.2 mtp -98.34 144.0 28.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.994 0.426 . . . . 0.0 111.041 -174.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 14' ' ' LYS . . . . . 0.522 ' HB2' ' HG3' ' C' ' 17' ' ' ARG . 37.8 mtmm -101.13 157.7 33.17 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.25 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 15' ' ' PRO . . . . . 0.533 ' HB3' ' HA ' ' C' ' 82' ' ' ASP . 92.2 Cg_exo -47.78 115.43 1.45 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.609 2.873 . . . . 0.0 113.585 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 16' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' C' ' 79' ' ' THR . 44.5 mt-10 59.81 58.36 2.83 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.306 0.574 . . . . 0.0 111.874 175.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 17' ' ' ARG . . . . . 0.522 ' HG3' ' HB2' ' C' ' 14' ' ' LYS . 29.0 mmt180 -118.72 153.24 34.71 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.939 174.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 18' ' ' LYS . . . . . 0.692 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 3.5 ttmp? -130.98 110.81 11.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.0 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -111.41 112.63 24.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.848 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 4.4 p -75.2 114.7 14.02 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 172.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -92.97 114.11 26.57 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.43 -165.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 24.0 m -93.53 119.52 32.69 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.124 172.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 42.4 mt -96.84 112.97 30.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.158 0.504 . . . . 0.0 111.324 -173.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 24' ' ' ILE . . . . . 0.448 ' N ' HD12 ' C' ' 24' ' ' ILE . 4.2 mp -88.88 -34.76 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.294 177.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 25' ' ' LYS . . . . . 0.413 ' HD2' HD13 ' C' ' 91' ' ' LEU . 19.4 pttt -132.76 128.76 37.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.097 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 16.2 m -56.25 148.4 18.54 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.806 -177.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 27' ' ' PHE . . . . . 0.733 ' HB3' HD23 ' C' ' 91' ' ' LEU . 38.5 p90 -158.02 162.88 38.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.722 0.772 . . . . 0.0 112.867 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 28' ' ' HIS . . . . . 0.545 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 2.0 t60 -119.19 123.84 45.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.392 176.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 29' ' ' ILE . . . . . 0.574 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 51.5 mt -85.21 134.64 26.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 170.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.545 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 61.8 p -117.5 -15.03 10.29 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -171.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 31' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -171.36 152.1 17.14 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 119.517 -1.325 . . . . 0.0 113.27 177.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.487 HG23 ' HG ' ' C' ' 87' ' ' LEU . 11.2 p -136.68 131.54 47.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 174.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.91 155.98 42.18 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 122.017 -0.427 . . . . 0.0 111.187 -176.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.496 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.1 pp -118.09 141.39 48.53 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.889 0.852 . . . . 0.0 111.918 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -110.16 -54.16 2.6 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.216 -1.356 . . . . 0.0 108.776 176.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -100.89 128.19 47.03 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 171.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 37' ' ' GLY . . . . . 0.557 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 139.25 161.51 8.75 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 119.532 -1.318 . . . . 0.0 113.319 176.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -103.32 -43.77 5.34 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 178.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -149.49 132.31 16.04 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 120.504 0.192 . . . . 0.0 111.039 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -131.72 113.72 13.89 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.41 0.624 . . . . 0.0 110.141 169.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' C' ' 79' ' ' THR . 97.4 mttt -96.28 110.67 22.95 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 175.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.404 ' HG ' ' CG2' ' C' ' 53' ' ' VAL . 51.1 tp -87.14 109.77 19.67 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.982 -172.42 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 43' ' ' TYR . . . . . 0.434 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 96.7 m-85 -108.24 141.81 39.45 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.284 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.564 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 1.5 tp -123.56 112.75 17.82 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.532 176.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 45' ' ' ALA . . . . . 0.583 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -99.16 108.78 21.48 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.143 0.497 . . . . 0.0 109.795 176.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.472 ' CB ' HG22 ' C' ' 75' ' ' ILE . . . -139.69 140.97 36.99 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.551 -177.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 53.19 41.97 32.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.575 0.703 . . . . 0.0 110.33 -177.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 39.2 mttp 69.95 21.38 6.25 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 114.843 -1.072 . . . . 0.0 112.39 172.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 49' ' ' GLN . . . . . 0.583 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 79.2 mm-40 -128.3 137.48 51.97 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.07 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -87.26 104.98 16.91 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 174.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 51' ' ' TYR . . . . . 0.437 ' CZ ' ' HB2' ' C' ' 49' ' ' GLN . 76.0 m-85 -99.98 120.26 39.54 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.698 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -77.31 99.92 2.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 170.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 53' ' ' VAL . . . . . 0.524 HG12 ' CD2' ' B' ' 88' ' ' LEU . 18.7 m -86.92 -34.66 7.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.85 -172.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 54' ' ' ALA . . . . . 0.557 ' HB2' ' CD2' ' C' ' 65' ' ' LEU . . . -151.06 140.92 21.91 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 120.343 -0.543 . . . . 0.0 112.092 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 21.4 m -111.5 101.34 9.77 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 169.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.26 113.69 43.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.757 0.789 . . . . 0.0 110.038 -176.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 77.2 p -123.22 -177.83 3.81 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.194 -175.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -64.05 -24.16 67.6 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.007 0.432 . . . . 0.0 110.52 169.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.4 -40.55 43.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.198 0.523 . . . . 0.0 110.125 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 79.5 mt -116.81 81.96 12.52 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 173.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.02 -5.09 12.69 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.218 2.612 . . . . 0.0 114.119 -167.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -160.49 128.61 4.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.185 0.517 . . . . 0.0 111.266 -175.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 88.0 t -118.54 108.21 23.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.43 175.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.7 121.4 30.08 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 65' ' ' LEU . . . . . 0.557 ' CD2' ' HB2' ' C' ' 54' ' ' ALA . 0.4 OUTLIER -143.65 168.88 18.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.17 0.51 . . . . 0.0 111.954 -174.554 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 66' ' ' ASP . . . . . 0.567 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 9.4 t0 -116.35 107.16 14.47 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.79 178.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.574 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 32.8 mt -126.5 107.76 10.54 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -111.08 127.79 55.67 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.958 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -127.07 150.26 49.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.919 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 58.1 m -102.56 161.77 13.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.978 0.418 . . . . 0.0 110.733 176.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -69.23 -5.22 21.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.194 177.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.76 -7.66 62.75 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 173.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -100.3 143.51 30.4 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -122.99 125.65 45.66 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.501 ' HB ' ' CD1' ' C' ' 44' ' ' LEU . 15.1 pt -132.05 172.18 16.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.663 -171.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 76' ' ' MET . . . . . . . . . . . . . 7.8 mtm -129.99 131.64 45.97 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 170.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 77' ' ' PHE . . . . . 0.564 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.9 OUTLIER -110.17 128.28 55.39 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.274 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 78' ' ' TYR . . . . . 0.692 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 41.0 p90 -153.61 140.42 19.09 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.291 -0.564 . . . . 0.0 112.116 -178.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 79' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 8.2 p -111.91 136.4 51.28 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.25 -177.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.59 161.05 14.45 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.29 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.497 ' O ' ' HG3' ' C' ' 16' ' ' GLU . . . 81.96 177.24 51.71 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -173.163 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 82' ' ' ASP . . . . . 0.533 ' HA ' ' HB3' ' C' ' 15' ' ' PRO . 6.9 p-10 -112.94 104.21 12.18 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 118.304 -1.358 . . . . 0.0 110.873 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 83' ' ' ALA . . . . . 0.557 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -164.82 153.25 12.24 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.66 -1.609 . . . . 0.0 109.869 169.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 6.4 p -104.96 123.4 47.7 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.496 HG12 ' HB3' ' C' ' 34' ' ' LEU . 3.6 m -118.24 144.48 26.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.582 0.706 . . . . 0.0 112.765 -173.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 50.6 m -108.14 116.22 31.57 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.67 175.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 87' ' ' LEU . . . . . 0.543 HD11 ' SD ' ' C' ' 13' ' ' MET . 4.5 mp -96.04 143.15 27.44 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 170.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 88' ' ' LEU . . . . . 0.523 HD12 ' CE1' ' C' ' 8' ' ' PHE . 2.6 mm? -125.06 151.97 44.94 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 174.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.55 -167.9 30.75 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.443 177.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -139.06 131.47 28.54 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.432 0.634 . . . . 0.0 110.852 176.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 91' ' ' LEU . . . . . 0.733 HD23 ' HB3' ' C' ' 27' ' ' PHE . 23.7 mt . . . . . 0 C--N 1.318 -0.764 0 CA-C-N 114.537 -1.21 . . . . 0.0 108.943 173.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 48.6 mtt . . . . . 0 C--O 1.223 -0.312 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' D' D ' 8' ' ' PHE . . . . . 0.563 ' CE1' HD21 ' E' ' 44' ' ' LEU . 70.7 t80 -69.35 146.37 52.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.217 0.532 . . . . 0.0 112.176 -175.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 9' ' ' TRP . . . . . 0.476 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 92.2 t90 -136.76 145.62 44.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.397 -0.819 . . . . 0.0 108.965 176.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.57 146.54 16.17 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.507 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 11' ' ' LEU . . . . . 0.506 HD23 HD13 ' D' ' 87' ' ' LEU . 44.0 tp -138.38 109.84 6.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.837 0.351 . . . . 0.0 110.595 177.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -97.29 105.04 17.12 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 13' ' ' MET . . . . . 0.556 ' SD ' HD11 ' D' ' 87' ' ' LEU . 44.5 mtp -98.42 143.94 28.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.965 0.412 . . . . 0.0 111.011 -174.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 14' ' ' LYS . . . . . 0.519 ' HB2' ' HG3' ' D' ' 17' ' ' ARG . 37.8 mtmm -101.04 157.74 33.09 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.257 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 15' ' ' PRO . . . . . 0.525 ' HB3' ' HA ' ' D' ' 82' ' ' ASP . 92.5 Cg_exo -47.81 115.36 1.42 Allowed 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.597 2.865 . . . . 0.0 113.686 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 16' ' ' GLU . . . . . 0.669 ' HA ' ' O ' ' D' ' 79' ' ' THR . 44.5 mt-10 59.88 58.38 2.79 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.333 0.587 . . . . 0.0 111.81 175.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 17' ' ' ARG . . . . . 0.519 ' HG3' ' HB2' ' D' ' 14' ' ' LYS . 29.0 mmt180 -118.72 153.12 34.91 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.899 174.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 18' ' ' LYS . . . . . 0.696 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 3.5 ttmp? -130.94 110.81 11.53 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.021 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -111.32 112.55 24.4 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.942 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -75.08 114.66 13.83 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 171.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -92.96 114.12 26.59 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.386 -165.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 23.8 m -93.68 119.53 32.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.126 172.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 42.6 mt -96.82 112.96 29.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.112 0.482 . . . . 0.0 111.36 -173.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 24' ' ' ILE . . . . . 0.449 HD12 ' N ' ' D' ' 24' ' ' ILE . 4.2 mp -88.81 -34.8 7.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.354 177.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 25' ' ' LYS . . . . . 0.406 ' HD2' HD13 ' D' ' 91' ' ' LEU . 19.4 pttt -132.67 128.81 37.83 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.077 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -56.21 148.36 18.49 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.757 -177.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 27' ' ' PHE . . . . . 0.744 ' HB3' HD23 ' D' ' 91' ' ' LEU . 38.6 p90 -158.06 162.93 38.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.782 0.801 . . . . 0.0 112.842 -178.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 28' ' ' HIS . . . . . 0.55 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 2.0 t60 -119.2 123.83 45.29 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.401 176.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 29' ' ' ILE . . . . . 0.569 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 51.3 mt -85.29 134.65 26.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 170.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 30' ' ' SER . . . . . 0.565 ' HB2' ' HB3' ' E' ' 66' ' ' ASP . 61.2 p -117.53 -15.0 10.28 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -171.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 31' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -171.35 152.07 17.09 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 119.488 -1.339 . . . . 0.0 113.246 177.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.469 HG23 ' HG ' ' D' ' 87' ' ' LEU . 11.4 p -136.62 131.49 47.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 174.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.86 156.01 42.24 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 122.057 -0.402 . . . . 0.0 111.185 -176.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 34' ' ' LEU . . . . . 0.489 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.1 pp -118.07 141.41 48.5 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.869 0.842 . . . . 0.0 111.905 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -110.18 -54.21 2.6 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.232 -1.349 . . . . 0.0 108.806 176.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -100.83 128.1 47.01 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.827 171.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 37' ' ' GLY . . . . . 0.557 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 139.27 161.54 8.77 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 119.64 -1.267 . . . . 0.0 113.378 176.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -103.34 -43.79 5.33 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 178.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -149.43 132.28 16.07 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 120.529 0.204 . . . . 0.0 111.048 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 40' ' ' ALA . . . . . 0.458 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -131.76 113.74 13.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.405 0.621 . . . . 0.0 110.146 169.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' D' ' 79' ' ' THR . 97.3 mttt -96.21 110.54 22.82 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 175.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.404 ' HG ' ' CG2' ' D' ' 53' ' ' VAL . 50.9 tp -87.0 109.71 19.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.005 -172.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 43' ' ' TYR . . . . . 0.438 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 96.6 m-85 -108.23 141.88 39.32 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.303 178.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.581 HD21 ' CE1' ' C' ' 8' ' ' PHE . 1.5 tp -123.61 112.81 17.87 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.489 176.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 45' ' ' ALA . . . . . 0.584 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -99.19 108.84 21.53 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.14 0.495 . . . . 0.0 109.806 176.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.469 ' CB ' HG22 ' D' ' 75' ' ' ILE . . . -139.67 140.96 37.02 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.51 -177.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 53.26 41.9 32.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.506 0.669 . . . . 0.0 110.273 -178.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 39.2 mttp 69.94 21.5 6.22 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.389 172.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 49' ' ' GLN . . . . . 0.584 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 79.2 mm-40 -128.41 137.48 51.88 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.055 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -87.35 105.02 16.97 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 174.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 51' ' ' TYR . . . . . 0.436 ' CZ ' ' HB2' ' D' ' 49' ' ' GLN . 75.9 m-85 -99.93 120.29 39.56 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.657 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -77.31 99.92 2.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 170.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 53' ' ' VAL . . . . . 0.515 HG12 ' CD2' ' C' ' 88' ' ' LEU . 18.5 m -86.99 -34.62 7.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.818 -172.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 54' ' ' ALA . . . . . 0.56 ' HB2' ' CD2' ' D' ' 65' ' ' LEU . . . -151.11 140.86 21.81 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 120.361 -0.535 . . . . 0.0 112.085 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 21.9 m -111.57 101.3 9.71 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 169.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.18 113.65 43.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.724 0.774 . . . . 0.0 110.036 -176.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 76.9 p -123.2 -177.86 3.81 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.25 -175.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -64.03 -24.19 67.61 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.01 0.433 . . . . 0.0 110.535 169.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.33 -40.58 43.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.192 176.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 79.5 mt -116.81 81.9 12.44 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 173.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.95 -5.19 12.87 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.264 2.643 . . . . 0.0 114.052 -167.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -160.44 128.57 4.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.351 0.596 . . . . 0.0 111.268 -175.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 89.8 t -118.43 108.16 23.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.455 175.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.78 121.54 30.32 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 174.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 65' ' ' LEU . . . . . 0.56 ' CD2' ' HB2' ' D' ' 54' ' ' ALA . 0.4 OUTLIER -143.65 168.88 18.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.113 0.482 . . . . 0.0 111.93 -174.541 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 66' ' ' ASP . . . . . 0.528 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 9.2 t0 -116.35 107.13 14.43 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.806 178.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.569 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 32.8 mt -126.43 107.69 10.51 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 177.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -111.08 127.78 55.67 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.939 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -127.12 150.28 49.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.902 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 58.1 m -102.57 161.83 13.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.025 0.441 . . . . 0.0 110.739 176.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -69.32 -5.26 22.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.16 177.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.71 -7.65 62.83 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 173.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -100.29 143.53 30.38 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -122.98 125.67 45.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.49 ' HB ' ' CD1' ' D' ' 44' ' ' LEU . 14.9 pt -132.08 172.22 16.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.625 -171.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 76' ' ' MET . . . . . . . . . . . . . 7.9 mtm -130.09 131.67 45.83 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 170.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 77' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.9 OUTLIER -110.18 128.23 55.37 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.37 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 78' ' ' TYR . . . . . 0.696 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 41.1 p90 -153.6 140.33 19.0 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.312 -0.555 . . . . 0.0 112.172 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 79' ' ' THR . . . . . 0.669 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 8.3 p -111.83 136.51 51.02 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.295 -177.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.66 161.06 14.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.244 174.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.501 ' O ' ' HG3' ' D' ' 16' ' ' GLU . . . 81.97 177.23 51.71 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -173.156 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 82' ' ' ASP . . . . . 0.525 ' HA ' ' HB3' ' D' ' 15' ' ' PRO . 6.9 p-10 -112.9 104.15 12.14 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 118.263 -1.375 . . . . 0.0 110.928 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 83' ' ' ALA . . . . . 0.557 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -164.8 153.32 12.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.75 -1.568 . . . . 0.0 109.858 169.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 6.6 p -104.94 123.41 47.7 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.686 -0.486 . . . . 0.0 109.686 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.489 HG12 ' HB3' ' D' ' 34' ' ' LEU . 3.6 m -118.23 144.5 26.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.603 0.716 . . . . 0.0 112.729 -173.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 50.6 m -108.11 116.32 31.75 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.704 175.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 87' ' ' LEU . . . . . 0.556 HD11 ' SD ' ' D' ' 13' ' ' MET . 4.5 mp -96.05 143.05 27.54 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 170.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.527 ' CD2' HG12 ' E' ' 53' ' ' VAL . 2.6 mm? -125.08 152.09 44.8 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 174.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.6 -167.91 30.8 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.365 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -139.13 131.49 28.45 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.496 0.665 . . . . 0.0 110.836 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 91' ' ' LEU . . . . . 0.744 HD23 ' HB3' ' D' ' 27' ' ' PHE . 23.7 mt . . . . . 0 C--N 1.318 -0.766 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.904 173.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 48.5 mtt . . . . . 0 C--O 1.224 -0.257 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' E' E ' 8' ' ' PHE . . . . . 0.529 ' CE1' HD21 ' A' ' 44' ' ' LEU . 70.7 t80 -69.36 146.35 52.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.163 0.506 . . . . 0.0 112.169 -175.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 9' ' ' TRP . . . . . 0.469 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 92.2 t90 -136.79 145.53 44.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.997 176.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.41 146.63 16.39 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.61 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 11' ' ' LEU . . . . . 0.521 HD23 HD13 ' E' ' 87' ' ' LEU . 43.8 tp -138.54 109.94 6.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.943 0.402 . . . . 0.0 110.55 177.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -97.37 105.05 17.13 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 176.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 13' ' ' MET . . . . . 0.548 ' SD ' HD11 ' E' ' 87' ' ' LEU . 44.6 mtp -98.4 143.95 28.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.993 0.425 . . . . 0.0 110.98 -174.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 14' ' ' LYS . . . . . 0.515 ' HB2' ' HG3' ' E' ' 17' ' ' ARG . 37.8 mtmm -101.07 157.8 32.97 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.334 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 15' ' ' PRO . . . . . 0.522 ' HB3' ' HA ' ' E' ' 82' ' ' ASP . 91.5 Cg_exo -47.88 115.35 1.43 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.588 2.859 . . . . 0.0 113.703 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 16' ' ' GLU . . . . . 0.663 ' HA ' ' O ' ' E' ' 79' ' ' THR . 44.4 mt-10 59.99 58.35 2.76 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.712 0.633 . . . . 0.0 111.728 175.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 17' ' ' ARG . . . . . 0.515 ' HG3' ' HB2' ' E' ' 14' ' ' LYS . 29.1 mmt180 -118.73 153.1 34.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.942 174.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 18' ' ' LYS . . . . . 0.697 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 3.5 ttmp? -130.88 110.83 11.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.032 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -111.38 112.55 24.38 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.895 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 4.5 p -75.13 114.67 13.9 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -92.93 114.06 26.52 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.353 -165.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 23.8 m -93.62 119.58 32.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.079 172.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 42.4 mt -96.85 112.96 30.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.131 0.491 . . . . 0.0 111.275 -173.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 24' ' ' ILE . . . . . 0.454 HD12 ' N ' ' E' ' 24' ' ' ILE . 4.2 mp -88.84 -34.79 7.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.329 177.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 25' ' ' LYS . . . . . 0.421 ' HD2' HD13 ' E' ' 91' ' ' LEU . 19.3 pttt -132.77 128.73 37.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.116 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -56.18 148.38 18.32 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.775 -177.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 27' ' ' PHE . . . . . 0.734 ' HB3' HD23 ' E' ' 91' ' ' LEU . 38.8 p90 -157.99 162.94 38.21 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.691 0.757 . . . . 0.0 112.916 -178.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 28' ' ' HIS . . . . . 0.544 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 2.0 t60 -119.16 123.9 45.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.341 -1.299 . . . . 0.0 109.427 176.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 29' ' ' ILE . . . . . 0.576 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 51.2 mt -85.32 134.65 26.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 170.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 30' ' ' SER . . . . . 0.558 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 61.9 p -117.44 -15.14 10.32 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -171.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 31' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -171.34 152.08 17.11 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 119.498 -1.335 . . . . 0.0 113.33 177.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.486 HG23 ' HG ' ' E' ' 87' ' ' LEU . 11.3 p -136.63 131.54 47.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 174.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.93 155.96 42.16 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.068 -0.395 . . . . 0.0 111.174 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 34' ' ' LEU . . . . . 0.493 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.1 pp -117.98 141.37 48.52 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.886 0.85 . . . . 0.0 111.93 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -110.22 -54.16 2.6 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.177 -1.374 . . . . 0.0 108.801 176.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -100.85 128.12 47.02 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 171.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 37' ' ' GLY . . . . . 0.551 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 139.19 161.5 8.75 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 119.586 -1.293 . . . . 0.0 113.333 176.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -103.24 -43.82 5.35 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 178.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -149.52 132.36 16.05 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.572 0.225 . . . . 0.0 111.023 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 40' ' ' ALA . . . . . 0.454 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -131.79 113.71 13.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.345 0.593 . . . . 0.0 110.152 169.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 41' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' E' ' 79' ' ' THR . 97.4 mttt -96.32 110.62 22.91 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.404 ' HG ' ' CG2' ' E' ' 53' ' ' VAL . 51.1 tp -87.02 109.76 19.61 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.018 -172.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 43' ' ' TYR . . . . . 0.436 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 96.8 m-85 -108.31 141.85 39.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.268 178.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 44' ' ' LEU . . . . . 0.564 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 1.5 tp -123.62 112.84 17.9 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.388 176.335 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 45' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -99.19 108.9 21.6 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.209 0.528 . . . . 0.0 109.78 176.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 46' ' ' ALA . . . . . 0.479 ' CB ' HG22 ' E' ' 75' ' ' ILE . . . -139.69 140.98 36.98 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.504 -177.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 53.25 41.95 32.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.604 0.716 . . . . 0.0 110.271 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 39.1 mttp 69.84 21.54 6.33 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.399 172.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 49' ' ' GLN . . . . . 0.586 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 79.2 mm-40 -128.45 137.44 51.82 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 122.245 -0.285 . . . . 0.0 111.066 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -87.27 105.02 16.95 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 174.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 51' ' ' TYR . . . . . 0.442 ' CZ ' ' HB2' ' E' ' 49' ' ' GLN . 75.9 m-85 -99.99 120.26 39.54 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.681 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -77.42 99.97 2.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 171.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 53' ' ' VAL . . . . . 0.527 HG12 ' CD2' ' D' ' 88' ' ' LEU . 18.3 m -87.06 -34.53 7.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.789 -172.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 54' ' ' ALA . . . . . 0.562 ' HB2' ' CD2' ' E' ' 65' ' ' LEU . . . -151.07 140.86 21.84 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 120.352 -0.539 . . . . 0.0 112.104 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 21.7 m -111.51 101.22 9.66 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 169.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.19 113.67 43.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.757 0.789 . . . . 0.0 110.062 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 77.8 p -123.15 -177.74 3.77 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.236 -175.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -64.17 -24.18 67.58 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.478 169.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.38 -40.58 43.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.25 0.548 . . . . 0.0 110.114 176.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 79.6 mt -116.88 81.95 12.67 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 173.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.99 -5.13 12.76 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.174 2.583 . . . . 0.0 114.088 -167.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -160.48 128.69 4.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.231 0.539 . . . . 0.0 111.238 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 89.2 t -118.5 108.19 23.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.456 175.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.69 121.44 30.13 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 174.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 65' ' ' LEU . . . . . 0.562 ' CD2' ' HB2' ' E' ' 54' ' ' ALA . 0.4 OUTLIER -143.66 168.84 18.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.207 0.527 . . . . 0.0 111.951 -174.47 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' E' E ' 66' ' ' ASP . . . . . 0.565 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 9.3 t0 -116.32 107.16 14.48 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.772 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 67' ' ' LEU . . . . . 0.576 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 33.1 mt -126.49 107.71 10.5 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 177.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -111.07 127.91 55.7 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.907 -178.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -127.15 150.39 49.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.87 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 58.0 m -102.63 161.75 13.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.043 0.449 . . . . 0.0 110.795 176.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -69.29 -5.09 20.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.219 177.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.86 -7.55 62.67 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 173.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -100.32 143.45 30.5 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 178.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -122.95 125.72 45.84 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 174.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 75' ' ' ILE . . . . . 0.492 ' HB ' ' CD1' ' E' ' 44' ' ' LEU . 15.1 pt -132.03 172.2 16.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.666 -171.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 76' ' ' MET . . . . . . . . . . . . . 7.9 mtm -130.12 131.66 45.8 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 170.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 77' ' ' PHE . . . . . 0.564 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.9 OUTLIER -110.21 128.36 55.45 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 177.292 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' E' E ' 78' ' ' TYR . . . . . 0.697 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 40.9 p90 -153.64 140.41 19.05 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.287 -0.565 . . . . 0.0 112.112 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 79' ' ' THR . . . . . 0.663 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 8.3 p -111.88 136.36 51.28 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.28 -177.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.55 161.03 14.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.258 174.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 81' ' ' GLY . . . . . 0.483 ' O ' ' HG3' ' E' ' 16' ' ' GLU . . . 81.99 177.2 51.7 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -173.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 82' ' ' ASP . . . . . 0.522 ' HA ' ' HB3' ' E' ' 15' ' ' PRO . 6.9 p-10 -112.88 104.21 12.2 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 118.276 -1.37 . . . . 0.0 110.903 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 83' ' ' ALA . . . . . 0.551 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -164.84 153.22 12.17 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 113.708 -1.587 . . . . 0.0 109.836 169.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 6.6 p -104.93 123.48 47.83 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 85' ' ' VAL . . . . . 0.493 HG12 ' HB3' ' E' ' 34' ' ' LEU . 3.6 m -118.2 144.43 26.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -173.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 50.8 m -108.05 116.25 31.61 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.701 175.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 87' ' ' LEU . . . . . 0.548 HD11 ' SD ' ' E' ' 13' ' ' MET . 4.5 mp -96.1 143.12 27.51 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 170.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 88' ' ' LEU . . . . . 0.52 ' CD2' HG12 ' A' ' 53' ' ' VAL . 2.6 mm? -125.03 152.07 44.74 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 174.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.6 -167.86 30.73 Favored Glycine 0 N--CA 1.435 -1.377 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.409 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 90' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -139.19 131.46 28.32 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.565 0.698 . . . . 0.0 110.803 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 91' ' ' LEU . . . . . 0.734 HD23 ' HB3' ' E' ' 27' ' ' PHE . 23.7 mt . . . . . 0 C--N 1.32 -0.717 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.903 173.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.551 ' HA ' ' OG ' ' B' ' 70' ' ' SER . 45.5 mtt . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 121.559 0.695 . . . . 0.0 112.621 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.501 ' CE1' HD21 ' B' ' 44' ' ' LEU . 55.8 t80 -59.71 142.71 52.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.262 -176.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.546 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 88.5 t90 -134.14 142.05 47.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.735 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.91 140.05 8.38 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.143 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.673 HD23 HD13 ' A' ' 87' ' ' LEU . 56.6 tp -128.36 108.29 10.45 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.974 0.416 . . . . 0.0 110.048 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -86.46 101.38 13.1 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 175.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.592 ' HB3' HG23 ' A' ' 85' ' ' VAL . 27.3 tpp -91.95 129.27 37.95 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.39 -171.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.489 ' N ' ' HD2' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -95.54 140.74 22.48 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.799 179.405 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.617 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 9.5 Cg_endo -53.63 121.73 10.04 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.624 2.882 . . . . 0.0 113.474 -175.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' A' ' 79' ' ' THR . 31.3 mt-10 61.53 47.0 6.9 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.911 177.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.52 ' NE ' ' HA ' ' A' ' 17' ' ' ARG . 1.2 tpm_? -122.33 137.39 54.87 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 173.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.661 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 88.4 mttt -108.81 121.47 45.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.685 0.279 . . . . 0.0 111.684 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -111.06 103.57 12.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.303 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 76' ' ' MET . 45.7 t -90.47 99.42 12.45 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 172.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -120.12 148.12 44.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.146 -168.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.5 m -93.44 141.27 28.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.49 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.412 ' HB ' ' HA ' ' A' ' 71' ' ' LYS . 67.9 mt -89.89 117.01 32.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 120.92 0.39 . . . . 0.0 111.243 -173.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.526 HD12 ' N ' ' A' ' 25' ' ' LYS . 1.4 pp -79.63 -27.57 12.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.735 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.526 ' N ' HD12 ' A' ' 24' ' ' ILE . 31.7 ttpt -155.28 136.17 13.66 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -178.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 39.2 m -58.32 130.03 44.82 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.659 0.599 . . . . 0.0 110.091 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.624 ' HB3' HD23 ' A' ' 91' ' ' LEU . 10.1 p90 -144.26 161.92 37.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.611 0.719 . . . . 0.0 112.886 -172.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.598 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 15.7 t60 -114.82 123.87 50.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.187 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 37.6 mt -92.6 136.28 25.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 170.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.589 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 64.8 p -123.08 -20.19 5.82 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -170.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -154.85 146.3 14.17 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 119.324 -1.417 . . . . 0.0 113.336 178.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.487 HG23 ' HG ' ' A' ' 87' ' ' LEU . 14.3 p -140.01 126.81 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 170.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.417 ' HA ' HG21 ' A' ' 56' ' ' VAL . . . -148.81 158.11 43.92 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.903 -0.498 . . . . 0.0 111.576 -174.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.586 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.0 pp -118.9 139.21 52.01 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.587 0.708 . . . . 0.0 111.456 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -108.13 -51.33 2.91 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.298 173.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -102.52 128.12 49.3 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 170.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.505 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 145.08 162.39 9.55 Favored Glycine 0 N--CA 1.437 -1.263 0 C-N-CA 119.949 -1.12 . . . . 0.0 113.098 176.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -102.7 -46.81 4.61 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 111.487 0.18 . . . . 0.0 111.487 177.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -150.68 130.88 13.57 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.73 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.473 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -130.83 113.0 13.53 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.585 0.707 . . . . 0.0 110.186 169.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 79' ' ' THR . 4.5 mptp? -95.34 106.38 18.43 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 174.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.518 HD23 ' HB ' ' A' ' 53' ' ' VAL . 41.6 tp -78.8 114.01 17.37 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -176.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -114.82 135.88 53.7 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.283 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.602 ' HB3' HG22 ' A' ' 53' ' ' VAL . 5.0 tp -115.77 116.15 27.54 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.498 176.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -103.38 103.73 13.76 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 176.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.441 ' HB2' HD11 ' A' ' 44' ' ' LEU . . . -130.53 140.85 50.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.105 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 58.0 32.44 21.97 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.71 0.767 . . . . 0.0 109.445 -175.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 57.44 37.11 27.72 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.466 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 6.6 tp-100 -127.75 131.77 49.63 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 176.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -87.35 112.27 21.93 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.427 -177.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -108.4 131.37 54.84 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.793 177.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -78.78 100.42 3.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 169.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.602 HG22 ' HB3' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -72.4 -51.49 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.877 -174.151 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.512 ' HA ' ' OE1' ' E' ' 62' ' ' GLN . . . -154.57 132.47 11.57 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.516 -177.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.3 t -101.95 102.46 13.01 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 174.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 40' ' ' ALA . 7.1 p -116.67 109.7 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-O 122.128 0.966 . . . . 0.0 110.047 -176.272 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 66.9 p -122.55 -176.95 3.5 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.378 -176.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -65.07 -20.61 66.57 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 119.976 -0.689 . . . . 0.0 110.574 169.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.95 -40.68 27.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.246 0.546 . . . . 0.0 110.047 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.4 mt -118.68 77.65 14.7 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 172.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 57' ' ' THR . 9.8 Cg_exo -71.73 0.84 6.43 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.11 2.54 . . . . 0.0 113.636 -168.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.492 ' OE1' ' HA ' ' B' ' 54' ' ' ALA . 10.3 tt0 -160.06 114.7 2.28 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.237 -170.159 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.495 HG11 ' HB1' ' A' ' 54' ' ' ALA . 86.5 t -112.8 115.16 49.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.061 0.458 . . . . 0.0 111.247 177.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.04 116.0 28.38 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 171.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.426 HD23 ' H ' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -134.64 168.3 19.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.817 0.341 . . . . 0.0 111.036 -171.661 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.551 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 7.4 t0 -122.91 109.43 14.14 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.139 0.495 . . . . 0.0 110.36 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.683 HD21 HD23 ' E' ' 88' ' ' LEU . 12.8 mt -124.05 138.84 54.39 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.683 177.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -138.43 114.61 10.22 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 173.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -109.17 163.07 13.68 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.385 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.535 ' OG ' ' HA ' ' E' ' 7' ' ' MET . 4.5 m -117.22 149.03 41.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.154 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.412 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -70.04 -5.9 29.86 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.736 -177.103 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.87 -28.54 45.84 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.319 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -101.3 171.25 7.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.702 0.287 . . . . 0.0 110.43 -176.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -137.3 136.5 38.06 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.467 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 22.6 pt -133.07 158.4 43.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.081 0.467 . . . . 0.0 111.571 -169.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.418 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 65.3 ttp -117.52 118.09 31.21 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.342 176.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.467 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -105.53 129.37 53.82 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.806 -177.773 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.661 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 39.0 p90 -155.74 162.79 40.47 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.847 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 12.6 p -125.21 143.86 50.74 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.108 178.187 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.3 149.48 26.87 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.231 173.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.0 -176.92 36.47 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -176.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -114.48 102.64 10.27 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.238 178.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.617 ' H ' ' HB3' ' A' ' 15' ' ' PRO . . . -166.74 150.05 6.85 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.479 168.078 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.2 p -106.04 122.11 45.5 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.592 HG23 ' HB3' ' A' ' 13' ' ' MET . 13.5 m -121.54 144.23 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-O 121.241 0.543 . . . . 0.0 111.801 -172.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 43.3 m -105.21 122.85 46.77 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.276 175.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.673 HD13 HD23 ' A' ' 11' ' ' LEU . 5.1 mp -95.22 143.93 26.23 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 170.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.695 HD23 HD21 ' B' ' 67' ' ' LEU . 0.9 OUTLIER -130.39 141.23 50.56 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.152 -178.718 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.66 -166.89 27.5 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.953 -0.642 . . . . 0.0 111.795 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -147.06 133.49 19.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.474 0.654 . . . . 0.0 111.161 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.624 HD23 ' HB3' ' A' ' 27' ' ' PHE . 15.1 mt . . . . . 0 C--N 1.322 -0.623 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.106 175.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 7' ' ' MET . . . . . 0.568 ' HA ' ' OG ' ' C' ' 70' ' ' SER . 45.5 mtt . . . . . 0 CA--C 1.518 -0.282 0 CA-C-O 121.533 0.682 . . . . 0.0 112.727 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 8' ' ' PHE . . . . . 0.507 ' CE1' HD21 ' C' ' 44' ' ' LEU . 55.5 t80 -59.76 142.74 52.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.247 -176.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 9' ' ' TRP . . . . . 0.541 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 88.6 t90 -134.14 142.01 47.32 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.75 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.87 140.06 8.39 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.253 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.681 HD23 HD13 ' B' ' 87' ' ' LEU . 56.8 tp -128.36 108.35 10.5 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.972 0.415 . . . . 0.0 110.079 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -86.46 101.29 13.03 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 175.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 13' ' ' MET . . . . . 0.585 ' HB3' HG23 ' B' ' 85' ' ' VAL . 27.4 tpp -91.95 129.37 37.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.349 -171.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.492 ' N ' ' HD2' ' B' ' 14' ' ' LYS . 0.3 OUTLIER -95.69 140.83 22.5 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.757 179.362 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.62 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 9.4 Cg_endo -53.62 121.71 10.0 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 123.656 2.904 . . . . 0.0 113.425 -175.333 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' B' ' 79' ' ' THR . 31.2 mt-10 61.58 47.04 6.8 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.835 177.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.515 ' NE ' ' HA ' ' B' ' 17' ' ' ARG . 1.1 tpm_? -122.36 137.3 54.9 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 173.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.657 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 88.5 mttt -108.84 121.57 45.37 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -111.2 103.56 11.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.233 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 45.0 t -90.4 99.47 12.48 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -120.2 148.17 44.01 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.55 0.69 . . . . 0.0 112.152 -168.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 19.7 m -93.49 141.27 28.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.436 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -89.93 117.07 32.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.085 0.469 . . . . 0.0 111.214 -173.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.523 HD12 ' N ' ' B' ' 25' ' ' LYS . 1.4 pp -79.63 -27.58 12.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.709 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.523 ' N ' HD12 ' B' ' 24' ' ' ILE . 31.7 ttpt -155.3 136.1 13.59 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 38.9 m -58.23 130.03 44.75 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.725 0.641 . . . . 0.0 110.096 -178.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 27' ' ' PHE . . . . . 0.616 ' HB3' HD23 ' B' ' 91' ' ' LEU . 10.0 p90 -144.25 161.86 37.83 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -172.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 28' ' ' HIS . . . . . 0.595 ' HA ' ' O ' ' B' ' 67' ' ' LEU . 16.1 t60 -114.74 123.9 50.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.194 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 37.8 mt -92.66 136.17 25.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 170.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.587 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 65.1 p -122.91 -20.28 5.87 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -170.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -154.82 146.19 13.97 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 119.508 -1.329 . . . . 0.0 113.416 179.073 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.483 HG23 ' HG ' ' B' ' 87' ' ' LEU . 14.4 p -139.99 126.71 23.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 170.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 33' ' ' ALA . . . . . 0.415 ' HA ' HG21 ' B' ' 56' ' ' VAL . . . -148.79 158.15 43.95 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.925 -0.484 . . . . 0.0 111.669 -174.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.591 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.0 pp -118.91 139.26 51.93 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.719 0.771 . . . . 0.0 111.356 178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -108.21 -51.29 2.92 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.355 173.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -102.46 128.15 49.19 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 170.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.507 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 145.01 162.43 9.56 Favored Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 119.906 -1.14 . . . . 0.0 113.01 176.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -102.73 -46.67 4.65 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 177.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -150.77 130.81 13.43 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.754 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.481 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -130.78 113.06 13.64 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.55 0.691 . . . . 0.0 110.165 169.009 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' B' ' 79' ' ' THR . 4.5 mptp? -95.42 106.33 18.38 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 174.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.519 HD23 ' HB ' ' B' ' 53' ' ' VAL . 41.4 tp -78.67 113.92 17.14 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -176.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -114.78 135.89 53.68 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.247 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.587 ' HB3' HG22 ' B' ' 53' ' ' VAL . 4.9 tp -115.85 116.18 27.55 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.509 176.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -103.31 103.71 13.75 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 176.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.447 ' HB2' HD11 ' B' ' 44' ' ' LEU . . . -130.61 140.79 50.43 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.125 -178.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 58.19 32.29 21.85 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.543 0.687 . . . . 0.0 109.34 -175.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 62.4 mttp 57.54 37.0 27.49 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.508 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.515 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 6.6 tp-100 -127.67 131.8 49.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.588 176.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -87.47 112.32 22.07 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.828 0.346 . . . . 0.0 110.389 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -108.48 131.37 54.87 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.763 177.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -78.82 100.41 3.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 169.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.587 HG22 ' HB3' ' B' ' 44' ' ' LEU . 0.9 OUTLIER -72.3 -51.53 29.11 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.011 -174.205 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.492 ' HA ' ' OE1' ' A' ' 62' ' ' GLN . . . -154.48 132.53 11.69 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.547 -177.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 7.5 t -101.97 102.43 12.96 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 174.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 56' ' ' VAL . . . . . 0.425 HG13 ' HB3' ' B' ' 40' ' ' ALA . 7.1 p -116.63 109.79 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-O 122.062 0.934 . . . . 0.0 109.964 -176.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' B' ' 61' ' ' PRO . 67.1 p -122.63 -176.94 3.51 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.352 -176.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -65.06 -20.63 66.57 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.551 169.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.86 -40.82 27.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.267 0.556 . . . . 0.0 110.02 176.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 74.2 mt -118.7 77.6 14.73 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 172.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 61' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' B' ' 57' ' ' THR . 9.7 Cg_exo -71.71 0.88 6.35 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.083 2.522 . . . . 0.0 113.721 -168.034 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 62' ' ' GLN . . . . . 0.507 ' OE1' ' HA ' ' C' ' 54' ' ' ALA . 10.3 tt0 -160.12 114.72 2.27 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.256 -170.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.487 HG11 ' HB1' ' B' ' 54' ' ' ALA . 86.0 t -112.75 115.17 49.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.108 0.48 . . . . 0.0 111.259 177.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.05 115.92 28.29 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 171.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.437 HD23 ' H ' ' B' ' 65' ' ' LEU . 0.7 OUTLIER -134.56 168.26 19.29 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.06 -171.67 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 66' ' ' ASP . . . . . 0.547 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 7.4 t0 -122.89 109.46 14.18 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.111 0.481 . . . . 0.0 110.365 -179.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.695 HD21 HD23 ' A' ' 88' ' ' LEU . 12.7 mt -124.02 138.91 54.39 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.67 177.046 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -138.64 114.65 10.12 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 173.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -109.23 162.99 13.77 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.395 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.551 ' OG ' ' HA ' ' A' ' 7' ' ' MET . 4.4 m -117.12 149.01 41.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.22 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -6.15 31.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.71 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.81 -28.38 46.7 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.365 177.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -101.24 171.32 7.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.764 0.316 . . . . 0.0 110.44 -176.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -137.37 136.47 37.93 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.458 ' HB ' ' CD1' ' B' ' 44' ' ' LEU . 22.3 pt -133.03 158.39 43.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.912 0.387 . . . . 0.0 111.668 -169.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.434 ' HA ' ' HA ' ' B' ' 20' ' ' SER . 65.3 ttp -117.47 118.21 31.56 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.056 0.455 . . . . 0.0 110.319 176.147 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 77' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.4 OUTLIER -105.63 129.39 53.88 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.788 -177.807 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.657 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 39.0 p90 -155.79 162.72 40.44 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.871 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 12.5 p -125.26 143.89 50.73 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.094 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.45 149.61 26.88 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.088 173.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.87 -176.95 36.69 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -176.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -114.38 102.67 10.31 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 117.988 0.894 . . . . 0.0 110.289 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.62 ' H ' ' HB3' ' B' ' 15' ' ' PRO . . . -166.72 150.04 6.88 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.465 168.073 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 6.1 p -106.05 122.17 45.62 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.591 HG12 ' HB3' ' B' ' 34' ' ' LEU . 13.4 m -121.59 144.26 31.33 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 121.241 0.544 . . . . 0.0 111.771 -172.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 44.0 m -105.25 122.88 46.86 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.24 175.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.681 HD13 HD23 ' B' ' 11' ' ' LEU . 5.1 mp -95.16 143.95 26.17 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.695 HD23 HD21 ' C' ' 67' ' ' LEU . 0.9 OUTLIER -130.44 141.23 50.53 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.17 -178.712 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.68 -166.93 27.59 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.752 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -147.0 133.54 19.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.428 0.633 . . . . 0.0 111.029 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 91' ' ' LEU . . . . . 0.616 HD23 ' HB3' ' B' ' 27' ' ' PHE . 15.1 mt . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.083 175.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 7' ' ' MET . . . . . 0.577 ' HA ' ' OG ' ' D' ' 70' ' ' SER . 45.3 mtt . . . . . 0 N--CA 1.454 -0.239 0 CA-C-O 121.522 0.677 . . . . 0.0 112.657 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 8' ' ' PHE . . . . . 0.492 ' CE1' HD21 ' D' ' 44' ' ' LEU . 55.5 t80 -59.78 142.66 52.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.401 -1.272 . . . . 0.0 112.203 -176.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 9' ' ' TRP . . . . . 0.533 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 88.4 t90 -134.08 142.08 47.41 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.766 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.84 140.07 8.41 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.148 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.67 HD23 HD13 ' C' ' 87' ' ' LEU . 56.3 tp -128.33 108.24 10.42 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.893 0.378 . . . . 0.0 110.153 178.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -86.27 101.25 12.89 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 175.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 13' ' ' MET . . . . . 0.587 ' HB3' HG23 ' C' ' 85' ' ' VAL . 27.2 tpp -91.99 129.42 37.95 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.362 -171.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 14' ' ' LYS . . . . . 0.482 ' N ' ' HD2' ' C' ' 14' ' ' LYS . 0.3 OUTLIER -95.68 140.74 22.46 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.833 179.385 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 15' ' ' PRO . . . . . 0.618 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 9.5 Cg_endo -53.59 121.73 10.03 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.606 2.871 . . . . 0.0 113.51 -175.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 16' ' ' GLU . . . . . 0.659 ' HA ' ' O ' ' C' ' 79' ' ' THR . 31.5 mt-10 61.56 47.04 6.84 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.838 177.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 17' ' ' ARG . . . . . 0.518 ' NE ' ' HA ' ' C' ' 17' ' ' ARG . 1.2 tpm_? -122.33 137.33 54.89 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 173.178 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 18' ' ' LYS . . . . . 0.657 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 88.4 mttt -108.85 121.51 45.24 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -111.07 103.71 12.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.252 176.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 20' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 45.2 t -90.59 99.52 12.53 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 172.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -120.23 148.14 44.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.125 -168.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 19.5 m -93.42 141.2 28.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.538 176.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 67.7 mt -89.84 117.06 32.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.974 0.416 . . . . 0.0 111.295 -173.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 24' ' ' ILE . . . . . 0.519 HD12 ' N ' ' C' ' 25' ' ' LYS . 1.4 pp -79.68 -27.5 12.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.703 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 25' ' ' LYS . . . . . 0.519 ' N ' HD12 ' C' ' 24' ' ' ILE . 31.7 ttpt -155.41 136.18 13.54 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 39.4 m -58.33 130.08 45.05 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.715 0.634 . . . . 0.0 110.085 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 27' ' ' PHE . . . . . 0.635 ' HB3' HD23 ' C' ' 91' ' ' LEU . 9.9 p90 -144.27 161.89 37.79 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.654 0.74 . . . . 0.0 112.905 -172.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 28' ' ' HIS . . . . . 0.606 ' HA ' ' O ' ' C' ' 67' ' ' LEU . 15.9 t60 -114.75 123.9 50.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.203 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 29' ' ' ILE . . . . . 0.56 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 38.0 mt -92.66 136.21 25.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 170.287 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.578 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 65.2 p -122.98 -20.25 5.84 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -170.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 31' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -154.74 146.21 14.04 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.403 -1.379 . . . . 0.0 113.395 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.49 HG23 ' HG ' ' C' ' 87' ' ' LEU . 14.4 p -140.08 126.73 22.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 170.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.412 ' HA ' HG21 ' C' ' 56' ' ' VAL . . . -148.73 158.21 43.99 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.617 -174.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.6 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.0 pp -118.99 139.21 52.07 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.739 0.781 . . . . 0.0 111.339 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -108.14 -51.28 2.92 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.572 -1.194 . . . . 0.0 108.382 173.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -102.42 128.03 49.2 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 170.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 37' ' ' GLY . . . . . 0.505 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 145.09 162.42 9.56 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.056 176.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -102.7 -46.73 4.63 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 177.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -150.73 130.81 13.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.809 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.495 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -130.81 113.02 13.56 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.53 0.681 . . . . 0.0 110.172 169.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' C' ' 79' ' ' THR . 4.5 mptp? -95.36 106.33 18.37 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 174.198 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.506 HD23 ' HB ' ' C' ' 53' ' ' VAL . 41.7 tp -78.69 113.97 17.21 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -176.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -114.86 135.88 53.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.244 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.61 ' HB3' HG22 ' C' ' 53' ' ' VAL . 4.9 tp -115.73 116.05 27.4 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.56 176.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 45' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -103.27 103.76 13.82 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 176.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.452 ' HB2' HD11 ' C' ' 44' ' ' LEU . . . -130.58 140.85 50.45 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.108 -178.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 58.05 32.4 21.93 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.611 0.719 . . . . 0.0 109.416 -175.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 62.4 mttp 57.38 37.11 27.84 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.523 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 49' ' ' GLN . . . . . 0.51 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 6.6 tp-100 -127.73 131.72 49.67 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.558 176.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -87.39 112.31 22.0 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.791 0.329 . . . . 0.0 110.401 -177.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -108.39 131.3 54.9 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.775 177.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -78.76 100.47 3.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 169.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 53' ' ' VAL . . . . . 0.61 HG22 ' HB3' ' C' ' 44' ' ' LEU . 0.9 OUTLIER -72.45 -51.46 28.85 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.955 -174.211 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 54' ' ' ALA . . . . . 0.507 ' HA ' ' OE1' ' B' ' 62' ' ' GLN . . . -154.5 132.5 11.65 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.597 -177.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 7.4 t -102.0 102.46 12.98 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 174.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 56' ' ' VAL . . . . . 0.412 HG21 ' HA ' ' C' ' 33' ' ' ALA . 7.1 p -116.61 109.74 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-O 122.005 0.907 . . . . 0.0 110.057 -176.252 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 57' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' C' ' 61' ' ' PRO . 66.9 p -122.62 -177.09 3.54 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.379 -176.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -64.95 -20.73 66.62 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.578 169.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.76 -40.82 27.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.247 0.546 . . . . 0.0 110.084 176.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 74.0 mt -118.7 77.64 14.77 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 172.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 61' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' C' ' 57' ' ' THR . 9.7 Cg_exo -71.74 0.86 6.39 Favored 'Trans proline' 0 N--CA 1.473 0.308 0 C-N-CA 123.099 2.532 . . . . 0.0 113.618 -168.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 62' ' ' GLN . . . . . 0.58 ' OE1' ' HA ' ' D' ' 54' ' ' ALA . 10.3 tt0 -160.13 114.73 2.27 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.733 0.301 . . . . 0.0 111.307 -170.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.494 HG11 ' HB1' ' C' ' 54' ' ' ALA . 85.9 t -112.79 115.16 49.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.13 0.49 . . . . 0.0 111.264 177.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.0 115.97 28.36 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 171.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 65' ' ' LEU . . . . . 0.443 HD23 ' H ' ' C' ' 65' ' ' LEU . 0.7 OUTLIER -134.53 168.35 19.12 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.138 -171.726 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 66' ' ' ASP . . . . . 0.493 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 7.4 t0 -122.95 109.37 14.05 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.077 0.465 . . . . 0.0 110.278 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.695 HD21 HD23 ' B' ' 88' ' ' LEU . 12.8 mt -124.03 138.79 54.4 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.696 176.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -138.45 114.57 10.17 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 172.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -109.12 163.0 13.72 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.348 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 70' ' ' SER . . . . . 0.568 ' OG ' ' HA ' ' B' ' 7' ' ' MET . 4.5 m -117.16 149.03 41.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.161 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.97 -6.04 30.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.737 -177.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.88 -28.44 46.16 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.269 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -101.2 171.32 7.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.603 0.239 . . . . 0.0 110.491 -176.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -137.35 136.54 38.02 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.457 ' HB ' ' CD1' ' C' ' 44' ' ' LEU . 22.6 pt -133.06 158.39 43.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.022 0.439 . . . . 0.0 111.647 -169.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' C' ' 20' ' ' SER . 65.4 ttp -117.46 118.08 31.22 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.279 176.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 77' ' ' PHE . . . . . 0.479 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.4 OUTLIER -105.62 129.34 53.88 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.791 -177.833 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 78' ' ' TYR . . . . . 0.657 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 38.9 p90 -155.73 162.72 40.48 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.839 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 79' ' ' THR . . . . . 0.659 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 12.6 p -125.12 143.88 50.71 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.143 178.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.43 149.63 26.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.072 173.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.88 -176.87 36.6 Favored Glycine 0 CA--C 1.508 -0.346 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -176.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -114.5 102.63 10.25 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.24 178.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 83' ' ' ALA . . . . . 0.618 ' H ' ' HB3' ' C' ' 15' ' ' PRO . . . -166.69 150.06 6.93 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.508 167.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 6.3 p -106.01 122.2 45.67 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.6 HG12 ' HB3' ' C' ' 34' ' ' LEU . 13.5 m -121.62 144.2 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-O 121.223 0.535 . . . . 0.0 111.769 -172.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 43.6 m -105.23 122.87 46.82 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.28 175.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 87' ' ' LEU . . . . . 0.67 HD13 HD23 ' C' ' 11' ' ' LEU . 5.1 mp -95.15 144.03 26.11 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 170.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 88' ' ' LEU . . . . . 0.693 HD23 HD21 ' D' ' 67' ' ' LEU . 0.9 OUTLIER -130.5 141.21 50.5 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.161 -178.685 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.67 -166.93 27.57 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.744 -177.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -146.95 133.57 19.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.384 0.612 . . . . 0.0 111.095 177.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 91' ' ' LEU . . . . . 0.635 HD23 ' HB3' ' C' ' 27' ' ' PHE . 15.1 mt . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.07 175.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 7' ' ' MET . . . . . 0.559 ' HA ' ' OG ' ' E' ' 70' ' ' SER . 45.2 mtt . . . . . 0 CA--C 1.518 -0.26 0 CA-C-O 121.566 0.698 . . . . 0.0 112.674 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 8' ' ' PHE . . . . . 0.513 ' CE1' HD21 ' E' ' 44' ' ' LEU . 55.8 t80 -59.64 142.74 52.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.341 -1.299 . . . . 0.0 112.24 -176.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 9' ' ' TRP . . . . . 0.539 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 88.4 t90 -134.27 142.08 47.19 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.9 140.08 8.4 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.188 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 11' ' ' LEU . . . . . 0.677 HD23 HD13 ' D' ' 87' ' ' LEU . 56.8 tp -128.3 108.23 10.42 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.899 0.381 . . . . 0.0 110.077 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -86.49 101.41 13.15 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 13' ' ' MET . . . . . 0.59 ' HB3' HG23 ' D' ' 85' ' ' VAL . 27.4 tpp -92.0 129.36 37.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.377 -171.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 14' ' ' LYS . . . . . 0.481 ' HD2' ' N ' ' D' ' 14' ' ' LYS . 0.3 OUTLIER -95.69 140.69 22.44 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.806 179.418 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 15' ' ' PRO . . . . . 0.619 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 9.5 Cg_endo -53.57 121.81 10.17 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 123.609 2.873 . . . . 0.0 113.411 -175.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 16' ' ' GLU . . . . . 0.644 ' HA ' ' O ' ' D' ' 79' ' ' THR . 31.4 mt-10 61.44 47.01 7.06 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.956 177.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 17' ' ' ARG . . . . . 0.519 ' NE ' ' HA ' ' D' ' 17' ' ' ARG . 1.1 tpm_? -122.29 137.28 54.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.056 173.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 18' ' ' LYS . . . . . 0.667 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 88.4 mttt -108.77 121.48 45.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.723 0.297 . . . . 0.0 111.695 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -111.14 103.65 12.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.283 176.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 20' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 44.9 t -90.48 99.49 12.51 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 172.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -120.25 148.21 43.99 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.105 -168.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 19.3 m -93.48 141.24 28.69 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.478 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 23' ' ' ILE . . . . . 0.408 ' HB ' ' HA ' ' D' ' 71' ' ' LYS . 67.9 mt -89.93 117.04 32.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.082 0.468 . . . . 0.0 111.227 -173.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 24' ' ' ILE . . . . . 0.523 HD12 ' N ' ' D' ' 25' ' ' LYS . 1.4 pp -79.55 -27.61 12.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.782 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 25' ' ' LYS . . . . . 0.531 ' HE3' ' HB3' ' D' ' 91' ' ' LEU . 31.7 ttpt -155.31 136.18 13.64 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 39.3 m -58.31 130.06 44.93 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.68 0.613 . . . . 0.0 110.134 -178.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 27' ' ' PHE . . . . . 0.623 ' HB3' HD23 ' D' ' 91' ' ' LEU . 9.9 p90 -144.28 161.86 37.86 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -172.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 28' ' ' HIS . . . . . 0.595 ' HA ' ' O ' ' D' ' 67' ' ' LEU . 16.0 t60 -114.74 123.92 50.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.173 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 29' ' ' ILE . . . . . 0.569 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 37.7 mt -92.7 136.18 25.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 170.218 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 30' ' ' SER . . . . . 0.594 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 65.9 p -122.96 -20.23 5.86 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -170.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 31' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -154.78 146.22 14.04 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 119.425 -1.369 . . . . 0.0 113.409 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.504 HG23 ' HG ' ' D' ' 87' ' ' LEU . 14.2 p -139.95 126.8 23.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 170.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 33' ' ' ALA . . . . . 0.404 ' HA ' HG21 ' D' ' 56' ' ' VAL . . . -148.87 158.14 43.94 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.8 -0.562 . . . . 0.0 111.654 -174.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 34' ' ' LEU . . . . . 0.584 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.0 pp -118.89 139.24 51.96 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.682 0.753 . . . . 0.0 111.431 178.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -108.21 -51.25 2.92 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.333 173.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -102.36 128.02 49.12 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 170.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 37' ' ' GLY . . . . . 0.496 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 145.1 162.41 9.56 Favored Glycine 0 N--CA 1.438 -1.167 0 C-N-CA 119.867 -1.159 . . . . 0.0 113.065 176.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -102.73 -46.66 4.65 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.609 0.242 . . . . 0.0 111.581 177.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -150.72 130.82 13.49 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.769 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 40' ' ' ALA . . . . . 0.479 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -130.79 113.0 13.56 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.492 0.663 . . . . 0.0 110.2 169.03 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' D' ' 79' ' ' THR . 4.5 mptp? -95.37 106.38 18.43 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 174.264 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.509 HD23 ' HB ' ' D' ' 53' ' ' VAL . 41.9 tp -78.88 113.96 17.41 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -176.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -114.79 135.95 53.62 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.336 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.594 ' HB3' HG22 ' D' ' 53' ' ' VAL . 4.9 tp -115.82 116.07 27.37 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.444 176.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 45' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -103.28 103.68 13.73 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.45 ' HB2' HD11 ' D' ' 44' ' ' LEU . . . -130.55 140.83 50.47 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.052 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 58.1 32.4 21.95 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.652 0.739 . . . . 0.0 109.365 -175.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 62.4 mttp 57.44 37.04 27.7 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 114.854 -1.067 . . . . 0.0 111.547 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 49' ' ' GLN . . . . . 0.515 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 6.6 tp-100 -127.69 131.78 49.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.573 176.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -87.42 112.35 22.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.383 -177.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -108.46 131.44 54.8 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.743 177.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -78.84 100.36 3.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 169.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 53' ' ' VAL . . . . . 0.594 HG22 ' HB3' ' D' ' 44' ' ' LEU . 0.9 OUTLIER -72.34 -51.49 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.988 -174.174 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 54' ' ' ALA . . . . . 0.58 ' HA ' ' OE1' ' C' ' 62' ' ' GLN . . . -154.46 132.38 11.6 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.538 -177.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 7.6 t -101.89 102.47 13.04 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 174.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 56' ' ' VAL . . . . . 0.432 HG13 ' HB3' ' D' ' 40' ' ' ALA . 7.1 p -116.69 109.76 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-O 122.039 0.923 . . . . 0.0 110.052 -176.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 57' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' D' ' 61' ' ' PRO . 67.3 p -122.64 -176.99 3.52 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.347 -176.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -65.03 -20.68 66.61 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.541 169.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.76 -40.84 27.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.265 0.555 . . . . 0.0 110.07 176.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 74.6 mt -118.73 77.64 14.87 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 172.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 61' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' D' ' 57' ' ' THR . 9.7 Cg_exo -71.7 0.88 6.35 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.159 2.573 . . . . 0.0 113.651 -168.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 62' ' ' GLN . . . . . 0.492 ' OE1' ' HA ' ' E' ' 54' ' ' ALA . 10.3 tt0 -160.09 114.77 2.28 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.274 -170.273 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.49 HG11 ' HB1' ' D' ' 54' ' ' ALA . 86.1 t -112.84 115.06 48.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.104 0.478 . . . . 0.0 111.236 177.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.87 115.92 28.34 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 171.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 65' ' ' LEU . . . . . 0.437 HD23 ' H ' ' D' ' 65' ' ' LEU . 0.7 OUTLIER -134.55 168.32 19.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.777 0.322 . . . . 0.0 111.092 -171.727 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 66' ' ' ASP . . . . . 0.545 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 7.5 t0 -122.91 109.39 14.09 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.127 0.489 . . . . 0.0 110.365 -178.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.693 HD21 HD23 ' C' ' 88' ' ' LEU . 12.8 mt -124.0 138.9 54.39 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.712 176.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -138.57 114.61 10.13 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 173.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -109.16 163.07 13.68 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.315 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 70' ' ' SER . . . . . 0.577 ' OG ' ' HA ' ' C' ' 7' ' ' MET . 4.4 m -117.21 149.06 41.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.186 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 71' ' ' LYS . . . . . 0.408 ' HA ' ' HB ' ' D' ' 23' ' ' ILE . 0.0 OUTLIER -70.05 -6.14 31.63 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.72 -177.104 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.68 -28.62 46.37 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.319 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -101.12 171.31 7.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.757 0.313 . . . . 0.0 110.449 -176.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -137.31 136.49 38.03 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 75' ' ' ILE . . . . . 0.462 ' HB ' ' CD1' ' D' ' 44' ' ' LEU . 22.6 pt -133.03 158.36 43.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.014 0.435 . . . . 0.0 111.642 -169.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 76' ' ' MET . . . . . 0.412 ' HA ' ' HA ' ' D' ' 20' ' ' SER . 65.4 ttp -117.43 118.08 31.24 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.372 176.138 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 77' ' ' PHE . . . . . 0.479 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.4 OUTLIER -105.57 129.42 53.83 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.789 -177.812 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 78' ' ' TYR . . . . . 0.667 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 39.0 p90 -155.76 162.78 40.45 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.881 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 79' ' ' THR . . . . . 0.644 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 12.6 p -125.22 143.87 50.74 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.116 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.35 149.61 26.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.097 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.87 -177.05 36.77 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -176.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -114.4 102.58 10.22 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.242 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 83' ' ' ALA . . . . . 0.619 ' H ' ' HB3' ' D' ' 15' ' ' PRO . . . -166.69 150.13 6.94 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.385 168.067 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 6.2 p -106.1 122.25 45.81 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.59 HG23 ' HB3' ' D' ' 13' ' ' MET . 13.4 m -121.65 144.19 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-O 121.203 0.525 . . . . 0.0 111.792 -172.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 43.6 m -105.1 122.79 46.63 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.322 175.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 87' ' ' LEU . . . . . 0.677 HD13 HD23 ' D' ' 11' ' ' LEU . 5.1 mp -95.22 143.97 26.2 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 170.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.684 HD23 HD21 ' E' ' 67' ' ' LEU . 0.9 OUTLIER -130.4 141.18 50.55 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.175 -178.686 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.58 -166.84 27.33 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.756 -177.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -147.05 133.51 19.69 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.437 0.637 . . . . 0.0 111.113 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 91' ' ' LEU . . . . . 0.623 HD23 ' HB3' ' D' ' 27' ' ' PHE . 15.1 mt . . . . . 0 C--N 1.322 -0.6 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.065 175.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 7' ' ' MET . . . . . 0.535 ' HA ' ' OG ' ' A' ' 70' ' ' SER . 45.2 mtt . . . . . 0 CA--C 1.519 -0.231 0 CA-C-O 121.653 0.739 . . . . 0.0 112.626 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 8' ' ' PHE . . . . . 0.469 ' CE1' HD21 ' A' ' 44' ' ' LEU . 55.6 t80 -59.64 142.7 52.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.291 -1.322 . . . . 0.0 112.293 -176.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 9' ' ' TRP . . . . . 0.528 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 88.6 t90 -134.21 142.04 47.25 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.84 140.06 8.4 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.162 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 11' ' ' LEU . . . . . 0.687 HD23 HD13 ' E' ' 87' ' ' LEU . 56.8 tp -128.36 108.32 10.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.966 0.412 . . . . 0.0 110.101 178.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -86.45 101.34 13.06 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 175.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 13' ' ' MET . . . . . 0.588 ' HB3' HG23 ' E' ' 85' ' ' VAL . 27.3 tpp -91.99 129.41 37.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.419 -171.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 14' ' ' LYS . . . . . 0.474 ' HD2' ' N ' ' E' ' 14' ' ' LYS . 0.3 OUTLIER -95.68 140.69 22.44 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.843 179.394 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' E' E ' 15' ' ' PRO . . . . . 0.603 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 9.5 Cg_endo -53.63 121.79 10.14 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 123.508 2.805 . . . . 0.0 113.514 -175.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 16' ' ' GLU . . . . . 0.648 ' HA ' ' O ' ' E' ' 79' ' ' THR . 31.3 mt-10 61.54 47.06 6.84 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.887 177.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 17' ' ' ARG . . . . . 0.52 ' NE ' ' HA ' ' E' ' 17' ' ' ARG . 1.2 tpm_? -122.41 137.34 54.9 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 173.252 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 18' ' ' LYS . . . . . 0.661 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 88.6 mttt -108.83 121.51 45.24 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -111.11 103.64 12.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.213 176.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 20' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' E' ' 76' ' ' MET . 44.5 t -90.46 99.39 12.43 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 172.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -120.22 148.11 44.09 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.523 0.678 . . . . 0.0 112.093 -168.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 19.8 m -93.46 141.22 28.7 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.469 176.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 67.8 mt -89.84 117.08 32.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.044 0.449 . . . . 0.0 111.284 -173.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 24' ' ' ILE . . . . . 0.522 HD12 ' N ' ' E' ' 25' ' ' LYS . 1.4 pp -79.67 -27.54 12.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.721 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 25' ' ' LYS . . . . . 0.522 ' N ' HD12 ' E' ' 24' ' ' ILE . 31.7 ttpt -155.37 136.14 13.55 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 39.6 m -58.3 130.09 45.07 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.654 0.596 . . . . 0.0 110.08 -178.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 27' ' ' PHE . . . . . 0.635 ' HB3' HD23 ' E' ' 91' ' ' LEU . 10.0 p90 -144.24 161.92 37.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -172.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 28' ' ' HIS . . . . . 0.603 ' HA ' ' O ' ' E' ' 67' ' ' LEU . 16.0 t60 -114.85 123.87 50.27 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.172 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 29' ' ' ILE . . . . . 0.575 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 38.1 mt -92.67 136.25 25.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 170.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 30' ' ' SER . . . . . 0.58 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 65.5 p -122.94 -20.26 5.86 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -170.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 31' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -154.81 146.23 14.06 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 119.36 -1.4 . . . . 0.0 113.365 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.495 HG23 ' HG ' ' E' ' 87' ' ' LEU . 14.4 p -140.02 126.84 23.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 170.287 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 33' ' ' ALA . . . . . 0.417 ' HA ' HG21 ' E' ' 56' ' ' VAL . . . -148.84 158.17 43.97 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 121.861 -0.524 . . . . 0.0 111.649 -174.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 34' ' ' LEU . . . . . 0.592 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.0 pp -119.0 139.21 52.07 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.713 0.768 . . . . 0.0 111.445 178.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -108.06 -51.29 2.92 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.392 173.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -102.38 127.94 49.17 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 170.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 37' ' ' GLY . . . . . 0.506 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 145.17 162.49 9.62 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 119.916 -1.135 . . . . 0.0 113.04 176.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -102.8 -46.65 4.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.536 0.208 . . . . 0.0 111.539 177.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -150.75 130.84 13.48 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.712 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 40' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -130.8 113.06 13.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.555 0.693 . . . . 0.0 110.175 168.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 41' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' E' ' 79' ' ' THR . 4.5 mptp? -95.42 106.43 18.49 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 174.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.514 HD23 ' HB ' ' E' ' 53' ' ' VAL . 41.7 tp -78.82 114.04 17.41 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -176.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -114.93 135.93 53.67 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.24 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 44' ' ' LEU . . . . . 0.602 ' HB3' HG22 ' E' ' 53' ' ' VAL . 5.0 tp -115.75 116.01 27.32 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.575 176.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 45' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -103.27 103.68 13.73 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 176.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 46' ' ' ALA . . . . . 0.442 ' HB2' HD11 ' E' ' 44' ' ' LEU . . . -130.54 140.74 50.48 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.168 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 58.2 32.33 21.89 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.61 0.719 . . . . 0.0 109.368 -175.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 62.4 mttp 57.43 37.1 27.73 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.479 -178.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 49' ' ' GLN . . . . . 0.52 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 6.6 tp-100 -127.65 131.74 49.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.612 176.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -87.37 112.24 21.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.43 -177.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -108.36 131.35 54.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.776 177.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -78.8 100.42 3.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 169.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 53' ' ' VAL . . . . . 0.602 HG22 ' HB3' ' E' ' 44' ' ' LEU . 0.9 OUTLIER -72.35 -51.49 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.998 -174.243 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' E' E ' 54' ' ' ALA . . . . . 0.492 ' HA ' ' OE1' ' D' ' 62' ' ' GLN . . . -154.51 132.53 11.67 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.513 -177.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 7.6 t -101.97 102.43 12.96 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 56' ' ' VAL . . . . . 0.428 HG13 ' HB3' ' E' ' 40' ' ' ALA . 7.1 p -116.62 109.72 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-O 122.048 0.928 . . . . 0.0 110.025 -176.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 57' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' E' ' 61' ' ' PRO . 68.3 p -122.62 -177.06 3.53 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.342 -176.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -64.98 -20.69 66.62 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.469 169.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.85 -40.82 27.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.313 0.577 . . . . 0.0 110.008 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 74.4 mt -118.66 77.6 14.61 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 172.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 61' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' E' ' 57' ' ' THR . 9.6 Cg_exo -71.69 0.89 6.33 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.095 2.53 . . . . 0.0 113.727 -168.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 62' ' ' GLN . . . . . 0.512 ' OE1' ' HA ' ' A' ' 54' ' ' ALA . 10.3 tt0 -160.11 114.66 2.26 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.792 0.329 . . . . 0.0 111.312 -170.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 63' ' ' VAL . . . . . 0.484 HG11 ' HB1' ' E' ' 54' ' ' ALA . 86.1 t -112.74 115.18 49.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.065 0.459 . . . . 0.0 111.199 177.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.11 115.99 28.36 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 171.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 65' ' ' LEU . . . . . 0.429 HD23 ' H ' ' E' ' 65' ' ' LEU . 0.7 OUTLIER -134.55 168.22 19.36 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.058 -171.612 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' E' E ' 66' ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 7.5 t0 -122.84 109.43 14.17 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.144 0.497 . . . . 0.0 110.417 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 67' ' ' LEU . . . . . 0.684 HD21 HD23 ' D' ' 88' ' ' LEU . 12.8 mt -123.99 138.91 54.39 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.7 176.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -138.57 114.55 10.08 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 173.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -109.1 163.0 13.73 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.519 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 70' ' ' SER . . . . . 0.559 ' OG ' ' HA ' ' D' ' 7' ' ' MET . 4.5 m -117.09 149.0 41.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.185 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.99 -6.05 30.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.698 -177.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.87 -28.4 46.38 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.344 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -101.24 171.28 7.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.704 0.288 . . . . 0.0 110.364 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -137.32 136.53 38.06 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 75' ' ' ILE . . . . . 0.45 ' HB ' ' CD1' ' E' ' 44' ' ' LEU . 22.4 pt -133.04 158.37 43.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.947 0.403 . . . . 0.0 111.66 -169.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 76' ' ' MET . . . . . 0.432 ' HA ' ' HA ' ' E' ' 20' ' ' SER . 65.3 ttp -117.49 118.11 31.29 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.055 0.455 . . . . 0.0 110.339 176.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 77' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.4 OUTLIER -105.59 129.47 53.84 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.693 -177.747 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' E' E ' 78' ' ' TYR . . . . . 0.661 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 38.8 p90 -155.76 162.68 40.47 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.838 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 79' ' ' THR . . . . . 0.648 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 12.7 p -125.14 143.82 50.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.209 178.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.37 149.68 26.75 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.095 173.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.82 -176.91 36.73 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -176.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -114.45 102.76 10.38 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.14 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 83' ' ' ALA . . . . . 0.603 ' H ' ' HB3' ' E' ' 15' ' ' PRO . . . -166.78 150.05 6.79 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.477 168.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 6.2 p -106.14 122.24 45.8 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 85' ' ' VAL . . . . . 0.592 HG12 ' HB3' ' E' ' 34' ' ' LEU . 13.7 m -121.57 144.19 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 CA-C-O 121.161 0.505 . . . . 0.0 111.831 -172.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 44.3 m -105.23 122.84 46.77 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.274 175.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 87' ' ' LEU . . . . . 0.687 HD13 HD23 ' E' ' 11' ' ' LEU . 5.1 mp -95.16 143.9 26.21 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 170.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 88' ' ' LEU . . . . . 0.683 HD23 HD21 ' A' ' 67' ' ' LEU . 0.9 OUTLIER -130.42 141.25 50.55 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.134 -178.664 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.67 -166.88 27.49 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.678 -177.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 90' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -147.05 133.59 19.78 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.469 0.652 . . . . 0.0 111.066 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 91' ' ' LEU . . . . . 0.635 HD23 ' HB3' ' E' ' 27' ' ' PHE . 15.1 mt . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.117 175.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.433 0.159 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 65.46 178.87 0.2 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.187 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.59 105.32 3.24 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.703 -176.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.16 -49.11 7.99 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 172.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.514 ' SD ' ' HA ' ' A' ' 94' ' ' ILE . 22.4 mmt 66.71 -65.73 0.2 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 114.671 -1.149 . . . . 0.0 112.098 174.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 91' ' ' LEU . . . -103.55 112.89 26.02 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.843 0.354 . . . . 0.0 110.674 -178.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 54.6 mtt -108.18 147.05 31.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.83 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.519 ' CE1' HD21 ' B' ' 44' ' ' LEU . 81.2 t80 -58.7 142.66 49.16 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -172.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.509 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 89.3 t90 -140.08 147.73 40.71 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.131 178.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.413 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -149.93 154.07 25.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.114 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.631 HD23 HD13 ' A' ' 87' ' ' LEU . 51.2 tp -146.61 109.05 4.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.818 0.342 . . . . 0.0 111.237 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -91.47 114.11 26.55 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.375 0.607 . . . . 0.0 111.093 176.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.539 ' HB2' HG23 ' A' ' 85' ' ' VAL . 3.5 mmt -93.15 137.32 32.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.016 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -100.64 153.34 37.79 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 171.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.441 ' HB3' ' HA ' ' A' ' 82' ' ' ASP . 84.1 Cg_exo -46.83 111.34 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.993 2.462 . . . . 0.0 113.096 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.686 ' HA ' ' O ' ' A' ' 79' ' ' THR . 39.6 mt-10 65.95 59.13 0.72 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.498 0.666 . . . . 0.0 111.356 177.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.43 ' HD3' ' HA ' ' A' ' 17' ' ' ARG . 70.5 mmt-85 -113.3 145.44 41.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.038 172.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.669 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 33.8 ttmt -128.02 111.27 13.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.308 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.414 ' OH ' ' HA ' ' A' ' 13' ' ' MET . 5.6 m-85 -108.69 104.12 13.34 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.686 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.417 ' HB3' ' SD ' ' A' ' 76' ' ' MET . 9.2 p -88.04 99.9 12.52 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 173.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -125.43 138.7 54.02 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.591 0.71 . . . . 0.0 112.378 -167.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 t -85.0 160.24 20.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.751 177.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.403 ' CD1' ' HB3' ' A' ' 69' ' ' PHE . 53.0 mt -114.14 116.74 53.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.005 0.431 . . . . 0.0 110.862 -176.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.754 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -104.0 -10.15 9.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.248 176.469 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.612 ' HD3' HD22 ' A' ' 91' ' ' LEU . 2.6 ptpp? -142.62 119.35 11.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.794 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.0 m -64.61 135.4 55.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.182 -177.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.78 ' HB3' HD23 ' A' ' 91' ' ' LEU . 19.2 p90 -147.25 160.78 42.09 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -174.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.49 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 5.3 t60 -114.87 128.07 56.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.405 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 56.5 mt -94.63 136.45 25.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 171.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.519 ' HB2' ' HB3' ' B' ' 66' ' ' ASP . 72.7 p -119.81 -16.74 8.69 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -170.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -163.78 144.85 9.84 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 119.365 -1.397 . . . . 0.0 113.5 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.448 HG23 ' HG ' ' A' ' 87' ' ' LEU . 12.4 p -129.02 125.71 63.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 170.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.66 152.18 41.02 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.606 -174.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.573 ' HB3' HG12 ' A' ' 85' ' ' VAL . 3.5 pp -114.26 137.9 51.18 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.871 0.843 . . . . 0.0 111.81 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -106.04 -55.35 2.34 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.436 175.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -101.98 126.87 49.01 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.745 170.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.458 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 147.96 162.51 10.16 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 119.612 -1.28 . . . . 0.0 113.561 176.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.442 ' O ' ' HG3' ' A' ' 58' ' ' LYS . 39.5 mt-30 -102.82 -48.13 4.18 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 178.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -151.77 134.49 15.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.382 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.561 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -135.39 117.46 15.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.376 0.608 . . . . 0.0 111.112 172.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 79' ' ' THR . 48.3 mttm -97.65 116.02 29.06 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 173.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.429 HD21 HD21 ' A' ' 87' ' ' LEU . 53.8 tp -91.44 105.4 17.74 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.154 0.502 . . . . 0.0 110.037 -173.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.408 ' HB2' ' CE2' ' A' ' 78' ' ' TYR . 96.9 m-85 -103.43 150.91 23.39 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.256 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.627 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 1.1 tp -133.5 117.41 17.12 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.701 176.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -102.06 104.32 14.96 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.425 0.631 . . . . 0.0 109.615 175.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.513 ' HB2' HD11 ' A' ' 44' ' ' LEU . . . -134.28 152.18 51.68 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 57.79 24.14 10.41 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -174.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 58.45 42.24 21.47 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.286 -175.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 28.2 tp60 -137.62 131.85 32.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.562 178.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -79.58 107.1 12.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.916 0.389 . . . . 0.0 110.45 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.405 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 74.5 m-85 -100.16 129.32 46.17 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.051 176.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 tp -89.95 99.89 10.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 172.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.475 ' CG1' ' HB3' ' A' ' 44' ' ' LEU . 2.6 m -84.27 -33.79 9.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.131 -169.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.524 ' HB2' HD13 ' A' ' 65' ' ' LEU . . . -159.3 148.93 18.66 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.117 0.484 . . . . 0.0 111.885 177.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.2 m -117.39 102.96 9.66 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 170.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.42 ' CG1' HG11 ' A' ' 85' ' ' VAL . 6.7 p -110.6 116.26 51.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.439 0.638 . . . . 0.0 110.224 -176.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.8 p -122.7 -177.48 3.66 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.297 -175.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 38' ' ' GLN . 52.7 mtmt -59.8 -33.68 72.05 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.99 0.424 . . . . 0.0 110.288 169.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.93 -40.81 68.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.39 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.6 mt -116.6 80.14 10.17 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 174.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -72.38 0.23 7.73 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.804 2.336 . . . . 0.0 113.927 -167.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -162.43 119.21 2.0 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.126 0.489 . . . . 0.0 110.875 -176.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.457 HG11 ' HB1' ' A' ' 54' ' ' ALA . 92.8 t -110.2 101.67 12.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.216 175.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.14 111.36 17.51 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 173.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.524 HD13 ' HB2' ' A' ' 54' ' ' ALA . 1.0 OUTLIER -133.05 150.78 52.09 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.079 -171.254 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.544 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 11.7 t0 -96.0 99.14 10.94 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.345 0.593 . . . . 0.0 110.006 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.557 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 4.2 mt -113.21 141.8 46.54 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.491 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.624 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 22.4 t-20 -148.87 132.46 16.79 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.1 177.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.513 ' CZ ' HD22 ' A' ' 67' ' ' LEU . 63.4 m-85 -127.54 158.02 38.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.831 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.9 p -120.97 154.86 35.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.386 178.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.465 ' HD3' ' H ' ' A' ' 71' ' ' LYS . 0.2 OUTLIER -70.9 11.48 0.38 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -174.837 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.03 -29.48 9.69 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.678 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -101.53 163.11 12.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.942 0.371 . . . . 0.0 110.929 -175.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -123.14 111.42 16.49 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.444 HG22 ' CB ' ' A' ' 46' ' ' ALA . 27.9 pt -111.15 161.43 9.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.122 0.487 . . . . 0.0 111.71 -168.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.417 ' SD ' ' HB3' ' A' ' 20' ' ' SER . 4.9 mtm -121.84 124.86 45.13 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 173.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.627 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -105.05 128.16 53.2 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.162 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.669 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 30.1 p90 -151.06 138.93 19.88 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.137 -0.625 . . . . 0.0 112.055 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.686 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 11.3 p -109.72 137.54 47.38 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.878 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.68 157.22 18.73 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.588 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.73 -173.9 35.6 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -176.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.441 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 11.6 m-20 -114.05 103.17 10.87 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.843 177.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -172.31 155.14 3.46 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.153 171.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.5 t -110.41 114.46 27.92 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.573 HG12 ' HB3' ' A' ' 34' ' ' LEU . 6.8 m -112.98 143.49 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-O 121.357 0.599 . . . . 0.0 112.15 -174.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.8 t -108.86 118.65 37.34 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.72 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.631 HD13 HD23 ' A' ' 11' ' ' LEU . 5.2 mp -94.04 151.9 19.19 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.41 ' CD2' HD21 ' B' ' 67' ' ' LEU . 2.2 tp -134.31 145.96 49.54 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.177 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.68 -167.52 29.44 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.455 -0.878 . . . . 0.0 112.084 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.611 ' CD2' ' HB3' ' B' ' 68' ' ' ASN . 8.7 p90 -151.54 130.23 12.33 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.732 0.777 . . . . 0.0 111.85 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.78 HD23 ' HB3' ' A' ' 27' ' ' PHE . 6.2 mt -66.97 122.68 18.27 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.121 -1.399 . . . . 0.0 109.595 175.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -101.62 108.55 20.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.368 0.604 . . . . 0.0 110.591 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -118.13 76.93 1.11 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.536 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.514 ' HA ' ' SD ' ' A' ' 5' ' ' MET . 5.0 tp -78.65 120.99 30.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.38 0.609 . . . . 0.0 110.503 -177.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -119.32 139.46 51.9 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.977 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 38.2 m -137.51 31.38 2.57 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.199 0.523 . . . . 0.0 110.005 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 64.86 -131.98 37.0 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.024 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.7 p . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.944 -0.551 . . . . 0.0 110.085 177.929 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 120.363 0.125 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 65.2 178.88 0.19 Allowed 'General case' 0 C--O 1.232 0.181 0 O-C-N 123.51 0.507 . . . . 0.0 111.278 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.64 105.28 3.24 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.65 -176.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.24 -49.14 7.93 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 172.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' MET . . . . . 0.506 ' SD ' ' HA ' ' B' ' 94' ' ' ILE . 22.4 mmt 66.78 -65.78 0.2 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.0 174.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' B' ' 91' ' ' LEU . . . -103.48 112.78 25.84 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.736 -177.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 54.6 mtt -108.23 147.15 31.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.806 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.53 ' CE1' HD21 ' C' ' 44' ' ' LEU . 80.5 t80 -58.85 142.76 49.61 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -172.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' TRP . . . . . 0.509 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 89.2 t90 -140.11 147.67 40.56 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.141 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.439 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -149.9 154.03 25.46 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.097 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.621 HD23 HD13 ' B' ' 87' ' ' LEU . 51.7 tp -146.49 108.9 4.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.772 0.32 . . . . 0.0 111.296 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -91.34 114.06 26.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.332 0.587 . . . . 0.0 111.096 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' MET . . . . . 0.558 ' HB2' HG23 ' B' ' 85' ' ' VAL . 3.5 mmt -93.17 137.27 32.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.964 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -100.55 153.38 37.78 Favored Pre-proline 0 C--N 1.317 -0.828 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 171.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.449 ' HB3' ' HA ' ' B' ' 82' ' ' ASP . 84.2 Cg_exo -46.77 111.21 0.35 Allowed 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 123.058 2.505 . . . . 0.0 113.15 -178.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.686 ' HA ' ' O ' ' B' ' 79' ' ' THR . 39.5 mt-10 66.01 59.11 0.71 Allowed 'General case' 0 C--O 1.233 0.224 0 O-C-N 123.693 0.621 . . . . 0.0 111.316 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.431 ' HD3' ' HA ' ' B' ' 17' ' ' ARG . 70.5 mmt-85 -113.28 145.47 40.98 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.037 172.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.664 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 33.9 ttmt -128.08 111.26 13.29 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.344 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' TYR . . . . . 0.423 ' OH ' ' HA ' ' B' ' 13' ' ' MET . 5.6 m-85 -108.68 104.05 13.27 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.687 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.415 ' HB3' ' SD ' ' B' ' 76' ' ' MET . 9.6 p -88.0 100.03 12.6 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 173.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -125.53 138.74 53.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.59 0.71 . . . . 0.0 112.335 -167.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 14.8 t -85.07 160.36 20.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.691 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.401 ' CD1' ' HB3' ' B' ' 69' ' ' PHE . 53.0 mt -114.11 116.76 53.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 120.973 0.416 . . . . 0.0 110.877 -176.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.758 ' H ' HD13 ' B' ' 24' ' ' ILE . 0.2 OUTLIER -104.05 -10.24 9.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.257 176.413 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.597 ' HD3' HD22 ' B' ' 91' ' ' LEU . 2.5 ptpp? -142.64 119.38 11.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.736 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 23.8 m -64.57 135.46 56.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.21 -177.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' PHE . . . . . 0.777 ' HB3' HD23 ' B' ' 91' ' ' LEU . 19.3 p90 -147.28 160.74 42.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.62 0.724 . . . . 0.0 112.908 -174.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' HIS . . . . . 0.495 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 5.3 t60 -114.85 128.06 56.08 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.418 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 56.5 mt -94.67 136.44 25.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 171.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.506 ' HB2' ' HB3' ' C' ' 66' ' ' ASP . 72.5 p -119.86 -16.64 8.67 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.961 -170.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -163.75 144.91 9.89 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 119.424 -1.369 . . . . 0.0 113.497 178.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.442 HG23 ' HG ' ' B' ' 87' ' ' LEU . 12.3 p -129.2 125.68 62.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 170.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.59 152.21 41.12 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 121.921 -0.487 . . . . 0.0 111.629 -174.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.591 ' HB3' HG12 ' B' ' 85' ' ' VAL . 3.5 pp -114.32 137.87 51.25 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.906 0.86 . . . . 0.0 111.781 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -105.94 -55.34 2.34 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.482 175.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -101.99 126.87 49.02 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.775 170.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.456 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 147.93 162.56 10.17 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 119.644 -1.265 . . . . 0.0 113.644 176.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' GLN . . . . . 0.44 ' O ' ' HG3' ' B' ' 58' ' ' LYS . 39.3 mt-30 -102.74 -48.14 4.19 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 178.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -151.86 134.47 15.45 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.433 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.559 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -135.37 117.39 15.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.39 0.614 . . . . 0.0 111.031 172.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' B' ' 79' ' ' THR . 48.3 mttm -97.58 116.01 28.98 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 173.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.427 HD21 HD21 ' B' ' 87' ' ' LEU . 53.7 tp -91.37 105.24 17.63 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.156 0.503 . . . . 0.0 110.111 -173.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' TYR . . . . . 0.415 ' HB2' ' CE2' ' B' ' 78' ' ' TYR . 96.9 m-85 -103.41 150.91 23.38 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.203 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.631 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 1.1 tp -133.55 117.36 17.02 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.619 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -102.03 104.25 14.9 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.382 0.611 . . . . 0.0 109.574 175.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.504 ' HB2' HD11 ' B' ' 44' ' ' LEU . . . -134.24 152.3 51.75 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.047 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 57.67 24.19 10.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.132 0.491 . . . . 0.0 109.729 -174.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 58.38 42.34 21.54 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.321 -175.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.497 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 28.3 tp60 -137.67 131.8 31.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.55 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -79.55 107.16 12.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.815 0.341 . . . . 0.0 110.428 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.413 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 74.6 m-85 -100.26 129.27 46.24 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.004 176.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 tp -89.84 99.93 10.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 172.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.47 ' CG1' ' HB3' ' B' ' 44' ' ' LEU . 2.6 m -84.25 -33.88 9.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.088 -169.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.498 ' HB2' HD13 ' B' ' 65' ' ' LEU . . . -159.3 148.94 18.66 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.026 0.441 . . . . 0.0 111.959 177.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 92.6 m -117.44 102.88 9.57 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 170.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.419 ' CG1' HG11 ' B' ' 85' ' ' VAL . 6.7 p -110.57 116.21 51.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.471 0.653 . . . . 0.0 110.225 -176.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 74.4 p -122.69 -177.42 3.64 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.305 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' B' ' 38' ' ' GLN . 52.6 mtmt -59.88 -33.72 72.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.963 0.411 . . . . 0.0 110.285 169.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.86 -40.75 68.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.472 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 74.9 mt -116.66 80.15 10.31 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 174.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -72.4 0.13 7.9 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.923 2.415 . . . . 0.0 113.881 -166.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -162.4 119.24 2.01 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.299 0.571 . . . . 0.0 110.866 -176.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.442 HG11 ' HB1' ' B' ' 54' ' ' ALA . 92.3 t -110.2 101.67 12.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.2 176.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.14 111.29 17.44 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 173.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.498 HD13 ' HB2' ' B' ' 54' ' ' ALA . 1.0 OUTLIER -133.03 150.75 52.11 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.167 -171.295 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 66' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 11.7 t0 -96.0 99.14 10.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.399 0.619 . . . . 0.0 109.993 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.572 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 4.2 mt -113.19 141.8 46.52 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.424 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' ASN . . . . . 0.611 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 22.4 t-20 -148.9 132.49 16.79 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.174 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' PHE . . . . . 0.527 ' CZ ' HD22 ' B' ' 67' ' ' LEU . 63.5 m-85 -127.6 158.08 38.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.825 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 4.8 p -121.05 154.92 35.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.304 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.469 ' HD3' ' H ' ' B' ' 71' ' ' LYS . 0.2 OUTLIER -70.92 11.47 0.39 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -174.785 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.06 -29.52 9.64 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.673 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -101.48 163.13 12.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.785 0.326 . . . . 0.0 110.918 -175.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -123.12 111.48 16.58 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 177.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.443 HG22 ' CB ' ' B' ' 46' ' ' ALA . 27.8 pt -111.2 161.41 9.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.092 0.472 . . . . 0.0 111.704 -168.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.415 ' SD ' ' HB3' ' B' ' 20' ' ' SER . 4.9 mtm -121.82 124.77 44.95 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 173.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 77' ' ' PHE . . . . . 0.631 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.5 OUTLIER -104.96 128.16 53.11 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.113 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.664 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 30.2 p90 -151.04 138.89 19.86 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.023 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.686 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 11.2 p -109.73 137.5 47.45 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.953 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.48 157.12 18.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.632 176.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.74 -173.76 35.44 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -176.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 82' ' ' ASP . . . . . 0.449 ' HA ' ' HB3' ' B' ' 15' ' ' PRO . 11.7 m-20 -114.14 103.14 10.82 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.763 178.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.559 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -172.31 155.18 3.47 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.131 171.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 24.4 t -110.41 114.32 27.66 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.591 HG12 ' HB3' ' B' ' 34' ' ' LEU . 6.8 m -112.86 143.62 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 CA-C-O 121.416 0.627 . . . . 0.0 112.198 -174.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 11.9 t -108.99 118.73 37.55 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.664 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.621 HD13 HD23 ' B' ' 11' ' ' LEU . 5.2 mp -94.17 151.87 19.15 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 174.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.4 ' CD2' HD21 ' C' ' 67' ' ' LEU . 2.2 tp -134.25 145.97 49.63 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.124 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.73 -167.51 29.46 Favored Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.053 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 90' ' ' TYR . . . . . 0.599 ' CD2' ' HB3' ' C' ' 68' ' ' ASN . 8.7 p90 -151.62 130.29 12.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.798 0.808 . . . . 0.0 111.842 177.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 91' ' ' LEU . . . . . 0.777 HD23 ' HB3' ' B' ' 27' ' ' PHE . 6.3 mt -66.98 122.59 18.08 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.023 -1.444 . . . . 0.0 109.555 175.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -101.48 108.49 20.09 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.363 0.602 . . . . 0.0 110.612 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -118.13 77.02 1.12 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.467 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 94' ' ' ILE . . . . . 0.506 ' HA ' ' SD ' ' B' ' 5' ' ' MET . 5.1 tp -78.58 120.94 30.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.542 -177.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -119.43 139.45 52.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.97 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 37.8 m -137.4 31.24 2.61 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.241 0.544 . . . . 0.0 110.055 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . 64.87 -131.93 36.93 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.172 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 11.7 p . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.826 -0.607 . . . . 0.0 110.147 177.888 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.422 0.153 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 65.32 178.86 0.19 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.181 0.515 . . . . 0.0 111.169 -177.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.62 105.33 3.25 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.615 -176.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.15 -49.12 7.99 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 171.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 5' ' ' MET . . . . . 0.512 ' SD ' ' HA ' ' C' ' 94' ' ' ILE . 22.4 mmt 66.67 -65.71 0.2 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 114.663 -1.153 . . . . 0.0 112.077 174.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 6' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' C' ' 91' ' ' LEU . . . -103.5 112.7 25.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.767 -178.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 54.7 mtt -108.17 147.13 31.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.756 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 8' ' ' PHE . . . . . 0.511 ' CE1' HD21 ' D' ' 44' ' ' LEU . 80.8 t80 -58.83 142.74 49.56 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -172.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 9' ' ' TRP . . . . . 0.51 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 89.1 t90 -140.11 147.67 40.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.169 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 10' ' ' GLY . . . . . 0.421 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -149.86 153.99 25.43 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.189 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.648 HD23 HD13 ' C' ' 87' ' ' LEU . 51.5 tp -146.52 109.0 4.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.77 0.319 . . . . 0.0 111.235 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -91.53 114.2 26.67 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.461 0.648 . . . . 0.0 111.005 176.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 13' ' ' MET . . . . . 0.543 ' HB2' HG23 ' C' ' 85' ' ' VAL . 3.5 mmt -93.21 137.29 32.68 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.006 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -100.56 153.29 37.83 Favored Pre-proline 0 C--N 1.318 -0.798 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 171.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 15' ' ' PRO . . . . . 0.44 ' HB3' ' HA ' ' C' ' 82' ' ' ASP . 85.4 Cg_exo -46.76 111.34 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.056 2.504 . . . . 0.0 113.183 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 16' ' ' GLU . . . . . 0.69 ' HA ' ' O ' ' C' ' 79' ' ' THR . 39.7 mt-10 65.83 59.2 0.74 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.471 0.653 . . . . 0.0 111.414 178.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 17' ' ' ARG . . . . . 0.441 ' HD3' ' HA ' ' C' ' 17' ' ' ARG . 70.4 mmt-85 -113.35 145.46 41.06 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.932 172.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 18' ' ' LYS . . . . . 0.671 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 33.8 ttmt -128.08 111.28 13.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.304 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 19' ' ' TYR . . . . . 0.416 ' OH ' ' HA ' ' C' ' 13' ' ' MET . 5.6 m-85 -108.69 104.06 13.28 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.695 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 20' ' ' SER . . . . . 0.418 ' HB3' ' SD ' ' C' ' 76' ' ' MET . 9.4 p -87.94 99.9 12.49 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 173.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -125.47 138.62 54.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.564 0.697 . . . . 0.0 112.368 -167.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 14.8 t -85.03 160.37 20.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.665 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 23' ' ' ILE . . . . . 0.4 ' CD1' ' HB3' ' C' ' 69' ' ' PHE . 53.2 mt -114.15 116.81 53.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.915 0.388 . . . . 0.0 110.793 -176.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 24' ' ' ILE . . . . . 0.764 ' H ' HD13 ' C' ' 24' ' ' ILE . 0.2 OUTLIER -104.0 -10.17 9.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.257 176.362 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 25' ' ' LYS . . . . . 0.607 ' HD3' HD22 ' C' ' 91' ' ' LEU . 2.5 ptpp? -142.63 119.34 11.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.763 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 24.0 m -64.65 135.41 55.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.185 -177.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 27' ' ' PHE . . . . . 0.777 ' HB3' HD23 ' C' ' 91' ' ' LEU . 19.2 p90 -147.19 160.73 42.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.62 0.724 . . . . 0.0 112.924 -174.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 28' ' ' HIS . . . . . 0.5 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 5.4 t60 -114.89 128.05 56.06 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.38 177.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 29' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 56.7 mt -94.61 136.48 25.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 171.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.521 ' HB2' ' HB3' ' D' ' 66' ' ' ASP . 72.8 p -119.89 -16.66 8.65 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.97 -170.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 31' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -163.75 144.97 9.95 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 119.45 -1.357 . . . . 0.0 113.457 178.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.441 HG23 ' HG ' ' C' ' 87' ' ' LEU . 12.2 p -129.21 125.68 62.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 170.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.65 152.28 41.16 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.612 -174.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.593 ' HB3' HG12 ' C' ' 85' ' ' VAL . 3.5 pp -114.27 137.85 51.25 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.896 0.855 . . . . 0.0 111.794 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -106.03 -55.27 2.35 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.218 -1.356 . . . . 0.0 108.459 175.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -102.02 126.85 49.05 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.765 170.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 37' ' ' GLY . . . . . 0.448 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 147.95 162.56 10.18 Favored Glycine 0 N--CA 1.438 -1.189 0 C-N-CA 119.602 -1.285 . . . . 0.0 113.617 176.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 38' ' ' GLN . . . . . 0.443 ' O ' ' HG3' ' C' ' 58' ' ' LYS . 39.3 mt-30 -102.88 -48.1 4.18 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 178.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -151.84 134.54 15.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.405 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.554 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -135.42 117.44 15.33 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.363 0.601 . . . . 0.0 111.093 172.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' C' ' 79' ' ' THR . 48.2 mttm -97.72 116.0 29.08 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 173.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.411 HD21 HD21 ' C' ' 87' ' ' LEU . 54.0 tp -91.44 105.4 17.74 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.12 0.486 . . . . 0.0 110.001 -173.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 43' ' ' TYR . . . . . 0.418 ' HB2' ' CE2' ' C' ' 78' ' ' TYR . 96.9 m-85 -103.49 150.83 23.51 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.218 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.63 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 1.1 tp -133.44 117.4 17.16 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.66 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 45' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -102.07 104.24 14.86 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.349 0.595 . . . . 0.0 109.582 175.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.503 ' HB2' HD11 ' C' ' 44' ' ' LEU . . . -134.21 152.21 51.71 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 57.74 24.11 10.3 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -174.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 58.43 42.33 21.42 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.255 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 49' ' ' GLN . . . . . 0.491 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 28.1 tp60 -137.65 131.91 32.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.628 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -79.72 107.17 12.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.804 0.335 . . . . 0.0 110.399 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 51' ' ' TYR . . . . . 0.439 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 74.7 m-85 -100.3 129.24 46.27 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.976 176.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 tp -89.83 99.88 10.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 172.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 53' ' ' VAL . . . . . 0.464 ' CG1' ' HB3' ' C' ' 44' ' ' LEU . 2.6 m -84.27 -33.77 9.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.129 -170.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 54' ' ' ALA . . . . . 0.508 ' HB2' HD13 ' C' ' 65' ' ' LEU . . . -159.37 148.96 18.55 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.093 0.473 . . . . 0.0 111.908 177.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 92.3 m -117.38 102.84 9.56 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 170.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 56' ' ' VAL . . . . . 0.42 ' CG1' HG11 ' C' ' 85' ' ' VAL . 6.7 p -110.6 116.35 52.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.498 0.666 . . . . 0.0 110.193 -176.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 74.3 p -122.75 -177.43 3.65 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.202 -175.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 58' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' C' ' 38' ' ' GLN . 52.6 mtmt -59.76 -33.71 72.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.119 0.485 . . . . 0.0 110.345 169.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.95 -40.79 68.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.371 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 74.4 mt -116.64 80.18 10.29 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -72.5 0.32 7.67 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.835 2.357 . . . . 0.0 113.831 -166.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -162.5 119.1 1.97 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.165 0.507 . . . . 0.0 110.86 -176.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.455 HG11 ' HB1' ' C' ' 54' ' ' ALA . 91.9 t -110.19 101.7 12.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.198 175.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.06 111.22 17.32 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 173.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 65' ' ' LEU . . . . . 0.508 HD13 ' HB2' ' C' ' 54' ' ' ALA . 1.0 OUTLIER -132.99 150.8 52.13 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.206 -171.396 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 66' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 11.6 t0 -96.02 99.18 10.97 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.415 0.626 . . . . 0.0 109.981 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.557 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 4.1 mt -113.25 141.87 46.48 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.427 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 68' ' ' ASN . . . . . 0.599 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 22.4 t-20 -148.91 132.5 16.78 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.175 177.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 69' ' ' PHE . . . . . 0.515 ' CZ ' HD22 ' C' ' 67' ' ' LEU . 63.7 m-85 -127.65 157.95 38.88 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.795 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 4.8 p -120.96 154.91 35.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.329 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 71' ' ' LYS . . . . . 0.472 ' HD3' ' H ' ' C' ' 71' ' ' LYS . 0.2 OUTLIER -70.92 11.41 0.39 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -174.705 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.97 -29.61 9.62 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.688 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -101.36 163.11 12.43 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 122.575 -0.367 . . . . 0.0 111.039 -175.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -123.13 111.42 16.5 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.433 HG22 ' CB ' ' C' ' 46' ' ' ALA . 27.8 pt -111.09 161.38 9.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.142 0.496 . . . . 0.0 111.706 -168.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.418 ' SD ' ' HB3' ' C' ' 20' ' ' SER . 4.9 mtm -121.84 124.84 45.09 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 173.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 77' ' ' PHE . . . . . 0.63 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.5 OUTLIER -105.05 128.16 53.2 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.158 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 78' ' ' TYR . . . . . 0.671 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 30.3 p90 -151.08 138.9 19.84 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.217 -0.593 . . . . 0.0 112.008 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 79' ' ' THR . . . . . 0.69 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 11.3 p -109.68 137.54 47.35 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.926 -179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.53 157.23 18.65 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.619 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.65 -173.85 35.67 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -176.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 82' ' ' ASP . . . . . 0.44 ' HA ' ' HB3' ' C' ' 15' ' ' PRO . 11.5 m-20 -114.05 103.14 10.84 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 119.601 -0.839 . . . . 0.0 109.8 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 83' ' ' ALA . . . . . 0.554 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -172.35 155.14 3.44 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.159 171.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 25.0 t -110.3 114.49 27.99 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.593 HG12 ' HB3' ' C' ' 34' ' ' LEU . 6.8 m -113.03 143.57 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 CA-C-O 121.419 0.628 . . . . 0.0 112.118 -174.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 12.0 t -108.94 118.75 37.61 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.617 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 87' ' ' LEU . . . . . 0.648 HD13 HD23 ' C' ' 11' ' ' LEU . 5.2 mp -94.15 151.89 19.15 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 174.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 88' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' C' ' 88' ' ' LEU . 2.2 tp -134.27 145.96 49.59 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.092 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.72 -167.51 29.46 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.228 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 90' ' ' TYR . . . . . 0.613 ' CD2' ' HB3' ' D' ' 68' ' ' ASN . 8.7 p90 -151.55 130.2 12.3 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.777 0.799 . . . . 0.0 111.901 177.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 91' ' ' LEU . . . . . 0.777 HD23 ' HB3' ' C' ' 27' ' ' PHE . 6.2 mt -66.94 122.66 18.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.643 175.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -101.57 108.57 20.16 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.408 0.623 . . . . 0.0 110.612 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -118.22 77.0 1.12 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.472 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 94' ' ' ILE . . . . . 0.512 ' HA ' ' SD ' ' C' ' 5' ' ' MET . 5.1 tp -78.52 120.97 30.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.596 -177.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -119.43 139.48 51.96 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.003 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 38.4 m -137.46 31.28 2.59 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.144 0.497 . . . . 0.0 109.988 177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 64.91 -131.93 36.81 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.179 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 11.7 p . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.958 -0.544 . . . . 0.0 110.076 177.874 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 120.394 0.14 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 65.21 178.83 0.19 Allowed 'General case' 0 C--O 1.232 0.161 0 O-C-N 123.544 0.528 . . . . 0.0 111.24 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.56 105.24 3.23 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.718 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.13 -49.03 8.06 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 172.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 5' ' ' MET . . . . . 0.512 ' SD ' ' HA ' ' D' ' 94' ' ' ILE . 22.4 mmt 66.7 -65.83 0.2 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.605 -1.18 . . . . 0.0 112.066 174.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 6' ' ' ALA . . . . . 0.572 ' HA ' ' O ' ' D' ' 91' ' ' LEU . . . -103.49 112.68 25.69 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.846 0.355 . . . . 0.0 110.801 -178.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 54.6 mtt -108.15 147.09 31.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.855 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 8' ' ' PHE . . . . . 0.519 ' CE1' HD21 ' E' ' 44' ' ' LEU . 81.0 t80 -58.7 142.66 49.15 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -172.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 9' ' ' TRP . . . . . 0.511 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 89.3 t90 -140.07 147.63 40.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.153 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 10' ' ' GLY . . . . . 0.438 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -149.84 154.0 25.45 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.215 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.645 HD23 HD13 ' D' ' 87' ' ' LEU . 51.2 tp -146.55 109.0 4.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.777 0.322 . . . . 0.0 111.173 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -91.41 114.1 26.54 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.375 0.607 . . . . 0.0 111.134 176.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 13' ' ' MET . . . . . 0.544 ' HB2' HG23 ' D' ' 85' ' ' VAL . 3.5 mmt -93.12 137.33 32.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.017 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -100.6 153.37 37.78 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 171.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 15' ' ' PRO . . . . . 0.434 ' HB3' ' HA ' ' D' ' 82' ' ' ASP . 83.8 Cg_exo -46.82 111.4 0.38 Allowed 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.025 2.484 . . . . 0.0 113.103 -178.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 16' ' ' GLU . . . . . 0.68 ' HA ' ' O ' ' D' ' 79' ' ' THR . 39.6 mt-10 65.87 59.06 0.74 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.538 0.685 . . . . 0.0 111.446 177.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 17' ' ' ARG . . . . . 0.426 ' HA ' ' HD3' ' D' ' 17' ' ' ARG . 70.7 mmt-85 -113.29 145.35 41.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.02 172.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 18' ' ' LYS . . . . . 0.644 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 33.8 ttmt -127.95 111.22 13.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.331 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 19' ' ' TYR . . . . . 0.418 ' OH ' ' HA ' ' D' ' 13' ' ' MET . 5.6 m-85 -108.56 104.17 13.43 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.662 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 20' ' ' SER . . . . . 0.419 ' HB3' ' SD ' ' D' ' 76' ' ' MET . 9.3 p -88.05 99.99 12.59 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 173.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -125.51 138.73 53.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.553 0.692 . . . . 0.0 112.324 -167.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 14.7 t -85.03 160.29 20.04 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.698 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 23' ' ' ILE . . . . . 0.402 ' CD1' ' HB3' ' D' ' 69' ' ' PHE . 53.4 mt -114.14 116.7 53.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.053 0.454 . . . . 0.0 110.845 -176.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 24' ' ' ILE . . . . . 0.772 ' H ' HD13 ' D' ' 24' ' ' ILE . 0.2 OUTLIER -103.9 -10.21 9.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.287 176.36 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 25' ' ' LYS . . . . . 0.591 ' HD3' HD22 ' D' ' 91' ' ' LEU . 2.5 ptpp? -142.65 119.35 11.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.751 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 23.9 m -64.65 135.44 55.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.246 -177.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 27' ' ' PHE . . . . . 0.774 ' HB3' HD23 ' D' ' 91' ' ' LEU . 19.2 p90 -147.23 160.69 42.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.664 0.745 . . . . 0.0 112.837 -174.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 28' ' ' HIS . . . . . 0.492 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 5.4 t60 -114.8 128.01 56.06 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.5 177.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 29' ' ' ILE . . . . . 0.567 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 56.6 mt -94.59 136.45 25.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 171.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 30' ' ' SER . . . . . 0.492 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 72.7 p -119.77 -16.73 8.71 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -170.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 31' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -163.82 144.84 9.82 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 119.331 -1.414 . . . . 0.0 113.447 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.442 HG23 ' HG ' ' D' ' 87' ' ' LEU . 12.3 p -129.05 125.72 63.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 170.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.66 152.21 41.06 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 121.882 -0.512 . . . . 0.0 111.615 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 34' ' ' LEU . . . . . 0.582 ' HB3' HG12 ' D' ' 85' ' ' VAL . 3.5 pp -114.28 137.76 51.37 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 121.905 0.859 . . . . 0.0 111.845 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -105.84 -55.39 2.33 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.218 -1.356 . . . . 0.0 108.524 175.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -101.92 126.91 48.93 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.822 170.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 37' ' ' GLY . . . . . 0.451 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 147.87 162.57 10.17 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 119.622 -1.275 . . . . 0.0 113.614 176.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 38' ' ' GLN . . . . . 0.443 ' O ' ' HG3' ' D' ' 58' ' ' LYS . 39.3 mt-30 -102.84 -48.17 4.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -151.82 134.5 15.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.447 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 40' ' ' ALA . . . . . 0.539 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -135.34 117.54 15.52 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.428 0.633 . . . . 0.0 111.152 172.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' D' ' 79' ' ' THR . 48.3 mttm -97.79 116.06 29.25 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 173.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.43 HD21 HD21 ' D' ' 87' ' ' LEU . 53.7 tp -91.45 105.35 17.7 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.163 0.506 . . . . 0.0 110.051 -173.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 43' ' ' TYR . . . . . 0.418 ' HB2' ' CE2' ' D' ' 78' ' ' TYR . 96.9 m-85 -103.46 150.92 23.41 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.17 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.623 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 1.1 tp -133.54 117.35 17.01 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.728 177.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 45' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -102.03 104.3 14.94 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.423 0.63 . . . . 0.0 109.543 175.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.509 ' HB2' HD11 ' D' ' 44' ' ' LEU . . . -134.27 152.14 51.65 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 57.85 24.17 10.54 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -174.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 58.32 42.26 21.88 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.298 -175.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 49' ' ' GLN . . . . . 0.498 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 28.1 tp60 -137.55 131.87 32.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.615 178.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -79.66 107.17 12.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.896 0.379 . . . . 0.0 110.401 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 51' ' ' TYR . . . . . 0.421 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 74.5 m-85 -100.3 129.28 46.27 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.047 176.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 tp -89.89 99.84 10.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 172.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 53' ' ' VAL . . . . . 0.466 ' CG1' ' HB3' ' D' ' 44' ' ' LEU . 2.6 m -84.29 -33.69 9.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.147 -169.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 54' ' ' ALA . . . . . 0.508 ' HB2' HD13 ' D' ' 65' ' ' LEU . . . -159.33 148.93 18.6 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.072 0.463 . . . . 0.0 111.971 177.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 92.4 m -117.45 102.89 9.58 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 170.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 56' ' ' VAL . . . . . 0.42 ' CG1' HG11 ' D' ' 85' ' ' VAL . 6.8 p -110.57 116.34 52.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.582 0.706 . . . . 0.0 110.215 -176.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 74.0 p -122.81 -177.47 3.67 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.206 -175.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 58' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' D' ' 38' ' ' GLN . 52.7 mtmt -59.89 -33.58 72.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.021 0.439 . . . . 0.0 110.357 169.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.05 -40.67 68.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.313 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 74.8 mt -116.67 80.19 10.38 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 174.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.54 0.36 7.64 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.824 2.35 . . . . 0.0 113.84 -166.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -162.52 119.12 1.96 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.157 0.504 . . . . 0.0 110.844 -176.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.445 HG11 ' HB1' ' D' ' 54' ' ' ALA . 91.9 t -110.12 101.74 12.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.193 176.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.07 111.3 17.4 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.529 173.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 65' ' ' LEU . . . . . 0.508 HD13 ' HB2' ' D' ' 54' ' ' ALA . 1.0 OUTLIER -133.05 150.79 52.09 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.153 -171.323 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 66' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 11.6 t0 -96.08 99.18 10.96 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.499 0.666 . . . . 0.0 110.006 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.567 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 4.2 mt -113.15 141.88 46.42 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.447 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 68' ' ' ASN . . . . . 0.613 ' HB3' ' CD2' ' C' ' 90' ' ' TYR . 22.4 t-20 -148.92 132.54 16.81 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.1 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 69' ' ' PHE . . . . . 0.526 ' CZ ' HD22 ' D' ' 67' ' ' LEU . 63.7 m-85 -127.74 157.97 38.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.764 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 4.7 p -120.97 154.89 35.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.281 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 71' ' ' LYS . . . . . 0.459 ' HD3' ' H ' ' D' ' 71' ' ' LYS . 0.2 OUTLIER -70.87 11.48 0.38 Allowed 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -174.822 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.0 -29.66 9.55 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.592 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -101.35 163.1 12.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.906 0.353 . . . . 0.0 111.012 -175.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -123.14 111.43 16.51 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.438 HG22 ' CB ' ' D' ' 46' ' ' ALA . 27.7 pt -111.1 161.38 9.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.039 0.447 . . . . 0.0 111.719 -168.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 76' ' ' MET . . . . . 0.419 ' SD ' ' HB3' ' D' ' 20' ' ' SER . 4.9 mtm -121.88 124.82 45.0 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 173.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 77' ' ' PHE . . . . . 0.623 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.5 OUTLIER -105.02 128.16 53.19 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.163 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 78' ' ' TYR . . . . . 0.644 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 30.4 p90 -151.07 138.87 19.82 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.245 -0.582 . . . . 0.0 112.108 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 79' ' ' THR . . . . . 0.68 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 11.4 p -109.71 137.57 47.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.923 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.57 157.17 18.72 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.612 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.8 -173.88 35.46 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 -176.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 82' ' ' ASP . . . . . 0.434 ' HA ' ' HB3' ' D' ' 15' ' ' PRO . 11.5 m-20 -114.03 103.27 10.97 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.803 177.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 83' ' ' ALA . . . . . 0.539 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -172.4 155.19 3.41 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.083 171.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 24.4 t -110.44 114.42 27.84 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.582 HG12 ' HB3' ' D' ' 34' ' ' LEU . 6.8 m -112.89 143.66 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-O 121.347 0.594 . . . . 0.0 112.159 -174.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 12.0 t -109.04 118.63 37.28 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.67 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 87' ' ' LEU . . . . . 0.645 HD13 HD23 ' D' ' 11' ' ' LEU . 5.2 mp -93.96 151.82 19.28 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 174.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tp -134.31 145.99 49.58 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.113 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.76 -167.49 29.46 Favored Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.087 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 90' ' ' TYR . . . . . 0.586 ' CD2' ' HB3' ' E' ' 68' ' ' ASN . 8.7 p90 -151.56 130.22 12.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.755 0.788 . . . . 0.0 111.876 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 91' ' ' LEU . . . . . 0.774 HD23 ' HB3' ' D' ' 27' ' ' PHE . 6.2 mt -66.92 122.6 18.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.631 175.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -101.58 108.5 20.07 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.405 0.621 . . . . 0.0 110.63 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -118.05 76.98 1.11 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.533 176.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 94' ' ' ILE . . . . . 0.512 ' HA ' ' SD ' ' D' ' 5' ' ' MET . 5.1 tp -78.52 120.92 30.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.584 -177.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -119.42 139.45 52.01 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.953 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 38.4 m -137.45 31.29 2.6 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.185 0.517 . . . . 0.0 110.141 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . 64.87 -131.94 36.95 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.187 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 11.8 p . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.107 177.811 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 120.313 0.102 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 65.25 178.87 0.19 Allowed 'General case' 0 C--O 1.233 0.228 0 O-C-N 123.588 0.555 . . . . 0.0 111.223 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.58 105.29 3.24 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.627 -176.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.22 -49.02 8.03 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 171.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 5' ' ' MET . . . . . 0.513 ' SD ' ' HA ' ' E' ' 94' ' ' ILE . 22.4 mmt 66.7 -65.75 0.2 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 114.601 -1.182 . . . . 0.0 112.065 174.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 6' ' ' ALA . . . . . 0.568 ' HA ' ' O ' ' E' ' 91' ' ' LEU . . . -103.52 112.73 25.77 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.78 0.324 . . . . 0.0 110.773 -178.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 54.7 mtt -108.21 147.12 31.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.778 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 8' ' ' PHE . . . . . 0.509 ' CE1' HD21 ' A' ' 44' ' ' LEU . 81.0 t80 -58.78 142.73 49.36 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -172.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 9' ' ' TRP . . . . . 0.512 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 89.2 t90 -140.11 147.71 40.64 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.104 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 10' ' ' GLY . . . . . 0.405 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -149.9 153.92 25.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.181 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 11' ' ' LEU . . . . . 0.625 HD23 HD13 ' E' ' 87' ' ' LEU . 51.6 tp -146.46 108.95 4.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.732 0.301 . . . . 0.0 111.251 -178.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -91.46 114.17 26.63 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.461 0.648 . . . . 0.0 110.994 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 13' ' ' MET . . . . . 0.551 ' HB2' HG23 ' E' ' 85' ' ' VAL . 3.5 mmt -93.15 137.32 32.6 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.043 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -100.67 153.31 37.81 Favored Pre-proline 0 C--N 1.318 -0.791 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 171.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 15' ' ' PRO . . . . . 0.446 ' HB3' ' HA ' ' E' ' 82' ' ' ASP . 84.9 Cg_exo -46.67 111.32 0.36 Allowed 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 123.08 2.52 . . . . 0.0 113.139 -178.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 16' ' ' GLU . . . . . 0.686 ' HA ' ' O ' ' E' ' 79' ' ' THR . 39.6 mt-10 65.94 59.02 0.73 Allowed 'General case' 0 C--O 1.232 0.181 0 O-C-N 123.77 0.669 . . . . 0.0 111.445 177.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 17' ' ' ARG . . . . . 0.44 ' HD3' ' HA ' ' E' ' 17' ' ' ARG . 70.4 mmt-85 -113.32 145.49 40.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.945 172.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 18' ' ' LYS . . . . . 0.668 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 33.8 ttmt -128.07 111.28 13.32 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.376 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 19' ' ' TYR . . . . . 0.416 ' OH ' ' HA ' ' E' ' 13' ' ' MET . 5.6 m-85 -108.61 104.03 13.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.681 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 20' ' ' SER . . . . . 0.418 ' HB3' ' SD ' ' E' ' 76' ' ' MET . 9.4 p -88.06 99.96 12.57 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 173.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -125.45 138.71 54.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.543 0.687 . . . . 0.0 112.32 -167.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 14.8 t -85.1 160.29 20.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.701 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 23' ' ' ILE . . . . . 0.402 ' CD1' ' HB3' ' E' ' 69' ' ' PHE . 53.4 mt -114.02 116.85 53.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 120.995 0.426 . . . . 0.0 110.856 -176.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 24' ' ' ILE . . . . . 0.773 ' H ' HD13 ' E' ' 24' ' ' ILE . 0.2 OUTLIER -104.08 -10.21 9.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.264 176.393 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 25' ' ' LYS . . . . . 0.593 ' HD3' HD22 ' E' ' 91' ' ' LEU . 2.5 ptpp? -142.57 119.32 11.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.793 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 24.0 m -64.55 135.4 55.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.249 -177.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 27' ' ' PHE . . . . . 0.773 ' HB3' HD23 ' E' ' 91' ' ' LEU . 19.1 p90 -147.22 160.76 42.09 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -174.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 28' ' ' HIS . . . . . 0.53 ' HE2' ' HB3' ' E' ' 30' ' ' SER . 5.3 t60 -114.93 127.99 56.02 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.348 177.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 29' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 56.6 mt -94.54 136.45 25.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 171.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 30' ' ' SER . . . . . 0.544 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 72.6 p -119.84 -16.67 8.68 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.712 -0.395 . . . . 0.0 112.018 -170.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 31' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -163.8 144.83 9.82 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 119.335 -1.412 . . . . 0.0 113.456 178.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.437 HG23 ' HG ' ' E' ' 87' ' ' LEU . 12.3 p -129.07 125.74 63.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 170.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.64 152.17 41.02 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.948 -0.47 . . . . 0.0 111.642 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 34' ' ' LEU . . . . . 0.591 ' HB3' HG12 ' E' ' 85' ' ' VAL . 3.5 pp -114.35 137.87 51.26 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 122.044 0.926 . . . . 0.0 111.719 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -106.09 -55.25 2.35 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.062 -1.427 . . . . 0.0 108.424 175.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -102.0 126.83 49.01 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.81 170.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 37' ' ' GLY . . . . . 0.454 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 147.94 162.52 10.16 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 119.576 -1.297 . . . . 0.0 113.596 176.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 38' ' ' GLN . . . . . 0.433 ' O ' ' HG3' ' E' ' 58' ' ' LYS . 39.2 mt-30 -102.77 -48.18 4.18 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 178.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -151.77 134.48 15.54 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.452 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 40' ' ' ALA . . . . . 0.553 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -135.27 117.34 15.38 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.278 0.561 . . . . 0.0 111.195 172.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 41' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' E' ' 79' ' ' THR . 48.2 mttm -97.62 116.08 29.15 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 173.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.412 HD21 HD21 ' E' ' 87' ' ' LEU . 53.6 tp -91.4 105.38 17.73 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.161 0.505 . . . . 0.0 110.053 -173.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 43' ' ' TYR . . . . . 0.413 ' HB2' ' CE2' ' E' ' 78' ' ' TYR . 97.1 m-85 -103.53 150.93 23.45 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.194 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 44' ' ' LEU . . . . . 0.619 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 1.1 tp -133.6 117.34 16.95 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.694 177.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 45' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -102.0 104.32 14.98 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.363 0.601 . . . . 0.0 109.554 175.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 46' ' ' ALA . . . . . 0.507 ' HB2' HD11 ' E' ' 44' ' ' LEU . . . -134.33 152.07 51.6 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 57.89 24.12 10.55 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -174.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 58.32 42.41 21.64 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.264 -175.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 49' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 28.1 tp60 -137.61 131.84 32.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.545 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -79.66 107.22 12.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.909 0.385 . . . . 0.0 110.387 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 51' ' ' TYR . . . . . 0.438 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 74.5 m-85 -100.27 129.32 46.25 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.109 175.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 tp -89.91 99.93 10.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 172.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 53' ' ' VAL . . . . . 0.467 ' CG1' ' HB3' ' E' ' 44' ' ' LEU . 2.6 m -84.32 -33.76 9.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.097 -169.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 54' ' ' ALA . . . . . 0.499 ' HB2' HD13 ' E' ' 65' ' ' LEU . . . -159.4 148.88 18.45 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.095 0.474 . . . . 0.0 111.887 177.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 92.4 m -117.36 102.9 9.62 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 170.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 56' ' ' VAL . . . . . 0.422 ' CG1' HG11 ' E' ' 85' ' ' VAL . 6.7 p -110.56 116.28 51.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.51 0.672 . . . . 0.0 110.214 -176.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 73.9 p -122.74 -177.44 3.65 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.248 -175.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 58' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' E' ' 38' ' ' GLN . 52.7 mtmt -59.86 -33.66 72.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.044 0.45 . . . . 0.0 110.309 169.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.92 -40.73 68.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.39 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 74.6 mt -116.64 80.09 10.22 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 174.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -72.46 0.27 7.73 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.87 2.38 . . . . 0.0 113.83 -166.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -162.44 119.11 1.99 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.196 0.522 . . . . 0.0 110.85 -176.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 63' ' ' VAL . . . . . 0.459 HG11 ' HB1' ' E' ' 54' ' ' ALA . 92.0 t -110.09 101.72 12.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.232 175.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.21 111.26 17.47 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 173.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.499 HD13 ' HB2' ' E' ' 54' ' ' ALA . 1.0 OUTLIER -133.0 150.87 52.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.109 -171.351 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 66' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 11.6 t0 -96.06 99.11 10.89 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.414 0.626 . . . . 0.0 110.042 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 67' ' ' LEU . . . . . 0.565 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 4.1 mt -113.12 141.83 46.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.436 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 68' ' ' ASN . . . . . 0.586 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 22.5 t-20 -148.92 132.48 16.76 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.068 177.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 69' ' ' PHE . . . . . 0.53 ' CZ ' HD22 ' E' ' 67' ' ' LEU . 63.4 m-85 -127.62 158.01 38.69 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.873 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 4.8 p -121.01 154.84 35.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.317 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 71' ' ' LYS . . . . . 0.46 ' HD3' ' H ' ' E' ' 71' ' ' LYS . 0.2 OUTLIER -70.82 11.41 0.38 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -174.802 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.03 -29.57 9.62 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.626 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -101.45 163.13 12.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.95 0.405 . . . . 0.0 110.92 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -123.06 111.57 16.72 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 75' ' ' ILE . . . . . 0.44 HG22 ' CB ' ' E' ' 46' ' ' ALA . 27.9 pt -111.3 161.29 9.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.053 0.454 . . . . 0.0 111.697 -168.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 76' ' ' MET . . . . . 0.418 ' SD ' ' HB3' ' E' ' 20' ' ' SER . 4.9 mtm -121.74 124.88 45.27 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 173.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 77' ' ' PHE . . . . . 0.619 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.5 OUTLIER -105.11 128.08 53.19 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.19 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 78' ' ' TYR . . . . . 0.668 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 30.2 p90 -151.01 138.86 19.86 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.059 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 79' ' ' THR . . . . . 0.686 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 11.1 p -109.74 137.55 47.38 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.898 -178.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.57 157.15 18.74 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.655 176.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.77 -173.84 35.46 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 82' ' ' ASP . . . . . 0.446 ' HA ' ' HB3' ' E' ' 15' ' ' PRO . 11.7 m-20 -114.05 103.18 10.88 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 119.609 -0.836 . . . . 0.0 109.873 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 83' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -172.36 155.19 3.44 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.18 171.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 24.3 t -110.42 114.45 27.9 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 85' ' ' VAL . . . . . 0.591 HG12 ' HB3' ' E' ' 34' ' ' LEU . 6.8 m -112.97 143.61 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 CA-C-O 121.514 0.673 . . . . 0.0 112.124 -174.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 11.9 t -108.97 118.73 37.56 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.641 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 87' ' ' LEU . . . . . 0.625 HD13 HD23 ' E' ' 11' ' ' LEU . 5.2 mp -94.17 151.89 19.13 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 174.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 88' ' ' LEU . . . . . 0.406 ' CD2' HD21 ' A' ' 67' ' ' LEU . 2.2 tp -134.32 145.95 49.52 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.089 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.73 -167.5 29.44 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.114 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 90' ' ' TYR . . . . . 0.624 ' CD2' ' HB3' ' A' ' 68' ' ' ASN . 8.8 p90 -151.58 130.24 12.31 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.742 0.782 . . . . 0.0 111.835 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 91' ' ' LEU . . . . . 0.773 HD23 ' HB3' ' E' ' 27' ' ' PHE . 6.3 mt -67.0 122.57 18.04 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.051 -1.431 . . . . 0.0 109.595 175.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -101.48 108.55 20.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.376 0.607 . . . . 0.0 110.611 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -118.14 77.0 1.11 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.465 176.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 94' ' ' ILE . . . . . 0.513 ' HA ' ' SD ' ' E' ' 5' ' ' MET . 5.0 tp -78.52 121.02 30.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.538 -177.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -119.47 139.48 52.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.961 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 37.7 m -137.44 31.21 2.6 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.056 0.455 . . . . 0.0 110.053 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . 64.93 -131.98 36.76 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.089 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 11.8 p . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.846 -0.597 . . . . 0.0 110.023 177.87 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 121.036 0.446 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -100.48 98.58 9.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.27 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.86 53.06 3.68 Favored Glycine 0 CA--C 1.517 0.165 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.64 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.61 -104.04 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 122.833 0.453 . . . . 0.0 109.805 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 42.5 ttp 53.59 28.8 8.28 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.089 0.556 . . . . 0.0 111.582 176.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.431 ' HB3' ' ND2' ' B' ' 68' ' ' ASN . . . -67.34 123.47 20.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.254 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 51.2 mtt -90.32 137.87 32.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.18 0.514 . . . . 0.0 111.603 -173.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.554 ' CE1' HD12 ' A' ' 88' ' ' LEU . 60.7 t80 -60.51 141.3 56.68 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.323 -174.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.508 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 91.9 t90 -130.41 144.8 51.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.915 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.1 140.81 9.11 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.395 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.626 HD23 HD13 ' A' ' 87' ' ' LEU . 56.6 tp -133.37 109.1 9.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.841 0.353 . . . . 0.0 110.348 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -97.78 104.11 16.11 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.571 ' SD ' HD11 ' A' ' 87' ' ' LEU . 35.9 mtp -98.4 137.86 36.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.588 -175.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -101.3 159.01 30.68 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.939 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.432 ' HB3' ' HA ' ' A' ' 82' ' ' ASP . 68.5 Cg_exo -42.89 118.45 1.22 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.752 2.968 . . . . 0.0 114.24 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.711 ' HA ' ' O ' ' A' ' 79' ' ' THR . 49.5 mt-10 57.16 55.99 5.54 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.068 174.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 78' ' ' TYR . 30.5 mmt180 -116.98 144.09 44.97 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.099 175.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.652 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 35.6 ttmt -126.23 112.78 16.16 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 123.491 0.494 . . . . 0.0 111.143 -176.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.415 ' OH ' ' HA ' ' A' ' 13' ' ' MET . 2.3 m-85 -111.27 104.89 13.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.252 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.42 ' HB3' ' SD ' ' A' ' 76' ' ' MET . 3.7 p -88.2 104.8 17.05 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 173.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -124.13 148.11 47.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.432 0.634 . . . . 0.0 112.696 -168.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.2 t -90.96 161.06 15.32 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.513 175.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.52 HD13 ' HB2' ' A' ' 69' ' ' PHE . 67.6 mt -114.25 131.36 66.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.101 0.477 . . . . 0.0 111.62 -173.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.468 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.2 mp -99.25 -48.92 11.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.085 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -114.46 140.55 48.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.657 177.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.2 m -63.54 109.4 1.64 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.482 ' HB3' HD23 ' A' ' 91' ' ' LEU . 14.7 p90 -125.02 159.54 31.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.626 0.727 . . . . 0.0 112.886 -170.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.578 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 9.4 t60 -116.45 125.85 52.57 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.077 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 61.2 mt -92.42 133.12 34.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 170.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.578 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 32.8 p -118.9 -14.35 9.43 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -169.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.541 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -167.33 147.98 12.49 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 119.153 -1.498 . . . . 0.0 113.416 178.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.442 HG23 ' HG ' ' A' ' 87' ' ' LEU . 11.4 p -134.63 129.06 51.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 172.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.08 155.5 42.24 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.896 -0.503 . . . . 0.0 111.653 -174.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.548 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.0 pp -120.98 142.27 49.93 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.442 0.639 . . . . 0.0 111.205 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -110.03 -50.08 3.01 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.572 173.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -103.18 127.45 50.47 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 168.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.455 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 152.21 158.97 8.7 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 119.906 -1.14 . . . . 0.0 113.19 176.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.464 ' O ' ' HG3' ' A' ' 58' ' ' LYS . 94.5 mt-30 -102.59 -45.35 5.07 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 120.625 0.25 . . . . 0.0 111.379 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.447 ' HG3' HG22 ' A' ' 57' ' ' THR . 13.5 tt0 -153.68 130.48 10.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.238 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.585 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -131.35 113.86 14.29 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.367 0.603 . . . . 0.0 110.492 169.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -97.14 111.6 23.76 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.456 ' HG ' ' CG2' ' A' ' 53' ' ' VAL . 45.4 tp -83.6 112.57 20.14 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.624 -174.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -110.96 137.17 48.92 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.293 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.582 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 1.2 tp -120.56 119.36 32.71 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.383 175.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -106.19 114.15 28.1 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.227 0.537 . . . . 0.0 109.671 176.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.544 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -145.97 154.59 42.08 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.98 -178.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 57.98 27.83 15.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.938 0.399 . . . . 0.0 110.381 -176.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm 59.22 44.6 15.42 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.743 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -150.86 140.22 21.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.963 178.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -85.98 126.99 34.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.18 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -123.14 123.92 41.9 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.704 176.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 tp -77.38 103.42 4.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 171.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.456 ' CG2' ' HG ' ' A' ' 42' ' ' LEU . 2.8 m -86.88 -35.17 8.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.875 -173.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.542 ' HB2' HD23 ' A' ' 65' ' ' LEU . . . -152.51 145.6 24.58 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.108 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.4 m -114.65 101.87 9.5 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 169.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.457 HG13 ' HB3' ' A' ' 40' ' ' ALA . 7.4 p -115.86 112.93 41.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.798 0.809 . . . . 0.0 110.164 -176.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.447 HG22 ' HG3' ' A' ' 39' ' ' GLU . 81.6 p -123.38 -176.82 3.54 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.217 -175.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 38' ' ' GLN . 34.7 mtmm -58.56 -34.58 71.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.179 0.514 . . . . 0.0 110.084 170.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.27 -40.88 64.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.467 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 72.4 mt -115.37 80.78 7.92 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 174.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -71.08 -0.01 7.32 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.122 2.548 . . . . 0.0 113.541 -168.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -161.94 124.69 2.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.41 0.624 . . . . 0.0 111.11 -176.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 85.7 t -113.73 102.96 14.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.355 174.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.93 109.8 17.89 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.441 173.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.542 HD23 ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -129.67 168.93 15.73 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.19 0.519 . . . . 0.0 111.539 -174.647 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 17.1 t0 -115.61 106.21 13.65 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.728 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.554 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 25.9 mt -123.55 142.96 50.51 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 175.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.664 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 4.9 t30 -150.79 130.79 13.4 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.073 177.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.52 ' HB2' HD13 ' A' ' 23' ' ' ILE . 3.1 m-85 -126.39 153.26 45.21 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.425 ' OG ' ' HG2' ' E' ' 7' ' ' MET . 89.1 p -98.36 164.68 12.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.036 0.446 . . . . 0.0 110.779 -178.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.403 ' H ' ' HG3' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -65.44 -5.47 7.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.821 177.876 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.25 -3.5 55.54 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 121.089 -0.577 . . . . 0.0 111.724 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -93.76 159.06 15.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.973 0.416 . . . . 0.0 110.873 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -144.14 125.48 14.74 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 174.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.544 HG22 ' HB2' ' A' ' 46' ' ' ALA . 18.1 pt -136.17 163.78 33.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.928 -166.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.42 ' SD ' ' HB3' ' A' ' 20' ' ' SER . 3.7 mtm -121.93 130.72 53.56 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.72 173.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.582 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -111.39 128.15 55.88 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.253 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.652 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 33.8 p90 -151.57 138.42 18.95 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.25 0.548 . . . . 0.0 111.788 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.711 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 6.0 p -107.44 134.87 49.85 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.144 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.69 154.18 19.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.112 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.2 -175.92 40.0 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -175.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.432 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 9.4 m-20 -113.62 103.29 11.1 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.209 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.585 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -170.09 155.08 5.31 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.819 172.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.2 t -112.05 123.29 49.93 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.548 HG12 ' HB3' ' A' ' 34' ' ' LEU . 6.1 m -121.46 145.86 27.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.415 0.626 . . . . 0.0 112.637 -172.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.3 m -109.91 120.86 43.79 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.591 175.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.626 HD13 HD23 ' A' ' 11' ' ' LEU . 4.7 mp -98.0 144.89 27.05 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 171.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.554 HD12 ' CE1' ' A' ' 8' ' ' PHE . 2.4 mm? -124.43 146.46 48.89 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.017 174.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.06 -168.33 23.81 Favored Glycine 0 N--CA 1.434 -1.434 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.189 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.632 ' CD2' ' HB3' ' B' ' 68' ' ' ASN . 9.9 p90 -151.41 128.52 11.13 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.828 0.823 . . . . 0.0 111.822 177.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.482 HD23 ' HB3' ' A' ' 27' ' ' PHE . 7.0 mt -68.5 130.87 44.14 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 113.863 -1.517 . . . . 0.0 109.104 175.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -79.58 108.0 12.78 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.161 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -106.58 171.27 7.45 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.987 177.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 7.9 tp -172.98 143.45 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.1 162.97 14.36 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 30.7 t -126.15 31.59 5.4 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.087 0.47 . . . . 0.0 110.369 -178.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.14 -140.12 3.17 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.281 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.517 179.165 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 . . . . . 0 N--CA 1.481 1.125 0 CA-C-O 120.99 0.424 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -100.59 98.64 9.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.189 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.8 53.02 3.65 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.613 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.58 -103.92 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 122.935 0.494 . . . . 0.0 109.897 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 42.4 ttp 53.41 28.83 7.96 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.054 0.542 . . . . 0.0 111.671 176.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.43 ' HB3' ' ND2' ' C' ' 68' ' ' ASN . . . -67.39 123.52 20.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.271 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 51.3 mtt -90.29 137.84 32.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.152 0.501 . . . . 0.0 111.657 -173.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.558 ' CE1' HD21 ' C' ' 44' ' ' LEU . 60.6 t80 -60.47 141.25 56.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.401 -174.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' TRP . . . . . 0.508 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 91.9 t90 -130.33 144.78 51.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.964 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.13 140.92 9.18 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.416 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.615 HD23 HD13 ' B' ' 87' ' ' LEU . 57.0 tp -133.54 109.13 9.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.828 0.347 . . . . 0.0 110.315 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -97.76 104.05 16.04 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' MET . . . . . 0.583 ' SD ' HD11 ' B' ' 87' ' ' LEU . 35.8 mtp -98.35 137.81 36.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.641 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -101.11 159.1 30.45 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.009 176.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.453 ' HB3' ' HA ' ' B' ' 82' ' ' ASP . 69.6 Cg_exo -42.93 118.48 1.24 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.672 2.915 . . . . 0.0 114.323 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.713 ' HA ' ' O ' ' B' ' 79' ' ' THR . 49.7 mt-10 57.06 56.15 5.5 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.05 174.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' B' ' 78' ' ' TYR . 30.4 mmt180 -117.11 144.07 45.1 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.079 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.671 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 35.6 ttmt -126.18 112.79 16.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.091 -176.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' TYR . . . . . 0.403 ' OH ' ' HA ' ' B' ' 13' ' ' MET . 2.4 m-85 -111.26 104.84 13.36 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.291 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.416 ' HB3' ' SD ' ' B' ' 76' ' ' MET . 3.7 p -88.25 104.77 17.04 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 173.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -124.02 148.12 47.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.498 0.666 . . . . 0.0 112.711 -168.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 13.2 t -91.0 161.08 15.29 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.544 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.52 HD13 ' HB2' ' B' ' 69' ' ' PHE . 67.8 mt -114.25 131.26 66.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.116 0.484 . . . . 0.0 111.677 -173.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.47 ' N ' HD12 ' B' ' 24' ' ' ILE . 4.2 mp -99.23 -48.97 11.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.037 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -114.43 140.72 48.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.627 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 19.2 m -63.57 109.22 1.59 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 173.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' PHE . . . . . 0.47 ' HB3' HD23 ' B' ' 91' ' ' LEU . 14.6 p90 -124.93 159.56 30.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.627 0.727 . . . . 0.0 112.845 -170.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' HIS . . . . . 0.59 ' HE2' ' HB3' ' B' ' 30' ' ' SER . 9.3 t60 -116.43 125.81 52.53 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.131 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 61.5 mt -92.44 133.11 34.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 170.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.59 ' HB3' ' HE2' ' B' ' 28' ' ' HIS . 33.2 p -118.88 -14.33 9.44 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -169.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -167.3 148.09 12.65 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 119.146 -1.502 . . . . 0.0 113.375 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.447 HG23 ' HG ' ' B' ' 87' ' ' LEU . 11.3 p -134.68 129.09 51.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 172.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.15 155.53 42.22 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.551 -174.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.561 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.0 pp -120.98 142.3 49.9 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.51 0.672 . . . . 0.0 111.206 178.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -110.06 -50.04 3.01 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.578 173.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -103.14 127.53 50.39 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 168.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 152.17 158.88 8.65 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.217 176.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' GLN . . . . . 0.472 ' O ' ' HG3' ' B' ' 58' ' ' LYS . 94.5 mt-30 -102.46 -45.4 5.08 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.572 0.225 . . . . 0.0 111.441 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.456 ' HG3' HG22 ' B' ' 57' ' ' THR . 13.4 tt0 -153.77 130.54 10.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.189 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.589 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -131.36 113.88 14.3 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.411 0.624 . . . . 0.0 110.507 169.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -97.15 111.68 23.8 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 173.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.454 ' HG ' ' CG2' ' B' ' 53' ' ' VAL . 45.8 tp -83.76 112.57 20.21 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.614 -174.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -110.91 137.15 48.91 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.335 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.592 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 1.2 tp -120.57 119.33 32.59 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.344 175.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -106.23 114.1 28.02 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.523 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -145.94 154.63 42.14 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.932 -178.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 57.95 27.82 15.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.947 0.403 . . . . 0.0 110.391 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm 59.18 44.61 15.53 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.722 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -150.82 140.17 21.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.901 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -85.82 127.07 34.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -123.16 123.83 41.69 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.655 176.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 tp -77.25 103.3 4.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 171.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.454 ' CG2' ' HG ' ' B' ' 42' ' ' LEU . 2.8 m -86.8 -35.31 8.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.853 -173.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.537 ' HB2' HD23 ' B' ' 65' ' ' LEU . . . -152.49 145.62 24.61 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 120.239 -0.584 . . . . 0.0 112.155 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 27.3 m -114.64 101.94 9.57 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 169.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' B' ' 40' ' ' ALA . 7.3 p -115.92 112.96 41.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.771 0.796 . . . . 0.0 110.079 -176.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.456 HG22 ' HG3' ' B' ' 39' ' ' GLU . 82.6 p -123.48 -176.93 3.57 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.185 -175.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' B' ' 38' ' ' GLN . 34.7 mtmm -58.39 -34.67 70.99 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.12 0.486 . . . . 0.0 110.062 170.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.408 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -73.31 -40.9 64.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.466 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 72.5 mt -115.32 80.81 7.81 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 10.2 Cg_exo -71.13 -0.0 7.34 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.107 2.538 . . . . 0.0 113.486 -168.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -161.93 124.86 3.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.375 0.607 . . . . 0.0 111.095 -176.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 85.7 t -113.78 102.93 14.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.311 174.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.95 109.81 17.91 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.46 173.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.537 HD23 ' HB2' ' B' ' 54' ' ' ALA . 0.4 OUTLIER -129.61 168.97 15.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.197 0.522 . . . . 0.0 111.608 -174.721 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 66' ' ' ASP . . . . . 0.526 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 16.9 t0 -115.65 106.3 13.74 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.719 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.557 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 26.2 mt -123.63 142.96 50.55 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 68' ' ' ASN . . . . . 0.632 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 4.9 t30 -150.83 130.76 13.33 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.062 177.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 69' ' ' PHE . . . . . 0.52 ' HB2' HD13 ' B' ' 23' ' ' ILE . 3.2 m-85 -126.43 153.2 45.34 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 88.9 p -98.3 164.72 12.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.003 0.43 . . . . 0.0 110.802 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.427 ' HG3' ' H ' ' B' ' 71' ' ' LYS . 0.0 OUTLIER -65.52 -5.45 8.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.805 177.921 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.19 -3.58 55.57 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.765 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -93.72 159.09 15.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.96 0.409 . . . . 0.0 110.776 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -144.22 125.5 14.69 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.523 HG22 ' HB2' ' B' ' 46' ' ' ALA . 18.0 pt -136.21 163.84 33.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.04 0.448 . . . . 0.0 111.91 -166.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.416 ' SD ' ' HB3' ' B' ' 20' ' ' SER . 3.7 mtm -121.99 130.78 53.59 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.698 173.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 77' ' ' PHE . . . . . 0.592 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.9 OUTLIER -111.36 128.18 55.89 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.269 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.671 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 33.5 p90 -151.61 138.47 18.96 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.199 0.523 . . . . 0.0 111.818 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.713 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 6.0 p -107.46 134.82 49.93 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.1 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.63 154.26 19.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.208 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.08 -175.88 40.15 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -175.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 82' ' ' ASP . . . . . 0.453 ' HA ' ' HB3' ' B' ' 15' ' ' PRO . 9.5 m-20 -113.65 103.34 11.14 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.136 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.589 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -170.16 154.99 5.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.838 172.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 16.1 t -111.99 123.31 49.98 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.561 HG12 ' HB3' ' B' ' 34' ' ' LEU . 6.1 m -121.54 145.81 27.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.494 0.664 . . . . 0.0 112.578 -172.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 20.3 m -109.88 120.87 43.81 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.575 175.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.615 HD13 HD23 ' B' ' 11' ' ' LEU . 4.7 mp -97.92 144.9 26.99 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 171.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.55 HD12 ' CE1' ' B' ' 8' ' ' PHE . 2.4 mm? -124.51 146.55 48.92 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.982 174.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.13 -168.36 23.91 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.25 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 90' ' ' TYR . . . . . 0.604 ' CD2' ' HB3' ' C' ' 68' ' ' ASN . 9.8 p90 -151.42 128.55 11.14 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.844 0.83 . . . . 0.0 111.777 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 91' ' ' LEU . . . . . 0.47 HD23 ' HB3' ' B' ' 27' ' ' PHE . 7.0 mt -68.56 130.94 44.34 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.097 175.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -79.67 108.01 12.89 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.105 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -106.62 171.2 7.49 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.831 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 7.9 tp -172.88 143.49 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.21 162.91 14.47 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 30.4 t -126.17 31.82 5.35 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.093 0.473 . . . . 0.0 110.388 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.29 -140.04 3.15 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.281 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.553 -0.736 . . . . 0.0 109.454 179.195 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 121.082 0.468 . . . . 0.0 110.529 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -100.59 98.59 9.15 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.202 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.74 52.92 3.62 Favored Glycine 0 CA--C 1.517 0.184 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.609 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.57 -104.03 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 122.889 0.476 . . . . 0.0 109.79 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 42.5 ttp 53.55 28.92 8.35 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.078 0.551 . . . . 0.0 111.589 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 6' ' ' ALA . . . . . 0.444 ' HB3' ' ND2' ' D' ' 68' ' ' ASN . . . -67.52 123.53 20.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.193 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 51.3 mtt -90.33 137.88 31.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.196 0.522 . . . . 0.0 111.601 -173.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 8' ' ' PHE . . . . . 0.579 ' CE1' HD21 ' D' ' 44' ' ' LEU . 60.8 t80 -60.5 141.3 56.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.355 -174.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 9' ' ' TRP . . . . . 0.507 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 91.9 t90 -130.42 144.78 51.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.924 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.13 140.84 9.12 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.482 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.633 HD23 HD13 ' C' ' 87' ' ' LEU . 56.6 tp -133.39 108.99 9.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.802 0.334 . . . . 0.0 110.342 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -97.75 104.05 16.04 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 13' ' ' MET . . . . . 0.575 ' SD ' HD11 ' C' ' 87' ' ' LEU . 35.8 mtp -98.35 137.78 36.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.616 -175.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -101.2 159.14 30.32 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.034 176.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 15' ' ' PRO . . . . . 0.428 ' HB3' ' HA ' ' C' ' 82' ' ' ASP . 69.1 Cg_exo -43.01 118.52 1.28 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.727 2.952 . . . . 0.0 114.282 -177.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 16' ' ' GLU . . . . . 0.71 ' HA ' ' O ' ' C' ' 79' ' ' THR . 49.6 mt-10 57.02 56.19 5.5 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.085 174.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 17' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' C' ' 78' ' ' TYR . 30.5 mmt180 -117.15 144.05 45.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.114 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 18' ' ' LYS . . . . . 0.674 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 35.6 ttmt -126.18 112.85 16.27 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 123.455 0.472 . . . . 0.0 111.096 -176.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 19' ' ' TYR . . . . . 0.413 ' OH ' ' HA ' ' C' ' 13' ' ' MET . 2.3 m-85 -111.34 104.77 13.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.302 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 20' ' ' SER . . . . . 0.419 ' HB3' ' SD ' ' C' ' 76' ' ' MET . 3.7 p -88.1 104.83 17.05 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 173.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -124.07 148.1 47.36 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.437 0.637 . . . . 0.0 112.715 -168.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 13.2 t -90.89 161.05 15.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.583 175.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 23' ' ' ILE . . . . . 0.504 HD13 ' HB2' ' C' ' 69' ' ' PHE . 67.7 mt -114.24 131.33 66.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.151 0.5 . . . . 0.0 111.667 -173.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 24' ' ' ILE . . . . . 0.468 ' N ' HD12 ' C' ' 24' ' ' ILE . 4.2 mp -99.27 -49.03 11.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.937 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -114.35 140.61 48.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.657 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 19.1 m -63.52 109.3 1.6 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 173.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 27' ' ' PHE . . . . . 0.483 ' HB3' HD23 ' C' ' 91' ' ' LEU . 14.7 p90 -124.92 159.53 30.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.703 0.764 . . . . 0.0 112.828 -170.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 28' ' ' HIS . . . . . 0.593 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 9.2 t60 -116.5 125.84 52.51 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.049 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 29' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 61.2 mt -92.46 133.08 34.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 170.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.593 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 33.0 p -118.83 -14.32 9.47 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -169.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 31' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -167.36 148.01 12.52 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 119.092 -1.528 . . . . 0.0 113.356 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.449 HG23 ' HG ' ' C' ' 87' ' ' LEU . 11.4 p -134.57 129.06 51.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 172.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.14 155.42 42.13 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.686 -174.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.554 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.0 pp -120.9 142.37 49.76 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.462 0.648 . . . . 0.0 111.213 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -110.14 -50.02 3.01 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.516 173.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -103.24 127.52 50.52 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 168.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 37' ' ' GLY . . . . . 0.461 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 152.16 158.83 8.63 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 119.875 -1.155 . . . . 0.0 113.231 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 38' ' ' GLN . . . . . 0.463 ' O ' ' HG3' ' C' ' 58' ' ' LYS . 94.7 mt-30 -102.48 -45.39 5.08 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.519 0.2 . . . . 0.0 111.373 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 39' ' ' GLU . . . . . 0.451 ' HG3' HG22 ' C' ' 57' ' ' THR . 13.4 tt0 -153.73 130.43 10.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.265 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.577 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -131.35 113.8 14.21 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.388 0.613 . . . . 0.0 110.454 169.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -97.02 111.74 23.82 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.453 ' HG ' ' CG2' ' C' ' 53' ' ' VAL . 45.7 tp -83.84 112.57 20.24 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.593 -174.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -110.92 137.22 48.83 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.354 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.594 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 1.2 tp -120.61 119.36 32.65 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.381 175.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -106.26 114.13 28.07 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.168 0.509 . . . . 0.0 109.635 176.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.528 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -145.95 154.67 42.17 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.929 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 58.02 27.76 15.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.971 0.415 . . . . 0.0 110.446 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm 59.27 44.44 15.48 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.788 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -150.73 140.1 21.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.983 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -85.69 127.04 34.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.235 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -123.23 123.85 41.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.62 176.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 tp -77.33 103.39 4.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 171.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 53' ' ' VAL . . . . . 0.453 ' CG2' ' HG ' ' C' ' 42' ' ' LEU . 2.8 m -86.87 -35.26 8.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.819 -173.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 54' ' ' ALA . . . . . 0.535 ' HB2' HD23 ' C' ' 65' ' ' LEU . . . -152.54 145.54 24.51 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.145 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 27.7 m -114.69 101.96 9.58 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 169.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 56' ' ' VAL . . . . . 0.449 HG13 ' HB3' ' C' ' 40' ' ' ALA . 7.4 p -115.87 113.02 42.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.775 0.798 . . . . 0.0 110.126 -176.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 57' ' ' THR . . . . . 0.451 HG22 ' HG3' ' C' ' 39' ' ' GLU . 81.5 p -123.53 -176.79 3.54 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.208 -175.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 58' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' C' ' 38' ' ' GLN . 34.7 mtmm -58.51 -34.65 71.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.143 0.497 . . . . 0.0 110.065 170.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 59' ' ' ALA . . . . . 0.405 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -73.3 -40.89 64.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.408 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 72.5 mt -115.35 80.74 7.84 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 174.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 61' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 10.3 Cg_exo -70.97 -0.07 7.35 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.027 2.485 . . . . 0.0 113.552 -168.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -161.92 124.83 3.01 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.449 0.643 . . . . 0.0 111.062 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 85.9 t -113.75 102.96 14.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.252 174.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.05 109.78 17.94 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 173.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 65' ' ' LEU . . . . . 0.535 HD23 ' HB2' ' C' ' 54' ' ' ALA . 0.4 OUTLIER -129.53 168.96 15.6 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.171 0.51 . . . . 0.0 111.545 -174.68 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 66' ' ' ASP . . . . . 0.518 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 17.1 t0 -115.59 106.16 13.61 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.667 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.549 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 26.1 mt -123.55 142.99 50.48 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 68' ' ' ASN . . . . . 0.604 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 4.9 t30 -150.87 130.72 13.26 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.1 177.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 69' ' ' PHE . . . . . 0.504 ' HB2' HD13 ' C' ' 23' ' ' ILE . 3.0 m-85 -126.32 153.24 45.12 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 88.9 p -98.4 164.67 12.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.073 0.463 . . . . 0.0 110.77 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 71' ' ' LYS . . . . . 0.424 ' H ' ' HG3' ' C' ' 71' ' ' LYS . 0.0 OUTLIER -65.44 -5.45 7.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.766 177.919 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.24 -3.54 55.53 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.738 176.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -93.77 159.17 15.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.991 0.424 . . . . 0.0 110.758 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -144.21 125.48 14.68 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 174.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.528 HG22 ' HB2' ' C' ' 46' ' ' ALA . 18.1 pt -136.13 163.83 33.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.999 0.428 . . . . 0.0 111.865 -166.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.419 ' SD ' ' HB3' ' C' ' 20' ' ' SER . 3.6 mtm -122.0 130.75 53.56 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.81 173.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 77' ' ' PHE . . . . . 0.594 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.9 OUTLIER -111.3 128.17 55.86 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.368 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 78' ' ' TYR . . . . . 0.674 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 34.0 p90 -151.68 138.37 18.81 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.177 0.513 . . . . 0.0 111.886 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 79' ' ' THR . . . . . 0.71 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 6.2 p -107.38 134.85 49.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.088 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.68 154.26 19.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.139 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.13 -175.85 40.04 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 82' ' ' ASP . . . . . 0.428 ' HA ' ' HB3' ' C' ' 15' ' ' PRO . 9.5 m-20 -113.68 103.33 11.12 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.159 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 83' ' ' ALA . . . . . 0.577 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -170.21 155.0 5.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.837 172.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 16.2 t -112.01 123.33 50.03 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.554 HG12 ' HB3' ' C' ' 34' ' ' LEU . 6.2 m -121.49 145.83 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 CA-C-O 121.505 0.669 . . . . 0.0 112.644 -172.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 20.3 m -109.92 120.9 43.92 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.591 175.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 87' ' ' LEU . . . . . 0.633 HD13 HD23 ' C' ' 11' ' ' LEU . 4.7 mp -97.98 144.81 27.13 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 171.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 88' ' ' LEU . . . . . 0.555 HD12 ' CE1' ' C' ' 8' ' ' PHE . 2.4 mm? -124.42 146.48 48.87 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.443 -0.798 . . . . 0.0 108.985 174.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.09 -168.34 23.84 Favored Glycine 0 N--CA 1.436 -1.366 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.204 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 90' ' ' TYR . . . . . 0.635 ' CD2' ' HB3' ' D' ' 68' ' ' ASN . 9.9 p90 -151.42 128.57 11.16 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.785 0.802 . . . . 0.0 111.783 177.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 91' ' ' LEU . . . . . 0.483 HD23 ' HB3' ' C' ' 27' ' ' PHE . 7.0 mt -68.62 130.99 44.45 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 113.858 -1.519 . . . . 0.0 108.993 175.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -79.75 108.05 13.0 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.125 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -106.61 171.18 7.5 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.892 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 7.9 tp -172.87 143.45 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.684 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.18 162.95 14.41 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 31.1 t -126.15 31.82 5.35 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.108 0.48 . . . . 0.0 110.419 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.28 -140.04 3.15 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.249 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.425 -0.798 . . . . 0.0 109.363 179.281 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 121.114 0.483 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -100.53 98.59 9.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.234 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.81 53.09 3.66 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.557 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.7 -103.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 122.858 0.463 . . . . 0.0 109.821 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 42.4 ttp 53.41 28.92 8.06 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.041 0.537 . . . . 0.0 111.642 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 6' ' ' ALA . . . . . 0.417 ' HB3' ' ND2' ' E' ' 68' ' ' ASN . . . -67.51 123.46 20.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.243 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 51.4 mtt -90.28 137.88 31.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.655 -173.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 8' ' ' PHE . . . . . 0.56 ' CE1' HD21 ' E' ' 44' ' ' LEU . 60.4 t80 -60.52 141.3 56.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.41 -174.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 9' ' ' TRP . . . . . 0.508 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 92.1 t90 -130.41 144.79 51.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.913 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.12 140.95 9.21 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.374 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.615 HD23 HD13 ' D' ' 87' ' ' LEU . 56.4 tp -133.45 109.08 9.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.768 0.318 . . . . 0.0 110.298 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -97.74 104.08 16.08 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 13' ' ' MET . . . . . 0.582 ' SD ' HD11 ' D' ' 87' ' ' LEU . 35.8 mtp -98.4 137.84 36.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.587 -175.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -101.14 159.13 30.36 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.052 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 15' ' ' PRO . . . . . 0.437 ' HB3' ' HA ' ' D' ' 82' ' ' ASP . 69.1 Cg_exo -42.94 118.44 1.23 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.696 2.931 . . . . 0.0 114.314 -177.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 16' ' ' GLU . . . . . 0.703 ' HA ' ' O ' ' D' ' 79' ' ' THR . 49.7 mt-10 57.19 56.07 5.46 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.024 174.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 17' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' D' ' 78' ' ' TYR . 30.5 mmt180 -117.08 144.04 45.1 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.033 175.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 18' ' ' LYS . . . . . 0.673 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 35.6 ttmt -126.18 112.86 16.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.07 -176.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 19' ' ' TYR . . . . . 0.406 ' OH ' ' HA ' ' D' ' 13' ' ' MET . 2.4 m-85 -111.3 104.77 13.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.308 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 20' ' ' SER . . . . . 0.418 ' HB3' ' SD ' ' D' ' 76' ' ' MET . 3.7 p -88.14 104.75 16.99 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 173.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -124.0 148.17 47.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.442 0.639 . . . . 0.0 112.72 -168.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 13.2 t -91.0 161.1 15.28 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.533 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 23' ' ' ILE . . . . . 0.506 HD13 ' HB2' ' D' ' 69' ' ' PHE . 67.5 mt -114.31 131.24 66.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.191 0.519 . . . . 0.0 111.678 -173.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 24' ' ' ILE . . . . . 0.463 HD12 ' N ' ' D' ' 24' ' ' ILE . 4.2 mp -99.12 -49.06 11.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.095 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -114.35 140.64 48.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.648 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 19.3 m -63.55 109.4 1.64 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 173.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 27' ' ' PHE . . . . . 0.482 ' HB3' HD23 ' D' ' 91' ' ' LEU . 14.5 p90 -125.01 159.49 31.18 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.692 0.758 . . . . 0.0 112.824 -170.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 28' ' ' HIS . . . . . 0.594 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 9.4 t60 -116.37 125.82 52.61 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.222 -1.354 . . . . 0.0 110.156 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 29' ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 61.3 mt -92.41 133.04 35.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 170.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 30' ' ' SER . . . . . 0.594 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 33.2 p -118.79 -14.4 9.5 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -169.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 31' ' ' GLY . . . . . 0.545 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -167.31 148.02 12.55 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 119.141 -1.504 . . . . 0.0 113.387 178.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.451 HG23 ' HG ' ' D' ' 87' ' ' LEU . 11.4 p -134.59 128.99 51.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 172.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.11 155.5 42.22 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.496 -0.481 . . . . 0.0 111.629 -174.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 34' ' ' LEU . . . . . 0.552 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.0 pp -120.98 142.24 49.96 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.455 0.645 . . . . 0.0 111.225 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -109.98 -50.16 3.0 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.554 173.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -103.09 127.54 50.32 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 168.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 37' ' ' GLY . . . . . 0.467 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 152.16 158.95 8.68 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 119.868 -1.158 . . . . 0.0 113.253 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 38' ' ' GLN . . . . . 0.46 ' O ' ' HG3' ' D' ' 58' ' ' LYS . 94.7 mt-30 -102.6 -45.35 5.07 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.625 0.25 . . . . 0.0 111.4 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 39' ' ' GLU . . . . . 0.459 ' HG3' HG22 ' D' ' 57' ' ' THR . 13.5 tt0 -153.67 130.58 10.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.221 178.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 40' ' ' ALA . . . . . 0.573 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -131.43 113.82 14.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.417 0.627 . . . . 0.0 110.46 169.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -97.08 111.63 23.77 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 173.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.458 ' HG ' ' CG2' ' D' ' 53' ' ' VAL . 45.9 tp -83.73 112.61 20.22 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.522 -174.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -110.86 137.15 48.86 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.326 178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.593 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 1.2 tp -120.61 119.44 32.87 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.37 175.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 45' ' ' ALA . . . . . . . . . . . . . . . -106.25 113.99 27.86 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.529 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -145.92 154.61 42.13 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.961 -178.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 58.06 27.75 15.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.931 0.396 . . . . 0.0 110.421 -176.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm 59.24 44.54 15.45 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.809 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -150.83 140.36 21.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.896 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -85.99 127.01 34.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.18 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -123.15 123.79 41.61 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.722 176.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 tp -77.26 103.33 4.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 171.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 53' ' ' VAL . . . . . 0.458 ' CG2' ' HG ' ' D' ' 42' ' ' LEU . 2.8 m -86.79 -35.29 8.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.861 -173.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 54' ' ' ALA . . . . . 0.54 ' HB2' HD23 ' D' ' 65' ' ' LEU . . . -152.46 145.64 24.65 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.284 -0.566 . . . . 0.0 112.167 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 27.2 m -114.74 101.98 9.59 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 169.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 56' ' ' VAL . . . . . 0.449 HG13 ' HB3' ' D' ' 40' ' ' ALA . 7.4 p -115.94 112.98 41.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.791 0.805 . . . . 0.0 110.081 -176.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 57' ' ' THR . . . . . 0.459 HG22 ' HG3' ' D' ' 39' ' ' GLU . 82.5 p -123.48 -176.81 3.54 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.208 -175.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 58' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' D' ' 38' ' ' GLN . 34.7 mtmm -58.56 -34.59 71.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.128 0.49 . . . . 0.0 110.069 170.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 59' ' ' ALA . . . . . 0.4 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -73.4 -40.73 64.07 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.452 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 72.4 mt -115.36 80.74 7.87 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 174.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 61' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 10.4 Cg_exo -71.05 -0.1 7.44 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.109 2.539 . . . . 0.0 113.516 -168.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -161.84 124.73 3.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.327 0.584 . . . . 0.0 111.127 -176.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 85.1 t -113.72 102.91 14.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.32 174.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.01 109.8 17.93 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.404 173.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 65' ' ' LEU . . . . . 0.54 HD23 ' HB2' ' D' ' 54' ' ' ALA . 0.4 OUTLIER -129.66 168.9 15.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.107 0.479 . . . . 0.0 111.606 -174.721 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 66' ' ' ASP . . . . . 0.518 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 17.2 t0 -115.47 106.21 13.7 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.735 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.546 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 25.9 mt -123.6 143.03 50.48 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 68' ' ' ASN . . . . . 0.635 ' HB3' ' CD2' ' C' ' 90' ' ' TYR . 4.9 t30 -150.83 130.73 13.31 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.026 177.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 69' ' ' PHE . . . . . 0.506 ' HB2' HD13 ' D' ' 23' ' ' ILE . 3.2 m-85 -126.33 153.23 45.16 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 89.0 p -98.36 164.63 12.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.029 0.442 . . . . 0.0 110.819 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 71' ' ' LYS . . . . . 0.42 ' H ' ' HG3' ' D' ' 71' ' ' LYS . 0.0 OUTLIER -65.39 -5.49 7.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.824 177.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.19 -3.64 55.55 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.714 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -93.66 159.1 15.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.969 0.414 . . . . 0.0 110.836 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -144.25 125.53 14.69 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.529 HG22 ' HB2' ' D' ' 46' ' ' ALA . 18.1 pt -136.13 163.79 33.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.925 -166.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 76' ' ' MET . . . . . 0.418 ' SD ' ' HB3' ' D' ' 20' ' ' SER . 3.6 mtm -121.95 130.67 53.51 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.752 173.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 77' ' ' PHE . . . . . 0.593 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.9 OUTLIER -111.34 128.21 55.89 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.277 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 78' ' ' TYR . . . . . 0.673 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 33.5 p90 -151.7 138.39 18.8 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.239 0.543 . . . . 0.0 111.822 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 79' ' ' THR . . . . . 0.703 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 6.0 p -107.4 134.89 49.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.101 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.74 154.16 19.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.189 175.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.24 -175.88 39.89 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -175.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 82' ' ' ASP . . . . . 0.437 ' HA ' ' HB3' ' D' ' 15' ' ' PRO . 9.5 m-20 -113.65 103.27 11.06 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.172 178.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 83' ' ' ALA . . . . . 0.573 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -170.16 155.02 5.21 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.814 172.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 15.7 t -111.95 123.39 50.16 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.552 HG12 ' HB3' ' D' ' 34' ' ' LEU . 6.2 m -121.52 145.85 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.454 0.645 . . . . 0.0 112.631 -172.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 20.2 m -109.88 120.83 43.71 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.582 175.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 87' ' ' LEU . . . . . 0.615 HD13 HD23 ' D' ' 11' ' ' LEU . 4.7 mp -97.96 144.87 27.05 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 170.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.549 HD12 ' CZ ' ' D' ' 8' ' ' PHE . 2.4 mm? -124.46 146.48 48.91 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.013 174.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.09 -168.26 23.74 Favored Glycine 0 N--CA 1.435 -1.421 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.189 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 90' ' ' TYR . . . . . 0.584 ' CD2' ' HB3' ' E' ' 68' ' ' ASN . 9.8 p90 -151.46 128.55 11.12 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.825 0.821 . . . . 0.0 111.757 177.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 91' ' ' LEU . . . . . 0.482 HD23 ' HB3' ' D' ' 27' ' ' PHE . 6.9 mt -68.62 131.04 44.54 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.852 -1.522 . . . . 0.0 109.047 175.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -79.76 108.03 13.01 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.099 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -106.61 171.18 7.5 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.929 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 7.9 tp -172.88 143.48 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.17 162.92 14.44 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 31.5 t -126.15 31.69 5.38 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.066 0.46 . . . . 0.0 110.364 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.21 -139.98 3.14 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.263 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.63 -0.7 . . . . 0.0 109.43 179.205 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 121.065 0.46 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -100.58 98.6 9.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.236 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.87 53.04 3.68 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 121.159 -0.544 . . . . 0.0 112.636 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.55 -104.02 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 122.87 0.468 . . . . 0.0 109.824 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 42.3 ttp 53.57 28.73 8.18 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.646 176.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 6' ' ' ALA . . . . . 0.464 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . . . -67.31 123.48 20.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.236 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 7' ' ' MET . . . . . 0.425 ' HG2' ' OG ' ' A' ' 70' ' ' SER . 51.3 mtt -90.3 137.82 32.04 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.138 0.494 . . . . 0.0 111.634 -173.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 8' ' ' PHE . . . . . 0.576 ' CE1' HD21 ' A' ' 44' ' ' LEU . 60.4 t80 -60.51 141.21 56.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.367 -174.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 9' ' ' TRP . . . . . 0.505 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 92.1 t90 -130.32 144.7 51.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.966 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.03 140.96 9.23 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.44 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 11' ' ' LEU . . . . . 0.629 HD23 HD13 ' E' ' 87' ' ' LEU . 56.7 tp -133.53 109.09 9.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.864 0.364 . . . . 0.0 110.335 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -97.78 104.05 16.04 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 13' ' ' MET . . . . . 0.58 ' SD ' HD11 ' E' ' 87' ' ' LEU . 35.8 mtp -98.3 137.74 36.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.615 -175.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -101.13 159.12 30.38 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.99 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 15' ' ' PRO . . . . . 0.436 ' HB3' ' HA ' ' E' ' 82' ' ' ASP . 68.6 Cg_exo -43.01 118.55 1.29 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.632 2.888 . . . . 0.0 114.298 -177.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 16' ' ' GLU . . . . . 0.707 ' HA ' ' O ' ' E' ' 79' ' ' THR . 49.6 mt-10 57.02 56.14 5.53 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.109 174.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 17' ' ' ARG . . . . . 0.429 ' O ' ' HA ' ' E' ' 78' ' ' TYR . 30.4 mmt180 -117.17 144.05 45.17 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.019 175.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 18' ' ' LYS . . . . . 0.68 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 35.6 ttmt -126.14 112.87 16.32 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 123.573 0.546 . . . . 0.0 111.096 -176.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 19' ' ' TYR . . . . . 0.413 ' OH ' ' HA ' ' E' ' 13' ' ' MET . 2.3 m-85 -111.26 104.74 13.26 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.288 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 20' ' ' SER . . . . . 0.417 ' HB3' ' SD ' ' E' ' 76' ' ' MET . 3.8 p -88.03 104.79 16.99 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 173.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -124.07 148.04 47.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.482 0.658 . . . . 0.0 112.692 -168.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 13.1 t -90.88 161.11 15.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.536 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 23' ' ' ILE . . . . . 0.511 HD13 ' HB2' ' E' ' 69' ' ' PHE . 67.6 mt -114.34 131.31 66.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.125 0.488 . . . . 0.0 111.709 -173.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 24' ' ' ILE . . . . . 0.457 HD12 ' N ' ' E' ' 24' ' ' ILE . 4.2 mp -99.22 -48.92 11.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.0 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -114.49 140.62 48.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.61 177.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 19.1 m -63.58 109.35 1.63 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 173.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 27' ' ' PHE . . . . . 0.473 ' HB3' HD23 ' E' ' 91' ' ' LEU . 14.6 p90 -124.92 159.55 30.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.643 0.735 . . . . 0.0 112.88 -170.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 28' ' ' HIS . . . . . 0.582 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 9.3 t60 -116.45 125.83 52.53 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.047 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 29' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 61.1 mt -92.38 133.12 34.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 170.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 30' ' ' SER . . . . . 0.582 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 32.9 p -118.96 -14.31 9.4 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -169.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 31' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -167.32 148.01 12.53 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.143 -1.504 . . . . 0.0 113.352 178.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.437 HG23 ' HG ' ' E' ' 87' ' ' LEU . 11.5 p -134.69 128.99 51.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 172.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.07 155.49 42.24 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 121.942 -0.474 . . . . 0.0 111.655 -174.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 34' ' ' LEU . . . . . 0.551 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.0 pp -121.0 142.29 49.93 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.511 0.672 . . . . 0.0 111.181 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -110.11 -50.05 3.01 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.476 173.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -103.17 127.46 50.46 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 168.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 37' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 152.17 158.85 8.64 Favored Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 119.875 -1.155 . . . . 0.0 113.293 176.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 38' ' ' GLN . . . . . 0.474 ' O ' ' HG3' ' E' ' 58' ' ' LYS . 94.4 mt-30 -102.47 -45.44 5.07 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 120.586 0.231 . . . . 0.0 111.39 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 39' ' ' GLU . . . . . 0.433 ' HG3' HG22 ' E' ' 57' ' ' THR . 13.4 tt0 -153.68 130.59 10.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.229 178.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 40' ' ' ALA . . . . . 0.583 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -131.41 113.83 14.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.388 0.613 . . . . 0.0 110.467 169.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 41' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -97.06 111.63 23.77 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.45 ' HG ' ' CG2' ' E' ' 53' ' ' VAL . 45.7 tp -83.69 112.57 20.17 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.627 -174.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -110.95 137.14 48.95 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.32 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 44' ' ' LEU . . . . . 0.594 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 1.2 tp -120.54 119.43 32.92 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.377 175.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 45' ' ' ALA . . . . . . . . . . . . . . . -106.24 114.15 28.1 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 46' ' ' ALA . . . . . 0.523 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -146.04 154.58 42.02 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.957 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 58.02 27.77 15.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.027 0.441 . . . . 0.0 110.406 -176.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm 59.23 44.61 15.38 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.749 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 49' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -150.89 140.23 21.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.922 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -85.89 127.1 34.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.15 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 51' ' ' TYR . . . . . 0.414 ' CB ' HD11 ' D' ' 88' ' ' LEU . 49.8 m-85 -123.23 123.96 41.94 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.669 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 tp -77.39 103.36 4.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 171.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 53' ' ' VAL . . . . . 0.45 ' CG2' ' HG ' ' E' ' 42' ' ' LEU . 2.8 m -86.83 -35.32 8.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.786 -173.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 54' ' ' ALA . . . . . 0.519 ' HB2' ' CD2' ' E' ' 65' ' ' LEU . . . -152.49 145.53 24.55 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.312 -0.555 . . . . 0.0 112.191 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 27.4 m -114.63 101.95 9.58 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 169.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 56' ' ' VAL . . . . . 0.454 HG13 ' HB3' ' E' ' 40' ' ' ALA . 7.4 p -115.92 112.99 41.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.783 0.802 . . . . 0.0 110.114 -176.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 57' ' ' THR . . . . . 0.433 HG22 ' HG3' ' E' ' 39' ' ' GLU . 82.8 p -123.4 -176.81 3.53 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.234 -175.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 58' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' E' ' 38' ' ' GLN . 34.6 mtmm -58.45 -34.8 71.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.199 0.523 . . . . 0.0 110.043 170.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 59' ' ' ALA . . . . . 0.404 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -73.24 -40.78 64.39 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.508 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 72.6 mt -115.38 80.67 7.87 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 61' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 10.3 Cg_exo -71.06 0.02 7.27 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.047 2.498 . . . . 0.0 113.448 -168.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -162.01 124.75 2.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.504 0.669 . . . . 0.0 111.08 -176.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 86.4 t -113.81 102.97 14.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.239 174.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.0 109.84 17.96 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.411 173.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.519 ' CD2' ' HB2' ' E' ' 54' ' ' ALA . 0.4 OUTLIER -129.62 168.97 15.64 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.081 0.467 . . . . 0.0 111.583 -174.657 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 66' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 17.1 t0 -115.68 106.26 13.68 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.708 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 67' ' ' LEU . . . . . 0.55 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 26.0 mt -123.55 143.0 50.47 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 175.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 68' ' ' ASN . . . . . 0.584 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 4.9 t30 -150.78 130.72 13.35 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.122 177.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 69' ' ' PHE . . . . . 0.511 ' HB2' HD13 ' E' ' 23' ' ' ILE . 3.1 m-85 -126.34 153.19 45.23 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 88.9 p -98.28 164.67 12.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.006 0.431 . . . . 0.0 110.786 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 71' ' ' LYS . . . . . 0.427 ' H ' ' HG3' ' E' ' 71' ' ' LYS . 0.0 OUTLIER -65.42 -5.57 7.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.781 177.884 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.18 -3.44 55.64 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 121.043 -0.599 . . . . 0.0 111.791 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -93.74 159.08 15.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.99 0.424 . . . . 0.0 110.747 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -144.21 125.47 14.67 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 174.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 75' ' ' ILE . . . . . 0.523 HG22 ' HB2' ' E' ' 46' ' ' ALA . 18.0 pt -136.09 163.8 33.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.92 -166.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 76' ' ' MET . . . . . 0.417 ' SD ' ' HB3' ' E' ' 20' ' ' SER . 3.7 mtm -121.95 130.76 53.59 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 173.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 77' ' ' PHE . . . . . 0.594 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.9 OUTLIER -111.41 128.18 55.9 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.248 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 78' ' ' TYR . . . . . 0.68 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 33.9 p90 -151.64 138.45 18.91 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.242 0.544 . . . . 0.0 111.8 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 79' ' ' THR . . . . . 0.707 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 6.2 p -107.4 134.84 49.86 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.13 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.67 154.17 19.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.17 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.19 -175.91 39.99 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -175.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 82' ' ' ASP . . . . . 0.436 ' HA ' ' HB3' ' E' ' 15' ' ' PRO . 9.2 m-20 -113.64 103.37 11.17 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.132 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 83' ' ' ALA . . . . . 0.583 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -170.24 155.03 5.14 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.832 172.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 16.2 t -112.03 123.45 50.28 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 85' ' ' VAL . . . . . 0.551 HG12 ' HB3' ' E' ' 34' ' ' LEU . 6.1 m -121.62 145.76 27.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.424 0.631 . . . . 0.0 112.617 -172.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 20.4 m -109.87 120.82 43.67 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.619 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 87' ' ' LEU . . . . . 0.629 HD13 HD23 ' E' ' 11' ' ' LEU . 4.7 mp -97.87 144.84 27.02 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 171.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 88' ' ' LEU . . . . . 0.552 HD12 ' CE1' ' E' ' 8' ' ' PHE . 2.4 mm? -124.4 146.46 48.86 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.075 174.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.07 -168.34 23.83 Favored Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.272 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 90' ' ' TYR . . . . . 0.664 ' CD2' ' HB3' ' A' ' 68' ' ' ASN . 9.9 p90 -151.4 128.57 11.17 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.814 0.816 . . . . 0.0 111.794 177.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 91' ' ' LEU . . . . . 0.473 HD23 ' HB3' ' E' ' 27' ' ' PHE . 7.1 mt -68.61 131.0 44.49 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 113.893 -1.503 . . . . 0.0 109.036 175.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -79.79 108.04 13.04 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.104 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -106.51 171.17 7.5 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.956 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 7.9 tp -172.93 143.38 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.08 162.97 14.34 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 31.0 t -126.07 31.65 5.4 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.208 0.527 . . . . 0.0 110.513 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.18 -139.96 3.14 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.524 -0.845 . . . . 0.0 112.243 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.509 -0.758 . . . . 0.0 109.392 179.315 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 69.16 -60.46 0.46 Allowed 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.82 0.7 . . . . 0.0 110.969 -176.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -91.01 -71.27 1.21 Allowed Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.93 176.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.21 133.16 43.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.019 0.438 . . . . 0.0 111.672 -177.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 67.4 mtp -144.18 -170.64 3.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.913 173.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' B' ' 70' ' ' SER . . . -50.14 137.56 17.51 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.677 0.611 . . . . 0.0 112.1 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 38.7 mtt -111.8 146.46 37.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.963 -176.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.438 ' CE1' HD21 ' B' ' 44' ' ' LEU . 61.0 t80 -64.7 146.39 54.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.54 -171.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.469 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 90.5 t90 -137.89 147.03 44.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.066 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.83 155.22 26.27 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.802 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.575 HD23 HD13 ' A' ' 87' ' ' LEU . 48.2 tp -143.86 108.72 4.93 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.768 0.318 . . . . 0.0 110.964 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -91.19 100.69 13.47 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.001 0.429 . . . . 0.0 110.057 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.519 ' SD ' HD11 ' A' ' 87' ' ' LEU . 57.0 mtp -90.56 138.03 31.88 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.21 -177.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.532 ' HB2' ' HD2' ' A' ' 17' ' ' ARG . 32.6 mmtp -101.24 150.94 37.57 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.911 -175.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.434 ' HD3' ' OG ' ' A' ' 84' ' ' SER . 81.9 Cg_exo -43.13 112.28 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 124.195 3.263 . . . . 0.0 114.745 -172.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.689 ' HA ' ' O ' ' A' ' 79' ' ' THR . 5.7 tt0 60.9 63.47 1.28 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.468 170.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.532 ' HD2' ' HB2' ' A' ' 14' ' ' LYS . 37.7 mtt85 -136.27 155.39 50.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.57 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.698 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 3.3 ttmp? -125.5 115.47 20.27 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.769 -175.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -112.6 119.49 38.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.866 176.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.3 p -79.54 133.39 36.47 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 172.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -108.69 115.95 31.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.08 0.467 . . . . 0.0 112.044 -167.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.6 m -93.18 123.12 36.23 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 169.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.9 mt -93.28 113.76 28.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.217 0.532 . . . . 0.0 111.548 -171.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.427 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.5 mp -85.66 -48.32 16.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.491 178.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.432 ' HD2' HD13 ' A' ' 91' ' ' LEU . 47.0 mttt -119.33 132.47 55.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.267 178.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.6 p -59.62 123.14 15.95 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.545 ' HB3' HD23 ' A' ' 91' ' ' LEU . 3.3 p90 -136.56 161.84 34.76 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -170.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.567 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 21.6 t60 -115.86 128.1 55.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.885 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.578 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 44.1 mt -98.76 131.7 45.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 170.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.567 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 40.5 p -116.05 -15.15 11.17 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -171.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.05 155.04 26.22 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 119.391 -1.385 . . . . 0.0 113.503 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.443 HG23 ' HG ' ' A' ' 87' ' ' LEU . 9.5 p -137.33 124.43 29.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 171.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 62' ' ' GLN . . . -125.87 150.04 48.2 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -170.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.865 ' HB2' HG22 ' A' ' 56' ' ' VAL . 1.8 tm? -104.53 109.52 21.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.689 -174.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.53 -59.42 1.95 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.914 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -104.09 129.4 51.77 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.605 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.588 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 134.84 177.59 15.06 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 119.275 -1.441 . . . . 0.0 113.506 174.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.429 ' HA ' ' HD2' ' A' ' 58' ' ' LYS . 74.4 mt-30 -103.41 -47.82 4.17 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.635 0.255 . . . . 0.0 111.295 176.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -151.2 133.27 15.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.42 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.88 114.86 17.02 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.322 0.582 . . . . 0.0 110.427 170.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -100.15 111.22 23.5 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.6 tp -84.2 115.78 22.6 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.044 -173.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.435 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 98.2 m-85 -117.47 145.34 44.24 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.497 ' HA ' ' O ' ' A' ' 76' ' ' MET . 0.2 OUTLIER -133.09 134.2 43.96 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 171.872 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -108.59 115.53 30.27 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.407 178.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.638 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -128.71 144.02 51.07 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 58.37 27.35 15.26 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -170.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.7 mttp 59.53 33.18 22.07 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.938 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.533 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 8.7 tp-100 -120.31 124.45 45.63 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -83.07 117.74 23.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.805 0.336 . . . . 0.0 110.878 -176.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -112.51 136.17 52.36 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.719 176.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.1 tp -78.38 109.89 13.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 168.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.481 HG13 ' CD2' ' E' ' 88' ' ' LEU . 2.7 t -82.97 -50.28 15.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.356 -173.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.433 ' HB1' HG11 ' A' ' 63' ' ' VAL . . . -155.4 144.16 20.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.187 -178.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.8 m -108.32 102.42 11.54 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 172.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.865 HG22 ' HB2' ' A' ' 34' ' ' LEU . 13.4 p -120.98 112.99 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-O 122.205 1.003 . . . . 0.0 110.781 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.7 p -123.31 -178.0 3.86 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.914 -174.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.429 ' HD2' ' HA ' ' A' ' 38' ' ' GLN . 29.8 mtpp -59.66 -31.55 69.64 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.053 0.454 . . . . 0.0 110.222 169.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.06 -40.35 62.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.614 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.7 mt -112.46 84.47 6.27 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 173.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.2 0.74 6.23 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.111 2.54 . . . . 0.0 114.352 -166.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 18.9 pt20 -169.81 130.46 1.02 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.096 0.474 . . . . 0.0 111.127 -177.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.433 HG11 ' HB1' ' A' ' 54' ' ' ALA . 95.4 t -118.81 116.56 51.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.297 175.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.44 122.41 39.3 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.04 176.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -138.78 168.5 19.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.057 0.456 . . . . 0.0 111.527 -176.566 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 7.7 t0 -116.07 99.56 7.33 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.188 0.518 . . . . 0.0 110.232 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.682 HD21 HD23 ' E' ' 88' ' ' LEU . 21.0 mt -113.42 137.37 51.63 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.893 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.66 ' HB2' ' CD2' ' E' ' 90' ' ' TYR . 3.8 m-20 -138.0 118.18 13.56 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 176.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -117.37 151.46 36.98 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.358 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' E' ' 6' ' ' ALA . 14.6 t -113.02 152.99 28.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.068 -177.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -69.68 -12.1 61.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.377 -176.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.2 -12.08 68.42 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.822 175.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -100.75 164.32 11.91 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -143.49 127.83 17.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.973 0.416 . . . . 0.0 109.961 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.638 HG22 ' HB2' ' A' ' 46' ' ' ALA . 10.9 pt -131.42 179.62 4.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.04 -170.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 12.0 mtm -136.05 135.56 39.51 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 171.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.447 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 1.1 m-85 -112.61 128.2 56.31 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.698 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 34.5 p90 -153.55 137.17 16.0 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.303 0.573 . . . . 0.0 112.105 -177.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.689 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 5.9 p -109.21 138.32 45.74 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.04 -177.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.79 162.3 13.91 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.194 176.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.87 -174.73 44.58 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -175.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -115.46 102.83 10.17 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.092 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.588 ' CB ' ' HA3' ' A' ' 37' ' ' GLY . . . -175.46 162.74 2.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.562 171.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.434 ' OG ' ' HD3' ' A' ' 15' ' ' PRO . 1.1 m -116.01 126.01 53.24 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.659 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.407 HG11 ' CG1' ' A' ' 56' ' ' VAL . 2.8 m -116.8 148.73 19.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -174.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.4 m -108.5 113.58 26.73 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.653 173.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.575 HD13 HD23 ' A' ' 11' ' ' LEU . 5.2 mp -89.62 148.64 23.22 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 170.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.702 HD23 HD21 ' B' ' 67' ' ' LEU . 0.9 OUTLIER -132.06 138.93 48.36 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.079 -178.906 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.7 -167.12 24.75 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.878 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.682 ' CD2' ' HB2' ' B' ' 68' ' ' ASN . 13.0 p90 -150.71 128.86 11.9 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.995 0.902 . . . . 0.0 111.745 177.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.545 HD23 ' HB3' ' A' ' 27' ' ' PHE . 8.2 mt -69.7 135.01 49.31 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 113.941 -1.481 . . . . 0.0 109.655 176.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -86.96 107.67 18.49 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -157.52 136.55 11.68 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -176.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.02 117.86 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.103 0.478 . . . . 0.0 110.77 -175.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -95.67 168.89 10.4 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.792 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 28.5 t 62.7 44.53 6.54 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.384 0.611 . . . . 0.0 109.986 -177.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.99 69.19 3.42 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.142 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.5 t . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.669 -0.681 . . . . 0.0 109.544 179.527 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 69.37 -60.59 0.46 Allowed 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.842 0.714 . . . . 0.0 110.925 -176.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.99 -71.16 1.21 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.958 176.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.21 133.17 43.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.02 0.438 . . . . 0.0 111.668 -177.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 67.1 mtp -144.16 -170.64 3.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.887 173.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' C' ' 70' ' ' SER . . . -50.14 137.64 17.36 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 123.706 0.629 . . . . 0.0 112.018 -176.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 38.7 mtt -111.9 146.41 37.81 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.904 -176.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.465 ' CE1' HD21 ' C' ' 44' ' ' LEU . 61.3 t80 -64.55 146.37 54.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.553 -171.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' TRP . . . . . 0.464 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 90.5 t90 -138.03 147.02 43.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.01 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.81 155.23 26.27 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.87 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.583 HD23 HD13 ' B' ' 87' ' ' LEU . 47.6 tp -143.88 108.78 4.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.743 0.306 . . . . 0.0 110.976 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -91.17 100.75 13.52 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.973 0.416 . . . . 0.0 110.039 173.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' MET . . . . . 0.523 ' SD ' HD11 ' B' ' 87' ' ' LEU . 57.4 mtp -90.61 137.96 31.94 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.196 -177.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.524 ' HB2' ' HD2' ' B' ' 17' ' ' ARG . 32.6 mmtp -101.17 150.99 37.58 Favored Pre-proline 0 C--N 1.317 -0.834 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.938 -175.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.436 ' HD3' ' OG ' ' B' ' 84' ' ' SER . 83.3 Cg_exo -43.19 112.23 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 124.187 3.258 . . . . 0.0 114.853 -172.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.683 ' HA ' ' O ' ' B' ' 79' ' ' THR . 5.7 tt0 61.0 63.33 1.28 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.502 170.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.524 ' HD2' ' HB2' ' B' ' 14' ' ' LYS . 37.7 mtt85 -136.19 155.56 49.96 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.601 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.694 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 3.3 ttmp? -125.61 115.43 20.13 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.762 -175.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -112.64 119.38 37.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.842 176.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 10.1 p -79.55 133.33 36.46 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 172.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -108.67 116.03 31.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.063 0.459 . . . . 0.0 112.02 -167.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 28.3 m -93.12 123.16 36.19 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 169.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 52.9 mt -93.28 113.77 28.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.179 0.514 . . . . 0.0 111.536 -172.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.425 ' N ' HD12 ' B' ' 24' ' ' ILE . 4.5 mp -85.56 -48.46 16.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.543 178.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.444 ' HD2' HD13 ' B' ' 91' ' ' LEU . 47.2 mttt -119.32 132.46 55.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.267 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 12.7 p -59.58 123.09 15.74 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' PHE . . . . . 0.538 ' HB3' HD23 ' B' ' 91' ' ' LEU . 3.3 p90 -136.56 161.76 34.98 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -169.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' HIS . . . . . 0.565 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 22.0 t60 -115.83 128.03 55.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.847 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.583 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 43.7 mt -98.68 131.7 45.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 170.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.565 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 41.0 p -116.06 -15.16 11.17 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -171.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.15 154.98 26.13 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 119.377 -1.392 . . . . 0.0 113.535 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.443 HG23 ' HG ' ' B' ' 87' ' ' LEU . 9.5 p -137.26 124.4 30.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 171.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' B' ' 62' ' ' GLN . . . -125.77 150.05 48.07 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -170.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.885 ' HB2' HG22 ' B' ' 56' ' ' VAL . 1.8 tm? -104.6 109.58 21.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.688 -174.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.52 -59.47 1.94 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.917 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -104.02 129.38 51.64 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.712 175.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.585 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 134.73 177.53 15.01 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 119.222 -1.466 . . . . 0.0 113.485 174.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' GLN . . . . . 0.427 ' HA ' ' HD2' ' B' ' 58' ' ' LYS . 74.3 mt-30 -103.37 -47.85 4.17 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.633 0.254 . . . . 0.0 111.294 176.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -151.2 133.29 15.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.385 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.92 114.89 17.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.356 0.598 . . . . 0.0 110.453 170.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -100.15 111.14 23.42 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 48.2 tp -84.1 115.74 22.53 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.098 -173.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' TYR . . . . . 0.435 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 98.2 m-85 -117.43 145.37 44.18 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.487 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.2 OUTLIER -133.17 134.19 43.79 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.235 0.54 . . . . 0.0 109.549 171.899 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -108.51 115.54 30.29 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.357 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.635 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -128.8 144.06 51.07 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 58.42 27.29 15.25 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -170.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 59.7 mttp 59.46 33.24 22.19 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.923 -175.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.54 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 8.7 tp-100 -120.31 124.48 45.7 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -82.98 117.61 22.92 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.767 0.318 . . . . 0.0 111.01 -176.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -112.47 136.2 52.26 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.672 176.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 6.2 tp -78.33 109.86 13.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 168.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.506 HG13 ' CD2' ' A' ' 88' ' ' LEU . 2.7 t -83.08 -50.14 15.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.3 -173.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.424 ' HB1' HG11 ' B' ' 63' ' ' VAL . . . -155.46 144.14 20.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.141 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 23.6 m -108.38 102.49 11.59 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 172.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.885 HG22 ' HB2' ' B' ' 34' ' ' LEU . 13.3 p -121.01 112.95 37.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 122.224 1.012 . . . . 0.0 110.739 -175.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 68.2 p -123.29 -177.89 3.83 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.975 -174.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' LYS . . . . . 0.427 ' HD2' ' HA ' ' B' ' 38' ' ' GLN . 29.8 mtpp -59.66 -31.6 69.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.18 0.514 . . . . 0.0 110.223 169.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.06 -40.3 62.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.629 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 83.9 mt -112.52 84.6 6.46 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 173.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.18 0.68 6.32 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.051 2.501 . . . . 0.0 114.427 -166.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' GLN . . . . . 0.432 ' HA ' ' HA ' ' B' ' 33' ' ' ALA . 18.9 pt20 -169.77 130.49 1.03 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.167 0.508 . . . . 0.0 111.095 -177.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.424 HG11 ' HB1' ' B' ' 54' ' ' ALA . 95.6 t -118.8 116.53 51.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.308 175.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.45 122.3 39.2 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.067 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' B' ' 30' ' ' SER . 0.3 OUTLIER -138.67 168.57 19.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.02 0.438 . . . . 0.0 111.541 -176.617 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 66' ' ' ASP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 7.6 t0 -116.07 99.56 7.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.145 0.498 . . . . 0.0 110.16 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.702 HD21 HD23 ' A' ' 88' ' ' LEU . 21.1 mt -113.48 137.21 51.88 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.978 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' ASN . . . . . 0.682 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 3.8 m-20 -137.88 118.16 13.66 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 176.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -117.42 151.51 36.9 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.271 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 6' ' ' ALA . 14.8 t -113.12 153.01 28.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.067 -177.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -69.65 -12.13 61.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.37 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.09 -12.19 68.48 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.849 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -100.72 164.25 11.95 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -143.44 127.9 17.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.936 0.398 . . . . 0.0 109.988 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.635 HG22 ' HB2' ' B' ' 46' ' ' ALA . 10.9 pt -131.56 179.63 4.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.958 -170.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.487 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 11.9 mtm -136.01 135.66 39.65 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 171.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 77' ' ' PHE . . . . . 0.46 ' CD1' ' HB2' ' B' ' 44' ' ' LEU . 1.1 m-85 -112.66 128.29 56.35 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.694 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 34.3 p90 -153.63 137.15 15.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.345 0.593 . . . . 0.0 112.093 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.683 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 5.9 p -109.15 138.21 45.86 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.068 -177.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.81 162.43 13.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.184 176.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.87 -174.78 44.64 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -175.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -115.45 102.83 10.17 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.614 -0.834 . . . . 0.0 110.026 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.585 ' CB ' ' HA3' ' B' ' 37' ' ' GLY . . . -175.54 162.69 2.84 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.528 171.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 84' ' ' SER . . . . . 0.436 ' OG ' ' HD3' ' B' ' 15' ' ' PRO . 1.1 m -115.98 126.01 53.27 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.553 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.413 HG11 ' CG1' ' B' ' 56' ' ' VAL . 2.7 m -116.87 148.81 19.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.147 0.499 . . . . 0.0 112.329 -174.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 86' ' ' SER . . . . . 0.419 ' OG ' HG22 ' C' ' 52' ' ' ILE . 43.1 m -108.52 113.63 26.8 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.63 173.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.583 HD13 HD23 ' B' ' 11' ' ' LEU . 5.3 mp -89.74 148.62 23.15 Favored 'General case' 0 CA--C 1.5 -0.953 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.448 170.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.675 HD23 HD21 ' C' ' 67' ' ' LEU . 0.9 OUTLIER -132.04 138.98 48.41 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.078 -178.888 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.78 -167.17 24.93 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.872 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 90' ' ' TYR . . . . . 0.66 ' CD2' ' HB2' ' C' ' 68' ' ' ASN . 12.9 p90 -150.66 128.84 11.93 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.889 0.852 . . . . 0.0 111.786 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 91' ' ' LEU . . . . . 0.538 HD23 ' HB3' ' B' ' 27' ' ' PHE . 8.3 mt -69.69 135.06 49.38 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.632 176.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -87.05 107.76 18.57 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 174.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -157.51 136.46 11.62 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.93 117.94 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.116 0.484 . . . . 0.0 110.759 -175.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -95.74 168.98 10.33 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.815 175.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 27.4 t 62.65 44.6 6.6 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.347 0.594 . . . . 0.0 109.881 -177.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . -83.09 69.43 3.38 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.036 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 12.2 t . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.75 -0.643 . . . . 0.0 109.643 179.346 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 69.4 -60.54 0.46 Allowed 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.822 0.701 . . . . 0.0 110.922 -176.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . -91.03 -71.23 1.21 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.943 176.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.22 133.2 43.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.981 0.42 . . . . 0.0 111.723 -177.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 67.0 mtp -144.18 -170.57 3.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.874 173.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 6' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' D' ' 70' ' ' SER . . . -50.18 137.63 17.56 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 123.692 0.62 . . . . 0.0 112.086 -176.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 38.6 mtt -111.88 146.36 37.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.921 -176.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 8' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' D' ' 46' ' ' ALA . 61.5 t80 -64.56 146.33 54.79 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.586 -171.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 9' ' ' TRP . . . . . 0.461 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 90.6 t90 -137.98 147.01 43.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.024 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.79 155.23 26.27 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.864 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.561 HD23 HD13 ' C' ' 87' ' ' LEU . 48.5 tp -143.93 108.71 4.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.805 0.336 . . . . 0.0 110.902 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -91.16 100.77 13.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.997 0.427 . . . . 0.0 109.992 173.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 13' ' ' MET . . . . . 0.515 ' SD ' HD11 ' C' ' 87' ' ' LEU . 57.3 mtp -90.65 137.96 31.95 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.216 -177.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 14' ' ' LYS . . . . . 0.513 ' HB2' ' HD2' ' C' ' 17' ' ' ARG . 32.6 mmtp -101.2 150.97 37.58 Favored Pre-proline 0 C--N 1.317 -0.81 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.898 -175.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 15' ' ' PRO . . . . . 0.438 ' HD3' ' OG ' ' C' ' 84' ' ' SER . 84.3 Cg_exo -43.15 112.33 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 124.146 3.231 . . . . 0.0 114.847 -172.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 16' ' ' GLU . . . . . 0.69 ' HA ' ' O ' ' C' ' 79' ' ' THR . 5.7 tt0 60.81 63.51 1.29 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.513 170.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 17' ' ' ARG . . . . . 0.513 ' HD2' ' HB2' ' C' ' 14' ' ' LYS . 37.8 mtt85 -136.28 155.53 49.96 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.613 178.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 18' ' ' LYS . . . . . 0.694 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 3.3 ttmp? -125.67 115.46 20.14 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.703 -175.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -112.73 119.42 38.01 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.893 176.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 10.0 p -79.53 133.46 36.47 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 172.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -108.68 116.03 31.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.089 0.471 . . . . 0.0 112.075 -167.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 28.3 m -93.19 123.2 36.3 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 169.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 52.8 mt -93.3 113.8 28.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.135 0.493 . . . . 0.0 111.448 -172.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 24' ' ' ILE . . . . . 0.425 ' N ' HD12 ' C' ' 24' ' ' ILE . 4.5 mp -85.62 -48.36 16.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.585 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 25' ' ' LYS . . . . . 0.451 ' HD2' HD13 ' C' ' 91' ' ' LEU . 47.1 mttt -119.39 132.4 55.83 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.242 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 12.4 p -59.54 123.13 15.87 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 177.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 27' ' ' PHE . . . . . 0.545 ' HB3' HD23 ' C' ' 91' ' ' LEU . 3.2 p90 -136.6 161.79 34.91 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -170.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 28' ' ' HIS . . . . . 0.572 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 21.9 t60 -115.83 128.06 55.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.26 -1.337 . . . . 0.0 109.879 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 29' ' ' ILE . . . . . 0.578 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 44.3 mt -98.69 131.71 45.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 170.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.572 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 39.7 p -116.06 -15.19 11.16 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.813 -171.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.04 155.04 26.22 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 119.355 -1.403 . . . . 0.0 113.533 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.438 HG23 ' HG ' ' C' ' 87' ' ' LEU . 9.5 p -137.36 124.36 29.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 171.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' C' ' 62' ' ' GLN . . . -125.78 150.17 47.99 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -170.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.868 ' HB2' HG22 ' C' ' 56' ' ' VAL . 1.8 tm? -104.68 109.58 21.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.63 -174.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.55 -59.45 1.95 Allowed 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.925 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -104.03 129.25 51.65 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.689 175.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 37' ' ' GLY . . . . . 0.593 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 134.87 177.7 15.14 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 119.339 -1.41 . . . . 0.0 113.451 174.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 38' ' ' GLN . . . . . 0.422 ' HA ' ' HD2' ' C' ' 58' ' ' LYS . 74.5 mt-30 -103.43 -47.84 4.16 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.69 0.281 . . . . 0.0 111.303 176.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -151.12 133.22 15.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.441 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.401 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -128.89 114.83 16.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.336 0.589 . . . . 0.0 110.404 170.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -100.07 111.25 23.55 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 48.6 tp -84.2 115.88 22.65 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.004 -173.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 43' ' ' TYR . . . . . 0.435 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 98.2 m-85 -117.51 145.38 44.26 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 176.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.492 ' HA ' ' O ' ' C' ' 76' ' ' MET . 0.2 OUTLIER -133.14 134.1 43.74 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 171.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 45' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -108.56 115.5 30.21 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.418 178.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.616 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -128.68 143.99 51.06 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 58.44 27.31 15.3 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -170.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 59.7 mttp 59.53 33.17 22.07 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.957 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 49' ' ' GLN . . . . . 0.545 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 8.7 tp-100 -120.2 124.39 45.59 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -83.05 117.75 23.05 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.917 0.389 . . . . 0.0 110.97 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -112.53 136.27 52.25 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.692 176.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 52' ' ' ILE . . . . . 0.419 HG22 ' OG ' ' B' ' 86' ' ' SER . 6.1 tp -78.4 109.92 13.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 168.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 53' ' ' VAL . . . . . 0.509 HG13 ' CD2' ' B' ' 88' ' ' LEU . 2.7 t -83.04 -50.21 15.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.377 -173.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 54' ' ' ALA . . . . . 0.421 ' HB1' HG11 ' C' ' 63' ' ' VAL . . . -155.49 144.09 20.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.187 -178.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 23.7 m -108.3 102.54 11.66 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 172.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 56' ' ' VAL . . . . . 0.868 HG22 ' HB2' ' C' ' 34' ' ' LEU . 13.3 p -121.02 113.02 38.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 122.225 1.012 . . . . 0.0 110.753 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 68.3 p -123.32 -177.95 3.85 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.969 -174.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 58' ' ' LYS . . . . . 0.422 ' HD2' ' HA ' ' C' ' 38' ' ' GLN . 29.8 mtpp -59.61 -31.62 69.66 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.106 0.479 . . . . 0.0 110.249 169.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.0 -40.38 62.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.598 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 84.0 mt -112.48 84.55 6.36 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 173.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.28 0.73 6.3 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.07 2.513 . . . . 0.0 114.367 -166.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 62' ' ' GLN . . . . . 0.44 ' HA ' ' HA ' ' C' ' 33' ' ' ALA . 18.8 pt20 -169.8 130.5 1.02 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.169 0.509 . . . . 0.0 111.133 -177.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.421 HG11 ' HB1' ' C' ' 54' ' ' ALA . 95.6 t -118.74 116.61 51.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.283 175.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.51 122.35 39.31 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.01 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 65' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' C' ' 30' ' ' SER . 0.3 OUTLIER -138.7 168.58 19.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.495 -176.576 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 66' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 7.6 t0 -116.1 99.51 7.29 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.232 0.539 . . . . 0.0 110.231 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.675 HD21 HD23 ' B' ' 88' ' ' LEU . 21.1 mt -113.43 137.26 51.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.916 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 68' ' ' ASN . . . . . 0.66 ' HB2' ' CD2' ' B' ' 90' ' ' TYR . 3.8 m-20 -137.91 118.1 13.56 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 176.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -117.36 151.44 37.01 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.257 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 70' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' B' ' 6' ' ' ALA . 14.8 t -113.06 153.07 28.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.085 -177.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -69.65 -12.24 61.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.322 -176.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.07 -12.17 68.59 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.818 -0.705 . . . . 0.0 111.911 175.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -100.68 164.33 11.92 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -143.49 127.93 17.9 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.616 HG22 ' HB2' ' C' ' 46' ' ' ALA . 10.8 pt -131.49 179.64 4.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.995 -170.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.492 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 12.0 mtm -136.08 135.62 39.49 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 171.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 77' ' ' PHE . . . . . 0.455 ' CD1' ' HB2' ' C' ' 44' ' ' LEU . 1.1 m-85 -112.56 128.2 56.29 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 78' ' ' TYR . . . . . 0.694 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 34.3 p90 -153.6 137.24 16.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.314 0.578 . . . . 0.0 112.031 -177.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 79' ' ' THR . . . . . 0.69 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 5.9 p -109.21 138.1 46.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.103 -177.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.73 162.36 13.85 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.223 176.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.82 -174.79 44.72 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -175.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -115.48 102.8 10.14 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.078 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 83' ' ' ALA . . . . . 0.593 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -175.42 162.7 2.9 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.571 171.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 84' ' ' SER . . . . . 0.438 ' OG ' ' HD3' ' C' ' 15' ' ' PRO . 1.0 OUTLIER -115.95 125.86 53.11 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.654 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.408 HG11 ' CG1' ' C' ' 56' ' ' VAL . 2.8 m -116.76 148.91 19.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.213 0.53 . . . . 0.0 112.358 -174.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 42.8 m -108.54 113.59 26.73 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.645 173.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 87' ' ' LEU . . . . . 0.561 HD13 HD23 ' C' ' 11' ' ' LEU . 5.3 mp -89.68 148.59 23.21 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 170.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 88' ' ' LEU . . . . . 0.707 HD23 HD21 ' D' ' 67' ' ' LEU . 0.9 OUTLIER -132.01 138.94 48.43 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.098 -178.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.71 -167.06 24.67 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.847 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 90' ' ' TYR . . . . . 0.674 ' CD2' ' HB2' ' D' ' 68' ' ' ASN . 12.8 p90 -150.74 128.77 11.81 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.91 0.862 . . . . 0.0 111.769 177.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 91' ' ' LEU . . . . . 0.545 HD23 ' HB3' ' C' ' 27' ' ' PHE . 8.3 mt -69.72 135.04 49.32 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.964 -1.471 . . . . 0.0 109.6 176.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -87.05 107.8 18.59 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -157.55 136.45 11.57 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -176.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.95 117.77 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.113 0.483 . . . . 0.0 110.762 -175.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -95.68 168.92 10.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.82 175.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 29.0 t 62.61 44.69 6.61 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.382 0.61 . . . . 0.0 109.887 -177.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -83.09 69.26 3.41 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.045 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 12.5 t . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.628 -0.701 . . . . 0.0 109.569 179.477 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 69.43 -60.51 0.46 Allowed 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.79 0.681 . . . . 0.0 110.879 -176.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . -91.15 -71.05 1.21 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.922 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.28 133.08 44.09 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.993 0.425 . . . . 0.0 111.674 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 67.1 mtp -144.11 -170.6 3.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.836 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 6' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' E' ' 70' ' ' SER . . . -50.2 137.67 17.55 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 123.677 0.611 . . . . 0.0 112.037 -176.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 38.6 mtt -111.89 146.46 37.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.986 -176.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 8' ' ' PHE . . . . . 0.439 ' CE1' HD21 ' E' ' 44' ' ' LEU . 61.1 t80 -64.59 146.44 54.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.481 -171.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 9' ' ' TRP . . . . . 0.465 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 90.5 t90 -138.09 147.06 43.65 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.034 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.85 155.17 26.24 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.792 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.582 HD23 HD13 ' D' ' 87' ' ' LEU . 48.4 tp -143.87 108.75 4.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.766 0.317 . . . . 0.0 110.973 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -91.23 100.75 13.51 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.002 0.429 . . . . 0.0 110.021 173.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 13' ' ' MET . . . . . 0.519 ' SD ' HD11 ' D' ' 87' ' ' LEU . 57.3 mtp -90.56 137.93 31.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.196 -177.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 14' ' ' LYS . . . . . 0.519 ' HB2' ' HD2' ' D' ' 17' ' ' ARG . 32.6 mmtp -101.22 150.99 37.6 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.909 -175.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 15' ' ' PRO . . . . . 0.436 ' HD3' ' OG ' ' D' ' 84' ' ' SER . 81.9 Cg_exo -43.3 112.34 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 124.133 3.222 . . . . 0.0 114.796 -172.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 16' ' ' GLU . . . . . 0.694 ' HA ' ' O ' ' D' ' 79' ' ' THR . 5.7 tt0 60.92 63.38 1.29 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.572 170.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 17' ' ' ARG . . . . . 0.519 ' HD2' ' HB2' ' D' ' 14' ' ' LYS . 37.7 mtt85 -136.22 155.45 50.1 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.613 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 18' ' ' LYS . . . . . 0.685 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 3.3 ttmp? -125.55 115.46 20.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.755 -175.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -112.75 119.36 37.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.878 176.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 10.0 p -79.55 133.42 36.46 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 172.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -108.7 116.0 31.16 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.089 0.471 . . . . 0.0 112.1 -167.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 28.4 m -93.08 123.17 36.15 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 169.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 52.5 mt -93.29 113.73 28.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.214 0.531 . . . . 0.0 111.542 -172.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 24' ' ' ILE . . . . . 0.436 HD12 ' N ' ' D' ' 24' ' ' ILE . 4.5 mp -85.64 -48.35 16.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.58 178.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 25' ' ' LYS . . . . . 0.443 ' HD2' HD13 ' D' ' 91' ' ' LEU . 47.1 mttt -119.35 132.45 55.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.283 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 12.5 p -59.54 123.14 15.91 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 27' ' ' PHE . . . . . 0.551 ' HB3' HD23 ' D' ' 91' ' ' LEU . 3.2 p90 -136.59 161.74 35.07 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -170.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 28' ' ' HIS . . . . . 0.561 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 22.1 t60 -115.78 128.07 55.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.899 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 29' ' ' ILE . . . . . 0.59 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 44.0 mt -98.67 131.6 45.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 170.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 30' ' ' SER . . . . . 0.561 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 41.3 p -115.96 -15.24 11.22 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -171.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.06 155.06 26.24 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 119.41 -1.376 . . . . 0.0 113.53 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.424 HG23 ' HG ' ' D' ' 87' ' ' LEU . 9.6 p -137.38 124.37 29.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 171.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 33' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' D' ' 62' ' ' GLN . . . -125.81 150.0 48.17 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -170.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 34' ' ' LEU . . . . . 0.851 ' HB2' HG22 ' D' ' 56' ' ' VAL . 1.8 tm? -104.58 109.53 21.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.65 -174.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.49 -59.51 1.94 Allowed 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.851 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -104.0 129.41 51.6 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 175.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 37' ' ' GLY . . . . . 0.595 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 134.73 177.58 15.05 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 119.306 -1.426 . . . . 0.0 113.489 174.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 38' ' ' GLN . . . . . 0.412 ' HA ' ' HD2' ' D' ' 58' ' ' LYS . 74.3 mt-30 -103.33 -47.79 4.19 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.691 0.282 . . . . 0.0 111.361 176.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -151.22 133.25 15.16 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.326 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.86 114.84 17.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.334 0.588 . . . . 0.0 110.447 170.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -100.15 111.16 23.44 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 48.5 tp -84.03 115.85 22.55 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.085 -173.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 43' ' ' TYR . . . . . 0.437 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 98.2 m-85 -117.52 145.38 44.26 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.49 ' HA ' ' O ' ' D' ' 76' ' ' MET . 0.2 OUTLIER -133.15 134.21 43.87 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 171.914 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 45' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -108.65 115.65 30.5 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.298 178.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.631 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -128.82 144.03 51.06 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 175.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 58.4 27.36 15.31 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -170.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 59.8 mttp 59.35 33.24 22.37 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.968 -175.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 49' ' ' GLN . . . . . 0.544 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 8.7 tp-100 -120.22 124.49 45.81 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -82.88 117.64 22.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.768 0.318 . . . . 0.0 111.011 -176.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -112.48 136.29 52.16 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.713 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 6.2 tp -78.43 109.83 13.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 168.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 53' ' ' VAL . . . . . 0.496 HG13 ' CD2' ' C' ' 88' ' ' LEU . 2.7 t -82.99 -50.22 15.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.311 -173.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 54' ' ' ALA . . . . . 0.437 ' HB1' HG11 ' D' ' 63' ' ' VAL . . . -155.47 144.1 20.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.175 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 23.7 m -108.26 102.54 11.65 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 172.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 56' ' ' VAL . . . . . 0.851 HG22 ' HB2' ' D' ' 34' ' ' LEU . 13.2 p -121.06 112.93 37.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 122.15 0.976 . . . . 0.0 110.743 -175.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 69.4 p -123.29 -177.87 3.82 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.937 -174.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 58' ' ' LYS . . . . . 0.412 ' HD2' ' HA ' ' D' ' 38' ' ' GLN . 29.8 mtpp -59.74 -31.53 69.72 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.184 169.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.09 -40.33 62.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.582 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 83.5 mt -112.43 84.56 6.3 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 173.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.18 0.73 6.24 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.017 2.478 . . . . 0.0 114.465 -166.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 62' ' ' GLN . . . . . 0.437 ' HA ' ' HA ' ' D' ' 33' ' ' ALA . 18.9 pt20 -169.82 130.46 1.02 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.197 0.522 . . . . 0.0 111.088 -177.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.437 HG11 ' HB1' ' D' ' 54' ' ' ALA . 95.0 t -118.82 116.71 51.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.237 175.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.51 122.4 39.37 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.039 176.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 65' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' D' ' 30' ' ' SER . 0.3 OUTLIER -138.76 168.58 19.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.465 -176.574 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 66' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 7.7 t0 -116.12 99.47 7.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.275 0.56 . . . . 0.0 110.26 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.707 HD21 HD23 ' C' ' 88' ' ' LEU . 21.0 mt -113.32 137.31 51.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.01 178.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 68' ' ' ASN . . . . . 0.674 ' HB2' ' CD2' ' C' ' 90' ' ' TYR . 3.8 m-20 -137.95 118.21 13.63 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 176.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -117.48 151.36 37.26 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.236 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 70' ' ' SER . . . . . 0.507 ' HB2' ' O ' ' C' ' 6' ' ' ALA . 14.7 t -112.97 153.06 28.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.094 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -69.72 -12.12 61.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.377 -176.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.14 -12.14 68.46 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.832 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -100.8 164.28 11.92 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -143.48 127.92 17.91 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.021 0.438 . . . . 0.0 109.928 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.631 HG22 ' HB2' ' D' ' 46' ' ' ALA . 10.9 pt -131.55 179.63 4.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.013 -170.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 76' ' ' MET . . . . . 0.49 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 12.0 mtm -136.08 135.58 39.45 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 171.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 77' ' ' PHE . . . . . 0.453 ' CD1' ' HB2' ' D' ' 44' ' ' LEU . 1.1 m-85 -112.61 128.26 56.32 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 78' ' ' TYR . . . . . 0.685 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 34.4 p90 -153.63 137.11 15.88 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.336 0.589 . . . . 0.0 112.064 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 79' ' ' THR . . . . . 0.694 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 5.9 p -109.09 138.22 45.79 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.07 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.83 162.47 13.77 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.14 176.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.82 -174.87 44.8 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 -175.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -115.41 102.8 10.16 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.037 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 83' ' ' ALA . . . . . 0.595 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -175.4 162.71 2.92 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.563 171.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 84' ' ' SER . . . . . 0.436 ' OG ' ' HD3' ' D' ' 15' ' ' PRO . 1.1 m -115.98 126.08 53.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.614 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.413 HG11 ' CG1' ' D' ' 56' ' ' VAL . 2.7 m -116.84 148.76 19.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.119 0.485 . . . . 0.0 112.306 -174.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 42.4 m -108.41 113.68 26.92 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.63 173.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 87' ' ' LEU . . . . . 0.582 HD13 HD23 ' D' ' 11' ' ' LEU . 5.2 mp -89.76 148.63 23.13 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 170.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.685 HD23 HD21 ' E' ' 67' ' ' LEU . 0.9 OUTLIER -132.1 138.99 48.32 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.002 -178.839 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.73 -167.15 24.84 Favored Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.897 -177.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 90' ' ' TYR . . . . . 0.656 ' CD2' ' HB2' ' E' ' 68' ' ' ASN . 13.0 p90 -150.66 128.86 11.95 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.873 0.844 . . . . 0.0 111.797 177.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 91' ' ' LEU . . . . . 0.551 HD23 ' HB3' ' D' ' 27' ' ' PHE . 8.1 mt -69.78 135.03 49.23 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.669 176.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -87.0 107.74 18.54 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -157.5 136.42 11.61 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -176.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.96 117.93 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.214 0.531 . . . . 0.0 110.74 -175.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -95.78 168.93 10.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.749 175.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 27.8 t 62.64 44.56 6.66 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.32 0.581 . . . . 0.0 109.942 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . -83.05 69.27 3.41 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.037 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 12.3 t . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.626 -0.702 . . . . 0.0 109.608 179.336 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 69.4 -60.51 0.46 Allowed 'General case' 0 N--CA 1.469 0.489 0 O-C-N 123.934 0.771 . . . . 0.0 110.933 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . -91.02 -71.26 1.21 Allowed Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.929 176.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.09 133.12 43.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.939 0.399 . . . . 0.0 111.675 -177.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 67.2 mtp -144.19 -170.57 3.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.887 173.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 6' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 70' ' ' SER . . . -50.12 137.59 17.36 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 123.626 0.579 . . . . 0.0 112.069 -176.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 38.7 mtt -111.84 146.44 37.69 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.003 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 8' ' ' PHE . . . . . 0.428 ' CE1' HD21 ' A' ' 44' ' ' LEU . 61.0 t80 -64.68 146.44 54.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.525 -171.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 9' ' ' TRP . . . . . 0.455 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 90.4 t90 -137.99 146.98 43.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.056 178.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.76 155.21 26.27 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.875 177.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 11' ' ' LEU . . . . . 0.578 HD23 HD13 ' E' ' 87' ' ' LEU . 47.9 tp -143.93 108.78 4.93 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.803 0.335 . . . . 0.0 111.014 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -91.17 100.72 13.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.98 0.419 . . . . 0.0 110.066 173.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 13' ' ' MET . . . . . 0.515 ' SD ' HD11 ' E' ' 87' ' ' LEU . 57.3 mtp -90.56 137.97 31.93 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.141 -177.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 14' ' ' LYS . . . . . 0.521 ' HB2' ' HD2' ' E' ' 17' ' ' ARG . 32.6 mmtp -101.28 150.94 37.59 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.884 -175.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 15' ' ' PRO . . . . . 0.431 ' HD3' ' OG ' ' E' ' 84' ' ' SER . 84.4 Cg_exo -43.1 112.18 0.27 Allowed 'Trans proline' 0 N--CA 1.474 0.368 0 C-N-CA 124.157 3.238 . . . . 0.0 114.869 -172.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 16' ' ' GLU . . . . . 0.693 ' HA ' ' O ' ' E' ' 79' ' ' THR . 5.7 tt0 61.06 63.24 1.28 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.579 170.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 17' ' ' ARG . . . . . 0.521 ' HD2' ' HB2' ' E' ' 14' ' ' LYS . 38.0 mtt85 -136.19 155.47 50.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.611 178.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 18' ' ' LYS . . . . . 0.687 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 3.3 ttmp? -125.51 115.38 20.12 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.777 -175.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -112.58 119.4 38.0 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 176.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 10.1 p -79.58 133.29 36.44 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -108.57 116.04 31.22 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.076 0.465 . . . . 0.0 112.098 -167.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 28.4 m -93.05 123.14 36.1 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 169.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 52.7 mt -93.27 113.8 28.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.242 0.544 . . . . 0.0 111.513 -172.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 24' ' ' ILE . . . . . 0.435 HD12 ' N ' ' E' ' 24' ' ' ILE . 4.5 mp -85.64 -48.37 16.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.502 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 25' ' ' LYS . . . . . 0.449 ' HD2' HD13 ' E' ' 91' ' ' LEU . 47.2 mttt -119.32 132.45 55.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.214 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 12.6 p -59.5 123.15 15.9 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 27' ' ' PHE . . . . . 0.533 ' HB3' HD23 ' E' ' 91' ' ' LEU . 3.3 p90 -136.55 161.73 35.06 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -170.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 28' ' ' HIS . . . . . 0.571 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 22.0 t60 -115.78 128.16 55.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.894 178.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 29' ' ' ILE . . . . . 0.578 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 44.3 mt -98.8 131.72 45.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 170.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 30' ' ' SER . . . . . 0.571 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 41.0 p -116.08 -15.09 11.16 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.858 -171.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.11 155.05 26.24 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 119.307 -1.425 . . . . 0.0 113.494 178.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.438 HG23 ' HG ' ' E' ' 87' ' ' LEU . 9.6 p -137.29 124.27 29.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 171.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 33' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' E' ' 62' ' ' GLN . . . -125.76 150.11 48.01 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -170.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 34' ' ' LEU . . . . . 0.872 ' HB2' HG22 ' E' ' 56' ' ' VAL . 1.8 tm? -104.61 109.58 21.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.628 -174.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.58 -59.45 1.95 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.87 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -104.02 129.41 51.64 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.68 175.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 37' ' ' GLY . . . . . 0.594 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 134.7 177.61 15.07 Favored Glycine 0 N--CA 1.437 -1.244 0 C-N-CA 119.325 -1.417 . . . . 0.0 113.506 174.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 38' ' ' GLN . . . . . 0.421 ' HA ' ' HD2' ' E' ' 58' ' ' LYS . 74.4 mt-30 -103.33 -47.89 4.17 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.669 0.271 . . . . 0.0 111.306 176.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -151.16 133.23 15.2 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.404 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 40' ' ' ALA . . . . . 0.402 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -128.89 114.89 17.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.394 0.616 . . . . 0.0 110.413 170.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 41' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -100.16 111.14 23.42 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 48.5 tp -84.08 115.75 22.53 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.061 -173.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 43' ' ' TYR . . . . . 0.427 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 98.2 m-85 -117.46 145.38 44.2 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 44' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' E' ' 76' ' ' MET . 0.2 OUTLIER -133.13 134.18 43.86 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 171.879 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 45' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -108.57 115.51 30.23 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.344 178.041 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 46' ' ' ALA . . . . . 0.615 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -128.74 143.95 51.05 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 58.57 27.22 15.39 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -170.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 59.7 mttp 59.49 33.17 22.13 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.937 -175.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 49' ' ' GLN . . . . . 0.543 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 8.7 tp-100 -120.24 124.5 45.82 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -83.07 117.68 23.02 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.826 0.346 . . . . 0.0 110.92 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -112.48 136.36 52.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.663 176.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 6.2 tp -78.5 109.88 13.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 168.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 53' ' ' VAL . . . . . 0.503 HG13 ' CD2' ' D' ' 88' ' ' LEU . 2.7 t -83.02 -50.24 15.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.319 -173.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 54' ' ' ALA . . . . . 0.425 ' HB1' HG11 ' E' ' 63' ' ' VAL . . . -155.39 144.19 20.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.205 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 23.6 m -108.37 102.51 11.61 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 172.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 56' ' ' VAL . . . . . 0.872 HG22 ' HB2' ' E' ' 34' ' ' LEU . 13.2 p -121.0 112.98 38.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 122.143 0.973 . . . . 0.0 110.761 -175.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 70.6 p -123.25 -177.87 3.82 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.982 -174.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 58' ' ' LYS . . . . . 0.421 ' HD2' ' HA ' ' E' ' 38' ' ' GLN . 29.8 mtpp -59.81 -31.51 69.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.03 0.443 . . . . 0.0 110.228 169.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.99 -40.47 62.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.566 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 83.9 mt -112.46 84.58 6.36 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 173.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.25 0.71 6.31 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.043 2.495 . . . . 0.0 114.393 -166.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 62' ' ' GLN . . . . . 0.435 ' HA ' ' HA ' ' E' ' 33' ' ' ALA . 18.9 pt20 -169.68 130.56 1.05 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.106 0.479 . . . . 0.0 111.085 -177.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 63' ' ' VAL . . . . . 0.425 HG11 ' HB1' ' E' ' 54' ' ' ALA . 95.8 t -118.84 116.64 51.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.328 175.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.45 122.31 39.21 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.049 176.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' E' ' 30' ' ' SER . 0.3 OUTLIER -138.72 168.55 19.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.436 -176.543 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 66' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 7.6 t0 -116.05 99.54 7.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.207 0.527 . . . . 0.0 110.201 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 67' ' ' LEU . . . . . 0.685 HD21 HD23 ' D' ' 88' ' ' LEU . 21.0 mt -113.45 137.36 51.65 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.918 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 68' ' ' ASN . . . . . 0.656 ' HB2' ' CD2' ' D' ' 90' ' ' TYR . 3.8 m-20 -137.98 118.16 13.56 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 176.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -117.38 151.42 37.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.36 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 70' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' D' ' 6' ' ' ALA . 15.1 t -113.06 152.97 28.89 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -177.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -69.69 -12.19 61.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.305 -176.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.06 -12.15 68.63 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.903 175.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -100.67 164.3 11.94 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -143.51 127.91 17.87 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 75' ' ' ILE . . . . . 0.615 HG22 ' HB2' ' E' ' 46' ' ' ALA . 10.9 pt -131.52 179.66 4.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.004 -170.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 76' ' ' MET . . . . . 0.483 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 11.9 mtm -136.09 135.51 39.39 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 171.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 77' ' ' PHE . . . . . 0.458 ' CD1' ' HB2' ' E' ' 44' ' ' LEU . 1.1 m-85 -112.55 128.25 56.3 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 78' ' ' TYR . . . . . 0.687 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 34.5 p90 -153.57 137.2 16.01 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.295 0.569 . . . . 0.0 112.133 -177.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 79' ' ' THR . . . . . 0.693 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 5.8 p -109.25 138.23 45.92 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.028 -177.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.77 162.42 13.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.16 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.8 -174.73 44.71 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.511 -1.035 . . . . 0.0 110.511 -175.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -115.51 102.8 10.13 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.119 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 83' ' ' ALA . . . . . 0.594 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -175.47 162.63 2.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.574 171.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 84' ' ' SER . . . . . 0.431 ' OG ' ' HD3' ' E' ' 15' ' ' PRO . 1.0 OUTLIER -115.89 125.94 53.28 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.666 179.727 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 85' ' ' VAL . . . . . 0.412 HG11 ' CG1' ' E' ' 56' ' ' VAL . 2.8 m -116.73 148.79 19.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -174.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 43.6 m -108.53 113.7 26.94 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.573 173.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 87' ' ' LEU . . . . . 0.578 HD13 HD23 ' E' ' 11' ' ' LEU . 5.2 mp -89.76 148.61 23.14 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 170.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 88' ' ' LEU . . . . . 0.682 HD23 HD21 ' A' ' 67' ' ' LEU . 0.9 OUTLIER -132.0 138.92 48.45 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.06 -178.875 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.64 -167.0 24.51 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.932 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 90' ' ' TYR . . . . . 0.66 ' CD2' ' HB2' ' A' ' 68' ' ' ASN . 13.2 p90 -150.75 128.82 11.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.851 0.834 . . . . 0.0 111.816 177.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 91' ' ' LEU . . . . . 0.533 HD23 ' HB3' ' E' ' 27' ' ' PHE . 8.3 mt -69.77 134.98 49.18 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.634 176.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -86.98 107.76 18.54 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -157.56 136.38 11.51 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -176.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.87 117.94 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.19 0.519 . . . . 0.0 110.76 -175.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -95.84 168.84 10.4 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.772 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 28.6 t 62.76 44.64 6.33 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.43 0.634 . . . . 0.0 109.891 -177.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . -83.06 69.2 3.42 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.077 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 12.4 t . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.703 -0.665 . . . . 0.0 109.485 179.554 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.528 ' O ' ' HB3' ' B' ' 25' ' ' LYS . 53.4 p90 . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -99.73 146.29 26.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 176.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -125.19 113.4 1.92 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.782 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -102.12 58.01 0.81 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.214 0.53 . . . . 0.0 110.241 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.408 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 24.8 mmt -101.97 -160.49 0.79 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.272 -176.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.408 ' H ' ' HB3' ' A' ' 5' ' ' MET . . . -50.75 148.37 4.08 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.139 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.441 ' HB2' HD12 ' A' ' 91' ' ' LEU . 47.5 mtt -108.53 165.61 11.4 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.309 -175.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.456 ' CE1' HD21 ' B' ' 44' ' ' LEU . 56.3 t80 -76.19 151.97 36.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.1 0.476 . . . . 0.0 112.194 -176.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.485 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 89.5 t90 -143.76 147.37 34.08 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.639 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.439 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -151.42 156.47 26.69 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.236 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.564 HD23 HD13 ' A' ' 87' ' ' LEU . 61.2 tp -149.01 109.66 4.25 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.854 0.359 . . . . 0.0 111.394 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -86.03 121.17 28.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.423 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.678 ' SD ' ' HE2' ' A' ' 19' ' ' TYR . 72.4 mmm -101.74 137.37 40.13 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.905 0.383 . . . . 0.0 111.056 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.495 ' HE3' ' HA ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -101.27 146.43 32.17 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.835 175.714 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -49.9 113.39 0.97 Allowed 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 123.174 2.583 . . . . 0.0 113.047 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 61.04 52.06 4.22 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.906 176.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -125.54 138.4 53.96 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.785 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.677 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 51.8 mttp -109.66 126.87 54.12 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.816 0.341 . . . . 0.0 111.767 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.678 ' HE2' ' SD ' ' A' ' 13' ' ' MET . 2.4 m-85 -111.64 103.79 12.12 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 173.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.2 p -86.06 100.58 12.26 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 173.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -114.92 148.78 38.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.379 0.609 . . . . 0.0 112.241 -168.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.9 m -107.97 141.95 38.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.132 173.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 69.0 mt -102.2 138.38 26.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.149 0.5 . . . . 0.0 111.74 -173.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.434 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.1 mp -110.62 -43.4 5.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.196 176.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.509 ' HD2' HD13 ' A' ' 91' ' ' LEU . 15.1 pttm -113.94 120.6 41.24 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.078 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.5 p -58.25 132.15 52.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.66 -178.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.59 ' HB3' HD23 ' A' ' 91' ' ' LEU . 54.5 p90 -139.2 157.6 45.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.577 0.703 . . . . 0.0 112.362 -176.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.626 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 7.1 t60 -114.69 124.76 52.63 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.458 177.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 42.7 mt -89.95 134.93 27.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 171.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.626 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 28.3 p -122.14 -12.32 8.32 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -171.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.12 155.81 27.31 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 119.617 -1.278 . . . . 0.0 113.195 177.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.438 ' CG2' ' HG ' ' A' ' 87' ' ' LEU . 12.3 p -143.3 125.53 12.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 172.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.436 ' HA ' HG21 ' A' ' 56' ' ' VAL . . . -144.22 161.01 39.99 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 122.036 -0.415 . . . . 0.0 111.66 -174.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.641 ' HB3' HG12 ' A' ' 85' ' ' VAL . 3.3 pp -123.44 142.32 51.11 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.828 0.823 . . . . 0.0 111.574 177.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -104.11 -52.6 2.9 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.444 173.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -104.22 128.6 51.96 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.308 -0.626 . . . . 0.0 109.308 169.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.417 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 151.95 156.07 7.3 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 119.627 -1.273 . . . . 0.0 113.587 175.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.474 ' HA ' ' HB2' ' A' ' 58' ' ' LYS . 94.1 mt-30 -102.73 -44.25 5.35 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.699 0.285 . . . . 0.0 111.306 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.52 ' HG3' HG22 ' A' ' 57' ' ' THR . 34.8 tt0 -152.71 122.17 6.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.954 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.559 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -123.67 114.24 19.71 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.558 0.694 . . . . 0.0 110.212 170.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.439 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 31.8 mmtp -96.86 105.85 18.05 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 176.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.9 tp -83.29 112.23 19.69 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -175.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.651 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 92.8 m-85 -118.68 147.2 44.05 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 175.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 76' ' ' MET . 0.3 OUTLIER -131.07 131.08 43.99 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 170.651 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -107.51 112.53 25.33 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.267 178.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.641 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -124.55 138.16 54.35 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.461 178.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 58.81 34.15 23.52 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.236 0.541 . . . . 0.0 110.026 -176.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.3 tttm 56.55 46.58 20.23 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.821 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.591 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 8.6 tp-100 -137.84 127.78 25.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.469 176.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -87.18 121.37 29.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.954 0.407 . . . . 0.0 110.372 -176.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.437 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 81.5 m-85 -113.41 130.57 56.27 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.355 175.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.452 HG22 ' HB3' ' E' ' 86' ' ' SER . 4.4 tp -79.57 105.83 9.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.705 0.764 . . . . 0.0 109.048 173.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.541 HG13 HD23 ' E' ' 88' ' ' LEU . 2.5 t -80.46 -49.16 19.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.633 -172.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.514 ' HB2' HD23 ' A' ' 65' ' ' LEU . . . -156.0 148.23 23.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.924 0.393 . . . . 0.0 111.709 -177.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.7 m -110.59 100.75 9.49 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 170.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.49 HG13 ' HB3' ' A' ' 40' ' ' ALA . 7.7 p -118.46 112.66 39.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.62 0.724 . . . . 0.0 109.699 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.52 HG22 ' HG3' ' A' ' 39' ' ' GLU . 63.8 p -122.86 -178.71 4.02 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.173 -172.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.474 ' HB2' ' HA ' ' A' ' 38' ' ' GLN . 56.0 tttt -59.52 -28.99 67.57 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.896 172.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.471 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -83.15 -40.41 19.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.622 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.0 mt -111.07 83.15 3.56 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 13.1 Cg_exo -69.82 0.18 6.06 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.084 2.523 . . . . 0.0 113.879 -168.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -163.2 131.34 3.75 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.335 0.588 . . . . 0.0 111.535 -176.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.403 HG23 ' HB ' ' A' ' 56' ' ' VAL . 96.1 t -118.87 112.66 38.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.382 173.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.95 116.12 27.76 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 174.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.514 HD23 ' HB2' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -137.19 169.6 17.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.055 0.455 . . . . 0.0 111.395 -175.263 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.524 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 9.6 t0 -118.66 119.01 33.18 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.114 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.592 HD21 HD23 ' E' ' 88' ' ' LEU . 8.0 mt -134.16 145.2 49.03 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 175.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -145.35 122.96 11.78 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 173.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -120.94 150.86 40.44 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.041 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' E' ' 6' ' ' ALA . 14.5 t -108.97 177.55 4.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.633 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.04 -19.27 65.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.192 0.52 . . . . 0.0 110.583 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.41 -9.81 81.03 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.272 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -92.72 120.02 32.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.132 0.491 . . . . 0.0 110.568 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -108.13 111.67 23.81 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 176.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.641 HG22 ' HB2' ' A' ' 46' ' ' ALA . 7.6 pt -128.71 156.08 40.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 120.949 0.404 . . . . 0.0 111.853 -168.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.511 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 4.5 mtm -115.61 119.39 35.97 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 173.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.475 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 1.1 m-85 -99.92 128.4 46.01 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.677 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 31.3 p90 -152.42 140.18 19.94 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.413 0.625 . . . . 0.0 112.194 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 2.3 p -113.16 125.77 54.71 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.854 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.439 ' HB3' ' HB2' ' A' ' 41' ' ' LYS . . . -96.53 164.82 12.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.607 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.16 -165.24 31.44 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -121.98 102.98 8.5 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.059 175.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.559 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -173.01 153.04 2.46 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.47 173.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.5 t -112.16 111.71 22.8 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.641 HG12 ' HB3' ' A' ' 34' ' ' LEU . 4.6 m -109.8 165.53 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.655 0 CA-C-O 121.408 0.623 . . . . 0.0 111.91 -174.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.48 ' HB3' HG22 ' B' ' 52' ' ' ILE . 23.8 t -131.61 123.16 27.31 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.914 176.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.565 HD23 HG21 ' A' ' 29' ' ' ILE . 4.9 mp -91.32 151.94 20.66 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 172.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.59 HD23 HD21 ' B' ' 67' ' ' LEU . 1.4 tp -134.77 142.49 46.73 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.746 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.0 -166.79 26.69 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.695 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -143.5 135.25 26.45 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.214 0.53 . . . . 0.0 110.931 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.59 HD23 ' HB3' ' A' ' 27' ' ' PHE . 64.5 mt -59.29 116.77 4.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.898 172.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.466 ' H ' ' HA ' ' A' ' 27' ' ' PHE . 72.5 t60 -87.53 108.34 19.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.895 -167.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -153.28 155.42 36.52 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.081 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 35.6 pt -122.9 143.1 37.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.959 0.409 . . . . 0.0 111.154 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -117.25 112.09 20.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.902 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.2 p -83.44 110.05 17.85 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.123 0.487 . . . . 0.0 110.785 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -70.25 -30.05 69.79 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.172 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 33.9 m . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.777 -0.63 . . . . 0.0 109.735 178.303 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.535 ' O ' ' HB3' ' C' ' 25' ' ' LYS . 53.4 p90 . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -99.67 146.31 26.63 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 176.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -125.18 113.27 1.89 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.323 -0.942 . . . . 0.0 112.874 -176.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -101.99 58.02 0.82 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.135 0.493 . . . . 0.0 110.293 177.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 24.7 mmt -102.0 -160.38 0.78 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.224 -176.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.87 148.49 4.11 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.075 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' MET . . . . . 0.44 ' HB2' HD12 ' B' ' 91' ' ' LEU . 47.4 mtt -108.56 165.55 11.45 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.327 -175.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.443 ' CE1' HD21 ' C' ' 44' ' ' LEU . 56.4 t80 -76.11 151.96 36.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.042 0.449 . . . . 0.0 112.194 -176.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' TRP . . . . . 0.482 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 89.7 t90 -143.86 147.44 34.05 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.583 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.43 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -151.5 156.44 26.68 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.19 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.553 HD23 HD13 ' B' ' 87' ' ' LEU . 61.3 tp -148.95 109.64 4.25 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 120.878 0.37 . . . . 0.0 111.422 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -85.98 121.12 28.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.461 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' MET . . . . . 0.669 ' SD ' ' HE2' ' B' ' 19' ' ' TYR . 72.5 mmm -101.75 137.33 40.19 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 120.931 0.396 . . . . 0.0 111.089 -178.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.506 ' HE3' ' HA ' ' B' ' 14' ' ' LYS . 0.0 OUTLIER -101.25 146.44 32.17 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.814 175.713 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -49.87 113.4 0.97 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.961 2.441 . . . . 0.0 113.098 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 61.16 52.01 4.14 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.912 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -125.61 138.32 53.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.736 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.692 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 51.8 mttp -109.74 126.86 54.18 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 120.874 0.369 . . . . 0.0 111.72 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' TYR . . . . . 0.669 ' HE2' ' SD ' ' B' ' 13' ' ' MET . 2.4 m-85 -111.64 103.89 12.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.739 173.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 9.2 p -86.11 100.51 12.25 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 173.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -114.82 148.8 38.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.35 0.595 . . . . 0.0 112.224 -168.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 38.3 m -107.96 141.95 38.82 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.192 173.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 69.4 mt -102.25 138.34 26.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.156 0.503 . . . . 0.0 111.743 -173.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.449 ' N ' HD12 ' B' ' 24' ' ' ILE . 4.1 mp -110.56 -43.34 5.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.312 176.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.528 ' HB3' ' O ' ' A' ' 1' ' ' PHE . 15.2 pttm -113.89 120.54 41.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.149 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 14.9 p -58.26 132.09 52.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.715 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' PHE . . . . . 0.596 ' HB3' HD23 ' B' ' 91' ' ' LEU . 54.3 p90 -139.14 157.59 45.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.625 0.726 . . . . 0.0 112.365 -176.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' HIS . . . . . 0.621 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 7.1 t60 -114.7 124.78 52.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.455 177.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.584 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 42.6 mt -89.93 134.97 27.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 171.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.621 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 29.0 p -122.06 -12.3 8.36 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -171.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.12 155.84 27.36 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 119.579 -1.296 . . . . 0.0 113.157 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.442 HG23 ' HG ' ' B' ' 87' ' ' LEU . 12.3 p -143.31 125.39 12.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 172.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' ALA . . . . . 0.423 ' HA ' HG21 ' B' ' 56' ' ' VAL . . . -144.14 161.06 39.81 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.08 -0.388 . . . . 0.0 111.651 -174.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.638 ' HB3' HG12 ' B' ' 85' ' ' VAL . 3.3 pp -123.41 142.27 51.14 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.749 0.785 . . . . 0.0 111.585 177.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -103.99 -52.6 2.92 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.563 -1.199 . . . . 0.0 108.645 173.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -104.2 128.55 51.93 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 169.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.412 ' HA3' ' HB1' ' B' ' 83' ' ' ALA . . . 152.01 156.13 7.33 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 119.605 -1.284 . . . . 0.0 113.571 175.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' GLN . . . . . 0.463 ' HA ' ' HB2' ' B' ' 58' ' ' LYS . 94.0 mt-30 -102.82 -44.25 5.33 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.661 0.267 . . . . 0.0 111.273 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.54 ' HG3' HG22 ' B' ' 57' ' ' THR . 34.9 tt0 -152.73 122.13 6.75 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 121.229 -0.188 . . . . 0.0 110.974 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.569 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -123.62 114.23 19.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.51 0.672 . . . . 0.0 110.223 170.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.447 ' HB2' ' HB3' ' B' ' 80' ' ' ALA . 31.8 mmtp -96.89 105.9 18.12 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 44.6 tp -83.31 112.17 19.66 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -175.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' TYR . . . . . 0.647 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 92.5 m-85 -118.62 147.12 44.08 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 175.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.521 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.3 OUTLIER -131.08 131.07 43.96 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 170.597 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.597 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -107.44 112.5 25.32 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.337 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.629 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -124.48 138.19 54.36 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.449 178.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 58.85 34.07 23.45 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 123.552 0.533 . . . . 0.0 110.012 -176.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 57.3 tttm 56.64 46.63 19.94 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.787 -177.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.597 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 8.6 tp-100 -137.99 127.74 25.29 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -87.13 121.4 29.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.066 0.46 . . . . 0.0 110.364 -176.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.439 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 81.7 m-85 -113.52 130.6 56.31 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.365 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' ILE . . . . . 0.48 HG22 ' HB3' ' A' ' 86' ' ' SER . 4.5 tp -79.59 105.74 9.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.626 0.727 . . . . 0.0 109.07 173.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.555 HG13 HD23 ' A' ' 88' ' ' LEU . 2.5 t -80.4 -49.21 19.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.625 -172.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.513 ' HB2' ' CD2' ' B' ' 65' ' ' LEU . . . -155.98 148.28 23.57 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.012 0.434 . . . . 0.0 111.701 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 68.6 m -110.48 100.72 9.5 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 170.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.481 HG13 ' HB3' ' B' ' 40' ' ' ALA . 7.7 p -118.42 112.72 39.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.718 0.77 . . . . 0.0 109.649 -177.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.54 HG22 ' HG3' ' B' ' 39' ' ' GLU . 60.9 p -122.9 -178.72 4.02 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.234 -172.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 58' ' ' LYS . . . . . 0.463 ' HB2' ' HA ' ' B' ' 38' ' ' GLN . 55.5 tttt -59.36 -29.04 67.4 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.944 171.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.464 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -83.21 -40.35 19.76 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.662 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 79.9 mt -111.13 83.11 3.61 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 13.0 Cg_exo -69.92 0.32 5.94 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.059 2.506 . . . . 0.0 113.789 -168.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -163.2 131.36 3.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.314 0.578 . . . . 0.0 111.554 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 96.3 t -118.91 112.72 39.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.336 173.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.98 116.17 27.83 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 174.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.513 ' CD2' ' HB2' ' B' ' 54' ' ' ALA . 0.3 OUTLIER -137.2 169.5 17.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.449 -175.295 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 66' ' ' ASP . . . . . 0.558 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 9.6 t0 -118.54 118.98 33.17 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.172 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.59 HD21 HD23 ' A' ' 88' ' ' LEU . 8.0 mt -134.19 145.25 49.04 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -145.38 123.0 11.79 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 173.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -120.93 150.86 40.44 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.062 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 14.4 t -108.93 177.43 4.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.774 -0.193 . . . . 0.0 110.637 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.9 -19.35 65.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.178 0.513 . . . . 0.0 110.674 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.31 -9.87 81.11 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.309 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -92.75 120.02 32.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.203 0.525 . . . . 0.0 110.588 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -108.13 111.58 23.67 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 176.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.629 HG22 ' HB2' ' B' ' 46' ' ' ALA . 7.6 pt -128.75 156.07 41.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.913 -168.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.521 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 4.5 mtm -115.44 119.44 36.24 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 173.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 77' ' ' PHE . . . . . 0.475 ' CD1' ' HB2' ' B' ' 44' ' ' LEU . 1.1 m-85 -99.91 128.42 46.01 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.692 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 31.2 p90 -152.49 140.15 19.84 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.415 0.626 . . . . 0.0 112.172 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' B' ' 41' ' ' LYS . 2.3 p -113.08 125.86 54.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.794 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 80' ' ' ALA . . . . . 0.447 ' HB3' ' HB2' ' B' ' 41' ' ' LYS . . . -96.66 164.86 12.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.672 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.15 -165.15 31.4 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -121.96 102.96 8.49 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.073 175.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.569 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -173.09 153.0 2.42 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.44 -1.255 . . . . 0.0 109.431 173.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 38.8 t -112.23 111.71 22.79 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.638 HG12 ' HB3' ' B' ' 34' ' ' LEU . 4.6 m -109.75 165.55 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.665 0 CA-C-O 121.411 0.624 . . . . 0.0 111.889 -174.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 86' ' ' SER . . . . . 0.47 ' HB3' HG22 ' C' ' 52' ' ' ILE . 24.3 t -131.6 123.21 27.42 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.846 176.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.556 HD23 HG21 ' B' ' 29' ' ' ILE . 4.9 mp -91.45 151.91 20.59 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 172.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.605 HD23 HD21 ' C' ' 67' ' ' LEU . 1.4 tp -134.75 142.44 46.75 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.77 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.96 -166.84 26.72 Favored Glycine 0 N--CA 1.438 -1.201 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.71 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -143.55 135.27 26.39 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.28 0.562 . . . . 0.0 110.907 177.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 91' ' ' LEU . . . . . 0.596 HD23 ' HB3' ' B' ' 27' ' ' PHE . 64.6 mt -59.27 116.81 4.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.843 173.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 92' ' ' HIS . . . . . 0.445 ' H ' ' HA ' ' B' ' 27' ' ' PHE . 72.5 t60 -87.57 108.32 19.0 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.889 -168.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -153.23 155.51 36.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.072 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 35.8 pt -122.9 143.09 37.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.854 0.359 . . . . 0.0 111.103 -176.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -117.3 112.19 20.42 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.898 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 3.2 p -83.46 110.05 17.86 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.042 0.448 . . . . 0.0 110.701 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . -70.33 -29.96 69.71 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.081 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 33.4 m . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.663 -0.684 . . . . 0.0 109.767 178.317 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 1' ' ' PHE . . . . . 0.535 ' O ' ' HB3' ' D' ' 25' ' ' LYS . 53.5 p90 . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -99.71 146.31 26.66 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 176.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . -125.23 113.27 1.89 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.83 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -102.03 58.06 0.82 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.128 0.49 . . . . 0.0 110.315 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 24.8 mmt -101.97 -160.45 0.79 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.289 -176.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.78 148.36 4.12 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.14 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 7' ' ' MET . . . . . 0.423 ' HB2' HD12 ' C' ' 91' ' ' LEU . 47.5 mtt -108.47 165.52 11.46 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.369 -175.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 8' ' ' PHE . . . . . 0.449 ' CE1' HD21 ' D' ' 44' ' ' LEU . 56.6 t80 -76.07 151.9 36.98 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -176.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 9' ' ' TRP . . . . . 0.477 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 89.8 t90 -143.81 147.52 34.24 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.514 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 10' ' ' GLY . . . . . 0.439 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -151.43 156.49 26.71 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.121 -0.562 . . . . 0.0 112.254 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.563 HD23 HD13 ' C' ' 87' ' ' LEU . 61.5 tp -149.0 109.57 4.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.894 0.378 . . . . 0.0 111.48 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -85.89 121.04 27.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.519 176.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 13' ' ' MET . . . . . 0.666 ' SD ' ' HE2' ' C' ' 19' ' ' TYR . 72.2 mmm -101.68 137.27 40.2 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 120.817 0.341 . . . . 0.0 111.126 -178.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 14' ' ' LYS . . . . . 0.481 ' HE3' ' HA ' ' C' ' 14' ' ' LYS . 0.0 OUTLIER -101.22 146.48 32.24 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.846 175.666 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -49.93 113.39 0.97 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.093 2.529 . . . . 0.0 113.043 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 60.99 52.05 4.26 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.961 176.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -125.49 138.42 53.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.8 175.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 18' ' ' LYS . . . . . 0.697 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 51.8 mttp -109.65 126.89 54.13 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.697 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 19' ' ' TYR . . . . . 0.666 ' HE2' ' SD ' ' C' ' 13' ' ' MET . 2.4 m-85 -111.68 103.75 12.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.818 172.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 20' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 9.3 p -86.01 100.57 12.24 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 173.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -114.93 148.67 38.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.431 0.634 . . . . 0.0 112.203 -168.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 39.0 m -107.84 142.03 38.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.165 173.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 69.2 mt -102.29 138.36 26.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.169 0.509 . . . . 0.0 111.75 -173.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 24' ' ' ILE . . . . . 0.44 ' N ' HD12 ' C' ' 24' ' ' ILE . 4.1 mp -110.55 -43.4 5.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.266 176.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 25' ' ' LYS . . . . . 0.535 ' HB3' ' O ' ' B' ' 1' ' ' PHE . 15.1 pttm -113.91 120.61 41.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.163 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 14.5 p -58.26 132.11 52.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.659 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 27' ' ' PHE . . . . . 0.603 ' HB3' HD23 ' C' ' 91' ' ' LEU . 54.2 p90 -139.12 157.56 45.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.597 0.713 . . . . 0.0 112.389 -176.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 28' ' ' HIS . . . . . 0.631 ' HE2' ' HB3' ' C' ' 30' ' ' SER . 7.1 t60 -114.68 124.76 52.63 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.475 177.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 29' ' ' ILE . . . . . 0.598 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 42.4 mt -89.93 134.96 27.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 171.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.631 ' HB3' ' HE2' ' C' ' 28' ' ' HIS . 29.1 p -122.1 -12.27 8.34 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -171.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.12 155.8 27.29 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 119.67 -1.252 . . . . 0.0 113.192 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.438 HG23 ' HG ' ' C' ' 87' ' ' LEU . 12.3 p -143.28 125.5 12.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 172.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.422 ' HA ' HG21 ' C' ' 56' ' ' VAL . . . -144.2 160.95 40.08 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.111 -0.368 . . . . 0.0 111.647 -174.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.658 ' HB3' HG12 ' C' ' 85' ' ' VAL . 3.4 pp -123.4 142.22 51.2 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.8 0.809 . . . . 0.0 111.619 177.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -104.02 -52.59 2.91 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.529 173.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -104.19 128.63 51.92 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 169.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 37' ' ' GLY . . . . . 0.416 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 151.95 156.02 7.28 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 119.619 -1.277 . . . . 0.0 113.653 175.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 38' ' ' GLN . . . . . 0.467 ' HA ' ' HB2' ' C' ' 58' ' ' LYS . 94.1 mt-30 -102.76 -44.31 5.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.648 0.261 . . . . 0.0 111.232 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 39' ' ' GLU . . . . . 0.525 ' HG3' HG22 ' C' ' 57' ' ' THR . 34.8 tt0 -152.67 122.09 6.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.766 -0.197 . . . . 0.0 110.98 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.586 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -123.57 114.26 19.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.605 0.716 . . . . 0.0 110.27 170.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.448 ' HB2' ' HB3' ' C' ' 80' ' ' ALA . 31.8 mmtp -96.87 105.8 18.0 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 44.9 tp -83.25 112.21 19.66 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -175.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 43' ' ' TYR . . . . . 0.653 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 92.8 m-85 -118.62 147.27 43.93 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.515 ' HA ' ' O ' ' C' ' 76' ' ' MET . 0.3 OUTLIER -131.08 131.13 44.0 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 170.648 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 45' ' ' ALA . . . . . 0.601 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -107.57 112.49 25.26 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.275 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.635 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -124.49 138.08 54.37 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.487 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 58.95 34.08 23.41 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.238 0.542 . . . . 0.0 109.99 -176.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 57.5 tttm 56.65 46.58 20.0 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.707 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 49' ' ' GLN . . . . . 0.601 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 8.6 tp-100 -137.92 127.77 25.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.465 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -87.2 121.39 29.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.077 0.465 . . . . 0.0 110.338 -176.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 51' ' ' TYR . . . . . 0.43 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 81.3 m-85 -113.49 130.56 56.31 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.411 175.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 52' ' ' ILE . . . . . 0.47 HG22 ' HB3' ' B' ' 86' ' ' SER . 4.5 tp -79.46 105.8 9.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.664 0.745 . . . . 0.0 109.019 173.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 53' ' ' VAL . . . . . 0.556 HG13 HD23 ' B' ' 88' ' ' LEU . 2.5 t -80.56 -49.07 19.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.65 -172.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 54' ' ' ALA . . . . . 0.513 ' HB2' HD23 ' C' ' 65' ' ' LEU . . . -155.99 148.22 23.5 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.812 -177.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 71.1 m -110.56 100.8 9.55 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 170.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 56' ' ' VAL . . . . . 0.487 HG13 ' HB3' ' C' ' 40' ' ' ALA . 7.7 p -118.49 112.74 39.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.658 0.742 . . . . 0.0 109.61 -177.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 57' ' ' THR . . . . . 0.525 HG22 ' HG3' ' C' ' 39' ' ' GLU . 64.4 p -122.87 -178.67 4.01 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.272 -172.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 58' ' ' LYS . . . . . 0.467 ' HB2' ' HA ' ' C' ' 38' ' ' GLN . 55.7 tttt -59.54 -28.97 67.57 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.855 172.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 59' ' ' ALA . . . . . 0.472 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -83.2 -40.39 19.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.648 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 80.1 mt -111.16 83.15 3.68 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 61' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 13.0 Cg_exo -69.84 0.18 6.08 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.074 2.516 . . . . 0.0 113.825 -168.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -163.13 131.34 3.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.297 0.57 . . . . 0.0 111.569 -176.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 96.0 t -118.91 112.67 38.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.392 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.91 116.14 27.75 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 174.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 65' ' ' LEU . . . . . 0.513 HD23 ' HB2' ' C' ' 54' ' ' ALA . 0.3 OUTLIER -137.24 169.5 17.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.95 0.405 . . . . 0.0 111.445 -175.26 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 66' ' ' ASP . . . . . 0.544 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 9.6 t0 -118.59 119.08 33.44 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.106 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.605 HD21 HD23 ' B' ' 88' ' ' LEU . 7.9 mt -134.18 145.26 49.05 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 175.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -145.43 123.03 11.78 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.721 -0.392 . . . . 0.0 109.947 173.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -120.91 150.89 40.38 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.965 -178.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 14.2 t -109.03 177.41 4.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.622 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.92 -19.29 65.7 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.258 0.552 . . . . 0.0 110.612 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.34 -9.9 81.01 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.261 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -92.63 119.93 32.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.059 0.457 . . . . 0.0 110.64 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -107.98 111.59 23.75 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.635 HG22 ' HB2' ' C' ' 46' ' ' ALA . 7.6 pt -128.73 156.1 41.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 120.962 0.41 . . . . 0.0 111.842 -168.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.515 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 4.5 mtm -115.48 119.42 36.13 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 173.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 77' ' ' PHE . . . . . 0.478 ' CD1' ' HB2' ' C' ' 44' ' ' LEU . 1.1 m-85 -99.9 128.37 45.99 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 78' ' ' TYR . . . . . 0.697 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 31.3 p90 -152.42 140.15 19.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.457 0.646 . . . . 0.0 112.252 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 79' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' C' ' 41' ' ' LYS . 2.3 p -113.04 125.79 54.78 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.837 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 80' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' C' ' 41' ' ' LYS . . . -96.69 164.93 12.37 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.628 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.05 -165.21 31.57 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 -177.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -121.9 103.06 8.57 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 119.864 -0.735 . . . . 0.0 110.073 175.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 83' ' ' ALA . . . . . 0.586 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -173.13 153.02 2.4 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.501 173.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 38.6 t -112.27 111.7 22.76 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.658 HG12 ' HB3' ' C' ' 34' ' ' LEU . 4.6 m -109.78 165.54 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 CA-C-O 121.308 0.575 . . . . 0.0 111.89 -174.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 86' ' ' SER . . . . . 0.466 ' HB3' HG22 ' D' ' 52' ' ' ILE . 23.9 t -131.58 123.09 27.2 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.953 176.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 87' ' ' LEU . . . . . 0.565 HD23 HG21 ' C' ' 29' ' ' ILE . 4.9 mp -91.31 151.94 20.67 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 172.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 88' ' ' LEU . . . . . 0.584 HD23 HD21 ' D' ' 67' ' ' LEU . 1.4 tp -134.7 142.46 46.81 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.843 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.94 -166.85 26.71 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.804 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -143.56 135.17 26.28 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.256 0.55 . . . . 0.0 110.928 177.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 91' ' ' LEU . . . . . 0.603 HD23 ' HB3' ' C' ' 27' ' ' PHE . 64.7 mt -59.2 116.83 4.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.83 173.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 92' ' ' HIS . . . . . 0.457 ' H ' ' HA ' ' C' ' 27' ' ' PHE . 72.8 t60 -87.63 108.32 19.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.867 -167.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -153.29 155.52 36.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.058 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 35.5 pt -122.91 143.06 37.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.919 0.39 . . . . 0.0 111.141 -176.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -117.22 112.24 20.54 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.941 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 3.2 p -83.49 110.03 17.86 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.015 0.436 . . . . 0.0 110.757 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -70.37 -29.87 69.7 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.138 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 33.2 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.727 -0.654 . . . . 0.0 109.847 178.254 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 1' ' ' PHE . . . . . 0.524 ' O ' ' HB3' ' E' ' 25' ' ' LYS . 53.4 p90 . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -99.69 146.34 26.62 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 176.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . -125.29 113.32 1.89 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.815 -176.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -102.01 57.96 0.82 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.087 0.47 . . . . 0.0 110.305 177.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 24.8 mmt -101.99 -160.42 0.79 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.315 -176.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.71 148.34 4.06 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 123.556 0.535 . . . . 0.0 112.164 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 7' ' ' MET . . . . . 0.445 ' HB2' HD12 ' D' ' 91' ' ' LEU . 47.5 mtt -108.47 165.5 11.47 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.376 -175.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 8' ' ' PHE . . . . . 0.438 ' CE1' HD21 ' E' ' 44' ' ' LEU . 56.7 t80 -76.1 151.92 36.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.113 0.482 . . . . 0.0 112.261 -176.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 9' ' ' TRP . . . . . 0.482 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 89.6 t90 -143.77 147.38 34.08 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.66 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 10' ' ' GLY . . . . . 0.449 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -151.38 156.53 26.73 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.216 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.566 HD23 HD13 ' D' ' 87' ' ' LEU . 61.3 tp -149.04 109.59 4.22 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.902 0.382 . . . . 0.0 111.403 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -85.96 121.1 28.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.387 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 13' ' ' MET . . . . . 0.672 ' SD ' ' HE2' ' D' ' 19' ' ' TYR . 72.3 mmm -101.76 137.3 40.24 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.884 0.373 . . . . 0.0 111.132 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 14' ' ' LYS . . . . . 0.486 ' HE3' ' HA ' ' D' ' 14' ' ' LYS . 0.0 OUTLIER -101.1 146.46 32.19 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.898 175.663 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -49.92 113.39 0.97 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.035 2.49 . . . . 0.0 113.066 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 61.11 51.98 4.2 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.928 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -125.5 138.35 53.98 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.737 175.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 18' ' ' LYS . . . . . 0.699 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 51.9 mttp -109.67 126.92 54.19 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 120.799 0.333 . . . . 0.0 111.732 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 19' ' ' TYR . . . . . 0.672 ' HE2' ' SD ' ' D' ' 13' ' ' MET . 2.4 m-85 -111.74 103.7 12.0 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 173.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 20' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 9.3 p -86.0 100.62 12.27 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 173.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -114.88 148.73 38.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.283 -168.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 38.7 m -107.83 142.01 38.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.181 173.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 69.2 mt -102.32 138.37 26.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.226 0.536 . . . . 0.0 111.713 -173.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 24' ' ' ILE . . . . . 0.437 HD12 ' N ' ' D' ' 24' ' ' ILE . 4.1 mp -110.63 -43.26 5.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.269 176.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 25' ' ' LYS . . . . . 0.535 ' HB3' ' O ' ' C' ' 1' ' ' PHE . 15.2 pttm -113.95 120.5 40.86 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.146 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 14.6 p -58.19 132.18 52.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.653 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 27' ' ' PHE . . . . . 0.61 ' HB3' HD23 ' D' ' 91' ' ' LEU . 54.4 p90 -139.24 157.55 45.72 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.632 0.73 . . . . 0.0 112.357 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 28' ' ' HIS . . . . . 0.637 ' HE2' ' HB3' ' D' ' 30' ' ' SER . 7.0 t60 -114.67 124.67 52.42 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.505 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 29' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 42.4 mt -89.85 134.98 27.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 171.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 30' ' ' SER . . . . . 0.637 ' HB3' ' HE2' ' D' ' 28' ' ' HIS . 28.7 p -122.13 -12.31 8.33 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -171.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.05 155.91 27.48 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.712 -1.232 . . . . 0.0 113.239 177.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.443 HG23 ' HG ' ' D' ' 87' ' ' LEU . 12.4 p -143.41 125.46 11.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 172.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 33' ' ' ALA . . . . . 0.426 ' HA ' HG21 ' D' ' 56' ' ' VAL . . . -144.11 161.06 39.8 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 122.023 -0.423 . . . . 0.0 111.682 -174.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 34' ' ' LEU . . . . . 0.636 ' HB3' HG12 ' D' ' 85' ' ' VAL . 3.3 pp -123.49 142.16 51.28 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.748 0.785 . . . . 0.0 111.621 177.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -104.04 -52.48 2.94 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.515 -1.221 . . . . 0.0 108.54 173.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -104.27 128.6 52.06 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 169.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 37' ' ' GLY . . . . . 0.414 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 152.0 155.99 7.27 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 119.584 -1.293 . . . . 0.0 113.632 175.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 38' ' ' GLN . . . . . 0.48 ' HA ' ' HB2' ' D' ' 58' ' ' LYS . 94.1 mt-30 -102.7 -44.28 5.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.621 0.248 . . . . 0.0 111.29 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 39' ' ' GLU . . . . . 0.535 ' HG3' HG22 ' D' ' 57' ' ' THR . 35.0 tt0 -152.74 122.08 6.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.025 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 40' ' ' ALA . . . . . 0.573 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -123.59 114.26 19.78 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.601 0.715 . . . . 0.0 110.203 170.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.442 ' HB2' ' HB3' ' D' ' 80' ' ' ALA . 31.8 mmtp -96.78 105.81 18.0 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 44.7 tp -83.25 112.19 19.64 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 43' ' ' TYR . . . . . 0.639 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 92.6 m-85 -118.66 147.17 44.07 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' D' ' 76' ' ' MET . 0.3 OUTLIER -131.06 131.07 44.0 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 170.572 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 45' ' ' ALA . . . . . 0.593 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -107.46 112.58 25.44 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.3 178.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.632 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -124.54 138.18 54.35 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.432 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 58.83 34.15 23.51 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.562 0.539 . . . . 0.0 109.975 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 57.3 tttm 56.64 46.42 20.31 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.807 -177.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 49' ' ' GLN . . . . . 0.593 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 8.6 tp-100 -137.85 127.79 25.62 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 176.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -87.19 121.39 29.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.062 0.458 . . . . 0.0 110.369 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 51' ' ' TYR . . . . . 0.439 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 81.7 m-85 -113.48 130.54 56.31 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.4 175.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 52' ' ' ILE . . . . . 0.466 HG22 ' HB3' ' C' ' 86' ' ' SER . 4.5 tp -79.55 105.79 9.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.646 0.736 . . . . 0.0 109.086 173.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 53' ' ' VAL . . . . . 0.57 HG13 HD23 ' C' ' 88' ' ' LEU . 2.5 t -80.46 -49.21 18.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.536 -172.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 54' ' ' ALA . . . . . 0.517 ' HB2' HD23 ' D' ' 65' ' ' LEU . . . -155.95 148.22 23.56 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 120.95 0.405 . . . . 0.0 111.731 -177.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 72.8 m -110.54 100.61 9.39 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 170.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 56' ' ' VAL . . . . . 0.486 HG13 ' HB3' ' D' ' 40' ' ' ALA . 7.7 p -118.36 112.65 39.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.658 0.742 . . . . 0.0 109.63 -177.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 57' ' ' THR . . . . . 0.535 HG22 ' HG3' ' D' ' 39' ' ' GLU . 61.9 p -122.79 -178.68 4.0 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.304 -172.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 58' ' ' LYS . . . . . 0.48 ' HB2' ' HA ' ' D' ' 38' ' ' GLN . 56.0 tttt -59.58 -28.88 67.54 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.899 172.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 59' ' ' ALA . . . . . 0.473 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -83.25 -40.44 19.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.592 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 79.6 mt -111.06 82.98 3.44 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 174.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 61' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 13.1 Cg_exo -69.72 0.22 5.92 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.047 2.498 . . . . 0.0 113.887 -168.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -163.13 131.26 3.76 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.273 0.559 . . . . 0.0 111.614 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.408 HG23 ' HB ' ' D' ' 56' ' ' VAL . 96.4 t -118.85 112.65 38.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.377 173.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.92 116.2 27.81 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 174.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 65' ' ' LEU . . . . . 0.517 HD23 ' HB2' ' D' ' 54' ' ' ALA . 0.3 OUTLIER -137.38 169.42 17.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.007 0.432 . . . . 0.0 111.426 -175.242 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 66' ' ' ASP . . . . . 0.545 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 9.7 t0 -118.45 118.97 33.18 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.114 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.601 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 8.0 mt -134.14 145.3 49.15 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -145.37 123.0 11.8 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 173.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -120.96 150.93 40.34 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.008 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 14.2 t -109.05 177.44 4.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.748 -0.206 . . . . 0.0 110.592 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.92 -19.27 65.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.163 0.506 . . . . 0.0 110.659 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.33 -9.95 80.95 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.272 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -92.65 120.07 32.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.218 0.532 . . . . 0.0 110.584 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -108.12 111.55 23.63 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 176.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.632 HG22 ' HB2' ' D' ' 46' ' ' ALA . 7.6 pt -128.63 156.15 40.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 120.963 0.411 . . . . 0.0 111.812 -168.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 76' ' ' MET . . . . . 0.519 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 4.5 mtm -115.53 119.37 35.94 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 173.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 77' ' ' PHE . . . . . 0.466 ' CD1' ' HB2' ' D' ' 44' ' ' LEU . 1.1 m-85 -99.85 128.36 45.95 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 78' ' ' TYR . . . . . 0.699 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 31.4 p90 -152.42 140.2 19.95 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.452 0.644 . . . . 0.0 112.227 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 79' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' D' ' 41' ' ' LYS . 2.3 p -113.15 125.74 54.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.802 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 80' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' D' ' 41' ' ' LYS . . . -96.58 164.86 12.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.62 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.12 -165.15 31.43 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -177.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -121.98 103.0 8.51 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.047 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 83' ' ' ALA . . . . . 0.573 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -173.07 153.09 2.45 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.528 173.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 38.6 t -112.27 111.62 22.62 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.636 HG12 ' HB3' ' D' ' 34' ' ' LEU . 4.6 m -109.77 165.44 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.673 0 CA-C-O 121.459 0.647 . . . . 0.0 111.87 -174.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 86' ' ' SER . . . . . 0.478 ' HB3' HG22 ' E' ' 52' ' ' ILE . 24.0 t -131.55 123.12 27.3 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.896 176.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 87' ' ' LEU . . . . . 0.566 HD13 HD23 ' D' ' 11' ' ' LEU . 4.9 mp -91.37 151.97 20.62 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 172.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.588 HD23 HD21 ' E' ' 67' ' ' LEU . 1.4 tp -134.78 142.53 46.72 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.738 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.01 -166.82 26.75 Favored Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.743 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -143.47 135.21 26.47 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.151 0.5 . . . . 0.0 110.919 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 91' ' ' LEU . . . . . 0.61 HD23 ' HB3' ' D' ' 27' ' ' PHE . 64.9 mt -59.36 116.81 4.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.904 173.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 92' ' ' HIS . . . . . 0.464 ' H ' ' HA ' ' D' ' 27' ' ' PHE . 72.6 t60 -87.5 108.23 18.94 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.921 -167.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -153.19 155.46 36.72 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.102 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 35.5 pt -122.9 143.07 37.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.845 0.355 . . . . 0.0 111.088 -176.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -117.27 112.22 20.47 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.868 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 3.2 p -83.52 110.03 17.87 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.033 0.444 . . . . 0.0 110.752 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . -70.35 -29.95 69.68 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.06 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 33.8 m . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.522 -0.751 . . . . 0.0 109.794 178.281 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' E' E ' 1' ' ' PHE . . . . . 0.507 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 53.3 p90 . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -99.74 146.31 26.69 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 176.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . -125.16 113.32 1.9 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.812 -176.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -102.1 58.07 0.82 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.2 0.524 . . . . 0.0 110.3 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 5' ' ' MET . . . . . 0.421 ' HB3' ' H ' ' E' ' 6' ' ' ALA . 24.8 mmt -102.06 -160.61 0.8 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.196 -176.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 6' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 70' ' ' SER . . . -50.65 148.26 4.06 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.129 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 7' ' ' MET . . . . . 0.443 ' HB2' HD12 ' E' ' 91' ' ' LEU . 47.4 mtt -108.38 165.52 11.45 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.333 -175.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 8' ' ' PHE . . . . . 0.416 ' CE1' HD21 ' A' ' 44' ' ' LEU . 56.2 t80 -76.13 151.99 36.85 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -176.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 9' ' ' TRP . . . . . 0.473 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 89.7 t90 -143.85 147.43 34.06 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.631 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 10' ' ' GLY . . . . . 0.437 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -151.46 156.46 26.69 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.144 178.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 11' ' ' LEU . . . . . 0.566 HD23 HD13 ' E' ' 87' ' ' LEU . 61.2 tp -148.94 109.62 4.25 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.855 0.359 . . . . 0.0 111.445 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -85.98 121.13 28.17 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.435 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 13' ' ' MET . . . . . 0.679 ' SD ' ' HE2' ' E' ' 19' ' ' TYR . 72.3 mmm -101.74 137.29 40.25 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.0 111.069 -178.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 14' ' ' LYS . . . . . 0.497 ' HE3' ' HA ' ' E' ' 14' ' ' LYS . 0.0 OUTLIER -101.12 146.44 32.16 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.872 175.657 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -49.95 113.35 0.96 Allowed 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.995 2.463 . . . . 0.0 113.152 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 61.21 52.03 4.09 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.837 176.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -125.58 138.35 53.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.785 175.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 18' ' ' LYS . . . . . 0.707 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 51.8 mttp -109.66 126.85 54.1 Favored 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 123.264 0.352 . . . . 0.0 111.688 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 19' ' ' TYR . . . . . 0.679 ' HE2' ' SD ' ' E' ' 13' ' ' MET . 2.4 m-85 -111.71 103.79 12.1 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.772 172.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 9.2 p -86.01 100.6 12.25 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 173.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -114.91 148.73 38.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.396 0.617 . . . . 0.0 112.235 -168.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 37.5 m -107.83 142.06 38.47 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.17 173.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 69.4 mt -102.39 138.37 26.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.233 0.54 . . . . 0.0 111.709 -173.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 24' ' ' ILE . . . . . 0.437 HD12 ' N ' ' E' ' 24' ' ' ILE . 4.1 mp -110.62 -43.42 5.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.203 176.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 25' ' ' LYS . . . . . 0.524 ' HB3' ' O ' ' D' ' 1' ' ' PHE . 15.1 pttm -113.86 120.62 41.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.177 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 14.4 p -58.31 132.23 53.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.65 -178.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 27' ' ' PHE . . . . . 0.601 ' HB3' HD23 ' E' ' 91' ' ' LEU . 54.2 p90 -139.22 157.49 45.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.603 0.716 . . . . 0.0 112.377 -176.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 28' ' ' HIS . . . . . 0.633 ' HE2' ' HB3' ' E' ' 30' ' ' SER . 7.2 t60 -114.6 124.72 52.56 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.552 177.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 29' ' ' ILE . . . . . 0.587 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 42.5 mt -89.91 134.91 27.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 171.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 30' ' ' SER . . . . . 0.633 ' HB3' ' HE2' ' E' ' 28' ' ' HIS . 29.1 p -122.02 -12.34 8.36 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -171.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.16 155.86 27.38 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 119.626 -1.273 . . . . 0.0 113.188 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.445 HG23 ' HG ' ' E' ' 87' ' ' LEU . 12.4 p -143.35 125.51 12.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 172.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 33' ' ' ALA . . . . . 0.429 ' HA ' HG21 ' E' ' 56' ' ' VAL . . . -144.21 161.06 39.85 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.62 -174.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 34' ' ' LEU . . . . . 0.66 ' HB3' HG12 ' E' ' 85' ' ' VAL . 3.3 pp -123.48 142.21 51.23 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.717 0.77 . . . . 0.0 111.629 177.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -103.98 -52.58 2.92 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.584 173.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -104.17 128.63 51.88 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 169.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 37' ' ' GLY . . . . . 0.416 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 151.96 156.05 7.3 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 119.568 -1.301 . . . . 0.0 113.644 175.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 38' ' ' GLN . . . . . 0.484 ' HA ' ' HB2' ' E' ' 58' ' ' LYS . 94.2 mt-30 -102.82 -44.22 5.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.692 0.282 . . . . 0.0 111.264 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 39' ' ' GLU . . . . . 0.527 ' HG3' HG22 ' E' ' 57' ' ' THR . 34.9 tt0 -152.73 122.05 6.72 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 121.161 -0.216 . . . . 0.0 110.96 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 40' ' ' ALA . . . . . 0.588 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -123.56 114.31 19.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.536 0.684 . . . . 0.0 110.13 170.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 41' ' ' LYS . . . . . 0.435 ' HB2' ' HB3' ' E' ' 80' ' ' ALA . 31.8 mmtp -96.94 105.89 18.11 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 176.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 44.6 tp -83.21 112.17 19.61 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 -175.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 43' ' ' TYR . . . . . 0.645 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 92.9 m-85 -118.65 147.18 44.05 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 175.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 44' ' ' LEU . . . . . 0.524 ' HA ' ' O ' ' E' ' 76' ' ' MET . 0.3 OUTLIER -131.08 131.04 43.95 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 170.628 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 45' ' ' ALA . . . . . 0.587 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -107.51 112.55 25.37 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.314 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 46' ' ' ALA . . . . . 0.635 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -124.56 138.18 54.35 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.476 178.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 58.82 34.16 23.52 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.168 0.509 . . . . 0.0 109.983 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 57.3 tttm 56.62 46.53 20.14 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.811 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 49' ' ' GLN . . . . . 0.587 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 8.5 tp-100 -137.89 127.74 25.48 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -87.13 121.39 29.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.056 0.455 . . . . 0.0 110.388 -176.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 51' ' ' TYR . . . . . 0.449 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 81.5 m-85 -113.51 130.5 56.33 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.375 175.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 52' ' ' ILE . . . . . 0.478 HG22 ' HB3' ' D' ' 86' ' ' SER . 4.5 tp -79.47 105.8 9.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.622 0.725 . . . . 0.0 109.09 173.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 53' ' ' VAL . . . . . 0.571 HG13 HD23 ' D' ' 88' ' ' LEU . 2.5 t -80.45 -49.21 19.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.638 -172.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 54' ' ' ALA . . . . . 0.514 ' HB2' ' CD2' ' E' ' 65' ' ' LEU . . . -155.92 148.27 23.64 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.748 -177.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 67.4 m -110.52 100.7 9.47 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 170.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 56' ' ' VAL . . . . . 0.476 HG13 ' HB3' ' E' ' 40' ' ' ALA . 7.7 p -118.45 112.6 38.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.624 0.726 . . . . 0.0 109.73 -177.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 57' ' ' THR . . . . . 0.527 HG22 ' HG3' ' E' ' 39' ' ' GLU . 64.0 p -122.82 -178.71 4.01 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.178 -172.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 58' ' ' LYS . . . . . 0.484 ' HB2' ' HA ' ' E' ' 38' ' ' GLN . 55.8 tttt -59.49 -28.92 67.46 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.826 172.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 59' ' ' ALA . . . . . 0.472 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -83.36 -40.25 19.65 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.678 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 79.9 mt -111.07 83.03 3.49 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 61' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 13.1 Cg_exo -69.85 0.28 5.94 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.028 2.485 . . . . 0.0 113.861 -168.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -163.16 131.4 3.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.3 0.571 . . . . 0.0 111.548 -176.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 63' ' ' VAL . . . . . 0.408 HG23 ' HB ' ' E' ' 56' ' ' VAL . 95.6 t -118.98 112.76 39.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.334 173.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.05 116.14 27.85 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 174.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.514 ' CD2' ' HB2' ' E' ' 54' ' ' ALA . 0.3 OUTLIER -137.19 169.54 17.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.492 -175.277 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 66' ' ' ASP . . . . . 0.529 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 9.5 t0 -118.67 119.01 33.18 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.072 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 67' ' ' LEU . . . . . 0.588 HD21 HD23 ' D' ' 88' ' ' LEU . 8.0 mt -134.19 145.21 49.0 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 175.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -145.34 123.0 11.82 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 173.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -120.88 150.88 40.38 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.095 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 14.1 t -108.94 177.45 4.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.821 -0.172 . . . . 0.0 110.663 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.88 -19.31 65.71 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.255 0.55 . . . . 0.0 110.667 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.35 -9.93 80.94 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.256 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -92.61 120.0 32.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.166 0.508 . . . . 0.0 110.524 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -108.1 111.58 23.69 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 75' ' ' ILE . . . . . 0.635 HG22 ' HB2' ' E' ' 46' ' ' ALA . 7.6 pt -128.61 156.07 40.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 120.991 0.424 . . . . 0.0 111.878 -168.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 76' ' ' MET . . . . . 0.524 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 4.5 mtm -115.53 119.44 36.18 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 173.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 77' ' ' PHE . . . . . 0.478 ' CD1' ' HB2' ' E' ' 44' ' ' LEU . 1.1 m-85 -99.9 128.4 46.0 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 78' ' ' TYR . . . . . 0.707 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 31.3 p90 -152.42 140.3 20.05 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.43 0.633 . . . . 0.0 112.156 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 79' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' E' ' 41' ' ' LYS . 2.3 p -113.22 125.77 54.68 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.762 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 80' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' E' ' 41' ' ' LYS . . . -96.58 164.87 12.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.697 178.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.08 -165.18 31.51 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -177.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -121.98 103.0 8.52 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.069 175.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 83' ' ' ALA . . . . . 0.588 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -173.07 153.08 2.45 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.504 173.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 39.2 t -112.27 111.58 22.55 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 85' ' ' VAL . . . . . 0.66 HG12 ' HB3' ' E' ' 34' ' ' LEU . 4.5 m -109.76 165.56 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-O 121.378 0.609 . . . . 0.0 111.842 -174.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 86' ' ' SER . . . . . 0.452 ' HB3' HG22 ' A' ' 52' ' ' ILE . 24.2 t -131.65 123.13 27.18 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.882 176.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 87' ' ' LEU . . . . . 0.566 HD13 HD23 ' E' ' 11' ' ' LEU . 4.9 mp -91.34 151.95 20.65 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 172.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 88' ' ' LEU . . . . . 0.592 HD23 HD21 ' A' ' 67' ' ' LEU . 1.4 tp -134.76 142.46 46.73 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.789 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.91 -166.8 26.6 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.756 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 90' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -143.56 135.3 26.41 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.2 0.524 . . . . 0.0 110.936 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 91' ' ' LEU . . . . . 0.601 HD23 ' HB3' ' E' ' 27' ' ' PHE . 64.7 mt -59.35 116.84 4.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.885 173.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 92' ' ' HIS . . . . . 0.45 ' H ' ' HA ' ' E' ' 27' ' ' PHE . 72.8 t60 -87.64 108.33 19.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.901 -167.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -153.29 155.45 36.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.035 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 35.6 pt -122.91 143.09 37.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.965 0.412 . . . . 0.0 111.095 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -117.2 112.22 20.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.839 177.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 3.3 p -83.61 110.05 17.94 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.058 0.456 . . . . 0.0 110.696 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . -70.32 -29.94 69.74 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.172 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 32.8 m . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.621 -0.704 . . . . 0.0 109.773 178.195 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 120.769 0.319 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -89.67 -41.25 12.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.219 0.533 . . . . 0.0 110.954 -173.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.507 ' H ' ' HB3' ' B' ' 93' ' ' ASP . . . 78.55 -139.75 22.7 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.541 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 65.95 -173.83 0.18 Allowed 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.095 0.558 . . . . 0.0 111.469 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 68.6 mtm 70.94 -74.22 0.09 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.993 176.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' B' ' 70' ' ' SER . . . -106.11 125.83 51.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.814 -174.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 46.9 mtt -119.28 173.74 6.77 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.113 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -82.18 147.45 29.0 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.491 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 91.2 t90 -139.29 150.1 45.03 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.395 177.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.421 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -154.26 152.21 23.82 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.43 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.61 HD23 HD13 ' A' ' 87' ' ' LEU . 41.0 tp -143.19 108.33 4.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.741 0.305 . . . . 0.0 110.385 177.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -86.11 99.38 11.46 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.416 0.627 . . . . 0.0 109.99 175.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.605 ' HB3' HG23 ' A' ' 85' ' ' VAL . 23.8 tpp -88.02 135.12 33.56 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.881 -175.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -98.83 145.15 29.45 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.119 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HB3' ' N ' ' A' ' 83' ' ' ALA . 10.3 Cg_endo -52.92 120.18 7.24 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 123.585 2.857 . . . . 0.0 113.276 -175.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.682 ' HA ' ' O ' ' A' ' 79' ' ' THR . 29.0 mt-10 58.26 63.07 1.83 Allowed 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 121.575 0.703 . . . . 0.0 111.596 177.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.59 148.95 46.28 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.592 174.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.656 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 35.0 ttmt -122.6 117.15 25.16 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 123.525 0.516 . . . . 0.0 111.314 -175.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -110.98 104.36 12.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.974 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 76' ' ' MET . 10.0 p -88.25 99.95 12.62 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 173.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -121.4 149.9 42.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.501 0.667 . . . . 0.0 112.347 -169.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.2 t -99.21 160.8 14.01 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.405 176.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 53.2 mt -118.99 125.79 74.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.1 0.476 . . . . 0.0 111.531 -173.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.462 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.2 mp -107.02 -33.56 2.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.336 177.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -118.94 122.18 41.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.572 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.486 ' CB ' ' HA2' ' E' ' 3' ' ' GLY . 20.5 t -60.82 133.06 55.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.879 -177.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.511 ' HB3' HD23 ' A' ' 91' ' ' LEU . 53.9 p90 -137.42 143.13 41.71 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.939 0.876 . . . . 0.0 111.881 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.642 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 3.5 t60 -102.4 129.87 49.0 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.827 174.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.6 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 48.9 mt -97.53 130.28 46.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.642 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 46.6 p -114.0 -18.02 11.83 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.565 -171.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -162.2 149.03 16.87 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 119.611 -1.281 . . . . 0.0 113.031 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.476 HG23 ' HG ' ' A' ' 87' ' ' LEU . 8.2 p -135.19 121.99 34.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 172.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.53 150.22 41.87 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.97 -171.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.536 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.3 pp -114.96 137.52 51.9 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 121.802 0.811 . . . . 0.0 111.167 178.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -107.01 -55.44 2.33 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.615 175.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -101.9 127.06 48.9 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.388 -0.823 . . . . 0.0 108.884 170.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.451 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 148.31 163.48 10.81 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.043 -1.075 . . . . 0.0 113.045 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -102.65 -47.19 4.51 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 121.099 -0.241 . . . . 0.0 111.404 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -151.92 136.39 16.86 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.632 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.446 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -133.49 113.59 12.65 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.478 0.656 . . . . 0.0 110.455 168.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 79' ' ' THR . 65.8 mttp -97.48 109.51 22.25 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.1 tp -85.75 114.78 22.97 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.993 -173.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.554 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 66.0 m-85 -116.41 145.75 43.02 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.509 ' HB2' ' CD1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -131.32 130.37 42.64 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 172.278 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -108.61 114.2 27.83 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.073 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.67 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -125.45 124.21 40.92 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.824 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.519 ' C ' ' HD2' ' A' ' 48' ' ' LYS . 4.2 mm-40 56.62 51.9 10.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.356 0.598 . . . . 0.0 111.066 -175.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.519 ' HD2' ' C ' ' A' ' 47' ' ' GLU . 6.7 mptt 59.0 39.58 23.35 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.459 174.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.591 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 24.0 tp60 -138.56 115.89 11.15 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -82.45 111.74 18.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.931 0.396 . . . . 0.0 110.714 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.438 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 80.3 m-85 -101.82 128.92 47.97 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.362 176.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -75.75 102.61 2.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 168.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.474 ' CG1' HD11 ' A' ' 67' ' ' LEU . 2.8 t -76.24 -51.52 19.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.579 -172.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.454 ' HB2' ' CD2' ' A' ' 65' ' ' LEU . . . -156.61 142.07 17.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.24 -177.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.8 m -105.1 101.35 10.91 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 172.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.71 112.55 40.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.783 0.802 . . . . 0.0 110.103 -177.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.8 p -123.47 -177.0 3.59 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.05 -176.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -59.13 -32.9 70.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.988 0.423 . . . . 0.0 110.44 169.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.64 -40.57 69.62 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.575 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.5 mt -117.69 81.77 15.34 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 174.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.64 -5.67 14.82 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.231 2.621 . . . . 0.0 113.988 -167.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -162.15 122.6 2.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.089 0.471 . . . . 0.0 110.974 -175.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.413 HG11 ' HB1' ' A' ' 54' ' ' ALA . 98.1 t -108.57 113.57 44.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.343 175.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.37 114.87 27.4 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.104 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -135.48 168.66 18.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.223 -176.19 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 6.0 t70 -114.56 99.82 7.82 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.44 0.638 . . . . 0.0 110.588 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.644 HD21 HD23 ' E' ' 88' ' ' LEU . 19.7 mt -111.41 140.98 45.55 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.12 116.57 9.62 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.415 174.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -116.7 139.76 50.19 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.525 ' HB2' ' O ' ' E' ' 6' ' ' ALA . 5.3 t -103.31 173.97 6.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.003 0.43 . . . . 0.0 110.613 -177.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.57 1.29 12.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.539 -177.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.06 -5.84 54.41 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 173.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -100.36 151.43 21.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.865 0.364 . . . . 0.0 110.376 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -140.12 132.42 28.29 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 172.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.67 HG22 ' HB2' ' A' ' 46' ' ' ALA . 6.8 pt -139.79 164.64 23.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.011 0.434 . . . . 0.0 111.817 -167.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.502 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 4.5 mtm -118.65 121.74 40.87 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 173.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.509 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 1.0 OUTLIER -103.66 127.92 51.05 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.754 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.656 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 40.4 p90 -153.56 140.77 19.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.256 0.55 . . . . 0.0 111.886 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.682 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 15.2 p -111.9 144.97 40.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.297 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.09 148.66 28.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.31 173.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.85 176.83 41.1 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -176.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -108.53 102.55 11.62 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.046 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.514 ' N ' ' HB3' ' A' ' 15' ' ' PRO . . . -165.88 148.92 7.55 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.363 167.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 27.1 t -103.97 123.98 48.17 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.605 HG23 ' HB3' ' A' ' 13' ' ' MET . 8.0 m -121.01 135.25 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-O 121.349 0.595 . . . . 0.0 111.961 -173.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.1 m -97.47 118.39 33.86 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.908 175.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.61 HD13 HD23 ' A' ' 11' ' ' LEU . 5.0 mp -91.27 140.77 29.48 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 171.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.637 HD23 HD21 ' B' ' 67' ' ' LEU . 0.8 OUTLIER -127.62 143.64 51.14 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -178.254 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 28' ' ' HIS . . . -166.28 -166.97 26.21 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.126 -1.035 . . . . 0.0 112.833 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -142.32 136.6 29.86 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 120.939 0.4 . . . . 0.0 110.676 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.511 HD23 ' HB3' ' A' ' 27' ' ' PHE . 84.5 mt -64.23 119.83 11.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.945 174.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 38.5 t60 -102.22 108.44 19.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.71 -172.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.456 ' HB3' ' H ' ' E' ' 3' ' ' GLY . 2.7 p30 -172.85 -174.32 1.09 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.687 170.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 20.4 pt -129.78 134.22 63.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.775 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -81.3 139.72 35.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.547 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.0 p -74.15 131.49 41.33 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.716 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 157.54 -34.95 0.54 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.094 -0.574 . . . . 0.0 111.745 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.4 p . . . . . 0 C--O 1.251 1.18 0 CA-C-O 118.704 -0.665 . . . . 0.0 110.248 178.149 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.666 0.269 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -89.71 -41.25 12.01 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.132 0.491 . . . . 0.0 110.888 -173.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' GLY . . . . . 0.511 ' H ' ' HB3' ' C' ' 93' ' ' ASP . . . 78.48 -139.79 22.79 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.551 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . 65.96 -173.82 0.18 Allowed 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.105 0.562 . . . . 0.0 111.455 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 68.6 mtm 70.91 -74.25 0.09 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.981 176.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' C' ' 70' ' ' SER . . . -106.05 125.85 51.49 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.876 -174.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 46.9 mtt -119.37 173.81 6.74 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.122 -178.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -82.22 147.44 28.97 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.908 0.385 . . . . 0.0 112.024 -177.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' TRP . . . . . 0.492 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 91.1 t90 -139.24 150.02 45.01 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.458 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.432 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -154.11 152.27 23.87 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.489 178.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.6 HD23 HD13 ' B' ' 87' ' ' LEU . 41.1 tp -143.24 108.41 4.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.749 0.309 . . . . 0.0 110.364 177.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -86.04 99.32 11.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.257 0.551 . . . . 0.0 110.036 175.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' MET . . . . . 0.587 ' HB3' HG23 ' B' ' 85' ' ' VAL . 24.1 tpp -88.0 135.13 33.55 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.86 -175.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -98.86 145.24 29.62 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.075 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.512 ' HB3' ' N ' ' B' ' 83' ' ' ALA . 10.3 Cg_endo -53.01 120.15 7.23 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 123.591 2.861 . . . . 0.0 113.257 -175.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.683 ' HA ' ' O ' ' B' ' 79' ' ' THR . 29.1 mt-10 58.36 62.94 1.84 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.558 0.694 . . . . 0.0 111.628 177.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.54 148.98 46.39 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.586 174.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.653 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 35.1 ttmt -122.62 117.11 25.06 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.596 0.56 . . . . 0.0 111.379 -175.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -110.97 104.23 12.79 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.05 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 9.8 p -88.19 99.98 12.62 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -121.44 149.9 42.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.369 0.604 . . . . 0.0 112.275 -169.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 12.1 t -99.34 160.88 13.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.369 176.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 53.1 mt -118.98 125.7 74.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.05 0.453 . . . . 0.0 111.606 -173.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.464 ' N ' HD12 ' B' ' 24' ' ' ILE . 4.2 mp -106.9 -33.63 2.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.357 177.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -118.94 122.2 41.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.563 177.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' SER . . . . . 0.487 ' CB ' ' HA2' ' A' ' 3' ' ' GLY . 20.3 t -60.81 133.14 55.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.917 -177.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' PHE . . . . . 0.501 ' HB3' HD23 ' B' ' 91' ' ' LEU . 53.8 p90 -137.48 143.17 41.6 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.932 0.872 . . . . 0.0 111.821 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' HIS . . . . . 0.63 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 3.6 t60 -102.4 129.88 49.01 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.1 -1.409 . . . . 0.0 108.823 174.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.607 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 49.2 mt -97.59 130.34 46.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 171.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.63 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 46.8 p -113.97 -17.99 11.85 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.531 -171.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -162.17 149.02 16.87 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 119.567 -1.302 . . . . 0.0 112.961 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.473 HG23 ' HG ' ' B' ' 87' ' ' LEU . 8.2 p -135.17 121.92 34.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 172.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.5 150.23 41.93 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.436 -0.506 . . . . 0.0 112.049 -171.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.523 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.3 pp -114.91 137.58 51.8 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.816 0.817 . . . . 0.0 111.071 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -107.1 -55.46 2.33 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.585 175.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -101.89 127.07 48.88 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 170.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.457 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 148.37 163.57 10.88 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 119.988 -1.101 . . . . 0.0 112.904 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -102.66 -47.23 4.49 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.57 0.224 . . . . 0.0 111.402 177.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -151.89 136.37 16.88 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.62 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.427 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -133.41 113.61 12.73 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.398 0.618 . . . . 0.0 110.419 168.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' B' ' 79' ' ' THR . 65.8 mttp -97.48 109.66 22.37 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 173.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 34.6 tp -85.68 114.75 22.9 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.067 -173.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' TYR . . . . . 0.55 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 66.1 m-85 -116.39 145.82 42.95 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 175.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.521 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.2 OUTLIER -131.4 130.33 42.43 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 172.268 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -108.59 114.2 27.82 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.118 178.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.662 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -125.33 124.32 41.32 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.812 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.516 ' C ' ' HD2' ' B' ' 48' ' ' LYS . 4.2 mm-40 56.36 52.02 10.66 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.688 0.618 . . . . 0.0 111.132 -175.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.516 ' HD2' ' C ' ' B' ' 47' ' ' GLU . 6.7 mptt 58.95 39.63 23.41 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.479 174.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.596 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 24.1 tp60 -138.56 115.95 11.2 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -82.58 111.79 18.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.83 0.348 . . . . 0.0 110.596 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.421 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 80.3 m-85 -101.85 128.91 48.02 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.301 176.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -75.81 102.62 2.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 168.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.476 ' CG1' HD11 ' B' ' 67' ' ' LEU . 2.8 t -76.17 -51.64 19.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.542 -172.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.453 ' HB2' ' CD2' ' B' ' 65' ' ' LEU . . . -156.5 142.16 17.74 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.193 -177.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 42.6 m -105.17 101.45 11.0 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 171.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.403 HG13 ' HB3' ' B' ' 40' ' ' ALA . 7.5 p -115.73 112.51 40.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.788 0.804 . . . . 0.0 110.067 -177.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 68.8 p -123.47 -177.09 3.61 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.054 -176.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -59.16 -32.73 70.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.976 0.417 . . . . 0.0 110.47 169.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.76 -40.59 69.2 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.523 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 76.4 mt -117.6 81.8 15.04 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 174.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.71 -5.64 14.82 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.312 2.675 . . . . 0.0 113.932 -167.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -162.18 122.64 2.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.208 0.528 . . . . 0.0 110.955 -175.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.413 HG11 ' HB1' ' B' ' 54' ' ' ALA . 97.9 t -108.57 113.51 44.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.374 175.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.36 114.85 27.38 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.102 175.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' B' ' 30' ' ' SER . 0.3 OUTLIER -135.46 168.7 18.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.191 -176.197 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 66' ' ' ASP . . . . . 0.527 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 5.9 t70 -114.58 99.7 7.73 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.393 0.616 . . . . 0.0 110.598 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.637 HD21 HD23 ' A' ' 88' ' ' LEU . 19.7 mt -111.35 140.97 45.49 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.17 116.64 9.64 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.351 174.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -116.78 139.68 50.3 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 6' ' ' ALA . 5.3 t -103.3 173.95 6.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.951 0.405 . . . . 0.0 110.633 -177.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.416 ' H ' ' HG3' ' B' ' 71' ' ' LYS . 0.0 OUTLIER -74.56 1.29 12.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.513 -177.009 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.0 -5.89 54.48 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 173.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -100.26 151.33 21.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.964 0.412 . . . . 0.0 110.35 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -140.1 132.48 28.43 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 172.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.662 HG22 ' HB2' ' B' ' 46' ' ' ALA . 6.9 pt -139.87 164.57 23.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.017 0.437 . . . . 0.0 111.837 -167.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.521 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 4.5 mtm -118.59 121.63 40.66 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 173.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 77' ' ' PHE . . . . . 0.518 ' CD1' ' HB2' ' B' ' 44' ' ' LEU . 1.1 m-85 -103.61 127.95 50.97 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.653 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 40.2 p90 -153.59 140.79 19.49 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.255 0.55 . . . . 0.0 111.845 -178.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.683 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 15.3 p -111.91 144.88 40.5 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.224 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.0 148.62 28.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.298 173.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.05 176.84 40.81 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -108.55 102.55 11.62 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.949 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.512 ' N ' ' HB3' ' B' ' 15' ' ' PRO . . . -165.92 148.85 7.47 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.382 167.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 27.2 t -103.94 124.02 48.22 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.587 HG23 ' HB3' ' B' ' 13' ' ' MET . 8.0 m -121.07 135.15 62.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-O 121.361 0.6 . . . . 0.0 111.895 -173.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 69.5 m -97.48 118.45 34.0 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.936 175.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.6 HD13 HD23 ' B' ' 11' ' ' LEU . 5.0 mp -91.27 140.79 29.46 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 171.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.636 HD23 HD21 ' C' ' 67' ' ' LEU . 0.8 OUTLIER -127.67 143.59 51.14 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.242 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 89' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' B' ' 28' ' ' HIS . . . -166.2 -166.92 26.04 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 120.112 -1.042 . . . . 0.0 112.801 -177.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -142.4 136.54 29.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.002 0.43 . . . . 0.0 110.655 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 91' ' ' LEU . . . . . 0.501 HD23 ' HB3' ' B' ' 27' ' ' PHE . 84.8 mt -64.22 119.77 10.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.921 174.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 38.1 t60 -102.11 108.5 19.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.681 -172.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 93' ' ' ASP . . . . . 0.507 ' HB3' ' H ' ' A' ' 3' ' ' GLY . 2.7 p30 -172.86 -174.28 1.08 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.794 170.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 20.2 pt -129.8 134.3 63.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.937 0.398 . . . . 0.0 110.713 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -81.36 139.71 35.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.64 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 4.1 p -74.11 131.48 41.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.743 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . 157.61 -34.91 0.54 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.817 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 12.3 p . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.589 -0.719 . . . . 0.0 110.327 178.153 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 . . . . . 0 N--CA 1.482 1.129 0 CA-C-O 120.794 0.331 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -89.68 -41.4 11.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.196 0.522 . . . . 0.0 110.853 -173.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 3' ' ' GLY . . . . . 0.456 ' HA2' ' CB ' ' D' ' 26' ' ' SER . . . 78.66 -139.79 22.66 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.46 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . 65.94 -173.85 0.18 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.105 0.562 . . . . 0.0 111.404 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 68.6 mtm 70.85 -74.18 0.09 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.03 176.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 6' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' D' ' 70' ' ' SER . . . -106.09 125.84 51.48 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.847 -174.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 7' ' ' MET . . . . . 0.408 ' O ' ' HA ' ' C' ' 90' ' ' TYR . 46.9 mtt -119.29 173.85 6.7 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.122 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 8' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -82.3 147.48 28.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.921 0.391 . . . . 0.0 111.955 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 9' ' ' TRP . . . . . 0.488 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 91.1 t90 -139.32 149.98 44.85 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.421 177.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 10' ' ' GLY . . . . . 0.43 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -154.09 152.29 23.89 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.523 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.626 HD23 HD13 ' C' ' 87' ' ' LEU . 41.2 tp -143.27 108.34 4.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.74 0.305 . . . . 0.0 110.35 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -85.96 99.17 11.24 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.306 0.574 . . . . 0.0 110.099 175.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 13' ' ' MET . . . . . 0.606 ' HB3' HG23 ' C' ' 85' ' ' VAL . 24.1 tpp -87.97 135.1 33.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.888 -175.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -98.78 145.25 29.62 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.077 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 15' ' ' PRO . . . . . 0.518 ' HB3' ' N ' ' C' ' 83' ' ' ALA . 10.3 Cg_endo -53.04 120.14 7.22 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 123.624 2.883 . . . . 0.0 113.287 -175.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 16' ' ' GLU . . . . . 0.686 ' HA ' ' O ' ' C' ' 79' ' ' THR . 29.1 mt-10 58.35 63.0 1.83 Allowed 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.579 0.704 . . . . 0.0 111.658 177.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.63 148.93 46.2 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.518 174.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 18' ' ' LYS . . . . . 0.647 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 35.1 ttmt -122.6 117.09 25.02 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 123.482 0.489 . . . . 0.0 111.351 -175.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -111.01 104.28 12.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.007 177.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 20' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 9.4 p -88.24 100.03 12.67 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 173.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -121.32 150.04 42.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.339 0.59 . . . . 0.0 112.369 -169.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 12.2 t -99.42 160.85 13.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.327 176.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 53.3 mt -119.01 125.7 74.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.01 0.434 . . . . 0.0 111.532 -173.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 24' ' ' ILE . . . . . 0.451 ' N ' HD12 ' C' ' 24' ' ' ILE . 4.2 mp -106.99 -33.52 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.241 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -118.94 122.18 41.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.524 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 26' ' ' SER . . . . . 0.469 ' CB ' ' HA2' ' B' ' 3' ' ' GLY . 20.3 t -60.82 133.13 55.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.837 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 27' ' ' PHE . . . . . 0.491 ' HB3' HD23 ' C' ' 91' ' ' LEU . 53.9 p90 -137.47 143.11 41.6 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.962 0.887 . . . . 0.0 111.906 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 28' ' ' HIS . . . . . 0.645 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 3.5 t60 -102.33 129.84 48.89 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.114 -1.403 . . . . 0.0 108.905 174.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 29' ' ' ILE . . . . . 0.619 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 48.9 mt -97.56 130.27 46.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 171.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.645 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 46.4 p -113.95 -17.98 11.86 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.541 -171.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 31' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -162.2 149.05 16.91 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 119.611 -1.28 . . . . 0.0 112.873 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.464 HG23 ' HG ' ' C' ' 87' ' ' LEU . 8.3 p -135.12 121.9 34.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 172.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.37 150.3 42.23 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.501 -0.48 . . . . 0.0 112.06 -171.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.529 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.3 pp -115.04 137.44 52.0 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.757 0.789 . . . . 0.0 111.147 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -106.96 -55.51 2.32 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.548 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -101.89 127.06 48.88 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 171.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 37' ' ' GLY . . . . . 0.459 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 148.28 163.53 10.84 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.016 -1.088 . . . . 0.0 112.981 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -102.66 -47.26 4.48 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.555 0.217 . . . . 0.0 111.385 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -151.9 136.32 16.84 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.701 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -133.48 113.55 12.63 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.429 0.633 . . . . 0.0 110.42 168.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' C' ' 79' ' ' THR . 65.8 mttp -97.45 109.55 22.28 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 174.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 35.0 tp -85.66 114.69 22.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.047 -173.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 43' ' ' TYR . . . . . 0.553 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 66.4 m-85 -116.37 145.75 42.99 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.513 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 0.2 OUTLIER -131.31 130.35 42.63 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 172.228 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 45' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -108.56 114.1 27.65 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.113 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.68 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -125.34 124.39 41.45 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.759 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 47' ' ' GLU . . . . . 0.519 ' C ' ' HD2' ' C' ' 48' ' ' LYS . 4.3 mm-40 56.37 52.06 10.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.347 0.594 . . . . 0.0 111.071 -175.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.519 ' HD2' ' C ' ' C' ' 47' ' ' GLU . 6.7 mptt 58.91 39.65 23.51 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.492 174.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 49' ' ' GLN . . . . . 0.591 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 24.1 tp60 -138.66 115.96 11.13 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -82.61 111.74 18.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.902 0.382 . . . . 0.0 110.635 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 51' ' ' TYR . . . . . 0.432 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 80.0 m-85 -101.78 128.85 47.95 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.398 176.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -75.78 102.58 2.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 168.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 53' ' ' VAL . . . . . 0.478 ' CG1' HD11 ' C' ' 67' ' ' LEU . 2.8 t -76.17 -51.61 19.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.543 -172.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 54' ' ' ALA . . . . . 0.453 ' HB2' ' CD2' ' C' ' 65' ' ' LEU . . . -156.57 142.15 17.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.133 -177.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 42.4 m -105.21 101.44 10.98 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 171.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.7 112.56 40.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.815 0.817 . . . . 0.0 110.074 -177.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 68.0 p -123.47 -176.98 3.58 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.064 -176.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -59.33 -32.73 70.35 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.418 169.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.66 -40.72 69.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.486 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 76.0 mt -117.53 81.82 14.81 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 174.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.77 -5.73 15.09 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.256 2.637 . . . . 0.0 113.888 -167.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -162.04 122.67 2.59 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.075 0.464 . . . . 0.0 110.963 -175.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 97.8 t -108.6 113.59 44.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.346 175.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.35 114.82 27.35 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.123 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 65' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' C' ' 30' ' ' SER . 0.3 OUTLIER -135.38 168.68 18.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.259 -176.198 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 66' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 5.9 t70 -114.64 99.78 7.78 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.542 0.687 . . . . 0.0 110.595 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.636 HD21 HD23 ' B' ' 88' ' ' LEU . 19.8 mt -111.35 141.02 45.44 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -142.2 116.63 9.61 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.366 174.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -116.81 139.68 50.32 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 70' ' ' SER . . . . . 0.48 ' HB2' ' O ' ' B' ' 6' ' ' ALA . 5.3 t -103.28 173.94 6.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.049 0.452 . . . . 0.0 110.635 -177.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 71' ' ' LYS . . . . . 0.434 ' H ' ' HG3' ' C' ' 71' ' ' LYS . 0.0 OUTLIER -74.53 1.3 12.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.487 -176.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.09 -5.75 54.45 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 173.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -100.36 151.32 21.64 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.793 0.33 . . . . 0.0 110.432 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -140.13 132.36 28.18 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 172.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.68 HG22 ' HB2' ' C' ' 46' ' ' ALA . 6.8 pt -139.74 164.5 23.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.966 0.412 . . . . 0.0 111.888 -167.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.506 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 4.5 mtm -118.57 121.68 40.79 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 173.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 77' ' ' PHE . . . . . 0.513 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 1.1 m-85 -103.65 128.02 51.01 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 78' ' ' TYR . . . . . 0.647 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 40.3 p90 -153.56 140.87 19.6 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.218 0.532 . . . . 0.0 111.879 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 79' ' ' THR . . . . . 0.686 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 15.2 p -112.0 144.98 40.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.22 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.1 148.83 28.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.248 173.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.71 176.89 41.31 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -176.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -108.55 102.45 11.52 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.019 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 83' ' ' ALA . . . . . 0.518 ' N ' ' HB3' ' C' ' 15' ' ' PRO . . . -165.83 148.93 7.61 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.356 167.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 27.1 t -104.0 123.89 48.01 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.606 HG23 ' HB3' ' C' ' 13' ' ' MET . 8.2 m -120.89 135.2 61.86 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 CA-C-O 121.323 0.582 . . . . 0.0 112.007 -173.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 68.7 m -97.39 118.32 33.6 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.439 -0.8 . . . . 0.0 108.957 175.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 87' ' ' LEU . . . . . 0.626 HD13 HD23 ' C' ' 11' ' ' LEU . 5.0 mp -91.16 140.83 29.44 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 171.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 88' ' ' LEU . . . . . 0.623 HD23 HD21 ' D' ' 67' ' ' LEU . 0.8 OUTLIER -127.66 143.58 51.14 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -178.253 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 89' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' C' ' 28' ' ' HIS . . . -166.26 -166.95 26.16 Favored Glycine 0 N--CA 1.439 -1.166 0 C-N-CA 120.051 -1.071 . . . . 0.0 112.738 -177.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 90' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' C' ' 7' ' ' MET . 5.1 p90 -142.31 136.59 29.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.984 0.421 . . . . 0.0 110.623 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 91' ' ' LEU . . . . . 0.491 HD23 ' HB3' ' C' ' 27' ' ' PHE . 84.7 mt -64.24 119.82 10.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.88 174.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -102.11 108.43 19.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.735 -172.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 93' ' ' ASP . . . . . 0.511 ' HB3' ' H ' ' B' ' 3' ' ' GLY . 2.7 p30 -172.87 -174.28 1.08 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.826 170.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 20.4 pt -129.82 134.25 63.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.022 0.439 . . . . 0.0 110.74 -178.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.24 139.7 35.33 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.671 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 4.0 p -74.18 131.56 41.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.713 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 157.58 -34.96 0.54 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.744 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 12.7 p . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.646 -0.693 . . . . 0.0 110.241 178.164 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.69 0.281 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -89.62 -41.34 12.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.248 0.547 . . . . 0.0 110.9 -173.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 3' ' ' GLY . . . . . 0.487 ' H ' ' HB3' ' E' ' 93' ' ' ASP . . . 78.64 -139.79 22.67 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.543 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . 65.87 -173.86 0.18 Allowed 'General case' 0 C--O 1.236 0.349 0 O-C-N 124.099 0.529 . . . . 0.0 111.51 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 68.5 mtm 71.04 -74.31 0.09 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.344 0.657 . . . . 0.0 111.945 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 6' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' E' ' 70' ' ' SER . . . -105.99 125.79 51.42 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.848 -174.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 47.1 mtt -119.31 173.86 6.7 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.053 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 8' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -82.27 147.49 28.88 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.919 0.39 . . . . 0.0 111.93 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 9' ' ' TRP . . . . . 0.49 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 91.2 t90 -139.3 149.94 44.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.45 177.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -154.12 152.3 23.9 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.511 178.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.624 HD23 HD13 ' D' ' 87' ' ' LEU . 40.8 tp -143.23 108.37 4.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.751 0.31 . . . . 0.0 110.344 177.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -86.15 99.42 11.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.375 0.607 . . . . 0.0 110.053 175.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 13' ' ' MET . . . . . 0.615 ' HB3' HG23 ' D' ' 85' ' ' VAL . 24.0 tpp -88.07 135.09 33.58 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.868 -175.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -98.84 145.13 29.41 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.158 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 15' ' ' PRO . . . . . 0.516 ' HB3' ' N ' ' D' ' 83' ' ' ALA . 10.3 Cg_endo -52.93 120.08 7.08 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.642 2.895 . . . . 0.0 113.237 -175.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 16' ' ' GLU . . . . . 0.677 ' HA ' ' O ' ' D' ' 79' ' ' THR . 28.9 mt-10 58.44 62.92 1.84 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.634 177.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.5 148.86 46.35 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.613 174.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 18' ' ' LYS . . . . . 0.665 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 35.1 ttmt -122.54 117.13 25.17 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 123.556 0.535 . . . . 0.0 111.386 -175.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -111.03 104.23 12.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.022 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 20' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 9.5 p -88.23 99.86 12.54 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 173.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -121.31 149.93 42.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.443 0.64 . . . . 0.0 112.373 -169.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 12.1 t -99.32 160.87 13.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.349 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 53.0 mt -118.97 125.74 74.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.012 0.434 . . . . 0.0 111.562 -173.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 24' ' ' ILE . . . . . 0.457 HD12 ' N ' ' D' ' 24' ' ' ILE . 4.2 mp -106.95 -33.56 2.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.311 177.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -118.94 122.16 41.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.587 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 26' ' ' SER . . . . . 0.456 ' CB ' ' HA2' ' C' ' 3' ' ' GLY . 20.4 t -60.72 133.06 55.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.856 -177.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 27' ' ' PHE . . . . . 0.499 ' HB3' HD23 ' D' ' 91' ' ' LEU . 53.9 p90 -137.42 143.1 41.71 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.87 0.843 . . . . 0.0 111.981 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 28' ' ' HIS . . . . . 0.631 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 3.5 t60 -102.37 129.88 48.96 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.839 174.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 29' ' ' ILE . . . . . 0.617 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 48.8 mt -97.5 130.33 46.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 171.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 30' ' ' SER . . . . . 0.631 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 45.7 p -114.0 -18.06 11.82 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 120.973 0.416 . . . . 0.0 111.587 -171.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 31' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -162.15 149.01 16.87 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 119.573 -1.299 . . . . 0.0 113.022 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.466 HG23 ' HG ' ' D' ' 87' ' ' LEU . 8.2 p -135.15 121.95 34.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 172.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.46 150.33 42.12 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.47 -0.492 . . . . 0.0 112.038 -171.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 34' ' ' LEU . . . . . 0.523 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.3 pp -114.99 137.5 51.92 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.785 0.802 . . . . 0.0 111.116 178.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -107.0 -55.46 2.33 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.502 -1.227 . . . . 0.0 108.615 175.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -101.96 127.06 48.98 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.857 171.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 37' ' ' GLY . . . . . 0.453 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 148.32 163.57 10.87 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.01 -1.091 . . . . 0.0 112.991 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -102.69 -47.23 4.48 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.408 177.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -151.84 136.39 16.95 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.669 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 40' ' ' ALA . . . . . 0.43 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -133.5 113.59 12.65 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.453 0.644 . . . . 0.0 110.402 168.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' D' ' 79' ' ' THR . 65.8 mttp -97.41 109.51 22.25 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 173.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 34.9 tp -85.63 114.77 22.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.087 -173.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 43' ' ' TYR . . . . . 0.544 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 66.1 m-85 -116.43 145.81 43.0 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 175.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.51 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.2 OUTLIER -131.45 130.33 42.34 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 172.342 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 45' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -108.58 114.02 27.5 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.102 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.672 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -125.28 124.37 41.48 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.832 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 47' ' ' GLU . . . . . 0.519 ' C ' ' HD2' ' D' ' 48' ' ' LYS . 4.3 mm-40 56.48 51.97 10.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.297 0.57 . . . . 0.0 111.042 -175.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 48' ' ' LYS . . . . . 0.519 ' HD2' ' C ' ' D' ' 47' ' ' GLU . 6.7 mptt 58.93 39.65 23.45 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.413 174.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 49' ' ' GLN . . . . . 0.585 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 24.7 tp60 -138.57 115.93 11.17 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -82.5 111.72 18.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.873 0.368 . . . . 0.0 110.713 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 51' ' ' TYR . . . . . 0.43 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 80.1 m-85 -101.82 128.85 47.99 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.278 176.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -75.73 102.61 2.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 168.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 53' ' ' VAL . . . . . 0.479 ' CG1' HD11 ' D' ' 67' ' ' LEU . 2.8 t -76.25 -51.54 19.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.542 -172.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 54' ' ' ALA . . . . . 0.451 ' HB2' ' CD2' ' D' ' 65' ' ' LEU . . . -156.59 142.0 17.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.207 -177.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 41.9 m -105.05 101.42 10.98 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 171.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 56' ' ' VAL . . . . . 0.402 HG13 ' HB3' ' D' ' 40' ' ' ALA . 7.5 p -115.71 112.65 40.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.801 0.81 . . . . 0.0 110.039 -177.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 70.0 p -123.54 -177.0 3.59 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.026 -176.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -59.19 -32.87 70.31 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.037 0.446 . . . . 0.0 110.434 169.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.6 -40.65 69.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.572 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 75.9 mt -117.53 81.79 14.77 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 174.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.72 -5.68 14.92 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.186 2.591 . . . . 0.0 114.007 -167.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -162.11 122.78 2.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.196 0.522 . . . . 0.0 110.916 -175.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.42 HG11 ' HB1' ' D' ' 54' ' ' ALA . 98.3 t -108.66 113.45 44.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.382 175.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.34 114.87 27.42 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.096 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 65' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' D' ' 30' ' ' SER . 0.3 OUTLIER -135.52 168.63 18.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.182 -176.185 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 66' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 5.9 t70 -114.52 99.82 7.83 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.407 0.622 . . . . 0.0 110.545 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.623 HD21 HD23 ' C' ' 88' ' ' LEU . 19.8 mt -111.4 141.0 45.53 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 175.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.17 116.62 9.63 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.384 174.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -116.8 139.76 50.22 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 70' ' ' SER . . . . . 0.527 ' HB2' ' O ' ' C' ' 6' ' ' ALA . 5.3 t -103.28 173.97 6.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.982 0.42 . . . . 0.0 110.643 -177.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 71' ' ' LYS . . . . . 0.404 ' HG3' ' H ' ' D' ' 71' ' ' LYS . 0.0 OUTLIER -74.62 1.38 12.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.53 -177.034 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.04 -5.95 54.35 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -100.3 151.4 21.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.825 0.345 . . . . 0.0 110.426 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -140.16 132.41 28.22 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 172.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.672 HG22 ' HB2' ' D' ' 46' ' ' ALA . 6.8 pt -139.91 164.53 23.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.97 0.414 . . . . 0.0 111.803 -167.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 76' ' ' MET . . . . . 0.507 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 4.5 mtm -118.52 121.63 40.72 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 173.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 77' ' ' PHE . . . . . 0.51 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 1.1 m-85 -103.61 127.96 50.97 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 78' ' ' TYR . . . . . 0.665 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 40.2 p90 -153.61 140.88 19.56 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.229 0.538 . . . . 0.0 111.85 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 79' ' ' THR . . . . . 0.677 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 15.0 p -112.01 145.02 40.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.18 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.19 148.66 28.6 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.297 173.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.95 176.86 40.96 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -108.53 102.58 11.65 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.033 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 83' ' ' ALA . . . . . 0.516 ' N ' ' HB3' ' D' ' 15' ' ' PRO . . . -165.87 148.89 7.54 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.329 167.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 26.9 t -103.95 124.02 48.23 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.615 HG23 ' HB3' ' D' ' 13' ' ' MET . 8.2 m -120.95 135.1 62.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.338 0.589 . . . . 0.0 111.933 -173.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 68.5 m -97.38 118.5 34.0 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.964 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 87' ' ' LEU . . . . . 0.624 HD13 HD23 ' D' ' 11' ' ' LEU . 5.0 mp -91.33 140.87 29.37 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 171.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.636 HD23 HD21 ' E' ' 67' ' ' LEU . 0.8 OUTLIER -127.75 143.58 51.13 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -178.207 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 89' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' D' ' 28' ' ' HIS . . . -166.21 -167.0 26.18 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 120.102 -1.047 . . . . 0.0 112.777 -177.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -142.29 136.56 29.89 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 120.948 0.404 . . . . 0.0 110.609 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 91' ' ' LEU . . . . . 0.499 HD23 ' HB3' ' D' ' 27' ' ' PHE . 84.5 mt -64.25 119.65 10.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.999 174.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 38.2 t60 -101.95 108.42 19.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.784 -172.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 93' ' ' ASP . . . . . 0.426 ' HB3' ' H ' ' C' ' 3' ' ' GLY . 2.7 p30 -172.81 -174.32 1.1 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.683 170.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 20.6 pt -129.73 134.24 63.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.962 0.41 . . . . 0.0 110.777 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -81.41 139.79 35.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.517 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 4.1 p -74.25 131.55 41.3 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.695 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . 157.58 -35.0 0.54 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.788 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 12.6 p . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.552 -0.737 . . . . 0.0 110.263 178.158 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 120.813 0.34 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -89.68 -41.31 12.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.156 0.503 . . . . 0.0 110.924 -173.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 3' ' ' GLY . . . . . 0.486 ' HA2' ' CB ' ' A' ' 26' ' ' SER . . . 78.61 -139.82 22.73 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.528 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . 66.03 -173.82 0.18 Allowed 'General case' 0 C--O 1.236 0.358 0 O-C-N 124.089 0.523 . . . . 0.0 111.493 178.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 68.6 mtm 70.89 -74.29 0.09 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.904 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 6' ' ' ALA . . . . . 0.525 ' O ' ' HB2' ' A' ' 70' ' ' SER . . . -106.05 125.72 51.33 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.832 -174.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 7' ' ' MET . . . . . 0.402 ' O ' ' HA ' ' E' ' 90' ' ' TYR . 47.0 mtt -119.25 173.8 6.73 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.2 -178.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 8' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -82.2 147.55 28.93 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.888 0.375 . . . . 0.0 111.988 -177.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 9' ' ' TRP . . . . . 0.485 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 90.9 t90 -139.31 149.97 44.85 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 10' ' ' GLY . . . . . 0.438 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -154.14 152.28 23.88 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.446 178.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 11' ' ' LEU . . . . . 0.609 HD23 HD13 ' E' ' 87' ' ' LEU . 41.4 tp -143.17 108.3 4.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.735 0.302 . . . . 0.0 110.359 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -86.12 99.33 11.43 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.334 0.587 . . . . 0.0 110.042 175.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 13' ' ' MET . . . . . 0.614 ' HB3' HG23 ' E' ' 85' ' ' VAL . 23.9 tpp -88.0 135.12 33.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.853 -175.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -98.75 145.18 29.49 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.13 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 15' ' ' PRO . . . . . 0.511 ' HB3' ' N ' ' E' ' 83' ' ' ALA . 10.3 Cg_endo -52.97 120.07 7.09 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 123.653 2.902 . . . . 0.0 113.254 -175.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 16' ' ' GLU . . . . . 0.682 ' HA ' ' O ' ' E' ' 79' ' ' THR . 29.0 mt-10 58.44 62.88 1.85 Allowed 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 121.526 0.679 . . . . 0.0 111.653 177.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.49 148.92 46.42 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.578 174.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 18' ' ' LYS . . . . . 0.648 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 35.1 ttmt -122.61 117.17 25.19 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 123.569 0.543 . . . . 0.0 111.316 -175.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -111.02 104.39 12.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.993 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 20' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' E' ' 76' ' ' MET . 9.9 p -88.34 99.99 12.68 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 173.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -121.3 150.0 42.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.386 0.613 . . . . 0.0 112.33 -169.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 12.2 t -99.3 160.81 14.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.331 176.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 52.9 mt -118.94 125.75 74.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.113 0.482 . . . . 0.0 111.663 -173.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 24' ' ' ILE . . . . . 0.451 HD12 ' N ' ' E' ' 24' ' ' ILE . 4.2 mp -106.98 -33.57 2.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.283 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -118.93 122.23 41.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.55 177.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 26' ' ' SER . . . . . 0.444 ' CB ' ' HA2' ' D' ' 3' ' ' GLY . 20.5 t -60.81 133.06 55.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.829 -177.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 27' ' ' PHE . . . . . 0.499 ' HB3' HD23 ' E' ' 91' ' ' LEU . 53.9 p90 -137.38 143.18 41.82 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.925 0.869 . . . . 0.0 111.954 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 28' ' ' HIS . . . . . 0.64 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 3.5 t60 -102.49 129.92 49.16 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.769 174.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 29' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 49.0 mt -97.44 130.3 46.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 171.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 30' ' ' SER . . . . . 0.64 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 46.5 p -114.0 -17.92 11.85 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.612 -171.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 31' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -162.23 148.97 16.72 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 119.656 -1.259 . . . . 0.0 112.984 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.469 HG23 ' HG ' ' E' ' 87' ' ' LEU . 8.3 p -135.11 121.92 34.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 172.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.47 150.24 41.99 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.52 -0.472 . . . . 0.0 112.01 -171.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 34' ' ' LEU . . . . . 0.528 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.3 pp -114.96 137.55 51.86 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.735 0.779 . . . . 0.0 111.111 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -107.07 -55.52 2.32 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.593 175.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -101.77 127.05 48.72 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 37' ' ' GLY . . . . . 0.455 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 148.28 163.55 10.84 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 119.995 -1.097 . . . . 0.0 112.998 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -102.7 -47.15 4.51 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.419 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -151.87 136.34 16.88 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.643 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 40' ' ' ALA . . . . . 0.428 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -133.41 113.56 12.68 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.451 0.643 . . . . 0.0 110.404 168.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 41' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' E' ' 79' ' ' THR . 65.8 mttp -97.36 109.57 22.3 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 34.5 tp -85.62 114.67 22.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.067 -173.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 43' ' ' TYR . . . . . 0.55 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 66.2 m-85 -116.37 145.77 42.98 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 44' ' ' LEU . . . . . 0.513 ' HB2' ' CD1' ' E' ' 77' ' ' PHE . 0.2 OUTLIER -131.37 130.41 42.59 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 172.288 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 45' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -108.67 114.09 27.6 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.145 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 46' ' ' ALA . . . . . 0.668 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -125.32 124.26 41.19 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.753 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 47' ' ' GLU . . . . . 0.518 ' C ' ' HD2' ' E' ' 48' ' ' LYS . 4.2 mm-40 56.57 52.03 10.37 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.663 0.602 . . . . 0.0 110.977 -175.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 48' ' ' LYS . . . . . 0.518 ' HD2' ' C ' ' E' ' 47' ' ' GLU . 6.7 mptt 59.0 39.5 23.43 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.493 174.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 49' ' ' GLN . . . . . 0.586 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 24.2 tp60 -138.61 116.03 11.22 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -82.55 111.73 18.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.897 0.379 . . . . 0.0 110.631 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -101.86 128.87 48.04 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.336 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -75.76 102.57 2.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 168.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 53' ' ' VAL . . . . . 0.472 ' CG1' HD11 ' E' ' 67' ' ' LEU . 2.8 t -76.22 -51.51 19.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.516 -172.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 54' ' ' ALA . . . . . 0.449 ' HB2' ' CD2' ' E' ' 65' ' ' LEU . . . -156.54 142.07 17.63 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.262 -177.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 43.3 m -105.14 101.45 11.0 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 171.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 56' ' ' VAL . . . . . 0.4 HG13 ' HB3' ' E' ' 40' ' ' ALA . 7.5 p -115.75 112.67 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-O 121.759 0.79 . . . . 0.0 110.033 -177.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 69.4 p -123.59 -177.07 3.62 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.008 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -59.18 -32.87 70.3 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.914 0.388 . . . . 0.0 110.385 169.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.62 -40.62 69.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.526 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 76.2 mt -117.58 81.77 14.93 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.67 -5.73 15.0 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.257 2.638 . . . . 0.0 113.965 -167.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -162.07 122.66 2.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.202 0.525 . . . . 0.0 110.925 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 63' ' ' VAL . . . . . 0.42 HG11 ' HB1' ' E' ' 54' ' ' ALA . 97.4 t -108.62 113.56 44.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.307 175.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.32 114.83 27.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.122 175.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' E' ' 30' ' ' SER . 0.3 OUTLIER -135.42 168.6 18.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.263 -176.244 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 66' ' ' ASP . . . . . 0.546 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 6.0 t70 -114.53 99.75 7.78 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.43 0.633 . . . . 0.0 110.66 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 67' ' ' LEU . . . . . 0.636 HD21 HD23 ' D' ' 88' ' ' LEU . 19.7 mt -111.35 140.99 45.47 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.13 116.57 9.62 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.417 174.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -116.72 139.74 50.21 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 70' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' D' ' 6' ' ' ALA . 5.3 t -103.31 173.92 6.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.977 0.418 . . . . 0.0 110.635 -177.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.59 1.37 12.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.516 -177.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.05 -5.98 54.3 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 173.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -100.26 151.33 21.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.769 0.319 . . . . 0.0 110.465 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -140.02 132.42 28.46 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 172.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 75' ' ' ILE . . . . . 0.668 HG22 ' HB2' ' E' ' 46' ' ' ALA . 6.8 pt -139.83 164.58 23.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.973 0.416 . . . . 0.0 111.87 -167.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 76' ' ' MET . . . . . 0.505 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 4.5 mtm -118.58 121.68 40.79 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 77' ' ' PHE . . . . . 0.513 ' CD1' ' HB2' ' E' ' 44' ' ' LEU . 1.0 OUTLIER -103.73 127.98 51.15 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.738 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 78' ' ' TYR . . . . . 0.648 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 40.1 p90 -153.51 140.9 19.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.213 0.53 . . . . 0.0 111.905 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 79' ' ' THR . . . . . 0.682 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 14.7 p -111.98 144.99 40.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.17 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.24 148.66 28.66 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.214 173.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.87 176.83 41.08 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -176.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -108.56 102.56 11.63 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.949 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 83' ' ' ALA . . . . . 0.511 ' N ' ' HB3' ' E' ' 15' ' ' PRO . . . -165.9 148.86 7.5 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.39 167.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 27.2 t -103.95 123.93 48.06 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 85' ' ' VAL . . . . . 0.614 HG23 ' HB3' ' E' ' 13' ' ' MET . 8.1 m -120.87 135.2 61.81 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-O 121.377 0.608 . . . . 0.0 112.005 -173.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 69.1 m -97.48 118.38 33.84 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.455 -0.793 . . . . 0.0 108.866 175.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 87' ' ' LEU . . . . . 0.609 HD13 HD23 ' E' ' 11' ' ' LEU . 5.0 mp -91.27 140.81 29.44 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 171.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 88' ' ' LEU . . . . . 0.644 HD23 HD21 ' A' ' 67' ' ' LEU . 0.8 OUTLIER -127.67 143.64 51.14 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -178.247 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 89' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' E' ' 28' ' ' HIS . . . -166.22 -166.98 26.16 Favored Glycine 0 N--CA 1.438 -1.185 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.799 -177.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 90' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' E' ' 7' ' ' MET . 5.2 p90 -142.29 136.62 29.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.954 0.407 . . . . 0.0 110.632 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 91' ' ' LEU . . . . . 0.499 HD23 ' HB3' ' E' ' 27' ' ' PHE . 84.4 mt -64.21 119.74 10.81 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.953 174.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 38.2 t60 -102.14 108.45 19.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.694 -172.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 93' ' ' ASP . . . . . 0.487 ' HB3' ' H ' ' D' ' 3' ' ' GLY . 2.7 p30 -172.86 -174.27 1.08 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.73 170.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 20.5 pt -129.83 134.24 63.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.745 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -81.32 139.76 35.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.584 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 4.0 p -74.24 131.48 41.25 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.734 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . 157.56 -34.92 0.54 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.795 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 12.4 p . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.646 -0.692 . . . . 0.0 110.266 178.119 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 120.976 0.417 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -136.16 163.62 29.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.17 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 122.3 25.57 1.99 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.209 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.425 ' HB3' HG13 ' B' ' 94' ' ' ILE . . . -167.31 53.43 0.07 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.037 0.446 . . . . 0.0 110.071 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.42 ' HB3' ' OG ' ' B' ' 70' ' ' SER . 3.6 mpp? -111.15 67.63 0.65 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.02 -174.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.48 ' HB3' ' ND2' ' B' ' 68' ' ' ASN . . . -60.81 131.37 50.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.77 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -81.33 150.88 28.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.164 0.507 . . . . 0.0 111.674 -174.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.64 ' CE1' HD21 ' B' ' 44' ' ' LEU . 31.1 t80 -72.26 145.87 47.63 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.409 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.422 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 92.1 t90 -134.31 147.97 50.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.391 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.502 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -152.25 154.92 25.83 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.855 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.526 HD23 HD13 ' A' ' 87' ' ' LEU . 49.8 tp -147.38 108.26 4.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.857 0.36 . . . . 0.0 111.019 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -90.42 119.94 31.12 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.963 0.411 . . . . 0.0 110.545 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.694 ' SD ' ' HE2' ' A' ' 19' ' ' TYR . 52.9 mmm -99.96 139.67 35.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.226 -175.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -100.32 145.06 29.62 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.583 174.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.468 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 11.0 Cg_endo -55.14 116.29 3.04 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.147 2.565 . . . . 0.0 112.925 -177.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 62.92 64.85 0.84 Allowed 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.876 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -145.71 138.78 26.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.682 173.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.728 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 86.4 mttt -107.1 126.54 52.49 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -176.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.694 ' HE2' ' SD ' ' A' ' 13' ' ' MET . 1.2 m-85 -112.6 103.84 11.9 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.192 174.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.0 p -88.37 100.33 12.94 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 174.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -113.24 144.37 42.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.434 0.635 . . . . 0.0 111.872 -170.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.5 m -101.95 140.91 35.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.556 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.403 HG22 ' HA ' ' A' ' 71' ' ' LYS . 74.1 mt -99.38 120.14 48.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.217 0.532 . . . . 0.0 111.723 -171.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.753 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -105.65 -9.84 10.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.276 176.044 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.516 ' HD2' HD13 ' A' ' 91' ' ' LEU . 35.5 pttt -141.55 119.16 11.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.872 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.9 p -67.05 133.67 50.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.809 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.671 ' HB3' HD23 ' A' ' 91' ' ' LEU . 32.6 p90 -147.56 166.49 27.19 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -173.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.554 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 9.4 t60 -118.88 126.21 51.27 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.908 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 42.6 mt -92.23 136.16 25.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 170.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.513 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 64.2 p -123.68 -5.66 8.09 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -170.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.46 160.79 27.76 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 119.086 -1.531 . . . . 0.0 113.823 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.466 HG23 ' HG ' ' A' ' 87' ' ' LEU . 11.5 p -144.5 129.96 14.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 174.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.45 157.7 43.97 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.012 -0.43 . . . . 0.0 111.482 -176.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.649 ' HB3' HG12 ' A' ' 85' ' ' VAL . 3.9 pp -122.05 145.3 48.28 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.795 0.807 . . . . 0.0 111.846 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -107.72 -56.02 2.28 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.64 173.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -103.14 127.26 50.49 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.368 173.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.59 ' O ' ' HG3' ' A' ' 58' ' ' LYS . . . 145.13 159.38 8.07 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 119.958 -1.115 . . . . 0.0 112.896 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -102.43 -45.61 5.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.477 0.18 . . . . 0.0 111.459 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -150.56 127.27 10.93 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 120.582 0.229 . . . . 0.0 111.056 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.519 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -127.42 114.94 18.17 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.295 0.569 . . . . 0.0 110.479 171.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 79' ' ' THR . 3.7 mppt? -95.1 112.05 23.8 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 174.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.6 tp -84.18 108.87 17.32 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -108.59 144.31 36.47 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.267 0.556 . . . . 0.0 110.073 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.674 HD21 ' CE1' ' E' ' 8' ' ' PHE . 0.2 OUTLIER -129.23 116.64 19.47 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.413 174.454 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -103.45 110.52 22.58 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.251 0.548 . . . . 0.0 109.706 177.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.52 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -140.13 145.58 37.75 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.333 -177.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 58.11 33.14 22.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.474 0.654 . . . . 0.0 109.774 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 62.59 38.13 12.55 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.814 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.545 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 6.5 tp-100 -140.66 138.92 34.67 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 178.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -90.92 110.04 21.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.88 0.371 . . . . 0.0 110.405 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.536 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 78.2 m-85 -101.82 130.65 48.32 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.473 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -85.24 101.86 10.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.74 0.781 . . . . 0.0 109.03 172.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.609 ' CG2' ' HB3' ' A' ' 44' ' ' LEU . 2.9 t -76.33 -49.81 23.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.72 -171.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.545 ' HB2' HD21 ' A' ' 65' ' ' LEU . . . -154.02 146.69 24.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.451 -177.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.5 m -111.06 100.94 9.53 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 170.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.464 HG11 HG11 ' A' ' 85' ' ' VAL . 7.5 p -115.8 114.65 46.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.665 0.745 . . . . 0.0 109.808 -176.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 78.0 p -122.86 -178.32 3.91 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.51 -173.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.59 ' HG3' ' O ' ' A' ' 37' ' ' GLY . 6.1 mttm -61.41 -29.9 70.23 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.012 0.434 . . . . 0.0 110.407 169.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.27 -40.2 52.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.431 178.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.2 mt -115.55 81.38 8.87 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -69.13 -0.47 6.44 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.152 2.568 . . . . 0.0 113.984 -167.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -163.06 130.24 3.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.361 0.601 . . . . 0.0 111.319 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 96.3 t -118.88 120.81 65.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.377 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.18 131.61 35.31 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 175.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.545 HD21 ' HB2' ' A' ' 54' ' ' ALA . 82.5 mt -124.0 167.14 14.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.449 0.642 . . . . 0.0 112.36 -173.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.451 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 14.4 t0 -143.15 99.18 3.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.514 170.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.596 HD21 HD23 ' E' ' 88' ' ' LEU . 2.4 mt -128.09 140.04 52.17 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.408 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.492 ' ND2' ' HB3' ' E' ' 6' ' ' ALA . 5.3 t30 -135.2 122.71 21.99 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.754 174.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -116.14 143.75 45.07 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.49 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.423 ' OG ' ' HB3' ' E' ' 5' ' ' MET . 34.1 t -94.34 166.24 12.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.239 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.403 ' HA ' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -74.57 -7.05 51.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.164 0.506 . . . . 0.0 110.138 178.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.86 -8.16 62.16 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.494 174.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -93.71 144.62 25.23 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -136.12 127.74 28.88 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 171.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.52 HG22 ' HB2' ' A' ' 46' ' ' ALA . 8.5 pt -135.5 160.31 39.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.581 -163.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.436 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 3.0 mtm -114.05 120.39 40.41 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.499 172.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.651 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -103.67 127.85 51.07 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 176.235 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.728 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 53.0 p90 -156.4 143.15 18.66 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 119.735 -0.786 . . . . 0.0 112.238 -176.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 2.0 p -114.92 132.11 56.66 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.301 -176.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.42 160.65 14.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.797 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.02 -175.67 40.08 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -175.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -110.4 102.53 11.16 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.877 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -174.51 155.7 2.3 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.557 171.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.5 t -115.92 117.26 29.67 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.371 -0.604 . . . . 0.0 109.371 177.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.649 HG12 ' HB3' ' A' ' 34' ' ' LEU . 3.7 m -111.34 164.97 6.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.213 0.53 . . . . 0.0 112.126 -174.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 21.2 t -129.76 120.85 25.74 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.125 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.526 HD13 HD23 ' A' ' 11' ' ' LEU . 5.3 mp -92.86 154.43 18.23 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 121.004 0.43 . . . . 0.0 110.172 173.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.599 HD23 HD21 ' B' ' 67' ' ' LEU . 0.2 OUTLIER -133.7 144.66 49.28 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.105 179.827 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.97 -167.45 28.64 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.01 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -145.99 136.48 24.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.513 0.673 . . . . 0.0 111.651 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.671 HD23 ' HB3' ' A' ' 27' ' ' PHE . 26.6 mt -77.66 137.28 38.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.495 175.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -73.15 119.17 17.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.012 0.434 . . . . 0.0 110.652 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -89.01 -6.64 57.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.863 0.839 . . . . 0.0 109.296 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.9 mp 69.93 86.77 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.303 -176.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.85 110.88 5.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.382 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.473 ' HA ' ' C ' ' E' ' 97' ' ' GLY . 20.2 m -79.17 -36.12 40.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.737 -177.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.504 ' C ' ' HA ' ' B' ' 96' ' ' SER . . . 72.91 -67.99 1.34 Allowed Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.736 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 C--O 1.251 1.145 0 CA-C-O 118.261 -0.876 . . . . 0.0 109.794 -178.052 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 . . . . . 0 N--CA 1.477 0.922 0 CA-C-O 120.949 0.404 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -136.18 163.58 30.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.22 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 122.3 25.53 2.0 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.266 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -167.36 53.44 0.07 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.115 0.483 . . . . 0.0 110.119 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' MET . . . . . 0.464 ' HB3' ' OG ' ' C' ' 70' ' ' SER . 3.6 mpp? -111.1 67.56 0.64 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.043 -174.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.464 ' HB3' ' ND2' ' C' ' 68' ' ' ASN . . . -60.75 131.4 50.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.901 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -81.36 150.77 28.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.188 0.518 . . . . 0.0 111.631 -174.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.655 ' CE1' HD21 ' C' ' 44' ' ' LEU . 31.8 t80 -72.13 145.8 47.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.462 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' TRP . . . . . 0.423 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 92.1 t90 -134.26 147.95 50.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.474 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.528 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -152.27 154.92 25.83 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.85 178.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.541 HD23 HD13 ' B' ' 87' ' ' LEU . 49.4 tp -147.37 108.34 4.21 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.856 0.36 . . . . 0.0 110.992 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -90.41 120.15 31.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.895 0.378 . . . . 0.0 110.479 176.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' MET . . . . . 0.705 ' SD ' ' HE2' ' B' ' 19' ' ' TYR . 53.4 mmm -100.1 139.62 35.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.145 -175.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -100.28 145.05 29.59 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.636 174.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.476 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 11.1 Cg_endo -55.15 116.26 3.02 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.136 2.558 . . . . 0.0 112.943 -177.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 62.96 64.85 0.84 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.89 176.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -145.74 138.89 26.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.622 173.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.734 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 86.4 mttt -107.26 126.39 52.36 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -176.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' TYR . . . . . 0.705 ' HE2' ' SD ' ' B' ' 13' ' ' MET . 1.2 m-85 -112.41 103.73 11.85 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.221 174.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 9.2 p -88.31 100.38 12.96 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -113.29 144.42 42.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.889 -170.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 27.6 m -101.94 140.96 35.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.521 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.405 HG22 ' HA ' ' B' ' 71' ' ' LYS . 73.6 mt -99.42 120.14 48.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.26 0.552 . . . . 0.0 111.754 -171.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.749 ' H ' HD13 ' B' ' 24' ' ' ILE . 0.2 OUTLIER -105.54 -9.88 10.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.323 175.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.5 ' HD2' HD13 ' B' ' 91' ' ' LEU . 35.4 pttt -141.52 119.11 11.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.872 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 5.9 p -67.02 133.75 50.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.818 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' PHE . . . . . 0.666 ' HB3' HD23 ' B' ' 91' ' ' LEU . 32.9 p90 -147.59 166.42 27.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.668 0.747 . . . . 0.0 112.922 -173.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' HIS . . . . . 0.543 ' HA ' ' O ' ' B' ' 67' ' ' LEU . 9.3 t60 -118.82 126.23 51.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.964 178.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.534 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 43.3 mt -92.28 136.18 25.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 170.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.512 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 64.2 p -123.73 -5.67 8.06 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -170.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.41 160.77 27.77 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 119.032 -1.556 . . . . 0.0 113.823 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.473 HG23 ' HG ' ' B' ' 87' ' ' LEU . 11.4 p -144.52 130.02 14.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 173.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.41 157.7 43.97 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 122.0 -0.438 . . . . 0.0 111.598 -176.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.654 ' HB3' HG12 ' B' ' 85' ' ' VAL . 3.9 pp -122.11 145.32 48.28 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.856 0.836 . . . . 0.0 111.825 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -107.75 -56.09 2.27 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.614 173.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -103.07 127.23 50.41 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.344 173.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.579 ' O ' ' HG3' ' B' ' 58' ' ' LYS . . . 145.21 159.37 8.07 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 120.016 -1.088 . . . . 0.0 112.809 178.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -102.42 -45.56 5.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.474 0.178 . . . . 0.0 111.46 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -150.62 127.3 10.9 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 120.615 0.245 . . . . 0.0 110.958 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.531 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -127.41 114.95 18.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.235 0.541 . . . . 0.0 110.461 171.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' B' ' 79' ' ' THR . 3.7 mppt? -94.97 112.01 23.75 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 174.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 46.6 tp -84.26 108.84 17.36 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -176.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -108.56 144.31 36.42 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.338 0.589 . . . . 0.0 110.08 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.662 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 0.2 OUTLIER -129.25 116.74 19.61 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.378 174.397 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.546 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -103.44 110.5 22.54 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.18 0.514 . . . . 0.0 109.702 177.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.513 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -140.08 145.63 37.91 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.358 -177.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 58.1 33.0 22.72 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.521 0.677 . . . . 0.0 109.833 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 62.77 38.0 12.08 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.82 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.546 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 6.5 tp-100 -140.64 139.0 34.77 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 178.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -90.98 110.05 21.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.922 0.392 . . . . 0.0 110.352 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.502 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 78.3 m-85 -101.82 130.72 48.32 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.484 178.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -85.32 101.87 10.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.742 0.782 . . . . 0.0 108.971 172.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.613 ' CG2' ' HB3' ' B' ' 44' ' ' LEU . 2.9 t -76.4 -49.76 23.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.704 -171.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.547 ' HB2' HD21 ' B' ' 65' ' ' LEU . . . -154.1 146.71 24.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.434 -177.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 27.4 m -110.99 100.98 9.58 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.468 HG11 HG11 ' B' ' 85' ' ' VAL . 7.5 p -115.8 114.71 47.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.655 0.741 . . . . 0.0 109.855 -176.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 78.7 p -122.87 -178.24 3.89 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.45 -173.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' LYS . . . . . 0.579 ' HG3' ' O ' ' B' ' 37' ' ' GLY . 6.1 mttm -61.49 -30.04 70.36 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.07 0.462 . . . . 0.0 110.29 169.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.12 -40.33 53.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.41 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 79.3 mt -115.55 81.4 8.91 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.15 -0.35 6.29 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.043 2.495 . . . . 0.0 114.006 -167.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -163.13 130.15 3.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.226 0.536 . . . . 0.0 111.346 -176.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 96.1 t -118.82 120.81 65.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.373 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.24 131.51 35.3 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.547 HD21 ' HB2' ' B' ' 54' ' ' ALA . 82.4 mt -123.93 167.17 14.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.479 0.657 . . . . 0.0 112.348 -173.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 66' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 14.4 t0 -143.13 99.11 3.39 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.563 170.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.599 HD21 HD23 ' A' ' 88' ' ' LEU . 2.4 mt -128.02 140.16 52.13 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.395 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 68' ' ' ASN . . . . . 0.48 ' ND2' ' HB3' ' A' ' 6' ' ' ALA . 5.3 t30 -135.35 122.7 21.8 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.714 174.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -116.08 143.72 45.1 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.508 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.42 ' OG ' ' HB3' ' A' ' 5' ' ' MET . 34.0 t -94.37 166.26 12.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.216 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.405 ' HA ' HG22 ' B' ' 23' ' ' ILE . 0.0 OUTLIER -74.59 -6.91 51.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.179 0.514 . . . . 0.0 110.175 178.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.95 -8.21 61.97 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.458 174.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -93.69 144.62 25.23 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -136.12 127.79 28.98 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 171.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.513 HG22 ' HB2' ' B' ' 46' ' ' ALA . 8.5 pt -135.46 160.41 40.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.606 -163.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.432 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 3.0 mtm -114.05 120.35 40.29 Favored 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.535 172.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 77' ' ' PHE . . . . . 0.662 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -103.75 127.78 51.19 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 176.288 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.734 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 52.7 p90 -156.31 143.18 18.79 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 119.802 -0.759 . . . . 0.0 112.238 -176.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' B' ' 41' ' ' LYS . 2.0 p -114.98 132.02 56.72 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.335 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.27 160.72 14.88 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.82 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.97 -175.67 40.16 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -175.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -110.37 102.58 11.21 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.878 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -174.55 155.62 2.27 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.567 171.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 32.2 t -115.91 117.25 29.66 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.654 HG12 ' HB3' ' B' ' 34' ' ' LEU . 3.7 m -111.3 164.88 6.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.245 0.545 . . . . 0.0 112.132 -174.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 21.3 t -129.7 120.83 25.79 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.156 176.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.541 HD13 HD23 ' B' ' 11' ' ' LEU . 5.3 mp -92.92 154.36 18.24 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.016 0.436 . . . . 0.0 110.163 173.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.58 HD23 HD21 ' C' ' 67' ' ' LEU . 0.2 OUTLIER -133.65 144.66 49.35 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.083 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.94 -167.41 28.55 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.962 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -146.07 136.49 23.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.582 0.706 . . . . 0.0 111.623 177.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 91' ' ' LEU . . . . . 0.666 HD23 ' HB3' ' B' ' 27' ' ' PHE . 26.4 mt -77.65 137.22 38.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.474 175.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -73.09 119.02 16.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.029 0.442 . . . . 0.0 110.657 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -88.89 -6.63 57.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.907 0.861 . . . . 0.0 109.404 176.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 94' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 4' ' ' ALA . 1.9 mp 69.88 86.8 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 114.176 -1.375 . . . . 0.0 109.347 -176.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.86 110.98 5.93 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.367 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 96' ' ' SER . . . . . 0.504 ' HA ' ' C ' ' A' ' 97' ' ' GLY . 20.3 m -79.29 -36.13 40.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.685 -177.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 97' ' ' GLY . . . . . 0.408 ' C ' ' HA ' ' C' ' 96' ' ' SER . . . 72.9 -67.96 1.34 Allowed Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.739 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.493 -0.765 . . . . 0.0 109.8 -178.029 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 120.985 0.421 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -136.15 163.61 29.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.161 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . 122.32 25.52 1.99 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.243 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -167.39 53.47 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.136 0.494 . . . . 0.0 110.048 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 5' ' ' MET . . . . . 0.435 ' HB3' ' OG ' ' D' ' 70' ' ' SER . 3.6 mpp? -111.1 67.66 0.65 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.001 -174.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 6' ' ' ALA . . . . . 0.5 ' HB3' ' ND2' ' D' ' 68' ' ' ASN . . . -60.81 131.39 50.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.85 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -81.39 150.88 28.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.094 0.473 . . . . 0.0 111.67 -174.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 8' ' ' PHE . . . . . 0.654 ' CE1' HD21 ' D' ' 44' ' ' LEU . 31.2 t80 -72.26 145.88 47.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.376 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 9' ' ' TRP . . . . . 0.419 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 92.1 t90 -134.35 147.96 50.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.464 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 10' ' ' GLY . . . . . 0.524 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -152.23 154.91 25.83 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.828 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.532 HD23 HD13 ' C' ' 87' ' ' LEU . 49.7 tp -147.37 108.37 4.22 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.923 0.392 . . . . 0.0 111.069 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -90.49 120.12 31.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.929 0.395 . . . . 0.0 110.536 176.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 13' ' ' MET . . . . . 0.706 ' SD ' ' HE2' ' C' ' 19' ' ' TYR . 53.2 mmm -100.01 139.66 35.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.254 -175.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -100.41 144.99 29.51 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.584 174.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 15' ' ' PRO . . . . . 0.481 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 11.0 Cg_endo -55.08 116.3 3.04 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 123.106 2.537 . . . . 0.0 112.932 -177.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 62.9 64.81 0.85 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.89 176.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -145.67 138.93 26.21 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.655 173.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 18' ' ' LYS . . . . . 0.727 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 86.7 mttt -107.13 126.48 52.43 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -176.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 19' ' ' TYR . . . . . 0.706 ' HE2' ' SD ' ' C' ' 13' ' ' MET . 1.2 m-85 -112.52 103.84 11.93 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.145 174.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 20' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 9.0 p -88.38 100.24 12.88 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -113.23 144.45 42.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.434 0.635 . . . . 0.0 111.848 -170.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 27.3 m -101.98 140.9 35.65 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.452 176.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 23' ' ' ILE . . . . . 0.403 HG22 ' HA ' ' C' ' 71' ' ' LYS . 73.9 mt -99.41 120.14 48.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.125 0.488 . . . . 0.0 111.772 -171.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 24' ' ' ILE . . . . . 0.767 ' H ' HD13 ' C' ' 24' ' ' ILE . 0.2 OUTLIER -105.57 -9.94 10.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.318 176.018 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 25' ' ' LYS . . . . . 0.516 ' HD2' HD13 ' C' ' 91' ' ' LEU . 35.7 pttt -141.47 119.07 11.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.893 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 5.8 p -67.04 133.72 50.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.738 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 27' ' ' PHE . . . . . 0.662 ' HB3' HD23 ' C' ' 91' ' ' LEU . 32.4 p90 -147.53 166.44 27.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.627 0.727 . . . . 0.0 112.956 -173.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 28' ' ' HIS . . . . . 0.545 ' HA ' ' O ' ' C' ' 67' ' ' LEU . 9.4 t60 -118.87 126.23 51.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.34 -1.3 . . . . 0.0 109.934 178.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 29' ' ' ILE . . . . . 0.542 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 42.7 mt -92.2 136.14 25.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 170.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.514 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 64.4 p -123.71 -5.62 8.07 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -170.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.45 160.71 27.64 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 119.038 -1.553 . . . . 0.0 113.816 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.477 HG23 ' HG ' ' C' ' 87' ' ' LEU . 11.5 p -144.49 129.99 14.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 173.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.42 157.72 43.97 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.889 -0.507 . . . . 0.0 111.517 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.669 ' HB3' HG12 ' C' ' 85' ' ' VAL . 3.8 pp -122.07 145.33 48.25 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.782 0.801 . . . . 0.0 111.803 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -107.79 -56.04 2.28 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.387 -1.278 . . . . 0.0 108.621 173.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -103.08 127.25 50.41 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.345 173.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 37' ' ' GLY . . . . . 0.588 ' O ' ' HG3' ' C' ' 58' ' ' LYS . . . 145.23 159.4 8.09 Favored Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 119.954 -1.117 . . . . 0.0 112.815 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -102.56 -45.58 5.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.465 0.174 . . . . 0.0 111.385 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -150.48 127.2 10.95 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.501 0.191 . . . . 0.0 111.094 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.53 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -127.38 115.0 18.28 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.328 0.585 . . . . 0.0 110.439 171.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' C' ' 79' ' ' THR . 3.7 mppt? -95.11 112.07 23.82 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 46.9 tp -84.31 108.93 17.44 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -176.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -108.62 144.33 36.49 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.327 0.584 . . . . 0.0 110.062 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.655 HD21 ' CE1' ' B' ' 8' ' ' PHE . 0.2 OUTLIER -129.28 116.79 19.65 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.364 174.395 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 45' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -103.51 110.4 22.42 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.206 0.527 . . . . 0.0 109.736 177.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.512 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -139.97 145.64 38.13 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.385 -177.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 57.95 33.18 22.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.451 0.643 . . . . 0.0 109.844 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 60.0 mttp 62.69 38.03 12.3 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.822 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 49' ' ' GLN . . . . . 0.552 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 6.5 tp-100 -140.64 139.06 34.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.588 0.232 . . . . 0.0 110.379 178.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -91.07 110.02 21.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.32 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 51' ' ' TYR . . . . . 0.528 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 78.1 m-85 -101.84 130.72 48.36 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.433 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -85.31 101.8 10.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.68 0.752 . . . . 0.0 108.995 173.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 53' ' ' VAL . . . . . 0.609 ' CG2' ' HB3' ' C' ' 44' ' ' LEU . 2.9 t -76.33 -49.88 23.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.696 -171.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 54' ' ' ALA . . . . . 0.542 ' HB2' HD21 ' C' ' 65' ' ' LEU . . . -153.98 146.71 24.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.511 -177.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 27.6 m -111.04 101.02 9.6 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 170.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 56' ' ' VAL . . . . . 0.463 HG11 HG11 ' C' ' 85' ' ' VAL . 7.5 p -115.83 114.67 46.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.617 0.722 . . . . 0.0 109.807 -176.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 78.1 p -122.89 -178.26 3.89 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.467 -173.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 58' ' ' LYS . . . . . 0.588 ' HG3' ' O ' ' C' ' 37' ' ' GLY . 6.2 mttm -61.51 -29.92 70.29 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.025 0.441 . . . . 0.0 110.35 169.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.18 -40.24 52.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.359 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 79.9 mt -115.65 81.48 9.23 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.18 -0.44 6.44 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.143 2.562 . . . . 0.0 113.972 -167.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -163.11 130.18 3.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.266 0.555 . . . . 0.0 111.333 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 96.9 t -118.72 120.84 65.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.458 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.29 131.58 35.3 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 65' ' ' LEU . . . . . 0.542 HD21 ' HB2' ' C' ' 54' ' ' ALA . 82.6 mt -123.99 167.19 14.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.473 0.654 . . . . 0.0 112.285 -173.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 66' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 14.3 t0 -143.14 99.12 3.39 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.478 170.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.58 HD21 HD23 ' B' ' 88' ' ' LEU . 2.4 mt -128.1 140.15 52.1 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.419 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 68' ' ' ASN . . . . . 0.464 ' ND2' ' HB3' ' B' ' 6' ' ' ALA . 5.2 t30 -135.32 122.73 21.88 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.75 174.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -116.12 143.75 45.07 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.429 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 70' ' ' SER . . . . . 0.464 ' OG ' ' HB3' ' B' ' 5' ' ' MET . 33.8 t -94.31 166.23 12.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.231 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 71' ' ' LYS . . . . . 0.403 ' HA ' HG22 ' C' ' 23' ' ' ILE . 0.0 OUTLIER -74.57 -6.88 51.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.182 0.515 . . . . 0.0 110.185 178.913 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.97 -8.34 61.84 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.462 174.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -93.61 144.58 25.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.815 0.34 . . . . 0.0 110.097 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -136.06 127.72 28.96 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 171.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.512 HG22 ' HB2' ' C' ' 46' ' ' ALA . 8.5 pt -135.36 160.45 40.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.532 -163.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.436 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 3.0 mtm -114.14 120.37 40.28 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.51 172.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 77' ' ' PHE . . . . . 0.653 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.7 OUTLIER -103.8 127.81 51.26 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.315 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 78' ' ' TYR . . . . . 0.727 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 53.3 p90 -156.31 143.17 18.78 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.311 -176.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 79' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' C' ' 41' ' ' LYS . 2.0 p -114.98 131.99 56.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.362 -176.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.29 160.66 14.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.862 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.93 -175.69 40.24 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -175.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -110.39 102.61 11.23 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 119.391 -0.924 . . . . 0.0 109.867 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 83' ' ' ALA . . . . . 0.53 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -174.53 155.61 2.28 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.633 171.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 32.3 t -115.84 117.28 29.76 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.669 HG12 ' HB3' ' C' ' 34' ' ' LEU . 3.7 m -111.39 164.92 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-O 121.313 0.578 . . . . 0.0 112.106 -174.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 21.1 t -129.72 120.8 25.7 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.217 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 87' ' ' LEU . . . . . 0.532 HD13 HD23 ' C' ' 11' ' ' LEU . 5.3 mp -92.89 154.4 18.23 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 120.987 0.422 . . . . 0.0 110.157 173.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 88' ' ' LEU . . . . . 0.581 HD23 HD21 ' D' ' 67' ' ' LEU . 0.2 OUTLIER -133.68 144.67 49.32 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.135 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.0 -167.36 28.54 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.978 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -146.06 136.45 23.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.564 0.697 . . . . 0.0 111.631 177.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 91' ' ' LEU . . . . . 0.662 HD23 ' HB3' ' C' ' 27' ' ' PHE . 26.3 mt -77.63 137.16 38.39 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.486 175.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -73.05 119.16 16.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.073 0.463 . . . . 0.0 110.64 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -88.93 -6.8 57.02 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.863 0.839 . . . . 0.0 109.348 176.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 1.9 mp 70.1 86.66 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 114.229 -1.35 . . . . 0.0 109.314 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.79 110.94 5.86 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.311 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 96' ' ' SER . . . . . 0.408 ' HA ' ' C ' ' B' ' 97' ' ' GLY . 20.1 m -79.25 -36.05 40.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.739 -177.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 97' ' ' GLY . . . . . 0.504 ' C ' ' HA ' ' D' ' 96' ' ' SER . . . 72.8 -67.85 1.32 Allowed Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.804 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.336 -0.84 . . . . 0.0 109.785 -178.079 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 . . . . . 0 N--CA 1.479 0.981 0 CA-C-O 120.914 0.388 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -136.2 163.58 30.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.164 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . 122.31 25.53 1.99 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.213 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 4' ' ' ALA . . . . . 0.407 ' HB3' HG13 ' E' ' 94' ' ' ILE . . . -167.42 53.58 0.07 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.925 0.393 . . . . 0.0 110.003 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 5' ' ' MET . . . . . 0.431 ' HB3' ' OG ' ' E' ' 70' ' ' SER . 3.6 mpp? -111.2 67.65 0.65 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.011 -174.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 6' ' ' ALA . . . . . 0.487 ' HB3' ' ND2' ' E' ' 68' ' ' ASN . . . -60.77 131.35 50.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.773 178.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -81.33 150.88 28.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.148 0.499 . . . . 0.0 111.663 -174.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 8' ' ' PHE . . . . . 0.639 ' CE1' HD21 ' E' ' 44' ' ' LEU . 31.0 t80 -72.27 145.78 47.66 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.37 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 9' ' ' TRP . . . . . 0.426 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 92.1 t90 -134.27 147.99 50.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.433 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 10' ' ' GLY . . . . . 0.513 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -152.21 154.91 25.83 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.872 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.54 HD23 HD13 ' D' ' 87' ' ' LEU . 50.1 tp -147.33 108.34 4.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.803 0.335 . . . . 0.0 111.02 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -90.52 120.09 31.32 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.974 0.416 . . . . 0.0 110.479 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 13' ' ' MET . . . . . 0.689 ' SD ' ' HE2' ' D' ' 19' ' ' TYR . 53.3 mmm -100.08 139.63 35.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.173 -175.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -100.3 145.07 29.63 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.59 174.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 15' ' ' PRO . . . . . 0.461 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 11.0 Cg_endo -55.23 116.3 3.04 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 123.099 2.533 . . . . 0.0 112.91 -177.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 63.04 64.79 0.83 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.843 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -145.65 138.86 26.19 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.598 173.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 18' ' ' LYS . . . . . 0.718 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 86.6 mttt -107.2 126.48 52.46 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -176.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 19' ' ' TYR . . . . . 0.689 ' HE2' ' SD ' ' D' ' 13' ' ' MET . 1.2 m-85 -112.63 103.81 11.87 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.104 174.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 20' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 8.7 p -88.38 100.28 12.9 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 174.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -113.13 144.4 42.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.88 -170.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 27.2 m -101.95 140.9 35.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.609 176.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 23' ' ' ILE . . . . . 0.418 HG22 ' HA ' ' D' ' 71' ' ' LYS . 74.2 mt -99.48 120.19 48.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.203 0.525 . . . . 0.0 111.651 -171.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 24' ' ' ILE . . . . . 0.775 ' H ' HD13 ' D' ' 24' ' ' ILE . 0.2 OUTLIER -105.61 -9.81 10.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.388 175.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 25' ' ' LYS . . . . . 0.507 ' HD2' HD13 ' D' ' 91' ' ' LEU . 35.4 pttt -141.55 119.08 11.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.847 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 5.8 p -67.06 133.72 50.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.783 -176.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 27' ' ' PHE . . . . . 0.68 ' HB3' HD23 ' D' ' 91' ' ' LEU . 32.7 p90 -147.56 166.39 27.48 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -173.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 28' ' ' HIS . . . . . 0.546 ' HA ' ' O ' ' D' ' 67' ' ' LEU . 9.3 t60 -118.73 126.23 51.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.973 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 29' ' ' ILE . . . . . 0.551 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 42.4 mt -92.24 136.14 25.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 170.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 30' ' ' SER . . . . . 0.522 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 64.3 p -123.77 -5.57 8.04 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -170.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.42 160.84 27.87 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 119.141 -1.504 . . . . 0.0 113.874 176.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.462 HG23 ' HG ' ' D' ' 87' ' ' LEU . 11.4 p -144.51 129.95 14.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 173.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.41 157.76 43.96 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.004 -0.435 . . . . 0.0 111.451 -176.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 34' ' ' LEU . . . . . 0.646 ' HB3' HG12 ' D' ' 85' ' ' VAL . 3.9 pp -122.11 145.26 48.34 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.8 0.809 . . . . 0.0 111.826 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -107.67 -55.98 2.28 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.663 173.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -103.2 127.25 50.56 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.336 173.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 37' ' ' GLY . . . . . 0.59 ' O ' ' HG3' ' D' ' 58' ' ' LYS . . . 145.15 159.33 8.04 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 119.997 -1.096 . . . . 0.0 112.83 178.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -102.47 -45.49 5.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -150.58 127.35 10.97 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.592 0.234 . . . . 0.0 110.955 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 40' ' ' ALA . . . . . 0.538 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -127.51 114.97 18.15 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.223 0.535 . . . . 0.0 110.452 171.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' D' ' 79' ' ' THR . 3.7 mppt? -95.14 112.07 23.82 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 47.2 tp -84.26 108.88 17.38 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -176.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -108.51 144.32 36.32 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.129 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.656 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.2 OUTLIER -129.28 116.73 19.57 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.411 174.355 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 45' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -103.34 110.43 22.42 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.698 177.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.508 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -140.05 145.53 37.84 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.339 -177.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 58.18 33.08 22.81 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.466 0.65 . . . . 0.0 109.819 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 62.65 37.95 12.48 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.904 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 49' ' ' GLN . . . . . 0.553 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 6.5 tp-100 -140.6 138.96 34.81 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 178.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -90.95 110.14 21.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.315 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 51' ' ' TYR . . . . . 0.524 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 78.5 m-85 -101.87 130.7 48.41 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.444 178.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -85.27 101.91 10.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 172.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 53' ' ' VAL . . . . . 0.607 ' CG2' ' HB3' ' D' ' 44' ' ' LEU . 2.9 t -76.49 -49.69 23.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.716 -171.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 54' ' ' ALA . . . . . 0.554 ' HB2' HD21 ' D' ' 65' ' ' LEU . . . -154.05 146.73 24.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.414 -177.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 27.3 m -111.06 100.93 9.52 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 170.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 56' ' ' VAL . . . . . 0.463 HG11 HG11 ' D' ' 85' ' ' VAL . 7.4 p -115.8 114.64 46.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.607 0.718 . . . . 0.0 109.85 -176.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 79.2 p -122.88 -178.24 3.89 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.487 -173.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 58' ' ' LYS . . . . . 0.59 ' HG3' ' O ' ' D' ' 37' ' ' GLY . 6.1 mttm -61.45 -29.95 70.28 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.037 0.446 . . . . 0.0 110.415 169.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.21 -40.21 52.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.438 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 79.5 mt -115.63 81.47 9.15 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 174.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -69.13 -0.42 6.37 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.15 2.567 . . . . 0.0 113.983 -167.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -163.15 130.1 3.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.222 0.534 . . . . 0.0 111.297 -176.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 96.4 t -118.76 120.87 65.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.39 174.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.2 131.49 35.3 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 65' ' ' LEU . . . . . 0.554 HD21 ' HB2' ' D' ' 54' ' ' ALA . 82.7 mt -123.96 167.17 14.5 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.474 0.654 . . . . 0.0 112.325 -173.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 66' ' ' ASP . . . . . 0.427 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 14.4 t0 -143.09 99.03 3.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.592 170.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.581 HD21 HD23 ' C' ' 88' ' ' LEU . 2.4 mt -127.96 140.11 52.18 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.436 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 68' ' ' ASN . . . . . 0.5 ' ND2' ' HB3' ' C' ' 6' ' ' ALA . 5.2 t30 -135.3 122.73 21.89 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.486 -0.485 . . . . 0.0 109.72 174.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -116.11 143.66 45.18 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.551 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 70' ' ' SER . . . . . 0.435 ' OG ' ' HB3' ' C' ' 5' ' ' MET . 34.0 t -94.38 166.26 12.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.219 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 71' ' ' LYS . . . . . 0.418 ' HA ' HG22 ' D' ' 23' ' ' ILE . 0.0 OUTLIER -74.56 -7.02 51.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.271 0.557 . . . . 0.0 110.141 179.065 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.91 -8.19 62.05 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.496 174.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -93.63 144.52 25.31 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -136.08 127.75 28.97 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 171.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.508 HG22 ' HB2' ' D' ' 46' ' ' ALA . 8.6 pt -135.34 160.5 40.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.568 -163.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 76' ' ' MET . . . . . 0.437 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 3.0 mtm -114.16 120.43 40.47 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.454 172.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 77' ' ' PHE . . . . . 0.656 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.7 OUTLIER -103.79 127.73 51.25 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.263 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 78' ' ' TYR . . . . . 0.718 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 52.9 p90 -156.25 143.14 18.83 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.248 -176.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 79' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' D' ' 41' ' ' LYS . 2.0 p -114.9 132.01 56.68 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.305 -176.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.28 160.69 14.91 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.874 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.96 -175.7 40.2 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -175.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -110.34 102.53 11.17 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.97 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 83' ' ' ALA . . . . . 0.538 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -174.54 155.54 2.26 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.591 171.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 32.4 t -115.81 117.14 29.39 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.646 HG12 ' HB3' ' D' ' 34' ' ' LEU . 3.7 m -111.27 164.87 6.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.21 0.528 . . . . 0.0 112.151 -174.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 21.3 t -129.65 120.83 25.87 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.17 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 87' ' ' LEU . . . . . 0.54 HD13 HD23 ' D' ' 11' ' ' LEU . 5.3 mp -92.92 154.44 18.19 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 121.022 0.439 . . . . 0.0 110.1 173.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.594 HD23 HD21 ' E' ' 67' ' ' LEU . 0.2 OUTLIER -133.7 144.65 49.27 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.111 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.88 -167.34 28.4 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.033 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -146.1 136.49 23.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.556 0.693 . . . . 0.0 111.653 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 91' ' ' LEU . . . . . 0.68 HD23 ' HB3' ' D' ' 27' ' ' PHE . 26.1 mt -77.59 137.22 38.45 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.536 175.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -73.08 119.09 16.85 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.965 0.412 . . . . 0.0 110.738 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -88.95 -6.67 57.09 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.95 0.881 . . . . 0.0 109.34 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 1.9 mp 69.97 86.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.361 -176.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.78 110.97 5.87 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.414 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 96' ' ' SER . . . . . 0.504 ' HA ' ' C ' ' C' ' 97' ' ' GLY . 20.1 m -79.24 -36.17 40.39 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.69 -177.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 97' ' ' GLY . . . . . 0.499 ' C ' ' HA ' ' E' ' 96' ' ' SER . . . 72.94 -67.87 1.35 Allowed Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.707 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.49 -0.766 . . . . 0.0 109.844 -178.053 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 120.894 0.378 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -136.16 163.56 30.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.227 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . 122.38 25.54 1.98 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.162 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -167.35 53.48 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.102 0.477 . . . . 0.0 110.058 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 5' ' ' MET . . . . . 0.423 ' HB3' ' OG ' ' A' ' 70' ' ' SER . 3.6 mpp? -111.17 67.69 0.65 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.977 -174.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 6' ' ' ALA . . . . . 0.492 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . . . -60.79 131.39 50.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.846 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -81.37 150.76 28.27 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.093 0.473 . . . . 0.0 111.647 -174.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 8' ' ' PHE . . . . . 0.674 ' CE1' HD21 ' A' ' 44' ' ' LEU . 31.2 t80 -72.13 145.9 47.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.46 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 9' ' ' TRP . . . . . 0.414 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 92.0 t90 -134.41 147.92 50.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.407 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 10' ' ' GLY . . . . . 0.536 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -152.18 154.93 25.84 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.908 178.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 11' ' ' LEU . . . . . 0.539 HD23 HD13 ' E' ' 87' ' ' LEU . 49.5 tp -147.34 108.31 4.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.829 0.347 . . . . 0.0 111.018 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -90.47 120.18 31.36 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.002 0.43 . . . . 0.0 110.478 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 13' ' ' MET . . . . . 0.685 ' SD ' ' HE2' ' E' ' 19' ' ' TYR . 53.0 mmm -100.08 139.57 35.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.247 -175.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -100.28 145.08 29.64 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.665 174.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 15' ' ' PRO . . . . . 0.465 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 11.0 Cg_endo -55.15 116.34 3.07 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.088 2.525 . . . . 0.0 112.951 -177.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 62.89 64.81 0.85 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.892 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -145.73 138.86 26.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.653 173.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 18' ' ' LYS . . . . . 0.713 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 86.7 mttt -107.11 126.36 52.27 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -176.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 19' ' ' TYR . . . . . 0.685 ' HE2' ' SD ' ' E' ' 13' ' ' MET . 1.2 m-85 -112.53 103.82 11.9 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.167 174.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 20' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' E' ' 76' ' ' MET . 9.1 p -88.31 100.25 12.86 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 174.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -113.16 144.37 42.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.899 -170.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 27.5 m -101.98 140.99 35.52 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.508 176.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 73.9 mt -99.47 120.21 48.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.225 0.536 . . . . 0.0 111.668 -171.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 24' ' ' ILE . . . . . 0.759 ' H ' HD13 ' E' ' 24' ' ' ILE . 0.2 OUTLIER -105.63 -9.86 10.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.297 175.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 25' ' ' LYS . . . . . 0.506 ' HD2' HD13 ' E' ' 91' ' ' LEU . 35.5 pttt -141.47 119.15 11.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.867 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 5.8 p -67.05 133.72 50.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.752 -176.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 27' ' ' PHE . . . . . 0.675 ' HB3' HD23 ' E' ' 91' ' ' LEU . 32.6 p90 -147.54 166.4 27.41 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -173.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 28' ' ' HIS . . . . . 0.55 ' HA ' ' O ' ' E' ' 67' ' ' LEU . 9.4 t60 -118.77 126.28 51.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.968 178.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 29' ' ' ILE . . . . . 0.542 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 42.8 mt -92.25 136.15 25.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 170.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 30' ' ' SER . . . . . 0.507 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 64.2 p -123.69 -5.65 8.08 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -170.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.39 160.84 27.91 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.063 -1.541 . . . . 0.0 113.823 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.47 HG23 ' HG ' ' E' ' 87' ' ' LEU . 11.5 p -144.55 129.91 14.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.39 157.72 43.97 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 121.904 -0.497 . . . . 0.0 111.518 -176.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 34' ' ' LEU . . . . . 0.667 ' HB3' HG12 ' E' ' 85' ' ' VAL . 3.9 pp -122.06 145.27 48.31 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.858 0.837 . . . . 0.0 111.856 178.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -107.71 -56.06 2.27 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.222 -1.354 . . . . 0.0 108.612 173.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -103.12 127.23 50.48 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.411 173.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 37' ' ' GLY . . . . . 0.587 ' O ' ' HG3' ' E' ' 58' ' ' LYS . . . 145.19 159.34 8.06 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.016 -1.087 . . . . 0.0 112.897 178.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -102.53 -45.49 5.04 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.473 0.175 . . . . 0.0 111.473 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -150.53 127.36 11.02 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 120.526 0.203 . . . . 0.0 110.982 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 40' ' ' ALA . . . . . 0.529 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -127.49 114.93 18.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.183 0.516 . . . . 0.0 110.473 171.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 41' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' E' ' 79' ' ' THR . 3.7 mppt? -95.08 112.1 23.84 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 174.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 46.7 tp -84.27 108.87 17.38 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -176.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -108.54 144.34 36.34 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.331 0.586 . . . . 0.0 110.112 177.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 44' ' ' LEU . . . . . 0.661 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 0.2 OUTLIER -129.26 116.76 19.63 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.42 174.384 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 45' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -103.51 110.47 22.52 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.236 0.541 . . . . 0.0 109.666 177.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 46' ' ' ALA . . . . . 0.507 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -140.11 145.54 37.74 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.273 -177.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 58.15 33.04 22.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.476 0.655 . . . . 0.0 109.813 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 62.73 37.99 12.2 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.778 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 49' ' ' GLN . . . . . 0.551 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 6.5 tp-100 -140.56 138.98 34.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.59 0.233 . . . . 0.0 110.39 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -90.97 110.09 21.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.363 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 51' ' ' TYR . . . . . 0.513 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 78.2 m-85 -101.79 130.74 48.28 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.419 178.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -85.37 101.87 10.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.706 0.765 . . . . 0.0 109.023 172.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 53' ' ' VAL . . . . . 0.617 ' CG2' ' HB3' ' E' ' 44' ' ' LEU . 2.9 t -76.43 -49.76 23.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.714 -171.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 54' ' ' ALA . . . . . 0.545 ' HB2' HD21 ' E' ' 65' ' ' LEU . . . -154.02 146.67 24.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.498 -177.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 27.7 m -111.04 101.03 9.61 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 170.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 56' ' ' VAL . . . . . 0.46 HG11 HG11 ' E' ' 85' ' ' VAL . 7.5 p -115.82 114.62 46.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.628 0.728 . . . . 0.0 109.754 -176.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 76.2 p -122.82 -178.23 3.88 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.465 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 58' ' ' LYS . . . . . 0.587 ' HG3' ' O ' ' E' ' 37' ' ' GLY . 6.1 mttm -61.53 -29.99 70.35 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.023 0.44 . . . . 0.0 110.287 169.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.06 -40.37 53.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.433 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 79.0 mt -115.51 81.49 8.9 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 174.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.2 -0.5 6.54 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.087 2.524 . . . . 0.0 114.029 -167.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -163.02 130.28 3.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.275 0.559 . . . . 0.0 111.305 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 96.5 t -118.85 120.83 65.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.388 174.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.29 131.48 35.29 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 175.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.545 HD21 ' HB2' ' E' ' 54' ' ' ALA . 82.6 mt -123.87 167.19 14.42 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.469 0.652 . . . . 0.0 112.336 -173.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 66' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 14.3 t0 -143.15 99.17 3.4 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.504 170.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 67' ' ' LEU . . . . . 0.594 HD21 HD23 ' D' ' 88' ' ' LEU . 2.5 mt -128.05 140.06 52.17 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.391 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 68' ' ' ASN . . . . . 0.487 ' ND2' ' HB3' ' D' ' 6' ' ' ALA . 5.3 t30 -135.21 122.71 21.99 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.79 174.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -116.08 143.71 45.11 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.492 -178.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 70' ' ' SER . . . . . 0.431 ' OG ' ' HB3' ' D' ' 5' ' ' MET . 34.2 t -94.4 166.27 12.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.194 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.55 -7.07 51.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.177 0.513 . . . . 0.0 110.151 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.8 -8.25 62.19 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.495 174.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -93.67 144.7 25.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.859 0.361 . . . . 0.0 110.074 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -136.2 127.72 28.69 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 171.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 75' ' ' ILE . . . . . 0.507 HG22 ' HB2' ' E' ' 46' ' ' ALA . 8.5 pt -135.4 160.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.634 -163.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 76' ' ' MET . . . . . 0.437 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 3.0 mtm -114.13 120.35 40.24 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 172.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 77' ' ' PHE . . . . . 0.661 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.7 OUTLIER -103.75 127.82 51.19 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.28 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 78' ' ' TYR . . . . . 0.713 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 53.2 p90 -156.37 143.11 18.67 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 119.79 -0.764 . . . . 0.0 112.269 -176.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 79' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' E' ' 41' ' ' LYS . 2.0 p -114.96 132.02 56.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.291 -176.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.37 160.7 14.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.817 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.0 -175.68 40.12 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -175.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -110.43 102.56 11.17 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.846 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 83' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -174.5 155.62 2.29 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.624 171.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 32.2 t -115.84 117.33 29.9 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 85' ' ' VAL . . . . . 0.667 HG12 ' HB3' ' E' ' 34' ' ' LEU . 3.7 m -111.36 164.9 6.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.268 0.556 . . . . 0.0 112.137 -174.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 21.2 t -129.75 120.9 25.84 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.18 176.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 87' ' ' LEU . . . . . 0.539 HD13 HD23 ' E' ' 11' ' ' LEU . 5.3 mp -92.98 154.48 18.13 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 121.023 0.439 . . . . 0.0 110.132 173.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 88' ' ' LEU . . . . . 0.596 HD23 HD21 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -133.7 144.7 49.3 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.086 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.99 -167.43 28.62 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.9 -0.666 . . . . 0.0 111.999 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 90' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -146.05 136.49 23.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.573 0.701 . . . . 0.0 111.663 177.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 91' ' ' LEU . . . . . 0.675 HD23 ' HB3' ' E' ' 27' ' ' PHE . 26.2 mt -77.54 137.15 38.45 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.574 175.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -73.08 119.06 16.8 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.959 0.409 . . . . 0.0 110.728 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -88.92 -6.64 57.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.893 0.854 . . . . 0.0 109.293 176.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 94' ' ' ILE . . . . . 0.407 HG13 ' HB3' ' D' ' 4' ' ' ALA . 1.9 mp 69.88 86.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.323 -176.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.93 111.0 5.99 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.382 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 96' ' ' SER . . . . . 0.499 ' HA ' ' C ' ' D' ' 97' ' ' GLY . 20.1 m -79.24 -36.19 40.36 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.689 -177.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 97' ' ' GLY . . . . . 0.473 ' C ' ' HA ' ' A' ' 96' ' ' SER . . . 72.91 -67.85 1.35 Allowed Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.689 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.383 -0.817 . . . . 0.0 109.822 -178.021 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -127.48 66.54 1.31 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.653 0.739 . . . . 0.0 109.569 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.48 136.53 20.29 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.996 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.92 146.9 22.25 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 59.4 mtt -125.94 39.84 3.86 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.343 0.402 . . . . 0.0 109.957 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -51.02 129.26 23.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.892 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 49.0 mtt -96.36 129.77 43.63 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.221 0.534 . . . . 0.0 111.524 -173.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.505 ' CE1' HD21 ' B' ' 44' ' ' LEU . 60.5 t80 -56.85 142.02 42.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.487 -173.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.45 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 87.5 t90 -135.41 141.49 45.47 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.763 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.503 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -143.2 155.46 26.02 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.068 178.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.643 HD23 HD13 ' A' ' 87' ' ' LEU . 57.2 tp -145.21 108.53 4.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.709 0.29 . . . . 0.0 110.901 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -89.0 106.42 18.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.492 0.663 . . . . 0.0 110.91 177.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.558 ' HB2' HG23 ' A' ' 85' ' ' VAL . 4.1 mmt -86.96 134.42 33.5 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.931 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.517 ' HB2' ' HG3' ' A' ' 17' ' ' ARG . 54.5 mtmt -100.26 146.08 31.36 Favored Pre-proline 0 C--N 1.316 -0.851 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 172.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.435 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 5.8 Cg_endo -48.12 110.37 0.32 Allowed 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 123.51 2.807 . . . . 0.0 113.432 -174.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.69 ' HA ' ' O ' ' A' ' 79' ' ' THR . 31.6 mt-10 69.5 54.07 0.41 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.531 178.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.517 ' HG3' ' HB2' ' A' ' 14' ' ' LYS . 19.5 mmt180 -110.75 152.7 26.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.868 172.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.719 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 36.0 ttmt -133.56 107.74 8.18 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.944 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.42 ' OH ' ' HA ' ' A' ' 13' ' ' MET . 0.8 OUTLIER -111.05 121.09 44.45 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.752 179.516 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.4 p -75.29 126.79 31.74 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 170.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -103.95 116.56 32.48 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.125 0.488 . . . . 0.0 111.727 -164.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.5 p -97.22 123.12 40.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.879 173.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.404 ' CG2' ' HA ' ' A' ' 71' ' ' LYS . 55.3 mt -92.97 108.43 20.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.199 0.524 . . . . 0.0 111.575 -172.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.713 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -76.08 -39.65 36.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.007 177.805 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -139.58 141.47 37.17 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.6 m -60.86 120.82 10.89 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.66 0.6 . . . . 0.0 109.85 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.548 ' HB3' HD23 ' A' ' 91' ' ' LEU . 2.2 p90 -134.25 166.01 23.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.706 0.765 . . . . 0.0 112.721 -169.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.621 ' HE2' ' HB2' ' A' ' 30' ' ' SER . 9.3 t60 -118.72 125.13 48.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.302 -1.317 . . . . 0.0 109.958 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.617 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 39.8 mt -94.6 138.48 20.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 169.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.621 ' HB2' ' HE2' ' A' ' 28' ' ' HIS . 26.2 t -119.62 -23.51 6.54 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -169.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -161.92 156.89 28.57 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 119.408 -1.377 . . . . 0.0 113.253 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.405 HG23 ' HG ' ' A' ' 87' ' ' LEU . 10.2 p -137.36 125.38 32.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 172.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.81 152.31 42.07 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -171.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.572 ' HB3' HG12 ' A' ' 85' ' ' VAL . 3.7 pp -119.18 142.73 47.71 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.583 0.706 . . . . 0.0 111.346 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -110.12 -48.46 3.18 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.615 173.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -102.49 127.27 49.62 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 170.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.522 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 145.83 159.54 8.22 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 119.392 -1.385 . . . . 0.0 113.948 176.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.428 ' HA ' ' HB2' ' A' ' 58' ' ' LYS . 54.3 mt-30 -103.15 -44.5 5.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.653 -0.274 . . . . 0.0 111.127 177.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -150.63 132.63 15.21 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 120.5 0.19 . . . . 0.0 111.026 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.527 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -133.02 114.32 13.84 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.286 0.565 . . . . 0.0 110.586 169.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 79' ' ' THR . 63.9 mttp -95.86 112.22 24.0 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 174.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 45.4 tp -83.99 115.93 22.57 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.439 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -117.02 144.01 45.08 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.533 ' HA ' ' O ' ' A' ' 76' ' ' MET . 0.2 OUTLIER -131.34 132.54 44.55 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.2 0.524 . . . . 0.0 109.723 172.086 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -107.09 110.07 22.09 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.3 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.587 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -126.22 151.95 46.71 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 43.36 37.49 1.38 Allowed 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.939 0.774 . . . . 0.0 111.142 -171.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.7 tptp 54.65 46.66 24.26 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.157 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.585 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 6.5 tp-100 -135.17 130.71 35.78 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.669 175.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -85.68 110.86 19.59 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.343 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.49 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 82.5 m-85 -104.62 129.16 52.77 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.7 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 tp -77.25 103.79 4.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 169.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.534 HG13 ' CD2' ' E' ' 88' ' ' LEU . 2.6 t -76.39 -49.52 24.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.293 -173.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.489 ' HB2' ' CD2' ' A' ' 65' ' ' LEU . . . -159.03 144.86 16.47 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.19 -178.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.3 m -110.5 101.49 10.17 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 171.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.431 ' CG1' HG11 ' A' ' 85' ' ' VAL . 7.5 p -111.26 120.44 61.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.133 -178.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 54.8 p -122.61 -179.81 4.35 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -172.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 38' ' ' GLN . 35.0 tttm -60.89 -27.04 67.86 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.272 0.558 . . . . 0.0 109.901 172.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.479 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -83.48 -40.57 19.07 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.734 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 90.9 mt -107.36 89.43 4.84 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 36.0 Cg_exo -61.32 -20.3 67.65 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.101 2.534 . . . . 0.0 113.941 -169.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -156.19 136.09 12.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.381 0.61 . . . . 0.0 111.974 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.453 HG11 ' HB1' ' A' ' 54' ' ' ALA . 98.4 t -111.38 113.8 45.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.729 171.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.03 122.15 34.27 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.08 177.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.489 ' CD2' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -142.6 143.5 32.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.248 0.547 . . . . 0.0 111.902 -177.084 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.471 ' HB3' ' OG ' ' E' ' 30' ' ' SER . 5.6 t70 -89.59 100.57 13.34 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.706 177.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.726 HD21 HD23 ' E' ' 88' ' ' LEU . 19.7 mt -110.81 138.39 47.27 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.686 176.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.649 ' HB2' ' CD2' ' E' ' 90' ' ' TYR . 10.5 m-80 -137.58 128.21 26.82 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 173.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -124.43 146.81 48.69 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.977 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.0 t -99.93 148.97 23.9 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.404 ' HA ' ' CG2' ' A' ' 23' ' ' ILE . 15.1 ptmm? -67.14 -10.72 53.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.326 -178.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.42 -9.87 66.38 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.107 176.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -100.74 160.06 14.67 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -135.12 125.43 26.37 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.587 HG22 ' HB2' ' A' ' 46' ' ' ALA . 11.3 pt -131.21 178.13 5.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.93 0.395 . . . . 0.0 111.609 -171.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.533 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 24.5 mtp -130.9 136.31 48.49 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 174.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.472 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 1.2 m-85 -117.86 128.21 54.62 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.145 176.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.719 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 34.6 p90 -155.08 145.64 22.2 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.966 -178.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.69 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 13.2 p -117.33 144.95 44.36 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.507 -177.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -115.04 151.33 34.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.915 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.58 -177.16 29.29 Favored Glycine 0 CA--C 1.509 -0.334 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -109.74 102.93 11.69 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.684 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -175.27 155.94 1.97 Allowed 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.87 172.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.6 t -113.03 118.87 36.0 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.572 HG12 ' HB3' ' A' ' 34' ' ' LEU . 10.5 m -118.94 137.39 53.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -173.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 54.6 m -101.17 120.94 40.97 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.048 175.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.643 HD13 HD23 ' A' ' 11' ' ' LEU . 5.3 mp -89.41 145.71 25.15 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 170.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.698 HD23 HD21 ' B' ' 67' ' ' LEU . 1.2 tp -131.48 132.17 44.05 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.679 -177.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -159.66 -166.76 19.22 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.701 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.634 ' CD2' ' HB2' ' B' ' 68' ' ' ASN . 18.7 p90 -153.02 133.72 13.83 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.919 0.866 . . . . 0.0 111.547 177.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.548 HD23 ' HB3' ' A' ' 27' ' ' PHE . 5.1 mt -71.32 138.21 49.1 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 113.981 -1.463 . . . . 0.0 108.926 174.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -68.01 123.77 21.55 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.78 -77.73 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 O-C-N 124.129 0.893 . . . . 0.0 113.352 -169.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 69.9 mt -137.18 115.94 14.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.942 0.401 . . . . 0.0 110.647 -177.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -93.01 84.88 4.96 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.0 t -167.38 130.43 1.72 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.818 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.38 150.06 36.3 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.803 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.488 -0.768 . . . . 0.0 110.206 -179.562 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -127.38 66.55 1.31 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.56 0.695 . . . . 0.0 109.572 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' C' ' 95' ' ' ASP . . . -75.55 136.52 20.22 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.978 178.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.92 146.85 22.21 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 59.4 mtt -125.97 39.85 3.86 Favored 'General case' 0 C--N 1.321 -0.65 0 O-C-N 123.32 0.388 . . . . 0.0 109.954 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -51.04 129.24 23.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.85 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 48.7 mtt -96.34 129.84 43.59 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.25 0.548 . . . . 0.0 111.546 -173.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.467 ' CE1' HD21 ' C' ' 44' ' ' LEU . 60.7 t80 -56.82 141.91 42.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.515 -173.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' TRP . . . . . 0.454 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 87.5 t90 -135.34 141.42 45.59 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.817 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.479 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -143.13 155.53 26.04 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.105 178.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.637 HD23 HD13 ' B' ' 87' ' ' LEU . 56.9 tp -145.34 108.5 4.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.784 0.326 . . . . 0.0 110.819 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -88.98 106.44 18.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.495 0.664 . . . . 0.0 110.947 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' MET . . . . . 0.553 ' HB2' HG23 ' B' ' 85' ' ' VAL . 4.1 mmt -86.98 134.41 33.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.041 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.526 ' HB2' ' HG3' ' B' ' 17' ' ' ARG . 54.5 mtmt -100.18 146.14 31.45 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 172.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.44 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 5.8 Cg_endo -48.19 110.35 0.32 Allowed 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 123.449 2.766 . . . . 0.0 113.444 -174.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.69 ' HA ' ' O ' ' B' ' 79' ' ' THR . 31.6 mt-10 69.52 54.1 0.4 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.48 178.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.526 ' HG3' ' HB2' ' B' ' 14' ' ' LYS . 19.5 mmt180 -110.73 152.72 26.24 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.879 172.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.724 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 36.0 ttmt -133.59 107.79 8.2 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.825 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' TYR . . . . . 0.42 ' OH ' ' HA ' ' B' ' 13' ' ' MET . 0.8 OUTLIER -110.99 121.07 44.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.803 179.423 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 5.2 p -75.3 126.74 31.63 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 170.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -103.83 116.45 32.3 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.713 -164.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 9.6 p -97.16 123.19 40.86 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.842 173.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 55.6 mt -93.02 108.51 20.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.032 0.444 . . . . 0.0 111.513 -172.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.711 ' H ' HD13 ' B' ' 24' ' ' ILE . 0.2 OUTLIER -76.1 -39.73 36.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.001 177.765 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -139.53 141.48 37.28 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 15.5 m -60.8 120.93 11.06 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.666 0.604 . . . . 0.0 109.814 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' PHE . . . . . 0.545 ' HB3' HD23 ' B' ' 91' ' ' LEU . 2.2 p90 -134.34 165.95 23.95 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.685 0.755 . . . . 0.0 112.73 -169.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' HIS . . . . . 0.62 ' HE2' ' HB2' ' B' ' 30' ' ' SER . 9.5 t60 -118.68 125.1 48.95 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.98 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.627 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 39.7 mt -94.53 138.54 20.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 169.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.62 ' HB2' ' HE2' ' B' ' 28' ' ' HIS . 26.1 t -119.65 -23.49 6.53 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -169.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -161.91 156.99 28.69 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.328 -1.415 . . . . 0.0 113.266 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.405 HG23 ' HG ' ' B' ' 87' ' ' LEU . 10.2 p -137.5 125.37 31.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 172.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.81 152.36 42.14 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -171.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.585 ' HB3' HG12 ' B' ' 85' ' ' VAL . 3.6 pp -119.21 142.75 47.73 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.542 0.687 . . . . 0.0 111.347 177.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -110.22 -48.5 3.17 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.554 173.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -102.41 127.18 49.54 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 170.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.518 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 145.97 159.66 8.3 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 119.38 -1.39 . . . . 0.0 113.8 176.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' GLN . . . . . 0.423 ' HA ' ' HB2' ' B' ' 58' ' ' LYS . 54.3 mt-30 -103.17 -44.55 5.16 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.593 -0.304 . . . . 0.0 111.177 177.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -150.64 132.66 15.23 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 120.536 0.208 . . . . 0.0 111.014 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.507 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -133.0 114.31 13.83 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.266 0.555 . . . . 0.0 110.485 169.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' B' ' 79' ' ' THR . 64.0 mttp -95.88 112.17 23.97 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 174.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 45.2 tp -83.93 116.0 22.57 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.489 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -117.12 143.96 45.22 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.526 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.2 OUTLIER -131.32 132.52 44.56 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.705 172.1 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -107.05 110.12 22.16 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.373 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.584 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -126.25 151.96 46.75 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 43.37 37.45 1.36 Allowed 'General case' 0 N--CA 1.474 0.77 0 O-C-N 123.918 0.761 . . . . 0.0 111.155 -171.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 25.7 tptp 54.55 46.86 23.98 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.116 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.585 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 6.5 tp-100 -135.28 130.72 35.57 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.603 175.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -85.74 110.9 19.66 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.315 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.503 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 82.3 m-85 -104.56 129.18 52.66 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.681 177.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 tp -77.39 103.83 4.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 169.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.53 HG13 ' CD2' ' A' ' 88' ' ' LEU . 2.6 t -76.35 -49.57 24.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.199 -173.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.478 ' HB2' ' CD2' ' B' ' 65' ' ' LEU . . . -159.1 144.84 16.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.178 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 43.7 m -110.51 101.55 10.23 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 171.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.431 ' CG1' HG11 ' B' ' 85' ' ' VAL . 7.5 p -111.3 120.48 61.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.147 -178.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 52.8 p -122.67 -179.75 4.34 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.098 0.475 . . . . 0.0 112.215 -172.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' B' ' 38' ' ' GLN . 34.9 tttm -60.9 -27.05 67.88 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.92 172.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.473 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -83.45 -40.57 19.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.791 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 90.9 mt -107.38 89.56 4.98 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 174.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 36.6 Cg_exo -61.46 -20.24 67.67 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.151 2.567 . . . . 0.0 113.949 -169.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -156.27 135.98 12.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.408 0.623 . . . . 0.0 111.886 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.457 HG11 ' HB1' ' B' ' 54' ' ' ALA . 98.6 t -111.3 113.79 45.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.726 171.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.03 122.19 34.31 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.109 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.478 ' CD2' ' HB2' ' B' ' 54' ' ' ALA . 0.2 OUTLIER -142.62 143.49 32.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.315 0.579 . . . . 0.0 111.916 -177.067 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 66' ' ' ASP . . . . . 0.432 ' HB3' ' OG ' ' A' ' 30' ' ' SER . 5.6 t70 -89.61 100.53 13.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.71 177.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.698 HD21 HD23 ' A' ' 88' ' ' LEU . 19.5 mt -110.87 138.38 47.35 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.64 176.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 68' ' ' ASN . . . . . 0.634 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 10.5 m-80 -137.5 128.18 26.92 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 173.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -124.4 146.77 48.68 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.03 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 28.8 t -100.03 148.93 24.0 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -67.17 -10.65 52.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.277 -177.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.46 -9.73 66.47 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.122 176.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -100.89 160.1 14.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -135.18 125.41 26.24 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.584 HG22 ' HB2' ' B' ' 46' ' ' ALA . 11.2 pt -131.19 178.06 6.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.901 0.381 . . . . 0.0 111.55 -171.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.526 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 24.7 mtp -130.87 136.4 48.6 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 174.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 77' ' ' PHE . . . . . 0.48 ' CD1' ' HB2' ' B' ' 44' ' ' LEU . 1.2 m-85 -117.91 128.16 54.55 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.146 176.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.724 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 34.3 p90 -155.07 145.7 22.27 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.922 -178.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.69 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 13.2 p -117.39 144.99 44.39 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.446 -177.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -115.12 151.27 34.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.903 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.7 -177.09 29.11 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -109.89 102.95 11.67 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 119.625 -0.83 . . . . 0.0 109.608 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.518 ' CB ' ' HA3' ' B' ' 37' ' ' GLY . . . -175.22 155.94 1.99 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.814 172.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 32.6 t -113.05 118.86 35.96 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.585 HG12 ' HB3' ' B' ' 34' ' ' LEU . 10.2 m -118.93 137.53 52.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 CA-C-O 121.403 0.621 . . . . 0.0 112.671 -173.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 54.5 m -101.27 120.92 40.97 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.093 175.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.637 HD13 HD23 ' B' ' 11' ' ' LEU . 5.3 mp -89.41 145.74 25.13 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 170.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.696 HD23 HD21 ' C' ' 67' ' ' LEU . 1.2 tp -131.54 132.16 43.94 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.645 -177.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -159.7 -166.78 19.28 Favored Glycine 0 N--CA 1.438 -1.233 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.638 -176.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 90' ' ' TYR . . . . . 0.629 ' CD2' ' HB2' ' C' ' 68' ' ' ASN . 18.7 p90 -152.97 133.68 13.85 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.909 0.861 . . . . 0.0 111.622 177.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 91' ' ' LEU . . . . . 0.545 HD23 ' HB3' ' B' ' 27' ' ' PHE . 5.2 mt -71.29 138.11 49.08 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 113.988 -1.46 . . . . 0.0 108.978 174.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -67.94 123.74 21.42 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.73 -77.73 0.02 OUTLIER 'General case' 0 C--O 1.235 0.319 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -169.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 70.1 mt -137.19 115.99 14.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.853 0.358 . . . . 0.0 110.67 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -92.99 84.81 4.95 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 29.4 t -167.36 130.42 1.73 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.832 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.42 150.09 36.28 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.883 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.672 -0.68 . . . . 0.0 110.233 -179.443 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -127.44 66.5 1.31 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.702 0.763 . . . . 0.0 109.636 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.46 136.51 20.28 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.988 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.91 146.89 22.25 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 59.3 mtt -125.92 39.68 3.9 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.323 0.389 . . . . 0.0 109.964 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.95 129.17 23.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.918 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 48.8 mtt -96.33 129.86 43.57 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.255 0.55 . . . . 0.0 111.578 -173.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 8' ' ' PHE . . . . . 0.487 ' CE1' HD21 ' D' ' 44' ' ' LEU . 60.1 t80 -56.88 141.94 43.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.448 -173.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 9' ' ' TRP . . . . . 0.457 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 87.5 t90 -135.33 141.41 45.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.802 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 10' ' ' GLY . . . . . 0.484 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -143.17 155.5 26.03 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.053 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.637 HD23 HD13 ' C' ' 87' ' ' LEU . 57.1 tp -145.26 108.58 4.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.821 0.343 . . . . 0.0 110.906 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -89.0 106.43 18.42 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.528 0.68 . . . . 0.0 110.852 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 13' ' ' MET . . . . . 0.555 ' HB2' HG23 ' C' ' 85' ' ' VAL . 4.1 mmt -86.96 134.38 33.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.014 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 14' ' ' LYS . . . . . 0.513 ' HB2' ' HG3' ' C' ' 17' ' ' ARG . 54.5 mtmt -100.16 146.16 31.46 Favored Pre-proline 0 C--N 1.316 -0.849 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 15' ' ' PRO . . . . . 0.436 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 5.8 Cg_endo -48.11 110.37 0.32 Allowed 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.52 2.814 . . . . 0.0 113.422 -174.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 16' ' ' GLU . . . . . 0.685 ' HA ' ' O ' ' C' ' 79' ' ' THR . 31.7 mt-10 69.47 54.08 0.41 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.541 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 17' ' ' ARG . . . . . 0.513 ' HG3' ' HB2' ' C' ' 14' ' ' LYS . 19.4 mmt180 -110.86 152.65 26.45 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.878 172.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 18' ' ' LYS . . . . . 0.718 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 36.0 ttmt -133.5 107.61 8.13 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.911 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 19' ' ' TYR . . . . . 0.422 ' OH ' ' HA ' ' C' ' 13' ' ' MET . 0.8 OUTLIER -110.96 121.06 44.4 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.803 -0.444 . . . . 0.0 109.803 179.5 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 5.2 p -75.35 126.7 31.54 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 171.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -103.77 116.55 32.51 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.722 -164.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 9.6 p -97.21 123.16 40.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.872 173.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 23' ' ' ILE . . . . . 0.402 ' CG2' ' HA ' ' C' ' 71' ' ' LYS . 55.2 mt -93.0 108.51 20.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.201 0.524 . . . . 0.0 111.54 -172.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 24' ' ' ILE . . . . . 0.697 ' H ' HD13 ' C' ' 24' ' ' ILE . 0.2 OUTLIER -76.13 -39.8 36.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.955 177.825 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -139.5 141.43 37.34 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 15.5 m -60.78 120.8 10.82 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 123.628 0.58 . . . . 0.0 109.858 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 27' ' ' PHE . . . . . 0.553 ' HB3' HD23 ' C' ' 91' ' ' LEU . 2.2 p90 -134.27 165.93 23.98 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.685 0.755 . . . . 0.0 112.715 -169.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 28' ' ' HIS . . . . . 0.626 ' HE2' ' HB2' ' C' ' 30' ' ' SER . 9.3 t60 -118.62 125.2 49.24 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.97 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 29' ' ' ILE . . . . . 0.605 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 39.9 mt -94.57 138.5 20.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 169.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.626 ' HB2' ' HE2' ' C' ' 28' ' ' HIS . 26.1 t -119.64 -23.47 6.54 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -169.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 31' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -161.9 157.0 28.7 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 119.374 -1.393 . . . . 0.0 113.29 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 10.2 p -137.45 125.41 31.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 172.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.85 152.34 42.05 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.636 -0.426 . . . . 0.0 112.143 -171.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.592 ' HB3' HG12 ' C' ' 85' ' ' VAL . 3.7 pp -119.2 142.74 47.72 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.49 0.662 . . . . 0.0 111.424 177.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -110.09 -48.58 3.17 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.581 173.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -102.38 127.24 49.48 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 170.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 37' ' ' GLY . . . . . 0.52 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 145.93 159.59 8.26 Favored Glycine 0 N--CA 1.437 -1.257 0 C-N-CA 119.318 -1.42 . . . . 0.0 113.834 176.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 38' ' ' GLN . . . . . 0.425 ' HA ' ' HB2' ' C' ' 58' ' ' LYS . 54.2 mt-30 -103.06 -44.55 5.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.658 -0.271 . . . . 0.0 111.214 177.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -150.67 132.61 15.15 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.483 0.182 . . . . 0.0 110.982 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.519 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -133.02 114.35 13.86 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.286 0.565 . . . . 0.0 110.5 169.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' C' ' 79' ' ' THR . 64.0 mttp -95.91 112.16 23.96 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 174.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 45.4 tp -83.94 116.0 22.58 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -117.11 143.95 45.23 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.52 ' HA ' ' O ' ' C' ' 76' ' ' MET . 0.2 OUTLIER -131.28 132.55 44.65 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.167 0.508 . . . . 0.0 109.665 172.07 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 45' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -107.06 110.14 22.18 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.341 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.573 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -126.28 151.91 46.85 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 43.38 37.47 1.38 Allowed 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.864 0.727 . . . . 0.0 111.193 -171.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 25.7 tptp 54.58 46.71 24.25 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.233 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 49' ' ' GLN . . . . . 0.591 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 6.5 tp-100 -135.22 130.72 35.69 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.567 175.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -85.78 110.84 19.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.906 0.384 . . . . 0.0 110.339 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 51' ' ' TYR . . . . . 0.479 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 82.4 m-85 -104.5 129.19 52.54 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.702 177.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 tp -77.29 103.79 4.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 169.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 53' ' ' VAL . . . . . 0.507 HG13 ' CD2' ' B' ' 88' ' ' LEU . 2.6 t -76.36 -49.62 24.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.243 -173.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 54' ' ' ALA . . . . . 0.466 ' HB2' ' CD2' ' C' ' 65' ' ' LEU . . . -159.0 144.87 16.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.228 -178.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 43.5 m -110.53 101.52 10.19 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 171.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 56' ' ' VAL . . . . . 0.429 ' CG1' HG11 ' C' ' 85' ' ' VAL . 7.6 p -111.26 120.53 62.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.204 -178.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 52.7 p -122.76 -179.74 4.34 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.078 0.466 . . . . 0.0 112.17 -172.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 58' ' ' LYS . . . . . 0.425 ' HB2' ' HA ' ' C' ' 38' ' ' GLN . 34.9 tttm -60.92 -27.16 68.0 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.281 0.562 . . . . 0.0 109.849 172.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 59' ' ' ALA . . . . . 0.476 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -83.43 -40.51 19.22 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.817 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 90.5 mt -107.43 89.48 4.96 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 174.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 61' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 37.5 Cg_exo -61.32 -20.31 67.68 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.145 2.563 . . . . 0.0 113.892 -169.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -156.25 136.02 12.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.479 0.657 . . . . 0.0 111.869 -178.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.456 HG11 ' HB1' ' C' ' 54' ' ' ALA . 98.0 t -111.36 113.92 45.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.663 171.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.15 122.21 34.42 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.025 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 65' ' ' LEU . . . . . 0.466 ' CD2' ' HB2' ' C' ' 54' ' ' ALA . 0.2 OUTLIER -142.59 143.43 32.43 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.287 0.565 . . . . 0.0 111.955 -177.1 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 66' ' ' ASP . . . . . 0.445 ' HB3' ' OG ' ' B' ' 30' ' ' SER . 5.6 t70 -89.54 100.5 13.29 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.718 177.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.696 HD21 HD23 ' B' ' 88' ' ' LEU . 19.7 mt -110.83 138.45 47.22 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.694 176.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 68' ' ' ASN . . . . . 0.629 ' HB2' ' CD2' ' B' ' 90' ' ' TYR . 10.5 m-80 -137.57 128.21 26.85 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 173.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -124.47 146.79 48.74 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.934 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 29.2 t -99.97 148.95 23.95 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 71' ' ' LYS . . . . . 0.402 ' HA ' ' CG2' ' C' ' 23' ' ' ILE . 15.1 ptmm? -67.06 -10.81 53.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.271 -178.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.42 -9.78 66.49 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.081 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -100.9 160.15 14.61 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -135.17 125.53 26.48 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.573 HG22 ' HB2' ' C' ' 46' ' ' ALA . 11.3 pt -131.33 178.04 6.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.836 0.35 . . . . 0.0 111.576 -171.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.52 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 24.6 mtp -130.79 136.25 48.53 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 77' ' ' PHE . . . . . 0.477 ' CD1' ' HB2' ' C' ' 44' ' ' LEU . 1.2 m-85 -117.79 128.23 54.66 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.17 176.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 78' ' ' TYR . . . . . 0.718 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 34.7 p90 -155.14 145.63 22.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.961 0.41 . . . . 0.0 111.987 -178.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 79' ' ' THR . . . . . 0.685 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 13.0 p -117.36 144.97 44.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.438 -177.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -115.09 151.28 34.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.972 177.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.67 -177.03 29.12 Favored Glycine 0 CA--C 1.508 -0.403 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -109.93 102.99 11.7 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.764 0.782 . . . . 0.0 109.637 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 83' ' ' ALA . . . . . 0.52 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -175.27 155.95 1.97 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.833 172.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 32.4 t -113.07 118.8 35.79 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.592 HG12 ' HB3' ' C' ' 34' ' ' LEU . 10.1 m -118.88 137.51 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -173.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 54.2 m -101.21 120.9 40.92 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.074 175.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 87' ' ' LEU . . . . . 0.637 HD13 HD23 ' C' ' 11' ' ' LEU . 5.3 mp -89.36 145.79 25.12 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 170.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 88' ' ' LEU . . . . . 0.687 HD23 HD21 ' D' ' 67' ' ' LEU . 1.2 tp -131.56 132.15 43.9 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.669 -177.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -159.71 -166.88 19.49 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.575 -176.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 90' ' ' TYR . . . . . 0.631 ' CD2' ' HB2' ' D' ' 68' ' ' ASN . 19.0 p90 -152.88 133.71 13.96 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.885 0.85 . . . . 0.0 111.658 177.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 91' ' ' LEU . . . . . 0.553 HD23 ' HB3' ' C' ' 27' ' ' PHE . 5.1 mt -71.33 138.11 49.01 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.011 -1.45 . . . . 0.0 108.97 174.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -67.95 123.73 21.4 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.61 -77.73 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -169.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 69.8 mt -137.17 115.91 14.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.819 0.342 . . . . 0.0 110.698 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 95' ' ' ASP . . . . . 0.406 ' HA ' ' HA3' ' B' ' 3' ' ' GLY . 12.6 t70 -92.97 84.78 4.96 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 30.0 t -167.26 130.45 1.76 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.839 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.35 150.12 36.44 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.84 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.472 -0.775 . . . . 0.0 110.303 -179.552 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 . . . . . 0 N--CA 1.476 0.827 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -127.42 66.6 1.31 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.685 0.755 . . . . 0.0 109.606 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.57 136.5 20.16 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.919 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.87 146.98 22.38 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 59.2 mtt -126.06 39.81 3.87 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.92 129.18 22.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.951 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 49.0 mtt -96.42 129.85 43.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.312 0.577 . . . . 0.0 111.446 -173.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 8' ' ' PHE . . . . . 0.496 ' CE1' HD21 ' E' ' 44' ' ' LEU . 60.6 t80 -56.78 141.92 42.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.685 -1.143 . . . . 0.0 112.49 -173.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 9' ' ' TRP . . . . . 0.454 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 87.5 t90 -135.38 141.4 45.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.75 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 10' ' ' GLY . . . . . 0.501 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -143.11 155.55 26.04 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.133 178.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.635 HD23 HD13 ' D' ' 87' ' ' LEU . 56.8 tp -145.35 108.51 4.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.832 0.348 . . . . 0.0 110.805 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -88.92 106.37 18.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.459 0.647 . . . . 0.0 110.932 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 13' ' ' MET . . . . . 0.566 ' HB2' HG23 ' D' ' 85' ' ' VAL . 4.1 mmt -86.9 134.44 33.52 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.046 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 14' ' ' LYS . . . . . 0.529 ' HB2' ' HG3' ' D' ' 17' ' ' ARG . 54.6 mtmt -100.32 146.15 31.48 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 172.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 15' ' ' PRO . . . . . 0.428 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 5.7 Cg_endo -48.11 110.39 0.32 Allowed 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 123.43 2.754 . . . . 0.0 113.441 -174.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 16' ' ' GLU . . . . . 0.684 ' HA ' ' O ' ' D' ' 79' ' ' THR . 31.6 mt-10 69.47 53.96 0.41 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.55 178.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 17' ' ' ARG . . . . . 0.529 ' HG3' ' HB2' ' D' ' 14' ' ' LYS . 19.5 mmt180 -110.57 152.72 26.08 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.948 172.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 18' ' ' LYS . . . . . 0.707 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 36.0 ttmt -133.62 107.75 8.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.903 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 19' ' ' TYR . . . . . 0.42 ' OH ' ' HA ' ' D' ' 13' ' ' MET . 0.8 OUTLIER -111.11 121.06 44.35 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.579 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 5.2 p -75.26 126.8 31.76 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 170.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -103.97 116.5 32.36 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.054 0.454 . . . . 0.0 111.648 -164.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 9.1 p -97.28 123.14 40.99 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.826 173.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 23' ' ' ILE . . . . . 0.405 ' CG2' ' HA ' ' D' ' 71' ' ' LYS . 55.2 mt -92.97 108.51 20.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.117 0.484 . . . . 0.0 111.521 -172.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 24' ' ' ILE . . . . . 0.709 ' H ' HD13 ' D' ' 24' ' ' ILE . 0.2 OUTLIER -76.23 -39.57 35.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.018 177.827 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -139.6 141.46 37.14 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 15.6 m -60.72 120.84 10.85 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 123.535 0.522 . . . . 0.0 109.747 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 27' ' ' PHE . . . . . 0.565 ' HB3' HD23 ' D' ' 91' ' ' LEU . 2.2 p90 -134.33 165.92 24.02 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.748 0.785 . . . . 0.0 112.725 -169.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 28' ' ' HIS . . . . . 0.631 ' HE2' ' HB2' ' D' ' 30' ' ' SER . 9.5 t60 -118.58 125.15 49.18 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.996 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 29' ' ' ILE . . . . . 0.616 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 39.5 mt -94.56 138.48 20.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 169.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 30' ' ' SER . . . . . 0.631 ' HB2' ' HE2' ' D' ' 28' ' ' HIS . 26.1 t -119.62 -23.46 6.55 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -169.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 31' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -161.97 156.94 28.65 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.385 -1.388 . . . . 0.0 113.257 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.403 HG23 ' HG ' ' D' ' 87' ' ' LEU . 10.4 p -137.4 125.42 32.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.84 152.36 42.08 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.641 -0.424 . . . . 0.0 112.039 -171.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 34' ' ' LEU . . . . . 0.578 ' HB3' HG12 ' D' ' 85' ' ' VAL . 3.7 pp -119.13 142.71 47.69 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.518 0.675 . . . . 0.0 111.415 177.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -110.08 -48.61 3.17 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.591 173.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -102.41 127.17 49.55 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 170.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 37' ' ' GLY . . . . . 0.525 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 145.86 159.63 8.27 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 119.379 -1.391 . . . . 0.0 113.916 176.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 38' ' ' GLN . . . . . 0.428 ' HA ' ' HB2' ' D' ' 58' ' ' LYS . 54.0 mt-30 -103.15 -44.53 5.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.702 -0.249 . . . . 0.0 111.157 177.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -150.68 132.61 15.14 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.566 0.222 . . . . 0.0 111.019 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 40' ' ' ALA . . . . . 0.522 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -132.98 114.33 13.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.234 0.54 . . . . 0.0 110.514 169.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' D' ' 79' ' ' THR . 64.0 mttp -95.86 112.05 23.88 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 45.3 tp -83.88 116.03 22.56 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -177.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -117.18 144.04 45.18 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.531 ' HA ' ' O ' ' D' ' 76' ' ' MET . 0.2 OUTLIER -131.4 132.5 44.42 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.697 172.095 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 45' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -107.04 110.12 22.17 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.396 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.593 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -126.31 151.9 46.92 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 43.4 37.49 1.4 Allowed 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.923 0.764 . . . . 0.0 111.09 -171.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 25.7 tptp 54.57 46.78 24.11 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.186 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 49' ' ' GLN . . . . . 0.589 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 6.5 tp-100 -135.18 130.71 35.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.623 175.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -85.69 110.81 19.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.342 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 51' ' ' TYR . . . . . 0.484 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 82.2 m-85 -104.45 129.2 52.46 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.707 177.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 tp -77.28 103.77 4.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 169.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 53' ' ' VAL . . . . . 0.53 HG13 ' CD2' ' C' ' 88' ' ' LEU . 2.6 t -76.38 -49.55 24.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.246 -173.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 54' ' ' ALA . . . . . 0.485 ' HB2' ' CD2' ' D' ' 65' ' ' LEU . . . -159.02 144.9 16.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.239 -178.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 43.9 m -110.54 101.55 10.22 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 171.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 56' ' ' VAL . . . . . 0.427 ' CG1' HG11 ' D' ' 85' ' ' VAL . 7.6 p -111.22 120.44 61.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.171 -178.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 52.5 p -122.73 -179.79 4.36 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.084 0.469 . . . . 0.0 112.151 -172.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 58' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' D' ' 38' ' ' GLN . 34.8 tttm -60.83 -27.18 67.87 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.289 0.566 . . . . 0.0 109.864 172.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 59' ' ' ALA . . . . . 0.477 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -83.39 -40.56 19.2 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.773 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 91.0 mt -107.33 89.48 4.86 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 61' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 37.6 Cg_exo -61.45 -20.29 67.87 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.193 2.595 . . . . 0.0 113.84 -169.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -156.24 136.03 12.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.409 0.623 . . . . 0.0 111.967 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.46 HG11 ' HB1' ' D' ' 54' ' ' ALA . 98.2 t -111.33 113.77 45.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.702 171.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.07 122.29 34.44 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.995 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 65' ' ' LEU . . . . . 0.485 ' CD2' ' HB2' ' D' ' 54' ' ' ALA . 0.2 OUTLIER -142.79 143.39 32.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.336 0.588 . . . . 0.0 111.856 -177.075 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 66' ' ' ASP . . . . . 0.457 ' HB3' ' OG ' ' C' ' 30' ' ' SER . 5.6 t70 -89.49 100.55 13.32 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.717 177.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.687 HD21 HD23 ' C' ' 88' ' ' LEU . 19.8 mt -110.81 138.39 47.26 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.683 176.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 68' ' ' ASN . . . . . 0.631 ' HB2' ' CD2' ' C' ' 90' ' ' TYR . 10.6 m-80 -137.58 128.22 26.84 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 173.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -124.53 146.77 48.81 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.956 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 29.4 t -99.98 149.01 23.88 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 71' ' ' LYS . . . . . 0.405 ' HA ' ' CG2' ' D' ' 23' ' ' ILE . 15.1 ptmm? -67.22 -10.66 52.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.265 -178.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.52 -9.72 66.38 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.143 176.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -100.95 160.17 14.59 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -135.21 125.35 26.08 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.593 HG22 ' HB2' ' D' ' 46' ' ' ALA . 11.3 pt -131.18 178.14 5.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.012 0.434 . . . . 0.0 111.491 -171.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 76' ' ' MET . . . . . 0.531 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 24.4 mtp -130.87 136.33 48.53 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 174.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 77' ' ' PHE . . . . . 0.476 ' CD1' ' HB2' ' D' ' 44' ' ' LEU . 1.2 m-85 -117.79 128.16 54.6 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.192 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 78' ' ' TYR . . . . . 0.707 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 34.5 p90 -155.1 145.63 22.17 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.953 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 79' ' ' THR . . . . . 0.684 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 13.4 p -117.29 144.94 44.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.522 -177.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -115.07 151.27 34.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.938 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.7 -177.04 29.09 Favored Glycine 0 CA--C 1.508 -0.348 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -109.82 102.89 11.63 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 119.661 -0.815 . . . . 0.0 109.686 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 83' ' ' ALA . . . . . 0.525 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -175.25 155.89 1.97 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.782 172.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 32.8 t -112.98 118.84 35.97 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.578 HG12 ' HB3' ' D' ' 34' ' ' LEU . 10.2 m -118.92 137.53 52.6 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -173.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 54.9 m -101.25 121.02 41.12 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.986 175.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 87' ' ' LEU . . . . . 0.635 HD13 HD23 ' D' ' 11' ' ' LEU . 5.3 mp -89.4 145.72 25.15 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 170.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.699 HD23 HD21 ' E' ' 67' ' ' LEU . 1.2 tp -131.49 132.1 43.97 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.733 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -159.64 -166.78 19.23 Favored Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.641 -176.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 90' ' ' TYR . . . . . 0.645 ' CD2' ' HB2' ' E' ' 68' ' ' ASN . 19.0 p90 -152.91 133.66 13.89 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.882 0.849 . . . . 0.0 111.654 177.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 91' ' ' LEU . . . . . 0.565 HD23 ' HB3' ' D' ' 27' ' ' PHE . 5.1 mt -71.16 138.04 49.28 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.003 174.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -67.98 123.75 21.47 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.64 -77.77 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 O-C-N 124.18 0.925 . . . . 0.0 113.354 -169.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 70.3 mt -137.17 115.91 14.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.865 0.364 . . . . 0.0 110.704 -177.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -93.06 84.81 4.93 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 176.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 29.2 t -167.34 130.44 1.73 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.803 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.32 150.07 36.44 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.866 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.335 -0.84 . . . . 0.0 110.266 -179.503 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -127.37 66.56 1.31 Allowed 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.654 0.74 . . . . 0.0 109.627 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.55 136.49 20.16 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.987 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.89 146.86 22.26 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 59.5 mtt -125.93 39.78 3.88 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 6' ' ' ALA . . . . . . . . . . . . . . . -51.02 129.22 23.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.921 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 48.8 mtt -96.27 129.73 43.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.218 0.532 . . . . 0.0 111.545 -173.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 8' ' ' PHE . . . . . 0.494 ' CE1' HD21 ' A' ' 44' ' ' LEU . 60.6 t80 -56.75 141.94 42.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.601 -173.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 9' ' ' TRP . . . . . 0.455 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 87.3 t90 -135.34 141.34 45.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.056 -0.975 . . . . 0.0 108.812 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 10' ' ' GLY . . . . . 0.49 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -143.18 155.5 26.04 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.07 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 11' ' ' LEU . . . . . 0.628 HD23 HD13 ' E' ' 87' ' ' LEU . 57.2 tp -145.22 108.45 4.59 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.747 0.308 . . . . 0.0 110.89 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -88.96 106.42 18.41 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.413 0.625 . . . . 0.0 110.93 177.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 13' ' ' MET . . . . . 0.566 ' HB2' HG23 ' E' ' 85' ' ' VAL . 4.1 mmt -86.95 134.36 33.51 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.995 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 14' ' ' LYS . . . . . 0.506 ' HB2' ' HG3' ' E' ' 17' ' ' ARG . 54.6 mtmt -100.22 146.18 31.51 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 172.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 15' ' ' PRO . . . . . 0.428 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 5.7 Cg_endo -48.19 110.44 0.33 Allowed 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 123.418 2.745 . . . . 0.0 113.449 -174.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 16' ' ' GLU . . . . . 0.683 ' HA ' ' O ' ' E' ' 79' ' ' THR . 31.5 mt-10 69.46 53.99 0.41 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.533 178.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 17' ' ' ARG . . . . . 0.506 ' HG3' ' HB2' ' E' ' 14' ' ' LYS . 19.6 mmt180 -110.56 152.74 26.06 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.889 172.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 18' ' ' LYS . . . . . 0.716 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 36.0 ttmt -133.62 107.79 8.18 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.923 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 19' ' ' TYR . . . . . 0.42 ' OH ' ' HA ' ' E' ' 13' ' ' MET . 0.8 OUTLIER -111.02 121.16 44.65 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 5.4 p -75.37 126.7 31.54 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 170.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -103.9 116.52 32.42 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.039 0.447 . . . . 0.0 111.66 -164.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 9.4 p -97.2 123.12 40.89 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.88 173.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 55.3 mt -92.99 108.5 20.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.18 0.514 . . . . 0.0 111.557 -172.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 24' ' ' ILE . . . . . 0.715 ' H ' HD13 ' E' ' 24' ' ' ILE . 0.2 OUTLIER -76.16 -39.7 36.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.97 177.814 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -139.58 141.43 37.19 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 15.5 m -60.69 120.87 10.9 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.671 0.607 . . . . 0.0 109.915 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 27' ' ' PHE . . . . . 0.543 ' HB3' HD23 ' E' ' 91' ' ' LEU . 2.2 p90 -134.39 165.92 24.04 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.741 0.782 . . . . 0.0 112.659 -169.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 28' ' ' HIS . . . . . 0.624 ' HE2' ' HB2' ' E' ' 30' ' ' SER . 9.4 t60 -118.6 125.13 49.11 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.933 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 29' ' ' ILE . . . . . 0.618 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 39.9 mt -94.57 138.49 20.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 169.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 30' ' ' SER . . . . . 0.624 ' HB2' ' HE2' ' E' ' 28' ' ' HIS . 26.1 t -119.66 -23.51 6.52 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -169.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 31' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -161.94 156.98 28.69 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 119.365 -1.398 . . . . 0.0 113.296 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.41 HG23 ' HG ' ' E' ' 87' ' ' LEU . 10.3 p -137.43 125.34 31.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 172.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.78 152.25 42.06 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -171.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 34' ' ' LEU . . . . . 0.59 ' HB3' HG12 ' E' ' 85' ' ' VAL . 3.6 pp -119.15 142.75 47.67 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.532 0.682 . . . . 0.0 111.38 177.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -110.13 -48.59 3.17 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.542 173.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -102.45 127.27 49.55 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 170.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 37' ' ' GLY . . . . . 0.526 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 145.85 159.49 8.2 Favored Glycine 0 N--CA 1.437 -1.242 0 C-N-CA 119.342 -1.409 . . . . 0.0 113.938 176.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 38' ' ' GLN . . . . . 0.423 ' HA ' ' HB2' ' E' ' 58' ' ' LYS . 54.3 mt-30 -103.11 -44.44 5.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.697 -0.252 . . . . 0.0 111.181 177.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -150.66 132.63 15.18 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 120.415 0.15 . . . . 0.0 110.974 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 40' ' ' ALA . . . . . 0.511 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -133.07 114.36 13.83 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.302 0.572 . . . . 0.0 110.498 169.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 41' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' E' ' 79' ' ' THR . 64.1 mttp -95.79 112.05 23.87 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 174.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 45.4 tp -83.87 115.97 22.53 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.484 -177.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -117.06 144.0 45.13 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 44' ' ' LEU . . . . . 0.514 ' HA ' ' O ' ' E' ' 76' ' ' MET . 0.2 OUTLIER -131.35 132.52 44.51 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.201 0.524 . . . . 0.0 109.684 172.061 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 45' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -107.05 110.11 22.16 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.371 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 46' ' ' ALA . . . . . 0.576 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -126.26 151.98 46.73 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 176.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 43.39 37.44 1.38 Allowed 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.919 0.762 . . . . 0.0 111.146 -171.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 25.7 tptp 54.61 46.79 24.05 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.144 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 49' ' ' GLN . . . . . 0.586 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 6.5 tp-100 -135.31 130.76 35.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.639 175.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -85.78 110.83 19.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.264 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 51' ' ' TYR . . . . . 0.501 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 82.3 m-85 -104.49 129.15 52.54 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.764 177.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 tp -77.34 103.8 4.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 169.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 53' ' ' VAL . . . . . 0.529 HG13 ' CD2' ' D' ' 88' ' ' LEU . 2.6 t -76.32 -49.57 24.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.291 -173.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 54' ' ' ALA . . . . . 0.483 ' HB2' ' CD2' ' E' ' 65' ' ' LEU . . . -159.07 144.88 16.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.211 -178.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 44.4 m -110.52 101.46 10.14 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 171.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 56' ' ' VAL . . . . . 0.425 ' CG1' HG11 ' E' ' 85' ' ' VAL . 7.5 p -111.22 120.54 62.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.176 -178.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 52.3 p -122.73 -179.79 4.35 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.065 0.459 . . . . 0.0 112.153 -172.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 58' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' E' ' 38' ' ' GLN . 34.9 tttm -60.84 -27.18 67.89 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.854 172.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 59' ' ' ALA . . . . . 0.474 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -83.38 -40.51 19.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.804 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 90.9 mt -107.45 89.51 5.01 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 174.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 61' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 36.2 Cg_exo -61.4 -20.31 67.86 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.193 2.595 . . . . 0.0 113.916 -169.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -156.32 136.07 12.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.452 0.644 . . . . 0.0 111.921 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 63' ' ' VAL . . . . . 0.471 HG11 ' HB1' ' E' ' 54' ' ' ALA . 98.9 t -111.33 113.73 45.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.763 171.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.06 122.22 34.36 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.057 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.483 ' CD2' ' HB2' ' E' ' 54' ' ' ALA . 0.2 OUTLIER -142.74 143.49 32.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.335 0.588 . . . . 0.0 111.936 -177.128 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 66' ' ' ASP . . . . . 0.442 ' HB3' ' OG ' ' D' ' 30' ' ' SER . 5.6 t70 -89.49 100.53 13.31 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.679 177.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 67' ' ' LEU . . . . . 0.699 HD21 HD23 ' D' ' 88' ' ' LEU . 19.9 mt -110.91 138.41 47.34 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.646 176.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 68' ' ' ASN . . . . . 0.645 ' HB2' ' CD2' ' D' ' 90' ' ' TYR . 10.5 m-80 -137.63 128.26 26.8 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 173.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -124.47 146.79 48.73 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.974 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 29.5 t -100.12 149.01 23.95 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -67.14 -10.71 53.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.284 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.44 -9.77 66.48 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.064 176.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -100.83 160.17 14.59 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -135.22 125.48 26.33 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 75' ' ' ILE . . . . . 0.576 HG22 ' HB2' ' E' ' 46' ' ' ALA . 11.3 pt -131.31 178.08 6.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.835 0.35 . . . . 0.0 111.56 -171.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 76' ' ' MET . . . . . 0.514 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 24.6 mtp -130.89 136.28 48.47 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 77' ' ' PHE . . . . . 0.478 ' CD1' ' HB2' ' E' ' 44' ' ' LEU . 1.2 m-85 -117.82 128.2 54.63 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.199 176.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 78' ' ' TYR . . . . . 0.716 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 34.4 p90 -155.1 145.62 22.16 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.979 -178.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 79' ' ' THR . . . . . 0.683 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 13.3 p -117.3 144.91 44.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.496 -177.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -115.01 151.38 34.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.912 177.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.64 -177.2 29.25 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -109.81 102.88 11.63 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 117.79 0.795 . . . . 0.0 109.733 177.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 83' ' ' ALA . . . . . 0.526 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -175.22 155.94 1.99 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.823 172.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 32.6 t -113.06 118.83 35.86 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 85' ' ' VAL . . . . . 0.59 HG12 ' HB3' ' E' ' 34' ' ' LEU . 10.1 m -118.91 137.54 52.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -173.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 54.1 m -101.27 120.96 41.02 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.077 175.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 87' ' ' LEU . . . . . 0.628 HD13 HD23 ' E' ' 11' ' ' LEU . 5.3 mp -89.39 145.83 25.07 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 170.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 88' ' ' LEU . . . . . 0.726 HD23 HD21 ' A' ' 67' ' ' LEU . 1.2 tp -131.61 132.15 43.81 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.701 -177.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -159.67 -166.82 19.34 Favored Glycine 0 N--CA 1.439 -1.125 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.551 -176.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 90' ' ' TYR . . . . . 0.649 ' CD2' ' HB2' ' A' ' 68' ' ' ASN . 19.0 p90 -152.94 133.67 13.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.864 0.84 . . . . 0.0 111.687 177.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 91' ' ' LEU . . . . . 0.543 HD23 ' HB3' ' E' ' 27' ' ' PHE . 5.3 mt -71.35 138.11 48.97 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.073 -1.421 . . . . 0.0 108.896 174.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -67.9 123.71 21.33 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.71 -77.76 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 O-C-N 124.121 0.888 . . . . 0.0 113.346 -169.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 70.1 mt -137.15 116.04 14.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.806 0.336 . . . . 0.0 110.659 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -93.04 84.79 4.93 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 176.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 29.4 t -167.28 130.4 1.75 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.854 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.34 150.13 36.47 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.913 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.563 -0.732 . . . . 0.0 110.137 -179.452 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 64.06 -164.98 0.24 Allowed 'General case' 0 C--O 1.235 0.308 0 O-C-N 123.842 0.714 . . . . 0.0 111.501 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 101.89 102.3 2.61 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.868 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.47 133.41 52.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.948 0.404 . . . . 0.0 111.144 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 76.1 mtm -99.11 141.35 31.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.565 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -110.2 154.98 22.61 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.32 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.0 mtt -111.67 139.9 46.74 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.96 -178.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.436 ' CE1' HD21 ' B' ' 44' ' ' LEU . 74.6 t80 -54.83 143.94 24.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.847 -173.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.594 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 89.6 t90 -139.27 148.7 43.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.104 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.554 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -149.98 153.37 25.05 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.715 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.727 HD23 HD13 ' A' ' 87' ' ' LEU . 59.2 tp -139.06 108.8 6.24 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.916 0.389 . . . . 0.0 111.108 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -80.38 105.72 11.85 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.706 173.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.595 ' HB3' HG23 ' A' ' 85' ' ' VAL . 35.7 tpp -99.41 132.32 44.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.045 0.45 . . . . 0.0 110.956 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -98.63 146.6 31.88 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.89 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.527 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 10.4 Cg_endo -53.6 115.82 2.57 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 123.433 2.756 . . . . 0.0 113.141 -176.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.711 ' HA ' ' O ' ' A' ' 79' ' ' THR . 34.5 mt-10 63.49 38.12 10.06 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.591 177.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -109.36 149.95 28.74 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 173.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.694 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 34.4 ttmt -125.94 119.21 27.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.716 0.293 . . . . 0.0 111.592 -174.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.467 ' OH ' ' HA ' ' A' ' 13' ' ' MET . 3.6 m-85 -110.6 104.96 13.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.442 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.9 p -87.67 99.49 12.11 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 171.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -125.34 148.7 48.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.542 0.687 . . . . 0.0 112.466 -166.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.4 t -92.38 160.31 15.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.029 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 68.2 mt -106.24 117.79 52.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.05 0.452 . . . . 0.0 110.806 -175.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.466 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.1 mp -79.31 -45.38 23.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.916 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -135.17 140.22 45.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.739 178.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.1 m -55.99 124.15 16.75 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.527 0.517 . . . . 0.0 109.647 177.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.549 ' HB3' HD23 ' A' ' 91' ' ' LEU . 3.9 p90 -140.09 158.53 43.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.685 0.755 . . . . 0.0 112.683 -171.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.577 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 14.3 t60 -112.8 125.94 54.89 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.102 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 44.6 mt -96.3 133.45 37.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 170.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.577 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 42.2 p -118.48 -15.07 9.66 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -170.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.83 151.97 22.53 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 119.329 -1.415 . . . . 0.0 113.48 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.465 HG23 ' HG ' ' A' ' 87' ' ' LEU . 9.1 p -140.76 123.88 16.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 171.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.422 ' HA ' HG21 ' A' ' 56' ' ' VAL . . . -143.49 154.68 43.89 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.394 -0.522 . . . . 0.0 112.044 -173.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.631 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.3 pp -118.28 138.86 52.08 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.726 0.774 . . . . 0.0 111.178 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -110.07 -47.6 3.3 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.495 172.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -103.15 127.42 50.44 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.171 170.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.459 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 147.28 163.05 10.33 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 119.729 -1.224 . . . . 0.0 113.443 177.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.455 ' O ' ' HG3' ' A' ' 58' ' ' LYS . 48.8 tt0 -102.23 -48.21 4.27 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.554 0.216 . . . . 0.0 111.207 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -153.07 137.85 17.03 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.729 -0.214 . . . . 0.0 110.657 176.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.549 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -136.39 114.97 11.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.395 0.616 . . . . 0.0 111.12 171.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 79' ' ' THR . 68.1 mttm -95.07 115.03 26.91 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 171.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.403 HD23 ' HB ' ' A' ' 53' ' ' VAL . 38.1 tp -84.11 116.25 22.8 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -176.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.409 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 93.9 m-85 -117.09 143.82 45.35 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' A' ' 76' ' ' MET . 0.1 OUTLIER -131.7 131.71 43.3 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 172.68 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.577 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -111.87 118.15 34.75 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.132 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.638 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -130.48 133.66 46.46 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.485 178.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 56.05 38.9 30.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.135 0.493 . . . . 0.0 110.67 -175.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm 65.8 22.52 11.47 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.333 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.577 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 28.9 mm-40 -113.32 124.48 52.57 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -87.42 116.87 25.82 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.569 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 72.4 m-85 -111.61 131.07 55.52 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.782 177.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -81.34 103.42 8.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 171.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.506 HG13 ' CD2' ' E' ' 88' ' ' LEU . 2.3 t -76.87 -47.64 27.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.473 -172.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.476 ' HB2' HD23 ' A' ' 65' ' ' LEU . . . -156.7 151.53 25.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.327 -178.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 98.1 m -114.81 101.77 9.37 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 169.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.469 HG11 HG11 ' A' ' 85' ' ' VAL . 7.4 p -113.04 114.12 46.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.675 0.75 . . . . 0.0 109.759 -177.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 77.1 p -123.31 -177.75 3.79 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.411 -174.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 38' ' ' GLN . 28.8 mtpp -57.22 -36.13 70.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.101 0.477 . . . . 0.0 110.374 169.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.27 -41.23 66.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.551 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.9 mt -115.74 82.66 10.61 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 174.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.1 0.5 6.53 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.858 2.372 . . . . 0.0 113.598 -168.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -162.76 128.0 3.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.153 0.501 . . . . 0.0 111.029 -176.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.426 HG23 ' HB ' ' A' ' 56' ' ' VAL . 92.8 t -114.23 111.23 35.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.478 174.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.83 112.15 23.85 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.679 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.476 HD23 ' HB2' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -130.51 168.44 17.04 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.57 -175.522 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 6.5 t0 -115.25 99.92 7.76 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.344 0.592 . . . . 0.0 110.33 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.656 HD21 HD23 ' E' ' 88' ' ' LEU . 17.7 mt -114.59 141.23 48.03 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.667 177.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.429 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 6.2 t30 -146.62 115.32 6.81 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.975 0.417 . . . . 0.0 110.053 174.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -110.18 159.93 16.94 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.0 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.7 p -112.4 149.61 32.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.551 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.426 ' HG3' ' H ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -71.46 10.45 0.62 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -175.645 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.68 -21.39 14.48 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.087 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -101.23 171.39 7.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.777 0.322 . . . . 0.0 110.883 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 -137.72 129.3 28.23 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.638 HG22 ' HB2' ' A' ' 46' ' ' ALA . 14.5 pt -129.24 163.04 35.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.062 0.458 . . . . 0.0 111.691 -170.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.544 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 4.8 mtm -118.3 122.82 43.85 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 175.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.537 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 1.0 OUTLIER -105.05 127.69 52.99 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.171 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.694 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 49.5 p90 -155.9 150.6 26.12 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.508 -177.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.711 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 11.2 p -117.2 149.12 40.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.735 -178.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.04 144.6 42.33 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.247 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.19 176.99 34.69 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -175.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -106.47 102.8 12.17 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.932 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.549 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -170.75 151.25 3.43 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.574 169.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.6 t -108.14 121.6 45.17 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.631 HG12 ' HB3' ' A' ' 34' ' ' LEU . 11.4 m -118.54 146.19 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 CA-C-O 121.435 0.636 . . . . 0.0 111.666 -173.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.2 t -111.88 120.94 43.62 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.727 HD13 HD23 ' A' ' 11' ' ' LEU . 5.1 mp -93.0 151.63 19.78 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 174.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.635 HD23 HD21 ' B' ' 67' ' ' LEU . 1.6 tp -133.58 141.11 47.53 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.162 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.16 -166.67 26.63 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.825 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.43 ' CD2' ' HB3' ' B' ' 68' ' ' ASN . 8.1 p90 -150.96 130.16 12.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.754 0.788 . . . . 0.0 111.698 176.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.549 HD23 ' HB3' ' A' ' 27' ' ' PHE . 5.3 mt -72.97 136.24 45.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.886 176.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -79.21 108.94 13.09 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 174.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -114.8 -177.16 3.06 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -176.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.429 ' N ' HD12 ' A' ' 94' ' ' ILE . 4.2 mp -105.2 -35.96 3.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 25.2 t70 65.87 135.51 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.366 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.2 p -88.6 6.41 38.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.929 -176.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.73 -65.07 3.77 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.678 -0.773 . . . . 0.0 111.399 -177.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.8 p . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.793 -0.622 . . . . 0.0 109.712 176.988 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 64.11 -165.08 0.24 Allowed 'General case' 0 C--O 1.235 0.334 0 O-C-N 123.771 0.669 . . . . 0.0 111.386 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 101.99 102.34 2.62 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.771 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.47 133.38 52.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.909 0.385 . . . . 0.0 111.201 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 75.9 mtm -99.08 141.27 32.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.606 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -110.15 155.01 22.52 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.345 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 59.9 mtt -111.63 139.98 46.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.965 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.483 ' CE1' HD21 ' C' ' 44' ' ' LEU . 73.9 t80 -54.97 144.03 24.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.853 -173.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' TRP . . . . . 0.589 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 89.5 t90 -139.38 148.6 43.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.971 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.587 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -149.85 153.44 25.11 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.828 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.735 HD23 HD13 ' B' ' 87' ' ' LEU . 59.5 tp -139.04 108.71 6.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.774 0.321 . . . . 0.0 111.197 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -80.35 105.84 11.92 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.706 173.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' MET . . . . . 0.611 ' HB3' HG23 ' B' ' 85' ' ' VAL . 35.6 tpp -99.53 132.44 44.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.156 0.503 . . . . 0.0 110.87 -176.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -98.61 146.61 31.9 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.915 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.525 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 10.3 Cg_endo -53.68 115.86 2.61 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 123.425 2.75 . . . . 0.0 113.134 -176.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.709 ' HA ' ' O ' ' B' ' 79' ' ' THR . 34.6 mt-10 63.5 38.02 10.1 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.666 177.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -109.31 149.84 28.86 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.69 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 34.3 ttmt -125.95 119.23 27.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.774 0.321 . . . . 0.0 111.617 -174.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' TYR . . . . . 0.48 ' OH ' ' HA ' ' B' ' 13' ' ' MET . 3.6 m-85 -110.54 104.94 13.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.399 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 11.9 p -87.59 99.4 12.02 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 171.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -125.27 148.81 48.53 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.616 0.722 . . . . 0.0 112.5 -166.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 11.5 t -92.46 160.34 15.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.998 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 68.0 mt -106.28 117.69 52.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.085 0.469 . . . . 0.0 110.823 -175.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.463 ' H ' HD12 ' B' ' 24' ' ' ILE . 4.1 mp -79.27 -45.36 23.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.984 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.401 ' HE3' ' OD2' ' B' ' 93' ' ' ASP . 35.0 mtmm -135.19 140.24 45.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.757 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 17.8 m -55.92 124.03 16.3 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 123.639 0.587 . . . . 0.0 109.646 177.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' PHE . . . . . 0.559 ' HB3' HD23 ' B' ' 91' ' ' LEU . 3.9 p90 -140.03 158.57 43.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.704 0.764 . . . . 0.0 112.739 -171.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' HIS . . . . . 0.576 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 14.2 t60 -112.86 126.05 55.03 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.07 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.608 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 44.0 mt -96.3 133.44 37.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 170.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.576 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 41.5 p -118.47 -15.04 9.67 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -170.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.87 151.97 22.52 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 119.276 -1.44 . . . . 0.0 113.456 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.463 HG23 ' HG ' ' B' ' 87' ' ' LEU . 9.1 p -140.74 123.88 16.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 171.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' ALA . . . . . 0.405 ' HA ' HG21 ' B' ' 56' ' ' VAL . . . -143.5 154.63 43.84 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.486 -0.485 . . . . 0.0 112.085 -172.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.636 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.3 pp -118.28 138.88 52.07 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.627 0.727 . . . . 0.0 111.155 177.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -110.17 -47.56 3.29 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.404 172.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -103.2 127.44 50.49 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.167 170.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.455 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 147.26 162.99 10.3 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 119.696 -1.24 . . . . 0.0 113.405 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' GLN . . . . . 0.464 ' O ' ' HG3' ' B' ' 58' ' ' LYS . 48.7 tt0 -102.16 -48.3 4.26 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.474 0.178 . . . . 0.0 111.149 178.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -153.07 137.77 16.96 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.713 -0.222 . . . . 0.0 110.652 176.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.542 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -136.31 114.89 11.9 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.279 0.561 . . . . 0.0 111.196 171.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' B' ' 79' ' ' THR . 68.1 mttm -95.03 114.99 26.86 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 171.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.406 HD23 ' HB ' ' B' ' 53' ' ' VAL . 38.1 tp -84.06 116.25 22.77 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -176.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' TYR . . . . . 0.409 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 93.9 m-85 -117.09 143.79 45.39 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.539 177.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.561 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.1 OUTLIER -131.63 131.71 43.44 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 172.657 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -111.88 118.1 34.59 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.087 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.631 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -130.44 133.67 46.51 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.444 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 56.07 38.78 30.27 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.516 0.51 . . . . 0.0 110.675 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm 65.9 22.44 11.35 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.344 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.574 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 28.9 mm-40 -113.32 124.5 52.61 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 177.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -87.52 116.92 25.97 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.554 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 72.3 m-85 -111.68 131.06 55.55 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.749 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -81.27 103.42 8.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 170.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.47 HG13 ' CD2' ' A' ' 88' ' ' LEU . 2.3 t -76.87 -47.65 27.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.476 -172.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.471 ' HB2' HD23 ' B' ' 65' ' ' LEU . . . -156.69 151.49 25.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.334 -178.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 99.9 m -114.78 101.77 9.38 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 169.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.474 HG11 HG11 ' B' ' 85' ' ' VAL . 7.4 p -113.0 114.07 45.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.578 0.704 . . . . 0.0 109.755 -177.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 76.3 p -123.27 -177.79 3.8 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.445 -174.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' B' ' 38' ' ' GLN . 28.8 mtpp -57.16 -36.18 70.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.073 0.463 . . . . 0.0 110.331 168.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.43 -41.19 66.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.503 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 76.3 mt -115.67 82.68 10.45 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 174.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.09 0.37 6.74 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.992 2.461 . . . . 0.0 113.606 -168.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -162.66 128.01 3.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.263 0.554 . . . . 0.0 111.005 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.432 HG23 ' HB ' ' B' ' 56' ' ' VAL . 94.9 t -114.13 111.24 35.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.54 174.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.81 112.0 23.62 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.728 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.471 HD23 ' HB2' ' B' ' 54' ' ' ALA . 0.3 OUTLIER -130.43 168.46 16.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.558 -175.497 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 66' ' ' ASP . . . . . 0.49 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 6.5 t0 -115.26 99.96 7.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.298 0.57 . . . . 0.0 110.405 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.635 HD21 HD23 ' A' ' 88' ' ' LEU . 17.7 mt -114.58 141.3 47.94 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.66 177.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 68' ' ' ASN . . . . . 0.43 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 6.3 t30 -146.71 115.27 6.76 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.013 0.435 . . . . 0.0 110.074 174.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -110.22 159.92 16.96 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.929 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 10.3 p -112.45 149.56 32.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.544 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.422 ' H ' ' HG3' ' B' ' 71' ' ' LYS . 0.0 OUTLIER -71.4 10.52 0.6 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -175.592 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.71 -21.51 14.21 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.118 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -101.13 171.39 7.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.775 0.321 . . . . 0.0 110.901 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 -137.76 129.49 28.44 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.631 HG22 ' HB2' ' B' ' 46' ' ' ALA . 14.7 pt -129.36 162.95 35.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.027 0.441 . . . . 0.0 111.703 -170.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.561 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 4.8 mtm -118.28 122.87 44.0 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 175.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 77' ' ' PHE . . . . . 0.54 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 1.0 OUTLIER -105.12 127.72 53.03 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.183 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.69 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 49.3 p90 -155.93 150.63 26.09 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.471 -177.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.709 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 11.2 p -117.32 149.08 41.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.922 0.392 . . . . 0.0 111.679 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.06 144.54 42.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.269 174.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.25 176.96 34.6 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -106.5 102.8 12.17 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.932 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.542 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -170.82 151.28 3.38 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.527 169.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 23.6 t -108.31 121.61 45.26 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.636 HG12 ' HB3' ' B' ' 34' ' ' LEU . 11.6 m -118.41 146.19 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 CA-C-O 121.406 0.622 . . . . 0.0 111.665 -173.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 15.3 t -111.87 120.86 43.37 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.735 HD13 HD23 ' B' ' 11' ' ' LEU . 5.0 mp -92.91 151.57 19.88 Favored 'General case' 0 CA--C 1.502 -0.895 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.64 174.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.618 HD23 HD21 ' C' ' 67' ' ' LEU . 1.6 tp -133.49 141.12 47.63 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.129 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.2 -166.69 26.71 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.812 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 90' ' ' TYR . . . . . 0.421 ' CD2' ' HB3' ' C' ' 68' ' ' ASN . 8.2 p90 -150.89 130.13 12.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.679 0.752 . . . . 0.0 111.778 176.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 91' ' ' LEU . . . . . 0.559 HD23 ' HB3' ' B' ' 27' ' ' PHE . 5.4 mt -72.92 136.26 45.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.238 -1.346 . . . . 0.0 109.933 176.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -79.17 108.82 12.95 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 93' ' ' ASP . . . . . 0.401 ' OD2' ' HE3' ' B' ' 25' ' ' LYS . 7.7 t70 -114.73 -177.05 3.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.752 -177.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 94' ' ' ILE . . . . . 0.436 ' N ' HD12 ' B' ' 94' ' ' ILE . 4.2 mp -105.26 -35.96 3.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 25.3 t70 65.82 135.57 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.366 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 11.3 p -88.64 6.63 37.4 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.931 -176.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.64 -65.1 3.74 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.471 -177.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 15.2 p . . . . . 0 C--O 1.252 1.191 0 CA-C-O 118.856 -0.592 . . . . 0.0 109.75 177.083 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 64.3 -165.13 0.24 Allowed 'General case' 0 C--O 1.235 0.3 0 O-C-N 123.68 0.613 . . . . 0.0 111.375 176.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . 102.03 102.33 2.62 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.793 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.53 133.42 52.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.995 0.426 . . . . 0.0 111.151 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 76.1 mtm -99.08 141.21 32.13 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.569 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 6' ' ' ALA . . . . . . . . . . . . . . . -110.11 155.06 22.41 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.347 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 59.9 mtt -111.7 139.87 46.8 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.906 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 8' ' ' PHE . . . . . 0.466 ' CE1' HD21 ' D' ' 44' ' ' LEU . 74.0 t80 -54.91 144.02 24.27 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.878 -173.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 9' ' ' TRP . . . . . 0.581 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 89.6 t90 -139.25 148.74 43.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.98 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 10' ' ' GLY . . . . . 0.543 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -149.97 153.44 25.09 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.764 177.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.716 HD23 HD13 ' C' ' 87' ' ' LEU . 59.5 tp -139.15 108.86 6.24 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.945 0.402 . . . . 0.0 111.093 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -80.35 105.7 11.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.751 173.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 13' ' ' MET . . . . . 0.615 ' HB3' HG23 ' C' ' 85' ' ' VAL . 35.8 tpp -99.48 132.27 44.93 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.116 0.484 . . . . 0.0 110.852 -176.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -98.47 146.53 31.74 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.013 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 15' ' ' PRO . . . . . 0.53 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 10.3 Cg_endo -53.62 115.95 2.67 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 123.362 2.708 . . . . 0.0 113.161 -176.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 16' ' ' GLU . . . . . 0.712 ' HA ' ' O ' ' C' ' 79' ' ' THR . 34.6 mt-10 63.4 38.07 10.33 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.699 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -109.3 149.85 28.85 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 173.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 18' ' ' LYS . . . . . 0.691 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 34.4 ttmt -126.05 119.26 27.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.748 0.309 . . . . 0.0 111.583 -174.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 19' ' ' TYR . . . . . 0.467 ' OH ' ' HA ' ' C' ' 13' ' ' MET . 3.6 m-85 -110.56 104.98 13.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.434 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 11.9 p -87.61 99.47 12.08 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 171.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -125.42 148.84 48.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.589 0.709 . . . . 0.0 112.462 -166.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 11.4 t -92.51 160.4 15.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.997 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -106.27 117.73 52.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.091 0.472 . . . . 0.0 110.824 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 24' ' ' ILE . . . . . 0.471 ' H ' HD12 ' C' ' 24' ' ' ILE . 4.1 mp -79.26 -45.44 23.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.965 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -135.16 140.3 45.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.707 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 18.0 m -56.03 124.15 16.78 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.582 0.551 . . . . 0.0 109.582 177.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 27' ' ' PHE . . . . . 0.562 ' HB3' HD23 ' C' ' 91' ' ' LEU . 3.9 p90 -140.08 158.5 43.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.739 0.781 . . . . 0.0 112.78 -171.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 28' ' ' HIS . . . . . 0.582 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 14.2 t60 -112.77 125.97 54.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.104 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 29' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 44.2 mt -96.28 133.44 37.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.582 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 41.1 p -118.49 -14.98 9.66 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -170.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.91 151.84 22.35 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 119.314 -1.422 . . . . 0.0 113.508 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.456 HG23 ' HG ' ' C' ' 87' ' ' LEU . 9.0 p -140.74 123.89 16.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 171.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.42 ' HA ' HG21 ' C' ' 56' ' ' VAL . . . -143.56 154.59 43.75 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.397 -0.521 . . . . 0.0 112.077 -172.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.617 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.3 pp -118.14 138.86 52.0 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.685 0.755 . . . . 0.0 111.241 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -110.19 -47.52 3.29 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.772 -1.103 . . . . 0.0 108.464 172.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -103.17 127.51 50.44 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.227 170.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 37' ' ' GLY . . . . . 0.454 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 147.21 163.06 10.32 Favored Glycine 0 N--CA 1.439 -1.111 0 C-N-CA 119.718 -1.229 . . . . 0.0 113.442 177.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 38' ' ' GLN . . . . . 0.456 ' O ' ' HG3' ' C' ' 58' ' ' LYS . 48.9 tt0 -102.28 -48.27 4.25 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.483 0.183 . . . . 0.0 111.122 178.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -153.07 137.77 16.96 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 122.162 0.185 . . . . 0.0 110.714 176.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.534 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -136.27 114.92 11.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.292 0.568 . . . . 0.0 111.171 171.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' C' ' 79' ' ' THR . 68.1 mttm -95.0 114.91 26.77 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 171.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.411 HD23 ' HB ' ' C' ' 53' ' ' VAL . 37.9 tp -84.04 116.26 22.76 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -176.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 43' ' ' TYR . . . . . 0.401 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 93.9 m-85 -117.09 143.77 45.42 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 177.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' C' ' 76' ' ' MET . 0.1 OUTLIER -131.66 131.64 43.32 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 172.662 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 45' ' ' ALA . . . . . 0.582 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -111.89 118.16 34.76 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.164 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.649 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -130.43 133.58 46.45 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.45 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 56.12 38.79 30.24 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.524 0.515 . . . . 0.0 110.654 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm 65.9 22.35 11.35 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.362 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 49' ' ' GLN . . . . . 0.582 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 29.0 mm-40 -113.25 124.46 52.57 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -87.48 116.93 25.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.928 0.394 . . . . 0.0 110.046 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 51' ' ' TYR . . . . . 0.587 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 72.5 m-85 -111.72 131.02 55.58 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.743 177.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -81.33 103.35 8.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 171.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 53' ' ' VAL . . . . . 0.499 HG13 ' CD2' ' B' ' 88' ' ' LEU . 2.3 t -76.87 -47.6 27.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.491 -172.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 54' ' ' ALA . . . . . 0.474 ' HB2' HD23 ' C' ' 65' ' ' LEU . . . -156.68 151.5 25.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.303 -178.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 99.6 m -114.74 101.69 9.31 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 169.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 56' ' ' VAL . . . . . 0.471 HG11 HG11 ' C' ' 85' ' ' VAL . 7.4 p -112.92 114.04 45.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.596 0.712 . . . . 0.0 109.781 -177.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 77.4 p -123.26 -177.74 3.78 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.496 -174.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 58' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' C' ' 38' ' ' GLN . 28.8 mtpp -57.2 -36.18 70.53 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.032 0.444 . . . . 0.0 110.378 168.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.35 -41.16 66.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.521 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 76.5 mt -115.76 82.77 10.78 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 174.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.11 0.44 6.64 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.865 2.377 . . . . 0.0 113.662 -168.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -162.66 128.06 3.29 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.139 0.495 . . . . 0.0 111.087 -176.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.431 HG23 ' HB ' ' C' ' 56' ' ' VAL . 92.1 t -114.29 111.36 35.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.439 174.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.85 112.04 23.7 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.698 174.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 65' ' ' LEU . . . . . 0.474 HD23 ' HB2' ' C' ' 54' ' ' ALA . 0.3 OUTLIER -130.45 168.44 17.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.069 0.461 . . . . 0.0 111.599 -175.518 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 66' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 6.6 t0 -115.23 99.95 7.78 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.345 0.593 . . . . 0.0 110.386 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.618 HD21 HD23 ' B' ' 88' ' ' LEU . 17.7 mt -114.58 141.22 48.03 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.695 177.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 68' ' ' ASN . . . . . 0.421 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 6.3 t30 -146.66 115.27 6.78 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.92 0.391 . . . . 0.0 110.043 174.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -110.07 159.93 16.89 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.061 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 10.7 p -112.49 149.49 32.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.557 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 71' ' ' LYS . . . . . 0.416 ' H ' ' HG3' ' C' ' 71' ' ' LYS . 0.0 OUTLIER -71.38 10.41 0.62 Allowed 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -175.58 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.63 -21.51 14.35 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.111 176.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -101.15 171.31 7.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.787 0.327 . . . . 0.0 110.828 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 -137.72 129.46 28.47 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.649 HG22 ' HB2' ' C' ' 46' ' ' ALA . 14.8 pt -129.35 163.01 35.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.104 0.478 . . . . 0.0 111.696 -169.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.544 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 4.8 mtm -118.41 122.89 43.9 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 175.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 77' ' ' PHE . . . . . 0.535 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 1.0 OUTLIER -105.08 127.77 53.04 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 177.204 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 78' ' ' TYR . . . . . 0.691 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 49.3 p90 -155.95 150.65 26.1 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.494 -177.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 79' ' ' THR . . . . . 0.712 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 11.0 p -117.34 149.14 40.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.898 0.38 . . . . 0.0 111.622 -178.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.11 144.62 42.34 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.323 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.19 176.93 34.69 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -175.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -106.49 102.75 12.12 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.062 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 83' ' ' ALA . . . . . 0.534 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -170.7 151.26 3.46 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.557 169.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 23.4 t -108.19 121.57 45.14 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.617 HG12 ' HB3' ' C' ' 34' ' ' LEU . 11.6 m -118.49 146.24 23.35 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-O 121.403 0.62 . . . . 0.0 111.663 -173.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 15.2 t -111.94 120.88 43.41 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 87' ' ' LEU . . . . . 0.716 HD13 HD23 ' C' ' 11' ' ' LEU . 5.0 mp -92.92 151.68 19.81 Favored 'General case' 0 CA--C 1.502 -0.894 0 C-N-CA 120.364 -0.534 . . . . 0.0 109.646 174.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 88' ' ' LEU . . . . . 0.65 HD23 HD21 ' D' ' 67' ' ' LEU . 1.6 tp -133.58 141.11 47.53 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.156 -178.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.21 -166.72 26.77 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.825 -0.703 . . . . 0.0 111.86 -176.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 90' ' ' TYR . . . . . 0.438 ' CD2' ' HB3' ' D' ' 68' ' ' ASN . 8.3 p90 -150.86 130.1 12.77 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.632 0.729 . . . . 0.0 111.765 176.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 91' ' ' LEU . . . . . 0.562 HD23 ' HB3' ' C' ' 27' ' ' PHE . 5.2 mt -72.93 136.2 45.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.253 -1.339 . . . . 0.0 109.93 176.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -79.16 108.87 12.98 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -114.73 -177.07 3.04 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.727 -176.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 94' ' ' ILE . . . . . 0.431 ' N ' HD12 ' C' ' 94' ' ' ILE . 4.2 mp -105.31 -35.91 3.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 25.2 t70 65.77 135.71 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.302 -176.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 11.3 p -88.71 6.51 38.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.84 -176.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.6 -64.97 3.75 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.395 -177.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 15.3 p . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.913 -0.565 . . . . 0.0 109.698 177.071 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 64.12 -165.09 0.24 Allowed 'General case' 0 C--O 1.235 0.312 0 O-C-N 123.715 0.635 . . . . 0.0 111.439 176.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . 101.93 102.4 2.62 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.893 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.53 133.45 52.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.893 0.378 . . . . 0.0 111.107 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 76.0 mtm -99.1 141.34 31.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.612 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 6' ' ' ALA . . . . . . . . . . . . . . . -110.22 154.99 22.6 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.351 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 59.9 mtt -111.68 139.95 46.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.924 0.392 . . . . 0.0 110.872 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 8' ' ' PHE . . . . . 0.48 ' CE1' HD21 ' E' ' 44' ' ' LEU . 74.2 t80 -55.01 144.06 24.55 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.849 -173.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 9' ' ' TRP . . . . . 0.589 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 89.7 t90 -139.29 148.7 43.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.987 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 10' ' ' GLY . . . . . 0.566 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -149.95 153.44 25.1 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.812 -0.708 . . . . 0.0 111.755 177.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.73 HD23 HD13 ' D' ' 87' ' ' LEU . 58.9 tp -139.13 108.81 6.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.965 0.412 . . . . 0.0 111.094 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -80.35 105.75 11.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.685 173.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 13' ' ' MET . . . . . 0.6 ' HB3' HG23 ' D' ' 85' ' ' VAL . 35.7 tpp -99.52 132.31 44.94 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.067 0.46 . . . . 0.0 110.942 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -98.57 146.55 31.79 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.95 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 15' ' ' PRO . . . . . 0.518 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 10.5 Cg_endo -53.52 115.85 2.59 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 123.428 2.752 . . . . 0.0 113.154 -176.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 16' ' ' GLU . . . . . 0.723 ' HA ' ' O ' ' D' ' 79' ' ' THR . 34.3 mt-10 63.42 38.14 10.22 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.617 177.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -109.37 149.82 28.95 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 173.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 18' ' ' LYS . . . . . 0.691 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 34.4 ttmt -125.96 119.22 27.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.771 0.319 . . . . 0.0 111.59 -174.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 19' ' ' TYR . . . . . 0.473 ' OH ' ' HA ' ' D' ' 13' ' ' MET . 3.6 m-85 -110.51 104.9 13.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.402 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 20' ' ' SER . . . . . 0.401 ' HB3' ' SD ' ' D' ' 76' ' ' MET . 11.7 p -87.69 99.43 12.07 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 171.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -125.25 148.7 48.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.492 0.663 . . . . 0.0 112.564 -166.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 11.4 t -92.32 160.35 15.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.049 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 68.0 mt -106.31 117.71 52.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.059 0.457 . . . . 0.0 110.771 -175.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 24' ' ' ILE . . . . . 0.476 HD12 ' H ' ' D' ' 24' ' ' ILE . 4.2 mp -79.26 -45.42 23.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.96 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 25' ' ' LYS . . . . . 0.4 ' HE3' ' OD2' ' D' ' 93' ' ' ASP . 35.0 mtmm -135.14 140.28 45.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.759 178.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 18.2 m -56.02 124.17 16.84 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 123.547 0.529 . . . . 0.0 109.595 177.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 27' ' ' PHE . . . . . 0.556 ' HB3' HD23 ' D' ' 91' ' ' LEU . 3.9 p90 -140.16 158.56 43.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.65 0.738 . . . . 0.0 112.731 -171.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 28' ' ' HIS . . . . . 0.577 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 14.1 t60 -112.87 125.99 54.97 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.048 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 29' ' ' ILE . . . . . 0.59 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 43.9 mt -96.3 133.46 37.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 30' ' ' SER . . . . . 0.577 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 42.4 p -118.53 -14.96 9.63 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -170.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.91 151.93 22.46 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 119.4 -1.381 . . . . 0.0 113.489 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.45 HG23 ' HG ' ' D' ' 87' ' ' LEU . 9.1 p -140.87 123.85 16.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 171.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 33' ' ' ALA . . . . . 0.417 ' HA ' HG21 ' D' ' 56' ' ' VAL . . . -143.48 154.61 43.83 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.419 -0.512 . . . . 0.0 112.076 -172.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 34' ' ' LEU . . . . . 0.619 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.3 pp -118.2 138.86 52.04 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.669 0.747 . . . . 0.0 111.222 177.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -110.1 -47.55 3.3 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.475 172.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -103.2 127.52 50.47 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.176 170.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 37' ' ' GLY . . . . . 0.451 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 147.3 162.99 10.31 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 119.659 -1.258 . . . . 0.0 113.364 177.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 38' ' ' GLN . . . . . 0.461 ' O ' ' HG3' ' D' ' 58' ' ' LYS . 48.6 tt0 -102.21 -48.32 4.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.524 0.202 . . . . 0.0 111.155 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -153.0 137.84 17.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.784 -0.189 . . . . 0.0 110.667 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 40' ' ' ALA . . . . . 0.535 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -136.37 114.91 11.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.37 0.605 . . . . 0.0 111.126 171.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' D' ' 79' ' ' THR . 68.1 mttm -95.01 114.92 26.78 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 171.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.411 HD23 ' HB ' ' D' ' 53' ' ' VAL . 38.0 tp -83.99 116.13 22.67 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -176.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 43' ' ' TYR . . . . . 0.41 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 94.4 m-85 -117.03 143.74 45.4 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.548 ' HA ' ' O ' ' D' ' 76' ' ' MET . 0.1 OUTLIER -131.62 131.77 43.5 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 172.699 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 45' ' ' ALA . . . . . 0.582 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -111.97 118.1 34.55 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.131 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.657 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -130.43 133.59 46.46 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.485 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 56.19 38.8 30.19 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 123.452 0.47 . . . . 0.0 110.591 -175.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm 65.94 22.43 11.31 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.214 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 49' ' ' GLN . . . . . 0.582 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 29.1 mm-40 -113.28 124.54 52.74 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -87.55 116.87 25.97 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 51' ' ' TYR . . . . . 0.543 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 72.3 m-85 -111.64 131.03 55.56 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.798 177.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -81.3 103.32 8.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 171.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 53' ' ' VAL . . . . . 0.499 HG13 ' CD2' ' C' ' 88' ' ' LEU . 2.3 t -76.76 -47.61 28.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.523 -172.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 54' ' ' ALA . . . . . 0.476 ' HB2' HD23 ' D' ' 65' ' ' LEU . . . -156.74 151.5 25.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.296 -178.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 99.9 m -114.74 101.64 9.26 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 169.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 56' ' ' VAL . . . . . 0.475 HG11 HG11 ' D' ' 85' ' ' VAL . 7.4 p -112.97 114.14 46.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.584 0.707 . . . . 0.0 109.777 -177.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 75.7 p -123.26 -177.82 3.81 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.495 -174.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 58' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' D' ' 38' ' ' GLN . 28.8 mtpp -57.2 -36.08 70.41 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.12 0.486 . . . . 0.0 110.43 168.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.4 -41.14 66.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.562 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 76.0 mt -115.72 82.69 10.59 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.03 0.42 6.63 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.839 2.359 . . . . 0.0 113.652 -168.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -162.64 128.22 3.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.154 0.502 . . . . 0.0 111.014 -176.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.425 HG23 ' HB ' ' D' ' 56' ' ' VAL . 92.7 t -114.39 111.36 35.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.433 174.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.93 112.01 23.7 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.678 174.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 65' ' ' LEU . . . . . 0.476 HD23 ' HB2' ' D' ' 54' ' ' ALA . 0.3 OUTLIER -130.41 168.56 16.77 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.065 0.46 . . . . 0.0 111.556 -175.518 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 66' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 6.5 t0 -115.32 99.99 7.79 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.33 0.586 . . . . 0.0 110.398 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.65 HD21 HD23 ' C' ' 88' ' ' LEU . 17.7 mt -114.66 141.32 47.95 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.561 177.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 68' ' ' ASN . . . . . 0.438 ' HB3' ' CD2' ' C' ' 90' ' ' TYR . 6.2 t30 -146.71 115.28 6.76 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.006 0.431 . . . . 0.0 110.083 173.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -110.11 159.93 16.91 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.012 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 10.0 p -112.56 149.59 32.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.479 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.56 10.59 0.61 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -175.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.72 -21.38 14.44 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.131 176.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -101.21 171.41 7.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.839 0.352 . . . . 0.0 110.859 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 -137.72 129.33 28.28 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.657 HG22 ' HB2' ' D' ' 46' ' ' ALA . 14.7 pt -129.3 162.94 35.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.088 0.47 . . . . 0.0 111.707 -169.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 76' ' ' MET . . . . . 0.548 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 4.8 mtm -118.22 122.79 43.87 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 175.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 77' ' ' PHE . . . . . 0.536 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 1.0 OUTLIER -105.03 127.77 53.02 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 177.209 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 78' ' ' TYR . . . . . 0.691 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 49.5 p90 -155.9 150.57 26.08 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.491 -177.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 79' ' ' THR . . . . . 0.723 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 11.1 p -117.23 149.19 40.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.935 0.397 . . . . 0.0 111.698 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.14 144.71 42.19 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.202 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.2 176.98 34.67 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -175.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -106.5 102.84 12.21 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.97 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 83' ' ' ALA . . . . . 0.535 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -170.82 151.27 3.38 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.486 169.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 23.5 t -108.21 121.49 44.98 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.619 HG12 ' HB3' ' D' ' 34' ' ' LEU . 11.7 m -118.41 146.18 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 CA-C-O 121.416 0.627 . . . . 0.0 111.69 -173.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 15.4 t -111.87 120.88 43.43 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 87' ' ' LEU . . . . . 0.73 HD13 HD23 ' D' ' 11' ' ' LEU . 5.0 mp -92.86 151.58 19.9 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 120.452 -0.499 . . . . 0.0 109.658 174.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.675 HD23 HD21 ' E' ' 67' ' ' LEU . 1.6 tp -133.55 141.18 47.6 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.081 -178.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.24 -166.7 26.76 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.799 -176.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 90' ' ' TYR . . . . . 0.463 ' CD2' ' HB3' ' E' ' 68' ' ' ASN . 8.2 p90 -150.95 130.12 12.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.742 0.782 . . . . 0.0 111.781 176.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 91' ' ' LEU . . . . . 0.556 HD23 ' HB3' ' D' ' 27' ' ' PHE . 5.3 mt -72.91 136.17 45.19 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.957 176.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -79.13 108.79 12.88 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 93' ' ' ASP . . . . . 0.4 ' OD2' ' HE3' ' D' ' 25' ' ' LYS . 7.7 t70 -114.7 -177.14 3.06 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -176.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 94' ' ' ILE . . . . . 0.432 ' N ' HD12 ' D' ' 94' ' ' ILE . 4.2 mp -105.26 -35.9 3.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 25.2 t70 65.78 135.52 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.352 -176.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 11.2 p -88.65 6.54 37.91 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.906 -176.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.6 -64.94 3.76 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.481 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 15.1 p . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.913 -0.565 . . . . 0.0 109.728 177.02 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 64.16 -165.08 0.24 Allowed 'General case' 0 C--O 1.236 0.361 0 O-C-N 123.686 0.616 . . . . 0.0 111.385 176.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . 102.04 102.25 2.62 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.804 -0.713 . . . . 0.0 111.851 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.47 133.49 52.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.922 0.391 . . . . 0.0 111.168 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 76.0 mtm -99.2 141.33 32.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.56 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 6' ' ' ALA . . . . . . . . . . . . . . . -110.09 154.94 22.55 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.399 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 59.9 mtt -111.67 139.97 46.68 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.943 0.401 . . . . 0.0 110.859 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 8' ' ' PHE . . . . . 0.475 ' CE1' HD21 ' A' ' 44' ' ' LEU . 74.2 t80 -54.92 144.03 24.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.805 -173.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 9' ' ' TRP . . . . . 0.574 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 89.5 t90 -139.38 148.63 43.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.96 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 10' ' ' GLY . . . . . 0.569 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -149.88 153.43 25.1 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.79 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 11' ' ' LEU . . . . . 0.744 HD23 HD13 ' E' ' 87' ' ' LEU . 59.2 tp -139.06 108.79 6.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.898 0.38 . . . . 0.0 111.144 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -80.28 105.71 11.75 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.769 173.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 13' ' ' MET . . . . . 0.594 ' HB3' HG23 ' E' ' 85' ' ' VAL . 35.5 tpp -99.5 132.32 44.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.117 0.484 . . . . 0.0 110.935 -176.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -98.56 146.67 31.99 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.945 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 15' ' ' PRO . . . . . 0.52 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 10.4 Cg_endo -53.73 115.96 2.68 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 123.4 2.734 . . . . 0.0 113.104 -176.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 16' ' ' GLU . . . . . 0.727 ' HA ' ' O ' ' E' ' 79' ' ' THR . 34.6 mt-10 63.35 38.17 10.37 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.69 177.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -109.41 149.9 28.87 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 173.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 18' ' ' LYS . . . . . 0.686 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 34.4 ttmt -125.99 119.19 27.04 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.736 0.303 . . . . 0.0 111.613 -174.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 19' ' ' TYR . . . . . 0.471 ' OH ' ' HA ' ' E' ' 13' ' ' MET . 3.5 m-85 -110.44 104.86 13.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.546 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 12.0 p -87.54 99.47 12.06 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 171.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -125.41 148.77 48.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.537 0.684 . . . . 0.0 112.517 -166.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 11.5 t -92.45 160.27 15.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.989 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 68.1 mt -106.25 117.66 52.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.082 0.468 . . . . 0.0 110.894 -175.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 24' ' ' ILE . . . . . 0.465 HD12 ' H ' ' E' ' 24' ' ' ILE . 4.1 mp -79.19 -45.42 24.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.977 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -135.13 140.23 45.27 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.775 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 18.0 m -56.06 124.09 16.62 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 123.619 0.574 . . . . 0.0 109.648 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 27' ' ' PHE . . . . . 0.566 ' HB3' HD23 ' E' ' 91' ' ' LEU . 3.9 p90 -140.04 158.53 43.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.725 0.774 . . . . 0.0 112.765 -171.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 28' ' ' HIS . . . . . 0.58 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 14.3 t60 -112.72 125.99 54.92 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.159 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 29' ' ' ILE . . . . . 0.604 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 44.2 mt -96.29 133.41 37.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 170.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 30' ' ' SER . . . . . 0.58 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 43.3 p -118.49 -14.93 9.66 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -170.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.86 151.93 22.47 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 119.373 -1.394 . . . . 0.0 113.566 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.46 HG23 ' HG ' ' E' ' 87' ' ' LEU . 9.1 p -140.81 123.86 16.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 171.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 33' ' ' ALA . . . . . 0.407 ' HA ' HG21 ' E' ' 56' ' ' VAL . . . -143.52 154.54 43.73 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.493 -0.483 . . . . 0.0 112.082 -172.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 34' ' ' LEU . . . . . 0.615 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.3 pp -118.2 138.89 52.01 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.714 0.769 . . . . 0.0 111.222 177.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -110.2 -47.44 3.3 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.485 172.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -103.28 127.47 50.6 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.201 170.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 37' ' ' GLY . . . . . 0.458 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 147.27 162.9 10.25 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 119.673 -1.251 . . . . 0.0 113.463 177.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 38' ' ' GLN . . . . . 0.457 ' O ' ' HG3' ' E' ' 58' ' ' LYS . 48.8 tt0 -102.22 -48.16 4.29 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.559 0.219 . . . . 0.0 111.143 178.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -153.11 137.76 16.91 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.781 -0.191 . . . . 0.0 110.639 176.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 40' ' ' ALA . . . . . 0.541 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -136.32 114.97 11.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.318 0.58 . . . . 0.0 111.147 171.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 41' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' E' ' 79' ' ' THR . 68.1 mttm -95.09 114.99 26.85 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 171.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.401 HD23 ' HB ' ' E' ' 53' ' ' VAL . 37.9 tp -84.05 116.17 22.72 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -176.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 43' ' ' TYR . . . . . 0.411 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 94.2 m-85 -117.05 143.72 45.43 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.501 177.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 44' ' ' LEU . . . . . 0.545 ' HA ' ' O ' ' E' ' 76' ' ' MET . 0.1 OUTLIER -131.59 131.66 43.45 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 172.653 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 45' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -111.88 118.07 34.51 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.158 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 46' ' ' ALA . . . . . 0.636 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -130.42 133.62 46.5 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.485 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 56.11 38.85 30.31 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.457 0.473 . . . . 0.0 110.587 -175.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm 65.96 22.48 11.28 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.259 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 49' ' ' GLN . . . . . 0.576 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 29.2 mm-40 -113.36 124.54 52.71 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -87.57 116.84 25.96 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.847 0.356 . . . . 0.0 110.064 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 51' ' ' TYR . . . . . 0.566 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 72.1 m-85 -111.61 131.02 55.56 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.798 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -81.35 103.45 8.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 171.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 53' ' ' VAL . . . . . 0.512 HG13 ' CD2' ' D' ' 88' ' ' LEU . 2.3 t -76.89 -47.59 27.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.495 -172.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 54' ' ' ALA . . . . . 0.463 ' HB2' HD23 ' E' ' 65' ' ' LEU . . . -156.71 151.56 25.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.286 -178.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 99.9 m -114.82 101.64 9.25 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 169.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 56' ' ' VAL . . . . . 0.482 HG11 HG11 ' E' ' 85' ' ' VAL . 7.4 p -112.92 114.07 45.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.626 0.727 . . . . 0.0 109.818 -177.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 75.4 p -123.23 -177.77 3.79 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.545 -174.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 58' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' E' ' 38' ' ' GLN . 28.8 mtpp -57.2 -36.25 70.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.074 0.464 . . . . 0.0 110.276 169.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.3 -41.13 66.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.508 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 76.4 mt -115.78 82.7 10.74 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.12 0.48 6.58 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.865 2.376 . . . . 0.0 113.707 -168.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -162.65 128.1 3.3 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.247 0.546 . . . . 0.0 111.048 -176.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 63' ' ' VAL . . . . . 0.421 HG23 ' HB ' ' E' ' 56' ' ' VAL . 92.7 t -114.32 111.35 35.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.412 174.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.96 112.13 23.88 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.602 174.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.463 HD23 ' HB2' ' E' ' 54' ' ' ALA . 0.3 OUTLIER -130.51 168.44 17.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.095 0.474 . . . . 0.0 111.515 -175.541 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 66' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 6.5 t0 -115.22 99.97 7.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.322 0.582 . . . . 0.0 110.343 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 67' ' ' LEU . . . . . 0.675 HD21 HD23 ' D' ' 88' ' ' LEU . 17.7 mt -114.61 141.35 47.89 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.621 177.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 68' ' ' ASN . . . . . 0.463 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 6.3 t30 -146.69 115.2 6.74 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.99 0.424 . . . . 0.0 110.086 174.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -110.11 159.91 16.93 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.029 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 10.2 p -112.47 149.56 32.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.47 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 71' ' ' LYS . . . . . 0.425 ' H ' ' HG3' ' E' ' 71' ' ' LYS . 0.0 OUTLIER -71.41 10.4 0.62 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -175.596 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.67 -21.39 14.51 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.116 176.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -101.23 171.34 7.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.75 0.309 . . . . 0.0 110.865 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 -137.76 129.4 28.3 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 75' ' ' ILE . . . . . 0.636 HG22 ' HB2' ' E' ' 46' ' ' ALA . 14.6 pt -129.21 162.96 35.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.012 0.434 . . . . 0.0 111.726 -169.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 76' ' ' MET . . . . . 0.545 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 4.8 mtm -118.38 122.91 43.98 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 175.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 77' ' ' PHE . . . . . 0.539 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 1.0 OUTLIER -105.12 127.59 52.97 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.295 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 78' ' ' TYR . . . . . 0.686 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 49.6 p90 -155.82 150.59 26.23 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.536 -177.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 79' ' ' THR . . . . . 0.727 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 11.3 p -117.2 149.14 40.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.828 0.347 . . . . 0.0 111.684 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.11 144.58 42.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.301 175.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.3 177.0 34.52 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -106.6 102.82 12.17 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.965 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 83' ' ' ALA . . . . . 0.541 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -170.77 151.22 3.4 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.595 169.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 23.7 t -108.17 121.48 44.94 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 85' ' ' VAL . . . . . 0.615 HG12 ' HB3' ' E' ' 34' ' ' LEU . 11.5 m -118.36 146.2 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 CA-C-O 121.382 0.61 . . . . 0.0 111.69 -173.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 15.3 t -111.94 120.92 43.55 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 87' ' ' LEU . . . . . 0.744 HD13 HD23 ' E' ' 11' ' ' LEU . 5.1 mp -92.95 151.68 19.78 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.652 174.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 88' ' ' LEU . . . . . 0.656 HD23 HD21 ' A' ' 67' ' ' LEU . 1.6 tp -133.6 141.1 47.51 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.203 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.16 -166.64 26.58 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.891 -176.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 90' ' ' TYR . . . . . 0.429 ' CD2' ' HB3' ' A' ' 68' ' ' ASN . 8.2 p90 -150.91 130.11 12.72 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.694 0.759 . . . . 0.0 111.804 176.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 91' ' ' LEU . . . . . 0.566 HD23 ' HB3' ' E' ' 27' ' ' PHE . 5.3 mt -72.89 136.24 45.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.903 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -79.25 108.94 13.12 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -114.78 -177.11 3.05 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.687 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 94' ' ' ILE . . . . . 0.436 ' N ' HD12 ' E' ' 94' ' ' ILE . 4.2 mp -105.27 -35.94 3.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 25.3 t70 65.92 135.57 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.355 -176.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 11.2 p -88.7 6.55 38.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.884 -176.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.59 -64.95 3.76 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.562 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 15.4 p . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.864 -0.588 . . . . 0.0 109.768 176.927 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.458 ' O ' ' HA ' ' A' ' 96' ' ' SER . 95.7 m-85 . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -157.72 64.21 0.47 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.38 0.61 . . . . 0.0 110.021 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.48 -21.59 37.1 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.964 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 55.67 73.9 0.4 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.473 0.654 . . . . 0.0 111.047 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 20.3 ptm -105.35 59.95 0.67 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.08 -176.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.497 ' HB3' ' ND2' ' B' ' 68' ' ' ASN . . . -54.55 140.28 35.3 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.715 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.524 ' HA ' ' HB2' ' B' ' 70' ' ' SER . 11.4 ttt -104.39 134.3 47.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.059 0.457 . . . . 0.0 111.898 -170.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.407 ' CE1' HD21 ' B' ' 44' ' ' LEU . 62.3 t80 -55.91 143.93 30.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.458 -175.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.445 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 89.8 t90 -137.47 150.18 47.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.052 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.595 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -150.84 159.78 28.31 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.086 177.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.58 HD23 HD13 ' A' ' 87' ' ' LEU . 36.8 tp -148.4 108.21 4.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.835 0.35 . . . . 0.0 111.066 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -92.37 103.75 16.16 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.017 0.437 . . . . 0.0 110.076 174.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.589 ' SD ' HD11 ' A' ' 87' ' ' LEU . 53.4 mtp -94.99 144.94 25.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.132 -175.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -100.45 149.36 36.03 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.853 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.566 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 11.6 Cg_endo -55.69 121.9 10.77 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 123.265 2.643 . . . . 0.0 113.294 -176.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 79' ' ' THR . 49.9 mt-10 60.84 57.28 2.67 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.532 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -132.54 142.74 49.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.166 175.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.675 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 35.6 ttmt -118.45 116.33 26.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.869 0.366 . . . . 0.0 111.648 -174.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -112.25 110.3 20.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.992 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.7 p -77.35 122.17 24.76 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 173.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -99.63 128.51 45.74 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.884 -167.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.5 p -98.77 125.19 44.05 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 169.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.3 mt -96.41 118.72 43.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.326 0.584 . . . . 0.0 111.749 -172.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.1 mp -93.94 -44.93 13.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.662 178.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -118.68 140.36 50.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.543 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.8 t -62.64 114.37 3.54 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 173.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -130.02 148.63 51.89 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.531 -0.868 . . . . 0.0 112.937 -170.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.579 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 17.6 t60 -106.08 125.68 51.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.242 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.575 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 46.9 mt -97.69 132.61 42.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 170.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.579 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 42.6 p -116.25 -14.71 11.07 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -170.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.56 152.49 22.21 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 119.232 -1.461 . . . . 0.0 113.411 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.423 HG23 ' HG ' ' A' ' 87' ' ' LEU . 8.5 p -138.01 122.82 23.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 172.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.408 ' HA ' HG21 ' A' ' 56' ' ' VAL . . . -140.61 156.14 46.35 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 122.148 -0.345 . . . . 0.0 111.394 -174.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.469 ' HB3' HG12 ' A' ' 85' ' ' VAL . 3.7 pp -115.15 141.28 48.23 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.838 0.827 . . . . 0.0 112.071 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -106.45 -57.3 2.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.055 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -102.6 127.46 49.68 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 169.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.493 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 153.4 160.61 9.82 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 119.338 -1.41 . . . . 0.0 113.749 176.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.602 ' O ' ' HG3' ' A' ' 58' ' ' LYS . 19.1 tt0 -102.22 -46.97 4.67 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.608 -0.296 . . . . 0.0 110.409 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.448 ' OE2' ' HG2' ' A' ' 38' ' ' GLN . 6.9 mp0 -152.25 129.52 11.25 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.383 176.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.663 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -125.96 119.53 27.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.352 0.596 . . . . 0.0 110.237 171.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -104.47 108.95 20.62 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.5 tp -84.9 115.0 22.53 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.248 -173.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.525 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 91.9 m-85 -116.33 145.52 43.13 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.579 ' HA ' ' O ' ' A' ' 76' ' ' MET . 0.2 OUTLIER -131.67 128.53 39.23 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 171.33 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -106.62 122.77 47.01 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.667 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.71 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -130.16 125.23 34.51 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 175.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 61.42 36.46 17.29 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -171.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.486 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 14.9 tmtt? 73.59 -7.5 1.56 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.383 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.535 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 24.1 tp60 -80.36 114.54 19.33 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 -177.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -81.32 110.14 16.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.937 0.399 . . . . 0.0 110.387 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.582 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 82.2 m-85 -99.34 129.95 45.59 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.259 177.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.27 99.46 4.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 171.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.467 HG13 ' CD2' ' E' ' 88' ' ' LEU . 2.4 t -74.67 -50.01 27.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.439 -171.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.425 ' HB2' ' CD2' ' A' ' 65' ' ' LEU . . . -158.27 138.94 12.85 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.404 -177.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.4 m -103.05 102.05 12.06 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 171.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.458 HG13 ' HB3' ' A' ' 40' ' ' ALA . 7.2 p -113.54 110.24 31.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.884 0.85 . . . . 0.0 109.814 -177.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 81.3 p -122.98 -176.97 3.54 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.137 -174.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.602 ' HG3' ' O ' ' A' ' 38' ' ' GLN . 9.7 mtmp? -56.72 -35.08 68.13 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.086 0.47 . . . . 0.0 110.288 169.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.3 -40.57 64.42 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.603 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 77.9 mt -117.11 80.49 11.78 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.16 -0.0 6.6 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.079 2.519 . . . . 0.0 113.264 -169.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -164.14 118.76 1.49 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.237 0.541 . . . . 0.0 110.948 -174.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.7 t -108.85 108.59 25.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.371 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.5 117.37 27.4 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.795 174.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -136.39 168.47 19.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.457 -176.013 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 8.9 t0 -113.96 99.47 7.69 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.204 0.526 . . . . 0.0 110.292 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.6 HD21 HD23 ' E' ' 88' ' ' LEU . 19.5 mt -112.66 142.01 45.76 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.486 177.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.469 ' ND2' ' HB3' ' E' ' 6' ' ' ALA . 63.0 t30 -150.63 115.75 5.35 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 174.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -110.28 158.73 18.08 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.943 -177.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.513 ' HB2' ' HA ' ' E' ' 7' ' ' MET . 8.6 t -110.57 158.71 18.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.226 0.536 . . . . 0.0 110.646 -176.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -70.57 -4.69 24.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.637 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.43 -26.86 14.33 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.487 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -100.69 168.24 9.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.003 0.43 . . . . 0.0 110.955 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.7 mtm180 -136.84 143.7 43.22 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.71 HG22 ' HB2' ' A' ' 46' ' ' ALA . 13.2 pt -140.0 176.07 5.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.123 -172.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.579 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 9.2 mtm -134.03 131.8 39.3 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 171.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.458 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 1.2 m-85 -108.33 128.22 54.56 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.675 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 38.9 p90 -152.84 136.27 15.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.303 0.573 . . . . 0.0 111.714 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 2.1 p -111.13 133.16 53.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.22 -177.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.28 168.29 9.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.748 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.94 -170.33 43.42 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 -177.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -114.9 102.65 10.18 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 117.708 0.754 . . . . 0.0 109.702 174.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.663 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -173.82 152.4 1.99 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.502 170.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.0 t -111.64 122.06 46.8 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.469 HG12 ' HB3' ' A' ' 34' ' ' LEU . 4.3 m -113.51 156.95 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 CA-C-O 121.546 0.688 . . . . 0.0 112.566 -172.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.9 t -123.63 113.84 19.2 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.595 177.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.589 HD11 ' SD ' ' A' ' 13' ' ' MET . 5.0 mp -90.15 153.57 20.42 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.106 0.479 . . . . 0.0 109.846 174.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.594 HD23 HD21 ' B' ' 67' ' ' LEU . 1.0 OUTLIER -133.49 139.34 46.6 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.093 -179.467 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.83 -166.85 24.45 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.886 -177.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -152.79 131.27 12.18 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.735 0.778 . . . . 0.0 111.856 176.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.7 mt -69.99 133.34 47.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.056 -1.429 . . . . 0.0 109.306 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -70.51 129.52 39.45 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -83.05 164.88 20.04 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.805 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 18.1 mt -127.5 49.85 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.473 0.654 . . . . 0.0 109.268 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -63.66 -32.04 73.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.042 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 1' ' ' PHE . 40.6 m -82.56 51.0 1.76 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.666 176.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -178.59 -52.02 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.136 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.396 178.793 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' B' ' 96' ' ' SER . 95.6 m-85 . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -157.75 64.27 0.47 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.404 0.621 . . . . 0.0 110.052 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.48 -21.56 37.19 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.957 177.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . 55.59 73.95 0.4 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.395 0.617 . . . . 0.0 111.075 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 20.3 ptm -105.36 59.81 0.67 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.013 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.492 ' HB3' ' ND2' ' C' ' 68' ' ' ASN . . . -54.43 140.27 34.55 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.73 178.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' MET . . . . . 0.516 ' HA ' ' HB2' ' C' ' 70' ' ' SER . 11.5 ttt -104.47 134.27 47.95 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.076 0.465 . . . . 0.0 111.774 -170.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.418 ' CE1' HD21 ' C' ' 44' ' ' LEU . 62.2 t80 -55.9 143.94 29.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.477 -175.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' TRP . . . . . 0.44 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 89.8 t90 -137.48 150.16 47.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.95 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.618 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -150.87 159.75 28.3 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.092 177.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.594 HD23 HD13 ' B' ' 87' ' ' LEU . 37.0 tp -148.32 108.24 4.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.864 0.364 . . . . 0.0 111.077 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -92.46 103.81 16.2 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.963 0.411 . . . . 0.0 110.011 174.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' MET . . . . . 0.602 ' SD ' HD11 ' B' ' 87' ' ' LEU . 53.7 mtp -95.11 144.95 25.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.06 -175.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -100.35 149.45 36.08 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.834 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.572 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 11.4 Cg_endo -55.85 121.81 10.63 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.283 2.655 . . . . 0.0 113.255 -176.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' B' ' 79' ' ' THR . 49.7 mt-10 60.9 57.38 2.61 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.49 178.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -132.6 142.63 49.22 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.207 175.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.657 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 35.6 ttmt -118.38 116.25 26.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.804 0.335 . . . . 0.0 111.722 -174.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -112.2 110.35 20.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.023 178.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 4.7 p -77.27 122.29 24.88 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 173.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -99.74 128.6 45.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.815 -167.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 28.5 p -98.73 125.12 43.97 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 169.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 43.5 mt -96.46 118.65 43.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.256 0.551 . . . . 0.0 111.744 -172.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.417 ' N ' HD12 ' B' ' 24' ' ' ILE . 4.1 mp -93.84 -45.0 13.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.652 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -118.61 140.54 49.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.479 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 11.3 t -62.67 114.38 3.56 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 173.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -130.02 148.73 51.91 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.502 -0.879 . . . . 0.0 112.923 -170.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' HIS . . . . . 0.576 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 17.9 t60 -106.15 125.65 51.25 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.194 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.597 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 47.5 mt -97.69 132.6 42.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 170.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.576 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 43.1 p -116.25 -14.75 11.07 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -170.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.55 152.45 22.15 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 119.322 -1.418 . . . . 0.0 113.464 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.426 HG23 ' HG ' ' B' ' 87' ' ' LEU . 8.7 p -137.91 122.78 23.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 172.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' ALA . . . . . 0.412 ' HA ' HG21 ' B' ' 56' ' ' VAL . . . -140.63 156.15 46.34 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.335 -174.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.469 ' HB3' HG12 ' B' ' 85' ' ' VAL . 3.7 pp -115.18 141.37 48.11 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.853 0.835 . . . . 0.0 112.053 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -106.54 -57.32 2.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.044 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -102.64 127.42 49.76 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 169.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.498 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 153.52 160.67 9.87 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 119.311 -1.423 . . . . 0.0 113.729 176.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' GLN . . . . . 0.592 ' O ' ' HG3' ' B' ' 58' ' ' LYS . 19.0 tt0 -102.22 -47.0 4.66 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 120.784 0.326 . . . . 0.0 110.426 177.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.448 ' OE2' ' HG2' ' B' ' 38' ' ' GLN . 6.9 mp0 -152.27 129.52 11.24 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.352 177.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.669 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -126.02 119.48 27.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.355 0.598 . . . . 0.0 110.305 171.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -104.5 108.92 20.59 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 43.7 tp -84.82 115.02 22.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.33 -173.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' TYR . . . . . 0.525 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 91.6 m-85 -116.31 145.48 43.15 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 175.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.577 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.2 OUTLIER -131.63 128.46 39.16 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 171.337 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -106.64 122.95 47.36 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.6 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.704 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -130.19 125.26 34.52 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 175.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 61.37 36.44 17.47 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 123.532 0.52 . . . . 0.0 109.698 -171.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.482 ' O ' ' HD3' ' B' ' 48' ' ' LYS . 14.9 tmtt? 73.6 -7.54 1.55 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.407 178.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.537 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 24.3 tp60 -80.46 114.61 19.48 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -177.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -81.42 110.2 16.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.993 0.425 . . . . 0.0 110.307 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.595 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 82.2 m-85 -99.37 129.93 45.61 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.293 177.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.28 99.44 4.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 171.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.482 HG13 ' CD2' ' A' ' 88' ' ' LEU . 2.4 t -74.63 -50.06 27.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.412 -171.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.433 ' HB2' ' CD2' ' B' ' 65' ' ' LEU . . . -158.25 138.92 12.84 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.429 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 23.2 m -103.06 102.04 12.04 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 171.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.468 HG13 ' HB3' ' B' ' 40' ' ' ALA . 7.3 p -113.46 110.19 31.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.796 0.808 . . . . 0.0 109.928 -177.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 81.5 p -122.96 -176.89 3.52 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.128 -174.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' LYS . . . . . 0.592 ' HG3' ' O ' ' B' ' 38' ' ' GLN . 9.7 mtmp? -56.77 -34.99 68.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.086 0.47 . . . . 0.0 110.372 169.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.5 -40.48 64.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.505 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 77.6 mt -117.16 80.57 12.04 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 173.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.15 -0.06 6.67 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.985 2.457 . . . . 0.0 113.251 -169.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -164.14 118.67 1.48 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.228 0.537 . . . . 0.0 111.111 -174.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 58.6 t -108.78 108.58 25.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.366 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.43 117.45 27.37 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.851 174.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' B' ' 30' ' ' SER . 0.3 OUTLIER -136.53 168.43 19.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.459 -176.013 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 66' ' ' ASP . . . . . 0.54 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 8.9 t0 -113.88 99.46 7.69 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.175 0.512 . . . . 0.0 110.328 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.597 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 19.5 mt -112.77 142.06 45.85 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.409 177.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 68' ' ' ASN . . . . . 0.497 ' ND2' ' HB3' ' A' ' 6' ' ' ALA . 63.1 t30 -150.6 115.87 5.39 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 174.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -110.32 158.78 18.06 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.906 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.524 ' HB2' ' HA ' ' A' ' 7' ' ' MET . 8.6 t -110.63 158.65 18.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.239 0.543 . . . . 0.0 110.627 -176.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -70.53 -4.76 24.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.67 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.35 -26.97 14.13 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.404 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -100.61 168.31 9.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.12 0.486 . . . . 0.0 110.92 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 73.7 mtm180 -136.94 143.55 42.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.1 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.704 HG22 ' HB2' ' B' ' 46' ' ' ALA . 13.1 pt -139.85 175.98 6.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.59 0.233 . . . . 0.0 111.141 -172.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.577 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 9.2 mtm -133.97 131.81 39.43 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 171.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 77' ' ' PHE . . . . . 0.468 ' CD1' ' HB2' ' B' ' 44' ' ' LEU . 1.2 m-85 -108.35 128.2 54.55 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.657 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 38.8 p90 -152.84 136.27 15.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.341 0.591 . . . . 0.0 111.765 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 2.1 p -111.12 133.13 53.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.185 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.24 168.27 9.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.795 177.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.98 -170.31 43.32 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -115.04 102.72 10.2 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.659 174.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.669 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -173.88 152.28 1.94 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.511 170.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 32.0 t -111.47 122.1 46.94 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.469 HG12 ' HB3' ' B' ' 34' ' ' LEU . 4.3 m -113.59 156.85 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-O 121.471 0.653 . . . . 0.0 112.567 -172.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 14.8 t -123.54 113.87 19.29 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.667 177.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.602 HD11 ' SD ' ' B' ' 13' ' ' MET . 5.0 mp -90.15 153.55 20.44 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 121.078 0.466 . . . . 0.0 109.887 174.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.578 HD23 HD21 ' C' ' 67' ' ' LEU . 1.0 OUTLIER -133.47 139.38 46.64 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.023 -179.43 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.87 -166.85 24.51 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.913 -177.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -152.73 131.31 12.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.751 0.786 . . . . 0.0 111.763 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 5.7 mt -70.05 133.32 47.08 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.078 -1.419 . . . . 0.0 109.301 174.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -70.44 129.43 39.25 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.961 0.41 . . . . 0.0 110.012 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -82.99 164.79 20.16 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.811 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 17.9 mt -127.44 49.87 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.533 0.683 . . . . 0.0 109.276 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -63.58 -32.06 73.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.08 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 96' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' B' ' 1' ' ' PHE . 40.3 m -82.61 50.99 1.77 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.527 0.679 . . . . 0.0 110.675 176.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . -178.61 -52.1 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.123 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 11.4 t . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.311 178.789 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 1' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' C' ' 96' ' ' SER . 95.4 m-85 . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -157.82 64.32 0.47 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.418 0.628 . . . . 0.0 110.046 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.55 -21.65 36.69 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.905 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . 55.69 73.9 0.4 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.38 0.609 . . . . 0.0 111.075 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 20.3 ptm -105.38 59.88 0.67 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.049 -176.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 6' ' ' ALA . . . . . 0.506 ' HB3' ' ND2' ' D' ' 68' ' ' ASN . . . -54.4 140.21 34.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.761 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 7' ' ' MET . . . . . 0.506 ' HA ' ' HB2' ' D' ' 70' ' ' SER . 11.5 ttt -104.45 134.38 47.75 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.057 0.456 . . . . 0.0 111.854 -170.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 8' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -55.93 143.86 30.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.53 -175.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 9' ' ' TRP . . . . . 0.432 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 90.1 t90 -137.46 150.18 47.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.976 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 10' ' ' GLY . . . . . 0.578 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -150.88 159.63 28.24 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.098 177.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.58 HD23 HD13 ' C' ' 87' ' ' LEU . 37.3 tp -148.26 108.21 4.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.827 0.346 . . . . 0.0 111.178 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -92.4 103.78 16.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.076 0.465 . . . . 0.0 110.005 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 13' ' ' MET . . . . . 0.591 ' SD ' HD11 ' C' ' 87' ' ' LEU . 53.2 mtp -95.0 144.99 25.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.118 -175.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -100.43 149.42 36.08 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.86 177.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 15' ' ' PRO . . . . . 0.579 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 11.6 Cg_endo -55.83 121.85 10.71 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.254 2.636 . . . . 0.0 113.253 -176.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 16' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' C' ' 79' ' ' THR . 49.9 mt-10 60.9 57.28 2.64 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.564 178.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -132.55 142.6 49.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.253 175.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 18' ' ' LYS . . . . . 0.666 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 35.5 ttmt -118.37 116.41 26.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.859 0.362 . . . . 0.0 111.721 -174.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -112.27 110.36 20.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.029 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -77.3 122.15 24.7 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 173.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -99.58 128.54 45.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.85 -167.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 28.0 p -98.7 125.01 43.89 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 169.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mt -96.43 118.72 43.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.2 0.524 . . . . 0.0 111.738 -172.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 24' ' ' ILE . . . . . 0.42 ' N ' HD12 ' C' ' 24' ' ' ILE . 4.1 mp -93.9 -44.97 13.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.649 178.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -118.64 140.39 49.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.539 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 11.6 t -62.58 114.3 3.48 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 173.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 27' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -130.05 148.62 51.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.888 0.851 . . . . 0.0 112.947 -170.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 28' ' ' HIS . . . . . 0.581 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 17.7 t60 -106.08 125.6 51.19 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.158 -1.383 . . . . 0.0 110.201 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 29' ' ' ILE . . . . . 0.579 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 46.8 mt -97.7 132.63 42.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 170.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.581 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 42.4 p -116.31 -14.65 11.04 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -170.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.63 152.47 22.17 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 119.304 -1.427 . . . . 0.0 113.438 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.424 HG23 ' HG ' ' C' ' 87' ' ' LEU . 8.7 p -138.0 122.76 23.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 172.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.408 ' HA ' HG21 ' C' ' 56' ' ' VAL . . . -140.63 156.18 46.33 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.091 -0.38 . . . . 0.0 111.328 -174.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.452 ' HB3' HG12 ' C' ' 85' ' ' VAL . 3.7 pp -115.12 141.35 48.13 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.786 0.803 . . . . 0.0 112.129 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -106.58 -57.31 2.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.98 176.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -102.68 127.41 49.81 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 169.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 37' ' ' GLY . . . . . 0.486 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 153.56 160.69 9.89 Favored Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 119.357 -1.402 . . . . 0.0 113.724 176.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 38' ' ' GLN . . . . . 0.607 ' O ' ' HG3' ' C' ' 58' ' ' LYS . 19.0 tt0 -102.22 -47.03 4.65 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 120.701 0.286 . . . . 0.0 110.467 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 39' ' ' GLU . . . . . 0.449 ' OE2' ' HG2' ' C' ' 38' ' ' GLN . 6.8 mp0 -152.26 129.52 11.25 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.412 176.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.663 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -125.95 119.56 28.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.35 0.595 . . . . 0.0 110.296 171.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -104.54 108.88 20.55 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 43.5 tp -84.84 115.04 22.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.261 -173.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 43' ' ' TYR . . . . . 0.51 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 91.5 m-85 -116.33 145.5 43.15 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 175.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.575 ' HA ' ' O ' ' C' ' 76' ' ' MET . 0.2 OUTLIER -131.69 128.48 39.07 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 171.434 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 45' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -106.55 122.9 47.25 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.633 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.712 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -130.3 125.16 34.05 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 61.46 36.42 17.19 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -171.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.493 ' O ' ' HD3' ' C' ' 48' ' ' LYS . 14.9 tmtt? 73.72 -7.67 1.54 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.351 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 49' ' ' GLN . . . . . 0.54 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 24.8 tp60 -80.36 114.59 19.37 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.887 -0.508 . . . . 0.0 109.69 -177.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -81.28 110.1 16.42 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.343 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 51' ' ' TYR . . . . . 0.618 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 82.2 m-85 -99.36 129.89 45.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.278 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.22 99.44 3.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 171.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 53' ' ' VAL . . . . . 0.474 HG13 ' CD2' ' B' ' 88' ' ' LEU . 2.4 t -74.64 -50.12 27.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.39 -171.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 54' ' ' ALA . . . . . 0.433 ' HB2' ' CD2' ' C' ' 65' ' ' LEU . . . -158.16 138.95 12.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.454 -177.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 23.5 m -103.05 102.09 12.09 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 171.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 56' ' ' VAL . . . . . 0.457 HG13 ' HB3' ' C' ' 40' ' ' ALA . 7.2 p -113.59 110.15 31.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.846 0.831 . . . . 0.0 109.889 -177.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 81.7 p -123.02 -177.01 3.55 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.124 -174.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 58' ' ' LYS . . . . . 0.607 ' HG3' ' O ' ' C' ' 38' ' ' GLN . 9.7 mtmp? -56.58 -35.11 67.82 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.058 0.456 . . . . 0.0 110.38 169.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.37 -40.55 64.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.514 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 77.9 mt -117.21 80.58 12.22 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 174.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.21 -0.07 6.74 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.053 2.502 . . . . 0.0 113.187 -169.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -164.12 118.68 1.49 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.139 0.495 . . . . 0.0 111.076 -174.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 58.9 t -108.79 108.65 25.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.281 175.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.53 117.41 27.46 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.772 174.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 65' ' ' LEU . . . . . 0.433 ' CD2' ' HB2' ' C' ' 54' ' ' ALA . 0.3 OUTLIER -136.39 168.49 19.35 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.497 -176.073 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 66' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 8.9 t0 -114.02 99.58 7.76 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.306 0.574 . . . . 0.0 110.203 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.579 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 19.6 mt -112.74 141.96 45.92 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.468 177.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 68' ' ' ASN . . . . . 0.492 ' ND2' ' HB3' ' B' ' 6' ' ' ALA . 63.2 t30 -150.58 115.78 5.37 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 174.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -110.26 158.76 18.04 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.937 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 70' ' ' SER . . . . . 0.516 ' HB2' ' HA ' ' B' ' 7' ' ' MET . 8.7 t -110.65 158.7 18.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.23 0.538 . . . . 0.0 110.654 -176.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -70.6 -4.67 24.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.596 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.51 -26.81 14.37 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.483 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -100.81 168.24 9.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.019 0.437 . . . . 0.0 110.846 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 73.7 mtm180 -136.86 143.59 43.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.136 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.712 HG22 ' HB2' ' C' ' 46' ' ' ALA . 13.2 pt -139.83 176.11 6.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.614 0.245 . . . . 0.0 111.128 -172.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.575 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 9.2 mtm -134.1 131.81 39.19 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 171.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 77' ' ' PHE . . . . . 0.456 ' CD1' ' HB2' ' C' ' 44' ' ' LEU . 1.2 m-85 -108.34 128.24 54.58 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 78' ' ' TYR . . . . . 0.666 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 38.9 p90 -152.8 136.32 15.97 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.37 0.605 . . . . 0.0 111.777 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 79' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 2.1 p -111.1 133.11 53.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.217 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.31 168.33 9.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.763 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.77 -170.26 43.68 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -114.97 102.7 10.21 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.651 174.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 83' ' ' ALA . . . . . 0.663 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -173.83 152.34 1.97 Allowed 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.942 -1.027 . . . . 0.0 109.473 170.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 32.1 t -111.47 122.16 47.09 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.454 HG11 HG11 ' C' ' 56' ' ' VAL . 4.3 m -113.71 156.91 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-O 121.564 0.697 . . . . 0.0 112.537 -172.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 15.1 t -123.62 113.84 19.2 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.637 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 87' ' ' LEU . . . . . 0.591 HD11 ' SD ' ' C' ' 13' ' ' MET . 5.0 mp -90.08 153.55 20.46 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.07 0.462 . . . . 0.0 109.913 174.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 88' ' ' LEU . . . . . 0.59 HD23 HD21 ' D' ' 67' ' ' LEU . 1.0 OUTLIER -133.5 139.34 46.59 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.051 -179.422 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.86 -166.81 24.43 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.875 -177.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -152.79 131.27 12.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.809 0.814 . . . . 0.0 111.812 176.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 5.8 mt -70.14 133.37 47.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.007 -1.452 . . . . 0.0 109.253 175.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -70.37 129.52 39.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.913 0.387 . . . . 0.0 109.974 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -83.06 164.87 20.03 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.838 177.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 18.2 mt -127.54 49.84 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.523 0.678 . . . . 0.0 109.238 176.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -63.47 -32.22 73.6 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.072 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 96' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' C' ' 1' ' ' PHE . 40.5 m -82.51 51.01 1.75 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.668 176.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -178.65 -51.95 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.116 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 11.5 t . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.405 178.795 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 1' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' D' ' 96' ' ' SER . 95.5 m-85 . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -157.69 64.33 0.47 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.381 0.61 . . . . 0.0 110.003 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.51 -21.63 36.89 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.901 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . 55.64 73.84 0.41 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.385 0.612 . . . . 0.0 111.1 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 20.3 ptm -105.2 59.85 0.68 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.084 -176.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 6' ' ' ALA . . . . . 0.523 ' HB3' ' ND2' ' E' ' 68' ' ' ASN . . . -54.47 140.31 34.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.788 178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 7' ' ' MET . . . . . 0.496 ' HA ' ' HB2' ' E' ' 70' ' ' SER . 11.5 ttt -104.53 134.28 47.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.038 0.446 . . . . 0.0 111.783 -170.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 8' ' ' PHE . . . . . 0.405 ' CE1' HD21 ' E' ' 44' ' ' LEU . 62.4 t80 -55.97 143.86 30.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.51 -175.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 9' ' ' TRP . . . . . 0.439 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 90.0 t90 -137.43 150.06 47.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.022 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 10' ' ' GLY . . . . . 0.585 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -150.83 159.71 28.28 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.098 177.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.594 HD23 HD13 ' D' ' 87' ' ' LEU . 36.7 tp -148.35 108.18 4.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.834 0.349 . . . . 0.0 111.03 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -92.28 103.82 16.24 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.988 0.423 . . . . 0.0 109.975 174.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 13' ' ' MET . . . . . 0.6 ' SD ' HD11 ' D' ' 87' ' ' LEU . 53.8 mtp -95.12 145.01 25.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.12 -175.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -100.47 149.42 36.08 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.86 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 15' ' ' PRO . . . . . 0.557 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 11.5 Cg_endo -55.76 121.72 10.46 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 123.314 2.676 . . . . 0.0 113.319 -176.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 16' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' D' ' 79' ' ' THR . 49.8 mt-10 60.89 57.45 2.6 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.465 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -132.64 142.66 49.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.202 175.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 18' ' ' LYS . . . . . 0.665 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 35.5 ttmt -118.41 116.26 26.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.86 0.362 . . . . 0.0 111.756 -175.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -112.09 110.25 20.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.095 178.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 4.7 p -77.17 122.22 24.72 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 173.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -99.67 128.45 45.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.886 -167.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 28.4 p -98.72 125.15 43.96 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 169.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 44.0 mt -96.41 118.58 43.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.205 0.526 . . . . 0.0 111.731 -172.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 24' ' ' ILE . . . . . 0.426 HD12 ' N ' ' D' ' 24' ' ' ILE . 4.1 mp -93.83 -44.98 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.673 178.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -118.65 140.44 49.91 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.491 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 11.6 t -62.65 114.37 3.54 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 173.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 27' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -129.97 148.64 51.85 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.607 -0.837 . . . . 0.0 112.99 -170.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 28' ' ' HIS . . . . . 0.578 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 18.0 t60 -106.1 125.7 51.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.184 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 29' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 46.8 mt -97.7 132.48 42.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 170.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 30' ' ' SER . . . . . 0.578 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 42.5 p -116.23 -14.65 11.09 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -170.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.58 152.48 22.2 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 119.278 -1.439 . . . . 0.0 113.453 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.424 HG23 ' HG ' ' D' ' 87' ' ' LEU . 8.6 p -137.97 122.86 23.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 172.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 33' ' ' ALA . . . . . 0.408 ' HA ' HG21 ' D' ' 56' ' ' VAL . . . -140.63 156.07 46.36 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 122.153 -0.342 . . . . 0.0 111.414 -174.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 34' ' ' LEU . . . . . 0.453 ' HB3' HG12 ' D' ' 85' ' ' VAL . 3.7 pp -115.1 141.34 48.15 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.818 0.818 . . . . 0.0 112.126 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -106.51 -57.27 2.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.024 176.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -102.64 127.35 49.78 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 169.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 37' ' ' GLY . . . . . 0.493 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 153.5 160.61 9.83 Favored Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 119.278 -1.439 . . . . 0.0 113.711 176.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 38' ' ' GLN . . . . . 0.607 ' O ' ' HG3' ' D' ' 58' ' ' LYS . 19.1 tt0 -102.21 -46.98 4.66 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.579 -0.311 . . . . 0.0 110.391 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 39' ' ' GLU . . . . . 0.45 ' OE2' ' HG2' ' D' ' 38' ' ' GLN . 6.9 mp0 -152.27 129.45 11.18 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.417 176.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 40' ' ' ALA . . . . . 0.673 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -125.97 119.63 28.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.4 0.619 . . . . 0.0 110.218 171.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -104.51 109.01 20.73 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 43.8 tp -84.99 114.97 22.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.218 -173.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 43' ' ' TYR . . . . . 0.523 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 91.6 m-85 -116.26 145.51 43.1 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 175.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.58 ' HA ' ' O ' ' D' ' 76' ' ' MET . 0.2 OUTLIER -131.66 128.47 39.11 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 171.367 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 45' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -106.57 122.93 47.3 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.654 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.718 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -130.3 125.14 34.01 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 61.47 36.4 17.17 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -171.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 48' ' ' LYS . . . . . 0.498 ' O ' ' HD3' ' D' ' 48' ' ' LYS . 14.9 tmtt? 73.69 -7.54 1.56 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.307 178.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 49' ' ' GLN . . . . . 0.537 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 24.5 tp60 -80.37 114.56 19.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -177.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -81.32 110.11 16.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.424 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 51' ' ' TYR . . . . . 0.578 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 82.1 m-85 -99.32 129.95 45.57 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.225 177.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.24 99.42 3.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 171.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 53' ' ' VAL . . . . . 0.468 HG13 ' CD2' ' C' ' 88' ' ' LEU . 2.4 t -74.69 -50.08 27.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.376 -171.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 54' ' ' ALA . . . . . 0.425 ' HB2' ' CD2' ' D' ' 65' ' ' LEU . . . -158.21 139.02 12.97 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.453 -177.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 22.9 m -103.11 102.1 12.09 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 171.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 56' ' ' VAL . . . . . 0.472 HG13 ' HB3' ' D' ' 40' ' ' ALA . 7.2 p -113.55 110.21 31.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.889 0.852 . . . . 0.0 109.932 -177.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 81.6 p -122.97 -176.95 3.54 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.123 -174.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 58' ' ' LYS . . . . . 0.607 ' HG3' ' O ' ' D' ' 38' ' ' GLN . 9.7 mtmp? -56.64 -35.18 68.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.146 0.498 . . . . 0.0 110.329 169.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.24 -40.72 64.43 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.549 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 77.6 mt -116.93 80.55 11.29 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 173.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.28 0.06 6.6 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.018 2.479 . . . . 0.0 113.238 -169.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -164.19 118.7 1.47 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.267 0.556 . . . . 0.0 111.003 -174.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 58.6 t -108.83 108.58 25.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.299 175.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.55 117.39 27.47 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.83 174.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 65' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' D' ' 30' ' ' SER . 0.3 OUTLIER -136.35 168.51 19.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.465 -175.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 66' ' ' ASP . . . . . 0.512 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 8.8 t0 -114.0 99.61 7.79 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.206 0.527 . . . . 0.0 110.257 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.59 HD21 HD23 ' C' ' 88' ' ' LEU . 19.5 mt -112.78 142.0 45.93 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.468 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 68' ' ' ASN . . . . . 0.506 ' ND2' ' HB3' ' C' ' 6' ' ' ALA . 63.2 t30 -150.58 115.78 5.37 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 174.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -110.29 158.8 18.02 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.917 -177.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 70' ' ' SER . . . . . 0.506 ' HB2' ' HA ' ' C' ' 7' ' ' MET . 8.6 t -110.68 158.68 18.35 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.212 0.529 . . . . 0.0 110.619 -176.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -70.5 -4.78 24.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.611 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.38 -26.96 14.14 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.49 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -100.66 168.24 9.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.033 0.444 . . . . 0.0 110.923 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -136.8 143.7 43.31 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.718 HG22 ' HB2' ' D' ' 46' ' ' ALA . 13.3 pt -139.96 176.0 6.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.113 -172.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 76' ' ' MET . . . . . 0.58 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 9.2 mtm -134.03 131.82 39.32 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 171.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 77' ' ' PHE . . . . . 0.457 ' CD1' ' HB2' ' D' ' 44' ' ' LEU . 1.2 m-85 -108.28 128.28 54.6 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 78' ' ' TYR . . . . . 0.665 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 39.0 p90 -152.86 136.32 15.91 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.36 0.6 . . . . 0.0 111.734 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 79' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 2.1 p -111.2 133.13 53.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.187 -177.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.25 168.28 9.45 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.777 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.94 -170.24 43.32 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -115.09 102.72 10.19 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 117.723 0.761 . . . . 0.0 109.61 174.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 83' ' ' ALA . . . . . 0.673 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -173.86 152.4 1.97 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.487 170.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 32.0 t -111.55 122.09 46.91 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.453 HG12 ' HB3' ' D' ' 34' ' ' LEU . 4.3 m -113.62 156.85 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.635 0 CA-C-O 121.476 0.655 . . . . 0.0 112.58 -172.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 14.9 t -123.53 113.82 19.23 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.656 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 87' ' ' LEU . . . . . 0.6 HD11 ' SD ' ' D' ' 13' ' ' MET . 5.0 mp -90.09 153.5 20.5 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 121.139 0.495 . . . . 0.0 109.852 174.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.561 HD23 HD21 ' E' ' 67' ' ' LEU . 1.0 OUTLIER -133.4 139.44 46.76 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.067 -179.526 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.87 -166.85 24.5 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.838 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -152.8 131.24 12.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.786 0.803 . . . . 0.0 111.843 176.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 5.7 mt -70.08 133.38 47.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.984 -1.462 . . . . 0.0 109.299 175.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -70.45 129.43 39.23 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -82.98 164.76 20.19 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.864 177.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 18.2 mt -127.42 49.89 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.499 0.666 . . . . 0.0 109.222 176.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -63.61 -32.16 73.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.036 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 96' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' D' ' 1' ' ' PHE . 40.8 m -82.52 51.08 1.77 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.69 176.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . -178.7 -51.95 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.126 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 11.3 t . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.34 178.73 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' E' E ' 1' ' ' PHE . . . . . 0.453 ' O ' ' HA ' ' E' ' 96' ' ' SER . 95.6 m-85 . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -157.73 64.47 0.47 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.467 0.651 . . . . 0.0 109.997 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.59 -21.57 36.81 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.96 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . 55.66 73.84 0.41 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.424 0.631 . . . . 0.0 111.078 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 20.2 ptm -105.33 59.87 0.67 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.035 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 6' ' ' ALA . . . . . 0.469 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . . . -54.47 140.26 34.85 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.766 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 7' ' ' MET . . . . . 0.513 ' HA ' ' HB2' ' A' ' 70' ' ' SER . 11.5 ttt -104.43 134.34 47.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.086 0.47 . . . . 0.0 111.825 -170.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 8' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -55.95 143.83 30.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.515 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 9' ' ' TRP . . . . . 0.429 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 89.9 t90 -137.4 150.13 47.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.044 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 10' ' ' GLY . . . . . 0.582 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -150.87 159.68 28.27 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.082 177.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 11' ' ' LEU . . . . . 0.599 HD23 HD13 ' E' ' 87' ' ' LEU . 37.3 tp -148.29 108.2 4.04 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.808 0.337 . . . . 0.0 111.151 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -92.38 103.78 16.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.081 0.467 . . . . 0.0 110.007 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 13' ' ' MET . . . . . 0.597 ' SD ' HD11 ' E' ' 87' ' ' LEU . 53.1 mtp -95.06 144.99 25.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.099 -175.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -100.48 149.38 36.05 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.787 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 15' ' ' PRO . . . . . 0.56 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 11.5 Cg_endo -55.75 121.77 10.56 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.29 2.66 . . . . 0.0 113.292 -176.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 16' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' E' ' 79' ' ' THR . 49.8 mt-10 60.95 57.23 2.63 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.505 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -132.43 142.67 49.36 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.29 174.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 18' ' ' LYS . . . . . 0.661 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 35.6 ttmt -118.42 116.3 26.43 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.881 0.372 . . . . 0.0 111.71 -175.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -112.21 110.33 20.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.013 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 4.8 p -77.3 122.04 24.56 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 173.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -99.57 128.59 45.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.872 -167.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 27.6 p -98.69 125.06 43.89 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 169.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 44.1 mt -96.43 118.67 43.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.303 0.573 . . . . 0.0 111.691 -172.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 24' ' ' ILE . . . . . 0.429 HD12 ' N ' ' E' ' 24' ' ' ILE . 4.1 mp -93.94 -44.93 13.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.581 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -118.72 140.32 50.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.471 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 11.3 t -62.53 114.39 3.52 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 173.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 27' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -130.04 148.7 51.92 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 119.528 -0.869 . . . . 0.0 112.927 -170.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 28' ' ' HIS . . . . . 0.58 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 17.8 t60 -106.08 125.66 51.26 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.115 -1.402 . . . . 0.0 110.283 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 29' ' ' ILE . . . . . 0.59 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 47.1 mt -97.7 132.55 42.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 30' ' ' SER . . . . . 0.58 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 44.1 p -116.28 -14.67 11.05 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -170.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.6 152.5 22.21 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 119.206 -1.473 . . . . 0.0 113.431 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.422 HG23 ' HG ' ' E' ' 87' ' ' LEU . 8.7 p -138.02 122.78 23.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 172.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 33' ' ' ALA . . . . . 0.416 ' HA ' HG21 ' E' ' 56' ' ' VAL . . . -140.6 156.17 46.35 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.345 -174.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 34' ' ' LEU . . . . . 0.449 ' HB3' HG12 ' E' ' 85' ' ' VAL . 3.7 pp -115.21 141.39 48.08 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.836 0.827 . . . . 0.0 112.093 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -106.57 -57.31 2.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.003 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -102.64 127.4 49.76 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 169.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 37' ' ' GLY . . . . . 0.494 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 153.55 160.7 9.89 Favored Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 119.485 -1.341 . . . . 0.0 113.762 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 38' ' ' GLN . . . . . 0.592 ' O ' ' HG3' ' E' ' 58' ' ' LYS . 19.2 tt0 -102.29 -46.89 4.67 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.574 -0.313 . . . . 0.0 110.363 177.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 39' ' ' GLU . . . . . 0.452 ' OE2' ' HG2' ' E' ' 38' ' ' GLN . 6.9 mp0 -152.38 129.42 11.08 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.4 176.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 40' ' ' ALA . . . . . 0.66 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -125.92 119.56 28.1 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.398 0.618 . . . . 0.0 110.25 171.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 41' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -104.54 108.97 20.67 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 43.6 tp -84.89 115.05 22.56 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.291 -173.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 43' ' ' TYR . . . . . 0.528 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 91.4 m-85 -116.31 145.53 43.11 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 175.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 44' ' ' LEU . . . . . 0.573 ' HA ' ' O ' ' E' ' 76' ' ' MET . 0.2 OUTLIER -131.67 128.39 38.94 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 171.408 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 45' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -106.58 122.88 47.21 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.651 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 46' ' ' ALA . . . . . 0.699 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -130.28 125.28 34.41 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 175.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 61.45 36.36 17.24 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.488 0.492 . . . . 0.0 109.719 -171.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 48' ' ' LYS . . . . . 0.494 ' O ' ' HD3' ' E' ' 48' ' ' LYS . 14.9 tmtt? 73.66 -7.52 1.56 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.413 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 49' ' ' GLN . . . . . 0.529 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 24.3 tp60 -80.39 114.58 19.39 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -177.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -81.39 110.21 16.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.999 0.428 . . . . 0.0 110.395 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 51' ' ' TYR . . . . . 0.585 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 82.2 m-85 -99.44 129.94 45.67 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.219 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.29 99.49 4.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 172.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 53' ' ' VAL . . . . . 0.479 HG13 ' CD2' ' D' ' 88' ' ' LEU . 2.4 t -74.67 -50.09 27.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.366 -171.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 54' ' ' ALA . . . . . 0.424 ' HB2' ' CD2' ' E' ' 65' ' ' LEU . . . -158.25 139.01 12.93 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.465 -177.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 23.2 m -102.98 102.12 12.15 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 171.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 56' ' ' VAL . . . . . 0.473 HG13 ' HB3' ' E' ' 40' ' ' ALA . 7.2 p -113.67 110.27 31.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.966 0.889 . . . . 0.0 109.844 -177.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 81.5 p -122.97 -176.89 3.52 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.181 -174.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 58' ' ' LYS . . . . . 0.592 ' HG3' ' O ' ' E' ' 38' ' ' GLN . 9.8 mtmp? -56.79 -35.01 68.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.016 0.436 . . . . 0.0 110.313 169.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.38 -40.62 64.21 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.506 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 77.8 mt -117.05 80.56 11.66 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.22 -0.04 6.7 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.038 2.492 . . . . 0.0 113.165 -169.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -164.11 118.69 1.49 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.159 0.504 . . . . 0.0 110.945 -174.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 63' ' ' VAL . . . . . 0.402 HG11 ' HB1' ' E' ' 54' ' ' ALA . 58.3 t -108.78 108.52 25.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.368 175.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.45 117.31 27.29 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.858 174.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' E' ' 30' ' ' SER . 0.3 OUTLIER -136.3 168.56 19.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.51 -176.043 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 66' ' ' ASP . . . . . 0.545 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 8.9 t0 -114.05 99.53 7.71 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.236 0.541 . . . . 0.0 110.258 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 67' ' ' LEU . . . . . 0.59 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 19.6 mt -112.74 142.11 45.75 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.458 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 68' ' ' ASN . . . . . 0.523 ' ND2' ' HB3' ' D' ' 6' ' ' ALA . 63.2 t30 -150.63 115.81 5.36 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 174.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -110.37 158.68 18.19 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.884 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 70' ' ' SER . . . . . 0.496 ' HB2' ' HA ' ' D' ' 7' ' ' MET . 8.6 t -110.58 158.68 18.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.35 0.595 . . . . 0.0 110.634 -176.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -70.53 -4.84 24.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.618 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.34 -26.87 14.46 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.49 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -100.63 168.27 9.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.104 0.478 . . . . 0.0 110.884 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -136.86 143.69 43.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.12 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 75' ' ' ILE . . . . . 0.699 HG22 ' HB2' ' E' ' 46' ' ' ALA . 13.2 pt -139.93 176.12 5.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.653 0.263 . . . . 0.0 111.071 -172.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 76' ' ' MET . . . . . 0.573 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 9.2 mtm -134.09 131.73 39.11 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 171.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 77' ' ' PHE . . . . . 0.465 ' CD1' ' HB2' ' E' ' 44' ' ' LEU . 1.2 m-85 -108.29 128.29 54.61 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 178.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 78' ' ' TYR . . . . . 0.661 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 38.8 p90 -152.84 136.32 15.93 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.325 0.583 . . . . 0.0 111.742 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 79' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 2.1 p -111.12 133.01 53.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.257 -177.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.1 168.22 9.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.9 177.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.0 -170.21 43.15 Favored Glycine 0 CA--C 1.508 -0.346 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -115.12 102.7 10.16 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 117.716 0.758 . . . . 0.0 109.626 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 83' ' ' ALA . . . . . 0.66 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -173.82 152.28 1.96 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.509 170.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 31.9 t -111.46 122.19 47.18 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 85' ' ' VAL . . . . . 0.449 HG12 ' HB3' ' E' ' 34' ' ' LEU . 4.3 m -113.64 156.89 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 CA-C-O 121.538 0.685 . . . . 0.0 112.542 -172.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 14.9 t -123.62 113.8 19.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.794 -1.094 . . . . 0.0 108.63 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 87' ' ' LEU . . . . . 0.599 HD13 HD23 ' E' ' 11' ' ' LEU . 5.0 mp -90.12 153.42 20.55 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.123 0.487 . . . . 0.0 109.867 174.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 88' ' ' LEU . . . . . 0.6 HD23 HD21 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -133.28 139.44 46.91 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 114.803 -1.089 . . . . 0.0 109.077 -179.494 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.94 -166.83 24.55 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.849 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 90' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -152.8 131.33 12.22 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.769 0.795 . . . . 0.0 111.799 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 91' ' ' LEU . . . . . . . . . . . . . 5.8 mt -70.19 133.37 47.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.269 175.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -70.39 129.49 39.42 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -83.02 164.86 20.08 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.852 177.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 18.1 mt -127.46 49.87 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.498 0.666 . . . . 0.0 109.216 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -63.51 -32.13 73.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.096 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 96' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' E' ' 1' ' ' PHE . 40.7 m -82.57 51.03 1.77 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.643 176.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . -178.61 -52.1 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.136 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.378 178.847 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.716 0.293 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -80.12 -47.93 14.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.079 0.466 . . . . 0.0 109.941 176.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 135.17 -175.84 20.41 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.601 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.4 -48.13 10.69 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.483 ' HG3' ' CB ' ' B' ' 95' ' ' ASP . 22.7 mmt 58.59 -100.14 0.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.854 -1.066 . . . . 0.0 112.942 172.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' B' ' 70' ' ' SER . . . -86.21 131.07 34.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.66 0.267 . . . . 0.0 110.402 -177.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 38.4 mtt -124.18 144.11 50.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.157 0.503 . . . . 0.0 112.089 -175.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.513 ' CE1' HD21 ' B' ' 44' ' ' LEU . 28.9 t80 -62.34 145.7 53.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.547 -178.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -135.75 147.4 48.4 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.431 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -150.97 153.86 25.23 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.197 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.598 HD23 HD13 ' A' ' 87' ' ' LEU . 33.3 tp -147.77 106.54 3.82 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 86' ' ' SER . 0.2 OUTLIER -97.85 110.54 23.09 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.543 0.687 . . . . 0.0 111.02 176.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.443 ' SD ' HG23 ' A' ' 79' ' ' THR . 7.3 mtt -85.19 142.22 29.61 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.285 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.431 ' HB2' ' HG3' ' A' ' 17' ' ' ARG . 91.6 mttt -89.82 144.26 31.38 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 170.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -46.31 109.77 0.22 Allowed 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 123.463 2.776 . . . . 0.0 113.594 -174.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.64 ' HA ' ' O ' ' A' ' 79' ' ' THR . 8.8 tt0 70.52 67.05 0.2 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.794 175.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.536 ' NE ' ' HA ' ' A' ' 17' ' ' ARG . 4.7 mmp_? -122.76 169.28 11.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.03 175.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.68 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 19.4 tttm -146.77 104.81 3.76 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.34 0.4 . . . . 0.0 111.274 -175.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -111.74 111.5 22.51 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.053 -177.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 76' ' ' MET . 29.2 t -90.78 111.06 22.29 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 170.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -133.86 150.01 51.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.635 0.731 . . . . 0.0 112.687 -168.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.7 p -91.18 160.91 15.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.679 177.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.436 HG22 ' HA ' ' A' ' 71' ' ' LYS . 73.8 mt -111.2 126.29 68.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.219 -174.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.521 HD12 ' N ' ' A' ' 25' ' ' LYS . 1.8 pp -92.53 -24.44 5.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.641 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.521 ' N ' HD12 ' A' ' 24' ' ' ILE . 24.8 mtpp -147.44 132.93 18.66 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.421 ' O ' ' HB3' ' A' ' 92' ' ' HIS . 15.6 m -55.05 119.4 5.39 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.407 ' HB3' HD23 ' A' ' 91' ' ' LEU . 5.7 p90 -137.34 156.72 47.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.737 0.78 . . . . 0.0 112.833 -170.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.588 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 15.1 t60 -109.88 124.65 51.73 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.118 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.574 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 39.3 mt -94.45 135.08 29.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 169.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.593 ' HB2' ' HB3' ' B' ' 66' ' ' ASP . 50.1 p -120.31 -15.85 8.55 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -169.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -160.39 145.21 10.84 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 119.288 -1.434 . . . . 0.0 113.324 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.443 HG23 ' HG ' ' A' ' 87' ' ' LEU . 12.2 p -129.85 121.55 52.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 168.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.07 154.38 43.9 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 121.928 -0.483 . . . . 0.0 112.018 -173.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.558 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.4 pp -125.15 144.0 50.65 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.499 0.666 . . . . 0.0 110.836 178.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -110.27 -45.98 3.49 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 173.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -103.63 128.66 50.89 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.593 171.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.496 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 146.63 163.01 10.18 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 119.627 -1.273 . . . . 0.0 113.501 176.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -102.24 -47.24 4.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.494 0.188 . . . . 0.0 110.97 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -152.16 133.71 14.63 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.093 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.478 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -134.29 113.46 11.97 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.391 0.615 . . . . 0.0 110.122 167.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -97.81 112.72 24.52 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 174.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.7 tp -83.81 113.29 20.82 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.557 -174.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.532 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 97.9 m-85 -115.78 141.45 48.07 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.541 ' HB2' ' CD1' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -129.85 131.82 46.25 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 173.885 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -110.71 114.96 28.74 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.028 177.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.619 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -129.91 142.54 50.64 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 58.65 29.24 18.28 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.949 0.404 . . . . 0.0 110.314 -174.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt 63.58 24.51 14.02 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.735 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 23.9 tp60 -115.65 126.69 54.47 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -83.44 125.01 31.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.891 0.377 . . . . 0.0 110.696 -177.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.465 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 66.3 m-85 -121.03 133.32 55.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.943 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -82.1 107.74 14.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 169.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.51 HG13 ' CD2' ' E' ' 88' ' ' LEU . 2.4 t -80.06 -49.56 18.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.64 -171.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.534 ' HB1' HG11 ' A' ' 63' ' ' VAL . . . -160.05 148.9 17.34 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.132 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.6 m -109.79 102.22 11.03 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 173.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.415 ' CG1' HG11 ' A' ' 85' ' ' VAL . 7.3 p -117.77 114.36 45.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.658 0.742 . . . . 0.0 110.016 -177.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 81.0 p -123.05 -178.3 3.92 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.55 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -63.47 -21.54 66.37 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.996 0.426 . . . . 0.0 110.444 170.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.406 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -83.47 -40.72 18.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.229 0.537 . . . . 0.0 110.244 177.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.1 mt -113.22 82.68 5.82 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 173.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 12.5 Cg_exo -70.06 -0.11 6.69 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.156 2.57 . . . . 0.0 114.059 -167.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.28 127.12 2.44 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.175 0.512 . . . . 0.0 111.445 -176.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.534 HG11 ' HB1' ' A' ' 54' ' ' ALA . 85.2 t -117.44 106.22 19.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.311 174.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.47 121.68 27.07 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 173.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -140.69 168.16 20.46 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.766 -173.001 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.569 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 11.6 t0 -118.85 105.29 11.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.359 0.6 . . . . 0.0 110.497 -177.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.591 HD21 HD23 ' E' ' 88' ' ' LEU . 15.1 mt -118.8 144.43 46.32 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.655 177.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.447 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 57.5 t30 -148.44 114.79 5.89 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 173.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.403 ' CZ ' HD22 ' A' ' 67' ' ' LEU . 51.7 m-85 -110.13 164.51 12.57 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.091 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.536 ' HB2' ' O ' ' E' ' 6' ' ' ALA . 33.0 t -107.85 149.15 28.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.859 0.361 . . . . 0.0 110.694 -177.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.436 ' HA ' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -68.14 -11.95 60.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.235 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.3 -5.76 61.83 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.537 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -100.25 167.9 10.13 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -145.23 128.21 16.5 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.619 HG22 ' HB2' ' A' ' 46' ' ' ALA . 15.4 pt -134.89 165.49 31.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.111 0.481 . . . . 0.0 111.79 -169.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.517 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 4.5 mtm -120.91 123.5 42.65 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.595 173.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.541 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -105.96 127.61 53.26 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.587 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.68 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 40.5 p90 -154.95 144.13 21.05 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 120.031 -0.668 . . . . 0.0 112.006 -177.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.64 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 6.3 p -116.18 141.64 47.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.394 -177.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.72 153.37 23.04 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.221 176.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.93 -175.36 36.69 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -175.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -118.78 104.85 10.96 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 122.118 0.961 . . . . 0.0 110.499 176.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.496 ' CB ' ' HA3' ' A' ' 37' ' ' GLY . . . -166.1 154.83 11.16 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.22 170.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.3 t -106.3 111.19 23.67 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.558 HG12 ' HB3' ' A' ' 34' ' ' LEU . 3.4 m -111.33 138.08 41.25 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 CA-C-O 121.219 0.533 . . . . 0.0 112.191 -174.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 7.4 t -108.91 118.25 36.32 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.598 HD13 HD23 ' A' ' 11' ' ' LEU . 5.4 mp -89.73 149.26 22.82 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.532 174.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.592 HD23 HD21 ' B' ' 67' ' ' LEU . 1.3 tp -132.02 140.71 49.01 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.938 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.39 -167.14 25.52 Favored Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.695 -177.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.436 ' CD2' ' HB3' ' B' ' 68' ' ' ASN . 12.9 p90 -153.34 132.18 12.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.746 0.784 . . . . 0.0 111.643 177.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.416 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 22.3 mt -64.62 126.97 29.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.112 173.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.421 ' HB3' ' O ' ' A' ' 26' ' ' SER . 28.4 t60 -66.84 144.43 56.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.472 0.653 . . . . 0.0 111.275 -175.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.414 ' CB ' ' HB3' ' A' ' 5' ' ' MET . 7.7 p-10 -73.39 -154.24 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.012 177.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.8 pt -72.19 133.13 32.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.418 0.628 . . . . 0.0 111.45 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.445 ' CB ' ' HG3' ' E' ' 5' ' ' MET . 8.6 m-20 -81.12 64.19 5.76 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.007 176.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 26.6 m 63.25 -165.15 0.24 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.025 -175.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 70.62 45.68 51.73 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.344 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.7 p . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.571 -0.728 . . . . 0.0 110.437 178.994 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 120.734 0.302 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -80.05 -47.97 14.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.105 0.479 . . . . 0.0 109.933 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 135.23 -175.87 20.41 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.652 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.39 -48.01 10.81 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' MET . . . . . 0.416 ' HG3' ' CB ' ' C' ' 95' ' ' ASP . 22.7 mmt 58.57 -100.14 0.11 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 114.834 -1.076 . . . . 0.0 112.933 172.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.579 ' O ' ' HB2' ' C' ' 70' ' ' SER . . . -86.18 131.06 34.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.427 -177.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 38.4 mtt -124.21 144.09 50.14 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.282 0.563 . . . . 0.0 112.041 -175.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.528 ' CE1' HD21 ' C' ' 44' ' ' LEU . 29.1 t80 -62.36 145.73 53.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.47 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -135.72 147.33 48.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.112 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.504 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -150.95 153.81 25.21 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.185 178.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.626 HD23 HD13 ' B' ' 87' ' ' LEU . 33.6 tp -147.7 106.59 3.83 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' ASN . . . . . 0.491 ' HA ' ' HA ' ' B' ' 86' ' ' SER . 0.2 OUTLIER -97.88 110.58 23.12 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.597 0.713 . . . . 0.0 110.959 177.01 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 13' ' ' MET . . . . . 0.439 ' SD ' HG23 ' B' ' 79' ' ' THR . 7.3 mtt -85.14 142.17 29.68 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.366 -178.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.439 ' HB2' ' HG3' ' B' ' 17' ' ' ARG . 91.5 mttt -89.77 144.31 31.53 Favored Pre-proline 0 C--N 1.316 -0.874 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 170.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -46.3 109.69 0.22 Allowed 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 123.56 2.84 . . . . 0.0 113.496 -174.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.642 ' HA ' ' O ' ' B' ' 79' ' ' THR . 8.8 tt0 70.54 67.09 0.2 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.734 175.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.534 ' NE ' ' HA ' ' B' ' 17' ' ' ARG . 4.6 mmp_? -122.76 169.18 11.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.089 175.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.67 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 19.5 tttm -146.68 104.77 3.77 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 123.325 0.391 . . . . 0.0 111.269 -175.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -111.76 111.53 22.57 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.079 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 29.3 t -90.73 111.05 22.26 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -133.92 150.09 51.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.667 0.746 . . . . 0.0 112.66 -168.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 3.8 p -91.25 160.91 15.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.665 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.436 HG22 ' HA ' ' B' ' 71' ' ' LYS . 74.0 mt -111.24 126.31 68.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.144 -174.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.527 HD12 ' N ' ' B' ' 25' ' ' LYS . 1.8 pp -92.49 -24.44 5.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.692 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.527 ' N ' HD12 ' B' ' 24' ' ' ILE . 24.9 mtpp -147.36 132.86 18.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.87 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' SER . . . . . 0.426 ' O ' ' HB3' ' B' ' 92' ' ' HIS . 15.5 m -54.96 119.32 5.25 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 175.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' PHE . . . . . 0.42 ' HB3' HD23 ' B' ' 91' ' ' LEU . 5.8 p90 -137.31 156.62 48.03 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.669 0.747 . . . . 0.0 112.853 -170.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' HIS . . . . . 0.587 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 15.1 t60 -109.92 124.59 51.64 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.151 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.571 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 39.3 mt -94.39 135.1 29.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 169.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.587 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 48.7 p -120.34 -15.79 8.54 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -169.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -160.31 145.16 10.79 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 119.301 -1.428 . . . . 0.0 113.377 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.439 HG23 ' HG ' ' B' ' 87' ' ' LEU . 12.3 p -129.81 121.59 52.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 168.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.11 154.31 43.79 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.983 -173.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.556 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.4 pp -125.08 143.99 50.64 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.468 0.651 . . . . 0.0 110.791 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -110.15 -46.12 3.49 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 173.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -103.57 128.67 50.78 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.515 171.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.493 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 146.55 163.01 10.17 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 119.676 -1.25 . . . . 0.0 113.6 175.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -102.3 -47.04 4.63 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.19 -0.204 . . . . 0.0 111.043 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -152.22 133.68 14.55 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.999 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.48 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -134.38 113.46 11.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.474 0.654 . . . . 0.0 110.127 167.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -97.83 112.7 24.51 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 174.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 43.6 tp -83.71 113.37 20.83 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.56 -174.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' TYR . . . . . 0.532 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 98.0 m-85 -115.89 141.41 48.14 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 176.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.551 ' HB2' ' CD1' ' B' ' 77' ' ' PHE . 0.1 OUTLIER -129.85 131.9 46.27 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 173.906 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -110.7 114.94 28.7 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.01 177.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.622 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -129.91 142.54 50.64 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 58.6 29.31 18.31 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.994 0.426 . . . . 0.0 110.338 -174.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt 63.5 24.5 14.09 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.705 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.473 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 24.0 tp60 -115.64 126.65 54.43 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -83.38 124.94 31.15 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.972 0.415 . . . . 0.0 110.702 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.431 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 66.4 m-85 -120.97 133.37 55.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.899 176.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -82.06 107.63 14.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 169.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.528 HG13 ' CD2' ' A' ' 88' ' ' LEU . 2.4 t -80.08 -49.54 18.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.61 -171.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.528 ' HB1' HG11 ' B' ' 63' ' ' VAL . . . -159.98 148.89 17.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.171 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 55.4 m -109.85 102.28 11.06 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 173.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.414 ' CG1' HG11 ' B' ' 85' ' ' VAL . 7.3 p -117.78 114.41 45.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.669 0.747 . . . . 0.0 110.001 -177.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 81.3 p -123.12 -178.38 3.95 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.608 -174.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -63.45 -21.47 66.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.932 0.396 . . . . 0.0 110.484 170.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.402 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -83.48 -40.77 18.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.206 0.527 . . . . 0.0 110.216 177.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 80.4 mt -113.22 82.63 5.78 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 12.5 Cg_exo -70.02 -0.2 6.78 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.17 2.58 . . . . 0.0 114.066 -167.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.21 127.17 2.47 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.159 0.504 . . . . 0.0 111.44 -176.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.528 HG11 ' HB1' ' B' ' 54' ' ' ALA . 85.5 t -117.35 106.21 19.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.35 174.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.49 121.7 27.1 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 173.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' B' ' 30' ' ' SER . 0.6 OUTLIER -140.76 168.12 20.55 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.741 -173.026 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 66' ' ' ASP . . . . . 0.593 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 11.8 t0 -118.73 105.26 11.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.264 0.554 . . . . 0.0 110.565 -177.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.592 HD21 HD23 ' A' ' 88' ' ' LEU . 15.1 mt -118.76 144.43 46.28 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.68 177.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 68' ' ' ASN . . . . . 0.436 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 57.4 t30 -148.52 114.8 5.86 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 173.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 69' ' ' PHE . . . . . 0.401 ' CZ ' HD22 ' B' ' 67' ' ' LEU . 51.7 m-85 -110.14 164.56 12.52 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.12 -178.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.536 ' HB2' ' O ' ' A' ' 6' ' ' ALA . 33.1 t -107.93 149.18 28.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 0.0 110.677 -177.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.436 ' HA ' HG22 ' B' ' 23' ' ' ILE . 0.0 OUTLIER -68.11 -11.95 60.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.271 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.28 -5.76 61.86 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.585 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -100.29 167.96 10.08 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -145.22 128.13 16.43 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.622 HG22 ' HB2' ' B' ' 46' ' ' ALA . 15.4 pt -134.84 165.44 31.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.082 0.467 . . . . 0.0 111.756 -169.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.52 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 4.5 mtm -120.91 123.61 42.93 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 173.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 77' ' ' PHE . . . . . 0.551 ' CD1' ' HB2' ' B' ' 44' ' ' LEU . 0.8 OUTLIER -106.02 127.62 53.29 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.441 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.67 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 40.4 p90 -154.9 144.19 21.16 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.993 -0.683 . . . . 0.0 112.034 -177.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.642 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 6.4 p -116.29 141.63 47.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.356 -177.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.72 153.41 22.99 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.241 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.79 -175.37 36.92 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -175.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -118.75 104.87 10.99 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.509 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.493 ' CB ' ' HA3' ' B' ' 37' ' ' GLY . . . -166.07 154.77 11.18 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.2 170.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 19.0 t -106.16 111.17 23.67 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.556 HG12 ' HB3' ' B' ' 34' ' ' LEU . 3.4 m -111.44 138.17 41.02 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 CA-C-O 121.3 0.571 . . . . 0.0 112.129 -174.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 86' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' B' ' 12' ' ' ASN . 7.4 t -108.94 118.25 36.32 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.793 178.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.626 HD13 HD23 ' B' ' 11' ' ' LEU . 5.4 mp -89.79 149.27 22.77 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.5 174.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.585 HD23 HD21 ' C' ' 67' ' ' LEU . 1.3 tp -131.99 140.69 49.04 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.971 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.41 -167.2 25.64 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.704 -177.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 90' ' ' TYR . . . . . 0.43 ' CD2' ' HB3' ' C' ' 68' ' ' ASN . 13.0 p90 -153.4 132.21 12.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.777 0.798 . . . . 0.0 111.603 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 91' ' ' LEU . . . . . 0.42 HD23 ' HB3' ' B' ' 27' ' ' PHE . 22.2 mt -64.49 126.98 29.58 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.131 173.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 92' ' ' HIS . . . . . 0.426 ' HB3' ' O ' ' B' ' 26' ' ' SER . 28.3 t60 -66.85 144.36 56.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.478 0.656 . . . . 0.0 111.23 -175.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 93' ' ' ASP . . . . . 0.41 ' CB ' ' HB3' ' B' ' 5' ' ' MET . 7.8 p-10 -73.34 -154.27 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.504 -1.225 . . . . 0.0 111.056 177.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 31.2 pt -72.15 133.19 32.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.418 0.628 . . . . 0.0 111.424 -177.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 95' ' ' ASP . . . . . 0.483 ' CB ' ' HG3' ' A' ' 5' ' ' MET . 8.5 m-20 -81.13 64.13 5.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.966 176.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 27.9 m 63.28 -165.22 0.24 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.003 -175.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . 70.73 45.75 50.6 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.305 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 10.6 p . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.768 -0.634 . . . . 0.0 110.445 179.034 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 120.788 0.328 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -80.12 -48.02 13.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.033 0.444 . . . . 0.0 109.833 176.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . 135.25 -175.91 20.38 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.625 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.36 -48.09 10.76 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 5' ' ' MET . . . . . 0.468 ' HG3' ' CB ' ' D' ' 95' ' ' ASP . 22.8 mmt 58.56 -100.14 0.11 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.982 172.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 6' ' ' ALA . . . . . 0.562 ' O ' ' HB2' ' D' ' 70' ' ' SER . . . -86.15 131.06 34.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.621 0.248 . . . . 0.0 110.434 -177.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 38.4 mtt -124.19 143.95 50.21 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.104 0.478 . . . . 0.0 112.106 -175.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 8' ' ' PHE . . . . . 0.502 ' CE1' HD21 ' D' ' 44' ' ' LEU . 28.9 t80 -62.35 145.78 52.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.492 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -135.65 147.44 48.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.177 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 10' ' ' GLY . . . . . 0.447 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -151.04 153.8 25.19 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.203 178.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.624 HD23 HD13 ' C' ' 87' ' ' LEU . 33.4 tp -147.78 106.57 3.82 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 12' ' ' ASN . . . . . 0.483 ' HA ' ' HA ' ' C' ' 86' ' ' SER . 0.2 OUTLIER -97.91 110.67 23.2 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.681 0.753 . . . . 0.0 110.937 177.034 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 13' ' ' MET . . . . . 0.445 ' SD ' HG23 ' C' ' 79' ' ' THR . 7.2 mtt -85.25 142.17 29.59 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.019 -0.992 . . . . 0.0 111.324 -178.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 14' ' ' LYS . . . . . 0.431 ' HB2' ' HG3' ' C' ' 17' ' ' ARG . 91.4 mttt -89.67 144.17 31.45 Favored Pre-proline 0 C--N 1.315 -0.902 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 170.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -46.23 109.65 0.21 Allowed 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 123.503 2.802 . . . . 0.0 113.543 -174.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 16' ' ' GLU . . . . . 0.634 ' HA ' ' O ' ' C' ' 79' ' ' THR . 8.8 tt0 70.59 67.08 0.19 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.767 175.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 17' ' ' ARG . . . . . 0.527 ' NE ' ' HA ' ' C' ' 17' ' ' ARG . 4.7 mmp_? -122.76 169.22 11.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.133 175.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 18' ' ' LYS . . . . . 0.682 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 19.4 tttm -146.67 104.8 3.77 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.346 0.404 . . . . 0.0 111.305 -175.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -111.76 111.53 22.57 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.093 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 20' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 29.5 t -90.84 111.05 22.29 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 170.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -133.89 150.11 51.34 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.693 0.758 . . . . 0.0 112.645 -168.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 3.8 p -91.2 160.83 15.34 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.657 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 23' ' ' ILE . . . . . 0.445 HG22 ' HA ' ' C' ' 71' ' ' LYS . 74.1 mt -111.13 126.25 68.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.171 -174.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 24' ' ' ILE . . . . . 0.537 HD12 ' N ' ' C' ' 25' ' ' LYS . 1.8 pp -92.5 -24.38 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.69 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 25' ' ' LYS . . . . . 0.537 ' N ' HD12 ' C' ' 24' ' ' ILE . 24.8 mtpp -147.44 132.94 18.67 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.836 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 26' ' ' SER . . . . . 0.427 ' O ' ' HB3' ' C' ' 92' ' ' HIS . 15.6 m -54.98 119.42 5.39 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 27' ' ' PHE . . . . . 0.421 ' HB3' HD23 ' C' ' 91' ' ' LEU . 5.8 p90 -137.38 156.63 47.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.694 0.759 . . . . 0.0 112.788 -170.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 28' ' ' HIS . . . . . 0.591 ' HA ' ' O ' ' C' ' 67' ' ' LEU . 15.1 t60 -109.9 124.61 51.66 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.244 -1.343 . . . . 0.0 110.101 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 29' ' ' ILE . . . . . 0.573 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 39.4 mt -94.45 134.99 30.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 169.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.589 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 50.0 p -120.2 -15.88 8.6 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -169.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 31' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -160.34 145.17 10.8 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.382 -1.389 . . . . 0.0 113.38 178.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.449 HG23 ' HG ' ' C' ' 87' ' ' LEU . 12.1 p -129.8 121.63 52.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 168.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.18 154.38 43.82 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.979 -173.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.555 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.4 pp -125.11 144.02 50.63 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.468 0.651 . . . . 0.0 110.787 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -110.16 -46.01 3.51 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -103.64 128.65 50.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.551 171.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 37' ' ' GLY . . . . . 0.483 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 146.67 163.0 10.18 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 119.664 -1.255 . . . . 0.0 113.576 176.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -102.25 -47.22 4.58 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.463 0.173 . . . . 0.0 110.976 177.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -152.16 133.75 14.65 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.063 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.469 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -134.35 113.42 11.89 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.362 0.601 . . . . 0.0 110.097 168.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -97.77 112.57 24.42 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 174.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 43.7 tp -83.76 113.32 20.82 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.577 -174.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 43' ' ' TYR . . . . . 0.529 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 98.0 m-85 -115.8 141.53 47.98 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.553 ' HB2' ' CD1' ' C' ' 77' ' ' PHE . 0.1 OUTLIER -129.91 131.79 46.15 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 173.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 45' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -110.74 114.85 28.53 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.981 177.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.597 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -129.86 142.47 50.66 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 58.78 29.17 18.36 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.89 0.376 . . . . 0.0 110.284 -174.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt 63.55 24.57 14.07 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.681 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 49' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 24.0 tp60 -115.67 126.67 54.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -83.42 124.85 31.09 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.869 0.366 . . . . 0.0 110.758 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 51' ' ' TYR . . . . . 0.504 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 66.8 m-85 -120.91 133.35 55.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 176.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -82.14 107.7 14.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 169.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 53' ' ' VAL . . . . . 0.509 HG13 ' CD2' ' B' ' 88' ' ' LEU . 2.4 t -80.07 -49.58 18.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.643 -171.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 54' ' ' ALA . . . . . 0.525 ' HB1' HG11 ' C' ' 63' ' ' VAL . . . -159.99 148.98 17.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.232 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 54.1 m -109.81 102.19 10.99 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 173.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 56' ' ' VAL . . . . . 0.412 ' CG1' HG11 ' C' ' 85' ' ' VAL . 7.4 p -117.69 114.39 45.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.653 0.739 . . . . 0.0 110.032 -177.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 81.2 p -123.05 -178.33 3.93 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.581 -174.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -63.57 -21.4 66.33 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.887 0.375 . . . . 0.0 110.491 170.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 59' ' ' ALA . . . . . 0.402 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -83.52 -40.67 18.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.166 0.508 . . . . 0.0 110.228 177.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 80.6 mt -113.28 82.71 5.94 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 174.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 61' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 12.5 Cg_exo -70.06 -0.13 6.71 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.15 2.567 . . . . 0.0 114.052 -167.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.3 127.18 2.44 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.146 0.498 . . . . 0.0 111.418 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.525 HG11 ' HB1' ' C' ' 54' ' ' ALA . 86.4 t -117.34 106.14 19.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.35 174.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.45 121.7 27.08 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 173.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 65' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' C' ' 30' ' ' SER . 0.6 OUTLIER -140.71 168.2 20.36 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.736 -172.974 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 66' ' ' ASP . . . . . 0.538 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 11.6 t0 -118.88 105.18 11.24 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.322 0.582 . . . . 0.0 110.569 -177.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.591 ' O ' ' HA ' ' C' ' 28' ' ' HIS . 15.2 mt -118.7 144.48 46.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.651 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 68' ' ' ASN . . . . . 0.43 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 57.4 t30 -148.55 114.74 5.83 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 173.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -110.09 164.5 12.57 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.122 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 70' ' ' SER . . . . . 0.579 ' HB2' ' O ' ' B' ' 6' ' ' ALA . 33.1 t -107.85 149.2 28.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.371 . . . . 0.0 110.679 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 71' ' ' LYS . . . . . 0.445 ' HA ' HG22 ' C' ' 23' ' ' ILE . 0.0 OUTLIER -68.19 -11.85 59.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.279 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.41 -5.8 61.63 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.565 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -100.13 167.9 10.16 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -145.2 128.14 16.45 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.597 HG22 ' HB2' ' C' ' 46' ' ' ALA . 15.3 pt -134.87 165.51 30.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.992 0.425 . . . . 0.0 111.75 -169.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.515 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 4.5 mtm -120.85 123.47 42.65 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.612 173.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 77' ' ' PHE . . . . . 0.553 ' CD1' ' HB2' ' C' ' 44' ' ' LEU . 0.8 OUTLIER -105.95 127.59 53.25 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.488 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 78' ' ' TYR . . . . . 0.682 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 40.5 p90 -154.92 144.16 21.12 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.086 -0.645 . . . . 0.0 111.994 -177.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 79' ' ' THR . . . . . 0.634 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 6.6 p -116.19 141.54 48.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.351 -177.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.69 153.44 22.93 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.248 175.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.83 -175.47 36.95 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -175.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -118.73 104.83 10.96 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 122.191 0.996 . . . . 0.0 110.58 176.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 83' ' ' ALA . . . . . 0.483 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -166.1 154.82 11.16 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.188 170.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 19.9 t -106.29 111.29 23.82 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.555 HG12 ' HB3' ' C' ' 34' ' ' LEU . 3.4 m -111.48 138.16 41.11 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 CA-C-O 121.304 0.573 . . . . 0.0 112.137 -174.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 86' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' C' ' 12' ' ' ASN . 7.4 t -108.99 118.37 36.63 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.76 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 87' ' ' LEU . . . . . 0.624 HD13 HD23 ' C' ' 11' ' ' LEU . 5.4 mp -89.84 149.28 22.73 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.525 174.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 88' ' ' LEU . . . . . 0.592 HD23 HD21 ' D' ' 67' ' ' LEU . 1.3 tp -131.98 140.68 49.04 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.018 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.32 -167.12 25.42 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.683 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 90' ' ' TYR . . . . . 0.464 ' CD2' ' HB3' ' D' ' 68' ' ' ASN . 13.2 p90 -153.4 132.18 12.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.767 0.794 . . . . 0.0 111.656 177.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 91' ' ' LEU . . . . . 0.421 HD23 ' HB3' ' C' ' 27' ' ' PHE . 21.9 mt -64.52 127.02 29.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.195 173.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 92' ' ' HIS . . . . . 0.427 ' HB3' ' O ' ' C' ' 26' ' ' SER . 28.4 t60 -66.86 144.37 56.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.489 0.661 . . . . 0.0 111.231 -175.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 93' ' ' ASP . . . . . 0.408 ' CB ' ' HB3' ' C' ' 5' ' ' MET . 7.7 p-10 -73.37 -154.2 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.007 177.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 31.0 pt -72.28 133.15 32.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.431 0.634 . . . . 0.0 111.419 -177.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 95' ' ' ASP . . . . . 0.416 ' CB ' ' HG3' ' B' ' 5' ' ' MET . 8.7 m-20 -81.14 64.23 5.8 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.958 176.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 27.8 m 63.14 -165.25 0.24 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.943 -175.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 70.78 45.58 51.35 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.432 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 10.7 p . . . . . 0 C--O 1.252 1.222 0 CA-C-O 118.626 -0.702 . . . . 0.0 110.433 179.139 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 120.76 0.314 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -80.1 -48.06 13.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.13 0.491 . . . . 0.0 109.88 176.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . 135.28 -175.9 20.4 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.566 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.3 -48.09 10.8 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 5' ' ' MET . . . . . 0.487 ' HG3' ' CB ' ' E' ' 95' ' ' ASP . 22.6 mmt 58.5 -100.07 0.1 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.918 172.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 6' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' E' ' 70' ' ' SER . . . -86.21 131.06 34.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.652 0.263 . . . . 0.0 110.453 -177.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 38.3 mtt -124.2 144.11 50.13 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.233 0.539 . . . . 0.0 112.041 -175.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 8' ' ' PHE . . . . . 0.494 ' CE1' HD21 ' E' ' 44' ' ' LEU . 29.4 t80 -62.34 145.77 52.96 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.507 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 9' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -135.75 147.4 48.41 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.079 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 10' ' ' GLY . . . . . 0.46 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -151.03 153.87 25.23 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.179 178.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.614 HD23 HD13 ' D' ' 87' ' ' LEU . 33.6 tp -147.69 106.54 3.83 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.34 -0.245 . . . . 0.0 110.34 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 12' ' ' ASN . . . . . 0.482 ' HA ' ' HA ' ' D' ' 86' ' ' SER . 0.2 OUTLIER -97.9 110.56 23.11 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.63 0.729 . . . . 0.0 110.979 177.035 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 13' ' ' MET . . . . . 0.435 ' SD ' HG23 ' D' ' 79' ' ' THR . 7.3 mtt -85.15 142.17 29.67 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.422 -178.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 14' ' ' LYS . . . . . 0.447 ' HB2' ' HG3' ' D' ' 17' ' ' ARG . 91.5 mttt -89.74 144.18 31.37 Favored Pre-proline 0 C--N 1.316 -0.891 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 170.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -46.27 109.73 0.22 Allowed 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 123.414 2.743 . . . . 0.0 113.605 -174.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 16' ' ' GLU . . . . . 0.619 ' HA ' ' O ' ' D' ' 79' ' ' THR . 8.9 tt0 70.61 67.07 0.19 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.762 175.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 17' ' ' ARG . . . . . 0.52 ' NE ' ' HA ' ' D' ' 17' ' ' ARG . 4.7 mmp_? -122.76 169.2 11.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.091 175.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 18' ' ' LYS . . . . . 0.689 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 19.4 tttm -146.69 104.79 3.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 123.292 0.37 . . . . 0.0 111.355 -175.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -111.69 111.55 22.62 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.115 -177.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 20' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 29.3 t -90.87 110.94 22.17 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -133.84 150.2 51.39 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.676 0.751 . . . . 0.0 112.743 -168.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 3.7 p -91.31 160.94 15.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.643 178.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 23' ' ' ILE . . . . . 0.43 HG22 ' HA ' ' D' ' 71' ' ' LYS . 73.8 mt -111.19 126.29 68.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.241 -174.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 24' ' ' ILE . . . . . 0.536 HD12 ' N ' ' D' ' 25' ' ' LYS . 1.8 pp -92.5 -24.41 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.765 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 25' ' ' LYS . . . . . 0.536 ' N ' HD12 ' D' ' 24' ' ' ILE . 24.8 mtpp -147.43 132.86 18.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.8 178.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 26' ' ' SER . . . . . 0.421 ' O ' ' HB3' ' D' ' 92' ' ' HIS . 15.5 m -54.96 119.4 5.35 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 175.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 27' ' ' PHE . . . . . 0.42 ' HB3' HD23 ' D' ' 91' ' ' LEU . 5.9 p90 -137.38 156.74 47.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.789 0.804 . . . . 0.0 112.792 -170.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 28' ' ' HIS . . . . . 0.597 ' HE2' ' HB3' ' D' ' 30' ' ' SER . 15.2 t60 -109.98 124.7 51.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.221 -1.354 . . . . 0.0 110.07 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 29' ' ' ILE . . . . . 0.581 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 39.5 mt -94.55 135.05 29.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 169.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 30' ' ' SER . . . . . 0.597 ' HB3' ' HE2' ' D' ' 28' ' ' HIS . 50.1 p -120.25 -15.89 8.57 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -169.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 31' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -160.27 145.16 10.81 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 119.374 -1.393 . . . . 0.0 113.366 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.458 HG23 ' HG ' ' D' ' 87' ' ' LEU . 12.1 p -129.85 121.61 52.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 168.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.06 154.41 43.93 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.94 -173.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 34' ' ' LEU . . . . . 0.553 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.4 pp -125.15 144.05 50.63 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.475 0.655 . . . . 0.0 110.777 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -110.17 -46.08 3.49 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 173.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -103.63 128.64 50.9 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.562 171.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 37' ' ' GLY . . . . . 0.493 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 146.63 163.07 10.22 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 119.682 -1.247 . . . . 0.0 113.559 176.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -102.29 -47.22 4.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.59 0.233 . . . . 0.0 111.011 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -152.12 133.67 14.63 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.059 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 40' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -134.35 113.44 11.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.455 0.645 . . . . 0.0 110.177 167.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' D' ' 79' ' ' THR . 98.6 mttt -97.77 112.67 24.48 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 43.5 tp -83.74 113.34 20.82 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.607 -174.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 43' ' ' TYR . . . . . 0.523 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 98.0 m-85 -115.77 141.48 48.03 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.554 ' HB2' ' CD1' ' D' ' 77' ' ' PHE . 0.1 OUTLIER -129.96 131.83 46.09 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 173.874 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 45' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -110.65 115.0 28.83 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.888 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.61 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -129.91 142.57 50.64 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 58.7 29.19 18.27 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.315 0.384 . . . . 0.0 110.28 -174.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt 63.61 24.48 13.98 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.711 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 49' ' ' GLN . . . . . 0.463 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 24.1 tp60 -115.73 126.64 54.33 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -83.39 124.85 31.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.807 0.336 . . . . 0.0 110.755 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 51' ' ' TYR . . . . . 0.447 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 66.7 m-85 -120.89 133.35 55.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.904 176.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.0 tp -82.06 107.72 14.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 169.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 53' ' ' VAL . . . . . 0.499 HG13 ' CD2' ' C' ' 88' ' ' LEU . 2.4 t -80.09 -49.6 18.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.589 -171.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 54' ' ' ALA . . . . . 0.521 ' HB1' HG11 ' D' ' 63' ' ' VAL . . . -160.01 148.93 17.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.173 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 53.3 m -109.81 102.28 11.08 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 56' ' ' VAL . . . . . 0.406 ' CG1' HG11 ' D' ' 85' ' ' VAL . 7.4 p -117.74 114.33 45.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.612 0.72 . . . . 0.0 109.981 -177.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 81.2 p -123.05 -178.27 3.91 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.523 -174.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -63.57 -21.46 66.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.944 0.402 . . . . 0.0 110.461 170.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 59' ' ' ALA . . . . . 0.405 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -83.51 -40.62 18.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.124 0.488 . . . . 0.0 110.222 177.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 80.3 mt -113.29 82.6 5.88 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 174.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 61' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 12.4 Cg_exo -69.99 -0.18 6.73 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.186 2.591 . . . . 0.0 114.114 -167.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.25 127.1 2.45 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.112 0.482 . . . . 0.0 111.483 -176.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.521 HG11 ' HB1' ' D' ' 54' ' ' ALA . 87.2 t -117.3 106.09 19.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.426 174.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.48 121.73 27.13 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 173.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 65' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' D' ' 30' ' ' SER . 0.6 OUTLIER -140.72 168.2 20.35 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.728 -173.034 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 66' ' ' ASP . . . . . 0.576 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 11.9 t0 -118.82 105.23 11.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.251 0.548 . . . . 0.0 110.586 -177.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.592 HD21 HD23 ' C' ' 88' ' ' LEU . 15.1 mt -118.8 144.43 46.32 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.674 177.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 68' ' ' ASN . . . . . 0.464 ' HB3' ' CD2' ' C' ' 90' ' ' TYR . 57.3 t30 -148.47 114.83 5.89 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 173.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 69' ' ' PHE . . . . . 0.4 ' CZ ' HD22 ' D' ' 67' ' ' LEU . 51.8 m-85 -110.15 164.58 12.5 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.106 -178.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 70' ' ' SER . . . . . 0.562 ' HB2' ' O ' ' C' ' 6' ' ' ALA . 33.0 t -107.97 149.12 28.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.856 0.36 . . . . 0.0 110.723 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 71' ' ' LYS . . . . . 0.43 ' HA ' HG22 ' D' ' 23' ' ' ILE . 0.0 OUTLIER -67.94 -12.03 59.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.344 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.35 -5.73 61.77 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.526 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -100.2 167.92 10.13 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -145.21 128.16 16.46 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.61 HG22 ' HB2' ' D' ' 46' ' ' ALA . 15.4 pt -134.92 165.39 31.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.077 0.465 . . . . 0.0 111.771 -169.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 76' ' ' MET . . . . . 0.521 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 4.5 mtm -120.85 123.5 42.72 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 173.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 77' ' ' PHE . . . . . 0.554 ' CD1' ' HB2' ' D' ' 44' ' ' LEU . 0.8 OUTLIER -106.02 127.59 53.27 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.502 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 78' ' ' TYR . . . . . 0.689 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 40.8 p90 -154.93 144.16 21.11 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.967 -177.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 79' ' ' THR . . . . . 0.619 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 6.5 p -116.22 141.61 47.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.364 -177.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.69 153.31 23.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.289 176.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.92 -175.36 36.7 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -175.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -118.81 104.97 11.05 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 118.114 0.957 . . . . 0.0 110.46 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 83' ' ' ALA . . . . . 0.493 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -166.15 154.77 11.02 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.204 170.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 19.9 t -106.25 111.23 23.74 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.553 HG12 ' HB3' ' D' ' 34' ' ' LEU . 3.4 m -111.43 138.11 41.24 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.706 0 CA-C-O 121.289 0.566 . . . . 0.0 112.144 -174.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 86' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' D' ' 12' ' ' ASN . 7.4 t -108.9 118.31 36.47 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.353 -0.84 . . . . 0.0 108.791 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 87' ' ' LEU . . . . . 0.614 HD13 HD23 ' D' ' 11' ' ' LEU . 5.4 mp -89.76 149.31 22.78 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.524 174.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.572 HD23 HD21 ' E' ' 67' ' ' LEU . 1.3 tp -132.05 140.68 48.97 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.956 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.32 -167.08 25.36 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.683 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 90' ' ' TYR . . . . . 0.442 ' CD2' ' HB3' ' E' ' 68' ' ' ASN . 13.0 p90 -153.42 132.13 12.31 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.74 0.781 . . . . 0.0 111.636 177.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 91' ' ' LEU . . . . . 0.42 HD23 ' HB3' ' D' ' 27' ' ' PHE . 22.4 mt -64.58 127.03 29.78 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.088 173.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 92' ' ' HIS . . . . . 0.421 ' HB3' ' O ' ' D' ' 26' ' ' SER . 28.3 t60 -66.88 144.38 56.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.366 0.603 . . . . 0.0 111.289 -175.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 93' ' ' ASP . . . . . 0.416 ' CB ' ' HB3' ' D' ' 5' ' ' MET . 7.7 p-10 -73.35 -154.27 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.966 177.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 31.1 pt -72.21 133.15 32.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.441 0.639 . . . . 0.0 111.5 -177.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 95' ' ' ASP . . . . . 0.468 ' CB ' ' HG3' ' C' ' 5' ' ' MET . 8.6 m-20 -81.11 64.2 5.76 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.947 176.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 28.1 m 63.24 -165.36 0.24 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.955 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . 70.87 45.67 50.25 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.311 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 10.4 p . . . . . 0 C--O 1.251 1.181 0 CA-C-O 118.556 -0.735 . . . . 0.0 110.333 179.144 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 . . . . . 0 N--CA 1.48 1.072 0 CA-C-O 120.7 0.286 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -80.13 -48.04 13.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.131 0.491 . . . . 0.0 109.875 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . 135.26 -176.01 20.32 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.589 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.23 -48.08 10.87 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 5' ' ' MET . . . . . 0.445 ' HG3' ' CB ' ' A' ' 95' ' ' ASP . 22.7 mmt 58.47 -99.98 0.1 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.956 172.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 6' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' A' ' 70' ' ' SER . . . -86.31 131.07 34.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.796 0.331 . . . . 0.0 110.373 -177.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 38.6 mtt -124.14 144.14 50.08 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.214 0.53 . . . . 0.0 112.096 -176.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 8' ' ' PHE . . . . . 0.493 ' CE1' HD21 ' A' ' 44' ' ' LEU . 29.0 t80 -62.4 145.77 53.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.492 -178.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 9' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -135.72 147.38 48.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.096 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 10' ' ' GLY . . . . . 0.465 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -151.0 153.81 25.2 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.273 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 11' ' ' LEU . . . . . 0.617 HD23 HD13 ' E' ' 87' ' ' LEU . 33.2 tp -147.77 106.6 3.83 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 12' ' ' ASN . . . . . 0.487 ' HA ' ' HA ' ' E' ' 86' ' ' SER . 0.2 OUTLIER -97.82 110.6 23.14 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.605 0.717 . . . . 0.0 110.987 176.98 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 13' ' ' MET . . . . . 0.438 ' SD ' HG23 ' E' ' 79' ' ' THR . 7.2 mtt -85.26 142.15 29.6 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.31 -178.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 14' ' ' LYS . . . . . 0.424 ' HB2' ' HG3' ' E' ' 17' ' ' ARG . 91.5 mttt -89.71 144.21 31.47 Favored Pre-proline 0 C--N 1.315 -0.919 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 170.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -46.29 109.66 0.22 Allowed 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 123.519 2.813 . . . . 0.0 113.613 -174.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 16' ' ' GLU . . . . . 0.632 ' HA ' ' O ' ' E' ' 79' ' ' THR . 8.8 tt0 70.56 67.1 0.19 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.762 175.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 17' ' ' ARG . . . . . 0.529 ' NE ' ' HA ' ' E' ' 17' ' ' ARG . 4.7 mmp_? -122.79 169.2 11.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.013 175.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 18' ' ' LYS . . . . . 0.673 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 19.4 tttm -146.68 104.89 3.78 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.36 0.413 . . . . 0.0 111.303 -175.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -111.81 111.55 22.6 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.071 -177.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 20' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' E' ' 76' ' ' MET . 28.9 t -90.82 111.0 22.21 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -133.84 150.1 51.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.661 0.743 . . . . 0.0 112.721 -168.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 3.9 p -91.18 160.9 15.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.649 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 23' ' ' ILE . . . . . 0.443 HG22 ' HA ' ' E' ' 71' ' ' LYS . 73.9 mt -111.14 126.26 68.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.176 -174.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 24' ' ' ILE . . . . . 0.523 HD12 ' N ' ' E' ' 25' ' ' LYS . 1.8 pp -92.55 -24.3 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.723 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 25' ' ' LYS . . . . . 0.523 ' N ' HD12 ' E' ' 24' ' ' ILE . 24.8 mtpp -147.56 132.96 18.57 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 26' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' E' ' 92' ' ' HIS . 15.5 m -54.9 119.4 5.33 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 27' ' ' PHE . . . . . 0.428 ' HB3' HD23 ' E' ' 91' ' ' LEU . 5.8 p90 -137.4 156.67 47.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.725 0.774 . . . . 0.0 112.792 -170.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 28' ' ' HIS . . . . . 0.585 ' HE2' ' HB3' ' E' ' 30' ' ' SER . 15.1 t60 -109.94 124.59 51.65 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.108 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 29' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 39.3 mt -94.43 135.06 29.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 169.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 30' ' ' SER . . . . . 0.585 ' HB3' ' HE2' ' E' ' 28' ' ' HIS . 50.2 p -120.26 -15.87 8.57 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -169.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 31' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -160.32 145.21 10.86 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.314 -1.422 . . . . 0.0 113.361 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.454 HG23 ' HG ' ' E' ' 87' ' ' LEU . 12.0 p -129.92 121.65 52.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 168.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.1 154.37 43.86 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.955 -173.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 34' ' ' LEU . . . . . 0.554 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.4 pp -125.13 144.0 50.64 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.5 0.667 . . . . 0.0 110.836 177.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -110.24 -45.96 3.5 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 173.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -103.67 128.57 50.99 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.56 171.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 37' ' ' GLY . . . . . 0.496 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 146.7 163.0 10.19 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 119.641 -1.266 . . . . 0.0 113.57 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -102.25 -47.15 4.6 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.164 -0.214 . . . . 0.0 111.001 177.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -152.1 133.72 14.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.739 -0.21 . . . . 0.0 111.056 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 40' ' ' ALA . . . . . 0.48 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -134.37 113.45 11.91 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.364 0.602 . . . . 0.0 110.167 167.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 41' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' E' ' 79' ' ' THR . 98.6 mttt -97.86 112.66 24.49 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 174.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 43.1 tp -83.72 113.3 20.79 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.59 -174.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 43' ' ' TYR . . . . . 0.525 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 98.0 m-85 -115.77 141.47 48.05 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 44' ' ' LEU . . . . . 0.552 ' HB2' ' CD1' ' E' ' 77' ' ' PHE . 0.1 OUTLIER -129.95 131.89 46.13 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 173.938 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 45' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -110.78 114.95 28.7 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.994 177.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 46' ' ' ALA . . . . . 0.601 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -129.86 142.49 50.66 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 58.79 29.19 18.4 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.372 0.42 . . . . 0.0 110.224 -174.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt 63.56 24.61 14.08 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.709 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 49' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 24.1 tp60 -115.67 126.69 54.46 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -83.4 124.83 31.06 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.86 0.362 . . . . 0.0 110.724 -177.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 51' ' ' TYR . . . . . 0.46 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 66.2 m-85 -120.84 133.35 55.31 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.0 tp -82.12 107.65 14.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 169.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 53' ' ' VAL . . . . . 0.493 HG13 ' CD2' ' D' ' 88' ' ' LEU . 2.4 t -80.01 -49.58 18.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.663 -171.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 54' ' ' ALA . . . . . 0.538 ' HB1' HG11 ' E' ' 63' ' ' VAL . . . -160.01 148.96 17.44 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.099 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 54.4 m -109.86 102.24 11.03 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 173.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 56' ' ' VAL . . . . . 0.411 ' CG1' HG11 ' E' ' 85' ' ' VAL . 7.4 p -117.76 114.27 44.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.625 0.726 . . . . 0.0 110.004 -177.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 81.1 p -123.06 -178.3 3.92 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.551 -174.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -63.58 -21.4 66.33 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.838 0.352 . . . . 0.0 110.414 170.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 59' ' ' ALA . . . . . 0.403 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -83.55 -40.53 19.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.198 0.523 . . . . 0.0 110.245 177.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 80.6 mt -113.4 82.7 6.12 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 174.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 61' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 12.6 Cg_exo -70.16 -0.17 6.85 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.106 2.537 . . . . 0.0 114.013 -167.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.15 127.15 2.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.163 0.506 . . . . 0.0 111.477 -176.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 63' ' ' VAL . . . . . 0.538 HG11 ' HB1' ' E' ' 54' ' ' ALA . 86.4 t -117.38 106.11 19.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.405 174.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.51 121.76 27.19 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 173.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' E' ' 30' ' ' SER . 0.6 OUTLIER -140.7 168.18 20.4 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.711 -173.044 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 66' ' ' ASP . . . . . 0.543 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 11.7 t0 -118.83 105.18 11.26 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.267 0.556 . . . . 0.0 110.532 -177.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 67' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' E' ' 28' ' ' HIS . 15.2 mt -118.74 144.51 46.21 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.65 177.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 68' ' ' ASN . . . . . 0.442 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 57.3 t30 -148.53 114.73 5.84 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 173.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 69' ' ' PHE . . . . . 0.401 ' CZ ' HD22 ' E' ' 67' ' ' LEU . 51.4 m-85 -110.06 164.53 12.53 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.187 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 70' ' ' SER . . . . . 0.535 ' HB2' ' O ' ' D' ' 6' ' ' ALA . 33.0 t -107.91 149.17 28.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.836 0.351 . . . . 0.0 110.687 -177.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 71' ' ' LYS . . . . . 0.443 ' HA ' HG22 ' E' ' 23' ' ' ILE . 0.0 OUTLIER -68.06 -11.91 59.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.345 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.38 -5.81 61.68 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.583 175.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -100.02 167.91 10.18 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -145.19 128.11 16.44 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 75' ' ' ILE . . . . . 0.601 HG22 ' HB2' ' E' ' 46' ' ' ALA . 15.3 pt -134.93 165.51 30.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.094 0.473 . . . . 0.0 111.763 -169.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 76' ' ' MET . . . . . 0.514 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 4.5 mtm -120.92 123.5 42.63 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 173.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 77' ' ' PHE . . . . . 0.552 ' CD1' ' HB2' ' E' ' 44' ' ' LEU . 0.7 OUTLIER -106.03 127.6 53.28 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.51 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 78' ' ' TYR . . . . . 0.673 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 40.7 p90 -154.93 144.13 21.09 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.958 -177.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 79' ' ' THR . . . . . 0.632 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 6.5 p -116.18 141.54 48.01 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.396 -177.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.59 153.4 22.94 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.319 176.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.93 -175.41 36.73 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -175.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -118.76 104.84 10.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 118.12 0.96 . . . . 0.0 110.527 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 83' ' ' ALA . . . . . 0.496 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -166.1 154.83 11.17 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.182 170.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 19.5 t -106.21 111.23 23.74 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 85' ' ' VAL . . . . . 0.554 HG12 ' HB3' ' E' ' 34' ' ' LEU . 3.4 m -111.48 138.23 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 CA-C-O 121.348 0.594 . . . . 0.0 112.095 -174.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 86' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' E' ' 12' ' ' ASN . 7.4 t -108.95 118.19 36.16 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.8 178.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 87' ' ' LEU . . . . . 0.617 HD13 HD23 ' E' ' 11' ' ' LEU . 5.4 mp -89.8 149.22 22.79 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.566 174.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 88' ' ' LEU . . . . . 0.591 HD23 HD21 ' A' ' 67' ' ' LEU . 1.3 tp -131.91 140.71 49.13 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.022 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.34 -167.14 25.47 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.776 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 90' ' ' TYR . . . . . 0.447 ' CD2' ' HB3' ' A' ' 68' ' ' ASN . 12.9 p90 -153.36 132.27 12.46 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.712 0.768 . . . . 0.0 111.604 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 91' ' ' LEU . . . . . 0.428 HD23 ' HB3' ' E' ' 27' ' ' PHE . 22.0 mt -64.6 126.97 29.57 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.177 173.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 92' ' ' HIS . . . . . 0.411 ' HB3' ' O ' ' E' ' 26' ' ' SER . 28.0 t60 -66.83 144.43 56.29 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.479 0.656 . . . . 0.0 111.242 -175.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 93' ' ' ASP . . . . . 0.416 ' CB ' ' HB3' ' E' ' 5' ' ' MET . 7.6 p-10 -73.46 -154.22 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.997 177.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 30.9 pt -72.2 133.06 32.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.377 0.608 . . . . 0.0 111.484 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 95' ' ' ASP . . . . . 0.487 ' CB ' ' HG3' ' D' ' 5' ' ' MET . 8.4 m-20 -81.03 64.27 5.72 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.028 176.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 28.4 m 63.17 -165.24 0.24 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.964 -175.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . 70.85 45.62 50.67 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.318 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 10.6 p . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.703 -0.665 . . . . 0.0 110.383 179.092 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 120.905 0.383 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -145.39 175.57 10.22 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.609 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.13 155.9 53.25 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.489 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.58 156.13 24.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.993 0.425 . . . . 0.0 111.332 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.404 ' HB3' ' CD2' ' B' ' 92' ' ' HIS . 22.1 ptm -136.75 148.58 47.34 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.51 -178.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -111.43 147.69 34.7 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.159 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.559 ' HA ' ' OG ' ' B' ' 70' ' ' SER . 16.5 ttt -93.44 168.87 10.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.275 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.568 ' CE1' HD12 ' A' ' 88' ' ' LEU . 54.1 t80 -79.66 129.7 34.71 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.062 0.458 . . . . 0.0 112.102 -177.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.537 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 87.8 t90 -113.82 148.49 36.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.596 174.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.19 145.55 13.96 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.258 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.644 HD23 HD13 ' A' ' 87' ' ' LEU . 58.5 tp -139.09 110.25 6.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.027 0.441 . . . . 0.0 110.93 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -86.04 116.41 24.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.958 176.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.634 ' HB2' HG23 ' A' ' 85' ' ' VAL . 4.1 mmt -98.52 130.81 45.1 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.455 ' HD2' ' HD2' ' A' ' 15' ' ' PRO . 48.2 tptt -100.55 132.06 22.89 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 174.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.543 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 2.0 Cg_endo -46.25 117.68 2.07 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.539 2.826 . . . . 0.0 113.476 -175.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.662 ' HA ' ' O ' ' A' ' 79' ' ' THR . 37.8 mt-10 64.14 56.24 1.4 Allowed 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.411 178.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.86 135.31 52.78 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.63 172.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.738 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 82.8 mttt -103.73 115.71 30.98 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 123.313 0.383 . . . . 0.0 111.272 177.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -105.52 102.9 12.33 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 p -89.36 98.93 12.04 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 173.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -111.83 146.39 37.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.229 -167.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.8 m -100.45 143.06 31.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.282 174.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.476 ' CD1' ' HB2' ' A' ' 69' ' ' PHE . 54.0 mt -108.52 125.84 65.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.202 0.525 . . . . 0.0 111.772 -172.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.454 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.2 mp -102.22 -50.6 9.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.395 -0.821 . . . . 0.0 108.852 176.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.528 ' HD2' HD22 ' A' ' 91' ' ' LEU . 12.7 pttp -103.21 122.41 44.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.552 174.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.6 t -60.94 142.71 56.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.964 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.488 ' HB3' HD23 ' A' ' 91' ' ' LEU . 54.6 p90 -147.8 148.27 30.74 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -177.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.538 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 2.1 t60 -102.65 125.18 49.29 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 114.147 -1.388 . . . . 0.0 109.601 176.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 47.0 mt -87.34 131.24 35.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 172.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.538 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 95.3 p -116.59 -12.25 10.97 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -169.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . 179.99 158.72 22.51 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 119.166 -1.492 . . . . 0.0 113.702 177.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.462 HG23 ' HG ' ' A' ' 87' ' ' LEU . 11.0 p -141.29 138.97 33.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 175.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -152.95 156.17 38.38 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 121.97 -0.457 . . . . 0.0 111.886 -177.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.702 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.1 pp -125.31 148.04 48.88 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.501 0.667 . . . . 0.0 111.911 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -110.64 -55.15 2.51 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.133 169.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -100.84 127.91 47.1 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.211 174.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.495 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 150.48 162.98 10.93 Favored Glycine 0 N--CA 1.434 -1.495 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.533 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.407 ' HA ' ' HD2' ' A' ' 58' ' ' LYS . 69.7 mt-30 -102.56 -47.04 4.57 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.713 0.292 . . . . 0.0 111.018 176.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -152.48 132.51 13.42 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.344 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.527 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -127.28 113.28 16.08 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.436 0.636 . . . . 0.0 110.061 168.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 79' ' ' THR . 97.5 mttt -95.34 112.02 23.8 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.443 HD21 HD21 ' A' ' 87' ' ' LEU . 34.5 tp -86.12 107.48 17.87 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -174.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -107.4 146.11 32.08 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.741 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.652 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 1.5 tp -129.98 116.32 18.42 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.665 176.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.55 109.28 21.12 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.436 ' HB2' HD11 ' A' ' 44' ' ' LEU . . . -143.14 150.05 38.91 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.423 -177.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 57.35 30.99 19.44 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.35 0.595 . . . . 0.0 109.98 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 61.2 40.49 14.6 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.204 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -144.16 136.59 26.73 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -87.35 117.72 26.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.936 0.398 . . . . 0.0 110.042 178.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -112.76 122.97 49.23 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.673 178.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -80.82 100.9 5.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 170.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.48 HG12 ' CD2' ' E' ' 88' ' ' LEU . 21.6 m -86.45 -33.19 7.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.749 -172.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.729 ' HB2' HD21 ' A' ' 65' ' ' LEU . . . -153.19 144.59 23.23 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 120.28 -0.568 . . . . 0.0 112.214 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.2 m -115.51 102.47 9.83 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 169.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.428 HG13 ' HB3' ' A' ' 40' ' ' ALA . 8.9 p -116.18 114.21 45.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.744 0.783 . . . . 0.0 110.15 -177.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 69.1 p -123.18 -177.12 3.6 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.963 -175.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 38' ' ' GLN . 27.3 mtpp -59.37 -35.89 74.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.035 0.445 . . . . 0.0 109.971 169.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.419 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -71.23 -40.59 71.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.498 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.2 mt -114.31 82.33 7.34 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 17.3 Cg_exo -67.31 -6.65 16.83 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.208 2.605 . . . . 0.0 113.891 -168.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -161.49 132.09 5.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.262 0.554 . . . . 0.0 111.164 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 87.5 t -119.74 118.6 57.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.543 176.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.76 128.15 33.32 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.729 HD21 ' HB2' ' A' ' 54' ' ' ALA . 86.2 mt -120.21 163.82 17.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.457 0.646 . . . . 0.0 112.25 -172.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -140.86 97.4 3.18 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.548 169.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 2.8 mt -131.19 156.34 45.49 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.528 ' HB2' ' CZ ' ' E' ' 90' ' ' TYR . 42.7 t-20 -155.32 128.79 8.41 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.476 ' HB2' ' CD1' ' A' ' 23' ' ' ILE . 4.3 m-85 -124.03 145.05 49.47 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.522 ' OG ' ' HA ' ' E' ' 7' ' ' MET . 37.2 m -100.4 -178.53 3.84 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -175.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -62.34 -30.95 71.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.222 0.534 . . . . 0.0 110.345 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.82 4.44 85.03 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.661 -0.7 . . . . 0.0 113.074 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -99.94 119.59 38.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 117.171 0.485 . . . . 0.0 110.791 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -111.96 106.29 14.94 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 173.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.409 HG22 ' CB ' ' A' ' 46' ' ' ALA . 10.9 pt -120.91 168.07 13.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.163 -167.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.9 mtm -122.27 125.98 47.17 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 171.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.652 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -107.9 127.72 53.99 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 175.003 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.738 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 53.4 p90 -155.68 140.43 17.08 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 119.845 -0.742 . . . . 0.0 112.193 -175.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.662 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 12.0 p -106.09 138.85 41.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.958 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.4 ' HB3' ' HB2' ' A' ' 41' ' ' LYS . . . -107.09 153.23 22.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.413 174.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.4 ' O ' ' HG3' ' A' ' 16' ' ' GLU . . . 93.45 -173.52 34.13 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -177.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -113.54 103.83 11.65 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.846 177.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.543 ' H ' ' HB3' ' A' ' 15' ' ' PRO . . . -170.87 153.65 4.0 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.89 169.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.7 p -110.23 123.23 49.4 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.15 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.702 HG12 ' HB3' ' A' ' 34' ' ' LEU . 10.9 m -124.74 153.35 31.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-O 121.459 0.647 . . . . 0.0 112.375 -173.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.5 m -113.26 126.78 55.78 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.854 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.644 HD13 HD23 ' A' ' 11' ' ' LEU . 4.6 mp -101.91 147.47 26.49 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 169.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.568 HD12 ' CE1' ' A' ' 8' ' ' PHE . 2.3 mm? -125.22 154.3 41.81 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 173.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.67 -168.81 25.15 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 119.755 -1.212 . . . . 0.0 114.193 -178.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.536 ' CZ ' ' HB2' ' B' ' 68' ' ' ASN . 3.2 m-85 -117.56 118.92 33.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.344 -0.928 . . . . 0.0 110.392 -176.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.528 HD22 ' HD2' ' A' ' 25' ' ' LYS . 16.5 mt -82.79 117.67 22.85 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.12 0.486 . . . . 0.0 110.337 172.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -93.72 173.72 7.54 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 175.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 74.25 4.81 4.59 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 122.911 0.484 . . . . 0.0 110.85 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 5.4 tp -69.91 126.19 29.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.568 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -77.12 79.97 3.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.308 0.575 . . . . 0.0 109.886 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.1 t -154.24 135.67 14.19 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.0 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -173.58 36.74 0.13 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.68 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.692 -0.67 . . . . 0.0 109.317 -178.779 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 120.954 0.407 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -145.38 175.6 10.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.594 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.22 155.82 53.2 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.444 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.47 156.11 23.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.154 0.502 . . . . 0.0 111.278 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 22.0 ptm -136.79 148.61 47.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.468 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -111.44 147.69 34.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.232 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' MET . . . . . 0.578 ' HA ' ' OG ' ' C' ' 70' ' ' SER . 16.6 ttt -93.43 168.79 10.83 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.295 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.572 ' CZ ' HD21 ' C' ' 44' ' ' LEU . 54.4 t80 -79.51 129.72 34.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.034 0.445 . . . . 0.0 112.117 -177.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 9' ' ' TRP . . . . . 0.531 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 88.0 t90 -113.94 148.49 36.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.48 174.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.16 145.69 14.25 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.246 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.629 HD23 HD13 ' B' ' 87' ' ' LEU . 58.3 tp -139.16 110.12 6.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.941 0.4 . . . . 0.0 110.968 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -86.05 116.39 24.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.941 176.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 13' ' ' MET . . . . . 0.62 ' HB2' HG23 ' B' ' 85' ' ' VAL . 4.1 mmt -98.43 130.78 45.05 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -176.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.465 ' HD2' ' HD2' ' B' ' 15' ' ' PRO . 48.2 tptt -100.59 132.09 22.82 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 174.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.546 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 2.1 Cg_endo -46.24 117.82 2.14 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.441 2.761 . . . . 0.0 113.533 -175.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.666 ' HA ' ' O ' ' B' ' 79' ' ' THR . 37.9 mt-10 63.98 56.19 1.47 Allowed 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.492 178.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.75 135.29 52.86 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.644 172.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.734 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 82.8 mttt -103.76 115.72 30.99 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 123.366 0.416 . . . . 0.0 111.236 177.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -105.49 102.82 12.26 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 14.7 p -89.3 98.84 11.99 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 173.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -111.78 146.39 37.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.389 0.614 . . . . 0.0 112.28 -167.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 28.9 m -100.43 143.1 31.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.249 174.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.468 ' CD1' ' HB2' ' B' ' 69' ' ' PHE . 54.2 mt -108.55 125.92 65.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.278 0.561 . . . . 0.0 111.748 -172.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.461 ' N ' HD12 ' B' ' 24' ' ' ILE . 4.2 mp -102.29 -50.56 9.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.825 176.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.531 ' HD2' HD22 ' B' ' 91' ' ' LEU . 12.8 pttp -103.13 122.31 44.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.63 174.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 35.6 t -60.97 142.73 56.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.95 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' PHE . . . . . 0.481 ' HB3' HD23 ' B' ' 91' ' ' LEU . 54.6 p90 -147.83 148.24 30.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.963 0.887 . . . . 0.0 113.296 -177.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 28' ' ' HIS . . . . . 0.537 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 2.1 t60 -102.55 125.15 49.17 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.692 176.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.5 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 46.8 mt -87.29 131.28 35.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 172.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.537 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 94.9 p -116.63 -12.33 10.92 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -169.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . 180.0 158.68 22.46 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 119.235 -1.46 . . . . 0.0 113.787 177.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.466 HG23 ' HG ' ' B' ' 87' ' ' LEU . 11.0 p -141.32 138.95 33.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 175.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -152.95 156.18 38.39 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.983 -0.448 . . . . 0.0 111.891 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.718 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.1 pp -125.31 148.03 48.88 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.52 0.676 . . . . 0.0 111.949 178.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -110.55 -55.3 2.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.129 169.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -100.79 128.06 46.98 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.26 174.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.492 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 150.42 163.02 10.95 Favored Glycine 0 N--CA 1.435 -1.423 0 C-N-CA 120.371 -0.918 . . . . 0.0 112.424 177.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -102.67 -46.94 4.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.647 0.26 . . . . 0.0 111.003 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -152.52 132.55 13.41 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.344 177.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.534 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -127.27 113.25 16.06 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.362 0.601 . . . . 0.0 110.166 167.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' B' ' 79' ' ' THR . 97.5 mttt -95.41 112.04 23.82 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.45 HD21 HD21 ' B' ' 87' ' ' LEU . 34.6 tp -86.15 107.47 17.88 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.711 -174.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -107.45 146.12 32.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.697 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.645 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 1.5 tp -129.94 116.39 18.55 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.69 176.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.57 109.24 21.07 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.203 0.525 . . . . 0.0 109.654 176.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.436 ' HB2' HD11 ' B' ' 44' ' ' LEU . . . -143.03 150.03 39.04 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.449 -177.096 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 57.41 30.88 19.31 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.44 0.638 . . . . 0.0 110.091 -179.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 61.18 40.55 14.59 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.213 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -144.19 136.74 26.83 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -87.43 117.67 26.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.867 0.365 . . . . 0.0 110.038 178.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -112.73 122.98 49.25 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.698 178.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -80.82 100.91 5.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 170.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.485 HG12 ' CD2' ' A' ' 88' ' ' LEU . 21.5 m -86.52 -33.13 6.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.748 -172.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.745 ' HB2' HD21 ' B' ' 65' ' ' LEU . . . -153.12 144.54 23.27 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 120.284 -0.566 . . . . 0.0 112.208 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 27.2 m -115.55 102.4 9.75 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 169.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.435 HG13 ' HB3' ' B' ' 40' ' ' ALA . 9.0 p -116.03 114.18 45.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.771 0.796 . . . . 0.0 110.149 -177.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 69.5 p -123.21 -177.19 3.62 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.905 -175.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -59.34 -35.87 74.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.06 0.457 . . . . 0.0 110.064 169.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.414 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -71.15 -40.6 71.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.538 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 79.0 mt -114.32 82.27 7.3 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 17.2 Cg_exo -67.22 -6.77 17.02 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.329 2.686 . . . . 0.0 113.795 -168.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -161.44 132.12 5.15 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.409 0.623 . . . . 0.0 111.188 -175.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 87.8 t -119.77 118.75 58.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.532 176.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.86 128.15 33.34 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.745 HD21 ' HB2' ' B' ' 54' ' ' ALA . 86.0 mt -120.22 163.79 17.23 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.426 0.632 . . . . 0.0 112.297 -172.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -140.83 97.38 3.18 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.254 -0.884 . . . . 0.0 108.628 169.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' B' ' 28' ' ' HIS . 2.7 mt -131.19 156.3 45.57 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 68' ' ' ASN . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 42.7 t-20 -155.32 128.68 8.36 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 174.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 69' ' ' PHE . . . . . 0.468 ' HB2' ' CD1' ' B' ' 23' ' ' ILE . 4.2 m-85 -123.88 145.05 49.38 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.559 ' OG ' ' HA ' ' A' ' 7' ' ' MET . 37.6 m -100.41 -178.54 3.84 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -175.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -62.31 -30.98 71.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.301 0.572 . . . . 0.0 110.31 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.91 4.53 85.08 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.696 -0.683 . . . . 0.0 113.022 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -100.06 119.56 38.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.058 0.456 . . . . 0.0 110.79 178.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -111.91 106.33 15.01 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 173.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.404 HG22 ' CB ' ' B' ' 46' ' ' ALA . 10.8 pt -121.02 168.0 13.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.193 -167.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 76' ' ' MET . . . . . . . . . . . . . 3.8 mtm -122.21 125.92 47.12 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 171.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 77' ' ' PHE . . . . . 0.645 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.3 OUTLIER -107.94 127.8 54.07 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 175.006 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.734 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 53.8 p90 -155.75 140.32 16.91 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 119.858 -0.737 . . . . 0.0 112.191 -175.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.666 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 12.1 p -105.98 138.8 41.54 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.975 -179.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.16 153.17 23.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.429 174.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.6 -173.5 33.89 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -113.53 103.88 11.71 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.832 177.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.546 ' H ' ' HB3' ' B' ' 15' ' ' PRO . . . -170.9 153.64 3.96 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.845 169.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 5.4 p -110.22 123.17 49.29 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.207 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.718 HG12 ' HB3' ' B' ' 34' ' ' LEU . 10.9 m -124.74 153.25 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-O 121.473 0.654 . . . . 0.0 112.364 -173.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 28.6 m -113.2 126.81 55.83 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.816 175.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.629 HD13 HD23 ' B' ' 11' ' ' LEU . 4.6 mp -101.98 147.46 26.54 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 169.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.565 HD13 ' O ' ' B' ' 87' ' ' LEU . 2.3 mm? -125.21 154.14 42.05 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 173.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.64 -168.73 24.99 Favored Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 119.776 -1.202 . . . . 0.0 114.21 -178.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 90' ' ' TYR . . . . . 0.538 ' CZ ' ' HB2' ' C' ' 68' ' ' ASN . 3.2 m-85 -117.55 118.91 33.45 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.348 -0.926 . . . . 0.0 110.396 -176.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 91' ' ' LEU . . . . . 0.531 HD22 ' HD2' ' B' ' 25' ' ' LYS . 16.4 mt -82.83 117.65 22.86 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.164 0.507 . . . . 0.0 110.336 172.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 92' ' ' HIS . . . . . 0.404 ' CD2' ' HB3' ' A' ' 5' ' ' MET . 61.1 t60 -93.73 173.73 7.54 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 175.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 74.28 4.81 4.57 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.799 0.44 . . . . 0.0 110.853 176.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 5.3 tp -70.01 126.19 29.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.103 0.478 . . . . 0.0 110.453 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -77.16 79.98 3.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.567 0.699 . . . . 0.0 109.895 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 14.3 t -154.28 135.63 14.12 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.374 -0.83 . . . . 0.0 108.96 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . -173.5 36.96 0.13 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.743 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.689 -0.672 . . . . 0.0 109.348 -178.773 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 . . . . . 0 N--CA 1.481 1.102 0 CA-C-O 120.952 0.406 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -145.43 175.58 10.21 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.596 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.25 155.91 53.22 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.455 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.43 156.18 23.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.058 0.456 . . . . 0.0 111.219 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 22.1 ptm -136.89 148.57 47.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.523 -178.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 6' ' ' ALA . . . . . . . . . . . . . . . -111.47 147.66 34.82 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.217 178.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 7' ' ' MET . . . . . 0.507 ' HA ' ' OG ' ' D' ' 70' ' ' SER . 16.6 ttt -93.36 168.87 10.79 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.276 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 8' ' ' PHE . . . . . 0.564 ' CE1' HD12 ' C' ' 88' ' ' LEU . 54.6 t80 -79.55 129.77 34.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.994 0.426 . . . . 0.0 112.093 -177.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 9' ' ' TRP . . . . . 0.534 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 87.9 t90 -114.01 148.52 36.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.456 174.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.23 145.58 14.0 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.286 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.632 HD23 HD13 ' C' ' 87' ' ' LEU . 58.3 tp -139.11 110.15 6.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.981 0.419 . . . . 0.0 110.937 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -86.01 116.37 24.18 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.98 176.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 13' ' ' MET . . . . . 0.634 ' HB2' HG23 ' C' ' 85' ' ' VAL . 4.1 mmt -98.48 130.74 45.08 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -176.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 14' ' ' LYS . . . . . 0.444 ' HD2' ' HD2' ' C' ' 15' ' ' PRO . 48.2 tptt -100.58 132.18 22.71 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 174.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 15' ' ' PRO . . . . . 0.543 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 2.0 Cg_endo -46.4 117.84 2.21 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.479 2.786 . . . . 0.0 113.52 -175.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 16' ' ' GLU . . . . . 0.667 ' HA ' ' O ' ' C' ' 79' ' ' THR . 38.0 mt-10 64.14 56.03 1.43 Allowed 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.481 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.75 135.31 52.88 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.64 173.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 18' ' ' LYS . . . . . 0.742 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 82.7 mttt -103.74 115.87 31.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.157 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -105.56 102.81 12.25 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 175.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 15.3 p -89.43 98.92 12.04 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 173.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -111.82 146.46 37.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.178 -167.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 28.7 m -100.54 143.18 31.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.253 174.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 23' ' ' ILE . . . . . 0.475 ' CD1' ' HB2' ' C' ' 69' ' ' PHE . 53.8 mt -108.58 125.89 65.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.236 0.541 . . . . 0.0 111.722 -172.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 24' ' ' ILE . . . . . 0.455 ' N ' HD12 ' C' ' 24' ' ' ILE . 4.2 mp -102.28 -50.59 9.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.43 -0.804 . . . . 0.0 108.88 176.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 25' ' ' LYS . . . . . 0.535 ' HD2' HD22 ' C' ' 91' ' ' LEU . 12.8 pttp -103.17 122.27 44.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.616 174.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 35.6 t -60.88 142.77 55.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.02 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 27' ' ' PHE . . . . . 0.487 ' HB3' HD23 ' C' ' 91' ' ' LEU . 54.7 p90 -147.87 148.28 30.68 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -177.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 28' ' ' HIS . . . . . 0.539 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 2.1 t60 -102.62 125.25 49.28 Favored 'General case' 0 C--O 1.217 -0.658 0 CA-C-N 114.084 -1.416 . . . . 0.0 109.645 176.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 29' ' ' ILE . . . . . 0.495 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 46.7 mt -87.33 131.36 35.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 172.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.539 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 94.6 p -116.73 -12.24 10.87 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -169.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 31' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . 179.99 158.73 22.53 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 119.073 -1.536 . . . . 0.0 113.651 177.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.467 HG23 ' HG ' ' C' ' 87' ' ' LEU . 11.0 p -141.27 138.93 33.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 175.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -152.92 156.22 38.51 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.98 -0.45 . . . . 0.0 111.94 -177.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.718 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.1 pp -125.35 148.03 48.91 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.571 0.7 . . . . 0.0 111.892 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -110.62 -55.12 2.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.162 169.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -100.92 127.98 47.15 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.157 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 37' ' ' GLY . . . . . 0.484 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 150.49 163.04 10.97 Favored Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 120.333 -0.936 . . . . 0.0 112.461 177.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -102.67 -47.03 4.55 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.567 0.222 . . . . 0.0 111.001 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -152.42 132.54 13.5 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.364 177.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.527 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -127.28 113.24 16.04 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.42 0.629 . . . . 0.0 110.113 168.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' C' ' 79' ' ' THR . 97.5 mttt -95.37 112.06 23.83 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 175.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.446 HD21 HD21 ' C' ' 87' ' ' LEU . 34.6 tp -86.17 107.48 17.9 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -174.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -107.47 146.14 32.15 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.7 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.657 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 1.5 tp -129.98 116.3 18.39 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.67 176.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.53 109.3 21.14 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.166 0.508 . . . . 0.0 109.668 176.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.431 ' HB2' HD11 ' C' ' 44' ' ' LEU . . . -143.12 150.1 39.01 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.495 -177.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 57.25 31.02 19.4 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.396 0.617 . . . . 0.0 110.033 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 97.0 mttt 61.13 40.5 14.8 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.261 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 15.0 tp60 -144.18 136.76 26.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.9 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -87.35 117.68 26.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.847 0.356 . . . . 0.0 110.066 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -112.79 123.02 49.37 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.651 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -80.85 100.92 5.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 170.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 53' ' ' VAL . . . . . 0.496 HG12 ' CD2' ' B' ' 88' ' ' LEU . 21.5 m -86.46 -33.18 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.756 -172.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 54' ' ' ALA . . . . . 0.734 ' HB2' HD21 ' C' ' 65' ' ' LEU . . . -153.16 144.51 23.2 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 120.394 -0.522 . . . . 0.0 112.201 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 27.3 m -115.52 102.5 9.85 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 169.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 56' ' ' VAL . . . . . 0.434 HG13 ' HB3' ' C' ' 40' ' ' ALA . 9.0 p -116.13 114.12 45.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.763 0.792 . . . . 0.0 110.18 -177.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 69.7 p -123.15 -177.18 3.61 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.972 -175.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -59.32 -35.93 74.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.075 0.465 . . . . 0.0 110.015 169.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 59' ' ' ALA . . . . . 0.412 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -71.17 -40.56 71.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.527 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 79.0 mt -114.36 82.29 7.38 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 174.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 61' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 17.2 Cg_exo -67.27 -6.72 16.96 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.268 2.645 . . . . 0.0 113.851 -168.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -161.46 132.16 5.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.288 0.566 . . . . 0.0 111.2 -175.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 87.9 t -119.76 118.61 57.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.524 176.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.79 128.13 33.3 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 65' ' ' LEU . . . . . 0.734 HD21 ' HB2' ' C' ' 54' ' ' ALA . 85.9 mt -120.14 163.86 17.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.396 0.617 . . . . 0.0 112.277 -172.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -140.9 97.43 3.19 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.206 -0.907 . . . . 0.0 108.554 169.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.526 ' O ' ' HA ' ' C' ' 28' ' ' HIS . 2.8 mt -131.22 156.31 45.58 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 68' ' ' ASN . . . . . 0.538 ' HB2' ' CZ ' ' B' ' 90' ' ' TYR . 42.7 t-20 -155.27 128.71 8.4 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 174.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 69' ' ' PHE . . . . . 0.475 ' HB2' ' CD1' ' C' ' 23' ' ' ILE . 4.2 m-85 -123.91 145.08 49.38 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 70' ' ' SER . . . . . 0.578 ' OG ' ' HA ' ' B' ' 7' ' ' MET . 37.7 m -100.51 -178.46 3.81 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -175.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -62.33 -30.91 71.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.244 0.545 . . . . 0.0 110.399 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.92 4.5 85.15 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.76 -0.654 . . . . 0.0 113.005 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -100.05 119.55 38.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.109 0.454 . . . . 0.0 110.81 178.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -111.96 106.34 15.0 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 173.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.412 HG22 ' CB ' ' C' ' 46' ' ' ALA . 10.8 pt -121.01 167.99 13.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.128 -167.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 76' ' ' MET . . . . . . . . . . . . . 3.9 mtm -122.15 126.06 47.52 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 171.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 77' ' ' PHE . . . . . 0.657 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.3 OUTLIER -107.99 127.7 53.99 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 174.864 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 78' ' ' TYR . . . . . 0.742 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 53.7 p90 -155.58 140.33 17.1 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 119.808 -0.757 . . . . 0.0 112.208 -175.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 79' ' ' THR . . . . . 0.667 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 12.3 p -105.9 138.82 41.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.052 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.13 153.21 22.98 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.364 174.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.46 -173.45 34.05 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -177.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -113.55 103.82 11.64 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.654 0.727 . . . . 0.0 109.842 177.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 83' ' ' ALA . . . . . 0.543 ' H ' ' HB3' ' C' ' 15' ' ' PRO . . . -170.92 153.6 3.93 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.813 169.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 5.7 p -110.22 123.27 49.47 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.192 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.718 HG12 ' HB3' ' C' ' 34' ' ' LEU . 10.8 m -124.82 153.36 31.76 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-O 121.447 0.642 . . . . 0.0 112.347 -173.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 29.0 m -113.3 126.66 55.63 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.772 175.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 87' ' ' LEU . . . . . 0.632 HD13 HD23 ' C' ' 11' ' ' LEU . 4.6 mp -101.83 147.42 26.52 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 169.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 88' ' ' LEU . . . . . 0.564 HD12 ' CE1' ' C' ' 8' ' ' PHE . 2.3 mm? -125.21 154.19 41.98 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 173.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.65 -168.73 25.0 Favored Glycine 0 N--CA 1.438 -1.213 0 C-N-CA 119.753 -1.213 . . . . 0.0 114.222 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 90' ' ' TYR . . . . . 0.506 ' CZ ' ' HB2' ' D' ' 68' ' ' ASN . 3.2 m-85 -117.62 118.96 33.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.351 -0.925 . . . . 0.0 110.29 -176.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 91' ' ' LEU . . . . . 0.535 HD22 ' HD2' ' C' ' 25' ' ' LYS . 16.4 mt -82.8 117.62 22.82 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.199 0.523 . . . . 0.0 110.35 172.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 61.1 t60 -93.66 173.73 7.54 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 175.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 74.27 4.73 4.56 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.401 0.438 . . . . 0.0 110.901 176.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 5.4 tp -69.91 126.23 29.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.54 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -77.15 79.88 3.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.398 0.618 . . . . 0.0 109.899 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 14.1 t -154.18 135.74 14.3 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.96 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -173.59 36.89 0.13 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.74 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.628 -0.701 . . . . 0.0 109.332 -178.768 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 120.983 0.42 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -145.37 175.58 10.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.67 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.21 155.91 53.23 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.47 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.49 156.13 23.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.158 0.504 . . . . 0.0 111.264 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 22.0 ptm -136.93 148.55 47.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.499 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 6' ' ' ALA . . . . . . . . . . . . . . . -111.45 147.69 34.74 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.187 178.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 7' ' ' MET . . . . . 0.552 ' HA ' ' OG ' ' E' ' 70' ' ' SER . 16.6 ttt -93.45 168.87 10.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.274 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 8' ' ' PHE . . . . . 0.563 ' CE1' HD12 ' D' ' 88' ' ' LEU . 54.5 t80 -79.59 129.62 34.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.005 0.431 . . . . 0.0 112.135 -177.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 9' ' ' TRP . . . . . 0.536 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 87.9 t90 -113.81 148.51 36.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.496 174.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.18 145.66 14.18 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.225 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.625 HD23 HD13 ' D' ' 87' ' ' LEU . 58.7 tp -139.11 110.15 6.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.893 0.378 . . . . 0.0 111.005 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -86.09 116.47 24.32 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.916 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 13' ' ' MET . . . . . 0.63 ' HB2' HG23 ' D' ' 85' ' ' VAL . 4.1 mmt -98.49 130.66 45.09 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -176.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 14' ' ' LYS . . . . . 0.455 ' HD2' ' HD2' ' D' ' 15' ' ' PRO . 48.2 tptt -100.54 132.11 22.83 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 15' ' ' PRO . . . . . 0.538 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 1.9 Cg_endo -46.32 117.82 2.17 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.527 2.818 . . . . 0.0 113.464 -175.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 16' ' ' GLU . . . . . 0.652 ' HA ' ' O ' ' D' ' 79' ' ' THR . 37.9 mt-10 64.08 56.14 1.44 Allowed 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.452 178.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.79 135.38 52.91 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.609 172.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 18' ' ' LYS . . . . . 0.729 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 82.8 mttt -103.68 115.76 31.09 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 123.327 0.392 . . . . 0.0 111.168 177.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -105.49 102.84 12.29 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 175.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 14.9 p -89.4 98.89 12.02 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -111.8 146.36 37.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.306 -167.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 29.0 m -100.47 143.17 30.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.234 174.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 23' ' ' ILE . . . . . 0.472 ' CD1' ' HB2' ' D' ' 69' ' ' PHE . 54.1 mt -108.46 125.87 65.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.193 0.52 . . . . 0.0 111.774 -172.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 24' ' ' ILE . . . . . 0.454 HD12 ' N ' ' D' ' 24' ' ' ILE . 4.2 mp -102.31 -50.57 9.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.382 -0.826 . . . . 0.0 108.884 176.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 25' ' ' LYS . . . . . 0.534 ' HD2' HD22 ' D' ' 91' ' ' LEU . 12.8 pttp -103.17 122.38 44.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.604 174.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 35.6 t -60.86 142.7 55.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.923 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 27' ' ' PHE . . . . . 0.49 ' HB3' HD23 ' D' ' 91' ' ' LEU . 54.7 p90 -147.83 148.33 30.77 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -177.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 28' ' ' HIS . . . . . 0.54 ' HA ' ' O ' ' D' ' 67' ' ' LEU . 2.1 t60 -102.66 125.2 49.31 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 114.106 -1.407 . . . . 0.0 109.649 176.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 29' ' ' ILE . . . . . 0.506 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 46.9 mt -87.3 131.31 35.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 172.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 30' ' ' SER . . . . . 0.525 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 94.6 p -116.66 -12.24 10.92 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -169.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 31' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . 179.92 158.7 22.44 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 119.145 -1.502 . . . . 0.0 113.72 177.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.462 HG23 ' HG ' ' D' ' 87' ' ' LEU . 11.0 p -141.3 138.85 33.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 175.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -152.85 156.23 38.61 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.878 -0.514 . . . . 0.0 111.92 -177.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 34' ' ' LEU . . . . . 0.702 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.1 pp -125.33 148.01 48.9 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.475 0.655 . . . . 0.0 111.944 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -110.57 -55.28 2.49 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.14 169.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -100.76 128.0 46.97 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.154 174.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 37' ' ' GLY . . . . . 0.49 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 150.39 163.09 10.99 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.428 177.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 38' ' ' GLN . . . . . 0.4 ' HA ' ' HD2' ' D' ' 58' ' ' LYS . 69.9 mt-30 -102.63 -47.01 4.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 120.58 0.228 . . . . 0.0 110.984 176.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -152.47 132.52 13.44 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.346 177.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 40' ' ' ALA . . . . . 0.543 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -127.26 113.26 16.08 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.414 0.626 . . . . 0.0 110.093 168.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' D' ' 79' ' ' THR . 97.5 mttt -95.34 112.01 23.79 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.438 ' HB3' ' HB3' ' D' ' 54' ' ' ALA . 34.6 tp -86.2 107.41 17.88 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -174.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -107.4 146.09 32.1 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.73 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.656 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 1.5 tp -129.95 116.34 18.47 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.65 176.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.62 109.3 21.16 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.427 ' HB2' HD11 ' D' ' 44' ' ' LEU . . . -143.04 150.18 39.24 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.423 -177.072 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 57.2 30.94 19.21 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.397 0.618 . . . . 0.0 110.043 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 61.2 40.59 14.47 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.154 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -144.16 136.66 26.8 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -87.3 117.71 26.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.912 0.387 . . . . 0.0 110.027 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -112.84 123.09 49.52 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.671 178.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -80.9 100.87 5.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 170.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 53' ' ' VAL . . . . . 0.492 HG12 ' CD2' ' C' ' 88' ' ' LEU . 21.4 m -86.42 -33.25 7.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.714 -172.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 54' ' ' ALA . . . . . 0.731 ' HB2' HD21 ' D' ' 65' ' ' LEU . . . -153.13 144.49 23.22 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 120.301 -0.56 . . . . 0.0 112.264 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 27.5 m -115.51 102.46 9.82 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 169.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 56' ' ' VAL . . . . . 0.424 HG11 HG11 ' D' ' 85' ' ' VAL . 8.9 p -116.12 114.19 45.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.75 0.786 . . . . 0.0 110.119 -177.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 67.7 p -123.19 -177.19 3.62 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.931 -175.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 58' ' ' LYS . . . . . 0.4 ' HD2' ' HA ' ' D' ' 38' ' ' GLN . 27.2 mtpp -59.27 -35.99 74.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.075 0.464 . . . . 0.0 110.008 169.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 59' ' ' ALA . . . . . 0.408 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -71.16 -40.49 71.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.632 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 79.0 mt -114.33 82.28 7.33 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 61' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 17.2 Cg_exo -67.26 -6.63 16.74 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.251 2.634 . . . . 0.0 113.904 -168.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -161.49 132.12 5.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.322 0.582 . . . . 0.0 111.169 -175.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 88.2 t -119.75 118.72 58.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.551 176.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.84 128.08 33.26 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 174.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 65' ' ' LEU . . . . . 0.731 HD21 ' HB2' ' D' ' 54' ' ' ALA . 86.1 mt -120.17 163.87 17.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.412 0.625 . . . . 0.0 112.287 -172.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -140.91 97.45 3.19 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 169.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' D' ' 28' ' ' HIS . 2.7 mt -131.21 156.29 45.6 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 68' ' ' ASN . . . . . 0.506 ' HB2' ' CZ ' ' C' ' 90' ' ' TYR . 42.8 t-20 -155.27 128.7 8.4 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 174.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 69' ' ' PHE . . . . . 0.472 ' HB2' ' CD1' ' D' ' 23' ' ' ILE . 4.3 m-85 -123.96 145.15 49.36 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 70' ' ' SER . . . . . 0.507 ' OG ' ' HA ' ' C' ' 7' ' ' MET . 37.7 m -100.43 -178.5 3.82 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -175.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -62.39 -30.9 71.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.291 0.567 . . . . 0.0 110.342 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.87 4.39 85.23 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.035 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -100.04 119.51 38.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.988 0.423 . . . . 0.0 110.775 178.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -111.81 106.37 15.1 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 173.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.413 HG22 ' CB ' ' D' ' 46' ' ' ALA . 10.9 pt -121.05 168.04 13.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.087 -167.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 76' ' ' MET . . . . . . . . . . . . . 3.9 mtm -122.27 125.96 47.14 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 171.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 77' ' ' PHE . . . . . 0.656 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.3 OUTLIER -107.95 127.72 54.0 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 78' ' ' TYR . . . . . 0.729 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 53.4 p90 -155.65 140.32 17.02 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.849 -0.74 . . . . 0.0 112.198 -175.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 79' ' ' THR . . . . . 0.652 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 12.1 p -106.04 138.85 41.51 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.017 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 80' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' D' ' 41' ' ' LYS . . . -107.17 153.15 23.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.401 174.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.4 ' O ' ' HG3' ' D' ' 16' ' ' GLU . . . 93.54 -173.58 34.06 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -176.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -113.52 103.8 11.62 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.879 177.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 83' ' ' ALA . . . . . 0.543 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -170.83 153.54 3.99 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.89 169.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 5.8 p -110.13 123.2 49.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.237 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.702 HG12 ' HB3' ' D' ' 34' ' ' LEU . 11.0 m -124.7 153.39 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-O 121.381 0.61 . . . . 0.0 112.38 -173.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 27.8 m -113.31 126.75 55.73 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.843 175.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 87' ' ' LEU . . . . . 0.625 HD13 HD23 ' D' ' 11' ' ' LEU . 4.6 mp -101.89 147.47 26.49 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 169.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.563 HD12 ' CE1' ' D' ' 8' ' ' PHE . 2.3 mm? -125.2 154.19 41.96 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 173.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.75 -168.81 25.24 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 119.758 -1.21 . . . . 0.0 114.165 -178.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 90' ' ' TYR . . . . . 0.549 ' CZ ' ' HB2' ' E' ' 68' ' ' ASN . 3.2 m-85 -117.61 118.9 33.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.375 -0.912 . . . . 0.0 110.34 -176.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 91' ' ' LEU . . . . . 0.534 HD22 ' HD2' ' D' ' 25' ' ' LYS . 16.5 mt -82.7 117.68 22.8 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.09 0.472 . . . . 0.0 110.377 172.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -93.81 173.69 7.55 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 74.37 4.77 4.53 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 122.887 0.475 . . . . 0.0 110.795 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 5.4 tp -69.91 126.23 29.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.519 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -77.25 80.04 3.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.538 0.685 . . . . 0.0 109.865 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 14.1 t -154.23 135.71 14.23 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.043 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . -173.65 36.83 0.13 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.679 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.675 -0.679 . . . . 0.0 109.333 -178.846 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 . . . . . 0 N--CA 1.479 1.024 0 CA-C-O 120.981 0.42 . . . . 0.0 110.4 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -145.33 175.64 10.15 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.617 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.29 155.82 53.18 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.424 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.35 156.17 23.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.074 0.464 . . . . 0.0 111.302 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 22.1 ptm -136.94 148.44 46.97 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.46 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 6' ' ' ALA . . . . . . . . . . . . . . . -111.38 147.71 34.61 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.198 178.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 7' ' ' MET . . . . . 0.522 ' HA ' ' OG ' ' A' ' 70' ' ' SER . 16.6 ttt -93.45 168.92 10.74 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.26 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 8' ' ' PHE . . . . . 0.566 ' CE1' HD12 ' E' ' 88' ' ' LEU . 54.1 t80 -79.71 129.73 34.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.076 0.465 . . . . 0.0 112.048 -177.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 9' ' ' TRP . . . . . 0.54 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 87.8 t90 -113.87 148.54 36.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.537 174.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.24 145.63 14.11 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.236 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 11' ' ' LEU . . . . . 0.636 HD23 HD13 ' E' ' 87' ' ' LEU . 58.3 tp -139.16 110.19 6.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.909 0.385 . . . . 0.0 110.981 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -86.07 116.37 24.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.931 176.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 13' ' ' MET . . . . . 0.64 ' HB2' HG23 ' E' ' 85' ' ' VAL . 4.1 mmt -98.41 130.77 45.04 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -176.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 14' ' ' LYS . . . . . 0.461 ' HD2' ' HD2' ' E' ' 15' ' ' PRO . 48.3 tptt -100.65 132.13 22.71 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 174.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 15' ' ' PRO . . . . . 0.522 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 2.0 Cg_endo -46.22 117.75 2.1 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 123.513 2.808 . . . . 0.0 113.507 -175.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 16' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' E' ' 79' ' ' THR . 37.8 mt-10 64.05 56.18 1.44 Allowed 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.472 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.73 135.29 52.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.673 172.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 18' ' ' LYS . . . . . 0.733 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 82.9 mttt -103.65 115.76 31.1 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 123.302 0.376 . . . . 0.0 111.249 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -105.48 102.84 12.28 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 175.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 15.4 p -89.35 98.85 12.0 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 173.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -111.92 146.41 37.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.449 0.642 . . . . 0.0 112.203 -167.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 29.2 m -100.49 143.1 31.07 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.218 174.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 23' ' ' ILE . . . . . 0.465 ' CD1' ' HB2' ' E' ' 69' ' ' PHE . 54.1 mt -108.52 125.92 65.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.143 0.497 . . . . 0.0 111.786 -172.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 24' ' ' ILE . . . . . 0.457 HD12 ' N ' ' E' ' 24' ' ' ILE . 4.3 mp -102.36 -50.56 9.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.823 176.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 25' ' ' LYS . . . . . 0.526 ' HD2' HD22 ' E' ' 91' ' ' LEU . 12.7 pttp -103.24 122.37 44.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.56 174.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 35.6 t -60.94 142.71 56.2 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.936 -177.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 27' ' ' PHE . . . . . 0.481 ' HB3' HD23 ' E' ' 91' ' ' LEU . 54.7 p90 -147.85 148.29 30.72 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -177.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 28' ' ' HIS . . . . . 0.536 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 2.1 t60 -102.52 125.18 49.16 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.714 176.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 29' ' ' ILE . . . . . 0.498 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 46.5 mt -87.32 131.28 35.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 172.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 30' ' ' SER . . . . . 0.536 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 94.9 p -116.61 -12.23 10.95 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -169.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 31' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . 179.95 158.65 22.37 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 119.144 -1.503 . . . . 0.0 113.724 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.468 HG23 ' HG ' ' E' ' 87' ' ' LEU . 11.0 p -141.28 138.94 33.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 175.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -152.91 156.17 38.41 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.967 -0.458 . . . . 0.0 111.945 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 34' ' ' LEU . . . . . 0.716 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.1 pp -125.29 148.06 48.86 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.593 0.711 . . . . 0.0 111.968 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -110.68 -55.13 2.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.068 169.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -100.87 127.96 47.11 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.226 174.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 37' ' ' GLY . . . . . 0.494 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 150.49 163.07 10.99 Favored Glycine 0 N--CA 1.434 -1.489 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.437 177.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 38' ' ' GLN . . . . . 0.409 ' HA ' ' HD2' ' E' ' 58' ' ' LYS . 25.7 mt-30 -102.6 -47.07 4.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.552 0.215 . . . . 0.0 111.037 176.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -152.45 132.45 13.41 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.356 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 40' ' ' ALA . . . . . 0.525 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -127.25 113.29 16.12 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.386 0.612 . . . . 0.0 110.109 168.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 41' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' E' ' 79' ' ' THR . 97.6 mttt -95.45 112.11 23.88 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 175.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.439 ' HB3' ' HB3' ' E' ' 54' ' ' ALA . 34.6 tp -86.21 107.53 17.95 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -174.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -107.41 146.01 32.23 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.765 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 44' ' ' LEU . . . . . 0.641 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 1.5 tp -129.93 116.42 18.61 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.662 176.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.55 109.31 21.15 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 46' ' ' ALA . . . . . 0.428 ' HB2' HD11 ' E' ' 44' ' ' LEU . . . -143.13 150.12 39.02 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.407 -177.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 57.32 30.9 19.26 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.429 0.633 . . . . 0.0 110.047 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 61.29 40.46 14.37 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.201 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 49' ' ' GLN . . . . . . . . . . . . . 15.0 tp60 -144.12 136.7 26.89 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.932 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -87.34 117.7 26.28 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.901 0.382 . . . . 0.0 110.076 178.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 51' ' ' TYR . . . . . 0.401 ' CG ' HD11 ' D' ' 88' ' ' LEU . 76.7 m-85 -112.83 123.02 49.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.655 178.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -80.87 100.95 5.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 170.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 53' ' ' VAL . . . . . 0.48 HG12 ' CD2' ' D' ' 88' ' ' LEU . 21.5 m -86.42 -33.29 7.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.7 -172.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 54' ' ' ALA . . . . . 0.737 ' HB2' HD21 ' E' ' 65' ' ' LEU . . . -153.2 144.52 23.17 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 120.271 -0.571 . . . . 0.0 112.203 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 27.5 m -115.46 102.45 9.83 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 169.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 56' ' ' VAL . . . . . 0.432 HG13 ' HB3' ' E' ' 40' ' ' ALA . 9.0 p -116.13 114.2 45.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.819 0.818 . . . . 0.0 110.097 -177.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 70.4 p -123.26 -177.05 3.59 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.91 -175.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 58' ' ' LYS . . . . . 0.409 ' HD2' ' HA ' ' E' ' 38' ' ' GLN . 27.2 mtpp -59.32 -35.91 74.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.257 0.551 . . . . 0.0 110.048 169.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 59' ' ' ALA . . . . . 0.418 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -71.25 -40.56 70.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.487 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 79.5 mt -114.34 82.37 7.42 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 174.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 61' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 17.2 Cg_exo -67.37 -6.67 16.94 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.232 2.621 . . . . 0.0 113.893 -168.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -161.41 132.09 5.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.256 0.551 . . . . 0.0 111.252 -175.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 87.3 t -119.76 118.72 58.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.511 176.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.85 128.19 33.38 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 174.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.737 HD21 ' HB2' ' E' ' 54' ' ' ALA . 86.2 mt -120.2 163.75 17.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.339 0.59 . . . . 0.0 112.283 -172.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 66' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -140.79 97.39 3.18 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 169.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 67' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' E' ' 28' ' ' HIS . 2.7 mt -131.19 156.29 45.6 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 68' ' ' ASN . . . . . 0.549 ' HB2' ' CZ ' ' D' ' 90' ' ' TYR . 42.6 t-20 -155.31 128.67 8.35 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 69' ' ' PHE . . . . . 0.465 ' HB2' ' CD1' ' E' ' 23' ' ' ILE . 4.2 m-85 -123.88 145.07 49.36 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 70' ' ' SER . . . . . 0.552 ' OG ' ' HA ' ' D' ' 7' ' ' MET . 37.1 m -100.43 -178.56 3.84 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -175.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -62.37 -30.75 71.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.245 0.545 . . . . 0.0 110.422 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -85.08 4.52 85.36 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.949 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -100.11 119.53 38.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.11 0.455 . . . . 0.0 110.795 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -111.83 106.39 15.11 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 173.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 75' ' ' ILE . . . . . 0.406 HG22 ' CB ' ' E' ' 46' ' ' ALA . 10.8 pt -121.05 167.96 13.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.134 -167.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 76' ' ' MET . . . . . . . . . . . . . 3.9 mtm -122.21 126.04 47.38 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 171.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 77' ' ' PHE . . . . . 0.641 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.3 OUTLIER -107.89 127.73 53.99 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 174.962 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' E' E ' 78' ' ' TYR . . . . . 0.733 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 53.3 p90 -155.63 140.37 17.08 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 119.818 -0.753 . . . . 0.0 112.187 -175.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 79' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 12.1 p -106.07 138.93 41.4 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.948 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.19 153.15 23.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.418 174.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.53 -173.37 33.86 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -177.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -113.66 103.83 11.62 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.87 177.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 83' ' ' ALA . . . . . 0.525 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -170.98 153.56 3.86 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.856 169.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 5.6 p -110.24 123.15 49.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.246 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 85' ' ' VAL . . . . . 0.716 HG12 ' HB3' ' E' ' 34' ' ' LEU . 11.1 m -124.71 153.26 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-O 121.456 0.646 . . . . 0.0 112.388 -173.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 29.3 m -113.2 126.82 55.85 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.833 175.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 87' ' ' LEU . . . . . 0.636 HD13 HD23 ' E' ' 11' ' ' LEU . 4.6 mp -101.99 147.5 26.48 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 169.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 88' ' ' LEU . . . . . 0.566 HD12 ' CE1' ' E' ' 8' ' ' PHE . 2.3 mm? -125.27 154.17 42.11 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 173.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.65 -168.76 25.05 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 119.728 -1.225 . . . . 0.0 114.161 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 90' ' ' TYR . . . . . 0.528 ' CZ ' ' HB2' ' A' ' 68' ' ' ASN . 3.2 m-85 -117.61 118.99 33.64 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.328 -0.936 . . . . 0.0 110.295 -176.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 91' ' ' LEU . . . . . 0.526 HD22 ' HD2' ' E' ' 25' ' ' LYS . 16.4 mt -82.86 117.71 22.92 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.189 0.519 . . . . 0.0 110.352 172.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 61.3 t60 -93.7 173.8 7.5 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 74.26 4.72 4.57 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.404 0.44 . . . . 0.0 110.864 176.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 5.4 tp -69.86 126.19 29.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.515 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -77.16 79.96 3.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.421 0.629 . . . . 0.0 109.861 177.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 14.3 t -154.21 135.68 14.22 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.009 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . -173.59 36.84 0.13 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.72 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.68 -0.676 . . . . 0.0 109.289 -178.779 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.421 ' HA ' ' OG ' ' B' ' 98' ' ' SER . 90.2 t80 . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 120.539 0.209 . . . . 0.0 110.511 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.679 ' O ' ' HB ' ' B' ' 94' ' ' ILE . 42.5 mt-30 54.52 -101.43 0.12 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.315 -177.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.608 ' HA2' ' O ' ' A' ' 94' ' ' ILE . . . 103.36 174.33 26.17 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.027 -1.083 . . . . 0.0 113.894 173.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 67.08 26.75 8.84 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.813 0.845 . . . . 0.0 111.314 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.43 ' HG3' ' HB2' ' B' ' 26' ' ' SER . 44.3 ttm -88.15 47.53 1.51 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.529 0.681 . . . . 0.0 109.845 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.581 ' HB3' ' ND2' ' B' ' 68' ' ' ASN . . . -65.92 151.96 45.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.337 -176.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.438 ' HA ' ' HB2' ' B' ' 70' ' ' SER . 46.1 ttm -104.29 142.5 34.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.823 -174.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.627 ' CE1' HD21 ' B' ' 44' ' ' LEU . 68.0 t80 -61.3 147.53 44.28 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -172.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.424 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 89.5 t90 -138.55 145.53 40.79 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.842 179.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.69 151.44 23.54 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.039 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.617 HD23 HD13 ' A' ' 87' ' ' LEU . 40.8 tp -146.28 109.66 4.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.63 0.252 . . . . 0.0 110.884 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 52.7 m-20 -88.46 125.31 34.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.475 0.655 . . . . 0.0 111.096 176.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.545 ' HB2' HG23 ' A' ' 85' ' ' VAL . 7.0 mmt -98.31 130.21 44.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.432 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.457 ' HB3' ' HG3' ' A' ' 17' ' ' ARG . 59.7 tttm -96.98 134.25 23.19 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 171.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.438 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 2.2 Cg_endo -43.95 112.95 0.36 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.398 2.732 . . . . 0.0 113.401 -174.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.666 ' HA ' ' O ' ' A' ' 79' ' ' THR . 48.8 mt-10 69.45 44.25 0.94 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.811 178.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.457 ' HG3' ' HB3' ' A' ' 14' ' ' LYS . 12.0 mmt180 -104.61 138.27 41.2 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.961 170.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.662 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 46.6 mttp -113.18 118.75 35.58 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 123.392 0.432 . . . . 0.0 110.501 175.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -110.51 103.84 12.49 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 177.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 76' ' ' MET . 42.7 t -86.43 102.46 14.07 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 172.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -116.84 144.36 44.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.799 -170.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.1 t -97.84 157.0 16.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.01 174.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.4 mt -120.3 124.11 71.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.098 0.475 . . . . 0.0 111.365 -173.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.625 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -114.44 -18.32 7.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.894 176.977 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -132.47 121.79 23.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.657 176.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.0 t -65.73 133.44 51.07 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.056 -174.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.854 ' HB3' HD23 ' A' ' 91' ' ' LEU . 46.5 p90 -137.59 147.28 44.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.648 0.737 . . . . 0.0 112.219 -177.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.551 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 7.4 t60 -104.64 125.06 50.39 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.664 174.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.57 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 45.0 mt -90.87 133.19 33.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 170.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.551 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 67.8 p -119.82 -7.36 10.01 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -171.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.64 159.14 26.74 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 119.2 -1.476 . . . . 0.0 113.706 177.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.458 HG23 ' HG ' ' A' ' 87' ' ' LEU . 11.1 p -144.43 131.7 16.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.429 ' HA ' HG21 ' A' ' 56' ' ' VAL . . . -148.5 157.66 43.61 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.968 -0.458 . . . . 0.0 112.115 -175.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.697 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.2 pp -126.63 146.18 50.27 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.541 0.686 . . . . 0.0 111.996 178.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -110.76 -52.19 2.81 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.614 -1.175 . . . . 0.0 108.864 168.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -99.74 127.68 45.87 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.447 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 142.4 159.4 7.92 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.543 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -101.47 -45.41 5.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.723 0.297 . . . . 0.0 111.164 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.414 ' HG3' HG22 ' A' ' 57' ' ' THR . 11.5 tt0 -152.27 126.45 9.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.582 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.564 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -127.61 113.7 16.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.389 0.614 . . . . 0.0 110.221 169.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -99.35 112.16 24.39 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 174.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.1 tp -81.61 115.51 20.92 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.692 -175.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -115.53 145.33 42.74 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.49 0.662 . . . . 0.0 110.245 178.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.621 HD21 ' CE1' ' E' ' 8' ' ' PHE . 0.9 OUTLIER -128.58 118.28 22.71 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.774 177.083 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -105.61 104.47 14.19 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.67 177.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.467 ' HB2' HD11 ' A' ' 44' ' ' LEU . . . -126.64 139.76 52.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.564 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 57.99 31.06 20.12 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 123.605 0.565 . . . . 0.0 110.06 -174.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 62.18 30.34 17.68 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.298 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 8.4 tp-100 -121.42 125.6 47.32 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 177.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -83.08 117.2 22.69 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.792 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -113.6 132.42 55.75 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.727 175.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -81.34 112.56 19.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 168.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.51 ' CG2' ' HB3' ' A' ' 44' ' ' LEU . 3.4 t -86.98 -51.62 12.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.737 -172.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.622 ' HB2' HD21 ' A' ' 65' ' ' LEU . . . -151.53 144.88 24.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.453 -176.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.5 m -109.29 101.7 10.69 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 171.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.429 HG21 ' HA ' ' A' ' 33' ' ' ALA . 7.2 p -117.18 110.84 32.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.907 0.86 . . . . 0.0 109.987 -177.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.414 HG22 ' HG3' ' A' ' 39' ' ' GLU . 81.0 p -123.58 -177.47 3.73 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.356 -174.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -56.98 -34.98 68.64 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.862 0.363 . . . . 0.0 110.634 167.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.98 -40.68 65.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.526 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.9 mt -116.24 83.37 12.71 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.39 -3.76 11.58 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.129 2.553 . . . . 0.0 113.972 -168.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -162.84 130.86 3.81 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.26 0.553 . . . . 0.0 111.17 -176.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 87.0 t -118.53 117.44 54.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.636 175.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.48 126.93 31.83 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.726 174.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.622 HD21 ' HB2' ' A' ' 54' ' ' ALA . 74.7 mt -121.02 167.02 13.05 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.405 0.621 . . . . 0.0 112.295 -173.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 10.9 t0 -137.51 98.18 3.64 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.549 168.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.717 HD21 HD23 ' E' ' 88' ' ' LEU . 4.9 mt -124.75 146.38 49.22 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.573 ' ND2' ' HB3' ' E' ' 6' ' ' ALA . 56.6 t30 -148.25 120.85 8.57 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.072 175.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -116.62 141.62 47.96 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.897 -177.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.462 ' HB2' ' HA ' ' E' ' 7' ' ' MET . 9.0 t -96.98 169.26 9.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.902 0.382 . . . . 0.0 110.145 -177.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -75.23 0.34 16.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.755 -178.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.08 -4.16 56.64 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 173.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -95.51 147.09 23.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.01 0.433 . . . . 0.0 110.926 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -130.85 118.24 20.47 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 172.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.44 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 16.8 pt -130.55 157.3 42.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.087 0.47 . . . . 0.0 111.869 -169.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.446 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 67.1 ttp -119.51 114.78 22.8 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.03 175.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.62 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -100.82 129.8 46.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.961 -177.119 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.662 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 53.4 p90 -152.5 150.66 29.84 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 119.959 -0.696 . . . . 0.0 112.049 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.666 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 7.3 p -113.32 136.34 52.86 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.384 177.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.24 152.03 23.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.517 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.95 -171.96 30.5 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -114.78 102.9 10.44 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.916 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.564 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -171.13 155.27 4.33 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.909 170.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.5 p -111.99 120.77 43.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.113 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.697 HG12 ' HB3' ' A' ' 34' ' ' LEU . 10.1 m -122.06 150.63 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 121.173 0.511 . . . . 0.0 112.341 -174.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 38.8 m -107.35 124.77 50.29 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.668 174.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.617 HD13 HD23 ' A' ' 11' ' ' LEU . 5.3 mp -94.94 146.56 24.15 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 169.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.685 HD23 HD21 ' B' ' 67' ' ' LEU . 1.0 OUTLIER -131.34 142.09 50.02 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.082 -178.582 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.08 -166.94 25.96 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.233 -176.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -154.33 134.62 13.3 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.859 0.838 . . . . 0.0 112.518 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.854 HD23 ' HB3' ' A' ' 27' ' ' PHE . 14.4 mt -70.6 139.35 51.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.985 175.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -86.13 109.27 18.75 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -172.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -134.96 74.95 1.54 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 167.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.634 ' HB ' ' O ' ' E' ' 2' ' ' GLN . 43.8 mm -74.45 -82.02 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.227 -172.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -82.26 84.09 7.21 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.238 0.542 . . . . 0.0 110.169 -178.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.7 m -68.58 -26.21 65.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.075 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -115.41 101.69 1.06 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.184 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.421 ' OG ' ' HA ' ' E' ' 1' ' ' PHE . 16.0 m . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.701 -0.666 . . . . 0.0 110.208 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.443 ' HA ' ' OG ' ' C' ' 98' ' ' SER . 90.2 t80 . . . . . 0 N--CA 1.484 1.228 0 N-CA-C 110.558 -0.164 . . . . 0.0 110.558 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 2' ' ' GLN . . . . . 0.683 ' O ' ' HB ' ' C' ' 94' ' ' ILE . 42.9 mt-30 54.82 -101.63 0.13 Allowed 'General case' 0 N--CA 1.464 0.25 0 O-C-N 123.724 0.64 . . . . 0.0 110.26 -177.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 3' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' B' ' 94' ' ' ILE . . . 103.46 174.44 26.07 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.088 -1.054 . . . . 0.0 113.799 173.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . 66.97 26.82 9.01 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.818 0.847 . . . . 0.0 111.326 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 44.5 ttm -88.24 47.6 1.52 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.613 0.72 . . . . 0.0 109.85 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.56 ' HB3' ' ND2' ' C' ' 68' ' ' ASN . . . -65.87 151.97 45.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.32 -176.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 7' ' ' MET . . . . . 0.437 ' HA ' ' HB2' ' C' ' 70' ' ' SER . 45.9 ttm -104.33 142.5 34.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.898 -174.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.61 ' CE1' HD21 ' C' ' 44' ' ' LEU . 67.9 t80 -61.22 147.49 44.13 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -172.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 9' ' ' TRP . . . . . 0.424 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 89.5 t90 -138.54 145.52 40.78 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.84 179.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.72 151.42 23.52 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.019 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.6 HD23 HD13 ' B' ' 87' ' ' LEU . 40.4 tp -146.3 109.64 4.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.638 0.256 . . . . 0.0 110.855 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 -88.44 125.34 34.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.38 0.61 . . . . 0.0 111.126 176.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' MET . . . . . 0.543 ' HB2' HG23 ' B' ' 85' ' ' VAL . 7.1 mmt -98.27 130.07 44.98 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.576 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.463 ' HB3' ' HG3' ' B' ' 17' ' ' ARG . 59.7 tttm -96.89 134.24 23.28 Favored Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 171.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.44 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 2.2 Cg_endo -43.92 112.84 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.454 2.769 . . . . 0.0 113.431 -174.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.653 ' HA ' ' O ' ' B' ' 79' ' ' THR . 48.8 mt-10 69.55 44.1 0.94 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.896 178.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.463 ' HG3' ' HB3' ' B' ' 14' ' ' LYS . 11.9 mmt180 -104.51 138.37 40.98 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.989 170.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.653 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 46.5 mttp -113.32 118.62 35.1 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.299 0.374 . . . . 0.0 110.513 175.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -110.35 103.84 12.54 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 42.2 t -86.39 102.68 14.25 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 172.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -117.07 144.38 44.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.747 -170.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 11.2 t -97.84 157.11 16.27 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.002 174.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 55.4 mt -120.36 124.03 71.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.051 0.453 . . . . 0.0 111.287 -173.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.628 ' H ' HD13 ' B' ' 24' ' ' ILE . 0.2 OUTLIER -114.39 -18.3 7.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.871 176.915 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -132.45 121.81 23.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.6 176.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 26' ' ' SER . . . . . 0.43 ' HB2' ' HG3' ' A' ' 5' ' ' MET . 46.9 t -65.75 133.48 51.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.06 -174.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 27' ' ' PHE . . . . . 0.862 ' HB3' HD23 ' B' ' 91' ' ' LEU . 46.3 p90 -137.58 147.35 44.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.708 0.766 . . . . 0.0 112.255 -177.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 28' ' ' HIS . . . . . 0.554 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 7.5 t60 -104.74 125.0 50.39 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.506 -1.224 . . . . 0.0 109.578 174.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.575 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 44.7 mt -90.79 133.27 33.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 170.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.554 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 67.5 p -119.88 -7.3 9.99 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -171.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.71 159.06 26.55 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 119.213 -1.47 . . . . 0.0 113.706 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.461 HG23 ' HG ' ' B' ' 87' ' ' LEU . 11.1 p -144.42 131.74 16.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 173.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 33' ' ' ALA . . . . . 0.414 ' HA ' HG21 ' B' ' 56' ' ' VAL . . . -148.57 157.54 43.53 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 121.944 -0.472 . . . . 0.0 112.098 -174.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.708 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.2 pp -126.48 146.28 50.17 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.607 0.718 . . . . 0.0 111.947 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -110.87 -52.17 2.81 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.583 -1.189 . . . . 0.0 108.825 168.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -99.62 127.66 45.73 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 175.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.447 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 142.32 159.32 7.89 Favored Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 120.176 -1.011 . . . . 0.0 112.617 178.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -101.33 -45.54 5.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.837 0.351 . . . . 0.0 111.115 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.407 ' HG3' HG22 ' B' ' 57' ' ' THR . 11.4 tt0 -152.23 126.45 9.23 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.617 -178.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.571 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -127.67 113.77 16.46 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.493 0.663 . . . . 0.0 110.267 169.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -99.42 112.19 24.42 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 47.2 tp -81.61 115.37 20.85 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.661 -174.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -115.49 145.36 42.68 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.457 0.646 . . . . 0.0 110.355 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.627 HD21 ' CE1' ' A' ' 8' ' ' PHE . 0.9 OUTLIER -128.56 118.34 22.83 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.862 177.101 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -105.7 104.39 14.1 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.724 177.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.459 ' HB2' HD11 ' B' ' 44' ' ' LEU . . . -126.47 139.75 52.99 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.511 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 58.09 30.97 20.08 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 123.528 0.518 . . . . 0.0 109.985 -174.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 62.17 30.37 17.69 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.311 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 8.4 tp-100 -121.41 125.71 47.58 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -83.18 117.19 22.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.764 -177.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -113.67 132.4 55.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.742 175.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -81.33 112.62 19.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 169.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.495 ' CG2' ' HB3' ' B' ' 44' ' ' LEU . 3.4 t -86.99 -51.66 12.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.648 -172.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.62 ' HB2' HD21 ' B' ' 65' ' ' LEU . . . -151.54 145.01 24.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.449 -176.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 28.3 m -109.32 101.71 10.69 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 171.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.418 ' CG1' HG11 ' B' ' 85' ' ' VAL . 7.2 p -117.25 111.08 33.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.877 0.846 . . . . 0.0 109.909 -178.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.407 HG22 ' HG3' ' B' ' 39' ' ' GLU . 81.3 p -123.71 -177.55 3.77 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.368 -174.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -56.91 -34.92 68.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.889 0.376 . . . . 0.0 110.68 167.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.99 -40.64 65.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.551 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 75.7 mt -116.33 83.43 13.04 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 175.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.43 -3.74 11.58 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.169 2.579 . . . . 0.0 113.972 -168.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -162.89 130.86 3.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.216 0.531 . . . . 0.0 111.228 -176.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 85.8 t -118.59 117.41 54.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.613 175.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.5 126.96 31.87 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.735 174.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.62 HD21 ' HB2' ' B' ' 54' ' ' ALA . 75.1 mt -121.07 167.05 13.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.497 0.665 . . . . 0.0 112.265 -173.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 66' ' ' ASP . . . . . 0.45 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 10.9 t0 -137.45 98.2 3.64 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.533 168.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.685 HD21 HD23 ' A' ' 88' ' ' LEU . 4.9 mt -124.71 146.45 49.15 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.11 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 68' ' ' ASN . . . . . 0.581 ' ND2' ' HB3' ' A' ' 6' ' ' ALA . 56.4 t30 -148.37 120.78 8.46 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.003 175.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -116.54 141.61 47.95 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.926 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.438 ' HB2' ' HA ' ' A' ' 7' ' ' MET . 9.0 t -97.03 169.14 10.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.898 0.38 . . . . 0.0 110.111 -177.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -75.08 0.39 16.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.802 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.23 -4.14 56.47 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 174.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -95.56 147.07 23.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.028 0.442 . . . . 0.0 110.946 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -130.79 118.29 20.6 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 172.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.445 HG22 ' HB2' ' B' ' 46' ' ' ALA . 16.7 pt -130.5 157.33 42.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.043 0.449 . . . . 0.0 111.827 -169.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.448 ' HA ' ' HA ' ' B' ' 20' ' ' SER . 67.1 ttp -119.61 114.87 22.88 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.949 175.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 77' ' ' PHE . . . . . 0.611 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.4 OUTLIER -100.86 129.8 46.78 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.017 -177.206 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.653 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 53.3 p90 -152.41 150.66 29.9 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.994 -0.683 . . . . 0.0 112.142 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.653 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 7.3 p -113.33 136.34 52.86 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.446 177.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.21 151.97 23.42 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.582 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.14 -172.02 30.29 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -114.71 102.86 10.42 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.011 177.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.571 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -171.11 155.22 4.32 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.947 170.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 10.1 p -111.89 120.7 42.82 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.204 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.708 HG12 ' HB3' ' B' ' 34' ' ' LEU . 10.3 m -121.91 150.78 25.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.206 0.527 . . . . 0.0 112.363 -174.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 86' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' B' ' 32' ' ' VAL . 38.7 m -107.43 124.76 50.34 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.579 174.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.6 HD13 HD23 ' B' ' 11' ' ' LEU . 5.3 mp -94.96 146.52 24.18 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 169.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.672 HD23 HD21 ' C' ' 67' ' ' LEU . 1.0 OUTLIER -131.22 142.13 50.13 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.142 -178.651 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.06 -166.91 25.87 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.259 -176.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -154.41 134.56 13.19 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.825 0.821 . . . . 0.0 112.582 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 91' ' ' LEU . . . . . 0.862 HD23 ' HB3' ' B' ' 27' ' ' PHE . 14.3 mt -70.5 139.32 51.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.872 -1.513 . . . . 0.0 110.006 175.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -86.14 109.2 18.71 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -172.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -134.93 75.06 1.55 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 167.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 94' ' ' ILE . . . . . 0.679 ' HB ' ' O ' ' A' ' 2' ' ' GLN . 44.0 mm -74.56 -82.06 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.217 -172.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -82.2 84.14 7.16 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.21 0.529 . . . . 0.0 110.217 -178.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 5.8 m -68.59 -26.18 65.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.103 -179.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . -115.46 101.75 1.06 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.122 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 98' ' ' SER . . . . . 0.421 ' OG ' ' HA ' ' A' ' 1' ' ' PHE . 15.9 m . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.763 -0.637 . . . . 0.0 110.25 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 1' ' ' PHE . . . . . 0.4 ' HA ' ' OG ' ' D' ' 98' ' ' SER . 90.2 t80 . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 110.514 -0.18 . . . . 0.0 110.514 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 2' ' ' GLN . . . . . 0.611 ' O ' ' HB ' ' D' ' 94' ' ' ILE . 42.8 mt-30 54.58 -101.44 0.12 Allowed 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.646 0.591 . . . . 0.0 110.326 -177.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 3' ' ' GLY . . . . . 0.623 ' HA2' ' O ' ' C' ' 94' ' ' ILE . . . 103.33 174.42 26.2 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.114 -1.041 . . . . 0.0 113.804 173.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . 66.99 26.82 8.97 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.793 0.837 . . . . 0.0 111.365 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 44.5 ttm -88.19 47.55 1.52 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.488 0.661 . . . . 0.0 109.8 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 6' ' ' ALA . . . . . 0.564 ' HB3' ' ND2' ' D' ' 68' ' ' ASN . . . -65.93 152.02 45.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.336 -176.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 7' ' ' MET . . . . . 0.47 ' HA ' ' HB2' ' D' ' 70' ' ' SER . 45.9 ttm -104.29 142.45 34.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.84 -174.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 8' ' ' PHE . . . . . 0.625 ' CE1' HD21 ' D' ' 44' ' ' LEU . 67.8 t80 -61.32 147.36 44.94 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -172.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 9' ' ' TRP . . . . . 0.419 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 89.5 t90 -138.42 145.52 41.07 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.867 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.61 151.53 23.63 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.083 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.606 HD23 HD13 ' C' ' 87' ' ' LEU . 40.6 tp -146.33 109.63 4.74 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.706 0.253 . . . . 0.0 110.945 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -88.54 125.26 34.7 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.451 0.643 . . . . 0.0 111.037 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 13' ' ' MET . . . . . 0.549 ' HB2' HG23 ' C' ' 85' ' ' VAL . 7.1 mmt -98.26 130.17 44.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.568 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 14' ' ' LYS . . . . . 0.459 ' HB3' ' HG3' ' C' ' 17' ' ' ARG . 59.8 tttm -97.01 134.21 23.21 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 171.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 15' ' ' PRO . . . . . 0.447 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 2.2 Cg_endo -43.85 112.88 0.35 Allowed 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 123.451 2.767 . . . . 0.0 113.396 -174.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 16' ' ' GLU . . . . . 0.662 ' HA ' ' O ' ' C' ' 79' ' ' THR . 48.8 mt-10 69.45 44.32 0.94 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.813 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 17' ' ' ARG . . . . . 0.459 ' HG3' ' HB3' ' C' ' 14' ' ' LYS . 12.0 mmt180 -104.65 138.26 41.24 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.974 170.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 18' ' ' LYS . . . . . 0.667 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 46.5 mttp -113.27 118.61 35.1 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 123.375 0.422 . . . . 0.0 110.512 175.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -110.38 103.92 12.62 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 177.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 20' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 42.0 t -86.51 102.56 14.22 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 172.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -116.94 144.46 44.53 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.8 -170.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 11.1 t -97.9 157.06 16.31 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.99 174.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 23' ' ' ILE . . . . . 0.405 HG22 ' HA ' ' C' ' 71' ' ' LYS . 55.6 mt -120.31 124.14 71.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.076 0.465 . . . . 0.0 111.309 -173.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 24' ' ' ILE . . . . . 0.622 ' H ' HD13 ' C' ' 24' ' ' ILE . 0.2 OUTLIER -114.48 -18.44 7.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.827 177.011 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -132.39 121.83 24.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.562 176.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 46.8 t -65.65 133.41 51.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.061 -174.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 27' ' ' PHE . . . . . 0.825 ' HB3' HD23 ' C' ' 91' ' ' LEU . 46.5 p90 -137.64 147.33 44.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.743 0.782 . . . . 0.0 112.184 -177.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 28' ' ' HIS . . . . . 0.555 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 7.3 t60 -104.84 125.12 50.55 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.521 174.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 29' ' ' ILE . . . . . 0.566 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 44.5 mt -90.82 133.2 33.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 170.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.555 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 68.1 p -119.87 -7.27 10.01 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -171.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.73 159.1 26.59 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 119.204 -1.474 . . . . 0.0 113.708 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.454 HG23 ' HG ' ' C' ' 87' ' ' LEU . 11.2 p -144.48 131.71 16.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 173.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.414 ' HA ' HG21 ' C' ' 56' ' ' VAL . . . -148.5 157.66 43.61 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.915 -0.491 . . . . 0.0 112.063 -175.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.719 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.2 pp -126.53 146.2 50.22 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.593 0.711 . . . . 0.0 111.966 178.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -110.7 -52.3 2.8 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.847 168.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -99.72 127.76 45.84 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 175.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 37' ' ' GLY . . . . . 0.447 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 142.29 159.31 7.88 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.53 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -101.45 -45.38 5.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.74 0.305 . . . . 0.0 111.166 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 39' ' ' GLU . . . . . 0.426 ' HG3' HG22 ' C' ' 57' ' ' THR . 11.5 tt0 -152.3 126.54 9.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.532 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.564 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -127.74 113.74 16.39 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.475 0.655 . . . . 0.0 110.21 169.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -99.4 112.24 24.46 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 46.8 tp -81.64 115.51 20.94 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.635 -175.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -115.56 145.35 42.74 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.413 0.625 . . . . 0.0 110.356 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.627 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 0.9 OUTLIER -128.65 118.31 22.69 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.814 177.145 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 45' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -105.65 104.42 14.14 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.657 177.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.455 ' HB2' HD11 ' C' ' 44' ' ' LEU . . . -126.56 139.68 53.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.503 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 58.22 30.88 20.08 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 123.568 0.542 . . . . 0.0 110.029 -174.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 62.19 30.35 17.66 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.373 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 49' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 8.4 tp-100 -121.38 125.68 47.55 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -83.14 117.18 22.71 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.851 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -113.62 132.43 55.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.696 176.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -81.4 112.49 19.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 169.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 53' ' ' VAL . . . . . 0.511 ' CG2' ' HB3' ' C' ' 44' ' ' LEU . 3.4 t -86.84 -51.74 12.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.736 -172.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 54' ' ' ALA . . . . . 0.604 ' HB2' HD21 ' C' ' 65' ' ' LEU . . . -151.43 144.97 24.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.504 -176.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 28.5 m -109.28 101.63 10.62 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 171.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 56' ' ' VAL . . . . . 0.426 ' CG1' HG11 ' C' ' 85' ' ' VAL . 7.2 p -117.19 110.99 33.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.91 0.862 . . . . 0.0 109.944 -178.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 57' ' ' THR . . . . . 0.426 HG22 ' HG3' ' C' ' 39' ' ' GLU . 81.1 p -123.68 -177.48 3.75 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.274 -174.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -57.02 -34.98 68.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.985 0.421 . . . . 0.0 110.663 167.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.84 -40.79 65.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.529 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 75.6 mt -116.18 83.43 12.62 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 175.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.36 -3.78 11.59 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.228 2.618 . . . . 0.0 113.996 -168.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -162.9 130.86 3.77 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.256 0.551 . . . . 0.0 111.109 -175.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 86.5 t -118.6 117.45 54.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.636 175.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.53 126.97 31.89 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 174.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 65' ' ' LEU . . . . . 0.604 HD21 ' HB2' ' C' ' 54' ' ' ALA . 75.1 mt -121.14 166.99 13.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.41 0.624 . . . . 0.0 112.311 -173.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 66' ' ' ASP . . . . . 0.439 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 10.9 t0 -137.43 98.11 3.63 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.585 168.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.672 HD21 HD23 ' B' ' 88' ' ' LEU . 4.9 mt -124.71 146.42 49.17 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 68' ' ' ASN . . . . . 0.56 ' ND2' ' HB3' ' B' ' 6' ' ' ALA . 56.4 t30 -148.28 120.87 8.57 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.005 175.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -116.62 141.7 47.85 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.86 -177.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 70' ' ' SER . . . . . 0.437 ' HB2' ' HA ' ' B' ' 7' ' ' MET . 9.0 t -97.11 169.2 9.97 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.901 0.382 . . . . 0.0 110.063 -177.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 71' ' ' LYS . . . . . 0.405 ' HA ' HG22 ' C' ' 23' ' ' ILE . 15.0 ptmm? -75.28 0.51 16.38 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.793 -178.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.18 -4.17 56.52 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 173.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -95.43 147.08 23.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.064 0.459 . . . . 0.0 110.943 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -130.82 118.39 20.72 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.452 HG22 ' HB2' ' C' ' 46' ' ' ALA . 16.8 pt -130.55 157.31 42.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.04 0.448 . . . . 0.0 111.86 -169.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.438 ' HA ' ' HA ' ' C' ' 20' ' ' SER . 67.1 ttp -119.67 114.84 22.8 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.954 175.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 77' ' ' PHE . . . . . 0.627 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.4 OUTLIER -100.84 129.84 46.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.009 -177.143 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 78' ' ' TYR . . . . . 0.667 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 53.2 p90 -152.44 150.63 29.85 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.051 -0.66 . . . . 0.0 112.135 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 79' ' ' THR . . . . . 0.662 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 7.3 p -113.26 136.34 52.85 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.445 177.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.19 151.93 23.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.526 177.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.08 -172.08 30.44 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -176.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -114.7 102.96 10.51 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.03 177.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 83' ' ' ALA . . . . . 0.564 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -171.2 155.2 4.26 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.831 170.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 10.3 p -111.87 120.67 42.75 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.133 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.719 HG12 ' HB3' ' C' ' 34' ' ' LEU . 9.9 m -121.95 150.77 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 CA-C-O 121.268 0.556 . . . . 0.0 112.236 -174.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 86' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' C' ' 32' ' ' VAL . 38.0 m -107.37 124.76 50.29 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.691 174.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 87' ' ' LEU . . . . . 0.606 HD13 HD23 ' C' ' 11' ' ' LEU . 5.3 mp -94.9 146.53 24.16 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 169.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 88' ' ' LEU . . . . . 0.707 HD23 HD21 ' D' ' 67' ' ' LEU . 1.0 OUTLIER -131.3 142.1 50.06 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.086 -178.632 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.07 -166.87 25.83 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.198 -176.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -154.41 134.55 13.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.865 0.84 . . . . 0.0 112.563 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 91' ' ' LEU . . . . . 0.825 HD23 ' HB3' ' C' ' 27' ' ' PHE . 14.3 mt -70.43 139.36 51.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 113.809 -1.541 . . . . 0.0 110.046 175.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -86.11 109.22 18.7 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -172.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -134.9 75.0 1.55 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 167.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 94' ' ' ILE . . . . . 0.683 ' HB ' ' O ' ' B' ' 2' ' ' GLN . 43.8 mm -74.55 -81.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.279 -172.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -82.27 84.17 7.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.19 0.519 . . . . 0.0 110.173 -178.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 5.7 m -68.6 -26.22 65.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.126 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -115.41 101.83 1.07 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.051 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 98' ' ' SER . . . . . 0.443 ' OG ' ' HA ' ' B' ' 1' ' ' PHE . 16.0 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.566 -0.73 . . . . 0.0 110.183 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 1' ' ' PHE . . . . . 0.449 ' HA ' ' OG ' ' E' ' 98' ' ' SER . 90.2 t80 . . . . . 0 N--CA 1.483 1.179 0 N-CA-C 110.5 -0.185 . . . . 0.0 110.5 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 2' ' ' GLN . . . . . 0.653 ' O ' ' HB ' ' E' ' 94' ' ' ILE . 42.8 mt-30 54.73 -101.47 0.13 Allowed 'General case' 0 N--CA 1.464 0.273 0 O-C-N 123.716 0.635 . . . . 0.0 110.319 -177.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 3' ' ' GLY . . . . . 0.616 ' HA2' ' O ' ' D' ' 94' ' ' ILE . . . 103.45 174.31 26.08 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.851 173.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . 67.07 26.8 8.85 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.797 0.839 . . . . 0.0 111.335 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 44.5 ttm -88.25 47.58 1.52 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.554 0.692 . . . . 0.0 109.838 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 6' ' ' ALA . . . . . 0.562 ' HB3' ' ND2' ' E' ' 68' ' ' ASN . . . -65.91 152.03 45.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.363 -176.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 7' ' ' MET . . . . . 0.457 ' HA ' ' HB2' ' E' ' 70' ' ' SER . 45.9 ttm -104.3 142.47 34.49 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.814 -174.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 8' ' ' PHE . . . . . 0.62 ' CE1' HD21 ' E' ' 44' ' ' LEU . 67.9 t80 -61.27 147.45 44.46 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -172.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 9' ' ' TRP . . . . . 0.421 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 89.6 t90 -138.5 145.54 40.9 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.817 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.67 151.4 23.5 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.072 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.608 HD23 HD13 ' D' ' 87' ' ' LEU . 40.1 tp -146.28 109.67 4.76 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.697 0.284 . . . . 0.0 110.909 -179.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -88.55 125.35 34.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.393 0.616 . . . . 0.0 111.046 176.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 13' ' ' MET . . . . . 0.55 ' HB2' HG23 ' D' ' 85' ' ' VAL . 7.1 mmt -98.3 130.14 44.99 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.526 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 14' ' ' LYS . . . . . 0.458 ' HB3' ' HG3' ' D' ' 17' ' ' ARG . 59.6 tttm -96.93 134.29 23.18 Favored Pre-proline 0 C--N 1.318 -0.799 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 171.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 15' ' ' PRO . . . . . 0.444 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 2.2 Cg_endo -44.03 112.91 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.482 2.788 . . . . 0.0 113.361 -174.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 16' ' ' GLU . . . . . 0.663 ' HA ' ' O ' ' D' ' 79' ' ' THR . 48.9 mt-10 69.47 44.2 0.94 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.869 178.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 17' ' ' ARG . . . . . 0.458 ' HG3' ' HB3' ' D' ' 14' ' ' LYS . 12.0 mmt180 -104.59 138.25 41.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.004 170.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 18' ' ' LYS . . . . . 0.649 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 46.6 mttp -113.26 118.64 35.22 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.367 0.417 . . . . 0.0 110.503 175.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -110.31 103.86 12.58 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 177.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 20' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 42.0 t -86.41 102.68 14.26 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 172.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -117.12 144.38 44.76 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.746 -170.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 11.3 t -97.8 157.08 16.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.068 174.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 55.7 mt -120.33 124.09 71.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.118 0.485 . . . . 0.0 111.287 -173.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 24' ' ' ILE . . . . . 0.638 ' H ' HD13 ' D' ' 24' ' ' ILE . 0.2 OUTLIER -114.43 -18.43 7.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.859 176.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -132.37 121.86 24.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.614 176.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 46.8 t -65.7 133.45 51.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.079 -174.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 27' ' ' PHE . . . . . 0.837 ' HB3' HD23 ' D' ' 91' ' ' LEU . 46.2 p90 -137.64 147.34 44.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.667 0.746 . . . . 0.0 112.171 -177.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 28' ' ' HIS . . . . . 0.559 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 7.4 t60 -104.77 125.04 50.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.616 174.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 29' ' ' ILE . . . . . 0.585 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 44.8 mt -90.78 133.18 33.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 170.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 30' ' ' SER . . . . . 0.559 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 67.4 p -119.82 -7.33 10.02 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -171.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.68 159.1 26.65 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 119.295 -1.431 . . . . 0.0 113.726 177.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.474 HG23 ' HG ' ' D' ' 87' ' ' LEU . 11.1 p -144.48 131.78 16.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 173.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 33' ' ' ALA . . . . . 0.414 ' HA ' HG21 ' D' ' 56' ' ' VAL . . . -148.56 157.57 43.55 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.857 -0.527 . . . . 0.0 112.018 -174.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 34' ' ' LEU . . . . . 0.698 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.2 pp -126.53 146.17 50.23 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.645 0.736 . . . . 0.0 111.994 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -110.7 -52.3 2.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.865 168.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -99.7 127.73 45.82 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 175.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 37' ' ' GLY . . . . . 0.439 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 142.38 159.32 7.89 Favored Glycine 0 N--CA 1.435 -1.375 0 C-N-CA 120.191 -1.005 . . . . 0.0 112.562 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -101.42 -45.44 5.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.775 0.321 . . . . 0.0 111.167 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 39' ' ' GLU . . . . . 0.415 ' HG3' HG22 ' D' ' 57' ' ' THR . 11.6 tt0 -152.28 126.49 9.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.634 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 40' ' ' ALA . . . . . 0.579 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -127.68 113.79 16.49 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.45 0.643 . . . . 0.0 110.227 169.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -99.44 112.15 24.39 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 46.9 tp -81.64 115.4 20.89 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.677 -174.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -115.49 145.3 42.74 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.394 0.616 . . . . 0.0 110.288 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.628 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.9 OUTLIER -128.46 118.34 22.93 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.845 177.032 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 45' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -105.7 104.47 14.19 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.641 177.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.455 ' HB2' HD11 ' D' ' 44' ' ' LEU . . . -126.62 139.76 52.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.575 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 58.13 30.93 20.06 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 123.509 0.506 . . . . 0.0 109.987 -174.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 62.24 30.46 17.59 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.232 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 49' ' ' GLN . . . . . 0.443 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 8.4 tp-100 -121.51 125.68 47.38 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.022 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -83.17 117.26 22.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.769 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -113.72 132.45 55.81 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.647 176.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -81.34 112.63 19.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 168.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 53' ' ' VAL . . . . . 0.508 ' CG2' ' HB3' ' D' ' 44' ' ' LEU . 3.4 t -87.01 -51.56 12.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.73 -172.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 54' ' ' ALA . . . . . 0.621 ' HB2' HD21 ' D' ' 65' ' ' LEU . . . -151.55 144.96 24.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.521 -176.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 28.5 m -109.33 101.73 10.7 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 171.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 56' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' D' ' 40' ' ' ALA . 7.2 p -117.25 110.98 32.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.956 0.884 . . . . 0.0 109.94 -178.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 57' ' ' THR . . . . . 0.415 HG22 ' HG3' ' D' ' 39' ' ' GLU . 81.0 p -123.58 -177.56 3.76 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.365 -174.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -57.03 -34.88 68.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.891 0.377 . . . . 0.0 110.642 167.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.01 -40.64 65.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.56 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 75.5 mt -116.27 83.45 12.9 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.48 -3.65 11.44 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.195 2.596 . . . . 0.0 113.933 -168.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -162.95 130.81 3.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.101 0.477 . . . . 0.0 111.162 -176.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 87.7 t -118.59 117.39 54.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.586 175.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.39 126.98 31.85 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 65' ' ' LEU . . . . . 0.621 HD21 ' HB2' ' D' ' 54' ' ' ALA . 75.6 mt -121.17 167.01 13.14 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.509 0.671 . . . . 0.0 112.209 -173.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 66' ' ' ASP . . . . . 0.434 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 10.8 t0 -137.46 98.14 3.63 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.538 168.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.707 HD21 HD23 ' C' ' 88' ' ' LEU . 4.9 mt -124.69 146.38 49.17 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 68' ' ' ASN . . . . . 0.564 ' ND2' ' HB3' ' C' ' 6' ' ' ALA . 56.5 t30 -148.32 120.77 8.48 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.061 175.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -116.54 141.67 47.88 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.9 -177.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 70' ' ' SER . . . . . 0.47 ' HB2' ' HA ' ' C' ' 7' ' ' MET . 9.0 t -97.0 169.15 10.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.875 0.369 . . . . 0.0 110.1 -177.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -75.26 0.46 16.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.74 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.19 -4.08 56.54 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 173.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -95.53 147.06 23.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.076 0.465 . . . . 0.0 110.936 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -130.82 118.32 20.62 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 172.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.453 HG22 ' HB2' ' D' ' 46' ' ' ALA . 16.8 pt -130.58 157.42 42.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.102 0.477 . . . . 0.0 111.788 -169.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 76' ' ' MET . . . . . 0.436 ' HA ' ' HA ' ' D' ' 20' ' ' SER . 67.1 ttp -119.71 114.8 22.72 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.947 175.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 77' ' ' PHE . . . . . 0.628 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.4 OUTLIER -100.84 129.7 46.75 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.018 -177.132 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 78' ' ' TYR . . . . . 0.649 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 53.3 p90 -152.33 150.61 29.92 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.151 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 79' ' ' THR . . . . . 0.663 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 7.2 p -113.25 136.36 52.82 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.453 177.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.2 151.97 23.42 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.503 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.01 -171.97 30.43 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 -176.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -114.67 102.87 10.44 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.042 177.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 83' ' ' ALA . . . . . 0.579 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -171.09 155.27 4.36 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.9 170.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 9.9 p -111.93 120.7 42.82 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.13 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.698 HG12 ' HB3' ' D' ' 34' ' ' LEU . 10.1 m -122.0 150.74 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-O 121.298 0.57 . . . . 0.0 112.289 -174.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 86' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' D' ' 32' ' ' VAL . 38.7 m -107.41 124.83 50.43 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.588 174.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 87' ' ' LEU . . . . . 0.608 HD13 HD23 ' D' ' 11' ' ' LEU . 5.3 mp -94.93 146.58 24.13 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 169.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.703 HD23 HD21 ' E' ' 67' ' ' LEU . 1.0 OUTLIER -131.31 142.09 50.05 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.125 -178.709 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.1 -166.99 26.05 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.229 -176.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -154.34 134.57 13.26 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.808 0.813 . . . . 0.0 112.583 178.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 91' ' ' LEU . . . . . 0.837 HD23 ' HB3' ' D' ' 27' ' ' PHE . 14.3 mt -70.52 139.32 51.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 113.89 -1.504 . . . . 0.0 109.987 175.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -86.06 109.13 18.61 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -172.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -134.9 75.05 1.55 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 167.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 94' ' ' ILE . . . . . 0.616 ' O ' ' HA2' ' D' ' 3' ' ' GLY . 43.9 mm -74.44 -82.02 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.258 -172.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -82.32 84.21 7.2 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.29 0.566 . . . . 0.0 110.163 -178.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 5.8 m -68.66 -26.18 65.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.129 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . -115.38 101.69 1.06 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.211 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 98' ' ' SER . . . . . 0.4 ' OG ' ' HA ' ' C' ' 1' ' ' PHE . 16.0 m . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.82 -0.61 . . . . 0.0 110.189 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 1' ' ' PHE . . . . . 0.421 ' HA ' ' OG ' ' A' ' 98' ' ' SER . 90.1 t80 . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 110.539 -0.171 . . . . 0.0 110.539 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 2' ' ' GLN . . . . . 0.634 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 42.6 mt-30 54.7 -101.56 0.13 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.319 -177.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 3' ' ' GLY . . . . . 0.616 ' HA2' ' O ' ' E' ' 94' ' ' ILE . . . 103.48 174.38 26.05 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 119.975 -1.107 . . . . 0.0 113.795 173.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . 67.04 26.76 8.9 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.806 0.842 . . . . 0.0 111.339 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 44.5 ttm -88.22 47.61 1.53 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.597 0.713 . . . . 0.0 109.836 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 6' ' ' ALA . . . . . 0.573 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . . . -65.98 151.98 45.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.338 -176.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 7' ' ' MET . . . . . 0.462 ' HA ' ' HB2' ' A' ' 70' ' ' SER . 45.9 ttm -104.25 142.47 34.47 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.835 -174.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 8' ' ' PHE . . . . . 0.621 ' CE1' HD21 ' A' ' 44' ' ' LEU . 68.1 t80 -61.26 147.45 44.44 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -172.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 9' ' ' TRP . . . . . 0.422 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 89.5 t90 -138.47 145.59 41.03 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.882 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.76 151.34 23.45 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.083 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 11' ' ' LEU . . . . . 0.602 HD23 HD13 ' E' ' 87' ' ' LEU . 40.8 tp -146.2 109.62 4.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.67 0.272 . . . . 0.0 110.928 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 -88.43 125.28 34.65 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.356 0.598 . . . . 0.0 111.112 176.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 13' ' ' MET . . . . . 0.554 ' HB2' HG23 ' E' ' 85' ' ' VAL . 7.1 mmt -98.3 130.16 44.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.522 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 14' ' ' LYS . . . . . 0.46 ' HB3' ' HG3' ' E' ' 17' ' ' ARG . 59.7 tttm -97.05 134.24 23.14 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 171.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 15' ' ' PRO . . . . . 0.451 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 2.3 Cg_endo -44.05 112.93 0.37 Allowed 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 123.43 2.754 . . . . 0.0 113.373 -174.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 16' ' ' GLU . . . . . 0.657 ' HA ' ' O ' ' E' ' 79' ' ' THR . 48.8 mt-10 69.53 44.16 0.94 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.827 178.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 17' ' ' ARG . . . . . 0.46 ' HG3' ' HB3' ' E' ' 14' ' ' LYS . 11.9 mmt180 -104.46 138.27 41.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.978 170.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 18' ' ' LYS . . . . . 0.663 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 46.6 mttp -113.29 118.72 35.41 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.47 0.481 . . . . 0.0 110.521 175.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -110.35 103.96 12.67 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 20' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' E' ' 76' ' ' MET . 42.3 t -86.5 102.5 14.16 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 172.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -117.01 144.35 44.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.772 -170.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 11.3 t -97.81 157.03 16.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.005 174.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 23' ' ' ILE . . . . . 0.402 HG22 ' HA ' ' E' ' 71' ' ' LYS . 55.5 mt -120.29 124.11 71.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.052 0.453 . . . . 0.0 111.323 -173.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 24' ' ' ILE . . . . . 0.633 ' H ' HD13 ' E' ' 24' ' ' ILE . 0.2 OUTLIER -114.43 -18.37 7.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.907 176.918 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -132.37 121.77 24.0 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.62 176.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 46.8 t -65.71 133.43 51.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.061 -174.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 27' ' ' PHE . . . . . 0.831 ' HB3' HD23 ' E' ' 91' ' ' LEU . 46.6 p90 -137.6 147.3 44.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.692 0.758 . . . . 0.0 112.241 -177.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 28' ' ' HIS . . . . . 0.545 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 7.4 t60 -104.73 124.99 50.36 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.64 174.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 29' ' ' ILE . . . . . 0.585 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 45.1 mt -90.75 133.15 33.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 170.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 30' ' ' SER . . . . . 0.545 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 67.5 p -119.87 -7.18 10.01 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -171.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.75 159.12 26.6 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 119.183 -1.484 . . . . 0.0 113.747 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.465 HG23 ' HG ' ' E' ' 87' ' ' LEU . 11.1 p -144.49 131.72 16.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 173.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 33' ' ' ALA . . . . . 0.419 ' HA ' HG21 ' E' ' 56' ' ' VAL . . . -148.48 157.64 43.6 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.932 -0.48 . . . . 0.0 112.02 -174.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 34' ' ' LEU . . . . . 0.719 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.2 pp -126.6 146.26 50.23 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.635 0.731 . . . . 0.0 111.948 178.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -110.85 -52.21 2.8 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.818 168.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -99.72 127.71 45.84 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 37' ' ' GLY . . . . . 0.445 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 142.37 159.32 7.88 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.589 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -101.37 -45.41 5.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.708 0.289 . . . . 0.0 111.18 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 39' ' ' GLU . . . . . 0.41 ' HG3' HG22 ' E' ' 57' ' ' THR . 11.5 tt0 -152.33 126.41 9.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.626 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 40' ' ' ALA . . . . . 0.561 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -127.61 113.81 16.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.438 0.637 . . . . 0.0 110.205 169.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 41' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -99.49 112.3 24.52 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 174.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 46.8 tp -81.66 115.41 20.91 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.651 -175.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -115.48 145.32 42.71 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.515 0.674 . . . . 0.0 110.297 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 44' ' ' LEU . . . . . 0.62 HD21 ' CE1' ' D' ' 8' ' ' PHE . 0.9 OUTLIER -128.6 118.34 22.79 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.801 177.066 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' E' E ' 45' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -105.64 104.42 14.13 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.697 177.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 46' ' ' ALA . . . . . 0.461 ' HB2' HD11 ' E' ' 44' ' ' LEU . . . -126.54 139.77 52.96 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.587 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 57.98 31.04 20.09 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 123.611 0.569 . . . . 0.0 110.058 -174.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 62.24 30.27 17.56 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.284 -178.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 49' ' ' GLN . . . . . 0.449 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 8.4 tp-100 -121.35 125.67 47.55 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 178.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -83.16 117.2 22.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.815 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -113.64 132.44 55.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.714 175.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -81.27 112.51 19.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 168.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 53' ' ' VAL . . . . . 0.506 ' CG2' ' HB3' ' E' ' 44' ' ' LEU . 3.4 t -86.98 -51.51 12.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.732 -172.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 54' ' ' ALA . . . . . 0.606 ' HB2' HD21 ' E' ' 65' ' ' LEU . . . -151.57 144.97 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.468 -176.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 28.2 m -109.23 101.69 10.69 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 171.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 56' ' ' VAL . . . . . 0.421 ' CG1' HG11 ' E' ' 85' ' ' VAL . 7.2 p -117.25 110.9 32.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.885 0.85 . . . . 0.0 109.9 -177.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 57' ' ' THR . . . . . 0.41 HG22 ' HG3' ' E' ' 39' ' ' GLU . 81.1 p -123.59 -177.54 3.75 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.342 -174.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -56.92 -35.05 68.59 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.965 0.412 . . . . 0.0 110.555 167.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.9 -40.63 65.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.534 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 75.5 mt -116.35 83.38 13.0 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 175.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.38 -3.78 11.61 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.177 2.584 . . . . 0.0 113.933 -168.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -162.84 130.83 3.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.247 0.546 . . . . 0.0 111.135 -175.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 87.9 t -118.66 117.51 54.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.556 175.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.5 126.94 31.85 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.672 174.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.606 HD21 ' HB2' ' E' ' 54' ' ' ALA . 75.0 mt -121.04 167.02 13.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.439 0.637 . . . . 0.0 112.307 -173.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 66' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 10.9 t0 -137.44 98.2 3.65 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.593 168.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 67' ' ' LEU . . . . . 0.703 HD21 HD23 ' D' ' 88' ' ' LEU . 4.9 mt -124.67 146.39 49.15 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.081 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 68' ' ' ASN . . . . . 0.562 ' ND2' ' HB3' ' D' ' 6' ' ' ALA . 56.4 t30 -148.31 120.82 8.52 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.023 175.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -116.55 141.67 47.88 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.941 -177.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 70' ' ' SER . . . . . 0.457 ' HB2' ' HA ' ' D' ' 7' ' ' MET . 9.0 t -97.04 169.22 9.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.924 0.392 . . . . 0.0 110.034 -177.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 71' ' ' LYS . . . . . 0.402 ' HA ' HG22 ' E' ' 23' ' ' ILE . 15.1 ptmm? -75.19 0.28 16.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.748 -178.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.0 -4.23 56.72 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 173.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -95.46 147.13 23.86 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 120.992 0.425 . . . . 0.0 110.946 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -130.84 118.32 20.61 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 172.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 75' ' ' ILE . . . . . 0.449 HG22 ' HB2' ' E' ' 46' ' ' ALA . 16.8 pt -130.61 157.32 42.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.131 0.491 . . . . 0.0 111.774 -169.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 76' ' ' MET . . . . . 0.437 ' HA ' ' HA ' ' E' ' 20' ' ' SER . 67.1 ttp -119.55 114.82 22.84 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.005 175.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 77' ' ' PHE . . . . . 0.611 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.4 OUTLIER -100.92 129.76 46.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.001 -177.133 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' E' E ' 78' ' ' TYR . . . . . 0.663 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 53.3 p90 -152.43 150.64 29.87 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.989 -0.685 . . . . 0.0 112.148 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 79' ' ' THR . . . . . 0.657 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 7.3 p -113.27 136.4 52.79 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.413 177.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.22 152.02 23.37 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.528 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.96 -171.9 30.43 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -176.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -114.73 102.84 10.39 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.054 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 83' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -171.04 155.32 4.41 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.889 170.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 10.4 p -112.0 120.77 43.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.121 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 85' ' ' VAL . . . . . 0.719 HG12 ' HB3' ' E' ' 34' ' ' LEU . 9.8 m -122.12 150.71 25.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.237 0.542 . . . . 0.0 112.232 -174.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 38.9 m -107.43 124.75 50.32 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.606 174.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 87' ' ' LEU . . . . . 0.602 HD13 HD23 ' E' ' 11' ' ' LEU . 5.3 mp -94.87 146.54 24.14 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 169.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 88' ' ' LEU . . . . . 0.717 HD23 HD21 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -131.28 142.05 50.06 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.164 -178.663 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.01 -166.87 25.77 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.259 -176.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 90' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -154.42 134.62 13.22 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.804 0.812 . . . . 0.0 112.561 178.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 91' ' ' LEU . . . . . 0.831 HD23 ' HB3' ' E' ' 27' ' ' PHE . 14.3 mt -70.56 139.34 51.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.842 -1.527 . . . . 0.0 109.956 175.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -86.14 109.19 18.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.359 0.6 . . . . 0.0 112.517 -172.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -134.91 74.95 1.55 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 167.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 94' ' ' ILE . . . . . 0.653 ' HB ' ' O ' ' D' ' 2' ' ' GLN . 44.1 mm -74.48 -81.98 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.298 -172.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -82.28 84.12 7.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.219 0.533 . . . . 0.0 110.159 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 5.8 m -68.63 -26.21 65.23 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.055 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . -115.43 101.78 1.06 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.119 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 98' ' ' SER . . . . . 0.449 ' OG ' ' HA ' ' D' ' 1' ' ' PHE . 16.1 m . . . . . 0 C--O 1.247 0.974 0 CA-C-O 118.822 -0.609 . . . . 0.0 110.21 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.83 0.348 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -156.28 179.35 9.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.238 -175.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.428 ' HA3' ' N ' ' B' ' 94' ' ' ILE . . . -78.64 65.92 3.38 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.35 -0.453 . . . . 0.0 113.294 -174.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -130.2 68.22 1.46 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.899 0.38 . . . . 0.0 110.345 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -105.15 -42.09 5.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.543 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.554 ' O ' ' HB2' ' B' ' 70' ' ' SER . . . -57.87 120.2 8.05 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.951 -174.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.502 ' HA ' ' HB2' ' B' ' 70' ' ' SER . 55.9 mtp -101.97 169.45 8.76 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.333 -176.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -88.34 152.2 22.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.244 -175.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 87.1 t90 -138.57 146.49 41.91 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.86 155.8 26.34 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.108 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.627 HD23 HD13 ' A' ' 87' ' ' LEU . 42.4 tp -149.98 108.27 3.77 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.695 0.283 . . . . 0.0 110.951 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -86.8 103.31 15.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.149 0.499 . . . . 0.0 110.855 175.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.563 ' HB2' HG23 ' A' ' 85' ' ' VAL . 2.9 mmt -80.69 136.61 36.22 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.345 -179.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.552 ' HB2' ' HG3' ' A' ' 17' ' ' ARG . 27.2 mtpp -99.85 142.58 24.88 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 173.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.526 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 7.5 Cg_endo -50.19 115.26 1.79 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 123.443 2.762 . . . . 0.0 113.283 -175.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.67 ' HA ' ' O ' ' A' ' 79' ' ' THR . 26.1 mt-10 65.1 57.54 0.95 Allowed 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.597 0.713 . . . . 0.0 111.569 177.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.552 ' HG3' ' HB2' ' A' ' 14' ' ' LYS . 13.5 mmt180 -117.6 163.43 16.45 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.473 171.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.627 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 3.3 ttmp? -139.46 109.92 6.6 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 123.474 0.484 . . . . 0.0 110.843 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -111.38 113.31 25.68 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.7 p -72.18 116.53 12.72 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 171.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -98.0 117.71 32.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.673 -163.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.5 t -91.99 143.44 26.47 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 171.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.9 mt -115.32 124.41 71.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.153 0.502 . . . . 0.0 111.768 -172.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.1 mp -90.41 -43.8 14.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.816 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -140.09 149.45 43.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.12 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.532 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 23.1 t -59.9 115.22 3.25 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.102 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.907 ' HB3' HD23 ' A' ' 91' ' ' LEU . 12.5 p90 -122.86 148.97 44.8 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.471 0.653 . . . . 0.0 111.62 -177.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.668 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 10.3 t60 -106.66 120.43 41.94 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.552 178.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.597 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 31.4 mt -89.38 134.2 29.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 171.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.668 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 15.8 p -122.38 -15.52 7.61 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -171.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -155.66 152.87 24.31 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 119.533 -1.318 . . . . 0.0 113.227 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.463 HG23 ' HG ' ' A' ' 87' ' ' LEU . 11.7 p -150.15 122.28 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 171.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.29 154.61 42.54 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 122.008 -0.432 . . . . 0.0 111.572 -173.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.515 ' HB3' HG12 ' A' ' 85' ' ' VAL . 3.7 pp -113.94 139.28 49.35 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.638 0.733 . . . . 0.0 111.552 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -104.59 -56.06 2.24 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.83 173.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -102.27 127.82 49.08 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 170.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.497 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 150.93 162.26 10.55 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 119.683 -1.246 . . . . 0.0 113.472 176.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.524 ' O ' ' HG3' ' A' ' 58' ' ' LYS . 70.0 mt-30 -102.55 -47.99 4.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.573 0.225 . . . . 0.0 111.285 176.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -151.54 133.02 14.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.388 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.533 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -132.54 116.22 16.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.411 0.625 . . . . 0.0 110.527 170.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 79' ' ' THR . 97.8 mttt -100.14 112.59 24.9 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.5 tp -84.55 114.41 21.94 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -176.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.475 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 98.5 m-85 -116.23 145.62 42.98 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 176.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.607 ' HA ' ' O ' ' A' ' 76' ' ' MET . 0.3 OUTLIER -131.9 130.85 42.13 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.667 171.919 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -104.36 113.74 27.51 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.764 177.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.753 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -126.07 139.22 53.57 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 174.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 57.3 30.34 18.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.27 0.557 . . . . 0.0 109.615 -171.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.535 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 0.3 OUTLIER 64.84 17.11 10.86 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.456 -179.109 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 47.9 tt0 -104.99 121.54 43.97 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -82.15 112.12 18.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.686 -177.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -102.96 136.58 42.51 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.492 177.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -82.23 103.05 8.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 171.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.51 ' CG1' HD11 ' A' ' 67' ' ' LEU . 2.9 t -78.63 -52.8 14.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.763 -172.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.487 ' HB2' ' CD2' ' A' ' 65' ' ' LEU . . . -146.89 137.63 23.82 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.544 -177.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.1 m -104.49 101.62 11.29 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 170.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.428 ' CG1' HG11 ' A' ' 85' ' ' VAL . 6.2 p -121.7 109.81 25.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.979 0.895 . . . . 0.0 110.205 -177.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.6 p -122.85 -176.79 3.49 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.758 -175.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 38' ' ' GLN . 9.9 mtmp? -58.01 -31.54 67.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.028 0.442 . . . . 0.0 110.437 170.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.14 -40.82 51.76 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.551 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 69.9 mt -116.11 76.49 6.55 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 173.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -76.45 1.59 8.25 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.797 2.332 . . . . 0.0 113.329 -168.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -154.9 100.93 2.24 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.643 -170.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 66.0 t -102.59 121.02 53.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.113 0.482 . . . . 0.0 110.729 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.67 110.75 22.95 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.708 174.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -126.93 169.22 13.53 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.051 0.453 . . . . 0.0 111.708 -175.107 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.556 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 27.1 t0 -119.38 104.99 10.85 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.761 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.643 HD21 HD23 ' E' ' 88' ' ' LEU . 18.7 mt -120.65 150.68 40.55 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.992 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.542 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 22.3 t-20 -152.41 127.14 9.5 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.943 0.401 . . . . 0.0 110.017 172.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' A' ' 26' ' ' SER . 38.3 m-85 -121.31 161.47 21.97 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.764 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.586 ' HB2' ' O ' ' E' ' 6' ' ' ALA . 42.6 t -115.86 158.22 23.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.328 0.585 . . . . 0.0 111.87 -174.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -21.83 66.47 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.33 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.05 -1.06 61.48 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.894 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -100.56 166.11 11.08 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -145.14 129.63 17.92 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.753 HG22 ' HB2' ' A' ' 46' ' ' ALA . 9.7 pt -134.82 174.66 12.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.435 -173.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.607 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 23.1 mtp -130.46 123.81 30.61 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -105.09 127.58 52.95 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.071 178.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.627 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 24.4 p90 -153.9 141.86 20.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.102 0.477 . . . . 0.0 111.811 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.67 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 11.6 p -113.32 141.88 46.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.08 -178.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -109.85 150.87 27.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.576 176.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.3 176.8 40.45 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -177.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -107.42 102.11 11.41 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.687 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.533 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -170.22 150.43 3.65 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.874 169.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.3 t -104.41 119.28 38.6 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.563 HG23 ' HB2' ' A' ' 13' ' ' MET . 5.7 m -119.21 135.18 60.44 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 CA-C-O 121.453 0.644 . . . . 0.0 112.135 -174.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.5 t -99.61 119.49 38.17 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.988 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.627 HD13 HD23 ' A' ' 11' ' ' LEU . 5.3 mp -92.96 147.11 23.11 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 173.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.589 HD23 HD21 ' B' ' 67' ' ' LEU . 1.5 tp -133.25 138.76 46.61 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.098 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.95 -167.6 23.62 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.985 -177.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.503 ' CD2' ' HB3' ' B' ' 68' ' ' ASN . 20.2 p90 -153.58 135.56 14.68 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.797 0.808 . . . . 0.0 112.567 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.907 HD23 ' HB3' ' A' ' 27' ' ' PHE . 5.3 mt -77.08 110.0 11.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.447 175.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -90.37 151.25 21.53 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.02 -177.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -139.36 167.61 21.68 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.412 ' N ' ' HA3' ' E' ' 3' ' ' GLY . 77.5 mt -129.06 123.24 58.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.001 0.429 . . . . 0.0 110.586 -177.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -148.87 154.82 40.02 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.0 p -70.76 -12.04 61.31 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -175.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.59 -6.97 81.24 Favored Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.6 t . . . . . 0 C--O 1.249 1.034 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.467 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 120.792 0.329 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -156.32 179.29 9.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.292 -175.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' GLY . . . . . 0.431 ' HA3' ' N ' ' C' ' 94' ' ' ILE . . . -78.59 65.86 3.37 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.348 -0.454 . . . . 0.0 113.309 -174.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -130.17 68.17 1.46 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.817 0.341 . . . . 0.0 110.338 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -105.12 -42.12 5.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.544 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' C' ' 70' ' ' SER . . . -57.91 120.22 8.1 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.898 -174.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 7' ' ' MET . . . . . 0.522 ' HA ' ' HB2' ' C' ' 70' ' ' SER . 56.0 mtp -102.02 169.42 8.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.308 -176.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -88.3 152.34 22.0 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.277 -175.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -138.7 146.46 41.58 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.9 155.83 26.35 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.13 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.64 HD23 HD13 ' B' ' 87' ' ' LEU . 42.2 tp -149.97 108.22 3.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.701 0.286 . . . . 0.0 110.822 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -86.71 103.31 15.05 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.056 0.455 . . . . 0.0 110.879 175.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' MET . . . . . 0.564 ' HB2' HG23 ' B' ' 85' ' ' VAL . 2.8 mmt -80.89 136.77 36.12 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.272 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.544 ' HB2' ' HG3' ' B' ' 17' ' ' ARG . 27.2 mtpp -99.89 142.61 24.94 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 173.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.525 ' HB3' ' N ' ' B' ' 83' ' ' ALA . 7.6 Cg_endo -50.15 115.23 1.77 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.413 2.742 . . . . 0.0 113.372 -175.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.663 ' HA ' ' O ' ' B' ' 79' ' ' THR . 25.9 mt-10 65.04 57.58 0.96 Allowed 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.623 0.725 . . . . 0.0 111.598 177.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.544 ' HG3' ' HB2' ' B' ' 14' ' ' LYS . 13.6 mmt180 -117.55 163.31 16.61 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.532 171.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.649 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 3.3 ttmp? -139.42 110.02 6.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.746 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -111.42 113.34 25.72 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 2.7 p -72.07 116.48 12.53 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 171.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -97.84 117.55 32.41 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.764 -163.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 13.5 t -91.92 143.54 26.39 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 171.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 48.7 mt -115.44 124.46 71.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.227 0.537 . . . . 0.0 111.654 -172.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.463 ' N ' HD12 ' B' ' 24' ' ' ILE . 4.1 mp -90.44 -43.86 14.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.817 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -140.18 149.59 43.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.001 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' B' ' 69' ' ' PHE . 22.7 t -59.83 115.19 3.21 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.137 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 27' ' ' PHE . . . . . 0.91 ' HB3' HD23 ' B' ' 91' ' ' LEU . 12.5 p90 -122.84 148.9 44.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.478 0.656 . . . . 0.0 111.682 -177.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 28' ' ' HIS . . . . . 0.668 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 10.4 t60 -106.62 120.43 41.94 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.605 178.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.584 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 31.6 mt -89.51 134.24 29.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 171.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.668 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 16.3 p -122.4 -15.4 7.63 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 112.179 0.436 . . . . 0.0 112.179 -170.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -155.75 152.9 24.32 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 119.513 -1.327 . . . . 0.0 113.137 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.462 HG23 ' HG ' ' B' ' 87' ' ' LEU . 11.5 p -150.14 122.35 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 171.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.28 154.63 42.56 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.554 -173.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.499 ' HB3' HG12 ' B' ' 85' ' ' VAL . 3.7 pp -113.96 139.28 49.36 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 121.624 0.726 . . . . 0.0 111.529 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -104.59 -56.01 2.25 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.796 173.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -102.28 127.78 49.11 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 170.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.498 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 150.89 162.17 10.48 Favored Glycine 0 N--CA 1.438 -1.211 0 C-N-CA 119.547 -1.311 . . . . 0.0 113.407 176.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 38' ' ' GLN . . . . . 0.521 ' O ' ' HG3' ' B' ' 58' ' ' LYS . 26.5 mt-30 -102.52 -47.98 4.29 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.601 0.238 . . . . 0.0 111.293 177.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -151.57 133.06 14.69 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.636 -0.257 . . . . 0.0 110.442 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.529 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -132.56 116.3 16.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.517 0.675 . . . . 0.0 110.516 170.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' B' ' 79' ' ' THR . 97.7 mttt -100.2 112.64 24.97 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 40.6 tp -84.63 114.48 22.03 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 43' ' ' TYR . . . . . 0.473 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 98.8 m-85 -116.36 145.65 43.06 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.608 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.3 OUTLIER -131.95 130.77 41.93 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 120.371 -0.531 . . . . 0.0 109.731 171.944 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -104.29 113.78 27.57 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.821 177.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.773 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -126.13 139.22 53.54 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 174.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 57.3 30.28 18.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.293 0.568 . . . . 0.0 109.645 -171.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.526 ' HA ' ' HE2' ' B' ' 48' ' ' LYS . 0.3 OUTLIER 64.9 17.05 10.87 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.383 -179.233 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.505 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 47.9 tt0 -104.95 121.47 43.81 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -82.06 112.14 18.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.684 -177.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -102.86 136.51 42.54 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.524 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -82.27 102.99 8.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.778 0.799 . . . . 0.0 108.897 171.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.512 ' CG1' HD11 ' B' ' 67' ' ' LEU . 2.9 t -78.58 -52.78 14.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.798 -171.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.485 ' HB2' ' CD2' ' B' ' 65' ' ' LEU . . . -146.9 137.72 23.86 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.492 -177.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 28.0 m -104.6 101.65 11.29 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 170.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.425 ' CG1' HG11 ' B' ' 85' ' ' VAL . 6.2 p -121.77 109.82 25.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 122.005 0.907 . . . . 0.0 110.202 -177.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 80.4 p -122.84 -176.77 3.48 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.76 -175.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 58' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' B' ' 38' ' ' GLN . 9.9 mtmp? -58.04 -31.52 67.1 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.453 170.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.05 -40.93 52.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.634 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 69.8 mt -116.02 76.49 6.38 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.44 1.6 8.23 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.731 2.287 . . . . 0.0 113.397 -168.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 62' ' ' GLN . . . . . 0.415 ' OE1' ' HA ' ' C' ' 54' ' ' ALA . 10.2 tt0 -154.82 101.03 2.26 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.705 -170.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 65.7 t -102.63 121.01 53.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.108 0.48 . . . . 0.0 110.695 177.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.7 110.78 22.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.651 174.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' B' ' 30' ' ' SER . 0.3 OUTLIER -126.97 169.14 13.62 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.042 0.449 . . . . 0.0 111.738 -175.117 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 66' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 26.9 t0 -119.27 105.01 10.92 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.72 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.589 HD21 HD23 ' A' ' 88' ' ' LEU . 18.6 mt -120.76 150.76 40.49 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.999 178.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 68' ' ' ASN . . . . . 0.503 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 22.4 t-20 -152.48 127.08 9.42 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.001 0.429 . . . . 0.0 110.022 172.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 69' ' ' PHE . . . . . 0.54 ' O ' ' HA ' ' B' ' 26' ' ' SER . 38.8 m-85 -121.31 161.49 21.94 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.695 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.554 ' HB2' ' O ' ' A' ' 6' ' ' ALA . 42.6 t -115.83 158.27 23.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.318 0.58 . . . . 0.0 111.874 -174.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -21.73 66.47 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.242 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.13 -0.84 61.45 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.897 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -100.69 166.01 11.1 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -145.12 129.5 17.81 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.773 HG22 ' HB2' ' B' ' 46' ' ' ALA . 9.7 pt -134.67 174.62 12.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.072 0.463 . . . . 0.0 111.404 -173.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.608 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 23.1 mtp -130.46 123.75 30.48 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 77' ' ' PHE . . . . . 0.403 ' CD1' ' HB2' ' B' ' 44' ' ' LEU . 0.9 OUTLIER -105.14 127.64 53.0 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.009 178.46 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.649 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 24.4 p90 -153.96 141.84 20.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.128 0.489 . . . . 0.0 111.772 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.663 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 11.6 p -113.3 141.83 46.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.053 -178.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -109.9 150.76 27.96 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.572 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.49 176.83 40.17 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -177.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -107.54 102.21 11.48 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.706 179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -170.28 150.42 3.6 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.825 169.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 32.4 t -104.44 119.4 38.88 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.564 HG23 ' HB2' ' B' ' 13' ' ' MET . 5.6 m -119.24 135.15 60.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 CA-C-O 121.488 0.661 . . . . 0.0 112.096 -174.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 7.5 t -99.6 119.56 38.27 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.98 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.64 HD13 HD23 ' B' ' 11' ' ' LEU . 5.3 mp -92.95 147.15 23.08 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 173.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.641 HD23 HD21 ' C' ' 67' ' ' LEU . 1.5 tp -133.19 138.73 46.67 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.117 -178.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.97 -167.61 23.64 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.972 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 90' ' ' TYR . . . . . 0.523 ' CD2' ' HB3' ' C' ' 68' ' ' ASN . 20.2 p90 -153.59 135.66 14.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.856 0.836 . . . . 0.0 112.451 178.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 91' ' ' LEU . . . . . 0.91 HD23 ' HB3' ' B' ' 27' ' ' PHE . 5.2 mt -77.22 110.02 11.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.098 -1.41 . . . . 0.0 109.42 175.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -90.33 151.22 21.57 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.082 -177.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -139.36 167.69 21.51 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 94' ' ' ILE . . . . . 0.428 ' N ' ' HA3' ' A' ' 3' ' ' GLY . 77.7 mt -129.13 123.23 58.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.001 0.429 . . . . 0.0 110.623 -177.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -148.91 154.84 40.01 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.532 -0.758 . . . . 0.0 108.961 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 10.9 p -70.74 -12.01 61.29 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.56 -6.99 81.11 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -177.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 20.1 t . . . . . 0 C--O 1.247 0.955 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.536 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 120.857 0.36 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -156.27 179.31 9.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.314 -175.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 3' ' ' GLY . . . . . 0.4 ' HA3' ' N ' ' D' ' 94' ' ' ILE . . . -78.62 65.88 3.38 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.434 -0.412 . . . . 0.0 113.267 -174.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -130.2 68.1 1.46 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.832 0.349 . . . . 0.0 110.342 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -105.08 -42.05 5.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.574 -177.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 6' ' ' ALA . . . . . 0.58 ' O ' ' HB2' ' D' ' 70' ' ' SER . . . -57.91 120.18 8.03 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.973 -174.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 7' ' ' MET . . . . . 0.512 ' HA ' ' HB2' ' D' ' 70' ' ' SER . 55.7 mtp -101.92 169.48 8.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.322 -176.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 8' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -88.4 152.28 22.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.242 -175.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -138.68 146.44 41.59 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.85 155.83 26.35 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.138 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.627 HD23 HD13 ' C' ' 87' ' ' LEU . 42.4 tp -150.02 108.3 3.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.719 0.295 . . . . 0.0 110.912 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -86.78 103.36 15.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.051 0.453 . . . . 0.0 110.814 175.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 13' ' ' MET . . . . . 0.546 ' HB2' HG23 ' C' ' 85' ' ' VAL . 2.8 mmt -80.91 136.75 36.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.191 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 14' ' ' LYS . . . . . 0.571 ' HB2' ' HG3' ' C' ' 17' ' ' ARG . 27.2 mtpp -99.81 142.6 24.92 Favored Pre-proline 0 C--N 1.316 -0.854 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 173.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 15' ' ' PRO . . . . . 0.522 ' HB3' ' N ' ' C' ' 83' ' ' ALA . 7.6 Cg_endo -50.13 115.22 1.76 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 123.454 2.769 . . . . 0.0 113.382 -175.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 16' ' ' GLU . . . . . 0.673 ' HA ' ' O ' ' C' ' 79' ' ' THR . 26.0 mt-10 64.97 57.56 0.97 Allowed 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.617 0.722 . . . . 0.0 111.648 177.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 17' ' ' ARG . . . . . 0.571 ' HG3' ' HB2' ' C' ' 14' ' ' LYS . 13.6 mmt180 -117.48 163.41 16.44 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.512 171.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 18' ' ' LYS . . . . . 0.639 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 3.3 ttmp? -139.5 109.93 6.6 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.811 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -111.34 113.29 25.66 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 2.7 p -72.05 116.39 12.4 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 171.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -97.81 117.69 32.7 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.777 -163.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 13.6 t -92.03 143.41 26.5 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 171.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 49.1 mt -115.36 124.48 71.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.168 0.509 . . . . 0.0 111.758 -172.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 24' ' ' ILE . . . . . 0.463 ' N ' HD12 ' C' ' 24' ' ' ILE . 4.1 mp -90.52 -43.72 14.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.794 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -140.23 149.47 42.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.039 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 26' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' C' ' 69' ' ' PHE . 23.0 t -59.89 115.28 3.29 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.064 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 27' ' ' PHE . . . . . 0.918 ' HB3' HD23 ' C' ' 91' ' ' LEU . 12.3 p90 -122.89 148.97 44.84 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.512 0.672 . . . . 0.0 111.608 -177.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 28' ' ' HIS . . . . . 0.659 ' HE2' ' HB3' ' C' ' 30' ' ' SER . 10.3 t60 -106.61 120.43 41.94 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.438 -1.256 . . . . 0.0 109.593 178.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 29' ' ' ILE . . . . . 0.595 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 31.7 mt -89.46 134.28 29.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 171.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.659 ' HB3' ' HE2' ' C' ' 28' ' ' HIS . 16.1 p -122.46 -15.41 7.59 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -171.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 31' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -155.68 152.92 24.36 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 119.54 -1.314 . . . . 0.0 113.179 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.454 HG23 ' HG ' ' C' ' 87' ' ' LEU . 11.5 p -150.18 122.35 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 171.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.32 154.53 42.43 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.091 -0.381 . . . . 0.0 111.581 -172.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.512 ' HB3' HG12 ' C' ' 85' ' ' VAL . 3.7 pp -113.86 139.3 49.29 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.703 0.763 . . . . 0.0 111.528 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -104.62 -55.99 2.25 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.929 173.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -102.31 127.9 49.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 37' ' ' GLY . . . . . 0.494 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 150.85 162.12 10.44 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 119.604 -1.284 . . . . 0.0 113.512 176.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 38' ' ' GLN . . . . . 0.529 ' O ' ' HG3' ' C' ' 58' ' ' LYS . 26.5 mt-30 -102.47 -47.97 4.3 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 120.644 0.259 . . . . 0.0 111.34 177.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -151.61 132.98 14.6 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.436 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.535 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -132.53 116.25 16.49 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.47 0.653 . . . . 0.0 110.515 170.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' C' ' 79' ' ' THR . 97.8 mttt -100.12 112.66 24.97 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 40.7 tp -84.56 114.43 21.96 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -176.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 43' ' ' TYR . . . . . 0.472 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 98.6 m-85 -116.34 145.62 43.06 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.606 ' HA ' ' O ' ' C' ' 76' ' ' MET . 0.3 OUTLIER -131.92 130.82 42.06 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.769 171.864 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 45' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -104.27 113.75 27.51 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.8 177.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.748 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -126.09 139.24 53.55 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 174.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 57.19 30.42 18.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.392 0.615 . . . . 0.0 109.709 -171.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.515 ' HA ' ' HE2' ' C' ' 48' ' ' LYS . 0.3 OUTLIER 64.77 17.08 10.8 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.467 -179.125 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 49' ' ' GLN . . . . . 0.498 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 47.9 tt0 -104.89 121.5 43.83 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -82.05 112.14 18.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.773 -177.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -102.96 136.61 42.46 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.505 177.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -82.29 103.03 8.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.803 0.811 . . . . 0.0 108.908 171.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 53' ' ' VAL . . . . . 0.513 ' CG1' HD11 ' C' ' 67' ' ' LEU . 3.0 t -78.62 -52.72 15.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.745 -171.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 54' ' ' ALA . . . . . 0.484 ' HB2' HD23 ' C' ' 65' ' ' LEU . . . -146.91 137.59 23.77 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.582 -177.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 27.9 m -104.46 101.62 11.29 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 170.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 56' ' ' VAL . . . . . 0.43 ' CG1' HG11 ' C' ' 85' ' ' VAL . 6.1 p -121.75 109.77 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-O 121.958 0.885 . . . . 0.0 110.172 -177.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 80.7 p -122.85 -176.81 3.49 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.762 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 58' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' C' ' 38' ' ' GLN . 9.9 mtmp? -57.98 -31.62 67.08 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.396 170.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.01 -40.91 52.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.633 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 69.7 mt -115.96 76.46 6.24 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 173.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -76.41 1.59 8.22 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.766 2.311 . . . . 0.0 113.383 -168.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 62' ' ' GLN . . . . . 0.424 ' OE1' ' HA ' ' D' ' 54' ' ' ALA . 10.2 tt0 -154.9 101.03 2.25 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.649 -170.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 66.0 t -102.61 121.01 53.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.072 0.463 . . . . 0.0 110.728 177.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.72 110.85 23.09 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.64 174.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 65' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' C' ' 30' ' ' SER . 0.3 OUTLIER -126.97 169.15 13.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.109 0.48 . . . . 0.0 111.604 -175.068 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 66' ' ' ASP . . . . . 0.561 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 27.4 t0 -119.3 105.04 10.94 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.764 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.641 HD21 HD23 ' B' ' 88' ' ' LEU . 18.7 mt -120.71 150.64 40.65 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.024 178.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 68' ' ' ASN . . . . . 0.523 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 22.3 t-20 -152.37 127.12 9.52 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.961 0.41 . . . . 0.0 110.077 172.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 69' ' ' PHE . . . . . 0.536 ' O ' ' HA ' ' C' ' 26' ' ' SER . 38.8 m-85 -121.36 161.54 21.92 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.699 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 70' ' ' SER . . . . . 0.552 ' HB2' ' O ' ' B' ' 6' ' ' ALA . 42.7 t -115.88 158.18 23.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.273 0.559 . . . . 0.0 111.856 -174.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -21.92 66.53 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.318 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.02 -0.83 61.64 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.91 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -100.72 166.04 11.08 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -145.09 129.65 17.98 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.748 HG22 ' HB2' ' C' ' 46' ' ' ALA . 9.7 pt -134.87 174.56 12.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.047 0.451 . . . . 0.0 111.375 -173.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.606 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 23.3 mtp -130.37 123.77 30.67 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.299 174.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 77' ' ' PHE . . . . . 0.405 ' CD1' ' HB2' ' C' ' 44' ' ' LEU . 1.0 OUTLIER -105.08 127.56 52.94 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.006 178.486 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 78' ' ' TYR . . . . . 0.639 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 24.4 p90 -153.94 141.83 20.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.067 0.46 . . . . 0.0 111.842 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 79' ' ' THR . . . . . 0.673 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 11.7 p -113.29 141.85 46.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.103 -178.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -109.9 150.74 28.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.629 176.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.41 176.77 40.28 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -177.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -107.48 102.22 11.5 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 119.436 -0.905 . . . . 0.0 109.715 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 83' ' ' ALA . . . . . 0.535 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -170.2 150.41 3.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.942 169.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 32.5 t -104.42 119.38 38.84 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.546 HG23 ' HB2' ' C' ' 13' ' ' MET . 5.6 m -119.28 135.08 60.82 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 CA-C-O 121.454 0.645 . . . . 0.0 112.126 -174.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 7.5 t -99.61 119.5 38.17 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.044 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 87' ' ' LEU . . . . . 0.627 HD13 HD23 ' C' ' 11' ' ' LEU . 5.3 mp -92.95 147.01 23.19 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 173.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 88' ' ' LEU . . . . . 0.619 HD23 HD21 ' D' ' 67' ' ' LEU . 1.5 tp -133.15 138.8 46.76 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.145 -178.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.89 -167.59 23.54 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.072 -177.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 90' ' ' TYR . . . . . 0.524 ' CD2' ' HB3' ' D' ' 68' ' ' ASN . 20.2 p90 -153.7 135.7 14.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.867 0.841 . . . . 0.0 112.455 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 91' ' ' LEU . . . . . 0.918 HD23 ' HB3' ' C' ' 27' ' ' PHE . 5.2 mt -77.2 109.95 11.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.487 176.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -90.33 151.28 21.54 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.039 -177.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -139.34 167.71 21.46 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 94' ' ' ILE . . . . . 0.431 ' N ' ' HA3' ' B' ' 3' ' ' GLY . 77.6 mt -129.24 123.17 57.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.028 0.442 . . . . 0.0 110.614 -177.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -148.79 154.85 40.13 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.533 -0.758 . . . . 0.0 108.981 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 11.1 p -70.72 -12.02 61.3 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.5 -7.01 80.9 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -177.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 19.7 t . . . . . 0 C--O 1.249 1.078 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.576 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 120.823 0.345 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -156.31 179.33 9.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.301 -175.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 3' ' ' GLY . . . . . 0.41 ' HA3' ' N ' ' E' ' 94' ' ' ILE . . . -78.61 65.89 3.37 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.382 -0.437 . . . . 0.0 113.297 -174.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -130.15 68.09 1.46 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.866 0.365 . . . . 0.0 110.325 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -105.15 -41.9 5.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.625 -177.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 6' ' ' ALA . . . . . 0.539 ' O ' ' HB2' ' E' ' 70' ' ' SER . . . -58.03 120.18 8.1 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.913 -174.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 7' ' ' MET . . . . . 0.51 ' HA ' ' HB2' ' E' ' 70' ' ' SER . 55.7 mtp -102.07 169.44 8.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.287 -176.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 8' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -88.29 152.23 22.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.287 -175.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 9' ' ' TRP . . . . . . . . . . . . . 87.1 t90 -138.64 146.44 41.68 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.83 155.89 26.38 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.038 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.639 HD23 HD13 ' D' ' 87' ' ' LEU . 42.4 tp -150.04 108.23 3.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.665 0.269 . . . . 0.0 110.872 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 -86.79 103.31 15.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.072 0.463 . . . . 0.0 110.857 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 13' ' ' MET . . . . . 0.57 ' HB2' HG23 ' D' ' 85' ' ' VAL . 2.8 mmt -80.71 136.71 36.22 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.309 -178.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 14' ' ' LYS . . . . . 0.549 ' HB2' ' HG3' ' D' ' 17' ' ' ARG . 27.2 mtpp -99.88 142.61 24.92 Favored Pre-proline 0 C--N 1.317 -0.833 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 15' ' ' PRO . . . . . 0.521 ' HB3' ' N ' ' D' ' 83' ' ' ALA . 7.5 Cg_endo -50.11 115.28 1.79 Allowed 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 123.482 2.788 . . . . 0.0 113.293 -175.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 16' ' ' GLU . . . . . 0.681 ' HA ' ' O ' ' D' ' 79' ' ' THR . 26.1 mt-10 64.94 57.54 0.99 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.627 0.727 . . . . 0.0 111.631 177.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 17' ' ' ARG . . . . . 0.549 ' HG3' ' HB2' ' D' ' 14' ' ' LYS . 13.7 mmt180 -117.44 163.23 16.69 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.597 171.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 18' ' ' LYS . . . . . 0.648 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 3.3 ttmp? -139.38 109.96 6.65 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 123.446 0.466 . . . . 0.0 110.829 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -111.39 113.31 25.68 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 2.7 p -72.08 116.38 12.42 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 171.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -97.87 117.71 32.81 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.694 -163.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 13.7 t -92.06 143.41 26.49 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 171.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 49.0 mt -115.24 124.5 71.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.257 0.551 . . . . 0.0 111.761 -172.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 24' ' ' ILE . . . . . 0.47 HD12 ' N ' ' D' ' 24' ' ' ILE . 4.1 mp -90.59 -43.79 14.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.704 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -140.07 149.56 43.27 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.102 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 26' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' D' ' 69' ' ' PHE . 22.7 t -59.9 115.2 3.24 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.151 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 27' ' ' PHE . . . . . 0.889 ' HB3' HD23 ' D' ' 91' ' ' LEU . 12.5 p90 -122.81 148.88 44.87 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.487 0.66 . . . . 0.0 111.697 -177.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 28' ' ' HIS . . . . . 0.676 ' HE2' ' HB3' ' D' ' 30' ' ' SER . 10.3 t60 -106.55 120.43 41.92 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.662 178.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 29' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 31.5 mt -89.43 134.3 29.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 171.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 30' ' ' SER . . . . . 0.676 ' HB3' ' HE2' ' D' ' 28' ' ' HIS . 16.1 p -122.46 -15.38 7.6 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -171.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 31' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -155.74 152.99 24.41 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 119.517 -1.325 . . . . 0.0 113.15 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.471 HG23 ' HG ' ' D' ' 87' ' ' LEU . 11.6 p -150.23 122.28 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 171.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.3 154.58 42.5 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.13 -0.356 . . . . 0.0 111.599 -172.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 34' ' ' LEU . . . . . 0.508 ' HB3' HG12 ' D' ' 85' ' ' VAL . 3.7 pp -113.94 139.3 49.33 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.6 0.714 . . . . 0.0 111.502 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -104.61 -55.98 2.26 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.846 173.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -102.32 127.77 49.16 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 170.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 37' ' ' GLY . . . . . 0.486 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 150.89 162.2 10.5 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 119.623 -1.275 . . . . 0.0 113.507 176.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 38' ' ' GLN . . . . . 0.516 ' O ' ' HG3' ' D' ' 58' ' ' LYS . 70.0 mt-30 -102.55 -47.94 4.29 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 121.191 -0.203 . . . . 0.0 111.286 177.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -151.53 132.93 14.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.598 -0.273 . . . . 0.0 110.419 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 40' ' ' ALA . . . . . 0.546 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -132.46 116.33 16.65 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.422 0.629 . . . . 0.0 110.512 170.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' D' ' 79' ' ' THR . 97.7 mttt -100.18 112.67 24.99 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 174.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 40.5 tp -84.62 114.55 22.07 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -176.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 43' ' ' TYR . . . . . 0.476 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 98.7 m-85 -116.37 145.67 43.05 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.612 ' HA ' ' O ' ' D' ' 76' ' ' MET . 0.3 OUTLIER -132.0 130.74 41.82 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.71 171.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 45' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -104.28 113.74 27.51 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.848 177.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.763 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -126.02 139.13 53.66 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 174.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 57.38 30.27 18.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.355 0.598 . . . . 0.0 109.674 -171.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 48' ' ' LYS . . . . . 0.54 ' HA ' ' HE2' ' D' ' 48' ' ' LYS . 0.3 OUTLIER 64.87 17.09 10.86 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.47 -179.088 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 49' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 48.0 tt0 -104.92 121.5 43.84 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -82.11 112.07 18.82 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.76 -177.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -102.88 136.6 42.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.523 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -82.36 103.09 9.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 171.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 53' ' ' VAL . . . . . 0.518 ' CG1' HD11 ' D' ' 67' ' ' LEU . 3.0 t -78.72 -52.72 15.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.735 -171.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 54' ' ' ALA . . . . . 0.485 ' HB2' ' CD2' ' D' ' 65' ' ' LEU . . . -146.92 137.73 23.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.498 -177.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 28.4 m -104.61 101.64 11.28 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 170.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 56' ' ' VAL . . . . . 0.416 ' CG1' HG11 ' D' ' 85' ' ' VAL . 6.1 p -121.73 109.85 25.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 122.019 0.914 . . . . 0.0 110.199 -177.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 80.7 p -122.88 -176.75 3.48 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.811 -175.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 58' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' D' ' 38' ' ' GLN . 9.9 mtmp? -57.94 -31.63 67.03 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.418 170.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.06 -40.87 52.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.606 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 69.9 mt -116.09 76.51 6.53 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 173.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -76.39 1.47 8.34 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.769 2.313 . . . . 0.0 113.381 -168.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -154.79 100.95 2.26 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.736 -170.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 65.9 t -102.58 121.05 53.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.038 0.447 . . . . 0.0 110.688 177.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.72 110.77 22.99 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.666 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 65' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' D' ' 30' ' ' SER . 0.3 OUTLIER -126.98 169.16 13.61 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.124 0.488 . . . . 0.0 111.639 -175.055 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 66' ' ' ASP . . . . . 0.57 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 27.2 t0 -119.32 105.1 10.99 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.712 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.619 HD21 HD23 ' C' ' 88' ' ' LEU . 18.6 mt -120.75 150.67 40.63 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.98 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 68' ' ' ASN . . . . . 0.524 ' HB3' ' CD2' ' C' ' 90' ' ' TYR . 22.4 t-20 -152.41 127.11 9.49 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.91 0.386 . . . . 0.0 110.049 172.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 69' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' D' ' 26' ' ' SER . 38.4 m-85 -121.31 161.49 21.94 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.72 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 70' ' ' SER . . . . . 0.58 ' HB2' ' O ' ' C' ' 6' ' ' ALA . 42.3 t -115.82 158.25 23.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.263 0.554 . . . . 0.0 111.847 -174.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -21.97 66.58 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.272 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.86 -1.07 61.79 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.906 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -100.57 166.02 11.12 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -145.04 129.59 17.98 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.763 HG22 ' HB2' ' D' ' 46' ' ' ALA . 9.8 pt -134.82 174.61 12.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.058 0.456 . . . . 0.0 111.322 -173.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 76' ' ' MET . . . . . 0.612 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 23.2 mtp -130.45 123.76 30.51 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.284 174.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 77' ' ' PHE . . . . . 0.411 ' CD1' ' HB2' ' D' ' 44' ' ' LEU . 1.0 OUTLIER -105.05 127.53 52.92 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.093 178.51 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 78' ' ' TYR . . . . . 0.648 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 24.2 p90 -153.89 141.91 20.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.096 0.474 . . . . 0.0 111.756 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 79' ' ' THR . . . . . 0.681 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 11.7 p -113.36 141.84 46.57 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.033 -178.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -109.88 150.72 28.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.622 176.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.42 176.79 40.28 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -177.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -107.4 102.21 11.51 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.716 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 83' ' ' ALA . . . . . 0.546 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -170.25 150.37 3.62 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.895 169.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 32.4 t -104.41 119.24 38.52 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.57 HG23 ' HB2' ' D' ' 13' ' ' MET . 5.7 m -119.14 135.19 60.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-O 121.425 0.631 . . . . 0.0 112.107 -174.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 7.5 t -99.67 119.47 38.16 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.976 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 87' ' ' LEU . . . . . 0.639 HD13 HD23 ' D' ' 11' ' ' LEU . 5.3 mp -92.87 147.07 23.15 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 173.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.613 HD23 HD21 ' E' ' 67' ' ' LEU . 1.5 tp -133.23 138.7 46.61 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.151 -178.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.82 -167.55 23.41 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.997 -177.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 90' ' ' TYR . . . . . 0.502 ' CD2' ' HB3' ' E' ' 68' ' ' ASN . 20.2 p90 -153.64 135.71 14.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.805 0.812 . . . . 0.0 112.497 178.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 91' ' ' LEU . . . . . 0.889 HD23 ' HB3' ' D' ' 27' ' ' PHE . 5.3 mt -77.33 110.02 11.71 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.396 176.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -90.35 151.22 21.55 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.011 -177.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -139.32 167.68 21.53 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 94' ' ' ILE . . . . . 0.4 ' N ' ' HA3' ' C' ' 3' ' ' GLY . 77.9 mt -129.15 123.34 58.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.064 0.459 . . . . 0.0 110.6 -177.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -148.91 154.8 39.94 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.008 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 11.0 p -70.62 -12.04 61.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -175.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.61 -7.07 80.95 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -177.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 19.5 t . . . . . 0 C--O 1.25 1.114 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.54 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 120.852 0.358 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -156.29 179.31 9.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.264 -175.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 3' ' ' GLY . . . . . 0.412 ' HA3' ' N ' ' A' ' 94' ' ' ILE . . . -78.6 65.79 3.39 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 116.246 -0.434 . . . . 0.0 113.289 -174.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -130.15 68.24 1.46 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.739 0.304 . . . . 0.0 110.272 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -105.1 -42.16 5.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.59 -177.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 6' ' ' ALA . . . . . 0.586 ' O ' ' HB2' ' A' ' 70' ' ' SER . . . -57.84 120.11 7.87 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.987 -174.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 7' ' ' MET . . . . . 0.527 ' HA ' ' HB2' ' A' ' 70' ' ' SER . 56.0 mtp -101.95 169.43 8.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.288 -176.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 8' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -88.33 152.17 22.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.316 -175.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 9' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -138.62 146.51 41.82 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -178.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.81 155.88 26.38 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.166 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 11' ' ' LEU . . . . . 0.633 HD23 HD13 ' E' ' 87' ' ' LEU . 42.2 tp -150.06 108.33 3.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.774 0.321 . . . . 0.0 110.912 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -86.81 103.37 15.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.161 0.505 . . . . 0.0 110.834 175.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 13' ' ' MET . . . . . 0.552 ' HB2' HG23 ' E' ' 85' ' ' VAL . 2.8 mmt -80.84 136.74 36.15 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.22 -178.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 14' ' ' LYS . . . . . 0.553 ' HB2' ' HG3' ' E' ' 17' ' ' ARG . 27.2 mtpp -99.87 142.6 24.91 Favored Pre-proline 0 C--N 1.318 -0.803 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 15' ' ' PRO . . . . . 0.527 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 7.6 Cg_endo -50.02 115.22 1.74 Allowed 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 123.46 2.773 . . . . 0.0 113.399 -175.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 16' ' ' GLU . . . . . 0.678 ' HA ' ' O ' ' E' ' 79' ' ' THR . 25.9 mt-10 65.03 57.53 0.96 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.539 0.685 . . . . 0.0 111.637 177.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 17' ' ' ARG . . . . . 0.553 ' HG3' ' HB2' ' E' ' 14' ' ' LYS . 13.6 mmt180 -117.57 163.27 16.68 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.503 171.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 18' ' ' LYS . . . . . 0.639 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 3.3 ttmp? -139.47 109.96 6.62 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 123.457 0.473 . . . . 0.0 110.858 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -111.3 113.34 25.75 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 2.7 p -72.18 116.48 12.66 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -97.88 117.68 32.75 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.714 -163.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 13.5 t -91.98 143.44 26.48 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 171.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 48.7 mt -115.4 124.43 71.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.25 0.548 . . . . 0.0 111.781 -172.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 24' ' ' ILE . . . . . 0.475 HD12 ' N ' ' E' ' 24' ' ' ILE . 4.1 mp -90.41 -43.82 14.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.787 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -140.15 149.45 43.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.099 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 26' ' ' SER . . . . . 0.545 ' HA ' ' O ' ' E' ' 69' ' ' PHE . 23.0 t -59.83 115.24 3.25 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.155 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 27' ' ' PHE . . . . . 0.922 ' HB3' HD23 ' E' ' 91' ' ' LEU . 12.4 p90 -122.88 148.86 44.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.463 0.649 . . . . 0.0 111.684 -177.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 28' ' ' HIS . . . . . 0.678 ' HE2' ' HB3' ' E' ' 30' ' ' SER . 10.6 t60 -106.53 120.43 41.91 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.592 178.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 29' ' ' ILE . . . . . 0.58 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 31.5 mt -89.44 134.32 29.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 171.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 30' ' ' SER . . . . . 0.678 ' HB3' ' HE2' ' E' ' 28' ' ' HIS . 16.1 p -122.51 -15.41 7.57 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -171.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 31' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -155.77 152.89 24.32 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.562 -1.304 . . . . 0.0 113.195 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.469 HG23 ' HG ' ' E' ' 87' ' ' LEU . 11.6 p -150.21 122.32 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 171.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.37 154.47 42.34 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 122.13 -0.356 . . . . 0.0 111.552 -172.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 34' ' ' LEU . . . . . 0.511 ' HB3' HG12 ' E' ' 85' ' ' VAL . 3.7 pp -113.84 139.32 49.25 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.677 0.751 . . . . 0.0 111.569 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -104.59 -56.08 2.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.829 173.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -102.31 127.86 49.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 170.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 37' ' ' GLY . . . . . 0.494 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 150.92 162.16 10.48 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 119.613 -1.28 . . . . 0.0 113.493 176.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 38' ' ' GLN . . . . . 0.508 ' O ' ' HG3' ' E' ' 58' ' ' LYS . 69.8 mt-30 -102.5 -47.98 4.29 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 121.155 -0.218 . . . . 0.0 111.3 177.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -151.55 132.97 14.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.439 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 40' ' ' ALA . . . . . 0.531 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -132.54 116.26 16.51 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.412 0.625 . . . . 0.0 110.557 170.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 41' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' E' ' 79' ' ' THR . 97.8 mttt -100.12 112.59 24.89 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 40.7 tp -84.58 114.54 22.05 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -176.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 43' ' ' TYR . . . . . 0.471 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 98.4 m-85 -116.39 145.62 43.1 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 44' ' ' LEU . . . . . 0.605 ' HA ' ' O ' ' E' ' 76' ' ' MET . 0.3 OUTLIER -132.0 130.83 41.92 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.673 171.9 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 45' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -104.3 113.82 27.64 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.787 177.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 46' ' ' ALA . . . . . 0.771 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -126.12 139.18 53.58 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 174.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 57.3 30.3 18.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.315 0.578 . . . . 0.0 109.687 -171.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 48' ' ' LYS . . . . . 0.532 ' HA ' ' HE2' ' E' ' 48' ' ' LYS . 0.3 OUTLIER 64.88 17.17 10.9 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.41 -179.194 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 49' ' ' GLN . . . . . 0.504 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 47.9 tt0 -105.07 121.49 43.91 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -82.04 112.05 18.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.76 -177.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -102.91 136.57 42.48 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.491 177.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -82.27 103.11 9.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 171.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 53' ' ' VAL . . . . . 0.508 ' CG1' HD11 ' E' ' 67' ' ' LEU . 2.9 t -78.63 -52.75 15.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.79 -172.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 54' ' ' ALA . . . . . 0.489 ' HB2' ' CD2' ' E' ' 65' ' ' LEU . . . -146.93 137.66 23.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.5 -177.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 28.2 m -104.55 101.61 11.26 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 170.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 56' ' ' VAL . . . . . 0.427 ' CG1' HG11 ' E' ' 85' ' ' VAL . 6.3 p -121.67 109.78 25.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.974 0.893 . . . . 0.0 110.263 -177.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 80.4 p -122.79 -176.76 3.47 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.816 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 58' ' ' LYS . . . . . 0.508 ' HG3' ' O ' ' E' ' 38' ' ' GLN . 9.9 mtmp? -57.95 -31.7 67.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.023 0.44 . . . . 0.0 110.417 170.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.97 -40.88 52.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.621 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 70.0 mt -116.05 76.41 6.4 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -76.33 1.58 8.2 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.836 2.357 . . . . 0.0 113.408 -168.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 62' ' ' GLN . . . . . 0.408 ' OE1' ' HA ' ' A' ' 54' ' ' ALA . 10.2 tt0 -154.89 100.99 2.25 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.613 -170.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 66.3 t -102.66 120.99 53.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.112 0.482 . . . . 0.0 110.788 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.69 110.9 23.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.603 175.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' E' ' 30' ' ' SER . 0.3 OUTLIER -127.03 169.19 13.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.663 -175.096 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 66' ' ' ASP . . . . . 0.557 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 27.1 t0 -119.35 104.98 10.86 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.709 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 67' ' ' LEU . . . . . 0.613 HD21 HD23 ' D' ' 88' ' ' LEU . 18.5 mt -120.74 150.64 40.67 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.979 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 68' ' ' ASN . . . . . 0.502 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 22.4 t-20 -152.38 127.17 9.55 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.922 0.391 . . . . 0.0 110.013 172.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 69' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' E' ' 26' ' ' SER . 38.5 m-85 -121.3 161.52 21.87 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.745 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 70' ' ' SER . . . . . 0.539 ' HB2' ' O ' ' D' ' 6' ' ' ALA . 42.1 t -115.89 158.26 23.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.262 0.553 . . . . 0.0 111.841 -174.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -21.81 66.49 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.297 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.98 -1.03 61.61 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.949 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -100.59 166.0 11.13 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -145.03 129.71 18.09 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 75' ' ' ILE . . . . . 0.771 HG22 ' HB2' ' E' ' 46' ' ' ALA . 9.7 pt -134.84 174.6 12.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.002 0.43 . . . . 0.0 111.376 -173.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 76' ' ' MET . . . . . 0.605 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 22.9 mtp -130.41 123.76 30.56 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 77' ' ' PHE . . . . . 0.404 ' CD1' ' HB2' ' E' ' 44' ' ' LEU . 0.9 OUTLIER -105.08 127.58 52.95 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.038 178.493 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 78' ' ' TYR . . . . . 0.639 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 24.5 p90 -153.91 141.85 20.2 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.118 0.485 . . . . 0.0 111.822 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 79' ' ' THR . . . . . 0.678 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 11.5 p -113.3 141.94 46.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.046 -178.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -110.03 150.78 28.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.534 176.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.4 176.86 40.3 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -177.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -107.46 102.18 11.47 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 119.409 -0.916 . . . . 0.0 109.713 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 83' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -170.2 150.38 3.66 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.863 169.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 32.3 t -104.42 119.31 38.69 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 85' ' ' VAL . . . . . 0.552 HG23 ' HB2' ' E' ' 13' ' ' MET . 5.7 m -119.2 135.1 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 CA-C-O 121.421 0.629 . . . . 0.0 112.17 -174.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 7.5 t -99.57 119.58 38.28 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.963 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 87' ' ' LEU . . . . . 0.633 HD13 HD23 ' E' ' 11' ' ' LEU . 5.3 mp -93.01 147.14 23.09 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 88' ' ' LEU . . . . . 0.643 HD23 HD21 ' A' ' 67' ' ' LEU . 1.5 tp -133.22 138.67 46.61 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.12 -178.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.86 -167.62 23.55 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.021 -177.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 90' ' ' TYR . . . . . 0.542 ' CD2' ' HB3' ' A' ' 68' ' ' ASN . 20.1 p90 -153.65 135.74 14.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.932 0.872 . . . . 0.0 112.403 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 91' ' ' LEU . . . . . 0.922 HD23 ' HB3' ' E' ' 27' ' ' PHE . 5.2 mt -77.25 110.05 11.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 113.983 -1.462 . . . . 0.0 109.402 176.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -90.41 151.29 21.49 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.044 -177.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -139.39 167.68 21.53 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 94' ' ' ILE . . . . . 0.41 ' N ' ' HA3' ' D' ' 3' ' ' GLY . 77.9 mt -129.17 123.3 58.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.008 0.433 . . . . 0.0 110.565 -177.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -148.89 154.86 40.05 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.444 -0.798 . . . . 0.0 108.958 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 10.9 p -70.73 -12.01 61.29 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -175.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.61 -6.99 81.24 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -177.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 20.2 t . . . . . 0 C--O 1.25 1.099 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.58 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 83.4 t80 . . . . . 0 N--CA 1.478 0.925 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.418 ' HG3' ' H ' ' A' ' 3' ' ' GLY . 3.9 pt20 53.44 -68.2 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.668 1.587 . . . . 0.0 114.14 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.418 ' H ' ' HG3' ' A' ' 2' ' ' GLN . . . -155.67 33.11 0.63 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.398 -177.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.06 -64.82 0.97 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.87 0.366 . . . . 0.0 110.646 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 26.3 mmt -105.53 43.89 1.08 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.35 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.12 134.97 53.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.971 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.416 ' HA ' ' HB2' ' B' ' 70' ' ' SER . 57.1 mtp -98.15 151.12 20.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.053 0.454 . . . . 0.0 111.23 -174.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.557 ' CE1' HD21 ' B' ' 44' ' ' LEU . 48.7 t80 -66.47 145.49 55.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.068 -176.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.56 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 90.2 t90 -132.71 146.08 51.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.007 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.1 146.69 16.36 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.095 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.56 ' HB2' ' CH2' ' A' ' 9' ' ' TRP . 63.5 tp -134.27 109.02 8.56 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.983 0.42 . . . . 0.0 110.454 178.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -91.52 107.71 19.4 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.516 177.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.565 ' SD ' HD11 ' A' ' 87' ' ' LEU . 54.2 mtp -102.27 143.82 31.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.38 0.61 . . . . 0.0 111.406 -174.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -100.92 151.39 37.6 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.193 -177.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.472 ' HB3' ' N ' ' A' ' 83' ' ' ALA . 11.2 Cg_endo -54.99 113.77 1.56 Allowed 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.19 2.593 . . . . 0.0 112.832 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 79' ' ' THR . 17.3 mt-10 59.96 70.96 0.6 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.508 0.67 . . . . 0.0 111.414 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.2 142.77 32.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.558 174.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.712 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 35.3 ttmt -116.44 117.46 29.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.389 -176.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.418 ' OH ' ' HA ' ' A' ' 13' ' ' MET . 1.9 m-85 -110.37 122.26 47.28 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.47 ' HB3' ' SD ' ' A' ' 76' ' ' MET . 6.0 p -102.51 99.78 9.83 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 169.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 19.9 pm0 -117.72 143.0 46.62 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.595 0.712 . . . . 0.0 112.274 -174.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.0 t -93.31 160.77 14.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.526 176.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.412 HG22 ' HA ' ' A' ' 71' ' ' LYS . 70.1 mt -112.47 119.35 60.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.066 0.46 . . . . 0.0 111.529 -173.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.407 HD12 ' N ' ' A' ' 25' ' ' LYS . 1.7 pp -99.6 -11.53 8.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.025 177.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.407 ' N ' HD12 ' A' ' 24' ' ' ILE . 84.7 tttt -148.0 119.53 7.96 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.3 p -61.7 140.53 58.18 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 123.379 0.425 . . . . 0.0 110.656 -175.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.798 ' HB3' HD23 ' A' ' 91' ' ' LEU . 42.6 p90 -152.13 162.79 40.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.718 0.77 . . . . 0.0 112.895 -174.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.544 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 7.7 t60 -114.74 124.52 52.0 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.009 176.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 41.6 mt -88.28 135.91 24.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 170.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.487 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 43.8 p -123.62 -5.26 8.15 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -170.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . 179.88 155.14 14.62 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 119.192 -1.48 . . . . 0.0 113.513 175.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.447 HG23 ' HG ' ' A' ' 87' ' ' LEU . 11.9 p -136.78 132.83 48.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.8 156.48 42.4 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.605 -176.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.613 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.1 pp -123.72 145.55 48.92 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.403 0.621 . . . . 0.0 111.01 177.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -110.2 -52.06 2.81 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.653 174.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -102.93 127.5 50.12 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 169.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.46 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 151.75 156.75 7.59 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 119.769 -1.205 . . . . 0.0 113.344 177.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.487 ' HA ' ' HB2' ' A' ' 58' ' ' LYS . 94.8 mt-30 -102.37 -44.48 5.37 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.616 0.246 . . . . 0.0 111.07 178.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -152.82 128.83 10.34 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.363 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.477 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -128.22 113.02 15.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.549 0.69 . . . . 0.0 109.981 168.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 79' ' ' THR . 28.6 mmmt -94.59 109.39 21.31 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.51 HD23 ' HB ' ' A' ' 53' ' ' VAL . 48.3 tp -82.08 109.52 16.47 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -174.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -112.24 136.33 51.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.108 177.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.698 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -123.88 121.76 36.21 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.525 175.441 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -109.92 111.1 22.29 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.02 178.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.522 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -128.72 139.32 52.28 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.539 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 56.61 35.65 26.41 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 123.751 0.657 . . . . 0.0 110.314 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.429 ' HB3' ' NZ ' ' A' ' 48' ' ' LYS . 9.1 mtpm? 63.6 32.26 14.1 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.102 -0.953 . . . . 0.0 112.284 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.559 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 59.4 tp60 -128.28 133.96 48.85 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 175.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -89.05 121.84 31.79 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 -177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -116.72 123.44 47.21 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.506 176.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -75.38 106.69 5.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 169.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.613 ' CG2' ' HB3' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -84.22 -46.37 17.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.532 -172.299 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.56 ' HB2' HD21 ' A' ' 65' ' ' LEU . . . -153.96 149.48 27.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.641 -177.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.2 m -113.02 101.6 9.62 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 169.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.45 HG13 ' HB3' ' A' ' 40' ' ' ALA . 7.8 p -115.7 114.36 46.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.544 0.688 . . . . 0.0 109.283 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 44.6 p -122.62 -179.12 4.11 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.214 -172.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HB2' ' HA ' ' A' ' 38' ' ' GLN . 58.1 tttt -58.68 -32.29 68.98 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.704 171.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.4 -40.87 22.77 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.922 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 84.5 mt -108.38 86.63 3.55 Favored Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 175.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.08 0.17 8.76 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.665 2.243 . . . . 0.0 113.843 -166.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -164.49 131.07 3.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.24 0.543 . . . . 0.0 111.516 -175.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 93.4 t -122.0 112.22 33.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.311 174.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.59 131.49 41.76 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 174.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.56 HD21 ' HB2' ' A' ' 54' ' ' ALA . 86.3 mt -124.16 168.14 13.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.482 0.658 . . . . 0.0 112.303 -173.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.491 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 18.5 t0 -142.33 99.48 3.51 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.351 169.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 2.4 mt -129.46 144.21 51.16 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.437 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 5.9 t30 -141.79 114.91 8.74 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.539 -0.465 . . . . 0.0 109.771 176.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -111.14 146.93 35.96 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.541 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.9 t -97.88 166.72 11.32 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.412 ' HA ' HG22 ' A' ' 23' ' ' ILE . 21.6 ptmt -75.57 2.21 12.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.241 0.543 . . . . 0.0 110.591 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.25 -7.77 51.47 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.294 172.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -93.18 138.75 31.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.044 0.449 . . . . 0.0 110.447 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -122.22 117.0 25.12 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.522 HG22 ' HB2' ' A' ' 46' ' ' ALA . 14.9 pt -128.58 162.73 34.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.188 0.518 . . . . 0.0 112.054 -168.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.482 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 4.9 mtm -119.93 125.67 49.0 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 172.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.698 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -109.6 127.09 54.27 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 176.548 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.712 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 53.2 p90 -155.42 139.22 16.18 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.009 -175.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.576 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 2.9 p -111.7 134.23 53.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.309 -176.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.423 ' HB3' ' HB2' ' A' ' 41' ' ' LYS . . . -100.74 157.09 16.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.536 175.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.81 179.08 46.16 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -176.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -108.18 102.96 12.06 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.003 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.477 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -168.79 150.8 4.83 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.505 170.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.3 t -109.74 121.86 46.17 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.613 HG12 ' HB3' ' A' ' 34' ' ' LEU . 7.0 m -117.68 155.26 19.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.316 0.579 . . . . 0.0 112.38 -173.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.4 m -120.72 122.43 40.39 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.58 173.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.565 HD11 ' SD ' ' A' ' 13' ' ' MET . 4.7 mp -96.03 145.76 25.19 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 170.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.526 HD13 ' O ' ' A' ' 87' ' ' LEU . 1.2 mm? -121.02 150.3 41.35 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 173.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.31 -167.81 27.54 Favored Glycine 0 N--CA 1.438 -1.18 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.248 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.436 ' CD2' ' HB3' ' B' ' 68' ' ' ASN . 3.4 p90 -147.57 129.18 15.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.735 0.779 . . . . 0.0 112.07 177.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.798 HD23 ' HB3' ' A' ' 27' ' ' PHE . 15.7 mt -71.43 140.94 50.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 113.918 -1.492 . . . . 0.0 109.815 176.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 55.9 m-70 -66.61 141.85 57.67 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.266 0.555 . . . . 0.0 111.504 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -90.48 124.58 35.1 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.306 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 16.3 pt -82.73 -48.46 17.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.368 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -175.23 42.46 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.939 0.4 . . . . 0.0 110.988 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.4 m -78.41 61.09 2.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.057 0.456 . . . . 0.0 110.692 -178.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.41 80.78 1.48 Allowed Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.871 -0.681 . . . . 0.0 111.618 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.9 m . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.459 -179.895 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 83.6 t80 . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' GLN . . . . . 0.42 ' HG3' ' H ' ' B' ' 3' ' ' GLY . 3.9 pt20 53.36 -68.28 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.714 1.605 . . . . 0.0 114.129 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 3' ' ' GLY . . . . . 0.42 ' H ' ' HG3' ' B' ' 2' ' ' GLN . . . -155.53 33.14 0.64 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.404 -177.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.14 -64.7 1.0 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.812 0.339 . . . . 0.0 110.613 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 26.3 mmt -105.55 43.8 1.09 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.366 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' C' ' 70' ' ' SER . . . -56.07 134.95 52.96 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.951 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 56.8 mtp -98.18 151.09 20.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.267 -174.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.614 ' CE1' HD21 ' C' ' 44' ' ' LEU . 48.2 t80 -66.5 145.55 55.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.057 -176.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 9' ' ' TRP . . . . . 0.565 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 90.1 t90 -132.75 146.06 51.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.003 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.19 146.74 16.44 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.118 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.565 ' HB2' ' CH2' ' B' ' 9' ' ' TRP . 63.5 tp -134.29 109.05 8.57 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.013 0.435 . . . . 0.0 110.557 178.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -91.43 107.68 19.37 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.556 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' MET . . . . . 0.579 ' SD ' HD11 ' B' ' 87' ' ' LEU . 53.8 mtp -102.29 143.67 31.76 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.396 0.617 . . . . 0.0 111.382 -174.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -100.88 151.48 37.62 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.095 -177.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.464 ' HB3' ' N ' ' B' ' 83' ' ' ALA . 11.1 Cg_endo -55.02 113.87 1.6 Allowed 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 123.142 2.561 . . . . 0.0 112.752 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.581 ' HA ' ' O ' ' B' ' 79' ' ' THR . 17.3 mt-10 59.91 71.02 0.59 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.501 0.667 . . . . 0.0 111.356 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.23 142.83 32.66 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.613 174.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.709 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 35.3 ttmt -116.6 117.49 29.99 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.32 -176.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 19' ' ' TYR . . . . . 0.42 ' OH ' ' HA ' ' B' ' 13' ' ' MET . 1.9 m-85 -110.43 122.3 47.38 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.464 ' HB3' ' SD ' ' B' ' 76' ' ' MET . 5.9 p -102.58 99.83 9.86 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 169.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 19.8 pm0 -117.83 142.98 46.7 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.576 0.703 . . . . 0.0 112.165 -174.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 13.0 t -93.21 160.71 14.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.549 176.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.415 HG22 ' HA ' ' B' ' 71' ' ' LYS . 70.1 mt -112.52 119.4 60.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.138 0.494 . . . . 0.0 111.523 -173.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.405 HD12 ' N ' ' B' ' 25' ' ' LYS . 1.7 pp -99.68 -11.52 8.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.906 177.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.405 ' N ' HD12 ' B' ' 24' ' ' ILE . 84.8 tttt -147.95 119.58 8.01 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 31.4 p -61.67 140.53 58.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.654 -175.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 27' ' ' PHE . . . . . 0.792 ' HB3' HD23 ' B' ' 91' ' ' LEU . 42.8 p90 -152.16 162.73 40.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.774 0.797 . . . . 0.0 112.903 -174.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 28' ' ' HIS . . . . . 0.53 ' HA ' ' O ' ' B' ' 67' ' ' LEU . 7.6 t60 -114.66 124.49 51.95 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.053 177.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 41.8 mt -88.26 135.89 24.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 170.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.491 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 45.2 p -123.64 -5.2 8.14 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -170.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . 179.86 155.17 14.68 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 119.188 -1.482 . . . . 0.0 113.538 175.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.452 HG23 ' HG ' ' B' ' 87' ' ' LEU . 11.9 p -136.85 132.75 47.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 174.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.76 156.51 42.45 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 121.937 -0.477 . . . . 0.0 111.6 -176.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.629 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.1 pp -123.82 145.43 49.08 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.541 0.686 . . . . 0.0 111.038 177.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -110.02 -52.1 2.81 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.719 174.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -102.93 127.38 50.16 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 169.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.456 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 151.9 156.79 7.62 Favored Glycine 0 N--CA 1.437 -1.253 0 C-N-CA 119.756 -1.211 . . . . 0.0 113.366 177.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 38' ' ' GLN . . . . . 0.479 ' HA ' ' HB2' ' B' ' 58' ' ' LYS . 94.9 mt-30 -102.36 -44.34 5.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.692 0.282 . . . . 0.0 111.091 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -152.95 128.77 10.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.561 0.22 . . . . 0.0 111.339 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.472 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -128.16 113.08 15.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.539 0.685 . . . . 0.0 109.916 167.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' B' ' 79' ' ' THR . 28.6 mmmt -94.57 109.31 21.22 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.509 HD23 ' HB ' ' B' ' 53' ' ' VAL . 48.6 tp -82.08 109.44 16.4 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -174.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -112.2 136.41 51.66 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.072 177.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.694 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 0.1 OUTLIER -123.94 121.67 35.9 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.478 175.465 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -109.82 111.24 22.55 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.968 178.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.536 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -128.75 139.28 52.28 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.602 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 56.63 35.61 26.37 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.746 0.654 . . . . 0.0 110.358 -177.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.435 ' HB3' ' NZ ' ' B' ' 48' ' ' LYS . 9.1 mtpm? 63.57 32.38 14.1 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.277 178.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.553 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 59.3 tp60 -128.37 133.85 48.72 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 175.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -88.94 121.78 31.65 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -177.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -116.67 123.44 47.27 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.461 176.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -75.39 106.66 5.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 169.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.613 ' CG2' ' HB3' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -84.15 -46.42 17.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.535 -172.299 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.553 ' HB2' HD21 ' B' ' 65' ' ' LEU . . . -153.92 149.41 27.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.715 -177.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 53.2 m -113.0 101.67 9.69 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 169.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.437 HG13 ' HB3' ' B' ' 40' ' ' ALA . 7.7 p -115.78 114.35 45.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.578 0.704 . . . . 0.0 109.249 -179.028 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 45.0 p -122.59 -179.18 4.13 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.195 -172.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 58' ' ' LYS . . . . . 0.479 ' HB2' ' HA ' ' B' ' 38' ' ' GLN . 58.0 tttt -58.66 -32.33 69.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.747 171.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.37 -40.87 22.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.928 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 84.0 mt -108.31 86.69 3.52 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.16 0.21 8.74 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.731 2.288 . . . . 0.0 113.807 -166.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -164.52 131.05 3.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.326 0.584 . . . . 0.0 111.528 -175.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 92.9 t -121.95 112.17 33.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.348 174.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.56 131.54 41.83 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 174.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.553 HD21 ' HB2' ' B' ' 54' ' ' ALA . 86.1 mt -124.2 168.12 13.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.46 0.648 . . . . 0.0 112.226 -173.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 66' ' ' ASP . . . . . 0.484 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 18.6 t0 -142.4 99.44 3.5 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.396 169.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' B' ' 28' ' ' HIS . 2.3 mt -129.34 144.27 51.17 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 68' ' ' ASN . . . . . 0.436 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 5.9 t30 -141.98 114.89 8.65 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.836 176.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -111.03 146.89 35.92 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.552 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.416 ' HB2' ' HA ' ' A' ' 7' ' ' MET . 21.9 t -97.83 166.7 11.34 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.415 ' HA ' HG22 ' B' ' 23' ' ' ILE . 21.6 ptmt -75.53 2.11 12.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.208 0.528 . . . . 0.0 110.568 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.11 -7.78 51.82 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.336 172.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -93.24 138.68 31.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.183 0.516 . . . . 0.0 110.493 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -122.17 116.95 25.07 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.536 HG22 ' HB2' ' B' ' 46' ' ' ALA . 14.9 pt -128.41 162.86 34.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.243 0.545 . . . . 0.0 111.983 -168.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.491 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 4.9 mtm -120.08 125.8 49.18 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.389 172.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 77' ' ' PHE . . . . . 0.694 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.8 OUTLIER -109.64 127.08 54.3 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.64 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.709 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 53.2 p90 -155.43 139.23 16.19 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.983 -175.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.581 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 3.0 p -111.59 134.16 53.36 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.404 -176.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 80' ' ' ALA . . . . . 0.427 ' HB3' ' HB2' ' B' ' 41' ' ' LYS . . . -100.64 157.03 16.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.518 175.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.91 178.96 46.04 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -176.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -108.08 102.91 12.03 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.971 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.472 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -168.76 150.88 4.88 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.47 170.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 15.9 t -109.76 121.89 46.26 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.629 HG12 ' HB3' ' B' ' 34' ' ' LEU . 7.0 m -117.79 155.29 19.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.415 0.626 . . . . 0.0 112.331 -173.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 49.3 m -120.64 122.44 40.49 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.583 173.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.579 HD11 ' SD ' ' B' ' 13' ' ' MET . 4.7 mp -96.02 145.71 25.23 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 170.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.528 HD13 ' O ' ' B' ' 87' ' ' LEU . 1.2 mm? -120.96 150.2 41.48 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 173.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.21 -167.89 27.55 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.327 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 90' ' ' TYR . . . . . 0.435 ' CD2' ' HB3' ' C' ' 68' ' ' ASN . 3.4 p90 -147.53 129.22 15.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.755 0.788 . . . . 0.0 112.166 177.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 91' ' ' LEU . . . . . 0.792 HD23 ' HB3' ' B' ' 27' ' ' PHE . 15.8 mt -71.52 140.98 50.13 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 113.949 -1.478 . . . . 0.0 109.766 176.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 -66.63 141.93 57.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.134 0.493 . . . . 0.0 111.515 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -90.57 124.7 35.24 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.232 177.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 16.5 pt -82.76 -48.41 17.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.459 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -175.24 42.47 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.879 0.371 . . . . 0.0 110.976 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 1.5 m -78.55 61.14 2.83 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.987 0.423 . . . . 0.0 110.665 -178.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.41 80.83 1.48 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.507 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 48.3 m . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.358 -179.999 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 83.4 t80 . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 2' ' ' GLN . . . . . 0.416 ' HG3' ' H ' ' C' ' 3' ' ' GLY . 3.9 pt20 53.26 -68.13 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.762 1.625 . . . . 0.0 114.134 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 3' ' ' GLY . . . . . 0.416 ' H ' ' HG3' ' C' ' 2' ' ' GLN . . . -155.59 33.08 0.63 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.361 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.09 -64.75 0.99 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.887 0.375 . . . . 0.0 110.614 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 26.3 mmt -105.55 43.89 1.08 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.29 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.18 135.03 53.39 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.953 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 7' ' ' MET . . . . . 0.422 ' HA ' ' HB2' ' D' ' 70' ' ' SER . 56.4 mtp -98.25 151.04 20.89 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.289 -174.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 8' ' ' PHE . . . . . 0.594 ' CE1' HD21 ' D' ' 44' ' ' LEU . 48.8 t80 -66.35 145.47 55.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.101 -176.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 9' ' ' TRP . . . . . 0.559 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 90.2 t90 -132.71 146.02 51.52 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.046 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.13 146.69 16.35 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.1 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.559 ' HB2' ' CH2' ' C' ' 9' ' ' TRP . 63.5 tp -134.29 109.0 8.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.032 0.444 . . . . 0.0 110.468 178.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -91.44 107.66 19.36 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.583 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 13' ' ' MET . . . . . 0.572 ' SD ' HD11 ' C' ' 87' ' ' LEU . 53.5 mtp -102.21 143.61 31.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.322 0.582 . . . . 0.0 111.496 -174.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -100.8 151.46 37.6 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.205 -177.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 15' ' ' PRO . . . . . 0.463 ' HB3' ' N ' ' C' ' 83' ' ' ALA . 11.2 Cg_endo -55.01 113.89 1.61 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 123.152 2.568 . . . . 0.0 112.796 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 16' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' C' ' 79' ' ' THR . 17.4 mt-10 59.96 70.97 0.6 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.46 0.648 . . . . 0.0 111.328 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.24 142.97 32.67 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.554 174.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 18' ' ' LYS . . . . . 0.703 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 35.2 ttmt -116.69 117.42 29.76 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.323 -176.078 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 19' ' ' TYR . . . . . 0.426 ' OH ' ' HA ' ' C' ' 13' ' ' MET . 1.9 m-85 -110.38 122.33 47.43 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 20' ' ' SER . . . . . 0.458 ' HB3' ' SD ' ' C' ' 76' ' ' MET . 6.1 p -102.59 99.84 9.87 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 169.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 19.8 pm0 -117.78 143.05 46.6 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.611 0.72 . . . . 0.0 112.163 -174.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 12.9 t -93.36 160.76 14.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.532 176.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 23' ' ' ILE . . . . . 0.404 HG22 ' HA ' ' C' ' 71' ' ' LYS . 70.3 mt -112.54 119.35 60.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.141 0.495 . . . . 0.0 111.531 -173.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 24' ' ' ILE . . . . . 0.414 HD12 ' N ' ' C' ' 25' ' ' LYS . 1.7 pp -99.6 -11.51 8.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.022 177.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 25' ' ' LYS . . . . . 0.414 ' N ' HD12 ' C' ' 24' ' ' ILE . 84.7 tttt -148.02 119.46 7.91 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 31.7 p -61.57 140.46 58.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.688 -175.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 27' ' ' PHE . . . . . 0.806 ' HB3' HD23 ' C' ' 91' ' ' LEU . 42.6 p90 -152.04 162.86 40.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.652 0.739 . . . . 0.0 112.969 -175.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 28' ' ' HIS . . . . . 0.538 ' HA ' ' O ' ' C' ' 67' ' ' LEU . 7.5 t60 -114.81 124.58 52.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.01 177.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 29' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 41.6 mt -88.32 135.92 24.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 170.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.502 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 44.9 p -123.59 -5.31 8.16 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -170.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 31' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . 179.89 155.09 14.49 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 119.181 -1.485 . . . . 0.0 113.547 176.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.463 HG23 ' HG ' ' C' ' 87' ' ' LEU . 12.0 p -136.8 132.84 48.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 174.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.82 156.52 42.45 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 121.952 -0.468 . . . . 0.0 111.589 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.625 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.1 pp -123.82 145.45 49.06 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.514 0.673 . . . . 0.0 111.044 177.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -110.03 -52.14 2.81 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.703 174.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -102.9 127.41 50.11 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 169.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 37' ' ' GLY . . . . . 0.465 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 151.86 156.76 7.6 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 119.848 -1.168 . . . . 0.0 113.46 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 38' ' ' GLN . . . . . 0.478 ' HA ' ' HB2' ' C' ' 58' ' ' LYS . 95.0 mt-30 -102.4 -44.34 5.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.642 0.258 . . . . 0.0 111.059 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -152.91 128.82 10.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.57 0.224 . . . . 0.0 111.361 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.471 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -128.24 112.94 15.05 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.524 0.678 . . . . 0.0 109.972 168.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' C' ' 79' ' ' THR . 28.7 mmmt -94.57 109.32 21.23 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 176.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.508 HD23 ' HB ' ' C' ' 53' ' ' VAL . 48.5 tp -82.08 109.46 16.42 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -174.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -112.3 136.4 51.78 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.071 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.7 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 0.1 OUTLIER -123.88 121.79 36.29 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.478 175.463 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 45' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -109.85 111.14 22.38 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.968 178.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.532 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -128.7 139.39 52.25 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.607 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 56.5 35.75 26.49 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 123.728 0.643 . . . . 0.0 110.304 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.426 ' HB3' ' NZ ' ' C' ' 48' ' ' LYS . 9.1 mtpm? 63.64 32.2 14.05 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.253 178.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 49' ' ' GLN . . . . . 0.554 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 59.5 tp60 -128.23 133.88 48.9 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 175.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -88.99 121.69 31.61 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -116.66 123.43 47.26 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.453 176.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -75.4 106.72 5.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 53' ' ' VAL . . . . . 0.608 ' CG2' ' HB3' ' C' ' 44' ' ' LEU . 0.7 OUTLIER -84.2 -46.41 17.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.553 -172.351 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 54' ' ' ALA . . . . . 0.552 ' HB2' HD21 ' C' ' 65' ' ' LEU . . . -153.97 149.44 27.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.696 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 52.6 m -112.96 101.6 9.63 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 169.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 56' ' ' VAL . . . . . 0.44 HG13 ' HB3' ' C' ' 40' ' ' ALA . 7.8 p -115.69 114.33 45.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.517 0.675 . . . . 0.0 109.298 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 44.3 p -122.62 -179.17 4.13 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.205 -172.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 58' ' ' LYS . . . . . 0.478 ' HB2' ' HA ' ' C' ' 38' ' ' GLN . 57.9 tttt -58.52 -32.35 68.76 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.745 171.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.38 -41.03 22.57 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.851 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 83.9 mt -108.22 86.7 3.46 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 174.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.19 0.2 8.77 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.74 2.293 . . . . 0.0 113.786 -166.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -164.46 131.12 3.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.245 0.545 . . . . 0.0 111.576 -175.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 94.0 t -122.03 112.18 33.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.303 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.67 131.48 41.69 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 65' ' ' LEU . . . . . 0.552 HD21 ' HB2' ' C' ' 54' ' ' ALA . 86.2 mt -124.17 168.17 13.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.46 0.648 . . . . 0.0 112.265 -173.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 66' ' ' ASP . . . . . 0.461 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 18.5 t0 -142.46 99.46 3.5 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.964 -1.017 . . . . 0.0 108.332 169.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' C' ' 28' ' ' HIS . 2.3 mt -129.42 144.29 51.19 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 68' ' ' ASN . . . . . 0.435 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 5.9 t30 -141.86 114.95 8.74 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.762 176.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -111.17 146.88 36.1 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.529 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 70' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' B' ' 6' ' ' ALA . 21.9 t -97.81 166.62 11.38 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 71' ' ' LYS . . . . . 0.404 ' HA ' HG22 ' C' ' 23' ' ' ILE . 21.6 ptmt -75.46 2.08 12.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.215 0.531 . . . . 0.0 110.588 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.15 -7.7 51.87 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.253 172.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -93.27 138.7 31.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.123 0.487 . . . . 0.0 110.428 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -122.24 116.97 25.06 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 175.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.532 HG22 ' HB2' ' C' ' 46' ' ' ALA . 15.0 pt -128.51 162.73 34.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.259 0.552 . . . . 0.0 112.014 -168.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.486 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 4.8 mtm -119.92 125.69 49.08 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.475 172.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 77' ' ' PHE . . . . . 0.7 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.8 OUTLIER -109.66 127.11 54.33 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 176.635 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 78' ' ' TYR . . . . . 0.703 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 53.3 p90 -155.42 139.21 16.18 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.862 -0.735 . . . . 0.0 112.079 -176.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 79' ' ' THR . . . . . 0.577 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 3.0 p -111.56 134.22 53.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.42 -176.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 80' ' ' ALA . . . . . 0.436 ' HB3' ' HB2' ' C' ' 41' ' ' LYS . . . -100.71 157.1 16.94 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.522 175.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.81 178.93 46.2 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -176.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -108.06 102.98 12.1 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.064 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 83' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -168.79 150.77 4.82 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.504 170.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 15.8 t -109.72 121.93 46.34 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.625 HG12 ' HB3' ' C' ' 34' ' ' LEU . 6.9 m -117.78 155.3 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 CA-C-O 121.344 0.592 . . . . 0.0 112.353 -173.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 49.9 m -120.62 122.41 40.45 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.573 173.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 87' ' ' LEU . . . . . 0.572 HD11 ' SD ' ' C' ' 13' ' ' MET . 4.7 mp -96.0 145.72 25.21 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 170.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 88' ' ' LEU . . . . . 0.521 HD13 ' O ' ' C' ' 87' ' ' LEU . 1.2 mm? -121.0 150.31 41.32 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 173.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.31 -167.96 27.77 Favored Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.249 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 90' ' ' TYR . . . . . 0.447 ' CD2' ' HB3' ' D' ' 68' ' ' ASN . 3.3 p90 -147.52 129.24 15.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.785 0.802 . . . . 0.0 112.086 177.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 91' ' ' LEU . . . . . 0.806 HD23 ' HB3' ' C' ' 27' ' ' PHE . 15.9 mt -71.53 141.03 50.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 113.911 -1.495 . . . . 0.0 109.761 176.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 55.8 m-70 -66.6 141.86 57.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.184 0.516 . . . . 0.0 111.499 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -90.57 124.64 35.19 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.202 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 16.6 pt -82.77 -48.48 17.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.384 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -175.2 42.54 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.874 0.369 . . . . 0.0 110.963 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 1.4 m -78.44 60.98 2.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.951 0.405 . . . . 0.0 110.645 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.46 80.91 1.48 Allowed Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 -177.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.394 -179.978 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 83.5 t80 . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 2' ' ' GLN . . . . . 0.43 ' HG3' ' H ' ' D' ' 3' ' ' GLY . 3.9 pt20 53.43 -68.22 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.704 1.602 . . . . 0.0 114.131 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 3' ' ' GLY . . . . . 0.43 ' H ' ' HG3' ' D' ' 2' ' ' GLN . . . -155.64 33.03 0.63 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.35 -177.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.03 -64.83 0.97 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.873 0.368 . . . . 0.0 110.634 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 26.3 mmt -105.45 43.84 1.09 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.348 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.1 134.91 53.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.939 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 56.7 mtp -98.17 151.07 20.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.03 0.443 . . . . 0.0 111.326 -174.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 8' ' ' PHE . . . . . 0.592 ' CE1' HD21 ' E' ' 44' ' ' LEU . 48.6 t80 -66.5 145.55 55.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.1 -176.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 9' ' ' TRP . . . . . 0.556 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 90.2 t90 -132.75 146.02 51.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.013 179.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.11 146.71 16.41 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.125 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.556 ' HB2' ' CH2' ' D' ' 9' ' ' TRP . 63.4 tp -134.31 108.95 8.5 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.031 0.443 . . . . 0.0 110.558 178.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -91.38 107.67 19.37 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.566 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 13' ' ' MET . . . . . 0.575 ' SD ' HD11 ' D' ' 87' ' ' LEU . 54.0 mtp -102.3 143.77 31.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.429 0.633 . . . . 0.0 111.408 -174.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -100.84 151.44 37.61 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.203 -177.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 15' ' ' PRO . . . . . 0.473 ' HB3' ' N ' ' D' ' 83' ' ' ALA . 11.1 Cg_endo -55.06 113.9 1.62 Allowed 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 123.119 2.546 . . . . 0.0 112.754 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 16' ' ' GLU . . . . . 0.57 ' HA ' ' O ' ' D' ' 79' ' ' THR . 17.3 mt-10 60.02 70.83 0.61 Allowed 'General case' 0 C--O 1.233 0.207 0 O-C-N 123.711 0.632 . . . . 0.0 111.36 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.13 142.97 32.81 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.516 174.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 18' ' ' LYS . . . . . 0.702 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 35.3 ttmt -116.69 117.44 29.81 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.373 -176.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 19' ' ' TYR . . . . . 0.426 ' OH ' ' HA ' ' D' ' 13' ' ' MET . 1.9 m-85 -110.29 122.38 47.52 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 20' ' ' SER . . . . . 0.462 ' HB3' ' SD ' ' D' ' 76' ' ' MET . 5.9 p -102.63 99.86 9.88 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 169.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 19.8 pm0 -117.76 142.98 46.66 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.516 0.674 . . . . 0.0 112.215 -174.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 13.0 t -93.24 160.77 14.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.609 176.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 70.1 mt -112.6 119.49 60.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.217 0.532 . . . . 0.0 111.449 -173.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 24' ' ' ILE . . . . . 0.409 HD12 ' N ' ' D' ' 25' ' ' LYS . 1.7 pp -99.7 -11.59 8.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.005 177.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 25' ' ' LYS . . . . . 0.409 ' N ' HD12 ' D' ' 24' ' ' ILE . 84.7 tttt -147.99 119.55 7.97 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 31.3 p -61.75 140.51 58.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.691 -175.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 27' ' ' PHE . . . . . 0.806 ' HB3' HD23 ' D' ' 91' ' ' LEU . 42.8 p90 -152.08 162.82 40.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.712 0.768 . . . . 0.0 112.898 -174.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 28' ' ' HIS . . . . . 0.53 ' HA ' ' O ' ' D' ' 67' ' ' LEU . 7.7 t60 -114.81 124.58 52.1 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.011 176.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 29' ' ' ILE . . . . . 0.513 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 42.1 mt -88.33 135.88 24.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 170.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 30' ' ' SER . . . . . 0.504 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 44.6 p -123.59 -5.28 8.16 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -170.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 31' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . 179.94 155.12 14.6 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 119.175 -1.488 . . . . 0.0 113.544 176.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.473 HG23 ' HG ' ' D' ' 87' ' ' LEU . 12.0 p -136.84 132.84 48.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 174.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.83 156.46 42.36 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.918 -0.489 . . . . 0.0 111.598 -176.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 34' ' ' LEU . . . . . 0.624 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.1 pp -123.77 145.43 49.04 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.538 0.685 . . . . 0.0 111.069 177.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -110.13 -51.93 2.83 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.706 174.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -103.02 127.4 50.28 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 169.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 37' ' ' GLY . . . . . 0.47 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 151.81 156.81 7.62 Favored Glycine 0 N--CA 1.437 -1.253 0 C-N-CA 119.811 -1.185 . . . . 0.0 113.384 177.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 38' ' ' GLN . . . . . 0.49 ' HA ' ' HB2' ' D' ' 58' ' ' LYS . 95.0 mt-30 -102.43 -44.41 5.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.662 0.267 . . . . 0.0 111.053 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -152.87 128.84 10.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.327 178.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 40' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -128.22 113.08 15.23 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.557 0.694 . . . . 0.0 109.884 168.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' D' ' 79' ' ' THR . 28.6 mmmt -94.6 109.35 21.27 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 176.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.51 HD23 ' HB ' ' D' ' 53' ' ' VAL . 48.5 tp -82.13 109.49 16.49 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -174.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -112.22 136.34 51.77 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.123 177.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.704 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.1 OUTLIER -123.91 121.78 36.24 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.498 175.427 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 45' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -109.91 111.16 22.39 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.915 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.532 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -128.72 139.39 52.24 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.567 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 56.57 35.72 26.5 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 123.654 0.596 . . . . 0.0 110.207 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 48' ' ' LYS . . . . . 0.431 ' HB3' ' NZ ' ' D' ' 48' ' ' LYS . 9.1 mtpm? 63.6 32.32 14.08 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.276 178.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 49' ' ' GLN . . . . . 0.558 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 59.5 tp60 -128.3 133.98 48.84 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -89.1 121.79 31.78 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -177.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -116.72 123.4 47.12 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.442 176.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -75.42 106.71 5.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 169.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 53' ' ' VAL . . . . . 0.61 ' CG2' ' HB3' ' D' ' 44' ' ' LEU . 0.7 OUTLIER -84.09 -46.44 18.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.599 -172.392 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 54' ' ' ALA . . . . . 0.55 ' HB2' HD21 ' D' ' 65' ' ' LEU . . . -153.89 149.38 27.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.728 -177.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 53.0 m -112.93 101.64 9.68 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 169.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 56' ' ' VAL . . . . . 0.444 HG13 ' HB3' ' D' ' 40' ' ' ALA . 7.8 p -115.71 114.37 46.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.605 0.716 . . . . 0.0 109.254 -179.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 44.7 p -122.65 -179.23 4.15 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.13 -172.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 58' ' ' LYS . . . . . 0.49 ' HB2' ' HA ' ' D' ' 38' ' ' GLN . 57.9 tttt -58.61 -32.3 68.87 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.721 171.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.38 -40.94 22.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.862 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 84.7 mt -108.33 86.68 3.53 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 175.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.11 0.23 8.7 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.79 2.327 . . . . 0.0 113.845 -166.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -164.52 131.07 3.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.342 0.591 . . . . 0.0 111.526 -175.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 93.5 t -122.09 112.24 33.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.308 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.64 131.56 41.8 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 174.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 65' ' ' LEU . . . . . 0.55 HD21 ' HB2' ' D' ' 54' ' ' ALA . 86.3 mt -124.2 168.16 13.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.559 0.695 . . . . 0.0 112.188 -173.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 66' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 18.6 t0 -142.44 99.46 3.5 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.319 169.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' D' ' 28' ' ' HIS . 2.3 mt -129.47 144.27 51.18 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 68' ' ' ASN . . . . . 0.447 ' HB3' ' CD2' ' C' ' 90' ' ' TYR . 5.9 t30 -141.88 114.9 8.7 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.538 -0.465 . . . . 0.0 109.805 176.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -111.06 146.86 36.0 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.569 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 70' ' ' SER . . . . . 0.422 ' HB2' ' HA ' ' C' ' 7' ' ' MET . 21.8 t -97.78 166.7 11.35 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -75.54 2.15 12.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.195 0.522 . . . . 0.0 110.583 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.14 -7.76 51.77 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.271 172.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -93.28 138.76 31.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.159 0.504 . . . . 0.0 110.489 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -122.3 116.98 25.02 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 175.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.532 HG22 ' HB2' ' D' ' 46' ' ' ALA . 14.9 pt -128.5 162.72 34.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.135 0.493 . . . . 0.0 112.051 -168.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 76' ' ' MET . . . . . 0.496 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 4.9 mtm -120.03 125.67 48.92 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.458 172.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 77' ' ' PHE . . . . . 0.704 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.8 OUTLIER -109.63 127.18 54.35 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.639 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 78' ' ' TYR . . . . . 0.702 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 53.3 p90 -155.52 139.2 16.07 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 119.814 -0.755 . . . . 0.0 112.006 -175.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 79' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 2.9 p -111.62 134.22 53.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.415 -176.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 80' ' ' ALA . . . . . 0.412 ' HB3' ' HB2' ' D' ' 41' ' ' LYS . . . -100.66 157.19 16.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.499 175.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.69 178.99 46.35 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -108.1 103.0 12.11 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 117.784 0.792 . . . . 0.0 110.013 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 83' ' ' ALA . . . . . 0.49 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -168.92 150.73 4.68 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.46 170.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 15.3 t -109.64 121.85 46.14 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.624 HG12 ' HB3' ' D' ' 34' ' ' LEU . 6.9 m -117.78 155.3 19.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.442 0.639 . . . . 0.0 112.288 -173.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 49.6 m -120.71 122.42 40.38 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.519 173.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 87' ' ' LEU . . . . . 0.575 HD11 ' SD ' ' D' ' 13' ' ' MET . 4.7 mp -96.0 145.72 25.21 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 170.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.521 HD13 ' O ' ' D' ' 87' ' ' LEU . 1.1 mm? -121.0 150.28 41.38 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.25 -167.89 27.6 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.25 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 90' ' ' TYR . . . . . 0.422 ' CD2' ' HB3' ' E' ' 68' ' ' ASN . 3.4 p90 -147.46 129.25 15.24 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.769 0.795 . . . . 0.0 112.115 177.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 91' ' ' LEU . . . . . 0.806 HD23 ' HB3' ' D' ' 27' ' ' PHE . 15.8 mt -71.52 141.0 50.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 113.901 -1.5 . . . . 0.0 109.759 176.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -66.7 141.89 57.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.237 0.541 . . . . 0.0 111.514 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -90.52 124.65 35.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.215 177.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 16.3 pt -82.77 -48.49 17.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.32 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -175.24 42.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.895 0.379 . . . . 0.0 110.9 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 1.5 m -78.58 61.1 2.85 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.112 0.482 . . . . 0.0 110.674 -178.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.37 80.89 1.48 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.599 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 C--O 1.247 0.931 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.338 -179.94 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 83.2 t80 . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' E' E ' 2' ' ' GLN . . . . . 0.426 ' HG3' ' H ' ' E' ' 3' ' ' GLY . 3.9 pt20 53.38 -68.18 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.743 1.617 . . . . 0.0 114.155 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 3' ' ' GLY . . . . . 0.426 ' H ' ' HG3' ' E' ' 2' ' ' GLN . . . -155.65 33.12 0.63 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.388 -177.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.08 -64.8 0.98 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.902 0.382 . . . . 0.0 110.59 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 26.3 mmt -105.58 43.92 1.08 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.325 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.11 135.04 53.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.966 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 56.4 mtp -98.33 151.05 20.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.089 0.471 . . . . 0.0 111.268 -174.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 8' ' ' PHE . . . . . 0.641 ' CE1' HD21 ' A' ' 44' ' ' LEU . 48.6 t80 -66.5 145.51 55.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.074 -176.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 9' ' ' TRP . . . . . 0.555 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 90.4 t90 -132.71 146.03 51.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.006 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.1 146.65 16.28 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.195 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 11' ' ' LEU . . . . . 0.555 ' HB2' ' CH2' ' E' ' 9' ' ' TRP . 63.5 tp -134.15 109.05 8.65 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.945 0.402 . . . . 0.0 110.502 178.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -91.48 107.69 19.38 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 13' ' ' MET . . . . . 0.576 ' SD ' HD11 ' E' ' 87' ' ' LEU . 53.9 mtp -102.3 143.71 31.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.419 0.628 . . . . 0.0 111.445 -174.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -100.85 151.46 37.61 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.149 -177.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 15' ' ' PRO . . . . . 0.462 ' HB3' ' N ' ' E' ' 83' ' ' ALA . 11.1 Cg_endo -55.14 113.95 1.64 Allowed 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 123.188 2.592 . . . . 0.0 112.697 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 16' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' E' ' 79' ' ' THR . 17.4 mt-10 59.87 70.95 0.6 Allowed 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.426 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.14 142.92 32.79 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.56 174.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 18' ' ' LYS . . . . . 0.688 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 35.3 ttmt -116.6 117.46 29.92 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.322 -176.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 19' ' ' TYR . . . . . 0.424 ' OH ' ' HA ' ' E' ' 13' ' ' MET . 1.9 m-85 -110.35 122.24 47.21 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 20' ' ' SER . . . . . 0.459 ' HB3' ' SD ' ' E' ' 76' ' ' MET . 6.1 p -102.46 99.8 9.87 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 169.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 19.8 pm0 -117.79 143.07 46.59 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.628 0.728 . . . . 0.0 112.242 -174.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 13.0 t -93.36 160.77 14.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.551 176.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 23' ' ' ILE . . . . . 0.406 HG22 ' HA ' ' E' ' 71' ' ' LYS . 69.9 mt -112.5 119.38 60.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.065 0.46 . . . . 0.0 111.579 -173.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 24' ' ' ILE . . . . . 0.407 HD12 ' N ' ' E' ' 25' ' ' LYS . 1.7 pp -99.6 -11.51 8.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.051 177.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 25' ' ' LYS . . . . . 0.407 ' N ' HD12 ' E' ' 24' ' ' ILE . 84.7 tttt -148.07 119.55 7.93 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 31.3 p -61.73 140.49 58.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.648 -175.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 27' ' ' PHE . . . . . 0.805 ' HB3' HD23 ' E' ' 91' ' ' LEU . 42.9 p90 -152.08 162.78 40.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.793 0.806 . . . . 0.0 112.907 -174.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 28' ' ' HIS . . . . . 0.539 ' HA ' ' O ' ' E' ' 67' ' ' LEU . 7.7 t60 -114.67 124.59 52.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.981 177.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 29' ' ' ILE . . . . . 0.508 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 42.2 mt -88.32 135.87 24.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 170.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 30' ' ' SER . . . . . 0.492 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 45.1 p -123.55 -5.31 8.18 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -170.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 31' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . 179.91 155.11 14.56 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 119.123 -1.513 . . . . 0.0 113.572 175.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.463 HG23 ' HG ' ' E' ' 87' ' ' LEU . 12.0 p -136.81 132.82 48.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 174.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.75 156.49 42.43 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 121.92 -0.487 . . . . 0.0 111.571 -176.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 34' ' ' LEU . . . . . 0.622 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.1 pp -123.81 145.52 49.0 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.607 0.718 . . . . 0.0 111.031 177.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -110.09 -52.07 2.81 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.977 -1.011 . . . . 0.0 108.683 174.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -102.98 127.31 50.27 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 169.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 37' ' ' GLY . . . . . 0.463 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 151.92 156.78 7.62 Favored Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 119.754 -1.212 . . . . 0.0 113.389 177.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 38' ' ' GLN . . . . . 0.495 ' HA ' ' HB2' ' E' ' 58' ' ' LYS . 94.9 mt-30 -102.39 -44.39 5.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.658 0.266 . . . . 0.0 111.094 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -152.88 128.81 10.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.411 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 40' ' ' ALA . . . . . 0.466 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -128.19 113.01 15.15 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.476 0.655 . . . . 0.0 109.89 168.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 41' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' E' ' 79' ' ' THR . 28.7 mmmt -94.59 109.34 21.26 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.503 HD23 ' HB ' ' E' ' 53' ' ' VAL . 48.1 tp -82.08 109.51 16.47 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -174.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -112.24 136.3 51.84 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.067 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 44' ' ' LEU . . . . . 0.689 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 0.1 OUTLIER -123.88 121.71 36.07 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.459 175.457 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' E' E ' 45' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -109.82 111.16 22.43 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.003 178.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 46' ' ' ALA . . . . . 0.532 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -128.77 139.32 52.25 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.513 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 56.56 35.75 26.53 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 123.688 0.618 . . . . 0.0 110.225 -177.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 48' ' ' LYS . . . . . 0.424 ' HB3' ' NZ ' ' E' ' 48' ' ' LYS . 9.1 mtpm? 63.66 32.28 13.94 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.221 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 49' ' ' GLN . . . . . 0.562 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 59.2 tp60 -128.25 133.9 48.88 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 175.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -89.03 121.74 31.68 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -116.65 123.38 47.14 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.496 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -75.27 106.65 5.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 169.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 53' ' ' VAL . . . . . 0.607 ' CG2' ' HB3' ' E' ' 44' ' ' LEU . 0.7 OUTLIER -84.25 -46.36 17.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.508 -172.313 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' E' E ' 54' ' ' ALA . . . . . 0.569 ' HB2' HD21 ' E' ' 65' ' ' LEU . . . -153.91 149.4 27.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.664 -177.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 52.6 m -112.93 101.7 9.74 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 169.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 56' ' ' VAL . . . . . 0.446 HG13 ' HB3' ' E' ' 40' ' ' ALA . 7.7 p -115.8 114.32 45.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.579 0.704 . . . . 0.0 109.212 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 45.0 p -122.59 -179.17 4.13 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.194 -172.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 58' ' ' LYS . . . . . 0.495 ' HB2' ' HA ' ' E' ' 38' ' ' GLN . 58.2 tttt -58.62 -32.23 68.83 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.783 171.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.42 -40.95 22.61 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.885 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 84.1 mt -108.3 86.64 3.49 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 174.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.09 0.18 8.75 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.756 2.304 . . . . 0.0 113.848 -166.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -164.45 131.18 3.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.289 0.566 . . . . 0.0 111.551 -175.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 94.2 t -122.08 112.21 33.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.281 174.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.57 131.5 41.79 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.569 HD21 ' HB2' ' E' ' 54' ' ' ALA . 86.3 mt -124.23 168.08 13.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.496 0.665 . . . . 0.0 112.283 -173.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 66' ' ' ASP . . . . . 0.475 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 18.5 t0 -142.41 99.49 3.51 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.383 170.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 67' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' E' ' 28' ' ' HIS . 2.3 mt -129.46 144.3 51.2 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 68' ' ' ASN . . . . . 0.422 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 5.8 t30 -141.91 114.92 8.7 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.558 -0.457 . . . . 0.0 109.783 176.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -111.12 146.84 36.1 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.535 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 21.9 t -97.7 166.71 11.36 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 71' ' ' LYS . . . . . 0.406 ' HA ' HG22 ' E' ' 23' ' ' ILE . 21.6 ptmt -75.59 2.17 12.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.229 0.537 . . . . 0.0 110.531 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.14 -7.79 51.73 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.305 172.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -93.25 138.71 31.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.108 0.48 . . . . 0.0 110.463 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -122.22 116.9 24.96 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 75' ' ' ILE . . . . . 0.532 HG22 ' HB2' ' E' ' 46' ' ' ALA . 14.9 pt -128.38 162.73 34.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.219 0.533 . . . . 0.0 112.029 -168.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 76' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 4.9 mtm -119.97 125.72 49.09 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 172.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 77' ' ' PHE . . . . . 0.689 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.8 OUTLIER -109.64 127.22 54.39 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 176.576 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' E' E ' 78' ' ' TYR . . . . . 0.688 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 53.2 p90 -155.55 139.21 16.05 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 119.79 -0.764 . . . . 0.0 112.001 -175.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 79' ' ' THR . . . . . 0.568 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 3.0 p -111.58 134.23 53.3 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.389 -176.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 80' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' E' ' 41' ' ' LYS . . . -100.7 157.16 16.9 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.537 175.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.79 179.01 46.2 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -176.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -108.17 102.93 12.04 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 119.714 -0.794 . . . . 0.0 110.044 178.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 83' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -168.8 150.83 4.82 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.436 170.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 15.5 t -109.76 121.89 46.25 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 85' ' ' VAL . . . . . 0.622 HG12 ' HB3' ' E' ' 34' ' ' LEU . 6.9 m -117.77 155.32 19.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.398 0.618 . . . . 0.0 112.311 -173.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 49.3 m -120.67 122.43 40.45 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.542 173.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 87' ' ' LEU . . . . . 0.576 HD11 ' SD ' ' E' ' 13' ' ' MET . 4.7 mp -96.07 145.77 25.2 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 170.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 88' ' ' LEU . . . . . 0.526 HD13 ' O ' ' E' ' 87' ' ' LEU . 1.2 mm? -120.96 150.25 41.39 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 173.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.31 -167.91 27.69 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.363 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 90' ' ' TYR . . . . . 0.437 ' CD2' ' HB3' ' A' ' 68' ' ' ASN . 3.4 p90 -147.49 129.24 15.19 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.758 0.789 . . . . 0.0 112.126 177.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 91' ' ' LEU . . . . . 0.805 HD23 ' HB3' ' E' ' 27' ' ' PHE . 15.8 mt -71.48 140.97 50.2 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 113.838 -1.528 . . . . 0.0 109.814 176.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -66.63 141.88 57.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.163 0.506 . . . . 0.0 111.526 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -90.55 124.72 35.24 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.246 177.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 16.5 pt -82.78 -48.55 17.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.379 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -175.17 42.59 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.864 0.364 . . . . 0.0 110.889 -178.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 1.4 m -78.58 61.08 2.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.992 0.425 . . . . 0.0 110.606 -178.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.41 80.91 1.48 Allowed Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.953 -0.642 . . . . 0.0 111.597 -177.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 48.4 m . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.279 -179.868 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 77.3 t80 . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.47 ' H ' HG21 ' B' ' 94' ' ' ILE . 11.8 pt20 -154.41 -47.26 0.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.711 0.291 . . . . 0.0 111.318 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.565 ' H ' HG21 ' B' ' 94' ' ' ILE . . . 83.22 -58.77 5.03 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.877 175.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 58.86 43.24 18.48 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.409 0.623 . . . . 0.0 110.299 -176.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.6 ttm -80.21 94.48 6.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.499 -177.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.97 152.38 24.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.577 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.409 ' HG2' ' OG ' ' B' ' 70' ' ' SER . 58.8 mtt -110.09 139.33 45.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.903 -176.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.521 ' CE1' HD21 ' B' ' 44' ' ' LEU . 77.1 t80 -59.77 140.29 56.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -172.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.449 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 87.4 t90 -132.73 146.74 52.1 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.549 178.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.414 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -151.61 152.69 24.41 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.261 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.731 HD23 HD13 ' A' ' 87' ' ' LEU . 59.3 tp -140.45 106.7 5.24 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 178.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -86.31 100.92 12.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.502 0.667 . . . . 0.0 109.755 175.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.471 ' HB3' HG23 ' A' ' 85' ' ' VAL . 3.7 ttt -94.65 134.22 37.46 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.142 -168.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.476 ' HB2' ' HG3' ' A' ' 17' ' ' ARG . 2.5 mptp? -100.28 149.57 36.17 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.811 -178.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.515 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 12.2 Cg_endo -56.43 122.32 11.59 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.122 2.548 . . . . 0.0 112.987 -178.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 79' ' ' THR . 44.9 mt-10 61.53 51.79 3.93 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.564 177.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.476 ' HG3' ' HB2' ' A' ' 14' ' ' LYS . 29.0 mmt180 -117.57 145.52 44.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.131 173.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.695 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 40.5 tttt -123.28 109.82 14.43 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 123.505 0.503 . . . . 0.0 110.551 -176.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.447 ' HE2' ' HG3' ' A' ' 13' ' ' MET . 3.4 m-85 -110.02 104.31 13.18 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.356 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.467 ' HB3' ' SD ' ' A' ' 76' ' ' MET . 13.8 p -84.99 99.45 11.0 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -113.41 143.99 43.55 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.568 0.699 . . . . 0.0 112.002 -168.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.3 p -96.43 157.35 15.94 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.612 174.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.442 ' CD1' ' HB3' ' A' ' 69' ' ' PHE . 54.1 mt -115.1 116.64 53.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.347 0.594 . . . . 0.0 111.18 -175.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.478 ' N ' HD12 ' A' ' 24' ' ' ILE . 3.9 mp -93.34 -40.97 12.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.101 178.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.8 pttt -123.88 128.22 49.16 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.586 176.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.8 p -64.65 141.83 58.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.259 -174.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.828 ' HB3' HD23 ' A' ' 91' ' ' LEU . 39.8 p90 -142.08 152.52 43.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.745 0.783 . . . . 0.0 112.226 -177.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.627 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 6.1 t60 -108.24 120.52 42.6 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.354 173.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 35.1 mt -84.51 133.65 28.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 170.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.545 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 56.0 p -120.43 -6.87 9.78 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.683 0.278 . . . . 0.0 111.64 -173.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.15 158.32 25.84 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 119.455 -1.355 . . . . 0.0 113.622 176.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.497 HG23 ' HG ' ' A' ' 87' ' ' LEU . 13.2 p -140.43 127.24 22.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 172.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.16 152.87 41.48 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 121.972 -0.455 . . . . 0.0 111.389 -175.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.606 ' HB3' HG12 ' A' ' 85' ' ' VAL . 3.7 pp -117.82 145.88 44.25 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.787 0.803 . . . . 0.0 111.733 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -106.73 -55.99 2.25 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.894 175.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -102.59 128.03 49.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.049 170.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.458 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 153.23 158.53 8.6 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 119.437 -1.363 . . . . 0.0 113.892 175.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -101.76 -45.62 5.18 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.426 -0.387 . . . . 0.0 110.571 176.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.46 ' HG3' HG22 ' A' ' 57' ' ' THR . 32.7 tt0 -153.14 123.01 6.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.091 -178.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.554 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -121.88 114.13 20.6 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.44 0.638 . . . . 0.0 110.033 170.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 79' ' ' THR . 13.7 mmmm -97.18 105.51 17.67 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.6 tp -83.71 111.47 19.19 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -174.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.546 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 79.9 m-85 -114.9 149.95 36.4 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 175.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.557 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -135.47 128.01 30.63 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.616 172.125 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -105.89 112.22 25.18 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.09 178.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.567 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -127.92 133.23 49.25 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.395 178.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 59.42 38.23 22.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.48 0.657 . . . . 0.0 109.629 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt 62.37 35.27 15.11 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.717 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.574 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 23.5 tp60 -130.18 118.23 21.1 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -81.63 108.29 15.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.878 0.371 . . . . 0.0 110.86 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.456 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 87.5 m-85 -99.87 133.41 44.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.519 177.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -80.14 104.65 8.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 168.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.481 HG21 ' HB3' ' A' ' 44' ' ' LEU . 3.2 t -79.68 -50.32 18.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.696 -172.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.6 ' HB2' HD21 ' A' ' 65' ' ' LEU . . . -153.46 147.22 25.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.656 -176.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.5 m -110.95 101.28 9.86 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 171.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.48 HG13 ' HB3' ' A' ' 40' ' ' ALA . 7.2 p -119.65 113.52 41.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.62 0.724 . . . . 0.0 109.741 -177.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.46 HG22 ' HG3' ' A' ' 39' ' ' GLU . 65.2 p -123.28 -178.42 3.98 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.684 -174.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -61.89 -23.01 66.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.908 0.385 . . . . 0.0 110.463 170.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.435 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -84.35 -40.87 17.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.245 0.545 . . . . 0.0 110.15 178.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.2 mt -112.75 82.62 5.14 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 11.5 Cg_exo -70.8 -0.38 7.68 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.06 2.506 . . . . 0.0 113.868 -167.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -162.99 127.0 2.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.339 0.59 . . . . 0.0 111.416 -176.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 87.0 t -116.38 121.92 68.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.399 174.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.43 127.63 32.99 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.973 176.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.6 HD21 ' HB2' ' A' ' 54' ' ' ALA . 91.0 mt -119.92 168.45 11.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.401 0.62 . . . . 0.0 112.226 -174.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 14.2 t0 -145.72 97.59 3.0 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 172.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.668 HD21 HD23 ' E' ' 88' ' ' LEU . 6.7 mt -133.54 110.0 9.63 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.797 -174.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.452 ' HB2' ' CG ' ' E' ' 90' ' ' TYR . 6.3 m-20 -103.82 113.92 27.8 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.442 ' HB3' ' CD1' ' A' ' 23' ' ' ILE . 86.0 m-85 -109.04 136.92 47.76 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.829 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.413 ' OG ' ' HG2' ' E' ' 7' ' ' MET . 87.8 p -97.35 166.69 11.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.744 0.307 . . . . 0.0 110.21 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.436 ' HE3' ' OG ' ' E' ' 98' ' ' SER . 14.9 ptmm? -73.05 -4.89 35.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.919 0.39 . . . . 0.0 110.893 -178.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.67 -9.16 58.96 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 174.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -88.49 140.3 29.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.929 0.395 . . . . 0.0 110.06 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -126.33 114.53 18.37 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 175.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.567 HG22 ' HB2' ' A' ' 46' ' ' ALA . 13.1 pt -131.03 158.7 43.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.053 0.454 . . . . 0.0 112.059 -166.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.494 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 3.6 mtm -119.19 123.92 45.51 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 174.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.557 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 1.1 m-85 -104.24 128.63 52.01 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.695 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 25.9 p90 -151.92 134.97 15.75 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.453 0.644 . . . . 0.0 112.488 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 2.6 p -108.94 130.58 55.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.748 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.9 164.72 11.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.439 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.57 -174.03 44.41 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -177.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -113.43 102.74 10.61 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.023 178.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.554 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -173.62 153.55 2.3 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.551 171.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.9 t -114.84 126.41 54.78 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.606 HG12 ' HB3' ' A' ' 34' ' ' LEU . 6.7 m -120.74 157.54 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-O 121.141 0.496 . . . . 0.0 112.144 -172.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.4 m -117.09 119.01 33.93 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.549 -0.75 . . . . 0.0 108.979 171.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.731 HD13 HD23 ' A' ' 11' ' ' LEU . 5.1 mp -89.78 145.33 25.27 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 170.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.708 HD23 HD21 ' B' ' 67' ' ' LEU . 0.8 OUTLIER -129.97 141.39 50.77 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.929 -177.756 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.82 -167.56 26.63 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.292 -177.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.486 ' CG ' ' HB2' ' B' ' 68' ' ' ASN . 13.7 p90 -150.29 129.6 12.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 122.093 0.949 . . . . 0.0 112.102 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.828 HD23 ' HB3' ' A' ' 27' ' ' PHE . 7.9 mt -66.77 141.12 57.84 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.778 176.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -80.92 109.32 15.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.672 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -132.76 173.8 10.98 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.507 HG21 ' H ' ' E' ' 3' ' ' GLY . 1.5 pp -142.42 14.01 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -174.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.85 87.53 3.43 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.231 0.539 . . . . 0.0 110.09 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.2 t -88.56 73.05 8.71 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.552 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.1 162.37 48.22 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.681 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 25.6 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 119.079 -0.486 . . . . 0.0 110.948 179.887 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 77.6 t80 . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' GLN . . . . . 0.461 ' H ' HG21 ' C' ' 94' ' ' ILE . 11.8 pt20 -154.36 -47.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.704 0.287 . . . . 0.0 111.303 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 3' ' ' GLY . . . . . 0.518 ' H ' HG21 ' C' ' 94' ' ' ILE . . . 83.32 -58.83 5.02 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.865 175.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . 58.93 43.22 18.27 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.332 0.586 . . . . 0.0 110.246 -176.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 48.6 ttm -80.14 94.37 5.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.514 -177.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.88 152.36 24.59 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.601 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' MET . . . . . 0.401 ' HG2' ' OG ' ' C' ' 70' ' ' SER . 58.9 mtt -110.01 139.45 45.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.88 -177.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.532 ' CE1' HD21 ' C' ' 44' ' ' LEU . 77.0 t80 -59.98 140.35 56.8 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -172.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 9' ' ' TRP . . . . . 0.449 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 87.3 t90 -132.74 146.74 52.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.547 178.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.439 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -151.65 152.69 24.41 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.262 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.739 HD23 HD13 ' B' ' 87' ' ' LEU . 59.7 tp -140.48 106.75 5.25 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -86.3 100.85 12.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.612 0.72 . . . . 0.0 109.785 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' MET . . . . . 0.465 ' HB3' HG23 ' B' ' 85' ' ' VAL . 3.7 ttt -94.61 134.24 37.39 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.68 -1.146 . . . . 0.0 111.059 -168.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.471 ' HB2' ' HG3' ' B' ' 17' ' ' ARG . 2.5 mptp? -100.43 149.45 36.1 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.788 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.517 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 12.2 Cg_endo -56.33 122.33 11.58 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.131 2.554 . . . . 0.0 112.965 -178.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' B' ' 79' ' ' THR . 44.8 mt-10 61.51 51.83 3.93 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.506 177.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.471 ' HG3' ' HB2' ' B' ' 14' ' ' LYS . 29.0 mmt180 -117.57 145.5 44.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.141 173.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.713 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 40.6 tttt -123.22 109.87 14.52 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 123.465 0.478 . . . . 0.0 110.513 -176.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 19' ' ' TYR . . . . . 0.434 ' HE2' ' HG3' ' B' ' 13' ' ' MET . 3.3 m-85 -110.09 104.36 13.22 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.289 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.462 ' HB3' ' SD ' ' B' ' 76' ' ' MET . 13.6 p -85.12 99.49 11.09 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 171.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -113.33 144.03 43.45 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.522 0.677 . . . . 0.0 112.019 -168.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 13.7 p -96.43 157.27 15.98 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.627 174.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.428 ' CD1' ' HB3' ' B' ' 69' ' ' PHE . 53.7 mt -115.06 116.56 52.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.335 0.588 . . . . 0.0 111.227 -175.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.479 ' N ' HD12 ' B' ' 24' ' ' ILE . 3.9 mp -93.27 -40.91 12.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.262 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 24.9 pttt -123.83 128.15 49.09 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.651 176.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 62.3 p -64.62 141.73 58.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.311 -174.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' PHE . . . . . 0.834 ' HB3' HD23 ' B' ' 91' ' ' LEU . 39.3 p90 -142.09 152.51 43.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.71 0.767 . . . . 0.0 112.231 -177.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 28' ' ' HIS . . . . . 0.639 ' HA ' ' O ' ' B' ' 67' ' ' LEU . 6.2 t60 -108.1 120.53 42.59 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.428 173.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.548 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 35.2 mt -84.6 133.55 29.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 170.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.548 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 56.4 p -120.29 -6.97 9.84 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.598 -173.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.13 158.31 25.82 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 119.462 -1.352 . . . . 0.0 113.555 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.496 HG23 ' HG ' ' B' ' 87' ' ' LEU . 13.2 p -140.36 127.33 22.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 172.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.2 152.85 41.42 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.958 -0.464 . . . . 0.0 111.342 -175.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.617 ' HB3' HG12 ' B' ' 85' ' ' VAL . 3.7 pp -117.89 145.79 44.38 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.791 0.805 . . . . 0.0 111.728 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -106.58 -56.21 2.22 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.859 175.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -102.43 127.98 49.23 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.096 170.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.455 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 153.2 158.53 8.59 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 119.393 -1.384 . . . . 0.0 113.893 175.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -101.77 -45.66 5.16 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.399 -0.4 . . . . 0.0 110.498 176.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.444 ' HG3' HG22 ' B' ' 57' ' ' THR . 32.9 tt0 -153.07 123.02 6.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.109 -178.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -121.88 114.22 20.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.539 0.685 . . . . 0.0 110.007 170.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' B' ' 79' ' ' THR . 13.7 mmmm -97.2 105.44 17.59 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 49.3 tp -83.65 111.51 19.19 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -174.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 43' ' ' TYR . . . . . 0.552 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 79.9 m-85 -114.9 149.96 36.38 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 175.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.564 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 0.2 OUTLIER -135.49 128.13 30.83 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.612 172.03 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.575 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -105.99 111.99 24.86 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.187 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.581 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -127.76 133.35 49.48 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.409 178.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 59.31 38.2 23.24 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.564 0.697 . . . . 0.0 109.743 -176.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt 62.3 35.39 15.24 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.637 178.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.575 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 23.1 tp60 -130.18 118.24 21.11 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 178.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -81.69 108.39 15.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.927 0.394 . . . . 0.0 110.799 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.414 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 86.9 m-85 -99.86 133.33 44.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.59 177.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -80.11 104.67 8.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 168.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.488 HG21 ' HB3' ' B' ' 44' ' ' LEU . 3.2 t -79.64 -50.32 18.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.779 -172.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.591 ' HB2' HD21 ' B' ' 65' ' ' LEU . . . -153.38 147.17 25.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.686 -176.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 31.1 m -110.96 101.26 9.84 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 171.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.465 HG13 ' HB3' ' B' ' 40' ' ' ALA . 7.1 p -119.6 113.48 41.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.6 0.714 . . . . 0.0 109.844 -177.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.444 HG22 ' HG3' ' B' ' 39' ' ' GLU . 65.5 p -123.2 -178.38 3.96 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.73 -174.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -62.06 -22.86 66.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.045 0.45 . . . . 0.0 110.514 170.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.424 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -84.41 -40.82 17.34 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.19 0.519 . . . . 0.0 110.195 178.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 80.8 mt -112.69 82.59 5.05 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 11.4 Cg_exo -70.78 -0.36 7.64 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.022 2.482 . . . . 0.0 113.907 -168.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -163.04 127.03 2.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.383 0.611 . . . . 0.0 111.392 -176.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 87.6 t -116.34 121.91 68.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.418 174.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.53 127.67 33.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.01 176.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.591 HD21 ' HB2' ' B' ' 54' ' ' ALA . 90.8 mt -119.93 168.47 11.1 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.371 0.605 . . . . 0.0 112.114 -174.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 66' ' ' ASP . . . . . 0.531 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 14.4 t0 -145.72 97.6 3.0 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 172.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.708 HD21 HD23 ' A' ' 88' ' ' LEU . 6.7 mt -133.58 110.08 9.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.723 -174.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 68' ' ' ASN . . . . . 0.486 ' HB2' ' CG ' ' A' ' 90' ' ' TYR . 6.4 m-20 -103.86 113.82 27.62 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 176.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 69' ' ' PHE . . . . . 0.428 ' HB3' ' CD1' ' B' ' 23' ' ' ILE . 85.6 m-85 -108.92 136.9 47.7 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.861 178.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.409 ' OG ' ' HG2' ' A' ' 7' ' ' MET . 87.9 p -97.29 166.66 11.45 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.783 0.325 . . . . 0.0 110.191 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -72.96 -5.04 35.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.006 0.432 . . . . 0.0 110.868 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.52 -9.18 59.13 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.611 -0.595 . . . . 0.0 111.611 174.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -88.42 140.24 29.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.903 0.382 . . . . 0.0 110.108 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -126.3 114.54 18.4 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.581 HG22 ' HB2' ' B' ' 46' ' ' ALA . 13.2 pt -131.0 158.7 43.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.074 0.464 . . . . 0.0 111.995 -166.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.505 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 3.7 mtm -119.19 124.03 45.8 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 174.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 77' ' ' PHE . . . . . 0.564 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 1.1 m-85 -104.38 128.65 52.27 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.713 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 25.9 p90 -151.95 134.99 15.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.474 0.654 . . . . 0.0 112.494 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 2.6 p -108.9 130.62 55.44 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.707 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.97 164.79 11.53 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.524 176.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.37 -174.02 44.76 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -177.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -113.33 102.74 10.63 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 119.726 -0.789 . . . . 0.0 110.031 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -173.67 153.55 2.28 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.548 171.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 18.8 t -114.77 126.42 54.82 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.617 HG12 ' HB3' ' B' ' 34' ' ' LEU . 6.7 m -120.81 157.58 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-O 121.116 0.484 . . . . 0.0 112.139 -172.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 67.1 m -117.12 119.02 33.96 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 171.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.739 HD13 HD23 ' B' ' 11' ' ' LEU . 5.2 mp -89.78 145.38 25.22 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 170.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.687 HD23 HD21 ' C' ' 67' ' ' LEU . 0.8 OUTLIER -130.04 141.35 50.74 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.465 -0.789 . . . . 0.0 108.888 -177.697 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.82 -167.53 26.59 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.275 -178.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 90' ' ' TYR . . . . . 0.443 ' CG ' ' HB2' ' C' ' 68' ' ' ASN . 13.8 p90 -150.24 129.52 12.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 122.02 0.914 . . . . 0.0 112.154 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 91' ' ' LEU . . . . . 0.834 HD23 ' HB3' ' B' ' 27' ' ' PHE . 8.0 mt -66.74 141.05 57.87 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 113.626 -1.624 . . . . 0.0 110.898 176.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -80.84 109.25 15.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.655 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -132.83 173.74 11.06 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 177.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 94' ' ' ILE . . . . . 0.565 HG21 ' H ' ' A' ' 3' ' ' GLY . 1.5 pp -142.31 13.98 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -174.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -76.84 87.57 3.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.283 0.563 . . . . 0.0 110.119 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 17.7 t -88.58 73.21 8.66 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.488 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.18 162.34 48.04 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.752 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 98' ' ' SER . . . . . 0.418 ' OG ' ' HE3' ' C' ' 71' ' ' LYS . 26.7 m . . . . . 0 C--O 1.247 0.949 0 CA-C-O 119.054 -0.498 . . . . 0.0 111.006 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 77.1 t80 . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 2' ' ' GLN . . . . . 0.417 ' H ' HG21 ' D' ' 94' ' ' ILE . 11.8 pt20 -154.38 -47.35 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.736 0.303 . . . . 0.0 111.256 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 3' ' ' GLY . . . . . 0.511 ' H ' HG21 ' D' ' 94' ' ' ILE . . . 83.37 -58.8 5.02 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.824 175.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . 58.88 43.25 18.41 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.372 0.606 . . . . 0.0 110.249 -176.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 48.6 ttm -80.2 94.49 6.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.524 -177.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.0 152.25 24.55 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.584 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 7' ' ' MET . . . . . 0.401 ' HG2' ' OG ' ' D' ' 70' ' ' SER . 58.8 mtt -109.99 139.41 45.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.985 -177.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 8' ' ' PHE . . . . . 0.546 ' CE1' HD21 ' D' ' 44' ' ' LEU . 77.4 t80 -59.9 140.27 56.79 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -172.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 9' ' ' TRP . . . . . 0.441 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 87.3 t90 -132.63 146.79 52.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.555 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 10' ' ' GLY . . . . . 0.44 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -151.61 152.71 24.43 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.289 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.714 HD23 HD13 ' C' ' 87' ' ' LEU . 59.5 tp -140.5 106.79 5.25 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -86.3 100.82 12.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.599 0.714 . . . . 0.0 109.8 175.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 13' ' ' MET . . . . . 0.464 ' HB3' HG23 ' C' ' 85' ' ' VAL . 3.7 ttt -94.56 134.25 37.32 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.078 -168.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 14' ' ' LYS . . . . . 0.457 ' HB2' ' HG3' ' C' ' 17' ' ' ARG . 2.5 mptp? -100.38 149.5 36.13 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.8 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 15' ' ' PRO . . . . . 0.517 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 12.3 Cg_endo -56.29 122.25 11.45 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 123.191 2.594 . . . . 0.0 113.011 -178.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 16' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' C' ' 79' ' ' THR . 44.8 mt-10 61.49 51.84 3.95 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.543 177.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 17' ' ' ARG . . . . . 0.457 ' HG3' ' HB2' ' C' ' 14' ' ' LYS . 28.9 mmt180 -117.52 145.57 44.15 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.132 173.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 18' ' ' LYS . . . . . 0.706 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 40.7 tttt -123.41 109.89 14.44 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 123.479 0.487 . . . . 0.0 110.513 -176.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 19' ' ' TYR . . . . . 0.448 ' HE2' ' HG3' ' C' ' 13' ' ' MET . 3.4 m-85 -110.09 104.29 13.14 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.342 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 20' ' ' SER . . . . . 0.474 ' HB3' ' SD ' ' C' ' 76' ' ' MET . 13.5 p -84.97 99.37 10.94 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 171.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -113.29 144.05 43.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.577 0.703 . . . . 0.0 112.064 -169.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 13.3 p -96.59 157.3 15.96 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.592 174.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 23' ' ' ILE . . . . . 0.442 ' CD1' ' HB3' ' C' ' 69' ' ' PHE . 53.8 mt -115.03 116.6 53.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.296 0.57 . . . . 0.0 111.16 -175.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 24' ' ' ILE . . . . . 0.481 ' N ' HD12 ' C' ' 24' ' ' ILE . 3.9 mp -93.26 -41.09 12.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.16 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 25.0 pttt -123.85 128.21 49.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.616 176.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 62.1 p -64.63 141.71 58.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.227 -174.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 27' ' ' PHE . . . . . 0.844 ' HB3' HD23 ' C' ' 91' ' ' LEU . 39.5 p90 -142.0 152.51 43.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.672 0.748 . . . . 0.0 112.23 -177.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 28' ' ' HIS . . . . . 0.634 ' HA ' ' O ' ' C' ' 67' ' ' LEU . 6.1 t60 -108.14 120.55 42.65 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.418 -1.264 . . . . 0.0 109.382 173.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 29' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 35.2 mt -84.59 133.59 28.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 170.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.548 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 56.1 p -120.41 -6.77 9.79 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.645 0.259 . . . . 0.0 111.639 -173.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.13 158.4 25.99 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 119.471 -1.347 . . . . 0.0 113.595 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.493 HG23 ' HG ' ' C' ' 87' ' ' LEU . 13.0 p -140.38 127.22 22.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.23 152.83 41.38 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.569 -0.453 . . . . 0.0 111.326 -175.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.621 ' HB3' HG12 ' C' ' 85' ' ' VAL . 3.7 pp -117.8 145.8 44.28 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 121.809 0.814 . . . . 0.0 111.792 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -106.58 -56.17 2.23 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.869 175.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -102.47 127.99 49.28 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.065 170.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 37' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 153.25 158.44 8.56 Favored Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 119.39 -1.386 . . . . 0.0 113.902 175.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -101.76 -45.6 5.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.484 -0.358 . . . . 0.0 110.545 176.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 39' ' ' GLU . . . . . 0.447 ' HG3' HG22 ' C' ' 57' ' ' THR . 32.8 tt0 -153.09 122.99 6.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.079 -178.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.569 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -121.88 114.23 20.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.518 0.675 . . . . 0.0 110.02 170.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' C' ' 79' ' ' THR . 13.7 mmmm -97.27 105.43 17.57 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 49.7 tp -83.66 111.48 19.17 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -174.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 43' ' ' TYR . . . . . 0.546 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 79.8 m-85 -114.86 149.93 36.35 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.566 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 0.2 OUTLIER -135.46 128.17 30.96 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.589 172.069 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 45' ' ' ALA . . . . . 0.569 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -105.97 112.0 24.87 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.116 178.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.579 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -127.8 133.41 49.43 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.368 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 59.25 38.23 23.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.53 0.681 . . . . 0.0 109.763 -176.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt 62.3 35.21 15.36 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.751 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 49' ' ' GLN . . . . . 0.569 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 23.4 tp60 -130.04 118.28 21.32 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -81.74 108.36 15.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.969 0.414 . . . . 0.0 110.769 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 51' ' ' TYR . . . . . 0.439 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 86.9 m-85 -99.79 133.39 44.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.627 177.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -80.12 104.57 8.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 168.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 53' ' ' VAL . . . . . 0.486 HG21 ' HB3' ' C' ' 44' ' ' LEU . 3.2 t -79.56 -50.44 18.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.652 -172.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 54' ' ' ALA . . . . . 0.592 ' HB2' HD21 ' C' ' 65' ' ' LEU . . . -153.37 147.17 25.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.723 -176.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 31.4 m -110.93 101.29 9.87 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 171.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 56' ' ' VAL . . . . . 0.474 HG13 ' HB3' ' C' ' 40' ' ' ALA . 7.2 p -119.6 113.47 41.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.513 0.673 . . . . 0.0 109.821 -177.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 57' ' ' THR . . . . . 0.447 HG22 ' HG3' ' C' ' 39' ' ' GLU . 66.0 p -123.24 -178.45 3.99 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.74 -174.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -61.99 -22.97 66.12 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.14 0.495 . . . . 0.0 110.43 171.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 59' ' ' ALA . . . . . 0.433 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -84.3 -40.76 17.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.19 0.519 . . . . 0.0 110.275 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 80.7 mt -112.8 82.5 5.11 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 174.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 61' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 11.4 Cg_exo -70.8 -0.2 7.41 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.997 2.465 . . . . 0.0 113.889 -167.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -163.12 127.04 2.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.325 0.583 . . . . 0.0 111.437 -176.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 86.2 t -116.38 122.02 68.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.345 174.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.49 127.54 32.93 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.131 175.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 65' ' ' LEU . . . . . 0.592 HD21 ' HB2' ' C' ' 54' ' ' ALA . 91.1 mt -119.76 168.45 11.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.471 0.653 . . . . 0.0 112.21 -174.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 66' ' ' ASP . . . . . 0.489 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 14.4 t0 -145.76 97.6 2.99 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 172.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.687 HD21 HD23 ' B' ' 88' ' ' LEU . 6.7 mt -133.54 110.0 9.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.772 -174.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 68' ' ' ASN . . . . . 0.443 ' HB2' ' CG ' ' B' ' 90' ' ' TYR . 6.4 m-20 -103.92 113.82 27.63 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 69' ' ' PHE . . . . . 0.442 ' HB3' ' CD1' ' C' ' 23' ' ' ILE . 86.0 m-85 -109.0 136.87 47.81 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.779 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 70' ' ' SER . . . . . 0.401 ' OG ' ' HG2' ' B' ' 7' ' ' MET . 88.1 p -97.24 166.66 11.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.745 0.307 . . . . 0.0 110.235 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 71' ' ' LYS . . . . . 0.418 ' HE3' ' OG ' ' B' ' 98' ' ' SER . 14.9 ptmm? -73.12 -4.83 35.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.015 0.436 . . . . 0.0 110.901 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.55 -9.27 59.02 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 174.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -88.28 140.23 29.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.893 0.378 . . . . 0.0 110.115 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -126.33 114.49 18.31 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 175.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.579 HG22 ' HB2' ' C' ' 46' ' ' ALA . 13.3 pt -131.07 158.67 43.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.047 0.451 . . . . 0.0 112.034 -166.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.498 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 3.7 mtm -119.22 123.97 45.61 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 77' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 1.1 m-85 -104.29 128.55 52.09 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 78' ' ' TYR . . . . . 0.706 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 25.9 p90 -151.87 134.96 15.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.419 0.628 . . . . 0.0 112.511 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 79' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 2.6 p -108.85 130.56 55.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.769 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.87 164.84 11.51 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.522 176.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.41 -173.98 44.64 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -177.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -113.38 102.77 10.65 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.031 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 83' ' ' ALA . . . . . 0.569 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -173.67 153.48 2.27 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.534 171.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 18.6 t -114.76 126.41 54.81 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.621 HG12 ' HB3' ' C' ' 34' ' ' LEU . 6.6 m -120.8 157.58 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 CA-C-O 121.213 0.53 . . . . 0.0 112.114 -172.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 66.6 m -117.04 119.02 33.99 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 171.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 87' ' ' LEU . . . . . 0.714 HD13 HD23 ' C' ' 11' ' ' LEU . 5.2 mp -89.75 145.29 25.3 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 170.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 88' ' ' LEU . . . . . 0.681 HD23 HD21 ' D' ' 67' ' ' LEU . 0.8 OUTLIER -130.01 141.46 50.74 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.438 -0.801 . . . . 0.0 108.913 -177.837 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.93 -167.59 26.79 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.331 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 90' ' ' TYR . . . . . 0.467 ' CG ' ' HB2' ' D' ' 68' ' ' ASN . 13.6 p90 -150.19 129.55 12.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 122.039 0.924 . . . . 0.0 112.109 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 91' ' ' LEU . . . . . 0.844 HD23 ' HB3' ' C' ' 27' ' ' PHE . 8.0 mt -66.84 141.15 57.78 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.826 176.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -80.85 109.34 15.32 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.686 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -132.96 173.77 11.06 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 94' ' ' ILE . . . . . 0.518 HG21 ' H ' ' B' ' 3' ' ' GLY . 1.5 pp -142.34 13.94 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -174.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.82 87.59 3.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.292 0.568 . . . . 0.0 110.131 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 17.9 t -88.56 73.14 8.69 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.409 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.04 162.31 48.27 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.706 -178.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 98' ' ' SER . . . . . 0.422 ' OG ' ' HE3' ' D' ' 71' ' ' LYS . 27.0 m . . . . . 0 C--O 1.249 1.034 0 C-N-CA 122.822 0.449 . . . . 0.0 111.063 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 77.1 t80 . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' 2' ' ' GLN . . . . . 0.481 ' H ' HG21 ' E' ' 94' ' ' ILE . 11.8 pt20 -154.38 -47.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.697 0.284 . . . . 0.0 111.235 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 3' ' ' GLY . . . . . 0.529 ' H ' HG21 ' E' ' 94' ' ' ILE . . . 83.23 -58.84 5.03 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.849 175.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . 58.88 43.2 18.46 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.377 0.608 . . . . 0.0 110.306 -176.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 48.5 ttm -80.19 94.41 6.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.527 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.93 152.28 24.59 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.557 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 7' ' ' MET . . . . . 0.435 ' HG2' ' OG ' ' E' ' 70' ' ' SER . 58.9 mtt -109.99 139.46 45.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 -177.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 8' ' ' PHE . . . . . 0.552 ' CE1' HD21 ' E' ' 44' ' ' LEU . 77.0 t80 -59.99 140.33 56.83 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -172.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 9' ' ' TRP . . . . . 0.447 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 87.3 t90 -132.76 146.68 52.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.552 178.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 10' ' ' GLY . . . . . 0.467 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -151.53 152.72 24.44 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.296 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.736 HD23 HD13 ' D' ' 87' ' ' LEU . 59.8 tp -140.5 106.73 5.24 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -86.24 100.86 12.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.579 0.704 . . . . 0.0 109.743 175.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 13' ' ' MET . . . . . 0.471 ' HB3' HG23 ' D' ' 85' ' ' VAL . 3.7 ttt -94.67 134.21 37.5 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.085 -168.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 14' ' ' LYS . . . . . 0.469 ' HB2' ' HG3' ' D' ' 17' ' ' ARG . 2.5 mptp? -100.33 149.56 36.17 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.802 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 15' ' ' PRO . . . . . 0.518 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 12.3 Cg_endo -56.45 122.28 11.51 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.134 2.556 . . . . 0.0 113.013 -178.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 16' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' D' ' 79' ' ' THR . 44.9 mt-10 61.5 51.88 3.92 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.571 177.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 17' ' ' ARG . . . . . 0.469 ' HG3' ' HB2' ' D' ' 14' ' ' LYS . 28.9 mmt180 -117.58 145.56 44.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.133 173.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 18' ' ' LYS . . . . . 0.705 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 40.7 tttt -123.36 109.91 14.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 123.542 0.526 . . . . 0.0 110.524 -176.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 19' ' ' TYR . . . . . 0.431 ' HE2' ' HG3' ' D' ' 13' ' ' MET . 3.3 m-85 -110.04 104.38 13.26 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.323 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 20' ' ' SER . . . . . 0.469 ' HB3' ' SD ' ' D' ' 76' ' ' MET . 13.4 p -85.08 99.45 11.05 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 171.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -113.37 144.01 43.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.483 0.659 . . . . 0.0 112.053 -168.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 14.0 p -96.49 157.31 15.96 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.627 174.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 23' ' ' ILE . . . . . 0.444 ' CD1' ' HB3' ' D' ' 69' ' ' PHE . 53.9 mt -115.02 116.61 53.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.15 0.5 . . . . 0.0 111.168 -175.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 24' ' ' ILE . . . . . 0.483 HD12 ' N ' ' D' ' 24' ' ' ILE . 3.9 mp -93.34 -40.95 12.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.125 178.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -123.88 128.24 49.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.663 176.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 61.9 p -64.65 141.72 58.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.258 -174.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 27' ' ' PHE . . . . . 0.807 ' HB3' HD23 ' D' ' 91' ' ' LEU . 39.4 p90 -141.97 152.59 43.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.713 0.768 . . . . 0.0 112.153 -177.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 28' ' ' HIS . . . . . 0.635 ' HA ' ' O ' ' D' ' 67' ' ' LEU . 6.2 t60 -108.21 120.5 42.54 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.407 -1.27 . . . . 0.0 109.399 173.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 29' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 35.2 mt -84.57 133.55 29.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 170.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 30' ' ' SER . . . . . 0.548 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 56.8 p -120.3 -6.89 9.84 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.65 -173.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.08 158.41 26.05 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 119.481 -1.343 . . . . 0.0 113.566 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.498 HG23 ' HG ' ' D' ' 87' ' ' LEU . 13.3 p -140.48 127.27 22.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 172.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.17 152.94 41.58 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.332 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 34' ' ' LEU . . . . . 0.603 ' HB3' HG12 ' D' ' 85' ' ' VAL . 3.7 pp -117.93 145.88 44.36 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.798 0.808 . . . . 0.0 111.709 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -106.71 -56.03 2.25 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.226 -1.352 . . . . 0.0 108.819 175.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -102.53 127.95 49.37 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.099 170.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 37' ' ' GLY . . . . . 0.468 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 153.22 158.45 8.56 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 119.415 -1.374 . . . . 0.0 113.99 175.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -101.71 -45.65 5.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.786 0.327 . . . . 0.0 110.557 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 39' ' ' GLU . . . . . 0.45 ' HG3' HG22 ' D' ' 57' ' ' THR . 32.8 tt0 -153.05 123.01 6.94 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.117 -178.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 40' ' ' ALA . . . . . 0.561 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -121.88 114.09 20.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.406 0.622 . . . . 0.0 110.06 170.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' D' ' 79' ' ' THR . 13.7 mmmm -97.11 105.42 17.56 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 49.5 tp -83.59 111.44 19.11 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -174.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 43' ' ' TYR . . . . . 0.554 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 80.4 m-85 -114.87 149.96 36.32 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 175.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.566 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.2 OUTLIER -135.41 128.09 30.92 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.672 172.004 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 45' ' ' ALA . . . . . 0.569 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -105.92 112.17 25.12 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.156 178.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.569 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -127.84 133.34 49.37 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.344 178.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 59.3 38.14 23.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.558 0.694 . . . . 0.0 109.718 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt 62.41 35.24 15.0 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.683 178.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 49' ' ' GLN . . . . . 0.569 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 23.5 tp60 -130.06 118.26 21.26 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -81.62 108.3 15.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.909 0.385 . . . . 0.0 110.841 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 51' ' ' TYR . . . . . 0.44 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 87.3 m-85 -99.92 133.34 44.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.612 177.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 tp -80.13 104.73 8.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 169.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 53' ' ' VAL . . . . . 0.488 HG21 ' HB3' ' D' ' 44' ' ' LEU . 3.2 t -79.64 -50.3 18.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.698 -172.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 54' ' ' ALA . . . . . 0.589 ' HB2' HD21 ' D' ' 65' ' ' LEU . . . -153.44 147.16 25.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.711 -176.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 31.5 m -111.02 101.29 9.86 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 171.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 56' ' ' VAL . . . . . 0.477 HG13 ' HB3' ' D' ' 40' ' ' ALA . 7.2 p -119.67 113.5 41.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.545 0.688 . . . . 0.0 109.808 -177.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 57' ' ' THR . . . . . 0.45 HG22 ' HG3' ' D' ' 39' ' ' GLU . 67.5 p -123.24 -178.44 3.98 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.756 -174.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -61.97 -22.93 66.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.039 0.447 . . . . 0.0 110.522 170.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 59' ' ' ALA . . . . . 0.436 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -84.39 -40.82 17.36 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.253 0.549 . . . . 0.0 110.187 178.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 81.0 mt -112.76 82.63 5.16 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 174.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 61' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 11.5 Cg_exo -70.81 -0.29 7.56 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.063 2.508 . . . . 0.0 113.868 -168.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -163.11 127.0 2.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.315 0.579 . . . . 0.0 111.417 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 87.4 t -116.33 121.88 68.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.424 174.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.47 127.54 32.92 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.063 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 65' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' D' ' 54' ' ' ALA . 90.8 mt -119.76 168.52 10.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.477 0.656 . . . . 0.0 112.2 -174.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 66' ' ' ASP . . . . . 0.517 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 14.2 t0 -145.79 97.59 2.99 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 172.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.681 HD21 HD23 ' C' ' 88' ' ' LEU . 6.7 mt -133.62 109.95 9.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.776 -174.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 68' ' ' ASN . . . . . 0.467 ' HB2' ' CG ' ' C' ' 90' ' ' TYR . 6.4 m-20 -103.76 113.87 27.71 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 176.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 69' ' ' PHE . . . . . 0.444 ' HB3' ' CD1' ' D' ' 23' ' ' ILE . 86.1 m-85 -109.08 136.97 47.72 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.771 178.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 70' ' ' SER . . . . . 0.401 ' OG ' ' HG2' ' C' ' 7' ' ' MET . 88.1 p -97.28 166.61 11.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.741 0.305 . . . . 0.0 110.239 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 71' ' ' LYS . . . . . 0.422 ' HE3' ' OG ' ' C' ' 98' ' ' SER . 14.9 ptmm? -73.07 -4.87 35.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.023 0.439 . . . . 0.0 110.873 -178.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.52 -9.32 59.02 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.584 -0.607 . . . . 0.0 111.584 174.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -88.37 140.16 29.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.861 0.362 . . . . 0.0 110.135 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -126.27 114.58 18.47 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.569 HG22 ' HB2' ' D' ' 46' ' ' ALA . 13.2 pt -131.02 158.74 43.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.132 0.491 . . . . 0.0 112.0 -166.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 76' ' ' MET . . . . . 0.493 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 3.6 mtm -119.23 123.97 45.61 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 174.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 77' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 1.1 m-85 -104.3 128.57 52.11 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 78' ' ' TYR . . . . . 0.705 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 25.7 p90 -151.86 134.94 15.78 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.47 0.652 . . . . 0.0 112.414 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 79' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 2.5 p -108.85 130.59 55.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.792 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.89 164.76 11.55 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.553 177.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.39 -174.11 44.8 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -113.27 102.64 10.54 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.06 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 83' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -173.65 153.51 2.28 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.531 171.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 18.9 t -114.84 126.5 54.89 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.603 HG12 ' HB3' ' D' ' 34' ' ' LEU . 6.6 m -120.94 157.48 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-O 121.161 0.505 . . . . 0.0 112.11 -172.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 66.5 m -116.95 118.97 33.91 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 171.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 87' ' ' LEU . . . . . 0.736 HD13 HD23 ' D' ' 11' ' ' LEU . 5.1 mp -89.77 145.4 25.21 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 170.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.678 HD23 HD21 ' E' ' 67' ' ' LEU . 0.8 OUTLIER -129.98 141.37 50.76 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.982 -177.797 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.81 -167.44 26.44 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.302 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 90' ' ' TYR . . . . . 0.462 ' CG ' ' HB2' ' E' ' 68' ' ' ASN . 13.6 p90 -150.33 129.55 12.79 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 122.102 0.954 . . . . 0.0 112.091 178.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 91' ' ' LEU . . . . . 0.807 HD23 ' HB3' ' D' ' 27' ' ' PHE . 8.1 mt -66.78 141.09 57.84 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.621 -1.627 . . . . 0.0 110.839 176.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -80.85 109.36 15.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.654 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -132.94 173.73 11.09 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 94' ' ' ILE . . . . . 0.511 HG21 ' H ' ' C' ' 3' ' ' GLY . 1.5 pp -142.34 13.88 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -174.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.77 87.56 3.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.256 0.55 . . . . 0.0 110.144 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 18.1 t -88.54 73.01 8.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.515 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.96 162.22 48.34 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.778 -178.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 98' ' ' SER . . . . . 0.411 ' OG ' ' HE3' ' E' ' 71' ' ' LYS . 28.7 m . . . . . 0 C--O 1.249 1.061 0 C-N-CA 122.896 0.478 . . . . 0.0 111.017 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 77.3 t80 . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' E' E ' 2' ' ' GLN . . . . . 0.456 ' H ' HG21 ' A' ' 94' ' ' ILE . 11.8 pt20 -154.43 -47.25 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.771 0.319 . . . . 0.0 111.245 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 3' ' ' GLY . . . . . 0.507 ' H ' HG21 ' A' ' 94' ' ' ILE . . . 83.29 -58.87 5.02 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.853 175.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . 58.91 43.21 18.35 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.319 0.581 . . . . 0.0 110.271 -176.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 48.5 ttm -80.12 94.48 6.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.482 -177.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.08 152.28 24.44 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.55 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 7' ' ' MET . . . . . 0.413 ' HG2' ' OG ' ' A' ' 70' ' ' SER . 58.9 mtt -109.98 139.46 45.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.841 -176.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 8' ' ' PHE . . . . . 0.545 ' CE1' HD21 ' A' ' 44' ' ' LEU . 76.9 t80 -59.93 140.3 56.79 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -172.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 9' ' ' TRP . . . . . 0.439 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 87.4 t90 -132.74 146.76 52.11 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 10' ' ' GLY . . . . . 0.456 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -151.68 152.68 24.4 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.233 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 11' ' ' LEU . . . . . 0.74 HD23 HD13 ' E' ' 87' ' ' LEU . 60.0 tp -140.44 106.71 5.25 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 178.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -86.31 100.87 12.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.571 0.7 . . . . 0.0 109.72 175.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 13' ' ' MET . . . . . 0.471 ' HB3' HG23 ' E' ' 85' ' ' VAL . 3.7 ttt -94.64 134.23 37.44 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.667 -1.152 . . . . 0.0 111.102 -168.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 14' ' ' LYS . . . . . 0.473 ' HB2' ' HG3' ' E' ' 17' ' ' ARG . 2.5 mptp? -100.29 149.53 36.14 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.791 -178.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 15' ' ' PRO . . . . . 0.502 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 12.2 Cg_endo -56.48 122.38 11.69 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.146 2.564 . . . . 0.0 112.95 -178.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 16' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' E' ' 79' ' ' THR . 44.7 mt-10 61.43 51.93 3.96 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.502 177.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 17' ' ' ARG . . . . . 0.473 ' HG3' ' HB2' ' E' ' 14' ' ' LYS . 29.0 mmt180 -117.61 145.52 44.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.161 173.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 18' ' ' LYS . . . . . 0.713 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 40.6 tttt -123.34 109.84 14.42 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 123.505 0.503 . . . . 0.0 110.465 -176.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 19' ' ' TYR . . . . . 0.447 ' HE2' ' HG3' ' E' ' 13' ' ' MET . 3.4 m-85 -110.06 104.4 13.27 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.367 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 20' ' ' SER . . . . . 0.474 ' HB3' ' SD ' ' E' ' 76' ' ' MET . 13.5 p -85.08 99.43 11.04 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -113.39 144.13 43.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.596 0.712 . . . . 0.0 112.01 -168.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 13.9 p -96.51 157.3 15.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.623 174.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 23' ' ' ILE . . . . . 0.442 ' CD1' ' HB3' ' E' ' 69' ' ' PHE . 53.7 mt -115.02 116.47 52.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.218 0.532 . . . . 0.0 111.211 -175.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 24' ' ' ILE . . . . . 0.483 HD12 ' N ' ' E' ' 24' ' ' ILE . 3.9 mp -93.23 -40.93 12.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.205 178.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -123.87 128.16 49.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.582 176.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 62.2 p -64.6 141.72 58.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.247 -174.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 27' ' ' PHE . . . . . 0.845 ' HB3' HD23 ' E' ' 91' ' ' LEU . 40.0 p90 -142.09 152.53 43.38 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.727 0.775 . . . . 0.0 112.235 -177.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 28' ' ' HIS . . . . . 0.639 ' HA ' ' O ' ' E' ' 67' ' ' LEU . 6.3 t60 -108.15 120.5 42.52 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.397 173.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 29' ' ' ILE . . . . . 0.543 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 35.2 mt -84.56 133.56 28.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.129 -1.064 . . . . 0.0 108.129 170.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 30' ' ' SER . . . . . 0.541 ' HB3' ' HE2' ' E' ' 28' ' ' HIS . 56.8 p -120.35 -6.88 9.82 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -173.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.13 158.34 25.88 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 119.569 -1.3 . . . . 0.0 113.609 176.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.5 HG23 ' HG ' ' E' ' 87' ' ' LEU . 13.1 p -140.42 127.16 22.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 172.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.13 152.84 41.48 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 121.934 -0.478 . . . . 0.0 111.324 -175.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 34' ' ' LEU . . . . . 0.623 ' HB3' HG12 ' E' ' 85' ' ' VAL . 3.7 pp -117.78 145.87 44.2 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 121.739 0.781 . . . . 0.0 111.794 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -106.68 -56.09 2.24 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.855 175.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -102.47 127.94 49.3 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.113 170.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 37' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 153.29 158.46 8.57 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 119.368 -1.396 . . . . 0.0 113.911 175.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -101.72 -45.67 5.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.497 -0.352 . . . . 0.0 110.559 176.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 39' ' ' GLU . . . . . 0.45 ' HG3' HG22 ' E' ' 57' ' ' THR . 32.7 tt0 -153.1 123.0 6.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.052 -178.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 40' ' ' ALA . . . . . 0.567 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -121.87 114.17 20.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.515 0.674 . . . . 0.0 110.002 170.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 41' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' E' ' 79' ' ' THR . 13.7 mmmm -97.18 105.46 17.61 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 49.8 tp -83.71 111.49 19.2 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -174.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 43' ' ' TYR . . . . . 0.559 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 80.0 m-85 -114.86 149.98 36.26 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 175.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 44' ' ' LEU . . . . . 0.562 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 0.2 OUTLIER -135.58 128.13 30.66 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.532 172.082 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' E' E ' 45' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -105.92 112.1 25.01 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.151 178.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 46' ' ' ALA . . . . . 0.581 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -127.87 133.29 49.33 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.344 178.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 59.29 38.24 23.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.607 0.718 . . . . 0.0 109.698 -176.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt 62.44 35.23 14.94 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.652 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 49' ' ' GLN . . . . . 0.566 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 23.2 tp60 -130.14 118.23 21.14 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -81.7 108.25 15.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.965 0.412 . . . . 0.0 110.859 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 51' ' ' TYR . . . . . 0.467 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 87.1 m-85 -99.81 133.33 44.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.615 177.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -80.06 104.71 8.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 169.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 53' ' ' VAL . . . . . 0.492 HG21 ' HB3' ' E' ' 44' ' ' LEU . 3.2 t -79.68 -50.4 18.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.667 -172.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 54' ' ' ALA . . . . . 0.61 ' HB2' HD21 ' E' ' 65' ' ' LEU . . . -153.33 147.18 25.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.723 -176.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 31.2 m -110.89 101.17 9.78 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 171.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 56' ' ' VAL . . . . . 0.47 HG13 ' HB3' ' E' ' 40' ' ' ALA . 7.1 p -119.54 113.45 41.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.64 0.733 . . . . 0.0 109.895 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 57' ' ' THR . . . . . 0.45 HG22 ' HG3' ' E' ' 39' ' ' GLU . 66.4 p -123.21 -178.43 3.98 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.746 -174.073 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -61.91 -22.98 66.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.961 0.41 . . . . 0.0 110.501 170.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 59' ' ' ALA . . . . . 0.437 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -84.34 -40.8 17.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.182 178.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 80.8 mt -112.78 82.56 5.13 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 174.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 61' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 11.5 Cg_exo -70.82 -0.29 7.56 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.066 2.511 . . . . 0.0 113.88 -167.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -163.12 127.1 2.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.399 0.618 . . . . 0.0 111.397 -176.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 86.9 t -116.42 121.93 68.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.344 174.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.56 127.56 32.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.032 176.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.61 HD21 ' HB2' ' E' ' 54' ' ' ALA . 90.8 mt -119.8 168.51 11.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.481 0.658 . . . . 0.0 112.184 -174.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 66' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 14.3 t0 -145.76 97.59 2.99 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 172.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 67' ' ' LEU . . . . . 0.678 HD21 HD23 ' D' ' 88' ' ' LEU . 6.7 mt -133.57 109.99 9.61 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.809 -174.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 68' ' ' ASN . . . . . 0.462 ' HB2' ' CG ' ' D' ' 90' ' ' TYR . 6.4 m-20 -103.84 113.87 27.71 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 69' ' ' PHE . . . . . 0.442 ' HB3' ' CD1' ' E' ' 23' ' ' ILE . 86.1 m-85 -109.1 136.98 47.71 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.721 178.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 70' ' ' SER . . . . . 0.435 ' OG ' ' HG2' ' D' ' 7' ' ' MET . 88.0 p -97.35 166.7 11.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.802 0.334 . . . . 0.0 110.17 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 71' ' ' LYS . . . . . 0.411 ' HE3' ' OG ' ' D' ' 98' ' ' SER . 14.9 ptmm? -73.19 -4.83 35.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.002 0.43 . . . . 0.0 110.843 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.6 -9.14 59.07 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 174.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -88.5 140.25 29.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.863 0.363 . . . . 0.0 110.059 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -126.32 114.47 18.29 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 75' ' ' ILE . . . . . 0.581 HG22 ' HB2' ' E' ' 46' ' ' ALA . 13.3 pt -131.04 158.71 43.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.104 0.478 . . . . 0.0 111.945 -166.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 76' ' ' MET . . . . . 0.495 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 3.7 mtm -119.28 123.97 45.55 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 174.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 77' ' ' PHE . . . . . 0.562 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 1.1 m-85 -104.28 128.61 52.08 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 78' ' ' TYR . . . . . 0.713 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 26.0 p90 -151.95 135.0 15.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.504 0.669 . . . . 0.0 112.442 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 79' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 2.6 p -108.99 130.54 55.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.767 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.85 164.76 11.55 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.51 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.44 -174.04 44.65 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -113.32 102.69 10.58 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.977 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 83' ' ' ALA . . . . . 0.567 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -173.7 153.56 2.27 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.536 171.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 18.9 t -114.84 126.42 54.8 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 85' ' ' VAL . . . . . 0.623 HG12 ' HB3' ' E' ' 34' ' ' LEU . 6.7 m -120.78 157.68 23.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-O 121.222 0.534 . . . . 0.0 112.075 -172.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 66.6 m -117.21 118.93 33.65 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 171.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 87' ' ' LEU . . . . . 0.74 HD13 HD23 ' E' ' 11' ' ' LEU . 5.1 mp -89.77 145.43 25.19 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 170.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 88' ' ' LEU . . . . . 0.668 HD23 HD21 ' A' ' 67' ' ' LEU . 0.8 OUTLIER -130.1 141.4 50.7 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.873 -177.738 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.87 -167.51 26.61 Favored Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.253 -178.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 90' ' ' TYR . . . . . 0.452 ' CG ' ' HB2' ' A' ' 68' ' ' ASN . 13.6 p90 -150.24 129.58 12.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 122.04 0.924 . . . . 0.0 112.06 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 91' ' ' LEU . . . . . 0.845 HD23 ' HB3' ' E' ' 27' ' ' PHE . 8.0 mt -66.8 141.13 57.81 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.81 176.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -80.92 109.36 15.42 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.684 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -132.9 173.74 11.07 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 177.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 94' ' ' ILE . . . . . 0.529 HG21 ' H ' ' D' ' 3' ' ' GLY . 1.5 pp -142.36 13.88 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -174.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -76.81 87.65 3.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.28 0.562 . . . . 0.0 110.125 178.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 18.4 t -88.64 73.1 8.63 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.13 162.3 48.1 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.708 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 98' ' ' SER . . . . . 0.436 ' OG ' ' HE3' ' A' ' 71' ' ' LYS . 27.1 m . . . . . 0 C--O 1.248 1.001 0 C-N-CA 122.938 0.495 . . . . 0.0 110.943 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -102.09 145.51 29.24 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 149.93 -171.71 29.91 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.795 -177.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.563 ' O ' ' HB3' ' A' ' 93' ' ' ASP . . . 57.02 44.26 23.1 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 123.882 0.401 . . . . 0.0 110.921 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -70.33 172.64 7.93 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.895 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.59 ' HB3' ' ND2' ' B' ' 68' ' ' ASN . . . -54.25 131.5 41.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.761 177.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 52.4 ttm -100.36 139.01 36.65 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.622 -173.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.439 ' CE1' HD21 ' B' ' 44' ' ' LEU . 61.4 t80 -52.77 142.1 19.64 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.619 -177.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.555 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 88.5 t90 -135.71 147.72 48.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.876 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.46 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -148.72 153.82 25.46 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.007 178.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.652 HD23 HD13 ' A' ' 87' ' ' LEU . 52.1 tp -140.44 108.18 5.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.022 0.439 . . . . 0.0 110.881 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -81.25 101.49 9.76 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.538 173.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.592 ' HB3' HG23 ' A' ' 85' ' ' VAL . 30.6 tpp -95.48 131.26 41.83 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.148 -174.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -100.82 145.31 30.15 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.915 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.598 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 12.3 Cg_endo -56.01 124.54 16.51 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 123.397 2.731 . . . . 0.0 113.493 -174.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.556 ' HA ' ' O ' ' A' ' 79' ' ' THR . 25.3 mt-10 60.3 47.91 8.57 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.062 177.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -121.79 138.67 54.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.687 172.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.726 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 84.5 mttt -111.21 118.98 37.43 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.414 0.446 . . . . 0.0 111.519 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.61 103.91 12.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.827 176.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.41 ' HB3' ' SD ' ' A' ' 76' ' ' MET . 7.8 p -88.47 98.84 11.85 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 174.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -117.36 144.84 44.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.472 0.653 . . . . 0.0 112.273 -169.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.5 m -94.06 143.15 26.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.542 177.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.435 ' CG2' ' HA ' ' A' ' 71' ' ' LYS . 59.4 mt -92.81 120.35 42.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.066 0.46 . . . . 0.0 111.119 -174.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.1 mp -79.34 -52.9 14.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.351 178.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.493 ' HE2' ' HB3' ' A' ' 91' ' ' LEU . 13.5 ptmt -131.08 137.53 49.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.942 175.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.2 m -54.45 141.76 29.65 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.921 -176.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.666 ' HB3' HD23 ' A' ' 91' ' ' LEU . 11.9 p90 -149.06 158.26 44.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.655 0.741 . . . . 0.0 112.819 -175.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.608 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 9.2 t60 -111.41 127.41 55.67 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.392 -1.276 . . . . 0.0 109.745 178.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.573 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 35.0 mt -96.78 137.97 23.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 170.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.608 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 56.6 p -123.5 -20.42 5.57 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -171.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -153.88 156.34 26.74 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 119.273 -1.442 . . . . 0.0 113.578 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.5 HG23 ' HG ' ' A' ' 87' ' ' LEU . 14.8 p -146.51 124.39 4.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 172.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.19 155.68 44.0 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.75 -174.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.581 ' HB3' HG12 ' A' ' 85' ' ' VAL . 3.7 pp -120.39 140.55 51.17 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.914 0.864 . . . . 0.0 111.755 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -105.12 -53.6 2.63 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.334 -1.303 . . . . 0.0 108.788 174.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -102.91 127.44 50.12 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 169.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.485 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 151.22 156.03 7.21 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 119.784 -1.198 . . . . 0.0 113.608 177.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.44 ' HA ' ' HB2' ' A' ' 58' ' ' LYS . 91.0 mt-30 -102.66 -44.27 5.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.68 0.276 . . . . 0.0 111.053 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -153.12 126.41 8.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.095 176.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.564 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -124.51 113.16 17.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.563 0.697 . . . . 0.0 109.7 169.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 79' ' ' THR . 19.9 mtpp -96.06 107.05 19.31 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 41.2 tp -81.57 114.84 20.55 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -173.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.55 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 97.6 m-85 -120.49 139.46 52.86 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.271 177.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.51 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -125.15 133.27 52.87 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 172.67 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.631 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -112.04 113.07 25.14 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.156 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.53 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -124.47 137.8 54.4 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.416 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 59.7 30.72 20.33 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.473 0.483 . . . . 0.0 110.301 -174.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.479 ' HB2' ' NZ ' ' A' ' 48' ' ' LYS . 0.1 OUTLIER 62.57 33.6 15.74 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.14 -177.072 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.631 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 8.5 tp-100 -123.46 130.38 52.61 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.66 123.59 32.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.905 0.383 . . . . 0.0 110.769 -176.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.499 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 84.7 m-85 -118.02 130.08 55.96 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 175.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.09 103.77 7.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 171.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.546 ' CG1' HD11 ' A' ' 67' ' ' LEU . 2.6 t -78.7 -49.49 20.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.712 -171.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.462 ' HB1' HG11 ' A' ' 63' ' ' VAL . . . -158.38 146.58 18.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.852 -178.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.4 m -109.46 101.43 10.39 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 173.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.456 HG11 HG11 ' A' ' 85' ' ' VAL . 7.4 p -115.63 116.2 51.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.557 0.694 . . . . 0.0 109.565 -177.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 47.1 p -122.37 -179.13 4.09 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.335 -172.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.44 ' HB2' ' HA ' ' A' ' 38' ' ' GLN . 38.1 tttm -61.58 -27.38 68.59 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.892 172.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.487 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -84.24 -40.63 17.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.643 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.2 mt -109.45 83.99 2.82 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 174.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 9.7 Cg_exo -70.91 0.07 7.08 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.016 2.478 . . . . 0.0 113.762 -168.087 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -162.8 131.74 4.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.224 0.535 . . . . 0.0 111.254 -176.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.462 HG11 ' HB1' ' A' ' 54' ' ' ALA . 68.7 t -120.49 132.68 69.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.105 172.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.43 113.11 25.49 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.224 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -121.46 170.01 10.07 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.34 -176.489 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.549 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 7.2 t0 -118.33 98.76 6.44 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.245 0.545 . . . . 0.0 109.619 175.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.613 HD21 HD23 ' E' ' 88' ' ' LEU . 19.8 mt -112.98 143.49 44.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.873 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.628 ' ND2' ' HB3' ' E' ' 6' ' ' ALA . 57.2 t30 -147.81 119.96 8.3 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 120.942 0.401 . . . . 0.0 110.008 174.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -114.93 153.53 30.38 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.25 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.7 t -103.67 148.88 25.51 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.983 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.493 ' HB2' ' NZ ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -74.75 9.97 1.6 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -174.656 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.62 -15.21 30.04 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.865 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -101.28 170.82 7.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.77 0.319 . . . . 0.0 110.868 -175.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 61.9 ttt-85 -138.32 122.6 18.18 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.53 HG22 ' HB2' ' A' ' 46' ' ' ALA . 14.4 pt -125.69 160.86 31.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.431 -170.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.48 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 2.8 mtm -115.23 129.02 56.52 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 174.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.51 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -109.82 128.41 55.3 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.109 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.726 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 51.3 p90 -155.83 157.47 36.48 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 120.226 -0.59 . . . . 0.0 112.24 -177.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 14.8 p -124.81 144.0 50.51 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.264 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.42 156.63 18.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.981 174.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.01 -166.83 31.32 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -176.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -123.71 102.68 7.96 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 117.715 0.758 . . . . 0.0 110.42 176.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.598 ' H ' ' HB3' ' A' ' 15' ' ' PRO . . . -169.31 151.81 4.71 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.187 169.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.5 t -109.1 122.85 48.16 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.592 HG23 ' HB3' ' A' ' 13' ' ' MET . 6.7 m -119.78 147.12 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-O 121.266 0.555 . . . . 0.0 111.832 -173.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.0 t -111.01 119.34 38.72 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.652 HD13 HD23 ' A' ' 11' ' ' LEU . 5.2 mp -91.84 151.45 20.56 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 174.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.568 HD23 HD21 ' B' ' 67' ' ' LEU . 1.2 tp -133.0 140.3 47.69 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.301 -178.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.23 -166.75 24.72 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.992 -177.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.408 ' CD2' ' HB3' ' B' ' 68' ' ' ASN . 11.5 p90 -152.93 132.86 13.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.697 0.76 . . . . 0.0 111.839 176.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.666 HD23 ' HB3' ' A' ' 27' ' ' PHE . 15.2 mt -67.56 139.84 56.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.095 177.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -72.97 113.46 10.03 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -174.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.563 ' HB3' ' O ' ' A' ' 4' ' ' ALA . 3.2 m-20 -142.21 136.24 29.71 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.113 -0.948 . . . . 0.0 108.937 171.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 39.5 pt -77.78 145.0 10.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.096 0.474 . . . . 0.0 111.358 -175.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -66.48 -9.31 33.16 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.053 -177.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.9 m 65.05 -159.52 0.29 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.569 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.16 -61.34 3.99 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.749 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 68.9 m . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.261 176.397 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -102.12 145.5 29.27 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' GLY . . . . . 0.402 ' HA2' ' SD ' ' B' ' 5' ' ' MET . . . 149.92 -171.71 29.9 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.782 -177.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.549 ' O ' ' HB3' ' B' ' 93' ' ' ASP . . . 57.03 44.35 22.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 0.0 110.868 -178.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' MET . . . . . 0.402 ' SD ' ' HA2' ' B' ' 3' ' ' GLY . 2.5 mpt? -70.43 172.66 8.01 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.862 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.627 ' HB3' ' ND2' ' C' ' 68' ' ' ASN . . . -54.26 131.46 41.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.677 177.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 52.5 ttm -100.34 139.06 36.55 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.582 -173.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.49 ' CE1' HD21 ' C' ' 44' ' ' LEU . 61.8 t80 -52.72 142.05 19.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.627 -177.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 9' ' ' TRP . . . . . 0.551 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 88.5 t90 -135.7 147.71 48.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.856 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.507 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -148.71 153.86 25.48 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.984 178.109 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.662 HD23 HD13 ' B' ' 87' ' ' LEU . 52.3 tp -140.46 108.13 5.63 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.086 0.47 . . . . 0.0 110.915 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -81.23 101.59 9.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.529 173.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 13' ' ' MET . . . . . 0.591 ' HB3' HG23 ' B' ' 85' ' ' VAL . 30.8 tpp -95.58 131.23 42.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.114 0.483 . . . . 0.0 111.151 -174.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -100.74 145.26 30.05 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.969 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.587 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 12.4 Cg_endo -56.09 124.67 16.82 Favored 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 123.445 2.763 . . . . 0.0 113.487 -174.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.549 ' HA ' ' O ' ' B' ' 79' ' ' THR . 25.3 mt-10 60.24 47.91 8.72 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.031 177.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -121.76 138.78 54.23 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.696 172.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.721 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 84.5 mttt -111.47 119.02 37.4 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 123.273 0.358 . . . . 0.0 111.491 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.67 103.86 12.47 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.766 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 7.3 p -88.48 98.87 11.87 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 174.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -117.39 144.81 44.57 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.538 0.685 . . . . 0.0 112.284 -169.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 17.7 m -94.06 143.11 26.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.523 177.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.445 ' CG2' ' HA ' ' B' ' 71' ' ' LYS . 59.3 mt -92.86 120.49 42.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.162 0.506 . . . . 0.0 111.117 -174.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.444 ' N ' HD12 ' B' ' 24' ' ' ILE . 4.0 mp -79.42 -52.89 14.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.286 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.502 ' HE2' ' HB3' ' B' ' 91' ' ' LEU . 13.5 ptmt -131.12 137.47 49.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.988 175.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 11.5 m -54.41 141.71 29.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.924 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 27' ' ' PHE . . . . . 0.66 ' HB3' HD23 ' B' ' 91' ' ' LEU . 12.1 p90 -149.03 158.28 44.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.685 0.755 . . . . 0.0 112.774 -175.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 28' ' ' HIS . . . . . 0.598 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 9.2 t60 -111.39 127.39 55.65 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.39 -1.277 . . . . 0.0 109.795 178.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.589 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 35.0 mt -96.79 137.98 23.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 170.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.598 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 56.4 p -123.52 -20.37 5.58 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -171.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -153.81 156.39 26.77 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 119.322 -1.418 . . . . 0.0 113.605 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.498 HG23 ' HG ' ' B' ' 87' ' ' LEU . 14.8 p -146.58 124.35 3.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 172.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.14 155.71 44.04 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.898 -0.501 . . . . 0.0 111.726 -174.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.586 ' HB3' HG12 ' B' ' 85' ' ' VAL . 3.7 pp -120.38 140.57 51.12 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.984 0.897 . . . . 0.0 111.728 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -105.01 -53.8 2.6 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.37 -1.286 . . . . 0.0 108.855 174.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -102.82 127.44 49.99 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 169.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.492 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 151.3 156.09 7.25 Favored Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 119.829 -1.177 . . . . 0.0 113.547 176.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 38' ' ' GLN . . . . . 0.438 ' HA ' ' HB2' ' B' ' 58' ' ' LYS . 91.0 mt-30 -102.58 -44.3 5.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.737 0.303 . . . . 0.0 111.125 178.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -153.08 126.41 8.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.089 177.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.555 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -124.53 113.12 17.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.511 0.672 . . . . 0.0 109.776 169.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' B' ' 79' ' ' THR . 19.9 mtpp -96.15 107.04 19.32 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 41.2 tp -81.5 114.84 20.49 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 -173.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 43' ' ' TYR . . . . . 0.553 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 97.6 m-85 -120.51 139.42 52.93 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.507 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 0.2 OUTLIER -125.07 133.29 52.96 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 172.575 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.625 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -112.02 113.11 25.21 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.184 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.515 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -124.54 137.82 54.38 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.344 178.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 59.63 30.88 20.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.046 0.451 . . . . 0.0 110.293 -174.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.488 ' HB2' ' NZ ' ' B' ' 48' ' ' LYS . 0.1 OUTLIER 62.62 33.6 15.61 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.12 -177.153 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.625 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 8.4 tp-100 -123.48 130.27 52.45 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.63 123.61 32.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.829 0.347 . . . . 0.0 110.7 -175.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.46 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 84.8 m-85 -117.99 130.15 56.02 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.888 175.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.1 tp -80.2 103.78 7.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.827 0.822 . . . . 0.0 108.807 171.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.552 ' CG1' HD11 ' B' ' 67' ' ' LEU . 2.6 t -78.7 -49.39 20.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.709 -171.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.468 ' HB1' HG11 ' B' ' 63' ' ' VAL . . . -158.38 146.65 18.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.889 -178.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 32.3 m -109.57 101.43 10.36 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.449 HG11 HG11 ' B' ' 85' ' ' VAL . 7.4 p -115.62 116.21 51.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.568 0.699 . . . . 0.0 109.557 -177.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 46.8 p -122.37 -179.17 4.1 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.371 -172.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 58' ' ' LYS . . . . . 0.438 ' HB2' ' HA ' ' B' ' 38' ' ' GLN . 38.1 tttm -61.53 -27.33 68.53 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.878 172.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.479 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -84.34 -40.67 17.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.577 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 86.1 mt -109.41 84.11 2.85 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 174.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 9.8 Cg_exo -71.03 0.09 7.14 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.981 2.454 . . . . 0.0 113.707 -168.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -162.79 131.71 4.11 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.121 0.486 . . . . 0.0 111.221 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.468 HG11 ' HB1' ' B' ' 54' ' ' ALA . 71.7 t -120.57 132.8 69.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.964 172.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.52 113.22 25.69 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.09 177.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.435 HD13 ' N ' ' B' ' 65' ' ' LEU . 0.0 OUTLIER -121.58 170.05 10.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.325 -176.575 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 66' ' ' ASP . . . . . 0.511 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 7.2 t0 -118.38 98.73 6.42 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.221 0.534 . . . . 0.0 109.602 175.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.589 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 19.7 mt -113.0 143.43 44.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.903 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 68' ' ' ASN . . . . . 0.59 ' ND2' ' HB3' ' A' ' 6' ' ' ALA . 57.0 t30 -147.79 120.0 8.34 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.951 0.405 . . . . 0.0 109.965 174.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -114.98 153.5 30.5 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.273 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 20.6 t -103.57 148.89 25.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.058 -178.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.486 ' HB2' ' NZ ' ' B' ' 71' ' ' LYS . 0.0 OUTLIER -74.88 10.07 1.6 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -174.579 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.61 -15.22 30.04 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.86 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -101.13 170.83 7.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.846 0.355 . . . . 0.0 110.838 -175.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 62.0 ttt-85 -138.37 122.55 18.07 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.515 HG22 ' HB2' ' B' ' 46' ' ' ALA . 14.5 pt -125.73 160.86 31.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.389 -170.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.483 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 2.8 mtm -115.25 129.01 56.51 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 174.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 77' ' ' PHE . . . . . 0.507 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -109.81 128.39 55.28 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.187 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.721 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 51.4 p90 -155.79 157.4 36.43 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 120.241 -0.584 . . . . 0.0 112.215 -177.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 14.6 p -124.77 144.06 50.46 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.277 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.43 156.69 18.68 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.981 174.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.87 -166.91 31.55 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -123.75 102.76 7.99 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.36 176.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.587 ' H ' ' HB3' ' B' ' 15' ' ' PRO . . . -169.23 151.88 4.79 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.21 169.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 33.7 t -109.23 122.83 48.17 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.591 HG23 ' HB3' ' B' ' 13' ' ' MET . 6.8 m -119.78 147.18 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 CA-C-O 121.307 0.575 . . . . 0.0 111.838 -173.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 17.0 t -111.08 119.33 38.63 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.662 HD13 HD23 ' B' ' 11' ' ' LEU . 5.2 mp -91.72 151.49 20.61 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 174.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.602 HD23 HD21 ' C' ' 67' ' ' LEU . 1.2 tp -133.07 140.31 47.61 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.267 -178.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.28 -166.67 24.65 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.961 -177.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 90' ' ' TYR . . . . . 0.42 ' CD2' ' HB3' ' C' ' 68' ' ' ASN . 11.3 p90 -153.11 132.92 13.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.811 0.815 . . . . 0.0 111.742 176.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 91' ' ' LEU . . . . . 0.66 HD23 ' HB3' ' B' ' 27' ' ' PHE . 15.1 mt -67.57 139.79 56.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.13 -1.395 . . . . 0.0 110.127 177.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -72.9 113.39 9.88 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -174.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 93' ' ' ASP . . . . . 0.549 ' HB3' ' O ' ' B' ' 4' ' ' ALA . 3.3 m-20 -142.21 136.11 29.58 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.909 171.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 39.5 pt -77.68 145.05 10.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.037 0.446 . . . . 0.0 111.497 -175.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -66.52 -9.33 33.66 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.085 -177.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 19.8 m 65.04 -159.65 0.29 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.594 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.29 -61.14 3.97 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.757 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 68.6 m . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.696 -0.669 . . . . 0.0 110.263 176.247 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -102.04 145.39 29.38 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . 149.94 -171.83 29.91 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.808 -177.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 4' ' ' ALA . . . . . 0.548 ' O ' ' HB3' ' C' ' 93' ' ' ASP . . . 57.21 44.13 22.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.853 0.359 . . . . 0.0 110.907 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -70.2 172.56 7.91 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.903 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 6' ' ' ALA . . . . . 0.584 ' HB3' ' ND2' ' D' ' 68' ' ' ASN . . . -54.2 131.39 41.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.68 177.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 52.4 ttm -100.33 138.99 36.64 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.567 -173.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 8' ' ' PHE . . . . . 0.491 ' CE1' HD21 ' D' ' 44' ' ' LEU . 61.4 t80 -52.73 142.1 19.48 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.937 -1.028 . . . . 0.0 112.62 -177.423 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 9' ' ' TRP . . . . . 0.537 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 88.3 t90 -135.71 147.57 48.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.867 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 10' ' ' GLY . . . . . 0.521 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -148.69 153.8 25.44 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.094 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.652 HD23 HD13 ' C' ' 87' ' ' LEU . 52.6 tp -140.36 108.15 5.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.989 0.423 . . . . 0.0 110.914 178.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -81.29 101.48 9.78 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.507 173.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 13' ' ' MET . . . . . 0.604 ' HB3' HG23 ' C' ' 85' ' ' VAL . 30.7 tpp -95.48 131.23 41.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.132 0.492 . . . . 0.0 111.128 -174.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -100.82 145.32 30.17 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.899 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 15' ' ' PRO . . . . . 0.591 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 12.4 Cg_endo -56.06 124.61 16.69 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 123.404 2.736 . . . . 0.0 113.459 -174.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 16' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' C' ' 79' ' ' THR . 25.1 mt-10 60.28 47.91 8.63 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.024 177.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -121.72 138.72 54.24 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.653 172.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 18' ' ' LYS . . . . . 0.729 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 84.5 mttt -111.37 119.06 37.58 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.454 0.471 . . . . 0.0 111.484 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -110.7 103.86 12.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.735 176.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 20' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 7.8 p -88.43 98.84 11.85 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 174.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -117.38 144.77 44.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.553 0.692 . . . . 0.0 112.271 -169.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 17.4 m -94.01 143.19 26.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.577 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 23' ' ' ILE . . . . . 0.435 ' CG2' ' HA ' ' C' ' 71' ' ' LYS . 59.4 mt -92.89 120.48 42.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.054 0.454 . . . . 0.0 111.09 -174.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 24' ' ' ILE . . . . . 0.449 ' N ' HD12 ' C' ' 24' ' ' ILE . 4.0 mp -79.43 -52.88 14.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.315 178.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 25' ' ' LYS . . . . . 0.492 ' HE2' ' HB3' ' C' ' 91' ' ' LEU . 13.6 ptmt -131.12 137.46 49.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.95 175.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 11.5 m -54.43 141.69 29.77 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.921 -176.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 27' ' ' PHE . . . . . 0.651 ' HB3' HD23 ' C' ' 91' ' ' LEU . 12.1 p90 -149.0 158.24 44.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.71 0.767 . . . . 0.0 112.834 -176.005 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 28' ' ' HIS . . . . . 0.603 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 9.2 t60 -111.41 127.41 55.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.405 -1.271 . . . . 0.0 109.864 178.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 29' ' ' ILE . . . . . 0.566 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 35.6 mt -96.82 138.02 23.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 170.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.603 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 56.4 p -123.46 -20.45 5.58 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -171.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -153.78 156.36 26.74 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 119.352 -1.404 . . . . 0.0 113.634 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.489 HG23 ' HG ' ' C' ' 87' ' ' LEU . 14.8 p -146.57 124.31 3.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.12 155.74 44.06 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.947 -0.471 . . . . 0.0 111.752 -174.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.597 ' HB3' HG12 ' C' ' 85' ' ' VAL . 3.7 pp -120.44 140.58 51.17 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.938 0.875 . . . . 0.0 111.752 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -105.13 -53.7 2.62 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.757 174.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -102.9 127.47 50.09 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 169.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 37' ' ' GLY . . . . . 0.48 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 151.24 156.09 7.24 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 119.901 -1.142 . . . . 0.0 113.685 177.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 38' ' ' GLN . . . . . 0.438 ' HA ' ' HB2' ' C' ' 58' ' ' LYS . 90.9 mt-30 -102.68 -44.23 5.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.766 0.317 . . . . 0.0 111.156 178.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -153.1 126.46 8.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.071 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.56 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -124.46 113.08 17.66 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.441 0.638 . . . . 0.0 109.793 169.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' C' ' 79' ' ' THR . 19.9 mtpp -96.07 107.02 19.27 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 176.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 41.3 tp -81.48 114.81 20.46 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -173.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 43' ' ' TYR . . . . . 0.553 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 97.6 m-85 -120.53 139.41 52.95 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.503 ' HB2' ' CD1' ' C' ' 77' ' ' PHE . 0.2 OUTLIER -125.12 133.25 52.92 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.656 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 45' ' ' ALA . . . . . 0.631 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -112.07 113.11 25.2 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.096 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.519 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -124.46 137.82 54.4 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.333 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 59.72 30.73 20.32 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 123.503 0.502 . . . . 0.0 110.258 -174.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.488 ' HB2' ' NZ ' ' C' ' 48' ' ' LYS . 0.1 OUTLIER 62.53 33.62 15.83 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.201 -177.033 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 49' ' ' GLN . . . . . 0.631 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 8.4 tp-100 -123.53 130.27 52.43 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.53 123.64 31.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.792 0.33 . . . . 0.0 110.806 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 51' ' ' TYR . . . . . 0.507 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 84.6 m-85 -118.03 130.12 55.98 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.84 175.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.1 tp -80.23 103.82 7.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 171.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 53' ' ' VAL . . . . . 0.555 ' CG1' HD11 ' C' ' 67' ' ' LEU . 2.6 t -78.7 -49.5 20.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.648 -171.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 54' ' ' ALA . . . . . 0.471 ' HB1' HG11 ' C' ' 63' ' ' VAL . . . -158.35 146.56 18.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.827 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 32.5 m -109.42 101.37 10.35 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 173.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 56' ' ' VAL . . . . . 0.462 HG11 HG11 ' C' ' 85' ' ' VAL . 7.4 p -115.54 116.27 51.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.587 0.708 . . . . 0.0 109.569 -177.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 47.0 p -122.44 -179.13 4.1 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.346 -172.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 58' ' ' LYS . . . . . 0.438 ' HB2' ' HA ' ' C' ' 38' ' ' GLN . 38.1 tttm -61.45 -27.53 68.63 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.871 172.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 59' ' ' ALA . . . . . 0.493 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -84.14 -40.66 17.95 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.647 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 86.1 mt -109.43 84.05 2.83 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 174.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 61' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 9.8 Cg_exo -71.03 0.12 7.09 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.099 2.533 . . . . 0.0 113.729 -168.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -162.77 131.69 4.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.166 0.508 . . . . 0.0 111.274 -176.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.471 HG11 ' HB1' ' C' ' 54' ' ' ALA . 69.0 t -120.47 132.86 68.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.0 172.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.61 113.12 25.5 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.115 177.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 65' ' ' LEU . . . . . 0.439 HD13 ' N ' ' C' ' 65' ' ' LEU . 0.0 OUTLIER -121.51 170.03 10.08 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.064 0.459 . . . . 0.0 111.294 -176.508 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 66' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 7.4 t0 -118.3 98.76 6.44 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.199 0.524 . . . . 0.0 109.678 175.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.602 HD21 HD23 ' B' ' 88' ' ' LEU . 19.7 mt -112.98 143.4 44.33 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.902 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 68' ' ' ASN . . . . . 0.627 ' ND2' ' HB3' ' B' ' 6' ' ' ALA . 57.1 t30 -147.75 119.96 8.34 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 174.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -115.01 153.53 30.48 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.186 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 20.5 t -103.61 148.88 25.47 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.991 -178.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 71' ' ' LYS . . . . . 0.48 ' HB2' ' NZ ' ' C' ' 71' ' ' LYS . 0.0 OUTLIER -74.76 9.91 1.63 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -174.66 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.57 -15.14 30.37 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.594 -0.813 . . . . 0.0 111.994 175.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -101.16 170.87 7.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.792 0.329 . . . . 0.0 110.91 -175.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 61.8 ttt-85 -138.36 122.64 18.19 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.519 HG22 ' HB2' ' C' ' 46' ' ' ALA . 14.4 pt -125.76 160.84 31.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.4 -170.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.476 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 2.8 mtm -115.24 129.02 56.52 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 174.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 77' ' ' PHE . . . . . 0.503 ' CD1' ' HB2' ' C' ' 44' ' ' LEU . 0.6 OUTLIER -109.91 128.38 55.32 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.179 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 78' ' ' TYR . . . . . 0.729 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 51.2 p90 -155.78 157.45 36.51 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 120.235 -0.586 . . . . 0.0 112.254 -177.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 79' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 14.7 p -124.74 143.98 50.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.234 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.34 156.62 18.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.017 174.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.04 -166.74 31.23 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -176.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -123.79 102.72 7.96 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 117.693 0.746 . . . . 0.0 110.462 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 83' ' ' ALA . . . . . 0.591 ' H ' ' HB3' ' C' ' 15' ' ' PRO . . . -169.26 151.81 4.74 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.366 -1.288 . . . . 0.0 109.258 169.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 33.5 t -109.18 122.78 48.03 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.604 HG23 ' HB3' ' C' ' 13' ' ' MET . 6.7 m -119.68 147.17 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 CA-C-O 121.264 0.554 . . . . 0.0 111.818 -173.228 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 86' ' ' SER . . . . . 0.4 ' HB3' HG22 ' D' ' 52' ' ' ILE . 17.2 t -111.11 119.36 38.74 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 87' ' ' LEU . . . . . 0.652 HD13 HD23 ' C' ' 11' ' ' LEU . 5.2 mp -91.67 151.46 20.66 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 174.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 88' ' ' LEU . . . . . 0.564 HD23 HD21 ' D' ' 67' ' ' LEU . 1.2 tp -133.07 140.33 47.62 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.3 -178.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.29 -166.73 24.77 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.955 -0.64 . . . . 0.0 111.991 -177.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -153.0 132.81 13.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.714 0.769 . . . . 0.0 111.817 176.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 91' ' ' LEU . . . . . 0.651 HD23 ' HB3' ' C' ' 27' ' ' PHE . 15.2 mt -67.6 139.76 56.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.094 177.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -72.83 113.39 9.8 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -174.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 93' ' ' ASP . . . . . 0.548 ' HB3' ' O ' ' C' ' 4' ' ' ALA . 3.2 m-20 -142.19 136.3 29.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.896 171.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 39.5 pt -77.86 144.99 10.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.016 0.436 . . . . 0.0 111.393 -175.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.42 -9.34 32.93 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.028 -177.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 20.1 m 64.93 -159.57 0.29 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.621 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.31 -61.36 3.94 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.831 -0.7 . . . . 0.0 111.68 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.716 -0.659 . . . . 0.0 110.209 176.435 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -102.01 145.38 29.38 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 3' ' ' GLY . . . . . 0.409 ' HA2' ' SD ' ' D' ' 5' ' ' MET . . . 150.0 -171.88 29.94 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.799 -177.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 4' ' ' ALA . . . . . 0.548 ' O ' ' HB3' ' D' ' 93' ' ' ASP . . . 57.25 44.2 22.43 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 123.834 0.373 . . . . 0.0 110.854 -178.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 5' ' ' MET . . . . . 0.409 ' SD ' ' HA2' ' D' ' 3' ' ' GLY . 2.5 mpt? -70.33 172.64 7.92 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.837 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 6' ' ' ALA . . . . . 0.585 ' HB3' ' ND2' ' E' ' 68' ' ' ASN . . . -54.27 131.48 41.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.69 177.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 52.4 ttm -100.36 139.06 36.58 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.594 -173.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 8' ' ' PHE . . . . . 0.496 ' CE1' HD21 ' E' ' 44' ' ' LEU . 61.4 t80 -52.76 142.16 19.48 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.603 -177.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 9' ' ' TRP . . . . . 0.55 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 88.2 t90 -135.81 147.67 48.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.113 -0.948 . . . . 0.0 108.899 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 10' ' ' GLY . . . . . 0.518 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -148.74 153.76 25.41 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.083 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.663 HD23 HD13 ' D' ' 87' ' ' LEU . 52.1 tp -140.32 108.25 5.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.065 0.46 . . . . 0.0 110.85 178.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -81.32 101.68 9.93 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.473 173.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 13' ' ' MET . . . . . 0.601 ' HB3' HG23 ' D' ' 85' ' ' VAL . 30.5 tpp -95.57 131.31 41.91 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.181 -174.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -100.87 145.32 30.19 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.885 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 15' ' ' PRO . . . . . 0.595 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 12.3 Cg_endo -56.12 124.61 16.69 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 123.421 2.747 . . . . 0.0 113.413 -174.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 16' ' ' GLU . . . . . 0.556 ' HA ' ' O ' ' D' ' 79' ' ' THR . 25.2 mt-10 60.33 47.91 8.52 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.547 -0.752 . . . . 0.0 112.017 177.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -121.78 138.69 54.27 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.654 172.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 18' ' ' LYS . . . . . 0.714 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 84.6 mttt -111.39 119.1 37.71 Favored 'General case' 0 CA--C 1.517 -0.316 0 O-C-N 123.384 0.428 . . . . 0.0 111.472 178.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.61 103.84 12.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.794 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 20' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 7.5 p -88.38 98.84 11.83 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 174.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -117.44 144.79 44.65 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.537 0.684 . . . . 0.0 112.271 -169.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 17.4 m -94.08 143.1 26.67 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.56 177.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 23' ' ' ILE . . . . . 0.443 ' CG2' ' HA ' ' D' ' 71' ' ' LYS . 59.5 mt -92.86 120.55 42.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.167 0.508 . . . . 0.0 111.077 -174.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 24' ' ' ILE . . . . . 0.452 HD12 ' N ' ' D' ' 24' ' ' ILE . 4.0 mp -79.47 -52.9 14.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.294 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 25' ' ' LYS . . . . . 0.498 ' HE2' ' HB3' ' D' ' 91' ' ' LEU . 13.6 ptmt -131.03 137.56 49.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.053 175.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 11.7 m -54.49 141.71 30.06 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 124.01 0.818 . . . . 0.0 110.894 -176.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 27' ' ' PHE . . . . . 0.657 ' HB3' HD23 ' D' ' 91' ' ' LEU . 11.9 p90 -149.04 158.28 44.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.717 0.77 . . . . 0.0 112.767 -175.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 28' ' ' HIS . . . . . 0.598 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 9.2 t60 -111.44 127.35 55.66 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.739 178.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 29' ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 35.4 mt -96.7 138.11 22.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 170.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 30' ' ' SER . . . . . 0.598 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 55.7 p -123.65 -20.35 5.53 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -171.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -153.79 156.38 26.76 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 119.305 -1.426 . . . . 0.0 113.635 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.489 HG23 ' HG ' ' D' ' 87' ' ' LEU . 14.8 p -146.63 124.23 3.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.11 155.74 44.07 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.91 -0.494 . . . . 0.0 111.791 -174.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 34' ' ' LEU . . . . . 0.576 ' HB3' HG12 ' D' ' 85' ' ' VAL . 3.7 pp -120.37 140.47 51.26 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.894 0.854 . . . . 0.0 111.781 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -105.07 -53.59 2.64 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.416 -1.266 . . . . 0.0 108.84 174.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -102.92 127.47 50.12 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 168.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 37' ' ' GLY . . . . . 0.488 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 151.18 155.92 7.16 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 119.859 -1.162 . . . . 0.0 113.688 177.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 38' ' ' GLN . . . . . 0.447 ' HA ' ' HB2' ' D' ' 58' ' ' LYS . 91.2 mt-30 -102.59 -44.2 5.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.662 0.268 . . . . 0.0 111.119 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -153.13 126.36 8.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.147 176.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 40' ' ' ALA . . . . . 0.559 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -124.48 113.15 17.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.535 0.683 . . . . 0.0 109.741 169.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' D' ' 79' ' ' THR . 19.9 mtpp -96.24 107.11 19.41 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 176.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 41.3 tp -81.52 114.83 20.5 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -173.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 43' ' ' TYR . . . . . 0.553 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 97.6 m-85 -120.55 139.4 52.99 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.505 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.2 OUTLIER -125.04 133.21 53.04 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 172.67 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 45' ' ' ALA . . . . . 0.635 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -112.03 113.16 25.28 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.131 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.512 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -124.49 137.69 54.4 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.419 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 59.74 30.89 20.48 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.504 0.503 . . . . 0.0 110.22 -174.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 48' ' ' LYS . . . . . 0.482 ' HB2' ' NZ ' ' D' ' 48' ' ' LYS . 0.1 OUTLIER 62.41 33.73 16.06 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.132 -177.104 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 49' ' ' GLN . . . . . 0.635 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 8.5 tp-100 -123.58 130.27 52.42 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.53 123.56 31.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.764 0.316 . . . . 0.0 110.784 -176.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 51' ' ' TYR . . . . . 0.521 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 84.6 m-85 -118.01 130.11 55.98 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 175.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 52' ' ' ILE . . . . . 0.4 HG22 ' HB3' ' C' ' 86' ' ' SER . 5.2 tp -80.15 103.78 7.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 171.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 53' ' ' VAL . . . . . 0.548 ' CG1' HD11 ' D' ' 67' ' ' LEU . 2.6 t -78.74 -49.52 20.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.662 -171.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 54' ' ' ALA . . . . . 0.459 ' HB1' HG11 ' D' ' 63' ' ' VAL . . . -158.3 146.61 18.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.9 -178.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 32.5 m -109.55 101.43 10.37 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 173.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 56' ' ' VAL . . . . . 0.451 HG11 HG11 ' D' ' 85' ' ' VAL . 7.4 p -115.6 116.2 51.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.564 0.697 . . . . 0.0 109.599 -177.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 46.2 p -122.38 -179.07 4.07 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.31 -172.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 58' ' ' LYS . . . . . 0.447 ' HB2' ' HA ' ' D' ' 38' ' ' GLN . 38.2 tttm -61.64 -27.39 68.63 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.82 172.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 59' ' ' ALA . . . . . 0.487 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -84.24 -40.69 17.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.652 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 86.1 mt -109.34 84.08 2.78 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 61' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 9.7 Cg_exo -71.04 0.09 7.14 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.038 2.492 . . . . 0.0 113.725 -168.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -162.76 131.64 4.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.132 0.492 . . . . 0.0 111.298 -176.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.459 HG11 ' HB1' ' D' ' 54' ' ' ALA . 69.2 t -120.43 132.71 69.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.107 172.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.49 113.13 25.52 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.197 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 65' ' ' LEU . . . . . 0.436 ' H ' HD13 ' D' ' 65' ' ' LEU . 0.0 OUTLIER -121.44 170.05 10.03 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.344 -176.508 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 66' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 7.3 t0 -118.42 98.84 6.47 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.284 0.564 . . . . 0.0 109.584 175.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.572 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 19.8 mt -113.0 143.46 44.27 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.929 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 68' ' ' ASN . . . . . 0.584 ' ND2' ' HB3' ' C' ' 6' ' ' ALA . 57.1 t30 -147.77 119.95 8.32 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.96 0.409 . . . . 0.0 109.961 174.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -114.98 153.55 30.41 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.24 -178.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 20.7 t -103.62 148.93 25.42 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.969 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 71' ' ' LYS . . . . . 0.492 ' HB2' ' NZ ' ' D' ' 71' ' ' LYS . 0.0 OUTLIER -74.91 10.02 1.63 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -174.614 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.51 -15.3 30.06 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.949 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -101.21 170.9 7.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.745 0.307 . . . . 0.0 110.876 -175.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 62.0 ttt-85 -138.43 122.65 18.12 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.512 HG22 ' HB2' ' D' ' 46' ' ' ALA . 14.3 pt -125.75 160.86 31.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.403 -170.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 76' ' ' MET . . . . . 0.486 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 2.9 mtm -115.24 128.98 56.5 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 174.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 77' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.6 OUTLIER -109.84 128.4 55.3 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.204 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 78' ' ' TYR . . . . . 0.714 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 51.6 p90 -155.79 157.46 36.51 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 120.231 -0.588 . . . . 0.0 112.232 -177.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 79' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 14.0 p -124.87 144.03 50.53 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.171 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.34 156.55 18.79 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.98 174.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.04 -166.83 31.29 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -176.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -123.67 102.74 8.0 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 117.797 0.799 . . . . 0.0 110.365 176.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 83' ' ' ALA . . . . . 0.595 ' H ' ' HB3' ' D' ' 15' ' ' PRO . . . -169.23 151.87 4.79 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.157 169.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 33.4 t -109.21 122.82 48.14 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.601 HG23 ' HB3' ' D' ' 13' ' ' MET . 6.8 m -119.75 147.11 23.6 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 CA-C-O 121.298 0.571 . . . . 0.0 111.814 -173.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 16.9 t -111.05 119.32 38.64 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 177.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 87' ' ' LEU . . . . . 0.663 HD13 HD23 ' D' ' 11' ' ' LEU . 5.2 mp -91.68 151.45 20.66 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 174.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.571 HD23 HD21 ' E' ' 67' ' ' LEU . 1.2 tp -133.07 140.26 47.6 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.287 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.24 -166.71 24.67 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.978 -177.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 90' ' ' TYR . . . . . 0.415 ' CD2' ' HB3' ' E' ' 68' ' ' ASN . 11.5 p90 -153.01 132.82 13.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.739 0.78 . . . . 0.0 111.814 176.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 91' ' ' LEU . . . . . 0.657 HD23 ' HB3' ' D' ' 27' ' ' PHE . 15.2 mt -67.61 139.78 56.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.096 177.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -72.91 113.46 9.96 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -174.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 93' ' ' ASP . . . . . 0.548 ' HB3' ' O ' ' D' ' 4' ' ' ALA . 3.2 m-20 -142.18 136.28 29.79 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.03 -0.987 . . . . 0.0 108.876 171.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 39.4 pt -77.87 144.93 10.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.156 0.503 . . . . 0.0 111.319 -175.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.43 -9.29 32.51 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.08 -177.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 19.9 m 65.02 -159.53 0.29 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.621 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.18 -61.28 3.99 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.757 -178.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 68.9 m . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.699 -0.667 . . . . 0.0 110.311 176.323 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -102.16 145.5 29.3 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 3' ' ' GLY . . . . . 0.409 ' HA2' ' SD ' ' E' ' 5' ' ' MET . . . 149.85 -171.85 29.83 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.815 -177.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 4' ' ' ALA . . . . . 0.562 ' O ' ' HB3' ' E' ' 93' ' ' ASP . . . 57.31 44.08 22.43 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 123.796 0.351 . . . . 0.0 110.816 -178.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 5' ' ' MET . . . . . 0.409 ' SD ' ' HA2' ' E' ' 3' ' ' GLY . 2.5 mpt? -70.15 172.61 7.77 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.982 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 6' ' ' ALA . . . . . 0.628 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . . . -54.27 131.43 41.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.727 177.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 52.4 ttm -100.24 139.06 36.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.567 -173.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 8' ' ' PHE . . . . . 0.495 ' CE1' HD21 ' A' ' 44' ' ' LEU . 61.2 t80 -52.8 142.17 19.59 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.548 -177.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 9' ' ' TRP . . . . . 0.535 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 88.3 t90 -135.73 147.68 48.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.838 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 10' ' ' GLY . . . . . 0.499 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -148.72 153.87 25.49 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.04 177.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 11' ' ' LEU . . . . . 0.671 HD23 HD13 ' E' ' 87' ' ' LEU . 52.7 tp -140.38 108.13 5.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.061 0.458 . . . . 0.0 110.919 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -81.15 101.56 9.73 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.553 173.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 13' ' ' MET . . . . . 0.597 ' HB3' HG23 ' E' ' 85' ' ' VAL . 30.6 tpp -95.49 131.19 41.92 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.109 0.48 . . . . 0.0 111.184 -174.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -100.78 145.38 30.27 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.97 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 15' ' ' PRO . . . . . 0.601 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 12.3 Cg_endo -56.2 124.65 16.78 Favored 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 123.365 2.71 . . . . 0.0 113.424 -174.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 16' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' E' ' 79' ' ' THR . 25.3 mt-10 60.37 47.82 8.5 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.016 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -121.66 138.71 54.22 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.652 172.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 18' ' ' LYS . . . . . 0.714 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 84.6 mttt -111.4 119.2 38.01 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.35 0.406 . . . . 0.0 111.414 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.72 103.84 12.43 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.853 176.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 20' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' E' ' 76' ' ' MET . 7.9 p -88.43 98.94 11.9 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 174.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -117.44 144.92 44.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.56 0.695 . . . . 0.0 112.266 -169.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 17.8 m -94.19 143.1 26.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.487 177.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 23' ' ' ILE . . . . . 0.447 ' CG2' ' HA ' ' E' ' 71' ' ' LYS . 59.4 mt -92.79 120.45 42.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.007 0.432 . . . . 0.0 111.17 -174.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 24' ' ' ILE . . . . . 0.438 HD12 ' N ' ' E' ' 24' ' ' ILE . 4.0 mp -79.42 -52.99 14.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.24 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 25' ' ' LYS . . . . . 0.495 ' HE2' ' HB3' ' E' ' 91' ' ' LEU . 13.5 ptmt -131.05 137.46 49.16 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.027 175.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 11.4 m -54.37 141.7 29.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.931 -176.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 27' ' ' PHE . . . . . 0.649 ' HB3' HD23 ' E' ' 91' ' ' LEU . 12.1 p90 -149.01 158.21 44.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.728 0.775 . . . . 0.0 112.762 -175.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 28' ' ' HIS . . . . . 0.601 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 9.3 t60 -111.39 127.37 55.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.842 178.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 29' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 35.6 mt -96.8 138.05 22.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 170.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 30' ' ' SER . . . . . 0.601 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 55.7 p -123.58 -20.33 5.57 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -171.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -153.76 156.42 26.78 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 119.27 -1.443 . . . . 0.0 113.578 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.5 HG23 ' HG ' ' E' ' 87' ' ' LEU . 14.8 p -146.61 124.35 3.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 172.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.15 155.64 44.01 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.931 -0.481 . . . . 0.0 111.764 -174.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 34' ' ' LEU . . . . . 0.597 ' HB3' HG12 ' E' ' 85' ' ' VAL . 3.7 pp -120.33 140.47 51.23 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.914 0.864 . . . . 0.0 111.771 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -104.98 -53.74 2.61 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.378 -1.283 . . . . 0.0 108.826 174.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -102.82 127.38 50.01 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 169.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 37' ' ' GLY . . . . . 0.489 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 151.3 156.04 7.22 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 119.794 -1.193 . . . . 0.0 113.631 176.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 38' ' ' GLN . . . . . 0.444 ' HA ' ' HB2' ' E' ' 58' ' ' LYS . 91.1 mt-30 -102.61 -44.19 5.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.681 0.277 . . . . 0.0 111.127 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -153.16 126.39 8.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.095 176.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 40' ' ' ALA . . . . . 0.563 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -124.51 113.14 17.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.534 0.683 . . . . 0.0 109.771 169.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 41' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' E' ' 79' ' ' THR . 19.9 mtpp -96.11 107.02 19.29 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 41.2 tp -81.45 114.85 20.47 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -173.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 43' ' ' TYR . . . . . 0.546 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 97.5 m-85 -120.59 139.39 53.04 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 177.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 44' ' ' LEU . . . . . 0.512 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 0.2 OUTLIER -125.09 133.26 52.96 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 172.574 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' E' E ' 45' ' ' ALA . . . . . 0.634 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -111.98 113.15 25.29 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.118 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 46' ' ' ALA . . . . . 0.519 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -124.53 137.77 54.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.371 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 59.81 30.8 20.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.001 0.429 . . . . 0.0 110.204 -174.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 48' ' ' LYS . . . . . 0.479 ' HB2' ' NZ ' ' E' ' 48' ' ' LYS . 0.1 OUTLIER 62.54 33.63 15.8 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.171 -177.045 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' E' E ' 49' ' ' GLN . . . . . 0.634 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 8.4 tp-100 -123.6 130.39 52.59 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -86.63 123.65 32.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.817 0.341 . . . . 0.0 110.726 -176.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 51' ' ' TYR . . . . . 0.518 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 84.6 m-85 -118.09 130.08 55.93 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.866 175.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.11 103.82 7.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 171.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 53' ' ' VAL . . . . . 0.544 ' CG1' HD11 ' E' ' 67' ' ' LEU . 2.6 t -78.76 -49.41 20.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.664 -171.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 54' ' ' ALA . . . . . 0.455 ' HB1' HG11 ' E' ' 63' ' ' VAL . . . -158.41 146.59 18.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.834 -178.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 32.5 m -109.52 101.45 10.39 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 173.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 56' ' ' VAL . . . . . 0.466 HG11 HG11 ' E' ' 85' ' ' VAL . 7.4 p -115.56 116.15 51.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.501 0.667 . . . . 0.0 109.635 -177.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 46.7 p -122.29 -179.08 4.06 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.43 -172.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 58' ' ' LYS . . . . . 0.444 ' HB2' ' HA ' ' E' ' 38' ' ' GLN . 38.2 tttm -61.67 -27.3 68.58 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.872 172.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 59' ' ' ALA . . . . . 0.493 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -84.26 -40.68 17.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.673 178.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 85.9 mt -109.35 83.98 2.74 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 174.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 61' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 9.6 Cg_exo -70.96 0.16 6.98 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.033 2.489 . . . . 0.0 113.746 -168.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -162.88 131.59 4.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.088 0.471 . . . . 0.0 111.3 -176.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 63' ' ' VAL . . . . . 0.455 HG11 ' HB1' ' E' ' 54' ' ' ALA . 70.0 t -120.43 132.73 69.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.049 172.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.45 113.07 25.43 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.193 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.428 HD13 ' N ' ' E' ' 65' ' ' LEU . 0.0 OUTLIER -121.48 170.07 10.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.346 -176.51 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' E' E ' 66' ' ' ASP . . . . . 0.511 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 7.3 t0 -118.31 98.73 6.43 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.193 0.521 . . . . 0.0 109.641 175.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 67' ' ' LEU . . . . . 0.577 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 19.8 mt -112.99 143.42 44.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.879 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 68' ' ' ASN . . . . . 0.585 ' ND2' ' HB3' ' D' ' 6' ' ' ALA . 57.1 t30 -147.77 119.92 8.3 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.945 0.402 . . . . 0.0 109.99 174.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -114.91 153.53 30.34 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.262 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 21.0 t -103.63 148.95 25.4 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.979 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 71' ' ' LYS . . . . . 0.493 ' HB2' ' NZ ' ' E' ' 71' ' ' LYS . 0.0 OUTLIER -74.92 10.12 1.6 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -174.596 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.71 -15.19 29.87 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.823 175.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -101.24 170.87 7.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.825 0.345 . . . . 0.0 110.902 -175.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 62.0 ttt-85 -138.33 122.56 18.13 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 75' ' ' ILE . . . . . 0.519 HG22 ' HB2' ' E' ' 46' ' ' ALA . 14.5 pt -125.72 160.9 31.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 120.897 0.38 . . . . 0.0 111.399 -170.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 76' ' ' MET . . . . . 0.481 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 2.9 mtm -115.3 129.0 56.49 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 77' ' ' PHE . . . . . 0.512 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.6 OUTLIER -109.82 128.44 55.32 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 177.207 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' E' E ' 78' ' ' TYR . . . . . 0.714 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 51.3 p90 -155.88 157.43 36.35 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.146 -0.622 . . . . 0.0 112.185 -177.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 79' ' ' THR . . . . . 0.552 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 14.6 p -124.77 143.94 50.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.238 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.31 156.57 18.75 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.985 174.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.99 -166.86 31.36 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -176.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -123.67 102.68 7.96 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 117.734 0.767 . . . . 0.0 110.5 176.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 83' ' ' ALA . . . . . 0.601 ' H ' ' HB3' ' E' ' 15' ' ' PRO . . . -169.25 151.8 4.75 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.16 169.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 33.4 t -109.15 122.8 48.07 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 85' ' ' VAL . . . . . 0.597 HG23 ' HB3' ' E' ' 13' ' ' MET . 6.8 m -119.68 147.16 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-O 121.274 0.559 . . . . 0.0 111.888 -173.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 17.1 t -111.12 119.28 38.44 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 87' ' ' LEU . . . . . 0.671 HD13 HD23 ' E' ' 11' ' ' LEU . 5.2 mp -91.64 151.52 20.65 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 174.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 88' ' ' LEU . . . . . 0.613 HD23 HD21 ' A' ' 67' ' ' LEU . 1.2 tp -133.13 140.26 47.53 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.304 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.23 -166.74 24.7 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.936 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 90' ' ' TYR . . . . . 0.451 ' CD2' ' HB3' ' A' ' 68' ' ' ASN . 11.4 p90 -153.04 132.8 13.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.787 0.804 . . . . 0.0 111.796 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 91' ' ' LEU . . . . . 0.649 HD23 ' HB3' ' E' ' 27' ' ' PHE . 15.1 mt -67.51 139.77 57.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.109 177.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -72.9 113.52 10.03 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -174.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 93' ' ' ASP . . . . . 0.562 ' HB3' ' O ' ' E' ' 4' ' ' ALA . 3.3 m-20 -142.25 136.29 29.67 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.785 171.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 39.4 pt -77.87 145.05 10.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.158 0.504 . . . . 0.0 111.374 -175.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -66.5 -9.32 33.44 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.069 -177.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 19.9 m 65.04 -159.59 0.29 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.629 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.17 -61.13 4.01 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.706 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 68.9 m . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.762 -0.637 . . . . 0.0 110.229 176.299 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.404 ' HB3' ' HA ' ' A' ' 98' ' ' SER . 96.5 m-85 . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.523 ' OE1' ' HB3' ' A' ' 95' ' ' ASP . 8.2 tt0 65.8 105.28 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.918 0.761 . . . . 0.0 112.019 177.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.3 -1.05 61.04 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.506 175.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.58 56.74 2.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.272 0.558 . . . . 0.0 111.276 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 66.4 mtt -97.78 -69.44 0.76 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.844 177.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.73 111.1 21.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.714 177.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.89 154.68 18.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.962 178.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.512 ' CE1' HD21 ' B' ' 44' ' ' LEU . 70.1 t80 -67.95 142.93 55.85 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.079 0.466 . . . . 0.0 112.124 -177.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.57 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 88.2 t90 -134.93 148.1 49.96 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.19 177.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.75 153.08 24.71 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.482 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.57 ' HB2' ' CH2' ' A' ' 9' ' ' TRP . 41.7 tp -144.18 109.94 5.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.81 0.338 . . . . 0.0 110.35 177.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -96.55 96.78 8.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.847 0.356 . . . . 0.0 110.078 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.621 ' SD ' HD11 ' A' ' 87' ' ' LEU . 62.6 mtp -92.98 144.1 25.59 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.941 -173.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -101.17 166.97 11.43 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.163 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.448 ' HB3' ' HA ' ' A' ' 82' ' ' ASP . 87.2 Cg_exo -49.84 115.69 1.98 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.737 2.292 . . . . 0.0 112.799 176.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 79' ' ' THR . 29.1 mt-10 63.31 39.5 9.44 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.29 0.566 . . . . 0.0 111.328 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 78' ' ' TYR . 0.5 OUTLIER -88.12 133.47 33.99 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.038 175.42 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.592 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 33.9 ttmt -123.31 116.09 22.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.122 0.487 . . . . 0.0 111.074 -178.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.471 ' CZ ' ' HG2' ' A' ' 17' ' ' ARG . 18.3 m-85 -107.11 102.59 11.92 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.591 178.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.0 p -90.11 97.2 11.05 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 169.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -117.09 145.46 43.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.508 0.67 . . . . 0.0 112.48 -165.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.7 m -97.62 132.93 42.82 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.011 174.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.43 ' CD1' ' HB3' ' A' ' 69' ' ' PHE . 70.3 mt -87.77 118.08 32.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-O 121.127 0.489 . . . . 0.0 110.987 -173.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.679 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -90.09 -18.05 7.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.057 -179.476 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 93' ' ' ASP . 83.4 tttt -155.12 129.2 8.82 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.101 -175.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.7 p -58.63 127.41 32.05 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.411 0.445 . . . . 0.0 110.652 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.746 ' HB3' HD23 ' A' ' 91' ' ' LEU . 10.4 p90 -143.68 166.34 25.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.693 0.758 . . . . 0.0 112.748 -174.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.564 ' HE2' ' HB3' ' A' ' 30' ' ' SER . 4.8 t60 -121.8 127.4 50.55 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.421 178.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.618 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 47.3 mt -94.55 135.22 29.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.564 ' HB3' ' HE2' ' A' ' 28' ' ' HIS . 56.0 p -119.85 -13.51 9.06 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -169.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -164.09 141.54 7.17 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 119.452 -1.356 . . . . 0.0 113.403 177.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.439 HG23 ' HG ' ' A' ' 87' ' ' LEU . 11.9 p -126.93 120.65 56.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 169.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.409 ' HA ' HG21 ' A' ' 56' ' ' VAL . . . -141.14 157.25 45.54 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 121.947 -0.471 . . . . 0.0 111.65 -174.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.629 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.6 pp -127.14 145.51 50.72 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.769 0.795 . . . . 0.0 111.237 178.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -110.21 -47.06 3.35 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.29 173.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -102.68 128.16 49.5 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.312 173.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.533 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 141.54 161.37 8.69 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 119.451 -1.357 . . . . 0.0 113.857 176.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -102.72 -43.98 5.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.681 0.276 . . . . 0.0 110.971 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -151.78 125.68 9.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.17 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -127.79 113.04 15.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.46 0.647 . . . . 0.0 109.699 168.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 79' ' ' THR . 56.0 mtpt -99.54 106.13 18.1 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 178.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.2 tp -79.11 108.77 12.84 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.819 -173.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -107.86 141.02 40.09 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.295 176.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.558 ' CD1' ' HB ' ' A' ' 75' ' ' ILE . 4.4 tp -124.48 116.38 22.42 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.082 176.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -101.78 104.21 14.98 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 174.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.488 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -127.08 136.44 52.17 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.4 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 56.38 35.99 26.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.371 0.605 . . . . 0.0 110.247 -175.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 61.36 39.7 15.01 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.123 178.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.553 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 8.5 tp-100 -134.63 128.09 32.45 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 175.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -85.28 105.72 16.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.937 0.398 . . . . 0.0 110.399 -178.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -100.13 131.29 46.16 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.461 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 tp -79.8 108.74 13.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 168.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.529 HG13 ' CD2' ' E' ' 88' ' ' LEU . 2.3 t -82.52 -51.32 14.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.578 -172.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.496 ' HB1' HG11 ' A' ' 63' ' ' VAL . . . -156.3 145.61 20.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.067 -178.174 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.6 m -109.21 101.77 10.77 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 173.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.476 HG13 ' HB3' ' A' ' 40' ' ' ALA . 7.4 p -115.5 114.93 47.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.534 0.683 . . . . 0.0 109.765 -177.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.5 p -122.93 -178.26 3.9 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.415 -174.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -63.92 -22.43 66.92 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.028 0.442 . . . . 0.0 110.271 171.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.439 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -83.95 -40.5 18.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.278 177.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.9 mt -112.38 81.63 4.13 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 173.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 12.2 Cg_exo -70.19 0.15 6.4 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.219 2.613 . . . . 0.0 113.972 -166.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -163.83 129.59 3.04 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.161 0.505 . . . . 0.0 111.464 -175.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.496 HG11 ' HB1' ' A' ' 54' ' ' ALA . 66.0 t -119.01 99.94 8.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.24 173.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.21 117.12 21.47 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 173.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.448 HD23 ' H ' ' A' ' 65' ' ' LEU . 0.9 OUTLIER -139.17 168.1 20.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.933 0.397 . . . . 0.0 110.994 -171.055 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.524 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 11.9 t0 -112.45 104.58 12.71 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.341 0.591 . . . . 0.0 110.077 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.667 HD21 HD23 ' E' ' 88' ' ' LEU . 11.1 mt -117.31 141.11 48.71 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.039 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -142.04 132.38 25.02 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.804 0.335 . . . . 0.0 110.7 174.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.477 ' CZ ' HD22 ' A' ' 67' ' ' LEU . 58.7 m-85 -129.92 160.56 33.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.009 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.4 t -120.08 158.78 26.14 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -79.44 9.09 5.16 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.865 0.364 . . . . 0.0 111.104 -175.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.21 -29.38 9.0 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 174.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -100.38 165.88 11.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.016 0.436 . . . . 0.0 110.737 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -135.76 143.46 45.29 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.558 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 25.0 pt -135.71 159.22 39.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.145 0.497 . . . . 0.0 112.27 -168.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.458 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 10.9 mtp -115.0 117.5 30.76 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.703 173.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.51 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -104.23 126.95 51.76 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.127 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.592 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 23.2 p90 -152.2 134.67 15.28 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.935 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 2.4 p -107.83 120.05 41.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.332 -177.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.27 160.95 15.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.672 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.47 -170.51 31.24 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -177.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.448 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 18.9 t70 -116.9 103.47 10.33 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 117.868 0.834 . . . . 0.0 109.983 176.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.533 ' CB ' ' HA3' ' A' ' 37' ' ' GLY . . . -173.31 158.69 3.62 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.736 172.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.4 t -117.74 122.44 43.47 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.629 HG12 ' HB3' ' A' ' 34' ' ' LEU . 4.9 m -115.84 156.07 17.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.529 0.68 . . . . 0.0 112.408 -172.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -119.07 117.19 28.07 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.038 173.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.621 HD11 ' SD ' ' A' ' 13' ' ' MET . 5.1 mp -91.68 147.05 23.28 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 171.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.692 HD23 HD21 ' B' ' 67' ' ' LEU . 0.7 OUTLIER -130.75 142.53 50.41 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.756 179.585 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.89 -167.97 27.34 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.106 -178.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -145.44 130.29 18.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.742 0.782 . . . . 0.0 112.132 178.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.746 HD23 ' HB3' ' A' ' 27' ' ' PHE . 18.2 mt -71.68 113.55 8.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.328 -1.305 . . . . 0.0 109.46 173.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -100.97 117.52 35.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.095 0.474 . . . . 0.0 110.74 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.403 ' HB2' ' HE3' ' A' ' 25' ' ' LYS . 26.6 t70 -98.44 -53.99 3.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.692 176.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 60.2 mt 64.65 88.5 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.264 177.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.523 ' HB3' ' OE1' ' A' ' 2' ' ' GLN . 30.0 t70 -127.02 134.47 50.32 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.829 178.127 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.2 m -96.6 27.45 3.86 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.944 0.402 . . . . 0.0 111.01 -177.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -80.05 78.86 1.76 Allowed Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.984 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.404 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 10.8 p . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.582 -0.723 . . . . 0.0 110.354 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.408 ' HB3' ' HA ' ' B' ' 98' ' ' SER . 96.2 m-85 . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 2' ' ' GLN . . . . . 0.521 ' OE1' ' HB3' ' B' ' 95' ' ' ASP . 8.2 tt0 65.9 105.22 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 O-C-N 123.947 0.779 . . . . 0.0 112.063 177.1 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.32 -1.09 60.99 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.418 175.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.47 56.77 2.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.288 0.566 . . . . 0.0 111.311 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 66.4 mtt -97.81 -69.42 0.76 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.852 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.74 111.15 21.73 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.733 177.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.93 154.75 18.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.941 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.517 ' CE1' HD21 ' C' ' 44' ' ' LEU . 69.8 t80 -68.08 143.0 55.65 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.036 0.446 . . . . 0.0 112.043 -177.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 9' ' ' TRP . . . . . 0.563 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 88.1 t90 -134.97 148.01 49.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.112 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.67 153.09 24.73 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.461 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.563 ' HB2' ' CH2' ' B' ' 9' ' ' TRP . 41.6 tp -144.13 109.9 5.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.764 0.316 . . . . 0.0 110.457 177.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -96.56 96.83 8.93 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 13' ' ' MET . . . . . 0.631 ' SD ' HD11 ' B' ' 87' ' ' LEU . 62.4 mtp -93.0 144.14 25.55 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.015 -173.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -101.28 167.01 11.32 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.162 177.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.432 ' HB3' ' HA ' ' B' ' 82' ' ' ASP . 86.5 Cg_exo -49.84 115.68 1.97 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.785 2.324 . . . . 0.0 112.723 176.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' B' ' 79' ' ' THR . 29.0 mt-10 63.27 39.65 9.39 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.285 0.564 . . . . 0.0 111.254 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' B' ' 78' ' ' TYR . 0.5 OUTLIER -88.16 133.5 34.0 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.342 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.589 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 33.8 ttmt -123.34 116.12 22.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.167 0.508 . . . . 0.0 111.086 -178.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 19' ' ' TYR . . . . . 0.458 ' CZ ' ' HG2' ' B' ' 17' ' ' ARG . 18.6 m-85 -107.09 102.54 11.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.565 178.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 10.9 p -90.03 97.21 11.06 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 169.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.13 145.54 43.75 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.489 0.661 . . . . 0.0 112.457 -165.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 21.4 m -97.77 132.86 43.01 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.949 174.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.431 ' CD1' ' HB3' ' B' ' 69' ' ' PHE . 70.0 mt -87.73 117.99 32.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.12 0.486 . . . . 0.0 111.074 -173.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.683 ' H ' HD13 ' B' ' 24' ' ' ILE . 0.2 OUTLIER -90.04 -18.02 7.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.069 -179.426 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.413 ' HE3' ' HB2' ' B' ' 93' ' ' ASP . 83.4 tttt -155.18 129.14 8.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.097 -175.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 6.9 p -58.55 127.38 31.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.683 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 27' ' ' PHE . . . . . 0.748 ' HB3' HD23 ' B' ' 91' ' ' LEU . 10.2 p90 -143.66 166.37 25.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.691 0.758 . . . . 0.0 112.687 -174.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 28' ' ' HIS . . . . . 0.573 ' HE2' ' HB3' ' B' ' 30' ' ' SER . 4.8 t60 -121.87 127.44 50.49 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.256 -1.338 . . . . 0.0 109.353 178.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.611 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 47.2 mt -94.59 135.3 29.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 171.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.573 ' HB3' ' HE2' ' B' ' 28' ' ' HIS . 55.9 p -119.82 -13.65 9.06 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -169.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -164.07 141.5 7.15 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 119.373 -1.394 . . . . 0.0 113.385 177.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.437 HG23 ' HG ' ' B' ' 87' ' ' LEU . 11.8 p -126.91 120.72 56.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 169.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 33' ' ' ALA . . . . . 0.406 ' HA ' HG21 ' B' ' 56' ' ' VAL . . . -141.19 157.19 45.6 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.605 -173.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.634 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.6 pp -127.1 145.62 50.67 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.696 0.76 . . . . 0.0 111.279 178.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -110.27 -46.94 3.36 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.27 173.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -102.68 128.15 49.5 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.257 173.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.527 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 141.51 161.3 8.66 Favored Glycine 0 N--CA 1.438 -1.189 0 C-N-CA 119.488 -1.339 . . . . 0.0 113.886 176.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -102.64 -44.09 5.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.62 -0.29 . . . . 0.0 110.929 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -151.73 125.71 9.16 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.201 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.499 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -127.79 113.14 15.58 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.44 0.638 . . . . 0.0 109.632 168.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' B' ' 79' ' ' THR . 56.0 mtpt -99.66 106.11 18.02 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 46.6 tp -79.22 108.83 13.02 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.753 -173.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -107.85 140.93 40.21 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.293 176.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.558 ' CD1' ' HB ' ' B' ' 75' ' ' ILE . 4.4 tp -124.4 116.44 22.57 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.115 176.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -101.83 104.25 15.0 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 174.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.49 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -127.12 136.45 52.14 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.351 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 56.37 35.99 26.78 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 123.592 0.557 . . . . 0.0 110.175 -175.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 61.47 39.53 14.88 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 114.816 -1.083 . . . . 0.0 112.165 178.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.549 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 8.6 tp-100 -134.58 128.03 32.41 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 175.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -85.2 105.65 16.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.902 0.382 . . . . 0.0 110.429 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -100.07 131.23 46.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.46 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 tp -79.67 108.72 13.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 168.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.528 HG13 ' CD2' ' A' ' 88' ' ' LEU . 2.3 t -82.59 -51.22 15.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.576 -172.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.474 ' HB1' HG11 ' B' ' 63' ' ' VAL . . . -156.33 145.57 20.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.079 -178.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 32.2 m -109.18 101.78 10.79 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 173.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.47 HG13 ' HB3' ' B' ' 40' ' ' ALA . 7.4 p -115.53 114.88 47.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.495 0.664 . . . . 0.0 109.744 -177.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 64.1 p -122.87 -178.31 3.91 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.428 -174.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -63.83 -22.52 66.95 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.047 0.451 . . . . 0.0 110.244 171.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.43 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -83.89 -40.51 18.51 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.194 0.521 . . . . 0.0 110.235 177.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.4 81.56 4.11 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 173.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 12.1 Cg_exo -70.16 0.15 6.38 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.126 2.55 . . . . 0.0 113.954 -166.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -163.78 129.6 3.06 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.163 0.506 . . . . 0.0 111.378 -175.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.474 HG11 ' HB1' ' B' ' 54' ' ' ALA . 66.6 t -119.06 99.93 8.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.24 173.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.15 117.15 21.46 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 173.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.444 HD23 ' H ' ' B' ' 65' ' ' LEU . 0.9 OUTLIER -139.05 168.15 20.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.95 0.405 . . . . 0.0 111.065 -171.186 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 66' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 12.1 t0 -112.4 104.52 12.66 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.262 0.553 . . . . 0.0 110.122 -178.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.692 HD21 HD23 ' A' ' 88' ' ' LEU . 11.0 mt -117.28 141.14 48.67 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.019 178.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.04 132.49 25.18 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.66 174.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 69' ' ' PHE . . . . . 0.484 ' CZ ' HD22 ' B' ' 67' ' ' LEU . 58.7 m-85 -130.02 160.55 33.33 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.985 178.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 18.5 t -120.18 158.78 26.23 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -79.4 9.11 5.11 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.966 0.412 . . . . 0.0 111.094 -175.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.32 -29.25 9.04 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 174.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -100.51 165.75 11.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.108 0.48 . . . . 0.0 110.698 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -135.68 143.36 45.39 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.233 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.558 ' HB ' ' CD1' ' B' ' 44' ' ' LEU . 25.0 pt -135.58 159.24 40.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.171 0.51 . . . . 0.0 112.216 -168.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.451 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 10.9 mtp -114.94 117.5 30.82 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.632 173.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 77' ' ' PHE . . . . . 0.507 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -104.25 126.97 51.8 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 175.987 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.589 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 23.2 p90 -152.21 134.65 15.25 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.311 -0.555 . . . . 0.0 111.999 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 2.5 p -107.79 120.04 41.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.345 -177.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.27 161.03 15.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.636 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.46 -170.68 31.41 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -177.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 82' ' ' ASP . . . . . 0.432 ' HA ' ' HB3' ' B' ' 15' ' ' PRO . 19.0 t70 -116.87 103.56 10.43 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.917 176.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.527 ' CB ' ' HA3' ' B' ' 37' ' ' GLY . . . -173.37 158.73 3.59 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.815 172.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 25.8 t -117.82 122.33 43.11 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.634 HG12 ' HB3' ' B' ' 34' ' ' LEU . 4.9 m -115.83 156.06 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-O 121.529 0.681 . . . . 0.0 112.445 -172.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 50.1 m -119.07 117.32 28.42 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.008 173.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.631 HD11 ' SD ' ' B' ' 13' ' ' MET . 5.1 mp -91.73 147.0 23.31 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 171.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.663 HD23 HD21 ' C' ' 67' ' ' LEU . 0.7 OUTLIER -130.84 142.51 50.39 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.959 -1.018 . . . . 0.0 108.748 179.582 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.9 -167.96 27.34 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.036 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -145.45 130.23 18.13 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.775 0.797 . . . . 0.0 112.056 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 91' ' ' LEU . . . . . 0.748 HD23 ' HB3' ' B' ' 27' ' ' PHE . 18.1 mt -71.6 113.48 8.68 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.255 -1.339 . . . . 0.0 109.396 173.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -100.96 117.48 35.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.122 0.487 . . . . 0.0 110.794 -178.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 93' ' ' ASP . . . . . 0.413 ' HB2' ' HE3' ' B' ' 25' ' ' LYS . 26.3 t70 -98.36 -53.95 3.19 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.753 176.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 59.7 mt 64.58 88.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.314 177.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 95' ' ' ASP . . . . . 0.521 ' HB3' ' OE1' ' B' ' 2' ' ' GLN . 29.9 t70 -126.89 134.63 50.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.777 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 18.9 m -96.68 27.49 3.88 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.073 0.463 . . . . 0.0 111.041 -177.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . -80.22 78.97 1.77 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.04 178.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 98' ' ' SER . . . . . 0.408 ' HA ' ' HB3' ' B' ' 1' ' ' PHE . 10.7 p . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.444 -0.789 . . . . 0.0 110.357 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 1' ' ' PHE . . . . . 0.402 ' HB3' ' HA ' ' C' ' 98' ' ' SER . 96.3 m-85 . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 2' ' ' GLN . . . . . 0.522 ' OE1' ' HB3' ' C' ' 95' ' ' ASP . 8.2 tt0 65.57 105.38 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.985 0.803 . . . . 0.0 112.086 177.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.36 -1.12 60.9 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.431 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.45 56.78 2.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.273 0.559 . . . . 0.0 111.287 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 66.5 mtt -97.92 -69.36 0.76 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.804 177.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.76 111.05 21.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.772 177.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.9 154.64 18.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.967 178.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 8' ' ' PHE . . . . . 0.516 ' CE1' HD21 ' D' ' 44' ' ' LEU . 70.0 t80 -67.88 142.95 55.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.039 0.447 . . . . 0.0 112.068 -177.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 9' ' ' TRP . . . . . 0.568 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 88.2 t90 -135.07 148.09 49.77 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.71 153.05 24.7 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.415 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.568 ' HB2' ' CH2' ' C' ' 9' ' ' TRP . 41.6 tp -144.13 109.95 5.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.773 0.32 . . . . 0.0 110.429 177.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -96.55 96.84 8.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.92 0.391 . . . . 0.0 110.11 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 13' ' ' MET . . . . . 0.628 ' SD ' HD11 ' C' ' 87' ' ' LEU . 62.7 mtp -93.05 144.11 25.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.001 -173.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -101.2 167.01 11.35 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.154 177.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 15' ' ' PRO . . . . . 0.449 ' HB3' ' HA ' ' C' ' 82' ' ' ASP . 88.0 Cg_exo -49.8 115.68 1.96 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.731 2.288 . . . . 0.0 112.818 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 16' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' C' ' 79' ' ' THR . 29.1 mt-10 63.19 39.66 9.55 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.432 0.634 . . . . 0.0 111.36 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 17' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' C' ' 78' ' ' TYR . 0.5 OUTLIER -88.15 133.41 34.02 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.431 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 18' ' ' LYS . . . . . 0.592 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 33.9 ttmt -123.21 116.13 22.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.047 0.451 . . . . 0.0 111.109 -178.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 19' ' ' TYR . . . . . 0.461 ' CZ ' ' HG2' ' C' ' 17' ' ' ARG . 18.8 m-85 -107.2 102.61 11.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.536 178.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 10.9 p -90.04 97.14 11.02 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 169.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.08 145.51 43.71 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.535 0.683 . . . . 0.0 112.55 -165.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 21.7 m -97.65 132.95 42.83 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.691 -1.141 . . . . 0.0 108.964 174.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 23' ' ' ILE . . . . . 0.432 ' CD1' ' HB3' ' C' ' 69' ' ' PHE . 70.4 mt -87.85 118.15 33.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.206 0.527 . . . . 0.0 110.995 -173.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 24' ' ' ILE . . . . . 0.684 ' H ' HD13 ' C' ' 24' ' ' ILE . 0.2 OUTLIER -90.14 -17.99 7.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.092 -179.456 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 25' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' C' ' 93' ' ' ASP . 83.4 tttt -155.15 129.22 8.81 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.103 -175.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 6.6 p -58.62 127.47 32.32 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.696 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 27' ' ' PHE . . . . . 0.741 ' HB3' HD23 ' C' ' 91' ' ' LEU . 10.2 p90 -143.64 166.42 24.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.633 0.73 . . . . 0.0 112.774 -174.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 28' ' ' HIS . . . . . 0.577 ' HE2' ' HB3' ' C' ' 30' ' ' SER . 4.8 t60 -121.94 127.47 50.42 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.291 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 29' ' ' ILE . . . . . 0.627 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 47.6 mt -94.57 135.3 29.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 171.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.577 ' HB3' ' HE2' ' C' ' 28' ' ' HIS . 55.8 p -119.87 -13.53 9.05 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -169.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 31' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -164.09 141.46 7.12 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 119.372 -1.394 . . . . 0.0 113.329 177.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.439 HG23 ' HG ' ' C' ' 87' ' ' LEU . 11.8 p -126.95 120.69 56.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 169.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.41 ' HA ' HG21 ' C' ' 56' ' ' VAL . . . -141.16 157.23 45.56 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.886 -0.509 . . . . 0.0 111.647 -173.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.627 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.6 pp -127.14 145.52 50.72 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.656 0.741 . . . . 0.0 111.284 178.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -110.32 -46.89 3.36 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.251 173.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -102.62 128.12 49.44 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.259 173.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 37' ' ' GLY . . . . . 0.529 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 141.64 161.36 8.7 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 119.446 -1.359 . . . . 0.0 113.888 176.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -102.71 -44.1 5.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.753 0.311 . . . . 0.0 110.973 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -151.73 125.71 9.16 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.119 -177.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.492 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -127.77 113.02 15.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.376 0.608 . . . . 0.0 109.655 168.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' C' ' 79' ' ' THR . 56.0 mtpt -99.56 106.11 18.06 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.4 HD23 ' HB ' ' C' ' 53' ' ' VAL . 46.5 tp -79.18 108.8 12.95 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.803 -173.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -107.83 141.0 40.08 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.339 176.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.551 ' CD1' ' HB ' ' C' ' 75' ' ' ILE . 4.4 tp -124.46 116.4 22.45 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.098 176.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 45' ' ' ALA . . . . . 0.546 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -101.77 104.22 15.0 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 174.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.478 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -127.08 136.42 52.14 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.367 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 56.31 36.01 26.78 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.642 0.589 . . . . 0.0 110.215 -175.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 61.5 39.59 14.71 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.087 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 49' ' ' GLN . . . . . 0.546 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 8.5 tp-100 -134.67 127.94 32.06 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 175.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -85.15 105.74 16.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.854 0.359 . . . . 0.0 110.444 -178.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -100.18 131.26 46.23 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.436 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 tp -79.78 108.74 13.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 168.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 53' ' ' VAL . . . . . 0.533 HG13 ' CD2' ' B' ' 88' ' ' LEU . 2.3 t -82.5 -51.25 15.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.642 -172.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 54' ' ' ALA . . . . . 0.49 ' HB1' HG11 ' C' ' 63' ' ' VAL . . . -156.29 145.58 20.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.006 -178.134 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 31.9 m -109.28 101.82 10.79 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 173.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 56' ' ' VAL . . . . . 0.471 HG13 ' HB3' ' C' ' 40' ' ' ALA . 7.4 p -115.57 114.91 47.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.533 0.682 . . . . 0.0 109.695 -177.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 64.2 p -123.03 -178.33 3.93 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.337 -174.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -63.83 -22.51 66.95 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.112 0.482 . . . . 0.0 110.227 171.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 59' ' ' ALA . . . . . 0.44 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -83.87 -40.56 18.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.237 177.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 78.0 mt -112.34 81.57 4.05 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 173.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 61' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 12.1 Cg_exo -70.07 -0.0 6.53 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.142 2.562 . . . . 0.0 114.025 -166.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -163.73 129.62 3.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.185 0.517 . . . . 0.0 111.52 -175.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.49 HG11 ' HB1' ' C' ' 54' ' ' ALA . 66.1 t -119.07 100.01 8.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.219 173.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.22 117.01 21.39 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 173.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 65' ' ' LEU . . . . . 0.442 HD23 ' H ' ' C' ' 65' ' ' LEU . 0.9 OUTLIER -139.01 168.09 20.6 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.952 0.406 . . . . 0.0 111.087 -171.137 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 66' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 12.1 t0 -112.39 104.6 12.75 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.315 0.579 . . . . 0.0 110.132 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.663 HD21 HD23 ' B' ' 88' ' ' LEU . 11.1 mt -117.3 141.22 48.57 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.048 178.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -142.11 132.47 25.04 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.641 174.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 69' ' ' PHE . . . . . 0.476 ' CZ ' HD22 ' C' ' 67' ' ' LEU . 59.1 m-85 -130.03 160.61 33.16 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.932 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 18.3 t -120.12 158.8 26.13 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -79.45 9.08 5.19 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.979 0.419 . . . . 0.0 111.083 -175.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.26 -29.23 9.08 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 174.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -100.5 165.8 11.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.966 0.413 . . . . 0.0 110.784 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -135.71 143.49 45.41 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.551 ' HB ' ' CD1' ' C' ' 44' ' ' LEU . 24.9 pt -135.67 159.14 39.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.12 0.486 . . . . 0.0 112.305 -168.134 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.462 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 10.8 mtp -114.88 117.51 30.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.764 173.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 77' ' ' PHE . . . . . 0.504 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.6 OUTLIER -104.16 126.89 51.64 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 176.104 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 78' ' ' TYR . . . . . 0.592 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 23.4 p90 -152.19 134.63 15.25 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.969 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 79' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 2.4 p -107.8 120.01 41.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.352 -177.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.24 160.92 15.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.613 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.6 -170.54 31.08 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 82' ' ' ASP . . . . . 0.449 ' HA ' ' HB3' ' C' ' 15' ' ' PRO . 19.0 t70 -116.91 103.49 10.34 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.955 176.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 83' ' ' ALA . . . . . 0.529 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -173.31 158.79 3.64 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.794 172.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 25.6 t -117.88 122.38 43.18 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.627 HG12 ' HB3' ' C' ' 34' ' ' LEU . 5.0 m -115.74 156.1 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-O 121.453 0.644 . . . . 0.0 112.464 -172.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 50.3 m -119.08 117.31 28.38 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.045 173.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 87' ' ' LEU . . . . . 0.628 HD11 ' SD ' ' C' ' 13' ' ' MET . 5.1 mp -91.76 146.97 23.34 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 171.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 88' ' ' LEU . . . . . 0.675 HD23 HD21 ' D' ' 67' ' ' LEU . 0.7 OUTLIER -130.74 142.47 50.41 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.796 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.89 -168.0 27.39 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.082 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -145.4 130.24 18.18 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.741 0.781 . . . . 0.0 112.158 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 91' ' ' LEU . . . . . 0.741 HD23 ' HB3' ' C' ' 27' ' ' PHE . 18.1 mt -71.63 113.61 8.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.321 -1.308 . . . . 0.0 109.415 173.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -101.05 117.48 35.11 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.203 0.525 . . . . 0.0 110.731 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 93' ' ' ASP . . . . . 0.415 ' HB2' ' HE3' ' C' ' 25' ' ' LYS . 26.5 t70 -98.38 -54.01 3.17 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.691 176.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 59.7 mt 64.62 88.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.297 177.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 95' ' ' ASP . . . . . 0.522 ' HB3' ' OE1' ' C' ' 2' ' ' GLN . 30.0 t70 -126.95 134.58 50.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.739 178.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 18.7 m -96.73 27.45 3.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.037 0.446 . . . . 0.0 110.996 -177.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -80.14 78.97 1.76 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.962 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 98' ' ' SER . . . . . 0.402 ' HA ' ' HB3' ' C' ' 1' ' ' PHE . 10.9 p . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.524 -0.75 . . . . 0.0 110.313 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 1' ' ' PHE . . . . . 0.415 ' HB3' ' HA ' ' D' ' 98' ' ' SER . 96.6 m-85 . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 2' ' ' GLN . . . . . 0.507 ' OE1' ' HB3' ' D' ' 95' ' ' ASP . 8.2 tt0 65.65 105.39 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 O-C-N 123.886 0.741 . . . . 0.0 111.996 177.014 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.43 -0.95 60.86 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.492 175.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.62 56.74 2.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.314 0.578 . . . . 0.0 111.3 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 66.4 mtt -97.69 -69.42 0.76 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.864 177.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.77 111.19 21.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.671 177.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.09 154.65 18.25 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.837 178.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 8' ' ' PHE . . . . . 0.522 ' CE1' HD21 ' E' ' 44' ' ' LEU . 70.4 t80 -67.93 142.96 55.86 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.17 0.509 . . . . 0.0 112.063 -177.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 9' ' ' TRP . . . . . 0.567 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 88.2 t90 -135.03 147.97 49.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.133 177.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.6 153.2 24.8 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.455 179.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.567 ' HB2' ' CH2' ' D' ' 9' ' ' TRP . 41.7 tp -144.19 109.95 5.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.751 0.31 . . . . 0.0 110.392 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -96.55 96.74 8.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.921 0.391 . . . . 0.0 110.102 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 13' ' ' MET . . . . . 0.627 ' SD ' HD11 ' D' ' 87' ' ' LEU . 62.7 mtp -93.05 144.24 25.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.961 -173.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -101.24 167.0 11.35 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.174 177.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 15' ' ' PRO . . . . . 0.434 ' HB3' ' HA ' ' D' ' 82' ' ' ASP . 86.9 Cg_exo -49.86 115.61 1.93 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.8 2.334 . . . . 0.0 112.74 176.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 16' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' D' ' 79' ' ' THR . 29.1 mt-10 63.37 39.53 9.26 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.326 0.584 . . . . 0.0 111.299 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 17' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' D' ' 78' ' ' TYR . 0.5 OUTLIER -88.04 133.44 33.97 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.383 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 18' ' ' LYS . . . . . 0.606 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 33.9 ttmt -123.26 116.13 22.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.199 0.524 . . . . 0.0 111.077 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 19' ' ' TYR . . . . . 0.47 ' CZ ' ' HG2' ' D' ' 17' ' ' ARG . 18.8 m-85 -107.11 102.46 11.79 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.595 178.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 11.0 p -89.97 97.18 11.04 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 169.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.07 145.5 43.7 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.556 0.693 . . . . 0.0 112.483 -165.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 21.5 m -97.71 132.83 42.98 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.99 174.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 23' ' ' ILE . . . . . 0.431 ' CD1' ' HB3' ' D' ' 69' ' ' PHE . 70.3 mt -87.68 118.08 32.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.11 0.481 . . . . 0.0 111.093 -173.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 24' ' ' ILE . . . . . 0.694 ' H ' HD13 ' D' ' 24' ' ' ILE . 0.2 OUTLIER -90.09 -18.02 7.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.097 -179.422 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 25' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' D' ' 93' ' ' ASP . 83.4 tttt -155.16 129.12 8.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.085 -175.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 6.8 p -58.49 127.46 32.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.689 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 27' ' ' PHE . . . . . 0.721 ' HB3' HD23 ' D' ' 91' ' ' LEU . 10.3 p90 -143.73 166.36 25.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.721 0.772 . . . . 0.0 112.727 -174.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 28' ' ' HIS . . . . . 0.569 ' HE2' ' HB3' ' D' ' 30' ' ' SER . 4.7 t60 -121.93 127.42 50.39 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.285 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 29' ' ' ILE . . . . . 0.621 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 47.4 mt -94.5 135.33 29.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 171.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 30' ' ' SER . . . . . 0.569 ' HB3' ' HE2' ' D' ' 28' ' ' HIS . 55.9 p -119.96 -13.43 9.03 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -169.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 31' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -164.14 141.5 7.14 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 119.431 -1.366 . . . . 0.0 113.354 177.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.45 HG23 ' HG ' ' D' ' 87' ' ' LEU . 11.8 p -126.97 120.69 56.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 169.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 33' ' ' ALA . . . . . 0.4 ' HA ' HG21 ' D' ' 56' ' ' VAL . . . -141.17 157.21 45.58 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 121.95 -0.469 . . . . 0.0 111.589 -173.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 34' ' ' LEU . . . . . 0.635 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.6 pp -127.11 145.56 50.7 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.682 0.753 . . . . 0.0 111.254 178.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -110.34 -46.91 3.35 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.761 -1.108 . . . . 0.0 108.24 173.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -102.61 128.14 49.42 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.279 173.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 37' ' ' GLY . . . . . 0.538 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 141.6 161.4 8.72 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 119.459 -1.353 . . . . 0.0 113.814 176.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -102.77 -44.06 5.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.616 -0.292 . . . . 0.0 110.975 177.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -151.71 125.71 9.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.204 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 40' ' ' ALA . . . . . 0.513 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -127.82 113.08 15.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.443 0.639 . . . . 0.0 109.724 168.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' D' ' 79' ' ' THR . 56.0 mtpt -99.58 106.06 18.0 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.401 HD23 ' HB ' ' D' ' 53' ' ' VAL . 46.4 tp -79.12 108.72 12.82 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.814 -173.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -107.77 140.98 40.03 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.363 176.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.55 ' CD1' ' HB ' ' D' ' 75' ' ' ILE . 4.4 tp -124.41 116.47 22.6 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.14 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 45' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -101.84 104.18 14.92 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 174.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.49 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -127.08 136.4 52.1 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.403 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 56.41 35.91 26.68 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.383 0.611 . . . . 0.0 110.25 -175.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 61.61 39.44 14.53 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.117 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 49' ' ' GLN . . . . . 0.553 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 8.5 tp-100 -134.57 127.95 32.29 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 175.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -85.15 105.71 16.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.88 0.371 . . . . 0.0 110.456 -178.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -100.1 131.28 46.14 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.44 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 tp -79.73 108.82 13.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 168.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 53' ' ' VAL . . . . . 0.548 HG13 ' CD2' ' C' ' 88' ' ' LEU . 2.3 t -82.69 -51.2 14.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.575 -172.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 54' ' ' ALA . . . . . 0.487 ' HB1' HG11 ' D' ' 63' ' ' VAL . . . -156.34 145.56 20.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.076 -178.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 31.9 m -109.2 101.8 10.8 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 173.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 56' ' ' VAL . . . . . 0.477 HG13 ' HB3' ' D' ' 40' ' ' ALA . 7.4 p -115.57 114.93 47.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.483 0.659 . . . . 0.0 109.701 -177.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 63.1 p -122.95 -178.31 3.91 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.433 -174.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -63.78 -22.48 66.93 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.992 0.425 . . . . 0.0 110.321 171.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 59' ' ' ALA . . . . . 0.439 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -83.91 -40.71 18.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.143 177.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 78.2 mt -112.24 81.54 3.94 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 173.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 61' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 12.1 Cg_exo -70.14 0.14 6.37 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.163 2.575 . . . . 0.0 114.007 -166.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -163.85 129.58 3.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.085 0.469 . . . . 0.0 111.432 -175.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.487 HG11 ' HB1' ' D' ' 54' ' ' ALA . 66.8 t -119.03 99.93 8.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.176 173.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.14 117.06 21.37 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 173.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 65' ' ' LEU . . . . . 0.443 HD23 ' H ' ' D' ' 65' ' ' LEU . 0.9 OUTLIER -139.05 168.13 20.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.865 0.364 . . . . 0.0 111.098 -171.129 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 66' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 12.2 t0 -112.44 104.48 12.61 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.354 0.597 . . . . 0.0 110.181 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.675 HD21 HD23 ' C' ' 88' ' ' LEU . 11.1 mt -117.31 141.18 48.62 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.985 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.04 132.48 25.17 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.583 174.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 69' ' ' PHE . . . . . 0.479 ' CZ ' HD22 ' D' ' 67' ' ' LEU . 59.0 m-85 -130.01 160.63 33.07 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.97 178.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 18.3 t -120.21 158.73 26.38 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -79.34 9.11 5.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.846 0.355 . . . . 0.0 111.103 -175.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.34 -29.21 9.05 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 174.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -100.42 165.82 11.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.044 0.449 . . . . 0.0 110.746 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -135.74 143.49 45.35 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.55 ' HB ' ' CD1' ' D' ' 44' ' ' LEU . 24.7 pt -135.72 159.2 39.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.211 0.529 . . . . 0.0 112.25 -168.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 76' ' ' MET . . . . . 0.459 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 10.9 mtp -114.95 117.41 30.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.801 173.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 77' ' ' PHE . . . . . 0.503 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.6 OUTLIER -104.19 126.95 51.71 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.134 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 78' ' ' TYR . . . . . 0.606 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 23.1 p90 -152.22 134.66 15.25 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.886 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 79' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 2.4 p -107.85 119.96 40.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.297 -177.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.23 160.88 15.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.619 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.61 -170.51 31.05 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 110.656 -0.977 . . . . 0.0 110.656 -177.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 82' ' ' ASP . . . . . 0.434 ' HA ' ' HB3' ' D' ' 15' ' ' PRO . 19.0 t70 -116.92 103.45 10.3 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 117.861 0.831 . . . . 0.0 109.951 176.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 83' ' ' ALA . . . . . 0.538 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -173.38 158.69 3.57 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.744 172.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 26.2 t -117.78 122.37 43.27 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.635 HG12 ' HB3' ' D' ' 34' ' ' LEU . 5.0 m -115.9 156.11 17.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.491 0.662 . . . . 0.0 112.429 -172.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -119.08 117.16 28.0 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.04 173.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 87' ' ' LEU . . . . . 0.627 HD11 ' SD ' ' D' ' 13' ' ' MET . 5.1 mp -91.69 146.99 23.33 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 171.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.658 HD23 HD21 ' E' ' 67' ' ' LEU . 0.7 OUTLIER -130.78 142.52 50.41 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.747 179.617 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.9 -167.98 27.36 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.981 -178.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -145.39 130.26 18.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.734 0.778 . . . . 0.0 112.156 178.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 91' ' ' LEU . . . . . 0.721 HD23 ' HB3' ' D' ' 27' ' ' PHE . 18.1 mt -71.61 113.51 8.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.469 173.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -100.99 117.53 35.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.143 0.497 . . . . 0.0 110.718 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 93' ' ' ASP . . . . . 0.403 ' HB2' ' HE3' ' D' ' 25' ' ' LYS . 26.7 t70 -98.47 -53.81 3.22 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.713 176.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 59.7 mt 64.54 88.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.259 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 95' ' ' ASP . . . . . 0.507 ' HB3' ' OE1' ' D' ' 2' ' ' GLN . 29.9 t70 -127.03 134.59 50.29 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.722 178.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 18.8 m -96.59 27.34 3.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.973 0.416 . . . . 0.0 110.932 -177.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . -80.16 79.09 1.75 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.972 -0.632 . . . . 0.0 111.963 178.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 98' ' ' SER . . . . . 0.415 ' HA ' ' HB3' ' D' ' 1' ' ' PHE . 10.5 p . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.448 -0.786 . . . . 0.0 110.362 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 1' ' ' PHE . . . . . 0.413 ' HB3' ' HA ' ' E' ' 98' ' ' SER . 96.3 m-85 . . . . . 0 N--CA 1.477 0.915 0 N-CA-C 110.348 -0.242 . . . . 0.0 110.348 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 2' ' ' GLN . . . . . 0.523 ' OE1' ' HB3' ' E' ' 95' ' ' ASP . 8.2 tt0 65.77 105.33 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.944 0.778 . . . . 0.0 112.025 176.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.37 -1.09 60.9 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.602 -0.809 . . . . 0.0 111.519 175.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.51 56.71 2.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.261 0.553 . . . . 0.0 111.339 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 66.5 mtt -97.76 -69.45 0.76 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.776 177.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.71 111.18 21.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.751 177.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 7' ' ' MET . . . . . 0.4 ' O ' ' HA ' ' E' ' 90' ' ' TYR . 0.0 OUTLIER -99.99 154.6 18.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.913 178.151 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' E' E ' 8' ' ' PHE . . . . . 0.524 ' CE1' HD21 ' A' ' 44' ' ' LEU . 70.2 t80 -67.8 142.99 56.02 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.036 0.446 . . . . 0.0 112.071 -177.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 9' ' ' TRP . . . . . 0.558 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 88.2 t90 -135.12 148.04 49.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.118 177.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.69 153.14 24.75 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.448 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 11' ' ' LEU . . . . . 0.558 ' HB2' ' CH2' ' E' ' 9' ' ' TRP . 41.2 tp -144.1 109.98 5.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.779 0.323 . . . . 0.0 110.455 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -96.59 96.73 8.85 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.908 0.385 . . . . 0.0 110.04 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 13' ' ' MET . . . . . 0.632 ' SD ' HD11 ' E' ' 87' ' ' LEU . 62.7 mtp -92.98 144.14 25.54 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.963 -173.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -101.19 166.91 11.52 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.139 177.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 15' ' ' PRO . . . . . 0.441 ' HB3' ' HA ' ' E' ' 82' ' ' ASP . 87.9 Cg_exo -49.77 115.61 1.92 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.78 2.32 . . . . 0.0 112.797 176.099 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 16' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' E' ' 79' ' ' THR . 29.0 mt-10 63.29 39.65 9.34 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.295 0.569 . . . . 0.0 111.259 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 17' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' E' ' 78' ' ' TYR . 0.5 OUTLIER -88.15 133.43 34.01 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.353 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' E' E ' 18' ' ' LYS . . . . . 0.586 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 33.9 ttmt -123.21 116.14 22.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.153 0.502 . . . . 0.0 111.036 -178.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 19' ' ' TYR . . . . . 0.462 ' CZ ' ' HG2' ' E' ' 17' ' ' ARG . 18.7 m-85 -107.1 102.7 12.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.568 177.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 10.9 p -90.22 97.26 11.08 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 169.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.18 145.5 43.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.474 0.654 . . . . 0.0 112.454 -165.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 21.8 m -97.68 132.82 42.97 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.949 174.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 23' ' ' ILE . . . . . 0.436 ' CD1' ' HB3' ' E' ' 69' ' ' PHE . 70.0 mt -87.72 118.06 32.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.085 0.469 . . . . 0.0 111.083 -173.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 24' ' ' ILE . . . . . 0.673 ' H ' HD13 ' E' ' 24' ' ' ILE . 0.2 OUTLIER -90.11 -17.98 7.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.092 -179.421 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' E' E ' 25' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' E' ' 93' ' ' ASP . 83.3 tttt -155.15 129.21 8.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.075 -175.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 7.0 p -58.54 127.4 31.95 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.458 0.474 . . . . 0.0 110.679 -178.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 27' ' ' PHE . . . . . 0.736 ' HB3' HD23 ' E' ' 91' ' ' LEU . 10.2 p90 -143.68 166.44 24.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.645 0.736 . . . . 0.0 112.726 -174.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 28' ' ' HIS . . . . . 0.568 ' HE2' ' HB3' ' E' ' 30' ' ' SER . 4.8 t60 -121.9 127.45 50.46 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.36 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 29' ' ' ILE . . . . . 0.625 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 47.6 mt -94.63 135.33 29.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 30' ' ' SER . . . . . 0.568 ' HB3' ' HE2' ' E' ' 28' ' ' HIS . 55.0 p -119.94 -13.48 9.03 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -169.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 31' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -164.14 141.48 7.13 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 119.36 -1.4 . . . . 0.0 113.339 177.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.449 HG23 ' HG ' ' E' ' 87' ' ' LEU . 11.9 p -126.89 120.71 56.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 169.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 33' ' ' ALA . . . . . 0.407 ' HA ' HG21 ' E' ' 56' ' ' VAL . . . -141.17 157.15 45.66 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.601 -173.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 34' ' ' LEU . . . . . 0.622 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.6 pp -127.11 145.55 50.7 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.686 0.755 . . . . 0.0 111.179 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -110.22 -47.01 3.35 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.256 173.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -102.64 128.11 49.47 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.294 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 37' ' ' GLY . . . . . 0.538 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 141.62 161.45 8.74 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 119.566 -1.302 . . . . 0.0 113.886 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -102.76 -44.08 5.39 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.734 0.302 . . . . 0.0 110.952 177.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -151.72 125.74 9.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.168 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 40' ' ' ALA . . . . . 0.491 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -127.84 113.1 15.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.422 0.629 . . . . 0.0 109.671 168.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 41' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' E' ' 79' ' ' THR . 56.0 mtpt -99.64 106.07 17.98 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 46.3 tp -79.16 108.77 12.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.792 -173.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -107.83 141.01 40.07 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.303 176.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 44' ' ' LEU . . . . . 0.554 ' CD1' ' HB ' ' E' ' 75' ' ' ILE . 4.4 tp -124.46 116.4 22.47 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.096 176.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 45' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -101.76 104.2 14.97 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 174.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 46' ' ' ALA . . . . . 0.479 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -127.12 136.36 52.0 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.387 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 56.53 35.87 26.7 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.657 0.598 . . . . 0.0 110.216 -175.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 61.52 39.49 14.77 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.154 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 49' ' ' GLN . . . . . 0.547 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 8.5 tp-100 -134.56 128.08 32.55 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 175.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -85.22 105.7 16.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.875 0.369 . . . . 0.0 110.381 -178.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -100.15 131.21 46.23 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.427 177.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 6.0 tp -79.6 108.74 13.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 168.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 53' ' ' VAL . . . . . 0.526 HG13 ' CD2' ' D' ' 88' ' ' LEU . 2.3 t -82.64 -51.27 14.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.526 -172.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 54' ' ' ALA . . . . . 0.49 ' HB1' HG11 ' E' ' 63' ' ' VAL . . . -156.32 145.64 20.65 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.012 -178.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 31.9 m -109.19 101.7 10.71 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 173.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 56' ' ' VAL . . . . . 0.462 HG13 ' HB3' ' E' ' 40' ' ' ALA . 7.4 p -115.51 114.92 47.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.621 0.724 . . . . 0.0 109.724 -177.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 63.2 p -122.87 -178.29 3.9 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.434 -174.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -63.87 -22.46 66.93 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.07 0.462 . . . . 0.0 110.298 171.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 59' ' ' ALA . . . . . 0.441 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -83.96 -40.59 18.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.187 177.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.38 81.53 4.07 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 173.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 61' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 12.0 Cg_exo -70.09 0.13 6.35 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.133 2.556 . . . . 0.0 114.024 -166.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -163.81 129.53 3.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.195 0.521 . . . . 0.0 111.469 -175.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 63' ' ' VAL . . . . . 0.49 HG11 ' HB1' ' E' ' 54' ' ' ALA . 66.5 t -119.03 100.03 9.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.207 173.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.2 117.09 21.44 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 173.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' E' ' 30' ' ' SER . 0.9 OUTLIER -139.1 168.16 20.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.893 0.378 . . . . 0.0 111.097 -171.168 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' E' E ' 66' ' ' ASP . . . . . 0.512 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 12.1 t0 -112.39 104.49 12.63 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.3 0.571 . . . . 0.0 110.121 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 67' ' ' LEU . . . . . 0.658 HD21 HD23 ' D' ' 88' ' ' LEU . 11.1 mt -117.31 141.25 48.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.988 178.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.11 132.46 25.03 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.849 0.357 . . . . 0.0 110.682 174.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 69' ' ' PHE . . . . . 0.468 ' CZ ' HD22 ' E' ' 67' ' ' LEU . 58.5 m-85 -130.04 160.54 33.36 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.91 178.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 18.1 t -120.11 158.75 26.23 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -79.46 9.1 5.19 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.06 0.457 . . . . 0.0 111.102 -175.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.3 -29.28 9.03 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.453 174.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -100.38 165.85 11.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.033 0.444 . . . . 0.0 110.706 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -135.77 143.41 45.24 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 75' ' ' ILE . . . . . 0.554 ' HB ' ' CD1' ' E' ' 44' ' ' LEU . 24.9 pt -135.65 159.2 40.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.179 0.514 . . . . 0.0 112.278 -168.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 76' ' ' MET . . . . . 0.456 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 10.8 mtp -115.0 117.48 30.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.752 173.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 77' ' ' PHE . . . . . 0.5 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.6 OUTLIER -104.14 126.92 51.65 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 176.147 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' E' E ' 78' ' ' TYR . . . . . 0.586 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 23.0 p90 -152.22 134.61 15.21 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.985 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 79' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 2.4 p -107.8 120.0 41.02 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.375 -177.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.23 160.89 15.96 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.65 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.6 -170.48 31.04 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -177.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 82' ' ' ASP . . . . . 0.441 ' HA ' ' HB3' ' E' ' 15' ' ' PRO . 19.1 t70 -116.88 103.46 10.32 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 119.676 -0.809 . . . . 0.0 109.941 176.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 83' ' ' ALA . . . . . 0.538 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -173.33 158.7 3.61 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.776 172.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 25.9 t -117.86 122.47 43.42 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 85' ' ' VAL . . . . . 0.622 HG12 ' HB3' ' E' ' 34' ' ' LEU . 4.9 m -115.85 156.13 17.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.487 0.66 . . . . 0.0 112.328 -172.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 50.4 m -119.09 117.17 28.02 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.042 173.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 87' ' ' LEU . . . . . 0.632 HD11 ' SD ' ' E' ' 13' ' ' MET . 5.1 mp -91.72 147.03 23.29 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 171.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 88' ' ' LEU . . . . . 0.667 HD23 HD21 ' A' ' 67' ' ' LEU . 0.7 OUTLIER -130.81 142.51 50.4 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.744 179.643 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.95 -168.0 27.45 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.016 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 90' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' E' ' 7' ' ' MET . 37.0 p90 -145.42 130.19 18.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.643 0.735 . . . . 0.0 112.191 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 91' ' ' LEU . . . . . 0.736 HD23 ' HB3' ' E' ' 27' ' ' PHE . 18.2 mt -71.62 113.48 8.7 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.498 173.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -101.03 117.54 35.24 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.161 0.505 . . . . 0.0 110.706 -178.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 93' ' ' ASP . . . . . 0.409 ' HB2' ' HE3' ' E' ' 25' ' ' LYS . 26.5 t70 -98.45 -53.94 3.18 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.638 176.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 59.9 mt 64.66 88.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.248 177.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 95' ' ' ASP . . . . . 0.523 ' HB3' ' OE1' ' E' ' 2' ' ' GLN . 29.9 t70 -126.99 134.6 50.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.765 178.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 18.9 m -96.73 27.59 3.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.0 0.429 . . . . 0.0 110.971 -177.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . -80.19 78.88 1.78 Allowed Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.047 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 98' ' ' SER . . . . . 0.413 ' HA ' ' HB3' ' E' ' 1' ' ' PHE . 10.9 p . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.45 -0.786 . . . . 0.0 110.397 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 . . . . . 0 N--CA 1.481 1.102 0 CA-C-O 120.516 0.198 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -71.42 90.51 0.97 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.976 0.417 . . . . 0.0 110.571 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 142.52 -137.7 7.96 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 -177.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -141.87 -175.01 4.24 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.537 0.208 . . . . 0.0 110.581 -179.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.451 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 2.7 mpt? -142.7 -173.68 3.95 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 175.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.55 120.0 5.14 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 174.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 21.7 ttt -103.37 140.78 36.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.188 0.518 . . . . 0.0 112.317 -170.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.569 ' CE1' HD12 ' A' ' 88' ' ' LEU . 77.7 t80 -54.49 141.45 30.96 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.967 -176.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.531 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 89.5 t90 -133.46 147.23 51.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.704 -1.134 . . . . 0.0 108.503 177.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.89 145.54 14.45 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.658 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.558 HD23 HD13 ' A' ' 87' ' ' LEU . 50.1 tp -135.89 108.74 7.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.894 0.378 . . . . 0.0 110.317 177.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -96.64 100.96 12.49 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 176.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.562 ' SD ' HD11 ' A' ' 87' ' ' LEU . 61.0 mtp -92.5 143.47 26.32 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.291 0.567 . . . . 0.0 111.383 -172.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -100.49 145.02 29.57 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.425 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.526 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 9.5 Cg_endo -51.84 123.22 11.89 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 123.64 2.893 . . . . 0.0 113.597 -174.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' A' ' 79' ' ' THR . 35.8 mt-10 57.71 73.6 0.46 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.689 178.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.85 138.34 19.59 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.224 176.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.723 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 50.2 mttp -107.34 121.9 45.51 Favored 'General case' 0 CA--C 1.512 -0.497 0 O-C-N 123.451 0.47 . . . . 0.0 111.368 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.57 102.79 11.34 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 76' ' ' MET . 44.4 t -90.08 99.22 12.28 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 173.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -115.55 139.76 49.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.594 0.712 . . . . 0.0 112.2 -168.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.1 m -84.72 132.17 34.48 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.348 174.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 59.3 mt -86.35 115.45 27.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.07 0.462 . . . . 0.0 110.934 -175.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.431 HD12 ' N ' ' A' ' 25' ' ' LYS . 1.9 pp -88.7 -12.44 10.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.399 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.431 ' N ' HD12 ' A' ' 24' ' ' ILE . 83.3 tttt -160.03 120.12 2.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.486 178.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.7 m -51.54 137.16 24.99 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.683 0.614 . . . . 0.0 110.403 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.715 ' HB3' HD23 ' A' ' 91' ' ' LEU . 33.1 p90 -147.35 165.32 30.52 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -174.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.498 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 8.3 t60 -116.17 120.28 38.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.699 177.024 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 42.6 mt -84.51 134.68 26.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 169.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.508 ' HB2' ' HB3' ' B' ' 66' ' ' ASP . 76.7 p -119.68 -10.05 9.65 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -171.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -178.11 158.57 23.53 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 119.263 -1.446 . . . . 0.0 113.628 177.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.483 HG23 ' HG ' ' A' ' 87' ' ' LEU . 11.9 p -139.67 137.24 39.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 175.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -150.18 154.83 38.69 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.903 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.562 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.3 pp -118.19 140.02 50.42 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.964 0.888 . . . . 0.0 111.615 178.265 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -110.28 -53.41 2.68 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.981 -1.463 . . . . 0.0 108.549 174.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -101.47 126.79 48.32 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.589 175.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.508 ' HA3' ' HA ' ' A' ' 83' ' ' ALA . . . 140.54 165.64 10.38 Favored Glycine 0 N--CA 1.439 -1.119 0 C-N-CA 119.588 -1.292 . . . . 0.0 113.542 178.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -102.72 -46.58 4.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.58 0.228 . . . . 0.0 111.395 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -151.46 134.23 15.65 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.018 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.509 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -132.77 113.71 13.27 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.46 0.648 . . . . 0.0 110.42 170.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 79' ' ' THR . 65.4 mttp -98.21 113.36 25.26 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 174.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.414 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 58.7 tp -89.93 109.03 20.08 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.424 -170.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.537 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 71.5 m-85 -109.02 148.6 30.52 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.852 178.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.658 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -128.41 117.07 20.75 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.606 176.046 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -102.9 104.45 14.68 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.429 0.633 . . . . 0.0 109.927 176.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.491 ' HB2' HD11 ' A' ' 44' ' ' LEU . . . -128.79 143.72 50.99 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.316 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 61.16 26.59 16.47 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.716 0.769 . . . . 0.0 109.074 -174.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.4 ' N ' ' HD2' ' A' ' 48' ' ' LYS . 4.2 mptp? 59.2 38.36 23.55 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.874 -177.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.567 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 6.6 tp-100 -129.5 127.91 41.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.823 178.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -81.38 106.01 13.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.096 0.474 . . . . 0.0 110.599 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -102.3 116.98 33.78 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.339 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 tp -74.71 99.84 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 171.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.502 HG12 ' CD2' ' E' ' 88' ' ' LEU . 29.3 m -87.43 -32.45 6.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.611 -172.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.746 ' HB2' HD21 ' A' ' 65' ' ' LEU . . . -152.93 142.42 21.75 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.371 -0.532 . . . . 0.0 112.211 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.1 m -112.97 101.93 9.94 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 169.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.0 p -118.36 112.43 38.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.932 0.873 . . . . 0.0 110.443 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 78.5 p -123.34 -177.34 3.67 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.194 -176.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -60.93 -29.37 69.57 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.445 168.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.22 -40.66 62.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.252 0.549 . . . . 0.0 110.292 178.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 77.4 mt -117.8 81.69 15.65 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.35 -4.17 12.34 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.191 2.594 . . . . 0.0 113.963 -168.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -160.67 129.71 4.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.281 0.562 . . . . 0.0 111.206 -175.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 96.7 t -120.17 125.59 74.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.525 176.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.36 130.68 34.54 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 175.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.746 HD21 ' HB2' ' A' ' 54' ' ' ALA . 88.5 mt -122.82 166.64 14.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.394 0.616 . . . . 0.0 112.288 -173.061 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.539 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 26.9 t0 -144.51 97.95 3.12 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 170.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.531 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 7.0 mt -133.0 109.38 9.51 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.347 -175.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.451 ' HB2' ' CD2' ' E' ' 90' ' ' TYR . 7.5 m-20 -104.73 114.7 29.08 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.839 0.352 . . . . 0.0 110.149 178.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -108.09 160.35 15.87 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.338 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.5 t -116.14 149.64 38.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.955 0.407 . . . . 0.0 110.625 -177.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -69.15 0.13 5.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.198 -176.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.46 -18.56 35.35 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.345 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -101.51 164.06 11.95 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.708 -0.289 . . . . 0.0 110.836 -175.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -130.9 108.76 10.06 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.4 pt -109.52 158.46 9.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.259 -170.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.436 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 2.6 mtm -116.69 122.88 45.82 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.873 175.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.658 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -104.49 128.57 52.45 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.688 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.723 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 36.4 p90 -149.98 135.34 18.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.529 0.68 . . . . 0.0 112.492 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 3.9 p -106.36 132.56 52.25 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.763 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.54 154.42 18.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.799 177.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.422 ' O ' ' HG3' ' A' ' 16' ' ' GLU . . . 91.33 -172.14 35.98 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -176.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.403 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 21.3 t70 -113.13 102.86 10.79 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.825 176.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.526 ' H ' ' HB3' ' A' ' 15' ' ' PRO . . . -169.28 153.74 5.51 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.85 167.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.4 t -111.05 120.66 43.08 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.562 HG12 ' HB3' ' A' ' 34' ' ' LEU . 3.8 m -114.9 149.31 17.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -172.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.8 m -110.93 115.4 29.43 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.598 175.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.562 HD11 ' SD ' ' A' ' 13' ' ' MET . 4.8 mp -94.85 145.17 25.08 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 170.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.569 HD12 ' CE1' ' A' ' 8' ' ' PHE . 2.4 mm? -124.28 149.53 46.4 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 175.064 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.82 -167.35 26.32 Favored Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.48 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.44 ' CD2' ' HB2' ' B' ' 68' ' ' ASN . 5.1 p90 -149.31 131.38 15.35 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.763 0.792 . . . . 0.0 111.795 176.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.715 HD23 ' HB3' ' A' ' 27' ' ' PHE . 27.3 mt -63.91 138.9 58.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.927 -1.488 . . . . 0.0 110.279 177.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.427 ' HD1' ' CG ' ' E' ' 95' ' ' ASP . 23.2 m-70 -65.64 120.3 12.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.786 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -150.82 169.65 21.17 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 5' ' ' MET . 2.2 pp -91.76 149.03 4.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 120.791 0.329 . . . . 0.0 110.796 -178.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.42 98.6 11.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.822 -178.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 28.4 t -67.04 105.64 1.72 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.076 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.38 -48.93 4.11 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.0 178.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.1 m . . . . . 0 C--O 1.249 1.053 0 CA-C-O 119.033 -0.508 . . . . 0.0 110.413 -176.873 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 120.483 0.182 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -71.43 90.42 0.97 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.015 0.436 . . . . 0.0 110.581 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 142.63 -137.67 7.91 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -177.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -141.92 -175.04 4.25 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.533 0.206 . . . . 0.0 110.615 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' MET . . . . . 0.443 ' HA ' ' O ' ' B' ' 94' ' ' ILE . 2.7 mpt? -142.58 -173.6 3.91 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 175.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.59 119.99 5.14 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 174.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 21.8 ttt -103.3 140.79 36.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.189 0.519 . . . . 0.0 112.251 -170.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.559 ' CE1' HD12 ' B' ' 88' ' ' LEU . 78.1 t80 -54.51 141.53 30.8 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 114.76 -1.109 . . . . 0.0 113.001 -176.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 9' ' ' TRP . . . . . 0.531 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 89.3 t90 -133.53 147.28 51.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.531 177.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.91 145.54 14.44 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.607 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.546 HD23 HD13 ' B' ' 87' ' ' LEU . 50.2 tp -135.9 108.8 7.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.91 0.386 . . . . 0.0 110.344 176.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -96.76 101.1 12.64 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 13' ' ' MET . . . . . 0.568 ' SD ' HD11 ' B' ' 87' ' ' LEU . 60.8 mtp -92.58 143.46 26.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.304 0.573 . . . . 0.0 111.372 -172.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -100.49 145.02 29.59 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 114.926 -1.033 . . . . 0.0 109.371 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.521 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 9.5 Cg_endo -51.91 123.13 11.74 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.708 2.938 . . . . 0.0 113.597 -174.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' B' ' 79' ' ' THR . 35.8 mt-10 57.86 73.44 0.47 Allowed 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.668 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.76 138.5 19.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.214 176.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.711 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 50.2 mttp -107.39 121.95 45.63 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 123.397 0.436 . . . . 0.0 111.322 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 19' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' B' ' 76' ' ' MET . 3.1 m-85 -110.6 102.65 11.21 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 174.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 45.2 t -89.84 99.2 12.25 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 173.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -115.55 139.74 49.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.3 -168.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 54.4 m -84.66 132.16 34.51 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.399 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 59.3 mt -86.33 115.48 27.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.041 0.448 . . . . 0.0 110.924 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.431 HD12 ' N ' ' B' ' 25' ' ' LYS . 1.9 pp -88.7 -12.57 10.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.369 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.431 ' N ' HD12 ' B' ' 24' ' ' ILE . 83.3 tttt -159.99 120.17 2.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.479 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 13.6 m -51.47 137.09 24.7 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 123.768 0.667 . . . . 0.0 110.515 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 27' ' ' PHE . . . . . 0.719 ' HB3' HD23 ' B' ' 91' ' ' LEU . 33.0 p90 -147.34 165.34 30.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.386 0.612 . . . . 0.0 112.51 -174.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 28' ' ' HIS . . . . . 0.484 ' HA ' ' O ' ' B' ' 67' ' ' LEU . 8.3 t60 -116.15 120.24 38.39 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.749 176.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.536 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 42.5 mt -84.56 134.69 26.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 169.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.53 ' HB2' ' HB3' ' C' ' 66' ' ' ASP . 77.2 p -119.61 -10.1 9.67 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -171.121 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -178.16 158.5 23.38 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.314 -1.422 . . . . 0.0 113.678 177.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.485 HG23 ' HG ' ' B' ' 87' ' ' LEU . 11.9 p -139.71 137.27 39.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -150.16 154.78 38.61 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.972 -0.455 . . . . 0.0 110.961 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.565 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.3 pp -118.14 140.06 50.35 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.963 0.887 . . . . 0.0 111.651 178.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -110.41 -53.25 2.7 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.067 -1.424 . . . . 0.0 108.508 174.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -101.55 126.74 48.42 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.672 175.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' B' ' 83' ' ' ALA . . . 140.67 165.72 10.41 Favored Glycine 0 N--CA 1.439 -1.132 0 C-N-CA 119.602 -1.285 . . . . 0.0 113.484 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -102.76 -46.48 4.7 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.589 0.233 . . . . 0.0 111.481 176.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -151.5 134.24 15.62 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.95 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.518 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -132.83 113.71 13.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.494 0.664 . . . . 0.0 110.423 170.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' B' ' 79' ' ' THR . 65.4 mttp -98.19 113.22 25.06 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 174.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.422 ' HB3' ' HB3' ' B' ' 54' ' ' ALA . 58.9 tp -89.85 109.14 20.17 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.367 -170.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 43' ' ' TYR . . . . . 0.554 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 71.1 m-85 -109.04 148.53 30.66 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.919 177.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.672 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 0.4 OUTLIER -128.37 117.12 20.86 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.589 176.058 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -102.89 104.4 14.64 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.358 0.599 . . . . 0.0 109.925 176.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.485 ' HB2' HD11 ' B' ' 44' ' ' LEU . . . -128.85 143.67 50.97 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 61.06 26.64 16.56 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.769 0.795 . . . . 0.0 109.168 -174.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 59.19 38.28 23.61 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.009 -177.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.564 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 6.6 tp-100 -129.46 127.97 41.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.727 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -81.43 106.04 13.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.966 0.413 . . . . 0.0 110.591 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -102.3 116.95 33.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.348 176.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -74.7 99.88 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 171.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.495 HG12 ' CD2' ' A' ' 88' ' ' LEU . 28.8 m -87.39 -32.51 6.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.576 -172.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.775 ' HB2' HD21 ' B' ' 65' ' ' LEU . . . -152.89 142.31 21.68 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 26.8 m -112.96 101.96 9.98 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 169.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 p -118.33 112.36 37.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.857 0.837 . . . . 0.0 110.468 -176.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 77.1 p -123.39 -177.39 3.69 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.107 -176.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -60.86 -29.41 69.51 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.507 168.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.15 -40.69 62.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.338 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 77.8 mt -117.73 81.64 15.31 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 173.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.34 -4.15 12.28 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.164 2.576 . . . . 0.0 113.922 -168.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -160.69 129.76 4.82 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.307 0.575 . . . . 0.0 111.164 -175.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 96.8 t -120.19 125.58 74.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.522 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.41 130.76 34.52 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.775 HD21 ' HB2' ' B' ' 54' ' ' ALA . 88.4 mt -122.91 166.59 14.79 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.408 0.623 . . . . 0.0 112.369 -173.111 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 66' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 26.1 t0 -144.45 97.94 3.12 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 170.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.536 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 7.0 mt -132.88 109.32 9.53 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.406 -175.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 68' ' ' ASN . . . . . 0.44 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 7.5 m-20 -104.69 114.65 29.0 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.899 0.38 . . . . 0.0 110.175 178.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -108.05 160.31 15.89 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.349 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 36.0 t -116.16 149.6 38.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.959 0.409 . . . . 0.0 110.563 -177.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -69.1 0.23 4.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.272 -176.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.54 -18.46 35.49 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.356 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -101.47 164.24 11.86 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.681 -0.305 . . . . 0.0 110.891 -176.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -131.11 108.81 10.02 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 22.4 pt -109.5 158.35 9.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.256 -170.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.438 ' HA ' ' HA ' ' B' ' 20' ' ' SER . 2.6 mtm -116.64 122.79 45.61 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 120.296 -0.562 . . . . 0.0 109.924 175.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 77' ' ' PHE . . . . . 0.672 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -104.49 128.61 52.46 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.665 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.711 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 36.0 p90 -150.08 135.37 18.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.589 0.709 . . . . 0.0 112.498 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 3.8 p -106.35 132.56 52.24 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.835 178.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.46 154.39 18.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.806 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.415 ' O ' ' HG3' ' B' ' 16' ' ' GLU . . . 91.38 -172.18 35.94 Favored Glycine 0 CA--C 1.506 -0.492 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -176.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 82' ' ' ASP . . . . . 0.407 ' HA ' ' HB3' ' B' ' 15' ' ' PRO . 21.5 t70 -113.09 102.9 10.83 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.854 176.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.521 ' H ' ' HB3' ' B' ' 15' ' ' PRO . . . -169.32 153.71 5.45 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.818 167.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 24.3 t -111.0 120.65 43.07 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.565 HG12 ' HB3' ' B' ' 34' ' ' LEU . 3.8 m -114.97 149.27 17.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.544 0.688 . . . . 0.0 112.816 -172.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 25.0 m -110.87 115.38 29.42 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.61 175.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.568 HD11 ' SD ' ' B' ' 13' ' ' MET . 4.8 mp -94.81 145.25 25.01 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 170.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.559 HD12 ' CE1' ' B' ' 8' ' ' PHE . 2.4 mm? -124.48 149.51 46.77 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.81 -167.29 26.22 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.512 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 90' ' ' TYR . . . . . 0.428 ' CD2' ' HB2' ' C' ' 68' ' ' ASN . 5.1 p90 -149.35 131.34 15.27 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.787 0.803 . . . . 0.0 111.682 176.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 91' ' ' LEU . . . . . 0.719 HD23 ' HB3' ' B' ' 27' ' ' PHE . 27.3 mt -63.89 139.01 58.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.256 176.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -65.89 120.42 13.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.679 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -150.87 169.57 21.39 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 94' ' ' ILE . . . . . 0.453 ' H ' HG13 ' B' ' 94' ' ' ILE . 2.2 pp -91.7 149.26 4.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.77 -178.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.62 98.68 11.92 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.785 -178.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 28.4 t -67.1 105.67 1.75 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.126 177.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.42 -48.75 4.16 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.111 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 16.6 m . . . . . 0 C--O 1.249 1.073 0 CA-C-O 119.143 -0.456 . . . . 0.0 110.547 -176.929 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 120.491 0.186 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -71.44 90.47 0.98 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.954 0.407 . . . . 0.0 110.583 -178.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . 142.52 -137.62 7.91 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 -177.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -141.93 -174.98 4.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.56 0.219 . . . . 0.0 110.528 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 5' ' ' MET . . . . . 0.444 ' HA ' ' O ' ' C' ' 94' ' ' ILE . 2.7 mpt? -142.69 -173.63 3.93 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.6 119.89 5.04 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 174.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 21.8 ttt -103.21 140.79 36.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.166 0.508 . . . . 0.0 112.325 -170.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 8' ' ' PHE . . . . . 0.571 ' CE1' HD12 ' C' ' 88' ' ' LEU . 77.8 t80 -54.56 141.55 31.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.788 -1.097 . . . . 0.0 112.917 -176.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 9' ' ' TRP . . . . . 0.524 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 89.4 t90 -133.48 147.23 51.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.582 177.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.85 145.65 14.7 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.554 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.563 HD23 HD13 ' C' ' 87' ' ' LEU . 50.0 tp -135.97 108.74 7.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.923 0.392 . . . . 0.0 110.254 177.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -96.7 101.1 12.64 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 13' ' ' MET . . . . . 0.557 ' SD ' HD11 ' C' ' 87' ' ' LEU . 60.9 mtp -92.57 143.44 26.34 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.282 0.563 . . . . 0.0 111.401 -172.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -100.48 144.98 29.51 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.424 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 15' ' ' PRO . . . . . 0.526 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 9.5 Cg_endo -51.87 123.23 11.94 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 123.647 2.898 . . . . 0.0 113.559 -174.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 16' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' C' ' 79' ' ' THR . 36.1 mt-10 57.8 73.45 0.47 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.686 178.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.82 138.43 19.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.173 176.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 18' ' ' LYS . . . . . 0.723 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 50.2 mttp -107.37 121.98 45.67 Favored 'General case' 0 CA--C 1.511 -0.531 0 O-C-N 123.368 0.418 . . . . 0.0 111.325 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 19' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' C' ' 76' ' ' MET . 3.1 m-85 -110.63 102.74 11.28 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 174.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 20' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 44.7 t -89.97 99.22 12.27 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 173.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -115.52 139.69 49.83 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.272 -168.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 54.2 m -84.63 132.13 34.52 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.426 174.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 59.1 mt -86.21 115.32 27.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.048 0.452 . . . . 0.0 111.001 -175.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 24' ' ' ILE . . . . . 0.426 HD12 ' N ' ' C' ' 25' ' ' LYS . 1.9 pp -88.64 -12.57 10.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.39 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 25' ' ' LYS . . . . . 0.426 ' N ' HD12 ' C' ' 24' ' ' ILE . 83.3 tttt -159.95 120.24 2.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.431 178.265 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 13.4 m -51.47 137.13 24.66 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 123.736 0.647 . . . . 0.0 110.532 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 27' ' ' PHE . . . . . 0.73 ' HB3' HD23 ' C' ' 91' ' ' LEU . 32.9 p90 -147.39 165.32 30.57 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.448 0.642 . . . . 0.0 112.579 -174.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 28' ' ' HIS . . . . . 0.497 ' HA ' ' O ' ' C' ' 67' ' ' LEU . 8.3 t60 -116.1 120.29 38.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.728 177.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 29' ' ' ILE . . . . . 0.518 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 42.3 mt -84.61 134.68 26.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 169.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.5 ' HB2' ' HB3' ' D' ' 66' ' ' ASP . 75.9 p -119.59 -10.05 9.68 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -171.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 31' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -178.11 158.45 23.32 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 119.194 -1.479 . . . . 0.0 113.617 177.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.492 HG23 ' HG ' ' C' ' 87' ' ' LEU . 12.0 p -139.67 137.28 39.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -150.17 154.79 38.63 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 121.946 -0.471 . . . . 0.0 110.922 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.546 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.3 pp -118.24 140.09 50.33 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 122.01 0.909 . . . . 0.0 111.585 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -110.33 -53.32 2.7 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.934 -1.485 . . . . 0.0 108.514 174.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -101.59 126.72 48.46 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.603 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 37' ' ' GLY . . . . . 0.491 ' HA3' ' HA ' ' C' ' 83' ' ' ALA . . . 140.72 165.68 10.4 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 119.55 -1.309 . . . . 0.0 113.56 178.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -102.78 -46.46 4.7 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 120.575 0.226 . . . . 0.0 111.452 176.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -151.49 134.31 15.68 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.979 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.5 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -132.83 113.66 13.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.401 0.62 . . . . 0.0 110.451 170.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' C' ' 79' ' ' THR . 65.4 mttp -98.17 113.27 25.13 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 174.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.428 ' HG ' ' CG2' ' C' ' 53' ' ' VAL . 59.0 tp -89.92 109.08 20.12 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.416 -170.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 43' ' ' TYR . . . . . 0.543 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 71.3 m-85 -108.99 148.58 30.53 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.92 177.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.671 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 0.4 OUTLIER -128.39 117.09 20.78 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.579 176.045 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 45' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -102.87 104.5 14.76 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.33 0.586 . . . . 0.0 109.851 176.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.498 ' HB2' HD11 ' C' ' 44' ' ' LEU . . . -128.76 143.74 50.99 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.34 178.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 61.11 26.52 16.42 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.768 0.794 . . . . 0.0 109.138 -174.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 59.28 38.27 23.32 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.969 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 49' ' ' GLN . . . . . 0.558 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 6.6 tp-100 -129.49 127.96 41.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.715 178.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -81.51 106.08 13.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.074 0.464 . . . . 0.0 110.565 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -102.29 116.97 33.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.304 176.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 tp -74.74 99.88 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 171.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 53' ' ' VAL . . . . . 0.48 HG12 ' CD2' ' B' ' 88' ' ' LEU . 28.4 m -87.43 -32.43 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.618 -172.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 54' ' ' ALA . . . . . 0.776 ' HB2' HD21 ' C' ' 65' ' ' LEU . . . -152.89 142.41 21.77 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 120.308 -0.557 . . . . 0.0 112.261 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 27.0 m -113.05 101.97 9.96 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 169.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 p -118.26 112.39 38.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.817 0.818 . . . . 0.0 110.414 -176.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 77.0 p -123.45 -177.35 3.69 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.205 -176.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -60.81 -29.47 69.48 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.484 168.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.13 -40.68 62.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.289 0.566 . . . . 0.0 110.329 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 77.5 mt -117.75 81.65 15.4 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 173.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.33 -4.12 12.22 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.148 2.565 . . . . 0.0 113.969 -168.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -160.69 129.7 4.8 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.348 0.594 . . . . 0.0 111.194 -175.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 97.2 t -120.1 125.55 74.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.552 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.39 130.76 34.52 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 175.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 65' ' ' LEU . . . . . 0.776 HD21 ' HB2' ' C' ' 54' ' ' ALA . 88.2 mt -122.84 166.59 14.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.506 0.669 . . . . 0.0 112.376 -173.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 66' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 26.4 t0 -144.52 98.07 3.14 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.518 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 7.0 mt -132.95 109.37 9.53 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.443 -175.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 68' ' ' ASN . . . . . 0.428 ' HB2' ' CD2' ' B' ' 90' ' ' TYR . 7.4 m-20 -104.7 114.63 28.97 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 120.802 0.334 . . . . 0.0 110.158 178.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -108.11 160.38 15.85 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.254 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 36.6 t -116.16 149.64 38.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.565 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -69.15 0.01 5.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.203 -176.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.32 -18.54 35.85 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.406 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -101.51 164.09 11.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.706 0.289 . . . . 0.0 110.841 -176.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -131.0 108.81 10.06 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 22.5 pt -109.52 158.41 9.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.216 -170.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.443 ' HA ' ' HA ' ' C' ' 20' ' ' SER . 2.5 mtm -116.69 122.81 45.61 Favored 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.887 175.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 77' ' ' PHE . . . . . 0.671 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.7 OUTLIER -104.55 128.63 52.56 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.721 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 78' ' ' TYR . . . . . 0.723 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 36.4 p90 -150.04 135.33 18.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.581 0.705 . . . . 0.0 112.531 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 79' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 3.9 p -106.35 132.51 52.3 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.777 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.48 154.5 18.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.778 177.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.408 ' O ' ' HG3' ' C' ' 16' ' ' GLU . . . 91.3 -172.16 36.03 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -176.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 82' ' ' ASP . . . . . 0.402 ' HA ' ' HB3' ' C' ' 15' ' ' PRO . 21.3 t70 -113.07 102.95 10.88 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.879 176.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 83' ' ' ALA . . . . . 0.526 ' H ' ' HB3' ' C' ' 15' ' ' PRO . . . -169.38 153.6 5.34 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.845 167.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 25.3 t -110.94 120.71 43.3 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.546 HG12 ' HB3' ' C' ' 34' ' ' LEU . 3.8 m -114.96 149.38 17.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 24.1 m -110.97 115.31 29.28 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.641 175.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 87' ' ' LEU . . . . . 0.563 HD13 HD23 ' C' ' 11' ' ' LEU . 4.8 mp -94.83 145.19 25.06 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 170.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 88' ' ' LEU . . . . . 0.571 HD12 ' CE1' ' C' ' 8' ' ' PHE . 2.4 mm? -124.38 149.49 46.61 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.77 -167.29 26.16 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.471 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 90' ' ' TYR . . . . . 0.424 ' CD2' ' HB2' ' D' ' 68' ' ' ASN . 5.1 p90 -149.33 131.41 15.36 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.744 0.783 . . . . 0.0 111.741 176.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 91' ' ' LEU . . . . . 0.73 HD23 ' HB3' ' C' ' 27' ' ' PHE . 27.7 mt -63.97 139.1 58.73 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.247 177.024 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -65.93 120.32 12.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.659 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -150.83 169.63 21.23 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 94' ' ' ILE . . . . . 0.462 ' H ' HG13 ' C' ' 94' ' ' ILE . 2.2 pp -91.73 149.16 4.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 120.799 0.333 . . . . 0.0 110.799 -178.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 95' ' ' ASP . . . . . 0.427 ' CG ' ' HD1' ' D' ' 92' ' ' HIS . 0.1 OUTLIER -90.53 98.67 11.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.786 -178.408 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 28.5 t -67.12 105.66 1.76 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.048 177.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.34 -48.93 4.12 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.079 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 C--O 1.247 0.964 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.522 -176.831 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 120.486 0.184 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -71.42 90.45 0.97 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.913 0.387 . . . . 0.0 110.547 -178.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . 142.51 -137.66 7.94 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -177.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -141.82 -174.95 4.22 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.627 0.214 . . . . 0.0 110.576 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 5' ' ' MET . . . . . 0.446 ' HA ' ' O ' ' D' ' 94' ' ' ILE . 2.7 mpt? -142.74 -173.61 3.93 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 175.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.62 119.94 5.11 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.741 0.305 . . . . 0.0 110.185 174.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 21.7 ttt -103.2 140.8 36.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.142 0.496 . . . . 0.0 112.28 -170.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 8' ' ' PHE . . . . . 0.561 ' CE1' HD12 ' D' ' 88' ' ' LEU . 78.0 t80 -54.55 141.59 30.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.971 -176.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 9' ' ' TRP . . . . . 0.529 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 89.3 t90 -133.53 147.21 51.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.536 177.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.79 145.64 14.68 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.591 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.55 HD23 HD13 ' D' ' 87' ' ' LEU . 49.9 tp -136.0 108.85 7.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.923 0.392 . . . . 0.0 110.246 176.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -96.76 101.01 12.53 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 13' ' ' MET . . . . . 0.569 ' SD ' HD11 ' D' ' 87' ' ' LEU . 60.8 mtp -92.42 143.45 26.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.241 0.543 . . . . 0.0 111.434 -173.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -100.47 144.94 29.43 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.416 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 15' ' ' PRO . . . . . 0.529 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 9.5 Cg_endo -51.73 123.16 11.7 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.645 2.896 . . . . 0.0 113.626 -174.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 16' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' D' ' 79' ' ' THR . 35.9 mt-10 57.81 73.46 0.47 Allowed 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.707 178.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.85 138.44 19.66 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.197 176.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 18' ' ' LYS . . . . . 0.714 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 50.2 mttp -107.39 121.98 45.67 Favored 'General case' 0 CA--C 1.511 -0.533 0 O-C-N 123.387 0.429 . . . . 0.0 111.399 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.61 102.64 11.2 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 174.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 20' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 44.9 t -89.97 99.17 12.24 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.127 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -115.51 139.8 49.73 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.219 -168.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 55.2 m -84.74 132.25 34.47 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.292 174.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 59.4 mt -86.38 115.35 27.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.057 0.456 . . . . 0.0 110.914 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 24' ' ' ILE . . . . . 0.416 HD12 ' N ' ' D' ' 25' ' ' LYS . 1.9 pp -88.67 -12.51 10.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.417 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 25' ' ' LYS . . . . . 0.416 ' N ' HD12 ' D' ' 24' ' ' ILE . 83.3 tttt -159.93 120.28 2.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.493 178.214 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 13.6 m -51.6 137.13 25.4 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 123.761 0.663 . . . . 0.0 110.415 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 27' ' ' PHE . . . . . 0.735 ' HB3' HD23 ' D' ' 91' ' ' LEU . 32.9 p90 -147.39 165.27 30.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.399 0.619 . . . . 0.0 112.569 -174.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 28' ' ' HIS . . . . . 0.495 ' HA ' ' O ' ' D' ' 67' ' ' LEU . 8.3 t60 -116.15 120.3 38.59 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.676 177.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 29' ' ' ILE . . . . . 0.53 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 42.4 mt -84.5 134.66 26.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 169.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 30' ' ' SER . . . . . 0.51 ' HB2' ' HB3' ' E' ' 66' ' ' ASP . 77.2 p -119.6 -10.12 9.67 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -171.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 31' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -178.15 158.5 23.38 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 119.309 -1.425 . . . . 0.0 113.686 177.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.476 HG23 ' HG ' ' D' ' 87' ' ' LEU . 12.0 p -139.67 137.26 39.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 175.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -150.16 154.85 38.74 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.025 -0.422 . . . . 0.0 110.916 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 34' ' ' LEU . . . . . 0.543 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.3 pp -118.24 140.01 50.45 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.957 0.884 . . . . 0.0 111.607 178.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -110.32 -53.31 2.7 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.556 174.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -101.54 126.79 48.41 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.631 175.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 37' ' ' GLY . . . . . 0.496 ' HA3' ' HA ' ' D' ' 83' ' ' ALA . . . 140.65 165.67 10.39 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 119.554 -1.308 . . . . 0.0 113.447 178.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -102.8 -46.46 4.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.485 0.183 . . . . 0.0 111.409 176.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -151.44 134.21 15.66 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.012 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 40' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -132.76 113.7 13.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.433 0.635 . . . . 0.0 110.53 170.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' D' ' 79' ' ' THR . 65.4 mttp -98.16 113.28 25.13 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 174.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.425 ' HG ' ' CG2' ' D' ' 53' ' ' VAL . 58.8 tp -89.95 109.05 20.1 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.409 -170.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 43' ' ' TYR . . . . . 0.548 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 70.6 m-85 -108.97 148.55 30.54 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.989 177.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.668 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.4 OUTLIER -128.37 117.08 20.8 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.568 176.092 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 45' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -102.89 104.46 14.7 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.376 0.608 . . . . 0.0 109.871 176.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.492 ' HB2' HD11 ' D' ' 44' ' ' LEU . . . -128.85 143.62 50.95 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.034 -0.984 . . . . 0.0 108.377 178.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 61.2 26.55 16.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.711 0.767 . . . . 0.0 109.104 -174.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 59.29 38.23 23.29 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.992 -177.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 49' ' ' GLN . . . . . 0.562 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 6.6 tp-100 -129.53 127.91 41.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.685 178.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -81.47 106.08 13.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.069 0.461 . . . . 0.0 110.607 -178.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -102.3 116.97 33.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.355 176.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -74.67 99.88 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 53' ' ' VAL . . . . . 0.463 HG12 ' CD2' ' C' ' 88' ' ' LEU . 28.6 m -87.43 -32.43 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.586 -172.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 54' ' ' ALA . . . . . 0.748 ' HB2' HD21 ' D' ' 65' ' ' LEU . . . -152.93 142.27 21.61 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.246 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 27.2 m -112.97 102.05 10.05 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 169.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 p -118.4 112.33 37.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.904 0.859 . . . . 0.0 110.421 -176.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 78.4 p -123.33 -177.34 3.68 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.155 -176.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -60.86 -29.47 69.55 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.486 168.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.12 -40.68 62.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.326 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 77.6 mt -117.77 81.7 15.54 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 173.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.38 -4.1 12.22 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.137 2.558 . . . . 0.0 113.938 -168.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -160.69 129.69 4.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.299 0.571 . . . . 0.0 111.164 -175.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 97.1 t -120.12 125.67 74.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.555 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.43 130.83 34.5 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 65' ' ' LEU . . . . . 0.748 HD21 ' HB2' ' D' ' 54' ' ' ALA . 88.3 mt -122.97 166.53 14.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.353 0.597 . . . . 0.0 112.302 -173.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 66' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 26.1 t0 -144.44 98.0 3.13 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 170.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.53 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 6.9 mt -132.94 109.33 9.51 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.415 -175.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 68' ' ' ASN . . . . . 0.424 ' HB2' ' CD2' ' C' ' 90' ' ' TYR . 7.5 m-20 -104.72 114.67 29.03 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.857 0.36 . . . . 0.0 110.119 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -108.1 160.33 15.89 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.333 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 35.6 t -116.17 149.54 38.92 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.696 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -69.07 0.12 5.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.241 -176.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.45 -18.41 35.93 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.437 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -101.49 164.16 11.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.735 0.302 . . . . 0.0 110.848 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -131.08 108.92 10.1 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 75' ' ' ILE . . . . . . . . . . . . . 22.4 pt -109.57 158.47 9.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.22 -170.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 76' ' ' MET . . . . . 0.444 ' HA ' ' HA ' ' D' ' 20' ' ' SER . 2.5 mtm -116.67 122.78 45.53 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 120.281 -0.567 . . . . 0.0 109.904 175.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 77' ' ' PHE . . . . . 0.668 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.7 OUTLIER -104.53 128.57 52.51 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.727 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 78' ' ' TYR . . . . . 0.714 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 36.5 p90 -149.97 135.38 18.19 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.622 0.725 . . . . 0.0 112.608 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 79' ' ' THR . . . . . 0.524 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 3.9 p -106.41 132.43 52.44 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.788 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.35 154.47 18.17 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.806 177.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.417 ' O ' ' HG3' ' D' ' 16' ' ' GLU . . . 91.41 -172.21 35.93 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -176.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 82' ' ' ASP . . . . . 0.413 ' HA ' ' HB3' ' D' ' 15' ' ' PRO . 21.2 t70 -113.09 102.79 10.73 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 119.584 -0.846 . . . . 0.0 109.894 176.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 83' ' ' ALA . . . . . 0.529 ' H ' ' HB3' ' D' ' 15' ' ' PRO . . . -169.2 153.7 5.56 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.846 167.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 24.3 t -110.98 120.73 43.36 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.543 HG12 ' HB3' ' D' ' 34' ' ' LEU . 3.8 m -115.0 149.37 17.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.538 0.685 . . . . 0.0 112.764 -172.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 24.6 m -110.97 115.39 29.4 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.569 175.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 87' ' ' LEU . . . . . 0.569 HD11 ' SD ' ' D' ' 13' ' ' MET . 4.7 mp -94.8 145.14 25.09 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 170.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.561 HD12 ' CE1' ' D' ' 8' ' ' PHE . 2.4 mm? -124.35 149.56 46.5 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.81 -167.28 26.2 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.441 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 90' ' ' TYR . . . . . 0.464 ' CD2' ' HB2' ' E' ' 68' ' ' ASN . 5.2 p90 -149.33 131.26 15.21 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.744 0.783 . . . . 0.0 111.811 176.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 91' ' ' LEU . . . . . 0.735 HD23 ' HB3' ' D' ' 27' ' ' PHE . 27.5 mt -63.81 138.95 58.7 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.289 176.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 92' ' ' HIS . . . . . 0.427 ' HD1' ' CG ' ' C' ' 95' ' ' ASP . 23.0 m-70 -65.8 120.33 12.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.761 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -150.79 169.67 21.11 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 94' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' D' ' 5' ' ' MET . 2.2 pp -91.75 149.13 4.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.808 -178.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 95' ' ' ASP . . . . . 0.415 ' CG ' ' HD1' ' E' ' 92' ' ' HIS . 0.1 OUTLIER -90.44 98.61 11.88 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.761 -178.447 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 28.5 t -67.09 105.72 1.76 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.079 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.39 -48.92 4.11 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.042 178.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.995 -0.526 . . . . 0.0 110.498 -176.827 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.513 0.197 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -71.4 90.39 0.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.039 0.447 . . . . 0.0 110.6 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . 142.56 -137.71 7.95 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 111.439 -0.665 . . . . 0.0 111.439 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -141.82 -175.03 4.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.671 0.235 . . . . 0.0 110.692 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 5' ' ' MET . . . . . 0.444 ' HA ' ' O ' ' E' ' 94' ' ' ILE . 2.7 mpt? -142.64 -173.65 3.93 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 175.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.58 119.98 5.13 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 174.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 21.7 ttt -103.29 140.82 36.91 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -170.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 8' ' ' PHE . . . . . 0.572 ' CE1' HD12 ' E' ' 88' ' ' LEU . 77.7 t80 -54.65 141.54 31.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.899 -176.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 9' ' ' TRP . . . . . 0.518 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 89.5 t90 -133.43 147.27 51.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.55 177.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.86 145.62 14.63 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.625 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 11' ' ' LEU . . . . . 0.557 HD23 HD13 ' E' ' 87' ' ' LEU . 49.8 tp -136.07 108.85 7.54 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.007 0.432 . . . . 0.0 110.261 176.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -96.68 100.98 12.51 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 13' ' ' MET . . . . . 0.563 ' SD ' HD11 ' E' ' 87' ' ' LEU . 60.3 mtp -92.41 143.47 26.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.227 0.537 . . . . 0.0 111.451 -172.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -100.51 144.95 29.45 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.386 178.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 15' ' ' PRO . . . . . 0.528 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 9.5 Cg_endo -51.8 123.21 11.85 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.651 2.901 . . . . 0.0 113.623 -174.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 16' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' E' ' 79' ' ' THR . 35.9 mt-10 57.77 73.45 0.47 Allowed 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.722 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.85 138.44 19.67 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.203 176.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 18' ' ' LYS . . . . . 0.718 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 50.2 mttp -107.32 121.99 45.67 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 123.387 0.43 . . . . 0.0 111.306 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 19' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' E' ' 76' ' ' MET . 3.1 m-85 -110.62 102.67 11.22 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 174.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 20' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' E' ' 76' ' ' MET . 44.6 t -89.99 99.18 12.24 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 173.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -115.5 139.85 49.68 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.279 -168.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 56.0 m -84.81 132.15 34.45 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.382 174.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 59.3 mt -86.32 115.37 27.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.086 0.469 . . . . 0.0 110.932 -175.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 24' ' ' ILE . . . . . 0.426 HD12 ' N ' ' E' ' 25' ' ' LYS . 1.9 pp -88.69 -12.49 10.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.414 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 25' ' ' LYS . . . . . 0.426 ' N ' HD12 ' E' ' 24' ' ' ILE . 83.3 tttt -159.95 120.19 2.97 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.501 178.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 13.6 m -51.53 137.07 25.1 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.801 0.688 . . . . 0.0 110.498 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 27' ' ' PHE . . . . . 0.729 ' HB3' HD23 ' E' ' 91' ' ' LEU . 33.1 p90 -147.31 165.19 30.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.422 0.629 . . . . 0.0 112.597 -174.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 28' ' ' HIS . . . . . 0.502 ' HA ' ' O ' ' E' ' 67' ' ' LEU . 8.3 t60 -115.97 120.32 38.78 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.682 -1.144 . . . . 0.0 109.786 176.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 29' ' ' ILE . . . . . 0.529 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 42.1 mt -84.61 134.66 26.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 169.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 30' ' ' SER . . . . . 0.539 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 76.6 p -119.59 -10.03 9.69 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -171.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 31' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -178.11 158.55 23.49 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.252 -1.451 . . . . 0.0 113.595 177.088 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.485 HG23 ' HG ' ' E' ' 87' ' ' LEU . 12.0 p -139.77 137.25 39.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 174.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -150.17 154.83 38.68 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.916 -178.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 34' ' ' LEU . . . . . 0.541 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.3 pp -118.24 140.04 50.4 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.953 0.882 . . . . 0.0 111.665 178.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -110.4 -53.3 2.7 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 113.98 -1.464 . . . . 0.0 108.494 174.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -101.54 126.77 48.4 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.676 175.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 37' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' E' ' 83' ' ' ALA . . . 140.55 165.73 10.41 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 119.6 -1.286 . . . . 0.0 113.552 178.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -102.79 -46.55 4.67 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 123.501 0.177 . . . . 0.0 111.417 177.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -151.39 134.28 15.75 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.693 -0.23 . . . . 0.0 110.992 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 40' ' ' ALA . . . . . 0.511 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -132.84 113.68 13.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.416 0.627 . . . . 0.0 110.442 170.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 41' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' E' ' 79' ' ' THR . 65.4 mttp -98.16 113.24 25.08 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 174.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.425 ' HG ' ' CG2' ' E' ' 53' ' ' VAL . 58.9 tp -89.91 109.08 20.12 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.396 -170.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 43' ' ' TYR . . . . . 0.542 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 71.2 m-85 -109.0 148.62 30.47 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.931 177.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 44' ' ' LEU . . . . . 0.672 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 0.4 OUTLIER -128.46 117.16 20.87 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.52 176.105 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' E' E ' 45' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -102.95 104.41 14.62 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.412 0.625 . . . . 0.0 109.877 176.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 46' ' ' ALA . . . . . 0.486 ' HB2' HD11 ' E' ' 44' ' ' LEU . . . -128.85 143.67 50.97 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.302 178.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 61.16 26.57 16.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.802 0.81 . . . . 0.0 109.131 -174.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 59.31 38.23 23.2 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.952 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 49' ' ' GLN . . . . . 0.56 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 6.6 tp-100 -129.49 127.92 41.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.696 178.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -81.53 106.13 13.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.081 0.467 . . . . 0.0 110.567 -178.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -102.35 116.97 33.73 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.33 176.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -74.71 99.85 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 53' ' ' VAL . . . . . 0.497 HG12 ' CD2' ' D' ' 88' ' ' LEU . 29.3 m -87.35 -32.54 6.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.606 -172.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 54' ' ' ALA . . . . . 0.762 ' HB2' HD21 ' E' ' 65' ' ' LEU . . . -152.9 142.35 21.71 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 120.334 -0.547 . . . . 0.0 112.191 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 27.0 m -112.92 102.05 10.07 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 169.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 p -118.37 112.37 37.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.881 0.848 . . . . 0.0 110.416 -176.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 76.1 p -123.44 -177.38 3.69 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.172 -176.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -60.89 -29.33 69.51 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.516 168.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.2 -40.71 62.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.266 0.555 . . . . 0.0 110.345 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 77.3 mt -117.64 81.57 14.89 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 173.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.31 -4.11 12.17 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.16 2.573 . . . . 0.0 113.97 -168.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -160.65 129.7 4.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.273 0.559 . . . . 0.0 111.148 -175.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 96.9 t -120.12 125.63 74.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.524 176.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.4 130.73 34.52 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 175.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.762 HD21 ' HB2' ' E' ' 54' ' ' ALA . 88.1 mt -122.82 166.51 14.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.444 0.64 . . . . 0.0 112.342 -173.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 66' ' ' ASP . . . . . 0.51 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 26.6 t0 -144.44 98.04 3.14 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 170.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 67' ' ' LEU . . . . . 0.529 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 7.0 mt -132.97 109.33 9.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.456 -175.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 68' ' ' ASN . . . . . 0.464 ' HB2' ' CD2' ' D' ' 90' ' ' TYR . 7.5 m-20 -104.66 114.67 29.03 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.831 0.348 . . . . 0.0 110.149 178.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -108.17 160.31 15.92 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.269 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 36.6 t -116.15 149.68 38.64 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.635 -177.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -69.15 0.11 5.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.136 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.51 -18.45 35.62 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.346 177.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -101.48 164.15 11.91 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.697 -0.296 . . . . 0.0 110.851 -176.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -131.09 108.77 9.99 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 75' ' ' ILE . . . . . . . . . . . . . 22.3 pt -109.43 158.39 9.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.29 -170.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 76' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' E' ' 20' ' ' SER . 2.5 mtm -116.66 122.79 45.59 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.906 175.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 77' ' ' PHE . . . . . 0.672 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.7 OUTLIER -104.46 128.62 52.4 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.653 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' E' E ' 78' ' ' TYR . . . . . 0.718 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 36.6 p90 -150.05 135.24 17.99 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.57 0.7 . . . . 0.0 112.569 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 79' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 3.9 p -106.29 132.57 52.18 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.806 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.55 154.38 18.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.778 177.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 81' ' ' GLY . . . . . 0.417 ' O ' ' HG3' ' E' ' 16' ' ' GLU . . . 91.46 -172.22 35.85 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -176.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -113.04 102.83 10.78 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.881 176.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 83' ' ' ALA . . . . . 0.528 ' H ' ' HB3' ' E' ' 15' ' ' PRO . . . -169.28 153.68 5.48 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.84 167.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 24.3 t -110.98 120.72 43.33 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 85' ' ' VAL . . . . . 0.541 HG12 ' HB3' ' E' ' 34' ' ' LEU . 3.8 m -114.98 149.39 17.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -172.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 24.6 m -110.97 115.24 29.15 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.619 175.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 87' ' ' LEU . . . . . 0.563 HD11 ' SD ' ' E' ' 13' ' ' MET . 4.8 mp -94.79 145.15 25.08 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 170.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 88' ' ' LEU . . . . . 0.572 HD12 ' CE1' ' E' ' 8' ' ' PHE . 2.4 mm? -124.34 149.58 46.45 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.92 -167.35 26.41 Favored Glycine 0 N--CA 1.437 -1.275 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.376 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 90' ' ' TYR . . . . . 0.451 ' CD2' ' HB2' ' A' ' 68' ' ' ASN . 5.1 p90 -149.31 131.34 15.31 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.744 0.783 . . . . 0.0 111.766 176.141 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 91' ' ' LEU . . . . . 0.729 HD23 ' HB3' ' E' ' 27' ' ' PHE . 27.2 mt -63.81 138.97 58.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.29 176.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 92' ' ' HIS . . . . . 0.415 ' HD1' ' CG ' ' D' ' 95' ' ' ASP . 22.7 m-70 -65.84 120.38 12.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.671 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -150.81 169.68 21.09 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 94' ' ' ILE . . . . . 0.448 ' O ' HD12 ' E' ' 94' ' ' ILE . 2.2 pp -91.75 149.16 4.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.798 -178.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 95' ' ' ASP . . . . . 0.427 ' CG ' ' HD1' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -90.48 98.68 11.92 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.805 -178.497 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 28.5 t -67.1 105.74 1.77 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.061 177.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.48 -48.86 4.11 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.048 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 17.0 m . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.899 -0.572 . . . . 0.0 110.454 -176.93 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.675 ' HA ' ' OD1' ' B' ' 95' ' ' ASP . 29.2 p90 . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 110.713 -0.106 . . . . 0.0 110.713 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 63.66 84.06 0.15 Allowed 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.719 0.637 . . . . 0.0 111.41 -176.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.53 55.7 4.68 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.237 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.15 34.77 0.52 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.112 0.482 . . . . 0.0 110.428 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 72.4 mtm -89.96 -13.82 35.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.53 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' A' ' 91' ' ' LEU . . . -109.92 99.54 8.64 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.765 177.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 48.5 mtt -105.11 167.68 9.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.754 -172.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.565 ' CE1' HD21 ' B' ' 44' ' ' LEU . 70.4 t80 -69.46 146.36 52.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.21 0.529 . . . . 0.0 112.191 -175.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.475 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 92.2 t90 -136.7 145.58 44.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.025 176.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.53 146.6 16.3 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.531 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.517 HD23 HD13 ' A' ' 87' ' ' LEU . 43.6 tp -138.48 109.9 6.98 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.885 0.374 . . . . 0.0 110.507 177.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -97.33 105.12 17.22 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.55 ' SD ' HD11 ' A' ' 87' ' ' LEU . 44.3 mtp -98.39 143.95 28.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.917 0.389 . . . . 0.0 111.038 -174.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.524 ' HB2' ' HG3' ' A' ' 17' ' ' ARG . 37.8 mtmm -100.98 157.7 33.16 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.367 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.518 ' HB3' ' HA ' ' A' ' 82' ' ' ASP . 91.1 Cg_exo -47.76 115.42 1.44 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.581 2.854 . . . . 0.0 113.66 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.667 ' HA ' ' O ' ' A' ' 79' ' ' THR . 44.6 mt-10 59.8 58.36 2.84 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.368 0.604 . . . . 0.0 111.848 175.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.524 ' HG3' ' HB2' ' A' ' 14' ' ' LYS . 29.1 mmt180 -118.68 153.17 34.79 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.946 174.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.683 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 3.5 ttmp? -130.95 110.82 11.53 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 123.456 0.473 . . . . 0.0 110.958 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -111.38 112.6 24.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.885 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -75.14 114.56 13.77 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 171.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -92.81 114.09 26.54 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.426 -165.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.7 m -93.62 119.56 32.8 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.108 172.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.3 mt -96.79 113.01 30.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.99 0.424 . . . . 0.0 111.342 -173.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.2 mp -88.91 -34.75 7.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.444 0.64 . . . . 0.0 109.342 177.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.427 ' HD2' HD13 ' A' ' 91' ' ' LEU . 19.4 pttt -132.73 128.74 37.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.183 178.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.2 m -56.2 148.36 18.46 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.746 -176.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.736 ' HB3' HD23 ' A' ' 91' ' ' LEU . 38.5 p90 -157.97 162.87 38.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.717 0.77 . . . . 0.0 112.924 -178.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.535 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 2.0 t60 -119.18 123.83 45.3 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.392 -1.277 . . . . 0.0 109.444 176.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.574 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 51.7 mt -85.27 134.68 26.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 170.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.541 ' HB2' ' HB3' ' B' ' 66' ' ' ASP . 61.7 p -117.55 -15.01 10.26 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -171.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -171.41 152.1 17.08 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 119.43 -1.367 . . . . 0.0 113.242 177.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.485 HG23 ' HG ' ' A' ' 87' ' ' LEU . 11.3 p -136.68 131.51 47.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 174.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.88 155.99 42.21 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.014 -0.429 . . . . 0.0 111.161 -176.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.489 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.1 pp -118.05 141.28 48.64 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.887 0.851 . . . . 0.0 111.925 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -110.07 -54.18 2.6 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.807 176.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -100.85 128.12 47.02 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 171.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.551 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 139.25 161.57 8.78 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 119.705 -1.236 . . . . 0.0 113.373 176.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -103.4 -43.81 5.32 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -149.42 132.32 16.11 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 120.512 0.196 . . . . 0.0 111.043 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.474 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -131.74 113.8 13.98 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.409 0.624 . . . . 0.0 110.128 169.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 79' ' ' THR . 97.4 mttt -96.25 110.57 22.85 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 175.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.403 ' HG ' ' CG2' ' A' ' 53' ' ' VAL . 51.0 tp -87.02 109.76 19.61 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.025 -172.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.434 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 96.8 m-85 -108.25 141.85 39.42 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.252 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.559 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 1.5 tp -123.57 112.79 17.86 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.488 176.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.582 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -99.18 108.84 21.53 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.19 0.519 . . . . 0.0 109.855 176.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.479 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -139.66 140.9 37.03 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.529 -177.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 53.33 41.93 32.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.526 0.679 . . . . 0.0 110.248 -178.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.2 mttp 69.87 21.46 6.32 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.414 172.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.582 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 79.2 mm-40 -128.36 137.44 51.9 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 122.211 -0.306 . . . . 0.0 111.097 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -87.31 104.94 16.88 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 174.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 49' ' ' GLN . 75.8 m-85 -99.83 120.22 39.41 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.775 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -77.36 99.96 2.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 170.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.52 HG12 ' CD2' ' E' ' 88' ' ' LEU . 18.5 m -86.97 -34.58 7.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.817 -172.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.563 ' HB2' ' CD2' ' A' ' 65' ' ' LEU . . . -151.13 140.83 21.75 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.107 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.7 m -111.52 101.25 9.68 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 169.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.15 113.71 43.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.724 0.773 . . . . 0.0 110.052 -176.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 78.2 p -123.27 -177.89 3.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.204 -175.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -64.0 -24.22 67.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.025 0.441 . . . . 0.0 110.53 169.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.39 -40.52 43.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.169 176.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.6 mt -116.84 81.92 12.53 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 173.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.94 -5.15 12.77 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.206 2.604 . . . . 0.0 114.133 -167.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -160.48 128.62 4.61 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.129 0.49 . . . . 0.0 111.189 -175.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.2 t -118.45 108.19 23.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.408 175.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.71 121.46 30.17 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 174.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.563 ' CD2' ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -143.66 168.79 19.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.147 0.499 . . . . 0.0 111.978 -174.42 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.558 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 9.5 t0 -116.36 107.13 14.43 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.739 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.574 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 32.9 mt -126.37 107.74 10.58 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 177.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -111.08 127.87 55.69 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.913 -178.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -127.19 150.32 49.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.908 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.0 m -102.59 161.78 13.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.057 0.456 . . . . 0.0 110.748 176.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -69.34 -5.1 21.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.159 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.78 -7.72 62.66 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.446 -0.661 . . . . 0.0 111.446 173.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -100.28 143.55 30.33 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -122.97 125.59 45.57 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 174.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.496 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 15.0 pt -132.06 172.18 16.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.744 -171.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 7.9 mtm -130.04 131.68 45.92 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 170.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.559 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -110.25 128.33 55.45 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 177.348 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.683 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 40.9 p90 -153.69 140.43 19.01 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.292 -0.563 . . . . 0.0 112.12 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.667 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 8.0 p -111.92 136.43 51.24 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.25 -177.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.61 161.07 14.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.232 174.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.5 ' O ' ' HG3' ' A' ' 16' ' ' GLU . . . 81.97 177.27 51.73 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -173.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.518 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 7.0 p-10 -112.97 104.11 12.07 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 118.284 -1.367 . . . . 0.0 110.848 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.551 ' CB ' ' HA3' ' A' ' 37' ' ' GLY . . . -164.76 153.26 12.37 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 113.734 -1.575 . . . . 0.0 109.882 169.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.6 p -104.97 123.39 47.7 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 177.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.489 HG12 ' HB3' ' A' ' 34' ' ' LEU . 3.6 m -118.23 144.43 26.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.556 0.693 . . . . 0.0 112.776 -173.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.8 m -108.02 116.25 31.61 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.739 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.55 HD11 ' SD ' ' A' ' 13' ' ' MET . 4.5 mp -96.02 143.02 27.55 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 170.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.543 ' CD2' HG12 ' B' ' 53' ' ' VAL . 2.6 mm? -124.97 152.04 44.71 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 174.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.6 -167.86 30.73 Favored Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.429 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -139.15 131.42 28.3 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.498 0.666 . . . . 0.0 110.805 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.736 HD23 ' HB3' ' A' ' 27' ' ' PHE . 24.1 mt -62.68 131.73 49.93 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.892 173.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.65 -179.46 4.13 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.747 -176.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -41.82 107.96 0.09 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.392 1.058 . . . . 0.0 112.192 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 47.1 mt -68.74 -13.51 17.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.715 174.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.596 ' OD1' ' HA ' ' E' ' 1' ' ' PHE . 40.5 t0 70.78 59.65 0.2 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.148 175.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.9 p -105.67 -33.74 7.95 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.206 175.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.426 ' HA2' ' CZ ' ' A' ' 1' ' ' PHE . . . -133.76 34.35 2.42 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.407 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 31.6 t . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.831 -179.57 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.693 ' HA ' ' OD1' ' C' ' 95' ' ' ASP . 29.5 p90 . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 110.735 -0.098 . . . . 0.0 110.735 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 63.73 83.99 0.15 Allowed 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.717 0.636 . . . . 0.0 111.455 -176.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.5 55.66 4.67 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.233 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.07 34.73 0.53 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.104 0.478 . . . . 0.0 110.365 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 72.4 mtm -89.84 -13.81 35.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.594 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' B' ' 91' ' ' LEU . . . -109.98 99.57 8.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.747 177.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 48.5 mtt -105.07 167.72 9.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.788 -172.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.561 ' CE1' HD21 ' C' ' 44' ' ' LEU . 70.5 t80 -69.42 146.35 52.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.231 0.539 . . . . 0.0 112.19 -175.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 9' ' ' TRP . . . . . 0.474 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 92.1 t90 -136.73 145.58 44.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.981 176.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.4 146.66 16.45 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.589 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.505 HD23 HD13 ' B' ' 87' ' ' LEU . 43.9 tp -138.44 109.84 6.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.792 0.329 . . . . 0.0 110.531 177.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -97.41 105.07 17.16 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 13' ' ' MET . . . . . 0.554 ' SD ' HD11 ' B' ' 87' ' ' LEU . 44.3 mtp -98.33 143.88 28.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.111 -174.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.525 ' HB2' ' HG3' ' B' ' 17' ' ' ARG . 37.9 mtmm -101.02 157.77 33.03 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.256 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.53 ' HB3' ' HA ' ' B' ' 82' ' ' ASP . 93.4 Cg_exo -47.86 115.4 1.45 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.619 2.879 . . . . 0.0 113.629 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.661 ' HA ' ' O ' ' B' ' 79' ' ' THR . 44.5 mt-10 59.87 58.39 2.8 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 121.256 0.55 . . . . 0.0 111.841 175.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.525 ' HG3' ' HB2' ' B' ' 14' ' ' LYS . 29.0 mmt180 -118.8 153.19 34.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.891 174.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.683 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 3.5 ttmp? -130.91 110.68 11.45 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.04 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -111.33 112.59 24.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.909 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 4.5 p -75.1 114.61 13.8 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 171.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -92.82 114.04 26.48 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.425 -165.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 22.9 m -93.51 119.46 32.61 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.175 172.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 42.1 mt -96.78 112.9 29.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.05 0.452 . . . . 0.0 111.407 -173.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.454 ' N ' HD12 ' B' ' 24' ' ' ILE . 4.2 mp -88.86 -34.78 7.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.302 177.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.406 ' HD2' HD13 ' B' ' 91' ' ' LEU . 19.5 pttt -132.75 128.74 37.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.088 178.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -56.21 148.35 18.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.84 -177.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 27' ' ' PHE . . . . . 0.73 ' HB3' HD23 ' B' ' 91' ' ' LEU . 38.7 p90 -157.96 162.91 38.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.702 0.763 . . . . 0.0 112.881 -178.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 28' ' ' HIS . . . . . 0.534 ' HE2' ' HB3' ' B' ' 30' ' ' SER . 2.0 t60 -119.24 123.83 45.24 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.345 176.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.578 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 51.6 mt -85.27 134.6 26.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 170.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.567 ' HB2' ' HB3' ' C' ' 66' ' ' ASP . 61.5 p -117.48 -15.01 10.31 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -171.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -171.38 152.15 17.24 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.443 -1.361 . . . . 0.0 113.245 177.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.488 HG23 ' HG ' ' B' ' 87' ' ' LEU . 11.2 p -136.67 131.53 47.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 174.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.91 156.01 42.22 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.066 -0.396 . . . . 0.0 111.134 -176.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.5 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.1 pp -118.08 141.42 48.5 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.848 0.833 . . . . 0.0 111.96 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -110.17 -54.17 2.6 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.768 176.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -100.92 128.1 47.1 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.862 171.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.555 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 139.32 161.55 8.77 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 119.583 -1.294 . . . . 0.0 113.35 176.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -103.32 -43.83 5.33 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 178.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -149.44 132.41 16.18 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.543 0.211 . . . . 0.0 110.983 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.459 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -131.84 113.71 13.82 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.388 0.613 . . . . 0.0 110.12 169.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' B' ' 79' ' ' THR . 97.3 mttt -96.22 110.59 22.86 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.409 ' HG ' ' CG2' ' B' ' 53' ' ' VAL . 51.1 tp -87.05 109.73 19.6 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.062 -172.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 43' ' ' TYR . . . . . 0.428 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 96.7 m-85 -108.2 141.85 39.32 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.293 178.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.565 HD21 ' CE1' ' A' ' 8' ' ' PHE . 1.5 tp -123.58 112.84 17.92 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.451 176.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -99.21 108.86 21.55 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.178 0.513 . . . . 0.0 109.82 176.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.481 ' CB ' HG22 ' B' ' 75' ' ' ILE . . . -139.69 140.97 36.97 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.535 -177.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 53.25 41.95 32.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.557 0.694 . . . . 0.0 110.238 -177.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 39.2 mttp 69.93 21.41 6.26 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.404 172.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.573 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 79.1 mm-40 -128.33 137.49 51.95 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.055 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -87.27 104.88 16.82 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.432 ' CZ ' ' HB2' ' B' ' 49' ' ' GLN . 76.0 m-85 -99.92 120.27 39.53 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.71 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -77.33 99.98 2.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 170.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.543 HG12 ' CD2' ' A' ' 88' ' ' LEU . 18.9 m -86.92 -34.68 7.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.878 -172.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.556 ' HB2' ' CD2' ' B' ' 65' ' ' LEU . . . -151.08 140.79 21.77 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 120.383 -0.527 . . . . 0.0 112.139 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 21.8 m -111.47 101.29 9.74 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 169.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.23 113.73 43.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.707 0.765 . . . . 0.0 110.052 -176.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 74.6 p -123.3 -177.82 3.81 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.201 -175.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -63.98 -24.27 67.65 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.508 169.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.33 -40.58 43.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.291 0.567 . . . . 0.0 110.187 176.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 79.8 mt -116.82 81.99 12.56 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 173.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.07 -5.16 12.93 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.232 2.621 . . . . 0.0 114.053 -167.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -160.42 128.63 4.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.273 0.558 . . . . 0.0 111.242 -175.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 88.9 t -118.58 108.23 23.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.462 175.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.72 121.47 30.19 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 174.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.556 ' CD2' ' HB2' ' B' ' 54' ' ' ALA . 0.4 OUTLIER -143.65 168.78 19.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.074 0.464 . . . . 0.0 112.009 -174.459 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 66' ' ' ASP . . . . . 0.541 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 9.4 t0 -116.32 107.13 14.44 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.772 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.578 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 32.7 mt -126.38 107.69 10.53 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 177.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -111.16 127.9 55.73 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.915 -178.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -127.13 150.34 49.54 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.883 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 58.1 m -102.62 161.78 13.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.071 0.462 . . . . 0.0 110.748 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -69.19 -5.22 21.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.231 177.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.79 -7.62 62.73 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 173.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -100.32 143.53 30.4 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -123.0 125.63 45.61 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 174.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.501 ' HB ' ' CD1' ' B' ' 44' ' ' LEU . 15.1 pt -132.07 172.15 16.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.718 -171.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 76' ' ' MET . . . . . . . . . . . . . 7.9 mtm -129.97 131.7 46.03 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 170.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 77' ' ' PHE . . . . . 0.564 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.9 OUTLIER -110.22 128.32 55.43 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.29 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.683 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 41.1 p90 -153.6 140.42 19.1 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.299 -0.56 . . . . 0.0 112.098 -178.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.661 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 8.1 p -111.91 136.48 51.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.216 -177.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.65 161.06 14.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.207 174.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.494 ' O ' ' HG3' ' B' ' 16' ' ' GLU . . . 81.93 177.38 51.78 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -173.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 82' ' ' ASP . . . . . 0.53 ' HA ' ' HB3' ' B' ' 15' ' ' PRO . 6.9 p-10 -113.14 104.18 12.1 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 118.267 -1.373 . . . . 0.0 110.82 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.555 ' CB ' ' HA3' ' B' ' 37' ' ' GLY . . . -164.83 153.25 12.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 113.638 -1.619 . . . . 0.0 109.861 169.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 6.7 p -104.96 123.4 47.71 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.5 HG12 ' HB3' ' B' ' 34' ' ' LEU . 3.5 m -118.21 144.44 26.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.571 0.7 . . . . 0.0 112.744 -173.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 50.9 m -108.11 116.25 31.62 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.704 175.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.554 HD11 ' SD ' ' B' ' 13' ' ' MET . 4.5 mp -96.04 143.14 27.45 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 170.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.524 ' CD2' HG12 ' C' ' 53' ' ' VAL . 2.6 mm? -125.09 151.96 44.99 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 174.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.55 -167.89 30.73 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.328 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -139.11 131.46 28.44 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.515 0.674 . . . . 0.0 110.851 176.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 91' ' ' LEU . . . . . 0.73 HD23 ' HB3' ' B' ' 27' ' ' PHE . 23.4 mt -62.65 131.62 49.61 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.923 173.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.61 -179.48 4.11 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 123.36 0.413 . . . . 0.0 110.699 -176.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -41.79 108.03 0.09 Allowed 'General case' 0 C--N 1.326 -0.424 0 O-C-N 124.4 1.062 . . . . 0.0 112.242 -175.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 47.2 mt -68.85 -13.45 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.673 0.749 . . . . 0.0 109.729 174.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 95' ' ' ASP . . . . . 0.675 ' OD1' ' HA ' ' A' ' 1' ' ' PHE . 40.4 t0 70.82 59.53 0.2 Allowed 'General case' 0 CA--C 1.523 -0.08 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.212 175.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 7.7 p -105.61 -33.63 8.01 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.166 175.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 97' ' ' GLY . . . . . 0.431 ' HA2' ' CZ ' ' B' ' 1' ' ' PHE . . . -133.79 34.29 2.42 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.367 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 31.9 t . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.461 -0.78 . . . . 0.0 109.805 -179.598 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' 1' ' ' PHE . . . . . 0.633 ' HA ' ' OD1' ' D' ' 95' ' ' ASP . 29.4 p90 . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 110.709 -0.108 . . . . 0.0 110.709 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 63.81 83.95 0.16 Allowed 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.646 0.592 . . . . 0.0 111.475 -176.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.48 55.65 4.67 Favored Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.258 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.13 34.63 0.53 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.172 0.51 . . . . 0.0 110.364 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 72.4 mtm -89.8 -13.79 35.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.594 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 6' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' C' ' 91' ' ' LEU . . . -110.03 99.65 8.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.728 177.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 48.6 mtt -105.27 167.75 9.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.666 -172.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 8' ' ' PHE . . . . . 0.581 ' CE1' HD21 ' D' ' 44' ' ' LEU . 70.6 t80 -69.41 146.36 52.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.284 0.564 . . . . 0.0 112.174 -175.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 9' ' ' TRP . . . . . 0.471 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 92.2 t90 -136.7 145.5 44.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.008 176.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.47 146.6 16.31 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.575 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.523 HD23 HD13 ' C' ' 87' ' ' LEU . 44.0 tp -138.37 109.87 7.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.834 0.35 . . . . 0.0 110.56 177.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -97.33 105.01 17.08 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 13' ' ' MET . . . . . 0.543 ' SD ' HD11 ' C' ' 87' ' ' LEU . 44.2 mtp -98.34 144.0 28.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.994 0.426 . . . . 0.0 111.041 -174.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 14' ' ' LYS . . . . . 0.522 ' HB2' ' HG3' ' C' ' 17' ' ' ARG . 37.8 mtmm -101.13 157.7 33.17 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.25 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 15' ' ' PRO . . . . . 0.533 ' HB3' ' HA ' ' C' ' 82' ' ' ASP . 92.2 Cg_exo -47.78 115.43 1.45 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.609 2.873 . . . . 0.0 113.585 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 16' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' C' ' 79' ' ' THR . 44.5 mt-10 59.81 58.36 2.83 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.306 0.574 . . . . 0.0 111.874 175.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 17' ' ' ARG . . . . . 0.522 ' HG3' ' HB2' ' C' ' 14' ' ' LYS . 29.0 mmt180 -118.72 153.24 34.71 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.939 174.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 18' ' ' LYS . . . . . 0.692 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 3.5 ttmp? -130.98 110.81 11.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.0 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -111.41 112.63 24.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.848 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 4.4 p -75.2 114.7 14.02 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 172.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -92.97 114.11 26.57 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.43 -165.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 24.0 m -93.53 119.52 32.69 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.124 172.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 42.4 mt -96.84 112.97 30.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.158 0.504 . . . . 0.0 111.324 -173.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 24' ' ' ILE . . . . . 0.448 ' N ' HD12 ' C' ' 24' ' ' ILE . 4.2 mp -88.88 -34.76 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.294 177.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 25' ' ' LYS . . . . . 0.413 ' HD2' HD13 ' C' ' 91' ' ' LEU . 19.4 pttt -132.76 128.76 37.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.097 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 16.2 m -56.25 148.4 18.54 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.806 -177.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 27' ' ' PHE . . . . . 0.733 ' HB3' HD23 ' C' ' 91' ' ' LEU . 38.5 p90 -158.02 162.88 38.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.722 0.772 . . . . 0.0 112.867 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 28' ' ' HIS . . . . . 0.545 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 2.0 t60 -119.19 123.84 45.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.392 176.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 29' ' ' ILE . . . . . 0.574 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 51.5 mt -85.21 134.64 26.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 170.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.545 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 61.8 p -117.5 -15.03 10.29 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -171.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 31' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -171.36 152.1 17.14 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 119.517 -1.325 . . . . 0.0 113.27 177.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.487 HG23 ' HG ' ' C' ' 87' ' ' LEU . 11.2 p -136.68 131.54 47.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 174.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.91 155.98 42.18 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 122.017 -0.427 . . . . 0.0 111.187 -176.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.496 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.1 pp -118.09 141.39 48.53 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.889 0.852 . . . . 0.0 111.918 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -110.16 -54.16 2.6 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.216 -1.356 . . . . 0.0 108.776 176.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -100.89 128.19 47.03 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 171.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 37' ' ' GLY . . . . . 0.557 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 139.25 161.51 8.75 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 119.532 -1.318 . . . . 0.0 113.319 176.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -103.32 -43.77 5.34 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 178.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -149.49 132.31 16.04 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 120.504 0.192 . . . . 0.0 111.039 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -131.72 113.72 13.89 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.41 0.624 . . . . 0.0 110.141 169.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' C' ' 79' ' ' THR . 97.4 mttt -96.28 110.67 22.95 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 175.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.404 ' HG ' ' CG2' ' C' ' 53' ' ' VAL . 51.1 tp -87.14 109.77 19.67 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.982 -172.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 43' ' ' TYR . . . . . 0.434 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 96.7 m-85 -108.24 141.81 39.45 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.284 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.564 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 1.5 tp -123.56 112.75 17.82 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.532 176.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 45' ' ' ALA . . . . . 0.583 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -99.16 108.78 21.48 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.143 0.497 . . . . 0.0 109.795 176.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.472 ' CB ' HG22 ' C' ' 75' ' ' ILE . . . -139.69 140.97 36.99 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.551 -177.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 53.19 41.97 32.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.575 0.703 . . . . 0.0 110.33 -177.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 39.2 mttp 69.95 21.38 6.25 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 114.843 -1.072 . . . . 0.0 112.39 172.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 49' ' ' GLN . . . . . 0.583 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 79.2 mm-40 -128.3 137.48 51.97 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.07 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -87.26 104.98 16.91 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 174.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 51' ' ' TYR . . . . . 0.437 ' CZ ' ' HB2' ' C' ' 49' ' ' GLN . 76.0 m-85 -99.98 120.26 39.54 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.698 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -77.31 99.92 2.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 170.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 53' ' ' VAL . . . . . 0.524 HG12 ' CD2' ' B' ' 88' ' ' LEU . 18.7 m -86.92 -34.66 7.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.85 -172.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 54' ' ' ALA . . . . . 0.557 ' HB2' ' CD2' ' C' ' 65' ' ' LEU . . . -151.06 140.92 21.91 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 120.343 -0.543 . . . . 0.0 112.092 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 21.4 m -111.5 101.34 9.77 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 169.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.26 113.69 43.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.757 0.789 . . . . 0.0 110.038 -176.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 77.2 p -123.22 -177.83 3.81 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.194 -175.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -64.05 -24.16 67.6 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.007 0.432 . . . . 0.0 110.52 169.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.4 -40.55 43.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.198 0.523 . . . . 0.0 110.125 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 79.5 mt -116.81 81.96 12.52 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 173.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.02 -5.09 12.69 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.218 2.612 . . . . 0.0 114.119 -167.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -160.49 128.61 4.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.185 0.517 . . . . 0.0 111.266 -175.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 88.0 t -118.54 108.21 23.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.43 175.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.7 121.4 30.08 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 65' ' ' LEU . . . . . 0.557 ' CD2' ' HB2' ' C' ' 54' ' ' ALA . 0.4 OUTLIER -143.65 168.88 18.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.17 0.51 . . . . 0.0 111.954 -174.554 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 66' ' ' ASP . . . . . 0.567 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 9.4 t0 -116.35 107.16 14.47 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.79 178.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.574 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 32.8 mt -126.5 107.76 10.54 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -111.08 127.79 55.67 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.958 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -127.07 150.26 49.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.919 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 58.1 m -102.56 161.77 13.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.978 0.418 . . . . 0.0 110.733 176.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -69.23 -5.22 21.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.194 177.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.76 -7.66 62.75 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 173.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -100.3 143.51 30.4 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -122.99 125.65 45.66 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.501 ' HB ' ' CD1' ' C' ' 44' ' ' LEU . 15.1 pt -132.05 172.18 16.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.663 -171.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 76' ' ' MET . . . . . . . . . . . . . 7.8 mtm -129.99 131.64 45.97 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 170.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 77' ' ' PHE . . . . . 0.564 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.9 OUTLIER -110.17 128.28 55.39 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.274 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 78' ' ' TYR . . . . . 0.692 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 41.0 p90 -153.61 140.42 19.09 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.291 -0.564 . . . . 0.0 112.116 -178.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 79' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 8.2 p -111.91 136.4 51.28 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.25 -177.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.59 161.05 14.45 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.29 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.497 ' O ' ' HG3' ' C' ' 16' ' ' GLU . . . 81.96 177.24 51.71 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -173.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 82' ' ' ASP . . . . . 0.533 ' HA ' ' HB3' ' C' ' 15' ' ' PRO . 6.9 p-10 -112.94 104.21 12.18 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 118.304 -1.358 . . . . 0.0 110.873 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 83' ' ' ALA . . . . . 0.557 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -164.82 153.25 12.24 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.66 -1.609 . . . . 0.0 109.869 169.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 6.4 p -104.96 123.4 47.7 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.496 HG12 ' HB3' ' C' ' 34' ' ' LEU . 3.6 m -118.24 144.48 26.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.582 0.706 . . . . 0.0 112.765 -173.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 50.6 m -108.14 116.22 31.57 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.67 175.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 87' ' ' LEU . . . . . 0.543 HD11 ' SD ' ' C' ' 13' ' ' MET . 4.5 mp -96.04 143.15 27.44 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 170.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 88' ' ' LEU . . . . . 0.523 HD12 ' CE1' ' C' ' 8' ' ' PHE . 2.6 mm? -125.06 151.97 44.94 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 174.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.55 -167.9 30.75 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.443 177.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -139.06 131.47 28.54 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.432 0.634 . . . . 0.0 110.852 176.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 91' ' ' LEU . . . . . 0.733 HD23 ' HB3' ' C' ' 27' ' ' PHE . 23.7 mt -62.78 131.7 49.73 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.537 -1.21 . . . . 0.0 108.943 173.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.59 -179.54 4.14 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 123.36 0.412 . . . . 0.0 110.654 -176.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -41.73 107.98 0.09 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.455 1.097 . . . . 0.0 112.239 -175.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 47.2 mt -68.83 -13.54 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.714 0.768 . . . . 0.0 109.72 174.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 95' ' ' ASP . . . . . 0.693 ' OD1' ' HA ' ' B' ' 1' ' ' PHE . 40.4 t0 70.78 59.75 0.2 Allowed 'General case' 0 N--CA 1.46 0.059 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.169 175.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 7.7 p -105.77 -33.66 7.93 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.159 175.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 97' ' ' GLY . . . . . 0.419 ' HA2' ' CZ ' ' C' ' 1' ' ' PHE . . . -133.79 34.27 2.43 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.377 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 C--O 1.245 0.857 0 CA-C-O 118.557 -0.735 . . . . 0.0 109.911 -179.515 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' D' D ' 1' ' ' PHE . . . . . 0.659 ' HA ' ' OD1' ' E' ' 95' ' ' ASP . 29.5 p90 . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 110.708 -0.108 . . . . 0.0 110.708 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 63.65 83.97 0.15 Allowed 'General case' 0 N--CA 1.464 0.263 0 O-C-N 123.653 0.595 . . . . 0.0 111.46 -176.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.41 55.65 4.65 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.287 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.19 34.75 0.52 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.156 0.503 . . . . 0.0 110.337 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 72.3 mtm -89.9 -13.81 35.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.635 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 6' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' D' ' 91' ' ' LEU . . . -110.07 99.56 8.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.756 177.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 48.6 mtt -105.15 167.71 9.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.757 -172.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 8' ' ' PHE . . . . . 0.563 ' CE1' HD21 ' E' ' 44' ' ' LEU . 70.7 t80 -69.35 146.37 52.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.217 0.532 . . . . 0.0 112.176 -175.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 9' ' ' TRP . . . . . 0.476 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 92.2 t90 -136.76 145.62 44.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.397 -0.819 . . . . 0.0 108.965 176.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.57 146.54 16.17 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.507 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.506 HD23 HD13 ' D' ' 87' ' ' LEU . 44.0 tp -138.38 109.84 6.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.837 0.351 . . . . 0.0 110.595 177.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -97.29 105.04 17.12 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 13' ' ' MET . . . . . 0.556 ' SD ' HD11 ' D' ' 87' ' ' LEU . 44.5 mtp -98.42 143.94 28.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.965 0.412 . . . . 0.0 111.011 -174.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 14' ' ' LYS . . . . . 0.519 ' HB2' ' HG3' ' D' ' 17' ' ' ARG . 37.8 mtmm -101.04 157.74 33.09 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.257 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 15' ' ' PRO . . . . . 0.525 ' HB3' ' HA ' ' D' ' 82' ' ' ASP . 92.5 Cg_exo -47.81 115.36 1.42 Allowed 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.597 2.865 . . . . 0.0 113.686 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 16' ' ' GLU . . . . . 0.669 ' HA ' ' O ' ' D' ' 79' ' ' THR . 44.5 mt-10 59.88 58.38 2.79 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.333 0.587 . . . . 0.0 111.81 175.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 17' ' ' ARG . . . . . 0.519 ' HG3' ' HB2' ' D' ' 14' ' ' LYS . 29.0 mmt180 -118.72 153.12 34.91 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.899 174.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 18' ' ' LYS . . . . . 0.696 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 3.5 ttmp? -130.94 110.81 11.53 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.021 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -111.32 112.55 24.4 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.942 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -75.08 114.66 13.83 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 171.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -92.96 114.12 26.59 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.386 -165.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 23.8 m -93.68 119.53 32.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.126 172.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 42.6 mt -96.82 112.96 29.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.112 0.482 . . . . 0.0 111.36 -173.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 24' ' ' ILE . . . . . 0.449 HD12 ' N ' ' D' ' 24' ' ' ILE . 4.2 mp -88.81 -34.8 7.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.354 177.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 25' ' ' LYS . . . . . 0.406 ' HD2' HD13 ' D' ' 91' ' ' LEU . 19.4 pttt -132.67 128.81 37.83 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.077 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -56.21 148.36 18.49 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.757 -177.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 27' ' ' PHE . . . . . 0.744 ' HB3' HD23 ' D' ' 91' ' ' LEU . 38.6 p90 -158.06 162.93 38.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.782 0.801 . . . . 0.0 112.842 -178.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 28' ' ' HIS . . . . . 0.55 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 2.0 t60 -119.2 123.83 45.29 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.401 176.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 29' ' ' ILE . . . . . 0.569 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 51.3 mt -85.29 134.65 26.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 170.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 30' ' ' SER . . . . . 0.565 ' HB2' ' HB3' ' E' ' 66' ' ' ASP . 61.2 p -117.53 -15.0 10.28 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -171.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 31' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -171.35 152.07 17.09 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 119.488 -1.339 . . . . 0.0 113.246 177.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.469 HG23 ' HG ' ' D' ' 87' ' ' LEU . 11.4 p -136.62 131.49 47.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 174.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.86 156.01 42.24 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 122.057 -0.402 . . . . 0.0 111.185 -176.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 34' ' ' LEU . . . . . 0.489 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.1 pp -118.07 141.41 48.5 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.869 0.842 . . . . 0.0 111.905 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -110.18 -54.21 2.6 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.232 -1.349 . . . . 0.0 108.806 176.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -100.83 128.1 47.01 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.827 171.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 37' ' ' GLY . . . . . 0.557 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 139.27 161.54 8.77 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 119.64 -1.267 . . . . 0.0 113.378 176.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -103.34 -43.79 5.33 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 178.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -149.43 132.28 16.07 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 120.529 0.204 . . . . 0.0 111.048 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 40' ' ' ALA . . . . . 0.458 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -131.76 113.74 13.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.405 0.621 . . . . 0.0 110.146 169.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' D' ' 79' ' ' THR . 97.3 mttt -96.21 110.54 22.82 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 175.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.404 ' HG ' ' CG2' ' D' ' 53' ' ' VAL . 50.9 tp -87.0 109.71 19.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.005 -172.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 43' ' ' TYR . . . . . 0.438 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 96.6 m-85 -108.23 141.88 39.32 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.303 178.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.581 HD21 ' CE1' ' C' ' 8' ' ' PHE . 1.5 tp -123.61 112.81 17.87 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.489 176.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 45' ' ' ALA . . . . . 0.584 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -99.19 108.84 21.53 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.14 0.495 . . . . 0.0 109.806 176.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.469 ' CB ' HG22 ' D' ' 75' ' ' ILE . . . -139.67 140.96 37.02 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.51 -177.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 53.26 41.9 32.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.506 0.669 . . . . 0.0 110.273 -178.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 39.2 mttp 69.94 21.5 6.22 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.389 172.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 49' ' ' GLN . . . . . 0.584 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 79.2 mm-40 -128.41 137.48 51.88 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.055 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -87.35 105.02 16.97 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 174.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 51' ' ' TYR . . . . . 0.436 ' CZ ' ' HB2' ' D' ' 49' ' ' GLN . 75.9 m-85 -99.93 120.29 39.56 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.657 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -77.31 99.92 2.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 170.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 53' ' ' VAL . . . . . 0.515 HG12 ' CD2' ' C' ' 88' ' ' LEU . 18.5 m -86.99 -34.62 7.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.818 -172.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 54' ' ' ALA . . . . . 0.56 ' HB2' ' CD2' ' D' ' 65' ' ' LEU . . . -151.11 140.86 21.81 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 120.361 -0.535 . . . . 0.0 112.085 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 21.9 m -111.57 101.3 9.71 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 169.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.18 113.65 43.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.724 0.774 . . . . 0.0 110.036 -176.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 76.9 p -123.2 -177.86 3.81 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.25 -175.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -64.03 -24.19 67.61 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.01 0.433 . . . . 0.0 110.535 169.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.33 -40.58 43.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.192 176.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 79.5 mt -116.81 81.9 12.44 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 173.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.95 -5.19 12.87 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.264 2.643 . . . . 0.0 114.052 -167.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -160.44 128.57 4.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.351 0.596 . . . . 0.0 111.268 -175.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 89.8 t -118.43 108.16 23.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.455 175.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.78 121.54 30.32 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 174.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 65' ' ' LEU . . . . . 0.56 ' CD2' ' HB2' ' D' ' 54' ' ' ALA . 0.4 OUTLIER -143.65 168.88 18.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.113 0.482 . . . . 0.0 111.93 -174.541 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 66' ' ' ASP . . . . . 0.528 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 9.2 t0 -116.35 107.13 14.43 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.806 178.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.569 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 32.8 mt -126.43 107.69 10.51 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 177.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -111.08 127.78 55.67 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.939 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -127.12 150.28 49.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.902 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 58.1 m -102.57 161.83 13.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.025 0.441 . . . . 0.0 110.739 176.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -69.32 -5.26 22.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.16 177.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.71 -7.65 62.83 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 173.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -100.29 143.53 30.38 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -122.98 125.67 45.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.49 ' HB ' ' CD1' ' D' ' 44' ' ' LEU . 14.9 pt -132.08 172.22 16.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.625 -171.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 76' ' ' MET . . . . . . . . . . . . . 7.9 mtm -130.09 131.67 45.83 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 170.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 77' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.9 OUTLIER -110.18 128.23 55.37 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.37 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 78' ' ' TYR . . . . . 0.696 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 41.1 p90 -153.6 140.33 19.0 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.312 -0.555 . . . . 0.0 112.172 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 79' ' ' THR . . . . . 0.669 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 8.3 p -111.83 136.51 51.02 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.295 -177.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.66 161.06 14.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.244 174.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.501 ' O ' ' HG3' ' D' ' 16' ' ' GLU . . . 81.97 177.23 51.71 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -173.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 82' ' ' ASP . . . . . 0.525 ' HA ' ' HB3' ' D' ' 15' ' ' PRO . 6.9 p-10 -112.9 104.15 12.14 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 118.263 -1.375 . . . . 0.0 110.928 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 83' ' ' ALA . . . . . 0.557 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -164.8 153.32 12.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.75 -1.568 . . . . 0.0 109.858 169.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 6.6 p -104.94 123.41 47.7 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.686 -0.486 . . . . 0.0 109.686 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.489 HG12 ' HB3' ' D' ' 34' ' ' LEU . 3.6 m -118.23 144.5 26.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.603 0.716 . . . . 0.0 112.729 -173.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 50.6 m -108.11 116.32 31.75 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.704 175.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 87' ' ' LEU . . . . . 0.556 HD11 ' SD ' ' D' ' 13' ' ' MET . 4.5 mp -96.05 143.05 27.54 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 170.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.527 ' CD2' HG12 ' E' ' 53' ' ' VAL . 2.6 mm? -125.08 152.09 44.8 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 174.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.6 -167.91 30.8 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.365 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -139.13 131.49 28.45 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.496 0.665 . . . . 0.0 110.836 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 91' ' ' LEU . . . . . 0.744 HD23 ' HB3' ' D' ' 27' ' ' PHE . 23.7 mt -62.72 131.76 49.99 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.904 173.179 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.72 -179.38 4.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.707 -176.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -41.88 107.95 0.09 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.31 1.006 . . . . 0.0 112.213 -175.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 46.7 mt -68.73 -13.58 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.736 0.779 . . . . 0.0 109.7 174.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 95' ' ' ASP . . . . . 0.633 ' OD1' ' HA ' ' C' ' 1' ' ' PHE . 40.3 t0 70.9 59.59 0.19 Allowed 'General case' 0 CA--C 1.524 -0.043 0 CA-C-N 114.463 -1.244 . . . . 0.0 111.163 175.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 7.9 p -105.74 -33.57 7.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.189 175.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 97' ' ' GLY . . . . . 0.43 ' HA2' ' CZ ' ' D' ' 1' ' ' PHE . . . -133.87 34.37 2.41 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.365 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 31.7 t . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.454 -0.784 . . . . 0.0 109.844 -179.621 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' E' E ' 1' ' ' PHE . . . . . 0.596 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 29.6 p90 . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 110.699 -0.112 . . . . 0.0 110.699 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 63.67 83.97 0.15 Allowed 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.761 0.663 . . . . 0.0 111.463 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.54 55.69 4.68 Favored Glycine 0 N--CA 1.453 -0.204 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.265 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.15 34.7 0.52 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.108 0.48 . . . . 0.0 110.385 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 72.3 mtm -89.95 -13.73 35.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.517 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 6' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' E' ' 91' ' ' LEU . . . -110.1 99.59 8.65 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 177.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 48.5 mtt -105.09 167.68 9.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.834 -172.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 8' ' ' PHE . . . . . 0.529 ' CE1' HD21 ' A' ' 44' ' ' LEU . 70.7 t80 -69.36 146.35 52.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.163 0.506 . . . . 0.0 112.169 -175.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 9' ' ' TRP . . . . . 0.469 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 92.2 t90 -136.79 145.53 44.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.997 176.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.41 146.63 16.39 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.61 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 11' ' ' LEU . . . . . 0.521 HD23 HD13 ' E' ' 87' ' ' LEU . 43.8 tp -138.54 109.94 6.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.943 0.402 . . . . 0.0 110.55 177.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -97.37 105.05 17.13 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 176.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 13' ' ' MET . . . . . 0.548 ' SD ' HD11 ' E' ' 87' ' ' LEU . 44.6 mtp -98.4 143.95 28.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.993 0.425 . . . . 0.0 110.98 -174.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 14' ' ' LYS . . . . . 0.515 ' HB2' ' HG3' ' E' ' 17' ' ' ARG . 37.8 mtmm -101.07 157.8 32.97 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.334 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 15' ' ' PRO . . . . . 0.522 ' HB3' ' HA ' ' E' ' 82' ' ' ASP . 91.5 Cg_exo -47.88 115.35 1.43 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.588 2.859 . . . . 0.0 113.703 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 16' ' ' GLU . . . . . 0.663 ' HA ' ' O ' ' E' ' 79' ' ' THR . 44.4 mt-10 59.99 58.35 2.76 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.712 0.633 . . . . 0.0 111.728 175.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 17' ' ' ARG . . . . . 0.515 ' HG3' ' HB2' ' E' ' 14' ' ' LYS . 29.1 mmt180 -118.73 153.1 34.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.942 174.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 18' ' ' LYS . . . . . 0.697 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 3.5 ttmp? -130.88 110.83 11.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.032 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -111.38 112.55 24.38 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.895 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 4.5 p -75.13 114.67 13.9 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -92.93 114.06 26.52 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.353 -165.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 23.8 m -93.62 119.58 32.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.079 172.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 42.4 mt -96.85 112.96 30.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.131 0.491 . . . . 0.0 111.275 -173.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 24' ' ' ILE . . . . . 0.454 HD12 ' N ' ' E' ' 24' ' ' ILE . 4.2 mp -88.84 -34.79 7.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.329 177.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 25' ' ' LYS . . . . . 0.421 ' HD2' HD13 ' E' ' 91' ' ' LEU . 19.3 pttt -132.77 128.73 37.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.116 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -56.18 148.38 18.32 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.775 -177.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 27' ' ' PHE . . . . . 0.734 ' HB3' HD23 ' E' ' 91' ' ' LEU . 38.8 p90 -157.99 162.94 38.21 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.691 0.757 . . . . 0.0 112.916 -178.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 28' ' ' HIS . . . . . 0.544 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 2.0 t60 -119.16 123.9 45.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.341 -1.299 . . . . 0.0 109.427 176.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 29' ' ' ILE . . . . . 0.576 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 51.2 mt -85.32 134.65 26.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 170.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 30' ' ' SER . . . . . 0.558 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 61.9 p -117.44 -15.14 10.32 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -171.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 31' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -171.34 152.08 17.11 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 119.498 -1.335 . . . . 0.0 113.33 177.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.486 HG23 ' HG ' ' E' ' 87' ' ' LEU . 11.3 p -136.63 131.54 47.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 174.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.93 155.96 42.16 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.068 -0.395 . . . . 0.0 111.174 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 34' ' ' LEU . . . . . 0.493 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.1 pp -117.98 141.37 48.52 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.886 0.85 . . . . 0.0 111.93 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -110.22 -54.16 2.6 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.177 -1.374 . . . . 0.0 108.801 176.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -100.85 128.12 47.02 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 171.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 37' ' ' GLY . . . . . 0.551 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 139.19 161.5 8.75 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 119.586 -1.293 . . . . 0.0 113.333 176.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -103.24 -43.82 5.35 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 178.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -149.52 132.36 16.05 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.572 0.225 . . . . 0.0 111.023 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 40' ' ' ALA . . . . . 0.454 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -131.79 113.71 13.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.345 0.593 . . . . 0.0 110.152 169.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 41' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' E' ' 79' ' ' THR . 97.4 mttt -96.32 110.62 22.91 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.404 ' HG ' ' CG2' ' E' ' 53' ' ' VAL . 51.1 tp -87.02 109.76 19.61 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.018 -172.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 43' ' ' TYR . . . . . 0.436 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 96.8 m-85 -108.31 141.85 39.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.268 178.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 44' ' ' LEU . . . . . 0.564 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 1.5 tp -123.62 112.84 17.9 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.388 176.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 45' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -99.19 108.9 21.6 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.209 0.528 . . . . 0.0 109.78 176.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 46' ' ' ALA . . . . . 0.479 ' CB ' HG22 ' E' ' 75' ' ' ILE . . . -139.69 140.98 36.98 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.504 -177.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 53.25 41.95 32.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.604 0.716 . . . . 0.0 110.271 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 39.1 mttp 69.84 21.54 6.33 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.399 172.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 49' ' ' GLN . . . . . 0.586 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 79.2 mm-40 -128.45 137.44 51.82 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 122.245 -0.285 . . . . 0.0 111.066 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -87.27 105.02 16.95 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 174.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 51' ' ' TYR . . . . . 0.442 ' CZ ' ' HB2' ' E' ' 49' ' ' GLN . 75.9 m-85 -99.99 120.26 39.54 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.681 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -77.42 99.97 2.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 171.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 53' ' ' VAL . . . . . 0.527 HG12 ' CD2' ' D' ' 88' ' ' LEU . 18.3 m -87.06 -34.53 7.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.789 -172.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 54' ' ' ALA . . . . . 0.562 ' HB2' ' CD2' ' E' ' 65' ' ' LEU . . . -151.07 140.86 21.84 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 120.352 -0.539 . . . . 0.0 112.104 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 21.7 m -111.51 101.22 9.66 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 169.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.19 113.67 43.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.757 0.789 . . . . 0.0 110.062 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 77.8 p -123.15 -177.74 3.77 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.236 -175.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -64.17 -24.18 67.58 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.478 169.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.38 -40.58 43.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.25 0.548 . . . . 0.0 110.114 176.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 79.6 mt -116.88 81.95 12.67 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 173.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.99 -5.13 12.76 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.174 2.583 . . . . 0.0 114.088 -167.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -160.48 128.69 4.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.231 0.539 . . . . 0.0 111.238 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 89.2 t -118.5 108.19 23.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.456 175.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.69 121.44 30.13 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 174.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.562 ' CD2' ' HB2' ' E' ' 54' ' ' ALA . 0.4 OUTLIER -143.66 168.84 18.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.207 0.527 . . . . 0.0 111.951 -174.47 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' E' E ' 66' ' ' ASP . . . . . 0.565 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 9.3 t0 -116.32 107.16 14.48 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.772 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 67' ' ' LEU . . . . . 0.576 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 33.1 mt -126.49 107.71 10.5 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 177.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -111.07 127.91 55.7 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.907 -178.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -127.15 150.39 49.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.87 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 58.0 m -102.63 161.75 13.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.043 0.449 . . . . 0.0 110.795 176.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -69.29 -5.09 20.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.219 177.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.86 -7.55 62.67 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 173.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -100.32 143.45 30.5 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 178.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -122.95 125.72 45.84 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 174.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 75' ' ' ILE . . . . . 0.492 ' HB ' ' CD1' ' E' ' 44' ' ' LEU . 15.1 pt -132.03 172.2 16.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.666 -171.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 76' ' ' MET . . . . . . . . . . . . . 7.9 mtm -130.12 131.66 45.8 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 170.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 77' ' ' PHE . . . . . 0.564 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.9 OUTLIER -110.21 128.36 55.45 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 177.292 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' E' E ' 78' ' ' TYR . . . . . 0.697 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 40.9 p90 -153.64 140.41 19.05 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.287 -0.565 . . . . 0.0 112.112 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 79' ' ' THR . . . . . 0.663 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 8.3 p -111.88 136.36 51.28 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.28 -177.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.55 161.03 14.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.258 174.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 81' ' ' GLY . . . . . 0.483 ' O ' ' HG3' ' E' ' 16' ' ' GLU . . . 81.99 177.2 51.7 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -173.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 82' ' ' ASP . . . . . 0.522 ' HA ' ' HB3' ' E' ' 15' ' ' PRO . 6.9 p-10 -112.88 104.21 12.2 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 118.276 -1.37 . . . . 0.0 110.903 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 83' ' ' ALA . . . . . 0.551 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -164.84 153.22 12.17 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 113.708 -1.587 . . . . 0.0 109.836 169.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 6.6 p -104.93 123.48 47.83 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 85' ' ' VAL . . . . . 0.493 HG12 ' HB3' ' E' ' 34' ' ' LEU . 3.6 m -118.2 144.43 26.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -173.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 50.8 m -108.05 116.25 31.61 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.701 175.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 87' ' ' LEU . . . . . 0.548 HD11 ' SD ' ' E' ' 13' ' ' MET . 4.5 mp -96.1 143.12 27.51 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 170.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 88' ' ' LEU . . . . . 0.52 ' CD2' HG12 ' A' ' 53' ' ' VAL . 2.6 mm? -125.03 152.07 44.74 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 174.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.6 -167.86 30.73 Favored Glycine 0 N--CA 1.435 -1.377 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.409 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 90' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -139.19 131.46 28.32 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.565 0.698 . . . . 0.0 110.803 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 91' ' ' LEU . . . . . 0.734 HD23 ' HB3' ' E' ' 27' ' ' PHE . 23.7 mt -62.65 131.61 49.57 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.903 173.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.64 -179.47 4.12 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.686 -176.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -41.68 107.86 0.08 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.311 1.007 . . . . 0.0 112.228 -175.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 46.8 mt -68.7 -13.6 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.59 0.709 . . . . 0.0 109.656 174.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 95' ' ' ASP . . . . . 0.659 ' OD1' ' HA ' ' D' ' 1' ' ' PHE . 40.3 t0 70.82 59.6 0.2 Allowed 'General case' 0 CA--C 1.524 -0.037 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.185 175.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 8.1 p -105.55 -33.78 7.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.244 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 97' ' ' GLY . . . . . 0.432 ' HA2' ' CZ ' ' E' ' 1' ' ' PHE . . . -133.73 34.29 2.43 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.388 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 31.5 t . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.4 -0.81 . . . . 0.0 109.815 -179.586 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 51.4 p90 . . . . . 0 N--CA 1.479 0.998 0 CA-C-O 120.823 0.344 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -90.7 -29.38 17.73 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.817 176.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 94' ' ' ILE . . . 77.47 -60.78 3.62 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.44 177.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.422 ' HB2' ' CG ' ' B' ' 92' ' ' HIS . . . -82.38 71.85 9.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.17 0.509 . . . . 0.0 110.93 -178.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.426 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 13.0 tpt -82.04 -3.99 55.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.268 173.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.46 107.29 0.9 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.974 177.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.551 ' HA ' ' OG ' ' B' ' 70' ' ' SER . 45.5 mtt -94.29 155.12 17.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.559 0.695 . . . . 0.0 112.621 -170.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.501 ' CE1' HD21 ' B' ' 44' ' ' LEU . 55.8 t80 -59.71 142.71 52.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.262 -176.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.546 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 88.5 t90 -134.14 142.05 47.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.735 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.91 140.05 8.38 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.143 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.673 HD23 HD13 ' A' ' 87' ' ' LEU . 56.6 tp -128.36 108.29 10.45 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.974 0.416 . . . . 0.0 110.048 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -86.46 101.38 13.1 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 175.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.592 ' HB3' HG23 ' A' ' 85' ' ' VAL . 27.3 tpp -91.95 129.27 37.95 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.39 -171.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.489 ' N ' ' HD2' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -95.54 140.74 22.48 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.799 179.405 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.617 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 9.5 Cg_endo -53.63 121.73 10.04 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.624 2.882 . . . . 0.0 113.474 -175.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' A' ' 79' ' ' THR . 31.3 mt-10 61.53 47.0 6.9 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.911 177.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.52 ' NE ' ' HA ' ' A' ' 17' ' ' ARG . 1.2 tpm_? -122.33 137.39 54.87 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 173.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.661 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 88.4 mttt -108.81 121.47 45.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.685 0.279 . . . . 0.0 111.684 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -111.06 103.57 12.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.303 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 76' ' ' MET . 45.7 t -90.47 99.42 12.45 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 172.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -120.12 148.12 44.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.146 -168.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.5 m -93.44 141.27 28.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.49 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.412 ' HB ' ' HA ' ' A' ' 71' ' ' LYS . 67.9 mt -89.89 117.01 32.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 120.92 0.39 . . . . 0.0 111.243 -173.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.526 HD12 ' N ' ' A' ' 25' ' ' LYS . 1.4 pp -79.63 -27.57 12.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.735 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.526 ' N ' HD12 ' A' ' 24' ' ' ILE . 31.7 ttpt -155.28 136.17 13.66 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -178.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 39.2 m -58.32 130.03 44.82 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.659 0.599 . . . . 0.0 110.091 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.624 ' HB3' HD23 ' A' ' 91' ' ' LEU . 10.1 p90 -144.26 161.92 37.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.611 0.719 . . . . 0.0 112.886 -172.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.598 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 15.7 t60 -114.82 123.87 50.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.187 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 37.6 mt -92.6 136.28 25.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 170.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.589 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 64.8 p -123.08 -20.19 5.82 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -170.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -154.85 146.3 14.17 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 119.324 -1.417 . . . . 0.0 113.336 178.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.487 HG23 ' HG ' ' A' ' 87' ' ' LEU . 14.3 p -140.01 126.81 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 170.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.417 ' HA ' HG21 ' A' ' 56' ' ' VAL . . . -148.81 158.11 43.92 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.903 -0.498 . . . . 0.0 111.576 -174.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.586 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.0 pp -118.9 139.21 52.01 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.587 0.708 . . . . 0.0 111.456 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -108.13 -51.33 2.91 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.298 173.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -102.52 128.12 49.3 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 170.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.505 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 145.08 162.39 9.55 Favored Glycine 0 N--CA 1.437 -1.263 0 C-N-CA 119.949 -1.12 . . . . 0.0 113.098 176.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -102.7 -46.81 4.61 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 111.487 0.18 . . . . 0.0 111.487 177.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -150.68 130.88 13.57 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.73 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.473 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -130.83 113.0 13.53 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.585 0.707 . . . . 0.0 110.186 169.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 79' ' ' THR . 4.5 mptp? -95.34 106.38 18.43 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 174.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.518 HD23 ' HB ' ' A' ' 53' ' ' VAL . 41.6 tp -78.8 114.01 17.37 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -176.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -114.82 135.88 53.7 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.283 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.602 ' HB3' HG22 ' A' ' 53' ' ' VAL . 5.0 tp -115.77 116.15 27.54 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.498 176.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -103.38 103.73 13.76 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 176.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.441 ' HB2' HD11 ' A' ' 44' ' ' LEU . . . -130.53 140.85 50.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.105 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 58.0 32.44 21.97 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.71 0.767 . . . . 0.0 109.445 -175.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 57.44 37.11 27.72 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.466 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 6.6 tp-100 -127.75 131.77 49.63 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 176.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -87.35 112.27 21.93 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.427 -177.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -108.4 131.37 54.84 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.793 177.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -78.78 100.42 3.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 169.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.602 HG22 ' HB3' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -72.4 -51.49 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.877 -174.151 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.512 ' HA ' ' OE1' ' E' ' 62' ' ' GLN . . . -154.57 132.47 11.57 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.516 -177.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.3 t -101.95 102.46 13.01 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 174.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 40' ' ' ALA . 7.1 p -116.67 109.7 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-O 122.128 0.966 . . . . 0.0 110.047 -176.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 66.9 p -122.55 -176.95 3.5 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.378 -176.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -65.07 -20.61 66.57 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 119.976 -0.689 . . . . 0.0 110.574 169.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.95 -40.68 27.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.246 0.546 . . . . 0.0 110.047 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.4 mt -118.68 77.65 14.7 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 172.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 57' ' ' THR . 9.8 Cg_exo -71.73 0.84 6.43 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.11 2.54 . . . . 0.0 113.636 -168.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.492 ' OE1' ' HA ' ' B' ' 54' ' ' ALA . 10.3 tt0 -160.06 114.7 2.28 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.237 -170.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.495 HG11 ' HB1' ' A' ' 54' ' ' ALA . 86.5 t -112.8 115.16 49.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.061 0.458 . . . . 0.0 111.247 177.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.04 116.0 28.38 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 171.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.426 HD23 ' H ' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -134.64 168.3 19.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.817 0.341 . . . . 0.0 111.036 -171.661 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.551 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 7.4 t0 -122.91 109.43 14.14 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.139 0.495 . . . . 0.0 110.36 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.683 HD21 HD23 ' E' ' 88' ' ' LEU . 12.8 mt -124.05 138.84 54.39 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.683 177.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -138.43 114.61 10.22 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 173.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -109.17 163.07 13.68 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.385 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.535 ' OG ' ' HA ' ' E' ' 7' ' ' MET . 4.5 m -117.22 149.03 41.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.154 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.412 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -70.04 -5.9 29.86 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.736 -177.103 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.87 -28.54 45.84 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.319 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -101.3 171.25 7.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.702 0.287 . . . . 0.0 110.43 -176.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -137.3 136.5 38.06 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.467 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 22.6 pt -133.07 158.4 43.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.081 0.467 . . . . 0.0 111.571 -169.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.418 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 65.3 ttp -117.52 118.09 31.21 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.342 176.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.467 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -105.53 129.37 53.82 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.806 -177.773 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.661 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 39.0 p90 -155.74 162.79 40.47 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.847 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 12.6 p -125.21 143.86 50.74 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.108 178.187 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.3 149.48 26.87 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.231 173.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.0 -176.92 36.47 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -176.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -114.48 102.64 10.27 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.238 178.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.617 ' H ' ' HB3' ' A' ' 15' ' ' PRO . . . -166.74 150.05 6.85 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.479 168.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.2 p -106.04 122.11 45.5 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.592 HG23 ' HB3' ' A' ' 13' ' ' MET . 13.5 m -121.54 144.23 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-O 121.241 0.543 . . . . 0.0 111.801 -172.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 43.3 m -105.21 122.85 46.77 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.276 175.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.673 HD13 HD23 ' A' ' 11' ' ' LEU . 5.1 mp -95.22 143.93 26.23 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 170.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.695 HD23 HD21 ' B' ' 67' ' ' LEU . 0.9 OUTLIER -130.39 141.23 50.56 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.152 -178.718 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.66 -166.89 27.5 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.953 -0.642 . . . . 0.0 111.795 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -147.06 133.49 19.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.474 0.654 . . . . 0.0 111.161 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.624 HD23 ' HB3' ' A' ' 27' ' ' PHE . 15.1 mt -69.68 128.8 37.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.106 175.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.421 ' CG ' ' HB2' ' E' ' 4' ' ' ALA . 38.7 t-80 -81.84 108.35 15.3 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.049 0.452 . . . . 0.0 111.158 -173.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -108.21 -79.44 0.58 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 168.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.502 ' HA ' ' O ' ' A' ' 3' ' ' GLY . 50.4 mm 62.1 99.98 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.447 176.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.426 ' OD2' ' HB2' ' A' ' 5' ' ' MET . 28.4 m-20 -76.3 133.72 39.95 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.664 -178.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 23.3 t -91.13 86.99 6.37 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.35 -50.69 64.83 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.965 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.8 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.946 177.564 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 51.6 p90 . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.741 0.305 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -90.86 -29.42 17.54 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.756 177.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' B' ' 94' ' ' ILE . . . 77.6 -60.95 3.65 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.423 177.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.28 71.96 9.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.178 0.514 . . . . 0.0 110.944 -178.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' MET . . . . . 0.426 ' HB2' ' OD2' ' B' ' 95' ' ' ASP . 12.9 tpt -82.15 -3.96 55.96 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.235 173.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.42 107.32 0.9 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.0 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' MET . . . . . 0.568 ' HA ' ' OG ' ' C' ' 70' ' ' SER . 45.5 mtt -94.25 155.1 17.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.533 0.682 . . . . 0.0 112.727 -170.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.507 ' CE1' HD21 ' C' ' 44' ' ' LEU . 55.5 t80 -59.76 142.74 52.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.247 -176.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 9' ' ' TRP . . . . . 0.541 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 88.6 t90 -134.14 142.01 47.32 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.75 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.87 140.06 8.39 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.253 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.681 HD23 HD13 ' B' ' 87' ' ' LEU . 56.8 tp -128.36 108.35 10.5 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.972 0.415 . . . . 0.0 110.079 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -86.46 101.29 13.03 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 175.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 13' ' ' MET . . . . . 0.585 ' HB3' HG23 ' B' ' 85' ' ' VAL . 27.4 tpp -91.95 129.37 37.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.349 -171.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.492 ' N ' ' HD2' ' B' ' 14' ' ' LYS . 0.3 OUTLIER -95.69 140.83 22.5 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.757 179.362 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.62 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 9.4 Cg_endo -53.62 121.71 10.0 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 123.656 2.904 . . . . 0.0 113.425 -175.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' B' ' 79' ' ' THR . 31.2 mt-10 61.58 47.04 6.8 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.835 177.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.515 ' NE ' ' HA ' ' B' ' 17' ' ' ARG . 1.1 tpm_? -122.36 137.3 54.9 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 173.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.657 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 88.5 mttt -108.84 121.57 45.37 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -111.2 103.56 11.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.233 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 45.0 t -90.4 99.47 12.48 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -120.2 148.17 44.01 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.55 0.69 . . . . 0.0 112.152 -168.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 19.7 m -93.49 141.27 28.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.436 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -89.93 117.07 32.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.085 0.469 . . . . 0.0 111.214 -173.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.523 HD12 ' N ' ' B' ' 25' ' ' LYS . 1.4 pp -79.63 -27.58 12.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.709 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.523 ' N ' HD12 ' B' ' 24' ' ' ILE . 31.7 ttpt -155.3 136.1 13.59 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 38.9 m -58.23 130.03 44.75 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.725 0.641 . . . . 0.0 110.096 -178.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 27' ' ' PHE . . . . . 0.616 ' HB3' HD23 ' B' ' 91' ' ' LEU . 10.0 p90 -144.25 161.86 37.83 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -172.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 28' ' ' HIS . . . . . 0.595 ' HA ' ' O ' ' B' ' 67' ' ' LEU . 16.1 t60 -114.74 123.9 50.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.194 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 37.8 mt -92.66 136.17 25.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 170.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.587 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 65.1 p -122.91 -20.28 5.87 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -170.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -154.82 146.19 13.97 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 119.508 -1.329 . . . . 0.0 113.416 179.073 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.483 HG23 ' HG ' ' B' ' 87' ' ' LEU . 14.4 p -139.99 126.71 23.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 170.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 33' ' ' ALA . . . . . 0.415 ' HA ' HG21 ' B' ' 56' ' ' VAL . . . -148.79 158.15 43.95 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.925 -0.484 . . . . 0.0 111.669 -174.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.591 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.0 pp -118.91 139.26 51.93 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.719 0.771 . . . . 0.0 111.356 178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -108.21 -51.29 2.92 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.355 173.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -102.46 128.15 49.19 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 170.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.507 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 145.01 162.43 9.56 Favored Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 119.906 -1.14 . . . . 0.0 113.01 176.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -102.73 -46.67 4.65 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 177.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -150.77 130.81 13.43 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.754 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.481 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -130.78 113.06 13.64 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.55 0.691 . . . . 0.0 110.165 169.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' B' ' 79' ' ' THR . 4.5 mptp? -95.42 106.33 18.38 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 174.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.519 HD23 ' HB ' ' B' ' 53' ' ' VAL . 41.4 tp -78.67 113.92 17.14 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -176.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -114.78 135.89 53.68 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.247 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.587 ' HB3' HG22 ' B' ' 53' ' ' VAL . 4.9 tp -115.85 116.18 27.55 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.509 176.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -103.31 103.71 13.75 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 176.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.447 ' HB2' HD11 ' B' ' 44' ' ' LEU . . . -130.61 140.79 50.43 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.125 -178.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 58.19 32.29 21.85 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.543 0.687 . . . . 0.0 109.34 -175.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 62.4 mttp 57.54 37.0 27.49 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.508 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.515 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 6.6 tp-100 -127.67 131.8 49.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.588 176.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -87.47 112.32 22.07 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.828 0.346 . . . . 0.0 110.389 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -108.48 131.37 54.87 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.763 177.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -78.82 100.41 3.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 169.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.587 HG22 ' HB3' ' B' ' 44' ' ' LEU . 0.9 OUTLIER -72.3 -51.53 29.11 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.011 -174.205 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.492 ' HA ' ' OE1' ' A' ' 62' ' ' GLN . . . -154.48 132.53 11.69 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.547 -177.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 7.5 t -101.97 102.43 12.96 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 174.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.425 HG13 ' HB3' ' B' ' 40' ' ' ALA . 7.1 p -116.63 109.79 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-O 122.062 0.934 . . . . 0.0 109.964 -176.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' B' ' 61' ' ' PRO . 67.1 p -122.63 -176.94 3.51 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.352 -176.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -65.06 -20.63 66.57 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.551 169.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.86 -40.82 27.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.267 0.556 . . . . 0.0 110.02 176.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 74.2 mt -118.7 77.6 14.73 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 172.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' B' ' 57' ' ' THR . 9.7 Cg_exo -71.71 0.88 6.35 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.083 2.522 . . . . 0.0 113.721 -168.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 62' ' ' GLN . . . . . 0.507 ' OE1' ' HA ' ' C' ' 54' ' ' ALA . 10.3 tt0 -160.12 114.72 2.27 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.256 -170.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.487 HG11 ' HB1' ' B' ' 54' ' ' ALA . 86.0 t -112.75 115.17 49.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.108 0.48 . . . . 0.0 111.259 177.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.05 115.92 28.29 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 171.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.437 HD23 ' H ' ' B' ' 65' ' ' LEU . 0.7 OUTLIER -134.56 168.26 19.29 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.06 -171.67 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 66' ' ' ASP . . . . . 0.547 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 7.4 t0 -122.89 109.46 14.18 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.111 0.481 . . . . 0.0 110.365 -179.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.695 HD21 HD23 ' A' ' 88' ' ' LEU . 12.7 mt -124.02 138.91 54.39 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.67 177.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -138.64 114.65 10.12 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 173.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -109.23 162.99 13.77 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.395 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.551 ' OG ' ' HA ' ' A' ' 7' ' ' MET . 4.4 m -117.12 149.01 41.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.22 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -6.15 31.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.71 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.81 -28.38 46.7 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.365 177.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -101.24 171.32 7.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.764 0.316 . . . . 0.0 110.44 -176.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -137.37 136.47 37.93 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.458 ' HB ' ' CD1' ' B' ' 44' ' ' LEU . 22.3 pt -133.03 158.39 43.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.912 0.387 . . . . 0.0 111.668 -169.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.434 ' HA ' ' HA ' ' B' ' 20' ' ' SER . 65.3 ttp -117.47 118.21 31.56 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.056 0.455 . . . . 0.0 110.319 176.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 77' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.4 OUTLIER -105.63 129.39 53.88 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.788 -177.807 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.657 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 39.0 p90 -155.79 162.72 40.44 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.871 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 12.5 p -125.26 143.89 50.73 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.094 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.45 149.61 26.88 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.088 173.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.87 -176.95 36.69 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -176.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -114.38 102.67 10.31 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 117.988 0.894 . . . . 0.0 110.289 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.62 ' H ' ' HB3' ' B' ' 15' ' ' PRO . . . -166.72 150.04 6.88 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.465 168.073 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 6.1 p -106.05 122.17 45.62 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.591 HG12 ' HB3' ' B' ' 34' ' ' LEU . 13.4 m -121.59 144.26 31.33 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 121.241 0.544 . . . . 0.0 111.771 -172.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 44.0 m -105.25 122.88 46.86 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.24 175.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.681 HD13 HD23 ' B' ' 11' ' ' LEU . 5.1 mp -95.16 143.95 26.17 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.695 HD23 HD21 ' C' ' 67' ' ' LEU . 0.9 OUTLIER -130.44 141.23 50.53 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.17 -178.712 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.68 -166.93 27.59 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.752 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -147.0 133.54 19.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.428 0.633 . . . . 0.0 111.029 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 91' ' ' LEU . . . . . 0.616 HD23 ' HB3' ' B' ' 27' ' ' PHE . 15.1 mt -69.8 128.9 38.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.083 175.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 92' ' ' HIS . . . . . 0.422 ' CG ' ' HB2' ' A' ' 4' ' ' ALA . 38.6 t-80 -81.85 108.26 15.23 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.068 0.461 . . . . 0.0 111.091 -173.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -108.24 -79.51 0.58 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 168.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 94' ' ' ILE . . . . . 0.503 ' HA ' ' O ' ' B' ' 3' ' ' GLY . 50.7 mm 62.19 100.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.336 176.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 95' ' ' ASP . . . . . 0.426 ' OD2' ' HB2' ' B' ' 5' ' ' MET . 28.2 m-20 -76.25 133.66 40.03 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.671 -178.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 23.3 t -91.05 87.02 6.41 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 176.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.4 -50.64 65.42 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.998 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 10.9 m . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.087 -0.958 . . . . 0.0 110.952 177.551 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 51.6 p90 . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.801 0.334 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -90.81 -29.41 17.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.793 176.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 3' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' C' ' 94' ' ' ILE . . . 77.67 -60.93 3.68 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.395 177.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 4' ' ' ALA . . . . . 0.408 ' HB2' ' CG ' ' D' ' 92' ' ' HIS . . . -82.24 71.84 9.29 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.213 0.53 . . . . 0.0 110.993 -178.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 5' ' ' MET . . . . . 0.419 ' HB2' ' OD2' ' C' ' 95' ' ' ASP . 13.0 tpt -82.09 -4.01 55.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.273 173.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.39 107.29 0.89 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.029 177.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 7' ' ' MET . . . . . 0.577 ' HA ' ' OG ' ' D' ' 70' ' ' SER . 45.3 mtt -94.31 155.16 17.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.522 0.677 . . . . 0.0 112.657 -170.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 8' ' ' PHE . . . . . 0.492 ' CE1' HD21 ' D' ' 44' ' ' LEU . 55.5 t80 -59.78 142.66 52.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.401 -1.272 . . . . 0.0 112.203 -176.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 9' ' ' TRP . . . . . 0.533 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 88.4 t90 -134.08 142.08 47.41 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.766 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.84 140.07 8.41 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.148 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.67 HD23 HD13 ' C' ' 87' ' ' LEU . 56.3 tp -128.33 108.24 10.42 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.893 0.378 . . . . 0.0 110.153 178.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -86.27 101.25 12.89 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 175.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 13' ' ' MET . . . . . 0.587 ' HB3' HG23 ' C' ' 85' ' ' VAL . 27.2 tpp -91.99 129.42 37.95 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.362 -171.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 14' ' ' LYS . . . . . 0.482 ' N ' ' HD2' ' C' ' 14' ' ' LYS . 0.3 OUTLIER -95.68 140.74 22.46 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.833 179.385 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 15' ' ' PRO . . . . . 0.618 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 9.5 Cg_endo -53.59 121.73 10.03 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.606 2.871 . . . . 0.0 113.51 -175.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 16' ' ' GLU . . . . . 0.659 ' HA ' ' O ' ' C' ' 79' ' ' THR . 31.5 mt-10 61.56 47.04 6.84 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.838 177.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 17' ' ' ARG . . . . . 0.518 ' NE ' ' HA ' ' C' ' 17' ' ' ARG . 1.2 tpm_? -122.33 137.33 54.89 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 173.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 18' ' ' LYS . . . . . 0.657 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 88.4 mttt -108.85 121.51 45.24 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -111.07 103.71 12.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.252 176.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 20' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 45.2 t -90.59 99.52 12.53 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 172.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -120.23 148.14 44.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.125 -168.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 19.5 m -93.42 141.2 28.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.538 176.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 67.7 mt -89.84 117.06 32.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.974 0.416 . . . . 0.0 111.295 -173.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 24' ' ' ILE . . . . . 0.519 HD12 ' N ' ' C' ' 25' ' ' LYS . 1.4 pp -79.68 -27.5 12.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.703 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 25' ' ' LYS . . . . . 0.519 ' N ' HD12 ' C' ' 24' ' ' ILE . 31.7 ttpt -155.41 136.18 13.54 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 39.4 m -58.33 130.08 45.05 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.715 0.634 . . . . 0.0 110.085 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 27' ' ' PHE . . . . . 0.635 ' HB3' HD23 ' C' ' 91' ' ' LEU . 9.9 p90 -144.27 161.89 37.79 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.654 0.74 . . . . 0.0 112.905 -172.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 28' ' ' HIS . . . . . 0.606 ' HA ' ' O ' ' C' ' 67' ' ' LEU . 15.9 t60 -114.75 123.9 50.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.203 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 29' ' ' ILE . . . . . 0.56 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 38.0 mt -92.66 136.21 25.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 170.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.578 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 65.2 p -122.98 -20.25 5.84 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -170.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 31' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -154.74 146.21 14.04 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.403 -1.379 . . . . 0.0 113.395 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.49 HG23 ' HG ' ' C' ' 87' ' ' LEU . 14.4 p -140.08 126.73 22.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 170.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.412 ' HA ' HG21 ' C' ' 56' ' ' VAL . . . -148.73 158.21 43.99 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.617 -174.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.6 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.0 pp -118.99 139.21 52.07 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.739 0.781 . . . . 0.0 111.339 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -108.14 -51.28 2.92 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.572 -1.194 . . . . 0.0 108.382 173.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -102.42 128.03 49.2 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 170.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 37' ' ' GLY . . . . . 0.505 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 145.09 162.42 9.56 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.056 176.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -102.7 -46.73 4.63 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 177.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -150.73 130.81 13.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.809 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.495 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -130.81 113.02 13.56 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.53 0.681 . . . . 0.0 110.172 169.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' C' ' 79' ' ' THR . 4.5 mptp? -95.36 106.33 18.37 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 174.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.506 HD23 ' HB ' ' C' ' 53' ' ' VAL . 41.7 tp -78.69 113.97 17.21 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -176.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -114.86 135.88 53.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.244 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.61 ' HB3' HG22 ' C' ' 53' ' ' VAL . 4.9 tp -115.73 116.05 27.4 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.56 176.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 45' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -103.27 103.76 13.82 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 176.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.452 ' HB2' HD11 ' C' ' 44' ' ' LEU . . . -130.58 140.85 50.45 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.108 -178.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 58.05 32.4 21.93 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.611 0.719 . . . . 0.0 109.416 -175.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 62.4 mttp 57.38 37.11 27.84 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.523 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 49' ' ' GLN . . . . . 0.51 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 6.6 tp-100 -127.73 131.72 49.67 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.558 176.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -87.39 112.31 22.0 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.791 0.329 . . . . 0.0 110.401 -177.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -108.39 131.3 54.9 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.775 177.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -78.76 100.47 3.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 169.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 53' ' ' VAL . . . . . 0.61 HG22 ' HB3' ' C' ' 44' ' ' LEU . 0.9 OUTLIER -72.45 -51.46 28.85 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.955 -174.211 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 54' ' ' ALA . . . . . 0.507 ' HA ' ' OE1' ' B' ' 62' ' ' GLN . . . -154.5 132.5 11.65 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.597 -177.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 7.4 t -102.0 102.46 12.98 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 174.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 56' ' ' VAL . . . . . 0.412 HG21 ' HA ' ' C' ' 33' ' ' ALA . 7.1 p -116.61 109.74 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-O 122.005 0.907 . . . . 0.0 110.057 -176.252 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 57' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' C' ' 61' ' ' PRO . 66.9 p -122.62 -177.09 3.54 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.379 -176.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -64.95 -20.73 66.62 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.578 169.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.76 -40.82 27.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.247 0.546 . . . . 0.0 110.084 176.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 74.0 mt -118.7 77.64 14.77 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 172.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 61' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' C' ' 57' ' ' THR . 9.7 Cg_exo -71.74 0.86 6.39 Favored 'Trans proline' 0 N--CA 1.473 0.308 0 C-N-CA 123.099 2.532 . . . . 0.0 113.618 -168.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 62' ' ' GLN . . . . . 0.58 ' OE1' ' HA ' ' D' ' 54' ' ' ALA . 10.3 tt0 -160.13 114.73 2.27 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.733 0.301 . . . . 0.0 111.307 -170.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.494 HG11 ' HB1' ' C' ' 54' ' ' ALA . 85.9 t -112.79 115.16 49.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.13 0.49 . . . . 0.0 111.264 177.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.0 115.97 28.36 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 171.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 65' ' ' LEU . . . . . 0.443 HD23 ' H ' ' C' ' 65' ' ' LEU . 0.7 OUTLIER -134.53 168.35 19.12 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.138 -171.726 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 66' ' ' ASP . . . . . 0.493 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 7.4 t0 -122.95 109.37 14.05 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.077 0.465 . . . . 0.0 110.278 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.695 HD21 HD23 ' B' ' 88' ' ' LEU . 12.8 mt -124.03 138.79 54.4 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.696 176.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -138.45 114.57 10.17 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 172.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -109.12 163.0 13.72 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.348 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 70' ' ' SER . . . . . 0.568 ' OG ' ' HA ' ' B' ' 7' ' ' MET . 4.5 m -117.16 149.03 41.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.161 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.97 -6.04 30.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.737 -177.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.88 -28.44 46.16 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.269 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -101.2 171.32 7.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.603 0.239 . . . . 0.0 110.491 -176.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -137.35 136.54 38.02 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.457 ' HB ' ' CD1' ' C' ' 44' ' ' LEU . 22.6 pt -133.06 158.39 43.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.022 0.439 . . . . 0.0 111.647 -169.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' C' ' 20' ' ' SER . 65.4 ttp -117.46 118.08 31.22 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.279 176.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 77' ' ' PHE . . . . . 0.479 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.4 OUTLIER -105.62 129.34 53.88 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.791 -177.833 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 78' ' ' TYR . . . . . 0.657 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 38.9 p90 -155.73 162.72 40.48 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.839 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 79' ' ' THR . . . . . 0.659 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 12.6 p -125.12 143.88 50.71 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.143 178.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.43 149.63 26.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.072 173.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.88 -176.87 36.6 Favored Glycine 0 CA--C 1.508 -0.346 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -176.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -114.5 102.63 10.25 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.24 178.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 83' ' ' ALA . . . . . 0.618 ' H ' ' HB3' ' C' ' 15' ' ' PRO . . . -166.69 150.06 6.93 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.508 167.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 6.3 p -106.01 122.2 45.67 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.6 HG12 ' HB3' ' C' ' 34' ' ' LEU . 13.5 m -121.62 144.2 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-O 121.223 0.535 . . . . 0.0 111.769 -172.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 43.6 m -105.23 122.87 46.82 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.28 175.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 87' ' ' LEU . . . . . 0.67 HD13 HD23 ' C' ' 11' ' ' LEU . 5.1 mp -95.15 144.03 26.11 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 170.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 88' ' ' LEU . . . . . 0.693 HD23 HD21 ' D' ' 67' ' ' LEU . 0.9 OUTLIER -130.5 141.21 50.5 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.161 -178.685 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.67 -166.93 27.57 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.744 -177.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -146.95 133.57 19.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.384 0.612 . . . . 0.0 111.095 177.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 91' ' ' LEU . . . . . 0.635 HD23 ' HB3' ' C' ' 27' ' ' PHE . 15.1 mt -69.79 128.89 38.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.07 175.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -81.89 108.32 15.31 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.052 0.453 . . . . 0.0 111.1 -173.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -108.17 -79.53 0.58 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 168.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 94' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' C' ' 3' ' ' GLY . 50.6 mm 62.14 100.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.373 176.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 95' ' ' ASP . . . . . 0.419 ' OD2' ' HB2' ' C' ' 5' ' ' MET . 28.2 m-20 -76.37 133.75 39.85 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.622 -178.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 23.3 t -91.05 86.98 6.4 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.33 -50.65 65.35 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.037 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 10.8 m . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.956 177.513 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 51.7 p90 . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 120.731 0.301 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -90.77 -29.52 17.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.771 177.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 3' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' D' ' 94' ' ' ILE . . . 77.64 -60.95 3.67 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.423 177.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 4' ' ' ALA . . . . . 0.426 ' HB2' ' CG ' ' E' ' 92' ' ' HIS . . . -82.22 71.82 9.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.176 0.513 . . . . 0.0 111.006 -178.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 5' ' ' MET . . . . . 0.432 ' HB2' ' OD2' ' D' ' 95' ' ' ASP . 12.9 tpt -82.08 -3.97 55.84 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.215 173.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.4 107.21 0.87 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.032 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 7' ' ' MET . . . . . 0.559 ' HA ' ' OG ' ' E' ' 70' ' ' SER . 45.2 mtt -94.27 155.12 17.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.566 0.698 . . . . 0.0 112.674 -170.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 8' ' ' PHE . . . . . 0.513 ' CE1' HD21 ' E' ' 44' ' ' LEU . 55.8 t80 -59.64 142.74 52.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.341 -1.299 . . . . 0.0 112.24 -176.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 9' ' ' TRP . . . . . 0.539 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 88.4 t90 -134.27 142.08 47.19 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.9 140.08 8.4 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.188 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.677 HD23 HD13 ' D' ' 87' ' ' LEU . 56.8 tp -128.3 108.23 10.42 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.899 0.381 . . . . 0.0 110.077 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -86.49 101.41 13.15 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 13' ' ' MET . . . . . 0.59 ' HB3' HG23 ' D' ' 85' ' ' VAL . 27.4 tpp -92.0 129.36 37.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.377 -171.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 14' ' ' LYS . . . . . 0.481 ' HD2' ' N ' ' D' ' 14' ' ' LYS . 0.3 OUTLIER -95.69 140.69 22.44 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.806 179.418 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 15' ' ' PRO . . . . . 0.619 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 9.5 Cg_endo -53.57 121.81 10.17 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 123.609 2.873 . . . . 0.0 113.411 -175.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 16' ' ' GLU . . . . . 0.644 ' HA ' ' O ' ' D' ' 79' ' ' THR . 31.4 mt-10 61.44 47.01 7.06 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.956 177.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 17' ' ' ARG . . . . . 0.519 ' NE ' ' HA ' ' D' ' 17' ' ' ARG . 1.1 tpm_? -122.29 137.28 54.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.056 173.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 18' ' ' LYS . . . . . 0.667 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 88.4 mttt -108.77 121.48 45.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.723 0.297 . . . . 0.0 111.695 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -111.14 103.65 12.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.283 176.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 20' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 44.9 t -90.48 99.49 12.51 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 172.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -120.25 148.21 43.99 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.105 -168.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 19.3 m -93.48 141.24 28.69 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.478 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 23' ' ' ILE . . . . . 0.408 ' HB ' ' HA ' ' D' ' 71' ' ' LYS . 67.9 mt -89.93 117.04 32.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.082 0.468 . . . . 0.0 111.227 -173.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 24' ' ' ILE . . . . . 0.523 HD12 ' N ' ' D' ' 25' ' ' LYS . 1.4 pp -79.55 -27.61 12.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.782 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 25' ' ' LYS . . . . . 0.531 ' HE3' ' HB3' ' D' ' 91' ' ' LEU . 31.7 ttpt -155.31 136.18 13.64 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 39.3 m -58.31 130.06 44.93 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.68 0.613 . . . . 0.0 110.134 -178.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 27' ' ' PHE . . . . . 0.623 ' HB3' HD23 ' D' ' 91' ' ' LEU . 9.9 p90 -144.28 161.86 37.86 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -172.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 28' ' ' HIS . . . . . 0.595 ' HA ' ' O ' ' D' ' 67' ' ' LEU . 16.0 t60 -114.74 123.92 50.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.173 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 29' ' ' ILE . . . . . 0.569 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 37.7 mt -92.7 136.18 25.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 170.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 30' ' ' SER . . . . . 0.594 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 65.9 p -122.96 -20.23 5.86 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -170.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 31' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -154.78 146.22 14.04 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 119.425 -1.369 . . . . 0.0 113.409 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.504 HG23 ' HG ' ' D' ' 87' ' ' LEU . 14.2 p -139.95 126.8 23.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 170.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 33' ' ' ALA . . . . . 0.404 ' HA ' HG21 ' D' ' 56' ' ' VAL . . . -148.87 158.14 43.94 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.8 -0.562 . . . . 0.0 111.654 -174.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 34' ' ' LEU . . . . . 0.584 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.0 pp -118.89 139.24 51.96 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.682 0.753 . . . . 0.0 111.431 178.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -108.21 -51.25 2.92 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.333 173.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -102.36 128.02 49.12 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 170.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 37' ' ' GLY . . . . . 0.496 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 145.1 162.41 9.56 Favored Glycine 0 N--CA 1.438 -1.167 0 C-N-CA 119.867 -1.159 . . . . 0.0 113.065 176.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -102.73 -46.66 4.65 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.609 0.242 . . . . 0.0 111.581 177.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -150.72 130.82 13.49 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.769 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 40' ' ' ALA . . . . . 0.479 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -130.79 113.0 13.56 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.492 0.663 . . . . 0.0 110.2 169.03 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' D' ' 79' ' ' THR . 4.5 mptp? -95.37 106.38 18.43 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 174.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.509 HD23 ' HB ' ' D' ' 53' ' ' VAL . 41.9 tp -78.88 113.96 17.41 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -176.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -114.79 135.95 53.62 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.336 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.594 ' HB3' HG22 ' D' ' 53' ' ' VAL . 4.9 tp -115.82 116.07 27.37 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.444 176.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 45' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -103.28 103.68 13.73 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.45 ' HB2' HD11 ' D' ' 44' ' ' LEU . . . -130.55 140.83 50.47 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.052 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 58.1 32.4 21.95 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.652 0.739 . . . . 0.0 109.365 -175.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 62.4 mttp 57.44 37.04 27.7 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 114.854 -1.067 . . . . 0.0 111.547 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 49' ' ' GLN . . . . . 0.515 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 6.6 tp-100 -127.69 131.78 49.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.573 176.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -87.42 112.35 22.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.383 -177.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -108.46 131.44 54.8 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.743 177.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -78.84 100.36 3.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 169.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 53' ' ' VAL . . . . . 0.594 HG22 ' HB3' ' D' ' 44' ' ' LEU . 0.9 OUTLIER -72.34 -51.49 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.988 -174.174 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 54' ' ' ALA . . . . . 0.58 ' HA ' ' OE1' ' C' ' 62' ' ' GLN . . . -154.46 132.38 11.6 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.538 -177.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 7.6 t -101.89 102.47 13.04 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 174.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 56' ' ' VAL . . . . . 0.432 HG13 ' HB3' ' D' ' 40' ' ' ALA . 7.1 p -116.69 109.76 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-O 122.039 0.923 . . . . 0.0 110.052 -176.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 57' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' D' ' 61' ' ' PRO . 67.3 p -122.64 -176.99 3.52 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.347 -176.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -65.03 -20.68 66.61 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.541 169.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.76 -40.84 27.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.265 0.555 . . . . 0.0 110.07 176.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 74.6 mt -118.73 77.64 14.87 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 172.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 61' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' D' ' 57' ' ' THR . 9.7 Cg_exo -71.7 0.88 6.35 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.159 2.573 . . . . 0.0 113.651 -168.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 62' ' ' GLN . . . . . 0.492 ' OE1' ' HA ' ' E' ' 54' ' ' ALA . 10.3 tt0 -160.09 114.77 2.28 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.274 -170.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.49 HG11 ' HB1' ' D' ' 54' ' ' ALA . 86.1 t -112.84 115.06 48.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.104 0.478 . . . . 0.0 111.236 177.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.87 115.92 28.34 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 171.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 65' ' ' LEU . . . . . 0.437 HD23 ' H ' ' D' ' 65' ' ' LEU . 0.7 OUTLIER -134.55 168.32 19.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.777 0.322 . . . . 0.0 111.092 -171.727 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 66' ' ' ASP . . . . . 0.545 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 7.5 t0 -122.91 109.39 14.09 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.127 0.489 . . . . 0.0 110.365 -178.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.693 HD21 HD23 ' C' ' 88' ' ' LEU . 12.8 mt -124.0 138.9 54.39 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.712 176.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -138.57 114.61 10.13 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 173.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -109.16 163.07 13.68 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.315 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 70' ' ' SER . . . . . 0.577 ' OG ' ' HA ' ' C' ' 7' ' ' MET . 4.4 m -117.21 149.06 41.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.186 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 71' ' ' LYS . . . . . 0.408 ' HA ' ' HB ' ' D' ' 23' ' ' ILE . 0.0 OUTLIER -70.05 -6.14 31.63 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.72 -177.104 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.68 -28.62 46.37 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.319 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -101.12 171.31 7.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.757 0.313 . . . . 0.0 110.449 -176.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -137.31 136.49 38.03 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 75' ' ' ILE . . . . . 0.462 ' HB ' ' CD1' ' D' ' 44' ' ' LEU . 22.6 pt -133.03 158.36 43.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.014 0.435 . . . . 0.0 111.642 -169.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 76' ' ' MET . . . . . 0.412 ' HA ' ' HA ' ' D' ' 20' ' ' SER . 65.4 ttp -117.43 118.08 31.24 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.372 176.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 77' ' ' PHE . . . . . 0.479 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.4 OUTLIER -105.57 129.42 53.83 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.789 -177.812 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 78' ' ' TYR . . . . . 0.667 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 39.0 p90 -155.76 162.78 40.45 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.881 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 79' ' ' THR . . . . . 0.644 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 12.6 p -125.22 143.87 50.74 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.116 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.35 149.61 26.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.097 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.87 -177.05 36.77 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -176.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -114.4 102.58 10.22 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.242 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 83' ' ' ALA . . . . . 0.619 ' H ' ' HB3' ' D' ' 15' ' ' PRO . . . -166.69 150.13 6.94 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.385 168.067 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 6.2 p -106.1 122.25 45.81 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.59 HG23 ' HB3' ' D' ' 13' ' ' MET . 13.4 m -121.65 144.19 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-O 121.203 0.525 . . . . 0.0 111.792 -172.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 43.6 m -105.1 122.79 46.63 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.322 175.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 87' ' ' LEU . . . . . 0.677 HD13 HD23 ' D' ' 11' ' ' LEU . 5.1 mp -95.22 143.97 26.2 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 170.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.684 HD23 HD21 ' E' ' 67' ' ' LEU . 0.9 OUTLIER -130.4 141.18 50.55 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.175 -178.686 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.58 -166.84 27.33 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.756 -177.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -147.05 133.51 19.69 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.437 0.637 . . . . 0.0 111.113 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 91' ' ' LEU . . . . . 0.623 HD23 ' HB3' ' D' ' 27' ' ' PHE . 15.1 mt -69.77 128.86 37.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.065 175.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 92' ' ' HIS . . . . . 0.408 ' CG ' ' HB2' ' C' ' 4' ' ' ALA . 38.7 t-80 -81.84 108.2 15.18 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.07 0.462 . . . . 0.0 111.094 -173.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -108.12 -79.36 0.58 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 168.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 94' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' D' ' 3' ' ' GLY . 50.6 mm 62.09 100.14 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.318 176.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 95' ' ' ASP . . . . . 0.432 ' OD2' ' HB2' ' D' ' 5' ' ' MET . 27.8 m-20 -76.44 133.73 39.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.588 -178.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 23.3 t -91.09 86.97 6.38 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.25 -50.72 64.55 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.035 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 10.5 m . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.996 177.541 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 51.6 p90 . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 120.89 0.376 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -90.64 -29.38 17.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.828 176.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 3' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' E' ' 94' ' ' ILE . . . 77.45 -60.84 3.61 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.461 177.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 4' ' ' ALA . . . . . 0.421 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . . . -82.19 71.82 9.25 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.153 0.501 . . . . 0.0 111.014 -178.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 5' ' ' MET . . . . . 0.42 ' HB2' ' OD2' ' E' ' 95' ' ' ASP . 13.0 tpt -82.16 -4.02 56.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.221 173.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.3 107.28 0.87 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.058 177.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 7' ' ' MET . . . . . 0.535 ' HA ' ' OG ' ' A' ' 70' ' ' SER . 45.2 mtt -94.36 155.07 17.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.653 0.739 . . . . 0.0 112.626 -170.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 8' ' ' PHE . . . . . 0.469 ' CE1' HD21 ' A' ' 44' ' ' LEU . 55.6 t80 -59.64 142.7 52.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.291 -1.322 . . . . 0.0 112.293 -176.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 9' ' ' TRP . . . . . 0.528 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 88.6 t90 -134.21 142.04 47.25 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.84 140.06 8.4 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.162 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 11' ' ' LEU . . . . . 0.687 HD23 HD13 ' E' ' 87' ' ' LEU . 56.8 tp -128.36 108.32 10.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.966 0.412 . . . . 0.0 110.101 178.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -86.45 101.34 13.06 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 175.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 13' ' ' MET . . . . . 0.588 ' HB3' HG23 ' E' ' 85' ' ' VAL . 27.3 tpp -91.99 129.41 37.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.419 -171.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 14' ' ' LYS . . . . . 0.474 ' HD2' ' N ' ' E' ' 14' ' ' LYS . 0.3 OUTLIER -95.68 140.69 22.44 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.843 179.394 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' E' E ' 15' ' ' PRO . . . . . 0.603 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 9.5 Cg_endo -53.63 121.79 10.14 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 123.508 2.805 . . . . 0.0 113.514 -175.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 16' ' ' GLU . . . . . 0.648 ' HA ' ' O ' ' E' ' 79' ' ' THR . 31.3 mt-10 61.54 47.06 6.84 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.887 177.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 17' ' ' ARG . . . . . 0.52 ' NE ' ' HA ' ' E' ' 17' ' ' ARG . 1.2 tpm_? -122.41 137.34 54.9 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 173.252 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 18' ' ' LYS . . . . . 0.661 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 88.6 mttt -108.83 121.51 45.24 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -111.11 103.64 12.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.213 176.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 20' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' E' ' 76' ' ' MET . 44.5 t -90.46 99.39 12.43 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 172.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -120.22 148.11 44.09 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.523 0.678 . . . . 0.0 112.093 -168.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 19.8 m -93.46 141.22 28.7 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.469 176.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 67.8 mt -89.84 117.08 32.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.044 0.449 . . . . 0.0 111.284 -173.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 24' ' ' ILE . . . . . 0.522 HD12 ' N ' ' E' ' 25' ' ' LYS . 1.4 pp -79.67 -27.54 12.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.721 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 25' ' ' LYS . . . . . 0.522 ' N ' HD12 ' E' ' 24' ' ' ILE . 31.7 ttpt -155.37 136.14 13.55 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 26' ' ' SER . . . . . 0.401 ' HB2' ' HB3' ' D' ' 4' ' ' ALA . 39.6 m -58.3 130.09 45.07 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.654 0.596 . . . . 0.0 110.08 -178.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 27' ' ' PHE . . . . . 0.635 ' HB3' HD23 ' E' ' 91' ' ' LEU . 10.0 p90 -144.24 161.92 37.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -172.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 28' ' ' HIS . . . . . 0.603 ' HA ' ' O ' ' E' ' 67' ' ' LEU . 16.0 t60 -114.85 123.87 50.27 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.172 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 29' ' ' ILE . . . . . 0.575 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 38.1 mt -92.67 136.25 25.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 170.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 30' ' ' SER . . . . . 0.58 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 65.5 p -122.94 -20.26 5.86 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -170.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 31' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -154.81 146.23 14.06 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 119.36 -1.4 . . . . 0.0 113.365 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.495 HG23 ' HG ' ' E' ' 87' ' ' LEU . 14.4 p -140.02 126.84 23.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 170.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 33' ' ' ALA . . . . . 0.417 ' HA ' HG21 ' E' ' 56' ' ' VAL . . . -148.84 158.17 43.97 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 121.861 -0.524 . . . . 0.0 111.649 -174.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 34' ' ' LEU . . . . . 0.592 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.0 pp -119.0 139.21 52.07 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.713 0.768 . . . . 0.0 111.445 178.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -108.06 -51.29 2.92 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.392 173.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -102.38 127.94 49.17 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 170.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 37' ' ' GLY . . . . . 0.506 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 145.17 162.49 9.62 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 119.916 -1.135 . . . . 0.0 113.04 176.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -102.8 -46.65 4.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.536 0.208 . . . . 0.0 111.539 177.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -150.75 130.84 13.48 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.712 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 40' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -130.8 113.06 13.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.555 0.693 . . . . 0.0 110.175 168.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 41' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' E' ' 79' ' ' THR . 4.5 mptp? -95.42 106.43 18.49 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 174.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.514 HD23 ' HB ' ' E' ' 53' ' ' VAL . 41.7 tp -78.82 114.04 17.41 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -176.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -114.93 135.93 53.67 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.24 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 44' ' ' LEU . . . . . 0.602 ' HB3' HG22 ' E' ' 53' ' ' VAL . 5.0 tp -115.75 116.01 27.32 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.575 176.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 45' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -103.27 103.68 13.73 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 176.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 46' ' ' ALA . . . . . 0.442 ' HB2' HD11 ' E' ' 44' ' ' LEU . . . -130.54 140.74 50.48 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.168 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 58.2 32.33 21.89 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.61 0.719 . . . . 0.0 109.368 -175.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 62.4 mttp 57.43 37.1 27.73 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.479 -178.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 49' ' ' GLN . . . . . 0.52 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 6.6 tp-100 -127.65 131.74 49.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.612 176.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -87.37 112.24 21.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.43 -177.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -108.36 131.35 54.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.776 177.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -78.8 100.42 3.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 169.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 53' ' ' VAL . . . . . 0.602 HG22 ' HB3' ' E' ' 44' ' ' LEU . 0.9 OUTLIER -72.35 -51.49 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.998 -174.243 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' E' E ' 54' ' ' ALA . . . . . 0.492 ' HA ' ' OE1' ' D' ' 62' ' ' GLN . . . -154.51 132.53 11.67 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.513 -177.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 7.6 t -101.97 102.43 12.96 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 56' ' ' VAL . . . . . 0.428 HG13 ' HB3' ' E' ' 40' ' ' ALA . 7.1 p -116.62 109.72 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-O 122.048 0.928 . . . . 0.0 110.025 -176.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 57' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' E' ' 61' ' ' PRO . 68.3 p -122.62 -177.06 3.53 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.342 -176.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -64.98 -20.69 66.62 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.469 169.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.85 -40.82 27.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.313 0.577 . . . . 0.0 110.008 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 74.4 mt -118.66 77.6 14.61 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 172.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 61' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' E' ' 57' ' ' THR . 9.6 Cg_exo -71.69 0.89 6.33 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.095 2.53 . . . . 0.0 113.727 -168.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 62' ' ' GLN . . . . . 0.512 ' OE1' ' HA ' ' A' ' 54' ' ' ALA . 10.3 tt0 -160.11 114.66 2.26 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.792 0.329 . . . . 0.0 111.312 -170.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 63' ' ' VAL . . . . . 0.484 HG11 ' HB1' ' E' ' 54' ' ' ALA . 86.1 t -112.74 115.18 49.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.065 0.459 . . . . 0.0 111.199 177.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.11 115.99 28.36 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 171.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.429 HD23 ' H ' ' E' ' 65' ' ' LEU . 0.7 OUTLIER -134.55 168.22 19.36 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.058 -171.612 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' E' E ' 66' ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 7.5 t0 -122.84 109.43 14.17 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.144 0.497 . . . . 0.0 110.417 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 67' ' ' LEU . . . . . 0.684 HD21 HD23 ' D' ' 88' ' ' LEU . 12.8 mt -123.99 138.91 54.39 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.7 176.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -138.57 114.55 10.08 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 173.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -109.1 163.0 13.73 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.519 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 70' ' ' SER . . . . . 0.559 ' OG ' ' HA ' ' D' ' 7' ' ' MET . 4.5 m -117.09 149.0 41.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.185 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.99 -6.05 30.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.698 -177.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.87 -28.4 46.38 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.344 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -101.24 171.28 7.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.704 0.288 . . . . 0.0 110.364 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -137.32 136.53 38.06 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 75' ' ' ILE . . . . . 0.45 ' HB ' ' CD1' ' E' ' 44' ' ' LEU . 22.4 pt -133.04 158.37 43.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.947 0.403 . . . . 0.0 111.66 -169.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 76' ' ' MET . . . . . 0.432 ' HA ' ' HA ' ' E' ' 20' ' ' SER . 65.3 ttp -117.49 118.11 31.29 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.055 0.455 . . . . 0.0 110.339 176.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 77' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.4 OUTLIER -105.59 129.47 53.84 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.693 -177.747 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' E' E ' 78' ' ' TYR . . . . . 0.661 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 38.8 p90 -155.76 162.68 40.47 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.838 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 79' ' ' THR . . . . . 0.648 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 12.7 p -125.14 143.82 50.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.209 178.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.37 149.68 26.75 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.095 173.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.82 -176.91 36.73 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -176.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -114.45 102.76 10.38 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.14 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 83' ' ' ALA . . . . . 0.603 ' H ' ' HB3' ' E' ' 15' ' ' PRO . . . -166.78 150.05 6.79 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.477 168.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 6.2 p -106.14 122.24 45.8 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 85' ' ' VAL . . . . . 0.592 HG12 ' HB3' ' E' ' 34' ' ' LEU . 13.7 m -121.57 144.19 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 CA-C-O 121.161 0.505 . . . . 0.0 111.831 -172.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 44.3 m -105.23 122.84 46.77 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.274 175.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 87' ' ' LEU . . . . . 0.687 HD13 HD23 ' E' ' 11' ' ' LEU . 5.1 mp -95.16 143.9 26.21 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 170.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 88' ' ' LEU . . . . . 0.683 HD23 HD21 ' A' ' 67' ' ' LEU . 0.9 OUTLIER -130.42 141.25 50.55 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.134 -178.664 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.67 -166.88 27.49 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.678 -177.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 90' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -147.05 133.59 19.78 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.469 0.652 . . . . 0.0 111.066 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 91' ' ' LEU . . . . . 0.635 HD23 ' HB3' ' E' ' 27' ' ' PHE . 15.1 mt -69.74 128.77 37.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.117 175.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 92' ' ' HIS . . . . . 0.426 ' CG ' ' HB2' ' D' ' 4' ' ' ALA . 38.6 t-80 -81.83 108.28 15.23 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.075 0.465 . . . . 0.0 111.105 -173.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -108.2 -79.45 0.58 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 168.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 94' ' ' ILE . . . . . 0.503 ' HA ' ' O ' ' E' ' 3' ' ' GLY . 50.5 mm 62.18 99.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 O-C-N 123.793 0.683 . . . . 0.0 111.385 176.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 95' ' ' ASP . . . . . 0.42 ' OD2' ' HB2' ' E' ' 5' ' ' MET . 28.7 m-20 -76.33 133.67 39.93 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.681 -178.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 23.3 t -91.11 87.05 6.4 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 176.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.34 -50.61 65.75 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.038 -179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 10.8 m . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.085 -0.959 . . . . 0.0 110.976 177.497 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 54.6 mtt . . . . . 0 C--O 1.224 -0.263 0 CA-C-O 120.715 0.293 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.519 ' CE1' HD21 ' B' ' 44' ' ' LEU . 81.2 t80 -58.7 142.66 49.16 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -172.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.509 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 89.3 t90 -140.08 147.73 40.71 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.131 178.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.413 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -149.93 154.07 25.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.114 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.631 HD23 HD13 ' A' ' 87' ' ' LEU . 51.2 tp -146.61 109.05 4.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.818 0.342 . . . . 0.0 111.237 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -91.47 114.11 26.55 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.375 0.607 . . . . 0.0 111.093 176.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.539 ' HB2' HG23 ' A' ' 85' ' ' VAL . 3.5 mmt -93.15 137.32 32.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.016 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -100.64 153.34 37.79 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 171.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.441 ' HB3' ' HA ' ' A' ' 82' ' ' ASP . 84.1 Cg_exo -46.83 111.34 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.993 2.462 . . . . 0.0 113.096 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.686 ' HA ' ' O ' ' A' ' 79' ' ' THR . 39.6 mt-10 65.95 59.13 0.72 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.498 0.666 . . . . 0.0 111.356 177.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.43 ' HD3' ' HA ' ' A' ' 17' ' ' ARG . 70.5 mmt-85 -113.3 145.44 41.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.038 172.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.669 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 33.8 ttmt -128.02 111.27 13.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.308 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.414 ' OH ' ' HA ' ' A' ' 13' ' ' MET . 5.6 m-85 -108.69 104.12 13.34 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.686 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.417 ' HB3' ' SD ' ' A' ' 76' ' ' MET . 9.2 p -88.04 99.9 12.52 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 173.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -125.43 138.7 54.02 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.591 0.71 . . . . 0.0 112.378 -167.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 t -85.0 160.24 20.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.751 177.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.403 ' CD1' ' HB3' ' A' ' 69' ' ' PHE . 53.0 mt -114.14 116.74 53.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.005 0.431 . . . . 0.0 110.862 -176.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.754 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -104.0 -10.15 9.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.248 176.469 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.612 ' HD3' HD22 ' A' ' 91' ' ' LEU . 2.6 ptpp? -142.62 119.35 11.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.794 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.0 m -64.61 135.4 55.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.182 -177.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.78 ' HB3' HD23 ' A' ' 91' ' ' LEU . 19.2 p90 -147.25 160.78 42.09 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -174.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.49 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 5.3 t60 -114.87 128.07 56.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.405 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 56.5 mt -94.63 136.45 25.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 171.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.519 ' HB2' ' HB3' ' B' ' 66' ' ' ASP . 72.7 p -119.81 -16.74 8.69 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -170.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -163.78 144.85 9.84 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 119.365 -1.397 . . . . 0.0 113.5 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.448 HG23 ' HG ' ' A' ' 87' ' ' LEU . 12.4 p -129.02 125.71 63.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 170.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.66 152.18 41.02 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.606 -174.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.573 ' HB3' HG12 ' A' ' 85' ' ' VAL . 3.5 pp -114.26 137.9 51.18 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.871 0.843 . . . . 0.0 111.81 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -106.04 -55.35 2.34 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.436 175.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -101.98 126.87 49.01 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.745 170.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.458 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 147.96 162.51 10.16 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 119.612 -1.28 . . . . 0.0 113.561 176.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.442 ' O ' ' HG3' ' A' ' 58' ' ' LYS . 39.5 mt-30 -102.82 -48.13 4.18 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 178.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -151.77 134.49 15.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.382 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.561 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -135.39 117.46 15.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.376 0.608 . . . . 0.0 111.112 172.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 79' ' ' THR . 48.3 mttm -97.65 116.02 29.06 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 173.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.429 HD21 HD21 ' A' ' 87' ' ' LEU . 53.8 tp -91.44 105.4 17.74 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.154 0.502 . . . . 0.0 110.037 -173.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.408 ' HB2' ' CE2' ' A' ' 78' ' ' TYR . 96.9 m-85 -103.43 150.91 23.39 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.256 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.627 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 1.1 tp -133.5 117.41 17.12 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.701 176.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -102.06 104.32 14.96 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.425 0.631 . . . . 0.0 109.615 175.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.513 ' HB2' HD11 ' A' ' 44' ' ' LEU . . . -134.28 152.18 51.68 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 57.79 24.14 10.41 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -174.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 58.45 42.24 21.47 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.286 -175.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 28.2 tp60 -137.62 131.85 32.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.562 178.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -79.58 107.1 12.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.916 0.389 . . . . 0.0 110.45 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.405 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 74.5 m-85 -100.16 129.32 46.17 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.051 176.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 tp -89.95 99.89 10.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 172.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.475 ' CG1' ' HB3' ' A' ' 44' ' ' LEU . 2.6 m -84.27 -33.79 9.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.131 -169.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.524 ' HB2' HD13 ' A' ' 65' ' ' LEU . . . -159.3 148.93 18.66 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.117 0.484 . . . . 0.0 111.885 177.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.2 m -117.39 102.96 9.66 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 170.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.42 ' CG1' HG11 ' A' ' 85' ' ' VAL . 6.7 p -110.6 116.26 51.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.439 0.638 . . . . 0.0 110.224 -176.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.8 p -122.7 -177.48 3.66 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.297 -175.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 38' ' ' GLN . 52.7 mtmt -59.8 -33.68 72.05 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.99 0.424 . . . . 0.0 110.288 169.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.93 -40.81 68.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.39 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.6 mt -116.6 80.14 10.17 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 174.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -72.38 0.23 7.73 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.804 2.336 . . . . 0.0 113.927 -167.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -162.43 119.21 2.0 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.126 0.489 . . . . 0.0 110.875 -176.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.457 HG11 ' HB1' ' A' ' 54' ' ' ALA . 92.8 t -110.2 101.67 12.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.216 175.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.14 111.36 17.51 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 173.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.524 HD13 ' HB2' ' A' ' 54' ' ' ALA . 1.0 OUTLIER -133.05 150.78 52.09 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.079 -171.254 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.544 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 11.7 t0 -96.0 99.14 10.94 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.345 0.593 . . . . 0.0 110.006 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.557 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 4.2 mt -113.21 141.8 46.54 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.491 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.624 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 6.2 t30 -148.87 132.46 16.79 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.1 177.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.513 ' CZ ' HD22 ' A' ' 67' ' ' LEU . 63.4 m-85 -127.54 158.02 38.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.831 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.9 p -120.97 154.86 35.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.386 178.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.465 ' HD3' ' H ' ' A' ' 71' ' ' LYS . 0.2 OUTLIER -70.9 11.48 0.38 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -174.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.03 -29.48 9.69 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.678 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -101.53 163.11 12.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.942 0.371 . . . . 0.0 110.929 -175.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -123.14 111.42 16.49 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.444 HG22 ' CB ' ' A' ' 46' ' ' ALA . 27.9 pt -111.15 161.43 9.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.122 0.487 . . . . 0.0 111.71 -168.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.417 ' SD ' ' HB3' ' A' ' 20' ' ' SER . 4.9 mtm -121.84 124.86 45.13 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 173.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.627 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -105.05 128.16 53.2 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.162 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.669 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 30.1 p90 -151.06 138.93 19.88 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.137 -0.625 . . . . 0.0 112.055 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.686 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 11.3 p -109.72 137.54 47.38 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.878 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.68 157.22 18.73 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.588 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.73 -173.9 35.6 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -176.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.441 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 11.6 m-20 -114.05 103.17 10.87 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.843 177.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -172.31 155.14 3.46 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.153 171.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.5 t -110.41 114.46 27.92 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.573 HG12 ' HB3' ' A' ' 34' ' ' LEU . 6.8 m -112.98 143.49 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-O 121.357 0.599 . . . . 0.0 112.15 -174.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.8 t -108.86 118.65 37.34 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.72 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.631 HD13 HD23 ' A' ' 11' ' ' LEU . 5.2 mp -94.04 151.9 19.19 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.41 ' CD2' HD21 ' B' ' 67' ' ' LEU . 2.2 tp -134.31 145.96 49.54 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.177 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.68 -167.52 29.44 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.455 -0.878 . . . . 0.0 112.084 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.611 ' CD2' ' HB3' ' B' ' 68' ' ' ASN . 8.7 p90 -151.54 130.23 12.33 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.732 0.777 . . . . 0.0 111.85 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.78 HD23 ' HB3' ' A' ' 27' ' ' PHE . 6.2 mt . . . . . 0 C--N 1.321 -0.671 0 CA-C-N 114.121 -1.399 . . . . 0.0 109.595 175.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 54.6 mtt . . . . . 0 C--O 1.225 -0.197 0 CA-C-O 120.876 0.369 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . 0.53 ' CE1' HD21 ' C' ' 44' ' ' LEU . 80.5 t80 -58.85 142.76 49.61 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -172.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . 0.509 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 89.2 t90 -140.11 147.67 40.56 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.141 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.439 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -149.9 154.03 25.46 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.097 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.621 HD23 HD13 ' B' ' 87' ' ' LEU . 51.7 tp -146.49 108.9 4.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.772 0.32 . . . . 0.0 111.296 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -91.34 114.06 26.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.332 0.587 . . . . 0.0 111.096 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . 0.558 ' HB2' HG23 ' B' ' 85' ' ' VAL . 3.5 mmt -93.17 137.27 32.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.964 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -100.55 153.38 37.78 Favored Pre-proline 0 C--N 1.317 -0.828 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 171.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.449 ' HB3' ' HA ' ' B' ' 82' ' ' ASP . 84.2 Cg_exo -46.77 111.21 0.35 Allowed 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 123.058 2.505 . . . . 0.0 113.15 -178.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.686 ' HA ' ' O ' ' B' ' 79' ' ' THR . 39.5 mt-10 66.01 59.11 0.71 Allowed 'General case' 0 C--O 1.233 0.224 0 O-C-N 123.693 0.621 . . . . 0.0 111.316 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.431 ' HD3' ' HA ' ' B' ' 17' ' ' ARG . 70.5 mmt-85 -113.28 145.47 40.98 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.037 172.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.664 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 33.9 ttmt -128.08 111.26 13.29 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.344 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' TYR . . . . . 0.423 ' OH ' ' HA ' ' B' ' 13' ' ' MET . 5.6 m-85 -108.68 104.05 13.27 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.687 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.415 ' HB3' ' SD ' ' B' ' 76' ' ' MET . 9.6 p -88.0 100.03 12.6 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 173.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -125.53 138.74 53.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.59 0.71 . . . . 0.0 112.335 -167.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 14.8 t -85.07 160.36 20.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.691 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.401 ' CD1' ' HB3' ' B' ' 69' ' ' PHE . 53.0 mt -114.11 116.76 53.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 120.973 0.416 . . . . 0.0 110.877 -176.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.758 ' H ' HD13 ' B' ' 24' ' ' ILE . 0.2 OUTLIER -104.05 -10.24 9.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.257 176.413 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.597 ' HD3' HD22 ' B' ' 91' ' ' LEU . 2.5 ptpp? -142.64 119.38 11.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.736 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 23.8 m -64.57 135.46 56.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.21 -177.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . 0.777 ' HB3' HD23 ' B' ' 91' ' ' LEU . 19.3 p90 -147.28 160.74 42.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.62 0.724 . . . . 0.0 112.908 -174.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' HIS . . . . . 0.495 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 5.3 t60 -114.85 128.06 56.08 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.418 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 56.5 mt -94.67 136.44 25.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 171.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.506 ' HB2' ' HB3' ' C' ' 66' ' ' ASP . 72.5 p -119.86 -16.64 8.67 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.961 -170.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -163.75 144.91 9.89 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 119.424 -1.369 . . . . 0.0 113.497 178.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.442 HG23 ' HG ' ' B' ' 87' ' ' LEU . 12.3 p -129.2 125.68 62.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 170.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.59 152.21 41.12 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 121.921 -0.487 . . . . 0.0 111.629 -174.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.591 ' HB3' HG12 ' B' ' 85' ' ' VAL . 3.5 pp -114.32 137.87 51.25 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.906 0.86 . . . . 0.0 111.781 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -105.94 -55.34 2.34 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.482 175.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -101.99 126.87 49.02 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.775 170.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.456 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 147.93 162.56 10.17 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 119.644 -1.265 . . . . 0.0 113.644 176.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . 0.44 ' O ' ' HG3' ' B' ' 58' ' ' LYS . 39.3 mt-30 -102.74 -48.14 4.19 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 178.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -151.86 134.47 15.45 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.433 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.559 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -135.37 117.39 15.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.39 0.614 . . . . 0.0 111.031 172.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' B' ' 79' ' ' THR . 48.3 mttm -97.58 116.01 28.98 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 173.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.427 HD21 HD21 ' B' ' 87' ' ' LEU . 53.7 tp -91.37 105.24 17.63 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.156 0.503 . . . . 0.0 110.111 -173.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . 0.415 ' HB2' ' CE2' ' B' ' 78' ' ' TYR . 96.9 m-85 -103.41 150.91 23.38 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.203 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.631 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 1.1 tp -133.55 117.36 17.02 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.619 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -102.03 104.25 14.9 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.382 0.611 . . . . 0.0 109.574 175.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.504 ' HB2' HD11 ' B' ' 44' ' ' LEU . . . -134.24 152.3 51.75 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.047 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 57.67 24.19 10.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.132 0.491 . . . . 0.0 109.729 -174.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 58.38 42.34 21.54 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.321 -175.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . 0.497 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 28.3 tp60 -137.67 131.8 31.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.55 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -79.55 107.16 12.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.815 0.341 . . . . 0.0 110.428 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.413 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 74.6 m-85 -100.26 129.27 46.24 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.004 176.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 tp -89.84 99.93 10.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 172.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.47 ' CG1' ' HB3' ' B' ' 44' ' ' LEU . 2.6 m -84.25 -33.88 9.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.088 -169.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.498 ' HB2' HD13 ' B' ' 65' ' ' LEU . . . -159.3 148.94 18.66 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.026 0.441 . . . . 0.0 111.959 177.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 92.6 m -117.44 102.88 9.57 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 170.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . 0.419 ' CG1' HG11 ' B' ' 85' ' ' VAL . 6.7 p -110.57 116.21 51.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.471 0.653 . . . . 0.0 110.225 -176.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 74.4 p -122.69 -177.42 3.64 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.305 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' B' ' 38' ' ' GLN . 52.6 mtmt -59.88 -33.72 72.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.963 0.411 . . . . 0.0 110.285 169.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.86 -40.75 68.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.472 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 74.9 mt -116.66 80.15 10.31 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 174.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -72.4 0.13 7.9 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.923 2.415 . . . . 0.0 113.881 -166.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -162.4 119.24 2.01 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.299 0.571 . . . . 0.0 110.866 -176.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.442 HG11 ' HB1' ' B' ' 54' ' ' ALA . 92.3 t -110.2 101.67 12.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.2 176.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.14 111.29 17.44 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 173.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.498 HD13 ' HB2' ' B' ' 54' ' ' ALA . 1.0 OUTLIER -133.03 150.75 52.11 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.167 -171.295 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 11.7 t0 -96.0 99.14 10.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.399 0.619 . . . . 0.0 109.993 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.572 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 4.2 mt -113.19 141.8 46.52 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.424 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . 0.611 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 6.2 t30 -148.9 132.49 16.79 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.174 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . 0.527 ' CZ ' HD22 ' B' ' 67' ' ' LEU . 63.5 m-85 -127.6 158.08 38.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.825 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 4.8 p -121.05 154.92 35.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.304 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . 0.469 ' H ' ' HD3' ' B' ' 71' ' ' LYS . 0.2 OUTLIER -70.92 11.47 0.39 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -174.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.06 -29.52 9.64 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.673 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -101.48 163.13 12.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.785 0.326 . . . . 0.0 110.918 -175.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -123.12 111.48 16.58 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 177.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.443 HG22 ' CB ' ' B' ' 46' ' ' ALA . 27.8 pt -111.2 161.41 9.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.092 0.472 . . . . 0.0 111.704 -168.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.415 ' SD ' ' HB3' ' B' ' 20' ' ' SER . 4.9 mtm -121.82 124.77 44.95 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 173.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . 0.631 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.5 OUTLIER -104.96 128.16 53.11 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.113 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.664 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 30.2 p90 -151.04 138.89 19.86 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.023 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.686 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 11.2 p -109.73 137.5 47.45 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.953 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.48 157.12 18.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.632 176.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.74 -173.76 35.44 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -176.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' ASP . . . . . 0.449 ' HA ' ' HB3' ' B' ' 15' ' ' PRO . 11.7 m-20 -114.14 103.14 10.82 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.763 178.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.559 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -172.31 155.18 3.47 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.131 171.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 24.4 t -110.41 114.32 27.66 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.591 HG12 ' HB3' ' B' ' 34' ' ' LEU . 6.8 m -112.86 143.62 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 CA-C-O 121.416 0.627 . . . . 0.0 112.198 -174.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 11.9 t -108.99 118.73 37.55 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.664 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.621 HD13 HD23 ' B' ' 11' ' ' LEU . 5.2 mp -94.17 151.87 19.15 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 174.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.4 ' CD2' HD21 ' C' ' 67' ' ' LEU . 2.2 tp -134.25 145.97 49.63 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.124 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.73 -167.51 29.46 Favored Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.053 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' TYR . . . . . 0.599 ' CD2' ' HB3' ' C' ' 68' ' ' ASN . 8.7 p90 -151.62 130.29 12.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.798 0.808 . . . . 0.0 111.842 177.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . 0.777 HD23 ' HB3' ' B' ' 27' ' ' PHE . 6.3 mt . . . . . 0 C--N 1.321 -0.631 0 CA-C-N 114.023 -1.444 . . . . 0.0 109.555 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 54.7 mtt . . . . . 0 C--O 1.225 -0.192 0 CA-C-O 120.736 0.303 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 8' ' ' PHE . . . . . 0.511 ' CE1' HD21 ' D' ' 44' ' ' LEU . 80.8 t80 -58.83 142.74 49.56 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -172.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . 0.51 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 89.1 t90 -140.11 147.67 40.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.169 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . 0.421 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -149.86 153.99 25.43 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.189 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.648 HD23 HD13 ' C' ' 87' ' ' LEU . 51.5 tp -146.52 109.0 4.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.77 0.319 . . . . 0.0 111.235 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -91.53 114.2 26.67 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.461 0.648 . . . . 0.0 111.005 176.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 13' ' ' MET . . . . . 0.543 ' HB2' HG23 ' C' ' 85' ' ' VAL . 3.5 mmt -93.21 137.29 32.68 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.006 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -100.56 153.29 37.83 Favored Pre-proline 0 C--N 1.318 -0.798 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 171.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . 0.44 ' HB3' ' HA ' ' C' ' 82' ' ' ASP . 85.4 Cg_exo -46.76 111.34 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.056 2.504 . . . . 0.0 113.183 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . 0.69 ' HA ' ' O ' ' C' ' 79' ' ' THR . 39.7 mt-10 65.83 59.2 0.74 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.471 0.653 . . . . 0.0 111.414 178.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 17' ' ' ARG . . . . . 0.441 ' HD3' ' HA ' ' C' ' 17' ' ' ARG . 70.4 mmt-85 -113.35 145.46 41.06 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.932 172.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 18' ' ' LYS . . . . . 0.671 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 33.8 ttmt -128.08 111.28 13.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.304 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . 0.416 ' OH ' ' HA ' ' C' ' 13' ' ' MET . 5.6 m-85 -108.69 104.06 13.28 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.695 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . 0.418 ' HB3' ' SD ' ' C' ' 76' ' ' MET . 9.4 p -87.94 99.9 12.49 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 173.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -125.47 138.62 54.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.564 0.697 . . . . 0.0 112.368 -167.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 14.8 t -85.03 160.37 20.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.665 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . 0.4 ' CD1' ' HB3' ' C' ' 69' ' ' PHE . 53.2 mt -114.15 116.81 53.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.915 0.388 . . . . 0.0 110.793 -176.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . 0.764 ' H ' HD13 ' C' ' 24' ' ' ILE . 0.2 OUTLIER -104.0 -10.17 9.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.257 176.362 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . 0.607 ' HD3' HD22 ' C' ' 91' ' ' LEU . 2.5 ptpp? -142.63 119.34 11.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.763 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 24.0 m -64.65 135.41 55.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.185 -177.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 27' ' ' PHE . . . . . 0.777 ' HB3' HD23 ' C' ' 91' ' ' LEU . 19.2 p90 -147.19 160.73 42.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.62 0.724 . . . . 0.0 112.924 -174.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 28' ' ' HIS . . . . . 0.5 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 5.4 t60 -114.89 128.05 56.06 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.38 177.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 56.7 mt -94.61 136.48 25.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 171.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.521 ' HB2' ' HB3' ' D' ' 66' ' ' ASP . 72.8 p -119.89 -16.66 8.65 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.97 -170.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 31' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -163.75 144.97 9.95 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 119.45 -1.357 . . . . 0.0 113.457 178.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.441 HG23 ' HG ' ' C' ' 87' ' ' LEU . 12.2 p -129.21 125.68 62.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 170.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.65 152.28 41.16 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.612 -174.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.593 ' HB3' HG12 ' C' ' 85' ' ' VAL . 3.5 pp -114.27 137.85 51.25 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.896 0.855 . . . . 0.0 111.794 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -106.03 -55.27 2.35 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.218 -1.356 . . . . 0.0 108.459 175.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -102.02 126.85 49.05 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.765 170.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 37' ' ' GLY . . . . . 0.448 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 147.95 162.56 10.18 Favored Glycine 0 N--CA 1.438 -1.189 0 C-N-CA 119.602 -1.285 . . . . 0.0 113.617 176.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 38' ' ' GLN . . . . . 0.443 ' O ' ' HG3' ' C' ' 58' ' ' LYS . 39.3 mt-30 -102.88 -48.1 4.18 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 178.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -151.84 134.54 15.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.405 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.554 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -135.42 117.44 15.33 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.363 0.601 . . . . 0.0 111.093 172.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' C' ' 79' ' ' THR . 48.2 mttm -97.72 116.0 29.08 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 173.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.411 HD21 HD21 ' C' ' 87' ' ' LEU . 54.0 tp -91.44 105.4 17.74 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.12 0.486 . . . . 0.0 110.001 -173.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 43' ' ' TYR . . . . . 0.418 ' HB2' ' CE2' ' C' ' 78' ' ' TYR . 96.9 m-85 -103.49 150.83 23.51 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.218 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.63 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 1.1 tp -133.44 117.4 17.16 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.66 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -102.07 104.24 14.86 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.349 0.595 . . . . 0.0 109.582 175.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.503 ' HB2' HD11 ' C' ' 44' ' ' LEU . . . -134.21 152.21 51.71 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 57.74 24.11 10.3 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -174.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 58.43 42.33 21.42 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.255 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . 0.491 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 28.1 tp60 -137.65 131.91 32.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.628 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -79.72 107.17 12.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.804 0.335 . . . . 0.0 110.399 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . 0.439 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 74.7 m-85 -100.3 129.24 46.27 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.976 176.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 tp -89.83 99.88 10.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 172.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 53' ' ' VAL . . . . . 0.464 ' CG1' ' HB3' ' C' ' 44' ' ' LEU . 2.6 m -84.27 -33.77 9.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.129 -170.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 54' ' ' ALA . . . . . 0.508 ' HB2' HD13 ' C' ' 65' ' ' LEU . . . -159.37 148.96 18.55 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.093 0.473 . . . . 0.0 111.908 177.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 92.3 m -117.38 102.84 9.56 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 170.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . 0.42 ' CG1' HG11 ' C' ' 85' ' ' VAL . 6.7 p -110.6 116.35 52.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.498 0.666 . . . . 0.0 110.193 -176.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 74.3 p -122.75 -177.43 3.65 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.202 -175.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 58' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' C' ' 38' ' ' GLN . 52.6 mtmt -59.76 -33.71 72.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.119 0.485 . . . . 0.0 110.345 169.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.95 -40.79 68.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.371 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 74.4 mt -116.64 80.18 10.29 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -72.5 0.32 7.67 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.835 2.357 . . . . 0.0 113.831 -166.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -162.5 119.1 1.97 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.165 0.507 . . . . 0.0 110.86 -176.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.455 HG11 ' HB1' ' C' ' 54' ' ' ALA . 91.9 t -110.19 101.7 12.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.198 175.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.06 111.22 17.32 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 173.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . 0.508 HD13 ' HB2' ' C' ' 54' ' ' ALA . 1.0 OUTLIER -132.99 150.8 52.13 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.206 -171.396 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 66' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 11.6 t0 -96.02 99.18 10.97 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.415 0.626 . . . . 0.0 109.981 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.557 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 4.1 mt -113.25 141.87 46.48 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.427 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . 0.599 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 6.2 t30 -148.91 132.5 16.78 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.175 177.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 69' ' ' PHE . . . . . 0.515 ' CZ ' HD22 ' C' ' 67' ' ' LEU . 63.7 m-85 -127.65 157.95 38.88 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.795 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 4.8 p -120.96 154.91 35.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.329 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . 0.472 ' H ' ' HD3' ' C' ' 71' ' ' LYS . 0.2 OUTLIER -70.92 11.41 0.39 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -174.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.97 -29.61 9.62 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.688 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -101.36 163.11 12.43 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 122.575 -0.367 . . . . 0.0 111.039 -175.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -123.13 111.42 16.5 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.433 HG22 ' CB ' ' C' ' 46' ' ' ALA . 27.8 pt -111.09 161.38 9.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.142 0.496 . . . . 0.0 111.706 -168.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.418 ' SD ' ' HB3' ' C' ' 20' ' ' SER . 4.9 mtm -121.84 124.84 45.09 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 173.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 77' ' ' PHE . . . . . 0.63 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.5 OUTLIER -105.05 128.16 53.2 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.158 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 78' ' ' TYR . . . . . 0.671 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 30.3 p90 -151.08 138.9 19.84 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.217 -0.593 . . . . 0.0 112.008 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . 0.69 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 11.3 p -109.68 137.54 47.35 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.926 -179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.53 157.23 18.65 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.619 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.65 -173.85 35.67 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -176.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 82' ' ' ASP . . . . . 0.44 ' HA ' ' HB3' ' C' ' 15' ' ' PRO . 11.5 m-20 -114.05 103.14 10.84 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 119.601 -0.839 . . . . 0.0 109.8 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . 0.554 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -172.35 155.14 3.44 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.159 171.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 25.0 t -110.3 114.49 27.99 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.593 HG12 ' HB3' ' C' ' 34' ' ' LEU . 6.8 m -113.03 143.57 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 CA-C-O 121.419 0.628 . . . . 0.0 112.118 -174.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 12.0 t -108.94 118.75 37.61 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.617 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . 0.648 HD13 HD23 ' C' ' 11' ' ' LEU . 5.2 mp -94.15 151.89 19.15 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 174.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' C' ' 88' ' ' LEU . 2.2 tp -134.27 145.96 49.59 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.092 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.72 -167.51 29.46 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.228 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 90' ' ' TYR . . . . . 0.613 ' CD2' ' HB3' ' D' ' 68' ' ' ASN . 8.7 p90 -151.55 130.2 12.3 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.777 0.799 . . . . 0.0 111.901 177.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . 0.777 HD23 ' HB3' ' C' ' 27' ' ' PHE . 6.2 mt . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.643 175.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 54.6 mtt . . . . . 0 C--O 1.226 -0.134 0 CA-C-O 120.745 0.307 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 8' ' ' PHE . . . . . 0.519 ' CE1' HD21 ' E' ' 44' ' ' LEU . 81.0 t80 -58.7 142.66 49.15 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -172.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 9' ' ' TRP . . . . . 0.511 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 89.3 t90 -140.07 147.63 40.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.153 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . 0.438 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -149.84 154.0 25.45 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.215 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . 0.645 HD23 HD13 ' D' ' 87' ' ' LEU . 51.2 tp -146.55 109.0 4.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.777 0.322 . . . . 0.0 111.173 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -91.41 114.1 26.54 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.375 0.607 . . . . 0.0 111.134 176.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 13' ' ' MET . . . . . 0.544 ' HB2' HG23 ' D' ' 85' ' ' VAL . 3.5 mmt -93.12 137.33 32.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.017 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -100.6 153.37 37.78 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 171.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . 0.434 ' HB3' ' HA ' ' D' ' 82' ' ' ASP . 83.8 Cg_exo -46.82 111.4 0.38 Allowed 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.025 2.484 . . . . 0.0 113.103 -178.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . 0.68 ' HA ' ' O ' ' D' ' 79' ' ' THR . 39.6 mt-10 65.87 59.06 0.74 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.538 0.685 . . . . 0.0 111.446 177.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 17' ' ' ARG . . . . . 0.426 ' HA ' ' HD3' ' D' ' 17' ' ' ARG . 70.7 mmt-85 -113.29 145.35 41.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.02 172.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . 0.644 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 33.8 ttmt -127.95 111.22 13.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.331 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 19' ' ' TYR . . . . . 0.418 ' OH ' ' HA ' ' D' ' 13' ' ' MET . 5.6 m-85 -108.56 104.17 13.43 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.662 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . 0.419 ' HB3' ' SD ' ' D' ' 76' ' ' MET . 9.3 p -88.05 99.99 12.59 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 173.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -125.51 138.73 53.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.553 0.692 . . . . 0.0 112.324 -167.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 14.7 t -85.03 160.29 20.04 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.698 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . 0.402 ' CD1' ' HB3' ' D' ' 69' ' ' PHE . 53.4 mt -114.14 116.7 53.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.053 0.454 . . . . 0.0 110.845 -176.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . 0.772 ' H ' HD13 ' D' ' 24' ' ' ILE . 0.2 OUTLIER -103.9 -10.21 9.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.287 176.36 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . 0.591 ' HD3' HD22 ' D' ' 91' ' ' LEU . 2.5 ptpp? -142.65 119.35 11.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.751 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 23.9 m -64.65 135.44 55.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.246 -177.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 27' ' ' PHE . . . . . 0.774 ' HB3' HD23 ' D' ' 91' ' ' LEU . 19.2 p90 -147.23 160.69 42.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.664 0.745 . . . . 0.0 112.837 -174.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 28' ' ' HIS . . . . . 0.492 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 5.4 t60 -114.8 128.01 56.06 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.5 177.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 29' ' ' ILE . . . . . 0.567 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 56.6 mt -94.59 136.45 25.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 171.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . 0.492 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 72.7 p -119.77 -16.73 8.71 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -170.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 31' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -163.82 144.84 9.82 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 119.331 -1.414 . . . . 0.0 113.447 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.442 HG23 ' HG ' ' D' ' 87' ' ' LEU . 12.3 p -129.05 125.72 63.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 170.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.66 152.21 41.06 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 121.882 -0.512 . . . . 0.0 111.615 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 34' ' ' LEU . . . . . 0.582 ' HB3' HG12 ' D' ' 85' ' ' VAL . 3.5 pp -114.28 137.76 51.37 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 121.905 0.859 . . . . 0.0 111.845 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -105.84 -55.39 2.33 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.218 -1.356 . . . . 0.0 108.524 175.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -101.92 126.91 48.93 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.822 170.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . 0.451 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 147.87 162.57 10.17 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 119.622 -1.275 . . . . 0.0 113.614 176.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 38' ' ' GLN . . . . . 0.443 ' O ' ' HG3' ' D' ' 58' ' ' LYS . 39.3 mt-30 -102.84 -48.17 4.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -151.82 134.5 15.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.447 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . 0.539 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -135.34 117.54 15.52 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.428 0.633 . . . . 0.0 111.152 172.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' D' ' 79' ' ' THR . 48.3 mttm -97.79 116.06 29.25 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 173.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.43 HD21 HD21 ' D' ' 87' ' ' LEU . 53.7 tp -91.45 105.35 17.7 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.163 0.506 . . . . 0.0 110.051 -173.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 43' ' ' TYR . . . . . 0.418 ' HB2' ' CE2' ' D' ' 78' ' ' TYR . 96.9 m-85 -103.46 150.92 23.41 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.17 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.623 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 1.1 tp -133.54 117.35 17.01 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.728 177.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 45' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -102.03 104.3 14.94 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.423 0.63 . . . . 0.0 109.543 175.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.509 ' HB2' HD11 ' D' ' 44' ' ' LEU . . . -134.27 152.14 51.65 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 57.85 24.17 10.54 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -174.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 58.32 42.26 21.88 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.298 -175.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . 0.498 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 28.1 tp60 -137.55 131.87 32.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.615 178.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -79.66 107.17 12.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.896 0.379 . . . . 0.0 110.401 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . 0.421 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 74.5 m-85 -100.3 129.28 46.27 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.047 176.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 tp -89.89 99.84 10.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 172.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 53' ' ' VAL . . . . . 0.466 ' CG1' ' HB3' ' D' ' 44' ' ' LEU . 2.6 m -84.29 -33.69 9.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.147 -169.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 54' ' ' ALA . . . . . 0.508 ' HB2' HD13 ' D' ' 65' ' ' LEU . . . -159.33 148.93 18.6 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.072 0.463 . . . . 0.0 111.971 177.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 92.4 m -117.45 102.89 9.58 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 170.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 56' ' ' VAL . . . . . 0.42 ' CG1' HG11 ' D' ' 85' ' ' VAL . 6.8 p -110.57 116.34 52.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.582 0.706 . . . . 0.0 110.215 -176.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 74.0 p -122.81 -177.47 3.67 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.206 -175.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 58' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' D' ' 38' ' ' GLN . 52.7 mtmt -59.89 -33.58 72.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.021 0.439 . . . . 0.0 110.357 169.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.05 -40.67 68.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.313 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 74.8 mt -116.67 80.19 10.38 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 174.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.54 0.36 7.64 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.824 2.35 . . . . 0.0 113.84 -166.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -162.52 119.12 1.96 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.157 0.504 . . . . 0.0 110.844 -176.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.445 HG11 ' HB1' ' D' ' 54' ' ' ALA . 91.9 t -110.12 101.74 12.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.193 176.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.07 111.3 17.4 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.529 173.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 65' ' ' LEU . . . . . 0.508 HD13 ' HB2' ' D' ' 54' ' ' ALA . 1.0 OUTLIER -133.05 150.79 52.09 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.153 -171.323 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 66' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 11.6 t0 -96.08 99.18 10.96 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.499 0.666 . . . . 0.0 110.006 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.567 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 4.2 mt -113.15 141.88 46.42 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.447 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 68' ' ' ASN . . . . . 0.613 ' HB3' ' CD2' ' C' ' 90' ' ' TYR . 6.3 t30 -148.92 132.54 16.81 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.1 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 69' ' ' PHE . . . . . 0.526 ' CZ ' HD22 ' D' ' 67' ' ' LEU . 63.7 m-85 -127.74 157.97 38.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.764 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 4.7 p -120.97 154.89 35.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.281 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 71' ' ' LYS . . . . . 0.459 ' HD3' ' H ' ' D' ' 71' ' ' LYS . 0.2 OUTLIER -70.87 11.48 0.38 Allowed 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -174.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.0 -29.66 9.55 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.592 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -101.35 163.1 12.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.906 0.353 . . . . 0.0 111.012 -175.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -123.14 111.43 16.51 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.438 HG22 ' CB ' ' D' ' 46' ' ' ALA . 27.7 pt -111.1 161.38 9.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.039 0.447 . . . . 0.0 111.719 -168.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 76' ' ' MET . . . . . 0.419 ' SD ' ' HB3' ' D' ' 20' ' ' SER . 4.9 mtm -121.88 124.82 45.0 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 173.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 77' ' ' PHE . . . . . 0.623 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.5 OUTLIER -105.02 128.16 53.19 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.163 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 78' ' ' TYR . . . . . 0.644 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 30.4 p90 -151.07 138.87 19.82 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.245 -0.582 . . . . 0.0 112.108 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 79' ' ' THR . . . . . 0.68 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 11.4 p -109.71 137.57 47.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.923 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.57 157.17 18.72 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.612 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.8 -173.88 35.46 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 -176.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 82' ' ' ASP . . . . . 0.434 ' HA ' ' HB3' ' D' ' 15' ' ' PRO . 11.5 m-20 -114.03 103.27 10.97 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.803 177.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . 0.539 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -172.4 155.19 3.41 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.083 171.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 24.4 t -110.44 114.42 27.84 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.582 HG12 ' HB3' ' D' ' 34' ' ' LEU . 6.8 m -112.89 143.66 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-O 121.347 0.594 . . . . 0.0 112.159 -174.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 12.0 t -109.04 118.63 37.28 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.67 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 87' ' ' LEU . . . . . 0.645 HD13 HD23 ' D' ' 11' ' ' LEU . 5.2 mp -93.96 151.82 19.28 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 174.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tp -134.31 145.99 49.58 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.113 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.76 -167.49 29.46 Favored Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.087 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 90' ' ' TYR . . . . . 0.586 ' CD2' ' HB3' ' E' ' 68' ' ' ASN . 8.7 p90 -151.56 130.22 12.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.755 0.788 . . . . 0.0 111.876 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . 0.774 HD23 ' HB3' ' D' ' 27' ' ' PHE . 6.2 mt . . . . . 0 C--N 1.321 -0.669 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.631 175.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 54.7 mtt . . . . . 0 C--O 1.225 -0.21 0 CA-C-O 120.834 0.35 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' E' E ' 8' ' ' PHE . . . . . 0.509 ' CE1' HD21 ' A' ' 44' ' ' LEU . 81.0 t80 -58.78 142.73 49.36 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -172.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 9' ' ' TRP . . . . . 0.512 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 89.2 t90 -140.11 147.71 40.64 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.104 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 10' ' ' GLY . . . . . 0.405 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -149.9 153.92 25.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.181 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 11' ' ' LEU . . . . . 0.625 HD23 HD13 ' E' ' 87' ' ' LEU . 51.6 tp -146.46 108.95 4.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.732 0.301 . . . . 0.0 111.251 -178.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -91.46 114.17 26.63 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.461 0.648 . . . . 0.0 110.994 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 13' ' ' MET . . . . . 0.551 ' HB2' HG23 ' E' ' 85' ' ' VAL . 3.5 mmt -93.15 137.32 32.6 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.043 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -100.67 153.31 37.81 Favored Pre-proline 0 C--N 1.318 -0.791 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 171.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . 0.446 ' HB3' ' HA ' ' E' ' 82' ' ' ASP . 84.9 Cg_exo -46.67 111.32 0.36 Allowed 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 123.08 2.52 . . . . 0.0 113.139 -178.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 16' ' ' GLU . . . . . 0.686 ' HA ' ' O ' ' E' ' 79' ' ' THR . 39.6 mt-10 65.94 59.02 0.73 Allowed 'General case' 0 C--O 1.232 0.181 0 O-C-N 123.77 0.669 . . . . 0.0 111.445 177.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 17' ' ' ARG . . . . . 0.44 ' HD3' ' HA ' ' E' ' 17' ' ' ARG . 70.4 mmt-85 -113.32 145.49 40.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.945 172.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . 0.668 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 33.8 ttmt -128.07 111.28 13.32 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.376 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . 0.416 ' OH ' ' HA ' ' E' ' 13' ' ' MET . 5.6 m-85 -108.61 104.03 13.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.681 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 20' ' ' SER . . . . . 0.418 ' HB3' ' SD ' ' E' ' 76' ' ' MET . 9.4 p -88.06 99.96 12.57 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 173.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -125.45 138.71 54.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.543 0.687 . . . . 0.0 112.32 -167.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 14.8 t -85.1 160.29 20.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.701 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 23' ' ' ILE . . . . . 0.402 ' CD1' ' HB3' ' E' ' 69' ' ' PHE . 53.4 mt -114.02 116.85 53.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 120.995 0.426 . . . . 0.0 110.856 -176.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . 0.773 ' H ' HD13 ' E' ' 24' ' ' ILE . 0.2 OUTLIER -104.08 -10.21 9.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.264 176.393 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . 0.593 ' HD3' HD22 ' E' ' 91' ' ' LEU . 2.5 ptpp? -142.57 119.32 11.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.793 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 24.0 m -64.55 135.4 55.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.249 -177.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 27' ' ' PHE . . . . . 0.773 ' HB3' HD23 ' E' ' 91' ' ' LEU . 19.1 p90 -147.22 160.76 42.09 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -174.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 28' ' ' HIS . . . . . 0.53 ' HE2' ' HB3' ' E' ' 30' ' ' SER . 5.3 t60 -114.93 127.99 56.02 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.348 177.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 29' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 56.6 mt -94.54 136.45 25.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 171.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . 0.544 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 72.6 p -119.84 -16.67 8.68 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.712 -0.395 . . . . 0.0 112.018 -170.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 31' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -163.8 144.83 9.82 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 119.335 -1.412 . . . . 0.0 113.456 178.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.437 HG23 ' HG ' ' E' ' 87' ' ' LEU . 12.3 p -129.07 125.74 63.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 170.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.64 152.17 41.02 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.948 -0.47 . . . . 0.0 111.642 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 34' ' ' LEU . . . . . 0.591 ' HB3' HG12 ' E' ' 85' ' ' VAL . 3.5 pp -114.35 137.87 51.26 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 122.044 0.926 . . . . 0.0 111.719 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -106.09 -55.25 2.35 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.062 -1.427 . . . . 0.0 108.424 175.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -102.0 126.83 49.01 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.81 170.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . 0.454 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 147.94 162.52 10.16 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 119.576 -1.297 . . . . 0.0 113.596 176.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 38' ' ' GLN . . . . . 0.433 ' O ' ' HG3' ' E' ' 58' ' ' LYS . 39.2 mt-30 -102.77 -48.18 4.18 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 178.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -151.77 134.48 15.54 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.452 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . 0.553 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -135.27 117.34 15.38 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.278 0.561 . . . . 0.0 111.195 172.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 41' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' E' ' 79' ' ' THR . 48.2 mttm -97.62 116.08 29.15 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 173.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.412 HD21 HD21 ' E' ' 87' ' ' LEU . 53.6 tp -91.4 105.38 17.73 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.161 0.505 . . . . 0.0 110.053 -173.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 43' ' ' TYR . . . . . 0.413 ' HB2' ' CE2' ' E' ' 78' ' ' TYR . 97.1 m-85 -103.53 150.93 23.45 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.194 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 44' ' ' LEU . . . . . 0.619 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 1.1 tp -133.6 117.34 16.95 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.694 177.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 45' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -102.0 104.32 14.98 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.363 0.601 . . . . 0.0 109.554 175.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . 0.507 ' HB2' HD11 ' E' ' 44' ' ' LEU . . . -134.33 152.07 51.6 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 57.89 24.12 10.55 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -174.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 58.32 42.41 21.64 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.264 -175.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 49' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 28.1 tp60 -137.61 131.84 32.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.545 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -79.66 107.22 12.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.909 0.385 . . . . 0.0 110.387 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . 0.438 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 74.5 m-85 -100.27 129.32 46.25 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.109 175.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 tp -89.91 99.93 10.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 172.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . 0.467 ' CG1' ' HB3' ' E' ' 44' ' ' LEU . 2.6 m -84.32 -33.76 9.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.097 -169.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 54' ' ' ALA . . . . . 0.499 ' HB2' HD13 ' E' ' 65' ' ' LEU . . . -159.4 148.88 18.45 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.095 0.474 . . . . 0.0 111.887 177.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 92.4 m -117.36 102.9 9.62 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 170.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . 0.422 ' CG1' HG11 ' E' ' 85' ' ' VAL . 6.7 p -110.56 116.28 51.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.51 0.672 . . . . 0.0 110.214 -176.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 73.9 p -122.74 -177.44 3.65 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.248 -175.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 58' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' E' ' 38' ' ' GLN . 52.7 mtmt -59.86 -33.66 72.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.044 0.45 . . . . 0.0 110.309 169.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.92 -40.73 68.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.39 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 74.6 mt -116.64 80.09 10.22 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 174.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -72.46 0.27 7.73 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.87 2.38 . . . . 0.0 113.83 -166.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -162.44 119.11 1.99 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.196 0.522 . . . . 0.0 110.85 -176.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . 0.459 HG11 ' HB1' ' E' ' 54' ' ' ALA . 92.0 t -110.09 101.72 12.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.232 175.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.21 111.26 17.47 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 173.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 65' ' ' LEU . . . . . 0.499 HD13 ' HB2' ' E' ' 54' ' ' ALA . 1.0 OUTLIER -133.0 150.87 52.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.109 -171.351 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 66' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 11.6 t0 -96.06 99.11 10.89 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.414 0.626 . . . . 0.0 110.042 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 67' ' ' LEU . . . . . 0.565 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 4.1 mt -113.12 141.83 46.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.436 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 68' ' ' ASN . . . . . 0.586 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 6.2 t30 -148.92 132.48 16.76 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.068 177.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 69' ' ' PHE . . . . . 0.53 ' CZ ' HD22 ' E' ' 67' ' ' LEU . 63.4 m-85 -127.62 158.01 38.69 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.873 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 4.8 p -121.01 154.84 35.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.317 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 71' ' ' LYS . . . . . 0.46 ' HD3' ' H ' ' E' ' 71' ' ' LYS . 0.2 OUTLIER -70.82 11.41 0.38 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -174.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.03 -29.57 9.62 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.626 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -101.45 163.13 12.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.95 0.405 . . . . 0.0 110.92 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -123.06 111.57 16.72 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 75' ' ' ILE . . . . . 0.44 HG22 ' CB ' ' E' ' 46' ' ' ALA . 27.9 pt -111.3 161.29 9.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.053 0.454 . . . . 0.0 111.697 -168.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 76' ' ' MET . . . . . 0.418 ' SD ' ' HB3' ' E' ' 20' ' ' SER . 4.9 mtm -121.74 124.88 45.27 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 173.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 77' ' ' PHE . . . . . 0.619 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.5 OUTLIER -105.11 128.08 53.19 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.19 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 78' ' ' TYR . . . . . 0.668 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 30.2 p90 -151.01 138.86 19.86 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.059 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 79' ' ' THR . . . . . 0.686 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 11.1 p -109.74 137.55 47.38 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.898 -178.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.57 157.15 18.74 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.655 176.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.77 -173.84 35.46 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 82' ' ' ASP . . . . . 0.446 ' HA ' ' HB3' ' E' ' 15' ' ' PRO . 11.7 m-20 -114.05 103.18 10.88 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 119.609 -0.836 . . . . 0.0 109.873 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 83' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -172.36 155.19 3.44 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.18 171.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 24.3 t -110.42 114.45 27.9 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 85' ' ' VAL . . . . . 0.591 HG12 ' HB3' ' E' ' 34' ' ' LEU . 6.8 m -112.97 143.61 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 CA-C-O 121.514 0.673 . . . . 0.0 112.124 -174.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 11.9 t -108.97 118.73 37.56 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.641 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 87' ' ' LEU . . . . . 0.625 HD13 HD23 ' E' ' 11' ' ' LEU . 5.2 mp -94.17 151.89 19.13 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 174.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . 0.406 ' CD2' HD21 ' A' ' 67' ' ' LEU . 2.2 tp -134.32 145.95 49.52 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.089 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.73 -167.5 29.44 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.114 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 90' ' ' TYR . . . . . 0.624 ' CD2' ' HB3' ' A' ' 68' ' ' ASN . 8.8 p90 -151.58 130.24 12.31 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.742 0.782 . . . . 0.0 111.835 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 91' ' ' LEU . . . . . 0.773 HD23 ' HB3' ' E' ' 27' ' ' PHE . 6.3 mt . . . . . 0 C--N 1.321 -0.663 0 CA-C-N 114.051 -1.431 . . . . 0.0 109.595 175.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 51.2 mtt . . . . . 0 CA--C 1.52 -0.191 0 CA-C-O 121.18 0.514 . . . . 0.0 111.603 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.554 ' CE1' HD12 ' A' ' 88' ' ' LEU . 60.7 t80 -60.51 141.3 56.68 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.323 -174.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.508 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 91.9 t90 -130.41 144.8 51.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.915 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.1 140.81 9.11 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.395 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.626 HD23 HD13 ' A' ' 87' ' ' LEU . 56.6 tp -133.37 109.1 9.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.841 0.353 . . . . 0.0 110.348 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -97.78 104.11 16.11 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.571 ' SD ' HD11 ' A' ' 87' ' ' LEU . 35.9 mtp -98.4 137.86 36.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.588 -175.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -101.3 159.01 30.68 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.939 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.432 ' HB3' ' HA ' ' A' ' 82' ' ' ASP . 68.5 Cg_exo -42.89 118.45 1.22 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.752 2.968 . . . . 0.0 114.24 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.711 ' HA ' ' O ' ' A' ' 79' ' ' THR . 49.5 mt-10 57.16 55.99 5.54 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.068 174.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 78' ' ' TYR . 30.5 mmt180 -116.98 144.09 44.97 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.099 175.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.652 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 35.6 ttmt -126.23 112.78 16.16 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 123.491 0.494 . . . . 0.0 111.143 -176.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.415 ' OH ' ' HA ' ' A' ' 13' ' ' MET . 2.3 m-85 -111.27 104.89 13.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.252 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.42 ' HB3' ' SD ' ' A' ' 76' ' ' MET . 3.7 p -88.2 104.8 17.05 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 173.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -124.13 148.11 47.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.432 0.634 . . . . 0.0 112.696 -168.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.2 t -90.96 161.06 15.32 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.513 175.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.52 HD13 ' HB2' ' A' ' 69' ' ' PHE . 67.6 mt -114.25 131.36 66.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.101 0.477 . . . . 0.0 111.62 -173.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.468 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.2 mp -99.25 -48.92 11.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.085 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -114.46 140.55 48.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.657 177.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.2 m -63.54 109.4 1.64 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.482 ' HB3' HD23 ' A' ' 91' ' ' LEU . 14.7 p90 -125.02 159.54 31.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.626 0.727 . . . . 0.0 112.886 -170.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.578 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 9.4 t60 -116.45 125.85 52.57 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.077 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 61.2 mt -92.42 133.12 34.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 170.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.578 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 32.8 p -118.9 -14.35 9.43 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -169.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.541 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -167.33 147.98 12.49 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 119.153 -1.498 . . . . 0.0 113.416 178.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.442 HG23 ' HG ' ' A' ' 87' ' ' LEU . 11.4 p -134.63 129.06 51.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 172.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.08 155.5 42.24 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.896 -0.503 . . . . 0.0 111.653 -174.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.548 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.0 pp -120.98 142.27 49.93 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.442 0.639 . . . . 0.0 111.205 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -110.03 -50.08 3.01 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.572 173.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -103.18 127.45 50.47 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 168.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.455 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 152.21 158.97 8.7 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 119.906 -1.14 . . . . 0.0 113.19 176.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.464 ' O ' ' HG3' ' A' ' 58' ' ' LYS . 94.5 mt-30 -102.59 -45.35 5.07 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 120.625 0.25 . . . . 0.0 111.379 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.447 ' HG3' HG22 ' A' ' 57' ' ' THR . 13.5 tt0 -153.68 130.48 10.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.238 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.585 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -131.35 113.86 14.29 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.367 0.603 . . . . 0.0 110.492 169.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -97.14 111.6 23.76 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.456 ' HG ' ' CG2' ' A' ' 53' ' ' VAL . 45.4 tp -83.6 112.57 20.14 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.624 -174.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -110.96 137.17 48.92 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.293 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.582 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 1.2 tp -120.56 119.36 32.71 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.383 175.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -106.19 114.15 28.1 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.227 0.537 . . . . 0.0 109.671 176.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.544 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -145.97 154.59 42.08 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.98 -178.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 57.98 27.83 15.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.938 0.399 . . . . 0.0 110.381 -176.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm 59.22 44.6 15.42 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.743 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -150.86 140.22 21.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.963 178.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -85.98 126.99 34.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.18 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -123.14 123.92 41.9 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.704 176.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 tp -77.38 103.42 4.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 171.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.456 ' CG2' ' HG ' ' A' ' 42' ' ' LEU . 2.8 m -86.88 -35.17 8.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.875 -173.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.542 ' HB2' HD23 ' A' ' 65' ' ' LEU . . . -152.51 145.6 24.58 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.108 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.4 m -114.65 101.87 9.5 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 169.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.457 HG13 ' HB3' ' A' ' 40' ' ' ALA . 7.4 p -115.86 112.93 41.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.798 0.809 . . . . 0.0 110.164 -176.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.447 HG22 ' HG3' ' A' ' 39' ' ' GLU . 81.6 p -123.38 -176.82 3.54 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.217 -175.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 38' ' ' GLN . 34.7 mtmm -58.56 -34.58 71.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.179 0.514 . . . . 0.0 110.084 170.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.27 -40.88 64.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.467 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 72.4 mt -115.37 80.78 7.92 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 174.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -71.08 -0.01 7.32 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.122 2.548 . . . . 0.0 113.541 -168.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -161.94 124.69 2.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.41 0.624 . . . . 0.0 111.11 -176.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 85.7 t -113.73 102.96 14.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.355 174.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.93 109.8 17.89 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.441 173.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.542 HD23 ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -129.67 168.93 15.73 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.19 0.519 . . . . 0.0 111.539 -174.647 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 17.1 t0 -115.61 106.21 13.65 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.728 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.554 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 25.9 mt -123.55 142.96 50.51 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 175.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.664 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 4.9 t30 -150.79 130.79 13.4 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.073 177.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.52 ' HB2' HD13 ' A' ' 23' ' ' ILE . 3.1 m-85 -126.39 153.26 45.21 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.425 ' OG ' ' HG2' ' E' ' 7' ' ' MET . 89.1 p -98.36 164.68 12.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.036 0.446 . . . . 0.0 110.779 -178.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.403 ' H ' ' HG3' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -65.44 -5.47 7.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.821 177.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.25 -3.5 55.54 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 121.089 -0.577 . . . . 0.0 111.724 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -93.76 159.06 15.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.973 0.416 . . . . 0.0 110.873 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -144.14 125.48 14.74 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 174.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.544 HG22 ' HB2' ' A' ' 46' ' ' ALA . 18.1 pt -136.17 163.78 33.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.928 -166.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.42 ' SD ' ' HB3' ' A' ' 20' ' ' SER . 3.7 mtm -121.93 130.72 53.56 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.72 173.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.582 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -111.39 128.15 55.88 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.253 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.652 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 33.8 p90 -151.57 138.42 18.95 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.25 0.548 . . . . 0.0 111.788 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.711 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 6.0 p -107.44 134.87 49.85 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.144 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.69 154.18 19.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.112 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.2 -175.92 40.0 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -175.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.432 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 9.4 m-20 -113.62 103.29 11.1 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.209 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.585 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -170.09 155.08 5.31 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.819 172.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.2 t -112.05 123.29 49.93 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.548 HG12 ' HB3' ' A' ' 34' ' ' LEU . 6.1 m -121.46 145.86 27.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.415 0.626 . . . . 0.0 112.637 -172.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.3 m -109.91 120.86 43.79 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.591 175.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.626 HD13 HD23 ' A' ' 11' ' ' LEU . 4.7 mp -98.0 144.89 27.05 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 171.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.554 HD12 ' CE1' ' A' ' 8' ' ' PHE . 2.4 mm? -124.43 146.46 48.89 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.017 174.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.06 -168.33 23.81 Favored Glycine 0 N--CA 1.434 -1.434 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.189 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.632 ' CD2' ' HB3' ' B' ' 68' ' ' ASN . 9.9 p90 -151.41 128.52 11.13 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.828 0.823 . . . . 0.0 111.822 177.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.482 HD23 ' HB3' ' A' ' 27' ' ' PHE . 7.0 mt . . . . . 0 C--N 1.32 -0.689 0 CA-C-N 113.863 -1.517 . . . . 0.0 109.104 175.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 51.3 mtt . . . . . 0 CA--C 1.52 -0.197 0 CA-C-O 121.152 0.501 . . . . 0.0 111.657 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . 0.558 ' CE1' HD21 ' C' ' 44' ' ' LEU . 60.6 t80 -60.47 141.25 56.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.401 -174.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . 0.508 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 91.9 t90 -130.33 144.78 51.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.964 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.13 140.92 9.18 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.416 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.615 HD23 HD13 ' B' ' 87' ' ' LEU . 57.0 tp -133.54 109.13 9.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.828 0.347 . . . . 0.0 110.315 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -97.76 104.05 16.04 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . 0.583 ' SD ' HD11 ' B' ' 87' ' ' LEU . 35.8 mtp -98.35 137.81 36.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.641 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -101.11 159.1 30.45 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.009 176.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.453 ' HB3' ' HA ' ' B' ' 82' ' ' ASP . 69.6 Cg_exo -42.93 118.48 1.24 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.672 2.915 . . . . 0.0 114.323 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.713 ' HA ' ' O ' ' B' ' 79' ' ' THR . 49.7 mt-10 57.06 56.15 5.5 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.05 174.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' B' ' 78' ' ' TYR . 30.4 mmt180 -117.11 144.07 45.1 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.079 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.671 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 35.6 ttmt -126.18 112.79 16.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.091 -176.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' TYR . . . . . 0.403 ' OH ' ' HA ' ' B' ' 13' ' ' MET . 2.4 m-85 -111.26 104.84 13.36 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.291 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.416 ' HB3' ' SD ' ' B' ' 76' ' ' MET . 3.7 p -88.25 104.77 17.04 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 173.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -124.02 148.12 47.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.498 0.666 . . . . 0.0 112.711 -168.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 13.2 t -91.0 161.08 15.29 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.544 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.52 HD13 ' HB2' ' B' ' 69' ' ' PHE . 67.8 mt -114.25 131.26 66.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.116 0.484 . . . . 0.0 111.677 -173.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.47 ' N ' HD12 ' B' ' 24' ' ' ILE . 4.2 mp -99.23 -48.97 11.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.037 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -114.43 140.72 48.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.627 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 19.2 m -63.57 109.22 1.59 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 173.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . 0.47 ' HB3' HD23 ' B' ' 91' ' ' LEU . 14.6 p90 -124.93 159.56 30.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.627 0.727 . . . . 0.0 112.845 -170.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' HIS . . . . . 0.59 ' HE2' ' HB3' ' B' ' 30' ' ' SER . 9.3 t60 -116.43 125.81 52.53 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.131 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 61.5 mt -92.44 133.11 34.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 170.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.59 ' HB3' ' HE2' ' B' ' 28' ' ' HIS . 33.2 p -118.88 -14.33 9.44 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -169.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -167.3 148.09 12.65 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 119.146 -1.502 . . . . 0.0 113.375 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.447 HG23 ' HG ' ' B' ' 87' ' ' LEU . 11.3 p -134.68 129.09 51.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 172.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.15 155.53 42.22 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.551 -174.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.561 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.0 pp -120.98 142.3 49.9 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.51 0.672 . . . . 0.0 111.206 178.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -110.06 -50.04 3.01 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.578 173.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -103.14 127.53 50.39 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 168.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 152.17 158.88 8.65 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.217 176.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . 0.472 ' O ' ' HG3' ' B' ' 58' ' ' LYS . 94.5 mt-30 -102.46 -45.4 5.08 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.572 0.225 . . . . 0.0 111.441 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.456 ' HG3' HG22 ' B' ' 57' ' ' THR . 13.4 tt0 -153.77 130.54 10.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.189 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.589 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -131.36 113.88 14.3 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.411 0.624 . . . . 0.0 110.507 169.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -97.15 111.68 23.8 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 173.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.454 ' HG ' ' CG2' ' B' ' 53' ' ' VAL . 45.8 tp -83.76 112.57 20.21 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.614 -174.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -110.91 137.15 48.91 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.335 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.592 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 1.2 tp -120.57 119.33 32.59 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.344 175.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -106.23 114.1 28.02 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.523 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -145.94 154.63 42.14 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.932 -178.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 57.95 27.82 15.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.947 0.403 . . . . 0.0 110.391 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm 59.18 44.61 15.53 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.722 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -150.82 140.17 21.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.901 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -85.82 127.07 34.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -123.16 123.83 41.69 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.655 176.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 tp -77.25 103.3 4.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 171.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.454 ' CG2' ' HG ' ' B' ' 42' ' ' LEU . 2.8 m -86.8 -35.31 8.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.853 -173.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.537 ' HB2' HD23 ' B' ' 65' ' ' LEU . . . -152.49 145.62 24.61 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 120.239 -0.584 . . . . 0.0 112.155 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 27.3 m -114.64 101.94 9.57 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 169.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' B' ' 40' ' ' ALA . 7.3 p -115.92 112.96 41.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.771 0.796 . . . . 0.0 110.079 -176.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.456 HG22 ' HG3' ' B' ' 39' ' ' GLU . 82.6 p -123.48 -176.93 3.57 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.185 -175.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' B' ' 38' ' ' GLN . 34.7 mtmm -58.39 -34.67 70.99 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.12 0.486 . . . . 0.0 110.062 170.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.408 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -73.31 -40.9 64.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.466 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 72.5 mt -115.32 80.81 7.81 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 10.2 Cg_exo -71.13 -0.0 7.34 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.107 2.538 . . . . 0.0 113.486 -168.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -161.93 124.86 3.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.375 0.607 . . . . 0.0 111.095 -176.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 85.7 t -113.78 102.93 14.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.311 174.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.95 109.81 17.91 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.46 173.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.537 HD23 ' HB2' ' B' ' 54' ' ' ALA . 0.4 OUTLIER -129.61 168.97 15.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.197 0.522 . . . . 0.0 111.608 -174.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . 0.526 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 16.9 t0 -115.65 106.3 13.74 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.719 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.557 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 26.2 mt -123.63 142.96 50.55 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . 0.632 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 4.9 t30 -150.83 130.76 13.33 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.062 177.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . 0.52 ' HB2' HD13 ' B' ' 23' ' ' ILE . 3.2 m-85 -126.43 153.2 45.34 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 88.9 p -98.3 164.72 12.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.003 0.43 . . . . 0.0 110.802 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . 0.427 ' HG3' ' H ' ' B' ' 71' ' ' LYS . 0.0 OUTLIER -65.52 -5.45 8.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.805 177.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.19 -3.58 55.57 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.765 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -93.72 159.09 15.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.96 0.409 . . . . 0.0 110.776 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -144.22 125.5 14.69 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.523 HG22 ' HB2' ' B' ' 46' ' ' ALA . 18.0 pt -136.21 163.84 33.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.04 0.448 . . . . 0.0 111.91 -166.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.416 ' SD ' ' HB3' ' B' ' 20' ' ' SER . 3.7 mtm -121.99 130.78 53.59 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.698 173.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . 0.592 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.9 OUTLIER -111.36 128.18 55.89 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.269 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.671 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 33.5 p90 -151.61 138.47 18.96 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.199 0.523 . . . . 0.0 111.818 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.713 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 6.0 p -107.46 134.82 49.93 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.1 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.63 154.26 19.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.208 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.08 -175.88 40.15 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -175.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' ASP . . . . . 0.453 ' HA ' ' HB3' ' B' ' 15' ' ' PRO . 9.5 m-20 -113.65 103.34 11.14 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.136 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.589 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -170.16 154.99 5.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.838 172.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 16.1 t -111.99 123.31 49.98 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.561 HG12 ' HB3' ' B' ' 34' ' ' LEU . 6.1 m -121.54 145.81 27.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.494 0.664 . . . . 0.0 112.578 -172.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 20.3 m -109.88 120.87 43.81 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.575 175.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.615 HD13 HD23 ' B' ' 11' ' ' LEU . 4.7 mp -97.92 144.9 26.99 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 171.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.55 HD12 ' CE1' ' B' ' 8' ' ' PHE . 2.4 mm? -124.51 146.55 48.92 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.982 174.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.13 -168.36 23.91 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.25 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' TYR . . . . . 0.604 ' CD2' ' HB3' ' C' ' 68' ' ' ASN . 9.8 p90 -151.42 128.55 11.14 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.844 0.83 . . . . 0.0 111.777 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . 0.47 HD23 ' HB3' ' B' ' 27' ' ' PHE . 7.0 mt . . . . . 0 C--N 1.32 -0.7 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.097 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 51.3 mtt . . . . . 0 CA--C 1.52 -0.182 0 CA-C-O 121.196 0.522 . . . . 0.0 111.601 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 8' ' ' PHE . . . . . 0.579 ' CE1' HD21 ' D' ' 44' ' ' LEU . 60.8 t80 -60.5 141.3 56.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.355 -174.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . 0.507 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 91.9 t90 -130.42 144.78 51.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.924 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.13 140.84 9.12 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.482 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.633 HD23 HD13 ' C' ' 87' ' ' LEU . 56.6 tp -133.39 108.99 9.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.802 0.334 . . . . 0.0 110.342 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -97.75 104.05 16.04 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 13' ' ' MET . . . . . 0.575 ' SD ' HD11 ' C' ' 87' ' ' LEU . 35.8 mtp -98.35 137.78 36.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.616 -175.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -101.2 159.14 30.32 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.034 176.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . 0.428 ' HB3' ' HA ' ' C' ' 82' ' ' ASP . 69.1 Cg_exo -43.01 118.52 1.28 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.727 2.952 . . . . 0.0 114.282 -177.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . 0.71 ' HA ' ' O ' ' C' ' 79' ' ' THR . 49.6 mt-10 57.02 56.19 5.5 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.085 174.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 17' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' C' ' 78' ' ' TYR . 30.5 mmt180 -117.15 144.05 45.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.114 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 18' ' ' LYS . . . . . 0.674 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 35.6 ttmt -126.18 112.85 16.27 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 123.455 0.472 . . . . 0.0 111.096 -176.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . 0.413 ' OH ' ' HA ' ' C' ' 13' ' ' MET . 2.3 m-85 -111.34 104.77 13.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.302 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . 0.419 ' HB3' ' SD ' ' C' ' 76' ' ' MET . 3.7 p -88.1 104.83 17.05 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 173.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -124.07 148.1 47.36 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.437 0.637 . . . . 0.0 112.715 -168.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 13.2 t -90.89 161.05 15.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.583 175.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . 0.504 HD13 ' HB2' ' C' ' 69' ' ' PHE . 67.7 mt -114.24 131.33 66.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.151 0.5 . . . . 0.0 111.667 -173.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . 0.468 HD12 ' N ' ' C' ' 24' ' ' ILE . 4.2 mp -99.27 -49.03 11.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.937 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -114.35 140.61 48.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.657 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 19.1 m -63.52 109.3 1.6 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 173.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 27' ' ' PHE . . . . . 0.483 ' HB3' HD23 ' C' ' 91' ' ' LEU . 14.7 p90 -124.92 159.53 30.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.703 0.764 . . . . 0.0 112.828 -170.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 28' ' ' HIS . . . . . 0.593 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 9.2 t60 -116.5 125.84 52.51 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.049 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 61.2 mt -92.46 133.08 34.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 170.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.593 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 33.0 p -118.83 -14.32 9.47 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -169.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 31' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -167.36 148.01 12.52 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 119.092 -1.528 . . . . 0.0 113.356 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.449 HG23 ' HG ' ' C' ' 87' ' ' LEU . 11.4 p -134.57 129.06 51.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 172.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.14 155.42 42.13 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.686 -174.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.554 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.0 pp -120.9 142.37 49.76 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.462 0.648 . . . . 0.0 111.213 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -110.14 -50.02 3.01 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.516 173.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -103.24 127.52 50.52 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 168.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 37' ' ' GLY . . . . . 0.461 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 152.16 158.83 8.63 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 119.875 -1.155 . . . . 0.0 113.231 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 38' ' ' GLN . . . . . 0.463 ' O ' ' HG3' ' C' ' 58' ' ' LYS . 94.7 mt-30 -102.48 -45.39 5.08 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.519 0.2 . . . . 0.0 111.373 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . 0.451 ' HG3' HG22 ' C' ' 57' ' ' THR . 13.4 tt0 -153.73 130.43 10.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.265 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.577 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -131.35 113.8 14.21 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.388 0.613 . . . . 0.0 110.454 169.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -97.02 111.74 23.82 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.453 ' HG ' ' CG2' ' C' ' 53' ' ' VAL . 45.7 tp -83.84 112.57 20.24 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.593 -174.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -110.92 137.22 48.83 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.354 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.594 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 1.2 tp -120.61 119.36 32.65 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.381 175.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -106.26 114.13 28.07 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.168 0.509 . . . . 0.0 109.635 176.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.528 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -145.95 154.67 42.17 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.929 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 58.02 27.76 15.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.971 0.415 . . . . 0.0 110.446 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm 59.27 44.44 15.48 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.788 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -150.73 140.1 21.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.983 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -85.69 127.04 34.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.235 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -123.23 123.85 41.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.62 176.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 tp -77.33 103.39 4.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 171.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 53' ' ' VAL . . . . . 0.453 ' CG2' ' HG ' ' C' ' 42' ' ' LEU . 2.8 m -86.87 -35.26 8.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.819 -173.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 54' ' ' ALA . . . . . 0.535 ' HB2' HD23 ' C' ' 65' ' ' LEU . . . -152.54 145.54 24.51 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.145 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 27.7 m -114.69 101.96 9.58 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 169.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . 0.449 HG13 ' HB3' ' C' ' 40' ' ' ALA . 7.4 p -115.87 113.02 42.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.775 0.798 . . . . 0.0 110.126 -176.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . 0.451 HG22 ' HG3' ' C' ' 39' ' ' GLU . 81.5 p -123.53 -176.79 3.54 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.208 -175.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 58' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' C' ' 38' ' ' GLN . 34.7 mtmm -58.51 -34.65 71.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.143 0.497 . . . . 0.0 110.065 170.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . 0.405 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -73.3 -40.89 64.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.408 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 72.5 mt -115.35 80.74 7.84 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 174.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 61' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 10.3 Cg_exo -70.97 -0.07 7.35 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.027 2.485 . . . . 0.0 113.552 -168.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -161.92 124.83 3.01 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.449 0.643 . . . . 0.0 111.062 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 85.9 t -113.75 102.96 14.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.252 174.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.05 109.78 17.94 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 173.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . 0.535 HD23 ' HB2' ' C' ' 54' ' ' ALA . 0.4 OUTLIER -129.53 168.96 15.6 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.171 0.51 . . . . 0.0 111.545 -174.68 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 66' ' ' ASP . . . . . 0.518 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 17.1 t0 -115.59 106.16 13.61 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.667 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.549 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 26.1 mt -123.55 142.99 50.48 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . 0.604 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 4.9 t30 -150.87 130.72 13.26 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.1 177.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 69' ' ' PHE . . . . . 0.504 ' HB2' HD13 ' C' ' 23' ' ' ILE . 3.0 m-85 -126.32 153.24 45.12 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 88.9 p -98.4 164.67 12.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.073 0.463 . . . . 0.0 110.77 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . 0.424 ' H ' ' HG3' ' C' ' 71' ' ' LYS . 0.0 OUTLIER -65.44 -5.45 7.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.766 177.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.24 -3.54 55.53 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.738 176.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -93.77 159.17 15.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.991 0.424 . . . . 0.0 110.758 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -144.21 125.48 14.68 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 174.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.528 HG22 ' HB2' ' C' ' 46' ' ' ALA . 18.1 pt -136.13 163.83 33.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.999 0.428 . . . . 0.0 111.865 -166.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.419 ' SD ' ' HB3' ' C' ' 20' ' ' SER . 3.6 mtm -122.0 130.75 53.56 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.81 173.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 77' ' ' PHE . . . . . 0.594 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.9 OUTLIER -111.3 128.17 55.86 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.368 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 78' ' ' TYR . . . . . 0.674 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 34.0 p90 -151.68 138.37 18.81 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.177 0.513 . . . . 0.0 111.886 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . 0.71 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 6.2 p -107.38 134.85 49.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.088 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.68 154.26 19.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.139 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.13 -175.85 40.04 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 82' ' ' ASP . . . . . 0.428 ' HA ' ' HB3' ' C' ' 15' ' ' PRO . 9.5 m-20 -113.68 103.33 11.12 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.159 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . 0.577 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -170.21 155.0 5.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.837 172.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 16.2 t -112.01 123.33 50.03 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.554 HG12 ' HB3' ' C' ' 34' ' ' LEU . 6.2 m -121.49 145.83 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 CA-C-O 121.505 0.669 . . . . 0.0 112.644 -172.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 20.3 m -109.92 120.9 43.92 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.591 175.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . 0.633 HD13 HD23 ' C' ' 11' ' ' LEU . 4.7 mp -97.98 144.81 27.13 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 171.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . 0.555 HD12 ' CE1' ' C' ' 8' ' ' PHE . 2.4 mm? -124.42 146.48 48.87 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.443 -0.798 . . . . 0.0 108.985 174.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.09 -168.34 23.84 Favored Glycine 0 N--CA 1.436 -1.366 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.204 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 90' ' ' TYR . . . . . 0.635 ' CD2' ' HB3' ' D' ' 68' ' ' ASN . 9.9 p90 -151.42 128.57 11.16 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.785 0.802 . . . . 0.0 111.783 177.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . 0.483 HD23 ' HB3' ' C' ' 27' ' ' PHE . 7.0 mt . . . . . 0 C--N 1.319 -0.737 0 CA-C-N 113.858 -1.519 . . . . 0.0 108.993 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 51.4 mtt . . . . . 0 CA--C 1.521 -0.16 0 CA-C-O 121.135 0.493 . . . . 0.0 111.655 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 8' ' ' PHE . . . . . 0.56 ' CE1' HD21 ' E' ' 44' ' ' LEU . 60.4 t80 -60.52 141.3 56.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.41 -174.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 9' ' ' TRP . . . . . 0.508 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 92.1 t90 -130.41 144.79 51.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.913 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.12 140.95 9.21 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.374 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . 0.615 HD23 HD13 ' D' ' 87' ' ' LEU . 56.4 tp -133.45 109.08 9.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.768 0.318 . . . . 0.0 110.298 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -97.74 104.08 16.08 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 13' ' ' MET . . . . . 0.582 ' SD ' HD11 ' D' ' 87' ' ' LEU . 35.8 mtp -98.4 137.84 36.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.587 -175.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -101.14 159.13 30.36 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.052 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . 0.437 ' HB3' ' HA ' ' D' ' 82' ' ' ASP . 69.1 Cg_exo -42.94 118.44 1.23 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.696 2.931 . . . . 0.0 114.314 -177.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . 0.703 ' HA ' ' O ' ' D' ' 79' ' ' THR . 49.7 mt-10 57.19 56.07 5.46 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.024 174.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 17' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' D' ' 78' ' ' TYR . 30.5 mmt180 -117.08 144.04 45.1 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.033 175.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . 0.673 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 35.6 ttmt -126.18 112.86 16.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.07 -176.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 19' ' ' TYR . . . . . 0.406 ' OH ' ' HA ' ' D' ' 13' ' ' MET . 2.4 m-85 -111.3 104.77 13.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.308 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . 0.418 ' HB3' ' SD ' ' D' ' 76' ' ' MET . 3.7 p -88.14 104.75 16.99 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 173.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -124.0 148.17 47.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.442 0.639 . . . . 0.0 112.72 -168.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 13.2 t -91.0 161.1 15.28 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.533 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . 0.506 HD13 ' HB2' ' D' ' 69' ' ' PHE . 67.5 mt -114.31 131.24 66.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.191 0.519 . . . . 0.0 111.678 -173.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . 0.463 HD12 ' N ' ' D' ' 24' ' ' ILE . 4.2 mp -99.12 -49.06 11.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.095 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -114.35 140.64 48.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.648 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 19.3 m -63.55 109.4 1.64 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 173.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 27' ' ' PHE . . . . . 0.482 ' HB3' HD23 ' D' ' 91' ' ' LEU . 14.5 p90 -125.01 159.49 31.18 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.692 0.758 . . . . 0.0 112.824 -170.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 28' ' ' HIS . . . . . 0.594 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 9.4 t60 -116.37 125.82 52.61 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.222 -1.354 . . . . 0.0 110.156 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 29' ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 61.3 mt -92.41 133.04 35.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 170.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . 0.594 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 33.2 p -118.79 -14.4 9.5 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -169.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 31' ' ' GLY . . . . . 0.545 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -167.31 148.02 12.55 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 119.141 -1.504 . . . . 0.0 113.387 178.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.451 HG23 ' HG ' ' D' ' 87' ' ' LEU . 11.4 p -134.59 128.99 51.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 172.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.11 155.5 42.22 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.496 -0.481 . . . . 0.0 111.629 -174.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 34' ' ' LEU . . . . . 0.552 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.0 pp -120.98 142.24 49.96 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.455 0.645 . . . . 0.0 111.225 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -109.98 -50.16 3.0 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.554 173.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -103.09 127.54 50.32 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 168.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . 0.467 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 152.16 158.95 8.68 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 119.868 -1.158 . . . . 0.0 113.253 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 38' ' ' GLN . . . . . 0.46 ' O ' ' HG3' ' D' ' 58' ' ' LYS . 94.7 mt-30 -102.6 -45.35 5.07 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.625 0.25 . . . . 0.0 111.4 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . 0.459 ' HG3' HG22 ' D' ' 57' ' ' THR . 13.5 tt0 -153.67 130.58 10.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.221 178.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . 0.573 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -131.43 113.82 14.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.417 0.627 . . . . 0.0 110.46 169.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -97.08 111.63 23.77 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 173.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.458 ' HG ' ' CG2' ' D' ' 53' ' ' VAL . 45.9 tp -83.73 112.61 20.22 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.522 -174.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -110.86 137.15 48.86 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.326 178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.593 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 1.2 tp -120.61 119.44 32.87 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.37 175.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 45' ' ' ALA . . . . . . . . . . . . . . . -106.25 113.99 27.86 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.529 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -145.92 154.61 42.13 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.961 -178.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 58.06 27.75 15.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.931 0.396 . . . . 0.0 110.421 -176.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm 59.24 44.54 15.45 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.809 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -150.83 140.36 21.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.896 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -85.99 127.01 34.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.18 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -123.15 123.79 41.61 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.722 176.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 tp -77.26 103.33 4.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 171.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 53' ' ' VAL . . . . . 0.458 ' CG2' ' HG ' ' D' ' 42' ' ' LEU . 2.8 m -86.79 -35.29 8.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.861 -173.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 54' ' ' ALA . . . . . 0.54 ' HB2' HD23 ' D' ' 65' ' ' LEU . . . -152.46 145.64 24.65 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.284 -0.566 . . . . 0.0 112.167 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 27.2 m -114.74 101.98 9.59 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 169.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 56' ' ' VAL . . . . . 0.449 HG13 ' HB3' ' D' ' 40' ' ' ALA . 7.4 p -115.94 112.98 41.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.791 0.805 . . . . 0.0 110.081 -176.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 57' ' ' THR . . . . . 0.459 HG22 ' HG3' ' D' ' 39' ' ' GLU . 82.5 p -123.48 -176.81 3.54 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.208 -175.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 58' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' D' ' 38' ' ' GLN . 34.7 mtmm -58.56 -34.59 71.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.128 0.49 . . . . 0.0 110.069 170.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 59' ' ' ALA . . . . . 0.4 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -73.4 -40.73 64.07 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.452 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 72.4 mt -115.36 80.74 7.87 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 174.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 61' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 10.4 Cg_exo -71.05 -0.1 7.44 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.109 2.539 . . . . 0.0 113.516 -168.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -161.84 124.73 3.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.327 0.584 . . . . 0.0 111.127 -176.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 85.1 t -113.72 102.91 14.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.32 174.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.01 109.8 17.93 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.404 173.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 65' ' ' LEU . . . . . 0.54 HD23 ' HB2' ' D' ' 54' ' ' ALA . 0.4 OUTLIER -129.66 168.9 15.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.107 0.479 . . . . 0.0 111.606 -174.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 66' ' ' ASP . . . . . 0.518 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 17.2 t0 -115.47 106.21 13.7 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.735 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.546 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 25.9 mt -123.6 143.03 50.48 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 68' ' ' ASN . . . . . 0.635 ' HB3' ' CD2' ' C' ' 90' ' ' TYR . 4.9 t30 -150.83 130.73 13.31 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.026 177.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 69' ' ' PHE . . . . . 0.506 ' HB2' HD13 ' D' ' 23' ' ' ILE . 3.2 m-85 -126.33 153.23 45.16 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 89.0 p -98.36 164.63 12.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.029 0.442 . . . . 0.0 110.819 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 71' ' ' LYS . . . . . 0.42 ' H ' ' HG3' ' D' ' 71' ' ' LYS . 0.0 OUTLIER -65.39 -5.49 7.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.824 177.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.19 -3.64 55.55 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.714 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -93.66 159.1 15.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.969 0.414 . . . . 0.0 110.836 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -144.25 125.53 14.69 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.529 HG22 ' HB2' ' D' ' 46' ' ' ALA . 18.1 pt -136.13 163.79 33.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.925 -166.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 76' ' ' MET . . . . . 0.418 ' SD ' ' HB3' ' D' ' 20' ' ' SER . 3.6 mtm -121.95 130.67 53.51 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.752 173.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 77' ' ' PHE . . . . . 0.593 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.9 OUTLIER -111.34 128.21 55.89 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.277 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 78' ' ' TYR . . . . . 0.673 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 33.5 p90 -151.7 138.39 18.8 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.239 0.543 . . . . 0.0 111.822 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 79' ' ' THR . . . . . 0.703 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 6.0 p -107.4 134.89 49.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.101 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.74 154.16 19.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.189 175.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.24 -175.88 39.89 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -175.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 82' ' ' ASP . . . . . 0.437 ' HA ' ' HB3' ' D' ' 15' ' ' PRO . 9.5 m-20 -113.65 103.27 11.06 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.172 178.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . 0.573 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -170.16 155.02 5.21 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.814 172.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 15.7 t -111.95 123.39 50.16 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.552 HG12 ' HB3' ' D' ' 34' ' ' LEU . 6.2 m -121.52 145.85 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.454 0.645 . . . . 0.0 112.631 -172.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 20.2 m -109.88 120.83 43.71 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.582 175.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 87' ' ' LEU . . . . . 0.615 HD13 HD23 ' D' ' 11' ' ' LEU . 4.7 mp -97.96 144.87 27.05 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 170.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.549 HD12 ' CZ ' ' D' ' 8' ' ' PHE . 2.4 mm? -124.46 146.48 48.91 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.013 174.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.09 -168.26 23.74 Favored Glycine 0 N--CA 1.435 -1.421 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.189 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 90' ' ' TYR . . . . . 0.584 ' CD2' ' HB3' ' E' ' 68' ' ' ASN . 9.8 p90 -151.46 128.55 11.12 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.825 0.821 . . . . 0.0 111.757 177.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . 0.482 HD23 ' HB3' ' D' ' 27' ' ' PHE . 6.9 mt . . . . . 0 C--N 1.32 -0.694 0 CA-C-N 113.852 -1.522 . . . . 0.0 109.047 175.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 7' ' ' MET . . . . . 0.425 ' HG2' ' OG ' ' A' ' 70' ' ' SER . 51.3 mtt . . . . . 0 CA--C 1.52 -0.201 0 CA-C-O 121.138 0.494 . . . . 0.0 111.634 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 8' ' ' PHE . . . . . 0.576 ' CE1' HD21 ' A' ' 44' ' ' LEU . 60.4 t80 -60.51 141.21 56.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.367 -174.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 9' ' ' TRP . . . . . 0.505 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 92.1 t90 -130.32 144.7 51.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.966 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.03 140.96 9.23 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.44 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 11' ' ' LEU . . . . . 0.629 HD23 HD13 ' E' ' 87' ' ' LEU . 56.7 tp -133.53 109.09 9.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.864 0.364 . . . . 0.0 110.335 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -97.78 104.05 16.04 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 13' ' ' MET . . . . . 0.58 ' SD ' HD11 ' E' ' 87' ' ' LEU . 35.8 mtp -98.3 137.74 36.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.615 -175.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -101.13 159.12 30.38 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.99 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . 0.436 ' HB3' ' HA ' ' E' ' 82' ' ' ASP . 68.6 Cg_exo -43.01 118.55 1.29 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.632 2.888 . . . . 0.0 114.298 -177.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 16' ' ' GLU . . . . . 0.707 ' HA ' ' O ' ' E' ' 79' ' ' THR . 49.6 mt-10 57.02 56.14 5.53 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.109 174.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 17' ' ' ARG . . . . . 0.429 ' O ' ' HA ' ' E' ' 78' ' ' TYR . 30.4 mmt180 -117.17 144.05 45.17 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.019 175.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . 0.68 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 35.6 ttmt -126.14 112.87 16.32 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 123.573 0.546 . . . . 0.0 111.096 -176.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . 0.413 ' OH ' ' HA ' ' E' ' 13' ' ' MET . 2.3 m-85 -111.26 104.74 13.26 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.288 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 20' ' ' SER . . . . . 0.417 ' HB3' ' SD ' ' E' ' 76' ' ' MET . 3.8 p -88.03 104.79 16.99 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 173.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -124.07 148.04 47.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.482 0.658 . . . . 0.0 112.692 -168.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 13.1 t -90.88 161.11 15.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.536 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 23' ' ' ILE . . . . . 0.511 HD13 ' HB2' ' E' ' 69' ' ' PHE . 67.6 mt -114.34 131.31 66.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.125 0.488 . . . . 0.0 111.709 -173.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . 0.457 HD12 ' N ' ' E' ' 24' ' ' ILE . 4.2 mp -99.22 -48.92 11.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.0 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -114.49 140.62 48.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.61 177.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 19.1 m -63.58 109.35 1.63 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 173.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 27' ' ' PHE . . . . . 0.473 ' HB3' HD23 ' E' ' 91' ' ' LEU . 14.6 p90 -124.92 159.55 30.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.643 0.735 . . . . 0.0 112.88 -170.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 28' ' ' HIS . . . . . 0.582 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 9.3 t60 -116.45 125.83 52.53 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.047 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 29' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 61.1 mt -92.38 133.12 34.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 170.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . 0.582 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 32.9 p -118.96 -14.31 9.4 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -169.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 31' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -167.32 148.01 12.53 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.143 -1.504 . . . . 0.0 113.352 178.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.437 HG23 ' HG ' ' E' ' 87' ' ' LEU . 11.5 p -134.69 128.99 51.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 172.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.07 155.49 42.24 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 121.942 -0.474 . . . . 0.0 111.655 -174.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 34' ' ' LEU . . . . . 0.551 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.0 pp -121.0 142.29 49.93 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.511 0.672 . . . . 0.0 111.181 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -110.11 -50.05 3.01 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.476 173.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -103.17 127.46 50.46 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 168.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 152.17 158.85 8.64 Favored Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 119.875 -1.155 . . . . 0.0 113.293 176.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 38' ' ' GLN . . . . . 0.474 ' O ' ' HG3' ' E' ' 58' ' ' LYS . 94.4 mt-30 -102.47 -45.44 5.07 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 120.586 0.231 . . . . 0.0 111.39 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 39' ' ' GLU . . . . . 0.433 ' HG3' HG22 ' E' ' 57' ' ' THR . 13.4 tt0 -153.68 130.59 10.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.229 178.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . 0.583 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -131.41 113.83 14.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.388 0.613 . . . . 0.0 110.467 169.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 41' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -97.06 111.63 23.77 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.45 ' HG ' ' CG2' ' E' ' 53' ' ' VAL . 45.7 tp -83.69 112.57 20.17 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.627 -174.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -110.95 137.14 48.95 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.32 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 44' ' ' LEU . . . . . 0.594 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 1.2 tp -120.54 119.43 32.92 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.377 175.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 45' ' ' ALA . . . . . . . . . . . . . . . -106.24 114.15 28.1 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . 0.523 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -146.04 154.58 42.02 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.957 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 58.02 27.77 15.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.027 0.441 . . . . 0.0 110.406 -176.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm 59.23 44.61 15.38 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.749 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 49' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -150.89 140.23 21.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.922 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -85.89 127.1 34.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.15 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . 0.414 ' CB ' HD11 ' D' ' 88' ' ' LEU . 49.8 m-85 -123.23 123.96 41.94 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.669 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 tp -77.39 103.36 4.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 171.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . 0.45 ' CG2' ' HG ' ' E' ' 42' ' ' LEU . 2.8 m -86.83 -35.32 8.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.786 -173.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 54' ' ' ALA . . . . . 0.519 ' HB2' ' CD2' ' E' ' 65' ' ' LEU . . . -152.49 145.53 24.55 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.312 -0.555 . . . . 0.0 112.191 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 27.4 m -114.63 101.95 9.58 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 169.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . 0.454 HG13 ' HB3' ' E' ' 40' ' ' ALA . 7.4 p -115.92 112.99 41.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.783 0.802 . . . . 0.0 110.114 -176.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 57' ' ' THR . . . . . 0.433 HG22 ' HG3' ' E' ' 39' ' ' GLU . 82.8 p -123.4 -176.81 3.53 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.234 -175.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 58' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' E' ' 38' ' ' GLN . 34.6 mtmm -58.45 -34.8 71.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.199 0.523 . . . . 0.0 110.043 170.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 59' ' ' ALA . . . . . 0.404 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -73.24 -40.78 64.39 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.508 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 72.6 mt -115.38 80.67 7.87 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 61' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 10.3 Cg_exo -71.06 0.02 7.27 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.047 2.498 . . . . 0.0 113.448 -168.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -162.01 124.75 2.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.504 0.669 . . . . 0.0 111.08 -176.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 86.4 t -113.81 102.97 14.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.239 174.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.0 109.84 17.96 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.411 173.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 65' ' ' LEU . . . . . 0.519 ' CD2' ' HB2' ' E' ' 54' ' ' ALA . 0.4 OUTLIER -129.62 168.97 15.64 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.081 0.467 . . . . 0.0 111.583 -174.657 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 66' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 17.1 t0 -115.68 106.26 13.68 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.708 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 67' ' ' LEU . . . . . 0.55 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 26.0 mt -123.55 143.0 50.47 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 175.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 68' ' ' ASN . . . . . 0.584 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 4.9 t30 -150.78 130.72 13.35 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.122 177.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 69' ' ' PHE . . . . . 0.511 ' HB2' HD13 ' E' ' 23' ' ' ILE . 3.1 m-85 -126.34 153.19 45.23 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 88.9 p -98.28 164.67 12.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.006 0.431 . . . . 0.0 110.786 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 71' ' ' LYS . . . . . 0.427 ' H ' ' HG3' ' E' ' 71' ' ' LYS . 0.0 OUTLIER -65.42 -5.57 7.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.781 177.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.18 -3.44 55.64 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 121.043 -0.599 . . . . 0.0 111.791 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -93.74 159.08 15.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.99 0.424 . . . . 0.0 110.747 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -144.21 125.47 14.67 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 174.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 75' ' ' ILE . . . . . 0.523 HG22 ' HB2' ' E' ' 46' ' ' ALA . 18.0 pt -136.09 163.8 33.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.92 -166.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 76' ' ' MET . . . . . 0.417 ' SD ' ' HB3' ' E' ' 20' ' ' SER . 3.7 mtm -121.95 130.76 53.59 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 173.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 77' ' ' PHE . . . . . 0.594 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.9 OUTLIER -111.41 128.18 55.9 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.248 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 78' ' ' TYR . . . . . 0.68 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 33.9 p90 -151.64 138.45 18.91 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.242 0.544 . . . . 0.0 111.8 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 79' ' ' THR . . . . . 0.707 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 6.2 p -107.4 134.84 49.86 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.13 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.67 154.17 19.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.17 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.19 -175.91 39.99 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -175.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 82' ' ' ASP . . . . . 0.436 ' HA ' ' HB3' ' E' ' 15' ' ' PRO . 9.2 m-20 -113.64 103.37 11.17 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.132 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 83' ' ' ALA . . . . . 0.583 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -170.24 155.03 5.14 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.832 172.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 16.2 t -112.03 123.45 50.28 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 85' ' ' VAL . . . . . 0.551 HG12 ' HB3' ' E' ' 34' ' ' LEU . 6.1 m -121.62 145.76 27.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.424 0.631 . . . . 0.0 112.617 -172.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 20.4 m -109.87 120.82 43.67 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.619 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 87' ' ' LEU . . . . . 0.629 HD13 HD23 ' E' ' 11' ' ' LEU . 4.7 mp -97.87 144.84 27.02 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 171.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . 0.552 HD12 ' CE1' ' E' ' 8' ' ' PHE . 2.4 mm? -124.4 146.46 48.86 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.075 174.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.07 -168.34 23.83 Favored Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.272 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 90' ' ' TYR . . . . . 0.664 ' CD2' ' HB3' ' A' ' 68' ' ' ASN . 9.9 p90 -151.4 128.57 11.17 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.814 0.816 . . . . 0.0 111.794 177.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 91' ' ' LEU . . . . . 0.473 HD23 ' HB3' ' E' ' 27' ' ' PHE . 7.1 mt . . . . . 0 C--N 1.32 -0.71 0 CA-C-N 113.893 -1.503 . . . . 0.0 109.036 175.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 38.7 mtt . . . . . 0 C--O 1.225 -0.21 0 CA-C-O 120.864 0.364 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.438 ' CE1' HD21 ' B' ' 44' ' ' LEU . 61.0 t80 -64.7 146.39 54.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.54 -171.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.469 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 90.5 t90 -137.89 147.03 44.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.066 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.83 155.22 26.27 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.802 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.575 HD23 HD13 ' A' ' 87' ' ' LEU . 48.2 tp -143.86 108.72 4.93 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.768 0.318 . . . . 0.0 110.964 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -91.19 100.69 13.47 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.001 0.429 . . . . 0.0 110.057 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.519 ' SD ' HD11 ' A' ' 87' ' ' LEU . 57.0 mtp -90.56 138.03 31.88 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.21 -177.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.532 ' HB2' ' HD2' ' A' ' 17' ' ' ARG . 32.6 mmtp -101.24 150.94 37.57 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.911 -175.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.434 ' HD3' ' OG ' ' A' ' 84' ' ' SER . 81.9 Cg_exo -43.13 112.28 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 124.195 3.263 . . . . 0.0 114.745 -172.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.689 ' HA ' ' O ' ' A' ' 79' ' ' THR . 5.7 tt0 60.9 63.47 1.28 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.468 170.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.532 ' HD2' ' HB2' ' A' ' 14' ' ' LYS . 37.7 mtt85 -136.27 155.39 50.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.57 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.698 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 3.3 ttmp? -125.5 115.47 20.27 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.769 -175.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -112.6 119.49 38.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.866 176.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.3 p -79.54 133.39 36.47 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 172.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -108.69 115.95 31.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.08 0.467 . . . . 0.0 112.044 -167.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.6 m -93.18 123.12 36.23 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 169.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.9 mt -93.28 113.76 28.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.217 0.532 . . . . 0.0 111.548 -171.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.427 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.5 mp -85.66 -48.32 16.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.491 178.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.432 ' HD2' HD13 ' A' ' 91' ' ' LEU . 47.0 mttt -119.33 132.47 55.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.267 178.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.6 p -59.62 123.14 15.95 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.545 ' HB3' HD23 ' A' ' 91' ' ' LEU . 3.3 p90 -136.56 161.84 34.76 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -170.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.567 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 21.6 t60 -115.86 128.1 55.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.885 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.578 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 44.1 mt -98.76 131.7 45.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 170.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.567 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 40.5 p -116.05 -15.15 11.17 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -171.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.05 155.04 26.22 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 119.391 -1.385 . . . . 0.0 113.503 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.443 HG23 ' HG ' ' A' ' 87' ' ' LEU . 9.5 p -137.33 124.43 29.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 171.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 62' ' ' GLN . . . -125.87 150.04 48.2 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -170.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.865 ' HB2' HG22 ' A' ' 56' ' ' VAL . 1.8 tm? -104.53 109.52 21.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.689 -174.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.53 -59.42 1.95 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.914 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -104.09 129.4 51.77 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.605 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.588 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 134.84 177.59 15.06 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 119.275 -1.441 . . . . 0.0 113.506 174.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.429 ' HA ' ' HD2' ' A' ' 58' ' ' LYS . 74.4 mt-30 -103.41 -47.82 4.17 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.635 0.255 . . . . 0.0 111.295 176.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -151.2 133.27 15.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.42 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.88 114.86 17.02 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.322 0.582 . . . . 0.0 110.427 170.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -100.15 111.22 23.5 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.6 tp -84.2 115.78 22.6 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.044 -173.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.435 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 98.2 m-85 -117.47 145.34 44.24 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.497 ' HA ' ' O ' ' A' ' 76' ' ' MET . 0.2 OUTLIER -133.09 134.2 43.96 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 171.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -108.59 115.53 30.27 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.407 178.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.638 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -128.71 144.02 51.07 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 58.37 27.35 15.26 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -170.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.7 mttp 59.53 33.18 22.07 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.938 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.533 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 8.7 tp-100 -120.31 124.45 45.63 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -83.07 117.74 23.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.805 0.336 . . . . 0.0 110.878 -176.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -112.51 136.17 52.36 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.719 176.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.1 tp -78.38 109.89 13.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 168.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.481 HG13 ' CD2' ' E' ' 88' ' ' LEU . 2.7 t -82.97 -50.28 15.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.356 -173.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.433 ' HB1' HG11 ' A' ' 63' ' ' VAL . . . -155.4 144.16 20.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.187 -178.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.8 m -108.32 102.42 11.54 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 172.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.865 HG22 ' HB2' ' A' ' 34' ' ' LEU . 13.4 p -120.98 112.99 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-O 122.205 1.003 . . . . 0.0 110.781 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.7 p -123.31 -178.0 3.86 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.914 -174.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.429 ' HD2' ' HA ' ' A' ' 38' ' ' GLN . 29.8 mtpp -59.66 -31.55 69.64 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.053 0.454 . . . . 0.0 110.222 169.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.06 -40.35 62.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.614 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.7 mt -112.46 84.47 6.27 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 173.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.2 0.74 6.23 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.111 2.54 . . . . 0.0 114.352 -166.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 18.9 pt20 -169.81 130.46 1.02 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.096 0.474 . . . . 0.0 111.127 -177.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.433 HG11 ' HB1' ' A' ' 54' ' ' ALA . 95.4 t -118.81 116.56 51.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.297 175.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.44 122.41 39.3 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.04 176.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -138.78 168.5 19.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.057 0.456 . . . . 0.0 111.527 -176.566 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 7.7 t0 -116.07 99.56 7.33 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.188 0.518 . . . . 0.0 110.232 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.682 HD21 HD23 ' E' ' 88' ' ' LEU . 21.0 mt -113.42 137.37 51.63 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.893 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.66 ' HB2' ' CD2' ' E' ' 90' ' ' TYR . 3.8 m-20 -138.0 118.18 13.56 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 176.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -117.37 151.46 36.98 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.358 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.6 t -113.02 152.99 28.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.068 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -69.68 -12.1 61.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.377 -176.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.2 -12.08 68.42 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.822 175.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -100.75 164.32 11.91 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -143.49 127.83 17.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.973 0.416 . . . . 0.0 109.961 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.638 HG22 ' HB2' ' A' ' 46' ' ' ALA . 10.9 pt -131.42 179.62 4.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.04 -170.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 12.0 mtm -136.05 135.56 39.51 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 171.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.447 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 1.1 m-85 -112.61 128.2 56.31 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.698 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 34.5 p90 -153.55 137.17 16.0 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.303 0.573 . . . . 0.0 112.105 -177.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.689 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 5.9 p -109.21 138.32 45.74 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.04 -177.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.79 162.3 13.91 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.194 176.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.87 -174.73 44.58 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -175.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -115.46 102.83 10.17 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.092 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.588 ' CB ' ' HA3' ' A' ' 37' ' ' GLY . . . -175.46 162.74 2.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.562 171.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.434 ' OG ' ' HD3' ' A' ' 15' ' ' PRO . 1.1 m -116.01 126.01 53.24 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.659 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.407 HG11 ' CG1' ' A' ' 56' ' ' VAL . 2.8 m -116.8 148.73 19.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -174.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.4 m -108.5 113.58 26.73 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.653 173.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.575 HD13 HD23 ' A' ' 11' ' ' LEU . 5.2 mp -89.62 148.64 23.22 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 170.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.702 HD23 HD21 ' B' ' 67' ' ' LEU . 0.9 OUTLIER -132.06 138.93 48.36 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.079 -178.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.7 -167.12 24.75 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.878 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.682 ' CD2' ' HB2' ' B' ' 68' ' ' ASN . 13.0 p90 -150.71 128.86 11.9 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.995 0.902 . . . . 0.0 111.745 177.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.545 HD23 ' HB3' ' A' ' 27' ' ' PHE . 8.2 mt . . . . . 0 C--N 1.322 -0.63 0 CA-C-N 113.941 -1.481 . . . . 0.0 109.655 176.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 38.7 mtt . . . . . 0 C--O 1.226 -0.183 0 CA-C-O 120.91 0.386 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . 0.465 ' CE1' HD21 ' C' ' 44' ' ' LEU . 61.3 t80 -64.55 146.37 54.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.553 -171.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . 0.464 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 90.5 t90 -138.03 147.02 43.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.01 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.81 155.23 26.27 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.87 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.583 HD23 HD13 ' B' ' 87' ' ' LEU . 47.6 tp -143.88 108.78 4.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.743 0.306 . . . . 0.0 110.976 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -91.17 100.75 13.52 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.973 0.416 . . . . 0.0 110.039 173.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . 0.523 ' SD ' HD11 ' B' ' 87' ' ' LEU . 57.4 mtp -90.61 137.96 31.94 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.196 -177.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.524 ' HB2' ' HD2' ' B' ' 17' ' ' ARG . 32.6 mmtp -101.17 150.99 37.58 Favored Pre-proline 0 C--N 1.317 -0.834 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.938 -175.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.436 ' HD3' ' OG ' ' B' ' 84' ' ' SER . 83.3 Cg_exo -43.19 112.23 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 124.187 3.258 . . . . 0.0 114.853 -172.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.683 ' HA ' ' O ' ' B' ' 79' ' ' THR . 5.7 tt0 61.0 63.33 1.28 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.502 170.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.524 ' HD2' ' HB2' ' B' ' 14' ' ' LYS . 37.7 mtt85 -136.19 155.56 49.96 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.601 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.694 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 3.3 ttmp? -125.61 115.43 20.13 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.762 -175.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -112.64 119.38 37.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.842 176.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 10.1 p -79.55 133.33 36.46 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 172.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -108.67 116.03 31.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.063 0.459 . . . . 0.0 112.02 -167.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 28.3 m -93.12 123.16 36.19 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 169.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 52.9 mt -93.28 113.77 28.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.179 0.514 . . . . 0.0 111.536 -172.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.425 ' N ' HD12 ' B' ' 24' ' ' ILE . 4.5 mp -85.56 -48.46 16.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.543 178.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.444 ' HD2' HD13 ' B' ' 91' ' ' LEU . 47.2 mttt -119.32 132.46 55.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.267 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 12.7 p -59.58 123.09 15.74 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . 0.538 ' HB3' HD23 ' B' ' 91' ' ' LEU . 3.3 p90 -136.56 161.76 34.98 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -169.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' HIS . . . . . 0.565 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 22.0 t60 -115.83 128.03 55.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.847 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.583 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 43.7 mt -98.68 131.7 45.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 170.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.565 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 41.0 p -116.06 -15.16 11.17 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -171.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.15 154.98 26.13 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 119.377 -1.392 . . . . 0.0 113.535 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.443 HG23 ' HG ' ' B' ' 87' ' ' LEU . 9.5 p -137.26 124.4 30.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 171.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' B' ' 62' ' ' GLN . . . -125.77 150.05 48.07 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -170.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.885 ' HB2' HG22 ' B' ' 56' ' ' VAL . 1.8 tm? -104.6 109.58 21.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.688 -174.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.52 -59.47 1.94 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.917 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -104.02 129.38 51.64 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.712 175.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.585 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 134.73 177.53 15.01 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 119.222 -1.466 . . . . 0.0 113.485 174.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . 0.427 ' HA ' ' HD2' ' B' ' 58' ' ' LYS . 74.3 mt-30 -103.37 -47.85 4.17 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.633 0.254 . . . . 0.0 111.294 176.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -151.2 133.29 15.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.385 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.92 114.89 17.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.356 0.598 . . . . 0.0 110.453 170.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -100.15 111.14 23.42 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 48.2 tp -84.1 115.74 22.53 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.098 -173.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . 0.435 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 98.2 m-85 -117.43 145.37 44.18 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.487 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.2 OUTLIER -133.17 134.19 43.79 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.235 0.54 . . . . 0.0 109.549 171.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -108.51 115.54 30.29 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.357 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.635 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -128.8 144.06 51.07 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 58.42 27.29 15.25 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -170.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 59.7 mttp 59.46 33.24 22.19 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.923 -175.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . 0.54 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 8.7 tp-100 -120.31 124.48 45.7 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -82.98 117.61 22.92 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.767 0.318 . . . . 0.0 111.01 -176.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -112.47 136.2 52.26 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.672 176.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 6.2 tp -78.33 109.86 13.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 168.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.506 HG13 ' CD2' ' A' ' 88' ' ' LEU . 2.7 t -83.08 -50.14 15.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.3 -173.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.424 ' HB1' HG11 ' B' ' 63' ' ' VAL . . . -155.46 144.14 20.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.141 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 23.6 m -108.38 102.49 11.59 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 172.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . 0.885 HG22 ' HB2' ' B' ' 34' ' ' LEU . 13.3 p -121.01 112.95 37.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 122.224 1.012 . . . . 0.0 110.739 -175.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 68.2 p -123.29 -177.89 3.83 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.975 -174.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . 0.427 ' HD2' ' HA ' ' B' ' 38' ' ' GLN . 29.8 mtpp -59.66 -31.6 69.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.18 0.514 . . . . 0.0 110.223 169.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.06 -40.3 62.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.629 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 83.9 mt -112.52 84.6 6.46 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 173.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.18 0.68 6.32 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.051 2.501 . . . . 0.0 114.427 -166.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . 0.432 ' HA ' ' HA ' ' B' ' 33' ' ' ALA . 18.9 pt20 -169.77 130.49 1.03 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.167 0.508 . . . . 0.0 111.095 -177.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.424 HG11 ' HB1' ' B' ' 54' ' ' ALA . 95.6 t -118.8 116.53 51.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.308 175.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.45 122.3 39.2 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.067 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' B' ' 30' ' ' SER . 0.3 OUTLIER -138.67 168.57 19.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.02 0.438 . . . . 0.0 111.541 -176.617 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 7.6 t0 -116.07 99.56 7.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.145 0.498 . . . . 0.0 110.16 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.702 HD21 HD23 ' A' ' 88' ' ' LEU . 21.1 mt -113.48 137.21 51.88 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.978 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . 0.682 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 3.8 m-20 -137.88 118.16 13.66 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 176.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -117.42 151.51 36.9 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.271 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 14.8 t -113.12 153.01 28.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.067 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -69.65 -12.13 61.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.37 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.09 -12.19 68.48 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.849 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -100.72 164.25 11.95 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -143.44 127.9 17.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.936 0.398 . . . . 0.0 109.988 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.635 HG22 ' HB2' ' B' ' 46' ' ' ALA . 10.9 pt -131.56 179.63 4.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.958 -170.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.487 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 11.9 mtm -136.01 135.66 39.65 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 171.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . 0.46 ' CD1' ' HB2' ' B' ' 44' ' ' LEU . 1.1 m-85 -112.66 128.29 56.35 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.694 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 34.3 p90 -153.63 137.15 15.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.345 0.593 . . . . 0.0 112.093 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.683 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 5.9 p -109.15 138.21 45.86 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.068 -177.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.81 162.43 13.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.184 176.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.87 -174.78 44.64 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -175.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -115.45 102.83 10.17 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.614 -0.834 . . . . 0.0 110.026 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.585 ' CB ' ' HA3' ' B' ' 37' ' ' GLY . . . -175.54 162.69 2.84 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.528 171.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . 0.436 ' OG ' ' HD3' ' B' ' 15' ' ' PRO . 1.1 m -115.98 126.01 53.27 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.553 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.413 HG11 ' CG1' ' B' ' 56' ' ' VAL . 2.7 m -116.87 148.81 19.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.147 0.499 . . . . 0.0 112.329 -174.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . 0.419 ' OG ' HG22 ' C' ' 52' ' ' ILE . 43.1 m -108.52 113.63 26.8 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.63 173.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.583 HD13 HD23 ' B' ' 11' ' ' LEU . 5.3 mp -89.74 148.62 23.15 Favored 'General case' 0 CA--C 1.5 -0.953 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.448 170.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.675 HD23 HD21 ' C' ' 67' ' ' LEU . 0.9 OUTLIER -132.04 138.98 48.41 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.078 -178.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.78 -167.17 24.93 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.872 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' TYR . . . . . 0.66 ' CD2' ' HB2' ' C' ' 68' ' ' ASN . 12.9 p90 -150.66 128.84 11.93 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.889 0.852 . . . . 0.0 111.786 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . 0.538 HD23 ' HB3' ' B' ' 27' ' ' PHE . 8.3 mt . . . . . 0 C--N 1.321 -0.673 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.632 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 38.6 mtt . . . . . 0 C--O 1.225 -0.226 0 CA-C-O 120.884 0.373 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 8' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' D' ' 46' ' ' ALA . 61.5 t80 -64.56 146.33 54.79 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.586 -171.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . 0.461 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 90.6 t90 -137.98 147.01 43.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.024 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.79 155.23 26.27 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.864 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.561 HD23 HD13 ' C' ' 87' ' ' LEU . 48.5 tp -143.93 108.71 4.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.805 0.336 . . . . 0.0 110.902 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -91.16 100.77 13.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.997 0.427 . . . . 0.0 109.992 173.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 13' ' ' MET . . . . . 0.515 ' SD ' HD11 ' C' ' 87' ' ' LEU . 57.3 mtp -90.65 137.96 31.95 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.216 -177.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . 0.513 ' HB2' ' HD2' ' C' ' 17' ' ' ARG . 32.6 mmtp -101.2 150.97 37.58 Favored Pre-proline 0 C--N 1.317 -0.81 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.898 -175.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . 0.438 ' HD3' ' OG ' ' C' ' 84' ' ' SER . 84.3 Cg_exo -43.15 112.33 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 124.146 3.231 . . . . 0.0 114.847 -172.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . 0.69 ' HA ' ' O ' ' C' ' 79' ' ' THR . 5.7 tt0 60.81 63.51 1.29 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.513 170.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 17' ' ' ARG . . . . . 0.513 ' HD2' ' HB2' ' C' ' 14' ' ' LYS . 37.8 mtt85 -136.28 155.53 49.96 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.613 178.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 18' ' ' LYS . . . . . 0.694 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 3.3 ttmp? -125.67 115.46 20.14 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.703 -175.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -112.73 119.42 38.01 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.893 176.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 10.0 p -79.53 133.46 36.47 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 172.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -108.68 116.03 31.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.089 0.471 . . . . 0.0 112.075 -167.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 28.3 m -93.19 123.2 36.3 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 169.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 52.8 mt -93.3 113.8 28.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.135 0.493 . . . . 0.0 111.448 -172.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . 0.425 HD12 ' N ' ' C' ' 24' ' ' ILE . 4.5 mp -85.62 -48.36 16.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.585 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . 0.451 ' HD2' HD13 ' C' ' 91' ' ' LEU . 47.1 mttt -119.39 132.4 55.83 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.242 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 12.4 p -59.54 123.13 15.87 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 177.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 27' ' ' PHE . . . . . 0.545 ' HB3' HD23 ' C' ' 91' ' ' LEU . 3.2 p90 -136.6 161.79 34.91 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -170.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 28' ' ' HIS . . . . . 0.572 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 21.9 t60 -115.83 128.06 55.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.26 -1.337 . . . . 0.0 109.879 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . 0.578 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 44.3 mt -98.69 131.71 45.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 170.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.572 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 39.7 p -116.06 -15.19 11.16 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.813 -171.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.04 155.04 26.22 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 119.355 -1.403 . . . . 0.0 113.533 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.438 HG23 ' HG ' ' C' ' 87' ' ' LEU . 9.5 p -137.36 124.36 29.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 171.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' C' ' 62' ' ' GLN . . . -125.78 150.17 47.99 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -170.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.868 ' HB2' HG22 ' C' ' 56' ' ' VAL . 1.8 tm? -104.68 109.58 21.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.63 -174.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.55 -59.45 1.95 Allowed 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.925 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -104.03 129.25 51.65 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.689 175.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 37' ' ' GLY . . . . . 0.593 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 134.87 177.7 15.14 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 119.339 -1.41 . . . . 0.0 113.451 174.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 38' ' ' GLN . . . . . 0.422 ' HA ' ' HD2' ' C' ' 58' ' ' LYS . 74.5 mt-30 -103.43 -47.84 4.16 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.69 0.281 . . . . 0.0 111.303 176.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -151.12 133.22 15.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.441 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.401 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -128.89 114.83 16.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.336 0.589 . . . . 0.0 110.404 170.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -100.07 111.25 23.55 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 48.6 tp -84.2 115.88 22.65 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.004 -173.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 43' ' ' TYR . . . . . 0.435 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 98.2 m-85 -117.51 145.38 44.26 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 176.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.492 ' HA ' ' O ' ' C' ' 76' ' ' MET . 0.2 OUTLIER -133.14 134.1 43.74 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 171.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -108.56 115.5 30.21 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.418 178.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.616 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -128.68 143.99 51.06 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 58.44 27.31 15.3 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -170.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 59.7 mttp 59.53 33.17 22.07 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.957 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . 0.545 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 8.7 tp-100 -120.2 124.39 45.59 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -83.05 117.75 23.05 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.917 0.389 . . . . 0.0 110.97 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -112.53 136.27 52.25 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.692 176.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . 0.419 HG22 ' OG ' ' B' ' 86' ' ' SER . 6.1 tp -78.4 109.92 13.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 168.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 53' ' ' VAL . . . . . 0.509 HG13 ' CD2' ' B' ' 88' ' ' LEU . 2.7 t -83.04 -50.21 15.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.377 -173.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 54' ' ' ALA . . . . . 0.421 ' HB1' HG11 ' C' ' 63' ' ' VAL . . . -155.49 144.09 20.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.187 -178.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 23.7 m -108.3 102.54 11.66 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 172.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . 0.868 HG22 ' HB2' ' C' ' 34' ' ' LEU . 13.3 p -121.02 113.02 38.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 122.225 1.012 . . . . 0.0 110.753 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 68.3 p -123.32 -177.95 3.85 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.969 -174.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 58' ' ' LYS . . . . . 0.422 ' HD2' ' HA ' ' C' ' 38' ' ' GLN . 29.8 mtpp -59.61 -31.62 69.66 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.106 0.479 . . . . 0.0 110.249 169.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.0 -40.38 62.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.598 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 84.0 mt -112.48 84.55 6.36 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 173.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.28 0.73 6.3 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.07 2.513 . . . . 0.0 114.367 -166.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . 0.44 ' HA ' ' HA ' ' C' ' 33' ' ' ALA . 18.8 pt20 -169.8 130.5 1.02 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.169 0.509 . . . . 0.0 111.133 -177.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.421 HG11 ' HB1' ' C' ' 54' ' ' ALA . 95.6 t -118.74 116.61 51.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.283 175.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.51 122.35 39.31 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.01 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' C' ' 30' ' ' SER . 0.3 OUTLIER -138.7 168.58 19.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.495 -176.576 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 66' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 7.6 t0 -116.1 99.51 7.29 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.232 0.539 . . . . 0.0 110.231 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.675 HD21 HD23 ' B' ' 88' ' ' LEU . 21.1 mt -113.43 137.26 51.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.916 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . 0.66 ' HB2' ' CD2' ' B' ' 90' ' ' TYR . 3.8 m-20 -137.91 118.1 13.56 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 176.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -117.36 151.44 37.01 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.257 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 14.8 t -113.06 153.07 28.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.085 -177.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -69.65 -12.24 61.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.322 -176.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.07 -12.17 68.59 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.818 -0.705 . . . . 0.0 111.911 175.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -100.68 164.33 11.92 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -143.49 127.93 17.9 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.616 HG22 ' HB2' ' C' ' 46' ' ' ALA . 10.8 pt -131.49 179.64 4.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.995 -170.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.492 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 12.0 mtm -136.08 135.62 39.49 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 171.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 77' ' ' PHE . . . . . 0.455 ' CD1' ' HB2' ' C' ' 44' ' ' LEU . 1.1 m-85 -112.56 128.2 56.29 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 78' ' ' TYR . . . . . 0.694 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 34.3 p90 -153.6 137.24 16.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.314 0.578 . . . . 0.0 112.031 -177.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . 0.69 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 5.9 p -109.21 138.1 46.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.103 -177.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.73 162.36 13.85 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.223 176.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.82 -174.79 44.72 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -175.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -115.48 102.8 10.14 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.078 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . 0.593 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -175.42 162.7 2.9 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.571 171.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . 0.438 ' OG ' ' HD3' ' C' ' 15' ' ' PRO . 1.0 OUTLIER -115.95 125.86 53.11 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.654 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.408 HG11 ' CG1' ' C' ' 56' ' ' VAL . 2.8 m -116.76 148.91 19.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.213 0.53 . . . . 0.0 112.358 -174.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 42.8 m -108.54 113.59 26.73 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.645 173.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . 0.561 HD13 HD23 ' C' ' 11' ' ' LEU . 5.3 mp -89.68 148.59 23.21 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 170.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . 0.707 HD23 HD21 ' D' ' 67' ' ' LEU . 0.9 OUTLIER -132.01 138.94 48.43 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.098 -178.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.71 -167.06 24.67 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.847 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 90' ' ' TYR . . . . . 0.674 ' CD2' ' HB2' ' D' ' 68' ' ' ASN . 12.8 p90 -150.74 128.77 11.81 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.91 0.862 . . . . 0.0 111.769 177.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . 0.545 HD23 ' HB3' ' C' ' 27' ' ' PHE . 8.3 mt . . . . . 0 C--N 1.321 -0.665 0 CA-C-N 113.964 -1.471 . . . . 0.0 109.6 176.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 38.6 mtt . . . . . 0 C--O 1.225 -0.221 0 CA-C-O 120.82 0.343 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 8' ' ' PHE . . . . . 0.439 ' CE1' HD21 ' E' ' 44' ' ' LEU . 61.1 t80 -64.59 146.44 54.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.481 -171.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 9' ' ' TRP . . . . . 0.465 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 90.5 t90 -138.09 147.06 43.65 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.034 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.85 155.17 26.24 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.792 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . 0.582 HD23 HD13 ' D' ' 87' ' ' LEU . 48.4 tp -143.87 108.75 4.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.766 0.317 . . . . 0.0 110.973 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -91.23 100.75 13.51 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.002 0.429 . . . . 0.0 110.021 173.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 13' ' ' MET . . . . . 0.519 ' SD ' HD11 ' D' ' 87' ' ' LEU . 57.3 mtp -90.56 137.93 31.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.196 -177.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 14' ' ' LYS . . . . . 0.519 ' HB2' ' HD2' ' D' ' 17' ' ' ARG . 32.6 mmtp -101.22 150.99 37.6 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.909 -175.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . 0.436 ' HD3' ' OG ' ' D' ' 84' ' ' SER . 81.9 Cg_exo -43.3 112.34 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 124.133 3.222 . . . . 0.0 114.796 -172.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . 0.694 ' HA ' ' O ' ' D' ' 79' ' ' THR . 5.7 tt0 60.92 63.38 1.29 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.572 170.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 17' ' ' ARG . . . . . 0.519 ' HD2' ' HB2' ' D' ' 14' ' ' LYS . 37.7 mtt85 -136.22 155.45 50.1 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.613 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . 0.685 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 3.3 ttmp? -125.55 115.46 20.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.755 -175.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -112.75 119.36 37.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.878 176.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 10.0 p -79.55 133.42 36.46 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 172.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -108.7 116.0 31.16 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.089 0.471 . . . . 0.0 112.1 -167.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 28.4 m -93.08 123.17 36.15 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 169.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 52.5 mt -93.29 113.73 28.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.214 0.531 . . . . 0.0 111.542 -172.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . 0.436 HD12 ' N ' ' D' ' 24' ' ' ILE . 4.5 mp -85.64 -48.35 16.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.58 178.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . 0.443 ' HD2' HD13 ' D' ' 91' ' ' LEU . 47.1 mttt -119.35 132.45 55.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.283 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 12.5 p -59.54 123.14 15.91 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 27' ' ' PHE . . . . . 0.551 ' HB3' HD23 ' D' ' 91' ' ' LEU . 3.2 p90 -136.59 161.74 35.07 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -170.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 28' ' ' HIS . . . . . 0.561 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 22.1 t60 -115.78 128.07 55.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.899 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 29' ' ' ILE . . . . . 0.59 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 44.0 mt -98.67 131.6 45.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 170.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . 0.561 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 41.3 p -115.96 -15.24 11.22 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -171.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.06 155.06 26.24 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 119.41 -1.376 . . . . 0.0 113.53 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.424 HG23 ' HG ' ' D' ' 87' ' ' LEU . 9.6 p -137.38 124.37 29.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 171.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' D' ' 62' ' ' GLN . . . -125.81 150.0 48.17 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -170.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 34' ' ' LEU . . . . . 0.851 ' HB2' HG22 ' D' ' 56' ' ' VAL . 1.8 tm? -104.58 109.53 21.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.65 -174.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.49 -59.51 1.94 Allowed 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.851 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -104.0 129.41 51.6 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 175.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . 0.595 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 134.73 177.58 15.05 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 119.306 -1.426 . . . . 0.0 113.489 174.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 38' ' ' GLN . . . . . 0.412 ' HA ' ' HD2' ' D' ' 58' ' ' LYS . 74.3 mt-30 -103.33 -47.79 4.19 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.691 0.282 . . . . 0.0 111.361 176.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -151.22 133.25 15.16 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.326 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.86 114.84 17.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.334 0.588 . . . . 0.0 110.447 170.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -100.15 111.16 23.44 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 48.5 tp -84.03 115.85 22.55 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.085 -173.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 43' ' ' TYR . . . . . 0.437 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 98.2 m-85 -117.52 145.38 44.26 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.49 ' HA ' ' O ' ' D' ' 76' ' ' MET . 0.2 OUTLIER -133.15 134.21 43.87 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 171.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 45' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -108.65 115.65 30.5 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.298 178.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.631 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -128.82 144.03 51.06 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 175.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 58.4 27.36 15.31 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -170.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 59.8 mttp 59.35 33.24 22.37 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.968 -175.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . 0.544 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 8.7 tp-100 -120.22 124.49 45.81 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -82.88 117.64 22.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.768 0.318 . . . . 0.0 111.011 -176.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -112.48 136.29 52.16 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.713 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 6.2 tp -78.43 109.83 13.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 168.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 53' ' ' VAL . . . . . 0.496 HG13 ' CD2' ' C' ' 88' ' ' LEU . 2.7 t -82.99 -50.22 15.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.311 -173.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 54' ' ' ALA . . . . . 0.437 ' HB1' HG11 ' D' ' 63' ' ' VAL . . . -155.47 144.1 20.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.175 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 23.7 m -108.26 102.54 11.65 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 172.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 56' ' ' VAL . . . . . 0.851 HG22 ' HB2' ' D' ' 34' ' ' LEU . 13.2 p -121.06 112.93 37.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 122.15 0.976 . . . . 0.0 110.743 -175.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 69.4 p -123.29 -177.87 3.82 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.937 -174.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 58' ' ' LYS . . . . . 0.412 ' HD2' ' HA ' ' D' ' 38' ' ' GLN . 29.8 mtpp -59.74 -31.53 69.72 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.184 169.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.09 -40.33 62.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.582 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 83.5 mt -112.43 84.56 6.3 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 173.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.18 0.73 6.24 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.017 2.478 . . . . 0.0 114.465 -166.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . 0.437 ' HA ' ' HA ' ' D' ' 33' ' ' ALA . 18.9 pt20 -169.82 130.46 1.02 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.197 0.522 . . . . 0.0 111.088 -177.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.437 HG11 ' HB1' ' D' ' 54' ' ' ALA . 95.0 t -118.82 116.71 51.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.237 175.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.51 122.4 39.37 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.039 176.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 65' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' D' ' 30' ' ' SER . 0.3 OUTLIER -138.76 168.58 19.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.465 -176.574 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 66' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 7.7 t0 -116.12 99.47 7.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.275 0.56 . . . . 0.0 110.26 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.707 HD21 HD23 ' C' ' 88' ' ' LEU . 21.0 mt -113.32 137.31 51.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.01 178.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 68' ' ' ASN . . . . . 0.674 ' HB2' ' CD2' ' C' ' 90' ' ' TYR . 3.8 m-20 -137.95 118.21 13.63 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 176.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -117.48 151.36 37.26 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.236 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 14.7 t -112.97 153.06 28.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.094 -177.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -69.72 -12.12 61.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.377 -176.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.14 -12.14 68.46 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.832 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -100.8 164.28 11.92 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -143.48 127.92 17.91 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.021 0.438 . . . . 0.0 109.928 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.631 HG22 ' HB2' ' D' ' 46' ' ' ALA . 10.9 pt -131.55 179.63 4.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.013 -170.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 76' ' ' MET . . . . . 0.49 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 12.0 mtm -136.08 135.58 39.45 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 171.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 77' ' ' PHE . . . . . 0.453 ' CD1' ' HB2' ' D' ' 44' ' ' LEU . 1.1 m-85 -112.61 128.26 56.32 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 78' ' ' TYR . . . . . 0.685 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 34.4 p90 -153.63 137.11 15.88 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.336 0.589 . . . . 0.0 112.064 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 79' ' ' THR . . . . . 0.694 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 5.9 p -109.09 138.22 45.79 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.07 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.83 162.47 13.77 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.14 176.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.82 -174.87 44.8 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 -175.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -115.41 102.8 10.16 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.037 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . 0.595 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -175.4 162.71 2.92 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.563 171.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 84' ' ' SER . . . . . 0.436 ' OG ' ' HD3' ' D' ' 15' ' ' PRO . 1.1 m -115.98 126.08 53.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.614 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.413 HG11 ' CG1' ' D' ' 56' ' ' VAL . 2.7 m -116.84 148.76 19.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.119 0.485 . . . . 0.0 112.306 -174.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 42.4 m -108.41 113.68 26.92 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.63 173.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 87' ' ' LEU . . . . . 0.582 HD13 HD23 ' D' ' 11' ' ' LEU . 5.2 mp -89.76 148.63 23.13 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 170.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.685 HD23 HD21 ' E' ' 67' ' ' LEU . 0.9 OUTLIER -132.1 138.99 48.32 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.002 -178.839 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.73 -167.15 24.84 Favored Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.897 -177.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 90' ' ' TYR . . . . . 0.656 ' CD2' ' HB2' ' E' ' 68' ' ' ASN . 13.0 p90 -150.66 128.86 11.95 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.873 0.844 . . . . 0.0 111.797 177.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . 0.551 HD23 ' HB3' ' D' ' 27' ' ' PHE . 8.1 mt . . . . . 0 C--N 1.321 -0.671 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.669 176.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 38.7 mtt . . . . . 0 C--O 1.225 -0.212 0 CA-C-O 120.846 0.355 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' E' E ' 8' ' ' PHE . . . . . 0.428 ' CE1' HD21 ' A' ' 44' ' ' LEU . 61.0 t80 -64.68 146.44 54.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.525 -171.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 9' ' ' TRP . . . . . 0.455 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 90.4 t90 -137.99 146.98 43.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.056 178.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.76 155.21 26.27 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.875 177.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 11' ' ' LEU . . . . . 0.578 HD23 HD13 ' E' ' 87' ' ' LEU . 47.9 tp -143.93 108.78 4.93 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.803 0.335 . . . . 0.0 111.014 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -91.17 100.72 13.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.98 0.419 . . . . 0.0 110.066 173.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 13' ' ' MET . . . . . 0.515 ' SD ' HD11 ' E' ' 87' ' ' LEU . 57.3 mtp -90.56 137.97 31.93 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.141 -177.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 14' ' ' LYS . . . . . 0.521 ' HB2' ' HD2' ' E' ' 17' ' ' ARG . 32.6 mmtp -101.28 150.94 37.59 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.884 -175.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . 0.431 ' HD3' ' OG ' ' E' ' 84' ' ' SER . 84.4 Cg_exo -43.1 112.18 0.27 Allowed 'Trans proline' 0 N--CA 1.474 0.368 0 C-N-CA 124.157 3.238 . . . . 0.0 114.869 -172.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 16' ' ' GLU . . . . . 0.693 ' HA ' ' O ' ' E' ' 79' ' ' THR . 5.7 tt0 61.06 63.24 1.28 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.579 170.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 17' ' ' ARG . . . . . 0.521 ' HD2' ' HB2' ' E' ' 14' ' ' LYS . 38.0 mtt85 -136.19 155.47 50.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.611 178.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . 0.687 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 3.3 ttmp? -125.51 115.38 20.12 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.777 -175.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -112.58 119.4 38.0 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 176.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 10.1 p -79.58 133.29 36.44 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -108.57 116.04 31.22 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.076 0.465 . . . . 0.0 112.098 -167.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 28.4 m -93.05 123.14 36.1 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 169.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 52.7 mt -93.27 113.8 28.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.242 0.544 . . . . 0.0 111.513 -172.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . 0.435 HD12 ' N ' ' E' ' 24' ' ' ILE . 4.5 mp -85.64 -48.37 16.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.502 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . 0.449 ' HD2' HD13 ' E' ' 91' ' ' LEU . 47.2 mttt -119.32 132.45 55.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.214 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 12.6 p -59.5 123.15 15.9 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 27' ' ' PHE . . . . . 0.533 ' HB3' HD23 ' E' ' 91' ' ' LEU . 3.3 p90 -136.55 161.73 35.06 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -170.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 28' ' ' HIS . . . . . 0.571 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 22.0 t60 -115.78 128.16 55.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.894 178.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 29' ' ' ILE . . . . . 0.578 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 44.3 mt -98.8 131.72 45.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 170.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . 0.571 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 41.0 p -116.08 -15.09 11.16 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.858 -171.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.11 155.05 26.24 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 119.307 -1.425 . . . . 0.0 113.494 178.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.438 HG23 ' HG ' ' E' ' 87' ' ' LEU . 9.6 p -137.29 124.27 29.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 171.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' E' ' 62' ' ' GLN . . . -125.76 150.11 48.01 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -170.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 34' ' ' LEU . . . . . 0.872 ' HB2' HG22 ' E' ' 56' ' ' VAL . 1.8 tm? -104.61 109.58 21.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.628 -174.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.58 -59.45 1.95 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.87 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -104.02 129.41 51.64 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.68 175.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . 0.594 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 134.7 177.61 15.07 Favored Glycine 0 N--CA 1.437 -1.244 0 C-N-CA 119.325 -1.417 . . . . 0.0 113.506 174.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 38' ' ' GLN . . . . . 0.421 ' HA ' ' HD2' ' E' ' 58' ' ' LYS . 74.4 mt-30 -103.33 -47.89 4.17 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.669 0.271 . . . . 0.0 111.306 176.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -151.16 133.23 15.2 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.404 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . 0.402 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -128.89 114.89 17.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.394 0.616 . . . . 0.0 110.413 170.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 41' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -100.16 111.14 23.42 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 48.5 tp -84.08 115.75 22.53 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.061 -173.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 43' ' ' TYR . . . . . 0.427 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 98.2 m-85 -117.46 145.38 44.2 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 44' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' E' ' 76' ' ' MET . 0.2 OUTLIER -133.13 134.18 43.86 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 171.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 45' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -108.57 115.51 30.23 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.344 178.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . 0.615 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -128.74 143.95 51.05 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 58.57 27.22 15.39 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -170.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 59.7 mttp 59.49 33.17 22.13 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.937 -175.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 49' ' ' GLN . . . . . 0.543 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 8.7 tp-100 -120.24 124.5 45.82 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -83.07 117.68 23.02 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.826 0.346 . . . . 0.0 110.92 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -112.48 136.36 52.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.663 176.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 6.2 tp -78.5 109.88 13.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 168.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . 0.503 HG13 ' CD2' ' D' ' 88' ' ' LEU . 2.7 t -83.02 -50.24 15.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.319 -173.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 54' ' ' ALA . . . . . 0.425 ' HB1' HG11 ' E' ' 63' ' ' VAL . . . -155.39 144.19 20.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.205 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 23.6 m -108.37 102.51 11.61 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 172.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . 0.872 HG22 ' HB2' ' E' ' 34' ' ' LEU . 13.2 p -121.0 112.98 38.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 122.143 0.973 . . . . 0.0 110.761 -175.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 70.6 p -123.25 -177.87 3.82 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.982 -174.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 58' ' ' LYS . . . . . 0.421 ' HD2' ' HA ' ' E' ' 38' ' ' GLN . 29.8 mtpp -59.81 -31.51 69.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.03 0.443 . . . . 0.0 110.228 169.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.99 -40.47 62.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.566 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 83.9 mt -112.46 84.58 6.36 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 173.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.25 0.71 6.31 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.043 2.495 . . . . 0.0 114.393 -166.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 62' ' ' GLN . . . . . 0.435 ' HA ' ' HA ' ' E' ' 33' ' ' ALA . 18.9 pt20 -169.68 130.56 1.05 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.106 0.479 . . . . 0.0 111.085 -177.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . 0.425 HG11 ' HB1' ' E' ' 54' ' ' ALA . 95.8 t -118.84 116.64 51.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.328 175.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.45 122.31 39.21 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.049 176.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 65' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' E' ' 30' ' ' SER . 0.3 OUTLIER -138.72 168.55 19.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.436 -176.543 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 66' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 7.6 t0 -116.05 99.54 7.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.207 0.527 . . . . 0.0 110.201 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 67' ' ' LEU . . . . . 0.685 HD21 HD23 ' D' ' 88' ' ' LEU . 21.0 mt -113.45 137.36 51.65 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.918 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 68' ' ' ASN . . . . . 0.656 ' HB2' ' CD2' ' D' ' 90' ' ' TYR . 3.8 m-20 -137.98 118.16 13.56 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 176.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -117.38 151.42 37.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.36 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 15.1 t -113.06 152.97 28.89 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -177.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -69.69 -12.19 61.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.305 -176.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.06 -12.15 68.63 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.903 175.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -100.67 164.3 11.94 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -143.51 127.91 17.87 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 75' ' ' ILE . . . . . 0.615 HG22 ' HB2' ' E' ' 46' ' ' ALA . 10.9 pt -131.52 179.66 4.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.004 -170.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 76' ' ' MET . . . . . 0.483 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 11.9 mtm -136.09 135.51 39.39 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 171.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 77' ' ' PHE . . . . . 0.458 ' CD1' ' HB2' ' E' ' 44' ' ' LEU . 1.1 m-85 -112.55 128.25 56.3 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 78' ' ' TYR . . . . . 0.687 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 34.5 p90 -153.57 137.2 16.01 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.295 0.569 . . . . 0.0 112.133 -177.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 79' ' ' THR . . . . . 0.693 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 5.8 p -109.25 138.23 45.92 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.028 -177.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.77 162.42 13.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.16 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.8 -174.73 44.71 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.511 -1.035 . . . . 0.0 110.511 -175.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -115.51 102.8 10.13 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.119 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 83' ' ' ALA . . . . . 0.594 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -175.47 162.63 2.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.574 171.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 84' ' ' SER . . . . . 0.431 ' OG ' ' HD3' ' E' ' 15' ' ' PRO . 1.0 OUTLIER -115.89 125.94 53.28 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.666 179.727 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 85' ' ' VAL . . . . . 0.412 HG11 ' CG1' ' E' ' 56' ' ' VAL . 2.8 m -116.73 148.79 19.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -174.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 43.6 m -108.53 113.7 26.94 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.573 173.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 87' ' ' LEU . . . . . 0.578 HD13 HD23 ' E' ' 11' ' ' LEU . 5.2 mp -89.76 148.61 23.14 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 170.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . 0.682 HD23 HD21 ' A' ' 67' ' ' LEU . 0.9 OUTLIER -132.0 138.92 48.45 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.06 -178.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.64 -167.0 24.51 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.932 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 90' ' ' TYR . . . . . 0.66 ' CD2' ' HB2' ' A' ' 68' ' ' ASN . 13.2 p90 -150.75 128.82 11.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.851 0.834 . . . . 0.0 111.816 177.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 91' ' ' LEU . . . . . 0.533 HD23 ' HB3' ' E' ' 27' ' ' PHE . 8.3 mt . . . . . 0 C--N 1.321 -0.651 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.634 176.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.441 ' HB2' HD12 ' A' ' 91' ' ' LEU . 47.5 mtt . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 120.584 0.23 . . . . 0.0 111.309 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.456 ' CE1' HD21 ' B' ' 44' ' ' LEU . 56.3 t80 -76.19 151.97 36.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.1 0.476 . . . . 0.0 112.194 -176.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.485 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 89.5 t90 -143.76 147.37 34.08 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.639 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.439 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -151.42 156.47 26.69 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.236 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.564 HD23 HD13 ' A' ' 87' ' ' LEU . 61.2 tp -149.01 109.66 4.25 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.854 0.359 . . . . 0.0 111.394 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -86.03 121.17 28.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.423 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.678 ' SD ' ' HE2' ' A' ' 19' ' ' TYR . 72.4 mmm -101.74 137.37 40.13 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.905 0.383 . . . . 0.0 111.056 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.495 ' HE3' ' HA ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -101.27 146.43 32.17 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.835 175.714 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -49.9 113.39 0.97 Allowed 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 123.174 2.583 . . . . 0.0 113.047 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 61.04 52.06 4.22 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.906 176.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -125.54 138.4 53.96 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.785 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.677 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 51.8 mttp -109.66 126.87 54.12 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.816 0.341 . . . . 0.0 111.767 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.678 ' HE2' ' SD ' ' A' ' 13' ' ' MET . 2.4 m-85 -111.64 103.79 12.12 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 173.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.2 p -86.06 100.58 12.26 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 173.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -114.92 148.78 38.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.379 0.609 . . . . 0.0 112.241 -168.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.9 m -107.97 141.95 38.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.132 173.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 69.0 mt -102.2 138.38 26.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.149 0.5 . . . . 0.0 111.74 -173.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.434 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.1 mp -110.62 -43.4 5.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.196 176.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.509 ' HD2' HD13 ' A' ' 91' ' ' LEU . 15.1 pttm -113.94 120.6 41.24 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.078 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.5 p -58.25 132.15 52.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.66 -178.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.59 ' HB3' HD23 ' A' ' 91' ' ' LEU . 54.5 p90 -139.2 157.6 45.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.577 0.703 . . . . 0.0 112.362 -176.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.626 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 7.1 t60 -114.69 124.76 52.63 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.458 177.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 42.7 mt -89.95 134.93 27.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 171.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.626 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 28.3 p -122.14 -12.32 8.32 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -171.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.12 155.81 27.31 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 119.617 -1.278 . . . . 0.0 113.195 177.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.438 ' CG2' ' HG ' ' A' ' 87' ' ' LEU . 12.3 p -143.3 125.53 12.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 172.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.436 ' HA ' HG21 ' A' ' 56' ' ' VAL . . . -144.22 161.01 39.99 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 122.036 -0.415 . . . . 0.0 111.66 -174.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.641 ' HB3' HG12 ' A' ' 85' ' ' VAL . 3.3 pp -123.44 142.32 51.11 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.828 0.823 . . . . 0.0 111.574 177.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -104.11 -52.6 2.9 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.444 173.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -104.22 128.6 51.96 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.308 -0.626 . . . . 0.0 109.308 169.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.417 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 151.95 156.07 7.3 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 119.627 -1.273 . . . . 0.0 113.587 175.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.474 ' HA ' ' HB2' ' A' ' 58' ' ' LYS . 94.1 mt-30 -102.73 -44.25 5.35 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.699 0.285 . . . . 0.0 111.306 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.52 ' HG3' HG22 ' A' ' 57' ' ' THR . 34.8 tt0 -152.71 122.17 6.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.954 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.559 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -123.67 114.24 19.71 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.558 0.694 . . . . 0.0 110.212 170.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.439 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 31.8 mmtp -96.86 105.85 18.05 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 176.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.9 tp -83.29 112.23 19.69 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -175.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.651 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 92.8 m-85 -118.68 147.2 44.05 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 175.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 76' ' ' MET . 0.3 OUTLIER -131.07 131.08 43.99 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 170.651 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -107.51 112.53 25.33 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.267 178.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.641 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -124.55 138.16 54.35 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.461 178.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 58.81 34.15 23.52 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.236 0.541 . . . . 0.0 110.026 -176.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.3 tttm 56.55 46.58 20.23 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.821 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.591 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 53.3 tp60 -137.84 127.78 25.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.469 176.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -87.18 121.37 29.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.954 0.407 . . . . 0.0 110.372 -176.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.437 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 81.5 m-85 -113.41 130.57 56.27 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.355 175.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.452 HG22 ' HB3' ' E' ' 86' ' ' SER . 4.4 tp -79.57 105.83 9.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.705 0.764 . . . . 0.0 109.048 173.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.541 HG13 HD23 ' E' ' 88' ' ' LEU . 2.5 t -80.46 -49.16 19.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.633 -172.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.514 ' HB2' HD23 ' A' ' 65' ' ' LEU . . . -156.0 148.23 23.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.924 0.393 . . . . 0.0 111.709 -177.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.7 m -110.59 100.75 9.49 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 170.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.49 HG13 ' HB3' ' A' ' 40' ' ' ALA . 7.7 p -118.46 112.66 39.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.62 0.724 . . . . 0.0 109.699 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.52 HG22 ' HG3' ' A' ' 39' ' ' GLU . 63.8 p -122.86 -178.71 4.02 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.173 -172.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.474 ' HB2' ' HA ' ' A' ' 38' ' ' GLN . 56.0 tttt -59.52 -28.99 67.57 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.896 172.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.471 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -83.15 -40.41 19.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.622 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.0 mt -111.07 83.15 3.56 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 13.1 Cg_exo -69.82 0.18 6.06 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.084 2.523 . . . . 0.0 113.879 -168.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -163.2 131.34 3.75 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.335 0.588 . . . . 0.0 111.535 -176.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.403 HG23 ' HB ' ' A' ' 56' ' ' VAL . 96.1 t -118.87 112.66 38.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.382 173.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.95 116.12 27.76 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 174.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.514 HD23 ' HB2' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -137.19 169.6 17.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.055 0.455 . . . . 0.0 111.395 -175.263 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.524 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 9.6 t0 -118.66 119.01 33.18 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.114 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.592 HD21 HD23 ' E' ' 88' ' ' LEU . 8.0 mt -134.16 145.2 49.03 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 175.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -145.35 122.96 11.78 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 173.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -120.94 150.86 40.44 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.041 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.5 t -108.97 177.55 4.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.633 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.04 -19.27 65.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.192 0.52 . . . . 0.0 110.583 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.41 -9.81 81.03 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.272 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -92.72 120.02 32.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.132 0.491 . . . . 0.0 110.568 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -108.13 111.67 23.81 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 176.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.641 HG22 ' HB2' ' A' ' 46' ' ' ALA . 7.6 pt -128.71 156.08 40.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 120.949 0.404 . . . . 0.0 111.853 -168.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.511 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 4.5 mtm -115.61 119.39 35.97 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 173.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.475 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 1.1 m-85 -99.92 128.4 46.01 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.677 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 31.3 p90 -152.42 140.18 19.94 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.413 0.625 . . . . 0.0 112.194 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 2.3 p -113.16 125.77 54.71 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.854 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.439 ' HB3' ' HB2' ' A' ' 41' ' ' LYS . . . -96.53 164.82 12.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.607 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.16 -165.24 31.44 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -121.98 102.98 8.5 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.059 175.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.559 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -173.01 153.04 2.46 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.47 173.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.5 t -112.16 111.71 22.8 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.641 HG12 ' HB3' ' A' ' 34' ' ' LEU . 4.6 m -109.8 165.53 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.655 0 CA-C-O 121.408 0.623 . . . . 0.0 111.91 -174.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.48 ' HB3' HG22 ' B' ' 52' ' ' ILE . 23.8 t -131.61 123.16 27.31 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.914 176.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.565 HD23 HG21 ' A' ' 29' ' ' ILE . 4.9 mp -91.32 151.94 20.66 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 172.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.59 HD23 HD21 ' B' ' 67' ' ' LEU . 1.4 tp -134.77 142.49 46.73 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.746 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.0 -166.79 26.69 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.695 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -143.5 135.25 26.45 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.214 0.53 . . . . 0.0 110.931 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.59 HD23 ' HB3' ' A' ' 27' ' ' PHE . 64.5 mt . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.898 172.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . 0.44 ' HB2' HD12 ' B' ' 91' ' ' LEU . 47.4 mtt . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 120.5 0.19 . . . . 0.0 111.327 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . 0.443 ' CE1' HD21 ' C' ' 44' ' ' LEU . 56.4 t80 -76.11 151.96 36.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.042 0.449 . . . . 0.0 112.194 -176.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . 0.482 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 89.7 t90 -143.86 147.44 34.05 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.583 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.43 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -151.5 156.44 26.68 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.19 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.553 HD23 HD13 ' B' ' 87' ' ' LEU . 61.3 tp -148.95 109.64 4.25 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 120.878 0.37 . . . . 0.0 111.422 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -85.98 121.12 28.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.461 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . 0.669 ' SD ' ' HE2' ' B' ' 19' ' ' TYR . 72.5 mmm -101.75 137.33 40.19 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 120.931 0.396 . . . . 0.0 111.089 -178.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.506 ' HE3' ' HA ' ' B' ' 14' ' ' LYS . 0.0 OUTLIER -101.25 146.44 32.17 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.814 175.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -49.87 113.4 0.97 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.961 2.441 . . . . 0.0 113.098 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 61.16 52.01 4.14 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.912 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -125.61 138.32 53.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.736 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.692 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 51.8 mttp -109.74 126.86 54.18 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 120.874 0.369 . . . . 0.0 111.72 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' TYR . . . . . 0.669 ' HE2' ' SD ' ' B' ' 13' ' ' MET . 2.4 m-85 -111.64 103.89 12.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.739 173.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 9.2 p -86.11 100.51 12.25 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 173.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -114.82 148.8 38.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.35 0.595 . . . . 0.0 112.224 -168.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 38.3 m -107.96 141.95 38.82 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.192 173.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 69.4 mt -102.25 138.34 26.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.156 0.503 . . . . 0.0 111.743 -173.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.449 ' N ' HD12 ' B' ' 24' ' ' ILE . 4.1 mp -110.56 -43.34 5.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.312 176.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.515 ' HD2' HD13 ' B' ' 91' ' ' LEU . 15.2 pttm -113.89 120.54 41.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.149 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 14.9 p -58.26 132.09 52.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.715 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . 0.596 ' HB3' HD23 ' B' ' 91' ' ' LEU . 54.3 p90 -139.14 157.59 45.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.625 0.726 . . . . 0.0 112.365 -176.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' HIS . . . . . 0.621 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 7.1 t60 -114.7 124.78 52.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.455 177.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.584 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 42.6 mt -89.93 134.97 27.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 171.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.621 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 29.0 p -122.06 -12.3 8.36 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -171.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.12 155.84 27.36 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 119.579 -1.296 . . . . 0.0 113.157 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.442 HG23 ' HG ' ' B' ' 87' ' ' LEU . 12.3 p -143.31 125.39 12.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 172.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . 0.423 ' HA ' HG21 ' B' ' 56' ' ' VAL . . . -144.14 161.06 39.81 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.08 -0.388 . . . . 0.0 111.651 -174.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.638 ' HB3' HG12 ' B' ' 85' ' ' VAL . 3.3 pp -123.41 142.27 51.14 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.749 0.785 . . . . 0.0 111.585 177.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -103.99 -52.6 2.92 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.563 -1.199 . . . . 0.0 108.645 173.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -104.2 128.55 51.93 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 169.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.412 ' HA3' ' HB1' ' B' ' 83' ' ' ALA . . . 152.01 156.13 7.33 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 119.605 -1.284 . . . . 0.0 113.571 175.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . 0.463 ' HA ' ' HB2' ' B' ' 58' ' ' LYS . 94.0 mt-30 -102.82 -44.25 5.33 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.661 0.267 . . . . 0.0 111.273 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.54 ' HG3' HG22 ' B' ' 57' ' ' THR . 34.9 tt0 -152.73 122.13 6.75 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 121.229 -0.188 . . . . 0.0 110.974 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.569 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -123.62 114.23 19.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.51 0.672 . . . . 0.0 110.223 170.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.447 ' HB2' ' HB3' ' B' ' 80' ' ' ALA . 31.8 mmtp -96.89 105.9 18.12 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 44.6 tp -83.31 112.17 19.66 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -175.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . 0.647 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 92.5 m-85 -118.62 147.12 44.08 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 175.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.521 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.3 OUTLIER -131.08 131.07 43.96 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 170.597 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.597 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -107.44 112.5 25.32 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.337 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.629 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -124.48 138.19 54.36 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.449 178.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 58.85 34.07 23.45 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 123.552 0.533 . . . . 0.0 110.012 -176.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 57.3 tttm 56.64 46.63 19.94 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.787 -177.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . 0.597 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 53.4 tp60 -137.99 127.74 25.29 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -87.13 121.4 29.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.066 0.46 . . . . 0.0 110.364 -176.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.439 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 81.7 m-85 -113.52 130.6 56.31 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.365 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . 0.48 HG22 ' HB3' ' A' ' 86' ' ' SER . 4.5 tp -79.59 105.74 9.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.626 0.727 . . . . 0.0 109.07 173.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.555 HG13 HD23 ' A' ' 88' ' ' LEU . 2.5 t -80.4 -49.21 19.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.625 -172.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.513 ' HB2' ' CD2' ' B' ' 65' ' ' LEU . . . -155.98 148.28 23.57 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.012 0.434 . . . . 0.0 111.701 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 68.6 m -110.48 100.72 9.5 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 170.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . 0.481 HG13 ' HB3' ' B' ' 40' ' ' ALA . 7.7 p -118.42 112.72 39.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.718 0.77 . . . . 0.0 109.649 -177.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.54 HG22 ' HG3' ' B' ' 39' ' ' GLU . 60.9 p -122.9 -178.72 4.02 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.234 -172.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . 0.463 ' HB2' ' HA ' ' B' ' 38' ' ' GLN . 55.5 tttt -59.36 -29.04 67.4 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.944 171.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.464 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -83.21 -40.35 19.76 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.662 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 79.9 mt -111.13 83.11 3.61 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 13.0 Cg_exo -69.92 0.32 5.94 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.059 2.506 . . . . 0.0 113.789 -168.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -163.2 131.36 3.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.314 0.578 . . . . 0.0 111.554 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 96.3 t -118.91 112.72 39.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.336 173.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.98 116.17 27.83 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 174.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.513 ' CD2' ' HB2' ' B' ' 54' ' ' ALA . 0.3 OUTLIER -137.2 169.5 17.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.449 -175.295 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . 0.558 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 9.6 t0 -118.54 118.98 33.17 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.172 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.59 HD21 HD23 ' A' ' 88' ' ' LEU . 8.0 mt -134.19 145.25 49.04 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -145.38 123.0 11.79 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 173.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -120.93 150.86 40.44 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.062 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 14.4 t -108.93 177.43 4.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.774 -0.193 . . . . 0.0 110.637 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.9 -19.35 65.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.178 0.513 . . . . 0.0 110.674 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.31 -9.87 81.11 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.309 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -92.75 120.02 32.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.203 0.525 . . . . 0.0 110.588 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -108.13 111.58 23.67 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 176.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.629 HG22 ' HB2' ' B' ' 46' ' ' ALA . 7.6 pt -128.75 156.07 41.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.913 -168.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.521 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 4.5 mtm -115.44 119.44 36.24 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 173.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . 0.475 ' CD1' ' HB2' ' B' ' 44' ' ' LEU . 1.1 m-85 -99.91 128.42 46.01 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.692 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 31.2 p90 -152.49 140.15 19.84 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.415 0.626 . . . . 0.0 112.172 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' B' ' 41' ' ' LYS . 2.3 p -113.08 125.86 54.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.794 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . 0.447 ' HB3' ' HB2' ' B' ' 41' ' ' LYS . . . -96.66 164.86 12.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.672 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.15 -165.15 31.4 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -121.96 102.96 8.49 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.073 175.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.569 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -173.09 153.0 2.42 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.44 -1.255 . . . . 0.0 109.431 173.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 38.8 t -112.23 111.71 22.79 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.638 HG12 ' HB3' ' B' ' 34' ' ' LEU . 4.6 m -109.75 165.55 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.665 0 CA-C-O 121.411 0.624 . . . . 0.0 111.889 -174.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . 0.47 ' HB3' HG22 ' C' ' 52' ' ' ILE . 24.3 t -131.6 123.21 27.42 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.846 176.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.556 HD23 HG21 ' B' ' 29' ' ' ILE . 4.9 mp -91.45 151.91 20.59 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 172.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.605 HD23 HD21 ' C' ' 67' ' ' LEU . 1.4 tp -134.75 142.44 46.75 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.77 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.96 -166.84 26.72 Favored Glycine 0 N--CA 1.438 -1.201 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.71 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -143.55 135.27 26.39 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.28 0.562 . . . . 0.0 110.907 177.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . 0.596 HD23 ' HB3' ' B' ' 27' ' ' PHE . 64.6 mt . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.843 173.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 7' ' ' MET . . . . . 0.423 ' HB2' HD12 ' C' ' 91' ' ' LEU . 47.5 mtt . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 120.542 0.211 . . . . 0.0 111.369 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 8' ' ' PHE . . . . . 0.449 ' CE1' HD21 ' D' ' 44' ' ' LEU . 56.6 t80 -76.07 151.9 36.98 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -176.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . 0.477 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 89.8 t90 -143.81 147.52 34.24 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.514 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . 0.439 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -151.43 156.49 26.71 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.121 -0.562 . . . . 0.0 112.254 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.563 HD23 HD13 ' C' ' 87' ' ' LEU . 61.5 tp -149.0 109.57 4.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.894 0.378 . . . . 0.0 111.48 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -85.89 121.04 27.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.519 176.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 13' ' ' MET . . . . . 0.666 ' SD ' ' HE2' ' C' ' 19' ' ' TYR . 72.2 mmm -101.68 137.27 40.2 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 120.817 0.341 . . . . 0.0 111.126 -178.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . 0.481 ' HE3' ' HA ' ' C' ' 14' ' ' LYS . 0.0 OUTLIER -101.22 146.48 32.24 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.846 175.666 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -49.93 113.39 0.97 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.093 2.529 . . . . 0.0 113.043 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 60.99 52.05 4.26 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.961 176.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -125.49 138.42 53.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.8 175.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 18' ' ' LYS . . . . . 0.697 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 51.8 mttp -109.65 126.89 54.13 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.697 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . 0.666 ' HE2' ' SD ' ' C' ' 13' ' ' MET . 2.4 m-85 -111.68 103.75 12.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.818 172.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 9.3 p -86.01 100.57 12.24 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 173.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -114.93 148.67 38.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.431 0.634 . . . . 0.0 112.203 -168.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 39.0 m -107.84 142.03 38.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.165 173.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 69.2 mt -102.29 138.36 26.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.169 0.509 . . . . 0.0 111.75 -173.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . 0.44 HD12 ' N ' ' C' ' 24' ' ' ILE . 4.1 mp -110.55 -43.4 5.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.266 176.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . 0.506 ' HD2' HD13 ' C' ' 91' ' ' LEU . 15.1 pttm -113.91 120.61 41.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.163 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 14.5 p -58.26 132.11 52.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.659 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 27' ' ' PHE . . . . . 0.603 ' HB3' HD23 ' C' ' 91' ' ' LEU . 54.2 p90 -139.12 157.56 45.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.597 0.713 . . . . 0.0 112.389 -176.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 28' ' ' HIS . . . . . 0.631 ' HE2' ' HB3' ' C' ' 30' ' ' SER . 7.1 t60 -114.68 124.76 52.63 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.475 177.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . 0.598 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 42.4 mt -89.93 134.96 27.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 171.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.631 ' HB3' ' HE2' ' C' ' 28' ' ' HIS . 29.1 p -122.1 -12.27 8.34 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -171.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.12 155.8 27.29 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 119.67 -1.252 . . . . 0.0 113.192 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.438 HG23 ' HG ' ' C' ' 87' ' ' LEU . 12.3 p -143.28 125.5 12.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 172.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.422 ' HA ' HG21 ' C' ' 56' ' ' VAL . . . -144.2 160.95 40.08 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.111 -0.368 . . . . 0.0 111.647 -174.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.658 ' HB3' HG12 ' C' ' 85' ' ' VAL . 3.4 pp -123.4 142.22 51.2 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.8 0.809 . . . . 0.0 111.619 177.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -104.02 -52.59 2.91 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.529 173.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -104.19 128.63 51.92 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 169.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 37' ' ' GLY . . . . . 0.416 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 151.95 156.02 7.28 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 119.619 -1.277 . . . . 0.0 113.653 175.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 38' ' ' GLN . . . . . 0.467 ' HA ' ' HB2' ' C' ' 58' ' ' LYS . 94.1 mt-30 -102.76 -44.31 5.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.648 0.261 . . . . 0.0 111.232 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . 0.525 ' HG3' HG22 ' C' ' 57' ' ' THR . 34.8 tt0 -152.67 122.09 6.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.766 -0.197 . . . . 0.0 110.98 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.586 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -123.57 114.26 19.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.605 0.716 . . . . 0.0 110.27 170.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.448 ' HB2' ' HB3' ' C' ' 80' ' ' ALA . 31.8 mmtp -96.87 105.8 18.0 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 44.9 tp -83.25 112.21 19.66 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -175.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 43' ' ' TYR . . . . . 0.653 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 92.8 m-85 -118.62 147.27 43.93 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.515 ' HA ' ' O ' ' C' ' 76' ' ' MET . 0.3 OUTLIER -131.08 131.13 44.0 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 170.648 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . 0.601 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -107.57 112.49 25.26 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.275 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.635 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -124.49 138.08 54.37 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.487 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 58.95 34.08 23.41 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.238 0.542 . . . . 0.0 109.99 -176.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 57.5 tttm 56.65 46.58 20.0 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.707 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . 0.601 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 53.7 tp60 -137.92 127.77 25.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.465 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -87.2 121.39 29.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.077 0.465 . . . . 0.0 110.338 -176.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . 0.43 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 81.3 m-85 -113.49 130.56 56.31 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.411 175.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . 0.47 HG22 ' HB3' ' B' ' 86' ' ' SER . 4.5 tp -79.46 105.8 9.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.664 0.745 . . . . 0.0 109.019 173.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 53' ' ' VAL . . . . . 0.556 HG13 HD23 ' B' ' 88' ' ' LEU . 2.5 t -80.56 -49.07 19.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.65 -172.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 54' ' ' ALA . . . . . 0.513 ' HB2' HD23 ' C' ' 65' ' ' LEU . . . -155.99 148.22 23.5 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.812 -177.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 71.1 m -110.56 100.8 9.55 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 170.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . 0.487 HG13 ' HB3' ' C' ' 40' ' ' ALA . 7.7 p -118.49 112.74 39.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.658 0.742 . . . . 0.0 109.61 -177.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . 0.525 HG22 ' HG3' ' C' ' 39' ' ' GLU . 64.4 p -122.87 -178.67 4.01 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.272 -172.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 58' ' ' LYS . . . . . 0.467 ' HB2' ' HA ' ' C' ' 38' ' ' GLN . 55.7 tttt -59.54 -28.97 67.57 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.855 172.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . 0.472 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -83.2 -40.39 19.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.648 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 80.1 mt -111.16 83.15 3.68 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 61' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 13.0 Cg_exo -69.84 0.18 6.08 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.074 2.516 . . . . 0.0 113.825 -168.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -163.13 131.34 3.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.297 0.57 . . . . 0.0 111.569 -176.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 96.0 t -118.91 112.67 38.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.392 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.91 116.14 27.75 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 174.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . 0.513 HD23 ' HB2' ' C' ' 54' ' ' ALA . 0.3 OUTLIER -137.24 169.5 17.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.95 0.405 . . . . 0.0 111.445 -175.26 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 66' ' ' ASP . . . . . 0.544 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 9.6 t0 -118.59 119.08 33.44 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.106 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.605 HD21 HD23 ' B' ' 88' ' ' LEU . 7.9 mt -134.18 145.26 49.05 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 175.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -145.43 123.03 11.78 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.721 -0.392 . . . . 0.0 109.947 173.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -120.91 150.89 40.38 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.965 -178.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 14.2 t -109.03 177.41 4.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.622 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.92 -19.29 65.7 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.258 0.552 . . . . 0.0 110.612 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.34 -9.9 81.01 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.261 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -92.63 119.93 32.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.059 0.457 . . . . 0.0 110.64 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -107.98 111.59 23.75 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.635 HG22 ' HB2' ' C' ' 46' ' ' ALA . 7.6 pt -128.73 156.1 41.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 120.962 0.41 . . . . 0.0 111.842 -168.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.515 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 4.5 mtm -115.48 119.42 36.13 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 173.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 77' ' ' PHE . . . . . 0.478 ' CD1' ' HB2' ' C' ' 44' ' ' LEU . 1.1 m-85 -99.9 128.37 45.99 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 78' ' ' TYR . . . . . 0.697 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 31.3 p90 -152.42 140.15 19.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.457 0.646 . . . . 0.0 112.252 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' C' ' 41' ' ' LYS . 2.3 p -113.04 125.79 54.78 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.837 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 80' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' C' ' 41' ' ' LYS . . . -96.69 164.93 12.37 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.628 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.05 -165.21 31.57 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 -177.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -121.9 103.06 8.57 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 119.864 -0.735 . . . . 0.0 110.073 175.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . 0.586 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -173.13 153.02 2.4 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.501 173.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 38.6 t -112.27 111.7 22.76 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.658 HG12 ' HB3' ' C' ' 34' ' ' LEU . 4.6 m -109.78 165.54 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 CA-C-O 121.308 0.575 . . . . 0.0 111.89 -174.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . 0.466 ' HB3' HG22 ' D' ' 52' ' ' ILE . 23.9 t -131.58 123.09 27.2 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.953 176.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . 0.565 HD23 HG21 ' C' ' 29' ' ' ILE . 4.9 mp -91.31 151.94 20.67 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 172.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . 0.584 HD23 HD21 ' D' ' 67' ' ' LEU . 1.4 tp -134.7 142.46 46.81 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.843 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.94 -166.85 26.71 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.804 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -143.56 135.17 26.28 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.256 0.55 . . . . 0.0 110.928 177.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . 0.603 HD23 ' HB3' ' C' ' 27' ' ' PHE . 64.7 mt . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.83 173.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 7' ' ' MET . . . . . 0.445 ' HB2' HD12 ' D' ' 91' ' ' LEU . 47.5 mtt . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 120.551 0.215 . . . . 0.0 111.376 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 8' ' ' PHE . . . . . 0.438 ' CE1' HD21 ' E' ' 44' ' ' LEU . 56.7 t80 -76.1 151.92 36.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.113 0.482 . . . . 0.0 112.261 -176.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 9' ' ' TRP . . . . . 0.482 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 89.6 t90 -143.77 147.38 34.08 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.66 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . 0.449 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -151.38 156.53 26.73 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.216 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . 0.566 HD23 HD13 ' D' ' 87' ' ' LEU . 61.3 tp -149.04 109.59 4.22 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.902 0.382 . . . . 0.0 111.403 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -85.96 121.1 28.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.387 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 13' ' ' MET . . . . . 0.672 ' SD ' ' HE2' ' D' ' 19' ' ' TYR . 72.3 mmm -101.76 137.3 40.24 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.884 0.373 . . . . 0.0 111.132 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 14' ' ' LYS . . . . . 0.486 ' HA ' ' HE3' ' D' ' 14' ' ' LYS . 0.0 OUTLIER -101.1 146.46 32.19 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.898 175.663 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -49.92 113.39 0.97 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.035 2.49 . . . . 0.0 113.066 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 61.11 51.98 4.2 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.928 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -125.5 138.35 53.98 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.737 175.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . 0.699 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 51.9 mttp -109.67 126.92 54.19 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 120.799 0.333 . . . . 0.0 111.732 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 19' ' ' TYR . . . . . 0.672 ' HE2' ' SD ' ' D' ' 13' ' ' MET . 2.4 m-85 -111.74 103.7 12.0 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 173.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 9.3 p -86.0 100.62 12.27 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 173.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -114.88 148.73 38.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.283 -168.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 38.7 m -107.83 142.01 38.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.181 173.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 69.2 mt -102.32 138.37 26.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.226 0.536 . . . . 0.0 111.713 -173.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . 0.437 HD12 ' N ' ' D' ' 24' ' ' ILE . 4.1 mp -110.63 -43.26 5.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.269 176.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . 0.508 ' HD2' HD13 ' D' ' 91' ' ' LEU . 15.2 pttm -113.95 120.5 40.86 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.146 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 14.6 p -58.19 132.18 52.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.653 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 27' ' ' PHE . . . . . 0.61 ' HB3' HD23 ' D' ' 91' ' ' LEU . 54.4 p90 -139.24 157.55 45.72 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.632 0.73 . . . . 0.0 112.357 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 28' ' ' HIS . . . . . 0.637 ' HE2' ' HB3' ' D' ' 30' ' ' SER . 7.0 t60 -114.67 124.67 52.42 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.505 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 29' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 42.4 mt -89.85 134.98 27.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 171.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . 0.637 ' HB3' ' HE2' ' D' ' 28' ' ' HIS . 28.7 p -122.13 -12.31 8.33 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -171.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.05 155.91 27.48 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.712 -1.232 . . . . 0.0 113.239 177.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.443 HG23 ' HG ' ' D' ' 87' ' ' LEU . 12.4 p -143.41 125.46 11.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 172.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . 0.426 ' HA ' HG21 ' D' ' 56' ' ' VAL . . . -144.11 161.06 39.8 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 122.023 -0.423 . . . . 0.0 111.682 -174.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 34' ' ' LEU . . . . . 0.636 ' HB3' HG12 ' D' ' 85' ' ' VAL . 3.3 pp -123.49 142.16 51.28 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.748 0.785 . . . . 0.0 111.621 177.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -104.04 -52.48 2.94 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.515 -1.221 . . . . 0.0 108.54 173.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -104.27 128.6 52.06 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 169.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . 0.414 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 152.0 155.99 7.27 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 119.584 -1.293 . . . . 0.0 113.632 175.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 38' ' ' GLN . . . . . 0.48 ' HA ' ' HB2' ' D' ' 58' ' ' LYS . 94.1 mt-30 -102.7 -44.28 5.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.621 0.248 . . . . 0.0 111.29 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . 0.535 ' HG3' HG22 ' D' ' 57' ' ' THR . 35.0 tt0 -152.74 122.08 6.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.025 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . 0.573 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -123.59 114.26 19.78 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.601 0.715 . . . . 0.0 110.203 170.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.442 ' HB2' ' HB3' ' D' ' 80' ' ' ALA . 31.8 mmtp -96.78 105.81 18.0 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 44.7 tp -83.25 112.19 19.64 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 43' ' ' TYR . . . . . 0.639 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 92.6 m-85 -118.66 147.17 44.07 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' D' ' 76' ' ' MET . 0.3 OUTLIER -131.06 131.07 44.0 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 170.572 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 45' ' ' ALA . . . . . 0.593 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -107.46 112.58 25.44 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.3 178.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.632 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -124.54 138.18 54.35 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.432 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 58.83 34.15 23.51 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.562 0.539 . . . . 0.0 109.975 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 57.3 tttm 56.64 46.42 20.31 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.807 -177.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . 0.593 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 53.6 tp60 -137.85 127.79 25.62 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 176.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -87.19 121.39 29.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.062 0.458 . . . . 0.0 110.369 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . 0.439 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 81.7 m-85 -113.48 130.54 56.31 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.4 175.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 52' ' ' ILE . . . . . 0.466 HG22 ' HB3' ' C' ' 86' ' ' SER . 4.5 tp -79.55 105.79 9.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.646 0.736 . . . . 0.0 109.086 173.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 53' ' ' VAL . . . . . 0.57 HG13 HD23 ' C' ' 88' ' ' LEU . 2.5 t -80.46 -49.21 18.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.536 -172.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 54' ' ' ALA . . . . . 0.517 ' HB2' HD23 ' D' ' 65' ' ' LEU . . . -155.95 148.22 23.56 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 120.95 0.405 . . . . 0.0 111.731 -177.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 72.8 m -110.54 100.61 9.39 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 170.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 56' ' ' VAL . . . . . 0.486 HG13 ' HB3' ' D' ' 40' ' ' ALA . 7.7 p -118.36 112.65 39.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.658 0.742 . . . . 0.0 109.63 -177.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 57' ' ' THR . . . . . 0.535 HG22 ' HG3' ' D' ' 39' ' ' GLU . 61.9 p -122.79 -178.68 4.0 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.304 -172.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 58' ' ' LYS . . . . . 0.48 ' HB2' ' HA ' ' D' ' 38' ' ' GLN . 56.0 tttt -59.58 -28.88 67.54 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.899 172.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 59' ' ' ALA . . . . . 0.473 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -83.25 -40.44 19.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.592 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 79.6 mt -111.06 82.98 3.44 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 174.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 61' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 13.1 Cg_exo -69.72 0.22 5.92 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.047 2.498 . . . . 0.0 113.887 -168.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -163.13 131.26 3.76 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.273 0.559 . . . . 0.0 111.614 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.408 HG23 ' HB ' ' D' ' 56' ' ' VAL . 96.4 t -118.85 112.65 38.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.377 173.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.92 116.2 27.81 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 174.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 65' ' ' LEU . . . . . 0.517 HD23 ' HB2' ' D' ' 54' ' ' ALA . 0.3 OUTLIER -137.38 169.42 17.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.007 0.432 . . . . 0.0 111.426 -175.242 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 66' ' ' ASP . . . . . 0.545 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 9.7 t0 -118.45 118.97 33.18 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.114 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.601 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 8.0 mt -134.14 145.3 49.15 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -145.37 123.0 11.8 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 173.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -120.96 150.93 40.34 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.008 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 14.2 t -109.05 177.44 4.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.748 -0.206 . . . . 0.0 110.592 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.92 -19.27 65.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.163 0.506 . . . . 0.0 110.659 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.33 -9.95 80.95 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.272 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -92.65 120.07 32.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.218 0.532 . . . . 0.0 110.584 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -108.12 111.55 23.63 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 176.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.632 HG22 ' HB2' ' D' ' 46' ' ' ALA . 7.6 pt -128.63 156.15 40.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 120.963 0.411 . . . . 0.0 111.812 -168.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 76' ' ' MET . . . . . 0.519 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 4.5 mtm -115.53 119.37 35.94 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 173.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 77' ' ' PHE . . . . . 0.466 ' CD1' ' HB2' ' D' ' 44' ' ' LEU . 1.1 m-85 -99.85 128.36 45.95 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 78' ' ' TYR . . . . . 0.699 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 31.4 p90 -152.42 140.2 19.95 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.452 0.644 . . . . 0.0 112.227 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 79' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' D' ' 41' ' ' LYS . 2.3 p -113.15 125.74 54.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.802 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 80' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' D' ' 41' ' ' LYS . . . -96.58 164.86 12.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.62 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.12 -165.15 31.43 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -177.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -121.98 103.0 8.51 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.047 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . 0.573 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -173.07 153.09 2.45 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.528 173.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 38.6 t -112.27 111.62 22.62 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.636 HG12 ' HB3' ' D' ' 34' ' ' LEU . 4.6 m -109.77 165.44 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.673 0 CA-C-O 121.459 0.647 . . . . 0.0 111.87 -174.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 86' ' ' SER . . . . . 0.478 ' HB3' HG22 ' E' ' 52' ' ' ILE . 24.0 t -131.55 123.12 27.3 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.896 176.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 87' ' ' LEU . . . . . 0.566 HD13 HD23 ' D' ' 11' ' ' LEU . 4.9 mp -91.37 151.97 20.62 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 172.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.588 HD23 HD21 ' E' ' 67' ' ' LEU . 1.4 tp -134.78 142.53 46.72 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.738 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.01 -166.82 26.75 Favored Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.743 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -143.47 135.21 26.47 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.151 0.5 . . . . 0.0 110.919 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . 0.61 HD23 ' HB3' ' D' ' 27' ' ' PHE . 64.9 mt . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.904 173.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 7' ' ' MET . . . . . 0.443 ' HB2' HD12 ' E' ' 91' ' ' LEU . 47.4 mtt . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 120.603 0.239 . . . . 0.0 111.333 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 8' ' ' PHE . . . . . 0.416 ' CE1' HD21 ' A' ' 44' ' ' LEU . 56.2 t80 -76.13 151.99 36.85 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -176.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 9' ' ' TRP . . . . . 0.473 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 89.7 t90 -143.85 147.43 34.06 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.631 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 10' ' ' GLY . . . . . 0.437 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -151.46 156.46 26.69 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.144 178.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 11' ' ' LEU . . . . . 0.566 HD23 HD13 ' E' ' 87' ' ' LEU . 61.2 tp -148.94 109.62 4.25 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.855 0.359 . . . . 0.0 111.445 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -85.98 121.13 28.17 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.435 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 13' ' ' MET . . . . . 0.679 ' SD ' ' HE2' ' E' ' 19' ' ' TYR . 72.3 mmm -101.74 137.29 40.25 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.0 111.069 -178.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 14' ' ' LYS . . . . . 0.497 ' HE3' ' HA ' ' E' ' 14' ' ' LYS . 0.0 OUTLIER -101.12 146.44 32.16 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.872 175.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -49.95 113.35 0.96 Allowed 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.995 2.463 . . . . 0.0 113.152 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 61.21 52.03 4.09 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.837 176.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -125.58 138.35 53.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.785 175.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . 0.707 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 51.8 mttp -109.66 126.85 54.1 Favored 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 123.264 0.352 . . . . 0.0 111.688 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . 0.679 ' HE2' ' SD ' ' E' ' 13' ' ' MET . 2.4 m-85 -111.71 103.79 12.1 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.772 172.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 9.2 p -86.01 100.6 12.25 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 173.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -114.91 148.73 38.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.396 0.617 . . . . 0.0 112.235 -168.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 37.5 m -107.83 142.06 38.47 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.17 173.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 69.4 mt -102.39 138.37 26.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.233 0.54 . . . . 0.0 111.709 -173.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . 0.437 HD12 ' N ' ' E' ' 24' ' ' ILE . 4.1 mp -110.62 -43.42 5.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.203 176.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . 0.505 ' HD2' HD13 ' E' ' 91' ' ' LEU . 15.1 pttm -113.86 120.62 41.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.177 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 14.4 p -58.31 132.23 53.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.65 -178.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 27' ' ' PHE . . . . . 0.601 ' HB3' HD23 ' E' ' 91' ' ' LEU . 54.2 p90 -139.22 157.49 45.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.603 0.716 . . . . 0.0 112.377 -176.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 28' ' ' HIS . . . . . 0.633 ' HE2' ' HB3' ' E' ' 30' ' ' SER . 7.2 t60 -114.6 124.72 52.56 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.552 177.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 29' ' ' ILE . . . . . 0.587 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 42.5 mt -89.91 134.91 27.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 171.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . 0.633 ' HB3' ' HE2' ' E' ' 28' ' ' HIS . 29.1 p -122.02 -12.34 8.36 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -171.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.16 155.86 27.38 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 119.626 -1.273 . . . . 0.0 113.188 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.445 HG23 ' HG ' ' E' ' 87' ' ' LEU . 12.4 p -143.35 125.51 12.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 172.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . 0.429 ' HA ' HG21 ' E' ' 56' ' ' VAL . . . -144.21 161.06 39.85 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.62 -174.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 34' ' ' LEU . . . . . 0.66 ' HB3' HG12 ' E' ' 85' ' ' VAL . 3.3 pp -123.48 142.21 51.23 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.717 0.77 . . . . 0.0 111.629 177.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -103.98 -52.58 2.92 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.584 173.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -104.17 128.63 51.88 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 169.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . 0.416 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 151.96 156.05 7.3 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 119.568 -1.301 . . . . 0.0 113.644 175.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 38' ' ' GLN . . . . . 0.484 ' HA ' ' HB2' ' E' ' 58' ' ' LYS . 94.2 mt-30 -102.82 -44.22 5.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.692 0.282 . . . . 0.0 111.264 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 39' ' ' GLU . . . . . 0.527 ' HG3' HG22 ' E' ' 57' ' ' THR . 34.9 tt0 -152.73 122.05 6.72 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 121.161 -0.216 . . . . 0.0 110.96 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . 0.588 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -123.56 114.31 19.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.536 0.684 . . . . 0.0 110.13 170.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 41' ' ' LYS . . . . . 0.435 ' HB2' ' HB3' ' E' ' 80' ' ' ALA . 31.8 mmtp -96.94 105.89 18.11 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 176.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 44.6 tp -83.21 112.17 19.61 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 -175.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 43' ' ' TYR . . . . . 0.645 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 92.9 m-85 -118.65 147.18 44.05 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 175.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 44' ' ' LEU . . . . . 0.524 ' HA ' ' O ' ' E' ' 76' ' ' MET . 0.3 OUTLIER -131.08 131.04 43.95 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 170.628 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 45' ' ' ALA . . . . . 0.587 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -107.51 112.55 25.37 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.314 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . 0.635 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -124.56 138.18 54.35 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.476 178.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 58.82 34.16 23.52 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.168 0.509 . . . . 0.0 109.983 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 57.3 tttm 56.62 46.53 20.14 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.811 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 49' ' ' GLN . . . . . 0.587 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 53.6 tp60 -137.89 127.74 25.48 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -87.13 121.39 29.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.056 0.455 . . . . 0.0 110.388 -176.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . 0.449 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 81.5 m-85 -113.51 130.5 56.33 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.375 175.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 52' ' ' ILE . . . . . 0.478 HG22 ' HB3' ' D' ' 86' ' ' SER . 4.5 tp -79.47 105.8 9.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.622 0.725 . . . . 0.0 109.09 173.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . 0.571 HG13 HD23 ' D' ' 88' ' ' LEU . 2.5 t -80.45 -49.21 19.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.638 -172.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 54' ' ' ALA . . . . . 0.514 ' HB2' ' CD2' ' E' ' 65' ' ' LEU . . . -155.92 148.27 23.64 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.748 -177.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 67.4 m -110.52 100.7 9.47 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 170.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . 0.476 HG13 ' HB3' ' E' ' 40' ' ' ALA . 7.7 p -118.45 112.6 38.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.624 0.726 . . . . 0.0 109.73 -177.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 57' ' ' THR . . . . . 0.527 HG22 ' HG3' ' E' ' 39' ' ' GLU . 64.0 p -122.82 -178.71 4.01 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.178 -172.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 58' ' ' LYS . . . . . 0.484 ' HB2' ' HA ' ' E' ' 38' ' ' GLN . 55.8 tttt -59.49 -28.92 67.46 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.826 172.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 59' ' ' ALA . . . . . 0.472 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -83.36 -40.25 19.65 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.678 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 79.9 mt -111.07 83.03 3.49 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 61' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 13.1 Cg_exo -69.85 0.28 5.94 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.028 2.485 . . . . 0.0 113.861 -168.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -163.16 131.4 3.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.3 0.571 . . . . 0.0 111.548 -176.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . 0.408 HG23 ' HB ' ' E' ' 56' ' ' VAL . 95.6 t -118.98 112.76 39.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.334 173.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.05 116.14 27.85 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 174.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 65' ' ' LEU . . . . . 0.514 ' CD2' ' HB2' ' E' ' 54' ' ' ALA . 0.3 OUTLIER -137.19 169.54 17.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.492 -175.277 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 66' ' ' ASP . . . . . 0.529 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 9.5 t0 -118.67 119.01 33.18 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.072 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 67' ' ' LEU . . . . . 0.588 HD21 HD23 ' D' ' 88' ' ' LEU . 8.0 mt -134.19 145.21 49.0 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 175.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -145.34 123.0 11.82 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 173.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -120.88 150.88 40.38 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.095 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 14.1 t -108.94 177.45 4.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.821 -0.172 . . . . 0.0 110.663 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.88 -19.31 65.71 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.255 0.55 . . . . 0.0 110.667 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.35 -9.93 80.94 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.256 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -92.61 120.0 32.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.166 0.508 . . . . 0.0 110.524 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -108.1 111.58 23.69 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 75' ' ' ILE . . . . . 0.635 HG22 ' HB2' ' E' ' 46' ' ' ALA . 7.6 pt -128.61 156.07 40.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 120.991 0.424 . . . . 0.0 111.878 -168.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 76' ' ' MET . . . . . 0.524 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 4.5 mtm -115.53 119.44 36.18 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 173.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 77' ' ' PHE . . . . . 0.478 ' CD1' ' HB2' ' E' ' 44' ' ' LEU . 1.1 m-85 -99.9 128.4 46.0 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 78' ' ' TYR . . . . . 0.707 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 31.3 p90 -152.42 140.3 20.05 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.43 0.633 . . . . 0.0 112.156 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 79' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' E' ' 41' ' ' LYS . 2.3 p -113.22 125.77 54.68 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.762 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 80' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' E' ' 41' ' ' LYS . . . -96.58 164.87 12.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.697 178.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.08 -165.18 31.51 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -177.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -121.98 103.0 8.52 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.069 175.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 83' ' ' ALA . . . . . 0.588 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -173.07 153.08 2.45 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.504 173.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 39.2 t -112.27 111.58 22.55 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 85' ' ' VAL . . . . . 0.66 HG12 ' HB3' ' E' ' 34' ' ' LEU . 4.5 m -109.76 165.56 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-O 121.378 0.609 . . . . 0.0 111.842 -174.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 86' ' ' SER . . . . . 0.452 ' HB3' HG22 ' A' ' 52' ' ' ILE . 24.2 t -131.65 123.13 27.18 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.882 176.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 87' ' ' LEU . . . . . 0.566 HD13 HD23 ' E' ' 11' ' ' LEU . 4.9 mp -91.34 151.95 20.65 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 172.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . 0.592 HD23 HD21 ' A' ' 67' ' ' LEU . 1.4 tp -134.76 142.46 46.73 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.789 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.91 -166.8 26.6 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.756 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 90' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -143.56 135.3 26.41 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.2 0.524 . . . . 0.0 110.936 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 91' ' ' LEU . . . . . 0.601 HD23 ' HB3' ' E' ' 27' ' ' PHE . 64.7 mt . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.885 173.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 46.9 mtt . . . . . 0 C--O 1.219 -0.522 0 CA-C-O 120.272 0.082 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -82.18 147.45 29.0 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.491 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 91.2 t90 -139.29 150.1 45.03 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.395 177.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.421 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -154.26 152.21 23.82 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.43 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.61 HD23 HD13 ' A' ' 87' ' ' LEU . 41.0 tp -143.19 108.33 4.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.741 0.305 . . . . 0.0 110.385 177.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -86.11 99.38 11.46 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.416 0.627 . . . . 0.0 109.99 175.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.605 ' HB3' HG23 ' A' ' 85' ' ' VAL . 23.8 tpp -88.02 135.12 33.56 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.881 -175.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -98.83 145.15 29.45 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.119 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HB3' ' N ' ' A' ' 83' ' ' ALA . 10.3 Cg_endo -52.92 120.18 7.24 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 123.585 2.857 . . . . 0.0 113.276 -175.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.682 ' HA ' ' O ' ' A' ' 79' ' ' THR . 29.0 mt-10 58.26 63.07 1.83 Allowed 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 121.575 0.703 . . . . 0.0 111.596 177.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.59 148.95 46.28 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.592 174.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.656 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 35.0 ttmt -122.6 117.15 25.16 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 123.525 0.516 . . . . 0.0 111.314 -175.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -110.98 104.36 12.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.974 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 76' ' ' MET . 10.0 p -88.25 99.95 12.62 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 173.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -121.4 149.9 42.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.501 0.667 . . . . 0.0 112.347 -169.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.2 t -99.21 160.8 14.01 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.405 176.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 53.2 mt -118.99 125.79 74.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.1 0.476 . . . . 0.0 111.531 -173.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.462 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.2 mp -107.02 -33.56 2.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.336 177.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -118.94 122.18 41.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.572 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.404 ' OG ' ' HA ' ' A' ' 70' ' ' SER . 20.5 t -60.82 133.06 55.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.879 -177.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.511 ' HB3' HD23 ' A' ' 91' ' ' LEU . 53.9 p90 -137.42 143.13 41.71 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.939 0.876 . . . . 0.0 111.881 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.642 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 3.5 t60 -102.4 129.87 49.0 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.827 174.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.6 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 48.9 mt -97.53 130.28 46.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.642 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 46.6 p -114.0 -18.02 11.83 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.565 -171.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -162.2 149.03 16.87 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 119.611 -1.281 . . . . 0.0 113.031 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.476 HG23 ' HG ' ' A' ' 87' ' ' LEU . 8.2 p -135.19 121.99 34.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 172.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.53 150.22 41.87 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.97 -171.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.536 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.3 pp -114.96 137.52 51.9 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 121.802 0.811 . . . . 0.0 111.167 178.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -107.01 -55.44 2.33 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.615 175.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -101.9 127.06 48.9 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.388 -0.823 . . . . 0.0 108.884 170.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.451 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 148.31 163.48 10.81 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.043 -1.075 . . . . 0.0 113.045 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -102.65 -47.19 4.51 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 121.099 -0.241 . . . . 0.0 111.404 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -151.92 136.39 16.86 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.632 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.446 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -133.49 113.59 12.65 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.478 0.656 . . . . 0.0 110.455 168.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 79' ' ' THR . 65.8 mttp -97.48 109.51 22.25 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.1 tp -85.75 114.78 22.97 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.993 -173.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.554 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 66.0 m-85 -116.41 145.75 43.02 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.509 ' HB2' ' CD1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -131.32 130.37 42.64 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 172.278 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -108.61 114.2 27.83 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.073 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.67 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -125.45 124.21 40.92 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.824 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.519 ' C ' ' HD2' ' A' ' 48' ' ' LYS . 4.2 mm-40 56.62 51.9 10.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.356 0.598 . . . . 0.0 111.066 -175.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.519 ' HD2' ' C ' ' A' ' 47' ' ' GLU . 6.7 mptt 59.0 39.58 23.35 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.459 174.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.591 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 24.0 tp60 -138.56 115.89 11.15 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -82.45 111.74 18.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.931 0.396 . . . . 0.0 110.714 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.438 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 80.3 m-85 -101.82 128.92 47.97 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.362 176.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -75.75 102.61 2.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 168.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.474 ' CG1' HD11 ' A' ' 67' ' ' LEU . 2.8 t -76.24 -51.52 19.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.579 -172.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.454 ' HB2' ' CD2' ' A' ' 65' ' ' LEU . . . -156.61 142.07 17.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.24 -177.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.8 m -105.1 101.35 10.91 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 172.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.71 112.55 40.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.783 0.802 . . . . 0.0 110.103 -177.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.8 p -123.47 -177.0 3.59 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.05 -176.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -59.13 -32.9 70.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.988 0.423 . . . . 0.0 110.44 169.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.64 -40.57 69.62 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.575 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.5 mt -117.69 81.77 15.34 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 174.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.64 -5.67 14.82 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.231 2.621 . . . . 0.0 113.988 -167.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -162.15 122.6 2.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.089 0.471 . . . . 0.0 110.974 -175.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.413 HG11 ' HB1' ' A' ' 54' ' ' ALA . 98.1 t -108.57 113.57 44.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.343 175.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.37 114.87 27.4 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.104 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -135.48 168.66 18.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.223 -176.19 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 6.0 t70 -114.56 99.82 7.82 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.44 0.638 . . . . 0.0 110.588 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.644 HD21 HD23 ' E' ' 88' ' ' LEU . 19.7 mt -111.41 140.98 45.55 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.12 116.57 9.62 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.415 174.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -116.7 139.76 50.19 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.404 ' HA ' ' OG ' ' A' ' 26' ' ' SER . 5.3 t -103.31 173.97 6.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.003 0.43 . . . . 0.0 110.613 -177.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.57 1.29 12.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.539 -177.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.06 -5.84 54.41 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 173.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -100.36 151.43 21.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.865 0.364 . . . . 0.0 110.376 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -140.12 132.42 28.29 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 172.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.67 HG22 ' HB2' ' A' ' 46' ' ' ALA . 6.8 pt -139.79 164.64 23.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.011 0.434 . . . . 0.0 111.817 -167.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.502 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 4.5 mtm -118.65 121.74 40.87 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 173.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.509 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 1.0 OUTLIER -103.66 127.92 51.05 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.656 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 40.4 p90 -153.56 140.77 19.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.256 0.55 . . . . 0.0 111.886 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.682 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 15.2 p -111.9 144.97 40.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.297 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.09 148.66 28.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.31 173.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.85 176.83 41.1 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -176.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -108.53 102.55 11.62 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.046 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.514 ' N ' ' HB3' ' A' ' 15' ' ' PRO . . . -165.88 148.92 7.55 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.363 167.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 27.1 t -103.97 123.98 48.17 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.605 HG23 ' HB3' ' A' ' 13' ' ' MET . 8.0 m -121.01 135.25 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-O 121.349 0.595 . . . . 0.0 111.961 -173.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.1 m -97.47 118.39 33.86 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.908 175.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.61 HD13 HD23 ' A' ' 11' ' ' LEU . 5.0 mp -91.27 140.77 29.48 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 171.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.637 HD23 HD21 ' B' ' 67' ' ' LEU . 0.8 OUTLIER -127.62 143.64 51.14 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -178.254 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 28' ' ' HIS . . . -166.28 -166.97 26.21 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.126 -1.035 . . . . 0.0 112.833 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -142.32 136.6 29.86 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 120.939 0.4 . . . . 0.0 110.676 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.511 HD23 ' HB3' ' A' ' 27' ' ' PHE . 84.5 mt . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.945 174.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 46.9 mtt . . . . . 0 C--O 1.219 -0.528 0 CA-C-O 120.272 0.082 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -82.22 147.44 28.97 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.908 0.385 . . . . 0.0 112.024 -177.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . 0.492 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 91.1 t90 -139.24 150.02 45.01 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.458 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.432 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -154.11 152.27 23.87 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.489 178.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.6 HD23 HD13 ' B' ' 87' ' ' LEU . 41.1 tp -143.24 108.41 4.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.749 0.309 . . . . 0.0 110.364 177.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -86.04 99.32 11.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.257 0.551 . . . . 0.0 110.036 175.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . 0.587 ' HB3' HG23 ' B' ' 85' ' ' VAL . 24.1 tpp -88.0 135.13 33.55 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.86 -175.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -98.86 145.24 29.62 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.075 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.512 ' HB3' ' N ' ' B' ' 83' ' ' ALA . 10.3 Cg_endo -53.01 120.15 7.23 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 123.591 2.861 . . . . 0.0 113.257 -175.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.683 ' HA ' ' O ' ' B' ' 79' ' ' THR . 29.1 mt-10 58.36 62.94 1.84 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.558 0.694 . . . . 0.0 111.628 177.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.54 148.98 46.39 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.586 174.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.653 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 35.1 ttmt -122.62 117.11 25.06 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.596 0.56 . . . . 0.0 111.379 -175.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -110.97 104.23 12.79 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.05 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 9.8 p -88.19 99.98 12.62 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -121.44 149.9 42.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.369 0.604 . . . . 0.0 112.275 -169.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 12.1 t -99.34 160.88 13.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.369 176.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 53.1 mt -118.98 125.7 74.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.05 0.453 . . . . 0.0 111.606 -173.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.464 ' N ' HD12 ' B' ' 24' ' ' ILE . 4.2 mp -106.9 -33.63 2.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.357 177.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -118.94 122.2 41.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.563 177.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 20.3 t -60.81 133.14 55.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.917 -177.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . 0.501 ' HB3' HD23 ' B' ' 91' ' ' LEU . 53.8 p90 -137.48 143.17 41.6 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.932 0.872 . . . . 0.0 111.821 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' HIS . . . . . 0.63 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 3.6 t60 -102.4 129.88 49.01 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.1 -1.409 . . . . 0.0 108.823 174.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.607 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 49.2 mt -97.59 130.34 46.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 171.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.63 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 46.8 p -113.97 -17.99 11.85 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.531 -171.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -162.17 149.02 16.87 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 119.567 -1.302 . . . . 0.0 112.961 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.473 HG23 ' HG ' ' B' ' 87' ' ' LEU . 8.2 p -135.17 121.92 34.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 172.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.5 150.23 41.93 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.436 -0.506 . . . . 0.0 112.049 -171.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.523 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.3 pp -114.91 137.58 51.8 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.816 0.817 . . . . 0.0 111.071 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -107.1 -55.46 2.33 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.585 175.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -101.89 127.07 48.88 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 170.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.457 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 148.37 163.57 10.88 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 119.988 -1.101 . . . . 0.0 112.904 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -102.66 -47.23 4.49 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.57 0.224 . . . . 0.0 111.402 177.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -151.89 136.37 16.88 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.62 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.427 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -133.41 113.61 12.73 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.398 0.618 . . . . 0.0 110.419 168.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' B' ' 79' ' ' THR . 65.8 mttp -97.48 109.66 22.37 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 173.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 34.6 tp -85.68 114.75 22.9 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.067 -173.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . 0.55 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 66.1 m-85 -116.39 145.82 42.95 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 175.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.521 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.2 OUTLIER -131.4 130.33 42.43 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 172.268 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -108.59 114.2 27.82 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.118 178.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.662 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -125.33 124.32 41.32 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.812 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.516 ' C ' ' HD2' ' B' ' 48' ' ' LYS . 4.2 mm-40 56.36 52.02 10.66 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.688 0.618 . . . . 0.0 111.132 -175.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.516 ' HD2' ' C ' ' B' ' 47' ' ' GLU . 6.7 mptt 58.95 39.63 23.41 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.479 174.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . 0.596 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 24.1 tp60 -138.56 115.95 11.2 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -82.58 111.79 18.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.83 0.348 . . . . 0.0 110.596 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.421 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 80.3 m-85 -101.85 128.91 48.02 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.301 176.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -75.81 102.62 2.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 168.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.476 ' CG1' HD11 ' B' ' 67' ' ' LEU . 2.8 t -76.17 -51.64 19.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.542 -172.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.453 ' HB2' ' CD2' ' B' ' 65' ' ' LEU . . . -156.5 142.16 17.74 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.193 -177.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 42.6 m -105.17 101.45 11.0 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 171.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . 0.403 HG13 ' HB3' ' B' ' 40' ' ' ALA . 7.5 p -115.73 112.51 40.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.788 0.804 . . . . 0.0 110.067 -177.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 68.8 p -123.47 -177.09 3.61 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.054 -176.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -59.16 -32.73 70.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.976 0.417 . . . . 0.0 110.47 169.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.76 -40.59 69.2 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.523 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 76.4 mt -117.6 81.8 15.04 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 174.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.71 -5.64 14.82 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.312 2.675 . . . . 0.0 113.932 -167.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -162.18 122.64 2.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.208 0.528 . . . . 0.0 110.955 -175.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.413 HG11 ' HB1' ' B' ' 54' ' ' ALA . 97.9 t -108.57 113.51 44.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.374 175.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.36 114.85 27.38 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.102 175.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' B' ' 30' ' ' SER . 0.3 OUTLIER -135.46 168.7 18.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.191 -176.197 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . 0.527 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 5.9 t70 -114.58 99.7 7.73 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.393 0.616 . . . . 0.0 110.598 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.637 HD21 HD23 ' A' ' 88' ' ' LEU . 19.7 mt -111.35 140.97 45.49 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.17 116.64 9.64 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.351 174.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -116.78 139.68 50.3 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 5.3 t -103.3 173.95 6.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.951 0.405 . . . . 0.0 110.633 -177.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . 0.416 ' H ' ' HG3' ' B' ' 71' ' ' LYS . 0.0 OUTLIER -74.56 1.29 12.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.513 -177.009 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.0 -5.89 54.48 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 173.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -100.26 151.33 21.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.964 0.412 . . . . 0.0 110.35 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -140.1 132.48 28.43 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 172.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.662 HG22 ' HB2' ' B' ' 46' ' ' ALA . 6.9 pt -139.87 164.57 23.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.017 0.437 . . . . 0.0 111.837 -167.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.521 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 4.5 mtm -118.59 121.63 40.66 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 173.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . 0.518 ' CD1' ' HB2' ' B' ' 44' ' ' LEU . 1.1 m-85 -103.61 127.95 50.97 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.653 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 40.2 p90 -153.59 140.79 19.49 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.255 0.55 . . . . 0.0 111.845 -178.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.683 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 15.3 p -111.91 144.88 40.5 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.224 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.0 148.62 28.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.298 173.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.05 176.84 40.81 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -108.55 102.55 11.62 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.949 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.512 ' N ' ' HB3' ' B' ' 15' ' ' PRO . . . -165.92 148.85 7.47 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.382 167.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 27.2 t -103.94 124.02 48.22 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.587 HG23 ' HB3' ' B' ' 13' ' ' MET . 8.0 m -121.07 135.15 62.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-O 121.361 0.6 . . . . 0.0 111.895 -173.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 69.5 m -97.48 118.45 34.0 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.936 175.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.6 HD13 HD23 ' B' ' 11' ' ' LEU . 5.0 mp -91.27 140.79 29.46 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 171.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.636 HD23 HD21 ' C' ' 67' ' ' LEU . 0.8 OUTLIER -127.67 143.59 51.14 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.242 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' B' ' 28' ' ' HIS . . . -166.2 -166.92 26.04 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 120.112 -1.042 . . . . 0.0 112.801 -177.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -142.4 136.54 29.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.002 0.43 . . . . 0.0 110.655 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . 0.501 HD23 ' HB3' ' B' ' 27' ' ' PHE . 84.8 mt . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.921 174.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 7' ' ' MET . . . . . 0.408 ' O ' ' HA ' ' C' ' 90' ' ' TYR . 46.9 mtt . . . . . 0 C--O 1.219 -0.539 0 CA-C-O 120.273 0.082 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 8' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -82.3 147.48 28.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.921 0.391 . . . . 0.0 111.955 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . 0.488 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 91.1 t90 -139.32 149.98 44.85 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.421 177.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . 0.43 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -154.09 152.29 23.89 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.523 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.626 HD23 HD13 ' C' ' 87' ' ' LEU . 41.2 tp -143.27 108.34 4.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.74 0.305 . . . . 0.0 110.35 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -85.96 99.17 11.24 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.306 0.574 . . . . 0.0 110.099 175.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 13' ' ' MET . . . . . 0.606 ' HB3' HG23 ' C' ' 85' ' ' VAL . 24.1 tpp -87.97 135.1 33.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.888 -175.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -98.78 145.25 29.62 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.077 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . 0.518 ' HB3' ' N ' ' C' ' 83' ' ' ALA . 10.3 Cg_endo -53.04 120.14 7.22 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 123.624 2.883 . . . . 0.0 113.287 -175.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . 0.686 ' HA ' ' O ' ' C' ' 79' ' ' THR . 29.1 mt-10 58.35 63.0 1.83 Allowed 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.579 0.704 . . . . 0.0 111.658 177.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.63 148.93 46.2 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.518 174.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 18' ' ' LYS . . . . . 0.647 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 35.1 ttmt -122.6 117.09 25.02 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 123.482 0.489 . . . . 0.0 111.351 -175.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -111.01 104.28 12.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.007 177.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 9.4 p -88.24 100.03 12.67 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 173.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -121.32 150.04 42.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.339 0.59 . . . . 0.0 112.369 -169.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 12.2 t -99.42 160.85 13.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.327 176.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 53.3 mt -119.01 125.7 74.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.01 0.434 . . . . 0.0 111.532 -173.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . 0.451 HD12 ' N ' ' C' ' 24' ' ' ILE . 4.2 mp -106.99 -33.52 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.241 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -118.94 122.18 41.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.524 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . 0.401 ' OG ' ' HA ' ' C' ' 70' ' ' SER . 20.3 t -60.82 133.13 55.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.837 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 27' ' ' PHE . . . . . 0.491 ' HB3' HD23 ' C' ' 91' ' ' LEU . 53.9 p90 -137.47 143.11 41.6 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.962 0.887 . . . . 0.0 111.906 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 28' ' ' HIS . . . . . 0.645 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 3.5 t60 -102.33 129.84 48.89 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.114 -1.403 . . . . 0.0 108.905 174.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . 0.619 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 48.9 mt -97.56 130.27 46.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 171.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.645 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 46.4 p -113.95 -17.98 11.86 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.541 -171.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 31' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -162.2 149.05 16.91 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 119.611 -1.28 . . . . 0.0 112.873 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.464 HG23 ' HG ' ' C' ' 87' ' ' LEU . 8.3 p -135.12 121.9 34.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 172.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.37 150.3 42.23 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.501 -0.48 . . . . 0.0 112.06 -171.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.529 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.3 pp -115.04 137.44 52.0 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.757 0.789 . . . . 0.0 111.147 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -106.96 -55.51 2.32 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.548 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -101.89 127.06 48.88 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 171.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 37' ' ' GLY . . . . . 0.459 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 148.28 163.53 10.84 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.016 -1.088 . . . . 0.0 112.981 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -102.66 -47.26 4.48 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.555 0.217 . . . . 0.0 111.385 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -151.9 136.32 16.84 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.701 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -133.48 113.55 12.63 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.429 0.633 . . . . 0.0 110.42 168.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' C' ' 79' ' ' THR . 65.8 mttp -97.45 109.55 22.28 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 174.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 35.0 tp -85.66 114.69 22.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.047 -173.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 43' ' ' TYR . . . . . 0.553 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 66.4 m-85 -116.37 145.75 42.99 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.513 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 0.2 OUTLIER -131.31 130.35 42.63 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 172.228 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -108.56 114.1 27.65 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.113 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.68 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -125.34 124.39 41.45 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.759 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 47' ' ' GLU . . . . . 0.519 ' C ' ' HD2' ' C' ' 48' ' ' LYS . 4.3 mm-40 56.37 52.06 10.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.347 0.594 . . . . 0.0 111.071 -175.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . 0.519 ' HD2' ' C ' ' C' ' 47' ' ' GLU . 6.7 mptt 58.91 39.65 23.51 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.492 174.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . 0.591 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 24.1 tp60 -138.66 115.96 11.13 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -82.61 111.74 18.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.902 0.382 . . . . 0.0 110.635 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . 0.432 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 80.0 m-85 -101.78 128.85 47.95 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.398 176.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -75.78 102.58 2.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 168.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 53' ' ' VAL . . . . . 0.478 ' CG1' HD11 ' C' ' 67' ' ' LEU . 2.8 t -76.17 -51.61 19.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.543 -172.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 54' ' ' ALA . . . . . 0.453 ' HB2' ' CD2' ' C' ' 65' ' ' LEU . . . -156.57 142.15 17.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.133 -177.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 42.4 m -105.21 101.44 10.98 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 171.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.7 112.56 40.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.815 0.817 . . . . 0.0 110.074 -177.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 68.0 p -123.47 -176.98 3.58 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.064 -176.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -59.33 -32.73 70.35 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.418 169.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.66 -40.72 69.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.486 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 76.0 mt -117.53 81.82 14.81 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 174.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.77 -5.73 15.09 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.256 2.637 . . . . 0.0 113.888 -167.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -162.04 122.67 2.59 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.075 0.464 . . . . 0.0 110.963 -175.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 97.8 t -108.6 113.59 44.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.346 175.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.35 114.82 27.35 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.123 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' C' ' 30' ' ' SER . 0.3 OUTLIER -135.38 168.68 18.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.259 -176.198 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 66' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 5.9 t70 -114.64 99.78 7.78 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.542 0.687 . . . . 0.0 110.595 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.636 HD21 HD23 ' B' ' 88' ' ' LEU . 19.8 mt -111.35 141.02 45.44 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -142.2 116.63 9.61 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.366 174.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -116.81 139.68 50.32 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . 0.401 ' HA ' ' OG ' ' C' ' 26' ' ' SER . 5.3 t -103.28 173.94 6.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.049 0.452 . . . . 0.0 110.635 -177.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . 0.434 ' H ' ' HG3' ' C' ' 71' ' ' LYS . 0.0 OUTLIER -74.53 1.3 12.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.487 -176.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.09 -5.75 54.45 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 173.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -100.36 151.32 21.64 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.793 0.33 . . . . 0.0 110.432 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -140.13 132.36 28.18 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 172.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.68 HG22 ' HB2' ' C' ' 46' ' ' ALA . 6.8 pt -139.74 164.5 23.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.966 0.412 . . . . 0.0 111.888 -167.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.506 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 4.5 mtm -118.57 121.68 40.79 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 173.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 77' ' ' PHE . . . . . 0.513 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 1.1 m-85 -103.65 128.02 51.01 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 78' ' ' TYR . . . . . 0.647 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 40.3 p90 -153.56 140.87 19.6 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.218 0.532 . . . . 0.0 111.879 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . 0.686 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 15.2 p -112.0 144.98 40.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.22 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.1 148.83 28.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.248 173.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.71 176.89 41.31 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -176.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -108.55 102.45 11.52 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.019 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . 0.518 ' N ' ' HB3' ' C' ' 15' ' ' PRO . . . -165.83 148.93 7.61 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.356 167.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 27.1 t -104.0 123.89 48.01 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.606 HG23 ' HB3' ' C' ' 13' ' ' MET . 8.2 m -120.89 135.2 61.86 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 CA-C-O 121.323 0.582 . . . . 0.0 112.007 -173.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 68.7 m -97.39 118.32 33.6 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.439 -0.8 . . . . 0.0 108.957 175.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . 0.626 HD13 HD23 ' C' ' 11' ' ' LEU . 5.0 mp -91.16 140.83 29.44 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 171.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . 0.623 HD23 HD21 ' D' ' 67' ' ' LEU . 0.8 OUTLIER -127.66 143.58 51.14 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -178.253 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 89' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' C' ' 28' ' ' HIS . . . -166.26 -166.95 26.16 Favored Glycine 0 N--CA 1.439 -1.166 0 C-N-CA 120.051 -1.071 . . . . 0.0 112.738 -177.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 90' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' C' ' 7' ' ' MET . 5.1 p90 -142.31 136.59 29.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.984 0.421 . . . . 0.0 110.623 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . 0.491 HD23 ' HB3' ' C' ' 27' ' ' PHE . 84.7 mt . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.88 174.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 47.1 mtt . . . . . 0 C--O 1.219 -0.543 0 CA-C-O 120.307 0.099 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 8' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -82.27 147.49 28.88 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.919 0.39 . . . . 0.0 111.93 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 9' ' ' TRP . . . . . 0.49 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 91.2 t90 -139.3 149.94 44.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.45 177.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -154.12 152.3 23.9 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.511 178.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . 0.624 HD23 HD13 ' D' ' 87' ' ' LEU . 40.8 tp -143.23 108.37 4.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.751 0.31 . . . . 0.0 110.344 177.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -86.15 99.42 11.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.375 0.607 . . . . 0.0 110.053 175.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 13' ' ' MET . . . . . 0.615 ' HB3' HG23 ' D' ' 85' ' ' VAL . 24.0 tpp -88.07 135.09 33.58 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.868 -175.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -98.84 145.13 29.41 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.158 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . 0.516 ' HB3' ' N ' ' D' ' 83' ' ' ALA . 10.3 Cg_endo -52.93 120.08 7.08 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.642 2.895 . . . . 0.0 113.237 -175.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . 0.677 ' HA ' ' O ' ' D' ' 79' ' ' THR . 28.9 mt-10 58.44 62.92 1.84 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.634 177.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.5 148.86 46.35 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.613 174.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . 0.665 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 35.1 ttmt -122.54 117.13 25.17 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 123.556 0.535 . . . . 0.0 111.386 -175.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -111.03 104.23 12.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.022 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 9.5 p -88.23 99.86 12.54 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 173.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -121.31 149.93 42.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.443 0.64 . . . . 0.0 112.373 -169.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 12.1 t -99.32 160.87 13.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.349 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 53.0 mt -118.97 125.74 74.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.012 0.434 . . . . 0.0 111.562 -173.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . 0.457 HD12 ' N ' ' D' ' 24' ' ' ILE . 4.2 mp -106.95 -33.56 2.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.311 177.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -118.94 122.16 41.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.587 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 26' ' ' SER . . . . . 0.407 ' OG ' ' HA ' ' D' ' 70' ' ' SER . 20.4 t -60.72 133.06 55.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.856 -177.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 27' ' ' PHE . . . . . 0.499 ' HB3' HD23 ' D' ' 91' ' ' LEU . 53.9 p90 -137.42 143.1 41.71 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.87 0.843 . . . . 0.0 111.981 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 28' ' ' HIS . . . . . 0.631 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 3.5 t60 -102.37 129.88 48.96 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.839 174.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 29' ' ' ILE . . . . . 0.617 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 48.8 mt -97.5 130.33 46.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 171.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . 0.631 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 45.7 p -114.0 -18.06 11.82 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 120.973 0.416 . . . . 0.0 111.587 -171.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 31' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -162.15 149.01 16.87 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 119.573 -1.299 . . . . 0.0 113.022 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.466 HG23 ' HG ' ' D' ' 87' ' ' LEU . 8.2 p -135.15 121.95 34.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 172.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.46 150.33 42.12 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.47 -0.492 . . . . 0.0 112.038 -171.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 34' ' ' LEU . . . . . 0.523 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.3 pp -114.99 137.5 51.92 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.785 0.802 . . . . 0.0 111.116 178.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -107.0 -55.46 2.33 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.502 -1.227 . . . . 0.0 108.615 175.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -101.96 127.06 48.98 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.857 171.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . 0.453 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 148.32 163.57 10.87 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.01 -1.091 . . . . 0.0 112.991 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -102.69 -47.23 4.48 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.408 177.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -151.84 136.39 16.95 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.669 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . 0.43 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -133.5 113.59 12.65 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.453 0.644 . . . . 0.0 110.402 168.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' D' ' 79' ' ' THR . 65.8 mttp -97.41 109.51 22.25 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 173.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 34.9 tp -85.63 114.77 22.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.087 -173.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 43' ' ' TYR . . . . . 0.544 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 66.1 m-85 -116.43 145.81 43.0 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 175.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.51 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.2 OUTLIER -131.45 130.33 42.34 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 172.342 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 45' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -108.58 114.02 27.5 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.102 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.672 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -125.28 124.37 41.48 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.832 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 47' ' ' GLU . . . . . 0.519 ' C ' ' HD2' ' D' ' 48' ' ' LYS . 4.3 mm-40 56.48 51.97 10.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.297 0.57 . . . . 0.0 111.042 -175.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 48' ' ' LYS . . . . . 0.519 ' HD2' ' C ' ' D' ' 47' ' ' GLU . 6.7 mptt 58.93 39.65 23.45 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.413 174.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . 0.585 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 24.7 tp60 -138.57 115.93 11.17 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -82.5 111.72 18.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.873 0.368 . . . . 0.0 110.713 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . 0.43 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 80.1 m-85 -101.82 128.85 47.99 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.278 176.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -75.73 102.61 2.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 168.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 53' ' ' VAL . . . . . 0.479 ' CG1' HD11 ' D' ' 67' ' ' LEU . 2.8 t -76.25 -51.54 19.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.542 -172.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 54' ' ' ALA . . . . . 0.451 ' HB2' ' CD2' ' D' ' 65' ' ' LEU . . . -156.59 142.0 17.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.207 -177.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 41.9 m -105.05 101.42 10.98 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 171.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 56' ' ' VAL . . . . . 0.402 HG13 ' HB3' ' D' ' 40' ' ' ALA . 7.5 p -115.71 112.65 40.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.801 0.81 . . . . 0.0 110.039 -177.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 70.0 p -123.54 -177.0 3.59 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.026 -176.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -59.19 -32.87 70.31 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.037 0.446 . . . . 0.0 110.434 169.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.6 -40.65 69.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.572 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 75.9 mt -117.53 81.79 14.77 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 174.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.72 -5.68 14.92 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.186 2.591 . . . . 0.0 114.007 -167.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -162.11 122.78 2.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.196 0.522 . . . . 0.0 110.916 -175.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.42 HG11 ' HB1' ' D' ' 54' ' ' ALA . 98.3 t -108.66 113.45 44.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.382 175.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.34 114.87 27.42 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.096 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 65' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' D' ' 30' ' ' SER . 0.3 OUTLIER -135.52 168.63 18.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.182 -176.185 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 66' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 5.9 t70 -114.52 99.82 7.83 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.407 0.622 . . . . 0.0 110.545 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.623 HD21 HD23 ' C' ' 88' ' ' LEU . 19.8 mt -111.4 141.0 45.53 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 175.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.17 116.62 9.63 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.384 174.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -116.8 139.76 50.22 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . 0.407 ' HA ' ' OG ' ' D' ' 26' ' ' SER . 5.3 t -103.28 173.97 6.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.982 0.42 . . . . 0.0 110.643 -177.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 71' ' ' LYS . . . . . 0.404 ' HG3' ' H ' ' D' ' 71' ' ' LYS . 0.0 OUTLIER -74.62 1.38 12.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.53 -177.034 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.04 -5.95 54.35 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -100.3 151.4 21.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.825 0.345 . . . . 0.0 110.426 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -140.16 132.41 28.22 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 172.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.672 HG22 ' HB2' ' D' ' 46' ' ' ALA . 6.8 pt -139.91 164.53 23.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.97 0.414 . . . . 0.0 111.803 -167.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 76' ' ' MET . . . . . 0.507 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 4.5 mtm -118.52 121.63 40.72 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 173.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 77' ' ' PHE . . . . . 0.51 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 1.1 m-85 -103.61 127.96 50.97 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 78' ' ' TYR . . . . . 0.665 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 40.2 p90 -153.61 140.88 19.56 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.229 0.538 . . . . 0.0 111.85 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 79' ' ' THR . . . . . 0.677 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 15.0 p -112.01 145.02 40.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.18 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.19 148.66 28.6 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.297 173.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.95 176.86 40.96 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -108.53 102.58 11.65 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.033 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . 0.516 ' N ' ' HB3' ' D' ' 15' ' ' PRO . . . -165.87 148.89 7.54 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.329 167.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 26.9 t -103.95 124.02 48.23 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.615 HG23 ' HB3' ' D' ' 13' ' ' MET . 8.2 m -120.95 135.1 62.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.338 0.589 . . . . 0.0 111.933 -173.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 68.5 m -97.38 118.5 34.0 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.964 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 87' ' ' LEU . . . . . 0.624 HD13 HD23 ' D' ' 11' ' ' LEU . 5.0 mp -91.33 140.87 29.37 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 171.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.636 HD23 HD21 ' E' ' 67' ' ' LEU . 0.8 OUTLIER -127.75 143.58 51.13 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -178.207 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 89' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' D' ' 28' ' ' HIS . . . -166.21 -167.0 26.18 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 120.102 -1.047 . . . . 0.0 112.777 -177.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -142.29 136.56 29.89 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 120.948 0.404 . . . . 0.0 110.609 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . 0.499 HD23 ' HB3' ' D' ' 27' ' ' PHE . 84.5 mt . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.999 174.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 7' ' ' MET . . . . . 0.402 ' O ' ' HA ' ' E' ' 90' ' ' TYR . 47.0 mtt . . . . . 0 C--O 1.22 -0.464 0 N-CA-C 111.2 0.074 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 8' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -82.2 147.55 28.93 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.888 0.375 . . . . 0.0 111.988 -177.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 9' ' ' TRP . . . . . 0.485 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 90.9 t90 -139.31 149.97 44.85 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 10' ' ' GLY . . . . . 0.438 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -154.14 152.28 23.88 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.446 178.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 11' ' ' LEU . . . . . 0.609 HD23 HD13 ' E' ' 87' ' ' LEU . 41.4 tp -143.17 108.3 4.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.735 0.302 . . . . 0.0 110.359 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -86.12 99.33 11.43 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.334 0.587 . . . . 0.0 110.042 175.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 13' ' ' MET . . . . . 0.614 ' HB3' HG23 ' E' ' 85' ' ' VAL . 23.9 tpp -88.0 135.12 33.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.853 -175.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -98.75 145.18 29.49 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.13 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . 0.511 ' HB3' ' N ' ' E' ' 83' ' ' ALA . 10.3 Cg_endo -52.97 120.07 7.09 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 123.653 2.902 . . . . 0.0 113.254 -175.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 16' ' ' GLU . . . . . 0.682 ' HA ' ' O ' ' E' ' 79' ' ' THR . 29.0 mt-10 58.44 62.88 1.85 Allowed 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 121.526 0.679 . . . . 0.0 111.653 177.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.49 148.92 46.42 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.578 174.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . 0.648 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 35.1 ttmt -122.61 117.17 25.19 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 123.569 0.543 . . . . 0.0 111.316 -175.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -111.02 104.39 12.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.993 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 20' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' E' ' 76' ' ' MET . 9.9 p -88.34 99.99 12.68 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 173.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -121.3 150.0 42.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.386 0.613 . . . . 0.0 112.33 -169.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 12.2 t -99.3 160.81 14.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.331 176.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 52.9 mt -118.94 125.75 74.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.113 0.482 . . . . 0.0 111.663 -173.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . 0.451 HD12 ' N ' ' E' ' 24' ' ' ILE . 4.2 mp -106.98 -33.57 2.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.283 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -118.93 122.23 41.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.55 177.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 26' ' ' SER . . . . . 0.407 ' OG ' ' HA ' ' E' ' 70' ' ' SER . 20.5 t -60.81 133.06 55.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.829 -177.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 27' ' ' PHE . . . . . 0.499 ' HB3' HD23 ' E' ' 91' ' ' LEU . 53.9 p90 -137.38 143.18 41.82 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.925 0.869 . . . . 0.0 111.954 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 28' ' ' HIS . . . . . 0.64 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 3.5 t60 -102.49 129.92 49.16 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.769 174.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 29' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 49.0 mt -97.44 130.3 46.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 171.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . 0.64 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 46.5 p -114.0 -17.92 11.85 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.612 -171.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 31' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -162.23 148.97 16.72 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 119.656 -1.259 . . . . 0.0 112.984 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.469 HG23 ' HG ' ' E' ' 87' ' ' LEU . 8.3 p -135.11 121.92 34.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 172.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.47 150.24 41.99 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.52 -0.472 . . . . 0.0 112.01 -171.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 34' ' ' LEU . . . . . 0.528 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.3 pp -114.96 137.55 51.86 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.735 0.779 . . . . 0.0 111.111 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -107.07 -55.52 2.32 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.593 175.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -101.77 127.05 48.72 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . 0.455 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 148.28 163.55 10.84 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 119.995 -1.097 . . . . 0.0 112.998 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -102.7 -47.15 4.51 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.419 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -151.87 136.34 16.88 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.643 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . 0.428 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -133.41 113.56 12.68 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.451 0.643 . . . . 0.0 110.404 168.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 41' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' E' ' 79' ' ' THR . 65.8 mttp -97.36 109.57 22.3 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 34.5 tp -85.62 114.67 22.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.067 -173.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 43' ' ' TYR . . . . . 0.55 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 66.2 m-85 -116.37 145.77 42.98 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 44' ' ' LEU . . . . . 0.513 ' HB2' ' CD1' ' E' ' 77' ' ' PHE . 0.2 OUTLIER -131.37 130.41 42.59 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 172.288 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 45' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -108.67 114.09 27.6 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.145 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . 0.668 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -125.32 124.26 41.19 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.753 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 47' ' ' GLU . . . . . 0.518 ' C ' ' HD2' ' E' ' 48' ' ' LYS . 4.2 mm-40 56.57 52.03 10.37 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.663 0.602 . . . . 0.0 110.977 -175.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 48' ' ' LYS . . . . . 0.518 ' HD2' ' C ' ' E' ' 47' ' ' GLU . 6.7 mptt 59.0 39.5 23.43 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.493 174.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 49' ' ' GLN . . . . . 0.586 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 24.2 tp60 -138.61 116.03 11.22 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -82.55 111.73 18.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.897 0.379 . . . . 0.0 110.631 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -101.86 128.87 48.04 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.336 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -75.76 102.57 2.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 168.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . 0.472 ' CG1' HD11 ' E' ' 67' ' ' LEU . 2.8 t -76.22 -51.51 19.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.516 -172.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 54' ' ' ALA . . . . . 0.449 ' HB2' ' CD2' ' E' ' 65' ' ' LEU . . . -156.54 142.07 17.63 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.262 -177.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 43.3 m -105.14 101.45 11.0 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 171.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . 0.4 HG13 ' HB3' ' E' ' 40' ' ' ALA . 7.5 p -115.75 112.67 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-O 121.759 0.79 . . . . 0.0 110.033 -177.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 69.4 p -123.59 -177.07 3.62 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.008 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -59.18 -32.87 70.3 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.914 0.388 . . . . 0.0 110.385 169.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.62 -40.62 69.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.526 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 76.2 mt -117.58 81.77 14.93 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.67 -5.73 15.0 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.257 2.638 . . . . 0.0 113.965 -167.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -162.07 122.66 2.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.202 0.525 . . . . 0.0 110.925 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . 0.42 HG11 ' HB1' ' E' ' 54' ' ' ALA . 97.4 t -108.62 113.56 44.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.307 175.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.32 114.83 27.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.122 175.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 65' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' E' ' 30' ' ' SER . 0.3 OUTLIER -135.42 168.6 18.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.263 -176.244 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 66' ' ' ASP . . . . . 0.546 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 6.0 t70 -114.53 99.75 7.78 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.43 0.633 . . . . 0.0 110.66 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 67' ' ' LEU . . . . . 0.636 HD21 HD23 ' D' ' 88' ' ' LEU . 19.7 mt -111.35 140.99 45.47 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.13 116.57 9.62 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.417 174.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -116.72 139.74 50.21 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 70' ' ' SER . . . . . 0.407 ' HA ' ' OG ' ' E' ' 26' ' ' SER . 5.3 t -103.31 173.92 6.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.977 0.418 . . . . 0.0 110.635 -177.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.59 1.37 12.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.516 -177.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.05 -5.98 54.3 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 173.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -100.26 151.33 21.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.769 0.319 . . . . 0.0 110.465 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -140.02 132.42 28.46 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 172.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 75' ' ' ILE . . . . . 0.668 HG22 ' HB2' ' E' ' 46' ' ' ALA . 6.8 pt -139.83 164.58 23.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.973 0.416 . . . . 0.0 111.87 -167.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 76' ' ' MET . . . . . 0.505 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 4.5 mtm -118.58 121.68 40.79 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 77' ' ' PHE . . . . . 0.513 ' CD1' ' HB2' ' E' ' 44' ' ' LEU . 1.0 OUTLIER -103.73 127.98 51.15 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.738 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 78' ' ' TYR . . . . . 0.648 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 40.1 p90 -153.51 140.9 19.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.213 0.53 . . . . 0.0 111.905 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 79' ' ' THR . . . . . 0.682 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 14.7 p -111.98 144.99 40.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.17 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.24 148.66 28.66 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.214 173.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.87 176.83 41.08 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -176.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -108.56 102.56 11.63 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.949 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 83' ' ' ALA . . . . . 0.511 ' N ' ' HB3' ' E' ' 15' ' ' PRO . . . -165.9 148.86 7.5 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.39 167.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 27.2 t -103.95 123.93 48.06 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 85' ' ' VAL . . . . . 0.614 HG23 ' HB3' ' E' ' 13' ' ' MET . 8.1 m -120.87 135.2 61.81 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-O 121.377 0.608 . . . . 0.0 112.005 -173.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 69.1 m -97.48 118.38 33.84 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.455 -0.793 . . . . 0.0 108.866 175.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 87' ' ' LEU . . . . . 0.609 HD13 HD23 ' E' ' 11' ' ' LEU . 5.0 mp -91.27 140.81 29.44 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 171.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . 0.644 HD23 HD21 ' A' ' 67' ' ' LEU . 0.8 OUTLIER -127.67 143.64 51.14 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -178.247 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 89' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' E' ' 28' ' ' HIS . . . -166.22 -166.98 26.16 Favored Glycine 0 N--CA 1.438 -1.185 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.799 -177.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 90' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' E' ' 7' ' ' MET . 5.2 p90 -142.29 136.62 29.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.954 0.407 . . . . 0.0 110.632 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 91' ' ' LEU . . . . . 0.499 HD23 ' HB3' ' E' ' 27' ' ' PHE . 84.4 mt . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.953 174.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 CA--C 1.516 -0.345 0 CA-C-O 121.164 0.507 . . . . 0.0 111.674 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.64 ' CE1' HD21 ' B' ' 44' ' ' LEU . 31.1 t80 -72.26 145.87 47.63 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.409 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.422 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 92.1 t90 -134.31 147.97 50.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.391 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.502 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -152.25 154.92 25.83 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.855 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.526 HD23 HD13 ' A' ' 87' ' ' LEU . 49.8 tp -147.38 108.26 4.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.857 0.36 . . . . 0.0 111.019 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -90.42 119.94 31.12 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.963 0.411 . . . . 0.0 110.545 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.694 ' SD ' ' HE2' ' A' ' 19' ' ' TYR . 52.9 mmm -99.96 139.67 35.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.226 -175.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -100.32 145.06 29.62 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.583 174.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.468 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 11.0 Cg_endo -55.14 116.29 3.04 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.147 2.565 . . . . 0.0 112.925 -177.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 62.92 64.85 0.84 Allowed 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.876 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -145.71 138.78 26.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.682 173.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.728 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 86.4 mttt -107.1 126.54 52.49 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -176.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.694 ' HE2' ' SD ' ' A' ' 13' ' ' MET . 1.2 m-85 -112.6 103.84 11.9 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.192 174.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.0 p -88.37 100.33 12.94 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 174.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -113.24 144.37 42.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.434 0.635 . . . . 0.0 111.872 -170.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.5 m -101.95 140.91 35.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.556 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.403 HG22 ' HA ' ' A' ' 71' ' ' LYS . 74.1 mt -99.38 120.14 48.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.217 0.532 . . . . 0.0 111.723 -171.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.753 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -105.65 -9.84 10.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.276 176.044 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.516 ' HD2' HD13 ' A' ' 91' ' ' LEU . 35.5 pttt -141.55 119.16 11.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.872 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.9 p -67.05 133.67 50.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.809 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.671 ' HB3' HD23 ' A' ' 91' ' ' LEU . 32.6 p90 -147.56 166.49 27.19 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -173.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.554 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 9.4 t60 -118.88 126.21 51.27 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.908 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 42.6 mt -92.23 136.16 25.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 170.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.513 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 64.2 p -123.68 -5.66 8.09 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -170.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.46 160.79 27.76 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 119.086 -1.531 . . . . 0.0 113.823 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.466 HG23 ' HG ' ' A' ' 87' ' ' LEU . 11.5 p -144.5 129.96 14.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 174.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.45 157.7 43.97 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.012 -0.43 . . . . 0.0 111.482 -176.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.649 ' HB3' HG12 ' A' ' 85' ' ' VAL . 3.9 pp -122.05 145.3 48.28 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.795 0.807 . . . . 0.0 111.846 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -107.72 -56.02 2.28 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.64 173.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -103.14 127.26 50.49 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.368 173.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.59 ' O ' ' HG3' ' A' ' 58' ' ' LYS . . . 145.13 159.38 8.07 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 119.958 -1.115 . . . . 0.0 112.896 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -102.43 -45.61 5.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.477 0.18 . . . . 0.0 111.459 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -150.56 127.27 10.93 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 120.582 0.229 . . . . 0.0 111.056 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.519 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -127.42 114.94 18.17 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.295 0.569 . . . . 0.0 110.479 171.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 79' ' ' THR . 3.7 mppt? -95.1 112.05 23.8 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 174.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.6 tp -84.18 108.87 17.32 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -108.59 144.31 36.47 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.267 0.556 . . . . 0.0 110.073 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.674 HD21 ' CE1' ' E' ' 8' ' ' PHE . 0.2 OUTLIER -129.23 116.64 19.47 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.413 174.454 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -103.45 110.52 22.58 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.251 0.548 . . . . 0.0 109.706 177.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.52 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -140.13 145.58 37.75 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.333 -177.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 58.11 33.14 22.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.474 0.654 . . . . 0.0 109.774 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 62.59 38.13 12.55 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.814 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.545 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 6.5 tp-100 -140.66 138.92 34.67 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 178.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -90.92 110.04 21.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.88 0.371 . . . . 0.0 110.405 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.536 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 78.2 m-85 -101.82 130.65 48.32 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.473 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -85.24 101.86 10.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.74 0.781 . . . . 0.0 109.03 172.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.609 ' CG2' ' HB3' ' A' ' 44' ' ' LEU . 2.9 t -76.33 -49.81 23.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.72 -171.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.545 ' HB2' HD21 ' A' ' 65' ' ' LEU . . . -154.02 146.69 24.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.451 -177.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.5 m -111.06 100.94 9.53 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 170.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.464 HG11 HG11 ' A' ' 85' ' ' VAL . 7.5 p -115.8 114.65 46.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.665 0.745 . . . . 0.0 109.808 -176.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 78.0 p -122.86 -178.32 3.91 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.51 -173.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.59 ' HG3' ' O ' ' A' ' 37' ' ' GLY . 6.1 mttm -61.41 -29.9 70.23 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.012 0.434 . . . . 0.0 110.407 169.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.27 -40.2 52.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.431 178.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.2 mt -115.55 81.38 8.87 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -69.13 -0.47 6.44 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.152 2.568 . . . . 0.0 113.984 -167.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -163.06 130.24 3.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.361 0.601 . . . . 0.0 111.319 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 96.3 t -118.88 120.81 65.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.377 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.18 131.61 35.31 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 175.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.545 HD21 ' HB2' ' A' ' 54' ' ' ALA . 82.5 mt -124.0 167.14 14.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.449 0.642 . . . . 0.0 112.36 -173.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.451 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 14.4 t0 -143.15 99.18 3.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.514 170.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.596 HD21 HD23 ' E' ' 88' ' ' LEU . 2.4 mt -128.09 140.04 52.17 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.408 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -135.2 122.71 21.99 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.754 174.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -116.14 143.75 45.07 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.49 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.1 t -94.34 166.24 12.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.239 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.403 ' HA ' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -74.57 -7.05 51.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.164 0.506 . . . . 0.0 110.138 178.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.86 -8.16 62.16 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.494 174.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -93.71 144.62 25.23 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -136.12 127.74 28.88 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 171.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.52 HG22 ' HB2' ' A' ' 46' ' ' ALA . 8.5 pt -135.5 160.31 39.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.581 -163.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.436 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 3.0 mtm -114.05 120.39 40.41 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.499 172.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.651 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -103.67 127.85 51.07 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 176.235 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.728 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 53.0 p90 -156.4 143.15 18.66 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 119.735 -0.786 . . . . 0.0 112.238 -176.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 2.0 p -114.92 132.11 56.66 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.301 -176.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.42 160.65 14.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.797 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.02 -175.67 40.08 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -175.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -110.4 102.53 11.16 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.877 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -174.51 155.7 2.3 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.557 171.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.5 t -115.92 117.26 29.67 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.371 -0.604 . . . . 0.0 109.371 177.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.649 HG12 ' HB3' ' A' ' 34' ' ' LEU . 3.7 m -111.34 164.97 6.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.213 0.53 . . . . 0.0 112.126 -174.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 21.2 t -129.76 120.85 25.74 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.125 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.526 HD13 HD23 ' A' ' 11' ' ' LEU . 5.3 mp -92.86 154.43 18.23 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 121.004 0.43 . . . . 0.0 110.172 173.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.599 HD23 HD21 ' B' ' 67' ' ' LEU . 0.2 OUTLIER -133.7 144.66 49.28 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.105 179.827 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.97 -167.45 28.64 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.01 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -145.99 136.48 24.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.513 0.673 . . . . 0.0 111.651 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.671 HD23 ' HB3' ' A' ' 27' ' ' PHE . 26.6 mt . . . . . 0 C--N 1.323 -0.564 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.495 175.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 CA--C 1.516 -0.334 0 CA-C-O 121.188 0.518 . . . . 0.0 111.631 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . 0.655 ' CE1' HD21 ' C' ' 44' ' ' LEU . 31.8 t80 -72.13 145.8 47.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.462 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . 0.423 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 92.1 t90 -134.26 147.95 50.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.474 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.528 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -152.27 154.92 25.83 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.85 178.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.541 HD23 HD13 ' B' ' 87' ' ' LEU . 49.4 tp -147.37 108.34 4.21 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.856 0.36 . . . . 0.0 110.992 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -90.41 120.15 31.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.895 0.378 . . . . 0.0 110.479 176.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . 0.705 ' SD ' ' HE2' ' B' ' 19' ' ' TYR . 53.4 mmm -100.1 139.62 35.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.145 -175.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -100.28 145.05 29.59 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.636 174.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.476 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 11.1 Cg_endo -55.15 116.26 3.02 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.136 2.558 . . . . 0.0 112.943 -177.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 62.96 64.85 0.84 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.89 176.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -145.74 138.89 26.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.622 173.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.734 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 86.4 mttt -107.26 126.39 52.36 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -176.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' TYR . . . . . 0.705 ' HE2' ' SD ' ' B' ' 13' ' ' MET . 1.2 m-85 -112.41 103.73 11.85 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.221 174.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 9.2 p -88.31 100.38 12.96 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -113.29 144.42 42.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.889 -170.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 27.6 m -101.94 140.96 35.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.521 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.405 HG22 ' HA ' ' B' ' 71' ' ' LYS . 73.6 mt -99.42 120.14 48.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.26 0.552 . . . . 0.0 111.754 -171.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.749 ' H ' HD13 ' B' ' 24' ' ' ILE . 0.2 OUTLIER -105.54 -9.88 10.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.323 175.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.5 ' HD2' HD13 ' B' ' 91' ' ' LEU . 35.4 pttt -141.52 119.11 11.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.872 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 5.9 p -67.02 133.75 50.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.818 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . 0.666 ' HB3' HD23 ' B' ' 91' ' ' LEU . 32.9 p90 -147.59 166.42 27.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.668 0.747 . . . . 0.0 112.922 -173.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' HIS . . . . . 0.543 ' HA ' ' O ' ' B' ' 67' ' ' LEU . 9.3 t60 -118.82 126.23 51.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.964 178.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.534 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 43.3 mt -92.28 136.18 25.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 170.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.512 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 64.2 p -123.73 -5.67 8.06 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -170.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.41 160.77 27.77 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 119.032 -1.556 . . . . 0.0 113.823 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.473 HG23 ' HG ' ' B' ' 87' ' ' LEU . 11.4 p -144.52 130.02 14.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 173.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.41 157.7 43.97 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 122.0 -0.438 . . . . 0.0 111.598 -176.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.654 ' HB3' HG12 ' B' ' 85' ' ' VAL . 3.9 pp -122.11 145.32 48.28 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.856 0.836 . . . . 0.0 111.825 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -107.75 -56.09 2.27 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.614 173.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -103.07 127.23 50.41 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.344 173.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.579 ' O ' ' HG3' ' B' ' 58' ' ' LYS . . . 145.21 159.37 8.07 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 120.016 -1.088 . . . . 0.0 112.809 178.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -102.42 -45.56 5.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.474 0.178 . . . . 0.0 111.46 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -150.62 127.3 10.9 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 120.615 0.245 . . . . 0.0 110.958 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.531 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -127.41 114.95 18.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.235 0.541 . . . . 0.0 110.461 171.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' B' ' 79' ' ' THR . 3.7 mppt? -94.97 112.01 23.75 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 174.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 46.6 tp -84.26 108.84 17.36 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -176.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -108.56 144.31 36.42 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.338 0.589 . . . . 0.0 110.08 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.662 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 0.2 OUTLIER -129.25 116.74 19.61 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.378 174.397 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.546 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -103.44 110.5 22.54 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.18 0.514 . . . . 0.0 109.702 177.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.513 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -140.08 145.63 37.91 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.358 -177.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 58.1 33.0 22.72 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.521 0.677 . . . . 0.0 109.833 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 62.77 38.0 12.08 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.82 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . 0.546 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 6.5 tp-100 -140.64 139.0 34.77 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 178.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -90.98 110.05 21.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.922 0.392 . . . . 0.0 110.352 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.502 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 78.3 m-85 -101.82 130.72 48.32 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.484 178.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -85.32 101.87 10.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.742 0.782 . . . . 0.0 108.971 172.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.613 ' CG2' ' HB3' ' B' ' 44' ' ' LEU . 2.9 t -76.4 -49.76 23.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.704 -171.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.547 ' HB2' HD21 ' B' ' 65' ' ' LEU . . . -154.1 146.71 24.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.434 -177.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 27.4 m -110.99 100.98 9.58 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . 0.468 HG11 HG11 ' B' ' 85' ' ' VAL . 7.5 p -115.8 114.71 47.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.655 0.741 . . . . 0.0 109.855 -176.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 78.7 p -122.87 -178.24 3.89 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.45 -173.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . 0.579 ' HG3' ' O ' ' B' ' 37' ' ' GLY . 6.1 mttm -61.49 -30.04 70.36 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.07 0.462 . . . . 0.0 110.29 169.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.12 -40.33 53.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.41 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 79.3 mt -115.55 81.4 8.91 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.15 -0.35 6.29 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.043 2.495 . . . . 0.0 114.006 -167.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -163.13 130.15 3.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.226 0.536 . . . . 0.0 111.346 -176.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 96.1 t -118.82 120.81 65.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.373 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.24 131.51 35.3 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.547 HD21 ' HB2' ' B' ' 54' ' ' ALA . 82.4 mt -123.93 167.17 14.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.479 0.657 . . . . 0.0 112.348 -173.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 14.4 t0 -143.13 99.11 3.39 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.563 170.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.599 HD21 HD23 ' A' ' 88' ' ' LEU . 2.4 mt -128.02 140.16 52.13 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.395 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -135.35 122.7 21.8 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.714 174.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -116.08 143.72 45.1 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.508 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 34.0 t -94.37 166.26 12.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.216 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . 0.405 ' HA ' HG22 ' B' ' 23' ' ' ILE . 0.0 OUTLIER -74.59 -6.91 51.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.179 0.514 . . . . 0.0 110.175 178.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.95 -8.21 61.97 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.458 174.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -93.69 144.62 25.23 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -136.12 127.79 28.98 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 171.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.513 HG22 ' HB2' ' B' ' 46' ' ' ALA . 8.5 pt -135.46 160.41 40.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.606 -163.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.432 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 3.0 mtm -114.05 120.35 40.29 Favored 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.535 172.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . 0.662 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -103.75 127.78 51.19 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 176.288 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.734 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 52.7 p90 -156.31 143.18 18.79 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 119.802 -0.759 . . . . 0.0 112.238 -176.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' B' ' 41' ' ' LYS . 2.0 p -114.98 132.02 56.72 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.335 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.27 160.72 14.88 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.82 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.97 -175.67 40.16 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -175.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -110.37 102.58 11.21 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.878 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -174.55 155.62 2.27 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.567 171.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 32.2 t -115.91 117.25 29.66 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.654 HG12 ' HB3' ' B' ' 34' ' ' LEU . 3.7 m -111.3 164.88 6.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.245 0.545 . . . . 0.0 112.132 -174.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 21.3 t -129.7 120.83 25.79 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.156 176.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.541 HD13 HD23 ' B' ' 11' ' ' LEU . 5.3 mp -92.92 154.36 18.24 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.016 0.436 . . . . 0.0 110.163 173.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.58 HD23 HD21 ' C' ' 67' ' ' LEU . 0.2 OUTLIER -133.65 144.66 49.35 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.083 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.94 -167.41 28.55 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.962 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -146.07 136.49 23.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.582 0.706 . . . . 0.0 111.623 177.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . 0.666 HD23 ' HB3' ' B' ' 27' ' ' PHE . 26.4 mt . . . . . 0 C--N 1.323 -0.572 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.474 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 C--O 1.223 -0.303 0 CA-C-O 121.094 0.473 . . . . 0.0 111.67 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 8' ' ' PHE . . . . . 0.654 ' CE1' HD21 ' D' ' 44' ' ' LEU . 31.2 t80 -72.26 145.88 47.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.376 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . 0.419 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 92.1 t90 -134.35 147.96 50.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.464 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . 0.524 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -152.23 154.91 25.83 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.828 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.532 HD23 HD13 ' C' ' 87' ' ' LEU . 49.7 tp -147.37 108.37 4.22 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.923 0.392 . . . . 0.0 111.069 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -90.49 120.12 31.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.929 0.395 . . . . 0.0 110.536 176.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 13' ' ' MET . . . . . 0.706 ' SD ' ' HE2' ' C' ' 19' ' ' TYR . 53.2 mmm -100.01 139.66 35.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.254 -175.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -100.41 144.99 29.51 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.584 174.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . 0.481 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 11.0 Cg_endo -55.08 116.3 3.04 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 123.106 2.537 . . . . 0.0 112.932 -177.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 62.9 64.81 0.85 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.89 176.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -145.67 138.93 26.21 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.655 173.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 18' ' ' LYS . . . . . 0.727 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 86.7 mttt -107.13 126.48 52.43 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -176.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . 0.706 ' HE2' ' SD ' ' C' ' 13' ' ' MET . 1.2 m-85 -112.52 103.84 11.93 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.145 174.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 9.0 p -88.38 100.24 12.88 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -113.23 144.45 42.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.434 0.635 . . . . 0.0 111.848 -170.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 27.3 m -101.98 140.9 35.65 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.452 176.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . 0.403 HG22 ' HA ' ' C' ' 71' ' ' LYS . 73.9 mt -99.41 120.14 48.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.125 0.488 . . . . 0.0 111.772 -171.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . 0.767 ' H ' HD13 ' C' ' 24' ' ' ILE . 0.2 OUTLIER -105.57 -9.94 10.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.318 176.018 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . 0.516 ' HD2' HD13 ' C' ' 91' ' ' LEU . 35.7 pttt -141.47 119.07 11.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.893 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 5.8 p -67.04 133.72 50.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.738 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 27' ' ' PHE . . . . . 0.662 ' HB3' HD23 ' C' ' 91' ' ' LEU . 32.4 p90 -147.53 166.44 27.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.627 0.727 . . . . 0.0 112.956 -173.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 28' ' ' HIS . . . . . 0.545 ' HA ' ' O ' ' C' ' 67' ' ' LEU . 9.4 t60 -118.87 126.23 51.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.34 -1.3 . . . . 0.0 109.934 178.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . 0.542 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 42.7 mt -92.2 136.14 25.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 170.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.514 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 64.4 p -123.71 -5.62 8.07 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -170.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.45 160.71 27.64 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 119.038 -1.553 . . . . 0.0 113.816 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.477 HG23 ' HG ' ' C' ' 87' ' ' LEU . 11.5 p -144.49 129.99 14.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 173.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.42 157.72 43.97 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.889 -0.507 . . . . 0.0 111.517 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.669 ' HB3' HG12 ' C' ' 85' ' ' VAL . 3.8 pp -122.07 145.33 48.25 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.782 0.801 . . . . 0.0 111.803 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -107.79 -56.04 2.28 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.387 -1.278 . . . . 0.0 108.621 173.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -103.08 127.25 50.41 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.345 173.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 37' ' ' GLY . . . . . 0.588 ' O ' ' HG3' ' C' ' 58' ' ' LYS . . . 145.23 159.4 8.09 Favored Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 119.954 -1.117 . . . . 0.0 112.815 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -102.56 -45.58 5.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.465 0.174 . . . . 0.0 111.385 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -150.48 127.2 10.95 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.501 0.191 . . . . 0.0 111.094 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.53 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -127.38 115.0 18.28 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.328 0.585 . . . . 0.0 110.439 171.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' C' ' 79' ' ' THR . 3.7 mppt? -95.11 112.07 23.82 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 46.9 tp -84.31 108.93 17.44 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -176.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -108.62 144.33 36.49 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.327 0.584 . . . . 0.0 110.062 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.655 HD21 ' CE1' ' B' ' 8' ' ' PHE . 0.2 OUTLIER -129.28 116.79 19.65 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.364 174.395 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -103.51 110.4 22.42 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.206 0.527 . . . . 0.0 109.736 177.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.512 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -139.97 145.64 38.13 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.385 -177.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 57.95 33.18 22.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.451 0.643 . . . . 0.0 109.844 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 60.0 mttp 62.69 38.03 12.3 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.822 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . 0.552 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 6.5 tp-100 -140.64 139.06 34.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.588 0.232 . . . . 0.0 110.379 178.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -91.07 110.02 21.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.32 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . 0.528 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 78.1 m-85 -101.84 130.72 48.36 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.433 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -85.31 101.8 10.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.68 0.752 . . . . 0.0 108.995 173.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 53' ' ' VAL . . . . . 0.609 ' CG2' ' HB3' ' C' ' 44' ' ' LEU . 2.9 t -76.33 -49.88 23.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.696 -171.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 54' ' ' ALA . . . . . 0.542 ' HB2' HD21 ' C' ' 65' ' ' LEU . . . -153.98 146.71 24.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.511 -177.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 27.6 m -111.04 101.02 9.6 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 170.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . 0.463 HG11 HG11 ' C' ' 85' ' ' VAL . 7.5 p -115.83 114.67 46.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.617 0.722 . . . . 0.0 109.807 -176.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 78.1 p -122.89 -178.26 3.89 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.467 -173.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 58' ' ' LYS . . . . . 0.588 ' HG3' ' O ' ' C' ' 37' ' ' GLY . 6.2 mttm -61.51 -29.92 70.29 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.025 0.441 . . . . 0.0 110.35 169.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.18 -40.24 52.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.359 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 79.9 mt -115.65 81.48 9.23 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.18 -0.44 6.44 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.143 2.562 . . . . 0.0 113.972 -167.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -163.11 130.18 3.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.266 0.555 . . . . 0.0 111.333 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 96.9 t -118.72 120.84 65.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.458 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.29 131.58 35.3 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . 0.542 HD21 ' HB2' ' C' ' 54' ' ' ALA . 82.6 mt -123.99 167.19 14.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.473 0.654 . . . . 0.0 112.285 -173.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 66' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 14.3 t0 -143.14 99.12 3.39 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.478 170.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.58 HD21 HD23 ' B' ' 88' ' ' LEU . 2.4 mt -128.1 140.15 52.1 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.419 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -135.32 122.73 21.88 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.75 174.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -116.12 143.75 45.07 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.429 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 33.8 t -94.31 166.23 12.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.231 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . 0.403 ' HA ' HG22 ' C' ' 23' ' ' ILE . 0.0 OUTLIER -74.57 -6.88 51.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.182 0.515 . . . . 0.0 110.185 178.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.97 -8.34 61.84 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.462 174.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -93.61 144.58 25.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.815 0.34 . . . . 0.0 110.097 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -136.06 127.72 28.96 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 171.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.512 HG22 ' HB2' ' C' ' 46' ' ' ALA . 8.5 pt -135.36 160.45 40.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.532 -163.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.436 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 3.0 mtm -114.14 120.37 40.28 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.51 172.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 77' ' ' PHE . . . . . 0.653 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.7 OUTLIER -103.8 127.81 51.26 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.315 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 78' ' ' TYR . . . . . 0.727 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 53.3 p90 -156.31 143.17 18.78 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.311 -176.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' C' ' 41' ' ' LYS . 2.0 p -114.98 131.99 56.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.362 -176.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.29 160.66 14.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.862 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.93 -175.69 40.24 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -175.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -110.39 102.61 11.23 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 119.391 -0.924 . . . . 0.0 109.867 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . 0.53 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -174.53 155.61 2.28 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.633 171.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 32.3 t -115.84 117.28 29.76 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.669 HG12 ' HB3' ' C' ' 34' ' ' LEU . 3.7 m -111.39 164.92 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-O 121.313 0.578 . . . . 0.0 112.106 -174.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 21.1 t -129.72 120.8 25.7 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.217 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . 0.532 HD13 HD23 ' C' ' 11' ' ' LEU . 5.3 mp -92.89 154.4 18.23 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 120.987 0.422 . . . . 0.0 110.157 173.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . 0.581 HD23 HD21 ' D' ' 67' ' ' LEU . 0.2 OUTLIER -133.68 144.67 49.32 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.135 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.0 -167.36 28.54 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.978 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -146.06 136.45 23.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.564 0.697 . . . . 0.0 111.631 177.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . 0.662 HD23 ' HB3' ' C' ' 27' ' ' PHE . 26.3 mt . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.486 175.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 C--O 1.224 -0.27 0 CA-C-O 121.148 0.499 . . . . 0.0 111.663 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 8' ' ' PHE . . . . . 0.639 ' CE1' HD21 ' E' ' 44' ' ' LEU . 31.0 t80 -72.27 145.78 47.66 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.37 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 9' ' ' TRP . . . . . 0.426 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 92.1 t90 -134.27 147.99 50.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.433 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . 0.513 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -152.21 154.91 25.83 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.872 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . 0.54 HD23 HD13 ' D' ' 87' ' ' LEU . 50.1 tp -147.33 108.34 4.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.803 0.335 . . . . 0.0 111.02 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -90.52 120.09 31.32 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.974 0.416 . . . . 0.0 110.479 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 13' ' ' MET . . . . . 0.689 ' SD ' ' HE2' ' D' ' 19' ' ' TYR . 53.3 mmm -100.08 139.63 35.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.173 -175.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -100.3 145.07 29.63 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.59 174.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . 0.461 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 11.0 Cg_endo -55.23 116.3 3.04 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 123.099 2.533 . . . . 0.0 112.91 -177.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 63.04 64.79 0.83 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.843 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -145.65 138.86 26.19 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.598 173.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . 0.718 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 86.6 mttt -107.2 126.48 52.46 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -176.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 19' ' ' TYR . . . . . 0.689 ' HE2' ' SD ' ' D' ' 13' ' ' MET . 1.2 m-85 -112.63 103.81 11.87 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.104 174.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 8.7 p -88.38 100.28 12.9 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 174.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -113.13 144.4 42.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.88 -170.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 27.2 m -101.95 140.9 35.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.609 176.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . 0.418 HG22 ' HA ' ' D' ' 71' ' ' LYS . 74.2 mt -99.48 120.19 48.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.203 0.525 . . . . 0.0 111.651 -171.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . 0.775 ' H ' HD13 ' D' ' 24' ' ' ILE . 0.2 OUTLIER -105.61 -9.81 10.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.388 175.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . 0.507 ' HD2' HD13 ' D' ' 91' ' ' LEU . 35.4 pttt -141.55 119.08 11.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.847 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 5.8 p -67.06 133.72 50.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.783 -176.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 27' ' ' PHE . . . . . 0.68 ' HB3' HD23 ' D' ' 91' ' ' LEU . 32.7 p90 -147.56 166.39 27.48 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -173.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 28' ' ' HIS . . . . . 0.546 ' HA ' ' O ' ' D' ' 67' ' ' LEU . 9.3 t60 -118.73 126.23 51.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.973 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 29' ' ' ILE . . . . . 0.551 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 42.4 mt -92.24 136.14 25.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 170.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . 0.522 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 64.3 p -123.77 -5.57 8.04 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -170.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.42 160.84 27.87 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 119.141 -1.504 . . . . 0.0 113.874 176.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.462 HG23 ' HG ' ' D' ' 87' ' ' LEU . 11.4 p -144.51 129.95 14.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 173.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.41 157.76 43.96 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.004 -0.435 . . . . 0.0 111.451 -176.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 34' ' ' LEU . . . . . 0.646 ' HB3' HG12 ' D' ' 85' ' ' VAL . 3.9 pp -122.11 145.26 48.34 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.8 0.809 . . . . 0.0 111.826 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -107.67 -55.98 2.28 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.663 173.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -103.2 127.25 50.56 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.336 173.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . 0.59 ' O ' ' HG3' ' D' ' 58' ' ' LYS . . . 145.15 159.33 8.04 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 119.997 -1.096 . . . . 0.0 112.83 178.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -102.47 -45.49 5.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -150.58 127.35 10.97 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.592 0.234 . . . . 0.0 110.955 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . 0.538 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -127.51 114.97 18.15 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.223 0.535 . . . . 0.0 110.452 171.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' D' ' 79' ' ' THR . 3.7 mppt? -95.14 112.07 23.82 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 47.2 tp -84.26 108.88 17.38 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -176.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -108.51 144.32 36.32 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.129 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.656 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.2 OUTLIER -129.28 116.73 19.57 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.411 174.355 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 45' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -103.34 110.43 22.42 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.698 177.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.508 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -140.05 145.53 37.84 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.339 -177.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 58.18 33.08 22.81 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.466 0.65 . . . . 0.0 109.819 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 62.65 37.95 12.48 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.904 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . 0.553 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 6.5 tp-100 -140.6 138.96 34.81 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 178.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -90.95 110.14 21.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.315 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . 0.524 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 78.5 m-85 -101.87 130.7 48.41 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.444 178.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -85.27 101.91 10.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 172.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 53' ' ' VAL . . . . . 0.607 ' CG2' ' HB3' ' D' ' 44' ' ' LEU . 2.9 t -76.49 -49.69 23.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.716 -171.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 54' ' ' ALA . . . . . 0.554 ' HB2' HD21 ' D' ' 65' ' ' LEU . . . -154.05 146.73 24.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.414 -177.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 27.3 m -111.06 100.93 9.52 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 170.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 56' ' ' VAL . . . . . 0.463 HG11 HG11 ' D' ' 85' ' ' VAL . 7.4 p -115.8 114.64 46.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.607 0.718 . . . . 0.0 109.85 -176.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 79.2 p -122.88 -178.24 3.89 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.487 -173.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 58' ' ' LYS . . . . . 0.59 ' HG3' ' O ' ' D' ' 37' ' ' GLY . 6.1 mttm -61.45 -29.95 70.28 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.037 0.446 . . . . 0.0 110.415 169.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.21 -40.21 52.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.438 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 79.5 mt -115.63 81.47 9.15 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 174.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -69.13 -0.42 6.37 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.15 2.567 . . . . 0.0 113.983 -167.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -163.15 130.1 3.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.222 0.534 . . . . 0.0 111.297 -176.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 96.4 t -118.76 120.87 65.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.39 174.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.2 131.49 35.3 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 65' ' ' LEU . . . . . 0.554 HD21 ' HB2' ' D' ' 54' ' ' ALA . 82.7 mt -123.96 167.17 14.5 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.474 0.654 . . . . 0.0 112.325 -173.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 66' ' ' ASP . . . . . 0.427 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 14.4 t0 -143.09 99.03 3.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.592 170.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.581 HD21 HD23 ' C' ' 88' ' ' LEU . 2.4 mt -127.96 140.11 52.18 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.436 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -135.3 122.73 21.89 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.486 -0.485 . . . . 0.0 109.72 174.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -116.11 143.66 45.18 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.551 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 34.0 t -94.38 166.26 12.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.219 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 71' ' ' LYS . . . . . 0.418 ' HA ' HG22 ' D' ' 23' ' ' ILE . 0.0 OUTLIER -74.56 -7.02 51.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.271 0.557 . . . . 0.0 110.141 179.065 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.91 -8.19 62.05 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.496 174.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -93.63 144.52 25.31 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -136.08 127.75 28.97 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 171.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.508 HG22 ' HB2' ' D' ' 46' ' ' ALA . 8.6 pt -135.34 160.5 40.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.568 -163.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 76' ' ' MET . . . . . 0.437 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 3.0 mtm -114.16 120.43 40.47 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.454 172.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 77' ' ' PHE . . . . . 0.656 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.7 OUTLIER -103.79 127.73 51.25 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.263 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 78' ' ' TYR . . . . . 0.718 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 52.9 p90 -156.25 143.14 18.83 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.248 -176.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 79' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' D' ' 41' ' ' LYS . 2.0 p -114.9 132.01 56.68 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.305 -176.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.28 160.69 14.91 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.874 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.96 -175.7 40.2 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -175.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -110.34 102.53 11.17 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.97 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . 0.538 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -174.54 155.54 2.26 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.591 171.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 32.4 t -115.81 117.14 29.39 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.646 HG12 ' HB3' ' D' ' 34' ' ' LEU . 3.7 m -111.27 164.87 6.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.21 0.528 . . . . 0.0 112.151 -174.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 21.3 t -129.65 120.83 25.87 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.17 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 87' ' ' LEU . . . . . 0.54 HD13 HD23 ' D' ' 11' ' ' LEU . 5.3 mp -92.92 154.44 18.19 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 121.022 0.439 . . . . 0.0 110.1 173.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.594 HD23 HD21 ' E' ' 67' ' ' LEU . 0.2 OUTLIER -133.7 144.65 49.27 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.111 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.88 -167.34 28.4 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.033 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -146.1 136.49 23.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.556 0.693 . . . . 0.0 111.653 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . 0.68 HD23 ' HB3' ' D' ' 27' ' ' PHE . 26.1 mt . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.536 175.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 C--O 1.223 -0.302 0 CA-C-O 121.093 0.473 . . . . 0.0 111.647 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' E' E ' 8' ' ' PHE . . . . . 0.674 ' CE1' HD21 ' A' ' 44' ' ' LEU . 31.2 t80 -72.13 145.9 47.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.46 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 9' ' ' TRP . . . . . 0.414 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 92.0 t90 -134.41 147.92 50.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.407 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 10' ' ' GLY . . . . . 0.536 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -152.18 154.93 25.84 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.908 178.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 11' ' ' LEU . . . . . 0.539 HD23 HD13 ' E' ' 87' ' ' LEU . 49.5 tp -147.34 108.31 4.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.829 0.347 . . . . 0.0 111.018 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -90.47 120.18 31.36 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.002 0.43 . . . . 0.0 110.478 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 13' ' ' MET . . . . . 0.685 ' SD ' ' HE2' ' E' ' 19' ' ' TYR . 53.0 mmm -100.08 139.57 35.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.247 -175.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -100.28 145.08 29.64 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.665 174.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . 0.465 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 11.0 Cg_endo -55.15 116.34 3.07 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.088 2.525 . . . . 0.0 112.951 -177.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 62.89 64.81 0.85 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.892 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -145.73 138.86 26.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.653 173.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . 0.713 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 86.7 mttt -107.11 126.36 52.27 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -176.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . 0.685 ' HE2' ' SD ' ' E' ' 13' ' ' MET . 1.2 m-85 -112.53 103.82 11.9 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.167 174.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 20' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' E' ' 76' ' ' MET . 9.1 p -88.31 100.25 12.86 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 174.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -113.16 144.37 42.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.899 -170.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 27.5 m -101.98 140.99 35.52 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.508 176.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 73.9 mt -99.47 120.21 48.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.225 0.536 . . . . 0.0 111.668 -171.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . 0.759 ' H ' HD13 ' E' ' 24' ' ' ILE . 0.2 OUTLIER -105.63 -9.86 10.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.297 175.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . 0.506 ' HD2' HD13 ' E' ' 91' ' ' LEU . 35.5 pttt -141.47 119.15 11.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.867 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 5.8 p -67.05 133.72 50.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.752 -176.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 27' ' ' PHE . . . . . 0.675 ' HB3' HD23 ' E' ' 91' ' ' LEU . 32.6 p90 -147.54 166.4 27.41 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -173.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 28' ' ' HIS . . . . . 0.55 ' HA ' ' O ' ' E' ' 67' ' ' LEU . 9.4 t60 -118.77 126.28 51.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.968 178.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 29' ' ' ILE . . . . . 0.542 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 42.8 mt -92.25 136.15 25.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 170.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . 0.507 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 64.2 p -123.69 -5.65 8.08 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -170.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.39 160.84 27.91 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.063 -1.541 . . . . 0.0 113.823 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.47 HG23 ' HG ' ' E' ' 87' ' ' LEU . 11.5 p -144.55 129.91 14.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.39 157.72 43.97 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 121.904 -0.497 . . . . 0.0 111.518 -176.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 34' ' ' LEU . . . . . 0.667 ' HB3' HG12 ' E' ' 85' ' ' VAL . 3.9 pp -122.06 145.27 48.31 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.858 0.837 . . . . 0.0 111.856 178.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -107.71 -56.06 2.27 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.222 -1.354 . . . . 0.0 108.612 173.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -103.12 127.23 50.48 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.411 173.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . 0.587 ' O ' ' HG3' ' E' ' 58' ' ' LYS . . . 145.19 159.34 8.06 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.016 -1.087 . . . . 0.0 112.897 178.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -102.53 -45.49 5.04 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.473 0.175 . . . . 0.0 111.473 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -150.53 127.36 11.02 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 120.526 0.203 . . . . 0.0 110.982 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . 0.529 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -127.49 114.93 18.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.183 0.516 . . . . 0.0 110.473 171.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 41' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' E' ' 79' ' ' THR . 3.7 mppt? -95.08 112.1 23.84 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 174.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 46.7 tp -84.27 108.87 17.38 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -176.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -108.54 144.34 36.34 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.331 0.586 . . . . 0.0 110.112 177.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 44' ' ' LEU . . . . . 0.661 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 0.2 OUTLIER -129.26 116.76 19.63 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.42 174.384 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 45' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -103.51 110.47 22.52 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.236 0.541 . . . . 0.0 109.666 177.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . 0.507 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -140.11 145.54 37.74 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.273 -177.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 58.15 33.04 22.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.476 0.655 . . . . 0.0 109.813 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 62.73 37.99 12.2 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.778 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 49' ' ' GLN . . . . . 0.551 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 6.5 tp-100 -140.56 138.98 34.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.59 0.233 . . . . 0.0 110.39 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -90.97 110.09 21.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.363 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . 0.513 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 78.2 m-85 -101.79 130.74 48.28 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.419 178.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -85.37 101.87 10.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.706 0.765 . . . . 0.0 109.023 172.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . 0.617 ' CG2' ' HB3' ' E' ' 44' ' ' LEU . 2.9 t -76.43 -49.76 23.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.714 -171.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 54' ' ' ALA . . . . . 0.545 ' HB2' HD21 ' E' ' 65' ' ' LEU . . . -154.02 146.67 24.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.498 -177.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 27.7 m -111.04 101.03 9.61 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 170.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . 0.46 HG11 HG11 ' E' ' 85' ' ' VAL . 7.5 p -115.82 114.62 46.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.628 0.728 . . . . 0.0 109.754 -176.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 76.2 p -122.82 -178.23 3.88 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.465 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 58' ' ' LYS . . . . . 0.587 ' HG3' ' O ' ' E' ' 37' ' ' GLY . 6.1 mttm -61.53 -29.99 70.35 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.023 0.44 . . . . 0.0 110.287 169.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.06 -40.37 53.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.433 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 79.0 mt -115.51 81.49 8.9 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 174.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.2 -0.5 6.54 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.087 2.524 . . . . 0.0 114.029 -167.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -163.02 130.28 3.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.275 0.559 . . . . 0.0 111.305 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 96.5 t -118.85 120.83 65.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.388 174.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.29 131.48 35.29 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 175.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 65' ' ' LEU . . . . . 0.545 HD21 ' HB2' ' E' ' 54' ' ' ALA . 82.6 mt -123.87 167.19 14.42 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.469 0.652 . . . . 0.0 112.336 -173.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 66' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 14.3 t0 -143.15 99.17 3.4 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.504 170.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 67' ' ' LEU . . . . . 0.594 HD21 HD23 ' D' ' 88' ' ' LEU . 2.5 mt -128.05 140.06 52.17 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.391 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -135.21 122.71 21.99 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.79 174.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -116.08 143.71 45.11 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.492 -178.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 34.2 t -94.4 166.27 12.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.194 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.55 -7.07 51.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.177 0.513 . . . . 0.0 110.151 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.8 -8.25 62.19 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.495 174.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -93.67 144.7 25.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.859 0.361 . . . . 0.0 110.074 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -136.2 127.72 28.69 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 171.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 75' ' ' ILE . . . . . 0.507 HG22 ' HB2' ' E' ' 46' ' ' ALA . 8.5 pt -135.4 160.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.634 -163.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 76' ' ' MET . . . . . 0.437 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 3.0 mtm -114.13 120.35 40.24 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 172.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 77' ' ' PHE . . . . . 0.661 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.7 OUTLIER -103.75 127.82 51.19 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.28 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 78' ' ' TYR . . . . . 0.713 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 53.2 p90 -156.37 143.11 18.67 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 119.79 -0.764 . . . . 0.0 112.269 -176.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 79' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' E' ' 41' ' ' LYS . 2.0 p -114.96 132.02 56.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.291 -176.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.37 160.7 14.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.817 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.0 -175.68 40.12 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -175.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -110.43 102.56 11.17 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.846 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 83' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -174.5 155.62 2.29 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.624 171.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 32.2 t -115.84 117.33 29.9 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 85' ' ' VAL . . . . . 0.667 HG12 ' HB3' ' E' ' 34' ' ' LEU . 3.7 m -111.36 164.9 6.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.268 0.556 . . . . 0.0 112.137 -174.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 21.2 t -129.75 120.9 25.84 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.18 176.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 87' ' ' LEU . . . . . 0.539 HD13 HD23 ' E' ' 11' ' ' LEU . 5.3 mp -92.98 154.48 18.13 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 121.023 0.439 . . . . 0.0 110.132 173.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . 0.596 HD23 HD21 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -133.7 144.7 49.3 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.086 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.99 -167.43 28.62 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.9 -0.666 . . . . 0.0 111.999 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 90' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -146.05 136.49 23.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.573 0.701 . . . . 0.0 111.663 177.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 91' ' ' LEU . . . . . 0.675 HD23 ' HB3' ' E' ' 27' ' ' PHE . 26.2 mt . . . . . 0 C--N 1.323 -0.549 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.574 175.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 49.0 mtt . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 121.221 0.534 . . . . 0.0 111.524 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.505 ' CE1' HD21 ' B' ' 44' ' ' LEU . 60.5 t80 -56.85 142.02 42.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.487 -173.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.45 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 87.5 t90 -135.41 141.49 45.47 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.763 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.503 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -143.2 155.46 26.02 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.068 178.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.643 HD23 HD13 ' A' ' 87' ' ' LEU . 57.2 tp -145.21 108.53 4.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.709 0.29 . . . . 0.0 110.901 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -89.0 106.42 18.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.492 0.663 . . . . 0.0 110.91 177.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.558 ' HB2' HG23 ' A' ' 85' ' ' VAL . 4.1 mmt -86.96 134.42 33.5 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.931 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.517 ' HB2' ' HG3' ' A' ' 17' ' ' ARG . 54.5 mtmt -100.26 146.08 31.36 Favored Pre-proline 0 C--N 1.316 -0.851 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 172.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.435 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 5.8 Cg_endo -48.12 110.37 0.32 Allowed 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 123.51 2.807 . . . . 0.0 113.432 -174.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.69 ' HA ' ' O ' ' A' ' 79' ' ' THR . 31.6 mt-10 69.5 54.07 0.41 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.531 178.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.517 ' HG3' ' HB2' ' A' ' 14' ' ' LYS . 19.5 mmt180 -110.75 152.7 26.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.868 172.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.719 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 36.0 ttmt -133.56 107.74 8.18 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.944 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.42 ' OH ' ' HA ' ' A' ' 13' ' ' MET . 0.8 OUTLIER -111.05 121.09 44.45 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.752 179.516 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.4 p -75.29 126.79 31.74 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 170.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -103.95 116.56 32.48 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.125 0.488 . . . . 0.0 111.727 -164.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.5 p -97.22 123.12 40.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.879 173.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.404 ' CG2' ' HA ' ' A' ' 71' ' ' LYS . 55.3 mt -92.97 108.43 20.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.199 0.524 . . . . 0.0 111.575 -172.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.713 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -76.08 -39.65 36.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.007 177.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -139.58 141.47 37.17 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.6 m -60.86 120.82 10.89 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.66 0.6 . . . . 0.0 109.85 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.548 ' HB3' HD23 ' A' ' 91' ' ' LEU . 2.2 p90 -134.25 166.01 23.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.706 0.765 . . . . 0.0 112.721 -169.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.621 ' HE2' ' HB2' ' A' ' 30' ' ' SER . 9.3 t60 -118.72 125.13 48.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.302 -1.317 . . . . 0.0 109.958 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.617 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 39.8 mt -94.6 138.48 20.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 169.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.621 ' HB2' ' HE2' ' A' ' 28' ' ' HIS . 26.2 t -119.62 -23.51 6.54 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -169.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -161.92 156.89 28.57 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 119.408 -1.377 . . . . 0.0 113.253 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.405 HG23 ' HG ' ' A' ' 87' ' ' LEU . 10.2 p -137.36 125.38 32.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 172.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.81 152.31 42.07 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -171.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.572 ' HB3' HG12 ' A' ' 85' ' ' VAL . 3.7 pp -119.18 142.73 47.71 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.583 0.706 . . . . 0.0 111.346 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -110.12 -48.46 3.18 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.615 173.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -102.49 127.27 49.62 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 170.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.522 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 145.83 159.54 8.22 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 119.392 -1.385 . . . . 0.0 113.948 176.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.428 ' HA ' ' HB2' ' A' ' 58' ' ' LYS . 54.3 mt-30 -103.15 -44.5 5.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.653 -0.274 . . . . 0.0 111.127 177.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -150.63 132.63 15.21 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 120.5 0.19 . . . . 0.0 111.026 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.527 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -133.02 114.32 13.84 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.286 0.565 . . . . 0.0 110.586 169.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 79' ' ' THR . 63.9 mttp -95.86 112.22 24.0 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 174.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 45.4 tp -83.99 115.93 22.57 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.439 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -117.02 144.01 45.08 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.533 ' HA ' ' O ' ' A' ' 76' ' ' MET . 0.2 OUTLIER -131.34 132.54 44.55 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.2 0.524 . . . . 0.0 109.723 172.086 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -107.09 110.07 22.09 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.3 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.587 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -126.22 151.95 46.71 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 43.36 37.49 1.38 Allowed 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.939 0.774 . . . . 0.0 111.142 -171.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.7 tptp 54.65 46.66 24.26 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.157 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.585 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 6.5 tp-100 -135.17 130.71 35.78 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.669 175.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -85.68 110.86 19.59 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.343 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.49 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 82.5 m-85 -104.62 129.16 52.77 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.7 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 tp -77.25 103.79 4.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 169.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.534 HG13 ' CD2' ' E' ' 88' ' ' LEU . 2.6 t -76.39 -49.52 24.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.293 -173.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.489 ' HB2' ' CD2' ' A' ' 65' ' ' LEU . . . -159.03 144.86 16.47 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.19 -178.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.3 m -110.5 101.49 10.17 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 171.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.431 ' CG1' HG11 ' A' ' 85' ' ' VAL . 7.5 p -111.26 120.44 61.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.133 -178.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 54.8 p -122.61 -179.81 4.35 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -172.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 38' ' ' GLN . 35.0 tttm -60.89 -27.04 67.86 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.272 0.558 . . . . 0.0 109.901 172.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.479 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -83.48 -40.57 19.07 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.734 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 90.9 mt -107.36 89.43 4.84 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 36.0 Cg_exo -61.32 -20.3 67.65 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.101 2.534 . . . . 0.0 113.941 -169.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -156.19 136.09 12.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.381 0.61 . . . . 0.0 111.974 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.453 HG11 ' HB1' ' A' ' 54' ' ' ALA . 98.4 t -111.38 113.8 45.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.729 171.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.03 122.15 34.27 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.08 177.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.489 ' CD2' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -142.6 143.5 32.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.248 0.547 . . . . 0.0 111.902 -177.084 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.471 ' HB3' ' OG ' ' E' ' 30' ' ' SER . 5.6 t70 -89.59 100.57 13.34 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.706 177.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.726 HD21 HD23 ' E' ' 88' ' ' LEU . 19.7 mt -110.81 138.39 47.27 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.686 176.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.649 ' HB2' ' CD2' ' E' ' 90' ' ' TYR . 10.5 m-80 -137.58 128.21 26.82 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 173.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -124.43 146.81 48.69 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.977 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.0 t -99.93 148.97 23.9 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.404 ' HA ' ' CG2' ' A' ' 23' ' ' ILE . 15.1 ptmm? -67.14 -10.72 53.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.326 -178.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.42 -9.87 66.38 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.107 176.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -100.74 160.06 14.67 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -135.12 125.43 26.37 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.587 HG22 ' HB2' ' A' ' 46' ' ' ALA . 11.3 pt -131.21 178.13 5.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.93 0.395 . . . . 0.0 111.609 -171.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.533 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 24.5 mtp -130.9 136.31 48.49 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 174.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.472 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 1.2 m-85 -117.86 128.21 54.62 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.145 176.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.719 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 34.6 p90 -155.08 145.64 22.2 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.966 -178.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.69 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 13.2 p -117.33 144.95 44.36 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.507 -177.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -115.04 151.33 34.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.915 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.58 -177.16 29.29 Favored Glycine 0 CA--C 1.509 -0.334 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -109.74 102.93 11.69 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.684 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -175.27 155.94 1.97 Allowed 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.87 172.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.6 t -113.03 118.87 36.0 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.572 HG12 ' HB3' ' A' ' 34' ' ' LEU . 10.5 m -118.94 137.39 53.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -173.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 54.6 m -101.17 120.94 40.97 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.048 175.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.643 HD13 HD23 ' A' ' 11' ' ' LEU . 5.3 mp -89.41 145.71 25.15 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 170.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.698 HD23 HD21 ' B' ' 67' ' ' LEU . 1.2 tp -131.48 132.17 44.05 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.679 -177.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -159.66 -166.76 19.22 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.701 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.634 ' CD2' ' HB2' ' B' ' 68' ' ' ASN . 18.7 p90 -153.02 133.72 13.83 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.919 0.866 . . . . 0.0 111.547 177.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.548 HD23 ' HB3' ' A' ' 27' ' ' PHE . 5.1 mt . . . . . 0 C--N 1.319 -0.748 0 CA-C-N 113.981 -1.463 . . . . 0.0 108.926 174.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 48.7 mtt . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 121.25 0.548 . . . . 0.0 111.546 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . 0.467 ' CE1' HD21 ' C' ' 44' ' ' LEU . 60.7 t80 -56.82 141.91 42.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.515 -173.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . 0.454 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 87.5 t90 -135.34 141.42 45.59 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.817 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.479 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -143.13 155.53 26.04 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.105 178.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.637 HD23 HD13 ' B' ' 87' ' ' LEU . 56.9 tp -145.34 108.5 4.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.784 0.326 . . . . 0.0 110.819 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -88.98 106.44 18.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.495 0.664 . . . . 0.0 110.947 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . 0.553 ' HB2' HG23 ' B' ' 85' ' ' VAL . 4.1 mmt -86.98 134.41 33.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.041 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.526 ' HB2' ' HG3' ' B' ' 17' ' ' ARG . 54.5 mtmt -100.18 146.14 31.45 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 172.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.44 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 5.8 Cg_endo -48.19 110.35 0.32 Allowed 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 123.449 2.766 . . . . 0.0 113.444 -174.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.69 ' HA ' ' O ' ' B' ' 79' ' ' THR . 31.6 mt-10 69.52 54.1 0.4 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.48 178.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.526 ' HG3' ' HB2' ' B' ' 14' ' ' LYS . 19.5 mmt180 -110.73 152.72 26.24 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.879 172.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.724 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 36.0 ttmt -133.59 107.79 8.2 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.825 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' TYR . . . . . 0.42 ' OH ' ' HA ' ' B' ' 13' ' ' MET . 0.8 OUTLIER -110.99 121.07 44.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.803 179.423 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 5.2 p -75.3 126.74 31.63 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 170.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -103.83 116.45 32.3 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.713 -164.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 9.6 p -97.16 123.19 40.86 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.842 173.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 55.6 mt -93.02 108.51 20.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.032 0.444 . . . . 0.0 111.513 -172.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.711 ' H ' HD13 ' B' ' 24' ' ' ILE . 0.2 OUTLIER -76.1 -39.73 36.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.001 177.765 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -139.53 141.48 37.28 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 15.5 m -60.8 120.93 11.06 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.666 0.604 . . . . 0.0 109.814 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . 0.545 ' HB3' HD23 ' B' ' 91' ' ' LEU . 2.2 p90 -134.34 165.95 23.95 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.685 0.755 . . . . 0.0 112.73 -169.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' HIS . . . . . 0.62 ' HE2' ' HB2' ' B' ' 30' ' ' SER . 9.5 t60 -118.68 125.1 48.95 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.98 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.627 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 39.7 mt -94.53 138.54 20.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 169.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.62 ' HB2' ' HE2' ' B' ' 28' ' ' HIS . 26.1 t -119.65 -23.49 6.53 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -169.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -161.91 156.99 28.69 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.328 -1.415 . . . . 0.0 113.266 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.405 HG23 ' HG ' ' B' ' 87' ' ' LEU . 10.2 p -137.5 125.37 31.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 172.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.81 152.36 42.14 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -171.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.585 ' HB3' HG12 ' B' ' 85' ' ' VAL . 3.6 pp -119.21 142.75 47.73 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.542 0.687 . . . . 0.0 111.347 177.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -110.22 -48.5 3.17 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.554 173.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -102.41 127.18 49.54 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 170.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.518 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 145.97 159.66 8.3 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 119.38 -1.39 . . . . 0.0 113.8 176.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . 0.423 ' HA ' ' HB2' ' B' ' 58' ' ' LYS . 54.3 mt-30 -103.17 -44.55 5.16 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.593 -0.304 . . . . 0.0 111.177 177.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -150.64 132.66 15.23 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 120.536 0.208 . . . . 0.0 111.014 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.507 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -133.0 114.31 13.83 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.266 0.555 . . . . 0.0 110.485 169.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' B' ' 79' ' ' THR . 64.0 mttp -95.88 112.17 23.97 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 174.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 45.2 tp -83.93 116.0 22.57 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.489 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -117.12 143.96 45.22 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.526 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.2 OUTLIER -131.32 132.52 44.56 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.705 172.1 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -107.05 110.12 22.16 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.373 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.584 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -126.25 151.96 46.75 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 43.37 37.45 1.36 Allowed 'General case' 0 N--CA 1.474 0.77 0 O-C-N 123.918 0.761 . . . . 0.0 111.155 -171.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 25.7 tptp 54.55 46.86 23.98 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.116 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . 0.585 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 6.5 tp-100 -135.28 130.72 35.57 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.603 175.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -85.74 110.9 19.66 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.315 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.503 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 82.3 m-85 -104.56 129.18 52.66 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.681 177.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 tp -77.39 103.83 4.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 169.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.53 HG13 ' CD2' ' A' ' 88' ' ' LEU . 2.6 t -76.35 -49.57 24.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.199 -173.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.478 ' HB2' ' CD2' ' B' ' 65' ' ' LEU . . . -159.1 144.84 16.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.178 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 43.7 m -110.51 101.55 10.23 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 171.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . 0.431 ' CG1' HG11 ' B' ' 85' ' ' VAL . 7.5 p -111.3 120.48 61.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.147 -178.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 52.8 p -122.67 -179.75 4.34 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.098 0.475 . . . . 0.0 112.215 -172.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' B' ' 38' ' ' GLN . 34.9 tttm -60.9 -27.05 67.88 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.92 172.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.473 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -83.45 -40.57 19.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.791 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 90.9 mt -107.38 89.56 4.98 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 174.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 36.6 Cg_exo -61.46 -20.24 67.67 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.151 2.567 . . . . 0.0 113.949 -169.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -156.27 135.98 12.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.408 0.623 . . . . 0.0 111.886 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.457 HG11 ' HB1' ' B' ' 54' ' ' ALA . 98.6 t -111.3 113.79 45.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.726 171.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.03 122.19 34.31 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.109 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.478 ' CD2' ' HB2' ' B' ' 54' ' ' ALA . 0.2 OUTLIER -142.62 143.49 32.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.315 0.579 . . . . 0.0 111.916 -177.067 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . 0.432 ' HB3' ' OG ' ' A' ' 30' ' ' SER . 5.6 t70 -89.61 100.53 13.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.71 177.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.698 HD21 HD23 ' A' ' 88' ' ' LEU . 19.5 mt -110.87 138.38 47.35 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.64 176.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . 0.634 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 10.5 m-80 -137.5 128.18 26.92 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 173.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -124.4 146.77 48.68 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.03 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 28.8 t -100.03 148.93 24.0 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -67.17 -10.65 52.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.277 -177.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.46 -9.73 66.47 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.122 176.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -100.89 160.1 14.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -135.18 125.41 26.24 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.584 HG22 ' HB2' ' B' ' 46' ' ' ALA . 11.2 pt -131.19 178.06 6.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.901 0.381 . . . . 0.0 111.55 -171.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.526 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 24.7 mtp -130.87 136.4 48.6 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 174.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . 0.48 ' CD1' ' HB2' ' B' ' 44' ' ' LEU . 1.2 m-85 -117.91 128.16 54.55 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.146 176.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.724 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 34.3 p90 -155.07 145.7 22.27 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.922 -178.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.69 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 13.2 p -117.39 144.99 44.39 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.446 -177.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -115.12 151.27 34.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.903 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.7 -177.09 29.11 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -109.89 102.95 11.67 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 119.625 -0.83 . . . . 0.0 109.608 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.518 ' CB ' ' HA3' ' B' ' 37' ' ' GLY . . . -175.22 155.94 1.99 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.814 172.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 32.6 t -113.05 118.86 35.96 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.585 HG12 ' HB3' ' B' ' 34' ' ' LEU . 10.2 m -118.93 137.53 52.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 CA-C-O 121.403 0.621 . . . . 0.0 112.671 -173.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 54.5 m -101.27 120.92 40.97 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.093 175.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.637 HD13 HD23 ' B' ' 11' ' ' LEU . 5.3 mp -89.41 145.74 25.13 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 170.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.696 HD23 HD21 ' C' ' 67' ' ' LEU . 1.2 tp -131.54 132.16 43.94 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.645 -177.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -159.7 -166.78 19.28 Favored Glycine 0 N--CA 1.438 -1.233 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.638 -176.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' TYR . . . . . 0.629 ' CD2' ' HB2' ' C' ' 68' ' ' ASN . 18.7 p90 -152.97 133.68 13.85 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.909 0.861 . . . . 0.0 111.622 177.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . 0.545 HD23 ' HB3' ' B' ' 27' ' ' PHE . 5.2 mt . . . . . 0 C--N 1.319 -0.745 0 CA-C-N 113.988 -1.46 . . . . 0.0 108.978 174.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 48.8 mtt . . . . . 0 CA--C 1.518 -0.272 0 CA-C-O 121.255 0.55 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 8' ' ' PHE . . . . . 0.487 ' CE1' HD21 ' D' ' 44' ' ' LEU . 60.1 t80 -56.88 141.94 43.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.448 -173.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . 0.457 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 87.5 t90 -135.33 141.41 45.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.802 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . 0.484 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -143.17 155.5 26.03 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.053 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.637 HD23 HD13 ' C' ' 87' ' ' LEU . 57.1 tp -145.26 108.58 4.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.821 0.343 . . . . 0.0 110.906 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -89.0 106.43 18.42 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.528 0.68 . . . . 0.0 110.852 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 13' ' ' MET . . . . . 0.555 ' HB2' HG23 ' C' ' 85' ' ' VAL . 4.1 mmt -86.96 134.38 33.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.014 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . 0.513 ' HB2' ' HG3' ' C' ' 17' ' ' ARG . 54.5 mtmt -100.16 146.16 31.46 Favored Pre-proline 0 C--N 1.316 -0.849 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . 0.436 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 5.8 Cg_endo -48.11 110.37 0.32 Allowed 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.52 2.814 . . . . 0.0 113.422 -174.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . 0.685 ' HA ' ' O ' ' C' ' 79' ' ' THR . 31.7 mt-10 69.47 54.08 0.41 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.541 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 17' ' ' ARG . . . . . 0.513 ' HG3' ' HB2' ' C' ' 14' ' ' LYS . 19.4 mmt180 -110.86 152.65 26.45 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.878 172.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 18' ' ' LYS . . . . . 0.718 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 36.0 ttmt -133.5 107.61 8.13 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.911 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . 0.422 ' OH ' ' HA ' ' C' ' 13' ' ' MET . 0.8 OUTLIER -110.96 121.06 44.4 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.803 -0.444 . . . . 0.0 109.803 179.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 5.2 p -75.35 126.7 31.54 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 171.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -103.77 116.55 32.51 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.722 -164.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 9.6 p -97.21 123.16 40.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.872 173.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . 0.402 ' CG2' ' HA ' ' C' ' 71' ' ' LYS . 55.2 mt -93.0 108.51 20.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.201 0.524 . . . . 0.0 111.54 -172.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . 0.697 ' H ' HD13 ' C' ' 24' ' ' ILE . 0.2 OUTLIER -76.13 -39.8 36.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.955 177.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -139.5 141.43 37.34 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 15.5 m -60.78 120.8 10.82 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 123.628 0.58 . . . . 0.0 109.858 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 27' ' ' PHE . . . . . 0.553 ' HB3' HD23 ' C' ' 91' ' ' LEU . 2.2 p90 -134.27 165.93 23.98 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.685 0.755 . . . . 0.0 112.715 -169.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 28' ' ' HIS . . . . . 0.626 ' HE2' ' HB2' ' C' ' 30' ' ' SER . 9.3 t60 -118.62 125.2 49.24 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.97 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . 0.605 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 39.9 mt -94.57 138.5 20.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 169.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.626 ' HB2' ' HE2' ' C' ' 28' ' ' HIS . 26.1 t -119.64 -23.47 6.54 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -169.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 31' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -161.9 157.0 28.7 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 119.374 -1.393 . . . . 0.0 113.29 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 10.2 p -137.45 125.41 31.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 172.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.85 152.34 42.05 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.636 -0.426 . . . . 0.0 112.143 -171.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.592 ' HB3' HG12 ' C' ' 85' ' ' VAL . 3.7 pp -119.2 142.74 47.72 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.49 0.662 . . . . 0.0 111.424 177.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -110.09 -48.58 3.17 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.581 173.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -102.38 127.24 49.48 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 170.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 37' ' ' GLY . . . . . 0.52 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 145.93 159.59 8.26 Favored Glycine 0 N--CA 1.437 -1.257 0 C-N-CA 119.318 -1.42 . . . . 0.0 113.834 176.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 38' ' ' GLN . . . . . 0.425 ' HA ' ' HB2' ' C' ' 58' ' ' LYS . 54.2 mt-30 -103.06 -44.55 5.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.658 -0.271 . . . . 0.0 111.214 177.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -150.67 132.61 15.15 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.483 0.182 . . . . 0.0 110.982 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.519 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -133.02 114.35 13.86 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.286 0.565 . . . . 0.0 110.5 169.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' C' ' 79' ' ' THR . 64.0 mttp -95.91 112.16 23.96 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 174.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 45.4 tp -83.94 116.0 22.58 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -117.11 143.95 45.23 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.52 ' HA ' ' O ' ' C' ' 76' ' ' MET . 0.2 OUTLIER -131.28 132.55 44.65 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.167 0.508 . . . . 0.0 109.665 172.07 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -107.06 110.14 22.18 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.341 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.573 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -126.28 151.91 46.85 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 43.38 37.47 1.38 Allowed 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.864 0.727 . . . . 0.0 111.193 -171.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 25.7 tptp 54.58 46.71 24.25 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.233 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . 0.591 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 6.5 tp-100 -135.22 130.72 35.69 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.567 175.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -85.78 110.84 19.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.906 0.384 . . . . 0.0 110.339 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . 0.479 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 82.4 m-85 -104.5 129.19 52.54 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.702 177.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 tp -77.29 103.79 4.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 169.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 53' ' ' VAL . . . . . 0.507 HG13 ' CD2' ' B' ' 88' ' ' LEU . 2.6 t -76.36 -49.62 24.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.243 -173.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 54' ' ' ALA . . . . . 0.466 ' HB2' ' CD2' ' C' ' 65' ' ' LEU . . . -159.0 144.87 16.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.228 -178.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 43.5 m -110.53 101.52 10.19 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 171.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . 0.429 ' CG1' HG11 ' C' ' 85' ' ' VAL . 7.6 p -111.26 120.53 62.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.204 -178.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 52.7 p -122.76 -179.74 4.34 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.078 0.466 . . . . 0.0 112.17 -172.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 58' ' ' LYS . . . . . 0.425 ' HB2' ' HA ' ' C' ' 38' ' ' GLN . 34.9 tttm -60.92 -27.16 68.0 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.281 0.562 . . . . 0.0 109.849 172.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . 0.476 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -83.43 -40.51 19.22 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.817 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 90.5 mt -107.43 89.48 4.96 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 174.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 61' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 37.5 Cg_exo -61.32 -20.31 67.68 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.145 2.563 . . . . 0.0 113.892 -169.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -156.25 136.02 12.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.479 0.657 . . . . 0.0 111.869 -178.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.456 HG11 ' HB1' ' C' ' 54' ' ' ALA . 98.0 t -111.36 113.92 45.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.663 171.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.15 122.21 34.42 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.025 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . 0.466 ' CD2' ' HB2' ' C' ' 54' ' ' ALA . 0.2 OUTLIER -142.59 143.43 32.43 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.287 0.565 . . . . 0.0 111.955 -177.1 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 66' ' ' ASP . . . . . 0.445 ' HB3' ' OG ' ' B' ' 30' ' ' SER . 5.6 t70 -89.54 100.5 13.29 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.718 177.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.696 HD21 HD23 ' B' ' 88' ' ' LEU . 19.7 mt -110.83 138.45 47.22 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.694 176.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . 0.629 ' HB2' ' CD2' ' B' ' 90' ' ' TYR . 10.5 m-80 -137.57 128.21 26.85 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 173.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -124.47 146.79 48.74 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.934 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 29.2 t -99.97 148.95 23.95 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . 0.402 ' HA ' ' CG2' ' C' ' 23' ' ' ILE . 15.1 ptmm? -67.06 -10.81 53.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.271 -178.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.42 -9.78 66.49 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.081 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -100.9 160.15 14.61 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -135.17 125.53 26.48 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.573 HG22 ' HB2' ' C' ' 46' ' ' ALA . 11.3 pt -131.33 178.04 6.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.836 0.35 . . . . 0.0 111.576 -171.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.52 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 24.6 mtp -130.79 136.25 48.53 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 77' ' ' PHE . . . . . 0.477 ' CD1' ' HB2' ' C' ' 44' ' ' LEU . 1.2 m-85 -117.79 128.23 54.66 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.17 176.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 78' ' ' TYR . . . . . 0.718 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 34.7 p90 -155.14 145.63 22.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.961 0.41 . . . . 0.0 111.987 -178.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . 0.685 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 13.0 p -117.36 144.97 44.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.438 -177.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -115.09 151.28 34.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.972 177.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.67 -177.03 29.12 Favored Glycine 0 CA--C 1.508 -0.403 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -109.93 102.99 11.7 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.764 0.782 . . . . 0.0 109.637 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . 0.52 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -175.27 155.95 1.97 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.833 172.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 32.4 t -113.07 118.8 35.79 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.592 HG12 ' HB3' ' C' ' 34' ' ' LEU . 10.1 m -118.88 137.51 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -173.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 54.2 m -101.21 120.9 40.92 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.074 175.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . 0.637 HD13 HD23 ' C' ' 11' ' ' LEU . 5.3 mp -89.36 145.79 25.12 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 170.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . 0.687 HD23 HD21 ' D' ' 67' ' ' LEU . 1.2 tp -131.56 132.15 43.9 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.669 -177.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -159.71 -166.88 19.49 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.575 -176.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 90' ' ' TYR . . . . . 0.631 ' CD2' ' HB2' ' D' ' 68' ' ' ASN . 19.0 p90 -152.88 133.71 13.96 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.885 0.85 . . . . 0.0 111.658 177.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . 0.553 HD23 ' HB3' ' C' ' 27' ' ' PHE . 5.1 mt . . . . . 0 C--N 1.319 -0.749 0 CA-C-N 114.011 -1.45 . . . . 0.0 108.97 174.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 49.0 mtt . . . . . 0 CA--C 1.519 -0.245 0 CA-C-O 121.312 0.577 . . . . 0.0 111.446 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 8' ' ' PHE . . . . . 0.496 ' CE1' HD21 ' E' ' 44' ' ' LEU . 60.6 t80 -56.78 141.92 42.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.685 -1.143 . . . . 0.0 112.49 -173.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 9' ' ' TRP . . . . . 0.454 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 87.5 t90 -135.38 141.4 45.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.75 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . 0.501 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -143.11 155.55 26.04 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.133 178.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . 0.635 HD23 HD13 ' D' ' 87' ' ' LEU . 56.8 tp -145.35 108.51 4.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.832 0.348 . . . . 0.0 110.805 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -88.92 106.37 18.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.459 0.647 . . . . 0.0 110.932 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 13' ' ' MET . . . . . 0.566 ' HB2' HG23 ' D' ' 85' ' ' VAL . 4.1 mmt -86.9 134.44 33.52 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.046 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 14' ' ' LYS . . . . . 0.529 ' HB2' ' HG3' ' D' ' 17' ' ' ARG . 54.6 mtmt -100.32 146.15 31.48 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 172.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . 0.428 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 5.7 Cg_endo -48.11 110.39 0.32 Allowed 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 123.43 2.754 . . . . 0.0 113.441 -174.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . 0.684 ' HA ' ' O ' ' D' ' 79' ' ' THR . 31.6 mt-10 69.47 53.96 0.41 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.55 178.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 17' ' ' ARG . . . . . 0.529 ' HG3' ' HB2' ' D' ' 14' ' ' LYS . 19.5 mmt180 -110.57 152.72 26.08 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.948 172.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . 0.707 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 36.0 ttmt -133.62 107.75 8.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.903 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 19' ' ' TYR . . . . . 0.42 ' OH ' ' HA ' ' D' ' 13' ' ' MET . 0.8 OUTLIER -111.11 121.06 44.35 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.579 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 5.2 p -75.26 126.8 31.76 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 170.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -103.97 116.5 32.36 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.054 0.454 . . . . 0.0 111.648 -164.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 9.1 p -97.28 123.14 40.99 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.826 173.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . 0.405 ' CG2' ' HA ' ' D' ' 71' ' ' LYS . 55.2 mt -92.97 108.51 20.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.117 0.484 . . . . 0.0 111.521 -172.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . 0.709 ' H ' HD13 ' D' ' 24' ' ' ILE . 0.2 OUTLIER -76.23 -39.57 35.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.018 177.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -139.6 141.46 37.14 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 15.6 m -60.72 120.84 10.85 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 123.535 0.522 . . . . 0.0 109.747 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 27' ' ' PHE . . . . . 0.565 ' HB3' HD23 ' D' ' 91' ' ' LEU . 2.2 p90 -134.33 165.92 24.02 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.748 0.785 . . . . 0.0 112.725 -169.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 28' ' ' HIS . . . . . 0.631 ' HE2' ' HB2' ' D' ' 30' ' ' SER . 9.5 t60 -118.58 125.15 49.18 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.996 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 29' ' ' ILE . . . . . 0.616 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 39.5 mt -94.56 138.48 20.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 169.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . 0.631 ' HB2' ' HE2' ' D' ' 28' ' ' HIS . 26.1 t -119.62 -23.46 6.55 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -169.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 31' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -161.97 156.94 28.65 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.385 -1.388 . . . . 0.0 113.257 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.403 HG23 ' HG ' ' D' ' 87' ' ' LEU . 10.4 p -137.4 125.42 32.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.84 152.36 42.08 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.641 -0.424 . . . . 0.0 112.039 -171.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 34' ' ' LEU . . . . . 0.578 ' HB3' HG12 ' D' ' 85' ' ' VAL . 3.7 pp -119.13 142.71 47.69 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.518 0.675 . . . . 0.0 111.415 177.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -110.08 -48.61 3.17 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.591 173.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -102.41 127.17 49.55 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 170.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . 0.525 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 145.86 159.63 8.27 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 119.379 -1.391 . . . . 0.0 113.916 176.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 38' ' ' GLN . . . . . 0.428 ' HA ' ' HB2' ' D' ' 58' ' ' LYS . 54.0 mt-30 -103.15 -44.53 5.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.702 -0.249 . . . . 0.0 111.157 177.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -150.68 132.61 15.14 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.566 0.222 . . . . 0.0 111.019 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . 0.522 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -132.98 114.33 13.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.234 0.54 . . . . 0.0 110.514 169.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' D' ' 79' ' ' THR . 64.0 mttp -95.86 112.05 23.88 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 45.3 tp -83.88 116.03 22.56 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -177.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -117.18 144.04 45.18 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.531 ' HA ' ' O ' ' D' ' 76' ' ' MET . 0.2 OUTLIER -131.4 132.5 44.42 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.697 172.095 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 45' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -107.04 110.12 22.17 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.396 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.593 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -126.31 151.9 46.92 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 43.4 37.49 1.4 Allowed 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.923 0.764 . . . . 0.0 111.09 -171.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 25.7 tptp 54.57 46.78 24.11 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.186 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . 0.589 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 6.5 tp-100 -135.18 130.71 35.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.623 175.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -85.69 110.81 19.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.342 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . 0.484 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 82.2 m-85 -104.45 129.2 52.46 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.707 177.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 tp -77.28 103.77 4.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 169.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 53' ' ' VAL . . . . . 0.53 HG13 ' CD2' ' C' ' 88' ' ' LEU . 2.6 t -76.38 -49.55 24.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.246 -173.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 54' ' ' ALA . . . . . 0.485 ' HB2' ' CD2' ' D' ' 65' ' ' LEU . . . -159.02 144.9 16.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.239 -178.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 43.9 m -110.54 101.55 10.22 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 171.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 56' ' ' VAL . . . . . 0.427 ' CG1' HG11 ' D' ' 85' ' ' VAL . 7.6 p -111.22 120.44 61.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.171 -178.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 52.5 p -122.73 -179.79 4.36 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.084 0.469 . . . . 0.0 112.151 -172.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 58' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' D' ' 38' ' ' GLN . 34.8 tttm -60.83 -27.18 67.87 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.289 0.566 . . . . 0.0 109.864 172.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 59' ' ' ALA . . . . . 0.477 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -83.39 -40.56 19.2 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.773 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 91.0 mt -107.33 89.48 4.86 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 61' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 37.6 Cg_exo -61.45 -20.29 67.87 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.193 2.595 . . . . 0.0 113.84 -169.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -156.24 136.03 12.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.409 0.623 . . . . 0.0 111.967 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.46 HG11 ' HB1' ' D' ' 54' ' ' ALA . 98.2 t -111.33 113.77 45.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.702 171.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.07 122.29 34.44 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.995 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 65' ' ' LEU . . . . . 0.485 ' CD2' ' HB2' ' D' ' 54' ' ' ALA . 0.2 OUTLIER -142.79 143.39 32.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.336 0.588 . . . . 0.0 111.856 -177.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 66' ' ' ASP . . . . . 0.457 ' HB3' ' OG ' ' C' ' 30' ' ' SER . 5.6 t70 -89.49 100.55 13.32 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.717 177.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.687 HD21 HD23 ' C' ' 88' ' ' LEU . 19.8 mt -110.81 138.39 47.26 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.683 176.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 68' ' ' ASN . . . . . 0.631 ' HB2' ' CD2' ' C' ' 90' ' ' TYR . 10.6 m-80 -137.58 128.22 26.84 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 173.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -124.53 146.77 48.81 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.956 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 29.4 t -99.98 149.01 23.88 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 71' ' ' LYS . . . . . 0.405 ' HA ' ' CG2' ' D' ' 23' ' ' ILE . 15.1 ptmm? -67.22 -10.66 52.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.265 -178.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.52 -9.72 66.38 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.143 176.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -100.95 160.17 14.59 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -135.21 125.35 26.08 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.593 HG22 ' HB2' ' D' ' 46' ' ' ALA . 11.3 pt -131.18 178.14 5.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.012 0.434 . . . . 0.0 111.491 -171.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 76' ' ' MET . . . . . 0.531 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 24.4 mtp -130.87 136.33 48.53 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 174.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 77' ' ' PHE . . . . . 0.476 ' CD1' ' HB2' ' D' ' 44' ' ' LEU . 1.2 m-85 -117.79 128.16 54.6 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.192 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 78' ' ' TYR . . . . . 0.707 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 34.5 p90 -155.1 145.63 22.17 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.953 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 79' ' ' THR . . . . . 0.684 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 13.4 p -117.29 144.94 44.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.522 -177.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -115.07 151.27 34.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.938 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.7 -177.04 29.09 Favored Glycine 0 CA--C 1.508 -0.348 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -109.82 102.89 11.63 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 119.661 -0.815 . . . . 0.0 109.686 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . 0.525 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -175.25 155.89 1.97 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.782 172.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 32.8 t -112.98 118.84 35.97 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.578 HG12 ' HB3' ' D' ' 34' ' ' LEU . 10.2 m -118.92 137.53 52.6 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -173.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 54.9 m -101.25 121.02 41.12 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.986 175.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 87' ' ' LEU . . . . . 0.635 HD13 HD23 ' D' ' 11' ' ' LEU . 5.3 mp -89.4 145.72 25.15 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 170.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.699 HD23 HD21 ' E' ' 67' ' ' LEU . 1.2 tp -131.49 132.1 43.97 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.733 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -159.64 -166.78 19.23 Favored Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.641 -176.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 90' ' ' TYR . . . . . 0.645 ' CD2' ' HB2' ' E' ' 68' ' ' ASN . 19.0 p90 -152.91 133.66 13.89 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.882 0.849 . . . . 0.0 111.654 177.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . 0.565 HD23 ' HB3' ' D' ' 27' ' ' PHE . 5.1 mt . . . . . 0 C--N 1.319 -0.73 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.003 174.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 48.8 mtt . . . . . 0 CA--C 1.518 -0.256 0 CA-C-O 121.218 0.532 . . . . 0.0 111.545 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' E' E ' 8' ' ' PHE . . . . . 0.494 ' CE1' HD21 ' A' ' 44' ' ' LEU . 60.6 t80 -56.75 141.94 42.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.601 -173.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 9' ' ' TRP . . . . . 0.455 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 87.3 t90 -135.34 141.34 45.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.056 -0.975 . . . . 0.0 108.812 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 10' ' ' GLY . . . . . 0.49 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -143.18 155.5 26.04 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.07 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 11' ' ' LEU . . . . . 0.628 HD23 HD13 ' E' ' 87' ' ' LEU . 57.2 tp -145.22 108.45 4.59 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.747 0.308 . . . . 0.0 110.89 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -88.96 106.42 18.41 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.413 0.625 . . . . 0.0 110.93 177.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 13' ' ' MET . . . . . 0.566 ' HB2' HG23 ' E' ' 85' ' ' VAL . 4.1 mmt -86.95 134.36 33.51 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.995 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 14' ' ' LYS . . . . . 0.506 ' HB2' ' HG3' ' E' ' 17' ' ' ARG . 54.6 mtmt -100.22 146.18 31.51 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 172.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . 0.428 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 5.7 Cg_endo -48.19 110.44 0.33 Allowed 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 123.418 2.745 . . . . 0.0 113.449 -174.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 16' ' ' GLU . . . . . 0.683 ' HA ' ' O ' ' E' ' 79' ' ' THR . 31.5 mt-10 69.46 53.99 0.41 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.533 178.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 17' ' ' ARG . . . . . 0.506 ' HG3' ' HB2' ' E' ' 14' ' ' LYS . 19.6 mmt180 -110.56 152.74 26.06 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.889 172.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . 0.716 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 36.0 ttmt -133.62 107.79 8.18 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.923 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . 0.42 ' OH ' ' HA ' ' E' ' 13' ' ' MET . 0.8 OUTLIER -111.02 121.16 44.65 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 5.4 p -75.37 126.7 31.54 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 170.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -103.9 116.52 32.42 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.039 0.447 . . . . 0.0 111.66 -164.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 9.4 p -97.2 123.12 40.89 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.88 173.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 55.3 mt -92.99 108.5 20.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.18 0.514 . . . . 0.0 111.557 -172.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . 0.715 ' H ' HD13 ' E' ' 24' ' ' ILE . 0.2 OUTLIER -76.16 -39.7 36.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.97 177.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -139.58 141.43 37.19 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 15.5 m -60.69 120.87 10.9 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.671 0.607 . . . . 0.0 109.915 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 27' ' ' PHE . . . . . 0.543 ' HB3' HD23 ' E' ' 91' ' ' LEU . 2.2 p90 -134.39 165.92 24.04 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.741 0.782 . . . . 0.0 112.659 -169.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 28' ' ' HIS . . . . . 0.624 ' HE2' ' HB2' ' E' ' 30' ' ' SER . 9.4 t60 -118.6 125.13 49.11 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.933 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 29' ' ' ILE . . . . . 0.618 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 39.9 mt -94.57 138.49 20.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 169.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . 0.624 ' HB2' ' HE2' ' E' ' 28' ' ' HIS . 26.1 t -119.66 -23.51 6.52 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -169.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 31' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -161.94 156.98 28.69 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 119.365 -1.398 . . . . 0.0 113.296 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.41 HG23 ' HG ' ' E' ' 87' ' ' LEU . 10.3 p -137.43 125.34 31.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 172.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.78 152.25 42.06 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -171.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 34' ' ' LEU . . . . . 0.59 ' HB3' HG12 ' E' ' 85' ' ' VAL . 3.6 pp -119.15 142.75 47.67 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.532 0.682 . . . . 0.0 111.38 177.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -110.13 -48.59 3.17 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.542 173.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -102.45 127.27 49.55 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 170.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . 0.526 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 145.85 159.49 8.2 Favored Glycine 0 N--CA 1.437 -1.242 0 C-N-CA 119.342 -1.409 . . . . 0.0 113.938 176.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 38' ' ' GLN . . . . . 0.423 ' HA ' ' HB2' ' E' ' 58' ' ' LYS . 54.3 mt-30 -103.11 -44.44 5.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.697 -0.252 . . . . 0.0 111.181 177.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -150.66 132.63 15.18 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 120.415 0.15 . . . . 0.0 110.974 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . 0.511 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -133.07 114.36 13.83 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.302 0.572 . . . . 0.0 110.498 169.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 41' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' E' ' 79' ' ' THR . 64.1 mttp -95.79 112.05 23.87 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 174.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 45.4 tp -83.87 115.97 22.53 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.484 -177.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -117.06 144.0 45.13 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 44' ' ' LEU . . . . . 0.514 ' HA ' ' O ' ' E' ' 76' ' ' MET . 0.2 OUTLIER -131.35 132.52 44.51 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.201 0.524 . . . . 0.0 109.684 172.061 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 45' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -107.05 110.11 22.16 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.371 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . 0.576 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -126.26 151.98 46.73 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 176.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 43.39 37.44 1.38 Allowed 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.919 0.762 . . . . 0.0 111.146 -171.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 25.7 tptp 54.61 46.79 24.05 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.144 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 49' ' ' GLN . . . . . 0.586 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 6.5 tp-100 -135.31 130.76 35.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.639 175.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -85.78 110.83 19.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.264 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . 0.501 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 82.3 m-85 -104.49 129.15 52.54 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.764 177.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 tp -77.34 103.8 4.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 169.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . 0.529 HG13 ' CD2' ' D' ' 88' ' ' LEU . 2.6 t -76.32 -49.57 24.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.291 -173.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 54' ' ' ALA . . . . . 0.483 ' HB2' ' CD2' ' E' ' 65' ' ' LEU . . . -159.07 144.88 16.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.211 -178.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 44.4 m -110.52 101.46 10.14 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 171.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . 0.425 ' CG1' HG11 ' E' ' 85' ' ' VAL . 7.5 p -111.22 120.54 62.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.176 -178.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 52.3 p -122.73 -179.79 4.35 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.065 0.459 . . . . 0.0 112.153 -172.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 58' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' E' ' 38' ' ' GLN . 34.9 tttm -60.84 -27.18 67.89 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.854 172.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 59' ' ' ALA . . . . . 0.474 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -83.38 -40.51 19.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.804 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 90.9 mt -107.45 89.51 5.01 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 174.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 61' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 36.2 Cg_exo -61.4 -20.31 67.86 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.193 2.595 . . . . 0.0 113.916 -169.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -156.32 136.07 12.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.452 0.644 . . . . 0.0 111.921 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . 0.471 HG11 ' HB1' ' E' ' 54' ' ' ALA . 98.9 t -111.33 113.73 45.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.763 171.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.06 122.22 34.36 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.057 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 65' ' ' LEU . . . . . 0.483 ' CD2' ' HB2' ' E' ' 54' ' ' ALA . 0.2 OUTLIER -142.74 143.49 32.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.335 0.588 . . . . 0.0 111.936 -177.128 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 66' ' ' ASP . . . . . 0.442 ' HB3' ' OG ' ' D' ' 30' ' ' SER . 5.6 t70 -89.49 100.53 13.31 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.679 177.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 67' ' ' LEU . . . . . 0.699 HD21 HD23 ' D' ' 88' ' ' LEU . 19.9 mt -110.91 138.41 47.34 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.646 176.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 68' ' ' ASN . . . . . 0.645 ' HB2' ' CD2' ' D' ' 90' ' ' TYR . 10.5 m-80 -137.63 128.26 26.8 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 173.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -124.47 146.79 48.73 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.974 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 29.5 t -100.12 149.01 23.95 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -67.14 -10.71 53.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.284 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.44 -9.77 66.48 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.064 176.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -100.83 160.17 14.59 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -135.22 125.48 26.33 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 75' ' ' ILE . . . . . 0.576 HG22 ' HB2' ' E' ' 46' ' ' ALA . 11.3 pt -131.31 178.08 6.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.835 0.35 . . . . 0.0 111.56 -171.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 76' ' ' MET . . . . . 0.514 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 24.6 mtp -130.89 136.28 48.47 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 77' ' ' PHE . . . . . 0.478 ' CD1' ' HB2' ' E' ' 44' ' ' LEU . 1.2 m-85 -117.82 128.2 54.63 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.199 176.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 78' ' ' TYR . . . . . 0.716 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 34.4 p90 -155.1 145.62 22.16 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.979 -178.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 79' ' ' THR . . . . . 0.683 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 13.3 p -117.3 144.91 44.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.496 -177.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -115.01 151.38 34.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.912 177.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.64 -177.2 29.25 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -109.81 102.88 11.63 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 117.79 0.795 . . . . 0.0 109.733 177.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 83' ' ' ALA . . . . . 0.526 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -175.22 155.94 1.99 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.823 172.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 32.6 t -113.06 118.83 35.86 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 85' ' ' VAL . . . . . 0.59 HG12 ' HB3' ' E' ' 34' ' ' LEU . 10.1 m -118.91 137.54 52.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -173.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 54.1 m -101.27 120.96 41.02 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.077 175.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 87' ' ' LEU . . . . . 0.628 HD13 HD23 ' E' ' 11' ' ' LEU . 5.3 mp -89.39 145.83 25.07 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 170.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . 0.726 HD23 HD21 ' A' ' 67' ' ' LEU . 1.2 tp -131.61 132.15 43.81 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.701 -177.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -159.67 -166.82 19.34 Favored Glycine 0 N--CA 1.439 -1.125 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.551 -176.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 90' ' ' TYR . . . . . 0.649 ' CD2' ' HB2' ' A' ' 68' ' ' ASN . 19.0 p90 -152.94 133.67 13.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.864 0.84 . . . . 0.0 111.687 177.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 91' ' ' LEU . . . . . 0.543 HD23 ' HB3' ' E' ' 27' ' ' PHE . 5.3 mt . . . . . 0 C--N 1.318 -0.775 0 CA-C-N 114.073 -1.421 . . . . 0.0 108.896 174.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.0 mtt . . . . . 0 C--O 1.226 -0.165 0 CA-C-O 120.886 0.374 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.436 ' CE1' HD21 ' B' ' 44' ' ' LEU . 74.6 t80 -54.83 143.94 24.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.847 -173.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.594 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 89.6 t90 -139.27 148.7 43.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.104 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.554 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -149.98 153.37 25.05 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.715 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.727 HD23 HD13 ' A' ' 87' ' ' LEU . 59.2 tp -139.06 108.8 6.24 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.916 0.389 . . . . 0.0 111.108 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -80.38 105.72 11.85 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.706 173.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.595 ' HB3' HG23 ' A' ' 85' ' ' VAL . 35.7 tpp -99.41 132.32 44.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.045 0.45 . . . . 0.0 110.956 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -98.63 146.6 31.88 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.89 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.527 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 10.4 Cg_endo -53.6 115.82 2.57 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 123.433 2.756 . . . . 0.0 113.141 -176.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.711 ' HA ' ' O ' ' A' ' 79' ' ' THR . 34.5 mt-10 63.49 38.12 10.06 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.591 177.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -109.36 149.95 28.74 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 173.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.694 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 34.4 ttmt -125.94 119.21 27.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.716 0.293 . . . . 0.0 111.592 -174.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.467 ' OH ' ' HA ' ' A' ' 13' ' ' MET . 3.6 m-85 -110.6 104.96 13.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.442 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.9 p -87.67 99.49 12.11 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 171.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -125.34 148.7 48.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.542 0.687 . . . . 0.0 112.466 -166.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.4 t -92.38 160.31 15.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.029 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 68.2 mt -106.24 117.79 52.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.05 0.452 . . . . 0.0 110.806 -175.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.466 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.1 mp -79.31 -45.38 23.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.916 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -135.17 140.22 45.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.739 178.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.1 m -55.99 124.15 16.75 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.527 0.517 . . . . 0.0 109.647 177.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.549 ' HB3' HD23 ' A' ' 91' ' ' LEU . 3.9 p90 -140.09 158.53 43.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.685 0.755 . . . . 0.0 112.683 -171.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.577 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 14.3 t60 -112.8 125.94 54.89 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.102 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 44.6 mt -96.3 133.45 37.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 170.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.577 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 42.2 p -118.48 -15.07 9.66 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -170.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.83 151.97 22.53 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 119.329 -1.415 . . . . 0.0 113.48 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.465 HG23 ' HG ' ' A' ' 87' ' ' LEU . 9.1 p -140.76 123.88 16.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 171.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.422 ' HA ' HG21 ' A' ' 56' ' ' VAL . . . -143.49 154.68 43.89 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.394 -0.522 . . . . 0.0 112.044 -173.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.631 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.3 pp -118.28 138.86 52.08 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.726 0.774 . . . . 0.0 111.178 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -110.07 -47.6 3.3 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.495 172.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -103.15 127.42 50.44 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.171 170.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.459 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 147.28 163.05 10.33 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 119.729 -1.224 . . . . 0.0 113.443 177.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.455 ' O ' ' HG3' ' A' ' 58' ' ' LYS . 8.3 tt0 -102.23 -48.21 4.27 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.554 0.216 . . . . 0.0 111.207 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -153.07 137.85 17.03 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.729 -0.214 . . . . 0.0 110.657 176.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.549 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -136.39 114.97 11.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.395 0.616 . . . . 0.0 111.12 171.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 79' ' ' THR . 68.1 mttm -95.07 115.03 26.91 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 171.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.403 HD23 ' HB ' ' A' ' 53' ' ' VAL . 38.1 tp -84.11 116.25 22.8 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -176.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.409 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 93.9 m-85 -117.09 143.82 45.35 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' A' ' 76' ' ' MET . 0.1 OUTLIER -131.7 131.71 43.3 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 172.68 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.577 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -111.87 118.15 34.75 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.132 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.638 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -130.48 133.66 46.46 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.485 178.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 56.05 38.9 30.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.135 0.493 . . . . 0.0 110.67 -175.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm 65.8 22.52 11.47 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.333 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.577 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 28.9 mm-40 -113.32 124.48 52.57 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -87.42 116.87 25.82 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.569 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 72.4 m-85 -111.61 131.07 55.52 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.782 177.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -81.34 103.42 8.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 171.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.506 HG13 ' CD2' ' E' ' 88' ' ' LEU . 2.3 t -76.87 -47.64 27.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.473 -172.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.476 ' HB2' HD23 ' A' ' 65' ' ' LEU . . . -156.7 151.53 25.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.327 -178.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 98.1 m -114.81 101.77 9.37 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 169.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.469 HG11 HG11 ' A' ' 85' ' ' VAL . 7.4 p -113.04 114.12 46.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.675 0.75 . . . . 0.0 109.759 -177.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 77.1 p -123.31 -177.75 3.79 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.411 -174.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 38' ' ' GLN . 28.8 mtpp -57.22 -36.13 70.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.101 0.477 . . . . 0.0 110.374 169.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.27 -41.23 66.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.551 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.9 mt -115.74 82.66 10.61 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 174.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.1 0.5 6.53 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.858 2.372 . . . . 0.0 113.598 -168.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -162.76 128.0 3.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.153 0.501 . . . . 0.0 111.029 -176.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.426 HG23 ' HB ' ' A' ' 56' ' ' VAL . 92.8 t -114.23 111.23 35.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.478 174.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.83 112.15 23.85 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.679 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.476 HD23 ' HB2' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -130.51 168.44 17.04 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.57 -175.522 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 6.5 t0 -115.25 99.92 7.76 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.344 0.592 . . . . 0.0 110.33 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.656 HD21 HD23 ' E' ' 88' ' ' LEU . 17.7 mt -114.59 141.23 48.03 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.667 177.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.429 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 6.2 t30 -146.62 115.32 6.81 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.975 0.417 . . . . 0.0 110.053 174.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -110.18 159.93 16.94 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.0 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.7 p -112.4 149.61 32.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.551 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.426 ' HG3' ' H ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -71.46 10.45 0.62 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -175.645 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.68 -21.39 14.48 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.087 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -101.23 171.39 7.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.777 0.322 . . . . 0.0 110.883 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 -137.72 129.3 28.23 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.638 HG22 ' HB2' ' A' ' 46' ' ' ALA . 14.5 pt -129.24 163.04 35.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.062 0.458 . . . . 0.0 111.691 -170.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.544 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 4.8 mtm -118.3 122.82 43.85 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 175.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.537 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 1.0 OUTLIER -105.05 127.69 52.99 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.171 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.694 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 49.5 p90 -155.9 150.6 26.12 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.508 -177.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.711 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 11.2 p -117.2 149.12 40.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.735 -178.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.04 144.6 42.33 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.247 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.19 176.99 34.69 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -175.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -106.47 102.8 12.17 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.932 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.549 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -170.75 151.25 3.43 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.574 169.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.6 t -108.14 121.6 45.17 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.631 HG12 ' HB3' ' A' ' 34' ' ' LEU . 11.4 m -118.54 146.19 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 CA-C-O 121.435 0.636 . . . . 0.0 111.666 -173.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.2 t -111.88 120.94 43.62 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.727 HD13 HD23 ' A' ' 11' ' ' LEU . 5.1 mp -93.0 151.63 19.78 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 174.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.635 HD23 HD21 ' B' ' 67' ' ' LEU . 1.6 tp -133.58 141.11 47.53 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.162 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.16 -166.67 26.63 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.825 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.43 ' CD2' ' HB3' ' B' ' 68' ' ' ASN . 8.1 p90 -150.96 130.16 12.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.754 0.788 . . . . 0.0 111.698 176.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.549 HD23 ' HB3' ' A' ' 27' ' ' PHE . 5.3 mt . . . . . 0 C--N 1.325 -0.485 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.886 176.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 59.9 mtt . . . . . 0 C--O 1.226 -0.179 0 CA-C-O 120.911 0.386 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . 0.483 ' CE1' HD21 ' C' ' 44' ' ' LEU . 73.9 t80 -54.97 144.03 24.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.853 -173.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . 0.589 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 89.5 t90 -139.38 148.6 43.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.971 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.587 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -149.85 153.44 25.11 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.828 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.735 HD23 HD13 ' B' ' 87' ' ' LEU . 59.5 tp -139.04 108.71 6.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.774 0.321 . . . . 0.0 111.197 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -80.35 105.84 11.92 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.706 173.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . 0.611 ' HB3' HG23 ' B' ' 85' ' ' VAL . 35.6 tpp -99.53 132.44 44.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.156 0.503 . . . . 0.0 110.87 -176.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -98.61 146.61 31.9 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.915 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.525 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 10.3 Cg_endo -53.68 115.86 2.61 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 123.425 2.75 . . . . 0.0 113.134 -176.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.709 ' HA ' ' O ' ' B' ' 79' ' ' THR . 34.6 mt-10 63.5 38.02 10.1 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.666 177.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -109.31 149.84 28.86 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.69 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 34.3 ttmt -125.95 119.23 27.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.774 0.321 . . . . 0.0 111.617 -174.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' TYR . . . . . 0.48 ' OH ' ' HA ' ' B' ' 13' ' ' MET . 3.6 m-85 -110.54 104.94 13.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.399 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 11.9 p -87.59 99.4 12.02 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 171.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -125.27 148.81 48.53 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.616 0.722 . . . . 0.0 112.5 -166.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 11.5 t -92.46 160.34 15.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.998 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 68.0 mt -106.28 117.69 52.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.085 0.469 . . . . 0.0 110.823 -175.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.463 ' H ' HD12 ' B' ' 24' ' ' ILE . 4.1 mp -79.27 -45.36 23.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.984 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -135.19 140.24 45.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.757 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 17.8 m -55.92 124.03 16.3 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 123.639 0.587 . . . . 0.0 109.646 177.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . 0.559 ' HB3' HD23 ' B' ' 91' ' ' LEU . 3.9 p90 -140.03 158.57 43.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.704 0.764 . . . . 0.0 112.739 -171.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' HIS . . . . . 0.576 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 14.2 t60 -112.86 126.05 55.03 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.07 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.608 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 44.0 mt -96.3 133.44 37.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 170.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.576 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 41.5 p -118.47 -15.04 9.67 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -170.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.87 151.97 22.52 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 119.276 -1.44 . . . . 0.0 113.456 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.463 HG23 ' HG ' ' B' ' 87' ' ' LEU . 9.1 p -140.74 123.88 16.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 171.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . 0.405 ' HA ' HG21 ' B' ' 56' ' ' VAL . . . -143.5 154.63 43.84 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.486 -0.485 . . . . 0.0 112.085 -172.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.636 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.3 pp -118.28 138.88 52.07 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.627 0.727 . . . . 0.0 111.155 177.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -110.17 -47.56 3.29 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.404 172.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -103.2 127.44 50.49 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.167 170.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.455 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 147.26 162.99 10.3 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 119.696 -1.24 . . . . 0.0 113.405 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . 0.464 ' O ' ' HG3' ' B' ' 58' ' ' LYS . 8.3 tt0 -102.16 -48.3 4.26 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.474 0.178 . . . . 0.0 111.149 178.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -153.07 137.77 16.96 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.713 -0.222 . . . . 0.0 110.652 176.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.542 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -136.31 114.89 11.9 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.279 0.561 . . . . 0.0 111.196 171.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' B' ' 79' ' ' THR . 68.1 mttm -95.03 114.99 26.86 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 171.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.406 HD23 ' HB ' ' B' ' 53' ' ' VAL . 38.1 tp -84.06 116.25 22.77 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -176.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . 0.409 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 93.9 m-85 -117.09 143.79 45.39 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.539 177.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.561 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.1 OUTLIER -131.63 131.71 43.44 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 172.657 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -111.88 118.1 34.59 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.087 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.631 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -130.44 133.67 46.51 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.444 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 56.07 38.78 30.27 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.516 0.51 . . . . 0.0 110.675 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm 65.9 22.44 11.35 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.344 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . 0.574 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 28.9 mm-40 -113.32 124.5 52.61 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 177.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -87.52 116.92 25.97 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.554 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 72.3 m-85 -111.68 131.06 55.55 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.749 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -81.27 103.42 8.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 170.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.47 HG13 ' CD2' ' A' ' 88' ' ' LEU . 2.3 t -76.87 -47.65 27.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.476 -172.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.471 ' HB2' HD23 ' B' ' 65' ' ' LEU . . . -156.69 151.49 25.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.334 -178.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 99.9 m -114.78 101.77 9.38 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 169.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . 0.474 HG11 HG11 ' B' ' 85' ' ' VAL . 7.4 p -113.0 114.07 45.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.578 0.704 . . . . 0.0 109.755 -177.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 76.3 p -123.27 -177.79 3.8 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.445 -174.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' B' ' 38' ' ' GLN . 28.8 mtpp -57.16 -36.18 70.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.073 0.463 . . . . 0.0 110.331 168.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.43 -41.19 66.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.503 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 76.3 mt -115.67 82.68 10.45 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 174.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.09 0.37 6.74 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.992 2.461 . . . . 0.0 113.606 -168.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -162.66 128.01 3.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.263 0.554 . . . . 0.0 111.005 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.432 HG23 ' HB ' ' B' ' 56' ' ' VAL . 94.9 t -114.13 111.24 35.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.54 174.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.81 112.0 23.62 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.728 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.471 HD23 ' HB2' ' B' ' 54' ' ' ALA . 0.3 OUTLIER -130.43 168.46 16.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.558 -175.497 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . 0.49 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 6.5 t0 -115.26 99.96 7.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.298 0.57 . . . . 0.0 110.405 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.635 HD21 HD23 ' A' ' 88' ' ' LEU . 17.7 mt -114.58 141.3 47.94 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.66 177.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . 0.43 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 6.3 t30 -146.71 115.27 6.76 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.013 0.435 . . . . 0.0 110.074 174.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -110.22 159.92 16.96 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.929 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 10.3 p -112.45 149.56 32.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.544 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . 0.422 ' H ' ' HG3' ' B' ' 71' ' ' LYS . 0.0 OUTLIER -71.4 10.52 0.6 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -175.592 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.71 -21.51 14.21 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.118 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -101.13 171.39 7.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.775 0.321 . . . . 0.0 110.901 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 -137.76 129.49 28.44 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.631 HG22 ' HB2' ' B' ' 46' ' ' ALA . 14.7 pt -129.36 162.95 35.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.027 0.441 . . . . 0.0 111.703 -170.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.561 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 4.8 mtm -118.28 122.87 44.0 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 175.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . 0.54 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 1.0 OUTLIER -105.12 127.72 53.03 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.183 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.69 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 49.3 p90 -155.93 150.63 26.09 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.471 -177.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.709 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 11.2 p -117.32 149.08 41.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.922 0.392 . . . . 0.0 111.679 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.06 144.54 42.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.269 174.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.25 176.96 34.6 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -106.5 102.8 12.17 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.932 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.542 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -170.82 151.28 3.38 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.527 169.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 23.6 t -108.31 121.61 45.26 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.636 HG12 ' HB3' ' B' ' 34' ' ' LEU . 11.6 m -118.41 146.19 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 CA-C-O 121.406 0.622 . . . . 0.0 111.665 -173.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 15.3 t -111.87 120.86 43.37 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.735 HD13 HD23 ' B' ' 11' ' ' LEU . 5.0 mp -92.91 151.57 19.88 Favored 'General case' 0 CA--C 1.502 -0.895 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.64 174.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.618 HD23 HD21 ' C' ' 67' ' ' LEU . 1.6 tp -133.49 141.12 47.63 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.129 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.2 -166.69 26.71 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.812 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' TYR . . . . . 0.421 ' CD2' ' HB3' ' C' ' 68' ' ' ASN . 8.2 p90 -150.89 130.13 12.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.679 0.752 . . . . 0.0 111.778 176.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . 0.559 HD23 ' HB3' ' B' ' 27' ' ' PHE . 5.4 mt . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 114.238 -1.346 . . . . 0.0 109.933 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 59.9 mtt . . . . . 0 C--O 1.227 -0.128 0 CA-C-O 120.874 0.369 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 8' ' ' PHE . . . . . 0.466 ' CE1' HD21 ' D' ' 44' ' ' LEU . 74.0 t80 -54.91 144.02 24.27 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.878 -173.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . 0.581 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 89.6 t90 -139.25 148.74 43.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.98 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . 0.543 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -149.97 153.44 25.09 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.764 177.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.716 HD23 HD13 ' C' ' 87' ' ' LEU . 59.5 tp -139.15 108.86 6.24 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.945 0.402 . . . . 0.0 111.093 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -80.35 105.7 11.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.751 173.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 13' ' ' MET . . . . . 0.615 ' HB3' HG23 ' C' ' 85' ' ' VAL . 35.8 tpp -99.48 132.27 44.93 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.116 0.484 . . . . 0.0 110.852 -176.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -98.47 146.53 31.74 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.013 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . 0.53 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 10.3 Cg_endo -53.62 115.95 2.67 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 123.362 2.708 . . . . 0.0 113.161 -176.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . 0.712 ' HA ' ' O ' ' C' ' 79' ' ' THR . 34.6 mt-10 63.4 38.07 10.33 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.699 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -109.3 149.85 28.85 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 173.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 18' ' ' LYS . . . . . 0.691 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 34.4 ttmt -126.05 119.26 27.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.748 0.309 . . . . 0.0 111.583 -174.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . 0.467 ' OH ' ' HA ' ' C' ' 13' ' ' MET . 3.6 m-85 -110.56 104.98 13.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.434 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 11.9 p -87.61 99.47 12.08 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 171.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -125.42 148.84 48.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.589 0.709 . . . . 0.0 112.462 -166.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 11.4 t -92.51 160.4 15.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.997 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -106.27 117.73 52.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.091 0.472 . . . . 0.0 110.824 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . 0.471 HD12 ' H ' ' C' ' 24' ' ' ILE . 4.1 mp -79.26 -45.44 23.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.965 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -135.16 140.3 45.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.707 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 18.0 m -56.03 124.15 16.78 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.582 0.551 . . . . 0.0 109.582 177.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 27' ' ' PHE . . . . . 0.562 ' HB3' HD23 ' C' ' 91' ' ' LEU . 3.9 p90 -140.08 158.5 43.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.739 0.781 . . . . 0.0 112.78 -171.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 28' ' ' HIS . . . . . 0.582 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 14.2 t60 -112.77 125.97 54.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.104 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 44.2 mt -96.28 133.44 37.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.582 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 41.1 p -118.49 -14.98 9.66 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -170.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.91 151.84 22.35 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 119.314 -1.422 . . . . 0.0 113.508 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.456 HG23 ' HG ' ' C' ' 87' ' ' LEU . 9.0 p -140.74 123.89 16.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 171.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.42 ' HA ' HG21 ' C' ' 56' ' ' VAL . . . -143.56 154.59 43.75 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.397 -0.521 . . . . 0.0 112.077 -172.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.617 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.3 pp -118.14 138.86 52.0 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.685 0.755 . . . . 0.0 111.241 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -110.19 -47.52 3.29 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.772 -1.103 . . . . 0.0 108.464 172.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -103.17 127.51 50.44 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.227 170.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 37' ' ' GLY . . . . . 0.454 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 147.21 163.06 10.32 Favored Glycine 0 N--CA 1.439 -1.111 0 C-N-CA 119.718 -1.229 . . . . 0.0 113.442 177.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 38' ' ' GLN . . . . . 0.456 ' O ' ' HG3' ' C' ' 58' ' ' LYS . 8.4 tt0 -102.28 -48.27 4.25 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.483 0.183 . . . . 0.0 111.122 178.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -153.07 137.77 16.96 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 122.162 0.185 . . . . 0.0 110.714 176.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.534 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -136.27 114.92 11.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.292 0.568 . . . . 0.0 111.171 171.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' C' ' 79' ' ' THR . 68.1 mttm -95.0 114.91 26.77 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 171.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.411 HD23 ' HB ' ' C' ' 53' ' ' VAL . 37.9 tp -84.04 116.26 22.76 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -176.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 43' ' ' TYR . . . . . 0.401 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 93.9 m-85 -117.09 143.77 45.42 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 177.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' C' ' 76' ' ' MET . 0.1 OUTLIER -131.66 131.64 43.32 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 172.662 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . 0.582 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -111.89 118.16 34.76 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.164 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.649 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -130.43 133.58 46.45 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.45 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 56.12 38.79 30.24 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.524 0.515 . . . . 0.0 110.654 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm 65.9 22.35 11.35 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.362 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . 0.582 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 29.0 mm-40 -113.25 124.46 52.57 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -87.48 116.93 25.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.928 0.394 . . . . 0.0 110.046 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . 0.587 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 72.5 m-85 -111.72 131.02 55.58 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.743 177.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -81.33 103.35 8.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 171.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 53' ' ' VAL . . . . . 0.499 HG13 ' CD2' ' B' ' 88' ' ' LEU . 2.3 t -76.87 -47.6 27.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.491 -172.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 54' ' ' ALA . . . . . 0.474 ' HB2' HD23 ' C' ' 65' ' ' LEU . . . -156.68 151.5 25.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.303 -178.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 99.6 m -114.74 101.69 9.31 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 169.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . 0.471 HG11 HG11 ' C' ' 85' ' ' VAL . 7.4 p -112.92 114.04 45.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.596 0.712 . . . . 0.0 109.781 -177.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 77.4 p -123.26 -177.74 3.78 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.496 -174.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 58' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' C' ' 38' ' ' GLN . 28.8 mtpp -57.2 -36.18 70.53 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.032 0.444 . . . . 0.0 110.378 168.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.35 -41.16 66.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.521 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 76.5 mt -115.76 82.77 10.78 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 174.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.11 0.44 6.64 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.865 2.377 . . . . 0.0 113.662 -168.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -162.66 128.06 3.29 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.139 0.495 . . . . 0.0 111.087 -176.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.431 HG23 ' HB ' ' C' ' 56' ' ' VAL . 92.1 t -114.29 111.36 35.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.439 174.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.85 112.04 23.7 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.698 174.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . 0.474 HD23 ' HB2' ' C' ' 54' ' ' ALA . 0.3 OUTLIER -130.45 168.44 17.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.069 0.461 . . . . 0.0 111.599 -175.518 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 66' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 6.6 t0 -115.23 99.95 7.78 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.345 0.593 . . . . 0.0 110.386 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.618 HD21 HD23 ' B' ' 88' ' ' LEU . 17.7 mt -114.58 141.22 48.03 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.695 177.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . 0.421 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 6.3 t30 -146.66 115.27 6.78 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.92 0.391 . . . . 0.0 110.043 174.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -110.07 159.93 16.89 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.061 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 10.7 p -112.49 149.49 32.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.557 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . 0.416 ' H ' ' HG3' ' C' ' 71' ' ' LYS . 0.0 OUTLIER -71.38 10.41 0.62 Allowed 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -175.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.63 -21.51 14.35 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.111 176.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -101.15 171.31 7.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.787 0.327 . . . . 0.0 110.828 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 -137.72 129.46 28.47 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.649 HG22 ' HB2' ' C' ' 46' ' ' ALA . 14.8 pt -129.35 163.01 35.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.104 0.478 . . . . 0.0 111.696 -169.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.544 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 4.8 mtm -118.41 122.89 43.9 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 175.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 77' ' ' PHE . . . . . 0.535 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 1.0 OUTLIER -105.08 127.77 53.04 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 177.204 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 78' ' ' TYR . . . . . 0.691 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 49.3 p90 -155.95 150.65 26.1 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.494 -177.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . 0.712 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 11.0 p -117.34 149.14 40.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.898 0.38 . . . . 0.0 111.622 -178.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.11 144.62 42.34 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.323 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.19 176.93 34.69 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -175.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -106.49 102.75 12.12 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.062 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . 0.534 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -170.7 151.26 3.46 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.557 169.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 23.4 t -108.19 121.57 45.14 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.617 HG12 ' HB3' ' C' ' 34' ' ' LEU . 11.6 m -118.49 146.24 23.35 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-O 121.403 0.62 . . . . 0.0 111.663 -173.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 15.2 t -111.94 120.88 43.41 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . 0.716 HD13 HD23 ' C' ' 11' ' ' LEU . 5.0 mp -92.92 151.68 19.81 Favored 'General case' 0 CA--C 1.502 -0.894 0 C-N-CA 120.364 -0.534 . . . . 0.0 109.646 174.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . 0.65 HD23 HD21 ' D' ' 67' ' ' LEU . 1.6 tp -133.58 141.11 47.53 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.156 -178.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.21 -166.72 26.77 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.825 -0.703 . . . . 0.0 111.86 -176.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 90' ' ' TYR . . . . . 0.438 ' CD2' ' HB3' ' D' ' 68' ' ' ASN . 8.3 p90 -150.86 130.1 12.77 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.632 0.729 . . . . 0.0 111.765 176.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . 0.562 HD23 ' HB3' ' C' ' 27' ' ' PHE . 5.2 mt . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 114.253 -1.339 . . . . 0.0 109.93 176.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 59.9 mtt . . . . . 0 C--O 1.225 -0.21 0 CA-C-O 120.924 0.392 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 8' ' ' PHE . . . . . 0.48 ' CE1' HD21 ' E' ' 44' ' ' LEU . 74.2 t80 -55.01 144.06 24.55 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.849 -173.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 9' ' ' TRP . . . . . 0.589 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 89.7 t90 -139.29 148.7 43.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.987 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . 0.566 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -149.95 153.44 25.1 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.812 -0.708 . . . . 0.0 111.755 177.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . 0.73 HD23 HD13 ' D' ' 87' ' ' LEU . 58.9 tp -139.13 108.81 6.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.965 0.412 . . . . 0.0 111.094 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -80.35 105.75 11.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.685 173.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 13' ' ' MET . . . . . 0.6 ' HB3' HG23 ' D' ' 85' ' ' VAL . 35.7 tpp -99.52 132.31 44.94 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.067 0.46 . . . . 0.0 110.942 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -98.57 146.55 31.79 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.95 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . 0.518 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 10.5 Cg_endo -53.52 115.85 2.59 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 123.428 2.752 . . . . 0.0 113.154 -176.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . 0.723 ' HA ' ' O ' ' D' ' 79' ' ' THR . 34.3 mt-10 63.42 38.14 10.22 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.617 177.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -109.37 149.82 28.95 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 173.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . 0.691 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 34.4 ttmt -125.96 119.22 27.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.771 0.319 . . . . 0.0 111.59 -174.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 19' ' ' TYR . . . . . 0.473 ' OH ' ' HA ' ' D' ' 13' ' ' MET . 3.6 m-85 -110.51 104.9 13.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.402 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . 0.401 ' HB3' ' SD ' ' D' ' 76' ' ' MET . 11.7 p -87.69 99.43 12.07 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 171.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -125.25 148.7 48.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.492 0.663 . . . . 0.0 112.564 -166.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 11.4 t -92.32 160.35 15.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.049 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 68.0 mt -106.31 117.71 52.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.059 0.457 . . . . 0.0 110.771 -175.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . 0.476 HD12 ' H ' ' D' ' 24' ' ' ILE . 4.2 mp -79.26 -45.42 23.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.96 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -135.14 140.28 45.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.759 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 18.2 m -56.02 124.17 16.84 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 123.547 0.529 . . . . 0.0 109.595 177.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 27' ' ' PHE . . . . . 0.556 ' HB3' HD23 ' D' ' 91' ' ' LEU . 3.9 p90 -140.16 158.56 43.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.65 0.738 . . . . 0.0 112.731 -171.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 28' ' ' HIS . . . . . 0.577 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 14.1 t60 -112.87 125.99 54.97 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.048 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 29' ' ' ILE . . . . . 0.59 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 43.9 mt -96.3 133.46 37.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . 0.577 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 42.4 p -118.53 -14.96 9.63 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -170.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.91 151.93 22.46 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 119.4 -1.381 . . . . 0.0 113.489 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.45 HG23 ' HG ' ' D' ' 87' ' ' LEU . 9.1 p -140.87 123.85 16.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 171.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . 0.417 ' HA ' HG21 ' D' ' 56' ' ' VAL . . . -143.48 154.61 43.83 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.419 -0.512 . . . . 0.0 112.076 -172.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 34' ' ' LEU . . . . . 0.619 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.3 pp -118.2 138.86 52.04 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.669 0.747 . . . . 0.0 111.222 177.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -110.1 -47.55 3.3 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.475 172.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -103.2 127.52 50.47 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.176 170.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . 0.451 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 147.3 162.99 10.31 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 119.659 -1.258 . . . . 0.0 113.364 177.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 38' ' ' GLN . . . . . 0.461 ' O ' ' HG3' ' D' ' 58' ' ' LYS . 8.4 tt0 -102.21 -48.32 4.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.524 0.202 . . . . 0.0 111.155 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -153.0 137.84 17.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.784 -0.189 . . . . 0.0 110.667 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . 0.535 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -136.37 114.91 11.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.37 0.605 . . . . 0.0 111.126 171.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' D' ' 79' ' ' THR . 68.1 mttm -95.01 114.92 26.78 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 171.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.411 HD23 ' HB ' ' D' ' 53' ' ' VAL . 38.0 tp -83.99 116.13 22.67 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -176.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 43' ' ' TYR . . . . . 0.41 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 94.4 m-85 -117.03 143.74 45.4 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.548 ' HA ' ' O ' ' D' ' 76' ' ' MET . 0.1 OUTLIER -131.62 131.77 43.5 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 172.699 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 45' ' ' ALA . . . . . 0.582 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -111.97 118.1 34.55 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.131 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.657 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -130.43 133.59 46.46 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.485 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 56.19 38.8 30.19 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 123.452 0.47 . . . . 0.0 110.591 -175.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm 65.94 22.43 11.31 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.214 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . 0.582 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 29.1 mm-40 -113.28 124.54 52.74 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -87.55 116.87 25.97 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . 0.543 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 72.3 m-85 -111.64 131.03 55.56 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.798 177.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -81.3 103.32 8.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 171.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 53' ' ' VAL . . . . . 0.499 HG13 ' CD2' ' C' ' 88' ' ' LEU . 2.3 t -76.76 -47.61 28.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.523 -172.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 54' ' ' ALA . . . . . 0.476 ' HB2' HD23 ' D' ' 65' ' ' LEU . . . -156.74 151.5 25.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.296 -178.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 99.9 m -114.74 101.64 9.26 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 169.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 56' ' ' VAL . . . . . 0.475 HG11 HG11 ' D' ' 85' ' ' VAL . 7.4 p -112.97 114.14 46.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.584 0.707 . . . . 0.0 109.777 -177.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 75.7 p -123.26 -177.82 3.81 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.495 -174.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 58' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' D' ' 38' ' ' GLN . 28.8 mtpp -57.2 -36.08 70.41 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.12 0.486 . . . . 0.0 110.43 168.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.4 -41.14 66.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.562 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 76.0 mt -115.72 82.69 10.59 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.03 0.42 6.63 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.839 2.359 . . . . 0.0 113.652 -168.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -162.64 128.22 3.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.154 0.502 . . . . 0.0 111.014 -176.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.425 HG23 ' HB ' ' D' ' 56' ' ' VAL . 92.7 t -114.39 111.36 35.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.433 174.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.93 112.01 23.7 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.678 174.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 65' ' ' LEU . . . . . 0.476 HD23 ' HB2' ' D' ' 54' ' ' ALA . 0.3 OUTLIER -130.41 168.56 16.77 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.065 0.46 . . . . 0.0 111.556 -175.518 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 66' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 6.5 t0 -115.32 99.99 7.79 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.33 0.586 . . . . 0.0 110.398 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.65 HD21 HD23 ' C' ' 88' ' ' LEU . 17.7 mt -114.66 141.32 47.95 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.561 177.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 68' ' ' ASN . . . . . 0.438 ' HB3' ' CD2' ' C' ' 90' ' ' TYR . 6.2 t30 -146.71 115.28 6.76 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.006 0.431 . . . . 0.0 110.083 173.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -110.11 159.93 16.91 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.012 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 10.0 p -112.56 149.59 32.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.479 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.56 10.59 0.61 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -175.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.72 -21.38 14.44 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.131 176.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -101.21 171.41 7.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.839 0.352 . . . . 0.0 110.859 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 -137.72 129.33 28.28 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.657 HG22 ' HB2' ' D' ' 46' ' ' ALA . 14.7 pt -129.3 162.94 35.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.088 0.47 . . . . 0.0 111.707 -169.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 76' ' ' MET . . . . . 0.548 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 4.8 mtm -118.22 122.79 43.87 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 175.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 77' ' ' PHE . . . . . 0.536 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 1.0 OUTLIER -105.03 127.77 53.02 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 177.209 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 78' ' ' TYR . . . . . 0.691 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 49.5 p90 -155.9 150.57 26.08 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.491 -177.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 79' ' ' THR . . . . . 0.723 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 11.1 p -117.23 149.19 40.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.935 0.397 . . . . 0.0 111.698 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.14 144.71 42.19 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.202 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.2 176.98 34.67 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -175.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -106.5 102.84 12.21 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.97 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . 0.535 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -170.82 151.27 3.38 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.486 169.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 23.5 t -108.21 121.49 44.98 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.619 HG12 ' HB3' ' D' ' 34' ' ' LEU . 11.7 m -118.41 146.18 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 CA-C-O 121.416 0.627 . . . . 0.0 111.69 -173.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 15.4 t -111.87 120.88 43.43 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 87' ' ' LEU . . . . . 0.73 HD13 HD23 ' D' ' 11' ' ' LEU . 5.0 mp -92.86 151.58 19.9 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 120.452 -0.499 . . . . 0.0 109.658 174.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.675 HD23 HD21 ' E' ' 67' ' ' LEU . 1.6 tp -133.55 141.18 47.6 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.081 -178.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.24 -166.7 26.76 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.799 -176.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 90' ' ' TYR . . . . . 0.463 ' CD2' ' HB3' ' E' ' 68' ' ' ASN . 8.2 p90 -150.95 130.12 12.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.742 0.782 . . . . 0.0 111.781 176.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . 0.556 HD23 ' HB3' ' D' ' 27' ' ' PHE . 5.3 mt . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.957 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 59.9 mtt . . . . . 0 C--O 1.225 -0.206 0 CA-C-O 120.943 0.401 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' E' E ' 8' ' ' PHE . . . . . 0.475 ' CE1' HD21 ' A' ' 44' ' ' LEU . 74.2 t80 -54.92 144.03 24.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.805 -173.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 9' ' ' TRP . . . . . 0.574 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 89.5 t90 -139.38 148.63 43.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.96 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 10' ' ' GLY . . . . . 0.569 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -149.88 153.43 25.1 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.79 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 11' ' ' LEU . . . . . 0.744 HD23 HD13 ' E' ' 87' ' ' LEU . 59.2 tp -139.06 108.79 6.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.898 0.38 . . . . 0.0 111.144 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -80.28 105.71 11.75 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.769 173.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 13' ' ' MET . . . . . 0.594 ' HB3' HG23 ' E' ' 85' ' ' VAL . 35.5 tpp -99.5 132.32 44.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.117 0.484 . . . . 0.0 110.935 -176.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -98.56 146.67 31.99 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.945 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . 0.52 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 10.4 Cg_endo -53.73 115.96 2.68 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 123.4 2.734 . . . . 0.0 113.104 -176.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 16' ' ' GLU . . . . . 0.727 ' HA ' ' O ' ' E' ' 79' ' ' THR . 34.6 mt-10 63.35 38.17 10.37 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.69 177.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -109.41 149.9 28.87 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 173.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . 0.686 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 34.4 ttmt -125.99 119.19 27.04 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.736 0.303 . . . . 0.0 111.613 -174.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . 0.471 ' OH ' ' HA ' ' E' ' 13' ' ' MET . 3.5 m-85 -110.44 104.86 13.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.546 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 12.0 p -87.54 99.47 12.06 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 171.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -125.41 148.77 48.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.537 0.684 . . . . 0.0 112.517 -166.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 11.5 t -92.45 160.27 15.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.989 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 68.1 mt -106.25 117.66 52.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.082 0.468 . . . . 0.0 110.894 -175.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . 0.465 HD12 ' H ' ' E' ' 24' ' ' ILE . 4.1 mp -79.19 -45.42 24.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.977 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -135.13 140.23 45.27 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.775 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 18.0 m -56.06 124.09 16.62 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 123.619 0.574 . . . . 0.0 109.648 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 27' ' ' PHE . . . . . 0.566 ' HB3' HD23 ' E' ' 91' ' ' LEU . 3.9 p90 -140.04 158.53 43.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.725 0.774 . . . . 0.0 112.765 -171.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 28' ' ' HIS . . . . . 0.58 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 14.3 t60 -112.72 125.99 54.92 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.159 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 29' ' ' ILE . . . . . 0.604 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 44.2 mt -96.29 133.41 37.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 170.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . 0.58 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 43.3 p -118.49 -14.93 9.66 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -170.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.86 151.93 22.47 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 119.373 -1.394 . . . . 0.0 113.566 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.46 HG23 ' HG ' ' E' ' 87' ' ' LEU . 9.1 p -140.81 123.86 16.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 171.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . 0.407 ' HA ' HG21 ' E' ' 56' ' ' VAL . . . -143.52 154.54 43.73 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.493 -0.483 . . . . 0.0 112.082 -172.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 34' ' ' LEU . . . . . 0.615 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.3 pp -118.2 138.89 52.01 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.714 0.769 . . . . 0.0 111.222 177.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -110.2 -47.44 3.3 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.485 172.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -103.28 127.47 50.6 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.201 170.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . 0.458 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 147.27 162.9 10.25 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 119.673 -1.251 . . . . 0.0 113.463 177.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 38' ' ' GLN . . . . . 0.457 ' O ' ' HG3' ' E' ' 58' ' ' LYS . 8.4 tt0 -102.22 -48.16 4.29 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.559 0.219 . . . . 0.0 111.143 178.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -153.11 137.76 16.91 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.781 -0.191 . . . . 0.0 110.639 176.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . 0.541 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -136.32 114.97 11.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.318 0.58 . . . . 0.0 111.147 171.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 41' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' E' ' 79' ' ' THR . 68.1 mttm -95.09 114.99 26.85 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 171.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.401 HD23 ' HB ' ' E' ' 53' ' ' VAL . 37.9 tp -84.05 116.17 22.72 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -176.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 43' ' ' TYR . . . . . 0.411 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 94.2 m-85 -117.05 143.72 45.43 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.501 177.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 44' ' ' LEU . . . . . 0.545 ' HA ' ' O ' ' E' ' 76' ' ' MET . 0.1 OUTLIER -131.59 131.66 43.45 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 172.653 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 45' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -111.88 118.07 34.51 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.158 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . 0.636 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -130.42 133.62 46.5 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.485 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 56.11 38.85 30.31 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.457 0.473 . . . . 0.0 110.587 -175.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm 65.96 22.48 11.28 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.259 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 49' ' ' GLN . . . . . 0.576 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 29.2 mm-40 -113.36 124.54 52.71 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -87.57 116.84 25.96 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.847 0.356 . . . . 0.0 110.064 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . 0.566 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 72.1 m-85 -111.61 131.02 55.56 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.798 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -81.35 103.45 8.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 171.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . 0.512 HG13 ' CD2' ' D' ' 88' ' ' LEU . 2.3 t -76.89 -47.59 27.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.495 -172.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 54' ' ' ALA . . . . . 0.463 ' HB2' HD23 ' E' ' 65' ' ' LEU . . . -156.71 151.56 25.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.286 -178.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 99.9 m -114.82 101.64 9.25 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 169.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . 0.482 HG11 HG11 ' E' ' 85' ' ' VAL . 7.4 p -112.92 114.07 45.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.626 0.727 . . . . 0.0 109.818 -177.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 75.4 p -123.23 -177.77 3.79 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.545 -174.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 58' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' E' ' 38' ' ' GLN . 28.8 mtpp -57.2 -36.25 70.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.074 0.464 . . . . 0.0 110.276 169.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.3 -41.13 66.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.508 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 76.4 mt -115.78 82.7 10.74 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.12 0.48 6.58 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.865 2.376 . . . . 0.0 113.707 -168.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -162.65 128.1 3.3 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.247 0.546 . . . . 0.0 111.048 -176.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . 0.421 HG23 ' HB ' ' E' ' 56' ' ' VAL . 92.7 t -114.32 111.35 35.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.412 174.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.96 112.13 23.88 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.602 174.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 65' ' ' LEU . . . . . 0.463 HD23 ' HB2' ' E' ' 54' ' ' ALA . 0.3 OUTLIER -130.51 168.44 17.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.095 0.474 . . . . 0.0 111.515 -175.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 66' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 6.5 t0 -115.22 99.97 7.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.322 0.582 . . . . 0.0 110.343 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 67' ' ' LEU . . . . . 0.675 HD21 HD23 ' D' ' 88' ' ' LEU . 17.7 mt -114.61 141.35 47.89 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.621 177.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 68' ' ' ASN . . . . . 0.463 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 6.3 t30 -146.69 115.2 6.74 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.99 0.424 . . . . 0.0 110.086 174.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -110.11 159.91 16.93 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.029 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 10.2 p -112.47 149.56 32.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.47 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 71' ' ' LYS . . . . . 0.425 ' H ' ' HG3' ' E' ' 71' ' ' LYS . 0.0 OUTLIER -71.41 10.4 0.62 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -175.596 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.67 -21.39 14.51 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.116 176.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -101.23 171.34 7.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.75 0.309 . . . . 0.0 110.865 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 -137.76 129.4 28.3 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 75' ' ' ILE . . . . . 0.636 HG22 ' HB2' ' E' ' 46' ' ' ALA . 14.6 pt -129.21 162.96 35.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.012 0.434 . . . . 0.0 111.726 -169.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 76' ' ' MET . . . . . 0.545 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 4.8 mtm -118.38 122.91 43.98 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 175.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 77' ' ' PHE . . . . . 0.539 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 1.0 OUTLIER -105.12 127.59 52.97 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.295 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 78' ' ' TYR . . . . . 0.686 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 49.6 p90 -155.82 150.59 26.23 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.536 -177.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 79' ' ' THR . . . . . 0.727 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 11.3 p -117.2 149.14 40.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.828 0.347 . . . . 0.0 111.684 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.11 144.58 42.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.301 175.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.3 177.0 34.52 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -106.6 102.82 12.17 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.965 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 83' ' ' ALA . . . . . 0.541 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -170.77 151.22 3.4 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.595 169.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 23.7 t -108.17 121.48 44.94 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 85' ' ' VAL . . . . . 0.615 HG12 ' HB3' ' E' ' 34' ' ' LEU . 11.5 m -118.36 146.2 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 CA-C-O 121.382 0.61 . . . . 0.0 111.69 -173.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 15.3 t -111.94 120.92 43.55 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 87' ' ' LEU . . . . . 0.744 HD13 HD23 ' E' ' 11' ' ' LEU . 5.1 mp -92.95 151.68 19.78 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.652 174.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . 0.656 HD23 HD21 ' A' ' 67' ' ' LEU . 1.6 tp -133.6 141.1 47.51 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.203 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.16 -166.64 26.58 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.891 -176.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 90' ' ' TYR . . . . . 0.429 ' CD2' ' HB3' ' A' ' 68' ' ' ASN . 8.2 p90 -150.91 130.11 12.72 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.694 0.759 . . . . 0.0 111.804 176.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 91' ' ' LEU . . . . . 0.566 HD23 ' HB3' ' E' ' 27' ' ' PHE . 5.3 mt . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.903 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.524 ' HA ' ' HB2' ' B' ' 70' ' ' SER . 11.4 ttt . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 121.059 0.457 . . . . 0.0 111.898 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.407 ' CE1' HD21 ' B' ' 44' ' ' LEU . 62.3 t80 -55.91 143.93 30.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.458 -175.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.445 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 89.8 t90 -137.47 150.18 47.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.052 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.595 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -150.84 159.78 28.31 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.086 177.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.58 HD23 HD13 ' A' ' 87' ' ' LEU . 36.8 tp -148.4 108.21 4.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.835 0.35 . . . . 0.0 111.066 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -92.37 103.75 16.16 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.017 0.437 . . . . 0.0 110.076 174.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.589 ' SD ' HD11 ' A' ' 87' ' ' LEU . 53.4 mtp -94.99 144.94 25.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.132 -175.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -100.45 149.36 36.03 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.853 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.566 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 11.6 Cg_endo -55.69 121.9 10.77 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 123.265 2.643 . . . . 0.0 113.294 -176.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 79' ' ' THR . 49.9 mt-10 60.84 57.28 2.67 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.532 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -132.54 142.74 49.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.166 175.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.675 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 35.6 ttmt -118.45 116.33 26.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.869 0.366 . . . . 0.0 111.648 -174.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -112.25 110.3 20.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.992 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.7 p -77.35 122.17 24.76 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 173.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -99.63 128.51 45.74 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.884 -167.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.5 p -98.77 125.19 44.05 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 169.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.3 mt -96.41 118.72 43.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.326 0.584 . . . . 0.0 111.749 -172.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.1 mp -93.94 -44.93 13.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.662 178.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -118.68 140.36 50.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.543 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.8 t -62.64 114.37 3.54 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 173.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -130.02 148.63 51.89 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.531 -0.868 . . . . 0.0 112.937 -170.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.579 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 17.6 t60 -106.08 125.68 51.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.242 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.575 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 46.9 mt -97.69 132.61 42.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 170.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.579 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 42.6 p -116.25 -14.71 11.07 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -170.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.56 152.49 22.21 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 119.232 -1.461 . . . . 0.0 113.411 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.423 HG23 ' HG ' ' A' ' 87' ' ' LEU . 8.5 p -138.01 122.82 23.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 172.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.408 ' HA ' HG21 ' A' ' 56' ' ' VAL . . . -140.61 156.14 46.35 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 122.148 -0.345 . . . . 0.0 111.394 -174.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.469 ' HB3' HG12 ' A' ' 85' ' ' VAL . 3.7 pp -115.15 141.28 48.23 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.838 0.827 . . . . 0.0 112.071 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -106.45 -57.3 2.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.055 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -102.6 127.46 49.68 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 169.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.493 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 153.4 160.61 9.82 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 119.338 -1.41 . . . . 0.0 113.749 176.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.602 ' O ' ' HG3' ' A' ' 58' ' ' LYS . 19.1 tt0 -102.22 -46.97 4.67 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.608 -0.296 . . . . 0.0 110.409 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.448 ' OE2' ' HG2' ' A' ' 38' ' ' GLN . 6.9 mp0 -152.25 129.52 11.25 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.383 176.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.663 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -125.96 119.53 27.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.352 0.596 . . . . 0.0 110.237 171.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -104.47 108.95 20.62 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.5 tp -84.9 115.0 22.53 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.248 -173.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.525 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 91.9 m-85 -116.33 145.52 43.13 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.579 ' HA ' ' O ' ' A' ' 76' ' ' MET . 0.2 OUTLIER -131.67 128.53 39.23 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 171.33 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -106.62 122.77 47.01 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.667 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.71 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -130.16 125.23 34.51 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 175.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 61.42 36.46 17.29 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -171.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.486 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 14.9 tmtt? 73.59 -7.5 1.56 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.383 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.535 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 24.1 tp60 -80.36 114.54 19.33 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 -177.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -81.32 110.14 16.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.937 0.399 . . . . 0.0 110.387 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.582 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 82.2 m-85 -99.34 129.95 45.59 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.259 177.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.27 99.46 4.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 171.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.467 HG13 ' CD2' ' E' ' 88' ' ' LEU . 2.4 t -74.67 -50.01 27.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.439 -171.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.425 ' HB2' ' CD2' ' A' ' 65' ' ' LEU . . . -158.27 138.94 12.85 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.404 -177.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.4 m -103.05 102.05 12.06 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 171.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.458 HG13 ' HB3' ' A' ' 40' ' ' ALA . 7.2 p -113.54 110.24 31.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.884 0.85 . . . . 0.0 109.814 -177.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 81.3 p -122.98 -176.97 3.54 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.137 -174.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.602 ' HG3' ' O ' ' A' ' 38' ' ' GLN . 9.7 mtmp? -56.72 -35.08 68.13 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.086 0.47 . . . . 0.0 110.288 169.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.3 -40.57 64.42 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.603 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 77.9 mt -117.11 80.49 11.78 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.16 -0.0 6.6 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.079 2.519 . . . . 0.0 113.264 -169.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -164.14 118.76 1.49 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.237 0.541 . . . . 0.0 110.948 -174.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.7 t -108.85 108.59 25.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.371 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.5 117.37 27.4 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.795 174.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -136.39 168.47 19.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.457 -176.013 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 8.9 t0 -113.96 99.47 7.69 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.204 0.526 . . . . 0.0 110.292 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.6 HD21 HD23 ' E' ' 88' ' ' LEU . 19.5 mt -112.66 142.01 45.76 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.486 177.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -150.63 115.75 5.35 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 174.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -110.28 158.73 18.08 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.943 -177.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.513 ' HB2' ' HA ' ' E' ' 7' ' ' MET . 8.6 t -110.57 158.71 18.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.226 0.536 . . . . 0.0 110.646 -176.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -70.57 -4.69 24.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.637 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.43 -26.86 14.33 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.487 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -100.69 168.24 9.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.003 0.43 . . . . 0.0 110.955 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.7 mtm180 -136.84 143.7 43.22 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.71 HG22 ' HB2' ' A' ' 46' ' ' ALA . 13.2 pt -140.0 176.07 5.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.123 -172.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.579 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 9.2 mtm -134.03 131.8 39.3 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 171.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.458 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 1.2 m-85 -108.33 128.22 54.56 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.675 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 38.9 p90 -152.84 136.27 15.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.303 0.573 . . . . 0.0 111.714 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 2.1 p -111.13 133.16 53.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.22 -177.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.28 168.29 9.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.748 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.94 -170.33 43.42 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 -177.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -114.9 102.65 10.18 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 117.708 0.754 . . . . 0.0 109.702 174.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.663 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -173.82 152.4 1.99 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.502 170.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.0 t -111.64 122.06 46.8 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.469 HG12 ' HB3' ' A' ' 34' ' ' LEU . 4.3 m -113.51 156.95 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 CA-C-O 121.546 0.688 . . . . 0.0 112.566 -172.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.9 t -123.63 113.84 19.2 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.595 177.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.589 HD11 ' SD ' ' A' ' 13' ' ' MET . 5.0 mp -90.15 153.57 20.42 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.106 0.479 . . . . 0.0 109.846 174.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.594 HD23 HD21 ' B' ' 67' ' ' LEU . 1.0 OUTLIER -133.49 139.34 46.6 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.093 -179.467 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.83 -166.85 24.45 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.886 -177.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -152.79 131.27 12.18 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.735 0.778 . . . . 0.0 111.856 176.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.7 mt . . . . . 0 C--N 1.322 -0.619 0 CA-C-N 114.056 -1.429 . . . . 0.0 109.306 175.094 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . 0.516 ' HA ' ' HB2' ' C' ' 70' ' ' SER . 11.5 ttt . . . . . 0 N--CA 1.456 -0.167 0 CA-C-O 121.076 0.465 . . . . 0.0 111.774 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . 0.418 ' CE1' HD21 ' C' ' 44' ' ' LEU . 62.2 t80 -55.9 143.94 29.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.477 -175.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . 0.44 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 89.8 t90 -137.48 150.16 47.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.95 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.618 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -150.87 159.75 28.3 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.092 177.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.594 HD23 HD13 ' B' ' 87' ' ' LEU . 37.0 tp -148.32 108.24 4.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.864 0.364 . . . . 0.0 111.077 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -92.46 103.81 16.2 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.963 0.411 . . . . 0.0 110.011 174.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . 0.602 ' SD ' HD11 ' B' ' 87' ' ' LEU . 53.7 mtp -95.11 144.95 25.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.06 -175.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -100.35 149.45 36.08 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.834 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.572 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 11.4 Cg_endo -55.85 121.81 10.63 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.283 2.655 . . . . 0.0 113.255 -176.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' B' ' 79' ' ' THR . 49.7 mt-10 60.9 57.38 2.61 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.49 178.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -132.6 142.63 49.22 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.207 175.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.657 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 35.6 ttmt -118.38 116.25 26.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.804 0.335 . . . . 0.0 111.722 -174.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -112.2 110.35 20.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.023 178.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 4.7 p -77.27 122.29 24.88 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 173.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -99.74 128.6 45.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.815 -167.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 28.5 p -98.73 125.12 43.97 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 169.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 43.5 mt -96.46 118.65 43.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.256 0.551 . . . . 0.0 111.744 -172.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.417 ' N ' HD12 ' B' ' 24' ' ' ILE . 4.1 mp -93.84 -45.0 13.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.652 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -118.61 140.54 49.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.479 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 11.3 t -62.67 114.38 3.56 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 173.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -130.02 148.73 51.91 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.502 -0.879 . . . . 0.0 112.923 -170.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' HIS . . . . . 0.576 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 17.9 t60 -106.15 125.65 51.25 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.194 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.597 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 47.5 mt -97.69 132.6 42.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 170.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.576 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 43.1 p -116.25 -14.75 11.07 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -170.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.55 152.45 22.15 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 119.322 -1.418 . . . . 0.0 113.464 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.426 HG23 ' HG ' ' B' ' 87' ' ' LEU . 8.7 p -137.91 122.78 23.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 172.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . 0.412 ' HA ' HG21 ' B' ' 56' ' ' VAL . . . -140.63 156.15 46.34 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.335 -174.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.469 ' HB3' HG12 ' B' ' 85' ' ' VAL . 3.7 pp -115.18 141.37 48.11 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.853 0.835 . . . . 0.0 112.053 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -106.54 -57.32 2.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.044 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -102.64 127.42 49.76 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 169.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.498 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 153.52 160.67 9.87 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 119.311 -1.423 . . . . 0.0 113.729 176.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . 0.592 ' O ' ' HG3' ' B' ' 58' ' ' LYS . 19.0 tt0 -102.22 -47.0 4.66 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 120.784 0.326 . . . . 0.0 110.426 177.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.448 ' OE2' ' HG2' ' B' ' 38' ' ' GLN . 6.9 mp0 -152.27 129.52 11.24 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.352 177.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.669 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -126.02 119.48 27.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.355 0.598 . . . . 0.0 110.305 171.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -104.5 108.92 20.59 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 43.7 tp -84.82 115.02 22.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.33 -173.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . 0.525 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 91.6 m-85 -116.31 145.48 43.15 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 175.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.577 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.2 OUTLIER -131.63 128.46 39.16 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 171.337 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -106.64 122.95 47.36 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.6 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.704 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -130.19 125.26 34.52 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 175.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 61.37 36.44 17.47 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 123.532 0.52 . . . . 0.0 109.698 -171.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.482 ' HD3' ' O ' ' B' ' 48' ' ' LYS . 14.9 tmtt? 73.6 -7.54 1.55 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.407 178.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . 0.537 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 24.3 tp60 -80.46 114.61 19.48 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -177.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -81.42 110.2 16.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.993 0.425 . . . . 0.0 110.307 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.595 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 82.2 m-85 -99.37 129.93 45.61 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.293 177.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.28 99.44 4.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 171.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.482 HG13 ' CD2' ' A' ' 88' ' ' LEU . 2.4 t -74.63 -50.06 27.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.412 -171.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.433 ' HB2' ' CD2' ' B' ' 65' ' ' LEU . . . -158.25 138.92 12.84 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.429 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 23.2 m -103.06 102.04 12.04 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 171.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . 0.468 HG13 ' HB3' ' B' ' 40' ' ' ALA . 7.3 p -113.46 110.19 31.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.796 0.808 . . . . 0.0 109.928 -177.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 81.5 p -122.96 -176.89 3.52 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.128 -174.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . 0.592 ' HG3' ' O ' ' B' ' 38' ' ' GLN . 9.7 mtmp? -56.77 -34.99 68.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.086 0.47 . . . . 0.0 110.372 169.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.5 -40.48 64.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.505 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 77.6 mt -117.16 80.57 12.04 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 173.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.15 -0.06 6.67 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.985 2.457 . . . . 0.0 113.251 -169.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -164.14 118.67 1.48 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.228 0.537 . . . . 0.0 111.111 -174.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 58.6 t -108.78 108.58 25.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.366 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.43 117.45 27.37 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.851 174.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' B' ' 30' ' ' SER . 0.3 OUTLIER -136.53 168.43 19.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.459 -176.013 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . 0.54 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 8.9 t0 -113.88 99.46 7.69 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.175 0.512 . . . . 0.0 110.328 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.597 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 19.5 mt -112.77 142.06 45.85 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.409 177.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -150.6 115.87 5.39 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 174.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -110.32 158.78 18.06 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.906 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.524 ' HB2' ' HA ' ' A' ' 7' ' ' MET . 8.6 t -110.63 158.65 18.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.239 0.543 . . . . 0.0 110.627 -176.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -70.53 -4.76 24.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.67 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.35 -26.97 14.13 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.404 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -100.61 168.31 9.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.12 0.486 . . . . 0.0 110.92 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 73.7 mtm180 -136.94 143.55 42.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.1 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.704 HG22 ' HB2' ' B' ' 46' ' ' ALA . 13.1 pt -139.85 175.98 6.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.59 0.233 . . . . 0.0 111.141 -172.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.577 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 9.2 mtm -133.97 131.81 39.43 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 171.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . 0.468 ' CD1' ' HB2' ' B' ' 44' ' ' LEU . 1.2 m-85 -108.35 128.2 54.55 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.657 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 38.8 p90 -152.84 136.27 15.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.341 0.591 . . . . 0.0 111.765 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 2.1 p -111.12 133.13 53.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.185 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.24 168.27 9.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.795 177.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.98 -170.31 43.32 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -115.04 102.72 10.2 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.659 174.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.669 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -173.88 152.28 1.94 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.511 170.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 32.0 t -111.47 122.1 46.94 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.469 HG12 ' HB3' ' B' ' 34' ' ' LEU . 4.3 m -113.59 156.85 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-O 121.471 0.653 . . . . 0.0 112.567 -172.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 14.8 t -123.54 113.87 19.29 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.667 177.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.602 HD11 ' SD ' ' B' ' 13' ' ' MET . 5.0 mp -90.15 153.55 20.44 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 121.078 0.466 . . . . 0.0 109.887 174.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.578 HD23 HD21 ' C' ' 67' ' ' LEU . 1.0 OUTLIER -133.47 139.38 46.64 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.023 -179.43 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.87 -166.85 24.51 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.913 -177.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -152.73 131.31 12.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.751 0.786 . . . . 0.0 111.763 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 5.7 mt . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 114.078 -1.419 . . . . 0.0 109.301 174.995 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 7' ' ' MET . . . . . 0.506 ' HA ' ' HB2' ' D' ' 70' ' ' SER . 11.5 ttt . . . . . 0 N--CA 1.454 -0.248 0 CA-C-O 121.057 0.456 . . . . 0.0 111.854 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 8' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -55.93 143.86 30.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.53 -175.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . 0.432 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 90.1 t90 -137.46 150.18 47.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.976 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . 0.578 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -150.88 159.63 28.24 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.098 177.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.58 HD23 HD13 ' C' ' 87' ' ' LEU . 37.3 tp -148.26 108.21 4.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.827 0.346 . . . . 0.0 111.178 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -92.4 103.78 16.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.076 0.465 . . . . 0.0 110.005 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 13' ' ' MET . . . . . 0.591 ' SD ' HD11 ' C' ' 87' ' ' LEU . 53.2 mtp -95.0 144.99 25.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.118 -175.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -100.43 149.42 36.08 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.86 177.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . 0.579 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 11.6 Cg_endo -55.83 121.85 10.71 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.254 2.636 . . . . 0.0 113.253 -176.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' C' ' 79' ' ' THR . 49.9 mt-10 60.9 57.28 2.64 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.564 178.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -132.55 142.6 49.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.253 175.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 18' ' ' LYS . . . . . 0.666 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 35.5 ttmt -118.37 116.41 26.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.859 0.362 . . . . 0.0 111.721 -174.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -112.27 110.36 20.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.029 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -77.3 122.15 24.7 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 173.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -99.58 128.54 45.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.85 -167.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 28.0 p -98.7 125.01 43.89 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 169.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mt -96.43 118.72 43.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.2 0.524 . . . . 0.0 111.738 -172.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . 0.42 HD12 ' N ' ' C' ' 24' ' ' ILE . 4.1 mp -93.9 -44.97 13.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.649 178.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -118.64 140.39 49.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.539 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 11.6 t -62.58 114.3 3.48 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 173.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 27' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -130.05 148.62 51.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.888 0.851 . . . . 0.0 112.947 -170.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 28' ' ' HIS . . . . . 0.581 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 17.7 t60 -106.08 125.6 51.19 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.158 -1.383 . . . . 0.0 110.201 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . 0.579 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 46.8 mt -97.7 132.63 42.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 170.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.581 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 42.4 p -116.31 -14.65 11.04 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -170.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.63 152.47 22.17 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 119.304 -1.427 . . . . 0.0 113.438 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.424 HG23 ' HG ' ' C' ' 87' ' ' LEU . 8.7 p -138.0 122.76 23.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 172.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.408 ' HA ' HG21 ' C' ' 56' ' ' VAL . . . -140.63 156.18 46.33 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.091 -0.38 . . . . 0.0 111.328 -174.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.452 ' HB3' HG12 ' C' ' 85' ' ' VAL . 3.7 pp -115.12 141.35 48.13 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.786 0.803 . . . . 0.0 112.129 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -106.58 -57.31 2.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.98 176.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -102.68 127.41 49.81 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 169.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 37' ' ' GLY . . . . . 0.486 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 153.56 160.69 9.89 Favored Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 119.357 -1.402 . . . . 0.0 113.724 176.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 38' ' ' GLN . . . . . 0.607 ' O ' ' HG3' ' C' ' 58' ' ' LYS . 19.0 tt0 -102.22 -47.03 4.65 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 120.701 0.286 . . . . 0.0 110.467 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . 0.449 ' OE2' ' HG2' ' C' ' 38' ' ' GLN . 6.8 mp0 -152.26 129.52 11.25 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.412 176.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.663 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -125.95 119.56 28.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.35 0.595 . . . . 0.0 110.296 171.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -104.54 108.88 20.55 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 43.5 tp -84.84 115.04 22.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.261 -173.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 43' ' ' TYR . . . . . 0.51 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 91.5 m-85 -116.33 145.5 43.15 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 175.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.575 ' HA ' ' O ' ' C' ' 76' ' ' MET . 0.2 OUTLIER -131.69 128.48 39.07 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 171.434 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -106.55 122.9 47.25 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.633 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.712 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -130.3 125.16 34.05 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 61.46 36.42 17.19 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -171.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . 0.493 ' HD3' ' O ' ' C' ' 48' ' ' LYS . 14.9 tmtt? 73.72 -7.67 1.54 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.351 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . 0.54 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 24.8 tp60 -80.36 114.59 19.37 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.887 -0.508 . . . . 0.0 109.69 -177.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -81.28 110.1 16.42 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.343 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . 0.618 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 82.2 m-85 -99.36 129.89 45.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.278 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.22 99.44 3.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 171.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 53' ' ' VAL . . . . . 0.474 HG13 ' CD2' ' B' ' 88' ' ' LEU . 2.4 t -74.64 -50.12 27.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.39 -171.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 54' ' ' ALA . . . . . 0.433 ' HB2' ' CD2' ' C' ' 65' ' ' LEU . . . -158.16 138.95 12.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.454 -177.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 23.5 m -103.05 102.09 12.09 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 171.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . 0.457 HG13 ' HB3' ' C' ' 40' ' ' ALA . 7.2 p -113.59 110.15 31.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.846 0.831 . . . . 0.0 109.889 -177.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 81.7 p -123.02 -177.01 3.55 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.124 -174.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 58' ' ' LYS . . . . . 0.607 ' HG3' ' O ' ' C' ' 38' ' ' GLN . 9.7 mtmp? -56.58 -35.11 67.82 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.058 0.456 . . . . 0.0 110.38 169.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.37 -40.55 64.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.514 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 77.9 mt -117.21 80.58 12.22 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 174.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.21 -0.07 6.74 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.053 2.502 . . . . 0.0 113.187 -169.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -164.12 118.68 1.49 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.139 0.495 . . . . 0.0 111.076 -174.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 58.9 t -108.79 108.65 25.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.281 175.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.53 117.41 27.46 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.772 174.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . 0.433 ' CD2' ' HB2' ' C' ' 54' ' ' ALA . 0.3 OUTLIER -136.39 168.49 19.35 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.497 -176.073 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 66' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 8.9 t0 -114.02 99.58 7.76 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.306 0.574 . . . . 0.0 110.203 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.579 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 19.6 mt -112.74 141.96 45.92 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.468 177.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -150.58 115.78 5.37 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 174.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -110.26 158.76 18.04 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.937 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . 0.516 ' HB2' ' HA ' ' B' ' 7' ' ' MET . 8.7 t -110.65 158.7 18.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.23 0.538 . . . . 0.0 110.654 -176.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -70.6 -4.67 24.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.596 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.51 -26.81 14.37 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.483 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -100.81 168.24 9.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.019 0.437 . . . . 0.0 110.846 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 73.7 mtm180 -136.86 143.59 43.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.136 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.712 HG22 ' HB2' ' C' ' 46' ' ' ALA . 13.2 pt -139.83 176.11 6.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.614 0.245 . . . . 0.0 111.128 -172.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.575 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 9.2 mtm -134.1 131.81 39.19 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 171.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 77' ' ' PHE . . . . . 0.456 ' CD1' ' HB2' ' C' ' 44' ' ' LEU . 1.2 m-85 -108.34 128.24 54.58 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 78' ' ' TYR . . . . . 0.666 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 38.9 p90 -152.8 136.32 15.97 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.37 0.605 . . . . 0.0 111.777 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 2.1 p -111.1 133.11 53.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.217 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.31 168.33 9.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.763 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.77 -170.26 43.68 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -114.97 102.7 10.21 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.651 174.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . 0.663 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -173.83 152.34 1.97 Allowed 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.942 -1.027 . . . . 0.0 109.473 170.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 32.1 t -111.47 122.16 47.09 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.454 HG11 HG11 ' C' ' 56' ' ' VAL . 4.3 m -113.71 156.91 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-O 121.564 0.697 . . . . 0.0 112.537 -172.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 15.1 t -123.62 113.84 19.2 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.637 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . 0.591 HD11 ' SD ' ' C' ' 13' ' ' MET . 5.0 mp -90.08 153.55 20.46 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.07 0.462 . . . . 0.0 109.913 174.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . 0.59 HD23 HD21 ' D' ' 67' ' ' LEU . 1.0 OUTLIER -133.5 139.34 46.59 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.051 -179.422 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.86 -166.81 24.43 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.875 -177.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -152.79 131.27 12.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.809 0.814 . . . . 0.0 111.812 176.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 5.8 mt . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 114.007 -1.452 . . . . 0.0 109.253 175.097 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 7' ' ' MET . . . . . 0.496 ' HA ' ' HB2' ' E' ' 70' ' ' SER . 11.5 ttt . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 121.038 0.446 . . . . 0.0 111.783 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 8' ' ' PHE . . . . . 0.405 ' CE1' HD21 ' E' ' 44' ' ' LEU . 62.4 t80 -55.97 143.86 30.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.51 -175.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 9' ' ' TRP . . . . . 0.439 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 90.0 t90 -137.43 150.06 47.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.022 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . 0.585 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -150.83 159.71 28.28 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.098 177.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . 0.594 HD23 HD13 ' D' ' 87' ' ' LEU . 36.7 tp -148.35 108.18 4.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.834 0.349 . . . . 0.0 111.03 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -92.28 103.82 16.24 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.988 0.423 . . . . 0.0 109.975 174.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 13' ' ' MET . . . . . 0.6 ' SD ' HD11 ' D' ' 87' ' ' LEU . 53.8 mtp -95.12 145.01 25.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.12 -175.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -100.47 149.42 36.08 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.86 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . 0.557 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 11.5 Cg_endo -55.76 121.72 10.46 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 123.314 2.676 . . . . 0.0 113.319 -176.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' D' ' 79' ' ' THR . 49.8 mt-10 60.89 57.45 2.6 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.465 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -132.64 142.66 49.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.202 175.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . 0.665 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 35.5 ttmt -118.41 116.26 26.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.86 0.362 . . . . 0.0 111.756 -175.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -112.09 110.25 20.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.095 178.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 4.7 p -77.17 122.22 24.72 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 173.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -99.67 128.45 45.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.886 -167.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 28.4 p -98.72 125.15 43.96 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 169.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 44.0 mt -96.41 118.58 43.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.205 0.526 . . . . 0.0 111.731 -172.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . 0.426 HD12 ' N ' ' D' ' 24' ' ' ILE . 4.1 mp -93.83 -44.98 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.673 178.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -118.65 140.44 49.91 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.491 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 11.6 t -62.65 114.37 3.54 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 173.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 27' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -129.97 148.64 51.85 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.607 -0.837 . . . . 0.0 112.99 -170.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 28' ' ' HIS . . . . . 0.578 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 18.0 t60 -106.1 125.7 51.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.184 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 29' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 46.8 mt -97.7 132.48 42.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 170.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . 0.578 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 42.5 p -116.23 -14.65 11.09 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -170.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.58 152.48 22.2 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 119.278 -1.439 . . . . 0.0 113.453 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.424 HG23 ' HG ' ' D' ' 87' ' ' LEU . 8.6 p -137.97 122.86 23.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 172.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . 0.408 ' HA ' HG21 ' D' ' 56' ' ' VAL . . . -140.63 156.07 46.36 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 122.153 -0.342 . . . . 0.0 111.414 -174.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 34' ' ' LEU . . . . . 0.453 ' HB3' HG12 ' D' ' 85' ' ' VAL . 3.7 pp -115.1 141.34 48.15 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.818 0.818 . . . . 0.0 112.126 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -106.51 -57.27 2.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.024 176.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -102.64 127.35 49.78 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 169.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . 0.493 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 153.5 160.61 9.83 Favored Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 119.278 -1.439 . . . . 0.0 113.711 176.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 38' ' ' GLN . . . . . 0.607 ' O ' ' HG3' ' D' ' 58' ' ' LYS . 19.1 tt0 -102.21 -46.98 4.66 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.579 -0.311 . . . . 0.0 110.391 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . 0.45 ' OE2' ' HG2' ' D' ' 38' ' ' GLN . 6.9 mp0 -152.27 129.45 11.18 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.417 176.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . 0.673 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -125.97 119.63 28.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.4 0.619 . . . . 0.0 110.218 171.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -104.51 109.01 20.73 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 43.8 tp -84.99 114.97 22.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.218 -173.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 43' ' ' TYR . . . . . 0.523 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 91.6 m-85 -116.26 145.51 43.1 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 175.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.58 ' HA ' ' O ' ' D' ' 76' ' ' MET . 0.2 OUTLIER -131.66 128.47 39.11 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 171.367 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 45' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -106.57 122.93 47.3 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.654 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.718 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -130.3 125.14 34.01 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 61.47 36.4 17.17 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -171.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 48' ' ' LYS . . . . . 0.498 ' HD3' ' O ' ' D' ' 48' ' ' LYS . 14.9 tmtt? 73.69 -7.54 1.56 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.307 178.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . 0.537 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 24.5 tp60 -80.37 114.56 19.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -177.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -81.32 110.11 16.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.424 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . 0.578 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 82.1 m-85 -99.32 129.95 45.57 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.225 177.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.24 99.42 3.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 171.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 53' ' ' VAL . . . . . 0.468 HG13 ' CD2' ' C' ' 88' ' ' LEU . 2.4 t -74.69 -50.08 27.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.376 -171.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 54' ' ' ALA . . . . . 0.425 ' HB2' ' CD2' ' D' ' 65' ' ' LEU . . . -158.21 139.02 12.97 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.453 -177.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 22.9 m -103.11 102.1 12.09 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 171.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 56' ' ' VAL . . . . . 0.472 HG13 ' HB3' ' D' ' 40' ' ' ALA . 7.2 p -113.55 110.21 31.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.889 0.852 . . . . 0.0 109.932 -177.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 81.6 p -122.97 -176.95 3.54 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.123 -174.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 58' ' ' LYS . . . . . 0.607 ' HG3' ' O ' ' D' ' 38' ' ' GLN . 9.7 mtmp? -56.64 -35.18 68.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.146 0.498 . . . . 0.0 110.329 169.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.24 -40.72 64.43 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.549 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 77.6 mt -116.93 80.55 11.29 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 173.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.28 0.06 6.6 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.018 2.479 . . . . 0.0 113.238 -169.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -164.19 118.7 1.47 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.267 0.556 . . . . 0.0 111.003 -174.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 58.6 t -108.83 108.58 25.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.299 175.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.55 117.39 27.47 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.83 174.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 65' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' D' ' 30' ' ' SER . 0.3 OUTLIER -136.35 168.51 19.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.465 -175.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 66' ' ' ASP . . . . . 0.512 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 8.8 t0 -114.0 99.61 7.79 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.206 0.527 . . . . 0.0 110.257 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.59 HD21 HD23 ' C' ' 88' ' ' LEU . 19.5 mt -112.78 142.0 45.93 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.468 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -150.58 115.78 5.37 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 174.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -110.29 158.8 18.02 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.917 -177.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . 0.506 ' HB2' ' HA ' ' C' ' 7' ' ' MET . 8.6 t -110.68 158.68 18.35 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.212 0.529 . . . . 0.0 110.619 -176.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -70.5 -4.78 24.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.611 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.38 -26.96 14.14 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.49 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -100.66 168.24 9.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.033 0.444 . . . . 0.0 110.923 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -136.8 143.7 43.31 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.718 HG22 ' HB2' ' D' ' 46' ' ' ALA . 13.3 pt -139.96 176.0 6.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.113 -172.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 76' ' ' MET . . . . . 0.58 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 9.2 mtm -134.03 131.82 39.32 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 171.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 77' ' ' PHE . . . . . 0.457 ' CD1' ' HB2' ' D' ' 44' ' ' LEU . 1.2 m-85 -108.28 128.28 54.6 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 78' ' ' TYR . . . . . 0.665 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 39.0 p90 -152.86 136.32 15.91 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.36 0.6 . . . . 0.0 111.734 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 79' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 2.1 p -111.2 133.13 53.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.187 -177.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.25 168.28 9.45 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.777 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.94 -170.24 43.32 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -115.09 102.72 10.19 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 117.723 0.761 . . . . 0.0 109.61 174.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . 0.673 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -173.86 152.4 1.97 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.487 170.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 32.0 t -111.55 122.09 46.91 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.453 HG12 ' HB3' ' D' ' 34' ' ' LEU . 4.3 m -113.62 156.85 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.635 0 CA-C-O 121.476 0.655 . . . . 0.0 112.58 -172.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 14.9 t -123.53 113.82 19.23 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.656 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 87' ' ' LEU . . . . . 0.6 HD11 ' SD ' ' D' ' 13' ' ' MET . 5.0 mp -90.09 153.5 20.5 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 121.139 0.495 . . . . 0.0 109.852 174.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.561 HD23 HD21 ' E' ' 67' ' ' LEU . 1.0 OUTLIER -133.4 139.44 46.76 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.067 -179.526 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.87 -166.85 24.5 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.838 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -152.8 131.24 12.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.786 0.803 . . . . 0.0 111.843 176.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 5.7 mt . . . . . 0 C--N 1.323 -0.571 0 CA-C-N 113.984 -1.462 . . . . 0.0 109.299 175.078 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' E' E ' 7' ' ' MET . . . . . 0.513 ' HA ' ' HB2' ' A' ' 70' ' ' SER . 11.5 ttt . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 121.086 0.47 . . . . 0.0 111.825 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 8' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -55.95 143.83 30.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.515 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 9' ' ' TRP . . . . . 0.429 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 89.9 t90 -137.4 150.13 47.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.044 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 10' ' ' GLY . . . . . 0.582 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -150.87 159.68 28.27 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.082 177.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 11' ' ' LEU . . . . . 0.599 HD23 HD13 ' E' ' 87' ' ' LEU . 37.3 tp -148.29 108.2 4.04 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.808 0.337 . . . . 0.0 111.151 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -92.38 103.78 16.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.081 0.467 . . . . 0.0 110.007 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 13' ' ' MET . . . . . 0.597 ' SD ' HD11 ' E' ' 87' ' ' LEU . 53.1 mtp -95.06 144.99 25.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.099 -175.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -100.48 149.38 36.05 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.787 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . 0.56 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 11.5 Cg_endo -55.75 121.77 10.56 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.29 2.66 . . . . 0.0 113.292 -176.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 16' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' E' ' 79' ' ' THR . 49.8 mt-10 60.95 57.23 2.63 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.505 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -132.43 142.67 49.36 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.29 174.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . 0.661 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 35.6 ttmt -118.42 116.3 26.43 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.881 0.372 . . . . 0.0 111.71 -175.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -112.21 110.33 20.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.013 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 4.8 p -77.3 122.04 24.56 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 173.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -99.57 128.59 45.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.872 -167.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 27.6 p -98.69 125.06 43.89 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 169.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 44.1 mt -96.43 118.67 43.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.303 0.573 . . . . 0.0 111.691 -172.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . 0.429 HD12 ' N ' ' E' ' 24' ' ' ILE . 4.1 mp -93.94 -44.93 13.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.581 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -118.72 140.32 50.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.471 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 11.3 t -62.53 114.39 3.52 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 173.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 27' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -130.04 148.7 51.92 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 119.528 -0.869 . . . . 0.0 112.927 -170.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 28' ' ' HIS . . . . . 0.58 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 17.8 t60 -106.08 125.66 51.26 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.115 -1.402 . . . . 0.0 110.283 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 29' ' ' ILE . . . . . 0.59 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 47.1 mt -97.7 132.55 42.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . 0.58 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 44.1 p -116.28 -14.67 11.05 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -170.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.6 152.5 22.21 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 119.206 -1.473 . . . . 0.0 113.431 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.422 HG23 ' HG ' ' E' ' 87' ' ' LEU . 8.7 p -138.02 122.78 23.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 172.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . 0.416 ' HA ' HG21 ' E' ' 56' ' ' VAL . . . -140.6 156.17 46.35 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.345 -174.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 34' ' ' LEU . . . . . 0.449 ' HB3' HG12 ' E' ' 85' ' ' VAL . 3.7 pp -115.21 141.39 48.08 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.836 0.827 . . . . 0.0 112.093 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -106.57 -57.31 2.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.003 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -102.64 127.4 49.76 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 169.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . 0.494 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 153.55 160.7 9.89 Favored Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 119.485 -1.341 . . . . 0.0 113.762 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 38' ' ' GLN . . . . . 0.592 ' O ' ' HG3' ' E' ' 58' ' ' LYS . 19.2 tt0 -102.29 -46.89 4.67 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.574 -0.313 . . . . 0.0 110.363 177.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 39' ' ' GLU . . . . . 0.452 ' OE2' ' HG2' ' E' ' 38' ' ' GLN . 6.9 mp0 -152.38 129.42 11.08 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.4 176.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . 0.66 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -125.92 119.56 28.1 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.398 0.618 . . . . 0.0 110.25 171.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 41' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -104.54 108.97 20.67 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 43.6 tp -84.89 115.05 22.56 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.291 -173.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 43' ' ' TYR . . . . . 0.528 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 91.4 m-85 -116.31 145.53 43.11 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 175.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 44' ' ' LEU . . . . . 0.573 ' HA ' ' O ' ' E' ' 76' ' ' MET . 0.2 OUTLIER -131.67 128.39 38.94 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 171.408 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 45' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -106.58 122.88 47.21 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.651 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . 0.699 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -130.28 125.28 34.41 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 175.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 61.45 36.36 17.24 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.488 0.492 . . . . 0.0 109.719 -171.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 48' ' ' LYS . . . . . 0.494 ' HD3' ' O ' ' E' ' 48' ' ' LYS . 14.9 tmtt? 73.66 -7.52 1.56 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.413 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 49' ' ' GLN . . . . . 0.529 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 24.3 tp60 -80.39 114.58 19.39 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -177.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -81.39 110.21 16.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.999 0.428 . . . . 0.0 110.395 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . 0.585 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 82.2 m-85 -99.44 129.94 45.67 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.219 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.29 99.49 4.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 172.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . 0.479 HG13 ' CD2' ' D' ' 88' ' ' LEU . 2.4 t -74.67 -50.09 27.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.366 -171.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 54' ' ' ALA . . . . . 0.424 ' HB2' ' CD2' ' E' ' 65' ' ' LEU . . . -158.25 139.01 12.93 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.465 -177.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 23.2 m -102.98 102.12 12.15 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 171.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . 0.473 HG13 ' HB3' ' E' ' 40' ' ' ALA . 7.2 p -113.67 110.27 31.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.966 0.889 . . . . 0.0 109.844 -177.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 81.5 p -122.97 -176.89 3.52 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.181 -174.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 58' ' ' LYS . . . . . 0.592 ' HG3' ' O ' ' E' ' 38' ' ' GLN . 9.8 mtmp? -56.79 -35.01 68.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.016 0.436 . . . . 0.0 110.313 169.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.38 -40.62 64.21 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.506 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 77.8 mt -117.05 80.56 11.66 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.22 -0.04 6.7 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.038 2.492 . . . . 0.0 113.165 -169.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -164.11 118.69 1.49 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.159 0.504 . . . . 0.0 110.945 -174.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . 0.402 HG11 ' HB1' ' E' ' 54' ' ' ALA . 58.3 t -108.78 108.52 25.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.368 175.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.45 117.31 27.29 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.858 174.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 65' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' E' ' 30' ' ' SER . 0.3 OUTLIER -136.3 168.56 19.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.51 -176.043 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 66' ' ' ASP . . . . . 0.545 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 8.9 t0 -114.05 99.53 7.71 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.236 0.541 . . . . 0.0 110.258 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 67' ' ' LEU . . . . . 0.59 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 19.6 mt -112.74 142.11 45.75 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.458 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -150.63 115.81 5.36 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 174.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -110.37 158.68 18.19 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.884 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 70' ' ' SER . . . . . 0.496 ' HB2' ' HA ' ' D' ' 7' ' ' MET . 8.6 t -110.58 158.68 18.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.35 0.595 . . . . 0.0 110.634 -176.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -70.53 -4.84 24.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.618 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.34 -26.87 14.46 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.49 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -100.63 168.27 9.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.104 0.478 . . . . 0.0 110.884 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -136.86 143.69 43.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.12 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 75' ' ' ILE . . . . . 0.699 HG22 ' HB2' ' E' ' 46' ' ' ALA . 13.2 pt -139.93 176.12 5.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.653 0.263 . . . . 0.0 111.071 -172.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 76' ' ' MET . . . . . 0.573 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 9.2 mtm -134.09 131.73 39.11 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 171.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 77' ' ' PHE . . . . . 0.465 ' CD1' ' HB2' ' E' ' 44' ' ' LEU . 1.2 m-85 -108.29 128.29 54.61 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 178.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 78' ' ' TYR . . . . . 0.661 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 38.8 p90 -152.84 136.32 15.93 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.325 0.583 . . . . 0.0 111.742 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 79' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 2.1 p -111.12 133.01 53.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.257 -177.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.1 168.22 9.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.9 177.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.0 -170.21 43.15 Favored Glycine 0 CA--C 1.508 -0.346 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -115.12 102.7 10.16 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 117.716 0.758 . . . . 0.0 109.626 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 83' ' ' ALA . . . . . 0.66 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -173.82 152.28 1.96 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.509 170.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 31.9 t -111.46 122.19 47.18 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 85' ' ' VAL . . . . . 0.449 HG11 HG11 ' E' ' 56' ' ' VAL . 4.3 m -113.64 156.89 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 CA-C-O 121.538 0.685 . . . . 0.0 112.542 -172.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 14.9 t -123.62 113.8 19.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.794 -1.094 . . . . 0.0 108.63 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 87' ' ' LEU . . . . . 0.599 HD13 HD23 ' E' ' 11' ' ' LEU . 5.0 mp -90.12 153.42 20.55 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.123 0.487 . . . . 0.0 109.867 174.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . 0.6 HD23 HD21 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -133.28 139.44 46.91 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 114.803 -1.089 . . . . 0.0 109.077 -179.494 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.94 -166.83 24.55 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.849 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 90' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -152.8 131.33 12.22 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.769 0.795 . . . . 0.0 111.799 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 91' ' ' LEU . . . . . . . . . . . . . 5.8 mt . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.269 175.16 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 38.4 mtt . . . . . 0 CA--C 1.518 -0.256 0 CA-C-O 121.157 0.503 . . . . 0.0 112.089 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.513 ' CE1' HD21 ' B' ' 44' ' ' LEU . 28.9 t80 -62.34 145.7 53.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.547 -178.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -135.75 147.4 48.4 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.431 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -150.97 153.86 25.23 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.197 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.598 HD23 HD13 ' A' ' 87' ' ' LEU . 33.3 tp -147.77 106.54 3.82 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 86' ' ' SER . 2.3 p30 -97.85 110.54 23.09 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.543 0.687 . . . . 0.0 111.02 176.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.443 ' SD ' HG23 ' A' ' 79' ' ' THR . 7.3 mtt -85.19 142.22 29.61 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.285 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.431 ' HB2' ' HG3' ' A' ' 17' ' ' ARG . 91.6 mttt -89.82 144.26 31.38 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 170.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -46.31 109.77 0.22 Allowed 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 123.463 2.776 . . . . 0.0 113.594 -174.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.64 ' HA ' ' O ' ' A' ' 79' ' ' THR . 8.8 tt0 70.52 67.05 0.2 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.794 175.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.536 ' HA ' ' NE ' ' A' ' 17' ' ' ARG . 4.7 mmp_? -122.76 169.28 11.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.03 175.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.68 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 19.4 tttm -146.77 104.81 3.76 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.34 0.4 . . . . 0.0 111.274 -175.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -111.74 111.5 22.51 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.053 -177.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 76' ' ' MET . 29.2 t -90.78 111.06 22.29 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 170.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -133.86 150.01 51.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.635 0.731 . . . . 0.0 112.687 -168.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.7 p -91.18 160.91 15.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.679 177.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.436 HG22 ' HA ' ' A' ' 71' ' ' LYS . 73.8 mt -111.2 126.29 68.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.219 -174.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.521 HD12 ' N ' ' A' ' 25' ' ' LYS . 1.8 pp -92.53 -24.44 5.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.641 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.521 ' N ' HD12 ' A' ' 24' ' ' ILE . 24.8 mtpp -147.44 132.93 18.66 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.6 m -55.05 119.4 5.39 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.407 ' HB3' HD23 ' A' ' 91' ' ' LEU . 5.7 p90 -137.34 156.72 47.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.737 0.78 . . . . 0.0 112.833 -170.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.588 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 15.1 t60 -109.88 124.65 51.73 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.118 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.574 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 39.3 mt -94.45 135.08 29.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 169.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.593 ' HB2' ' HB3' ' B' ' 66' ' ' ASP . 50.1 p -120.31 -15.85 8.55 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -169.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -160.39 145.21 10.84 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 119.288 -1.434 . . . . 0.0 113.324 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.443 HG23 ' HG ' ' A' ' 87' ' ' LEU . 12.2 p -129.85 121.55 52.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 168.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.07 154.38 43.9 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 121.928 -0.483 . . . . 0.0 112.018 -173.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.558 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.4 pp -125.15 144.0 50.65 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.499 0.666 . . . . 0.0 110.836 178.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -110.27 -45.98 3.49 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 173.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -103.63 128.66 50.89 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.593 171.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.496 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 146.63 163.01 10.18 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 119.627 -1.273 . . . . 0.0 113.501 176.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -102.24 -47.24 4.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.494 0.188 . . . . 0.0 110.97 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -152.16 133.71 14.63 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.093 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.478 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -134.29 113.46 11.97 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.391 0.615 . . . . 0.0 110.122 167.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -97.81 112.72 24.52 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 174.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.7 tp -83.81 113.29 20.82 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.557 -174.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.532 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 97.9 m-85 -115.78 141.45 48.07 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.541 ' HB2' ' CD1' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -129.85 131.82 46.25 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 173.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -110.71 114.96 28.74 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.028 177.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.619 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -129.91 142.54 50.64 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 58.65 29.24 18.28 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.949 0.404 . . . . 0.0 110.314 -174.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt 63.58 24.51 14.02 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.735 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 23.9 tp60 -115.65 126.69 54.47 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -83.44 125.01 31.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.891 0.377 . . . . 0.0 110.696 -177.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.465 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 66.3 m-85 -121.03 133.32 55.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.943 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -82.1 107.74 14.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 169.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.51 HG13 ' CD2' ' E' ' 88' ' ' LEU . 2.4 t -80.06 -49.56 18.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.64 -171.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.534 ' HB1' HG11 ' A' ' 63' ' ' VAL . . . -160.05 148.9 17.34 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.132 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.6 m -109.79 102.22 11.03 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 173.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.415 ' CG1' HG11 ' A' ' 85' ' ' VAL . 7.3 p -117.77 114.36 45.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.658 0.742 . . . . 0.0 110.016 -177.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 81.0 p -123.05 -178.3 3.92 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.55 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -63.47 -21.54 66.37 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.996 0.426 . . . . 0.0 110.444 170.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.406 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -83.47 -40.72 18.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.229 0.537 . . . . 0.0 110.244 177.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.1 mt -113.22 82.68 5.82 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 173.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 12.5 Cg_exo -70.06 -0.11 6.69 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.156 2.57 . . . . 0.0 114.059 -167.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.28 127.12 2.44 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.175 0.512 . . . . 0.0 111.445 -176.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.534 HG11 ' HB1' ' A' ' 54' ' ' ALA . 85.2 t -117.44 106.22 19.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.311 174.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.47 121.68 27.07 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 173.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -140.69 168.16 20.46 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.766 -173.001 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.569 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 11.6 t0 -118.85 105.29 11.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.359 0.6 . . . . 0.0 110.497 -177.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.591 HD21 HD23 ' E' ' 88' ' ' LEU . 15.1 mt -118.8 144.43 46.32 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.655 177.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.447 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 57.5 t30 -148.44 114.79 5.89 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 173.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.403 ' CZ ' HD22 ' A' ' 67' ' ' LEU . 51.7 m-85 -110.13 164.51 12.57 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.091 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.0 t -107.85 149.15 28.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.859 0.361 . . . . 0.0 110.694 -177.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.436 ' HA ' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -68.14 -11.95 60.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.235 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.3 -5.76 61.83 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.537 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -100.25 167.9 10.13 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -145.23 128.21 16.5 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.619 HG22 ' HB2' ' A' ' 46' ' ' ALA . 15.4 pt -134.89 165.49 31.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.111 0.481 . . . . 0.0 111.79 -169.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.517 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 4.5 mtm -120.91 123.5 42.65 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.595 173.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.541 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -105.96 127.61 53.26 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.587 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.68 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 40.5 p90 -154.95 144.13 21.05 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 120.031 -0.668 . . . . 0.0 112.006 -177.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.64 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 6.3 p -116.18 141.64 47.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.394 -177.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.72 153.37 23.04 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.221 176.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.93 -175.36 36.69 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -175.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -118.78 104.85 10.96 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 122.118 0.961 . . . . 0.0 110.499 176.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.496 ' CB ' ' HA3' ' A' ' 37' ' ' GLY . . . -166.1 154.83 11.16 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.22 170.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.3 t -106.3 111.19 23.67 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.558 HG12 ' HB3' ' A' ' 34' ' ' LEU . 3.4 m -111.33 138.08 41.25 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 CA-C-O 121.219 0.533 . . . . 0.0 112.191 -174.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 7.4 t -108.91 118.25 36.32 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.598 HD13 HD23 ' A' ' 11' ' ' LEU . 5.4 mp -89.73 149.26 22.82 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.532 174.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.592 HD23 HD21 ' B' ' 67' ' ' LEU . 1.3 tp -132.02 140.71 49.01 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.938 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.39 -167.14 25.52 Favored Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.695 -177.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.436 ' CD2' ' HB3' ' B' ' 68' ' ' ASN . 12.9 p90 -153.34 132.18 12.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.746 0.784 . . . . 0.0 111.643 177.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.416 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 22.3 mt . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.112 173.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 38.4 mtt . . . . . 0 CA--C 1.518 -0.269 0 CA-C-O 121.282 0.563 . . . . 0.0 112.041 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . 0.528 ' CE1' HD21 ' C' ' 44' ' ' LEU . 29.1 t80 -62.36 145.73 53.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.47 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -135.72 147.33 48.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.112 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.504 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -150.95 153.81 25.21 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.185 178.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.626 HD23 HD13 ' B' ' 87' ' ' LEU . 33.6 tp -147.7 106.59 3.83 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . 0.491 ' HA ' ' HA ' ' B' ' 86' ' ' SER . 2.3 p30 -97.88 110.58 23.12 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.597 0.713 . . . . 0.0 110.959 177.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . 0.439 ' SD ' HG23 ' B' ' 79' ' ' THR . 7.3 mtt -85.14 142.17 29.68 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.366 -178.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.439 ' HB2' ' HG3' ' B' ' 17' ' ' ARG . 91.5 mttt -89.77 144.31 31.53 Favored Pre-proline 0 C--N 1.316 -0.874 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 170.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -46.3 109.69 0.22 Allowed 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 123.56 2.84 . . . . 0.0 113.496 -174.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.642 ' HA ' ' O ' ' B' ' 79' ' ' THR . 8.8 tt0 70.54 67.09 0.2 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.734 175.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.534 ' NE ' ' HA ' ' B' ' 17' ' ' ARG . 4.6 mmp_? -122.76 169.18 11.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.089 175.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.67 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 19.5 tttm -146.68 104.77 3.77 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 123.325 0.391 . . . . 0.0 111.269 -175.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -111.76 111.53 22.57 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.079 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 29.3 t -90.73 111.05 22.26 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -133.92 150.09 51.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.667 0.746 . . . . 0.0 112.66 -168.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 3.8 p -91.25 160.91 15.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.665 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.436 HG22 ' HA ' ' B' ' 71' ' ' LYS . 74.0 mt -111.24 126.31 68.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.144 -174.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.527 HD12 ' N ' ' B' ' 25' ' ' LYS . 1.8 pp -92.49 -24.44 5.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.692 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.527 ' N ' HD12 ' B' ' 24' ' ' ILE . 24.9 mtpp -147.36 132.86 18.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.87 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 15.5 m -54.96 119.32 5.25 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . 0.42 ' HB3' HD23 ' B' ' 91' ' ' LEU . 5.8 p90 -137.31 156.62 48.03 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.669 0.747 . . . . 0.0 112.853 -170.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' HIS . . . . . 0.587 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 15.1 t60 -109.92 124.59 51.64 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.151 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.571 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 39.3 mt -94.39 135.1 29.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 169.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.587 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 48.7 p -120.34 -15.79 8.54 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -169.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -160.31 145.16 10.79 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 119.301 -1.428 . . . . 0.0 113.377 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.439 HG23 ' HG ' ' B' ' 87' ' ' LEU . 12.3 p -129.81 121.59 52.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 168.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.11 154.31 43.79 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.983 -173.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.556 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.4 pp -125.08 143.99 50.64 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.468 0.651 . . . . 0.0 110.791 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -110.15 -46.12 3.49 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 173.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -103.57 128.67 50.78 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.515 171.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.493 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 146.55 163.01 10.17 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 119.676 -1.25 . . . . 0.0 113.6 175.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -102.3 -47.04 4.63 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.19 -0.204 . . . . 0.0 111.043 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -152.22 133.68 14.55 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.999 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.48 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -134.38 113.46 11.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.474 0.654 . . . . 0.0 110.127 167.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -97.83 112.7 24.51 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 174.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 43.6 tp -83.71 113.37 20.83 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.56 -174.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . 0.532 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 98.0 m-85 -115.89 141.41 48.14 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 176.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.551 ' HB2' ' CD1' ' B' ' 77' ' ' PHE . 0.1 OUTLIER -129.85 131.9 46.27 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 173.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -110.7 114.94 28.7 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.01 177.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.622 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -129.91 142.54 50.64 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 58.6 29.31 18.31 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.994 0.426 . . . . 0.0 110.338 -174.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt 63.5 24.5 14.09 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.705 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . 0.473 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 24.0 tp60 -115.64 126.65 54.43 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -83.38 124.94 31.15 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.972 0.415 . . . . 0.0 110.702 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.431 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 66.4 m-85 -120.97 133.37 55.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.899 176.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -82.06 107.63 14.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 169.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.528 HG13 ' CD2' ' A' ' 88' ' ' LEU . 2.4 t -80.08 -49.54 18.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.61 -171.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.528 ' HB1' HG11 ' B' ' 63' ' ' VAL . . . -159.98 148.89 17.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.171 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 55.4 m -109.85 102.28 11.06 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 173.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . 0.414 ' CG1' HG11 ' B' ' 85' ' ' VAL . 7.3 p -117.78 114.41 45.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.669 0.747 . . . . 0.0 110.001 -177.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 81.3 p -123.12 -178.38 3.95 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.608 -174.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -63.45 -21.47 66.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.932 0.396 . . . . 0.0 110.484 170.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.402 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -83.48 -40.77 18.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.206 0.527 . . . . 0.0 110.216 177.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 80.4 mt -113.22 82.63 5.78 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 12.5 Cg_exo -70.02 -0.2 6.78 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.17 2.58 . . . . 0.0 114.066 -167.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.21 127.17 2.47 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.159 0.504 . . . . 0.0 111.44 -176.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.528 HG11 ' HB1' ' B' ' 54' ' ' ALA . 85.5 t -117.35 106.21 19.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.35 174.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.49 121.7 27.1 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 173.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' B' ' 30' ' ' SER . 0.6 OUTLIER -140.76 168.12 20.55 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.741 -173.026 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . 0.593 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 11.8 t0 -118.73 105.26 11.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.264 0.554 . . . . 0.0 110.565 -177.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.592 HD21 HD23 ' A' ' 88' ' ' LEU . 15.1 mt -118.76 144.43 46.28 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.68 177.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . 0.436 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 57.4 t30 -148.52 114.8 5.86 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 173.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . 0.401 ' CZ ' HD22 ' B' ' 67' ' ' LEU . 51.7 m-85 -110.14 164.56 12.52 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.12 -178.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 33.1 t -107.93 149.18 28.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 0.0 110.677 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . 0.436 ' HA ' HG22 ' B' ' 23' ' ' ILE . 0.0 OUTLIER -68.11 -11.95 60.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.271 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.28 -5.76 61.86 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.585 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -100.29 167.96 10.08 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -145.22 128.13 16.43 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.622 HG22 ' HB2' ' B' ' 46' ' ' ALA . 15.4 pt -134.84 165.44 31.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.082 0.467 . . . . 0.0 111.756 -169.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.52 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 4.5 mtm -120.91 123.61 42.93 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 173.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . 0.551 ' CD1' ' HB2' ' B' ' 44' ' ' LEU . 0.8 OUTLIER -106.02 127.62 53.29 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.441 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.67 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 40.4 p90 -154.9 144.19 21.16 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.993 -0.683 . . . . 0.0 112.034 -177.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.642 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 6.4 p -116.29 141.63 47.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.356 -177.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.72 153.41 22.99 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.241 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.79 -175.37 36.92 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -175.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -118.75 104.87 10.99 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.509 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.493 ' CB ' ' HA3' ' B' ' 37' ' ' GLY . . . -166.07 154.77 11.18 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.2 170.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 19.0 t -106.16 111.17 23.67 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.556 HG12 ' HB3' ' B' ' 34' ' ' LEU . 3.4 m -111.44 138.17 41.02 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 CA-C-O 121.3 0.571 . . . . 0.0 112.129 -174.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' B' ' 12' ' ' ASN . 7.4 t -108.94 118.25 36.32 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.793 178.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.626 HD13 HD23 ' B' ' 11' ' ' LEU . 5.4 mp -89.79 149.27 22.77 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.5 174.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.585 HD23 HD21 ' C' ' 67' ' ' LEU . 1.3 tp -131.99 140.69 49.04 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.971 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.41 -167.2 25.64 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.704 -177.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' TYR . . . . . 0.43 ' CD2' ' HB3' ' C' ' 68' ' ' ASN . 13.0 p90 -153.4 132.21 12.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.777 0.798 . . . . 0.0 111.603 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . 0.42 HD23 ' HB3' ' B' ' 27' ' ' PHE . 22.2 mt . . . . . 0 C--N 1.322 -0.591 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.131 173.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 38.4 mtt . . . . . 0 CA--C 1.519 -0.233 0 CA-C-O 121.104 0.478 . . . . 0.0 112.106 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 8' ' ' PHE . . . . . 0.502 ' CE1' HD21 ' D' ' 44' ' ' LEU . 28.9 t80 -62.35 145.78 52.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.492 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -135.65 147.44 48.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.177 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . 0.447 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -151.04 153.8 25.19 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.203 178.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.624 HD23 HD13 ' C' ' 87' ' ' LEU . 33.4 tp -147.78 106.57 3.82 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . 0.483 ' HA ' ' HA ' ' C' ' 86' ' ' SER . 2.3 p30 -97.91 110.67 23.2 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.681 0.753 . . . . 0.0 110.937 177.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 13' ' ' MET . . . . . 0.445 ' SD ' HG23 ' C' ' 79' ' ' THR . 7.2 mtt -85.25 142.17 29.59 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.019 -0.992 . . . . 0.0 111.324 -178.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . 0.431 ' HB2' ' HG3' ' C' ' 17' ' ' ARG . 91.4 mttt -89.67 144.17 31.45 Favored Pre-proline 0 C--N 1.315 -0.902 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 170.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -46.23 109.65 0.21 Allowed 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 123.503 2.802 . . . . 0.0 113.543 -174.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . 0.634 ' HA ' ' O ' ' C' ' 79' ' ' THR . 8.8 tt0 70.59 67.08 0.19 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.767 175.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 17' ' ' ARG . . . . . 0.527 ' NE ' ' HA ' ' C' ' 17' ' ' ARG . 4.7 mmp_? -122.76 169.22 11.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.133 175.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 18' ' ' LYS . . . . . 0.682 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 19.4 tttm -146.67 104.8 3.77 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.346 0.404 . . . . 0.0 111.305 -175.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -111.76 111.53 22.57 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.093 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 29.5 t -90.84 111.05 22.29 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 170.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -133.89 150.11 51.34 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.693 0.758 . . . . 0.0 112.645 -168.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 3.8 p -91.2 160.83 15.34 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.657 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . 0.445 HG22 ' HA ' ' C' ' 71' ' ' LYS . 74.1 mt -111.13 126.25 68.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.171 -174.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . 0.537 HD12 ' N ' ' C' ' 25' ' ' LYS . 1.8 pp -92.5 -24.38 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.69 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . 0.537 ' N ' HD12 ' C' ' 24' ' ' ILE . 24.8 mtpp -147.44 132.94 18.67 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.836 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 15.6 m -54.98 119.42 5.39 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 27' ' ' PHE . . . . . 0.421 ' HB3' HD23 ' C' ' 91' ' ' LEU . 5.8 p90 -137.38 156.63 47.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.694 0.759 . . . . 0.0 112.788 -170.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 28' ' ' HIS . . . . . 0.591 ' HA ' ' O ' ' C' ' 67' ' ' LEU . 15.1 t60 -109.9 124.61 51.66 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.244 -1.343 . . . . 0.0 110.101 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . 0.573 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 39.4 mt -94.45 134.99 30.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 169.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.589 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 50.0 p -120.2 -15.88 8.6 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -169.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 31' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -160.34 145.17 10.8 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.382 -1.389 . . . . 0.0 113.38 178.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.449 HG23 ' HG ' ' C' ' 87' ' ' LEU . 12.1 p -129.8 121.63 52.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 168.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.18 154.38 43.82 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.979 -173.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.555 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.4 pp -125.11 144.02 50.63 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.468 0.651 . . . . 0.0 110.787 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -110.16 -46.01 3.51 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -103.64 128.65 50.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.551 171.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 37' ' ' GLY . . . . . 0.483 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 146.67 163.0 10.18 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 119.664 -1.255 . . . . 0.0 113.576 176.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -102.25 -47.22 4.58 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.463 0.173 . . . . 0.0 110.976 177.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -152.16 133.75 14.65 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.063 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.469 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -134.35 113.42 11.89 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.362 0.601 . . . . 0.0 110.097 168.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -97.77 112.57 24.42 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 174.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 43.7 tp -83.76 113.32 20.82 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.577 -174.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 43' ' ' TYR . . . . . 0.529 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 98.0 m-85 -115.8 141.53 47.98 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.553 ' HB2' ' CD1' ' C' ' 77' ' ' PHE . 0.1 OUTLIER -129.91 131.79 46.15 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 173.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -110.74 114.85 28.53 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.981 177.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.597 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -129.86 142.47 50.66 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 58.78 29.17 18.36 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.89 0.376 . . . . 0.0 110.284 -174.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt 63.55 24.57 14.07 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.681 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 24.0 tp60 -115.67 126.67 54.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -83.42 124.85 31.09 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.869 0.366 . . . . 0.0 110.758 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . 0.504 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 66.8 m-85 -120.91 133.35 55.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 176.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -82.14 107.7 14.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 169.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 53' ' ' VAL . . . . . 0.509 HG13 ' CD2' ' B' ' 88' ' ' LEU . 2.4 t -80.07 -49.58 18.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.643 -171.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 54' ' ' ALA . . . . . 0.525 ' HB1' HG11 ' C' ' 63' ' ' VAL . . . -159.99 148.98 17.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.232 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 54.1 m -109.81 102.19 10.99 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 173.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . 0.412 ' CG1' HG11 ' C' ' 85' ' ' VAL . 7.4 p -117.69 114.39 45.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.653 0.739 . . . . 0.0 110.032 -177.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 81.2 p -123.05 -178.33 3.93 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.581 -174.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -63.57 -21.4 66.33 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.887 0.375 . . . . 0.0 110.491 170.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . 0.402 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -83.52 -40.67 18.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.166 0.508 . . . . 0.0 110.228 177.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 80.6 mt -113.28 82.71 5.94 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 174.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 61' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 12.5 Cg_exo -70.06 -0.13 6.71 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.15 2.567 . . . . 0.0 114.052 -167.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.3 127.18 2.44 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.146 0.498 . . . . 0.0 111.418 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.525 HG11 ' HB1' ' C' ' 54' ' ' ALA . 86.4 t -117.34 106.14 19.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.35 174.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.45 121.7 27.08 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 173.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' C' ' 30' ' ' SER . 0.6 OUTLIER -140.71 168.2 20.36 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.736 -172.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 66' ' ' ASP . . . . . 0.538 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 11.6 t0 -118.88 105.18 11.24 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.322 0.582 . . . . 0.0 110.569 -177.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.591 ' O ' ' HA ' ' C' ' 28' ' ' HIS . 15.2 mt -118.7 144.48 46.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.651 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . 0.43 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 57.4 t30 -148.55 114.74 5.83 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 173.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -110.09 164.5 12.57 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.122 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 33.1 t -107.85 149.2 28.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.371 . . . . 0.0 110.679 -177.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . 0.445 ' HA ' HG22 ' C' ' 23' ' ' ILE . 0.0 OUTLIER -68.19 -11.85 59.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.279 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.41 -5.8 61.63 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.565 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -100.13 167.9 10.16 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -145.2 128.14 16.45 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.597 HG22 ' HB2' ' C' ' 46' ' ' ALA . 15.3 pt -134.87 165.51 30.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.992 0.425 . . . . 0.0 111.75 -169.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.515 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 4.5 mtm -120.85 123.47 42.65 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.612 173.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 77' ' ' PHE . . . . . 0.553 ' CD1' ' HB2' ' C' ' 44' ' ' LEU . 0.8 OUTLIER -105.95 127.59 53.25 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.488 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 78' ' ' TYR . . . . . 0.682 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 40.5 p90 -154.92 144.16 21.12 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.086 -0.645 . . . . 0.0 111.994 -177.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . 0.634 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 6.6 p -116.19 141.54 48.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.351 -177.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.69 153.44 22.93 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.248 175.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.83 -175.47 36.95 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -175.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -118.73 104.83 10.96 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 122.191 0.996 . . . . 0.0 110.58 176.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . 0.483 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -166.1 154.82 11.16 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.188 170.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 19.9 t -106.29 111.29 23.82 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.555 HG12 ' HB3' ' C' ' 34' ' ' LEU . 3.4 m -111.48 138.16 41.11 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 CA-C-O 121.304 0.573 . . . . 0.0 112.137 -174.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' C' ' 12' ' ' ASN . 7.4 t -108.99 118.37 36.63 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.76 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . 0.624 HD13 HD23 ' C' ' 11' ' ' LEU . 5.4 mp -89.84 149.28 22.73 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.525 174.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . 0.592 HD23 HD21 ' D' ' 67' ' ' LEU . 1.3 tp -131.98 140.68 49.04 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.018 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.32 -167.12 25.42 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.683 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 90' ' ' TYR . . . . . 0.464 ' CD2' ' HB3' ' D' ' 68' ' ' ASN . 13.2 p90 -153.4 132.18 12.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.767 0.794 . . . . 0.0 111.656 177.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . 0.421 HD23 ' HB3' ' C' ' 27' ' ' PHE . 21.9 mt . . . . . 0 C--N 1.322 -0.596 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.195 173.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 38.3 mtt . . . . . 0 CA--C 1.518 -0.256 0 CA-C-O 121.233 0.539 . . . . 0.0 112.041 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 8' ' ' PHE . . . . . 0.494 ' CE1' HD21 ' E' ' 44' ' ' LEU . 29.4 t80 -62.34 145.77 52.96 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.507 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 9' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -135.75 147.4 48.41 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.079 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . 0.46 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -151.03 153.87 25.23 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.179 178.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . 0.614 HD23 HD13 ' D' ' 87' ' ' LEU . 33.6 tp -147.69 106.54 3.83 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.34 -0.245 . . . . 0.0 110.34 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . 0.482 ' HA ' ' HA ' ' D' ' 86' ' ' SER . 2.3 p30 -97.9 110.56 23.11 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.63 0.729 . . . . 0.0 110.979 177.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 13' ' ' MET . . . . . 0.435 ' SD ' HG23 ' D' ' 79' ' ' THR . 7.3 mtt -85.15 142.17 29.67 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.422 -178.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 14' ' ' LYS . . . . . 0.447 ' HB2' ' HG3' ' D' ' 17' ' ' ARG . 91.5 mttt -89.74 144.18 31.37 Favored Pre-proline 0 C--N 1.316 -0.891 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 170.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -46.27 109.73 0.22 Allowed 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 123.414 2.743 . . . . 0.0 113.605 -174.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . 0.619 ' HA ' ' O ' ' D' ' 79' ' ' THR . 8.9 tt0 70.61 67.07 0.19 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.762 175.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 17' ' ' ARG . . . . . 0.52 ' HA ' ' NE ' ' D' ' 17' ' ' ARG . 4.7 mmp_? -122.76 169.2 11.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.091 175.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . 0.689 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 19.4 tttm -146.69 104.79 3.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 123.292 0.37 . . . . 0.0 111.355 -175.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -111.69 111.55 22.62 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.115 -177.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 29.3 t -90.87 110.94 22.17 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -133.84 150.2 51.39 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.676 0.751 . . . . 0.0 112.743 -168.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 3.7 p -91.31 160.94 15.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.643 178.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . 0.43 HG22 ' HA ' ' D' ' 71' ' ' LYS . 73.8 mt -111.19 126.29 68.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.241 -174.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . 0.536 HD12 ' N ' ' D' ' 25' ' ' LYS . 1.8 pp -92.5 -24.41 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.765 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . 0.536 ' N ' HD12 ' D' ' 24' ' ' ILE . 24.8 mtpp -147.43 132.86 18.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.8 178.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 15.5 m -54.96 119.4 5.35 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 175.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 27' ' ' PHE . . . . . 0.42 ' HB3' HD23 ' D' ' 91' ' ' LEU . 5.9 p90 -137.38 156.74 47.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.789 0.804 . . . . 0.0 112.792 -170.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 28' ' ' HIS . . . . . 0.597 ' HE2' ' HB3' ' D' ' 30' ' ' SER . 15.2 t60 -109.98 124.7 51.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.221 -1.354 . . . . 0.0 110.07 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 29' ' ' ILE . . . . . 0.581 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 39.5 mt -94.55 135.05 29.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 169.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . 0.597 ' HB3' ' HE2' ' D' ' 28' ' ' HIS . 50.1 p -120.25 -15.89 8.57 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -169.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 31' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -160.27 145.16 10.81 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 119.374 -1.393 . . . . 0.0 113.366 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.458 HG23 ' HG ' ' D' ' 87' ' ' LEU . 12.1 p -129.85 121.61 52.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 168.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.06 154.41 43.93 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.94 -173.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 34' ' ' LEU . . . . . 0.553 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.4 pp -125.15 144.05 50.63 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.475 0.655 . . . . 0.0 110.777 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -110.17 -46.08 3.49 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 173.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -103.63 128.64 50.9 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.562 171.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . 0.493 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 146.63 163.07 10.22 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 119.682 -1.247 . . . . 0.0 113.559 176.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -102.29 -47.22 4.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.59 0.233 . . . . 0.0 111.011 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -152.12 133.67 14.63 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.059 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -134.35 113.44 11.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.455 0.645 . . . . 0.0 110.177 167.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' D' ' 79' ' ' THR . 98.6 mttt -97.77 112.67 24.48 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 43.5 tp -83.74 113.34 20.82 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.607 -174.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 43' ' ' TYR . . . . . 0.523 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 98.0 m-85 -115.77 141.48 48.03 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.554 ' HB2' ' CD1' ' D' ' 77' ' ' PHE . 0.1 OUTLIER -129.96 131.83 46.09 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 173.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 45' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -110.65 115.0 28.83 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.888 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.61 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -129.91 142.57 50.64 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 58.7 29.19 18.27 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.315 0.384 . . . . 0.0 110.28 -174.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt 63.61 24.48 13.98 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.711 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . 0.47 ' HG3' HD21 ' C' ' 12' ' ' ASN . 24.1 tp60 -115.73 126.64 54.33 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -83.39 124.85 31.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.807 0.336 . . . . 0.0 110.755 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . 0.447 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 66.7 m-85 -120.89 133.35 55.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.904 176.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.0 tp -82.06 107.72 14.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 169.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 53' ' ' VAL . . . . . 0.499 HG13 ' CD2' ' C' ' 88' ' ' LEU . 2.4 t -80.09 -49.6 18.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.589 -171.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 54' ' ' ALA . . . . . 0.521 ' HB1' HG11 ' D' ' 63' ' ' VAL . . . -160.01 148.93 17.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.173 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 53.3 m -109.81 102.28 11.08 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 56' ' ' VAL . . . . . 0.406 ' CG1' HG11 ' D' ' 85' ' ' VAL . 7.4 p -117.74 114.33 45.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.612 0.72 . . . . 0.0 109.981 -177.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 81.2 p -123.05 -178.27 3.91 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.523 -174.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -63.57 -21.46 66.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.944 0.402 . . . . 0.0 110.461 170.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 59' ' ' ALA . . . . . 0.405 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -83.51 -40.62 18.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.124 0.488 . . . . 0.0 110.222 177.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 80.3 mt -113.29 82.6 5.88 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 174.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 61' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 12.4 Cg_exo -69.99 -0.18 6.73 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.186 2.591 . . . . 0.0 114.114 -167.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.25 127.1 2.45 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.112 0.482 . . . . 0.0 111.483 -176.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.521 HG11 ' HB1' ' D' ' 54' ' ' ALA . 87.2 t -117.3 106.09 19.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.426 174.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.48 121.73 27.13 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 173.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 65' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' D' ' 30' ' ' SER . 0.6 OUTLIER -140.72 168.2 20.35 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.728 -173.034 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 66' ' ' ASP . . . . . 0.576 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 11.9 t0 -118.82 105.23 11.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.251 0.548 . . . . 0.0 110.586 -177.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.592 HD21 HD23 ' C' ' 88' ' ' LEU . 15.1 mt -118.8 144.43 46.32 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.674 177.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 68' ' ' ASN . . . . . 0.464 ' HB3' ' CD2' ' C' ' 90' ' ' TYR . 57.3 t30 -148.47 114.83 5.89 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 173.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 69' ' ' PHE . . . . . 0.4 ' CZ ' HD22 ' D' ' 67' ' ' LEU . 51.8 m-85 -110.15 164.58 12.5 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.106 -178.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 33.0 t -107.97 149.12 28.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.856 0.36 . . . . 0.0 110.723 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 71' ' ' LYS . . . . . 0.43 ' HA ' HG22 ' D' ' 23' ' ' ILE . 0.0 OUTLIER -67.94 -12.03 59.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.344 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.35 -5.73 61.77 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.526 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -100.2 167.92 10.13 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -145.21 128.16 16.46 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.61 HG22 ' HB2' ' D' ' 46' ' ' ALA . 15.4 pt -134.92 165.39 31.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.077 0.465 . . . . 0.0 111.771 -169.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 76' ' ' MET . . . . . 0.521 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 4.5 mtm -120.85 123.5 42.72 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 173.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 77' ' ' PHE . . . . . 0.554 ' CD1' ' HB2' ' D' ' 44' ' ' LEU . 0.8 OUTLIER -106.02 127.59 53.27 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.502 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 78' ' ' TYR . . . . . 0.689 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 40.8 p90 -154.93 144.16 21.11 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.967 -177.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 79' ' ' THR . . . . . 0.619 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 6.5 p -116.22 141.61 47.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.364 -177.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.69 153.31 23.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.289 176.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.92 -175.36 36.7 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -175.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -118.81 104.97 11.05 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 118.114 0.957 . . . . 0.0 110.46 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . 0.493 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -166.15 154.77 11.02 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.204 170.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 19.9 t -106.25 111.23 23.74 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.553 HG12 ' HB3' ' D' ' 34' ' ' LEU . 3.4 m -111.43 138.11 41.24 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.706 0 CA-C-O 121.289 0.566 . . . . 0.0 112.144 -174.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 86' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' D' ' 12' ' ' ASN . 7.4 t -108.9 118.31 36.47 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.353 -0.84 . . . . 0.0 108.791 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 87' ' ' LEU . . . . . 0.614 HD13 HD23 ' D' ' 11' ' ' LEU . 5.4 mp -89.76 149.31 22.78 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.524 174.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.572 HD23 HD21 ' E' ' 67' ' ' LEU . 1.3 tp -132.05 140.68 48.97 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.956 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.32 -167.08 25.36 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.683 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 90' ' ' TYR . . . . . 0.442 ' CD2' ' HB3' ' E' ' 68' ' ' ASN . 13.0 p90 -153.42 132.13 12.31 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.74 0.781 . . . . 0.0 111.636 177.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . 0.42 HD23 ' HB3' ' D' ' 27' ' ' PHE . 22.4 mt . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.088 173.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 38.6 mtt . . . . . 0 CA--C 1.52 -0.205 0 CA-C-O 121.214 0.53 . . . . 0.0 112.096 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' E' E ' 8' ' ' PHE . . . . . 0.493 ' CE1' HD21 ' A' ' 44' ' ' LEU . 29.0 t80 -62.4 145.77 53.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.492 -178.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 9' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -135.72 147.38 48.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.096 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 10' ' ' GLY . . . . . 0.465 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -151.0 153.81 25.2 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.273 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 11' ' ' LEU . . . . . 0.617 HD23 HD13 ' E' ' 87' ' ' LEU . 33.2 tp -147.77 106.6 3.83 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 12' ' ' ASN . . . . . 0.487 ' HA ' ' HA ' ' E' ' 86' ' ' SER . 2.3 p30 -97.82 110.6 23.14 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.605 0.717 . . . . 0.0 110.987 176.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 13' ' ' MET . . . . . 0.438 ' SD ' HG23 ' E' ' 79' ' ' THR . 7.2 mtt -85.26 142.15 29.6 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.31 -178.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 14' ' ' LYS . . . . . 0.424 ' HB2' ' HG3' ' E' ' 17' ' ' ARG . 91.5 mttt -89.71 144.21 31.47 Favored Pre-proline 0 C--N 1.315 -0.919 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 170.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -46.29 109.66 0.22 Allowed 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 123.519 2.813 . . . . 0.0 113.613 -174.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 16' ' ' GLU . . . . . 0.632 ' HA ' ' O ' ' E' ' 79' ' ' THR . 8.8 tt0 70.56 67.1 0.19 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.762 175.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 17' ' ' ARG . . . . . 0.529 ' HA ' ' NE ' ' E' ' 17' ' ' ARG . 4.7 mmp_? -122.79 169.2 11.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.013 175.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . 0.673 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 19.4 tttm -146.68 104.89 3.78 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.36 0.413 . . . . 0.0 111.303 -175.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -111.81 111.55 22.6 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.071 -177.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 20' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' E' ' 76' ' ' MET . 28.9 t -90.82 111.0 22.21 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -133.84 150.1 51.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.661 0.743 . . . . 0.0 112.721 -168.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 3.9 p -91.18 160.9 15.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.649 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 23' ' ' ILE . . . . . 0.443 HG22 ' HA ' ' E' ' 71' ' ' LYS . 73.9 mt -111.14 126.26 68.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.176 -174.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . 0.523 HD12 ' N ' ' E' ' 25' ' ' LYS . 1.8 pp -92.55 -24.3 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.723 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . 0.523 ' N ' HD12 ' E' ' 24' ' ' ILE . 24.8 mtpp -147.56 132.96 18.57 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 15.5 m -54.9 119.4 5.33 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 27' ' ' PHE . . . . . 0.428 ' HB3' HD23 ' E' ' 91' ' ' LEU . 5.8 p90 -137.4 156.67 47.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.725 0.774 . . . . 0.0 112.792 -170.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 28' ' ' HIS . . . . . 0.585 ' HE2' ' HB3' ' E' ' 30' ' ' SER . 15.1 t60 -109.94 124.59 51.65 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.108 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 29' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 39.3 mt -94.43 135.06 29.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 169.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . 0.585 ' HB3' ' HE2' ' E' ' 28' ' ' HIS . 50.2 p -120.26 -15.87 8.57 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -169.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 31' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -160.32 145.21 10.86 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.314 -1.422 . . . . 0.0 113.361 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.454 HG23 ' HG ' ' E' ' 87' ' ' LEU . 12.0 p -129.92 121.65 52.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 168.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.1 154.37 43.86 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.955 -173.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 34' ' ' LEU . . . . . 0.554 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.4 pp -125.13 144.0 50.64 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.5 0.667 . . . . 0.0 110.836 177.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -110.24 -45.96 3.5 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 173.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -103.67 128.57 50.99 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.56 171.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . 0.496 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 146.7 163.0 10.19 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 119.641 -1.266 . . . . 0.0 113.57 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -102.25 -47.15 4.6 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.164 -0.214 . . . . 0.0 111.001 177.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -152.1 133.72 14.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.739 -0.21 . . . . 0.0 111.056 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . 0.48 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -134.37 113.45 11.91 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.364 0.602 . . . . 0.0 110.167 167.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 41' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' E' ' 79' ' ' THR . 98.6 mttt -97.86 112.66 24.49 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 174.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 43.1 tp -83.72 113.3 20.79 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.59 -174.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 43' ' ' TYR . . . . . 0.525 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 98.0 m-85 -115.77 141.47 48.05 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 44' ' ' LEU . . . . . 0.552 ' HB2' ' CD1' ' E' ' 77' ' ' PHE . 0.1 OUTLIER -129.95 131.89 46.13 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 173.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 45' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -110.78 114.95 28.7 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.994 177.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . 0.601 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -129.86 142.49 50.66 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 58.79 29.19 18.4 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.372 0.42 . . . . 0.0 110.224 -174.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt 63.56 24.61 14.08 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.709 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 49' ' ' GLN . . . . . 0.473 ' HG3' HD21 ' D' ' 12' ' ' ASN . 24.1 tp60 -115.67 126.69 54.46 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -83.4 124.83 31.06 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.86 0.362 . . . . 0.0 110.724 -177.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . 0.46 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 66.2 m-85 -120.84 133.35 55.31 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.0 tp -82.12 107.65 14.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 169.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . 0.493 HG13 ' CD2' ' D' ' 88' ' ' LEU . 2.4 t -80.01 -49.58 18.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.663 -171.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 54' ' ' ALA . . . . . 0.538 ' HB1' HG11 ' E' ' 63' ' ' VAL . . . -160.01 148.96 17.44 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.099 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 54.4 m -109.86 102.24 11.03 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 173.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . 0.411 ' CG1' HG11 ' E' ' 85' ' ' VAL . 7.4 p -117.76 114.27 44.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.625 0.726 . . . . 0.0 110.004 -177.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 81.1 p -123.06 -178.3 3.92 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.551 -174.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -63.58 -21.4 66.33 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.838 0.352 . . . . 0.0 110.414 170.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 59' ' ' ALA . . . . . 0.403 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -83.55 -40.53 19.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.198 0.523 . . . . 0.0 110.245 177.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 80.6 mt -113.4 82.7 6.12 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 174.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 61' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 12.6 Cg_exo -70.16 -0.17 6.85 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.106 2.537 . . . . 0.0 114.013 -167.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.15 127.15 2.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.163 0.506 . . . . 0.0 111.477 -176.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . 0.538 HG11 ' HB1' ' E' ' 54' ' ' ALA . 86.4 t -117.38 106.11 19.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.405 174.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.51 121.76 27.19 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 173.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 65' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' E' ' 30' ' ' SER . 0.6 OUTLIER -140.7 168.18 20.4 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.711 -173.044 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 66' ' ' ASP . . . . . 0.543 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 11.7 t0 -118.83 105.18 11.26 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.267 0.556 . . . . 0.0 110.532 -177.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 67' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' E' ' 28' ' ' HIS . 15.2 mt -118.74 144.51 46.21 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.65 177.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 68' ' ' ASN . . . . . 0.442 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 57.3 t30 -148.53 114.73 5.84 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 173.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 69' ' ' PHE . . . . . 0.401 ' CZ ' HD22 ' E' ' 67' ' ' LEU . 51.4 m-85 -110.06 164.53 12.53 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.187 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 33.0 t -107.91 149.17 28.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.836 0.351 . . . . 0.0 110.687 -177.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 71' ' ' LYS . . . . . 0.443 ' HA ' HG22 ' E' ' 23' ' ' ILE . 0.0 OUTLIER -68.06 -11.91 59.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.345 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.38 -5.81 61.68 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.583 175.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -100.02 167.91 10.18 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -145.19 128.11 16.44 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 75' ' ' ILE . . . . . 0.601 HG22 ' HB2' ' E' ' 46' ' ' ALA . 15.3 pt -134.93 165.51 30.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.094 0.473 . . . . 0.0 111.763 -169.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 76' ' ' MET . . . . . 0.514 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 4.5 mtm -120.92 123.5 42.63 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 173.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 77' ' ' PHE . . . . . 0.552 ' CD1' ' HB2' ' E' ' 44' ' ' LEU . 0.7 OUTLIER -106.03 127.6 53.28 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 78' ' ' TYR . . . . . 0.673 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 40.7 p90 -154.93 144.13 21.09 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.958 -177.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 79' ' ' THR . . . . . 0.632 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 6.5 p -116.18 141.54 48.01 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.396 -177.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.59 153.4 22.94 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.319 176.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.93 -175.41 36.73 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -175.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -118.76 104.84 10.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 118.12 0.96 . . . . 0.0 110.527 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 83' ' ' ALA . . . . . 0.496 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -166.1 154.83 11.17 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.182 170.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 19.5 t -106.21 111.23 23.74 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 85' ' ' VAL . . . . . 0.554 HG12 ' HB3' ' E' ' 34' ' ' LEU . 3.4 m -111.48 138.23 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 CA-C-O 121.348 0.594 . . . . 0.0 112.095 -174.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 86' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' E' ' 12' ' ' ASN . 7.4 t -108.95 118.19 36.16 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.8 178.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 87' ' ' LEU . . . . . 0.617 HD13 HD23 ' E' ' 11' ' ' LEU . 5.4 mp -89.8 149.22 22.79 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.566 174.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . 0.591 HD23 HD21 ' A' ' 67' ' ' LEU . 1.3 tp -131.91 140.71 49.13 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.022 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.34 -167.14 25.47 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.776 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 90' ' ' TYR . . . . . 0.447 ' CD2' ' HB3' ' A' ' 68' ' ' ASN . 12.9 p90 -153.36 132.27 12.46 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.712 0.768 . . . . 0.0 111.604 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 91' ' ' LEU . . . . . 0.428 HD23 ' HB3' ' E' ' 27' ' ' PHE . 22.0 mt . . . . . 0 C--N 1.321 -0.644 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.177 173.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.559 ' HA ' ' OG ' ' B' ' 70' ' ' SER . 16.5 ttt . . . . . 0 CA--C 1.529 0.165 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.568 ' CE1' HD12 ' A' ' 88' ' ' LEU . 54.1 t80 -79.66 129.7 34.71 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.062 0.458 . . . . 0.0 112.102 -177.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.537 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 87.8 t90 -113.82 148.49 36.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.596 174.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.19 145.55 13.96 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.258 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.644 HD23 HD13 ' A' ' 87' ' ' LEU . 58.5 tp -139.09 110.25 6.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.027 0.441 . . . . 0.0 110.93 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -86.04 116.41 24.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.958 176.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.634 ' HB2' HG23 ' A' ' 85' ' ' VAL . 4.1 mmt -98.52 130.81 45.1 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.455 ' HD2' ' HD2' ' A' ' 15' ' ' PRO . 48.2 tptt -100.55 132.06 22.89 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 174.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.543 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 2.0 Cg_endo -46.25 117.68 2.07 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.539 2.826 . . . . 0.0 113.476 -175.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.662 ' HA ' ' O ' ' A' ' 79' ' ' THR . 37.8 mt-10 64.14 56.24 1.4 Allowed 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.411 178.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.86 135.31 52.78 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.63 172.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.738 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 82.8 mttt -103.73 115.71 30.98 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 123.313 0.383 . . . . 0.0 111.272 177.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -105.52 102.9 12.33 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 p -89.36 98.93 12.04 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 173.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -111.83 146.39 37.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.229 -167.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.8 m -100.45 143.06 31.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.282 174.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.476 ' CD1' ' HB2' ' A' ' 69' ' ' PHE . 54.0 mt -108.52 125.84 65.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.202 0.525 . . . . 0.0 111.772 -172.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.454 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.2 mp -102.22 -50.6 9.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.395 -0.821 . . . . 0.0 108.852 176.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.528 ' HD2' HD22 ' A' ' 91' ' ' LEU . 12.7 pttp -103.21 122.41 44.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.552 174.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.6 t -60.94 142.71 56.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.964 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.488 ' HB3' HD23 ' A' ' 91' ' ' LEU . 54.6 p90 -147.8 148.27 30.74 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -177.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.538 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 2.1 t60 -102.65 125.18 49.29 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 114.147 -1.388 . . . . 0.0 109.601 176.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 47.0 mt -87.34 131.24 35.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 172.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.538 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 95.3 p -116.59 -12.25 10.97 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -169.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . 179.99 158.72 22.51 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 119.166 -1.492 . . . . 0.0 113.702 177.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.462 HG23 ' HG ' ' A' ' 87' ' ' LEU . 11.0 p -141.29 138.97 33.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 175.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -152.95 156.17 38.38 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 121.97 -0.457 . . . . 0.0 111.886 -177.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.702 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.1 pp -125.31 148.04 48.88 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.501 0.667 . . . . 0.0 111.911 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -110.64 -55.15 2.51 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.133 169.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -100.84 127.91 47.1 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.211 174.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.495 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 150.48 162.98 10.93 Favored Glycine 0 N--CA 1.434 -1.495 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.533 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.407 ' HA ' ' HD2' ' A' ' 58' ' ' LYS . 25.7 mt-30 -102.56 -47.04 4.57 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.713 0.292 . . . . 0.0 111.018 176.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -152.48 132.51 13.42 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.344 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.527 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -127.28 113.28 16.08 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.436 0.636 . . . . 0.0 110.061 168.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 79' ' ' THR . 97.5 mttt -95.34 112.02 23.8 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.443 HD21 HD21 ' A' ' 87' ' ' LEU . 34.5 tp -86.12 107.48 17.87 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -174.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -107.4 146.11 32.08 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.741 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.652 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 1.5 tp -129.98 116.32 18.42 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.665 176.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.55 109.28 21.12 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.436 ' HB2' HD11 ' A' ' 44' ' ' LEU . . . -143.14 150.05 38.91 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.423 -177.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 57.35 30.99 19.44 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.35 0.595 . . . . 0.0 109.98 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 61.2 40.49 14.6 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.204 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -144.16 136.59 26.73 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -87.35 117.72 26.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.936 0.398 . . . . 0.0 110.042 178.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -112.76 122.97 49.23 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.673 178.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -80.82 100.9 5.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 170.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.48 HG12 ' CD2' ' E' ' 88' ' ' LEU . 21.6 m -86.45 -33.19 7.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.749 -172.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.729 ' HB2' HD21 ' A' ' 65' ' ' LEU . . . -153.19 144.59 23.23 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 120.28 -0.568 . . . . 0.0 112.214 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.2 m -115.51 102.47 9.83 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 169.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.428 HG13 ' HB3' ' A' ' 40' ' ' ALA . 8.9 p -116.18 114.21 45.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.744 0.783 . . . . 0.0 110.15 -177.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 69.1 p -123.18 -177.12 3.6 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.963 -175.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 38' ' ' GLN . 27.3 mtpp -59.37 -35.89 74.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.035 0.445 . . . . 0.0 109.971 169.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.419 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -71.23 -40.59 71.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.498 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.2 mt -114.31 82.33 7.34 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 17.3 Cg_exo -67.31 -6.65 16.83 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.208 2.605 . . . . 0.0 113.891 -168.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -161.49 132.09 5.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.262 0.554 . . . . 0.0 111.164 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 87.5 t -119.74 118.6 57.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.543 176.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.76 128.15 33.32 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.729 HD21 ' HB2' ' A' ' 54' ' ' ALA . 86.2 mt -120.21 163.82 17.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.457 0.646 . . . . 0.0 112.25 -172.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -140.86 97.4 3.18 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.548 169.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 2.8 mt -131.19 156.34 45.49 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.528 ' HB2' ' CZ ' ' E' ' 90' ' ' TYR . 42.7 t-20 -155.32 128.79 8.41 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.476 ' HB2' ' CD1' ' A' ' 23' ' ' ILE . 4.3 m-85 -124.03 145.05 49.47 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.522 ' OG ' ' HA ' ' E' ' 7' ' ' MET . 37.2 m -100.4 -178.53 3.84 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -175.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -62.34 -30.95 71.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.222 0.534 . . . . 0.0 110.345 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.82 4.44 85.03 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.661 -0.7 . . . . 0.0 113.074 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -99.94 119.59 38.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 117.171 0.485 . . . . 0.0 110.791 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -111.96 106.29 14.94 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 173.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.409 HG22 ' CB ' ' A' ' 46' ' ' ALA . 10.9 pt -120.91 168.07 13.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.163 -167.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.9 mtm -122.27 125.98 47.17 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 171.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.652 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -107.9 127.72 53.99 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 175.003 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.738 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 53.4 p90 -155.68 140.43 17.08 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 119.845 -0.742 . . . . 0.0 112.193 -175.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.662 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 12.0 p -106.09 138.85 41.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.958 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.4 ' HB3' ' HB2' ' A' ' 41' ' ' LYS . . . -107.09 153.23 22.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.413 174.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.4 ' O ' ' HG3' ' A' ' 16' ' ' GLU . . . 93.45 -173.52 34.13 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -177.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -113.54 103.83 11.65 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.846 177.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.543 ' H ' ' HB3' ' A' ' 15' ' ' PRO . . . -170.87 153.65 4.0 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.89 169.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.7 p -110.23 123.23 49.4 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.15 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.702 HG12 ' HB3' ' A' ' 34' ' ' LEU . 10.9 m -124.74 153.35 31.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-O 121.459 0.647 . . . . 0.0 112.375 -173.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.5 m -113.26 126.78 55.78 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.854 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.644 HD13 HD23 ' A' ' 11' ' ' LEU . 4.6 mp -101.91 147.47 26.49 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 169.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.568 HD12 ' CE1' ' A' ' 8' ' ' PHE . 2.3 mm? -125.22 154.3 41.81 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 173.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.67 -168.81 25.15 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 119.755 -1.212 . . . . 0.0 114.193 -178.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.536 ' CZ ' ' HB2' ' B' ' 68' ' ' ASN . 3.2 m-85 -117.56 118.92 33.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.344 -0.928 . . . . 0.0 110.392 -176.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.528 HD22 ' HD2' ' A' ' 25' ' ' LYS . 16.5 mt . . . . . 0 C--N 1.317 -0.819 0 CA-C-O 121.12 0.486 . . . . 0.0 110.337 172.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . 0.578 ' HA ' ' OG ' ' C' ' 70' ' ' SER . 16.6 ttt . . . . . 0 N--CA 1.456 -0.163 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . 0.572 ' CZ ' HD21 ' C' ' 44' ' ' LEU . 54.4 t80 -79.51 129.72 34.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.034 0.445 . . . . 0.0 112.117 -177.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . 0.531 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 88.0 t90 -113.94 148.49 36.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.48 174.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.16 145.69 14.25 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.246 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.629 HD23 HD13 ' B' ' 87' ' ' LEU . 58.3 tp -139.16 110.12 6.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.941 0.4 . . . . 0.0 110.968 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -86.05 116.39 24.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.941 176.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . 0.62 ' HB2' HG23 ' B' ' 85' ' ' VAL . 4.1 mmt -98.43 130.78 45.05 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -176.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.465 ' HD2' ' HD2' ' B' ' 15' ' ' PRO . 48.2 tptt -100.59 132.09 22.82 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 174.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.546 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 2.1 Cg_endo -46.24 117.82 2.14 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.441 2.761 . . . . 0.0 113.533 -175.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.666 ' HA ' ' O ' ' B' ' 79' ' ' THR . 37.9 mt-10 63.98 56.19 1.47 Allowed 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.492 178.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.75 135.29 52.86 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.644 172.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.734 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 82.8 mttt -103.76 115.72 30.99 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 123.366 0.416 . . . . 0.0 111.236 177.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -105.49 102.82 12.26 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 14.7 p -89.3 98.84 11.99 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 173.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -111.78 146.39 37.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.389 0.614 . . . . 0.0 112.28 -167.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 28.9 m -100.43 143.1 31.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.249 174.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.468 ' CD1' ' HB2' ' B' ' 69' ' ' PHE . 54.2 mt -108.55 125.92 65.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.278 0.561 . . . . 0.0 111.748 -172.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.461 ' N ' HD12 ' B' ' 24' ' ' ILE . 4.2 mp -102.29 -50.56 9.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.825 176.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.531 ' HD2' HD22 ' B' ' 91' ' ' LEU . 12.8 pttp -103.13 122.31 44.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.63 174.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 35.6 t -60.97 142.73 56.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.95 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . 0.481 ' HB3' HD23 ' B' ' 91' ' ' LEU . 54.6 p90 -147.83 148.24 30.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.963 0.887 . . . . 0.0 113.296 -177.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' HIS . . . . . 0.537 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 2.1 t60 -102.55 125.15 49.17 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.692 176.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.5 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 46.8 mt -87.29 131.28 35.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 172.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.537 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 94.9 p -116.63 -12.33 10.92 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -169.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . 180.0 158.68 22.46 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 119.235 -1.46 . . . . 0.0 113.787 177.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.466 HG23 ' HG ' ' B' ' 87' ' ' LEU . 11.0 p -141.32 138.95 33.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 175.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -152.95 156.18 38.39 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.983 -0.448 . . . . 0.0 111.891 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.718 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.1 pp -125.31 148.03 48.88 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.52 0.676 . . . . 0.0 111.949 178.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -110.55 -55.3 2.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.129 169.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -100.79 128.06 46.98 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.26 174.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.492 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 150.42 163.02 10.95 Favored Glycine 0 N--CA 1.435 -1.423 0 C-N-CA 120.371 -0.918 . . . . 0.0 112.424 177.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -102.67 -46.94 4.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.647 0.26 . . . . 0.0 111.003 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -152.52 132.55 13.41 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.344 177.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.534 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -127.27 113.25 16.06 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.362 0.601 . . . . 0.0 110.166 167.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' B' ' 79' ' ' THR . 97.5 mttt -95.41 112.04 23.82 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.45 HD21 HD21 ' B' ' 87' ' ' LEU . 34.6 tp -86.15 107.47 17.88 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.711 -174.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -107.45 146.12 32.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.697 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.645 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 1.5 tp -129.94 116.39 18.55 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.69 176.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.57 109.24 21.07 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.203 0.525 . . . . 0.0 109.654 176.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.436 ' HB2' HD11 ' B' ' 44' ' ' LEU . . . -143.03 150.03 39.04 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.449 -177.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 57.41 30.88 19.31 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.44 0.638 . . . . 0.0 110.091 -179.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 61.18 40.55 14.59 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.213 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -144.19 136.74 26.83 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -87.43 117.67 26.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.867 0.365 . . . . 0.0 110.038 178.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -112.73 122.98 49.25 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.698 178.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -80.82 100.91 5.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 170.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.485 HG12 ' CD2' ' A' ' 88' ' ' LEU . 21.5 m -86.52 -33.13 6.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.748 -172.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.745 ' HB2' HD21 ' B' ' 65' ' ' LEU . . . -153.12 144.54 23.27 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 120.284 -0.566 . . . . 0.0 112.208 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 27.2 m -115.55 102.4 9.75 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 169.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . 0.435 HG13 ' HB3' ' B' ' 40' ' ' ALA . 9.0 p -116.03 114.18 45.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.771 0.796 . . . . 0.0 110.149 -177.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 69.5 p -123.21 -177.19 3.62 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.905 -175.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -59.34 -35.87 74.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.06 0.457 . . . . 0.0 110.064 169.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.414 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -71.15 -40.6 71.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.538 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 79.0 mt -114.32 82.27 7.3 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 17.2 Cg_exo -67.22 -6.77 17.02 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.329 2.686 . . . . 0.0 113.795 -168.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -161.44 132.12 5.15 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.409 0.623 . . . . 0.0 111.188 -175.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 87.8 t -119.77 118.75 58.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.532 176.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.86 128.15 33.34 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.745 HD21 ' HB2' ' B' ' 54' ' ' ALA . 86.0 mt -120.22 163.79 17.23 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.426 0.632 . . . . 0.0 112.297 -172.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -140.83 97.38 3.18 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.254 -0.884 . . . . 0.0 108.628 169.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' B' ' 28' ' ' HIS . 2.7 mt -131.19 156.3 45.57 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 42.7 t-20 -155.32 128.68 8.36 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 174.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . 0.468 ' HB2' ' CD1' ' B' ' 23' ' ' ILE . 4.2 m-85 -123.88 145.05 49.38 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.559 ' OG ' ' HA ' ' A' ' 7' ' ' MET . 37.6 m -100.41 -178.54 3.84 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -175.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -62.31 -30.98 71.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.301 0.572 . . . . 0.0 110.31 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.91 4.53 85.08 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.696 -0.683 . . . . 0.0 113.022 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -100.06 119.56 38.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.058 0.456 . . . . 0.0 110.79 178.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -111.91 106.33 15.01 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 173.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.404 HG22 ' CB ' ' B' ' 46' ' ' ALA . 10.8 pt -121.02 168.0 13.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.193 -167.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . . . . . . . . . 3.8 mtm -122.21 125.92 47.12 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 171.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . 0.645 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.3 OUTLIER -107.94 127.8 54.07 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 175.006 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.734 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 53.8 p90 -155.75 140.32 16.91 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 119.858 -0.737 . . . . 0.0 112.191 -175.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.666 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 12.1 p -105.98 138.8 41.54 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.975 -179.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.16 153.17 23.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.429 174.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.6 -173.5 33.89 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -113.53 103.88 11.71 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.832 177.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.546 ' H ' ' HB3' ' B' ' 15' ' ' PRO . . . -170.9 153.64 3.96 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.845 169.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 5.4 p -110.22 123.17 49.29 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.207 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.718 HG12 ' HB3' ' B' ' 34' ' ' LEU . 10.9 m -124.74 153.25 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-O 121.473 0.654 . . . . 0.0 112.364 -173.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 28.6 m -113.2 126.81 55.83 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.816 175.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.629 HD13 HD23 ' B' ' 11' ' ' LEU . 4.6 mp -101.98 147.46 26.54 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 169.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.565 HD13 ' O ' ' B' ' 87' ' ' LEU . 2.3 mm? -125.21 154.14 42.05 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 173.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.64 -168.73 24.99 Favored Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 119.776 -1.202 . . . . 0.0 114.21 -178.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 90' ' ' TYR . . . . . 0.538 ' CZ ' ' HB2' ' C' ' 68' ' ' ASN . 3.2 m-85 -117.55 118.91 33.45 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.348 -0.926 . . . . 0.0 110.396 -176.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . 0.531 HD22 ' HD2' ' B' ' 25' ' ' LYS . 16.4 mt . . . . . 0 C--N 1.316 -0.852 0 CA-C-O 121.164 0.507 . . . . 0.0 110.336 172.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 7' ' ' MET . . . . . 0.507 ' HA ' ' OG ' ' D' ' 70' ' ' SER . 16.6 ttt . . . . . 0 N--CA 1.456 -0.151 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 8' ' ' PHE . . . . . 0.564 ' CE1' HD12 ' C' ' 88' ' ' LEU . 54.6 t80 -79.55 129.77 34.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.994 0.426 . . . . 0.0 112.093 -177.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . 0.534 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 87.9 t90 -114.01 148.52 36.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.456 174.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.23 145.58 14.0 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.286 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.632 HD23 HD13 ' C' ' 87' ' ' LEU . 58.3 tp -139.11 110.15 6.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.981 0.419 . . . . 0.0 110.937 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -86.01 116.37 24.18 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.98 176.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 13' ' ' MET . . . . . 0.634 ' HB2' HG23 ' C' ' 85' ' ' VAL . 4.1 mmt -98.48 130.74 45.08 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -176.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . 0.444 ' HD2' ' HD2' ' C' ' 15' ' ' PRO . 48.2 tptt -100.58 132.18 22.71 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 174.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . 0.543 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 2.0 Cg_endo -46.4 117.84 2.21 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.479 2.786 . . . . 0.0 113.52 -175.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . 0.667 ' HA ' ' O ' ' C' ' 79' ' ' THR . 38.0 mt-10 64.14 56.03 1.43 Allowed 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.481 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.75 135.31 52.88 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.64 173.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 18' ' ' LYS . . . . . 0.742 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 82.7 mttt -103.74 115.87 31.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.157 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -105.56 102.81 12.25 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 175.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 15.3 p -89.43 98.92 12.04 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 173.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -111.82 146.46 37.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.178 -167.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 28.7 m -100.54 143.18 31.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.253 174.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . 0.475 ' CD1' ' HB2' ' C' ' 69' ' ' PHE . 53.8 mt -108.58 125.89 65.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.236 0.541 . . . . 0.0 111.722 -172.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . 0.455 HD12 ' N ' ' C' ' 24' ' ' ILE . 4.2 mp -102.28 -50.59 9.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.43 -0.804 . . . . 0.0 108.88 176.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . 0.535 ' HD2' HD22 ' C' ' 91' ' ' LEU . 12.8 pttp -103.17 122.27 44.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.616 174.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 35.6 t -60.88 142.77 55.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.02 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 27' ' ' PHE . . . . . 0.487 ' HB3' HD23 ' C' ' 91' ' ' LEU . 54.7 p90 -147.87 148.28 30.68 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -177.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 28' ' ' HIS . . . . . 0.539 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 2.1 t60 -102.62 125.25 49.28 Favored 'General case' 0 C--O 1.217 -0.658 0 CA-C-N 114.084 -1.416 . . . . 0.0 109.645 176.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . 0.495 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 46.7 mt -87.33 131.36 35.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 172.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.539 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 94.6 p -116.73 -12.24 10.87 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -169.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 31' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . 179.99 158.73 22.53 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 119.073 -1.536 . . . . 0.0 113.651 177.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.467 HG23 ' HG ' ' C' ' 87' ' ' LEU . 11.0 p -141.27 138.93 33.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 175.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -152.92 156.22 38.51 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.98 -0.45 . . . . 0.0 111.94 -177.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.718 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.1 pp -125.35 148.03 48.91 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.571 0.7 . . . . 0.0 111.892 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -110.62 -55.12 2.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.162 169.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -100.92 127.98 47.15 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.157 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 37' ' ' GLY . . . . . 0.484 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 150.49 163.04 10.97 Favored Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 120.333 -0.936 . . . . 0.0 112.461 177.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -102.67 -47.03 4.55 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.567 0.222 . . . . 0.0 111.001 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -152.42 132.54 13.5 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.364 177.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.527 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -127.28 113.24 16.04 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.42 0.629 . . . . 0.0 110.113 168.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' C' ' 79' ' ' THR . 97.5 mttt -95.37 112.06 23.83 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 175.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.446 HD21 HD21 ' C' ' 87' ' ' LEU . 34.6 tp -86.17 107.48 17.9 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -174.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -107.47 146.14 32.15 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.7 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.657 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 1.5 tp -129.98 116.3 18.39 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.67 176.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.53 109.3 21.14 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.166 0.508 . . . . 0.0 109.668 176.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.431 ' HB2' HD11 ' C' ' 44' ' ' LEU . . . -143.12 150.1 39.01 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.495 -177.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 57.25 31.02 19.4 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.396 0.617 . . . . 0.0 110.033 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 97.0 mttt 61.13 40.5 14.8 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.261 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 15.0 tp60 -144.18 136.76 26.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.9 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -87.35 117.68 26.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.847 0.356 . . . . 0.0 110.066 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -112.79 123.02 49.37 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.651 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -80.85 100.92 5.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 170.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 53' ' ' VAL . . . . . 0.496 HG12 ' CD2' ' B' ' 88' ' ' LEU . 21.5 m -86.46 -33.18 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.756 -172.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 54' ' ' ALA . . . . . 0.734 ' HB2' HD21 ' C' ' 65' ' ' LEU . . . -153.16 144.51 23.2 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 120.394 -0.522 . . . . 0.0 112.201 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 27.3 m -115.52 102.5 9.85 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 169.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . 0.434 HG13 ' HB3' ' C' ' 40' ' ' ALA . 9.0 p -116.13 114.12 45.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.763 0.792 . . . . 0.0 110.18 -177.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 69.7 p -123.15 -177.18 3.61 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.972 -175.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -59.32 -35.93 74.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.075 0.465 . . . . 0.0 110.015 169.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . 0.412 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -71.17 -40.56 71.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.527 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 79.0 mt -114.36 82.29 7.38 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 174.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 61' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 17.2 Cg_exo -67.27 -6.72 16.96 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.268 2.645 . . . . 0.0 113.851 -168.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -161.46 132.16 5.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.288 0.566 . . . . 0.0 111.2 -175.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 87.9 t -119.76 118.61 57.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.524 176.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.79 128.13 33.3 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . 0.734 HD21 ' HB2' ' C' ' 54' ' ' ALA . 85.9 mt -120.14 163.86 17.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.396 0.617 . . . . 0.0 112.277 -172.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -140.9 97.43 3.19 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.206 -0.907 . . . . 0.0 108.554 169.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.526 ' O ' ' HA ' ' C' ' 28' ' ' HIS . 2.8 mt -131.22 156.31 45.58 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . 0.538 ' HB2' ' CZ ' ' B' ' 90' ' ' TYR . 42.7 t-20 -155.27 128.71 8.4 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 174.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 69' ' ' PHE . . . . . 0.475 ' HB2' ' CD1' ' C' ' 23' ' ' ILE . 4.2 m-85 -123.91 145.08 49.38 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . 0.578 ' OG ' ' HA ' ' B' ' 7' ' ' MET . 37.7 m -100.51 -178.46 3.81 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -175.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -62.33 -30.91 71.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.244 0.545 . . . . 0.0 110.399 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.92 4.5 85.15 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.76 -0.654 . . . . 0.0 113.005 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -100.05 119.55 38.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.109 0.454 . . . . 0.0 110.81 178.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -111.96 106.34 15.0 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 173.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.412 HG22 ' CB ' ' C' ' 46' ' ' ALA . 10.8 pt -121.01 167.99 13.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.128 -167.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . . . . . . . . . 3.9 mtm -122.15 126.06 47.52 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 171.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 77' ' ' PHE . . . . . 0.657 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.3 OUTLIER -107.99 127.7 53.99 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 174.864 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 78' ' ' TYR . . . . . 0.742 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 53.7 p90 -155.58 140.33 17.1 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 119.808 -0.757 . . . . 0.0 112.208 -175.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . 0.667 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 12.3 p -105.9 138.82 41.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.052 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.13 153.21 22.98 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.364 174.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.46 -173.45 34.05 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -177.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -113.55 103.82 11.64 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.654 0.727 . . . . 0.0 109.842 177.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . 0.543 ' H ' ' HB3' ' C' ' 15' ' ' PRO . . . -170.92 153.6 3.93 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.813 169.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 5.7 p -110.22 123.27 49.47 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.192 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.718 HG12 ' HB3' ' C' ' 34' ' ' LEU . 10.8 m -124.82 153.36 31.76 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-O 121.447 0.642 . . . . 0.0 112.347 -173.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 29.0 m -113.3 126.66 55.63 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.772 175.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . 0.632 HD13 HD23 ' C' ' 11' ' ' LEU . 4.6 mp -101.83 147.42 26.52 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 169.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . 0.564 HD12 ' CE1' ' C' ' 8' ' ' PHE . 2.3 mm? -125.21 154.19 41.98 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 173.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.65 -168.73 25.0 Favored Glycine 0 N--CA 1.438 -1.213 0 C-N-CA 119.753 -1.213 . . . . 0.0 114.222 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 90' ' ' TYR . . . . . 0.506 ' CZ ' ' HB2' ' D' ' 68' ' ' ASN . 3.2 m-85 -117.62 118.96 33.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.351 -0.925 . . . . 0.0 110.29 -176.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . 0.535 HD22 ' HD2' ' C' ' 25' ' ' LYS . 16.4 mt . . . . . 0 C--N 1.317 -0.821 0 CA-C-O 121.199 0.523 . . . . 0.0 110.35 172.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 7' ' ' MET . . . . . 0.552 ' HA ' ' OG ' ' E' ' 70' ' ' SER . 16.6 ttt . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 8' ' ' PHE . . . . . 0.563 ' CE1' HD12 ' D' ' 88' ' ' LEU . 54.5 t80 -79.59 129.62 34.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.005 0.431 . . . . 0.0 112.135 -177.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 9' ' ' TRP . . . . . 0.536 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 87.9 t90 -113.81 148.51 36.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.496 174.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.18 145.66 14.18 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.225 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . 0.625 HD23 HD13 ' D' ' 87' ' ' LEU . 58.7 tp -139.11 110.15 6.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.893 0.378 . . . . 0.0 111.005 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -86.09 116.47 24.32 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.916 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 13' ' ' MET . . . . . 0.63 ' HB2' HG23 ' D' ' 85' ' ' VAL . 4.1 mmt -98.49 130.66 45.09 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -176.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 14' ' ' LYS . . . . . 0.455 ' HD2' ' HD2' ' D' ' 15' ' ' PRO . 48.2 tptt -100.54 132.11 22.83 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . 0.538 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 1.9 Cg_endo -46.32 117.82 2.17 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.527 2.818 . . . . 0.0 113.464 -175.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . 0.652 ' HA ' ' O ' ' D' ' 79' ' ' THR . 37.9 mt-10 64.08 56.14 1.44 Allowed 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.452 178.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.79 135.38 52.91 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.609 172.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . 0.729 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 82.8 mttt -103.68 115.76 31.09 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 123.327 0.392 . . . . 0.0 111.168 177.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -105.49 102.84 12.29 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 175.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 14.9 p -89.4 98.89 12.02 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -111.8 146.36 37.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.306 -167.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 29.0 m -100.47 143.17 30.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.234 174.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . 0.472 ' CD1' ' HB2' ' D' ' 69' ' ' PHE . 54.1 mt -108.46 125.87 65.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.193 0.52 . . . . 0.0 111.774 -172.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . 0.454 HD12 ' N ' ' D' ' 24' ' ' ILE . 4.2 mp -102.31 -50.57 9.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.382 -0.826 . . . . 0.0 108.884 176.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . 0.534 ' HD2' HD22 ' D' ' 91' ' ' LEU . 12.8 pttp -103.17 122.38 44.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.604 174.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 35.6 t -60.86 142.7 55.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.923 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 27' ' ' PHE . . . . . 0.49 ' HB3' HD23 ' D' ' 91' ' ' LEU . 54.7 p90 -147.83 148.33 30.77 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -177.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 28' ' ' HIS . . . . . 0.54 ' HA ' ' O ' ' D' ' 67' ' ' LEU . 2.1 t60 -102.66 125.2 49.31 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 114.106 -1.407 . . . . 0.0 109.649 176.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 29' ' ' ILE . . . . . 0.506 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 46.9 mt -87.3 131.31 35.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 172.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . 0.525 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 94.6 p -116.66 -12.24 10.92 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -169.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 31' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . 179.92 158.7 22.44 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 119.145 -1.502 . . . . 0.0 113.72 177.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.462 HG23 ' HG ' ' D' ' 87' ' ' LEU . 11.0 p -141.3 138.85 33.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 175.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -152.85 156.23 38.61 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.878 -0.514 . . . . 0.0 111.92 -177.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 34' ' ' LEU . . . . . 0.702 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.1 pp -125.33 148.01 48.9 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.475 0.655 . . . . 0.0 111.944 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -110.57 -55.28 2.49 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.14 169.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -100.76 128.0 46.97 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.154 174.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . 0.49 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 150.39 163.09 10.99 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.428 177.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 38' ' ' GLN . . . . . 0.4 ' HA ' ' HD2' ' D' ' 58' ' ' LYS . 25.7 mt-30 -102.63 -47.01 4.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 120.58 0.228 . . . . 0.0 110.984 176.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -152.47 132.52 13.44 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.346 177.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . 0.543 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -127.26 113.26 16.08 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.414 0.626 . . . . 0.0 110.093 168.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' D' ' 79' ' ' THR . 97.5 mttt -95.34 112.01 23.79 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.438 ' HB3' ' HB3' ' D' ' 54' ' ' ALA . 34.6 tp -86.2 107.41 17.88 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -174.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -107.4 146.09 32.1 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.73 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.656 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 1.5 tp -129.95 116.34 18.47 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.65 176.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.62 109.3 21.16 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.427 ' HB2' HD11 ' D' ' 44' ' ' LEU . . . -143.04 150.18 39.24 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.423 -177.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 57.2 30.94 19.21 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.397 0.618 . . . . 0.0 110.043 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 61.2 40.59 14.47 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.154 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -144.16 136.66 26.8 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -87.3 117.71 26.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.912 0.387 . . . . 0.0 110.027 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -112.84 123.09 49.52 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.671 178.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -80.9 100.87 5.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 170.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 53' ' ' VAL . . . . . 0.492 HG12 ' CD2' ' C' ' 88' ' ' LEU . 21.4 m -86.42 -33.25 7.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.714 -172.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 54' ' ' ALA . . . . . 0.731 ' HB2' HD21 ' D' ' 65' ' ' LEU . . . -153.13 144.49 23.22 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 120.301 -0.56 . . . . 0.0 112.264 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 27.5 m -115.51 102.46 9.82 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 169.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 56' ' ' VAL . . . . . 0.424 HG11 HG11 ' D' ' 85' ' ' VAL . 8.9 p -116.12 114.19 45.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.75 0.786 . . . . 0.0 110.119 -177.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 67.7 p -123.19 -177.19 3.62 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.931 -175.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 58' ' ' LYS . . . . . 0.4 ' HD2' ' HA ' ' D' ' 38' ' ' GLN . 27.2 mtpp -59.27 -35.99 74.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.075 0.464 . . . . 0.0 110.008 169.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 59' ' ' ALA . . . . . 0.408 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -71.16 -40.49 71.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.632 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 79.0 mt -114.33 82.28 7.33 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 61' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 17.2 Cg_exo -67.26 -6.63 16.74 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.251 2.634 . . . . 0.0 113.904 -168.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -161.49 132.12 5.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.322 0.582 . . . . 0.0 111.169 -175.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 88.2 t -119.75 118.72 58.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.551 176.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.84 128.08 33.26 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 174.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 65' ' ' LEU . . . . . 0.731 HD21 ' HB2' ' D' ' 54' ' ' ALA . 86.1 mt -120.17 163.87 17.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.412 0.625 . . . . 0.0 112.287 -172.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -140.91 97.45 3.19 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 169.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' D' ' 28' ' ' HIS . 2.7 mt -131.21 156.29 45.6 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 68' ' ' ASN . . . . . 0.506 ' HB2' ' CZ ' ' C' ' 90' ' ' TYR . 42.8 t-20 -155.27 128.7 8.4 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 174.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 69' ' ' PHE . . . . . 0.472 ' HB2' ' CD1' ' D' ' 23' ' ' ILE . 4.3 m-85 -123.96 145.15 49.36 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . 0.507 ' OG ' ' HA ' ' C' ' 7' ' ' MET . 37.7 m -100.43 -178.5 3.82 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -175.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -62.39 -30.9 71.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.291 0.567 . . . . 0.0 110.342 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.87 4.39 85.23 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.035 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -100.04 119.51 38.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.988 0.423 . . . . 0.0 110.775 178.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -111.81 106.37 15.1 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 173.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.413 HG22 ' CB ' ' D' ' 46' ' ' ALA . 10.9 pt -121.05 168.04 13.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.087 -167.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 76' ' ' MET . . . . . . . . . . . . . 3.9 mtm -122.27 125.96 47.14 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 171.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 77' ' ' PHE . . . . . 0.656 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.3 OUTLIER -107.95 127.72 54.0 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 78' ' ' TYR . . . . . 0.729 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 53.4 p90 -155.65 140.32 17.02 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.849 -0.74 . . . . 0.0 112.198 -175.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 79' ' ' THR . . . . . 0.652 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 12.1 p -106.04 138.85 41.51 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.017 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 80' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' D' ' 41' ' ' LYS . . . -107.17 153.15 23.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.401 174.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.4 ' O ' ' HG3' ' D' ' 16' ' ' GLU . . . 93.54 -173.58 34.06 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -176.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -113.52 103.8 11.62 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.879 177.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . 0.543 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -170.83 153.54 3.99 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.89 169.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 5.8 p -110.13 123.2 49.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.237 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.702 HG12 ' HB3' ' D' ' 34' ' ' LEU . 11.0 m -124.7 153.39 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-O 121.381 0.61 . . . . 0.0 112.38 -173.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 27.8 m -113.31 126.75 55.73 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.843 175.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 87' ' ' LEU . . . . . 0.625 HD13 HD23 ' D' ' 11' ' ' LEU . 4.6 mp -101.89 147.47 26.49 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 169.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.563 HD12 ' CE1' ' D' ' 8' ' ' PHE . 2.3 mm? -125.2 154.19 41.96 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 173.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.75 -168.81 25.24 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 119.758 -1.21 . . . . 0.0 114.165 -178.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 90' ' ' TYR . . . . . 0.549 ' CZ ' ' HB2' ' E' ' 68' ' ' ASN . 3.2 m-85 -117.61 118.9 33.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.375 -0.912 . . . . 0.0 110.34 -176.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . 0.534 HD22 ' HD2' ' D' ' 25' ' ' LYS . 16.5 mt . . . . . 0 C--N 1.317 -0.845 0 CA-C-O 121.09 0.472 . . . . 0.0 110.377 172.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 7' ' ' MET . . . . . 0.522 ' HA ' ' OG ' ' A' ' 70' ' ' SER . 16.6 ttt . . . . . 0 CA--C 1.53 0.176 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 8' ' ' PHE . . . . . 0.566 ' CE1' HD12 ' E' ' 88' ' ' LEU . 54.1 t80 -79.71 129.73 34.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.076 0.465 . . . . 0.0 112.048 -177.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 9' ' ' TRP . . . . . 0.54 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 87.8 t90 -113.87 148.54 36.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.537 174.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.24 145.63 14.11 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.236 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 11' ' ' LEU . . . . . 0.636 HD23 HD13 ' E' ' 87' ' ' LEU . 58.3 tp -139.16 110.19 6.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.909 0.385 . . . . 0.0 110.981 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -86.07 116.37 24.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.931 176.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 13' ' ' MET . . . . . 0.64 ' HB2' HG23 ' E' ' 85' ' ' VAL . 4.1 mmt -98.41 130.77 45.04 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -176.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 14' ' ' LYS . . . . . 0.461 ' HD2' ' HD2' ' E' ' 15' ' ' PRO . 48.3 tptt -100.65 132.13 22.71 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 174.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . 0.522 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 2.0 Cg_endo -46.22 117.75 2.1 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 123.513 2.808 . . . . 0.0 113.507 -175.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 16' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' E' ' 79' ' ' THR . 37.8 mt-10 64.05 56.18 1.44 Allowed 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.472 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.73 135.29 52.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.673 172.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . 0.733 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 82.9 mttt -103.65 115.76 31.1 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 123.302 0.376 . . . . 0.0 111.249 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -105.48 102.84 12.28 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 175.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 15.4 p -89.35 98.85 12.0 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 173.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -111.92 146.41 37.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.449 0.642 . . . . 0.0 112.203 -167.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 29.2 m -100.49 143.1 31.07 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.218 174.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 23' ' ' ILE . . . . . 0.465 ' CD1' ' HB2' ' E' ' 69' ' ' PHE . 54.1 mt -108.52 125.92 65.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.143 0.497 . . . . 0.0 111.786 -172.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . 0.457 HD12 ' N ' ' E' ' 24' ' ' ILE . 4.3 mp -102.36 -50.56 9.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.823 176.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . 0.526 ' HD2' HD22 ' E' ' 91' ' ' LEU . 12.7 pttp -103.24 122.37 44.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.56 174.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 35.6 t -60.94 142.71 56.2 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.936 -177.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 27' ' ' PHE . . . . . 0.481 ' HB3' HD23 ' E' ' 91' ' ' LEU . 54.7 p90 -147.85 148.29 30.72 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -177.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 28' ' ' HIS . . . . . 0.536 ' HA ' ' O ' ' E' ' 67' ' ' LEU . 2.1 t60 -102.52 125.18 49.16 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.714 176.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 29' ' ' ILE . . . . . 0.498 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 46.5 mt -87.32 131.28 35.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 172.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . 0.536 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 94.9 p -116.61 -12.23 10.95 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -169.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 31' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . 179.95 158.65 22.37 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 119.144 -1.503 . . . . 0.0 113.724 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.468 HG23 ' HG ' ' E' ' 87' ' ' LEU . 11.0 p -141.28 138.94 33.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 175.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -152.91 156.17 38.41 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.967 -0.458 . . . . 0.0 111.945 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 34' ' ' LEU . . . . . 0.716 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.1 pp -125.29 148.06 48.86 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.593 0.711 . . . . 0.0 111.968 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -110.68 -55.13 2.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.068 169.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -100.87 127.96 47.11 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.226 174.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . 0.494 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 150.49 163.07 10.99 Favored Glycine 0 N--CA 1.434 -1.489 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.437 177.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 38' ' ' GLN . . . . . 0.409 ' HA ' ' HD2' ' E' ' 58' ' ' LYS . 25.7 mt-30 -102.6 -47.07 4.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.552 0.215 . . . . 0.0 111.037 176.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -152.45 132.45 13.41 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.356 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . 0.525 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -127.25 113.29 16.12 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.386 0.612 . . . . 0.0 110.109 168.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 41' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' E' ' 79' ' ' THR . 97.6 mttt -95.45 112.11 23.88 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 175.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.439 ' HB3' ' HB3' ' E' ' 54' ' ' ALA . 34.6 tp -86.21 107.53 17.95 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -174.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -107.41 146.01 32.23 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.765 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 44' ' ' LEU . . . . . 0.641 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 1.5 tp -129.93 116.42 18.61 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.662 176.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.55 109.31 21.15 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . 0.428 ' HB2' HD11 ' E' ' 44' ' ' LEU . . . -143.13 150.12 39.02 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.407 -177.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 57.32 30.9 19.26 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.429 0.633 . . . . 0.0 110.047 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 61.29 40.46 14.37 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.201 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 49' ' ' GLN . . . . . . . . . . . . . 15.0 tp60 -144.12 136.7 26.89 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.932 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -87.34 117.7 26.28 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.901 0.382 . . . . 0.0 110.076 178.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . 0.401 ' CG ' HD11 ' D' ' 88' ' ' LEU . 76.7 m-85 -112.83 123.02 49.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.655 178.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -80.87 100.95 5.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 170.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . 0.48 HG12 ' CD2' ' D' ' 88' ' ' LEU . 21.5 m -86.42 -33.29 7.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.7 -172.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 54' ' ' ALA . . . . . 0.737 ' HB2' HD21 ' E' ' 65' ' ' LEU . . . -153.2 144.52 23.17 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 120.271 -0.571 . . . . 0.0 112.203 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 27.5 m -115.46 102.45 9.83 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 169.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . 0.432 HG13 ' HB3' ' E' ' 40' ' ' ALA . 9.0 p -116.13 114.2 45.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.819 0.818 . . . . 0.0 110.097 -177.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 70.4 p -123.26 -177.05 3.59 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.91 -175.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 58' ' ' LYS . . . . . 0.409 ' HD2' ' HA ' ' E' ' 38' ' ' GLN . 27.2 mtpp -59.32 -35.91 74.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.257 0.551 . . . . 0.0 110.048 169.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 59' ' ' ALA . . . . . 0.418 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -71.25 -40.56 70.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.487 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 79.5 mt -114.34 82.37 7.42 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 174.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 61' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 17.2 Cg_exo -67.37 -6.67 16.94 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.232 2.621 . . . . 0.0 113.893 -168.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -161.41 132.09 5.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.256 0.551 . . . . 0.0 111.252 -175.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 87.3 t -119.76 118.72 58.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.511 176.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.85 128.19 33.38 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 174.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 65' ' ' LEU . . . . . 0.737 HD21 ' HB2' ' E' ' 54' ' ' ALA . 86.2 mt -120.2 163.75 17.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.339 0.59 . . . . 0.0 112.283 -172.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 66' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -140.79 97.39 3.18 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 169.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 67' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' E' ' 28' ' ' HIS . 2.7 mt -131.19 156.29 45.6 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 68' ' ' ASN . . . . . 0.549 ' HB2' ' CZ ' ' D' ' 90' ' ' TYR . 42.6 t-20 -155.31 128.67 8.35 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 69' ' ' PHE . . . . . 0.465 ' HB2' ' CD1' ' E' ' 23' ' ' ILE . 4.2 m-85 -123.88 145.07 49.36 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 70' ' ' SER . . . . . 0.552 ' OG ' ' HA ' ' D' ' 7' ' ' MET . 37.1 m -100.43 -178.56 3.84 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -175.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -62.37 -30.75 71.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.245 0.545 . . . . 0.0 110.422 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -85.08 4.52 85.36 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.949 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -100.11 119.53 38.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.11 0.455 . . . . 0.0 110.795 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -111.83 106.39 15.11 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 173.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 75' ' ' ILE . . . . . 0.406 HG22 ' CB ' ' E' ' 46' ' ' ALA . 10.8 pt -121.05 167.96 13.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.134 -167.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 76' ' ' MET . . . . . . . . . . . . . 3.9 mtm -122.21 126.04 47.38 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 171.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 77' ' ' PHE . . . . . 0.641 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.3 OUTLIER -107.89 127.73 53.99 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 174.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' E' E ' 78' ' ' TYR . . . . . 0.733 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 53.3 p90 -155.63 140.37 17.08 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 119.818 -0.753 . . . . 0.0 112.187 -175.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 79' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 12.1 p -106.07 138.93 41.4 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.948 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.19 153.15 23.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.418 174.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.53 -173.37 33.86 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -177.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -113.66 103.83 11.62 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.87 177.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 83' ' ' ALA . . . . . 0.525 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -170.98 153.56 3.86 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.856 169.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 5.6 p -110.24 123.15 49.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.246 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 85' ' ' VAL . . . . . 0.716 HG12 ' HB3' ' E' ' 34' ' ' LEU . 11.1 m -124.71 153.26 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-O 121.456 0.646 . . . . 0.0 112.388 -173.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 29.3 m -113.2 126.82 55.85 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.833 175.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 87' ' ' LEU . . . . . 0.636 HD13 HD23 ' E' ' 11' ' ' LEU . 4.6 mp -101.99 147.5 26.48 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 169.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . 0.566 HD12 ' CE1' ' E' ' 8' ' ' PHE . 2.3 mm? -125.27 154.17 42.11 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 173.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.65 -168.76 25.05 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 119.728 -1.225 . . . . 0.0 114.161 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 90' ' ' TYR . . . . . 0.528 ' CZ ' ' HB2' ' A' ' 68' ' ' ASN . 3.2 m-85 -117.61 118.99 33.64 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.328 -0.936 . . . . 0.0 110.295 -176.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 91' ' ' LEU . . . . . 0.526 HD22 ' HD2' ' E' ' 25' ' ' LYS . 16.4 mt . . . . . 0 C--N 1.317 -0.815 0 CA-C-O 121.189 0.519 . . . . 0.0 110.352 172.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.438 ' HA ' ' HB2' ' B' ' 70' ' ' SER . 46.1 ttm . . . . . 0 C--O 1.223 -0.334 0 CA-C-O 120.707 0.289 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.627 ' CE1' HD21 ' B' ' 44' ' ' LEU . 68.0 t80 -61.3 147.53 44.28 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -172.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.424 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 89.5 t90 -138.55 145.53 40.79 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.842 179.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.69 151.44 23.54 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.039 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.617 HD23 HD13 ' A' ' 87' ' ' LEU . 40.8 tp -146.28 109.66 4.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.63 0.252 . . . . 0.0 110.884 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 52.7 m-20 -88.46 125.31 34.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.475 0.655 . . . . 0.0 111.096 176.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.545 ' HB2' HG23 ' A' ' 85' ' ' VAL . 7.0 mmt -98.31 130.21 44.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.432 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.457 ' HB3' ' HG3' ' A' ' 17' ' ' ARG . 59.7 tttm -96.98 134.25 23.19 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 171.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.438 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 2.2 Cg_endo -43.95 112.95 0.36 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.398 2.732 . . . . 0.0 113.401 -174.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.666 ' HA ' ' O ' ' A' ' 79' ' ' THR . 48.8 mt-10 69.45 44.25 0.94 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.811 178.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.457 ' HG3' ' HB3' ' A' ' 14' ' ' LYS . 12.0 mmt180 -104.61 138.27 41.2 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.961 170.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.662 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 46.6 mttp -113.18 118.75 35.58 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 123.392 0.432 . . . . 0.0 110.501 175.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -110.51 103.84 12.49 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 177.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 76' ' ' MET . 42.7 t -86.43 102.46 14.07 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 172.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -116.84 144.36 44.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.799 -170.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.1 t -97.84 157.0 16.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.01 174.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.4 mt -120.3 124.11 71.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.098 0.475 . . . . 0.0 111.365 -173.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.625 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -114.44 -18.32 7.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.894 176.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -132.47 121.79 23.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.657 176.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.0 t -65.73 133.44 51.07 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.056 -174.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.854 ' HB3' HD23 ' A' ' 91' ' ' LEU . 46.5 p90 -137.59 147.28 44.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.648 0.737 . . . . 0.0 112.219 -177.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.551 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 7.4 t60 -104.64 125.06 50.39 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.664 174.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.57 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 45.0 mt -90.87 133.19 33.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 170.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.551 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 67.8 p -119.82 -7.36 10.01 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -171.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.64 159.14 26.74 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 119.2 -1.476 . . . . 0.0 113.706 177.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.458 HG23 ' HG ' ' A' ' 87' ' ' LEU . 11.1 p -144.43 131.7 16.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.429 ' HA ' HG21 ' A' ' 56' ' ' VAL . . . -148.5 157.66 43.61 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.968 -0.458 . . . . 0.0 112.115 -175.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.697 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.2 pp -126.63 146.18 50.27 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.541 0.686 . . . . 0.0 111.996 178.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -110.76 -52.19 2.81 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.614 -1.175 . . . . 0.0 108.864 168.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -99.74 127.68 45.87 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.447 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 142.4 159.4 7.92 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.543 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -101.47 -45.41 5.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.723 0.297 . . . . 0.0 111.164 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.414 ' HG3' HG22 ' A' ' 57' ' ' THR . 11.5 tt0 -152.27 126.45 9.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.582 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.564 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -127.61 113.7 16.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.389 0.614 . . . . 0.0 110.221 169.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -99.35 112.16 24.39 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 174.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.1 tp -81.61 115.51 20.92 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.692 -175.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -115.53 145.33 42.74 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.49 0.662 . . . . 0.0 110.245 178.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.621 HD21 ' CE1' ' E' ' 8' ' ' PHE . 0.9 OUTLIER -128.58 118.28 22.71 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.774 177.083 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -105.61 104.47 14.19 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.67 177.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.467 ' HB2' HD11 ' A' ' 44' ' ' LEU . . . -126.64 139.76 52.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.564 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 57.99 31.06 20.12 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 123.605 0.565 . . . . 0.0 110.06 -174.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 62.18 30.34 17.68 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.298 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 8.4 tp-100 -121.42 125.6 47.32 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 177.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -83.08 117.2 22.69 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.792 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -113.6 132.42 55.75 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.727 175.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -81.34 112.56 19.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 168.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.51 ' CG2' ' HB3' ' A' ' 44' ' ' LEU . 3.4 t -86.98 -51.62 12.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.737 -172.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.622 ' HB2' HD21 ' A' ' 65' ' ' LEU . . . -151.53 144.88 24.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.453 -176.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.5 m -109.29 101.7 10.69 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 171.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.429 HG21 ' HA ' ' A' ' 33' ' ' ALA . 7.2 p -117.18 110.84 32.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.907 0.86 . . . . 0.0 109.987 -177.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.414 HG22 ' HG3' ' A' ' 39' ' ' GLU . 81.0 p -123.58 -177.47 3.73 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.356 -174.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -56.98 -34.98 68.64 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.862 0.363 . . . . 0.0 110.634 167.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.98 -40.68 65.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.526 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.9 mt -116.24 83.37 12.71 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.39 -3.76 11.58 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.129 2.553 . . . . 0.0 113.972 -168.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -162.84 130.86 3.81 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.26 0.553 . . . . 0.0 111.17 -176.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 87.0 t -118.53 117.44 54.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.636 175.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.48 126.93 31.83 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.726 174.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.622 HD21 ' HB2' ' A' ' 54' ' ' ALA . 74.7 mt -121.02 167.02 13.05 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.405 0.621 . . . . 0.0 112.295 -173.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 10.9 t0 -137.51 98.18 3.64 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.549 168.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.717 HD21 HD23 ' E' ' 88' ' ' LEU . 4.9 mt -124.75 146.38 49.22 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -148.25 120.85 8.57 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.072 175.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -116.62 141.62 47.96 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.897 -177.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.462 ' HB2' ' HA ' ' E' ' 7' ' ' MET . 9.0 t -96.98 169.26 9.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.902 0.382 . . . . 0.0 110.145 -177.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -75.23 0.34 16.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.755 -178.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.08 -4.16 56.64 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 173.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -95.51 147.09 23.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.01 0.433 . . . . 0.0 110.926 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -130.85 118.24 20.47 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 172.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.44 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 16.8 pt -130.55 157.3 42.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.087 0.47 . . . . 0.0 111.869 -169.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.446 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 67.1 ttp -119.51 114.78 22.8 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.03 175.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.62 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -100.82 129.8 46.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.961 -177.119 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.662 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 53.4 p90 -152.5 150.66 29.84 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 119.959 -0.696 . . . . 0.0 112.049 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.666 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 7.3 p -113.32 136.34 52.86 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.384 177.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.24 152.03 23.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.517 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.95 -171.96 30.5 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -114.78 102.9 10.44 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.916 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.564 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -171.13 155.27 4.33 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.909 170.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.5 p -111.99 120.77 43.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.113 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.697 HG12 ' HB3' ' A' ' 34' ' ' LEU . 10.1 m -122.06 150.63 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 121.173 0.511 . . . . 0.0 112.341 -174.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 38.8 m -107.35 124.77 50.29 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.668 174.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.617 HD13 HD23 ' A' ' 11' ' ' LEU . 5.3 mp -94.94 146.56 24.15 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 169.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.685 HD23 HD21 ' B' ' 67' ' ' LEU . 1.0 OUTLIER -131.34 142.09 50.02 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.082 -178.582 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.08 -166.94 25.96 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.233 -176.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -154.33 134.62 13.3 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.859 0.838 . . . . 0.0 112.518 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.854 HD23 ' HB3' ' A' ' 27' ' ' PHE . 14.4 mt . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.985 175.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . 0.437 ' HA ' ' HB2' ' C' ' 70' ' ' SER . 45.9 ttm . . . . . 0 C--O 1.223 -0.341 0 CA-C-O 120.703 0.287 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . 0.61 ' CE1' HD21 ' C' ' 44' ' ' LEU . 67.9 t80 -61.22 147.49 44.13 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -172.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . 0.424 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 89.5 t90 -138.54 145.52 40.78 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.84 179.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.72 151.42 23.52 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.019 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.6 HD23 HD13 ' B' ' 87' ' ' LEU . 40.4 tp -146.3 109.64 4.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.638 0.256 . . . . 0.0 110.855 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 -88.44 125.34 34.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.38 0.61 . . . . 0.0 111.126 176.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . 0.543 ' HB2' HG23 ' B' ' 85' ' ' VAL . 7.1 mmt -98.27 130.07 44.98 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.576 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.463 ' HB3' ' HG3' ' B' ' 17' ' ' ARG . 59.7 tttm -96.89 134.24 23.28 Favored Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 171.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.44 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 2.2 Cg_endo -43.92 112.84 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.454 2.769 . . . . 0.0 113.431 -174.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.653 ' HA ' ' O ' ' B' ' 79' ' ' THR . 48.8 mt-10 69.55 44.1 0.94 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.896 178.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.463 ' HG3' ' HB3' ' B' ' 14' ' ' LYS . 11.9 mmt180 -104.51 138.37 40.98 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.989 170.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.653 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 46.5 mttp -113.32 118.62 35.1 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.299 0.374 . . . . 0.0 110.513 175.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -110.35 103.84 12.54 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 42.2 t -86.39 102.68 14.25 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 172.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -117.07 144.38 44.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.747 -170.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 11.2 t -97.84 157.11 16.27 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.002 174.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 55.4 mt -120.36 124.03 71.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.051 0.453 . . . . 0.0 111.287 -173.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.628 ' H ' HD13 ' B' ' 24' ' ' ILE . 0.2 OUTLIER -114.39 -18.3 7.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.871 176.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -132.45 121.81 23.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.6 176.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 46.9 t -65.75 133.48 51.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.06 -174.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . 0.862 ' HB3' HD23 ' B' ' 91' ' ' LEU . 46.3 p90 -137.58 147.35 44.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.708 0.766 . . . . 0.0 112.255 -177.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' HIS . . . . . 0.554 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 7.5 t60 -104.74 125.0 50.39 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.506 -1.224 . . . . 0.0 109.578 174.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.575 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 44.7 mt -90.79 133.27 33.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 170.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.554 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 67.5 p -119.88 -7.3 9.99 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -171.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.71 159.06 26.55 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 119.213 -1.47 . . . . 0.0 113.706 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.461 HG23 ' HG ' ' B' ' 87' ' ' LEU . 11.1 p -144.42 131.74 16.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 173.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . 0.414 ' HA ' HG21 ' B' ' 56' ' ' VAL . . . -148.57 157.54 43.53 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 121.944 -0.472 . . . . 0.0 112.098 -174.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.708 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.2 pp -126.48 146.28 50.17 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.607 0.718 . . . . 0.0 111.947 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -110.87 -52.17 2.81 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.583 -1.189 . . . . 0.0 108.825 168.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -99.62 127.66 45.73 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 175.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.447 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 142.32 159.32 7.89 Favored Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 120.176 -1.011 . . . . 0.0 112.617 178.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -101.33 -45.54 5.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.837 0.351 . . . . 0.0 111.115 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.407 ' HG3' HG22 ' B' ' 57' ' ' THR . 11.4 tt0 -152.23 126.45 9.23 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.617 -178.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.571 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -127.67 113.77 16.46 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.493 0.663 . . . . 0.0 110.267 169.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -99.42 112.19 24.42 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 47.2 tp -81.61 115.37 20.85 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.661 -174.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -115.49 145.36 42.68 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.457 0.646 . . . . 0.0 110.355 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.627 HD21 ' CE1' ' A' ' 8' ' ' PHE . 0.9 OUTLIER -128.56 118.34 22.83 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.862 177.101 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -105.7 104.39 14.1 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.724 177.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.459 ' HB2' HD11 ' B' ' 44' ' ' LEU . . . -126.47 139.75 52.99 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.511 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 58.09 30.97 20.08 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 123.528 0.518 . . . . 0.0 109.985 -174.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 62.17 30.37 17.69 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.311 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 8.4 tp-100 -121.41 125.71 47.58 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -83.18 117.19 22.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.764 -177.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -113.67 132.4 55.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.742 175.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -81.33 112.62 19.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 169.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.495 ' CG2' ' HB3' ' B' ' 44' ' ' LEU . 3.4 t -86.99 -51.66 12.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.648 -172.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.62 ' HB2' HD21 ' B' ' 65' ' ' LEU . . . -151.54 145.01 24.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.449 -176.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 28.3 m -109.32 101.71 10.69 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 171.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . 0.418 ' CG1' HG11 ' B' ' 85' ' ' VAL . 7.2 p -117.25 111.08 33.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.877 0.846 . . . . 0.0 109.909 -178.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.407 HG22 ' HG3' ' B' ' 39' ' ' GLU . 81.3 p -123.71 -177.55 3.77 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.368 -174.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -56.91 -34.92 68.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.889 0.376 . . . . 0.0 110.68 167.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.99 -40.64 65.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.551 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 75.7 mt -116.33 83.43 13.04 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 175.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.43 -3.74 11.58 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.169 2.579 . . . . 0.0 113.972 -168.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -162.89 130.86 3.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.216 0.531 . . . . 0.0 111.228 -176.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 85.8 t -118.59 117.41 54.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.613 175.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.5 126.96 31.87 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.735 174.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.62 HD21 ' HB2' ' B' ' 54' ' ' ALA . 75.1 mt -121.07 167.05 13.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.497 0.665 . . . . 0.0 112.265 -173.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . 0.45 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 10.9 t0 -137.45 98.2 3.64 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.533 168.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.685 HD21 HD23 ' A' ' 88' ' ' LEU . 4.9 mt -124.71 146.45 49.15 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.11 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -148.37 120.78 8.46 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.003 175.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -116.54 141.61 47.95 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.926 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.438 ' HB2' ' HA ' ' A' ' 7' ' ' MET . 9.0 t -97.03 169.14 10.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.898 0.38 . . . . 0.0 110.111 -177.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -75.08 0.39 16.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.802 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.23 -4.14 56.47 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 174.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -95.56 147.07 23.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.028 0.442 . . . . 0.0 110.946 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -130.79 118.29 20.6 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 172.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.445 HG22 ' HB2' ' B' ' 46' ' ' ALA . 16.7 pt -130.5 157.33 42.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.043 0.449 . . . . 0.0 111.827 -169.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.448 ' HA ' ' HA ' ' B' ' 20' ' ' SER . 67.1 ttp -119.61 114.87 22.88 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.949 175.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . 0.611 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.4 OUTLIER -100.86 129.8 46.78 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.017 -177.206 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.653 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 53.3 p90 -152.41 150.66 29.9 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.994 -0.683 . . . . 0.0 112.142 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.653 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 7.3 p -113.33 136.34 52.86 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.446 177.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.21 151.97 23.42 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.582 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.14 -172.02 30.29 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -114.71 102.86 10.42 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.011 177.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.571 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -171.11 155.22 4.32 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.947 170.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 10.1 p -111.89 120.7 42.82 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.204 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.708 HG12 ' HB3' ' B' ' 34' ' ' LEU . 10.3 m -121.91 150.78 25.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.206 0.527 . . . . 0.0 112.363 -174.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' B' ' 32' ' ' VAL . 38.7 m -107.43 124.76 50.34 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.579 174.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.6 HD13 HD23 ' B' ' 11' ' ' LEU . 5.3 mp -94.96 146.52 24.18 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 169.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.672 HD23 HD21 ' C' ' 67' ' ' LEU . 1.0 OUTLIER -131.22 142.13 50.13 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.142 -178.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.06 -166.91 25.87 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.259 -176.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -154.41 134.56 13.19 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.825 0.821 . . . . 0.0 112.582 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . 0.862 HD23 ' HB3' ' B' ' 27' ' ' PHE . 14.3 mt . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 113.872 -1.513 . . . . 0.0 110.006 175.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 7' ' ' MET . . . . . 0.47 ' HA ' ' HB2' ' D' ' 70' ' ' SER . 45.9 ttm . . . . . 0 C--O 1.223 -0.327 0 CA-C-O 120.638 0.256 . . . . 0.0 110.84 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 8' ' ' PHE . . . . . 0.625 ' CE1' HD21 ' D' ' 44' ' ' LEU . 67.8 t80 -61.32 147.36 44.94 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -172.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . 0.419 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 89.5 t90 -138.42 145.52 41.07 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.867 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.61 151.53 23.63 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.083 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.606 HD23 HD13 ' C' ' 87' ' ' LEU . 40.6 tp -146.33 109.63 4.74 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.706 0.253 . . . . 0.0 110.945 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -88.54 125.26 34.7 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.451 0.643 . . . . 0.0 111.037 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 13' ' ' MET . . . . . 0.549 ' HB2' HG23 ' C' ' 85' ' ' VAL . 7.1 mmt -98.26 130.17 44.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.568 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . 0.459 ' HB3' ' HG3' ' C' ' 17' ' ' ARG . 59.8 tttm -97.01 134.21 23.21 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 171.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . 0.447 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 2.2 Cg_endo -43.85 112.88 0.35 Allowed 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 123.451 2.767 . . . . 0.0 113.396 -174.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . 0.662 ' HA ' ' O ' ' C' ' 79' ' ' THR . 48.8 mt-10 69.45 44.32 0.94 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.813 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 17' ' ' ARG . . . . . 0.459 ' HG3' ' HB3' ' C' ' 14' ' ' LYS . 12.0 mmt180 -104.65 138.26 41.24 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.974 170.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 18' ' ' LYS . . . . . 0.667 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 46.5 mttp -113.27 118.61 35.1 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 123.375 0.422 . . . . 0.0 110.512 175.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -110.38 103.92 12.62 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 177.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 42.0 t -86.51 102.56 14.22 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 172.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -116.94 144.46 44.53 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.8 -170.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 11.1 t -97.9 157.06 16.31 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.99 174.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . 0.405 HG22 ' HA ' ' C' ' 71' ' ' LYS . 55.6 mt -120.31 124.14 71.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.076 0.465 . . . . 0.0 111.309 -173.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . 0.622 ' H ' HD13 ' C' ' 24' ' ' ILE . 0.2 OUTLIER -114.48 -18.44 7.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.827 177.011 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -132.39 121.83 24.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.562 176.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 46.8 t -65.65 133.41 51.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.061 -174.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 27' ' ' PHE . . . . . 0.825 ' HB3' HD23 ' C' ' 91' ' ' LEU . 46.5 p90 -137.64 147.33 44.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.743 0.782 . . . . 0.0 112.184 -177.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 28' ' ' HIS . . . . . 0.555 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 7.3 t60 -104.84 125.12 50.55 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.521 174.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . 0.566 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 44.5 mt -90.82 133.2 33.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 170.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.555 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 68.1 p -119.87 -7.27 10.01 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -171.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.73 159.1 26.59 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 119.204 -1.474 . . . . 0.0 113.708 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.454 HG23 ' HG ' ' C' ' 87' ' ' LEU . 11.2 p -144.48 131.71 16.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 173.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.414 ' HA ' HG21 ' C' ' 56' ' ' VAL . . . -148.5 157.66 43.61 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.915 -0.491 . . . . 0.0 112.063 -175.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.719 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.2 pp -126.53 146.2 50.22 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.593 0.711 . . . . 0.0 111.966 178.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -110.7 -52.3 2.8 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.847 168.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -99.72 127.76 45.84 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 175.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 37' ' ' GLY . . . . . 0.447 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 142.29 159.31 7.88 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.53 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -101.45 -45.38 5.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.74 0.305 . . . . 0.0 111.166 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . 0.426 ' HG3' HG22 ' C' ' 57' ' ' THR . 11.5 tt0 -152.3 126.54 9.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.532 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.564 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -127.74 113.74 16.39 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.475 0.655 . . . . 0.0 110.21 169.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -99.4 112.24 24.46 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 46.8 tp -81.64 115.51 20.94 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.635 -175.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -115.56 145.35 42.74 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.413 0.625 . . . . 0.0 110.356 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.627 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 0.9 OUTLIER -128.65 118.31 22.69 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.814 177.145 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -105.65 104.42 14.14 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.657 177.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.455 ' HB2' HD11 ' C' ' 44' ' ' LEU . . . -126.56 139.68 53.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.503 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 58.22 30.88 20.08 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 123.568 0.542 . . . . 0.0 110.029 -174.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 62.19 30.35 17.66 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.373 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 8.4 tp-100 -121.38 125.68 47.55 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -83.14 117.18 22.71 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.851 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -113.62 132.43 55.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.696 176.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -81.4 112.49 19.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 169.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 53' ' ' VAL . . . . . 0.511 ' CG2' ' HB3' ' C' ' 44' ' ' LEU . 3.4 t -86.84 -51.74 12.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.736 -172.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 54' ' ' ALA . . . . . 0.604 ' HB2' HD21 ' C' ' 65' ' ' LEU . . . -151.43 144.97 24.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.504 -176.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 28.5 m -109.28 101.63 10.62 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 171.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . 0.426 ' CG1' HG11 ' C' ' 85' ' ' VAL . 7.2 p -117.19 110.99 33.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.91 0.862 . . . . 0.0 109.944 -178.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . 0.426 HG22 ' HG3' ' C' ' 39' ' ' GLU . 81.1 p -123.68 -177.48 3.75 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.274 -174.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -57.02 -34.98 68.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.985 0.421 . . . . 0.0 110.663 167.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.84 -40.79 65.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.529 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 75.6 mt -116.18 83.43 12.62 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 175.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.36 -3.78 11.59 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.228 2.618 . . . . 0.0 113.996 -168.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -162.9 130.86 3.77 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.256 0.551 . . . . 0.0 111.109 -175.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 86.5 t -118.6 117.45 54.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.636 175.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.53 126.97 31.89 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 174.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . 0.604 HD21 ' HB2' ' C' ' 54' ' ' ALA . 75.1 mt -121.14 166.99 13.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.41 0.624 . . . . 0.0 112.311 -173.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 66' ' ' ASP . . . . . 0.439 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 10.9 t0 -137.43 98.11 3.63 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.585 168.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.672 HD21 HD23 ' B' ' 88' ' ' LEU . 4.9 mt -124.71 146.42 49.17 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -148.28 120.87 8.57 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.005 175.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -116.62 141.7 47.85 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.86 -177.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . 0.437 ' HB2' ' HA ' ' B' ' 7' ' ' MET . 9.0 t -97.11 169.2 9.97 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.901 0.382 . . . . 0.0 110.063 -177.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . 0.405 ' HA ' HG22 ' C' ' 23' ' ' ILE . 15.0 ptmm? -75.28 0.51 16.38 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.793 -178.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.18 -4.17 56.52 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 173.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -95.43 147.08 23.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.064 0.459 . . . . 0.0 110.943 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -130.82 118.39 20.72 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.452 HG22 ' HB2' ' C' ' 46' ' ' ALA . 16.8 pt -130.55 157.31 42.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.04 0.448 . . . . 0.0 111.86 -169.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.438 ' HA ' ' HA ' ' C' ' 20' ' ' SER . 67.1 ttp -119.67 114.84 22.8 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.954 175.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 77' ' ' PHE . . . . . 0.627 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.4 OUTLIER -100.84 129.84 46.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.009 -177.143 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 78' ' ' TYR . . . . . 0.667 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 53.2 p90 -152.44 150.63 29.85 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.051 -0.66 . . . . 0.0 112.135 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . 0.662 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 7.3 p -113.26 136.34 52.85 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.445 177.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.19 151.93 23.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.526 177.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.08 -172.08 30.44 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -176.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -114.7 102.96 10.51 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.03 177.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . 0.564 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -171.2 155.2 4.26 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.831 170.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 10.3 p -111.87 120.67 42.75 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.133 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.719 HG12 ' HB3' ' C' ' 34' ' ' LEU . 9.9 m -121.95 150.77 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 CA-C-O 121.268 0.556 . . . . 0.0 112.236 -174.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' C' ' 32' ' ' VAL . 38.0 m -107.37 124.76 50.29 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.691 174.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . 0.606 HD13 HD23 ' C' ' 11' ' ' LEU . 5.3 mp -94.9 146.53 24.16 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 169.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . 0.707 HD23 HD21 ' D' ' 67' ' ' LEU . 1.0 OUTLIER -131.3 142.1 50.06 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.086 -178.632 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.07 -166.87 25.83 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.198 -176.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -154.41 134.55 13.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.865 0.84 . . . . 0.0 112.563 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . 0.825 HD23 ' HB3' ' C' ' 27' ' ' PHE . 14.3 mt . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 113.809 -1.541 . . . . 0.0 110.046 175.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 7' ' ' MET . . . . . 0.457 ' HA ' ' HB2' ' E' ' 70' ' ' SER . 45.9 ttm . . . . . 0 C--O 1.223 -0.334 0 CA-C-O 120.753 0.311 . . . . 0.0 110.814 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 8' ' ' PHE . . . . . 0.62 ' CE1' HD21 ' E' ' 44' ' ' LEU . 67.9 t80 -61.27 147.45 44.46 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -172.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 9' ' ' TRP . . . . . 0.421 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 89.6 t90 -138.5 145.54 40.9 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.817 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.67 151.4 23.5 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.072 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . 0.608 HD23 HD13 ' D' ' 87' ' ' LEU . 40.1 tp -146.28 109.67 4.76 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.697 0.284 . . . . 0.0 110.909 -179.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -88.55 125.35 34.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.393 0.616 . . . . 0.0 111.046 176.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 13' ' ' MET . . . . . 0.55 ' HB2' HG23 ' D' ' 85' ' ' VAL . 7.1 mmt -98.3 130.14 44.99 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.526 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 14' ' ' LYS . . . . . 0.458 ' HB3' ' HG3' ' D' ' 17' ' ' ARG . 59.6 tttm -96.93 134.29 23.18 Favored Pre-proline 0 C--N 1.318 -0.799 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 171.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . 0.444 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 2.2 Cg_endo -44.03 112.91 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.482 2.788 . . . . 0.0 113.361 -174.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . 0.663 ' HA ' ' O ' ' D' ' 79' ' ' THR . 48.9 mt-10 69.47 44.2 0.94 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.869 178.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 17' ' ' ARG . . . . . 0.458 ' HG3' ' HB3' ' D' ' 14' ' ' LYS . 12.0 mmt180 -104.59 138.25 41.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.004 170.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . 0.649 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 46.6 mttp -113.26 118.64 35.22 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.367 0.417 . . . . 0.0 110.503 175.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -110.31 103.86 12.58 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 177.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 42.0 t -86.41 102.68 14.26 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 172.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -117.12 144.38 44.76 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.746 -170.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 11.3 t -97.8 157.08 16.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.068 174.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 55.7 mt -120.33 124.09 71.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.118 0.485 . . . . 0.0 111.287 -173.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . 0.638 ' H ' HD13 ' D' ' 24' ' ' ILE . 0.2 OUTLIER -114.43 -18.43 7.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.859 176.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -132.37 121.86 24.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.614 176.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 46.8 t -65.7 133.45 51.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.079 -174.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 27' ' ' PHE . . . . . 0.837 ' HB3' HD23 ' D' ' 91' ' ' LEU . 46.2 p90 -137.64 147.34 44.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.667 0.746 . . . . 0.0 112.171 -177.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 28' ' ' HIS . . . . . 0.559 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 7.4 t60 -104.77 125.04 50.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.616 174.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 29' ' ' ILE . . . . . 0.585 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 44.8 mt -90.78 133.18 33.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 170.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . 0.559 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 67.4 p -119.82 -7.33 10.02 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -171.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.68 159.1 26.65 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 119.295 -1.431 . . . . 0.0 113.726 177.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.474 HG23 ' HG ' ' D' ' 87' ' ' LEU . 11.1 p -144.48 131.78 16.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 173.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . 0.414 ' HA ' HG21 ' D' ' 56' ' ' VAL . . . -148.56 157.57 43.55 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.857 -0.527 . . . . 0.0 112.018 -174.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 34' ' ' LEU . . . . . 0.698 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.2 pp -126.53 146.17 50.23 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.645 0.736 . . . . 0.0 111.994 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -110.7 -52.3 2.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.865 168.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -99.7 127.73 45.82 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 175.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . 0.439 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 142.38 159.32 7.89 Favored Glycine 0 N--CA 1.435 -1.375 0 C-N-CA 120.191 -1.005 . . . . 0.0 112.562 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -101.42 -45.44 5.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.775 0.321 . . . . 0.0 111.167 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . 0.415 ' HG3' HG22 ' D' ' 57' ' ' THR . 11.6 tt0 -152.28 126.49 9.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.634 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . 0.579 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -127.68 113.79 16.49 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.45 0.643 . . . . 0.0 110.227 169.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -99.44 112.15 24.39 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 46.9 tp -81.64 115.4 20.89 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.677 -174.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -115.49 145.3 42.74 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.394 0.616 . . . . 0.0 110.288 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.628 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.9 OUTLIER -128.46 118.34 22.93 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.845 177.032 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 45' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -105.7 104.47 14.19 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.641 177.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.455 ' HB2' HD11 ' D' ' 44' ' ' LEU . . . -126.62 139.76 52.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.575 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 58.13 30.93 20.06 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 123.509 0.506 . . . . 0.0 109.987 -174.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 62.24 30.46 17.59 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.232 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . 0.443 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 8.4 tp-100 -121.51 125.68 47.38 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -83.17 117.26 22.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.769 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -113.72 132.45 55.81 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.647 176.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -81.34 112.63 19.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 168.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 53' ' ' VAL . . . . . 0.508 ' CG2' ' HB3' ' D' ' 44' ' ' LEU . 3.4 t -87.01 -51.56 12.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.73 -172.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 54' ' ' ALA . . . . . 0.621 ' HB2' HD21 ' D' ' 65' ' ' LEU . . . -151.55 144.96 24.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.521 -176.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 28.5 m -109.33 101.73 10.7 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 171.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 56' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' D' ' 40' ' ' ALA . 7.2 p -117.25 110.98 32.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.956 0.884 . . . . 0.0 109.94 -178.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 57' ' ' THR . . . . . 0.415 HG22 ' HG3' ' D' ' 39' ' ' GLU . 81.0 p -123.58 -177.56 3.76 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.365 -174.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -57.03 -34.88 68.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.891 0.377 . . . . 0.0 110.642 167.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.01 -40.64 65.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.56 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 75.5 mt -116.27 83.45 12.9 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.48 -3.65 11.44 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.195 2.596 . . . . 0.0 113.933 -168.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -162.95 130.81 3.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.101 0.477 . . . . 0.0 111.162 -176.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 87.7 t -118.59 117.39 54.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.586 175.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.39 126.98 31.85 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 65' ' ' LEU . . . . . 0.621 HD21 ' HB2' ' D' ' 54' ' ' ALA . 75.6 mt -121.17 167.01 13.14 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.509 0.671 . . . . 0.0 112.209 -173.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 66' ' ' ASP . . . . . 0.434 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 10.8 t0 -137.46 98.14 3.63 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.538 168.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.707 HD21 HD23 ' C' ' 88' ' ' LEU . 4.9 mt -124.69 146.38 49.17 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -148.32 120.77 8.48 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.061 175.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -116.54 141.67 47.88 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.9 -177.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . 0.47 ' HB2' ' HA ' ' C' ' 7' ' ' MET . 9.0 t -97.0 169.15 10.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.875 0.369 . . . . 0.0 110.1 -177.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -75.26 0.46 16.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.74 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.19 -4.08 56.54 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 173.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -95.53 147.06 23.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.076 0.465 . . . . 0.0 110.936 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -130.82 118.32 20.62 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 172.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.453 HG22 ' HB2' ' D' ' 46' ' ' ALA . 16.8 pt -130.58 157.42 42.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.102 0.477 . . . . 0.0 111.788 -169.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 76' ' ' MET . . . . . 0.436 ' HA ' ' HA ' ' D' ' 20' ' ' SER . 67.1 ttp -119.71 114.8 22.72 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.947 175.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 77' ' ' PHE . . . . . 0.628 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.4 OUTLIER -100.84 129.7 46.75 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.018 -177.132 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 78' ' ' TYR . . . . . 0.649 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 53.3 p90 -152.33 150.61 29.92 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.151 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 79' ' ' THR . . . . . 0.663 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 7.2 p -113.25 136.36 52.82 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.453 177.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.2 151.97 23.42 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.503 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.01 -171.97 30.43 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 -176.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -114.67 102.87 10.44 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.042 177.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . 0.579 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -171.09 155.27 4.36 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.9 170.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 9.9 p -111.93 120.7 42.82 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.13 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.698 HG12 ' HB3' ' D' ' 34' ' ' LEU . 10.1 m -122.0 150.74 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-O 121.298 0.57 . . . . 0.0 112.289 -174.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 86' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' D' ' 32' ' ' VAL . 38.7 m -107.41 124.83 50.43 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.588 174.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 87' ' ' LEU . . . . . 0.608 HD13 HD23 ' D' ' 11' ' ' LEU . 5.3 mp -94.93 146.58 24.13 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 169.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.703 HD23 HD21 ' E' ' 67' ' ' LEU . 1.0 OUTLIER -131.31 142.09 50.05 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.125 -178.709 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.1 -166.99 26.05 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.229 -176.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -154.34 134.57 13.26 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.808 0.813 . . . . 0.0 112.583 178.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . 0.837 HD23 ' HB3' ' D' ' 27' ' ' PHE . 14.3 mt . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 113.89 -1.504 . . . . 0.0 109.987 175.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 7' ' ' MET . . . . . 0.462 ' HA ' ' HB2' ' A' ' 70' ' ' SER . 45.9 ttm . . . . . 0 C--O 1.223 -0.31 0 CA-C-O 120.734 0.302 . . . . 0.0 110.835 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 8' ' ' PHE . . . . . 0.621 ' CE1' HD21 ' A' ' 44' ' ' LEU . 68.1 t80 -61.26 147.45 44.44 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -172.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 9' ' ' TRP . . . . . 0.422 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 89.5 t90 -138.47 145.59 41.03 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.882 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.76 151.34 23.45 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.083 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 11' ' ' LEU . . . . . 0.602 HD23 HD13 ' E' ' 87' ' ' LEU . 40.8 tp -146.2 109.62 4.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.67 0.272 . . . . 0.0 110.928 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 -88.43 125.28 34.65 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.356 0.598 . . . . 0.0 111.112 176.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 13' ' ' MET . . . . . 0.554 ' HB2' HG23 ' E' ' 85' ' ' VAL . 7.1 mmt -98.3 130.16 44.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.522 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 14' ' ' LYS . . . . . 0.46 ' HB3' ' HG3' ' E' ' 17' ' ' ARG . 59.7 tttm -97.05 134.24 23.14 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 171.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . 0.451 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 2.3 Cg_endo -44.05 112.93 0.37 Allowed 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 123.43 2.754 . . . . 0.0 113.373 -174.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 16' ' ' GLU . . . . . 0.657 ' HA ' ' O ' ' E' ' 79' ' ' THR . 48.8 mt-10 69.53 44.16 0.94 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.827 178.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 17' ' ' ARG . . . . . 0.46 ' HG3' ' HB3' ' E' ' 14' ' ' LYS . 11.9 mmt180 -104.46 138.27 41.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.978 170.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . 0.663 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 46.6 mttp -113.29 118.72 35.41 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.47 0.481 . . . . 0.0 110.521 175.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -110.35 103.96 12.67 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 20' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' E' ' 76' ' ' MET . 42.3 t -86.5 102.5 14.16 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 172.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -117.01 144.35 44.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.772 -170.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 11.3 t -97.81 157.03 16.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.005 174.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 23' ' ' ILE . . . . . 0.402 HG22 ' HA ' ' E' ' 71' ' ' LYS . 55.5 mt -120.29 124.11 71.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.052 0.453 . . . . 0.0 111.323 -173.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . 0.633 ' H ' HD13 ' E' ' 24' ' ' ILE . 0.2 OUTLIER -114.43 -18.37 7.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.907 176.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -132.37 121.77 24.0 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.62 176.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 46.8 t -65.71 133.43 51.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.061 -174.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 27' ' ' PHE . . . . . 0.831 ' HB3' HD23 ' E' ' 91' ' ' LEU . 46.6 p90 -137.6 147.3 44.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.692 0.758 . . . . 0.0 112.241 -177.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 28' ' ' HIS . . . . . 0.545 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 7.4 t60 -104.73 124.99 50.36 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.64 174.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 29' ' ' ILE . . . . . 0.585 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 45.1 mt -90.75 133.15 33.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 170.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . 0.545 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 67.5 p -119.87 -7.18 10.01 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -171.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.75 159.12 26.6 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 119.183 -1.484 . . . . 0.0 113.747 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.465 HG23 ' HG ' ' E' ' 87' ' ' LEU . 11.1 p -144.49 131.72 16.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 173.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . 0.419 ' HA ' HG21 ' E' ' 56' ' ' VAL . . . -148.48 157.64 43.6 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.932 -0.48 . . . . 0.0 112.02 -174.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 34' ' ' LEU . . . . . 0.719 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.2 pp -126.6 146.26 50.23 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.635 0.731 . . . . 0.0 111.948 178.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -110.85 -52.21 2.8 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.818 168.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -99.72 127.71 45.84 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . 0.445 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 142.37 159.32 7.88 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.589 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -101.37 -45.41 5.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.708 0.289 . . . . 0.0 111.18 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 39' ' ' GLU . . . . . 0.41 ' HG3' HG22 ' E' ' 57' ' ' THR . 11.5 tt0 -152.33 126.41 9.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.626 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . 0.561 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -127.61 113.81 16.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.438 0.637 . . . . 0.0 110.205 169.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 41' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -99.49 112.3 24.52 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 174.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 46.8 tp -81.66 115.41 20.91 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.651 -175.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -115.48 145.32 42.71 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.515 0.674 . . . . 0.0 110.297 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 44' ' ' LEU . . . . . 0.62 HD21 ' CE1' ' D' ' 8' ' ' PHE . 0.9 OUTLIER -128.6 118.34 22.79 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.801 177.066 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' E' E ' 45' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -105.64 104.42 14.13 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.697 177.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . 0.461 ' HB2' HD11 ' E' ' 44' ' ' LEU . . . -126.54 139.77 52.96 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.587 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 57.98 31.04 20.09 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 123.611 0.569 . . . . 0.0 110.058 -174.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 62.24 30.27 17.56 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.284 -178.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 49' ' ' GLN . . . . . 0.449 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 8.4 tp-100 -121.35 125.67 47.55 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 178.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -83.16 117.2 22.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.815 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -113.64 132.44 55.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.714 175.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -81.27 112.51 19.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 168.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . 0.506 ' CG2' ' HB3' ' E' ' 44' ' ' LEU . 3.4 t -86.98 -51.51 12.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.732 -172.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 54' ' ' ALA . . . . . 0.606 ' HB2' HD21 ' E' ' 65' ' ' LEU . . . -151.57 144.97 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.468 -176.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 28.2 m -109.23 101.69 10.69 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 171.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . 0.421 ' CG1' HG11 ' E' ' 85' ' ' VAL . 7.2 p -117.25 110.9 32.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.885 0.85 . . . . 0.0 109.9 -177.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 57' ' ' THR . . . . . 0.41 HG22 ' HG3' ' E' ' 39' ' ' GLU . 81.1 p -123.59 -177.54 3.75 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.342 -174.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -56.92 -35.05 68.59 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.965 0.412 . . . . 0.0 110.555 167.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.9 -40.63 65.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.534 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 75.5 mt -116.35 83.38 13.0 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 175.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.38 -3.78 11.61 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.177 2.584 . . . . 0.0 113.933 -168.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -162.84 130.83 3.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.247 0.546 . . . . 0.0 111.135 -175.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 87.9 t -118.66 117.51 54.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.556 175.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.5 126.94 31.85 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.672 174.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 65' ' ' LEU . . . . . 0.606 HD21 ' HB2' ' E' ' 54' ' ' ALA . 75.0 mt -121.04 167.02 13.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.439 0.637 . . . . 0.0 112.307 -173.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 66' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 10.9 t0 -137.44 98.2 3.65 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.593 168.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 67' ' ' LEU . . . . . 0.703 HD21 HD23 ' D' ' 88' ' ' LEU . 4.9 mt -124.67 146.39 49.15 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.081 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -148.31 120.82 8.52 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.023 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -116.55 141.67 47.88 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.941 -177.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 70' ' ' SER . . . . . 0.457 ' HB2' ' HA ' ' D' ' 7' ' ' MET . 9.0 t -97.04 169.22 9.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.924 0.392 . . . . 0.0 110.034 -177.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 71' ' ' LYS . . . . . 0.402 ' HA ' HG22 ' E' ' 23' ' ' ILE . 15.1 ptmm? -75.19 0.28 16.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.748 -178.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.0 -4.23 56.72 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 173.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -95.46 147.13 23.86 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 120.992 0.425 . . . . 0.0 110.946 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -130.84 118.32 20.61 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 172.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 75' ' ' ILE . . . . . 0.449 HG22 ' HB2' ' E' ' 46' ' ' ALA . 16.8 pt -130.61 157.32 42.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.131 0.491 . . . . 0.0 111.774 -169.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 76' ' ' MET . . . . . 0.437 ' HA ' ' HA ' ' E' ' 20' ' ' SER . 67.1 ttp -119.55 114.82 22.84 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.005 175.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 77' ' ' PHE . . . . . 0.611 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.4 OUTLIER -100.92 129.76 46.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.001 -177.133 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' E' E ' 78' ' ' TYR . . . . . 0.663 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 53.3 p90 -152.43 150.64 29.87 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.989 -0.685 . . . . 0.0 112.148 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 79' ' ' THR . . . . . 0.657 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 7.3 p -113.27 136.4 52.79 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.413 177.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.22 152.02 23.37 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.528 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.96 -171.9 30.43 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -176.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -114.73 102.84 10.39 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.054 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 83' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -171.04 155.32 4.41 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.889 170.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 10.4 p -112.0 120.77 43.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.121 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 85' ' ' VAL . . . . . 0.719 HG12 ' HB3' ' E' ' 34' ' ' LEU . 9.8 m -122.12 150.71 25.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.237 0.542 . . . . 0.0 112.232 -174.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 38.9 m -107.43 124.75 50.32 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.606 174.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 87' ' ' LEU . . . . . 0.602 HD13 HD23 ' E' ' 11' ' ' LEU . 5.3 mp -94.87 146.54 24.14 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 169.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . 0.717 HD23 HD21 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -131.28 142.05 50.06 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.164 -178.663 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.01 -166.87 25.77 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.259 -176.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 90' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -154.42 134.62 13.22 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.804 0.812 . . . . 0.0 112.561 178.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 91' ' ' LEU . . . . . 0.831 HD23 ' HB3' ' E' ' 27' ' ' PHE . 14.3 mt . . . . . 0 C--N 1.326 -0.438 0 CA-C-N 113.842 -1.527 . . . . 0.0 109.956 175.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.502 ' HA ' ' HB2' ' B' ' 70' ' ' SER . 55.9 mtp . . . . . 0 C--O 1.224 -0.281 0 CA-C-O 120.69 0.281 . . . . 0.0 111.333 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -88.34 152.2 22.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.244 -175.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 87.1 t90 -138.57 146.49 41.91 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.86 155.8 26.34 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.108 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.627 HD23 HD13 ' A' ' 87' ' ' LEU . 42.4 tp -149.98 108.27 3.77 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.695 0.283 . . . . 0.0 110.951 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -86.8 103.31 15.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.149 0.499 . . . . 0.0 110.855 175.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.563 ' HB2' HG23 ' A' ' 85' ' ' VAL . 2.9 mmt -80.69 136.61 36.22 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.345 -179.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.552 ' HB2' ' HG3' ' A' ' 17' ' ' ARG . 27.2 mtpp -99.85 142.58 24.88 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 173.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.526 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 7.5 Cg_endo -50.19 115.26 1.79 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 123.443 2.762 . . . . 0.0 113.283 -175.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.67 ' HA ' ' O ' ' A' ' 79' ' ' THR . 26.1 mt-10 65.1 57.54 0.95 Allowed 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.597 0.713 . . . . 0.0 111.569 177.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.552 ' HG3' ' HB2' ' A' ' 14' ' ' LYS . 13.5 mmt180 -117.6 163.43 16.45 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.473 171.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.627 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 3.3 ttmp? -139.46 109.92 6.6 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 123.474 0.484 . . . . 0.0 110.843 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -111.38 113.31 25.68 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.7 p -72.18 116.53 12.72 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 171.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -98.0 117.71 32.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.673 -163.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.5 t -91.99 143.44 26.47 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 171.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.9 mt -115.32 124.41 71.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.153 0.502 . . . . 0.0 111.768 -172.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.1 mp -90.41 -43.8 14.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.816 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -140.09 149.45 43.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.12 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.532 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 23.1 t -59.9 115.22 3.25 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.102 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.907 ' HB3' HD23 ' A' ' 91' ' ' LEU . 12.5 p90 -122.86 148.97 44.8 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.471 0.653 . . . . 0.0 111.62 -177.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.668 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 10.3 t60 -106.66 120.43 41.94 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.552 178.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.597 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 31.4 mt -89.38 134.2 29.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 171.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.668 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 15.8 p -122.38 -15.52 7.61 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -171.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -155.66 152.87 24.31 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 119.533 -1.318 . . . . 0.0 113.227 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.463 HG23 ' HG ' ' A' ' 87' ' ' LEU . 11.7 p -150.15 122.28 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 171.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.29 154.61 42.54 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 122.008 -0.432 . . . . 0.0 111.572 -173.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.515 ' HB3' HG12 ' A' ' 85' ' ' VAL . 3.7 pp -113.94 139.28 49.35 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.638 0.733 . . . . 0.0 111.552 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -104.59 -56.06 2.24 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.83 173.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -102.27 127.82 49.08 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 170.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.497 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 150.93 162.26 10.55 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 119.683 -1.246 . . . . 0.0 113.472 176.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.524 ' O ' ' HG3' ' A' ' 58' ' ' LYS . 26.6 mt-30 -102.55 -47.99 4.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.573 0.225 . . . . 0.0 111.285 176.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -151.54 133.02 14.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.388 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.533 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -132.54 116.22 16.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.411 0.625 . . . . 0.0 110.527 170.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 79' ' ' THR . 97.8 mttt -100.14 112.59 24.9 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.5 tp -84.55 114.41 21.94 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -176.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.475 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 98.5 m-85 -116.23 145.62 42.98 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 176.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.607 ' HA ' ' O ' ' A' ' 76' ' ' MET . 0.3 OUTLIER -131.9 130.85 42.13 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.667 171.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -104.36 113.74 27.51 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.764 177.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.753 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -126.07 139.22 53.57 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 174.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 57.3 30.34 18.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.27 0.557 . . . . 0.0 109.615 -171.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.535 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 0.3 OUTLIER 64.84 17.11 10.86 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.456 -179.109 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 7.7 tt0 -104.99 121.54 43.97 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -82.15 112.12 18.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.686 -177.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -102.96 136.58 42.51 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.492 177.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -82.23 103.05 8.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 171.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.51 ' CG1' HD11 ' A' ' 67' ' ' LEU . 2.9 t -78.63 -52.8 14.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.763 -172.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.487 ' HB2' ' CD2' ' A' ' 65' ' ' LEU . . . -146.89 137.63 23.82 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.544 -177.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.1 m -104.49 101.62 11.29 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 170.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.428 ' CG1' HG11 ' A' ' 85' ' ' VAL . 6.2 p -121.7 109.81 25.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.979 0.895 . . . . 0.0 110.205 -177.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.6 p -122.85 -176.79 3.49 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.758 -175.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 38' ' ' GLN . 9.9 mtmp? -58.01 -31.54 67.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.028 0.442 . . . . 0.0 110.437 170.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.14 -40.82 51.76 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.551 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 69.9 mt -116.11 76.49 6.55 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 173.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -76.45 1.59 8.25 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.797 2.332 . . . . 0.0 113.329 -168.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -154.9 100.93 2.24 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.643 -170.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 66.0 t -102.59 121.02 53.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.113 0.482 . . . . 0.0 110.729 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.67 110.75 22.95 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.708 174.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -126.93 169.22 13.53 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.051 0.453 . . . . 0.0 111.708 -175.107 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.556 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 27.1 t0 -119.38 104.99 10.85 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.761 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.643 HD21 HD23 ' E' ' 88' ' ' LEU . 18.7 mt -120.65 150.68 40.55 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.992 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.542 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 5.9 t30 -152.41 127.14 9.5 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.943 0.401 . . . . 0.0 110.017 172.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' A' ' 26' ' ' SER . 38.3 m-85 -121.31 161.47 21.97 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.764 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.527 ' HB2' ' HA ' ' E' ' 7' ' ' MET . 42.6 t -115.86 158.22 23.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.328 0.585 . . . . 0.0 111.87 -174.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -21.83 66.47 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.33 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.05 -1.06 61.48 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.894 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -100.56 166.11 11.08 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -145.14 129.63 17.92 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.753 HG22 ' HB2' ' A' ' 46' ' ' ALA . 9.7 pt -134.82 174.66 12.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.435 -173.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.607 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 23.1 mtp -130.46 123.81 30.61 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -105.09 127.58 52.95 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.071 178.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.627 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 24.4 p90 -153.9 141.86 20.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.102 0.477 . . . . 0.0 111.811 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.67 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 11.6 p -113.32 141.88 46.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.08 -178.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -109.85 150.87 27.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.576 176.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.3 176.8 40.45 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -177.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -107.42 102.11 11.41 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.687 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.533 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -170.22 150.43 3.65 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.874 169.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.3 t -104.41 119.28 38.6 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.563 HG23 ' HB2' ' A' ' 13' ' ' MET . 5.7 m -119.21 135.18 60.44 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 CA-C-O 121.453 0.644 . . . . 0.0 112.135 -174.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.5 t -99.61 119.49 38.17 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.988 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.627 HD13 HD23 ' A' ' 11' ' ' LEU . 5.3 mp -92.96 147.11 23.11 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 173.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.589 HD23 HD21 ' B' ' 67' ' ' LEU . 1.5 tp -133.25 138.76 46.61 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.098 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.95 -167.6 23.62 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.985 -177.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.503 ' CD2' ' HB3' ' B' ' 68' ' ' ASN . 20.2 p90 -153.58 135.56 14.68 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.797 0.808 . . . . 0.0 112.567 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.907 HD23 ' HB3' ' A' ' 27' ' ' PHE . 5.3 mt . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.447 175.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . 0.522 ' HA ' ' HB2' ' C' ' 70' ' ' SER . 56.0 mtp . . . . . 0 C--O 1.224 -0.262 0 CA-C-O 120.716 0.294 . . . . 0.0 111.308 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -88.3 152.34 22.0 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.277 -175.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -138.7 146.46 41.58 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.9 155.83 26.35 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.13 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.64 HD23 HD13 ' B' ' 87' ' ' LEU . 42.2 tp -149.97 108.22 3.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.701 0.286 . . . . 0.0 110.822 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -86.71 103.31 15.05 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.056 0.455 . . . . 0.0 110.879 175.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . 0.564 ' HB2' HG23 ' B' ' 85' ' ' VAL . 2.8 mmt -80.89 136.77 36.12 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.272 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.544 ' HB2' ' HG3' ' B' ' 17' ' ' ARG . 27.2 mtpp -99.89 142.61 24.94 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 173.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.525 ' HB3' ' N ' ' B' ' 83' ' ' ALA . 7.6 Cg_endo -50.15 115.23 1.77 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.413 2.742 . . . . 0.0 113.372 -175.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.663 ' HA ' ' O ' ' B' ' 79' ' ' THR . 25.9 mt-10 65.04 57.58 0.96 Allowed 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.623 0.725 . . . . 0.0 111.598 177.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.544 ' HG3' ' HB2' ' B' ' 14' ' ' LYS . 13.6 mmt180 -117.55 163.31 16.61 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.532 171.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.649 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 3.3 ttmp? -139.42 110.02 6.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.746 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -111.42 113.34 25.72 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 2.7 p -72.07 116.48 12.53 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 171.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -97.84 117.55 32.41 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.764 -163.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 13.5 t -91.92 143.54 26.39 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 171.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 48.7 mt -115.44 124.46 71.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.227 0.537 . . . . 0.0 111.654 -172.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.463 ' N ' HD12 ' B' ' 24' ' ' ILE . 4.1 mp -90.44 -43.86 14.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.817 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -140.18 149.59 43.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.001 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' B' ' 69' ' ' PHE . 22.7 t -59.83 115.19 3.21 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.137 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . 0.91 ' HB3' HD23 ' B' ' 91' ' ' LEU . 12.5 p90 -122.84 148.9 44.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.478 0.656 . . . . 0.0 111.682 -177.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' HIS . . . . . 0.668 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 10.4 t60 -106.62 120.43 41.94 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.605 178.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.584 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 31.6 mt -89.51 134.24 29.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 171.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.668 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 16.3 p -122.4 -15.4 7.63 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 112.179 0.436 . . . . 0.0 112.179 -170.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -155.75 152.9 24.32 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 119.513 -1.327 . . . . 0.0 113.137 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.462 HG23 ' HG ' ' B' ' 87' ' ' LEU . 11.5 p -150.14 122.35 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 171.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.28 154.63 42.56 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.554 -173.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.499 ' HB3' HG12 ' B' ' 85' ' ' VAL . 3.7 pp -113.96 139.28 49.36 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 121.624 0.726 . . . . 0.0 111.529 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -104.59 -56.01 2.25 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.796 173.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -102.28 127.78 49.11 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 170.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.498 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 150.89 162.17 10.48 Favored Glycine 0 N--CA 1.438 -1.211 0 C-N-CA 119.547 -1.311 . . . . 0.0 113.407 176.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . 0.521 ' O ' ' HG3' ' B' ' 58' ' ' LYS . 26.5 mt-30 -102.52 -47.98 4.29 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.601 0.238 . . . . 0.0 111.293 177.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -151.57 133.06 14.69 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.636 -0.257 . . . . 0.0 110.442 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.529 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -132.56 116.3 16.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.517 0.675 . . . . 0.0 110.516 170.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' B' ' 79' ' ' THR . 97.7 mttt -100.2 112.64 24.97 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 40.6 tp -84.63 114.48 22.03 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . 0.473 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 98.8 m-85 -116.36 145.65 43.06 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.608 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.3 OUTLIER -131.95 130.77 41.93 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 120.371 -0.531 . . . . 0.0 109.731 171.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -104.29 113.78 27.57 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.821 177.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.773 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -126.13 139.22 53.54 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 174.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 57.3 30.28 18.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.293 0.568 . . . . 0.0 109.645 -171.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.526 ' HA ' ' HE2' ' B' ' 48' ' ' LYS . 0.3 OUTLIER 64.9 17.05 10.87 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.383 -179.233 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . 0.505 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 7.7 tt0 -104.95 121.47 43.81 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -82.06 112.14 18.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.684 -177.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -102.86 136.51 42.54 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.524 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -82.27 102.99 8.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.778 0.799 . . . . 0.0 108.897 171.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.512 ' CG1' HD11 ' B' ' 67' ' ' LEU . 2.9 t -78.58 -52.78 14.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.798 -171.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.485 ' HB2' ' CD2' ' B' ' 65' ' ' LEU . . . -146.9 137.72 23.86 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.492 -177.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 28.0 m -104.6 101.65 11.29 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 170.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . 0.425 ' CG1' HG11 ' B' ' 85' ' ' VAL . 6.2 p -121.77 109.82 25.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 122.005 0.907 . . . . 0.0 110.202 -177.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 80.4 p -122.84 -176.77 3.48 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.76 -175.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' B' ' 38' ' ' GLN . 9.9 mtmp? -58.04 -31.52 67.1 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.453 170.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.05 -40.93 52.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.634 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 69.8 mt -116.02 76.49 6.38 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.44 1.6 8.23 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.731 2.287 . . . . 0.0 113.397 -168.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . 0.415 ' OE1' ' HA ' ' C' ' 54' ' ' ALA . 10.2 tt0 -154.82 101.03 2.26 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.705 -170.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 65.7 t -102.63 121.01 53.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.108 0.48 . . . . 0.0 110.695 177.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.7 110.78 22.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.651 174.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' B' ' 30' ' ' SER . 0.3 OUTLIER -126.97 169.14 13.62 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.042 0.449 . . . . 0.0 111.738 -175.117 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 26.9 t0 -119.27 105.01 10.92 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.72 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.589 HD21 HD23 ' A' ' 88' ' ' LEU . 18.6 mt -120.76 150.76 40.49 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.999 178.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . 0.503 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 5.9 t30 -152.48 127.08 9.42 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.001 0.429 . . . . 0.0 110.022 172.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . 0.54 ' O ' ' HA ' ' B' ' 26' ' ' SER . 38.8 m-85 -121.31 161.49 21.94 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.695 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.502 ' HB2' ' HA ' ' A' ' 7' ' ' MET . 42.6 t -115.83 158.27 23.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.318 0.58 . . . . 0.0 111.874 -174.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -21.73 66.47 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.242 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.13 -0.84 61.45 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.897 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -100.69 166.01 11.1 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -145.12 129.5 17.81 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.773 HG22 ' HB2' ' B' ' 46' ' ' ALA . 9.7 pt -134.67 174.62 12.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.072 0.463 . . . . 0.0 111.404 -173.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.608 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 23.1 mtp -130.46 123.75 30.48 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . 0.403 ' CD1' ' HB2' ' B' ' 44' ' ' LEU . 0.9 OUTLIER -105.14 127.64 53.0 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.009 178.46 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.649 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 24.4 p90 -153.96 141.84 20.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.128 0.489 . . . . 0.0 111.772 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.663 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 11.6 p -113.3 141.83 46.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.053 -178.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -109.9 150.76 27.96 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.572 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.49 176.83 40.17 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -177.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -107.54 102.21 11.48 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.706 179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -170.28 150.42 3.6 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.825 169.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 32.4 t -104.44 119.4 38.88 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.564 HG23 ' HB2' ' B' ' 13' ' ' MET . 5.6 m -119.24 135.15 60.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 CA-C-O 121.488 0.661 . . . . 0.0 112.096 -174.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 7.5 t -99.6 119.56 38.27 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.98 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.64 HD13 HD23 ' B' ' 11' ' ' LEU . 5.3 mp -92.95 147.15 23.08 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 173.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.641 HD23 HD21 ' C' ' 67' ' ' LEU . 1.5 tp -133.19 138.73 46.67 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.117 -178.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.97 -167.61 23.64 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.972 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 90' ' ' TYR . . . . . 0.523 ' CD2' ' HB3' ' C' ' 68' ' ' ASN . 20.2 p90 -153.59 135.66 14.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.856 0.836 . . . . 0.0 112.451 178.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . 0.91 HD23 ' HB3' ' B' ' 27' ' ' PHE . 5.2 mt . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 114.098 -1.41 . . . . 0.0 109.42 175.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 7' ' ' MET . . . . . 0.512 ' HA ' ' HB2' ' D' ' 70' ' ' SER . 55.7 mtp . . . . . 0 C--O 1.225 -0.199 0 CA-C-O 120.761 0.315 . . . . 0.0 111.322 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 8' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -88.4 152.28 22.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.242 -175.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -138.68 146.44 41.59 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.85 155.83 26.35 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.138 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.627 HD23 HD13 ' C' ' 87' ' ' LEU . 42.4 tp -150.02 108.3 3.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.719 0.295 . . . . 0.0 110.912 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -86.78 103.36 15.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.051 0.453 . . . . 0.0 110.814 175.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 13' ' ' MET . . . . . 0.546 ' HB2' HG23 ' C' ' 85' ' ' VAL . 2.8 mmt -80.91 136.75 36.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.191 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . 0.571 ' HB2' ' HG3' ' C' ' 17' ' ' ARG . 27.2 mtpp -99.81 142.6 24.92 Favored Pre-proline 0 C--N 1.316 -0.854 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 173.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . 0.522 ' HB3' ' N ' ' C' ' 83' ' ' ALA . 7.6 Cg_endo -50.13 115.22 1.76 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 123.454 2.769 . . . . 0.0 113.382 -175.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . 0.673 ' HA ' ' O ' ' C' ' 79' ' ' THR . 26.0 mt-10 64.97 57.56 0.97 Allowed 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.617 0.722 . . . . 0.0 111.648 177.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 17' ' ' ARG . . . . . 0.571 ' HG3' ' HB2' ' C' ' 14' ' ' LYS . 13.6 mmt180 -117.48 163.41 16.44 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.512 171.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 18' ' ' LYS . . . . . 0.639 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 3.3 ttmp? -139.5 109.93 6.6 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.811 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -111.34 113.29 25.66 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 2.7 p -72.05 116.39 12.4 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 171.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -97.81 117.69 32.7 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.777 -163.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 13.6 t -92.03 143.41 26.5 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 171.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 49.1 mt -115.36 124.48 71.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.168 0.509 . . . . 0.0 111.758 -172.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . 0.463 HD12 ' N ' ' C' ' 24' ' ' ILE . 4.1 mp -90.52 -43.72 14.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.794 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -140.23 149.47 42.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.039 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' C' ' 69' ' ' PHE . 23.0 t -59.89 115.28 3.29 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.064 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 27' ' ' PHE . . . . . 0.918 ' HB3' HD23 ' C' ' 91' ' ' LEU . 12.3 p90 -122.89 148.97 44.84 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.512 0.672 . . . . 0.0 111.608 -177.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 28' ' ' HIS . . . . . 0.659 ' HE2' ' HB3' ' C' ' 30' ' ' SER . 10.3 t60 -106.61 120.43 41.94 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.438 -1.256 . . . . 0.0 109.593 178.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . 0.595 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 31.7 mt -89.46 134.28 29.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 171.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.659 ' HB3' ' HE2' ' C' ' 28' ' ' HIS . 16.1 p -122.46 -15.41 7.59 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -171.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 31' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -155.68 152.92 24.36 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 119.54 -1.314 . . . . 0.0 113.179 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.454 HG23 ' HG ' ' C' ' 87' ' ' LEU . 11.5 p -150.18 122.35 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 171.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.32 154.53 42.43 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.091 -0.381 . . . . 0.0 111.581 -172.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.512 ' HB3' HG12 ' C' ' 85' ' ' VAL . 3.7 pp -113.86 139.3 49.29 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.703 0.763 . . . . 0.0 111.528 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -104.62 -55.99 2.25 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.929 173.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -102.31 127.9 49.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 37' ' ' GLY . . . . . 0.494 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 150.85 162.12 10.44 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 119.604 -1.284 . . . . 0.0 113.512 176.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 38' ' ' GLN . . . . . 0.529 ' O ' ' HG3' ' C' ' 58' ' ' LYS . 26.5 mt-30 -102.47 -47.97 4.3 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 120.644 0.259 . . . . 0.0 111.34 177.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -151.61 132.98 14.6 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.436 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.535 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -132.53 116.25 16.49 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.47 0.653 . . . . 0.0 110.515 170.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' C' ' 79' ' ' THR . 97.8 mttt -100.12 112.66 24.97 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 40.7 tp -84.56 114.43 21.96 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -176.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 43' ' ' TYR . . . . . 0.472 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 98.6 m-85 -116.34 145.62 43.06 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.606 ' HA ' ' O ' ' C' ' 76' ' ' MET . 0.3 OUTLIER -131.92 130.82 42.06 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.769 171.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -104.27 113.75 27.51 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.8 177.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.748 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -126.09 139.24 53.55 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 174.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 57.19 30.42 18.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.392 0.615 . . . . 0.0 109.709 -171.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . 0.515 ' HE2' ' HA ' ' C' ' 48' ' ' LYS . 0.3 OUTLIER 64.77 17.08 10.8 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.467 -179.125 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . 0.498 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 7.8 tt0 -104.89 121.5 43.83 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -82.05 112.14 18.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.773 -177.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -102.96 136.61 42.46 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.505 177.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -82.29 103.03 8.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.803 0.811 . . . . 0.0 108.908 171.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 53' ' ' VAL . . . . . 0.513 ' CG1' HD11 ' C' ' 67' ' ' LEU . 3.0 t -78.62 -52.72 15.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.745 -171.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 54' ' ' ALA . . . . . 0.484 ' HB2' HD23 ' C' ' 65' ' ' LEU . . . -146.91 137.59 23.77 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.582 -177.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 27.9 m -104.46 101.62 11.29 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 170.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . 0.43 ' CG1' HG11 ' C' ' 85' ' ' VAL . 6.1 p -121.75 109.77 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-O 121.958 0.885 . . . . 0.0 110.172 -177.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 80.7 p -122.85 -176.81 3.49 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.762 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 58' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' C' ' 38' ' ' GLN . 9.9 mtmp? -57.98 -31.62 67.08 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.396 170.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.01 -40.91 52.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.633 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 69.7 mt -115.96 76.46 6.24 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 173.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -76.41 1.59 8.22 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.766 2.311 . . . . 0.0 113.383 -168.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . 0.424 ' OE1' ' HA ' ' D' ' 54' ' ' ALA . 10.2 tt0 -154.9 101.03 2.25 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.649 -170.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 66.0 t -102.61 121.01 53.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.072 0.463 . . . . 0.0 110.728 177.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.72 110.85 23.09 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.64 174.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' C' ' 30' ' ' SER . 0.3 OUTLIER -126.97 169.15 13.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.109 0.48 . . . . 0.0 111.604 -175.068 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 66' ' ' ASP . . . . . 0.561 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 27.4 t0 -119.3 105.04 10.94 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.764 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.641 HD21 HD23 ' B' ' 88' ' ' LEU . 18.7 mt -120.71 150.64 40.65 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.024 178.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . 0.523 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 6.0 t30 -152.37 127.12 9.52 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.961 0.41 . . . . 0.0 110.077 172.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 69' ' ' PHE . . . . . 0.536 ' O ' ' HA ' ' C' ' 26' ' ' SER . 38.8 m-85 -121.36 161.54 21.92 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.699 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . 0.522 ' HB2' ' HA ' ' B' ' 7' ' ' MET . 42.7 t -115.88 158.18 23.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.273 0.559 . . . . 0.0 111.856 -174.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -21.92 66.53 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.318 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.02 -0.83 61.64 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.91 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -100.72 166.04 11.08 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -145.09 129.65 17.98 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.748 HG22 ' HB2' ' C' ' 46' ' ' ALA . 9.7 pt -134.87 174.56 12.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.047 0.451 . . . . 0.0 111.375 -173.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.606 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 23.3 mtp -130.37 123.77 30.67 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.299 174.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 77' ' ' PHE . . . . . 0.405 ' CD1' ' HB2' ' C' ' 44' ' ' LEU . 1.0 OUTLIER -105.08 127.56 52.94 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.006 178.486 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 78' ' ' TYR . . . . . 0.639 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 24.4 p90 -153.94 141.83 20.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.067 0.46 . . . . 0.0 111.842 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . 0.673 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 11.7 p -113.29 141.85 46.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.103 -178.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -109.9 150.74 28.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.629 176.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.41 176.77 40.28 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -177.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -107.48 102.22 11.5 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 119.436 -0.905 . . . . 0.0 109.715 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . 0.535 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -170.2 150.41 3.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.942 169.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 32.5 t -104.42 119.38 38.84 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.546 HG23 ' HB2' ' C' ' 13' ' ' MET . 5.6 m -119.28 135.08 60.82 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 CA-C-O 121.454 0.645 . . . . 0.0 112.126 -174.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 7.5 t -99.61 119.5 38.17 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.044 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . 0.627 HD13 HD23 ' C' ' 11' ' ' LEU . 5.3 mp -92.95 147.01 23.19 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 173.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . 0.619 HD23 HD21 ' D' ' 67' ' ' LEU . 1.5 tp -133.15 138.8 46.76 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.145 -178.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.89 -167.59 23.54 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.072 -177.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 90' ' ' TYR . . . . . 0.524 ' CD2' ' HB3' ' D' ' 68' ' ' ASN . 20.2 p90 -153.7 135.7 14.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.867 0.841 . . . . 0.0 112.455 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . 0.918 HD23 ' HB3' ' C' ' 27' ' ' PHE . 5.2 mt . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.487 176.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 7' ' ' MET . . . . . 0.51 ' HA ' ' HB2' ' E' ' 70' ' ' SER . 55.7 mtp . . . . . 0 C--O 1.225 -0.231 0 CA-C-O 120.756 0.312 . . . . 0.0 111.287 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 8' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -88.29 152.23 22.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.287 -175.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 9' ' ' TRP . . . . . . . . . . . . . 87.1 t90 -138.64 146.44 41.68 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.83 155.89 26.38 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.038 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . 0.639 HD23 HD13 ' D' ' 87' ' ' LEU . 42.4 tp -150.04 108.23 3.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.665 0.269 . . . . 0.0 110.872 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 -86.79 103.31 15.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.072 0.463 . . . . 0.0 110.857 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 13' ' ' MET . . . . . 0.57 ' HB2' HG23 ' D' ' 85' ' ' VAL . 2.8 mmt -80.71 136.71 36.22 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.309 -178.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 14' ' ' LYS . . . . . 0.549 ' HB2' ' HG3' ' D' ' 17' ' ' ARG . 27.2 mtpp -99.88 142.61 24.92 Favored Pre-proline 0 C--N 1.317 -0.833 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . 0.521 ' HB3' ' N ' ' D' ' 83' ' ' ALA . 7.5 Cg_endo -50.11 115.28 1.79 Allowed 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 123.482 2.788 . . . . 0.0 113.293 -175.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . 0.681 ' HA ' ' O ' ' D' ' 79' ' ' THR . 26.1 mt-10 64.94 57.54 0.99 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.627 0.727 . . . . 0.0 111.631 177.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 17' ' ' ARG . . . . . 0.549 ' HG3' ' HB2' ' D' ' 14' ' ' LYS . 13.7 mmt180 -117.44 163.23 16.69 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.597 171.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . 0.648 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 3.3 ttmp? -139.38 109.96 6.65 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 123.446 0.466 . . . . 0.0 110.829 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -111.39 113.31 25.68 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 2.7 p -72.08 116.38 12.42 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 171.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -97.87 117.71 32.81 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.694 -163.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 13.7 t -92.06 143.41 26.49 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 171.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 49.0 mt -115.24 124.5 71.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.257 0.551 . . . . 0.0 111.761 -172.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . 0.47 HD12 ' N ' ' D' ' 24' ' ' ILE . 4.1 mp -90.59 -43.79 14.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.704 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -140.07 149.56 43.27 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.102 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 26' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' D' ' 69' ' ' PHE . 22.7 t -59.9 115.2 3.24 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.151 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 27' ' ' PHE . . . . . 0.889 ' HB3' HD23 ' D' ' 91' ' ' LEU . 12.5 p90 -122.81 148.88 44.87 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.487 0.66 . . . . 0.0 111.697 -177.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 28' ' ' HIS . . . . . 0.676 ' HE2' ' HB3' ' D' ' 30' ' ' SER . 10.3 t60 -106.55 120.43 41.92 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.662 178.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 29' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 31.5 mt -89.43 134.3 29.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 171.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . 0.676 ' HB3' ' HE2' ' D' ' 28' ' ' HIS . 16.1 p -122.46 -15.38 7.6 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -171.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 31' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -155.74 152.99 24.41 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 119.517 -1.325 . . . . 0.0 113.15 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.471 HG23 ' HG ' ' D' ' 87' ' ' LEU . 11.6 p -150.23 122.28 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 171.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.3 154.58 42.5 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.13 -0.356 . . . . 0.0 111.599 -172.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 34' ' ' LEU . . . . . 0.508 ' HB3' HG12 ' D' ' 85' ' ' VAL . 3.7 pp -113.94 139.3 49.33 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.6 0.714 . . . . 0.0 111.502 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -104.61 -55.98 2.26 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.846 173.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -102.32 127.77 49.16 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 170.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . 0.486 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 150.89 162.2 10.5 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 119.623 -1.275 . . . . 0.0 113.507 176.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 38' ' ' GLN . . . . . 0.516 ' O ' ' HG3' ' D' ' 58' ' ' LYS . 26.6 mt-30 -102.55 -47.94 4.29 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 121.191 -0.203 . . . . 0.0 111.286 177.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -151.53 132.93 14.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.598 -0.273 . . . . 0.0 110.419 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . 0.546 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -132.46 116.33 16.65 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.422 0.629 . . . . 0.0 110.512 170.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' D' ' 79' ' ' THR . 97.7 mttt -100.18 112.67 24.99 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 174.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 40.5 tp -84.62 114.55 22.07 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -176.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 43' ' ' TYR . . . . . 0.476 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 98.7 m-85 -116.37 145.67 43.05 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.612 ' HA ' ' O ' ' D' ' 76' ' ' MET . 0.3 OUTLIER -132.0 130.74 41.82 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.71 171.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 45' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -104.28 113.74 27.51 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.848 177.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.763 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -126.02 139.13 53.66 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 174.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 57.38 30.27 18.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.355 0.598 . . . . 0.0 109.674 -171.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 48' ' ' LYS . . . . . 0.54 ' HE2' ' HA ' ' D' ' 48' ' ' LYS . 0.3 OUTLIER 64.87 17.09 10.86 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.47 -179.088 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 7.8 tt0 -104.92 121.5 43.84 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -82.11 112.07 18.82 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.76 -177.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -102.88 136.6 42.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.523 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -82.36 103.09 9.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 171.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 53' ' ' VAL . . . . . 0.518 ' CG1' HD11 ' D' ' 67' ' ' LEU . 3.0 t -78.72 -52.72 15.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.735 -171.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 54' ' ' ALA . . . . . 0.485 ' HB2' ' CD2' ' D' ' 65' ' ' LEU . . . -146.92 137.73 23.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.498 -177.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 28.4 m -104.61 101.64 11.28 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 170.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 56' ' ' VAL . . . . . 0.416 ' CG1' HG11 ' D' ' 85' ' ' VAL . 6.1 p -121.73 109.85 25.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 122.019 0.914 . . . . 0.0 110.199 -177.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 80.7 p -122.88 -176.75 3.48 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.811 -175.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 58' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' D' ' 38' ' ' GLN . 9.9 mtmp? -57.94 -31.63 67.03 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.418 170.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.06 -40.87 52.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.606 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 69.9 mt -116.09 76.51 6.53 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 173.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -76.39 1.47 8.34 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.769 2.313 . . . . 0.0 113.381 -168.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -154.79 100.95 2.26 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.736 -170.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 65.9 t -102.58 121.05 53.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.038 0.447 . . . . 0.0 110.688 177.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.72 110.77 22.99 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.666 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 65' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' D' ' 30' ' ' SER . 0.3 OUTLIER -126.98 169.16 13.61 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.124 0.488 . . . . 0.0 111.639 -175.055 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 66' ' ' ASP . . . . . 0.57 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 27.2 t0 -119.32 105.1 10.99 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.712 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.619 HD21 HD23 ' C' ' 88' ' ' LEU . 18.6 mt -120.75 150.67 40.63 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.98 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 68' ' ' ASN . . . . . 0.524 ' HB3' ' CD2' ' C' ' 90' ' ' TYR . 6.0 t30 -152.41 127.11 9.49 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.91 0.386 . . . . 0.0 110.049 172.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 69' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' D' ' 26' ' ' SER . 38.4 m-85 -121.31 161.49 21.94 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.72 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . 0.512 ' HB2' ' HA ' ' C' ' 7' ' ' MET . 42.3 t -115.82 158.25 23.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.263 0.554 . . . . 0.0 111.847 -174.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -21.97 66.58 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.272 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.86 -1.07 61.79 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.906 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -100.57 166.02 11.12 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -145.04 129.59 17.98 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.763 HG22 ' HB2' ' D' ' 46' ' ' ALA . 9.8 pt -134.82 174.61 12.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.058 0.456 . . . . 0.0 111.322 -173.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 76' ' ' MET . . . . . 0.612 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 23.2 mtp -130.45 123.76 30.51 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.284 174.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 77' ' ' PHE . . . . . 0.411 ' CD1' ' HB2' ' D' ' 44' ' ' LEU . 1.0 OUTLIER -105.05 127.53 52.92 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.093 178.51 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 78' ' ' TYR . . . . . 0.648 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 24.2 p90 -153.89 141.91 20.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.096 0.474 . . . . 0.0 111.756 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 79' ' ' THR . . . . . 0.681 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 11.7 p -113.36 141.84 46.57 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.033 -178.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -109.88 150.72 28.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.622 176.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.42 176.79 40.28 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -177.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -107.4 102.21 11.51 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.716 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . 0.546 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -170.25 150.37 3.62 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.895 169.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 32.4 t -104.41 119.24 38.52 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.57 HG23 ' HB2' ' D' ' 13' ' ' MET . 5.7 m -119.14 135.19 60.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-O 121.425 0.631 . . . . 0.0 112.107 -174.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 7.5 t -99.67 119.47 38.16 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.976 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 87' ' ' LEU . . . . . 0.639 HD13 HD23 ' D' ' 11' ' ' LEU . 5.3 mp -92.87 147.07 23.15 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 173.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.613 HD23 HD21 ' E' ' 67' ' ' LEU . 1.5 tp -133.23 138.7 46.61 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.151 -178.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.82 -167.55 23.41 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.997 -177.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 90' ' ' TYR . . . . . 0.502 ' CD2' ' HB3' ' E' ' 68' ' ' ASN . 20.2 p90 -153.64 135.71 14.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.805 0.812 . . . . 0.0 112.497 178.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . 0.889 HD23 ' HB3' ' D' ' 27' ' ' PHE . 5.3 mt . . . . . 0 C--N 1.324 -0.504 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.396 176.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 7' ' ' MET . . . . . 0.527 ' HA ' ' HB2' ' A' ' 70' ' ' SER . 56.0 mtp . . . . . 0 C--O 1.224 -0.285 0 CA-C-O 120.681 0.277 . . . . 0.0 111.288 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 8' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -88.33 152.17 22.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.316 -175.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 9' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -138.62 146.51 41.82 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -178.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.81 155.88 26.38 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.166 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 11' ' ' LEU . . . . . 0.633 HD23 HD13 ' E' ' 87' ' ' LEU . 42.2 tp -150.06 108.33 3.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.774 0.321 . . . . 0.0 110.912 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -86.81 103.37 15.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.161 0.505 . . . . 0.0 110.834 175.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 13' ' ' MET . . . . . 0.552 ' HB2' HG23 ' E' ' 85' ' ' VAL . 2.8 mmt -80.84 136.74 36.15 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.22 -178.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 14' ' ' LYS . . . . . 0.553 ' HB2' ' HG3' ' E' ' 17' ' ' ARG . 27.2 mtpp -99.87 142.6 24.91 Favored Pre-proline 0 C--N 1.318 -0.803 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . 0.527 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 7.6 Cg_endo -50.02 115.22 1.74 Allowed 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 123.46 2.773 . . . . 0.0 113.399 -175.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 16' ' ' GLU . . . . . 0.678 ' HA ' ' O ' ' E' ' 79' ' ' THR . 25.9 mt-10 65.03 57.53 0.96 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.539 0.685 . . . . 0.0 111.637 177.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 17' ' ' ARG . . . . . 0.553 ' HG3' ' HB2' ' E' ' 14' ' ' LYS . 13.6 mmt180 -117.57 163.27 16.68 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.503 171.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . 0.639 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 3.3 ttmp? -139.47 109.96 6.62 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 123.457 0.473 . . . . 0.0 110.858 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -111.3 113.34 25.75 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 2.7 p -72.18 116.48 12.66 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -97.88 117.68 32.75 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.714 -163.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 13.5 t -91.98 143.44 26.48 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 171.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 48.7 mt -115.4 124.43 71.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.25 0.548 . . . . 0.0 111.781 -172.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . 0.475 HD12 ' N ' ' E' ' 24' ' ' ILE . 4.1 mp -90.41 -43.82 14.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.787 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -140.15 149.45 43.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.099 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 26' ' ' SER . . . . . 0.545 ' HA ' ' O ' ' E' ' 69' ' ' PHE . 23.0 t -59.83 115.24 3.25 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.155 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 27' ' ' PHE . . . . . 0.922 ' HB3' HD23 ' E' ' 91' ' ' LEU . 12.4 p90 -122.88 148.86 44.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.463 0.649 . . . . 0.0 111.684 -177.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 28' ' ' HIS . . . . . 0.678 ' HE2' ' HB3' ' E' ' 30' ' ' SER . 10.6 t60 -106.53 120.43 41.91 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.592 178.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 29' ' ' ILE . . . . . 0.58 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 31.5 mt -89.44 134.32 29.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 171.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . 0.678 ' HB3' ' HE2' ' E' ' 28' ' ' HIS . 16.1 p -122.51 -15.41 7.57 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -171.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 31' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -155.77 152.89 24.32 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.562 -1.304 . . . . 0.0 113.195 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.469 HG23 ' HG ' ' E' ' 87' ' ' LEU . 11.6 p -150.21 122.32 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 171.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.37 154.47 42.34 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 122.13 -0.356 . . . . 0.0 111.552 -172.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 34' ' ' LEU . . . . . 0.511 ' HB3' HG12 ' E' ' 85' ' ' VAL . 3.7 pp -113.84 139.32 49.25 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.677 0.751 . . . . 0.0 111.569 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -104.59 -56.08 2.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.829 173.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -102.31 127.86 49.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 170.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . 0.494 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 150.92 162.16 10.48 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 119.613 -1.28 . . . . 0.0 113.493 176.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 38' ' ' GLN . . . . . 0.508 ' O ' ' HG3' ' E' ' 58' ' ' LYS . 26.5 mt-30 -102.5 -47.98 4.29 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 121.155 -0.218 . . . . 0.0 111.3 177.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -151.55 132.97 14.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.439 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . 0.531 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -132.54 116.26 16.51 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.412 0.625 . . . . 0.0 110.557 170.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 41' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' E' ' 79' ' ' THR . 97.8 mttt -100.12 112.59 24.89 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 40.7 tp -84.58 114.54 22.05 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -176.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 43' ' ' TYR . . . . . 0.471 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 98.4 m-85 -116.39 145.62 43.1 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 44' ' ' LEU . . . . . 0.605 ' HA ' ' O ' ' E' ' 76' ' ' MET . 0.3 OUTLIER -132.0 130.83 41.92 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.673 171.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' E' E ' 45' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -104.3 113.82 27.64 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.787 177.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . 0.771 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -126.12 139.18 53.58 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 174.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 57.3 30.3 18.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.315 0.578 . . . . 0.0 109.687 -171.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 48' ' ' LYS . . . . . 0.532 ' HE2' ' HA ' ' E' ' 48' ' ' LYS . 0.3 OUTLIER 64.88 17.17 10.9 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.41 -179.194 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' E' E ' 49' ' ' GLN . . . . . 0.504 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 7.7 tt0 -105.07 121.49 43.91 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -82.04 112.05 18.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.76 -177.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -102.91 136.57 42.48 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.491 177.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -82.27 103.11 9.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 171.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . 0.508 ' CG1' HD11 ' E' ' 67' ' ' LEU . 2.9 t -78.63 -52.75 15.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.79 -172.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 54' ' ' ALA . . . . . 0.489 ' HB2' ' CD2' ' E' ' 65' ' ' LEU . . . -146.93 137.66 23.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.5 -177.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 28.2 m -104.55 101.61 11.26 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 170.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . 0.427 ' CG1' HG11 ' E' ' 85' ' ' VAL . 6.3 p -121.67 109.78 25.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.974 0.893 . . . . 0.0 110.263 -177.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 80.4 p -122.79 -176.76 3.47 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.816 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 58' ' ' LYS . . . . . 0.508 ' HG3' ' O ' ' E' ' 38' ' ' GLN . 9.9 mtmp? -57.95 -31.7 67.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.023 0.44 . . . . 0.0 110.417 170.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.97 -40.88 52.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.621 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 70.0 mt -116.05 76.41 6.4 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -76.33 1.58 8.2 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.836 2.357 . . . . 0.0 113.408 -168.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 62' ' ' GLN . . . . . 0.408 ' OE1' ' HA ' ' A' ' 54' ' ' ALA . 10.2 tt0 -154.89 100.99 2.25 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.613 -170.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 66.3 t -102.66 120.99 53.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.112 0.482 . . . . 0.0 110.788 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.69 110.9 23.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.603 175.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 65' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' E' ' 30' ' ' SER . 0.3 OUTLIER -127.03 169.19 13.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.663 -175.096 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' E' E ' 66' ' ' ASP . . . . . 0.557 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 27.1 t0 -119.35 104.98 10.86 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.709 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 67' ' ' LEU . . . . . 0.613 HD21 HD23 ' D' ' 88' ' ' LEU . 18.5 mt -120.74 150.64 40.67 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.979 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 68' ' ' ASN . . . . . 0.502 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 6.0 t30 -152.38 127.17 9.55 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.922 0.391 . . . . 0.0 110.013 172.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 69' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' E' ' 26' ' ' SER . 38.5 m-85 -121.3 161.52 21.87 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.745 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 70' ' ' SER . . . . . 0.51 ' HB2' ' HA ' ' D' ' 7' ' ' MET . 42.1 t -115.89 158.26 23.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.262 0.553 . . . . 0.0 111.841 -174.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -21.81 66.49 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.297 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.98 -1.03 61.61 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.949 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -100.59 166.0 11.13 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -145.03 129.71 18.09 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 75' ' ' ILE . . . . . 0.771 HG22 ' HB2' ' E' ' 46' ' ' ALA . 9.7 pt -134.84 174.6 12.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.002 0.43 . . . . 0.0 111.376 -173.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 76' ' ' MET . . . . . 0.605 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 22.9 mtp -130.41 123.76 30.56 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 77' ' ' PHE . . . . . 0.404 ' CD1' ' HB2' ' E' ' 44' ' ' LEU . 0.9 OUTLIER -105.08 127.58 52.95 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.038 178.493 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' E' E ' 78' ' ' TYR . . . . . 0.639 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 24.5 p90 -153.91 141.85 20.2 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.118 0.485 . . . . 0.0 111.822 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 79' ' ' THR . . . . . 0.678 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 11.5 p -113.3 141.94 46.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.046 -178.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -110.03 150.78 28.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.534 176.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.4 176.86 40.3 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -177.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -107.46 102.18 11.47 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 119.409 -0.916 . . . . 0.0 109.713 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 83' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -170.2 150.38 3.66 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.863 169.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 32.3 t -104.42 119.31 38.69 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 85' ' ' VAL . . . . . 0.552 HG23 ' HB2' ' E' ' 13' ' ' MET . 5.7 m -119.2 135.1 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 CA-C-O 121.421 0.629 . . . . 0.0 112.17 -174.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 7.5 t -99.57 119.58 38.28 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.963 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 87' ' ' LEU . . . . . 0.633 HD13 HD23 ' E' ' 11' ' ' LEU . 5.3 mp -93.01 147.14 23.09 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . 0.643 HD23 HD21 ' A' ' 67' ' ' LEU . 1.5 tp -133.22 138.67 46.61 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.12 -178.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.86 -167.62 23.55 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.021 -177.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 90' ' ' TYR . . . . . 0.542 ' CD2' ' HB3' ' A' ' 68' ' ' ASN . 20.1 p90 -153.65 135.74 14.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.932 0.872 . . . . 0.0 112.403 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 91' ' ' LEU . . . . . 0.922 HD23 ' HB3' ' E' ' 27' ' ' PHE . 5.2 mt . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 113.983 -1.462 . . . . 0.0 109.402 176.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.416 ' HA ' ' HB2' ' B' ' 70' ' ' SER . 57.1 mtp . . . . . 0 CA--C 1.521 -0.145 0 CA-C-O 121.053 0.454 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.557 ' CE1' HD21 ' B' ' 44' ' ' LEU . 48.7 t80 -66.47 145.49 55.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.068 -176.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.56 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 90.2 t90 -132.71 146.08 51.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.007 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.1 146.69 16.36 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.095 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.56 ' HB2' ' CH2' ' A' ' 9' ' ' TRP . 63.5 tp -134.27 109.02 8.56 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.983 0.42 . . . . 0.0 110.454 178.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -91.52 107.71 19.4 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.516 177.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.565 ' SD ' HD11 ' A' ' 87' ' ' LEU . 54.2 mtp -102.27 143.82 31.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.38 0.61 . . . . 0.0 111.406 -174.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -100.92 151.39 37.6 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.193 -177.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.472 ' HB3' ' N ' ' A' ' 83' ' ' ALA . 11.2 Cg_endo -54.99 113.77 1.56 Allowed 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.19 2.593 . . . . 0.0 112.832 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 79' ' ' THR . 17.3 mt-10 59.96 70.96 0.6 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.508 0.67 . . . . 0.0 111.414 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.2 142.77 32.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.558 174.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.712 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 35.3 ttmt -116.44 117.46 29.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.389 -176.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.418 ' OH ' ' HA ' ' A' ' 13' ' ' MET . 1.9 m-85 -110.37 122.26 47.28 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.47 ' HB3' ' SD ' ' A' ' 76' ' ' MET . 6.0 p -102.51 99.78 9.83 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 169.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 19.9 pm0 -117.72 143.0 46.62 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.595 0.712 . . . . 0.0 112.274 -174.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.0 t -93.31 160.77 14.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.526 176.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.412 HG22 ' HA ' ' A' ' 71' ' ' LYS . 70.1 mt -112.47 119.35 60.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.066 0.46 . . . . 0.0 111.529 -173.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.407 HD12 ' N ' ' A' ' 25' ' ' LYS . 1.7 pp -99.6 -11.53 8.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.025 177.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.407 ' N ' HD12 ' A' ' 24' ' ' ILE . 84.7 tttt -148.0 119.53 7.96 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.3 p -61.7 140.53 58.18 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 123.379 0.425 . . . . 0.0 110.656 -175.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.798 ' HB3' HD23 ' A' ' 91' ' ' LEU . 42.6 p90 -152.13 162.79 40.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.718 0.77 . . . . 0.0 112.895 -174.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.544 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 7.7 t60 -114.74 124.52 52.0 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.009 176.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 41.6 mt -88.28 135.91 24.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 170.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.487 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 43.8 p -123.62 -5.26 8.15 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -170.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . 179.88 155.14 14.62 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 119.192 -1.48 . . . . 0.0 113.513 175.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.447 HG23 ' HG ' ' A' ' 87' ' ' LEU . 11.9 p -136.78 132.83 48.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.8 156.48 42.4 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.605 -176.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.613 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.1 pp -123.72 145.55 48.92 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.403 0.621 . . . . 0.0 111.01 177.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -110.2 -52.06 2.81 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.653 174.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -102.93 127.5 50.12 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 169.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.46 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 151.75 156.75 7.59 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 119.769 -1.205 . . . . 0.0 113.344 177.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.487 ' HA ' ' HB2' ' A' ' 58' ' ' LYS . 94.8 mt-30 -102.37 -44.48 5.37 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.616 0.246 . . . . 0.0 111.07 178.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -152.82 128.83 10.34 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.363 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.477 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -128.22 113.02 15.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.549 0.69 . . . . 0.0 109.981 168.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 79' ' ' THR . 28.6 mmmt -94.59 109.39 21.31 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.51 HD23 ' HB ' ' A' ' 53' ' ' VAL . 48.3 tp -82.08 109.52 16.47 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -174.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -112.24 136.33 51.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.108 177.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.698 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -123.88 121.76 36.21 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.525 175.441 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -109.92 111.1 22.29 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.02 178.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.522 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -128.72 139.32 52.28 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.539 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 56.61 35.65 26.41 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 123.751 0.657 . . . . 0.0 110.314 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.429 ' HB3' ' NZ ' ' A' ' 48' ' ' LYS . 9.1 mtpm? 63.6 32.26 14.1 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.102 -0.953 . . . . 0.0 112.284 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.559 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 59.4 tp60 -128.28 133.96 48.85 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 175.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -89.05 121.84 31.79 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 -177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -116.72 123.44 47.21 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.506 176.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -75.38 106.69 5.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 169.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.613 ' CG2' ' HB3' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -84.22 -46.37 17.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.532 -172.299 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.56 ' HB2' HD21 ' A' ' 65' ' ' LEU . . . -153.96 149.48 27.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.641 -177.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.2 m -113.02 101.6 9.62 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 169.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.45 HG13 ' HB3' ' A' ' 40' ' ' ALA . 7.8 p -115.7 114.36 46.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.544 0.688 . . . . 0.0 109.283 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 44.6 p -122.62 -179.12 4.11 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.214 -172.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HB2' ' HA ' ' A' ' 38' ' ' GLN . 58.1 tttt -58.68 -32.29 68.98 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.704 171.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.4 -40.87 22.77 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.922 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 84.5 mt -108.38 86.63 3.55 Favored Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 175.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.08 0.17 8.76 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.665 2.243 . . . . 0.0 113.843 -166.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -164.49 131.07 3.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.24 0.543 . . . . 0.0 111.516 -175.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 93.4 t -122.0 112.22 33.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.311 174.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.59 131.49 41.76 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 174.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.56 HD21 ' HB2' ' A' ' 54' ' ' ALA . 86.3 mt -124.16 168.14 13.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.482 0.658 . . . . 0.0 112.303 -173.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.491 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 18.5 t0 -142.33 99.48 3.51 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.351 169.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 2.4 mt -129.46 144.21 51.16 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.437 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 5.9 t30 -141.79 114.91 8.74 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.539 -0.465 . . . . 0.0 109.771 176.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -111.14 146.93 35.96 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.541 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.9 t -97.88 166.72 11.32 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.412 ' HA ' HG22 ' A' ' 23' ' ' ILE . 21.6 ptmt -75.57 2.21 12.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.241 0.543 . . . . 0.0 110.591 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.25 -7.77 51.47 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.294 172.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -93.18 138.75 31.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.044 0.449 . . . . 0.0 110.447 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -122.22 117.0 25.12 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.522 HG22 ' HB2' ' A' ' 46' ' ' ALA . 14.9 pt -128.58 162.73 34.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.188 0.518 . . . . 0.0 112.054 -168.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.482 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 4.9 mtm -119.93 125.67 49.0 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 172.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.698 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -109.6 127.09 54.27 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 176.548 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.712 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 53.2 p90 -155.42 139.22 16.18 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.009 -175.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.576 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 2.9 p -111.7 134.23 53.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.309 -176.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.423 ' HB3' ' HB2' ' A' ' 41' ' ' LYS . . . -100.74 157.09 16.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.536 175.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.81 179.08 46.16 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -176.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -108.18 102.96 12.06 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.003 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.477 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -168.79 150.8 4.83 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.505 170.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.3 t -109.74 121.86 46.17 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.613 HG12 ' HB3' ' A' ' 34' ' ' LEU . 7.0 m -117.68 155.26 19.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.316 0.579 . . . . 0.0 112.38 -173.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.4 m -120.72 122.43 40.39 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.58 173.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.565 HD11 ' SD ' ' A' ' 13' ' ' MET . 4.7 mp -96.03 145.76 25.19 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 170.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.526 HD13 ' O ' ' A' ' 87' ' ' LEU . 1.2 mm? -121.02 150.3 41.35 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 173.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.31 -167.81 27.54 Favored Glycine 0 N--CA 1.438 -1.18 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.248 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.436 ' CD2' ' HB3' ' B' ' 68' ' ' ASN . 3.4 p90 -147.57 129.18 15.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.735 0.779 . . . . 0.0 112.07 177.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.798 HD23 ' HB3' ' A' ' 27' ' ' PHE . 15.7 mt . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 113.918 -1.492 . . . . 0.0 109.815 176.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 56.8 mtp . . . . . 0 CA--C 1.521 -0.162 0 CA-C-O 121.012 0.434 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . 0.614 ' CE1' HD21 ' C' ' 44' ' ' LEU . 48.2 t80 -66.5 145.55 55.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.057 -176.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . 0.565 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 90.1 t90 -132.75 146.06 51.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.003 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.19 146.74 16.44 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.118 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.565 ' HB2' ' CH2' ' B' ' 9' ' ' TRP . 63.5 tp -134.29 109.05 8.57 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.013 0.435 . . . . 0.0 110.557 178.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -91.43 107.68 19.37 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.556 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . 0.579 ' SD ' HD11 ' B' ' 87' ' ' LEU . 53.8 mtp -102.29 143.67 31.76 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.396 0.617 . . . . 0.0 111.382 -174.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -100.88 151.48 37.62 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.095 -177.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.464 ' HB3' ' N ' ' B' ' 83' ' ' ALA . 11.1 Cg_endo -55.02 113.87 1.6 Allowed 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 123.142 2.561 . . . . 0.0 112.752 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.581 ' HA ' ' O ' ' B' ' 79' ' ' THR . 17.3 mt-10 59.91 71.02 0.59 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.501 0.667 . . . . 0.0 111.356 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.23 142.83 32.66 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.613 174.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.709 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 35.3 ttmt -116.6 117.49 29.99 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.32 -176.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' TYR . . . . . 0.42 ' OH ' ' HA ' ' B' ' 13' ' ' MET . 1.9 m-85 -110.43 122.3 47.38 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.464 ' HB3' ' SD ' ' B' ' 76' ' ' MET . 5.9 p -102.58 99.83 9.86 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 169.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 19.8 pm0 -117.83 142.98 46.7 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.576 0.703 . . . . 0.0 112.165 -174.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 13.0 t -93.21 160.71 14.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.549 176.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.415 HG22 ' HA ' ' B' ' 71' ' ' LYS . 70.1 mt -112.52 119.4 60.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.138 0.494 . . . . 0.0 111.523 -173.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.405 HD12 ' N ' ' B' ' 25' ' ' LYS . 1.7 pp -99.68 -11.52 8.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.906 177.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.405 ' N ' HD12 ' B' ' 24' ' ' ILE . 84.8 tttt -147.95 119.58 8.01 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 31.4 p -61.67 140.53 58.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.654 -175.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . 0.792 ' HB3' HD23 ' B' ' 91' ' ' LEU . 42.8 p90 -152.16 162.73 40.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.774 0.797 . . . . 0.0 112.903 -174.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' HIS . . . . . 0.53 ' HA ' ' O ' ' B' ' 67' ' ' LEU . 7.6 t60 -114.66 124.49 51.95 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.053 177.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 41.8 mt -88.26 135.89 24.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 170.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.491 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 45.2 p -123.64 -5.2 8.14 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -170.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . 179.86 155.17 14.68 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 119.188 -1.482 . . . . 0.0 113.538 175.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.452 HG23 ' HG ' ' B' ' 87' ' ' LEU . 11.9 p -136.85 132.75 47.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 174.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.76 156.51 42.45 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 121.937 -0.477 . . . . 0.0 111.6 -176.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.629 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.1 pp -123.82 145.43 49.08 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.541 0.686 . . . . 0.0 111.038 177.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -110.02 -52.1 2.81 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.719 174.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -102.93 127.38 50.16 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 169.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.456 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 151.9 156.79 7.62 Favored Glycine 0 N--CA 1.437 -1.253 0 C-N-CA 119.756 -1.211 . . . . 0.0 113.366 177.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . 0.479 ' HA ' ' HB2' ' B' ' 58' ' ' LYS . 94.9 mt-30 -102.36 -44.34 5.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.692 0.282 . . . . 0.0 111.091 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -152.95 128.77 10.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.561 0.22 . . . . 0.0 111.339 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.472 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -128.16 113.08 15.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.539 0.685 . . . . 0.0 109.916 167.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' B' ' 79' ' ' THR . 28.6 mmmt -94.57 109.31 21.22 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.509 HD23 ' HB ' ' B' ' 53' ' ' VAL . 48.6 tp -82.08 109.44 16.4 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -174.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -112.2 136.41 51.66 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.072 177.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.694 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 0.1 OUTLIER -123.94 121.67 35.9 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.478 175.465 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -109.82 111.24 22.55 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.968 178.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.536 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -128.75 139.28 52.28 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.602 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 56.63 35.61 26.37 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.746 0.654 . . . . 0.0 110.358 -177.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.435 ' HB3' ' NZ ' ' B' ' 48' ' ' LYS . 9.1 mtpm? 63.57 32.38 14.1 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.277 178.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . 0.553 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 59.3 tp60 -128.37 133.85 48.72 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 175.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -88.94 121.78 31.65 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -177.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -116.67 123.44 47.27 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.461 176.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -75.39 106.66 5.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 169.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.613 ' CG2' ' HB3' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -84.15 -46.42 17.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.535 -172.299 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.553 ' HB2' HD21 ' B' ' 65' ' ' LEU . . . -153.92 149.41 27.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.715 -177.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 53.2 m -113.0 101.67 9.69 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 169.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . 0.437 HG13 ' HB3' ' B' ' 40' ' ' ALA . 7.7 p -115.78 114.35 45.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.578 0.704 . . . . 0.0 109.249 -179.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 45.0 p -122.59 -179.18 4.13 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.195 -172.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . 0.479 ' HB2' ' HA ' ' B' ' 38' ' ' GLN . 58.0 tttt -58.66 -32.33 69.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.747 171.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.37 -40.87 22.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.928 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 84.0 mt -108.31 86.69 3.52 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.16 0.21 8.74 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.731 2.288 . . . . 0.0 113.807 -166.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -164.52 131.05 3.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.326 0.584 . . . . 0.0 111.528 -175.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 92.9 t -121.95 112.17 33.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.348 174.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.56 131.54 41.83 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 174.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.553 HD21 ' HB2' ' B' ' 54' ' ' ALA . 86.1 mt -124.2 168.12 13.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.46 0.648 . . . . 0.0 112.226 -173.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . 0.484 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 18.6 t0 -142.4 99.44 3.5 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.396 169.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' B' ' 28' ' ' HIS . 2.3 mt -129.34 144.27 51.17 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . 0.436 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 5.9 t30 -141.98 114.89 8.65 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.836 176.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -111.03 146.89 35.92 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.552 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.416 ' HB2' ' HA ' ' A' ' 7' ' ' MET . 21.9 t -97.83 166.7 11.34 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . 0.415 ' HA ' HG22 ' B' ' 23' ' ' ILE . 21.6 ptmt -75.53 2.11 12.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.208 0.528 . . . . 0.0 110.568 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.11 -7.78 51.82 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.336 172.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -93.24 138.68 31.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.183 0.516 . . . . 0.0 110.493 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -122.17 116.95 25.07 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.536 HG22 ' HB2' ' B' ' 46' ' ' ALA . 14.9 pt -128.41 162.86 34.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.243 0.545 . . . . 0.0 111.983 -168.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.491 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 4.9 mtm -120.08 125.8 49.18 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.389 172.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . 0.694 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.8 OUTLIER -109.64 127.08 54.3 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.64 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.709 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 53.2 p90 -155.43 139.23 16.19 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.983 -175.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.581 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 3.0 p -111.59 134.16 53.36 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.404 -176.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . 0.427 ' HB3' ' HB2' ' B' ' 41' ' ' LYS . . . -100.64 157.03 16.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.518 175.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.91 178.96 46.04 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -176.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -108.08 102.91 12.03 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.971 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.472 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -168.76 150.88 4.88 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.47 170.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 15.9 t -109.76 121.89 46.26 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.629 HG12 ' HB3' ' B' ' 34' ' ' LEU . 7.0 m -117.79 155.29 19.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.415 0.626 . . . . 0.0 112.331 -173.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 49.3 m -120.64 122.44 40.49 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.583 173.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.579 HD11 ' SD ' ' B' ' 13' ' ' MET . 4.7 mp -96.02 145.71 25.23 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 170.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.528 HD13 ' O ' ' B' ' 87' ' ' LEU . 1.2 mm? -120.96 150.2 41.48 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 173.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.21 -167.89 27.55 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.327 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 90' ' ' TYR . . . . . 0.435 ' CD2' ' HB3' ' C' ' 68' ' ' ASN . 3.4 p90 -147.53 129.22 15.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.755 0.788 . . . . 0.0 112.166 177.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . 0.792 HD23 ' HB3' ' B' ' 27' ' ' PHE . 15.8 mt . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 113.949 -1.478 . . . . 0.0 109.766 176.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 7' ' ' MET . . . . . 0.422 ' HA ' ' HB2' ' D' ' 70' ' ' SER . 56.4 mtp . . . . . 0 CA--C 1.521 -0.144 0 CA-C-O 120.973 0.416 . . . . 0.0 111.289 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 8' ' ' PHE . . . . . 0.594 ' CE1' HD21 ' D' ' 44' ' ' LEU . 48.8 t80 -66.35 145.47 55.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.101 -176.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . 0.559 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 90.2 t90 -132.71 146.02 51.52 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.046 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.13 146.69 16.35 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.1 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.559 ' HB2' ' CH2' ' C' ' 9' ' ' TRP . 63.5 tp -134.29 109.0 8.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.032 0.444 . . . . 0.0 110.468 178.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -91.44 107.66 19.36 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.583 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 13' ' ' MET . . . . . 0.572 ' SD ' HD11 ' C' ' 87' ' ' LEU . 53.5 mtp -102.21 143.61 31.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.322 0.582 . . . . 0.0 111.496 -174.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -100.8 151.46 37.6 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.205 -177.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . 0.463 ' HB3' ' N ' ' C' ' 83' ' ' ALA . 11.2 Cg_endo -55.01 113.89 1.61 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 123.152 2.568 . . . . 0.0 112.796 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' C' ' 79' ' ' THR . 17.4 mt-10 59.96 70.97 0.6 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.46 0.648 . . . . 0.0 111.328 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.24 142.97 32.67 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.554 174.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 18' ' ' LYS . . . . . 0.703 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 35.2 ttmt -116.69 117.42 29.76 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.323 -176.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . 0.426 ' OH ' ' HA ' ' C' ' 13' ' ' MET . 1.9 m-85 -110.38 122.33 47.43 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . 0.458 ' HB3' ' SD ' ' C' ' 76' ' ' MET . 6.1 p -102.59 99.84 9.87 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 169.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 19.8 pm0 -117.78 143.05 46.6 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.611 0.72 . . . . 0.0 112.163 -174.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 12.9 t -93.36 160.76 14.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.532 176.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . 0.404 HG22 ' HA ' ' C' ' 71' ' ' LYS . 70.3 mt -112.54 119.35 60.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.141 0.495 . . . . 0.0 111.531 -173.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . 0.414 HD12 ' N ' ' C' ' 25' ' ' LYS . 1.7 pp -99.6 -11.51 8.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.022 177.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . 0.414 ' N ' HD12 ' C' ' 24' ' ' ILE . 84.7 tttt -148.02 119.46 7.91 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 31.7 p -61.57 140.46 58.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.688 -175.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 27' ' ' PHE . . . . . 0.806 ' HB3' HD23 ' C' ' 91' ' ' LEU . 42.6 p90 -152.04 162.86 40.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.652 0.739 . . . . 0.0 112.969 -175.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 28' ' ' HIS . . . . . 0.538 ' HA ' ' O ' ' C' ' 67' ' ' LEU . 7.5 t60 -114.81 124.58 52.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.01 177.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 41.6 mt -88.32 135.92 24.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 170.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.502 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 44.9 p -123.59 -5.31 8.16 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -170.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 31' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . 179.89 155.09 14.49 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 119.181 -1.485 . . . . 0.0 113.547 176.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.463 HG23 ' HG ' ' C' ' 87' ' ' LEU . 12.0 p -136.8 132.84 48.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 174.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.82 156.52 42.45 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 121.952 -0.468 . . . . 0.0 111.589 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.625 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.1 pp -123.82 145.45 49.06 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.514 0.673 . . . . 0.0 111.044 177.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -110.03 -52.14 2.81 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.703 174.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -102.9 127.41 50.11 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 169.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 37' ' ' GLY . . . . . 0.465 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 151.86 156.76 7.6 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 119.848 -1.168 . . . . 0.0 113.46 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 38' ' ' GLN . . . . . 0.478 ' HA ' ' HB2' ' C' ' 58' ' ' LYS . 95.0 mt-30 -102.4 -44.34 5.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.642 0.258 . . . . 0.0 111.059 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -152.91 128.82 10.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.57 0.224 . . . . 0.0 111.361 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.471 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -128.24 112.94 15.05 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.524 0.678 . . . . 0.0 109.972 168.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' C' ' 79' ' ' THR . 28.7 mmmt -94.57 109.32 21.23 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 176.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.508 HD23 ' HB ' ' C' ' 53' ' ' VAL . 48.5 tp -82.08 109.46 16.42 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -174.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -112.3 136.4 51.78 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.071 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.7 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 0.1 OUTLIER -123.88 121.79 36.29 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.478 175.463 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -109.85 111.14 22.38 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.968 178.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.532 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -128.7 139.39 52.25 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.607 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 56.5 35.75 26.49 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 123.728 0.643 . . . . 0.0 110.304 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . 0.426 ' HB3' ' NZ ' ' C' ' 48' ' ' LYS . 9.1 mtpm? 63.64 32.2 14.05 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.253 178.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . 0.554 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 59.5 tp60 -128.23 133.88 48.9 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 175.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -88.99 121.69 31.61 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -116.66 123.43 47.26 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.453 176.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -75.4 106.72 5.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 53' ' ' VAL . . . . . 0.608 ' CG2' ' HB3' ' C' ' 44' ' ' LEU . 0.7 OUTLIER -84.2 -46.41 17.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.553 -172.351 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 54' ' ' ALA . . . . . 0.552 ' HB2' HD21 ' C' ' 65' ' ' LEU . . . -153.97 149.44 27.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.696 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 52.6 m -112.96 101.6 9.63 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 169.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . 0.44 HG13 ' HB3' ' C' ' 40' ' ' ALA . 7.8 p -115.69 114.33 45.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.517 0.675 . . . . 0.0 109.298 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 44.3 p -122.62 -179.17 4.13 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.205 -172.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 58' ' ' LYS . . . . . 0.478 ' HB2' ' HA ' ' C' ' 38' ' ' GLN . 57.9 tttt -58.52 -32.35 68.76 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.745 171.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.38 -41.03 22.57 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.851 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 83.9 mt -108.22 86.7 3.46 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 174.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.19 0.2 8.77 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.74 2.293 . . . . 0.0 113.786 -166.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -164.46 131.12 3.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.245 0.545 . . . . 0.0 111.576 -175.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 94.0 t -122.03 112.18 33.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.303 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.67 131.48 41.69 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . 0.552 HD21 ' HB2' ' C' ' 54' ' ' ALA . 86.2 mt -124.17 168.17 13.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.46 0.648 . . . . 0.0 112.265 -173.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 66' ' ' ASP . . . . . 0.461 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 18.5 t0 -142.46 99.46 3.5 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.964 -1.017 . . . . 0.0 108.332 169.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' C' ' 28' ' ' HIS . 2.3 mt -129.42 144.29 51.19 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . 0.435 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 5.9 t30 -141.86 114.95 8.74 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.762 176.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -111.17 146.88 36.1 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.529 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 21.9 t -97.81 166.62 11.38 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . 0.404 ' HA ' HG22 ' C' ' 23' ' ' ILE . 21.6 ptmt -75.46 2.08 12.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.215 0.531 . . . . 0.0 110.588 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.15 -7.7 51.87 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.253 172.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -93.27 138.7 31.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.123 0.487 . . . . 0.0 110.428 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -122.24 116.97 25.06 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 175.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.532 HG22 ' HB2' ' C' ' 46' ' ' ALA . 15.0 pt -128.51 162.73 34.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.259 0.552 . . . . 0.0 112.014 -168.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.486 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 4.8 mtm -119.92 125.69 49.08 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.475 172.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 77' ' ' PHE . . . . . 0.7 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.8 OUTLIER -109.66 127.11 54.33 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 176.635 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 78' ' ' TYR . . . . . 0.703 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 53.3 p90 -155.42 139.21 16.18 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.862 -0.735 . . . . 0.0 112.079 -176.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . 0.577 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 3.0 p -111.56 134.22 53.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.42 -176.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 80' ' ' ALA . . . . . 0.436 ' HB3' ' HB2' ' C' ' 41' ' ' LYS . . . -100.71 157.1 16.94 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.522 175.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.81 178.93 46.2 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -176.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -108.06 102.98 12.1 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.064 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -168.79 150.77 4.82 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.504 170.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 15.8 t -109.72 121.93 46.34 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.625 HG12 ' HB3' ' C' ' 34' ' ' LEU . 6.9 m -117.78 155.3 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 CA-C-O 121.344 0.592 . . . . 0.0 112.353 -173.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 49.9 m -120.62 122.41 40.45 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.573 173.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . 0.572 HD11 ' SD ' ' C' ' 13' ' ' MET . 4.7 mp -96.0 145.72 25.21 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 170.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . 0.521 HD13 ' O ' ' C' ' 87' ' ' LEU . 1.2 mm? -121.0 150.31 41.32 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 173.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.31 -167.96 27.77 Favored Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.249 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 90' ' ' TYR . . . . . 0.447 ' CD2' ' HB3' ' D' ' 68' ' ' ASN . 3.3 p90 -147.52 129.24 15.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.785 0.802 . . . . 0.0 112.086 177.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . 0.806 HD23 ' HB3' ' C' ' 27' ' ' PHE . 15.9 mt . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 113.911 -1.495 . . . . 0.0 109.761 176.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 56.7 mtp . . . . . 0 CA--C 1.52 -0.183 0 CA-C-O 121.03 0.443 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 8' ' ' PHE . . . . . 0.592 ' CE1' HD21 ' E' ' 44' ' ' LEU . 48.6 t80 -66.5 145.55 55.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.1 -176.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 9' ' ' TRP . . . . . 0.556 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 90.2 t90 -132.75 146.02 51.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.013 179.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.11 146.71 16.41 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.125 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . 0.556 ' HB2' ' CH2' ' D' ' 9' ' ' TRP . 63.4 tp -134.31 108.95 8.5 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.031 0.443 . . . . 0.0 110.558 178.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -91.38 107.67 19.37 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.566 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 13' ' ' MET . . . . . 0.575 ' SD ' HD11 ' D' ' 87' ' ' LEU . 54.0 mtp -102.3 143.77 31.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.429 0.633 . . . . 0.0 111.408 -174.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -100.84 151.44 37.61 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.203 -177.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . 0.473 ' HB3' ' N ' ' D' ' 83' ' ' ALA . 11.1 Cg_endo -55.06 113.9 1.62 Allowed 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 123.119 2.546 . . . . 0.0 112.754 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . 0.57 ' HA ' ' O ' ' D' ' 79' ' ' THR . 17.3 mt-10 60.02 70.83 0.61 Allowed 'General case' 0 C--O 1.233 0.207 0 O-C-N 123.711 0.632 . . . . 0.0 111.36 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.13 142.97 32.81 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.516 174.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . 0.702 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 35.3 ttmt -116.69 117.44 29.81 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.373 -176.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 19' ' ' TYR . . . . . 0.426 ' OH ' ' HA ' ' D' ' 13' ' ' MET . 1.9 m-85 -110.29 122.38 47.52 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . 0.462 ' HB3' ' SD ' ' D' ' 76' ' ' MET . 5.9 p -102.63 99.86 9.88 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 169.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 19.8 pm0 -117.76 142.98 46.66 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.516 0.674 . . . . 0.0 112.215 -174.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 13.0 t -93.24 160.77 14.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.609 176.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 70.1 mt -112.6 119.49 60.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.217 0.532 . . . . 0.0 111.449 -173.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . 0.409 HD12 ' N ' ' D' ' 25' ' ' LYS . 1.7 pp -99.7 -11.59 8.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.005 177.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . 0.409 ' N ' HD12 ' D' ' 24' ' ' ILE . 84.7 tttt -147.99 119.55 7.97 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 31.3 p -61.75 140.51 58.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.691 -175.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 27' ' ' PHE . . . . . 0.806 ' HB3' HD23 ' D' ' 91' ' ' LEU . 42.8 p90 -152.08 162.82 40.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.712 0.768 . . . . 0.0 112.898 -174.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 28' ' ' HIS . . . . . 0.53 ' HA ' ' O ' ' D' ' 67' ' ' LEU . 7.7 t60 -114.81 124.58 52.1 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.011 176.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 29' ' ' ILE . . . . . 0.513 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 42.1 mt -88.33 135.88 24.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 170.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . 0.504 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 44.6 p -123.59 -5.28 8.16 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -170.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 31' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . 179.94 155.12 14.6 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 119.175 -1.488 . . . . 0.0 113.544 176.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.473 HG23 ' HG ' ' D' ' 87' ' ' LEU . 12.0 p -136.84 132.84 48.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 174.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.83 156.46 42.36 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.918 -0.489 . . . . 0.0 111.598 -176.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 34' ' ' LEU . . . . . 0.624 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.1 pp -123.77 145.43 49.04 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.538 0.685 . . . . 0.0 111.069 177.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -110.13 -51.93 2.83 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.706 174.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -103.02 127.4 50.28 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 169.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . 0.47 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 151.81 156.81 7.62 Favored Glycine 0 N--CA 1.437 -1.253 0 C-N-CA 119.811 -1.185 . . . . 0.0 113.384 177.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 38' ' ' GLN . . . . . 0.49 ' HA ' ' HB2' ' D' ' 58' ' ' LYS . 95.0 mt-30 -102.43 -44.41 5.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.662 0.267 . . . . 0.0 111.053 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -152.87 128.84 10.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.327 178.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -128.22 113.08 15.23 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.557 0.694 . . . . 0.0 109.884 168.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' D' ' 79' ' ' THR . 28.6 mmmt -94.6 109.35 21.27 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 176.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.51 HD23 ' HB ' ' D' ' 53' ' ' VAL . 48.5 tp -82.13 109.49 16.49 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -174.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -112.22 136.34 51.77 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.123 177.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.704 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.1 OUTLIER -123.91 121.78 36.24 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.498 175.427 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 45' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -109.91 111.16 22.39 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.915 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.532 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -128.72 139.39 52.24 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.567 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 56.57 35.72 26.5 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 123.654 0.596 . . . . 0.0 110.207 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 48' ' ' LYS . . . . . 0.431 ' NZ ' ' HB3' ' D' ' 48' ' ' LYS . 9.1 mtpm? 63.6 32.32 14.08 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.276 178.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . 0.558 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 59.5 tp60 -128.3 133.98 48.84 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -89.1 121.79 31.78 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -177.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -116.72 123.4 47.12 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.442 176.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -75.42 106.71 5.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 169.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 53' ' ' VAL . . . . . 0.61 ' CG2' ' HB3' ' D' ' 44' ' ' LEU . 0.7 OUTLIER -84.09 -46.44 18.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.599 -172.392 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 54' ' ' ALA . . . . . 0.55 ' HB2' HD21 ' D' ' 65' ' ' LEU . . . -153.89 149.38 27.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.728 -177.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 53.0 m -112.93 101.64 9.68 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 169.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 56' ' ' VAL . . . . . 0.444 HG13 ' HB3' ' D' ' 40' ' ' ALA . 7.8 p -115.71 114.37 46.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.605 0.716 . . . . 0.0 109.254 -179.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 44.7 p -122.65 -179.23 4.15 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.13 -172.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 58' ' ' LYS . . . . . 0.49 ' HB2' ' HA ' ' D' ' 38' ' ' GLN . 57.9 tttt -58.61 -32.3 68.87 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.721 171.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.38 -40.94 22.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.862 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 84.7 mt -108.33 86.68 3.53 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 175.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.11 0.23 8.7 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.79 2.327 . . . . 0.0 113.845 -166.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -164.52 131.07 3.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.342 0.591 . . . . 0.0 111.526 -175.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 93.5 t -122.09 112.24 33.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.308 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.64 131.56 41.8 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 174.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 65' ' ' LEU . . . . . 0.55 HD21 ' HB2' ' D' ' 54' ' ' ALA . 86.3 mt -124.2 168.16 13.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.559 0.695 . . . . 0.0 112.188 -173.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 66' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 18.6 t0 -142.44 99.46 3.5 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.319 169.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' D' ' 28' ' ' HIS . 2.3 mt -129.47 144.27 51.18 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 68' ' ' ASN . . . . . 0.447 ' HB3' ' CD2' ' C' ' 90' ' ' TYR . 5.9 t30 -141.88 114.9 8.7 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.538 -0.465 . . . . 0.0 109.805 176.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -111.06 146.86 36.0 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.569 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . 0.422 ' HB2' ' HA ' ' C' ' 7' ' ' MET . 21.8 t -97.78 166.7 11.35 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -75.54 2.15 12.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.195 0.522 . . . . 0.0 110.583 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.14 -7.76 51.77 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.271 172.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -93.28 138.76 31.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.159 0.504 . . . . 0.0 110.489 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -122.3 116.98 25.02 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 175.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.532 HG22 ' HB2' ' D' ' 46' ' ' ALA . 14.9 pt -128.5 162.72 34.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.135 0.493 . . . . 0.0 112.051 -168.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 76' ' ' MET . . . . . 0.496 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 4.9 mtm -120.03 125.67 48.92 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.458 172.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 77' ' ' PHE . . . . . 0.704 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.8 OUTLIER -109.63 127.18 54.35 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.639 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 78' ' ' TYR . . . . . 0.702 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 53.3 p90 -155.52 139.2 16.07 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 119.814 -0.755 . . . . 0.0 112.006 -175.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 79' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 2.9 p -111.62 134.22 53.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.415 -176.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 80' ' ' ALA . . . . . 0.412 ' HB3' ' HB2' ' D' ' 41' ' ' LYS . . . -100.66 157.19 16.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.499 175.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.69 178.99 46.35 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -108.1 103.0 12.11 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 117.784 0.792 . . . . 0.0 110.013 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . 0.49 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -168.92 150.73 4.68 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.46 170.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 15.3 t -109.64 121.85 46.14 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.624 HG12 ' HB3' ' D' ' 34' ' ' LEU . 6.9 m -117.78 155.3 19.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.442 0.639 . . . . 0.0 112.288 -173.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 49.6 m -120.71 122.42 40.38 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.519 173.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 87' ' ' LEU . . . . . 0.575 HD11 ' SD ' ' D' ' 13' ' ' MET . 4.7 mp -96.0 145.72 25.21 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 170.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.521 HD13 ' O ' ' D' ' 87' ' ' LEU . 1.1 mm? -121.0 150.28 41.38 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.25 -167.89 27.6 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.25 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 90' ' ' TYR . . . . . 0.422 ' CD2' ' HB3' ' E' ' 68' ' ' ASN . 3.4 p90 -147.46 129.25 15.24 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.769 0.795 . . . . 0.0 112.115 177.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . 0.806 HD23 ' HB3' ' D' ' 27' ' ' PHE . 15.8 mt . . . . . 0 C--N 1.325 -0.461 0 CA-C-N 113.901 -1.5 . . . . 0.0 109.759 176.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 56.4 mtp . . . . . 0 CA--C 1.52 -0.195 0 CA-C-O 121.089 0.471 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' E' E ' 8' ' ' PHE . . . . . 0.641 ' CE1' HD21 ' A' ' 44' ' ' LEU . 48.6 t80 -66.5 145.51 55.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.074 -176.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 9' ' ' TRP . . . . . 0.555 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 90.4 t90 -132.71 146.03 51.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.006 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.1 146.65 16.28 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.195 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 11' ' ' LEU . . . . . 0.555 ' HB2' ' CH2' ' E' ' 9' ' ' TRP . 63.5 tp -134.15 109.05 8.65 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.945 0.402 . . . . 0.0 110.502 178.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -91.48 107.69 19.38 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 13' ' ' MET . . . . . 0.576 ' SD ' HD11 ' E' ' 87' ' ' LEU . 53.9 mtp -102.3 143.71 31.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.419 0.628 . . . . 0.0 111.445 -174.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -100.85 151.46 37.61 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.149 -177.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . 0.462 ' HB3' ' N ' ' E' ' 83' ' ' ALA . 11.1 Cg_endo -55.14 113.95 1.64 Allowed 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 123.188 2.592 . . . . 0.0 112.697 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 16' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' E' ' 79' ' ' THR . 17.4 mt-10 59.87 70.95 0.6 Allowed 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.426 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.14 142.92 32.79 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.56 174.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . 0.688 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 35.3 ttmt -116.6 117.46 29.92 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.322 -176.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . 0.424 ' OH ' ' HA ' ' E' ' 13' ' ' MET . 1.9 m-85 -110.35 122.24 47.21 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 20' ' ' SER . . . . . 0.459 ' HB3' ' SD ' ' E' ' 76' ' ' MET . 6.1 p -102.46 99.8 9.87 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 169.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 19.8 pm0 -117.79 143.07 46.59 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.628 0.728 . . . . 0.0 112.242 -174.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 13.0 t -93.36 160.77 14.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.551 176.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 23' ' ' ILE . . . . . 0.406 HG22 ' HA ' ' E' ' 71' ' ' LYS . 69.9 mt -112.5 119.38 60.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.065 0.46 . . . . 0.0 111.579 -173.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . 0.407 HD12 ' N ' ' E' ' 25' ' ' LYS . 1.7 pp -99.6 -11.51 8.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.051 177.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . 0.407 ' N ' HD12 ' E' ' 24' ' ' ILE . 84.7 tttt -148.07 119.55 7.93 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 31.3 p -61.73 140.49 58.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.648 -175.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 27' ' ' PHE . . . . . 0.805 ' HB3' HD23 ' E' ' 91' ' ' LEU . 42.9 p90 -152.08 162.78 40.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.793 0.806 . . . . 0.0 112.907 -174.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 28' ' ' HIS . . . . . 0.539 ' HA ' ' O ' ' E' ' 67' ' ' LEU . 7.7 t60 -114.67 124.59 52.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.981 177.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 29' ' ' ILE . . . . . 0.508 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 42.2 mt -88.32 135.87 24.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 170.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . 0.492 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 45.1 p -123.55 -5.31 8.18 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -170.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 31' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . 179.91 155.11 14.56 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 119.123 -1.513 . . . . 0.0 113.572 175.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.463 HG23 ' HG ' ' E' ' 87' ' ' LEU . 12.0 p -136.81 132.82 48.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 174.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.75 156.49 42.43 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 121.92 -0.487 . . . . 0.0 111.571 -176.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 34' ' ' LEU . . . . . 0.622 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.1 pp -123.81 145.52 49.0 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.607 0.718 . . . . 0.0 111.031 177.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -110.09 -52.07 2.81 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.977 -1.011 . . . . 0.0 108.683 174.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -102.98 127.31 50.27 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 169.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . 0.463 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 151.92 156.78 7.62 Favored Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 119.754 -1.212 . . . . 0.0 113.389 177.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 38' ' ' GLN . . . . . 0.495 ' HA ' ' HB2' ' E' ' 58' ' ' LYS . 94.9 mt-30 -102.39 -44.39 5.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.658 0.266 . . . . 0.0 111.094 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -152.88 128.81 10.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.411 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . 0.466 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -128.19 113.01 15.15 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.476 0.655 . . . . 0.0 109.89 168.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 41' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' E' ' 79' ' ' THR . 28.7 mmmt -94.59 109.34 21.26 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.503 HD23 ' HB ' ' E' ' 53' ' ' VAL . 48.1 tp -82.08 109.51 16.47 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -174.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -112.24 136.3 51.84 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.067 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 44' ' ' LEU . . . . . 0.689 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 0.1 OUTLIER -123.88 121.71 36.07 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.459 175.457 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' E' E ' 45' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -109.82 111.16 22.43 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.003 178.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . 0.532 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -128.77 139.32 52.25 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.513 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 56.56 35.75 26.53 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 123.688 0.618 . . . . 0.0 110.225 -177.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 48' ' ' LYS . . . . . 0.424 ' NZ ' ' HB3' ' E' ' 48' ' ' LYS . 9.1 mtpm? 63.66 32.28 13.94 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.221 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 49' ' ' GLN . . . . . 0.562 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 59.2 tp60 -128.25 133.9 48.88 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 175.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -89.03 121.74 31.68 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -116.65 123.38 47.14 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.496 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -75.27 106.65 5.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 169.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . 0.607 ' CG2' ' HB3' ' E' ' 44' ' ' LEU . 0.7 OUTLIER -84.25 -46.36 17.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.508 -172.313 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' E' E ' 54' ' ' ALA . . . . . 0.569 ' HB2' HD21 ' E' ' 65' ' ' LEU . . . -153.91 149.4 27.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.664 -177.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 52.6 m -112.93 101.7 9.74 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 169.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . 0.446 HG13 ' HB3' ' E' ' 40' ' ' ALA . 7.7 p -115.8 114.32 45.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.579 0.704 . . . . 0.0 109.212 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 45.0 p -122.59 -179.17 4.13 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.194 -172.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 58' ' ' LYS . . . . . 0.495 ' HB2' ' HA ' ' E' ' 38' ' ' GLN . 58.2 tttt -58.62 -32.23 68.83 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.783 171.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.42 -40.95 22.61 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.885 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 84.1 mt -108.3 86.64 3.49 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 174.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.09 0.18 8.75 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.756 2.304 . . . . 0.0 113.848 -166.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -164.45 131.18 3.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.289 0.566 . . . . 0.0 111.551 -175.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 94.2 t -122.08 112.21 33.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.281 174.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.57 131.5 41.79 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 65' ' ' LEU . . . . . 0.569 HD21 ' HB2' ' E' ' 54' ' ' ALA . 86.3 mt -124.23 168.08 13.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.496 0.665 . . . . 0.0 112.283 -173.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 66' ' ' ASP . . . . . 0.475 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 18.5 t0 -142.41 99.49 3.51 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.383 170.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 67' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' E' ' 28' ' ' HIS . 2.3 mt -129.46 144.3 51.2 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 68' ' ' ASN . . . . . 0.422 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 5.8 t30 -141.91 114.92 8.7 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.558 -0.457 . . . . 0.0 109.783 176.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -111.12 146.84 36.1 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.535 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 21.9 t -97.7 166.71 11.36 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 71' ' ' LYS . . . . . 0.406 ' HA ' HG22 ' E' ' 23' ' ' ILE . 21.6 ptmt -75.59 2.17 12.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.229 0.537 . . . . 0.0 110.531 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.14 -7.79 51.73 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.305 172.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -93.25 138.71 31.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.108 0.48 . . . . 0.0 110.463 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -122.22 116.9 24.96 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 75' ' ' ILE . . . . . 0.532 HG22 ' HB2' ' E' ' 46' ' ' ALA . 14.9 pt -128.38 162.73 34.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.219 0.533 . . . . 0.0 112.029 -168.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 76' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 4.9 mtm -119.97 125.72 49.09 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 172.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 77' ' ' PHE . . . . . 0.689 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.8 OUTLIER -109.64 127.22 54.39 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 176.576 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' E' E ' 78' ' ' TYR . . . . . 0.688 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 53.2 p90 -155.55 139.21 16.05 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 119.79 -0.764 . . . . 0.0 112.001 -175.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 79' ' ' THR . . . . . 0.568 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 3.0 p -111.58 134.23 53.3 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.389 -176.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 80' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' E' ' 41' ' ' LYS . . . -100.7 157.16 16.9 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.537 175.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.79 179.01 46.2 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -176.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -108.17 102.93 12.04 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 119.714 -0.794 . . . . 0.0 110.044 178.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 83' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -168.8 150.83 4.82 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.436 170.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 15.5 t -109.76 121.89 46.25 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 85' ' ' VAL . . . . . 0.622 HG12 ' HB3' ' E' ' 34' ' ' LEU . 6.9 m -117.77 155.32 19.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.398 0.618 . . . . 0.0 112.311 -173.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 49.3 m -120.67 122.43 40.45 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.542 173.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 87' ' ' LEU . . . . . 0.576 HD11 ' SD ' ' E' ' 13' ' ' MET . 4.7 mp -96.07 145.77 25.2 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 170.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . 0.526 HD13 ' O ' ' E' ' 87' ' ' LEU . 1.2 mm? -120.96 150.25 41.39 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 173.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.31 -167.91 27.69 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.363 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 90' ' ' TYR . . . . . 0.437 ' CD2' ' HB3' ' A' ' 68' ' ' ASN . 3.4 p90 -147.49 129.24 15.19 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.758 0.789 . . . . 0.0 112.126 177.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 91' ' ' LEU . . . . . 0.805 HD23 ' HB3' ' E' ' 27' ' ' PHE . 15.8 mt . . . . . 0 C--N 1.326 -0.454 0 CA-C-N 113.838 -1.528 . . . . 0.0 109.814 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.409 ' HG2' ' OG ' ' B' ' 70' ' ' SER . 58.8 mtt . . . . . 0 C--O 1.224 -0.273 0 CA-C-O 120.68 0.276 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.521 ' CE1' HD21 ' B' ' 44' ' ' LEU . 77.1 t80 -59.77 140.29 56.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -172.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.449 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 87.4 t90 -132.73 146.74 52.1 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.549 178.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.414 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -151.61 152.69 24.41 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.261 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.731 HD23 HD13 ' A' ' 87' ' ' LEU . 59.3 tp -140.45 106.7 5.24 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 178.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -86.31 100.92 12.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.502 0.667 . . . . 0.0 109.755 175.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.471 ' HB3' HG23 ' A' ' 85' ' ' VAL . 3.7 ttt -94.65 134.22 37.46 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.142 -168.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.476 ' HB2' ' HG3' ' A' ' 17' ' ' ARG . 2.5 mptp? -100.28 149.57 36.17 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.811 -178.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.515 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 12.2 Cg_endo -56.43 122.32 11.59 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.122 2.548 . . . . 0.0 112.987 -178.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 79' ' ' THR . 44.9 mt-10 61.53 51.79 3.93 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.564 177.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.476 ' HG3' ' HB2' ' A' ' 14' ' ' LYS . 29.0 mmt180 -117.57 145.52 44.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.131 173.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.695 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 40.5 tttt -123.28 109.82 14.43 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 123.505 0.503 . . . . 0.0 110.551 -176.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.447 ' HE2' ' HG3' ' A' ' 13' ' ' MET . 3.4 m-85 -110.02 104.31 13.18 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.356 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.467 ' HB3' ' SD ' ' A' ' 76' ' ' MET . 13.8 p -84.99 99.45 11.0 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -113.41 143.99 43.55 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.568 0.699 . . . . 0.0 112.002 -168.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.3 p -96.43 157.35 15.94 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.612 174.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.442 ' CD1' ' HB3' ' A' ' 69' ' ' PHE . 54.1 mt -115.1 116.64 53.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.347 0.594 . . . . 0.0 111.18 -175.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.478 ' N ' HD12 ' A' ' 24' ' ' ILE . 3.9 mp -93.34 -40.97 12.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.101 178.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.8 pttt -123.88 128.22 49.16 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.586 176.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.8 p -64.65 141.83 58.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.259 -174.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.828 ' HB3' HD23 ' A' ' 91' ' ' LEU . 39.8 p90 -142.08 152.52 43.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.745 0.783 . . . . 0.0 112.226 -177.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.627 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 6.1 t60 -108.24 120.52 42.6 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.354 173.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 35.1 mt -84.51 133.65 28.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 170.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.545 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 56.0 p -120.43 -6.87 9.78 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.683 0.278 . . . . 0.0 111.64 -173.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.15 158.32 25.84 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 119.455 -1.355 . . . . 0.0 113.622 176.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.497 HG23 ' HG ' ' A' ' 87' ' ' LEU . 13.2 p -140.43 127.24 22.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 172.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.16 152.87 41.48 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 121.972 -0.455 . . . . 0.0 111.389 -175.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.606 ' HB3' HG12 ' A' ' 85' ' ' VAL . 3.7 pp -117.82 145.88 44.25 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.787 0.803 . . . . 0.0 111.733 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -106.73 -55.99 2.25 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.894 175.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -102.59 128.03 49.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.049 170.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.458 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 153.23 158.53 8.6 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 119.437 -1.363 . . . . 0.0 113.892 175.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -101.76 -45.62 5.18 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.426 -0.387 . . . . 0.0 110.571 176.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.46 ' HG3' HG22 ' A' ' 57' ' ' THR . 32.7 tt0 -153.14 123.01 6.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.091 -178.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.554 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -121.88 114.13 20.6 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.44 0.638 . . . . 0.0 110.033 170.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 79' ' ' THR . 13.7 mmmm -97.18 105.51 17.67 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.6 tp -83.71 111.47 19.19 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -174.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.546 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 79.9 m-85 -114.9 149.95 36.4 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 175.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.557 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -135.47 128.01 30.63 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.616 172.125 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -105.89 112.22 25.18 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.09 178.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.567 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -127.92 133.23 49.25 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.395 178.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 59.42 38.23 22.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.48 0.657 . . . . 0.0 109.629 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt 62.37 35.27 15.11 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.717 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.574 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 23.5 tp60 -130.18 118.23 21.1 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -81.63 108.29 15.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.878 0.371 . . . . 0.0 110.86 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.456 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 87.5 m-85 -99.87 133.41 44.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.519 177.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -80.14 104.65 8.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 168.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.481 HG21 ' HB3' ' A' ' 44' ' ' LEU . 3.2 t -79.68 -50.32 18.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.696 -172.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.6 ' HB2' HD21 ' A' ' 65' ' ' LEU . . . -153.46 147.22 25.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.656 -176.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.5 m -110.95 101.28 9.86 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 171.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.48 HG13 ' HB3' ' A' ' 40' ' ' ALA . 7.2 p -119.65 113.52 41.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.62 0.724 . . . . 0.0 109.741 -177.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.46 HG22 ' HG3' ' A' ' 39' ' ' GLU . 65.2 p -123.28 -178.42 3.98 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.684 -174.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -61.89 -23.01 66.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.908 0.385 . . . . 0.0 110.463 170.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.435 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -84.35 -40.87 17.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.245 0.545 . . . . 0.0 110.15 178.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.2 mt -112.75 82.62 5.14 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 11.5 Cg_exo -70.8 -0.38 7.68 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.06 2.506 . . . . 0.0 113.868 -167.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -162.99 127.0 2.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.339 0.59 . . . . 0.0 111.416 -176.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 87.0 t -116.38 121.92 68.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.399 174.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.43 127.63 32.99 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.973 176.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.6 HD21 ' HB2' ' A' ' 54' ' ' ALA . 91.0 mt -119.92 168.45 11.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.401 0.62 . . . . 0.0 112.226 -174.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 14.2 t0 -145.72 97.59 3.0 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 172.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.668 HD21 HD23 ' E' ' 88' ' ' LEU . 6.7 mt -133.54 110.0 9.63 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.797 -174.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.452 ' HB2' ' CG ' ' E' ' 90' ' ' TYR . 6.3 m-20 -103.82 113.92 27.8 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.442 ' HB3' ' CD1' ' A' ' 23' ' ' ILE . 86.0 m-85 -109.04 136.92 47.76 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.829 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.413 ' OG ' ' HG2' ' E' ' 7' ' ' MET . 87.8 p -97.35 166.69 11.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.744 0.307 . . . . 0.0 110.21 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -73.05 -4.89 35.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.919 0.39 . . . . 0.0 110.893 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.67 -9.16 58.96 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 174.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -88.49 140.3 29.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.929 0.395 . . . . 0.0 110.06 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -126.33 114.53 18.37 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 175.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.567 HG22 ' HB2' ' A' ' 46' ' ' ALA . 13.1 pt -131.03 158.7 43.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.053 0.454 . . . . 0.0 112.059 -166.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.494 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 3.6 mtm -119.19 123.92 45.51 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 174.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.557 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 1.1 m-85 -104.24 128.63 52.01 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.695 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 25.9 p90 -151.92 134.97 15.75 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.453 0.644 . . . . 0.0 112.488 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 2.6 p -108.94 130.58 55.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.748 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.9 164.72 11.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.439 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.57 -174.03 44.41 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -177.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -113.43 102.74 10.61 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.023 178.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.554 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -173.62 153.55 2.3 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.551 171.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.9 t -114.84 126.41 54.78 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.606 HG12 ' HB3' ' A' ' 34' ' ' LEU . 6.7 m -120.74 157.54 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-O 121.141 0.496 . . . . 0.0 112.144 -172.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.4 m -117.09 119.01 33.93 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.549 -0.75 . . . . 0.0 108.979 171.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.731 HD13 HD23 ' A' ' 11' ' ' LEU . 5.1 mp -89.78 145.33 25.27 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 170.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.708 HD23 HD21 ' B' ' 67' ' ' LEU . 0.8 OUTLIER -129.97 141.39 50.77 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.929 -177.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.82 -167.56 26.63 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.292 -177.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.486 ' CG ' ' HB2' ' B' ' 68' ' ' ASN . 13.7 p90 -150.29 129.6 12.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 122.093 0.949 . . . . 0.0 112.102 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.828 HD23 ' HB3' ' A' ' 27' ' ' PHE . 7.9 mt . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.778 176.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . 0.401 ' HG2' ' OG ' ' C' ' 70' ' ' SER . 58.9 mtt . . . . . 0 C--O 1.222 -0.367 0 CA-C-O 120.737 0.303 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . 0.532 ' CE1' HD21 ' C' ' 44' ' ' LEU . 77.0 t80 -59.98 140.35 56.8 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -172.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . 0.449 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 87.3 t90 -132.74 146.74 52.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.547 178.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.439 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -151.65 152.69 24.41 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.262 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.739 HD23 HD13 ' B' ' 87' ' ' LEU . 59.7 tp -140.48 106.75 5.25 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -86.3 100.85 12.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.612 0.72 . . . . 0.0 109.785 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . 0.465 ' HB3' HG23 ' B' ' 85' ' ' VAL . 3.7 ttt -94.61 134.24 37.39 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.68 -1.146 . . . . 0.0 111.059 -168.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.471 ' HB2' ' HG3' ' B' ' 17' ' ' ARG . 2.5 mptp? -100.43 149.45 36.1 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.788 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.517 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 12.2 Cg_endo -56.33 122.33 11.58 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.131 2.554 . . . . 0.0 112.965 -178.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' B' ' 79' ' ' THR . 44.8 mt-10 61.51 51.83 3.93 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.506 177.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.471 ' HG3' ' HB2' ' B' ' 14' ' ' LYS . 29.0 mmt180 -117.57 145.5 44.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.141 173.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.713 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 40.6 tttt -123.22 109.87 14.52 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 123.465 0.478 . . . . 0.0 110.513 -176.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' TYR . . . . . 0.434 ' HE2' ' HG3' ' B' ' 13' ' ' MET . 3.3 m-85 -110.09 104.36 13.22 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.289 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.462 ' HB3' ' SD ' ' B' ' 76' ' ' MET . 13.6 p -85.12 99.49 11.09 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 171.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -113.33 144.03 43.45 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.522 0.677 . . . . 0.0 112.019 -168.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 13.7 p -96.43 157.27 15.98 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.627 174.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.428 ' CD1' ' HB3' ' B' ' 69' ' ' PHE . 53.7 mt -115.06 116.56 52.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.335 0.588 . . . . 0.0 111.227 -175.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.479 ' N ' HD12 ' B' ' 24' ' ' ILE . 3.9 mp -93.27 -40.91 12.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.262 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 24.9 pttt -123.83 128.15 49.09 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.651 176.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 62.3 p -64.62 141.73 58.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.311 -174.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . 0.834 ' HB3' HD23 ' B' ' 91' ' ' LEU . 39.3 p90 -142.09 152.51 43.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.71 0.767 . . . . 0.0 112.231 -177.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' HIS . . . . . 0.639 ' HA ' ' O ' ' B' ' 67' ' ' LEU . 6.2 t60 -108.1 120.53 42.59 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.428 173.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.548 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 35.2 mt -84.6 133.55 29.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 170.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.548 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 56.4 p -120.29 -6.97 9.84 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.598 -173.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.13 158.31 25.82 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 119.462 -1.352 . . . . 0.0 113.555 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.496 HG23 ' HG ' ' B' ' 87' ' ' LEU . 13.2 p -140.36 127.33 22.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 172.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.2 152.85 41.42 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.958 -0.464 . . . . 0.0 111.342 -175.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.617 ' HB3' HG12 ' B' ' 85' ' ' VAL . 3.7 pp -117.89 145.79 44.38 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.791 0.805 . . . . 0.0 111.728 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -106.58 -56.21 2.22 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.859 175.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -102.43 127.98 49.23 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.096 170.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.455 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 153.2 158.53 8.59 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 119.393 -1.384 . . . . 0.0 113.893 175.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -101.77 -45.66 5.16 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.399 -0.4 . . . . 0.0 110.498 176.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.444 ' HG3' HG22 ' B' ' 57' ' ' THR . 32.9 tt0 -153.07 123.02 6.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.109 -178.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -121.88 114.22 20.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.539 0.685 . . . . 0.0 110.007 170.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' B' ' 79' ' ' THR . 13.7 mmmm -97.2 105.44 17.59 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 49.3 tp -83.65 111.51 19.19 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -174.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . 0.552 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 79.9 m-85 -114.9 149.96 36.38 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 175.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.564 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 0.2 OUTLIER -135.49 128.13 30.83 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.612 172.03 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.575 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -105.99 111.99 24.86 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.187 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.581 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -127.76 133.35 49.48 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.409 178.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 59.31 38.2 23.24 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.564 0.697 . . . . 0.0 109.743 -176.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt 62.3 35.39 15.24 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.637 178.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . 0.575 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 23.1 tp60 -130.18 118.24 21.11 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 178.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -81.69 108.39 15.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.927 0.394 . . . . 0.0 110.799 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.414 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 86.9 m-85 -99.86 133.33 44.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.59 177.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -80.11 104.67 8.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 168.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.488 HG21 ' HB3' ' B' ' 44' ' ' LEU . 3.2 t -79.64 -50.32 18.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.779 -172.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.591 ' HB2' HD21 ' B' ' 65' ' ' LEU . . . -153.38 147.17 25.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.686 -176.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 31.1 m -110.96 101.26 9.84 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 171.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . 0.465 HG13 ' HB3' ' B' ' 40' ' ' ALA . 7.1 p -119.6 113.48 41.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.6 0.714 . . . . 0.0 109.844 -177.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.444 HG22 ' HG3' ' B' ' 39' ' ' GLU . 65.5 p -123.2 -178.38 3.96 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.73 -174.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -62.06 -22.86 66.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.045 0.45 . . . . 0.0 110.514 170.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.424 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -84.41 -40.82 17.34 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.19 0.519 . . . . 0.0 110.195 178.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 80.8 mt -112.69 82.59 5.05 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 11.4 Cg_exo -70.78 -0.36 7.64 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.022 2.482 . . . . 0.0 113.907 -168.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -163.04 127.03 2.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.383 0.611 . . . . 0.0 111.392 -176.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 87.6 t -116.34 121.91 68.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.418 174.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.53 127.67 33.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.01 176.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.591 HD21 ' HB2' ' B' ' 54' ' ' ALA . 90.8 mt -119.93 168.47 11.1 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.371 0.605 . . . . 0.0 112.114 -174.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . 0.531 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 14.4 t0 -145.72 97.6 3.0 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 172.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.708 HD21 HD23 ' A' ' 88' ' ' LEU . 6.7 mt -133.58 110.08 9.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.723 -174.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . 0.486 ' HB2' ' CG ' ' A' ' 90' ' ' TYR . 6.4 m-20 -103.86 113.82 27.62 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 176.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . 0.428 ' HB3' ' CD1' ' B' ' 23' ' ' ILE . 85.6 m-85 -108.92 136.9 47.7 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.861 178.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.409 ' OG ' ' HG2' ' A' ' 7' ' ' MET . 87.9 p -97.29 166.66 11.45 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.783 0.325 . . . . 0.0 110.191 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -72.96 -5.04 35.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.006 0.432 . . . . 0.0 110.868 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.52 -9.18 59.13 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.611 -0.595 . . . . 0.0 111.611 174.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -88.42 140.24 29.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.903 0.382 . . . . 0.0 110.108 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -126.3 114.54 18.4 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.581 HG22 ' HB2' ' B' ' 46' ' ' ALA . 13.2 pt -131.0 158.7 43.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.074 0.464 . . . . 0.0 111.995 -166.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.505 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 3.7 mtm -119.19 124.03 45.8 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 174.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . 0.564 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 1.1 m-85 -104.38 128.65 52.27 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.713 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 25.9 p90 -151.95 134.99 15.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.474 0.654 . . . . 0.0 112.494 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 2.6 p -108.9 130.62 55.44 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.707 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.97 164.79 11.53 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.524 176.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.37 -174.02 44.76 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -177.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -113.33 102.74 10.63 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 119.726 -0.789 . . . . 0.0 110.031 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -173.67 153.55 2.28 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.548 171.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 18.8 t -114.77 126.42 54.82 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.617 HG12 ' HB3' ' B' ' 34' ' ' LEU . 6.7 m -120.81 157.58 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-O 121.116 0.484 . . . . 0.0 112.139 -172.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 67.1 m -117.12 119.02 33.96 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 171.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.739 HD13 HD23 ' B' ' 11' ' ' LEU . 5.2 mp -89.78 145.38 25.22 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 170.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.687 HD23 HD21 ' C' ' 67' ' ' LEU . 0.8 OUTLIER -130.04 141.35 50.74 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.465 -0.789 . . . . 0.0 108.888 -177.697 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.82 -167.53 26.59 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.275 -178.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 90' ' ' TYR . . . . . 0.443 ' CG ' ' HB2' ' C' ' 68' ' ' ASN . 13.8 p90 -150.24 129.52 12.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 122.02 0.914 . . . . 0.0 112.154 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . 0.834 HD23 ' HB3' ' B' ' 27' ' ' PHE . 8.0 mt . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 113.626 -1.624 . . . . 0.0 110.898 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 7' ' ' MET . . . . . 0.401 ' HG2' ' OG ' ' D' ' 70' ' ' SER . 58.8 mtt . . . . . 0 C--O 1.224 -0.279 0 CA-C-O 120.677 0.275 . . . . 0.0 110.985 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 8' ' ' PHE . . . . . 0.546 ' CE1' HD21 ' D' ' 44' ' ' LEU . 77.4 t80 -59.9 140.27 56.79 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -172.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . 0.441 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 87.3 t90 -132.63 146.79 52.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.555 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . 0.44 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -151.61 152.71 24.43 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.289 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.714 HD23 HD13 ' C' ' 87' ' ' LEU . 59.5 tp -140.5 106.79 5.25 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -86.3 100.82 12.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.599 0.714 . . . . 0.0 109.8 175.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 13' ' ' MET . . . . . 0.464 ' HB3' HG23 ' C' ' 85' ' ' VAL . 3.7 ttt -94.56 134.25 37.32 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.078 -168.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . 0.457 ' HB2' ' HG3' ' C' ' 17' ' ' ARG . 2.5 mptp? -100.38 149.5 36.13 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.8 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . 0.517 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 12.3 Cg_endo -56.29 122.25 11.45 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 123.191 2.594 . . . . 0.0 113.011 -178.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' C' ' 79' ' ' THR . 44.8 mt-10 61.49 51.84 3.95 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.543 177.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 17' ' ' ARG . . . . . 0.457 ' HG3' ' HB2' ' C' ' 14' ' ' LYS . 28.9 mmt180 -117.52 145.57 44.15 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.132 173.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 18' ' ' LYS . . . . . 0.706 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 40.7 tttt -123.41 109.89 14.44 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 123.479 0.487 . . . . 0.0 110.513 -176.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . 0.448 ' HE2' ' HG3' ' C' ' 13' ' ' MET . 3.4 m-85 -110.09 104.29 13.14 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.342 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . 0.474 ' HB3' ' SD ' ' C' ' 76' ' ' MET . 13.5 p -84.97 99.37 10.94 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 171.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -113.29 144.05 43.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.577 0.703 . . . . 0.0 112.064 -169.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 13.3 p -96.59 157.3 15.96 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.592 174.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . 0.442 ' CD1' ' HB3' ' C' ' 69' ' ' PHE . 53.8 mt -115.03 116.6 53.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.296 0.57 . . . . 0.0 111.16 -175.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . 0.481 HD12 ' N ' ' C' ' 24' ' ' ILE . 3.9 mp -93.26 -41.09 12.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.16 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 25.0 pttt -123.85 128.21 49.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.616 176.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 62.1 p -64.63 141.71 58.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.227 -174.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 27' ' ' PHE . . . . . 0.844 ' HB3' HD23 ' C' ' 91' ' ' LEU . 39.5 p90 -142.0 152.51 43.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.672 0.748 . . . . 0.0 112.23 -177.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 28' ' ' HIS . . . . . 0.634 ' HA ' ' O ' ' C' ' 67' ' ' LEU . 6.1 t60 -108.14 120.55 42.65 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.418 -1.264 . . . . 0.0 109.382 173.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 35.2 mt -84.59 133.59 28.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 170.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.548 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 56.1 p -120.41 -6.77 9.79 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.645 0.259 . . . . 0.0 111.639 -173.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.13 158.4 25.99 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 119.471 -1.347 . . . . 0.0 113.595 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.493 HG23 ' HG ' ' C' ' 87' ' ' LEU . 13.0 p -140.38 127.22 22.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.23 152.83 41.38 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.569 -0.453 . . . . 0.0 111.326 -175.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.621 ' HB3' HG12 ' C' ' 85' ' ' VAL . 3.7 pp -117.8 145.8 44.28 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 121.809 0.814 . . . . 0.0 111.792 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -106.58 -56.17 2.23 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.869 175.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -102.47 127.99 49.28 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.065 170.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 37' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 153.25 158.44 8.56 Favored Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 119.39 -1.386 . . . . 0.0 113.902 175.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -101.76 -45.6 5.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.484 -0.358 . . . . 0.0 110.545 176.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . 0.447 ' HG3' HG22 ' C' ' 57' ' ' THR . 32.8 tt0 -153.09 122.99 6.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.079 -178.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.569 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -121.88 114.23 20.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.518 0.675 . . . . 0.0 110.02 170.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' C' ' 79' ' ' THR . 13.7 mmmm -97.27 105.43 17.57 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 49.7 tp -83.66 111.48 19.17 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -174.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 43' ' ' TYR . . . . . 0.546 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 79.8 m-85 -114.86 149.93 36.35 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.566 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 0.2 OUTLIER -135.46 128.17 30.96 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.589 172.069 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . 0.569 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -105.97 112.0 24.87 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.116 178.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.579 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -127.8 133.41 49.43 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.368 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 59.25 38.23 23.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.53 0.681 . . . . 0.0 109.763 -176.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt 62.3 35.21 15.36 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.751 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . 0.569 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 23.4 tp60 -130.04 118.28 21.32 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -81.74 108.36 15.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.969 0.414 . . . . 0.0 110.769 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . 0.439 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 86.9 m-85 -99.79 133.39 44.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.627 177.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -80.12 104.57 8.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 168.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 53' ' ' VAL . . . . . 0.486 HG21 ' HB3' ' C' ' 44' ' ' LEU . 3.2 t -79.56 -50.44 18.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.652 -172.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 54' ' ' ALA . . . . . 0.592 ' HB2' HD21 ' C' ' 65' ' ' LEU . . . -153.37 147.17 25.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.723 -176.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 31.4 m -110.93 101.29 9.87 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 171.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . 0.474 HG13 ' HB3' ' C' ' 40' ' ' ALA . 7.2 p -119.6 113.47 41.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.513 0.673 . . . . 0.0 109.821 -177.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . 0.447 HG22 ' HG3' ' C' ' 39' ' ' GLU . 66.0 p -123.24 -178.45 3.99 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.74 -174.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -61.99 -22.97 66.12 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.14 0.495 . . . . 0.0 110.43 171.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . 0.433 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -84.3 -40.76 17.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.19 0.519 . . . . 0.0 110.275 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 80.7 mt -112.8 82.5 5.11 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 174.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 61' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 11.4 Cg_exo -70.8 -0.2 7.41 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.997 2.465 . . . . 0.0 113.889 -167.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -163.12 127.04 2.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.325 0.583 . . . . 0.0 111.437 -176.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 86.2 t -116.38 122.02 68.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.345 174.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.49 127.54 32.93 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.131 175.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . 0.592 HD21 ' HB2' ' C' ' 54' ' ' ALA . 91.1 mt -119.76 168.45 11.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.471 0.653 . . . . 0.0 112.21 -174.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 66' ' ' ASP . . . . . 0.489 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 14.4 t0 -145.76 97.6 2.99 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 172.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.687 HD21 HD23 ' B' ' 88' ' ' LEU . 6.7 mt -133.54 110.0 9.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.772 -174.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . 0.443 ' HB2' ' CG ' ' B' ' 90' ' ' TYR . 6.4 m-20 -103.92 113.82 27.63 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 69' ' ' PHE . . . . . 0.442 ' HB3' ' CD1' ' C' ' 23' ' ' ILE . 86.0 m-85 -109.0 136.87 47.81 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.779 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . 0.401 ' OG ' ' HG2' ' B' ' 7' ' ' MET . 88.1 p -97.24 166.66 11.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.745 0.307 . . . . 0.0 110.235 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -73.12 -4.83 35.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.015 0.436 . . . . 0.0 110.901 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.55 -9.27 59.02 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 174.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -88.28 140.23 29.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.893 0.378 . . . . 0.0 110.115 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -126.33 114.49 18.31 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 175.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.579 HG22 ' HB2' ' C' ' 46' ' ' ALA . 13.3 pt -131.07 158.67 43.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.047 0.451 . . . . 0.0 112.034 -166.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.498 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 3.7 mtm -119.22 123.97 45.61 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 77' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 1.1 m-85 -104.29 128.55 52.09 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 78' ' ' TYR . . . . . 0.706 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 25.9 p90 -151.87 134.96 15.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.419 0.628 . . . . 0.0 112.511 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 2.6 p -108.85 130.56 55.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.769 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.87 164.84 11.51 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.522 176.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.41 -173.98 44.64 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -177.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -113.38 102.77 10.65 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.031 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . 0.569 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -173.67 153.48 2.27 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.534 171.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 18.6 t -114.76 126.41 54.81 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.621 HG12 ' HB3' ' C' ' 34' ' ' LEU . 6.6 m -120.8 157.58 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 CA-C-O 121.213 0.53 . . . . 0.0 112.114 -172.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 66.6 m -117.04 119.02 33.99 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 171.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . 0.714 HD13 HD23 ' C' ' 11' ' ' LEU . 5.2 mp -89.75 145.29 25.3 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 170.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . 0.681 HD23 HD21 ' D' ' 67' ' ' LEU . 0.8 OUTLIER -130.01 141.46 50.74 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.438 -0.801 . . . . 0.0 108.913 -177.837 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.93 -167.59 26.79 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.331 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 90' ' ' TYR . . . . . 0.467 ' CG ' ' HB2' ' D' ' 68' ' ' ASN . 13.6 p90 -150.19 129.55 12.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 122.039 0.924 . . . . 0.0 112.109 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . 0.844 HD23 ' HB3' ' C' ' 27' ' ' PHE . 8.0 mt . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.826 176.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 7' ' ' MET . . . . . 0.435 ' HG2' ' OG ' ' E' ' 70' ' ' SER . 58.9 mtt . . . . . 0 C--O 1.224 -0.286 0 CA-C-O 120.748 0.309 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 8' ' ' PHE . . . . . 0.552 ' CE1' HD21 ' E' ' 44' ' ' LEU . 77.0 t80 -59.99 140.33 56.83 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -172.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 9' ' ' TRP . . . . . 0.447 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 87.3 t90 -132.76 146.68 52.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.552 178.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . 0.467 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -151.53 152.72 24.44 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.296 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . 0.736 HD23 HD13 ' D' ' 87' ' ' LEU . 59.8 tp -140.5 106.73 5.24 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -86.24 100.86 12.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.579 0.704 . . . . 0.0 109.743 175.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 13' ' ' MET . . . . . 0.471 ' HB3' HG23 ' D' ' 85' ' ' VAL . 3.7 ttt -94.67 134.21 37.5 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.085 -168.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 14' ' ' LYS . . . . . 0.469 ' HB2' ' HG3' ' D' ' 17' ' ' ARG . 2.5 mptp? -100.33 149.56 36.17 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.802 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . 0.518 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 12.3 Cg_endo -56.45 122.28 11.51 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.134 2.556 . . . . 0.0 113.013 -178.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' D' ' 79' ' ' THR . 44.9 mt-10 61.5 51.88 3.92 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.571 177.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 17' ' ' ARG . . . . . 0.469 ' HG3' ' HB2' ' D' ' 14' ' ' LYS . 28.9 mmt180 -117.58 145.56 44.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.133 173.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . 0.705 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 40.7 tttt -123.36 109.91 14.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 123.542 0.526 . . . . 0.0 110.524 -176.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 19' ' ' TYR . . . . . 0.431 ' HE2' ' HG3' ' D' ' 13' ' ' MET . 3.3 m-85 -110.04 104.38 13.26 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.323 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . 0.469 ' HB3' ' SD ' ' D' ' 76' ' ' MET . 13.4 p -85.08 99.45 11.05 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 171.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -113.37 144.01 43.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.483 0.659 . . . . 0.0 112.053 -168.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 14.0 p -96.49 157.31 15.96 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.627 174.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . 0.444 ' CD1' ' HB3' ' D' ' 69' ' ' PHE . 53.9 mt -115.02 116.61 53.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.15 0.5 . . . . 0.0 111.168 -175.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . 0.483 HD12 ' N ' ' D' ' 24' ' ' ILE . 3.9 mp -93.34 -40.95 12.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.125 178.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -123.88 128.24 49.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.663 176.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 61.9 p -64.65 141.72 58.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.258 -174.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 27' ' ' PHE . . . . . 0.807 ' HB3' HD23 ' D' ' 91' ' ' LEU . 39.4 p90 -141.97 152.59 43.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.713 0.768 . . . . 0.0 112.153 -177.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 28' ' ' HIS . . . . . 0.635 ' HA ' ' O ' ' D' ' 67' ' ' LEU . 6.2 t60 -108.21 120.5 42.54 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.407 -1.27 . . . . 0.0 109.399 173.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 29' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 35.2 mt -84.57 133.55 29.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 170.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . 0.548 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 56.8 p -120.3 -6.89 9.84 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.65 -173.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.08 158.41 26.05 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 119.481 -1.343 . . . . 0.0 113.566 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.498 HG23 ' HG ' ' D' ' 87' ' ' LEU . 13.3 p -140.48 127.27 22.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 172.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.17 152.94 41.58 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.332 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 34' ' ' LEU . . . . . 0.603 ' HB3' HG12 ' D' ' 85' ' ' VAL . 3.7 pp -117.93 145.88 44.36 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.798 0.808 . . . . 0.0 111.709 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -106.71 -56.03 2.25 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.226 -1.352 . . . . 0.0 108.819 175.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -102.53 127.95 49.37 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.099 170.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . 0.468 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 153.22 158.45 8.56 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 119.415 -1.374 . . . . 0.0 113.99 175.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -101.71 -45.65 5.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.786 0.327 . . . . 0.0 110.557 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . 0.45 ' HG3' HG22 ' D' ' 57' ' ' THR . 32.8 tt0 -153.05 123.01 6.94 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.117 -178.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . 0.561 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -121.88 114.09 20.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.406 0.622 . . . . 0.0 110.06 170.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' D' ' 79' ' ' THR . 13.7 mmmm -97.11 105.42 17.56 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 49.5 tp -83.59 111.44 19.11 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -174.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 43' ' ' TYR . . . . . 0.554 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 80.4 m-85 -114.87 149.96 36.32 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 175.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.566 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.2 OUTLIER -135.41 128.09 30.92 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.672 172.004 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 45' ' ' ALA . . . . . 0.569 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -105.92 112.17 25.12 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.156 178.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.569 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -127.84 133.34 49.37 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.344 178.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 59.3 38.14 23.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.558 0.694 . . . . 0.0 109.718 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt 62.41 35.24 15.0 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.683 178.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . 0.569 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 23.5 tp60 -130.06 118.26 21.26 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -81.62 108.3 15.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.909 0.385 . . . . 0.0 110.841 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . 0.44 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 87.3 m-85 -99.92 133.34 44.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.612 177.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 tp -80.13 104.73 8.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 169.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 53' ' ' VAL . . . . . 0.488 HG21 ' HB3' ' D' ' 44' ' ' LEU . 3.2 t -79.64 -50.3 18.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.698 -172.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 54' ' ' ALA . . . . . 0.589 ' HB2' HD21 ' D' ' 65' ' ' LEU . . . -153.44 147.16 25.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.711 -176.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 31.5 m -111.02 101.29 9.86 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 171.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 56' ' ' VAL . . . . . 0.477 HG13 ' HB3' ' D' ' 40' ' ' ALA . 7.2 p -119.67 113.5 41.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.545 0.688 . . . . 0.0 109.808 -177.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 57' ' ' THR . . . . . 0.45 HG22 ' HG3' ' D' ' 39' ' ' GLU . 67.5 p -123.24 -178.44 3.98 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.756 -174.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -61.97 -22.93 66.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.039 0.447 . . . . 0.0 110.522 170.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 59' ' ' ALA . . . . . 0.436 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -84.39 -40.82 17.36 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.253 0.549 . . . . 0.0 110.187 178.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 81.0 mt -112.76 82.63 5.16 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 174.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 61' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 11.5 Cg_exo -70.81 -0.29 7.56 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.063 2.508 . . . . 0.0 113.868 -168.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -163.11 127.0 2.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.315 0.579 . . . . 0.0 111.417 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 87.4 t -116.33 121.88 68.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.424 174.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.47 127.54 32.92 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.063 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 65' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' D' ' 54' ' ' ALA . 90.8 mt -119.76 168.52 10.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.477 0.656 . . . . 0.0 112.2 -174.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 66' ' ' ASP . . . . . 0.517 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 14.2 t0 -145.79 97.59 2.99 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 172.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.681 HD21 HD23 ' C' ' 88' ' ' LEU . 6.7 mt -133.62 109.95 9.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.776 -174.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 68' ' ' ASN . . . . . 0.467 ' HB2' ' CG ' ' C' ' 90' ' ' TYR . 6.4 m-20 -103.76 113.87 27.71 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 176.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 69' ' ' PHE . . . . . 0.444 ' HB3' ' CD1' ' D' ' 23' ' ' ILE . 86.1 m-85 -109.08 136.97 47.72 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.771 178.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . 0.401 ' OG ' ' HG2' ' C' ' 7' ' ' MET . 88.1 p -97.28 166.61 11.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.741 0.305 . . . . 0.0 110.239 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -73.07 -4.87 35.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.023 0.439 . . . . 0.0 110.873 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.52 -9.32 59.02 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.584 -0.607 . . . . 0.0 111.584 174.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -88.37 140.16 29.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.861 0.362 . . . . 0.0 110.135 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -126.27 114.58 18.47 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.569 HG22 ' HB2' ' D' ' 46' ' ' ALA . 13.2 pt -131.02 158.74 43.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.132 0.491 . . . . 0.0 112.0 -166.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 76' ' ' MET . . . . . 0.493 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 3.6 mtm -119.23 123.97 45.61 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 174.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 77' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 1.1 m-85 -104.3 128.57 52.11 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 78' ' ' TYR . . . . . 0.705 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 25.7 p90 -151.86 134.94 15.78 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.47 0.652 . . . . 0.0 112.414 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 79' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 2.5 p -108.85 130.59 55.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.792 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.89 164.76 11.55 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.553 177.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.39 -174.11 44.8 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -113.27 102.64 10.54 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.06 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -173.65 153.51 2.28 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.531 171.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 18.9 t -114.84 126.5 54.89 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.603 HG12 ' HB3' ' D' ' 34' ' ' LEU . 6.6 m -120.94 157.48 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-O 121.161 0.505 . . . . 0.0 112.11 -172.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 66.5 m -116.95 118.97 33.91 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 171.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 87' ' ' LEU . . . . . 0.736 HD13 HD23 ' D' ' 11' ' ' LEU . 5.1 mp -89.77 145.4 25.21 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 170.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.678 HD23 HD21 ' E' ' 67' ' ' LEU . 0.8 OUTLIER -129.98 141.37 50.76 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.982 -177.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.81 -167.44 26.44 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.302 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 90' ' ' TYR . . . . . 0.462 ' CG ' ' HB2' ' E' ' 68' ' ' ASN . 13.6 p90 -150.33 129.55 12.79 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 122.102 0.954 . . . . 0.0 112.091 178.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . 0.807 HD23 ' HB3' ' D' ' 27' ' ' PHE . 8.1 mt . . . . . 0 C--N 1.322 -0.626 0 CA-C-N 113.621 -1.627 . . . . 0.0 110.839 176.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 7' ' ' MET . . . . . 0.413 ' HG2' ' OG ' ' A' ' 70' ' ' SER . 58.9 mtt . . . . . 0 C--O 1.223 -0.314 0 CA-C-O 120.787 0.327 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 8' ' ' PHE . . . . . 0.545 ' CE1' HD21 ' A' ' 44' ' ' LEU . 76.9 t80 -59.93 140.3 56.79 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -172.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 9' ' ' TRP . . . . . 0.439 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 87.4 t90 -132.74 146.76 52.11 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 10' ' ' GLY . . . . . 0.456 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -151.68 152.68 24.4 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.233 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 11' ' ' LEU . . . . . 0.74 HD23 HD13 ' E' ' 87' ' ' LEU . 60.0 tp -140.44 106.71 5.25 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 178.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -86.31 100.87 12.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.571 0.7 . . . . 0.0 109.72 175.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 13' ' ' MET . . . . . 0.471 ' HB3' HG23 ' E' ' 85' ' ' VAL . 3.7 ttt -94.64 134.23 37.44 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.667 -1.152 . . . . 0.0 111.102 -168.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 14' ' ' LYS . . . . . 0.473 ' HB2' ' HG3' ' E' ' 17' ' ' ARG . 2.5 mptp? -100.29 149.53 36.14 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.791 -178.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . 0.502 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 12.2 Cg_endo -56.48 122.38 11.69 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.146 2.564 . . . . 0.0 112.95 -178.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 16' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' E' ' 79' ' ' THR . 44.7 mt-10 61.43 51.93 3.96 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.502 177.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 17' ' ' ARG . . . . . 0.473 ' HG3' ' HB2' ' E' ' 14' ' ' LYS . 29.0 mmt180 -117.61 145.52 44.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.161 173.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . 0.713 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 40.6 tttt -123.34 109.84 14.42 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 123.505 0.503 . . . . 0.0 110.465 -176.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . 0.447 ' HE2' ' HG3' ' E' ' 13' ' ' MET . 3.4 m-85 -110.06 104.4 13.27 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.367 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 20' ' ' SER . . . . . 0.474 ' HB3' ' SD ' ' E' ' 76' ' ' MET . 13.5 p -85.08 99.43 11.04 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -113.39 144.13 43.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.596 0.712 . . . . 0.0 112.01 -168.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 13.9 p -96.51 157.3 15.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.623 174.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 23' ' ' ILE . . . . . 0.442 ' CD1' ' HB3' ' E' ' 69' ' ' PHE . 53.7 mt -115.02 116.47 52.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.218 0.532 . . . . 0.0 111.211 -175.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . 0.483 HD12 ' N ' ' E' ' 24' ' ' ILE . 3.9 mp -93.23 -40.93 12.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.205 178.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -123.87 128.16 49.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.582 176.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 62.2 p -64.6 141.72 58.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.247 -174.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 27' ' ' PHE . . . . . 0.845 ' HB3' HD23 ' E' ' 91' ' ' LEU . 40.0 p90 -142.09 152.53 43.38 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.727 0.775 . . . . 0.0 112.235 -177.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 28' ' ' HIS . . . . . 0.639 ' HA ' ' O ' ' E' ' 67' ' ' LEU . 6.3 t60 -108.15 120.5 42.52 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.397 173.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 29' ' ' ILE . . . . . 0.543 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 35.2 mt -84.56 133.56 28.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.129 -1.064 . . . . 0.0 108.129 170.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . 0.539 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 56.8 p -120.35 -6.88 9.82 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -173.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.13 158.34 25.88 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 119.569 -1.3 . . . . 0.0 113.609 176.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.5 HG23 ' HG ' ' E' ' 87' ' ' LEU . 13.1 p -140.42 127.16 22.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 172.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.13 152.84 41.48 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 121.934 -0.478 . . . . 0.0 111.324 -175.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 34' ' ' LEU . . . . . 0.623 ' HB3' HG12 ' E' ' 85' ' ' VAL . 3.7 pp -117.78 145.87 44.2 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 121.739 0.781 . . . . 0.0 111.794 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -106.68 -56.09 2.24 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.855 175.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -102.47 127.94 49.3 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.113 170.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 153.29 158.46 8.57 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 119.368 -1.396 . . . . 0.0 113.911 175.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -101.72 -45.67 5.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.497 -0.352 . . . . 0.0 110.559 176.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 39' ' ' GLU . . . . . 0.45 ' HG3' HG22 ' E' ' 57' ' ' THR . 32.7 tt0 -153.1 123.0 6.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.052 -178.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . 0.567 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -121.87 114.17 20.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.515 0.674 . . . . 0.0 110.002 170.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 41' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' E' ' 79' ' ' THR . 13.7 mmmm -97.18 105.46 17.61 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 49.8 tp -83.71 111.49 19.2 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -174.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 43' ' ' TYR . . . . . 0.559 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 80.0 m-85 -114.86 149.98 36.26 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 175.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 44' ' ' LEU . . . . . 0.562 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 0.2 OUTLIER -135.58 128.13 30.66 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.532 172.082 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' E' E ' 45' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -105.92 112.1 25.01 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.151 178.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . 0.581 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -127.87 133.29 49.33 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.344 178.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 59.29 38.24 23.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.607 0.718 . . . . 0.0 109.698 -176.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt 62.44 35.23 14.94 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.652 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 49' ' ' GLN . . . . . 0.566 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 23.2 tp60 -130.14 118.23 21.14 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -81.7 108.25 15.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.965 0.412 . . . . 0.0 110.859 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . 0.467 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 87.1 m-85 -99.81 133.33 44.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.615 177.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -80.06 104.71 8.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 169.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . 0.492 HG21 ' HB3' ' E' ' 44' ' ' LEU . 3.2 t -79.68 -50.4 18.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.667 -172.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 54' ' ' ALA . . . . . 0.61 ' HB2' HD21 ' E' ' 65' ' ' LEU . . . -153.33 147.18 25.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.723 -176.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 31.2 m -110.89 101.17 9.78 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 171.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . 0.47 HG13 ' HB3' ' E' ' 40' ' ' ALA . 7.1 p -119.54 113.45 41.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.64 0.733 . . . . 0.0 109.895 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 57' ' ' THR . . . . . 0.45 HG22 ' HG3' ' E' ' 39' ' ' GLU . 66.4 p -123.21 -178.43 3.98 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.746 -174.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -61.91 -22.98 66.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.961 0.41 . . . . 0.0 110.501 170.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 59' ' ' ALA . . . . . 0.437 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -84.34 -40.8 17.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.182 178.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 80.8 mt -112.78 82.56 5.13 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 174.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 61' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 11.5 Cg_exo -70.82 -0.29 7.56 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.066 2.511 . . . . 0.0 113.88 -167.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -163.12 127.1 2.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.399 0.618 . . . . 0.0 111.397 -176.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 86.9 t -116.42 121.93 68.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.344 174.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.56 127.56 32.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.032 176.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 65' ' ' LEU . . . . . 0.61 HD21 ' HB2' ' E' ' 54' ' ' ALA . 90.8 mt -119.8 168.51 11.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.481 0.658 . . . . 0.0 112.184 -174.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 66' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 14.3 t0 -145.76 97.59 2.99 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 172.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 67' ' ' LEU . . . . . 0.678 HD21 HD23 ' D' ' 88' ' ' LEU . 6.7 mt -133.57 109.99 9.61 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.809 -174.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 68' ' ' ASN . . . . . 0.462 ' HB2' ' CG ' ' D' ' 90' ' ' TYR . 6.4 m-20 -103.84 113.87 27.71 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 69' ' ' PHE . . . . . 0.442 ' HB3' ' CD1' ' E' ' 23' ' ' ILE . 86.1 m-85 -109.1 136.98 47.71 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.721 178.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 70' ' ' SER . . . . . 0.435 ' OG ' ' HG2' ' D' ' 7' ' ' MET . 88.0 p -97.35 166.7 11.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.802 0.334 . . . . 0.0 110.17 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -73.19 -4.83 35.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.002 0.43 . . . . 0.0 110.843 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.6 -9.14 59.07 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 174.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -88.5 140.25 29.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.863 0.363 . . . . 0.0 110.059 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -126.32 114.47 18.29 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 75' ' ' ILE . . . . . 0.581 HG22 ' HB2' ' E' ' 46' ' ' ALA . 13.3 pt -131.04 158.71 43.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.104 0.478 . . . . 0.0 111.945 -166.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 76' ' ' MET . . . . . 0.495 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 3.7 mtm -119.28 123.97 45.55 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 174.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 77' ' ' PHE . . . . . 0.562 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 1.1 m-85 -104.28 128.61 52.08 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 78' ' ' TYR . . . . . 0.713 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 26.0 p90 -151.95 135.0 15.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.504 0.669 . . . . 0.0 112.442 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 79' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 2.6 p -108.99 130.54 55.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.767 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.85 164.76 11.55 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.51 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.44 -174.04 44.65 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -113.32 102.69 10.58 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.977 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 83' ' ' ALA . . . . . 0.567 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -173.7 153.56 2.27 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.536 171.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 18.9 t -114.84 126.42 54.8 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 85' ' ' VAL . . . . . 0.623 HG12 ' HB3' ' E' ' 34' ' ' LEU . 6.7 m -120.78 157.68 23.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-O 121.222 0.534 . . . . 0.0 112.075 -172.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 66.6 m -117.21 118.93 33.65 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 171.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 87' ' ' LEU . . . . . 0.74 HD13 HD23 ' E' ' 11' ' ' LEU . 5.1 mp -89.77 145.43 25.19 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 170.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . 0.668 HD23 HD21 ' A' ' 67' ' ' LEU . 0.8 OUTLIER -130.1 141.4 50.7 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.873 -177.738 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.87 -167.51 26.61 Favored Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.253 -178.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 90' ' ' TYR . . . . . 0.452 ' CG ' ' HB2' ' A' ' 68' ' ' ASN . 13.6 p90 -150.24 129.58 12.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 122.04 0.924 . . . . 0.0 112.06 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 91' ' ' LEU . . . . . 0.845 HD23 ' HB3' ' E' ' 27' ' ' PHE . 8.0 mt . . . . . 0 C--N 1.321 -0.669 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.81 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 52.4 ttm . . . . . 0 N--CA 1.455 -0.181 0 CA-C-O 121.008 0.432 . . . . 0.0 111.622 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.439 ' CE1' HD21 ' B' ' 44' ' ' LEU . 61.4 t80 -52.77 142.1 19.64 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.619 -177.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.555 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 88.5 t90 -135.71 147.72 48.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.876 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.46 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -148.72 153.82 25.46 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.007 178.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.652 HD23 HD13 ' A' ' 87' ' ' LEU . 52.1 tp -140.44 108.18 5.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.022 0.439 . . . . 0.0 110.881 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -81.25 101.49 9.76 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.538 173.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.592 ' HB3' HG23 ' A' ' 85' ' ' VAL . 30.6 tpp -95.48 131.26 41.83 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.148 -174.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -100.82 145.31 30.15 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.915 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.598 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 12.3 Cg_endo -56.01 124.54 16.51 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 123.397 2.731 . . . . 0.0 113.493 -174.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.556 ' HA ' ' O ' ' A' ' 79' ' ' THR . 25.3 mt-10 60.3 47.91 8.57 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.062 177.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -121.79 138.67 54.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.687 172.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.726 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 84.5 mttt -111.21 118.98 37.43 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.414 0.446 . . . . 0.0 111.519 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.61 103.91 12.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.827 176.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.41 ' HB3' ' SD ' ' A' ' 76' ' ' MET . 7.8 p -88.47 98.84 11.85 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 174.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -117.36 144.84 44.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.472 0.653 . . . . 0.0 112.273 -169.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.5 m -94.06 143.15 26.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.542 177.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.435 ' CG2' ' HA ' ' A' ' 71' ' ' LYS . 59.4 mt -92.81 120.35 42.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.066 0.46 . . . . 0.0 111.119 -174.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.1 mp -79.34 -52.9 14.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.351 178.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.493 ' HE2' ' HB3' ' A' ' 91' ' ' LEU . 13.5 ptmt -131.08 137.53 49.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.942 175.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.2 m -54.45 141.76 29.65 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.921 -176.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.666 ' HB3' HD23 ' A' ' 91' ' ' LEU . 11.9 p90 -149.06 158.26 44.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.655 0.741 . . . . 0.0 112.819 -175.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.608 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 9.2 t60 -111.41 127.41 55.67 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.392 -1.276 . . . . 0.0 109.745 178.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.573 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 35.0 mt -96.78 137.97 23.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 170.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.608 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 56.6 p -123.5 -20.42 5.57 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -171.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -153.88 156.34 26.74 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 119.273 -1.442 . . . . 0.0 113.578 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.5 HG23 ' HG ' ' A' ' 87' ' ' LEU . 14.8 p -146.51 124.39 4.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 172.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.19 155.68 44.0 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.75 -174.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.581 ' HB3' HG12 ' A' ' 85' ' ' VAL . 3.7 pp -120.39 140.55 51.17 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.914 0.864 . . . . 0.0 111.755 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -105.12 -53.6 2.63 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.334 -1.303 . . . . 0.0 108.788 174.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -102.91 127.44 50.12 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 169.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.485 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 151.22 156.03 7.21 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 119.784 -1.198 . . . . 0.0 113.608 177.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.44 ' HA ' ' HB2' ' A' ' 58' ' ' LYS . 91.0 mt-30 -102.66 -44.27 5.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.68 0.276 . . . . 0.0 111.053 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -153.12 126.41 8.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.095 176.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.564 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -124.51 113.16 17.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.563 0.697 . . . . 0.0 109.7 169.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 79' ' ' THR . 19.9 mtpp -96.06 107.05 19.31 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 41.2 tp -81.57 114.84 20.55 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -173.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.55 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 97.6 m-85 -120.49 139.46 52.86 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.271 177.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.51 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -125.15 133.27 52.87 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 172.67 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.631 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -112.04 113.07 25.14 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.156 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.53 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -124.47 137.8 54.4 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.416 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 59.7 30.72 20.33 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.473 0.483 . . . . 0.0 110.301 -174.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.479 ' NZ ' ' HB2' ' A' ' 48' ' ' LYS . 0.1 OUTLIER 62.57 33.6 15.74 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.14 -177.072 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.631 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 8.5 tp-100 -123.46 130.38 52.61 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.66 123.59 32.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.905 0.383 . . . . 0.0 110.769 -176.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.499 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 84.7 m-85 -118.02 130.08 55.96 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 175.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.09 103.77 7.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 171.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.546 ' CG1' HD11 ' A' ' 67' ' ' LEU . 2.6 t -78.7 -49.49 20.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.712 -171.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.462 ' HB1' HG11 ' A' ' 63' ' ' VAL . . . -158.38 146.58 18.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.852 -178.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.4 m -109.46 101.43 10.39 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 173.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.456 HG11 HG11 ' A' ' 85' ' ' VAL . 7.4 p -115.63 116.2 51.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.557 0.694 . . . . 0.0 109.565 -177.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 47.1 p -122.37 -179.13 4.09 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.335 -172.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.44 ' HB2' ' HA ' ' A' ' 38' ' ' GLN . 38.1 tttm -61.58 -27.38 68.59 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.892 172.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.487 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -84.24 -40.63 17.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.643 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.2 mt -109.45 83.99 2.82 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 174.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 9.7 Cg_exo -70.91 0.07 7.08 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.016 2.478 . . . . 0.0 113.762 -168.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -162.8 131.74 4.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.224 0.535 . . . . 0.0 111.254 -176.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.462 HG11 ' HB1' ' A' ' 54' ' ' ALA . 68.7 t -120.49 132.68 69.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.105 172.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.43 113.11 25.49 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.224 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -121.46 170.01 10.07 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.34 -176.489 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.549 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 7.2 t0 -118.33 98.76 6.44 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.245 0.545 . . . . 0.0 109.619 175.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.613 HD21 HD23 ' E' ' 88' ' ' LEU . 19.8 mt -112.98 143.49 44.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.873 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.451 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 57.2 t30 -147.81 119.96 8.3 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 120.942 0.401 . . . . 0.0 110.008 174.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -114.93 153.53 30.38 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.25 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.7 t -103.67 148.88 25.51 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.983 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.493 ' NZ ' ' HB2' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -74.75 9.97 1.6 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -174.656 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.62 -15.21 30.04 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.865 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -101.28 170.82 7.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.77 0.319 . . . . 0.0 110.868 -175.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 61.9 ttt-85 -138.32 122.6 18.18 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.53 HG22 ' HB2' ' A' ' 46' ' ' ALA . 14.4 pt -125.69 160.86 31.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.431 -170.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.48 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 2.8 mtm -115.23 129.02 56.52 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 174.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.51 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -109.82 128.41 55.3 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.109 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.726 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 51.3 p90 -155.83 157.47 36.48 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 120.226 -0.59 . . . . 0.0 112.24 -177.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 14.8 p -124.81 144.0 50.51 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.264 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.42 156.63 18.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.981 174.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.01 -166.83 31.32 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -176.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -123.71 102.68 7.96 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 117.715 0.758 . . . . 0.0 110.42 176.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.598 ' H ' ' HB3' ' A' ' 15' ' ' PRO . . . -169.31 151.81 4.71 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.187 169.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.5 t -109.1 122.85 48.16 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.592 HG23 ' HB3' ' A' ' 13' ' ' MET . 6.7 m -119.78 147.12 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-O 121.266 0.555 . . . . 0.0 111.832 -173.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.0 t -111.01 119.34 38.72 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.652 HD13 HD23 ' A' ' 11' ' ' LEU . 5.2 mp -91.84 151.45 20.56 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 174.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.568 HD23 HD21 ' B' ' 67' ' ' LEU . 1.2 tp -133.0 140.3 47.69 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.301 -178.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.23 -166.75 24.72 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.992 -177.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.408 ' CD2' ' HB3' ' B' ' 68' ' ' ASN . 11.5 p90 -152.93 132.86 13.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.697 0.76 . . . . 0.0 111.839 176.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.666 HD23 ' HB3' ' A' ' 27' ' ' PHE . 15.2 mt . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.095 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 52.5 ttm . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 121.002 0.429 . . . . 0.0 111.582 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . 0.49 ' CE1' HD21 ' C' ' 44' ' ' LEU . 61.8 t80 -52.72 142.05 19.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.627 -177.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . 0.551 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 88.5 t90 -135.7 147.71 48.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.856 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.507 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -148.71 153.86 25.48 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.984 178.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.662 HD23 HD13 ' B' ' 87' ' ' LEU . 52.3 tp -140.46 108.13 5.63 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.086 0.47 . . . . 0.0 110.915 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -81.23 101.59 9.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.529 173.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . 0.591 ' HB3' HG23 ' B' ' 85' ' ' VAL . 30.8 tpp -95.58 131.23 42.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.114 0.483 . . . . 0.0 111.151 -174.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -100.74 145.26 30.05 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.969 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.587 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 12.4 Cg_endo -56.09 124.67 16.82 Favored 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 123.445 2.763 . . . . 0.0 113.487 -174.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.549 ' HA ' ' O ' ' B' ' 79' ' ' THR . 25.3 mt-10 60.24 47.91 8.72 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.031 177.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -121.76 138.78 54.23 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.696 172.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.721 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 84.5 mttt -111.47 119.02 37.4 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 123.273 0.358 . . . . 0.0 111.491 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.67 103.86 12.47 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.766 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 7.3 p -88.48 98.87 11.87 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 174.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -117.39 144.81 44.57 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.538 0.685 . . . . 0.0 112.284 -169.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 17.7 m -94.06 143.11 26.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.523 177.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.445 ' CG2' ' HA ' ' B' ' 71' ' ' LYS . 59.3 mt -92.86 120.49 42.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.162 0.506 . . . . 0.0 111.117 -174.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.444 ' N ' HD12 ' B' ' 24' ' ' ILE . 4.0 mp -79.42 -52.89 14.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.286 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.502 ' HE2' ' HB3' ' B' ' 91' ' ' LEU . 13.5 ptmt -131.12 137.47 49.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.988 175.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 11.5 m -54.41 141.71 29.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.924 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . 0.66 ' HB3' HD23 ' B' ' 91' ' ' LEU . 12.1 p90 -149.03 158.28 44.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.685 0.755 . . . . 0.0 112.774 -175.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' HIS . . . . . 0.598 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 9.2 t60 -111.39 127.39 55.65 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.39 -1.277 . . . . 0.0 109.795 178.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.589 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 35.0 mt -96.79 137.98 23.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 170.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.598 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 56.4 p -123.52 -20.37 5.58 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -171.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -153.81 156.39 26.77 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 119.322 -1.418 . . . . 0.0 113.605 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.498 HG23 ' HG ' ' B' ' 87' ' ' LEU . 14.8 p -146.58 124.35 3.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 172.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.14 155.71 44.04 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.898 -0.501 . . . . 0.0 111.726 -174.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.586 ' HB3' HG12 ' B' ' 85' ' ' VAL . 3.7 pp -120.38 140.57 51.12 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.984 0.897 . . . . 0.0 111.728 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -105.01 -53.8 2.6 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.37 -1.286 . . . . 0.0 108.855 174.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -102.82 127.44 49.99 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 169.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.492 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 151.3 156.09 7.25 Favored Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 119.829 -1.177 . . . . 0.0 113.547 176.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . 0.438 ' HA ' ' HB2' ' B' ' 58' ' ' LYS . 91.0 mt-30 -102.58 -44.3 5.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.737 0.303 . . . . 0.0 111.125 178.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -153.08 126.41 8.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.089 177.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.555 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -124.53 113.12 17.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.511 0.672 . . . . 0.0 109.776 169.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' B' ' 79' ' ' THR . 19.9 mtpp -96.15 107.04 19.32 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 41.2 tp -81.5 114.84 20.49 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 -173.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . 0.553 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 97.6 m-85 -120.51 139.42 52.93 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.507 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 0.2 OUTLIER -125.07 133.29 52.96 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 172.575 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.625 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -112.02 113.11 25.21 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.184 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.515 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -124.54 137.82 54.38 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.344 178.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 59.63 30.88 20.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.046 0.451 . . . . 0.0 110.293 -174.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.488 ' NZ ' ' HB2' ' B' ' 48' ' ' LYS . 0.1 OUTLIER 62.62 33.6 15.61 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.12 -177.153 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . 0.625 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 8.4 tp-100 -123.48 130.27 52.45 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.63 123.61 32.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.829 0.347 . . . . 0.0 110.7 -175.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.46 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 84.8 m-85 -117.99 130.15 56.02 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.888 175.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.1 tp -80.2 103.78 7.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.827 0.822 . . . . 0.0 108.807 171.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.552 ' CG1' HD11 ' B' ' 67' ' ' LEU . 2.6 t -78.7 -49.39 20.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.709 -171.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.468 ' HB1' HG11 ' B' ' 63' ' ' VAL . . . -158.38 146.65 18.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.889 -178.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 32.3 m -109.57 101.43 10.36 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . 0.449 HG11 HG11 ' B' ' 85' ' ' VAL . 7.4 p -115.62 116.21 51.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.568 0.699 . . . . 0.0 109.557 -177.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 46.8 p -122.37 -179.17 4.1 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.371 -172.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . 0.438 ' HB2' ' HA ' ' B' ' 38' ' ' GLN . 38.1 tttm -61.53 -27.33 68.53 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.878 172.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.479 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -84.34 -40.67 17.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.577 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 86.1 mt -109.41 84.11 2.85 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 174.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 9.8 Cg_exo -71.03 0.09 7.14 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.981 2.454 . . . . 0.0 113.707 -168.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -162.79 131.71 4.11 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.121 0.486 . . . . 0.0 111.221 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.468 HG11 ' HB1' ' B' ' 54' ' ' ALA . 71.7 t -120.57 132.8 69.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.964 172.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.52 113.22 25.69 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.09 177.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.435 HD13 ' N ' ' B' ' 65' ' ' LEU . 0.0 OUTLIER -121.58 170.05 10.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.325 -176.575 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . 0.511 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 7.2 t0 -118.38 98.73 6.42 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.221 0.534 . . . . 0.0 109.602 175.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.589 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 19.7 mt -113.0 143.43 44.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.903 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . 0.408 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 57.0 t30 -147.79 120.0 8.34 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.951 0.405 . . . . 0.0 109.965 174.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -114.98 153.5 30.5 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.273 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 20.6 t -103.57 148.89 25.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.058 -178.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . 0.486 ' NZ ' ' HB2' ' B' ' 71' ' ' LYS . 0.0 OUTLIER -74.88 10.07 1.6 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -174.579 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.61 -15.22 30.04 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.86 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -101.13 170.83 7.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.846 0.355 . . . . 0.0 110.838 -175.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 62.0 ttt-85 -138.37 122.55 18.07 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.515 HG22 ' HB2' ' B' ' 46' ' ' ALA . 14.5 pt -125.73 160.86 31.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.389 -170.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.483 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 2.8 mtm -115.25 129.01 56.51 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 174.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . 0.507 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -109.81 128.39 55.28 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.187 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.721 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 51.4 p90 -155.79 157.4 36.43 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 120.241 -0.584 . . . . 0.0 112.215 -177.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 14.6 p -124.77 144.06 50.46 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.277 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.43 156.69 18.68 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.981 174.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.87 -166.91 31.55 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -123.75 102.76 7.99 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.36 176.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.587 ' H ' ' HB3' ' B' ' 15' ' ' PRO . . . -169.23 151.88 4.79 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.21 169.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 33.7 t -109.23 122.83 48.17 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.591 HG23 ' HB3' ' B' ' 13' ' ' MET . 6.8 m -119.78 147.18 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 CA-C-O 121.307 0.575 . . . . 0.0 111.838 -173.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 17.0 t -111.08 119.33 38.63 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.662 HD13 HD23 ' B' ' 11' ' ' LEU . 5.2 mp -91.72 151.49 20.61 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 174.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.602 HD23 HD21 ' C' ' 67' ' ' LEU . 1.2 tp -133.07 140.31 47.61 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.267 -178.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.28 -166.67 24.65 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.961 -177.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 90' ' ' TYR . . . . . 0.42 ' CD2' ' HB3' ' C' ' 68' ' ' ASN . 11.3 p90 -153.11 132.92 13.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.811 0.815 . . . . 0.0 111.742 176.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . 0.66 HD23 ' HB3' ' B' ' 27' ' ' PHE . 15.1 mt . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 114.13 -1.395 . . . . 0.0 110.127 177.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 52.4 ttm . . . . . 0 C--O 1.226 -0.161 0 CA-C-O 121.005 0.431 . . . . 0.0 111.567 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' C' C ' 8' ' ' PHE . . . . . 0.491 ' CE1' HD21 ' D' ' 44' ' ' LEU . 61.4 t80 -52.73 142.1 19.48 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.937 -1.028 . . . . 0.0 112.62 -177.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . 0.537 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 88.3 t90 -135.71 147.57 48.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.867 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . 0.521 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -148.69 153.8 25.44 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.094 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.652 HD23 HD13 ' C' ' 87' ' ' LEU . 52.6 tp -140.36 108.15 5.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.989 0.423 . . . . 0.0 110.914 178.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -81.29 101.48 9.78 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.507 173.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 13' ' ' MET . . . . . 0.604 ' HB3' HG23 ' C' ' 85' ' ' VAL . 30.7 tpp -95.48 131.23 41.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.132 0.492 . . . . 0.0 111.128 -174.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -100.82 145.32 30.17 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.899 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . 0.591 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 12.4 Cg_endo -56.06 124.61 16.69 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 123.404 2.736 . . . . 0.0 113.459 -174.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' C' ' 79' ' ' THR . 25.1 mt-10 60.28 47.91 8.63 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.024 177.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -121.72 138.72 54.24 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.653 172.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 18' ' ' LYS . . . . . 0.729 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 84.5 mttt -111.37 119.06 37.58 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.454 0.471 . . . . 0.0 111.484 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -110.7 103.86 12.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.735 176.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 7.8 p -88.43 98.84 11.85 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 174.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -117.38 144.77 44.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.553 0.692 . . . . 0.0 112.271 -169.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 17.4 m -94.01 143.19 26.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.577 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . 0.435 ' CG2' ' HA ' ' C' ' 71' ' ' LYS . 59.4 mt -92.89 120.48 42.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.054 0.454 . . . . 0.0 111.09 -174.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . 0.449 HD12 ' N ' ' C' ' 24' ' ' ILE . 4.0 mp -79.43 -52.88 14.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.315 178.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . 0.492 ' HE2' ' HB3' ' C' ' 91' ' ' LEU . 13.6 ptmt -131.12 137.46 49.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.95 175.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 11.5 m -54.43 141.69 29.77 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.921 -176.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 27' ' ' PHE . . . . . 0.651 ' HB3' HD23 ' C' ' 91' ' ' LEU . 12.1 p90 -149.0 158.24 44.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.71 0.767 . . . . 0.0 112.834 -176.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 28' ' ' HIS . . . . . 0.603 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 9.2 t60 -111.41 127.41 55.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.405 -1.271 . . . . 0.0 109.864 178.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . 0.566 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 35.6 mt -96.82 138.02 23.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 170.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.603 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 56.4 p -123.46 -20.45 5.58 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -171.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -153.78 156.36 26.74 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 119.352 -1.404 . . . . 0.0 113.634 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.489 HG23 ' HG ' ' C' ' 87' ' ' LEU . 14.8 p -146.57 124.31 3.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.12 155.74 44.06 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.947 -0.471 . . . . 0.0 111.752 -174.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.597 ' HB3' HG12 ' C' ' 85' ' ' VAL . 3.7 pp -120.44 140.58 51.17 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.938 0.875 . . . . 0.0 111.752 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -105.13 -53.7 2.62 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.757 174.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -102.9 127.47 50.09 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 169.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 37' ' ' GLY . . . . . 0.48 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 151.24 156.09 7.24 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 119.901 -1.142 . . . . 0.0 113.685 177.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 38' ' ' GLN . . . . . 0.438 ' HA ' ' HB2' ' C' ' 58' ' ' LYS . 90.9 mt-30 -102.68 -44.23 5.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.766 0.317 . . . . 0.0 111.156 178.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -153.1 126.46 8.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.071 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.56 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -124.46 113.08 17.66 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.441 0.638 . . . . 0.0 109.793 169.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' C' ' 79' ' ' THR . 19.9 mtpp -96.07 107.02 19.27 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 176.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 41.3 tp -81.48 114.81 20.46 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -173.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 43' ' ' TYR . . . . . 0.553 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 97.6 m-85 -120.53 139.41 52.95 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.503 ' HB2' ' CD1' ' C' ' 77' ' ' PHE . 0.2 OUTLIER -125.12 133.25 52.92 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.656 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . 0.631 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -112.07 113.11 25.2 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.096 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.519 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -124.46 137.82 54.4 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.333 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 59.72 30.73 20.32 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 123.503 0.502 . . . . 0.0 110.258 -174.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . 0.488 ' NZ ' ' HB2' ' C' ' 48' ' ' LYS . 0.1 OUTLIER 62.53 33.62 15.83 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.201 -177.033 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . 0.631 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 8.4 tp-100 -123.53 130.27 52.43 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.53 123.64 31.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.792 0.33 . . . . 0.0 110.806 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . 0.507 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 84.6 m-85 -118.03 130.12 55.98 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.84 175.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.1 tp -80.23 103.82 7.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 171.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 53' ' ' VAL . . . . . 0.555 ' CG1' HD11 ' C' ' 67' ' ' LEU . 2.6 t -78.7 -49.5 20.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.648 -171.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 54' ' ' ALA . . . . . 0.471 ' HB1' HG11 ' C' ' 63' ' ' VAL . . . -158.35 146.56 18.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.827 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 32.5 m -109.42 101.37 10.35 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 173.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . 0.462 HG11 HG11 ' C' ' 85' ' ' VAL . 7.4 p -115.54 116.27 51.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.587 0.708 . . . . 0.0 109.569 -177.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 47.0 p -122.44 -179.13 4.1 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.346 -172.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 58' ' ' LYS . . . . . 0.438 ' HB2' ' HA ' ' C' ' 38' ' ' GLN . 38.1 tttm -61.45 -27.53 68.63 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.871 172.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . 0.493 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -84.14 -40.66 17.95 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.647 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 86.1 mt -109.43 84.05 2.83 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 174.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 61' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 9.8 Cg_exo -71.03 0.12 7.09 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.099 2.533 . . . . 0.0 113.729 -168.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -162.77 131.69 4.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.166 0.508 . . . . 0.0 111.274 -176.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.471 HG11 ' HB1' ' C' ' 54' ' ' ALA . 69.0 t -120.47 132.86 68.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.0 172.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.61 113.12 25.5 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.115 177.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . 0.439 ' N ' HD13 ' C' ' 65' ' ' LEU . 0.0 OUTLIER -121.51 170.03 10.08 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.064 0.459 . . . . 0.0 111.294 -176.508 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 66' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 7.4 t0 -118.3 98.76 6.44 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.199 0.524 . . . . 0.0 109.678 175.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.602 HD21 HD23 ' B' ' 88' ' ' LEU . 19.7 mt -112.98 143.4 44.33 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.902 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . 0.42 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 57.1 t30 -147.75 119.96 8.34 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 174.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -115.01 153.53 30.48 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.186 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 20.5 t -103.61 148.88 25.47 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.991 -178.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . 0.48 ' NZ ' ' HB2' ' C' ' 71' ' ' LYS . 0.0 OUTLIER -74.76 9.91 1.63 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -174.66 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.57 -15.14 30.37 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.594 -0.813 . . . . 0.0 111.994 175.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -101.16 170.87 7.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.792 0.329 . . . . 0.0 110.91 -175.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 61.8 ttt-85 -138.36 122.64 18.19 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.519 HG22 ' HB2' ' C' ' 46' ' ' ALA . 14.4 pt -125.76 160.84 31.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.4 -170.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.476 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 2.8 mtm -115.24 129.02 56.52 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 174.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 77' ' ' PHE . . . . . 0.503 ' CD1' ' HB2' ' C' ' 44' ' ' LEU . 0.6 OUTLIER -109.91 128.38 55.32 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.179 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 78' ' ' TYR . . . . . 0.729 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 51.2 p90 -155.78 157.45 36.51 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 120.235 -0.586 . . . . 0.0 112.254 -177.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 14.7 p -124.74 143.98 50.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.234 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.34 156.62 18.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.017 174.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.04 -166.74 31.23 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -176.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -123.79 102.72 7.96 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 117.693 0.746 . . . . 0.0 110.462 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . 0.591 ' H ' ' HB3' ' C' ' 15' ' ' PRO . . . -169.26 151.81 4.74 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.366 -1.288 . . . . 0.0 109.258 169.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 33.5 t -109.18 122.78 48.03 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.604 HG23 ' HB3' ' C' ' 13' ' ' MET . 6.7 m -119.68 147.17 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 CA-C-O 121.264 0.554 . . . . 0.0 111.818 -173.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . 0.4 ' HB3' HG22 ' D' ' 52' ' ' ILE . 17.2 t -111.11 119.36 38.74 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . 0.652 HD13 HD23 ' C' ' 11' ' ' LEU . 5.2 mp -91.67 151.46 20.66 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 174.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . 0.564 HD23 HD21 ' D' ' 67' ' ' LEU . 1.2 tp -133.07 140.33 47.62 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.3 -178.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.29 -166.73 24.77 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.955 -0.64 . . . . 0.0 111.991 -177.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -153.0 132.81 13.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.714 0.769 . . . . 0.0 111.817 176.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . 0.651 HD23 ' HB3' ' C' ' 27' ' ' PHE . 15.2 mt . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.094 177.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 52.4 ttm . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 120.997 0.427 . . . . 0.0 111.594 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' D' D ' 8' ' ' PHE . . . . . 0.496 ' CE1' HD21 ' E' ' 44' ' ' LEU . 61.4 t80 -52.76 142.16 19.48 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.603 -177.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 9' ' ' TRP . . . . . 0.55 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 88.2 t90 -135.81 147.67 48.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.113 -0.948 . . . . 0.0 108.899 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . 0.518 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -148.74 153.76 25.41 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.083 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . 0.663 HD23 HD13 ' D' ' 87' ' ' LEU . 52.1 tp -140.32 108.25 5.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.065 0.46 . . . . 0.0 110.85 178.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -81.32 101.68 9.93 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.473 173.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 13' ' ' MET . . . . . 0.601 ' HB3' HG23 ' D' ' 85' ' ' VAL . 30.5 tpp -95.57 131.31 41.91 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.181 -174.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -100.87 145.32 30.19 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.885 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . 0.595 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 12.3 Cg_endo -56.12 124.61 16.69 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 123.421 2.747 . . . . 0.0 113.413 -174.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . 0.556 ' HA ' ' O ' ' D' ' 79' ' ' THR . 25.2 mt-10 60.33 47.91 8.52 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.547 -0.752 . . . . 0.0 112.017 177.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -121.78 138.69 54.27 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.654 172.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . 0.714 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 84.6 mttt -111.39 119.1 37.71 Favored 'General case' 0 CA--C 1.517 -0.316 0 O-C-N 123.384 0.428 . . . . 0.0 111.472 178.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.61 103.84 12.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.794 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 7.5 p -88.38 98.84 11.83 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 174.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -117.44 144.79 44.65 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.537 0.684 . . . . 0.0 112.271 -169.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 17.4 m -94.08 143.1 26.67 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.56 177.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . 0.443 ' CG2' ' HA ' ' D' ' 71' ' ' LYS . 59.5 mt -92.86 120.55 42.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.167 0.508 . . . . 0.0 111.077 -174.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . 0.452 HD12 ' N ' ' D' ' 24' ' ' ILE . 4.0 mp -79.47 -52.9 14.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.294 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . 0.498 ' HE2' ' HB3' ' D' ' 91' ' ' LEU . 13.6 ptmt -131.03 137.56 49.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.053 175.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 11.7 m -54.49 141.71 30.06 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 124.01 0.818 . . . . 0.0 110.894 -176.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 27' ' ' PHE . . . . . 0.657 ' HB3' HD23 ' D' ' 91' ' ' LEU . 11.9 p90 -149.04 158.28 44.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.717 0.77 . . . . 0.0 112.767 -175.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 28' ' ' HIS . . . . . 0.598 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 9.2 t60 -111.44 127.35 55.66 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.739 178.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 29' ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 35.4 mt -96.7 138.11 22.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 170.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . 0.598 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 55.7 p -123.65 -20.35 5.53 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -171.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -153.79 156.38 26.76 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 119.305 -1.426 . . . . 0.0 113.635 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.489 HG23 ' HG ' ' D' ' 87' ' ' LEU . 14.8 p -146.63 124.23 3.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.11 155.74 44.07 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.91 -0.494 . . . . 0.0 111.791 -174.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 34' ' ' LEU . . . . . 0.576 ' HB3' HG12 ' D' ' 85' ' ' VAL . 3.7 pp -120.37 140.47 51.26 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.894 0.854 . . . . 0.0 111.781 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -105.07 -53.59 2.64 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.416 -1.266 . . . . 0.0 108.84 174.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -102.92 127.47 50.12 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 168.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . 0.488 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 151.18 155.92 7.16 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 119.859 -1.162 . . . . 0.0 113.688 177.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 38' ' ' GLN . . . . . 0.447 ' HA ' ' HB2' ' D' ' 58' ' ' LYS . 91.2 mt-30 -102.59 -44.2 5.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.662 0.268 . . . . 0.0 111.119 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -153.13 126.36 8.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.147 176.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . 0.559 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -124.48 113.15 17.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.535 0.683 . . . . 0.0 109.741 169.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' D' ' 79' ' ' THR . 19.9 mtpp -96.24 107.11 19.41 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 176.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 41.3 tp -81.52 114.83 20.5 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -173.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 43' ' ' TYR . . . . . 0.553 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 97.6 m-85 -120.55 139.4 52.99 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.505 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.2 OUTLIER -125.04 133.21 53.04 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 172.67 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 45' ' ' ALA . . . . . 0.635 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -112.03 113.16 25.28 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.131 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.512 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -124.49 137.69 54.4 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.419 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 59.74 30.89 20.48 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.504 0.503 . . . . 0.0 110.22 -174.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 48' ' ' LYS . . . . . 0.482 ' NZ ' ' HB2' ' D' ' 48' ' ' LYS . 0.1 OUTLIER 62.41 33.73 16.06 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.132 -177.104 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . 0.635 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 8.5 tp-100 -123.58 130.27 52.42 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.53 123.56 31.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.764 0.316 . . . . 0.0 110.784 -176.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . 0.521 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 84.6 m-85 -118.01 130.11 55.98 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 175.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 52' ' ' ILE . . . . . 0.4 HG22 ' HB3' ' C' ' 86' ' ' SER . 5.2 tp -80.15 103.78 7.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 171.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 53' ' ' VAL . . . . . 0.548 ' CG1' HD11 ' D' ' 67' ' ' LEU . 2.6 t -78.74 -49.52 20.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.662 -171.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 54' ' ' ALA . . . . . 0.459 ' HB1' HG11 ' D' ' 63' ' ' VAL . . . -158.3 146.61 18.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.9 -178.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 32.5 m -109.55 101.43 10.37 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 173.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 56' ' ' VAL . . . . . 0.451 HG11 HG11 ' D' ' 85' ' ' VAL . 7.4 p -115.6 116.2 51.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.564 0.697 . . . . 0.0 109.599 -177.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 46.2 p -122.38 -179.07 4.07 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.31 -172.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 58' ' ' LYS . . . . . 0.447 ' HB2' ' HA ' ' D' ' 38' ' ' GLN . 38.2 tttm -61.64 -27.39 68.63 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.82 172.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 59' ' ' ALA . . . . . 0.487 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -84.24 -40.69 17.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.652 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 86.1 mt -109.34 84.08 2.78 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 61' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 9.7 Cg_exo -71.04 0.09 7.14 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.038 2.492 . . . . 0.0 113.725 -168.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -162.76 131.64 4.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.132 0.492 . . . . 0.0 111.298 -176.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.459 HG11 ' HB1' ' D' ' 54' ' ' ALA . 69.2 t -120.43 132.71 69.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.107 172.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.49 113.13 25.52 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.197 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 65' ' ' LEU . . . . . 0.436 ' H ' HD13 ' D' ' 65' ' ' LEU . 0.0 OUTLIER -121.44 170.05 10.03 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.344 -176.508 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 66' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 7.3 t0 -118.42 98.84 6.47 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.284 0.564 . . . . 0.0 109.584 175.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.572 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 19.8 mt -113.0 143.46 44.27 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.929 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -147.77 119.95 8.32 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.96 0.409 . . . . 0.0 109.961 174.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -114.98 153.55 30.41 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.24 -178.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 20.7 t -103.62 148.93 25.42 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.969 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 71' ' ' LYS . . . . . 0.492 ' NZ ' ' HB2' ' D' ' 71' ' ' LYS . 0.0 OUTLIER -74.91 10.02 1.63 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -174.614 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.51 -15.3 30.06 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.949 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -101.21 170.9 7.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.745 0.307 . . . . 0.0 110.876 -175.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 62.0 ttt-85 -138.43 122.65 18.12 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.512 HG22 ' HB2' ' D' ' 46' ' ' ALA . 14.3 pt -125.75 160.86 31.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.403 -170.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 76' ' ' MET . . . . . 0.486 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 2.9 mtm -115.24 128.98 56.5 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 174.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 77' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.6 OUTLIER -109.84 128.4 55.3 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.204 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 78' ' ' TYR . . . . . 0.714 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 51.6 p90 -155.79 157.46 36.51 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 120.231 -0.588 . . . . 0.0 112.232 -177.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 79' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 14.0 p -124.87 144.03 50.53 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.171 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.34 156.55 18.79 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.98 174.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.04 -166.83 31.29 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -176.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -123.67 102.74 8.0 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 117.797 0.799 . . . . 0.0 110.365 176.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . 0.595 ' H ' ' HB3' ' D' ' 15' ' ' PRO . . . -169.23 151.87 4.79 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.157 169.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 33.4 t -109.21 122.82 48.14 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.601 HG23 ' HB3' ' D' ' 13' ' ' MET . 6.8 m -119.75 147.11 23.6 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 CA-C-O 121.298 0.571 . . . . 0.0 111.814 -173.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 16.9 t -111.05 119.32 38.64 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 177.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 87' ' ' LEU . . . . . 0.663 HD13 HD23 ' D' ' 11' ' ' LEU . 5.2 mp -91.68 151.45 20.66 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 174.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.571 HD23 HD21 ' E' ' 67' ' ' LEU . 1.2 tp -133.07 140.26 47.6 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.287 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.24 -166.71 24.67 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.978 -177.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 90' ' ' TYR . . . . . 0.415 ' CD2' ' HB3' ' E' ' 68' ' ' ASN . 11.5 p90 -153.01 132.82 13.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.739 0.78 . . . . 0.0 111.814 176.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . 0.657 HD23 ' HB3' ' D' ' 27' ' ' PHE . 15.2 mt . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.096 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 52.4 ttm . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 121.021 0.439 . . . . 0.0 111.567 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' E' E ' 8' ' ' PHE . . . . . 0.495 ' CE1' HD21 ' A' ' 44' ' ' LEU . 61.2 t80 -52.8 142.17 19.59 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.548 -177.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 9' ' ' TRP . . . . . 0.535 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 88.3 t90 -135.73 147.68 48.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.838 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 10' ' ' GLY . . . . . 0.499 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -148.72 153.87 25.49 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.04 177.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 11' ' ' LEU . . . . . 0.671 HD23 HD13 ' E' ' 87' ' ' LEU . 52.7 tp -140.38 108.13 5.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.061 0.458 . . . . 0.0 110.919 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -81.15 101.56 9.73 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.553 173.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 13' ' ' MET . . . . . 0.597 ' HB3' HG23 ' E' ' 85' ' ' VAL . 30.6 tpp -95.49 131.19 41.92 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.109 0.48 . . . . 0.0 111.184 -174.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -100.78 145.38 30.27 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.97 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . 0.601 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 12.3 Cg_endo -56.2 124.65 16.78 Favored 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 123.365 2.71 . . . . 0.0 113.424 -174.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 16' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' E' ' 79' ' ' THR . 25.3 mt-10 60.37 47.82 8.5 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.016 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -121.66 138.71 54.22 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.652 172.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . 0.714 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 84.6 mttt -111.4 119.2 38.01 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.35 0.406 . . . . 0.0 111.414 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.72 103.84 12.43 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.853 176.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 20' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' E' ' 76' ' ' MET . 7.9 p -88.43 98.94 11.9 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 174.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -117.44 144.92 44.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.56 0.695 . . . . 0.0 112.266 -169.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 17.8 m -94.19 143.1 26.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.487 177.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 23' ' ' ILE . . . . . 0.447 ' CG2' ' HA ' ' E' ' 71' ' ' LYS . 59.4 mt -92.79 120.45 42.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.007 0.432 . . . . 0.0 111.17 -174.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . 0.438 HD12 ' N ' ' E' ' 24' ' ' ILE . 4.0 mp -79.42 -52.99 14.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.24 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . 0.495 ' HE2' ' HB3' ' E' ' 91' ' ' LEU . 13.5 ptmt -131.05 137.46 49.16 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.027 175.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 11.4 m -54.37 141.7 29.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.931 -176.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 27' ' ' PHE . . . . . 0.649 ' HB3' HD23 ' E' ' 91' ' ' LEU . 12.1 p90 -149.01 158.21 44.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.728 0.775 . . . . 0.0 112.762 -175.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 28' ' ' HIS . . . . . 0.601 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 9.3 t60 -111.39 127.37 55.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.842 178.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 29' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 35.6 mt -96.8 138.05 22.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 170.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . 0.601 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 55.7 p -123.58 -20.33 5.57 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -171.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -153.76 156.42 26.78 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 119.27 -1.443 . . . . 0.0 113.578 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.5 HG23 ' HG ' ' E' ' 87' ' ' LEU . 14.8 p -146.61 124.35 3.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 172.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.15 155.64 44.01 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.931 -0.481 . . . . 0.0 111.764 -174.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 34' ' ' LEU . . . . . 0.597 ' HB3' HG12 ' E' ' 85' ' ' VAL . 3.7 pp -120.33 140.47 51.23 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.914 0.864 . . . . 0.0 111.771 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -104.98 -53.74 2.61 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.378 -1.283 . . . . 0.0 108.826 174.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -102.82 127.38 50.01 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 169.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . 0.489 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 151.3 156.04 7.22 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 119.794 -1.193 . . . . 0.0 113.631 176.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 38' ' ' GLN . . . . . 0.444 ' HA ' ' HB2' ' E' ' 58' ' ' LYS . 91.1 mt-30 -102.61 -44.19 5.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.681 0.277 . . . . 0.0 111.127 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -153.16 126.39 8.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.095 176.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . 0.563 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -124.51 113.14 17.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.534 0.683 . . . . 0.0 109.771 169.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 41' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' E' ' 79' ' ' THR . 19.9 mtpp -96.11 107.02 19.29 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 41.2 tp -81.45 114.85 20.47 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -173.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 43' ' ' TYR . . . . . 0.546 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 97.5 m-85 -120.59 139.39 53.04 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 177.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 44' ' ' LEU . . . . . 0.512 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 0.2 OUTLIER -125.09 133.26 52.96 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 172.574 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' E' E ' 45' ' ' ALA . . . . . 0.634 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -111.98 113.15 25.29 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.118 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . 0.519 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -124.53 137.77 54.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.371 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 59.81 30.8 20.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.001 0.429 . . . . 0.0 110.204 -174.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 48' ' ' LYS . . . . . 0.479 ' HB2' ' NZ ' ' E' ' 48' ' ' LYS . 0.1 OUTLIER 62.54 33.63 15.8 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.171 -177.045 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' E' E ' 49' ' ' GLN . . . . . 0.634 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 8.4 tp-100 -123.6 130.39 52.59 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -86.63 123.65 32.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.817 0.341 . . . . 0.0 110.726 -176.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . 0.518 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 84.6 m-85 -118.09 130.08 55.93 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.866 175.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.11 103.82 7.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 171.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . 0.544 ' CG1' HD11 ' E' ' 67' ' ' LEU . 2.6 t -78.76 -49.41 20.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.664 -171.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 54' ' ' ALA . . . . . 0.455 ' HB1' HG11 ' E' ' 63' ' ' VAL . . . -158.41 146.59 18.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.834 -178.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 32.5 m -109.52 101.45 10.39 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 173.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . 0.466 HG11 HG11 ' E' ' 85' ' ' VAL . 7.4 p -115.56 116.15 51.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.501 0.667 . . . . 0.0 109.635 -177.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 46.7 p -122.29 -179.08 4.06 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.43 -172.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 58' ' ' LYS . . . . . 0.444 ' HB2' ' HA ' ' E' ' 38' ' ' GLN . 38.2 tttm -61.67 -27.3 68.58 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.872 172.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 59' ' ' ALA . . . . . 0.493 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -84.26 -40.68 17.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.673 178.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 85.9 mt -109.35 83.98 2.74 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 174.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 61' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 9.6 Cg_exo -70.96 0.16 6.98 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.033 2.489 . . . . 0.0 113.746 -168.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -162.88 131.59 4.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.088 0.471 . . . . 0.0 111.3 -176.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . 0.455 HG11 ' HB1' ' E' ' 54' ' ' ALA . 70.0 t -120.43 132.73 69.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.049 172.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.45 113.07 25.43 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.193 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 65' ' ' LEU . . . . . 0.428 HD13 ' N ' ' E' ' 65' ' ' LEU . 0.0 OUTLIER -121.48 170.07 10.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.346 -176.51 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' E' E ' 66' ' ' ASP . . . . . 0.511 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 7.3 t0 -118.31 98.73 6.43 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.193 0.521 . . . . 0.0 109.641 175.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 67' ' ' LEU . . . . . 0.577 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 19.8 mt -112.99 143.42 44.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.879 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 68' ' ' ASN . . . . . 0.415 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 57.1 t30 -147.77 119.92 8.3 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.945 0.402 . . . . 0.0 109.99 174.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -114.91 153.53 30.34 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.262 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 21.0 t -103.63 148.95 25.4 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.979 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 71' ' ' LYS . . . . . 0.493 ' NZ ' ' HB2' ' E' ' 71' ' ' LYS . 0.0 OUTLIER -74.92 10.12 1.6 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -174.596 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.71 -15.19 29.87 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.823 175.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -101.24 170.87 7.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.825 0.345 . . . . 0.0 110.902 -175.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 62.0 ttt-85 -138.33 122.56 18.13 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 75' ' ' ILE . . . . . 0.519 HG22 ' HB2' ' E' ' 46' ' ' ALA . 14.5 pt -125.72 160.9 31.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 120.897 0.38 . . . . 0.0 111.399 -170.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 76' ' ' MET . . . . . 0.481 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 2.9 mtm -115.3 129.0 56.49 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 77' ' ' PHE . . . . . 0.512 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.6 OUTLIER -109.82 128.44 55.32 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 177.207 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' E' E ' 78' ' ' TYR . . . . . 0.714 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 51.3 p90 -155.88 157.43 36.35 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.146 -0.622 . . . . 0.0 112.185 -177.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 79' ' ' THR . . . . . 0.552 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 14.6 p -124.77 143.94 50.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.238 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.31 156.57 18.75 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.985 174.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.99 -166.86 31.36 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -176.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -123.67 102.68 7.96 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 117.734 0.767 . . . . 0.0 110.5 176.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 83' ' ' ALA . . . . . 0.601 ' H ' ' HB3' ' E' ' 15' ' ' PRO . . . -169.25 151.8 4.75 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.16 169.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 33.4 t -109.15 122.8 48.07 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 85' ' ' VAL . . . . . 0.597 HG23 ' HB3' ' E' ' 13' ' ' MET . 6.8 m -119.68 147.16 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-O 121.274 0.559 . . . . 0.0 111.888 -173.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 17.1 t -111.12 119.28 38.44 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 87' ' ' LEU . . . . . 0.671 HD13 HD23 ' E' ' 11' ' ' LEU . 5.2 mp -91.64 151.52 20.65 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 174.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . 0.613 HD23 HD21 ' A' ' 67' ' ' LEU . 1.2 tp -133.13 140.26 47.53 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.304 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.23 -166.74 24.7 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.936 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 90' ' ' TYR . . . . . 0.451 ' CD2' ' HB3' ' A' ' 68' ' ' ASN . 11.4 p90 -153.04 132.8 13.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.787 0.804 . . . . 0.0 111.796 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 91' ' ' LEU . . . . . 0.649 HD23 ' HB3' ' E' ' 27' ' ' PHE . 15.1 mt . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.109 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.223 -0.324 0 CA-C-O 120.502 0.191 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.512 ' CE1' HD21 ' B' ' 44' ' ' LEU . 70.1 t80 -67.95 142.93 55.85 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.079 0.466 . . . . 0.0 112.124 -177.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.57 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 88.2 t90 -134.93 148.1 49.96 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.19 177.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.75 153.08 24.71 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.482 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.57 ' HB2' ' CH2' ' A' ' 9' ' ' TRP . 41.7 tp -144.18 109.94 5.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.81 0.338 . . . . 0.0 110.35 177.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -96.55 96.78 8.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.847 0.356 . . . . 0.0 110.078 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.621 ' SD ' HD11 ' A' ' 87' ' ' LEU . 62.6 mtp -92.98 144.1 25.59 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.941 -173.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -101.17 166.97 11.43 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.163 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.448 ' HB3' ' HA ' ' A' ' 82' ' ' ASP . 87.2 Cg_exo -49.84 115.69 1.98 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.737 2.292 . . . . 0.0 112.799 176.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 79' ' ' THR . 29.1 mt-10 63.31 39.5 9.44 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.29 0.566 . . . . 0.0 111.328 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 78' ' ' TYR . 0.5 OUTLIER -88.12 133.47 33.99 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.038 175.42 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.592 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 33.9 ttmt -123.31 116.09 22.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.122 0.487 . . . . 0.0 111.074 -178.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.471 ' CZ ' ' HG2' ' A' ' 17' ' ' ARG . 18.3 m-85 -107.11 102.59 11.92 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.591 178.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.0 p -90.11 97.2 11.05 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 169.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -117.09 145.46 43.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.508 0.67 . . . . 0.0 112.48 -165.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.7 m -97.62 132.93 42.82 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.011 174.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.43 ' CD1' ' HB3' ' A' ' 69' ' ' PHE . 70.3 mt -87.77 118.08 32.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-O 121.127 0.489 . . . . 0.0 110.987 -173.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.679 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -90.09 -18.05 7.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.057 -179.476 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -155.12 129.2 8.82 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.101 -175.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.7 p -58.63 127.41 32.05 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.411 0.445 . . . . 0.0 110.652 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.746 ' HB3' HD23 ' A' ' 91' ' ' LEU . 10.4 p90 -143.68 166.34 25.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.693 0.758 . . . . 0.0 112.748 -174.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.564 ' HE2' ' HB3' ' A' ' 30' ' ' SER . 4.8 t60 -121.8 127.4 50.55 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.421 178.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.618 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 47.3 mt -94.55 135.22 29.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.564 ' HB3' ' HE2' ' A' ' 28' ' ' HIS . 56.0 p -119.85 -13.51 9.06 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -169.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -164.09 141.54 7.17 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 119.452 -1.356 . . . . 0.0 113.403 177.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.439 HG23 ' HG ' ' A' ' 87' ' ' LEU . 11.9 p -126.93 120.65 56.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 169.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.409 ' HA ' HG21 ' A' ' 56' ' ' VAL . . . -141.14 157.25 45.54 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 121.947 -0.471 . . . . 0.0 111.65 -174.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.629 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.6 pp -127.14 145.51 50.72 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.769 0.795 . . . . 0.0 111.237 178.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -110.21 -47.06 3.35 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.29 173.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -102.68 128.16 49.5 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.312 173.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.533 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 141.54 161.37 8.69 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 119.451 -1.357 . . . . 0.0 113.857 176.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -102.72 -43.98 5.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.681 0.276 . . . . 0.0 110.971 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -151.78 125.68 9.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.17 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -127.79 113.04 15.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.46 0.647 . . . . 0.0 109.699 168.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 79' ' ' THR . 56.0 mtpt -99.54 106.13 18.1 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 178.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.2 tp -79.11 108.77 12.84 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.819 -173.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -107.86 141.02 40.09 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.295 176.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.558 ' CD1' ' HB ' ' A' ' 75' ' ' ILE . 4.4 tp -124.48 116.38 22.42 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.082 176.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -101.78 104.21 14.98 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 174.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.488 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -127.08 136.44 52.17 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.4 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 56.38 35.99 26.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.371 0.605 . . . . 0.0 110.247 -175.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 61.36 39.7 15.01 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.123 178.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.553 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 8.5 tp-100 -134.63 128.09 32.45 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 175.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -85.28 105.72 16.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.937 0.398 . . . . 0.0 110.399 -178.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -100.13 131.29 46.16 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.461 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 tp -79.8 108.74 13.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 168.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.529 HG13 ' CD2' ' E' ' 88' ' ' LEU . 2.3 t -82.52 -51.32 14.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.578 -172.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.496 ' HB1' HG11 ' A' ' 63' ' ' VAL . . . -156.3 145.61 20.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.067 -178.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.6 m -109.21 101.77 10.77 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 173.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.476 HG13 ' HB3' ' A' ' 40' ' ' ALA . 7.4 p -115.5 114.93 47.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.534 0.683 . . . . 0.0 109.765 -177.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.5 p -122.93 -178.26 3.9 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.415 -174.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -63.92 -22.43 66.92 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.028 0.442 . . . . 0.0 110.271 171.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.439 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -83.95 -40.5 18.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.278 177.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.9 mt -112.38 81.63 4.13 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 173.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 12.2 Cg_exo -70.19 0.15 6.4 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.219 2.613 . . . . 0.0 113.972 -166.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -163.83 129.59 3.04 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.161 0.505 . . . . 0.0 111.464 -175.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.496 HG11 ' HB1' ' A' ' 54' ' ' ALA . 66.0 t -119.01 99.94 8.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.24 173.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.21 117.12 21.47 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 173.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.448 HD23 ' H ' ' A' ' 65' ' ' LEU . 0.9 OUTLIER -139.17 168.1 20.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.933 0.397 . . . . 0.0 110.994 -171.055 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.524 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 11.9 t0 -112.45 104.58 12.71 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.341 0.591 . . . . 0.0 110.077 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.667 HD21 HD23 ' E' ' 88' ' ' LEU . 11.1 mt -117.31 141.11 48.71 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.039 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -142.04 132.38 25.02 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.804 0.335 . . . . 0.0 110.7 174.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.477 ' CZ ' HD22 ' A' ' 67' ' ' LEU . 58.7 m-85 -129.92 160.56 33.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.009 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.4 t -120.08 158.78 26.14 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -79.44 9.09 5.16 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.865 0.364 . . . . 0.0 111.104 -175.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.21 -29.38 9.0 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 174.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -100.38 165.88 11.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.016 0.436 . . . . 0.0 110.737 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -135.76 143.46 45.29 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.558 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 25.0 pt -135.71 159.22 39.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.145 0.497 . . . . 0.0 112.27 -168.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.458 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 10.9 mtp -115.0 117.5 30.76 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.703 173.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.51 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -104.23 126.95 51.76 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.127 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.592 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 23.2 p90 -152.2 134.67 15.28 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.935 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 2.4 p -107.83 120.05 41.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.332 -177.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.27 160.95 15.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.672 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.47 -170.51 31.24 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -177.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.448 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 18.9 t70 -116.9 103.47 10.33 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 117.868 0.834 . . . . 0.0 109.983 176.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.533 ' CB ' ' HA3' ' A' ' 37' ' ' GLY . . . -173.31 158.69 3.62 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.736 172.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.4 t -117.74 122.44 43.47 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.629 HG12 ' HB3' ' A' ' 34' ' ' LEU . 4.9 m -115.84 156.07 17.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.529 0.68 . . . . 0.0 112.408 -172.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -119.07 117.19 28.07 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.038 173.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.621 HD11 ' SD ' ' A' ' 13' ' ' MET . 5.1 mp -91.68 147.05 23.28 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 171.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.692 HD23 HD21 ' B' ' 67' ' ' LEU . 0.7 OUTLIER -130.75 142.53 50.41 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.756 179.585 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.89 -167.97 27.34 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.106 -178.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -145.44 130.29 18.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.742 0.782 . . . . 0.0 112.132 178.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.746 HD23 ' HB3' ' A' ' 27' ' ' PHE . 18.2 mt . . . . . 0 C--N 1.325 -0.499 0 CA-C-N 114.328 -1.305 . . . . 0.0 109.46 173.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.222 -0.394 0 CA-C-O 120.481 0.182 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . 0.517 ' CE1' HD21 ' C' ' 44' ' ' LEU . 69.8 t80 -68.08 143.0 55.65 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.036 0.446 . . . . 0.0 112.043 -177.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . 0.563 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 88.1 t90 -134.97 148.01 49.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.112 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.67 153.09 24.73 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.461 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.563 ' HB2' ' CH2' ' B' ' 9' ' ' TRP . 41.6 tp -144.13 109.9 5.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.764 0.316 . . . . 0.0 110.457 177.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -96.56 96.83 8.93 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . 0.631 ' SD ' HD11 ' B' ' 87' ' ' LEU . 62.4 mtp -93.0 144.14 25.55 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.015 -173.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -101.28 167.01 11.32 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.162 177.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.432 ' HB3' ' HA ' ' B' ' 82' ' ' ASP . 86.5 Cg_exo -49.84 115.68 1.97 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.785 2.324 . . . . 0.0 112.723 176.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' B' ' 79' ' ' THR . 29.0 mt-10 63.27 39.65 9.39 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.285 0.564 . . . . 0.0 111.254 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' B' ' 78' ' ' TYR . 0.5 OUTLIER -88.16 133.5 34.0 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.342 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.589 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 33.8 ttmt -123.34 116.12 22.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.167 0.508 . . . . 0.0 111.086 -178.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' TYR . . . . . 0.458 ' CZ ' ' HG2' ' B' ' 17' ' ' ARG . 18.6 m-85 -107.09 102.54 11.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.565 178.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 10.9 p -90.03 97.21 11.06 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 169.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.13 145.54 43.75 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.489 0.661 . . . . 0.0 112.457 -165.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 21.4 m -97.77 132.86 43.01 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.949 174.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.431 ' CD1' ' HB3' ' B' ' 69' ' ' PHE . 70.0 mt -87.73 117.99 32.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.12 0.486 . . . . 0.0 111.074 -173.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.683 ' H ' HD13 ' B' ' 24' ' ' ILE . 0.2 OUTLIER -90.04 -18.02 7.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.069 -179.426 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -155.18 129.14 8.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.097 -175.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 6.9 p -58.55 127.38 31.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.683 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . 0.748 ' HB3' HD23 ' B' ' 91' ' ' LEU . 10.2 p90 -143.66 166.37 25.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.691 0.758 . . . . 0.0 112.687 -174.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' HIS . . . . . 0.573 ' HE2' ' HB3' ' B' ' 30' ' ' SER . 4.8 t60 -121.87 127.44 50.49 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.256 -1.338 . . . . 0.0 109.353 178.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.611 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 47.2 mt -94.59 135.3 29.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 171.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.573 ' HB3' ' HE2' ' B' ' 28' ' ' HIS . 55.9 p -119.82 -13.65 9.06 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -169.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -164.07 141.5 7.15 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 119.373 -1.394 . . . . 0.0 113.385 177.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.437 HG23 ' HG ' ' B' ' 87' ' ' LEU . 11.8 p -126.91 120.72 56.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 169.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . 0.406 ' HA ' HG21 ' B' ' 56' ' ' VAL . . . -141.19 157.19 45.6 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.605 -173.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.634 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.6 pp -127.1 145.62 50.67 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.696 0.76 . . . . 0.0 111.279 178.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -110.27 -46.94 3.36 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.27 173.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -102.68 128.15 49.5 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.257 173.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.527 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 141.51 161.3 8.66 Favored Glycine 0 N--CA 1.438 -1.189 0 C-N-CA 119.488 -1.339 . . . . 0.0 113.886 176.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -102.64 -44.09 5.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.62 -0.29 . . . . 0.0 110.929 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -151.73 125.71 9.16 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.201 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.499 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -127.79 113.14 15.58 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.44 0.638 . . . . 0.0 109.632 168.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' B' ' 79' ' ' THR . 56.0 mtpt -99.66 106.11 18.02 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 46.6 tp -79.22 108.83 13.02 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.753 -173.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -107.85 140.93 40.21 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.293 176.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.558 ' CD1' ' HB ' ' B' ' 75' ' ' ILE . 4.4 tp -124.4 116.44 22.57 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.115 176.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -101.83 104.25 15.0 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 174.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.49 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -127.12 136.45 52.14 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.351 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 56.37 35.99 26.78 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 123.592 0.557 . . . . 0.0 110.175 -175.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 61.47 39.53 14.88 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 114.816 -1.083 . . . . 0.0 112.165 178.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . 0.549 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 8.6 tp-100 -134.58 128.03 32.41 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 175.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -85.2 105.65 16.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.902 0.382 . . . . 0.0 110.429 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -100.07 131.23 46.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.46 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 tp -79.67 108.72 13.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 168.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.528 HG13 ' CD2' ' A' ' 88' ' ' LEU . 2.3 t -82.59 -51.22 15.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.576 -172.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.474 ' HB1' HG11 ' B' ' 63' ' ' VAL . . . -156.33 145.57 20.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.079 -178.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 32.2 m -109.18 101.78 10.79 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 173.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . 0.47 HG13 ' HB3' ' B' ' 40' ' ' ALA . 7.4 p -115.53 114.88 47.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.495 0.664 . . . . 0.0 109.744 -177.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 64.1 p -122.87 -178.31 3.91 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.428 -174.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -63.83 -22.52 66.95 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.047 0.451 . . . . 0.0 110.244 171.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.43 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -83.89 -40.51 18.51 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.194 0.521 . . . . 0.0 110.235 177.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.4 81.56 4.11 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 173.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 12.1 Cg_exo -70.16 0.15 6.38 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.126 2.55 . . . . 0.0 113.954 -166.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -163.78 129.6 3.06 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.163 0.506 . . . . 0.0 111.378 -175.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.474 HG11 ' HB1' ' B' ' 54' ' ' ALA . 66.6 t -119.06 99.93 8.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.24 173.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.15 117.15 21.46 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 173.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.444 ' H ' HD23 ' B' ' 65' ' ' LEU . 0.9 OUTLIER -139.05 168.15 20.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.95 0.405 . . . . 0.0 111.065 -171.186 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 12.1 t0 -112.4 104.52 12.66 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.262 0.553 . . . . 0.0 110.122 -178.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.692 HD21 HD23 ' A' ' 88' ' ' LEU . 11.0 mt -117.28 141.14 48.67 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.019 178.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.04 132.49 25.18 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.66 174.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . 0.484 ' CZ ' HD22 ' B' ' 67' ' ' LEU . 58.7 m-85 -130.02 160.55 33.33 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.985 178.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 18.5 t -120.18 158.78 26.23 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -79.4 9.11 5.11 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.966 0.412 . . . . 0.0 111.094 -175.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.32 -29.25 9.04 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 174.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -100.51 165.75 11.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.108 0.48 . . . . 0.0 110.698 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -135.68 143.36 45.39 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.233 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.558 ' HB ' ' CD1' ' B' ' 44' ' ' LEU . 25.0 pt -135.58 159.24 40.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.171 0.51 . . . . 0.0 112.216 -168.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.451 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 10.9 mtp -114.94 117.5 30.82 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.632 173.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . 0.507 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -104.25 126.97 51.8 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 175.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.589 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 23.2 p90 -152.21 134.65 15.25 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.311 -0.555 . . . . 0.0 111.999 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 2.5 p -107.79 120.04 41.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.345 -177.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.27 161.03 15.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.636 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.46 -170.68 31.41 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -177.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 82' ' ' ASP . . . . . 0.432 ' HA ' ' HB3' ' B' ' 15' ' ' PRO . 19.0 t70 -116.87 103.56 10.43 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.917 176.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.527 ' CB ' ' HA3' ' B' ' 37' ' ' GLY . . . -173.37 158.73 3.59 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.815 172.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 25.8 t -117.82 122.33 43.11 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.634 HG12 ' HB3' ' B' ' 34' ' ' LEU . 4.9 m -115.83 156.06 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-O 121.529 0.681 . . . . 0.0 112.445 -172.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 50.1 m -119.07 117.32 28.42 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.008 173.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.631 HD11 ' SD ' ' B' ' 13' ' ' MET . 5.1 mp -91.73 147.0 23.31 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 171.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.663 HD23 HD21 ' C' ' 67' ' ' LEU . 0.7 OUTLIER -130.84 142.51 50.39 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.959 -1.018 . . . . 0.0 108.748 179.582 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.9 -167.96 27.34 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.036 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -145.45 130.23 18.13 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.775 0.797 . . . . 0.0 112.056 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . 0.748 HD23 ' HB3' ' B' ' 27' ' ' PHE . 18.1 mt . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 114.255 -1.339 . . . . 0.0 109.396 173.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.302 0 CA-C-O 120.467 0.175 . . . . 0.0 110.967 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 8' ' ' PHE . . . . . 0.516 ' CE1' HD21 ' D' ' 44' ' ' LEU . 70.0 t80 -67.88 142.95 55.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.039 0.447 . . . . 0.0 112.068 -177.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . 0.568 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 88.2 t90 -135.07 148.09 49.77 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.71 153.05 24.7 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.415 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.568 ' HB2' ' CH2' ' C' ' 9' ' ' TRP . 41.6 tp -144.13 109.95 5.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.773 0.32 . . . . 0.0 110.429 177.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -96.55 96.84 8.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.92 0.391 . . . . 0.0 110.11 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 13' ' ' MET . . . . . 0.628 ' SD ' HD11 ' C' ' 87' ' ' LEU . 62.7 mtp -93.05 144.11 25.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.001 -173.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -101.2 167.01 11.35 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.154 177.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . 0.449 ' HB3' ' HA ' ' C' ' 82' ' ' ASP . 88.0 Cg_exo -49.8 115.68 1.96 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.731 2.288 . . . . 0.0 112.818 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' C' ' 79' ' ' THR . 29.1 mt-10 63.19 39.66 9.55 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.432 0.634 . . . . 0.0 111.36 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 17' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' C' ' 78' ' ' TYR . 0.5 OUTLIER -88.15 133.41 34.02 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.431 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 18' ' ' LYS . . . . . 0.592 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 33.9 ttmt -123.21 116.13 22.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.047 0.451 . . . . 0.0 111.109 -178.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . 0.461 ' CZ ' ' HG2' ' C' ' 17' ' ' ARG . 18.8 m-85 -107.2 102.61 11.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.536 178.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 10.9 p -90.04 97.14 11.02 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 169.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.08 145.51 43.71 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.535 0.683 . . . . 0.0 112.55 -165.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 21.7 m -97.65 132.95 42.83 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.691 -1.141 . . . . 0.0 108.964 174.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . 0.432 ' CD1' ' HB3' ' C' ' 69' ' ' PHE . 70.4 mt -87.85 118.15 33.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.206 0.527 . . . . 0.0 110.995 -173.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . 0.684 ' H ' HD13 ' C' ' 24' ' ' ILE . 0.2 OUTLIER -90.14 -17.99 7.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.092 -179.456 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -155.15 129.22 8.81 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.103 -175.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 6.6 p -58.62 127.47 32.32 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.696 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 27' ' ' PHE . . . . . 0.741 ' HB3' HD23 ' C' ' 91' ' ' LEU . 10.2 p90 -143.64 166.42 24.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.633 0.73 . . . . 0.0 112.774 -174.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 28' ' ' HIS . . . . . 0.577 ' HE2' ' HB3' ' C' ' 30' ' ' SER . 4.8 t60 -121.94 127.47 50.42 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.291 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . 0.627 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 47.6 mt -94.57 135.3 29.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 171.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.577 ' HB3' ' HE2' ' C' ' 28' ' ' HIS . 55.8 p -119.87 -13.53 9.05 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -169.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 31' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -164.09 141.46 7.12 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 119.372 -1.394 . . . . 0.0 113.329 177.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.439 HG23 ' HG ' ' C' ' 87' ' ' LEU . 11.8 p -126.95 120.69 56.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 169.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.41 ' HA ' HG21 ' C' ' 56' ' ' VAL . . . -141.16 157.23 45.56 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.886 -0.509 . . . . 0.0 111.647 -173.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.627 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.6 pp -127.14 145.52 50.72 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.656 0.741 . . . . 0.0 111.284 178.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -110.32 -46.89 3.36 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.251 173.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -102.62 128.12 49.44 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.259 173.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 37' ' ' GLY . . . . . 0.529 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 141.64 161.36 8.7 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 119.446 -1.359 . . . . 0.0 113.888 176.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -102.71 -44.1 5.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.753 0.311 . . . . 0.0 110.973 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -151.73 125.71 9.16 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.119 -177.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.492 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -127.77 113.02 15.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.376 0.608 . . . . 0.0 109.655 168.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' C' ' 79' ' ' THR . 56.0 mtpt -99.56 106.11 18.06 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.4 HD23 ' HB ' ' C' ' 53' ' ' VAL . 46.5 tp -79.18 108.8 12.95 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.803 -173.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -107.83 141.0 40.08 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.339 176.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.551 ' CD1' ' HB ' ' C' ' 75' ' ' ILE . 4.4 tp -124.46 116.4 22.45 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.098 176.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . 0.546 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -101.77 104.22 15.0 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 174.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.478 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -127.08 136.42 52.14 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.367 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 56.31 36.01 26.78 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.642 0.589 . . . . 0.0 110.215 -175.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 61.5 39.59 14.71 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.087 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . 0.546 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 8.5 tp-100 -134.67 127.94 32.06 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 175.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -85.15 105.74 16.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.854 0.359 . . . . 0.0 110.444 -178.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -100.18 131.26 46.23 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.436 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 tp -79.78 108.74 13.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 168.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 53' ' ' VAL . . . . . 0.533 HG13 ' CD2' ' B' ' 88' ' ' LEU . 2.3 t -82.5 -51.25 15.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.642 -172.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 54' ' ' ALA . . . . . 0.49 ' HB1' HG11 ' C' ' 63' ' ' VAL . . . -156.29 145.58 20.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.006 -178.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 31.9 m -109.28 101.82 10.79 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 173.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . 0.471 HG13 ' HB3' ' C' ' 40' ' ' ALA . 7.4 p -115.57 114.91 47.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.533 0.682 . . . . 0.0 109.695 -177.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 64.2 p -123.03 -178.33 3.93 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.337 -174.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -63.83 -22.51 66.95 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.112 0.482 . . . . 0.0 110.227 171.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . 0.44 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -83.87 -40.56 18.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.237 177.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 78.0 mt -112.34 81.57 4.05 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 173.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 61' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 12.1 Cg_exo -70.07 -0.0 6.53 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.142 2.562 . . . . 0.0 114.025 -166.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -163.73 129.62 3.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.185 0.517 . . . . 0.0 111.52 -175.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.49 HG11 ' HB1' ' C' ' 54' ' ' ALA . 66.1 t -119.07 100.01 8.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.219 173.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.22 117.01 21.39 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 173.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . 0.442 HD23 ' H ' ' C' ' 65' ' ' LEU . 0.9 OUTLIER -139.01 168.09 20.6 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.952 0.406 . . . . 0.0 111.087 -171.137 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 66' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 12.1 t0 -112.39 104.6 12.75 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.315 0.579 . . . . 0.0 110.132 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.663 HD21 HD23 ' B' ' 88' ' ' LEU . 11.1 mt -117.3 141.22 48.57 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.048 178.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -142.11 132.47 25.04 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.641 174.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 69' ' ' PHE . . . . . 0.476 ' CZ ' HD22 ' C' ' 67' ' ' LEU . 59.1 m-85 -130.03 160.61 33.16 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.932 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 18.3 t -120.12 158.8 26.13 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -79.45 9.08 5.19 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.979 0.419 . . . . 0.0 111.083 -175.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.26 -29.23 9.08 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 174.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -100.5 165.8 11.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.966 0.413 . . . . 0.0 110.784 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -135.71 143.49 45.41 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.551 ' HB ' ' CD1' ' C' ' 44' ' ' LEU . 24.9 pt -135.67 159.14 39.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.12 0.486 . . . . 0.0 112.305 -168.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.462 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 10.8 mtp -114.88 117.51 30.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.764 173.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 77' ' ' PHE . . . . . 0.504 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.6 OUTLIER -104.16 126.89 51.64 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 176.104 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 78' ' ' TYR . . . . . 0.592 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 23.4 p90 -152.19 134.63 15.25 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.969 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 2.4 p -107.8 120.01 41.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.352 -177.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.24 160.92 15.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.613 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.6 -170.54 31.08 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 82' ' ' ASP . . . . . 0.449 ' HA ' ' HB3' ' C' ' 15' ' ' PRO . 19.0 t70 -116.91 103.49 10.34 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.955 176.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . 0.529 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -173.31 158.79 3.64 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.794 172.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 25.6 t -117.88 122.38 43.18 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.627 HG12 ' HB3' ' C' ' 34' ' ' LEU . 5.0 m -115.74 156.1 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-O 121.453 0.644 . . . . 0.0 112.464 -172.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 50.3 m -119.08 117.31 28.38 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.045 173.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . 0.628 HD11 ' SD ' ' C' ' 13' ' ' MET . 5.1 mp -91.76 146.97 23.34 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 171.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . 0.675 HD23 HD21 ' D' ' 67' ' ' LEU . 0.7 OUTLIER -130.74 142.47 50.41 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.796 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.89 -168.0 27.39 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.082 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -145.4 130.24 18.18 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.741 0.781 . . . . 0.0 112.158 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . 0.741 HD23 ' HB3' ' C' ' 27' ' ' PHE . 18.1 mt . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 114.321 -1.308 . . . . 0.0 109.415 173.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.222 -0.377 0 CA-C-O 120.557 0.218 . . . . 0.0 110.837 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 8' ' ' PHE . . . . . 0.522 ' CE1' HD21 ' E' ' 44' ' ' LEU . 70.4 t80 -67.93 142.96 55.86 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.17 0.509 . . . . 0.0 112.063 -177.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 9' ' ' TRP . . . . . 0.567 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 88.2 t90 -135.03 147.97 49.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.133 177.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.6 153.2 24.8 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.455 179.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . 0.567 ' HB2' ' CH2' ' D' ' 9' ' ' TRP . 41.7 tp -144.19 109.95 5.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.751 0.31 . . . . 0.0 110.392 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -96.55 96.74 8.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.921 0.391 . . . . 0.0 110.102 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 13' ' ' MET . . . . . 0.627 ' SD ' HD11 ' D' ' 87' ' ' LEU . 62.7 mtp -93.05 144.24 25.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.961 -173.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -101.24 167.0 11.35 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.174 177.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . 0.434 ' HB3' ' HA ' ' D' ' 82' ' ' ASP . 86.9 Cg_exo -49.86 115.61 1.93 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.8 2.334 . . . . 0.0 112.74 176.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' D' ' 79' ' ' THR . 29.1 mt-10 63.37 39.53 9.26 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.326 0.584 . . . . 0.0 111.299 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 17' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' D' ' 78' ' ' TYR . 0.5 OUTLIER -88.04 133.44 33.97 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.383 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . 0.606 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 33.9 ttmt -123.26 116.13 22.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.199 0.524 . . . . 0.0 111.077 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 19' ' ' TYR . . . . . 0.47 ' CZ ' ' HG2' ' D' ' 17' ' ' ARG . 18.8 m-85 -107.11 102.46 11.79 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.595 178.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 11.0 p -89.97 97.18 11.04 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 169.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.07 145.5 43.7 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.556 0.693 . . . . 0.0 112.483 -165.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 21.5 m -97.71 132.83 42.98 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.99 174.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . 0.431 ' CD1' ' HB3' ' D' ' 69' ' ' PHE . 70.3 mt -87.68 118.08 32.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.11 0.481 . . . . 0.0 111.093 -173.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . 0.694 ' H ' HD13 ' D' ' 24' ' ' ILE . 0.2 OUTLIER -90.09 -18.02 7.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.097 -179.422 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -155.16 129.12 8.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.085 -175.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 6.8 p -58.49 127.46 32.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.689 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 27' ' ' PHE . . . . . 0.721 ' HB3' HD23 ' D' ' 91' ' ' LEU . 10.3 p90 -143.73 166.36 25.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.721 0.772 . . . . 0.0 112.727 -174.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 28' ' ' HIS . . . . . 0.569 ' HE2' ' HB3' ' D' ' 30' ' ' SER . 4.7 t60 -121.93 127.42 50.39 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.285 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 29' ' ' ILE . . . . . 0.621 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 47.4 mt -94.5 135.33 29.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 171.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . 0.569 ' HB3' ' HE2' ' D' ' 28' ' ' HIS . 55.9 p -119.96 -13.43 9.03 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -169.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 31' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -164.14 141.5 7.14 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 119.431 -1.366 . . . . 0.0 113.354 177.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.45 HG23 ' HG ' ' D' ' 87' ' ' LEU . 11.8 p -126.97 120.69 56.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 169.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . 0.4 ' HA ' HG21 ' D' ' 56' ' ' VAL . . . -141.17 157.21 45.58 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 121.95 -0.469 . . . . 0.0 111.589 -173.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 34' ' ' LEU . . . . . 0.635 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.6 pp -127.11 145.56 50.7 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.682 0.753 . . . . 0.0 111.254 178.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -110.34 -46.91 3.35 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.761 -1.108 . . . . 0.0 108.24 173.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -102.61 128.14 49.42 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.279 173.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . 0.538 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 141.6 161.4 8.72 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 119.459 -1.353 . . . . 0.0 113.814 176.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -102.77 -44.06 5.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.616 -0.292 . . . . 0.0 110.975 177.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -151.71 125.71 9.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.204 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . 0.513 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -127.82 113.08 15.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.443 0.639 . . . . 0.0 109.724 168.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' D' ' 79' ' ' THR . 56.0 mtpt -99.58 106.06 18.0 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.401 HD23 ' HB ' ' D' ' 53' ' ' VAL . 46.4 tp -79.12 108.72 12.82 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.814 -173.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -107.77 140.98 40.03 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.363 176.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.55 ' CD1' ' HB ' ' D' ' 75' ' ' ILE . 4.4 tp -124.41 116.47 22.6 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.14 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 45' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -101.84 104.18 14.92 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 174.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.49 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -127.08 136.4 52.1 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.403 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 56.41 35.91 26.68 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.383 0.611 . . . . 0.0 110.25 -175.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 61.61 39.44 14.53 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.117 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . 0.553 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 8.5 tp-100 -134.57 127.95 32.29 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 175.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -85.15 105.71 16.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.88 0.371 . . . . 0.0 110.456 -178.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -100.1 131.28 46.14 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.44 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 tp -79.73 108.82 13.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 168.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 53' ' ' VAL . . . . . 0.548 HG13 ' CD2' ' C' ' 88' ' ' LEU . 2.3 t -82.69 -51.2 14.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.575 -172.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 54' ' ' ALA . . . . . 0.487 ' HB1' HG11 ' D' ' 63' ' ' VAL . . . -156.34 145.56 20.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.076 -178.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 31.9 m -109.2 101.8 10.8 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 173.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 56' ' ' VAL . . . . . 0.477 HG13 ' HB3' ' D' ' 40' ' ' ALA . 7.4 p -115.57 114.93 47.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.483 0.659 . . . . 0.0 109.701 -177.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 63.1 p -122.95 -178.31 3.91 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.433 -174.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -63.78 -22.48 66.93 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.992 0.425 . . . . 0.0 110.321 171.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 59' ' ' ALA . . . . . 0.439 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -83.91 -40.71 18.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.143 177.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 78.2 mt -112.24 81.54 3.94 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 173.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 61' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 12.1 Cg_exo -70.14 0.14 6.37 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.163 2.575 . . . . 0.0 114.007 -166.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -163.85 129.58 3.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.085 0.469 . . . . 0.0 111.432 -175.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.487 HG11 ' HB1' ' D' ' 54' ' ' ALA . 66.8 t -119.03 99.93 8.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.176 173.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.14 117.06 21.37 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 173.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 65' ' ' LEU . . . . . 0.443 HD23 ' H ' ' D' ' 65' ' ' LEU . 0.9 OUTLIER -139.05 168.13 20.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.865 0.364 . . . . 0.0 111.098 -171.129 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 66' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 12.2 t0 -112.44 104.48 12.61 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.354 0.597 . . . . 0.0 110.181 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.675 HD21 HD23 ' C' ' 88' ' ' LEU . 11.1 mt -117.31 141.18 48.62 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.985 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.04 132.48 25.17 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.583 174.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 69' ' ' PHE . . . . . 0.479 ' CZ ' HD22 ' D' ' 67' ' ' LEU . 59.0 m-85 -130.01 160.63 33.07 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.97 178.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 18.3 t -120.21 158.73 26.38 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -79.34 9.11 5.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.846 0.355 . . . . 0.0 111.103 -175.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.34 -29.21 9.05 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 174.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -100.42 165.82 11.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.044 0.449 . . . . 0.0 110.746 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -135.74 143.49 45.35 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.55 ' HB ' ' CD1' ' D' ' 44' ' ' LEU . 24.7 pt -135.72 159.2 39.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.211 0.529 . . . . 0.0 112.25 -168.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 76' ' ' MET . . . . . 0.459 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 10.9 mtp -114.95 117.41 30.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.801 173.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 77' ' ' PHE . . . . . 0.503 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.6 OUTLIER -104.19 126.95 51.71 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.134 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 78' ' ' TYR . . . . . 0.606 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 23.1 p90 -152.22 134.66 15.25 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.886 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 79' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 2.4 p -107.85 119.96 40.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.297 -177.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.23 160.88 15.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.619 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.61 -170.51 31.05 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 110.656 -0.977 . . . . 0.0 110.656 -177.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 82' ' ' ASP . . . . . 0.434 ' HA ' ' HB3' ' D' ' 15' ' ' PRO . 19.0 t70 -116.92 103.45 10.3 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 117.861 0.831 . . . . 0.0 109.951 176.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . 0.538 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -173.38 158.69 3.57 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.744 172.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 26.2 t -117.78 122.37 43.27 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.635 HG12 ' HB3' ' D' ' 34' ' ' LEU . 5.0 m -115.9 156.11 17.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.491 0.662 . . . . 0.0 112.429 -172.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -119.08 117.16 28.0 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.04 173.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 87' ' ' LEU . . . . . 0.627 HD11 ' SD ' ' D' ' 13' ' ' MET . 5.1 mp -91.69 146.99 23.33 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 171.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.658 HD23 HD21 ' E' ' 67' ' ' LEU . 0.7 OUTLIER -130.78 142.52 50.41 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.747 179.617 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.9 -167.98 27.36 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.981 -178.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -145.39 130.26 18.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.734 0.778 . . . . 0.0 112.156 178.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . 0.721 HD23 ' HB3' ' D' ' 27' ' ' PHE . 18.1 mt . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.469 173.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 7' ' ' MET . . . . . 0.4 ' O ' ' HA ' ' E' ' 90' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.222 -0.346 0 CA-C-O 120.524 0.202 . . . . 0.0 110.913 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 8' ' ' PHE . . . . . 0.524 ' CE1' HD21 ' A' ' 44' ' ' LEU . 70.2 t80 -67.8 142.99 56.02 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.036 0.446 . . . . 0.0 112.071 -177.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 9' ' ' TRP . . . . . 0.558 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 88.2 t90 -135.12 148.04 49.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.118 177.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.69 153.14 24.75 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.448 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 11' ' ' LEU . . . . . 0.558 ' HB2' ' CH2' ' E' ' 9' ' ' TRP . 41.2 tp -144.1 109.98 5.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.779 0.323 . . . . 0.0 110.455 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -96.59 96.73 8.85 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.908 0.385 . . . . 0.0 110.04 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 13' ' ' MET . . . . . 0.632 ' SD ' HD11 ' E' ' 87' ' ' LEU . 62.7 mtp -92.98 144.14 25.54 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.963 -173.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -101.19 166.91 11.52 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.139 177.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . 0.441 ' HB3' ' HA ' ' E' ' 82' ' ' ASP . 87.9 Cg_exo -49.77 115.61 1.92 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.78 2.32 . . . . 0.0 112.797 176.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 16' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' E' ' 79' ' ' THR . 29.0 mt-10 63.29 39.65 9.34 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.295 0.569 . . . . 0.0 111.259 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 17' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' E' ' 78' ' ' TYR . 0.5 OUTLIER -88.15 133.43 34.01 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.353 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . 0.586 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 33.9 ttmt -123.21 116.14 22.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.153 0.502 . . . . 0.0 111.036 -178.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . 0.462 ' CZ ' ' HG2' ' E' ' 17' ' ' ARG . 18.7 m-85 -107.1 102.7 12.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.568 177.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 10.9 p -90.22 97.26 11.08 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 169.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.18 145.5 43.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.474 0.654 . . . . 0.0 112.454 -165.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 21.8 m -97.68 132.82 42.97 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.949 174.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 23' ' ' ILE . . . . . 0.436 ' CD1' ' HB3' ' E' ' 69' ' ' PHE . 70.0 mt -87.72 118.06 32.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.085 0.469 . . . . 0.0 111.083 -173.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . 0.673 ' H ' HD13 ' E' ' 24' ' ' ILE . 0.2 OUTLIER -90.11 -17.98 7.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.092 -179.421 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -155.15 129.21 8.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.075 -175.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 7.0 p -58.54 127.4 31.95 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.458 0.474 . . . . 0.0 110.679 -178.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 27' ' ' PHE . . . . . 0.736 ' HB3' HD23 ' E' ' 91' ' ' LEU . 10.2 p90 -143.68 166.44 24.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.645 0.736 . . . . 0.0 112.726 -174.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 28' ' ' HIS . . . . . 0.568 ' HE2' ' HB3' ' E' ' 30' ' ' SER . 4.8 t60 -121.9 127.45 50.46 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.36 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 29' ' ' ILE . . . . . 0.625 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 47.6 mt -94.63 135.33 29.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . 0.568 ' HB3' ' HE2' ' E' ' 28' ' ' HIS . 55.0 p -119.94 -13.48 9.03 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -169.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 31' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -164.14 141.48 7.13 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 119.36 -1.4 . . . . 0.0 113.339 177.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.449 HG23 ' HG ' ' E' ' 87' ' ' LEU . 11.9 p -126.89 120.71 56.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 169.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . 0.407 ' HA ' HG21 ' E' ' 56' ' ' VAL . . . -141.17 157.15 45.66 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.601 -173.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 34' ' ' LEU . . . . . 0.622 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.6 pp -127.11 145.55 50.7 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.686 0.755 . . . . 0.0 111.179 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -110.22 -47.01 3.35 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.256 173.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -102.64 128.11 49.47 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.294 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . 0.538 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 141.62 161.45 8.74 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 119.566 -1.302 . . . . 0.0 113.886 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -102.76 -44.08 5.39 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.734 0.302 . . . . 0.0 110.952 177.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -151.72 125.74 9.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.168 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . 0.491 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -127.84 113.1 15.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.422 0.629 . . . . 0.0 109.671 168.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 41' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' E' ' 79' ' ' THR . 56.0 mtpt -99.64 106.07 17.98 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 46.3 tp -79.16 108.77 12.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.792 -173.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -107.83 141.01 40.07 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.303 176.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 44' ' ' LEU . . . . . 0.554 ' CD1' ' HB ' ' E' ' 75' ' ' ILE . 4.4 tp -124.46 116.4 22.47 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.096 176.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 45' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -101.76 104.2 14.97 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 174.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . 0.479 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -127.12 136.36 52.0 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.387 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 56.53 35.87 26.7 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.657 0.598 . . . . 0.0 110.216 -175.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 61.52 39.49 14.77 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.154 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 49' ' ' GLN . . . . . 0.547 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 8.5 tp-100 -134.56 128.08 32.55 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 175.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -85.22 105.7 16.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.875 0.369 . . . . 0.0 110.381 -178.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -100.15 131.21 46.23 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.427 177.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 6.0 tp -79.6 108.74 13.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 168.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . 0.526 HG13 ' CD2' ' D' ' 88' ' ' LEU . 2.3 t -82.64 -51.27 14.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.526 -172.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 54' ' ' ALA . . . . . 0.49 ' HB1' HG11 ' E' ' 63' ' ' VAL . . . -156.32 145.64 20.65 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.012 -178.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 31.9 m -109.19 101.7 10.71 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 173.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . 0.462 HG13 ' HB3' ' E' ' 40' ' ' ALA . 7.4 p -115.51 114.92 47.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.621 0.724 . . . . 0.0 109.724 -177.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 63.2 p -122.87 -178.29 3.9 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.434 -174.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -63.87 -22.46 66.93 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.07 0.462 . . . . 0.0 110.298 171.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 59' ' ' ALA . . . . . 0.441 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -83.96 -40.59 18.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.187 177.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.38 81.53 4.07 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 173.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 61' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 12.0 Cg_exo -70.09 0.13 6.35 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.133 2.556 . . . . 0.0 114.024 -166.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -163.81 129.53 3.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.195 0.521 . . . . 0.0 111.469 -175.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . 0.49 HG11 ' HB1' ' E' ' 54' ' ' ALA . 66.5 t -119.03 100.03 9.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.207 173.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.2 117.09 21.44 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 173.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 65' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' E' ' 30' ' ' SER . 0.9 OUTLIER -139.1 168.16 20.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.893 0.378 . . . . 0.0 111.097 -171.168 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' E' E ' 66' ' ' ASP . . . . . 0.512 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 12.1 t0 -112.39 104.49 12.63 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.3 0.571 . . . . 0.0 110.121 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 67' ' ' LEU . . . . . 0.658 HD21 HD23 ' D' ' 88' ' ' LEU . 11.1 mt -117.31 141.25 48.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.988 178.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.11 132.46 25.03 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.849 0.357 . . . . 0.0 110.682 174.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 69' ' ' PHE . . . . . 0.468 ' CZ ' HD22 ' E' ' 67' ' ' LEU . 58.5 m-85 -130.04 160.54 33.36 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.91 178.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 18.1 t -120.11 158.75 26.23 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -79.46 9.1 5.19 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.06 0.457 . . . . 0.0 111.102 -175.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.3 -29.28 9.03 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.453 174.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -100.38 165.85 11.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.033 0.444 . . . . 0.0 110.706 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -135.77 143.41 45.24 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 75' ' ' ILE . . . . . 0.554 ' HB ' ' CD1' ' E' ' 44' ' ' LEU . 24.9 pt -135.65 159.2 40.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.179 0.514 . . . . 0.0 112.278 -168.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 76' ' ' MET . . . . . 0.456 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 10.8 mtp -115.0 117.48 30.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.752 173.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 77' ' ' PHE . . . . . 0.5 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.6 OUTLIER -104.14 126.92 51.65 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 176.147 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' E' E ' 78' ' ' TYR . . . . . 0.586 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 23.0 p90 -152.22 134.61 15.21 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.985 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 79' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 2.4 p -107.8 120.0 41.02 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.375 -177.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.23 160.89 15.96 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.65 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.6 -170.48 31.04 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -177.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 82' ' ' ASP . . . . . 0.441 ' HA ' ' HB3' ' E' ' 15' ' ' PRO . 19.1 t70 -116.88 103.46 10.32 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 119.676 -0.809 . . . . 0.0 109.941 176.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 83' ' ' ALA . . . . . 0.538 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -173.33 158.7 3.61 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.776 172.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 25.9 t -117.86 122.47 43.42 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 85' ' ' VAL . . . . . 0.622 HG12 ' HB3' ' E' ' 34' ' ' LEU . 4.9 m -115.85 156.13 17.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.487 0.66 . . . . 0.0 112.328 -172.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 50.4 m -119.09 117.17 28.02 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.042 173.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 87' ' ' LEU . . . . . 0.632 HD11 ' SD ' ' E' ' 13' ' ' MET . 5.1 mp -91.72 147.03 23.29 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 171.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . 0.667 HD23 HD21 ' A' ' 67' ' ' LEU . 0.7 OUTLIER -130.81 142.51 50.4 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.744 179.643 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.95 -168.0 27.45 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.016 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 90' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' E' ' 7' ' ' MET . 37.0 p90 -145.42 130.19 18.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.643 0.735 . . . . 0.0 112.191 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 91' ' ' LEU . . . . . 0.736 HD23 ' HB3' ' E' ' 27' ' ' PHE . 18.2 mt . . . . . 0 C--N 1.324 -0.518 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.498 173.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 21.7 ttt . . . . . 0 C--O 1.226 -0.137 0 CA-C-O 121.188 0.518 . . . . 0.0 112.317 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.569 ' CE1' HD12 ' A' ' 88' ' ' LEU . 77.7 t80 -54.49 141.45 30.96 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.967 -176.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.531 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 89.5 t90 -133.46 147.23 51.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.704 -1.134 . . . . 0.0 108.503 177.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.89 145.54 14.45 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.658 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.558 HD23 HD13 ' A' ' 87' ' ' LEU . 50.1 tp -135.89 108.74 7.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.894 0.378 . . . . 0.0 110.317 177.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -96.64 100.96 12.49 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 176.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.562 ' SD ' HD11 ' A' ' 87' ' ' LEU . 61.0 mtp -92.5 143.47 26.32 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.291 0.567 . . . . 0.0 111.383 -172.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -100.49 145.02 29.57 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.425 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.526 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 9.5 Cg_endo -51.84 123.22 11.89 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 123.64 2.893 . . . . 0.0 113.597 -174.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' A' ' 79' ' ' THR . 35.8 mt-10 57.71 73.6 0.46 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.689 178.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.85 138.34 19.59 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.224 176.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.723 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 50.2 mttp -107.34 121.9 45.51 Favored 'General case' 0 CA--C 1.512 -0.497 0 O-C-N 123.451 0.47 . . . . 0.0 111.368 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.57 102.79 11.34 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 76' ' ' MET . 44.4 t -90.08 99.22 12.28 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 173.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -115.55 139.76 49.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.594 0.712 . . . . 0.0 112.2 -168.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.1 m -84.72 132.17 34.48 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.348 174.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 59.3 mt -86.35 115.45 27.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.07 0.462 . . . . 0.0 110.934 -175.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.431 HD12 ' N ' ' A' ' 25' ' ' LYS . 1.9 pp -88.7 -12.44 10.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.399 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.431 ' N ' HD12 ' A' ' 24' ' ' ILE . 83.3 tttt -160.03 120.12 2.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.486 178.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.7 m -51.54 137.16 24.99 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.683 0.614 . . . . 0.0 110.403 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.715 ' HB3' HD23 ' A' ' 91' ' ' LEU . 33.1 p90 -147.35 165.32 30.52 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -174.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.498 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 8.3 t60 -116.17 120.28 38.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.699 177.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 42.6 mt -84.51 134.68 26.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 169.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.508 ' HB2' ' HB3' ' B' ' 66' ' ' ASP . 76.7 p -119.68 -10.05 9.65 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -171.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -178.11 158.57 23.53 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 119.263 -1.446 . . . . 0.0 113.628 177.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.483 HG23 ' HG ' ' A' ' 87' ' ' LEU . 11.9 p -139.67 137.24 39.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 175.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -150.18 154.83 38.69 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.903 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.562 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.3 pp -118.19 140.02 50.42 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.964 0.888 . . . . 0.0 111.615 178.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -110.28 -53.41 2.68 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.981 -1.463 . . . . 0.0 108.549 174.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -101.47 126.79 48.32 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.589 175.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.508 ' HA3' ' HA ' ' A' ' 83' ' ' ALA . . . 140.54 165.64 10.38 Favored Glycine 0 N--CA 1.439 -1.119 0 C-N-CA 119.588 -1.292 . . . . 0.0 113.542 178.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -102.72 -46.58 4.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.58 0.228 . . . . 0.0 111.395 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -151.46 134.23 15.65 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.018 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.509 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -132.77 113.71 13.27 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.46 0.648 . . . . 0.0 110.42 170.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 79' ' ' THR . 65.4 mttp -98.21 113.36 25.26 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 174.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.414 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 58.7 tp -89.93 109.03 20.08 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.424 -170.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.537 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 71.5 m-85 -109.02 148.6 30.52 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.852 178.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.658 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -128.41 117.07 20.75 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.606 176.046 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -102.9 104.45 14.68 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.429 0.633 . . . . 0.0 109.927 176.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.491 ' HB2' HD11 ' A' ' 44' ' ' LEU . . . -128.79 143.72 50.99 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.316 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 61.16 26.59 16.47 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.716 0.769 . . . . 0.0 109.074 -174.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.4 ' N ' ' HD2' ' A' ' 48' ' ' LYS . 4.2 mptp? 59.2 38.36 23.55 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.874 -177.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.567 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 6.6 tp-100 -129.5 127.91 41.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.823 178.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -81.38 106.01 13.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.096 0.474 . . . . 0.0 110.599 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -102.3 116.98 33.78 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.339 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 tp -74.71 99.84 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 171.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.502 HG12 ' CD2' ' E' ' 88' ' ' LEU . 29.3 m -87.43 -32.45 6.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.611 -172.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.746 ' HB2' HD21 ' A' ' 65' ' ' LEU . . . -152.93 142.42 21.75 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.371 -0.532 . . . . 0.0 112.211 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.1 m -112.97 101.93 9.94 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 169.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.0 p -118.36 112.43 38.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.932 0.873 . . . . 0.0 110.443 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 78.5 p -123.34 -177.34 3.67 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.194 -176.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -60.93 -29.37 69.57 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.445 168.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.22 -40.66 62.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.252 0.549 . . . . 0.0 110.292 178.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 77.4 mt -117.8 81.69 15.65 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.35 -4.17 12.34 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.191 2.594 . . . . 0.0 113.963 -168.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -160.67 129.71 4.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.281 0.562 . . . . 0.0 111.206 -175.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 96.7 t -120.17 125.59 74.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.525 176.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.36 130.68 34.54 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 175.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.746 HD21 ' HB2' ' A' ' 54' ' ' ALA . 88.5 mt -122.82 166.64 14.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.394 0.616 . . . . 0.0 112.288 -173.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.539 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 26.9 t0 -144.51 97.95 3.12 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 170.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.531 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 7.0 mt -133.0 109.38 9.51 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.347 -175.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.451 ' HB2' ' CD2' ' E' ' 90' ' ' TYR . 7.5 m-20 -104.73 114.7 29.08 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.839 0.352 . . . . 0.0 110.149 178.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -108.09 160.35 15.87 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.338 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.5 t -116.14 149.64 38.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.955 0.407 . . . . 0.0 110.625 -177.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -69.15 0.13 5.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.198 -176.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.46 -18.56 35.35 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.345 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -101.51 164.06 11.95 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.708 -0.289 . . . . 0.0 110.836 -175.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -130.9 108.76 10.06 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.4 pt -109.52 158.46 9.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.259 -170.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.436 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 2.6 mtm -116.69 122.88 45.82 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.873 175.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.658 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -104.49 128.57 52.45 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.688 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.723 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 36.4 p90 -149.98 135.34 18.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.529 0.68 . . . . 0.0 112.492 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 3.9 p -106.36 132.56 52.25 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.763 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.54 154.42 18.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.799 177.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.422 ' O ' ' HG3' ' A' ' 16' ' ' GLU . . . 91.33 -172.14 35.98 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -176.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.403 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 21.3 t70 -113.13 102.86 10.79 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.825 176.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.526 ' H ' ' HB3' ' A' ' 15' ' ' PRO . . . -169.28 153.74 5.51 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.85 167.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.4 t -111.05 120.66 43.08 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.562 HG12 ' HB3' ' A' ' 34' ' ' LEU . 3.8 m -114.9 149.31 17.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -172.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.8 m -110.93 115.4 29.43 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.598 175.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.562 HD11 ' SD ' ' A' ' 13' ' ' MET . 4.8 mp -94.85 145.17 25.08 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 170.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.569 HD12 ' CE1' ' A' ' 8' ' ' PHE . 2.4 mm? -124.28 149.53 46.4 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 175.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.82 -167.35 26.32 Favored Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.48 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.44 ' CD2' ' HB2' ' B' ' 68' ' ' ASN . 5.1 p90 -149.31 131.38 15.35 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.763 0.792 . . . . 0.0 111.795 176.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.715 HD23 ' HB3' ' A' ' 27' ' ' PHE . 27.3 mt . . . . . 0 C--N 1.323 -0.582 0 CA-C-N 113.927 -1.488 . . . . 0.0 110.279 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 21.8 ttt . . . . . 0 C--O 1.225 -0.208 0 CA-C-O 121.189 0.519 . . . . 0.0 112.251 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . 0.559 ' CE1' HD12 ' B' ' 88' ' ' LEU . 78.1 t80 -54.51 141.53 30.8 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 114.76 -1.109 . . . . 0.0 113.001 -176.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . 0.531 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 89.3 t90 -133.53 147.28 51.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.531 177.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.91 145.54 14.44 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.607 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.546 HD23 HD13 ' B' ' 87' ' ' LEU . 50.2 tp -135.9 108.8 7.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.91 0.386 . . . . 0.0 110.344 176.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -96.76 101.1 12.64 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . 0.568 ' SD ' HD11 ' B' ' 87' ' ' LEU . 60.8 mtp -92.58 143.46 26.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.304 0.573 . . . . 0.0 111.372 -172.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -100.49 145.02 29.59 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 114.926 -1.033 . . . . 0.0 109.371 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.521 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 9.5 Cg_endo -51.91 123.13 11.74 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.708 2.938 . . . . 0.0 113.597 -174.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' B' ' 79' ' ' THR . 35.8 mt-10 57.86 73.44 0.47 Allowed 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.668 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.76 138.5 19.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.214 176.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.711 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 50.2 mttp -107.39 121.95 45.63 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 123.397 0.436 . . . . 0.0 111.322 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' B' ' 76' ' ' MET . 3.1 m-85 -110.6 102.65 11.21 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 174.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 45.2 t -89.84 99.2 12.25 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 173.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -115.55 139.74 49.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.3 -168.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 54.4 m -84.66 132.16 34.51 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.399 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 59.3 mt -86.33 115.48 27.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.041 0.448 . . . . 0.0 110.924 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.431 HD12 ' N ' ' B' ' 25' ' ' LYS . 1.9 pp -88.7 -12.57 10.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.369 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.431 ' N ' HD12 ' B' ' 24' ' ' ILE . 83.3 tttt -159.99 120.17 2.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.479 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 13.6 m -51.47 137.09 24.7 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 123.768 0.667 . . . . 0.0 110.515 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . 0.719 ' HB3' HD23 ' B' ' 91' ' ' LEU . 33.0 p90 -147.34 165.34 30.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.386 0.612 . . . . 0.0 112.51 -174.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' HIS . . . . . 0.484 ' HA ' ' O ' ' B' ' 67' ' ' LEU . 8.3 t60 -116.15 120.24 38.39 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.749 176.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.536 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 42.5 mt -84.56 134.69 26.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 169.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.53 ' HB2' ' HB3' ' C' ' 66' ' ' ASP . 77.2 p -119.61 -10.1 9.67 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -171.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -178.16 158.5 23.38 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.314 -1.422 . . . . 0.0 113.678 177.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.485 HG23 ' HG ' ' B' ' 87' ' ' LEU . 11.9 p -139.71 137.27 39.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -150.16 154.78 38.61 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.972 -0.455 . . . . 0.0 110.961 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.565 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.3 pp -118.14 140.06 50.35 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.963 0.887 . . . . 0.0 111.651 178.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -110.41 -53.25 2.7 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.067 -1.424 . . . . 0.0 108.508 174.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -101.55 126.74 48.42 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.672 175.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' B' ' 83' ' ' ALA . . . 140.67 165.72 10.41 Favored Glycine 0 N--CA 1.439 -1.132 0 C-N-CA 119.602 -1.285 . . . . 0.0 113.484 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -102.76 -46.48 4.7 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.589 0.233 . . . . 0.0 111.481 176.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -151.5 134.24 15.62 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.95 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.518 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -132.83 113.71 13.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.494 0.664 . . . . 0.0 110.423 170.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' B' ' 79' ' ' THR . 65.4 mttp -98.19 113.22 25.06 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 174.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.422 ' HB3' ' HB3' ' B' ' 54' ' ' ALA . 58.9 tp -89.85 109.14 20.17 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.367 -170.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . 0.554 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 71.1 m-85 -109.04 148.53 30.66 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.919 177.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.672 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 0.4 OUTLIER -128.37 117.12 20.86 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.589 176.058 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -102.89 104.4 14.64 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.358 0.599 . . . . 0.0 109.925 176.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.485 ' HB2' HD11 ' B' ' 44' ' ' LEU . . . -128.85 143.67 50.97 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 61.06 26.64 16.56 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.769 0.795 . . . . 0.0 109.168 -174.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 59.19 38.28 23.61 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.009 -177.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . 0.564 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 6.6 tp-100 -129.46 127.97 41.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.727 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -81.43 106.04 13.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.966 0.413 . . . . 0.0 110.591 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -102.3 116.95 33.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.348 176.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -74.7 99.88 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 171.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.495 HG12 ' CD2' ' A' ' 88' ' ' LEU . 28.8 m -87.39 -32.51 6.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.576 -172.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.775 ' HB2' HD21 ' B' ' 65' ' ' LEU . . . -152.89 142.31 21.68 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 26.8 m -112.96 101.96 9.98 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 169.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 p -118.33 112.36 37.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.857 0.837 . . . . 0.0 110.468 -176.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 77.1 p -123.39 -177.39 3.69 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.107 -176.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -60.86 -29.41 69.51 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.507 168.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.15 -40.69 62.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.338 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 77.8 mt -117.73 81.64 15.31 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 173.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.34 -4.15 12.28 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.164 2.576 . . . . 0.0 113.922 -168.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -160.69 129.76 4.82 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.307 0.575 . . . . 0.0 111.164 -175.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 96.8 t -120.19 125.58 74.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.522 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.41 130.76 34.52 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.775 HD21 ' HB2' ' B' ' 54' ' ' ALA . 88.4 mt -122.91 166.59 14.79 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.408 0.623 . . . . 0.0 112.369 -173.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 26.1 t0 -144.45 97.94 3.12 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 170.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.536 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 7.0 mt -132.88 109.32 9.53 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.406 -175.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . 0.44 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 7.5 m-20 -104.69 114.65 29.0 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.899 0.38 . . . . 0.0 110.175 178.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -108.05 160.31 15.89 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.349 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 36.0 t -116.16 149.6 38.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.959 0.409 . . . . 0.0 110.563 -177.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -69.1 0.23 4.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.272 -176.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.54 -18.46 35.49 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.356 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -101.47 164.24 11.86 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.681 -0.305 . . . . 0.0 110.891 -176.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -131.11 108.81 10.02 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 22.4 pt -109.5 158.35 9.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.256 -170.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.438 ' HA ' ' HA ' ' B' ' 20' ' ' SER . 2.6 mtm -116.64 122.79 45.61 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 120.296 -0.562 . . . . 0.0 109.924 175.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . 0.672 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -104.49 128.61 52.46 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.665 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.711 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 36.0 p90 -150.08 135.37 18.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.589 0.709 . . . . 0.0 112.498 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 3.8 p -106.35 132.56 52.24 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.835 178.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.46 154.39 18.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.806 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.415 ' O ' ' HG3' ' B' ' 16' ' ' GLU . . . 91.38 -172.18 35.94 Favored Glycine 0 CA--C 1.506 -0.492 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -176.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 82' ' ' ASP . . . . . 0.407 ' HA ' ' HB3' ' B' ' 15' ' ' PRO . 21.5 t70 -113.09 102.9 10.83 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.854 176.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.521 ' H ' ' HB3' ' B' ' 15' ' ' PRO . . . -169.32 153.71 5.45 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.818 167.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 24.3 t -111.0 120.65 43.07 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.565 HG12 ' HB3' ' B' ' 34' ' ' LEU . 3.8 m -114.97 149.27 17.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.544 0.688 . . . . 0.0 112.816 -172.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 25.0 m -110.87 115.38 29.42 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.61 175.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.568 HD11 ' SD ' ' B' ' 13' ' ' MET . 4.8 mp -94.81 145.25 25.01 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 170.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.559 HD12 ' CE1' ' B' ' 8' ' ' PHE . 2.4 mm? -124.48 149.51 46.77 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.81 -167.29 26.22 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.512 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 90' ' ' TYR . . . . . 0.428 ' CD2' ' HB2' ' C' ' 68' ' ' ASN . 5.1 p90 -149.35 131.34 15.27 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.787 0.803 . . . . 0.0 111.682 176.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . 0.719 HD23 ' HB3' ' B' ' 27' ' ' PHE . 27.3 mt . . . . . 0 C--N 1.324 -0.543 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.256 176.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 21.8 ttt . . . . . 0 C--O 1.226 -0.183 0 CA-C-O 121.166 0.508 . . . . 0.0 112.325 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' C' C ' 8' ' ' PHE . . . . . 0.571 ' CE1' HD12 ' C' ' 88' ' ' LEU . 77.8 t80 -54.56 141.55 31.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.788 -1.097 . . . . 0.0 112.917 -176.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . 0.524 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 89.4 t90 -133.48 147.23 51.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.582 177.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.85 145.65 14.7 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.554 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.563 HD23 HD13 ' C' ' 87' ' ' LEU . 50.0 tp -135.97 108.74 7.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.923 0.392 . . . . 0.0 110.254 177.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -96.7 101.1 12.64 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 13' ' ' MET . . . . . 0.557 ' SD ' HD11 ' C' ' 87' ' ' LEU . 60.9 mtp -92.57 143.44 26.34 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.282 0.563 . . . . 0.0 111.401 -172.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -100.48 144.98 29.51 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.424 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . 0.526 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 9.5 Cg_endo -51.87 123.23 11.94 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 123.647 2.898 . . . . 0.0 113.559 -174.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' C' ' 79' ' ' THR . 36.1 mt-10 57.8 73.45 0.47 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.686 178.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.82 138.43 19.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.173 176.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 18' ' ' LYS . . . . . 0.723 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 50.2 mttp -107.37 121.98 45.67 Favored 'General case' 0 CA--C 1.511 -0.531 0 O-C-N 123.368 0.418 . . . . 0.0 111.325 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' C' ' 76' ' ' MET . 3.1 m-85 -110.63 102.74 11.28 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 174.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 44.7 t -89.97 99.22 12.27 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 173.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -115.52 139.69 49.83 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.272 -168.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 54.2 m -84.63 132.13 34.52 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.426 174.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 59.1 mt -86.21 115.32 27.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.048 0.452 . . . . 0.0 111.001 -175.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . 0.426 HD12 ' N ' ' C' ' 25' ' ' LYS . 1.9 pp -88.64 -12.57 10.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.39 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . 0.426 ' N ' HD12 ' C' ' 24' ' ' ILE . 83.3 tttt -159.95 120.24 2.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.431 178.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 13.4 m -51.47 137.13 24.66 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 123.736 0.647 . . . . 0.0 110.532 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 27' ' ' PHE . . . . . 0.73 ' HB3' HD23 ' C' ' 91' ' ' LEU . 32.9 p90 -147.39 165.32 30.57 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.448 0.642 . . . . 0.0 112.579 -174.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 28' ' ' HIS . . . . . 0.497 ' HA ' ' O ' ' C' ' 67' ' ' LEU . 8.3 t60 -116.1 120.29 38.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.728 177.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . 0.518 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 42.3 mt -84.61 134.68 26.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 169.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.5 ' HB2' ' HB3' ' D' ' 66' ' ' ASP . 75.9 p -119.59 -10.05 9.68 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -171.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 31' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -178.11 158.45 23.32 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 119.194 -1.479 . . . . 0.0 113.617 177.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.492 HG23 ' HG ' ' C' ' 87' ' ' LEU . 12.0 p -139.67 137.28 39.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -150.17 154.79 38.63 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 121.946 -0.471 . . . . 0.0 110.922 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.546 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.3 pp -118.24 140.09 50.33 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 122.01 0.909 . . . . 0.0 111.585 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -110.33 -53.32 2.7 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.934 -1.485 . . . . 0.0 108.514 174.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -101.59 126.72 48.46 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.603 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 37' ' ' GLY . . . . . 0.491 ' HA3' ' HA ' ' C' ' 83' ' ' ALA . . . 140.72 165.68 10.4 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 119.55 -1.309 . . . . 0.0 113.56 178.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -102.78 -46.46 4.7 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 120.575 0.226 . . . . 0.0 111.452 176.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -151.49 134.31 15.68 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.979 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.5 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -132.83 113.66 13.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.401 0.62 . . . . 0.0 110.451 170.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' C' ' 79' ' ' THR . 65.4 mttp -98.17 113.27 25.13 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 174.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.428 ' HG ' ' CG2' ' C' ' 53' ' ' VAL . 59.0 tp -89.92 109.08 20.12 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.416 -170.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 43' ' ' TYR . . . . . 0.543 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 71.3 m-85 -108.99 148.58 30.53 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.92 177.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.671 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 0.4 OUTLIER -128.39 117.09 20.78 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.579 176.045 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -102.87 104.5 14.76 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.33 0.586 . . . . 0.0 109.851 176.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.498 ' HB2' HD11 ' C' ' 44' ' ' LEU . . . -128.76 143.74 50.99 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.34 178.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 61.11 26.52 16.42 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.768 0.794 . . . . 0.0 109.138 -174.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 59.28 38.27 23.32 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.969 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . 0.558 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 6.6 tp-100 -129.49 127.96 41.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.715 178.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -81.51 106.08 13.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.074 0.464 . . . . 0.0 110.565 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -102.29 116.97 33.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.304 176.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 tp -74.74 99.88 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 171.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 53' ' ' VAL . . . . . 0.48 HG12 ' CD2' ' B' ' 88' ' ' LEU . 28.4 m -87.43 -32.43 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.618 -172.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 54' ' ' ALA . . . . . 0.776 ' HB2' HD21 ' C' ' 65' ' ' LEU . . . -152.89 142.41 21.77 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 120.308 -0.557 . . . . 0.0 112.261 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 27.0 m -113.05 101.97 9.96 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 169.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 p -118.26 112.39 38.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.817 0.818 . . . . 0.0 110.414 -176.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 77.0 p -123.45 -177.35 3.69 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.205 -176.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -60.81 -29.47 69.48 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.484 168.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.13 -40.68 62.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.289 0.566 . . . . 0.0 110.329 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 77.5 mt -117.75 81.65 15.4 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 173.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.33 -4.12 12.22 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.148 2.565 . . . . 0.0 113.969 -168.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -160.69 129.7 4.8 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.348 0.594 . . . . 0.0 111.194 -175.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 97.2 t -120.1 125.55 74.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.552 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.39 130.76 34.52 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 175.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . 0.776 HD21 ' HB2' ' C' ' 54' ' ' ALA . 88.2 mt -122.84 166.59 14.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.506 0.669 . . . . 0.0 112.376 -173.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 66' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 26.4 t0 -144.52 98.07 3.14 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.518 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 7.0 mt -132.95 109.37 9.53 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.443 -175.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . 0.428 ' HB2' ' CD2' ' B' ' 90' ' ' TYR . 7.4 m-20 -104.7 114.63 28.97 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 120.802 0.334 . . . . 0.0 110.158 178.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -108.11 160.38 15.85 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.254 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 36.6 t -116.16 149.64 38.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.565 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -69.15 0.01 5.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.203 -176.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.32 -18.54 35.85 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.406 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -101.51 164.09 11.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.706 0.289 . . . . 0.0 110.841 -176.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -131.0 108.81 10.06 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 22.5 pt -109.52 158.41 9.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.216 -170.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.443 ' HA ' ' HA ' ' C' ' 20' ' ' SER . 2.5 mtm -116.69 122.81 45.61 Favored 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.887 175.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 77' ' ' PHE . . . . . 0.671 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.7 OUTLIER -104.55 128.63 52.56 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.721 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 78' ' ' TYR . . . . . 0.723 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 36.4 p90 -150.04 135.33 18.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.581 0.705 . . . . 0.0 112.531 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 3.9 p -106.35 132.51 52.3 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.777 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.48 154.5 18.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.778 177.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.408 ' O ' ' HG3' ' C' ' 16' ' ' GLU . . . 91.3 -172.16 36.03 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -176.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 82' ' ' ASP . . . . . 0.402 ' HA ' ' HB3' ' C' ' 15' ' ' PRO . 21.3 t70 -113.07 102.95 10.88 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.879 176.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . 0.526 ' H ' ' HB3' ' C' ' 15' ' ' PRO . . . -169.38 153.6 5.34 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.845 167.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 25.3 t -110.94 120.71 43.3 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.546 HG12 ' HB3' ' C' ' 34' ' ' LEU . 3.8 m -114.96 149.38 17.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 24.1 m -110.97 115.31 29.28 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.641 175.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . 0.563 HD13 HD23 ' C' ' 11' ' ' LEU . 4.8 mp -94.83 145.19 25.06 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 170.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . 0.571 HD12 ' CE1' ' C' ' 8' ' ' PHE . 2.4 mm? -124.38 149.49 46.61 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.77 -167.29 26.16 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.471 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 90' ' ' TYR . . . . . 0.424 ' CD2' ' HB2' ' D' ' 68' ' ' ASN . 5.1 p90 -149.33 131.41 15.36 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.744 0.783 . . . . 0.0 111.741 176.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . 0.73 HD23 ' HB3' ' C' ' 27' ' ' PHE . 27.7 mt . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.247 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 21.7 ttt . . . . . 0 C--O 1.225 -0.223 0 CA-C-O 121.142 0.496 . . . . 0.0 112.28 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' D' D ' 8' ' ' PHE . . . . . 0.561 ' CE1' HD12 ' D' ' 88' ' ' LEU . 78.0 t80 -54.55 141.59 30.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.971 -176.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 9' ' ' TRP . . . . . 0.529 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 89.3 t90 -133.53 147.21 51.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.536 177.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.79 145.64 14.68 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.591 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . 0.55 HD23 HD13 ' D' ' 87' ' ' LEU . 49.9 tp -136.0 108.85 7.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.923 0.392 . . . . 0.0 110.246 176.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -96.76 101.01 12.53 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 13' ' ' MET . . . . . 0.569 ' SD ' HD11 ' D' ' 87' ' ' LEU . 60.8 mtp -92.42 143.45 26.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.241 0.543 . . . . 0.0 111.434 -173.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -100.47 144.94 29.43 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.416 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . 0.529 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 9.5 Cg_endo -51.73 123.16 11.7 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.645 2.896 . . . . 0.0 113.626 -174.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' D' ' 79' ' ' THR . 35.9 mt-10 57.81 73.46 0.47 Allowed 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.707 178.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.85 138.44 19.66 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.197 176.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . 0.714 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 50.2 mttp -107.39 121.98 45.67 Favored 'General case' 0 CA--C 1.511 -0.533 0 O-C-N 123.387 0.429 . . . . 0.0 111.399 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.61 102.64 11.2 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 174.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 44.9 t -89.97 99.17 12.24 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -115.51 139.8 49.73 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.219 -168.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 55.2 m -84.74 132.25 34.47 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.292 174.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 59.4 mt -86.38 115.35 27.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.057 0.456 . . . . 0.0 110.914 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . 0.416 HD12 ' N ' ' D' ' 25' ' ' LYS . 1.9 pp -88.67 -12.51 10.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.417 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . 0.416 ' N ' HD12 ' D' ' 24' ' ' ILE . 83.3 tttt -159.93 120.28 2.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.493 178.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 13.6 m -51.6 137.13 25.4 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 123.761 0.663 . . . . 0.0 110.415 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 27' ' ' PHE . . . . . 0.735 ' HB3' HD23 ' D' ' 91' ' ' LEU . 32.9 p90 -147.39 165.27 30.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.399 0.619 . . . . 0.0 112.569 -174.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 28' ' ' HIS . . . . . 0.495 ' HA ' ' O ' ' D' ' 67' ' ' LEU . 8.3 t60 -116.15 120.3 38.59 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.676 177.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 29' ' ' ILE . . . . . 0.53 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 42.4 mt -84.5 134.66 26.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 169.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . 0.51 ' HB2' ' HB3' ' E' ' 66' ' ' ASP . 77.2 p -119.6 -10.12 9.67 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -171.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 31' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -178.15 158.5 23.38 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 119.309 -1.425 . . . . 0.0 113.686 177.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.476 HG23 ' HG ' ' D' ' 87' ' ' LEU . 12.0 p -139.67 137.26 39.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 175.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -150.16 154.85 38.74 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.025 -0.422 . . . . 0.0 110.916 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 34' ' ' LEU . . . . . 0.543 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.3 pp -118.24 140.01 50.45 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.957 0.884 . . . . 0.0 111.607 178.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -110.32 -53.31 2.7 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.556 174.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -101.54 126.79 48.41 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.631 175.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . 0.496 ' HA3' ' HA ' ' D' ' 83' ' ' ALA . . . 140.65 165.67 10.39 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 119.554 -1.308 . . . . 0.0 113.447 178.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -102.8 -46.46 4.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.485 0.183 . . . . 0.0 111.409 176.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -151.44 134.21 15.66 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.012 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -132.76 113.7 13.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.433 0.635 . . . . 0.0 110.53 170.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' D' ' 79' ' ' THR . 65.4 mttp -98.16 113.28 25.13 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 174.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.425 ' HG ' ' CG2' ' D' ' 53' ' ' VAL . 58.8 tp -89.95 109.05 20.1 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.409 -170.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 43' ' ' TYR . . . . . 0.548 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 70.6 m-85 -108.97 148.55 30.54 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.989 177.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.668 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.4 OUTLIER -128.37 117.08 20.8 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.568 176.092 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 45' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -102.89 104.46 14.7 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.376 0.608 . . . . 0.0 109.871 176.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.492 ' HB2' HD11 ' D' ' 44' ' ' LEU . . . -128.85 143.62 50.95 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.034 -0.984 . . . . 0.0 108.377 178.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 61.2 26.55 16.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.711 0.767 . . . . 0.0 109.104 -174.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 59.29 38.23 23.29 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.992 -177.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . 0.562 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 6.6 tp-100 -129.53 127.91 41.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.685 178.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -81.47 106.08 13.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.069 0.461 . . . . 0.0 110.607 -178.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -102.3 116.97 33.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.355 176.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -74.67 99.88 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 53' ' ' VAL . . . . . 0.463 HG12 ' CD2' ' C' ' 88' ' ' LEU . 28.6 m -87.43 -32.43 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.586 -172.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 54' ' ' ALA . . . . . 0.748 ' HB2' HD21 ' D' ' 65' ' ' LEU . . . -152.93 142.27 21.61 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.246 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 27.2 m -112.97 102.05 10.05 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 169.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 p -118.4 112.33 37.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.904 0.859 . . . . 0.0 110.421 -176.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 78.4 p -123.33 -177.34 3.68 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.155 -176.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -60.86 -29.47 69.55 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.486 168.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.12 -40.68 62.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.326 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 77.6 mt -117.77 81.7 15.54 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 173.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.38 -4.1 12.22 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.137 2.558 . . . . 0.0 113.938 -168.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -160.69 129.69 4.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.299 0.571 . . . . 0.0 111.164 -175.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 97.1 t -120.12 125.67 74.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.555 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.43 130.83 34.5 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 65' ' ' LEU . . . . . 0.748 HD21 ' HB2' ' D' ' 54' ' ' ALA . 88.3 mt -122.97 166.53 14.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.353 0.597 . . . . 0.0 112.302 -173.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 66' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 26.1 t0 -144.44 98.0 3.13 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 170.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.53 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 6.9 mt -132.94 109.33 9.51 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.415 -175.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 68' ' ' ASN . . . . . 0.424 ' HB2' ' CD2' ' C' ' 90' ' ' TYR . 7.5 m-20 -104.72 114.67 29.03 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.857 0.36 . . . . 0.0 110.119 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -108.1 160.33 15.89 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.333 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 35.6 t -116.17 149.54 38.92 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.696 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -69.07 0.12 5.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.241 -176.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.45 -18.41 35.93 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.437 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -101.49 164.16 11.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.735 0.302 . . . . 0.0 110.848 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -131.08 108.92 10.1 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . . . . . . . . . 22.4 pt -109.57 158.47 9.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.22 -170.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 76' ' ' MET . . . . . 0.444 ' HA ' ' HA ' ' D' ' 20' ' ' SER . 2.5 mtm -116.67 122.78 45.53 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 120.281 -0.567 . . . . 0.0 109.904 175.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 77' ' ' PHE . . . . . 0.668 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.7 OUTLIER -104.53 128.57 52.51 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.727 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 78' ' ' TYR . . . . . 0.714 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 36.5 p90 -149.97 135.38 18.19 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.622 0.725 . . . . 0.0 112.608 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 79' ' ' THR . . . . . 0.524 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 3.9 p -106.41 132.43 52.44 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.788 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.35 154.47 18.17 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.806 177.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.417 ' O ' ' HG3' ' D' ' 16' ' ' GLU . . . 91.41 -172.21 35.93 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -176.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 82' ' ' ASP . . . . . 0.413 ' HA ' ' HB3' ' D' ' 15' ' ' PRO . 21.2 t70 -113.09 102.79 10.73 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 119.584 -0.846 . . . . 0.0 109.894 176.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . 0.529 ' H ' ' HB3' ' D' ' 15' ' ' PRO . . . -169.2 153.7 5.56 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.846 167.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 24.3 t -110.98 120.73 43.36 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.543 HG12 ' HB3' ' D' ' 34' ' ' LEU . 3.8 m -115.0 149.37 17.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.538 0.685 . . . . 0.0 112.764 -172.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 24.6 m -110.97 115.39 29.4 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.569 175.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 87' ' ' LEU . . . . . 0.569 HD11 ' SD ' ' D' ' 13' ' ' MET . 4.7 mp -94.8 145.14 25.09 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 170.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.561 HD12 ' CE1' ' D' ' 8' ' ' PHE . 2.4 mm? -124.35 149.56 46.5 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.81 -167.28 26.2 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.441 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 90' ' ' TYR . . . . . 0.464 ' CD2' ' HB2' ' E' ' 68' ' ' ASN . 5.2 p90 -149.33 131.26 15.21 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.744 0.783 . . . . 0.0 111.811 176.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . 0.735 HD23 ' HB3' ' D' ' 27' ' ' PHE . 27.5 mt . . . . . 0 C--N 1.323 -0.569 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.289 176.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 21.7 ttt . . . . . 0 C--O 1.225 -0.192 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' E' E ' 8' ' ' PHE . . . . . 0.572 ' CE1' HD12 ' E' ' 88' ' ' LEU . 77.7 t80 -54.65 141.54 31.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.899 -176.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 9' ' ' TRP . . . . . 0.518 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 89.5 t90 -133.43 147.27 51.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.55 177.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.86 145.62 14.63 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.625 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 11' ' ' LEU . . . . . 0.557 HD23 HD13 ' E' ' 87' ' ' LEU . 49.8 tp -136.07 108.85 7.54 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.007 0.432 . . . . 0.0 110.261 176.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -96.68 100.98 12.51 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 13' ' ' MET . . . . . 0.563 ' SD ' HD11 ' E' ' 87' ' ' LEU . 60.3 mtp -92.41 143.47 26.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.227 0.537 . . . . 0.0 111.451 -172.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -100.51 144.95 29.45 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.386 178.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . 0.528 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 9.5 Cg_endo -51.8 123.21 11.85 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.651 2.901 . . . . 0.0 113.623 -174.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 16' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' E' ' 79' ' ' THR . 35.9 mt-10 57.77 73.45 0.47 Allowed 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.722 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.85 138.44 19.67 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.203 176.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . 0.718 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 50.2 mttp -107.32 121.99 45.67 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 123.387 0.43 . . . . 0.0 111.306 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' E' ' 76' ' ' MET . 3.1 m-85 -110.62 102.67 11.22 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 174.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 20' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' E' ' 76' ' ' MET . 44.6 t -89.99 99.18 12.24 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 173.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -115.5 139.85 49.68 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.279 -168.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 56.0 m -84.81 132.15 34.45 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.382 174.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 59.3 mt -86.32 115.37 27.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.086 0.469 . . . . 0.0 110.932 -175.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . 0.426 HD12 ' N ' ' E' ' 25' ' ' LYS . 1.9 pp -88.69 -12.49 10.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.414 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . 0.426 ' N ' HD12 ' E' ' 24' ' ' ILE . 83.3 tttt -159.95 120.19 2.97 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.501 178.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 13.6 m -51.53 137.07 25.1 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.801 0.688 . . . . 0.0 110.498 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 27' ' ' PHE . . . . . 0.729 ' HB3' HD23 ' E' ' 91' ' ' LEU . 33.1 p90 -147.31 165.19 30.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.422 0.629 . . . . 0.0 112.597 -174.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 28' ' ' HIS . . . . . 0.502 ' HA ' ' O ' ' E' ' 67' ' ' LEU . 8.3 t60 -115.97 120.32 38.78 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.682 -1.144 . . . . 0.0 109.786 176.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 29' ' ' ILE . . . . . 0.529 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 42.1 mt -84.61 134.66 26.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 169.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . 0.539 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 76.6 p -119.59 -10.03 9.69 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -171.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 31' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -178.11 158.55 23.49 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.252 -1.451 . . . . 0.0 113.595 177.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.485 HG23 ' HG ' ' E' ' 87' ' ' LEU . 12.0 p -139.77 137.25 39.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 174.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -150.17 154.83 38.68 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.916 -178.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 34' ' ' LEU . . . . . 0.541 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.3 pp -118.24 140.04 50.4 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.953 0.882 . . . . 0.0 111.665 178.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -110.4 -53.3 2.7 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 113.98 -1.464 . . . . 0.0 108.494 174.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -101.54 126.77 48.4 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.676 175.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' E' ' 83' ' ' ALA . . . 140.55 165.73 10.41 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 119.6 -1.286 . . . . 0.0 113.552 178.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -102.79 -46.55 4.67 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 123.501 0.177 . . . . 0.0 111.417 177.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -151.39 134.28 15.75 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.693 -0.23 . . . . 0.0 110.992 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . 0.511 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -132.84 113.68 13.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.416 0.627 . . . . 0.0 110.442 170.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 41' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' E' ' 79' ' ' THR . 65.4 mttp -98.16 113.24 25.08 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 174.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.425 ' HG ' ' CG2' ' E' ' 53' ' ' VAL . 58.9 tp -89.91 109.08 20.12 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.396 -170.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 43' ' ' TYR . . . . . 0.542 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 71.2 m-85 -109.0 148.62 30.47 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.931 177.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 44' ' ' LEU . . . . . 0.672 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 0.4 OUTLIER -128.46 117.16 20.87 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.52 176.105 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' E' E ' 45' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -102.95 104.41 14.62 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.412 0.625 . . . . 0.0 109.877 176.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . 0.486 ' HB2' HD11 ' E' ' 44' ' ' LEU . . . -128.85 143.67 50.97 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.302 178.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 61.16 26.57 16.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.802 0.81 . . . . 0.0 109.131 -174.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 59.31 38.23 23.2 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.952 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 49' ' ' GLN . . . . . 0.56 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 6.6 tp-100 -129.49 127.92 41.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.696 178.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -81.53 106.13 13.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.081 0.467 . . . . 0.0 110.567 -178.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -102.35 116.97 33.73 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.33 176.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -74.71 99.85 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . 0.497 HG12 ' CD2' ' D' ' 88' ' ' LEU . 29.3 m -87.35 -32.54 6.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.606 -172.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 54' ' ' ALA . . . . . 0.762 ' HB2' HD21 ' E' ' 65' ' ' LEU . . . -152.9 142.35 21.71 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 120.334 -0.547 . . . . 0.0 112.191 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 27.0 m -112.92 102.05 10.07 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 169.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 p -118.37 112.37 37.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.881 0.848 . . . . 0.0 110.416 -176.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 76.1 p -123.44 -177.38 3.69 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.172 -176.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -60.89 -29.33 69.51 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.516 168.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.2 -40.71 62.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.266 0.555 . . . . 0.0 110.345 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 77.3 mt -117.64 81.57 14.89 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 173.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.31 -4.11 12.17 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.16 2.573 . . . . 0.0 113.97 -168.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -160.65 129.7 4.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.273 0.559 . . . . 0.0 111.148 -175.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 96.9 t -120.12 125.63 74.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.524 176.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.4 130.73 34.52 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 175.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 65' ' ' LEU . . . . . 0.762 HD21 ' HB2' ' E' ' 54' ' ' ALA . 88.1 mt -122.82 166.51 14.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.444 0.64 . . . . 0.0 112.342 -173.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 66' ' ' ASP . . . . . 0.51 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 26.6 t0 -144.44 98.04 3.14 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 170.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 67' ' ' LEU . . . . . 0.529 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 7.0 mt -132.97 109.33 9.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.456 -175.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 68' ' ' ASN . . . . . 0.464 ' HB2' ' CD2' ' D' ' 90' ' ' TYR . 7.5 m-20 -104.66 114.67 29.03 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.831 0.348 . . . . 0.0 110.149 178.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -108.17 160.31 15.92 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.269 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 36.6 t -116.15 149.68 38.64 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.635 -177.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -69.15 0.11 5.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.136 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.51 -18.45 35.62 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.346 177.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -101.48 164.15 11.91 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.697 -0.296 . . . . 0.0 110.851 -176.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -131.09 108.77 9.99 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 75' ' ' ILE . . . . . . . . . . . . . 22.3 pt -109.43 158.39 9.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.29 -170.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 76' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' E' ' 20' ' ' SER . 2.5 mtm -116.66 122.79 45.59 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.906 175.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 77' ' ' PHE . . . . . 0.672 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.7 OUTLIER -104.46 128.62 52.4 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.653 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' E' E ' 78' ' ' TYR . . . . . 0.718 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 36.6 p90 -150.05 135.24 17.99 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.57 0.7 . . . . 0.0 112.569 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 79' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 3.9 p -106.29 132.57 52.18 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.806 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.55 154.38 18.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.778 177.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 81' ' ' GLY . . . . . 0.417 ' O ' ' HG3' ' E' ' 16' ' ' GLU . . . 91.46 -172.22 35.85 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -176.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -113.04 102.83 10.78 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.881 176.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 83' ' ' ALA . . . . . 0.528 ' H ' ' HB3' ' E' ' 15' ' ' PRO . . . -169.28 153.68 5.48 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.84 167.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 24.3 t -110.98 120.72 43.33 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 85' ' ' VAL . . . . . 0.541 HG12 ' HB3' ' E' ' 34' ' ' LEU . 3.8 m -114.98 149.39 17.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -172.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 24.6 m -110.97 115.24 29.15 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.619 175.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 87' ' ' LEU . . . . . 0.563 HD11 ' SD ' ' E' ' 13' ' ' MET . 4.8 mp -94.79 145.15 25.08 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 170.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . 0.572 HD12 ' CE1' ' E' ' 8' ' ' PHE . 2.4 mm? -124.34 149.58 46.45 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.92 -167.35 26.41 Favored Glycine 0 N--CA 1.437 -1.275 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.376 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 90' ' ' TYR . . . . . 0.451 ' CD2' ' HB2' ' A' ' 68' ' ' ASN . 5.1 p90 -149.31 131.34 15.31 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.744 0.783 . . . . 0.0 111.766 176.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 91' ' ' LEU . . . . . 0.729 HD23 ' HB3' ' E' ' 27' ' ' PHE . 27.2 mt . . . . . 0 C--N 1.323 -0.555 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.29 176.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 48.5 mtt . . . . . 0 C--O 1.224 -0.276 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.565 ' CE1' HD21 ' B' ' 44' ' ' LEU . 70.4 t80 -69.46 146.36 52.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.21 0.529 . . . . 0.0 112.191 -175.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.475 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 92.2 t90 -136.7 145.58 44.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.025 176.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.53 146.6 16.3 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.531 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.517 HD23 HD13 ' A' ' 87' ' ' LEU . 43.6 tp -138.48 109.9 6.98 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.885 0.374 . . . . 0.0 110.507 177.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -97.33 105.12 17.22 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.55 ' SD ' HD11 ' A' ' 87' ' ' LEU . 44.3 mtp -98.39 143.95 28.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.917 0.389 . . . . 0.0 111.038 -174.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.524 ' HB2' ' HG3' ' A' ' 17' ' ' ARG . 37.8 mtmm -100.98 157.7 33.16 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.367 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.518 ' HB3' ' HA ' ' A' ' 82' ' ' ASP . 91.1 Cg_exo -47.76 115.42 1.44 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.581 2.854 . . . . 0.0 113.66 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.667 ' HA ' ' O ' ' A' ' 79' ' ' THR . 44.6 mt-10 59.8 58.36 2.84 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.368 0.604 . . . . 0.0 111.848 175.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.524 ' HG3' ' HB2' ' A' ' 14' ' ' LYS . 29.1 mmt180 -118.68 153.17 34.79 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.946 174.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.683 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 3.5 ttmp? -130.95 110.82 11.53 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 123.456 0.473 . . . . 0.0 110.958 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -111.38 112.6 24.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.885 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -75.14 114.56 13.77 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 171.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -92.81 114.09 26.54 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.426 -165.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.7 m -93.62 119.56 32.8 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.108 172.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.3 mt -96.79 113.01 30.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.99 0.424 . . . . 0.0 111.342 -173.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.2 mp -88.91 -34.75 7.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.444 0.64 . . . . 0.0 109.342 177.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.427 ' HD2' HD13 ' A' ' 91' ' ' LEU . 19.4 pttt -132.73 128.74 37.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.183 178.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.2 m -56.2 148.36 18.46 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.746 -176.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.736 ' HB3' HD23 ' A' ' 91' ' ' LEU . 38.5 p90 -157.97 162.87 38.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.717 0.77 . . . . 0.0 112.924 -178.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.535 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 2.0 t60 -119.18 123.83 45.3 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.392 -1.277 . . . . 0.0 109.444 176.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.574 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 51.7 mt -85.27 134.68 26.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 170.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.541 ' HB2' ' HB3' ' B' ' 66' ' ' ASP . 61.7 p -117.55 -15.01 10.26 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -171.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -171.41 152.1 17.08 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 119.43 -1.367 . . . . 0.0 113.242 177.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.485 HG23 ' HG ' ' A' ' 87' ' ' LEU . 11.3 p -136.68 131.51 47.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 174.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.88 155.99 42.21 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.014 -0.429 . . . . 0.0 111.161 -176.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.489 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.1 pp -118.05 141.28 48.64 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.887 0.851 . . . . 0.0 111.925 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -110.07 -54.18 2.6 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.807 176.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -100.85 128.12 47.02 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 171.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.551 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 139.25 161.57 8.78 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 119.705 -1.236 . . . . 0.0 113.373 176.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -103.4 -43.81 5.32 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -149.42 132.32 16.11 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 120.512 0.196 . . . . 0.0 111.043 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.474 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -131.74 113.8 13.98 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.409 0.624 . . . . 0.0 110.128 169.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 79' ' ' THR . 97.4 mttt -96.25 110.57 22.85 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 175.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.403 ' HG ' ' CG2' ' A' ' 53' ' ' VAL . 51.0 tp -87.02 109.76 19.61 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.025 -172.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.434 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 96.8 m-85 -108.25 141.85 39.42 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.252 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.559 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 1.5 tp -123.57 112.79 17.86 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.488 176.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.582 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -99.18 108.84 21.53 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.19 0.519 . . . . 0.0 109.855 176.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.479 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -139.66 140.9 37.03 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.529 -177.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 53.33 41.93 32.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.526 0.679 . . . . 0.0 110.248 -178.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.2 mttp 69.87 21.46 6.32 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.414 172.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.582 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 79.2 mm-40 -128.36 137.44 51.9 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 122.211 -0.306 . . . . 0.0 111.097 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -87.31 104.94 16.88 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 174.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 49' ' ' GLN . 75.8 m-85 -99.83 120.22 39.41 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.775 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -77.36 99.96 2.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 170.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.52 HG12 ' CD2' ' E' ' 88' ' ' LEU . 18.5 m -86.97 -34.58 7.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.817 -172.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.563 ' HB2' ' CD2' ' A' ' 65' ' ' LEU . . . -151.13 140.83 21.75 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.107 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.7 m -111.52 101.25 9.68 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 169.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.15 113.71 43.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.724 0.773 . . . . 0.0 110.052 -176.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 78.2 p -123.27 -177.89 3.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.204 -175.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -64.0 -24.22 67.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.025 0.441 . . . . 0.0 110.53 169.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.39 -40.52 43.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.169 176.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.6 mt -116.84 81.92 12.53 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 173.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.94 -5.15 12.77 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.206 2.604 . . . . 0.0 114.133 -167.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -160.48 128.62 4.61 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.129 0.49 . . . . 0.0 111.189 -175.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.2 t -118.45 108.19 23.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.408 175.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.71 121.46 30.17 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 174.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.563 ' CD2' ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -143.66 168.79 19.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.147 0.499 . . . . 0.0 111.978 -174.42 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.558 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 9.5 t0 -116.36 107.13 14.43 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.739 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.574 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 32.9 mt -126.37 107.74 10.58 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 177.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -111.08 127.87 55.69 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.913 -178.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -127.19 150.32 49.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.908 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.0 m -102.59 161.78 13.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.057 0.456 . . . . 0.0 110.748 176.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -69.34 -5.1 21.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.159 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.78 -7.72 62.66 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.446 -0.661 . . . . 0.0 111.446 173.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -100.28 143.55 30.33 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -122.97 125.59 45.57 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 174.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.496 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 15.0 pt -132.06 172.18 16.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.744 -171.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 7.9 mtm -130.04 131.68 45.92 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 170.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.559 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -110.25 128.33 55.45 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 177.348 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.683 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 40.9 p90 -153.69 140.43 19.01 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.292 -0.563 . . . . 0.0 112.12 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.667 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 8.0 p -111.92 136.43 51.24 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.25 -177.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.61 161.07 14.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.232 174.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.5 ' O ' ' HG3' ' A' ' 16' ' ' GLU . . . 81.97 177.27 51.73 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -173.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.518 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 7.0 p-10 -112.97 104.11 12.07 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 118.284 -1.367 . . . . 0.0 110.848 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.551 ' CB ' ' HA3' ' A' ' 37' ' ' GLY . . . -164.76 153.26 12.37 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 113.734 -1.575 . . . . 0.0 109.882 169.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.6 p -104.97 123.39 47.7 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 177.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.489 HG12 ' HB3' ' A' ' 34' ' ' LEU . 3.6 m -118.23 144.43 26.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.556 0.693 . . . . 0.0 112.776 -173.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.8 m -108.02 116.25 31.61 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.739 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.55 HD11 ' SD ' ' A' ' 13' ' ' MET . 4.5 mp -96.02 143.02 27.55 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 170.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.543 ' CD2' HG12 ' B' ' 53' ' ' VAL . 2.6 mm? -124.97 152.04 44.71 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 174.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.6 -167.86 30.73 Favored Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.429 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -139.15 131.42 28.3 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.498 0.666 . . . . 0.0 110.805 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.736 HD23 ' HB3' ' A' ' 27' ' ' PHE . 24.1 mt . . . . . 0 C--N 1.319 -0.744 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.892 173.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 48.5 mtt . . . . . 0 C--O 1.224 -0.283 0 CA-C-O 120.731 0.3 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . 0.561 ' CE1' HD21 ' C' ' 44' ' ' LEU . 70.5 t80 -69.42 146.35 52.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.231 0.539 . . . . 0.0 112.19 -175.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . 0.474 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 92.1 t90 -136.73 145.58 44.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.981 176.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.4 146.66 16.45 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.589 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.505 HD23 HD13 ' B' ' 87' ' ' LEU . 43.9 tp -138.44 109.84 6.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.792 0.329 . . . . 0.0 110.531 177.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -97.41 105.07 17.16 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . 0.554 ' SD ' HD11 ' B' ' 87' ' ' LEU . 44.3 mtp -98.33 143.88 28.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.111 -174.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.525 ' HB2' ' HG3' ' B' ' 17' ' ' ARG . 37.9 mtmm -101.02 157.77 33.03 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.256 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.53 ' HB3' ' HA ' ' B' ' 82' ' ' ASP . 93.4 Cg_exo -47.86 115.4 1.45 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.619 2.879 . . . . 0.0 113.629 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.661 ' HA ' ' O ' ' B' ' 79' ' ' THR . 44.5 mt-10 59.87 58.39 2.8 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 121.256 0.55 . . . . 0.0 111.841 175.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.525 ' HG3' ' HB2' ' B' ' 14' ' ' LYS . 29.0 mmt180 -118.8 153.19 34.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.891 174.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.683 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 3.5 ttmp? -130.91 110.68 11.45 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.04 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -111.33 112.59 24.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.909 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 4.5 p -75.1 114.61 13.8 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 171.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -92.82 114.04 26.48 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.425 -165.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 22.9 m -93.51 119.46 32.61 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.175 172.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 42.1 mt -96.78 112.9 29.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.05 0.452 . . . . 0.0 111.407 -173.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.454 ' N ' HD12 ' B' ' 24' ' ' ILE . 4.2 mp -88.86 -34.78 7.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.302 177.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.406 ' HD2' HD13 ' B' ' 91' ' ' LEU . 19.5 pttt -132.75 128.74 37.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.088 178.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -56.21 148.35 18.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.84 -177.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . 0.73 ' HB3' HD23 ' B' ' 91' ' ' LEU . 38.7 p90 -157.96 162.91 38.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.702 0.763 . . . . 0.0 112.881 -178.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' HIS . . . . . 0.532 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 2.0 t60 -119.24 123.83 45.24 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.345 176.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.578 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 51.6 mt -85.27 134.6 26.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 170.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.567 ' HB2' ' HB3' ' C' ' 66' ' ' ASP . 61.5 p -117.48 -15.01 10.31 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -171.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -171.38 152.15 17.24 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.443 -1.361 . . . . 0.0 113.245 177.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.488 HG23 ' HG ' ' B' ' 87' ' ' LEU . 11.2 p -136.67 131.53 47.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 174.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.91 156.01 42.22 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.066 -0.396 . . . . 0.0 111.134 -176.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.5 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.1 pp -118.08 141.42 48.5 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.848 0.833 . . . . 0.0 111.96 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -110.17 -54.17 2.6 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.768 176.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -100.92 128.1 47.1 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.862 171.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.555 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 139.32 161.55 8.77 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 119.583 -1.294 . . . . 0.0 113.35 176.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -103.32 -43.83 5.33 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 178.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -149.44 132.41 16.18 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.543 0.211 . . . . 0.0 110.983 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.459 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -131.84 113.71 13.82 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.388 0.613 . . . . 0.0 110.12 169.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' B' ' 79' ' ' THR . 97.3 mttt -96.22 110.59 22.86 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.409 ' HG ' ' CG2' ' B' ' 53' ' ' VAL . 51.1 tp -87.05 109.73 19.6 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.062 -172.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . 0.428 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 96.7 m-85 -108.2 141.85 39.32 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.293 178.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.565 HD21 ' CE1' ' A' ' 8' ' ' PHE . 1.5 tp -123.58 112.84 17.92 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.451 176.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -99.21 108.86 21.55 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.178 0.513 . . . . 0.0 109.82 176.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.481 ' CB ' HG22 ' B' ' 75' ' ' ILE . . . -139.69 140.97 36.97 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.535 -177.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 53.25 41.95 32.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.557 0.694 . . . . 0.0 110.238 -177.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 39.2 mttp 69.93 21.41 6.26 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.404 172.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . 0.573 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 79.1 mm-40 -128.33 137.49 51.95 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.055 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -87.27 104.88 16.82 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.432 ' CZ ' ' HB2' ' B' ' 49' ' ' GLN . 76.0 m-85 -99.92 120.27 39.53 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.71 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -77.33 99.98 2.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 170.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.543 HG12 ' CD2' ' A' ' 88' ' ' LEU . 18.9 m -86.92 -34.68 7.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.878 -172.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.556 ' HB2' ' CD2' ' B' ' 65' ' ' LEU . . . -151.08 140.79 21.77 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 120.383 -0.527 . . . . 0.0 112.139 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 21.8 m -111.47 101.29 9.74 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 169.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.23 113.73 43.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.707 0.765 . . . . 0.0 110.052 -176.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 74.6 p -123.3 -177.82 3.81 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.201 -175.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -63.98 -24.27 67.65 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.508 169.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.33 -40.58 43.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.291 0.567 . . . . 0.0 110.187 176.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 79.8 mt -116.82 81.99 12.56 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 173.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.07 -5.16 12.93 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.232 2.621 . . . . 0.0 114.053 -167.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -160.42 128.63 4.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.273 0.558 . . . . 0.0 111.242 -175.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 88.9 t -118.58 108.23 23.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.462 175.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.72 121.47 30.19 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 174.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.556 ' CD2' ' HB2' ' B' ' 54' ' ' ALA . 0.4 OUTLIER -143.65 168.78 19.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.074 0.464 . . . . 0.0 112.009 -174.459 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . 0.541 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 9.4 t0 -116.32 107.13 14.44 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.772 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.578 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 32.7 mt -126.38 107.69 10.53 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 177.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -111.16 127.9 55.73 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.915 -178.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -127.13 150.34 49.54 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.883 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 58.1 m -102.62 161.78 13.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.071 0.462 . . . . 0.0 110.748 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -69.19 -5.22 21.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.231 177.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.79 -7.62 62.73 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 173.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -100.32 143.53 30.4 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -123.0 125.63 45.61 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 174.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.501 ' HB ' ' CD1' ' B' ' 44' ' ' LEU . 15.1 pt -132.07 172.15 16.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.718 -171.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . . . . . . . . . 7.9 mtm -129.97 131.7 46.03 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 170.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . 0.564 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.9 OUTLIER -110.22 128.32 55.43 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.29 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.683 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 41.1 p90 -153.6 140.42 19.1 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.299 -0.56 . . . . 0.0 112.098 -178.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.661 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 8.1 p -111.91 136.48 51.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.216 -177.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.65 161.06 14.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.207 174.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.494 ' O ' ' HG3' ' B' ' 16' ' ' GLU . . . 81.93 177.38 51.78 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -173.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 82' ' ' ASP . . . . . 0.53 ' HA ' ' HB3' ' B' ' 15' ' ' PRO . 6.9 p-10 -113.14 104.18 12.1 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 118.267 -1.373 . . . . 0.0 110.82 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.555 ' CB ' ' HA3' ' B' ' 37' ' ' GLY . . . -164.83 153.25 12.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 113.638 -1.619 . . . . 0.0 109.861 169.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 6.7 p -104.96 123.4 47.71 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.5 HG12 ' HB3' ' B' ' 34' ' ' LEU . 3.5 m -118.21 144.44 26.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.571 0.7 . . . . 0.0 112.744 -173.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 50.9 m -108.11 116.25 31.62 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.704 175.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.554 HD11 ' SD ' ' B' ' 13' ' ' MET . 4.5 mp -96.04 143.14 27.45 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 170.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.524 ' CD2' HG12 ' C' ' 53' ' ' VAL . 2.6 mm? -125.09 151.96 44.99 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 174.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.55 -167.89 30.73 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.328 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -139.11 131.46 28.44 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.515 0.674 . . . . 0.0 110.851 176.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . 0.73 HD23 ' HB3' ' B' ' 27' ' ' PHE . 23.4 mt . . . . . 0 C--N 1.319 -0.745 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.923 173.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 48.6 mtt . . . . . 0 C--O 1.222 -0.345 0 CA-C-O 120.75 0.309 . . . . 0.0 111.666 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' C' C ' 8' ' ' PHE . . . . . 0.581 ' CE1' HD21 ' D' ' 44' ' ' LEU . 70.6 t80 -69.41 146.36 52.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.284 0.564 . . . . 0.0 112.174 -175.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . 0.471 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 92.2 t90 -136.7 145.5 44.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.008 176.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.47 146.6 16.31 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.575 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.523 HD23 HD13 ' C' ' 87' ' ' LEU . 44.0 tp -138.37 109.87 7.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.834 0.35 . . . . 0.0 110.56 177.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -97.33 105.01 17.08 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 13' ' ' MET . . . . . 0.543 ' SD ' HD11 ' C' ' 87' ' ' LEU . 44.2 mtp -98.34 144.0 28.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.994 0.426 . . . . 0.0 111.041 -174.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . 0.522 ' HB2' ' HG3' ' C' ' 17' ' ' ARG . 37.8 mtmm -101.13 157.7 33.17 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.25 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . 0.533 ' HB3' ' HA ' ' C' ' 82' ' ' ASP . 92.2 Cg_exo -47.78 115.43 1.45 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.609 2.873 . . . . 0.0 113.585 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' C' ' 79' ' ' THR . 44.5 mt-10 59.81 58.36 2.83 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.306 0.574 . . . . 0.0 111.874 175.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 17' ' ' ARG . . . . . 0.522 ' HG3' ' HB2' ' C' ' 14' ' ' LYS . 29.0 mmt180 -118.72 153.24 34.71 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.939 174.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 18' ' ' LYS . . . . . 0.692 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 3.5 ttmp? -130.98 110.81 11.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.0 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -111.41 112.63 24.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.848 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 4.4 p -75.2 114.7 14.02 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 172.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -92.97 114.11 26.57 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.43 -165.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 24.0 m -93.53 119.52 32.69 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.124 172.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 42.4 mt -96.84 112.97 30.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.158 0.504 . . . . 0.0 111.324 -173.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . 0.448 HD12 ' N ' ' C' ' 24' ' ' ILE . 4.2 mp -88.88 -34.76 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.294 177.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . 0.413 ' HD2' HD13 ' C' ' 91' ' ' LEU . 19.4 pttt -132.76 128.76 37.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.097 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 16.2 m -56.25 148.4 18.54 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.806 -177.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 27' ' ' PHE . . . . . 0.733 ' HB3' HD23 ' C' ' 91' ' ' LEU . 38.5 p90 -158.02 162.88 38.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.722 0.772 . . . . 0.0 112.867 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 28' ' ' HIS . . . . . 0.545 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 2.0 t60 -119.19 123.84 45.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.392 176.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . 0.574 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 51.5 mt -85.21 134.64 26.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 170.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.545 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 61.8 p -117.5 -15.03 10.29 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -171.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 31' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -171.36 152.1 17.14 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 119.517 -1.325 . . . . 0.0 113.27 177.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.487 HG23 ' HG ' ' C' ' 87' ' ' LEU . 11.2 p -136.68 131.54 47.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 174.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.91 155.98 42.18 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 122.017 -0.427 . . . . 0.0 111.187 -176.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.496 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.1 pp -118.09 141.39 48.53 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.889 0.852 . . . . 0.0 111.918 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -110.16 -54.16 2.6 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.216 -1.356 . . . . 0.0 108.776 176.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -100.89 128.19 47.03 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 171.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 37' ' ' GLY . . . . . 0.557 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 139.25 161.51 8.75 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 119.532 -1.318 . . . . 0.0 113.319 176.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -103.32 -43.77 5.34 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 178.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -149.49 132.31 16.04 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 120.504 0.192 . . . . 0.0 111.039 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -131.72 113.72 13.89 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.41 0.624 . . . . 0.0 110.141 169.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' C' ' 79' ' ' THR . 97.4 mttt -96.28 110.67 22.95 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 175.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.404 ' HG ' ' CG2' ' C' ' 53' ' ' VAL . 51.1 tp -87.14 109.77 19.67 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.982 -172.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 43' ' ' TYR . . . . . 0.434 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 96.7 m-85 -108.24 141.81 39.45 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.284 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.564 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 1.5 tp -123.56 112.75 17.82 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.532 176.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . 0.583 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -99.16 108.78 21.48 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.143 0.497 . . . . 0.0 109.795 176.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.472 ' CB ' HG22 ' C' ' 75' ' ' ILE . . . -139.69 140.97 36.99 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.551 -177.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 53.19 41.97 32.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.575 0.703 . . . . 0.0 110.33 -177.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 39.2 mttp 69.95 21.38 6.25 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 114.843 -1.072 . . . . 0.0 112.39 172.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . 0.583 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 79.2 mm-40 -128.3 137.48 51.97 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.07 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -87.26 104.98 16.91 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 174.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . 0.437 ' CZ ' ' HB2' ' C' ' 49' ' ' GLN . 76.0 m-85 -99.98 120.26 39.54 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.698 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -77.31 99.92 2.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 170.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 53' ' ' VAL . . . . . 0.524 HG12 ' CD2' ' B' ' 88' ' ' LEU . 18.7 m -86.92 -34.66 7.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.85 -172.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 54' ' ' ALA . . . . . 0.557 ' HB2' ' CD2' ' C' ' 65' ' ' LEU . . . -151.06 140.92 21.91 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 120.343 -0.543 . . . . 0.0 112.092 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 21.4 m -111.5 101.34 9.77 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 169.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.26 113.69 43.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.757 0.789 . . . . 0.0 110.038 -176.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 77.2 p -123.22 -177.83 3.81 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.194 -175.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -64.05 -24.16 67.6 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.007 0.432 . . . . 0.0 110.52 169.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.4 -40.55 43.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.198 0.523 . . . . 0.0 110.125 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 79.5 mt -116.81 81.96 12.52 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 173.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.02 -5.09 12.69 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.218 2.612 . . . . 0.0 114.119 -167.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -160.49 128.61 4.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.185 0.517 . . . . 0.0 111.266 -175.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 88.0 t -118.54 108.21 23.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.43 175.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.7 121.4 30.08 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . 0.557 ' CD2' ' HB2' ' C' ' 54' ' ' ALA . 0.4 OUTLIER -143.65 168.88 18.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.17 0.51 . . . . 0.0 111.954 -174.554 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 66' ' ' ASP . . . . . 0.567 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 9.4 t0 -116.35 107.16 14.47 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.79 178.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.574 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 32.8 mt -126.5 107.76 10.54 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -111.08 127.79 55.67 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.958 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -127.07 150.26 49.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.919 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 58.1 m -102.56 161.77 13.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.978 0.418 . . . . 0.0 110.733 176.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -69.23 -5.22 21.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.194 177.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.76 -7.66 62.75 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 173.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -100.3 143.51 30.4 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -122.99 125.65 45.66 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.501 ' HB ' ' CD1' ' C' ' 44' ' ' LEU . 15.1 pt -132.05 172.18 16.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.663 -171.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . . . . . . . . . 7.8 mtm -129.99 131.64 45.97 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 170.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 77' ' ' PHE . . . . . 0.564 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.9 OUTLIER -110.17 128.28 55.39 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.274 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 78' ' ' TYR . . . . . 0.692 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 41.0 p90 -153.61 140.42 19.09 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.291 -0.564 . . . . 0.0 112.116 -178.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 8.2 p -111.91 136.4 51.28 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.25 -177.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.59 161.05 14.45 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.29 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.497 ' O ' ' HG3' ' C' ' 16' ' ' GLU . . . 81.96 177.24 51.71 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -173.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 82' ' ' ASP . . . . . 0.533 ' HA ' ' HB3' ' C' ' 15' ' ' PRO . 6.9 p-10 -112.94 104.21 12.18 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 118.304 -1.358 . . . . 0.0 110.873 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . 0.557 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -164.82 153.25 12.24 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.66 -1.609 . . . . 0.0 109.869 169.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 6.4 p -104.96 123.4 47.7 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.496 HG12 ' HB3' ' C' ' 34' ' ' LEU . 3.6 m -118.24 144.48 26.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.582 0.706 . . . . 0.0 112.765 -173.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 50.6 m -108.14 116.22 31.57 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.67 175.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . 0.543 HD11 ' SD ' ' C' ' 13' ' ' MET . 4.5 mp -96.04 143.15 27.44 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 170.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . 0.523 HD12 ' CE1' ' C' ' 8' ' ' PHE . 2.6 mm? -125.06 151.97 44.94 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 174.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.55 -167.9 30.75 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.443 177.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -139.06 131.47 28.54 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.432 0.634 . . . . 0.0 110.852 176.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . 0.733 HD23 ' HB3' ' C' ' 27' ' ' PHE . 23.7 mt . . . . . 0 C--N 1.318 -0.764 0 CA-C-N 114.537 -1.21 . . . . 0.0 108.943 173.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 48.6 mtt . . . . . 0 C--O 1.223 -0.312 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' D' D ' 8' ' ' PHE . . . . . 0.563 ' CE1' HD21 ' E' ' 44' ' ' LEU . 70.7 t80 -69.35 146.37 52.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.217 0.532 . . . . 0.0 112.176 -175.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 9' ' ' TRP . . . . . 0.476 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 92.2 t90 -136.76 145.62 44.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.397 -0.819 . . . . 0.0 108.965 176.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.57 146.54 16.17 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.507 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . 0.506 HD23 HD13 ' D' ' 87' ' ' LEU . 44.0 tp -138.38 109.84 6.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.837 0.351 . . . . 0.0 110.595 177.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -97.29 105.04 17.12 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 13' ' ' MET . . . . . 0.556 ' SD ' HD11 ' D' ' 87' ' ' LEU . 44.5 mtp -98.42 143.94 28.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.965 0.412 . . . . 0.0 111.011 -174.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 14' ' ' LYS . . . . . 0.519 ' HB2' ' HG3' ' D' ' 17' ' ' ARG . 37.8 mtmm -101.04 157.74 33.09 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.257 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . 0.525 ' HB3' ' HA ' ' D' ' 82' ' ' ASP . 92.5 Cg_exo -47.81 115.36 1.42 Allowed 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.597 2.865 . . . . 0.0 113.686 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . 0.669 ' HA ' ' O ' ' D' ' 79' ' ' THR . 44.5 mt-10 59.88 58.38 2.79 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.333 0.587 . . . . 0.0 111.81 175.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 17' ' ' ARG . . . . . 0.519 ' HG3' ' HB2' ' D' ' 14' ' ' LYS . 29.0 mmt180 -118.72 153.12 34.91 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.899 174.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . 0.696 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 3.5 ttmp? -130.94 110.81 11.53 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.021 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -111.32 112.55 24.4 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.942 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -75.08 114.66 13.83 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 171.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -92.96 114.12 26.59 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.386 -165.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 23.8 m -93.68 119.53 32.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.126 172.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 42.6 mt -96.82 112.96 29.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.112 0.482 . . . . 0.0 111.36 -173.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . 0.449 HD12 ' N ' ' D' ' 24' ' ' ILE . 4.2 mp -88.81 -34.8 7.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.354 177.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . 0.406 ' HD2' HD13 ' D' ' 91' ' ' LEU . 19.4 pttt -132.67 128.81 37.83 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.077 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -56.21 148.36 18.49 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.757 -177.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 27' ' ' PHE . . . . . 0.744 ' HB3' HD23 ' D' ' 91' ' ' LEU . 38.6 p90 -158.06 162.93 38.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.782 0.801 . . . . 0.0 112.842 -178.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 28' ' ' HIS . . . . . 0.55 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 2.0 t60 -119.2 123.83 45.29 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.401 176.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 29' ' ' ILE . . . . . 0.569 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 51.3 mt -85.29 134.65 26.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 170.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . 0.565 ' HB2' ' HB3' ' E' ' 66' ' ' ASP . 61.2 p -117.53 -15.0 10.28 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -171.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 31' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -171.35 152.07 17.09 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 119.488 -1.339 . . . . 0.0 113.246 177.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.469 HG23 ' HG ' ' D' ' 87' ' ' LEU . 11.4 p -136.62 131.49 47.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 174.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.86 156.01 42.24 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 122.057 -0.402 . . . . 0.0 111.185 -176.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 34' ' ' LEU . . . . . 0.489 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.1 pp -118.07 141.41 48.5 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.869 0.842 . . . . 0.0 111.905 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -110.18 -54.21 2.6 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.232 -1.349 . . . . 0.0 108.806 176.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -100.83 128.1 47.01 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.827 171.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . 0.557 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 139.27 161.54 8.77 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 119.64 -1.267 . . . . 0.0 113.378 176.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -103.34 -43.79 5.33 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 178.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -149.43 132.28 16.07 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 120.529 0.204 . . . . 0.0 111.048 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . 0.458 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -131.76 113.74 13.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.405 0.621 . . . . 0.0 110.146 169.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' D' ' 79' ' ' THR . 97.3 mttt -96.21 110.54 22.82 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 175.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.404 ' HG ' ' CG2' ' D' ' 53' ' ' VAL . 50.9 tp -87.0 109.71 19.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.005 -172.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 43' ' ' TYR . . . . . 0.438 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 96.6 m-85 -108.23 141.88 39.32 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.303 178.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.581 HD21 ' CE1' ' C' ' 8' ' ' PHE . 1.5 tp -123.61 112.81 17.87 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.489 176.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 45' ' ' ALA . . . . . 0.584 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -99.19 108.84 21.53 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.14 0.495 . . . . 0.0 109.806 176.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.469 ' CB ' HG22 ' D' ' 75' ' ' ILE . . . -139.67 140.96 37.02 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.51 -177.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 53.26 41.9 32.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.506 0.669 . . . . 0.0 110.273 -178.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 39.2 mttp 69.94 21.5 6.22 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.389 172.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . 0.584 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 79.2 mm-40 -128.41 137.48 51.88 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.055 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -87.35 105.02 16.97 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 174.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . 0.436 ' CZ ' ' HB2' ' D' ' 49' ' ' GLN . 75.9 m-85 -99.93 120.29 39.56 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.657 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -77.31 99.92 2.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 170.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 53' ' ' VAL . . . . . 0.515 HG12 ' CD2' ' C' ' 88' ' ' LEU . 18.5 m -86.99 -34.62 7.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.818 -172.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 54' ' ' ALA . . . . . 0.56 ' HB2' ' CD2' ' D' ' 65' ' ' LEU . . . -151.11 140.86 21.81 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 120.361 -0.535 . . . . 0.0 112.085 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 21.9 m -111.57 101.3 9.71 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 169.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.18 113.65 43.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.724 0.774 . . . . 0.0 110.036 -176.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 76.9 p -123.2 -177.86 3.81 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.25 -175.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -64.03 -24.19 67.61 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.01 0.433 . . . . 0.0 110.535 169.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.33 -40.58 43.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.192 176.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 79.5 mt -116.81 81.9 12.44 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 173.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.95 -5.19 12.87 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.264 2.643 . . . . 0.0 114.052 -167.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -160.44 128.57 4.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.351 0.596 . . . . 0.0 111.268 -175.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 89.8 t -118.43 108.16 23.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.455 175.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.78 121.54 30.32 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 174.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 65' ' ' LEU . . . . . 0.56 ' CD2' ' HB2' ' D' ' 54' ' ' ALA . 0.4 OUTLIER -143.65 168.88 18.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.113 0.482 . . . . 0.0 111.93 -174.541 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 66' ' ' ASP . . . . . 0.528 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 9.2 t0 -116.35 107.13 14.43 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.806 178.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.569 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 32.8 mt -126.43 107.69 10.51 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 177.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -111.08 127.78 55.67 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.939 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -127.12 150.28 49.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.902 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 58.1 m -102.57 161.83 13.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.025 0.441 . . . . 0.0 110.739 176.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -69.32 -5.26 22.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.16 177.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.71 -7.65 62.83 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 173.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -100.29 143.53 30.38 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -122.98 125.67 45.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.49 ' HB ' ' CD1' ' D' ' 44' ' ' LEU . 14.9 pt -132.08 172.22 16.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.625 -171.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 76' ' ' MET . . . . . . . . . . . . . 7.9 mtm -130.09 131.67 45.83 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 170.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 77' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.9 OUTLIER -110.18 128.23 55.37 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.37 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 78' ' ' TYR . . . . . 0.696 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 41.1 p90 -153.6 140.33 19.0 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.312 -0.555 . . . . 0.0 112.172 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 79' ' ' THR . . . . . 0.669 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 8.3 p -111.83 136.51 51.02 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.295 -177.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.66 161.06 14.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.244 174.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.501 ' O ' ' HG3' ' D' ' 16' ' ' GLU . . . 81.97 177.23 51.71 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -173.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 82' ' ' ASP . . . . . 0.525 ' HA ' ' HB3' ' D' ' 15' ' ' PRO . 6.9 p-10 -112.9 104.15 12.14 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 118.263 -1.375 . . . . 0.0 110.928 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . 0.557 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -164.8 153.32 12.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.75 -1.568 . . . . 0.0 109.858 169.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 6.6 p -104.94 123.41 47.7 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.686 -0.486 . . . . 0.0 109.686 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.489 HG12 ' HB3' ' D' ' 34' ' ' LEU . 3.6 m -118.23 144.5 26.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.603 0.716 . . . . 0.0 112.729 -173.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 50.6 m -108.11 116.32 31.75 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.704 175.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 87' ' ' LEU . . . . . 0.556 HD11 ' SD ' ' D' ' 13' ' ' MET . 4.5 mp -96.05 143.05 27.54 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 170.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.527 ' CD2' HG12 ' E' ' 53' ' ' VAL . 2.6 mm? -125.08 152.09 44.8 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 174.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.6 -167.91 30.8 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.365 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -139.13 131.49 28.45 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.496 0.665 . . . . 0.0 110.836 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . 0.744 HD23 ' HB3' ' D' ' 27' ' ' PHE . 23.7 mt . . . . . 0 C--N 1.318 -0.766 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.904 173.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 48.5 mtt . . . . . 0 C--O 1.224 -0.257 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' E' E ' 8' ' ' PHE . . . . . 0.529 ' CE1' HD21 ' A' ' 44' ' ' LEU . 70.7 t80 -69.36 146.35 52.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.163 0.506 . . . . 0.0 112.169 -175.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 9' ' ' TRP . . . . . 0.469 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 92.2 t90 -136.79 145.53 44.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.997 176.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.41 146.63 16.39 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.61 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 11' ' ' LEU . . . . . 0.521 HD23 HD13 ' E' ' 87' ' ' LEU . 43.8 tp -138.54 109.94 6.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.943 0.402 . . . . 0.0 110.55 177.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -97.37 105.05 17.13 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 176.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 13' ' ' MET . . . . . 0.548 ' SD ' HD11 ' E' ' 87' ' ' LEU . 44.6 mtp -98.4 143.95 28.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.993 0.425 . . . . 0.0 110.98 -174.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 14' ' ' LYS . . . . . 0.515 ' HB2' ' HG3' ' E' ' 17' ' ' ARG . 37.8 mtmm -101.07 157.8 32.97 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.334 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . 0.522 ' HB3' ' HA ' ' E' ' 82' ' ' ASP . 91.5 Cg_exo -47.88 115.35 1.43 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.588 2.859 . . . . 0.0 113.703 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 16' ' ' GLU . . . . . 0.663 ' HA ' ' O ' ' E' ' 79' ' ' THR . 44.4 mt-10 59.99 58.35 2.76 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.712 0.633 . . . . 0.0 111.728 175.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 17' ' ' ARG . . . . . 0.515 ' HG3' ' HB2' ' E' ' 14' ' ' LYS . 29.1 mmt180 -118.73 153.1 34.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.942 174.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . 0.697 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 3.5 ttmp? -130.88 110.83 11.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.032 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -111.38 112.55 24.38 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.895 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 4.5 p -75.13 114.67 13.9 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -92.93 114.06 26.52 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.353 -165.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 23.8 m -93.62 119.58 32.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.079 172.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 42.4 mt -96.85 112.96 30.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.131 0.491 . . . . 0.0 111.275 -173.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . 0.454 HD12 ' N ' ' E' ' 24' ' ' ILE . 4.2 mp -88.84 -34.79 7.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.329 177.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . 0.421 ' HD2' HD13 ' E' ' 91' ' ' LEU . 19.3 pttt -132.77 128.73 37.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.116 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -56.18 148.38 18.32 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.775 -177.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 27' ' ' PHE . . . . . 0.734 ' HB3' HD23 ' E' ' 91' ' ' LEU . 38.8 p90 -157.99 162.94 38.21 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.691 0.757 . . . . 0.0 112.916 -178.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 28' ' ' HIS . . . . . 0.544 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 2.0 t60 -119.16 123.9 45.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.341 -1.299 . . . . 0.0 109.427 176.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 29' ' ' ILE . . . . . 0.576 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 51.2 mt -85.32 134.65 26.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 170.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . 0.558 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 61.9 p -117.44 -15.14 10.32 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -171.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 31' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -171.34 152.08 17.11 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 119.498 -1.335 . . . . 0.0 113.33 177.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.486 HG23 ' HG ' ' E' ' 87' ' ' LEU . 11.3 p -136.63 131.54 47.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 174.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.93 155.96 42.16 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.068 -0.395 . . . . 0.0 111.174 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 34' ' ' LEU . . . . . 0.493 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.1 pp -117.98 141.37 48.52 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.886 0.85 . . . . 0.0 111.93 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -110.22 -54.16 2.6 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.177 -1.374 . . . . 0.0 108.801 176.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -100.85 128.12 47.02 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 171.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . 0.551 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 139.19 161.5 8.75 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 119.586 -1.293 . . . . 0.0 113.333 176.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -103.24 -43.82 5.35 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 178.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -149.52 132.36 16.05 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.572 0.225 . . . . 0.0 111.023 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . 0.454 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -131.79 113.71 13.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.345 0.593 . . . . 0.0 110.152 169.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 41' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' E' ' 79' ' ' THR . 97.4 mttt -96.32 110.62 22.91 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.404 ' HG ' ' CG2' ' E' ' 53' ' ' VAL . 51.1 tp -87.02 109.76 19.61 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.018 -172.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 43' ' ' TYR . . . . . 0.436 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 96.8 m-85 -108.31 141.85 39.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.268 178.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 44' ' ' LEU . . . . . 0.564 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 1.5 tp -123.62 112.84 17.9 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.388 176.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 45' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -99.19 108.9 21.6 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.209 0.528 . . . . 0.0 109.78 176.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . 0.479 ' CB ' HG22 ' E' ' 75' ' ' ILE . . . -139.69 140.98 36.98 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.504 -177.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 53.25 41.95 32.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.604 0.716 . . . . 0.0 110.271 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 39.1 mttp 69.84 21.54 6.33 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.399 172.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 49' ' ' GLN . . . . . 0.586 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 79.2 mm-40 -128.45 137.44 51.82 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 122.245 -0.285 . . . . 0.0 111.066 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -87.27 105.02 16.95 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 174.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . 0.442 ' CZ ' ' HB2' ' E' ' 49' ' ' GLN . 75.9 m-85 -99.99 120.26 39.54 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.681 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -77.42 99.97 2.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 171.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . 0.527 HG12 ' CD2' ' D' ' 88' ' ' LEU . 18.3 m -87.06 -34.53 7.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.789 -172.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 54' ' ' ALA . . . . . 0.562 ' HB2' ' CD2' ' E' ' 65' ' ' LEU . . . -151.07 140.86 21.84 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 120.352 -0.539 . . . . 0.0 112.104 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 21.7 m -111.51 101.22 9.66 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 169.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.19 113.67 43.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.757 0.789 . . . . 0.0 110.062 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 77.8 p -123.15 -177.74 3.77 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.236 -175.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -64.17 -24.18 67.58 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.478 169.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.38 -40.58 43.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.25 0.548 . . . . 0.0 110.114 176.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 79.6 mt -116.88 81.95 12.67 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 173.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.99 -5.13 12.76 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.174 2.583 . . . . 0.0 114.088 -167.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -160.48 128.69 4.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.231 0.539 . . . . 0.0 111.238 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 89.2 t -118.5 108.19 23.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.456 175.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.69 121.44 30.13 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 174.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 65' ' ' LEU . . . . . 0.562 ' CD2' ' HB2' ' E' ' 54' ' ' ALA . 0.4 OUTLIER -143.66 168.84 18.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.207 0.527 . . . . 0.0 111.951 -174.47 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' E' E ' 66' ' ' ASP . . . . . 0.565 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 9.3 t0 -116.32 107.16 14.48 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.772 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 67' ' ' LEU . . . . . 0.576 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 33.1 mt -126.49 107.71 10.5 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 177.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -111.07 127.91 55.7 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.907 -178.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -127.15 150.39 49.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.87 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 58.0 m -102.63 161.75 13.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.043 0.449 . . . . 0.0 110.795 176.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -69.29 -5.09 20.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.219 177.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.86 -7.55 62.67 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 173.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -100.32 143.45 30.5 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 178.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -122.95 125.72 45.84 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 174.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 75' ' ' ILE . . . . . 0.492 ' HB ' ' CD1' ' E' ' 44' ' ' LEU . 15.1 pt -132.03 172.2 16.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.666 -171.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 76' ' ' MET . . . . . . . . . . . . . 7.9 mtm -130.12 131.66 45.8 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 170.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 77' ' ' PHE . . . . . 0.564 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.9 OUTLIER -110.21 128.36 55.45 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 177.292 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' E' E ' 78' ' ' TYR . . . . . 0.697 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 40.9 p90 -153.64 140.41 19.05 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.287 -0.565 . . . . 0.0 112.112 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 79' ' ' THR . . . . . 0.663 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 8.3 p -111.88 136.36 51.28 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.28 -177.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.55 161.03 14.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.258 174.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 81' ' ' GLY . . . . . 0.483 ' O ' ' HG3' ' E' ' 16' ' ' GLU . . . 81.99 177.2 51.7 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -173.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 82' ' ' ASP . . . . . 0.522 ' HA ' ' HB3' ' E' ' 15' ' ' PRO . 6.9 p-10 -112.88 104.21 12.2 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 118.276 -1.37 . . . . 0.0 110.903 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 83' ' ' ALA . . . . . 0.551 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -164.84 153.22 12.17 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 113.708 -1.587 . . . . 0.0 109.836 169.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 6.6 p -104.93 123.48 47.83 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 85' ' ' VAL . . . . . 0.493 HG12 ' HB3' ' E' ' 34' ' ' LEU . 3.6 m -118.2 144.43 26.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -173.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 50.8 m -108.05 116.25 31.61 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.701 175.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 87' ' ' LEU . . . . . 0.548 HD11 ' SD ' ' E' ' 13' ' ' MET . 4.5 mp -96.1 143.12 27.51 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 170.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . 0.52 ' CD2' HG12 ' A' ' 53' ' ' VAL . 2.6 mm? -125.03 152.07 44.74 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 174.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.6 -167.86 30.73 Favored Glycine 0 N--CA 1.435 -1.377 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.409 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 90' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -139.19 131.46 28.32 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.565 0.698 . . . . 0.0 110.803 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 91' ' ' LEU . . . . . 0.734 HD23 ' HB3' ' E' ' 27' ' ' PHE . 23.7 mt . . . . . 0 C--N 1.32 -0.717 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.903 173.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.551 ' HA ' ' OG ' ' B' ' 70' ' ' SER . 45.5 mtt . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 121.559 0.695 . . . . 0.0 112.621 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.501 ' CE1' HD21 ' B' ' 44' ' ' LEU . 55.8 t80 -59.71 142.71 52.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.262 -176.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.546 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 88.5 t90 -134.14 142.05 47.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.735 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.91 140.05 8.38 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.143 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.673 HD23 HD13 ' A' ' 87' ' ' LEU . 56.6 tp -128.36 108.29 10.45 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.974 0.416 . . . . 0.0 110.048 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -86.46 101.38 13.1 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 175.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.592 ' HB3' HG23 ' A' ' 85' ' ' VAL . 27.3 tpp -91.95 129.27 37.95 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.39 -171.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.489 ' HD2' ' N ' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -95.54 140.74 22.48 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.799 179.405 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.617 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 9.5 Cg_endo -53.63 121.73 10.04 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.624 2.882 . . . . 0.0 113.474 -175.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' A' ' 79' ' ' THR . 31.3 mt-10 61.53 47.0 6.9 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.911 177.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.52 ' HA ' ' NE ' ' A' ' 17' ' ' ARG . 1.2 tpm_? -122.33 137.39 54.87 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 173.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.661 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 88.4 mttt -108.81 121.47 45.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.685 0.279 . . . . 0.0 111.684 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -111.06 103.57 12.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.303 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 76' ' ' MET . 45.7 t -90.47 99.42 12.45 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 172.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -120.12 148.12 44.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.146 -168.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.5 m -93.44 141.27 28.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.49 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.412 ' HB ' ' HA ' ' A' ' 71' ' ' LYS . 67.9 mt -89.89 117.01 32.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 120.92 0.39 . . . . 0.0 111.243 -173.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.526 HD12 ' N ' ' A' ' 25' ' ' LYS . 1.4 pp -79.63 -27.57 12.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.735 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.526 ' N ' HD12 ' A' ' 24' ' ' ILE . 31.7 ttpt -155.28 136.17 13.66 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -178.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 39.2 m -58.32 130.03 44.82 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.659 0.599 . . . . 0.0 110.091 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.624 ' HB3' HD23 ' A' ' 91' ' ' LEU . 10.1 p90 -144.26 161.92 37.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.611 0.719 . . . . 0.0 112.886 -172.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.598 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 15.7 t60 -114.82 123.87 50.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.187 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 37.6 mt -92.6 136.28 25.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 170.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.589 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 64.8 p -123.08 -20.19 5.82 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -170.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -154.85 146.3 14.17 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 119.324 -1.417 . . . . 0.0 113.336 178.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.487 HG23 ' HG ' ' A' ' 87' ' ' LEU . 14.3 p -140.01 126.81 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 170.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.417 ' HA ' HG21 ' A' ' 56' ' ' VAL . . . -148.81 158.11 43.92 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.903 -0.498 . . . . 0.0 111.576 -174.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.586 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.0 pp -118.9 139.21 52.01 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.587 0.708 . . . . 0.0 111.456 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -108.13 -51.33 2.91 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.298 173.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -102.52 128.12 49.3 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 170.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.505 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 145.08 162.39 9.55 Favored Glycine 0 N--CA 1.437 -1.263 0 C-N-CA 119.949 -1.12 . . . . 0.0 113.098 176.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -102.7 -46.81 4.61 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 111.487 0.18 . . . . 0.0 111.487 177.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -150.68 130.88 13.57 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.73 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.473 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -130.83 113.0 13.53 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.585 0.707 . . . . 0.0 110.186 169.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 79' ' ' THR . 4.5 mptp? -95.34 106.38 18.43 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 174.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.518 HD23 ' HB ' ' A' ' 53' ' ' VAL . 41.6 tp -78.8 114.01 17.37 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -176.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -114.82 135.88 53.7 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.283 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.602 ' HB3' HG22 ' A' ' 53' ' ' VAL . 5.0 tp -115.77 116.15 27.54 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.498 176.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -103.38 103.73 13.76 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 176.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.441 ' HB2' HD11 ' A' ' 44' ' ' LEU . . . -130.53 140.85 50.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.105 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 58.0 32.44 21.97 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.71 0.767 . . . . 0.0 109.445 -175.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 57.44 37.11 27.72 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.466 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 6.6 tp-100 -127.75 131.77 49.63 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 176.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -87.35 112.27 21.93 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.427 -177.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -108.4 131.37 54.84 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.793 177.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -78.78 100.42 3.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 169.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.602 HG22 ' HB3' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -72.4 -51.49 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.877 -174.151 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.512 ' HA ' ' OE1' ' E' ' 62' ' ' GLN . . . -154.57 132.47 11.57 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.516 -177.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.3 t -101.95 102.46 13.01 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 174.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 40' ' ' ALA . 7.1 p -116.67 109.7 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-O 122.128 0.966 . . . . 0.0 110.047 -176.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 66.9 p -122.55 -176.95 3.5 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.378 -176.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -65.07 -20.61 66.57 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 119.976 -0.689 . . . . 0.0 110.574 169.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.95 -40.68 27.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.246 0.546 . . . . 0.0 110.047 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.4 mt -118.68 77.65 14.7 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 172.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 57' ' ' THR . 9.8 Cg_exo -71.73 0.84 6.43 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.11 2.54 . . . . 0.0 113.636 -168.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.492 ' OE1' ' HA ' ' B' ' 54' ' ' ALA . 10.3 tt0 -160.06 114.7 2.28 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.237 -170.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.495 HG11 ' HB1' ' A' ' 54' ' ' ALA . 86.5 t -112.8 115.16 49.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.061 0.458 . . . . 0.0 111.247 177.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.04 116.0 28.38 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 171.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.426 HD23 ' H ' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -134.64 168.3 19.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.817 0.341 . . . . 0.0 111.036 -171.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.551 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 7.4 t0 -122.91 109.43 14.14 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.139 0.495 . . . . 0.0 110.36 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.683 HD21 HD23 ' E' ' 88' ' ' LEU . 12.8 mt -124.05 138.84 54.39 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.683 177.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -138.43 114.61 10.22 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 173.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -109.17 163.07 13.68 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.385 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.535 ' OG ' ' HA ' ' E' ' 7' ' ' MET . 4.5 m -117.22 149.03 41.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.154 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.412 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -70.04 -5.9 29.86 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.736 -177.103 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.87 -28.54 45.84 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.319 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -101.3 171.25 7.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.702 0.287 . . . . 0.0 110.43 -176.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -137.3 136.5 38.06 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.467 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 22.6 pt -133.07 158.4 43.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.081 0.467 . . . . 0.0 111.571 -169.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.418 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 65.3 ttp -117.52 118.09 31.21 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.342 176.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.467 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -105.53 129.37 53.82 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.806 -177.773 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.661 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 39.0 p90 -155.74 162.79 40.47 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.847 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 12.6 p -125.21 143.86 50.74 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.108 178.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.3 149.48 26.87 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.231 173.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.0 -176.92 36.47 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -176.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -114.48 102.64 10.27 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.238 178.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.617 ' H ' ' HB3' ' A' ' 15' ' ' PRO . . . -166.74 150.05 6.85 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.479 168.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.2 p -106.04 122.11 45.5 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.592 HG23 ' HB3' ' A' ' 13' ' ' MET . 13.5 m -121.54 144.23 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-O 121.241 0.543 . . . . 0.0 111.801 -172.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 43.3 m -105.21 122.85 46.77 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.276 175.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.673 HD13 HD23 ' A' ' 11' ' ' LEU . 5.1 mp -95.22 143.93 26.23 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 170.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.695 HD23 HD21 ' B' ' 67' ' ' LEU . 0.9 OUTLIER -130.39 141.23 50.56 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.152 -178.718 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.66 -166.89 27.5 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.953 -0.642 . . . . 0.0 111.795 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -147.06 133.49 19.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.474 0.654 . . . . 0.0 111.161 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.624 HD23 ' HB3' ' A' ' 27' ' ' PHE . 15.1 mt . . . . . 0 C--N 1.322 -0.623 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.106 175.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . 0.568 ' HA ' ' OG ' ' C' ' 70' ' ' SER . 45.5 mtt . . . . . 0 CA--C 1.518 -0.282 0 CA-C-O 121.533 0.682 . . . . 0.0 112.727 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . 0.507 ' CE1' HD21 ' C' ' 44' ' ' LEU . 55.5 t80 -59.76 142.74 52.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.247 -176.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . 0.541 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 88.6 t90 -134.14 142.01 47.32 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.75 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.87 140.06 8.39 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.253 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.681 HD23 HD13 ' B' ' 87' ' ' LEU . 56.8 tp -128.36 108.35 10.5 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.972 0.415 . . . . 0.0 110.079 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -86.46 101.29 13.03 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 175.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' MET . . . . . 0.585 ' HB3' HG23 ' B' ' 85' ' ' VAL . 27.4 tpp -91.95 129.37 37.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.349 -171.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.492 ' N ' ' HD2' ' B' ' 14' ' ' LYS . 0.3 OUTLIER -95.69 140.83 22.5 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.757 179.362 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.62 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 9.4 Cg_endo -53.62 121.71 10.0 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 123.656 2.904 . . . . 0.0 113.425 -175.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' B' ' 79' ' ' THR . 31.2 mt-10 61.58 47.04 6.8 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.835 177.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.515 ' NE ' ' HA ' ' B' ' 17' ' ' ARG . 1.1 tpm_? -122.36 137.3 54.9 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 173.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.657 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 88.5 mttt -108.84 121.57 45.37 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -111.2 103.56 11.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.233 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 45.0 t -90.4 99.47 12.48 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -120.2 148.17 44.01 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.55 0.69 . . . . 0.0 112.152 -168.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 19.7 m -93.49 141.27 28.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.436 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -89.93 117.07 32.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.085 0.469 . . . . 0.0 111.214 -173.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.523 HD12 ' N ' ' B' ' 25' ' ' LYS . 1.4 pp -79.63 -27.58 12.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.709 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.523 ' N ' HD12 ' B' ' 24' ' ' ILE . 31.7 ttpt -155.3 136.1 13.59 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 38.9 m -58.23 130.03 44.75 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.725 0.641 . . . . 0.0 110.096 -178.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . 0.616 ' HB3' HD23 ' B' ' 91' ' ' LEU . 10.0 p90 -144.25 161.86 37.83 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -172.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' HIS . . . . . 0.595 ' HA ' ' O ' ' B' ' 67' ' ' LEU . 16.1 t60 -114.74 123.9 50.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.194 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 37.8 mt -92.66 136.17 25.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 170.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.587 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 65.1 p -122.91 -20.28 5.87 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -170.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -154.82 146.19 13.97 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 119.508 -1.329 . . . . 0.0 113.416 179.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.483 HG23 ' HG ' ' B' ' 87' ' ' LEU . 14.4 p -139.99 126.71 23.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 170.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . 0.415 ' HA ' HG21 ' B' ' 56' ' ' VAL . . . -148.79 158.15 43.95 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.925 -0.484 . . . . 0.0 111.669 -174.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.591 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.0 pp -118.91 139.26 51.93 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.719 0.771 . . . . 0.0 111.356 178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -108.21 -51.29 2.92 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.355 173.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -102.46 128.15 49.19 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 170.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.507 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 145.01 162.43 9.56 Favored Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 119.906 -1.14 . . . . 0.0 113.01 176.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -102.73 -46.67 4.65 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 177.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -150.77 130.81 13.43 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.754 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.481 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -130.78 113.06 13.64 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.55 0.691 . . . . 0.0 110.165 169.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' B' ' 79' ' ' THR . 4.5 mptp? -95.42 106.33 18.38 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 174.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.519 HD23 ' HB ' ' B' ' 53' ' ' VAL . 41.4 tp -78.67 113.92 17.14 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -176.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -114.78 135.89 53.68 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.247 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.587 ' HB3' HG22 ' B' ' 53' ' ' VAL . 4.9 tp -115.85 116.18 27.55 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.509 176.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -103.31 103.71 13.75 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 176.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.447 ' HB2' HD11 ' B' ' 44' ' ' LEU . . . -130.61 140.79 50.43 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.125 -178.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 58.19 32.29 21.85 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.543 0.687 . . . . 0.0 109.34 -175.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 62.4 mttp 57.54 37.0 27.49 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.508 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . 0.515 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 6.6 tp-100 -127.67 131.8 49.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.588 176.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -87.47 112.32 22.07 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.828 0.346 . . . . 0.0 110.389 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -108.48 131.37 54.87 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.763 177.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -78.82 100.41 3.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 169.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.587 HG22 ' HB3' ' B' ' 44' ' ' LEU . 0.9 OUTLIER -72.3 -51.53 29.11 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.011 -174.205 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.492 ' HA ' ' OE1' ' A' ' 62' ' ' GLN . . . -154.48 132.53 11.69 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.547 -177.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 7.5 t -101.97 102.43 12.96 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 174.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . 0.425 HG13 ' HB3' ' B' ' 40' ' ' ALA . 7.1 p -116.63 109.79 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-O 122.062 0.934 . . . . 0.0 109.964 -176.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' B' ' 61' ' ' PRO . 67.1 p -122.63 -176.94 3.51 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.352 -176.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -65.06 -20.63 66.57 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.551 169.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.86 -40.82 27.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.267 0.556 . . . . 0.0 110.02 176.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 74.2 mt -118.7 77.6 14.73 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 172.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' B' ' 57' ' ' THR . 9.7 Cg_exo -71.71 0.88 6.35 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.083 2.522 . . . . 0.0 113.721 -168.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . 0.507 ' OE1' ' HA ' ' C' ' 54' ' ' ALA . 10.3 tt0 -160.12 114.72 2.27 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.256 -170.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.487 HG11 ' HB1' ' B' ' 54' ' ' ALA . 86.0 t -112.75 115.17 49.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.108 0.48 . . . . 0.0 111.259 177.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.05 115.92 28.29 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 171.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.437 ' H ' HD23 ' B' ' 65' ' ' LEU . 0.7 OUTLIER -134.56 168.26 19.29 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.06 -171.67 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . 0.547 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 7.4 t0 -122.89 109.46 14.18 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.111 0.481 . . . . 0.0 110.365 -179.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.695 HD21 HD23 ' A' ' 88' ' ' LEU . 12.7 mt -124.02 138.91 54.39 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.67 177.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -138.64 114.65 10.12 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 173.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -109.23 162.99 13.77 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.395 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.551 ' OG ' ' HA ' ' A' ' 7' ' ' MET . 4.4 m -117.12 149.01 41.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.22 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -6.15 31.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.71 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.81 -28.38 46.7 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.365 177.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -101.24 171.32 7.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.764 0.316 . . . . 0.0 110.44 -176.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -137.37 136.47 37.93 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.458 ' HB ' ' CD1' ' B' ' 44' ' ' LEU . 22.3 pt -133.03 158.39 43.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.912 0.387 . . . . 0.0 111.668 -169.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.434 ' HA ' ' HA ' ' B' ' 20' ' ' SER . 65.3 ttp -117.47 118.21 31.56 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.056 0.455 . . . . 0.0 110.319 176.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.4 OUTLIER -105.63 129.39 53.88 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.788 -177.807 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.657 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 39.0 p90 -155.79 162.72 40.44 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.871 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 12.5 p -125.26 143.89 50.73 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.094 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.45 149.61 26.88 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.088 173.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.87 -176.95 36.69 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -176.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -114.38 102.67 10.31 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 117.988 0.894 . . . . 0.0 110.289 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.62 ' H ' ' HB3' ' B' ' 15' ' ' PRO . . . -166.72 150.04 6.88 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.465 168.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 6.1 p -106.05 122.17 45.62 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.591 HG12 ' HB3' ' B' ' 34' ' ' LEU . 13.4 m -121.59 144.26 31.33 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 121.241 0.544 . . . . 0.0 111.771 -172.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 44.0 m -105.25 122.88 46.86 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.24 175.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.681 HD13 HD23 ' B' ' 11' ' ' LEU . 5.1 mp -95.16 143.95 26.17 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.695 HD23 HD21 ' C' ' 67' ' ' LEU . 0.9 OUTLIER -130.44 141.23 50.53 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.17 -178.712 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.68 -166.93 27.59 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.752 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -147.0 133.54 19.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.428 0.633 . . . . 0.0 111.029 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . 0.616 HD23 ' HB3' ' B' ' 27' ' ' PHE . 15.1 mt . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.083 175.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 7' ' ' MET . . . . . 0.577 ' HA ' ' OG ' ' D' ' 70' ' ' SER . 45.3 mtt . . . . . 0 N--CA 1.454 -0.239 0 CA-C-O 121.522 0.677 . . . . 0.0 112.657 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 8' ' ' PHE . . . . . 0.492 ' CE1' HD21 ' D' ' 44' ' ' LEU . 55.5 t80 -59.78 142.66 52.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.401 -1.272 . . . . 0.0 112.203 -176.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . 0.533 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 88.4 t90 -134.08 142.08 47.41 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.766 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.84 140.07 8.41 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.148 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.67 HD23 HD13 ' C' ' 87' ' ' LEU . 56.3 tp -128.33 108.24 10.42 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.893 0.378 . . . . 0.0 110.153 178.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -86.27 101.25 12.89 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 175.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 13' ' ' MET . . . . . 0.587 ' HB3' HG23 ' C' ' 85' ' ' VAL . 27.2 tpp -91.99 129.42 37.95 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.362 -171.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . 0.482 ' HD2' ' N ' ' C' ' 14' ' ' LYS . 0.3 OUTLIER -95.68 140.74 22.46 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.833 179.385 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . 0.618 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 9.5 Cg_endo -53.59 121.73 10.03 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.606 2.871 . . . . 0.0 113.51 -175.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . 0.659 ' HA ' ' O ' ' C' ' 79' ' ' THR . 31.5 mt-10 61.56 47.04 6.84 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.838 177.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 17' ' ' ARG . . . . . 0.518 ' NE ' ' HA ' ' C' ' 17' ' ' ARG . 1.2 tpm_? -122.33 137.33 54.89 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 173.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 18' ' ' LYS . . . . . 0.657 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 88.4 mttt -108.85 121.51 45.24 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -111.07 103.71 12.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.252 176.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 45.2 t -90.59 99.52 12.53 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 172.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -120.23 148.14 44.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.125 -168.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 19.5 m -93.42 141.2 28.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.538 176.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 67.7 mt -89.84 117.06 32.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.974 0.416 . . . . 0.0 111.295 -173.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . 0.519 HD12 ' N ' ' C' ' 25' ' ' LYS . 1.4 pp -79.68 -27.5 12.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.703 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . 0.519 ' N ' HD12 ' C' ' 24' ' ' ILE . 31.7 ttpt -155.41 136.18 13.54 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 39.4 m -58.33 130.08 45.05 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.715 0.634 . . . . 0.0 110.085 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 27' ' ' PHE . . . . . 0.635 ' HB3' HD23 ' C' ' 91' ' ' LEU . 9.9 p90 -144.27 161.89 37.79 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.654 0.74 . . . . 0.0 112.905 -172.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 28' ' ' HIS . . . . . 0.606 ' HA ' ' O ' ' C' ' 67' ' ' LEU . 15.9 t60 -114.75 123.9 50.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.203 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . 0.56 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 38.0 mt -92.66 136.21 25.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 170.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.578 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 65.2 p -122.98 -20.25 5.84 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -170.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 31' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -154.74 146.21 14.04 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.403 -1.379 . . . . 0.0 113.395 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.49 HG23 ' HG ' ' C' ' 87' ' ' LEU . 14.4 p -140.08 126.73 22.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 170.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.412 ' HA ' HG21 ' C' ' 56' ' ' VAL . . . -148.73 158.21 43.99 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.617 -174.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.6 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.0 pp -118.99 139.21 52.07 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.739 0.781 . . . . 0.0 111.339 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -108.14 -51.28 2.92 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.572 -1.194 . . . . 0.0 108.382 173.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -102.42 128.03 49.2 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 170.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 37' ' ' GLY . . . . . 0.505 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 145.09 162.42 9.56 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.056 176.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -102.7 -46.73 4.63 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 177.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -150.73 130.81 13.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.809 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.495 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -130.81 113.02 13.56 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.53 0.681 . . . . 0.0 110.172 169.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' C' ' 79' ' ' THR . 4.5 mptp? -95.36 106.33 18.37 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 174.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.506 HD23 ' HB ' ' C' ' 53' ' ' VAL . 41.7 tp -78.69 113.97 17.21 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -176.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -114.86 135.88 53.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.244 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.61 ' HB3' HG22 ' C' ' 53' ' ' VAL . 4.9 tp -115.73 116.05 27.4 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.56 176.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -103.27 103.76 13.82 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 176.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.452 ' HB2' HD11 ' C' ' 44' ' ' LEU . . . -130.58 140.85 50.45 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.108 -178.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 58.05 32.4 21.93 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.611 0.719 . . . . 0.0 109.416 -175.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 62.4 mttp 57.38 37.11 27.84 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.523 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . 0.51 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 6.6 tp-100 -127.73 131.72 49.67 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.558 176.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -87.39 112.31 22.0 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.791 0.329 . . . . 0.0 110.401 -177.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -108.39 131.3 54.9 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.775 177.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -78.76 100.47 3.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 169.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 53' ' ' VAL . . . . . 0.61 HG22 ' HB3' ' C' ' 44' ' ' LEU . 0.9 OUTLIER -72.45 -51.46 28.85 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.955 -174.211 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 54' ' ' ALA . . . . . 0.507 ' HA ' ' OE1' ' B' ' 62' ' ' GLN . . . -154.5 132.5 11.65 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.597 -177.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 7.4 t -102.0 102.46 12.98 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 174.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . 0.412 HG21 ' HA ' ' C' ' 33' ' ' ALA . 7.1 p -116.61 109.74 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-O 122.005 0.907 . . . . 0.0 110.057 -176.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 57' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' C' ' 61' ' ' PRO . 66.9 p -122.62 -177.09 3.54 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.379 -176.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -64.95 -20.73 66.62 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.578 169.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.76 -40.82 27.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.247 0.546 . . . . 0.0 110.084 176.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 74.0 mt -118.7 77.64 14.77 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 172.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 61' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' C' ' 57' ' ' THR . 9.7 Cg_exo -71.74 0.86 6.39 Favored 'Trans proline' 0 N--CA 1.473 0.308 0 C-N-CA 123.099 2.532 . . . . 0.0 113.618 -168.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . 0.58 ' OE1' ' HA ' ' D' ' 54' ' ' ALA . 10.3 tt0 -160.13 114.73 2.27 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.733 0.301 . . . . 0.0 111.307 -170.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.494 HG11 ' HB1' ' C' ' 54' ' ' ALA . 85.9 t -112.79 115.16 49.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.13 0.49 . . . . 0.0 111.264 177.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.0 115.97 28.36 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 171.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . 0.443 HD23 ' H ' ' C' ' 65' ' ' LEU . 0.7 OUTLIER -134.53 168.35 19.12 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.138 -171.726 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 66' ' ' ASP . . . . . 0.493 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 7.4 t0 -122.95 109.37 14.05 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.077 0.465 . . . . 0.0 110.278 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.695 HD21 HD23 ' B' ' 88' ' ' LEU . 12.8 mt -124.03 138.79 54.4 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.696 176.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -138.45 114.57 10.17 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 172.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -109.12 163.0 13.72 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.348 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . 0.568 ' OG ' ' HA ' ' B' ' 7' ' ' MET . 4.5 m -117.16 149.03 41.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.161 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.97 -6.04 30.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.737 -177.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.88 -28.44 46.16 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.269 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -101.2 171.32 7.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.603 0.239 . . . . 0.0 110.491 -176.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -137.35 136.54 38.02 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.457 ' HB ' ' CD1' ' C' ' 44' ' ' LEU . 22.6 pt -133.06 158.39 43.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.022 0.439 . . . . 0.0 111.647 -169.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' C' ' 20' ' ' SER . 65.4 ttp -117.46 118.08 31.22 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.279 176.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 77' ' ' PHE . . . . . 0.479 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.4 OUTLIER -105.62 129.34 53.88 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.791 -177.833 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 78' ' ' TYR . . . . . 0.657 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 38.9 p90 -155.73 162.72 40.48 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.839 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . 0.659 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 12.6 p -125.12 143.88 50.71 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.143 178.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.43 149.63 26.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.072 173.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.88 -176.87 36.6 Favored Glycine 0 CA--C 1.508 -0.346 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -176.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -114.5 102.63 10.25 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.24 178.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . 0.618 ' H ' ' HB3' ' C' ' 15' ' ' PRO . . . -166.69 150.06 6.93 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.508 167.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 6.3 p -106.01 122.2 45.67 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.6 HG12 ' HB3' ' C' ' 34' ' ' LEU . 13.5 m -121.62 144.2 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-O 121.223 0.535 . . . . 0.0 111.769 -172.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 43.6 m -105.23 122.87 46.82 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.28 175.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . 0.67 HD13 HD23 ' C' ' 11' ' ' LEU . 5.1 mp -95.15 144.03 26.11 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 170.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . 0.693 HD23 HD21 ' D' ' 67' ' ' LEU . 0.9 OUTLIER -130.5 141.21 50.5 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.161 -178.685 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.67 -166.93 27.57 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.744 -177.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -146.95 133.57 19.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.384 0.612 . . . . 0.0 111.095 177.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . 0.635 HD23 ' HB3' ' C' ' 27' ' ' PHE . 15.1 mt . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.07 175.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 7' ' ' MET . . . . . 0.559 ' HA ' ' OG ' ' E' ' 70' ' ' SER . 45.2 mtt . . . . . 0 CA--C 1.518 -0.26 0 CA-C-O 121.566 0.698 . . . . 0.0 112.674 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 8' ' ' PHE . . . . . 0.513 ' CE1' HD21 ' E' ' 44' ' ' LEU . 55.8 t80 -59.64 142.74 52.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.341 -1.299 . . . . 0.0 112.24 -176.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 9' ' ' TRP . . . . . 0.539 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 88.4 t90 -134.27 142.08 47.19 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.9 140.08 8.4 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.188 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . 0.677 HD23 HD13 ' D' ' 87' ' ' LEU . 56.8 tp -128.3 108.23 10.42 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.899 0.381 . . . . 0.0 110.077 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -86.49 101.41 13.15 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 13' ' ' MET . . . . . 0.59 ' HB3' HG23 ' D' ' 85' ' ' VAL . 27.4 tpp -92.0 129.36 37.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.377 -171.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 14' ' ' LYS . . . . . 0.481 ' HD2' ' N ' ' D' ' 14' ' ' LYS . 0.3 OUTLIER -95.69 140.69 22.44 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.806 179.418 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . 0.619 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 9.5 Cg_endo -53.57 121.81 10.17 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 123.609 2.873 . . . . 0.0 113.411 -175.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . 0.644 ' HA ' ' O ' ' D' ' 79' ' ' THR . 31.4 mt-10 61.44 47.01 7.06 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.956 177.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 17' ' ' ARG . . . . . 0.519 ' HA ' ' NE ' ' D' ' 17' ' ' ARG . 1.1 tpm_? -122.29 137.28 54.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.056 173.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . 0.667 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 88.4 mttt -108.77 121.48 45.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.723 0.297 . . . . 0.0 111.695 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -111.14 103.65 12.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.283 176.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 44.9 t -90.48 99.49 12.51 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 172.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -120.25 148.21 43.99 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.105 -168.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 19.3 m -93.48 141.24 28.69 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.478 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . 0.408 ' HB ' ' HA ' ' D' ' 71' ' ' LYS . 67.9 mt -89.93 117.04 32.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.082 0.468 . . . . 0.0 111.227 -173.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . 0.523 HD12 ' N ' ' D' ' 25' ' ' LYS . 1.4 pp -79.55 -27.61 12.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.782 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . 0.531 ' HE3' ' HB3' ' D' ' 91' ' ' LEU . 31.7 ttpt -155.31 136.18 13.64 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 39.3 m -58.31 130.06 44.93 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.68 0.613 . . . . 0.0 110.134 -178.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 27' ' ' PHE . . . . . 0.623 ' HB3' HD23 ' D' ' 91' ' ' LEU . 9.9 p90 -144.28 161.86 37.86 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -172.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 28' ' ' HIS . . . . . 0.595 ' HA ' ' O ' ' D' ' 67' ' ' LEU . 16.0 t60 -114.74 123.92 50.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.173 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 29' ' ' ILE . . . . . 0.569 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 37.7 mt -92.7 136.18 25.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 170.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . 0.594 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 65.9 p -122.96 -20.23 5.86 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -170.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 31' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -154.78 146.22 14.04 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 119.425 -1.369 . . . . 0.0 113.409 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.504 HG23 ' HG ' ' D' ' 87' ' ' LEU . 14.2 p -139.95 126.8 23.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 170.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . 0.404 ' HA ' HG21 ' D' ' 56' ' ' VAL . . . -148.87 158.14 43.94 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.8 -0.562 . . . . 0.0 111.654 -174.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 34' ' ' LEU . . . . . 0.584 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.0 pp -118.89 139.24 51.96 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.682 0.753 . . . . 0.0 111.431 178.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -108.21 -51.25 2.92 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.333 173.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -102.36 128.02 49.12 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 170.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . 0.496 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 145.1 162.41 9.56 Favored Glycine 0 N--CA 1.438 -1.167 0 C-N-CA 119.867 -1.159 . . . . 0.0 113.065 176.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -102.73 -46.66 4.65 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.609 0.242 . . . . 0.0 111.581 177.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -150.72 130.82 13.49 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.769 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . 0.479 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -130.79 113.0 13.56 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.492 0.663 . . . . 0.0 110.2 169.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' D' ' 79' ' ' THR . 4.5 mptp? -95.37 106.38 18.43 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 174.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.509 HD23 ' HB ' ' D' ' 53' ' ' VAL . 41.9 tp -78.88 113.96 17.41 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -176.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -114.79 135.95 53.62 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.336 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.594 ' HB3' HG22 ' D' ' 53' ' ' VAL . 4.9 tp -115.82 116.07 27.37 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.444 176.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 45' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -103.28 103.68 13.73 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.45 ' HB2' HD11 ' D' ' 44' ' ' LEU . . . -130.55 140.83 50.47 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.052 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 58.1 32.4 21.95 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.652 0.739 . . . . 0.0 109.365 -175.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 62.4 mttp 57.44 37.04 27.7 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 114.854 -1.067 . . . . 0.0 111.547 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . 0.515 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 6.6 tp-100 -127.69 131.78 49.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.573 176.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -87.42 112.35 22.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.383 -177.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -108.46 131.44 54.8 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.743 177.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -78.84 100.36 3.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 169.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 53' ' ' VAL . . . . . 0.594 HG22 ' HB3' ' D' ' 44' ' ' LEU . 0.9 OUTLIER -72.34 -51.49 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.988 -174.174 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 54' ' ' ALA . . . . . 0.58 ' HA ' ' OE1' ' C' ' 62' ' ' GLN . . . -154.46 132.38 11.6 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.538 -177.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 7.6 t -101.89 102.47 13.04 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 174.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 56' ' ' VAL . . . . . 0.432 HG13 ' HB3' ' D' ' 40' ' ' ALA . 7.1 p -116.69 109.76 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-O 122.039 0.923 . . . . 0.0 110.052 -176.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 57' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' D' ' 61' ' ' PRO . 67.3 p -122.64 -176.99 3.52 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.347 -176.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -65.03 -20.68 66.61 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.541 169.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.76 -40.84 27.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.265 0.555 . . . . 0.0 110.07 176.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 74.6 mt -118.73 77.64 14.87 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 172.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 61' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' D' ' 57' ' ' THR . 9.7 Cg_exo -71.7 0.88 6.35 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.159 2.573 . . . . 0.0 113.651 -168.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . 0.492 ' OE1' ' HA ' ' E' ' 54' ' ' ALA . 10.3 tt0 -160.09 114.77 2.28 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.274 -170.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.49 HG11 ' HB1' ' D' ' 54' ' ' ALA . 86.1 t -112.84 115.06 48.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.104 0.478 . . . . 0.0 111.236 177.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.87 115.92 28.34 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 171.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 65' ' ' LEU . . . . . 0.437 HD23 ' H ' ' D' ' 65' ' ' LEU . 0.7 OUTLIER -134.55 168.32 19.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.777 0.322 . . . . 0.0 111.092 -171.727 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 66' ' ' ASP . . . . . 0.545 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 7.5 t0 -122.91 109.39 14.09 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.127 0.489 . . . . 0.0 110.365 -178.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.693 HD21 HD23 ' C' ' 88' ' ' LEU . 12.8 mt -124.0 138.9 54.39 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.712 176.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -138.57 114.61 10.13 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 173.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -109.16 163.07 13.68 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.315 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 70' ' ' SER . . . . . 0.577 ' OG ' ' HA ' ' C' ' 7' ' ' MET . 4.4 m -117.21 149.06 41.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.186 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 71' ' ' LYS . . . . . 0.408 ' HA ' ' HB ' ' D' ' 23' ' ' ILE . 0.0 OUTLIER -70.05 -6.14 31.63 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.72 -177.104 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.68 -28.62 46.37 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.319 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -101.12 171.31 7.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.757 0.313 . . . . 0.0 110.449 -176.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -137.31 136.49 38.03 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 75' ' ' ILE . . . . . 0.462 ' HB ' ' CD1' ' D' ' 44' ' ' LEU . 22.6 pt -133.03 158.36 43.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.014 0.435 . . . . 0.0 111.642 -169.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 76' ' ' MET . . . . . 0.412 ' HA ' ' HA ' ' D' ' 20' ' ' SER . 65.4 ttp -117.43 118.08 31.24 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.372 176.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 77' ' ' PHE . . . . . 0.479 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.4 OUTLIER -105.57 129.42 53.83 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.789 -177.812 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 78' ' ' TYR . . . . . 0.667 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 39.0 p90 -155.76 162.78 40.45 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.881 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 79' ' ' THR . . . . . 0.644 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 12.6 p -125.22 143.87 50.74 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.116 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.35 149.61 26.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.097 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.87 -177.05 36.77 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -176.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -114.4 102.58 10.22 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.242 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . 0.619 ' H ' ' HB3' ' D' ' 15' ' ' PRO . . . -166.69 150.13 6.94 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.385 168.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 6.2 p -106.1 122.25 45.81 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.59 HG23 ' HB3' ' D' ' 13' ' ' MET . 13.4 m -121.65 144.19 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-O 121.203 0.525 . . . . 0.0 111.792 -172.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 43.6 m -105.1 122.79 46.63 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.322 175.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 87' ' ' LEU . . . . . 0.677 HD13 HD23 ' D' ' 11' ' ' LEU . 5.1 mp -95.22 143.97 26.2 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 170.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.684 HD23 HD21 ' E' ' 67' ' ' LEU . 0.9 OUTLIER -130.4 141.18 50.55 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.175 -178.686 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.58 -166.84 27.33 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.756 -177.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -147.05 133.51 19.69 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.437 0.637 . . . . 0.0 111.113 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . 0.623 HD23 ' HB3' ' D' ' 27' ' ' PHE . 15.1 mt . . . . . 0 C--N 1.322 -0.6 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.065 175.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 7' ' ' MET . . . . . 0.535 ' HA ' ' OG ' ' A' ' 70' ' ' SER . 45.2 mtt . . . . . 0 CA--C 1.519 -0.231 0 CA-C-O 121.653 0.739 . . . . 0.0 112.626 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 8' ' ' PHE . . . . . 0.469 ' CE1' HD21 ' A' ' 44' ' ' LEU . 55.6 t80 -59.64 142.7 52.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.291 -1.322 . . . . 0.0 112.293 -176.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 9' ' ' TRP . . . . . 0.528 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 88.6 t90 -134.21 142.04 47.25 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.84 140.06 8.4 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.162 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 11' ' ' LEU . . . . . 0.687 HD23 HD13 ' E' ' 87' ' ' LEU . 56.8 tp -128.36 108.32 10.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.966 0.412 . . . . 0.0 110.101 178.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -86.45 101.34 13.06 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 175.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 13' ' ' MET . . . . . 0.588 ' HB3' HG23 ' E' ' 85' ' ' VAL . 27.3 tpp -91.99 129.41 37.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.419 -171.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 14' ' ' LYS . . . . . 0.474 ' N ' ' HD2' ' E' ' 14' ' ' LYS . 0.3 OUTLIER -95.68 140.69 22.44 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.843 179.394 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . 0.603 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 9.5 Cg_endo -53.63 121.79 10.14 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 123.508 2.805 . . . . 0.0 113.514 -175.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 16' ' ' GLU . . . . . 0.648 ' HA ' ' O ' ' E' ' 79' ' ' THR . 31.3 mt-10 61.54 47.06 6.84 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.887 177.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 17' ' ' ARG . . . . . 0.52 ' HA ' ' NE ' ' E' ' 17' ' ' ARG . 1.2 tpm_? -122.41 137.34 54.9 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 173.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . 0.661 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 88.6 mttt -108.83 121.51 45.24 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -111.11 103.64 12.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.213 176.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 20' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' E' ' 76' ' ' MET . 44.5 t -90.46 99.39 12.43 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 172.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -120.22 148.11 44.09 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.523 0.678 . . . . 0.0 112.093 -168.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 19.8 m -93.46 141.22 28.7 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.469 176.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 67.8 mt -89.84 117.08 32.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.044 0.449 . . . . 0.0 111.284 -173.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . 0.522 HD12 ' N ' ' E' ' 25' ' ' LYS . 1.4 pp -79.67 -27.54 12.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.721 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . 0.522 ' N ' HD12 ' E' ' 24' ' ' ILE . 31.7 ttpt -155.37 136.14 13.55 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 39.6 m -58.3 130.09 45.07 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.654 0.596 . . . . 0.0 110.08 -178.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 27' ' ' PHE . . . . . 0.635 ' HB3' HD23 ' E' ' 91' ' ' LEU . 10.0 p90 -144.24 161.92 37.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -172.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 28' ' ' HIS . . . . . 0.603 ' HA ' ' O ' ' E' ' 67' ' ' LEU . 16.0 t60 -114.85 123.87 50.27 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.172 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 29' ' ' ILE . . . . . 0.575 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 38.1 mt -92.67 136.25 25.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 170.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . 0.58 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 65.5 p -122.94 -20.26 5.86 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -170.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 31' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -154.81 146.23 14.06 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 119.36 -1.4 . . . . 0.0 113.365 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.495 HG23 ' HG ' ' E' ' 87' ' ' LEU . 14.4 p -140.02 126.84 23.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 170.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . 0.417 ' HA ' HG21 ' E' ' 56' ' ' VAL . . . -148.84 158.17 43.97 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 121.861 -0.524 . . . . 0.0 111.649 -174.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 34' ' ' LEU . . . . . 0.592 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.0 pp -119.0 139.21 52.07 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.713 0.768 . . . . 0.0 111.445 178.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -108.06 -51.29 2.92 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.392 173.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -102.38 127.94 49.17 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 170.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . 0.506 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 145.17 162.49 9.62 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 119.916 -1.135 . . . . 0.0 113.04 176.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -102.8 -46.65 4.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.536 0.208 . . . . 0.0 111.539 177.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -150.75 130.84 13.48 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.712 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -130.8 113.06 13.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.555 0.693 . . . . 0.0 110.175 168.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 41' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' E' ' 79' ' ' THR . 4.5 mptp? -95.42 106.43 18.49 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 174.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.514 HD23 ' HB ' ' E' ' 53' ' ' VAL . 41.7 tp -78.82 114.04 17.41 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -176.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -114.93 135.93 53.67 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.24 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 44' ' ' LEU . . . . . 0.602 ' HB3' HG22 ' E' ' 53' ' ' VAL . 5.0 tp -115.75 116.01 27.32 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.575 176.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 45' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -103.27 103.68 13.73 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 176.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . 0.442 ' HB2' HD11 ' E' ' 44' ' ' LEU . . . -130.54 140.74 50.48 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.168 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 58.2 32.33 21.89 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.61 0.719 . . . . 0.0 109.368 -175.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 62.4 mttp 57.43 37.1 27.73 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.479 -178.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 49' ' ' GLN . . . . . 0.52 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 6.6 tp-100 -127.65 131.74 49.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.612 176.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -87.37 112.24 21.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.43 -177.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -108.36 131.35 54.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.776 177.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -78.8 100.42 3.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 169.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . 0.602 HG22 ' HB3' ' E' ' 44' ' ' LEU . 0.9 OUTLIER -72.35 -51.49 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.998 -174.243 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' E' E ' 54' ' ' ALA . . . . . 0.492 ' HA ' ' OE1' ' D' ' 62' ' ' GLN . . . -154.51 132.53 11.67 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.513 -177.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 7.6 t -101.97 102.43 12.96 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . 0.428 HG13 ' HB3' ' E' ' 40' ' ' ALA . 7.1 p -116.62 109.72 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-O 122.048 0.928 . . . . 0.0 110.025 -176.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 57' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' E' ' 61' ' ' PRO . 68.3 p -122.62 -177.06 3.53 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.342 -176.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -64.98 -20.69 66.62 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.469 169.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.85 -40.82 27.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.313 0.577 . . . . 0.0 110.008 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 74.4 mt -118.66 77.6 14.61 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 172.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 61' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' E' ' 57' ' ' THR . 9.6 Cg_exo -71.69 0.89 6.33 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.095 2.53 . . . . 0.0 113.727 -168.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 62' ' ' GLN . . . . . 0.512 ' OE1' ' HA ' ' A' ' 54' ' ' ALA . 10.3 tt0 -160.11 114.66 2.26 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.792 0.329 . . . . 0.0 111.312 -170.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . 0.484 HG11 ' HB1' ' E' ' 54' ' ' ALA . 86.1 t -112.74 115.18 49.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.065 0.459 . . . . 0.0 111.199 177.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.11 115.99 28.36 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 171.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 65' ' ' LEU . . . . . 0.429 HD23 ' H ' ' E' ' 65' ' ' LEU . 0.7 OUTLIER -134.55 168.22 19.36 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.058 -171.612 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' E' E ' 66' ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 7.5 t0 -122.84 109.43 14.17 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.144 0.497 . . . . 0.0 110.417 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 67' ' ' LEU . . . . . 0.684 HD21 HD23 ' D' ' 88' ' ' LEU . 12.8 mt -123.99 138.91 54.39 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.7 176.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -138.57 114.55 10.08 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 173.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -109.1 163.0 13.73 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.519 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 70' ' ' SER . . . . . 0.559 ' OG ' ' HA ' ' D' ' 7' ' ' MET . 4.5 m -117.09 149.0 41.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.185 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.99 -6.05 30.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.698 -177.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.87 -28.4 46.38 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.344 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -101.24 171.28 7.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.704 0.288 . . . . 0.0 110.364 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -137.32 136.53 38.06 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 75' ' ' ILE . . . . . 0.45 ' HB ' ' CD1' ' E' ' 44' ' ' LEU . 22.4 pt -133.04 158.37 43.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.947 0.403 . . . . 0.0 111.66 -169.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 76' ' ' MET . . . . . 0.432 ' HA ' ' HA ' ' E' ' 20' ' ' SER . 65.3 ttp -117.49 118.11 31.29 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.055 0.455 . . . . 0.0 110.339 176.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 77' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.4 OUTLIER -105.59 129.47 53.84 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.693 -177.747 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' E' E ' 78' ' ' TYR . . . . . 0.661 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 38.8 p90 -155.76 162.68 40.47 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.838 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 79' ' ' THR . . . . . 0.648 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 12.7 p -125.14 143.82 50.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.209 178.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.37 149.68 26.75 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.095 173.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.82 -176.91 36.73 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -176.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -114.45 102.76 10.38 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.14 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 83' ' ' ALA . . . . . 0.603 ' H ' ' HB3' ' E' ' 15' ' ' PRO . . . -166.78 150.05 6.79 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.477 168.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 6.2 p -106.14 122.24 45.8 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 85' ' ' VAL . . . . . 0.592 HG12 ' HB3' ' E' ' 34' ' ' LEU . 13.7 m -121.57 144.19 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 CA-C-O 121.161 0.505 . . . . 0.0 111.831 -172.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 44.3 m -105.23 122.84 46.77 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.274 175.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 87' ' ' LEU . . . . . 0.687 HD13 HD23 ' E' ' 11' ' ' LEU . 5.1 mp -95.16 143.9 26.21 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 170.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . 0.683 HD23 HD21 ' A' ' 67' ' ' LEU . 0.9 OUTLIER -130.42 141.25 50.55 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.134 -178.664 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.67 -166.88 27.49 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.678 -177.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 90' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -147.05 133.59 19.78 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.469 0.652 . . . . 0.0 111.066 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 91' ' ' LEU . . . . . 0.635 HD23 ' HB3' ' E' ' 27' ' ' PHE . 15.1 mt . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.117 175.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.433 0.159 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 65.46 178.87 0.2 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.187 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.59 105.32 3.24 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.703 -176.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.16 -49.11 7.99 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 172.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.514 ' SD ' ' HA ' ' A' ' 94' ' ' ILE . 22.4 mmt 66.71 -65.73 0.2 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 114.671 -1.149 . . . . 0.0 112.098 174.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 91' ' ' LEU . . . -103.55 112.89 26.02 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.843 0.354 . . . . 0.0 110.674 -178.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 54.6 mtt -108.18 147.05 31.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.83 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.519 ' CE1' HD21 ' B' ' 44' ' ' LEU . 81.2 t80 -58.7 142.66 49.16 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -172.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.509 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 89.3 t90 -140.08 147.73 40.71 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.131 178.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.413 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -149.93 154.07 25.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.114 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.631 HD23 HD13 ' A' ' 87' ' ' LEU . 51.2 tp -146.61 109.05 4.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.818 0.342 . . . . 0.0 111.237 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -91.47 114.11 26.55 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.375 0.607 . . . . 0.0 111.093 176.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.539 ' HB2' HG23 ' A' ' 85' ' ' VAL . 3.5 mmt -93.15 137.32 32.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.016 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -100.64 153.34 37.79 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 171.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.441 ' HB3' ' HA ' ' A' ' 82' ' ' ASP . 84.1 Cg_exo -46.83 111.34 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.993 2.462 . . . . 0.0 113.096 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.686 ' HA ' ' O ' ' A' ' 79' ' ' THR . 39.6 mt-10 65.95 59.13 0.72 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.498 0.666 . . . . 0.0 111.356 177.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.43 ' HD3' ' HA ' ' A' ' 17' ' ' ARG . 70.5 mmt-85 -113.3 145.44 41.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.038 172.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.669 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 33.8 ttmt -128.02 111.27 13.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.308 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.414 ' OH ' ' HA ' ' A' ' 13' ' ' MET . 5.6 m-85 -108.69 104.12 13.34 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.686 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.417 ' HB3' ' SD ' ' A' ' 76' ' ' MET . 9.2 p -88.04 99.9 12.52 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 173.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -125.43 138.7 54.02 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.591 0.71 . . . . 0.0 112.378 -167.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 t -85.0 160.24 20.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.751 177.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.403 ' CD1' ' HB3' ' A' ' 69' ' ' PHE . 53.0 mt -114.14 116.74 53.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.005 0.431 . . . . 0.0 110.862 -176.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.754 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -104.0 -10.15 9.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.248 176.469 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.612 ' HD3' HD22 ' A' ' 91' ' ' LEU . 2.6 ptpp? -142.62 119.35 11.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.794 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.0 m -64.61 135.4 55.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.182 -177.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.78 ' HB3' HD23 ' A' ' 91' ' ' LEU . 19.2 p90 -147.25 160.78 42.09 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -174.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.49 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 5.3 t60 -114.87 128.07 56.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.405 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 56.5 mt -94.63 136.45 25.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 171.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.519 ' HB2' ' HB3' ' B' ' 66' ' ' ASP . 72.7 p -119.81 -16.74 8.69 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -170.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -163.78 144.85 9.84 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 119.365 -1.397 . . . . 0.0 113.5 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.448 HG23 ' HG ' ' A' ' 87' ' ' LEU . 12.4 p -129.02 125.71 63.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 170.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.66 152.18 41.02 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.606 -174.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.573 ' HB3' HG12 ' A' ' 85' ' ' VAL . 3.5 pp -114.26 137.9 51.18 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.871 0.843 . . . . 0.0 111.81 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -106.04 -55.35 2.34 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.436 175.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -101.98 126.87 49.01 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.745 170.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.458 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 147.96 162.51 10.16 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 119.612 -1.28 . . . . 0.0 113.561 176.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.442 ' O ' ' HG3' ' A' ' 58' ' ' LYS . 39.5 mt-30 -102.82 -48.13 4.18 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 178.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -151.77 134.49 15.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.382 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.561 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -135.39 117.46 15.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.376 0.608 . . . . 0.0 111.112 172.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 79' ' ' THR . 48.3 mttm -97.65 116.02 29.06 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 173.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.429 HD21 HD21 ' A' ' 87' ' ' LEU . 53.8 tp -91.44 105.4 17.74 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.154 0.502 . . . . 0.0 110.037 -173.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.408 ' HB2' ' CE2' ' A' ' 78' ' ' TYR . 96.9 m-85 -103.43 150.91 23.39 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.256 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.627 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 1.1 tp -133.5 117.41 17.12 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.701 176.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -102.06 104.32 14.96 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.425 0.631 . . . . 0.0 109.615 175.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.513 ' HB2' HD11 ' A' ' 44' ' ' LEU . . . -134.28 152.18 51.68 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 57.79 24.14 10.41 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -174.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 58.45 42.24 21.47 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.286 -175.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 28.2 tp60 -137.62 131.85 32.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.562 178.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -79.58 107.1 12.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.916 0.389 . . . . 0.0 110.45 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.405 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 74.5 m-85 -100.16 129.32 46.17 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.051 176.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 tp -89.95 99.89 10.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 172.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.475 ' CG1' ' HB3' ' A' ' 44' ' ' LEU . 2.6 m -84.27 -33.79 9.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.131 -169.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.524 ' HB2' HD13 ' A' ' 65' ' ' LEU . . . -159.3 148.93 18.66 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.117 0.484 . . . . 0.0 111.885 177.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.2 m -117.39 102.96 9.66 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 170.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.42 ' CG1' HG11 ' A' ' 85' ' ' VAL . 6.7 p -110.6 116.26 51.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.439 0.638 . . . . 0.0 110.224 -176.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.8 p -122.7 -177.48 3.66 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.297 -175.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 38' ' ' GLN . 52.7 mtmt -59.8 -33.68 72.05 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.99 0.424 . . . . 0.0 110.288 169.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.93 -40.81 68.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.39 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.6 mt -116.6 80.14 10.17 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 174.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -72.38 0.23 7.73 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.804 2.336 . . . . 0.0 113.927 -167.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -162.43 119.21 2.0 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.126 0.489 . . . . 0.0 110.875 -176.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.457 HG11 ' HB1' ' A' ' 54' ' ' ALA . 92.8 t -110.2 101.67 12.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.216 175.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.14 111.36 17.51 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 173.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.524 HD13 ' HB2' ' A' ' 54' ' ' ALA . 1.0 OUTLIER -133.05 150.78 52.09 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.079 -171.254 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.544 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 11.7 t0 -96.0 99.14 10.94 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.345 0.593 . . . . 0.0 110.006 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.557 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 4.2 mt -113.21 141.8 46.54 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.491 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.624 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 6.2 t30 -148.87 132.46 16.79 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.1 177.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.513 ' CZ ' HD22 ' A' ' 67' ' ' LEU . 63.4 m-85 -127.54 158.02 38.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.831 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.9 p -120.97 154.86 35.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.386 178.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.465 ' HD3' ' H ' ' A' ' 71' ' ' LYS . 0.2 OUTLIER -70.9 11.48 0.38 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -174.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.03 -29.48 9.69 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.678 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -101.53 163.11 12.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.942 0.371 . . . . 0.0 110.929 -175.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -123.14 111.42 16.49 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.444 HG22 ' CB ' ' A' ' 46' ' ' ALA . 27.9 pt -111.15 161.43 9.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.122 0.487 . . . . 0.0 111.71 -168.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.417 ' SD ' ' HB3' ' A' ' 20' ' ' SER . 4.9 mtm -121.84 124.86 45.13 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 173.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.627 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -105.05 128.16 53.2 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.162 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.669 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 30.1 p90 -151.06 138.93 19.88 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.137 -0.625 . . . . 0.0 112.055 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.686 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 11.3 p -109.72 137.54 47.38 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.878 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.68 157.22 18.73 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.588 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.73 -173.9 35.6 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -176.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.441 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 11.6 m-20 -114.05 103.17 10.87 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.843 177.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -172.31 155.14 3.46 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.153 171.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.5 t -110.41 114.46 27.92 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.573 HG12 ' HB3' ' A' ' 34' ' ' LEU . 6.8 m -112.98 143.49 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-O 121.357 0.599 . . . . 0.0 112.15 -174.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.8 t -108.86 118.65 37.34 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.72 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.631 HD13 HD23 ' A' ' 11' ' ' LEU . 5.2 mp -94.04 151.9 19.19 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.41 ' CD2' HD21 ' B' ' 67' ' ' LEU . 2.2 tp -134.31 145.96 49.54 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.177 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.68 -167.52 29.44 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.455 -0.878 . . . . 0.0 112.084 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.611 ' CD2' ' HB3' ' B' ' 68' ' ' ASN . 8.7 p90 -151.54 130.23 12.33 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.732 0.777 . . . . 0.0 111.85 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.78 HD23 ' HB3' ' A' ' 27' ' ' PHE . 6.2 mt -66.97 122.68 18.27 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.121 -1.399 . . . . 0.0 109.595 175.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -101.62 108.55 20.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.368 0.604 . . . . 0.0 110.591 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -118.13 76.93 1.11 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.536 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.514 ' HA ' ' SD ' ' A' ' 5' ' ' MET . 5.0 tp -78.65 120.99 30.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.38 0.609 . . . . 0.0 110.503 -177.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -119.32 139.46 51.9 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.977 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 38.2 m -137.51 31.38 2.57 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.199 0.523 . . . . 0.0 110.005 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 64.86 -131.98 37.0 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.024 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.7 p . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.944 -0.551 . . . . 0.0 110.085 177.929 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 120.363 0.125 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 65.2 178.88 0.19 Allowed 'General case' 0 C--O 1.232 0.181 0 O-C-N 123.51 0.507 . . . . 0.0 111.278 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.64 105.28 3.24 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.65 -176.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.24 -49.14 7.93 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 172.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . 0.506 ' SD ' ' HA ' ' B' ' 94' ' ' ILE . 22.4 mmt 66.78 -65.78 0.2 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.0 174.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' B' ' 91' ' ' LEU . . . -103.48 112.78 25.84 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.736 -177.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 54.6 mtt -108.23 147.15 31.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.806 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.53 ' CE1' HD21 ' C' ' 44' ' ' LEU . 80.5 t80 -58.85 142.76 49.61 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -172.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . 0.509 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 89.2 t90 -140.11 147.67 40.56 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.141 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.439 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -149.9 154.03 25.46 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.097 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.621 HD23 HD13 ' B' ' 87' ' ' LEU . 51.7 tp -146.49 108.9 4.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.772 0.32 . . . . 0.0 111.296 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -91.34 114.06 26.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.332 0.587 . . . . 0.0 111.096 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . 0.558 ' HB2' HG23 ' B' ' 85' ' ' VAL . 3.5 mmt -93.17 137.27 32.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.964 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -100.55 153.38 37.78 Favored Pre-proline 0 C--N 1.317 -0.828 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 171.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.449 ' HB3' ' HA ' ' B' ' 82' ' ' ASP . 84.2 Cg_exo -46.77 111.21 0.35 Allowed 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 123.058 2.505 . . . . 0.0 113.15 -178.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.686 ' HA ' ' O ' ' B' ' 79' ' ' THR . 39.5 mt-10 66.01 59.11 0.71 Allowed 'General case' 0 C--O 1.233 0.224 0 O-C-N 123.693 0.621 . . . . 0.0 111.316 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.431 ' HD3' ' HA ' ' B' ' 17' ' ' ARG . 70.5 mmt-85 -113.28 145.47 40.98 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.037 172.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.664 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 33.9 ttmt -128.08 111.26 13.29 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.344 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' TYR . . . . . 0.423 ' OH ' ' HA ' ' B' ' 13' ' ' MET . 5.6 m-85 -108.68 104.05 13.27 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.687 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.415 ' HB3' ' SD ' ' B' ' 76' ' ' MET . 9.6 p -88.0 100.03 12.6 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 173.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -125.53 138.74 53.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.59 0.71 . . . . 0.0 112.335 -167.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 14.8 t -85.07 160.36 20.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.691 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.401 ' CD1' ' HB3' ' B' ' 69' ' ' PHE . 53.0 mt -114.11 116.76 53.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 120.973 0.416 . . . . 0.0 110.877 -176.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.758 ' H ' HD13 ' B' ' 24' ' ' ILE . 0.2 OUTLIER -104.05 -10.24 9.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.257 176.413 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.597 ' HD3' HD22 ' B' ' 91' ' ' LEU . 2.5 ptpp? -142.64 119.38 11.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.736 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 23.8 m -64.57 135.46 56.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.21 -177.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . 0.777 ' HB3' HD23 ' B' ' 91' ' ' LEU . 19.3 p90 -147.28 160.74 42.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.62 0.724 . . . . 0.0 112.908 -174.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' HIS . . . . . 0.495 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 5.3 t60 -114.85 128.06 56.08 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.418 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 56.5 mt -94.67 136.44 25.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 171.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.506 ' HB2' ' HB3' ' C' ' 66' ' ' ASP . 72.5 p -119.86 -16.64 8.67 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.961 -170.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -163.75 144.91 9.89 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 119.424 -1.369 . . . . 0.0 113.497 178.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.442 HG23 ' HG ' ' B' ' 87' ' ' LEU . 12.3 p -129.2 125.68 62.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 170.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.59 152.21 41.12 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 121.921 -0.487 . . . . 0.0 111.629 -174.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.591 ' HB3' HG12 ' B' ' 85' ' ' VAL . 3.5 pp -114.32 137.87 51.25 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.906 0.86 . . . . 0.0 111.781 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -105.94 -55.34 2.34 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.482 175.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -101.99 126.87 49.02 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.775 170.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.456 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 147.93 162.56 10.17 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 119.644 -1.265 . . . . 0.0 113.644 176.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . 0.44 ' O ' ' HG3' ' B' ' 58' ' ' LYS . 39.3 mt-30 -102.74 -48.14 4.19 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 178.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -151.86 134.47 15.45 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.433 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.559 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -135.37 117.39 15.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.39 0.614 . . . . 0.0 111.031 172.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' B' ' 79' ' ' THR . 48.3 mttm -97.58 116.01 28.98 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 173.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.427 HD21 HD21 ' B' ' 87' ' ' LEU . 53.7 tp -91.37 105.24 17.63 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.156 0.503 . . . . 0.0 110.111 -173.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . 0.415 ' HB2' ' CE2' ' B' ' 78' ' ' TYR . 96.9 m-85 -103.41 150.91 23.38 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.203 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.631 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 1.1 tp -133.55 117.36 17.02 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.619 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -102.03 104.25 14.9 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.382 0.611 . . . . 0.0 109.574 175.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.504 ' HB2' HD11 ' B' ' 44' ' ' LEU . . . -134.24 152.3 51.75 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.047 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 57.67 24.19 10.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.132 0.491 . . . . 0.0 109.729 -174.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 58.38 42.34 21.54 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.321 -175.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.497 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 28.3 tp60 -137.67 131.8 31.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.55 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -79.55 107.16 12.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.815 0.341 . . . . 0.0 110.428 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.413 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 74.6 m-85 -100.26 129.27 46.24 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.004 176.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 tp -89.84 99.93 10.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 172.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.47 ' CG1' ' HB3' ' B' ' 44' ' ' LEU . 2.6 m -84.25 -33.88 9.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.088 -169.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.498 ' HB2' HD13 ' B' ' 65' ' ' LEU . . . -159.3 148.94 18.66 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.026 0.441 . . . . 0.0 111.959 177.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 92.6 m -117.44 102.88 9.57 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 170.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.419 ' CG1' HG11 ' B' ' 85' ' ' VAL . 6.7 p -110.57 116.21 51.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.471 0.653 . . . . 0.0 110.225 -176.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 74.4 p -122.69 -177.42 3.64 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.305 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' B' ' 38' ' ' GLN . 52.6 mtmt -59.88 -33.72 72.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.963 0.411 . . . . 0.0 110.285 169.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.86 -40.75 68.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.472 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 74.9 mt -116.66 80.15 10.31 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 174.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -72.4 0.13 7.9 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.923 2.415 . . . . 0.0 113.881 -166.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -162.4 119.24 2.01 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.299 0.571 . . . . 0.0 110.866 -176.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.442 HG11 ' HB1' ' B' ' 54' ' ' ALA . 92.3 t -110.2 101.67 12.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.2 176.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.14 111.29 17.44 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 173.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.498 HD13 ' HB2' ' B' ' 54' ' ' ALA . 1.0 OUTLIER -133.03 150.75 52.11 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.167 -171.295 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 11.7 t0 -96.0 99.14 10.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.399 0.619 . . . . 0.0 109.993 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.572 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 4.2 mt -113.19 141.8 46.52 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.424 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . 0.611 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 6.2 t30 -148.9 132.49 16.79 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.174 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . 0.527 ' CZ ' HD22 ' B' ' 67' ' ' LEU . 63.5 m-85 -127.6 158.08 38.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.825 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 4.8 p -121.05 154.92 35.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.304 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.469 ' H ' ' HD3' ' B' ' 71' ' ' LYS . 0.2 OUTLIER -70.92 11.47 0.39 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -174.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.06 -29.52 9.64 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.673 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -101.48 163.13 12.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.785 0.326 . . . . 0.0 110.918 -175.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -123.12 111.48 16.58 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 177.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.443 HG22 ' CB ' ' B' ' 46' ' ' ALA . 27.8 pt -111.2 161.41 9.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.092 0.472 . . . . 0.0 111.704 -168.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.415 ' SD ' ' HB3' ' B' ' 20' ' ' SER . 4.9 mtm -121.82 124.77 44.95 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 173.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . 0.631 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.5 OUTLIER -104.96 128.16 53.11 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.113 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.664 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 30.2 p90 -151.04 138.89 19.86 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.023 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.686 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 11.2 p -109.73 137.5 47.45 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.953 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.48 157.12 18.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.632 176.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.74 -173.76 35.44 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -176.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' ASP . . . . . 0.449 ' HA ' ' HB3' ' B' ' 15' ' ' PRO . 11.7 m-20 -114.14 103.14 10.82 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.763 178.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.559 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -172.31 155.18 3.47 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.131 171.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 24.4 t -110.41 114.32 27.66 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.591 HG12 ' HB3' ' B' ' 34' ' ' LEU . 6.8 m -112.86 143.62 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 CA-C-O 121.416 0.627 . . . . 0.0 112.198 -174.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 11.9 t -108.99 118.73 37.55 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.664 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.621 HD13 HD23 ' B' ' 11' ' ' LEU . 5.2 mp -94.17 151.87 19.15 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 174.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.4 ' CD2' HD21 ' C' ' 67' ' ' LEU . 2.2 tp -134.25 145.97 49.63 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.124 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.73 -167.51 29.46 Favored Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.053 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' TYR . . . . . 0.599 ' CD2' ' HB3' ' C' ' 68' ' ' ASN . 8.7 p90 -151.62 130.29 12.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.798 0.808 . . . . 0.0 111.842 177.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . 0.777 HD23 ' HB3' ' B' ' 27' ' ' PHE . 6.3 mt -66.98 122.59 18.08 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.023 -1.444 . . . . 0.0 109.555 175.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -101.48 108.49 20.09 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.363 0.602 . . . . 0.0 110.612 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -118.13 77.02 1.12 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.467 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . 0.506 ' HA ' ' SD ' ' B' ' 5' ' ' MET . 5.1 tp -78.58 120.94 30.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.542 -177.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -119.43 139.45 52.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.97 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 37.8 m -137.4 31.24 2.61 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.241 0.544 . . . . 0.0 110.055 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . 64.87 -131.93 36.93 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.172 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 11.7 p . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.826 -0.607 . . . . 0.0 110.147 177.888 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.422 0.153 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 65.32 178.86 0.19 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.181 0.515 . . . . 0.0 111.169 -177.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.62 105.33 3.25 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.615 -176.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.15 -49.12 7.99 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 171.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' MET . . . . . 0.512 ' SD ' ' HA ' ' C' ' 94' ' ' ILE . 22.4 mmt 66.67 -65.71 0.2 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 114.663 -1.153 . . . . 0.0 112.077 174.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' C' ' 91' ' ' LEU . . . -103.5 112.7 25.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.767 -178.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 54.7 mtt -108.17 147.13 31.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.756 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' PHE . . . . . 0.511 ' CE1' HD21 ' D' ' 44' ' ' LEU . 80.8 t80 -58.83 142.74 49.56 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -172.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . 0.51 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 89.1 t90 -140.11 147.67 40.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.169 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . 0.421 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -149.86 153.99 25.43 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.189 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.648 HD23 HD13 ' C' ' 87' ' ' LEU . 51.5 tp -146.52 109.0 4.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.77 0.319 . . . . 0.0 111.235 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -91.53 114.2 26.67 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.461 0.648 . . . . 0.0 111.005 176.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' MET . . . . . 0.543 ' HB2' HG23 ' C' ' 85' ' ' VAL . 3.5 mmt -93.21 137.29 32.68 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.006 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -100.56 153.29 37.83 Favored Pre-proline 0 C--N 1.318 -0.798 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 171.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . 0.44 ' HB3' ' HA ' ' C' ' 82' ' ' ASP . 85.4 Cg_exo -46.76 111.34 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.056 2.504 . . . . 0.0 113.183 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . 0.69 ' HA ' ' O ' ' C' ' 79' ' ' THR . 39.7 mt-10 65.83 59.2 0.74 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.471 0.653 . . . . 0.0 111.414 178.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' ARG . . . . . 0.441 ' HD3' ' HA ' ' C' ' 17' ' ' ARG . 70.4 mmt-85 -113.35 145.46 41.06 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.932 172.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' LYS . . . . . 0.671 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 33.8 ttmt -128.08 111.28 13.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.304 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . 0.416 ' OH ' ' HA ' ' C' ' 13' ' ' MET . 5.6 m-85 -108.69 104.06 13.28 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.695 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . 0.418 ' HB3' ' SD ' ' C' ' 76' ' ' MET . 9.4 p -87.94 99.9 12.49 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 173.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -125.47 138.62 54.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.564 0.697 . . . . 0.0 112.368 -167.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 14.8 t -85.03 160.37 20.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.665 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . 0.4 ' CD1' ' HB3' ' C' ' 69' ' ' PHE . 53.2 mt -114.15 116.81 53.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.915 0.388 . . . . 0.0 110.793 -176.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . 0.764 ' H ' HD13 ' C' ' 24' ' ' ILE . 0.2 OUTLIER -104.0 -10.17 9.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.257 176.362 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . 0.607 ' HD3' HD22 ' C' ' 91' ' ' LEU . 2.5 ptpp? -142.63 119.34 11.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.763 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 24.0 m -64.65 135.41 55.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.185 -177.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' PHE . . . . . 0.777 ' HB3' HD23 ' C' ' 91' ' ' LEU . 19.2 p90 -147.19 160.73 42.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.62 0.724 . . . . 0.0 112.924 -174.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' HIS . . . . . 0.5 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 5.4 t60 -114.89 128.05 56.06 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.38 177.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 56.7 mt -94.61 136.48 25.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 171.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.521 ' HB2' ' HB3' ' D' ' 66' ' ' ASP . 72.8 p -119.89 -16.66 8.65 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.97 -170.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -163.75 144.97 9.95 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 119.45 -1.357 . . . . 0.0 113.457 178.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.441 HG23 ' HG ' ' C' ' 87' ' ' LEU . 12.2 p -129.21 125.68 62.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 170.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.65 152.28 41.16 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.612 -174.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.593 ' HB3' HG12 ' C' ' 85' ' ' VAL . 3.5 pp -114.27 137.85 51.25 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.896 0.855 . . . . 0.0 111.794 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -106.03 -55.27 2.35 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.218 -1.356 . . . . 0.0 108.459 175.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -102.02 126.85 49.05 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.765 170.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' GLY . . . . . 0.448 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 147.95 162.56 10.18 Favored Glycine 0 N--CA 1.438 -1.189 0 C-N-CA 119.602 -1.285 . . . . 0.0 113.617 176.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' GLN . . . . . 0.443 ' O ' ' HG3' ' C' ' 58' ' ' LYS . 39.3 mt-30 -102.88 -48.1 4.18 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 178.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -151.84 134.54 15.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.405 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.554 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -135.42 117.44 15.33 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.363 0.601 . . . . 0.0 111.093 172.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' C' ' 79' ' ' THR . 48.2 mttm -97.72 116.0 29.08 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 173.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.411 HD21 HD21 ' C' ' 87' ' ' LEU . 54.0 tp -91.44 105.4 17.74 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.12 0.486 . . . . 0.0 110.001 -173.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' TYR . . . . . 0.418 ' HB2' ' CE2' ' C' ' 78' ' ' TYR . 96.9 m-85 -103.49 150.83 23.51 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.218 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.63 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 1.1 tp -133.44 117.4 17.16 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.66 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -102.07 104.24 14.86 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.349 0.595 . . . . 0.0 109.582 175.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.503 ' HB2' HD11 ' C' ' 44' ' ' LEU . . . -134.21 152.21 51.71 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 57.74 24.11 10.3 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -174.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 58.43 42.33 21.42 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.255 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . 0.491 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 28.1 tp60 -137.65 131.91 32.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.628 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -79.72 107.17 12.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.804 0.335 . . . . 0.0 110.399 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . 0.439 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 74.7 m-85 -100.3 129.24 46.27 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.976 176.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 tp -89.83 99.88 10.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 172.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' VAL . . . . . 0.464 ' CG1' ' HB3' ' C' ' 44' ' ' LEU . 2.6 m -84.27 -33.77 9.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.129 -170.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' ALA . . . . . 0.508 ' HB2' HD13 ' C' ' 65' ' ' LEU . . . -159.37 148.96 18.55 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.093 0.473 . . . . 0.0 111.908 177.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 92.3 m -117.38 102.84 9.56 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 170.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . 0.42 ' CG1' HG11 ' C' ' 85' ' ' VAL . 6.7 p -110.6 116.35 52.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.498 0.666 . . . . 0.0 110.193 -176.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 74.3 p -122.75 -177.43 3.65 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.202 -175.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' C' ' 38' ' ' GLN . 52.6 mtmt -59.76 -33.71 72.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.119 0.485 . . . . 0.0 110.345 169.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.95 -40.79 68.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.371 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 74.4 mt -116.64 80.18 10.29 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -72.5 0.32 7.67 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.835 2.357 . . . . 0.0 113.831 -166.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -162.5 119.1 1.97 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.165 0.507 . . . . 0.0 110.86 -176.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.455 HG11 ' HB1' ' C' ' 54' ' ' ALA . 91.9 t -110.19 101.7 12.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.198 175.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.06 111.22 17.32 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 173.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . 0.508 HD13 ' HB2' ' C' ' 54' ' ' ALA . 1.0 OUTLIER -132.99 150.8 52.13 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.206 -171.396 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 66' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 11.6 t0 -96.02 99.18 10.97 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.415 0.626 . . . . 0.0 109.981 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.557 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 4.1 mt -113.25 141.87 46.48 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.427 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . 0.599 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 6.2 t30 -148.91 132.5 16.78 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.175 177.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 69' ' ' PHE . . . . . 0.515 ' CZ ' HD22 ' C' ' 67' ' ' LEU . 63.7 m-85 -127.65 157.95 38.88 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.795 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 4.8 p -120.96 154.91 35.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.329 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . 0.472 ' H ' ' HD3' ' C' ' 71' ' ' LYS . 0.2 OUTLIER -70.92 11.41 0.39 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -174.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.97 -29.61 9.62 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.688 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -101.36 163.11 12.43 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 122.575 -0.367 . . . . 0.0 111.039 -175.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -123.13 111.42 16.5 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.433 HG22 ' CB ' ' C' ' 46' ' ' ALA . 27.8 pt -111.09 161.38 9.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.142 0.496 . . . . 0.0 111.706 -168.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.418 ' SD ' ' HB3' ' C' ' 20' ' ' SER . 4.9 mtm -121.84 124.84 45.09 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 173.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 77' ' ' PHE . . . . . 0.63 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.5 OUTLIER -105.05 128.16 53.2 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.158 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 78' ' ' TYR . . . . . 0.671 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 30.3 p90 -151.08 138.9 19.84 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.217 -0.593 . . . . 0.0 112.008 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . 0.69 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 11.3 p -109.68 137.54 47.35 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.926 -179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.53 157.23 18.65 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.619 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.65 -173.85 35.67 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -176.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 82' ' ' ASP . . . . . 0.44 ' HA ' ' HB3' ' C' ' 15' ' ' PRO . 11.5 m-20 -114.05 103.14 10.84 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 119.601 -0.839 . . . . 0.0 109.8 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . 0.554 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -172.35 155.14 3.44 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.159 171.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 25.0 t -110.3 114.49 27.99 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.593 HG12 ' HB3' ' C' ' 34' ' ' LEU . 6.8 m -113.03 143.57 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 CA-C-O 121.419 0.628 . . . . 0.0 112.118 -174.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 12.0 t -108.94 118.75 37.61 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.617 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . 0.648 HD13 HD23 ' C' ' 11' ' ' LEU . 5.2 mp -94.15 151.89 19.15 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 174.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' C' ' 88' ' ' LEU . 2.2 tp -134.27 145.96 49.59 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.092 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.72 -167.51 29.46 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.228 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 90' ' ' TYR . . . . . 0.613 ' CD2' ' HB3' ' D' ' 68' ' ' ASN . 8.7 p90 -151.55 130.2 12.3 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.777 0.799 . . . . 0.0 111.901 177.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . 0.777 HD23 ' HB3' ' C' ' 27' ' ' PHE . 6.2 mt -66.94 122.66 18.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.643 175.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -101.57 108.57 20.16 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.408 0.623 . . . . 0.0 110.612 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -118.22 77.0 1.12 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.472 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . 0.512 ' HA ' ' SD ' ' C' ' 5' ' ' MET . 5.1 tp -78.52 120.97 30.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.596 -177.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -119.43 139.48 51.96 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.003 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 38.4 m -137.46 31.28 2.59 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.144 0.497 . . . . 0.0 109.988 177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 64.91 -131.93 36.81 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.179 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 11.7 p . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.958 -0.544 . . . . 0.0 110.076 177.874 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 120.394 0.14 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 65.21 178.83 0.19 Allowed 'General case' 0 C--O 1.232 0.161 0 O-C-N 123.544 0.528 . . . . 0.0 111.24 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.56 105.24 3.23 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.718 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.13 -49.03 8.06 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 172.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 5' ' ' MET . . . . . 0.512 ' SD ' ' HA ' ' D' ' 94' ' ' ILE . 22.4 mmt 66.7 -65.83 0.2 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.605 -1.18 . . . . 0.0 112.066 174.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 6' ' ' ALA . . . . . 0.572 ' HA ' ' O ' ' D' ' 91' ' ' LEU . . . -103.49 112.68 25.69 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.846 0.355 . . . . 0.0 110.801 -178.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 54.6 mtt -108.15 147.09 31.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.855 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 8' ' ' PHE . . . . . 0.519 ' CE1' HD21 ' E' ' 44' ' ' LEU . 81.0 t80 -58.7 142.66 49.15 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -172.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 9' ' ' TRP . . . . . 0.511 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 89.3 t90 -140.07 147.63 40.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.153 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . 0.438 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -149.84 154.0 25.45 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.215 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.645 HD23 HD13 ' D' ' 87' ' ' LEU . 51.2 tp -146.55 109.0 4.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.777 0.322 . . . . 0.0 111.173 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -91.41 114.1 26.54 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.375 0.607 . . . . 0.0 111.134 176.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 13' ' ' MET . . . . . 0.544 ' HB2' HG23 ' D' ' 85' ' ' VAL . 3.5 mmt -93.12 137.33 32.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.017 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -100.6 153.37 37.78 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 171.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . 0.434 ' HB3' ' HA ' ' D' ' 82' ' ' ASP . 83.8 Cg_exo -46.82 111.4 0.38 Allowed 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.025 2.484 . . . . 0.0 113.103 -178.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . 0.68 ' HA ' ' O ' ' D' ' 79' ' ' THR . 39.6 mt-10 65.87 59.06 0.74 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.538 0.685 . . . . 0.0 111.446 177.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 17' ' ' ARG . . . . . 0.426 ' HA ' ' HD3' ' D' ' 17' ' ' ARG . 70.7 mmt-85 -113.29 145.35 41.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.02 172.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . 0.644 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 33.8 ttmt -127.95 111.22 13.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.331 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 19' ' ' TYR . . . . . 0.418 ' OH ' ' HA ' ' D' ' 13' ' ' MET . 5.6 m-85 -108.56 104.17 13.43 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.662 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . 0.419 ' HB3' ' SD ' ' D' ' 76' ' ' MET . 9.3 p -88.05 99.99 12.59 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 173.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -125.51 138.73 53.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.553 0.692 . . . . 0.0 112.324 -167.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 14.7 t -85.03 160.29 20.04 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.698 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . 0.402 ' CD1' ' HB3' ' D' ' 69' ' ' PHE . 53.4 mt -114.14 116.7 53.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.053 0.454 . . . . 0.0 110.845 -176.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . 0.772 ' H ' HD13 ' D' ' 24' ' ' ILE . 0.2 OUTLIER -103.9 -10.21 9.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.287 176.36 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . 0.591 ' HD3' HD22 ' D' ' 91' ' ' LEU . 2.5 ptpp? -142.65 119.35 11.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.751 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 23.9 m -64.65 135.44 55.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.246 -177.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 27' ' ' PHE . . . . . 0.774 ' HB3' HD23 ' D' ' 91' ' ' LEU . 19.2 p90 -147.23 160.69 42.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.664 0.745 . . . . 0.0 112.837 -174.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 28' ' ' HIS . . . . . 0.492 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 5.4 t60 -114.8 128.01 56.06 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.5 177.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 29' ' ' ILE . . . . . 0.567 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 56.6 mt -94.59 136.45 25.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 171.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . 0.492 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 72.7 p -119.77 -16.73 8.71 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -170.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 31' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -163.82 144.84 9.82 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 119.331 -1.414 . . . . 0.0 113.447 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.442 HG23 ' HG ' ' D' ' 87' ' ' LEU . 12.3 p -129.05 125.72 63.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 170.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.66 152.21 41.06 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 121.882 -0.512 . . . . 0.0 111.615 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 34' ' ' LEU . . . . . 0.582 ' HB3' HG12 ' D' ' 85' ' ' VAL . 3.5 pp -114.28 137.76 51.37 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 121.905 0.859 . . . . 0.0 111.845 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -105.84 -55.39 2.33 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.218 -1.356 . . . . 0.0 108.524 175.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -101.92 126.91 48.93 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.822 170.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . 0.451 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 147.87 162.57 10.17 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 119.622 -1.275 . . . . 0.0 113.614 176.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 38' ' ' GLN . . . . . 0.443 ' O ' ' HG3' ' D' ' 58' ' ' LYS . 39.3 mt-30 -102.84 -48.17 4.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -151.82 134.5 15.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.447 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . 0.539 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -135.34 117.54 15.52 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.428 0.633 . . . . 0.0 111.152 172.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' D' ' 79' ' ' THR . 48.3 mttm -97.79 116.06 29.25 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 173.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.43 HD21 HD21 ' D' ' 87' ' ' LEU . 53.7 tp -91.45 105.35 17.7 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.163 0.506 . . . . 0.0 110.051 -173.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 43' ' ' TYR . . . . . 0.418 ' HB2' ' CE2' ' D' ' 78' ' ' TYR . 96.9 m-85 -103.46 150.92 23.41 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.17 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.623 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 1.1 tp -133.54 117.35 17.01 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.728 177.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 45' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -102.03 104.3 14.94 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.423 0.63 . . . . 0.0 109.543 175.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.509 ' HB2' HD11 ' D' ' 44' ' ' LEU . . . -134.27 152.14 51.65 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 57.85 24.17 10.54 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -174.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 58.32 42.26 21.88 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.298 -175.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . 0.498 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 28.1 tp60 -137.55 131.87 32.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.615 178.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -79.66 107.17 12.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.896 0.379 . . . . 0.0 110.401 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . 0.421 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 74.5 m-85 -100.3 129.28 46.27 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.047 176.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 tp -89.89 99.84 10.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 172.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 53' ' ' VAL . . . . . 0.466 ' CG1' ' HB3' ' D' ' 44' ' ' LEU . 2.6 m -84.29 -33.69 9.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.147 -169.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 54' ' ' ALA . . . . . 0.508 ' HB2' HD13 ' D' ' 65' ' ' LEU . . . -159.33 148.93 18.6 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.072 0.463 . . . . 0.0 111.971 177.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 92.4 m -117.45 102.89 9.58 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 170.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 56' ' ' VAL . . . . . 0.42 ' CG1' HG11 ' D' ' 85' ' ' VAL . 6.8 p -110.57 116.34 52.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.582 0.706 . . . . 0.0 110.215 -176.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 74.0 p -122.81 -177.47 3.67 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.206 -175.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 58' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' D' ' 38' ' ' GLN . 52.7 mtmt -59.89 -33.58 72.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.021 0.439 . . . . 0.0 110.357 169.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.05 -40.67 68.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.313 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 74.8 mt -116.67 80.19 10.38 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 174.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.54 0.36 7.64 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.824 2.35 . . . . 0.0 113.84 -166.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -162.52 119.12 1.96 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.157 0.504 . . . . 0.0 110.844 -176.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.445 HG11 ' HB1' ' D' ' 54' ' ' ALA . 91.9 t -110.12 101.74 12.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.193 176.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.07 111.3 17.4 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.529 173.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 65' ' ' LEU . . . . . 0.508 HD13 ' HB2' ' D' ' 54' ' ' ALA . 1.0 OUTLIER -133.05 150.79 52.09 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.153 -171.323 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 66' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 11.6 t0 -96.08 99.18 10.96 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.499 0.666 . . . . 0.0 110.006 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.567 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 4.2 mt -113.15 141.88 46.42 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.447 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 68' ' ' ASN . . . . . 0.613 ' HB3' ' CD2' ' C' ' 90' ' ' TYR . 6.3 t30 -148.92 132.54 16.81 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.1 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 69' ' ' PHE . . . . . 0.526 ' CZ ' HD22 ' D' ' 67' ' ' LEU . 63.7 m-85 -127.74 157.97 38.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.764 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 4.7 p -120.97 154.89 35.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.281 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 71' ' ' LYS . . . . . 0.459 ' HD3' ' H ' ' D' ' 71' ' ' LYS . 0.2 OUTLIER -70.87 11.48 0.38 Allowed 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -174.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.0 -29.66 9.55 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.592 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -101.35 163.1 12.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.906 0.353 . . . . 0.0 111.012 -175.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -123.14 111.43 16.51 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.438 HG22 ' CB ' ' D' ' 46' ' ' ALA . 27.7 pt -111.1 161.38 9.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.039 0.447 . . . . 0.0 111.719 -168.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 76' ' ' MET . . . . . 0.419 ' SD ' ' HB3' ' D' ' 20' ' ' SER . 4.9 mtm -121.88 124.82 45.0 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 173.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 77' ' ' PHE . . . . . 0.623 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.5 OUTLIER -105.02 128.16 53.19 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.163 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 78' ' ' TYR . . . . . 0.644 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 30.4 p90 -151.07 138.87 19.82 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.245 -0.582 . . . . 0.0 112.108 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 79' ' ' THR . . . . . 0.68 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 11.4 p -109.71 137.57 47.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.923 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.57 157.17 18.72 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.612 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.8 -173.88 35.46 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 -176.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 82' ' ' ASP . . . . . 0.434 ' HA ' ' HB3' ' D' ' 15' ' ' PRO . 11.5 m-20 -114.03 103.27 10.97 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.803 177.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . 0.539 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -172.4 155.19 3.41 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.083 171.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 24.4 t -110.44 114.42 27.84 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.582 HG12 ' HB3' ' D' ' 34' ' ' LEU . 6.8 m -112.89 143.66 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-O 121.347 0.594 . . . . 0.0 112.159 -174.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 12.0 t -109.04 118.63 37.28 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.67 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 87' ' ' LEU . . . . . 0.645 HD13 HD23 ' D' ' 11' ' ' LEU . 5.2 mp -93.96 151.82 19.28 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 174.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tp -134.31 145.99 49.58 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.113 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.76 -167.49 29.46 Favored Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.087 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 90' ' ' TYR . . . . . 0.586 ' CD2' ' HB3' ' E' ' 68' ' ' ASN . 8.7 p90 -151.56 130.22 12.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.755 0.788 . . . . 0.0 111.876 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . 0.774 HD23 ' HB3' ' D' ' 27' ' ' PHE . 6.2 mt -66.92 122.6 18.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.631 175.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -101.58 108.5 20.07 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.405 0.621 . . . . 0.0 110.63 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -118.05 76.98 1.11 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.533 176.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . 0.512 ' HA ' ' SD ' ' D' ' 5' ' ' MET . 5.1 tp -78.52 120.92 30.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.584 -177.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -119.42 139.45 52.01 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.953 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 38.4 m -137.45 31.29 2.6 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.185 0.517 . . . . 0.0 110.141 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . 64.87 -131.94 36.95 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.187 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 11.8 p . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.107 177.811 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 120.313 0.102 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 65.25 178.87 0.19 Allowed 'General case' 0 C--O 1.233 0.228 0 O-C-N 123.588 0.555 . . . . 0.0 111.223 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.58 105.29 3.24 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.627 -176.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.22 -49.02 8.03 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 171.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 5' ' ' MET . . . . . 0.513 ' SD ' ' HA ' ' E' ' 94' ' ' ILE . 22.4 mmt 66.7 -65.75 0.2 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 114.601 -1.182 . . . . 0.0 112.065 174.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 6' ' ' ALA . . . . . 0.568 ' HA ' ' O ' ' E' ' 91' ' ' LEU . . . -103.52 112.73 25.77 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.78 0.324 . . . . 0.0 110.773 -178.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 54.7 mtt -108.21 147.12 31.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.778 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 8' ' ' PHE . . . . . 0.509 ' CE1' HD21 ' A' ' 44' ' ' LEU . 81.0 t80 -58.78 142.73 49.36 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -172.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 9' ' ' TRP . . . . . 0.512 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 89.2 t90 -140.11 147.71 40.64 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.104 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 10' ' ' GLY . . . . . 0.405 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -149.9 153.92 25.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.181 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . 0.625 HD23 HD13 ' E' ' 87' ' ' LEU . 51.6 tp -146.46 108.95 4.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.732 0.301 . . . . 0.0 111.251 -178.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -91.46 114.17 26.63 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.461 0.648 . . . . 0.0 110.994 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 13' ' ' MET . . . . . 0.551 ' HB2' HG23 ' E' ' 85' ' ' VAL . 3.5 mmt -93.15 137.32 32.6 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.043 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -100.67 153.31 37.81 Favored Pre-proline 0 C--N 1.318 -0.791 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 171.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . 0.446 ' HB3' ' HA ' ' E' ' 82' ' ' ASP . 84.9 Cg_exo -46.67 111.32 0.36 Allowed 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 123.08 2.52 . . . . 0.0 113.139 -178.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 16' ' ' GLU . . . . . 0.686 ' HA ' ' O ' ' E' ' 79' ' ' THR . 39.6 mt-10 65.94 59.02 0.73 Allowed 'General case' 0 C--O 1.232 0.181 0 O-C-N 123.77 0.669 . . . . 0.0 111.445 177.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 17' ' ' ARG . . . . . 0.44 ' HD3' ' HA ' ' E' ' 17' ' ' ARG . 70.4 mmt-85 -113.32 145.49 40.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.945 172.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . 0.668 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 33.8 ttmt -128.07 111.28 13.32 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.376 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . 0.416 ' OH ' ' HA ' ' E' ' 13' ' ' MET . 5.6 m-85 -108.61 104.03 13.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.681 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 20' ' ' SER . . . . . 0.418 ' HB3' ' SD ' ' E' ' 76' ' ' MET . 9.4 p -88.06 99.96 12.57 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 173.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -125.45 138.71 54.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.543 0.687 . . . . 0.0 112.32 -167.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 14.8 t -85.1 160.29 20.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.701 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 23' ' ' ILE . . . . . 0.402 ' CD1' ' HB3' ' E' ' 69' ' ' PHE . 53.4 mt -114.02 116.85 53.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 120.995 0.426 . . . . 0.0 110.856 -176.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . 0.773 ' H ' HD13 ' E' ' 24' ' ' ILE . 0.2 OUTLIER -104.08 -10.21 9.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.264 176.393 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . 0.593 ' HD3' HD22 ' E' ' 91' ' ' LEU . 2.5 ptpp? -142.57 119.32 11.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.793 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 24.0 m -64.55 135.4 55.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.249 -177.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 27' ' ' PHE . . . . . 0.773 ' HB3' HD23 ' E' ' 91' ' ' LEU . 19.1 p90 -147.22 160.76 42.09 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -174.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 28' ' ' HIS . . . . . 0.53 ' HE2' ' HB3' ' E' ' 30' ' ' SER . 5.3 t60 -114.93 127.99 56.02 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.348 177.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 29' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 56.6 mt -94.54 136.45 25.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 171.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . 0.544 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 72.6 p -119.84 -16.67 8.68 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.712 -0.395 . . . . 0.0 112.018 -170.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 31' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -163.8 144.83 9.82 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 119.335 -1.412 . . . . 0.0 113.456 178.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.437 HG23 ' HG ' ' E' ' 87' ' ' LEU . 12.3 p -129.07 125.74 63.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 170.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.64 152.17 41.02 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.948 -0.47 . . . . 0.0 111.642 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 34' ' ' LEU . . . . . 0.591 ' HB3' HG12 ' E' ' 85' ' ' VAL . 3.5 pp -114.35 137.87 51.26 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 122.044 0.926 . . . . 0.0 111.719 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -106.09 -55.25 2.35 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.062 -1.427 . . . . 0.0 108.424 175.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -102.0 126.83 49.01 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.81 170.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . 0.454 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 147.94 162.52 10.16 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 119.576 -1.297 . . . . 0.0 113.596 176.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 38' ' ' GLN . . . . . 0.433 ' O ' ' HG3' ' E' ' 58' ' ' LYS . 39.2 mt-30 -102.77 -48.18 4.18 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 178.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -151.77 134.48 15.54 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.452 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . 0.553 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -135.27 117.34 15.38 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.278 0.561 . . . . 0.0 111.195 172.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 41' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' E' ' 79' ' ' THR . 48.2 mttm -97.62 116.08 29.15 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 173.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.412 HD21 HD21 ' E' ' 87' ' ' LEU . 53.6 tp -91.4 105.38 17.73 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.161 0.505 . . . . 0.0 110.053 -173.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 43' ' ' TYR . . . . . 0.413 ' HB2' ' CE2' ' E' ' 78' ' ' TYR . 97.1 m-85 -103.53 150.93 23.45 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.194 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 44' ' ' LEU . . . . . 0.619 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 1.1 tp -133.6 117.34 16.95 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.694 177.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 45' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -102.0 104.32 14.98 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.363 0.601 . . . . 0.0 109.554 175.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . 0.507 ' HB2' HD11 ' E' ' 44' ' ' LEU . . . -134.33 152.07 51.6 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 57.89 24.12 10.55 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -174.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 58.32 42.41 21.64 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.264 -175.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 49' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 28.1 tp60 -137.61 131.84 32.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.545 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -79.66 107.22 12.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.909 0.385 . . . . 0.0 110.387 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . 0.438 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 74.5 m-85 -100.27 129.32 46.25 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.109 175.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 tp -89.91 99.93 10.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 172.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . 0.467 ' CG1' ' HB3' ' E' ' 44' ' ' LEU . 2.6 m -84.32 -33.76 9.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.097 -169.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 54' ' ' ALA . . . . . 0.499 ' HB2' HD13 ' E' ' 65' ' ' LEU . . . -159.4 148.88 18.45 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.095 0.474 . . . . 0.0 111.887 177.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 92.4 m -117.36 102.9 9.62 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 170.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . 0.422 ' CG1' HG11 ' E' ' 85' ' ' VAL . 6.7 p -110.56 116.28 51.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.51 0.672 . . . . 0.0 110.214 -176.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 73.9 p -122.74 -177.44 3.65 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.248 -175.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 58' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' E' ' 38' ' ' GLN . 52.7 mtmt -59.86 -33.66 72.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.044 0.45 . . . . 0.0 110.309 169.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.92 -40.73 68.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.39 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 74.6 mt -116.64 80.09 10.22 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 174.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -72.46 0.27 7.73 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.87 2.38 . . . . 0.0 113.83 -166.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -162.44 119.11 1.99 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.196 0.522 . . . . 0.0 110.85 -176.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . 0.459 HG11 ' HB1' ' E' ' 54' ' ' ALA . 92.0 t -110.09 101.72 12.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.232 175.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.21 111.26 17.47 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 173.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.499 HD13 ' HB2' ' E' ' 54' ' ' ALA . 1.0 OUTLIER -133.0 150.87 52.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.109 -171.351 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 66' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 11.6 t0 -96.06 99.11 10.89 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.414 0.626 . . . . 0.0 110.042 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 67' ' ' LEU . . . . . 0.565 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 4.1 mt -113.12 141.83 46.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.436 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 68' ' ' ASN . . . . . 0.586 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 6.2 t30 -148.92 132.48 16.76 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.068 177.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 69' ' ' PHE . . . . . 0.53 ' CZ ' HD22 ' E' ' 67' ' ' LEU . 63.4 m-85 -127.62 158.01 38.69 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.873 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 4.8 p -121.01 154.84 35.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.317 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 71' ' ' LYS . . . . . 0.46 ' HD3' ' H ' ' E' ' 71' ' ' LYS . 0.2 OUTLIER -70.82 11.41 0.38 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -174.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.03 -29.57 9.62 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.626 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -101.45 163.13 12.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.95 0.405 . . . . 0.0 110.92 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -123.06 111.57 16.72 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 75' ' ' ILE . . . . . 0.44 HG22 ' CB ' ' E' ' 46' ' ' ALA . 27.9 pt -111.3 161.29 9.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.053 0.454 . . . . 0.0 111.697 -168.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 76' ' ' MET . . . . . 0.418 ' SD ' ' HB3' ' E' ' 20' ' ' SER . 4.9 mtm -121.74 124.88 45.27 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 173.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 77' ' ' PHE . . . . . 0.619 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.5 OUTLIER -105.11 128.08 53.19 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.19 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 78' ' ' TYR . . . . . 0.668 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 30.2 p90 -151.01 138.86 19.86 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.059 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 79' ' ' THR . . . . . 0.686 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 11.1 p -109.74 137.55 47.38 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.898 -178.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.57 157.15 18.74 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.655 176.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.77 -173.84 35.46 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 82' ' ' ASP . . . . . 0.446 ' HA ' ' HB3' ' E' ' 15' ' ' PRO . 11.7 m-20 -114.05 103.18 10.88 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 119.609 -0.836 . . . . 0.0 109.873 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 83' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -172.36 155.19 3.44 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.18 171.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 24.3 t -110.42 114.45 27.9 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 85' ' ' VAL . . . . . 0.591 HG12 ' HB3' ' E' ' 34' ' ' LEU . 6.8 m -112.97 143.61 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 CA-C-O 121.514 0.673 . . . . 0.0 112.124 -174.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 11.9 t -108.97 118.73 37.56 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.641 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 87' ' ' LEU . . . . . 0.625 HD13 HD23 ' E' ' 11' ' ' LEU . 5.2 mp -94.17 151.89 19.13 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 174.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . 0.406 ' CD2' HD21 ' A' ' 67' ' ' LEU . 2.2 tp -134.32 145.95 49.52 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.089 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.73 -167.5 29.44 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.114 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 90' ' ' TYR . . . . . 0.624 ' CD2' ' HB3' ' A' ' 68' ' ' ASN . 8.8 p90 -151.58 130.24 12.31 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.742 0.782 . . . . 0.0 111.835 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 91' ' ' LEU . . . . . 0.773 HD23 ' HB3' ' E' ' 27' ' ' PHE . 6.3 mt -67.0 122.57 18.04 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.051 -1.431 . . . . 0.0 109.595 175.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -101.48 108.55 20.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.376 0.607 . . . . 0.0 110.611 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -118.14 77.0 1.11 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.465 176.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 94' ' ' ILE . . . . . 0.513 ' HA ' ' SD ' ' E' ' 5' ' ' MET . 5.0 tp -78.52 121.02 30.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.538 -177.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -119.47 139.48 52.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.961 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 37.7 m -137.44 31.21 2.6 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.056 0.455 . . . . 0.0 110.053 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . 64.93 -131.98 36.76 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.089 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 11.8 p . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.846 -0.597 . . . . 0.0 110.023 177.87 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 121.036 0.446 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -100.48 98.58 9.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.27 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.86 53.06 3.68 Favored Glycine 0 CA--C 1.517 0.165 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.64 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.61 -104.04 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 122.833 0.453 . . . . 0.0 109.805 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 42.5 ttp 53.59 28.8 8.28 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.089 0.556 . . . . 0.0 111.582 176.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.431 ' HB3' ' ND2' ' B' ' 68' ' ' ASN . . . -67.34 123.47 20.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.254 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 51.2 mtt -90.32 137.87 32.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.18 0.514 . . . . 0.0 111.603 -173.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.554 ' CE1' HD12 ' A' ' 88' ' ' LEU . 60.7 t80 -60.51 141.3 56.68 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.323 -174.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.508 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 91.9 t90 -130.41 144.8 51.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.915 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.1 140.81 9.11 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.395 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.626 HD23 HD13 ' A' ' 87' ' ' LEU . 56.6 tp -133.37 109.1 9.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.841 0.353 . . . . 0.0 110.348 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -97.78 104.11 16.11 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.571 ' SD ' HD11 ' A' ' 87' ' ' LEU . 35.9 mtp -98.4 137.86 36.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.588 -175.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -101.3 159.01 30.68 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.939 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.432 ' HB3' ' HA ' ' A' ' 82' ' ' ASP . 68.5 Cg_exo -42.89 118.45 1.22 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.752 2.968 . . . . 0.0 114.24 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.711 ' HA ' ' O ' ' A' ' 79' ' ' THR . 49.5 mt-10 57.16 55.99 5.54 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.068 174.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 78' ' ' TYR . 30.5 mmt180 -116.98 144.09 44.97 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.099 175.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.652 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 35.6 ttmt -126.23 112.78 16.16 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 123.491 0.494 . . . . 0.0 111.143 -176.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.415 ' OH ' ' HA ' ' A' ' 13' ' ' MET . 2.3 m-85 -111.27 104.89 13.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.252 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.42 ' HB3' ' SD ' ' A' ' 76' ' ' MET . 3.7 p -88.2 104.8 17.05 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 173.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -124.13 148.11 47.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.432 0.634 . . . . 0.0 112.696 -168.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.2 t -90.96 161.06 15.32 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.513 175.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.52 HD13 ' HB2' ' A' ' 69' ' ' PHE . 67.6 mt -114.25 131.36 66.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.101 0.477 . . . . 0.0 111.62 -173.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.468 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.2 mp -99.25 -48.92 11.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.085 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -114.46 140.55 48.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.657 177.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.2 m -63.54 109.4 1.64 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.482 ' HB3' HD23 ' A' ' 91' ' ' LEU . 14.7 p90 -125.02 159.54 31.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.626 0.727 . . . . 0.0 112.886 -170.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.578 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 9.4 t60 -116.45 125.85 52.57 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.077 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 61.2 mt -92.42 133.12 34.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 170.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.578 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 32.8 p -118.9 -14.35 9.43 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -169.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.541 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -167.33 147.98 12.49 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 119.153 -1.498 . . . . 0.0 113.416 178.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.442 HG23 ' HG ' ' A' ' 87' ' ' LEU . 11.4 p -134.63 129.06 51.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 172.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.08 155.5 42.24 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.896 -0.503 . . . . 0.0 111.653 -174.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.548 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.0 pp -120.98 142.27 49.93 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.442 0.639 . . . . 0.0 111.205 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -110.03 -50.08 3.01 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.572 173.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -103.18 127.45 50.47 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 168.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.455 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 152.21 158.97 8.7 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 119.906 -1.14 . . . . 0.0 113.19 176.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.464 ' O ' ' HG3' ' A' ' 58' ' ' LYS . 94.5 mt-30 -102.59 -45.35 5.07 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 120.625 0.25 . . . . 0.0 111.379 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.447 ' HG3' HG22 ' A' ' 57' ' ' THR . 13.5 tt0 -153.68 130.48 10.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.238 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.585 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -131.35 113.86 14.29 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.367 0.603 . . . . 0.0 110.492 169.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -97.14 111.6 23.76 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.456 ' HG ' ' CG2' ' A' ' 53' ' ' VAL . 45.4 tp -83.6 112.57 20.14 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.624 -174.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -110.96 137.17 48.92 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.293 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.582 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 1.2 tp -120.56 119.36 32.71 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.383 175.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -106.19 114.15 28.1 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.227 0.537 . . . . 0.0 109.671 176.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.544 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -145.97 154.59 42.08 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.98 -178.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 57.98 27.83 15.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.938 0.399 . . . . 0.0 110.381 -176.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm 59.22 44.6 15.42 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.743 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -150.86 140.22 21.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.963 178.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -85.98 126.99 34.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.18 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -123.14 123.92 41.9 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.704 176.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 tp -77.38 103.42 4.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 171.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.456 ' CG2' ' HG ' ' A' ' 42' ' ' LEU . 2.8 m -86.88 -35.17 8.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.875 -173.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.542 ' HB2' HD23 ' A' ' 65' ' ' LEU . . . -152.51 145.6 24.58 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.108 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.4 m -114.65 101.87 9.5 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 169.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.457 HG13 ' HB3' ' A' ' 40' ' ' ALA . 7.4 p -115.86 112.93 41.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.798 0.809 . . . . 0.0 110.164 -176.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.447 HG22 ' HG3' ' A' ' 39' ' ' GLU . 81.6 p -123.38 -176.82 3.54 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.217 -175.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 38' ' ' GLN . 34.7 mtmm -58.56 -34.58 71.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.179 0.514 . . . . 0.0 110.084 170.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.27 -40.88 64.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.467 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 72.4 mt -115.37 80.78 7.92 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 174.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -71.08 -0.01 7.32 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.122 2.548 . . . . 0.0 113.541 -168.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -161.94 124.69 2.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.41 0.624 . . . . 0.0 111.11 -176.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 85.7 t -113.73 102.96 14.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.355 174.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.93 109.8 17.89 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.441 173.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.542 HD23 ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -129.67 168.93 15.73 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.19 0.519 . . . . 0.0 111.539 -174.647 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 17.1 t0 -115.61 106.21 13.65 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.728 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.554 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 25.9 mt -123.55 142.96 50.51 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 175.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.664 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 4.9 t30 -150.79 130.79 13.4 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.073 177.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.52 ' HB2' HD13 ' A' ' 23' ' ' ILE . 3.1 m-85 -126.39 153.26 45.21 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.425 ' OG ' ' HG2' ' E' ' 7' ' ' MET . 89.1 p -98.36 164.68 12.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.036 0.446 . . . . 0.0 110.779 -178.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.403 ' H ' ' HG3' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -65.44 -5.47 7.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.821 177.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.25 -3.5 55.54 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 121.089 -0.577 . . . . 0.0 111.724 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -93.76 159.06 15.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.973 0.416 . . . . 0.0 110.873 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -144.14 125.48 14.74 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 174.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.544 HG22 ' HB2' ' A' ' 46' ' ' ALA . 18.1 pt -136.17 163.78 33.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.928 -166.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.42 ' SD ' ' HB3' ' A' ' 20' ' ' SER . 3.7 mtm -121.93 130.72 53.56 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.72 173.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.582 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -111.39 128.15 55.88 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.253 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.652 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 33.8 p90 -151.57 138.42 18.95 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.25 0.548 . . . . 0.0 111.788 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.711 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 6.0 p -107.44 134.87 49.85 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.144 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.69 154.18 19.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.112 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.2 -175.92 40.0 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -175.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.432 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 9.4 m-20 -113.62 103.29 11.1 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.209 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.585 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -170.09 155.08 5.31 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.819 172.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.2 t -112.05 123.29 49.93 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.548 HG12 ' HB3' ' A' ' 34' ' ' LEU . 6.1 m -121.46 145.86 27.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.415 0.626 . . . . 0.0 112.637 -172.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.3 m -109.91 120.86 43.79 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.591 175.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.626 HD13 HD23 ' A' ' 11' ' ' LEU . 4.7 mp -98.0 144.89 27.05 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 171.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.554 HD12 ' CE1' ' A' ' 8' ' ' PHE . 2.4 mm? -124.43 146.46 48.89 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.017 174.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.06 -168.33 23.81 Favored Glycine 0 N--CA 1.434 -1.434 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.189 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.632 ' CD2' ' HB3' ' B' ' 68' ' ' ASN . 9.9 p90 -151.41 128.52 11.13 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.828 0.823 . . . . 0.0 111.822 177.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.482 HD23 ' HB3' ' A' ' 27' ' ' PHE . 7.0 mt -68.5 130.87 44.14 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 113.863 -1.517 . . . . 0.0 109.104 175.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -79.58 108.0 12.78 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.161 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -106.58 171.27 7.45 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.987 177.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 7.9 tp -172.98 143.45 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.1 162.97 14.36 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 30.7 t -126.15 31.59 5.4 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.087 0.47 . . . . 0.0 110.369 -178.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.14 -140.12 3.17 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.281 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.517 179.165 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 . . . . . 0 N--CA 1.481 1.125 0 CA-C-O 120.99 0.424 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -100.59 98.64 9.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.189 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.8 53.02 3.65 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.613 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.58 -103.92 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 122.935 0.494 . . . . 0.0 109.897 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 42.4 ttp 53.41 28.83 7.96 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.054 0.542 . . . . 0.0 111.671 176.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.43 ' HB3' ' ND2' ' C' ' 68' ' ' ASN . . . -67.39 123.52 20.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.271 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 51.3 mtt -90.29 137.84 32.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.152 0.501 . . . . 0.0 111.657 -173.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.558 ' CE1' HD21 ' C' ' 44' ' ' LEU . 60.6 t80 -60.47 141.25 56.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.401 -174.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . 0.508 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 91.9 t90 -130.33 144.78 51.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.964 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.13 140.92 9.18 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.416 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.615 HD23 HD13 ' B' ' 87' ' ' LEU . 57.0 tp -133.54 109.13 9.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.828 0.347 . . . . 0.0 110.315 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -97.76 104.05 16.04 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . 0.583 ' SD ' HD11 ' B' ' 87' ' ' LEU . 35.8 mtp -98.35 137.81 36.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.641 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -101.11 159.1 30.45 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.009 176.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.453 ' HB3' ' HA ' ' B' ' 82' ' ' ASP . 69.6 Cg_exo -42.93 118.48 1.24 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.672 2.915 . . . . 0.0 114.323 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.713 ' HA ' ' O ' ' B' ' 79' ' ' THR . 49.7 mt-10 57.06 56.15 5.5 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.05 174.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' B' ' 78' ' ' TYR . 30.4 mmt180 -117.11 144.07 45.1 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.079 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.671 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 35.6 ttmt -126.18 112.79 16.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.091 -176.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' TYR . . . . . 0.403 ' OH ' ' HA ' ' B' ' 13' ' ' MET . 2.4 m-85 -111.26 104.84 13.36 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.291 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.416 ' HB3' ' SD ' ' B' ' 76' ' ' MET . 3.7 p -88.25 104.77 17.04 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 173.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -124.02 148.12 47.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.498 0.666 . . . . 0.0 112.711 -168.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 13.2 t -91.0 161.08 15.29 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.544 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.52 HD13 ' HB2' ' B' ' 69' ' ' PHE . 67.8 mt -114.25 131.26 66.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.116 0.484 . . . . 0.0 111.677 -173.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.47 ' N ' HD12 ' B' ' 24' ' ' ILE . 4.2 mp -99.23 -48.97 11.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.037 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -114.43 140.72 48.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.627 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 19.2 m -63.57 109.22 1.59 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 173.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . 0.47 ' HB3' HD23 ' B' ' 91' ' ' LEU . 14.6 p90 -124.93 159.56 30.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.627 0.727 . . . . 0.0 112.845 -170.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' HIS . . . . . 0.59 ' HE2' ' HB3' ' B' ' 30' ' ' SER . 9.3 t60 -116.43 125.81 52.53 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.131 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 61.5 mt -92.44 133.11 34.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 170.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.59 ' HB3' ' HE2' ' B' ' 28' ' ' HIS . 33.2 p -118.88 -14.33 9.44 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -169.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -167.3 148.09 12.65 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 119.146 -1.502 . . . . 0.0 113.375 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.447 HG23 ' HG ' ' B' ' 87' ' ' LEU . 11.3 p -134.68 129.09 51.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 172.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.15 155.53 42.22 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.551 -174.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.561 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.0 pp -120.98 142.3 49.9 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.51 0.672 . . . . 0.0 111.206 178.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -110.06 -50.04 3.01 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.578 173.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -103.14 127.53 50.39 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 168.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 152.17 158.88 8.65 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.217 176.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . 0.472 ' O ' ' HG3' ' B' ' 58' ' ' LYS . 94.5 mt-30 -102.46 -45.4 5.08 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.572 0.225 . . . . 0.0 111.441 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.456 ' HG3' HG22 ' B' ' 57' ' ' THR . 13.4 tt0 -153.77 130.54 10.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.189 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.589 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -131.36 113.88 14.3 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.411 0.624 . . . . 0.0 110.507 169.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -97.15 111.68 23.8 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 173.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.454 ' HG ' ' CG2' ' B' ' 53' ' ' VAL . 45.8 tp -83.76 112.57 20.21 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.614 -174.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -110.91 137.15 48.91 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.335 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.592 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 1.2 tp -120.57 119.33 32.59 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.344 175.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -106.23 114.1 28.02 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.523 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -145.94 154.63 42.14 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.932 -178.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 57.95 27.82 15.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.947 0.403 . . . . 0.0 110.391 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm 59.18 44.61 15.53 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.722 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -150.82 140.17 21.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.901 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -85.82 127.07 34.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -123.16 123.83 41.69 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.655 176.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 tp -77.25 103.3 4.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 171.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.454 ' CG2' ' HG ' ' B' ' 42' ' ' LEU . 2.8 m -86.8 -35.31 8.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.853 -173.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.537 ' HB2' HD23 ' B' ' 65' ' ' LEU . . . -152.49 145.62 24.61 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 120.239 -0.584 . . . . 0.0 112.155 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 27.3 m -114.64 101.94 9.57 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 169.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' B' ' 40' ' ' ALA . 7.3 p -115.92 112.96 41.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.771 0.796 . . . . 0.0 110.079 -176.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.456 HG22 ' HG3' ' B' ' 39' ' ' GLU . 82.6 p -123.48 -176.93 3.57 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.185 -175.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' B' ' 38' ' ' GLN . 34.7 mtmm -58.39 -34.67 70.99 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.12 0.486 . . . . 0.0 110.062 170.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.408 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -73.31 -40.9 64.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.466 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 72.5 mt -115.32 80.81 7.81 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 10.2 Cg_exo -71.13 -0.0 7.34 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.107 2.538 . . . . 0.0 113.486 -168.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -161.93 124.86 3.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.375 0.607 . . . . 0.0 111.095 -176.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 85.7 t -113.78 102.93 14.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.311 174.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.95 109.81 17.91 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.46 173.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.537 HD23 ' HB2' ' B' ' 54' ' ' ALA . 0.4 OUTLIER -129.61 168.97 15.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.197 0.522 . . . . 0.0 111.608 -174.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . 0.526 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 16.9 t0 -115.65 106.3 13.74 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.719 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.557 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 26.2 mt -123.63 142.96 50.55 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . 0.632 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 4.9 t30 -150.83 130.76 13.33 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.062 177.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . 0.52 ' HB2' HD13 ' B' ' 23' ' ' ILE . 3.2 m-85 -126.43 153.2 45.34 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 88.9 p -98.3 164.72 12.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.003 0.43 . . . . 0.0 110.802 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.427 ' HG3' ' H ' ' B' ' 71' ' ' LYS . 0.0 OUTLIER -65.52 -5.45 8.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.805 177.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.19 -3.58 55.57 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.765 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -93.72 159.09 15.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.96 0.409 . . . . 0.0 110.776 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -144.22 125.5 14.69 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.523 HG22 ' HB2' ' B' ' 46' ' ' ALA . 18.0 pt -136.21 163.84 33.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.04 0.448 . . . . 0.0 111.91 -166.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.416 ' SD ' ' HB3' ' B' ' 20' ' ' SER . 3.7 mtm -121.99 130.78 53.59 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.698 173.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . 0.592 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.9 OUTLIER -111.36 128.18 55.89 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.269 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.671 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 33.5 p90 -151.61 138.47 18.96 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.199 0.523 . . . . 0.0 111.818 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.713 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 6.0 p -107.46 134.82 49.93 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.1 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.63 154.26 19.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.208 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.08 -175.88 40.15 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -175.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' ASP . . . . . 0.453 ' HA ' ' HB3' ' B' ' 15' ' ' PRO . 9.5 m-20 -113.65 103.34 11.14 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.136 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.589 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -170.16 154.99 5.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.838 172.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 16.1 t -111.99 123.31 49.98 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.561 HG12 ' HB3' ' B' ' 34' ' ' LEU . 6.1 m -121.54 145.81 27.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.494 0.664 . . . . 0.0 112.578 -172.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 20.3 m -109.88 120.87 43.81 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.575 175.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.615 HD13 HD23 ' B' ' 11' ' ' LEU . 4.7 mp -97.92 144.9 26.99 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 171.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.55 HD12 ' CE1' ' B' ' 8' ' ' PHE . 2.4 mm? -124.51 146.55 48.92 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.982 174.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.13 -168.36 23.91 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.25 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' TYR . . . . . 0.604 ' CD2' ' HB3' ' C' ' 68' ' ' ASN . 9.8 p90 -151.42 128.55 11.14 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.844 0.83 . . . . 0.0 111.777 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . 0.47 HD23 ' HB3' ' B' ' 27' ' ' PHE . 7.0 mt -68.56 130.94 44.34 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.097 175.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -79.67 108.01 12.89 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.105 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -106.62 171.2 7.49 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.831 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 7.9 tp -172.88 143.49 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.21 162.91 14.47 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 30.4 t -126.17 31.82 5.35 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.093 0.473 . . . . 0.0 110.388 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.29 -140.04 3.15 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.281 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.553 -0.736 . . . . 0.0 109.454 179.195 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 121.082 0.468 . . . . 0.0 110.529 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -100.59 98.59 9.15 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.202 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.74 52.92 3.62 Favored Glycine 0 CA--C 1.517 0.184 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.609 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.57 -104.03 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 122.889 0.476 . . . . 0.0 109.79 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 42.5 ttp 53.55 28.92 8.35 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.078 0.551 . . . . 0.0 111.589 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 6' ' ' ALA . . . . . 0.444 ' HB3' ' ND2' ' D' ' 68' ' ' ASN . . . -67.52 123.53 20.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.193 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 51.3 mtt -90.33 137.88 31.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.196 0.522 . . . . 0.0 111.601 -173.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 8' ' ' PHE . . . . . 0.579 ' CE1' HD21 ' D' ' 44' ' ' LEU . 60.8 t80 -60.5 141.3 56.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.355 -174.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . 0.507 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 91.9 t90 -130.42 144.78 51.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.924 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.13 140.84 9.12 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.482 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.633 HD23 HD13 ' C' ' 87' ' ' LEU . 56.6 tp -133.39 108.99 9.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.802 0.334 . . . . 0.0 110.342 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -97.75 104.05 16.04 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 13' ' ' MET . . . . . 0.575 ' SD ' HD11 ' C' ' 87' ' ' LEU . 35.8 mtp -98.35 137.78 36.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.616 -175.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -101.2 159.14 30.32 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.034 176.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . 0.428 ' HB3' ' HA ' ' C' ' 82' ' ' ASP . 69.1 Cg_exo -43.01 118.52 1.28 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.727 2.952 . . . . 0.0 114.282 -177.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . 0.71 ' HA ' ' O ' ' C' ' 79' ' ' THR . 49.6 mt-10 57.02 56.19 5.5 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.085 174.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 17' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' C' ' 78' ' ' TYR . 30.5 mmt180 -117.15 144.05 45.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.114 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 18' ' ' LYS . . . . . 0.674 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 35.6 ttmt -126.18 112.85 16.27 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 123.455 0.472 . . . . 0.0 111.096 -176.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . 0.413 ' OH ' ' HA ' ' C' ' 13' ' ' MET . 2.3 m-85 -111.34 104.77 13.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.302 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . 0.419 ' HB3' ' SD ' ' C' ' 76' ' ' MET . 3.7 p -88.1 104.83 17.05 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 173.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -124.07 148.1 47.36 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.437 0.637 . . . . 0.0 112.715 -168.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 13.2 t -90.89 161.05 15.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.583 175.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . 0.504 HD13 ' HB2' ' C' ' 69' ' ' PHE . 67.7 mt -114.24 131.33 66.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.151 0.5 . . . . 0.0 111.667 -173.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . 0.468 HD12 ' N ' ' C' ' 24' ' ' ILE . 4.2 mp -99.27 -49.03 11.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.937 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -114.35 140.61 48.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.657 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 19.1 m -63.52 109.3 1.6 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 173.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 27' ' ' PHE . . . . . 0.483 ' HB3' HD23 ' C' ' 91' ' ' LEU . 14.7 p90 -124.92 159.53 30.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.703 0.764 . . . . 0.0 112.828 -170.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 28' ' ' HIS . . . . . 0.593 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 9.2 t60 -116.5 125.84 52.51 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.049 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 61.2 mt -92.46 133.08 34.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 170.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.593 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 33.0 p -118.83 -14.32 9.47 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -169.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -167.36 148.01 12.52 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 119.092 -1.528 . . . . 0.0 113.356 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.449 HG23 ' HG ' ' C' ' 87' ' ' LEU . 11.4 p -134.57 129.06 51.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 172.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.14 155.42 42.13 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.686 -174.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.554 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.0 pp -120.9 142.37 49.76 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.462 0.648 . . . . 0.0 111.213 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -110.14 -50.02 3.01 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.516 173.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -103.24 127.52 50.52 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 168.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 37' ' ' GLY . . . . . 0.461 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 152.16 158.83 8.63 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 119.875 -1.155 . . . . 0.0 113.231 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 38' ' ' GLN . . . . . 0.463 ' O ' ' HG3' ' C' ' 58' ' ' LYS . 94.7 mt-30 -102.48 -45.39 5.08 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.519 0.2 . . . . 0.0 111.373 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . 0.451 ' HG3' HG22 ' C' ' 57' ' ' THR . 13.4 tt0 -153.73 130.43 10.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.265 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.577 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -131.35 113.8 14.21 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.388 0.613 . . . . 0.0 110.454 169.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -97.02 111.74 23.82 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.453 ' HG ' ' CG2' ' C' ' 53' ' ' VAL . 45.7 tp -83.84 112.57 20.24 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.593 -174.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -110.92 137.22 48.83 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.354 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.594 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 1.2 tp -120.61 119.36 32.65 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.381 175.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -106.26 114.13 28.07 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.168 0.509 . . . . 0.0 109.635 176.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.528 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -145.95 154.67 42.17 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.929 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 58.02 27.76 15.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.971 0.415 . . . . 0.0 110.446 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm 59.27 44.44 15.48 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.788 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -150.73 140.1 21.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.983 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -85.69 127.04 34.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.235 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -123.23 123.85 41.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.62 176.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 tp -77.33 103.39 4.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 171.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 53' ' ' VAL . . . . . 0.453 ' CG2' ' HG ' ' C' ' 42' ' ' LEU . 2.8 m -86.87 -35.26 8.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.819 -173.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 54' ' ' ALA . . . . . 0.535 ' HB2' HD23 ' C' ' 65' ' ' LEU . . . -152.54 145.54 24.51 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.145 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 27.7 m -114.69 101.96 9.58 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 169.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . 0.449 HG13 ' HB3' ' C' ' 40' ' ' ALA . 7.4 p -115.87 113.02 42.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.775 0.798 . . . . 0.0 110.126 -176.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . 0.451 HG22 ' HG3' ' C' ' 39' ' ' GLU . 81.5 p -123.53 -176.79 3.54 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.208 -175.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 58' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' C' ' 38' ' ' GLN . 34.7 mtmm -58.51 -34.65 71.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.143 0.497 . . . . 0.0 110.065 170.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . 0.405 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -73.3 -40.89 64.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.408 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 72.5 mt -115.35 80.74 7.84 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 174.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 61' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 10.3 Cg_exo -70.97 -0.07 7.35 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.027 2.485 . . . . 0.0 113.552 -168.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -161.92 124.83 3.01 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.449 0.643 . . . . 0.0 111.062 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 85.9 t -113.75 102.96 14.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.252 174.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.05 109.78 17.94 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 173.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . 0.535 HD23 ' HB2' ' C' ' 54' ' ' ALA . 0.4 OUTLIER -129.53 168.96 15.6 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.171 0.51 . . . . 0.0 111.545 -174.68 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 66' ' ' ASP . . . . . 0.518 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 17.1 t0 -115.59 106.16 13.61 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.667 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.549 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 26.1 mt -123.55 142.99 50.48 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . 0.604 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 4.9 t30 -150.87 130.72 13.26 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.1 177.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 69' ' ' PHE . . . . . 0.504 ' HB2' HD13 ' C' ' 23' ' ' ILE . 3.0 m-85 -126.32 153.24 45.12 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 88.9 p -98.4 164.67 12.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.073 0.463 . . . . 0.0 110.77 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . 0.424 ' H ' ' HG3' ' C' ' 71' ' ' LYS . 0.0 OUTLIER -65.44 -5.45 7.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.766 177.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.24 -3.54 55.53 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.738 176.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -93.77 159.17 15.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.991 0.424 . . . . 0.0 110.758 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -144.21 125.48 14.68 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 174.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.528 HG22 ' HB2' ' C' ' 46' ' ' ALA . 18.1 pt -136.13 163.83 33.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.999 0.428 . . . . 0.0 111.865 -166.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.419 ' SD ' ' HB3' ' C' ' 20' ' ' SER . 3.6 mtm -122.0 130.75 53.56 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.81 173.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 77' ' ' PHE . . . . . 0.594 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.9 OUTLIER -111.3 128.17 55.86 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.368 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 78' ' ' TYR . . . . . 0.674 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 34.0 p90 -151.68 138.37 18.81 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.177 0.513 . . . . 0.0 111.886 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . 0.71 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 6.2 p -107.38 134.85 49.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.088 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.68 154.26 19.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.139 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.13 -175.85 40.04 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 82' ' ' ASP . . . . . 0.428 ' HA ' ' HB3' ' C' ' 15' ' ' PRO . 9.5 m-20 -113.68 103.33 11.12 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.159 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . 0.577 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -170.21 155.0 5.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.837 172.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 16.2 t -112.01 123.33 50.03 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.554 HG12 ' HB3' ' C' ' 34' ' ' LEU . 6.2 m -121.49 145.83 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 CA-C-O 121.505 0.669 . . . . 0.0 112.644 -172.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 20.3 m -109.92 120.9 43.92 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.591 175.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . 0.633 HD13 HD23 ' C' ' 11' ' ' LEU . 4.7 mp -97.98 144.81 27.13 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 171.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . 0.555 HD12 ' CE1' ' C' ' 8' ' ' PHE . 2.4 mm? -124.42 146.48 48.87 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.443 -0.798 . . . . 0.0 108.985 174.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.09 -168.34 23.84 Favored Glycine 0 N--CA 1.436 -1.366 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.204 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 90' ' ' TYR . . . . . 0.635 ' CD2' ' HB3' ' D' ' 68' ' ' ASN . 9.9 p90 -151.42 128.57 11.16 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.785 0.802 . . . . 0.0 111.783 177.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . 0.483 HD23 ' HB3' ' C' ' 27' ' ' PHE . 7.0 mt -68.62 130.99 44.45 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 113.858 -1.519 . . . . 0.0 108.993 175.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -79.75 108.05 13.0 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.125 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -106.61 171.18 7.5 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.892 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 7.9 tp -172.87 143.45 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.684 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.18 162.95 14.41 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 31.1 t -126.15 31.82 5.35 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.108 0.48 . . . . 0.0 110.419 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.28 -140.04 3.15 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.249 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.425 -0.798 . . . . 0.0 109.363 179.281 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 121.114 0.483 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -100.53 98.59 9.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.234 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.81 53.09 3.66 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.557 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.7 -103.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 122.858 0.463 . . . . 0.0 109.821 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 42.4 ttp 53.41 28.92 8.06 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.041 0.537 . . . . 0.0 111.642 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 6' ' ' ALA . . . . . 0.417 ' HB3' ' ND2' ' E' ' 68' ' ' ASN . . . -67.51 123.46 20.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.243 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 51.4 mtt -90.28 137.88 31.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.655 -173.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 8' ' ' PHE . . . . . 0.56 ' CE1' HD21 ' E' ' 44' ' ' LEU . 60.4 t80 -60.52 141.3 56.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.41 -174.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 9' ' ' TRP . . . . . 0.508 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 92.1 t90 -130.41 144.79 51.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.913 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.12 140.95 9.21 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.374 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.615 HD23 HD13 ' D' ' 87' ' ' LEU . 56.4 tp -133.45 109.08 9.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.768 0.318 . . . . 0.0 110.298 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -97.74 104.08 16.08 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 13' ' ' MET . . . . . 0.582 ' SD ' HD11 ' D' ' 87' ' ' LEU . 35.8 mtp -98.4 137.84 36.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.587 -175.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -101.14 159.13 30.36 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.052 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . 0.437 ' HB3' ' HA ' ' D' ' 82' ' ' ASP . 69.1 Cg_exo -42.94 118.44 1.23 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.696 2.931 . . . . 0.0 114.314 -177.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . 0.703 ' HA ' ' O ' ' D' ' 79' ' ' THR . 49.7 mt-10 57.19 56.07 5.46 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.024 174.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 17' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' D' ' 78' ' ' TYR . 30.5 mmt180 -117.08 144.04 45.1 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.033 175.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . 0.673 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 35.6 ttmt -126.18 112.86 16.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.07 -176.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 19' ' ' TYR . . . . . 0.406 ' OH ' ' HA ' ' D' ' 13' ' ' MET . 2.4 m-85 -111.3 104.77 13.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.308 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . 0.418 ' HB3' ' SD ' ' D' ' 76' ' ' MET . 3.7 p -88.14 104.75 16.99 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 173.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -124.0 148.17 47.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.442 0.639 . . . . 0.0 112.72 -168.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 13.2 t -91.0 161.1 15.28 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.533 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . 0.506 HD13 ' HB2' ' D' ' 69' ' ' PHE . 67.5 mt -114.31 131.24 66.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.191 0.519 . . . . 0.0 111.678 -173.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . 0.463 HD12 ' N ' ' D' ' 24' ' ' ILE . 4.2 mp -99.12 -49.06 11.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.095 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -114.35 140.64 48.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.648 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 19.3 m -63.55 109.4 1.64 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 173.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 27' ' ' PHE . . . . . 0.482 ' HB3' HD23 ' D' ' 91' ' ' LEU . 14.5 p90 -125.01 159.49 31.18 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.692 0.758 . . . . 0.0 112.824 -170.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 28' ' ' HIS . . . . . 0.594 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 9.4 t60 -116.37 125.82 52.61 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.222 -1.354 . . . . 0.0 110.156 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 29' ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 61.3 mt -92.41 133.04 35.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 170.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . 0.594 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 33.2 p -118.79 -14.4 9.5 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -169.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 31' ' ' GLY . . . . . 0.545 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -167.31 148.02 12.55 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 119.141 -1.504 . . . . 0.0 113.387 178.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.451 HG23 ' HG ' ' D' ' 87' ' ' LEU . 11.4 p -134.59 128.99 51.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 172.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.11 155.5 42.22 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.496 -0.481 . . . . 0.0 111.629 -174.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 34' ' ' LEU . . . . . 0.552 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.0 pp -120.98 142.24 49.96 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.455 0.645 . . . . 0.0 111.225 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -109.98 -50.16 3.0 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.554 173.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -103.09 127.54 50.32 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 168.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . 0.467 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 152.16 158.95 8.68 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 119.868 -1.158 . . . . 0.0 113.253 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 38' ' ' GLN . . . . . 0.46 ' O ' ' HG3' ' D' ' 58' ' ' LYS . 94.7 mt-30 -102.6 -45.35 5.07 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.625 0.25 . . . . 0.0 111.4 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . 0.459 ' HG3' HG22 ' D' ' 57' ' ' THR . 13.5 tt0 -153.67 130.58 10.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.221 178.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . 0.573 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -131.43 113.82 14.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.417 0.627 . . . . 0.0 110.46 169.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -97.08 111.63 23.77 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 173.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.458 ' HG ' ' CG2' ' D' ' 53' ' ' VAL . 45.9 tp -83.73 112.61 20.22 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.522 -174.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -110.86 137.15 48.86 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.326 178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.593 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 1.2 tp -120.61 119.44 32.87 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.37 175.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 45' ' ' ALA . . . . . . . . . . . . . . . -106.25 113.99 27.86 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.529 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -145.92 154.61 42.13 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.961 -178.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 58.06 27.75 15.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.931 0.396 . . . . 0.0 110.421 -176.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm 59.24 44.54 15.45 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.809 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -150.83 140.36 21.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.896 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -85.99 127.01 34.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.18 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -123.15 123.79 41.61 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.722 176.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 tp -77.26 103.33 4.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 171.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 53' ' ' VAL . . . . . 0.458 ' CG2' ' HG ' ' D' ' 42' ' ' LEU . 2.8 m -86.79 -35.29 8.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.861 -173.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 54' ' ' ALA . . . . . 0.54 ' HB2' HD23 ' D' ' 65' ' ' LEU . . . -152.46 145.64 24.65 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.284 -0.566 . . . . 0.0 112.167 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 27.2 m -114.74 101.98 9.59 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 169.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 56' ' ' VAL . . . . . 0.449 HG13 ' HB3' ' D' ' 40' ' ' ALA . 7.4 p -115.94 112.98 41.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.791 0.805 . . . . 0.0 110.081 -176.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 57' ' ' THR . . . . . 0.459 HG22 ' HG3' ' D' ' 39' ' ' GLU . 82.5 p -123.48 -176.81 3.54 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.208 -175.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 58' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' D' ' 38' ' ' GLN . 34.7 mtmm -58.56 -34.59 71.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.128 0.49 . . . . 0.0 110.069 170.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 59' ' ' ALA . . . . . 0.4 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -73.4 -40.73 64.07 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.452 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 72.4 mt -115.36 80.74 7.87 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 174.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 61' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 10.4 Cg_exo -71.05 -0.1 7.44 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.109 2.539 . . . . 0.0 113.516 -168.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -161.84 124.73 3.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.327 0.584 . . . . 0.0 111.127 -176.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 85.1 t -113.72 102.91 14.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.32 174.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.01 109.8 17.93 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.404 173.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 65' ' ' LEU . . . . . 0.54 HD23 ' HB2' ' D' ' 54' ' ' ALA . 0.4 OUTLIER -129.66 168.9 15.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.107 0.479 . . . . 0.0 111.606 -174.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 66' ' ' ASP . . . . . 0.518 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 17.2 t0 -115.47 106.21 13.7 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.735 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.546 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 25.9 mt -123.6 143.03 50.48 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 68' ' ' ASN . . . . . 0.635 ' HB3' ' CD2' ' C' ' 90' ' ' TYR . 4.9 t30 -150.83 130.73 13.31 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.026 177.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 69' ' ' PHE . . . . . 0.506 ' HB2' HD13 ' D' ' 23' ' ' ILE . 3.2 m-85 -126.33 153.23 45.16 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 89.0 p -98.36 164.63 12.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.029 0.442 . . . . 0.0 110.819 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 71' ' ' LYS . . . . . 0.42 ' H ' ' HG3' ' D' ' 71' ' ' LYS . 0.0 OUTLIER -65.39 -5.49 7.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.824 177.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.19 -3.64 55.55 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.714 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -93.66 159.1 15.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.969 0.414 . . . . 0.0 110.836 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -144.25 125.53 14.69 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.529 HG22 ' HB2' ' D' ' 46' ' ' ALA . 18.1 pt -136.13 163.79 33.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.925 -166.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 76' ' ' MET . . . . . 0.418 ' SD ' ' HB3' ' D' ' 20' ' ' SER . 3.6 mtm -121.95 130.67 53.51 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.752 173.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 77' ' ' PHE . . . . . 0.593 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.9 OUTLIER -111.34 128.21 55.89 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.277 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 78' ' ' TYR . . . . . 0.673 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 33.5 p90 -151.7 138.39 18.8 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.239 0.543 . . . . 0.0 111.822 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 79' ' ' THR . . . . . 0.703 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 6.0 p -107.4 134.89 49.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.101 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.74 154.16 19.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.189 175.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.24 -175.88 39.89 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -175.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 82' ' ' ASP . . . . . 0.437 ' HA ' ' HB3' ' D' ' 15' ' ' PRO . 9.5 m-20 -113.65 103.27 11.06 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.172 178.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . 0.573 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -170.16 155.02 5.21 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.814 172.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 15.7 t -111.95 123.39 50.16 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.552 HG12 ' HB3' ' D' ' 34' ' ' LEU . 6.2 m -121.52 145.85 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.454 0.645 . . . . 0.0 112.631 -172.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 20.2 m -109.88 120.83 43.71 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.582 175.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 87' ' ' LEU . . . . . 0.615 HD13 HD23 ' D' ' 11' ' ' LEU . 4.7 mp -97.96 144.87 27.05 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 170.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.549 HD12 ' CZ ' ' D' ' 8' ' ' PHE . 2.4 mm? -124.46 146.48 48.91 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.013 174.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.09 -168.26 23.74 Favored Glycine 0 N--CA 1.435 -1.421 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.189 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 90' ' ' TYR . . . . . 0.584 ' CD2' ' HB3' ' E' ' 68' ' ' ASN . 9.8 p90 -151.46 128.55 11.12 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.825 0.821 . . . . 0.0 111.757 177.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . 0.482 HD23 ' HB3' ' D' ' 27' ' ' PHE . 6.9 mt -68.62 131.04 44.54 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.852 -1.522 . . . . 0.0 109.047 175.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -79.76 108.03 13.01 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.099 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -106.61 171.18 7.5 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.929 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 7.9 tp -172.88 143.48 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.17 162.92 14.44 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 31.5 t -126.15 31.69 5.38 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.066 0.46 . . . . 0.0 110.364 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.21 -139.98 3.14 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.263 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.63 -0.7 . . . . 0.0 109.43 179.205 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 121.065 0.46 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -100.58 98.6 9.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.236 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.87 53.04 3.68 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 121.159 -0.544 . . . . 0.0 112.636 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.55 -104.02 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 122.87 0.468 . . . . 0.0 109.824 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 42.3 ttp 53.57 28.73 8.18 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.646 176.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 6' ' ' ALA . . . . . 0.464 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . . . -67.31 123.48 20.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.236 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 7' ' ' MET . . . . . 0.425 ' HG2' ' OG ' ' A' ' 70' ' ' SER . 51.3 mtt -90.3 137.82 32.04 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.138 0.494 . . . . 0.0 111.634 -173.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 8' ' ' PHE . . . . . 0.576 ' CE1' HD21 ' A' ' 44' ' ' LEU . 60.4 t80 -60.51 141.21 56.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.367 -174.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 9' ' ' TRP . . . . . 0.505 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 92.1 t90 -130.32 144.7 51.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.966 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.03 140.96 9.23 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.44 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . 0.629 HD23 HD13 ' E' ' 87' ' ' LEU . 56.7 tp -133.53 109.09 9.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.864 0.364 . . . . 0.0 110.335 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -97.78 104.05 16.04 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 13' ' ' MET . . . . . 0.58 ' SD ' HD11 ' E' ' 87' ' ' LEU . 35.8 mtp -98.3 137.74 36.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.615 -175.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -101.13 159.12 30.38 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.99 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . 0.436 ' HB3' ' HA ' ' E' ' 82' ' ' ASP . 68.6 Cg_exo -43.01 118.55 1.29 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.632 2.888 . . . . 0.0 114.298 -177.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 16' ' ' GLU . . . . . 0.707 ' HA ' ' O ' ' E' ' 79' ' ' THR . 49.6 mt-10 57.02 56.14 5.53 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.109 174.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 17' ' ' ARG . . . . . 0.429 ' O ' ' HA ' ' E' ' 78' ' ' TYR . 30.4 mmt180 -117.17 144.05 45.17 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.019 175.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . 0.68 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 35.6 ttmt -126.14 112.87 16.32 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 123.573 0.546 . . . . 0.0 111.096 -176.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . 0.413 ' OH ' ' HA ' ' E' ' 13' ' ' MET . 2.3 m-85 -111.26 104.74 13.26 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.288 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 20' ' ' SER . . . . . 0.417 ' HB3' ' SD ' ' E' ' 76' ' ' MET . 3.8 p -88.03 104.79 16.99 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 173.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -124.07 148.04 47.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.482 0.658 . . . . 0.0 112.692 -168.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 13.1 t -90.88 161.11 15.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.536 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 23' ' ' ILE . . . . . 0.511 HD13 ' HB2' ' E' ' 69' ' ' PHE . 67.6 mt -114.34 131.31 66.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.125 0.488 . . . . 0.0 111.709 -173.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . 0.457 HD12 ' N ' ' E' ' 24' ' ' ILE . 4.2 mp -99.22 -48.92 11.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.0 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -114.49 140.62 48.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.61 177.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 19.1 m -63.58 109.35 1.63 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 173.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 27' ' ' PHE . . . . . 0.473 ' HB3' HD23 ' E' ' 91' ' ' LEU . 14.6 p90 -124.92 159.55 30.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.643 0.735 . . . . 0.0 112.88 -170.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 28' ' ' HIS . . . . . 0.582 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 9.3 t60 -116.45 125.83 52.53 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.047 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 29' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 61.1 mt -92.38 133.12 34.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 170.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . 0.582 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 32.9 p -118.96 -14.31 9.4 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -169.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 31' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -167.32 148.01 12.53 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.143 -1.504 . . . . 0.0 113.352 178.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.437 HG23 ' HG ' ' E' ' 87' ' ' LEU . 11.5 p -134.69 128.99 51.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 172.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.07 155.49 42.24 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 121.942 -0.474 . . . . 0.0 111.655 -174.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 34' ' ' LEU . . . . . 0.551 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.0 pp -121.0 142.29 49.93 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.511 0.672 . . . . 0.0 111.181 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -110.11 -50.05 3.01 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.476 173.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -103.17 127.46 50.46 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 168.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 152.17 158.85 8.64 Favored Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 119.875 -1.155 . . . . 0.0 113.293 176.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 38' ' ' GLN . . . . . 0.474 ' O ' ' HG3' ' E' ' 58' ' ' LYS . 94.4 mt-30 -102.47 -45.44 5.07 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 120.586 0.231 . . . . 0.0 111.39 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 39' ' ' GLU . . . . . 0.433 ' HG3' HG22 ' E' ' 57' ' ' THR . 13.4 tt0 -153.68 130.59 10.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.229 178.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . 0.583 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -131.41 113.83 14.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.388 0.613 . . . . 0.0 110.467 169.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 41' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -97.06 111.63 23.77 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.45 ' HG ' ' CG2' ' E' ' 53' ' ' VAL . 45.7 tp -83.69 112.57 20.17 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.627 -174.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -110.95 137.14 48.95 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.32 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 44' ' ' LEU . . . . . 0.594 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 1.2 tp -120.54 119.43 32.92 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.377 175.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 45' ' ' ALA . . . . . . . . . . . . . . . -106.24 114.15 28.1 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . 0.523 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -146.04 154.58 42.02 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.957 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 58.02 27.77 15.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.027 0.441 . . . . 0.0 110.406 -176.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm 59.23 44.61 15.38 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.749 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 49' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -150.89 140.23 21.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.922 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -85.89 127.1 34.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.15 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . 0.414 ' CB ' HD11 ' D' ' 88' ' ' LEU . 49.8 m-85 -123.23 123.96 41.94 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.669 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 tp -77.39 103.36 4.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 171.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . 0.45 ' CG2' ' HG ' ' E' ' 42' ' ' LEU . 2.8 m -86.83 -35.32 8.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.786 -173.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 54' ' ' ALA . . . . . 0.519 ' HB2' ' CD2' ' E' ' 65' ' ' LEU . . . -152.49 145.53 24.55 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.312 -0.555 . . . . 0.0 112.191 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 27.4 m -114.63 101.95 9.58 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 169.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . 0.454 HG13 ' HB3' ' E' ' 40' ' ' ALA . 7.4 p -115.92 112.99 41.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.783 0.802 . . . . 0.0 110.114 -176.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 57' ' ' THR . . . . . 0.433 HG22 ' HG3' ' E' ' 39' ' ' GLU . 82.8 p -123.4 -176.81 3.53 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.234 -175.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 58' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' E' ' 38' ' ' GLN . 34.6 mtmm -58.45 -34.8 71.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.199 0.523 . . . . 0.0 110.043 170.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 59' ' ' ALA . . . . . 0.404 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -73.24 -40.78 64.39 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.508 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 72.6 mt -115.38 80.67 7.87 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 61' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 10.3 Cg_exo -71.06 0.02 7.27 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.047 2.498 . . . . 0.0 113.448 -168.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -162.01 124.75 2.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.504 0.669 . . . . 0.0 111.08 -176.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 86.4 t -113.81 102.97 14.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.239 174.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.0 109.84 17.96 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.411 173.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.519 ' CD2' ' HB2' ' E' ' 54' ' ' ALA . 0.4 OUTLIER -129.62 168.97 15.64 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.081 0.467 . . . . 0.0 111.583 -174.657 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 66' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 17.1 t0 -115.68 106.26 13.68 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.708 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 67' ' ' LEU . . . . . 0.55 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 26.0 mt -123.55 143.0 50.47 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 175.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 68' ' ' ASN . . . . . 0.584 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 4.9 t30 -150.78 130.72 13.35 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.122 177.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 69' ' ' PHE . . . . . 0.511 ' HB2' HD13 ' E' ' 23' ' ' ILE . 3.1 m-85 -126.34 153.19 45.23 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 88.9 p -98.28 164.67 12.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.006 0.431 . . . . 0.0 110.786 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 71' ' ' LYS . . . . . 0.427 ' H ' ' HG3' ' E' ' 71' ' ' LYS . 0.0 OUTLIER -65.42 -5.57 7.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.781 177.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.18 -3.44 55.64 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 121.043 -0.599 . . . . 0.0 111.791 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -93.74 159.08 15.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.99 0.424 . . . . 0.0 110.747 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -144.21 125.47 14.67 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 174.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 75' ' ' ILE . . . . . 0.523 HG22 ' HB2' ' E' ' 46' ' ' ALA . 18.0 pt -136.09 163.8 33.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.92 -166.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 76' ' ' MET . . . . . 0.417 ' SD ' ' HB3' ' E' ' 20' ' ' SER . 3.7 mtm -121.95 130.76 53.59 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 173.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 77' ' ' PHE . . . . . 0.594 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.9 OUTLIER -111.41 128.18 55.9 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.248 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 78' ' ' TYR . . . . . 0.68 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 33.9 p90 -151.64 138.45 18.91 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.242 0.544 . . . . 0.0 111.8 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 79' ' ' THR . . . . . 0.707 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 6.2 p -107.4 134.84 49.86 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.13 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.67 154.17 19.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.17 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.19 -175.91 39.99 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -175.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 82' ' ' ASP . . . . . 0.436 ' HA ' ' HB3' ' E' ' 15' ' ' PRO . 9.2 m-20 -113.64 103.37 11.17 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.132 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 83' ' ' ALA . . . . . 0.583 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -170.24 155.03 5.14 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.832 172.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 16.2 t -112.03 123.45 50.28 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 85' ' ' VAL . . . . . 0.551 HG12 ' HB3' ' E' ' 34' ' ' LEU . 6.1 m -121.62 145.76 27.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.424 0.631 . . . . 0.0 112.617 -172.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 20.4 m -109.87 120.82 43.67 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.619 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 87' ' ' LEU . . . . . 0.629 HD13 HD23 ' E' ' 11' ' ' LEU . 4.7 mp -97.87 144.84 27.02 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 171.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . 0.552 HD12 ' CE1' ' E' ' 8' ' ' PHE . 2.4 mm? -124.4 146.46 48.86 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.075 174.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.07 -168.34 23.83 Favored Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.272 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 90' ' ' TYR . . . . . 0.664 ' CD2' ' HB3' ' A' ' 68' ' ' ASN . 9.9 p90 -151.4 128.57 11.17 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.814 0.816 . . . . 0.0 111.794 177.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 91' ' ' LEU . . . . . 0.473 HD23 ' HB3' ' E' ' 27' ' ' PHE . 7.1 mt -68.61 131.0 44.49 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 113.893 -1.503 . . . . 0.0 109.036 175.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -79.79 108.04 13.04 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.104 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -106.51 171.17 7.5 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.956 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 7.9 tp -172.93 143.38 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.08 162.97 14.34 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 31.0 t -126.07 31.65 5.4 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.208 0.527 . . . . 0.0 110.513 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.18 -139.96 3.14 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.524 -0.845 . . . . 0.0 112.243 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.509 -0.758 . . . . 0.0 109.392 179.315 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 69.16 -60.46 0.46 Allowed 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.82 0.7 . . . . 0.0 110.969 -176.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -91.01 -71.27 1.21 Allowed Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.93 176.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.21 133.16 43.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.019 0.438 . . . . 0.0 111.672 -177.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 67.4 mtp -144.18 -170.64 3.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.913 173.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' B' ' 70' ' ' SER . . . -50.14 137.56 17.51 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.677 0.611 . . . . 0.0 112.1 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 38.7 mtt -111.8 146.46 37.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.963 -176.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.438 ' CE1' HD21 ' B' ' 44' ' ' LEU . 61.0 t80 -64.7 146.39 54.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.54 -171.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.469 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 90.5 t90 -137.89 147.03 44.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.066 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.83 155.22 26.27 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.802 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.575 HD23 HD13 ' A' ' 87' ' ' LEU . 48.2 tp -143.86 108.72 4.93 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.768 0.318 . . . . 0.0 110.964 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -91.19 100.69 13.47 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.001 0.429 . . . . 0.0 110.057 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.519 ' SD ' HD11 ' A' ' 87' ' ' LEU . 57.0 mtp -90.56 138.03 31.88 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.21 -177.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.532 ' HB2' ' HD2' ' A' ' 17' ' ' ARG . 32.6 mmtp -101.24 150.94 37.57 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.911 -175.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.434 ' HD3' ' OG ' ' A' ' 84' ' ' SER . 81.9 Cg_exo -43.13 112.28 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 124.195 3.263 . . . . 0.0 114.745 -172.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.689 ' HA ' ' O ' ' A' ' 79' ' ' THR . 5.7 tt0 60.9 63.47 1.28 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.468 170.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.532 ' HD2' ' HB2' ' A' ' 14' ' ' LYS . 37.7 mtt85 -136.27 155.39 50.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.57 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.698 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 3.3 ttmp? -125.5 115.47 20.27 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.769 -175.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -112.6 119.49 38.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.866 176.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.3 p -79.54 133.39 36.47 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 172.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -108.69 115.95 31.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.08 0.467 . . . . 0.0 112.044 -167.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.6 m -93.18 123.12 36.23 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 169.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.9 mt -93.28 113.76 28.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.217 0.532 . . . . 0.0 111.548 -171.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.427 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.5 mp -85.66 -48.32 16.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.491 178.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.432 ' HD2' HD13 ' A' ' 91' ' ' LEU . 47.0 mttt -119.33 132.47 55.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.267 178.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.6 p -59.62 123.14 15.95 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.545 ' HB3' HD23 ' A' ' 91' ' ' LEU . 3.3 p90 -136.56 161.84 34.76 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -170.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.567 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 21.6 t60 -115.86 128.1 55.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.885 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.578 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 44.1 mt -98.76 131.7 45.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 170.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.567 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 40.5 p -116.05 -15.15 11.17 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -171.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.05 155.04 26.22 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 119.391 -1.385 . . . . 0.0 113.503 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.443 HG23 ' HG ' ' A' ' 87' ' ' LEU . 9.5 p -137.33 124.43 29.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 171.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 62' ' ' GLN . . . -125.87 150.04 48.2 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -170.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.865 ' HB2' HG22 ' A' ' 56' ' ' VAL . 1.8 tm? -104.53 109.52 21.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.689 -174.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.53 -59.42 1.95 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.914 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -104.09 129.4 51.77 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.605 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.588 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 134.84 177.59 15.06 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 119.275 -1.441 . . . . 0.0 113.506 174.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.429 ' HA ' ' HD2' ' A' ' 58' ' ' LYS . 74.4 mt-30 -103.41 -47.82 4.17 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.635 0.255 . . . . 0.0 111.295 176.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -151.2 133.27 15.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.42 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.88 114.86 17.02 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.322 0.582 . . . . 0.0 110.427 170.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -100.15 111.22 23.5 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.6 tp -84.2 115.78 22.6 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.044 -173.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.435 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 98.2 m-85 -117.47 145.34 44.24 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.497 ' HA ' ' O ' ' A' ' 76' ' ' MET . 0.2 OUTLIER -133.09 134.2 43.96 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 171.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -108.59 115.53 30.27 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.407 178.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.638 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -128.71 144.02 51.07 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 58.37 27.35 15.26 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -170.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.7 mttp 59.53 33.18 22.07 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.938 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.533 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 8.7 tp-100 -120.31 124.45 45.63 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -83.07 117.74 23.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.805 0.336 . . . . 0.0 110.878 -176.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -112.51 136.17 52.36 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.719 176.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.1 tp -78.38 109.89 13.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 168.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.481 HG13 ' CD2' ' E' ' 88' ' ' LEU . 2.7 t -82.97 -50.28 15.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.356 -173.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.433 ' HB1' HG11 ' A' ' 63' ' ' VAL . . . -155.4 144.16 20.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.187 -178.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.8 m -108.32 102.42 11.54 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 172.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.865 HG22 ' HB2' ' A' ' 34' ' ' LEU . 13.4 p -120.98 112.99 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-O 122.205 1.003 . . . . 0.0 110.781 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.7 p -123.31 -178.0 3.86 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.914 -174.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.429 ' HD2' ' HA ' ' A' ' 38' ' ' GLN . 29.8 mtpp -59.66 -31.55 69.64 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.053 0.454 . . . . 0.0 110.222 169.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.06 -40.35 62.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.614 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.7 mt -112.46 84.47 6.27 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 173.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.2 0.74 6.23 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.111 2.54 . . . . 0.0 114.352 -166.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 18.9 pt20 -169.81 130.46 1.02 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.096 0.474 . . . . 0.0 111.127 -177.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.433 HG11 ' HB1' ' A' ' 54' ' ' ALA . 95.4 t -118.81 116.56 51.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.297 175.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.44 122.41 39.3 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.04 176.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -138.78 168.5 19.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.057 0.456 . . . . 0.0 111.527 -176.566 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 7.7 t0 -116.07 99.56 7.33 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.188 0.518 . . . . 0.0 110.232 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.682 HD21 HD23 ' E' ' 88' ' ' LEU . 21.0 mt -113.42 137.37 51.63 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.893 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.66 ' HB2' ' CD2' ' E' ' 90' ' ' TYR . 3.8 m-20 -138.0 118.18 13.56 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 176.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -117.37 151.46 36.98 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.358 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' E' ' 6' ' ' ALA . 14.6 t -113.02 152.99 28.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.068 -177.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -69.68 -12.1 61.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.377 -176.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.2 -12.08 68.42 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.822 175.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -100.75 164.32 11.91 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -143.49 127.83 17.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.973 0.416 . . . . 0.0 109.961 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.638 HG22 ' HB2' ' A' ' 46' ' ' ALA . 10.9 pt -131.42 179.62 4.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.04 -170.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 12.0 mtm -136.05 135.56 39.51 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 171.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.447 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 1.1 m-85 -112.61 128.2 56.31 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.698 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 34.5 p90 -153.55 137.17 16.0 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.303 0.573 . . . . 0.0 112.105 -177.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.689 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 5.9 p -109.21 138.32 45.74 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.04 -177.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.79 162.3 13.91 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.194 176.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.87 -174.73 44.58 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -175.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -115.46 102.83 10.17 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.092 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.588 ' CB ' ' HA3' ' A' ' 37' ' ' GLY . . . -175.46 162.74 2.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.562 171.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.434 ' OG ' ' HD3' ' A' ' 15' ' ' PRO . 1.1 m -116.01 126.01 53.24 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.659 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.407 HG11 ' CG1' ' A' ' 56' ' ' VAL . 2.8 m -116.8 148.73 19.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -174.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.4 m -108.5 113.58 26.73 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.653 173.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.575 HD13 HD23 ' A' ' 11' ' ' LEU . 5.2 mp -89.62 148.64 23.22 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 170.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.702 HD23 HD21 ' B' ' 67' ' ' LEU . 0.9 OUTLIER -132.06 138.93 48.36 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.079 -178.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.7 -167.12 24.75 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.878 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.682 ' CD2' ' HB2' ' B' ' 68' ' ' ASN . 13.0 p90 -150.71 128.86 11.9 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.995 0.902 . . . . 0.0 111.745 177.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.545 HD23 ' HB3' ' A' ' 27' ' ' PHE . 8.2 mt -69.7 135.01 49.31 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 113.941 -1.481 . . . . 0.0 109.655 176.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -86.96 107.67 18.49 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -157.52 136.55 11.68 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -176.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.02 117.86 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.103 0.478 . . . . 0.0 110.77 -175.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -95.67 168.89 10.4 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.792 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 28.5 t 62.7 44.53 6.54 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.384 0.611 . . . . 0.0 109.986 -177.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.99 69.19 3.42 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.142 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.5 t . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.669 -0.681 . . . . 0.0 109.544 179.527 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 69.37 -60.59 0.46 Allowed 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.842 0.714 . . . . 0.0 110.925 -176.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.99 -71.16 1.21 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.958 176.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.21 133.17 43.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.02 0.438 . . . . 0.0 111.668 -177.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 67.1 mtp -144.16 -170.64 3.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.887 173.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' C' ' 70' ' ' SER . . . -50.14 137.64 17.36 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 123.706 0.629 . . . . 0.0 112.018 -176.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 38.7 mtt -111.9 146.41 37.81 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.904 -176.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.465 ' CE1' HD21 ' C' ' 44' ' ' LEU . 61.3 t80 -64.55 146.37 54.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.553 -171.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . 0.464 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 90.5 t90 -138.03 147.02 43.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.01 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.81 155.23 26.27 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.87 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.583 HD23 HD13 ' B' ' 87' ' ' LEU . 47.6 tp -143.88 108.78 4.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.743 0.306 . . . . 0.0 110.976 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -91.17 100.75 13.52 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.973 0.416 . . . . 0.0 110.039 173.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . 0.523 ' SD ' HD11 ' B' ' 87' ' ' LEU . 57.4 mtp -90.61 137.96 31.94 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.196 -177.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.524 ' HB2' ' HD2' ' B' ' 17' ' ' ARG . 32.6 mmtp -101.17 150.99 37.58 Favored Pre-proline 0 C--N 1.317 -0.834 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.938 -175.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.436 ' HD3' ' OG ' ' B' ' 84' ' ' SER . 83.3 Cg_exo -43.19 112.23 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 124.187 3.258 . . . . 0.0 114.853 -172.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.683 ' HA ' ' O ' ' B' ' 79' ' ' THR . 5.7 tt0 61.0 63.33 1.28 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.502 170.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.524 ' HD2' ' HB2' ' B' ' 14' ' ' LYS . 37.7 mtt85 -136.19 155.56 49.96 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.601 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.694 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 3.3 ttmp? -125.61 115.43 20.13 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.762 -175.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -112.64 119.38 37.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.842 176.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 10.1 p -79.55 133.33 36.46 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 172.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -108.67 116.03 31.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.063 0.459 . . . . 0.0 112.02 -167.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 28.3 m -93.12 123.16 36.19 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 169.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 52.9 mt -93.28 113.77 28.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.179 0.514 . . . . 0.0 111.536 -172.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.425 ' N ' HD12 ' B' ' 24' ' ' ILE . 4.5 mp -85.56 -48.46 16.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.543 178.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.444 ' HD2' HD13 ' B' ' 91' ' ' LEU . 47.2 mttt -119.32 132.46 55.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.267 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 12.7 p -59.58 123.09 15.74 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . 0.538 ' HB3' HD23 ' B' ' 91' ' ' LEU . 3.3 p90 -136.56 161.76 34.98 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -169.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' HIS . . . . . 0.565 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 22.0 t60 -115.83 128.03 55.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.847 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.583 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 43.7 mt -98.68 131.7 45.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 170.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.565 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 41.0 p -116.06 -15.16 11.17 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -171.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.15 154.98 26.13 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 119.377 -1.392 . . . . 0.0 113.535 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.443 HG23 ' HG ' ' B' ' 87' ' ' LEU . 9.5 p -137.26 124.4 30.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 171.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' B' ' 62' ' ' GLN . . . -125.77 150.05 48.07 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -170.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.885 ' HB2' HG22 ' B' ' 56' ' ' VAL . 1.8 tm? -104.6 109.58 21.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.688 -174.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.52 -59.47 1.94 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.917 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -104.02 129.38 51.64 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.712 175.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.585 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 134.73 177.53 15.01 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 119.222 -1.466 . . . . 0.0 113.485 174.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . 0.427 ' HA ' ' HD2' ' B' ' 58' ' ' LYS . 74.3 mt-30 -103.37 -47.85 4.17 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.633 0.254 . . . . 0.0 111.294 176.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -151.2 133.29 15.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.385 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.92 114.89 17.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.356 0.598 . . . . 0.0 110.453 170.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -100.15 111.14 23.42 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 48.2 tp -84.1 115.74 22.53 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.098 -173.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . 0.435 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 98.2 m-85 -117.43 145.37 44.18 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.487 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.2 OUTLIER -133.17 134.19 43.79 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.235 0.54 . . . . 0.0 109.549 171.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -108.51 115.54 30.29 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.357 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.635 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -128.8 144.06 51.07 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 58.42 27.29 15.25 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -170.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 59.7 mttp 59.46 33.24 22.19 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.923 -175.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.54 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 8.7 tp-100 -120.31 124.48 45.7 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -82.98 117.61 22.92 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.767 0.318 . . . . 0.0 111.01 -176.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -112.47 136.2 52.26 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.672 176.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 6.2 tp -78.33 109.86 13.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 168.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.506 HG13 ' CD2' ' A' ' 88' ' ' LEU . 2.7 t -83.08 -50.14 15.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.3 -173.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.424 ' HB1' HG11 ' B' ' 63' ' ' VAL . . . -155.46 144.14 20.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.141 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 23.6 m -108.38 102.49 11.59 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 172.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.885 HG22 ' HB2' ' B' ' 34' ' ' LEU . 13.3 p -121.01 112.95 37.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 122.224 1.012 . . . . 0.0 110.739 -175.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 68.2 p -123.29 -177.89 3.83 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.975 -174.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . 0.427 ' HD2' ' HA ' ' B' ' 38' ' ' GLN . 29.8 mtpp -59.66 -31.6 69.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.18 0.514 . . . . 0.0 110.223 169.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.06 -40.3 62.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.629 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 83.9 mt -112.52 84.6 6.46 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 173.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.18 0.68 6.32 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.051 2.501 . . . . 0.0 114.427 -166.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . 0.432 ' HA ' ' HA ' ' B' ' 33' ' ' ALA . 18.9 pt20 -169.77 130.49 1.03 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.167 0.508 . . . . 0.0 111.095 -177.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.424 HG11 ' HB1' ' B' ' 54' ' ' ALA . 95.6 t -118.8 116.53 51.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.308 175.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.45 122.3 39.2 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.067 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' B' ' 30' ' ' SER . 0.3 OUTLIER -138.67 168.57 19.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.02 0.438 . . . . 0.0 111.541 -176.617 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 7.6 t0 -116.07 99.56 7.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.145 0.498 . . . . 0.0 110.16 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.702 HD21 HD23 ' A' ' 88' ' ' LEU . 21.1 mt -113.48 137.21 51.88 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.978 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . 0.682 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 3.8 m-20 -137.88 118.16 13.66 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 176.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -117.42 151.51 36.9 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.271 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 6' ' ' ALA . 14.8 t -113.12 153.01 28.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.067 -177.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -69.65 -12.13 61.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.37 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.09 -12.19 68.48 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.849 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -100.72 164.25 11.95 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -143.44 127.9 17.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.936 0.398 . . . . 0.0 109.988 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.635 HG22 ' HB2' ' B' ' 46' ' ' ALA . 10.9 pt -131.56 179.63 4.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.958 -170.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.487 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 11.9 mtm -136.01 135.66 39.65 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 171.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . 0.46 ' CD1' ' HB2' ' B' ' 44' ' ' LEU . 1.1 m-85 -112.66 128.29 56.35 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.694 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 34.3 p90 -153.63 137.15 15.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.345 0.593 . . . . 0.0 112.093 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.683 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 5.9 p -109.15 138.21 45.86 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.068 -177.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.81 162.43 13.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.184 176.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.87 -174.78 44.64 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -175.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -115.45 102.83 10.17 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.614 -0.834 . . . . 0.0 110.026 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.585 ' CB ' ' HA3' ' B' ' 37' ' ' GLY . . . -175.54 162.69 2.84 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.528 171.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . 0.436 ' OG ' ' HD3' ' B' ' 15' ' ' PRO . 1.1 m -115.98 126.01 53.27 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.553 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.413 HG11 ' CG1' ' B' ' 56' ' ' VAL . 2.7 m -116.87 148.81 19.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.147 0.499 . . . . 0.0 112.329 -174.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . 0.419 ' OG ' HG22 ' C' ' 52' ' ' ILE . 43.1 m -108.52 113.63 26.8 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.63 173.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.583 HD13 HD23 ' B' ' 11' ' ' LEU . 5.3 mp -89.74 148.62 23.15 Favored 'General case' 0 CA--C 1.5 -0.953 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.448 170.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.675 HD23 HD21 ' C' ' 67' ' ' LEU . 0.9 OUTLIER -132.04 138.98 48.41 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.078 -178.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.78 -167.17 24.93 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.872 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' TYR . . . . . 0.66 ' CD2' ' HB2' ' C' ' 68' ' ' ASN . 12.9 p90 -150.66 128.84 11.93 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.889 0.852 . . . . 0.0 111.786 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . 0.538 HD23 ' HB3' ' B' ' 27' ' ' PHE . 8.3 mt -69.69 135.06 49.38 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.632 176.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -87.05 107.76 18.57 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 174.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -157.51 136.46 11.62 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.93 117.94 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.116 0.484 . . . . 0.0 110.759 -175.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -95.74 168.98 10.33 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.815 175.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 27.4 t 62.65 44.6 6.6 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.347 0.594 . . . . 0.0 109.881 -177.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . -83.09 69.43 3.38 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.036 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 12.2 t . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.75 -0.643 . . . . 0.0 109.643 179.346 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 69.4 -60.54 0.46 Allowed 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.822 0.701 . . . . 0.0 110.922 -176.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . -91.03 -71.23 1.21 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.943 176.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.22 133.2 43.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.981 0.42 . . . . 0.0 111.723 -177.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 67.0 mtp -144.18 -170.57 3.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.874 173.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 6' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' D' ' 70' ' ' SER . . . -50.18 137.63 17.56 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 123.692 0.62 . . . . 0.0 112.086 -176.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 38.6 mtt -111.88 146.36 37.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.921 -176.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 8' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' D' ' 46' ' ' ALA . 61.5 t80 -64.56 146.33 54.79 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.586 -171.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . 0.461 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 90.6 t90 -137.98 147.01 43.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.024 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.79 155.23 26.27 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.864 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.561 HD23 HD13 ' C' ' 87' ' ' LEU . 48.5 tp -143.93 108.71 4.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.805 0.336 . . . . 0.0 110.902 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -91.16 100.77 13.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.997 0.427 . . . . 0.0 109.992 173.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 13' ' ' MET . . . . . 0.515 ' SD ' HD11 ' C' ' 87' ' ' LEU . 57.3 mtp -90.65 137.96 31.95 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.216 -177.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . 0.513 ' HB2' ' HD2' ' C' ' 17' ' ' ARG . 32.6 mmtp -101.2 150.97 37.58 Favored Pre-proline 0 C--N 1.317 -0.81 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.898 -175.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . 0.438 ' HD3' ' OG ' ' C' ' 84' ' ' SER . 84.3 Cg_exo -43.15 112.33 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 124.146 3.231 . . . . 0.0 114.847 -172.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . 0.69 ' HA ' ' O ' ' C' ' 79' ' ' THR . 5.7 tt0 60.81 63.51 1.29 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.513 170.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 17' ' ' ARG . . . . . 0.513 ' HD2' ' HB2' ' C' ' 14' ' ' LYS . 37.8 mtt85 -136.28 155.53 49.96 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.613 178.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 18' ' ' LYS . . . . . 0.694 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 3.3 ttmp? -125.67 115.46 20.14 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.703 -175.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -112.73 119.42 38.01 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.893 176.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 10.0 p -79.53 133.46 36.47 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 172.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -108.68 116.03 31.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.089 0.471 . . . . 0.0 112.075 -167.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 28.3 m -93.19 123.2 36.3 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 169.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 52.8 mt -93.3 113.8 28.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.135 0.493 . . . . 0.0 111.448 -172.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . 0.425 HD12 ' N ' ' C' ' 24' ' ' ILE . 4.5 mp -85.62 -48.36 16.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.585 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . 0.451 ' HD2' HD13 ' C' ' 91' ' ' LEU . 47.1 mttt -119.39 132.4 55.83 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.242 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 12.4 p -59.54 123.13 15.87 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 177.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 27' ' ' PHE . . . . . 0.545 ' HB3' HD23 ' C' ' 91' ' ' LEU . 3.2 p90 -136.6 161.79 34.91 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -170.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 28' ' ' HIS . . . . . 0.572 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 21.9 t60 -115.83 128.06 55.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.26 -1.337 . . . . 0.0 109.879 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . 0.578 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 44.3 mt -98.69 131.71 45.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 170.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.572 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 39.7 p -116.06 -15.19 11.16 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.813 -171.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.04 155.04 26.22 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 119.355 -1.403 . . . . 0.0 113.533 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.438 HG23 ' HG ' ' C' ' 87' ' ' LEU . 9.5 p -137.36 124.36 29.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 171.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' C' ' 62' ' ' GLN . . . -125.78 150.17 47.99 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -170.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.868 ' HB2' HG22 ' C' ' 56' ' ' VAL . 1.8 tm? -104.68 109.58 21.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.63 -174.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.55 -59.45 1.95 Allowed 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.925 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -104.03 129.25 51.65 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.689 175.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 37' ' ' GLY . . . . . 0.593 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 134.87 177.7 15.14 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 119.339 -1.41 . . . . 0.0 113.451 174.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 38' ' ' GLN . . . . . 0.422 ' HA ' ' HD2' ' C' ' 58' ' ' LYS . 74.5 mt-30 -103.43 -47.84 4.16 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.69 0.281 . . . . 0.0 111.303 176.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -151.12 133.22 15.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.441 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.401 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -128.89 114.83 16.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.336 0.589 . . . . 0.0 110.404 170.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -100.07 111.25 23.55 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 48.6 tp -84.2 115.88 22.65 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.004 -173.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 43' ' ' TYR . . . . . 0.435 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 98.2 m-85 -117.51 145.38 44.26 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 176.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.492 ' HA ' ' O ' ' C' ' 76' ' ' MET . 0.2 OUTLIER -133.14 134.1 43.74 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 171.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -108.56 115.5 30.21 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.418 178.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.616 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -128.68 143.99 51.06 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 58.44 27.31 15.3 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -170.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 59.7 mttp 59.53 33.17 22.07 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.957 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . 0.545 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 8.7 tp-100 -120.2 124.39 45.59 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -83.05 117.75 23.05 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.917 0.389 . . . . 0.0 110.97 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -112.53 136.27 52.25 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.692 176.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . 0.419 HG22 ' OG ' ' B' ' 86' ' ' SER . 6.1 tp -78.4 109.92 13.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 168.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 53' ' ' VAL . . . . . 0.509 HG13 ' CD2' ' B' ' 88' ' ' LEU . 2.7 t -83.04 -50.21 15.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.377 -173.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 54' ' ' ALA . . . . . 0.421 ' HB1' HG11 ' C' ' 63' ' ' VAL . . . -155.49 144.09 20.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.187 -178.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 23.7 m -108.3 102.54 11.66 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 172.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . 0.868 HG22 ' HB2' ' C' ' 34' ' ' LEU . 13.3 p -121.02 113.02 38.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 122.225 1.012 . . . . 0.0 110.753 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 68.3 p -123.32 -177.95 3.85 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.969 -174.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 58' ' ' LYS . . . . . 0.422 ' HD2' ' HA ' ' C' ' 38' ' ' GLN . 29.8 mtpp -59.61 -31.62 69.66 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.106 0.479 . . . . 0.0 110.249 169.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.0 -40.38 62.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.598 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 84.0 mt -112.48 84.55 6.36 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 173.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.28 0.73 6.3 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.07 2.513 . . . . 0.0 114.367 -166.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . 0.44 ' HA ' ' HA ' ' C' ' 33' ' ' ALA . 18.8 pt20 -169.8 130.5 1.02 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.169 0.509 . . . . 0.0 111.133 -177.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.421 HG11 ' HB1' ' C' ' 54' ' ' ALA . 95.6 t -118.74 116.61 51.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.283 175.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.51 122.35 39.31 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.01 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' C' ' 30' ' ' SER . 0.3 OUTLIER -138.7 168.58 19.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.495 -176.576 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 66' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 7.6 t0 -116.1 99.51 7.29 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.232 0.539 . . . . 0.0 110.231 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.675 HD21 HD23 ' B' ' 88' ' ' LEU . 21.1 mt -113.43 137.26 51.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.916 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . 0.66 ' HB2' ' CD2' ' B' ' 90' ' ' TYR . 3.8 m-20 -137.91 118.1 13.56 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 176.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -117.36 151.44 37.01 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.257 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' B' ' 6' ' ' ALA . 14.8 t -113.06 153.07 28.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.085 -177.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -69.65 -12.24 61.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.322 -176.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.07 -12.17 68.59 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.818 -0.705 . . . . 0.0 111.911 175.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -100.68 164.33 11.92 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -143.49 127.93 17.9 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.616 HG22 ' HB2' ' C' ' 46' ' ' ALA . 10.8 pt -131.49 179.64 4.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.995 -170.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.492 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 12.0 mtm -136.08 135.62 39.49 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 171.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 77' ' ' PHE . . . . . 0.455 ' CD1' ' HB2' ' C' ' 44' ' ' LEU . 1.1 m-85 -112.56 128.2 56.29 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 78' ' ' TYR . . . . . 0.694 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 34.3 p90 -153.6 137.24 16.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.314 0.578 . . . . 0.0 112.031 -177.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . 0.69 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 5.9 p -109.21 138.1 46.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.103 -177.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.73 162.36 13.85 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.223 176.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.82 -174.79 44.72 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -175.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -115.48 102.8 10.14 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.078 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . 0.593 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -175.42 162.7 2.9 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.571 171.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . 0.438 ' OG ' ' HD3' ' C' ' 15' ' ' PRO . 1.0 OUTLIER -115.95 125.86 53.11 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.654 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.408 HG11 ' CG1' ' C' ' 56' ' ' VAL . 2.8 m -116.76 148.91 19.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.213 0.53 . . . . 0.0 112.358 -174.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 42.8 m -108.54 113.59 26.73 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.645 173.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . 0.561 HD13 HD23 ' C' ' 11' ' ' LEU . 5.3 mp -89.68 148.59 23.21 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 170.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . 0.707 HD23 HD21 ' D' ' 67' ' ' LEU . 0.9 OUTLIER -132.01 138.94 48.43 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.098 -178.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.71 -167.06 24.67 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.847 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 90' ' ' TYR . . . . . 0.674 ' CD2' ' HB2' ' D' ' 68' ' ' ASN . 12.8 p90 -150.74 128.77 11.81 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.91 0.862 . . . . 0.0 111.769 177.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . 0.545 HD23 ' HB3' ' C' ' 27' ' ' PHE . 8.3 mt -69.72 135.04 49.32 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.964 -1.471 . . . . 0.0 109.6 176.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -87.05 107.8 18.59 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -157.55 136.45 11.57 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -176.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.95 117.77 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.113 0.483 . . . . 0.0 110.762 -175.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -95.68 168.92 10.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.82 175.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 29.0 t 62.61 44.69 6.61 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.382 0.61 . . . . 0.0 109.887 -177.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -83.09 69.26 3.41 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.045 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 12.5 t . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.628 -0.701 . . . . 0.0 109.569 179.477 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 69.43 -60.51 0.46 Allowed 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.79 0.681 . . . . 0.0 110.879 -176.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . -91.15 -71.05 1.21 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.922 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.28 133.08 44.09 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.993 0.425 . . . . 0.0 111.674 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 67.1 mtp -144.11 -170.6 3.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.836 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 6' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' E' ' 70' ' ' SER . . . -50.2 137.67 17.55 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 123.677 0.611 . . . . 0.0 112.037 -176.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 38.6 mtt -111.89 146.46 37.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.986 -176.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 8' ' ' PHE . . . . . 0.439 ' CE1' HD21 ' E' ' 44' ' ' LEU . 61.1 t80 -64.59 146.44 54.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.481 -171.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 9' ' ' TRP . . . . . 0.465 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 90.5 t90 -138.09 147.06 43.65 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.034 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.85 155.17 26.24 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.792 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.582 HD23 HD13 ' D' ' 87' ' ' LEU . 48.4 tp -143.87 108.75 4.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.766 0.317 . . . . 0.0 110.973 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -91.23 100.75 13.51 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.002 0.429 . . . . 0.0 110.021 173.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 13' ' ' MET . . . . . 0.519 ' SD ' HD11 ' D' ' 87' ' ' LEU . 57.3 mtp -90.56 137.93 31.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.196 -177.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 14' ' ' LYS . . . . . 0.519 ' HB2' ' HD2' ' D' ' 17' ' ' ARG . 32.6 mmtp -101.22 150.99 37.6 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.909 -175.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . 0.436 ' HD3' ' OG ' ' D' ' 84' ' ' SER . 81.9 Cg_exo -43.3 112.34 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 124.133 3.222 . . . . 0.0 114.796 -172.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . 0.694 ' HA ' ' O ' ' D' ' 79' ' ' THR . 5.7 tt0 60.92 63.38 1.29 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.572 170.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 17' ' ' ARG . . . . . 0.519 ' HD2' ' HB2' ' D' ' 14' ' ' LYS . 37.7 mtt85 -136.22 155.45 50.1 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.613 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . 0.685 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 3.3 ttmp? -125.55 115.46 20.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.755 -175.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -112.75 119.36 37.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.878 176.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 10.0 p -79.55 133.42 36.46 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 172.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -108.7 116.0 31.16 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.089 0.471 . . . . 0.0 112.1 -167.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 28.4 m -93.08 123.17 36.15 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 169.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 52.5 mt -93.29 113.73 28.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.214 0.531 . . . . 0.0 111.542 -172.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . 0.436 HD12 ' N ' ' D' ' 24' ' ' ILE . 4.5 mp -85.64 -48.35 16.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.58 178.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . 0.443 ' HD2' HD13 ' D' ' 91' ' ' LEU . 47.1 mttt -119.35 132.45 55.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.283 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 12.5 p -59.54 123.14 15.91 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 27' ' ' PHE . . . . . 0.551 ' HB3' HD23 ' D' ' 91' ' ' LEU . 3.2 p90 -136.59 161.74 35.07 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -170.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 28' ' ' HIS . . . . . 0.561 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 22.1 t60 -115.78 128.07 55.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.899 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 29' ' ' ILE . . . . . 0.59 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 44.0 mt -98.67 131.6 45.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 170.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . 0.561 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 41.3 p -115.96 -15.24 11.22 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -171.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.06 155.06 26.24 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 119.41 -1.376 . . . . 0.0 113.53 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.424 HG23 ' HG ' ' D' ' 87' ' ' LEU . 9.6 p -137.38 124.37 29.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 171.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' D' ' 62' ' ' GLN . . . -125.81 150.0 48.17 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -170.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 34' ' ' LEU . . . . . 0.851 ' HB2' HG22 ' D' ' 56' ' ' VAL . 1.8 tm? -104.58 109.53 21.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.65 -174.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.49 -59.51 1.94 Allowed 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.851 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -104.0 129.41 51.6 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 175.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . 0.595 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 134.73 177.58 15.05 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 119.306 -1.426 . . . . 0.0 113.489 174.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 38' ' ' GLN . . . . . 0.412 ' HA ' ' HD2' ' D' ' 58' ' ' LYS . 74.3 mt-30 -103.33 -47.79 4.19 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.691 0.282 . . . . 0.0 111.361 176.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -151.22 133.25 15.16 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.326 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.86 114.84 17.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.334 0.588 . . . . 0.0 110.447 170.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -100.15 111.16 23.44 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 48.5 tp -84.03 115.85 22.55 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.085 -173.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 43' ' ' TYR . . . . . 0.437 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 98.2 m-85 -117.52 145.38 44.26 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.49 ' HA ' ' O ' ' D' ' 76' ' ' MET . 0.2 OUTLIER -133.15 134.21 43.87 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 171.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 45' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -108.65 115.65 30.5 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.298 178.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.631 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -128.82 144.03 51.06 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 175.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 58.4 27.36 15.31 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -170.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 59.8 mttp 59.35 33.24 22.37 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.968 -175.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . 0.544 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 8.7 tp-100 -120.22 124.49 45.81 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -82.88 117.64 22.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.768 0.318 . . . . 0.0 111.011 -176.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -112.48 136.29 52.16 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.713 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 6.2 tp -78.43 109.83 13.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 168.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 53' ' ' VAL . . . . . 0.496 HG13 ' CD2' ' C' ' 88' ' ' LEU . 2.7 t -82.99 -50.22 15.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.311 -173.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 54' ' ' ALA . . . . . 0.437 ' HB1' HG11 ' D' ' 63' ' ' VAL . . . -155.47 144.1 20.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.175 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 23.7 m -108.26 102.54 11.65 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 172.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 56' ' ' VAL . . . . . 0.851 HG22 ' HB2' ' D' ' 34' ' ' LEU . 13.2 p -121.06 112.93 37.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 122.15 0.976 . . . . 0.0 110.743 -175.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 69.4 p -123.29 -177.87 3.82 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.937 -174.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 58' ' ' LYS . . . . . 0.412 ' HD2' ' HA ' ' D' ' 38' ' ' GLN . 29.8 mtpp -59.74 -31.53 69.72 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.184 169.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.09 -40.33 62.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.582 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 83.5 mt -112.43 84.56 6.3 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 173.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.18 0.73 6.24 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.017 2.478 . . . . 0.0 114.465 -166.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . 0.437 ' HA ' ' HA ' ' D' ' 33' ' ' ALA . 18.9 pt20 -169.82 130.46 1.02 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.197 0.522 . . . . 0.0 111.088 -177.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.437 HG11 ' HB1' ' D' ' 54' ' ' ALA . 95.0 t -118.82 116.71 51.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.237 175.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.51 122.4 39.37 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.039 176.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 65' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' D' ' 30' ' ' SER . 0.3 OUTLIER -138.76 168.58 19.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.465 -176.574 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 66' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 7.7 t0 -116.12 99.47 7.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.275 0.56 . . . . 0.0 110.26 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.707 HD21 HD23 ' C' ' 88' ' ' LEU . 21.0 mt -113.32 137.31 51.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.01 178.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 68' ' ' ASN . . . . . 0.674 ' HB2' ' CD2' ' C' ' 90' ' ' TYR . 3.8 m-20 -137.95 118.21 13.63 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 176.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -117.48 151.36 37.26 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.236 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . 0.507 ' HB2' ' O ' ' C' ' 6' ' ' ALA . 14.7 t -112.97 153.06 28.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.094 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -69.72 -12.12 61.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.377 -176.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.14 -12.14 68.46 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.832 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -100.8 164.28 11.92 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -143.48 127.92 17.91 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.021 0.438 . . . . 0.0 109.928 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.631 HG22 ' HB2' ' D' ' 46' ' ' ALA . 10.9 pt -131.55 179.63 4.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.013 -170.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 76' ' ' MET . . . . . 0.49 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 12.0 mtm -136.08 135.58 39.45 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 171.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 77' ' ' PHE . . . . . 0.453 ' CD1' ' HB2' ' D' ' 44' ' ' LEU . 1.1 m-85 -112.61 128.26 56.32 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 78' ' ' TYR . . . . . 0.685 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 34.4 p90 -153.63 137.11 15.88 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.336 0.589 . . . . 0.0 112.064 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 79' ' ' THR . . . . . 0.694 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 5.9 p -109.09 138.22 45.79 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.07 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.83 162.47 13.77 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.14 176.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.82 -174.87 44.8 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 -175.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -115.41 102.8 10.16 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.037 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . 0.595 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -175.4 162.71 2.92 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.563 171.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 84' ' ' SER . . . . . 0.436 ' OG ' ' HD3' ' D' ' 15' ' ' PRO . 1.1 m -115.98 126.08 53.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.614 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.413 HG11 ' CG1' ' D' ' 56' ' ' VAL . 2.7 m -116.84 148.76 19.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.119 0.485 . . . . 0.0 112.306 -174.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 42.4 m -108.41 113.68 26.92 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.63 173.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 87' ' ' LEU . . . . . 0.582 HD13 HD23 ' D' ' 11' ' ' LEU . 5.2 mp -89.76 148.63 23.13 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 170.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.685 HD23 HD21 ' E' ' 67' ' ' LEU . 0.9 OUTLIER -132.1 138.99 48.32 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.002 -178.839 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.73 -167.15 24.84 Favored Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.897 -177.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 90' ' ' TYR . . . . . 0.656 ' CD2' ' HB2' ' E' ' 68' ' ' ASN . 13.0 p90 -150.66 128.86 11.95 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.873 0.844 . . . . 0.0 111.797 177.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . 0.551 HD23 ' HB3' ' D' ' 27' ' ' PHE . 8.1 mt -69.78 135.03 49.23 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.669 176.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -87.0 107.74 18.54 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -157.5 136.42 11.61 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -176.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.96 117.93 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.214 0.531 . . . . 0.0 110.74 -175.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -95.78 168.93 10.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.749 175.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 27.8 t 62.64 44.56 6.66 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.32 0.581 . . . . 0.0 109.942 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . -83.05 69.27 3.41 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.037 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 12.3 t . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.626 -0.702 . . . . 0.0 109.608 179.336 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 69.4 -60.51 0.46 Allowed 'General case' 0 N--CA 1.469 0.489 0 O-C-N 123.934 0.771 . . . . 0.0 110.933 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . -91.02 -71.26 1.21 Allowed Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.929 176.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.09 133.12 43.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.939 0.399 . . . . 0.0 111.675 -177.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 67.2 mtp -144.19 -170.57 3.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.887 173.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 6' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 70' ' ' SER . . . -50.12 137.59 17.36 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 123.626 0.579 . . . . 0.0 112.069 -176.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 38.7 mtt -111.84 146.44 37.69 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.003 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 8' ' ' PHE . . . . . 0.428 ' CE1' HD21 ' A' ' 44' ' ' LEU . 61.0 t80 -64.68 146.44 54.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.525 -171.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 9' ' ' TRP . . . . . 0.455 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 90.4 t90 -137.99 146.98 43.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.056 178.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.76 155.21 26.27 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.875 177.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . 0.578 HD23 HD13 ' E' ' 87' ' ' LEU . 47.9 tp -143.93 108.78 4.93 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.803 0.335 . . . . 0.0 111.014 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -91.17 100.72 13.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.98 0.419 . . . . 0.0 110.066 173.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 13' ' ' MET . . . . . 0.515 ' SD ' HD11 ' E' ' 87' ' ' LEU . 57.3 mtp -90.56 137.97 31.93 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.141 -177.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 14' ' ' LYS . . . . . 0.521 ' HB2' ' HD2' ' E' ' 17' ' ' ARG . 32.6 mmtp -101.28 150.94 37.59 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.884 -175.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . 0.431 ' HD3' ' OG ' ' E' ' 84' ' ' SER . 84.4 Cg_exo -43.1 112.18 0.27 Allowed 'Trans proline' 0 N--CA 1.474 0.368 0 C-N-CA 124.157 3.238 . . . . 0.0 114.869 -172.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 16' ' ' GLU . . . . . 0.693 ' HA ' ' O ' ' E' ' 79' ' ' THR . 5.7 tt0 61.06 63.24 1.28 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.579 170.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 17' ' ' ARG . . . . . 0.521 ' HD2' ' HB2' ' E' ' 14' ' ' LYS . 38.0 mtt85 -136.19 155.47 50.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.611 178.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . 0.687 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 3.3 ttmp? -125.51 115.38 20.12 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.777 -175.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -112.58 119.4 38.0 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 176.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 10.1 p -79.58 133.29 36.44 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -108.57 116.04 31.22 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.076 0.465 . . . . 0.0 112.098 -167.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 28.4 m -93.05 123.14 36.1 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 169.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 52.7 mt -93.27 113.8 28.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.242 0.544 . . . . 0.0 111.513 -172.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . 0.435 HD12 ' N ' ' E' ' 24' ' ' ILE . 4.5 mp -85.64 -48.37 16.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.502 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . 0.449 ' HD2' HD13 ' E' ' 91' ' ' LEU . 47.2 mttt -119.32 132.45 55.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.214 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 12.6 p -59.5 123.15 15.9 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 27' ' ' PHE . . . . . 0.533 ' HB3' HD23 ' E' ' 91' ' ' LEU . 3.3 p90 -136.55 161.73 35.06 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -170.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 28' ' ' HIS . . . . . 0.571 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 22.0 t60 -115.78 128.16 55.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.894 178.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 29' ' ' ILE . . . . . 0.578 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 44.3 mt -98.8 131.72 45.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 170.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . 0.571 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 41.0 p -116.08 -15.09 11.16 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.858 -171.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.11 155.05 26.24 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 119.307 -1.425 . . . . 0.0 113.494 178.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.438 HG23 ' HG ' ' E' ' 87' ' ' LEU . 9.6 p -137.29 124.27 29.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 171.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' E' ' 62' ' ' GLN . . . -125.76 150.11 48.01 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -170.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 34' ' ' LEU . . . . . 0.872 ' HB2' HG22 ' E' ' 56' ' ' VAL . 1.8 tm? -104.61 109.58 21.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.628 -174.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.58 -59.45 1.95 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.87 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -104.02 129.41 51.64 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.68 175.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . 0.594 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 134.7 177.61 15.07 Favored Glycine 0 N--CA 1.437 -1.244 0 C-N-CA 119.325 -1.417 . . . . 0.0 113.506 174.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 38' ' ' GLN . . . . . 0.421 ' HA ' ' HD2' ' E' ' 58' ' ' LYS . 74.4 mt-30 -103.33 -47.89 4.17 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.669 0.271 . . . . 0.0 111.306 176.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -151.16 133.23 15.2 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.404 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . 0.402 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -128.89 114.89 17.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.394 0.616 . . . . 0.0 110.413 170.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 41' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -100.16 111.14 23.42 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 48.5 tp -84.08 115.75 22.53 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.061 -173.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 43' ' ' TYR . . . . . 0.427 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 98.2 m-85 -117.46 145.38 44.2 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 44' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' E' ' 76' ' ' MET . 0.2 OUTLIER -133.13 134.18 43.86 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 171.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 45' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -108.57 115.51 30.23 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.344 178.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . 0.615 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -128.74 143.95 51.05 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 58.57 27.22 15.39 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -170.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 59.7 mttp 59.49 33.17 22.13 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.937 -175.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 49' ' ' GLN . . . . . 0.543 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 8.7 tp-100 -120.24 124.5 45.82 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -83.07 117.68 23.02 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.826 0.346 . . . . 0.0 110.92 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -112.48 136.36 52.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.663 176.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 6.2 tp -78.5 109.88 13.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 168.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . 0.503 HG13 ' CD2' ' D' ' 88' ' ' LEU . 2.7 t -83.02 -50.24 15.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.319 -173.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 54' ' ' ALA . . . . . 0.425 ' HB1' HG11 ' E' ' 63' ' ' VAL . . . -155.39 144.19 20.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.205 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 23.6 m -108.37 102.51 11.61 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 172.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . 0.872 HG22 ' HB2' ' E' ' 34' ' ' LEU . 13.2 p -121.0 112.98 38.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 122.143 0.973 . . . . 0.0 110.761 -175.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 70.6 p -123.25 -177.87 3.82 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.982 -174.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 58' ' ' LYS . . . . . 0.421 ' HD2' ' HA ' ' E' ' 38' ' ' GLN . 29.8 mtpp -59.81 -31.51 69.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.03 0.443 . . . . 0.0 110.228 169.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.99 -40.47 62.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.566 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 83.9 mt -112.46 84.58 6.36 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 173.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.25 0.71 6.31 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.043 2.495 . . . . 0.0 114.393 -166.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 62' ' ' GLN . . . . . 0.435 ' HA ' ' HA ' ' E' ' 33' ' ' ALA . 18.9 pt20 -169.68 130.56 1.05 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.106 0.479 . . . . 0.0 111.085 -177.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . 0.425 HG11 ' HB1' ' E' ' 54' ' ' ALA . 95.8 t -118.84 116.64 51.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.328 175.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.45 122.31 39.21 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.049 176.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' E' ' 30' ' ' SER . 0.3 OUTLIER -138.72 168.55 19.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.436 -176.543 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 66' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 7.6 t0 -116.05 99.54 7.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.207 0.527 . . . . 0.0 110.201 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 67' ' ' LEU . . . . . 0.685 HD21 HD23 ' D' ' 88' ' ' LEU . 21.0 mt -113.45 137.36 51.65 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.918 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 68' ' ' ASN . . . . . 0.656 ' HB2' ' CD2' ' D' ' 90' ' ' TYR . 3.8 m-20 -137.98 118.16 13.56 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 176.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -117.38 151.42 37.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.36 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 70' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' D' ' 6' ' ' ALA . 15.1 t -113.06 152.97 28.89 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -177.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -69.69 -12.19 61.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.305 -176.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.06 -12.15 68.63 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.903 175.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -100.67 164.3 11.94 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -143.51 127.91 17.87 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 75' ' ' ILE . . . . . 0.615 HG22 ' HB2' ' E' ' 46' ' ' ALA . 10.9 pt -131.52 179.66 4.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.004 -170.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 76' ' ' MET . . . . . 0.483 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 11.9 mtm -136.09 135.51 39.39 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 171.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 77' ' ' PHE . . . . . 0.458 ' CD1' ' HB2' ' E' ' 44' ' ' LEU . 1.1 m-85 -112.55 128.25 56.3 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 78' ' ' TYR . . . . . 0.687 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 34.5 p90 -153.57 137.2 16.01 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.295 0.569 . . . . 0.0 112.133 -177.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 79' ' ' THR . . . . . 0.693 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 5.8 p -109.25 138.23 45.92 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.028 -177.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.77 162.42 13.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.16 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.8 -174.73 44.71 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.511 -1.035 . . . . 0.0 110.511 -175.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -115.51 102.8 10.13 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.119 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 83' ' ' ALA . . . . . 0.594 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -175.47 162.63 2.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.574 171.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 84' ' ' SER . . . . . 0.431 ' OG ' ' HD3' ' E' ' 15' ' ' PRO . 1.0 OUTLIER -115.89 125.94 53.28 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.666 179.727 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 85' ' ' VAL . . . . . 0.412 HG11 ' CG1' ' E' ' 56' ' ' VAL . 2.8 m -116.73 148.79 19.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -174.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 43.6 m -108.53 113.7 26.94 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.573 173.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 87' ' ' LEU . . . . . 0.578 HD13 HD23 ' E' ' 11' ' ' LEU . 5.2 mp -89.76 148.61 23.14 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 170.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . 0.682 HD23 HD21 ' A' ' 67' ' ' LEU . 0.9 OUTLIER -132.0 138.92 48.45 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.06 -178.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.64 -167.0 24.51 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.932 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 90' ' ' TYR . . . . . 0.66 ' CD2' ' HB2' ' A' ' 68' ' ' ASN . 13.2 p90 -150.75 128.82 11.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.851 0.834 . . . . 0.0 111.816 177.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 91' ' ' LEU . . . . . 0.533 HD23 ' HB3' ' E' ' 27' ' ' PHE . 8.3 mt -69.77 134.98 49.18 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.634 176.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -86.98 107.76 18.54 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -157.56 136.38 11.51 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -176.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.87 117.94 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.19 0.519 . . . . 0.0 110.76 -175.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -95.84 168.84 10.4 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.772 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 28.6 t 62.76 44.64 6.33 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.43 0.634 . . . . 0.0 109.891 -177.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . -83.06 69.2 3.42 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.077 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 12.4 t . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.703 -0.665 . . . . 0.0 109.485 179.554 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.528 ' O ' ' HB3' ' B' ' 25' ' ' LYS . 53.4 p90 . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -99.73 146.29 26.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 176.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -125.19 113.4 1.92 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.782 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -102.12 58.01 0.81 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.214 0.53 . . . . 0.0 110.241 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.408 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 24.8 mmt -101.97 -160.49 0.79 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.272 -176.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.408 ' H ' ' HB3' ' A' ' 5' ' ' MET . . . -50.75 148.37 4.08 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.139 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.441 ' HB2' HD12 ' A' ' 91' ' ' LEU . 47.5 mtt -108.53 165.61 11.4 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.309 -175.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.456 ' CE1' HD21 ' B' ' 44' ' ' LEU . 56.3 t80 -76.19 151.97 36.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.1 0.476 . . . . 0.0 112.194 -176.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.485 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 89.5 t90 -143.76 147.37 34.08 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.639 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.439 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -151.42 156.47 26.69 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.236 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.564 HD23 HD13 ' A' ' 87' ' ' LEU . 61.2 tp -149.01 109.66 4.25 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.854 0.359 . . . . 0.0 111.394 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -86.03 121.17 28.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.423 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.678 ' SD ' ' HE2' ' A' ' 19' ' ' TYR . 72.4 mmm -101.74 137.37 40.13 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.905 0.383 . . . . 0.0 111.056 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.495 ' HE3' ' HA ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -101.27 146.43 32.17 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.835 175.714 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -49.9 113.39 0.97 Allowed 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 123.174 2.583 . . . . 0.0 113.047 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 61.04 52.06 4.22 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.906 176.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -125.54 138.4 53.96 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.785 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.677 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 51.8 mttp -109.66 126.87 54.12 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.816 0.341 . . . . 0.0 111.767 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.678 ' HE2' ' SD ' ' A' ' 13' ' ' MET . 2.4 m-85 -111.64 103.79 12.12 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 173.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.2 p -86.06 100.58 12.26 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 173.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -114.92 148.78 38.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.379 0.609 . . . . 0.0 112.241 -168.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.9 m -107.97 141.95 38.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.132 173.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 69.0 mt -102.2 138.38 26.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.149 0.5 . . . . 0.0 111.74 -173.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.434 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.1 mp -110.62 -43.4 5.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.196 176.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.509 ' HD2' HD13 ' A' ' 91' ' ' LEU . 15.1 pttm -113.94 120.6 41.24 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.078 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.5 p -58.25 132.15 52.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.66 -178.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.59 ' HB3' HD23 ' A' ' 91' ' ' LEU . 54.5 p90 -139.2 157.6 45.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.577 0.703 . . . . 0.0 112.362 -176.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.626 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 7.1 t60 -114.69 124.76 52.63 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.458 177.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 42.7 mt -89.95 134.93 27.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 171.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.626 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 28.3 p -122.14 -12.32 8.32 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -171.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.12 155.81 27.31 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 119.617 -1.278 . . . . 0.0 113.195 177.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.438 ' CG2' ' HG ' ' A' ' 87' ' ' LEU . 12.3 p -143.3 125.53 12.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 172.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.436 ' HA ' HG21 ' A' ' 56' ' ' VAL . . . -144.22 161.01 39.99 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 122.036 -0.415 . . . . 0.0 111.66 -174.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.641 ' HB3' HG12 ' A' ' 85' ' ' VAL . 3.3 pp -123.44 142.32 51.11 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.828 0.823 . . . . 0.0 111.574 177.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -104.11 -52.6 2.9 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.444 173.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -104.22 128.6 51.96 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.308 -0.626 . . . . 0.0 109.308 169.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.417 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 151.95 156.07 7.3 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 119.627 -1.273 . . . . 0.0 113.587 175.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.474 ' HA ' ' HB2' ' A' ' 58' ' ' LYS . 94.1 mt-30 -102.73 -44.25 5.35 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.699 0.285 . . . . 0.0 111.306 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.52 ' HG3' HG22 ' A' ' 57' ' ' THR . 34.8 tt0 -152.71 122.17 6.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.954 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.559 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -123.67 114.24 19.71 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.558 0.694 . . . . 0.0 110.212 170.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.439 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 31.8 mmtp -96.86 105.85 18.05 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 176.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.9 tp -83.29 112.23 19.69 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -175.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.651 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 92.8 m-85 -118.68 147.2 44.05 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 175.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 76' ' ' MET . 0.3 OUTLIER -131.07 131.08 43.99 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 170.651 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -107.51 112.53 25.33 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.267 178.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.641 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -124.55 138.16 54.35 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.461 178.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 58.81 34.15 23.52 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.236 0.541 . . . . 0.0 110.026 -176.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.3 tttm 56.55 46.58 20.23 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.821 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.591 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 53.3 tp60 -137.84 127.78 25.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.469 176.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -87.18 121.37 29.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.954 0.407 . . . . 0.0 110.372 -176.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.437 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 81.5 m-85 -113.41 130.57 56.27 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.355 175.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.452 HG22 ' HB3' ' E' ' 86' ' ' SER . 4.4 tp -79.57 105.83 9.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.705 0.764 . . . . 0.0 109.048 173.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.541 HG13 HD23 ' E' ' 88' ' ' LEU . 2.5 t -80.46 -49.16 19.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.633 -172.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.514 ' HB2' HD23 ' A' ' 65' ' ' LEU . . . -156.0 148.23 23.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.924 0.393 . . . . 0.0 111.709 -177.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.7 m -110.59 100.75 9.49 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 170.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.49 HG13 ' HB3' ' A' ' 40' ' ' ALA . 7.7 p -118.46 112.66 39.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.62 0.724 . . . . 0.0 109.699 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.52 HG22 ' HG3' ' A' ' 39' ' ' GLU . 63.8 p -122.86 -178.71 4.02 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.173 -172.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.474 ' HB2' ' HA ' ' A' ' 38' ' ' GLN . 56.0 tttt -59.52 -28.99 67.57 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.896 172.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.471 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -83.15 -40.41 19.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.622 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.0 mt -111.07 83.15 3.56 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 13.1 Cg_exo -69.82 0.18 6.06 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.084 2.523 . . . . 0.0 113.879 -168.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -163.2 131.34 3.75 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.335 0.588 . . . . 0.0 111.535 -176.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.403 HG23 ' HB ' ' A' ' 56' ' ' VAL . 96.1 t -118.87 112.66 38.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.382 173.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.95 116.12 27.76 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 174.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.514 HD23 ' HB2' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -137.19 169.6 17.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.055 0.455 . . . . 0.0 111.395 -175.263 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.524 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 9.6 t0 -118.66 119.01 33.18 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.114 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.592 HD21 HD23 ' E' ' 88' ' ' LEU . 8.0 mt -134.16 145.2 49.03 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 175.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -145.35 122.96 11.78 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 173.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -120.94 150.86 40.44 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.041 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' E' ' 6' ' ' ALA . 14.5 t -108.97 177.55 4.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.633 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.04 -19.27 65.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.192 0.52 . . . . 0.0 110.583 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.41 -9.81 81.03 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.272 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -92.72 120.02 32.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.132 0.491 . . . . 0.0 110.568 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -108.13 111.67 23.81 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 176.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.641 HG22 ' HB2' ' A' ' 46' ' ' ALA . 7.6 pt -128.71 156.08 40.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 120.949 0.404 . . . . 0.0 111.853 -168.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.511 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 4.5 mtm -115.61 119.39 35.97 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 173.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.475 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 1.1 m-85 -99.92 128.4 46.01 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.677 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 31.3 p90 -152.42 140.18 19.94 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.413 0.625 . . . . 0.0 112.194 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 2.3 p -113.16 125.77 54.71 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.854 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.439 ' HB3' ' HB2' ' A' ' 41' ' ' LYS . . . -96.53 164.82 12.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.607 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.16 -165.24 31.44 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -121.98 102.98 8.5 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.059 175.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.559 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -173.01 153.04 2.46 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.47 173.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.5 t -112.16 111.71 22.8 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.641 HG12 ' HB3' ' A' ' 34' ' ' LEU . 4.6 m -109.8 165.53 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.655 0 CA-C-O 121.408 0.623 . . . . 0.0 111.91 -174.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.48 ' HB3' HG22 ' B' ' 52' ' ' ILE . 23.8 t -131.61 123.16 27.31 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.914 176.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.565 HD23 HG21 ' A' ' 29' ' ' ILE . 4.9 mp -91.32 151.94 20.66 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 172.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.59 HD23 HD21 ' B' ' 67' ' ' LEU . 1.4 tp -134.77 142.49 46.73 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.746 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.0 -166.79 26.69 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.695 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -143.5 135.25 26.45 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.214 0.53 . . . . 0.0 110.931 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.59 HD23 ' HB3' ' A' ' 27' ' ' PHE . 64.5 mt -59.29 116.77 4.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.898 172.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.466 ' H ' ' HA ' ' A' ' 27' ' ' PHE . 72.5 t60 -87.53 108.34 19.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.895 -167.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -153.28 155.42 36.52 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.081 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 35.6 pt -122.9 143.1 37.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.959 0.409 . . . . 0.0 111.154 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -117.25 112.09 20.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.902 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.2 p -83.44 110.05 17.85 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.123 0.487 . . . . 0.0 110.785 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -70.25 -30.05 69.79 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.172 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 33.9 m . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.777 -0.63 . . . . 0.0 109.735 178.303 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.535 ' O ' ' HB3' ' C' ' 25' ' ' LYS . 53.4 p90 . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -99.67 146.31 26.63 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 176.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -125.18 113.27 1.89 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.323 -0.942 . . . . 0.0 112.874 -176.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -101.99 58.02 0.82 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.135 0.493 . . . . 0.0 110.293 177.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 24.7 mmt -102.0 -160.38 0.78 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.224 -176.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.87 148.49 4.11 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.075 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . 0.44 ' HB2' HD12 ' B' ' 91' ' ' LEU . 47.4 mtt -108.56 165.55 11.45 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.327 -175.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.443 ' CE1' HD21 ' C' ' 44' ' ' LEU . 56.4 t80 -76.11 151.96 36.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.042 0.449 . . . . 0.0 112.194 -176.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . 0.482 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 89.7 t90 -143.86 147.44 34.05 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.583 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.43 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -151.5 156.44 26.68 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.19 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.553 HD23 HD13 ' B' ' 87' ' ' LEU . 61.3 tp -148.95 109.64 4.25 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 120.878 0.37 . . . . 0.0 111.422 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -85.98 121.12 28.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.461 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . 0.669 ' SD ' ' HE2' ' B' ' 19' ' ' TYR . 72.5 mmm -101.75 137.33 40.19 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 120.931 0.396 . . . . 0.0 111.089 -178.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.506 ' HE3' ' HA ' ' B' ' 14' ' ' LYS . 0.0 OUTLIER -101.25 146.44 32.17 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.814 175.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -49.87 113.4 0.97 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.961 2.441 . . . . 0.0 113.098 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 61.16 52.01 4.14 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.912 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -125.61 138.32 53.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.736 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.692 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 51.8 mttp -109.74 126.86 54.18 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 120.874 0.369 . . . . 0.0 111.72 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' TYR . . . . . 0.669 ' HE2' ' SD ' ' B' ' 13' ' ' MET . 2.4 m-85 -111.64 103.89 12.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.739 173.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 9.2 p -86.11 100.51 12.25 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 173.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -114.82 148.8 38.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.35 0.595 . . . . 0.0 112.224 -168.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 38.3 m -107.96 141.95 38.82 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.192 173.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 69.4 mt -102.25 138.34 26.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.156 0.503 . . . . 0.0 111.743 -173.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.449 ' N ' HD12 ' B' ' 24' ' ' ILE . 4.1 mp -110.56 -43.34 5.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.312 176.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.528 ' HB3' ' O ' ' A' ' 1' ' ' PHE . 15.2 pttm -113.89 120.54 41.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.149 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 14.9 p -58.26 132.09 52.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.715 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . 0.596 ' HB3' HD23 ' B' ' 91' ' ' LEU . 54.3 p90 -139.14 157.59 45.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.625 0.726 . . . . 0.0 112.365 -176.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' HIS . . . . . 0.621 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 7.1 t60 -114.7 124.78 52.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.455 177.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.584 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 42.6 mt -89.93 134.97 27.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 171.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.621 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 29.0 p -122.06 -12.3 8.36 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -171.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.12 155.84 27.36 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 119.579 -1.296 . . . . 0.0 113.157 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.442 HG23 ' HG ' ' B' ' 87' ' ' LEU . 12.3 p -143.31 125.39 12.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 172.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . 0.423 ' HA ' HG21 ' B' ' 56' ' ' VAL . . . -144.14 161.06 39.81 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.08 -0.388 . . . . 0.0 111.651 -174.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.638 ' HB3' HG12 ' B' ' 85' ' ' VAL . 3.3 pp -123.41 142.27 51.14 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.749 0.785 . . . . 0.0 111.585 177.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -103.99 -52.6 2.92 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.563 -1.199 . . . . 0.0 108.645 173.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -104.2 128.55 51.93 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 169.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.412 ' HA3' ' HB1' ' B' ' 83' ' ' ALA . . . 152.01 156.13 7.33 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 119.605 -1.284 . . . . 0.0 113.571 175.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . 0.463 ' HA ' ' HB2' ' B' ' 58' ' ' LYS . 94.0 mt-30 -102.82 -44.25 5.33 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.661 0.267 . . . . 0.0 111.273 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.54 ' HG3' HG22 ' B' ' 57' ' ' THR . 34.9 tt0 -152.73 122.13 6.75 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 121.229 -0.188 . . . . 0.0 110.974 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.569 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -123.62 114.23 19.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.51 0.672 . . . . 0.0 110.223 170.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.447 ' HB2' ' HB3' ' B' ' 80' ' ' ALA . 31.8 mmtp -96.89 105.9 18.12 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 44.6 tp -83.31 112.17 19.66 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -175.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . 0.647 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 92.5 m-85 -118.62 147.12 44.08 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 175.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.521 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.3 OUTLIER -131.08 131.07 43.96 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 170.597 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.597 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -107.44 112.5 25.32 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.337 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.629 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -124.48 138.19 54.36 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.449 178.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 58.85 34.07 23.45 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 123.552 0.533 . . . . 0.0 110.012 -176.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 57.3 tttm 56.64 46.63 19.94 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.787 -177.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.597 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 53.4 tp60 -137.99 127.74 25.29 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -87.13 121.4 29.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.066 0.46 . . . . 0.0 110.364 -176.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.439 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 81.7 m-85 -113.52 130.6 56.31 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.365 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . 0.48 HG22 ' HB3' ' A' ' 86' ' ' SER . 4.5 tp -79.59 105.74 9.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.626 0.727 . . . . 0.0 109.07 173.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.555 HG13 HD23 ' A' ' 88' ' ' LEU . 2.5 t -80.4 -49.21 19.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.625 -172.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.513 ' HB2' ' CD2' ' B' ' 65' ' ' LEU . . . -155.98 148.28 23.57 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.012 0.434 . . . . 0.0 111.701 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 68.6 m -110.48 100.72 9.5 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 170.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.481 HG13 ' HB3' ' B' ' 40' ' ' ALA . 7.7 p -118.42 112.72 39.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.718 0.77 . . . . 0.0 109.649 -177.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.54 HG22 ' HG3' ' B' ' 39' ' ' GLU . 60.9 p -122.9 -178.72 4.02 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.234 -172.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . 0.463 ' HB2' ' HA ' ' B' ' 38' ' ' GLN . 55.5 tttt -59.36 -29.04 67.4 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.944 171.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.464 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -83.21 -40.35 19.76 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.662 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 79.9 mt -111.13 83.11 3.61 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 13.0 Cg_exo -69.92 0.32 5.94 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.059 2.506 . . . . 0.0 113.789 -168.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -163.2 131.36 3.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.314 0.578 . . . . 0.0 111.554 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 96.3 t -118.91 112.72 39.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.336 173.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.98 116.17 27.83 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 174.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.513 ' CD2' ' HB2' ' B' ' 54' ' ' ALA . 0.3 OUTLIER -137.2 169.5 17.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.449 -175.295 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . 0.558 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 9.6 t0 -118.54 118.98 33.17 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.172 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.59 HD21 HD23 ' A' ' 88' ' ' LEU . 8.0 mt -134.19 145.25 49.04 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -145.38 123.0 11.79 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 173.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -120.93 150.86 40.44 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.062 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 14.4 t -108.93 177.43 4.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.774 -0.193 . . . . 0.0 110.637 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.9 -19.35 65.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.178 0.513 . . . . 0.0 110.674 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.31 -9.87 81.11 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.309 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -92.75 120.02 32.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.203 0.525 . . . . 0.0 110.588 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -108.13 111.58 23.67 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 176.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.629 HG22 ' HB2' ' B' ' 46' ' ' ALA . 7.6 pt -128.75 156.07 41.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.913 -168.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.521 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 4.5 mtm -115.44 119.44 36.24 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 173.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . 0.475 ' CD1' ' HB2' ' B' ' 44' ' ' LEU . 1.1 m-85 -99.91 128.42 46.01 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.692 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 31.2 p90 -152.49 140.15 19.84 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.415 0.626 . . . . 0.0 112.172 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' B' ' 41' ' ' LYS . 2.3 p -113.08 125.86 54.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.794 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . 0.447 ' HB3' ' HB2' ' B' ' 41' ' ' LYS . . . -96.66 164.86 12.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.672 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.15 -165.15 31.4 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -121.96 102.96 8.49 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.073 175.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.569 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -173.09 153.0 2.42 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.44 -1.255 . . . . 0.0 109.431 173.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 38.8 t -112.23 111.71 22.79 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.638 HG12 ' HB3' ' B' ' 34' ' ' LEU . 4.6 m -109.75 165.55 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.665 0 CA-C-O 121.411 0.624 . . . . 0.0 111.889 -174.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . 0.47 ' HB3' HG22 ' C' ' 52' ' ' ILE . 24.3 t -131.6 123.21 27.42 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.846 176.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.556 HD23 HG21 ' B' ' 29' ' ' ILE . 4.9 mp -91.45 151.91 20.59 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 172.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.605 HD23 HD21 ' C' ' 67' ' ' LEU . 1.4 tp -134.75 142.44 46.75 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.77 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.96 -166.84 26.72 Favored Glycine 0 N--CA 1.438 -1.201 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.71 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -143.55 135.27 26.39 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.28 0.562 . . . . 0.0 110.907 177.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . 0.596 HD23 ' HB3' ' B' ' 27' ' ' PHE . 64.6 mt -59.27 116.81 4.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.843 173.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . 0.445 ' H ' ' HA ' ' B' ' 27' ' ' PHE . 72.5 t60 -87.57 108.32 19.0 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.889 -168.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -153.23 155.51 36.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.072 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 35.8 pt -122.9 143.09 37.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.854 0.359 . . . . 0.0 111.103 -176.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -117.3 112.19 20.42 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.898 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 3.2 p -83.46 110.05 17.86 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.042 0.448 . . . . 0.0 110.701 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . -70.33 -29.96 69.71 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.081 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 33.4 m . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.663 -0.684 . . . . 0.0 109.767 178.317 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 1' ' ' PHE . . . . . 0.535 ' O ' ' HB3' ' D' ' 25' ' ' LYS . 53.5 p90 . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -99.71 146.31 26.66 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 176.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . -125.23 113.27 1.89 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.83 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -102.03 58.06 0.82 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.128 0.49 . . . . 0.0 110.315 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 24.8 mmt -101.97 -160.45 0.79 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.289 -176.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.78 148.36 4.12 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.14 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 7' ' ' MET . . . . . 0.423 ' HB2' HD12 ' C' ' 91' ' ' LEU . 47.5 mtt -108.47 165.52 11.46 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.369 -175.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 8' ' ' PHE . . . . . 0.449 ' CE1' HD21 ' D' ' 44' ' ' LEU . 56.6 t80 -76.07 151.9 36.98 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -176.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . 0.477 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 89.8 t90 -143.81 147.52 34.24 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.514 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . 0.439 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -151.43 156.49 26.71 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.121 -0.562 . . . . 0.0 112.254 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.563 HD23 HD13 ' C' ' 87' ' ' LEU . 61.5 tp -149.0 109.57 4.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.894 0.378 . . . . 0.0 111.48 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -85.89 121.04 27.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.519 176.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 13' ' ' MET . . . . . 0.666 ' SD ' ' HE2' ' C' ' 19' ' ' TYR . 72.2 mmm -101.68 137.27 40.2 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 120.817 0.341 . . . . 0.0 111.126 -178.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . 0.481 ' HE3' ' HA ' ' C' ' 14' ' ' LYS . 0.0 OUTLIER -101.22 146.48 32.24 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.846 175.666 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -49.93 113.39 0.97 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.093 2.529 . . . . 0.0 113.043 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 60.99 52.05 4.26 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.961 176.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -125.49 138.42 53.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.8 175.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 18' ' ' LYS . . . . . 0.697 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 51.8 mttp -109.65 126.89 54.13 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.697 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . 0.666 ' HE2' ' SD ' ' C' ' 13' ' ' MET . 2.4 m-85 -111.68 103.75 12.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.818 172.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 9.3 p -86.01 100.57 12.24 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 173.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -114.93 148.67 38.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.431 0.634 . . . . 0.0 112.203 -168.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 39.0 m -107.84 142.03 38.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.165 173.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 69.2 mt -102.29 138.36 26.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.169 0.509 . . . . 0.0 111.75 -173.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . 0.44 HD12 ' N ' ' C' ' 24' ' ' ILE . 4.1 mp -110.55 -43.4 5.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.266 176.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . 0.535 ' HB3' ' O ' ' B' ' 1' ' ' PHE . 15.1 pttm -113.91 120.61 41.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.163 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 14.5 p -58.26 132.11 52.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.659 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 27' ' ' PHE . . . . . 0.603 ' HB3' HD23 ' C' ' 91' ' ' LEU . 54.2 p90 -139.12 157.56 45.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.597 0.713 . . . . 0.0 112.389 -176.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 28' ' ' HIS . . . . . 0.631 ' HE2' ' HB3' ' C' ' 30' ' ' SER . 7.1 t60 -114.68 124.76 52.63 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.475 177.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . 0.598 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 42.4 mt -89.93 134.96 27.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 171.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.631 ' HB3' ' HE2' ' C' ' 28' ' ' HIS . 29.1 p -122.1 -12.27 8.34 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -171.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.12 155.8 27.29 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 119.67 -1.252 . . . . 0.0 113.192 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.438 HG23 ' HG ' ' C' ' 87' ' ' LEU . 12.3 p -143.28 125.5 12.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 172.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.422 ' HA ' HG21 ' C' ' 56' ' ' VAL . . . -144.2 160.95 40.08 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.111 -0.368 . . . . 0.0 111.647 -174.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.658 ' HB3' HG12 ' C' ' 85' ' ' VAL . 3.4 pp -123.4 142.22 51.2 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.8 0.809 . . . . 0.0 111.619 177.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -104.02 -52.59 2.91 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.529 173.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -104.19 128.63 51.92 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 169.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 37' ' ' GLY . . . . . 0.416 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 151.95 156.02 7.28 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 119.619 -1.277 . . . . 0.0 113.653 175.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 38' ' ' GLN . . . . . 0.467 ' HA ' ' HB2' ' C' ' 58' ' ' LYS . 94.1 mt-30 -102.76 -44.31 5.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.648 0.261 . . . . 0.0 111.232 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . 0.525 ' HG3' HG22 ' C' ' 57' ' ' THR . 34.8 tt0 -152.67 122.09 6.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.766 -0.197 . . . . 0.0 110.98 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.586 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -123.57 114.26 19.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.605 0.716 . . . . 0.0 110.27 170.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.448 ' HB2' ' HB3' ' C' ' 80' ' ' ALA . 31.8 mmtp -96.87 105.8 18.0 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 44.9 tp -83.25 112.21 19.66 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -175.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 43' ' ' TYR . . . . . 0.653 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 92.8 m-85 -118.62 147.27 43.93 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.515 ' HA ' ' O ' ' C' ' 76' ' ' MET . 0.3 OUTLIER -131.08 131.13 44.0 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 170.648 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . 0.601 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -107.57 112.49 25.26 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.275 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.635 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -124.49 138.08 54.37 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.487 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 58.95 34.08 23.41 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.238 0.542 . . . . 0.0 109.99 -176.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 57.5 tttm 56.65 46.58 20.0 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.707 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . 0.601 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 53.7 tp60 -137.92 127.77 25.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.465 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -87.2 121.39 29.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.077 0.465 . . . . 0.0 110.338 -176.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . 0.43 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 81.3 m-85 -113.49 130.56 56.31 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.411 175.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . 0.47 HG22 ' HB3' ' B' ' 86' ' ' SER . 4.5 tp -79.46 105.8 9.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.664 0.745 . . . . 0.0 109.019 173.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 53' ' ' VAL . . . . . 0.556 HG13 HD23 ' B' ' 88' ' ' LEU . 2.5 t -80.56 -49.07 19.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.65 -172.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 54' ' ' ALA . . . . . 0.513 ' HB2' HD23 ' C' ' 65' ' ' LEU . . . -155.99 148.22 23.5 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.812 -177.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 71.1 m -110.56 100.8 9.55 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 170.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . 0.487 HG13 ' HB3' ' C' ' 40' ' ' ALA . 7.7 p -118.49 112.74 39.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.658 0.742 . . . . 0.0 109.61 -177.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . 0.525 HG22 ' HG3' ' C' ' 39' ' ' GLU . 64.4 p -122.87 -178.67 4.01 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.272 -172.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 58' ' ' LYS . . . . . 0.467 ' HB2' ' HA ' ' C' ' 38' ' ' GLN . 55.7 tttt -59.54 -28.97 67.57 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.855 172.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . 0.472 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -83.2 -40.39 19.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.648 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 80.1 mt -111.16 83.15 3.68 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 61' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 13.0 Cg_exo -69.84 0.18 6.08 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.074 2.516 . . . . 0.0 113.825 -168.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -163.13 131.34 3.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.297 0.57 . . . . 0.0 111.569 -176.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 96.0 t -118.91 112.67 38.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.392 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.91 116.14 27.75 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 174.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . 0.513 HD23 ' HB2' ' C' ' 54' ' ' ALA . 0.3 OUTLIER -137.24 169.5 17.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.95 0.405 . . . . 0.0 111.445 -175.26 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 66' ' ' ASP . . . . . 0.544 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 9.6 t0 -118.59 119.08 33.44 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.106 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.605 HD21 HD23 ' B' ' 88' ' ' LEU . 7.9 mt -134.18 145.26 49.05 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 175.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -145.43 123.03 11.78 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.721 -0.392 . . . . 0.0 109.947 173.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -120.91 150.89 40.38 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.965 -178.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 14.2 t -109.03 177.41 4.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.622 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.92 -19.29 65.7 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.258 0.552 . . . . 0.0 110.612 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.34 -9.9 81.01 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.261 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -92.63 119.93 32.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.059 0.457 . . . . 0.0 110.64 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -107.98 111.59 23.75 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.635 HG22 ' HB2' ' C' ' 46' ' ' ALA . 7.6 pt -128.73 156.1 41.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 120.962 0.41 . . . . 0.0 111.842 -168.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.515 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 4.5 mtm -115.48 119.42 36.13 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 173.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 77' ' ' PHE . . . . . 0.478 ' CD1' ' HB2' ' C' ' 44' ' ' LEU . 1.1 m-85 -99.9 128.37 45.99 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 78' ' ' TYR . . . . . 0.697 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 31.3 p90 -152.42 140.15 19.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.457 0.646 . . . . 0.0 112.252 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' C' ' 41' ' ' LYS . 2.3 p -113.04 125.79 54.78 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.837 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 80' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' C' ' 41' ' ' LYS . . . -96.69 164.93 12.37 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.628 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.05 -165.21 31.57 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 -177.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -121.9 103.06 8.57 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 119.864 -0.735 . . . . 0.0 110.073 175.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . 0.586 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -173.13 153.02 2.4 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.501 173.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 38.6 t -112.27 111.7 22.76 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.658 HG12 ' HB3' ' C' ' 34' ' ' LEU . 4.6 m -109.78 165.54 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 CA-C-O 121.308 0.575 . . . . 0.0 111.89 -174.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . 0.466 ' HB3' HG22 ' D' ' 52' ' ' ILE . 23.9 t -131.58 123.09 27.2 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.953 176.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . 0.565 HD23 HG21 ' C' ' 29' ' ' ILE . 4.9 mp -91.31 151.94 20.67 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 172.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . 0.584 HD23 HD21 ' D' ' 67' ' ' LEU . 1.4 tp -134.7 142.46 46.81 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.843 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.94 -166.85 26.71 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.804 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -143.56 135.17 26.28 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.256 0.55 . . . . 0.0 110.928 177.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . 0.603 HD23 ' HB3' ' C' ' 27' ' ' PHE . 64.7 mt -59.2 116.83 4.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.83 173.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 92' ' ' HIS . . . . . 0.457 ' H ' ' HA ' ' C' ' 27' ' ' PHE . 72.8 t60 -87.63 108.32 19.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.867 -167.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -153.29 155.52 36.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.058 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 35.5 pt -122.91 143.06 37.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.919 0.39 . . . . 0.0 111.141 -176.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -117.22 112.24 20.54 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.941 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 3.2 p -83.49 110.03 17.86 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.015 0.436 . . . . 0.0 110.757 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -70.37 -29.87 69.7 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.138 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 33.2 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.727 -0.654 . . . . 0.0 109.847 178.254 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . 0.524 ' O ' ' HB3' ' E' ' 25' ' ' LYS . 53.4 p90 . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -99.69 146.34 26.62 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 176.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . -125.29 113.32 1.89 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.815 -176.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -102.01 57.96 0.82 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.087 0.47 . . . . 0.0 110.305 177.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 24.8 mmt -101.99 -160.42 0.79 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.315 -176.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.71 148.34 4.06 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 123.556 0.535 . . . . 0.0 112.164 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 7' ' ' MET . . . . . 0.445 ' HB2' HD12 ' D' ' 91' ' ' LEU . 47.5 mtt -108.47 165.5 11.47 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.376 -175.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 8' ' ' PHE . . . . . 0.438 ' CE1' HD21 ' E' ' 44' ' ' LEU . 56.7 t80 -76.1 151.92 36.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.113 0.482 . . . . 0.0 112.261 -176.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 9' ' ' TRP . . . . . 0.482 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 89.6 t90 -143.77 147.38 34.08 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.66 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . 0.449 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -151.38 156.53 26.73 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.216 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.566 HD23 HD13 ' D' ' 87' ' ' LEU . 61.3 tp -149.04 109.59 4.22 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.902 0.382 . . . . 0.0 111.403 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -85.96 121.1 28.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.387 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 13' ' ' MET . . . . . 0.672 ' SD ' ' HE2' ' D' ' 19' ' ' TYR . 72.3 mmm -101.76 137.3 40.24 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.884 0.373 . . . . 0.0 111.132 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 14' ' ' LYS . . . . . 0.486 ' HA ' ' HE3' ' D' ' 14' ' ' LYS . 0.0 OUTLIER -101.1 146.46 32.19 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.898 175.663 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -49.92 113.39 0.97 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.035 2.49 . . . . 0.0 113.066 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 61.11 51.98 4.2 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.928 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -125.5 138.35 53.98 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.737 175.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . 0.699 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 51.9 mttp -109.67 126.92 54.19 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 120.799 0.333 . . . . 0.0 111.732 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 19' ' ' TYR . . . . . 0.672 ' HE2' ' SD ' ' D' ' 13' ' ' MET . 2.4 m-85 -111.74 103.7 12.0 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 173.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 9.3 p -86.0 100.62 12.27 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 173.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -114.88 148.73 38.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.283 -168.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 38.7 m -107.83 142.01 38.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.181 173.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 69.2 mt -102.32 138.37 26.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.226 0.536 . . . . 0.0 111.713 -173.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . 0.437 HD12 ' N ' ' D' ' 24' ' ' ILE . 4.1 mp -110.63 -43.26 5.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.269 176.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . 0.535 ' HB3' ' O ' ' C' ' 1' ' ' PHE . 15.2 pttm -113.95 120.5 40.86 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.146 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 14.6 p -58.19 132.18 52.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.653 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 27' ' ' PHE . . . . . 0.61 ' HB3' HD23 ' D' ' 91' ' ' LEU . 54.4 p90 -139.24 157.55 45.72 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.632 0.73 . . . . 0.0 112.357 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 28' ' ' HIS . . . . . 0.637 ' HE2' ' HB3' ' D' ' 30' ' ' SER . 7.0 t60 -114.67 124.67 52.42 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.505 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 29' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 42.4 mt -89.85 134.98 27.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 171.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . 0.637 ' HB3' ' HE2' ' D' ' 28' ' ' HIS . 28.7 p -122.13 -12.31 8.33 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -171.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.05 155.91 27.48 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.712 -1.232 . . . . 0.0 113.239 177.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.443 HG23 ' HG ' ' D' ' 87' ' ' LEU . 12.4 p -143.41 125.46 11.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 172.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . 0.426 ' HA ' HG21 ' D' ' 56' ' ' VAL . . . -144.11 161.06 39.8 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 122.023 -0.423 . . . . 0.0 111.682 -174.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 34' ' ' LEU . . . . . 0.636 ' HB3' HG12 ' D' ' 85' ' ' VAL . 3.3 pp -123.49 142.16 51.28 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.748 0.785 . . . . 0.0 111.621 177.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -104.04 -52.48 2.94 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.515 -1.221 . . . . 0.0 108.54 173.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -104.27 128.6 52.06 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 169.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . 0.414 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 152.0 155.99 7.27 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 119.584 -1.293 . . . . 0.0 113.632 175.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 38' ' ' GLN . . . . . 0.48 ' HA ' ' HB2' ' D' ' 58' ' ' LYS . 94.1 mt-30 -102.7 -44.28 5.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.621 0.248 . . . . 0.0 111.29 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . 0.535 ' HG3' HG22 ' D' ' 57' ' ' THR . 35.0 tt0 -152.74 122.08 6.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.025 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . 0.573 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -123.59 114.26 19.78 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.601 0.715 . . . . 0.0 110.203 170.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.442 ' HB2' ' HB3' ' D' ' 80' ' ' ALA . 31.8 mmtp -96.78 105.81 18.0 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 44.7 tp -83.25 112.19 19.64 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 43' ' ' TYR . . . . . 0.639 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 92.6 m-85 -118.66 147.17 44.07 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' D' ' 76' ' ' MET . 0.3 OUTLIER -131.06 131.07 44.0 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 170.572 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 45' ' ' ALA . . . . . 0.593 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -107.46 112.58 25.44 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.3 178.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.632 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -124.54 138.18 54.35 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.432 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 58.83 34.15 23.51 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.562 0.539 . . . . 0.0 109.975 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 57.3 tttm 56.64 46.42 20.31 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.807 -177.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . 0.593 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 53.6 tp60 -137.85 127.79 25.62 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 176.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -87.19 121.39 29.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.062 0.458 . . . . 0.0 110.369 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . 0.439 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 81.7 m-85 -113.48 130.54 56.31 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.4 175.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 52' ' ' ILE . . . . . 0.466 HG22 ' HB3' ' C' ' 86' ' ' SER . 4.5 tp -79.55 105.79 9.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.646 0.736 . . . . 0.0 109.086 173.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 53' ' ' VAL . . . . . 0.57 HG13 HD23 ' C' ' 88' ' ' LEU . 2.5 t -80.46 -49.21 18.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.536 -172.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 54' ' ' ALA . . . . . 0.517 ' HB2' HD23 ' D' ' 65' ' ' LEU . . . -155.95 148.22 23.56 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 120.95 0.405 . . . . 0.0 111.731 -177.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 72.8 m -110.54 100.61 9.39 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 170.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 56' ' ' VAL . . . . . 0.486 HG13 ' HB3' ' D' ' 40' ' ' ALA . 7.7 p -118.36 112.65 39.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.658 0.742 . . . . 0.0 109.63 -177.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 57' ' ' THR . . . . . 0.535 HG22 ' HG3' ' D' ' 39' ' ' GLU . 61.9 p -122.79 -178.68 4.0 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.304 -172.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 58' ' ' LYS . . . . . 0.48 ' HB2' ' HA ' ' D' ' 38' ' ' GLN . 56.0 tttt -59.58 -28.88 67.54 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.899 172.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 59' ' ' ALA . . . . . 0.473 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -83.25 -40.44 19.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.592 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 79.6 mt -111.06 82.98 3.44 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 174.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 61' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 13.1 Cg_exo -69.72 0.22 5.92 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.047 2.498 . . . . 0.0 113.887 -168.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -163.13 131.26 3.76 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.273 0.559 . . . . 0.0 111.614 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.408 HG23 ' HB ' ' D' ' 56' ' ' VAL . 96.4 t -118.85 112.65 38.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.377 173.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.92 116.2 27.81 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 174.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 65' ' ' LEU . . . . . 0.517 HD23 ' HB2' ' D' ' 54' ' ' ALA . 0.3 OUTLIER -137.38 169.42 17.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.007 0.432 . . . . 0.0 111.426 -175.242 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 66' ' ' ASP . . . . . 0.545 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 9.7 t0 -118.45 118.97 33.18 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.114 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.601 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 8.0 mt -134.14 145.3 49.15 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -145.37 123.0 11.8 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 173.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -120.96 150.93 40.34 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.008 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 14.2 t -109.05 177.44 4.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.748 -0.206 . . . . 0.0 110.592 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.92 -19.27 65.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.163 0.506 . . . . 0.0 110.659 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.33 -9.95 80.95 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.272 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -92.65 120.07 32.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.218 0.532 . . . . 0.0 110.584 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -108.12 111.55 23.63 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 176.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.632 HG22 ' HB2' ' D' ' 46' ' ' ALA . 7.6 pt -128.63 156.15 40.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 120.963 0.411 . . . . 0.0 111.812 -168.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 76' ' ' MET . . . . . 0.519 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 4.5 mtm -115.53 119.37 35.94 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 173.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 77' ' ' PHE . . . . . 0.466 ' CD1' ' HB2' ' D' ' 44' ' ' LEU . 1.1 m-85 -99.85 128.36 45.95 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 78' ' ' TYR . . . . . 0.699 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 31.4 p90 -152.42 140.2 19.95 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.452 0.644 . . . . 0.0 112.227 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 79' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' D' ' 41' ' ' LYS . 2.3 p -113.15 125.74 54.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.802 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 80' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' D' ' 41' ' ' LYS . . . -96.58 164.86 12.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.62 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.12 -165.15 31.43 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -177.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -121.98 103.0 8.51 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.047 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . 0.573 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -173.07 153.09 2.45 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.528 173.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 38.6 t -112.27 111.62 22.62 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.636 HG12 ' HB3' ' D' ' 34' ' ' LEU . 4.6 m -109.77 165.44 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.673 0 CA-C-O 121.459 0.647 . . . . 0.0 111.87 -174.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 86' ' ' SER . . . . . 0.478 ' HB3' HG22 ' E' ' 52' ' ' ILE . 24.0 t -131.55 123.12 27.3 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.896 176.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 87' ' ' LEU . . . . . 0.566 HD13 HD23 ' D' ' 11' ' ' LEU . 4.9 mp -91.37 151.97 20.62 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 172.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.588 HD23 HD21 ' E' ' 67' ' ' LEU . 1.4 tp -134.78 142.53 46.72 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.738 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.01 -166.82 26.75 Favored Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.743 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -143.47 135.21 26.47 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.151 0.5 . . . . 0.0 110.919 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . 0.61 HD23 ' HB3' ' D' ' 27' ' ' PHE . 64.9 mt -59.36 116.81 4.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.904 173.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . 0.464 ' H ' ' HA ' ' D' ' 27' ' ' PHE . 72.6 t60 -87.5 108.23 18.94 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.921 -167.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -153.19 155.46 36.72 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.102 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 35.5 pt -122.9 143.07 37.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.845 0.355 . . . . 0.0 111.088 -176.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -117.27 112.22 20.47 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.868 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 3.2 p -83.52 110.03 17.87 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.033 0.444 . . . . 0.0 110.752 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . -70.35 -29.95 69.68 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.06 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 33.8 m . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.522 -0.751 . . . . 0.0 109.794 178.281 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' E' E ' 1' ' ' PHE . . . . . 0.507 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 53.3 p90 . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -99.74 146.31 26.69 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 176.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . -125.16 113.32 1.9 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.812 -176.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -102.1 58.07 0.82 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.2 0.524 . . . . 0.0 110.3 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 5' ' ' MET . . . . . 0.421 ' HB3' ' H ' ' E' ' 6' ' ' ALA . 24.8 mmt -102.06 -160.61 0.8 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.196 -176.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 6' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 70' ' ' SER . . . -50.65 148.26 4.06 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.129 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 7' ' ' MET . . . . . 0.443 ' HB2' HD12 ' E' ' 91' ' ' LEU . 47.4 mtt -108.38 165.52 11.45 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.333 -175.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 8' ' ' PHE . . . . . 0.416 ' CE1' HD21 ' A' ' 44' ' ' LEU . 56.2 t80 -76.13 151.99 36.85 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -176.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 9' ' ' TRP . . . . . 0.473 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 89.7 t90 -143.85 147.43 34.06 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.631 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 10' ' ' GLY . . . . . 0.437 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -151.46 156.46 26.69 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.144 178.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . 0.566 HD23 HD13 ' E' ' 87' ' ' LEU . 61.2 tp -148.94 109.62 4.25 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.855 0.359 . . . . 0.0 111.445 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -85.98 121.13 28.17 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.435 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 13' ' ' MET . . . . . 0.679 ' SD ' ' HE2' ' E' ' 19' ' ' TYR . 72.3 mmm -101.74 137.29 40.25 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.0 111.069 -178.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 14' ' ' LYS . . . . . 0.497 ' HE3' ' HA ' ' E' ' 14' ' ' LYS . 0.0 OUTLIER -101.12 146.44 32.16 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.872 175.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -49.95 113.35 0.96 Allowed 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.995 2.463 . . . . 0.0 113.152 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 61.21 52.03 4.09 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.837 176.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -125.58 138.35 53.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.785 175.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . 0.707 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 51.8 mttp -109.66 126.85 54.1 Favored 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 123.264 0.352 . . . . 0.0 111.688 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . 0.679 ' HE2' ' SD ' ' E' ' 13' ' ' MET . 2.4 m-85 -111.71 103.79 12.1 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.772 172.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 9.2 p -86.01 100.6 12.25 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 173.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -114.91 148.73 38.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.396 0.617 . . . . 0.0 112.235 -168.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 37.5 m -107.83 142.06 38.47 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.17 173.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 69.4 mt -102.39 138.37 26.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.233 0.54 . . . . 0.0 111.709 -173.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . 0.437 HD12 ' N ' ' E' ' 24' ' ' ILE . 4.1 mp -110.62 -43.42 5.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.203 176.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . 0.524 ' HB3' ' O ' ' D' ' 1' ' ' PHE . 15.1 pttm -113.86 120.62 41.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.177 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 14.4 p -58.31 132.23 53.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.65 -178.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 27' ' ' PHE . . . . . 0.601 ' HB3' HD23 ' E' ' 91' ' ' LEU . 54.2 p90 -139.22 157.49 45.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.603 0.716 . . . . 0.0 112.377 -176.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 28' ' ' HIS . . . . . 0.633 ' HE2' ' HB3' ' E' ' 30' ' ' SER . 7.2 t60 -114.6 124.72 52.56 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.552 177.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 29' ' ' ILE . . . . . 0.587 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 42.5 mt -89.91 134.91 27.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 171.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . 0.633 ' HB3' ' HE2' ' E' ' 28' ' ' HIS . 29.1 p -122.02 -12.34 8.36 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -171.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.16 155.86 27.38 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 119.626 -1.273 . . . . 0.0 113.188 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.445 HG23 ' HG ' ' E' ' 87' ' ' LEU . 12.4 p -143.35 125.51 12.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 172.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . 0.429 ' HA ' HG21 ' E' ' 56' ' ' VAL . . . -144.21 161.06 39.85 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.62 -174.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 34' ' ' LEU . . . . . 0.66 ' HB3' HG12 ' E' ' 85' ' ' VAL . 3.3 pp -123.48 142.21 51.23 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.717 0.77 . . . . 0.0 111.629 177.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -103.98 -52.58 2.92 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.584 173.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -104.17 128.63 51.88 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 169.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . 0.416 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 151.96 156.05 7.3 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 119.568 -1.301 . . . . 0.0 113.644 175.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 38' ' ' GLN . . . . . 0.484 ' HA ' ' HB2' ' E' ' 58' ' ' LYS . 94.2 mt-30 -102.82 -44.22 5.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.692 0.282 . . . . 0.0 111.264 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 39' ' ' GLU . . . . . 0.527 ' HG3' HG22 ' E' ' 57' ' ' THR . 34.9 tt0 -152.73 122.05 6.72 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 121.161 -0.216 . . . . 0.0 110.96 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . 0.588 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -123.56 114.31 19.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.536 0.684 . . . . 0.0 110.13 170.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 41' ' ' LYS . . . . . 0.435 ' HB2' ' HB3' ' E' ' 80' ' ' ALA . 31.8 mmtp -96.94 105.89 18.11 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 176.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 44.6 tp -83.21 112.17 19.61 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 -175.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 43' ' ' TYR . . . . . 0.645 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 92.9 m-85 -118.65 147.18 44.05 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 175.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 44' ' ' LEU . . . . . 0.524 ' HA ' ' O ' ' E' ' 76' ' ' MET . 0.3 OUTLIER -131.08 131.04 43.95 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 170.628 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 45' ' ' ALA . . . . . 0.587 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -107.51 112.55 25.37 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.314 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . 0.635 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -124.56 138.18 54.35 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.476 178.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 58.82 34.16 23.52 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.168 0.509 . . . . 0.0 109.983 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 57.3 tttm 56.62 46.53 20.14 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.811 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 49' ' ' GLN . . . . . 0.587 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 53.6 tp60 -137.89 127.74 25.48 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -87.13 121.39 29.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.056 0.455 . . . . 0.0 110.388 -176.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . 0.449 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 81.5 m-85 -113.51 130.5 56.33 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.375 175.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 52' ' ' ILE . . . . . 0.478 HG22 ' HB3' ' D' ' 86' ' ' SER . 4.5 tp -79.47 105.8 9.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.622 0.725 . . . . 0.0 109.09 173.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . 0.571 HG13 HD23 ' D' ' 88' ' ' LEU . 2.5 t -80.45 -49.21 19.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.638 -172.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 54' ' ' ALA . . . . . 0.514 ' HB2' ' CD2' ' E' ' 65' ' ' LEU . . . -155.92 148.27 23.64 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.748 -177.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 67.4 m -110.52 100.7 9.47 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 170.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . 0.476 HG13 ' HB3' ' E' ' 40' ' ' ALA . 7.7 p -118.45 112.6 38.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.624 0.726 . . . . 0.0 109.73 -177.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 57' ' ' THR . . . . . 0.527 HG22 ' HG3' ' E' ' 39' ' ' GLU . 64.0 p -122.82 -178.71 4.01 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.178 -172.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 58' ' ' LYS . . . . . 0.484 ' HB2' ' HA ' ' E' ' 38' ' ' GLN . 55.8 tttt -59.49 -28.92 67.46 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.826 172.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 59' ' ' ALA . . . . . 0.472 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -83.36 -40.25 19.65 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.678 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 79.9 mt -111.07 83.03 3.49 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 61' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 13.1 Cg_exo -69.85 0.28 5.94 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.028 2.485 . . . . 0.0 113.861 -168.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -163.16 131.4 3.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.3 0.571 . . . . 0.0 111.548 -176.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . 0.408 HG23 ' HB ' ' E' ' 56' ' ' VAL . 95.6 t -118.98 112.76 39.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.334 173.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.05 116.14 27.85 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 174.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.514 ' CD2' ' HB2' ' E' ' 54' ' ' ALA . 0.3 OUTLIER -137.19 169.54 17.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.492 -175.277 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 66' ' ' ASP . . . . . 0.529 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 9.5 t0 -118.67 119.01 33.18 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.072 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 67' ' ' LEU . . . . . 0.588 HD21 HD23 ' D' ' 88' ' ' LEU . 8.0 mt -134.19 145.21 49.0 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 175.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -145.34 123.0 11.82 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 173.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -120.88 150.88 40.38 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.095 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 14.1 t -108.94 177.45 4.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.821 -0.172 . . . . 0.0 110.663 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.88 -19.31 65.71 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.255 0.55 . . . . 0.0 110.667 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.35 -9.93 80.94 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.256 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -92.61 120.0 32.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.166 0.508 . . . . 0.0 110.524 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -108.1 111.58 23.69 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 75' ' ' ILE . . . . . 0.635 HG22 ' HB2' ' E' ' 46' ' ' ALA . 7.6 pt -128.61 156.07 40.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 120.991 0.424 . . . . 0.0 111.878 -168.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 76' ' ' MET . . . . . 0.524 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 4.5 mtm -115.53 119.44 36.18 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 173.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 77' ' ' PHE . . . . . 0.478 ' CD1' ' HB2' ' E' ' 44' ' ' LEU . 1.1 m-85 -99.9 128.4 46.0 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 78' ' ' TYR . . . . . 0.707 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 31.3 p90 -152.42 140.3 20.05 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.43 0.633 . . . . 0.0 112.156 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 79' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' E' ' 41' ' ' LYS . 2.3 p -113.22 125.77 54.68 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.762 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 80' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' E' ' 41' ' ' LYS . . . -96.58 164.87 12.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.697 178.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.08 -165.18 31.51 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -177.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -121.98 103.0 8.52 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.069 175.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 83' ' ' ALA . . . . . 0.588 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -173.07 153.08 2.45 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.504 173.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 39.2 t -112.27 111.58 22.55 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 85' ' ' VAL . . . . . 0.66 HG12 ' HB3' ' E' ' 34' ' ' LEU . 4.5 m -109.76 165.56 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-O 121.378 0.609 . . . . 0.0 111.842 -174.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 86' ' ' SER . . . . . 0.452 ' HB3' HG22 ' A' ' 52' ' ' ILE . 24.2 t -131.65 123.13 27.18 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.882 176.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 87' ' ' LEU . . . . . 0.566 HD13 HD23 ' E' ' 11' ' ' LEU . 4.9 mp -91.34 151.95 20.65 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 172.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . 0.592 HD23 HD21 ' A' ' 67' ' ' LEU . 1.4 tp -134.76 142.46 46.73 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.789 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.91 -166.8 26.6 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.756 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 90' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -143.56 135.3 26.41 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.2 0.524 . . . . 0.0 110.936 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 91' ' ' LEU . . . . . 0.601 HD23 ' HB3' ' E' ' 27' ' ' PHE . 64.7 mt -59.35 116.84 4.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.885 173.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 92' ' ' HIS . . . . . 0.45 ' H ' ' HA ' ' E' ' 27' ' ' PHE . 72.8 t60 -87.64 108.33 19.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.901 -167.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -153.29 155.45 36.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.035 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 35.6 pt -122.91 143.09 37.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.965 0.412 . . . . 0.0 111.095 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -117.2 112.22 20.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.839 177.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 3.3 p -83.61 110.05 17.94 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.058 0.456 . . . . 0.0 110.696 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . -70.32 -29.94 69.74 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.172 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 32.8 m . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.621 -0.704 . . . . 0.0 109.773 178.195 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 120.769 0.319 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -89.67 -41.25 12.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.219 0.533 . . . . 0.0 110.954 -173.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.507 ' H ' ' HB3' ' B' ' 93' ' ' ASP . . . 78.55 -139.75 22.7 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.541 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 65.95 -173.83 0.18 Allowed 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.095 0.558 . . . . 0.0 111.469 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 68.6 mtm 70.94 -74.22 0.09 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.993 176.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' B' ' 70' ' ' SER . . . -106.11 125.83 51.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.814 -174.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 46.9 mtt -119.28 173.74 6.77 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.113 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -82.18 147.45 29.0 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.491 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 91.2 t90 -139.29 150.1 45.03 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.395 177.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.421 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -154.26 152.21 23.82 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.43 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.61 HD23 HD13 ' A' ' 87' ' ' LEU . 41.0 tp -143.19 108.33 4.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.741 0.305 . . . . 0.0 110.385 177.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -86.11 99.38 11.46 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.416 0.627 . . . . 0.0 109.99 175.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.605 ' HB3' HG23 ' A' ' 85' ' ' VAL . 23.8 tpp -88.02 135.12 33.56 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.881 -175.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -98.83 145.15 29.45 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.119 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HB3' ' N ' ' A' ' 83' ' ' ALA . 10.3 Cg_endo -52.92 120.18 7.24 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 123.585 2.857 . . . . 0.0 113.276 -175.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.682 ' HA ' ' O ' ' A' ' 79' ' ' THR . 29.0 mt-10 58.26 63.07 1.83 Allowed 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 121.575 0.703 . . . . 0.0 111.596 177.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.59 148.95 46.28 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.592 174.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.656 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 35.0 ttmt -122.6 117.15 25.16 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 123.525 0.516 . . . . 0.0 111.314 -175.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -110.98 104.36 12.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.974 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 76' ' ' MET . 10.0 p -88.25 99.95 12.62 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 173.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -121.4 149.9 42.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.501 0.667 . . . . 0.0 112.347 -169.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.2 t -99.21 160.8 14.01 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.405 176.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 53.2 mt -118.99 125.79 74.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.1 0.476 . . . . 0.0 111.531 -173.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.462 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.2 mp -107.02 -33.56 2.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.336 177.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -118.94 122.18 41.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.572 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.486 ' CB ' ' HA2' ' E' ' 3' ' ' GLY . 20.5 t -60.82 133.06 55.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.879 -177.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.511 ' HB3' HD23 ' A' ' 91' ' ' LEU . 53.9 p90 -137.42 143.13 41.71 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.939 0.876 . . . . 0.0 111.881 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.642 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 3.5 t60 -102.4 129.87 49.0 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.827 174.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.6 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 48.9 mt -97.53 130.28 46.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.642 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 46.6 p -114.0 -18.02 11.83 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.565 -171.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -162.2 149.03 16.87 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 119.611 -1.281 . . . . 0.0 113.031 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.476 HG23 ' HG ' ' A' ' 87' ' ' LEU . 8.2 p -135.19 121.99 34.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 172.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.53 150.22 41.87 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.97 -171.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.536 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.3 pp -114.96 137.52 51.9 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 121.802 0.811 . . . . 0.0 111.167 178.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -107.01 -55.44 2.33 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.615 175.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -101.9 127.06 48.9 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.388 -0.823 . . . . 0.0 108.884 170.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.451 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 148.31 163.48 10.81 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.043 -1.075 . . . . 0.0 113.045 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -102.65 -47.19 4.51 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 121.099 -0.241 . . . . 0.0 111.404 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -151.92 136.39 16.86 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.632 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.446 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -133.49 113.59 12.65 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.478 0.656 . . . . 0.0 110.455 168.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 79' ' ' THR . 65.8 mttp -97.48 109.51 22.25 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.1 tp -85.75 114.78 22.97 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.993 -173.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.554 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 66.0 m-85 -116.41 145.75 43.02 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.509 ' HB2' ' CD1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -131.32 130.37 42.64 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 172.278 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -108.61 114.2 27.83 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.073 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.67 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -125.45 124.21 40.92 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.824 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.519 ' C ' ' HD2' ' A' ' 48' ' ' LYS . 4.2 mm-40 56.62 51.9 10.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.356 0.598 . . . . 0.0 111.066 -175.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.519 ' HD2' ' C ' ' A' ' 47' ' ' GLU . 6.7 mptt 59.0 39.58 23.35 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.459 174.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.591 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 24.0 tp60 -138.56 115.89 11.15 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -82.45 111.74 18.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.931 0.396 . . . . 0.0 110.714 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.438 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 80.3 m-85 -101.82 128.92 47.97 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.362 176.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -75.75 102.61 2.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 168.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.474 ' CG1' HD11 ' A' ' 67' ' ' LEU . 2.8 t -76.24 -51.52 19.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.579 -172.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.454 ' HB2' ' CD2' ' A' ' 65' ' ' LEU . . . -156.61 142.07 17.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.24 -177.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.8 m -105.1 101.35 10.91 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 172.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.71 112.55 40.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.783 0.802 . . . . 0.0 110.103 -177.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.8 p -123.47 -177.0 3.59 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.05 -176.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -59.13 -32.9 70.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.988 0.423 . . . . 0.0 110.44 169.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.64 -40.57 69.62 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.575 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.5 mt -117.69 81.77 15.34 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 174.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.64 -5.67 14.82 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.231 2.621 . . . . 0.0 113.988 -167.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -162.15 122.6 2.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.089 0.471 . . . . 0.0 110.974 -175.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.413 HG11 ' HB1' ' A' ' 54' ' ' ALA . 98.1 t -108.57 113.57 44.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.343 175.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.37 114.87 27.4 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.104 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -135.48 168.66 18.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.223 -176.19 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 6.0 t70 -114.56 99.82 7.82 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.44 0.638 . . . . 0.0 110.588 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.644 HD21 HD23 ' E' ' 88' ' ' LEU . 19.7 mt -111.41 140.98 45.55 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.12 116.57 9.62 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.415 174.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -116.7 139.76 50.19 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.525 ' HB2' ' O ' ' E' ' 6' ' ' ALA . 5.3 t -103.31 173.97 6.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.003 0.43 . . . . 0.0 110.613 -177.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.57 1.29 12.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.539 -177.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.06 -5.84 54.41 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 173.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -100.36 151.43 21.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.865 0.364 . . . . 0.0 110.376 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -140.12 132.42 28.29 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 172.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.67 HG22 ' HB2' ' A' ' 46' ' ' ALA . 6.8 pt -139.79 164.64 23.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.011 0.434 . . . . 0.0 111.817 -167.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.502 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 4.5 mtm -118.65 121.74 40.87 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 173.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.509 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 1.0 OUTLIER -103.66 127.92 51.05 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.656 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 40.4 p90 -153.56 140.77 19.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.256 0.55 . . . . 0.0 111.886 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.682 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 15.2 p -111.9 144.97 40.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.297 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.09 148.66 28.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.31 173.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.85 176.83 41.1 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -176.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -108.53 102.55 11.62 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.046 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.514 ' N ' ' HB3' ' A' ' 15' ' ' PRO . . . -165.88 148.92 7.55 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.363 167.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 27.1 t -103.97 123.98 48.17 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.605 HG23 ' HB3' ' A' ' 13' ' ' MET . 8.0 m -121.01 135.25 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-O 121.349 0.595 . . . . 0.0 111.961 -173.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.1 m -97.47 118.39 33.86 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.908 175.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.61 HD13 HD23 ' A' ' 11' ' ' LEU . 5.0 mp -91.27 140.77 29.48 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 171.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.637 HD23 HD21 ' B' ' 67' ' ' LEU . 0.8 OUTLIER -127.62 143.64 51.14 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -178.254 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 28' ' ' HIS . . . -166.28 -166.97 26.21 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.126 -1.035 . . . . 0.0 112.833 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -142.32 136.6 29.86 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 120.939 0.4 . . . . 0.0 110.676 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.511 HD23 ' HB3' ' A' ' 27' ' ' PHE . 84.5 mt -64.23 119.83 11.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.945 174.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 38.5 t60 -102.22 108.44 19.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.71 -172.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.456 ' HB3' ' H ' ' E' ' 3' ' ' GLY . 2.7 p30 -172.85 -174.32 1.09 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.687 170.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 20.4 pt -129.78 134.22 63.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.775 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -81.3 139.72 35.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.547 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.0 p -74.15 131.49 41.33 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.716 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 157.54 -34.95 0.54 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.094 -0.574 . . . . 0.0 111.745 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.4 p . . . . . 0 C--O 1.251 1.18 0 CA-C-O 118.704 -0.665 . . . . 0.0 110.248 178.149 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.666 0.269 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -89.71 -41.25 12.01 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.132 0.491 . . . . 0.0 110.888 -173.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . 0.511 ' H ' ' HB3' ' C' ' 93' ' ' ASP . . . 78.48 -139.79 22.79 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.551 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . 65.96 -173.82 0.18 Allowed 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.105 0.562 . . . . 0.0 111.455 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 68.6 mtm 70.91 -74.25 0.09 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.981 176.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' C' ' 70' ' ' SER . . . -106.05 125.85 51.49 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.876 -174.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 46.9 mtt -119.37 173.81 6.74 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.122 -178.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -82.22 147.44 28.97 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.908 0.385 . . . . 0.0 112.024 -177.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . 0.492 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 91.1 t90 -139.24 150.02 45.01 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.458 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.432 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -154.11 152.27 23.87 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.489 178.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.6 HD23 HD13 ' B' ' 87' ' ' LEU . 41.1 tp -143.24 108.41 4.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.749 0.309 . . . . 0.0 110.364 177.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -86.04 99.32 11.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.257 0.551 . . . . 0.0 110.036 175.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . 0.587 ' HB3' HG23 ' B' ' 85' ' ' VAL . 24.1 tpp -88.0 135.13 33.55 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.86 -175.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -98.86 145.24 29.62 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.075 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.512 ' HB3' ' N ' ' B' ' 83' ' ' ALA . 10.3 Cg_endo -53.01 120.15 7.23 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 123.591 2.861 . . . . 0.0 113.257 -175.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.683 ' HA ' ' O ' ' B' ' 79' ' ' THR . 29.1 mt-10 58.36 62.94 1.84 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.558 0.694 . . . . 0.0 111.628 177.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.54 148.98 46.39 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.586 174.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.653 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 35.1 ttmt -122.62 117.11 25.06 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.596 0.56 . . . . 0.0 111.379 -175.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -110.97 104.23 12.79 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.05 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 9.8 p -88.19 99.98 12.62 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -121.44 149.9 42.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.369 0.604 . . . . 0.0 112.275 -169.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 12.1 t -99.34 160.88 13.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.369 176.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 53.1 mt -118.98 125.7 74.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.05 0.453 . . . . 0.0 111.606 -173.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.464 ' N ' HD12 ' B' ' 24' ' ' ILE . 4.2 mp -106.9 -33.63 2.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.357 177.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -118.94 122.2 41.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.563 177.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . 0.487 ' CB ' ' HA2' ' A' ' 3' ' ' GLY . 20.3 t -60.81 133.14 55.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.917 -177.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . 0.501 ' HB3' HD23 ' B' ' 91' ' ' LEU . 53.8 p90 -137.48 143.17 41.6 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.932 0.872 . . . . 0.0 111.821 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' HIS . . . . . 0.63 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 3.6 t60 -102.4 129.88 49.01 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.1 -1.409 . . . . 0.0 108.823 174.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.607 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 49.2 mt -97.59 130.34 46.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 171.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.63 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 46.8 p -113.97 -17.99 11.85 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.531 -171.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -162.17 149.02 16.87 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 119.567 -1.302 . . . . 0.0 112.961 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.473 HG23 ' HG ' ' B' ' 87' ' ' LEU . 8.2 p -135.17 121.92 34.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 172.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.5 150.23 41.93 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.436 -0.506 . . . . 0.0 112.049 -171.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.523 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.3 pp -114.91 137.58 51.8 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.816 0.817 . . . . 0.0 111.071 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -107.1 -55.46 2.33 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.585 175.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -101.89 127.07 48.88 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 170.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.457 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 148.37 163.57 10.88 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 119.988 -1.101 . . . . 0.0 112.904 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -102.66 -47.23 4.49 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.57 0.224 . . . . 0.0 111.402 177.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -151.89 136.37 16.88 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.62 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.427 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -133.41 113.61 12.73 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.398 0.618 . . . . 0.0 110.419 168.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' B' ' 79' ' ' THR . 65.8 mttp -97.48 109.66 22.37 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 173.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 34.6 tp -85.68 114.75 22.9 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.067 -173.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . 0.55 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 66.1 m-85 -116.39 145.82 42.95 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 175.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.521 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.2 OUTLIER -131.4 130.33 42.43 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 172.268 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -108.59 114.2 27.82 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.118 178.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.662 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -125.33 124.32 41.32 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.812 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.516 ' C ' ' HD2' ' B' ' 48' ' ' LYS . 4.2 mm-40 56.36 52.02 10.66 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.688 0.618 . . . . 0.0 111.132 -175.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.516 ' HD2' ' C ' ' B' ' 47' ' ' GLU . 6.7 mptt 58.95 39.63 23.41 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.479 174.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.596 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 24.1 tp60 -138.56 115.95 11.2 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -82.58 111.79 18.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.83 0.348 . . . . 0.0 110.596 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.421 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 80.3 m-85 -101.85 128.91 48.02 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.301 176.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -75.81 102.62 2.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 168.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.476 ' CG1' HD11 ' B' ' 67' ' ' LEU . 2.8 t -76.17 -51.64 19.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.542 -172.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.453 ' HB2' ' CD2' ' B' ' 65' ' ' LEU . . . -156.5 142.16 17.74 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.193 -177.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 42.6 m -105.17 101.45 11.0 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 171.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.403 HG13 ' HB3' ' B' ' 40' ' ' ALA . 7.5 p -115.73 112.51 40.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.788 0.804 . . . . 0.0 110.067 -177.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 68.8 p -123.47 -177.09 3.61 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.054 -176.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -59.16 -32.73 70.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.976 0.417 . . . . 0.0 110.47 169.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.76 -40.59 69.2 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.523 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 76.4 mt -117.6 81.8 15.04 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 174.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.71 -5.64 14.82 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.312 2.675 . . . . 0.0 113.932 -167.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -162.18 122.64 2.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.208 0.528 . . . . 0.0 110.955 -175.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.413 HG11 ' HB1' ' B' ' 54' ' ' ALA . 97.9 t -108.57 113.51 44.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.374 175.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.36 114.85 27.38 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.102 175.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' B' ' 30' ' ' SER . 0.3 OUTLIER -135.46 168.7 18.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.191 -176.197 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . 0.527 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 5.9 t70 -114.58 99.7 7.73 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.393 0.616 . . . . 0.0 110.598 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.637 HD21 HD23 ' A' ' 88' ' ' LEU . 19.7 mt -111.35 140.97 45.49 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.17 116.64 9.64 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.351 174.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -116.78 139.68 50.3 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 6' ' ' ALA . 5.3 t -103.3 173.95 6.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.951 0.405 . . . . 0.0 110.633 -177.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.416 ' H ' ' HG3' ' B' ' 71' ' ' LYS . 0.0 OUTLIER -74.56 1.29 12.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.513 -177.009 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.0 -5.89 54.48 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 173.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -100.26 151.33 21.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.964 0.412 . . . . 0.0 110.35 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -140.1 132.48 28.43 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 172.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.662 HG22 ' HB2' ' B' ' 46' ' ' ALA . 6.9 pt -139.87 164.57 23.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.017 0.437 . . . . 0.0 111.837 -167.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.521 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 4.5 mtm -118.59 121.63 40.66 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 173.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . 0.518 ' CD1' ' HB2' ' B' ' 44' ' ' LEU . 1.1 m-85 -103.61 127.95 50.97 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.653 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 40.2 p90 -153.59 140.79 19.49 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.255 0.55 . . . . 0.0 111.845 -178.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.683 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 15.3 p -111.91 144.88 40.5 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.224 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.0 148.62 28.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.298 173.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.05 176.84 40.81 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -108.55 102.55 11.62 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.949 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.512 ' N ' ' HB3' ' B' ' 15' ' ' PRO . . . -165.92 148.85 7.47 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.382 167.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 27.2 t -103.94 124.02 48.22 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.587 HG23 ' HB3' ' B' ' 13' ' ' MET . 8.0 m -121.07 135.15 62.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-O 121.361 0.6 . . . . 0.0 111.895 -173.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 69.5 m -97.48 118.45 34.0 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.936 175.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.6 HD13 HD23 ' B' ' 11' ' ' LEU . 5.0 mp -91.27 140.79 29.46 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 171.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.636 HD23 HD21 ' C' ' 67' ' ' LEU . 0.8 OUTLIER -127.67 143.59 51.14 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.242 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' B' ' 28' ' ' HIS . . . -166.2 -166.92 26.04 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 120.112 -1.042 . . . . 0.0 112.801 -177.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -142.4 136.54 29.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.002 0.43 . . . . 0.0 110.655 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . 0.501 HD23 ' HB3' ' B' ' 27' ' ' PHE . 84.8 mt -64.22 119.77 10.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.921 174.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 38.1 t60 -102.11 108.5 19.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.681 -172.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . 0.507 ' HB3' ' H ' ' A' ' 3' ' ' GLY . 2.7 p30 -172.86 -174.28 1.08 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.794 170.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 20.2 pt -129.8 134.3 63.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.937 0.398 . . . . 0.0 110.713 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -81.36 139.71 35.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.64 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 4.1 p -74.11 131.48 41.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.743 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . 157.61 -34.91 0.54 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.817 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 12.3 p . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.589 -0.719 . . . . 0.0 110.327 178.153 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 . . . . . 0 N--CA 1.482 1.129 0 CA-C-O 120.794 0.331 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -89.68 -41.4 11.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.196 0.522 . . . . 0.0 110.853 -173.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 3' ' ' GLY . . . . . 0.456 ' HA2' ' CB ' ' D' ' 26' ' ' SER . . . 78.66 -139.79 22.66 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.46 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . 65.94 -173.85 0.18 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.105 0.562 . . . . 0.0 111.404 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 68.6 mtm 70.85 -74.18 0.09 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.03 176.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 6' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' D' ' 70' ' ' SER . . . -106.09 125.84 51.48 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.847 -174.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 7' ' ' MET . . . . . 0.408 ' O ' ' HA ' ' C' ' 90' ' ' TYR . 46.9 mtt -119.29 173.85 6.7 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.122 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 8' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -82.3 147.48 28.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.921 0.391 . . . . 0.0 111.955 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . 0.488 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 91.1 t90 -139.32 149.98 44.85 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.421 177.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . 0.43 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -154.09 152.29 23.89 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.523 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.626 HD23 HD13 ' C' ' 87' ' ' LEU . 41.2 tp -143.27 108.34 4.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.74 0.305 . . . . 0.0 110.35 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -85.96 99.17 11.24 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.306 0.574 . . . . 0.0 110.099 175.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 13' ' ' MET . . . . . 0.606 ' HB3' HG23 ' C' ' 85' ' ' VAL . 24.1 tpp -87.97 135.1 33.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.888 -175.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -98.78 145.25 29.62 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.077 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . 0.518 ' HB3' ' N ' ' C' ' 83' ' ' ALA . 10.3 Cg_endo -53.04 120.14 7.22 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 123.624 2.883 . . . . 0.0 113.287 -175.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . 0.686 ' HA ' ' O ' ' C' ' 79' ' ' THR . 29.1 mt-10 58.35 63.0 1.83 Allowed 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.579 0.704 . . . . 0.0 111.658 177.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.63 148.93 46.2 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.518 174.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 18' ' ' LYS . . . . . 0.647 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 35.1 ttmt -122.6 117.09 25.02 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 123.482 0.489 . . . . 0.0 111.351 -175.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -111.01 104.28 12.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.007 177.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 9.4 p -88.24 100.03 12.67 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 173.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -121.32 150.04 42.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.339 0.59 . . . . 0.0 112.369 -169.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 12.2 t -99.42 160.85 13.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.327 176.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 53.3 mt -119.01 125.7 74.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.01 0.434 . . . . 0.0 111.532 -173.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . 0.451 HD12 ' N ' ' C' ' 24' ' ' ILE . 4.2 mp -106.99 -33.52 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.241 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -118.94 122.18 41.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.524 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . 0.469 ' CB ' ' HA2' ' B' ' 3' ' ' GLY . 20.3 t -60.82 133.13 55.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.837 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 27' ' ' PHE . . . . . 0.491 ' HB3' HD23 ' C' ' 91' ' ' LEU . 53.9 p90 -137.47 143.11 41.6 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.962 0.887 . . . . 0.0 111.906 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 28' ' ' HIS . . . . . 0.645 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 3.5 t60 -102.33 129.84 48.89 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.114 -1.403 . . . . 0.0 108.905 174.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . 0.619 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 48.9 mt -97.56 130.27 46.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 171.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.645 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 46.4 p -113.95 -17.98 11.86 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.541 -171.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -162.2 149.05 16.91 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 119.611 -1.28 . . . . 0.0 112.873 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.464 HG23 ' HG ' ' C' ' 87' ' ' LEU . 8.3 p -135.12 121.9 34.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 172.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.37 150.3 42.23 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.501 -0.48 . . . . 0.0 112.06 -171.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.529 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.3 pp -115.04 137.44 52.0 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.757 0.789 . . . . 0.0 111.147 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -106.96 -55.51 2.32 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.548 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -101.89 127.06 48.88 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 171.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 37' ' ' GLY . . . . . 0.459 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 148.28 163.53 10.84 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.016 -1.088 . . . . 0.0 112.981 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -102.66 -47.26 4.48 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.555 0.217 . . . . 0.0 111.385 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -151.9 136.32 16.84 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.701 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -133.48 113.55 12.63 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.429 0.633 . . . . 0.0 110.42 168.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' C' ' 79' ' ' THR . 65.8 mttp -97.45 109.55 22.28 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 174.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 35.0 tp -85.66 114.69 22.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.047 -173.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 43' ' ' TYR . . . . . 0.553 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 66.4 m-85 -116.37 145.75 42.99 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.513 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 0.2 OUTLIER -131.31 130.35 42.63 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 172.228 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -108.56 114.1 27.65 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.113 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.68 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -125.34 124.39 41.45 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.759 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 47' ' ' GLU . . . . . 0.519 ' C ' ' HD2' ' C' ' 48' ' ' LYS . 4.3 mm-40 56.37 52.06 10.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.347 0.594 . . . . 0.0 111.071 -175.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.519 ' HD2' ' C ' ' C' ' 47' ' ' GLU . 6.7 mptt 58.91 39.65 23.51 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.492 174.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . 0.591 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 24.1 tp60 -138.66 115.96 11.13 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -82.61 111.74 18.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.902 0.382 . . . . 0.0 110.635 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . 0.432 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 80.0 m-85 -101.78 128.85 47.95 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.398 176.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -75.78 102.58 2.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 168.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 53' ' ' VAL . . . . . 0.478 ' CG1' HD11 ' C' ' 67' ' ' LEU . 2.8 t -76.17 -51.61 19.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.543 -172.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 54' ' ' ALA . . . . . 0.453 ' HB2' ' CD2' ' C' ' 65' ' ' LEU . . . -156.57 142.15 17.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.133 -177.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 42.4 m -105.21 101.44 10.98 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 171.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.7 112.56 40.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.815 0.817 . . . . 0.0 110.074 -177.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 68.0 p -123.47 -176.98 3.58 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.064 -176.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -59.33 -32.73 70.35 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.418 169.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.66 -40.72 69.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.486 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 76.0 mt -117.53 81.82 14.81 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 174.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.77 -5.73 15.09 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.256 2.637 . . . . 0.0 113.888 -167.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -162.04 122.67 2.59 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.075 0.464 . . . . 0.0 110.963 -175.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 97.8 t -108.6 113.59 44.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.346 175.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.35 114.82 27.35 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.123 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' C' ' 30' ' ' SER . 0.3 OUTLIER -135.38 168.68 18.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.259 -176.198 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 66' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 5.9 t70 -114.64 99.78 7.78 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.542 0.687 . . . . 0.0 110.595 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.636 HD21 HD23 ' B' ' 88' ' ' LEU . 19.8 mt -111.35 141.02 45.44 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -142.2 116.63 9.61 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.366 174.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -116.81 139.68 50.32 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . 0.48 ' HB2' ' O ' ' B' ' 6' ' ' ALA . 5.3 t -103.28 173.94 6.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.049 0.452 . . . . 0.0 110.635 -177.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . 0.434 ' H ' ' HG3' ' C' ' 71' ' ' LYS . 0.0 OUTLIER -74.53 1.3 12.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.487 -176.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.09 -5.75 54.45 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 173.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -100.36 151.32 21.64 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.793 0.33 . . . . 0.0 110.432 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -140.13 132.36 28.18 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 172.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.68 HG22 ' HB2' ' C' ' 46' ' ' ALA . 6.8 pt -139.74 164.5 23.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.966 0.412 . . . . 0.0 111.888 -167.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.506 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 4.5 mtm -118.57 121.68 40.79 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 173.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 77' ' ' PHE . . . . . 0.513 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 1.1 m-85 -103.65 128.02 51.01 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 78' ' ' TYR . . . . . 0.647 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 40.3 p90 -153.56 140.87 19.6 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.218 0.532 . . . . 0.0 111.879 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . 0.686 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 15.2 p -112.0 144.98 40.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.22 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.1 148.83 28.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.248 173.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.71 176.89 41.31 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -176.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -108.55 102.45 11.52 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.019 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . 0.518 ' N ' ' HB3' ' C' ' 15' ' ' PRO . . . -165.83 148.93 7.61 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.356 167.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 27.1 t -104.0 123.89 48.01 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.606 HG23 ' HB3' ' C' ' 13' ' ' MET . 8.2 m -120.89 135.2 61.86 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 CA-C-O 121.323 0.582 . . . . 0.0 112.007 -173.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 68.7 m -97.39 118.32 33.6 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.439 -0.8 . . . . 0.0 108.957 175.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . 0.626 HD13 HD23 ' C' ' 11' ' ' LEU . 5.0 mp -91.16 140.83 29.44 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 171.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . 0.623 HD23 HD21 ' D' ' 67' ' ' LEU . 0.8 OUTLIER -127.66 143.58 51.14 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -178.253 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 89' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' C' ' 28' ' ' HIS . . . -166.26 -166.95 26.16 Favored Glycine 0 N--CA 1.439 -1.166 0 C-N-CA 120.051 -1.071 . . . . 0.0 112.738 -177.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 90' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' C' ' 7' ' ' MET . 5.1 p90 -142.31 136.59 29.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.984 0.421 . . . . 0.0 110.623 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . 0.491 HD23 ' HB3' ' C' ' 27' ' ' PHE . 84.7 mt -64.24 119.82 10.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.88 174.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -102.11 108.43 19.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.735 -172.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 93' ' ' ASP . . . . . 0.511 ' HB3' ' H ' ' B' ' 3' ' ' GLY . 2.7 p30 -172.87 -174.28 1.08 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.826 170.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 20.4 pt -129.82 134.25 63.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.022 0.439 . . . . 0.0 110.74 -178.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.24 139.7 35.33 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.671 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 4.0 p -74.18 131.56 41.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.713 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 157.58 -34.96 0.54 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.744 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 12.7 p . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.646 -0.693 . . . . 0.0 110.241 178.164 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.69 0.281 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -89.62 -41.34 12.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.248 0.547 . . . . 0.0 110.9 -173.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 3' ' ' GLY . . . . . 0.487 ' H ' ' HB3' ' E' ' 93' ' ' ASP . . . 78.64 -139.79 22.67 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.543 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . 65.87 -173.86 0.18 Allowed 'General case' 0 C--O 1.236 0.349 0 O-C-N 124.099 0.529 . . . . 0.0 111.51 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 68.5 mtm 71.04 -74.31 0.09 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.344 0.657 . . . . 0.0 111.945 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 6' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' E' ' 70' ' ' SER . . . -105.99 125.79 51.42 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.848 -174.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 47.1 mtt -119.31 173.86 6.7 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.053 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 8' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -82.27 147.49 28.88 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.919 0.39 . . . . 0.0 111.93 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 9' ' ' TRP . . . . . 0.49 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 91.2 t90 -139.3 149.94 44.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.45 177.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -154.12 152.3 23.9 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.511 178.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.624 HD23 HD13 ' D' ' 87' ' ' LEU . 40.8 tp -143.23 108.37 4.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.751 0.31 . . . . 0.0 110.344 177.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -86.15 99.42 11.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.375 0.607 . . . . 0.0 110.053 175.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 13' ' ' MET . . . . . 0.615 ' HB3' HG23 ' D' ' 85' ' ' VAL . 24.0 tpp -88.07 135.09 33.58 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.868 -175.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -98.84 145.13 29.41 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.158 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . 0.516 ' HB3' ' N ' ' D' ' 83' ' ' ALA . 10.3 Cg_endo -52.93 120.08 7.08 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.642 2.895 . . . . 0.0 113.237 -175.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . 0.677 ' HA ' ' O ' ' D' ' 79' ' ' THR . 28.9 mt-10 58.44 62.92 1.84 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.634 177.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.5 148.86 46.35 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.613 174.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . 0.665 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 35.1 ttmt -122.54 117.13 25.17 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 123.556 0.535 . . . . 0.0 111.386 -175.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -111.03 104.23 12.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.022 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 9.5 p -88.23 99.86 12.54 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 173.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -121.31 149.93 42.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.443 0.64 . . . . 0.0 112.373 -169.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 12.1 t -99.32 160.87 13.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.349 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 53.0 mt -118.97 125.74 74.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.012 0.434 . . . . 0.0 111.562 -173.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . 0.457 HD12 ' N ' ' D' ' 24' ' ' ILE . 4.2 mp -106.95 -33.56 2.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.311 177.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -118.94 122.16 41.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.587 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 26' ' ' SER . . . . . 0.456 ' CB ' ' HA2' ' C' ' 3' ' ' GLY . 20.4 t -60.72 133.06 55.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.856 -177.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 27' ' ' PHE . . . . . 0.499 ' HB3' HD23 ' D' ' 91' ' ' LEU . 53.9 p90 -137.42 143.1 41.71 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.87 0.843 . . . . 0.0 111.981 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 28' ' ' HIS . . . . . 0.631 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 3.5 t60 -102.37 129.88 48.96 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.839 174.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 29' ' ' ILE . . . . . 0.617 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 48.8 mt -97.5 130.33 46.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 171.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . 0.631 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 45.7 p -114.0 -18.06 11.82 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 120.973 0.416 . . . . 0.0 111.587 -171.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 31' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -162.15 149.01 16.87 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 119.573 -1.299 . . . . 0.0 113.022 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.466 HG23 ' HG ' ' D' ' 87' ' ' LEU . 8.2 p -135.15 121.95 34.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 172.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.46 150.33 42.12 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.47 -0.492 . . . . 0.0 112.038 -171.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 34' ' ' LEU . . . . . 0.523 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.3 pp -114.99 137.5 51.92 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.785 0.802 . . . . 0.0 111.116 178.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -107.0 -55.46 2.33 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.502 -1.227 . . . . 0.0 108.615 175.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -101.96 127.06 48.98 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.857 171.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . 0.453 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 148.32 163.57 10.87 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.01 -1.091 . . . . 0.0 112.991 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -102.69 -47.23 4.48 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.408 177.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -151.84 136.39 16.95 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.669 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . 0.43 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -133.5 113.59 12.65 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.453 0.644 . . . . 0.0 110.402 168.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' D' ' 79' ' ' THR . 65.8 mttp -97.41 109.51 22.25 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 173.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 34.9 tp -85.63 114.77 22.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.087 -173.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 43' ' ' TYR . . . . . 0.544 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 66.1 m-85 -116.43 145.81 43.0 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 175.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.51 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.2 OUTLIER -131.45 130.33 42.34 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 172.342 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 45' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -108.58 114.02 27.5 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.102 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.672 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -125.28 124.37 41.48 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.832 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 47' ' ' GLU . . . . . 0.519 ' C ' ' HD2' ' D' ' 48' ' ' LYS . 4.3 mm-40 56.48 51.97 10.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.297 0.57 . . . . 0.0 111.042 -175.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 48' ' ' LYS . . . . . 0.519 ' HD2' ' C ' ' D' ' 47' ' ' GLU . 6.7 mptt 58.93 39.65 23.45 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.413 174.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . 0.585 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 24.7 tp60 -138.57 115.93 11.17 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -82.5 111.72 18.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.873 0.368 . . . . 0.0 110.713 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . 0.43 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 80.1 m-85 -101.82 128.85 47.99 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.278 176.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -75.73 102.61 2.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 168.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 53' ' ' VAL . . . . . 0.479 ' CG1' HD11 ' D' ' 67' ' ' LEU . 2.8 t -76.25 -51.54 19.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.542 -172.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 54' ' ' ALA . . . . . 0.451 ' HB2' ' CD2' ' D' ' 65' ' ' LEU . . . -156.59 142.0 17.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.207 -177.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 41.9 m -105.05 101.42 10.98 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 171.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 56' ' ' VAL . . . . . 0.402 HG13 ' HB3' ' D' ' 40' ' ' ALA . 7.5 p -115.71 112.65 40.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.801 0.81 . . . . 0.0 110.039 -177.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 70.0 p -123.54 -177.0 3.59 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.026 -176.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -59.19 -32.87 70.31 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.037 0.446 . . . . 0.0 110.434 169.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.6 -40.65 69.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.572 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 75.9 mt -117.53 81.79 14.77 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 174.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.72 -5.68 14.92 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.186 2.591 . . . . 0.0 114.007 -167.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -162.11 122.78 2.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.196 0.522 . . . . 0.0 110.916 -175.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.42 HG11 ' HB1' ' D' ' 54' ' ' ALA . 98.3 t -108.66 113.45 44.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.382 175.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.34 114.87 27.42 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.096 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 65' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' D' ' 30' ' ' SER . 0.3 OUTLIER -135.52 168.63 18.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.182 -176.185 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 66' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 5.9 t70 -114.52 99.82 7.83 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.407 0.622 . . . . 0.0 110.545 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.623 HD21 HD23 ' C' ' 88' ' ' LEU . 19.8 mt -111.4 141.0 45.53 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 175.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.17 116.62 9.63 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.384 174.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -116.8 139.76 50.22 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . 0.527 ' HB2' ' O ' ' C' ' 6' ' ' ALA . 5.3 t -103.28 173.97 6.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.982 0.42 . . . . 0.0 110.643 -177.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 71' ' ' LYS . . . . . 0.404 ' HG3' ' H ' ' D' ' 71' ' ' LYS . 0.0 OUTLIER -74.62 1.38 12.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.53 -177.034 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.04 -5.95 54.35 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -100.3 151.4 21.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.825 0.345 . . . . 0.0 110.426 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -140.16 132.41 28.22 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 172.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.672 HG22 ' HB2' ' D' ' 46' ' ' ALA . 6.8 pt -139.91 164.53 23.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.97 0.414 . . . . 0.0 111.803 -167.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 76' ' ' MET . . . . . 0.507 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 4.5 mtm -118.52 121.63 40.72 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 173.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 77' ' ' PHE . . . . . 0.51 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 1.1 m-85 -103.61 127.96 50.97 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 78' ' ' TYR . . . . . 0.665 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 40.2 p90 -153.61 140.88 19.56 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.229 0.538 . . . . 0.0 111.85 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 79' ' ' THR . . . . . 0.677 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 15.0 p -112.01 145.02 40.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.18 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.19 148.66 28.6 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.297 173.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.95 176.86 40.96 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -108.53 102.58 11.65 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.033 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . 0.516 ' N ' ' HB3' ' D' ' 15' ' ' PRO . . . -165.87 148.89 7.54 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.329 167.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 26.9 t -103.95 124.02 48.23 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.615 HG23 ' HB3' ' D' ' 13' ' ' MET . 8.2 m -120.95 135.1 62.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.338 0.589 . . . . 0.0 111.933 -173.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 68.5 m -97.38 118.5 34.0 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.964 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 87' ' ' LEU . . . . . 0.624 HD13 HD23 ' D' ' 11' ' ' LEU . 5.0 mp -91.33 140.87 29.37 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 171.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.636 HD23 HD21 ' E' ' 67' ' ' LEU . 0.8 OUTLIER -127.75 143.58 51.13 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -178.207 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 89' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' D' ' 28' ' ' HIS . . . -166.21 -167.0 26.18 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 120.102 -1.047 . . . . 0.0 112.777 -177.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -142.29 136.56 29.89 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 120.948 0.404 . . . . 0.0 110.609 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . 0.499 HD23 ' HB3' ' D' ' 27' ' ' PHE . 84.5 mt -64.25 119.65 10.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.999 174.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 38.2 t60 -101.95 108.42 19.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.784 -172.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 93' ' ' ASP . . . . . 0.426 ' HB3' ' H ' ' C' ' 3' ' ' GLY . 2.7 p30 -172.81 -174.32 1.1 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.683 170.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 20.6 pt -129.73 134.24 63.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.962 0.41 . . . . 0.0 110.777 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -81.41 139.79 35.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.517 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 4.1 p -74.25 131.55 41.3 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.695 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . 157.58 -35.0 0.54 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.788 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 12.6 p . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.552 -0.737 . . . . 0.0 110.263 178.158 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 120.813 0.34 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -89.68 -41.31 12.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.156 0.503 . . . . 0.0 110.924 -173.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 3' ' ' GLY . . . . . 0.486 ' HA2' ' CB ' ' A' ' 26' ' ' SER . . . 78.61 -139.82 22.73 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.528 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . 66.03 -173.82 0.18 Allowed 'General case' 0 C--O 1.236 0.358 0 O-C-N 124.089 0.523 . . . . 0.0 111.493 178.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 68.6 mtm 70.89 -74.29 0.09 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.904 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 6' ' ' ALA . . . . . 0.525 ' O ' ' HB2' ' A' ' 70' ' ' SER . . . -106.05 125.72 51.33 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.832 -174.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 7' ' ' MET . . . . . 0.402 ' O ' ' HA ' ' E' ' 90' ' ' TYR . 47.0 mtt -119.25 173.8 6.73 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.2 -178.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 8' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -82.2 147.55 28.93 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.888 0.375 . . . . 0.0 111.988 -177.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 9' ' ' TRP . . . . . 0.485 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 90.9 t90 -139.31 149.97 44.85 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 10' ' ' GLY . . . . . 0.438 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -154.14 152.28 23.88 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.446 178.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . 0.609 HD23 HD13 ' E' ' 87' ' ' LEU . 41.4 tp -143.17 108.3 4.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.735 0.302 . . . . 0.0 110.359 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -86.12 99.33 11.43 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.334 0.587 . . . . 0.0 110.042 175.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 13' ' ' MET . . . . . 0.614 ' HB3' HG23 ' E' ' 85' ' ' VAL . 23.9 tpp -88.0 135.12 33.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.853 -175.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -98.75 145.18 29.49 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.13 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . 0.511 ' HB3' ' N ' ' E' ' 83' ' ' ALA . 10.3 Cg_endo -52.97 120.07 7.09 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 123.653 2.902 . . . . 0.0 113.254 -175.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 16' ' ' GLU . . . . . 0.682 ' HA ' ' O ' ' E' ' 79' ' ' THR . 29.0 mt-10 58.44 62.88 1.85 Allowed 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 121.526 0.679 . . . . 0.0 111.653 177.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.49 148.92 46.42 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.578 174.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . 0.648 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 35.1 ttmt -122.61 117.17 25.19 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 123.569 0.543 . . . . 0.0 111.316 -175.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -111.02 104.39 12.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.993 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 20' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' E' ' 76' ' ' MET . 9.9 p -88.34 99.99 12.68 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 173.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -121.3 150.0 42.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.386 0.613 . . . . 0.0 112.33 -169.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 12.2 t -99.3 160.81 14.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.331 176.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 52.9 mt -118.94 125.75 74.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.113 0.482 . . . . 0.0 111.663 -173.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . 0.451 HD12 ' N ' ' E' ' 24' ' ' ILE . 4.2 mp -106.98 -33.57 2.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.283 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -118.93 122.23 41.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.55 177.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 26' ' ' SER . . . . . 0.444 ' CB ' ' HA2' ' D' ' 3' ' ' GLY . 20.5 t -60.81 133.06 55.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.829 -177.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 27' ' ' PHE . . . . . 0.499 ' HB3' HD23 ' E' ' 91' ' ' LEU . 53.9 p90 -137.38 143.18 41.82 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.925 0.869 . . . . 0.0 111.954 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 28' ' ' HIS . . . . . 0.64 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 3.5 t60 -102.49 129.92 49.16 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.769 174.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 29' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 49.0 mt -97.44 130.3 46.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 171.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . 0.64 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 46.5 p -114.0 -17.92 11.85 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.612 -171.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 31' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -162.23 148.97 16.72 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 119.656 -1.259 . . . . 0.0 112.984 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.469 HG23 ' HG ' ' E' ' 87' ' ' LEU . 8.3 p -135.11 121.92 34.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 172.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.47 150.24 41.99 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.52 -0.472 . . . . 0.0 112.01 -171.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 34' ' ' LEU . . . . . 0.528 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.3 pp -114.96 137.55 51.86 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.735 0.779 . . . . 0.0 111.111 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -107.07 -55.52 2.32 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.593 175.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -101.77 127.05 48.72 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . 0.455 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 148.28 163.55 10.84 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 119.995 -1.097 . . . . 0.0 112.998 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -102.7 -47.15 4.51 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.419 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -151.87 136.34 16.88 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.643 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . 0.428 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -133.41 113.56 12.68 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.451 0.643 . . . . 0.0 110.404 168.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 41' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' E' ' 79' ' ' THR . 65.8 mttp -97.36 109.57 22.3 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 34.5 tp -85.62 114.67 22.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.067 -173.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 43' ' ' TYR . . . . . 0.55 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 66.2 m-85 -116.37 145.77 42.98 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 44' ' ' LEU . . . . . 0.513 ' HB2' ' CD1' ' E' ' 77' ' ' PHE . 0.2 OUTLIER -131.37 130.41 42.59 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 172.288 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 45' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -108.67 114.09 27.6 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.145 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . 0.668 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -125.32 124.26 41.19 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.753 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 47' ' ' GLU . . . . . 0.518 ' C ' ' HD2' ' E' ' 48' ' ' LYS . 4.2 mm-40 56.57 52.03 10.37 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.663 0.602 . . . . 0.0 110.977 -175.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 48' ' ' LYS . . . . . 0.518 ' HD2' ' C ' ' E' ' 47' ' ' GLU . 6.7 mptt 59.0 39.5 23.43 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.493 174.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 49' ' ' GLN . . . . . 0.586 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 24.2 tp60 -138.61 116.03 11.22 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -82.55 111.73 18.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.897 0.379 . . . . 0.0 110.631 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -101.86 128.87 48.04 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.336 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tp -75.76 102.57 2.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 168.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . 0.472 ' CG1' HD11 ' E' ' 67' ' ' LEU . 2.8 t -76.22 -51.51 19.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.516 -172.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 54' ' ' ALA . . . . . 0.449 ' HB2' ' CD2' ' E' ' 65' ' ' LEU . . . -156.54 142.07 17.63 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.262 -177.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 43.3 m -105.14 101.45 11.0 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 171.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . 0.4 HG13 ' HB3' ' E' ' 40' ' ' ALA . 7.5 p -115.75 112.67 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-O 121.759 0.79 . . . . 0.0 110.033 -177.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 69.4 p -123.59 -177.07 3.62 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.008 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -59.18 -32.87 70.3 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.914 0.388 . . . . 0.0 110.385 169.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.62 -40.62 69.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.526 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 76.2 mt -117.58 81.77 14.93 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.67 -5.73 15.0 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.257 2.638 . . . . 0.0 113.965 -167.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -162.07 122.66 2.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.202 0.525 . . . . 0.0 110.925 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . 0.42 HG11 ' HB1' ' E' ' 54' ' ' ALA . 97.4 t -108.62 113.56 44.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.307 175.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.32 114.83 27.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.122 175.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' E' ' 30' ' ' SER . 0.3 OUTLIER -135.42 168.6 18.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.263 -176.244 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 66' ' ' ASP . . . . . 0.546 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 6.0 t70 -114.53 99.75 7.78 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.43 0.633 . . . . 0.0 110.66 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 67' ' ' LEU . . . . . 0.636 HD21 HD23 ' D' ' 88' ' ' LEU . 19.7 mt -111.35 140.99 45.47 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.13 116.57 9.62 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.417 174.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -116.72 139.74 50.21 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 70' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' D' ' 6' ' ' ALA . 5.3 t -103.31 173.92 6.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.977 0.418 . . . . 0.0 110.635 -177.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.59 1.37 12.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.516 -177.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.05 -5.98 54.3 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 173.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -100.26 151.33 21.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.769 0.319 . . . . 0.0 110.465 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -140.02 132.42 28.46 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 172.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 75' ' ' ILE . . . . . 0.668 HG22 ' HB2' ' E' ' 46' ' ' ALA . 6.8 pt -139.83 164.58 23.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.973 0.416 . . . . 0.0 111.87 -167.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 76' ' ' MET . . . . . 0.505 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 4.5 mtm -118.58 121.68 40.79 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 77' ' ' PHE . . . . . 0.513 ' CD1' ' HB2' ' E' ' 44' ' ' LEU . 1.0 OUTLIER -103.73 127.98 51.15 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.738 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 78' ' ' TYR . . . . . 0.648 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 40.1 p90 -153.51 140.9 19.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.213 0.53 . . . . 0.0 111.905 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 79' ' ' THR . . . . . 0.682 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 14.7 p -111.98 144.99 40.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.17 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.24 148.66 28.66 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.214 173.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.87 176.83 41.08 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -176.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -108.56 102.56 11.63 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.949 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 83' ' ' ALA . . . . . 0.511 ' N ' ' HB3' ' E' ' 15' ' ' PRO . . . -165.9 148.86 7.5 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.39 167.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 27.2 t -103.95 123.93 48.06 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 85' ' ' VAL . . . . . 0.614 HG23 ' HB3' ' E' ' 13' ' ' MET . 8.1 m -120.87 135.2 61.81 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-O 121.377 0.608 . . . . 0.0 112.005 -173.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 69.1 m -97.48 118.38 33.84 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.455 -0.793 . . . . 0.0 108.866 175.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 87' ' ' LEU . . . . . 0.609 HD13 HD23 ' E' ' 11' ' ' LEU . 5.0 mp -91.27 140.81 29.44 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 171.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . 0.644 HD23 HD21 ' A' ' 67' ' ' LEU . 0.8 OUTLIER -127.67 143.64 51.14 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -178.247 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 89' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' E' ' 28' ' ' HIS . . . -166.22 -166.98 26.16 Favored Glycine 0 N--CA 1.438 -1.185 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.799 -177.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 90' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' E' ' 7' ' ' MET . 5.2 p90 -142.29 136.62 29.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.954 0.407 . . . . 0.0 110.632 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 91' ' ' LEU . . . . . 0.499 HD23 ' HB3' ' E' ' 27' ' ' PHE . 84.4 mt -64.21 119.74 10.81 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.953 174.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 38.2 t60 -102.14 108.45 19.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.694 -172.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 93' ' ' ASP . . . . . 0.487 ' HB3' ' H ' ' D' ' 3' ' ' GLY . 2.7 p30 -172.86 -174.27 1.08 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.73 170.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 20.5 pt -129.83 134.24 63.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.745 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -81.32 139.76 35.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.584 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 4.0 p -74.24 131.48 41.25 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.734 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . 157.56 -34.92 0.54 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.795 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 12.4 p . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.646 -0.692 . . . . 0.0 110.266 178.119 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 120.976 0.417 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -136.16 163.62 29.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.17 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 122.3 25.57 1.99 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.209 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.425 ' HB3' HG13 ' B' ' 94' ' ' ILE . . . -167.31 53.43 0.07 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.037 0.446 . . . . 0.0 110.071 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.42 ' HB3' ' OG ' ' B' ' 70' ' ' SER . 3.6 mpp? -111.15 67.63 0.65 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.02 -174.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.48 ' HB3' ' ND2' ' B' ' 68' ' ' ASN . . . -60.81 131.37 50.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.77 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -81.33 150.88 28.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.164 0.507 . . . . 0.0 111.674 -174.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.64 ' CE1' HD21 ' B' ' 44' ' ' LEU . 31.1 t80 -72.26 145.87 47.63 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.409 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.422 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 92.1 t90 -134.31 147.97 50.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.391 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.502 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -152.25 154.92 25.83 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.855 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.526 HD23 HD13 ' A' ' 87' ' ' LEU . 49.8 tp -147.38 108.26 4.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.857 0.36 . . . . 0.0 111.019 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -90.42 119.94 31.12 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.963 0.411 . . . . 0.0 110.545 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.694 ' SD ' ' HE2' ' A' ' 19' ' ' TYR . 52.9 mmm -99.96 139.67 35.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.226 -175.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -100.32 145.06 29.62 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.583 174.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.468 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 11.0 Cg_endo -55.14 116.29 3.04 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.147 2.565 . . . . 0.0 112.925 -177.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 62.92 64.85 0.84 Allowed 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.876 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -145.71 138.78 26.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.682 173.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.728 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 86.4 mttt -107.1 126.54 52.49 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -176.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.694 ' HE2' ' SD ' ' A' ' 13' ' ' MET . 1.2 m-85 -112.6 103.84 11.9 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.192 174.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.0 p -88.37 100.33 12.94 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 174.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -113.24 144.37 42.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.434 0.635 . . . . 0.0 111.872 -170.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.5 m -101.95 140.91 35.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.556 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.403 HG22 ' HA ' ' A' ' 71' ' ' LYS . 74.1 mt -99.38 120.14 48.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.217 0.532 . . . . 0.0 111.723 -171.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.753 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -105.65 -9.84 10.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.276 176.044 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.516 ' HD2' HD13 ' A' ' 91' ' ' LEU . 35.5 pttt -141.55 119.16 11.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.872 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.9 p -67.05 133.67 50.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.809 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.671 ' HB3' HD23 ' A' ' 91' ' ' LEU . 32.6 p90 -147.56 166.49 27.19 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -173.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.554 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 9.4 t60 -118.88 126.21 51.27 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.908 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 42.6 mt -92.23 136.16 25.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 170.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.513 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 64.2 p -123.68 -5.66 8.09 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -170.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.46 160.79 27.76 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 119.086 -1.531 . . . . 0.0 113.823 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.466 HG23 ' HG ' ' A' ' 87' ' ' LEU . 11.5 p -144.5 129.96 14.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 174.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.45 157.7 43.97 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.012 -0.43 . . . . 0.0 111.482 -176.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.649 ' HB3' HG12 ' A' ' 85' ' ' VAL . 3.9 pp -122.05 145.3 48.28 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.795 0.807 . . . . 0.0 111.846 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -107.72 -56.02 2.28 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.64 173.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -103.14 127.26 50.49 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.368 173.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.59 ' O ' ' HG3' ' A' ' 58' ' ' LYS . . . 145.13 159.38 8.07 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 119.958 -1.115 . . . . 0.0 112.896 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -102.43 -45.61 5.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.477 0.18 . . . . 0.0 111.459 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -150.56 127.27 10.93 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 120.582 0.229 . . . . 0.0 111.056 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.519 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -127.42 114.94 18.17 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.295 0.569 . . . . 0.0 110.479 171.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 79' ' ' THR . 3.7 mppt? -95.1 112.05 23.8 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 174.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.6 tp -84.18 108.87 17.32 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -108.59 144.31 36.47 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.267 0.556 . . . . 0.0 110.073 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.674 HD21 ' CE1' ' E' ' 8' ' ' PHE . 0.2 OUTLIER -129.23 116.64 19.47 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.413 174.454 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -103.45 110.52 22.58 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.251 0.548 . . . . 0.0 109.706 177.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.52 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -140.13 145.58 37.75 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.333 -177.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 58.11 33.14 22.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.474 0.654 . . . . 0.0 109.774 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 62.59 38.13 12.55 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.814 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.545 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 6.5 tp-100 -140.66 138.92 34.67 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 178.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -90.92 110.04 21.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.88 0.371 . . . . 0.0 110.405 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.536 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 78.2 m-85 -101.82 130.65 48.32 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.473 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -85.24 101.86 10.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.74 0.781 . . . . 0.0 109.03 172.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.609 ' CG2' ' HB3' ' A' ' 44' ' ' LEU . 2.9 t -76.33 -49.81 23.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.72 -171.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.545 ' HB2' HD21 ' A' ' 65' ' ' LEU . . . -154.02 146.69 24.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.451 -177.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.5 m -111.06 100.94 9.53 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 170.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.464 HG11 HG11 ' A' ' 85' ' ' VAL . 7.5 p -115.8 114.65 46.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.665 0.745 . . . . 0.0 109.808 -176.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 78.0 p -122.86 -178.32 3.91 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.51 -173.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.59 ' HG3' ' O ' ' A' ' 37' ' ' GLY . 6.1 mttm -61.41 -29.9 70.23 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.012 0.434 . . . . 0.0 110.407 169.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.27 -40.2 52.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.431 178.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.2 mt -115.55 81.38 8.87 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -69.13 -0.47 6.44 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.152 2.568 . . . . 0.0 113.984 -167.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -163.06 130.24 3.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.361 0.601 . . . . 0.0 111.319 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 96.3 t -118.88 120.81 65.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.377 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.18 131.61 35.31 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 175.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.545 HD21 ' HB2' ' A' ' 54' ' ' ALA . 82.5 mt -124.0 167.14 14.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.449 0.642 . . . . 0.0 112.36 -173.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.451 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 14.4 t0 -143.15 99.18 3.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.514 170.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.596 HD21 HD23 ' E' ' 88' ' ' LEU . 2.4 mt -128.09 140.04 52.17 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.408 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.492 ' ND2' ' HB3' ' E' ' 6' ' ' ALA . 5.3 t30 -135.2 122.71 21.99 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.754 174.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -116.14 143.75 45.07 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.49 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.423 ' OG ' ' HB3' ' E' ' 5' ' ' MET . 34.1 t -94.34 166.24 12.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.239 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.403 ' HA ' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -74.57 -7.05 51.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.164 0.506 . . . . 0.0 110.138 178.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.86 -8.16 62.16 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.494 174.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -93.71 144.62 25.23 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -136.12 127.74 28.88 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 171.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.52 HG22 ' HB2' ' A' ' 46' ' ' ALA . 8.5 pt -135.5 160.31 39.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.581 -163.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.436 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 3.0 mtm -114.05 120.39 40.41 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.499 172.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.651 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -103.67 127.85 51.07 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 176.235 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.728 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 53.0 p90 -156.4 143.15 18.66 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 119.735 -0.786 . . . . 0.0 112.238 -176.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 2.0 p -114.92 132.11 56.66 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.301 -176.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.42 160.65 14.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.797 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.02 -175.67 40.08 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -175.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -110.4 102.53 11.16 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.877 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -174.51 155.7 2.3 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.557 171.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.5 t -115.92 117.26 29.67 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.371 -0.604 . . . . 0.0 109.371 177.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.649 HG12 ' HB3' ' A' ' 34' ' ' LEU . 3.7 m -111.34 164.97 6.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.213 0.53 . . . . 0.0 112.126 -174.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 21.2 t -129.76 120.85 25.74 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.125 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.526 HD13 HD23 ' A' ' 11' ' ' LEU . 5.3 mp -92.86 154.43 18.23 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 121.004 0.43 . . . . 0.0 110.172 173.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.599 HD23 HD21 ' B' ' 67' ' ' LEU . 0.2 OUTLIER -133.7 144.66 49.28 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.105 179.827 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.97 -167.45 28.64 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.01 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -145.99 136.48 24.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.513 0.673 . . . . 0.0 111.651 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.671 HD23 ' HB3' ' A' ' 27' ' ' PHE . 26.6 mt -77.66 137.28 38.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.495 175.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -73.15 119.17 17.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.012 0.434 . . . . 0.0 110.652 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -89.01 -6.64 57.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.863 0.839 . . . . 0.0 109.296 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.9 mp 69.93 86.77 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.303 -176.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.85 110.88 5.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.382 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.473 ' HA ' ' C ' ' E' ' 97' ' ' GLY . 20.2 m -79.17 -36.12 40.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.737 -177.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.504 ' C ' ' HA ' ' B' ' 96' ' ' SER . . . 72.91 -67.99 1.34 Allowed Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.736 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 C--O 1.251 1.145 0 CA-C-O 118.261 -0.876 . . . . 0.0 109.794 -178.052 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 . . . . . 0 N--CA 1.477 0.922 0 CA-C-O 120.949 0.404 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -136.18 163.58 30.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.22 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 122.3 25.53 2.0 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.266 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -167.36 53.44 0.07 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.115 0.483 . . . . 0.0 110.119 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . 0.464 ' HB3' ' OG ' ' C' ' 70' ' ' SER . 3.6 mpp? -111.1 67.56 0.64 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.043 -174.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.464 ' HB3' ' ND2' ' C' ' 68' ' ' ASN . . . -60.75 131.4 50.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.901 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -81.36 150.77 28.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.188 0.518 . . . . 0.0 111.631 -174.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.655 ' CE1' HD21 ' C' ' 44' ' ' LEU . 31.8 t80 -72.13 145.8 47.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.462 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . 0.423 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 92.1 t90 -134.26 147.95 50.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.474 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.528 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -152.27 154.92 25.83 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.85 178.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.541 HD23 HD13 ' B' ' 87' ' ' LEU . 49.4 tp -147.37 108.34 4.21 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.856 0.36 . . . . 0.0 110.992 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -90.41 120.15 31.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.895 0.378 . . . . 0.0 110.479 176.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . 0.705 ' SD ' ' HE2' ' B' ' 19' ' ' TYR . 53.4 mmm -100.1 139.62 35.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.145 -175.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -100.28 145.05 29.59 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.636 174.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.476 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 11.1 Cg_endo -55.15 116.26 3.02 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.136 2.558 . . . . 0.0 112.943 -177.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 62.96 64.85 0.84 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.89 176.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -145.74 138.89 26.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.622 173.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.734 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 86.4 mttt -107.26 126.39 52.36 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -176.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' TYR . . . . . 0.705 ' HE2' ' SD ' ' B' ' 13' ' ' MET . 1.2 m-85 -112.41 103.73 11.85 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.221 174.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 9.2 p -88.31 100.38 12.96 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -113.29 144.42 42.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.889 -170.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 27.6 m -101.94 140.96 35.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.521 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.405 HG22 ' HA ' ' B' ' 71' ' ' LYS . 73.6 mt -99.42 120.14 48.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.26 0.552 . . . . 0.0 111.754 -171.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.749 ' H ' HD13 ' B' ' 24' ' ' ILE . 0.2 OUTLIER -105.54 -9.88 10.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.323 175.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.5 ' HD2' HD13 ' B' ' 91' ' ' LEU . 35.4 pttt -141.52 119.11 11.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.872 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 5.9 p -67.02 133.75 50.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.818 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . 0.666 ' HB3' HD23 ' B' ' 91' ' ' LEU . 32.9 p90 -147.59 166.42 27.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.668 0.747 . . . . 0.0 112.922 -173.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' HIS . . . . . 0.543 ' HA ' ' O ' ' B' ' 67' ' ' LEU . 9.3 t60 -118.82 126.23 51.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.964 178.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.534 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 43.3 mt -92.28 136.18 25.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 170.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.512 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 64.2 p -123.73 -5.67 8.06 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -170.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.41 160.77 27.77 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 119.032 -1.556 . . . . 0.0 113.823 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.473 HG23 ' HG ' ' B' ' 87' ' ' LEU . 11.4 p -144.52 130.02 14.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 173.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.41 157.7 43.97 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 122.0 -0.438 . . . . 0.0 111.598 -176.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.654 ' HB3' HG12 ' B' ' 85' ' ' VAL . 3.9 pp -122.11 145.32 48.28 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.856 0.836 . . . . 0.0 111.825 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -107.75 -56.09 2.27 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.614 173.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -103.07 127.23 50.41 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.344 173.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.579 ' O ' ' HG3' ' B' ' 58' ' ' LYS . . . 145.21 159.37 8.07 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 120.016 -1.088 . . . . 0.0 112.809 178.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -102.42 -45.56 5.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.474 0.178 . . . . 0.0 111.46 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -150.62 127.3 10.9 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 120.615 0.245 . . . . 0.0 110.958 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.531 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -127.41 114.95 18.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.235 0.541 . . . . 0.0 110.461 171.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' B' ' 79' ' ' THR . 3.7 mppt? -94.97 112.01 23.75 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 174.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 46.6 tp -84.26 108.84 17.36 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -176.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -108.56 144.31 36.42 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.338 0.589 . . . . 0.0 110.08 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.662 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 0.2 OUTLIER -129.25 116.74 19.61 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.378 174.397 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.546 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -103.44 110.5 22.54 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.18 0.514 . . . . 0.0 109.702 177.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.513 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -140.08 145.63 37.91 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.358 -177.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 58.1 33.0 22.72 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.521 0.677 . . . . 0.0 109.833 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 62.77 38.0 12.08 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.82 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.546 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 6.5 tp-100 -140.64 139.0 34.77 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 178.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -90.98 110.05 21.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.922 0.392 . . . . 0.0 110.352 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.502 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 78.3 m-85 -101.82 130.72 48.32 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.484 178.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -85.32 101.87 10.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.742 0.782 . . . . 0.0 108.971 172.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.613 ' CG2' ' HB3' ' B' ' 44' ' ' LEU . 2.9 t -76.4 -49.76 23.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.704 -171.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.547 ' HB2' HD21 ' B' ' 65' ' ' LEU . . . -154.1 146.71 24.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.434 -177.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 27.4 m -110.99 100.98 9.58 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.468 HG11 HG11 ' B' ' 85' ' ' VAL . 7.5 p -115.8 114.71 47.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.655 0.741 . . . . 0.0 109.855 -176.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 78.7 p -122.87 -178.24 3.89 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.45 -173.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . 0.579 ' HG3' ' O ' ' B' ' 37' ' ' GLY . 6.1 mttm -61.49 -30.04 70.36 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.07 0.462 . . . . 0.0 110.29 169.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.12 -40.33 53.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.41 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 79.3 mt -115.55 81.4 8.91 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.15 -0.35 6.29 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.043 2.495 . . . . 0.0 114.006 -167.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -163.13 130.15 3.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.226 0.536 . . . . 0.0 111.346 -176.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 96.1 t -118.82 120.81 65.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.373 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.24 131.51 35.3 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.547 HD21 ' HB2' ' B' ' 54' ' ' ALA . 82.4 mt -123.93 167.17 14.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.479 0.657 . . . . 0.0 112.348 -173.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 14.4 t0 -143.13 99.11 3.39 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.563 170.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.599 HD21 HD23 ' A' ' 88' ' ' LEU . 2.4 mt -128.02 140.16 52.13 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.395 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . 0.48 ' ND2' ' HB3' ' A' ' 6' ' ' ALA . 5.3 t30 -135.35 122.7 21.8 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.714 174.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -116.08 143.72 45.1 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.508 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.42 ' OG ' ' HB3' ' A' ' 5' ' ' MET . 34.0 t -94.37 166.26 12.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.216 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.405 ' HA ' HG22 ' B' ' 23' ' ' ILE . 0.0 OUTLIER -74.59 -6.91 51.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.179 0.514 . . . . 0.0 110.175 178.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.95 -8.21 61.97 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.458 174.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -93.69 144.62 25.23 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -136.12 127.79 28.98 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 171.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.513 HG22 ' HB2' ' B' ' 46' ' ' ALA . 8.5 pt -135.46 160.41 40.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.606 -163.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.432 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 3.0 mtm -114.05 120.35 40.29 Favored 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.535 172.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . 0.662 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -103.75 127.78 51.19 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 176.288 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.734 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 52.7 p90 -156.31 143.18 18.79 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 119.802 -0.759 . . . . 0.0 112.238 -176.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' B' ' 41' ' ' LYS . 2.0 p -114.98 132.02 56.72 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.335 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.27 160.72 14.88 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.82 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.97 -175.67 40.16 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -175.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -110.37 102.58 11.21 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.878 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -174.55 155.62 2.27 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.567 171.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 32.2 t -115.91 117.25 29.66 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.654 HG12 ' HB3' ' B' ' 34' ' ' LEU . 3.7 m -111.3 164.88 6.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.245 0.545 . . . . 0.0 112.132 -174.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 21.3 t -129.7 120.83 25.79 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.156 176.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.541 HD13 HD23 ' B' ' 11' ' ' LEU . 5.3 mp -92.92 154.36 18.24 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.016 0.436 . . . . 0.0 110.163 173.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.58 HD23 HD21 ' C' ' 67' ' ' LEU . 0.2 OUTLIER -133.65 144.66 49.35 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.083 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.94 -167.41 28.55 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.962 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -146.07 136.49 23.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.582 0.706 . . . . 0.0 111.623 177.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . 0.666 HD23 ' HB3' ' B' ' 27' ' ' PHE . 26.4 mt -77.65 137.22 38.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.474 175.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -73.09 119.02 16.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.029 0.442 . . . . 0.0 110.657 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -88.89 -6.63 57.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.907 0.861 . . . . 0.0 109.404 176.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 4' ' ' ALA . 1.9 mp 69.88 86.8 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 114.176 -1.375 . . . . 0.0 109.347 -176.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.86 110.98 5.93 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.367 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' SER . . . . . 0.504 ' HA ' ' C ' ' A' ' 97' ' ' GLY . 20.3 m -79.29 -36.13 40.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.685 -177.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' GLY . . . . . 0.408 ' C ' ' HA ' ' C' ' 96' ' ' SER . . . 72.9 -67.96 1.34 Allowed Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.739 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.493 -0.765 . . . . 0.0 109.8 -178.029 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 120.985 0.421 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -136.15 163.61 29.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.161 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . 122.32 25.52 1.99 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.243 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -167.39 53.47 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.136 0.494 . . . . 0.0 110.048 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 5' ' ' MET . . . . . 0.435 ' HB3' ' OG ' ' D' ' 70' ' ' SER . 3.6 mpp? -111.1 67.66 0.65 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.001 -174.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 6' ' ' ALA . . . . . 0.5 ' HB3' ' ND2' ' D' ' 68' ' ' ASN . . . -60.81 131.39 50.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.85 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -81.39 150.88 28.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.094 0.473 . . . . 0.0 111.67 -174.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 8' ' ' PHE . . . . . 0.654 ' CE1' HD21 ' D' ' 44' ' ' LEU . 31.2 t80 -72.26 145.88 47.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.376 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . 0.419 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 92.1 t90 -134.35 147.96 50.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.464 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . 0.524 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -152.23 154.91 25.83 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.828 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.532 HD23 HD13 ' C' ' 87' ' ' LEU . 49.7 tp -147.37 108.37 4.22 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.923 0.392 . . . . 0.0 111.069 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -90.49 120.12 31.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.929 0.395 . . . . 0.0 110.536 176.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 13' ' ' MET . . . . . 0.706 ' SD ' ' HE2' ' C' ' 19' ' ' TYR . 53.2 mmm -100.01 139.66 35.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.254 -175.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -100.41 144.99 29.51 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.584 174.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . 0.481 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 11.0 Cg_endo -55.08 116.3 3.04 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 123.106 2.537 . . . . 0.0 112.932 -177.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 62.9 64.81 0.85 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.89 176.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -145.67 138.93 26.21 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.655 173.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 18' ' ' LYS . . . . . 0.727 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 86.7 mttt -107.13 126.48 52.43 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -176.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . 0.706 ' HE2' ' SD ' ' C' ' 13' ' ' MET . 1.2 m-85 -112.52 103.84 11.93 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.145 174.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 9.0 p -88.38 100.24 12.88 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -113.23 144.45 42.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.434 0.635 . . . . 0.0 111.848 -170.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 27.3 m -101.98 140.9 35.65 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.452 176.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . 0.403 HG22 ' HA ' ' C' ' 71' ' ' LYS . 73.9 mt -99.41 120.14 48.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.125 0.488 . . . . 0.0 111.772 -171.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . 0.767 ' H ' HD13 ' C' ' 24' ' ' ILE . 0.2 OUTLIER -105.57 -9.94 10.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.318 176.018 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . 0.516 ' HD2' HD13 ' C' ' 91' ' ' LEU . 35.7 pttt -141.47 119.07 11.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.893 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 5.8 p -67.04 133.72 50.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.738 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 27' ' ' PHE . . . . . 0.662 ' HB3' HD23 ' C' ' 91' ' ' LEU . 32.4 p90 -147.53 166.44 27.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.627 0.727 . . . . 0.0 112.956 -173.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 28' ' ' HIS . . . . . 0.545 ' HA ' ' O ' ' C' ' 67' ' ' LEU . 9.4 t60 -118.87 126.23 51.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.34 -1.3 . . . . 0.0 109.934 178.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . 0.542 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 42.7 mt -92.2 136.14 25.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 170.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.514 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 64.4 p -123.71 -5.62 8.07 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -170.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.45 160.71 27.64 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 119.038 -1.553 . . . . 0.0 113.816 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.477 HG23 ' HG ' ' C' ' 87' ' ' LEU . 11.5 p -144.49 129.99 14.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 173.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.42 157.72 43.97 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.889 -0.507 . . . . 0.0 111.517 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.669 ' HB3' HG12 ' C' ' 85' ' ' VAL . 3.8 pp -122.07 145.33 48.25 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.782 0.801 . . . . 0.0 111.803 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -107.79 -56.04 2.28 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.387 -1.278 . . . . 0.0 108.621 173.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -103.08 127.25 50.41 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.345 173.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 37' ' ' GLY . . . . . 0.588 ' O ' ' HG3' ' C' ' 58' ' ' LYS . . . 145.23 159.4 8.09 Favored Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 119.954 -1.117 . . . . 0.0 112.815 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -102.56 -45.58 5.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.465 0.174 . . . . 0.0 111.385 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -150.48 127.2 10.95 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.501 0.191 . . . . 0.0 111.094 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.53 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -127.38 115.0 18.28 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.328 0.585 . . . . 0.0 110.439 171.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' C' ' 79' ' ' THR . 3.7 mppt? -95.11 112.07 23.82 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 46.9 tp -84.31 108.93 17.44 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -176.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -108.62 144.33 36.49 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.327 0.584 . . . . 0.0 110.062 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.655 HD21 ' CE1' ' B' ' 8' ' ' PHE . 0.2 OUTLIER -129.28 116.79 19.65 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.364 174.395 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -103.51 110.4 22.42 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.206 0.527 . . . . 0.0 109.736 177.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.512 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -139.97 145.64 38.13 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.385 -177.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 57.95 33.18 22.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.451 0.643 . . . . 0.0 109.844 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 60.0 mttp 62.69 38.03 12.3 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.822 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . 0.552 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 6.5 tp-100 -140.64 139.06 34.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.588 0.232 . . . . 0.0 110.379 178.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -91.07 110.02 21.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.32 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . 0.528 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 78.1 m-85 -101.84 130.72 48.36 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.433 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -85.31 101.8 10.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.68 0.752 . . . . 0.0 108.995 173.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 53' ' ' VAL . . . . . 0.609 ' CG2' ' HB3' ' C' ' 44' ' ' LEU . 2.9 t -76.33 -49.88 23.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.696 -171.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 54' ' ' ALA . . . . . 0.542 ' HB2' HD21 ' C' ' 65' ' ' LEU . . . -153.98 146.71 24.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.511 -177.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 27.6 m -111.04 101.02 9.6 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 170.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . 0.463 HG11 HG11 ' C' ' 85' ' ' VAL . 7.5 p -115.83 114.67 46.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.617 0.722 . . . . 0.0 109.807 -176.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 78.1 p -122.89 -178.26 3.89 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.467 -173.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 58' ' ' LYS . . . . . 0.588 ' HG3' ' O ' ' C' ' 37' ' ' GLY . 6.2 mttm -61.51 -29.92 70.29 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.025 0.441 . . . . 0.0 110.35 169.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.18 -40.24 52.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.359 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 79.9 mt -115.65 81.48 9.23 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.18 -0.44 6.44 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.143 2.562 . . . . 0.0 113.972 -167.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -163.11 130.18 3.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.266 0.555 . . . . 0.0 111.333 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 96.9 t -118.72 120.84 65.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.458 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.29 131.58 35.3 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . 0.542 HD21 ' HB2' ' C' ' 54' ' ' ALA . 82.6 mt -123.99 167.19 14.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.473 0.654 . . . . 0.0 112.285 -173.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 66' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 14.3 t0 -143.14 99.12 3.39 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.478 170.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.58 HD21 HD23 ' B' ' 88' ' ' LEU . 2.4 mt -128.1 140.15 52.1 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.419 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . 0.464 ' ND2' ' HB3' ' B' ' 6' ' ' ALA . 5.2 t30 -135.32 122.73 21.88 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.75 174.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -116.12 143.75 45.07 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.429 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . 0.464 ' OG ' ' HB3' ' B' ' 5' ' ' MET . 33.8 t -94.31 166.23 12.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.231 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . 0.403 ' HA ' HG22 ' C' ' 23' ' ' ILE . 0.0 OUTLIER -74.57 -6.88 51.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.182 0.515 . . . . 0.0 110.185 178.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.97 -8.34 61.84 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.462 174.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -93.61 144.58 25.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.815 0.34 . . . . 0.0 110.097 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -136.06 127.72 28.96 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 171.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.512 HG22 ' HB2' ' C' ' 46' ' ' ALA . 8.5 pt -135.36 160.45 40.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.532 -163.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.436 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 3.0 mtm -114.14 120.37 40.28 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.51 172.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 77' ' ' PHE . . . . . 0.653 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.7 OUTLIER -103.8 127.81 51.26 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.315 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 78' ' ' TYR . . . . . 0.727 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 53.3 p90 -156.31 143.17 18.78 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.311 -176.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' C' ' 41' ' ' LYS . 2.0 p -114.98 131.99 56.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.362 -176.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.29 160.66 14.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.862 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.93 -175.69 40.24 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -175.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -110.39 102.61 11.23 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 119.391 -0.924 . . . . 0.0 109.867 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . 0.53 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -174.53 155.61 2.28 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.633 171.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 32.3 t -115.84 117.28 29.76 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.669 HG12 ' HB3' ' C' ' 34' ' ' LEU . 3.7 m -111.39 164.92 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-O 121.313 0.578 . . . . 0.0 112.106 -174.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 21.1 t -129.72 120.8 25.7 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.217 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . 0.532 HD13 HD23 ' C' ' 11' ' ' LEU . 5.3 mp -92.89 154.4 18.23 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 120.987 0.422 . . . . 0.0 110.157 173.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . 0.581 HD23 HD21 ' D' ' 67' ' ' LEU . 0.2 OUTLIER -133.68 144.67 49.32 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.135 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.0 -167.36 28.54 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.978 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -146.06 136.45 23.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.564 0.697 . . . . 0.0 111.631 177.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . 0.662 HD23 ' HB3' ' C' ' 27' ' ' PHE . 26.3 mt -77.63 137.16 38.39 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.486 175.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -73.05 119.16 16.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.073 0.463 . . . . 0.0 110.64 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -88.93 -6.8 57.02 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.863 0.839 . . . . 0.0 109.348 176.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 1.9 mp 70.1 86.66 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 114.229 -1.35 . . . . 0.0 109.314 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.79 110.94 5.86 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.311 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . 0.408 ' HA ' ' C ' ' B' ' 97' ' ' GLY . 20.1 m -79.25 -36.05 40.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.739 -177.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . 0.504 ' C ' ' HA ' ' D' ' 96' ' ' SER . . . 72.8 -67.85 1.32 Allowed Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.804 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.336 -0.84 . . . . 0.0 109.785 -178.079 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 . . . . . 0 N--CA 1.479 0.981 0 CA-C-O 120.914 0.388 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -136.2 163.58 30.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.164 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . 122.31 25.53 1.99 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.213 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 4' ' ' ALA . . . . . 0.407 ' HB3' HG13 ' E' ' 94' ' ' ILE . . . -167.42 53.58 0.07 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.925 0.393 . . . . 0.0 110.003 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 5' ' ' MET . . . . . 0.431 ' HB3' ' OG ' ' E' ' 70' ' ' SER . 3.6 mpp? -111.2 67.65 0.65 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.011 -174.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 6' ' ' ALA . . . . . 0.487 ' HB3' ' ND2' ' E' ' 68' ' ' ASN . . . -60.77 131.35 50.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.773 178.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -81.33 150.88 28.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.148 0.499 . . . . 0.0 111.663 -174.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 8' ' ' PHE . . . . . 0.639 ' CE1' HD21 ' E' ' 44' ' ' LEU . 31.0 t80 -72.27 145.78 47.66 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.37 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 9' ' ' TRP . . . . . 0.426 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 92.1 t90 -134.27 147.99 50.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.433 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . 0.513 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -152.21 154.91 25.83 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.872 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.54 HD23 HD13 ' D' ' 87' ' ' LEU . 50.1 tp -147.33 108.34 4.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.803 0.335 . . . . 0.0 111.02 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -90.52 120.09 31.32 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.974 0.416 . . . . 0.0 110.479 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 13' ' ' MET . . . . . 0.689 ' SD ' ' HE2' ' D' ' 19' ' ' TYR . 53.3 mmm -100.08 139.63 35.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.173 -175.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -100.3 145.07 29.63 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.59 174.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . 0.461 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 11.0 Cg_endo -55.23 116.3 3.04 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 123.099 2.533 . . . . 0.0 112.91 -177.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 63.04 64.79 0.83 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.843 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -145.65 138.86 26.19 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.598 173.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . 0.718 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 86.6 mttt -107.2 126.48 52.46 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -176.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 19' ' ' TYR . . . . . 0.689 ' HE2' ' SD ' ' D' ' 13' ' ' MET . 1.2 m-85 -112.63 103.81 11.87 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.104 174.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 8.7 p -88.38 100.28 12.9 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 174.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -113.13 144.4 42.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.88 -170.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 27.2 m -101.95 140.9 35.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.609 176.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . 0.418 HG22 ' HA ' ' D' ' 71' ' ' LYS . 74.2 mt -99.48 120.19 48.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.203 0.525 . . . . 0.0 111.651 -171.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . 0.775 ' H ' HD13 ' D' ' 24' ' ' ILE . 0.2 OUTLIER -105.61 -9.81 10.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.388 175.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . 0.507 ' HD2' HD13 ' D' ' 91' ' ' LEU . 35.4 pttt -141.55 119.08 11.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.847 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 5.8 p -67.06 133.72 50.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.783 -176.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 27' ' ' PHE . . . . . 0.68 ' HB3' HD23 ' D' ' 91' ' ' LEU . 32.7 p90 -147.56 166.39 27.48 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -173.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 28' ' ' HIS . . . . . 0.546 ' HA ' ' O ' ' D' ' 67' ' ' LEU . 9.3 t60 -118.73 126.23 51.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.973 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 29' ' ' ILE . . . . . 0.551 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 42.4 mt -92.24 136.14 25.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 170.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . 0.522 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 64.3 p -123.77 -5.57 8.04 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -170.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.42 160.84 27.87 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 119.141 -1.504 . . . . 0.0 113.874 176.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.462 HG23 ' HG ' ' D' ' 87' ' ' LEU . 11.4 p -144.51 129.95 14.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 173.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.41 157.76 43.96 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.004 -0.435 . . . . 0.0 111.451 -176.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 34' ' ' LEU . . . . . 0.646 ' HB3' HG12 ' D' ' 85' ' ' VAL . 3.9 pp -122.11 145.26 48.34 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.8 0.809 . . . . 0.0 111.826 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -107.67 -55.98 2.28 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.663 173.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -103.2 127.25 50.56 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.336 173.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . 0.59 ' O ' ' HG3' ' D' ' 58' ' ' LYS . . . 145.15 159.33 8.04 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 119.997 -1.096 . . . . 0.0 112.83 178.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -102.47 -45.49 5.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -150.58 127.35 10.97 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.592 0.234 . . . . 0.0 110.955 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . 0.538 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -127.51 114.97 18.15 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.223 0.535 . . . . 0.0 110.452 171.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' D' ' 79' ' ' THR . 3.7 mppt? -95.14 112.07 23.82 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 47.2 tp -84.26 108.88 17.38 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -176.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -108.51 144.32 36.32 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.129 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.656 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.2 OUTLIER -129.28 116.73 19.57 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.411 174.355 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 45' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -103.34 110.43 22.42 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.698 177.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.508 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -140.05 145.53 37.84 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.339 -177.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 58.18 33.08 22.81 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.466 0.65 . . . . 0.0 109.819 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 62.65 37.95 12.48 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.904 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . 0.553 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 6.5 tp-100 -140.6 138.96 34.81 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 178.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -90.95 110.14 21.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.315 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . 0.524 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 78.5 m-85 -101.87 130.7 48.41 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.444 178.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -85.27 101.91 10.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 172.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 53' ' ' VAL . . . . . 0.607 ' CG2' ' HB3' ' D' ' 44' ' ' LEU . 2.9 t -76.49 -49.69 23.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.716 -171.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 54' ' ' ALA . . . . . 0.554 ' HB2' HD21 ' D' ' 65' ' ' LEU . . . -154.05 146.73 24.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.414 -177.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 27.3 m -111.06 100.93 9.52 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 170.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 56' ' ' VAL . . . . . 0.463 HG11 HG11 ' D' ' 85' ' ' VAL . 7.4 p -115.8 114.64 46.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.607 0.718 . . . . 0.0 109.85 -176.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 79.2 p -122.88 -178.24 3.89 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.487 -173.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 58' ' ' LYS . . . . . 0.59 ' HG3' ' O ' ' D' ' 37' ' ' GLY . 6.1 mttm -61.45 -29.95 70.28 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.037 0.446 . . . . 0.0 110.415 169.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.21 -40.21 52.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.438 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 79.5 mt -115.63 81.47 9.15 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 174.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -69.13 -0.42 6.37 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.15 2.567 . . . . 0.0 113.983 -167.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -163.15 130.1 3.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.222 0.534 . . . . 0.0 111.297 -176.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 96.4 t -118.76 120.87 65.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.39 174.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.2 131.49 35.3 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 65' ' ' LEU . . . . . 0.554 HD21 ' HB2' ' D' ' 54' ' ' ALA . 82.7 mt -123.96 167.17 14.5 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.474 0.654 . . . . 0.0 112.325 -173.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 66' ' ' ASP . . . . . 0.427 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 14.4 t0 -143.09 99.03 3.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.592 170.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.581 HD21 HD23 ' C' ' 88' ' ' LEU . 2.4 mt -127.96 140.11 52.18 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.436 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 68' ' ' ASN . . . . . 0.5 ' ND2' ' HB3' ' C' ' 6' ' ' ALA . 5.2 t30 -135.3 122.73 21.89 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.486 -0.485 . . . . 0.0 109.72 174.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -116.11 143.66 45.18 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.551 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . 0.435 ' OG ' ' HB3' ' C' ' 5' ' ' MET . 34.0 t -94.38 166.26 12.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.219 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 71' ' ' LYS . . . . . 0.418 ' HA ' HG22 ' D' ' 23' ' ' ILE . 0.0 OUTLIER -74.56 -7.02 51.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.271 0.557 . . . . 0.0 110.141 179.065 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.91 -8.19 62.05 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.496 174.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -93.63 144.52 25.31 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -136.08 127.75 28.97 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 171.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.508 HG22 ' HB2' ' D' ' 46' ' ' ALA . 8.6 pt -135.34 160.5 40.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.568 -163.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 76' ' ' MET . . . . . 0.437 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 3.0 mtm -114.16 120.43 40.47 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.454 172.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 77' ' ' PHE . . . . . 0.656 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.7 OUTLIER -103.79 127.73 51.25 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.263 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 78' ' ' TYR . . . . . 0.718 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 52.9 p90 -156.25 143.14 18.83 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.248 -176.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 79' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' D' ' 41' ' ' LYS . 2.0 p -114.9 132.01 56.68 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.305 -176.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.28 160.69 14.91 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.874 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.96 -175.7 40.2 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -175.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -110.34 102.53 11.17 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.97 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . 0.538 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -174.54 155.54 2.26 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.591 171.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 32.4 t -115.81 117.14 29.39 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.646 HG12 ' HB3' ' D' ' 34' ' ' LEU . 3.7 m -111.27 164.87 6.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.21 0.528 . . . . 0.0 112.151 -174.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 21.3 t -129.65 120.83 25.87 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.17 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 87' ' ' LEU . . . . . 0.54 HD13 HD23 ' D' ' 11' ' ' LEU . 5.3 mp -92.92 154.44 18.19 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 121.022 0.439 . . . . 0.0 110.1 173.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.594 HD23 HD21 ' E' ' 67' ' ' LEU . 0.2 OUTLIER -133.7 144.65 49.27 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.111 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.88 -167.34 28.4 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.033 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -146.1 136.49 23.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.556 0.693 . . . . 0.0 111.653 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . 0.68 HD23 ' HB3' ' D' ' 27' ' ' PHE . 26.1 mt -77.59 137.22 38.45 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.536 175.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -73.08 119.09 16.85 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.965 0.412 . . . . 0.0 110.738 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -88.95 -6.67 57.09 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.95 0.881 . . . . 0.0 109.34 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 1.9 mp 69.97 86.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.361 -176.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.78 110.97 5.87 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.414 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 96' ' ' SER . . . . . 0.504 ' HA ' ' C ' ' C' ' 97' ' ' GLY . 20.1 m -79.24 -36.17 40.39 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.69 -177.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 97' ' ' GLY . . . . . 0.499 ' C ' ' HA ' ' E' ' 96' ' ' SER . . . 72.94 -67.87 1.35 Allowed Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.707 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.49 -0.766 . . . . 0.0 109.844 -178.053 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 120.894 0.378 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -136.16 163.56 30.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.227 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . 122.38 25.54 1.98 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.162 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -167.35 53.48 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.102 0.477 . . . . 0.0 110.058 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 5' ' ' MET . . . . . 0.423 ' HB3' ' OG ' ' A' ' 70' ' ' SER . 3.6 mpp? -111.17 67.69 0.65 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.977 -174.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 6' ' ' ALA . . . . . 0.492 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . . . -60.79 131.39 50.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.846 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -81.37 150.76 28.27 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.093 0.473 . . . . 0.0 111.647 -174.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 8' ' ' PHE . . . . . 0.674 ' CE1' HD21 ' A' ' 44' ' ' LEU . 31.2 t80 -72.13 145.9 47.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.46 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 9' ' ' TRP . . . . . 0.414 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 92.0 t90 -134.41 147.92 50.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.407 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 10' ' ' GLY . . . . . 0.536 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -152.18 154.93 25.84 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.908 178.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . 0.539 HD23 HD13 ' E' ' 87' ' ' LEU . 49.5 tp -147.34 108.31 4.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.829 0.347 . . . . 0.0 111.018 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -90.47 120.18 31.36 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.002 0.43 . . . . 0.0 110.478 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 13' ' ' MET . . . . . 0.685 ' SD ' ' HE2' ' E' ' 19' ' ' TYR . 53.0 mmm -100.08 139.57 35.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.247 -175.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -100.28 145.08 29.64 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.665 174.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . 0.465 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 11.0 Cg_endo -55.15 116.34 3.07 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.088 2.525 . . . . 0.0 112.951 -177.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 62.89 64.81 0.85 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.892 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -145.73 138.86 26.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.653 173.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . 0.713 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 86.7 mttt -107.11 126.36 52.27 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -176.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . 0.685 ' HE2' ' SD ' ' E' ' 13' ' ' MET . 1.2 m-85 -112.53 103.82 11.9 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.167 174.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 20' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' E' ' 76' ' ' MET . 9.1 p -88.31 100.25 12.86 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 174.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -113.16 144.37 42.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.899 -170.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 27.5 m -101.98 140.99 35.52 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.508 176.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 73.9 mt -99.47 120.21 48.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.225 0.536 . . . . 0.0 111.668 -171.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . 0.759 ' H ' HD13 ' E' ' 24' ' ' ILE . 0.2 OUTLIER -105.63 -9.86 10.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.297 175.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . 0.506 ' HD2' HD13 ' E' ' 91' ' ' LEU . 35.5 pttt -141.47 119.15 11.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.867 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 5.8 p -67.05 133.72 50.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.752 -176.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 27' ' ' PHE . . . . . 0.675 ' HB3' HD23 ' E' ' 91' ' ' LEU . 32.6 p90 -147.54 166.4 27.41 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -173.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 28' ' ' HIS . . . . . 0.55 ' HA ' ' O ' ' E' ' 67' ' ' LEU . 9.4 t60 -118.77 126.28 51.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.968 178.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 29' ' ' ILE . . . . . 0.542 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 42.8 mt -92.25 136.15 25.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 170.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . 0.507 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 64.2 p -123.69 -5.65 8.08 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -170.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.39 160.84 27.91 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.063 -1.541 . . . . 0.0 113.823 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.47 HG23 ' HG ' ' E' ' 87' ' ' LEU . 11.5 p -144.55 129.91 14.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.39 157.72 43.97 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 121.904 -0.497 . . . . 0.0 111.518 -176.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 34' ' ' LEU . . . . . 0.667 ' HB3' HG12 ' E' ' 85' ' ' VAL . 3.9 pp -122.06 145.27 48.31 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.858 0.837 . . . . 0.0 111.856 178.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -107.71 -56.06 2.27 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.222 -1.354 . . . . 0.0 108.612 173.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -103.12 127.23 50.48 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.411 173.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . 0.587 ' O ' ' HG3' ' E' ' 58' ' ' LYS . . . 145.19 159.34 8.06 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.016 -1.087 . . . . 0.0 112.897 178.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -102.53 -45.49 5.04 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.473 0.175 . . . . 0.0 111.473 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -150.53 127.36 11.02 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 120.526 0.203 . . . . 0.0 110.982 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . 0.529 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -127.49 114.93 18.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.183 0.516 . . . . 0.0 110.473 171.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 41' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' E' ' 79' ' ' THR . 3.7 mppt? -95.08 112.1 23.84 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 174.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 46.7 tp -84.27 108.87 17.38 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -176.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -108.54 144.34 36.34 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.331 0.586 . . . . 0.0 110.112 177.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 44' ' ' LEU . . . . . 0.661 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 0.2 OUTLIER -129.26 116.76 19.63 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.42 174.384 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 45' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -103.51 110.47 22.52 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.236 0.541 . . . . 0.0 109.666 177.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . 0.507 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -140.11 145.54 37.74 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.273 -177.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 58.15 33.04 22.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.476 0.655 . . . . 0.0 109.813 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 62.73 37.99 12.2 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.778 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 49' ' ' GLN . . . . . 0.551 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 6.5 tp-100 -140.56 138.98 34.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.59 0.233 . . . . 0.0 110.39 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -90.97 110.09 21.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.363 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . 0.513 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 78.2 m-85 -101.79 130.74 48.28 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.419 178.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -85.37 101.87 10.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.706 0.765 . . . . 0.0 109.023 172.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . 0.617 ' CG2' ' HB3' ' E' ' 44' ' ' LEU . 2.9 t -76.43 -49.76 23.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.714 -171.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 54' ' ' ALA . . . . . 0.545 ' HB2' HD21 ' E' ' 65' ' ' LEU . . . -154.02 146.67 24.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.498 -177.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 27.7 m -111.04 101.03 9.61 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 170.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . 0.46 HG11 HG11 ' E' ' 85' ' ' VAL . 7.5 p -115.82 114.62 46.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.628 0.728 . . . . 0.0 109.754 -176.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 76.2 p -122.82 -178.23 3.88 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.465 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 58' ' ' LYS . . . . . 0.587 ' HG3' ' O ' ' E' ' 37' ' ' GLY . 6.1 mttm -61.53 -29.99 70.35 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.023 0.44 . . . . 0.0 110.287 169.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.06 -40.37 53.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.433 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 79.0 mt -115.51 81.49 8.9 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 174.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.2 -0.5 6.54 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.087 2.524 . . . . 0.0 114.029 -167.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -163.02 130.28 3.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.275 0.559 . . . . 0.0 111.305 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 96.5 t -118.85 120.83 65.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.388 174.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.29 131.48 35.29 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 175.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.545 HD21 ' HB2' ' E' ' 54' ' ' ALA . 82.6 mt -123.87 167.19 14.42 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.469 0.652 . . . . 0.0 112.336 -173.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 66' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 14.3 t0 -143.15 99.17 3.4 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.504 170.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 67' ' ' LEU . . . . . 0.594 HD21 HD23 ' D' ' 88' ' ' LEU . 2.5 mt -128.05 140.06 52.17 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.391 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 68' ' ' ASN . . . . . 0.487 ' ND2' ' HB3' ' D' ' 6' ' ' ALA . 5.3 t30 -135.21 122.71 21.99 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.79 174.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -116.08 143.71 45.11 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.492 -178.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 70' ' ' SER . . . . . 0.431 ' OG ' ' HB3' ' D' ' 5' ' ' MET . 34.2 t -94.4 166.27 12.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.194 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.55 -7.07 51.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.177 0.513 . . . . 0.0 110.151 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.8 -8.25 62.19 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.495 174.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -93.67 144.7 25.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.859 0.361 . . . . 0.0 110.074 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -136.2 127.72 28.69 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 171.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 75' ' ' ILE . . . . . 0.507 HG22 ' HB2' ' E' ' 46' ' ' ALA . 8.5 pt -135.4 160.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.634 -163.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 76' ' ' MET . . . . . 0.437 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 3.0 mtm -114.13 120.35 40.24 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 172.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 77' ' ' PHE . . . . . 0.661 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.7 OUTLIER -103.75 127.82 51.19 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.28 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 78' ' ' TYR . . . . . 0.713 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 53.2 p90 -156.37 143.11 18.67 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 119.79 -0.764 . . . . 0.0 112.269 -176.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 79' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' E' ' 41' ' ' LYS . 2.0 p -114.96 132.02 56.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.291 -176.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.37 160.7 14.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.817 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.0 -175.68 40.12 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -175.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -110.43 102.56 11.17 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.846 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 83' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -174.5 155.62 2.29 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.624 171.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 32.2 t -115.84 117.33 29.9 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 85' ' ' VAL . . . . . 0.667 HG12 ' HB3' ' E' ' 34' ' ' LEU . 3.7 m -111.36 164.9 6.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.268 0.556 . . . . 0.0 112.137 -174.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 21.2 t -129.75 120.9 25.84 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.18 176.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 87' ' ' LEU . . . . . 0.539 HD13 HD23 ' E' ' 11' ' ' LEU . 5.3 mp -92.98 154.48 18.13 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 121.023 0.439 . . . . 0.0 110.132 173.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . 0.596 HD23 HD21 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -133.7 144.7 49.3 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.086 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.99 -167.43 28.62 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.9 -0.666 . . . . 0.0 111.999 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 90' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -146.05 136.49 23.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.573 0.701 . . . . 0.0 111.663 177.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 91' ' ' LEU . . . . . 0.675 HD23 ' HB3' ' E' ' 27' ' ' PHE . 26.2 mt -77.54 137.15 38.45 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.574 175.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -73.08 119.06 16.8 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.959 0.409 . . . . 0.0 110.728 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -88.92 -6.64 57.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.893 0.854 . . . . 0.0 109.293 176.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 94' ' ' ILE . . . . . 0.407 HG13 ' HB3' ' D' ' 4' ' ' ALA . 1.9 mp 69.88 86.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.323 -176.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.93 111.0 5.99 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.382 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 96' ' ' SER . . . . . 0.499 ' HA ' ' C ' ' D' ' 97' ' ' GLY . 20.1 m -79.24 -36.19 40.36 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.689 -177.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 97' ' ' GLY . . . . . 0.473 ' C ' ' HA ' ' A' ' 96' ' ' SER . . . 72.91 -67.85 1.35 Allowed Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.689 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.383 -0.817 . . . . 0.0 109.822 -178.021 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -127.48 66.54 1.31 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.653 0.739 . . . . 0.0 109.569 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.48 136.53 20.29 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.996 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.92 146.9 22.25 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 59.4 mtt -125.94 39.84 3.86 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.343 0.402 . . . . 0.0 109.957 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -51.02 129.26 23.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.892 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 49.0 mtt -96.36 129.77 43.63 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.221 0.534 . . . . 0.0 111.524 -173.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.505 ' CE1' HD21 ' B' ' 44' ' ' LEU . 60.5 t80 -56.85 142.02 42.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.487 -173.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.45 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 87.5 t90 -135.41 141.49 45.47 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.763 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.503 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -143.2 155.46 26.02 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.068 178.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.643 HD23 HD13 ' A' ' 87' ' ' LEU . 57.2 tp -145.21 108.53 4.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.709 0.29 . . . . 0.0 110.901 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -89.0 106.42 18.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.492 0.663 . . . . 0.0 110.91 177.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.558 ' HB2' HG23 ' A' ' 85' ' ' VAL . 4.1 mmt -86.96 134.42 33.5 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.931 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.517 ' HB2' ' HG3' ' A' ' 17' ' ' ARG . 54.5 mtmt -100.26 146.08 31.36 Favored Pre-proline 0 C--N 1.316 -0.851 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 172.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.435 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 5.8 Cg_endo -48.12 110.37 0.32 Allowed 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 123.51 2.807 . . . . 0.0 113.432 -174.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.69 ' HA ' ' O ' ' A' ' 79' ' ' THR . 31.6 mt-10 69.5 54.07 0.41 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.531 178.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.517 ' HG3' ' HB2' ' A' ' 14' ' ' LYS . 19.5 mmt180 -110.75 152.7 26.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.868 172.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.719 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 36.0 ttmt -133.56 107.74 8.18 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.944 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.42 ' OH ' ' HA ' ' A' ' 13' ' ' MET . 0.8 OUTLIER -111.05 121.09 44.45 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.752 179.516 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.4 p -75.29 126.79 31.74 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 170.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -103.95 116.56 32.48 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.125 0.488 . . . . 0.0 111.727 -164.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.5 p -97.22 123.12 40.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.879 173.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.404 ' CG2' ' HA ' ' A' ' 71' ' ' LYS . 55.3 mt -92.97 108.43 20.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.199 0.524 . . . . 0.0 111.575 -172.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.713 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -76.08 -39.65 36.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.007 177.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -139.58 141.47 37.17 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.6 m -60.86 120.82 10.89 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.66 0.6 . . . . 0.0 109.85 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.548 ' HB3' HD23 ' A' ' 91' ' ' LEU . 2.2 p90 -134.25 166.01 23.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.706 0.765 . . . . 0.0 112.721 -169.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.621 ' HE2' ' HB2' ' A' ' 30' ' ' SER . 9.3 t60 -118.72 125.13 48.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.302 -1.317 . . . . 0.0 109.958 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.617 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 39.8 mt -94.6 138.48 20.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 169.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.621 ' HB2' ' HE2' ' A' ' 28' ' ' HIS . 26.2 t -119.62 -23.51 6.54 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -169.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -161.92 156.89 28.57 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 119.408 -1.377 . . . . 0.0 113.253 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.405 HG23 ' HG ' ' A' ' 87' ' ' LEU . 10.2 p -137.36 125.38 32.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 172.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.81 152.31 42.07 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -171.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.572 ' HB3' HG12 ' A' ' 85' ' ' VAL . 3.7 pp -119.18 142.73 47.71 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.583 0.706 . . . . 0.0 111.346 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -110.12 -48.46 3.18 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.615 173.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -102.49 127.27 49.62 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 170.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.522 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 145.83 159.54 8.22 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 119.392 -1.385 . . . . 0.0 113.948 176.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.428 ' HA ' ' HB2' ' A' ' 58' ' ' LYS . 54.3 mt-30 -103.15 -44.5 5.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.653 -0.274 . . . . 0.0 111.127 177.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -150.63 132.63 15.21 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 120.5 0.19 . . . . 0.0 111.026 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.527 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -133.02 114.32 13.84 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.286 0.565 . . . . 0.0 110.586 169.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 79' ' ' THR . 63.9 mttp -95.86 112.22 24.0 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 174.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 45.4 tp -83.99 115.93 22.57 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.439 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -117.02 144.01 45.08 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.533 ' HA ' ' O ' ' A' ' 76' ' ' MET . 0.2 OUTLIER -131.34 132.54 44.55 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.2 0.524 . . . . 0.0 109.723 172.086 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -107.09 110.07 22.09 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.3 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.587 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -126.22 151.95 46.71 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 43.36 37.49 1.38 Allowed 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.939 0.774 . . . . 0.0 111.142 -171.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.7 tptp 54.65 46.66 24.26 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.157 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.585 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 6.5 tp-100 -135.17 130.71 35.78 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.669 175.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -85.68 110.86 19.59 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.343 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.49 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 82.5 m-85 -104.62 129.16 52.77 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.7 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 tp -77.25 103.79 4.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 169.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.534 HG13 ' CD2' ' E' ' 88' ' ' LEU . 2.6 t -76.39 -49.52 24.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.293 -173.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.489 ' HB2' ' CD2' ' A' ' 65' ' ' LEU . . . -159.03 144.86 16.47 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.19 -178.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.3 m -110.5 101.49 10.17 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 171.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.431 ' CG1' HG11 ' A' ' 85' ' ' VAL . 7.5 p -111.26 120.44 61.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.133 -178.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 54.8 p -122.61 -179.81 4.35 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -172.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 38' ' ' GLN . 35.0 tttm -60.89 -27.04 67.86 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.272 0.558 . . . . 0.0 109.901 172.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.479 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -83.48 -40.57 19.07 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.734 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 90.9 mt -107.36 89.43 4.84 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 36.0 Cg_exo -61.32 -20.3 67.65 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.101 2.534 . . . . 0.0 113.941 -169.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -156.19 136.09 12.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.381 0.61 . . . . 0.0 111.974 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.453 HG11 ' HB1' ' A' ' 54' ' ' ALA . 98.4 t -111.38 113.8 45.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.729 171.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.03 122.15 34.27 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.08 177.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.489 ' CD2' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -142.6 143.5 32.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.248 0.547 . . . . 0.0 111.902 -177.084 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.471 ' HB3' ' OG ' ' E' ' 30' ' ' SER . 5.6 t70 -89.59 100.57 13.34 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.706 177.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.726 HD21 HD23 ' E' ' 88' ' ' LEU . 19.7 mt -110.81 138.39 47.27 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.686 176.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.649 ' HB2' ' CD2' ' E' ' 90' ' ' TYR . 10.5 m-80 -137.58 128.21 26.82 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 173.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -124.43 146.81 48.69 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.977 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.0 t -99.93 148.97 23.9 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.404 ' HA ' ' CG2' ' A' ' 23' ' ' ILE . 15.1 ptmm? -67.14 -10.72 53.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.326 -178.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.42 -9.87 66.38 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.107 176.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -100.74 160.06 14.67 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -135.12 125.43 26.37 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.587 HG22 ' HB2' ' A' ' 46' ' ' ALA . 11.3 pt -131.21 178.13 5.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.93 0.395 . . . . 0.0 111.609 -171.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.533 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 24.5 mtp -130.9 136.31 48.49 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 174.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.472 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 1.2 m-85 -117.86 128.21 54.62 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.145 176.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.719 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 34.6 p90 -155.08 145.64 22.2 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.966 -178.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.69 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 13.2 p -117.33 144.95 44.36 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.507 -177.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -115.04 151.33 34.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.915 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.58 -177.16 29.29 Favored Glycine 0 CA--C 1.509 -0.334 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -109.74 102.93 11.69 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.684 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -175.27 155.94 1.97 Allowed 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.87 172.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.6 t -113.03 118.87 36.0 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.572 HG12 ' HB3' ' A' ' 34' ' ' LEU . 10.5 m -118.94 137.39 53.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -173.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 54.6 m -101.17 120.94 40.97 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.048 175.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.643 HD13 HD23 ' A' ' 11' ' ' LEU . 5.3 mp -89.41 145.71 25.15 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 170.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.698 HD23 HD21 ' B' ' 67' ' ' LEU . 1.2 tp -131.48 132.17 44.05 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.679 -177.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -159.66 -166.76 19.22 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.701 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.634 ' CD2' ' HB2' ' B' ' 68' ' ' ASN . 18.7 p90 -153.02 133.72 13.83 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.919 0.866 . . . . 0.0 111.547 177.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.548 HD23 ' HB3' ' A' ' 27' ' ' PHE . 5.1 mt -71.32 138.21 49.1 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 113.981 -1.463 . . . . 0.0 108.926 174.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -68.01 123.77 21.55 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.78 -77.73 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 O-C-N 124.129 0.893 . . . . 0.0 113.352 -169.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 69.9 mt -137.18 115.94 14.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.942 0.401 . . . . 0.0 110.647 -177.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -93.01 84.88 4.96 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.0 t -167.38 130.43 1.72 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.818 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.38 150.06 36.3 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.803 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.488 -0.768 . . . . 0.0 110.206 -179.562 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -127.38 66.55 1.31 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.56 0.695 . . . . 0.0 109.572 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' C' ' 95' ' ' ASP . . . -75.55 136.52 20.22 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.978 178.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.92 146.85 22.21 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 59.4 mtt -125.97 39.85 3.86 Favored 'General case' 0 C--N 1.321 -0.65 0 O-C-N 123.32 0.388 . . . . 0.0 109.954 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -51.04 129.24 23.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.85 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 48.7 mtt -96.34 129.84 43.59 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.25 0.548 . . . . 0.0 111.546 -173.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.467 ' CE1' HD21 ' C' ' 44' ' ' LEU . 60.7 t80 -56.82 141.91 42.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.515 -173.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . 0.454 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 87.5 t90 -135.34 141.42 45.59 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.817 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.479 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -143.13 155.53 26.04 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.105 178.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.637 HD23 HD13 ' B' ' 87' ' ' LEU . 56.9 tp -145.34 108.5 4.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.784 0.326 . . . . 0.0 110.819 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -88.98 106.44 18.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.495 0.664 . . . . 0.0 110.947 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . 0.553 ' HB2' HG23 ' B' ' 85' ' ' VAL . 4.1 mmt -86.98 134.41 33.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.041 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.526 ' HB2' ' HG3' ' B' ' 17' ' ' ARG . 54.5 mtmt -100.18 146.14 31.45 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 172.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.44 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 5.8 Cg_endo -48.19 110.35 0.32 Allowed 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 123.449 2.766 . . . . 0.0 113.444 -174.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.69 ' HA ' ' O ' ' B' ' 79' ' ' THR . 31.6 mt-10 69.52 54.1 0.4 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.48 178.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.526 ' HG3' ' HB2' ' B' ' 14' ' ' LYS . 19.5 mmt180 -110.73 152.72 26.24 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.879 172.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.724 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 36.0 ttmt -133.59 107.79 8.2 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.825 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' TYR . . . . . 0.42 ' OH ' ' HA ' ' B' ' 13' ' ' MET . 0.8 OUTLIER -110.99 121.07 44.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.803 179.423 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 5.2 p -75.3 126.74 31.63 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 170.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -103.83 116.45 32.3 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.713 -164.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 9.6 p -97.16 123.19 40.86 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.842 173.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 55.6 mt -93.02 108.51 20.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.032 0.444 . . . . 0.0 111.513 -172.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.711 ' H ' HD13 ' B' ' 24' ' ' ILE . 0.2 OUTLIER -76.1 -39.73 36.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.001 177.765 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -139.53 141.48 37.28 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 15.5 m -60.8 120.93 11.06 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.666 0.604 . . . . 0.0 109.814 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . 0.545 ' HB3' HD23 ' B' ' 91' ' ' LEU . 2.2 p90 -134.34 165.95 23.95 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.685 0.755 . . . . 0.0 112.73 -169.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' HIS . . . . . 0.62 ' HE2' ' HB2' ' B' ' 30' ' ' SER . 9.5 t60 -118.68 125.1 48.95 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.98 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.627 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 39.7 mt -94.53 138.54 20.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 169.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.62 ' HB2' ' HE2' ' B' ' 28' ' ' HIS . 26.1 t -119.65 -23.49 6.53 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -169.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -161.91 156.99 28.69 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.328 -1.415 . . . . 0.0 113.266 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.405 HG23 ' HG ' ' B' ' 87' ' ' LEU . 10.2 p -137.5 125.37 31.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 172.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.81 152.36 42.14 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -171.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.585 ' HB3' HG12 ' B' ' 85' ' ' VAL . 3.6 pp -119.21 142.75 47.73 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.542 0.687 . . . . 0.0 111.347 177.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -110.22 -48.5 3.17 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.554 173.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -102.41 127.18 49.54 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 170.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.518 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 145.97 159.66 8.3 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 119.38 -1.39 . . . . 0.0 113.8 176.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . 0.423 ' HA ' ' HB2' ' B' ' 58' ' ' LYS . 54.3 mt-30 -103.17 -44.55 5.16 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.593 -0.304 . . . . 0.0 111.177 177.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -150.64 132.66 15.23 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 120.536 0.208 . . . . 0.0 111.014 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.507 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -133.0 114.31 13.83 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.266 0.555 . . . . 0.0 110.485 169.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' B' ' 79' ' ' THR . 64.0 mttp -95.88 112.17 23.97 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 174.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 45.2 tp -83.93 116.0 22.57 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.489 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -117.12 143.96 45.22 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.526 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.2 OUTLIER -131.32 132.52 44.56 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.705 172.1 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -107.05 110.12 22.16 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.373 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.584 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -126.25 151.96 46.75 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 43.37 37.45 1.36 Allowed 'General case' 0 N--CA 1.474 0.77 0 O-C-N 123.918 0.761 . . . . 0.0 111.155 -171.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 25.7 tptp 54.55 46.86 23.98 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.116 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.585 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 6.5 tp-100 -135.28 130.72 35.57 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.603 175.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -85.74 110.9 19.66 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.315 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.503 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 82.3 m-85 -104.56 129.18 52.66 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.681 177.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 tp -77.39 103.83 4.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 169.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.53 HG13 ' CD2' ' A' ' 88' ' ' LEU . 2.6 t -76.35 -49.57 24.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.199 -173.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.478 ' HB2' ' CD2' ' B' ' 65' ' ' LEU . . . -159.1 144.84 16.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.178 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 43.7 m -110.51 101.55 10.23 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 171.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.431 ' CG1' HG11 ' B' ' 85' ' ' VAL . 7.5 p -111.3 120.48 61.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.147 -178.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 52.8 p -122.67 -179.75 4.34 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.098 0.475 . . . . 0.0 112.215 -172.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' B' ' 38' ' ' GLN . 34.9 tttm -60.9 -27.05 67.88 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.92 172.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.473 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -83.45 -40.57 19.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.791 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 90.9 mt -107.38 89.56 4.98 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 174.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 36.6 Cg_exo -61.46 -20.24 67.67 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.151 2.567 . . . . 0.0 113.949 -169.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -156.27 135.98 12.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.408 0.623 . . . . 0.0 111.886 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.457 HG11 ' HB1' ' B' ' 54' ' ' ALA . 98.6 t -111.3 113.79 45.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.726 171.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.03 122.19 34.31 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.109 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.478 ' CD2' ' HB2' ' B' ' 54' ' ' ALA . 0.2 OUTLIER -142.62 143.49 32.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.315 0.579 . . . . 0.0 111.916 -177.067 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . 0.432 ' HB3' ' OG ' ' A' ' 30' ' ' SER . 5.6 t70 -89.61 100.53 13.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.71 177.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.698 HD21 HD23 ' A' ' 88' ' ' LEU . 19.5 mt -110.87 138.38 47.35 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.64 176.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . 0.634 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 10.5 m-80 -137.5 128.18 26.92 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 173.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -124.4 146.77 48.68 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.03 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 28.8 t -100.03 148.93 24.0 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -67.17 -10.65 52.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.277 -177.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.46 -9.73 66.47 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.122 176.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -100.89 160.1 14.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -135.18 125.41 26.24 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.584 HG22 ' HB2' ' B' ' 46' ' ' ALA . 11.2 pt -131.19 178.06 6.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.901 0.381 . . . . 0.0 111.55 -171.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.526 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 24.7 mtp -130.87 136.4 48.6 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 174.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . 0.48 ' CD1' ' HB2' ' B' ' 44' ' ' LEU . 1.2 m-85 -117.91 128.16 54.55 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.146 176.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.724 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 34.3 p90 -155.07 145.7 22.27 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.922 -178.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.69 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 13.2 p -117.39 144.99 44.39 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.446 -177.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -115.12 151.27 34.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.903 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.7 -177.09 29.11 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -109.89 102.95 11.67 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 119.625 -0.83 . . . . 0.0 109.608 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.518 ' CB ' ' HA3' ' B' ' 37' ' ' GLY . . . -175.22 155.94 1.99 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.814 172.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 32.6 t -113.05 118.86 35.96 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.585 HG12 ' HB3' ' B' ' 34' ' ' LEU . 10.2 m -118.93 137.53 52.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 CA-C-O 121.403 0.621 . . . . 0.0 112.671 -173.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 54.5 m -101.27 120.92 40.97 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.093 175.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.637 HD13 HD23 ' B' ' 11' ' ' LEU . 5.3 mp -89.41 145.74 25.13 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 170.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.696 HD23 HD21 ' C' ' 67' ' ' LEU . 1.2 tp -131.54 132.16 43.94 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.645 -177.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -159.7 -166.78 19.28 Favored Glycine 0 N--CA 1.438 -1.233 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.638 -176.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' TYR . . . . . 0.629 ' CD2' ' HB2' ' C' ' 68' ' ' ASN . 18.7 p90 -152.97 133.68 13.85 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.909 0.861 . . . . 0.0 111.622 177.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . 0.545 HD23 ' HB3' ' B' ' 27' ' ' PHE . 5.2 mt -71.29 138.11 49.08 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 113.988 -1.46 . . . . 0.0 108.978 174.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -67.94 123.74 21.42 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.73 -77.73 0.02 OUTLIER 'General case' 0 C--O 1.235 0.319 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -169.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 70.1 mt -137.19 115.99 14.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.853 0.358 . . . . 0.0 110.67 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -92.99 84.81 4.95 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 29.4 t -167.36 130.42 1.73 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.832 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.42 150.09 36.28 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.883 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.672 -0.68 . . . . 0.0 110.233 -179.443 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -127.44 66.5 1.31 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.702 0.763 . . . . 0.0 109.636 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.46 136.51 20.28 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.988 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.91 146.89 22.25 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 59.3 mtt -125.92 39.68 3.9 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.323 0.389 . . . . 0.0 109.964 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.95 129.17 23.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.918 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 48.8 mtt -96.33 129.86 43.57 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.255 0.55 . . . . 0.0 111.578 -173.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 8' ' ' PHE . . . . . 0.487 ' CE1' HD21 ' D' ' 44' ' ' LEU . 60.1 t80 -56.88 141.94 43.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.448 -173.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . 0.457 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 87.5 t90 -135.33 141.41 45.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.802 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . 0.484 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -143.17 155.5 26.03 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.053 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.637 HD23 HD13 ' C' ' 87' ' ' LEU . 57.1 tp -145.26 108.58 4.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.821 0.343 . . . . 0.0 110.906 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -89.0 106.43 18.42 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.528 0.68 . . . . 0.0 110.852 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 13' ' ' MET . . . . . 0.555 ' HB2' HG23 ' C' ' 85' ' ' VAL . 4.1 mmt -86.96 134.38 33.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.014 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . 0.513 ' HB2' ' HG3' ' C' ' 17' ' ' ARG . 54.5 mtmt -100.16 146.16 31.46 Favored Pre-proline 0 C--N 1.316 -0.849 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . 0.436 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 5.8 Cg_endo -48.11 110.37 0.32 Allowed 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.52 2.814 . . . . 0.0 113.422 -174.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . 0.685 ' HA ' ' O ' ' C' ' 79' ' ' THR . 31.7 mt-10 69.47 54.08 0.41 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.541 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 17' ' ' ARG . . . . . 0.513 ' HG3' ' HB2' ' C' ' 14' ' ' LYS . 19.4 mmt180 -110.86 152.65 26.45 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.878 172.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 18' ' ' LYS . . . . . 0.718 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 36.0 ttmt -133.5 107.61 8.13 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.911 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . 0.422 ' OH ' ' HA ' ' C' ' 13' ' ' MET . 0.8 OUTLIER -110.96 121.06 44.4 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.803 -0.444 . . . . 0.0 109.803 179.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 5.2 p -75.35 126.7 31.54 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 171.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -103.77 116.55 32.51 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.722 -164.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 9.6 p -97.21 123.16 40.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.872 173.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . 0.402 ' CG2' ' HA ' ' C' ' 71' ' ' LYS . 55.2 mt -93.0 108.51 20.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.201 0.524 . . . . 0.0 111.54 -172.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . 0.697 ' H ' HD13 ' C' ' 24' ' ' ILE . 0.2 OUTLIER -76.13 -39.8 36.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.955 177.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -139.5 141.43 37.34 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 15.5 m -60.78 120.8 10.82 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 123.628 0.58 . . . . 0.0 109.858 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 27' ' ' PHE . . . . . 0.553 ' HB3' HD23 ' C' ' 91' ' ' LEU . 2.2 p90 -134.27 165.93 23.98 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.685 0.755 . . . . 0.0 112.715 -169.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 28' ' ' HIS . . . . . 0.626 ' HE2' ' HB2' ' C' ' 30' ' ' SER . 9.3 t60 -118.62 125.2 49.24 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.97 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . 0.605 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 39.9 mt -94.57 138.5 20.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 169.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.626 ' HB2' ' HE2' ' C' ' 28' ' ' HIS . 26.1 t -119.64 -23.47 6.54 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -169.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -161.9 157.0 28.7 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 119.374 -1.393 . . . . 0.0 113.29 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 10.2 p -137.45 125.41 31.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 172.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.85 152.34 42.05 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.636 -0.426 . . . . 0.0 112.143 -171.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.592 ' HB3' HG12 ' C' ' 85' ' ' VAL . 3.7 pp -119.2 142.74 47.72 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.49 0.662 . . . . 0.0 111.424 177.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -110.09 -48.58 3.17 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.581 173.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -102.38 127.24 49.48 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 170.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 37' ' ' GLY . . . . . 0.52 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 145.93 159.59 8.26 Favored Glycine 0 N--CA 1.437 -1.257 0 C-N-CA 119.318 -1.42 . . . . 0.0 113.834 176.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 38' ' ' GLN . . . . . 0.425 ' HA ' ' HB2' ' C' ' 58' ' ' LYS . 54.2 mt-30 -103.06 -44.55 5.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.658 -0.271 . . . . 0.0 111.214 177.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -150.67 132.61 15.15 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.483 0.182 . . . . 0.0 110.982 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.519 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -133.02 114.35 13.86 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.286 0.565 . . . . 0.0 110.5 169.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' C' ' 79' ' ' THR . 64.0 mttp -95.91 112.16 23.96 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 174.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 45.4 tp -83.94 116.0 22.58 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -117.11 143.95 45.23 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.52 ' HA ' ' O ' ' C' ' 76' ' ' MET . 0.2 OUTLIER -131.28 132.55 44.65 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.167 0.508 . . . . 0.0 109.665 172.07 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -107.06 110.14 22.18 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.341 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.573 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -126.28 151.91 46.85 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 43.38 37.47 1.38 Allowed 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.864 0.727 . . . . 0.0 111.193 -171.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 25.7 tptp 54.58 46.71 24.25 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.233 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . 0.591 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 6.5 tp-100 -135.22 130.72 35.69 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.567 175.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -85.78 110.84 19.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.906 0.384 . . . . 0.0 110.339 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . 0.479 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 82.4 m-85 -104.5 129.19 52.54 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.702 177.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 tp -77.29 103.79 4.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 169.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 53' ' ' VAL . . . . . 0.507 HG13 ' CD2' ' B' ' 88' ' ' LEU . 2.6 t -76.36 -49.62 24.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.243 -173.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 54' ' ' ALA . . . . . 0.466 ' HB2' ' CD2' ' C' ' 65' ' ' LEU . . . -159.0 144.87 16.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.228 -178.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 43.5 m -110.53 101.52 10.19 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 171.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . 0.429 ' CG1' HG11 ' C' ' 85' ' ' VAL . 7.6 p -111.26 120.53 62.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.204 -178.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 52.7 p -122.76 -179.74 4.34 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.078 0.466 . . . . 0.0 112.17 -172.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 58' ' ' LYS . . . . . 0.425 ' HB2' ' HA ' ' C' ' 38' ' ' GLN . 34.9 tttm -60.92 -27.16 68.0 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.281 0.562 . . . . 0.0 109.849 172.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . 0.476 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -83.43 -40.51 19.22 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.817 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 90.5 mt -107.43 89.48 4.96 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 174.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 61' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 37.5 Cg_exo -61.32 -20.31 67.68 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.145 2.563 . . . . 0.0 113.892 -169.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -156.25 136.02 12.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.479 0.657 . . . . 0.0 111.869 -178.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.456 HG11 ' HB1' ' C' ' 54' ' ' ALA . 98.0 t -111.36 113.92 45.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.663 171.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.15 122.21 34.42 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.025 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . 0.466 ' CD2' ' HB2' ' C' ' 54' ' ' ALA . 0.2 OUTLIER -142.59 143.43 32.43 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.287 0.565 . . . . 0.0 111.955 -177.1 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 66' ' ' ASP . . . . . 0.445 ' HB3' ' OG ' ' B' ' 30' ' ' SER . 5.6 t70 -89.54 100.5 13.29 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.718 177.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.696 HD21 HD23 ' B' ' 88' ' ' LEU . 19.7 mt -110.83 138.45 47.22 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.694 176.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . 0.629 ' HB2' ' CD2' ' B' ' 90' ' ' TYR . 10.5 m-80 -137.57 128.21 26.85 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 173.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -124.47 146.79 48.74 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.934 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 29.2 t -99.97 148.95 23.95 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . 0.402 ' HA ' ' CG2' ' C' ' 23' ' ' ILE . 15.1 ptmm? -67.06 -10.81 53.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.271 -178.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.42 -9.78 66.49 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.081 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -100.9 160.15 14.61 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -135.17 125.53 26.48 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.573 HG22 ' HB2' ' C' ' 46' ' ' ALA . 11.3 pt -131.33 178.04 6.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.836 0.35 . . . . 0.0 111.576 -171.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.52 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 24.6 mtp -130.79 136.25 48.53 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 77' ' ' PHE . . . . . 0.477 ' CD1' ' HB2' ' C' ' 44' ' ' LEU . 1.2 m-85 -117.79 128.23 54.66 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.17 176.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 78' ' ' TYR . . . . . 0.718 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 34.7 p90 -155.14 145.63 22.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.961 0.41 . . . . 0.0 111.987 -178.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . 0.685 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 13.0 p -117.36 144.97 44.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.438 -177.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -115.09 151.28 34.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.972 177.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.67 -177.03 29.12 Favored Glycine 0 CA--C 1.508 -0.403 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -109.93 102.99 11.7 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.764 0.782 . . . . 0.0 109.637 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . 0.52 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -175.27 155.95 1.97 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.833 172.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 32.4 t -113.07 118.8 35.79 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.592 HG12 ' HB3' ' C' ' 34' ' ' LEU . 10.1 m -118.88 137.51 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -173.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 54.2 m -101.21 120.9 40.92 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.074 175.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . 0.637 HD13 HD23 ' C' ' 11' ' ' LEU . 5.3 mp -89.36 145.79 25.12 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 170.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . 0.687 HD23 HD21 ' D' ' 67' ' ' LEU . 1.2 tp -131.56 132.15 43.9 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.669 -177.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -159.71 -166.88 19.49 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.575 -176.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 90' ' ' TYR . . . . . 0.631 ' CD2' ' HB2' ' D' ' 68' ' ' ASN . 19.0 p90 -152.88 133.71 13.96 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.885 0.85 . . . . 0.0 111.658 177.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . 0.553 HD23 ' HB3' ' C' ' 27' ' ' PHE . 5.1 mt -71.33 138.11 49.01 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.011 -1.45 . . . . 0.0 108.97 174.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -67.95 123.73 21.4 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.61 -77.73 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -169.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 69.8 mt -137.17 115.91 14.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.819 0.342 . . . . 0.0 110.698 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 95' ' ' ASP . . . . . 0.406 ' HA ' ' HA3' ' B' ' 3' ' ' GLY . 12.6 t70 -92.97 84.78 4.96 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 30.0 t -167.26 130.45 1.76 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.839 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.35 150.12 36.44 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.84 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.472 -0.775 . . . . 0.0 110.303 -179.552 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 . . . . . 0 N--CA 1.476 0.827 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -127.42 66.6 1.31 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.685 0.755 . . . . 0.0 109.606 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.57 136.5 20.16 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.919 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.87 146.98 22.38 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 59.2 mtt -126.06 39.81 3.87 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.92 129.18 22.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.951 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 49.0 mtt -96.42 129.85 43.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.312 0.577 . . . . 0.0 111.446 -173.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 8' ' ' PHE . . . . . 0.496 ' CE1' HD21 ' E' ' 44' ' ' LEU . 60.6 t80 -56.78 141.92 42.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.685 -1.143 . . . . 0.0 112.49 -173.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 9' ' ' TRP . . . . . 0.454 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 87.5 t90 -135.38 141.4 45.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.75 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . 0.501 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -143.11 155.55 26.04 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.133 178.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.635 HD23 HD13 ' D' ' 87' ' ' LEU . 56.8 tp -145.35 108.51 4.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.832 0.348 . . . . 0.0 110.805 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -88.92 106.37 18.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.459 0.647 . . . . 0.0 110.932 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 13' ' ' MET . . . . . 0.566 ' HB2' HG23 ' D' ' 85' ' ' VAL . 4.1 mmt -86.9 134.44 33.52 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.046 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 14' ' ' LYS . . . . . 0.529 ' HB2' ' HG3' ' D' ' 17' ' ' ARG . 54.6 mtmt -100.32 146.15 31.48 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 172.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . 0.428 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 5.7 Cg_endo -48.11 110.39 0.32 Allowed 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 123.43 2.754 . . . . 0.0 113.441 -174.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . 0.684 ' HA ' ' O ' ' D' ' 79' ' ' THR . 31.6 mt-10 69.47 53.96 0.41 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.55 178.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 17' ' ' ARG . . . . . 0.529 ' HG3' ' HB2' ' D' ' 14' ' ' LYS . 19.5 mmt180 -110.57 152.72 26.08 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.948 172.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . 0.707 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 36.0 ttmt -133.62 107.75 8.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.903 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 19' ' ' TYR . . . . . 0.42 ' OH ' ' HA ' ' D' ' 13' ' ' MET . 0.8 OUTLIER -111.11 121.06 44.35 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.579 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 5.2 p -75.26 126.8 31.76 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 170.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -103.97 116.5 32.36 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.054 0.454 . . . . 0.0 111.648 -164.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 9.1 p -97.28 123.14 40.99 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.826 173.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . 0.405 ' CG2' ' HA ' ' D' ' 71' ' ' LYS . 55.2 mt -92.97 108.51 20.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.117 0.484 . . . . 0.0 111.521 -172.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . 0.709 ' H ' HD13 ' D' ' 24' ' ' ILE . 0.2 OUTLIER -76.23 -39.57 35.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.018 177.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -139.6 141.46 37.14 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 15.6 m -60.72 120.84 10.85 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 123.535 0.522 . . . . 0.0 109.747 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 27' ' ' PHE . . . . . 0.565 ' HB3' HD23 ' D' ' 91' ' ' LEU . 2.2 p90 -134.33 165.92 24.02 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.748 0.785 . . . . 0.0 112.725 -169.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 28' ' ' HIS . . . . . 0.631 ' HE2' ' HB2' ' D' ' 30' ' ' SER . 9.5 t60 -118.58 125.15 49.18 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.996 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 29' ' ' ILE . . . . . 0.616 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 39.5 mt -94.56 138.48 20.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 169.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . 0.631 ' HB2' ' HE2' ' D' ' 28' ' ' HIS . 26.1 t -119.62 -23.46 6.55 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -169.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 31' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -161.97 156.94 28.65 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.385 -1.388 . . . . 0.0 113.257 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.403 HG23 ' HG ' ' D' ' 87' ' ' LEU . 10.4 p -137.4 125.42 32.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.84 152.36 42.08 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.641 -0.424 . . . . 0.0 112.039 -171.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 34' ' ' LEU . . . . . 0.578 ' HB3' HG12 ' D' ' 85' ' ' VAL . 3.7 pp -119.13 142.71 47.69 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.518 0.675 . . . . 0.0 111.415 177.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -110.08 -48.61 3.17 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.591 173.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -102.41 127.17 49.55 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 170.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . 0.525 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 145.86 159.63 8.27 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 119.379 -1.391 . . . . 0.0 113.916 176.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 38' ' ' GLN . . . . . 0.428 ' HA ' ' HB2' ' D' ' 58' ' ' LYS . 54.0 mt-30 -103.15 -44.53 5.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.702 -0.249 . . . . 0.0 111.157 177.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -150.68 132.61 15.14 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.566 0.222 . . . . 0.0 111.019 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . 0.522 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -132.98 114.33 13.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.234 0.54 . . . . 0.0 110.514 169.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' D' ' 79' ' ' THR . 64.0 mttp -95.86 112.05 23.88 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 45.3 tp -83.88 116.03 22.56 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -177.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -117.18 144.04 45.18 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.531 ' HA ' ' O ' ' D' ' 76' ' ' MET . 0.2 OUTLIER -131.4 132.5 44.42 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.697 172.095 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 45' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -107.04 110.12 22.17 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.396 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.593 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -126.31 151.9 46.92 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 43.4 37.49 1.4 Allowed 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.923 0.764 . . . . 0.0 111.09 -171.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 25.7 tptp 54.57 46.78 24.11 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.186 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . 0.589 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 6.5 tp-100 -135.18 130.71 35.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.623 175.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -85.69 110.81 19.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.342 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . 0.484 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 82.2 m-85 -104.45 129.2 52.46 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.707 177.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 tp -77.28 103.77 4.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 169.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 53' ' ' VAL . . . . . 0.53 HG13 ' CD2' ' C' ' 88' ' ' LEU . 2.6 t -76.38 -49.55 24.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.246 -173.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 54' ' ' ALA . . . . . 0.485 ' HB2' ' CD2' ' D' ' 65' ' ' LEU . . . -159.02 144.9 16.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.239 -178.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 43.9 m -110.54 101.55 10.22 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 171.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 56' ' ' VAL . . . . . 0.427 ' CG1' HG11 ' D' ' 85' ' ' VAL . 7.6 p -111.22 120.44 61.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.171 -178.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 52.5 p -122.73 -179.79 4.36 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.084 0.469 . . . . 0.0 112.151 -172.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 58' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' D' ' 38' ' ' GLN . 34.8 tttm -60.83 -27.18 67.87 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.289 0.566 . . . . 0.0 109.864 172.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 59' ' ' ALA . . . . . 0.477 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -83.39 -40.56 19.2 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.773 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 91.0 mt -107.33 89.48 4.86 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 61' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 37.6 Cg_exo -61.45 -20.29 67.87 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.193 2.595 . . . . 0.0 113.84 -169.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -156.24 136.03 12.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.409 0.623 . . . . 0.0 111.967 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.46 HG11 ' HB1' ' D' ' 54' ' ' ALA . 98.2 t -111.33 113.77 45.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.702 171.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.07 122.29 34.44 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.995 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 65' ' ' LEU . . . . . 0.485 ' CD2' ' HB2' ' D' ' 54' ' ' ALA . 0.2 OUTLIER -142.79 143.39 32.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.336 0.588 . . . . 0.0 111.856 -177.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 66' ' ' ASP . . . . . 0.457 ' HB3' ' OG ' ' C' ' 30' ' ' SER . 5.6 t70 -89.49 100.55 13.32 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.717 177.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.687 HD21 HD23 ' C' ' 88' ' ' LEU . 19.8 mt -110.81 138.39 47.26 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.683 176.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 68' ' ' ASN . . . . . 0.631 ' HB2' ' CD2' ' C' ' 90' ' ' TYR . 10.6 m-80 -137.58 128.22 26.84 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 173.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -124.53 146.77 48.81 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.956 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 29.4 t -99.98 149.01 23.88 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 71' ' ' LYS . . . . . 0.405 ' HA ' ' CG2' ' D' ' 23' ' ' ILE . 15.1 ptmm? -67.22 -10.66 52.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.265 -178.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.52 -9.72 66.38 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.143 176.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -100.95 160.17 14.59 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -135.21 125.35 26.08 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.593 HG22 ' HB2' ' D' ' 46' ' ' ALA . 11.3 pt -131.18 178.14 5.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.012 0.434 . . . . 0.0 111.491 -171.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 76' ' ' MET . . . . . 0.531 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 24.4 mtp -130.87 136.33 48.53 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 174.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 77' ' ' PHE . . . . . 0.476 ' CD1' ' HB2' ' D' ' 44' ' ' LEU . 1.2 m-85 -117.79 128.16 54.6 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.192 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 78' ' ' TYR . . . . . 0.707 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 34.5 p90 -155.1 145.63 22.17 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.953 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 79' ' ' THR . . . . . 0.684 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 13.4 p -117.29 144.94 44.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.522 -177.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -115.07 151.27 34.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.938 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.7 -177.04 29.09 Favored Glycine 0 CA--C 1.508 -0.348 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -109.82 102.89 11.63 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 119.661 -0.815 . . . . 0.0 109.686 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . 0.525 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -175.25 155.89 1.97 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.782 172.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 32.8 t -112.98 118.84 35.97 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.578 HG12 ' HB3' ' D' ' 34' ' ' LEU . 10.2 m -118.92 137.53 52.6 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -173.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 54.9 m -101.25 121.02 41.12 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.986 175.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 87' ' ' LEU . . . . . 0.635 HD13 HD23 ' D' ' 11' ' ' LEU . 5.3 mp -89.4 145.72 25.15 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 170.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.699 HD23 HD21 ' E' ' 67' ' ' LEU . 1.2 tp -131.49 132.1 43.97 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.733 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -159.64 -166.78 19.23 Favored Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.641 -176.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 90' ' ' TYR . . . . . 0.645 ' CD2' ' HB2' ' E' ' 68' ' ' ASN . 19.0 p90 -152.91 133.66 13.89 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.882 0.849 . . . . 0.0 111.654 177.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . 0.565 HD23 ' HB3' ' D' ' 27' ' ' PHE . 5.1 mt -71.16 138.04 49.28 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.003 174.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -67.98 123.75 21.47 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.64 -77.77 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 O-C-N 124.18 0.925 . . . . 0.0 113.354 -169.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 70.3 mt -137.17 115.91 14.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.865 0.364 . . . . 0.0 110.704 -177.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -93.06 84.81 4.93 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 176.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 29.2 t -167.34 130.44 1.73 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.803 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.32 150.07 36.44 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.866 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.335 -0.84 . . . . 0.0 110.266 -179.503 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -127.37 66.56 1.31 Allowed 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.654 0.74 . . . . 0.0 109.627 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.55 136.49 20.16 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.987 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.89 146.86 22.26 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 59.5 mtt -125.93 39.78 3.88 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 6' ' ' ALA . . . . . . . . . . . . . . . -51.02 129.22 23.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.921 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 48.8 mtt -96.27 129.73 43.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.218 0.532 . . . . 0.0 111.545 -173.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 8' ' ' PHE . . . . . 0.494 ' CE1' HD21 ' A' ' 44' ' ' LEU . 60.6 t80 -56.75 141.94 42.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.601 -173.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 9' ' ' TRP . . . . . 0.455 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 87.3 t90 -135.34 141.34 45.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.056 -0.975 . . . . 0.0 108.812 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 10' ' ' GLY . . . . . 0.49 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -143.18 155.5 26.04 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.07 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . 0.628 HD23 HD13 ' E' ' 87' ' ' LEU . 57.2 tp -145.22 108.45 4.59 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.747 0.308 . . . . 0.0 110.89 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -88.96 106.42 18.41 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.413 0.625 . . . . 0.0 110.93 177.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 13' ' ' MET . . . . . 0.566 ' HB2' HG23 ' E' ' 85' ' ' VAL . 4.1 mmt -86.95 134.36 33.51 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.995 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 14' ' ' LYS . . . . . 0.506 ' HB2' ' HG3' ' E' ' 17' ' ' ARG . 54.6 mtmt -100.22 146.18 31.51 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 172.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . 0.428 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 5.7 Cg_endo -48.19 110.44 0.33 Allowed 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 123.418 2.745 . . . . 0.0 113.449 -174.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 16' ' ' GLU . . . . . 0.683 ' HA ' ' O ' ' E' ' 79' ' ' THR . 31.5 mt-10 69.46 53.99 0.41 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.533 178.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 17' ' ' ARG . . . . . 0.506 ' HG3' ' HB2' ' E' ' 14' ' ' LYS . 19.6 mmt180 -110.56 152.74 26.06 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.889 172.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . 0.716 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 36.0 ttmt -133.62 107.79 8.18 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.923 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . 0.42 ' OH ' ' HA ' ' E' ' 13' ' ' MET . 0.8 OUTLIER -111.02 121.16 44.65 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 5.4 p -75.37 126.7 31.54 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 170.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -103.9 116.52 32.42 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.039 0.447 . . . . 0.0 111.66 -164.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 9.4 p -97.2 123.12 40.89 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.88 173.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 55.3 mt -92.99 108.5 20.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.18 0.514 . . . . 0.0 111.557 -172.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . 0.715 ' H ' HD13 ' E' ' 24' ' ' ILE . 0.2 OUTLIER -76.16 -39.7 36.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.97 177.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -139.58 141.43 37.19 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 15.5 m -60.69 120.87 10.9 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.671 0.607 . . . . 0.0 109.915 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 27' ' ' PHE . . . . . 0.543 ' HB3' HD23 ' E' ' 91' ' ' LEU . 2.2 p90 -134.39 165.92 24.04 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.741 0.782 . . . . 0.0 112.659 -169.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 28' ' ' HIS . . . . . 0.624 ' HE2' ' HB2' ' E' ' 30' ' ' SER . 9.4 t60 -118.6 125.13 49.11 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.933 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 29' ' ' ILE . . . . . 0.618 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 39.9 mt -94.57 138.49 20.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 169.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . 0.624 ' HB2' ' HE2' ' E' ' 28' ' ' HIS . 26.1 t -119.66 -23.51 6.52 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -169.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 31' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -161.94 156.98 28.69 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 119.365 -1.398 . . . . 0.0 113.296 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.41 HG23 ' HG ' ' E' ' 87' ' ' LEU . 10.3 p -137.43 125.34 31.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 172.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -142.78 152.25 42.06 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -171.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 34' ' ' LEU . . . . . 0.59 ' HB3' HG12 ' E' ' 85' ' ' VAL . 3.6 pp -119.15 142.75 47.67 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.532 0.682 . . . . 0.0 111.38 177.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -110.13 -48.59 3.17 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.542 173.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -102.45 127.27 49.55 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 170.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . 0.526 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 145.85 159.49 8.2 Favored Glycine 0 N--CA 1.437 -1.242 0 C-N-CA 119.342 -1.409 . . . . 0.0 113.938 176.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 38' ' ' GLN . . . . . 0.423 ' HA ' ' HB2' ' E' ' 58' ' ' LYS . 54.3 mt-30 -103.11 -44.44 5.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.697 -0.252 . . . . 0.0 111.181 177.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -150.66 132.63 15.18 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 120.415 0.15 . . . . 0.0 110.974 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . 0.511 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -133.07 114.36 13.83 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.302 0.572 . . . . 0.0 110.498 169.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 41' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' E' ' 79' ' ' THR . 64.1 mttp -95.79 112.05 23.87 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 174.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 45.4 tp -83.87 115.97 22.53 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.484 -177.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -117.06 144.0 45.13 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 44' ' ' LEU . . . . . 0.514 ' HA ' ' O ' ' E' ' 76' ' ' MET . 0.2 OUTLIER -131.35 132.52 44.51 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.201 0.524 . . . . 0.0 109.684 172.061 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 45' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -107.05 110.11 22.16 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.371 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . 0.576 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -126.26 151.98 46.73 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 176.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 43.39 37.44 1.38 Allowed 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.919 0.762 . . . . 0.0 111.146 -171.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 25.7 tptp 54.61 46.79 24.05 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.144 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 49' ' ' GLN . . . . . 0.586 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 6.5 tp-100 -135.31 130.76 35.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.639 175.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -85.78 110.83 19.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.264 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . 0.501 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 82.3 m-85 -104.49 129.15 52.54 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.764 177.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 tp -77.34 103.8 4.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 169.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . 0.529 HG13 ' CD2' ' D' ' 88' ' ' LEU . 2.6 t -76.32 -49.57 24.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.291 -173.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 54' ' ' ALA . . . . . 0.483 ' HB2' ' CD2' ' E' ' 65' ' ' LEU . . . -159.07 144.88 16.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.211 -178.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 44.4 m -110.52 101.46 10.14 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 171.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . 0.425 ' CG1' HG11 ' E' ' 85' ' ' VAL . 7.5 p -111.22 120.54 62.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.176 -178.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 52.3 p -122.73 -179.79 4.35 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.065 0.459 . . . . 0.0 112.153 -172.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 58' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' E' ' 38' ' ' GLN . 34.9 tttm -60.84 -27.18 67.89 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.854 172.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 59' ' ' ALA . . . . . 0.474 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -83.38 -40.51 19.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.804 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 90.9 mt -107.45 89.51 5.01 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 174.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 61' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 36.2 Cg_exo -61.4 -20.31 67.86 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.193 2.595 . . . . 0.0 113.916 -169.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -156.32 136.07 12.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.452 0.644 . . . . 0.0 111.921 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . 0.471 HG11 ' HB1' ' E' ' 54' ' ' ALA . 98.9 t -111.33 113.73 45.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.763 171.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.06 122.22 34.36 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.057 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.483 ' CD2' ' HB2' ' E' ' 54' ' ' ALA . 0.2 OUTLIER -142.74 143.49 32.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.335 0.588 . . . . 0.0 111.936 -177.128 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 66' ' ' ASP . . . . . 0.442 ' HB3' ' OG ' ' D' ' 30' ' ' SER . 5.6 t70 -89.49 100.53 13.31 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.679 177.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 67' ' ' LEU . . . . . 0.699 HD21 HD23 ' D' ' 88' ' ' LEU . 19.9 mt -110.91 138.41 47.34 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.646 176.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 68' ' ' ASN . . . . . 0.645 ' HB2' ' CD2' ' D' ' 90' ' ' TYR . 10.5 m-80 -137.63 128.26 26.8 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 173.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -124.47 146.79 48.73 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.974 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 29.5 t -100.12 149.01 23.95 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -67.14 -10.71 53.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.284 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.44 -9.77 66.48 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.064 176.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -100.83 160.17 14.59 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -135.22 125.48 26.33 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 75' ' ' ILE . . . . . 0.576 HG22 ' HB2' ' E' ' 46' ' ' ALA . 11.3 pt -131.31 178.08 6.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.835 0.35 . . . . 0.0 111.56 -171.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 76' ' ' MET . . . . . 0.514 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 24.6 mtp -130.89 136.28 48.47 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 77' ' ' PHE . . . . . 0.478 ' CD1' ' HB2' ' E' ' 44' ' ' LEU . 1.2 m-85 -117.82 128.2 54.63 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.199 176.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 78' ' ' TYR . . . . . 0.716 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 34.4 p90 -155.1 145.62 22.16 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.979 -178.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 79' ' ' THR . . . . . 0.683 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 13.3 p -117.3 144.91 44.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.496 -177.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -115.01 151.38 34.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.912 177.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.64 -177.2 29.25 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -109.81 102.88 11.63 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 117.79 0.795 . . . . 0.0 109.733 177.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 83' ' ' ALA . . . . . 0.526 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -175.22 155.94 1.99 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.823 172.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 32.6 t -113.06 118.83 35.86 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 85' ' ' VAL . . . . . 0.59 HG12 ' HB3' ' E' ' 34' ' ' LEU . 10.1 m -118.91 137.54 52.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -173.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 54.1 m -101.27 120.96 41.02 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.077 175.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 87' ' ' LEU . . . . . 0.628 HD13 HD23 ' E' ' 11' ' ' LEU . 5.3 mp -89.39 145.83 25.07 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 170.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . 0.726 HD23 HD21 ' A' ' 67' ' ' LEU . 1.2 tp -131.61 132.15 43.81 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.701 -177.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -159.67 -166.82 19.34 Favored Glycine 0 N--CA 1.439 -1.125 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.551 -176.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 90' ' ' TYR . . . . . 0.649 ' CD2' ' HB2' ' A' ' 68' ' ' ASN . 19.0 p90 -152.94 133.67 13.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.864 0.84 . . . . 0.0 111.687 177.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 91' ' ' LEU . . . . . 0.543 HD23 ' HB3' ' E' ' 27' ' ' PHE . 5.3 mt -71.35 138.11 48.97 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.073 -1.421 . . . . 0.0 108.896 174.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -67.9 123.71 21.33 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.71 -77.76 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 O-C-N 124.121 0.888 . . . . 0.0 113.346 -169.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 70.1 mt -137.15 116.04 14.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.806 0.336 . . . . 0.0 110.659 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -93.04 84.79 4.93 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 176.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 29.4 t -167.28 130.4 1.75 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.854 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.34 150.13 36.47 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.913 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.563 -0.732 . . . . 0.0 110.137 -179.452 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 64.06 -164.98 0.24 Allowed 'General case' 0 C--O 1.235 0.308 0 O-C-N 123.842 0.714 . . . . 0.0 111.501 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 101.89 102.3 2.61 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.868 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.47 133.41 52.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.948 0.404 . . . . 0.0 111.144 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 76.1 mtm -99.11 141.35 31.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.565 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -110.2 154.98 22.61 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.32 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.0 mtt -111.67 139.9 46.74 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.96 -178.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.436 ' CE1' HD21 ' B' ' 44' ' ' LEU . 74.6 t80 -54.83 143.94 24.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.847 -173.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.594 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 89.6 t90 -139.27 148.7 43.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.104 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.554 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -149.98 153.37 25.05 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.715 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.727 HD23 HD13 ' A' ' 87' ' ' LEU . 59.2 tp -139.06 108.8 6.24 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.916 0.389 . . . . 0.0 111.108 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -80.38 105.72 11.85 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.706 173.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.595 ' HB3' HG23 ' A' ' 85' ' ' VAL . 35.7 tpp -99.41 132.32 44.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.045 0.45 . . . . 0.0 110.956 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -98.63 146.6 31.88 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.89 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.527 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 10.4 Cg_endo -53.6 115.82 2.57 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 123.433 2.756 . . . . 0.0 113.141 -176.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.711 ' HA ' ' O ' ' A' ' 79' ' ' THR . 34.5 mt-10 63.49 38.12 10.06 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.591 177.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -109.36 149.95 28.74 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 173.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.694 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 34.4 ttmt -125.94 119.21 27.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.716 0.293 . . . . 0.0 111.592 -174.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.467 ' OH ' ' HA ' ' A' ' 13' ' ' MET . 3.6 m-85 -110.6 104.96 13.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.442 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.9 p -87.67 99.49 12.11 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 171.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -125.34 148.7 48.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.542 0.687 . . . . 0.0 112.466 -166.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.4 t -92.38 160.31 15.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.029 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 68.2 mt -106.24 117.79 52.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.05 0.452 . . . . 0.0 110.806 -175.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.466 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.1 mp -79.31 -45.38 23.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.916 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -135.17 140.22 45.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.739 178.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.1 m -55.99 124.15 16.75 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.527 0.517 . . . . 0.0 109.647 177.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.549 ' HB3' HD23 ' A' ' 91' ' ' LEU . 3.9 p90 -140.09 158.53 43.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.685 0.755 . . . . 0.0 112.683 -171.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.577 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 14.3 t60 -112.8 125.94 54.89 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.102 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 44.6 mt -96.3 133.45 37.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 170.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.577 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 42.2 p -118.48 -15.07 9.66 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -170.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.83 151.97 22.53 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 119.329 -1.415 . . . . 0.0 113.48 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.465 HG23 ' HG ' ' A' ' 87' ' ' LEU . 9.1 p -140.76 123.88 16.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 171.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.422 ' HA ' HG21 ' A' ' 56' ' ' VAL . . . -143.49 154.68 43.89 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.394 -0.522 . . . . 0.0 112.044 -173.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.631 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.3 pp -118.28 138.86 52.08 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.726 0.774 . . . . 0.0 111.178 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -110.07 -47.6 3.3 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.495 172.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -103.15 127.42 50.44 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.171 170.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.459 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 147.28 163.05 10.33 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 119.729 -1.224 . . . . 0.0 113.443 177.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.455 ' O ' ' HG3' ' A' ' 58' ' ' LYS . 8.3 tt0 -102.23 -48.21 4.27 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.554 0.216 . . . . 0.0 111.207 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -153.07 137.85 17.03 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.729 -0.214 . . . . 0.0 110.657 176.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.549 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -136.39 114.97 11.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.395 0.616 . . . . 0.0 111.12 171.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 79' ' ' THR . 68.1 mttm -95.07 115.03 26.91 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 171.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.403 HD23 ' HB ' ' A' ' 53' ' ' VAL . 38.1 tp -84.11 116.25 22.8 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -176.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.409 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 93.9 m-85 -117.09 143.82 45.35 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' A' ' 76' ' ' MET . 0.1 OUTLIER -131.7 131.71 43.3 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 172.68 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.577 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -111.87 118.15 34.75 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.132 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.638 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -130.48 133.66 46.46 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.485 178.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 56.05 38.9 30.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.135 0.493 . . . . 0.0 110.67 -175.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm 65.8 22.52 11.47 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.333 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.577 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 28.9 mm-40 -113.32 124.48 52.57 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -87.42 116.87 25.82 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.569 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 72.4 m-85 -111.61 131.07 55.52 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.782 177.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -81.34 103.42 8.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 171.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.506 HG13 ' CD2' ' E' ' 88' ' ' LEU . 2.3 t -76.87 -47.64 27.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.473 -172.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.476 ' HB2' HD23 ' A' ' 65' ' ' LEU . . . -156.7 151.53 25.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.327 -178.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 98.1 m -114.81 101.77 9.37 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 169.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.469 HG11 HG11 ' A' ' 85' ' ' VAL . 7.4 p -113.04 114.12 46.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.675 0.75 . . . . 0.0 109.759 -177.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 77.1 p -123.31 -177.75 3.79 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.411 -174.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 38' ' ' GLN . 28.8 mtpp -57.22 -36.13 70.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.101 0.477 . . . . 0.0 110.374 169.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.27 -41.23 66.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.551 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.9 mt -115.74 82.66 10.61 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 174.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.1 0.5 6.53 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.858 2.372 . . . . 0.0 113.598 -168.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -162.76 128.0 3.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.153 0.501 . . . . 0.0 111.029 -176.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.426 HG23 ' HB ' ' A' ' 56' ' ' VAL . 92.8 t -114.23 111.23 35.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.478 174.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.83 112.15 23.85 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.679 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.476 HD23 ' HB2' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -130.51 168.44 17.04 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.57 -175.522 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 6.5 t0 -115.25 99.92 7.76 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.344 0.592 . . . . 0.0 110.33 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.656 HD21 HD23 ' E' ' 88' ' ' LEU . 17.7 mt -114.59 141.23 48.03 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.667 177.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.429 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 6.2 t30 -146.62 115.32 6.81 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.975 0.417 . . . . 0.0 110.053 174.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -110.18 159.93 16.94 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.0 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.7 p -112.4 149.61 32.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.551 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.426 ' HG3' ' H ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -71.46 10.45 0.62 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -175.645 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.68 -21.39 14.48 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.087 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -101.23 171.39 7.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.777 0.322 . . . . 0.0 110.883 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 -137.72 129.3 28.23 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.638 HG22 ' HB2' ' A' ' 46' ' ' ALA . 14.5 pt -129.24 163.04 35.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.062 0.458 . . . . 0.0 111.691 -170.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.544 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 4.8 mtm -118.3 122.82 43.85 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 175.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.537 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 1.0 OUTLIER -105.05 127.69 52.99 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.171 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.694 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 49.5 p90 -155.9 150.6 26.12 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.508 -177.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.711 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 11.2 p -117.2 149.12 40.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.735 -178.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.04 144.6 42.33 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.247 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.19 176.99 34.69 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -175.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -106.47 102.8 12.17 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.932 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.549 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -170.75 151.25 3.43 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.574 169.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.6 t -108.14 121.6 45.17 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.631 HG12 ' HB3' ' A' ' 34' ' ' LEU . 11.4 m -118.54 146.19 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 CA-C-O 121.435 0.636 . . . . 0.0 111.666 -173.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.2 t -111.88 120.94 43.62 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.727 HD13 HD23 ' A' ' 11' ' ' LEU . 5.1 mp -93.0 151.63 19.78 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 174.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.635 HD23 HD21 ' B' ' 67' ' ' LEU . 1.6 tp -133.58 141.11 47.53 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.162 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.16 -166.67 26.63 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.825 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.43 ' CD2' ' HB3' ' B' ' 68' ' ' ASN . 8.1 p90 -150.96 130.16 12.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.754 0.788 . . . . 0.0 111.698 176.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.549 HD23 ' HB3' ' A' ' 27' ' ' PHE . 5.3 mt -72.97 136.24 45.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.886 176.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -79.21 108.94 13.09 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 174.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -114.8 -177.16 3.06 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -176.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.429 HD12 ' N ' ' A' ' 94' ' ' ILE . 4.2 mp -105.2 -35.96 3.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 25.2 t70 65.87 135.51 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.366 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.2 p -88.6 6.41 38.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.929 -176.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.73 -65.07 3.77 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.678 -0.773 . . . . 0.0 111.399 -177.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.8 p . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.793 -0.622 . . . . 0.0 109.712 176.988 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 64.11 -165.08 0.24 Allowed 'General case' 0 C--O 1.235 0.334 0 O-C-N 123.771 0.669 . . . . 0.0 111.386 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 101.99 102.34 2.62 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.771 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.47 133.38 52.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.909 0.385 . . . . 0.0 111.201 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 75.9 mtm -99.08 141.27 32.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.606 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -110.15 155.01 22.52 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.345 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 59.9 mtt -111.63 139.98 46.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.965 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.483 ' CE1' HD21 ' C' ' 44' ' ' LEU . 73.9 t80 -54.97 144.03 24.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.853 -173.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . 0.589 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 89.5 t90 -139.38 148.6 43.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.971 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.587 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -149.85 153.44 25.11 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.828 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.735 HD23 HD13 ' B' ' 87' ' ' LEU . 59.5 tp -139.04 108.71 6.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.774 0.321 . . . . 0.0 111.197 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -80.35 105.84 11.92 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.706 173.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . 0.611 ' HB3' HG23 ' B' ' 85' ' ' VAL . 35.6 tpp -99.53 132.44 44.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.156 0.503 . . . . 0.0 110.87 -176.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -98.61 146.61 31.9 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.915 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.525 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 10.3 Cg_endo -53.68 115.86 2.61 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 123.425 2.75 . . . . 0.0 113.134 -176.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.709 ' HA ' ' O ' ' B' ' 79' ' ' THR . 34.6 mt-10 63.5 38.02 10.1 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.666 177.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -109.31 149.84 28.86 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.69 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 34.3 ttmt -125.95 119.23 27.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.774 0.321 . . . . 0.0 111.617 -174.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' TYR . . . . . 0.48 ' OH ' ' HA ' ' B' ' 13' ' ' MET . 3.6 m-85 -110.54 104.94 13.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.399 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 11.9 p -87.59 99.4 12.02 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 171.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -125.27 148.81 48.53 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.616 0.722 . . . . 0.0 112.5 -166.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 11.5 t -92.46 160.34 15.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.998 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 68.0 mt -106.28 117.69 52.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.085 0.469 . . . . 0.0 110.823 -175.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.463 ' H ' HD12 ' B' ' 24' ' ' ILE . 4.1 mp -79.27 -45.36 23.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.984 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.401 ' HE3' ' OD2' ' B' ' 93' ' ' ASP . 35.0 mtmm -135.19 140.24 45.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.757 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 17.8 m -55.92 124.03 16.3 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 123.639 0.587 . . . . 0.0 109.646 177.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . 0.559 ' HB3' HD23 ' B' ' 91' ' ' LEU . 3.9 p90 -140.03 158.57 43.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.704 0.764 . . . . 0.0 112.739 -171.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' HIS . . . . . 0.576 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 14.2 t60 -112.86 126.05 55.03 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.07 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.608 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 44.0 mt -96.3 133.44 37.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 170.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.576 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 41.5 p -118.47 -15.04 9.67 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -170.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.87 151.97 22.52 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 119.276 -1.44 . . . . 0.0 113.456 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.463 HG23 ' HG ' ' B' ' 87' ' ' LEU . 9.1 p -140.74 123.88 16.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 171.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . 0.405 ' HA ' HG21 ' B' ' 56' ' ' VAL . . . -143.5 154.63 43.84 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.486 -0.485 . . . . 0.0 112.085 -172.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.636 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.3 pp -118.28 138.88 52.07 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.627 0.727 . . . . 0.0 111.155 177.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -110.17 -47.56 3.29 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.404 172.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -103.2 127.44 50.49 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.167 170.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.455 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 147.26 162.99 10.3 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 119.696 -1.24 . . . . 0.0 113.405 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . 0.464 ' O ' ' HG3' ' B' ' 58' ' ' LYS . 8.3 tt0 -102.16 -48.3 4.26 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.474 0.178 . . . . 0.0 111.149 178.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -153.07 137.77 16.96 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.713 -0.222 . . . . 0.0 110.652 176.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.542 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -136.31 114.89 11.9 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.279 0.561 . . . . 0.0 111.196 171.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' B' ' 79' ' ' THR . 68.1 mttm -95.03 114.99 26.86 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 171.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.406 HD23 ' HB ' ' B' ' 53' ' ' VAL . 38.1 tp -84.06 116.25 22.77 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -176.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . 0.409 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 93.9 m-85 -117.09 143.79 45.39 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.539 177.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.561 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.1 OUTLIER -131.63 131.71 43.44 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 172.657 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -111.88 118.1 34.59 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.087 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.631 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -130.44 133.67 46.51 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.444 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 56.07 38.78 30.27 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.516 0.51 . . . . 0.0 110.675 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm 65.9 22.44 11.35 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.344 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.574 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 28.9 mm-40 -113.32 124.5 52.61 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 177.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -87.52 116.92 25.97 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.554 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 72.3 m-85 -111.68 131.06 55.55 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.749 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -81.27 103.42 8.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 170.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.47 HG13 ' CD2' ' A' ' 88' ' ' LEU . 2.3 t -76.87 -47.65 27.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.476 -172.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.471 ' HB2' HD23 ' B' ' 65' ' ' LEU . . . -156.69 151.49 25.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.334 -178.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 99.9 m -114.78 101.77 9.38 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 169.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.474 HG11 HG11 ' B' ' 85' ' ' VAL . 7.4 p -113.0 114.07 45.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.578 0.704 . . . . 0.0 109.755 -177.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 76.3 p -123.27 -177.79 3.8 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.445 -174.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' B' ' 38' ' ' GLN . 28.8 mtpp -57.16 -36.18 70.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.073 0.463 . . . . 0.0 110.331 168.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.43 -41.19 66.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.503 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 76.3 mt -115.67 82.68 10.45 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 174.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.09 0.37 6.74 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.992 2.461 . . . . 0.0 113.606 -168.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -162.66 128.01 3.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.263 0.554 . . . . 0.0 111.005 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.432 HG23 ' HB ' ' B' ' 56' ' ' VAL . 94.9 t -114.13 111.24 35.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.54 174.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.81 112.0 23.62 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.728 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.471 HD23 ' HB2' ' B' ' 54' ' ' ALA . 0.3 OUTLIER -130.43 168.46 16.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.558 -175.497 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . 0.49 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 6.5 t0 -115.26 99.96 7.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.298 0.57 . . . . 0.0 110.405 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.635 HD21 HD23 ' A' ' 88' ' ' LEU . 17.7 mt -114.58 141.3 47.94 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.66 177.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . 0.43 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 6.3 t30 -146.71 115.27 6.76 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.013 0.435 . . . . 0.0 110.074 174.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -110.22 159.92 16.96 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.929 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 10.3 p -112.45 149.56 32.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.544 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.422 ' H ' ' HG3' ' B' ' 71' ' ' LYS . 0.0 OUTLIER -71.4 10.52 0.6 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -175.592 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.71 -21.51 14.21 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.118 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -101.13 171.39 7.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.775 0.321 . . . . 0.0 110.901 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 -137.76 129.49 28.44 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.631 HG22 ' HB2' ' B' ' 46' ' ' ALA . 14.7 pt -129.36 162.95 35.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.027 0.441 . . . . 0.0 111.703 -170.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.561 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 4.8 mtm -118.28 122.87 44.0 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 175.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . 0.54 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 1.0 OUTLIER -105.12 127.72 53.03 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.183 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.69 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 49.3 p90 -155.93 150.63 26.09 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.471 -177.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.709 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 11.2 p -117.32 149.08 41.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.922 0.392 . . . . 0.0 111.679 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.06 144.54 42.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.269 174.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.25 176.96 34.6 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -106.5 102.8 12.17 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.932 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.542 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -170.82 151.28 3.38 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.527 169.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 23.6 t -108.31 121.61 45.26 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.636 HG12 ' HB3' ' B' ' 34' ' ' LEU . 11.6 m -118.41 146.19 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 CA-C-O 121.406 0.622 . . . . 0.0 111.665 -173.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 15.3 t -111.87 120.86 43.37 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.735 HD13 HD23 ' B' ' 11' ' ' LEU . 5.0 mp -92.91 151.57 19.88 Favored 'General case' 0 CA--C 1.502 -0.895 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.64 174.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.618 HD23 HD21 ' C' ' 67' ' ' LEU . 1.6 tp -133.49 141.12 47.63 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.129 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.2 -166.69 26.71 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.812 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' TYR . . . . . 0.421 ' CD2' ' HB3' ' C' ' 68' ' ' ASN . 8.2 p90 -150.89 130.13 12.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.679 0.752 . . . . 0.0 111.778 176.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . 0.559 HD23 ' HB3' ' B' ' 27' ' ' PHE . 5.4 mt -72.92 136.26 45.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.238 -1.346 . . . . 0.0 109.933 176.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -79.17 108.82 12.95 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . 0.401 ' OD2' ' HE3' ' B' ' 25' ' ' LYS . 7.7 t70 -114.73 -177.05 3.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.752 -177.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . 0.436 ' N ' HD12 ' B' ' 94' ' ' ILE . 4.2 mp -105.26 -35.96 3.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 25.3 t70 65.82 135.57 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.366 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 11.3 p -88.64 6.63 37.4 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.931 -176.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.64 -65.1 3.74 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.471 -177.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 15.2 p . . . . . 0 C--O 1.252 1.191 0 CA-C-O 118.856 -0.592 . . . . 0.0 109.75 177.083 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 64.3 -165.13 0.24 Allowed 'General case' 0 C--O 1.235 0.3 0 O-C-N 123.68 0.613 . . . . 0.0 111.375 176.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . 102.03 102.33 2.62 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.793 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.53 133.42 52.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.995 0.426 . . . . 0.0 111.151 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 76.1 mtm -99.08 141.21 32.13 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.569 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 6' ' ' ALA . . . . . . . . . . . . . . . -110.11 155.06 22.41 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.347 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 59.9 mtt -111.7 139.87 46.8 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.906 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 8' ' ' PHE . . . . . 0.466 ' CE1' HD21 ' D' ' 44' ' ' LEU . 74.0 t80 -54.91 144.02 24.27 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.878 -173.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . 0.581 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 89.6 t90 -139.25 148.74 43.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.98 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . 0.543 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -149.97 153.44 25.09 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.764 177.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.716 HD23 HD13 ' C' ' 87' ' ' LEU . 59.5 tp -139.15 108.86 6.24 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.945 0.402 . . . . 0.0 111.093 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -80.35 105.7 11.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.751 173.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 13' ' ' MET . . . . . 0.615 ' HB3' HG23 ' C' ' 85' ' ' VAL . 35.8 tpp -99.48 132.27 44.93 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.116 0.484 . . . . 0.0 110.852 -176.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -98.47 146.53 31.74 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.013 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . 0.53 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 10.3 Cg_endo -53.62 115.95 2.67 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 123.362 2.708 . . . . 0.0 113.161 -176.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . 0.712 ' HA ' ' O ' ' C' ' 79' ' ' THR . 34.6 mt-10 63.4 38.07 10.33 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.699 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -109.3 149.85 28.85 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 173.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 18' ' ' LYS . . . . . 0.691 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 34.4 ttmt -126.05 119.26 27.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.748 0.309 . . . . 0.0 111.583 -174.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . 0.467 ' OH ' ' HA ' ' C' ' 13' ' ' MET . 3.6 m-85 -110.56 104.98 13.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.434 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 11.9 p -87.61 99.47 12.08 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 171.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -125.42 148.84 48.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.589 0.709 . . . . 0.0 112.462 -166.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 11.4 t -92.51 160.4 15.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.997 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -106.27 117.73 52.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.091 0.472 . . . . 0.0 110.824 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . 0.471 HD12 ' H ' ' C' ' 24' ' ' ILE . 4.1 mp -79.26 -45.44 23.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.965 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -135.16 140.3 45.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.707 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 18.0 m -56.03 124.15 16.78 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.582 0.551 . . . . 0.0 109.582 177.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 27' ' ' PHE . . . . . 0.562 ' HB3' HD23 ' C' ' 91' ' ' LEU . 3.9 p90 -140.08 158.5 43.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.739 0.781 . . . . 0.0 112.78 -171.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 28' ' ' HIS . . . . . 0.582 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 14.2 t60 -112.77 125.97 54.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.104 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 44.2 mt -96.28 133.44 37.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.582 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 41.1 p -118.49 -14.98 9.66 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -170.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.91 151.84 22.35 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 119.314 -1.422 . . . . 0.0 113.508 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.456 HG23 ' HG ' ' C' ' 87' ' ' LEU . 9.0 p -140.74 123.89 16.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 171.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.42 ' HA ' HG21 ' C' ' 56' ' ' VAL . . . -143.56 154.59 43.75 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.397 -0.521 . . . . 0.0 112.077 -172.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.617 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.3 pp -118.14 138.86 52.0 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.685 0.755 . . . . 0.0 111.241 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -110.19 -47.52 3.29 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.772 -1.103 . . . . 0.0 108.464 172.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -103.17 127.51 50.44 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.227 170.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 37' ' ' GLY . . . . . 0.454 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 147.21 163.06 10.32 Favored Glycine 0 N--CA 1.439 -1.111 0 C-N-CA 119.718 -1.229 . . . . 0.0 113.442 177.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 38' ' ' GLN . . . . . 0.456 ' O ' ' HG3' ' C' ' 58' ' ' LYS . 8.4 tt0 -102.28 -48.27 4.25 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.483 0.183 . . . . 0.0 111.122 178.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -153.07 137.77 16.96 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 122.162 0.185 . . . . 0.0 110.714 176.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.534 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -136.27 114.92 11.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.292 0.568 . . . . 0.0 111.171 171.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' C' ' 79' ' ' THR . 68.1 mttm -95.0 114.91 26.77 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 171.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.411 HD23 ' HB ' ' C' ' 53' ' ' VAL . 37.9 tp -84.04 116.26 22.76 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -176.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 43' ' ' TYR . . . . . 0.401 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 93.9 m-85 -117.09 143.77 45.42 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 177.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' C' ' 76' ' ' MET . 0.1 OUTLIER -131.66 131.64 43.32 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 172.662 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . 0.582 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -111.89 118.16 34.76 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.164 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.649 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -130.43 133.58 46.45 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.45 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 56.12 38.79 30.24 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.524 0.515 . . . . 0.0 110.654 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm 65.9 22.35 11.35 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.362 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . 0.582 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 29.0 mm-40 -113.25 124.46 52.57 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -87.48 116.93 25.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.928 0.394 . . . . 0.0 110.046 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . 0.587 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 72.5 m-85 -111.72 131.02 55.58 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.743 177.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -81.33 103.35 8.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 171.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 53' ' ' VAL . . . . . 0.499 HG13 ' CD2' ' B' ' 88' ' ' LEU . 2.3 t -76.87 -47.6 27.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.491 -172.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 54' ' ' ALA . . . . . 0.474 ' HB2' HD23 ' C' ' 65' ' ' LEU . . . -156.68 151.5 25.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.303 -178.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 99.6 m -114.74 101.69 9.31 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 169.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . 0.471 HG11 HG11 ' C' ' 85' ' ' VAL . 7.4 p -112.92 114.04 45.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.596 0.712 . . . . 0.0 109.781 -177.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 77.4 p -123.26 -177.74 3.78 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.496 -174.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 58' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' C' ' 38' ' ' GLN . 28.8 mtpp -57.2 -36.18 70.53 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.032 0.444 . . . . 0.0 110.378 168.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.35 -41.16 66.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.521 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 76.5 mt -115.76 82.77 10.78 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 174.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.11 0.44 6.64 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.865 2.377 . . . . 0.0 113.662 -168.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -162.66 128.06 3.29 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.139 0.495 . . . . 0.0 111.087 -176.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.431 HG23 ' HB ' ' C' ' 56' ' ' VAL . 92.1 t -114.29 111.36 35.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.439 174.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.85 112.04 23.7 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.698 174.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . 0.474 HD23 ' HB2' ' C' ' 54' ' ' ALA . 0.3 OUTLIER -130.45 168.44 17.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.069 0.461 . . . . 0.0 111.599 -175.518 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 66' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 6.6 t0 -115.23 99.95 7.78 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.345 0.593 . . . . 0.0 110.386 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.618 HD21 HD23 ' B' ' 88' ' ' LEU . 17.7 mt -114.58 141.22 48.03 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.695 177.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . 0.421 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 6.3 t30 -146.66 115.27 6.78 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.92 0.391 . . . . 0.0 110.043 174.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -110.07 159.93 16.89 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.061 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 10.7 p -112.49 149.49 32.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.557 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . 0.416 ' H ' ' HG3' ' C' ' 71' ' ' LYS . 0.0 OUTLIER -71.38 10.41 0.62 Allowed 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -175.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.63 -21.51 14.35 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.111 176.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -101.15 171.31 7.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.787 0.327 . . . . 0.0 110.828 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 -137.72 129.46 28.47 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.649 HG22 ' HB2' ' C' ' 46' ' ' ALA . 14.8 pt -129.35 163.01 35.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.104 0.478 . . . . 0.0 111.696 -169.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.544 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 4.8 mtm -118.41 122.89 43.9 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 175.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 77' ' ' PHE . . . . . 0.535 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 1.0 OUTLIER -105.08 127.77 53.04 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 177.204 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 78' ' ' TYR . . . . . 0.691 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 49.3 p90 -155.95 150.65 26.1 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.494 -177.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . 0.712 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 11.0 p -117.34 149.14 40.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.898 0.38 . . . . 0.0 111.622 -178.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.11 144.62 42.34 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.323 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.19 176.93 34.69 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -175.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -106.49 102.75 12.12 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.062 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . 0.534 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -170.7 151.26 3.46 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.557 169.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 23.4 t -108.19 121.57 45.14 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.617 HG12 ' HB3' ' C' ' 34' ' ' LEU . 11.6 m -118.49 146.24 23.35 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-O 121.403 0.62 . . . . 0.0 111.663 -173.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 15.2 t -111.94 120.88 43.41 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . 0.716 HD13 HD23 ' C' ' 11' ' ' LEU . 5.0 mp -92.92 151.68 19.81 Favored 'General case' 0 CA--C 1.502 -0.894 0 C-N-CA 120.364 -0.534 . . . . 0.0 109.646 174.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . 0.65 HD23 HD21 ' D' ' 67' ' ' LEU . 1.6 tp -133.58 141.11 47.53 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.156 -178.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.21 -166.72 26.77 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.825 -0.703 . . . . 0.0 111.86 -176.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 90' ' ' TYR . . . . . 0.438 ' CD2' ' HB3' ' D' ' 68' ' ' ASN . 8.3 p90 -150.86 130.1 12.77 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.632 0.729 . . . . 0.0 111.765 176.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . 0.562 HD23 ' HB3' ' C' ' 27' ' ' PHE . 5.2 mt -72.93 136.2 45.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.253 -1.339 . . . . 0.0 109.93 176.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -79.16 108.87 12.98 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -114.73 -177.07 3.04 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.727 -176.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . 0.431 ' N ' HD12 ' C' ' 94' ' ' ILE . 4.2 mp -105.31 -35.91 3.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 25.2 t70 65.77 135.71 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.302 -176.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 11.3 p -88.71 6.51 38.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.84 -176.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.6 -64.97 3.75 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.395 -177.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 15.3 p . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.913 -0.565 . . . . 0.0 109.698 177.071 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 64.12 -165.09 0.24 Allowed 'General case' 0 C--O 1.235 0.312 0 O-C-N 123.715 0.635 . . . . 0.0 111.439 176.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . 101.93 102.4 2.62 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.893 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.53 133.45 52.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.893 0.378 . . . . 0.0 111.107 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 76.0 mtm -99.1 141.34 31.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.612 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 6' ' ' ALA . . . . . . . . . . . . . . . -110.22 154.99 22.6 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.351 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 59.9 mtt -111.68 139.95 46.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.924 0.392 . . . . 0.0 110.872 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 8' ' ' PHE . . . . . 0.48 ' CE1' HD21 ' E' ' 44' ' ' LEU . 74.2 t80 -55.01 144.06 24.55 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.849 -173.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 9' ' ' TRP . . . . . 0.589 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 89.7 t90 -139.29 148.7 43.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.987 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . 0.566 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -149.95 153.44 25.1 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.812 -0.708 . . . . 0.0 111.755 177.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.73 HD23 HD13 ' D' ' 87' ' ' LEU . 58.9 tp -139.13 108.81 6.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.965 0.412 . . . . 0.0 111.094 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -80.35 105.75 11.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.685 173.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 13' ' ' MET . . . . . 0.6 ' HB3' HG23 ' D' ' 85' ' ' VAL . 35.7 tpp -99.52 132.31 44.94 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.067 0.46 . . . . 0.0 110.942 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -98.57 146.55 31.79 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.95 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . 0.518 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 10.5 Cg_endo -53.52 115.85 2.59 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 123.428 2.752 . . . . 0.0 113.154 -176.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . 0.723 ' HA ' ' O ' ' D' ' 79' ' ' THR . 34.3 mt-10 63.42 38.14 10.22 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.617 177.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -109.37 149.82 28.95 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 173.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . 0.691 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 34.4 ttmt -125.96 119.22 27.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.771 0.319 . . . . 0.0 111.59 -174.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 19' ' ' TYR . . . . . 0.473 ' OH ' ' HA ' ' D' ' 13' ' ' MET . 3.6 m-85 -110.51 104.9 13.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.402 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . 0.401 ' HB3' ' SD ' ' D' ' 76' ' ' MET . 11.7 p -87.69 99.43 12.07 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 171.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -125.25 148.7 48.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.492 0.663 . . . . 0.0 112.564 -166.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 11.4 t -92.32 160.35 15.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.049 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 68.0 mt -106.31 117.71 52.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.059 0.457 . . . . 0.0 110.771 -175.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . 0.476 HD12 ' H ' ' D' ' 24' ' ' ILE . 4.2 mp -79.26 -45.42 23.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.96 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . 0.4 ' HE3' ' OD2' ' D' ' 93' ' ' ASP . 35.0 mtmm -135.14 140.28 45.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.759 178.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 18.2 m -56.02 124.17 16.84 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 123.547 0.529 . . . . 0.0 109.595 177.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 27' ' ' PHE . . . . . 0.556 ' HB3' HD23 ' D' ' 91' ' ' LEU . 3.9 p90 -140.16 158.56 43.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.65 0.738 . . . . 0.0 112.731 -171.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 28' ' ' HIS . . . . . 0.577 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 14.1 t60 -112.87 125.99 54.97 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.048 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 29' ' ' ILE . . . . . 0.59 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 43.9 mt -96.3 133.46 37.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . 0.577 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 42.4 p -118.53 -14.96 9.63 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -170.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.91 151.93 22.46 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 119.4 -1.381 . . . . 0.0 113.489 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.45 HG23 ' HG ' ' D' ' 87' ' ' LEU . 9.1 p -140.87 123.85 16.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 171.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . 0.417 ' HA ' HG21 ' D' ' 56' ' ' VAL . . . -143.48 154.61 43.83 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.419 -0.512 . . . . 0.0 112.076 -172.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 34' ' ' LEU . . . . . 0.619 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.3 pp -118.2 138.86 52.04 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.669 0.747 . . . . 0.0 111.222 177.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -110.1 -47.55 3.3 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.475 172.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -103.2 127.52 50.47 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.176 170.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . 0.451 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 147.3 162.99 10.31 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 119.659 -1.258 . . . . 0.0 113.364 177.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 38' ' ' GLN . . . . . 0.461 ' O ' ' HG3' ' D' ' 58' ' ' LYS . 8.4 tt0 -102.21 -48.32 4.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.524 0.202 . . . . 0.0 111.155 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -153.0 137.84 17.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.784 -0.189 . . . . 0.0 110.667 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . 0.535 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -136.37 114.91 11.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.37 0.605 . . . . 0.0 111.126 171.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' D' ' 79' ' ' THR . 68.1 mttm -95.01 114.92 26.78 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 171.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.411 HD23 ' HB ' ' D' ' 53' ' ' VAL . 38.0 tp -83.99 116.13 22.67 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -176.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 43' ' ' TYR . . . . . 0.41 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 94.4 m-85 -117.03 143.74 45.4 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.548 ' HA ' ' O ' ' D' ' 76' ' ' MET . 0.1 OUTLIER -131.62 131.77 43.5 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 172.699 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 45' ' ' ALA . . . . . 0.582 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -111.97 118.1 34.55 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.131 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.657 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -130.43 133.59 46.46 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.485 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 56.19 38.8 30.19 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 123.452 0.47 . . . . 0.0 110.591 -175.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm 65.94 22.43 11.31 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.214 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . 0.582 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 29.1 mm-40 -113.28 124.54 52.74 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -87.55 116.87 25.97 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . 0.543 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 72.3 m-85 -111.64 131.03 55.56 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.798 177.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -81.3 103.32 8.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 171.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 53' ' ' VAL . . . . . 0.499 HG13 ' CD2' ' C' ' 88' ' ' LEU . 2.3 t -76.76 -47.61 28.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.523 -172.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 54' ' ' ALA . . . . . 0.476 ' HB2' HD23 ' D' ' 65' ' ' LEU . . . -156.74 151.5 25.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.296 -178.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 99.9 m -114.74 101.64 9.26 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 169.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 56' ' ' VAL . . . . . 0.475 HG11 HG11 ' D' ' 85' ' ' VAL . 7.4 p -112.97 114.14 46.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.584 0.707 . . . . 0.0 109.777 -177.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 75.7 p -123.26 -177.82 3.81 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.495 -174.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 58' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' D' ' 38' ' ' GLN . 28.8 mtpp -57.2 -36.08 70.41 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.12 0.486 . . . . 0.0 110.43 168.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.4 -41.14 66.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.562 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 76.0 mt -115.72 82.69 10.59 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.03 0.42 6.63 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.839 2.359 . . . . 0.0 113.652 -168.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -162.64 128.22 3.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.154 0.502 . . . . 0.0 111.014 -176.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.425 HG23 ' HB ' ' D' ' 56' ' ' VAL . 92.7 t -114.39 111.36 35.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.433 174.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.93 112.01 23.7 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.678 174.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 65' ' ' LEU . . . . . 0.476 HD23 ' HB2' ' D' ' 54' ' ' ALA . 0.3 OUTLIER -130.41 168.56 16.77 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.065 0.46 . . . . 0.0 111.556 -175.518 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 66' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 6.5 t0 -115.32 99.99 7.79 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.33 0.586 . . . . 0.0 110.398 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.65 HD21 HD23 ' C' ' 88' ' ' LEU . 17.7 mt -114.66 141.32 47.95 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.561 177.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 68' ' ' ASN . . . . . 0.438 ' HB3' ' CD2' ' C' ' 90' ' ' TYR . 6.2 t30 -146.71 115.28 6.76 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.006 0.431 . . . . 0.0 110.083 173.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -110.11 159.93 16.91 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.012 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 10.0 p -112.56 149.59 32.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.479 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.56 10.59 0.61 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -175.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.72 -21.38 14.44 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.131 176.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -101.21 171.41 7.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.839 0.352 . . . . 0.0 110.859 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 -137.72 129.33 28.28 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.657 HG22 ' HB2' ' D' ' 46' ' ' ALA . 14.7 pt -129.3 162.94 35.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.088 0.47 . . . . 0.0 111.707 -169.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 76' ' ' MET . . . . . 0.548 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 4.8 mtm -118.22 122.79 43.87 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 175.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 77' ' ' PHE . . . . . 0.536 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 1.0 OUTLIER -105.03 127.77 53.02 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 177.209 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 78' ' ' TYR . . . . . 0.691 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 49.5 p90 -155.9 150.57 26.08 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.491 -177.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 79' ' ' THR . . . . . 0.723 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 11.1 p -117.23 149.19 40.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.935 0.397 . . . . 0.0 111.698 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.14 144.71 42.19 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.202 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.2 176.98 34.67 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -175.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -106.5 102.84 12.21 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.97 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . 0.535 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -170.82 151.27 3.38 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.486 169.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 23.5 t -108.21 121.49 44.98 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.619 HG12 ' HB3' ' D' ' 34' ' ' LEU . 11.7 m -118.41 146.18 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 CA-C-O 121.416 0.627 . . . . 0.0 111.69 -173.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 15.4 t -111.87 120.88 43.43 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 87' ' ' LEU . . . . . 0.73 HD13 HD23 ' D' ' 11' ' ' LEU . 5.0 mp -92.86 151.58 19.9 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 120.452 -0.499 . . . . 0.0 109.658 174.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.675 HD23 HD21 ' E' ' 67' ' ' LEU . 1.6 tp -133.55 141.18 47.6 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.081 -178.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.24 -166.7 26.76 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.799 -176.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 90' ' ' TYR . . . . . 0.463 ' CD2' ' HB3' ' E' ' 68' ' ' ASN . 8.2 p90 -150.95 130.12 12.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.742 0.782 . . . . 0.0 111.781 176.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . 0.556 HD23 ' HB3' ' D' ' 27' ' ' PHE . 5.3 mt -72.91 136.17 45.19 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.957 176.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -79.13 108.79 12.88 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 93' ' ' ASP . . . . . 0.4 ' OD2' ' HE3' ' D' ' 25' ' ' LYS . 7.7 t70 -114.7 -177.14 3.06 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -176.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . 0.432 ' N ' HD12 ' D' ' 94' ' ' ILE . 4.2 mp -105.26 -35.9 3.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 25.2 t70 65.78 135.52 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.352 -176.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 11.2 p -88.65 6.54 37.91 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.906 -176.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.6 -64.94 3.76 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.481 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 15.1 p . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.913 -0.565 . . . . 0.0 109.728 177.02 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 64.16 -165.08 0.24 Allowed 'General case' 0 C--O 1.236 0.361 0 O-C-N 123.686 0.616 . . . . 0.0 111.385 176.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . 102.04 102.25 2.62 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.804 -0.713 . . . . 0.0 111.851 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.47 133.49 52.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.922 0.391 . . . . 0.0 111.168 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 76.0 mtm -99.2 141.33 32.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.56 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 6' ' ' ALA . . . . . . . . . . . . . . . -110.09 154.94 22.55 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.399 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 59.9 mtt -111.67 139.97 46.68 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.943 0.401 . . . . 0.0 110.859 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 8' ' ' PHE . . . . . 0.475 ' CE1' HD21 ' A' ' 44' ' ' LEU . 74.2 t80 -54.92 144.03 24.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.805 -173.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 9' ' ' TRP . . . . . 0.574 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 89.5 t90 -139.38 148.63 43.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.96 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 10' ' ' GLY . . . . . 0.569 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -149.88 153.43 25.1 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.79 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . 0.744 HD23 HD13 ' E' ' 87' ' ' LEU . 59.2 tp -139.06 108.79 6.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.898 0.38 . . . . 0.0 111.144 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -80.28 105.71 11.75 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.769 173.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 13' ' ' MET . . . . . 0.594 ' HB3' HG23 ' E' ' 85' ' ' VAL . 35.5 tpp -99.5 132.32 44.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.117 0.484 . . . . 0.0 110.935 -176.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -98.56 146.67 31.99 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.945 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . 0.52 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 10.4 Cg_endo -53.73 115.96 2.68 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 123.4 2.734 . . . . 0.0 113.104 -176.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 16' ' ' GLU . . . . . 0.727 ' HA ' ' O ' ' E' ' 79' ' ' THR . 34.6 mt-10 63.35 38.17 10.37 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.69 177.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -109.41 149.9 28.87 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 173.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . 0.686 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 34.4 ttmt -125.99 119.19 27.04 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.736 0.303 . . . . 0.0 111.613 -174.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . 0.471 ' OH ' ' HA ' ' E' ' 13' ' ' MET . 3.5 m-85 -110.44 104.86 13.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.546 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 12.0 p -87.54 99.47 12.06 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 171.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -125.41 148.77 48.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.537 0.684 . . . . 0.0 112.517 -166.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 11.5 t -92.45 160.27 15.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.989 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 68.1 mt -106.25 117.66 52.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.082 0.468 . . . . 0.0 110.894 -175.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . 0.465 HD12 ' H ' ' E' ' 24' ' ' ILE . 4.1 mp -79.19 -45.42 24.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.977 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -135.13 140.23 45.27 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.775 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 18.0 m -56.06 124.09 16.62 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 123.619 0.574 . . . . 0.0 109.648 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 27' ' ' PHE . . . . . 0.566 ' HB3' HD23 ' E' ' 91' ' ' LEU . 3.9 p90 -140.04 158.53 43.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.725 0.774 . . . . 0.0 112.765 -171.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 28' ' ' HIS . . . . . 0.58 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 14.3 t60 -112.72 125.99 54.92 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.159 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 29' ' ' ILE . . . . . 0.604 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 44.2 mt -96.29 133.41 37.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 170.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . 0.58 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 43.3 p -118.49 -14.93 9.66 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -170.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.86 151.93 22.47 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 119.373 -1.394 . . . . 0.0 113.566 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.46 HG23 ' HG ' ' E' ' 87' ' ' LEU . 9.1 p -140.81 123.86 16.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 171.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . 0.407 ' HA ' HG21 ' E' ' 56' ' ' VAL . . . -143.52 154.54 43.73 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.493 -0.483 . . . . 0.0 112.082 -172.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 34' ' ' LEU . . . . . 0.615 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.3 pp -118.2 138.89 52.01 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.714 0.769 . . . . 0.0 111.222 177.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -110.2 -47.44 3.3 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.485 172.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -103.28 127.47 50.6 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.201 170.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . 0.458 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 147.27 162.9 10.25 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 119.673 -1.251 . . . . 0.0 113.463 177.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 38' ' ' GLN . . . . . 0.457 ' O ' ' HG3' ' E' ' 58' ' ' LYS . 8.4 tt0 -102.22 -48.16 4.29 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.559 0.219 . . . . 0.0 111.143 178.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -153.11 137.76 16.91 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.781 -0.191 . . . . 0.0 110.639 176.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . 0.541 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -136.32 114.97 11.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.318 0.58 . . . . 0.0 111.147 171.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 41' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' E' ' 79' ' ' THR . 68.1 mttm -95.09 114.99 26.85 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 171.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.401 HD23 ' HB ' ' E' ' 53' ' ' VAL . 37.9 tp -84.05 116.17 22.72 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -176.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 43' ' ' TYR . . . . . 0.411 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 94.2 m-85 -117.05 143.72 45.43 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.501 177.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 44' ' ' LEU . . . . . 0.545 ' HA ' ' O ' ' E' ' 76' ' ' MET . 0.1 OUTLIER -131.59 131.66 43.45 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 172.653 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 45' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -111.88 118.07 34.51 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.158 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . 0.636 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -130.42 133.62 46.5 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.485 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 56.11 38.85 30.31 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.457 0.473 . . . . 0.0 110.587 -175.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm 65.96 22.48 11.28 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.259 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 49' ' ' GLN . . . . . 0.576 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 29.2 mm-40 -113.36 124.54 52.71 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -87.57 116.84 25.96 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.847 0.356 . . . . 0.0 110.064 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . 0.566 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 72.1 m-85 -111.61 131.02 55.56 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.798 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -81.35 103.45 8.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 171.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . 0.512 HG13 ' CD2' ' D' ' 88' ' ' LEU . 2.3 t -76.89 -47.59 27.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.495 -172.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 54' ' ' ALA . . . . . 0.463 ' HB2' HD23 ' E' ' 65' ' ' LEU . . . -156.71 151.56 25.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.286 -178.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 99.9 m -114.82 101.64 9.25 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 169.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . 0.482 HG11 HG11 ' E' ' 85' ' ' VAL . 7.4 p -112.92 114.07 45.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.626 0.727 . . . . 0.0 109.818 -177.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 75.4 p -123.23 -177.77 3.79 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.545 -174.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 58' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' E' ' 38' ' ' GLN . 28.8 mtpp -57.2 -36.25 70.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.074 0.464 . . . . 0.0 110.276 169.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.3 -41.13 66.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.508 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 76.4 mt -115.78 82.7 10.74 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.12 0.48 6.58 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.865 2.376 . . . . 0.0 113.707 -168.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -162.65 128.1 3.3 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.247 0.546 . . . . 0.0 111.048 -176.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . 0.421 HG23 ' HB ' ' E' ' 56' ' ' VAL . 92.7 t -114.32 111.35 35.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.412 174.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.96 112.13 23.88 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.602 174.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.463 HD23 ' HB2' ' E' ' 54' ' ' ALA . 0.3 OUTLIER -130.51 168.44 17.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.095 0.474 . . . . 0.0 111.515 -175.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 66' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 6.5 t0 -115.22 99.97 7.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.322 0.582 . . . . 0.0 110.343 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 67' ' ' LEU . . . . . 0.675 HD21 HD23 ' D' ' 88' ' ' LEU . 17.7 mt -114.61 141.35 47.89 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.621 177.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 68' ' ' ASN . . . . . 0.463 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 6.3 t30 -146.69 115.2 6.74 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.99 0.424 . . . . 0.0 110.086 174.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -110.11 159.91 16.93 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.029 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 10.2 p -112.47 149.56 32.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.47 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 71' ' ' LYS . . . . . 0.425 ' H ' ' HG3' ' E' ' 71' ' ' LYS . 0.0 OUTLIER -71.41 10.4 0.62 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -175.596 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.67 -21.39 14.51 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.116 176.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -101.23 171.34 7.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.75 0.309 . . . . 0.0 110.865 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 -137.76 129.4 28.3 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 75' ' ' ILE . . . . . 0.636 HG22 ' HB2' ' E' ' 46' ' ' ALA . 14.6 pt -129.21 162.96 35.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.012 0.434 . . . . 0.0 111.726 -169.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 76' ' ' MET . . . . . 0.545 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 4.8 mtm -118.38 122.91 43.98 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 175.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 77' ' ' PHE . . . . . 0.539 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 1.0 OUTLIER -105.12 127.59 52.97 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.295 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 78' ' ' TYR . . . . . 0.686 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 49.6 p90 -155.82 150.59 26.23 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.536 -177.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 79' ' ' THR . . . . . 0.727 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 11.3 p -117.2 149.14 40.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.828 0.347 . . . . 0.0 111.684 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.11 144.58 42.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.301 175.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.3 177.0 34.52 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -106.6 102.82 12.17 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.965 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 83' ' ' ALA . . . . . 0.541 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -170.77 151.22 3.4 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.595 169.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 23.7 t -108.17 121.48 44.94 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 85' ' ' VAL . . . . . 0.615 HG12 ' HB3' ' E' ' 34' ' ' LEU . 11.5 m -118.36 146.2 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 CA-C-O 121.382 0.61 . . . . 0.0 111.69 -173.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 15.3 t -111.94 120.92 43.55 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 87' ' ' LEU . . . . . 0.744 HD13 HD23 ' E' ' 11' ' ' LEU . 5.1 mp -92.95 151.68 19.78 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.652 174.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . 0.656 HD23 HD21 ' A' ' 67' ' ' LEU . 1.6 tp -133.6 141.1 47.51 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.203 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.16 -166.64 26.58 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.891 -176.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 90' ' ' TYR . . . . . 0.429 ' CD2' ' HB3' ' A' ' 68' ' ' ASN . 8.2 p90 -150.91 130.11 12.72 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.694 0.759 . . . . 0.0 111.804 176.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 91' ' ' LEU . . . . . 0.566 HD23 ' HB3' ' E' ' 27' ' ' PHE . 5.3 mt -72.89 136.24 45.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.903 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -79.25 108.94 13.12 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -114.78 -177.11 3.05 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.687 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 94' ' ' ILE . . . . . 0.436 ' N ' HD12 ' E' ' 94' ' ' ILE . 4.2 mp -105.27 -35.94 3.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 25.3 t70 65.92 135.57 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.355 -176.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 11.2 p -88.7 6.55 38.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.884 -176.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.59 -64.95 3.76 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.562 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 15.4 p . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.864 -0.588 . . . . 0.0 109.768 176.927 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.458 ' O ' ' HA ' ' A' ' 96' ' ' SER . 95.7 m-85 . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -157.72 64.21 0.47 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.38 0.61 . . . . 0.0 110.021 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.48 -21.59 37.1 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.964 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 55.67 73.9 0.4 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.473 0.654 . . . . 0.0 111.047 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 20.3 ptm -105.35 59.95 0.67 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.08 -176.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.497 ' HB3' ' ND2' ' B' ' 68' ' ' ASN . . . -54.55 140.28 35.3 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.715 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.524 ' HA ' ' HB2' ' B' ' 70' ' ' SER . 11.4 ttt -104.39 134.3 47.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.059 0.457 . . . . 0.0 111.898 -170.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.407 ' CE1' HD21 ' B' ' 44' ' ' LEU . 62.3 t80 -55.91 143.93 30.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.458 -175.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.445 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 89.8 t90 -137.47 150.18 47.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.052 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.595 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -150.84 159.78 28.31 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.086 177.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.58 HD23 HD13 ' A' ' 87' ' ' LEU . 36.8 tp -148.4 108.21 4.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.835 0.35 . . . . 0.0 111.066 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -92.37 103.75 16.16 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.017 0.437 . . . . 0.0 110.076 174.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.589 ' SD ' HD11 ' A' ' 87' ' ' LEU . 53.4 mtp -94.99 144.94 25.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.132 -175.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -100.45 149.36 36.03 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.853 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.566 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 11.6 Cg_endo -55.69 121.9 10.77 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 123.265 2.643 . . . . 0.0 113.294 -176.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 79' ' ' THR . 49.9 mt-10 60.84 57.28 2.67 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.532 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -132.54 142.74 49.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.166 175.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.675 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 35.6 ttmt -118.45 116.33 26.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.869 0.366 . . . . 0.0 111.648 -174.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -112.25 110.3 20.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.992 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.7 p -77.35 122.17 24.76 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 173.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -99.63 128.51 45.74 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.884 -167.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.5 p -98.77 125.19 44.05 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 169.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.3 mt -96.41 118.72 43.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.326 0.584 . . . . 0.0 111.749 -172.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.1 mp -93.94 -44.93 13.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.662 178.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -118.68 140.36 50.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.543 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.8 t -62.64 114.37 3.54 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 173.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -130.02 148.63 51.89 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.531 -0.868 . . . . 0.0 112.937 -170.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.579 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 17.6 t60 -106.08 125.68 51.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.242 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.575 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 46.9 mt -97.69 132.61 42.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 170.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.579 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 42.6 p -116.25 -14.71 11.07 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -170.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.56 152.49 22.21 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 119.232 -1.461 . . . . 0.0 113.411 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.423 HG23 ' HG ' ' A' ' 87' ' ' LEU . 8.5 p -138.01 122.82 23.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 172.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.408 ' HA ' HG21 ' A' ' 56' ' ' VAL . . . -140.61 156.14 46.35 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 122.148 -0.345 . . . . 0.0 111.394 -174.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.469 ' HB3' HG12 ' A' ' 85' ' ' VAL . 3.7 pp -115.15 141.28 48.23 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.838 0.827 . . . . 0.0 112.071 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -106.45 -57.3 2.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.055 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -102.6 127.46 49.68 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 169.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.493 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 153.4 160.61 9.82 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 119.338 -1.41 . . . . 0.0 113.749 176.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.602 ' O ' ' HG3' ' A' ' 58' ' ' LYS . 19.1 tt0 -102.22 -46.97 4.67 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.608 -0.296 . . . . 0.0 110.409 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.448 ' OE2' ' HG2' ' A' ' 38' ' ' GLN . 6.9 mp0 -152.25 129.52 11.25 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.383 176.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.663 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -125.96 119.53 27.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.352 0.596 . . . . 0.0 110.237 171.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -104.47 108.95 20.62 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.5 tp -84.9 115.0 22.53 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.248 -173.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.525 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 91.9 m-85 -116.33 145.52 43.13 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.579 ' HA ' ' O ' ' A' ' 76' ' ' MET . 0.2 OUTLIER -131.67 128.53 39.23 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 171.33 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -106.62 122.77 47.01 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.667 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.71 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -130.16 125.23 34.51 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 175.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 61.42 36.46 17.29 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -171.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.486 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 14.9 tmtt? 73.59 -7.5 1.56 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.383 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.535 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 24.1 tp60 -80.36 114.54 19.33 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 -177.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -81.32 110.14 16.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.937 0.399 . . . . 0.0 110.387 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.582 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 82.2 m-85 -99.34 129.95 45.59 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.259 177.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.27 99.46 4.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 171.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.467 HG13 ' CD2' ' E' ' 88' ' ' LEU . 2.4 t -74.67 -50.01 27.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.439 -171.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.425 ' HB2' ' CD2' ' A' ' 65' ' ' LEU . . . -158.27 138.94 12.85 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.404 -177.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.4 m -103.05 102.05 12.06 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 171.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.458 HG13 ' HB3' ' A' ' 40' ' ' ALA . 7.2 p -113.54 110.24 31.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.884 0.85 . . . . 0.0 109.814 -177.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 81.3 p -122.98 -176.97 3.54 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.137 -174.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.602 ' HG3' ' O ' ' A' ' 38' ' ' GLN . 9.7 mtmp? -56.72 -35.08 68.13 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.086 0.47 . . . . 0.0 110.288 169.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.3 -40.57 64.42 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.603 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 77.9 mt -117.11 80.49 11.78 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.16 -0.0 6.6 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.079 2.519 . . . . 0.0 113.264 -169.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -164.14 118.76 1.49 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.237 0.541 . . . . 0.0 110.948 -174.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.7 t -108.85 108.59 25.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.371 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.5 117.37 27.4 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.795 174.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -136.39 168.47 19.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.457 -176.013 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 8.9 t0 -113.96 99.47 7.69 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.204 0.526 . . . . 0.0 110.292 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.6 HD21 HD23 ' E' ' 88' ' ' LEU . 19.5 mt -112.66 142.01 45.76 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.486 177.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.469 ' ND2' ' HB3' ' E' ' 6' ' ' ALA . 63.0 t30 -150.63 115.75 5.35 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 174.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -110.28 158.73 18.08 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.943 -177.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.513 ' HB2' ' HA ' ' E' ' 7' ' ' MET . 8.6 t -110.57 158.71 18.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.226 0.536 . . . . 0.0 110.646 -176.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -70.57 -4.69 24.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.637 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.43 -26.86 14.33 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.487 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -100.69 168.24 9.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.003 0.43 . . . . 0.0 110.955 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.7 mtm180 -136.84 143.7 43.22 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.71 HG22 ' HB2' ' A' ' 46' ' ' ALA . 13.2 pt -140.0 176.07 5.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.123 -172.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.579 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 9.2 mtm -134.03 131.8 39.3 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 171.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.458 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 1.2 m-85 -108.33 128.22 54.56 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.675 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 38.9 p90 -152.84 136.27 15.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.303 0.573 . . . . 0.0 111.714 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 2.1 p -111.13 133.16 53.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.22 -177.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.28 168.29 9.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.748 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.94 -170.33 43.42 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 -177.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -114.9 102.65 10.18 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 117.708 0.754 . . . . 0.0 109.702 174.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.663 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -173.82 152.4 1.99 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.502 170.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.0 t -111.64 122.06 46.8 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.469 HG12 ' HB3' ' A' ' 34' ' ' LEU . 4.3 m -113.51 156.95 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 CA-C-O 121.546 0.688 . . . . 0.0 112.566 -172.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.9 t -123.63 113.84 19.2 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.595 177.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.589 HD11 ' SD ' ' A' ' 13' ' ' MET . 5.0 mp -90.15 153.57 20.42 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.106 0.479 . . . . 0.0 109.846 174.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.594 HD23 HD21 ' B' ' 67' ' ' LEU . 1.0 OUTLIER -133.49 139.34 46.6 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.093 -179.467 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.83 -166.85 24.45 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.886 -177.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -152.79 131.27 12.18 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.735 0.778 . . . . 0.0 111.856 176.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.7 mt -69.99 133.34 47.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.056 -1.429 . . . . 0.0 109.306 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -70.51 129.52 39.45 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -83.05 164.88 20.04 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.805 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 18.1 mt -127.5 49.85 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.473 0.654 . . . . 0.0 109.268 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -63.66 -32.04 73.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.042 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 1' ' ' PHE . 40.6 m -82.56 51.0 1.76 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.666 176.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -178.59 -52.02 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.136 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.396 178.793 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' B' ' 96' ' ' SER . 95.6 m-85 . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -157.75 64.27 0.47 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.404 0.621 . . . . 0.0 110.052 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.48 -21.56 37.19 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.957 177.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . 55.59 73.95 0.4 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.395 0.617 . . . . 0.0 111.075 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 20.3 ptm -105.36 59.81 0.67 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.013 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.492 ' HB3' ' ND2' ' C' ' 68' ' ' ASN . . . -54.43 140.27 34.55 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.73 178.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . 0.516 ' HA ' ' HB2' ' C' ' 70' ' ' SER . 11.5 ttt -104.47 134.27 47.95 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.076 0.465 . . . . 0.0 111.774 -170.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.418 ' CE1' HD21 ' C' ' 44' ' ' LEU . 62.2 t80 -55.9 143.94 29.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.477 -175.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . 0.44 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 89.8 t90 -137.48 150.16 47.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.95 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.618 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -150.87 159.75 28.3 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.092 177.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.594 HD23 HD13 ' B' ' 87' ' ' LEU . 37.0 tp -148.32 108.24 4.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.864 0.364 . . . . 0.0 111.077 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -92.46 103.81 16.2 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.963 0.411 . . . . 0.0 110.011 174.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . 0.602 ' SD ' HD11 ' B' ' 87' ' ' LEU . 53.7 mtp -95.11 144.95 25.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.06 -175.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -100.35 149.45 36.08 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.834 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.572 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 11.4 Cg_endo -55.85 121.81 10.63 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.283 2.655 . . . . 0.0 113.255 -176.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' B' ' 79' ' ' THR . 49.7 mt-10 60.9 57.38 2.61 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.49 178.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -132.6 142.63 49.22 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.207 175.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.657 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 35.6 ttmt -118.38 116.25 26.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.804 0.335 . . . . 0.0 111.722 -174.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -112.2 110.35 20.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.023 178.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 4.7 p -77.27 122.29 24.88 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 173.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -99.74 128.6 45.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.815 -167.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 28.5 p -98.73 125.12 43.97 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 169.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 43.5 mt -96.46 118.65 43.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.256 0.551 . . . . 0.0 111.744 -172.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.417 ' N ' HD12 ' B' ' 24' ' ' ILE . 4.1 mp -93.84 -45.0 13.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.652 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -118.61 140.54 49.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.479 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 11.3 t -62.67 114.38 3.56 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 173.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -130.02 148.73 51.91 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.502 -0.879 . . . . 0.0 112.923 -170.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' HIS . . . . . 0.576 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 17.9 t60 -106.15 125.65 51.25 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.194 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.597 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 47.5 mt -97.69 132.6 42.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 170.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.576 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 43.1 p -116.25 -14.75 11.07 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -170.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.55 152.45 22.15 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 119.322 -1.418 . . . . 0.0 113.464 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.426 HG23 ' HG ' ' B' ' 87' ' ' LEU . 8.7 p -137.91 122.78 23.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 172.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . 0.412 ' HA ' HG21 ' B' ' 56' ' ' VAL . . . -140.63 156.15 46.34 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.335 -174.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.469 ' HB3' HG12 ' B' ' 85' ' ' VAL . 3.7 pp -115.18 141.37 48.11 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.853 0.835 . . . . 0.0 112.053 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -106.54 -57.32 2.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.044 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -102.64 127.42 49.76 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 169.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.498 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 153.52 160.67 9.87 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 119.311 -1.423 . . . . 0.0 113.729 176.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . 0.592 ' O ' ' HG3' ' B' ' 58' ' ' LYS . 19.0 tt0 -102.22 -47.0 4.66 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 120.784 0.326 . . . . 0.0 110.426 177.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.448 ' OE2' ' HG2' ' B' ' 38' ' ' GLN . 6.9 mp0 -152.27 129.52 11.24 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.352 177.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.669 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -126.02 119.48 27.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.355 0.598 . . . . 0.0 110.305 171.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -104.5 108.92 20.59 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 43.7 tp -84.82 115.02 22.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.33 -173.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . 0.525 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 91.6 m-85 -116.31 145.48 43.15 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 175.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.577 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.2 OUTLIER -131.63 128.46 39.16 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 171.337 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -106.64 122.95 47.36 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.6 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.704 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -130.19 125.26 34.52 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 175.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 61.37 36.44 17.47 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 123.532 0.52 . . . . 0.0 109.698 -171.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.482 ' HD3' ' O ' ' B' ' 48' ' ' LYS . 14.9 tmtt? 73.6 -7.54 1.55 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.407 178.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.537 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 24.3 tp60 -80.46 114.61 19.48 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -177.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -81.42 110.2 16.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.993 0.425 . . . . 0.0 110.307 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.595 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 82.2 m-85 -99.37 129.93 45.61 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.293 177.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.28 99.44 4.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 171.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.482 HG13 ' CD2' ' A' ' 88' ' ' LEU . 2.4 t -74.63 -50.06 27.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.412 -171.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.433 ' HB2' ' CD2' ' B' ' 65' ' ' LEU . . . -158.25 138.92 12.84 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.429 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 23.2 m -103.06 102.04 12.04 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 171.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.468 HG13 ' HB3' ' B' ' 40' ' ' ALA . 7.3 p -113.46 110.19 31.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.796 0.808 . . . . 0.0 109.928 -177.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 81.5 p -122.96 -176.89 3.52 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.128 -174.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . 0.592 ' HG3' ' O ' ' B' ' 38' ' ' GLN . 9.7 mtmp? -56.77 -34.99 68.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.086 0.47 . . . . 0.0 110.372 169.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.5 -40.48 64.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.505 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 77.6 mt -117.16 80.57 12.04 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 173.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.15 -0.06 6.67 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.985 2.457 . . . . 0.0 113.251 -169.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -164.14 118.67 1.48 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.228 0.537 . . . . 0.0 111.111 -174.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 58.6 t -108.78 108.58 25.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.366 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.43 117.45 27.37 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.851 174.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' B' ' 30' ' ' SER . 0.3 OUTLIER -136.53 168.43 19.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.459 -176.013 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . 0.54 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 8.9 t0 -113.88 99.46 7.69 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.175 0.512 . . . . 0.0 110.328 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.597 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 19.5 mt -112.77 142.06 45.85 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.409 177.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . 0.497 ' ND2' ' HB3' ' A' ' 6' ' ' ALA . 63.1 t30 -150.6 115.87 5.39 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 174.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -110.32 158.78 18.06 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.906 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.524 ' HB2' ' HA ' ' A' ' 7' ' ' MET . 8.6 t -110.63 158.65 18.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.239 0.543 . . . . 0.0 110.627 -176.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -70.53 -4.76 24.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.67 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.35 -26.97 14.13 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.404 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -100.61 168.31 9.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.12 0.486 . . . . 0.0 110.92 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 73.7 mtm180 -136.94 143.55 42.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.1 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.704 HG22 ' HB2' ' B' ' 46' ' ' ALA . 13.1 pt -139.85 175.98 6.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.59 0.233 . . . . 0.0 111.141 -172.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.577 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 9.2 mtm -133.97 131.81 39.43 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 171.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . 0.468 ' CD1' ' HB2' ' B' ' 44' ' ' LEU . 1.2 m-85 -108.35 128.2 54.55 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.657 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 38.8 p90 -152.84 136.27 15.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.341 0.591 . . . . 0.0 111.765 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 2.1 p -111.12 133.13 53.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.185 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.24 168.27 9.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.795 177.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.98 -170.31 43.32 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -115.04 102.72 10.2 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.659 174.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.669 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -173.88 152.28 1.94 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.511 170.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 32.0 t -111.47 122.1 46.94 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.469 HG12 ' HB3' ' B' ' 34' ' ' LEU . 4.3 m -113.59 156.85 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-O 121.471 0.653 . . . . 0.0 112.567 -172.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 14.8 t -123.54 113.87 19.29 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.667 177.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.602 HD11 ' SD ' ' B' ' 13' ' ' MET . 5.0 mp -90.15 153.55 20.44 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 121.078 0.466 . . . . 0.0 109.887 174.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.578 HD23 HD21 ' C' ' 67' ' ' LEU . 1.0 OUTLIER -133.47 139.38 46.64 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.023 -179.43 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.87 -166.85 24.51 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.913 -177.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -152.73 131.31 12.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.751 0.786 . . . . 0.0 111.763 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 5.7 mt -70.05 133.32 47.08 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.078 -1.419 . . . . 0.0 109.301 174.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -70.44 129.43 39.25 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.961 0.41 . . . . 0.0 110.012 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -82.99 164.79 20.16 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.811 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 17.9 mt -127.44 49.87 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.533 0.683 . . . . 0.0 109.276 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -63.58 -32.06 73.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.08 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' B' ' 1' ' ' PHE . 40.3 m -82.61 50.99 1.77 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.527 0.679 . . . . 0.0 110.675 176.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . -178.61 -52.1 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.123 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 11.4 t . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.311 178.789 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 1' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' C' ' 96' ' ' SER . 95.4 m-85 . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -157.82 64.32 0.47 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.418 0.628 . . . . 0.0 110.046 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.55 -21.65 36.69 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.905 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . 55.69 73.9 0.4 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.38 0.609 . . . . 0.0 111.075 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 20.3 ptm -105.38 59.88 0.67 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.049 -176.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 6' ' ' ALA . . . . . 0.506 ' HB3' ' ND2' ' D' ' 68' ' ' ASN . . . -54.4 140.21 34.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.761 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 7' ' ' MET . . . . . 0.506 ' HA ' ' HB2' ' D' ' 70' ' ' SER . 11.5 ttt -104.45 134.38 47.75 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.057 0.456 . . . . 0.0 111.854 -170.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 8' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -55.93 143.86 30.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.53 -175.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . 0.432 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 90.1 t90 -137.46 150.18 47.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.976 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . 0.578 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -150.88 159.63 28.24 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.098 177.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.58 HD23 HD13 ' C' ' 87' ' ' LEU . 37.3 tp -148.26 108.21 4.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.827 0.346 . . . . 0.0 111.178 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -92.4 103.78 16.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.076 0.465 . . . . 0.0 110.005 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 13' ' ' MET . . . . . 0.591 ' SD ' HD11 ' C' ' 87' ' ' LEU . 53.2 mtp -95.0 144.99 25.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.118 -175.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -100.43 149.42 36.08 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.86 177.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . 0.579 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 11.6 Cg_endo -55.83 121.85 10.71 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.254 2.636 . . . . 0.0 113.253 -176.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' C' ' 79' ' ' THR . 49.9 mt-10 60.9 57.28 2.64 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.564 178.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -132.55 142.6 49.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.253 175.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 18' ' ' LYS . . . . . 0.666 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 35.5 ttmt -118.37 116.41 26.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.859 0.362 . . . . 0.0 111.721 -174.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -112.27 110.36 20.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.029 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -77.3 122.15 24.7 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 173.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -99.58 128.54 45.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.85 -167.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 28.0 p -98.7 125.01 43.89 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 169.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mt -96.43 118.72 43.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.2 0.524 . . . . 0.0 111.738 -172.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . 0.42 HD12 ' N ' ' C' ' 24' ' ' ILE . 4.1 mp -93.9 -44.97 13.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.649 178.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -118.64 140.39 49.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.539 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 11.6 t -62.58 114.3 3.48 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 173.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 27' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -130.05 148.62 51.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.888 0.851 . . . . 0.0 112.947 -170.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 28' ' ' HIS . . . . . 0.581 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 17.7 t60 -106.08 125.6 51.19 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.158 -1.383 . . . . 0.0 110.201 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . 0.579 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 46.8 mt -97.7 132.63 42.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 170.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.581 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 42.4 p -116.31 -14.65 11.04 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -170.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.63 152.47 22.17 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 119.304 -1.427 . . . . 0.0 113.438 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.424 HG23 ' HG ' ' C' ' 87' ' ' LEU . 8.7 p -138.0 122.76 23.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 172.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.408 ' HA ' HG21 ' C' ' 56' ' ' VAL . . . -140.63 156.18 46.33 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.091 -0.38 . . . . 0.0 111.328 -174.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.452 ' HB3' HG12 ' C' ' 85' ' ' VAL . 3.7 pp -115.12 141.35 48.13 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.786 0.803 . . . . 0.0 112.129 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -106.58 -57.31 2.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.98 176.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -102.68 127.41 49.81 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 169.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 37' ' ' GLY . . . . . 0.486 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 153.56 160.69 9.89 Favored Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 119.357 -1.402 . . . . 0.0 113.724 176.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 38' ' ' GLN . . . . . 0.607 ' O ' ' HG3' ' C' ' 58' ' ' LYS . 19.0 tt0 -102.22 -47.03 4.65 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 120.701 0.286 . . . . 0.0 110.467 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . 0.449 ' OE2' ' HG2' ' C' ' 38' ' ' GLN . 6.8 mp0 -152.26 129.52 11.25 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.412 176.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.663 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -125.95 119.56 28.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.35 0.595 . . . . 0.0 110.296 171.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -104.54 108.88 20.55 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 43.5 tp -84.84 115.04 22.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.261 -173.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 43' ' ' TYR . . . . . 0.51 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 91.5 m-85 -116.33 145.5 43.15 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 175.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.575 ' HA ' ' O ' ' C' ' 76' ' ' MET . 0.2 OUTLIER -131.69 128.48 39.07 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 171.434 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -106.55 122.9 47.25 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.633 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.712 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -130.3 125.16 34.05 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 61.46 36.42 17.19 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -171.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.493 ' HD3' ' O ' ' C' ' 48' ' ' LYS . 14.9 tmtt? 73.72 -7.67 1.54 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.351 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . 0.54 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 24.8 tp60 -80.36 114.59 19.37 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.887 -0.508 . . . . 0.0 109.69 -177.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -81.28 110.1 16.42 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.343 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . 0.618 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 82.2 m-85 -99.36 129.89 45.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.278 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.22 99.44 3.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 171.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 53' ' ' VAL . . . . . 0.474 HG13 ' CD2' ' B' ' 88' ' ' LEU . 2.4 t -74.64 -50.12 27.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.39 -171.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 54' ' ' ALA . . . . . 0.433 ' HB2' ' CD2' ' C' ' 65' ' ' LEU . . . -158.16 138.95 12.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.454 -177.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 23.5 m -103.05 102.09 12.09 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 171.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . 0.457 HG13 ' HB3' ' C' ' 40' ' ' ALA . 7.2 p -113.59 110.15 31.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.846 0.831 . . . . 0.0 109.889 -177.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 81.7 p -123.02 -177.01 3.55 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.124 -174.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 58' ' ' LYS . . . . . 0.607 ' HG3' ' O ' ' C' ' 38' ' ' GLN . 9.7 mtmp? -56.58 -35.11 67.82 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.058 0.456 . . . . 0.0 110.38 169.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.37 -40.55 64.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.514 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 77.9 mt -117.21 80.58 12.22 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 174.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.21 -0.07 6.74 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.053 2.502 . . . . 0.0 113.187 -169.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -164.12 118.68 1.49 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.139 0.495 . . . . 0.0 111.076 -174.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 58.9 t -108.79 108.65 25.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.281 175.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.53 117.41 27.46 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.772 174.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . 0.433 ' CD2' ' HB2' ' C' ' 54' ' ' ALA . 0.3 OUTLIER -136.39 168.49 19.35 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.497 -176.073 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 66' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 8.9 t0 -114.02 99.58 7.76 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.306 0.574 . . . . 0.0 110.203 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.579 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 19.6 mt -112.74 141.96 45.92 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.468 177.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . 0.492 ' ND2' ' HB3' ' B' ' 6' ' ' ALA . 63.2 t30 -150.58 115.78 5.37 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 174.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -110.26 158.76 18.04 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.937 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . 0.516 ' HB2' ' HA ' ' B' ' 7' ' ' MET . 8.7 t -110.65 158.7 18.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.23 0.538 . . . . 0.0 110.654 -176.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -70.6 -4.67 24.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.596 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.51 -26.81 14.37 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.483 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -100.81 168.24 9.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.019 0.437 . . . . 0.0 110.846 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 73.7 mtm180 -136.86 143.59 43.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.136 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.712 HG22 ' HB2' ' C' ' 46' ' ' ALA . 13.2 pt -139.83 176.11 6.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.614 0.245 . . . . 0.0 111.128 -172.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.575 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 9.2 mtm -134.1 131.81 39.19 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 171.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 77' ' ' PHE . . . . . 0.456 ' CD1' ' HB2' ' C' ' 44' ' ' LEU . 1.2 m-85 -108.34 128.24 54.58 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 78' ' ' TYR . . . . . 0.666 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 38.9 p90 -152.8 136.32 15.97 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.37 0.605 . . . . 0.0 111.777 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 2.1 p -111.1 133.11 53.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.217 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.31 168.33 9.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.763 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.77 -170.26 43.68 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -114.97 102.7 10.21 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.651 174.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . 0.663 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -173.83 152.34 1.97 Allowed 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.942 -1.027 . . . . 0.0 109.473 170.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 32.1 t -111.47 122.16 47.09 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.454 HG11 HG11 ' C' ' 56' ' ' VAL . 4.3 m -113.71 156.91 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-O 121.564 0.697 . . . . 0.0 112.537 -172.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 15.1 t -123.62 113.84 19.2 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.637 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . 0.591 HD11 ' SD ' ' C' ' 13' ' ' MET . 5.0 mp -90.08 153.55 20.46 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.07 0.462 . . . . 0.0 109.913 174.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . 0.59 HD23 HD21 ' D' ' 67' ' ' LEU . 1.0 OUTLIER -133.5 139.34 46.59 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.051 -179.422 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.86 -166.81 24.43 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.875 -177.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -152.79 131.27 12.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.809 0.814 . . . . 0.0 111.812 176.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 5.8 mt -70.14 133.37 47.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.007 -1.452 . . . . 0.0 109.253 175.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -70.37 129.52 39.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.913 0.387 . . . . 0.0 109.974 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -83.06 164.87 20.03 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.838 177.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 18.2 mt -127.54 49.84 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.523 0.678 . . . . 0.0 109.238 176.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -63.47 -32.22 73.6 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.072 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' C' ' 1' ' ' PHE . 40.5 m -82.51 51.01 1.75 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.668 176.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -178.65 -51.95 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.116 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 11.5 t . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.405 178.795 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' D' ' 96' ' ' SER . 95.5 m-85 . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -157.69 64.33 0.47 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.381 0.61 . . . . 0.0 110.003 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.51 -21.63 36.89 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.901 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . 55.64 73.84 0.41 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.385 0.612 . . . . 0.0 111.1 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 20.3 ptm -105.2 59.85 0.68 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.084 -176.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 6' ' ' ALA . . . . . 0.523 ' HB3' ' ND2' ' E' ' 68' ' ' ASN . . . -54.47 140.31 34.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.788 178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 7' ' ' MET . . . . . 0.496 ' HA ' ' HB2' ' E' ' 70' ' ' SER . 11.5 ttt -104.53 134.28 47.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.038 0.446 . . . . 0.0 111.783 -170.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 8' ' ' PHE . . . . . 0.405 ' CE1' HD21 ' E' ' 44' ' ' LEU . 62.4 t80 -55.97 143.86 30.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.51 -175.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 9' ' ' TRP . . . . . 0.439 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 90.0 t90 -137.43 150.06 47.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.022 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . 0.585 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -150.83 159.71 28.28 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.098 177.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.594 HD23 HD13 ' D' ' 87' ' ' LEU . 36.7 tp -148.35 108.18 4.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.834 0.349 . . . . 0.0 111.03 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -92.28 103.82 16.24 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.988 0.423 . . . . 0.0 109.975 174.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 13' ' ' MET . . . . . 0.6 ' SD ' HD11 ' D' ' 87' ' ' LEU . 53.8 mtp -95.12 145.01 25.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.12 -175.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -100.47 149.42 36.08 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.86 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . 0.557 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 11.5 Cg_endo -55.76 121.72 10.46 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 123.314 2.676 . . . . 0.0 113.319 -176.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' D' ' 79' ' ' THR . 49.8 mt-10 60.89 57.45 2.6 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.465 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -132.64 142.66 49.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.202 175.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . 0.665 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 35.5 ttmt -118.41 116.26 26.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.86 0.362 . . . . 0.0 111.756 -175.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -112.09 110.25 20.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.095 178.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 4.7 p -77.17 122.22 24.72 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 173.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -99.67 128.45 45.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.886 -167.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 28.4 p -98.72 125.15 43.96 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 169.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 44.0 mt -96.41 118.58 43.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.205 0.526 . . . . 0.0 111.731 -172.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . 0.426 HD12 ' N ' ' D' ' 24' ' ' ILE . 4.1 mp -93.83 -44.98 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.673 178.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -118.65 140.44 49.91 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.491 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 11.6 t -62.65 114.37 3.54 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 173.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 27' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -129.97 148.64 51.85 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.607 -0.837 . . . . 0.0 112.99 -170.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 28' ' ' HIS . . . . . 0.578 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 18.0 t60 -106.1 125.7 51.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.184 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 29' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 46.8 mt -97.7 132.48 42.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 170.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . 0.578 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 42.5 p -116.23 -14.65 11.09 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -170.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.58 152.48 22.2 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 119.278 -1.439 . . . . 0.0 113.453 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.424 HG23 ' HG ' ' D' ' 87' ' ' LEU . 8.6 p -137.97 122.86 23.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 172.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . 0.408 ' HA ' HG21 ' D' ' 56' ' ' VAL . . . -140.63 156.07 46.36 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 122.153 -0.342 . . . . 0.0 111.414 -174.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 34' ' ' LEU . . . . . 0.453 ' HB3' HG12 ' D' ' 85' ' ' VAL . 3.7 pp -115.1 141.34 48.15 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.818 0.818 . . . . 0.0 112.126 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -106.51 -57.27 2.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.024 176.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -102.64 127.35 49.78 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 169.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . 0.493 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 153.5 160.61 9.83 Favored Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 119.278 -1.439 . . . . 0.0 113.711 176.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 38' ' ' GLN . . . . . 0.607 ' O ' ' HG3' ' D' ' 58' ' ' LYS . 19.1 tt0 -102.21 -46.98 4.66 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.579 -0.311 . . . . 0.0 110.391 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . 0.45 ' OE2' ' HG2' ' D' ' 38' ' ' GLN . 6.9 mp0 -152.27 129.45 11.18 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.417 176.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . 0.673 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -125.97 119.63 28.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.4 0.619 . . . . 0.0 110.218 171.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -104.51 109.01 20.73 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 43.8 tp -84.99 114.97 22.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.218 -173.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 43' ' ' TYR . . . . . 0.523 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 91.6 m-85 -116.26 145.51 43.1 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 175.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.58 ' HA ' ' O ' ' D' ' 76' ' ' MET . 0.2 OUTLIER -131.66 128.47 39.11 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 171.367 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 45' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -106.57 122.93 47.3 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.654 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.718 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -130.3 125.14 34.01 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 61.47 36.4 17.17 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -171.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 48' ' ' LYS . . . . . 0.498 ' HD3' ' O ' ' D' ' 48' ' ' LYS . 14.9 tmtt? 73.69 -7.54 1.56 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.307 178.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . 0.537 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 24.5 tp60 -80.37 114.56 19.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -177.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -81.32 110.11 16.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.424 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . 0.578 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 82.1 m-85 -99.32 129.95 45.57 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.225 177.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.24 99.42 3.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 171.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 53' ' ' VAL . . . . . 0.468 HG13 ' CD2' ' C' ' 88' ' ' LEU . 2.4 t -74.69 -50.08 27.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.376 -171.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 54' ' ' ALA . . . . . 0.425 ' HB2' ' CD2' ' D' ' 65' ' ' LEU . . . -158.21 139.02 12.97 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.453 -177.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 22.9 m -103.11 102.1 12.09 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 171.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 56' ' ' VAL . . . . . 0.472 HG13 ' HB3' ' D' ' 40' ' ' ALA . 7.2 p -113.55 110.21 31.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.889 0.852 . . . . 0.0 109.932 -177.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 81.6 p -122.97 -176.95 3.54 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.123 -174.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 58' ' ' LYS . . . . . 0.607 ' HG3' ' O ' ' D' ' 38' ' ' GLN . 9.7 mtmp? -56.64 -35.18 68.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.146 0.498 . . . . 0.0 110.329 169.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.24 -40.72 64.43 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.549 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 77.6 mt -116.93 80.55 11.29 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 173.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.28 0.06 6.6 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.018 2.479 . . . . 0.0 113.238 -169.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -164.19 118.7 1.47 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.267 0.556 . . . . 0.0 111.003 -174.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 58.6 t -108.83 108.58 25.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.299 175.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.55 117.39 27.47 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.83 174.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 65' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' D' ' 30' ' ' SER . 0.3 OUTLIER -136.35 168.51 19.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.465 -175.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 66' ' ' ASP . . . . . 0.512 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 8.8 t0 -114.0 99.61 7.79 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.206 0.527 . . . . 0.0 110.257 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.59 HD21 HD23 ' C' ' 88' ' ' LEU . 19.5 mt -112.78 142.0 45.93 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.468 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 68' ' ' ASN . . . . . 0.506 ' ND2' ' HB3' ' C' ' 6' ' ' ALA . 63.2 t30 -150.58 115.78 5.37 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 174.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -110.29 158.8 18.02 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.917 -177.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . 0.506 ' HB2' ' HA ' ' C' ' 7' ' ' MET . 8.6 t -110.68 158.68 18.35 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.212 0.529 . . . . 0.0 110.619 -176.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -70.5 -4.78 24.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.611 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.38 -26.96 14.14 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.49 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -100.66 168.24 9.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.033 0.444 . . . . 0.0 110.923 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -136.8 143.7 43.31 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.718 HG22 ' HB2' ' D' ' 46' ' ' ALA . 13.3 pt -139.96 176.0 6.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.113 -172.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 76' ' ' MET . . . . . 0.58 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 9.2 mtm -134.03 131.82 39.32 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 171.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 77' ' ' PHE . . . . . 0.457 ' CD1' ' HB2' ' D' ' 44' ' ' LEU . 1.2 m-85 -108.28 128.28 54.6 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 78' ' ' TYR . . . . . 0.665 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 39.0 p90 -152.86 136.32 15.91 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.36 0.6 . . . . 0.0 111.734 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 79' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 2.1 p -111.2 133.13 53.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.187 -177.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.25 168.28 9.45 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.777 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.94 -170.24 43.32 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -115.09 102.72 10.19 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 117.723 0.761 . . . . 0.0 109.61 174.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . 0.673 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -173.86 152.4 1.97 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.487 170.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 32.0 t -111.55 122.09 46.91 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.453 HG12 ' HB3' ' D' ' 34' ' ' LEU . 4.3 m -113.62 156.85 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.635 0 CA-C-O 121.476 0.655 . . . . 0.0 112.58 -172.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 14.9 t -123.53 113.82 19.23 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.656 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 87' ' ' LEU . . . . . 0.6 HD11 ' SD ' ' D' ' 13' ' ' MET . 5.0 mp -90.09 153.5 20.5 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 121.139 0.495 . . . . 0.0 109.852 174.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.561 HD23 HD21 ' E' ' 67' ' ' LEU . 1.0 OUTLIER -133.4 139.44 46.76 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.067 -179.526 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.87 -166.85 24.5 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.838 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -152.8 131.24 12.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.786 0.803 . . . . 0.0 111.843 176.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 5.7 mt -70.08 133.38 47.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.984 -1.462 . . . . 0.0 109.299 175.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -70.45 129.43 39.23 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -82.98 164.76 20.19 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.864 177.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 18.2 mt -127.42 49.89 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.499 0.666 . . . . 0.0 109.222 176.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -63.61 -32.16 73.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.036 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 96' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' D' ' 1' ' ' PHE . 40.8 m -82.52 51.08 1.77 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.69 176.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . -178.7 -51.95 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.126 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 11.3 t . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.34 178.73 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' E' E ' 1' ' ' PHE . . . . . 0.453 ' O ' ' HA ' ' E' ' 96' ' ' SER . 95.6 m-85 . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -157.73 64.47 0.47 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.467 0.651 . . . . 0.0 109.997 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.59 -21.57 36.81 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.96 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . 55.66 73.84 0.41 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.424 0.631 . . . . 0.0 111.078 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 20.2 ptm -105.33 59.87 0.67 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.035 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 6' ' ' ALA . . . . . 0.469 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . . . -54.47 140.26 34.85 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.766 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 7' ' ' MET . . . . . 0.513 ' HA ' ' HB2' ' A' ' 70' ' ' SER . 11.5 ttt -104.43 134.34 47.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.086 0.47 . . . . 0.0 111.825 -170.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 8' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -55.95 143.83 30.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.515 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 9' ' ' TRP . . . . . 0.429 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 89.9 t90 -137.4 150.13 47.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.044 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 10' ' ' GLY . . . . . 0.582 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -150.87 159.68 28.27 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.082 177.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . 0.599 HD23 HD13 ' E' ' 87' ' ' LEU . 37.3 tp -148.29 108.2 4.04 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.808 0.337 . . . . 0.0 111.151 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -92.38 103.78 16.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.081 0.467 . . . . 0.0 110.007 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 13' ' ' MET . . . . . 0.597 ' SD ' HD11 ' E' ' 87' ' ' LEU . 53.1 mtp -95.06 144.99 25.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.099 -175.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -100.48 149.38 36.05 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.787 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . 0.56 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 11.5 Cg_endo -55.75 121.77 10.56 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.29 2.66 . . . . 0.0 113.292 -176.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 16' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' E' ' 79' ' ' THR . 49.8 mt-10 60.95 57.23 2.63 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.505 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -132.43 142.67 49.36 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.29 174.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . 0.661 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 35.6 ttmt -118.42 116.3 26.43 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.881 0.372 . . . . 0.0 111.71 -175.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -112.21 110.33 20.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.013 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 4.8 p -77.3 122.04 24.56 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 173.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -99.57 128.59 45.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.872 -167.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 27.6 p -98.69 125.06 43.89 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 169.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 44.1 mt -96.43 118.67 43.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.303 0.573 . . . . 0.0 111.691 -172.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . 0.429 HD12 ' N ' ' E' ' 24' ' ' ILE . 4.1 mp -93.94 -44.93 13.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.581 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -118.72 140.32 50.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.471 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 11.3 t -62.53 114.39 3.52 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 173.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 27' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -130.04 148.7 51.92 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 119.528 -0.869 . . . . 0.0 112.927 -170.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 28' ' ' HIS . . . . . 0.58 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 17.8 t60 -106.08 125.66 51.26 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.115 -1.402 . . . . 0.0 110.283 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 29' ' ' ILE . . . . . 0.59 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 47.1 mt -97.7 132.55 42.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . 0.58 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 44.1 p -116.28 -14.67 11.05 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -170.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.6 152.5 22.21 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 119.206 -1.473 . . . . 0.0 113.431 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.422 HG23 ' HG ' ' E' ' 87' ' ' LEU . 8.7 p -138.02 122.78 23.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 172.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . 0.416 ' HA ' HG21 ' E' ' 56' ' ' VAL . . . -140.6 156.17 46.35 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.345 -174.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 34' ' ' LEU . . . . . 0.449 ' HB3' HG12 ' E' ' 85' ' ' VAL . 3.7 pp -115.21 141.39 48.08 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.836 0.827 . . . . 0.0 112.093 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -106.57 -57.31 2.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.003 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -102.64 127.4 49.76 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 169.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . 0.494 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 153.55 160.7 9.89 Favored Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 119.485 -1.341 . . . . 0.0 113.762 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 38' ' ' GLN . . . . . 0.592 ' O ' ' HG3' ' E' ' 58' ' ' LYS . 19.2 tt0 -102.29 -46.89 4.67 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.574 -0.313 . . . . 0.0 110.363 177.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 39' ' ' GLU . . . . . 0.452 ' OE2' ' HG2' ' E' ' 38' ' ' GLN . 6.9 mp0 -152.38 129.42 11.08 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.4 176.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . 0.66 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -125.92 119.56 28.1 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.398 0.618 . . . . 0.0 110.25 171.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 41' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -104.54 108.97 20.67 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 43.6 tp -84.89 115.05 22.56 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.291 -173.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 43' ' ' TYR . . . . . 0.528 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 91.4 m-85 -116.31 145.53 43.11 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 175.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 44' ' ' LEU . . . . . 0.573 ' HA ' ' O ' ' E' ' 76' ' ' MET . 0.2 OUTLIER -131.67 128.39 38.94 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 171.408 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 45' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -106.58 122.88 47.21 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.651 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . 0.699 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -130.28 125.28 34.41 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 175.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 61.45 36.36 17.24 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.488 0.492 . . . . 0.0 109.719 -171.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 48' ' ' LYS . . . . . 0.494 ' HD3' ' O ' ' E' ' 48' ' ' LYS . 14.9 tmtt? 73.66 -7.52 1.56 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.413 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 49' ' ' GLN . . . . . 0.529 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 24.3 tp60 -80.39 114.58 19.39 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -177.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -81.39 110.21 16.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.999 0.428 . . . . 0.0 110.395 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . 0.585 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 82.2 m-85 -99.44 129.94 45.67 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.219 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.29 99.49 4.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 172.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . 0.479 HG13 ' CD2' ' D' ' 88' ' ' LEU . 2.4 t -74.67 -50.09 27.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.366 -171.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 54' ' ' ALA . . . . . 0.424 ' HB2' ' CD2' ' E' ' 65' ' ' LEU . . . -158.25 139.01 12.93 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.465 -177.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 23.2 m -102.98 102.12 12.15 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 171.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . 0.473 HG13 ' HB3' ' E' ' 40' ' ' ALA . 7.2 p -113.67 110.27 31.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.966 0.889 . . . . 0.0 109.844 -177.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 81.5 p -122.97 -176.89 3.52 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.181 -174.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 58' ' ' LYS . . . . . 0.592 ' HG3' ' O ' ' E' ' 38' ' ' GLN . 9.8 mtmp? -56.79 -35.01 68.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.016 0.436 . . . . 0.0 110.313 169.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.38 -40.62 64.21 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.506 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 77.8 mt -117.05 80.56 11.66 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.22 -0.04 6.7 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.038 2.492 . . . . 0.0 113.165 -169.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -164.11 118.69 1.49 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.159 0.504 . . . . 0.0 110.945 -174.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . 0.402 HG11 ' HB1' ' E' ' 54' ' ' ALA . 58.3 t -108.78 108.52 25.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.368 175.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.45 117.31 27.29 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.858 174.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' E' ' 30' ' ' SER . 0.3 OUTLIER -136.3 168.56 19.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.51 -176.043 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 66' ' ' ASP . . . . . 0.545 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 8.9 t0 -114.05 99.53 7.71 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.236 0.541 . . . . 0.0 110.258 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 67' ' ' LEU . . . . . 0.59 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 19.6 mt -112.74 142.11 45.75 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.458 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 68' ' ' ASN . . . . . 0.523 ' ND2' ' HB3' ' D' ' 6' ' ' ALA . 63.2 t30 -150.63 115.81 5.36 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 174.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -110.37 158.68 18.19 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.884 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 70' ' ' SER . . . . . 0.496 ' HB2' ' HA ' ' D' ' 7' ' ' MET . 8.6 t -110.58 158.68 18.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.35 0.595 . . . . 0.0 110.634 -176.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -70.53 -4.84 24.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.618 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.34 -26.87 14.46 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.49 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -100.63 168.27 9.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.104 0.478 . . . . 0.0 110.884 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -136.86 143.69 43.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.12 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 75' ' ' ILE . . . . . 0.699 HG22 ' HB2' ' E' ' 46' ' ' ALA . 13.2 pt -139.93 176.12 5.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.653 0.263 . . . . 0.0 111.071 -172.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 76' ' ' MET . . . . . 0.573 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 9.2 mtm -134.09 131.73 39.11 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 171.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 77' ' ' PHE . . . . . 0.465 ' CD1' ' HB2' ' E' ' 44' ' ' LEU . 1.2 m-85 -108.29 128.29 54.61 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 178.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 78' ' ' TYR . . . . . 0.661 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 38.8 p90 -152.84 136.32 15.93 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.325 0.583 . . . . 0.0 111.742 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 79' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 2.1 p -111.12 133.01 53.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.257 -177.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.1 168.22 9.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.9 177.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.0 -170.21 43.15 Favored Glycine 0 CA--C 1.508 -0.346 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -115.12 102.7 10.16 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 117.716 0.758 . . . . 0.0 109.626 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 83' ' ' ALA . . . . . 0.66 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -173.82 152.28 1.96 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.509 170.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 31.9 t -111.46 122.19 47.18 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 85' ' ' VAL . . . . . 0.449 HG11 HG11 ' E' ' 56' ' ' VAL . 4.3 m -113.64 156.89 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 CA-C-O 121.538 0.685 . . . . 0.0 112.542 -172.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 14.9 t -123.62 113.8 19.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.794 -1.094 . . . . 0.0 108.63 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 87' ' ' LEU . . . . . 0.599 HD13 HD23 ' E' ' 11' ' ' LEU . 5.0 mp -90.12 153.42 20.55 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.123 0.487 . . . . 0.0 109.867 174.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . 0.6 HD23 HD21 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -133.28 139.44 46.91 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 114.803 -1.089 . . . . 0.0 109.077 -179.494 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.94 -166.83 24.55 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.849 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 90' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -152.8 131.33 12.22 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.769 0.795 . . . . 0.0 111.799 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 91' ' ' LEU . . . . . . . . . . . . . 5.8 mt -70.19 133.37 47.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.269 175.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -70.39 129.49 39.42 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -83.02 164.86 20.08 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.852 177.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 18.1 mt -127.46 49.87 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.498 0.666 . . . . 0.0 109.216 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -63.51 -32.13 73.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.096 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 96' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' E' ' 1' ' ' PHE . 40.7 m -82.57 51.03 1.77 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.643 176.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . -178.61 -52.1 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.136 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.378 178.847 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.716 0.293 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -80.12 -47.93 14.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.079 0.466 . . . . 0.0 109.941 176.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 135.17 -175.84 20.41 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.601 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.4 -48.13 10.69 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.483 ' HG3' ' CB ' ' B' ' 95' ' ' ASP . 22.7 mmt 58.59 -100.14 0.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.854 -1.066 . . . . 0.0 112.942 172.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' B' ' 70' ' ' SER . . . -86.21 131.07 34.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.66 0.267 . . . . 0.0 110.402 -177.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 38.4 mtt -124.18 144.11 50.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.157 0.503 . . . . 0.0 112.089 -175.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.513 ' CE1' HD21 ' B' ' 44' ' ' LEU . 28.9 t80 -62.34 145.7 53.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.547 -178.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -135.75 147.4 48.4 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.431 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -150.97 153.86 25.23 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.197 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.598 HD23 HD13 ' A' ' 87' ' ' LEU . 33.3 tp -147.77 106.54 3.82 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 86' ' ' SER . 2.3 p30 -97.85 110.54 23.09 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.543 0.687 . . . . 0.0 111.02 176.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.443 ' SD ' HG23 ' A' ' 79' ' ' THR . 7.3 mtt -85.19 142.22 29.61 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.285 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.431 ' HB2' ' HG3' ' A' ' 17' ' ' ARG . 91.6 mttt -89.82 144.26 31.38 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 170.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -46.31 109.77 0.22 Allowed 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 123.463 2.776 . . . . 0.0 113.594 -174.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.64 ' HA ' ' O ' ' A' ' 79' ' ' THR . 8.8 tt0 70.52 67.05 0.2 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.794 175.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.536 ' HA ' ' NE ' ' A' ' 17' ' ' ARG . 4.7 mmp_? -122.76 169.28 11.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.03 175.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.68 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 19.4 tttm -146.77 104.81 3.76 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.34 0.4 . . . . 0.0 111.274 -175.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -111.74 111.5 22.51 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.053 -177.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 76' ' ' MET . 29.2 t -90.78 111.06 22.29 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 170.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -133.86 150.01 51.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.635 0.731 . . . . 0.0 112.687 -168.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.7 p -91.18 160.91 15.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.679 177.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.436 HG22 ' HA ' ' A' ' 71' ' ' LYS . 73.8 mt -111.2 126.29 68.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.219 -174.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.521 HD12 ' N ' ' A' ' 25' ' ' LYS . 1.8 pp -92.53 -24.44 5.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.641 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.521 ' N ' HD12 ' A' ' 24' ' ' ILE . 24.8 mtpp -147.44 132.93 18.66 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.421 ' O ' ' HB3' ' A' ' 92' ' ' HIS . 15.6 m -55.05 119.4 5.39 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.407 ' HB3' HD23 ' A' ' 91' ' ' LEU . 5.7 p90 -137.34 156.72 47.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.737 0.78 . . . . 0.0 112.833 -170.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.588 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 15.1 t60 -109.88 124.65 51.73 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.118 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.574 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 39.3 mt -94.45 135.08 29.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 169.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.593 ' HB2' ' HB3' ' B' ' 66' ' ' ASP . 50.1 p -120.31 -15.85 8.55 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -169.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -160.39 145.21 10.84 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 119.288 -1.434 . . . . 0.0 113.324 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.443 HG23 ' HG ' ' A' ' 87' ' ' LEU . 12.2 p -129.85 121.55 52.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 168.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.07 154.38 43.9 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 121.928 -0.483 . . . . 0.0 112.018 -173.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.558 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.4 pp -125.15 144.0 50.65 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.499 0.666 . . . . 0.0 110.836 178.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -110.27 -45.98 3.49 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 173.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -103.63 128.66 50.89 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.593 171.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.496 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 146.63 163.01 10.18 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 119.627 -1.273 . . . . 0.0 113.501 176.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -102.24 -47.24 4.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.494 0.188 . . . . 0.0 110.97 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -152.16 133.71 14.63 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.093 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.478 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -134.29 113.46 11.97 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.391 0.615 . . . . 0.0 110.122 167.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -97.81 112.72 24.52 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 174.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.7 tp -83.81 113.29 20.82 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.557 -174.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.532 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 97.9 m-85 -115.78 141.45 48.07 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.541 ' HB2' ' CD1' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -129.85 131.82 46.25 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 173.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -110.71 114.96 28.74 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.028 177.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.619 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -129.91 142.54 50.64 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 58.65 29.24 18.28 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.949 0.404 . . . . 0.0 110.314 -174.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt 63.58 24.51 14.02 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.735 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 23.9 tp60 -115.65 126.69 54.47 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -83.44 125.01 31.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.891 0.377 . . . . 0.0 110.696 -177.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.465 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 66.3 m-85 -121.03 133.32 55.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.943 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -82.1 107.74 14.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 169.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.51 HG13 ' CD2' ' E' ' 88' ' ' LEU . 2.4 t -80.06 -49.56 18.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.64 -171.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.534 ' HB1' HG11 ' A' ' 63' ' ' VAL . . . -160.05 148.9 17.34 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.132 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.6 m -109.79 102.22 11.03 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 173.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.415 ' CG1' HG11 ' A' ' 85' ' ' VAL . 7.3 p -117.77 114.36 45.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.658 0.742 . . . . 0.0 110.016 -177.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 81.0 p -123.05 -178.3 3.92 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.55 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -63.47 -21.54 66.37 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.996 0.426 . . . . 0.0 110.444 170.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.406 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -83.47 -40.72 18.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.229 0.537 . . . . 0.0 110.244 177.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.1 mt -113.22 82.68 5.82 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 173.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 12.5 Cg_exo -70.06 -0.11 6.69 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.156 2.57 . . . . 0.0 114.059 -167.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.28 127.12 2.44 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.175 0.512 . . . . 0.0 111.445 -176.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.534 HG11 ' HB1' ' A' ' 54' ' ' ALA . 85.2 t -117.44 106.22 19.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.311 174.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.47 121.68 27.07 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 173.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -140.69 168.16 20.46 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.766 -173.001 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.569 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 11.6 t0 -118.85 105.29 11.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.359 0.6 . . . . 0.0 110.497 -177.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.591 HD21 HD23 ' E' ' 88' ' ' LEU . 15.1 mt -118.8 144.43 46.32 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.655 177.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.447 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 57.5 t30 -148.44 114.79 5.89 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 173.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.403 ' CZ ' HD22 ' A' ' 67' ' ' LEU . 51.7 m-85 -110.13 164.51 12.57 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.091 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.536 ' HB2' ' O ' ' E' ' 6' ' ' ALA . 33.0 t -107.85 149.15 28.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.859 0.361 . . . . 0.0 110.694 -177.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.436 ' HA ' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -68.14 -11.95 60.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.235 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.3 -5.76 61.83 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.537 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -100.25 167.9 10.13 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -145.23 128.21 16.5 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.619 HG22 ' HB2' ' A' ' 46' ' ' ALA . 15.4 pt -134.89 165.49 31.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.111 0.481 . . . . 0.0 111.79 -169.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.517 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 4.5 mtm -120.91 123.5 42.65 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.595 173.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.541 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -105.96 127.61 53.26 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.587 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.68 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 40.5 p90 -154.95 144.13 21.05 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 120.031 -0.668 . . . . 0.0 112.006 -177.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.64 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 6.3 p -116.18 141.64 47.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.394 -177.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.72 153.37 23.04 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.221 176.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.93 -175.36 36.69 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -175.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -118.78 104.85 10.96 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 122.118 0.961 . . . . 0.0 110.499 176.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.496 ' CB ' ' HA3' ' A' ' 37' ' ' GLY . . . -166.1 154.83 11.16 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.22 170.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.3 t -106.3 111.19 23.67 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.558 HG12 ' HB3' ' A' ' 34' ' ' LEU . 3.4 m -111.33 138.08 41.25 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 CA-C-O 121.219 0.533 . . . . 0.0 112.191 -174.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 7.4 t -108.91 118.25 36.32 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.598 HD13 HD23 ' A' ' 11' ' ' LEU . 5.4 mp -89.73 149.26 22.82 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.532 174.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.592 HD23 HD21 ' B' ' 67' ' ' LEU . 1.3 tp -132.02 140.71 49.01 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.938 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.39 -167.14 25.52 Favored Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.695 -177.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.436 ' CD2' ' HB3' ' B' ' 68' ' ' ASN . 12.9 p90 -153.34 132.18 12.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.746 0.784 . . . . 0.0 111.643 177.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.416 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 22.3 mt -64.62 126.97 29.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.112 173.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.421 ' HB3' ' O ' ' A' ' 26' ' ' SER . 28.4 t60 -66.84 144.43 56.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.472 0.653 . . . . 0.0 111.275 -175.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.414 ' CB ' ' HB3' ' A' ' 5' ' ' MET . 7.7 p-10 -73.39 -154.24 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.012 177.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.8 pt -72.19 133.13 32.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.418 0.628 . . . . 0.0 111.45 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.445 ' CB ' ' HG3' ' E' ' 5' ' ' MET . 8.6 m-20 -81.12 64.19 5.76 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.007 176.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 26.6 m 63.25 -165.15 0.24 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.025 -175.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 70.62 45.68 51.73 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.344 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.7 p . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.571 -0.728 . . . . 0.0 110.437 178.994 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 120.734 0.302 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -80.05 -47.97 14.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.105 0.479 . . . . 0.0 109.933 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 135.23 -175.87 20.41 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.652 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.39 -48.01 10.81 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . 0.416 ' HG3' ' CB ' ' C' ' 95' ' ' ASP . 22.7 mmt 58.57 -100.14 0.11 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 114.834 -1.076 . . . . 0.0 112.933 172.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.579 ' O ' ' HB2' ' C' ' 70' ' ' SER . . . -86.18 131.06 34.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.427 -177.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 38.4 mtt -124.21 144.09 50.14 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.282 0.563 . . . . 0.0 112.041 -175.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.528 ' CE1' HD21 ' C' ' 44' ' ' LEU . 29.1 t80 -62.36 145.73 53.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.47 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -135.72 147.33 48.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.112 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.504 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -150.95 153.81 25.21 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.185 178.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.626 HD23 HD13 ' B' ' 87' ' ' LEU . 33.6 tp -147.7 106.59 3.83 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . 0.491 ' HA ' ' HA ' ' B' ' 86' ' ' SER . 2.3 p30 -97.88 110.58 23.12 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.597 0.713 . . . . 0.0 110.959 177.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . 0.439 ' SD ' HG23 ' B' ' 79' ' ' THR . 7.3 mtt -85.14 142.17 29.68 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.366 -178.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.439 ' HB2' ' HG3' ' B' ' 17' ' ' ARG . 91.5 mttt -89.77 144.31 31.53 Favored Pre-proline 0 C--N 1.316 -0.874 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 170.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -46.3 109.69 0.22 Allowed 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 123.56 2.84 . . . . 0.0 113.496 -174.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.642 ' HA ' ' O ' ' B' ' 79' ' ' THR . 8.8 tt0 70.54 67.09 0.2 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.734 175.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.534 ' NE ' ' HA ' ' B' ' 17' ' ' ARG . 4.6 mmp_? -122.76 169.18 11.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.089 175.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.67 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 19.5 tttm -146.68 104.77 3.77 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 123.325 0.391 . . . . 0.0 111.269 -175.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -111.76 111.53 22.57 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.079 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 29.3 t -90.73 111.05 22.26 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -133.92 150.09 51.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.667 0.746 . . . . 0.0 112.66 -168.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 3.8 p -91.25 160.91 15.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.665 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.436 HG22 ' HA ' ' B' ' 71' ' ' LYS . 74.0 mt -111.24 126.31 68.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.144 -174.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.527 HD12 ' N ' ' B' ' 25' ' ' LYS . 1.8 pp -92.49 -24.44 5.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.692 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.527 ' N ' HD12 ' B' ' 24' ' ' ILE . 24.9 mtpp -147.36 132.86 18.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.87 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . 0.426 ' O ' ' HB3' ' B' ' 92' ' ' HIS . 15.5 m -54.96 119.32 5.25 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 175.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . 0.42 ' HB3' HD23 ' B' ' 91' ' ' LEU . 5.8 p90 -137.31 156.62 48.03 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.669 0.747 . . . . 0.0 112.853 -170.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' HIS . . . . . 0.587 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 15.1 t60 -109.92 124.59 51.64 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.151 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.571 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 39.3 mt -94.39 135.1 29.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 169.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.587 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 48.7 p -120.34 -15.79 8.54 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -169.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -160.31 145.16 10.79 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 119.301 -1.428 . . . . 0.0 113.377 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.439 HG23 ' HG ' ' B' ' 87' ' ' LEU . 12.3 p -129.81 121.59 52.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 168.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.11 154.31 43.79 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.983 -173.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.556 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.4 pp -125.08 143.99 50.64 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.468 0.651 . . . . 0.0 110.791 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -110.15 -46.12 3.49 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 173.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -103.57 128.67 50.78 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.515 171.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.493 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 146.55 163.01 10.17 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 119.676 -1.25 . . . . 0.0 113.6 175.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -102.3 -47.04 4.63 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.19 -0.204 . . . . 0.0 111.043 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -152.22 133.68 14.55 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.999 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.48 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -134.38 113.46 11.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.474 0.654 . . . . 0.0 110.127 167.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -97.83 112.7 24.51 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 174.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 43.6 tp -83.71 113.37 20.83 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.56 -174.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . 0.532 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 98.0 m-85 -115.89 141.41 48.14 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 176.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.551 ' HB2' ' CD1' ' B' ' 77' ' ' PHE . 0.1 OUTLIER -129.85 131.9 46.27 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 173.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -110.7 114.94 28.7 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.01 177.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.622 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -129.91 142.54 50.64 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 58.6 29.31 18.31 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.994 0.426 . . . . 0.0 110.338 -174.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt 63.5 24.5 14.09 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.705 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.473 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 24.0 tp60 -115.64 126.65 54.43 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -83.38 124.94 31.15 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.972 0.415 . . . . 0.0 110.702 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.431 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 66.4 m-85 -120.97 133.37 55.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.899 176.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -82.06 107.63 14.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 169.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.528 HG13 ' CD2' ' A' ' 88' ' ' LEU . 2.4 t -80.08 -49.54 18.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.61 -171.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.528 ' HB1' HG11 ' B' ' 63' ' ' VAL . . . -159.98 148.89 17.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.171 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 55.4 m -109.85 102.28 11.06 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 173.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.414 ' CG1' HG11 ' B' ' 85' ' ' VAL . 7.3 p -117.78 114.41 45.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.669 0.747 . . . . 0.0 110.001 -177.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 81.3 p -123.12 -178.38 3.95 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.608 -174.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -63.45 -21.47 66.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.932 0.396 . . . . 0.0 110.484 170.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.402 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -83.48 -40.77 18.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.206 0.527 . . . . 0.0 110.216 177.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 80.4 mt -113.22 82.63 5.78 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 12.5 Cg_exo -70.02 -0.2 6.78 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.17 2.58 . . . . 0.0 114.066 -167.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.21 127.17 2.47 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.159 0.504 . . . . 0.0 111.44 -176.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.528 HG11 ' HB1' ' B' ' 54' ' ' ALA . 85.5 t -117.35 106.21 19.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.35 174.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.49 121.7 27.1 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 173.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' B' ' 30' ' ' SER . 0.6 OUTLIER -140.76 168.12 20.55 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.741 -173.026 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . 0.593 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 11.8 t0 -118.73 105.26 11.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.264 0.554 . . . . 0.0 110.565 -177.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.592 HD21 HD23 ' A' ' 88' ' ' LEU . 15.1 mt -118.76 144.43 46.28 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.68 177.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . 0.436 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 57.4 t30 -148.52 114.8 5.86 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 173.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . 0.401 ' CZ ' HD22 ' B' ' 67' ' ' LEU . 51.7 m-85 -110.14 164.56 12.52 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.12 -178.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.536 ' HB2' ' O ' ' A' ' 6' ' ' ALA . 33.1 t -107.93 149.18 28.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 0.0 110.677 -177.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.436 ' HA ' HG22 ' B' ' 23' ' ' ILE . 0.0 OUTLIER -68.11 -11.95 60.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.271 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.28 -5.76 61.86 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.585 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -100.29 167.96 10.08 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -145.22 128.13 16.43 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.622 HG22 ' HB2' ' B' ' 46' ' ' ALA . 15.4 pt -134.84 165.44 31.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.082 0.467 . . . . 0.0 111.756 -169.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.52 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 4.5 mtm -120.91 123.61 42.93 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 173.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . 0.551 ' CD1' ' HB2' ' B' ' 44' ' ' LEU . 0.8 OUTLIER -106.02 127.62 53.29 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.441 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.67 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 40.4 p90 -154.9 144.19 21.16 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.993 -0.683 . . . . 0.0 112.034 -177.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.642 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 6.4 p -116.29 141.63 47.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.356 -177.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.72 153.41 22.99 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.241 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.79 -175.37 36.92 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -175.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -118.75 104.87 10.99 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.509 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.493 ' CB ' ' HA3' ' B' ' 37' ' ' GLY . . . -166.07 154.77 11.18 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.2 170.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 19.0 t -106.16 111.17 23.67 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.556 HG12 ' HB3' ' B' ' 34' ' ' LEU . 3.4 m -111.44 138.17 41.02 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 CA-C-O 121.3 0.571 . . . . 0.0 112.129 -174.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' B' ' 12' ' ' ASN . 7.4 t -108.94 118.25 36.32 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.793 178.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.626 HD13 HD23 ' B' ' 11' ' ' LEU . 5.4 mp -89.79 149.27 22.77 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.5 174.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.585 HD23 HD21 ' C' ' 67' ' ' LEU . 1.3 tp -131.99 140.69 49.04 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.971 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.41 -167.2 25.64 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.704 -177.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' TYR . . . . . 0.43 ' CD2' ' HB3' ' C' ' 68' ' ' ASN . 13.0 p90 -153.4 132.21 12.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.777 0.798 . . . . 0.0 111.603 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . 0.42 HD23 ' HB3' ' B' ' 27' ' ' PHE . 22.2 mt -64.49 126.98 29.58 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.131 173.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . 0.426 ' HB3' ' O ' ' B' ' 26' ' ' SER . 28.3 t60 -66.85 144.36 56.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.478 0.656 . . . . 0.0 111.23 -175.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . 0.41 ' CB ' ' HB3' ' B' ' 5' ' ' MET . 7.8 p-10 -73.34 -154.27 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.504 -1.225 . . . . 0.0 111.056 177.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 31.2 pt -72.15 133.19 32.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.418 0.628 . . . . 0.0 111.424 -177.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . 0.483 ' CB ' ' HG3' ' A' ' 5' ' ' MET . 8.5 m-20 -81.13 64.13 5.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.966 176.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 27.9 m 63.28 -165.22 0.24 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.003 -175.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . 70.73 45.75 50.6 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.305 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 10.6 p . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.768 -0.634 . . . . 0.0 110.445 179.034 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 120.788 0.328 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -80.12 -48.02 13.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.033 0.444 . . . . 0.0 109.833 176.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . 135.25 -175.91 20.38 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.625 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.36 -48.09 10.76 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 5' ' ' MET . . . . . 0.468 ' HG3' ' CB ' ' D' ' 95' ' ' ASP . 22.8 mmt 58.56 -100.14 0.11 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.982 172.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 6' ' ' ALA . . . . . 0.562 ' O ' ' HB2' ' D' ' 70' ' ' SER . . . -86.15 131.06 34.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.621 0.248 . . . . 0.0 110.434 -177.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 38.4 mtt -124.19 143.95 50.21 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.104 0.478 . . . . 0.0 112.106 -175.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 8' ' ' PHE . . . . . 0.502 ' CE1' HD21 ' D' ' 44' ' ' LEU . 28.9 t80 -62.35 145.78 52.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.492 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -135.65 147.44 48.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.177 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . 0.447 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -151.04 153.8 25.19 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.203 178.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.624 HD23 HD13 ' C' ' 87' ' ' LEU . 33.4 tp -147.78 106.57 3.82 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . 0.483 ' HA ' ' HA ' ' C' ' 86' ' ' SER . 2.3 p30 -97.91 110.67 23.2 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.681 0.753 . . . . 0.0 110.937 177.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 13' ' ' MET . . . . . 0.445 ' SD ' HG23 ' C' ' 79' ' ' THR . 7.2 mtt -85.25 142.17 29.59 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.019 -0.992 . . . . 0.0 111.324 -178.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . 0.431 ' HB2' ' HG3' ' C' ' 17' ' ' ARG . 91.4 mttt -89.67 144.17 31.45 Favored Pre-proline 0 C--N 1.315 -0.902 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 170.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -46.23 109.65 0.21 Allowed 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 123.503 2.802 . . . . 0.0 113.543 -174.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . 0.634 ' HA ' ' O ' ' C' ' 79' ' ' THR . 8.8 tt0 70.59 67.08 0.19 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.767 175.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 17' ' ' ARG . . . . . 0.527 ' NE ' ' HA ' ' C' ' 17' ' ' ARG . 4.7 mmp_? -122.76 169.22 11.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.133 175.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 18' ' ' LYS . . . . . 0.682 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 19.4 tttm -146.67 104.8 3.77 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.346 0.404 . . . . 0.0 111.305 -175.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -111.76 111.53 22.57 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.093 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 29.5 t -90.84 111.05 22.29 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 170.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -133.89 150.11 51.34 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.693 0.758 . . . . 0.0 112.645 -168.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 3.8 p -91.2 160.83 15.34 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.657 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . 0.445 HG22 ' HA ' ' C' ' 71' ' ' LYS . 74.1 mt -111.13 126.25 68.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.171 -174.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . 0.537 HD12 ' N ' ' C' ' 25' ' ' LYS . 1.8 pp -92.5 -24.38 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.69 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . 0.537 ' N ' HD12 ' C' ' 24' ' ' ILE . 24.8 mtpp -147.44 132.94 18.67 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.836 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . 0.427 ' O ' ' HB3' ' C' ' 92' ' ' HIS . 15.6 m -54.98 119.42 5.39 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 27' ' ' PHE . . . . . 0.421 ' HB3' HD23 ' C' ' 91' ' ' LEU . 5.8 p90 -137.38 156.63 47.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.694 0.759 . . . . 0.0 112.788 -170.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 28' ' ' HIS . . . . . 0.591 ' HA ' ' O ' ' C' ' 67' ' ' LEU . 15.1 t60 -109.9 124.61 51.66 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.244 -1.343 . . . . 0.0 110.101 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . 0.573 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 39.4 mt -94.45 134.99 30.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 169.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.589 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 50.0 p -120.2 -15.88 8.6 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -169.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -160.34 145.17 10.8 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.382 -1.389 . . . . 0.0 113.38 178.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.449 HG23 ' HG ' ' C' ' 87' ' ' LEU . 12.1 p -129.8 121.63 52.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 168.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.18 154.38 43.82 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.979 -173.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.555 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.4 pp -125.11 144.02 50.63 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.468 0.651 . . . . 0.0 110.787 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -110.16 -46.01 3.51 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -103.64 128.65 50.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.551 171.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 37' ' ' GLY . . . . . 0.483 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 146.67 163.0 10.18 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 119.664 -1.255 . . . . 0.0 113.576 176.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -102.25 -47.22 4.58 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.463 0.173 . . . . 0.0 110.976 177.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -152.16 133.75 14.65 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.063 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.469 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -134.35 113.42 11.89 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.362 0.601 . . . . 0.0 110.097 168.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -97.77 112.57 24.42 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 174.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 43.7 tp -83.76 113.32 20.82 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.577 -174.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 43' ' ' TYR . . . . . 0.529 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 98.0 m-85 -115.8 141.53 47.98 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.553 ' HB2' ' CD1' ' C' ' 77' ' ' PHE . 0.1 OUTLIER -129.91 131.79 46.15 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 173.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -110.74 114.85 28.53 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.981 177.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.597 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -129.86 142.47 50.66 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 58.78 29.17 18.36 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.89 0.376 . . . . 0.0 110.284 -174.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt 63.55 24.57 14.07 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.681 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 24.0 tp60 -115.67 126.67 54.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -83.42 124.85 31.09 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.869 0.366 . . . . 0.0 110.758 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . 0.504 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 66.8 m-85 -120.91 133.35 55.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 176.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -82.14 107.7 14.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 169.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 53' ' ' VAL . . . . . 0.509 HG13 ' CD2' ' B' ' 88' ' ' LEU . 2.4 t -80.07 -49.58 18.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.643 -171.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 54' ' ' ALA . . . . . 0.525 ' HB1' HG11 ' C' ' 63' ' ' VAL . . . -159.99 148.98 17.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.232 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 54.1 m -109.81 102.19 10.99 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 173.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . 0.412 ' CG1' HG11 ' C' ' 85' ' ' VAL . 7.4 p -117.69 114.39 45.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.653 0.739 . . . . 0.0 110.032 -177.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 81.2 p -123.05 -178.33 3.93 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.581 -174.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -63.57 -21.4 66.33 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.887 0.375 . . . . 0.0 110.491 170.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . 0.402 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -83.52 -40.67 18.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.166 0.508 . . . . 0.0 110.228 177.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 80.6 mt -113.28 82.71 5.94 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 174.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 61' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 12.5 Cg_exo -70.06 -0.13 6.71 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.15 2.567 . . . . 0.0 114.052 -167.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.3 127.18 2.44 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.146 0.498 . . . . 0.0 111.418 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.525 HG11 ' HB1' ' C' ' 54' ' ' ALA . 86.4 t -117.34 106.14 19.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.35 174.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.45 121.7 27.08 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 173.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' C' ' 30' ' ' SER . 0.6 OUTLIER -140.71 168.2 20.36 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.736 -172.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 66' ' ' ASP . . . . . 0.538 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 11.6 t0 -118.88 105.18 11.24 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.322 0.582 . . . . 0.0 110.569 -177.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.591 ' O ' ' HA ' ' C' ' 28' ' ' HIS . 15.2 mt -118.7 144.48 46.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.651 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . 0.43 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 57.4 t30 -148.55 114.74 5.83 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 173.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -110.09 164.5 12.57 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.122 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . 0.579 ' HB2' ' O ' ' B' ' 6' ' ' ALA . 33.1 t -107.85 149.2 28.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.371 . . . . 0.0 110.679 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . 0.445 ' HA ' HG22 ' C' ' 23' ' ' ILE . 0.0 OUTLIER -68.19 -11.85 59.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.279 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.41 -5.8 61.63 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.565 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -100.13 167.9 10.16 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -145.2 128.14 16.45 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.597 HG22 ' HB2' ' C' ' 46' ' ' ALA . 15.3 pt -134.87 165.51 30.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.992 0.425 . . . . 0.0 111.75 -169.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.515 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 4.5 mtm -120.85 123.47 42.65 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.612 173.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 77' ' ' PHE . . . . . 0.553 ' CD1' ' HB2' ' C' ' 44' ' ' LEU . 0.8 OUTLIER -105.95 127.59 53.25 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.488 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 78' ' ' TYR . . . . . 0.682 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 40.5 p90 -154.92 144.16 21.12 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.086 -0.645 . . . . 0.0 111.994 -177.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . 0.634 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 6.6 p -116.19 141.54 48.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.351 -177.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.69 153.44 22.93 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.248 175.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.83 -175.47 36.95 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -175.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -118.73 104.83 10.96 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 122.191 0.996 . . . . 0.0 110.58 176.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . 0.483 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -166.1 154.82 11.16 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.188 170.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 19.9 t -106.29 111.29 23.82 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.555 HG12 ' HB3' ' C' ' 34' ' ' LEU . 3.4 m -111.48 138.16 41.11 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 CA-C-O 121.304 0.573 . . . . 0.0 112.137 -174.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' C' ' 12' ' ' ASN . 7.4 t -108.99 118.37 36.63 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.76 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . 0.624 HD13 HD23 ' C' ' 11' ' ' LEU . 5.4 mp -89.84 149.28 22.73 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.525 174.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . 0.592 HD23 HD21 ' D' ' 67' ' ' LEU . 1.3 tp -131.98 140.68 49.04 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.018 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.32 -167.12 25.42 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.683 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 90' ' ' TYR . . . . . 0.464 ' CD2' ' HB3' ' D' ' 68' ' ' ASN . 13.2 p90 -153.4 132.18 12.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.767 0.794 . . . . 0.0 111.656 177.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . 0.421 HD23 ' HB3' ' C' ' 27' ' ' PHE . 21.9 mt -64.52 127.02 29.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.195 173.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 92' ' ' HIS . . . . . 0.427 ' HB3' ' O ' ' C' ' 26' ' ' SER . 28.4 t60 -66.86 144.37 56.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.489 0.661 . . . . 0.0 111.231 -175.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 93' ' ' ASP . . . . . 0.408 ' CB ' ' HB3' ' C' ' 5' ' ' MET . 7.7 p-10 -73.37 -154.2 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.007 177.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 31.0 pt -72.28 133.15 32.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.431 0.634 . . . . 0.0 111.419 -177.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 95' ' ' ASP . . . . . 0.416 ' CB ' ' HG3' ' B' ' 5' ' ' MET . 8.7 m-20 -81.14 64.23 5.8 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.958 176.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 27.8 m 63.14 -165.25 0.24 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.943 -175.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 70.78 45.58 51.35 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.432 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 10.7 p . . . . . 0 C--O 1.252 1.222 0 CA-C-O 118.626 -0.702 . . . . 0.0 110.433 179.139 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 120.76 0.314 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -80.1 -48.06 13.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.13 0.491 . . . . 0.0 109.88 176.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . 135.28 -175.9 20.4 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.566 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.3 -48.09 10.8 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 5' ' ' MET . . . . . 0.487 ' HG3' ' CB ' ' E' ' 95' ' ' ASP . 22.6 mmt 58.5 -100.07 0.1 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.918 172.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 6' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' E' ' 70' ' ' SER . . . -86.21 131.06 34.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.652 0.263 . . . . 0.0 110.453 -177.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 38.3 mtt -124.2 144.11 50.13 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.233 0.539 . . . . 0.0 112.041 -175.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 8' ' ' PHE . . . . . 0.494 ' CE1' HD21 ' E' ' 44' ' ' LEU . 29.4 t80 -62.34 145.77 52.96 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.507 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 9' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -135.75 147.4 48.41 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.079 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . 0.46 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -151.03 153.87 25.23 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.179 178.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.614 HD23 HD13 ' D' ' 87' ' ' LEU . 33.6 tp -147.69 106.54 3.83 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.34 -0.245 . . . . 0.0 110.34 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . 0.482 ' HA ' ' HA ' ' D' ' 86' ' ' SER . 2.3 p30 -97.9 110.56 23.11 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.63 0.729 . . . . 0.0 110.979 177.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 13' ' ' MET . . . . . 0.435 ' SD ' HG23 ' D' ' 79' ' ' THR . 7.3 mtt -85.15 142.17 29.67 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.422 -178.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 14' ' ' LYS . . . . . 0.447 ' HB2' ' HG3' ' D' ' 17' ' ' ARG . 91.5 mttt -89.74 144.18 31.37 Favored Pre-proline 0 C--N 1.316 -0.891 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 170.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -46.27 109.73 0.22 Allowed 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 123.414 2.743 . . . . 0.0 113.605 -174.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . 0.619 ' HA ' ' O ' ' D' ' 79' ' ' THR . 8.9 tt0 70.61 67.07 0.19 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.762 175.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 17' ' ' ARG . . . . . 0.52 ' HA ' ' NE ' ' D' ' 17' ' ' ARG . 4.7 mmp_? -122.76 169.2 11.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.091 175.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . 0.689 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 19.4 tttm -146.69 104.79 3.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 123.292 0.37 . . . . 0.0 111.355 -175.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -111.69 111.55 22.62 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.115 -177.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 29.3 t -90.87 110.94 22.17 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -133.84 150.2 51.39 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.676 0.751 . . . . 0.0 112.743 -168.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 3.7 p -91.31 160.94 15.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.643 178.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . 0.43 HG22 ' HA ' ' D' ' 71' ' ' LYS . 73.8 mt -111.19 126.29 68.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.241 -174.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . 0.536 HD12 ' N ' ' D' ' 25' ' ' LYS . 1.8 pp -92.5 -24.41 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.765 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . 0.536 ' N ' HD12 ' D' ' 24' ' ' ILE . 24.8 mtpp -147.43 132.86 18.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.8 178.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 26' ' ' SER . . . . . 0.421 ' O ' ' HB3' ' D' ' 92' ' ' HIS . 15.5 m -54.96 119.4 5.35 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 175.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 27' ' ' PHE . . . . . 0.42 ' HB3' HD23 ' D' ' 91' ' ' LEU . 5.9 p90 -137.38 156.74 47.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.789 0.804 . . . . 0.0 112.792 -170.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 28' ' ' HIS . . . . . 0.597 ' HE2' ' HB3' ' D' ' 30' ' ' SER . 15.2 t60 -109.98 124.7 51.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.221 -1.354 . . . . 0.0 110.07 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 29' ' ' ILE . . . . . 0.581 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 39.5 mt -94.55 135.05 29.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 169.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . 0.597 ' HB3' ' HE2' ' D' ' 28' ' ' HIS . 50.1 p -120.25 -15.89 8.57 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -169.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 31' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -160.27 145.16 10.81 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 119.374 -1.393 . . . . 0.0 113.366 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.458 HG23 ' HG ' ' D' ' 87' ' ' LEU . 12.1 p -129.85 121.61 52.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 168.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.06 154.41 43.93 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.94 -173.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 34' ' ' LEU . . . . . 0.553 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.4 pp -125.15 144.05 50.63 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.475 0.655 . . . . 0.0 110.777 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -110.17 -46.08 3.49 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 173.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -103.63 128.64 50.9 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.562 171.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . 0.493 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 146.63 163.07 10.22 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 119.682 -1.247 . . . . 0.0 113.559 176.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -102.29 -47.22 4.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.59 0.233 . . . . 0.0 111.011 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -152.12 133.67 14.63 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.059 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -134.35 113.44 11.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.455 0.645 . . . . 0.0 110.177 167.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' D' ' 79' ' ' THR . 98.6 mttt -97.77 112.67 24.48 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 43.5 tp -83.74 113.34 20.82 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.607 -174.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 43' ' ' TYR . . . . . 0.523 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 98.0 m-85 -115.77 141.48 48.03 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.554 ' HB2' ' CD1' ' D' ' 77' ' ' PHE . 0.1 OUTLIER -129.96 131.83 46.09 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 173.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 45' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -110.65 115.0 28.83 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.888 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.61 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -129.91 142.57 50.64 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 58.7 29.19 18.27 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.315 0.384 . . . . 0.0 110.28 -174.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt 63.61 24.48 13.98 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.711 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . 0.47 ' HG3' HD21 ' C' ' 12' ' ' ASN . 24.1 tp60 -115.73 126.64 54.33 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -83.39 124.85 31.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.807 0.336 . . . . 0.0 110.755 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . 0.447 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 66.7 m-85 -120.89 133.35 55.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.904 176.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.0 tp -82.06 107.72 14.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 169.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 53' ' ' VAL . . . . . 0.499 HG13 ' CD2' ' C' ' 88' ' ' LEU . 2.4 t -80.09 -49.6 18.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.589 -171.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 54' ' ' ALA . . . . . 0.521 ' HB1' HG11 ' D' ' 63' ' ' VAL . . . -160.01 148.93 17.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.173 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 53.3 m -109.81 102.28 11.08 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 56' ' ' VAL . . . . . 0.406 ' CG1' HG11 ' D' ' 85' ' ' VAL . 7.4 p -117.74 114.33 45.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.612 0.72 . . . . 0.0 109.981 -177.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 81.2 p -123.05 -178.27 3.91 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.523 -174.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -63.57 -21.46 66.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.944 0.402 . . . . 0.0 110.461 170.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 59' ' ' ALA . . . . . 0.405 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -83.51 -40.62 18.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.124 0.488 . . . . 0.0 110.222 177.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 80.3 mt -113.29 82.6 5.88 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 174.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 61' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 12.4 Cg_exo -69.99 -0.18 6.73 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.186 2.591 . . . . 0.0 114.114 -167.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.25 127.1 2.45 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.112 0.482 . . . . 0.0 111.483 -176.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.521 HG11 ' HB1' ' D' ' 54' ' ' ALA . 87.2 t -117.3 106.09 19.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.426 174.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.48 121.73 27.13 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 173.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 65' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' D' ' 30' ' ' SER . 0.6 OUTLIER -140.72 168.2 20.35 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.728 -173.034 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 66' ' ' ASP . . . . . 0.576 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 11.9 t0 -118.82 105.23 11.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.251 0.548 . . . . 0.0 110.586 -177.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.592 HD21 HD23 ' C' ' 88' ' ' LEU . 15.1 mt -118.8 144.43 46.32 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.674 177.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 68' ' ' ASN . . . . . 0.464 ' HB3' ' CD2' ' C' ' 90' ' ' TYR . 57.3 t30 -148.47 114.83 5.89 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 173.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 69' ' ' PHE . . . . . 0.4 ' CZ ' HD22 ' D' ' 67' ' ' LEU . 51.8 m-85 -110.15 164.58 12.5 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.106 -178.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . 0.562 ' HB2' ' O ' ' C' ' 6' ' ' ALA . 33.0 t -107.97 149.12 28.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.856 0.36 . . . . 0.0 110.723 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 71' ' ' LYS . . . . . 0.43 ' HA ' HG22 ' D' ' 23' ' ' ILE . 0.0 OUTLIER -67.94 -12.03 59.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.344 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.35 -5.73 61.77 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.526 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -100.2 167.92 10.13 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -145.21 128.16 16.46 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.61 HG22 ' HB2' ' D' ' 46' ' ' ALA . 15.4 pt -134.92 165.39 31.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.077 0.465 . . . . 0.0 111.771 -169.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 76' ' ' MET . . . . . 0.521 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 4.5 mtm -120.85 123.5 42.72 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 173.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 77' ' ' PHE . . . . . 0.554 ' CD1' ' HB2' ' D' ' 44' ' ' LEU . 0.8 OUTLIER -106.02 127.59 53.27 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.502 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 78' ' ' TYR . . . . . 0.689 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 40.8 p90 -154.93 144.16 21.11 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.967 -177.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 79' ' ' THR . . . . . 0.619 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 6.5 p -116.22 141.61 47.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.364 -177.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.69 153.31 23.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.289 176.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.92 -175.36 36.7 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -175.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -118.81 104.97 11.05 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 118.114 0.957 . . . . 0.0 110.46 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . 0.493 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -166.15 154.77 11.02 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.204 170.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 19.9 t -106.25 111.23 23.74 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.553 HG12 ' HB3' ' D' ' 34' ' ' LEU . 3.4 m -111.43 138.11 41.24 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.706 0 CA-C-O 121.289 0.566 . . . . 0.0 112.144 -174.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 86' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' D' ' 12' ' ' ASN . 7.4 t -108.9 118.31 36.47 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.353 -0.84 . . . . 0.0 108.791 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 87' ' ' LEU . . . . . 0.614 HD13 HD23 ' D' ' 11' ' ' LEU . 5.4 mp -89.76 149.31 22.78 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.524 174.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.572 HD23 HD21 ' E' ' 67' ' ' LEU . 1.3 tp -132.05 140.68 48.97 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.956 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.32 -167.08 25.36 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.683 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 90' ' ' TYR . . . . . 0.442 ' CD2' ' HB3' ' E' ' 68' ' ' ASN . 13.0 p90 -153.42 132.13 12.31 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.74 0.781 . . . . 0.0 111.636 177.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . 0.42 HD23 ' HB3' ' D' ' 27' ' ' PHE . 22.4 mt -64.58 127.03 29.78 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.088 173.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . 0.421 ' HB3' ' O ' ' D' ' 26' ' ' SER . 28.3 t60 -66.88 144.38 56.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.366 0.603 . . . . 0.0 111.289 -175.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 93' ' ' ASP . . . . . 0.416 ' CB ' ' HB3' ' D' ' 5' ' ' MET . 7.7 p-10 -73.35 -154.27 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.966 177.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 31.1 pt -72.21 133.15 32.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.441 0.639 . . . . 0.0 111.5 -177.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 95' ' ' ASP . . . . . 0.468 ' CB ' ' HG3' ' C' ' 5' ' ' MET . 8.6 m-20 -81.11 64.2 5.76 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.947 176.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 28.1 m 63.24 -165.36 0.24 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.955 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . 70.87 45.67 50.25 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.311 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 10.4 p . . . . . 0 C--O 1.251 1.181 0 CA-C-O 118.556 -0.735 . . . . 0.0 110.333 179.144 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 . . . . . 0 N--CA 1.48 1.072 0 CA-C-O 120.7 0.286 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -80.13 -48.04 13.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.131 0.491 . . . . 0.0 109.875 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . 135.26 -176.01 20.32 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.589 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.23 -48.08 10.87 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 5' ' ' MET . . . . . 0.445 ' HG3' ' CB ' ' A' ' 95' ' ' ASP . 22.7 mmt 58.47 -99.98 0.1 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.956 172.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 6' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' A' ' 70' ' ' SER . . . -86.31 131.07 34.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.796 0.331 . . . . 0.0 110.373 -177.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 38.6 mtt -124.14 144.14 50.08 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.214 0.53 . . . . 0.0 112.096 -176.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 8' ' ' PHE . . . . . 0.493 ' CE1' HD21 ' A' ' 44' ' ' LEU . 29.0 t80 -62.4 145.77 53.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.492 -178.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 9' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -135.72 147.38 48.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.096 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 10' ' ' GLY . . . . . 0.465 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -151.0 153.81 25.2 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.273 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . 0.617 HD23 HD13 ' E' ' 87' ' ' LEU . 33.2 tp -147.77 106.6 3.83 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 12' ' ' ASN . . . . . 0.487 ' HA ' ' HA ' ' E' ' 86' ' ' SER . 2.3 p30 -97.82 110.6 23.14 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.605 0.717 . . . . 0.0 110.987 176.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 13' ' ' MET . . . . . 0.438 ' SD ' HG23 ' E' ' 79' ' ' THR . 7.2 mtt -85.26 142.15 29.6 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.31 -178.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 14' ' ' LYS . . . . . 0.424 ' HB2' ' HG3' ' E' ' 17' ' ' ARG . 91.5 mttt -89.71 144.21 31.47 Favored Pre-proline 0 C--N 1.315 -0.919 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 170.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -46.29 109.66 0.22 Allowed 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 123.519 2.813 . . . . 0.0 113.613 -174.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 16' ' ' GLU . . . . . 0.632 ' HA ' ' O ' ' E' ' 79' ' ' THR . 8.8 tt0 70.56 67.1 0.19 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.762 175.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 17' ' ' ARG . . . . . 0.529 ' HA ' ' NE ' ' E' ' 17' ' ' ARG . 4.7 mmp_? -122.79 169.2 11.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.013 175.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . 0.673 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 19.4 tttm -146.68 104.89 3.78 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.36 0.413 . . . . 0.0 111.303 -175.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -111.81 111.55 22.6 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.071 -177.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 20' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' E' ' 76' ' ' MET . 28.9 t -90.82 111.0 22.21 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -133.84 150.1 51.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.661 0.743 . . . . 0.0 112.721 -168.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 3.9 p -91.18 160.9 15.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.649 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 23' ' ' ILE . . . . . 0.443 HG22 ' HA ' ' E' ' 71' ' ' LYS . 73.9 mt -111.14 126.26 68.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.176 -174.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . 0.523 HD12 ' N ' ' E' ' 25' ' ' LYS . 1.8 pp -92.55 -24.3 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.723 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . 0.523 ' N ' HD12 ' E' ' 24' ' ' ILE . 24.8 mtpp -147.56 132.96 18.57 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 26' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' E' ' 92' ' ' HIS . 15.5 m -54.9 119.4 5.33 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 27' ' ' PHE . . . . . 0.428 ' HB3' HD23 ' E' ' 91' ' ' LEU . 5.8 p90 -137.4 156.67 47.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.725 0.774 . . . . 0.0 112.792 -170.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 28' ' ' HIS . . . . . 0.585 ' HE2' ' HB3' ' E' ' 30' ' ' SER . 15.1 t60 -109.94 124.59 51.65 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.108 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 29' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 39.3 mt -94.43 135.06 29.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 169.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . 0.585 ' HB3' ' HE2' ' E' ' 28' ' ' HIS . 50.2 p -120.26 -15.87 8.57 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -169.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 31' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -160.32 145.21 10.86 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.314 -1.422 . . . . 0.0 113.361 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.454 HG23 ' HG ' ' E' ' 87' ' ' LEU . 12.0 p -129.92 121.65 52.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 168.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.1 154.37 43.86 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.955 -173.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 34' ' ' LEU . . . . . 0.554 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.4 pp -125.13 144.0 50.64 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.5 0.667 . . . . 0.0 110.836 177.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -110.24 -45.96 3.5 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 173.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -103.67 128.57 50.99 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.56 171.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . 0.496 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 146.7 163.0 10.19 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 119.641 -1.266 . . . . 0.0 113.57 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -102.25 -47.15 4.6 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.164 -0.214 . . . . 0.0 111.001 177.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -152.1 133.72 14.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.739 -0.21 . . . . 0.0 111.056 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . 0.48 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -134.37 113.45 11.91 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.364 0.602 . . . . 0.0 110.167 167.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 41' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' E' ' 79' ' ' THR . 98.6 mttt -97.86 112.66 24.49 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 174.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 43.1 tp -83.72 113.3 20.79 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.59 -174.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 43' ' ' TYR . . . . . 0.525 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 98.0 m-85 -115.77 141.47 48.05 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 44' ' ' LEU . . . . . 0.552 ' HB2' ' CD1' ' E' ' 77' ' ' PHE . 0.1 OUTLIER -129.95 131.89 46.13 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 173.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 45' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -110.78 114.95 28.7 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.994 177.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . 0.601 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -129.86 142.49 50.66 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 58.79 29.19 18.4 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.372 0.42 . . . . 0.0 110.224 -174.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt 63.56 24.61 14.08 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.709 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 49' ' ' GLN . . . . . 0.473 ' HG3' HD21 ' D' ' 12' ' ' ASN . 24.1 tp60 -115.67 126.69 54.46 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -83.4 124.83 31.06 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.86 0.362 . . . . 0.0 110.724 -177.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . 0.46 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 66.2 m-85 -120.84 133.35 55.31 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.0 tp -82.12 107.65 14.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 169.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . 0.493 HG13 ' CD2' ' D' ' 88' ' ' LEU . 2.4 t -80.01 -49.58 18.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.663 -171.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 54' ' ' ALA . . . . . 0.538 ' HB1' HG11 ' E' ' 63' ' ' VAL . . . -160.01 148.96 17.44 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.099 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 54.4 m -109.86 102.24 11.03 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 173.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . 0.411 ' CG1' HG11 ' E' ' 85' ' ' VAL . 7.4 p -117.76 114.27 44.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.625 0.726 . . . . 0.0 110.004 -177.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 81.1 p -123.06 -178.3 3.92 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.551 -174.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -63.58 -21.4 66.33 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.838 0.352 . . . . 0.0 110.414 170.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 59' ' ' ALA . . . . . 0.403 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -83.55 -40.53 19.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.198 0.523 . . . . 0.0 110.245 177.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 80.6 mt -113.4 82.7 6.12 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 174.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 61' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 12.6 Cg_exo -70.16 -0.17 6.85 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.106 2.537 . . . . 0.0 114.013 -167.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.15 127.15 2.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.163 0.506 . . . . 0.0 111.477 -176.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . 0.538 HG11 ' HB1' ' E' ' 54' ' ' ALA . 86.4 t -117.38 106.11 19.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.405 174.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.51 121.76 27.19 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 173.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' E' ' 30' ' ' SER . 0.6 OUTLIER -140.7 168.18 20.4 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.711 -173.044 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 66' ' ' ASP . . . . . 0.543 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 11.7 t0 -118.83 105.18 11.26 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.267 0.556 . . . . 0.0 110.532 -177.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 67' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' E' ' 28' ' ' HIS . 15.2 mt -118.74 144.51 46.21 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.65 177.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 68' ' ' ASN . . . . . 0.442 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 57.3 t30 -148.53 114.73 5.84 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 173.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 69' ' ' PHE . . . . . 0.401 ' CZ ' HD22 ' E' ' 67' ' ' LEU . 51.4 m-85 -110.06 164.53 12.53 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.187 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 70' ' ' SER . . . . . 0.535 ' HB2' ' O ' ' D' ' 6' ' ' ALA . 33.0 t -107.91 149.17 28.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.836 0.351 . . . . 0.0 110.687 -177.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 71' ' ' LYS . . . . . 0.443 ' HA ' HG22 ' E' ' 23' ' ' ILE . 0.0 OUTLIER -68.06 -11.91 59.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.345 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.38 -5.81 61.68 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.583 175.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -100.02 167.91 10.18 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -145.19 128.11 16.44 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 75' ' ' ILE . . . . . 0.601 HG22 ' HB2' ' E' ' 46' ' ' ALA . 15.3 pt -134.93 165.51 30.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.094 0.473 . . . . 0.0 111.763 -169.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 76' ' ' MET . . . . . 0.514 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 4.5 mtm -120.92 123.5 42.63 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 173.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 77' ' ' PHE . . . . . 0.552 ' CD1' ' HB2' ' E' ' 44' ' ' LEU . 0.7 OUTLIER -106.03 127.6 53.28 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 78' ' ' TYR . . . . . 0.673 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 40.7 p90 -154.93 144.13 21.09 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.958 -177.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 79' ' ' THR . . . . . 0.632 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 6.5 p -116.18 141.54 48.01 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.396 -177.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.59 153.4 22.94 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.319 176.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.93 -175.41 36.73 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -175.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -118.76 104.84 10.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 118.12 0.96 . . . . 0.0 110.527 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 83' ' ' ALA . . . . . 0.496 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -166.1 154.83 11.17 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.182 170.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 19.5 t -106.21 111.23 23.74 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 85' ' ' VAL . . . . . 0.554 HG12 ' HB3' ' E' ' 34' ' ' LEU . 3.4 m -111.48 138.23 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 CA-C-O 121.348 0.594 . . . . 0.0 112.095 -174.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 86' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' E' ' 12' ' ' ASN . 7.4 t -108.95 118.19 36.16 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.8 178.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 87' ' ' LEU . . . . . 0.617 HD13 HD23 ' E' ' 11' ' ' LEU . 5.4 mp -89.8 149.22 22.79 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.566 174.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . 0.591 HD23 HD21 ' A' ' 67' ' ' LEU . 1.3 tp -131.91 140.71 49.13 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.022 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.34 -167.14 25.47 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.776 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 90' ' ' TYR . . . . . 0.447 ' CD2' ' HB3' ' A' ' 68' ' ' ASN . 12.9 p90 -153.36 132.27 12.46 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.712 0.768 . . . . 0.0 111.604 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 91' ' ' LEU . . . . . 0.428 HD23 ' HB3' ' E' ' 27' ' ' PHE . 22.0 mt -64.6 126.97 29.57 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.177 173.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 92' ' ' HIS . . . . . 0.411 ' HB3' ' O ' ' E' ' 26' ' ' SER . 28.0 t60 -66.83 144.43 56.29 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.479 0.656 . . . . 0.0 111.242 -175.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 93' ' ' ASP . . . . . 0.416 ' CB ' ' HB3' ' E' ' 5' ' ' MET . 7.6 p-10 -73.46 -154.22 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.997 177.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 30.9 pt -72.2 133.06 32.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.377 0.608 . . . . 0.0 111.484 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 95' ' ' ASP . . . . . 0.487 ' CB ' ' HG3' ' D' ' 5' ' ' MET . 8.4 m-20 -81.03 64.27 5.72 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.028 176.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 28.4 m 63.17 -165.24 0.24 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.964 -175.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . 70.85 45.62 50.67 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.318 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 10.6 p . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.703 -0.665 . . . . 0.0 110.383 179.092 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 120.905 0.383 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -145.39 175.57 10.22 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.609 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.13 155.9 53.25 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.489 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.58 156.13 24.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.993 0.425 . . . . 0.0 111.332 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.404 ' HB3' ' CD2' ' B' ' 92' ' ' HIS . 22.1 ptm -136.75 148.58 47.34 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.51 -178.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -111.43 147.69 34.7 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.159 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.559 ' HA ' ' OG ' ' B' ' 70' ' ' SER . 16.5 ttt -93.44 168.87 10.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.275 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.568 ' CE1' HD12 ' A' ' 88' ' ' LEU . 54.1 t80 -79.66 129.7 34.71 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.062 0.458 . . . . 0.0 112.102 -177.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.537 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 87.8 t90 -113.82 148.49 36.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.596 174.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.19 145.55 13.96 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.258 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.644 HD23 HD13 ' A' ' 87' ' ' LEU . 58.5 tp -139.09 110.25 6.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.027 0.441 . . . . 0.0 110.93 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -86.04 116.41 24.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.958 176.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.634 ' HB2' HG23 ' A' ' 85' ' ' VAL . 4.1 mmt -98.52 130.81 45.1 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.455 ' HD2' ' HD2' ' A' ' 15' ' ' PRO . 48.2 tptt -100.55 132.06 22.89 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 174.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.543 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 2.0 Cg_endo -46.25 117.68 2.07 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.539 2.826 . . . . 0.0 113.476 -175.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.662 ' HA ' ' O ' ' A' ' 79' ' ' THR . 37.8 mt-10 64.14 56.24 1.4 Allowed 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.411 178.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.86 135.31 52.78 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.63 172.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.738 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 82.8 mttt -103.73 115.71 30.98 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 123.313 0.383 . . . . 0.0 111.272 177.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -105.52 102.9 12.33 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 p -89.36 98.93 12.04 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 173.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -111.83 146.39 37.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.229 -167.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.8 m -100.45 143.06 31.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.282 174.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.476 ' CD1' ' HB2' ' A' ' 69' ' ' PHE . 54.0 mt -108.52 125.84 65.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.202 0.525 . . . . 0.0 111.772 -172.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.454 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.2 mp -102.22 -50.6 9.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.395 -0.821 . . . . 0.0 108.852 176.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.528 ' HD2' HD22 ' A' ' 91' ' ' LEU . 12.7 pttp -103.21 122.41 44.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.552 174.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.6 t -60.94 142.71 56.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.964 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.488 ' HB3' HD23 ' A' ' 91' ' ' LEU . 54.6 p90 -147.8 148.27 30.74 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -177.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.538 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 2.1 t60 -102.65 125.18 49.29 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 114.147 -1.388 . . . . 0.0 109.601 176.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 47.0 mt -87.34 131.24 35.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 172.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.538 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 95.3 p -116.59 -12.25 10.97 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -169.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . 179.99 158.72 22.51 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 119.166 -1.492 . . . . 0.0 113.702 177.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.462 HG23 ' HG ' ' A' ' 87' ' ' LEU . 11.0 p -141.29 138.97 33.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 175.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -152.95 156.17 38.38 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 121.97 -0.457 . . . . 0.0 111.886 -177.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.702 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.1 pp -125.31 148.04 48.88 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.501 0.667 . . . . 0.0 111.911 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -110.64 -55.15 2.51 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.133 169.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -100.84 127.91 47.1 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.211 174.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.495 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 150.48 162.98 10.93 Favored Glycine 0 N--CA 1.434 -1.495 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.533 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.407 ' HA ' ' HD2' ' A' ' 58' ' ' LYS . 25.7 mt-30 -102.56 -47.04 4.57 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.713 0.292 . . . . 0.0 111.018 176.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -152.48 132.51 13.42 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.344 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.527 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -127.28 113.28 16.08 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.436 0.636 . . . . 0.0 110.061 168.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 79' ' ' THR . 97.5 mttt -95.34 112.02 23.8 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.443 HD21 HD21 ' A' ' 87' ' ' LEU . 34.5 tp -86.12 107.48 17.87 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -174.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -107.4 146.11 32.08 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.741 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.652 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 1.5 tp -129.98 116.32 18.42 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.665 176.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.55 109.28 21.12 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.436 ' HB2' HD11 ' A' ' 44' ' ' LEU . . . -143.14 150.05 38.91 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.423 -177.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 57.35 30.99 19.44 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.35 0.595 . . . . 0.0 109.98 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 61.2 40.49 14.6 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.204 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -144.16 136.59 26.73 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -87.35 117.72 26.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.936 0.398 . . . . 0.0 110.042 178.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -112.76 122.97 49.23 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.673 178.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -80.82 100.9 5.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 170.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.48 HG12 ' CD2' ' E' ' 88' ' ' LEU . 21.6 m -86.45 -33.19 7.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.749 -172.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.729 ' HB2' HD21 ' A' ' 65' ' ' LEU . . . -153.19 144.59 23.23 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 120.28 -0.568 . . . . 0.0 112.214 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.2 m -115.51 102.47 9.83 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 169.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.428 HG13 ' HB3' ' A' ' 40' ' ' ALA . 8.9 p -116.18 114.21 45.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.744 0.783 . . . . 0.0 110.15 -177.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 69.1 p -123.18 -177.12 3.6 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.963 -175.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 38' ' ' GLN . 27.3 mtpp -59.37 -35.89 74.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.035 0.445 . . . . 0.0 109.971 169.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.419 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -71.23 -40.59 71.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.498 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.2 mt -114.31 82.33 7.34 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 17.3 Cg_exo -67.31 -6.65 16.83 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.208 2.605 . . . . 0.0 113.891 -168.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -161.49 132.09 5.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.262 0.554 . . . . 0.0 111.164 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 87.5 t -119.74 118.6 57.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.543 176.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.76 128.15 33.32 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.729 HD21 ' HB2' ' A' ' 54' ' ' ALA . 86.2 mt -120.21 163.82 17.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.457 0.646 . . . . 0.0 112.25 -172.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -140.86 97.4 3.18 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.548 169.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 2.8 mt -131.19 156.34 45.49 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.528 ' HB2' ' CZ ' ' E' ' 90' ' ' TYR . 42.7 t-20 -155.32 128.79 8.41 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.476 ' HB2' ' CD1' ' A' ' 23' ' ' ILE . 4.3 m-85 -124.03 145.05 49.47 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.522 ' OG ' ' HA ' ' E' ' 7' ' ' MET . 37.2 m -100.4 -178.53 3.84 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -175.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -62.34 -30.95 71.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.222 0.534 . . . . 0.0 110.345 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.82 4.44 85.03 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.661 -0.7 . . . . 0.0 113.074 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -99.94 119.59 38.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 117.171 0.485 . . . . 0.0 110.791 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -111.96 106.29 14.94 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 173.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.409 HG22 ' CB ' ' A' ' 46' ' ' ALA . 10.9 pt -120.91 168.07 13.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.163 -167.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.9 mtm -122.27 125.98 47.17 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 171.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.652 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -107.9 127.72 53.99 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 175.003 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.738 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 53.4 p90 -155.68 140.43 17.08 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 119.845 -0.742 . . . . 0.0 112.193 -175.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.662 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 12.0 p -106.09 138.85 41.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.958 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.4 ' HB3' ' HB2' ' A' ' 41' ' ' LYS . . . -107.09 153.23 22.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.413 174.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.4 ' O ' ' HG3' ' A' ' 16' ' ' GLU . . . 93.45 -173.52 34.13 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -177.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -113.54 103.83 11.65 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.846 177.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.543 ' H ' ' HB3' ' A' ' 15' ' ' PRO . . . -170.87 153.65 4.0 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.89 169.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.7 p -110.23 123.23 49.4 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.15 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.702 HG12 ' HB3' ' A' ' 34' ' ' LEU . 10.9 m -124.74 153.35 31.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-O 121.459 0.647 . . . . 0.0 112.375 -173.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.5 m -113.26 126.78 55.78 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.854 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.644 HD13 HD23 ' A' ' 11' ' ' LEU . 4.6 mp -101.91 147.47 26.49 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 169.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.568 HD12 ' CE1' ' A' ' 8' ' ' PHE . 2.3 mm? -125.22 154.3 41.81 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 173.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.67 -168.81 25.15 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 119.755 -1.212 . . . . 0.0 114.193 -178.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.536 ' CZ ' ' HB2' ' B' ' 68' ' ' ASN . 3.2 m-85 -117.56 118.92 33.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.344 -0.928 . . . . 0.0 110.392 -176.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.528 HD22 ' HD2' ' A' ' 25' ' ' LYS . 16.5 mt -82.79 117.67 22.85 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.12 0.486 . . . . 0.0 110.337 172.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -93.72 173.72 7.54 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 175.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 74.25 4.81 4.59 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 122.911 0.484 . . . . 0.0 110.85 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 5.4 tp -69.91 126.19 29.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.568 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -77.12 79.97 3.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.308 0.575 . . . . 0.0 109.886 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.1 t -154.24 135.67 14.19 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.0 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -173.58 36.74 0.13 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.68 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.692 -0.67 . . . . 0.0 109.317 -178.779 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 120.954 0.407 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -145.38 175.6 10.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.594 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.22 155.82 53.2 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.444 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.47 156.11 23.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.154 0.502 . . . . 0.0 111.278 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 22.0 ptm -136.79 148.61 47.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.468 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -111.44 147.69 34.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.232 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . 0.578 ' HA ' ' OG ' ' C' ' 70' ' ' SER . 16.6 ttt -93.43 168.79 10.83 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.295 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.572 ' CZ ' HD21 ' C' ' 44' ' ' LEU . 54.4 t80 -79.51 129.72 34.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.034 0.445 . . . . 0.0 112.117 -177.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . 0.531 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 88.0 t90 -113.94 148.49 36.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.48 174.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.16 145.69 14.25 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.246 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.629 HD23 HD13 ' B' ' 87' ' ' LEU . 58.3 tp -139.16 110.12 6.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.941 0.4 . . . . 0.0 110.968 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -86.05 116.39 24.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.941 176.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . 0.62 ' HB2' HG23 ' B' ' 85' ' ' VAL . 4.1 mmt -98.43 130.78 45.05 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -176.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.465 ' HD2' ' HD2' ' B' ' 15' ' ' PRO . 48.2 tptt -100.59 132.09 22.82 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 174.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.546 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 2.1 Cg_endo -46.24 117.82 2.14 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.441 2.761 . . . . 0.0 113.533 -175.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.666 ' HA ' ' O ' ' B' ' 79' ' ' THR . 37.9 mt-10 63.98 56.19 1.47 Allowed 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.492 178.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.75 135.29 52.86 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.644 172.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.734 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 82.8 mttt -103.76 115.72 30.99 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 123.366 0.416 . . . . 0.0 111.236 177.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -105.49 102.82 12.26 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 14.7 p -89.3 98.84 11.99 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 173.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -111.78 146.39 37.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.389 0.614 . . . . 0.0 112.28 -167.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 28.9 m -100.43 143.1 31.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.249 174.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.468 ' CD1' ' HB2' ' B' ' 69' ' ' PHE . 54.2 mt -108.55 125.92 65.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.278 0.561 . . . . 0.0 111.748 -172.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.461 ' N ' HD12 ' B' ' 24' ' ' ILE . 4.2 mp -102.29 -50.56 9.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.825 176.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.531 ' HD2' HD22 ' B' ' 91' ' ' LEU . 12.8 pttp -103.13 122.31 44.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.63 174.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 35.6 t -60.97 142.73 56.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.95 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . 0.481 ' HB3' HD23 ' B' ' 91' ' ' LEU . 54.6 p90 -147.83 148.24 30.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.963 0.887 . . . . 0.0 113.296 -177.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' HIS . . . . . 0.537 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 2.1 t60 -102.55 125.15 49.17 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.692 176.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.5 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 46.8 mt -87.29 131.28 35.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 172.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.537 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 94.9 p -116.63 -12.33 10.92 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -169.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . 180.0 158.68 22.46 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 119.235 -1.46 . . . . 0.0 113.787 177.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.466 HG23 ' HG ' ' B' ' 87' ' ' LEU . 11.0 p -141.32 138.95 33.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 175.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -152.95 156.18 38.39 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.983 -0.448 . . . . 0.0 111.891 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.718 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.1 pp -125.31 148.03 48.88 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.52 0.676 . . . . 0.0 111.949 178.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -110.55 -55.3 2.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.129 169.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -100.79 128.06 46.98 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.26 174.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.492 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 150.42 163.02 10.95 Favored Glycine 0 N--CA 1.435 -1.423 0 C-N-CA 120.371 -0.918 . . . . 0.0 112.424 177.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -102.67 -46.94 4.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.647 0.26 . . . . 0.0 111.003 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -152.52 132.55 13.41 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.344 177.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.534 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -127.27 113.25 16.06 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.362 0.601 . . . . 0.0 110.166 167.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' B' ' 79' ' ' THR . 97.5 mttt -95.41 112.04 23.82 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.45 HD21 HD21 ' B' ' 87' ' ' LEU . 34.6 tp -86.15 107.47 17.88 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.711 -174.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -107.45 146.12 32.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.697 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.645 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 1.5 tp -129.94 116.39 18.55 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.69 176.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.57 109.24 21.07 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.203 0.525 . . . . 0.0 109.654 176.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.436 ' HB2' HD11 ' B' ' 44' ' ' LEU . . . -143.03 150.03 39.04 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.449 -177.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 57.41 30.88 19.31 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.44 0.638 . . . . 0.0 110.091 -179.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 61.18 40.55 14.59 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.213 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -144.19 136.74 26.83 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -87.43 117.67 26.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.867 0.365 . . . . 0.0 110.038 178.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -112.73 122.98 49.25 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.698 178.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -80.82 100.91 5.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 170.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.485 HG12 ' CD2' ' A' ' 88' ' ' LEU . 21.5 m -86.52 -33.13 6.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.748 -172.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.745 ' HB2' HD21 ' B' ' 65' ' ' LEU . . . -153.12 144.54 23.27 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 120.284 -0.566 . . . . 0.0 112.208 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 27.2 m -115.55 102.4 9.75 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 169.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.435 HG13 ' HB3' ' B' ' 40' ' ' ALA . 9.0 p -116.03 114.18 45.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.771 0.796 . . . . 0.0 110.149 -177.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 69.5 p -123.21 -177.19 3.62 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.905 -175.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -59.34 -35.87 74.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.06 0.457 . . . . 0.0 110.064 169.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.414 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -71.15 -40.6 71.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.538 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 79.0 mt -114.32 82.27 7.3 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 17.2 Cg_exo -67.22 -6.77 17.02 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.329 2.686 . . . . 0.0 113.795 -168.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -161.44 132.12 5.15 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.409 0.623 . . . . 0.0 111.188 -175.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 87.8 t -119.77 118.75 58.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.532 176.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.86 128.15 33.34 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.745 HD21 ' HB2' ' B' ' 54' ' ' ALA . 86.0 mt -120.22 163.79 17.23 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.426 0.632 . . . . 0.0 112.297 -172.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -140.83 97.38 3.18 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.254 -0.884 . . . . 0.0 108.628 169.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' B' ' 28' ' ' HIS . 2.7 mt -131.19 156.3 45.57 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 42.7 t-20 -155.32 128.68 8.36 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 174.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . 0.468 ' HB2' ' CD1' ' B' ' 23' ' ' ILE . 4.2 m-85 -123.88 145.05 49.38 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.559 ' OG ' ' HA ' ' A' ' 7' ' ' MET . 37.6 m -100.41 -178.54 3.84 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -175.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -62.31 -30.98 71.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.301 0.572 . . . . 0.0 110.31 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.91 4.53 85.08 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.696 -0.683 . . . . 0.0 113.022 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -100.06 119.56 38.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.058 0.456 . . . . 0.0 110.79 178.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -111.91 106.33 15.01 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 173.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.404 HG22 ' CB ' ' B' ' 46' ' ' ALA . 10.8 pt -121.02 168.0 13.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.193 -167.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . . . . . . . . . 3.8 mtm -122.21 125.92 47.12 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 171.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . 0.645 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.3 OUTLIER -107.94 127.8 54.07 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 175.006 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.734 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 53.8 p90 -155.75 140.32 16.91 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 119.858 -0.737 . . . . 0.0 112.191 -175.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.666 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 12.1 p -105.98 138.8 41.54 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.975 -179.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.16 153.17 23.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.429 174.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.6 -173.5 33.89 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -113.53 103.88 11.71 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.832 177.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.546 ' H ' ' HB3' ' B' ' 15' ' ' PRO . . . -170.9 153.64 3.96 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.845 169.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 5.4 p -110.22 123.17 49.29 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.207 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.718 HG12 ' HB3' ' B' ' 34' ' ' LEU . 10.9 m -124.74 153.25 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-O 121.473 0.654 . . . . 0.0 112.364 -173.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 28.6 m -113.2 126.81 55.83 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.816 175.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.629 HD13 HD23 ' B' ' 11' ' ' LEU . 4.6 mp -101.98 147.46 26.54 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 169.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.565 HD13 ' O ' ' B' ' 87' ' ' LEU . 2.3 mm? -125.21 154.14 42.05 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 173.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.64 -168.73 24.99 Favored Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 119.776 -1.202 . . . . 0.0 114.21 -178.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' TYR . . . . . 0.538 ' CZ ' ' HB2' ' C' ' 68' ' ' ASN . 3.2 m-85 -117.55 118.91 33.45 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.348 -0.926 . . . . 0.0 110.396 -176.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . 0.531 HD22 ' HD2' ' B' ' 25' ' ' LYS . 16.4 mt -82.83 117.65 22.86 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.164 0.507 . . . . 0.0 110.336 172.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . 0.404 ' CD2' ' HB3' ' A' ' 5' ' ' MET . 61.1 t60 -93.73 173.73 7.54 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 175.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 74.28 4.81 4.57 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.799 0.44 . . . . 0.0 110.853 176.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 5.3 tp -70.01 126.19 29.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.103 0.478 . . . . 0.0 110.453 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -77.16 79.98 3.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.567 0.699 . . . . 0.0 109.895 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 14.3 t -154.28 135.63 14.12 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.374 -0.83 . . . . 0.0 108.96 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . -173.5 36.96 0.13 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.743 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.689 -0.672 . . . . 0.0 109.348 -178.773 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 . . . . . 0 N--CA 1.481 1.102 0 CA-C-O 120.952 0.406 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -145.43 175.58 10.21 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.596 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.25 155.91 53.22 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.455 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.43 156.18 23.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.058 0.456 . . . . 0.0 111.219 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 22.1 ptm -136.89 148.57 47.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.523 -178.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 6' ' ' ALA . . . . . . . . . . . . . . . -111.47 147.66 34.82 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.217 178.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 7' ' ' MET . . . . . 0.507 ' HA ' ' OG ' ' D' ' 70' ' ' SER . 16.6 ttt -93.36 168.87 10.79 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.276 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 8' ' ' PHE . . . . . 0.564 ' CE1' HD12 ' C' ' 88' ' ' LEU . 54.6 t80 -79.55 129.77 34.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.994 0.426 . . . . 0.0 112.093 -177.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . 0.534 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 87.9 t90 -114.01 148.52 36.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.456 174.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.23 145.58 14.0 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.286 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.632 HD23 HD13 ' C' ' 87' ' ' LEU . 58.3 tp -139.11 110.15 6.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.981 0.419 . . . . 0.0 110.937 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -86.01 116.37 24.18 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.98 176.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 13' ' ' MET . . . . . 0.634 ' HB2' HG23 ' C' ' 85' ' ' VAL . 4.1 mmt -98.48 130.74 45.08 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -176.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . 0.444 ' HD2' ' HD2' ' C' ' 15' ' ' PRO . 48.2 tptt -100.58 132.18 22.71 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 174.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . 0.543 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 2.0 Cg_endo -46.4 117.84 2.21 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.479 2.786 . . . . 0.0 113.52 -175.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . 0.667 ' HA ' ' O ' ' C' ' 79' ' ' THR . 38.0 mt-10 64.14 56.03 1.43 Allowed 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.481 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.75 135.31 52.88 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.64 173.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 18' ' ' LYS . . . . . 0.742 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 82.7 mttt -103.74 115.87 31.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.157 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -105.56 102.81 12.25 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 175.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 15.3 p -89.43 98.92 12.04 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 173.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -111.82 146.46 37.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.178 -167.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 28.7 m -100.54 143.18 31.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.253 174.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . 0.475 ' CD1' ' HB2' ' C' ' 69' ' ' PHE . 53.8 mt -108.58 125.89 65.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.236 0.541 . . . . 0.0 111.722 -172.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . 0.455 HD12 ' N ' ' C' ' 24' ' ' ILE . 4.2 mp -102.28 -50.59 9.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.43 -0.804 . . . . 0.0 108.88 176.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . 0.535 ' HD2' HD22 ' C' ' 91' ' ' LEU . 12.8 pttp -103.17 122.27 44.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.616 174.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 35.6 t -60.88 142.77 55.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.02 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 27' ' ' PHE . . . . . 0.487 ' HB3' HD23 ' C' ' 91' ' ' LEU . 54.7 p90 -147.87 148.28 30.68 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -177.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 28' ' ' HIS . . . . . 0.539 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 2.1 t60 -102.62 125.25 49.28 Favored 'General case' 0 C--O 1.217 -0.658 0 CA-C-N 114.084 -1.416 . . . . 0.0 109.645 176.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . 0.495 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 46.7 mt -87.33 131.36 35.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 172.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.539 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 94.6 p -116.73 -12.24 10.87 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -169.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . 179.99 158.73 22.53 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 119.073 -1.536 . . . . 0.0 113.651 177.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.467 HG23 ' HG ' ' C' ' 87' ' ' LEU . 11.0 p -141.27 138.93 33.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 175.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -152.92 156.22 38.51 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.98 -0.45 . . . . 0.0 111.94 -177.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.718 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.1 pp -125.35 148.03 48.91 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.571 0.7 . . . . 0.0 111.892 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -110.62 -55.12 2.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.162 169.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -100.92 127.98 47.15 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.157 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 37' ' ' GLY . . . . . 0.484 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 150.49 163.04 10.97 Favored Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 120.333 -0.936 . . . . 0.0 112.461 177.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -102.67 -47.03 4.55 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.567 0.222 . . . . 0.0 111.001 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -152.42 132.54 13.5 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.364 177.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.527 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -127.28 113.24 16.04 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.42 0.629 . . . . 0.0 110.113 168.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' C' ' 79' ' ' THR . 97.5 mttt -95.37 112.06 23.83 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 175.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.446 HD21 HD21 ' C' ' 87' ' ' LEU . 34.6 tp -86.17 107.48 17.9 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -174.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -107.47 146.14 32.15 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.7 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.657 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 1.5 tp -129.98 116.3 18.39 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.67 176.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.53 109.3 21.14 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.166 0.508 . . . . 0.0 109.668 176.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.431 ' HB2' HD11 ' C' ' 44' ' ' LEU . . . -143.12 150.1 39.01 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.495 -177.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 57.25 31.02 19.4 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.396 0.617 . . . . 0.0 110.033 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 97.0 mttt 61.13 40.5 14.8 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.261 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 15.0 tp60 -144.18 136.76 26.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.9 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -87.35 117.68 26.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.847 0.356 . . . . 0.0 110.066 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -112.79 123.02 49.37 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.651 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -80.85 100.92 5.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 170.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 53' ' ' VAL . . . . . 0.496 HG12 ' CD2' ' B' ' 88' ' ' LEU . 21.5 m -86.46 -33.18 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.756 -172.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 54' ' ' ALA . . . . . 0.734 ' HB2' HD21 ' C' ' 65' ' ' LEU . . . -153.16 144.51 23.2 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 120.394 -0.522 . . . . 0.0 112.201 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 27.3 m -115.52 102.5 9.85 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 169.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . 0.434 HG13 ' HB3' ' C' ' 40' ' ' ALA . 9.0 p -116.13 114.12 45.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.763 0.792 . . . . 0.0 110.18 -177.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 69.7 p -123.15 -177.18 3.61 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.972 -175.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -59.32 -35.93 74.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.075 0.465 . . . . 0.0 110.015 169.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . 0.412 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -71.17 -40.56 71.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.527 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 79.0 mt -114.36 82.29 7.38 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 174.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 61' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 17.2 Cg_exo -67.27 -6.72 16.96 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.268 2.645 . . . . 0.0 113.851 -168.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -161.46 132.16 5.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.288 0.566 . . . . 0.0 111.2 -175.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 87.9 t -119.76 118.61 57.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.524 176.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.79 128.13 33.3 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . 0.734 HD21 ' HB2' ' C' ' 54' ' ' ALA . 85.9 mt -120.14 163.86 17.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.396 0.617 . . . . 0.0 112.277 -172.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -140.9 97.43 3.19 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.206 -0.907 . . . . 0.0 108.554 169.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.526 ' O ' ' HA ' ' C' ' 28' ' ' HIS . 2.8 mt -131.22 156.31 45.58 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . 0.538 ' HB2' ' CZ ' ' B' ' 90' ' ' TYR . 42.7 t-20 -155.27 128.71 8.4 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 174.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 69' ' ' PHE . . . . . 0.475 ' HB2' ' CD1' ' C' ' 23' ' ' ILE . 4.2 m-85 -123.91 145.08 49.38 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . 0.578 ' OG ' ' HA ' ' B' ' 7' ' ' MET . 37.7 m -100.51 -178.46 3.81 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -175.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -62.33 -30.91 71.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.244 0.545 . . . . 0.0 110.399 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.92 4.5 85.15 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.76 -0.654 . . . . 0.0 113.005 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -100.05 119.55 38.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.109 0.454 . . . . 0.0 110.81 178.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -111.96 106.34 15.0 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 173.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.412 HG22 ' CB ' ' C' ' 46' ' ' ALA . 10.8 pt -121.01 167.99 13.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.128 -167.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . . . . . . . . . 3.9 mtm -122.15 126.06 47.52 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 171.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 77' ' ' PHE . . . . . 0.657 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.3 OUTLIER -107.99 127.7 53.99 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 174.864 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 78' ' ' TYR . . . . . 0.742 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 53.7 p90 -155.58 140.33 17.1 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 119.808 -0.757 . . . . 0.0 112.208 -175.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . 0.667 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 12.3 p -105.9 138.82 41.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.052 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.13 153.21 22.98 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.364 174.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.46 -173.45 34.05 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -177.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -113.55 103.82 11.64 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.654 0.727 . . . . 0.0 109.842 177.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . 0.543 ' H ' ' HB3' ' C' ' 15' ' ' PRO . . . -170.92 153.6 3.93 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.813 169.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 5.7 p -110.22 123.27 49.47 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.192 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.718 HG12 ' HB3' ' C' ' 34' ' ' LEU . 10.8 m -124.82 153.36 31.76 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-O 121.447 0.642 . . . . 0.0 112.347 -173.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 29.0 m -113.3 126.66 55.63 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.772 175.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . 0.632 HD13 HD23 ' C' ' 11' ' ' LEU . 4.6 mp -101.83 147.42 26.52 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 169.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . 0.564 HD12 ' CE1' ' C' ' 8' ' ' PHE . 2.3 mm? -125.21 154.19 41.98 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 173.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.65 -168.73 25.0 Favored Glycine 0 N--CA 1.438 -1.213 0 C-N-CA 119.753 -1.213 . . . . 0.0 114.222 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 90' ' ' TYR . . . . . 0.506 ' CZ ' ' HB2' ' D' ' 68' ' ' ASN . 3.2 m-85 -117.62 118.96 33.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.351 -0.925 . . . . 0.0 110.29 -176.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . 0.535 HD22 ' HD2' ' C' ' 25' ' ' LYS . 16.4 mt -82.8 117.62 22.82 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.199 0.523 . . . . 0.0 110.35 172.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 61.1 t60 -93.66 173.73 7.54 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 175.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 74.27 4.73 4.56 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.401 0.438 . . . . 0.0 110.901 176.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 5.4 tp -69.91 126.23 29.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.54 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -77.15 79.88 3.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.398 0.618 . . . . 0.0 109.899 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 14.1 t -154.18 135.74 14.3 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.96 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -173.59 36.89 0.13 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.74 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.628 -0.701 . . . . 0.0 109.332 -178.768 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 120.983 0.42 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -145.37 175.58 10.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.67 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.21 155.91 53.23 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.47 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.49 156.13 23.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.158 0.504 . . . . 0.0 111.264 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 22.0 ptm -136.93 148.55 47.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.499 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 6' ' ' ALA . . . . . . . . . . . . . . . -111.45 147.69 34.74 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.187 178.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 7' ' ' MET . . . . . 0.552 ' HA ' ' OG ' ' E' ' 70' ' ' SER . 16.6 ttt -93.45 168.87 10.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.274 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 8' ' ' PHE . . . . . 0.563 ' CE1' HD12 ' D' ' 88' ' ' LEU . 54.5 t80 -79.59 129.62 34.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.005 0.431 . . . . 0.0 112.135 -177.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 9' ' ' TRP . . . . . 0.536 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 87.9 t90 -113.81 148.51 36.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.496 174.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.18 145.66 14.18 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.225 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.625 HD23 HD13 ' D' ' 87' ' ' LEU . 58.7 tp -139.11 110.15 6.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.893 0.378 . . . . 0.0 111.005 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -86.09 116.47 24.32 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.916 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 13' ' ' MET . . . . . 0.63 ' HB2' HG23 ' D' ' 85' ' ' VAL . 4.1 mmt -98.49 130.66 45.09 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -176.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 14' ' ' LYS . . . . . 0.455 ' HD2' ' HD2' ' D' ' 15' ' ' PRO . 48.2 tptt -100.54 132.11 22.83 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . 0.538 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 1.9 Cg_endo -46.32 117.82 2.17 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.527 2.818 . . . . 0.0 113.464 -175.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . 0.652 ' HA ' ' O ' ' D' ' 79' ' ' THR . 37.9 mt-10 64.08 56.14 1.44 Allowed 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.452 178.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.79 135.38 52.91 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.609 172.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . 0.729 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 82.8 mttt -103.68 115.76 31.09 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 123.327 0.392 . . . . 0.0 111.168 177.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -105.49 102.84 12.29 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 175.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 14.9 p -89.4 98.89 12.02 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -111.8 146.36 37.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.306 -167.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 29.0 m -100.47 143.17 30.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.234 174.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . 0.472 ' CD1' ' HB2' ' D' ' 69' ' ' PHE . 54.1 mt -108.46 125.87 65.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.193 0.52 . . . . 0.0 111.774 -172.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . 0.454 HD12 ' N ' ' D' ' 24' ' ' ILE . 4.2 mp -102.31 -50.57 9.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.382 -0.826 . . . . 0.0 108.884 176.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . 0.534 ' HD2' HD22 ' D' ' 91' ' ' LEU . 12.8 pttp -103.17 122.38 44.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.604 174.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 35.6 t -60.86 142.7 55.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.923 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 27' ' ' PHE . . . . . 0.49 ' HB3' HD23 ' D' ' 91' ' ' LEU . 54.7 p90 -147.83 148.33 30.77 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -177.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 28' ' ' HIS . . . . . 0.54 ' HA ' ' O ' ' D' ' 67' ' ' LEU . 2.1 t60 -102.66 125.2 49.31 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 114.106 -1.407 . . . . 0.0 109.649 176.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 29' ' ' ILE . . . . . 0.506 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 46.9 mt -87.3 131.31 35.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 172.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . 0.525 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 94.6 p -116.66 -12.24 10.92 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -169.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 31' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . 179.92 158.7 22.44 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 119.145 -1.502 . . . . 0.0 113.72 177.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.462 HG23 ' HG ' ' D' ' 87' ' ' LEU . 11.0 p -141.3 138.85 33.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 175.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -152.85 156.23 38.61 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.878 -0.514 . . . . 0.0 111.92 -177.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 34' ' ' LEU . . . . . 0.702 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.1 pp -125.33 148.01 48.9 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.475 0.655 . . . . 0.0 111.944 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -110.57 -55.28 2.49 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.14 169.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -100.76 128.0 46.97 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.154 174.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . 0.49 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 150.39 163.09 10.99 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.428 177.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 38' ' ' GLN . . . . . 0.4 ' HA ' ' HD2' ' D' ' 58' ' ' LYS . 25.7 mt-30 -102.63 -47.01 4.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 120.58 0.228 . . . . 0.0 110.984 176.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -152.47 132.52 13.44 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.346 177.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . 0.543 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -127.26 113.26 16.08 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.414 0.626 . . . . 0.0 110.093 168.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' D' ' 79' ' ' THR . 97.5 mttt -95.34 112.01 23.79 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.438 ' HB3' ' HB3' ' D' ' 54' ' ' ALA . 34.6 tp -86.2 107.41 17.88 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -174.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -107.4 146.09 32.1 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.73 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.656 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 1.5 tp -129.95 116.34 18.47 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.65 176.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.62 109.3 21.16 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.427 ' HB2' HD11 ' D' ' 44' ' ' LEU . . . -143.04 150.18 39.24 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.423 -177.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 57.2 30.94 19.21 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.397 0.618 . . . . 0.0 110.043 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 61.2 40.59 14.47 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.154 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -144.16 136.66 26.8 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -87.3 117.71 26.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.912 0.387 . . . . 0.0 110.027 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -112.84 123.09 49.52 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.671 178.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 tp -80.9 100.87 5.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 170.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 53' ' ' VAL . . . . . 0.492 HG12 ' CD2' ' C' ' 88' ' ' LEU . 21.4 m -86.42 -33.25 7.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.714 -172.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 54' ' ' ALA . . . . . 0.731 ' HB2' HD21 ' D' ' 65' ' ' LEU . . . -153.13 144.49 23.22 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 120.301 -0.56 . . . . 0.0 112.264 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 27.5 m -115.51 102.46 9.82 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 169.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 56' ' ' VAL . . . . . 0.424 HG11 HG11 ' D' ' 85' ' ' VAL . 8.9 p -116.12 114.19 45.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.75 0.786 . . . . 0.0 110.119 -177.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 67.7 p -123.19 -177.19 3.62 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.931 -175.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 58' ' ' LYS . . . . . 0.4 ' HD2' ' HA ' ' D' ' 38' ' ' GLN . 27.2 mtpp -59.27 -35.99 74.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.075 0.464 . . . . 0.0 110.008 169.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 59' ' ' ALA . . . . . 0.408 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -71.16 -40.49 71.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.632 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 79.0 mt -114.33 82.28 7.33 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 61' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 17.2 Cg_exo -67.26 -6.63 16.74 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.251 2.634 . . . . 0.0 113.904 -168.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -161.49 132.12 5.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.322 0.582 . . . . 0.0 111.169 -175.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 88.2 t -119.75 118.72 58.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.551 176.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.84 128.08 33.26 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 174.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 65' ' ' LEU . . . . . 0.731 HD21 ' HB2' ' D' ' 54' ' ' ALA . 86.1 mt -120.17 163.87 17.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.412 0.625 . . . . 0.0 112.287 -172.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -140.91 97.45 3.19 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 169.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' D' ' 28' ' ' HIS . 2.7 mt -131.21 156.29 45.6 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 68' ' ' ASN . . . . . 0.506 ' HB2' ' CZ ' ' C' ' 90' ' ' TYR . 42.8 t-20 -155.27 128.7 8.4 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 174.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 69' ' ' PHE . . . . . 0.472 ' HB2' ' CD1' ' D' ' 23' ' ' ILE . 4.3 m-85 -123.96 145.15 49.36 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . 0.507 ' OG ' ' HA ' ' C' ' 7' ' ' MET . 37.7 m -100.43 -178.5 3.82 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -175.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -62.39 -30.9 71.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.291 0.567 . . . . 0.0 110.342 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.87 4.39 85.23 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.035 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -100.04 119.51 38.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.988 0.423 . . . . 0.0 110.775 178.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -111.81 106.37 15.1 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 173.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.413 HG22 ' CB ' ' D' ' 46' ' ' ALA . 10.9 pt -121.05 168.04 13.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.087 -167.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 76' ' ' MET . . . . . . . . . . . . . 3.9 mtm -122.27 125.96 47.14 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 171.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 77' ' ' PHE . . . . . 0.656 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.3 OUTLIER -107.95 127.72 54.0 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 78' ' ' TYR . . . . . 0.729 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 53.4 p90 -155.65 140.32 17.02 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.849 -0.74 . . . . 0.0 112.198 -175.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 79' ' ' THR . . . . . 0.652 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 12.1 p -106.04 138.85 41.51 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.017 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 80' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' D' ' 41' ' ' LYS . . . -107.17 153.15 23.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.401 174.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.4 ' O ' ' HG3' ' D' ' 16' ' ' GLU . . . 93.54 -173.58 34.06 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -176.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -113.52 103.8 11.62 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.879 177.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . 0.543 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -170.83 153.54 3.99 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.89 169.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 5.8 p -110.13 123.2 49.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.237 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.702 HG12 ' HB3' ' D' ' 34' ' ' LEU . 11.0 m -124.7 153.39 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-O 121.381 0.61 . . . . 0.0 112.38 -173.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 27.8 m -113.31 126.75 55.73 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.843 175.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 87' ' ' LEU . . . . . 0.625 HD13 HD23 ' D' ' 11' ' ' LEU . 4.6 mp -101.89 147.47 26.49 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 169.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.563 HD12 ' CE1' ' D' ' 8' ' ' PHE . 2.3 mm? -125.2 154.19 41.96 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 173.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.75 -168.81 25.24 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 119.758 -1.21 . . . . 0.0 114.165 -178.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 90' ' ' TYR . . . . . 0.549 ' CZ ' ' HB2' ' E' ' 68' ' ' ASN . 3.2 m-85 -117.61 118.9 33.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.375 -0.912 . . . . 0.0 110.34 -176.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . 0.534 HD22 ' HD2' ' D' ' 25' ' ' LYS . 16.5 mt -82.7 117.68 22.8 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.09 0.472 . . . . 0.0 110.377 172.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -93.81 173.69 7.55 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 74.37 4.77 4.53 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 122.887 0.475 . . . . 0.0 110.795 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 5.4 tp -69.91 126.23 29.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.519 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -77.25 80.04 3.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.538 0.685 . . . . 0.0 109.865 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 14.1 t -154.23 135.71 14.23 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.043 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . -173.65 36.83 0.13 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.679 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.675 -0.679 . . . . 0.0 109.333 -178.846 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 . . . . . 0 N--CA 1.479 1.024 0 CA-C-O 120.981 0.42 . . . . 0.0 110.4 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -145.33 175.64 10.15 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.617 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.29 155.82 53.18 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.424 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.35 156.17 23.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.074 0.464 . . . . 0.0 111.302 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 22.1 ptm -136.94 148.44 46.97 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.46 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 6' ' ' ALA . . . . . . . . . . . . . . . -111.38 147.71 34.61 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.198 178.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 7' ' ' MET . . . . . 0.522 ' HA ' ' OG ' ' A' ' 70' ' ' SER . 16.6 ttt -93.45 168.92 10.74 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.26 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 8' ' ' PHE . . . . . 0.566 ' CE1' HD12 ' E' ' 88' ' ' LEU . 54.1 t80 -79.71 129.73 34.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.076 0.465 . . . . 0.0 112.048 -177.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 9' ' ' TRP . . . . . 0.54 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 87.8 t90 -113.87 148.54 36.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.537 174.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.24 145.63 14.11 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.236 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . 0.636 HD23 HD13 ' E' ' 87' ' ' LEU . 58.3 tp -139.16 110.19 6.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.909 0.385 . . . . 0.0 110.981 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -86.07 116.37 24.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.931 176.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 13' ' ' MET . . . . . 0.64 ' HB2' HG23 ' E' ' 85' ' ' VAL . 4.1 mmt -98.41 130.77 45.04 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -176.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 14' ' ' LYS . . . . . 0.461 ' HD2' ' HD2' ' E' ' 15' ' ' PRO . 48.3 tptt -100.65 132.13 22.71 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 174.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . 0.522 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 2.0 Cg_endo -46.22 117.75 2.1 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 123.513 2.808 . . . . 0.0 113.507 -175.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 16' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' E' ' 79' ' ' THR . 37.8 mt-10 64.05 56.18 1.44 Allowed 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.472 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.73 135.29 52.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.673 172.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . 0.733 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 82.9 mttt -103.65 115.76 31.1 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 123.302 0.376 . . . . 0.0 111.249 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -105.48 102.84 12.28 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 175.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 15.4 p -89.35 98.85 12.0 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 173.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -111.92 146.41 37.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.449 0.642 . . . . 0.0 112.203 -167.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 29.2 m -100.49 143.1 31.07 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.218 174.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 23' ' ' ILE . . . . . 0.465 ' CD1' ' HB2' ' E' ' 69' ' ' PHE . 54.1 mt -108.52 125.92 65.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.143 0.497 . . . . 0.0 111.786 -172.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . 0.457 HD12 ' N ' ' E' ' 24' ' ' ILE . 4.3 mp -102.36 -50.56 9.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.823 176.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . 0.526 ' HD2' HD22 ' E' ' 91' ' ' LEU . 12.7 pttp -103.24 122.37 44.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.56 174.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 35.6 t -60.94 142.71 56.2 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.936 -177.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 27' ' ' PHE . . . . . 0.481 ' HB3' HD23 ' E' ' 91' ' ' LEU . 54.7 p90 -147.85 148.29 30.72 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -177.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 28' ' ' HIS . . . . . 0.536 ' HA ' ' O ' ' E' ' 67' ' ' LEU . 2.1 t60 -102.52 125.18 49.16 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.714 176.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 29' ' ' ILE . . . . . 0.498 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 46.5 mt -87.32 131.28 35.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 172.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . 0.536 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 94.9 p -116.61 -12.23 10.95 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -169.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 31' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . 179.95 158.65 22.37 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 119.144 -1.503 . . . . 0.0 113.724 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.468 HG23 ' HG ' ' E' ' 87' ' ' LEU . 11.0 p -141.28 138.94 33.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 175.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -152.91 156.17 38.41 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.967 -0.458 . . . . 0.0 111.945 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 34' ' ' LEU . . . . . 0.716 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.1 pp -125.29 148.06 48.86 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.593 0.711 . . . . 0.0 111.968 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -110.68 -55.13 2.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.068 169.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -100.87 127.96 47.11 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.226 174.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . 0.494 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 150.49 163.07 10.99 Favored Glycine 0 N--CA 1.434 -1.489 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.437 177.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 38' ' ' GLN . . . . . 0.409 ' HA ' ' HD2' ' E' ' 58' ' ' LYS . 25.7 mt-30 -102.6 -47.07 4.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.552 0.215 . . . . 0.0 111.037 176.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -152.45 132.45 13.41 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.356 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . 0.525 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -127.25 113.29 16.12 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.386 0.612 . . . . 0.0 110.109 168.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 41' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' E' ' 79' ' ' THR . 97.6 mttt -95.45 112.11 23.88 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 175.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.439 ' HB3' ' HB3' ' E' ' 54' ' ' ALA . 34.6 tp -86.21 107.53 17.95 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -174.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -107.41 146.01 32.23 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.765 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 44' ' ' LEU . . . . . 0.641 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 1.5 tp -129.93 116.42 18.61 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.662 176.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.55 109.31 21.15 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . 0.428 ' HB2' HD11 ' E' ' 44' ' ' LEU . . . -143.13 150.12 39.02 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.407 -177.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 57.32 30.9 19.26 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.429 0.633 . . . . 0.0 110.047 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 61.29 40.46 14.37 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.201 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 49' ' ' GLN . . . . . . . . . . . . . 15.0 tp60 -144.12 136.7 26.89 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.932 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -87.34 117.7 26.28 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.901 0.382 . . . . 0.0 110.076 178.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . 0.401 ' CG ' HD11 ' D' ' 88' ' ' LEU . 76.7 m-85 -112.83 123.02 49.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.655 178.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -80.87 100.95 5.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 170.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . 0.48 HG12 ' CD2' ' D' ' 88' ' ' LEU . 21.5 m -86.42 -33.29 7.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.7 -172.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 54' ' ' ALA . . . . . 0.737 ' HB2' HD21 ' E' ' 65' ' ' LEU . . . -153.2 144.52 23.17 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 120.271 -0.571 . . . . 0.0 112.203 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 27.5 m -115.46 102.45 9.83 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 169.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . 0.432 HG13 ' HB3' ' E' ' 40' ' ' ALA . 9.0 p -116.13 114.2 45.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.819 0.818 . . . . 0.0 110.097 -177.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 70.4 p -123.26 -177.05 3.59 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.91 -175.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 58' ' ' LYS . . . . . 0.409 ' HD2' ' HA ' ' E' ' 38' ' ' GLN . 27.2 mtpp -59.32 -35.91 74.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.257 0.551 . . . . 0.0 110.048 169.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 59' ' ' ALA . . . . . 0.418 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -71.25 -40.56 70.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.487 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 79.5 mt -114.34 82.37 7.42 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 174.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 61' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 17.2 Cg_exo -67.37 -6.67 16.94 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.232 2.621 . . . . 0.0 113.893 -168.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -161.41 132.09 5.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.256 0.551 . . . . 0.0 111.252 -175.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 87.3 t -119.76 118.72 58.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.511 176.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.85 128.19 33.38 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 174.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.737 HD21 ' HB2' ' E' ' 54' ' ' ALA . 86.2 mt -120.2 163.75 17.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.339 0.59 . . . . 0.0 112.283 -172.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 66' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -140.79 97.39 3.18 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 169.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 67' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' E' ' 28' ' ' HIS . 2.7 mt -131.19 156.29 45.6 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 68' ' ' ASN . . . . . 0.549 ' HB2' ' CZ ' ' D' ' 90' ' ' TYR . 42.6 t-20 -155.31 128.67 8.35 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 69' ' ' PHE . . . . . 0.465 ' HB2' ' CD1' ' E' ' 23' ' ' ILE . 4.2 m-85 -123.88 145.07 49.36 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 70' ' ' SER . . . . . 0.552 ' OG ' ' HA ' ' D' ' 7' ' ' MET . 37.1 m -100.43 -178.56 3.84 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -175.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -62.37 -30.75 71.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.245 0.545 . . . . 0.0 110.422 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -85.08 4.52 85.36 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.949 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -100.11 119.53 38.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.11 0.455 . . . . 0.0 110.795 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -111.83 106.39 15.11 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 173.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 75' ' ' ILE . . . . . 0.406 HG22 ' CB ' ' E' ' 46' ' ' ALA . 10.8 pt -121.05 167.96 13.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.134 -167.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 76' ' ' MET . . . . . . . . . . . . . 3.9 mtm -122.21 126.04 47.38 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 171.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 77' ' ' PHE . . . . . 0.641 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.3 OUTLIER -107.89 127.73 53.99 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 174.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' E' E ' 78' ' ' TYR . . . . . 0.733 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 53.3 p90 -155.63 140.37 17.08 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 119.818 -0.753 . . . . 0.0 112.187 -175.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 79' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 12.1 p -106.07 138.93 41.4 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.948 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.19 153.15 23.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.418 174.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.53 -173.37 33.86 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -177.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -113.66 103.83 11.62 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.87 177.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 83' ' ' ALA . . . . . 0.525 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -170.98 153.56 3.86 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.856 169.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 5.6 p -110.24 123.15 49.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.246 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 85' ' ' VAL . . . . . 0.716 HG12 ' HB3' ' E' ' 34' ' ' LEU . 11.1 m -124.71 153.26 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-O 121.456 0.646 . . . . 0.0 112.388 -173.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 29.3 m -113.2 126.82 55.85 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.833 175.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 87' ' ' LEU . . . . . 0.636 HD13 HD23 ' E' ' 11' ' ' LEU . 4.6 mp -101.99 147.5 26.48 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 169.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . 0.566 HD12 ' CE1' ' E' ' 8' ' ' PHE . 2.3 mm? -125.27 154.17 42.11 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 173.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.65 -168.76 25.05 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 119.728 -1.225 . . . . 0.0 114.161 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 90' ' ' TYR . . . . . 0.528 ' CZ ' ' HB2' ' A' ' 68' ' ' ASN . 3.2 m-85 -117.61 118.99 33.64 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.328 -0.936 . . . . 0.0 110.295 -176.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 91' ' ' LEU . . . . . 0.526 HD22 ' HD2' ' E' ' 25' ' ' LYS . 16.4 mt -82.86 117.71 22.92 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.189 0.519 . . . . 0.0 110.352 172.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 61.3 t60 -93.7 173.8 7.5 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 74.26 4.72 4.57 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.404 0.44 . . . . 0.0 110.864 176.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 5.4 tp -69.86 126.19 29.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.515 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -77.16 79.96 3.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.421 0.629 . . . . 0.0 109.861 177.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 14.3 t -154.21 135.68 14.22 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.009 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . -173.59 36.84 0.13 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.72 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.68 -0.676 . . . . 0.0 109.289 -178.779 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.421 ' HA ' ' OG ' ' B' ' 98' ' ' SER . 90.2 t80 . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 120.539 0.209 . . . . 0.0 110.511 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.679 ' O ' ' HB ' ' B' ' 94' ' ' ILE . 42.5 mt-30 54.52 -101.43 0.12 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.315 -177.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.608 ' HA2' ' O ' ' A' ' 94' ' ' ILE . . . 103.36 174.33 26.17 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.027 -1.083 . . . . 0.0 113.894 173.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 67.08 26.75 8.84 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.813 0.845 . . . . 0.0 111.314 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.43 ' HG3' ' HB2' ' B' ' 26' ' ' SER . 44.3 ttm -88.15 47.53 1.51 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.529 0.681 . . . . 0.0 109.845 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.581 ' HB3' ' ND2' ' B' ' 68' ' ' ASN . . . -65.92 151.96 45.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.337 -176.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.438 ' HA ' ' HB2' ' B' ' 70' ' ' SER . 46.1 ttm -104.29 142.5 34.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.823 -174.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.627 ' CE1' HD21 ' B' ' 44' ' ' LEU . 68.0 t80 -61.3 147.53 44.28 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -172.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.424 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 89.5 t90 -138.55 145.53 40.79 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.842 179.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.69 151.44 23.54 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.039 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.617 HD23 HD13 ' A' ' 87' ' ' LEU . 40.8 tp -146.28 109.66 4.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.63 0.252 . . . . 0.0 110.884 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 52.7 m-20 -88.46 125.31 34.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.475 0.655 . . . . 0.0 111.096 176.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.545 ' HB2' HG23 ' A' ' 85' ' ' VAL . 7.0 mmt -98.31 130.21 44.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.432 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.457 ' HB3' ' HG3' ' A' ' 17' ' ' ARG . 59.7 tttm -96.98 134.25 23.19 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 171.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.438 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 2.2 Cg_endo -43.95 112.95 0.36 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.398 2.732 . . . . 0.0 113.401 -174.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.666 ' HA ' ' O ' ' A' ' 79' ' ' THR . 48.8 mt-10 69.45 44.25 0.94 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.811 178.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.457 ' HG3' ' HB3' ' A' ' 14' ' ' LYS . 12.0 mmt180 -104.61 138.27 41.2 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.961 170.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.662 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 46.6 mttp -113.18 118.75 35.58 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 123.392 0.432 . . . . 0.0 110.501 175.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -110.51 103.84 12.49 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 177.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 76' ' ' MET . 42.7 t -86.43 102.46 14.07 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 172.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -116.84 144.36 44.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.799 -170.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.1 t -97.84 157.0 16.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.01 174.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.4 mt -120.3 124.11 71.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.098 0.475 . . . . 0.0 111.365 -173.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.625 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -114.44 -18.32 7.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.894 176.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -132.47 121.79 23.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.657 176.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.0 t -65.73 133.44 51.07 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.056 -174.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.854 ' HB3' HD23 ' A' ' 91' ' ' LEU . 46.5 p90 -137.59 147.28 44.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.648 0.737 . . . . 0.0 112.219 -177.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.551 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 7.4 t60 -104.64 125.06 50.39 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.664 174.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.57 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 45.0 mt -90.87 133.19 33.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 170.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.551 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 67.8 p -119.82 -7.36 10.01 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -171.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.64 159.14 26.74 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 119.2 -1.476 . . . . 0.0 113.706 177.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.458 HG23 ' HG ' ' A' ' 87' ' ' LEU . 11.1 p -144.43 131.7 16.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.429 ' HA ' HG21 ' A' ' 56' ' ' VAL . . . -148.5 157.66 43.61 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.968 -0.458 . . . . 0.0 112.115 -175.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.697 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.2 pp -126.63 146.18 50.27 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.541 0.686 . . . . 0.0 111.996 178.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -110.76 -52.19 2.81 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.614 -1.175 . . . . 0.0 108.864 168.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -99.74 127.68 45.87 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.447 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 142.4 159.4 7.92 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.543 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -101.47 -45.41 5.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.723 0.297 . . . . 0.0 111.164 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.414 ' HG3' HG22 ' A' ' 57' ' ' THR . 11.5 tt0 -152.27 126.45 9.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.582 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.564 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -127.61 113.7 16.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.389 0.614 . . . . 0.0 110.221 169.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -99.35 112.16 24.39 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 174.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.1 tp -81.61 115.51 20.92 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.692 -175.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -115.53 145.33 42.74 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.49 0.662 . . . . 0.0 110.245 178.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.621 HD21 ' CE1' ' E' ' 8' ' ' PHE . 0.9 OUTLIER -128.58 118.28 22.71 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.774 177.083 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -105.61 104.47 14.19 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.67 177.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.467 ' HB2' HD11 ' A' ' 44' ' ' LEU . . . -126.64 139.76 52.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.564 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 57.99 31.06 20.12 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 123.605 0.565 . . . . 0.0 110.06 -174.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 62.18 30.34 17.68 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.298 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 8.4 tp-100 -121.42 125.6 47.32 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 177.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -83.08 117.2 22.69 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.792 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -113.6 132.42 55.75 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.727 175.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -81.34 112.56 19.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 168.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.51 ' CG2' ' HB3' ' A' ' 44' ' ' LEU . 3.4 t -86.98 -51.62 12.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.737 -172.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.622 ' HB2' HD21 ' A' ' 65' ' ' LEU . . . -151.53 144.88 24.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.453 -176.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.5 m -109.29 101.7 10.69 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 171.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.429 HG21 ' HA ' ' A' ' 33' ' ' ALA . 7.2 p -117.18 110.84 32.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.907 0.86 . . . . 0.0 109.987 -177.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.414 HG22 ' HG3' ' A' ' 39' ' ' GLU . 81.0 p -123.58 -177.47 3.73 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.356 -174.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -56.98 -34.98 68.64 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.862 0.363 . . . . 0.0 110.634 167.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.98 -40.68 65.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.526 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.9 mt -116.24 83.37 12.71 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.39 -3.76 11.58 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.129 2.553 . . . . 0.0 113.972 -168.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -162.84 130.86 3.81 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.26 0.553 . . . . 0.0 111.17 -176.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 87.0 t -118.53 117.44 54.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.636 175.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.48 126.93 31.83 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.726 174.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.622 HD21 ' HB2' ' A' ' 54' ' ' ALA . 74.7 mt -121.02 167.02 13.05 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.405 0.621 . . . . 0.0 112.295 -173.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 10.9 t0 -137.51 98.18 3.64 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.549 168.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.717 HD21 HD23 ' E' ' 88' ' ' LEU . 4.9 mt -124.75 146.38 49.22 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.573 ' ND2' ' HB3' ' E' ' 6' ' ' ALA . 56.6 t30 -148.25 120.85 8.57 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.072 175.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -116.62 141.62 47.96 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.897 -177.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.462 ' HB2' ' HA ' ' E' ' 7' ' ' MET . 9.0 t -96.98 169.26 9.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.902 0.382 . . . . 0.0 110.145 -177.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -75.23 0.34 16.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.755 -178.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.08 -4.16 56.64 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 173.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -95.51 147.09 23.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.01 0.433 . . . . 0.0 110.926 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -130.85 118.24 20.47 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 172.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.44 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 16.8 pt -130.55 157.3 42.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.087 0.47 . . . . 0.0 111.869 -169.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.446 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 67.1 ttp -119.51 114.78 22.8 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.03 175.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.62 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -100.82 129.8 46.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.961 -177.119 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.662 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 53.4 p90 -152.5 150.66 29.84 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 119.959 -0.696 . . . . 0.0 112.049 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.666 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 7.3 p -113.32 136.34 52.86 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.384 177.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.24 152.03 23.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.517 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.95 -171.96 30.5 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -114.78 102.9 10.44 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.916 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.564 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -171.13 155.27 4.33 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.909 170.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.5 p -111.99 120.77 43.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.113 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.697 HG12 ' HB3' ' A' ' 34' ' ' LEU . 10.1 m -122.06 150.63 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 121.173 0.511 . . . . 0.0 112.341 -174.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 38.8 m -107.35 124.77 50.29 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.668 174.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.617 HD13 HD23 ' A' ' 11' ' ' LEU . 5.3 mp -94.94 146.56 24.15 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 169.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.685 HD23 HD21 ' B' ' 67' ' ' LEU . 1.0 OUTLIER -131.34 142.09 50.02 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.082 -178.582 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.08 -166.94 25.96 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.233 -176.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -154.33 134.62 13.3 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.859 0.838 . . . . 0.0 112.518 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.854 HD23 ' HB3' ' A' ' 27' ' ' PHE . 14.4 mt -70.6 139.35 51.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.985 175.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -86.13 109.27 18.75 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -172.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -134.96 74.95 1.54 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 167.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.634 ' HB ' ' O ' ' E' ' 2' ' ' GLN . 43.8 mm -74.45 -82.02 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.227 -172.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -82.26 84.09 7.21 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.238 0.542 . . . . 0.0 110.169 -178.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.7 m -68.58 -26.21 65.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.075 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -115.41 101.69 1.06 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.184 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.421 ' OG ' ' HA ' ' E' ' 1' ' ' PHE . 16.0 m . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.701 -0.666 . . . . 0.0 110.208 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.443 ' HA ' ' OG ' ' C' ' 98' ' ' SER . 90.2 t80 . . . . . 0 N--CA 1.484 1.228 0 N-CA-C 110.558 -0.164 . . . . 0.0 110.558 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . 0.683 ' O ' ' HB ' ' C' ' 94' ' ' ILE . 42.9 mt-30 54.82 -101.63 0.13 Allowed 'General case' 0 N--CA 1.464 0.25 0 O-C-N 123.724 0.64 . . . . 0.0 110.26 -177.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' B' ' 94' ' ' ILE . . . 103.46 174.44 26.07 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.088 -1.054 . . . . 0.0 113.799 173.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . 66.97 26.82 9.01 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.818 0.847 . . . . 0.0 111.326 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 44.5 ttm -88.24 47.6 1.52 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.613 0.72 . . . . 0.0 109.85 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.56 ' HB3' ' ND2' ' C' ' 68' ' ' ASN . . . -65.87 151.97 45.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.32 -176.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . 0.437 ' HA ' ' HB2' ' C' ' 70' ' ' SER . 45.9 ttm -104.33 142.5 34.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.898 -174.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.61 ' CE1' HD21 ' C' ' 44' ' ' LEU . 67.9 t80 -61.22 147.49 44.13 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -172.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . 0.424 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 89.5 t90 -138.54 145.52 40.78 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.84 179.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.72 151.42 23.52 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.019 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.6 HD23 HD13 ' B' ' 87' ' ' LEU . 40.4 tp -146.3 109.64 4.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.638 0.256 . . . . 0.0 110.855 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 -88.44 125.34 34.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.38 0.61 . . . . 0.0 111.126 176.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . 0.543 ' HB2' HG23 ' B' ' 85' ' ' VAL . 7.1 mmt -98.27 130.07 44.98 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.576 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.463 ' HB3' ' HG3' ' B' ' 17' ' ' ARG . 59.7 tttm -96.89 134.24 23.28 Favored Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 171.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.44 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 2.2 Cg_endo -43.92 112.84 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.454 2.769 . . . . 0.0 113.431 -174.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.653 ' HA ' ' O ' ' B' ' 79' ' ' THR . 48.8 mt-10 69.55 44.1 0.94 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.896 178.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.463 ' HG3' ' HB3' ' B' ' 14' ' ' LYS . 11.9 mmt180 -104.51 138.37 40.98 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.989 170.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.653 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 46.5 mttp -113.32 118.62 35.1 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.299 0.374 . . . . 0.0 110.513 175.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -110.35 103.84 12.54 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 42.2 t -86.39 102.68 14.25 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 172.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -117.07 144.38 44.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.747 -170.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 11.2 t -97.84 157.11 16.27 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.002 174.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 55.4 mt -120.36 124.03 71.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.051 0.453 . . . . 0.0 111.287 -173.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.628 ' H ' HD13 ' B' ' 24' ' ' ILE . 0.2 OUTLIER -114.39 -18.3 7.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.871 176.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -132.45 121.81 23.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.6 176.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . 0.43 ' HB2' ' HG3' ' A' ' 5' ' ' MET . 46.9 t -65.75 133.48 51.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.06 -174.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . 0.862 ' HB3' HD23 ' B' ' 91' ' ' LEU . 46.3 p90 -137.58 147.35 44.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.708 0.766 . . . . 0.0 112.255 -177.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' HIS . . . . . 0.554 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 7.5 t60 -104.74 125.0 50.39 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.506 -1.224 . . . . 0.0 109.578 174.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.575 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 44.7 mt -90.79 133.27 33.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 170.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.554 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 67.5 p -119.88 -7.3 9.99 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -171.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.71 159.06 26.55 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 119.213 -1.47 . . . . 0.0 113.706 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.461 HG23 ' HG ' ' B' ' 87' ' ' LEU . 11.1 p -144.42 131.74 16.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 173.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . 0.414 ' HA ' HG21 ' B' ' 56' ' ' VAL . . . -148.57 157.54 43.53 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 121.944 -0.472 . . . . 0.0 112.098 -174.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.708 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.2 pp -126.48 146.28 50.17 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.607 0.718 . . . . 0.0 111.947 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -110.87 -52.17 2.81 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.583 -1.189 . . . . 0.0 108.825 168.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -99.62 127.66 45.73 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 175.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.447 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 142.32 159.32 7.89 Favored Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 120.176 -1.011 . . . . 0.0 112.617 178.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -101.33 -45.54 5.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.837 0.351 . . . . 0.0 111.115 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.407 ' HG3' HG22 ' B' ' 57' ' ' THR . 11.4 tt0 -152.23 126.45 9.23 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.617 -178.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.571 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -127.67 113.77 16.46 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.493 0.663 . . . . 0.0 110.267 169.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -99.42 112.19 24.42 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 47.2 tp -81.61 115.37 20.85 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.661 -174.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -115.49 145.36 42.68 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.457 0.646 . . . . 0.0 110.355 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.627 HD21 ' CE1' ' A' ' 8' ' ' PHE . 0.9 OUTLIER -128.56 118.34 22.83 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.862 177.101 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -105.7 104.39 14.1 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.724 177.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.459 ' HB2' HD11 ' B' ' 44' ' ' LEU . . . -126.47 139.75 52.99 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.511 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 58.09 30.97 20.08 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 123.528 0.518 . . . . 0.0 109.985 -174.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 62.17 30.37 17.69 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.311 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 8.4 tp-100 -121.41 125.71 47.58 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -83.18 117.19 22.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.764 -177.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -113.67 132.4 55.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.742 175.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -81.33 112.62 19.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 169.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.495 ' CG2' ' HB3' ' B' ' 44' ' ' LEU . 3.4 t -86.99 -51.66 12.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.648 -172.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.62 ' HB2' HD21 ' B' ' 65' ' ' LEU . . . -151.54 145.01 24.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.449 -176.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 28.3 m -109.32 101.71 10.69 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 171.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.418 ' CG1' HG11 ' B' ' 85' ' ' VAL . 7.2 p -117.25 111.08 33.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.877 0.846 . . . . 0.0 109.909 -178.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.407 HG22 ' HG3' ' B' ' 39' ' ' GLU . 81.3 p -123.71 -177.55 3.77 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.368 -174.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -56.91 -34.92 68.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.889 0.376 . . . . 0.0 110.68 167.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.99 -40.64 65.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.551 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 75.7 mt -116.33 83.43 13.04 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 175.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.43 -3.74 11.58 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.169 2.579 . . . . 0.0 113.972 -168.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -162.89 130.86 3.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.216 0.531 . . . . 0.0 111.228 -176.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 85.8 t -118.59 117.41 54.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.613 175.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.5 126.96 31.87 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.735 174.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.62 HD21 ' HB2' ' B' ' 54' ' ' ALA . 75.1 mt -121.07 167.05 13.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.497 0.665 . . . . 0.0 112.265 -173.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . 0.45 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 10.9 t0 -137.45 98.2 3.64 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.533 168.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.685 HD21 HD23 ' A' ' 88' ' ' LEU . 4.9 mt -124.71 146.45 49.15 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.11 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . 0.581 ' ND2' ' HB3' ' A' ' 6' ' ' ALA . 56.4 t30 -148.37 120.78 8.46 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.003 175.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -116.54 141.61 47.95 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.926 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.438 ' HB2' ' HA ' ' A' ' 7' ' ' MET . 9.0 t -97.03 169.14 10.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.898 0.38 . . . . 0.0 110.111 -177.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -75.08 0.39 16.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.802 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.23 -4.14 56.47 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 174.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -95.56 147.07 23.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.028 0.442 . . . . 0.0 110.946 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -130.79 118.29 20.6 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 172.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.445 HG22 ' HB2' ' B' ' 46' ' ' ALA . 16.7 pt -130.5 157.33 42.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.043 0.449 . . . . 0.0 111.827 -169.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.448 ' HA ' ' HA ' ' B' ' 20' ' ' SER . 67.1 ttp -119.61 114.87 22.88 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.949 175.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . 0.611 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.4 OUTLIER -100.86 129.8 46.78 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.017 -177.206 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.653 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 53.3 p90 -152.41 150.66 29.9 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.994 -0.683 . . . . 0.0 112.142 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.653 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 7.3 p -113.33 136.34 52.86 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.446 177.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.21 151.97 23.42 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.582 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.14 -172.02 30.29 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -114.71 102.86 10.42 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.011 177.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.571 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -171.11 155.22 4.32 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.947 170.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 10.1 p -111.89 120.7 42.82 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.204 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.708 HG12 ' HB3' ' B' ' 34' ' ' LEU . 10.3 m -121.91 150.78 25.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.206 0.527 . . . . 0.0 112.363 -174.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' B' ' 32' ' ' VAL . 38.7 m -107.43 124.76 50.34 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.579 174.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.6 HD13 HD23 ' B' ' 11' ' ' LEU . 5.3 mp -94.96 146.52 24.18 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 169.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.672 HD23 HD21 ' C' ' 67' ' ' LEU . 1.0 OUTLIER -131.22 142.13 50.13 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.142 -178.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.06 -166.91 25.87 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.259 -176.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -154.41 134.56 13.19 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.825 0.821 . . . . 0.0 112.582 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . 0.862 HD23 ' HB3' ' B' ' 27' ' ' PHE . 14.3 mt -70.5 139.32 51.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.872 -1.513 . . . . 0.0 110.006 175.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -86.14 109.2 18.71 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -172.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -134.93 75.06 1.55 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 167.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . 0.679 ' HB ' ' O ' ' A' ' 2' ' ' GLN . 44.0 mm -74.56 -82.06 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.217 -172.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -82.2 84.14 7.16 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.21 0.529 . . . . 0.0 110.217 -178.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 5.8 m -68.59 -26.18 65.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.103 -179.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . -115.46 101.75 1.06 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.122 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 98' ' ' SER . . . . . 0.421 ' OG ' ' HA ' ' A' ' 1' ' ' PHE . 15.9 m . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.763 -0.637 . . . . 0.0 110.25 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 1' ' ' PHE . . . . . 0.4 ' HA ' ' OG ' ' D' ' 98' ' ' SER . 90.2 t80 . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 110.514 -0.18 . . . . 0.0 110.514 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . 0.611 ' O ' ' HB ' ' D' ' 94' ' ' ILE . 42.8 mt-30 54.58 -101.44 0.12 Allowed 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.646 0.591 . . . . 0.0 110.326 -177.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 3' ' ' GLY . . . . . 0.623 ' HA2' ' O ' ' C' ' 94' ' ' ILE . . . 103.33 174.42 26.2 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.114 -1.041 . . . . 0.0 113.804 173.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . 66.99 26.82 8.97 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.793 0.837 . . . . 0.0 111.365 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 44.5 ttm -88.19 47.55 1.52 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.488 0.661 . . . . 0.0 109.8 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 6' ' ' ALA . . . . . 0.564 ' HB3' ' ND2' ' D' ' 68' ' ' ASN . . . -65.93 152.02 45.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.336 -176.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 7' ' ' MET . . . . . 0.47 ' HA ' ' HB2' ' D' ' 70' ' ' SER . 45.9 ttm -104.29 142.45 34.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.84 -174.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 8' ' ' PHE . . . . . 0.625 ' CE1' HD21 ' D' ' 44' ' ' LEU . 67.8 t80 -61.32 147.36 44.94 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -172.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . 0.419 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 89.5 t90 -138.42 145.52 41.07 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.867 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.61 151.53 23.63 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.083 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.606 HD23 HD13 ' C' ' 87' ' ' LEU . 40.6 tp -146.33 109.63 4.74 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.706 0.253 . . . . 0.0 110.945 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -88.54 125.26 34.7 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.451 0.643 . . . . 0.0 111.037 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 13' ' ' MET . . . . . 0.549 ' HB2' HG23 ' C' ' 85' ' ' VAL . 7.1 mmt -98.26 130.17 44.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.568 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . 0.459 ' HB3' ' HG3' ' C' ' 17' ' ' ARG . 59.8 tttm -97.01 134.21 23.21 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 171.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . 0.447 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 2.2 Cg_endo -43.85 112.88 0.35 Allowed 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 123.451 2.767 . . . . 0.0 113.396 -174.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . 0.662 ' HA ' ' O ' ' C' ' 79' ' ' THR . 48.8 mt-10 69.45 44.32 0.94 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.813 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 17' ' ' ARG . . . . . 0.459 ' HG3' ' HB3' ' C' ' 14' ' ' LYS . 12.0 mmt180 -104.65 138.26 41.24 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.974 170.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 18' ' ' LYS . . . . . 0.667 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 46.5 mttp -113.27 118.61 35.1 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 123.375 0.422 . . . . 0.0 110.512 175.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -110.38 103.92 12.62 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 177.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 42.0 t -86.51 102.56 14.22 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 172.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -116.94 144.46 44.53 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.8 -170.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 11.1 t -97.9 157.06 16.31 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.99 174.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . 0.405 HG22 ' HA ' ' C' ' 71' ' ' LYS . 55.6 mt -120.31 124.14 71.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.076 0.465 . . . . 0.0 111.309 -173.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . 0.622 ' H ' HD13 ' C' ' 24' ' ' ILE . 0.2 OUTLIER -114.48 -18.44 7.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.827 177.011 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -132.39 121.83 24.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.562 176.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 46.8 t -65.65 133.41 51.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.061 -174.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 27' ' ' PHE . . . . . 0.825 ' HB3' HD23 ' C' ' 91' ' ' LEU . 46.5 p90 -137.64 147.33 44.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.743 0.782 . . . . 0.0 112.184 -177.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 28' ' ' HIS . . . . . 0.555 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 7.3 t60 -104.84 125.12 50.55 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.521 174.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . 0.566 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 44.5 mt -90.82 133.2 33.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 170.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.555 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 68.1 p -119.87 -7.27 10.01 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -171.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.73 159.1 26.59 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 119.204 -1.474 . . . . 0.0 113.708 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.454 HG23 ' HG ' ' C' ' 87' ' ' LEU . 11.2 p -144.48 131.71 16.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 173.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.414 ' HA ' HG21 ' C' ' 56' ' ' VAL . . . -148.5 157.66 43.61 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.915 -0.491 . . . . 0.0 112.063 -175.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.719 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.2 pp -126.53 146.2 50.22 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.593 0.711 . . . . 0.0 111.966 178.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -110.7 -52.3 2.8 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.847 168.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -99.72 127.76 45.84 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 175.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 37' ' ' GLY . . . . . 0.447 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 142.29 159.31 7.88 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.53 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -101.45 -45.38 5.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.74 0.305 . . . . 0.0 111.166 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . 0.426 ' HG3' HG22 ' C' ' 57' ' ' THR . 11.5 tt0 -152.3 126.54 9.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.532 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.564 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -127.74 113.74 16.39 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.475 0.655 . . . . 0.0 110.21 169.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -99.4 112.24 24.46 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 46.8 tp -81.64 115.51 20.94 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.635 -175.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -115.56 145.35 42.74 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.413 0.625 . . . . 0.0 110.356 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.627 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 0.9 OUTLIER -128.65 118.31 22.69 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.814 177.145 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -105.65 104.42 14.14 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.657 177.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.455 ' HB2' HD11 ' C' ' 44' ' ' LEU . . . -126.56 139.68 53.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.503 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 58.22 30.88 20.08 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 123.568 0.542 . . . . 0.0 110.029 -174.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 62.19 30.35 17.66 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.373 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 8.4 tp-100 -121.38 125.68 47.55 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -83.14 117.18 22.71 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.851 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -113.62 132.43 55.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.696 176.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -81.4 112.49 19.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 169.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 53' ' ' VAL . . . . . 0.511 ' CG2' ' HB3' ' C' ' 44' ' ' LEU . 3.4 t -86.84 -51.74 12.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.736 -172.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 54' ' ' ALA . . . . . 0.604 ' HB2' HD21 ' C' ' 65' ' ' LEU . . . -151.43 144.97 24.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.504 -176.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 28.5 m -109.28 101.63 10.62 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 171.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . 0.426 ' CG1' HG11 ' C' ' 85' ' ' VAL . 7.2 p -117.19 110.99 33.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.91 0.862 . . . . 0.0 109.944 -178.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . 0.426 HG22 ' HG3' ' C' ' 39' ' ' GLU . 81.1 p -123.68 -177.48 3.75 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.274 -174.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -57.02 -34.98 68.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.985 0.421 . . . . 0.0 110.663 167.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.84 -40.79 65.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.529 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 75.6 mt -116.18 83.43 12.62 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 175.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.36 -3.78 11.59 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.228 2.618 . . . . 0.0 113.996 -168.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -162.9 130.86 3.77 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.256 0.551 . . . . 0.0 111.109 -175.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 86.5 t -118.6 117.45 54.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.636 175.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.53 126.97 31.89 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 174.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . 0.604 HD21 ' HB2' ' C' ' 54' ' ' ALA . 75.1 mt -121.14 166.99 13.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.41 0.624 . . . . 0.0 112.311 -173.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 66' ' ' ASP . . . . . 0.439 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 10.9 t0 -137.43 98.11 3.63 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.585 168.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.672 HD21 HD23 ' B' ' 88' ' ' LEU . 4.9 mt -124.71 146.42 49.17 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . 0.56 ' ND2' ' HB3' ' B' ' 6' ' ' ALA . 56.4 t30 -148.28 120.87 8.57 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.005 175.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -116.62 141.7 47.85 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.86 -177.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . 0.437 ' HB2' ' HA ' ' B' ' 7' ' ' MET . 9.0 t -97.11 169.2 9.97 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.901 0.382 . . . . 0.0 110.063 -177.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . 0.405 ' HA ' HG22 ' C' ' 23' ' ' ILE . 15.0 ptmm? -75.28 0.51 16.38 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.793 -178.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.18 -4.17 56.52 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 173.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -95.43 147.08 23.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.064 0.459 . . . . 0.0 110.943 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -130.82 118.39 20.72 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.452 HG22 ' HB2' ' C' ' 46' ' ' ALA . 16.8 pt -130.55 157.31 42.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.04 0.448 . . . . 0.0 111.86 -169.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.438 ' HA ' ' HA ' ' C' ' 20' ' ' SER . 67.1 ttp -119.67 114.84 22.8 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.954 175.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 77' ' ' PHE . . . . . 0.627 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.4 OUTLIER -100.84 129.84 46.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.009 -177.143 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 78' ' ' TYR . . . . . 0.667 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 53.2 p90 -152.44 150.63 29.85 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.051 -0.66 . . . . 0.0 112.135 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . 0.662 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 7.3 p -113.26 136.34 52.85 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.445 177.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.19 151.93 23.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.526 177.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.08 -172.08 30.44 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -176.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -114.7 102.96 10.51 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.03 177.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . 0.564 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -171.2 155.2 4.26 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.831 170.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 10.3 p -111.87 120.67 42.75 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.133 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.719 HG12 ' HB3' ' C' ' 34' ' ' LEU . 9.9 m -121.95 150.77 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 CA-C-O 121.268 0.556 . . . . 0.0 112.236 -174.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' C' ' 32' ' ' VAL . 38.0 m -107.37 124.76 50.29 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.691 174.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . 0.606 HD13 HD23 ' C' ' 11' ' ' LEU . 5.3 mp -94.9 146.53 24.16 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 169.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . 0.707 HD23 HD21 ' D' ' 67' ' ' LEU . 1.0 OUTLIER -131.3 142.1 50.06 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.086 -178.632 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.07 -166.87 25.83 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.198 -176.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -154.41 134.55 13.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.865 0.84 . . . . 0.0 112.563 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . 0.825 HD23 ' HB3' ' C' ' 27' ' ' PHE . 14.3 mt -70.43 139.36 51.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 113.809 -1.541 . . . . 0.0 110.046 175.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -86.11 109.22 18.7 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -172.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -134.9 75.0 1.55 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 167.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . 0.683 ' HB ' ' O ' ' B' ' 2' ' ' GLN . 43.8 mm -74.55 -81.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.279 -172.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -82.27 84.17 7.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.19 0.519 . . . . 0.0 110.173 -178.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 5.7 m -68.6 -26.22 65.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.126 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -115.41 101.83 1.07 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.051 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 98' ' ' SER . . . . . 0.443 ' OG ' ' HA ' ' B' ' 1' ' ' PHE . 16.0 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.566 -0.73 . . . . 0.0 110.183 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . 0.449 ' HA ' ' OG ' ' E' ' 98' ' ' SER . 90.2 t80 . . . . . 0 N--CA 1.483 1.179 0 N-CA-C 110.5 -0.185 . . . . 0.0 110.5 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . 0.653 ' O ' ' HB ' ' E' ' 94' ' ' ILE . 42.8 mt-30 54.73 -101.47 0.13 Allowed 'General case' 0 N--CA 1.464 0.273 0 O-C-N 123.716 0.635 . . . . 0.0 110.319 -177.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 3' ' ' GLY . . . . . 0.616 ' HA2' ' O ' ' D' ' 94' ' ' ILE . . . 103.45 174.31 26.08 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.851 173.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . 67.07 26.8 8.85 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.797 0.839 . . . . 0.0 111.335 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 44.5 ttm -88.25 47.58 1.52 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.554 0.692 . . . . 0.0 109.838 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 6' ' ' ALA . . . . . 0.562 ' HB3' ' ND2' ' E' ' 68' ' ' ASN . . . -65.91 152.03 45.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.363 -176.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 7' ' ' MET . . . . . 0.457 ' HA ' ' HB2' ' E' ' 70' ' ' SER . 45.9 ttm -104.3 142.47 34.49 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.814 -174.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 8' ' ' PHE . . . . . 0.62 ' CE1' HD21 ' E' ' 44' ' ' LEU . 67.9 t80 -61.27 147.45 44.46 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -172.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 9' ' ' TRP . . . . . 0.421 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 89.6 t90 -138.5 145.54 40.9 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.817 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.67 151.4 23.5 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.072 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.608 HD23 HD13 ' D' ' 87' ' ' LEU . 40.1 tp -146.28 109.67 4.76 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.697 0.284 . . . . 0.0 110.909 -179.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -88.55 125.35 34.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.393 0.616 . . . . 0.0 111.046 176.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 13' ' ' MET . . . . . 0.55 ' HB2' HG23 ' D' ' 85' ' ' VAL . 7.1 mmt -98.3 130.14 44.99 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.526 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 14' ' ' LYS . . . . . 0.458 ' HB3' ' HG3' ' D' ' 17' ' ' ARG . 59.6 tttm -96.93 134.29 23.18 Favored Pre-proline 0 C--N 1.318 -0.799 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 171.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . 0.444 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 2.2 Cg_endo -44.03 112.91 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.482 2.788 . . . . 0.0 113.361 -174.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . 0.663 ' HA ' ' O ' ' D' ' 79' ' ' THR . 48.9 mt-10 69.47 44.2 0.94 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.869 178.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 17' ' ' ARG . . . . . 0.458 ' HG3' ' HB3' ' D' ' 14' ' ' LYS . 12.0 mmt180 -104.59 138.25 41.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.004 170.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . 0.649 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 46.6 mttp -113.26 118.64 35.22 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.367 0.417 . . . . 0.0 110.503 175.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -110.31 103.86 12.58 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 177.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 42.0 t -86.41 102.68 14.26 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 172.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -117.12 144.38 44.76 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.746 -170.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 11.3 t -97.8 157.08 16.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.068 174.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 55.7 mt -120.33 124.09 71.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.118 0.485 . . . . 0.0 111.287 -173.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . 0.638 ' H ' HD13 ' D' ' 24' ' ' ILE . 0.2 OUTLIER -114.43 -18.43 7.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.859 176.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -132.37 121.86 24.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.614 176.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 46.8 t -65.7 133.45 51.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.079 -174.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 27' ' ' PHE . . . . . 0.837 ' HB3' HD23 ' D' ' 91' ' ' LEU . 46.2 p90 -137.64 147.34 44.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.667 0.746 . . . . 0.0 112.171 -177.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 28' ' ' HIS . . . . . 0.559 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 7.4 t60 -104.77 125.04 50.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.616 174.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 29' ' ' ILE . . . . . 0.585 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 44.8 mt -90.78 133.18 33.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 170.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . 0.559 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 67.4 p -119.82 -7.33 10.02 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -171.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.68 159.1 26.65 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 119.295 -1.431 . . . . 0.0 113.726 177.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.474 HG23 ' HG ' ' D' ' 87' ' ' LEU . 11.1 p -144.48 131.78 16.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 173.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . 0.414 ' HA ' HG21 ' D' ' 56' ' ' VAL . . . -148.56 157.57 43.55 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.857 -0.527 . . . . 0.0 112.018 -174.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 34' ' ' LEU . . . . . 0.698 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.2 pp -126.53 146.17 50.23 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.645 0.736 . . . . 0.0 111.994 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -110.7 -52.3 2.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.865 168.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -99.7 127.73 45.82 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 175.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . 0.439 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 142.38 159.32 7.89 Favored Glycine 0 N--CA 1.435 -1.375 0 C-N-CA 120.191 -1.005 . . . . 0.0 112.562 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -101.42 -45.44 5.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.775 0.321 . . . . 0.0 111.167 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . 0.415 ' HG3' HG22 ' D' ' 57' ' ' THR . 11.6 tt0 -152.28 126.49 9.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.634 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . 0.579 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -127.68 113.79 16.49 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.45 0.643 . . . . 0.0 110.227 169.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -99.44 112.15 24.39 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 46.9 tp -81.64 115.4 20.89 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.677 -174.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -115.49 145.3 42.74 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.394 0.616 . . . . 0.0 110.288 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.628 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.9 OUTLIER -128.46 118.34 22.93 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.845 177.032 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 45' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -105.7 104.47 14.19 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.641 177.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.455 ' HB2' HD11 ' D' ' 44' ' ' LEU . . . -126.62 139.76 52.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.575 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 58.13 30.93 20.06 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 123.509 0.506 . . . . 0.0 109.987 -174.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 62.24 30.46 17.59 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.232 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . 0.443 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 8.4 tp-100 -121.51 125.68 47.38 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -83.17 117.26 22.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.769 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -113.72 132.45 55.81 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.647 176.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -81.34 112.63 19.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 168.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 53' ' ' VAL . . . . . 0.508 ' CG2' ' HB3' ' D' ' 44' ' ' LEU . 3.4 t -87.01 -51.56 12.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.73 -172.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 54' ' ' ALA . . . . . 0.621 ' HB2' HD21 ' D' ' 65' ' ' LEU . . . -151.55 144.96 24.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.521 -176.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 28.5 m -109.33 101.73 10.7 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 171.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 56' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' D' ' 40' ' ' ALA . 7.2 p -117.25 110.98 32.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.956 0.884 . . . . 0.0 109.94 -178.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 57' ' ' THR . . . . . 0.415 HG22 ' HG3' ' D' ' 39' ' ' GLU . 81.0 p -123.58 -177.56 3.76 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.365 -174.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -57.03 -34.88 68.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.891 0.377 . . . . 0.0 110.642 167.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.01 -40.64 65.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.56 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 75.5 mt -116.27 83.45 12.9 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.48 -3.65 11.44 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.195 2.596 . . . . 0.0 113.933 -168.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -162.95 130.81 3.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.101 0.477 . . . . 0.0 111.162 -176.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 87.7 t -118.59 117.39 54.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.586 175.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.39 126.98 31.85 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 65' ' ' LEU . . . . . 0.621 HD21 ' HB2' ' D' ' 54' ' ' ALA . 75.6 mt -121.17 167.01 13.14 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.509 0.671 . . . . 0.0 112.209 -173.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 66' ' ' ASP . . . . . 0.434 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 10.8 t0 -137.46 98.14 3.63 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.538 168.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.707 HD21 HD23 ' C' ' 88' ' ' LEU . 4.9 mt -124.69 146.38 49.17 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 68' ' ' ASN . . . . . 0.564 ' ND2' ' HB3' ' C' ' 6' ' ' ALA . 56.5 t30 -148.32 120.77 8.48 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.061 175.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -116.54 141.67 47.88 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.9 -177.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . 0.47 ' HB2' ' HA ' ' C' ' 7' ' ' MET . 9.0 t -97.0 169.15 10.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.875 0.369 . . . . 0.0 110.1 -177.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -75.26 0.46 16.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.74 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.19 -4.08 56.54 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 173.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -95.53 147.06 23.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.076 0.465 . . . . 0.0 110.936 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -130.82 118.32 20.62 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 172.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.453 HG22 ' HB2' ' D' ' 46' ' ' ALA . 16.8 pt -130.58 157.42 42.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.102 0.477 . . . . 0.0 111.788 -169.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 76' ' ' MET . . . . . 0.436 ' HA ' ' HA ' ' D' ' 20' ' ' SER . 67.1 ttp -119.71 114.8 22.72 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.947 175.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 77' ' ' PHE . . . . . 0.628 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.4 OUTLIER -100.84 129.7 46.75 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.018 -177.132 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 78' ' ' TYR . . . . . 0.649 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 53.3 p90 -152.33 150.61 29.92 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.151 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 79' ' ' THR . . . . . 0.663 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 7.2 p -113.25 136.36 52.82 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.453 177.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.2 151.97 23.42 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.503 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.01 -171.97 30.43 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 -176.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -114.67 102.87 10.44 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.042 177.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . 0.579 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -171.09 155.27 4.36 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.9 170.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 9.9 p -111.93 120.7 42.82 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.13 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.698 HG12 ' HB3' ' D' ' 34' ' ' LEU . 10.1 m -122.0 150.74 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-O 121.298 0.57 . . . . 0.0 112.289 -174.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 86' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' D' ' 32' ' ' VAL . 38.7 m -107.41 124.83 50.43 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.588 174.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 87' ' ' LEU . . . . . 0.608 HD13 HD23 ' D' ' 11' ' ' LEU . 5.3 mp -94.93 146.58 24.13 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 169.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.703 HD23 HD21 ' E' ' 67' ' ' LEU . 1.0 OUTLIER -131.31 142.09 50.05 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.125 -178.709 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.1 -166.99 26.05 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.229 -176.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -154.34 134.57 13.26 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.808 0.813 . . . . 0.0 112.583 178.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . 0.837 HD23 ' HB3' ' D' ' 27' ' ' PHE . 14.3 mt -70.52 139.32 51.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 113.89 -1.504 . . . . 0.0 109.987 175.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -86.06 109.13 18.61 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -172.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -134.9 75.05 1.55 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 167.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . 0.616 ' O ' ' HA2' ' D' ' 3' ' ' GLY . 43.9 mm -74.44 -82.02 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.258 -172.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -82.32 84.21 7.2 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.29 0.566 . . . . 0.0 110.163 -178.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 5.8 m -68.66 -26.18 65.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.129 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . -115.38 101.69 1.06 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.211 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 98' ' ' SER . . . . . 0.4 ' OG ' ' HA ' ' C' ' 1' ' ' PHE . 16.0 m . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.82 -0.61 . . . . 0.0 110.189 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 1' ' ' PHE . . . . . 0.421 ' HA ' ' OG ' ' A' ' 98' ' ' SER . 90.1 t80 . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 110.539 -0.171 . . . . 0.0 110.539 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 2' ' ' GLN . . . . . 0.634 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 42.6 mt-30 54.7 -101.56 0.13 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.319 -177.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 3' ' ' GLY . . . . . 0.616 ' HA2' ' O ' ' E' ' 94' ' ' ILE . . . 103.48 174.38 26.05 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 119.975 -1.107 . . . . 0.0 113.795 173.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . 67.04 26.76 8.9 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.806 0.842 . . . . 0.0 111.339 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 44.5 ttm -88.22 47.61 1.53 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.597 0.713 . . . . 0.0 109.836 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 6' ' ' ALA . . . . . 0.573 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . . . -65.98 151.98 45.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.338 -176.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 7' ' ' MET . . . . . 0.462 ' HA ' ' HB2' ' A' ' 70' ' ' SER . 45.9 ttm -104.25 142.47 34.47 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.835 -174.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 8' ' ' PHE . . . . . 0.621 ' CE1' HD21 ' A' ' 44' ' ' LEU . 68.1 t80 -61.26 147.45 44.44 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -172.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 9' ' ' TRP . . . . . 0.422 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 89.5 t90 -138.47 145.59 41.03 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.882 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.76 151.34 23.45 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.083 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . 0.602 HD23 HD13 ' E' ' 87' ' ' LEU . 40.8 tp -146.2 109.62 4.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.67 0.272 . . . . 0.0 110.928 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 -88.43 125.28 34.65 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.356 0.598 . . . . 0.0 111.112 176.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 13' ' ' MET . . . . . 0.554 ' HB2' HG23 ' E' ' 85' ' ' VAL . 7.1 mmt -98.3 130.16 44.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.522 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 14' ' ' LYS . . . . . 0.46 ' HB3' ' HG3' ' E' ' 17' ' ' ARG . 59.7 tttm -97.05 134.24 23.14 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 171.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . 0.451 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 2.3 Cg_endo -44.05 112.93 0.37 Allowed 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 123.43 2.754 . . . . 0.0 113.373 -174.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 16' ' ' GLU . . . . . 0.657 ' HA ' ' O ' ' E' ' 79' ' ' THR . 48.8 mt-10 69.53 44.16 0.94 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.827 178.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 17' ' ' ARG . . . . . 0.46 ' HG3' ' HB3' ' E' ' 14' ' ' LYS . 11.9 mmt180 -104.46 138.27 41.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.978 170.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . 0.663 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 46.6 mttp -113.29 118.72 35.41 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.47 0.481 . . . . 0.0 110.521 175.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -110.35 103.96 12.67 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 20' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' E' ' 76' ' ' MET . 42.3 t -86.5 102.5 14.16 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 172.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -117.01 144.35 44.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.772 -170.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 11.3 t -97.81 157.03 16.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.005 174.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 23' ' ' ILE . . . . . 0.402 HG22 ' HA ' ' E' ' 71' ' ' LYS . 55.5 mt -120.29 124.11 71.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.052 0.453 . . . . 0.0 111.323 -173.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . 0.633 ' H ' HD13 ' E' ' 24' ' ' ILE . 0.2 OUTLIER -114.43 -18.37 7.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.907 176.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -132.37 121.77 24.0 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.62 176.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 46.8 t -65.71 133.43 51.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.061 -174.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 27' ' ' PHE . . . . . 0.831 ' HB3' HD23 ' E' ' 91' ' ' LEU . 46.6 p90 -137.6 147.3 44.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.692 0.758 . . . . 0.0 112.241 -177.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 28' ' ' HIS . . . . . 0.545 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 7.4 t60 -104.73 124.99 50.36 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.64 174.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 29' ' ' ILE . . . . . 0.585 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 45.1 mt -90.75 133.15 33.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 170.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . 0.545 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 67.5 p -119.87 -7.18 10.01 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -171.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.75 159.12 26.6 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 119.183 -1.484 . . . . 0.0 113.747 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.465 HG23 ' HG ' ' E' ' 87' ' ' LEU . 11.1 p -144.49 131.72 16.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 173.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . 0.419 ' HA ' HG21 ' E' ' 56' ' ' VAL . . . -148.48 157.64 43.6 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.932 -0.48 . . . . 0.0 112.02 -174.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 34' ' ' LEU . . . . . 0.719 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.2 pp -126.6 146.26 50.23 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.635 0.731 . . . . 0.0 111.948 178.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -110.85 -52.21 2.8 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.818 168.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -99.72 127.71 45.84 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . 0.445 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 142.37 159.32 7.88 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.589 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -101.37 -45.41 5.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.708 0.289 . . . . 0.0 111.18 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 39' ' ' GLU . . . . . 0.41 ' HG3' HG22 ' E' ' 57' ' ' THR . 11.5 tt0 -152.33 126.41 9.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.626 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . 0.561 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -127.61 113.81 16.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.438 0.637 . . . . 0.0 110.205 169.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 41' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -99.49 112.3 24.52 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 174.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 46.8 tp -81.66 115.41 20.91 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.651 -175.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -115.48 145.32 42.71 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.515 0.674 . . . . 0.0 110.297 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 44' ' ' LEU . . . . . 0.62 HD21 ' CE1' ' D' ' 8' ' ' PHE . 0.9 OUTLIER -128.6 118.34 22.79 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.801 177.066 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' E' E ' 45' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -105.64 104.42 14.13 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.697 177.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . 0.461 ' HB2' HD11 ' E' ' 44' ' ' LEU . . . -126.54 139.77 52.96 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.587 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 57.98 31.04 20.09 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 123.611 0.569 . . . . 0.0 110.058 -174.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 62.24 30.27 17.56 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.284 -178.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 49' ' ' GLN . . . . . 0.449 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 8.4 tp-100 -121.35 125.67 47.55 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 178.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -83.16 117.2 22.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.815 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -113.64 132.44 55.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.714 175.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -81.27 112.51 19.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 168.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . 0.506 ' CG2' ' HB3' ' E' ' 44' ' ' LEU . 3.4 t -86.98 -51.51 12.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.732 -172.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 54' ' ' ALA . . . . . 0.606 ' HB2' HD21 ' E' ' 65' ' ' LEU . . . -151.57 144.97 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.468 -176.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 28.2 m -109.23 101.69 10.69 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 171.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . 0.421 ' CG1' HG11 ' E' ' 85' ' ' VAL . 7.2 p -117.25 110.9 32.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.885 0.85 . . . . 0.0 109.9 -177.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 57' ' ' THR . . . . . 0.41 HG22 ' HG3' ' E' ' 39' ' ' GLU . 81.1 p -123.59 -177.54 3.75 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.342 -174.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -56.92 -35.05 68.59 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.965 0.412 . . . . 0.0 110.555 167.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.9 -40.63 65.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.534 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 75.5 mt -116.35 83.38 13.0 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 175.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.38 -3.78 11.61 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.177 2.584 . . . . 0.0 113.933 -168.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -162.84 130.83 3.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.247 0.546 . . . . 0.0 111.135 -175.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 87.9 t -118.66 117.51 54.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.556 175.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.5 126.94 31.85 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.672 174.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.606 HD21 ' HB2' ' E' ' 54' ' ' ALA . 75.0 mt -121.04 167.02 13.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.439 0.637 . . . . 0.0 112.307 -173.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 66' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 10.9 t0 -137.44 98.2 3.65 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.593 168.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 67' ' ' LEU . . . . . 0.703 HD21 HD23 ' D' ' 88' ' ' LEU . 4.9 mt -124.67 146.39 49.15 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.081 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 68' ' ' ASN . . . . . 0.562 ' ND2' ' HB3' ' D' ' 6' ' ' ALA . 56.4 t30 -148.31 120.82 8.52 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.023 175.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -116.55 141.67 47.88 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.941 -177.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 70' ' ' SER . . . . . 0.457 ' HB2' ' HA ' ' D' ' 7' ' ' MET . 9.0 t -97.04 169.22 9.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.924 0.392 . . . . 0.0 110.034 -177.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 71' ' ' LYS . . . . . 0.402 ' HA ' HG22 ' E' ' 23' ' ' ILE . 15.1 ptmm? -75.19 0.28 16.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.748 -178.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.0 -4.23 56.72 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 173.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -95.46 147.13 23.86 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 120.992 0.425 . . . . 0.0 110.946 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -130.84 118.32 20.61 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 172.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 75' ' ' ILE . . . . . 0.449 HG22 ' HB2' ' E' ' 46' ' ' ALA . 16.8 pt -130.61 157.32 42.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.131 0.491 . . . . 0.0 111.774 -169.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 76' ' ' MET . . . . . 0.437 ' HA ' ' HA ' ' E' ' 20' ' ' SER . 67.1 ttp -119.55 114.82 22.84 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.005 175.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 77' ' ' PHE . . . . . 0.611 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.4 OUTLIER -100.92 129.76 46.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.001 -177.133 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' E' E ' 78' ' ' TYR . . . . . 0.663 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 53.3 p90 -152.43 150.64 29.87 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.989 -0.685 . . . . 0.0 112.148 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 79' ' ' THR . . . . . 0.657 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 7.3 p -113.27 136.4 52.79 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.413 177.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.22 152.02 23.37 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.528 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.96 -171.9 30.43 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -176.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -114.73 102.84 10.39 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.054 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 83' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -171.04 155.32 4.41 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.889 170.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 10.4 p -112.0 120.77 43.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.121 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 85' ' ' VAL . . . . . 0.719 HG12 ' HB3' ' E' ' 34' ' ' LEU . 9.8 m -122.12 150.71 25.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.237 0.542 . . . . 0.0 112.232 -174.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 38.9 m -107.43 124.75 50.32 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.606 174.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 87' ' ' LEU . . . . . 0.602 HD13 HD23 ' E' ' 11' ' ' LEU . 5.3 mp -94.87 146.54 24.14 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 169.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . 0.717 HD23 HD21 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -131.28 142.05 50.06 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.164 -178.663 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.01 -166.87 25.77 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.259 -176.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 90' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -154.42 134.62 13.22 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.804 0.812 . . . . 0.0 112.561 178.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 91' ' ' LEU . . . . . 0.831 HD23 ' HB3' ' E' ' 27' ' ' PHE . 14.3 mt -70.56 139.34 51.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.842 -1.527 . . . . 0.0 109.956 175.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -86.14 109.19 18.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.359 0.6 . . . . 0.0 112.517 -172.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -134.91 74.95 1.55 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 167.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 94' ' ' ILE . . . . . 0.653 ' HB ' ' O ' ' D' ' 2' ' ' GLN . 44.1 mm -74.48 -81.98 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.298 -172.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -82.28 84.12 7.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.219 0.533 . . . . 0.0 110.159 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 5.8 m -68.63 -26.21 65.23 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.055 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . -115.43 101.78 1.06 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.119 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 98' ' ' SER . . . . . 0.449 ' OG ' ' HA ' ' D' ' 1' ' ' PHE . 16.1 m . . . . . 0 C--O 1.247 0.974 0 CA-C-O 118.822 -0.609 . . . . 0.0 110.21 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.83 0.348 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.507 ' NE2' ' HD3' ' B' ' 25' ' ' LYS . 4.4 pt20 -156.28 179.35 9.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.238 -175.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.428 ' HA3' ' N ' ' B' ' 94' ' ' ILE . . . -78.64 65.92 3.38 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.35 -0.453 . . . . 0.0 113.294 -174.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -130.2 68.22 1.46 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.899 0.38 . . . . 0.0 110.345 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -105.15 -42.09 5.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.543 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.554 ' O ' ' HB2' ' B' ' 70' ' ' SER . . . -57.87 120.2 8.05 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.951 -174.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.502 ' HA ' ' HB2' ' B' ' 70' ' ' SER . 55.9 mtp -101.97 169.45 8.76 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.333 -176.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -88.34 152.2 22.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.244 -175.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 87.1 t90 -138.57 146.49 41.91 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.86 155.8 26.34 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.108 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.627 HD23 HD13 ' A' ' 87' ' ' LEU . 42.4 tp -149.98 108.27 3.77 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.695 0.283 . . . . 0.0 110.951 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -86.8 103.31 15.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.149 0.499 . . . . 0.0 110.855 175.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.563 ' HB2' HG23 ' A' ' 85' ' ' VAL . 2.9 mmt -80.69 136.61 36.22 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.345 -179.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.552 ' HB2' ' HG3' ' A' ' 17' ' ' ARG . 27.2 mtpp -99.85 142.58 24.88 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 173.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.526 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 7.5 Cg_endo -50.19 115.26 1.79 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 123.443 2.762 . . . . 0.0 113.283 -175.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.67 ' HA ' ' O ' ' A' ' 79' ' ' THR . 26.1 mt-10 65.1 57.54 0.95 Allowed 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.597 0.713 . . . . 0.0 111.569 177.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.552 ' HG3' ' HB2' ' A' ' 14' ' ' LYS . 13.5 mmt180 -117.6 163.43 16.45 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.473 171.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.627 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 3.3 ttmp? -139.46 109.92 6.6 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 123.474 0.484 . . . . 0.0 110.843 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -111.38 113.31 25.68 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.7 p -72.18 116.53 12.72 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 171.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -98.0 117.71 32.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.673 -163.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.5 t -91.99 143.44 26.47 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 171.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.9 mt -115.32 124.41 71.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.153 0.502 . . . . 0.0 111.768 -172.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.1 mp -90.41 -43.8 14.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.816 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.465 ' HD3' ' NE2' ' E' ' 2' ' ' GLN . 27.3 ttpt -140.09 149.45 43.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.12 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.532 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 23.1 t -59.9 115.22 3.25 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.102 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.907 ' HB3' HD23 ' A' ' 91' ' ' LEU . 12.5 p90 -122.86 148.97 44.8 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.471 0.653 . . . . 0.0 111.62 -177.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.668 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 10.3 t60 -106.66 120.43 41.94 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.552 178.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.597 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 31.4 mt -89.38 134.2 29.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 171.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.668 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 15.8 p -122.38 -15.52 7.61 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -171.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -155.66 152.87 24.31 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 119.533 -1.318 . . . . 0.0 113.227 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.463 HG23 ' HG ' ' A' ' 87' ' ' LEU . 11.7 p -150.15 122.28 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 171.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.29 154.61 42.54 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 122.008 -0.432 . . . . 0.0 111.572 -173.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.515 ' HB3' HG12 ' A' ' 85' ' ' VAL . 3.7 pp -113.94 139.28 49.35 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.638 0.733 . . . . 0.0 111.552 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -104.59 -56.06 2.24 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.83 173.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -102.27 127.82 49.08 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 170.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.497 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 150.93 162.26 10.55 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 119.683 -1.246 . . . . 0.0 113.472 176.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.524 ' O ' ' HG3' ' A' ' 58' ' ' LYS . 26.6 mt-30 -102.55 -47.99 4.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.573 0.225 . . . . 0.0 111.285 176.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -151.54 133.02 14.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.388 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.533 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -132.54 116.22 16.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.411 0.625 . . . . 0.0 110.527 170.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 79' ' ' THR . 97.8 mttt -100.14 112.59 24.9 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.5 tp -84.55 114.41 21.94 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -176.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.475 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 98.5 m-85 -116.23 145.62 42.98 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 176.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.607 ' HA ' ' O ' ' A' ' 76' ' ' MET . 0.3 OUTLIER -131.9 130.85 42.13 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.667 171.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -104.36 113.74 27.51 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.764 177.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.753 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -126.07 139.22 53.57 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 174.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 57.3 30.34 18.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.27 0.557 . . . . 0.0 109.615 -171.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.535 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 0.3 OUTLIER 64.84 17.11 10.86 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.456 -179.109 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 7.7 tt0 -104.99 121.54 43.97 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -82.15 112.12 18.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.686 -177.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -102.96 136.58 42.51 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.492 177.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -82.23 103.05 8.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 171.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.51 ' CG1' HD11 ' A' ' 67' ' ' LEU . 2.9 t -78.63 -52.8 14.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.763 -172.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.487 ' HB2' ' CD2' ' A' ' 65' ' ' LEU . . . -146.89 137.63 23.82 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.544 -177.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.1 m -104.49 101.62 11.29 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 170.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.428 ' CG1' HG11 ' A' ' 85' ' ' VAL . 6.2 p -121.7 109.81 25.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.979 0.895 . . . . 0.0 110.205 -177.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.6 p -122.85 -176.79 3.49 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.758 -175.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 38' ' ' GLN . 9.9 mtmp? -58.01 -31.54 67.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.028 0.442 . . . . 0.0 110.437 170.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.14 -40.82 51.76 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.551 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 69.9 mt -116.11 76.49 6.55 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 173.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -76.45 1.59 8.25 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.797 2.332 . . . . 0.0 113.329 -168.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -154.9 100.93 2.24 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.643 -170.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 66.0 t -102.59 121.02 53.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.113 0.482 . . . . 0.0 110.729 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.67 110.75 22.95 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.708 174.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -126.93 169.22 13.53 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.051 0.453 . . . . 0.0 111.708 -175.107 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.556 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 27.1 t0 -119.38 104.99 10.85 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.761 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.643 HD21 HD23 ' E' ' 88' ' ' LEU . 18.7 mt -120.65 150.68 40.55 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.992 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.542 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 5.9 t30 -152.41 127.14 9.5 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.943 0.401 . . . . 0.0 110.017 172.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' A' ' 26' ' ' SER . 38.3 m-85 -121.31 161.47 21.97 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.764 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.586 ' HB2' ' O ' ' E' ' 6' ' ' ALA . 42.6 t -115.86 158.22 23.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.328 0.585 . . . . 0.0 111.87 -174.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -21.83 66.47 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.33 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.05 -1.06 61.48 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.894 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -100.56 166.11 11.08 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -145.14 129.63 17.92 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.753 HG22 ' HB2' ' A' ' 46' ' ' ALA . 9.7 pt -134.82 174.66 12.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.435 -173.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.607 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 23.1 mtp -130.46 123.81 30.61 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -105.09 127.58 52.95 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.071 178.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.627 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 24.4 p90 -153.9 141.86 20.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.102 0.477 . . . . 0.0 111.811 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.67 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 11.6 p -113.32 141.88 46.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.08 -178.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -109.85 150.87 27.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.576 176.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.3 176.8 40.45 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -177.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -107.42 102.11 11.41 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.687 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.533 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -170.22 150.43 3.65 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.874 169.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.3 t -104.41 119.28 38.6 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.563 HG23 ' HB2' ' A' ' 13' ' ' MET . 5.7 m -119.21 135.18 60.44 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 CA-C-O 121.453 0.644 . . . . 0.0 112.135 -174.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.5 t -99.61 119.49 38.17 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.988 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.627 HD13 HD23 ' A' ' 11' ' ' LEU . 5.3 mp -92.96 147.11 23.11 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 173.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.589 HD23 HD21 ' B' ' 67' ' ' LEU . 1.5 tp -133.25 138.76 46.61 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.098 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.95 -167.6 23.62 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.985 -177.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.503 ' CD2' ' HB3' ' B' ' 68' ' ' ASN . 20.2 p90 -153.58 135.56 14.68 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.797 0.808 . . . . 0.0 112.567 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.907 HD23 ' HB3' ' A' ' 27' ' ' PHE . 5.3 mt -77.08 110.0 11.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.447 175.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -90.37 151.25 21.53 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.02 -177.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -139.36 167.61 21.68 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.412 ' N ' ' HA3' ' E' ' 3' ' ' GLY . 77.5 mt -129.06 123.24 58.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.001 0.429 . . . . 0.0 110.586 -177.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -148.87 154.82 40.02 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.0 p -70.76 -12.04 61.31 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -175.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.59 -6.97 81.24 Favored Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.6 t . . . . . 0 C--O 1.249 1.034 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.467 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 120.792 0.329 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . 0.456 ' NE2' ' HD3' ' C' ' 25' ' ' LYS . 4.4 pt20 -156.32 179.29 9.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.292 -175.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . 0.431 ' HA3' ' N ' ' C' ' 94' ' ' ILE . . . -78.59 65.86 3.37 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.348 -0.454 . . . . 0.0 113.309 -174.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -130.17 68.17 1.46 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.817 0.341 . . . . 0.0 110.338 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -105.12 -42.12 5.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.544 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' C' ' 70' ' ' SER . . . -57.91 120.22 8.1 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.898 -174.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . 0.522 ' HA ' ' HB2' ' C' ' 70' ' ' SER . 56.0 mtp -102.02 169.42 8.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.308 -176.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -88.3 152.34 22.0 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.277 -175.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -138.7 146.46 41.58 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.9 155.83 26.35 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.13 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.64 HD23 HD13 ' B' ' 87' ' ' LEU . 42.2 tp -149.97 108.22 3.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.701 0.286 . . . . 0.0 110.822 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -86.71 103.31 15.05 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.056 0.455 . . . . 0.0 110.879 175.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . 0.564 ' HB2' HG23 ' B' ' 85' ' ' VAL . 2.8 mmt -80.89 136.77 36.12 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.272 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.544 ' HB2' ' HG3' ' B' ' 17' ' ' ARG . 27.2 mtpp -99.89 142.61 24.94 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 173.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.525 ' HB3' ' N ' ' B' ' 83' ' ' ALA . 7.6 Cg_endo -50.15 115.23 1.77 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.413 2.742 . . . . 0.0 113.372 -175.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.663 ' HA ' ' O ' ' B' ' 79' ' ' THR . 25.9 mt-10 65.04 57.58 0.96 Allowed 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.623 0.725 . . . . 0.0 111.598 177.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.544 ' HG3' ' HB2' ' B' ' 14' ' ' LYS . 13.6 mmt180 -117.55 163.31 16.61 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.532 171.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.649 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 3.3 ttmp? -139.42 110.02 6.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.746 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -111.42 113.34 25.72 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 2.7 p -72.07 116.48 12.53 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 171.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -97.84 117.55 32.41 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.764 -163.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 13.5 t -91.92 143.54 26.39 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 171.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 48.7 mt -115.44 124.46 71.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.227 0.537 . . . . 0.0 111.654 -172.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.463 ' N ' HD12 ' B' ' 24' ' ' ILE . 4.1 mp -90.44 -43.86 14.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.817 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.507 ' HD3' ' NE2' ' A' ' 2' ' ' GLN . 27.2 ttpt -140.18 149.59 43.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.001 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' B' ' 69' ' ' PHE . 22.7 t -59.83 115.19 3.21 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.137 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . 0.91 ' HB3' HD23 ' B' ' 91' ' ' LEU . 12.5 p90 -122.84 148.9 44.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.478 0.656 . . . . 0.0 111.682 -177.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' HIS . . . . . 0.668 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 10.4 t60 -106.62 120.43 41.94 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.605 178.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.584 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 31.6 mt -89.51 134.24 29.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 171.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.668 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 16.3 p -122.4 -15.4 7.63 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 112.179 0.436 . . . . 0.0 112.179 -170.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -155.75 152.9 24.32 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 119.513 -1.327 . . . . 0.0 113.137 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.462 HG23 ' HG ' ' B' ' 87' ' ' LEU . 11.5 p -150.14 122.35 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 171.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.28 154.63 42.56 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.554 -173.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.499 ' HB3' HG12 ' B' ' 85' ' ' VAL . 3.7 pp -113.96 139.28 49.36 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 121.624 0.726 . . . . 0.0 111.529 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -104.59 -56.01 2.25 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.796 173.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -102.28 127.78 49.11 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 170.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.498 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 150.89 162.17 10.48 Favored Glycine 0 N--CA 1.438 -1.211 0 C-N-CA 119.547 -1.311 . . . . 0.0 113.407 176.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . 0.521 ' O ' ' HG3' ' B' ' 58' ' ' LYS . 26.5 mt-30 -102.52 -47.98 4.29 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.601 0.238 . . . . 0.0 111.293 177.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -151.57 133.06 14.69 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.636 -0.257 . . . . 0.0 110.442 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.529 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -132.56 116.3 16.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.517 0.675 . . . . 0.0 110.516 170.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' B' ' 79' ' ' THR . 97.7 mttt -100.2 112.64 24.97 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 40.6 tp -84.63 114.48 22.03 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . 0.473 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 98.8 m-85 -116.36 145.65 43.06 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.608 ' HA ' ' O ' ' B' ' 76' ' ' MET . 0.3 OUTLIER -131.95 130.77 41.93 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 120.371 -0.531 . . . . 0.0 109.731 171.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -104.29 113.78 27.57 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.821 177.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.773 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -126.13 139.22 53.54 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 174.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 57.3 30.28 18.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.293 0.568 . . . . 0.0 109.645 -171.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.526 ' HA ' ' HE2' ' B' ' 48' ' ' LYS . 0.3 OUTLIER 64.9 17.05 10.87 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.383 -179.233 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.505 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 7.7 tt0 -104.95 121.47 43.81 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -82.06 112.14 18.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.684 -177.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -102.86 136.51 42.54 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.524 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -82.27 102.99 8.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.778 0.799 . . . . 0.0 108.897 171.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.512 ' CG1' HD11 ' B' ' 67' ' ' LEU . 2.9 t -78.58 -52.78 14.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.798 -171.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.485 ' HB2' ' CD2' ' B' ' 65' ' ' LEU . . . -146.9 137.72 23.86 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.492 -177.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 28.0 m -104.6 101.65 11.29 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 170.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.425 ' CG1' HG11 ' B' ' 85' ' ' VAL . 6.2 p -121.77 109.82 25.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 122.005 0.907 . . . . 0.0 110.202 -177.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 80.4 p -122.84 -176.77 3.48 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.76 -175.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' B' ' 38' ' ' GLN . 9.9 mtmp? -58.04 -31.52 67.1 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.453 170.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.05 -40.93 52.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.634 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 69.8 mt -116.02 76.49 6.38 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.44 1.6 8.23 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.731 2.287 . . . . 0.0 113.397 -168.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . 0.415 ' OE1' ' HA ' ' C' ' 54' ' ' ALA . 10.2 tt0 -154.82 101.03 2.26 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.705 -170.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 65.7 t -102.63 121.01 53.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.108 0.48 . . . . 0.0 110.695 177.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.7 110.78 22.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.651 174.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' B' ' 30' ' ' SER . 0.3 OUTLIER -126.97 169.14 13.62 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.042 0.449 . . . . 0.0 111.738 -175.117 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 26.9 t0 -119.27 105.01 10.92 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.72 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.589 HD21 HD23 ' A' ' 88' ' ' LEU . 18.6 mt -120.76 150.76 40.49 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.999 178.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . 0.503 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 5.9 t30 -152.48 127.08 9.42 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.001 0.429 . . . . 0.0 110.022 172.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . 0.54 ' O ' ' HA ' ' B' ' 26' ' ' SER . 38.8 m-85 -121.31 161.49 21.94 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.695 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.554 ' HB2' ' O ' ' A' ' 6' ' ' ALA . 42.6 t -115.83 158.27 23.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.318 0.58 . . . . 0.0 111.874 -174.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -21.73 66.47 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.242 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.13 -0.84 61.45 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.897 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -100.69 166.01 11.1 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -145.12 129.5 17.81 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.773 HG22 ' HB2' ' B' ' 46' ' ' ALA . 9.7 pt -134.67 174.62 12.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.072 0.463 . . . . 0.0 111.404 -173.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.608 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 23.1 mtp -130.46 123.75 30.48 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . 0.403 ' CD1' ' HB2' ' B' ' 44' ' ' LEU . 0.9 OUTLIER -105.14 127.64 53.0 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.009 178.46 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.649 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 24.4 p90 -153.96 141.84 20.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.128 0.489 . . . . 0.0 111.772 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.663 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 11.6 p -113.3 141.83 46.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.053 -178.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -109.9 150.76 27.96 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.572 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.49 176.83 40.17 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -177.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -107.54 102.21 11.48 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.706 179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -170.28 150.42 3.6 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.825 169.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 32.4 t -104.44 119.4 38.88 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.564 HG23 ' HB2' ' B' ' 13' ' ' MET . 5.6 m -119.24 135.15 60.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 CA-C-O 121.488 0.661 . . . . 0.0 112.096 -174.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 7.5 t -99.6 119.56 38.27 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.98 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.64 HD13 HD23 ' B' ' 11' ' ' LEU . 5.3 mp -92.95 147.15 23.08 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 173.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.641 HD23 HD21 ' C' ' 67' ' ' LEU . 1.5 tp -133.19 138.73 46.67 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.117 -178.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.97 -167.61 23.64 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.972 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' TYR . . . . . 0.523 ' CD2' ' HB3' ' C' ' 68' ' ' ASN . 20.2 p90 -153.59 135.66 14.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.856 0.836 . . . . 0.0 112.451 178.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . 0.91 HD23 ' HB3' ' B' ' 27' ' ' PHE . 5.2 mt -77.22 110.02 11.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.098 -1.41 . . . . 0.0 109.42 175.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -90.33 151.22 21.57 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.082 -177.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -139.36 167.69 21.51 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . 0.428 ' N ' ' HA3' ' A' ' 3' ' ' GLY . 77.7 mt -129.13 123.23 58.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.001 0.429 . . . . 0.0 110.623 -177.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -148.91 154.84 40.01 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.532 -0.758 . . . . 0.0 108.961 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 10.9 p -70.74 -12.01 61.29 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.56 -6.99 81.11 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -177.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 20.1 t . . . . . 0 C--O 1.247 0.955 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.536 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 120.857 0.36 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . 0.468 ' NE2' ' HD3' ' D' ' 25' ' ' LYS . 4.4 pt20 -156.27 179.31 9.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.314 -175.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 3' ' ' GLY . . . . . 0.4 ' HA3' ' N ' ' D' ' 94' ' ' ILE . . . -78.62 65.88 3.38 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.434 -0.412 . . . . 0.0 113.267 -174.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -130.2 68.1 1.46 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.832 0.349 . . . . 0.0 110.342 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -105.08 -42.05 5.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.574 -177.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 6' ' ' ALA . . . . . 0.58 ' O ' ' HB2' ' D' ' 70' ' ' SER . . . -57.91 120.18 8.03 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.973 -174.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 7' ' ' MET . . . . . 0.512 ' HA ' ' HB2' ' D' ' 70' ' ' SER . 55.7 mtp -101.92 169.48 8.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.322 -176.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 8' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -88.4 152.28 22.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.242 -175.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -138.68 146.44 41.59 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.85 155.83 26.35 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.138 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.627 HD23 HD13 ' C' ' 87' ' ' LEU . 42.4 tp -150.02 108.3 3.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.719 0.295 . . . . 0.0 110.912 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -86.78 103.36 15.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.051 0.453 . . . . 0.0 110.814 175.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 13' ' ' MET . . . . . 0.546 ' HB2' HG23 ' C' ' 85' ' ' VAL . 2.8 mmt -80.91 136.75 36.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.191 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . 0.571 ' HB2' ' HG3' ' C' ' 17' ' ' ARG . 27.2 mtpp -99.81 142.6 24.92 Favored Pre-proline 0 C--N 1.316 -0.854 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 173.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . 0.522 ' HB3' ' N ' ' C' ' 83' ' ' ALA . 7.6 Cg_endo -50.13 115.22 1.76 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 123.454 2.769 . . . . 0.0 113.382 -175.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . 0.673 ' HA ' ' O ' ' C' ' 79' ' ' THR . 26.0 mt-10 64.97 57.56 0.97 Allowed 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.617 0.722 . . . . 0.0 111.648 177.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 17' ' ' ARG . . . . . 0.571 ' HG3' ' HB2' ' C' ' 14' ' ' LYS . 13.6 mmt180 -117.48 163.41 16.44 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.512 171.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 18' ' ' LYS . . . . . 0.639 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 3.3 ttmp? -139.5 109.93 6.6 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.811 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -111.34 113.29 25.66 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 2.7 p -72.05 116.39 12.4 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 171.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -97.81 117.69 32.7 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.777 -163.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 13.6 t -92.03 143.41 26.5 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 171.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 49.1 mt -115.36 124.48 71.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.168 0.509 . . . . 0.0 111.758 -172.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . 0.463 HD12 ' N ' ' C' ' 24' ' ' ILE . 4.1 mp -90.52 -43.72 14.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.794 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . 0.456 ' HD3' ' NE2' ' B' ' 2' ' ' GLN . 27.3 ttpt -140.23 149.47 42.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.039 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' C' ' 69' ' ' PHE . 23.0 t -59.89 115.28 3.29 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.064 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 27' ' ' PHE . . . . . 0.918 ' HB3' HD23 ' C' ' 91' ' ' LEU . 12.3 p90 -122.89 148.97 44.84 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.512 0.672 . . . . 0.0 111.608 -177.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 28' ' ' HIS . . . . . 0.659 ' HE2' ' HB3' ' C' ' 30' ' ' SER . 10.3 t60 -106.61 120.43 41.94 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.438 -1.256 . . . . 0.0 109.593 178.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . 0.595 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 31.7 mt -89.46 134.28 29.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 171.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.659 ' HB3' ' HE2' ' C' ' 28' ' ' HIS . 16.1 p -122.46 -15.41 7.59 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -171.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -155.68 152.92 24.36 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 119.54 -1.314 . . . . 0.0 113.179 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.454 HG23 ' HG ' ' C' ' 87' ' ' LEU . 11.5 p -150.18 122.35 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 171.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.32 154.53 42.43 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.091 -0.381 . . . . 0.0 111.581 -172.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.512 ' HB3' HG12 ' C' ' 85' ' ' VAL . 3.7 pp -113.86 139.3 49.29 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.703 0.763 . . . . 0.0 111.528 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -104.62 -55.99 2.25 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.929 173.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -102.31 127.9 49.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 37' ' ' GLY . . . . . 0.494 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 150.85 162.12 10.44 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 119.604 -1.284 . . . . 0.0 113.512 176.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 38' ' ' GLN . . . . . 0.529 ' O ' ' HG3' ' C' ' 58' ' ' LYS . 26.5 mt-30 -102.47 -47.97 4.3 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 120.644 0.259 . . . . 0.0 111.34 177.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -151.61 132.98 14.6 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.436 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.535 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -132.53 116.25 16.49 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.47 0.653 . . . . 0.0 110.515 170.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' C' ' 79' ' ' THR . 97.8 mttt -100.12 112.66 24.97 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 40.7 tp -84.56 114.43 21.96 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -176.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 43' ' ' TYR . . . . . 0.472 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 98.6 m-85 -116.34 145.62 43.06 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.606 ' HA ' ' O ' ' C' ' 76' ' ' MET . 0.3 OUTLIER -131.92 130.82 42.06 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.769 171.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -104.27 113.75 27.51 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.8 177.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.748 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -126.09 139.24 53.55 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 174.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 57.19 30.42 18.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.392 0.615 . . . . 0.0 109.709 -171.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.515 ' HE2' ' HA ' ' C' ' 48' ' ' LYS . 0.3 OUTLIER 64.77 17.08 10.8 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.467 -179.125 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . 0.498 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 7.8 tt0 -104.89 121.5 43.83 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -82.05 112.14 18.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.773 -177.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -102.96 136.61 42.46 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.505 177.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -82.29 103.03 8.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.803 0.811 . . . . 0.0 108.908 171.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 53' ' ' VAL . . . . . 0.513 ' CG1' HD11 ' C' ' 67' ' ' LEU . 3.0 t -78.62 -52.72 15.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.745 -171.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 54' ' ' ALA . . . . . 0.484 ' HB2' HD23 ' C' ' 65' ' ' LEU . . . -146.91 137.59 23.77 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.582 -177.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 27.9 m -104.46 101.62 11.29 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 170.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . 0.43 ' CG1' HG11 ' C' ' 85' ' ' VAL . 6.1 p -121.75 109.77 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-O 121.958 0.885 . . . . 0.0 110.172 -177.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 80.7 p -122.85 -176.81 3.49 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.762 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 58' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' C' ' 38' ' ' GLN . 9.9 mtmp? -57.98 -31.62 67.08 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.396 170.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.01 -40.91 52.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.633 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 69.7 mt -115.96 76.46 6.24 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 173.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -76.41 1.59 8.22 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.766 2.311 . . . . 0.0 113.383 -168.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . 0.424 ' OE1' ' HA ' ' D' ' 54' ' ' ALA . 10.2 tt0 -154.9 101.03 2.25 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.649 -170.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 66.0 t -102.61 121.01 53.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.072 0.463 . . . . 0.0 110.728 177.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.72 110.85 23.09 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.64 174.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' C' ' 30' ' ' SER . 0.3 OUTLIER -126.97 169.15 13.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.109 0.48 . . . . 0.0 111.604 -175.068 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 66' ' ' ASP . . . . . 0.561 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 27.4 t0 -119.3 105.04 10.94 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.764 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.641 HD21 HD23 ' B' ' 88' ' ' LEU . 18.7 mt -120.71 150.64 40.65 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.024 178.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . 0.523 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 6.0 t30 -152.37 127.12 9.52 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.961 0.41 . . . . 0.0 110.077 172.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 69' ' ' PHE . . . . . 0.536 ' O ' ' HA ' ' C' ' 26' ' ' SER . 38.8 m-85 -121.36 161.54 21.92 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.699 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . 0.552 ' HB2' ' O ' ' B' ' 6' ' ' ALA . 42.7 t -115.88 158.18 23.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.273 0.559 . . . . 0.0 111.856 -174.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -21.92 66.53 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.318 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.02 -0.83 61.64 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.91 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -100.72 166.04 11.08 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -145.09 129.65 17.98 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.748 HG22 ' HB2' ' C' ' 46' ' ' ALA . 9.7 pt -134.87 174.56 12.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.047 0.451 . . . . 0.0 111.375 -173.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.606 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 23.3 mtp -130.37 123.77 30.67 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.299 174.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 77' ' ' PHE . . . . . 0.405 ' CD1' ' HB2' ' C' ' 44' ' ' LEU . 1.0 OUTLIER -105.08 127.56 52.94 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.006 178.486 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 78' ' ' TYR . . . . . 0.639 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 24.4 p90 -153.94 141.83 20.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.067 0.46 . . . . 0.0 111.842 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . 0.673 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 11.7 p -113.29 141.85 46.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.103 -178.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -109.9 150.74 28.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.629 176.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.41 176.77 40.28 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -177.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -107.48 102.22 11.5 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 119.436 -0.905 . . . . 0.0 109.715 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . 0.535 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -170.2 150.41 3.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.942 169.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 32.5 t -104.42 119.38 38.84 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.546 HG23 ' HB2' ' C' ' 13' ' ' MET . 5.6 m -119.28 135.08 60.82 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 CA-C-O 121.454 0.645 . . . . 0.0 112.126 -174.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 7.5 t -99.61 119.5 38.17 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.044 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . 0.627 HD13 HD23 ' C' ' 11' ' ' LEU . 5.3 mp -92.95 147.01 23.19 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 173.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . 0.619 HD23 HD21 ' D' ' 67' ' ' LEU . 1.5 tp -133.15 138.8 46.76 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.145 -178.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.89 -167.59 23.54 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.072 -177.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 90' ' ' TYR . . . . . 0.524 ' CD2' ' HB3' ' D' ' 68' ' ' ASN . 20.2 p90 -153.7 135.7 14.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.867 0.841 . . . . 0.0 112.455 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . 0.918 HD23 ' HB3' ' C' ' 27' ' ' PHE . 5.2 mt -77.2 109.95 11.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.487 176.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -90.33 151.28 21.54 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.039 -177.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -139.34 167.71 21.46 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . 0.431 ' N ' ' HA3' ' B' ' 3' ' ' GLY . 77.6 mt -129.24 123.17 57.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.028 0.442 . . . . 0.0 110.614 -177.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -148.79 154.85 40.13 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.533 -0.758 . . . . 0.0 108.981 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 11.1 p -70.72 -12.02 61.3 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.5 -7.01 80.9 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -177.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 19.7 t . . . . . 0 C--O 1.249 1.078 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.576 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 120.823 0.345 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . 0.455 ' NE2' ' HD3' ' E' ' 25' ' ' LYS . 4.4 pt20 -156.31 179.33 9.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.301 -175.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 3' ' ' GLY . . . . . 0.41 ' HA3' ' N ' ' E' ' 94' ' ' ILE . . . -78.61 65.89 3.37 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.382 -0.437 . . . . 0.0 113.297 -174.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -130.15 68.09 1.46 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.866 0.365 . . . . 0.0 110.325 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -105.15 -41.9 5.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.625 -177.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 6' ' ' ALA . . . . . 0.539 ' O ' ' HB2' ' E' ' 70' ' ' SER . . . -58.03 120.18 8.1 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.913 -174.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 7' ' ' MET . . . . . 0.51 ' HA ' ' HB2' ' E' ' 70' ' ' SER . 55.7 mtp -102.07 169.44 8.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.287 -176.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 8' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -88.29 152.23 22.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.287 -175.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 9' ' ' TRP . . . . . . . . . . . . . 87.1 t90 -138.64 146.44 41.68 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.83 155.89 26.38 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.038 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.639 HD23 HD13 ' D' ' 87' ' ' LEU . 42.4 tp -150.04 108.23 3.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.665 0.269 . . . . 0.0 110.872 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 -86.79 103.31 15.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.072 0.463 . . . . 0.0 110.857 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 13' ' ' MET . . . . . 0.57 ' HB2' HG23 ' D' ' 85' ' ' VAL . 2.8 mmt -80.71 136.71 36.22 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.309 -178.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 14' ' ' LYS . . . . . 0.549 ' HB2' ' HG3' ' D' ' 17' ' ' ARG . 27.2 mtpp -99.88 142.61 24.92 Favored Pre-proline 0 C--N 1.317 -0.833 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . 0.521 ' HB3' ' N ' ' D' ' 83' ' ' ALA . 7.5 Cg_endo -50.11 115.28 1.79 Allowed 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 123.482 2.788 . . . . 0.0 113.293 -175.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . 0.681 ' HA ' ' O ' ' D' ' 79' ' ' THR . 26.1 mt-10 64.94 57.54 0.99 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.627 0.727 . . . . 0.0 111.631 177.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 17' ' ' ARG . . . . . 0.549 ' HG3' ' HB2' ' D' ' 14' ' ' LYS . 13.7 mmt180 -117.44 163.23 16.69 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.597 171.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . 0.648 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 3.3 ttmp? -139.38 109.96 6.65 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 123.446 0.466 . . . . 0.0 110.829 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -111.39 113.31 25.68 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 2.7 p -72.08 116.38 12.42 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 171.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -97.87 117.71 32.81 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.694 -163.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 13.7 t -92.06 143.41 26.49 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 171.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 49.0 mt -115.24 124.5 71.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.257 0.551 . . . . 0.0 111.761 -172.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . 0.47 HD12 ' N ' ' D' ' 24' ' ' ILE . 4.1 mp -90.59 -43.79 14.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.704 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . 0.468 ' HD3' ' NE2' ' C' ' 2' ' ' GLN . 27.3 ttpt -140.07 149.56 43.27 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.102 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 26' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' D' ' 69' ' ' PHE . 22.7 t -59.9 115.2 3.24 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.151 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 27' ' ' PHE . . . . . 0.889 ' HB3' HD23 ' D' ' 91' ' ' LEU . 12.5 p90 -122.81 148.88 44.87 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.487 0.66 . . . . 0.0 111.697 -177.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 28' ' ' HIS . . . . . 0.676 ' HE2' ' HB3' ' D' ' 30' ' ' SER . 10.3 t60 -106.55 120.43 41.92 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.662 178.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 29' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 31.5 mt -89.43 134.3 29.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 171.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . 0.676 ' HB3' ' HE2' ' D' ' 28' ' ' HIS . 16.1 p -122.46 -15.38 7.6 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -171.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 31' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -155.74 152.99 24.41 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 119.517 -1.325 . . . . 0.0 113.15 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.471 HG23 ' HG ' ' D' ' 87' ' ' LEU . 11.6 p -150.23 122.28 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 171.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.3 154.58 42.5 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.13 -0.356 . . . . 0.0 111.599 -172.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 34' ' ' LEU . . . . . 0.508 ' HB3' HG12 ' D' ' 85' ' ' VAL . 3.7 pp -113.94 139.3 49.33 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.6 0.714 . . . . 0.0 111.502 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -104.61 -55.98 2.26 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.846 173.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -102.32 127.77 49.16 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 170.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . 0.486 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 150.89 162.2 10.5 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 119.623 -1.275 . . . . 0.0 113.507 176.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 38' ' ' GLN . . . . . 0.516 ' O ' ' HG3' ' D' ' 58' ' ' LYS . 26.6 mt-30 -102.55 -47.94 4.29 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 121.191 -0.203 . . . . 0.0 111.286 177.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -151.53 132.93 14.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.598 -0.273 . . . . 0.0 110.419 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . 0.546 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -132.46 116.33 16.65 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.422 0.629 . . . . 0.0 110.512 170.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' D' ' 79' ' ' THR . 97.7 mttt -100.18 112.67 24.99 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 174.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 40.5 tp -84.62 114.55 22.07 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -176.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 43' ' ' TYR . . . . . 0.476 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 98.7 m-85 -116.37 145.67 43.05 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.612 ' HA ' ' O ' ' D' ' 76' ' ' MET . 0.3 OUTLIER -132.0 130.74 41.82 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.71 171.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 45' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -104.28 113.74 27.51 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.848 177.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.763 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -126.02 139.13 53.66 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 174.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 57.38 30.27 18.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.355 0.598 . . . . 0.0 109.674 -171.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 48' ' ' LYS . . . . . 0.54 ' HE2' ' HA ' ' D' ' 48' ' ' LYS . 0.3 OUTLIER 64.87 17.09 10.86 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.47 -179.088 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 7.8 tt0 -104.92 121.5 43.84 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -82.11 112.07 18.82 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.76 -177.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -102.88 136.6 42.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.523 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -82.36 103.09 9.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 171.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 53' ' ' VAL . . . . . 0.518 ' CG1' HD11 ' D' ' 67' ' ' LEU . 3.0 t -78.72 -52.72 15.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.735 -171.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 54' ' ' ALA . . . . . 0.485 ' HB2' ' CD2' ' D' ' 65' ' ' LEU . . . -146.92 137.73 23.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.498 -177.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 28.4 m -104.61 101.64 11.28 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 170.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 56' ' ' VAL . . . . . 0.416 ' CG1' HG11 ' D' ' 85' ' ' VAL . 6.1 p -121.73 109.85 25.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 122.019 0.914 . . . . 0.0 110.199 -177.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 80.7 p -122.88 -176.75 3.48 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.811 -175.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 58' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' D' ' 38' ' ' GLN . 9.9 mtmp? -57.94 -31.63 67.03 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.418 170.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.06 -40.87 52.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.606 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 69.9 mt -116.09 76.51 6.53 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 173.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -76.39 1.47 8.34 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.769 2.313 . . . . 0.0 113.381 -168.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -154.79 100.95 2.26 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.736 -170.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 65.9 t -102.58 121.05 53.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.038 0.447 . . . . 0.0 110.688 177.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.72 110.77 22.99 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.666 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 65' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' D' ' 30' ' ' SER . 0.3 OUTLIER -126.98 169.16 13.61 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.124 0.488 . . . . 0.0 111.639 -175.055 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 66' ' ' ASP . . . . . 0.57 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 27.2 t0 -119.32 105.1 10.99 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.712 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.619 HD21 HD23 ' C' ' 88' ' ' LEU . 18.6 mt -120.75 150.67 40.63 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.98 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 68' ' ' ASN . . . . . 0.524 ' HB3' ' CD2' ' C' ' 90' ' ' TYR . 6.0 t30 -152.41 127.11 9.49 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.91 0.386 . . . . 0.0 110.049 172.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 69' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' D' ' 26' ' ' SER . 38.4 m-85 -121.31 161.49 21.94 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.72 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . 0.58 ' HB2' ' O ' ' C' ' 6' ' ' ALA . 42.3 t -115.82 158.25 23.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.263 0.554 . . . . 0.0 111.847 -174.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -21.97 66.58 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.272 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.86 -1.07 61.79 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.906 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -100.57 166.02 11.12 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -145.04 129.59 17.98 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.763 HG22 ' HB2' ' D' ' 46' ' ' ALA . 9.8 pt -134.82 174.61 12.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.058 0.456 . . . . 0.0 111.322 -173.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 76' ' ' MET . . . . . 0.612 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 23.2 mtp -130.45 123.76 30.51 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.284 174.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 77' ' ' PHE . . . . . 0.411 ' CD1' ' HB2' ' D' ' 44' ' ' LEU . 1.0 OUTLIER -105.05 127.53 52.92 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.093 178.51 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 78' ' ' TYR . . . . . 0.648 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 24.2 p90 -153.89 141.91 20.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.096 0.474 . . . . 0.0 111.756 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 79' ' ' THR . . . . . 0.681 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 11.7 p -113.36 141.84 46.57 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.033 -178.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -109.88 150.72 28.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.622 176.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.42 176.79 40.28 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -177.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -107.4 102.21 11.51 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.716 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . 0.546 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -170.25 150.37 3.62 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.895 169.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 32.4 t -104.41 119.24 38.52 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.57 HG23 ' HB2' ' D' ' 13' ' ' MET . 5.7 m -119.14 135.19 60.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-O 121.425 0.631 . . . . 0.0 112.107 -174.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 7.5 t -99.67 119.47 38.16 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.976 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 87' ' ' LEU . . . . . 0.639 HD13 HD23 ' D' ' 11' ' ' LEU . 5.3 mp -92.87 147.07 23.15 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 173.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.613 HD23 HD21 ' E' ' 67' ' ' LEU . 1.5 tp -133.23 138.7 46.61 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.151 -178.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.82 -167.55 23.41 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.997 -177.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 90' ' ' TYR . . . . . 0.502 ' CD2' ' HB3' ' E' ' 68' ' ' ASN . 20.2 p90 -153.64 135.71 14.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.805 0.812 . . . . 0.0 112.497 178.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . 0.889 HD23 ' HB3' ' D' ' 27' ' ' PHE . 5.3 mt -77.33 110.02 11.71 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.396 176.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -90.35 151.22 21.55 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.011 -177.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -139.32 167.68 21.53 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . 0.4 ' N ' ' HA3' ' C' ' 3' ' ' GLY . 77.9 mt -129.15 123.34 58.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.064 0.459 . . . . 0.0 110.6 -177.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -148.91 154.8 39.94 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.008 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 11.0 p -70.62 -12.04 61.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -175.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.61 -7.07 80.95 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -177.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 19.5 t . . . . . 0 C--O 1.25 1.114 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.54 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 120.852 0.358 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' E' E ' 2' ' ' GLN . . . . . 0.465 ' NE2' ' HD3' ' A' ' 25' ' ' LYS . 4.5 pt20 -156.29 179.31 9.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.264 -175.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 3' ' ' GLY . . . . . 0.412 ' HA3' ' N ' ' A' ' 94' ' ' ILE . . . -78.6 65.79 3.39 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 116.246 -0.434 . . . . 0.0 113.289 -174.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -130.15 68.24 1.46 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.739 0.304 . . . . 0.0 110.272 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -105.1 -42.16 5.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.59 -177.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 6' ' ' ALA . . . . . 0.586 ' O ' ' HB2' ' A' ' 70' ' ' SER . . . -57.84 120.11 7.87 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.987 -174.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 7' ' ' MET . . . . . 0.527 ' HA ' ' HB2' ' A' ' 70' ' ' SER . 56.0 mtp -101.95 169.43 8.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.288 -176.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 8' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -88.33 152.17 22.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.316 -175.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 9' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -138.62 146.51 41.82 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -178.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.81 155.88 26.38 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.166 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . 0.633 HD23 HD13 ' E' ' 87' ' ' LEU . 42.2 tp -150.06 108.33 3.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.774 0.321 . . . . 0.0 110.912 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -86.81 103.37 15.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.161 0.505 . . . . 0.0 110.834 175.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 13' ' ' MET . . . . . 0.552 ' HB2' HG23 ' E' ' 85' ' ' VAL . 2.8 mmt -80.84 136.74 36.15 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.22 -178.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 14' ' ' LYS . . . . . 0.553 ' HB2' ' HG3' ' E' ' 17' ' ' ARG . 27.2 mtpp -99.87 142.6 24.91 Favored Pre-proline 0 C--N 1.318 -0.803 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . 0.527 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 7.6 Cg_endo -50.02 115.22 1.74 Allowed 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 123.46 2.773 . . . . 0.0 113.399 -175.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 16' ' ' GLU . . . . . 0.678 ' HA ' ' O ' ' E' ' 79' ' ' THR . 25.9 mt-10 65.03 57.53 0.96 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.539 0.685 . . . . 0.0 111.637 177.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 17' ' ' ARG . . . . . 0.553 ' HG3' ' HB2' ' E' ' 14' ' ' LYS . 13.6 mmt180 -117.57 163.27 16.68 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.503 171.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . 0.639 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 3.3 ttmp? -139.47 109.96 6.62 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 123.457 0.473 . . . . 0.0 110.858 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -111.3 113.34 25.75 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 2.7 p -72.18 116.48 12.66 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -97.88 117.68 32.75 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.714 -163.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 13.5 t -91.98 143.44 26.48 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 171.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 48.7 mt -115.4 124.43 71.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.25 0.548 . . . . 0.0 111.781 -172.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . 0.475 HD12 ' N ' ' E' ' 24' ' ' ILE . 4.1 mp -90.41 -43.82 14.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.787 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . 0.455 ' HD3' ' NE2' ' D' ' 2' ' ' GLN . 27.3 ttpt -140.15 149.45 43.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.099 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 26' ' ' SER . . . . . 0.545 ' HA ' ' O ' ' E' ' 69' ' ' PHE . 23.0 t -59.83 115.24 3.25 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.155 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 27' ' ' PHE . . . . . 0.922 ' HB3' HD23 ' E' ' 91' ' ' LEU . 12.4 p90 -122.88 148.86 44.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.463 0.649 . . . . 0.0 111.684 -177.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 28' ' ' HIS . . . . . 0.678 ' HE2' ' HB3' ' E' ' 30' ' ' SER . 10.6 t60 -106.53 120.43 41.91 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.592 178.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 29' ' ' ILE . . . . . 0.58 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 31.5 mt -89.44 134.32 29.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 171.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . 0.678 ' HB3' ' HE2' ' E' ' 28' ' ' HIS . 16.1 p -122.51 -15.41 7.57 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -171.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 31' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -155.77 152.89 24.32 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.562 -1.304 . . . . 0.0 113.195 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.469 HG23 ' HG ' ' E' ' 87' ' ' LEU . 11.6 p -150.21 122.32 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 171.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.37 154.47 42.34 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 122.13 -0.356 . . . . 0.0 111.552 -172.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 34' ' ' LEU . . . . . 0.511 ' HB3' HG12 ' E' ' 85' ' ' VAL . 3.7 pp -113.84 139.32 49.25 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.677 0.751 . . . . 0.0 111.569 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -104.59 -56.08 2.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.829 173.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -102.31 127.86 49.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 170.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . 0.494 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 150.92 162.16 10.48 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 119.613 -1.28 . . . . 0.0 113.493 176.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 38' ' ' GLN . . . . . 0.508 ' O ' ' HG3' ' E' ' 58' ' ' LYS . 26.5 mt-30 -102.5 -47.98 4.29 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 121.155 -0.218 . . . . 0.0 111.3 177.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -151.55 132.97 14.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.439 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . 0.531 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -132.54 116.26 16.51 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.412 0.625 . . . . 0.0 110.557 170.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 41' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' E' ' 79' ' ' THR . 97.8 mttt -100.12 112.59 24.89 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 40.7 tp -84.58 114.54 22.05 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -176.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 43' ' ' TYR . . . . . 0.471 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 98.4 m-85 -116.39 145.62 43.1 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 44' ' ' LEU . . . . . 0.605 ' HA ' ' O ' ' E' ' 76' ' ' MET . 0.3 OUTLIER -132.0 130.83 41.92 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.673 171.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 45' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -104.3 113.82 27.64 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.787 177.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . 0.771 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -126.12 139.18 53.58 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 174.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 57.3 30.3 18.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.315 0.578 . . . . 0.0 109.687 -171.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 48' ' ' LYS . . . . . 0.532 ' HE2' ' HA ' ' E' ' 48' ' ' LYS . 0.3 OUTLIER 64.88 17.17 10.9 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.41 -179.194 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 49' ' ' GLN . . . . . 0.504 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 7.7 tt0 -105.07 121.49 43.91 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -82.04 112.05 18.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.76 -177.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -102.91 136.57 42.48 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.491 177.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -82.27 103.11 9.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 171.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . 0.508 ' CG1' HD11 ' E' ' 67' ' ' LEU . 2.9 t -78.63 -52.75 15.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.79 -172.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 54' ' ' ALA . . . . . 0.489 ' HB2' ' CD2' ' E' ' 65' ' ' LEU . . . -146.93 137.66 23.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.5 -177.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 28.2 m -104.55 101.61 11.26 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 170.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . 0.427 ' CG1' HG11 ' E' ' 85' ' ' VAL . 6.3 p -121.67 109.78 25.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.974 0.893 . . . . 0.0 110.263 -177.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 80.4 p -122.79 -176.76 3.47 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.816 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 58' ' ' LYS . . . . . 0.508 ' HG3' ' O ' ' E' ' 38' ' ' GLN . 9.9 mtmp? -57.95 -31.7 67.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.023 0.44 . . . . 0.0 110.417 170.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.97 -40.88 52.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.621 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 70.0 mt -116.05 76.41 6.4 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -76.33 1.58 8.2 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.836 2.357 . . . . 0.0 113.408 -168.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 62' ' ' GLN . . . . . 0.408 ' OE1' ' HA ' ' A' ' 54' ' ' ALA . 10.2 tt0 -154.89 100.99 2.25 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.613 -170.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 66.3 t -102.66 120.99 53.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.112 0.482 . . . . 0.0 110.788 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.69 110.9 23.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.603 175.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' E' ' 30' ' ' SER . 0.3 OUTLIER -127.03 169.19 13.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.663 -175.096 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 66' ' ' ASP . . . . . 0.557 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 27.1 t0 -119.35 104.98 10.86 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.709 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 67' ' ' LEU . . . . . 0.613 HD21 HD23 ' D' ' 88' ' ' LEU . 18.5 mt -120.74 150.64 40.67 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.979 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 68' ' ' ASN . . . . . 0.502 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 6.0 t30 -152.38 127.17 9.55 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.922 0.391 . . . . 0.0 110.013 172.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 69' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' E' ' 26' ' ' SER . 38.5 m-85 -121.3 161.52 21.87 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.745 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 70' ' ' SER . . . . . 0.539 ' HB2' ' O ' ' D' ' 6' ' ' ALA . 42.1 t -115.89 158.26 23.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.262 0.553 . . . . 0.0 111.841 -174.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -21.81 66.49 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.297 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.98 -1.03 61.61 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.949 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -100.59 166.0 11.13 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -145.03 129.71 18.09 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 75' ' ' ILE . . . . . 0.771 HG22 ' HB2' ' E' ' 46' ' ' ALA . 9.7 pt -134.84 174.6 12.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.002 0.43 . . . . 0.0 111.376 -173.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 76' ' ' MET . . . . . 0.605 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 22.9 mtp -130.41 123.76 30.56 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 77' ' ' PHE . . . . . 0.404 ' CD1' ' HB2' ' E' ' 44' ' ' LEU . 0.9 OUTLIER -105.08 127.58 52.95 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.038 178.493 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 78' ' ' TYR . . . . . 0.639 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 24.5 p90 -153.91 141.85 20.2 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.118 0.485 . . . . 0.0 111.822 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 79' ' ' THR . . . . . 0.678 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 11.5 p -113.3 141.94 46.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.046 -178.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -110.03 150.78 28.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.534 176.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.4 176.86 40.3 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -177.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -107.46 102.18 11.47 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 119.409 -0.916 . . . . 0.0 109.713 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 83' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -170.2 150.38 3.66 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.863 169.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 32.3 t -104.42 119.31 38.69 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 85' ' ' VAL . . . . . 0.552 HG23 ' HB2' ' E' ' 13' ' ' MET . 5.7 m -119.2 135.1 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 CA-C-O 121.421 0.629 . . . . 0.0 112.17 -174.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 7.5 t -99.57 119.58 38.28 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.963 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 87' ' ' LEU . . . . . 0.633 HD13 HD23 ' E' ' 11' ' ' LEU . 5.3 mp -93.01 147.14 23.09 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . 0.643 HD23 HD21 ' A' ' 67' ' ' LEU . 1.5 tp -133.22 138.67 46.61 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.12 -178.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.86 -167.62 23.55 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.021 -177.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 90' ' ' TYR . . . . . 0.542 ' CD2' ' HB3' ' A' ' 68' ' ' ASN . 20.1 p90 -153.65 135.74 14.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.932 0.872 . . . . 0.0 112.403 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 91' ' ' LEU . . . . . 0.922 HD23 ' HB3' ' E' ' 27' ' ' PHE . 5.2 mt -77.25 110.05 11.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 113.983 -1.462 . . . . 0.0 109.402 176.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -90.41 151.29 21.49 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.044 -177.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -139.39 167.68 21.53 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 94' ' ' ILE . . . . . 0.41 ' N ' ' HA3' ' D' ' 3' ' ' GLY . 77.9 mt -129.17 123.3 58.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.008 0.433 . . . . 0.0 110.565 -177.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -148.89 154.86 40.05 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.444 -0.798 . . . . 0.0 108.958 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 10.9 p -70.73 -12.01 61.29 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -175.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.61 -6.99 81.24 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -177.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 20.2 t . . . . . 0 C--O 1.25 1.099 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.58 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 83.4 t80 . . . . . 0 N--CA 1.478 0.925 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.418 ' HG3' ' H ' ' A' ' 3' ' ' GLY . 3.9 pt20 53.44 -68.2 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.668 1.587 . . . . 0.0 114.14 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.418 ' H ' ' HG3' ' A' ' 2' ' ' GLN . . . -155.67 33.11 0.63 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.398 -177.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.06 -64.82 0.97 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.87 0.366 . . . . 0.0 110.646 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 26.3 mmt -105.53 43.89 1.08 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.35 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.12 134.97 53.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.971 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.416 ' HA ' ' HB2' ' B' ' 70' ' ' SER . 57.1 mtp -98.15 151.12 20.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.053 0.454 . . . . 0.0 111.23 -174.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.557 ' CE1' HD21 ' B' ' 44' ' ' LEU . 48.7 t80 -66.47 145.49 55.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.068 -176.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.56 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 90.2 t90 -132.71 146.08 51.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.007 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.1 146.69 16.36 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.095 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.56 ' HB2' ' CH2' ' A' ' 9' ' ' TRP . 63.5 tp -134.27 109.02 8.56 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.983 0.42 . . . . 0.0 110.454 178.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -91.52 107.71 19.4 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.516 177.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.565 ' SD ' HD11 ' A' ' 87' ' ' LEU . 54.2 mtp -102.27 143.82 31.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.38 0.61 . . . . 0.0 111.406 -174.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -100.92 151.39 37.6 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.193 -177.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.472 ' HB3' ' N ' ' A' ' 83' ' ' ALA . 11.2 Cg_endo -54.99 113.77 1.56 Allowed 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.19 2.593 . . . . 0.0 112.832 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 79' ' ' THR . 17.3 mt-10 59.96 70.96 0.6 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.508 0.67 . . . . 0.0 111.414 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.2 142.77 32.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.558 174.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.712 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 35.3 ttmt -116.44 117.46 29.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.389 -176.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.418 ' OH ' ' HA ' ' A' ' 13' ' ' MET . 1.9 m-85 -110.37 122.26 47.28 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.47 ' HB3' ' SD ' ' A' ' 76' ' ' MET . 6.0 p -102.51 99.78 9.83 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 169.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 19.9 pm0 -117.72 143.0 46.62 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.595 0.712 . . . . 0.0 112.274 -174.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.0 t -93.31 160.77 14.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.526 176.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.412 HG22 ' HA ' ' A' ' 71' ' ' LYS . 70.1 mt -112.47 119.35 60.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.066 0.46 . . . . 0.0 111.529 -173.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.407 HD12 ' N ' ' A' ' 25' ' ' LYS . 1.7 pp -99.6 -11.53 8.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.025 177.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.407 ' N ' HD12 ' A' ' 24' ' ' ILE . 84.7 tttt -148.0 119.53 7.96 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.3 p -61.7 140.53 58.18 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 123.379 0.425 . . . . 0.0 110.656 -175.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.798 ' HB3' HD23 ' A' ' 91' ' ' LEU . 42.6 p90 -152.13 162.79 40.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.718 0.77 . . . . 0.0 112.895 -174.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.544 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 7.7 t60 -114.74 124.52 52.0 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.009 176.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 41.6 mt -88.28 135.91 24.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 170.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.487 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 43.8 p -123.62 -5.26 8.15 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -170.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . 179.88 155.14 14.62 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 119.192 -1.48 . . . . 0.0 113.513 175.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.447 HG23 ' HG ' ' A' ' 87' ' ' LEU . 11.9 p -136.78 132.83 48.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.8 156.48 42.4 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.605 -176.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.613 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.1 pp -123.72 145.55 48.92 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.403 0.621 . . . . 0.0 111.01 177.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -110.2 -52.06 2.81 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.653 174.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -102.93 127.5 50.12 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 169.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.46 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 151.75 156.75 7.59 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 119.769 -1.205 . . . . 0.0 113.344 177.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.487 ' HA ' ' HB2' ' A' ' 58' ' ' LYS . 94.8 mt-30 -102.37 -44.48 5.37 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.616 0.246 . . . . 0.0 111.07 178.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -152.82 128.83 10.34 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.363 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.477 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -128.22 113.02 15.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.549 0.69 . . . . 0.0 109.981 168.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 79' ' ' THR . 28.6 mmmt -94.59 109.39 21.31 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.51 HD23 ' HB ' ' A' ' 53' ' ' VAL . 48.3 tp -82.08 109.52 16.47 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -174.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -112.24 136.33 51.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.108 177.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.698 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -123.88 121.76 36.21 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.525 175.441 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -109.92 111.1 22.29 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.02 178.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.522 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -128.72 139.32 52.28 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.539 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 56.61 35.65 26.41 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 123.751 0.657 . . . . 0.0 110.314 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.429 ' HB3' ' NZ ' ' A' ' 48' ' ' LYS . 9.1 mtpm? 63.6 32.26 14.1 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.102 -0.953 . . . . 0.0 112.284 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.559 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 59.4 tp60 -128.28 133.96 48.85 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 175.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -89.05 121.84 31.79 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 -177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -116.72 123.44 47.21 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.506 176.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -75.38 106.69 5.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 169.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.613 ' CG2' ' HB3' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -84.22 -46.37 17.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.532 -172.299 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.56 ' HB2' HD21 ' A' ' 65' ' ' LEU . . . -153.96 149.48 27.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.641 -177.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.2 m -113.02 101.6 9.62 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 169.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.45 HG13 ' HB3' ' A' ' 40' ' ' ALA . 7.8 p -115.7 114.36 46.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.544 0.688 . . . . 0.0 109.283 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 44.6 p -122.62 -179.12 4.11 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.214 -172.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HB2' ' HA ' ' A' ' 38' ' ' GLN . 58.1 tttt -58.68 -32.29 68.98 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.704 171.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.4 -40.87 22.77 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.922 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 84.5 mt -108.38 86.63 3.55 Favored Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 175.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.08 0.17 8.76 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.665 2.243 . . . . 0.0 113.843 -166.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -164.49 131.07 3.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.24 0.543 . . . . 0.0 111.516 -175.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 93.4 t -122.0 112.22 33.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.311 174.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.59 131.49 41.76 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 174.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.56 HD21 ' HB2' ' A' ' 54' ' ' ALA . 86.3 mt -124.16 168.14 13.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.482 0.658 . . . . 0.0 112.303 -173.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.491 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 18.5 t0 -142.33 99.48 3.51 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.351 169.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 2.4 mt -129.46 144.21 51.16 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.437 ' HB3' ' CD2' ' E' ' 90' ' ' TYR . 5.9 t30 -141.79 114.91 8.74 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.539 -0.465 . . . . 0.0 109.771 176.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -111.14 146.93 35.96 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.541 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.9 t -97.88 166.72 11.32 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.412 ' HA ' HG22 ' A' ' 23' ' ' ILE . 21.6 ptmt -75.57 2.21 12.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.241 0.543 . . . . 0.0 110.591 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.25 -7.77 51.47 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.294 172.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -93.18 138.75 31.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.044 0.449 . . . . 0.0 110.447 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -122.22 117.0 25.12 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.522 HG22 ' HB2' ' A' ' 46' ' ' ALA . 14.9 pt -128.58 162.73 34.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.188 0.518 . . . . 0.0 112.054 -168.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.482 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 4.9 mtm -119.93 125.67 49.0 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 172.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.698 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -109.6 127.09 54.27 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 176.548 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.712 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 53.2 p90 -155.42 139.22 16.18 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.009 -175.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.576 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 2.9 p -111.7 134.23 53.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.309 -176.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.423 ' HB3' ' HB2' ' A' ' 41' ' ' LYS . . . -100.74 157.09 16.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.536 175.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.81 179.08 46.16 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -176.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -108.18 102.96 12.06 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.003 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.477 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -168.79 150.8 4.83 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.505 170.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.3 t -109.74 121.86 46.17 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.613 HG12 ' HB3' ' A' ' 34' ' ' LEU . 7.0 m -117.68 155.26 19.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.316 0.579 . . . . 0.0 112.38 -173.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.4 m -120.72 122.43 40.39 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.58 173.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.565 HD11 ' SD ' ' A' ' 13' ' ' MET . 4.7 mp -96.03 145.76 25.19 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 170.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.526 HD13 ' O ' ' A' ' 87' ' ' LEU . 1.2 mm? -121.02 150.3 41.35 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 173.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.31 -167.81 27.54 Favored Glycine 0 N--CA 1.438 -1.18 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.248 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.436 ' CD2' ' HB3' ' B' ' 68' ' ' ASN . 3.4 p90 -147.57 129.18 15.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.735 0.779 . . . . 0.0 112.07 177.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.798 HD23 ' HB3' ' A' ' 27' ' ' PHE . 15.7 mt -71.43 140.94 50.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 113.918 -1.492 . . . . 0.0 109.815 176.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 55.9 m-70 -66.61 141.85 57.67 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.266 0.555 . . . . 0.0 111.504 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -90.48 124.58 35.1 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.306 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 16.3 pt -82.73 -48.46 17.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.368 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -175.23 42.46 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.939 0.4 . . . . 0.0 110.988 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.4 m -78.41 61.09 2.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.057 0.456 . . . . 0.0 110.692 -178.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.41 80.78 1.48 Allowed Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.871 -0.681 . . . . 0.0 111.618 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.9 m . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.459 -179.895 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 83.6 t80 . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . 0.42 ' HG3' ' H ' ' B' ' 3' ' ' GLY . 3.9 pt20 53.36 -68.28 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.714 1.605 . . . . 0.0 114.129 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . 0.42 ' H ' ' HG3' ' B' ' 2' ' ' GLN . . . -155.53 33.14 0.64 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.404 -177.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.14 -64.7 1.0 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.812 0.339 . . . . 0.0 110.613 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 26.3 mmt -105.55 43.8 1.09 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.366 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' C' ' 70' ' ' SER . . . -56.07 134.95 52.96 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.951 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 56.8 mtp -98.18 151.09 20.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.267 -174.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.614 ' CE1' HD21 ' C' ' 44' ' ' LEU . 48.2 t80 -66.5 145.55 55.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.057 -176.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . 0.565 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 90.1 t90 -132.75 146.06 51.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.003 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.19 146.74 16.44 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.118 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.565 ' HB2' ' CH2' ' B' ' 9' ' ' TRP . 63.5 tp -134.29 109.05 8.57 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.013 0.435 . . . . 0.0 110.557 178.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -91.43 107.68 19.37 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.556 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . 0.579 ' SD ' HD11 ' B' ' 87' ' ' LEU . 53.8 mtp -102.29 143.67 31.76 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.396 0.617 . . . . 0.0 111.382 -174.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -100.88 151.48 37.62 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.095 -177.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.464 ' HB3' ' N ' ' B' ' 83' ' ' ALA . 11.1 Cg_endo -55.02 113.87 1.6 Allowed 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 123.142 2.561 . . . . 0.0 112.752 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.581 ' HA ' ' O ' ' B' ' 79' ' ' THR . 17.3 mt-10 59.91 71.02 0.59 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.501 0.667 . . . . 0.0 111.356 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.23 142.83 32.66 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.613 174.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.709 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 35.3 ttmt -116.6 117.49 29.99 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.32 -176.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' TYR . . . . . 0.42 ' OH ' ' HA ' ' B' ' 13' ' ' MET . 1.9 m-85 -110.43 122.3 47.38 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.464 ' HB3' ' SD ' ' B' ' 76' ' ' MET . 5.9 p -102.58 99.83 9.86 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 169.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 19.8 pm0 -117.83 142.98 46.7 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.576 0.703 . . . . 0.0 112.165 -174.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 13.0 t -93.21 160.71 14.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.549 176.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.415 HG22 ' HA ' ' B' ' 71' ' ' LYS . 70.1 mt -112.52 119.4 60.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.138 0.494 . . . . 0.0 111.523 -173.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.405 HD12 ' N ' ' B' ' 25' ' ' LYS . 1.7 pp -99.68 -11.52 8.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.906 177.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.405 ' N ' HD12 ' B' ' 24' ' ' ILE . 84.8 tttt -147.95 119.58 8.01 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 31.4 p -61.67 140.53 58.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.654 -175.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . 0.792 ' HB3' HD23 ' B' ' 91' ' ' LEU . 42.8 p90 -152.16 162.73 40.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.774 0.797 . . . . 0.0 112.903 -174.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' HIS . . . . . 0.53 ' HA ' ' O ' ' B' ' 67' ' ' LEU . 7.6 t60 -114.66 124.49 51.95 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.053 177.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 41.8 mt -88.26 135.89 24.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 170.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.491 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 45.2 p -123.64 -5.2 8.14 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -170.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . 179.86 155.17 14.68 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 119.188 -1.482 . . . . 0.0 113.538 175.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.452 HG23 ' HG ' ' B' ' 87' ' ' LEU . 11.9 p -136.85 132.75 47.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 174.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.76 156.51 42.45 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 121.937 -0.477 . . . . 0.0 111.6 -176.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.629 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.1 pp -123.82 145.43 49.08 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.541 0.686 . . . . 0.0 111.038 177.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -110.02 -52.1 2.81 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.719 174.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -102.93 127.38 50.16 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 169.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.456 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 151.9 156.79 7.62 Favored Glycine 0 N--CA 1.437 -1.253 0 C-N-CA 119.756 -1.211 . . . . 0.0 113.366 177.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . 0.479 ' HA ' ' HB2' ' B' ' 58' ' ' LYS . 94.9 mt-30 -102.36 -44.34 5.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.692 0.282 . . . . 0.0 111.091 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -152.95 128.77 10.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.561 0.22 . . . . 0.0 111.339 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.472 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -128.16 113.08 15.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.539 0.685 . . . . 0.0 109.916 167.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' B' ' 79' ' ' THR . 28.6 mmmt -94.57 109.31 21.22 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.509 HD23 ' HB ' ' B' ' 53' ' ' VAL . 48.6 tp -82.08 109.44 16.4 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -174.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -112.2 136.41 51.66 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.072 177.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.694 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 0.1 OUTLIER -123.94 121.67 35.9 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.478 175.465 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -109.82 111.24 22.55 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.968 178.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.536 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -128.75 139.28 52.28 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.602 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 56.63 35.61 26.37 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.746 0.654 . . . . 0.0 110.358 -177.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.435 ' HB3' ' NZ ' ' B' ' 48' ' ' LYS . 9.1 mtpm? 63.57 32.38 14.1 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.277 178.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.553 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 59.3 tp60 -128.37 133.85 48.72 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 175.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -88.94 121.78 31.65 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -177.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -116.67 123.44 47.27 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.461 176.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -75.39 106.66 5.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 169.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.613 ' CG2' ' HB3' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -84.15 -46.42 17.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.535 -172.299 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.553 ' HB2' HD21 ' B' ' 65' ' ' LEU . . . -153.92 149.41 27.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.715 -177.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 53.2 m -113.0 101.67 9.69 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 169.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.437 HG13 ' HB3' ' B' ' 40' ' ' ALA . 7.7 p -115.78 114.35 45.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.578 0.704 . . . . 0.0 109.249 -179.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 45.0 p -122.59 -179.18 4.13 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.195 -172.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . 0.479 ' HB2' ' HA ' ' B' ' 38' ' ' GLN . 58.0 tttt -58.66 -32.33 69.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.747 171.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.37 -40.87 22.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.928 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 84.0 mt -108.31 86.69 3.52 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.16 0.21 8.74 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.731 2.288 . . . . 0.0 113.807 -166.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -164.52 131.05 3.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.326 0.584 . . . . 0.0 111.528 -175.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 92.9 t -121.95 112.17 33.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.348 174.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.56 131.54 41.83 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 174.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.553 HD21 ' HB2' ' B' ' 54' ' ' ALA . 86.1 mt -124.2 168.12 13.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.46 0.648 . . . . 0.0 112.226 -173.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . 0.484 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 18.6 t0 -142.4 99.44 3.5 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.396 169.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' B' ' 28' ' ' HIS . 2.3 mt -129.34 144.27 51.17 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . 0.436 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 5.9 t30 -141.98 114.89 8.65 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.836 176.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -111.03 146.89 35.92 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.552 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.416 ' HB2' ' HA ' ' A' ' 7' ' ' MET . 21.9 t -97.83 166.7 11.34 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.415 ' HA ' HG22 ' B' ' 23' ' ' ILE . 21.6 ptmt -75.53 2.11 12.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.208 0.528 . . . . 0.0 110.568 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.11 -7.78 51.82 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.336 172.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -93.24 138.68 31.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.183 0.516 . . . . 0.0 110.493 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -122.17 116.95 25.07 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.536 HG22 ' HB2' ' B' ' 46' ' ' ALA . 14.9 pt -128.41 162.86 34.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.243 0.545 . . . . 0.0 111.983 -168.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.491 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 4.9 mtm -120.08 125.8 49.18 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.389 172.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . 0.694 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.8 OUTLIER -109.64 127.08 54.3 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.64 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.709 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 53.2 p90 -155.43 139.23 16.19 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.983 -175.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.581 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 3.0 p -111.59 134.16 53.36 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.404 -176.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . 0.427 ' HB3' ' HB2' ' B' ' 41' ' ' LYS . . . -100.64 157.03 16.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.518 175.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.91 178.96 46.04 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -176.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -108.08 102.91 12.03 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.971 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.472 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -168.76 150.88 4.88 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.47 170.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 15.9 t -109.76 121.89 46.26 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.629 HG12 ' HB3' ' B' ' 34' ' ' LEU . 7.0 m -117.79 155.29 19.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.415 0.626 . . . . 0.0 112.331 -173.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 49.3 m -120.64 122.44 40.49 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.583 173.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.579 HD11 ' SD ' ' B' ' 13' ' ' MET . 4.7 mp -96.02 145.71 25.23 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 170.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.528 HD13 ' O ' ' B' ' 87' ' ' LEU . 1.2 mm? -120.96 150.2 41.48 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 173.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.21 -167.89 27.55 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.327 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' TYR . . . . . 0.435 ' CD2' ' HB3' ' C' ' 68' ' ' ASN . 3.4 p90 -147.53 129.22 15.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.755 0.788 . . . . 0.0 112.166 177.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . 0.792 HD23 ' HB3' ' B' ' 27' ' ' PHE . 15.8 mt -71.52 140.98 50.13 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 113.949 -1.478 . . . . 0.0 109.766 176.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 -66.63 141.93 57.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.134 0.493 . . . . 0.0 111.515 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -90.57 124.7 35.24 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.232 177.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 16.5 pt -82.76 -48.41 17.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.459 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -175.24 42.47 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.879 0.371 . . . . 0.0 110.976 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 1.5 m -78.55 61.14 2.83 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.987 0.423 . . . . 0.0 110.665 -178.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.41 80.83 1.48 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.507 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 48.3 m . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.358 -179.999 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 83.4 t80 . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . 0.416 ' HG3' ' H ' ' C' ' 3' ' ' GLY . 3.9 pt20 53.26 -68.13 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.762 1.625 . . . . 0.0 114.134 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 3' ' ' GLY . . . . . 0.416 ' H ' ' HG3' ' C' ' 2' ' ' GLN . . . -155.59 33.08 0.63 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.361 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.09 -64.75 0.99 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.887 0.375 . . . . 0.0 110.614 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 26.3 mmt -105.55 43.89 1.08 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.29 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.18 135.03 53.39 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.953 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 7' ' ' MET . . . . . 0.422 ' HA ' ' HB2' ' D' ' 70' ' ' SER . 56.4 mtp -98.25 151.04 20.89 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.289 -174.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 8' ' ' PHE . . . . . 0.594 ' CE1' HD21 ' D' ' 44' ' ' LEU . 48.8 t80 -66.35 145.47 55.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.101 -176.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . 0.559 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 90.2 t90 -132.71 146.02 51.52 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.046 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.13 146.69 16.35 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.1 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.559 ' HB2' ' CH2' ' C' ' 9' ' ' TRP . 63.5 tp -134.29 109.0 8.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.032 0.444 . . . . 0.0 110.468 178.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -91.44 107.66 19.36 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.583 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 13' ' ' MET . . . . . 0.572 ' SD ' HD11 ' C' ' 87' ' ' LEU . 53.5 mtp -102.21 143.61 31.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.322 0.582 . . . . 0.0 111.496 -174.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -100.8 151.46 37.6 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.205 -177.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . 0.463 ' HB3' ' N ' ' C' ' 83' ' ' ALA . 11.2 Cg_endo -55.01 113.89 1.61 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 123.152 2.568 . . . . 0.0 112.796 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' C' ' 79' ' ' THR . 17.4 mt-10 59.96 70.97 0.6 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.46 0.648 . . . . 0.0 111.328 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.24 142.97 32.67 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.554 174.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 18' ' ' LYS . . . . . 0.703 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 35.2 ttmt -116.69 117.42 29.76 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.323 -176.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . 0.426 ' OH ' ' HA ' ' C' ' 13' ' ' MET . 1.9 m-85 -110.38 122.33 47.43 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . 0.458 ' HB3' ' SD ' ' C' ' 76' ' ' MET . 6.1 p -102.59 99.84 9.87 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 169.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 19.8 pm0 -117.78 143.05 46.6 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.611 0.72 . . . . 0.0 112.163 -174.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 12.9 t -93.36 160.76 14.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.532 176.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . 0.404 HG22 ' HA ' ' C' ' 71' ' ' LYS . 70.3 mt -112.54 119.35 60.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.141 0.495 . . . . 0.0 111.531 -173.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . 0.414 HD12 ' N ' ' C' ' 25' ' ' LYS . 1.7 pp -99.6 -11.51 8.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.022 177.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . 0.414 ' N ' HD12 ' C' ' 24' ' ' ILE . 84.7 tttt -148.02 119.46 7.91 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 31.7 p -61.57 140.46 58.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.688 -175.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 27' ' ' PHE . . . . . 0.806 ' HB3' HD23 ' C' ' 91' ' ' LEU . 42.6 p90 -152.04 162.86 40.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.652 0.739 . . . . 0.0 112.969 -175.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 28' ' ' HIS . . . . . 0.538 ' HA ' ' O ' ' C' ' 67' ' ' LEU . 7.5 t60 -114.81 124.58 52.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.01 177.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 41.6 mt -88.32 135.92 24.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 170.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.502 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 44.9 p -123.59 -5.31 8.16 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -170.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . 179.89 155.09 14.49 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 119.181 -1.485 . . . . 0.0 113.547 176.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.463 HG23 ' HG ' ' C' ' 87' ' ' LEU . 12.0 p -136.8 132.84 48.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 174.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.82 156.52 42.45 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 121.952 -0.468 . . . . 0.0 111.589 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.625 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.1 pp -123.82 145.45 49.06 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.514 0.673 . . . . 0.0 111.044 177.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -110.03 -52.14 2.81 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.703 174.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -102.9 127.41 50.11 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 169.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 37' ' ' GLY . . . . . 0.465 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 151.86 156.76 7.6 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 119.848 -1.168 . . . . 0.0 113.46 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 38' ' ' GLN . . . . . 0.478 ' HA ' ' HB2' ' C' ' 58' ' ' LYS . 95.0 mt-30 -102.4 -44.34 5.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.642 0.258 . . . . 0.0 111.059 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -152.91 128.82 10.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.57 0.224 . . . . 0.0 111.361 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.471 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -128.24 112.94 15.05 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.524 0.678 . . . . 0.0 109.972 168.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' C' ' 79' ' ' THR . 28.7 mmmt -94.57 109.32 21.23 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 176.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.508 HD23 ' HB ' ' C' ' 53' ' ' VAL . 48.5 tp -82.08 109.46 16.42 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -174.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -112.3 136.4 51.78 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.071 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.7 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 0.1 OUTLIER -123.88 121.79 36.29 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.478 175.463 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -109.85 111.14 22.38 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.968 178.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.532 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -128.7 139.39 52.25 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.607 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 56.5 35.75 26.49 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 123.728 0.643 . . . . 0.0 110.304 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.426 ' HB3' ' NZ ' ' C' ' 48' ' ' LYS . 9.1 mtpm? 63.64 32.2 14.05 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.253 178.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . 0.554 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 59.5 tp60 -128.23 133.88 48.9 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 175.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -88.99 121.69 31.61 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -116.66 123.43 47.26 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.453 176.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -75.4 106.72 5.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 53' ' ' VAL . . . . . 0.608 ' CG2' ' HB3' ' C' ' 44' ' ' LEU . 0.7 OUTLIER -84.2 -46.41 17.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.553 -172.351 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 54' ' ' ALA . . . . . 0.552 ' HB2' HD21 ' C' ' 65' ' ' LEU . . . -153.97 149.44 27.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.696 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 52.6 m -112.96 101.6 9.63 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 169.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . 0.44 HG13 ' HB3' ' C' ' 40' ' ' ALA . 7.8 p -115.69 114.33 45.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.517 0.675 . . . . 0.0 109.298 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 44.3 p -122.62 -179.17 4.13 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.205 -172.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 58' ' ' LYS . . . . . 0.478 ' HB2' ' HA ' ' C' ' 38' ' ' GLN . 57.9 tttt -58.52 -32.35 68.76 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.745 171.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.38 -41.03 22.57 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.851 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 83.9 mt -108.22 86.7 3.46 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 174.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.19 0.2 8.77 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.74 2.293 . . . . 0.0 113.786 -166.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -164.46 131.12 3.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.245 0.545 . . . . 0.0 111.576 -175.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 94.0 t -122.03 112.18 33.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.303 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.67 131.48 41.69 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . 0.552 HD21 ' HB2' ' C' ' 54' ' ' ALA . 86.2 mt -124.17 168.17 13.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.46 0.648 . . . . 0.0 112.265 -173.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 66' ' ' ASP . . . . . 0.461 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 18.5 t0 -142.46 99.46 3.5 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.964 -1.017 . . . . 0.0 108.332 169.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' C' ' 28' ' ' HIS . 2.3 mt -129.42 144.29 51.19 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . 0.435 ' HB3' ' CD2' ' B' ' 90' ' ' TYR . 5.9 t30 -141.86 114.95 8.74 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.762 176.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -111.17 146.88 36.1 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.529 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' B' ' 6' ' ' ALA . 21.9 t -97.81 166.62 11.38 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . 0.404 ' HA ' HG22 ' C' ' 23' ' ' ILE . 21.6 ptmt -75.46 2.08 12.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.215 0.531 . . . . 0.0 110.588 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.15 -7.7 51.87 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.253 172.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -93.27 138.7 31.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.123 0.487 . . . . 0.0 110.428 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -122.24 116.97 25.06 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 175.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.532 HG22 ' HB2' ' C' ' 46' ' ' ALA . 15.0 pt -128.51 162.73 34.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.259 0.552 . . . . 0.0 112.014 -168.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.486 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 4.8 mtm -119.92 125.69 49.08 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.475 172.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 77' ' ' PHE . . . . . 0.7 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.8 OUTLIER -109.66 127.11 54.33 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 176.635 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 78' ' ' TYR . . . . . 0.703 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 53.3 p90 -155.42 139.21 16.18 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.862 -0.735 . . . . 0.0 112.079 -176.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . 0.577 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 3.0 p -111.56 134.22 53.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.42 -176.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 80' ' ' ALA . . . . . 0.436 ' HB3' ' HB2' ' C' ' 41' ' ' LYS . . . -100.71 157.1 16.94 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.522 175.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.81 178.93 46.2 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -176.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -108.06 102.98 12.1 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.064 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -168.79 150.77 4.82 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.504 170.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 15.8 t -109.72 121.93 46.34 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.625 HG12 ' HB3' ' C' ' 34' ' ' LEU . 6.9 m -117.78 155.3 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 CA-C-O 121.344 0.592 . . . . 0.0 112.353 -173.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 49.9 m -120.62 122.41 40.45 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.573 173.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . 0.572 HD11 ' SD ' ' C' ' 13' ' ' MET . 4.7 mp -96.0 145.72 25.21 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 170.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . 0.521 HD13 ' O ' ' C' ' 87' ' ' LEU . 1.2 mm? -121.0 150.31 41.32 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 173.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.31 -167.96 27.77 Favored Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.249 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 90' ' ' TYR . . . . . 0.447 ' CD2' ' HB3' ' D' ' 68' ' ' ASN . 3.3 p90 -147.52 129.24 15.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.785 0.802 . . . . 0.0 112.086 177.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . 0.806 HD23 ' HB3' ' C' ' 27' ' ' PHE . 15.9 mt -71.53 141.03 50.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 113.911 -1.495 . . . . 0.0 109.761 176.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 55.8 m-70 -66.6 141.86 57.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.184 0.516 . . . . 0.0 111.499 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -90.57 124.64 35.19 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.202 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 16.6 pt -82.77 -48.48 17.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.384 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -175.2 42.54 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.874 0.369 . . . . 0.0 110.963 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 1.4 m -78.44 60.98 2.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.951 0.405 . . . . 0.0 110.645 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.46 80.91 1.48 Allowed Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 -177.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.394 -179.978 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 83.5 t80 . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . 0.43 ' HG3' ' H ' ' D' ' 3' ' ' GLY . 3.9 pt20 53.43 -68.22 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.704 1.602 . . . . 0.0 114.131 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 3' ' ' GLY . . . . . 0.43 ' H ' ' HG3' ' D' ' 2' ' ' GLN . . . -155.64 33.03 0.63 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.35 -177.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.03 -64.83 0.97 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.873 0.368 . . . . 0.0 110.634 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 26.3 mmt -105.45 43.84 1.09 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.348 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.1 134.91 53.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.939 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 56.7 mtp -98.17 151.07 20.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.03 0.443 . . . . 0.0 111.326 -174.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 8' ' ' PHE . . . . . 0.592 ' CE1' HD21 ' E' ' 44' ' ' LEU . 48.6 t80 -66.5 145.55 55.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.1 -176.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 9' ' ' TRP . . . . . 0.556 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 90.2 t90 -132.75 146.02 51.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.013 179.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.11 146.71 16.41 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.125 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.556 ' HB2' ' CH2' ' D' ' 9' ' ' TRP . 63.4 tp -134.31 108.95 8.5 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.031 0.443 . . . . 0.0 110.558 178.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -91.38 107.67 19.37 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.566 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 13' ' ' MET . . . . . 0.575 ' SD ' HD11 ' D' ' 87' ' ' LEU . 54.0 mtp -102.3 143.77 31.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.429 0.633 . . . . 0.0 111.408 -174.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -100.84 151.44 37.61 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.203 -177.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . 0.473 ' HB3' ' N ' ' D' ' 83' ' ' ALA . 11.1 Cg_endo -55.06 113.9 1.62 Allowed 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 123.119 2.546 . . . . 0.0 112.754 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . 0.57 ' HA ' ' O ' ' D' ' 79' ' ' THR . 17.3 mt-10 60.02 70.83 0.61 Allowed 'General case' 0 C--O 1.233 0.207 0 O-C-N 123.711 0.632 . . . . 0.0 111.36 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.13 142.97 32.81 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.516 174.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . 0.702 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 35.3 ttmt -116.69 117.44 29.81 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.373 -176.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 19' ' ' TYR . . . . . 0.426 ' OH ' ' HA ' ' D' ' 13' ' ' MET . 1.9 m-85 -110.29 122.38 47.52 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . 0.462 ' HB3' ' SD ' ' D' ' 76' ' ' MET . 5.9 p -102.63 99.86 9.88 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 169.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 19.8 pm0 -117.76 142.98 46.66 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.516 0.674 . . . . 0.0 112.215 -174.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 13.0 t -93.24 160.77 14.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.609 176.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 70.1 mt -112.6 119.49 60.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.217 0.532 . . . . 0.0 111.449 -173.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . 0.409 HD12 ' N ' ' D' ' 25' ' ' LYS . 1.7 pp -99.7 -11.59 8.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.005 177.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . 0.409 ' N ' HD12 ' D' ' 24' ' ' ILE . 84.7 tttt -147.99 119.55 7.97 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 31.3 p -61.75 140.51 58.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.691 -175.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 27' ' ' PHE . . . . . 0.806 ' HB3' HD23 ' D' ' 91' ' ' LEU . 42.8 p90 -152.08 162.82 40.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.712 0.768 . . . . 0.0 112.898 -174.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 28' ' ' HIS . . . . . 0.53 ' HA ' ' O ' ' D' ' 67' ' ' LEU . 7.7 t60 -114.81 124.58 52.1 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.011 176.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 29' ' ' ILE . . . . . 0.513 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 42.1 mt -88.33 135.88 24.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 170.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . 0.504 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 44.6 p -123.59 -5.28 8.16 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -170.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 31' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . 179.94 155.12 14.6 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 119.175 -1.488 . . . . 0.0 113.544 176.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.473 HG23 ' HG ' ' D' ' 87' ' ' LEU . 12.0 p -136.84 132.84 48.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 174.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.83 156.46 42.36 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.918 -0.489 . . . . 0.0 111.598 -176.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 34' ' ' LEU . . . . . 0.624 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.1 pp -123.77 145.43 49.04 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.538 0.685 . . . . 0.0 111.069 177.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -110.13 -51.93 2.83 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.706 174.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -103.02 127.4 50.28 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 169.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . 0.47 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 151.81 156.81 7.62 Favored Glycine 0 N--CA 1.437 -1.253 0 C-N-CA 119.811 -1.185 . . . . 0.0 113.384 177.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 38' ' ' GLN . . . . . 0.49 ' HA ' ' HB2' ' D' ' 58' ' ' LYS . 95.0 mt-30 -102.43 -44.41 5.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.662 0.267 . . . . 0.0 111.053 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -152.87 128.84 10.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.327 178.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -128.22 113.08 15.23 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.557 0.694 . . . . 0.0 109.884 168.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' D' ' 79' ' ' THR . 28.6 mmmt -94.6 109.35 21.27 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 176.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.51 HD23 ' HB ' ' D' ' 53' ' ' VAL . 48.5 tp -82.13 109.49 16.49 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -174.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -112.22 136.34 51.77 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.123 177.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.704 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.1 OUTLIER -123.91 121.78 36.24 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.498 175.427 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 45' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -109.91 111.16 22.39 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.915 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.532 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -128.72 139.39 52.24 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.567 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 56.57 35.72 26.5 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 123.654 0.596 . . . . 0.0 110.207 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 48' ' ' LYS . . . . . 0.431 ' NZ ' ' HB3' ' D' ' 48' ' ' LYS . 9.1 mtpm? 63.6 32.32 14.08 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.276 178.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . 0.558 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 59.5 tp60 -128.3 133.98 48.84 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -89.1 121.79 31.78 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -177.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -116.72 123.4 47.12 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.442 176.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -75.42 106.71 5.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 169.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 53' ' ' VAL . . . . . 0.61 ' CG2' ' HB3' ' D' ' 44' ' ' LEU . 0.7 OUTLIER -84.09 -46.44 18.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.599 -172.392 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 54' ' ' ALA . . . . . 0.55 ' HB2' HD21 ' D' ' 65' ' ' LEU . . . -153.89 149.38 27.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.728 -177.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 53.0 m -112.93 101.64 9.68 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 169.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 56' ' ' VAL . . . . . 0.444 HG13 ' HB3' ' D' ' 40' ' ' ALA . 7.8 p -115.71 114.37 46.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.605 0.716 . . . . 0.0 109.254 -179.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 44.7 p -122.65 -179.23 4.15 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.13 -172.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 58' ' ' LYS . . . . . 0.49 ' HB2' ' HA ' ' D' ' 38' ' ' GLN . 57.9 tttt -58.61 -32.3 68.87 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.721 171.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.38 -40.94 22.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.862 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 84.7 mt -108.33 86.68 3.53 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 175.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.11 0.23 8.7 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.79 2.327 . . . . 0.0 113.845 -166.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -164.52 131.07 3.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.342 0.591 . . . . 0.0 111.526 -175.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 93.5 t -122.09 112.24 33.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.308 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.64 131.56 41.8 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 174.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 65' ' ' LEU . . . . . 0.55 HD21 ' HB2' ' D' ' 54' ' ' ALA . 86.3 mt -124.2 168.16 13.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.559 0.695 . . . . 0.0 112.188 -173.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 66' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 18.6 t0 -142.44 99.46 3.5 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.319 169.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' D' ' 28' ' ' HIS . 2.3 mt -129.47 144.27 51.18 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 68' ' ' ASN . . . . . 0.447 ' HB3' ' CD2' ' C' ' 90' ' ' TYR . 5.9 t30 -141.88 114.9 8.7 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.538 -0.465 . . . . 0.0 109.805 176.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -111.06 146.86 36.0 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.569 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . 0.422 ' HB2' ' HA ' ' C' ' 7' ' ' MET . 21.8 t -97.78 166.7 11.35 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -75.54 2.15 12.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.195 0.522 . . . . 0.0 110.583 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.14 -7.76 51.77 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.271 172.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -93.28 138.76 31.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.159 0.504 . . . . 0.0 110.489 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -122.3 116.98 25.02 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 175.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.532 HG22 ' HB2' ' D' ' 46' ' ' ALA . 14.9 pt -128.5 162.72 34.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.135 0.493 . . . . 0.0 112.051 -168.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 76' ' ' MET . . . . . 0.496 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 4.9 mtm -120.03 125.67 48.92 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.458 172.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 77' ' ' PHE . . . . . 0.704 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.8 OUTLIER -109.63 127.18 54.35 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.639 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 78' ' ' TYR . . . . . 0.702 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 53.3 p90 -155.52 139.2 16.07 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 119.814 -0.755 . . . . 0.0 112.006 -175.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 79' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 2.9 p -111.62 134.22 53.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.415 -176.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 80' ' ' ALA . . . . . 0.412 ' HB3' ' HB2' ' D' ' 41' ' ' LYS . . . -100.66 157.19 16.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.499 175.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.69 178.99 46.35 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -108.1 103.0 12.11 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 117.784 0.792 . . . . 0.0 110.013 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . 0.49 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -168.92 150.73 4.68 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.46 170.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 15.3 t -109.64 121.85 46.14 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.624 HG12 ' HB3' ' D' ' 34' ' ' LEU . 6.9 m -117.78 155.3 19.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.442 0.639 . . . . 0.0 112.288 -173.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 49.6 m -120.71 122.42 40.38 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.519 173.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 87' ' ' LEU . . . . . 0.575 HD11 ' SD ' ' D' ' 13' ' ' MET . 4.7 mp -96.0 145.72 25.21 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 170.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.521 HD13 ' O ' ' D' ' 87' ' ' LEU . 1.1 mm? -121.0 150.28 41.38 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.25 -167.89 27.6 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.25 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 90' ' ' TYR . . . . . 0.422 ' CD2' ' HB3' ' E' ' 68' ' ' ASN . 3.4 p90 -147.46 129.25 15.24 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.769 0.795 . . . . 0.0 112.115 177.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . 0.806 HD23 ' HB3' ' D' ' 27' ' ' PHE . 15.8 mt -71.52 141.0 50.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 113.901 -1.5 . . . . 0.0 109.759 176.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -66.7 141.89 57.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.237 0.541 . . . . 0.0 111.514 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -90.52 124.65 35.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.215 177.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 16.3 pt -82.77 -48.49 17.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.32 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -175.24 42.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.895 0.379 . . . . 0.0 110.9 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 1.5 m -78.58 61.1 2.85 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.112 0.482 . . . . 0.0 110.674 -178.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.37 80.89 1.48 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.599 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 C--O 1.247 0.931 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.338 -179.94 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 83.2 t80 . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' E' E ' 2' ' ' GLN . . . . . 0.426 ' HG3' ' H ' ' E' ' 3' ' ' GLY . 3.9 pt20 53.38 -68.18 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.743 1.617 . . . . 0.0 114.155 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 3' ' ' GLY . . . . . 0.426 ' H ' ' HG3' ' E' ' 2' ' ' GLN . . . -155.65 33.12 0.63 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.388 -177.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.08 -64.8 0.98 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.902 0.382 . . . . 0.0 110.59 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 26.3 mmt -105.58 43.92 1.08 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.325 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.11 135.04 53.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.966 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 56.4 mtp -98.33 151.05 20.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.089 0.471 . . . . 0.0 111.268 -174.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 8' ' ' PHE . . . . . 0.641 ' CE1' HD21 ' A' ' 44' ' ' LEU . 48.6 t80 -66.5 145.51 55.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.074 -176.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 9' ' ' TRP . . . . . 0.555 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 90.4 t90 -132.71 146.03 51.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.006 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.1 146.65 16.28 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.195 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . 0.555 ' HB2' ' CH2' ' E' ' 9' ' ' TRP . 63.5 tp -134.15 109.05 8.65 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.945 0.402 . . . . 0.0 110.502 178.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -91.48 107.69 19.38 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 13' ' ' MET . . . . . 0.576 ' SD ' HD11 ' E' ' 87' ' ' LEU . 53.9 mtp -102.3 143.71 31.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.419 0.628 . . . . 0.0 111.445 -174.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -100.85 151.46 37.61 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.149 -177.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . 0.462 ' HB3' ' N ' ' E' ' 83' ' ' ALA . 11.1 Cg_endo -55.14 113.95 1.64 Allowed 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 123.188 2.592 . . . . 0.0 112.697 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 16' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' E' ' 79' ' ' THR . 17.4 mt-10 59.87 70.95 0.6 Allowed 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.426 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.14 142.92 32.79 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.56 174.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . 0.688 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 35.3 ttmt -116.6 117.46 29.92 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.322 -176.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . 0.424 ' OH ' ' HA ' ' E' ' 13' ' ' MET . 1.9 m-85 -110.35 122.24 47.21 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 20' ' ' SER . . . . . 0.459 ' HB3' ' SD ' ' E' ' 76' ' ' MET . 6.1 p -102.46 99.8 9.87 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 169.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 19.8 pm0 -117.79 143.07 46.59 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.628 0.728 . . . . 0.0 112.242 -174.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 13.0 t -93.36 160.77 14.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.551 176.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 23' ' ' ILE . . . . . 0.406 HG22 ' HA ' ' E' ' 71' ' ' LYS . 69.9 mt -112.5 119.38 60.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.065 0.46 . . . . 0.0 111.579 -173.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . 0.407 HD12 ' N ' ' E' ' 25' ' ' LYS . 1.7 pp -99.6 -11.51 8.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.051 177.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . 0.407 ' N ' HD12 ' E' ' 24' ' ' ILE . 84.7 tttt -148.07 119.55 7.93 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 31.3 p -61.73 140.49 58.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.648 -175.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 27' ' ' PHE . . . . . 0.805 ' HB3' HD23 ' E' ' 91' ' ' LEU . 42.9 p90 -152.08 162.78 40.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.793 0.806 . . . . 0.0 112.907 -174.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 28' ' ' HIS . . . . . 0.539 ' HA ' ' O ' ' E' ' 67' ' ' LEU . 7.7 t60 -114.67 124.59 52.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.981 177.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 29' ' ' ILE . . . . . 0.508 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 42.2 mt -88.32 135.87 24.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 170.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . 0.492 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 45.1 p -123.55 -5.31 8.18 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -170.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 31' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . 179.91 155.11 14.56 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 119.123 -1.513 . . . . 0.0 113.572 175.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.463 HG23 ' HG ' ' E' ' 87' ' ' LEU . 12.0 p -136.81 132.82 48.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 174.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -148.75 156.49 42.43 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 121.92 -0.487 . . . . 0.0 111.571 -176.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 34' ' ' LEU . . . . . 0.622 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.1 pp -123.81 145.52 49.0 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.607 0.718 . . . . 0.0 111.031 177.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -110.09 -52.07 2.81 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.977 -1.011 . . . . 0.0 108.683 174.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -102.98 127.31 50.27 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 169.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . 0.463 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 151.92 156.78 7.62 Favored Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 119.754 -1.212 . . . . 0.0 113.389 177.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 38' ' ' GLN . . . . . 0.495 ' HA ' ' HB2' ' E' ' 58' ' ' LYS . 94.9 mt-30 -102.39 -44.39 5.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.658 0.266 . . . . 0.0 111.094 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -152.88 128.81 10.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.411 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . 0.466 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -128.19 113.01 15.15 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.476 0.655 . . . . 0.0 109.89 168.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 41' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' E' ' 79' ' ' THR . 28.7 mmmt -94.59 109.34 21.26 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.503 HD23 ' HB ' ' E' ' 53' ' ' VAL . 48.1 tp -82.08 109.51 16.47 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -174.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -112.24 136.3 51.84 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.067 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 44' ' ' LEU . . . . . 0.689 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 0.1 OUTLIER -123.88 121.71 36.07 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.459 175.457 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' E' E ' 45' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -109.82 111.16 22.43 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.003 178.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . 0.532 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -128.77 139.32 52.25 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.513 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 56.56 35.75 26.53 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 123.688 0.618 . . . . 0.0 110.225 -177.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 48' ' ' LYS . . . . . 0.424 ' NZ ' ' HB3' ' E' ' 48' ' ' LYS . 9.1 mtpm? 63.66 32.28 13.94 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.221 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 49' ' ' GLN . . . . . 0.562 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 59.2 tp60 -128.25 133.9 48.88 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 175.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -89.03 121.74 31.68 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -116.65 123.38 47.14 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.496 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -75.27 106.65 5.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 169.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . 0.607 ' CG2' ' HB3' ' E' ' 44' ' ' LEU . 0.7 OUTLIER -84.25 -46.36 17.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.508 -172.313 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' E' E ' 54' ' ' ALA . . . . . 0.569 ' HB2' HD21 ' E' ' 65' ' ' LEU . . . -153.91 149.4 27.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.664 -177.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 52.6 m -112.93 101.7 9.74 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 169.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . 0.446 HG13 ' HB3' ' E' ' 40' ' ' ALA . 7.7 p -115.8 114.32 45.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.579 0.704 . . . . 0.0 109.212 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 45.0 p -122.59 -179.17 4.13 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.194 -172.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 58' ' ' LYS . . . . . 0.495 ' HB2' ' HA ' ' E' ' 38' ' ' GLN . 58.2 tttt -58.62 -32.23 68.83 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.783 171.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.42 -40.95 22.61 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.885 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 84.1 mt -108.3 86.64 3.49 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 174.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.09 0.18 8.75 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.756 2.304 . . . . 0.0 113.848 -166.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -164.45 131.18 3.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.289 0.566 . . . . 0.0 111.551 -175.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 94.2 t -122.08 112.21 33.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.281 174.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.57 131.5 41.79 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.569 HD21 ' HB2' ' E' ' 54' ' ' ALA . 86.3 mt -124.23 168.08 13.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.496 0.665 . . . . 0.0 112.283 -173.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 66' ' ' ASP . . . . . 0.475 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 18.5 t0 -142.41 99.49 3.51 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.383 170.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 67' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' E' ' 28' ' ' HIS . 2.3 mt -129.46 144.3 51.2 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 68' ' ' ASN . . . . . 0.422 ' HB3' ' CD2' ' D' ' 90' ' ' TYR . 5.8 t30 -141.91 114.92 8.7 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.558 -0.457 . . . . 0.0 109.783 176.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -111.12 146.84 36.1 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.535 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 21.9 t -97.7 166.71 11.36 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 71' ' ' LYS . . . . . 0.406 ' HA ' HG22 ' E' ' 23' ' ' ILE . 21.6 ptmt -75.59 2.17 12.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.229 0.537 . . . . 0.0 110.531 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.14 -7.79 51.73 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.305 172.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -93.25 138.71 31.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.108 0.48 . . . . 0.0 110.463 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -122.22 116.9 24.96 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 75' ' ' ILE . . . . . 0.532 HG22 ' HB2' ' E' ' 46' ' ' ALA . 14.9 pt -128.38 162.73 34.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.219 0.533 . . . . 0.0 112.029 -168.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 76' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 4.9 mtm -119.97 125.72 49.09 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 172.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 77' ' ' PHE . . . . . 0.689 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.8 OUTLIER -109.64 127.22 54.39 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 176.576 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' E' E ' 78' ' ' TYR . . . . . 0.688 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 53.2 p90 -155.55 139.21 16.05 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 119.79 -0.764 . . . . 0.0 112.001 -175.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 79' ' ' THR . . . . . 0.568 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 3.0 p -111.58 134.23 53.3 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.389 -176.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 80' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' E' ' 41' ' ' LYS . . . -100.7 157.16 16.9 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.537 175.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.79 179.01 46.2 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -176.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -108.17 102.93 12.04 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 119.714 -0.794 . . . . 0.0 110.044 178.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 83' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -168.8 150.83 4.82 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.436 170.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 15.5 t -109.76 121.89 46.25 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 85' ' ' VAL . . . . . 0.622 HG12 ' HB3' ' E' ' 34' ' ' LEU . 6.9 m -117.77 155.32 19.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.398 0.618 . . . . 0.0 112.311 -173.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 49.3 m -120.67 122.43 40.45 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.542 173.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 87' ' ' LEU . . . . . 0.576 HD11 ' SD ' ' E' ' 13' ' ' MET . 4.7 mp -96.07 145.77 25.2 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 170.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . 0.526 HD13 ' O ' ' E' ' 87' ' ' LEU . 1.2 mm? -120.96 150.25 41.39 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 173.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.31 -167.91 27.69 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.363 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 90' ' ' TYR . . . . . 0.437 ' CD2' ' HB3' ' A' ' 68' ' ' ASN . 3.4 p90 -147.49 129.24 15.19 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.758 0.789 . . . . 0.0 112.126 177.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 91' ' ' LEU . . . . . 0.805 HD23 ' HB3' ' E' ' 27' ' ' PHE . 15.8 mt -71.48 140.97 50.2 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 113.838 -1.528 . . . . 0.0 109.814 176.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -66.63 141.88 57.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.163 0.506 . . . . 0.0 111.526 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -90.55 124.72 35.24 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.246 177.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 16.5 pt -82.78 -48.55 17.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.379 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -175.17 42.59 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.864 0.364 . . . . 0.0 110.889 -178.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 1.4 m -78.58 61.08 2.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.992 0.425 . . . . 0.0 110.606 -178.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.41 80.91 1.48 Allowed Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.953 -0.642 . . . . 0.0 111.597 -177.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 48.4 m . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.279 -179.868 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 77.3 t80 . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.47 ' H ' HG21 ' B' ' 94' ' ' ILE . 3.7 pt20 -154.41 -47.26 0.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.711 0.291 . . . . 0.0 111.318 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.565 ' H ' HG21 ' B' ' 94' ' ' ILE . . . 83.22 -58.77 5.03 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.877 175.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 58.86 43.24 18.48 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.409 0.623 . . . . 0.0 110.299 -176.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.6 ttm -80.21 94.48 6.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.499 -177.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.97 152.38 24.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.577 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.409 ' HG2' ' OG ' ' B' ' 70' ' ' SER . 58.8 mtt -110.09 139.33 45.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.903 -176.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.521 ' CE1' HD21 ' B' ' 44' ' ' LEU . 77.1 t80 -59.77 140.29 56.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -172.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.449 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 87.4 t90 -132.73 146.74 52.1 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.549 178.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.414 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -151.61 152.69 24.41 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.261 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.731 HD23 HD13 ' A' ' 87' ' ' LEU . 59.3 tp -140.45 106.7 5.24 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 178.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -86.31 100.92 12.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.502 0.667 . . . . 0.0 109.755 175.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.471 ' HB3' HG23 ' A' ' 85' ' ' VAL . 3.7 ttt -94.65 134.22 37.46 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.142 -168.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.476 ' HB2' ' HG3' ' A' ' 17' ' ' ARG . 2.5 mptp? -100.28 149.57 36.17 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.811 -178.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.515 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 12.2 Cg_endo -56.43 122.32 11.59 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.122 2.548 . . . . 0.0 112.987 -178.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 79' ' ' THR . 44.9 mt-10 61.53 51.79 3.93 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.564 177.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.476 ' HG3' ' HB2' ' A' ' 14' ' ' LYS . 29.0 mmt180 -117.57 145.52 44.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.131 173.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.695 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 40.5 tttt -123.28 109.82 14.43 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 123.505 0.503 . . . . 0.0 110.551 -176.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.447 ' HE2' ' HG3' ' A' ' 13' ' ' MET . 3.4 m-85 -110.02 104.31 13.18 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.356 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.467 ' HB3' ' SD ' ' A' ' 76' ' ' MET . 13.8 p -84.99 99.45 11.0 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -113.41 143.99 43.55 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.568 0.699 . . . . 0.0 112.002 -168.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.3 p -96.43 157.35 15.94 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.612 174.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.442 ' CD1' ' HB3' ' A' ' 69' ' ' PHE . 54.1 mt -115.1 116.64 53.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.347 0.594 . . . . 0.0 111.18 -175.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.478 ' N ' HD12 ' A' ' 24' ' ' ILE . 3.9 mp -93.34 -40.97 12.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.101 178.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.8 pttt -123.88 128.22 49.16 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.586 176.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.8 p -64.65 141.83 58.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.259 -174.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.828 ' HB3' HD23 ' A' ' 91' ' ' LEU . 39.8 p90 -142.08 152.52 43.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.745 0.783 . . . . 0.0 112.226 -177.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.627 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 6.1 t60 -108.24 120.52 42.6 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.354 173.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 35.1 mt -84.51 133.65 28.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 170.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.545 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 56.0 p -120.43 -6.87 9.78 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.683 0.278 . . . . 0.0 111.64 -173.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.15 158.32 25.84 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 119.455 -1.355 . . . . 0.0 113.622 176.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.497 HG23 ' HG ' ' A' ' 87' ' ' LEU . 13.2 p -140.43 127.24 22.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 172.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.16 152.87 41.48 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 121.972 -0.455 . . . . 0.0 111.389 -175.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.606 ' HB3' HG12 ' A' ' 85' ' ' VAL . 3.7 pp -117.82 145.88 44.25 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.787 0.803 . . . . 0.0 111.733 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -106.73 -55.99 2.25 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.894 175.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -102.59 128.03 49.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.049 170.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.458 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 153.23 158.53 8.6 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 119.437 -1.363 . . . . 0.0 113.892 175.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -101.76 -45.62 5.18 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.426 -0.387 . . . . 0.0 110.571 176.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.46 ' HG3' HG22 ' A' ' 57' ' ' THR . 32.7 tt0 -153.14 123.01 6.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.091 -178.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.554 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -121.88 114.13 20.6 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.44 0.638 . . . . 0.0 110.033 170.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 79' ' ' THR . 13.7 mmmm -97.18 105.51 17.67 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.6 tp -83.71 111.47 19.19 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -174.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.546 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 79.9 m-85 -114.9 149.95 36.4 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 175.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.557 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -135.47 128.01 30.63 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.616 172.125 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -105.89 112.22 25.18 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.09 178.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.567 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -127.92 133.23 49.25 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.395 178.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 59.42 38.23 22.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.48 0.657 . . . . 0.0 109.629 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt 62.37 35.27 15.11 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.717 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.574 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 23.5 tp60 -130.18 118.23 21.1 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -81.63 108.29 15.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.878 0.371 . . . . 0.0 110.86 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.456 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 87.5 m-85 -99.87 133.41 44.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.519 177.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -80.14 104.65 8.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 168.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.481 HG21 ' HB3' ' A' ' 44' ' ' LEU . 3.2 t -79.68 -50.32 18.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.696 -172.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.6 ' HB2' HD21 ' A' ' 65' ' ' LEU . . . -153.46 147.22 25.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.656 -176.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.5 m -110.95 101.28 9.86 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 171.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.48 HG13 ' HB3' ' A' ' 40' ' ' ALA . 7.2 p -119.65 113.52 41.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.62 0.724 . . . . 0.0 109.741 -177.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.46 HG22 ' HG3' ' A' ' 39' ' ' GLU . 65.2 p -123.28 -178.42 3.98 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.684 -174.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -61.89 -23.01 66.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.908 0.385 . . . . 0.0 110.463 170.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.435 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -84.35 -40.87 17.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.245 0.545 . . . . 0.0 110.15 178.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.2 mt -112.75 82.62 5.14 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 11.5 Cg_exo -70.8 -0.38 7.68 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.06 2.506 . . . . 0.0 113.868 -167.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -162.99 127.0 2.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.339 0.59 . . . . 0.0 111.416 -176.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 87.0 t -116.38 121.92 68.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.399 174.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.43 127.63 32.99 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.973 176.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.6 HD21 ' HB2' ' A' ' 54' ' ' ALA . 91.0 mt -119.92 168.45 11.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.401 0.62 . . . . 0.0 112.226 -174.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 14.2 t0 -145.72 97.59 3.0 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 172.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.668 HD21 HD23 ' E' ' 88' ' ' LEU . 6.7 mt -133.54 110.0 9.63 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.797 -174.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.452 ' HB2' ' CG ' ' E' ' 90' ' ' TYR . 6.3 m-20 -103.82 113.92 27.8 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.442 ' HB3' ' CD1' ' A' ' 23' ' ' ILE . 86.0 m-85 -109.04 136.92 47.76 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.829 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.413 ' OG ' ' HG2' ' E' ' 7' ' ' MET . 87.8 p -97.35 166.69 11.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.744 0.307 . . . . 0.0 110.21 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.436 ' HE3' ' OG ' ' E' ' 98' ' ' SER . 14.9 ptmm? -73.05 -4.89 35.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.919 0.39 . . . . 0.0 110.893 -178.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.67 -9.16 58.96 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 174.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -88.49 140.3 29.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.929 0.395 . . . . 0.0 110.06 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -126.33 114.53 18.37 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 175.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.567 HG22 ' HB2' ' A' ' 46' ' ' ALA . 13.1 pt -131.03 158.7 43.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.053 0.454 . . . . 0.0 112.059 -166.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.494 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 3.6 mtm -119.19 123.92 45.51 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 174.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.557 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 1.1 m-85 -104.24 128.63 52.01 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.695 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 25.9 p90 -151.92 134.97 15.75 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.453 0.644 . . . . 0.0 112.488 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 2.6 p -108.94 130.58 55.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.748 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.9 164.72 11.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.439 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.57 -174.03 44.41 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -177.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -113.43 102.74 10.61 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.023 178.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.554 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . . . -173.62 153.55 2.3 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.551 171.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.9 t -114.84 126.41 54.78 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.606 HG12 ' HB3' ' A' ' 34' ' ' LEU . 6.7 m -120.74 157.54 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-O 121.141 0.496 . . . . 0.0 112.144 -172.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.4 m -117.09 119.01 33.93 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.549 -0.75 . . . . 0.0 108.979 171.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.731 HD13 HD23 ' A' ' 11' ' ' LEU . 5.1 mp -89.78 145.33 25.27 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 170.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.708 HD23 HD21 ' B' ' 67' ' ' LEU . 0.8 OUTLIER -129.97 141.39 50.77 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.929 -177.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.82 -167.56 26.63 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.292 -177.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.486 ' CG ' ' HB2' ' B' ' 68' ' ' ASN . 13.7 p90 -150.29 129.6 12.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 122.093 0.949 . . . . 0.0 112.102 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.828 HD23 ' HB3' ' A' ' 27' ' ' PHE . 7.9 mt -66.77 141.12 57.84 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.778 176.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -80.92 109.32 15.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.672 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -132.76 173.8 10.98 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.507 HG21 ' H ' ' E' ' 3' ' ' GLY . 1.5 pp -142.42 14.01 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -174.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.85 87.53 3.43 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.231 0.539 . . . . 0.0 110.09 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.2 t -88.56 73.05 8.71 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.552 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.1 162.37 48.22 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.681 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 25.6 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 119.079 -0.486 . . . . 0.0 110.948 179.887 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 77.6 t80 . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . 0.461 ' H ' HG21 ' C' ' 94' ' ' ILE . 3.7 pt20 -154.36 -47.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.704 0.287 . . . . 0.0 111.303 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . 0.518 ' H ' HG21 ' C' ' 94' ' ' ILE . . . 83.32 -58.83 5.02 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.865 175.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . 58.93 43.22 18.27 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.332 0.586 . . . . 0.0 110.246 -176.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 48.6 ttm -80.14 94.37 5.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.514 -177.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.88 152.36 24.59 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.601 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . 0.401 ' HG2' ' OG ' ' C' ' 70' ' ' SER . 58.9 mtt -110.01 139.45 45.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.88 -177.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.532 ' CE1' HD21 ' C' ' 44' ' ' LEU . 77.0 t80 -59.98 140.35 56.8 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -172.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . 0.449 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 87.3 t90 -132.74 146.74 52.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.547 178.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.439 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -151.65 152.69 24.41 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.262 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.739 HD23 HD13 ' B' ' 87' ' ' LEU . 59.7 tp -140.48 106.75 5.25 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -86.3 100.85 12.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.612 0.72 . . . . 0.0 109.785 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . 0.465 ' HB3' HG23 ' B' ' 85' ' ' VAL . 3.7 ttt -94.61 134.24 37.39 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.68 -1.146 . . . . 0.0 111.059 -168.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.471 ' HB2' ' HG3' ' B' ' 17' ' ' ARG . 2.5 mptp? -100.43 149.45 36.1 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.788 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.517 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 12.2 Cg_endo -56.33 122.33 11.58 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.131 2.554 . . . . 0.0 112.965 -178.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' B' ' 79' ' ' THR . 44.8 mt-10 61.51 51.83 3.93 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.506 177.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.471 ' HG3' ' HB2' ' B' ' 14' ' ' LYS . 29.0 mmt180 -117.57 145.5 44.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.141 173.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.713 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 40.6 tttt -123.22 109.87 14.52 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 123.465 0.478 . . . . 0.0 110.513 -176.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' TYR . . . . . 0.434 ' HE2' ' HG3' ' B' ' 13' ' ' MET . 3.3 m-85 -110.09 104.36 13.22 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.289 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.462 ' HB3' ' SD ' ' B' ' 76' ' ' MET . 13.6 p -85.12 99.49 11.09 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 171.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -113.33 144.03 43.45 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.522 0.677 . . . . 0.0 112.019 -168.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 13.7 p -96.43 157.27 15.98 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.627 174.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.428 ' CD1' ' HB3' ' B' ' 69' ' ' PHE . 53.7 mt -115.06 116.56 52.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.335 0.588 . . . . 0.0 111.227 -175.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.479 ' N ' HD12 ' B' ' 24' ' ' ILE . 3.9 mp -93.27 -40.91 12.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.262 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 24.9 pttt -123.83 128.15 49.09 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.651 176.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 62.3 p -64.62 141.73 58.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.311 -174.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . 0.834 ' HB3' HD23 ' B' ' 91' ' ' LEU . 39.3 p90 -142.09 152.51 43.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.71 0.767 . . . . 0.0 112.231 -177.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' HIS . . . . . 0.639 ' HA ' ' O ' ' B' ' 67' ' ' LEU . 6.2 t60 -108.1 120.53 42.59 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.428 173.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.548 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 35.2 mt -84.6 133.55 29.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 170.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.548 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 56.4 p -120.29 -6.97 9.84 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.598 -173.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.13 158.31 25.82 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 119.462 -1.352 . . . . 0.0 113.555 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.496 HG23 ' HG ' ' B' ' 87' ' ' LEU . 13.2 p -140.36 127.33 22.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 172.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.2 152.85 41.42 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.958 -0.464 . . . . 0.0 111.342 -175.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.617 ' HB3' HG12 ' B' ' 85' ' ' VAL . 3.7 pp -117.89 145.79 44.38 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.791 0.805 . . . . 0.0 111.728 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -106.58 -56.21 2.22 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.859 175.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -102.43 127.98 49.23 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.096 170.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.455 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 153.2 158.53 8.59 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 119.393 -1.384 . . . . 0.0 113.893 175.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -101.77 -45.66 5.16 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.399 -0.4 . . . . 0.0 110.498 176.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.444 ' HG3' HG22 ' B' ' 57' ' ' THR . 32.9 tt0 -153.07 123.02 6.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.109 -178.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -121.88 114.22 20.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.539 0.685 . . . . 0.0 110.007 170.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' B' ' 79' ' ' THR . 13.7 mmmm -97.2 105.44 17.59 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 49.3 tp -83.65 111.51 19.19 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -174.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . 0.552 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 79.9 m-85 -114.9 149.96 36.38 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 175.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.564 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 0.2 OUTLIER -135.49 128.13 30.83 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.612 172.03 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.575 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -105.99 111.99 24.86 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.187 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.581 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -127.76 133.35 49.48 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.409 178.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 59.31 38.2 23.24 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.564 0.697 . . . . 0.0 109.743 -176.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt 62.3 35.39 15.24 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.637 178.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.575 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 23.1 tp60 -130.18 118.24 21.11 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 178.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -81.69 108.39 15.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.927 0.394 . . . . 0.0 110.799 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.414 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 86.9 m-85 -99.86 133.33 44.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.59 177.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -80.11 104.67 8.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 168.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.488 HG21 ' HB3' ' B' ' 44' ' ' LEU . 3.2 t -79.64 -50.32 18.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.779 -172.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.591 ' HB2' HD21 ' B' ' 65' ' ' LEU . . . -153.38 147.17 25.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.686 -176.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 31.1 m -110.96 101.26 9.84 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 171.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.465 HG13 ' HB3' ' B' ' 40' ' ' ALA . 7.1 p -119.6 113.48 41.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.6 0.714 . . . . 0.0 109.844 -177.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.444 HG22 ' HG3' ' B' ' 39' ' ' GLU . 65.5 p -123.2 -178.38 3.96 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.73 -174.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -62.06 -22.86 66.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.045 0.45 . . . . 0.0 110.514 170.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.424 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -84.41 -40.82 17.34 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.19 0.519 . . . . 0.0 110.195 178.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 80.8 mt -112.69 82.59 5.05 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 11.4 Cg_exo -70.78 -0.36 7.64 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.022 2.482 . . . . 0.0 113.907 -168.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -163.04 127.03 2.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.383 0.611 . . . . 0.0 111.392 -176.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 87.6 t -116.34 121.91 68.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.418 174.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.53 127.67 33.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.01 176.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.591 HD21 ' HB2' ' B' ' 54' ' ' ALA . 90.8 mt -119.93 168.47 11.1 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.371 0.605 . . . . 0.0 112.114 -174.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . 0.531 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 14.4 t0 -145.72 97.6 3.0 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 172.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.708 HD21 HD23 ' A' ' 88' ' ' LEU . 6.7 mt -133.58 110.08 9.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.723 -174.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . 0.486 ' HB2' ' CG ' ' A' ' 90' ' ' TYR . 6.4 m-20 -103.86 113.82 27.62 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 176.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . 0.428 ' HB3' ' CD1' ' B' ' 23' ' ' ILE . 85.6 m-85 -108.92 136.9 47.7 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.861 178.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.409 ' OG ' ' HG2' ' A' ' 7' ' ' MET . 87.9 p -97.29 166.66 11.45 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.783 0.325 . . . . 0.0 110.191 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -72.96 -5.04 35.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.006 0.432 . . . . 0.0 110.868 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.52 -9.18 59.13 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.611 -0.595 . . . . 0.0 111.611 174.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -88.42 140.24 29.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.903 0.382 . . . . 0.0 110.108 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -126.3 114.54 18.4 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.581 HG22 ' HB2' ' B' ' 46' ' ' ALA . 13.2 pt -131.0 158.7 43.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.074 0.464 . . . . 0.0 111.995 -166.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.505 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 3.7 mtm -119.19 124.03 45.8 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 174.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . 0.564 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 1.1 m-85 -104.38 128.65 52.27 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.713 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 25.9 p90 -151.95 134.99 15.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.474 0.654 . . . . 0.0 112.494 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 2.6 p -108.9 130.62 55.44 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.707 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.97 164.79 11.53 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.524 176.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.37 -174.02 44.76 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -177.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -113.33 102.74 10.63 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 119.726 -0.789 . . . . 0.0 110.031 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' B' ' 40' ' ' ALA . . . -173.67 153.55 2.28 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.548 171.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 18.8 t -114.77 126.42 54.82 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.617 HG12 ' HB3' ' B' ' 34' ' ' LEU . 6.7 m -120.81 157.58 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-O 121.116 0.484 . . . . 0.0 112.139 -172.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 67.1 m -117.12 119.02 33.96 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 171.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.739 HD13 HD23 ' B' ' 11' ' ' LEU . 5.2 mp -89.78 145.38 25.22 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 170.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.687 HD23 HD21 ' C' ' 67' ' ' LEU . 0.8 OUTLIER -130.04 141.35 50.74 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.465 -0.789 . . . . 0.0 108.888 -177.697 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.82 -167.53 26.59 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.275 -178.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' TYR . . . . . 0.443 ' CG ' ' HB2' ' C' ' 68' ' ' ASN . 13.8 p90 -150.24 129.52 12.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 122.02 0.914 . . . . 0.0 112.154 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . 0.834 HD23 ' HB3' ' B' ' 27' ' ' PHE . 8.0 mt -66.74 141.05 57.87 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 113.626 -1.624 . . . . 0.0 110.898 176.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -80.84 109.25 15.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.655 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -132.83 173.74 11.06 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 177.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . 0.565 HG21 ' H ' ' A' ' 3' ' ' GLY . 1.5 pp -142.31 13.98 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -174.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -76.84 87.57 3.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.283 0.563 . . . . 0.0 110.119 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 17.7 t -88.58 73.21 8.66 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.488 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.18 162.34 48.04 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.752 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 98' ' ' SER . . . . . 0.418 ' OG ' ' HE3' ' C' ' 71' ' ' LYS . 26.7 m . . . . . 0 C--O 1.247 0.949 0 CA-C-O 119.054 -0.498 . . . . 0.0 111.006 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 77.1 t80 . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . 0.417 ' H ' HG21 ' D' ' 94' ' ' ILE . 3.7 pt20 -154.38 -47.35 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.736 0.303 . . . . 0.0 111.256 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 3' ' ' GLY . . . . . 0.511 ' H ' HG21 ' D' ' 94' ' ' ILE . . . 83.37 -58.8 5.02 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.824 175.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . 58.88 43.25 18.41 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.372 0.606 . . . . 0.0 110.249 -176.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 48.6 ttm -80.2 94.49 6.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.524 -177.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.0 152.25 24.55 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.584 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 7' ' ' MET . . . . . 0.401 ' HG2' ' OG ' ' D' ' 70' ' ' SER . 58.8 mtt -109.99 139.41 45.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.985 -177.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 8' ' ' PHE . . . . . 0.546 ' CE1' HD21 ' D' ' 44' ' ' LEU . 77.4 t80 -59.9 140.27 56.79 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -172.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . 0.441 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 87.3 t90 -132.63 146.79 52.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.555 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . 0.44 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -151.61 152.71 24.43 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.289 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.714 HD23 HD13 ' C' ' 87' ' ' LEU . 59.5 tp -140.5 106.79 5.25 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -86.3 100.82 12.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.599 0.714 . . . . 0.0 109.8 175.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 13' ' ' MET . . . . . 0.464 ' HB3' HG23 ' C' ' 85' ' ' VAL . 3.7 ttt -94.56 134.25 37.32 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.078 -168.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . 0.457 ' HB2' ' HG3' ' C' ' 17' ' ' ARG . 2.5 mptp? -100.38 149.5 36.13 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.8 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . 0.517 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 12.3 Cg_endo -56.29 122.25 11.45 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 123.191 2.594 . . . . 0.0 113.011 -178.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' C' ' 79' ' ' THR . 44.8 mt-10 61.49 51.84 3.95 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.543 177.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 17' ' ' ARG . . . . . 0.457 ' HG3' ' HB2' ' C' ' 14' ' ' LYS . 28.9 mmt180 -117.52 145.57 44.15 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.132 173.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 18' ' ' LYS . . . . . 0.706 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 40.7 tttt -123.41 109.89 14.44 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 123.479 0.487 . . . . 0.0 110.513 -176.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . 0.448 ' HE2' ' HG3' ' C' ' 13' ' ' MET . 3.4 m-85 -110.09 104.29 13.14 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.342 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . 0.474 ' HB3' ' SD ' ' C' ' 76' ' ' MET . 13.5 p -84.97 99.37 10.94 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 171.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -113.29 144.05 43.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.577 0.703 . . . . 0.0 112.064 -169.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 13.3 p -96.59 157.3 15.96 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.592 174.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . 0.442 ' CD1' ' HB3' ' C' ' 69' ' ' PHE . 53.8 mt -115.03 116.6 53.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.296 0.57 . . . . 0.0 111.16 -175.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . 0.481 HD12 ' N ' ' C' ' 24' ' ' ILE . 3.9 mp -93.26 -41.09 12.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.16 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 25.0 pttt -123.85 128.21 49.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.616 176.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 62.1 p -64.63 141.71 58.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.227 -174.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 27' ' ' PHE . . . . . 0.844 ' HB3' HD23 ' C' ' 91' ' ' LEU . 39.5 p90 -142.0 152.51 43.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.672 0.748 . . . . 0.0 112.23 -177.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 28' ' ' HIS . . . . . 0.634 ' HA ' ' O ' ' C' ' 67' ' ' LEU . 6.1 t60 -108.14 120.55 42.65 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.418 -1.264 . . . . 0.0 109.382 173.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 35.2 mt -84.59 133.59 28.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 170.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.548 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 56.1 p -120.41 -6.77 9.79 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.645 0.259 . . . . 0.0 111.639 -173.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.13 158.4 25.99 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 119.471 -1.347 . . . . 0.0 113.595 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.493 HG23 ' HG ' ' C' ' 87' ' ' LEU . 13.0 p -140.38 127.22 22.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.23 152.83 41.38 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.569 -0.453 . . . . 0.0 111.326 -175.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.621 ' HB3' HG12 ' C' ' 85' ' ' VAL . 3.7 pp -117.8 145.8 44.28 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 121.809 0.814 . . . . 0.0 111.792 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -106.58 -56.17 2.23 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.869 175.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -102.47 127.99 49.28 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.065 170.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 37' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 153.25 158.44 8.56 Favored Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 119.39 -1.386 . . . . 0.0 113.902 175.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -101.76 -45.6 5.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.484 -0.358 . . . . 0.0 110.545 176.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . 0.447 ' HG3' HG22 ' C' ' 57' ' ' THR . 32.8 tt0 -153.09 122.99 6.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.079 -178.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.569 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -121.88 114.23 20.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.518 0.675 . . . . 0.0 110.02 170.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' C' ' 79' ' ' THR . 13.7 mmmm -97.27 105.43 17.57 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 49.7 tp -83.66 111.48 19.17 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -174.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 43' ' ' TYR . . . . . 0.546 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 79.8 m-85 -114.86 149.93 36.35 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.566 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 0.2 OUTLIER -135.46 128.17 30.96 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.589 172.069 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . 0.569 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -105.97 112.0 24.87 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.116 178.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.579 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -127.8 133.41 49.43 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.368 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 59.25 38.23 23.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.53 0.681 . . . . 0.0 109.763 -176.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt 62.3 35.21 15.36 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.751 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . 0.569 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 23.4 tp60 -130.04 118.28 21.32 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -81.74 108.36 15.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.969 0.414 . . . . 0.0 110.769 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . 0.439 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 86.9 m-85 -99.79 133.39 44.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.627 177.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -80.12 104.57 8.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 168.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 53' ' ' VAL . . . . . 0.486 HG21 ' HB3' ' C' ' 44' ' ' LEU . 3.2 t -79.56 -50.44 18.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.652 -172.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 54' ' ' ALA . . . . . 0.592 ' HB2' HD21 ' C' ' 65' ' ' LEU . . . -153.37 147.17 25.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.723 -176.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 31.4 m -110.93 101.29 9.87 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 171.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . 0.474 HG13 ' HB3' ' C' ' 40' ' ' ALA . 7.2 p -119.6 113.47 41.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.513 0.673 . . . . 0.0 109.821 -177.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . 0.447 HG22 ' HG3' ' C' ' 39' ' ' GLU . 66.0 p -123.24 -178.45 3.99 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.74 -174.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -61.99 -22.97 66.12 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.14 0.495 . . . . 0.0 110.43 171.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . 0.433 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -84.3 -40.76 17.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.19 0.519 . . . . 0.0 110.275 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 80.7 mt -112.8 82.5 5.11 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 174.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 61' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 11.4 Cg_exo -70.8 -0.2 7.41 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.997 2.465 . . . . 0.0 113.889 -167.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -163.12 127.04 2.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.325 0.583 . . . . 0.0 111.437 -176.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 86.2 t -116.38 122.02 68.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.345 174.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.49 127.54 32.93 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.131 175.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . 0.592 HD21 ' HB2' ' C' ' 54' ' ' ALA . 91.1 mt -119.76 168.45 11.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.471 0.653 . . . . 0.0 112.21 -174.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 66' ' ' ASP . . . . . 0.489 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 14.4 t0 -145.76 97.6 2.99 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 172.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.687 HD21 HD23 ' B' ' 88' ' ' LEU . 6.7 mt -133.54 110.0 9.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.772 -174.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . 0.443 ' HB2' ' CG ' ' B' ' 90' ' ' TYR . 6.4 m-20 -103.92 113.82 27.63 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 69' ' ' PHE . . . . . 0.442 ' HB3' ' CD1' ' C' ' 23' ' ' ILE . 86.0 m-85 -109.0 136.87 47.81 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.779 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . 0.401 ' OG ' ' HG2' ' B' ' 7' ' ' MET . 88.1 p -97.24 166.66 11.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.745 0.307 . . . . 0.0 110.235 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . 0.418 ' HE3' ' OG ' ' B' ' 98' ' ' SER . 14.9 ptmm? -73.12 -4.83 35.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.015 0.436 . . . . 0.0 110.901 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.55 -9.27 59.02 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 174.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -88.28 140.23 29.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.893 0.378 . . . . 0.0 110.115 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -126.33 114.49 18.31 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 175.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.579 HG22 ' HB2' ' C' ' 46' ' ' ALA . 13.3 pt -131.07 158.67 43.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.047 0.451 . . . . 0.0 112.034 -166.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.498 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 3.7 mtm -119.22 123.97 45.61 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 77' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 1.1 m-85 -104.29 128.55 52.09 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 78' ' ' TYR . . . . . 0.706 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 25.9 p90 -151.87 134.96 15.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.419 0.628 . . . . 0.0 112.511 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 2.6 p -108.85 130.56 55.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.769 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.87 164.84 11.51 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.522 176.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.41 -173.98 44.64 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -177.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -113.38 102.77 10.65 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.031 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . 0.569 ' HB3' ' HB2' ' C' ' 40' ' ' ALA . . . -173.67 153.48 2.27 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.534 171.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 18.6 t -114.76 126.41 54.81 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.621 HG12 ' HB3' ' C' ' 34' ' ' LEU . 6.6 m -120.8 157.58 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 CA-C-O 121.213 0.53 . . . . 0.0 112.114 -172.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 66.6 m -117.04 119.02 33.99 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 171.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . 0.714 HD13 HD23 ' C' ' 11' ' ' LEU . 5.2 mp -89.75 145.29 25.3 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 170.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . 0.681 HD23 HD21 ' D' ' 67' ' ' LEU . 0.8 OUTLIER -130.01 141.46 50.74 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.438 -0.801 . . . . 0.0 108.913 -177.837 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.93 -167.59 26.79 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.331 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 90' ' ' TYR . . . . . 0.467 ' CG ' ' HB2' ' D' ' 68' ' ' ASN . 13.6 p90 -150.19 129.55 12.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 122.039 0.924 . . . . 0.0 112.109 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . 0.844 HD23 ' HB3' ' C' ' 27' ' ' PHE . 8.0 mt -66.84 141.15 57.78 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.826 176.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -80.85 109.34 15.32 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.686 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -132.96 173.77 11.06 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . 0.518 HG21 ' H ' ' B' ' 3' ' ' GLY . 1.5 pp -142.34 13.94 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -174.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.82 87.59 3.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.292 0.568 . . . . 0.0 110.131 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 17.9 t -88.56 73.14 8.69 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.409 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.04 162.31 48.27 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.706 -178.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 98' ' ' SER . . . . . 0.422 ' OG ' ' HE3' ' D' ' 71' ' ' LYS . 27.0 m . . . . . 0 C--O 1.249 1.034 0 C-N-CA 122.822 0.449 . . . . 0.0 111.063 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 77.1 t80 . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . 0.481 ' H ' HG21 ' E' ' 94' ' ' ILE . 3.7 pt20 -154.38 -47.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.697 0.284 . . . . 0.0 111.235 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 3' ' ' GLY . . . . . 0.529 ' H ' HG21 ' E' ' 94' ' ' ILE . . . 83.23 -58.84 5.03 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.849 175.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . 58.88 43.2 18.46 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.377 0.608 . . . . 0.0 110.306 -176.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 48.5 ttm -80.19 94.41 6.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.527 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.93 152.28 24.59 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.557 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 7' ' ' MET . . . . . 0.435 ' HG2' ' OG ' ' E' ' 70' ' ' SER . 58.9 mtt -109.99 139.46 45.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 -177.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 8' ' ' PHE . . . . . 0.552 ' CE1' HD21 ' E' ' 44' ' ' LEU . 77.0 t80 -59.99 140.33 56.83 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -172.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 9' ' ' TRP . . . . . 0.447 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 87.3 t90 -132.76 146.68 52.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.552 178.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . 0.467 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -151.53 152.72 24.44 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.296 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.736 HD23 HD13 ' D' ' 87' ' ' LEU . 59.8 tp -140.5 106.73 5.24 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -86.24 100.86 12.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.579 0.704 . . . . 0.0 109.743 175.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 13' ' ' MET . . . . . 0.471 ' HB3' HG23 ' D' ' 85' ' ' VAL . 3.7 ttt -94.67 134.21 37.5 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.085 -168.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 14' ' ' LYS . . . . . 0.469 ' HB2' ' HG3' ' D' ' 17' ' ' ARG . 2.5 mptp? -100.33 149.56 36.17 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.802 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . 0.518 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 12.3 Cg_endo -56.45 122.28 11.51 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.134 2.556 . . . . 0.0 113.013 -178.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' D' ' 79' ' ' THR . 44.9 mt-10 61.5 51.88 3.92 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.571 177.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 17' ' ' ARG . . . . . 0.469 ' HG3' ' HB2' ' D' ' 14' ' ' LYS . 28.9 mmt180 -117.58 145.56 44.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.133 173.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . 0.705 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 40.7 tttt -123.36 109.91 14.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 123.542 0.526 . . . . 0.0 110.524 -176.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 19' ' ' TYR . . . . . 0.431 ' HE2' ' HG3' ' D' ' 13' ' ' MET . 3.3 m-85 -110.04 104.38 13.26 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.323 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . 0.469 ' HB3' ' SD ' ' D' ' 76' ' ' MET . 13.4 p -85.08 99.45 11.05 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 171.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -113.37 144.01 43.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.483 0.659 . . . . 0.0 112.053 -168.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 14.0 p -96.49 157.31 15.96 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.627 174.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . 0.444 ' CD1' ' HB3' ' D' ' 69' ' ' PHE . 53.9 mt -115.02 116.61 53.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.15 0.5 . . . . 0.0 111.168 -175.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . 0.483 HD12 ' N ' ' D' ' 24' ' ' ILE . 3.9 mp -93.34 -40.95 12.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.125 178.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -123.88 128.24 49.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.663 176.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 61.9 p -64.65 141.72 58.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.258 -174.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 27' ' ' PHE . . . . . 0.807 ' HB3' HD23 ' D' ' 91' ' ' LEU . 39.4 p90 -141.97 152.59 43.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.713 0.768 . . . . 0.0 112.153 -177.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 28' ' ' HIS . . . . . 0.635 ' HA ' ' O ' ' D' ' 67' ' ' LEU . 6.2 t60 -108.21 120.5 42.54 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.407 -1.27 . . . . 0.0 109.399 173.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 29' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 35.2 mt -84.57 133.55 29.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 170.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . 0.548 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 56.8 p -120.3 -6.89 9.84 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.65 -173.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.08 158.41 26.05 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 119.481 -1.343 . . . . 0.0 113.566 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.498 HG23 ' HG ' ' D' ' 87' ' ' LEU . 13.3 p -140.48 127.27 22.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 172.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.17 152.94 41.58 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.332 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 34' ' ' LEU . . . . . 0.603 ' HB3' HG12 ' D' ' 85' ' ' VAL . 3.7 pp -117.93 145.88 44.36 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.798 0.808 . . . . 0.0 111.709 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -106.71 -56.03 2.25 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.226 -1.352 . . . . 0.0 108.819 175.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -102.53 127.95 49.37 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.099 170.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . 0.468 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 153.22 158.45 8.56 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 119.415 -1.374 . . . . 0.0 113.99 175.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -101.71 -45.65 5.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.786 0.327 . . . . 0.0 110.557 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . 0.45 ' HG3' HG22 ' D' ' 57' ' ' THR . 32.8 tt0 -153.05 123.01 6.94 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.117 -178.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . 0.561 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -121.88 114.09 20.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.406 0.622 . . . . 0.0 110.06 170.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' D' ' 79' ' ' THR . 13.7 mmmm -97.11 105.42 17.56 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 49.5 tp -83.59 111.44 19.11 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -174.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 43' ' ' TYR . . . . . 0.554 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 80.4 m-85 -114.87 149.96 36.32 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 175.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.566 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.2 OUTLIER -135.41 128.09 30.92 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.672 172.004 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 45' ' ' ALA . . . . . 0.569 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -105.92 112.17 25.12 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.156 178.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.569 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -127.84 133.34 49.37 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.344 178.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 59.3 38.14 23.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.558 0.694 . . . . 0.0 109.718 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt 62.41 35.24 15.0 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.683 178.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . 0.569 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 23.5 tp60 -130.06 118.26 21.26 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -81.62 108.3 15.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.909 0.385 . . . . 0.0 110.841 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . 0.44 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 87.3 m-85 -99.92 133.34 44.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.612 177.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 tp -80.13 104.73 8.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 169.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 53' ' ' VAL . . . . . 0.488 HG21 ' HB3' ' D' ' 44' ' ' LEU . 3.2 t -79.64 -50.3 18.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.698 -172.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 54' ' ' ALA . . . . . 0.589 ' HB2' HD21 ' D' ' 65' ' ' LEU . . . -153.44 147.16 25.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.711 -176.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 31.5 m -111.02 101.29 9.86 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 171.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 56' ' ' VAL . . . . . 0.477 HG13 ' HB3' ' D' ' 40' ' ' ALA . 7.2 p -119.67 113.5 41.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.545 0.688 . . . . 0.0 109.808 -177.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 57' ' ' THR . . . . . 0.45 HG22 ' HG3' ' D' ' 39' ' ' GLU . 67.5 p -123.24 -178.44 3.98 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.756 -174.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -61.97 -22.93 66.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.039 0.447 . . . . 0.0 110.522 170.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 59' ' ' ALA . . . . . 0.436 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -84.39 -40.82 17.36 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.253 0.549 . . . . 0.0 110.187 178.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 81.0 mt -112.76 82.63 5.16 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 174.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 61' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 11.5 Cg_exo -70.81 -0.29 7.56 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.063 2.508 . . . . 0.0 113.868 -168.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -163.11 127.0 2.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.315 0.579 . . . . 0.0 111.417 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 87.4 t -116.33 121.88 68.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.424 174.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.47 127.54 32.92 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.063 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 65' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' D' ' 54' ' ' ALA . 90.8 mt -119.76 168.52 10.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.477 0.656 . . . . 0.0 112.2 -174.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 66' ' ' ASP . . . . . 0.517 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 14.2 t0 -145.79 97.59 2.99 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 172.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.681 HD21 HD23 ' C' ' 88' ' ' LEU . 6.7 mt -133.62 109.95 9.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.776 -174.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 68' ' ' ASN . . . . . 0.467 ' HB2' ' CG ' ' C' ' 90' ' ' TYR . 6.4 m-20 -103.76 113.87 27.71 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 176.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 69' ' ' PHE . . . . . 0.444 ' HB3' ' CD1' ' D' ' 23' ' ' ILE . 86.1 m-85 -109.08 136.97 47.72 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.771 178.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . 0.401 ' OG ' ' HG2' ' C' ' 7' ' ' MET . 88.1 p -97.28 166.61 11.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.741 0.305 . . . . 0.0 110.239 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 71' ' ' LYS . . . . . 0.422 ' HE3' ' OG ' ' C' ' 98' ' ' SER . 14.9 ptmm? -73.07 -4.87 35.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.023 0.439 . . . . 0.0 110.873 -178.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.52 -9.32 59.02 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.584 -0.607 . . . . 0.0 111.584 174.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -88.37 140.16 29.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.861 0.362 . . . . 0.0 110.135 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -126.27 114.58 18.47 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.569 HG22 ' HB2' ' D' ' 46' ' ' ALA . 13.2 pt -131.02 158.74 43.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.132 0.491 . . . . 0.0 112.0 -166.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 76' ' ' MET . . . . . 0.493 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 3.6 mtm -119.23 123.97 45.61 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 174.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 77' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 1.1 m-85 -104.3 128.57 52.11 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 78' ' ' TYR . . . . . 0.705 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 25.7 p90 -151.86 134.94 15.78 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.47 0.652 . . . . 0.0 112.414 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 79' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 2.5 p -108.85 130.59 55.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.792 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.89 164.76 11.55 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.553 177.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.39 -174.11 44.8 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -113.27 102.64 10.54 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.06 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' D' ' 40' ' ' ALA . . . -173.65 153.51 2.28 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.531 171.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 18.9 t -114.84 126.5 54.89 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.603 HG12 ' HB3' ' D' ' 34' ' ' LEU . 6.6 m -120.94 157.48 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-O 121.161 0.505 . . . . 0.0 112.11 -172.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 66.5 m -116.95 118.97 33.91 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 171.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 87' ' ' LEU . . . . . 0.736 HD13 HD23 ' D' ' 11' ' ' LEU . 5.1 mp -89.77 145.4 25.21 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 170.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.678 HD23 HD21 ' E' ' 67' ' ' LEU . 0.8 OUTLIER -129.98 141.37 50.76 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.982 -177.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.81 -167.44 26.44 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.302 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 90' ' ' TYR . . . . . 0.462 ' CG ' ' HB2' ' E' ' 68' ' ' ASN . 13.6 p90 -150.33 129.55 12.79 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 122.102 0.954 . . . . 0.0 112.091 178.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . 0.807 HD23 ' HB3' ' D' ' 27' ' ' PHE . 8.1 mt -66.78 141.09 57.84 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.621 -1.627 . . . . 0.0 110.839 176.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -80.85 109.36 15.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.654 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -132.94 173.73 11.09 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . 0.511 HG21 ' H ' ' C' ' 3' ' ' GLY . 1.5 pp -142.34 13.88 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -174.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.77 87.56 3.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.256 0.55 . . . . 0.0 110.144 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 18.1 t -88.54 73.01 8.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.515 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.96 162.22 48.34 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.778 -178.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 98' ' ' SER . . . . . 0.411 ' OG ' ' HE3' ' E' ' 71' ' ' LYS . 28.7 m . . . . . 0 C--O 1.249 1.061 0 C-N-CA 122.896 0.478 . . . . 0.0 111.017 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 77.3 t80 . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' E' E ' 2' ' ' GLN . . . . . 0.456 ' H ' HG21 ' A' ' 94' ' ' ILE . 3.7 pt20 -154.43 -47.25 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.771 0.319 . . . . 0.0 111.245 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 3' ' ' GLY . . . . . 0.507 ' H ' HG21 ' A' ' 94' ' ' ILE . . . 83.29 -58.87 5.02 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.853 175.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . 58.91 43.21 18.35 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.319 0.581 . . . . 0.0 110.271 -176.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 48.5 ttm -80.12 94.48 6.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.482 -177.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.08 152.28 24.44 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.55 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 7' ' ' MET . . . . . 0.413 ' HG2' ' OG ' ' A' ' 70' ' ' SER . 58.9 mtt -109.98 139.46 45.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.841 -176.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 8' ' ' PHE . . . . . 0.545 ' CE1' HD21 ' A' ' 44' ' ' LEU . 76.9 t80 -59.93 140.3 56.79 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -172.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 9' ' ' TRP . . . . . 0.439 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 87.4 t90 -132.74 146.76 52.11 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 10' ' ' GLY . . . . . 0.456 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -151.68 152.68 24.4 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.233 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . 0.74 HD23 HD13 ' E' ' 87' ' ' LEU . 60.0 tp -140.44 106.71 5.25 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 178.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -86.31 100.87 12.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.571 0.7 . . . . 0.0 109.72 175.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 13' ' ' MET . . . . . 0.471 ' HB3' HG23 ' E' ' 85' ' ' VAL . 3.7 ttt -94.64 134.23 37.44 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.667 -1.152 . . . . 0.0 111.102 -168.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 14' ' ' LYS . . . . . 0.473 ' HB2' ' HG3' ' E' ' 17' ' ' ARG . 2.5 mptp? -100.29 149.53 36.14 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.791 -178.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . 0.502 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 12.2 Cg_endo -56.48 122.38 11.69 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.146 2.564 . . . . 0.0 112.95 -178.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 16' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' E' ' 79' ' ' THR . 44.7 mt-10 61.43 51.93 3.96 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.502 177.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 17' ' ' ARG . . . . . 0.473 ' HG3' ' HB2' ' E' ' 14' ' ' LYS . 29.0 mmt180 -117.61 145.52 44.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.161 173.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . 0.713 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 40.6 tttt -123.34 109.84 14.42 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 123.505 0.503 . . . . 0.0 110.465 -176.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . 0.447 ' HE2' ' HG3' ' E' ' 13' ' ' MET . 3.4 m-85 -110.06 104.4 13.27 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.367 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 20' ' ' SER . . . . . 0.474 ' HB3' ' SD ' ' E' ' 76' ' ' MET . 13.5 p -85.08 99.43 11.04 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -113.39 144.13 43.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.596 0.712 . . . . 0.0 112.01 -168.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 13.9 p -96.51 157.3 15.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.623 174.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 23' ' ' ILE . . . . . 0.442 ' CD1' ' HB3' ' E' ' 69' ' ' PHE . 53.7 mt -115.02 116.47 52.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.218 0.532 . . . . 0.0 111.211 -175.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . 0.483 HD12 ' N ' ' E' ' 24' ' ' ILE . 3.9 mp -93.23 -40.93 12.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.205 178.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -123.87 128.16 49.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.582 176.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 62.2 p -64.6 141.72 58.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.247 -174.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 27' ' ' PHE . . . . . 0.845 ' HB3' HD23 ' E' ' 91' ' ' LEU . 40.0 p90 -142.09 152.53 43.38 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.727 0.775 . . . . 0.0 112.235 -177.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 28' ' ' HIS . . . . . 0.639 ' HA ' ' O ' ' E' ' 67' ' ' LEU . 6.3 t60 -108.15 120.5 42.52 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.397 173.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 29' ' ' ILE . . . . . 0.543 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 35.2 mt -84.56 133.56 28.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.129 -1.064 . . . . 0.0 108.129 170.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . 0.539 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 56.8 p -120.35 -6.88 9.82 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -173.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.13 158.34 25.88 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 119.569 -1.3 . . . . 0.0 113.609 176.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.5 HG23 ' HG ' ' E' ' 87' ' ' LEU . 13.1 p -140.42 127.16 22.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 172.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.13 152.84 41.48 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 121.934 -0.478 . . . . 0.0 111.324 -175.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 34' ' ' LEU . . . . . 0.623 ' HB3' HG12 ' E' ' 85' ' ' VAL . 3.7 pp -117.78 145.87 44.2 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 121.739 0.781 . . . . 0.0 111.794 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -106.68 -56.09 2.24 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.855 175.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -102.47 127.94 49.3 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.113 170.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 153.29 158.46 8.57 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 119.368 -1.396 . . . . 0.0 113.911 175.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -101.72 -45.67 5.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.497 -0.352 . . . . 0.0 110.559 176.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 39' ' ' GLU . . . . . 0.45 ' HG3' HG22 ' E' ' 57' ' ' THR . 32.7 tt0 -153.1 123.0 6.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.052 -178.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . 0.567 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -121.87 114.17 20.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.515 0.674 . . . . 0.0 110.002 170.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 41' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' E' ' 79' ' ' THR . 13.7 mmmm -97.18 105.46 17.61 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 49.8 tp -83.71 111.49 19.2 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -174.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 43' ' ' TYR . . . . . 0.559 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 80.0 m-85 -114.86 149.98 36.26 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 175.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 44' ' ' LEU . . . . . 0.562 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 0.2 OUTLIER -135.58 128.13 30.66 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.532 172.082 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' E' E ' 45' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -105.92 112.1 25.01 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.151 178.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . 0.581 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -127.87 133.29 49.33 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.344 178.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 59.29 38.24 23.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.607 0.718 . . . . 0.0 109.698 -176.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt 62.44 35.23 14.94 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.652 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 49' ' ' GLN . . . . . 0.566 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 23.2 tp60 -130.14 118.23 21.14 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -81.7 108.25 15.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.965 0.412 . . . . 0.0 110.859 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . 0.467 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 87.1 m-85 -99.81 133.33 44.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.615 177.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -80.06 104.71 8.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 169.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . 0.492 HG21 ' HB3' ' E' ' 44' ' ' LEU . 3.2 t -79.68 -50.4 18.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.667 -172.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 54' ' ' ALA . . . . . 0.61 ' HB2' HD21 ' E' ' 65' ' ' LEU . . . -153.33 147.18 25.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.723 -176.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 31.2 m -110.89 101.17 9.78 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 171.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . 0.47 HG13 ' HB3' ' E' ' 40' ' ' ALA . 7.1 p -119.54 113.45 41.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.64 0.733 . . . . 0.0 109.895 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 57' ' ' THR . . . . . 0.45 HG22 ' HG3' ' E' ' 39' ' ' GLU . 66.4 p -123.21 -178.43 3.98 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.746 -174.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -61.91 -22.98 66.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.961 0.41 . . . . 0.0 110.501 170.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 59' ' ' ALA . . . . . 0.437 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -84.34 -40.8 17.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.182 178.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 80.8 mt -112.78 82.56 5.13 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 174.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 61' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 11.5 Cg_exo -70.82 -0.29 7.56 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.066 2.511 . . . . 0.0 113.88 -167.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -163.12 127.1 2.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.399 0.618 . . . . 0.0 111.397 -176.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 86.9 t -116.42 121.93 68.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.344 174.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.56 127.56 32.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.032 176.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.61 HD21 ' HB2' ' E' ' 54' ' ' ALA . 90.8 mt -119.8 168.51 11.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.481 0.658 . . . . 0.0 112.184 -174.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 66' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 14.3 t0 -145.76 97.59 2.99 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 172.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 67' ' ' LEU . . . . . 0.678 HD21 HD23 ' D' ' 88' ' ' LEU . 6.7 mt -133.57 109.99 9.61 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.809 -174.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 68' ' ' ASN . . . . . 0.462 ' HB2' ' CG ' ' D' ' 90' ' ' TYR . 6.4 m-20 -103.84 113.87 27.71 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 69' ' ' PHE . . . . . 0.442 ' HB3' ' CD1' ' E' ' 23' ' ' ILE . 86.1 m-85 -109.1 136.98 47.71 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.721 178.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 70' ' ' SER . . . . . 0.435 ' OG ' ' HG2' ' D' ' 7' ' ' MET . 88.0 p -97.35 166.7 11.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.802 0.334 . . . . 0.0 110.17 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 71' ' ' LYS . . . . . 0.411 ' HE3' ' OG ' ' D' ' 98' ' ' SER . 14.9 ptmm? -73.19 -4.83 35.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.002 0.43 . . . . 0.0 110.843 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.6 -9.14 59.07 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 174.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -88.5 140.25 29.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.863 0.363 . . . . 0.0 110.059 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -126.32 114.47 18.29 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 75' ' ' ILE . . . . . 0.581 HG22 ' HB2' ' E' ' 46' ' ' ALA . 13.3 pt -131.04 158.71 43.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.104 0.478 . . . . 0.0 111.945 -166.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 76' ' ' MET . . . . . 0.495 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 3.7 mtm -119.28 123.97 45.55 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 174.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 77' ' ' PHE . . . . . 0.562 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 1.1 m-85 -104.28 128.61 52.08 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 78' ' ' TYR . . . . . 0.713 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 26.0 p90 -151.95 135.0 15.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.504 0.669 . . . . 0.0 112.442 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 79' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 2.6 p -108.99 130.54 55.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.767 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.85 164.76 11.55 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.51 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.44 -174.04 44.65 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -113.32 102.69 10.58 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.977 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 83' ' ' ALA . . . . . 0.567 ' HB3' ' HB2' ' E' ' 40' ' ' ALA . . . -173.7 153.56 2.27 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.536 171.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 18.9 t -114.84 126.42 54.8 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 85' ' ' VAL . . . . . 0.623 HG12 ' HB3' ' E' ' 34' ' ' LEU . 6.7 m -120.78 157.68 23.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-O 121.222 0.534 . . . . 0.0 112.075 -172.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 66.6 m -117.21 118.93 33.65 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 171.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 87' ' ' LEU . . . . . 0.74 HD13 HD23 ' E' ' 11' ' ' LEU . 5.1 mp -89.77 145.43 25.19 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 170.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . 0.668 HD23 HD21 ' A' ' 67' ' ' LEU . 0.8 OUTLIER -130.1 141.4 50.7 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.873 -177.738 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.87 -167.51 26.61 Favored Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.253 -178.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 90' ' ' TYR . . . . . 0.452 ' CG ' ' HB2' ' A' ' 68' ' ' ASN . 13.6 p90 -150.24 129.58 12.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 122.04 0.924 . . . . 0.0 112.06 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 91' ' ' LEU . . . . . 0.845 HD23 ' HB3' ' E' ' 27' ' ' PHE . 8.0 mt -66.8 141.13 57.81 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.81 176.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -80.92 109.36 15.42 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.684 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -132.9 173.74 11.07 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 177.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 94' ' ' ILE . . . . . 0.529 HG21 ' H ' ' D' ' 3' ' ' GLY . 1.5 pp -142.36 13.88 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -174.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -76.81 87.65 3.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.28 0.562 . . . . 0.0 110.125 178.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 18.4 t -88.64 73.1 8.63 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.13 162.3 48.1 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.708 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 98' ' ' SER . . . . . 0.436 ' OG ' ' HE3' ' A' ' 71' ' ' LYS . 27.1 m . . . . . 0 C--O 1.248 1.001 0 C-N-CA 122.938 0.495 . . . . 0.0 110.943 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -102.09 145.51 29.24 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 149.93 -171.71 29.91 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.795 -177.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.563 ' O ' ' HB3' ' A' ' 93' ' ' ASP . . . 57.02 44.26 23.1 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 123.882 0.401 . . . . 0.0 110.921 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -70.33 172.64 7.93 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.895 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.59 ' HB3' ' ND2' ' B' ' 68' ' ' ASN . . . -54.25 131.5 41.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.761 177.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 52.4 ttm -100.36 139.01 36.65 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.622 -173.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.439 ' CE1' HD21 ' B' ' 44' ' ' LEU . 61.4 t80 -52.77 142.1 19.64 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.619 -177.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.555 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 88.5 t90 -135.71 147.72 48.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.876 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.46 ' HA3' ' CE1' ' B' ' 51' ' ' TYR . . . -148.72 153.82 25.46 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.007 178.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.652 HD23 HD13 ' A' ' 87' ' ' LEU . 52.1 tp -140.44 108.18 5.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.022 0.439 . . . . 0.0 110.881 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -81.25 101.49 9.76 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.538 173.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.592 ' HB3' HG23 ' A' ' 85' ' ' VAL . 30.6 tpp -95.48 131.26 41.83 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.148 -174.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -100.82 145.31 30.15 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.915 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.598 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 12.3 Cg_endo -56.01 124.54 16.51 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 123.397 2.731 . . . . 0.0 113.493 -174.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.556 ' HA ' ' O ' ' A' ' 79' ' ' THR . 25.3 mt-10 60.3 47.91 8.57 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.062 177.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -121.79 138.67 54.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.687 172.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.726 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 84.5 mttt -111.21 118.98 37.43 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.414 0.446 . . . . 0.0 111.519 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.61 103.91 12.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.827 176.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.41 ' HB3' ' SD ' ' A' ' 76' ' ' MET . 7.8 p -88.47 98.84 11.85 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 174.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -117.36 144.84 44.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.472 0.653 . . . . 0.0 112.273 -169.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.5 m -94.06 143.15 26.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.542 177.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.435 ' CG2' ' HA ' ' A' ' 71' ' ' LYS . 59.4 mt -92.81 120.35 42.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.066 0.46 . . . . 0.0 111.119 -174.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.1 mp -79.34 -52.9 14.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.351 178.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.493 ' HE2' ' HB3' ' A' ' 91' ' ' LEU . 13.5 ptmt -131.08 137.53 49.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.942 175.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.2 m -54.45 141.76 29.65 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.921 -176.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.666 ' HB3' HD23 ' A' ' 91' ' ' LEU . 11.9 p90 -149.06 158.26 44.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.655 0.741 . . . . 0.0 112.819 -175.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.608 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 9.2 t60 -111.41 127.41 55.67 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.392 -1.276 . . . . 0.0 109.745 178.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.573 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 35.0 mt -96.78 137.97 23.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 170.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.608 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 56.6 p -123.5 -20.42 5.57 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -171.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -153.88 156.34 26.74 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 119.273 -1.442 . . . . 0.0 113.578 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.5 HG23 ' HG ' ' A' ' 87' ' ' LEU . 14.8 p -146.51 124.39 4.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 172.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.19 155.68 44.0 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.75 -174.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.581 ' HB3' HG12 ' A' ' 85' ' ' VAL . 3.7 pp -120.39 140.55 51.17 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.914 0.864 . . . . 0.0 111.755 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -105.12 -53.6 2.63 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.334 -1.303 . . . . 0.0 108.788 174.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -102.91 127.44 50.12 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 169.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.485 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 151.22 156.03 7.21 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 119.784 -1.198 . . . . 0.0 113.608 177.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.44 ' HA ' ' HB2' ' A' ' 58' ' ' LYS . 91.0 mt-30 -102.66 -44.27 5.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.68 0.276 . . . . 0.0 111.053 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -153.12 126.41 8.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.095 176.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.564 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -124.51 113.16 17.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.563 0.697 . . . . 0.0 109.7 169.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 79' ' ' THR . 19.9 mtpp -96.06 107.05 19.31 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 41.2 tp -81.57 114.84 20.55 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -173.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.55 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 97.6 m-85 -120.49 139.46 52.86 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.271 177.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.51 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -125.15 133.27 52.87 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 172.67 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.631 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -112.04 113.07 25.14 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.156 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.53 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -124.47 137.8 54.4 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.416 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 59.7 30.72 20.33 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.473 0.483 . . . . 0.0 110.301 -174.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.479 ' NZ ' ' HB2' ' A' ' 48' ' ' LYS . 0.1 OUTLIER 62.57 33.6 15.74 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.14 -177.072 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.631 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 8.5 tp-100 -123.46 130.38 52.61 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.66 123.59 32.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.905 0.383 . . . . 0.0 110.769 -176.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.499 ' CE1' ' HA3' ' E' ' 10' ' ' GLY . 84.7 m-85 -118.02 130.08 55.96 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 175.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.09 103.77 7.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 171.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.546 ' CG1' HD11 ' A' ' 67' ' ' LEU . 2.6 t -78.7 -49.49 20.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.712 -171.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.462 ' HB1' HG11 ' A' ' 63' ' ' VAL . . . -158.38 146.58 18.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.852 -178.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.4 m -109.46 101.43 10.39 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 173.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.456 HG11 HG11 ' A' ' 85' ' ' VAL . 7.4 p -115.63 116.2 51.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.557 0.694 . . . . 0.0 109.565 -177.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 47.1 p -122.37 -179.13 4.09 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.335 -172.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.44 ' HB2' ' HA ' ' A' ' 38' ' ' GLN . 38.1 tttm -61.58 -27.38 68.59 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.892 172.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.487 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -84.24 -40.63 17.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.643 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.2 mt -109.45 83.99 2.82 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 174.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 9.7 Cg_exo -70.91 0.07 7.08 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.016 2.478 . . . . 0.0 113.762 -168.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -162.8 131.74 4.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.224 0.535 . . . . 0.0 111.254 -176.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.462 HG11 ' HB1' ' A' ' 54' ' ' ALA . 68.7 t -120.49 132.68 69.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.105 172.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.43 113.11 25.49 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.224 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -121.46 170.01 10.07 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.34 -176.489 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.549 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 7.2 t0 -118.33 98.76 6.44 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.245 0.545 . . . . 0.0 109.619 175.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.613 HD21 HD23 ' E' ' 88' ' ' LEU . 19.8 mt -112.98 143.49 44.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.873 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.628 ' ND2' ' HB3' ' E' ' 6' ' ' ALA . 57.2 t30 -147.81 119.96 8.3 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 120.942 0.401 . . . . 0.0 110.008 174.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -114.93 153.53 30.38 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.25 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.7 t -103.67 148.88 25.51 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.983 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.493 ' NZ ' ' HB2' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -74.75 9.97 1.6 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -174.656 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.62 -15.21 30.04 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.865 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -101.28 170.82 7.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.77 0.319 . . . . 0.0 110.868 -175.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 61.9 ttt-85 -138.32 122.6 18.18 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.53 HG22 ' HB2' ' A' ' 46' ' ' ALA . 14.4 pt -125.69 160.86 31.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.431 -170.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.48 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 2.8 mtm -115.23 129.02 56.52 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 174.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.51 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -109.82 128.41 55.3 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.109 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.726 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 51.3 p90 -155.83 157.47 36.48 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 120.226 -0.59 . . . . 0.0 112.24 -177.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 14.8 p -124.81 144.0 50.51 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.264 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.42 156.63 18.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.981 174.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.01 -166.83 31.32 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -176.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -123.71 102.68 7.96 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 117.715 0.758 . . . . 0.0 110.42 176.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.598 ' H ' ' HB3' ' A' ' 15' ' ' PRO . . . -169.31 151.81 4.71 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.187 169.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.5 t -109.1 122.85 48.16 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.592 HG23 ' HB3' ' A' ' 13' ' ' MET . 6.7 m -119.78 147.12 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-O 121.266 0.555 . . . . 0.0 111.832 -173.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.0 t -111.01 119.34 38.72 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.652 HD13 HD23 ' A' ' 11' ' ' LEU . 5.2 mp -91.84 151.45 20.56 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 174.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.568 HD23 HD21 ' B' ' 67' ' ' LEU . 1.2 tp -133.0 140.3 47.69 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.301 -178.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.23 -166.75 24.72 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.992 -177.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.408 ' CD2' ' HB3' ' B' ' 68' ' ' ASN . 11.5 p90 -152.93 132.86 13.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.697 0.76 . . . . 0.0 111.839 176.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.666 HD23 ' HB3' ' A' ' 27' ' ' PHE . 15.2 mt -67.56 139.84 56.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.095 177.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -72.97 113.46 10.03 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -174.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.563 ' HB3' ' O ' ' A' ' 4' ' ' ALA . 3.2 m-20 -142.21 136.24 29.71 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.113 -0.948 . . . . 0.0 108.937 171.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 39.5 pt -77.78 145.0 10.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.096 0.474 . . . . 0.0 111.358 -175.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -66.48 -9.31 33.16 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.053 -177.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.9 m 65.05 -159.52 0.29 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.569 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.16 -61.34 3.99 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.749 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 68.9 m . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.261 176.397 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -102.12 145.5 29.27 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . 0.402 ' HA2' ' SD ' ' B' ' 5' ' ' MET . . . 149.92 -171.71 29.9 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.782 -177.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.549 ' O ' ' HB3' ' B' ' 93' ' ' ASP . . . 57.03 44.35 22.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 0.0 110.868 -178.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . 0.402 ' SD ' ' HA2' ' B' ' 3' ' ' GLY . 2.5 mpt? -70.43 172.66 8.01 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.862 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.627 ' HB3' ' ND2' ' C' ' 68' ' ' ASN . . . -54.26 131.46 41.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.677 177.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 52.5 ttm -100.34 139.06 36.55 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.582 -173.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.49 ' CE1' HD21 ' C' ' 44' ' ' LEU . 61.8 t80 -52.72 142.05 19.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.627 -177.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . 0.551 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 88.5 t90 -135.7 147.71 48.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.856 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.507 ' HA3' ' CE1' ' C' ' 51' ' ' TYR . . . -148.71 153.86 25.48 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.984 178.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.662 HD23 HD13 ' B' ' 87' ' ' LEU . 52.3 tp -140.46 108.13 5.63 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.086 0.47 . . . . 0.0 110.915 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -81.23 101.59 9.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.529 173.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . 0.591 ' HB3' HG23 ' B' ' 85' ' ' VAL . 30.8 tpp -95.58 131.23 42.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.114 0.483 . . . . 0.0 111.151 -174.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -100.74 145.26 30.05 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.969 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.587 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 12.4 Cg_endo -56.09 124.67 16.82 Favored 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 123.445 2.763 . . . . 0.0 113.487 -174.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.549 ' HA ' ' O ' ' B' ' 79' ' ' THR . 25.3 mt-10 60.24 47.91 8.72 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.031 177.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -121.76 138.78 54.23 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.696 172.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.721 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 84.5 mttt -111.47 119.02 37.4 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 123.273 0.358 . . . . 0.0 111.491 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.67 103.86 12.47 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.766 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 7.3 p -88.48 98.87 11.87 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 174.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -117.39 144.81 44.57 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.538 0.685 . . . . 0.0 112.284 -169.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 17.7 m -94.06 143.11 26.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.523 177.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.445 ' CG2' ' HA ' ' B' ' 71' ' ' LYS . 59.3 mt -92.86 120.49 42.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.162 0.506 . . . . 0.0 111.117 -174.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.444 ' N ' HD12 ' B' ' 24' ' ' ILE . 4.0 mp -79.42 -52.89 14.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.286 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.502 ' HE2' ' HB3' ' B' ' 91' ' ' LEU . 13.5 ptmt -131.12 137.47 49.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.988 175.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 11.5 m -54.41 141.71 29.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.924 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . 0.66 ' HB3' HD23 ' B' ' 91' ' ' LEU . 12.1 p90 -149.03 158.28 44.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.685 0.755 . . . . 0.0 112.774 -175.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' HIS . . . . . 0.598 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 9.2 t60 -111.39 127.39 55.65 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.39 -1.277 . . . . 0.0 109.795 178.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.589 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 35.0 mt -96.79 137.98 23.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 170.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.598 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 56.4 p -123.52 -20.37 5.58 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -171.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -153.81 156.39 26.77 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 119.322 -1.418 . . . . 0.0 113.605 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.498 HG23 ' HG ' ' B' ' 87' ' ' LEU . 14.8 p -146.58 124.35 3.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 172.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.14 155.71 44.04 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.898 -0.501 . . . . 0.0 111.726 -174.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.586 ' HB3' HG12 ' B' ' 85' ' ' VAL . 3.7 pp -120.38 140.57 51.12 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.984 0.897 . . . . 0.0 111.728 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -105.01 -53.8 2.6 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.37 -1.286 . . . . 0.0 108.855 174.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -102.82 127.44 49.99 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 169.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.492 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 151.3 156.09 7.25 Favored Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 119.829 -1.177 . . . . 0.0 113.547 176.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . 0.438 ' HA ' ' HB2' ' B' ' 58' ' ' LYS . 91.0 mt-30 -102.58 -44.3 5.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.737 0.303 . . . . 0.0 111.125 178.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -153.08 126.41 8.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.089 177.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.555 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -124.53 113.12 17.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.511 0.672 . . . . 0.0 109.776 169.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' B' ' 79' ' ' THR . 19.9 mtpp -96.15 107.04 19.32 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 41.2 tp -81.5 114.84 20.49 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 -173.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . 0.553 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 97.6 m-85 -120.51 139.42 52.93 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.507 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 0.2 OUTLIER -125.07 133.29 52.96 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 172.575 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.625 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -112.02 113.11 25.21 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.184 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.515 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -124.54 137.82 54.38 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.344 178.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 59.63 30.88 20.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.046 0.451 . . . . 0.0 110.293 -174.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.488 ' NZ ' ' HB2' ' B' ' 48' ' ' LYS . 0.1 OUTLIER 62.62 33.6 15.61 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.12 -177.153 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.625 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 8.4 tp-100 -123.48 130.27 52.45 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.63 123.61 32.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.829 0.347 . . . . 0.0 110.7 -175.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.46 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 84.8 m-85 -117.99 130.15 56.02 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.888 175.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.1 tp -80.2 103.78 7.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.827 0.822 . . . . 0.0 108.807 171.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.552 ' CG1' HD11 ' B' ' 67' ' ' LEU . 2.6 t -78.7 -49.39 20.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.709 -171.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.468 ' HB1' HG11 ' B' ' 63' ' ' VAL . . . -158.38 146.65 18.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.889 -178.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 32.3 m -109.57 101.43 10.36 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.449 HG11 HG11 ' B' ' 85' ' ' VAL . 7.4 p -115.62 116.21 51.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.568 0.699 . . . . 0.0 109.557 -177.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 46.8 p -122.37 -179.17 4.1 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.371 -172.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . 0.438 ' HB2' ' HA ' ' B' ' 38' ' ' GLN . 38.1 tttm -61.53 -27.33 68.53 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.878 172.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.479 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -84.34 -40.67 17.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.577 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 86.1 mt -109.41 84.11 2.85 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 174.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 9.8 Cg_exo -71.03 0.09 7.14 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.981 2.454 . . . . 0.0 113.707 -168.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -162.79 131.71 4.11 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.121 0.486 . . . . 0.0 111.221 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.468 HG11 ' HB1' ' B' ' 54' ' ' ALA . 71.7 t -120.57 132.8 69.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.964 172.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.52 113.22 25.69 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.09 177.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.435 HD13 ' N ' ' B' ' 65' ' ' LEU . 0.0 OUTLIER -121.58 170.05 10.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.325 -176.575 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . 0.511 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 7.2 t0 -118.38 98.73 6.42 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.221 0.534 . . . . 0.0 109.602 175.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.589 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 19.7 mt -113.0 143.43 44.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.903 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . 0.59 ' ND2' ' HB3' ' A' ' 6' ' ' ALA . 57.0 t30 -147.79 120.0 8.34 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.951 0.405 . . . . 0.0 109.965 174.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -114.98 153.5 30.5 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.273 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 20.6 t -103.57 148.89 25.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.058 -178.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.486 ' NZ ' ' HB2' ' B' ' 71' ' ' LYS . 0.0 OUTLIER -74.88 10.07 1.6 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -174.579 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.61 -15.22 30.04 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.86 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -101.13 170.83 7.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.846 0.355 . . . . 0.0 110.838 -175.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 62.0 ttt-85 -138.37 122.55 18.07 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.515 HG22 ' HB2' ' B' ' 46' ' ' ALA . 14.5 pt -125.73 160.86 31.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.389 -170.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.483 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 2.8 mtm -115.25 129.01 56.51 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 174.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . 0.507 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -109.81 128.39 55.28 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.187 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.721 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 51.4 p90 -155.79 157.4 36.43 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 120.241 -0.584 . . . . 0.0 112.215 -177.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 14.6 p -124.77 144.06 50.46 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.277 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.43 156.69 18.68 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.981 174.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.87 -166.91 31.55 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -123.75 102.76 7.99 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.36 176.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.587 ' H ' ' HB3' ' B' ' 15' ' ' PRO . . . -169.23 151.88 4.79 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.21 169.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 33.7 t -109.23 122.83 48.17 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.591 HG23 ' HB3' ' B' ' 13' ' ' MET . 6.8 m -119.78 147.18 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 CA-C-O 121.307 0.575 . . . . 0.0 111.838 -173.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 17.0 t -111.08 119.33 38.63 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.662 HD13 HD23 ' B' ' 11' ' ' LEU . 5.2 mp -91.72 151.49 20.61 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 174.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.602 HD23 HD21 ' C' ' 67' ' ' LEU . 1.2 tp -133.07 140.31 47.61 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.267 -178.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.28 -166.67 24.65 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.961 -177.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' TYR . . . . . 0.42 ' CD2' ' HB3' ' C' ' 68' ' ' ASN . 11.3 p90 -153.11 132.92 13.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.811 0.815 . . . . 0.0 111.742 176.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . 0.66 HD23 ' HB3' ' B' ' 27' ' ' PHE . 15.1 mt -67.57 139.79 56.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.13 -1.395 . . . . 0.0 110.127 177.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -72.9 113.39 9.88 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -174.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . 0.549 ' HB3' ' O ' ' B' ' 4' ' ' ALA . 3.3 m-20 -142.21 136.11 29.58 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.909 171.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 39.5 pt -77.68 145.05 10.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.037 0.446 . . . . 0.0 111.497 -175.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -66.52 -9.33 33.66 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.085 -177.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 19.8 m 65.04 -159.65 0.29 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.594 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.29 -61.14 3.97 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.757 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 68.6 m . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.696 -0.669 . . . . 0.0 110.263 176.247 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -102.04 145.39 29.38 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . 149.94 -171.83 29.91 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.808 -177.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . 0.548 ' O ' ' HB3' ' C' ' 93' ' ' ASP . . . 57.21 44.13 22.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.853 0.359 . . . . 0.0 110.907 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -70.2 172.56 7.91 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.903 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 6' ' ' ALA . . . . . 0.584 ' HB3' ' ND2' ' D' ' 68' ' ' ASN . . . -54.2 131.39 41.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.68 177.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 52.4 ttm -100.33 138.99 36.64 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.567 -173.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 8' ' ' PHE . . . . . 0.491 ' CE1' HD21 ' D' ' 44' ' ' LEU . 61.4 t80 -52.73 142.1 19.48 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.937 -1.028 . . . . 0.0 112.62 -177.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . 0.537 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 88.3 t90 -135.71 147.57 48.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.867 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . 0.521 ' HA3' ' CE1' ' D' ' 51' ' ' TYR . . . -148.69 153.8 25.44 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.094 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.652 HD23 HD13 ' C' ' 87' ' ' LEU . 52.6 tp -140.36 108.15 5.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.989 0.423 . . . . 0.0 110.914 178.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -81.29 101.48 9.78 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.507 173.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 13' ' ' MET . . . . . 0.604 ' HB3' HG23 ' C' ' 85' ' ' VAL . 30.7 tpp -95.48 131.23 41.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.132 0.492 . . . . 0.0 111.128 -174.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -100.82 145.32 30.17 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.899 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . 0.591 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 12.4 Cg_endo -56.06 124.61 16.69 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 123.404 2.736 . . . . 0.0 113.459 -174.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' C' ' 79' ' ' THR . 25.1 mt-10 60.28 47.91 8.63 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.024 177.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -121.72 138.72 54.24 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.653 172.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 18' ' ' LYS . . . . . 0.729 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 84.5 mttt -111.37 119.06 37.58 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.454 0.471 . . . . 0.0 111.484 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -110.7 103.86 12.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.735 176.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 7.8 p -88.43 98.84 11.85 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 174.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -117.38 144.77 44.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.553 0.692 . . . . 0.0 112.271 -169.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 17.4 m -94.01 143.19 26.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.577 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . 0.435 ' CG2' ' HA ' ' C' ' 71' ' ' LYS . 59.4 mt -92.89 120.48 42.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.054 0.454 . . . . 0.0 111.09 -174.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . 0.449 HD12 ' N ' ' C' ' 24' ' ' ILE . 4.0 mp -79.43 -52.88 14.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.315 178.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . 0.492 ' HE2' ' HB3' ' C' ' 91' ' ' LEU . 13.6 ptmt -131.12 137.46 49.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.95 175.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 11.5 m -54.43 141.69 29.77 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.921 -176.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 27' ' ' PHE . . . . . 0.651 ' HB3' HD23 ' C' ' 91' ' ' LEU . 12.1 p90 -149.0 158.24 44.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.71 0.767 . . . . 0.0 112.834 -176.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 28' ' ' HIS . . . . . 0.603 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 9.2 t60 -111.41 127.41 55.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.405 -1.271 . . . . 0.0 109.864 178.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . 0.566 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 35.6 mt -96.82 138.02 23.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 170.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.603 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 56.4 p -123.46 -20.45 5.58 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -171.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -153.78 156.36 26.74 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 119.352 -1.404 . . . . 0.0 113.634 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.489 HG23 ' HG ' ' C' ' 87' ' ' LEU . 14.8 p -146.57 124.31 3.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.12 155.74 44.06 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.947 -0.471 . . . . 0.0 111.752 -174.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.597 ' HB3' HG12 ' C' ' 85' ' ' VAL . 3.7 pp -120.44 140.58 51.17 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.938 0.875 . . . . 0.0 111.752 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -105.13 -53.7 2.62 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.757 174.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -102.9 127.47 50.09 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 169.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 37' ' ' GLY . . . . . 0.48 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 151.24 156.09 7.24 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 119.901 -1.142 . . . . 0.0 113.685 177.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 38' ' ' GLN . . . . . 0.438 ' HA ' ' HB2' ' C' ' 58' ' ' LYS . 90.9 mt-30 -102.68 -44.23 5.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.766 0.317 . . . . 0.0 111.156 178.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -153.1 126.46 8.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.071 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.56 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -124.46 113.08 17.66 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.441 0.638 . . . . 0.0 109.793 169.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' C' ' 79' ' ' THR . 19.9 mtpp -96.07 107.02 19.27 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 176.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 41.3 tp -81.48 114.81 20.46 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -173.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 43' ' ' TYR . . . . . 0.553 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 97.6 m-85 -120.53 139.41 52.95 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.503 ' HB2' ' CD1' ' C' ' 77' ' ' PHE . 0.2 OUTLIER -125.12 133.25 52.92 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.656 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . 0.631 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -112.07 113.11 25.2 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.096 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.519 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -124.46 137.82 54.4 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.333 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 59.72 30.73 20.32 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 123.503 0.502 . . . . 0.0 110.258 -174.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.488 ' NZ ' ' HB2' ' C' ' 48' ' ' LYS . 0.1 OUTLIER 62.53 33.62 15.83 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.201 -177.033 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . 0.631 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 8.4 tp-100 -123.53 130.27 52.43 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.53 123.64 31.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.792 0.33 . . . . 0.0 110.806 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . 0.507 ' CE1' ' HA3' ' B' ' 10' ' ' GLY . 84.6 m-85 -118.03 130.12 55.98 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.84 175.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.1 tp -80.23 103.82 7.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 171.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 53' ' ' VAL . . . . . 0.555 ' CG1' HD11 ' C' ' 67' ' ' LEU . 2.6 t -78.7 -49.5 20.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.648 -171.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 54' ' ' ALA . . . . . 0.471 ' HB1' HG11 ' C' ' 63' ' ' VAL . . . -158.35 146.56 18.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.827 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 32.5 m -109.42 101.37 10.35 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 173.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . 0.462 HG11 HG11 ' C' ' 85' ' ' VAL . 7.4 p -115.54 116.27 51.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.587 0.708 . . . . 0.0 109.569 -177.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 47.0 p -122.44 -179.13 4.1 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.346 -172.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 58' ' ' LYS . . . . . 0.438 ' HB2' ' HA ' ' C' ' 38' ' ' GLN . 38.1 tttm -61.45 -27.53 68.63 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.871 172.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . 0.493 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -84.14 -40.66 17.95 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.647 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 86.1 mt -109.43 84.05 2.83 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 174.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 61' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 9.8 Cg_exo -71.03 0.12 7.09 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.099 2.533 . . . . 0.0 113.729 -168.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -162.77 131.69 4.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.166 0.508 . . . . 0.0 111.274 -176.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.471 HG11 ' HB1' ' C' ' 54' ' ' ALA . 69.0 t -120.47 132.86 68.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.0 172.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.61 113.12 25.5 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.115 177.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . 0.439 ' N ' HD13 ' C' ' 65' ' ' LEU . 0.0 OUTLIER -121.51 170.03 10.08 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.064 0.459 . . . . 0.0 111.294 -176.508 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 66' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 7.4 t0 -118.3 98.76 6.44 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.199 0.524 . . . . 0.0 109.678 175.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.602 HD21 HD23 ' B' ' 88' ' ' LEU . 19.7 mt -112.98 143.4 44.33 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.902 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . 0.627 ' ND2' ' HB3' ' B' ' 6' ' ' ALA . 57.1 t30 -147.75 119.96 8.34 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 174.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -115.01 153.53 30.48 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.186 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 20.5 t -103.61 148.88 25.47 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.991 -178.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . 0.48 ' NZ ' ' HB2' ' C' ' 71' ' ' LYS . 0.0 OUTLIER -74.76 9.91 1.63 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -174.66 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.57 -15.14 30.37 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.594 -0.813 . . . . 0.0 111.994 175.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -101.16 170.87 7.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.792 0.329 . . . . 0.0 110.91 -175.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 61.8 ttt-85 -138.36 122.64 18.19 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.519 HG22 ' HB2' ' C' ' 46' ' ' ALA . 14.4 pt -125.76 160.84 31.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.4 -170.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.476 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 2.8 mtm -115.24 129.02 56.52 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 174.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 77' ' ' PHE . . . . . 0.503 ' CD1' ' HB2' ' C' ' 44' ' ' LEU . 0.6 OUTLIER -109.91 128.38 55.32 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.179 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 78' ' ' TYR . . . . . 0.729 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 51.2 p90 -155.78 157.45 36.51 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 120.235 -0.586 . . . . 0.0 112.254 -177.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 14.7 p -124.74 143.98 50.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.234 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.34 156.62 18.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.017 174.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.04 -166.74 31.23 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -176.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -123.79 102.72 7.96 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 117.693 0.746 . . . . 0.0 110.462 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . 0.591 ' H ' ' HB3' ' C' ' 15' ' ' PRO . . . -169.26 151.81 4.74 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.366 -1.288 . . . . 0.0 109.258 169.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 33.5 t -109.18 122.78 48.03 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.604 HG23 ' HB3' ' C' ' 13' ' ' MET . 6.7 m -119.68 147.17 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 CA-C-O 121.264 0.554 . . . . 0.0 111.818 -173.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . 0.4 ' HB3' HG22 ' D' ' 52' ' ' ILE . 17.2 t -111.11 119.36 38.74 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . 0.652 HD13 HD23 ' C' ' 11' ' ' LEU . 5.2 mp -91.67 151.46 20.66 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 174.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . 0.564 HD23 HD21 ' D' ' 67' ' ' LEU . 1.2 tp -133.07 140.33 47.62 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.3 -178.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.29 -166.73 24.77 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.955 -0.64 . . . . 0.0 111.991 -177.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -153.0 132.81 13.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.714 0.769 . . . . 0.0 111.817 176.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . 0.651 HD23 ' HB3' ' C' ' 27' ' ' PHE . 15.2 mt -67.6 139.76 56.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.094 177.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -72.83 113.39 9.8 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -174.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 93' ' ' ASP . . . . . 0.548 ' HB3' ' O ' ' C' ' 4' ' ' ALA . 3.2 m-20 -142.19 136.3 29.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.896 171.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 39.5 pt -77.86 144.99 10.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.016 0.436 . . . . 0.0 111.393 -175.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.42 -9.34 32.93 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.028 -177.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 20.1 m 64.93 -159.57 0.29 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.621 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.31 -61.36 3.94 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.831 -0.7 . . . . 0.0 111.68 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.716 -0.659 . . . . 0.0 110.209 176.435 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -102.01 145.38 29.38 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 3' ' ' GLY . . . . . 0.409 ' HA2' ' SD ' ' D' ' 5' ' ' MET . . . 150.0 -171.88 29.94 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.799 -177.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 4' ' ' ALA . . . . . 0.548 ' O ' ' HB3' ' D' ' 93' ' ' ASP . . . 57.25 44.2 22.43 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 123.834 0.373 . . . . 0.0 110.854 -178.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 5' ' ' MET . . . . . 0.409 ' SD ' ' HA2' ' D' ' 3' ' ' GLY . 2.5 mpt? -70.33 172.64 7.92 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.837 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 6' ' ' ALA . . . . . 0.585 ' HB3' ' ND2' ' E' ' 68' ' ' ASN . . . -54.27 131.48 41.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.69 177.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 52.4 ttm -100.36 139.06 36.58 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.594 -173.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 8' ' ' PHE . . . . . 0.496 ' CE1' HD21 ' E' ' 44' ' ' LEU . 61.4 t80 -52.76 142.16 19.48 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.603 -177.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 9' ' ' TRP . . . . . 0.55 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 88.2 t90 -135.81 147.67 48.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.113 -0.948 . . . . 0.0 108.899 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . 0.518 ' HA3' ' CE1' ' E' ' 51' ' ' TYR . . . -148.74 153.76 25.41 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.083 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.663 HD23 HD13 ' D' ' 87' ' ' LEU . 52.1 tp -140.32 108.25 5.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.065 0.46 . . . . 0.0 110.85 178.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -81.32 101.68 9.93 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.473 173.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 13' ' ' MET . . . . . 0.601 ' HB3' HG23 ' D' ' 85' ' ' VAL . 30.5 tpp -95.57 131.31 41.91 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.181 -174.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -100.87 145.32 30.19 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.885 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . 0.595 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 12.3 Cg_endo -56.12 124.61 16.69 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 123.421 2.747 . . . . 0.0 113.413 -174.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . 0.556 ' HA ' ' O ' ' D' ' 79' ' ' THR . 25.2 mt-10 60.33 47.91 8.52 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.547 -0.752 . . . . 0.0 112.017 177.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -121.78 138.69 54.27 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.654 172.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . 0.714 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 84.6 mttt -111.39 119.1 37.71 Favored 'General case' 0 CA--C 1.517 -0.316 0 O-C-N 123.384 0.428 . . . . 0.0 111.472 178.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.61 103.84 12.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.794 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 7.5 p -88.38 98.84 11.83 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 174.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -117.44 144.79 44.65 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.537 0.684 . . . . 0.0 112.271 -169.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 17.4 m -94.08 143.1 26.67 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.56 177.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . 0.443 ' CG2' ' HA ' ' D' ' 71' ' ' LYS . 59.5 mt -92.86 120.55 42.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.167 0.508 . . . . 0.0 111.077 -174.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . 0.452 HD12 ' N ' ' D' ' 24' ' ' ILE . 4.0 mp -79.47 -52.9 14.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.294 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . 0.498 ' HE2' ' HB3' ' D' ' 91' ' ' LEU . 13.6 ptmt -131.03 137.56 49.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.053 175.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 11.7 m -54.49 141.71 30.06 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 124.01 0.818 . . . . 0.0 110.894 -176.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 27' ' ' PHE . . . . . 0.657 ' HB3' HD23 ' D' ' 91' ' ' LEU . 11.9 p90 -149.04 158.28 44.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.717 0.77 . . . . 0.0 112.767 -175.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 28' ' ' HIS . . . . . 0.598 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 9.2 t60 -111.44 127.35 55.66 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.739 178.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 29' ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 35.4 mt -96.7 138.11 22.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 170.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . 0.598 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 55.7 p -123.65 -20.35 5.53 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -171.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -153.79 156.38 26.76 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 119.305 -1.426 . . . . 0.0 113.635 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.489 HG23 ' HG ' ' D' ' 87' ' ' LEU . 14.8 p -146.63 124.23 3.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.11 155.74 44.07 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.91 -0.494 . . . . 0.0 111.791 -174.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 34' ' ' LEU . . . . . 0.576 ' HB3' HG12 ' D' ' 85' ' ' VAL . 3.7 pp -120.37 140.47 51.26 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.894 0.854 . . . . 0.0 111.781 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -105.07 -53.59 2.64 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.416 -1.266 . . . . 0.0 108.84 174.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -102.92 127.47 50.12 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 168.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . 0.488 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 151.18 155.92 7.16 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 119.859 -1.162 . . . . 0.0 113.688 177.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 38' ' ' GLN . . . . . 0.447 ' HA ' ' HB2' ' D' ' 58' ' ' LYS . 91.2 mt-30 -102.59 -44.2 5.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.662 0.268 . . . . 0.0 111.119 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -153.13 126.36 8.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.147 176.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . 0.559 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -124.48 113.15 17.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.535 0.683 . . . . 0.0 109.741 169.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' D' ' 79' ' ' THR . 19.9 mtpp -96.24 107.11 19.41 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 176.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 41.3 tp -81.52 114.83 20.5 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -173.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 43' ' ' TYR . . . . . 0.553 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 97.6 m-85 -120.55 139.4 52.99 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.505 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.2 OUTLIER -125.04 133.21 53.04 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 172.67 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 45' ' ' ALA . . . . . 0.635 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -112.03 113.16 25.28 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.131 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.512 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -124.49 137.69 54.4 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.419 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 59.74 30.89 20.48 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.504 0.503 . . . . 0.0 110.22 -174.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 48' ' ' LYS . . . . . 0.482 ' NZ ' ' HB2' ' D' ' 48' ' ' LYS . 0.1 OUTLIER 62.41 33.73 16.06 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.132 -177.104 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . 0.635 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 8.5 tp-100 -123.58 130.27 52.42 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.53 123.56 31.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.764 0.316 . . . . 0.0 110.784 -176.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . 0.521 ' CE1' ' HA3' ' C' ' 10' ' ' GLY . 84.6 m-85 -118.01 130.11 55.98 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 175.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 52' ' ' ILE . . . . . 0.4 HG22 ' HB3' ' C' ' 86' ' ' SER . 5.2 tp -80.15 103.78 7.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 171.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 53' ' ' VAL . . . . . 0.548 ' CG1' HD11 ' D' ' 67' ' ' LEU . 2.6 t -78.74 -49.52 20.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.662 -171.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 54' ' ' ALA . . . . . 0.459 ' HB1' HG11 ' D' ' 63' ' ' VAL . . . -158.3 146.61 18.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.9 -178.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 32.5 m -109.55 101.43 10.37 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 173.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 56' ' ' VAL . . . . . 0.451 HG11 HG11 ' D' ' 85' ' ' VAL . 7.4 p -115.6 116.2 51.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.564 0.697 . . . . 0.0 109.599 -177.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 46.2 p -122.38 -179.07 4.07 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.31 -172.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 58' ' ' LYS . . . . . 0.447 ' HB2' ' HA ' ' D' ' 38' ' ' GLN . 38.2 tttm -61.64 -27.39 68.63 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.82 172.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 59' ' ' ALA . . . . . 0.487 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -84.24 -40.69 17.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.652 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 86.1 mt -109.34 84.08 2.78 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 61' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 9.7 Cg_exo -71.04 0.09 7.14 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.038 2.492 . . . . 0.0 113.725 -168.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -162.76 131.64 4.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.132 0.492 . . . . 0.0 111.298 -176.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.459 HG11 ' HB1' ' D' ' 54' ' ' ALA . 69.2 t -120.43 132.71 69.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.107 172.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.49 113.13 25.52 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.197 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 65' ' ' LEU . . . . . 0.436 ' H ' HD13 ' D' ' 65' ' ' LEU . 0.0 OUTLIER -121.44 170.05 10.03 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.344 -176.508 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 66' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 7.3 t0 -118.42 98.84 6.47 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.284 0.564 . . . . 0.0 109.584 175.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.572 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 19.8 mt -113.0 143.46 44.27 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.929 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 68' ' ' ASN . . . . . 0.584 ' ND2' ' HB3' ' C' ' 6' ' ' ALA . 57.1 t30 -147.77 119.95 8.32 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.96 0.409 . . . . 0.0 109.961 174.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -114.98 153.55 30.41 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.24 -178.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 20.7 t -103.62 148.93 25.42 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.969 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 71' ' ' LYS . . . . . 0.492 ' NZ ' ' HB2' ' D' ' 71' ' ' LYS . 0.0 OUTLIER -74.91 10.02 1.63 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -174.614 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.51 -15.3 30.06 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.949 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -101.21 170.9 7.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.745 0.307 . . . . 0.0 110.876 -175.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 62.0 ttt-85 -138.43 122.65 18.12 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.512 HG22 ' HB2' ' D' ' 46' ' ' ALA . 14.3 pt -125.75 160.86 31.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.403 -170.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 76' ' ' MET . . . . . 0.486 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 2.9 mtm -115.24 128.98 56.5 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 174.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 77' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.6 OUTLIER -109.84 128.4 55.3 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.204 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 78' ' ' TYR . . . . . 0.714 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 51.6 p90 -155.79 157.46 36.51 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 120.231 -0.588 . . . . 0.0 112.232 -177.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 79' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 14.0 p -124.87 144.03 50.53 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.171 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.34 156.55 18.79 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.98 174.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.04 -166.83 31.29 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -176.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -123.67 102.74 8.0 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 117.797 0.799 . . . . 0.0 110.365 176.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . 0.595 ' H ' ' HB3' ' D' ' 15' ' ' PRO . . . -169.23 151.87 4.79 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.157 169.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 33.4 t -109.21 122.82 48.14 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.601 HG23 ' HB3' ' D' ' 13' ' ' MET . 6.8 m -119.75 147.11 23.6 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 CA-C-O 121.298 0.571 . . . . 0.0 111.814 -173.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 16.9 t -111.05 119.32 38.64 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 177.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 87' ' ' LEU . . . . . 0.663 HD13 HD23 ' D' ' 11' ' ' LEU . 5.2 mp -91.68 151.45 20.66 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 174.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.571 HD23 HD21 ' E' ' 67' ' ' LEU . 1.2 tp -133.07 140.26 47.6 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.287 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.24 -166.71 24.67 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.978 -177.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 90' ' ' TYR . . . . . 0.415 ' CD2' ' HB3' ' E' ' 68' ' ' ASN . 11.5 p90 -153.01 132.82 13.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.739 0.78 . . . . 0.0 111.814 176.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . 0.657 HD23 ' HB3' ' D' ' 27' ' ' PHE . 15.2 mt -67.61 139.78 56.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.096 177.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -72.91 113.46 9.96 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -174.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 93' ' ' ASP . . . . . 0.548 ' HB3' ' O ' ' D' ' 4' ' ' ALA . 3.2 m-20 -142.18 136.28 29.79 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.03 -0.987 . . . . 0.0 108.876 171.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 39.4 pt -77.87 144.93 10.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.156 0.503 . . . . 0.0 111.319 -175.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.43 -9.29 32.51 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.08 -177.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 19.9 m 65.02 -159.53 0.29 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.621 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.18 -61.28 3.99 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.757 -178.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 68.9 m . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.699 -0.667 . . . . 0.0 110.311 176.323 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -102.16 145.5 29.3 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 3' ' ' GLY . . . . . 0.409 ' HA2' ' SD ' ' E' ' 5' ' ' MET . . . 149.85 -171.85 29.83 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.815 -177.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 4' ' ' ALA . . . . . 0.562 ' O ' ' HB3' ' E' ' 93' ' ' ASP . . . 57.31 44.08 22.43 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 123.796 0.351 . . . . 0.0 110.816 -178.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 5' ' ' MET . . . . . 0.409 ' SD ' ' HA2' ' E' ' 3' ' ' GLY . 2.5 mpt? -70.15 172.61 7.77 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.982 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 6' ' ' ALA . . . . . 0.628 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . . . -54.27 131.43 41.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.727 177.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 52.4 ttm -100.24 139.06 36.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.567 -173.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 8' ' ' PHE . . . . . 0.495 ' CE1' HD21 ' A' ' 44' ' ' LEU . 61.2 t80 -52.8 142.17 19.59 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.548 -177.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 9' ' ' TRP . . . . . 0.535 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 88.3 t90 -135.73 147.68 48.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.838 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 10' ' ' GLY . . . . . 0.499 ' HA3' ' CE1' ' A' ' 51' ' ' TYR . . . -148.72 153.87 25.49 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.04 177.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . 0.671 HD23 HD13 ' E' ' 87' ' ' LEU . 52.7 tp -140.38 108.13 5.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.061 0.458 . . . . 0.0 110.919 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -81.15 101.56 9.73 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.553 173.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 13' ' ' MET . . . . . 0.597 ' HB3' HG23 ' E' ' 85' ' ' VAL . 30.6 tpp -95.49 131.19 41.92 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.109 0.48 . . . . 0.0 111.184 -174.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -100.78 145.38 30.27 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.97 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . 0.601 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 12.3 Cg_endo -56.2 124.65 16.78 Favored 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 123.365 2.71 . . . . 0.0 113.424 -174.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 16' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' E' ' 79' ' ' THR . 25.3 mt-10 60.37 47.82 8.5 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.016 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -121.66 138.71 54.22 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.652 172.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . 0.714 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 84.6 mttt -111.4 119.2 38.01 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.35 0.406 . . . . 0.0 111.414 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.72 103.84 12.43 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.853 176.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 20' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' E' ' 76' ' ' MET . 7.9 p -88.43 98.94 11.9 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 174.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -117.44 144.92 44.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.56 0.695 . . . . 0.0 112.266 -169.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 17.8 m -94.19 143.1 26.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.487 177.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 23' ' ' ILE . . . . . 0.447 ' CG2' ' HA ' ' E' ' 71' ' ' LYS . 59.4 mt -92.79 120.45 42.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.007 0.432 . . . . 0.0 111.17 -174.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . 0.438 HD12 ' N ' ' E' ' 24' ' ' ILE . 4.0 mp -79.42 -52.99 14.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.24 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . 0.495 ' HE2' ' HB3' ' E' ' 91' ' ' LEU . 13.5 ptmt -131.05 137.46 49.16 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.027 175.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 11.4 m -54.37 141.7 29.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.931 -176.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 27' ' ' PHE . . . . . 0.649 ' HB3' HD23 ' E' ' 91' ' ' LEU . 12.1 p90 -149.01 158.21 44.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.728 0.775 . . . . 0.0 112.762 -175.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 28' ' ' HIS . . . . . 0.601 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 9.3 t60 -111.39 127.37 55.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.842 178.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 29' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 35.6 mt -96.8 138.05 22.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 170.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . 0.601 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 55.7 p -123.58 -20.33 5.57 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -171.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -153.76 156.42 26.78 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 119.27 -1.443 . . . . 0.0 113.578 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.5 HG23 ' HG ' ' E' ' 87' ' ' LEU . 14.8 p -146.61 124.35 3.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 172.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.15 155.64 44.01 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.931 -0.481 . . . . 0.0 111.764 -174.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 34' ' ' LEU . . . . . 0.597 ' HB3' HG12 ' E' ' 85' ' ' VAL . 3.7 pp -120.33 140.47 51.23 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.914 0.864 . . . . 0.0 111.771 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -104.98 -53.74 2.61 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.378 -1.283 . . . . 0.0 108.826 174.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -102.82 127.38 50.01 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 169.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . 0.489 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 151.3 156.04 7.22 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 119.794 -1.193 . . . . 0.0 113.631 176.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 38' ' ' GLN . . . . . 0.444 ' HA ' ' HB2' ' E' ' 58' ' ' LYS . 91.1 mt-30 -102.61 -44.19 5.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.681 0.277 . . . . 0.0 111.127 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -153.16 126.39 8.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.095 176.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . 0.563 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -124.51 113.14 17.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.534 0.683 . . . . 0.0 109.771 169.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 41' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' E' ' 79' ' ' THR . 19.9 mtpp -96.11 107.02 19.29 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 41.2 tp -81.45 114.85 20.47 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -173.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 43' ' ' TYR . . . . . 0.546 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 97.5 m-85 -120.59 139.39 53.04 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 177.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 44' ' ' LEU . . . . . 0.512 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 0.2 OUTLIER -125.09 133.26 52.96 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 172.574 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' E' E ' 45' ' ' ALA . . . . . 0.634 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -111.98 113.15 25.29 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.118 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . 0.519 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -124.53 137.77 54.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.371 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 59.81 30.8 20.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.001 0.429 . . . . 0.0 110.204 -174.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 48' ' ' LYS . . . . . 0.479 ' HB2' ' NZ ' ' E' ' 48' ' ' LYS . 0.1 OUTLIER 62.54 33.63 15.8 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.171 -177.045 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' E' E ' 49' ' ' GLN . . . . . 0.634 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 8.4 tp-100 -123.6 130.39 52.59 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -86.63 123.65 32.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.817 0.341 . . . . 0.0 110.726 -176.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . 0.518 ' CE1' ' HA3' ' D' ' 10' ' ' GLY . 84.6 m-85 -118.09 130.08 55.93 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.866 175.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -80.11 103.82 7.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 171.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . 0.544 ' CG1' HD11 ' E' ' 67' ' ' LEU . 2.6 t -78.76 -49.41 20.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.664 -171.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 54' ' ' ALA . . . . . 0.455 ' HB1' HG11 ' E' ' 63' ' ' VAL . . . -158.41 146.59 18.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.834 -178.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 32.5 m -109.52 101.45 10.39 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 173.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . 0.466 HG11 HG11 ' E' ' 85' ' ' VAL . 7.4 p -115.56 116.15 51.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.501 0.667 . . . . 0.0 109.635 -177.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 46.7 p -122.29 -179.08 4.06 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.43 -172.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 58' ' ' LYS . . . . . 0.444 ' HB2' ' HA ' ' E' ' 38' ' ' GLN . 38.2 tttm -61.67 -27.3 68.58 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.872 172.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 59' ' ' ALA . . . . . 0.493 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -84.26 -40.68 17.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.673 178.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 85.9 mt -109.35 83.98 2.74 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 174.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 61' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 9.6 Cg_exo -70.96 0.16 6.98 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.033 2.489 . . . . 0.0 113.746 -168.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -162.88 131.59 4.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.088 0.471 . . . . 0.0 111.3 -176.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . 0.455 HG11 ' HB1' ' E' ' 54' ' ' ALA . 70.0 t -120.43 132.73 69.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.049 172.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -110.45 113.07 25.43 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.193 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.428 HD13 ' N ' ' E' ' 65' ' ' LEU . 0.0 OUTLIER -121.48 170.07 10.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.346 -176.51 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' E' E ' 66' ' ' ASP . . . . . 0.511 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 7.3 t0 -118.31 98.73 6.43 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.193 0.521 . . . . 0.0 109.641 175.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 67' ' ' LEU . . . . . 0.577 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 19.8 mt -112.99 143.42 44.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.879 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 68' ' ' ASN . . . . . 0.585 ' ND2' ' HB3' ' D' ' 6' ' ' ALA . 57.1 t30 -147.77 119.92 8.3 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.945 0.402 . . . . 0.0 109.99 174.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -114.91 153.53 30.34 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.262 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 21.0 t -103.63 148.95 25.4 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.979 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 71' ' ' LYS . . . . . 0.493 ' NZ ' ' HB2' ' E' ' 71' ' ' LYS . 0.0 OUTLIER -74.92 10.12 1.6 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -174.596 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.71 -15.19 29.87 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.823 175.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -101.24 170.87 7.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.825 0.345 . . . . 0.0 110.902 -175.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 62.0 ttt-85 -138.33 122.56 18.13 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 75' ' ' ILE . . . . . 0.519 HG22 ' HB2' ' E' ' 46' ' ' ALA . 14.5 pt -125.72 160.9 31.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 120.897 0.38 . . . . 0.0 111.399 -170.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 76' ' ' MET . . . . . 0.481 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 2.9 mtm -115.3 129.0 56.49 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 77' ' ' PHE . . . . . 0.512 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.6 OUTLIER -109.82 128.44 55.32 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 177.207 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' E' E ' 78' ' ' TYR . . . . . 0.714 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 51.3 p90 -155.88 157.43 36.35 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.146 -0.622 . . . . 0.0 112.185 -177.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 79' ' ' THR . . . . . 0.552 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 14.6 p -124.77 143.94 50.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.238 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.31 156.57 18.75 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.985 174.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.99 -166.86 31.36 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -176.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -123.67 102.68 7.96 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 117.734 0.767 . . . . 0.0 110.5 176.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 83' ' ' ALA . . . . . 0.601 ' H ' ' HB3' ' E' ' 15' ' ' PRO . . . -169.25 151.8 4.75 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.16 169.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 33.4 t -109.15 122.8 48.07 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 85' ' ' VAL . . . . . 0.597 HG23 ' HB3' ' E' ' 13' ' ' MET . 6.8 m -119.68 147.16 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-O 121.274 0.559 . . . . 0.0 111.888 -173.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 17.1 t -111.12 119.28 38.44 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 87' ' ' LEU . . . . . 0.671 HD13 HD23 ' E' ' 11' ' ' LEU . 5.2 mp -91.64 151.52 20.65 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 174.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . 0.613 HD23 HD21 ' A' ' 67' ' ' LEU . 1.2 tp -133.13 140.26 47.53 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.304 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.23 -166.74 24.7 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.936 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 90' ' ' TYR . . . . . 0.451 ' CD2' ' HB3' ' A' ' 68' ' ' ASN . 11.4 p90 -153.04 132.8 13.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.787 0.804 . . . . 0.0 111.796 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 91' ' ' LEU . . . . . 0.649 HD23 ' HB3' ' E' ' 27' ' ' PHE . 15.1 mt -67.51 139.77 57.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.109 177.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -72.9 113.52 10.03 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -174.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 93' ' ' ASP . . . . . 0.562 ' HB3' ' O ' ' E' ' 4' ' ' ALA . 3.3 m-20 -142.25 136.29 29.67 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.785 171.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 39.4 pt -77.87 145.05 10.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.158 0.504 . . . . 0.0 111.374 -175.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -66.5 -9.32 33.44 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.069 -177.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 19.9 m 65.04 -159.59 0.29 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.629 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.17 -61.13 4.01 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.706 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 68.9 m . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.762 -0.637 . . . . 0.0 110.229 176.299 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.404 ' HB3' ' HA ' ' A' ' 98' ' ' SER . 96.5 m-85 . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.523 ' OE1' ' HB3' ' A' ' 95' ' ' ASP . 8.2 tt0 65.8 105.28 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.918 0.761 . . . . 0.0 112.019 177.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.3 -1.05 61.04 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.506 175.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.58 56.74 2.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.272 0.558 . . . . 0.0 111.276 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 66.4 mtt -97.78 -69.44 0.76 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.844 177.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.73 111.1 21.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.714 177.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.89 154.68 18.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.962 178.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.512 ' CE1' HD21 ' B' ' 44' ' ' LEU . 70.1 t80 -67.95 142.93 55.85 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.079 0.466 . . . . 0.0 112.124 -177.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.57 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 88.2 t90 -134.93 148.1 49.96 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.19 177.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.75 153.08 24.71 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.482 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.57 ' HB2' ' CH2' ' A' ' 9' ' ' TRP . 41.7 tp -144.18 109.94 5.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.81 0.338 . . . . 0.0 110.35 177.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -96.55 96.78 8.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.847 0.356 . . . . 0.0 110.078 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.621 ' SD ' HD11 ' A' ' 87' ' ' LEU . 62.6 mtp -92.98 144.1 25.59 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.941 -173.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -101.17 166.97 11.43 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.163 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.448 ' HB3' ' HA ' ' A' ' 82' ' ' ASP . 87.2 Cg_exo -49.84 115.69 1.98 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.737 2.292 . . . . 0.0 112.799 176.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 79' ' ' THR . 29.1 mt-10 63.31 39.5 9.44 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.29 0.566 . . . . 0.0 111.328 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 78' ' ' TYR . 0.5 OUTLIER -88.12 133.47 33.99 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.038 175.42 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.592 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 33.9 ttmt -123.31 116.09 22.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.122 0.487 . . . . 0.0 111.074 -178.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.471 ' CZ ' ' HG2' ' A' ' 17' ' ' ARG . 18.3 m-85 -107.11 102.59 11.92 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.591 178.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.0 p -90.11 97.2 11.05 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 169.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -117.09 145.46 43.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.508 0.67 . . . . 0.0 112.48 -165.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.7 m -97.62 132.93 42.82 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.011 174.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.43 ' CD1' ' HB3' ' A' ' 69' ' ' PHE . 70.3 mt -87.77 118.08 32.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-O 121.127 0.489 . . . . 0.0 110.987 -173.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.679 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -90.09 -18.05 7.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.057 -179.476 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 93' ' ' ASP . 83.4 tttt -155.12 129.2 8.82 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.101 -175.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.7 p -58.63 127.41 32.05 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.411 0.445 . . . . 0.0 110.652 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.746 ' HB3' HD23 ' A' ' 91' ' ' LEU . 10.4 p90 -143.68 166.34 25.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.693 0.758 . . . . 0.0 112.748 -174.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.564 ' HE2' ' HB3' ' A' ' 30' ' ' SER . 4.8 t60 -121.8 127.4 50.55 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.421 178.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.618 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 47.3 mt -94.55 135.22 29.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.564 ' HB3' ' HE2' ' A' ' 28' ' ' HIS . 56.0 p -119.85 -13.51 9.06 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -169.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -164.09 141.54 7.17 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 119.452 -1.356 . . . . 0.0 113.403 177.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.439 HG23 ' HG ' ' A' ' 87' ' ' LEU . 11.9 p -126.93 120.65 56.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 169.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.409 ' HA ' HG21 ' A' ' 56' ' ' VAL . . . -141.14 157.25 45.54 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 121.947 -0.471 . . . . 0.0 111.65 -174.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.629 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.6 pp -127.14 145.51 50.72 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.769 0.795 . . . . 0.0 111.237 178.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -110.21 -47.06 3.35 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.29 173.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -102.68 128.16 49.5 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.312 173.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.533 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 141.54 161.37 8.69 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 119.451 -1.357 . . . . 0.0 113.857 176.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -102.72 -43.98 5.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.681 0.276 . . . . 0.0 110.971 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -151.78 125.68 9.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.17 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -127.79 113.04 15.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.46 0.647 . . . . 0.0 109.699 168.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 79' ' ' THR . 56.0 mtpt -99.54 106.13 18.1 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 178.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.2 tp -79.11 108.77 12.84 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.819 -173.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -107.86 141.02 40.09 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.295 176.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.558 ' CD1' ' HB ' ' A' ' 75' ' ' ILE . 4.4 tp -124.48 116.38 22.42 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.082 176.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -101.78 104.21 14.98 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 174.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.488 ' HB2' HG22 ' A' ' 75' ' ' ILE . . . -127.08 136.44 52.17 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.4 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 56.38 35.99 26.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.371 0.605 . . . . 0.0 110.247 -175.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 61.36 39.7 15.01 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.123 178.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.553 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 8.5 tp-100 -134.63 128.09 32.45 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 175.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -85.28 105.72 16.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.937 0.398 . . . . 0.0 110.399 -178.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -100.13 131.29 46.16 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.461 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 tp -79.8 108.74 13.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 168.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.529 HG13 ' CD2' ' E' ' 88' ' ' LEU . 2.3 t -82.52 -51.32 14.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.578 -172.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.496 ' HB1' HG11 ' A' ' 63' ' ' VAL . . . -156.3 145.61 20.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.067 -178.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.6 m -109.21 101.77 10.77 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 173.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.476 HG13 ' HB3' ' A' ' 40' ' ' ALA . 7.4 p -115.5 114.93 47.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.534 0.683 . . . . 0.0 109.765 -177.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.5 p -122.93 -178.26 3.9 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.415 -174.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -63.92 -22.43 66.92 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.028 0.442 . . . . 0.0 110.271 171.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.439 ' O ' ' HD3' ' A' ' 61' ' ' PRO . . . -83.95 -40.5 18.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.278 177.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.9 mt -112.38 81.63 4.13 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 173.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 59' ' ' ALA . 12.2 Cg_exo -70.19 0.15 6.4 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.219 2.613 . . . . 0.0 113.972 -166.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -163.83 129.59 3.04 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.161 0.505 . . . . 0.0 111.464 -175.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.496 HG11 ' HB1' ' A' ' 54' ' ' ALA . 66.0 t -119.01 99.94 8.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.24 173.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.21 117.12 21.47 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 173.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.448 HD23 ' H ' ' A' ' 65' ' ' LEU . 0.9 OUTLIER -139.17 168.1 20.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.933 0.397 . . . . 0.0 110.994 -171.055 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.524 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 11.9 t0 -112.45 104.58 12.71 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.341 0.591 . . . . 0.0 110.077 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.667 HD21 HD23 ' E' ' 88' ' ' LEU . 11.1 mt -117.31 141.11 48.71 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.039 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -142.04 132.38 25.02 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.804 0.335 . . . . 0.0 110.7 174.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.477 ' CZ ' HD22 ' A' ' 67' ' ' LEU . 58.7 m-85 -129.92 160.56 33.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.009 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.4 t -120.08 158.78 26.14 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -79.44 9.09 5.16 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.865 0.364 . . . . 0.0 111.104 -175.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.21 -29.38 9.0 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 174.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -100.38 165.88 11.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.016 0.436 . . . . 0.0 110.737 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -135.76 143.46 45.29 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.558 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 25.0 pt -135.71 159.22 39.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.145 0.497 . . . . 0.0 112.27 -168.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.458 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 10.9 mtp -115.0 117.5 30.76 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.703 173.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.51 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -104.23 126.95 51.76 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.127 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.592 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 23.2 p90 -152.2 134.67 15.28 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.935 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 2.4 p -107.83 120.05 41.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.332 -177.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.27 160.95 15.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.672 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.47 -170.51 31.24 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -177.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.448 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 18.9 t70 -116.9 103.47 10.33 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 117.868 0.834 . . . . 0.0 109.983 176.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.533 ' CB ' ' HA3' ' A' ' 37' ' ' GLY . . . -173.31 158.69 3.62 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.736 172.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.4 t -117.74 122.44 43.47 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.629 HG12 ' HB3' ' A' ' 34' ' ' LEU . 4.9 m -115.84 156.07 17.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.529 0.68 . . . . 0.0 112.408 -172.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -119.07 117.19 28.07 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.038 173.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.621 HD11 ' SD ' ' A' ' 13' ' ' MET . 5.1 mp -91.68 147.05 23.28 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 171.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.692 HD23 HD21 ' B' ' 67' ' ' LEU . 0.7 OUTLIER -130.75 142.53 50.41 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.756 179.585 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.89 -167.97 27.34 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.106 -178.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -145.44 130.29 18.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.742 0.782 . . . . 0.0 112.132 178.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.746 HD23 ' HB3' ' A' ' 27' ' ' PHE . 18.2 mt -71.68 113.55 8.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.328 -1.305 . . . . 0.0 109.46 173.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -100.97 117.52 35.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.095 0.474 . . . . 0.0 110.74 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.403 ' HB2' ' HE3' ' A' ' 25' ' ' LYS . 26.6 t70 -98.44 -53.99 3.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.692 176.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 60.2 mt 64.65 88.5 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.264 177.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.523 ' HB3' ' OE1' ' A' ' 2' ' ' GLN . 30.0 t70 -127.02 134.47 50.32 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.829 178.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.2 m -96.6 27.45 3.86 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.944 0.402 . . . . 0.0 111.01 -177.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -80.05 78.86 1.76 Allowed Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.984 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.404 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 10.8 p . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.582 -0.723 . . . . 0.0 110.354 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.408 ' HB3' ' HA ' ' B' ' 98' ' ' SER . 96.2 m-85 . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . 0.521 ' OE1' ' HB3' ' B' ' 95' ' ' ASP . 8.2 tt0 65.9 105.22 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 O-C-N 123.947 0.779 . . . . 0.0 112.063 177.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.32 -1.09 60.99 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.418 175.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.47 56.77 2.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.288 0.566 . . . . 0.0 111.311 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 66.4 mtt -97.81 -69.42 0.76 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.852 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.74 111.15 21.73 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.733 177.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.93 154.75 18.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.941 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.517 ' CE1' HD21 ' C' ' 44' ' ' LEU . 69.8 t80 -68.08 143.0 55.65 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.036 0.446 . . . . 0.0 112.043 -177.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . 0.563 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 88.1 t90 -134.97 148.01 49.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.112 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.67 153.09 24.73 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.461 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.563 ' HB2' ' CH2' ' B' ' 9' ' ' TRP . 41.6 tp -144.13 109.9 5.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.764 0.316 . . . . 0.0 110.457 177.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -96.56 96.83 8.93 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . 0.631 ' SD ' HD11 ' B' ' 87' ' ' LEU . 62.4 mtp -93.0 144.14 25.55 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.015 -173.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -101.28 167.01 11.32 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.162 177.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.432 ' HB3' ' HA ' ' B' ' 82' ' ' ASP . 86.5 Cg_exo -49.84 115.68 1.97 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.785 2.324 . . . . 0.0 112.723 176.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' B' ' 79' ' ' THR . 29.0 mt-10 63.27 39.65 9.39 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.285 0.564 . . . . 0.0 111.254 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' B' ' 78' ' ' TYR . 0.5 OUTLIER -88.16 133.5 34.0 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.342 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.589 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 33.8 ttmt -123.34 116.12 22.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.167 0.508 . . . . 0.0 111.086 -178.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' TYR . . . . . 0.458 ' CZ ' ' HG2' ' B' ' 17' ' ' ARG . 18.6 m-85 -107.09 102.54 11.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.565 178.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 10.9 p -90.03 97.21 11.06 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 169.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.13 145.54 43.75 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.489 0.661 . . . . 0.0 112.457 -165.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 21.4 m -97.77 132.86 43.01 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.949 174.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.431 ' CD1' ' HB3' ' B' ' 69' ' ' PHE . 70.0 mt -87.73 117.99 32.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.12 0.486 . . . . 0.0 111.074 -173.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.683 ' H ' HD13 ' B' ' 24' ' ' ILE . 0.2 OUTLIER -90.04 -18.02 7.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.069 -179.426 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.413 ' HE3' ' HB2' ' B' ' 93' ' ' ASP . 83.4 tttt -155.18 129.14 8.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.097 -175.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 6.9 p -58.55 127.38 31.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.683 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . 0.748 ' HB3' HD23 ' B' ' 91' ' ' LEU . 10.2 p90 -143.66 166.37 25.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.691 0.758 . . . . 0.0 112.687 -174.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' HIS . . . . . 0.573 ' HE2' ' HB3' ' B' ' 30' ' ' SER . 4.8 t60 -121.87 127.44 50.49 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.256 -1.338 . . . . 0.0 109.353 178.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.611 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 47.2 mt -94.59 135.3 29.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 171.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.573 ' HB3' ' HE2' ' B' ' 28' ' ' HIS . 55.9 p -119.82 -13.65 9.06 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -169.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -164.07 141.5 7.15 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 119.373 -1.394 . . . . 0.0 113.385 177.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.437 HG23 ' HG ' ' B' ' 87' ' ' LEU . 11.8 p -126.91 120.72 56.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 169.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . 0.406 ' HA ' HG21 ' B' ' 56' ' ' VAL . . . -141.19 157.19 45.6 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.605 -173.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.634 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.6 pp -127.1 145.62 50.67 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.696 0.76 . . . . 0.0 111.279 178.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -110.27 -46.94 3.36 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.27 173.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -102.68 128.15 49.5 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.257 173.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.527 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 141.51 161.3 8.66 Favored Glycine 0 N--CA 1.438 -1.189 0 C-N-CA 119.488 -1.339 . . . . 0.0 113.886 176.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -102.64 -44.09 5.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.62 -0.29 . . . . 0.0 110.929 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -151.73 125.71 9.16 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.201 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.499 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -127.79 113.14 15.58 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.44 0.638 . . . . 0.0 109.632 168.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' B' ' 79' ' ' THR . 56.0 mtpt -99.66 106.11 18.02 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 46.6 tp -79.22 108.83 13.02 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.753 -173.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -107.85 140.93 40.21 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.293 176.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.558 ' CD1' ' HB ' ' B' ' 75' ' ' ILE . 4.4 tp -124.4 116.44 22.57 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.115 176.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -101.83 104.25 15.0 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 174.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.49 ' HB2' HG22 ' B' ' 75' ' ' ILE . . . -127.12 136.45 52.14 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.351 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 56.37 35.99 26.78 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 123.592 0.557 . . . . 0.0 110.175 -175.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 61.47 39.53 14.88 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 114.816 -1.083 . . . . 0.0 112.165 178.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.549 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 8.6 tp-100 -134.58 128.03 32.41 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 175.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -85.2 105.65 16.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.902 0.382 . . . . 0.0 110.429 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -100.07 131.23 46.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.46 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 tp -79.67 108.72 13.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 168.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.528 HG13 ' CD2' ' A' ' 88' ' ' LEU . 2.3 t -82.59 -51.22 15.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.576 -172.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.474 ' HB1' HG11 ' B' ' 63' ' ' VAL . . . -156.33 145.57 20.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.079 -178.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 32.2 m -109.18 101.78 10.79 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 173.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.47 HG13 ' HB3' ' B' ' 40' ' ' ALA . 7.4 p -115.53 114.88 47.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.495 0.664 . . . . 0.0 109.744 -177.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 64.1 p -122.87 -178.31 3.91 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.428 -174.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -63.83 -22.52 66.95 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.047 0.451 . . . . 0.0 110.244 171.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.43 ' O ' ' HD3' ' B' ' 61' ' ' PRO . . . -83.89 -40.51 18.51 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.194 0.521 . . . . 0.0 110.235 177.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.4 81.56 4.11 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 173.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' B' ' 59' ' ' ALA . 12.1 Cg_exo -70.16 0.15 6.38 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.126 2.55 . . . . 0.0 113.954 -166.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -163.78 129.6 3.06 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.163 0.506 . . . . 0.0 111.378 -175.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.474 HG11 ' HB1' ' B' ' 54' ' ' ALA . 66.6 t -119.06 99.93 8.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.24 173.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.15 117.15 21.46 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 173.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.444 ' H ' HD23 ' B' ' 65' ' ' LEU . 0.9 OUTLIER -139.05 168.15 20.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.95 0.405 . . . . 0.0 111.065 -171.186 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 12.1 t0 -112.4 104.52 12.66 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.262 0.553 . . . . 0.0 110.122 -178.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.692 HD21 HD23 ' A' ' 88' ' ' LEU . 11.0 mt -117.28 141.14 48.67 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.019 178.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.04 132.49 25.18 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.66 174.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . 0.484 ' CZ ' HD22 ' B' ' 67' ' ' LEU . 58.7 m-85 -130.02 160.55 33.33 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.985 178.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 18.5 t -120.18 158.78 26.23 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -79.4 9.11 5.11 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.966 0.412 . . . . 0.0 111.094 -175.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.32 -29.25 9.04 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 174.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -100.51 165.75 11.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.108 0.48 . . . . 0.0 110.698 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -135.68 143.36 45.39 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.233 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.558 ' HB ' ' CD1' ' B' ' 44' ' ' LEU . 25.0 pt -135.58 159.24 40.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.171 0.51 . . . . 0.0 112.216 -168.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.451 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 10.9 mtp -114.94 117.5 30.82 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.632 173.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . 0.507 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -104.25 126.97 51.8 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 175.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.589 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 23.2 p90 -152.21 134.65 15.25 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.311 -0.555 . . . . 0.0 111.999 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 2.5 p -107.79 120.04 41.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.345 -177.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.27 161.03 15.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.636 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.46 -170.68 31.41 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -177.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' ASP . . . . . 0.432 ' HA ' ' HB3' ' B' ' 15' ' ' PRO . 19.0 t70 -116.87 103.56 10.43 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.917 176.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.527 ' CB ' ' HA3' ' B' ' 37' ' ' GLY . . . -173.37 158.73 3.59 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.815 172.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 25.8 t -117.82 122.33 43.11 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.634 HG12 ' HB3' ' B' ' 34' ' ' LEU . 4.9 m -115.83 156.06 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-O 121.529 0.681 . . . . 0.0 112.445 -172.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 50.1 m -119.07 117.32 28.42 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.008 173.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.631 HD11 ' SD ' ' B' ' 13' ' ' MET . 5.1 mp -91.73 147.0 23.31 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 171.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.663 HD23 HD21 ' C' ' 67' ' ' LEU . 0.7 OUTLIER -130.84 142.51 50.39 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.959 -1.018 . . . . 0.0 108.748 179.582 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.9 -167.96 27.34 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.036 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -145.45 130.23 18.13 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.775 0.797 . . . . 0.0 112.056 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . 0.748 HD23 ' HB3' ' B' ' 27' ' ' PHE . 18.1 mt -71.6 113.48 8.68 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.255 -1.339 . . . . 0.0 109.396 173.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -100.96 117.48 35.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.122 0.487 . . . . 0.0 110.794 -178.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . 0.413 ' HB2' ' HE3' ' B' ' 25' ' ' LYS . 26.3 t70 -98.36 -53.95 3.19 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.753 176.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 59.7 mt 64.58 88.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.314 177.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . 0.521 ' HB3' ' OE1' ' B' ' 2' ' ' GLN . 29.9 t70 -126.89 134.63 50.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.777 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 18.9 m -96.68 27.49 3.88 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.073 0.463 . . . . 0.0 111.041 -177.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . -80.22 78.97 1.77 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.04 178.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 98' ' ' SER . . . . . 0.408 ' HA ' ' HB3' ' B' ' 1' ' ' PHE . 10.7 p . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.444 -0.789 . . . . 0.0 110.357 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 1' ' ' PHE . . . . . 0.402 ' HB3' ' HA ' ' C' ' 98' ' ' SER . 96.3 m-85 . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . 0.522 ' OE1' ' HB3' ' C' ' 95' ' ' ASP . 8.2 tt0 65.57 105.38 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.985 0.803 . . . . 0.0 112.086 177.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.36 -1.12 60.9 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.431 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.45 56.78 2.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.273 0.559 . . . . 0.0 111.287 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 66.5 mtt -97.92 -69.36 0.76 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.804 177.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.76 111.05 21.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.772 177.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.9 154.64 18.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.967 178.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 8' ' ' PHE . . . . . 0.516 ' CE1' HD21 ' D' ' 44' ' ' LEU . 70.0 t80 -67.88 142.95 55.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.039 0.447 . . . . 0.0 112.068 -177.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . 0.568 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 88.2 t90 -135.07 148.09 49.77 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.71 153.05 24.7 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.415 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.568 ' HB2' ' CH2' ' C' ' 9' ' ' TRP . 41.6 tp -144.13 109.95 5.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.773 0.32 . . . . 0.0 110.429 177.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -96.55 96.84 8.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.92 0.391 . . . . 0.0 110.11 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 13' ' ' MET . . . . . 0.628 ' SD ' HD11 ' C' ' 87' ' ' LEU . 62.7 mtp -93.05 144.11 25.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.001 -173.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -101.2 167.01 11.35 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.154 177.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . 0.449 ' HB3' ' HA ' ' C' ' 82' ' ' ASP . 88.0 Cg_exo -49.8 115.68 1.96 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.731 2.288 . . . . 0.0 112.818 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' C' ' 79' ' ' THR . 29.1 mt-10 63.19 39.66 9.55 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.432 0.634 . . . . 0.0 111.36 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 17' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' C' ' 78' ' ' TYR . 0.5 OUTLIER -88.15 133.41 34.02 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.431 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 18' ' ' LYS . . . . . 0.592 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 33.9 ttmt -123.21 116.13 22.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.047 0.451 . . . . 0.0 111.109 -178.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . 0.461 ' CZ ' ' HG2' ' C' ' 17' ' ' ARG . 18.8 m-85 -107.2 102.61 11.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.536 178.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 10.9 p -90.04 97.14 11.02 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 169.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.08 145.51 43.71 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.535 0.683 . . . . 0.0 112.55 -165.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 21.7 m -97.65 132.95 42.83 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.691 -1.141 . . . . 0.0 108.964 174.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . 0.432 ' CD1' ' HB3' ' C' ' 69' ' ' PHE . 70.4 mt -87.85 118.15 33.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.206 0.527 . . . . 0.0 110.995 -173.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . 0.684 ' H ' HD13 ' C' ' 24' ' ' ILE . 0.2 OUTLIER -90.14 -17.99 7.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.092 -179.456 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' C' ' 93' ' ' ASP . 83.4 tttt -155.15 129.22 8.81 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.103 -175.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 6.6 p -58.62 127.47 32.32 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.696 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 27' ' ' PHE . . . . . 0.741 ' HB3' HD23 ' C' ' 91' ' ' LEU . 10.2 p90 -143.64 166.42 24.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.633 0.73 . . . . 0.0 112.774 -174.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 28' ' ' HIS . . . . . 0.577 ' HE2' ' HB3' ' C' ' 30' ' ' SER . 4.8 t60 -121.94 127.47 50.42 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.291 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . 0.627 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 47.6 mt -94.57 135.3 29.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 171.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.577 ' HB3' ' HE2' ' C' ' 28' ' ' HIS . 55.8 p -119.87 -13.53 9.05 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -169.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -164.09 141.46 7.12 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 119.372 -1.394 . . . . 0.0 113.329 177.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.439 HG23 ' HG ' ' C' ' 87' ' ' LEU . 11.8 p -126.95 120.69 56.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 169.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.41 ' HA ' HG21 ' C' ' 56' ' ' VAL . . . -141.16 157.23 45.56 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.886 -0.509 . . . . 0.0 111.647 -173.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.627 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.6 pp -127.14 145.52 50.72 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.656 0.741 . . . . 0.0 111.284 178.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -110.32 -46.89 3.36 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.251 173.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -102.62 128.12 49.44 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.259 173.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 37' ' ' GLY . . . . . 0.529 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 141.64 161.36 8.7 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 119.446 -1.359 . . . . 0.0 113.888 176.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -102.71 -44.1 5.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.753 0.311 . . . . 0.0 110.973 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -151.73 125.71 9.16 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.119 -177.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.492 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -127.77 113.02 15.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.376 0.608 . . . . 0.0 109.655 168.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' C' ' 79' ' ' THR . 56.0 mtpt -99.56 106.11 18.06 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.4 HD23 ' HB ' ' C' ' 53' ' ' VAL . 46.5 tp -79.18 108.8 12.95 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.803 -173.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -107.83 141.0 40.08 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.339 176.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.551 ' CD1' ' HB ' ' C' ' 75' ' ' ILE . 4.4 tp -124.46 116.4 22.45 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.098 176.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . 0.546 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -101.77 104.22 15.0 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 174.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.478 ' HB2' HG22 ' C' ' 75' ' ' ILE . . . -127.08 136.42 52.14 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.367 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 56.31 36.01 26.78 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.642 0.589 . . . . 0.0 110.215 -175.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 61.5 39.59 14.71 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.087 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . 0.546 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 8.5 tp-100 -134.67 127.94 32.06 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 175.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -85.15 105.74 16.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.854 0.359 . . . . 0.0 110.444 -178.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -100.18 131.26 46.23 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.436 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 tp -79.78 108.74 13.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 168.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 53' ' ' VAL . . . . . 0.533 HG13 ' CD2' ' B' ' 88' ' ' LEU . 2.3 t -82.5 -51.25 15.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.642 -172.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 54' ' ' ALA . . . . . 0.49 ' HB1' HG11 ' C' ' 63' ' ' VAL . . . -156.29 145.58 20.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.006 -178.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 31.9 m -109.28 101.82 10.79 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 173.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . 0.471 HG13 ' HB3' ' C' ' 40' ' ' ALA . 7.4 p -115.57 114.91 47.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.533 0.682 . . . . 0.0 109.695 -177.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 64.2 p -123.03 -178.33 3.93 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.337 -174.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -63.83 -22.51 66.95 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.112 0.482 . . . . 0.0 110.227 171.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . 0.44 ' O ' ' HD3' ' C' ' 61' ' ' PRO . . . -83.87 -40.56 18.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.237 177.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 78.0 mt -112.34 81.57 4.05 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 173.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 61' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' C' ' 59' ' ' ALA . 12.1 Cg_exo -70.07 -0.0 6.53 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.142 2.562 . . . . 0.0 114.025 -166.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -163.73 129.62 3.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.185 0.517 . . . . 0.0 111.52 -175.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.49 HG11 ' HB1' ' C' ' 54' ' ' ALA . 66.1 t -119.07 100.01 8.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.219 173.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.22 117.01 21.39 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 173.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . 0.442 HD23 ' H ' ' C' ' 65' ' ' LEU . 0.9 OUTLIER -139.01 168.09 20.6 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.952 0.406 . . . . 0.0 111.087 -171.137 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 66' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 12.1 t0 -112.39 104.6 12.75 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.315 0.579 . . . . 0.0 110.132 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.663 HD21 HD23 ' B' ' 88' ' ' LEU . 11.1 mt -117.3 141.22 48.57 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.048 178.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -142.11 132.47 25.04 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.641 174.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 69' ' ' PHE . . . . . 0.476 ' CZ ' HD22 ' C' ' 67' ' ' LEU . 59.1 m-85 -130.03 160.61 33.16 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.932 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 18.3 t -120.12 158.8 26.13 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -79.45 9.08 5.19 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.979 0.419 . . . . 0.0 111.083 -175.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.26 -29.23 9.08 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 174.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -100.5 165.8 11.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.966 0.413 . . . . 0.0 110.784 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -135.71 143.49 45.41 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.551 ' HB ' ' CD1' ' C' ' 44' ' ' LEU . 24.9 pt -135.67 159.14 39.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.12 0.486 . . . . 0.0 112.305 -168.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.462 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 10.8 mtp -114.88 117.51 30.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.764 173.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 77' ' ' PHE . . . . . 0.504 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.6 OUTLIER -104.16 126.89 51.64 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 176.104 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 78' ' ' TYR . . . . . 0.592 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 23.4 p90 -152.19 134.63 15.25 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.969 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 2.4 p -107.8 120.01 41.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.352 -177.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.24 160.92 15.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.613 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.6 -170.54 31.08 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 82' ' ' ASP . . . . . 0.449 ' HA ' ' HB3' ' C' ' 15' ' ' PRO . 19.0 t70 -116.91 103.49 10.34 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.955 176.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . 0.529 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -173.31 158.79 3.64 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.794 172.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 25.6 t -117.88 122.38 43.18 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.627 HG12 ' HB3' ' C' ' 34' ' ' LEU . 5.0 m -115.74 156.1 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-O 121.453 0.644 . . . . 0.0 112.464 -172.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 50.3 m -119.08 117.31 28.38 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.045 173.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . 0.628 HD11 ' SD ' ' C' ' 13' ' ' MET . 5.1 mp -91.76 146.97 23.34 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 171.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . 0.675 HD23 HD21 ' D' ' 67' ' ' LEU . 0.7 OUTLIER -130.74 142.47 50.41 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.796 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.89 -168.0 27.39 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.082 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -145.4 130.24 18.18 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.741 0.781 . . . . 0.0 112.158 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . 0.741 HD23 ' HB3' ' C' ' 27' ' ' PHE . 18.1 mt -71.63 113.61 8.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.321 -1.308 . . . . 0.0 109.415 173.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -101.05 117.48 35.11 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.203 0.525 . . . . 0.0 110.731 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 93' ' ' ASP . . . . . 0.415 ' HB2' ' HE3' ' C' ' 25' ' ' LYS . 26.5 t70 -98.38 -54.01 3.17 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.691 176.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 59.7 mt 64.62 88.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.297 177.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 95' ' ' ASP . . . . . 0.522 ' HB3' ' OE1' ' C' ' 2' ' ' GLN . 30.0 t70 -126.95 134.58 50.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.739 178.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 18.7 m -96.73 27.45 3.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.037 0.446 . . . . 0.0 110.996 -177.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -80.14 78.97 1.76 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.962 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 98' ' ' SER . . . . . 0.402 ' HA ' ' HB3' ' C' ' 1' ' ' PHE . 10.9 p . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.524 -0.75 . . . . 0.0 110.313 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . 0.415 ' HB3' ' HA ' ' D' ' 98' ' ' SER . 96.6 m-85 . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . 0.507 ' OE1' ' HB3' ' D' ' 95' ' ' ASP . 8.2 tt0 65.65 105.39 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 O-C-N 123.886 0.741 . . . . 0.0 111.996 177.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.43 -0.95 60.86 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.492 175.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.62 56.74 2.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.314 0.578 . . . . 0.0 111.3 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 66.4 mtt -97.69 -69.42 0.76 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.864 177.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.77 111.19 21.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.671 177.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.09 154.65 18.25 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.837 178.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 8' ' ' PHE . . . . . 0.522 ' CE1' HD21 ' E' ' 44' ' ' LEU . 70.4 t80 -67.93 142.96 55.86 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.17 0.509 . . . . 0.0 112.063 -177.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 9' ' ' TRP . . . . . 0.567 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 88.2 t90 -135.03 147.97 49.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.133 177.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.6 153.2 24.8 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.455 179.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.567 ' HB2' ' CH2' ' D' ' 9' ' ' TRP . 41.7 tp -144.19 109.95 5.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.751 0.31 . . . . 0.0 110.392 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -96.55 96.74 8.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.921 0.391 . . . . 0.0 110.102 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 13' ' ' MET . . . . . 0.627 ' SD ' HD11 ' D' ' 87' ' ' LEU . 62.7 mtp -93.05 144.24 25.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.961 -173.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -101.24 167.0 11.35 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.174 177.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . 0.434 ' HB3' ' HA ' ' D' ' 82' ' ' ASP . 86.9 Cg_exo -49.86 115.61 1.93 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.8 2.334 . . . . 0.0 112.74 176.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' D' ' 79' ' ' THR . 29.1 mt-10 63.37 39.53 9.26 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.326 0.584 . . . . 0.0 111.299 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 17' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' D' ' 78' ' ' TYR . 0.5 OUTLIER -88.04 133.44 33.97 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.383 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . 0.606 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 33.9 ttmt -123.26 116.13 22.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.199 0.524 . . . . 0.0 111.077 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 19' ' ' TYR . . . . . 0.47 ' CZ ' ' HG2' ' D' ' 17' ' ' ARG . 18.8 m-85 -107.11 102.46 11.79 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.595 178.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 11.0 p -89.97 97.18 11.04 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 169.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.07 145.5 43.7 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.556 0.693 . . . . 0.0 112.483 -165.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 21.5 m -97.71 132.83 42.98 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.99 174.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . 0.431 ' CD1' ' HB3' ' D' ' 69' ' ' PHE . 70.3 mt -87.68 118.08 32.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.11 0.481 . . . . 0.0 111.093 -173.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . 0.694 ' H ' HD13 ' D' ' 24' ' ' ILE . 0.2 OUTLIER -90.09 -18.02 7.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.097 -179.422 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' D' ' 93' ' ' ASP . 83.4 tttt -155.16 129.12 8.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.085 -175.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 6.8 p -58.49 127.46 32.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.689 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 27' ' ' PHE . . . . . 0.721 ' HB3' HD23 ' D' ' 91' ' ' LEU . 10.3 p90 -143.73 166.36 25.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.721 0.772 . . . . 0.0 112.727 -174.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 28' ' ' HIS . . . . . 0.569 ' HE2' ' HB3' ' D' ' 30' ' ' SER . 4.7 t60 -121.93 127.42 50.39 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.285 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 29' ' ' ILE . . . . . 0.621 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 47.4 mt -94.5 135.33 29.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 171.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . 0.569 ' HB3' ' HE2' ' D' ' 28' ' ' HIS . 55.9 p -119.96 -13.43 9.03 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -169.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 31' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -164.14 141.5 7.14 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 119.431 -1.366 . . . . 0.0 113.354 177.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.45 HG23 ' HG ' ' D' ' 87' ' ' LEU . 11.8 p -126.97 120.69 56.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 169.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . 0.4 ' HA ' HG21 ' D' ' 56' ' ' VAL . . . -141.17 157.21 45.58 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 121.95 -0.469 . . . . 0.0 111.589 -173.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 34' ' ' LEU . . . . . 0.635 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.6 pp -127.11 145.56 50.7 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.682 0.753 . . . . 0.0 111.254 178.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -110.34 -46.91 3.35 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.761 -1.108 . . . . 0.0 108.24 173.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -102.61 128.14 49.42 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.279 173.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . 0.538 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 141.6 161.4 8.72 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 119.459 -1.353 . . . . 0.0 113.814 176.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -102.77 -44.06 5.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.616 -0.292 . . . . 0.0 110.975 177.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -151.71 125.71 9.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.204 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . 0.513 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -127.82 113.08 15.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.443 0.639 . . . . 0.0 109.724 168.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' D' ' 79' ' ' THR . 56.0 mtpt -99.58 106.06 18.0 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.401 HD23 ' HB ' ' D' ' 53' ' ' VAL . 46.4 tp -79.12 108.72 12.82 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.814 -173.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -107.77 140.98 40.03 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.363 176.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.55 ' CD1' ' HB ' ' D' ' 75' ' ' ILE . 4.4 tp -124.41 116.47 22.6 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.14 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 45' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -101.84 104.18 14.92 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 174.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.49 ' HB2' HG22 ' D' ' 75' ' ' ILE . . . -127.08 136.4 52.1 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.403 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 56.41 35.91 26.68 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.383 0.611 . . . . 0.0 110.25 -175.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 61.61 39.44 14.53 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.117 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . 0.553 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 8.5 tp-100 -134.57 127.95 32.29 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 175.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -85.15 105.71 16.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.88 0.371 . . . . 0.0 110.456 -178.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -100.1 131.28 46.14 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.44 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 tp -79.73 108.82 13.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 168.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 53' ' ' VAL . . . . . 0.548 HG13 ' CD2' ' C' ' 88' ' ' LEU . 2.3 t -82.69 -51.2 14.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.575 -172.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 54' ' ' ALA . . . . . 0.487 ' HB1' HG11 ' D' ' 63' ' ' VAL . . . -156.34 145.56 20.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.076 -178.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 31.9 m -109.2 101.8 10.8 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 173.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 56' ' ' VAL . . . . . 0.477 HG13 ' HB3' ' D' ' 40' ' ' ALA . 7.4 p -115.57 114.93 47.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.483 0.659 . . . . 0.0 109.701 -177.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 63.1 p -122.95 -178.31 3.91 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.433 -174.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -63.78 -22.48 66.93 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.992 0.425 . . . . 0.0 110.321 171.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 59' ' ' ALA . . . . . 0.439 ' O ' ' HD3' ' D' ' 61' ' ' PRO . . . -83.91 -40.71 18.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.143 177.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 78.2 mt -112.24 81.54 3.94 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 173.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 61' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' D' ' 59' ' ' ALA . 12.1 Cg_exo -70.14 0.14 6.37 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.163 2.575 . . . . 0.0 114.007 -166.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -163.85 129.58 3.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.085 0.469 . . . . 0.0 111.432 -175.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.487 HG11 ' HB1' ' D' ' 54' ' ' ALA . 66.8 t -119.03 99.93 8.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.176 173.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.14 117.06 21.37 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 173.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 65' ' ' LEU . . . . . 0.443 HD23 ' H ' ' D' ' 65' ' ' LEU . 0.9 OUTLIER -139.05 168.13 20.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.865 0.364 . . . . 0.0 111.098 -171.129 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 66' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 12.2 t0 -112.44 104.48 12.61 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.354 0.597 . . . . 0.0 110.181 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.675 HD21 HD23 ' C' ' 88' ' ' LEU . 11.1 mt -117.31 141.18 48.62 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.985 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.04 132.48 25.17 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.583 174.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 69' ' ' PHE . . . . . 0.479 ' CZ ' HD22 ' D' ' 67' ' ' LEU . 59.0 m-85 -130.01 160.63 33.07 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.97 178.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 18.3 t -120.21 158.73 26.38 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -79.34 9.11 5.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.846 0.355 . . . . 0.0 111.103 -175.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.34 -29.21 9.05 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 174.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -100.42 165.82 11.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.044 0.449 . . . . 0.0 110.746 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -135.74 143.49 45.35 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.55 ' HB ' ' CD1' ' D' ' 44' ' ' LEU . 24.7 pt -135.72 159.2 39.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.211 0.529 . . . . 0.0 112.25 -168.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 76' ' ' MET . . . . . 0.459 ' O ' ' HA ' ' D' ' 44' ' ' LEU . 10.9 mtp -114.95 117.41 30.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.801 173.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 77' ' ' PHE . . . . . 0.503 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.6 OUTLIER -104.19 126.95 51.71 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.134 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 78' ' ' TYR . . . . . 0.606 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 23.1 p90 -152.22 134.66 15.25 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.886 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 79' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 2.4 p -107.85 119.96 40.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.297 -177.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.23 160.88 15.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.619 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.61 -170.51 31.05 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 110.656 -0.977 . . . . 0.0 110.656 -177.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 82' ' ' ASP . . . . . 0.434 ' HA ' ' HB3' ' D' ' 15' ' ' PRO . 19.0 t70 -116.92 103.45 10.3 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 117.861 0.831 . . . . 0.0 109.951 176.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . 0.538 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -173.38 158.69 3.57 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.744 172.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 26.2 t -117.78 122.37 43.27 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.635 HG12 ' HB3' ' D' ' 34' ' ' LEU . 5.0 m -115.9 156.11 17.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.491 0.662 . . . . 0.0 112.429 -172.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -119.08 117.16 28.0 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.04 173.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 87' ' ' LEU . . . . . 0.627 HD11 ' SD ' ' D' ' 13' ' ' MET . 5.1 mp -91.69 146.99 23.33 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 171.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.658 HD23 HD21 ' E' ' 67' ' ' LEU . 0.7 OUTLIER -130.78 142.52 50.41 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.747 179.617 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.9 -167.98 27.36 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.981 -178.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -145.39 130.26 18.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.734 0.778 . . . . 0.0 112.156 178.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . 0.721 HD23 ' HB3' ' D' ' 27' ' ' PHE . 18.1 mt -71.61 113.51 8.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.469 173.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -100.99 117.53 35.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.143 0.497 . . . . 0.0 110.718 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 93' ' ' ASP . . . . . 0.403 ' HB2' ' HE3' ' D' ' 25' ' ' LYS . 26.7 t70 -98.47 -53.81 3.22 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.713 176.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 59.7 mt 64.54 88.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.259 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 95' ' ' ASP . . . . . 0.507 ' HB3' ' OE1' ' D' ' 2' ' ' GLN . 29.9 t70 -127.03 134.59 50.29 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.722 178.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 18.8 m -96.59 27.34 3.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.973 0.416 . . . . 0.0 110.932 -177.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . -80.16 79.09 1.75 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.972 -0.632 . . . . 0.0 111.963 178.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 98' ' ' SER . . . . . 0.415 ' HA ' ' HB3' ' D' ' 1' ' ' PHE . 10.5 p . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.448 -0.786 . . . . 0.0 110.362 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 1' ' ' PHE . . . . . 0.413 ' HB3' ' HA ' ' E' ' 98' ' ' SER . 96.3 m-85 . . . . . 0 N--CA 1.477 0.915 0 N-CA-C 110.348 -0.242 . . . . 0.0 110.348 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 2' ' ' GLN . . . . . 0.523 ' OE1' ' HB3' ' E' ' 95' ' ' ASP . 8.2 tt0 65.77 105.33 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.944 0.778 . . . . 0.0 112.025 176.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.37 -1.09 60.9 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.602 -0.809 . . . . 0.0 111.519 175.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.51 56.71 2.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.261 0.553 . . . . 0.0 111.339 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 66.5 mtt -97.76 -69.45 0.76 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.776 177.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.71 111.18 21.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.751 177.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 7' ' ' MET . . . . . 0.4 ' O ' ' HA ' ' E' ' 90' ' ' TYR . 0.0 OUTLIER -99.99 154.6 18.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.913 178.151 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' E' E ' 8' ' ' PHE . . . . . 0.524 ' CE1' HD21 ' A' ' 44' ' ' LEU . 70.2 t80 -67.8 142.99 56.02 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.036 0.446 . . . . 0.0 112.071 -177.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 9' ' ' TRP . . . . . 0.558 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 88.2 t90 -135.12 148.04 49.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.118 177.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.69 153.14 24.75 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.448 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . 0.558 ' HB2' ' CH2' ' E' ' 9' ' ' TRP . 41.2 tp -144.1 109.98 5.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.779 0.323 . . . . 0.0 110.455 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -96.59 96.73 8.85 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.908 0.385 . . . . 0.0 110.04 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 13' ' ' MET . . . . . 0.632 ' SD ' HD11 ' E' ' 87' ' ' LEU . 62.7 mtp -92.98 144.14 25.54 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.963 -173.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -101.19 166.91 11.52 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.139 177.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . 0.441 ' HB3' ' HA ' ' E' ' 82' ' ' ASP . 87.9 Cg_exo -49.77 115.61 1.92 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.78 2.32 . . . . 0.0 112.797 176.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 16' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' E' ' 79' ' ' THR . 29.0 mt-10 63.29 39.65 9.34 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.295 0.569 . . . . 0.0 111.259 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 17' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' E' ' 78' ' ' TYR . 0.5 OUTLIER -88.15 133.43 34.01 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.353 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . 0.586 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 33.9 ttmt -123.21 116.14 22.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.153 0.502 . . . . 0.0 111.036 -178.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . 0.462 ' CZ ' ' HG2' ' E' ' 17' ' ' ARG . 18.7 m-85 -107.1 102.7 12.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.568 177.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 10.9 p -90.22 97.26 11.08 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 169.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.18 145.5 43.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.474 0.654 . . . . 0.0 112.454 -165.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 21.8 m -97.68 132.82 42.97 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.949 174.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 23' ' ' ILE . . . . . 0.436 ' CD1' ' HB3' ' E' ' 69' ' ' PHE . 70.0 mt -87.72 118.06 32.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.085 0.469 . . . . 0.0 111.083 -173.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . 0.673 ' H ' HD13 ' E' ' 24' ' ' ILE . 0.2 OUTLIER -90.11 -17.98 7.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.092 -179.421 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' E' ' 93' ' ' ASP . 83.3 tttt -155.15 129.21 8.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.075 -175.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 7.0 p -58.54 127.4 31.95 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.458 0.474 . . . . 0.0 110.679 -178.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 27' ' ' PHE . . . . . 0.736 ' HB3' HD23 ' E' ' 91' ' ' LEU . 10.2 p90 -143.68 166.44 24.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.645 0.736 . . . . 0.0 112.726 -174.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 28' ' ' HIS . . . . . 0.568 ' HE2' ' HB3' ' E' ' 30' ' ' SER . 4.8 t60 -121.9 127.45 50.46 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.36 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 29' ' ' ILE . . . . . 0.625 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 47.6 mt -94.63 135.33 29.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . 0.568 ' HB3' ' HE2' ' E' ' 28' ' ' HIS . 55.0 p -119.94 -13.48 9.03 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -169.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 31' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -164.14 141.48 7.13 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 119.36 -1.4 . . . . 0.0 113.339 177.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.449 HG23 ' HG ' ' E' ' 87' ' ' LEU . 11.9 p -126.89 120.71 56.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 169.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . 0.407 ' HA ' HG21 ' E' ' 56' ' ' VAL . . . -141.17 157.15 45.66 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.601 -173.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 34' ' ' LEU . . . . . 0.622 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.6 pp -127.11 145.55 50.7 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.686 0.755 . . . . 0.0 111.179 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -110.22 -47.01 3.35 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.256 173.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -102.64 128.11 49.47 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.294 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . 0.538 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 141.62 161.45 8.74 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 119.566 -1.302 . . . . 0.0 113.886 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -102.76 -44.08 5.39 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.734 0.302 . . . . 0.0 110.952 177.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -151.72 125.74 9.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.168 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . 0.491 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -127.84 113.1 15.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.422 0.629 . . . . 0.0 109.671 168.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 41' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' E' ' 79' ' ' THR . 56.0 mtpt -99.64 106.07 17.98 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 46.3 tp -79.16 108.77 12.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.792 -173.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -107.83 141.01 40.07 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.303 176.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 44' ' ' LEU . . . . . 0.554 ' CD1' ' HB ' ' E' ' 75' ' ' ILE . 4.4 tp -124.46 116.4 22.47 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.096 176.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 45' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -101.76 104.2 14.97 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 174.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . 0.479 ' HB2' HG22 ' E' ' 75' ' ' ILE . . . -127.12 136.36 52.0 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.387 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 56.53 35.87 26.7 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.657 0.598 . . . . 0.0 110.216 -175.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 61.52 39.49 14.77 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.154 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 49' ' ' GLN . . . . . 0.547 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 8.5 tp-100 -134.56 128.08 32.55 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 175.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -85.22 105.7 16.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.875 0.369 . . . . 0.0 110.381 -178.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -100.15 131.21 46.23 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.427 177.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 6.0 tp -79.6 108.74 13.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 168.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . 0.526 HG13 ' CD2' ' D' ' 88' ' ' LEU . 2.3 t -82.64 -51.27 14.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.526 -172.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 54' ' ' ALA . . . . . 0.49 ' HB1' HG11 ' E' ' 63' ' ' VAL . . . -156.32 145.64 20.65 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.012 -178.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 31.9 m -109.19 101.7 10.71 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 173.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . 0.462 HG13 ' HB3' ' E' ' 40' ' ' ALA . 7.4 p -115.51 114.92 47.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.621 0.724 . . . . 0.0 109.724 -177.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 63.2 p -122.87 -178.29 3.9 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.434 -174.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -63.87 -22.46 66.93 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.07 0.462 . . . . 0.0 110.298 171.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 59' ' ' ALA . . . . . 0.441 ' O ' ' HD3' ' E' ' 61' ' ' PRO . . . -83.96 -40.59 18.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.187 177.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.38 81.53 4.07 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 173.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 61' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' E' ' 59' ' ' ALA . 12.0 Cg_exo -70.09 0.13 6.35 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.133 2.556 . . . . 0.0 114.024 -166.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -163.81 129.53 3.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.195 0.521 . . . . 0.0 111.469 -175.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . 0.49 HG11 ' HB1' ' E' ' 54' ' ' ALA . 66.5 t -119.03 100.03 9.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.207 173.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.2 117.09 21.44 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 173.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' E' ' 30' ' ' SER . 0.9 OUTLIER -139.1 168.16 20.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.893 0.378 . . . . 0.0 111.097 -171.168 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' E' E ' 66' ' ' ASP . . . . . 0.512 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 12.1 t0 -112.39 104.49 12.63 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.3 0.571 . . . . 0.0 110.121 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 67' ' ' LEU . . . . . 0.658 HD21 HD23 ' D' ' 88' ' ' LEU . 11.1 mt -117.31 141.25 48.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.988 178.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -142.11 132.46 25.03 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.849 0.357 . . . . 0.0 110.682 174.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 69' ' ' PHE . . . . . 0.468 ' CZ ' HD22 ' E' ' 67' ' ' LEU . 58.5 m-85 -130.04 160.54 33.36 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.91 178.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 18.1 t -120.11 158.75 26.23 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -79.46 9.1 5.19 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.06 0.457 . . . . 0.0 111.102 -175.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.3 -29.28 9.03 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.453 174.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -100.38 165.85 11.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.033 0.444 . . . . 0.0 110.706 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -135.77 143.41 45.24 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 75' ' ' ILE . . . . . 0.554 ' HB ' ' CD1' ' E' ' 44' ' ' LEU . 24.9 pt -135.65 159.2 40.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.179 0.514 . . . . 0.0 112.278 -168.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 76' ' ' MET . . . . . 0.456 ' O ' ' HA ' ' E' ' 44' ' ' LEU . 10.8 mtp -115.0 117.48 30.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.752 173.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 77' ' ' PHE . . . . . 0.5 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.6 OUTLIER -104.14 126.92 51.65 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 176.147 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' E' E ' 78' ' ' TYR . . . . . 0.586 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 23.0 p90 -152.22 134.61 15.21 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.985 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 79' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 2.4 p -107.8 120.0 41.02 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.375 -177.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.23 160.89 15.96 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.65 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.6 -170.48 31.04 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -177.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 82' ' ' ASP . . . . . 0.441 ' HA ' ' HB3' ' E' ' 15' ' ' PRO . 19.1 t70 -116.88 103.46 10.32 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 119.676 -0.809 . . . . 0.0 109.941 176.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 83' ' ' ALA . . . . . 0.538 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -173.33 158.7 3.61 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.776 172.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 25.9 t -117.86 122.47 43.42 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 85' ' ' VAL . . . . . 0.622 HG12 ' HB3' ' E' ' 34' ' ' LEU . 4.9 m -115.85 156.13 17.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.487 0.66 . . . . 0.0 112.328 -172.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 50.4 m -119.09 117.17 28.02 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.042 173.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 87' ' ' LEU . . . . . 0.632 HD11 ' SD ' ' E' ' 13' ' ' MET . 5.1 mp -91.72 147.03 23.29 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 171.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . 0.667 HD23 HD21 ' A' ' 67' ' ' LEU . 0.7 OUTLIER -130.81 142.51 50.4 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.744 179.643 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.95 -168.0 27.45 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.016 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 90' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' E' ' 7' ' ' MET . 37.0 p90 -145.42 130.19 18.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.643 0.735 . . . . 0.0 112.191 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 91' ' ' LEU . . . . . 0.736 HD23 ' HB3' ' E' ' 27' ' ' PHE . 18.2 mt -71.62 113.48 8.7 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.498 173.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -101.03 117.54 35.24 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.161 0.505 . . . . 0.0 110.706 -178.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 93' ' ' ASP . . . . . 0.409 ' HB2' ' HE3' ' E' ' 25' ' ' LYS . 26.5 t70 -98.45 -53.94 3.18 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.638 176.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 59.9 mt 64.66 88.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.248 177.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 95' ' ' ASP . . . . . 0.523 ' HB3' ' OE1' ' E' ' 2' ' ' GLN . 29.9 t70 -126.99 134.6 50.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.765 178.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 18.9 m -96.73 27.59 3.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.0 0.429 . . . . 0.0 110.971 -177.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . -80.19 78.88 1.78 Allowed Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.047 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 98' ' ' SER . . . . . 0.413 ' HA ' ' HB3' ' E' ' 1' ' ' PHE . 10.9 p . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.45 -0.786 . . . . 0.0 110.397 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 . . . . . 0 N--CA 1.481 1.102 0 CA-C-O 120.516 0.198 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -71.42 90.51 0.97 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.976 0.417 . . . . 0.0 110.571 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 142.52 -137.7 7.96 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 -177.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -141.87 -175.01 4.24 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.537 0.208 . . . . 0.0 110.581 -179.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.451 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 2.7 mpt? -142.7 -173.68 3.95 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 175.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.55 120.0 5.14 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 174.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 21.7 ttt -103.37 140.78 36.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.188 0.518 . . . . 0.0 112.317 -170.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.569 ' CE1' HD12 ' A' ' 88' ' ' LEU . 77.7 t80 -54.49 141.45 30.96 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.967 -176.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.531 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 89.5 t90 -133.46 147.23 51.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.704 -1.134 . . . . 0.0 108.503 177.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.89 145.54 14.45 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.658 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.558 HD23 HD13 ' A' ' 87' ' ' LEU . 50.1 tp -135.89 108.74 7.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.894 0.378 . . . . 0.0 110.317 177.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -96.64 100.96 12.49 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 176.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.562 ' SD ' HD11 ' A' ' 87' ' ' LEU . 61.0 mtp -92.5 143.47 26.32 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.291 0.567 . . . . 0.0 111.383 -172.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -100.49 145.02 29.57 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.425 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.526 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 9.5 Cg_endo -51.84 123.22 11.89 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 123.64 2.893 . . . . 0.0 113.597 -174.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' A' ' 79' ' ' THR . 35.8 mt-10 57.71 73.6 0.46 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.689 178.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.85 138.34 19.59 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.224 176.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.723 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 50.2 mttp -107.34 121.9 45.51 Favored 'General case' 0 CA--C 1.512 -0.497 0 O-C-N 123.451 0.47 . . . . 0.0 111.368 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.57 102.79 11.34 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 76' ' ' MET . 44.4 t -90.08 99.22 12.28 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 173.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -115.55 139.76 49.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.594 0.712 . . . . 0.0 112.2 -168.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.1 m -84.72 132.17 34.48 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.348 174.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 59.3 mt -86.35 115.45 27.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.07 0.462 . . . . 0.0 110.934 -175.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.431 HD12 ' N ' ' A' ' 25' ' ' LYS . 1.9 pp -88.7 -12.44 10.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.399 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.431 ' N ' HD12 ' A' ' 24' ' ' ILE . 83.3 tttt -160.03 120.12 2.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.486 178.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.7 m -51.54 137.16 24.99 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.683 0.614 . . . . 0.0 110.403 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.715 ' HB3' HD23 ' A' ' 91' ' ' LEU . 33.1 p90 -147.35 165.32 30.52 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -174.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.498 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 8.3 t60 -116.17 120.28 38.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.699 177.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 42.6 mt -84.51 134.68 26.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 169.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.508 ' HB2' ' HB3' ' B' ' 66' ' ' ASP . 76.7 p -119.68 -10.05 9.65 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -171.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -178.11 158.57 23.53 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 119.263 -1.446 . . . . 0.0 113.628 177.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.483 HG23 ' HG ' ' A' ' 87' ' ' LEU . 11.9 p -139.67 137.24 39.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 175.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -150.18 154.83 38.69 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.903 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.562 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.3 pp -118.19 140.02 50.42 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.964 0.888 . . . . 0.0 111.615 178.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -110.28 -53.41 2.68 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.981 -1.463 . . . . 0.0 108.549 174.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -101.47 126.79 48.32 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.589 175.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.508 ' HA3' ' HA ' ' A' ' 83' ' ' ALA . . . 140.54 165.64 10.38 Favored Glycine 0 N--CA 1.439 -1.119 0 C-N-CA 119.588 -1.292 . . . . 0.0 113.542 178.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -102.72 -46.58 4.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.58 0.228 . . . . 0.0 111.395 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -151.46 134.23 15.65 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.018 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.509 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -132.77 113.71 13.27 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.46 0.648 . . . . 0.0 110.42 170.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 79' ' ' THR . 65.4 mttp -98.21 113.36 25.26 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 174.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.414 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 58.7 tp -89.93 109.03 20.08 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.424 -170.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.537 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 71.5 m-85 -109.02 148.6 30.52 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.852 178.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.658 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -128.41 117.07 20.75 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.606 176.046 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -102.9 104.45 14.68 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.429 0.633 . . . . 0.0 109.927 176.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.491 ' HB2' HD11 ' A' ' 44' ' ' LEU . . . -128.79 143.72 50.99 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.316 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 61.16 26.59 16.47 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.716 0.769 . . . . 0.0 109.074 -174.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.4 ' N ' ' HD2' ' A' ' 48' ' ' LYS . 4.2 mptp? 59.2 38.36 23.55 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.874 -177.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.567 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 6.6 tp-100 -129.5 127.91 41.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.823 178.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -81.38 106.01 13.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.096 0.474 . . . . 0.0 110.599 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -102.3 116.98 33.78 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.339 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 tp -74.71 99.84 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 171.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.502 HG12 ' CD2' ' E' ' 88' ' ' LEU . 29.3 m -87.43 -32.45 6.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.611 -172.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.746 ' HB2' HD21 ' A' ' 65' ' ' LEU . . . -152.93 142.42 21.75 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.371 -0.532 . . . . 0.0 112.211 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.1 m -112.97 101.93 9.94 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 169.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.0 p -118.36 112.43 38.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.932 0.873 . . . . 0.0 110.443 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 78.5 p -123.34 -177.34 3.67 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.194 -176.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -60.93 -29.37 69.57 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.445 168.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.22 -40.66 62.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.252 0.549 . . . . 0.0 110.292 178.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 77.4 mt -117.8 81.69 15.65 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.35 -4.17 12.34 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.191 2.594 . . . . 0.0 113.963 -168.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -160.67 129.71 4.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.281 0.562 . . . . 0.0 111.206 -175.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 96.7 t -120.17 125.59 74.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.525 176.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.36 130.68 34.54 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 175.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.746 HD21 ' HB2' ' A' ' 54' ' ' ALA . 88.5 mt -122.82 166.64 14.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.394 0.616 . . . . 0.0 112.288 -173.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.539 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 26.9 t0 -144.51 97.95 3.12 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 170.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.531 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 7.0 mt -133.0 109.38 9.51 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.347 -175.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.451 ' HB2' ' CD2' ' E' ' 90' ' ' TYR . 7.5 m-20 -104.73 114.7 29.08 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.839 0.352 . . . . 0.0 110.149 178.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -108.09 160.35 15.87 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.338 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.5 t -116.14 149.64 38.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.955 0.407 . . . . 0.0 110.625 -177.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -69.15 0.13 5.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.198 -176.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.46 -18.56 35.35 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.345 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -101.51 164.06 11.95 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.708 -0.289 . . . . 0.0 110.836 -175.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -130.9 108.76 10.06 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.4 pt -109.52 158.46 9.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.259 -170.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.436 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 2.6 mtm -116.69 122.88 45.82 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.873 175.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.658 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -104.49 128.57 52.45 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.688 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.723 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 36.4 p90 -149.98 135.34 18.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.529 0.68 . . . . 0.0 112.492 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 3.9 p -106.36 132.56 52.25 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.763 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.54 154.42 18.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.799 177.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.422 ' O ' ' HG3' ' A' ' 16' ' ' GLU . . . 91.33 -172.14 35.98 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -176.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.403 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 21.3 t70 -113.13 102.86 10.79 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.825 176.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.526 ' H ' ' HB3' ' A' ' 15' ' ' PRO . . . -169.28 153.74 5.51 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.85 167.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.4 t -111.05 120.66 43.08 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.562 HG12 ' HB3' ' A' ' 34' ' ' LEU . 3.8 m -114.9 149.31 17.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -172.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.8 m -110.93 115.4 29.43 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.598 175.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.562 HD11 ' SD ' ' A' ' 13' ' ' MET . 4.8 mp -94.85 145.17 25.08 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 170.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.569 HD12 ' CE1' ' A' ' 8' ' ' PHE . 2.4 mm? -124.28 149.53 46.4 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 175.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.82 -167.35 26.32 Favored Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.48 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.44 ' CD2' ' HB2' ' B' ' 68' ' ' ASN . 5.1 p90 -149.31 131.38 15.35 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.763 0.792 . . . . 0.0 111.795 176.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.715 HD23 ' HB3' ' A' ' 27' ' ' PHE . 27.3 mt -63.91 138.9 58.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.927 -1.488 . . . . 0.0 110.279 177.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.427 ' HD1' ' CG ' ' E' ' 95' ' ' ASP . 23.2 m-70 -65.64 120.3 12.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.786 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -150.82 169.65 21.17 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 5' ' ' MET . 2.2 pp -91.76 149.03 4.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 120.791 0.329 . . . . 0.0 110.796 -178.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.42 98.6 11.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.822 -178.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 28.4 t -67.04 105.64 1.72 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.076 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.38 -48.93 4.11 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.0 178.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.1 m . . . . . 0 C--O 1.249 1.053 0 CA-C-O 119.033 -0.508 . . . . 0.0 110.413 -176.873 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 120.483 0.182 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -71.43 90.42 0.97 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.015 0.436 . . . . 0.0 110.581 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 142.63 -137.67 7.91 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -177.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -141.92 -175.04 4.25 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.533 0.206 . . . . 0.0 110.615 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . 0.443 ' HA ' ' O ' ' B' ' 94' ' ' ILE . 2.7 mpt? -142.58 -173.6 3.91 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 175.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.59 119.99 5.14 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 174.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 21.8 ttt -103.3 140.79 36.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.189 0.519 . . . . 0.0 112.251 -170.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.559 ' CE1' HD12 ' B' ' 88' ' ' LEU . 78.1 t80 -54.51 141.53 30.8 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 114.76 -1.109 . . . . 0.0 113.001 -176.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . 0.531 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 89.3 t90 -133.53 147.28 51.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.531 177.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.91 145.54 14.44 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.607 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.546 HD23 HD13 ' B' ' 87' ' ' LEU . 50.2 tp -135.9 108.8 7.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.91 0.386 . . . . 0.0 110.344 176.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -96.76 101.1 12.64 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . 0.568 ' SD ' HD11 ' B' ' 87' ' ' LEU . 60.8 mtp -92.58 143.46 26.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.304 0.573 . . . . 0.0 111.372 -172.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -100.49 145.02 29.59 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 114.926 -1.033 . . . . 0.0 109.371 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.521 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 9.5 Cg_endo -51.91 123.13 11.74 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.708 2.938 . . . . 0.0 113.597 -174.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' B' ' 79' ' ' THR . 35.8 mt-10 57.86 73.44 0.47 Allowed 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.668 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.76 138.5 19.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.214 176.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.711 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 50.2 mttp -107.39 121.95 45.63 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 123.397 0.436 . . . . 0.0 111.322 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' B' ' 76' ' ' MET . 3.1 m-85 -110.6 102.65 11.21 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 174.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 45.2 t -89.84 99.2 12.25 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 173.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -115.55 139.74 49.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.3 -168.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 54.4 m -84.66 132.16 34.51 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.399 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 59.3 mt -86.33 115.48 27.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.041 0.448 . . . . 0.0 110.924 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.431 HD12 ' N ' ' B' ' 25' ' ' LYS . 1.9 pp -88.7 -12.57 10.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.369 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.431 ' N ' HD12 ' B' ' 24' ' ' ILE . 83.3 tttt -159.99 120.17 2.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.479 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 13.6 m -51.47 137.09 24.7 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 123.768 0.667 . . . . 0.0 110.515 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . 0.719 ' HB3' HD23 ' B' ' 91' ' ' LEU . 33.0 p90 -147.34 165.34 30.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.386 0.612 . . . . 0.0 112.51 -174.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' HIS . . . . . 0.484 ' HA ' ' O ' ' B' ' 67' ' ' LEU . 8.3 t60 -116.15 120.24 38.39 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.749 176.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.536 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 42.5 mt -84.56 134.69 26.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 169.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.53 ' HB2' ' HB3' ' C' ' 66' ' ' ASP . 77.2 p -119.61 -10.1 9.67 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -171.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -178.16 158.5 23.38 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.314 -1.422 . . . . 0.0 113.678 177.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.485 HG23 ' HG ' ' B' ' 87' ' ' LEU . 11.9 p -139.71 137.27 39.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -150.16 154.78 38.61 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.972 -0.455 . . . . 0.0 110.961 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.565 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.3 pp -118.14 140.06 50.35 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.963 0.887 . . . . 0.0 111.651 178.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -110.41 -53.25 2.7 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.067 -1.424 . . . . 0.0 108.508 174.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -101.55 126.74 48.42 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.672 175.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' B' ' 83' ' ' ALA . . . 140.67 165.72 10.41 Favored Glycine 0 N--CA 1.439 -1.132 0 C-N-CA 119.602 -1.285 . . . . 0.0 113.484 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -102.76 -46.48 4.7 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.589 0.233 . . . . 0.0 111.481 176.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -151.5 134.24 15.62 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.95 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.518 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -132.83 113.71 13.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.494 0.664 . . . . 0.0 110.423 170.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' B' ' 79' ' ' THR . 65.4 mttp -98.19 113.22 25.06 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 174.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.422 ' HB3' ' HB3' ' B' ' 54' ' ' ALA . 58.9 tp -89.85 109.14 20.17 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.367 -170.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . 0.554 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 71.1 m-85 -109.04 148.53 30.66 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.919 177.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.672 ' HB2' ' CE1' ' B' ' 77' ' ' PHE . 0.4 OUTLIER -128.37 117.12 20.86 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.589 176.058 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -102.89 104.4 14.64 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.358 0.599 . . . . 0.0 109.925 176.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.485 ' HB2' HD11 ' B' ' 44' ' ' LEU . . . -128.85 143.67 50.97 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 61.06 26.64 16.56 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.769 0.795 . . . . 0.0 109.168 -174.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 59.19 38.28 23.61 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.009 -177.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.564 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 6.6 tp-100 -129.46 127.97 41.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.727 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -81.43 106.04 13.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.966 0.413 . . . . 0.0 110.591 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -102.3 116.95 33.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.348 176.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -74.7 99.88 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 171.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.495 HG12 ' CD2' ' A' ' 88' ' ' LEU . 28.8 m -87.39 -32.51 6.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.576 -172.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.775 ' HB2' HD21 ' B' ' 65' ' ' LEU . . . -152.89 142.31 21.68 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 26.8 m -112.96 101.96 9.98 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 169.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 p -118.33 112.36 37.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.857 0.837 . . . . 0.0 110.468 -176.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 77.1 p -123.39 -177.39 3.69 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.107 -176.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -60.86 -29.41 69.51 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.507 168.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.15 -40.69 62.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.338 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 77.8 mt -117.73 81.64 15.31 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 173.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.34 -4.15 12.28 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.164 2.576 . . . . 0.0 113.922 -168.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -160.69 129.76 4.82 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.307 0.575 . . . . 0.0 111.164 -175.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 96.8 t -120.19 125.58 74.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.522 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.41 130.76 34.52 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.775 HD21 ' HB2' ' B' ' 54' ' ' ALA . 88.4 mt -122.91 166.59 14.79 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.408 0.623 . . . . 0.0 112.369 -173.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 26.1 t0 -144.45 97.94 3.12 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 170.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.536 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 7.0 mt -132.88 109.32 9.53 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.406 -175.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . 0.44 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 7.5 m-20 -104.69 114.65 29.0 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.899 0.38 . . . . 0.0 110.175 178.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -108.05 160.31 15.89 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.349 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 36.0 t -116.16 149.6 38.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.959 0.409 . . . . 0.0 110.563 -177.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -69.1 0.23 4.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.272 -176.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.54 -18.46 35.49 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.356 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -101.47 164.24 11.86 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.681 -0.305 . . . . 0.0 110.891 -176.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -131.11 108.81 10.02 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 22.4 pt -109.5 158.35 9.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.256 -170.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.438 ' HA ' ' HA ' ' B' ' 20' ' ' SER . 2.6 mtm -116.64 122.79 45.61 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 120.296 -0.562 . . . . 0.0 109.924 175.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . 0.672 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -104.49 128.61 52.46 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.665 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.711 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 36.0 p90 -150.08 135.37 18.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.589 0.709 . . . . 0.0 112.498 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 3.8 p -106.35 132.56 52.24 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.835 178.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.46 154.39 18.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.806 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.415 ' O ' ' HG3' ' B' ' 16' ' ' GLU . . . 91.38 -172.18 35.94 Favored Glycine 0 CA--C 1.506 -0.492 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -176.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' ASP . . . . . 0.407 ' HA ' ' HB3' ' B' ' 15' ' ' PRO . 21.5 t70 -113.09 102.9 10.83 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.854 176.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.521 ' H ' ' HB3' ' B' ' 15' ' ' PRO . . . -169.32 153.71 5.45 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.818 167.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 24.3 t -111.0 120.65 43.07 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.565 HG12 ' HB3' ' B' ' 34' ' ' LEU . 3.8 m -114.97 149.27 17.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.544 0.688 . . . . 0.0 112.816 -172.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 25.0 m -110.87 115.38 29.42 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.61 175.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.568 HD11 ' SD ' ' B' ' 13' ' ' MET . 4.8 mp -94.81 145.25 25.01 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 170.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.559 HD12 ' CE1' ' B' ' 8' ' ' PHE . 2.4 mm? -124.48 149.51 46.77 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.81 -167.29 26.22 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.512 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' TYR . . . . . 0.428 ' CD2' ' HB2' ' C' ' 68' ' ' ASN . 5.1 p90 -149.35 131.34 15.27 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.787 0.803 . . . . 0.0 111.682 176.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . 0.719 HD23 ' HB3' ' B' ' 27' ' ' PHE . 27.3 mt -63.89 139.01 58.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.256 176.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -65.89 120.42 13.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.679 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -150.87 169.57 21.39 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . 0.453 ' H ' HG13 ' B' ' 94' ' ' ILE . 2.2 pp -91.7 149.26 4.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.77 -178.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.62 98.68 11.92 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.785 -178.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 28.4 t -67.1 105.67 1.75 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.126 177.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.42 -48.75 4.16 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.111 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 16.6 m . . . . . 0 C--O 1.249 1.073 0 CA-C-O 119.143 -0.456 . . . . 0.0 110.547 -176.929 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 120.491 0.186 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -71.44 90.47 0.98 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.954 0.407 . . . . 0.0 110.583 -178.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . 142.52 -137.62 7.91 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 -177.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -141.93 -174.98 4.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.56 0.219 . . . . 0.0 110.528 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 5' ' ' MET . . . . . 0.444 ' HA ' ' O ' ' C' ' 94' ' ' ILE . 2.7 mpt? -142.69 -173.63 3.93 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.6 119.89 5.04 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 174.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 21.8 ttt -103.21 140.79 36.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.166 0.508 . . . . 0.0 112.325 -170.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 8' ' ' PHE . . . . . 0.571 ' CE1' HD12 ' C' ' 88' ' ' LEU . 77.8 t80 -54.56 141.55 31.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.788 -1.097 . . . . 0.0 112.917 -176.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . 0.524 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 89.4 t90 -133.48 147.23 51.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.582 177.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.85 145.65 14.7 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.554 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.563 HD23 HD13 ' C' ' 87' ' ' LEU . 50.0 tp -135.97 108.74 7.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.923 0.392 . . . . 0.0 110.254 177.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -96.7 101.1 12.64 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 13' ' ' MET . . . . . 0.557 ' SD ' HD11 ' C' ' 87' ' ' LEU . 60.9 mtp -92.57 143.44 26.34 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.282 0.563 . . . . 0.0 111.401 -172.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -100.48 144.98 29.51 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.424 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . 0.526 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 9.5 Cg_endo -51.87 123.23 11.94 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 123.647 2.898 . . . . 0.0 113.559 -174.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' C' ' 79' ' ' THR . 36.1 mt-10 57.8 73.45 0.47 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.686 178.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.82 138.43 19.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.173 176.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 18' ' ' LYS . . . . . 0.723 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 50.2 mttp -107.37 121.98 45.67 Favored 'General case' 0 CA--C 1.511 -0.531 0 O-C-N 123.368 0.418 . . . . 0.0 111.325 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' C' ' 76' ' ' MET . 3.1 m-85 -110.63 102.74 11.28 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 174.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 44.7 t -89.97 99.22 12.27 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 173.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -115.52 139.69 49.83 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.272 -168.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 54.2 m -84.63 132.13 34.52 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.426 174.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 59.1 mt -86.21 115.32 27.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.048 0.452 . . . . 0.0 111.001 -175.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . 0.426 HD12 ' N ' ' C' ' 25' ' ' LYS . 1.9 pp -88.64 -12.57 10.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.39 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . 0.426 ' N ' HD12 ' C' ' 24' ' ' ILE . 83.3 tttt -159.95 120.24 2.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.431 178.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 13.4 m -51.47 137.13 24.66 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 123.736 0.647 . . . . 0.0 110.532 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 27' ' ' PHE . . . . . 0.73 ' HB3' HD23 ' C' ' 91' ' ' LEU . 32.9 p90 -147.39 165.32 30.57 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.448 0.642 . . . . 0.0 112.579 -174.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 28' ' ' HIS . . . . . 0.497 ' HA ' ' O ' ' C' ' 67' ' ' LEU . 8.3 t60 -116.1 120.29 38.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.728 177.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . 0.518 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 42.3 mt -84.61 134.68 26.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 169.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.5 ' HB2' ' HB3' ' D' ' 66' ' ' ASP . 75.9 p -119.59 -10.05 9.68 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -171.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -178.11 158.45 23.32 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 119.194 -1.479 . . . . 0.0 113.617 177.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.492 HG23 ' HG ' ' C' ' 87' ' ' LEU . 12.0 p -139.67 137.28 39.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -150.17 154.79 38.63 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 121.946 -0.471 . . . . 0.0 110.922 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.546 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.3 pp -118.24 140.09 50.33 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 122.01 0.909 . . . . 0.0 111.585 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -110.33 -53.32 2.7 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.934 -1.485 . . . . 0.0 108.514 174.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -101.59 126.72 48.46 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.603 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 37' ' ' GLY . . . . . 0.491 ' HA3' ' HA ' ' C' ' 83' ' ' ALA . . . 140.72 165.68 10.4 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 119.55 -1.309 . . . . 0.0 113.56 178.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -102.78 -46.46 4.7 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 120.575 0.226 . . . . 0.0 111.452 176.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -151.49 134.31 15.68 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.979 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.5 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -132.83 113.66 13.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.401 0.62 . . . . 0.0 110.451 170.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' C' ' 79' ' ' THR . 65.4 mttp -98.17 113.27 25.13 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 174.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.428 ' HG ' ' CG2' ' C' ' 53' ' ' VAL . 59.0 tp -89.92 109.08 20.12 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.416 -170.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 43' ' ' TYR . . . . . 0.543 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 71.3 m-85 -108.99 148.58 30.53 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.92 177.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.671 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 0.4 OUTLIER -128.39 117.09 20.78 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.579 176.045 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -102.87 104.5 14.76 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.33 0.586 . . . . 0.0 109.851 176.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.498 ' HB2' HD11 ' C' ' 44' ' ' LEU . . . -128.76 143.74 50.99 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.34 178.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 61.11 26.52 16.42 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.768 0.794 . . . . 0.0 109.138 -174.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 59.28 38.27 23.32 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.969 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . 0.558 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 6.6 tp-100 -129.49 127.96 41.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.715 178.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -81.51 106.08 13.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.074 0.464 . . . . 0.0 110.565 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -102.29 116.97 33.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.304 176.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 tp -74.74 99.88 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 171.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 53' ' ' VAL . . . . . 0.48 HG12 ' CD2' ' B' ' 88' ' ' LEU . 28.4 m -87.43 -32.43 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.618 -172.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 54' ' ' ALA . . . . . 0.776 ' HB2' HD21 ' C' ' 65' ' ' LEU . . . -152.89 142.41 21.77 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 120.308 -0.557 . . . . 0.0 112.261 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 27.0 m -113.05 101.97 9.96 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 169.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 p -118.26 112.39 38.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.817 0.818 . . . . 0.0 110.414 -176.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 77.0 p -123.45 -177.35 3.69 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.205 -176.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -60.81 -29.47 69.48 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.484 168.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.13 -40.68 62.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.289 0.566 . . . . 0.0 110.329 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 77.5 mt -117.75 81.65 15.4 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 173.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.33 -4.12 12.22 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.148 2.565 . . . . 0.0 113.969 -168.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -160.69 129.7 4.8 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.348 0.594 . . . . 0.0 111.194 -175.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 97.2 t -120.1 125.55 74.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.552 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.39 130.76 34.52 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 175.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . 0.776 HD21 ' HB2' ' C' ' 54' ' ' ALA . 88.2 mt -122.84 166.59 14.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.506 0.669 . . . . 0.0 112.376 -173.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 66' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 26.4 t0 -144.52 98.07 3.14 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.518 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 7.0 mt -132.95 109.37 9.53 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.443 -175.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . 0.428 ' HB2' ' CD2' ' B' ' 90' ' ' TYR . 7.4 m-20 -104.7 114.63 28.97 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 120.802 0.334 . . . . 0.0 110.158 178.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -108.11 160.38 15.85 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.254 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 36.6 t -116.16 149.64 38.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.565 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -69.15 0.01 5.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.203 -176.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.32 -18.54 35.85 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.406 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -101.51 164.09 11.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.706 0.289 . . . . 0.0 110.841 -176.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -131.0 108.81 10.06 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 22.5 pt -109.52 158.41 9.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.216 -170.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.443 ' HA ' ' HA ' ' C' ' 20' ' ' SER . 2.5 mtm -116.69 122.81 45.61 Favored 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.887 175.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 77' ' ' PHE . . . . . 0.671 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.7 OUTLIER -104.55 128.63 52.56 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.721 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 78' ' ' TYR . . . . . 0.723 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 36.4 p90 -150.04 135.33 18.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.581 0.705 . . . . 0.0 112.531 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 3.9 p -106.35 132.51 52.3 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.777 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.48 154.5 18.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.778 177.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.408 ' O ' ' HG3' ' C' ' 16' ' ' GLU . . . 91.3 -172.16 36.03 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -176.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 82' ' ' ASP . . . . . 0.402 ' HA ' ' HB3' ' C' ' 15' ' ' PRO . 21.3 t70 -113.07 102.95 10.88 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.879 176.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . 0.526 ' H ' ' HB3' ' C' ' 15' ' ' PRO . . . -169.38 153.6 5.34 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.845 167.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 25.3 t -110.94 120.71 43.3 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.546 HG12 ' HB3' ' C' ' 34' ' ' LEU . 3.8 m -114.96 149.38 17.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 24.1 m -110.97 115.31 29.28 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.641 175.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . 0.563 HD13 HD23 ' C' ' 11' ' ' LEU . 4.8 mp -94.83 145.19 25.06 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 170.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . 0.571 HD12 ' CE1' ' C' ' 8' ' ' PHE . 2.4 mm? -124.38 149.49 46.61 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.77 -167.29 26.16 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.471 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 90' ' ' TYR . . . . . 0.424 ' CD2' ' HB2' ' D' ' 68' ' ' ASN . 5.1 p90 -149.33 131.41 15.36 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.744 0.783 . . . . 0.0 111.741 176.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . 0.73 HD23 ' HB3' ' C' ' 27' ' ' PHE . 27.7 mt -63.97 139.1 58.73 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.247 177.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -65.93 120.32 12.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.659 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -150.83 169.63 21.23 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . 0.462 ' H ' HG13 ' C' ' 94' ' ' ILE . 2.2 pp -91.73 149.16 4.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 120.799 0.333 . . . . 0.0 110.799 -178.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 95' ' ' ASP . . . . . 0.427 ' CG ' ' HD1' ' D' ' 92' ' ' HIS . 0.1 OUTLIER -90.53 98.67 11.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.786 -178.408 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 28.5 t -67.12 105.66 1.76 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.048 177.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.34 -48.93 4.12 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.079 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 C--O 1.247 0.964 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.522 -176.831 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 120.486 0.184 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -71.42 90.45 0.97 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.913 0.387 . . . . 0.0 110.547 -178.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . 142.51 -137.66 7.94 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -177.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -141.82 -174.95 4.22 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.627 0.214 . . . . 0.0 110.576 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 5' ' ' MET . . . . . 0.446 ' HA ' ' O ' ' D' ' 94' ' ' ILE . 2.7 mpt? -142.74 -173.61 3.93 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 175.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.62 119.94 5.11 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.741 0.305 . . . . 0.0 110.185 174.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 21.7 ttt -103.2 140.8 36.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.142 0.496 . . . . 0.0 112.28 -170.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 8' ' ' PHE . . . . . 0.561 ' CE1' HD12 ' D' ' 88' ' ' LEU . 78.0 t80 -54.55 141.59 30.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.971 -176.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 9' ' ' TRP . . . . . 0.529 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 89.3 t90 -133.53 147.21 51.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.536 177.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.79 145.64 14.68 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.591 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.55 HD23 HD13 ' D' ' 87' ' ' LEU . 49.9 tp -136.0 108.85 7.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.923 0.392 . . . . 0.0 110.246 176.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -96.76 101.01 12.53 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 13' ' ' MET . . . . . 0.569 ' SD ' HD11 ' D' ' 87' ' ' LEU . 60.8 mtp -92.42 143.45 26.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.241 0.543 . . . . 0.0 111.434 -173.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -100.47 144.94 29.43 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.416 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . 0.529 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 9.5 Cg_endo -51.73 123.16 11.7 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.645 2.896 . . . . 0.0 113.626 -174.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' D' ' 79' ' ' THR . 35.9 mt-10 57.81 73.46 0.47 Allowed 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.707 178.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.85 138.44 19.66 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.197 176.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . 0.714 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 50.2 mttp -107.39 121.98 45.67 Favored 'General case' 0 CA--C 1.511 -0.533 0 O-C-N 123.387 0.429 . . . . 0.0 111.399 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.61 102.64 11.2 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 174.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 44.9 t -89.97 99.17 12.24 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -115.51 139.8 49.73 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.219 -168.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 55.2 m -84.74 132.25 34.47 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.292 174.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 59.4 mt -86.38 115.35 27.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.057 0.456 . . . . 0.0 110.914 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . 0.416 HD12 ' N ' ' D' ' 25' ' ' LYS . 1.9 pp -88.67 -12.51 10.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.417 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . 0.416 ' N ' HD12 ' D' ' 24' ' ' ILE . 83.3 tttt -159.93 120.28 2.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.493 178.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 13.6 m -51.6 137.13 25.4 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 123.761 0.663 . . . . 0.0 110.415 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 27' ' ' PHE . . . . . 0.735 ' HB3' HD23 ' D' ' 91' ' ' LEU . 32.9 p90 -147.39 165.27 30.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.399 0.619 . . . . 0.0 112.569 -174.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 28' ' ' HIS . . . . . 0.495 ' HA ' ' O ' ' D' ' 67' ' ' LEU . 8.3 t60 -116.15 120.3 38.59 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.676 177.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 29' ' ' ILE . . . . . 0.53 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 42.4 mt -84.5 134.66 26.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 169.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . 0.51 ' HB2' ' HB3' ' E' ' 66' ' ' ASP . 77.2 p -119.6 -10.12 9.67 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -171.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 31' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -178.15 158.5 23.38 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 119.309 -1.425 . . . . 0.0 113.686 177.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.476 HG23 ' HG ' ' D' ' 87' ' ' LEU . 12.0 p -139.67 137.26 39.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 175.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -150.16 154.85 38.74 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.025 -0.422 . . . . 0.0 110.916 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 34' ' ' LEU . . . . . 0.543 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.3 pp -118.24 140.01 50.45 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.957 0.884 . . . . 0.0 111.607 178.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -110.32 -53.31 2.7 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.556 174.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -101.54 126.79 48.41 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.631 175.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . 0.496 ' HA3' ' HA ' ' D' ' 83' ' ' ALA . . . 140.65 165.67 10.39 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 119.554 -1.308 . . . . 0.0 113.447 178.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -102.8 -46.46 4.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.485 0.183 . . . . 0.0 111.409 176.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -151.44 134.21 15.66 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.012 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -132.76 113.7 13.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.433 0.635 . . . . 0.0 110.53 170.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' D' ' 79' ' ' THR . 65.4 mttp -98.16 113.28 25.13 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 174.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.425 ' HG ' ' CG2' ' D' ' 53' ' ' VAL . 58.8 tp -89.95 109.05 20.1 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.409 -170.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 43' ' ' TYR . . . . . 0.548 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 70.6 m-85 -108.97 148.55 30.54 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.989 177.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.668 ' HB2' ' CE1' ' D' ' 77' ' ' PHE . 0.4 OUTLIER -128.37 117.08 20.8 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.568 176.092 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 45' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -102.89 104.46 14.7 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.376 0.608 . . . . 0.0 109.871 176.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.492 ' HB2' HD11 ' D' ' 44' ' ' LEU . . . -128.85 143.62 50.95 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.034 -0.984 . . . . 0.0 108.377 178.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 61.2 26.55 16.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.711 0.767 . . . . 0.0 109.104 -174.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 59.29 38.23 23.29 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.992 -177.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . 0.562 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 6.6 tp-100 -129.53 127.91 41.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.685 178.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -81.47 106.08 13.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.069 0.461 . . . . 0.0 110.607 -178.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -102.3 116.97 33.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.355 176.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -74.67 99.88 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 53' ' ' VAL . . . . . 0.463 HG12 ' CD2' ' C' ' 88' ' ' LEU . 28.6 m -87.43 -32.43 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.586 -172.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 54' ' ' ALA . . . . . 0.748 ' HB2' HD21 ' D' ' 65' ' ' LEU . . . -152.93 142.27 21.61 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.246 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 27.2 m -112.97 102.05 10.05 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 169.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 p -118.4 112.33 37.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.904 0.859 . . . . 0.0 110.421 -176.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 78.4 p -123.33 -177.34 3.68 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.155 -176.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -60.86 -29.47 69.55 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.486 168.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.12 -40.68 62.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.326 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 77.6 mt -117.77 81.7 15.54 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 173.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.38 -4.1 12.22 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.137 2.558 . . . . 0.0 113.938 -168.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -160.69 129.69 4.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.299 0.571 . . . . 0.0 111.164 -175.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 97.1 t -120.12 125.67 74.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.555 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.43 130.83 34.5 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 65' ' ' LEU . . . . . 0.748 HD21 ' HB2' ' D' ' 54' ' ' ALA . 88.3 mt -122.97 166.53 14.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.353 0.597 . . . . 0.0 112.302 -173.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 66' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 26.1 t0 -144.44 98.0 3.13 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 170.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.53 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 6.9 mt -132.94 109.33 9.51 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.415 -175.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 68' ' ' ASN . . . . . 0.424 ' HB2' ' CD2' ' C' ' 90' ' ' TYR . 7.5 m-20 -104.72 114.67 29.03 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.857 0.36 . . . . 0.0 110.119 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -108.1 160.33 15.89 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.333 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 35.6 t -116.17 149.54 38.92 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.696 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -69.07 0.12 5.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.241 -176.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.45 -18.41 35.93 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.437 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -101.49 164.16 11.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.735 0.302 . . . . 0.0 110.848 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -131.08 108.92 10.1 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . . . . . . . . . 22.4 pt -109.57 158.47 9.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.22 -170.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 76' ' ' MET . . . . . 0.444 ' HA ' ' HA ' ' D' ' 20' ' ' SER . 2.5 mtm -116.67 122.78 45.53 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 120.281 -0.567 . . . . 0.0 109.904 175.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 77' ' ' PHE . . . . . 0.668 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.7 OUTLIER -104.53 128.57 52.51 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.727 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 78' ' ' TYR . . . . . 0.714 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 36.5 p90 -149.97 135.38 18.19 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.622 0.725 . . . . 0.0 112.608 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 79' ' ' THR . . . . . 0.524 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 3.9 p -106.41 132.43 52.44 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.788 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.35 154.47 18.17 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.806 177.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.417 ' O ' ' HG3' ' D' ' 16' ' ' GLU . . . 91.41 -172.21 35.93 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -176.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 82' ' ' ASP . . . . . 0.413 ' HA ' ' HB3' ' D' ' 15' ' ' PRO . 21.2 t70 -113.09 102.79 10.73 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 119.584 -0.846 . . . . 0.0 109.894 176.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . 0.529 ' H ' ' HB3' ' D' ' 15' ' ' PRO . . . -169.2 153.7 5.56 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.846 167.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 24.3 t -110.98 120.73 43.36 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.543 HG12 ' HB3' ' D' ' 34' ' ' LEU . 3.8 m -115.0 149.37 17.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.538 0.685 . . . . 0.0 112.764 -172.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 24.6 m -110.97 115.39 29.4 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.569 175.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 87' ' ' LEU . . . . . 0.569 HD11 ' SD ' ' D' ' 13' ' ' MET . 4.7 mp -94.8 145.14 25.09 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 170.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.561 HD12 ' CE1' ' D' ' 8' ' ' PHE . 2.4 mm? -124.35 149.56 46.5 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.81 -167.28 26.2 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.441 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 90' ' ' TYR . . . . . 0.464 ' CD2' ' HB2' ' E' ' 68' ' ' ASN . 5.2 p90 -149.33 131.26 15.21 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.744 0.783 . . . . 0.0 111.811 176.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . 0.735 HD23 ' HB3' ' D' ' 27' ' ' PHE . 27.5 mt -63.81 138.95 58.7 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.289 176.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . 0.427 ' HD1' ' CG ' ' C' ' 95' ' ' ASP . 23.0 m-70 -65.8 120.33 12.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.761 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -150.79 169.67 21.11 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' D' ' 5' ' ' MET . 2.2 pp -91.75 149.13 4.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.808 -178.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 95' ' ' ASP . . . . . 0.415 ' CG ' ' HD1' ' E' ' 92' ' ' HIS . 0.1 OUTLIER -90.44 98.61 11.88 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.761 -178.447 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 28.5 t -67.09 105.72 1.76 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.079 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.39 -48.92 4.11 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.042 178.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.995 -0.526 . . . . 0.0 110.498 -176.827 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.513 0.197 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -71.4 90.39 0.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.039 0.447 . . . . 0.0 110.6 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . 142.56 -137.71 7.95 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 111.439 -0.665 . . . . 0.0 111.439 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -141.82 -175.03 4.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.671 0.235 . . . . 0.0 110.692 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 5' ' ' MET . . . . . 0.444 ' HA ' ' O ' ' E' ' 94' ' ' ILE . 2.7 mpt? -142.64 -173.65 3.93 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 175.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.58 119.98 5.13 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 174.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 21.7 ttt -103.29 140.82 36.91 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -170.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 8' ' ' PHE . . . . . 0.572 ' CE1' HD12 ' E' ' 88' ' ' LEU . 77.7 t80 -54.65 141.54 31.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.899 -176.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 9' ' ' TRP . . . . . 0.518 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 89.5 t90 -133.43 147.27 51.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.55 177.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.86 145.62 14.63 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.625 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . 0.557 HD23 HD13 ' E' ' 87' ' ' LEU . 49.8 tp -136.07 108.85 7.54 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.007 0.432 . . . . 0.0 110.261 176.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -96.68 100.98 12.51 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 13' ' ' MET . . . . . 0.563 ' SD ' HD11 ' E' ' 87' ' ' LEU . 60.3 mtp -92.41 143.47 26.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.227 0.537 . . . . 0.0 111.451 -172.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -100.51 144.95 29.45 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.386 178.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . 0.528 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 9.5 Cg_endo -51.8 123.21 11.85 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.651 2.901 . . . . 0.0 113.623 -174.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 16' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' E' ' 79' ' ' THR . 35.9 mt-10 57.77 73.45 0.47 Allowed 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.722 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.85 138.44 19.67 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.203 176.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . 0.718 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 50.2 mttp -107.32 121.99 45.67 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 123.387 0.43 . . . . 0.0 111.306 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' E' ' 76' ' ' MET . 3.1 m-85 -110.62 102.67 11.22 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 174.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 20' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' E' ' 76' ' ' MET . 44.6 t -89.99 99.18 12.24 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 173.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -115.5 139.85 49.68 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.279 -168.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 56.0 m -84.81 132.15 34.45 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.382 174.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 59.3 mt -86.32 115.37 27.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.086 0.469 . . . . 0.0 110.932 -175.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . 0.426 HD12 ' N ' ' E' ' 25' ' ' LYS . 1.9 pp -88.69 -12.49 10.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.414 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . 0.426 ' N ' HD12 ' E' ' 24' ' ' ILE . 83.3 tttt -159.95 120.19 2.97 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.501 178.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 13.6 m -51.53 137.07 25.1 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.801 0.688 . . . . 0.0 110.498 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 27' ' ' PHE . . . . . 0.729 ' HB3' HD23 ' E' ' 91' ' ' LEU . 33.1 p90 -147.31 165.19 30.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.422 0.629 . . . . 0.0 112.597 -174.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 28' ' ' HIS . . . . . 0.502 ' HA ' ' O ' ' E' ' 67' ' ' LEU . 8.3 t60 -115.97 120.32 38.78 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.682 -1.144 . . . . 0.0 109.786 176.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 29' ' ' ILE . . . . . 0.529 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 42.1 mt -84.61 134.66 26.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 169.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . 0.539 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 76.6 p -119.59 -10.03 9.69 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -171.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 31' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -178.11 158.55 23.49 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.252 -1.451 . . . . 0.0 113.595 177.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.485 HG23 ' HG ' ' E' ' 87' ' ' LEU . 12.0 p -139.77 137.25 39.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 174.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -150.17 154.83 38.68 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.916 -178.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 34' ' ' LEU . . . . . 0.541 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.3 pp -118.24 140.04 50.4 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.953 0.882 . . . . 0.0 111.665 178.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -110.4 -53.3 2.7 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 113.98 -1.464 . . . . 0.0 108.494 174.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -101.54 126.77 48.4 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.676 175.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' E' ' 83' ' ' ALA . . . 140.55 165.73 10.41 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 119.6 -1.286 . . . . 0.0 113.552 178.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -102.79 -46.55 4.67 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 123.501 0.177 . . . . 0.0 111.417 177.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -151.39 134.28 15.75 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.693 -0.23 . . . . 0.0 110.992 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . 0.511 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -132.84 113.68 13.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.416 0.627 . . . . 0.0 110.442 170.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 41' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' E' ' 79' ' ' THR . 65.4 mttp -98.16 113.24 25.08 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 174.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.425 ' HG ' ' CG2' ' E' ' 53' ' ' VAL . 58.9 tp -89.91 109.08 20.12 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.396 -170.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 43' ' ' TYR . . . . . 0.542 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 71.2 m-85 -109.0 148.62 30.47 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.931 177.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 44' ' ' LEU . . . . . 0.672 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 0.4 OUTLIER -128.46 117.16 20.87 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.52 176.105 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' E' E ' 45' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -102.95 104.41 14.62 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.412 0.625 . . . . 0.0 109.877 176.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . 0.486 ' HB2' HD11 ' E' ' 44' ' ' LEU . . . -128.85 143.67 50.97 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.302 178.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 61.16 26.57 16.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.802 0.81 . . . . 0.0 109.131 -174.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 59.31 38.23 23.2 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.952 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 49' ' ' GLN . . . . . 0.56 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 6.6 tp-100 -129.49 127.92 41.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.696 178.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -81.53 106.13 13.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.081 0.467 . . . . 0.0 110.567 -178.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -102.35 116.97 33.73 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.33 176.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 tp -74.71 99.85 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . 0.497 HG12 ' CD2' ' D' ' 88' ' ' LEU . 29.3 m -87.35 -32.54 6.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.606 -172.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 54' ' ' ALA . . . . . 0.762 ' HB2' HD21 ' E' ' 65' ' ' LEU . . . -152.9 142.35 21.71 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 120.334 -0.547 . . . . 0.0 112.191 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 27.0 m -112.92 102.05 10.07 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 169.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 p -118.37 112.37 37.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.881 0.848 . . . . 0.0 110.416 -176.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 76.1 p -123.44 -177.38 3.69 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.172 -176.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -60.89 -29.33 69.51 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.516 168.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.2 -40.71 62.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.266 0.555 . . . . 0.0 110.345 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 77.3 mt -117.64 81.57 14.89 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 173.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.31 -4.11 12.17 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.16 2.573 . . . . 0.0 113.97 -168.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -160.65 129.7 4.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.273 0.559 . . . . 0.0 111.148 -175.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 96.9 t -120.12 125.63 74.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.524 176.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.4 130.73 34.52 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 175.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.762 HD21 ' HB2' ' E' ' 54' ' ' ALA . 88.1 mt -122.82 166.51 14.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.444 0.64 . . . . 0.0 112.342 -173.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 66' ' ' ASP . . . . . 0.51 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 26.6 t0 -144.44 98.04 3.14 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 170.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 67' ' ' LEU . . . . . 0.529 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 7.0 mt -132.97 109.33 9.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.456 -175.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 68' ' ' ASN . . . . . 0.464 ' HB2' ' CD2' ' D' ' 90' ' ' TYR . 7.5 m-20 -104.66 114.67 29.03 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.831 0.348 . . . . 0.0 110.149 178.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -108.17 160.31 15.92 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.269 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 36.6 t -116.15 149.68 38.64 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.635 -177.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -69.15 0.11 5.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.136 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -94.51 -18.45 35.62 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.346 177.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -101.48 164.15 11.91 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.697 -0.296 . . . . 0.0 110.851 -176.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -131.09 108.77 9.99 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 75' ' ' ILE . . . . . . . . . . . . . 22.3 pt -109.43 158.39 9.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.29 -170.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 76' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' E' ' 20' ' ' SER . 2.5 mtm -116.66 122.79 45.59 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.906 175.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 77' ' ' PHE . . . . . 0.672 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.7 OUTLIER -104.46 128.62 52.4 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.653 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' E' E ' 78' ' ' TYR . . . . . 0.718 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 36.6 p90 -150.05 135.24 17.99 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.57 0.7 . . . . 0.0 112.569 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 79' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 3.9 p -106.29 132.57 52.18 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.806 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.55 154.38 18.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.778 177.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 81' ' ' GLY . . . . . 0.417 ' O ' ' HG3' ' E' ' 16' ' ' GLU . . . 91.46 -172.22 35.85 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -176.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -113.04 102.83 10.78 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.881 176.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 83' ' ' ALA . . . . . 0.528 ' H ' ' HB3' ' E' ' 15' ' ' PRO . . . -169.28 153.68 5.48 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.84 167.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 24.3 t -110.98 120.72 43.33 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 85' ' ' VAL . . . . . 0.541 HG12 ' HB3' ' E' ' 34' ' ' LEU . 3.8 m -114.98 149.39 17.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -172.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 24.6 m -110.97 115.24 29.15 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.619 175.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 87' ' ' LEU . . . . . 0.563 HD11 ' SD ' ' E' ' 13' ' ' MET . 4.8 mp -94.79 145.15 25.08 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 170.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . 0.572 HD12 ' CE1' ' E' ' 8' ' ' PHE . 2.4 mm? -124.34 149.58 46.45 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.92 -167.35 26.41 Favored Glycine 0 N--CA 1.437 -1.275 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.376 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 90' ' ' TYR . . . . . 0.451 ' CD2' ' HB2' ' A' ' 68' ' ' ASN . 5.1 p90 -149.31 131.34 15.31 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.744 0.783 . . . . 0.0 111.766 176.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 91' ' ' LEU . . . . . 0.729 HD23 ' HB3' ' E' ' 27' ' ' PHE . 27.2 mt -63.81 138.97 58.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.29 176.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 92' ' ' HIS . . . . . 0.415 ' HD1' ' CG ' ' D' ' 95' ' ' ASP . 22.7 m-70 -65.84 120.38 12.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.671 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -150.81 169.68 21.09 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 94' ' ' ILE . . . . . 0.448 ' O ' HD12 ' E' ' 94' ' ' ILE . 2.2 pp -91.75 149.16 4.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.798 -178.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 95' ' ' ASP . . . . . 0.427 ' CG ' ' HD1' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -90.48 98.68 11.92 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.805 -178.497 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 28.5 t -67.1 105.74 1.77 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.061 177.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.48 -48.86 4.11 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.048 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 17.0 m . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.899 -0.572 . . . . 0.0 110.454 -176.93 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.675 ' HA ' ' OD1' ' B' ' 95' ' ' ASP . 29.2 p90 . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 110.713 -0.106 . . . . 0.0 110.713 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 63.66 84.06 0.15 Allowed 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.719 0.637 . . . . 0.0 111.41 -176.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.53 55.7 4.68 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.237 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.15 34.77 0.52 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.112 0.482 . . . . 0.0 110.428 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 72.4 mtm -89.96 -13.82 35.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.53 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' A' ' 91' ' ' LEU . . . -109.92 99.54 8.64 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.765 177.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 48.5 mtt -105.11 167.68 9.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.754 -172.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.565 ' CE1' HD21 ' B' ' 44' ' ' LEU . 70.4 t80 -69.46 146.36 52.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.21 0.529 . . . . 0.0 112.191 -175.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.475 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 92.2 t90 -136.7 145.58 44.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.025 176.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.53 146.6 16.3 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.531 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.517 HD23 HD13 ' A' ' 87' ' ' LEU . 43.6 tp -138.48 109.9 6.98 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.885 0.374 . . . . 0.0 110.507 177.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -97.33 105.12 17.22 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.55 ' SD ' HD11 ' A' ' 87' ' ' LEU . 44.3 mtp -98.39 143.95 28.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.917 0.389 . . . . 0.0 111.038 -174.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.524 ' HB2' ' HG3' ' A' ' 17' ' ' ARG . 37.8 mtmm -100.98 157.7 33.16 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.367 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.518 ' HB3' ' HA ' ' A' ' 82' ' ' ASP . 91.1 Cg_exo -47.76 115.42 1.44 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.581 2.854 . . . . 0.0 113.66 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.667 ' HA ' ' O ' ' A' ' 79' ' ' THR . 44.6 mt-10 59.8 58.36 2.84 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.368 0.604 . . . . 0.0 111.848 175.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.524 ' HG3' ' HB2' ' A' ' 14' ' ' LYS . 29.1 mmt180 -118.68 153.17 34.79 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.946 174.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.683 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 3.5 ttmp? -130.95 110.82 11.53 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 123.456 0.473 . . . . 0.0 110.958 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -111.38 112.6 24.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.885 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -75.14 114.56 13.77 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 171.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -92.81 114.09 26.54 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.426 -165.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.7 m -93.62 119.56 32.8 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.108 172.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.3 mt -96.79 113.01 30.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.99 0.424 . . . . 0.0 111.342 -173.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.2 mp -88.91 -34.75 7.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.444 0.64 . . . . 0.0 109.342 177.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.427 ' HD2' HD13 ' A' ' 91' ' ' LEU . 19.4 pttt -132.73 128.74 37.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.183 178.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.2 m -56.2 148.36 18.46 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.746 -176.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.736 ' HB3' HD23 ' A' ' 91' ' ' LEU . 38.5 p90 -157.97 162.87 38.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.717 0.77 . . . . 0.0 112.924 -178.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.535 ' NE2' ' HB3' ' A' ' 30' ' ' SER . 2.0 t60 -119.18 123.83 45.3 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.392 -1.277 . . . . 0.0 109.444 176.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.574 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 51.7 mt -85.27 134.68 26.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 170.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.541 ' HB2' ' HB3' ' B' ' 66' ' ' ASP . 61.7 p -117.55 -15.01 10.26 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -171.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -171.41 152.1 17.08 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 119.43 -1.367 . . . . 0.0 113.242 177.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.485 HG23 ' HG ' ' A' ' 87' ' ' LEU . 11.3 p -136.68 131.51 47.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 174.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.88 155.99 42.21 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.014 -0.429 . . . . 0.0 111.161 -176.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.489 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.1 pp -118.05 141.28 48.64 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.887 0.851 . . . . 0.0 111.925 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -110.07 -54.18 2.6 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.807 176.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -100.85 128.12 47.02 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 171.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.551 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 139.25 161.57 8.78 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 119.705 -1.236 . . . . 0.0 113.373 176.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -103.4 -43.81 5.32 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -149.42 132.32 16.11 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 120.512 0.196 . . . . 0.0 111.043 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.474 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -131.74 113.8 13.98 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.409 0.624 . . . . 0.0 110.128 169.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 79' ' ' THR . 97.4 mttt -96.25 110.57 22.85 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 175.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.403 ' HG ' ' CG2' ' A' ' 53' ' ' VAL . 51.0 tp -87.02 109.76 19.61 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.025 -172.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.434 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . 96.8 m-85 -108.25 141.85 39.42 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.252 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.559 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 1.5 tp -123.57 112.79 17.86 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.488 176.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.582 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -99.18 108.84 21.53 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.19 0.519 . . . . 0.0 109.855 176.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.479 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -139.66 140.9 37.03 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.529 -177.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 53.33 41.93 32.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.526 0.679 . . . . 0.0 110.248 -178.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.2 mttp 69.87 21.46 6.32 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.414 172.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.582 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 79.2 mm-40 -128.36 137.44 51.9 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 122.211 -0.306 . . . . 0.0 111.097 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -87.31 104.94 16.88 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 174.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 49' ' ' GLN . 75.8 m-85 -99.83 120.22 39.41 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.775 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -77.36 99.96 2.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 170.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.52 HG12 ' CD2' ' E' ' 88' ' ' LEU . 18.5 m -86.97 -34.58 7.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.817 -172.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.563 ' HB2' ' CD2' ' A' ' 65' ' ' LEU . . . -151.13 140.83 21.75 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.107 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.7 m -111.52 101.25 9.68 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 169.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.15 113.71 43.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.724 0.773 . . . . 0.0 110.052 -176.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 78.2 p -123.27 -177.89 3.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.204 -175.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -64.0 -24.22 67.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.025 0.441 . . . . 0.0 110.53 169.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.39 -40.52 43.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.169 176.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.6 mt -116.84 81.92 12.53 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 173.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.94 -5.15 12.77 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.206 2.604 . . . . 0.0 114.133 -167.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -160.48 128.62 4.61 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.129 0.49 . . . . 0.0 111.189 -175.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.2 t -118.45 108.19 23.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.408 175.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.71 121.46 30.17 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 174.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.563 ' CD2' ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -143.66 168.79 19.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.147 0.499 . . . . 0.0 111.978 -174.42 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.558 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 9.5 t0 -116.36 107.13 14.43 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.739 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.574 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 32.9 mt -126.37 107.74 10.58 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 177.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -111.08 127.87 55.69 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.913 -178.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -127.19 150.32 49.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.908 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.0 m -102.59 161.78 13.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.057 0.456 . . . . 0.0 110.748 176.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -69.34 -5.1 21.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.159 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.78 -7.72 62.66 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.446 -0.661 . . . . 0.0 111.446 173.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -100.28 143.55 30.33 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -122.97 125.59 45.57 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 174.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.496 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 15.0 pt -132.06 172.18 16.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.744 -171.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 7.9 mtm -130.04 131.68 45.92 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 170.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.559 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -110.25 128.33 55.45 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 177.348 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.683 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 40.9 p90 -153.69 140.43 19.01 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.292 -0.563 . . . . 0.0 112.12 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.667 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 8.0 p -111.92 136.43 51.24 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.25 -177.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.61 161.07 14.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.232 174.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.5 ' O ' ' HG3' ' A' ' 16' ' ' GLU . . . 81.97 177.27 51.73 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -173.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.518 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 7.0 p-10 -112.97 104.11 12.07 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 118.284 -1.367 . . . . 0.0 110.848 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.551 ' CB ' ' HA3' ' A' ' 37' ' ' GLY . . . -164.76 153.26 12.37 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 113.734 -1.575 . . . . 0.0 109.882 169.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.6 p -104.97 123.39 47.7 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 177.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.489 HG12 ' HB3' ' A' ' 34' ' ' LEU . 3.6 m -118.23 144.43 26.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.556 0.693 . . . . 0.0 112.776 -173.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.8 m -108.02 116.25 31.61 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.739 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.55 HD11 ' SD ' ' A' ' 13' ' ' MET . 4.5 mp -96.02 143.02 27.55 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 170.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.543 ' CD2' HG12 ' B' ' 53' ' ' VAL . 2.6 mm? -124.97 152.04 44.71 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 174.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.6 -167.86 30.73 Favored Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.429 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -139.15 131.42 28.3 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.498 0.666 . . . . 0.0 110.805 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.736 HD23 ' HB3' ' A' ' 27' ' ' PHE . 24.1 mt -62.68 131.73 49.93 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.892 173.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.65 -179.46 4.13 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.747 -176.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -41.82 107.96 0.09 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.392 1.058 . . . . 0.0 112.192 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 47.1 mt -68.74 -13.51 17.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.715 174.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.596 ' OD1' ' HA ' ' E' ' 1' ' ' PHE . 40.5 t0 70.78 59.65 0.2 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.148 175.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.9 p -105.67 -33.74 7.95 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.206 175.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.426 ' HA2' ' CZ ' ' A' ' 1' ' ' PHE . . . -133.76 34.35 2.42 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.407 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 31.6 t . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.831 -179.57 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.693 ' HA ' ' OD1' ' C' ' 95' ' ' ASP . 29.5 p90 . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 110.735 -0.098 . . . . 0.0 110.735 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 63.73 83.99 0.15 Allowed 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.717 0.636 . . . . 0.0 111.455 -176.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.5 55.66 4.67 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.233 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.07 34.73 0.53 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.104 0.478 . . . . 0.0 110.365 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 72.4 mtm -89.84 -13.81 35.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.594 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' B' ' 91' ' ' LEU . . . -109.98 99.57 8.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.747 177.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 48.5 mtt -105.07 167.72 9.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.788 -172.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.561 ' CE1' HD21 ' C' ' 44' ' ' LEU . 70.5 t80 -69.42 146.35 52.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.231 0.539 . . . . 0.0 112.19 -175.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . 0.474 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 92.1 t90 -136.73 145.58 44.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.981 176.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.4 146.66 16.45 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.589 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.505 HD23 HD13 ' B' ' 87' ' ' LEU . 43.9 tp -138.44 109.84 6.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.792 0.329 . . . . 0.0 110.531 177.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -97.41 105.07 17.16 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . 0.554 ' SD ' HD11 ' B' ' 87' ' ' LEU . 44.3 mtp -98.33 143.88 28.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.111 -174.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.525 ' HB2' ' HG3' ' B' ' 17' ' ' ARG . 37.9 mtmm -101.02 157.77 33.03 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.256 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.53 ' HB3' ' HA ' ' B' ' 82' ' ' ASP . 93.4 Cg_exo -47.86 115.4 1.45 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.619 2.879 . . . . 0.0 113.629 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.661 ' HA ' ' O ' ' B' ' 79' ' ' THR . 44.5 mt-10 59.87 58.39 2.8 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 121.256 0.55 . . . . 0.0 111.841 175.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.525 ' HG3' ' HB2' ' B' ' 14' ' ' LYS . 29.0 mmt180 -118.8 153.19 34.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.891 174.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.683 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 3.5 ttmp? -130.91 110.68 11.45 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.04 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -111.33 112.59 24.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.909 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 4.5 p -75.1 114.61 13.8 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 171.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -92.82 114.04 26.48 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.425 -165.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 22.9 m -93.51 119.46 32.61 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.175 172.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 42.1 mt -96.78 112.9 29.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.05 0.452 . . . . 0.0 111.407 -173.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.454 ' N ' HD12 ' B' ' 24' ' ' ILE . 4.2 mp -88.86 -34.78 7.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.302 177.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.406 ' HD2' HD13 ' B' ' 91' ' ' LEU . 19.5 pttt -132.75 128.74 37.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.088 178.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -56.21 148.35 18.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.84 -177.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . 0.73 ' HB3' HD23 ' B' ' 91' ' ' LEU . 38.7 p90 -157.96 162.91 38.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.702 0.763 . . . . 0.0 112.881 -178.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' HIS . . . . . 0.532 ' NE2' ' HB3' ' B' ' 30' ' ' SER . 2.0 t60 -119.24 123.83 45.24 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.345 176.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.578 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 51.6 mt -85.27 134.6 26.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 170.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.567 ' HB2' ' HB3' ' C' ' 66' ' ' ASP . 61.5 p -117.48 -15.01 10.31 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -171.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -171.38 152.15 17.24 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.443 -1.361 . . . . 0.0 113.245 177.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.488 HG23 ' HG ' ' B' ' 87' ' ' LEU . 11.2 p -136.67 131.53 47.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 174.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.91 156.01 42.22 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.066 -0.396 . . . . 0.0 111.134 -176.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.5 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.1 pp -118.08 141.42 48.5 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.848 0.833 . . . . 0.0 111.96 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -110.17 -54.17 2.6 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.768 176.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -100.92 128.1 47.1 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.862 171.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.555 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 139.32 161.55 8.77 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 119.583 -1.294 . . . . 0.0 113.35 176.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -103.32 -43.83 5.33 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 178.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -149.44 132.41 16.18 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.543 0.211 . . . . 0.0 110.983 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.459 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -131.84 113.71 13.82 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.388 0.613 . . . . 0.0 110.12 169.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' B' ' 79' ' ' THR . 97.3 mttt -96.22 110.59 22.86 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.409 ' HG ' ' CG2' ' B' ' 53' ' ' VAL . 51.1 tp -87.05 109.73 19.6 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.062 -172.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . 0.428 ' HB2' ' CE1' ' B' ' 78' ' ' TYR . 96.7 m-85 -108.2 141.85 39.32 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.293 178.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.565 HD21 ' CE1' ' A' ' 8' ' ' PHE . 1.5 tp -123.58 112.84 17.92 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.451 176.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -99.21 108.86 21.55 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.178 0.513 . . . . 0.0 109.82 176.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.481 ' CB ' HG22 ' B' ' 75' ' ' ILE . . . -139.69 140.97 36.97 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.535 -177.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 53.25 41.95 32.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.557 0.694 . . . . 0.0 110.238 -177.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 39.2 mttp 69.93 21.41 6.26 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.404 172.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.573 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 79.1 mm-40 -128.33 137.49 51.95 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.055 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -87.27 104.88 16.82 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.432 ' CZ ' ' HB2' ' B' ' 49' ' ' GLN . 76.0 m-85 -99.92 120.27 39.53 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.71 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -77.33 99.98 2.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 170.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.543 HG12 ' CD2' ' A' ' 88' ' ' LEU . 18.9 m -86.92 -34.68 7.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.878 -172.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.556 ' HB2' ' CD2' ' B' ' 65' ' ' LEU . . . -151.08 140.79 21.77 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 120.383 -0.527 . . . . 0.0 112.139 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 21.8 m -111.47 101.29 9.74 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 169.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.23 113.73 43.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.707 0.765 . . . . 0.0 110.052 -176.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 74.6 p -123.3 -177.82 3.81 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.201 -175.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -63.98 -24.27 67.65 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.508 169.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.33 -40.58 43.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.291 0.567 . . . . 0.0 110.187 176.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 79.8 mt -116.82 81.99 12.56 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 173.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.07 -5.16 12.93 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.232 2.621 . . . . 0.0 114.053 -167.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -160.42 128.63 4.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.273 0.558 . . . . 0.0 111.242 -175.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 88.9 t -118.58 108.23 23.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.462 175.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.72 121.47 30.19 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 174.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.556 ' CD2' ' HB2' ' B' ' 54' ' ' ALA . 0.4 OUTLIER -143.65 168.78 19.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.074 0.464 . . . . 0.0 112.009 -174.459 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . 0.541 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 9.4 t0 -116.32 107.13 14.44 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.772 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.578 ' HB2' ' HB ' ' B' ' 29' ' ' ILE . 32.7 mt -126.38 107.69 10.53 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 177.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -111.16 127.9 55.73 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.915 -178.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -127.13 150.34 49.54 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.883 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 58.1 m -102.62 161.78 13.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.071 0.462 . . . . 0.0 110.748 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -69.19 -5.22 21.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.231 177.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.79 -7.62 62.73 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 173.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -100.32 143.53 30.4 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -123.0 125.63 45.61 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 174.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.501 ' HB ' ' CD1' ' B' ' 44' ' ' LEU . 15.1 pt -132.07 172.15 16.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.718 -171.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . . . . . . . . . 7.9 mtm -129.97 131.7 46.03 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 170.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . 0.564 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.9 OUTLIER -110.22 128.32 55.43 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.29 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.683 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 41.1 p90 -153.6 140.42 19.1 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.299 -0.56 . . . . 0.0 112.098 -178.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.661 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 8.1 p -111.91 136.48 51.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.216 -177.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.65 161.06 14.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.207 174.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.494 ' O ' ' HG3' ' B' ' 16' ' ' GLU . . . 81.93 177.38 51.78 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -173.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' ASP . . . . . 0.53 ' HA ' ' HB3' ' B' ' 15' ' ' PRO . 6.9 p-10 -113.14 104.18 12.1 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 118.267 -1.373 . . . . 0.0 110.82 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.555 ' CB ' ' HA3' ' B' ' 37' ' ' GLY . . . -164.83 153.25 12.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 113.638 -1.619 . . . . 0.0 109.861 169.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 6.7 p -104.96 123.4 47.71 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.5 HG12 ' HB3' ' B' ' 34' ' ' LEU . 3.5 m -118.21 144.44 26.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.571 0.7 . . . . 0.0 112.744 -173.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 50.9 m -108.11 116.25 31.62 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.704 175.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.554 HD11 ' SD ' ' B' ' 13' ' ' MET . 4.5 mp -96.04 143.14 27.45 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 170.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.524 ' CD2' HG12 ' C' ' 53' ' ' VAL . 2.6 mm? -125.09 151.96 44.99 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 174.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.55 -167.89 30.73 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.328 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -139.11 131.46 28.44 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.515 0.674 . . . . 0.0 110.851 176.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . 0.73 HD23 ' HB3' ' B' ' 27' ' ' PHE . 23.4 mt -62.65 131.62 49.61 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.923 173.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.61 -179.48 4.11 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 123.36 0.413 . . . . 0.0 110.699 -176.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -41.79 108.03 0.09 Allowed 'General case' 0 C--N 1.326 -0.424 0 O-C-N 124.4 1.062 . . . . 0.0 112.242 -175.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . . . . . . . . . 47.2 mt -68.85 -13.45 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.673 0.749 . . . . 0.0 109.729 174.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . 0.675 ' OD1' ' HA ' ' A' ' 1' ' ' PHE . 40.4 t0 70.82 59.53 0.2 Allowed 'General case' 0 CA--C 1.523 -0.08 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.212 175.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 7.7 p -105.61 -33.63 8.01 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.166 175.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 97' ' ' GLY . . . . . 0.431 ' HA2' ' CZ ' ' B' ' 1' ' ' PHE . . . -133.79 34.29 2.42 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.367 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 31.9 t . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.461 -0.78 . . . . 0.0 109.805 -179.598 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' 1' ' ' PHE . . . . . 0.633 ' HA ' ' OD1' ' D' ' 95' ' ' ASP . 29.4 p90 . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 110.709 -0.108 . . . . 0.0 110.709 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 63.81 83.95 0.16 Allowed 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.646 0.592 . . . . 0.0 111.475 -176.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.48 55.65 4.67 Favored Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.258 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.13 34.63 0.53 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.172 0.51 . . . . 0.0 110.364 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 5' ' ' MET . . . . . . . . . . . . . 72.4 mtm -89.8 -13.79 35.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.594 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 6' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' C' ' 91' ' ' LEU . . . -110.03 99.65 8.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.728 177.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 48.6 mtt -105.27 167.75 9.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.666 -172.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 8' ' ' PHE . . . . . 0.581 ' CE1' HD21 ' D' ' 44' ' ' LEU . 70.6 t80 -69.41 146.36 52.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.284 0.564 . . . . 0.0 112.174 -175.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . 0.471 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 92.2 t90 -136.7 145.5 44.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.008 176.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.47 146.6 16.31 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.575 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.523 HD23 HD13 ' C' ' 87' ' ' LEU . 44.0 tp -138.37 109.87 7.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.834 0.35 . . . . 0.0 110.56 177.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -97.33 105.01 17.08 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 13' ' ' MET . . . . . 0.543 ' SD ' HD11 ' C' ' 87' ' ' LEU . 44.2 mtp -98.34 144.0 28.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.994 0.426 . . . . 0.0 111.041 -174.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . 0.522 ' HB2' ' HG3' ' C' ' 17' ' ' ARG . 37.8 mtmm -101.13 157.7 33.17 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.25 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . 0.533 ' HB3' ' HA ' ' C' ' 82' ' ' ASP . 92.2 Cg_exo -47.78 115.43 1.45 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.609 2.873 . . . . 0.0 113.585 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' C' ' 79' ' ' THR . 44.5 mt-10 59.81 58.36 2.83 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.306 0.574 . . . . 0.0 111.874 175.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 17' ' ' ARG . . . . . 0.522 ' HG3' ' HB2' ' C' ' 14' ' ' LYS . 29.0 mmt180 -118.72 153.24 34.71 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.939 174.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 18' ' ' LYS . . . . . 0.692 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 3.5 ttmp? -130.98 110.81 11.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.0 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -111.41 112.63 24.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.848 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 4.4 p -75.2 114.7 14.02 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 172.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -92.97 114.11 26.57 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.43 -165.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 24.0 m -93.53 119.52 32.69 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.124 172.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 42.4 mt -96.84 112.97 30.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.158 0.504 . . . . 0.0 111.324 -173.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . 0.448 HD12 ' N ' ' C' ' 24' ' ' ILE . 4.2 mp -88.88 -34.76 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.294 177.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . 0.413 ' HD2' HD13 ' C' ' 91' ' ' LEU . 19.4 pttt -132.76 128.76 37.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.097 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 16.2 m -56.25 148.4 18.54 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.806 -177.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 27' ' ' PHE . . . . . 0.733 ' HB3' HD23 ' C' ' 91' ' ' LEU . 38.5 p90 -158.02 162.88 38.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.722 0.772 . . . . 0.0 112.867 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 28' ' ' HIS . . . . . 0.545 ' NE2' ' HB3' ' C' ' 30' ' ' SER . 2.0 t60 -119.19 123.84 45.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.392 176.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . 0.574 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 51.5 mt -85.21 134.64 26.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 170.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.545 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 61.8 p -117.5 -15.03 10.29 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -171.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -171.36 152.1 17.14 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 119.517 -1.325 . . . . 0.0 113.27 177.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.487 HG23 ' HG ' ' C' ' 87' ' ' LEU . 11.2 p -136.68 131.54 47.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 174.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.91 155.98 42.18 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 122.017 -0.427 . . . . 0.0 111.187 -176.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.496 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.1 pp -118.09 141.39 48.53 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.889 0.852 . . . . 0.0 111.918 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -110.16 -54.16 2.6 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.216 -1.356 . . . . 0.0 108.776 176.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -100.89 128.19 47.03 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 171.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 37' ' ' GLY . . . . . 0.557 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 139.25 161.51 8.75 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 119.532 -1.318 . . . . 0.0 113.319 176.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -103.32 -43.77 5.34 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 178.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -149.49 132.31 16.04 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 120.504 0.192 . . . . 0.0 111.039 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -131.72 113.72 13.89 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.41 0.624 . . . . 0.0 110.141 169.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' C' ' 79' ' ' THR . 97.4 mttt -96.28 110.67 22.95 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 175.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.404 ' HG ' ' CG2' ' C' ' 53' ' ' VAL . 51.1 tp -87.14 109.77 19.67 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.982 -172.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 43' ' ' TYR . . . . . 0.434 ' HB2' ' CE1' ' C' ' 78' ' ' TYR . 96.7 m-85 -108.24 141.81 39.45 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.284 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.564 ' HB2' ' CE1' ' C' ' 77' ' ' PHE . 1.5 tp -123.56 112.75 17.82 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.532 176.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . 0.583 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -99.16 108.78 21.48 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.143 0.497 . . . . 0.0 109.795 176.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.472 ' CB ' HG22 ' C' ' 75' ' ' ILE . . . -139.69 140.97 36.99 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.551 -177.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 53.19 41.97 32.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.575 0.703 . . . . 0.0 110.33 -177.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 39.2 mttp 69.95 21.38 6.25 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 114.843 -1.072 . . . . 0.0 112.39 172.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . 0.583 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 79.2 mm-40 -128.3 137.48 51.97 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.07 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -87.26 104.98 16.91 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 174.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . 0.437 ' CZ ' ' HB2' ' C' ' 49' ' ' GLN . 76.0 m-85 -99.98 120.26 39.54 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.698 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -77.31 99.92 2.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 170.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 53' ' ' VAL . . . . . 0.524 HG12 ' CD2' ' B' ' 88' ' ' LEU . 18.7 m -86.92 -34.66 7.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.85 -172.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 54' ' ' ALA . . . . . 0.557 ' HB2' ' CD2' ' C' ' 65' ' ' LEU . . . -151.06 140.92 21.91 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 120.343 -0.543 . . . . 0.0 112.092 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 21.4 m -111.5 101.34 9.77 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 169.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.26 113.69 43.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.757 0.789 . . . . 0.0 110.038 -176.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . . . . . . . . . 77.2 p -123.22 -177.83 3.81 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.194 -175.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -64.05 -24.16 67.6 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.007 0.432 . . . . 0.0 110.52 169.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.4 -40.55 43.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.198 0.523 . . . . 0.0 110.125 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 79.5 mt -116.81 81.96 12.52 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 173.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.02 -5.09 12.69 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.218 2.612 . . . . 0.0 114.119 -167.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -160.49 128.61 4.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.185 0.517 . . . . 0.0 111.266 -175.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 88.0 t -118.54 108.21 23.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.43 175.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.7 121.4 30.08 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . 0.557 ' CD2' ' HB2' ' C' ' 54' ' ' ALA . 0.4 OUTLIER -143.65 168.88 18.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.17 0.51 . . . . 0.0 111.954 -174.554 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 66' ' ' ASP . . . . . 0.567 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 9.4 t0 -116.35 107.16 14.47 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.79 178.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.574 ' HB2' ' HB ' ' C' ' 29' ' ' ILE . 32.8 mt -126.5 107.76 10.54 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -111.08 127.79 55.67 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.958 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -127.07 150.26 49.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.919 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 58.1 m -102.56 161.77 13.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.978 0.418 . . . . 0.0 110.733 176.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -69.23 -5.22 21.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.194 177.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.76 -7.66 62.75 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 173.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -100.3 143.51 30.4 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -122.99 125.65 45.66 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.501 ' HB ' ' CD1' ' C' ' 44' ' ' LEU . 15.1 pt -132.05 172.18 16.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.663 -171.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . . . . . . . . . 7.8 mtm -129.99 131.64 45.97 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 170.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 77' ' ' PHE . . . . . 0.564 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.9 OUTLIER -110.17 128.28 55.39 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.274 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 78' ' ' TYR . . . . . 0.692 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 41.0 p90 -153.61 140.42 19.09 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.291 -0.564 . . . . 0.0 112.116 -178.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 8.2 p -111.91 136.4 51.28 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.25 -177.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.59 161.05 14.45 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.29 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.497 ' O ' ' HG3' ' C' ' 16' ' ' GLU . . . 81.96 177.24 51.71 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -173.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 82' ' ' ASP . . . . . 0.533 ' HA ' ' HB3' ' C' ' 15' ' ' PRO . 6.9 p-10 -112.94 104.21 12.18 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 118.304 -1.358 . . . . 0.0 110.873 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . 0.557 ' CB ' ' HA3' ' C' ' 37' ' ' GLY . . . -164.82 153.25 12.24 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.66 -1.609 . . . . 0.0 109.869 169.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 6.4 p -104.96 123.4 47.7 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.496 HG12 ' HB3' ' C' ' 34' ' ' LEU . 3.6 m -118.24 144.48 26.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.582 0.706 . . . . 0.0 112.765 -173.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 50.6 m -108.14 116.22 31.57 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.67 175.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . 0.543 HD11 ' SD ' ' C' ' 13' ' ' MET . 4.5 mp -96.04 143.15 27.44 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 170.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . 0.523 HD12 ' CE1' ' C' ' 8' ' ' PHE . 2.6 mm? -125.06 151.97 44.94 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 174.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.55 -167.9 30.75 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.443 177.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -139.06 131.47 28.54 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.432 0.634 . . . . 0.0 110.852 176.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . 0.733 HD23 ' HB3' ' C' ' 27' ' ' PHE . 23.7 mt -62.78 131.7 49.73 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.537 -1.21 . . . . 0.0 108.943 173.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.59 -179.54 4.14 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 123.36 0.412 . . . . 0.0 110.654 -176.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -41.73 107.98 0.09 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.455 1.097 . . . . 0.0 112.239 -175.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 47.2 mt -68.83 -13.54 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.714 0.768 . . . . 0.0 109.72 174.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 95' ' ' ASP . . . . . 0.693 ' OD1' ' HA ' ' B' ' 1' ' ' PHE . 40.4 t0 70.78 59.75 0.2 Allowed 'General case' 0 N--CA 1.46 0.059 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.169 175.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 7.7 p -105.77 -33.66 7.93 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.159 175.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . 0.419 ' HA2' ' CZ ' ' C' ' 1' ' ' PHE . . . -133.79 34.27 2.43 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.377 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 C--O 1.245 0.857 0 CA-C-O 118.557 -0.735 . . . . 0.0 109.911 -179.515 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . 0.659 ' HA ' ' OD1' ' E' ' 95' ' ' ASP . 29.5 p90 . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 110.708 -0.108 . . . . 0.0 110.708 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 63.65 83.97 0.15 Allowed 'General case' 0 N--CA 1.464 0.263 0 O-C-N 123.653 0.595 . . . . 0.0 111.46 -176.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.41 55.65 4.65 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.287 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.19 34.75 0.52 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.156 0.503 . . . . 0.0 110.337 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 5' ' ' MET . . . . . . . . . . . . . 72.3 mtm -89.9 -13.81 35.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.635 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 6' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' D' ' 91' ' ' LEU . . . -110.07 99.56 8.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.756 177.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 48.6 mtt -105.15 167.71 9.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.757 -172.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 8' ' ' PHE . . . . . 0.563 ' CE1' HD21 ' E' ' 44' ' ' LEU . 70.7 t80 -69.35 146.37 52.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.217 0.532 . . . . 0.0 112.176 -175.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 9' ' ' TRP . . . . . 0.476 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 92.2 t90 -136.76 145.62 44.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.397 -0.819 . . . . 0.0 108.965 176.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.57 146.54 16.17 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.507 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.506 HD23 HD13 ' D' ' 87' ' ' LEU . 44.0 tp -138.38 109.84 6.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.837 0.351 . . . . 0.0 110.595 177.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -97.29 105.04 17.12 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 13' ' ' MET . . . . . 0.556 ' SD ' HD11 ' D' ' 87' ' ' LEU . 44.5 mtp -98.42 143.94 28.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.965 0.412 . . . . 0.0 111.011 -174.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 14' ' ' LYS . . . . . 0.519 ' HB2' ' HG3' ' D' ' 17' ' ' ARG . 37.8 mtmm -101.04 157.74 33.09 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.257 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . 0.525 ' HB3' ' HA ' ' D' ' 82' ' ' ASP . 92.5 Cg_exo -47.81 115.36 1.42 Allowed 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.597 2.865 . . . . 0.0 113.686 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . 0.669 ' HA ' ' O ' ' D' ' 79' ' ' THR . 44.5 mt-10 59.88 58.38 2.79 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.333 0.587 . . . . 0.0 111.81 175.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 17' ' ' ARG . . . . . 0.519 ' HG3' ' HB2' ' D' ' 14' ' ' LYS . 29.0 mmt180 -118.72 153.12 34.91 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.899 174.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . 0.696 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 3.5 ttmp? -130.94 110.81 11.53 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.021 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -111.32 112.55 24.4 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.942 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -75.08 114.66 13.83 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 171.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -92.96 114.12 26.59 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.386 -165.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 23.8 m -93.68 119.53 32.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.126 172.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 42.6 mt -96.82 112.96 29.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.112 0.482 . . . . 0.0 111.36 -173.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . 0.449 HD12 ' N ' ' D' ' 24' ' ' ILE . 4.2 mp -88.81 -34.8 7.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.354 177.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . 0.406 ' HD2' HD13 ' D' ' 91' ' ' LEU . 19.4 pttt -132.67 128.81 37.83 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.077 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -56.21 148.36 18.49 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.757 -177.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 27' ' ' PHE . . . . . 0.744 ' HB3' HD23 ' D' ' 91' ' ' LEU . 38.6 p90 -158.06 162.93 38.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.782 0.801 . . . . 0.0 112.842 -178.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 28' ' ' HIS . . . . . 0.55 ' NE2' ' HB3' ' D' ' 30' ' ' SER . 2.0 t60 -119.2 123.83 45.29 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.401 176.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 29' ' ' ILE . . . . . 0.569 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 51.3 mt -85.29 134.65 26.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 170.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . 0.565 ' HB2' ' HB3' ' E' ' 66' ' ' ASP . 61.2 p -117.53 -15.0 10.28 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -171.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 31' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -171.35 152.07 17.09 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 119.488 -1.339 . . . . 0.0 113.246 177.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.469 HG23 ' HG ' ' D' ' 87' ' ' LEU . 11.4 p -136.62 131.49 47.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 174.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.86 156.01 42.24 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 122.057 -0.402 . . . . 0.0 111.185 -176.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 34' ' ' LEU . . . . . 0.489 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.1 pp -118.07 141.41 48.5 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.869 0.842 . . . . 0.0 111.905 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -110.18 -54.21 2.6 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.232 -1.349 . . . . 0.0 108.806 176.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -100.83 128.1 47.01 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.827 171.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . 0.557 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 139.27 161.54 8.77 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 119.64 -1.267 . . . . 0.0 113.378 176.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -103.34 -43.79 5.33 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 178.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -149.43 132.28 16.07 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 120.529 0.204 . . . . 0.0 111.048 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . 0.458 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -131.76 113.74 13.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.405 0.621 . . . . 0.0 110.146 169.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' D' ' 79' ' ' THR . 97.3 mttt -96.21 110.54 22.82 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 175.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.404 ' HG ' ' CG2' ' D' ' 53' ' ' VAL . 50.9 tp -87.0 109.71 19.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.005 -172.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 43' ' ' TYR . . . . . 0.438 ' HB2' ' CE1' ' D' ' 78' ' ' TYR . 96.6 m-85 -108.23 141.88 39.32 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.303 178.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.581 HD21 ' CE1' ' C' ' 8' ' ' PHE . 1.5 tp -123.61 112.81 17.87 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.489 176.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 45' ' ' ALA . . . . . 0.584 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -99.19 108.84 21.53 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.14 0.495 . . . . 0.0 109.806 176.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.469 ' CB ' HG22 ' D' ' 75' ' ' ILE . . . -139.67 140.96 37.02 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.51 -177.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 53.26 41.9 32.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.506 0.669 . . . . 0.0 110.273 -178.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 39.2 mttp 69.94 21.5 6.22 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.389 172.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . 0.584 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 79.2 mm-40 -128.41 137.48 51.88 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.055 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -87.35 105.02 16.97 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 174.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . 0.436 ' CZ ' ' HB2' ' D' ' 49' ' ' GLN . 75.9 m-85 -99.93 120.29 39.56 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.657 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 tp -77.31 99.92 2.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 170.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 53' ' ' VAL . . . . . 0.515 HG12 ' CD2' ' C' ' 88' ' ' LEU . 18.5 m -86.99 -34.62 7.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.818 -172.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 54' ' ' ALA . . . . . 0.56 ' HB2' ' CD2' ' D' ' 65' ' ' LEU . . . -151.11 140.86 21.81 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 120.361 -0.535 . . . . 0.0 112.085 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 21.9 m -111.57 101.3 9.71 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 169.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.18 113.65 43.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.724 0.774 . . . . 0.0 110.036 -176.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 57' ' ' THR . . . . . . . . . . . . . 76.9 p -123.2 -177.86 3.81 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.25 -175.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -64.03 -24.19 67.61 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.01 0.433 . . . . 0.0 110.535 169.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.33 -40.58 43.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.192 176.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 79.5 mt -116.81 81.9 12.44 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 173.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.95 -5.19 12.87 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.264 2.643 . . . . 0.0 114.052 -167.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -160.44 128.57 4.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.351 0.596 . . . . 0.0 111.268 -175.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 89.8 t -118.43 108.16 23.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.455 175.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.78 121.54 30.32 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 174.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 65' ' ' LEU . . . . . 0.56 ' CD2' ' HB2' ' D' ' 54' ' ' ALA . 0.4 OUTLIER -143.65 168.88 18.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.113 0.482 . . . . 0.0 111.93 -174.541 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 66' ' ' ASP . . . . . 0.528 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 9.2 t0 -116.35 107.13 14.43 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.806 178.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.569 ' HB2' ' HB ' ' D' ' 29' ' ' ILE . 32.8 mt -126.43 107.69 10.51 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 177.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -111.08 127.78 55.67 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.939 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -127.12 150.28 49.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.902 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . . . . . . . . . 58.1 m -102.57 161.83 13.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.025 0.441 . . . . 0.0 110.739 176.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -69.32 -5.26 22.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.16 177.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.71 -7.65 62.83 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 173.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -100.29 143.53 30.38 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -122.98 125.67 45.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.49 ' HB ' ' CD1' ' D' ' 44' ' ' LEU . 14.9 pt -132.08 172.22 16.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.625 -171.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 76' ' ' MET . . . . . . . . . . . . . 7.9 mtm -130.09 131.67 45.83 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 170.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 77' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.9 OUTLIER -110.18 128.23 55.37 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.37 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 78' ' ' TYR . . . . . 0.696 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 41.1 p90 -153.6 140.33 19.0 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.312 -0.555 . . . . 0.0 112.172 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 79' ' ' THR . . . . . 0.669 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 8.3 p -111.83 136.51 51.02 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.295 -177.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.66 161.06 14.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.244 174.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.501 ' O ' ' HG3' ' D' ' 16' ' ' GLU . . . 81.97 177.23 51.71 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -173.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 82' ' ' ASP . . . . . 0.525 ' HA ' ' HB3' ' D' ' 15' ' ' PRO . 6.9 p-10 -112.9 104.15 12.14 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 118.263 -1.375 . . . . 0.0 110.928 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . 0.557 ' CB ' ' HA3' ' D' ' 37' ' ' GLY . . . -164.8 153.32 12.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.75 -1.568 . . . . 0.0 109.858 169.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 6.6 p -104.94 123.41 47.7 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.686 -0.486 . . . . 0.0 109.686 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.489 HG12 ' HB3' ' D' ' 34' ' ' LEU . 3.6 m -118.23 144.5 26.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.603 0.716 . . . . 0.0 112.729 -173.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 50.6 m -108.11 116.32 31.75 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.704 175.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 87' ' ' LEU . . . . . 0.556 HD11 ' SD ' ' D' ' 13' ' ' MET . 4.5 mp -96.05 143.05 27.54 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 170.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.527 ' CD2' HG12 ' E' ' 53' ' ' VAL . 2.6 mm? -125.08 152.09 44.8 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 174.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.6 -167.91 30.8 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.365 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -139.13 131.49 28.45 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.496 0.665 . . . . 0.0 110.836 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . 0.744 HD23 ' HB3' ' D' ' 27' ' ' PHE . 23.7 mt -62.72 131.76 49.99 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.904 173.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.72 -179.38 4.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.707 -176.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -41.88 107.95 0.09 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.31 1.006 . . . . 0.0 112.213 -175.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 46.7 mt -68.73 -13.58 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.736 0.779 . . . . 0.0 109.7 174.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 95' ' ' ASP . . . . . 0.633 ' OD1' ' HA ' ' C' ' 1' ' ' PHE . 40.3 t0 70.9 59.59 0.19 Allowed 'General case' 0 CA--C 1.524 -0.043 0 CA-C-N 114.463 -1.244 . . . . 0.0 111.163 175.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 7.9 p -105.74 -33.57 7.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.189 175.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 97' ' ' GLY . . . . . 0.43 ' HA2' ' CZ ' ' D' ' 1' ' ' PHE . . . -133.87 34.37 2.41 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.365 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 31.7 t . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.454 -0.784 . . . . 0.0 109.844 -179.621 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' E' E ' 1' ' ' PHE . . . . . 0.596 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 29.6 p90 . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 110.699 -0.112 . . . . 0.0 110.699 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 63.67 83.97 0.15 Allowed 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.761 0.663 . . . . 0.0 111.463 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.54 55.69 4.68 Favored Glycine 0 N--CA 1.453 -0.204 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.265 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.15 34.7 0.52 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.108 0.48 . . . . 0.0 110.385 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 5' ' ' MET . . . . . . . . . . . . . 72.3 mtm -89.95 -13.73 35.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.517 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 6' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' E' ' 91' ' ' LEU . . . -110.1 99.59 8.65 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 177.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 48.5 mtt -105.09 167.68 9.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.834 -172.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 8' ' ' PHE . . . . . 0.529 ' CE1' HD21 ' A' ' 44' ' ' LEU . 70.7 t80 -69.36 146.35 52.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.163 0.506 . . . . 0.0 112.169 -175.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 9' ' ' TRP . . . . . 0.469 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 92.2 t90 -136.79 145.53 44.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.997 176.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.41 146.63 16.39 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.61 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . 0.521 HD23 HD13 ' E' ' 87' ' ' LEU . 43.8 tp -138.54 109.94 6.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.943 0.402 . . . . 0.0 110.55 177.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -97.37 105.05 17.13 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 176.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 13' ' ' MET . . . . . 0.548 ' SD ' HD11 ' E' ' 87' ' ' LEU . 44.6 mtp -98.4 143.95 28.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.993 0.425 . . . . 0.0 110.98 -174.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 14' ' ' LYS . . . . . 0.515 ' HB2' ' HG3' ' E' ' 17' ' ' ARG . 37.8 mtmm -101.07 157.8 32.97 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.334 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . 0.522 ' HB3' ' HA ' ' E' ' 82' ' ' ASP . 91.5 Cg_exo -47.88 115.35 1.43 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.588 2.859 . . . . 0.0 113.703 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 16' ' ' GLU . . . . . 0.663 ' HA ' ' O ' ' E' ' 79' ' ' THR . 44.4 mt-10 59.99 58.35 2.76 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.712 0.633 . . . . 0.0 111.728 175.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 17' ' ' ARG . . . . . 0.515 ' HG3' ' HB2' ' E' ' 14' ' ' LYS . 29.1 mmt180 -118.73 153.1 34.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.942 174.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . 0.697 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 3.5 ttmp? -130.88 110.83 11.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.032 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -111.38 112.55 24.38 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.895 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 20' ' ' SER . . . . . . . . . . . . . 4.5 p -75.13 114.67 13.9 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -92.93 114.06 26.52 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.353 -165.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 23.8 m -93.62 119.58 32.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.079 172.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 42.4 mt -96.85 112.96 30.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.131 0.491 . . . . 0.0 111.275 -173.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . 0.454 HD12 ' N ' ' E' ' 24' ' ' ILE . 4.2 mp -88.84 -34.79 7.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.329 177.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . 0.421 ' HD2' HD13 ' E' ' 91' ' ' LEU . 19.3 pttt -132.77 128.73 37.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.116 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -56.18 148.38 18.32 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.775 -177.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 27' ' ' PHE . . . . . 0.734 ' HB3' HD23 ' E' ' 91' ' ' LEU . 38.8 p90 -157.99 162.94 38.21 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.691 0.757 . . . . 0.0 112.916 -178.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 28' ' ' HIS . . . . . 0.544 ' NE2' ' HB3' ' E' ' 30' ' ' SER . 2.0 t60 -119.16 123.9 45.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.341 -1.299 . . . . 0.0 109.427 176.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 29' ' ' ILE . . . . . 0.576 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 51.2 mt -85.32 134.65 26.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 170.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . 0.558 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 61.9 p -117.44 -15.14 10.32 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -171.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 31' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -171.34 152.08 17.11 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 119.498 -1.335 . . . . 0.0 113.33 177.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.486 HG23 ' HG ' ' E' ' 87' ' ' LEU . 11.3 p -136.63 131.54 47.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 174.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.93 155.96 42.16 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.068 -0.395 . . . . 0.0 111.174 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 34' ' ' LEU . . . . . 0.493 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.1 pp -117.98 141.37 48.52 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.886 0.85 . . . . 0.0 111.93 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -110.22 -54.16 2.6 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.177 -1.374 . . . . 0.0 108.801 176.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -100.85 128.12 47.02 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 171.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . 0.551 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 139.19 161.5 8.75 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 119.586 -1.293 . . . . 0.0 113.333 176.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -103.24 -43.82 5.35 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 178.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -149.52 132.36 16.05 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.572 0.225 . . . . 0.0 111.023 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . 0.454 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -131.79 113.71 13.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.345 0.593 . . . . 0.0 110.152 169.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 41' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' E' ' 79' ' ' THR . 97.4 mttt -96.32 110.62 22.91 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.404 ' HG ' ' CG2' ' E' ' 53' ' ' VAL . 51.1 tp -87.02 109.76 19.61 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.018 -172.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 43' ' ' TYR . . . . . 0.436 ' HB2' ' CE1' ' E' ' 78' ' ' TYR . 96.8 m-85 -108.31 141.85 39.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.268 178.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 44' ' ' LEU . . . . . 0.564 ' HB2' ' CE1' ' E' ' 77' ' ' PHE . 1.5 tp -123.62 112.84 17.9 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.388 176.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 45' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -99.19 108.9 21.6 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.209 0.528 . . . . 0.0 109.78 176.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . 0.479 ' CB ' HG22 ' E' ' 75' ' ' ILE . . . -139.69 140.98 36.98 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.504 -177.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 53.25 41.95 32.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.604 0.716 . . . . 0.0 110.271 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 39.1 mttp 69.84 21.54 6.33 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.399 172.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 49' ' ' GLN . . . . . 0.586 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 79.2 mm-40 -128.45 137.44 51.82 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 122.245 -0.285 . . . . 0.0 111.066 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -87.27 105.02 16.95 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 174.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . 0.442 ' CZ ' ' HB2' ' E' ' 49' ' ' GLN . 75.9 m-85 -99.99 120.26 39.54 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.681 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -77.42 99.97 2.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 171.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . 0.527 HG12 ' CD2' ' D' ' 88' ' ' LEU . 18.3 m -87.06 -34.53 7.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.789 -172.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 54' ' ' ALA . . . . . 0.562 ' HB2' ' CD2' ' E' ' 65' ' ' LEU . . . -151.07 140.86 21.84 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 120.352 -0.539 . . . . 0.0 112.104 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 21.7 m -111.51 101.22 9.66 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 169.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.19 113.67 43.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.757 0.789 . . . . 0.0 110.062 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 77.8 p -123.15 -177.74 3.77 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.236 -175.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -64.17 -24.18 67.58 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.478 169.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.38 -40.58 43.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.25 0.548 . . . . 0.0 110.114 176.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 79.6 mt -116.88 81.95 12.67 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 173.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.99 -5.13 12.76 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.174 2.583 . . . . 0.0 114.088 -167.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 62' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -160.48 128.69 4.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.231 0.539 . . . . 0.0 111.238 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 89.2 t -118.5 108.19 23.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.456 175.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.69 121.44 30.13 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 174.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.562 ' CD2' ' HB2' ' E' ' 54' ' ' ALA . 0.4 OUTLIER -143.66 168.84 18.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.207 0.527 . . . . 0.0 111.951 -174.47 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' E' E ' 66' ' ' ASP . . . . . 0.565 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 9.3 t0 -116.32 107.16 14.48 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.772 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 67' ' ' LEU . . . . . 0.576 ' HB2' ' HB ' ' E' ' 29' ' ' ILE . 33.1 mt -126.49 107.71 10.5 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 177.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -111.07 127.91 55.7 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.907 -178.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -127.15 150.39 49.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.87 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 70' ' ' SER . . . . . . . . . . . . . 58.0 m -102.63 161.75 13.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.043 0.449 . . . . 0.0 110.795 176.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -69.29 -5.09 20.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.219 177.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.86 -7.55 62.67 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 173.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -100.32 143.45 30.5 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 178.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -122.95 125.72 45.84 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 174.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 75' ' ' ILE . . . . . 0.492 ' HB ' ' CD1' ' E' ' 44' ' ' LEU . 15.1 pt -132.03 172.2 16.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.666 -171.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 76' ' ' MET . . . . . . . . . . . . . 7.9 mtm -130.12 131.66 45.8 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 170.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 77' ' ' PHE . . . . . 0.564 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.9 OUTLIER -110.21 128.36 55.45 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 177.292 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' E' E ' 78' ' ' TYR . . . . . 0.697 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 40.9 p90 -153.64 140.41 19.05 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.287 -0.565 . . . . 0.0 112.112 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 79' ' ' THR . . . . . 0.663 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 8.3 p -111.88 136.36 51.28 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.28 -177.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.55 161.03 14.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.258 174.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 81' ' ' GLY . . . . . 0.483 ' O ' ' HG3' ' E' ' 16' ' ' GLU . . . 81.99 177.2 51.7 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -173.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 82' ' ' ASP . . . . . 0.522 ' HA ' ' HB3' ' E' ' 15' ' ' PRO . 6.9 p-10 -112.88 104.21 12.2 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 118.276 -1.37 . . . . 0.0 110.903 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 83' ' ' ALA . . . . . 0.551 ' CB ' ' HA3' ' E' ' 37' ' ' GLY . . . -164.84 153.22 12.17 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 113.708 -1.587 . . . . 0.0 109.836 169.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 6.6 p -104.93 123.48 47.83 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 85' ' ' VAL . . . . . 0.493 HG12 ' HB3' ' E' ' 34' ' ' LEU . 3.6 m -118.2 144.43 26.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -173.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 50.8 m -108.05 116.25 31.61 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.701 175.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 87' ' ' LEU . . . . . 0.548 HD11 ' SD ' ' E' ' 13' ' ' MET . 4.5 mp -96.1 143.12 27.51 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 170.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . 0.52 ' CD2' HG12 ' A' ' 53' ' ' VAL . 2.6 mm? -125.03 152.07 44.74 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 174.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.6 -167.86 30.73 Favored Glycine 0 N--CA 1.435 -1.377 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.409 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 90' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -139.19 131.46 28.32 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.565 0.698 . . . . 0.0 110.803 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 91' ' ' LEU . . . . . 0.734 HD23 ' HB3' ' E' ' 27' ' ' PHE . 23.7 mt -62.65 131.61 49.57 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.903 173.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.64 -179.47 4.12 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.686 -176.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -41.68 107.86 0.08 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.311 1.007 . . . . 0.0 112.228 -175.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 46.8 mt -68.7 -13.6 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.59 0.709 . . . . 0.0 109.656 174.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 95' ' ' ASP . . . . . 0.659 ' OD1' ' HA ' ' D' ' 1' ' ' PHE . 40.3 t0 70.82 59.6 0.2 Allowed 'General case' 0 CA--C 1.524 -0.037 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.185 175.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 8.1 p -105.55 -33.78 7.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.244 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 97' ' ' GLY . . . . . 0.432 ' HA2' ' CZ ' ' E' ' 1' ' ' PHE . . . -133.73 34.29 2.43 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.388 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 31.5 t . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.4 -0.81 . . . . 0.0 109.815 -179.586 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 51.4 p90 . . . . . 0 N--CA 1.479 0.998 0 CA-C-O 120.823 0.344 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -90.7 -29.38 17.73 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.817 176.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 94' ' ' ILE . . . 77.47 -60.78 3.62 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.44 177.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.422 ' HB2' ' CG ' ' B' ' 92' ' ' HIS . . . -82.38 71.85 9.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.17 0.509 . . . . 0.0 110.93 -178.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.426 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 13.0 tpt -82.04 -3.99 55.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.268 173.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.46 107.29 0.9 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.974 177.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.551 ' HA ' ' OG ' ' B' ' 70' ' ' SER . 45.5 mtt -94.29 155.12 17.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.559 0.695 . . . . 0.0 112.621 -170.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.501 ' CE1' HD21 ' B' ' 44' ' ' LEU . 55.8 t80 -59.71 142.71 52.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.262 -176.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.546 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 88.5 t90 -134.14 142.05 47.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.735 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.91 140.05 8.38 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.143 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.673 HD23 HD13 ' A' ' 87' ' ' LEU . 56.6 tp -128.36 108.29 10.45 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.974 0.416 . . . . 0.0 110.048 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -86.46 101.38 13.1 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 175.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.592 ' HB3' HG23 ' A' ' 85' ' ' VAL . 27.3 tpp -91.95 129.27 37.95 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.39 -171.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.489 ' HD2' ' N ' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -95.54 140.74 22.48 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.799 179.405 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.617 ' HB3' ' H ' ' A' ' 83' ' ' ALA . 9.5 Cg_endo -53.63 121.73 10.04 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.624 2.882 . . . . 0.0 113.474 -175.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' A' ' 79' ' ' THR . 31.3 mt-10 61.53 47.0 6.9 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.911 177.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.52 ' HA ' ' NE ' ' A' ' 17' ' ' ARG . 1.2 tpm_? -122.33 137.39 54.87 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 173.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.661 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 88.4 mttt -108.81 121.47 45.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.685 0.279 . . . . 0.0 111.684 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -111.06 103.57 12.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.303 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 76' ' ' MET . 45.7 t -90.47 99.42 12.45 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 172.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -120.12 148.12 44.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.146 -168.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.5 m -93.44 141.27 28.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.49 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.412 ' HB ' ' HA ' ' A' ' 71' ' ' LYS . 67.9 mt -89.89 117.01 32.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 120.92 0.39 . . . . 0.0 111.243 -173.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.526 HD12 ' N ' ' A' ' 25' ' ' LYS . 1.4 pp -79.63 -27.57 12.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.735 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.526 ' N ' HD12 ' A' ' 24' ' ' ILE . 31.7 ttpt -155.28 136.17 13.66 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -178.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 39.2 m -58.32 130.03 44.82 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.659 0.599 . . . . 0.0 110.091 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.624 ' HB3' HD23 ' A' ' 91' ' ' LEU . 10.1 p90 -144.26 161.92 37.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.611 0.719 . . . . 0.0 112.886 -172.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.598 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 15.7 t60 -114.82 123.87 50.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.187 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 67' ' ' LEU . 37.6 mt -92.6 136.28 25.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 170.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.589 ' HB3' ' NE2' ' A' ' 28' ' ' HIS . 64.8 p -123.08 -20.19 5.82 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -170.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 87' ' ' LEU . . . -154.85 146.3 14.17 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 119.324 -1.417 . . . . 0.0 113.336 178.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.487 HG23 ' HG ' ' A' ' 87' ' ' LEU . 14.3 p -140.01 126.81 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 170.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.417 ' HA ' HG21 ' A' ' 56' ' ' VAL . . . -148.81 158.11 43.92 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.903 -0.498 . . . . 0.0 111.576 -174.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.586 ' HB3' HG12 ' A' ' 85' ' ' VAL . 4.0 pp -118.9 139.21 52.01 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.587 0.708 . . . . 0.0 111.456 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -108.13 -51.33 2.91 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.298 173.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -102.52 128.12 49.3 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 170.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.505 ' HA3' ' CB ' ' A' ' 83' ' ' ALA . . . 145.08 162.39 9.55 Favored Glycine 0 N--CA 1.437 -1.263 0 C-N-CA 119.949 -1.12 . . . . 0.0 113.098 176.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -102.7 -46.81 4.61 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 111.487 0.18 . . . . 0.0 111.487 177.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -150.68 130.88 13.57 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.73 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.473 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -130.83 113.0 13.53 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.585 0.707 . . . . 0.0 110.186 169.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 79' ' ' THR . 4.5 mptp? -95.34 106.38 18.43 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 174.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.518 HD23 ' HB ' ' A' ' 53' ' ' VAL . 41.6 tp -78.8 114.01 17.37 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -176.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -114.82 135.88 53.7 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.283 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.602 ' HB3' HG22 ' A' ' 53' ' ' VAL . 5.0 tp -115.77 116.15 27.54 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.498 176.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 49' ' ' GLN . . . -103.38 103.73 13.76 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 176.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.441 ' HB2' HD11 ' A' ' 44' ' ' LEU . . . -130.53 140.85 50.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.105 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 58.0 32.44 21.97 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.71 0.767 . . . . 0.0 109.445 -175.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 57.44 37.11 27.72 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.466 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 6.6 tp-100 -127.75 131.77 49.63 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 176.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -87.35 112.27 21.93 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.427 -177.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -108.4 131.37 54.84 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.793 177.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -78.78 100.42 3.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 169.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.602 HG22 ' HB3' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -72.4 -51.49 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.877 -174.151 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.512 ' HA ' ' OE1' ' E' ' 62' ' ' GLN . . . -154.57 132.47 11.57 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.516 -177.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.3 t -101.95 102.46 13.01 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 174.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 40' ' ' ALA . 7.1 p -116.67 109.7 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-O 122.128 0.966 . . . . 0.0 110.047 -176.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 66.9 p -122.55 -176.95 3.5 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.378 -176.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -65.07 -20.61 66.57 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 119.976 -0.689 . . . . 0.0 110.574 169.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.95 -40.68 27.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.246 0.546 . . . . 0.0 110.047 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.4 mt -118.68 77.65 14.7 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 172.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 57' ' ' THR . 9.8 Cg_exo -71.73 0.84 6.43 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.11 2.54 . . . . 0.0 113.636 -168.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.492 ' OE1' ' HA ' ' B' ' 54' ' ' ALA . 10.3 tt0 -160.06 114.7 2.28 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.237 -170.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.495 HG11 ' HB1' ' A' ' 54' ' ' ALA . 86.5 t -112.8 115.16 49.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.061 0.458 . . . . 0.0 111.247 177.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.04 116.0 28.38 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 171.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.426 HD23 ' H ' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -134.64 168.3 19.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.817 0.341 . . . . 0.0 111.036 -171.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.551 ' HB3' ' HB2' ' E' ' 30' ' ' SER . 7.4 t0 -122.91 109.43 14.14 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.139 0.495 . . . . 0.0 110.36 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.683 HD21 HD23 ' E' ' 88' ' ' LEU . 12.8 mt -124.05 138.84 54.39 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.683 177.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -138.43 114.61 10.22 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 173.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -109.17 163.07 13.68 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.385 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.535 ' OG ' ' HA ' ' E' ' 7' ' ' MET . 4.5 m -117.22 149.03 41.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.154 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.412 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -70.04 -5.9 29.86 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.736 -177.103 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.87 -28.54 45.84 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.319 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -101.3 171.25 7.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.702 0.287 . . . . 0.0 110.43 -176.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -137.3 136.5 38.06 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.467 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 22.6 pt -133.07 158.4 43.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.081 0.467 . . . . 0.0 111.571 -169.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.418 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 65.3 ttp -117.52 118.09 31.21 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.342 176.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.467 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -105.53 129.37 53.82 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.806 -177.773 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.661 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . 39.0 p90 -155.74 162.79 40.47 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.847 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 12.6 p -125.21 143.86 50.74 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.108 178.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.3 149.48 26.87 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.231 173.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.0 -176.92 36.47 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -176.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -114.48 102.64 10.27 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.238 178.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.617 ' H ' ' HB3' ' A' ' 15' ' ' PRO . . . -166.74 150.05 6.85 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.479 168.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.2 p -106.04 122.11 45.5 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.592 HG23 ' HB3' ' A' ' 13' ' ' MET . 13.5 m -121.54 144.23 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-O 121.241 0.543 . . . . 0.0 111.801 -172.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 43.3 m -105.21 122.85 46.77 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.276 175.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.673 HD13 HD23 ' A' ' 11' ' ' LEU . 5.1 mp -95.22 143.93 26.23 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 170.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.695 HD23 HD21 ' B' ' 67' ' ' LEU . 0.9 OUTLIER -130.39 141.23 50.56 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.152 -178.718 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.66 -166.89 27.5 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.953 -0.642 . . . . 0.0 111.795 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -147.06 133.49 19.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.474 0.654 . . . . 0.0 111.161 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.624 HD23 ' HB3' ' A' ' 27' ' ' PHE . 15.1 mt -69.68 128.8 37.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.106 175.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.421 ' CG ' ' HB2' ' E' ' 4' ' ' ALA . 12.3 t60 -81.84 108.35 15.3 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.049 0.452 . . . . 0.0 111.158 -173.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -108.21 -79.44 0.58 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 168.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.502 ' HA ' ' O ' ' A' ' 3' ' ' GLY . 50.4 mm 62.1 99.98 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.447 176.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.426 ' OD2' ' HB2' ' A' ' 5' ' ' MET . 28.4 m-20 -76.3 133.72 39.95 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.664 -178.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 23.3 t -91.13 86.99 6.37 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.35 -50.69 64.83 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.965 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.8 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.946 177.564 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 51.6 p90 . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.741 0.305 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -90.86 -29.42 17.54 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.756 177.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' B' ' 94' ' ' ILE . . . 77.6 -60.95 3.65 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.423 177.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.28 71.96 9.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.178 0.514 . . . . 0.0 110.944 -178.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . 0.426 ' HB2' ' OD2' ' B' ' 95' ' ' ASP . 12.9 tpt -82.15 -3.96 55.96 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.235 173.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.42 107.32 0.9 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.0 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . 0.568 ' HA ' ' OG ' ' C' ' 70' ' ' SER . 45.5 mtt -94.25 155.1 17.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.533 0.682 . . . . 0.0 112.727 -170.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.507 ' CE1' HD21 ' C' ' 44' ' ' LEU . 55.5 t80 -59.76 142.74 52.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.247 -176.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . 0.541 ' CH2' ' HB2' ' B' ' 11' ' ' LEU . 88.6 t90 -134.14 142.01 47.32 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.75 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.87 140.06 8.39 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.253 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.681 HD23 HD13 ' B' ' 87' ' ' LEU . 56.8 tp -128.36 108.35 10.5 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.972 0.415 . . . . 0.0 110.079 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -86.46 101.29 13.03 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 175.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . 0.585 ' HB3' HG23 ' B' ' 85' ' ' VAL . 27.4 tpp -91.95 129.37 37.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.349 -171.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.492 ' N ' ' HD2' ' B' ' 14' ' ' LYS . 0.3 OUTLIER -95.69 140.83 22.5 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.757 179.362 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.62 ' HB3' ' H ' ' B' ' 83' ' ' ALA . 9.4 Cg_endo -53.62 121.71 10.0 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 123.656 2.904 . . . . 0.0 113.425 -175.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' B' ' 79' ' ' THR . 31.2 mt-10 61.58 47.04 6.8 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.835 177.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.515 ' NE ' ' HA ' ' B' ' 17' ' ' ARG . 1.1 tpm_? -122.36 137.3 54.9 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 173.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.657 ' HA ' ' HB3' ' B' ' 78' ' ' TYR . 88.5 mttt -108.84 121.57 45.37 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -111.2 103.56 11.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.233 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' B' ' 76' ' ' MET . 45.0 t -90.4 99.47 12.48 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -120.2 148.17 44.01 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.55 0.69 . . . . 0.0 112.152 -168.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 19.7 m -93.49 141.27 28.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.436 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -89.93 117.07 32.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.085 0.469 . . . . 0.0 111.214 -173.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.523 HD12 ' N ' ' B' ' 25' ' ' LYS . 1.4 pp -79.63 -27.58 12.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.709 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.523 ' N ' HD12 ' B' ' 24' ' ' ILE . 31.7 ttpt -155.3 136.1 13.59 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 38.9 m -58.23 130.03 44.75 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.725 0.641 . . . . 0.0 110.096 -178.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . 0.616 ' HB3' HD23 ' B' ' 91' ' ' LEU . 10.0 p90 -144.25 161.86 37.83 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -172.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' HIS . . . . . 0.595 ' HA ' ' O ' ' B' ' 67' ' ' LEU . 16.1 t60 -114.74 123.9 50.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.194 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' B' ' 67' ' ' LEU . 37.8 mt -92.66 136.17 25.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 170.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.587 ' HB3' ' NE2' ' B' ' 28' ' ' HIS . 65.1 p -122.91 -20.28 5.87 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -170.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' B' ' 87' ' ' LEU . . . -154.82 146.19 13.97 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 119.508 -1.329 . . . . 0.0 113.416 179.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.483 HG23 ' HG ' ' B' ' 87' ' ' LEU . 14.4 p -139.99 126.71 23.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 170.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . 0.415 ' HA ' HG21 ' B' ' 56' ' ' VAL . . . -148.79 158.15 43.95 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.925 -0.484 . . . . 0.0 111.669 -174.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.591 ' HB3' HG12 ' B' ' 85' ' ' VAL . 4.0 pp -118.91 139.26 51.93 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.719 0.771 . . . . 0.0 111.356 178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -108.21 -51.29 2.92 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.355 173.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -102.46 128.15 49.19 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 170.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.507 ' HA3' ' CB ' ' B' ' 83' ' ' ALA . . . 145.01 162.43 9.56 Favored Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 119.906 -1.14 . . . . 0.0 113.01 176.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -102.73 -46.67 4.65 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 177.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -150.77 130.81 13.43 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.754 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.481 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . . . -130.78 113.06 13.64 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.55 0.691 . . . . 0.0 110.165 169.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' B' ' 79' ' ' THR . 4.5 mptp? -95.42 106.33 18.38 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 174.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.519 HD23 ' HB ' ' B' ' 53' ' ' VAL . 41.4 tp -78.67 113.92 17.14 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -176.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -114.78 135.89 53.68 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.247 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.587 ' HB3' HG22 ' B' ' 53' ' ' VAL . 4.9 tp -115.85 116.18 27.55 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.509 176.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' B' ' 49' ' ' GLN . . . -103.31 103.71 13.75 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 176.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.447 ' HB2' HD11 ' B' ' 44' ' ' LEU . . . -130.61 140.79 50.43 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.125 -178.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 58.19 32.29 21.85 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.543 0.687 . . . . 0.0 109.34 -175.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 62.4 mttp 57.54 37.0 27.49 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.508 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.515 ' O ' ' HA ' ' B' ' 45' ' ' ALA . 6.6 tp-100 -127.67 131.8 49.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.588 176.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -87.47 112.32 22.07 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.828 0.346 . . . . 0.0 110.389 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -108.48 131.37 54.87 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.763 177.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -78.82 100.41 3.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 169.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.587 HG22 ' HB3' ' B' ' 44' ' ' LEU . 0.9 OUTLIER -72.3 -51.53 29.11 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.011 -174.205 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.492 ' HA ' ' OE1' ' A' ' 62' ' ' GLN . . . -154.48 132.53 11.69 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.547 -177.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 7.5 t -101.97 102.43 12.96 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 174.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.425 HG13 ' HB3' ' B' ' 40' ' ' ALA . 7.1 p -116.63 109.79 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-O 122.062 0.934 . . . . 0.0 109.964 -176.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' B' ' 61' ' ' PRO . 67.1 p -122.63 -176.94 3.51 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.352 -176.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -65.06 -20.63 66.57 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.551 169.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.86 -40.82 27.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.267 0.556 . . . . 0.0 110.02 176.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 74.2 mt -118.7 77.6 14.73 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 172.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' B' ' 57' ' ' THR . 9.7 Cg_exo -71.71 0.88 6.35 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.083 2.522 . . . . 0.0 113.721 -168.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . 0.507 ' OE1' ' HA ' ' C' ' 54' ' ' ALA . 10.3 tt0 -160.12 114.72 2.27 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.256 -170.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.487 HG11 ' HB1' ' B' ' 54' ' ' ALA . 86.0 t -112.75 115.17 49.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.108 0.48 . . . . 0.0 111.259 177.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.05 115.92 28.29 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 171.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.437 ' H ' HD23 ' B' ' 65' ' ' LEU . 0.7 OUTLIER -134.56 168.26 19.29 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.06 -171.67 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . 0.547 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 7.4 t0 -122.89 109.46 14.18 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.111 0.481 . . . . 0.0 110.365 -179.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.695 HD21 HD23 ' A' ' 88' ' ' LEU . 12.7 mt -124.02 138.91 54.39 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.67 177.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -138.64 114.65 10.12 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 173.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -109.23 162.99 13.77 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.395 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.551 ' OG ' ' HA ' ' A' ' 7' ' ' MET . 4.4 m -117.12 149.01 41.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.22 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -6.15 31.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.71 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.81 -28.38 46.7 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.365 177.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -101.24 171.32 7.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.764 0.316 . . . . 0.0 110.44 -176.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -137.37 136.47 37.93 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.458 ' HB ' ' CD1' ' B' ' 44' ' ' LEU . 22.3 pt -133.03 158.39 43.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.912 0.387 . . . . 0.0 111.668 -169.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.434 ' HA ' ' HA ' ' B' ' 20' ' ' SER . 65.3 ttp -117.47 118.21 31.56 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.056 0.455 . . . . 0.0 110.319 176.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 0.4 OUTLIER -105.63 129.39 53.88 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.788 -177.807 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.657 ' HB3' ' HA ' ' B' ' 18' ' ' LYS . 39.0 p90 -155.79 162.72 40.44 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.871 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 12.5 p -125.26 143.89 50.73 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.094 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.45 149.61 26.88 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.088 173.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.87 -176.95 36.69 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -176.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -114.38 102.67 10.31 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 117.988 0.894 . . . . 0.0 110.289 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.62 ' H ' ' HB3' ' B' ' 15' ' ' PRO . . . -166.72 150.04 6.88 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.465 168.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 6.1 p -106.05 122.17 45.62 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.591 HG12 ' HB3' ' B' ' 34' ' ' LEU . 13.4 m -121.59 144.26 31.33 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 121.241 0.544 . . . . 0.0 111.771 -172.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 44.0 m -105.25 122.88 46.86 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.24 175.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.681 HD13 HD23 ' B' ' 11' ' ' LEU . 5.1 mp -95.16 143.95 26.17 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.695 HD23 HD21 ' C' ' 67' ' ' LEU . 0.9 OUTLIER -130.44 141.23 50.53 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.17 -178.712 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.68 -166.93 27.59 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.752 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -147.0 133.54 19.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.428 0.633 . . . . 0.0 111.029 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . 0.616 HD23 ' HB3' ' B' ' 27' ' ' PHE . 15.1 mt -69.8 128.9 38.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.083 175.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . 0.422 ' CG ' ' HB2' ' A' ' 4' ' ' ALA . 12.3 t60 -81.85 108.26 15.23 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.068 0.461 . . . . 0.0 111.091 -173.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -108.24 -79.51 0.58 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 168.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . 0.503 ' HA ' ' O ' ' B' ' 3' ' ' GLY . 50.7 mm 62.19 100.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.336 176.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . 0.426 ' OD2' ' HB2' ' B' ' 5' ' ' MET . 28.2 m-20 -76.25 133.66 40.03 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.671 -178.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 23.3 t -91.05 87.02 6.41 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 176.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.4 -50.64 65.42 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.998 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 10.9 m . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.087 -0.958 . . . . 0.0 110.952 177.551 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 51.6 p90 . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.801 0.334 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -90.81 -29.41 17.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.793 176.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 3' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' C' ' 94' ' ' ILE . . . 77.67 -60.93 3.68 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.395 177.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 4' ' ' ALA . . . . . 0.408 ' HB2' ' CG ' ' D' ' 92' ' ' HIS . . . -82.24 71.84 9.29 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.213 0.53 . . . . 0.0 110.993 -178.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 5' ' ' MET . . . . . 0.419 ' HB2' ' OD2' ' C' ' 95' ' ' ASP . 13.0 tpt -82.09 -4.01 55.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.273 173.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.39 107.29 0.89 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.029 177.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 7' ' ' MET . . . . . 0.577 ' HA ' ' OG ' ' D' ' 70' ' ' SER . 45.3 mtt -94.31 155.16 17.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.522 0.677 . . . . 0.0 112.657 -170.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 8' ' ' PHE . . . . . 0.492 ' CE1' HD21 ' D' ' 44' ' ' LEU . 55.5 t80 -59.78 142.66 52.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.401 -1.272 . . . . 0.0 112.203 -176.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . 0.533 ' CH2' ' HB2' ' C' ' 11' ' ' LEU . 88.4 t90 -134.08 142.08 47.41 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.766 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.84 140.07 8.41 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.148 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.67 HD23 HD13 ' C' ' 87' ' ' LEU . 56.3 tp -128.33 108.24 10.42 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.893 0.378 . . . . 0.0 110.153 178.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -86.27 101.25 12.89 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 175.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 13' ' ' MET . . . . . 0.587 ' HB3' HG23 ' C' ' 85' ' ' VAL . 27.2 tpp -91.99 129.42 37.95 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.362 -171.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . 0.482 ' HD2' ' N ' ' C' ' 14' ' ' LYS . 0.3 OUTLIER -95.68 140.74 22.46 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.833 179.385 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . 0.618 ' HB3' ' H ' ' C' ' 83' ' ' ALA . 9.5 Cg_endo -53.59 121.73 10.03 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.606 2.871 . . . . 0.0 113.51 -175.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . 0.659 ' HA ' ' O ' ' C' ' 79' ' ' THR . 31.5 mt-10 61.56 47.04 6.84 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.838 177.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 17' ' ' ARG . . . . . 0.518 ' NE ' ' HA ' ' C' ' 17' ' ' ARG . 1.2 tpm_? -122.33 137.33 54.89 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 173.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 18' ' ' LYS . . . . . 0.657 ' HA ' ' HB3' ' C' ' 78' ' ' TYR . 88.4 mttt -108.85 121.51 45.24 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -111.07 103.71 12.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.252 176.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' C' ' 76' ' ' MET . 45.2 t -90.59 99.52 12.53 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 172.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 21' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -120.23 148.14 44.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.125 -168.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 19.5 m -93.42 141.2 28.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.538 176.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 67.7 mt -89.84 117.06 32.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.974 0.416 . . . . 0.0 111.295 -173.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . 0.519 HD12 ' N ' ' C' ' 25' ' ' LYS . 1.4 pp -79.68 -27.5 12.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.703 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . 0.519 ' N ' HD12 ' C' ' 24' ' ' ILE . 31.7 ttpt -155.41 136.18 13.54 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 39.4 m -58.33 130.08 45.05 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.715 0.634 . . . . 0.0 110.085 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 27' ' ' PHE . . . . . 0.635 ' HB3' HD23 ' C' ' 91' ' ' LEU . 9.9 p90 -144.27 161.89 37.79 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.654 0.74 . . . . 0.0 112.905 -172.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 28' ' ' HIS . . . . . 0.606 ' HA ' ' O ' ' C' ' 67' ' ' LEU . 15.9 t60 -114.75 123.9 50.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.203 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . 0.56 ' HB ' ' HB2' ' C' ' 67' ' ' LEU . 38.0 mt -92.66 136.21 25.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 170.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.578 ' HB3' ' NE2' ' C' ' 28' ' ' HIS . 65.2 p -122.98 -20.25 5.84 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -170.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' C' ' 87' ' ' LEU . . . -154.74 146.21 14.04 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.403 -1.379 . . . . 0.0 113.395 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.49 HG23 ' HG ' ' C' ' 87' ' ' LEU . 14.4 p -140.08 126.73 22.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 170.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.412 ' HA ' HG21 ' C' ' 56' ' ' VAL . . . -148.73 158.21 43.99 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.617 -174.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.6 ' HB3' HG12 ' C' ' 85' ' ' VAL . 4.0 pp -118.99 139.21 52.07 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.739 0.781 . . . . 0.0 111.339 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -108.14 -51.28 2.92 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.572 -1.194 . . . . 0.0 108.382 173.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -102.42 128.03 49.2 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 170.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 37' ' ' GLY . . . . . 0.505 ' HA3' ' CB ' ' C' ' 83' ' ' ALA . . . 145.09 162.42 9.56 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.056 176.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 38' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -102.7 -46.73 4.63 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 177.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -150.73 130.81 13.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.809 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.495 ' HB2' ' HB3' ' C' ' 83' ' ' ALA . . . -130.81 113.02 13.56 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.53 0.681 . . . . 0.0 110.172 169.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' C' ' 79' ' ' THR . 4.5 mptp? -95.36 106.33 18.37 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 174.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.506 HD23 ' HB ' ' C' ' 53' ' ' VAL . 41.7 tp -78.69 113.97 17.21 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -176.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 43' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -114.86 135.88 53.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.244 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.61 ' HB3' HG22 ' C' ' 53' ' ' VAL . 4.9 tp -115.73 116.05 27.4 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.56 176.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' C' ' 49' ' ' GLN . . . -103.27 103.76 13.82 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 176.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.452 ' HB2' HD11 ' C' ' 44' ' ' LEU . . . -130.58 140.85 50.45 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.108 -178.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 58.05 32.4 21.93 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.611 0.719 . . . . 0.0 109.416 -175.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 62.4 mttp 57.38 37.11 27.84 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.523 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . 0.51 ' O ' ' HA ' ' C' ' 45' ' ' ALA . 6.6 tp-100 -127.73 131.72 49.67 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.558 176.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -87.39 112.31 22.0 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.791 0.329 . . . . 0.0 110.401 -177.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -108.39 131.3 54.9 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.775 177.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -78.76 100.47 3.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 169.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 53' ' ' VAL . . . . . 0.61 HG22 ' HB3' ' C' ' 44' ' ' LEU . 0.9 OUTLIER -72.45 -51.46 28.85 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.955 -174.211 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 54' ' ' ALA . . . . . 0.507 ' HA ' ' OE1' ' B' ' 62' ' ' GLN . . . -154.5 132.5 11.65 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.597 -177.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 7.4 t -102.0 102.46 12.98 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 174.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . 0.412 HG21 ' HA ' ' C' ' 33' ' ' ALA . 7.1 p -116.61 109.74 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-O 122.005 0.907 . . . . 0.0 110.057 -176.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 57' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' C' ' 61' ' ' PRO . 66.9 p -122.62 -177.09 3.54 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.379 -176.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -64.95 -20.73 66.62 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.578 169.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.76 -40.82 27.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.247 0.546 . . . . 0.0 110.084 176.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 74.0 mt -118.7 77.64 14.77 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 172.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 61' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' C' ' 57' ' ' THR . 9.7 Cg_exo -71.74 0.86 6.39 Favored 'Trans proline' 0 N--CA 1.473 0.308 0 C-N-CA 123.099 2.532 . . . . 0.0 113.618 -168.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . 0.58 ' OE1' ' HA ' ' D' ' 54' ' ' ALA . 10.3 tt0 -160.13 114.73 2.27 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.733 0.301 . . . . 0.0 111.307 -170.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.494 HG11 ' HB1' ' C' ' 54' ' ' ALA . 85.9 t -112.79 115.16 49.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.13 0.49 . . . . 0.0 111.264 177.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.0 115.97 28.36 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 171.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . 0.443 HD23 ' H ' ' C' ' 65' ' ' LEU . 0.7 OUTLIER -134.53 168.35 19.12 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.138 -171.726 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 66' ' ' ASP . . . . . 0.493 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 7.4 t0 -122.95 109.37 14.05 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.077 0.465 . . . . 0.0 110.278 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.695 HD21 HD23 ' B' ' 88' ' ' LEU . 12.8 mt -124.03 138.79 54.4 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.696 176.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -138.45 114.57 10.17 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 172.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 69' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -109.12 163.0 13.72 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.348 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . 0.568 ' OG ' ' HA ' ' B' ' 7' ' ' MET . 4.5 m -117.16 149.03 41.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.161 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.97 -6.04 30.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.737 -177.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.88 -28.44 46.16 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.269 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -101.2 171.32 7.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.603 0.239 . . . . 0.0 110.491 -176.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -137.35 136.54 38.02 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.457 ' HB ' ' CD1' ' C' ' 44' ' ' LEU . 22.6 pt -133.06 158.39 43.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.022 0.439 . . . . 0.0 111.647 -169.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' C' ' 20' ' ' SER . 65.4 ttp -117.46 118.08 31.22 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.279 176.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 77' ' ' PHE . . . . . 0.479 ' CE1' ' HB2' ' C' ' 44' ' ' LEU . 0.4 OUTLIER -105.62 129.34 53.88 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.791 -177.833 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 78' ' ' TYR . . . . . 0.657 ' HB3' ' HA ' ' C' ' 18' ' ' LYS . 38.9 p90 -155.73 162.72 40.48 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.839 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . 0.659 ' O ' ' HA ' ' C' ' 16' ' ' GLU . 12.6 p -125.12 143.88 50.71 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.143 178.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.43 149.63 26.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.072 173.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.88 -176.87 36.6 Favored Glycine 0 CA--C 1.508 -0.346 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -176.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 82' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -114.5 102.63 10.25 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.24 178.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . 0.618 ' H ' ' HB3' ' C' ' 15' ' ' PRO . . . -166.69 150.06 6.93 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.508 167.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 6.3 p -106.01 122.2 45.67 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.6 HG12 ' HB3' ' C' ' 34' ' ' LEU . 13.5 m -121.62 144.2 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-O 121.223 0.535 . . . . 0.0 111.769 -172.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 43.6 m -105.23 122.87 46.82 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.28 175.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . 0.67 HD13 HD23 ' C' ' 11' ' ' LEU . 5.1 mp -95.15 144.03 26.11 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 170.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . 0.693 HD23 HD21 ' D' ' 67' ' ' LEU . 0.9 OUTLIER -130.5 141.21 50.5 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.161 -178.685 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.67 -166.93 27.57 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.744 -177.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 90' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -146.95 133.57 19.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.384 0.612 . . . . 0.0 111.095 177.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . 0.635 HD23 ' HB3' ' C' ' 27' ' ' PHE . 15.1 mt -69.79 128.89 38.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.07 175.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 92' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -81.89 108.32 15.31 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.052 0.453 . . . . 0.0 111.1 -173.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 93' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -108.17 -79.53 0.58 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 168.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' C' ' 3' ' ' GLY . 50.6 mm 62.14 100.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.373 176.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 95' ' ' ASP . . . . . 0.419 ' OD2' ' HB2' ' C' ' 5' ' ' MET . 28.2 m-20 -76.37 133.75 39.85 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.622 -178.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 23.3 t -91.05 86.98 6.4 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.33 -50.65 65.35 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.037 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 98' ' ' SER . . . . . . . . . . . . . 10.8 m . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.956 177.513 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 51.7 p90 . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 120.731 0.301 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -90.77 -29.52 17.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.771 177.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 3' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' D' ' 94' ' ' ILE . . . 77.64 -60.95 3.67 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.423 177.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 4' ' ' ALA . . . . . 0.426 ' HB2' ' CG ' ' E' ' 92' ' ' HIS . . . -82.22 71.82 9.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.176 0.513 . . . . 0.0 111.006 -178.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 5' ' ' MET . . . . . 0.432 ' HB2' ' OD2' ' D' ' 95' ' ' ASP . 12.9 tpt -82.08 -3.97 55.84 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.215 173.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.4 107.21 0.87 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.032 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 7' ' ' MET . . . . . 0.559 ' HA ' ' OG ' ' E' ' 70' ' ' SER . 45.2 mtt -94.27 155.12 17.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.566 0.698 . . . . 0.0 112.674 -170.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 8' ' ' PHE . . . . . 0.513 ' CE1' HD21 ' E' ' 44' ' ' LEU . 55.8 t80 -59.64 142.74 52.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.341 -1.299 . . . . 0.0 112.24 -176.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 9' ' ' TRP . . . . . 0.539 ' CH2' ' HB2' ' D' ' 11' ' ' LEU . 88.4 t90 -134.27 142.08 47.19 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.9 140.08 8.4 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.188 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.677 HD23 HD13 ' D' ' 87' ' ' LEU . 56.8 tp -128.3 108.23 10.42 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.899 0.381 . . . . 0.0 110.077 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -86.49 101.41 13.15 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 13' ' ' MET . . . . . 0.59 ' HB3' HG23 ' D' ' 85' ' ' VAL . 27.4 tpp -92.0 129.36 37.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.377 -171.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 14' ' ' LYS . . . . . 0.481 ' HD2' ' N ' ' D' ' 14' ' ' LYS . 0.3 OUTLIER -95.69 140.69 22.44 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.806 179.418 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . 0.619 ' HB3' ' H ' ' D' ' 83' ' ' ALA . 9.5 Cg_endo -53.57 121.81 10.17 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 123.609 2.873 . . . . 0.0 113.411 -175.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . 0.644 ' HA ' ' O ' ' D' ' 79' ' ' THR . 31.4 mt-10 61.44 47.01 7.06 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.956 177.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 17' ' ' ARG . . . . . 0.519 ' HA ' ' NE ' ' D' ' 17' ' ' ARG . 1.1 tpm_? -122.29 137.28 54.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.056 173.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . 0.667 ' HA ' ' HB3' ' D' ' 78' ' ' TYR . 88.4 mttt -108.77 121.48 45.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.723 0.297 . . . . 0.0 111.695 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 19' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -111.14 103.65 12.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.283 176.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' D' ' 76' ' ' MET . 44.9 t -90.48 99.49 12.51 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 172.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 21' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -120.25 148.21 43.99 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.105 -168.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 19.3 m -93.48 141.24 28.69 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.478 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . 0.408 ' HB ' ' HA ' ' D' ' 71' ' ' LYS . 67.9 mt -89.93 117.04 32.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.082 0.468 . . . . 0.0 111.227 -173.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . 0.523 HD12 ' N ' ' D' ' 25' ' ' LYS . 1.4 pp -79.55 -27.61 12.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.782 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . 0.531 ' HE3' ' HB3' ' D' ' 91' ' ' LEU . 31.7 ttpt -155.31 136.18 13.64 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 26' ' ' SER . . . . . . . . . . . . . 39.3 m -58.31 130.06 44.93 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.68 0.613 . . . . 0.0 110.134 -178.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 27' ' ' PHE . . . . . 0.623 ' HB3' HD23 ' D' ' 91' ' ' LEU . 9.9 p90 -144.28 161.86 37.86 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -172.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 28' ' ' HIS . . . . . 0.595 ' HA ' ' O ' ' D' ' 67' ' ' LEU . 16.0 t60 -114.74 123.92 50.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.173 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 29' ' ' ILE . . . . . 0.569 ' HB ' ' HB2' ' D' ' 67' ' ' LEU . 37.7 mt -92.7 136.18 25.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 170.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . 0.594 ' HB3' ' NE2' ' D' ' 28' ' ' HIS . 65.9 p -122.96 -20.23 5.86 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -170.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 31' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' D' ' 87' ' ' LEU . . . -154.78 146.22 14.04 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 119.425 -1.369 . . . . 0.0 113.409 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.504 HG23 ' HG ' ' D' ' 87' ' ' LEU . 14.2 p -139.95 126.8 23.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 170.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . 0.404 ' HA ' HG21 ' D' ' 56' ' ' VAL . . . -148.87 158.14 43.94 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.8 -0.562 . . . . 0.0 111.654 -174.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 34' ' ' LEU . . . . . 0.584 ' HB3' HG12 ' D' ' 85' ' ' VAL . 4.0 pp -118.89 139.24 51.96 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.682 0.753 . . . . 0.0 111.431 178.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -108.21 -51.25 2.92 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.333 173.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 36' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -102.36 128.02 49.12 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 170.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . 0.496 ' HA3' ' CB ' ' D' ' 83' ' ' ALA . . . 145.1 162.41 9.56 Favored Glycine 0 N--CA 1.438 -1.167 0 C-N-CA 119.867 -1.159 . . . . 0.0 113.065 176.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 38' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -102.73 -46.66 4.65 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.609 0.242 . . . . 0.0 111.581 177.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -150.72 130.82 13.49 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.769 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . 0.479 ' HB2' ' HB3' ' D' ' 83' ' ' ALA . . . -130.79 113.0 13.56 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.492 0.663 . . . . 0.0 110.2 169.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' D' ' 79' ' ' THR . 4.5 mptp? -95.37 106.38 18.43 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 174.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.509 HD23 ' HB ' ' D' ' 53' ' ' VAL . 41.9 tp -78.88 113.96 17.41 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -176.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 43' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -114.79 135.95 53.62 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.336 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.594 ' HB3' HG22 ' D' ' 53' ' ' VAL . 4.9 tp -115.82 116.07 27.37 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.444 176.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 45' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' D' ' 49' ' ' GLN . . . -103.28 103.68 13.73 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.45 ' HB2' HD11 ' D' ' 44' ' ' LEU . . . -130.55 140.83 50.47 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.052 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 47' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 58.1 32.4 21.95 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.652 0.739 . . . . 0.0 109.365 -175.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 62.4 mttp 57.44 37.04 27.7 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 114.854 -1.067 . . . . 0.0 111.547 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . 0.515 ' O ' ' HA ' ' D' ' 45' ' ' ALA . 6.6 tp-100 -127.69 131.78 49.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.573 176.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -87.42 112.35 22.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.383 -177.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -108.46 131.44 54.8 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.743 177.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -78.84 100.36 3.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 169.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 53' ' ' VAL . . . . . 0.594 HG22 ' HB3' ' D' ' 44' ' ' LEU . 0.9 OUTLIER -72.34 -51.49 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.988 -174.174 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 54' ' ' ALA . . . . . 0.58 ' HA ' ' OE1' ' C' ' 62' ' ' GLN . . . -154.46 132.38 11.6 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.538 -177.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 7.6 t -101.89 102.47 13.04 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 174.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 56' ' ' VAL . . . . . 0.432 HG13 ' HB3' ' D' ' 40' ' ' ALA . 7.1 p -116.69 109.76 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-O 122.039 0.923 . . . . 0.0 110.052 -176.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 57' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' D' ' 61' ' ' PRO . 67.3 p -122.64 -176.99 3.52 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.347 -176.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 58' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -65.03 -20.68 66.61 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.541 169.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.76 -40.84 27.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.265 0.555 . . . . 0.0 110.07 176.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 74.6 mt -118.73 77.64 14.87 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 172.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 61' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' D' ' 57' ' ' THR . 9.7 Cg_exo -71.7 0.88 6.35 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.159 2.573 . . . . 0.0 113.651 -168.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . 0.492 ' OE1' ' HA ' ' E' ' 54' ' ' ALA . 10.3 tt0 -160.09 114.77 2.28 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.274 -170.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.49 HG11 ' HB1' ' D' ' 54' ' ' ALA . 86.1 t -112.84 115.06 48.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.104 0.478 . . . . 0.0 111.236 177.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.87 115.92 28.34 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 171.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 65' ' ' LEU . . . . . 0.437 HD23 ' H ' ' D' ' 65' ' ' LEU . 0.7 OUTLIER -134.55 168.32 19.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.777 0.322 . . . . 0.0 111.092 -171.727 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 66' ' ' ASP . . . . . 0.545 ' HB3' ' HB2' ' C' ' 30' ' ' SER . 7.5 t0 -122.91 109.39 14.09 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.127 0.489 . . . . 0.0 110.365 -178.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.693 HD21 HD23 ' C' ' 88' ' ' LEU . 12.8 mt -124.0 138.9 54.39 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.712 176.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -138.57 114.61 10.13 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 173.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -109.16 163.07 13.68 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.315 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 70' ' ' SER . . . . . 0.577 ' OG ' ' HA ' ' C' ' 7' ' ' MET . 4.4 m -117.21 149.06 41.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.186 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 71' ' ' LYS . . . . . 0.408 ' HA ' ' HB ' ' D' ' 23' ' ' ILE . 0.0 OUTLIER -70.05 -6.14 31.63 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.72 -177.104 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.68 -28.62 46.37 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.319 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -101.12 171.31 7.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.757 0.313 . . . . 0.0 110.449 -176.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -137.31 136.49 38.03 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 75' ' ' ILE . . . . . 0.462 ' HB ' ' CD1' ' D' ' 44' ' ' LEU . 22.6 pt -133.03 158.36 43.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.014 0.435 . . . . 0.0 111.642 -169.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 76' ' ' MET . . . . . 0.412 ' HA ' ' HA ' ' D' ' 20' ' ' SER . 65.4 ttp -117.43 118.08 31.24 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.372 176.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 77' ' ' PHE . . . . . 0.479 ' CE1' ' HB2' ' D' ' 44' ' ' LEU . 0.4 OUTLIER -105.57 129.42 53.83 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.789 -177.812 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 78' ' ' TYR . . . . . 0.667 ' HB3' ' HA ' ' D' ' 18' ' ' LYS . 39.0 p90 -155.76 162.78 40.45 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.881 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 79' ' ' THR . . . . . 0.644 ' O ' ' HA ' ' D' ' 16' ' ' GLU . 12.6 p -125.22 143.87 50.74 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.116 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.35 149.61 26.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.097 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.87 -177.05 36.77 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -176.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 82' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -114.4 102.58 10.22 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.242 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . 0.619 ' H ' ' HB3' ' D' ' 15' ' ' PRO . . . -166.69 150.13 6.94 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.385 168.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 84' ' ' SER . . . . . . . . . . . . . 6.2 p -106.1 122.25 45.81 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.59 HG23 ' HB3' ' D' ' 13' ' ' MET . 13.4 m -121.65 144.19 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-O 121.203 0.525 . . . . 0.0 111.792 -172.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 86' ' ' SER . . . . . . . . . . . . . 43.6 m -105.1 122.79 46.63 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.322 175.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 87' ' ' LEU . . . . . 0.677 HD13 HD23 ' D' ' 11' ' ' LEU . 5.1 mp -95.22 143.97 26.2 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 170.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.684 HD23 HD21 ' E' ' 67' ' ' LEU . 0.9 OUTLIER -130.4 141.18 50.55 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.175 -178.686 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.58 -166.84 27.33 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.756 -177.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 90' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -147.05 133.51 19.69 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.437 0.637 . . . . 0.0 111.113 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . 0.623 HD23 ' HB3' ' D' ' 27' ' ' PHE . 15.1 mt -69.77 128.86 37.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.065 175.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . 0.408 ' CG ' ' HB2' ' C' ' 4' ' ' ALA . 12.4 t60 -81.84 108.2 15.18 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.07 0.462 . . . . 0.0 111.094 -173.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 93' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -108.12 -79.36 0.58 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 168.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' D' ' 3' ' ' GLY . 50.6 mm 62.09 100.14 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.318 176.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 95' ' ' ASP . . . . . 0.432 ' OD2' ' HB2' ' D' ' 5' ' ' MET . 27.8 m-20 -76.44 133.73 39.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.588 -178.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 23.3 t -91.09 86.97 6.38 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.25 -50.72 64.55 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.035 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 98' ' ' SER . . . . . . . . . . . . . 10.5 m . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.996 177.541 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' E' E ' 1' ' ' PHE . . . . . . . . . . . . . 51.6 p90 . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 120.89 0.376 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' E' E ' 2' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -90.64 -29.38 17.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.828 176.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 3' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' E' ' 94' ' ' ILE . . . 77.45 -60.84 3.61 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.461 177.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 4' ' ' ALA . . . . . 0.421 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . . . -82.19 71.82 9.25 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.153 0.501 . . . . 0.0 111.014 -178.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 5' ' ' MET . . . . . 0.42 ' HB2' ' OD2' ' E' ' 95' ' ' ASP . 13.0 tpt -82.16 -4.02 56.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.221 173.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.3 107.28 0.87 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.058 177.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 7' ' ' MET . . . . . 0.535 ' HA ' ' OG ' ' A' ' 70' ' ' SER . 45.2 mtt -94.36 155.07 17.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.653 0.739 . . . . 0.0 112.626 -170.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 8' ' ' PHE . . . . . 0.469 ' CE1' HD21 ' A' ' 44' ' ' LEU . 55.6 t80 -59.64 142.7 52.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.291 -1.322 . . . . 0.0 112.293 -176.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 9' ' ' TRP . . . . . 0.528 ' CH2' ' HB2' ' E' ' 11' ' ' LEU . 88.6 t90 -134.21 142.04 47.25 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.84 140.06 8.4 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.162 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . 0.687 HD23 HD13 ' E' ' 87' ' ' LEU . 56.8 tp -128.36 108.32 10.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.966 0.412 . . . . 0.0 110.101 178.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 12' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -86.45 101.34 13.06 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 175.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 13' ' ' MET . . . . . 0.588 ' HB3' HG23 ' E' ' 85' ' ' VAL . 27.3 tpp -91.99 129.41 37.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.419 -171.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 14' ' ' LYS . . . . . 0.474 ' N ' ' HD2' ' E' ' 14' ' ' LYS . 0.3 OUTLIER -95.68 140.69 22.44 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.843 179.394 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . 0.603 ' HB3' ' H ' ' E' ' 83' ' ' ALA . 9.5 Cg_endo -53.63 121.79 10.14 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 123.508 2.805 . . . . 0.0 113.514 -175.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 16' ' ' GLU . . . . . 0.648 ' HA ' ' O ' ' E' ' 79' ' ' THR . 31.3 mt-10 61.54 47.06 6.84 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.887 177.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 17' ' ' ARG . . . . . 0.52 ' HA ' ' NE ' ' E' ' 17' ' ' ARG . 1.2 tpm_? -122.41 137.34 54.9 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 173.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . 0.661 ' HA ' ' HB3' ' E' ' 78' ' ' TYR . 88.6 mttt -108.83 121.51 45.24 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -111.11 103.64 12.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.213 176.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 20' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' E' ' 76' ' ' MET . 44.5 t -90.46 99.39 12.43 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 172.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 21' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -120.22 148.11 44.09 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.523 0.678 . . . . 0.0 112.093 -168.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 19.8 m -93.46 141.22 28.7 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.469 176.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 23' ' ' ILE . . . . . . . . . . . . . 67.8 mt -89.84 117.08 32.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.044 0.449 . . . . 0.0 111.284 -173.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . 0.522 HD12 ' N ' ' E' ' 25' ' ' LYS . 1.4 pp -79.67 -27.54 12.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.721 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . 0.522 ' N ' HD12 ' E' ' 24' ' ' ILE . 31.7 ttpt -155.37 136.14 13.55 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 26' ' ' SER . . . . . 0.401 ' HB2' ' HB3' ' D' ' 4' ' ' ALA . 39.6 m -58.3 130.09 45.07 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.654 0.596 . . . . 0.0 110.08 -178.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 27' ' ' PHE . . . . . 0.635 ' HB3' HD23 ' E' ' 91' ' ' LEU . 10.0 p90 -144.24 161.92 37.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -172.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 28' ' ' HIS . . . . . 0.603 ' HA ' ' O ' ' E' ' 67' ' ' LEU . 16.0 t60 -114.85 123.87 50.27 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.172 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 29' ' ' ILE . . . . . 0.575 ' HB ' ' HB2' ' E' ' 67' ' ' LEU . 38.1 mt -92.67 136.25 25.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 170.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . 0.58 ' HB3' ' NE2' ' E' ' 28' ' ' HIS . 65.5 p -122.94 -20.26 5.86 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -170.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 31' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' E' ' 87' ' ' LEU . . . -154.81 146.23 14.06 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 119.36 -1.4 . . . . 0.0 113.365 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.495 HG23 ' HG ' ' E' ' 87' ' ' LEU . 14.4 p -140.02 126.84 23.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 170.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . 0.417 ' HA ' HG21 ' E' ' 56' ' ' VAL . . . -148.84 158.17 43.97 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 121.861 -0.524 . . . . 0.0 111.649 -174.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 34' ' ' LEU . . . . . 0.592 ' HB3' HG12 ' E' ' 85' ' ' VAL . 4.0 pp -119.0 139.21 52.07 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.713 0.768 . . . . 0.0 111.445 178.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -108.06 -51.29 2.92 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.392 173.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 36' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -102.38 127.94 49.17 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 170.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . 0.506 ' HA3' ' CB ' ' E' ' 83' ' ' ALA . . . 145.17 162.49 9.62 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 119.916 -1.135 . . . . 0.0 113.04 176.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 38' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -102.8 -46.65 4.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.536 0.208 . . . . 0.0 111.539 177.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -150.75 130.84 13.48 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.712 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' E' ' 83' ' ' ALA . . . -130.8 113.06 13.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.555 0.693 . . . . 0.0 110.175 168.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 41' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' E' ' 79' ' ' THR . 4.5 mptp? -95.42 106.43 18.49 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 174.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.514 HD23 ' HB ' ' E' ' 53' ' ' VAL . 41.7 tp -78.82 114.04 17.41 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -176.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 43' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -114.93 135.93 53.67 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.24 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 44' ' ' LEU . . . . . 0.602 ' HB3' HG22 ' E' ' 53' ' ' VAL . 5.0 tp -115.75 116.01 27.32 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.575 176.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 45' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' E' ' 49' ' ' GLN . . . -103.27 103.68 13.73 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 176.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . 0.442 ' HB2' HD11 ' E' ' 44' ' ' LEU . . . -130.54 140.74 50.48 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.168 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 47' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 58.2 32.33 21.89 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.61 0.719 . . . . 0.0 109.368 -175.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 62.4 mttp 57.43 37.1 27.73 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.479 -178.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 49' ' ' GLN . . . . . 0.52 ' O ' ' HA ' ' E' ' 45' ' ' ALA . 6.6 tp-100 -127.65 131.74 49.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.612 176.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 50' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -87.37 112.24 21.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.43 -177.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -108.36 131.35 54.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.776 177.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 tp -78.8 100.42 3.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 169.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . 0.602 HG22 ' HB3' ' E' ' 44' ' ' LEU . 0.9 OUTLIER -72.35 -51.49 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.998 -174.243 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' E' E ' 54' ' ' ALA . . . . . 0.492 ' HA ' ' OE1' ' D' ' 62' ' ' GLN . . . -154.51 132.53 11.67 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.513 -177.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 55' ' ' THR . . . . . . . . . . . . . 7.6 t -101.97 102.43 12.96 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . 0.428 HG13 ' HB3' ' E' ' 40' ' ' ALA . 7.1 p -116.62 109.72 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-O 122.048 0.928 . . . . 0.0 110.025 -176.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 57' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' E' ' 61' ' ' PRO . 68.3 p -122.62 -177.06 3.53 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.342 -176.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -64.98 -20.69 66.62 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.469 169.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.85 -40.82 27.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.313 0.577 . . . . 0.0 110.008 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 60' ' ' ILE . . . . . . . . . . . . . 74.4 mt -118.66 77.6 14.61 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 172.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 61' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' E' ' 57' ' ' THR . 9.6 Cg_exo -71.69 0.89 6.33 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.095 2.53 . . . . 0.0 113.727 -168.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 62' ' ' GLN . . . . . 0.512 ' OE1' ' HA ' ' A' ' 54' ' ' ALA . 10.3 tt0 -160.11 114.66 2.26 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.792 0.329 . . . . 0.0 111.312 -170.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . 0.484 HG11 ' HB1' ' E' ' 54' ' ' ALA . 86.1 t -112.74 115.18 49.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.065 0.459 . . . . 0.0 111.199 177.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.11 115.99 28.36 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 171.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.429 HD23 ' H ' ' E' ' 65' ' ' LEU . 0.7 OUTLIER -134.55 168.22 19.36 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.058 -171.612 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' E' E ' 66' ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' D' ' 30' ' ' SER . 7.5 t0 -122.84 109.43 14.17 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.144 0.497 . . . . 0.0 110.417 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 67' ' ' LEU . . . . . 0.684 HD21 HD23 ' D' ' 88' ' ' LEU . 12.8 mt -123.99 138.91 54.39 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.7 176.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -138.57 114.55 10.08 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 173.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -109.1 163.0 13.73 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.519 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 70' ' ' SER . . . . . 0.559 ' OG ' ' HA ' ' D' ' 7' ' ' MET . 4.5 m -117.09 149.0 41.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.185 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.99 -6.05 30.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.698 -177.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.87 -28.4 46.38 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.344 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -101.24 171.28 7.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.704 0.288 . . . . 0.0 110.364 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 74' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -137.32 136.53 38.06 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 75' ' ' ILE . . . . . 0.45 ' HB ' ' CD1' ' E' ' 44' ' ' LEU . 22.4 pt -133.04 158.37 43.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.947 0.403 . . . . 0.0 111.66 -169.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 76' ' ' MET . . . . . 0.432 ' HA ' ' HA ' ' E' ' 20' ' ' SER . 65.3 ttp -117.49 118.11 31.29 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.055 0.455 . . . . 0.0 110.339 176.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 77' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' E' ' 44' ' ' LEU . 0.4 OUTLIER -105.59 129.47 53.84 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.693 -177.747 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' E' E ' 78' ' ' TYR . . . . . 0.661 ' HB3' ' HA ' ' E' ' 18' ' ' LYS . 38.8 p90 -155.76 162.68 40.47 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.838 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 79' ' ' THR . . . . . 0.648 ' O ' ' HA ' ' E' ' 16' ' ' GLU . 12.7 p -125.14 143.82 50.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.209 178.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.37 149.68 26.75 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.095 173.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.82 -176.91 36.73 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -176.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 82' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -114.45 102.76 10.38 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.14 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 83' ' ' ALA . . . . . 0.603 ' H ' ' HB3' ' E' ' 15' ' ' PRO . . . -166.78 150.05 6.79 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.477 168.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 6.2 p -106.14 122.24 45.8 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 85' ' ' VAL . . . . . 0.592 HG12 ' HB3' ' E' ' 34' ' ' LEU . 13.7 m -121.57 144.19 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 CA-C-O 121.161 0.505 . . . . 0.0 111.831 -172.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 86' ' ' SER . . . . . . . . . . . . . 44.3 m -105.23 122.84 46.77 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.274 175.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 87' ' ' LEU . . . . . 0.687 HD13 HD23 ' E' ' 11' ' ' LEU . 5.1 mp -95.16 143.9 26.21 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 170.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . 0.683 HD23 HD21 ' A' ' 67' ' ' LEU . 0.9 OUTLIER -130.42 141.25 50.55 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.134 -178.664 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' E' E ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.67 -166.88 27.49 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.678 -177.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 90' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -147.05 133.59 19.78 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.469 0.652 . . . . 0.0 111.066 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 91' ' ' LEU . . . . . 0.635 HD23 ' HB3' ' E' ' 27' ' ' PHE . 15.1 mt -69.74 128.77 37.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.117 175.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 92' ' ' HIS . . . . . 0.426 ' CG ' ' HB2' ' D' ' 4' ' ' ALA . 12.3 t60 -81.83 108.28 15.23 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.075 0.465 . . . . 0.0 111.105 -173.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -108.2 -79.45 0.58 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 168.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 94' ' ' ILE . . . . . 0.503 ' HA ' ' O ' ' E' ' 3' ' ' GLY . 50.5 mm 62.18 99.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 O-C-N 123.793 0.683 . . . . 0.0 111.385 176.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 95' ' ' ASP . . . . . 0.42 ' OD2' ' HB2' ' E' ' 5' ' ' MET . 28.7 m-20 -76.33 133.67 39.93 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.681 -178.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 96' ' ' SER . . . . . . . . . . . . . 23.3 t -91.11 87.05 6.4 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 176.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.34 -50.61 65.75 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.038 -179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 98' ' ' SER . . . . . . . . . . . . . 10.8 m . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.085 -0.959 . . . . 0.0 110.976 177.497 . . . . . . . . 0 0 . 1 stop_ save_